Name;Mutation;Mutation type;PID;Type
ESSENTIAL HYPERTENSION;ANKFN1;Gene;PA447288;Disease
HYDROCHLOROTHIAZIDE;ANKFN1;Gene;PA449899;Chemical
IMATINIB;NQO1;Gene;PA10804;Chemical
FLUOROURACIL;NQO1;Gene;PA128406956;Chemical
OXALIPLATIN;NQO1;Gene;PA131285527;Chemical
GASTROINTESTINAL STROMAL TUMORS;NQO1;Gene;PA151958383;Disease
PLATINUM COMPOUNDS;NQO1;Gene;PA164713176;Chemical
BREAST NEOPLASMS;NQO1;Gene;PA443560;Disease
HEMORRHAGE;NQO1;Gene;PA444417;Disease
LEUKEMIA;NQO1;Gene;PA444750;Disease
LUNG NEOPLASMS;NQO1;Gene;PA444818;Disease
METASTATIC NEOPLASM;NQO1;Gene;PA445058;Disease
NEOPLASMS;NQO1;Gene;PA445062;Disease
STOMACH NEOPLASMS;NQO1;Gene;PA445742;Disease
THROMBOTIC DISEASE;NQO1;Gene;PA445850;Disease
CISPLATIN;NQO1;Gene;PA449014;Chemical
CYCLOPHOSPHAMIDE;NQO1;Gene;PA449165;Chemical
DICUMAROL;NQO1;Gene;PA449298;Chemical
DOXORUBICIN;NQO1;Gene;PA449412;Chemical
EPIRUBICIN;NQO1;Gene;PA449476;Chemical
WARFARIN;NQO1;Gene;PA451906;Chemical
BENZENE;NQO1;Gene;PA451991;Chemical
EMAPALUMAB;STXBP2;Gene;PA166182763;Chemical
ALDH1A1;chloroacetaldehyde;Chemical;PA24692;Gene
MURAGLITAZAR;REN;Gene;PA162356187;Chemical
DIABETES MELLITUS;REN;Gene;PA443886;Disease
EDEMA;REN;Gene;PA443994;Disease
HYPERLIPIDEMIAS;REN;Gene;PA444528;Disease
VITAMIN D AND ANALOGUES;REN;Gene;PA451899;Chemical
CYP2C9;Rheumatic Heart Disease;Disease;PA126;Gene
CYP2C9*1;Rheumatic Heart Disease;Disease;PA165816542;Haplotype
CYP2C9*2;Rheumatic Heart Disease;Disease;PA165816543;Haplotype
CYP2C9*3;Rheumatic Heart Disease;Disease;PA165816544;Haplotype
ARIPIPRAZOLE;CYP2D6*21;Haplotype;PA10026;Chemical
RECURRENCE FREE SURVIVAL;CYP2D6*21;Haplotype;PA166127658;Disease
ARRHYTHMIAS, CARDIAC;CYP2D6*21;Haplotype;PA443421;Disease
BREAST NEOPLASMS;CYP2D6*21;Haplotype;PA443560;Disease
RECURRENCE;CYP2D6*21;Haplotype;PA445506;Disease
DEXTROMETHORPHAN;CYP2D6*21;Haplotype;PA449273;Chemical
FLECAINIDE;CYP2D6*21;Haplotype;PA449646;Chemical
TAMOXIFEN;CYP2D6*21;Haplotype;PA451581;Chemical
DEBRISOQUINE;CYP2D6*21;Haplotype;PA452616;Chemical
METABOLIC SYNDROME;INSIG2;Gene;PA162370415;Disease
SCHIZOPHRENIA;INSIG2;Gene;PA447216;Disease
ANTIPSYCHOTICS;INSIG2;Gene;PA452233;Chemical
OXYCODONE;rs6848893;Variant;PA450741;Chemical
CONJUGATED ESTROGENS;SLCO1B1*12;Haplotype;PA164754789;Chemical
NEONATAL ABSTINENCE SYNDROME;rs351776;Variant;PA165108809;Disease
BUPRENORPHINE;rs351776;Variant;PA448685;Chemical
METHADONE;rs351776;Variant;PA450401;Chemical
HAND-FOOT SYNDROME;CDA;Gene;PA166114377;Disease
DIFLUORODEOXYURIDINE;CDA;Gene;PA166131569;Chemical
NON-SMALL CELL LUNG CARCINOMA;CDA;Gene;PA443622;Disease
DRUG TOXICITY;CDA;Gene;PA443937;Disease
HYPERBILIRUBINEMIA;CDA;Gene;PA444511;Disease
LEUKEMIA;CDA;Gene;PA444750;Disease
LEUKEMIA, MYELOID, ACUTE;CDA;Gene;PA444760;Disease
LEUKEMIA, MYELOID;CDA;Gene;PA444761;Disease
LYMPHOMA;CDA;Gene;PA444840;Disease
MESOTHELIOMA;CDA;Gene;PA444937;Disease
NAUSEA;CDA;Gene;PA445048;Disease
NEOPLASMS;CDA;Gene;PA445062;Disease
NEUTROPENIA;CDA;Gene;PA445113;Disease
PANCREATIC NEOPLASMS;CDA;Gene;PA445218;Disease
LYMPHOMA, T-CELL;CDA;Gene;PA446309;Disease
CAPECITABINE;CDA;Gene;PA448771;Chemical
CYTARABINE;CDA;Gene;PA449177;Chemical
GEMCITABINE;CDA;Gene;PA449748;Chemical
PACLITAXEL;CDA;Gene;PA450761;Chemical
AZACITIDINE;CDA;Gene;PA451996;Chemical
PAIN;rs4818;Variant;PA445208;Disease
SCHIZOPHRENIA;rs4818;Variant;PA447216;Disease
QUETIAPINE;rs4818;Variant;PA451201;Chemical
RISPERIDONE;rs4818;Variant;PA451257;Chemical
OPIOIDS;rs4818;Variant;PA452618;Chemical
NEOPLASMS;rs11045585;Variant;PA445062;Disease
DOCETAXEL;rs11045585;Variant;PA449383;Chemical
BEVACIZUMAB;rs2228014;Variant;PA130232992;Chemical
COLORECTAL NEOPLASMS;rs2228014;Variant;PA446108;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;rs367398;Variant;PA166120929;Disease
ALLOPURINOL;rs367398;Variant;PA448320;Chemical
CYB5R3;sodium nitrite;Chemical;PA27331;Gene
G6PD;sodium nitrite;Chemical;PA28469;Gene
MAJOR DEPRESSIVE DISORDER;rs28401781;Variant;PA447321;Disease
CITALOPRAM;rs28401781;Variant;PA449015;Chemical
FLUOXETINE;rs28401781;Variant;PA449673;Chemical
PAROXETINE;rs28401781;Variant;PA450801;Chemical
SERTRALINE;rs28401781;Variant;PA451333;Chemical
ALCOHOL ABUSE;CRHBP;Gene;PA443309;Disease
ETHANOL;CRHBP;Gene;PA448073;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;CSRP3;Gene;PA164713366;Chemical
RHEUMATOID ARTHRITIS;CSRP3;Gene;PA443434;Disease
PROSTATIC NEOPLASMS;CHST3;Gene;PA445425;Disease
DOCETAXEL;CHST3;Gene;PA449383;Chemical
THALIDOMIDE;CHST3;Gene;PA451644;Chemical
ARAF;MRAS;Gene;PA24928;Gene
BRAF;MRAS;Gene;PA25408;Gene
MAP3K1;MRAS;Gene;PA30592;Gene
RAF1;MRAS;Gene;PA34183;Gene
EGFR;MRAS;Gene;PA7360;Gene
ABCB1;pentazocine;Chemical;PA267;Gene
DBH;Memory impairment;Disease;PA136;Gene
RS1611114;Memory impairment;Disease;PA166233886;Variant
BEVACIZUMAB;rs1061170;Variant;PA130232992;Chemical
MACULAR DEGENERATION;rs1061170;Variant;PA134850558;Disease
RANIBIZUMAB;rs1061170;Variant;PA164746012;Chemical
PHOTODYNAMIC THERAPY;rs1061170;Variant;PA165984462;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs780668;Variant;PA443622;Disease
GEMCITABINE;rs780668;Variant;PA449748;Chemical
HYPERTENSION;rs200148;Variant;PA444552;Disease
AMLODIPINE;rs200148;Variant;PA448388;Chemical
CHLORTHALIDONE;rs200148;Variant;PA448970;Chemical
LISINOPRIL;rs200148;Variant;PA450242;Chemical
OPIOID-RELATED DISORDERS;rs11782370;Variant;PA445043;Disease
BUPRENORPHINE;rs11782370;Variant;PA448685;Chemical
DRUGS USED IN NICOTINE DEPENDENCE;CHRNA3;Gene;PA164712720;Chemical
OPIUM ALKALOIDS AND DERIVATIVES;CHRNA3;Gene;PA164712950;Chemical
ECULIZUMAB;CHRNA3;Gene;PA164776637;Chemical
PREGNANCY;CHRNA3;Gene;PA166048714;Disease
COTININE;CHRNA3;Gene;PA166114414;Chemical
EFGARTIGIMOD ALFA;CHRNA3;Gene;PA166268781;Chemical
RAVULIZUMAB;CHRNA3;Gene;PA166277861;Chemical
ROZANOLIXIZUMAB;CHRNA3;Gene;PA166313325;Chemical
ZILUCOPLAN;CHRNA3;Gene;PA166328901;Chemical
ALCOHOL ABUSE;CHRNA3;Gene;PA443309;Disease
PAIN;CHRNA3;Gene;PA445208;Disease
TOBACCO USE DISORDER;CHRNA3;Gene;PA445876;Disease
COCAINE DEPENDENCE;CHRNA3;Gene;PA446878;Disease
ETHANOL;CHRNA3;Gene;PA448073;Chemical
COCAINE;CHRNA3;Gene;PA449072;Chemical
NICOTINE;CHRNA3;Gene;PA450626;Chemical
BIPOLAR DISORDER;rs6438552;Variant;PA447199;Disease
LITHIUM;rs6438552;Variant;PA450243;Chemical
HYPERBILIRUBINEMIA;rs12119882;Variant;PA444511;Disease
NEOPLASMS;rs12119882;Variant;PA445062;Disease
CAPECITABINE;rs12119882;Variant;PA448771;Chemical
F5;estrogens;Chemical;PA159;Gene
SULT1A1;estrogens;Chemical;PA343;Gene
DIABETES MELLITUS, TYPE 2;rs72552763;Variant;PA443890;Disease
INFECTION;rs72552763;Variant;PA444614;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;rs72552763;Variant;PA446155;Disease
MERCAPTOPURINE;rs72552763;Variant;PA450379;Chemical
METFORMIN;rs72552763;Variant;PA450395;Chemical
MORPHINE;rs72552763;Variant;PA450550;Chemical
PROGUANIL;rs72552763;Variant;PA451124;Chemical
RANITIDINE;rs72552763;Variant;PA451224;Chemical
GEMCITABINE;rs73748206;Variant;PA449748;Chemical
PEGINTERFERON ALFA-2A;rs14158;Variant;PA164749390;Chemical
PEGINTERFERON ALFA-2B;rs14158;Variant;PA164784024;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;rs14158;Variant;PA446863;Disease
HIV INFECTIOUS DISEASE;rs14158;Variant;PA447230;Disease
RIBAVIRIN;rs14158;Variant;PA451241;Chemical
FLUOROURACIL;TPMT*1;Haplotype;PA128406956;Chemical
TRANSPLANTATION;TPMT*1;Haplotype;PA134850491;Disease
OTOTOXICITY;TPMT*1;Haplotype;PA162263534;Disease
KIDNEY TRANSPLANTATION;TPMT*1;Haplotype;PA165817016;Disease
MYELOSUPPRESSION;TPMT*1;Haplotype;PA165817398;Disease
TRANSPLANT REJECTION;TPMT*1;Haplotype;PA166114454;Disease
HEART TRANSPLANTATION;TPMT*1;Haplotype;PA166114458;Disease
EVENT-FREE SURVIVAL;TPMT*1;Haplotype;PA166123366;Disease
DISCONTINUATION;TPMT*1;Haplotype;PA166123507;Disease
DOSE REDUCTION;TPMT*1;Haplotype;PA166159953;Disease
TPMT;TPMT*1;Haplotype;PA356;Gene
ARTHRITIS, RHEUMATOID;TPMT*1;Haplotype;PA443434;Disease
CROHN DISEASE;TPMT*1;Haplotype;PA443815;Disease
DIZZINESS;TPMT*1;Haplotype;PA443928;Disease
DRUG TOXICITY;TPMT*1;Haplotype;PA443937;Disease
FATIGUE;TPMT*1;Haplotype;PA444153;Disease
HEMATOLOGIC DISEASES;TPMT*1;Haplotype;PA444395;Disease
INFECTION;TPMT*1;Haplotype;PA444614;Disease
INFLAMMATION;TPMT*1;Haplotype;PA444620;Disease
LEUKEMIA;TPMT*1;Haplotype;PA444750;Disease
LEUKEMIA, MYELOID, ACUTE;TPMT*1;Haplotype;PA444760;Disease
LEUKOPENIA;TPMT*1;Haplotype;PA444773;Disease
LUPUS ERYTHEMATOSUS, SYSTEMIC;TPMT*1;Haplotype;PA444822;Disease
NEOPLASMS;TPMT*1;Haplotype;PA445062;Disease
NEUTROPENIA;TPMT*1;Haplotype;PA445113;Disease
PANCYTOPENIA;TPMT*1;Haplotype;PA445221;Disease
RHEUMATIC DISEASES;TPMT*1;Haplotype;PA445555;Disease
SKIN NEOPLASMS;TPMT*1;Haplotype;PA445683;Disease
STOMATITIS;TPMT*1;Haplotype;PA445746;Disease
THROMBOCYTOPENIA;TPMT*1;Haplotype;PA445846;Disease
INFLAMMATORY BOWEL DISEASES;TPMT*1;Haplotype;PA446116;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;TPMT*1;Haplotype;PA446155;Disease
HEPATITIS, AUTOIMMUNE;TPMT*1;Haplotype;PA446861;Disease
LIVER TRANSPLANTATION;TPMT*1;Haplotype;PA447247;Disease
AZATHIOPRINE;TPMT*1;Haplotype;PA448515;Chemical
CISPLATIN;TPMT*1;Haplotype;PA449014;Chemical
CYCLOSPORINE;TPMT*1;Haplotype;PA449167;Chemical
MERCAPTOPURINE;TPMT*1;Haplotype;PA450379;Chemical
METHOTREXATE;TPMT*1;Haplotype;PA450428;Chemical
OLANZAPINE;TPMT*1;Haplotype;PA450688;Chemical
PREDNISONE;TPMT*1;Haplotype;PA451100;Chemical
THIOGUANINE;TPMT*1;Haplotype;PA451663;Chemical
PURINE ANALOGUES;TPMT*1;Haplotype;PA452634;Chemical
COTININE;rs553202;Variant;PA166114414;Chemical
ETHANOL;rs553202;Variant;PA448073;Chemical
NICOTINE;rs553202;Variant;PA450626;Chemical
ABCC2;Arrhythmias, Cardiac;Disease;PA116;Gene
CYP2D6;Arrhythmias, Cardiac;Disease;PA128;Gene
CYP2D6*1;Arrhythmias, Cardiac;Disease;PA165816576;Haplotype
CYP2D6*2;Arrhythmias, Cardiac;Disease;PA165816577;Haplotype
CYP2D6*4;Arrhythmias, Cardiac;Disease;PA165816579;Haplotype
CYP2D6*10;Arrhythmias, Cardiac;Disease;PA165816582;Haplotype
CYP2D6*5;Arrhythmias, Cardiac;Disease;PA165948092;Haplotype
CYP2D6*21;Arrhythmias, Cardiac;Disease;PA165988484;Haplotype
CYP2D6*36;Arrhythmias, Cardiac;Disease;PA165988488;Haplotype
RS17222723;Arrhythmias, Cardiac;Disease;PA166154163;Variant
RS45511401;Arrhythmias, Cardiac;Disease;PA166155130;Variant
RS3842;Arrhythmias, Cardiac;Disease;PA166157239;Variant
ABCC1;Arrhythmias, Cardiac;Disease;PA244;Gene
ABCB1;Arrhythmias, Cardiac;Disease;PA267;Gene
CYP2C9*1;VKORC1;Gene;PA165816542;Haplotype
CYP2C9*2;VKORC1;Gene;PA165816543;Haplotype
CYP2C9*3;VKORC1;Gene;PA165816544;Haplotype
CYP2C9*5;VKORC1;Gene;PA165816546;Haplotype
CYP2C9*6;VKORC1;Gene;PA165816547;Haplotype
CYP2C9*8;VKORC1;Gene;PA165816549;Haplotype
CYP2C9*11;VKORC1;Gene;PA165816552;Haplotype
FLUINDIONE;VKORC1;Gene;PA165980614;Chemical
OVER-ANTICOAGULATION;VKORC1;Gene;PA166123298;Disease
TIME IN THERAPEUTIC RANGE;VKORC1;Gene;PA166129531;Disease
TIME TO THERAPEUTIC INR;VKORC1;Gene;PA166129532;Disease
TIME ABOVE THERAPEUTIC RANGE;VKORC1;Gene;PA166129534;Disease
RS12777823;VKORC1;Gene;PA166154157;Variant
RS9923231;VKORC1;Gene;PA166155091;Variant
RS9934438;VKORC1;Gene;PA166155096;Variant
RS2108622;VKORC1;Gene;PA166155381;Variant
ATRIAL FIBRILLATION;VKORC1;Gene;PA443459;Disease
HEART DISEASES;VKORC1;Gene;PA444368;Disease
HEMORRHAGE;VKORC1;Gene;PA444417;Disease
THROMBOEMBOLISM;VKORC1;Gene;PA445848;Disease
VASCULAR DISEASES;VKORC1;Gene;PA446021;Disease
COAGULATION PROTEIN DISORDERS;VKORC1;Gene;PA446900;Disease
PHENPROCOUMON;VKORC1;Gene;PA450921;Chemical
WARFARIN;VKORC1;Gene;PA451906;Chemical
ACENOCOUMAROL;VKORC1;Gene;PA452632;Chemical
DULOXETINE;NCAM1;Gene;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;NCAM1;Gene;PA447321;Disease
DRUG-INDUCED LIVER INJURY;IRF6;Gene;PA166119041;Disease
MULTIPLE SCLEROSIS;IRF6;Gene;PA444987;Disease
INTERFERON BETA-1A;IRF6;Gene;PA450037;Chemical
INTERFERON BETA-1B;IRF6;Gene;PA450039;Chemical
CYP2C9;time above therapeutic range;Disease;PA126;Gene
VKORC1;time above therapeutic range;Disease;PA133787052;Gene
CYP2C9*1;time above therapeutic range;Disease;PA165816542;Haplotype
CYP2C9*2;time above therapeutic range;Disease;PA165816543;Haplotype
CYP2C9*3;time above therapeutic range;Disease;PA165816544;Haplotype
RS9923231;time above therapeutic range;Disease;PA166155091;Variant
COMT;paroxetine;Chemical;PA117;Gene
CYP2B6;paroxetine;Chemical;PA123;Gene
CYP2C19;paroxetine;Chemical;PA124;Gene
CYP2C9;paroxetine;Chemical;PA126;Gene
CYP2D6;paroxetine;Chemical;PA128;Gene
CYP3A4;paroxetine;Chemical;PA130;Gene
CYP3A5;paroxetine;Chemical;PA131;Gene
RPP30;paroxetine;Chemical;PA134876345;Gene
REEP5;paroxetine;Chemical;PA134882361;Gene
MDGA2;paroxetine;Chemical;PA162395090;Gene
CYP2D6*1;paroxetine;Chemical;PA165816576;Haplotype
CYP2D6*2;paroxetine;Chemical;PA165816577;Haplotype
CYP2D6*3;paroxetine;Chemical;PA165816578;Haplotype
CYP2D6*4;paroxetine;Chemical;PA165816579;Haplotype
CYP2D6*6;paroxetine;Chemical;PA165816581;Haplotype
CYP2D6*10;paroxetine;Chemical;PA165816582;Haplotype
CYP2D6*41;paroxetine;Chemical;PA165816584;Haplotype
CYP2D6*5;paroxetine;Chemical;PA165948092;Haplotype
CYP2D6*9;paroxetine;Chemical;PA165948317;Haplotype
CYP2D6*1XN;paroxetine;Chemical;PA165988479;Haplotype
CYP2D6*2XN;paroxetine;Chemical;PA165988480;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);paroxetine;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);paroxetine;Chemical;PA166116466;Haplotype
SLC6A4 L ALLELE-RS25531T;paroxetine;Chemical;PA166117146;Haplotype
SLC6A4 L ALLELE-RS25531C;paroxetine;Chemical;PA166117147;Haplotype
RS6265;paroxetine;Chemical;PA166154259;Variant
RS1176744;paroxetine;Chemical;PA166154324;Variant
RS1800532;paroxetine;Chemical;PA166154340;Variant
RS11042725;paroxetine;Chemical;PA166154449;Variant
RS6311;paroxetine;Chemical;PA166154673;Variant
RS6313;paroxetine;Chemical;PA166154675;Variant
RS7997012;paroxetine;Chemical;PA166154726;Variant
RS1160351;paroxetine;Chemical;PA166154774;Variant
RS762551;paroxetine;Chemical;PA166154850;Variant
RS2470890;paroxetine;Chemical;PA166154893;Variant
RS2472304;paroxetine;Chemical;PA166154898;Variant
RS4646425;paroxetine;Chemical;PA166154909;Variant
RS4646427;paroxetine;Chemical;PA166154910;Variant
RS4680;paroxetine;Chemical;PA166156024;Variant
RS6280;paroxetine;Chemical;PA166156277;Variant
RS6295;paroxetine;Chemical;PA166156708;Variant
RS153549;paroxetine;Chemical;PA166156716;Variant
RS153560;paroxetine;Chemical;PA166156717;Variant
RS495794;paroxetine;Chemical;PA166156736;Variant
RS1364043;paroxetine;Chemical;PA166156760;Variant
RS2216711;paroxetine;Chemical;PA166156787;Variant
RS2973049;paroxetine;Chemical;PA166156811;Variant
RS10042486;paroxetine;Chemical;PA166156855;Variant
RS130058;paroxetine;Chemical;PA166156908;Variant
RS1360780;paroxetine;Chemical;PA166156983;Variant
RS2032582;paroxetine;Chemical;PA166157316;Variant
RS2032583;paroxetine;Chemical;PA166157317;Variant
RS2235015;paroxetine;Chemical;PA166157336;Variant
RS2235040;paroxetine;Chemical;PA166157338;Variant
RS2235067;paroxetine;Chemical;PA166157341;Variant
RS4148739;paroxetine;Chemical;PA166157386;Variant
RS4148740;paroxetine;Chemical;PA166157387;Variant
RS7787082;paroxetine;Chemical;PA166157428;Variant
RS10248420;paroxetine;Chemical;PA166157440;Variant
RS10280101;paroxetine;Chemical;PA166157445;Variant
RS11983225;paroxetine;Chemical;PA166157453;Variant
RS12720067;paroxetine;Chemical;PA166157458;Variant
RS28401781;paroxetine;Chemical;PA166157485;Variant
RS57098334;paroxetine;Chemical;PA166158926;Variant
CYP2D6*14;paroxetine;Chemical;PA166181185;Haplotype
RS7905446;paroxetine;Chemical;PA166182096;Variant
HTR1A;paroxetine;Chemical;PA192;Gene
HTR2A;paroxetine;Chemical;PA193;Gene
HTR2C;paroxetine;Chemical;PA194;Gene
ADM;paroxetine;Chemical;PA24580;Gene
ABCB1;paroxetine;Chemical;PA267;Gene
CYP1A2;paroxetine;Chemical;PA27093;Gene
DRD2;paroxetine;Chemical;PA27478;Gene
DRD3;paroxetine;Chemical;PA27479;Gene
FKBP5;paroxetine;Chemical;PA28162;Gene
GDNF;paroxetine;Chemical;PA28644;Gene
HTR1B;paroxetine;Chemical;PA29549;Gene
HTR3B;paroxetine;Chemical;PA29556;Gene
HTR7;paroxetine;Chemical;PA29561;Gene
SLC6A4;paroxetine;Chemical;PA312;Gene
BDNF;paroxetine;Chemical;PA31891;Gene
POLG;paroxetine;Chemical;PA33500;Gene
HLA-A;paroxetine;Chemical;PA35055;Gene
HLA-B;paroxetine;Chemical;PA35056;Gene
TPH1;paroxetine;Chemical;PA355;Gene
SRP19;paroxetine;Chemical;PA36124;Gene
UGT1A4;paroxetine;Chemical;PA37179;Gene
CYP3A4;benzphetamine;Chemical;PA130;Gene
RS8330;Liver Failure, Acute;Disease;PA166155584;Variant
RS1042640;Liver Failure, Acute;Disease;PA166155616;Variant
RS10929303;Liver Failure, Acute;Disease;PA166155795;Variant
UGT1A;Liver Failure, Acute;Disease;PA37173;Gene
UGT1A9;Liver Failure, Acute;Disease;PA419;Gene
RS532545;Leukemia, Myeloid;Disease;PA166153575;Variant
CDA;Leukemia, Myeloid;Disease;PA98;Gene
FLUOROURACIL;rs1801266;Variant;PA128406956;Chemical
DPYD;rs1801266;Variant;PA145;Gene
CAPECITABINE;rs1801266;Variant;PA448771;Chemical
TEGAFUR;rs1801266;Variant;PA452620;Chemical
CYP2D6;sparteine;Chemical;PA128;Gene
CYP2D6*1;sparteine;Chemical;PA165816576;Haplotype
CYP2D6*2;sparteine;Chemical;PA165816577;Haplotype
CYP2D6*3;sparteine;Chemical;PA165816578;Haplotype
CYP2D6*4;sparteine;Chemical;PA165816579;Haplotype
CYP2D6*6;sparteine;Chemical;PA165816581;Haplotype
CYP2D6*10;sparteine;Chemical;PA165816582;Haplotype
CYP2D6*41;sparteine;Chemical;PA165816584;Haplotype
CYP2D6*5;sparteine;Chemical;PA165948092;Haplotype
CYP2D6*9;sparteine;Chemical;PA165948317;Haplotype
CYP2D6*7;sparteine;Chemical;PA165971559;Haplotype
CYP2D6*8;sparteine;Chemical;PA165971560;Haplotype
CYP2D6*11;sparteine;Chemical;PA165971564;Haplotype
CYP2D6*12;sparteine;Chemical;PA165971565;Haplotype
CYP2D6*18;sparteine;Chemical;PA165971569;Haplotype
CYP2D6*35XN;sparteine;Chemical;PA165971588;Haplotype
CYP2D6*59;sparteine;Chemical;PA165971614;Haplotype
CYP2D6*62;sparteine;Chemical;PA165971617;Haplotype
CYP2D6*2XN;sparteine;Chemical;PA165988480;Haplotype
DRUGS FOR TREATMENT OF TUBERCULOSIS;rs1495741;Variant;PA164712708;Chemical
TUBERCULOSIS;rs1495741;Variant;PA445941;Disease
ESSENTIAL HYPERTENSION;rs4431329;Variant;PA447288;Disease
HYDROCHLOROTHIAZIDE;rs4431329;Variant;PA449899;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*39:09;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*39:09;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*39:09;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-B*39:09;Haplotype;PA450616;Chemical
PROSTATIC NEOPLASMS;TMPRSS2;Gene;PA445425;Disease
HYPERTENSION;rs10739150;Variant;PA444552;Disease
ATENOLOL;rs10739150;Variant;PA448499;Chemical
CORTICOSTEROIDS;ST13;Gene;PA10832;Chemical
ASTHMA;ST13;Gene;PA443450;Disease
HYPERTENSION;rs16960228;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs16960228;Variant;PA449899;Chemical
CYP2C9;Hematoma, Subdural;Disease;PA126;Gene
CYP2C9*1;Hematoma, Subdural;Disease;PA165816542;Haplotype
CYP2C9*3;Hematoma, Subdural;Disease;PA165816544;Haplotype
LONAFARNIB;ZMPSTE24;Gene;PA166129466;Chemical
HYPERTENSION;rs444904;Variant;PA444552;Disease
SORAFENIB;rs444904;Variant;PA7000;Chemical
TAMOXIFEN;rs4986938;Variant;PA451581;Chemical
RS179008;imiquimod;Chemical;PA166157851;Variant
TLR7;imiquimod;Chemical;PA38008;Gene
FLUOROURACIL;rs25648;Variant;PA128406956;Chemical
OXALIPLATIN;rs25648;Variant;PA131285527;Chemical
STOMACH NEOPLASMS;rs25648;Variant;PA445742;Disease
CISPLATIN;rs25648;Variant;PA449014;Chemical
HYPERTRIGLYCERIDEMIA;rs676210;Variant;PA446120;Disease
FENOFIBRATE;rs676210;Variant;PA449594;Chemical
CYP2D6;arformoterol;Chemical;PA128;Gene
UGT1A1;arformoterol;Chemical;PA420;Gene
HMG COA REDUCTASE INHIBITORS;rs1008805;Variant;PA133950441;Chemical
MENOPAUSE;rs1008805;Variant;PA166048848;Disease
BREAST NEOPLASMS;rs1008805;Variant;PA443560;Disease
ANASTROZOLE;rs1008805;Variant;PA448432;Chemical
LETROZOLE;rs1008805;Variant;PA450196;Chemical
HEART VALVE REPLACEMENT;rs1367117;Variant;PA166123431;Disease
HEMORRHAGE;rs1367117;Variant;PA444417;Disease
HYPERTENSION;rs1367117;Variant;PA444552;Disease
IRBESARTAN;rs1367117;Variant;PA450084;Chemical
WARFARIN;rs1367117;Variant;PA451906;Chemical
ALK;brigatinib;Chemical;PA24719;Gene
TM6SF2;Fatty Liver;Disease;PA36562;Gene
GEFITINIB;ERBB2;Gene;PA131301952;Chemical
ERLOTINIB;ERBB2;Gene;PA134687924;Chemical
LAPATINIB;ERBB2;Gene;PA152241907;Chemical
EVEROLIMUS;ERBB2;Gene;PA164746311;Chemical
FULVESTRANT;ERBB2;Gene;PA164747170;Chemical
OLAPARIB;ERBB2;Gene;PA164920420;Chemical
IXABEPILONE;ERBB2;Gene;PA165110439;Chemical
PERTUZUMAB;ERBB2;Gene;PA165290933;Chemical
NERATINIB;ERBB2;Gene;PA165291472;Chemical
TRASTUZUMAB EMTANSINE;ERBB2;Gene;PA165958441;Chemical
PEMBROLIZUMAB;ERBB2;Gene;PA166124615;Chemical
NIVOLUMAB;ERBB2;Gene;PA166129522;Chemical
PALBOCICLIB;ERBB2;Gene;PA166153469;Chemical
RIBOCICLIB;ERBB2;Gene;PA166153470;Chemical
ABEMACICLIB;ERBB2;Gene;PA166153471;Chemical
RS113488022;ERBB2;Gene;PA166157522;Variant
ERIBULIN;ERBB2;Gene;PA166182723;Chemical
TALAZOPARIB;ERBB2;Gene;PA166182740;Chemical
ALPELISIB;ERBB2;Gene;PA166184523;Chemical
TIPIRACIL / TRIFLURIDINE;ERBB2;Gene;PA166184566;Chemical
TRASTUZUMAB DERUXTECAN;ERBB2;Gene;PA166190621;Chemical
SACITUZUMAB GOVITECAN;ERBB2;Gene;PA166225061;Chemical
TUCATINIB;ERBB2;Gene;PA166225141;Chemical
MARGETUXIMAB;ERBB2;Gene;PA166235241;Chemical
ELACESTRANT;ERBB2;Gene;PA166313327;Chemical
CAPIVASERTIB;ERBB2;Gene;PA166328761;Chemical
ZOLBETUXIMAB;ERBB2;Gene;PA166345562;Chemical
INAVOLISIB;ERBB2;Gene;PA166400101;Chemical
ZANIDATAMAB;ERBB2;Gene;PA166400141;Chemical
JAK1;ERBB2;Gene;PA29988;Gene
PIK3CA;ERBB2;Gene;PA33308;Gene
PIK3CB;ERBB2;Gene;PA33309;Gene
PIK3CD;ERBB2;Gene;PA33310;Gene
PIK3CG;ERBB2;Gene;PA33311;Gene
PIK3R1;ERBB2;Gene;PA33312;Gene
PIK3R2;ERBB2;Gene;PA33313;Gene
PIK3R3;ERBB2;Gene;PA33314;Gene
PLCG1;ERBB2;Gene;PA33392;Gene
PLCG2;ERBB2;Gene;PA33393;Gene
BREAST NEOPLASMS;ERBB2;Gene;PA443560;Disease
DRUG TOXICITY;ERBB2;Gene;PA443937;Disease
CAPECITABINE;ERBB2;Gene;PA448771;Chemical
CARBOPLATIN;ERBB2;Gene;PA448803;Chemical
DOCETAXEL;ERBB2;Gene;PA449383;Chemical
TRASTUZUMAB;ERBB2;Gene;PA451743;Chemical
ECULIZUMAB;CHRNE;Gene;PA164776637;Chemical
EFGARTIGIMOD ALFA;CHRNE;Gene;PA166268781;Chemical
RAVULIZUMAB;CHRNE;Gene;PA166277861;Chemical
ROZANOLIXIZUMAB;CHRNE;Gene;PA166313325;Chemical
ZILUCOPLAN;CHRNE;Gene;PA166328901;Chemical
SLC22A16;doxorubicinol;Chemical;PA134911502;Gene
RS20572;doxorubicinol;Chemical;PA166155974;Variant
RS714368;doxorubicinol;Chemical;PA166156940;Variant
RS6690497;doxorubicinol;Chemical;PA166248081;Variant
RS2229540;doxorubicinol;Chemical;PA166248082;Variant
AKR1A1;doxorubicinol;Chemical;PA24674;Gene
CBR1;doxorubicinol;Chemical;PA26121;Gene
TENOFOVIR;ABCC2;Gene;PA10204;Chemical
ATAZANAVIR;ABCC2;Gene;PA10251;Chemical
IMATINIB;ABCC2;Gene;PA10804;Chemical
PEMETREXED;ABCC2;Gene;PA10810;Chemical
FLUOROURACIL;ABCC2;Gene;PA128406956;Chemical
OXALIPLATIN;ABCC2;Gene;PA131285527;Chemical
CALCEIN;ABCC2;Gene;PA132595336;Chemical
ORGAN TRANSPLANTATION;ABCC2;Gene;PA133888799;Disease
HMG COA REDUCTASE INHIBITORS;ABCC2;Gene;PA133950441;Chemical
PITAVASTATIN;ABCC2;Gene;PA142650384;Chemical
ANTIEPILEPTICS;ABCC2;Gene;PA143485705;Chemical
TALINOLOL;ABCC2;Gene;PA146123005;Chemical
GASTROINTESTINAL STROMAL TUMORS;ABCC2;Gene;PA151958383;Disease
DRUGS FOR TREATMENT OF TUBERCULOSIS;ABCC2;Gene;PA164712708;Chemical
PLATINUM COMPOUNDS;ABCC2;Gene;PA164713176;Chemical
MYCOPHENOLIC ACID;ABCC2;Gene;PA164748728;Chemical
DEFERASIROX;ABCC2;Gene;PA164760843;Chemical
TOXIC LIVER DISEASE;ABCC2;Gene;PA164925725;Disease
SN-38;ABCC2;Gene;PA165110775;Chemical
KIDNEY TRANSPLANTATION;ABCC2;Gene;PA165817016;Disease
MUCOSITIS;ABCC2;Gene;PA166122058;Disease
DUBIN-JOHNSON SYNDROME;ABCC2;Gene;PA166307601;Disease
NR1I2;ABCC2;Gene;PA378;Gene
CARDIAC RHYTHM DISEASE;ABCC2;Gene;PA443421;Disease
RHEUMATOID ARTHRITIS;ABCC2;Gene;PA443434;Disease
BREAST NEOPLASMS;ABCC2;Gene;PA443560;Disease
BURKITT LYMPHOMA;ABCC2;Gene;PA443580;Disease
NON-SMALL CELL LUNG CARCINOMA;ABCC2;Gene;PA443622;Disease
CENTRAL NERVOUS SYSTEM INFECTIOUS DISORDER;ABCC2;Gene;PA443658;Disease
COLONIC NEOPLASMS;ABCC2;Gene;PA443756;Disease
DRUG TOXICITY;ABCC2;Gene;PA443937;Disease
EPILEPSY;ABCC2;Gene;PA444065;Disease
EXANTHEMA;ABCC2;Gene;PA444109;Disease
FANCONI RENOTUBULAR SYNDROME;ABCC2;Gene;PA444145;Disease
HYPERCHOLESTEROLEMIA;ABCC2;Gene;PA444516;Disease
KIDNEY DISORDER;ABCC2;Gene;PA444682;Disease
LEUKEMIA;ABCC2;Gene;PA444750;Disease
LYMPHOID LEUKEMIA;ABCC2;Gene;PA444756;Disease
LEUKOPENIA;ABCC2;Gene;PA444773;Disease
LYMPHOMA;ABCC2;Gene;PA444840;Disease
NON-HODGKIN LYMPHOMA;ABCC2;Gene;PA444845;Disease
MESOTHELIOMA;ABCC2;Gene;PA444937;Disease
OSTEOSARCOMA;ABCC2;Gene;PA445601;Disease
TUBERCULOSIS;ABCC2;Gene;PA445941;Disease
COLORECTAL NEOPLASMS;ABCC2;Gene;PA446108;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;ABCC2;Gene;PA446155;Disease
BETA-THALASSEMIA AND RELATED DISEASES;ABCC2;Gene;PA446432;Disease
HIV INFECTIOUS DISEASE;ABCC2;Gene;PA447230;Disease
ATORVASTATIN;ABCC2;Gene;PA448500;Chemical
CARBAMAZEPINE;ABCC2;Gene;PA448785;Chemical
CEFTRIAXONE;ABCC2;Gene;PA448866;Chemical
CISPLATIN;ABCC2;Gene;PA449014;Chemical
CYCLOPHOSPHAMIDE;ABCC2;Gene;PA449165;Chemical
DOCETAXEL;ABCC2;Gene;PA449383;Chemical
DOXORUBICIN;ABCC2;Gene;PA449412;Chemical
EFAVIRENZ;ABCC2;Gene;PA449441;Chemical
ERYTHROMYCIN;ABCC2;Gene;PA449493;Chemical
IRINOTECAN;ABCC2;Gene;PA450085;Chemical
LAMIVUDINE;ABCC2;Gene;PA450163;Chemical
LEUCOVORIN;ABCC2;Gene;PA450198;Chemical
LOPINAVIR;ABCC2;Gene;PA450264;Chemical
METHOTREXATE;ABCC2;Gene;PA450428;Chemical
MYCOPHENOLATE MOFETIL;ABCC2;Gene;PA450566;Chemical
OXCARBAZEPINE;ABCC2;Gene;PA450732;Chemical
PACLITAXEL;ABCC2;Gene;PA450761;Chemical
PRAVASTATIN;ABCC2;Gene;PA451089;Chemical
RITONAVIR;ABCC2;Gene;PA451260;Chemical
SIMVASTATIN;ABCC2;Gene;PA451363;Chemical
TACROLIMUS;ABCC2;Gene;PA451578;Chemical
TAMOXIFEN;ABCC2;Gene;PA451581;Chemical
VINCRISTINE;ABCC2;Gene;PA451879;Chemical
SORAFENIB;ABCC2;Gene;PA7000;Chemical
HYPOTHYROIDISM;TSBP1;Gene;PA444589;Disease
ACUTE CORONARY SYNDROME;rs2307240;Variant;PA165108401;Disease
REMIMAZOLAM;rs2307240;Variant;PA166321761;Chemical
CLOPIDOGREL;rs2307240;Variant;PA449053;Chemical
CDK6;Hypertension;Disease;PA103;Gene
CYP2C9;Hypertension;Disease;PA126;Gene
CYP2D6;Hypertension;Disease;PA128;Gene
CYP3A4;Hypertension;Disease;PA130;Gene
CYP3A5;Hypertension;Disease;PA131;Gene
CYP11B2;Hypertension;Disease;PA134;Gene
PIK3R5;Hypertension;Disease;PA134890823;Gene
PLEKHH2;Hypertension;Disease;PA134912826;Gene
TXNDC11;Hypertension;Disease;PA134915251;Gene
PLEKHJ1;Hypertension;Disease;PA134936152;Gene
ACY3;Hypertension;Disease;PA134936640;Gene
LRRC15;Hypertension;Disease;PA134956867;Gene
STN1;Hypertension;Disease;PA134987118;Gene
YEATS4;Hypertension;Disease;PA134992686;Gene
DOT1L;Hypertension;Disease;PA134993717;Gene
ACE;Hypertension;Disease;PA139;Gene
ZMAT4;Hypertension;Disease;PA142670525;Gene
TANC2;Hypertension;Disease;PA142670837;Gene
SLC25A31;Hypertension;Disease;PA142670904;Gene
SH2B3;Hypertension;Disease;PA145148124;Gene
DPYS;Hypertension;Disease;PA146;Gene
FTO;Hypertension;Disease;PA152208656;Gene
ADO;Hypertension;Disease;PA162375713;Gene
RRP1B;Hypertension;Disease;PA162402138;Gene
SULT1C3;Hypertension;Disease;PA162405069;Gene
XIRP2;Hypertension;Disease;PA162409337;Gene
CLNK;Hypertension;Disease;PA164718067;Gene
C5ORF56;Hypertension;Disease;PA165660191;Gene
CYP2C9*1;Hypertension;Disease;PA165816542;Haplotype
CYP2C9*2;Hypertension;Disease;PA165816543;Haplotype
CYP2C9*3;Hypertension;Disease;PA165816544;Haplotype
CYP2C9*33;Hypertension;Disease;PA165816561;Haplotype
CYP2C9*30;Hypertension;Disease;PA165816574;Haplotype
CYP2D6*1;Hypertension;Disease;PA165816576;Haplotype
CYP2D6*2;Hypertension;Disease;PA165816577;Haplotype
CYP2D6*3;Hypertension;Disease;PA165816578;Haplotype
CYP2D6*4;Hypertension;Disease;PA165816579;Haplotype
CYP2D6*6;Hypertension;Disease;PA165816581;Haplotype
CYP2D6*10;Hypertension;Disease;PA165816582;Haplotype
CYP2D6*17;Hypertension;Disease;PA165816583;Haplotype
CYP2D6*41;Hypertension;Disease;PA165816584;Haplotype
CYP2D6*5;Hypertension;Disease;PA165948092;Haplotype
CYP2D6*9;Hypertension;Disease;PA165948317;Haplotype
CYP2D6*29;Hypertension;Disease;PA165948318;Haplotype
NAT2*4;Hypertension;Disease;PA165949098;Haplotype
NAT2*5A;Hypertension;Disease;PA165949099;Haplotype
NAT2*12A;Hypertension;Disease;PA165949138;Haplotype
HLA-DRB1*04:01;Hypertension;Disease;PA165951493;Haplotype
CYP2D6*31;Hypertension;Disease;PA165971582;Haplotype
CYP2D6*46;Hypertension;Disease;PA165971600;Haplotype
NAT2*6;Hypertension;Disease;PA165981635;Haplotype
NAT2*7;Hypertension;Disease;PA165981636;Haplotype
NAT2*14;Hypertension;Disease;PA165981640;Haplotype
CYP2D6*35;Hypertension;Disease;PA165988487;Haplotype
CYP2D6*45;Hypertension;Disease;PA165988489;Haplotype
RS699;Hypertension;Disease;PA166153539;Variant
RS4762;Hypertension;Disease;PA166153545;Variant
RS5051;Hypertension;Disease;PA166153547;Variant
RS5065;Hypertension;Disease;PA166153549;Variant
RS7079;Hypertension;Disease;PA166153556;Variant
RS340874;Hypertension;Disease;PA166153570;Variant
RS1126742;Hypertension;Disease;PA166153623;Variant
RS1801133;Hypertension;Disease;PA166153644;Variant
RS2144297;Hypertension;Disease;PA166153673;Variant
RS2144300;Hypertension;Disease;PA166153674;Variant
RS4648287;Hypertension;Disease;PA166153771;Variant
RS10157410;Hypertension;Disease;PA166153799;Variant
RS11209716;Hypertension;Disease;PA166153821;Variant
RS34717272;Hypertension;Disease;PA166153877;Variant
RS1801252;Hypertension;Disease;PA166153976;Variant
RS4132670;Hypertension;Disease;PA166154046;Variant
RS4506565;Hypertension;Disease;PA166154056;Variant
RS7917983;Hypertension;Disease;PA166154091;Variant
RS588076;Hypertension;Disease;PA166154284;Variant
RS658903;Hypertension;Disease;PA166154290;Variant
RS2229437;Hypertension;Disease;PA166154352;Variant
RS2279238;Hypertension;Disease;PA166154362;Variant
RS10792367;Hypertension;Disease;PA166154436;Variant
RS10898815;Hypertension;Disease;PA166154441;Variant
RS11039149;Hypertension;Disease;PA166154448;Variant
RS11600347;Hypertension;Disease;PA166154459;Variant
RS12221497;Hypertension;Disease;PA166154461;Variant
RS12795437;Hypertension;Disease;PA166154466;Variant
RS880054;Hypertension;Disease;PA166154506;Variant
RS1051375;Hypertension;Disease;PA166154509;Variant
RS2238032;Hypertension;Disease;PA166154533;Variant
RS2239050;Hypertension;Disease;PA166154534;Variant
RS2239128;Hypertension;Disease;PA166154535;Variant
RS3184504;Hypertension;Disease;PA166154560;Variant
RS7297610;Hypertension;Disease;PA166154598;Variant
RS12817819;Hypertension;Disease;PA166154643;Variant
RS2776546;Hypertension;Disease;PA166154798;Variant
RS8012552;Hypertension;Disease;PA166154814;Variant
RS1378942;Hypertension;Disease;PA166154861;Variant
RS9940629;Hypertension;Disease;PA166155099;Variant
RS12595985;Hypertension;Disease;PA166155112;Variant
RS4291;Hypertension;Disease;PA166155143;Variant
RS4344;Hypertension;Disease;PA166155148;Variant
RS4359;Hypertension;Disease;PA166155149;Variant
RS1799752;Hypertension;Disease;PA166155187;Variant
RS2429427;Hypertension;Disease;PA166155209;Variant
RS4791040;Hypertension;Disease;PA166155224;Variant
RS12946454;Hypertension;Disease;PA166155253;Variant
RS16960228;Hypertension;Disease;PA166155256;Variant
RS1123617;Hypertension;Disease;PA166155278;Variant
RS3745009;Hypertension;Disease;PA166155291;Variant
RS4149601;Hypertension;Disease;PA166155293;Variant
RS688;Hypertension;Disease;PA166155337;Variant
RS2269879;Hypertension;Disease;PA166155390;Variant
RS1367117;Hypertension;Disease;PA166155632;Variant
RS2273359;Hypertension;Disease;PA166155924;Variant
RS4815273;Hypertension;Disease;PA166155948;Variant
RS5182;Hypertension;Disease;PA166156275;Variant
RS5186;Hypertension;Disease;PA166156276;Variant
RS2016848;Hypertension;Disease;PA166156337;Variant
RS11313667;Hypertension;Disease;PA166156442;Variant
RS4961;Hypertension;Disease;PA166156480;Variant
RS5522;Hypertension;Disease;PA166156481;Variant
RS1024323;Hypertension;Disease;PA166156499;Variant
RS1870377;Hypertension;Disease;PA166156528;Variant
RS201279313;Hypertension;Disease;PA166156703;Variant
RS1042714;Hypertension;Disease;PA166156749;Variant
RS2301149;Hypertension;Disease;PA166156798;Variant
RS11739136;Hypertension;Disease;PA166156869;Variant
RS200148;Hypertension;Disease;PA166156912;Variant
RS699947;Hypertension;Disease;PA166156938;Variant
RS776746;Hypertension;Disease;PA166157267;Variant
RS1045642;Hypertension;Disease;PA166157284;Variant
RS2070744;Hypertension;Disease;PA166157325;Variant
RS2246709;Hypertension;Disease;PA166157346;Variant
RS2740574;Hypertension;Disease;PA166157367;Variant
RS3213619;Hypertension;Disease;PA166157373;Variant
RS10267099;Hypertension;Disease;PA166157442;Variant
RS17655652;Hypertension;Disease;PA166157478;Variant
RS1048101;Hypertension;Disease;PA166157550;Variant
RS1367094;Hypertension;Disease;PA166157555;Variant
RS1799998;Hypertension;Disease;PA166157566;Variant
RS2669429;Hypertension;Disease;PA166157579;Variant
RS238;Hypertension;Disease;PA166157695;Variant
RS495828;Hypertension;Disease;PA166157707;Variant
RS1104514;Hypertension;Disease;PA166157719;Variant
RS4742610;Hypertension;Disease;PA166157776;Variant
RS10739150;Hypertension;Disease;PA166157809;Variant
RS12346562;Hypertension;Disease;PA166157835;Variant
RS2106809;Hypertension;Disease;PA166157865;Variant
RS2514036;Hypertension;Disease;PA166159082;Variant
RS3814995;Hypertension;Disease;PA166159103;Variant
RS11124945;Hypertension;Disease;PA166161873;Variant
RS10995;Hypertension;Disease;PA166162510;Variant
RS13144136;Hypertension;Disease;PA166163480;Variant
RS34550074;Hypertension;Disease;PA166169840;Variant
RS9943291;Hypertension;Disease;PA166177889;Variant
RS61824877;Hypertension;Disease;PA166177898;Variant
RS6929249;Hypertension;Disease;PA166179287;Variant
RS3734704;Hypertension;Disease;PA166179288;Variant
RS834576;Hypertension;Disease;PA166179289;Variant
RS9381299;Hypertension;Disease;PA166179290;Variant
RS11065987;Hypertension;Disease;PA166179453;Variant
RS261316;Hypertension;Disease;PA166179574;Variant
RS35123024;Hypertension;Disease;PA166179575;Variant
RS1225367412;Hypertension;Disease;PA166180969;Variant
RS35068180;Hypertension;Disease;PA166181205;Variant
RS3890011;Hypertension;Disease;PA166184563;Variant
RS7184292;Hypertension;Disease;PA166185404;Variant
RS7606603;Hypertension;Disease;PA166185405;Variant
RS16872401;Hypertension;Disease;PA166185406;Variant
RS3784921;Hypertension;Disease;PA166185466;Variant
RS6487504;Hypertension;Disease;PA166195021;Variant
RS11749255;Hypertension;Disease;PA166195022;Variant
RS324498;Hypertension;Disease;PA166195023;Variant
RS294610;Hypertension;Disease;PA166196761;Variant
RS45545233;Hypertension;Disease;PA166196763;Variant
RS1275988;Hypertension;Disease;PA166199001;Variant
RS6722745;Hypertension;Disease;PA166199002;Variant
RS12579720;Hypertension;Disease;PA166199003;Variant
RS4387287;Hypertension;Disease;PA166199004;Variant
RS10995311;Hypertension;Disease;PA166199005;Variant
RS8068318;Hypertension;Disease;PA166199006;Variant
RS932764;Hypertension;Disease;PA166199007;Variant
RS740406;Hypertension;Disease;PA166199008;Variant
RS10224002;Hypertension;Disease;PA166199021;Variant
RS12521868;Hypertension;Disease;PA166199022;Variant
RS757081;Hypertension;Disease;PA166199041;Variant
RS9306160;Hypertension;Disease;PA166199042;Variant
RS1446468;Hypertension;Disease;PA166199061;Variant
RS28404156;Hypertension;Disease;PA166199981;Variant
RS444904;Hypertension;Disease;PA166283281;Variant
RS1346563;Hypertension;Disease;PA166283381;Variant
RS11125039;Hypertension;Disease;PA166283383;Variant
RS2330951;Hypertension;Disease;PA166283401;Variant
RS6770663;Hypertension;Disease;PA166348241;Variant
NAT2;Hypertension;Disease;PA18;Gene
KCNJ1;Hypertension;Disease;PA213;Gene
KCNMB1;Hypertension;Disease;PA221;Gene
LDLR;Hypertension;Disease;PA227;Gene
NR3C2;Hypertension;Disease;PA242;Gene
MTHFR;Hypertension;Disease;PA245;Gene
ADAMTS18;Hypertension;Disease;PA24544;Gene
ALDH1A2;Hypertension;Disease;PA24693;Gene
ATP2B1;Hypertension;Disease;PA25107;Gene
NOS3;Hypertension;Disease;PA254;Gene
BST1;Hypertension;Disease;PA25435;Gene
NPPA;Hypertension;Disease;PA256;Gene
ABCB1;Hypertension;Disease;PA267;Gene
CSK;Hypertension;Disease;PA26946;Gene
PLA2G4A;Hypertension;Disease;PA271;Gene
CYP2J2;Hypertension;Disease;PA27112;Gene
CYP4A11;Hypertension;Disease;PA27118;Gene
FBN1;Hypertension;Disease;PA28016;Gene
GALNT2;Hypertension;Disease;PA28537;Gene
PTGER3;Hypertension;Disease;PA288;Gene
GRK4;Hypertension;Disease;PA28941;Gene
H19;Hypertension;Disease;PA29091;Gene
PTGIS;Hypertension;Disease;PA292;Gene
PTGS2;Hypertension;Disease;PA293;Gene
HMGCS2;Hypertension;Disease;PA29338;Gene
HSP90AB1;Hypertension;Disease;PA29524;Gene
RELA;Hypertension;Disease;PA296;Gene
KCNIP1;Hypertension;Disease;PA30041;Gene
KCNK3;Hypertension;Disease;PA30060;Gene
KDR;Hypertension;Disease;PA30086;Gene
MME;Hypertension;Disease;PA30864;Gene
MMP3;Hypertension;Disease;PA30886;Gene
ADD1;Hypertension;Disease;PA31;Gene
NEDD4L;Hypertension;Disease;PA31534;Gene
NFAT5;Hypertension;Disease;PA31581;Gene
NPC1L1;Hypertension;Disease;PA31699;Gene
NPHS1;Hypertension;Disease;PA31709;Gene
NR1H3;Hypertension;Disease;PA31751;Gene
NUCB2;Hypertension;Disease;PA31826;Gene
NUMA1;Hypertension;Disease;PA31844;Gene
PDE1A;Hypertension;Disease;PA33122;Gene
PDE3A;Hypertension;Disease;PA33126;Gene
PICALM;Hypertension;Disease;PA33287;Gene
PLCD3;Hypertension;Disease;PA33389;Gene
PLCE1;Hypertension;Disease;PA33391;Gene
PRCP;Hypertension;Disease;PA33705;Gene
PRKAG2;Hypertension;Disease;PA33752;Gene
PRKCA;Hypertension;Disease;PA33759;Gene
PRKCE;Hypertension;Disease;PA33765;Gene
WNK1;Hypertension;Disease;PA33782;Gene
PROX1;Hypertension;Disease;PA33812;Gene
ADRA1A;Hypertension;Disease;PA34;Gene
PTPRD;Hypertension;Disease;PA34013;Gene
RGS2;Hypertension;Disease;PA34372;Gene
HLA-DQB1;Hypertension;Disease;PA35068;Gene
HLA-DRB1;Hypertension;Disease;PA35072;Gene
HOXC@;Hypertension;Disease;PA35099;Gene
SLC14A2;Hypertension;Disease;PA35811;Gene
SLCO2A1;Hypertension;Disease;PA35840;Gene
SLC4A1;Hypertension;Disease;PA35895;Gene
TBX2;Hypertension;Disease;PA36360;Gene
TCF7L2;Hypertension;Disease;PA36394;Gene
KCNAB1;Hypertension;Disease;PA370;Gene
VASP;Hypertension;Disease;PA37276;Gene
VCL;Hypertension;Disease;PA37288;Gene
VEGFA;Hypertension;Disease;PA37302;Gene
ADRB1;Hypertension;Disease;PA38;Gene
NELFCD;Hypertension;Disease;PA38055;Gene
ADRB2;Hypertension;Disease;PA39;Gene
AGT;Hypertension;Disease;PA42;Gene
ACE2;Hypertension;Disease;PA425;Gene
AGTR1;Hypertension;Disease;PA43;Gene
APOB;Hypertension;Disease;PA50;Gene
EGFR;Hypertension;Disease;PA7360;Gene
BDKRB2;Hypertension;Disease;PA80;Gene
CACNA1C;Hypertension;Disease;PA83;Gene
CACNA1S;Hypertension;Disease;PA85;Gene
CYP3A4;treatment modification;Disease;PA130;Gene
DPYD;treatment modification;Disease;PA145;Gene
CYP3A4*1;treatment modification;Disease;PA165819201;Haplotype
CYP3A4*8;treatment modification;Disease;PA165819226;Haplotype
CYP3A4*20;treatment modification;Disease;PA165819244;Haplotype
ABCC2;ceftriaxone;Chemical;PA116;Gene
RS2273697;ceftriaxone;Chemical;PA166154007;Variant
RS13120400;ceftriaxone;Chemical;PA166156664;Variant
CYB5R3;ceftriaxone;Chemical;PA27331;Gene
G6PD;ceftriaxone;Chemical;PA28469;Gene
ABCG2;ceftriaxone;Chemical;PA390;Gene
RS2032582;dexrazoxane;Chemical;PA166157316;Variant
ABCB1;dexrazoxane;Chemical;PA267;Gene
CROHN DISEASE;rs1143634;Variant;PA443815;Disease
PAIN, POSTOPERATIVE;rs1143634;Variant;PA445210;Disease
SCHIZOPHRENIA;rs1143634;Variant;PA447216;Disease
MORPHINE;rs1143634;Variant;PA450550;Chemical
ANTIPSYCHOTICS;rs1143634;Variant;PA452233;Chemical
INFLIXIMAB;rs1143634;Variant;PA452639;Chemical
TEMOZOLOMIDE;HDAC4;Gene;PA451609;Chemical
CYP2D6;tamsulosin;Chemical;PA128;Gene
CYP3A4;tamsulosin;Chemical;PA130;Gene
CYP3A5;tamsulosin;Chemical;PA131;Gene
CYP2D6 EXTENSIVE METABOLIZER GENOTYPE;tamsulosin;Chemical;PA166157896;Variant
DPYD;rs45589337;Variant;PA145;Gene
CAPECITABINE;rs45589337;Variant;PA448771;Chemical
HYPERTRIGLYCERIDEMIA;rs2241883;Variant;PA446120;Disease
FENOFIBRATE;rs2241883;Variant;PA449594;Chemical
HEROIN DEPENDENCE;rs508448;Variant;PA444460;Disease
HEROIN;rs508448;Variant;PA452619;Chemical
CFTR;rs150212784;Variant;PA109;Gene
IVACAFTOR;rs150212784;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs150212784;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs150212784;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs150212784;Variant;PA443829;Disease
G6PD;succimer;Chemical;PA28469;Gene
HYPERTENSION;rs7917983;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs7917983;Variant;PA449899;Chemical
MAJOR DEPRESSIVE DISORDER;rs2270007;Variant;PA447321;Disease
CITALOPRAM;rs2270007;Variant;PA449015;Chemical
GAA;alglucosidase alfa;Chemical;PA28476;Gene
RS1695;dimethyl fumarate;Chemical;PA166154249;Variant
GSTP1;dimethyl fumarate;Chemical;PA29028;Gene
RS10161126;Bone Diseases;Disease;PA166154611;Variant
MVK;Bone Diseases;Disease;PA31331;Gene
PITRAKINRA;rs3024530;Variant;PA165983754;Chemical
ASTHMA;rs3024530;Variant;PA443450;Disease
MAJOR DEPRESSIVE DISORDER;rs6966038;Variant;PA447321;Disease
CITALOPRAM;rs6966038;Variant;PA449015;Chemical
HYPERTRIGLYCERIDEMIA;rs320;Variant;PA446120;Disease
FENOFIBRATE;rs320;Variant;PA449594;Chemical
IMATINIB;rs45605536;Variant;PA10804;Chemical
DASATINIB;rs45605536;Variant;PA162372878;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*52;Haplotype;PA166127651;Chemical
DEXTROMETHORPHAN;CYP2D6*52;Haplotype;PA449273;Chemical
PRIMAQUINE;CYP2D6*52;Haplotype;PA451103;Chemical
LIVER TRANSPLANTATION;rs11265572;Variant;PA447247;Disease
TACROLIMUS;rs11265572;Variant;PA451578;Chemical
TPMT;TPMT*7;Haplotype;PA356;Gene
CROHN DISEASE;TPMT*7;Haplotype;PA443815;Disease
AZATHIOPRINE;TPMT*7;Haplotype;PA448515;Chemical
MERCAPTOPURINE;TPMT*7;Haplotype;PA450379;Chemical
THIOGUANINE;TPMT*7;Haplotype;PA451663;Chemical
DPYD;rs140602333;Variant;PA145;Gene
CAPECITABINE;rs140602333;Variant;PA448771;Chemical
RS104894021;short qt syndrome 1;Disease;PA166183768;Variant
KCNH2;short qt syndrome 1;Disease;PA212;Gene
EPILEPSY;CYP2C9*50;Haplotype;PA444065;Disease
DICLOFENAC;CYP2C9*50;Haplotype;PA449293;Chemical
PHENYTOIN;CYP2C9*50;Haplotype;PA450947;Chemical
VORICONAZOLE;CYP2C19*31;Haplotype;PA10233;Chemical
NEBIVOLOL;CYP2C19*31;Haplotype;PA151958426;Chemical
FLUOXETINE;CYP2C19*31;Haplotype;PA449673;Chemical
IBUPROFEN;CYP2C19*31;Haplotype;PA449957;Chemical
MEPHENYTOIN;CYP2C19*31;Haplotype;PA450373;Chemical
METHADONE;CYP2C19*31;Haplotype;PA450401;Chemical
OMEPRAZOLE;CYP2C19*31;Haplotype;PA450704;Chemical
DAUNORUBICIN;rs34186955;Variant;PA449212;Chemical
DOXORUBICIN;rs34186955;Variant;PA449412;Chemical
DESMETHYLNAPROXEN;rs28374453;Variant;PA166163690;Chemical
TAPENTADOL;rs28374453;Variant;PA166179720;Chemical
ACETAMINOPHEN;rs28374453;Variant;PA448015;Chemical
WEIGHT GAIN;ADRB3;Gene;PA128406954;Disease
SCHIZOPHRENIA;ADRB3;Gene;PA447216;Disease
OLANZAPINE;ADRB3;Gene;PA450688;Chemical
OPIUM ALKALOIDS AND DERIVATIVES;rs660652;Variant;PA164712950;Chemical
PAIN;rs660652;Variant;PA445208;Disease
TOBACCO USE DISORDER;rs660652;Variant;PA445876;Disease
NICOTINE;rs660652;Variant;PA450626;Chemical
RS16944;tiludronate;Chemical;PA166155587;Variant
IL1B;tiludronate;Chemical;PA29808;Gene
DDC;carbidopa;Chemical;PA140;Gene
MTHFR;carbidopa;Chemical;PA245;Gene
P2RY12;GNAI1;Gene;PA134971947;Gene
ADCY3;GNAI1;Gene;PA164741137;Gene
HTR1A;GNAI1;Gene;PA192;Gene
ADCY1;GNAI1;Gene;PA24560;Gene
ADCY2;GNAI1;Gene;PA24561;Gene
ADCY4;GNAI1;Gene;PA24562;Gene
ADCY5;GNAI1;Gene;PA24563;Gene
ADCY6;GNAI1;Gene;PA27;Gene
ADCY7;GNAI1;Gene;PA28;Gene
ADCY8;GNAI1;Gene;PA29;Gene
HTR1B;GNAI1;Gene;PA29549;Gene
HTR1D;GNAI1;Gene;PA29550;Gene
HTR1E;GNAI1;Gene;PA29552;Gene
HTR1F;GNAI1;Gene;PA29553;Gene
ADCY9;GNAI1;Gene;PA30;Gene
RGS1;GNAI1;Gene;PA34361;Gene
ADRB2;GNAI1;Gene;PA39;Gene
CYP2B6;(S)-methadone;Chemical;PA123;Gene
CYP2B6*1;(S)-methadone;Chemical;PA165818750;Haplotype
CYP2B6*5;(S)-methadone;Chemical;PA165818760;Haplotype
CYP2B6*6;(S)-methadone;Chemical;PA165818762;Haplotype
CYP2B6*7;(S)-methadone;Chemical;PA165818765;Haplotype
CYP2B6*9;(S)-methadone;Chemical;PA165818807;Haplotype
CYP2B6*18;(S)-methadone;Chemical;PA165818808;Haplotype
WARFARIN;rs4760658;Variant;PA451906;Chemical
HYPERTENSION;ADO;Gene;PA444552;Disease
HYDROCHLOROTHIAZIDE;ADO;Gene;PA449899;Chemical
ASPIRIN-INDUCED ASTHMA;HLA-DPB1*04:01;Haplotype;PA131285571;Disease
AGRANULOCYTOSIS;HLA-DPB1*04:01;Haplotype;PA443297;Disease
ASTHMA;HLA-DPB1*04:01;Haplotype;PA443450;Disease
SCHIZOPHRENIA;HLA-DPB1*04:01;Haplotype;PA447216;Disease
ASPIRIN;HLA-DPB1*04:01;Haplotype;PA448497;Chemical
CLOZAPINE;HLA-DPB1*04:01;Haplotype;PA449061;Chemical
SLC6A4 HTTLPR LONG FORM (L ALLELE);evodiamine;Chemical;PA166116465;Haplotype
SLC6A4;evodiamine;Chemical;PA312;Gene
BIPOLAR DISORDER;rs2284017;Variant;PA447199;Disease
LITHIUM;rs2284017;Variant;PA450243;Chemical
F5;eltrombopag;Chemical;PA159;Gene
UGT1A1*1;eltrombopag;Chemical;PA166115841;Haplotype
UGT1A1*28;eltrombopag;Chemical;PA166115842;Haplotype
RS6025;eltrombopag;Chemical;PA166153554;Variant
SERPINC1;eltrombopag;Chemical;PA35026;Gene
UGT1A1;eltrombopag;Chemical;PA420;Gene
TENOFOVIR;rs7917432;Variant;PA10204;Chemical
HIV INFECTIOUS DISEASE;rs7917432;Variant;PA447230;Disease
GEFITINIB;rs2233407;Variant;PA131301952;Chemical
TOXIC LIVER DISEASE;rs2233407;Variant;PA164925725;Disease
NON-SMALL CELL LUNG CARCINOMA;rs2233407;Variant;PA443622;Disease
LAPATINIB;HLA-C*08:02;Haplotype;PA152241907;Chemical
BREAST NEOPLASMS;HLA-C*08:02;Haplotype;PA443560;Disease
DRUG HYPERSENSITIVITY;HLA-C*08:02;Haplotype;PA443936;Disease
EXANTHEMA;HLA-C*08:02;Haplotype;PA444109;Disease
HIV INFECTIONS;HLA-C*08:02;Haplotype;PA447230;Disease
NEVIRAPINE;HLA-C*08:02;Haplotype;PA450616;Chemical
MULTIPLE MYELOMA;rs1051685;Variant;PA444985;Disease
THALIDOMIDE;rs1051685;Variant;PA451644;Chemical
DULOXETINE;rs10123866;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs10123866;Variant;PA447321;Disease
KIDNEY TRANSPLANTATION;rs4844880;Variant;PA165817016;Disease
TACROLIMUS;rs4844880;Variant;PA451578;Chemical
EXEMESTANE;rs62621365;Variant;PA449563;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;TPH2;Gene;PA164713257;Chemical
HEROIN DEPENDENCE;TPH2;Gene;PA444460;Disease
DEPRESSIVE DISORDER;TPH2;Gene;PA447207;Disease
DEPRESSION;TPH2;Gene;PA447278;Disease
MAJOR DEPRESSIVE DISORDER;TPH2;Gene;PA447321;Disease
CITALOPRAM;TPH2;Gene;PA449015;Chemical
METHADONE;TPH2;Gene;PA450401;Chemical
MIRTAZAPINE;TPH2;Gene;PA450522;Chemical
VENLAFAXINE;TPH2;Gene;PA451866;Chemical
ANTIDEPRESSANTS;TPH2;Gene;PA452229;Chemical
SULT1A1;minoxidil;Chemical;PA343;Gene
HYPERTENSION;rs757081;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs757081;Variant;PA449899;Chemical
RS1801133;vitamin b-complex, plain;Chemical;PA166153644;Variant
RS1801394;vitamin b-complex, plain;Chemical;PA166156776;Variant
MTHFR;vitamin b-complex, plain;Chemical;PA245;Gene
MTRR;vitamin b-complex, plain;Chemical;PA31277;Gene
CYP2D6;mephedrone;Chemical;PA128;Gene
CYP2D6*1;mephedrone;Chemical;PA165816576;Haplotype
CYP2D6*2;mephedrone;Chemical;PA165816577;Haplotype
CYP2D6*3;mephedrone;Chemical;PA165816578;Haplotype
CYP2D6*4;mephedrone;Chemical;PA165816579;Haplotype
CYP2D6*10;mephedrone;Chemical;PA165816582;Haplotype
CYP2D6*41;mephedrone;Chemical;PA165816584;Haplotype
CYP2D6*5;mephedrone;Chemical;PA165948092;Haplotype
CYP2D6*9;mephedrone;Chemical;PA165948317;Haplotype
CYP3A5;isotretinoin;Chemical;PA131;Gene
TAXANES;rs3594;Variant;PA150481189;Chemical
OVARIAN NEOPLASMS;rs3594;Variant;PA445204;Disease
CARBOPLATIN;rs3594;Variant;PA448803;Chemical
SMOKING CESSATION;rs3852209;Variant;PA166123046;Disease
TOBACCO USE DISORDER;rs3852209;Variant;PA445876;Disease
NICOTINE;rs3852209;Variant;PA450626;Chemical
ABCB1;Phenothiazine derivatives;Chemical;PA267;Gene
NPC1;levacetylleucine;Chemical;PA31698;Gene
NPC2;levacetylleucine;Chemical;PA31700;Gene
CYP2C19;felbamate;Chemical;PA124;Gene
CYP3A4;felbamate;Chemical;PA130;Gene
CYB5R4;isosorbide dinitrate;Chemical;PA134904907;Gene
CYB5R1;isosorbide dinitrate;Chemical;PA134979668;Gene
CYB5R2;isosorbide dinitrate;Chemical;PA142672060;Gene
CYB5R3;isosorbide dinitrate;Chemical;PA27331;Gene
MYCOPHENOLIC ACID;rs7311358;Variant;PA164748728;Chemical
KIDNEY TRANSPLANTATION;rs7311358;Variant;PA165817016;Disease
TRANSPLANT REJECTION;rs7311358;Variant;PA166114454;Disease
LUNG TRANSPLANTATION;rs7311358;Variant;PA166114457;Disease
OVERALL SURVIVAL;rs7311358;Variant;PA166123207;Disease
CHRONIC LUNG ALLOGRAFT DYSFUNCTION;rs7311358;Variant;PA166195784;Disease
NON-SMALL CELL LUNG CARCINOMA;rs7311358;Variant;PA443622;Disease
CARBOPLATIN;rs7311358;Variant;PA448803;Chemical
DOCETAXEL;rs7311358;Variant;PA449383;Chemical
MYCOPHENOLATE MOFETIL;rs7311358;Variant;PA450566;Chemical
PACLITAXEL;rs7311358;Variant;PA450761;Chemical
CLOPIDOGREL;B4GALT2;Gene;PA449053;Chemical
HBB;luspatercept;Chemical;PA29202;Gene
CYP2C9;rs12777823;Variant;PA126;Gene
VKORC1;rs12777823;Variant;PA133787052;Gene
CYP4F2;rs12777823;Variant;PA27121;Gene
WARFARIN;rs12777823;Variant;PA451906;Chemical
RS11568482;cefotaxime;Chemical;PA166154457;Variant
SLC22A8;cefotaxime;Chemical;PA389;Gene
GNAI1;ADCY5;Gene;PA172;Gene
GNAI3;ADCY5;Gene;PA173;Gene
GNAS;ADCY5;Gene;PA175;Gene
GNAI2;ADCY5;Gene;PA24347;Gene
ETHANOL;rs2948694;Variant;PA448073;Chemical
ACUTE CORONARY SYNDROME;EFR3A;Gene;PA165108401;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);EFR3A;Gene;PA166129560;Disease
ASPIRIN;EFR3A;Gene;PA448497;Chemical
CLOPIDOGREL;EFR3A;Gene;PA449053;Chemical
MAPK8;NRL;Gene;PA283;Gene
MAPK14;NRL;Gene;PA30621;Gene
MTHFR;Down Syndrome;Disease;PA245;Gene
NAUSEA;rs9397685;Variant;PA445048;Disease
PAIN, POSTOPERATIVE;rs9397685;Variant;PA445210;Disease
VOMITING;rs9397685;Variant;PA446051;Disease
FENTANYL;rs9397685;Variant;PA449599;Chemical
IMATINIB;GSTT1 null;Haplotype;PA10804;Chemical
OTOTOXICITY;GSTT1 null;Haplotype;PA162263534;Disease
DRUGS FOR TREATMENT OF TUBERCULOSIS;GSTT1 null;Haplotype;PA164712708;Chemical
ETHAMBUTOL;GSTT1 null;Haplotype;PA164784021;Chemical
TOXIC LIVER DISEASE;GSTT1 null;Haplotype;PA164925725;Disease
HEMATOPOIETIC STEM CELL TRANSPLANTATION;GSTT1 null;Haplotype;PA166123007;Disease
PROGRESSION-FREE SURVIVAL;GSTT1 null;Haplotype;PA166123026;Disease
EXACERBATION OF ASTHMA;GSTT1 null;Haplotype;PA166179129;Disease
ASTHMA;GSTT1 null;Haplotype;PA443450;Disease
DEAFNESS;GSTT1 null;Haplotype;PA443840;Disease
GRAFT VS HOST DISEASE;GSTT1 null;Haplotype;PA444320;Disease
NEOPLASMS;GSTT1 null;Haplotype;PA445062;Disease
NEUTROPENIA;GSTT1 null;Haplotype;PA445113;Disease
OSTEOSARCOMA;GSTT1 null;Haplotype;PA445601;Disease
TUBERCULOSIS;GSTT1 null;Haplotype;PA445941;Disease
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;GSTT1 null;Haplotype;PA446171;Disease
CISPLATIN;GSTT1 null;Haplotype;PA449014;Chemical
CLOZAPINE;GSTT1 null;Haplotype;PA449061;Chemical
CYCLOPHOSPHAMIDE;GSTT1 null;Haplotype;PA449165;Chemical
DOXORUBICIN;GSTT1 null;Haplotype;PA449412;Chemical
ISONIAZID;GSTT1 null;Haplotype;PA450112;Chemical
METHOTREXATE;GSTT1 null;Haplotype;PA450428;Chemical
PYRAZINAMIDE;GSTT1 null;Haplotype;PA451182;Chemical
RIFAMPIN;GSTT1 null;Haplotype;PA451250;Chemical
STREPTOMYCIN;GSTT1 null;Haplotype;PA451512;Chemical
SCHIZOPHRENIA;GIPR;Gene;PA447216;Disease
OLANZAPINE;GIPR;Gene;PA450688;Chemical
DULOXETINE;rs9873889;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs9873889;Variant;PA447321;Disease
PRKAA1;ACACA;Gene;PA33744;Gene
PRKAA2;ACACA;Gene;PA33745;Gene
PRKAB1;ACACA;Gene;PA33746;Gene
PRKAB2;ACACA;Gene;PA33747;Gene
PRKAG1;ACACA;Gene;PA33751;Gene
PRKAG2;ACACA;Gene;PA33752;Gene
PRKAG3;ACACA;Gene;PA33753;Gene
METABOLIC SYNDROME;rs11123469;Variant;PA162370415;Disease
SCHIZOPHRENIA;rs11123469;Variant;PA447216;Disease
ANTIPSYCHOTICS;rs11123469;Variant;PA452233;Chemical
MAJOR DEPRESSIVE DISORDER;rs2216711;Variant;PA447321;Disease
PAROXETINE;rs2216711;Variant;PA450801;Chemical
PLCB1;GNB1L;Gene;PA33384;Gene
PLCB2;GNB1L;Gene;PA33385;Gene
PLCB3;GNB1L;Gene;PA33386;Gene
PLCB4;GNB1L;Gene;PA33387;Gene
MYELOSUPPRESSION;TPMT*6;Haplotype;PA165817398;Disease
TPMT;TPMT*6;Haplotype;PA356;Gene
LEUKOPENIA;TPMT*6;Haplotype;PA444773;Disease
AZATHIOPRINE;TPMT*6;Haplotype;PA448515;Chemical
MERCAPTOPURINE;TPMT*6;Haplotype;PA450379;Chemical
THIOGUANINE;TPMT*6;Haplotype;PA451663;Chemical
CYP3A4;CYP3A4*11;Haplotype;PA130;Gene
TICAGRELOR;CYP3A4*11;Haplotype;PA165374673;Chemical
CABOZANTINIB;CYP3A4*11;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*11;Haplotype;PA165958362;Chemical
REGORAFENIB;CYP3A4*11;Haplotype;PA166114943;Chemical
VANDETANIB;CYP3A4*11;Haplotype;PA166118341;Chemical
BREXPIPRAZOLE;CYP3A4*11;Haplotype;PA166160053;Chemical
ACALABRUTINIB;CYP3A4*11;Haplotype;PA166198581;Chemical
MACITENTAN;CYP3A4*11;Haplotype;PA166261201;Chemical
AMIODARONE;CYP3A4*11;Haplotype;PA448383;Chemical
LIDOCAINE;CYP3A4*11;Haplotype;PA450226;Chemical
METHADONE;CYP3A4*11;Haplotype;PA450401;Chemical
OXYCODONE;CYP3A4*11;Haplotype;PA450741;Chemical
QUETIAPINE;CYP3A4*11;Haplotype;PA451201;Chemical
TESTOSTERONE;CYP3A4*11;Haplotype;PA451627;Chemical
RS1799971;Overdose;Disease;PA166156991;Variant
RS115208233;Overdose;Disease;PA166199581;Variant
RS116181528;Overdose;Disease;PA166199582;Variant
RS114077267;Overdose;Disease;PA166199601;Variant
MCOLN1;Overdose;Disease;PA30699;Gene
OPRM1;Overdose;Disease;PA31945;Gene
RHEUMATOID ARTHRITIS;rs2267076;Variant;PA443434;Disease
METHOTREXATE;rs2267076;Variant;PA450428;Chemical
CARDIOVASCULAR DISEASE;rs2819742;Variant;PA443635;Disease
RHABDOMYOLYSIS;rs2819742;Variant;PA445549;Disease
ATORVASTATIN;rs2819742;Variant;PA448500;Chemical
CERIVASTATIN;rs2819742;Variant;PA448897;Chemical
SIMVASTATIN;rs2819742;Variant;PA451363;Chemical
SLCO1B1;rs11045879;Variant;PA134865839;Gene
GASTROINTESTINAL TOXICITY;rs11045879;Variant;PA166124386;Disease
MTHFR;rs11045879;Variant;PA245;Gene
ABCB1;rs11045879;Variant;PA267;Gene
SLC19A1;rs11045879;Variant;PA327;Gene
LYMPHOMA;rs11045879;Variant;PA444840;Disease
NEOPLASMS;rs11045879;Variant;PA445062;Disease
OSTEOSARCOMA;rs11045879;Variant;PA445601;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs11045879;Variant;PA446155;Disease
MERCAPTOPURINE;rs11045879;Variant;PA450379;Chemical
METHOTREXATE;rs11045879;Variant;PA450428;Chemical
VORICONAZOLE;rs4646437;Variant;PA10233;Chemical
KIDNEY TRANSPLANTATION;rs4646437;Variant;PA165817016;Disease
HEROIN DEPENDENCE;rs4646437;Variant;PA444460;Disease
MYCOSES;rs4646437;Variant;PA445009;Disease
PROTEINURIA;rs4646437;Variant;PA445431;Disease
LIVER TRANSPLANTATION;rs4646437;Variant;PA447247;Disease
CYCLOSPORINE;rs4646437;Variant;PA449167;Chemical
METHADONE;rs4646437;Variant;PA450401;Chemical
TACROLIMUS;rs4646437;Variant;PA451578;Chemical
ARIPIPRAZOLE;rs2514218;Variant;PA10026;Chemical
SCHIZOAFFECTIVE DISORDER;rs2514218;Variant;PA166123368;Disease
PSYCHOMOTOR AGITATION;rs2514218;Variant;PA445452;Disease
PSYCHOTIC DISORDER;rs2514218;Variant;PA447215;Disease
SCHIZOPHRENIA;rs2514218;Variant;PA447216;Disease
RISPERIDONE;rs2514218;Variant;PA451257;Chemical
SCHIZOPHRENIA;rs5993883;Variant;PA447216;Disease
QUETIAPINE;rs5993883;Variant;PA451201;Chemical
PAIN;rs795484;Variant;PA445208;Disease
PAIN, POSTOPERATIVE;rs795484;Variant;PA445210;Disease
MORPHINE;rs795484;Variant;PA450550;Chemical
OPIOIDS;rs795484;Variant;PA452618;Chemical
NEOPLASMS;rs7867504;Variant;PA445062;Disease
GEMCITABINE;rs7867504;Variant;PA449748;Chemical
ASTHMA;rs16851030;Variant;PA443450;Disease
ASPIRIN;rs16851030;Variant;PA448497;Chemical
SODIUM OXYBATE;ALDH5A1;Gene;PA166236501;Chemical
OPIOID-RELATED DISORDERS;ALDH5A1;Gene;PA445043;Disease
METHADONE;ALDH5A1;Gene;PA450401;Chemical
VALPROIC ACID;ALDH5A1;Gene;PA451846;Chemical
HEROIN DEPENDENCE;rs5326;Variant;PA444460;Disease
METHADONE;rs5326;Variant;PA450401;Chemical
HYPERTENSION;rs5051;Variant;PA444552;Disease
ATENOLOL;rs5051;Variant;PA448499;Chemical
BENAZEPRIL;rs5051;Variant;PA448561;Chemical
IMIDAPRIL;rs5051;Variant;PA452640;Chemical
KIDNEY TRANSPLANTATION;rs11572076;Variant;PA165817016;Disease
MYCOPHENOLATE MOFETIL;rs11572076;Variant;PA450566;Chemical
FLUOROURACIL;rs79430272;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs79430272;Variant;PA443560;Disease
NEUTROPENIA;rs79430272;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs79430272;Variant;PA449165;Chemical
EPIRUBICIN;rs79430272;Variant;PA449476;Chemical
RS121908585;avapritinib;Chemical;PA166285041;Variant
KIT;avapritinib;Chemical;PA30128;Gene
PDGFRA;avapritinib;Chemical;PA33147;Gene
DEPRESSIVE DISORDER;rs11580409;Variant;PA447207;Disease
ANTIDEPRESSANTS;rs11580409;Variant;PA452229;Chemical
DPYD;rs200562975;Variant;PA145;Gene
CAPECITABINE;rs200562975;Variant;PA448771;Chemical
EFAVIRENZ;rs142421637;Variant;PA449441;Chemical
PROPOFOL;rs142421637;Variant;PA451141;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs3115672;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs3115672;Variant;PA445846;Disease
CARBOPLATIN;rs3115672;Variant;PA448803;Chemical
GEMCITABINE;rs3115672;Variant;PA449748;Chemical
CYP2D6;dronedarone;Chemical;PA128;Gene
CYP3A4;dronedarone;Chemical;PA130;Gene
METABOLIC SYNDROME;rs1414334;Variant;PA162370415;Disease
MENTAL DISORDERS;rs1414334;Variant;PA447208;Disease
SCHIZOPHRENIA;rs1414334;Variant;PA447216;Disease
CLOZAPINE;rs1414334;Variant;PA449061;Chemical
OLANZAPINE;rs1414334;Variant;PA450688;Chemical
RISPERIDONE;rs1414334;Variant;PA451257;Chemical
CDKL5;ganaxolone;Chemical;PA36218;Gene
SODIUM PHENYLBUTYRATE;OTC;Gene;PA166114316;Chemical
SODIUM BENZOATE / SODIUM PHENYLACETATE;OTC;Gene;PA166176020;Chemical
GLYCEROL PHENYLBUTYRATE;OTC;Gene;PA166268801;Chemical
VALPROIC ACID;OTC;Gene;PA451846;Chemical
ROSUVASTATIN;LDLR;Gene;PA134308647;Chemical
PITAVASTATIN;LDLR;Gene;PA142650384;Chemical
PEGINTERFERON ALFA-2A;LDLR;Gene;PA164749390;Chemical
PEGINTERFERON ALFA-2B;LDLR;Gene;PA164784024;Chemical
LOMITAPIDE;LDLR;Gene;PA166114922;Chemical
MIPOMERSEN;LDLR;Gene;PA166114927;Chemical
FAMILIAL HYPERCHOLESTEROLEMIA;LDLR;Gene;PA166114942;Disease
ALIROCUMAB;LDLR;Gene;PA166159961;Chemical
EVINACUMAB;LDLR;Gene;PA166222281;Chemical
INCLISIRAN;LDLR;Gene;PA166268802;Chemical
CORONARY DISEASE;LDLR;Gene;PA443797;Disease
HYPERTENSION;LDLR;Gene;PA444552;Disease
VASCULAR DISEASES;LDLR;Gene;PA446021;Disease
CHRONIC HEPATITIS C VIRUS INFECTION;LDLR;Gene;PA446863;Disease
HIV INFECTIOUS DISEASE;LDLR;Gene;PA447230;Disease
ATENOLOL;LDLR;Gene;PA448499;Chemical
ATORVASTATIN;LDLR;Gene;PA448500;Chemical
LOVASTATIN;LDLR;Gene;PA450272;Chemical
PRAVASTATIN;LDLR;Gene;PA451089;Chemical
RIBAVIRIN;LDLR;Gene;PA451241;Chemical
ABCC2;Lymphoid Leukemia;Disease;PA116;Gene
RS717620;Lymphoid Leukemia;Disease;PA166153953;Variant
G6PD DEFICIENCY;Lymphoid Leukemia;Disease;PA166157959;Variant
G6PD;Lymphoid Leukemia;Disease;PA28469;Gene
VALPROIC ACID;meropenem;Chemical;PA451846;Chemical
CYP2C19;event-free survival;Disease;PA124;Gene
CYP2D6;event-free survival;Disease;PA128;Gene
CYP2D6*1;event-free survival;Disease;PA165816576;Haplotype
CYP2D6*2;event-free survival;Disease;PA165816577;Haplotype
CYP2D6*3;event-free survival;Disease;PA165816578;Haplotype
CYP2D6*4;event-free survival;Disease;PA165816579;Haplotype
CYP2D6*6;event-free survival;Disease;PA165816581;Haplotype
CYP2D6*10;event-free survival;Disease;PA165816582;Haplotype
CYP2D6*41;event-free survival;Disease;PA165816584;Haplotype
TPMT*1;event-free survival;Disease;PA165819268;Haplotype
TPMT*2;event-free survival;Disease;PA165819269;Haplotype
TPMT*3A;event-free survival;Disease;PA165819270;Haplotype
TPMT*3C;event-free survival;Disease;PA165819272;Haplotype
TPMT*9;event-free survival;Disease;PA165819279;Haplotype
TPMT*21;event-free survival;Disease;PA165819291;Haplotype
CYP2D6*5;event-free survival;Disease;PA165948092;Haplotype
CYP2D6*9;event-free survival;Disease;PA165948317;Haplotype
CYP2D6*7;event-free survival;Disease;PA165971559;Haplotype
CYP2D6*11;event-free survival;Disease;PA165971564;Haplotype
CYP2D6*20;event-free survival;Disease;PA165971571;Haplotype
CYP2C19*1;event-free survival;Disease;PA165980634;Haplotype
CYP2C19*2;event-free survival;Disease;PA165980635;Haplotype
UGT2B15*1;event-free survival;Disease;PA165984975;Haplotype
UGT2B15*2;event-free survival;Disease;PA165984976;Haplotype
CYP2D6*1XN;event-free survival;Disease;PA165988479;Haplotype
CYP2D6*35;event-free survival;Disease;PA165988487;Haplotype
CYP2D6*36;event-free survival;Disease;PA165988488;Haplotype
TPMT*32;event-free survival;Disease;PA166005223;Haplotype
TPMT*33;event-free survival;Disease;PA166005224;Haplotype
TPMT*34;event-free survival;Disease;PA166005225;Haplotype
TPMT;event-free survival;Disease;PA356;Gene
UGT2B15;event-free survival;Disease;PA37188;Gene
CALCIUM CHANNEL BLOCKERS;PICALM;Gene;PA10407;Chemical
HYPERTENSION;PICALM;Gene;PA444552;Disease
IFNL3;ombitasvir / paritaprevir / ritonavir;Chemical;PA134952671;Gene
IFNL4;ombitasvir / paritaprevir / ritonavir;Chemical;PA166049147;Gene
RS12979860;ombitasvir / paritaprevir / ritonavir;Chemical;PA166155468;Variant
ILOPERIDONE;rs4799915;Variant;PA161199368;Chemical
ACQUIRED LONG QT SYNDROME (ALQTS);rs4799915;Variant;PA447300;Disease
GSTM1;lazertinib;Chemical;PA182;Gene
EGFR;lazertinib;Chemical;PA7360;Gene
DULOXETINE;rs61908410;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs61908410;Variant;PA447321;Disease
NICOTINE;rs772964366;Variant;PA450626;Chemical
CYP3A4;clozapine n-oxide;Chemical;PA130;Gene
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;SPSB2;Gene;PA447197;Disease
METHYLPHENIDATE;SPSB2;Gene;PA450464;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs4696480;Variant;PA164713366;Chemical
ULCERATIVE COLITIS;rs4696480;Variant;PA443750;Disease
PSORIASIS;rs4696480;Variant;PA445451;Disease
ADRA1D;dopamine;Chemical;PA24597;Gene
ADRA1B;dopamine;Chemical;PA33;Gene
ADRA1A;dopamine;Chemical;PA34;Gene
ADRA2A;dopamine;Chemical;PA35;Gene
ADRA2B;dopamine;Chemical;PA36;Gene
ADRA2C;dopamine;Chemical;PA37;Gene
ADRB1;dopamine;Chemical;PA38;Gene
OTOTOXICITY;ABCC3;Gene;PA162263534;Disease
DRUG TOXICITY;ABCC3;Gene;PA443937;Disease
NEOPLASMS;ABCC3;Gene;PA445062;Disease
PAIN;ABCC3;Gene;PA445208;Disease
OSTEOSARCOMA;ABCC3;Gene;PA445601;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;ABCC3;Gene;PA446155;Disease
CISPLATIN;ABCC3;Gene;PA449014;Chemical
CYCLOPHOSPHAMIDE;ABCC3;Gene;PA449165;Chemical
DOXORUBICIN;ABCC3;Gene;PA449412;Chemical
LAMIVUDINE;ABCC3;Gene;PA450163;Chemical
METHOTREXATE;ABCC3;Gene;PA450428;Chemical
MORPHINE;ABCC3;Gene;PA450550;Chemical
VINCRISTINE;ABCC3;Gene;PA451879;Chemical
MULTIVITAMINS, PLAIN;rs70991108;Variant;PA164712913;Chemical
DRUG-INDUCED LIVER INJURY;rs70991108;Variant;PA166119041;Disease
BREAST NEOPLASMS;rs70991108;Variant;PA443560;Disease
LEUKOPENIA;rs70991108;Variant;PA444773;Disease
THROMBOCYTOPENIA;rs70991108;Variant;PA445846;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;rs70991108;Variant;PA446155;Disease
METHOTREXATE;rs70991108;Variant;PA450428;Chemical
WEIGHT GAIN;GHRL;Gene;PA128406954;Disease
CLOBAZAM;POR;Gene;PA10888;Chemical
TRANSPLANTATION;POR;Gene;PA134850491;Disease
GASTROINTESTINAL STROMAL TUMORS;POR;Gene;PA151958383;Disease
SUNITINIB;POR;Gene;PA162372840;Chemical
KIDNEY TRANSPLANTATION;POR;Gene;PA165817016;Disease
FAMILIAL HYPERCHOLESTEROLEMIA;POR;Gene;PA166114942;Disease
ATORVASTATIN;POR;Gene;PA448500;Chemical
CYCLOSPORINE;POR;Gene;PA449167;Chemical
MIDAZOLAM;POR;Gene;PA450496;Chemical
NICOTINE;POR;Gene;PA450626;Chemical
SIROLIMUS;POR;Gene;PA451365;Chemical
TACROLIMUS;POR;Gene;PA451578;Chemical
WARFARIN;POR;Gene;PA451906;Chemical
ZIDOVUDINE;POR;Gene;PA451954;Chemical
ARIPIPRAZOLE;CYP2D6*5;Haplotype;PA10026;Chemical
DULOXETINE;CYP2D6*5;Haplotype;PA10066;Chemical
ESCITALOPRAM;CYP2D6*5;Haplotype;PA10074;Chemical
GEFITINIB;CYP2D6*5;Haplotype;PA131301952;Chemical
3,4-METHYLENEDIOXYMETHAMPHETAMINE;CYP2D6*5;Haplotype;PA131887008;Chemical
MIANSERIN;CYP2D6*5;Haplotype;PA134687937;Chemical
ATOMOXETINE;CYP2D6*5;Haplotype;PA134688071;Chemical
TROPISETRON;CYP2D6*5;Haplotype;PA161925594;Chemical
TOLTERODINE;CYP2D6*5;Haplotype;PA164746757;Chemical
TOXIC LIVER DISEASE;CYP2D6*5;Haplotype;PA164925725;Disease
DRY MOUTH;CYP2D6*5;Haplotype;PA166115462;Disease
PROGRESSION-FREE SURVIVAL;CYP2D6*5;Haplotype;PA166123026;Disease
OVERALL SURVIVAL;CYP2D6*5;Haplotype;PA166123207;Disease
AGITATION;CYP2D6*5;Haplotype;PA166123306;Disease
EVENT-FREE SURVIVAL;CYP2D6*5;Haplotype;PA166123366;Disease
SCHIZOAFFECTIVE DISORDER;CYP2D6*5;Haplotype;PA166123368;Disease
ENDOXIFEN;CYP2D6*5;Haplotype;PA166124478;Chemical
4-HYDROXYTAMOXIFEN;CYP2D6*5;Haplotype;PA166127652;Chemical
RECURRENCE FREE SURVIVAL;CYP2D6*5;Haplotype;PA166127658;Disease
CARDIOTOXICITY;CYP2D6*5;Haplotype;PA166128121;Disease
SEDATION;CYP2D6*5;Haplotype;PA166129521;Disease
O-DESMETHYLTRAMADOL;CYP2D6*5;Haplotype;PA166131379;Chemical
N-DESMETHYLTRAMADOL;CYP2D6*5;Haplotype;PA166131493;Chemical
N,O-DIDESMETHYLTRAMADOL;CYP2D6*5;Haplotype;PA166131494;Chemical
TOLPERISONE;CYP2D6*5;Haplotype;PA166152940;Chemical
MEPHEDRONE;CYP2D6*5;Haplotype;PA166184711;Chemical
DYSPHORIA;CYP2D6*5;Haplotype;PA166185295;Disease
ADENOCARCINOMA;CYP2D6*5;Haplotype;PA443265;Disease
ALZHEIMER DISEASE;CYP2D6*5;Haplotype;PA443319;Disease
ANEMIA, SICKLE CELL;CYP2D6*5;Haplotype;PA443355;Disease
ARRHYTHMIAS, CARDIAC;CYP2D6*5;Haplotype;PA443421;Disease
BRAIN NEOPLASMS;CYP2D6*5;Haplotype;PA443557;Disease
BREAST NEOPLASMS;CYP2D6*5;Haplotype;PA443560;Disease
CARCINOMA, NON-SMALL-CELL LUNG;CYP2D6*5;Haplotype;PA443622;Disease
CONSTIPATION;CYP2D6*5;Haplotype;PA443782;Disease
DEATH;CYP2D6*5;Haplotype;PA443842;Disease
DEMENTIA;CYP2D6*5;Haplotype;PA443853;Disease
DIABETIC NEUROPATHIES;CYP2D6*5;Haplotype;PA443894;Disease
DIZZINESS;CYP2D6*5;Haplotype;PA443928;Disease
DRUG TOXICITY;CYP2D6*5;Haplotype;PA443937;Disease
DYSTONIA;CYP2D6*5;Haplotype;PA443970;Disease
EDEMA;CYP2D6*5;Haplotype;PA443994;Disease
EXANTHEMA;CYP2D6*5;Haplotype;PA444109;Disease
HEAD AND NECK NEOPLASMS;CYP2D6*5;Haplotype;PA444352;Disease
HEART DISEASES;CYP2D6*5;Haplotype;PA444368;Disease
HEART FAILURE;CYP2D6*5;Haplotype;PA444370;Disease
HYPERTENSION;CYP2D6*5;Haplotype;PA444552;Disease
INAPPROPRIATE ADH SYNDROME;CYP2D6*5;Haplotype;PA444607;Disease
MALARIA;CYP2D6*5;Haplotype;PA444859;Disease
NAUSEA;CYP2D6*5;Haplotype;PA445048;Disease
PAIN;CYP2D6*5;Haplotype;PA445208;Disease
PAIN, POSTOPERATIVE;CYP2D6*5;Haplotype;PA445210;Disease
RECURRENCE;CYP2D6*5;Haplotype;PA445506;Disease
TACHYCARDIA;CYP2D6*5;Haplotype;PA445802;Disease
VOMITING;CYP2D6*5;Haplotype;PA446051;Disease
ALCOHOL-RELATED DISORDERS;CYP2D6*5;Haplotype;PA446879;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CYP2D6*5;Haplotype;PA447197;Disease
AUTISTIC DISORDER;CYP2D6*5;Haplotype;PA447198;Disease
DEPRESSIVE DISORDER;CYP2D6*5;Haplotype;PA447207;Disease
MENTAL DISORDERS;CYP2D6*5;Haplotype;PA447208;Disease
OBSESSIVE-COMPULSIVE DISORDER;CYP2D6*5;Haplotype;PA447211;Disease
PSYCHOTIC DISORDERS;CYP2D6*5;Haplotype;PA447215;Disease
SCHIZOPHRENIA;CYP2D6*5;Haplotype;PA447216;Disease
TARDIVE DYSKINESIA;CYP2D6*5;Haplotype;PA447268;Disease
DEPRESSION;CYP2D6*5;Haplotype;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2D6*5;Haplotype;PA447321;Disease
AMITRIPTYLINE;CYP2D6*5;Haplotype;PA448385;Chemical
ASPIRIN;CYP2D6*5;Haplotype;PA448497;Chemical
CARVEDILOL;CYP2D6*5;Haplotype;PA448817;Chemical
CITALOPRAM;CYP2D6*5;Haplotype;PA449015;Chemical
CLOMIPRAMINE;CYP2D6*5;Haplotype;PA449048;Chemical
CODEINE;CYP2D6*5;Haplotype;PA449088;Chemical
DESIPRAMINE;CYP2D6*5;Haplotype;PA449233;Chemical
DEXTROMETHORPHAN;CYP2D6*5;Haplotype;PA449273;Chemical
DONEPEZIL;CYP2D6*5;Haplotype;PA449394;Chemical
DOXEPIN;CYP2D6*5;Haplotype;PA449409;Chemical
FLECAINIDE;CYP2D6*5;Haplotype;PA449646;Chemical
FLUOXETINE;CYP2D6*5;Haplotype;PA449673;Chemical
FLUVOXAMINE;CYP2D6*5;Haplotype;PA449690;Chemical
GALANTAMINE;CYP2D6*5;Haplotype;PA449726;Chemical
HALOPERIDOL;CYP2D6*5;Haplotype;PA449841;Chemical
HYDROCODONE;CYP2D6*5;Haplotype;PA449900;Chemical
HYDROMORPHONE;CYP2D6*5;Haplotype;PA449918;Chemical
IMIPRAMINE;CYP2D6*5;Haplotype;PA449969;Chemical
KETOPROFEN;CYP2D6*5;Haplotype;PA450149;Chemical
LOVASTATIN;CYP2D6*5;Haplotype;PA450272;Chemical
METHYLPHENIDATE;CYP2D6*5;Haplotype;PA450464;Chemical
METOPROLOL;CYP2D6*5;Haplotype;PA450480;Chemical
MIRTAZAPINE;CYP2D6*5;Haplotype;PA450522;Chemical
NORTRIPTYLINE;CYP2D6*5;Haplotype;PA450657;Chemical
ONDANSETRON;CYP2D6*5;Haplotype;PA450705;Chemical
OXYCODONE;CYP2D6*5;Haplotype;PA450741;Chemical
PAROXETINE;CYP2D6*5;Haplotype;PA450801;Chemical
PRIMAQUINE;CYP2D6*5;Haplotype;PA451103;Chemical
PROPAFENONE;CYP2D6*5;Haplotype;PA451131;Chemical
RISPERIDONE;CYP2D6*5;Haplotype;PA451257;Chemical
SULFASALAZINE;CYP2D6*5;Haplotype;PA451547;Chemical
TAMOXIFEN;CYP2D6*5;Haplotype;PA451581;Chemical
TIMOLOL;CYP2D6*5;Haplotype;PA451690;Chemical
TRAMADOL;CYP2D6*5;Haplotype;PA451735;Chemical
TRIMIPRAMINE;CYP2D6*5;Haplotype;PA451791;Chemical
VENLAFAXINE;CYP2D6*5;Haplotype;PA451866;Chemical
ANTIPSYCHOTICS;CYP2D6*5;Haplotype;PA452233;Chemical
SPARTEINE;CYP2D6*5;Haplotype;PA452610;Chemical
DEBRISOQUINE;CYP2D6*5;Haplotype;PA452616;Chemical
ANTINEOPLASTIC AGENTS;CYP2D6*5;Haplotype;PA452621;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;C9orf72;Gene;PA164713366;Chemical
RHEUMATOID ARTHRITIS;C9orf72;Gene;PA443434;Disease
DPYD;rs138616379;Variant;PA145;Gene
CAPECITABINE;rs138616379;Variant;PA448771;Chemical
CHRNA3;rozanolixizumab;Chemical;PA113;Gene
CHRNA7;rozanolixizumab;Chemical;PA114;Gene
CHRNA1;rozanolixizumab;Chemical;PA26487;Gene
CHRNA4;rozanolixizumab;Chemical;PA26490;Gene
CHRNA5;rozanolixizumab;Chemical;PA26491;Gene
CHRNA6;rozanolixizumab;Chemical;PA26492;Gene
CHRNB1;rozanolixizumab;Chemical;PA26494;Gene
CHRNE;rozanolixizumab;Chemical;PA26498;Gene
MUSK;rozanolixizumab;Chemical;PA31326;Gene
LAMIVUDINE;PCYT2;Gene;PA450163;Chemical
BISPHOSPHONATES;rs1678387;Variant;PA164712563;Chemical
OSTEONECROSIS;rs1678387;Variant;PA445187;Disease
HEROIN DEPENDENCE;rs3802279;Variant;PA444460;Disease
METHADONE;rs3802279;Variant;PA450401;Chemical
WARFARIN;rs1877724;Variant;PA451906;Chemical
RHEUMATOID ARTHRITIS;rs9977268;Variant;PA443434;Disease
METHOTREXATE;rs9977268;Variant;PA450428;Chemical
RS121434568;dacomitinib;Chemical;PA166157527;Variant
EGFR;dacomitinib;Chemical;PA7360;Gene
IVACAFTOR;rs397508435;Variant;PA165950341;Chemical
CYSTIC FIBROSIS;rs397508435;Variant;PA443829;Disease
ANTHRACYCLINES AND RELATED SUBSTANCES;rs1149222;Variant;PA130620651;Chemical
NEOPLASMS;rs1149222;Variant;PA445062;Disease
CORONARY ARTERY DISEASE;KCNMB1;Gene;PA443796;Disease
HYPERTENSION;KCNMB1;Gene;PA444552;Disease
VERAPAMIL;KCNMB1;Gene;PA451868;Chemical
HMG COA REDUCTASE INHIBITORS;APOE;Gene;PA133950441;Chemical
ANTIVIRALS FOR TREATMENT OF HIV INFECTIONS, COMBINATIONS;APOE;Gene;PA164712505;Chemical
MTTP;APOE;Gene;PA164742099;Gene
RS7412;APOE;Gene;PA166155341;Variant
RS429358;APOE;Gene;PA166155351;Variant
LECANEMAB;APOE;Gene;PA166313301;Chemical
ADUCANUMAB;APOE;Gene;PA166350685;Chemical
DONANEMAB;APOE;Gene;PA166400001;Chemical
ALZHEIMER DISEASE;APOE;Gene;PA443319;Disease
CORONARY DISEASE;APOE;Gene;PA443797;Disease
HEMORRHAGE;APOE;Gene;PA444417;Disease
HYPERLIPIDEMIAS;APOE;Gene;PA444528;Disease
MYOCARDIAL INFARCTION;APOE;Gene;PA445019;Disease
HYPERTRIGLYCERIDEMIA;APOE;Gene;PA446120;Disease
HIV INFECTIOUS DISEASE;APOE;Gene;PA447230;Disease
VENOUS THROMBOEMBOLISM;APOE;Gene;PA447298;Disease
ATORVASTATIN;APOE;Gene;PA448500;Chemical
FENOFIBRATE;APOE;Gene;PA449594;Chemical
FLUVASTATIN;APOE;Gene;PA449688;Chemical
PRAVASTATIN;APOE;Gene;PA451089;Chemical
RITONAVIR;APOE;Gene;PA451260;Chemical
SIMVASTATIN;APOE;Gene;PA451363;Chemical
WARFARIN;APOE;Gene;PA451906;Chemical
ACENOCOUMAROL;APOE;Gene;PA452632;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*70;Haplotype;PA166127651;Chemical
PRIMAQUINE;CYP2D6*70;Haplotype;PA451103;Chemical
IMATINIB;rs2231137;Variant;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;rs2231137;Variant;PA151958383;Disease
DASATINIB;rs2231137;Variant;PA162372878;Chemical
NILOTINIB;rs2231137;Variant;PA165958345;Chemical
RESMETIROM;rs2231137;Variant;PA166353181;Chemical
ABCG2;rs2231137;Variant;PA390;Gene
NON-SMALL CELL LUNG CARCINOMA;rs2231137;Variant;PA443622;Disease
DRUG TOXICITY;rs2231137;Variant;PA443937;Disease
IRINOTECAN;rs2231137;Variant;PA450085;Chemical
DIURETICS;NELFCD;Gene;PA151249535;Chemical
THIAZIDES, PLAIN;NELFCD;Gene;PA164713347;Chemical
HYPERTENSION;NELFCD;Gene;PA444552;Disease
HYDROCHLOROTHIAZIDE;NELFCD;Gene;PA449899;Chemical
DULOXETINE;rs9310657;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs9310657;Variant;PA447321;Disease
EZETIMIBE;rs4149056;Variant;PA10816;Chemical
CYP2C9;rs4149056;Variant;PA126;Gene
FLUOROURACIL;rs4149056;Variant;PA128406956;Chemical
HMG COA REDUCTASE INHIBITORS;rs4149056;Variant;PA133950441;Chemical
ROSUVASTATIN;rs4149056;Variant;PA134308647;Chemical
SLCO1B1;rs4149056;Variant;PA134865839;Gene
PITAVASTATIN;rs4149056;Variant;PA142650384;Chemical
NEPHROTOXICITY;rs4149056;Variant;PA162263533;Disease
GEMTUZUMAB OZOGAMICIN;rs4149056;Variant;PA164749431;Chemical
DYSLIPIDAEMIA;rs4149056;Variant;PA165108110;Disease
ACUTE CORONARY SYNDROME;rs4149056;Variant;PA165108401;Disease
SN-38;rs4149056;Variant;PA165110775;Chemical
TICAGRELOR;rs4149056;Variant;PA165374673;Chemical
KIDNEY TRANSPLANTATION;rs4149056;Variant;PA165817016;Disease
GLUCARPIDASE;rs4149056;Variant;PA165949771;Chemical
FAMILIAL HYPERCHOLESTEROLEMIA;rs4149056;Variant;PA166114942;Disease
SIMVASTATIN ACID;rs4149056;Variant;PA166129446;Chemical
LOVASTATIN ACID;rs4149056;Variant;PA166163161;Chemical
STATIN-RELATED MYOPATHY;rs4149056;Variant;PA166163391;Disease
ELAGOLIX;rs4149056;Variant;PA166182348;Chemical
AMLODIPINE / ATORVASTATIN / PERINDOPRIL ARGININE;rs4149056;Variant;PA166183785;Chemical
LETERMOVIR;rs4149056;Variant;PA166184379;Chemical
EZETIMIBE / SIMVASTATIN;rs4149056;Variant;PA166184495;Chemical
EZETIMIBE / ROSUVASTATIN;rs4149056;Variant;PA166184498;Chemical
DULAGLUTIDE;rs4149056;Variant;PA166285081;Chemical
G6PD;rs4149056;Variant;PA28469;Gene
ABCG2;rs4149056;Variant;PA390;Gene
UGT1A1;rs4149056;Variant;PA420;Gene
BREAST NEOPLASMS;rs4149056;Variant;PA443560;Disease
NON-SMALL CELL LUNG CARCINOMA;rs4149056;Variant;PA443622;Disease
CARDIOVASCULAR DISEASE;rs4149056;Variant;PA443635;Disease
DIABETES MELLITUS, TYPE 2;rs4149056;Variant;PA443890;Disease
HYPERCHOLESTEROLEMIA;rs4149056;Variant;PA444516;Disease
HYPERLIPIDEMIAS;rs4149056;Variant;PA444528;Disease
LEUKEMIA, MYELOID, ACUTE;rs4149056;Variant;PA444760;Disease
NEOPLASMS;rs4149056;Variant;PA445062;Disease
RHABDOMYOLYSIS;rs4149056;Variant;PA445549;Disease
OSTEOSARCOMA;rs4149056;Variant;PA445601;Disease
THROMBOCYTOPENIA;rs4149056;Variant;PA445846;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs4149056;Variant;PA446155;Disease
HIV INFECTIOUS DISEASE;rs4149056;Variant;PA447230;Disease
ESSENTIAL HYPERTENSION;rs4149056;Variant;PA447288;Disease
AMPRENAVIR;rs4149056;Variant;PA448422;Chemical
ATORVASTATIN;rs4149056;Variant;PA448500;Chemical
CARVEDILOL;rs4149056;Variant;PA448817;Chemical
CERIVASTATIN;rs4149056;Variant;PA448897;Chemical
CYCLOPHOSPHAMIDE;rs4149056;Variant;PA449165;Chemical
CYTARABINE;rs4149056;Variant;PA449177;Chemical
DILTIAZEM;rs4149056;Variant;PA449334;Chemical
DOCETAXEL;rs4149056;Variant;PA449383;Chemical
DOXORUBICIN;rs4149056;Variant;PA449412;Chemical
ENALAPRIL;rs4149056;Variant;PA449456;Chemical
EPIRUBICIN;rs4149056;Variant;PA449476;Chemical
FENOFIBRATE;rs4149056;Variant;PA449594;Chemical
FLUDARABINE;rs4149056;Variant;PA449655;Chemical
FLUOXETINE;rs4149056;Variant;PA449673;Chemical
FLUVASTATIN;rs4149056;Variant;PA449688;Chemical
FUROSEMIDE;rs4149056;Variant;PA449719;Chemical
IDARUBICIN;rs4149056;Variant;PA449961;Chemical
IRINOTECAN;rs4149056;Variant;PA450085;Chemical
LANSOPRAZOLE;rs4149056;Variant;PA450180;Chemical
LEVOTHYROXINE;rs4149056;Variant;PA450221;Chemical
LOPINAVIR;rs4149056;Variant;PA450264;Chemical
LORAZEPAM;rs4149056;Variant;PA450267;Chemical
LOVASTATIN;rs4149056;Variant;PA450272;Chemical
MERCAPTOPURINE;rs4149056;Variant;PA450379;Chemical
METHOTREXATE;rs4149056;Variant;PA450428;Chemical
MYCOPHENOLATE MOFETIL;rs4149056;Variant;PA450566;Chemical
PRAVASTATIN;rs4149056;Variant;PA451089;Chemical
REPAGLINIDE;rs4149056;Variant;PA451234;Chemical
RIFAMPIN;rs4149056;Variant;PA451250;Chemical
ROSIGLITAZONE;rs4149056;Variant;PA451283;Chemical
SIMVASTATIN;rs4149056;Variant;PA451363;Chemical
WARFARIN;rs4149056;Variant;PA451906;Chemical
SORAFENIB;rs4149056;Variant;PA7000;Chemical
CYP2C8;delayed graft function;Disease;PA125;Gene
CYP3A5;delayed graft function;Disease;PA131;Gene
CYP2C8*3;delayed graft function;Disease;PA165958685;Haplotype
CYP3A5*1;delayed graft function;Disease;PA166128213;Haplotype
CYP3A5*3;delayed graft function;Disease;PA166128219;Haplotype
CYP3A5*6;delayed graft function;Disease;PA166128233;Haplotype
CYP3A5*7;delayed graft function;Disease;PA166128234;Haplotype
CYP2C8*1;delayed graft function;Disease;PA166242948;Haplotype
ADEFOVIR DIPIVOXIL;ABCC4;Gene;PA10005;Chemical
TENOFOVIR;ABCC4;Gene;PA10204;Chemical
VALGANCICLOVIR;ABCC4;Gene;PA10227;Chemical
IMATINIB;ABCC4;Gene;PA10804;Chemical
FLUOROURACIL;ABCC4;Gene;PA128406956;Chemical
GASTROINTESTINAL STROMAL TUMORS;ABCC4;Gene;PA151958383;Disease
NEPHROTOXICITY;ABCC4;Gene;PA162263533;Disease
BISPHOSPHONATES;ABCC4;Gene;PA164712563;Chemical
LATANOPROST;ABCC4;Gene;PA164774763;Chemical
KIDNEY TRANSPLANTATION;ABCC4;Gene;PA165817016;Disease
GLUCARPIDASE;ABCC4;Gene;PA165949771;Chemical
TENOFOVIR DISOPROXIL FUMARATE;ABCC4;Gene;PA166201941;Chemical
17BETA-ESTRADIOL GLUCURONIDE;ABCC4;Gene;PA166277182;Chemical
NPM1;ABCC4;Gene;PA31712;Gene
BREAST NEOPLASMS;ABCC4;Gene;PA443560;Disease
BURKITT LYMPHOMA;ABCC4;Gene;PA443580;Disease
DEATH;ABCC4;Gene;PA443842;Disease
DRUG TOXICITY;ABCC4;Gene;PA443937;Disease
OPEN-ANGLE GLAUCOMA;ABCC4;Gene;PA444282;Disease
HEART FAILURE;ABCC4;Gene;PA444370;Disease
NEOPLASMS;ABCC4;Gene;PA445062;Disease
NEUTROPENIA;ABCC4;Gene;PA445113;Disease
OSTEONECROSIS;ABCC4;Gene;PA445187;Disease
INFLAMMATORY BOWEL DISEASES;ABCC4;Gene;PA446116;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;ABCC4;Gene;PA446155;Disease
SMALL CELL CARCINOMA;ABCC4;Gene;PA446661;Disease
HIV INFECTIOUS DISEASE;ABCC4;Gene;PA447230;Disease
AZATHIOPRINE;ABCC4;Gene;PA448515;Chemical
CISPLATIN;ABCC4;Gene;PA449014;Chemical
CYCLOPHOSPHAMIDE;ABCC4;Gene;PA449165;Chemical
CYTARABINE;ABCC4;Gene;PA449177;Chemical
DOXORUBICIN;ABCC4;Gene;PA449412;Chemical
FUROSEMIDE;ABCC4;Gene;PA449719;Chemical
IRINOTECAN;ABCC4;Gene;PA450085;Chemical
LAMIVUDINE;ABCC4;Gene;PA450163;Chemical
MERCAPTOPURINE;ABCC4;Gene;PA450379;Chemical
METHOTREXATE;ABCC4;Gene;PA450428;Chemical
ZIDOVUDINE;ABCC4;Gene;PA451954;Chemical
PURINE ANALOGUES;ABCC4;Gene;PA452634;Chemical
FLUOROURACIL;PARD3B;Gene;PA128406956;Chemical
OXALIPLATIN;PARD3B;Gene;PA131285527;Chemical
DRUG TOXICITY;PARD3B;Gene;PA443937;Disease
COLORECTAL NEOPLASMS;PARD3B;Gene;PA446108;Disease
ADALIMUMAB;PTPRC;Gene;PA10004;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;PTPRC;Gene;PA164713366;Chemical
RHEUMATOID ARTHRITIS;PTPRC;Gene;PA443434;Disease
ETANERCEPT;PTPRC;Gene;PA449515;Chemical
INFLIXIMAB;PTPRC;Gene;PA452639;Chemical
CFTR;latonduine a;Chemical;PA109;Gene
RS113993960;latonduine a;Chemical;PA166157525;Variant
THYROTROPIN ALFA;rs6166;Variant;PA164746560;Chemical
MENOTROPINS;rs6166;Variant;PA164749406;Chemical
OVARIAN HYPERSTIMULATION SYNDROME;rs6166;Variant;PA165108853;Disease
INFERTILITY DISORDER;rs6166;Variant;PA444617;Disease
INFERTILITY, FEMALE;rs6166;Variant;PA444618;Disease
FOLLITROPIN BETA;rs6166;Variant;PA449693;Chemical
GONADOTROPIN,CHORIONIC;rs6166;Variant;PA449804;Chemical
UROFOLLITROPIN;rs6166;Variant;PA451835;Chemical
ROFLUMILAST;rs121909011;Variant;PA165948052;Chemical
IVACAFTOR;rs121909011;Variant;PA165950341;Chemical
IVACAFTOR / LUMACAFTOR;rs121909011;Variant;PA166152935;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs121909011;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs121909011;Variant;PA443829;Disease
COMT;haloperidol;Chemical;PA117;Gene
CYP2D6;haloperidol;Chemical;PA128;Gene
CYP3A5;haloperidol;Chemical;PA131;Gene
ANKK1;haloperidol;Chemical;PA134872551;Gene
HTR3E;haloperidol;Chemical;PA134900226;Gene
ZIC4;haloperidol;Chemical;PA134937175;Gene
ARID5B;haloperidol;Chemical;PA134943193;Gene
EIF2AK4;haloperidol;Chemical;PA134947616;Gene
PLEKHA6;haloperidol;Chemical;PA134955964;Gene
HOMER1;haloperidol;Chemical;PA134972608;Gene
DRD1;haloperidol;Chemical;PA147;Gene
RTKN2;haloperidol;Chemical;PA162402276;Gene
CYP2D6*1;haloperidol;Chemical;PA165816576;Haplotype
CYP2D6*2;haloperidol;Chemical;PA165816577;Haplotype
CYP2D6*3;haloperidol;Chemical;PA165816578;Haplotype
CYP2D6*4;haloperidol;Chemical;PA165816579;Haplotype
CYP2D6*6;haloperidol;Chemical;PA165816581;Haplotype
CYP2D6*10;haloperidol;Chemical;PA165816582;Haplotype
CYP2D6*17;haloperidol;Chemical;PA165816583;Haplotype
CYP2D6*5;haloperidol;Chemical;PA165948092;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);haloperidol;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);haloperidol;Chemical;PA166116466;Haplotype
RS324420;haloperidol;Chemical;PA166153569;Variant
RS7912580;haloperidol;Chemical;PA166154088;Variant
RS2298826;haloperidol;Chemical;PA166154366;Variant
RS2412459;haloperidol;Chemical;PA166154891;Variant
RS489693;haloperidol;Chemical;PA166155269;Variant
RS4680;haloperidol;Chemical;PA166156024;Variant
RS909706;haloperidol;Chemical;PA166156964;Variant
RS1415744;haloperidol;Chemical;PA166156984;Variant
RS17143212;haloperidol;Chemical;PA166157469;Variant
FLUOROBENZOYLPROPIONIC ACID;haloperidol;Chemical;PA166163822;Chemical
HTR2C;haloperidol;Chemical;PA194;Gene
KCNH2;haloperidol;Chemical;PA212;Gene
ABCB5;haloperidol;Chemical;PA24387;Gene
AKAP13;haloperidol;Chemical;PA24665;Gene
ABCB1;haloperidol;Chemical;PA267;Gene
DPP6;haloperidol;Chemical;PA27468;Gene
DRD2;haloperidol;Chemical;PA27478;Gene
DTNBP1;haloperidol;Chemical;PA27512;Gene
TOR1A;haloperidol;Chemical;PA27556;Gene
EPM2A;haloperidol;Chemical;PA27832;Gene
FAAH;haloperidol;Chemical;PA27955;Gene
GRIA1;haloperidol;Chemical;PA28966;Gene
GRIK4;haloperidol;Chemical;PA28976;Gene
GRIN1;haloperidol;Chemical;PA28978;Gene
GRIN2A;haloperidol;Chemical;PA28979;Gene
GRIN2B;haloperidol;Chemical;PA28980;Gene
HSPG2;haloperidol;Chemical;PA29537;Gene
HTR3A;haloperidol;Chemical;PA29555;Gene
IL1RN;haloperidol;Chemical;PA29816;Gene
MC4R;haloperidol;Chemical;PA30676;Gene
SLC6A3;haloperidol;Chemical;PA311;Gene
SLC6A4;haloperidol;Chemical;PA312;Gene
NKX6-1;haloperidol;Chemical;PA31646;Gene
NTS;haloperidol;Chemical;PA31820;Gene
RGS2;haloperidol;Chemical;PA34372;Gene
RYR1;haloperidol;Chemical;PA34896;Gene
SLC6A5;haloperidol;Chemical;PA35911;Gene
CACNA1C;haloperidol;Chemical;PA83;Gene
COLORECTAL NEOPLASMS;rs11692021;Variant;PA446108;Disease
IRINOTECAN;rs11692021;Variant;PA450085;Chemical
HEROIN DEPENDENCE;rs3749034;Variant;PA444460;Disease
METHADONE;rs3749034;Variant;PA450401;Chemical
OPIOID-RELATED DISORDERS;rs718656;Variant;PA445043;Disease
OPIOIDS;rs718656;Variant;PA452618;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*25;Haplotype;PA166127651;Chemical
PRIMAQUINE;CYP2D6*25;Haplotype;PA451103;Chemical
TENOFOVIR;rs113165732;Variant;PA10204;Chemical
HIV INFECTIOUS DISEASE;rs113165732;Variant;PA447230;Disease
NAUSEA;rs36024412;Variant;PA445048;Disease
VOMITING;rs36024412;Variant;PA446051;Disease
OPIOIDS;rs36024412;Variant;PA452618;Chemical
G6PD B (REFERENCE);Anemia, Hemolytic;Disease;PA165947826;Haplotype
G6PD A- 202A_376G;Anemia, Hemolytic;Disease;PA165947827;Haplotype
G6PD MEDITERRANEAN HAPLOTYPE;Anemia, Hemolytic;Disease;PA165947830;Haplotype
G6PD MEDITERRANEAN, DALLAS, PANAMA, SASSARI, CAGLIARI, BIRMINGHAM;Anemia, Hemolytic;Disease;PA166121127;Haplotype
G6PD CANTON, TAIWAN-HAKKA, GIFU-LIKE, AGRIGENTO-LIKE;Anemia, Hemolytic;Disease;PA166121153;Haplotype
RS72554665;Anemia, Hemolytic;Disease;PA166157888;Variant
G6PD DEFICIENCY;Anemia, Hemolytic;Disease;PA166157959;Variant
G6PD;Anemia, Hemolytic;Disease;PA28469;Gene
CLAVULANATE;HLA-DRB5*01:01;Haplotype;PA164742987;Chemical
HEPATITIS;HLA-DRB5*01:01;Haplotype;PA444435;Disease
INFECTION;HLA-DRB5*01:01;Haplotype;PA444614;Disease
AMOXICILLIN;HLA-DRB5*01:01;Haplotype;PA448406;Chemical
ASTHMA;ABCC9;Gene;PA443450;Disease
MONTELUKAST;ABCC9;Gene;PA450546;Chemical
NEPHROTOXICITY;rs7317112;Variant;PA162263533;Disease
GLUCARPIDASE;rs7317112;Variant;PA165949771;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;rs7317112;Variant;PA446155;Disease
METHOTREXATE;rs7317112;Variant;PA450428;Chemical
DEPRESSIVE DISORDER;rs12800734;Variant;PA447207;Disease
ANTIDEPRESSANTS;rs12800734;Variant;PA452229;Chemical
FLUOROURACIL;rs1801516;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs1801516;Variant;PA443560;Disease
CYCLOPHOSPHAMIDE;rs1801516;Variant;PA449165;Chemical
DOXORUBICIN;rs1801516;Variant;PA449412;Chemical
VALPROIC ACID;ABAT;Gene;PA451846;Chemical
CYP2C19;androstenedione;Chemical;PA124;Gene
CYP2C19*9;androstenedione;Chemical;PA165816525;Haplotype
CYP2C19*11;androstenedione;Chemical;PA165816527;Haplotype
CYP2C19*23;androstenedione;Chemical;PA165816537;Haplotype
CYP2C19*1;androstenedione;Chemical;PA165980634;Haplotype
DICLOFENAC;CYP2C9*62;Haplotype;PA449293;Chemical
LOSARTAN;CYP2C9*62;Haplotype;PA450268;Chemical
TOLBUTAMIDE;CYP2C9*62;Haplotype;PA451718;Chemical
CRP;Coronary Disease;Disease;PA120;Gene
CYP2C19;Coronary Disease;Disease;PA124;Gene
SLCO1B1;Coronary Disease;Disease;PA134865839;Gene
CES1P1;Coronary Disease;Disease;PA134906523;Gene
KIF6;Coronary Disease;Disease;PA134920075;Gene
P2RY12;Coronary Disease;Disease;PA134971947;Gene
ACE;Coronary Disease;Disease;PA139;Gene
CYP2C19*1;Coronary Disease;Disease;PA165980634;Haplotype
CYP2C19*2;Coronary Disease;Disease;PA165980635;Haplotype
CYP2C19*3;Coronary Disease;Disease;PA165980636;Haplotype
RS1205;Coronary Disease;Disease;PA166153541;Variant
RS5065;Coronary Disease;Disease;PA166153549;Variant
RS1137101;Coronary Disease;Disease;PA166153626;Variant
RS2297480;Coronary Disease;Disease;PA166153695;Variant
RS2808630;Coronary Disease;Disease;PA166153717;Variant
RS11264359;Coronary Disease;Disease;PA166153825;Variant
RS2306283;Coronary Disease;Disease;PA166154547;Variant
RS4149081;Coronary Disease;Disease;PA166154581;Variant
RS3785161;Coronary Disease;Disease;PA166155056;Variant
RS1799752;Coronary Disease;Disease;PA166155187;Variant
RS7412;Coronary Disease;Disease;PA166155341;Variant
RS2738466;Coronary Disease;Disease;PA166155400;Variant
RS428785;Coronary Disease;Disease;PA166155981;Variant
RS4253778;Coronary Disease;Disease;PA166156106;Variant
RS1126643;Coronary Disease;Disease;PA166156755;Variant
RS20455;Coronary Disease;Disease;PA166156905;Variant
RS1045642;Coronary Disease;Disease;PA166157284;Variant
RS1799983;Coronary Disease;Disease;PA166157303;Variant
RS2230806;Coronary Disease;Disease;PA166157744;Variant
RS3732759;Coronary Disease;Disease;PA166163134;Variant
ITGA2;Coronary Disease;Disease;PA204;Gene
LDLR;Coronary Disease;Disease;PA227;Gene
LEPR;Coronary Disease;Disease;PA229;Gene
ABCA1;Coronary Disease;Disease;PA24373;Gene
ADAMTS1;Coronary Disease;Disease;PA24536;Gene
NOS3;Coronary Disease;Disease;PA254;Gene
NPPA;Coronary Disease;Disease;PA256;Gene
ABCB1;Coronary Disease;Disease;PA267;Gene
PPARA;Coronary Disease;Disease;PA280;Gene
FDPS;Coronary Disease;Disease;PA28075;Gene
PTGS2;Coronary Disease;Disease;PA293;Gene
APOE;Coronary Disease;Disease;PA55;Gene
CYP2B6;CYP2B6*18;Haplotype;PA123;Gene
S-EDDP;CYP2B6*18;Haplotype;PA166177606;Chemical
(S)-METHADONE;CYP2B6*18;Haplotype;PA166178554;Chemical
R-EDDP;CYP2B6*18;Haplotype;PA166247521;Chemical
HEROIN DEPENDENCE;CYP2B6*18;Haplotype;PA444460;Disease
OPIOID-RELATED DISORDERS;CYP2B6*18;Haplotype;PA445043;Disease
SCOLIOSIS;CYP2B6*18;Haplotype;PA445619;Disease
TOBACCO USE DISORDER;CYP2B6*18;Haplotype;PA445876;Disease
HIV INFECTIONS;CYP2B6*18;Haplotype;PA447230;Disease
BUPROPION;CYP2B6*18;Haplotype;PA448687;Chemical
EFAVIRENZ;CYP2B6*18;Haplotype;PA449441;Chemical
METHADONE;CYP2B6*18;Haplotype;PA450401;Chemical
NEVIRAPINE;CYP2B6*18;Haplotype;PA450616;Chemical
MYCOPHENOLIC ACID;rs3832043;Variant;PA164748728;Chemical
SN-38;rs3832043;Variant;PA165110775;Chemical
KIDNEY TRANSPLANTATION;rs3832043;Variant;PA165817016;Disease
HAND-FOOT SYNDROME;rs3832043;Variant;PA166114377;Disease
MUCOSITIS;rs3832043;Variant;PA166122058;Disease
ALOPECIA;rs3832043;Variant;PA443314;Disease
NON-SMALL CELL LUNG CARCINOMA;rs3832043;Variant;PA443622;Disease
DRUG TOXICITY;rs3832043;Variant;PA443937;Disease
THYROID NEOPLASMS;rs3832043;Variant;PA445857;Disease
IRINOTECAN;rs3832043;Variant;PA450085;Chemical
MYCOPHENOLATE MOFETIL;rs3832043;Variant;PA450566;Chemical
SORAFENIB;rs3832043;Variant;PA7000;Chemical
MIGALASTAT;rs28935490;Variant;PA166182881;Chemical
FABRY DISEASE;rs28935490;Variant;PA443367;Disease
ANTHRACYCLINES AND RELATED SUBSTANCES;rs2229774;Variant;PA130620651;Chemical
CARDIOTOXICITY;rs2229774;Variant;PA166128121;Disease
RARG;rs2229774;Variant;PA34227;Gene
UGT1A6;rs2229774;Variant;PA37181;Gene
SLC28A3;rs2229774;Variant;PA426;Gene
NEOPLASMS;rs2229774;Variant;PA445062;Disease
DAUNORUBICIN;rs2229774;Variant;PA449212;Chemical
DOXORUBICIN;rs2229774;Variant;PA449412;Chemical
VOMITING;rs540825;Variant;PA446051;Disease
FENTANYL;rs540825;Variant;PA449599;Chemical
PALONOSETRON;ERCC1;Gene;PA10352;Chemical
FLUOROURACIL;ERCC1;Gene;PA128406956;Chemical
OXALIPLATIN;ERCC1;Gene;PA131285527;Chemical
PLATINUM;ERCC1;Gene;PA150595617;Chemical
PLATINUM COMPOUNDS;ERCC1;Gene;PA164713176;Chemical
MUCOSITIS;ERCC1;Gene;PA166122058;Disease
RADIOTHERAPY;ERCC1;Gene;PA166122986;Chemical
FEBRILE NEUTROPENIA;ERCC1;Gene;PA166170245;Disease
BREAST NEOPLASMS;ERCC1;Gene;PA443560;Disease
NON-SMALL CELL LUNG CARCINOMA;ERCC1;Gene;PA443622;Disease
COLONIC NEOPLASMS;ERCC1;Gene;PA443756;Disease
DRUG TOXICITY;ERCC1;Gene;PA443937;Disease
NEOPLASM OF ESOPHAGUS;ERCC1;Gene;PA444101;Disease
INFECTIOUS DISEASE;ERCC1;Gene;PA444614;Disease
LEUKOPENIA;ERCC1;Gene;PA444773;Disease
MESOTHELIOMA;ERCC1;Gene;PA444937;Disease
MULTIPLE MYELOMA;ERCC1;Gene;PA444985;Disease
NAUSEA;ERCC1;Gene;PA445048;Disease
NEOPLASMS;ERCC1;Gene;PA445062;Disease
OVARIAN NEOPLASMS;ERCC1;Gene;PA445204;Disease
PANCREATIC NEOPLASMS;ERCC1;Gene;PA445218;Disease
RECTAL NEOPLASMS;ERCC1;Gene;PA445503;Disease
OSTEOSARCOMA;ERCC1;Gene;PA445601;Disease
STOMACH NEOPLASMS;ERCC1;Gene;PA445742;Disease
TESTICULAR NEOPLASMS;ERCC1;Gene;PA445828;Disease
VOMITING;ERCC1;Gene;PA446051;Disease
COLORECTAL NEOPLASMS;ERCC1;Gene;PA446108;Disease
BLEOMYCIN;ERCC1;Gene;PA448645;Chemical
CAPECITABINE;ERCC1;Gene;PA448771;Chemical
CARBOPLATIN;ERCC1;Gene;PA448803;Chemical
CISPLATIN;ERCC1;Gene;PA449014;Chemical
CYCLOPHOSPHAMIDE;ERCC1;Gene;PA449165;Chemical
DOCETAXEL;ERCC1;Gene;PA449383;Chemical
DOXORUBICIN;ERCC1;Gene;PA449412;Chemical
ETOPOSIDE;ERCC1;Gene;PA449552;Chemical
GEMCITABINE;ERCC1;Gene;PA449748;Chemical
GRANISETRON;ERCC1;Gene;PA449809;Chemical
LEUCOVORIN;ERCC1;Gene;PA450198;Chemical
PACLITAXEL;ERCC1;Gene;PA450761;Chemical
THALIDOMIDE;ERCC1;Gene;PA451644;Chemical
TOXIC LIVER DISEASE;CYP2C8*2;Haplotype;PA164925725;Disease
BREAST NEOPLASMS;CYP2C8*2;Haplotype;PA443560;Disease
DRUG TOXICITY;CYP2C8*2;Haplotype;PA443937;Disease
NEUTROPENIA;CYP2C8*2;Haplotype;PA445113;Disease
PAIN, POSTOPERATIVE;CYP2C8*2;Haplotype;PA445210;Disease
PERIPHERAL NERVOUS SYSTEM DISEASES;CYP2C8*2;Haplotype;PA445301;Disease
AMODIAQUINE;CYP2C8*2;Haplotype;PA448404;Chemical
IBUPROFEN;CYP2C8*2;Haplotype;PA449957;Chemical
PACLITAXEL;CYP2C8*2;Haplotype;PA450761;Chemical
PIOGLITAZONE;CYP2C8*2;Haplotype;PA450970;Chemical
DULOXETINE;rs78482393;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs78482393;Variant;PA447321;Disease
HAND-FOOT SYNDROME;rs3215400;Variant;PA166114377;Disease
DRUG TOXICITY;rs3215400;Variant;PA443937;Disease
LEUKEMIA;rs3215400;Variant;PA444750;Disease
NEOPLASMS;rs3215400;Variant;PA445062;Disease
LYMPHOMA, T-CELL;rs3215400;Variant;PA446309;Disease
CAPECITABINE;rs3215400;Variant;PA448771;Chemical
CYTARABINE;rs3215400;Variant;PA449177;Chemical
AZACITIDINE;rs3215400;Variant;PA451996;Chemical
ALBENDAZOLE;CYP2J2;Gene;PA164746058;Chemical
DANAZOL;CYP2J2;Gene;PA164749056;Chemical
KIDNEY TRANSPLANTATION;CYP2J2;Gene;PA165817016;Disease
CORONARY ARTERY DISEASE;CYP2J2;Gene;PA443796;Disease
HYPERTENSION;CYP2J2;Gene;PA444552;Disease
MYOCARDIAL INFARCTION;CYP2J2;Gene;PA445019;Disease
AMIODARONE;CYP2J2;Gene;PA448383;Chemical
ASTEMIZOLE;CYP2J2;Gene;PA448498;Chemical
DICLOFENAC;CYP2J2;Gene;PA449293;Chemical
MESORIDAZINE;CYP2J2;Gene;PA450386;Chemical
NABUMETONE;CYP2J2;Gene;PA450572;Chemical
TACROLIMUS;CYP2J2;Gene;PA451578;Chemical
TERFENADINE;CYP2J2;Gene;PA451619;Chemical
THIORIDAZINE;CYP2J2;Gene;PA451666;Chemical
EPILEPSY;UGT1A6*1a;Haplotype;PA444065;Disease
BETA-THALASSEMIA;UGT1A6*1a;Haplotype;PA446432;Disease
ACETAMINOPHEN;UGT1A6*1a;Haplotype;PA448015;Chemical
VALPROIC ACID;UGT1A6*1a;Haplotype;PA451846;Chemical
ABIRATERONE;rs3828743;Variant;PA166123407;Chemical
PROSTATIC NEOPLASMS;rs3828743;Variant;PA445425;Disease
PREDNISOLONE;rs3828743;Variant;PA451096;Chemical
OPIOID-RELATED DISORDERS;rs6600879;Variant;PA445043;Disease
METHADONE;rs6600879;Variant;PA450401;Chemical
DULOXETINE;rs62319299;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs62319299;Variant;PA447321;Disease
PALBOCICLIB;CDKN2A;Gene;PA166153469;Chemical
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;CDKN2A;Gene;PA446155;Disease
CYP3A4;theophylline;Chemical;PA130;Gene
CYP1A2;theophylline;Chemical;PA27093;Gene
FLUOROURACIL;rs141084494;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs141084494;Variant;PA443560;Disease
NEUTROPENIA;rs141084494;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs141084494;Variant;PA449165;Chemical
EPIRUBICIN;rs141084494;Variant;PA449476;Chemical
DULOXETINE;rs3889402;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs3889402;Variant;PA447321;Disease
PEGASPARGASE;ARHGAP28;Gene;PA164760860;Chemical
ANEMIA;rs2501873;Variant;PA443340;Disease
NASOPHARYNGEAL NEOPLASMS;rs2501873;Variant;PA445046;Disease
DOCETAXEL;rs2501873;Variant;PA449383;Chemical
WARFARIN;rs2501873;Variant;PA451906;Chemical
WARFARIN;rs11168292;Variant;PA451906;Chemical
RS10774053;ritodrine;Chemical;PA166163612;Variant
ADRB2;ritodrine;Chemical;PA39;Gene
CACNA1C;ritodrine;Chemical;PA83;Gene
DEXTROMETHORPHAN;CYP2D6*153;Haplotype;PA449273;Chemical
CYP2C19;eosinophilic esophagitis;Disease;PA124;Gene
CYP2C19*17;eosinophilic esophagitis;Disease;PA165816533;Haplotype
CYP2C19*1;eosinophilic esophagitis;Disease;PA165980634;Haplotype
RS1059513;eosinophilic esophagitis;Disease;PA166224541;Variant
STAT6;eosinophilic esophagitis;Disease;PA339;Gene
PLATINUM COMPOUNDS;rs2227310;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs2227310;Variant;PA443622;Disease
DOCETAXEL;rs2227310;Variant;PA449383;Chemical
GEMCITABINE;rs2227310;Variant;PA449748;Chemical
PACLITAXEL;rs2227310;Variant;PA450761;Chemical
VINORELBINE;rs2227310;Variant;PA451881;Chemical
DULOXETINE;rs56355515;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs56355515;Variant;PA447321;Disease
BEVACIZUMAB;EDN1;Gene;PA130232992;Chemical
MURAGLITAZAR;EDN1;Gene;PA162356187;Chemical
BREAST NEOPLASMS;EDN1;Gene;PA443560;Disease
DIABETES MELLITUS;EDN1;Gene;PA443886;Disease
EDEMA;EDN1;Gene;PA443994;Disease
HYPERLIPIDEMIAS;EDN1;Gene;PA444528;Disease
ESSENTIAL HYPERTENSION;EDN1;Gene;PA447288;Disease
ATENOLOL;EDN1;Gene;PA448499;Chemical
IRBESARTAN;EDN1;Gene;PA450084;Chemical
TENOFOVIR;rs899494;Variant;PA10204;Chemical
DRUG TOXICITY;rs899494;Variant;PA443937;Disease
HIV INFECTIOUS DISEASE;rs899494;Variant;PA447230;Disease
ALCOHOL ABUSE;rs2066702;Variant;PA443309;Disease
ETHANOL;rs2066702;Variant;PA448073;Chemical
NALTREXONE;rs2066702;Variant;PA450588;Chemical
SCHIZOPHRENIA;SPOPL;Gene;PA447216;Disease
OLANZAPINE;SPOPL;Gene;PA450688;Chemical
CD274;ipilimumab;Chemical;PA134915280;Gene
HLA-A*02:01;ipilimumab;Chemical;PA166123427;Haplotype
ALK;ipilimumab;Chemical;PA24719;Gene
HLA-A;ipilimumab;Chemical;PA35055;Gene
EGFR;ipilimumab;Chemical;PA7360;Gene
HAND-FOOT SYNDROME;rs3025040;Variant;PA166114377;Disease
HEPATOCELLULAR CARCINOMA;rs3025040;Variant;PA444447;Disease
SORAFENIB;rs3025040;Variant;PA7000;Chemical
TPMT;TPMT*5;Haplotype;PA356;Gene
AZATHIOPRINE;TPMT*5;Haplotype;PA448515;Chemical
MERCAPTOPURINE;TPMT*5;Haplotype;PA450379;Chemical
THIOGUANINE;TPMT*5;Haplotype;PA451663;Chemical
DINUTUXIMAB;MYCN;Gene;PA166160060;Chemical
EFLORNITHINE;MYCN;Gene;PA166328781;Chemical
SLCO1B1;furosemide;Chemical;PA134865839;Gene
ACE;furosemide;Chemical;PA139;Gene
NPPA-AS1;furosemide;Chemical;PA165752124;Gene
RS5063;furosemide;Chemical;PA166153548;Variant
RS5443;furosemide;Chemical;PA166154486;Variant
RS4149056;furosemide;Chemical;PA166154579;Variant
RS1529927;furosemide;Chemical;PA166155014;Variant
RS1799752;furosemide;Chemical;PA166155187;Variant
RS4961;furosemide;Chemical;PA166156480;Variant
RS17268282;furosemide;Chemical;PA166161197;Variant
GNB3;furosemide;Chemical;PA176;Gene
ADD1;furosemide;Chemical;PA31;Gene
SLC12A3;furosemide;Chemical;PA321;Gene
ABCC4;furosemide;Chemical;PA397;Gene
O-DESMETHYLTRAMADOL;rs767263838;Variant;PA166131379;Chemical
TAPENTADOL;rs767263838;Variant;PA166179720;Chemical
ACETAMINOPHEN;rs767263838;Variant;PA448015;Chemical
MORPHINE;rs767263838;Variant;PA450550;Chemical
TRAMADOL;rs767263838;Variant;PA451735;Chemical
SUNITINIB;rs307821;Variant;PA162372840;Chemical
RENAL CELL CARCINOMA;rs307821;Variant;PA443624;Disease
ANTHRACYCLINES AND RELATED SUBSTANCES;SLC28A1;Gene;PA130620651;Chemical
CARCINOMA, NON-SMALL-CELL LUNG;SLC28A1;Gene;PA443622;Disease
NEOPLASMS;SLC28A1;Gene;PA445062;Disease
NEUTROPENIA;SLC28A1;Gene;PA445113;Disease
PANCREATIC NEOPLASMS;SLC28A1;Gene;PA445218;Disease
GEMCITABINE;SLC28A1;Gene;PA449748;Chemical
ZIDOVUDINE;SLC28A1;Gene;PA451954;Chemical
SLCO1B1;simvastatin acid;Chemical;PA134865839;Gene
SLCO1B1*5;simvastatin acid;Chemical;PA165819255;Haplotype
SLCO1B1*15;simvastatin acid;Chemical;PA165819265;Haplotype
SLCO1B1*1;simvastatin acid;Chemical;PA165981641;Haplotype
RS4149056;simvastatin acid;Chemical;PA166154579;Variant
AMLODIPINE;simvastatin acid;Chemical;PA448388;Chemical
FGFR3;Skeletal Dysplasia;Disease;PA28129;Gene
ADRA1D;methoxamine;Chemical;PA24597;Gene
ADRA1B;methoxamine;Chemical;PA33;Gene
ADRA1A;methoxamine;Chemical;PA34;Gene
DESFLURANE;rs121918595;Variant;PA164749136;Chemical
RYR1;rs121918595;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs121918595;Variant;PA444863;Disease
ENFLURANE;rs121918595;Variant;PA449461;Chemical
HALOTHANE;rs121918595;Variant;PA449845;Chemical
ISOFLURANE;rs121918595;Variant;PA450106;Chemical
METHOXYFLURANE;rs121918595;Variant;PA450434;Chemical
SEVOFLURANE;rs121918595;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs121918595;Variant;PA451522;Chemical
CACNA1S;rs121918595;Variant;PA85;Gene
DEMENTIA;SLC6A4 L allele-rs25531C;Haplotype;PA443853;Disease
COCAINE-RELATED DISORDERS;SLC6A4 L allele-rs25531C;Haplotype;PA446878;Disease
MOOD DISORDERS;SLC6A4 L allele-rs25531C;Haplotype;PA447209;Disease
SCHIZOPHRENIA;SLC6A4 L allele-rs25531C;Haplotype;PA447216;Disease
DEPRESSIVE DISORDER, MAJOR;SLC6A4 L allele-rs25531C;Haplotype;PA447321;Disease
CITALOPRAM;SLC6A4 L allele-rs25531C;Haplotype;PA449015;Chemical
CLOZAPINE;SLC6A4 L allele-rs25531C;Haplotype;PA449061;Chemical
DISULFIRAM;SLC6A4 L allele-rs25531C;Haplotype;PA449376;Chemical
FLUVOXAMINE;SLC6A4 L allele-rs25531C;Haplotype;PA449690;Chemical
PAROXETINE;SLC6A4 L allele-rs25531C;Haplotype;PA450801;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;CAT;Gene;PA130620651;Chemical
ALCOHOL ABUSE;CAT;Gene;PA443309;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;CAT;Gene;PA446155;Disease
ETHANOL;CAT;Gene;PA448073;Chemical
CYP2D6;hydroxyamitriptyline;Chemical;PA128;Gene
CYP2D6*1;hydroxyamitriptyline;Chemical;PA165816576;Haplotype
CYP2D6*10;hydroxyamitriptyline;Chemical;PA165816582;Haplotype
ROSUVASTATIN;rs5882;Variant;PA134308647;Chemical
HYPERCHOLESTEROLEMIA;rs5882;Variant;PA444516;Disease
FLUVASTATIN;rs5882;Variant;PA449688;Chemical
SIMVASTATIN;rs5882;Variant;PA451363;Chemical
PHENPROCOUMON;rs7294;Variant;PA450921;Chemical
WARFARIN;rs7294;Variant;PA451906;Chemical
ACENOCOUMAROL;rs7294;Variant;PA452632;Chemical
PLTP;APOA4;Gene;PA273;Gene
CFTR;rs397508748;Variant;PA109;Gene
IVACAFTOR;rs397508748;Variant;PA165950341;Chemical
CELECOXIB;CACNA1H;Gene;PA448871;Chemical
DRUG TOXICITY;rs1806201;Variant;PA443937;Disease
QUETIAPINE;rs1806201;Variant;PA451201;Chemical
RISPERIDONE;rs1806201;Variant;PA451257;Chemical
SEVOFLURANE;rs1806201;Variant;PA451341;Chemical
FLUOROURACIL;rs699947;Variant;PA128406956;Chemical
BEVACIZUMAB;rs699947;Variant;PA130232992;Chemical
OXALIPLATIN;rs699947;Variant;PA131285527;Chemical
MACULAR DEGENERATION;rs699947;Variant;PA134850558;Disease
SUNITINIB;rs699947;Variant;PA162372840;Chemical
RANIBIZUMAB;rs699947;Variant;PA164746012;Chemical
BREAST NEOPLASMS;rs699947;Variant;PA443560;Disease
HYPERTENSION;rs699947;Variant;PA444552;Disease
ERECTILE DYSFUNCTION;rs699947;Variant;PA444606;Disease
COLORECTAL NEOPLASMS;rs699947;Variant;PA446108;Disease
CAPECITABINE;rs699947;Variant;PA448771;Chemical
DOCETAXEL;rs699947;Variant;PA449383;Chemical
ENALAPRIL;rs699947;Variant;PA449456;Chemical
IRINOTECAN;rs699947;Variant;PA450085;Chemical
LEUCOVORIN;rs699947;Variant;PA450198;Chemical
SILDENAFIL;rs699947;Variant;PA451346;Chemical
PEGINTERFERON ALFA-2A;rs760370;Variant;PA164749390;Chemical
PEGINTERFERON ALFA-2B;rs760370;Variant;PA164784024;Chemical
TIPIRACIL HYDROCHLORIDE;rs760370;Variant;PA166171170;Chemical
NEOPLASMS;rs760370;Variant;PA445062;Disease
COLORECTAL NEOPLASMS;rs760370;Variant;PA446108;Disease
CHRONIC HEPATITIS C VIRUS INFECTION;rs760370;Variant;PA446863;Disease
GEMCITABINE;rs760370;Variant;PA449748;Chemical
RIBAVIRIN;rs760370;Variant;PA451241;Chemical
TRIFLURIDINE;rs760370;Variant;PA451775;Chemical
FLUOROURACIL;rs568367673;Variant;PA128406956;Chemical
DRUG TOXICITY;rs568367673;Variant;PA443937;Disease
CYP2D6;dapoxetine;Chemical;PA128;Gene
CYP2D6*1;dapoxetine;Chemical;PA165816576;Haplotype
CYP2D6*2;dapoxetine;Chemical;PA165816577;Haplotype
CYP2D6*10;dapoxetine;Chemical;PA165816582;Haplotype
CYP2D6*87;dapoxetine;Chemical;PA166123327;Haplotype
CYP2D6*88;dapoxetine;Chemical;PA166123328;Haplotype
CYP2D6*89;dapoxetine;Chemical;PA166123329;Haplotype
CYP2D6*90;dapoxetine;Chemical;PA166123330;Haplotype
CYP2D6*91;dapoxetine;Chemical;PA166123331;Haplotype
CYP2D6*93;dapoxetine;Chemical;PA166123333;Haplotype
CYP2D6*95;dapoxetine;Chemical;PA166123336;Haplotype
CYP2D6*97;dapoxetine;Chemical;PA166123338;Haplotype
CYP2D6*98;dapoxetine;Chemical;PA166123339;Haplotype
CYP2D6*94;dapoxetine;Chemical;PA166128737;Haplotype
SCHIZOPHRENIA;rs362267;Variant;PA447216;Disease
RISPERIDONE;rs362267;Variant;PA451257;Chemical
IVACAFTOR;rs121909047;Variant;PA165950341;Chemical
LUMACAFTOR;rs121909047;Variant;PA166114483;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs121909047;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs121909047;Variant;PA443829;Disease
FLUOROURACIL;rs8110364;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs8110364;Variant;PA443560;Disease
NEUTROPENIA;rs8110364;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs8110364;Variant;PA449165;Chemical
EPIRUBICIN;rs8110364;Variant;PA449476;Chemical
INFLUENZA VACCINES;HLA-DQB1*06:02;Haplotype;PA164712830;Chemical
CLAVULANATE;HLA-DQB1*06:02;Haplotype;PA164742987;Chemical
LUMIRACOXIB;HLA-DQB1*06:02;Haplotype;PA164769031;Chemical
FLUCLOXACILLIN;HLA-DQB1*06:02;Haplotype;PA164781042;Chemical
TOXIC LIVER DISEASE;HLA-DQB1*06:02;Haplotype;PA164925725;Disease
DRUG-INDUCED LIVER INJURY;HLA-DQB1*06:02;Haplotype;PA166119041;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-DQB1*06:02;Haplotype;PA166120927;Disease
DRUG HYPERSENSITIVITY;HLA-DQB1*06:02;Haplotype;PA443936;Disease
HEPATITIS;HLA-DQB1*06:02;Haplotype;PA444435;Disease
INFECTION;HLA-DQB1*06:02;Haplotype;PA444614;Disease
NARCOLEPSY;HLA-DQB1*06:02;Haplotype;PA445042;Disease
HIV INFECTIONS;HLA-DQB1*06:02;Haplotype;PA447230;Disease
AMOXICILLIN;HLA-DQB1*06:02;Haplotype;PA448406;Chemical
NEVIRAPINE;HLA-DQB1*06:02;Haplotype;PA450616;Chemical
HYPERTENSION;KCNK3;Gene;PA444552;Disease
CANDESARTAN;KCNK3;Gene;PA448765;Chemical
SEVOFLURANE;KCNK3;Gene;PA451341;Chemical
MAJOR DEPRESSIVE DISORDER;rs17135437;Variant;PA447321;Disease
CITALOPRAM;rs17135437;Variant;PA449015;Chemical
ANTIHYPERTENSIVES;ATP2B1;Gene;PA164712445;Chemical
CORONARY ARTERY DISEASE;ATP2B1;Gene;PA443796;Disease
HYPERTENSION;ATP2B1;Gene;PA444552;Disease
PHENAZOPYRIDINE;G6PD Mediterranean Haplotype;Haplotype;PA164746899;Chemical
ANEMIA, HEMOLYTIC;G6PD Mediterranean Haplotype;Haplotype;PA443343;Disease
HEMOLYSIS;G6PD Mediterranean Haplotype;Haplotype;PA444411;Disease
CHLOROQUINE;G6PD Mediterranean Haplotype;Haplotype;PA448948;Chemical
CIPROFLOXACIN;G6PD Mediterranean Haplotype;Haplotype;PA449009;Chemical
COMT;Erythema;Disease;PA117;Gene
RS4680;Erythema;Disease;PA166156024;Variant
RS1799971;Erythema;Disease;PA166156991;Variant
OPRM1;Erythema;Disease;PA31945;Gene
CYP2C19;Myocardial Infarction;Disease;PA124;Gene
CYP3A5;Myocardial Infarction;Disease;PA131;Gene
KIF6;Myocardial Infarction;Disease;PA134920075;Gene
ACE;Myocardial Infarction;Disease;PA139;Gene
PEAR1;Myocardial Infarction;Disease;PA162399233;Gene
CYP2C19*17;Myocardial Infarction;Disease;PA165816533;Haplotype
CYP2C19*1;Myocardial Infarction;Disease;PA165980634;Haplotype
CYP2C19*2;Myocardial Infarction;Disease;PA165980635;Haplotype
CYP2C19*3;Myocardial Infarction;Disease;PA165980636;Haplotype
CYP2C19*4;Myocardial Infarction;Disease;PA165980637;Haplotype
CYP2C19*5;Myocardial Infarction;Disease;PA165980638;Haplotype
RS1801133;Myocardial Infarction;Disease;PA166153644;Variant
RS12041331;Myocardial Infarction;Disease;PA166153839;Variant
RS11568732;Myocardial Infarction;Disease;PA166154138;Variant
RS5443;Myocardial Infarction;Disease;PA166154486;Variant
RS762551;Myocardial Infarction;Disease;PA166154850;Variant
RS9806699;Myocardial Infarction;Disease;PA166154927;Variant
RS5918;Myocardial Infarction;Disease;PA166155152;Variant
RS429358;Myocardial Infarction;Disease;PA166155351;Variant
RS428785;Myocardial Infarction;Disease;PA166155981;Variant
RS1065776;Myocardial Infarction;Disease;PA166156310;Variant
RS4961;Myocardial Infarction;Disease;PA166156480;Variant
RS2231142;Myocardial Infarction;Disease;PA166156544;Variant
RS1062535;Myocardial Infarction;Disease;PA166156753;Variant
RS1126643;Myocardial Infarction;Disease;PA166156755;Variant
RS20455;Myocardial Infarction;Disease;PA166156905;Variant
RS662;Myocardial Infarction;Disease;PA166157238;Variant
RS776746;Myocardial Infarction;Disease;PA166157267;Variant
RS1045642;Myocardial Infarction;Disease;PA166157284;Variant
RS10306114;Myocardial Infarction;Disease;PA166157803;Variant
GNB3;Myocardial Infarction;Disease;PA176;Gene
ITGA2;Myocardial Infarction;Disease;PA204;Gene
ITGB3;Myocardial Infarction;Disease;PA205;Gene
PTGS1;Myocardial Infarction;Disease;PA24346;Gene
MTHFR;Myocardial Infarction;Disease;PA245;Gene
ADAMTS1;Myocardial Infarction;Disease;PA24536;Gene
ABCB1;Myocardial Infarction;Disease;PA267;Gene
CYP1A2;Myocardial Infarction;Disease;PA27093;Gene
CYP2J2;Myocardial Infarction;Disease;PA27112;Gene
GATM;Myocardial Infarction;Disease;PA28590;Gene
PTGIS;Myocardial Infarction;Disease;PA292;Gene
PTGS2;Myocardial Infarction;Disease;PA293;Gene
ADD1;Myocardial Infarction;Disease;PA31;Gene
P2RY1;Myocardial Infarction;Disease;PA32868;Gene
PON1;Myocardial Infarction;Disease;PA33529;Gene
VDR;Myocardial Infarction;Disease;PA37301;Gene
ADRB1;Myocardial Infarction;Disease;PA38;Gene
ABCG2;Myocardial Infarction;Disease;PA390;Gene
APOE;Myocardial Infarction;Disease;PA55;Gene
CYP2C19;hydroxyprogesterone;Chemical;PA124;Gene
CYP2C19*11;hydroxyprogesterone;Chemical;PA165816527;Haplotype
CYP2C19*23;hydroxyprogesterone;Chemical;PA165816537;Haplotype
CYP2C19*1;hydroxyprogesterone;Chemical;PA165980634;Haplotype
COMT;Death;Disease;PA117;Gene
CYP2C19;Death;Disease;PA124;Gene
CYP2D6;Death;Disease;PA128;Gene
ACE;Death;Disease;PA139;Gene
DPYD;Death;Disease;PA145;Gene
CYP2D6*1;Death;Disease;PA165816576;Haplotype
CYP2D6*2;Death;Disease;PA165816577;Haplotype
CYP2D6*3;Death;Disease;PA165816578;Haplotype
CYP2D6*4;Death;Disease;PA165816579;Haplotype
CYP2D6*10;Death;Disease;PA165816582;Haplotype
CYP2D6*41;Death;Disease;PA165816584;Haplotype
CYP2D6*5;Death;Disease;PA165948092;Haplotype
CYP2C19*1;Death;Disease;PA165980634;Haplotype
CYP2C19*2;Death;Disease;PA165980635;Haplotype
CYP2C19*3;Death;Disease;PA165980636;Haplotype
CYP2D6*2XN;Death;Disease;PA165988480;Haplotype
CYP2D6*35;Death;Disease;PA165988487;Haplotype
GSTM1 NULL;Death;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Death;Disease;PA166048676;Haplotype
UGT1A1*1;Death;Disease;PA166115841;Haplotype
UGT1A1*28;Death;Disease;PA166115842;Haplotype
RS1800497;Death;Disease;PA166154339;Variant
RS1799752;Death;Disease;PA166155187;Variant
RS4680;Death;Disease;PA166156024;Variant
RS61767072;Death;Disease;PA166156691;Variant
RS3836790;Death;Disease;PA166156819;Variant
RS1045642;Death;Disease;PA166157284;Variant
RS9282564;Death;Disease;PA166157435;Variant
DPYD DEFICIENCY;Death;Disease;PA166157931;Variant
GSTM1;Death;Disease;PA182;Gene
ABCB1;Death;Disease;PA267;Gene
DRD2;Death;Disease;PA27478;Gene
SLC6A3;Death;Disease;PA311;Gene
TPMT;Death;Disease;PA356;Gene
ADRA2C;Death;Disease;PA37;Gene
ABCC4;Death;Disease;PA397;Gene
UGT1A1;Death;Disease;PA420;Gene
HYPERTENSION;rs10224002;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs10224002;Variant;PA449899;Chemical
ARIPIPRAZOLE;rs4305746;Variant;PA10026;Chemical
SCHIZOPHRENIA;rs4305746;Variant;PA447216;Disease
FLUOROURACIL;rs1056515;Variant;PA128406956;Chemical
BEVACIZUMAB;rs1056515;Variant;PA130232992;Chemical
COLORECTAL NEOPLASMS;rs1056515;Variant;PA446108;Disease
IRINOTECAN;rs1056515;Variant;PA450085;Chemical
LEUCOVORIN;rs1056515;Variant;PA450198;Chemical
CELECOXIB;CACNA2D1;Gene;PA448871;Chemical
THIOGUANINE;TPMT*22;Haplotype;PA451663;Chemical
ACUTE CORONARY SYNDROME;LEPR;Gene;PA165108401;Disease
SETMELANOTIDE;LEPR;Gene;PA166235341;Chemical
CORONARY DISEASE;LEPR;Gene;PA443797;Disease
EPILEPSY;LEPR;Gene;PA444065;Disease
HYPERLIPIDEMIAS;LEPR;Gene;PA444528;Disease
ATORVASTATIN;LEPR;Gene;PA448500;Chemical
SIMVASTATIN;LEPR;Gene;PA451363;Chemical
VALPROIC ACID;LEPR;Gene;PA451846;Chemical
ANTIPSYCHOTICS;LEPR;Gene;PA452233;Chemical
AMLODIPINE;rs12143842;Variant;PA448388;Chemical
CHLORTHALIDONE;rs12143842;Variant;PA448970;Chemical
LISINOPRIL;rs12143842;Variant;PA450242;Chemical
SI;sacrosidase;Chemical;PA35758;Gene
PTGS2;etoricoxib;Chemical;PA293;Gene
IMATINIB;rs28656907;Variant;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;rs28656907;Variant;PA151958383;Disease
DRUG TOXICITY;rs28656907;Variant;PA443937;Disease
HYPERCHOLESTEROLEMIA;rs12487736;Variant;PA444516;Disease
ATORVASTATIN;rs12487736;Variant;PA448500;Chemical
SIMVASTATIN;rs12487736;Variant;PA451363;Chemical
THIOGUANINE;TPMT*19;Haplotype;PA451663;Chemical
HEMORRHAGE;rs11568732;Variant;PA444417;Disease
MYOCARDIAL INFARCTION;rs11568732;Variant;PA445019;Disease
CLOPIDOGREL;rs11568732;Variant;PA449053;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs113878252;Variant;PA164713366;Chemical
HIV INFECTIOUS DISEASE;rs2307424;Variant;PA447230;Disease
EFAVIRENZ;rs2307424;Variant;PA449441;Chemical
CYP2C9;heart valve replacement;Disease;PA126;Gene
CYP2C9*1;heart valve replacement;Disease;PA165816542;Haplotype
CYP2C9*2;heart valve replacement;Disease;PA165816543;Haplotype
CYP2C9*3;heart valve replacement;Disease;PA165816544;Haplotype
CYP2C9*13;heart valve replacement;Disease;PA165816554;Haplotype
CYP2C9*14;heart valve replacement;Disease;PA165816555;Haplotype
RS887829;heart valve replacement;Disease;PA166155607;Variant
RS1367117;heart valve replacement;Disease;PA166155632;Variant
RS2304429;heart valve replacement;Disease;PA166160865;Variant
RS3826041;heart valve replacement;Disease;PA166160867;Variant
RS72800847;heart valve replacement;Disease;PA166160869;Variant
RS679899;heart valve replacement;Disease;PA166197882;Variant
CYP1A1;heart valve replacement;Disease;PA27092;Gene
DNMT3A;heart valve replacement;Disease;PA27445;Gene
STX1B;heart valve replacement;Disease;PA38345;Gene
UGT1A1;heart valve replacement;Disease;PA420;Gene
APOB;heart valve replacement;Disease;PA50;Gene
PEPTIC ULCER DISEASE;rs12678747;Variant;PA447240;Disease
ASPIRIN;rs12678747;Variant;PA448497;Chemical
HYPERTENSION;STN1;Gene;PA444552;Disease
ATENOLOL;STN1;Gene;PA448499;Chemical
OLUTASIDENIB;rs121913500;Variant;PA166293881;Chemical
IDH1;rs121913500;Variant;PA29630;Gene
VALGANCICLOVIR;rs11568658;Variant;PA10227;Chemical
LATANOPROST;rs11568658;Variant;PA164774763;Chemical
KIDNEY TRANSPLANTATION;rs11568658;Variant;PA165817016;Disease
OPEN-ANGLE GLAUCOMA;rs11568658;Variant;PA444282;Disease
NON-SMALL CELL LUNG CARCINOMA;ATAT1;Gene;PA443622;Disease
THROMBOCYTOPENIA;ATAT1;Gene;PA445846;Disease
CARBOPLATIN;ATAT1;Gene;PA448803;Chemical
GEMCITABINE;ATAT1;Gene;PA449748;Chemical
HIV INFECTIOUS DISEASE;rs1884613;Variant;PA447230;Disease
EFAVIRENZ;rs1884613;Variant;PA449441;Chemical
SULFAMETHOXAZOLE / TRIMETHOPRIM;NAT2*5;Haplotype;PA10715;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;NAT2*5;Haplotype;PA164712708;Chemical
TOXIC LIVER DISEASE;NAT2*5;Haplotype;PA164925725;Disease
DRUG-INDUCED LIVER INJURY;NAT2*5;Haplotype;PA166119041;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;NAT2*5;Haplotype;PA166120929;Disease
ADVERSE EVENTS;NAT2*5;Haplotype;PA166151827;Disease
SOLITHROMYCIN;NAT2*5;Haplotype;PA166165147;Chemical
HYPERSENSITIVITY;NAT2*5;Haplotype;PA444546;Disease
TUBERCULOSIS;NAT2*5;Haplotype;PA445941;Disease
HYDRALAZINE;NAT2*5;Haplotype;PA449894;Chemical
ISONIAZID;NAT2*5;Haplotype;PA450112;Chemical
BOSENTAN;NR1I2;Gene;PA10034;Chemical
CYPROTERONE;NR1I2;Gene;PA10049;Chemical
ATAZANAVIR;NR1I2;Gene;PA10251;Chemical
MEMANTINE;NR1I2;Gene;PA10364;Chemical
CORTICOSTEROIDS;NR1I2;Gene;PA10832;Chemical
ABCC2;NR1I2;Gene;PA116;Gene
CYP2B6;NR1I2;Gene;PA123;Gene
CYP2C8;NR1I2;Gene;PA125;Gene
TROLEANDOMYCIN;NR1I2;Gene;PA127840611;Chemical
CYP3A4;NR1I2;Gene;PA130;Gene
FORSKOLIN;NR1I2;Gene;PA146096022;Chemical
TAXANES;NR1I2;Gene;PA150481189;Chemical
NEPHROLITHIASIS;NR1I2;Gene;PA162355520;Disease
SUNITINIB;NR1I2;Gene;PA162372840;Chemical
PERMETHRIN;NR1I2;Gene;PA164743137;Chemical
PENICILLIN V;NR1I2;Gene;PA164745442;Chemical
DEMECLOCYCLINE;NR1I2;Gene;PA164745513;Chemical
ECONAZOLE;NR1I2;Gene;PA164746010;Chemical
TEMSIROLIMUS;NR1I2;Gene;PA164746890;Chemical
SULFISOXAZOLE;NR1I2;Gene;PA164748964;Chemical
CEFACLOR;NR1I2;Gene;PA164749137;Chemical
DICLOXACILLIN;NR1I2;Gene;PA164749649;Chemical
BEXAROTENE;NR1I2;Gene;PA164752250;Chemical
OXICONAZOLE;NR1I2;Gene;PA164754742;Chemical
FLUCLOXACILLIN;NR1I2;Gene;PA164781042;Chemical
RIFAPENTINE;NR1I2;Gene;PA164783809;Chemical
ST. JOHN'S WORT;NR1I2;Gene;PA164924486;Chemical
TOXIC LIVER DISEASE;NR1I2;Gene;PA164925725;Disease
ARTEMISININ;NR1I2;Gene;PA165111696;Chemical
KIDNEY TRANSPLANTATION;NR1I2;Gene;PA165817016;Disease
MYELOSUPPRESSION;NR1I2;Gene;PA165817398;Disease
DOLUTEGRAVIR;NR1I2;Gene;PA166114961;Chemical
DISCONTINUATION;NR1I2;Gene;PA166123507;Disease
GASTROINTESTINAL TOXICITY;NR1I2;Gene;PA166124386;Disease
ADVERSE EVENTS;NR1I2;Gene;PA166151827;Disease
ABCC1;NR1I2;Gene;PA244;Gene
ABCB1;NR1I2;Gene;PA267;Gene
ABCG2;NR1I2;Gene;PA390;Gene
ACQUIRED IMMUNODEFICIENCY SYNDROME;NR1I2;Gene;PA443250;Disease
ANEMIA;NR1I2;Gene;PA443340;Disease
URINARY BLADDER NEOPLASMS;NR1I2;Gene;PA443512;Disease
COLITIS, ULCERATIVE;NR1I2;Gene;PA443750;Disease
COLONIC NEOPLASMS;NR1I2;Gene;PA443756;Disease
CROHN DISEASE;NR1I2;Gene;PA443815;Disease
DEMENTIA;NR1I2;Gene;PA443853;Disease
EPILEPSY;NR1I2;Gene;PA444065;Disease
NASOPHARYNGEAL NEOPLASMS;NR1I2;Gene;PA445046;Disease
NEOPLASMS;NR1I2;Gene;PA445062;Disease
OVARIAN NEOPLASMS;NR1I2;Gene;PA445204;Disease
PROSTATIC NEOPLASMS;NR1I2;Gene;PA445425;Disease
OSTEOSARCOMA;NR1I2;Gene;PA445601;Disease
INFLAMMATORY BOWEL DISEASES;NR1I2;Gene;PA446116;Disease
ENDOMETRIAL NEOPLASMS;NR1I2;Gene;PA446411;Disease
SUBSTANCE-RELATED DISORDERS;NR1I2;Gene;PA446876;Disease
BIPOLAR DISORDER;NR1I2;Gene;PA447199;Disease
PSYCHOTIC DISORDER;NR1I2;Gene;PA447215;Disease
HIV INFECTIONS;NR1I2;Gene;PA447230;Disease
DEPRESSION;NR1I2;Gene;PA447278;Disease
AMOXICILLIN;NR1I2;Gene;PA448406;Chemical
AMPICILLIN;NR1I2;Gene;PA448419;Chemical
ATORVASTATIN;NR1I2;Gene;PA448500;Chemical
BUDESONIDE;NR1I2;Gene;PA448681;Chemical
CARBAMAZEPINE;NR1I2;Gene;PA448785;Chemical
CEFADROXIL;NR1I2;Gene;PA448835;Chemical
CEFUROXIME;NR1I2;Gene;PA448868;Chemical
CEPHALEXIN;NR1I2;Gene;PA448883;Chemical
CEFRADINE;NR1I2;Gene;PA448890;Chemical
CHLORPROMAZINE;NR1I2;Gene;PA448964;Chemical
CISPLATIN;NR1I2;Gene;PA449014;Chemical
CLINDAMYCIN;NR1I2;Gene;PA449035;Chemical
CLOTRIMAZOLE;NR1I2;Gene;PA449057;Chemical
CYCLOPHOSPHAMIDE;NR1I2;Gene;PA449165;Chemical
CYCLOSPORINE;NR1I2;Gene;PA449167;Chemical
DEXAMETHASONE;NR1I2;Gene;PA449247;Chemical
DIETHYLSTILBESTROL;NR1I2;Gene;PA449307;Chemical
DOCETAXEL;NR1I2;Gene;PA449383;Chemical
DOXORUBICIN;NR1I2;Gene;PA449412;Chemical
DOXYCYCLINE;NR1I2;Gene;PA449415;Chemical
EFAVIRENZ;NR1I2;Gene;PA449441;Chemical
ERYTHROMYCIN;NR1I2;Gene;PA449493;Chemical
FLUTAMIDE;NR1I2;Gene;PA449685;Chemical
FLUVASTATIN;NR1I2;Gene;PA449688;Chemical
GLYBURIDE;NR1I2;Gene;PA449782;Chemical
GRISEOFULVIN;NR1I2;Gene;PA449814;Chemical
HYDROCORTISONE;NR1I2;Gene;PA449905;Chemical
IFOSFAMIDE;NR1I2;Gene;PA449964;Chemical
IRINOTECAN;NR1I2;Gene;PA450085;Chemical
ISONIAZID;NR1I2;Gene;PA450112;Chemical
ISRADIPINE;NR1I2;Gene;PA450131;Chemical
LANSOPRAZOLE;NR1I2;Gene;PA450180;Chemical
LOVASTATIN;NR1I2;Gene;PA450272;Chemical
METFORMIN;NR1I2;Gene;PA450395;Chemical
METHADONE;NR1I2;Gene;PA450401;Chemical
METYRAPONE;NR1I2;Gene;PA450486;Chemical
MICONAZOLE;NR1I2;Gene;PA450494;Chemical
MINOCYCLINE;NR1I2;Gene;PA450519;Chemical
MODAFINIL;NR1I2;Gene;PA450530;Chemical
NAFCILLIN;NR1I2;Gene;PA450576;Chemical
NEVIRAPINE;NR1I2;Gene;PA450616;Chemical
NICARDIPINE;NR1I2;Gene;PA450620;Chemical
NIFEDIPINE;NR1I2;Gene;PA450631;Chemical
OMEPRAZOLE;NR1I2;Gene;PA450704;Chemical
PACLITAXEL;NR1I2;Gene;PA450761;Chemical
PHENOBARBITAL;NR1I2;Gene;PA450911;Chemical
PHENYLBUTAZONE;NR1I2;Gene;PA450932;Chemical
PHENYTOIN;NR1I2;Gene;PA450947;Chemical
PIOGLITAZONE;NR1I2;Gene;PA450970;Chemical
PROGESTERONE;NR1I2;Gene;PA451123;Chemical
REPAGLINIDE;NR1I2;Gene;PA451234;Chemical
RESERPINE;NR1I2;Gene;PA451236;Chemical
RIFABUTIN;NR1I2;Gene;PA451249;Chemical
RIFAMPIN;NR1I2;Gene;PA451250;Chemical
RISPERIDONE;NR1I2;Gene;PA451257;Chemical
RITONAVIR;NR1I2;Gene;PA451260;Chemical
ROSIGLITAZONE;NR1I2;Gene;PA451283;Chemical
SAQUINAVIR;NR1I2;Gene;PA451305;Chemical
SIMVASTATIN;NR1I2;Gene;PA451363;Chemical
SIROLIMUS;NR1I2;Gene;PA451365;Chemical
SPIRONOLACTONE;NR1I2;Gene;PA451483;Chemical
SULFAMETHAZINE;NR1I2;Gene;PA451542;Chemical
SULFINPYRAZONE;NR1I2;Gene;PA451550;Chemical
TACROLIMUS;NR1I2;Gene;PA451578;Chemical
TAMOXIFEN;NR1I2;Gene;PA451581;Chemical
TERBINAFINE;NR1I2;Gene;PA451614;Chemical
TETRACYCLINE;NR1I2;Gene;PA451640;Chemical
TOPIRAMATE;NR1I2;Gene;PA451728;Chemical
TROGLITAZONE;NR1I2;Gene;PA451799;Chemical
VALPROIC ACID;NR1I2;Gene;PA451846;Chemical
VINBLASTINE;NR1I2;Gene;PA451877;Chemical
VINCRISTINE;NR1I2;Gene;PA451879;Chemical
XENOBIOTICS;NR1I2;Gene;PA452604;Chemical
SUNITINIB;rs1800925;Variant;PA162372840;Chemical
RENAL CELL CARCINOMA;rs1800925;Variant;PA443624;Disease
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs397508166;Variant;PA166190041;Chemical
CYP2D6;Gastrointestinal Neoplasms;Disease;PA128;Gene
CYP3A5;Gastrointestinal Neoplasms;Disease;PA131;Gene
DPYD;Gastrointestinal Neoplasms;Disease;PA145;Gene
CYP2D6*1;Gastrointestinal Neoplasms;Disease;PA165816576;Haplotype
CYP2D6*10;Gastrointestinal Neoplasms;Disease;PA165816582;Haplotype
UGT1A1*1;Gastrointestinal Neoplasms;Disease;PA166115841;Haplotype
UGT1A1*28;Gastrointestinal Neoplasms;Disease;PA166115842;Haplotype
CYP3A5*1;Gastrointestinal Neoplasms;Disease;PA166128213;Haplotype
CYP3A5*3;Gastrointestinal Neoplasms;Disease;PA166128219;Haplotype
RS1695;Gastrointestinal Neoplasms;Disease;PA166154249;Variant
RS45445694;Gastrointestinal Neoplasms;Disease;PA166155331;Variant
DPYD POOR METABOLIZER;Gastrointestinal Neoplasms;Disease;PA166157958;Variant
GSTP1;Gastrointestinal Neoplasms;Disease;PA29028;Gene
TYMS;Gastrointestinal Neoplasms;Disease;PA359;Gene
UGT1A1;Gastrointestinal Neoplasms;Disease;PA420;Gene
CHRNA3;cotinine;Chemical;PA113;Gene
CYP2A6;cotinine;Chemical;PA121;Gene
CYP2B6;cotinine;Chemical;PA123;Gene
CYP2B6*1;cotinine;Chemical;PA165818750;Haplotype
CYP2B6*6;cotinine;Chemical;PA165818762;Haplotype
CYP2A6*1;cotinine;Chemical;PA165924690;Haplotype
CYP2A6*2;cotinine;Chemical;PA165924719;Haplotype
CYP2A6*17;cotinine;Chemical;PA165924744;Haplotype
CYP2A6*20;cotinine;Chemical;PA165924749;Haplotype
CYP2A6*9;cotinine;Chemical;PA165980914;Haplotype
RS7170068;cotinine;Chemical;PA166154919;Variant
RS10851907;cotinine;Chemical;PA166154929;Variant
RS16969968;cotinine;Chemical;PA166154938;Variant
RS57064725;cotinine;Chemical;PA166154955;Variant
RS77107237;cotinine;Chemical;PA166156696;Variant
RS510769;cotinine;Chemical;PA166156924;Variant
RS1799971;cotinine;Chemical;PA166156991;Variant
RS2075572;cotinine;Chemical;PA166157015;Variant
RS13253389;cotinine;Chemical;PA166157644;Variant
RS2942857;cotinine;Chemical;PA166163174;Variant
RS1074287;cotinine;Chemical;PA166177785;Variant
RS6912029;cotinine;Chemical;PA166177786;Variant
RS12209447;cotinine;Chemical;PA166177787;Variant
RS3798676;cotinine;Chemical;PA166177788;Variant
RS553202;cotinine;Chemical;PA166177789;Variant
RS7748401;cotinine;Chemical;PA166177791;Variant
RS495491;cotinine;Chemical;PA166177792;Variant
RS10457090;cotinine;Chemical;PA166177793;Variant
RS589046;cotinine;Chemical;PA166177794;Variant
RS3778152;cotinine;Chemical;PA166177795;Variant
RS563649;cotinine;Chemical;PA166177796;Variant
NAT1;cotinine;Chemical;PA17;Gene
CHRNA5;cotinine;Chemical;PA26491;Gene
CHRNB4;cotinine;Chemical;PA26496;Gene
OPRM1;cotinine;Chemical;PA31945;Gene
PSMA4;cotinine;Chemical;PA33878;Gene
UGT2B10;cotinine;Chemical;PA37186;Gene
COTININE;rs1074287;Variant;PA166114414;Chemical
NICOTINE;rs1074287;Variant;PA450626;Chemical
ALCOHOL ABUSE;rs4654327;Variant;PA443309;Disease
HEROIN DEPENDENCE;rs4654327;Variant;PA444460;Disease
NALTREXONE;rs4654327;Variant;PA450588;Chemical
HEROIN;rs4654327;Variant;PA452619;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;rs187238;Variant;PA446863;Disease
RIBAVIRIN;rs187238;Variant;PA451241;Chemical
INTERFERONS;rs187238;Variant;PA451999;Chemical
PRALSETINIB;rs77709286;Variant;PA166235321;Chemical
RET;rs77709286;Variant;PA34335;Gene
GNAS;PTGER2;Gene;PA175;Gene
ASTHMA;PTGER2;Gene;PA443450;Disease
ASPIRIN;PTGER2;Gene;PA448497;Chemical
ESSENTIAL HYPERTENSION;rs77876672;Variant;PA447288;Disease
HYDROCHLOROTHIAZIDE;rs77876672;Variant;PA449899;Chemical
CYP2C19;Pancreatic Neoplasms;Disease;PA124;Gene
DCK;Pancreatic Neoplasms;Disease;PA137;Gene
DCTD;Pancreatic Neoplasms;Disease;PA138;Gene
SH2D5;Pancreatic Neoplasms;Disease;PA142670927;Gene
KLC3;Pancreatic Neoplasms;Disease;PA142671588;Gene
DPYD;Pancreatic Neoplasms;Disease;PA145;Gene
SLC29A1;Pancreatic Neoplasms;Disease;PA154;Gene
ERCC1;Pancreatic Neoplasms;Disease;PA155;Gene
CMPK1;Pancreatic Neoplasms;Disease;PA162382539;Gene
CYP2C19*1;Pancreatic Neoplasms;Disease;PA165980634;Haplotype
CYP2C19*2;Pancreatic Neoplasms;Disease;PA165980635;Haplotype
UGT1A1*1;Pancreatic Neoplasms;Disease;PA166115841;Haplotype
UGT1A1*28;Pancreatic Neoplasms;Disease;PA166115842;Haplotype
UGT1A1*6;Pancreatic Neoplasms;Disease;PA166115858;Haplotype
RS1760217;Pancreatic Neoplasms;Disease;PA166153636;Variant
RS2072671;Pancreatic Neoplasms;Disease;PA166153667;Variant
RS7543016;Pancreatic Neoplasms;Disease;PA166153793;Variant
RS10916852;Pancreatic Neoplasms;Disease;PA166153814;Variant
RS35687416;Pancreatic Neoplasms;Disease;PA166153880;Variant
RS4244285;Pancreatic Neoplasms;Disease;PA166154053;Variant
RS944050;Pancreatic Neoplasms;Disease;PA166154769;Variant
RS17091162;Pancreatic Neoplasms;Disease;PA166154830;Variant
RS2847153;Pancreatic Neoplasms;Disease;PA166155288;Variant
RS45445694;Pancreatic Neoplasms;Disease;PA166155331;Variant
RS11615;Pancreatic Neoplasms;Disease;PA166155342;Variant
RS13181;Pancreatic Neoplasms;Disease;PA166155343;Variant
RS4694362;Pancreatic Neoplasms;Disease;PA166156595;Variant
RS12507552;Pancreatic Neoplasms;Disease;PA166156661;Variant
RS274713;Pancreatic Neoplasms;Disease;PA166156724;Variant
RS274717;Pancreatic Neoplasms;Disease;PA166156725;Variant
RS992160;Pancreatic Neoplasms;Disease;PA166156966;Variant
RS9394992;Pancreatic Neoplasms;Disease;PA166157157;Variant
RS2227983;Pancreatic Neoplasms;Disease;PA166157331;Variant
RS11280056;Pancreatic Neoplasms;Disease;PA166180936;Variant
RS3825876;Pancreatic Neoplasms;Disease;PA166182208;Variant
RS471760;Pancreatic Neoplasms;Disease;PA166182211;Variant
RS12148896;Pancreatic Neoplasms;Disease;PA166182212;Variant
BRCA1;Pancreatic Neoplasms;Disease;PA25411;Gene
CDC5L;Pancreatic Neoplasms;Disease;PA26270;Gene
ERCC2;Pancreatic Neoplasms;Disease;PA27848;Gene
ESR2;Pancreatic Neoplasms;Disease;PA27886;Gene
TENT4A;Pancreatic Neoplasms;Disease;PA33523;Gene
SERPINA3;Pancreatic Neoplasms;Disease;PA35020;Gene
TYMS;Pancreatic Neoplasms;Disease;PA359;Gene
SLC28A1;Pancreatic Neoplasms;Disease;PA387;Gene
UGT1A1;Pancreatic Neoplasms;Disease;PA420;Gene
EGFR;Pancreatic Neoplasms;Disease;PA7360;Gene
CDA;Pancreatic Neoplasms;Disease;PA98;Gene
FENTANYL;rs6853;Variant;PA449599;Chemical
DULOXETINE;TREML4;Gene;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;TREML4;Gene;PA447321;Disease
CYP2D6;Inappropriate ADH Syndrome;Disease;PA128;Gene
CYP2D6*1;Inappropriate ADH Syndrome;Disease;PA165816576;Haplotype
CYP2D6*5;Inappropriate ADH Syndrome;Disease;PA165948092;Haplotype
ASTHMA;rs1423515;Variant;PA443450;Disease
SALBUTAMOL;rs1423515;Variant;PA448068;Chemical
CYP2C9;lumiracoxib;Chemical;PA126;Gene
HLA-DQA1*01:01;lumiracoxib;Chemical;PA165951273;Haplotype
HLA-DQA1*01:02;lumiracoxib;Chemical;PA165951275;Haplotype
HLA-DRB1*01:01;lumiracoxib;Chemical;PA165951320;Haplotype
HLA-DRB1*15:01;lumiracoxib;Chemical;PA165952269;Haplotype
HLA-DQB1*06:02;lumiracoxib;Chemical;PA165958103;Haplotype
PTGS2;lumiracoxib;Chemical;PA293;Gene
HLA-DQA1;lumiracoxib;Chemical;PA35066;Gene
HLA-DQB1;lumiracoxib;Chemical;PA35068;Gene
HLA-DRB1;lumiracoxib;Chemical;PA35072;Gene
CYP3A4;sulfadiazine;Chemical;PA130;Gene
G6PD;sulfadiazine;Chemical;PA28469;Gene
HLA-DQA1*01:04;Measles vaccines;Chemical;PA165951284;Haplotype
HLA-DQA1*02:01;Measles vaccines;Chemical;PA165951292;Haplotype
HLA-DRB1*01:01;Measles vaccines;Chemical;PA165951320;Haplotype
HLA-DRB1*08:01;Measles vaccines;Chemical;PA165951669;Haplotype
HLA-B*07:02;Measles vaccines;Chemical;PA165954366;Haplotype
HLA-B*08:01;Measles vaccines;Chemical;PA165954547;Haplotype
HLA-B*13:01;Measles vaccines;Chemical;PA165954643;Haplotype
HLA-B*44:02;Measles vaccines;Chemical;PA165955891;Haplotype
HLA-B*51:01;Measles vaccines;Chemical;PA165956201;Haplotype
HLA-DRB1*03:01;Measles vaccines;Chemical;PA166123430;Haplotype
RS3775291;Measles vaccines;Chemical;PA166156579;Variant
HLA-B;Measles vaccines;Chemical;PA35056;Gene
HLA-DQA1;Measles vaccines;Chemical;PA35066;Gene
HLA-DRB1;Measles vaccines;Chemical;PA35072;Gene
TLR3;Measles vaccines;Chemical;PA36551;Gene
RISPERIDONE;rs2069062;Variant;PA451257;Chemical
RS34548976;adrenergics, inhalants;Chemical;PA166157486;Variant
IFNL3;daclatasvir;Chemical;PA134952671;Gene
IFNL4;daclatasvir;Chemical;PA166049147;Gene
RS12979860;daclatasvir;Chemical;PA166155468;Variant
COMT;Opioid-Related Disorders;Disease;PA117;Gene
CYP2B6;Opioid-Related Disorders;Disease;PA123;Gene
CYP2D6;Opioid-Related Disorders;Disease;PA128;Gene
CYP3A4;Opioid-Related Disorders;Disease;PA130;Gene
CYP3A5;Opioid-Related Disorders;Disease;PA131;Gene
ANKK1;Opioid-Related Disorders;Disease;PA134872551;Gene
ADAMTSL2;Opioid-Related Disorders;Disease;PA134920655;Gene
CNIH3;Opioid-Related Disorders;Disease;PA134929862;Gene
EXOC4;Opioid-Related Disorders;Disease;PA134944654;Gene
BDNF-AS;Opioid-Related Disorders;Disease;PA134953249;Gene
ADGRV1;Opioid-Related Disorders;Disease;PA134960779;Gene
ZSCAN25;Opioid-Related Disorders;Disease;PA134962723;Gene
NECTIN4;Opioid-Related Disorders;Disease;PA134991624;Gene
DBH;Opioid-Related Disorders;Disease;PA136;Gene
LKAAEAR1;Opioid-Related Disorders;Disease;PA162378956;Gene
NGF;Opioid-Related Disorders;Disease;PA162397475;Gene
ZNF804A;Opioid-Related Disorders;Disease;PA162410599;Gene
CYP2D6*1;Opioid-Related Disorders;Disease;PA165816576;Haplotype
CYP2D6*2;Opioid-Related Disorders;Disease;PA165816577;Haplotype
CYP2D6*3;Opioid-Related Disorders;Disease;PA165816578;Haplotype
CYP2D6*4;Opioid-Related Disorders;Disease;PA165816579;Haplotype
CYP2D6*6;Opioid-Related Disorders;Disease;PA165816581;Haplotype
CYP2B6*1;Opioid-Related Disorders;Disease;PA165818750;Haplotype
CYP2B6*4;Opioid-Related Disorders;Disease;PA165818757;Haplotype
CYP2B6*5;Opioid-Related Disorders;Disease;PA165818760;Haplotype
CYP2B6*6;Opioid-Related Disorders;Disease;PA165818762;Haplotype
CYP2B6*7;Opioid-Related Disorders;Disease;PA165818765;Haplotype
CYP2B6*18;Opioid-Related Disorders;Disease;PA165818808;Haplotype
CYP2D6*1XN;Opioid-Related Disorders;Disease;PA165988479;Haplotype
CYP2D6*2XN;Opioid-Related Disorders;Disease;PA165988480;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);Opioid-Related Disorders;Disease;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);Opioid-Related Disorders;Disease;PA166116466;Haplotype
RS529520;Opioid-Related Disorders;Disease;PA166153574;Variant
RS581111;Opioid-Related Disorders;Disease;PA166153578;Variant
RS2236861;Opioid-Related Disorders;Disease;PA166153682;Variant
RS2239622;Opioid-Related Disorders;Disease;PA166153683;Variant
RS948854;Opioid-Related Disorders;Disease;PA166154302;Variant
RS1076560;Opioid-Related Disorders;Disease;PA166154313;Variant
RS1125394;Opioid-Related Disorders;Disease;PA166154319;Variant
RS1491850;Opioid-Related Disorders;Disease;PA166154329;Variant
RS1800497;Opioid-Related Disorders;Disease;PA166154339;Variant
RS2283265;Opioid-Related Disorders;Disease;PA166154364;Variant
RS7118900;Opioid-Related Disorders;Disease;PA166154420;Variant
RS7934165;Opioid-Related Disorders;Disease;PA166154427;Variant
RS10770141;Opioid-Related Disorders;Disease;PA166154434;Variant
RS10835210;Opioid-Related Disorders;Disease;PA166154437;Variant
RS5443;Opioid-Related Disorders;Disease;PA166154486;Variant
RS2069514;Opioid-Related Disorders;Disease;PA166154874;Variant
RS1045280;Opioid-Related Disorders;Disease;PA166155174;Variant
RS3745274;Opioid-Related Disorders;Disease;PA166155409;Variant
RS4680;Opioid-Related Disorders;Disease;PA166156024;Variant
RS933271;Opioid-Related Disorders;Disease;PA166156059;Variant
RS1065852;Opioid-Related Disorders;Disease;PA166156062;Variant
RS6280;Opioid-Related Disorders;Disease;PA166156277;Variant
RS2654754;Opioid-Related Disorders;Disease;PA166156360;Variant
RS9288993;Opioid-Related Disorders;Disease;PA166156428;Variant
RS4292394;Opioid-Related Disorders;Disease;PA166156584;Variant
RS4554144;Opioid-Related Disorders;Disease;PA166156589;Variant
RS6600879;Opioid-Related Disorders;Disease;PA166156603;Variant
RS6600880;Opioid-Related Disorders;Disease;PA166156604;Variant
RS6600893;Opioid-Related Disorders;Disease;PA166156605;Variant
RS7438135;Opioid-Related Disorders;Disease;PA166156617;Variant
RS7439366;Opioid-Related Disorders;Disease;PA166156619;Variant
RS7662029;Opioid-Related Disorders;Disease;PA166156621;Variant
RS7668258;Opioid-Related Disorders;Disease;PA166156625;Variant
RS11940316;Opioid-Related Disorders;Disease;PA166156655;Variant
RS510769;Opioid-Related Disorders;Disease;PA166156924;Variant
RS558025;Opioid-Related Disorders;Disease;PA166156928;Variant
RS1799971;Opioid-Related Disorders;Disease;PA166156991;Variant
RS2075572;Opioid-Related Disorders;Disease;PA166157015;Variant
RS2760118;Opioid-Related Disorders;Disease;PA166157047;Variant
RS9479757;Opioid-Related Disorders;Disease;PA166157164;Variant
RS15524;Opioid-Related Disorders;Disease;PA166157243;Variant
RS776746;Opioid-Related Disorders;Disease;PA166157267;Variant
RS1045642;Opioid-Related Disorders;Disease;PA166157284;Variant
RS1128503;Opioid-Related Disorders;Disease;PA166157288;Variant
RS2032582;Opioid-Related Disorders;Disease;PA166157316;Variant
RS2740574;Opioid-Related Disorders;Disease;PA166157367;Variant
RS9282564;Opioid-Related Disorders;Disease;PA166157435;Variant
RS1948308;Opioid-Related Disorders;Disease;PA166157739;Variant
RS2120266;Opioid-Related Disorders;Disease;PA166157742;Variant
RS2289658;Opioid-Related Disorders;Disease;PA166157749;Variant
RS2378676;Opioid-Related Disorders;Disease;PA166157752;Variant
RS4358872;Opioid-Related Disorders;Disease;PA166157773;Variant
RS4877900;Opioid-Related Disorders;Disease;PA166157779;Variant
RS17180299;Opioid-Related Disorders;Disease;PA166159971;Variant
RS10485058;Opioid-Related Disorders;Disease;PA166161944;Variant
RS1611131;Opioid-Related Disorders;Disease;PA166175925;Variant
RS2070762;Opioid-Related Disorders;Disease;PA166175927;Variant
RS1129844;Opioid-Related Disorders;Disease;PA166175942;Variant
RS678849;Opioid-Related Disorders;Disease;PA166175994;Variant
RS2234918;Opioid-Related Disorders;Disease;PA166175997;Variant
RS648893;Opioid-Related Disorders;Disease;PA166176243;Variant
RS6090041;Opioid-Related Disorders;Disease;PA166177052;Variant
RS6090043;Opioid-Related Disorders;Disease;PA166177053;Variant
RS1799972;Opioid-Related Disorders;Disease;PA166177739;Variant
RS495491;Opioid-Related Disorders;Disease;PA166177792;Variant
RS10457090;Opioid-Related Disorders;Disease;PA166177793;Variant
RS589046;Opioid-Related Disorders;Disease;PA166177794;Variant
RS1997794;Opioid-Related Disorders;Disease;PA166177932;Variant
RS1022563;Opioid-Related Disorders;Disease;PA166177933;Variant
RS910080;Opioid-Related Disorders;Disease;PA166177939;Variant
RS548646;Opioid-Related Disorders;Disease;PA166179967;Variant
RS511435;Opioid-Related Disorders;Disease;PA166183701;Variant
RS524731;Opioid-Related Disorders;Disease;PA166183702;Variant
RS3823010;Opioid-Related Disorders;Disease;PA166183703;Variant
RS3778156;Opioid-Related Disorders;Disease;PA166183705;Variant
RS609148;Opioid-Related Disorders;Disease;PA166183707;Variant
RS1079596;Opioid-Related Disorders;Disease;PA166183998;Variant
RS6928499;Opioid-Related Disorders;Disease;PA166184035;Variant
RS997917;Opioid-Related Disorders;Disease;PA166198164;Variant
RS2366929;Opioid-Related Disorders;Disease;PA166205161;Variant
RS10770140;Opioid-Related Disorders;Disease;PA166208983;Variant
RS11265549;Opioid-Related Disorders;Disease;PA166233022;Variant
RS11030096;Opioid-Related Disorders;Disease;PA166235681;Variant
RS4906902;Opioid-Related Disorders;Disease;PA166235724;Variant
RS735668;Opioid-Related Disorders;Disease;PA166235762;Variant
RS7597593;Opioid-Related Disorders;Disease;PA166235764;Variant
RS2023239;Opioid-Related Disorders;Disease;PA166235801;Variant
RS324029;Opioid-Related Disorders;Disease;PA166235844;Variant
RS718656;Opioid-Related Disorders;Disease;PA166235847;Variant
RS1384401;Opioid-Related Disorders;Disease;PA166235849;Variant
RS4530637;Opioid-Related Disorders;Disease;PA166235850;Variant
RS10799590;Opioid-Related Disorders;Disease;PA166252261;Variant
RS62368105;Opioid-Related Disorders;Disease;PA166259901;Variant
RS6973474;Opioid-Related Disorders;Disease;PA166259902;Variant
RS756770;Opioid-Related Disorders;Disease;PA166259903;Variant
RS7205113;Opioid-Related Disorders;Disease;PA166259904;Variant
RS13169373;Opioid-Related Disorders;Disease;PA166259921;Variant
RS11782370;Opioid-Related Disorders;Disease;PA166259922;Variant
RS73568641;Opioid-Related Disorders;Disease;PA166263562;Variant
GNB3;Opioid-Related Disorders;Disease;PA176;Gene
ALDH5A1;Opioid-Related Disorders;Disease;PA24702;Gene
CNR1;Opioid-Related Disorders;Disease;PA26681;Gene
ABCB1;Opioid-Related Disorders;Disease;PA267;Gene
CYP1A2;Opioid-Related Disorders;Disease;PA27093;Gene
CYP2A7P1;Opioid-Related Disorders;Disease;PA27103;Gene
CYP3A;Opioid-Related Disorders;Disease;PA27114;Gene
DRD2;Opioid-Related Disorders;Disease;PA27478;Gene
DRD3;Opioid-Related Disorders;Disease;PA27479;Gene
GABRB3;Opioid-Related Disorders;Disease;PA28497;Gene
GAL;Opioid-Related Disorders;Disease;PA28529;Gene
SLC6A4;Opioid-Related Disorders;Disease;PA312;Gene
NTRK2;Opioid-Related Disorders;Disease;PA31818;Gene
BDNF;Opioid-Related Disorders;Disease;PA31891;Gene
OPRD1;Opioid-Related Disorders;Disease;PA31942;Gene
OPRK1;Opioid-Related Disorders;Disease;PA31943;Gene
OPRL1;Opioid-Related Disorders;Disease;PA31944;Gene
OPRM1;Opioid-Related Disorders;Disease;PA31945;Gene
PDYN;Opioid-Related Disorders;Disease;PA33163;Gene
RGS19;Opioid-Related Disorders;Disease;PA34370;Gene
TH;Opioid-Related Disorders;Disease;PA351;Gene
CCL11;Opioid-Related Disorders;Disease;PA35543;Gene
UGT2B7;Opioid-Related Disorders;Disease;PA361;Gene
TACR1;Opioid-Related Disorders;Disease;PA36302;Gene
TACR3;Opioid-Related Disorders;Disease;PA36304;Gene
TXNRD2;Opioid-Related Disorders;Disease;PA38302;Gene
ARRB2;Opioid-Related Disorders;Disease;PA60;Gene
COMT;Narcolepsy;Disease;PA117;Gene
HLA-DQB1*06:02;Narcolepsy;Disease;PA165958103;Haplotype
RS1045642;Narcolepsy;Disease;PA166157284;Variant
RS1128503;Narcolepsy;Disease;PA166157288;Variant
RS2032582;Narcolepsy;Disease;PA166157316;Variant
ABCB1;Narcolepsy;Disease;PA267;Gene
HLA-DQB1;Narcolepsy;Disease;PA35068;Gene
DAUNORUBICIN;SETD4;Gene;PA449212;Chemical
DOXORUBICIN;SETD4;Gene;PA449412;Chemical
KIDNEY FAILURE, CHRONIC;CYB5R3 deficiency;Variant;PA444684;Disease
METHEMOGLOBINEMIA;CYB5R3 deficiency;Variant;PA444942;Disease
METOCLOPRAMIDE;CYB5R3 deficiency;Variant;PA450475;Chemical
NEPHROTOXICITY;CLCN6;Gene;PA162263533;Disease
OSTEOSARCOMA;CLCN6;Gene;PA445601;Disease
SCHIZOPHRENIA;CLCN6;Gene;PA447216;Disease
CISPLATIN;CLCN6;Gene;PA449014;Chemical
DOXORUBICIN;CLCN6;Gene;PA449412;Chemical
METHOTREXATE;CLCN6;Gene;PA450428;Chemical
ANTIPSYCHOTICS;CLCN6;Gene;PA452233;Chemical
CYP2D6;Galactorrhea;Disease;PA128;Gene
CYP2D6*1;Galactorrhea;Disease;PA165816576;Haplotype
CYP2D6*4;Galactorrhea;Disease;PA165816579;Haplotype
CYP2D6*41;Galactorrhea;Disease;PA165816584;Haplotype
ALCOHOL ABUSE;rs3778156;Variant;PA443309;Disease
OPIOID-RELATED DISORDERS;rs3778156;Variant;PA445043;Disease
COCAINE DEPENDENCE;rs3778156;Variant;PA446878;Disease
ETHANOL;rs3778156;Variant;PA448073;Chemical
COCAINE;rs3778156;Variant;PA449072;Chemical
OPIOIDS;rs3778156;Variant;PA452618;Chemical
NR1I2;forskolin;Chemical;PA378;Gene
MULTIPLE SCLEROSIS;RORA;Gene;PA444987;Disease
MAJOR DEPRESSIVE DISORDER;RORA;Gene;PA447321;Disease
CITALOPRAM;RORA;Gene;PA449015;Chemical
INTERFERON BETA-1A;RORA;Gene;PA450037;Chemical
CYP2C19;Thrombosis;Disease;PA124;Gene
F5;Thrombosis;Disease;PA159;Gene
CYP2C19*17;Thrombosis;Disease;PA165816533;Haplotype
CYP2C19*1;Thrombosis;Disease;PA165980634;Haplotype
CYP2C19*2;Thrombosis;Disease;PA165980635;Haplotype
CYP2C19*3;Thrombosis;Disease;PA165980636;Haplotype
RS6025;Thrombosis;Disease;PA166153554;Variant
RS1800566;Thrombosis;Disease;PA166155017;Variant
RS662;Thrombosis;Disease;PA166157238;Variant
NQO1;Thrombosis;Disease;PA31744;Gene
SLC19A1;Thrombosis;Disease;PA327;Gene
PON1;Thrombosis;Disease;PA33529;Gene
RS1042714;terbutaline;Chemical;PA166156749;Variant
ADRB2;terbutaline;Chemical;PA39;Gene
ETHANOL;rs17376019;Variant;PA448073;Chemical
CYP2D6;metoclopramide;Chemical;PA128;Gene
CYB5R4;metoclopramide;Chemical;PA134904907;Gene
CYB5R1;metoclopramide;Chemical;PA134979668;Gene
CYB5R2;metoclopramide;Chemical;PA142672060;Gene
CYB5R3 DEFICIENCY;metoclopramide;Chemical;PA166157902;Variant
CYB5R3;metoclopramide;Chemical;PA27331;Gene
G6PD;metoclopramide;Chemical;PA28469;Gene
CYP2C19;norethindrone;Chemical;PA124;Gene
IFNL3;ledipasvir;Chemical;PA134952671;Gene
IFNL4;ledipasvir;Chemical;PA166049147;Gene
RS8099917;ledipasvir;Chemical;PA166155435;Variant
RS12979860;ledipasvir;Chemical;PA166155468;Variant
RS2108622;arachidonic acid;Chemical;PA166155381;Variant
RS114396708;arachidonic acid;Chemical;PA166304144;Variant
RS753169154;arachidonic acid;Chemical;PA166316641;Variant
RS754533672;arachidonic acid;Chemical;PA166316645;Variant
RS1292029455;arachidonic acid;Chemical;PA166316681;Variant
RS550261161;arachidonic acid;Chemical;PA166316683;Variant
CYP4F2;arachidonic acid;Chemical;PA27121;Gene
CYP2C19;cardiotoxicity;Disease;PA124;Gene
CYP2D6;cardiotoxicity;Disease;PA128;Gene
RNF144A;cardiotoxicity;Disease;PA162401542;Gene
CYP2C19*17;cardiotoxicity;Disease;PA165816533;Haplotype
CYP2D6*1;cardiotoxicity;Disease;PA165816576;Haplotype
CYP2D6*2;cardiotoxicity;Disease;PA165816577;Haplotype
CYP2D6*3;cardiotoxicity;Disease;PA165816578;Haplotype
CYP2D6*4;cardiotoxicity;Disease;PA165816579;Haplotype
CYP2D6*6;cardiotoxicity;Disease;PA165816581;Haplotype
CYP2D6*5;cardiotoxicity;Disease;PA165948092;Haplotype
CYP2C19*1;cardiotoxicity;Disease;PA165980634;Haplotype
CYP2D6*1XN;cardiotoxicity;Disease;PA165988479;Haplotype
CYP2D6*2XN;cardiotoxicity;Disease;PA165988480;Haplotype
CYP2D6*81;cardiotoxicity;Disease;PA166123321;Haplotype
RS1695;cardiotoxicity;Disease;PA166154249;Variant
RS2229774;cardiotoxicity;Disease;PA166154532;Variant
RS7853758;cardiotoxicity;Disease;PA166157790;Variant
GSTP1;cardiotoxicity;Disease;PA29028;Gene
RARG;cardiotoxicity;Disease;PA34227;Gene
SLC28A3;cardiotoxicity;Disease;PA426;Gene
MULTIPLE SCLEROSIS;rs1448673;Variant;PA444987;Disease
INTERFERON BETA-1A;rs1448673;Variant;PA450037;Chemical
INTERFERON BETA-1B;rs1448673;Variant;PA450039;Chemical
G6PD;quinacrine;Chemical;PA28469;Gene
ASTHMA;rs2243250;Variant;PA443450;Disease
ASPIRIN;rs2243250;Variant;PA448497;Chemical
RENAL CELL CARCINOMA;rs4796793;Variant;PA443624;Disease
INTERFERONS;rs4796793;Variant;PA451999;Chemical
OPIOID-RELATED DISORDERS;rs17180299;Variant;PA445043;Disease
METHADONE;rs17180299;Variant;PA450401;Chemical
ABCB1;ivermectin;Chemical;PA267;Gene
EMAPALUMAB;PRF1;Gene;PA166182763;Chemical
BUPROPION;rs11746641;Variant;PA448687;Chemical
NICOTINE;rs11746641;Variant;PA450626;Chemical
ACUTE CORONARY SYNDROME;JMJD8;Gene;PA165108401;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);JMJD8;Gene;PA166129560;Disease
ASPIRIN;JMJD8;Gene;PA448497;Chemical
CLOPIDOGREL;JMJD8;Gene;PA449053;Chemical
CYP19A1;Enzyme inhibitors;Chemical;PA27091;Gene
PSYCHOTIC DISORDER;rs1126442;Variant;PA447215;Disease
METHAMPHETAMINE;rs1126442;Variant;PA450403;Chemical
ROPEGINTERFERON ALFA-2B;rs77375493;Variant;PA166268921;Chemical
JAK2;rs77375493;Variant;PA29989;Gene
EMAPALUMAB;XIAP;Gene;PA166182763;Chemical
IVACAFTOR;rs7512462;Variant;PA165950341;Chemical
CYSTIC FIBROSIS;rs7512462;Variant;PA443829;Disease
RADIOTHERAPY;rs264663;Variant;PA166122986;Chemical
PROSTATIC NEOPLASMS;rs264663;Variant;PA445425;Disease
PITRAKINRA;rs1805010;Variant;PA165983754;Chemical
ASTHMA;rs1805010;Variant;PA443450;Disease
COTININE;rs2942857;Variant;PA166114414;Chemical
TOBACCO USE DISORDER;rs2942857;Variant;PA445876;Disease
DRUGS FOR TREATMENT OF TUBERCULOSIS;rs2031920;Variant;PA164712708;Chemical
ALCOHOL ABUSE;rs2031920;Variant;PA443309;Disease
TUBERCULOSIS;rs2031920;Variant;PA445941;Disease
ETHANOL;rs2031920;Variant;PA448073;Chemical
SEVOFLURANE;rs2031920;Variant;PA451341;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs6071980;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs6071980;Variant;PA443434;Disease
TOXIC LIVER DISEASE;rs2236225;Variant;PA164925725;Disease
MUCOSITIS;rs2236225;Variant;PA166122058;Disease
ANEMIA;rs2236225;Variant;PA443340;Disease
LEUKOPENIA;rs2236225;Variant;PA444773;Disease
NON-HODGKIN LYMPHOMA;rs2236225;Variant;PA444845;Disease
MESOTHELIOMA;rs2236225;Variant;PA444937;Disease
OSTEOSARCOMA;rs2236225;Variant;PA445601;Disease
THROMBOCYTOPENIA;rs2236225;Variant;PA445846;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs2236225;Variant;PA446155;Disease
CISPLATIN;rs2236225;Variant;PA449014;Chemical
DOXORUBICIN;rs2236225;Variant;PA449412;Chemical
METHOTREXATE;rs2236225;Variant;PA450428;Chemical
HYPERTENSION;rs4762;Variant;PA444552;Disease
HYPERTROPHY, LEFT VENTRICULAR;rs4762;Variant;PA446479;Disease
IRBESARTAN;rs4762;Variant;PA450084;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs11572078;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs11572078;Variant;PA445846;Disease
CARBOPLATIN;rs11572078;Variant;PA448803;Chemical
GEMCITABINE;rs11572078;Variant;PA449748;Chemical
MUSCULAR DISEASES;rs1799762;Variant;PA444997;Disease
OSTEONECROSIS;rs1799762;Variant;PA445187;Disease
PEMPHIGUS;rs1799762;Variant;PA445273;Disease
METHYLPREDNISOLONE;rs1799762;Variant;PA450466;Chemical
SLCO1B1;familial hypercholesterolemia;Disease;PA134865839;Gene
RS4149056;familial hypercholesterolemia;Disease;PA166154579;Variant
RS1057868;familial hypercholesterolemia;Disease;PA166157286;Variant
LDLR;familial hypercholesterolemia;Disease;PA227;Gene
POR;familial hypercholesterolemia;Disease;PA33532;Gene
PCSK9;familial hypercholesterolemia;Disease;PA38617;Gene
APOB;familial hypercholesterolemia;Disease;PA50;Gene
G6PD B (REFERENCE);mefloquine;Chemical;PA165947826;Haplotype
G6PD A- 202A_376G;mefloquine;Chemical;PA165947827;Haplotype
G6PD DEFICIENCY;mefloquine;Chemical;PA166157959;Variant
ABCB1;mefloquine;Chemical;PA267;Gene
G6PD;mefloquine;Chemical;PA28469;Gene
DESFLURANE;rs144336148;Variant;PA164749136;Chemical
RYR1;rs144336148;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs144336148;Variant;PA444863;Disease
ENFLURANE;rs144336148;Variant;PA449461;Chemical
HALOTHANE;rs144336148;Variant;PA449845;Chemical
ISOFLURANE;rs144336148;Variant;PA450106;Chemical
METHOXYFLURANE;rs144336148;Variant;PA450434;Chemical
SEVOFLURANE;rs144336148;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs144336148;Variant;PA451522;Chemical
CACNA1S;rs144336148;Variant;PA85;Gene
MAJOR ADVERSE CARDIAC EVENTS (MACE);rs2254638;Variant;PA166129560;Disease
CLOPIDOGREL;rs2254638;Variant;PA449053;Chemical
HIV INFECTIOUS DISEASE;CCHCR1;Gene;PA447230;Disease
NEVIRAPINE;CCHCR1;Gene;PA450616;Chemical
RS1803274;Lewy Body Disease;Disease;PA166156332;Variant
BCHE;Lewy Body Disease;Disease;PA25294;Gene
BUFURALOL;CYP2D6*75;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*75;Haplotype;PA166127651;Chemical
DEXTROMETHORPHAN;CYP2D6*75;Haplotype;PA449273;Chemical
PRIMAQUINE;CYP2D6*75;Haplotype;PA451103;Chemical
DEBRISOQUINE;CYP2D6*75;Haplotype;PA452616;Chemical
SLCO1B1;amprenavir;Chemical;PA134865839;Gene
RS4149056;amprenavir;Chemical;PA166154579;Variant
ABCB1;amprenavir;Chemical;PA267;Gene
DRUG TOXICITY;rs1029359343;Variant;PA443937;Disease
PHENYTOIN;rs1029359343;Variant;PA450947;Chemical
HYPERTENSION;rs11313667;Variant;PA444552;Disease
ATENOLOL;rs11313667;Variant;PA448499;Chemical
HYDROCHLOROTHIAZIDE;rs11313667;Variant;PA449899;Chemical
METOPROLOL;rs11313667;Variant;PA450480;Chemical
DRUG TOXICITY;rs3217164;Variant;PA443937;Disease
CAPECITABINE;rs3217164;Variant;PA448771;Chemical
AGRANULOCYTOSIS;HLA-DRB1*04:02;Haplotype;PA443297;Disease
SCHIZOPHRENIA;HLA-DRB1*04:02;Haplotype;PA447216;Disease
CLOZAPINE;HLA-DRB1*04:02;Haplotype;PA449061;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs854547;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs854547;Variant;PA443434;Disease
ANXIETY DISORDERS;rs242941;Variant;PA447196;Disease
MAJOR DEPRESSIVE DISORDER;rs242941;Variant;PA447321;Disease
FLUOXETINE;rs242941;Variant;PA449673;Chemical
COL22A1;salbutamol;Chemical;PA134914705;Gene
RS11252394;salbutamol;Chemical;PA166154136;Variant
RS9552679;salbutamol;Chemical;PA166154738;Variant
RS1663330;salbutamol;Chemical;PA166154783;Variant
RS1663332;salbutamol;Chemical;PA166154784;Variant
RS518350;salbutamol;Chemical;PA166156053;Variant
RS6002674;salbutamol;Chemical;PA166156127;Variant
RS1522113;salbutamol;Chemical;PA166156517;Variant
RS17701271;salbutamol;Chemical;PA166156673;Variant
RS881152;salbutamol;Chemical;PA166156744;Variant
RS1042713;salbutamol;Chemical;PA166156748;Variant
RS1423515;salbutamol;Chemical;PA166156762;Variant
RS1800888;salbutamol;Chemical;PA166156773;Variant
RS17495520;salbutamol;Chemical;PA166156887;Variant
RS255100;salbutamol;Chemical;PA166157250;Variant
RS1419555;salbutamol;Chemical;PA166157294;Variant
RS2267715;salbutamol;Chemical;PA166157348;Variant
RS2284220;salbutamol;Chemical;PA166157353;Variant
RS7793837;salbutamol;Chemical;PA166157430;Variant
RS6988229;salbutamol;Chemical;PA166157622;Variant
RS10511905;salbutamol;Chemical;PA166157806;Variant
CLOCK;salbutamol;Chemical;PA26609;Gene
CRHR2;salbutamol;Chemical;PA26875;Gene
DUSP1;salbutamol;Chemical;PA27519;Gene
ADRB2;salbutamol;Chemical;PA39;Gene
OSTEOSARCOMA;REV1;Gene;PA445601;Disease
CISPLATIN;REV1;Gene;PA449014;Chemical
ATRIAL FIBRILLATION;CYP2C9*60;Haplotype;PA443459;Disease
DICLOFENAC;CYP2C9*60;Haplotype;PA449293;Chemical
TOLBUTAMIDE;CYP2C9*60;Haplotype;PA451718;Chemical
WARFARIN;CYP2C9*60;Haplotype;PA451906;Chemical
KCNH2;pyrilamine;Chemical;PA212;Gene
LOSARTAN;rs6749447;Variant;PA450268;Chemical
IMATINIB;rs628031;Variant;PA10804;Chemical
GASTROINTESTINAL TOXICITY;rs628031;Variant;PA166124386;Disease
DIABETES MELLITUS, TYPE 2;rs628031;Variant;PA443890;Disease
EPILEPSY;rs628031;Variant;PA444065;Disease
NEOPLASMS;rs628031;Variant;PA445062;Disease
LAMOTRIGINE;rs628031;Variant;PA450164;Chemical
METFORMIN;rs628031;Variant;PA450395;Chemical
CARDIOVASCULAR DISEASES;MIR224;Gene;PA443635;Disease
UNC13D;emapalumab;Chemical;PA134919958;Gene
XIAP;emapalumab;Chemical;PA25361;Gene
PRF1;emapalumab;Chemical;PA33732;Gene
RAB27A;emapalumab;Chemical;PA34117;Gene
SH2D1A;emapalumab;Chemical;PA35728;Gene
STX11;emapalumab;Chemical;PA36229;Gene
STXBP2;emapalumab;Chemical;PA36242;Gene
MTTP;APOC3;Gene;PA164742099;Gene
HYPERLIPIDEMIAS;APOC3;Gene;PA444528;Disease
HIV INFECTIOUS DISEASE;APOC3;Gene;PA447230;Disease
OLANZAPINE;APOC3;Gene;PA450688;Chemical
RITONAVIR;APOC3;Gene;PA451260;Chemical
HALOPERIDOL;NKX6-1;Gene;PA449841;Chemical
CYP2C8;liver transplantation;Disease;PA125;Gene
CYP3A4;liver transplantation;Disease;PA130;Gene
CYP3A5;liver transplantation;Disease;PA131;Gene
ZSCAN25;liver transplantation;Disease;PA134962723;Gene
SUMO4;liver transplantation;Disease;PA134979206;Gene
CYP3A4*1;liver transplantation;Disease;PA165819201;Haplotype
CYP3A4*18;liver transplantation;Disease;PA165819240;Haplotype
CYP3A4*20;liver transplantation;Disease;PA165819244;Haplotype
TPMT*1;liver transplantation;Disease;PA165819268;Haplotype
TPMT*3A;liver transplantation;Disease;PA165819270;Haplotype
CYP2C8*3;liver transplantation;Disease;PA165958685;Haplotype
CYP3A4*22;liver transplantation;Disease;PA166048680;Haplotype
CYP3A5*1;liver transplantation;Disease;PA166128213;Haplotype
CYP3A5*3;liver transplantation;Disease;PA166128219;Haplotype
CYP3A5*6;liver transplantation;Disease;PA166128233;Haplotype
CYP3A5*7;liver transplantation;Disease;PA166128234;Haplotype
RS1800871;liver transplantation;Disease;PA166153639;Variant
RS1800872;liver transplantation;Disease;PA166153640;Variant
RS1800896;liver transplantation;Disease;PA166153642;Variant
RS11265572;liver transplantation;Disease;PA166153827;Variant
RS290487;liver transplantation;Disease;PA166153946;Variant
RS7903146;liver transplantation;Disease;PA166154084;Variant
RS1127354;liver transplantation;Disease;PA166155915;Variant
RS15524;liver transplantation;Disease;PA166157243;Variant
RS776746;liver transplantation;Disease;PA166157267;Variant
RS2032582;liver transplantation;Disease;PA166157316;Variant
RS2242480;liver transplantation;Disease;PA166157345;Variant
RS4646437;liver transplantation;Disease;PA166157391;Variant
RS9200;liver transplantation;Disease;PA166169844;Variant
RS10052999;liver transplantation;Disease;PA166169847;Variant
RS4646450;liver transplantation;Disease;PA166176608;Variant
RS237025;liver transplantation;Disease;PA166176908;Variant
CYP2C8*1;liver transplantation;Disease;PA166242948;Haplotype
C6;liver transplantation;Disease;PA25921;Gene
ABCB1;liver transplantation;Disease;PA267;Gene
IL10;liver transplantation;Disease;PA29778;Gene
ITPA;liver transplantation;Disease;PA29973;Gene
TPMT;liver transplantation;Disease;PA356;Gene
TCF7L2;liver transplantation;Disease;PA36394;Gene
CYP2C19;leflunomide;Chemical;PA124;Gene
ESR1;leflunomide;Chemical;PA156;Gene
CYP2C19*17;leflunomide;Chemical;PA165816533;Haplotype
CYP2C19*1;leflunomide;Chemical;PA165980634;Haplotype
CYP2C19*2;leflunomide;Chemical;PA165980635;Haplotype
RS762551;leflunomide;Chemical;PA166154850;Variant
RS3213422;leflunomide;Chemical;PA166155048;Variant
RS2234693;leflunomide;Chemical;PA166157026;Variant
RS9340799;leflunomide;Chemical;PA166157143;Variant
CYP1A2;leflunomide;Chemical;PA27093;Gene
DHODH;leflunomide;Chemical;PA27327;Gene
GRK5;pindolol;Chemical;PA180;Gene
GRK4;pindolol;Chemical;PA28941;Gene
ADRA2C;pindolol;Chemical;PA37;Gene
ADRB1;pindolol;Chemical;PA38;Gene
ADRB2;pindolol;Chemical;PA39;Gene
DEPRESSION;rs61888800;Variant;PA447278;Disease
MAJOR DEPRESSIVE DISORDER;rs61888800;Variant;PA447321;Disease
DESIPRAMINE;rs61888800;Variant;PA449233;Chemical
FLUOXETINE;rs61888800;Variant;PA449673;Chemical
ANTIDEPRESSANTS;rs61888800;Variant;PA452229;Chemical
TPMT*1;Rheumatic Diseases;Disease;PA165819268;Haplotype
TPMT*2;Rheumatic Diseases;Disease;PA165819269;Haplotype
TPMT*3A;Rheumatic Diseases;Disease;PA165819270;Haplotype
TPMT;Rheumatic Diseases;Disease;PA356;Gene
ESSENTIAL HYPERTENSION;rs3758785;Variant;PA447288;Disease
CANDESARTAN;rs3758785;Variant;PA448765;Chemical
HYDROCHLOROTHIAZIDE;rs3758785;Variant;PA449899;Chemical
PANCREATIC NEOPLASMS;rs274717;Variant;PA445218;Disease
GEMCITABINE;rs274717;Variant;PA449748;Chemical
SULFONAMIDES, UREA DERIVATIVES;rs757110;Variant;PA10390;Chemical
DIABETES MELLITUS;rs757110;Variant;PA443886;Disease
TUBERCULOSIS;rs7958375;Variant;PA445941;Disease
RIFAMPIN;rs7958375;Variant;PA451250;Chemical
ACE INHIBITORS, PLAIN;MME;Gene;PA164712308;Chemical
COUGH;MME;Gene;PA443803;Disease
HYPERTENSION;MME;Gene;PA444552;Disease
CYP2D6;acetaminophen / caffeine / dihydrocodeine;Chemical;PA128;Gene
HYPERTENSION;rs4506565;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs4506565;Variant;PA449899;Chemical
ESCITALOPRAM;rs7997012;Variant;PA10074;Chemical
ANXIETY DISORDERS;rs7997012;Variant;PA447196;Disease
BIPOLAR DISORDER;rs7997012;Variant;PA447199;Disease
DEPRESSIVE DISORDER;rs7997012;Variant;PA447207;Disease
DEPRESSION;rs7997012;Variant;PA447278;Disease
MAJOR DEPRESSIVE DISORDER;rs7997012;Variant;PA447321;Disease
CITALOPRAM;rs7997012;Variant;PA449015;Chemical
FLUOXETINE;rs7997012;Variant;PA449673;Chemical
OLANZAPINE;rs7997012;Variant;PA450688;Chemical
PAROXETINE;rs7997012;Variant;PA450801;Chemical
SERTRALINE;rs7997012;Variant;PA451333;Chemical
VENLAFAXINE;rs7997012;Variant;PA451866;Chemical
ANTIDEPRESSANTS;rs7997012;Variant;PA452229;Chemical
SIRT1;PPARGC1A;Gene;PA37935;Gene
INSULIN RESISTANCE;NAT2 deficiency;Variant;PA444626;Disease
ATAZANAVIR;CYP3A5*3;Haplotype;PA10251;Chemical
CYP2C19;CYP3A5*3;Haplotype;PA124;Gene
CYP3A4;CYP3A5*3;Haplotype;PA130;Gene
CYP3A5;CYP3A5*3;Haplotype;PA131;Gene
GEFITINIB;CYP3A5*3;Haplotype;PA131301952;Chemical
ORGAN TRANSPLANTATION;CYP3A5*3;Haplotype;PA133888799;Disease
TRANSPLANTATION;CYP3A5*3;Haplotype;PA134850491;Disease
MYALGIA UNSPECIFIED;CYP3A5*3;Haplotype;PA157379134;Disease
NEPHROTOXICITY;CYP3A5*3;Haplotype;PA162263533;Disease
EVEROLIMUS;CYP3A5*3;Haplotype;PA164746311;Chemical
CILOSTAZOL;CYP3A5*3;Haplotype;PA164746334;Chemical
MARAVIROC;CYP3A5*3;Haplotype;PA164768835;Chemical
TOXIC LIVER DISEASE;CYP3A5*3;Haplotype;PA164925725;Disease
DABIGATRAN;CYP3A5*3;Haplotype;PA165110351;Chemical
KIDNEY TRANSPLANTATION;CYP3A5*3;Haplotype;PA165817016;Disease
TRANSPLANT REJECTION;CYP3A5*3;Haplotype;PA166114454;Disease
LUNG TRANSPLANTATION;CYP3A5*3;Haplotype;PA166114457;Disease
HEART TRANSPLANTATION;CYP3A5*3;Haplotype;PA166114458;Disease
DRUG-INDUCED LIVER INJURY;CYP3A5*3;Haplotype;PA166119041;Disease
HEMATOPOIETIC STEM CELL TRANSPLANTATION;CYP3A5*3;Haplotype;PA166123007;Disease
SCHIZOAFFECTIVE DISORDER;CYP3A5*3;Haplotype;PA166123368;Disease
DELAYED GRAFT FUNCTION;CYP3A5*3;Haplotype;PA166123755;Disease
RECURRENCE FREE SURVIVAL;CYP3A5*3;Haplotype;PA166127658;Disease
ADVERSE EVENTS;CYP3A5*3;Haplotype;PA166151827;Disease
LAPAROSCOPIC SLEEVE GASTRECTOMY;CYP3A5*3;Haplotype;PA166169562;Disease
S-EDDP;CYP3A5*3;Haplotype;PA166177606;Chemical
DEXTROPROPOXYPHENE;CYP3A5*3;Haplotype;PA166183939;Chemical
SOMNOLENCE;CYP3A5*3;Haplotype;PA166185626;Disease
3,4-DEHYDROCILOSTAZOL;CYP3A5*3;Haplotype;PA166254461;Chemical
MAVACAMTEN;CYP3A5*3;Haplotype;PA166272922;Chemical
ARTHRITIS, RHEUMATOID;CYP3A5*3;Haplotype;PA443434;Disease
AUTOIMMUNE DISEASES;CYP3A5*3;Haplotype;PA443464;Disease
BRADYCARDIA;CYP3A5*3;Haplotype;PA443548;Disease
BREAST NEOPLASMS;CYP3A5*3;Haplotype;PA443560;Disease
CARCINOMA, NON-SMALL-CELL LUNG;CYP3A5*3;Haplotype;PA443622;Disease
CEREBRAL INFARCTION;CYP3A5*3;Haplotype;PA443670;Disease
COLITIS, ULCERATIVE;CYP3A5*3;Haplotype;PA443750;Disease
CORONARY ARTERY DISEASE;CYP3A5*3;Haplotype;PA443796;Disease
DIABETES MELLITUS;CYP3A5*3;Haplotype;PA443886;Disease
DIARRHEA;CYP3A5*3;Haplotype;PA443899;Disease
DRUG TOXICITY;CYP3A5*3;Haplotype;PA443937;Disease
EPILEPSY;CYP3A5*3;Haplotype;PA444065;Disease
GASTROINTESTINAL NEOPLASMS;CYP3A5*3;Haplotype;PA444257;Disease
GRAFT VS HOST DISEASE;CYP3A5*3;Haplotype;PA444320;Disease
INFECTION;CYP3A5*3;Haplotype;PA444614;Disease
KIDNEY NEOPLASMS;CYP3A5*3;Haplotype;PA444685;Disease
LEUKEMIA;CYP3A5*3;Haplotype;PA444750;Disease
LEUKOPENIA;CYP3A5*3;Haplotype;PA444773;Disease
LUPUS ERYTHEMATOSUS, SYSTEMIC;CYP3A5*3;Haplotype;PA444822;Disease
LUPUS NEPHRITIS;CYP3A5*3;Haplotype;PA444823;Disease
LYMPHOMA, NON-HODGKIN;CYP3A5*3;Haplotype;PA444845;Disease
MUSCULAR DISEASES;CYP3A5*3;Haplotype;PA444997;Disease
MYASTHENIA GRAVIS;CYP3A5*3;Haplotype;PA445004;Disease
NEOPLASMS;CYP3A5*3;Haplotype;PA445062;Disease
NEPHROTIC SYNDROME;CYP3A5*3;Haplotype;PA445089;Disease
NEUTROPENIA;CYP3A5*3;Haplotype;PA445113;Disease
OBESITY;CYP3A5*3;Haplotype;PA445131;Disease
OVARIAN NEOPLASMS;CYP3A5*3;Haplotype;PA445204;Disease
PAIN;CYP3A5*3;Haplotype;PA445208;Disease
PAIN, POSTOPERATIVE;CYP3A5*3;Haplotype;PA445210;Disease
PERIPHERAL NERVOUS SYSTEM DISEASES;CYP3A5*3;Haplotype;PA445301;Disease
URINARY TRACT INFECTIONS;CYP3A5*3;Haplotype;PA445992;Disease
VIRUS DISEASES;CYP3A5*3;Haplotype;PA446038;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;CYP3A5*3;Haplotype;PA446155;Disease
NEUROENDOCRINE TUMORS;CYP3A5*3;Haplotype;PA446713;Disease
NEUROTOXICITY SYNDROMES;CYP3A5*3;Haplotype;PA446975;Disease
ANXIETY DISORDERS;CYP3A5*3;Haplotype;PA447196;Disease
SCHIZOPHRENIA;CYP3A5*3;Haplotype;PA447216;Disease
HIV INFECTIONS;CYP3A5*3;Haplotype;PA447230;Disease
LIVER TRANSPLANTATION;CYP3A5*3;Haplotype;PA447247;Disease
DEPRESSION;CYP3A5*3;Haplotype;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;CYP3A5*3;Haplotype;PA447321;Disease
ALFENTANIL;CYP3A5*3;Haplotype;PA448084;Chemical
AMLODIPINE;CYP3A5*3;Haplotype;PA448388;Chemical
ATORVASTATIN;CYP3A5*3;Haplotype;PA448500;Chemical
CARBAMAZEPINE;CYP3A5*3;Haplotype;PA448785;Chemical
CARBOPLATIN;CYP3A5*3;Haplotype;PA448803;Chemical
CLOMIPRAMINE;CYP3A5*3;Haplotype;PA449048;Chemical
CLOPIDOGREL;CYP3A5*3;Haplotype;PA449053;Chemical
CLOZAPINE;CYP3A5*3;Haplotype;PA449061;Chemical
CYCLOPHOSPHAMIDE;CYP3A5*3;Haplotype;PA449165;Chemical
CYCLOSPORINE;CYP3A5*3;Haplotype;PA449167;Chemical
FELODIPINE;CYP3A5*3;Haplotype;PA449591;Chemical
FENTANYL;CYP3A5*3;Haplotype;PA449599;Chemical
FLECAINIDE;CYP3A5*3;Haplotype;PA449646;Chemical
FLUOXETINE;CYP3A5*3;Haplotype;PA449673;Chemical
GRANISETRON;CYP3A5*3;Haplotype;PA449809;Chemical
ITRACONAZOLE;CYP3A5*3;Haplotype;PA450132;Chemical
KETOCONAZOLE;CYP3A5*3;Haplotype;PA450146;Chemical
METHADONE;CYP3A5*3;Haplotype;PA450401;Chemical
MIDAZOLAM;CYP3A5*3;Haplotype;PA450496;Chemical
NIMODIPINE;CYP3A5*3;Haplotype;PA450633;Chemical
OLANZAPINE;CYP3A5*3;Haplotype;PA450688;Chemical
OXYCODONE;CYP3A5*3;Haplotype;PA450741;Chemical
PACLITAXEL;CYP3A5*3;Haplotype;PA450761;Chemical
RITONAVIR;CYP3A5*3;Haplotype;PA451260;Chemical
SIMVASTATIN;CYP3A5*3;Haplotype;PA451363;Chemical
SIROLIMUS;CYP3A5*3;Haplotype;PA451365;Chemical
SUFENTANIL;CYP3A5*3;Haplotype;PA451527;Chemical
TACROLIMUS;CYP3A5*3;Haplotype;PA451578;Chemical
TAMOXIFEN;CYP3A5*3;Haplotype;PA451581;Chemical
VINCRISTINE;CYP3A5*3;Haplotype;PA451879;Chemical
PEGINTERFERON ALFA-2A;rs8099917;Variant;PA164749390;Chemical
PEGINTERFERON ALFA-2B;rs8099917;Variant;PA164784024;Chemical
TELAPREVIR;rs8099917;Variant;PA165958354;Chemical
SIMEPREVIR;rs8099917;Variant;PA166122590;Chemical
SOFOSBUVIR;rs8099917;Variant;PA166122593;Chemical
LEDIPASVIR;rs8099917;Variant;PA166128166;Chemical
HEPATITIS C VIRUS INFECTION;rs8099917;Variant;PA444445;Disease
CHRONIC HEPATITIS C VIRUS INFECTION;rs8099917;Variant;PA446863;Disease
RIBAVIRIN;rs8099917;Variant;PA451241;Chemical
INTERFERONS;rs8099917;Variant;PA451999;Chemical
CFTR;rs397508761;Variant;PA109;Gene
IVACAFTOR;rs397508761;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs397508761;Variant;PA166179845;Chemical
MIR21;Cholangiocarcinoma;Disease;PA164722590;Gene
ANTHRACYCLINES AND RELATED SUBSTANCES;rs2305364;Variant;PA130620651;Chemical
NEOPLASMS;rs2305364;Variant;PA445062;Disease
CYP2C19;Asthma;Disease;PA124;Gene
CYP2C8;Asthma;Disease;PA125;Gene
PRORP;Asthma;Disease;PA134879499;Gene
TAAR6;Asthma;Disease;PA134881141;Gene
COL22A1;Asthma;Disease;PA134914705;Gene
CEP68;Asthma;Disease;PA134991391;Gene
ACE;Asthma;Disease;PA139;Gene
FSIP1;Asthma;Disease;PA142671750;Gene
F13A1;Asthma;Disease;PA162;Gene
GSDMB;Asthma;Disease;PA162390303;Gene
RAP1GAP2;Asthma;Disease;PA165432528;Gene
DCAF4;Asthma;Disease;PA165478762;Gene
CYP2C19*8;Asthma;Disease;PA165816524;Haplotype
CYP2C19*9;Asthma;Disease;PA165816525;Haplotype
HLA-DPB1*03:01;Asthma;Disease;PA165951131;Haplotype
HLA-DPB1*04:01;Asthma;Disease;PA165951133;Haplotype
CYP2C8*3;Asthma;Disease;PA165958685;Haplotype
CYP2C8*4;Asthma;Disease;PA165958686;Haplotype
UGT1A3*1;Asthma;Disease;PA165959980;Haplotype
UGT1A3*2;Asthma;Disease;PA165959981;Haplotype
CYP2C19*1;Asthma;Disease;PA165980634;Haplotype
CYP2C19*2;Asthma;Disease;PA165980635;Haplotype
CYP2C19*3;Asthma;Disease;PA165980636;Haplotype
GSTM1 NULL;Asthma;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Asthma;Disease;PA166048676;Haplotype
GSTT1 NULL;Asthma;Disease;PA166048678;Haplotype
GSTT1 NON-NULL;Asthma;Disease;PA166048679;Haplotype
RS1741981;Asthma;Disease;PA166153635;Variant
RS2228079;Asthma;Disease;PA166153677;Variant
RS7551789;Asthma;Disease;PA166153796;Variant
RS11587213;Asthma;Disease;PA166153832;Variant
RS16851030;Asthma;Disease;PA166153865;Variant
RS1786929;Asthma;Disease;PA166153971;Variant
RS2115819;Asthma;Disease;PA166153996;Variant
RS11252394;Asthma;Disease;PA166154136;Variant
RS11819745;Asthma;Disease;PA166154143;Variant
RS12422149;Asthma;Disease;PA166154465;Variant
RS557881;Asthma;Disease;PA166154498;Variant
RS1540339;Asthma;Disease;PA166154515;Variant
RS2239179;Asthma;Disease;PA166154536;Variant
RS2660845;Asthma;Disease;PA166154552;Variant
RS953977;Asthma;Disease;PA166154690;Variant
RS9552679;Asthma;Disease;PA166154738;Variant
RS1353411;Asthma;Disease;PA166154781;Variant
RS1663330;Asthma;Disease;PA166154783;Variant
RS1663332;Asthma;Disease;PA166154784;Variant
RS2075797;Asthma;Disease;PA166154788;Variant
RS7160796;Asthma;Disease;PA166154813;Variant
RS7179742;Asthma;Disease;PA166154922;Variant
RS8832;Asthma;Disease;PA166154978;Variant
RS119774;Asthma;Disease;PA166154984;Variant
RS1029489;Asthma;Disease;PA166155004;Variant
RS1110470;Asthma;Disease;PA166155008;Variant
RS1805010;Asthma;Disease;PA166155022;Variant
RS2239347;Asthma;Disease;PA166155035;Variant
RS3024530;Asthma;Disease;PA166155046;Variant
RS4291;Asthma;Disease;PA166155143;Variant
RS4292;Asthma;Disease;PA166155144;Variant
RS967676;Asthma;Disease;PA166155171;Variant
RS1876828;Asthma;Disease;PA166155193;Variant
RS2240017;Asthma;Disease;PA166155202;Variant
RS1126510;Asthma;Disease;PA166155363;Variant
RS1131882;Asthma;Disease;PA166155365;Variant
RS7572857;Asthma;Disease;PA166155764;Variant
RS138335;Asthma;Disease;PA166156042;Variant
RS138337;Asthma;Disease;PA166156043;Variant
RS518350;Asthma;Disease;PA166156053;Variant
RS6002674;Asthma;Disease;PA166156127;Variant
RS3856806;Asthma;Disease;PA166156388;Variant
RS1364805;Asthma;Disease;PA166156511;Variant
RS1522113;Asthma;Disease;PA166156517;Variant
RS3775291;Asthma;Disease;PA166156579;Variant
RS17701271;Asthma;Disease;PA166156673;Variant
RS730012;Asthma;Disease;PA166156740;Variant
RS881152;Asthma;Disease;PA166156744;Variant
RS1042713;Asthma;Disease;PA166156748;Variant
RS1423515;Asthma;Disease;PA166156762;Variant
RS2243250;Asthma;Disease;PA166156792;Variant
RS17495520;Asthma;Disease;PA166156887;Variant
RS1042136;Asthma;Disease;PA166156970;Variant
RS1042151;Asthma;Disease;PA166156971;Variant
RS1059288;Asthma;Disease;PA166156974;Variant
RS1063320;Asthma;Disease;PA166156976;Variant
RS2071888;Asthma;Disease;PA166157012;Variant
RS2305089;Asthma;Disease;PA166157033;Variant
RS2781659;Asthma;Disease;PA166157048;Variant
RS3129294;Asthma;Disease;PA166157067;Variant
RS3130100;Asthma;Disease;PA166157068;Variant
RS7772821;Asthma;Disease;PA166157130;Variant
RS37973;Asthma;Disease;PA166157244;Variant
RS255100;Asthma;Disease;PA166157250;Variant
RS1074373;Asthma;Disease;PA166157287;Variant
RS1419555;Asthma;Disease;PA166157294;Variant
RS2267715;Asthma;Disease;PA166157348;Variant
RS2284220;Asthma;Disease;PA166157353;Variant
RS6962291;Asthma;Disease;PA166157423;Variant
RS7793837;Asthma;Disease;PA166157430;Variant
RS7794356;Asthma;Disease;PA166157431;Variant
RS34548976;Asthma;Disease;PA166157486;Variant
RS4271002;Asthma;Disease;PA166157597;Variant
RS6988229;Asthma;Disease;PA166157622;Variant
RS6475448;Asthma;Disease;PA166157785;Variant
RS7862221;Asthma;Disease;PA166157794;Variant
RS10511905;Asthma;Disease;PA166157806;Variant
RS12436663;Asthma;Disease;PA166161141;Variant
RS7604115;Asthma;Disease;PA166179590;Variant
RS704212;Asthma;Disease;PA166179594;Variant
RS1047303;Asthma;Disease;PA166186981;Variant
RS2392165;Asthma;Disease;PA166200821;Variant
CYP2C8*1;Asthma;Disease;PA166242948;Haplotype
NAT2;Asthma;Disease;PA18;Gene
GSTM1;Asthma;Disease;PA182;Gene
GSTT1;Asthma;Disease;PA183;Gene
IL4;Asthma;Disease;PA197;Gene
LTC4S;Asthma;Disease;PA235;Gene
LTA4H;Asthma;Disease;PA24345;Gene
ABCC1;Asthma;Disease;PA244;Gene
ADH1B;Asthma;Disease;PA24571;Gene
ADORA1;Asthma;Disease;PA24583;Gene
ARG1;Asthma;Disease;PA24947;Gene
CA10;Asthma;Disease;PA25985;Gene
CLOCK;Asthma;Disease;PA26609;Gene
CRHR1;Asthma;Disease;PA26874;Gene
CRHR2;Asthma;Disease;PA26875;Gene
DUSP1;Asthma;Disease;PA27519;Gene
FADS2;Asthma;Disease;PA27974;Gene
FCER1G;Asthma;Disease;PA28057;Gene
PPARG;Asthma;Disease;PA281;Gene
PTGER2;Asthma;Disease;PA287;Gene
PTGER3;Asthma;Disease;PA288;Gene
PTGIR;Asthma;Disease;PA291;Gene
HDAC1;Asthma;Disease;PA29226;Gene
HSD3B1;Asthma;Disease;PA29486;Gene
IL4R;Asthma;Disease;PA29832;Gene
IRF1;Asthma;Disease;PA29915;Gene
MLLT3;Asthma;Disease;PA30852;Gene
NAGA;Asthma;Disease;PA31435;Gene
ORMDL3;Asthma;Disease;PA32821;Gene
TBXA2R;Asthma;Disease;PA348;Gene
TBXAS1;Asthma;Disease;PA349;Gene
HLA-DPB1;Asthma;Disease;PA35064;Gene
HLA-DPB2;Asthma;Disease;PA35065;Gene
HLA-G;Asthma;Disease;PA35083;Gene
SLCO2B1;Asthma;Disease;PA35845;Gene
SLC6A12;Asthma;Disease;PA35908;Gene
ST13;Asthma;Disease;PA36167;Gene
TBXT;Asthma;Disease;PA36296;Gene
TAPBP;Asthma;Disease;PA36331;Gene
TBX21;Asthma;Disease;PA36362;Gene
TERC;Asthma;Disease;PA36444;Gene
THRA;Asthma;Disease;PA36507;Gene
TLR3;Asthma;Disease;PA36551;Gene
TSC1;Asthma;Disease;PA37034;Gene
UGT1A3;Asthma;Disease;PA37178;Gene
VDR;Asthma;Disease;PA37301;Gene
ZBTB22;Asthma;Disease;PA37661;Gene
GALNT17;Asthma;Disease;PA38124;Gene
GLCCI1;Asthma;Disease;PA38657;Gene
ADRB2;Asthma;Disease;PA39;Gene
ABCC9;Asthma;Disease;PA396;Gene
ALOX5;Asthma;Disease;PA46;Gene
CFTR;rs397508602;Variant;PA109;Gene
IVACAFTOR;rs397508602;Variant;PA165950341;Chemical
CYSTIC FIBROSIS;rs397508602;Variant;PA443829;Disease
CYP2C8;zoledronate;Chemical;PA125;Gene
PPCDC;zoledronate;Chemical;PA142671157;Gene
RS2297480;zoledronate;Chemical;PA166153695;Variant
RS1934951;zoledronate;Chemical;PA166153985;Variant
RS147451859;zoledronate;Chemical;PA166199721;Variant
RS17587029;zoledronate;Chemical;PA166199722;Variant
FDPS;zoledronate;Chemical;PA28075;Gene
ABCB1;dipyridamole;Chemical;PA267;Gene
DRUG TOXICITY;rs7557402;Variant;PA443937;Disease
SORAFENIB;rs7557402;Variant;PA7000;Chemical
DULOXETINE;rs61908411;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs61908411;Variant;PA447321;Disease
BIPOLAR DISORDER;CACNG2;Gene;PA447199;Disease
LITHIUM;CACNG2;Gene;PA450243;Chemical
HIV INFECTIOUS DISEASE;rs9461684;Variant;PA447230;Disease
NEVIRAPINE;rs9461684;Variant;PA450616;Chemical
PHENPROCOUMON;rs1799808;Variant;PA450921;Chemical
CYP2B6;fludarabine;Chemical;PA123;Gene
CYP2E1;fludarabine;Chemical;PA129;Gene
SLCO1B1;fludarabine;Chemical;PA134865839;Gene
CYP2B6*1;fludarabine;Chemical;PA165818750;Haplotype
CYP2B6*6;fludarabine;Chemical;PA165818762;Haplotype
RS2070673;fludarabine;Chemical;PA166153993;Variant
RS2515641;fludarabine;Chemical;PA166154017;Variant
RS11231825;fludarabine;Chemical;PA166154455;Variant
RS4149056;fludarabine;Chemical;PA166154579;Variant
RS2302948;fludarabine;Chemical;PA166155396;Variant
RS1801157;fludarabine;Chemical;PA166159131;Variant
CXCL12;fludarabine;Chemical;PA35602;Gene
SULT2B1;fludarabine;Chemical;PA36249;Gene
SLC22A12;fludarabine;Chemical;PA38478;Gene
BRADYCARDIA;rs16947;Variant;PA443548;Disease
PROPAFENONE;rs16947;Variant;PA451131;Chemical
TIMOLOL;rs16947;Variant;PA451690;Chemical
INTERFERON ALFA-2A, RECOMBINANT;rs9939609;Variant;PA164779048;Chemical
INTERFERON ALFA-2B, RECOMBINANT;rs9939609;Variant;PA164783990;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;rs9939609;Variant;PA446863;Disease
HIV INFECTIOUS DISEASE;rs9939609;Variant;PA447230;Disease
RIBAVIRIN;rs9939609;Variant;PA451241;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs1061631;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs1061631;Variant;PA443434;Disease
RS113488022;encorafenib;Chemical;PA166157522;Variant
BRAF;encorafenib;Chemical;PA25408;Gene
HRAS;encorafenib;Chemical;PA29444;Gene
KRAS;encorafenib;Chemical;PA30196;Gene
NRAS;encorafenib;Chemical;PA31768;Gene
FLUOROURACIL;rs72549306;Variant;PA128406956;Chemical
DPYD;rs72549306;Variant;PA145;Gene
CAPECITABINE;rs72549306;Variant;PA448771;Chemical
HYPERTENSION;PRCP;Gene;PA444552;Disease
BENAZEPRIL;PRCP;Gene;PA448561;Chemical
CELECOXIB;KCNQ2;Gene;PA448871;Chemical
CYP2B6;drug reaction with eosinophilia and systemic symptoms;Disease;PA123;Gene
CYP2C9;drug reaction with eosinophilia and systemic symptoms;Disease;PA126;Gene
CYCSP5;drug reaction with eosinophilia and systemic symptoms;Disease;PA142672032;Gene
CYP2C9*3;drug reaction with eosinophilia and systemic symptoms;Disease;PA165816544;Haplotype
HLA-DRB1*01:02;drug reaction with eosinophilia and systemic symptoms;Disease;PA165951340;Haplotype
HLA-DRB1*01:03;drug reaction with eosinophilia and systemic symptoms;Disease;PA165951348;Haplotype
HLA-DRB1*04:04;drug reaction with eosinophilia and systemic symptoms;Disease;PA165951511;Haplotype
HLA-DRB1*08:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165951669;Haplotype
HLA-DRB1*10:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165951757;Haplotype
HLA-DRB1*15:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165952269;Haplotype
HLA-A*24:02;drug reaction with eosinophilia and systemic symptoms;Disease;PA165953564;Haplotype
HLA-A*31:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165954030;Haplotype
HLA-A*32:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165954097;Haplotype
HLA-B*07:02;drug reaction with eosinophilia and systemic symptoms;Disease;PA165954366;Haplotype
HLA-B*13:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165954643;Haplotype
HLA-B*13:02;drug reaction with eosinophilia and systemic symptoms;Disease;PA165954649;Haplotype
HLA-B*15:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165954745;Haplotype
HLA-B*15:02;drug reaction with eosinophilia and systemic symptoms;Disease;PA165954769;Haplotype
HLA-B*15:05;drug reaction with eosinophilia and systemic symptoms;Disease;PA165954778;Haplotype
HLA-B*15:11;drug reaction with eosinophilia and systemic symptoms;Disease;PA165954787;Haplotype
HLA-B*15:12;drug reaction with eosinophilia and systemic symptoms;Disease;PA165954792;Haplotype
HLA-B*15:13;drug reaction with eosinophilia and systemic symptoms;Disease;PA165954793;Haplotype
HLA-B*15:21;drug reaction with eosinophilia and systemic symptoms;Disease;PA165954809;Haplotype
HLA-B*15:24;drug reaction with eosinophilia and systemic symptoms;Disease;PA165954811;Haplotype
HLA-B*15:25;drug reaction with eosinophilia and systemic symptoms;Disease;PA165954812;Haplotype
HLA-B*15:27;drug reaction with eosinophilia and systemic symptoms;Disease;PA165954816;Haplotype
HLA-B*15:32;drug reaction with eosinophilia and systemic symptoms;Disease;PA165954823;Haplotype
HLA-B*15:35;drug reaction with eosinophilia and systemic symptoms;Disease;PA165954826;Haplotype
HLA-B*35:10;drug reaction with eosinophilia and systemic symptoms;Disease;PA165955274;Haplotype
HLA-B*38:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165955500;Haplotype
HLA-B*38:02;drug reaction with eosinophilia and systemic symptoms;Disease;PA165955505;Haplotype
HLA-B*39:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165955543;Haplotype
HLA-B*39:05;drug reaction with eosinophilia and systemic symptoms;Disease;PA165955559;Haplotype
HLA-B*39:06;drug reaction with eosinophilia and systemic symptoms;Disease;PA165955561;Haplotype
HLA-B*39:09;drug reaction with eosinophilia and systemic symptoms;Disease;PA165955565;Haplotype
HLA-B*39:10;drug reaction with eosinophilia and systemic symptoms;Disease;PA165955566;Haplotype
HLA-B*40:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165955628;Haplotype
HLA-B*46:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165956083;Haplotype
HLA-B*51:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165956201;Haplotype
HLA-B*51:02;drug reaction with eosinophilia and systemic symptoms;Disease;PA165956231;Haplotype
HLA-B*52:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165956366;Haplotype
HLA-B*54:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165956438;Haplotype
HLA-B*55:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165956463;Haplotype
HLA-B*55:02;drug reaction with eosinophilia and systemic symptoms;Disease;PA165956471;Haplotype
HLA-B*56:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165956528;Haplotype
HLA-B*56:02;drug reaction with eosinophilia and systemic symptoms;Disease;PA165956532;Haplotype
HLA-B*56:06;drug reaction with eosinophilia and systemic symptoms;Disease;PA165956537;Haplotype
HLA-B*67:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165956680;Haplotype
HLA-B*78:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165956686;Haplotype
HLA-C*04:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165957046;Haplotype
HLA-C*04:03;drug reaction with eosinophilia and systemic symptoms;Disease;PA165957085;Haplotype
HLA-C*04:06;drug reaction with eosinophilia and systemic symptoms;Disease;PA165957089;Haplotype
HLA-C*04:07;drug reaction with eosinophilia and systemic symptoms;Disease;PA165957090;Haplotype
HLA-C*05:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165957192;Haplotype
HLA-C*05:09;drug reaction with eosinophilia and systemic symptoms;Disease;PA165957217;Haplotype
HLA-C*18:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165958003;Haplotype
HLA-DQB1*06:02;drug reaction with eosinophilia and systemic symptoms;Disease;PA165958103;Haplotype
HLA-DQB1*03:02;drug reaction with eosinophilia and systemic symptoms;Disease;PA165958175;Haplotype
HLA-B*57:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165987830;Haplotype
HLA-B*58:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA165987831;Haplotype
HLA-A*02:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA166123427;Haplotype
HLA-B*48:01;drug reaction with eosinophilia and systemic symptoms;Disease;PA166123429;Haplotype
RS3745274;drug reaction with eosinophilia and systemic symptoms;Disease;PA166155409;Variant
RS3099844;drug reaction with eosinophilia and systemic symptoms;Disease;PA166157066;Variant
RS2734583;drug reaction with eosinophilia and systemic symptoms;Disease;PA166161405;Variant
RS9263726;drug reaction with eosinophilia and systemic symptoms;Disease;PA166161422;Variant
PSORS1C1;drug reaction with eosinophilia and systemic symptoms;Disease;PA33919;Gene
HLA-A;drug reaction with eosinophilia and systemic symptoms;Disease;PA35055;Gene
HLA-B;drug reaction with eosinophilia and systemic symptoms;Disease;PA35056;Gene
HLA-C;drug reaction with eosinophilia and systemic symptoms;Disease;PA35057;Gene
HLA-DQB1;drug reaction with eosinophilia and systemic symptoms;Disease;PA35068;Gene
HLA-DRB1;drug reaction with eosinophilia and systemic symptoms;Disease;PA35072;Gene
CYP2C19;doxepin;Chemical;PA124;Gene
CYP2C9;doxepin;Chemical;PA126;Gene
CYP2D6;doxepin;Chemical;PA128;Gene
CYP3A4;doxepin;Chemical;PA130;Gene
CYP2C9*1;doxepin;Chemical;PA165816542;Haplotype
CYP2C9*3;doxepin;Chemical;PA165816544;Haplotype
CYP2D6*1;doxepin;Chemical;PA165816576;Haplotype
CYP2D6*2;doxepin;Chemical;PA165816577;Haplotype
CYP2D6*3;doxepin;Chemical;PA165816578;Haplotype
CYP2D6*4;doxepin;Chemical;PA165816579;Haplotype
CYP2D6*10;doxepin;Chemical;PA165816582;Haplotype
CYP2D6*41;doxepin;Chemical;PA165816584;Haplotype
CYP2D6*5;doxepin;Chemical;PA165948092;Haplotype
CYP2D6*9;doxepin;Chemical;PA165948317;Haplotype
CYP2D6*35XN;doxepin;Chemical;PA165971588;Haplotype
CYP2C19*1;doxepin;Chemical;PA165980634;Haplotype
CYP2C19*2;doxepin;Chemical;PA165980635;Haplotype
CYP2D6*1XN;doxepin;Chemical;PA165988479;Haplotype
CYP2D6*2XN;doxepin;Chemical;PA165988480;Haplotype
CYP2D6*35;doxepin;Chemical;PA165988487;Haplotype
KCNH2;doxepin;Chemical;PA212;Gene
CYP1A2;doxepin;Chemical;PA27093;Gene
ESOMEPRAZOLE;pazopanib;Chemical;PA10075;Chemical
CYP2C8;pazopanib;Chemical;PA125;Gene
CYP3A4;pazopanib;Chemical;PA130;Gene
HLA-B*15:02;pazopanib;Chemical;PA165954769;Haplotype
HLA-B*51:01;pazopanib;Chemical;PA165956201;Haplotype
CYP2C8*3;pazopanib;Chemical;PA165958685;Haplotype
HLA-B*57:01;pazopanib;Chemical;PA165987830;Haplotype
UGT1A1*1;pazopanib;Chemical;PA166115841;Haplotype
UGT1A1*28;pazopanib;Chemical;PA166115842;Haplotype
UGT1A1*37;pazopanib;Chemical;PA166115844;Haplotype
UGT1A1*6;pazopanib;Chemical;PA166115858;Haplotype
RS34231037;pazopanib;Chemical;PA166156679;Variant
CXCL8;pazopanib;Chemical;PA29841;Gene
KDR;pazopanib;Chemical;PA30086;Gene
HLA-B;pazopanib;Chemical;PA35056;Gene
ABCG2;pazopanib;Chemical;PA390;Gene
UGT1A1;pazopanib;Chemical;PA420;Gene
KETOCONAZOLE;pazopanib;Chemical;PA450146;Chemical
FLUOROURACIL;rs1184321568;Variant;PA128406956;Chemical
HIV INFECTIOUS DISEASE;rs12721646;Variant;PA447230;Disease
NEVIRAPINE;rs12721646;Variant;PA450616;Chemical
ACUTE CORONARY SYNDROME;CYP3A43;Gene;PA165108401;Disease
TICAGRELOR;CYP3A43;Gene;PA165374673;Chemical
SCHIZOPHRENIA;CYP3A43;Gene;PA447216;Disease
OLANZAPINE;CYP3A43;Gene;PA450688;Chemical
CYP2C19;Elderly Adult;Disease;PA124;Gene
CYP2D6;Elderly Adult;Disease;PA128;Gene
PRASUGREL;rs822442;Variant;PA154410481;Chemical
URINARY BLADDER NEOPLASMS;CSNK2A3;Gene;PA443512;Disease
CISPLATIN;CSNK2A3;Gene;PA449014;Chemical
PROSTATIC NEOPLASMS;rs4148950;Variant;PA445425;Disease
DOCETAXEL;rs4148950;Variant;PA449383;Chemical
THALIDOMIDE;rs4148950;Variant;PA451644;Chemical
RET;selpercatinib;Chemical;PA34335;Gene
CYP2B6;Lupus Nephritis;Disease;PA123;Gene
CYP3A5;Lupus Nephritis;Disease;PA131;Gene
CYP3A5*1;Lupus Nephritis;Disease;PA166128213;Haplotype
CYP3A5*3;Lupus Nephritis;Disease;PA166128219;Haplotype
RS3745274;Lupus Nephritis;Disease;PA166155409;Variant
RS3957356;Lupus Nephritis;Disease;PA166157093;Variant
CYP2A7P1;Lupus Nephritis;Disease;PA27103;Gene
GSTA1;Lupus Nephritis;Disease;PA29016;Gene
TPMT;s-adenosylmethionine;Chemical;PA356;Gene
HYPERGLYCEMIA;rs2669429;Variant;PA444522;Disease
HYPERTENSION;rs2669429;Variant;PA444552;Disease
ATENOLOL;rs2669429;Variant;PA448499;Chemical
DPYD;rs202144771;Variant;PA145;Gene
CAPECITABINE;rs202144771;Variant;PA448771;Chemical
MYCOPHENOLIC ACID;UGT1A10;Gene;PA164748728;Chemical
SN-38;UGT1A10;Gene;PA165110775;Chemical
FEBUXOSTAT;UGT1A10;Gene;PA165958521;Chemical
EPILEPSY;UGT1A10;Gene;PA444065;Disease
GOUT;UGT1A10;Gene;PA444318;Disease
OSTEOSARCOMA;UGT1A10;Gene;PA445601;Disease
SEIZURES;UGT1A10;Gene;PA445629;Disease
SCHIZOPHRENIA;UGT1A10;Gene;PA447216;Disease
ALLOPURINOL;UGT1A10;Gene;PA448320;Chemical
METHOTREXATE;UGT1A10;Gene;PA450428;Chemical
OXCARBAZEPINE;UGT1A10;Gene;PA450732;Chemical
RISPERIDONE;UGT1A10;Gene;PA451257;Chemical
VALPROIC ACID;UGT1A10;Gene;PA451846;Chemical
DRUG TOXICITY;rs3770102;Variant;PA443937;Disease
NEUROTOXICITY SYNDROMES;rs3770102;Variant;PA446975;Disease
VINCRISTINE;rs3770102;Variant;PA451879;Chemical
HEROIN DEPENDENCE;rs16974799;Variant;PA444460;Disease
METHADONE;rs16974799;Variant;PA450401;Chemical
DRUG-INDUCED LIVER INJURY;rs2205986;Variant;PA166119041;Disease
MULTIPLE SCLEROSIS;rs2205986;Variant;PA444987;Disease
INTERFERON BETA-1A;rs2205986;Variant;PA450037;Chemical
INTERFERON BETA-1B;rs2205986;Variant;PA450039;Chemical
BUPROPION;rs2168631;Variant;PA448687;Chemical
NICOTINE;rs2168631;Variant;PA450626;Chemical
ANTIEPILEPTICS;rs3789243;Variant;PA143485705;Chemical
EPILEPSY;rs3789243;Variant;PA444065;Disease
HIV INFECTIOUS DISEASE;rs12768009;Variant;PA447230;Disease
NEVIRAPINE;rs12768009;Variant;PA450616;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;SLC28A3;Gene;PA130620651;Chemical
CARDIOTOXICITY;SLC28A3;Gene;PA166128121;Disease
RS2229774;SLC28A3;Gene;PA166154532;Variant
RS17863783;SLC28A3;Gene;PA166155854;Variant
RS7853758;SLC28A3;Gene;PA166157790;Variant
LEUKEMIA, MYELOID, ACUTE;SLC28A3;Gene;PA444760;Disease
NEOPLASMS;SLC28A3;Gene;PA445062;Disease
CYTARABINE;SLC28A3;Gene;PA449177;Chemical
DAUNORUBICIN;SLC28A3;Gene;PA449212;Chemical
DOXORUBICIN;SLC28A3;Gene;PA449412;Chemical
GEMCITABINE;SLC28A3;Gene;PA449748;Chemical
ZIDOVUDINE;SLC28A3;Gene;PA451954;Chemical
ADALIMUMAB;HLA-DRB1*04:01;Haplotype;PA10004;Chemical
ARTHRITIS, RHEUMATOID;HLA-DRB1*04:01;Haplotype;PA443434;Disease
HYPERTENSION;HLA-DRB1*04:01;Haplotype;PA444552;Disease
MULTIPLE SCLEROSIS;HLA-DRB1*04:01;Haplotype;PA444987;Disease
ETANERCEPT;HLA-DRB1*04:01;Haplotype;PA449515;Chemical
HYDRALAZINE;HLA-DRB1*04:01;Haplotype;PA449894;Chemical
INTERFERON BETA-1A;HLA-DRB1*04:01;Haplotype;PA450037;Chemical
INFLIXIMAB;HLA-DRB1*04:01;Haplotype;PA452639;Chemical
SCHIZOPHRENIA;rs2513265;Variant;PA447216;Disease
ANTIPSYCHOTICS;rs2513265;Variant;PA452233;Chemical
PROSTATIC NEOPLASMS;MLH3;Gene;PA445425;Disease
HMG COA REDUCTASE INHIBITORS;rs13210472;Variant;PA133950441;Chemical
NEOPLASMS;rs13210472;Variant;PA445062;Disease
RS1801157;chlorambucil;Chemical;PA166159131;Variant
CXCL12;chlorambucil;Chemical;PA35602;Gene
IMATINIB;KIT;Gene;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;KIT;Gene;PA151958383;Disease
SUNITINIB;KIT;Gene;PA162372840;Chemical
MIDOSTAURIN;KIT;Gene;PA166169917;Chemical
AVAPRITINIB;KIT;Gene;PA166223903;Chemical
HOXB4;KIT;Gene;PA29391;Gene
HRAS;KIT;Gene;PA29444;Gene
KRAS;KIT;Gene;PA30196;Gene
NRAS;KIT;Gene;PA31768;Gene
PDGFRA;KIT;Gene;PA33147;Gene
SORAFENIB;KIT;Gene;PA7000;Chemical
DEPRESSION;rs12720067;Variant;PA447278;Disease
AMITRIPTYLINE;rs12720067;Variant;PA448385;Chemical
CITALOPRAM;rs12720067;Variant;PA449015;Chemical
PAROXETINE;rs12720067;Variant;PA450801;Chemical
VENLAFAXINE;rs12720067;Variant;PA451866;Chemical
OLANZAPINE;rs12720462;Variant;PA450688;Chemical
ANTIEPILEPTICS;rs17183814;Variant;PA143485705;Chemical
EPILEPSY;rs17183814;Variant;PA444065;Disease
CARBAMAZEPINE;rs17183814;Variant;PA448785;Chemical
PHENOBARBITAL;rs17183814;Variant;PA450911;Chemical
PHENYTOIN;rs17183814;Variant;PA450947;Chemical
VALPROIC ACID;rs17183814;Variant;PA451846;Chemical
DIABETES MELLITUS;rs3792269;Variant;PA443886;Disease
METFORMIN;rs3792269;Variant;PA450395;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;ADH7;Gene;PA130620651;Chemical
CFTR;rs1800103;Variant;PA109;Gene
IVACAFTOR;rs1800103;Variant;PA165950341;Chemical
MAJOR DEPRESSIVE DISORDER;COL26A1;Gene;PA447321;Disease
ASPIRIN;COL26A1;Gene;PA448497;Chemical
CITALOPRAM;COL26A1;Gene;PA449015;Chemical
CARBAMAZEPINE;BAG6;Gene;PA448785;Chemical
EPILEPSY;rs7643645;Variant;PA444065;Disease
PSYCHOTIC DISORDER;rs7643645;Variant;PA447215;Disease
CARBAMAZEPINE;rs7643645;Variant;PA448785;Chemical
RISPERIDONE;rs7643645;Variant;PA451257;Chemical
HYPERTENSION;rs11065987;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs11065987;Variant;PA449899;Chemical
COMT;Depressive Disorder, Major;Disease;PA117;Gene
CRH;Depressive Disorder, Major;Disease;PA119;Gene
CYP2B6;Depressive Disorder, Major;Disease;PA123;Gene
CYP2C19;Depressive Disorder, Major;Disease;PA124;Gene
CYP2C9;Depressive Disorder, Major;Disease;PA126;Gene
CYP2D6;Depressive Disorder, Major;Disease;PA128;Gene
TPH2;Depressive Disorder, Major;Disease;PA128747823;Gene
CYP3A5;Depressive Disorder, Major;Disease;PA131;Gene
MTRF1L;Depressive Disorder, Major;Disease;PA134870441;Gene
REEP5;Depressive Disorder, Major;Disease;PA134882361;Gene
COL26A1;Depressive Disorder, Major;Disease;PA134887081;Gene
P3H3;Depressive Disorder, Major;Disease;PA134890414;Gene
RAPGEF5;Depressive Disorder, Major;Disease;PA134902361;Gene
PAPLN;Depressive Disorder, Major;Disease;PA134914395;Gene
TEX10;Depressive Disorder, Major;Disease;PA134991964;Gene
TREML4;Depressive Disorder, Major;Disease;PA134993202;Gene
DBH;Depressive Disorder, Major;Disease;PA136;Gene
ACE;Depressive Disorder, Major;Disease;PA139;Gene
MDGA2;Depressive Disorder, Major;Disease;PA162395090;Gene
SKIC3;Depressive Disorder, Major;Disease;PA162407226;Gene
ZNF385D;Depressive Disorder, Major;Disease;PA162410152;Gene
CYP2C19*17;Depressive Disorder, Major;Disease;PA165816533;Haplotype
CYP2C9*1;Depressive Disorder, Major;Disease;PA165816542;Haplotype
CYP2C9*2;Depressive Disorder, Major;Disease;PA165816543;Haplotype
CYP2C9*3;Depressive Disorder, Major;Disease;PA165816544;Haplotype
CYP2D6*1;Depressive Disorder, Major;Disease;PA165816576;Haplotype
CYP2D6*2;Depressive Disorder, Major;Disease;PA165816577;Haplotype
CYP2D6*3;Depressive Disorder, Major;Disease;PA165816578;Haplotype
CYP2D6*4;Depressive Disorder, Major;Disease;PA165816579;Haplotype
CYP2D6*6;Depressive Disorder, Major;Disease;PA165816581;Haplotype
CYP2D6*10;Depressive Disorder, Major;Disease;PA165816582;Haplotype
CYP2D6*17;Depressive Disorder, Major;Disease;PA165816583;Haplotype
CYP2D6*41;Depressive Disorder, Major;Disease;PA165816584;Haplotype
CYP2B6*1;Depressive Disorder, Major;Disease;PA165818750;Haplotype
CYP2B6*6;Depressive Disorder, Major;Disease;PA165818762;Haplotype
CYP2B6*9;Depressive Disorder, Major;Disease;PA165818807;Haplotype
CYP2D6*5;Depressive Disorder, Major;Disease;PA165948092;Haplotype
CYP2D6*9;Depressive Disorder, Major;Disease;PA165948317;Haplotype
CYP2C19*1;Depressive Disorder, Major;Disease;PA165980634;Haplotype
CYP2C19*2;Depressive Disorder, Major;Disease;PA165980635;Haplotype
CYP2C19*3;Depressive Disorder, Major;Disease;PA165980636;Haplotype
CYP2C19*4;Depressive Disorder, Major;Disease;PA165980637;Haplotype
CYP2D6*1XN;Depressive Disorder, Major;Disease;PA165988479;Haplotype
CYP2D6*2XN;Depressive Disorder, Major;Disease;PA165988480;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);Depressive Disorder, Major;Disease;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);Depressive Disorder, Major;Disease;PA166116466;Haplotype
SLC6A4 L ALLELE-RS25531T;Depressive Disorder, Major;Disease;PA166117146;Haplotype
SLC6A4 L ALLELE-RS25531C;Depressive Disorder, Major;Disease;PA166117147;Haplotype
CYP2D6*81;Depressive Disorder, Major;Disease;PA166123321;Haplotype
CYP3A5*1;Depressive Disorder, Major;Disease;PA166128213;Haplotype
CYP3A5*3;Depressive Disorder, Major;Disease;PA166128219;Haplotype
RS521093;Depressive Disorder, Major;Disease;PA166153573;Variant
RS1801131;Depressive Disorder, Major;Disease;PA166153643;Variant
RS1801133;Depressive Disorder, Major;Disease;PA166153644;Variant
RS1800544;Depressive Disorder, Major;Disease;PA166153974;Variant
RS10997242;Depressive Disorder, Major;Disease;PA166154121;Variant
RS6265;Depressive Disorder, Major;Disease;PA166154259;Variant
RS948854;Depressive Disorder, Major;Disease;PA166154302;Variant
RS962369;Depressive Disorder, Major;Disease;PA166154303;Variant
RS1800532;Depressive Disorder, Major;Disease;PA166154340;Variant
RS2734833;Depressive Disorder, Major;Disease;PA166154384;Variant
RS4460839;Depressive Disorder, Major;Disease;PA166154408;Variant
RS7103411;Depressive Disorder, Major;Disease;PA166154418;Variant
RS7124442;Depressive Disorder, Major;Disease;PA166154421;Variant
RS11042725;Depressive Disorder, Major;Disease;PA166154449;Variant
RS61888800;Depressive Disorder, Major;Disease;PA166154478;Variant
RS5443;Depressive Disorder, Major;Disease;PA166154486;Variant
RS1006737;Depressive Disorder, Major;Disease;PA166154507;Variant
RS2532560;Depressive Disorder, Major;Disease;PA166154551;Variant
RS10848635;Depressive Disorder, Major;Disease;PA166154620;Variant
RS10879346;Depressive Disorder, Major;Disease;PA166154625;Variant
RS6311;Depressive Disorder, Major;Disease;PA166154673;Variant
RS6313;Depressive Disorder, Major;Disease;PA166154675;Variant
RS6314;Depressive Disorder, Major;Disease;PA166154676;Variant
RS7997012;Depressive Disorder, Major;Disease;PA166154726;Variant
RS9315310;Depressive Disorder, Major;Disease;PA166154730;Variant
RS16965962;Depressive Disorder, Major;Disease;PA166154752;Variant
RS1160351;Depressive Disorder, Major;Disease;PA166154774;Variant
RS11628713;Depressive Disorder, Major;Disease;PA166154824;Variant
RS762551;Depressive Disorder, Major;Disease;PA166154850;Variant
RS809736;Depressive Disorder, Major;Disease;PA166154851;Variant
RS2069521;Depressive Disorder, Major;Disease;PA166154875;Variant
RS2069526;Depressive Disorder, Major;Disease;PA166154877;Variant
RS2470890;Depressive Disorder, Major;Disease;PA166154893;Variant
RS2472304;Depressive Disorder, Major;Disease;PA166154898;Variant
RS4646425;Depressive Disorder, Major;Disease;PA166154909;Variant
RS4646427;Depressive Disorder, Major;Disease;PA166154910;Variant
RS2228478;Depressive Disorder, Major;Disease;PA166155030;Variant
RS2228479;Depressive Disorder, Major;Disease;PA166155031;Variant
RS2242446;Depressive Disorder, Major;Disease;PA166155036;Variant
RS25531;Depressive Disorder, Major;Disease;PA166155159;Variant
RS242941;Depressive Disorder, Major;Disease;PA166155163;Variant
RS28364032;Depressive Disorder, Major;Disease;PA166155259;Variant
RS2112460;Depressive Disorder, Major;Disease;PA166155383;Variant
RS889895;Depressive Disorder, Major;Disease;PA166155608;Variant
RS4675690;Depressive Disorder, Major;Disease;PA166155734;Variant
RS13432159;Depressive Disorder, Major;Disease;PA166155835;Variant
RS6127921;Depressive Disorder, Major;Disease;PA166155961;Variant
RS2831440;Depressive Disorder, Major;Disease;PA166156000;Variant
RS4680;Depressive Disorder, Major;Disease;PA166156024;Variant
RS1065852;Depressive Disorder, Major;Disease;PA166156062;Variant
RS13306278;Depressive Disorder, Major;Disease;PA166156141;Variant
RS6280;Depressive Disorder, Major;Disease;PA166156277;Variant
RS49411;Depressive Disorder, Major;Disease;PA166156278;Variant
RS334558;Depressive Disorder, Major;Disease;PA166156287;Variant
RS1969624;Depressive Disorder, Major;Disease;PA166156336;Variant
RS2245705;Depressive Disorder, Major;Disease;PA166156349;Variant
RS2251954;Depressive Disorder, Major;Disease;PA166156350;Variant
RS2742390;Depressive Disorder, Major;Disease;PA166156364;Variant
RS2742417;Depressive Disorder, Major;Disease;PA166156365;Variant
RS2742421;Depressive Disorder, Major;Disease;PA166156366;Variant
RS2742423;Depressive Disorder, Major;Disease;PA166156367;Variant
RS2742435;Depressive Disorder, Major;Disease;PA166156368;Variant
RS2433320;Depressive Disorder, Major;Disease;PA166156558;Variant
RS6295;Depressive Disorder, Major;Disease;PA166156708;Variant
RS153549;Depressive Disorder, Major;Disease;PA166156716;Variant
RS153560;Depressive Disorder, Major;Disease;PA166156717;Variant
RS495794;Depressive Disorder, Major;Disease;PA166156736;Variant
RS1364043;Depressive Disorder, Major;Disease;PA166156760;Variant
RS1992647;Depressive Disorder, Major;Disease;PA166156777;Variant
RS2216711;Depressive Disorder, Major;Disease;PA166156787;Variant
RS2973049;Depressive Disorder, Major;Disease;PA166156811;Variant
RS10036156;Depressive Disorder, Major;Disease;PA166156853;Variant
RS10042486;Depressive Disorder, Major;Disease;PA166156855;Variant
RS12054895;Depressive Disorder, Major;Disease;PA166156874;Variant
RS6296;Depressive Disorder, Major;Disease;PA166156903;Variant
RS672170;Depressive Disorder, Major;Disease;PA166156935;Variant
RS760761;Depressive Disorder, Major;Disease;PA166156948;Variant
RS766127;Depressive Disorder, Major;Disease;PA166156951;Variant
RS1799971;Depressive Disorder, Major;Disease;PA166156991;Variant
RS2500535;Depressive Disorder, Major;Disease;PA166157039;Variant
RS9380524;Depressive Disorder, Major;Disease;PA166157154;Variant
RS41271330;Depressive Disorder, Major;Disease;PA166157204;Variant
RS1045642;Depressive Disorder, Major;Disease;PA166157284;Variant
RS1128503;Depressive Disorder, Major;Disease;PA166157288;Variant
RS1799889;Depressive Disorder, Major;Disease;PA166157302;Variant
RS2032583;Depressive Disorder, Major;Disease;PA166157317;Variant
RS2227631;Depressive Disorder, Major;Disease;PA166157329;Variant
RS2235015;Depressive Disorder, Major;Disease;PA166157336;Variant
RS2235067;Depressive Disorder, Major;Disease;PA166157341;Variant
RS2270007;Depressive Disorder, Major;Disease;PA166157349;Variant
RS2299267;Depressive Disorder, Major;Disease;PA166157359;Variant
RS4148739;Depressive Disorder, Major;Disease;PA166157386;Variant
RS4148740;Depressive Disorder, Major;Disease;PA166157387;Variant
RS6966038;Depressive Disorder, Major;Disease;PA166157424;Variant
RS16873129;Depressive Disorder, Major;Disease;PA166157467;Variant
RS17135437;Depressive Disorder, Major;Disease;PA166157468;Variant
RS28401781;Depressive Disorder, Major;Disease;PA166157485;Variant
RS352428;Depressive Disorder, Major;Disease;PA166157546;Variant
RS4737771;Depressive Disorder, Major;Disease;PA166157606;Variant
RS10975641;Depressive Disorder, Major;Disease;PA166157824;Variant
RS502434;Depressive Disorder, Major;Disease;PA166157853;Variant
RS3761554;Depressive Disorder, Major;Disease;PA166157871;Variant
RS3761555;Depressive Disorder, Major;Disease;PA166157872;Variant
RS3810651;Depressive Disorder, Major;Disease;PA166157873;Variant
CYP2D6 POOR METABOLIZER;Depressive Disorder, Major;Disease;PA166157927;Variant
CYP2C19 POOR METABOLIZER;Depressive Disorder, Major;Disease;PA166157938;Variant
RS57098334;Depressive Disorder, Major;Disease;PA166158926;Variant
RS1439050;Depressive Disorder, Major;Disease;PA166161252;Variant
RS9361233;Depressive Disorder, Major;Disease;PA166163186;Variant
RS6700741;Depressive Disorder, Major;Disease;PA166177102;Variant
RS4971678;Depressive Disorder, Major;Disease;PA166177103;Variant
RS2933304;Depressive Disorder, Major;Disease;PA166177104;Variant
RS13093500;Depressive Disorder, Major;Disease;PA166177107;Variant
RS4261893;Depressive Disorder, Major;Disease;PA166177108;Variant
RS4334661;Depressive Disorder, Major;Disease;PA166177109;Variant
RS4858478;Depressive Disorder, Major;Disease;PA166177110;Variant
RS7616119;Depressive Disorder, Major;Disease;PA166177112;Variant
RS7625956;Depressive Disorder, Major;Disease;PA166177113;Variant
RS7653345;Depressive Disorder, Major;Disease;PA166177114;Variant
RS9310657;Depressive Disorder, Major;Disease;PA166177115;Variant
RS9310658;Depressive Disorder, Major;Disease;PA166177116;Variant
RS9819548;Depressive Disorder, Major;Disease;PA166177117;Variant
RS9824595;Depressive Disorder, Major;Disease;PA166177118;Variant
RS9873889;Depressive Disorder, Major;Disease;PA166177119;Variant
RS9879065;Depressive Disorder, Major;Disease;PA166177120;Variant
RS10007051;Depressive Disorder, Major;Disease;PA166177121;Variant
RS11933890;Depressive Disorder, Major;Disease;PA166177122;Variant
RS55881666;Depressive Disorder, Major;Disease;PA166177123;Variant
RS56229625;Depressive Disorder, Major;Disease;PA166177124;Variant
RS61692318;Depressive Disorder, Major;Disease;PA166177125;Variant
RS62319299;Depressive Disorder, Major;Disease;PA166177126;Variant
RS10123866;Depressive Disorder, Major;Disease;PA166177127;Variant
RS10124893;Depressive Disorder, Major;Disease;PA166177128;Variant
RS10989064;Depressive Disorder, Major;Disease;PA166177130;Variant
RS6479008;Depressive Disorder, Major;Disease;PA166177131;Variant
RS7035619;Depressive Disorder, Major;Disease;PA166177132;Variant
RS7472;Depressive Disorder, Major;Disease;PA166177133;Variant
RS12595802;Depressive Disorder, Major;Disease;PA166177136;Variant
RS12603700;Depressive Disorder, Major;Disease;PA166177137;Variant
RS3889402;Depressive Disorder, Major;Disease;PA166177138;Variant
RS56355515;Depressive Disorder, Major;Disease;PA166177139;Variant
RS58042962;Depressive Disorder, Major;Disease;PA166177140;Variant
RS12630569;Depressive Disorder, Major;Disease;PA166177145;Variant
RS12094644;Depressive Disorder, Major;Disease;PA166177177;Variant
RS2419128;Depressive Disorder, Major;Disease;PA166177178;Variant
RS4437856;Depressive Disorder, Major;Disease;PA166177179;Variant
RS12502866;Depressive Disorder, Major;Disease;PA166177180;Variant
RS12657120;Depressive Disorder, Major;Disease;PA166177181;Variant
RS4639250;Depressive Disorder, Major;Disease;PA166177182;Variant
RS13204353;Depressive Disorder, Major;Disease;PA166177183;Variant
RS9369266;Depressive Disorder, Major;Disease;PA166177184;Variant
RS3124955;Depressive Disorder, Major;Disease;PA166177185;Variant
RS3128624;Depressive Disorder, Major;Disease;PA166177186;Variant
RS10771997;Depressive Disorder, Major;Disease;PA166177187;Variant
RS10771998;Depressive Disorder, Major;Disease;PA166177188;Variant
RS10771999;Depressive Disorder, Major;Disease;PA166177189;Variant
RS17724452;Depressive Disorder, Major;Disease;PA166177190;Variant
RS17724464;Depressive Disorder, Major;Disease;PA166177191;Variant
RS17724494;Depressive Disorder, Major;Disease;PA166177192;Variant
RS17786394;Depressive Disorder, Major;Disease;PA166177193;Variant
RS17786400;Depressive Disorder, Major;Disease;PA166177194;Variant
RS17786412;Depressive Disorder, Major;Disease;PA166177195;Variant
RS61908402;Depressive Disorder, Major;Disease;PA166177196;Variant
RS61908403;Depressive Disorder, Major;Disease;PA166177197;Variant
RS61908404;Depressive Disorder, Major;Disease;PA166177198;Variant
RS61908405;Depressive Disorder, Major;Disease;PA166177199;Variant
RS61908406;Depressive Disorder, Major;Disease;PA166177200;Variant
RS61908407;Depressive Disorder, Major;Disease;PA166177201;Variant
RS61908408;Depressive Disorder, Major;Disease;PA166177202;Variant
RS61908409;Depressive Disorder, Major;Disease;PA166177203;Variant
RS61908410;Depressive Disorder, Major;Disease;PA166177204;Variant
RS61908411;Depressive Disorder, Major;Disease;PA166177205;Variant
RS7306991;Depressive Disorder, Major;Disease;PA166177206;Variant
RS7316769;Depressive Disorder, Major;Disease;PA166177207;Variant
RS78482393;Depressive Disorder, Major;Disease;PA166177208;Variant
RS78615940;Depressive Disorder, Major;Disease;PA166177209;Variant
RS2303377;Depressive Disorder, Major;Disease;PA166180924;Variant
RS117986340;Depressive Disorder, Major;Disease;PA166180928;Variant
RS2770296;Depressive Disorder, Major;Disease;PA166184248;Variant
RS8075924;Depressive Disorder, Major;Disease;PA166184249;Variant
RS2873804;Depressive Disorder, Major;Disease;PA166184250;Variant
RS363225;Depressive Disorder, Major;Disease;PA166184251;Variant
RS363226;Depressive Disorder, Major;Disease;PA166184252;Variant
RS17614642;Depressive Disorder, Major;Disease;PA166184253;Variant
RS5441;Depressive Disorder, Major;Disease;PA166185647;Variant
GNB3;Depressive Disorder, Major;Disease;PA176;Gene
HTR1A;Depressive Disorder, Major;Disease;PA192;Gene
HTR2A;Depressive Disorder, Major;Disease;PA193;Gene
MTHFR;Depressive Disorder, Major;Disease;PA245;Gene
ADM;Depressive Disorder, Major;Disease;PA24580;Gene
ATP10A;Depressive Disorder, Major;Disease;PA25097;Gene
BMP5;Depressive Disorder, Major;Disease;PA25382;Gene
ANO2;Depressive Disorder, Major;Disease;PA25504;Gene
PARP11;Depressive Disorder, Major;Disease;PA25507;Gene
CACNA1A;Depressive Disorder, Major;Disease;PA26007;Gene
SERPINE1;Depressive Disorder, Major;Disease;PA261;Gene
ABCB1;Depressive Disorder, Major;Disease;PA267;Gene
CREB1;Depressive Disorder, Major;Disease;PA26864;Gene
CRHR1;Depressive Disorder, Major;Disease;PA26874;Gene
CRHR2;Depressive Disorder, Major;Disease;PA26875;Gene
CTNNA3;Depressive Disorder, Major;Disease;PA27010;Gene
CYP1A2;Depressive Disorder, Major;Disease;PA27093;Gene
DRD2;Depressive Disorder, Major;Disease;PA27478;Gene
DRD3;Depressive Disorder, Major;Disease;PA27479;Gene
DTNBP1;Depressive Disorder, Major;Disease;PA27512;Gene
FCN2;Depressive Disorder, Major;Disease;PA28070;Gene
FHIT;Depressive Disorder, Major;Disease;PA28140;Gene
FKBP5;Depressive Disorder, Major;Disease;PA28162;Gene
GABRA6;Depressive Disorder, Major;Disease;PA28494;Gene
GABRP;Depressive Disorder, Major;Disease;PA28503;Gene
GABRQ;Depressive Disorder, Major;Disease;PA28504;Gene
GAL;Depressive Disorder, Major;Disease;PA28529;Gene
GDNF;Depressive Disorder, Major;Disease;PA28644;Gene
GLDC;Depressive Disorder, Major;Disease;PA28716;Gene
GRIA3;Depressive Disorder, Major;Disease;PA28968;Gene
GSK3B;Depressive Disorder, Major;Disease;PA29009;Gene
HTR1B;Depressive Disorder, Major;Disease;PA29549;Gene
MC1R;Depressive Disorder, Major;Disease;PA30673;Gene
SLC6A2;Depressive Disorder, Major;Disease;PA310;Gene
SLC6A4;Depressive Disorder, Major;Disease;PA312;Gene
NBEA;Depressive Disorder, Major;Disease;PA31454;Gene
NCAM1;Depressive Disorder, Major;Disease;PA31459;Gene
NRXN1;Depressive Disorder, Major;Disease;PA31786;Gene
NTRK2;Depressive Disorder, Major;Disease;PA31818;Gene
BDNF;Depressive Disorder, Major;Disease;PA31891;Gene
OPRM1;Depressive Disorder, Major;Disease;PA31945;Gene
SLC18A2;Depressive Disorder, Major;Disease;PA325;Gene
PON2;Depressive Disorder, Major;Disease;PA33530;Gene
RGS17;Depressive Disorder, Major;Disease;PA34368;Gene
RORA;Depressive Disorder, Major;Disease;PA34630;Gene
SACM1L;Depressive Disorder, Major;Disease;PA34925;Gene
ADRA2A;Depressive Disorder, Major;Disease;PA35;Gene
TPH1;Depressive Disorder, Major;Disease;PA355;Gene
SRP19;Depressive Disorder, Major;Disease;PA36124;Gene
UST;Depressive Disorder, Major;Disease;PA38213;Gene
MIEF2;Depressive Disorder, Major;Disease;PA38265;Gene
INVS;Depressive Disorder, Major;Disease;PA38472;Gene
KMT2E;Depressive Disorder, Major;Disease;PA38568;Gene
CACNA1C;Depressive Disorder, Major;Disease;PA83;Gene
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA;DSP;Gene;PA446847;Disease
HYPERTENSION;rs7079;Variant;PA444552;Disease
BENAZEPRIL;rs7079;Variant;PA448561;Chemical
FOSDENOPTERIN;MOCS1;Gene;PA166252761;Chemical
COTININE;rs495491;Variant;PA166114414;Chemical
ALCOHOL ABUSE;rs495491;Variant;PA443309;Disease
HEROIN DEPENDENCE;rs495491;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs495491;Variant;PA445043;Disease
COCAINE DEPENDENCE;rs495491;Variant;PA446878;Disease
ETHANOL;rs495491;Variant;PA448073;Chemical
COCAINE;rs495491;Variant;PA449072;Chemical
NICOTINE;rs495491;Variant;PA450626;Chemical
OPIOIDS;rs495491;Variant;PA452618;Chemical
HEROIN;rs495491;Variant;PA452619;Chemical
FLUOROURACIL;rs9402944;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs9402944;Variant;PA443560;Disease
NEUTROPENIA;rs9402944;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs9402944;Variant;PA449165;Chemical
EPIRUBICIN;rs9402944;Variant;PA449476;Chemical
RS671;acetaldehyde;Chemical;PA166154482;Variant
RS1229976;acetaldehyde;Chemical;PA166156506;Variant
RS1229984;acetaldehyde;Chemical;PA166156507;Variant
RS4643;acetaldehyde;Chemical;PA166186239;Variant
ADH1A;acetaldehyde;Chemical;PA24570;Gene
ADH1B;acetaldehyde;Chemical;PA24571;Gene
ALDH2;acetaldehyde;Chemical;PA24696;Gene
PGM1;acetaldehyde;Chemical;PA33242;Gene
ASPIRIN-INDUCED ASTHMA;rs3130100;Variant;PA131285571;Disease
ASTHMA;rs3130100;Variant;PA443450;Disease
ASPIRIN;rs3130100;Variant;PA448497;Chemical
FLUOROURACIL;LGR5;Gene;PA128406956;Chemical
COLONIC NEOPLASMS;LGR5;Gene;PA443756;Disease
GLATIRAMER ACETATE;rs1056854;Variant;PA449760;Chemical
GEFITINIB;rs121434568;Variant;PA131301952;Chemical
ERLOTINIB;rs121434568;Variant;PA134687924;Chemical
AFATINIB;rs121434568;Variant;PA165981154;Chemical
OSIMERTINIB;rs121434568;Variant;PA166131626;Chemical
DACOMITINIB;rs121434568;Variant;PA166182279;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs121434568;Variant;PA443622;Disease
EGFR;rs121434568;Variant;PA7360;Gene
CYP3A7;etonogestrel;Chemical;PA122;Gene
CYP3A7*1A;etonogestrel;Chemical;PA165948045;Haplotype
CYP3A7*1C;etonogestrel;Chemical;PA165948047;Haplotype
DESFLURANE;rs193922876;Variant;PA164749136;Chemical
RYR1;rs193922876;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs193922876;Variant;PA444863;Disease
ENFLURANE;rs193922876;Variant;PA449461;Chemical
HALOTHANE;rs193922876;Variant;PA449845;Chemical
ISOFLURANE;rs193922876;Variant;PA450106;Chemical
METHOXYFLURANE;rs193922876;Variant;PA450434;Chemical
SEVOFLURANE;rs193922876;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs193922876;Variant;PA451522;Chemical
CACNA1S;rs193922876;Variant;PA85;Gene
HYPERTENSION;rs1799998;Variant;PA444552;Disease
ESSENTIAL HYPERTENSION;rs1799998;Variant;PA447288;Disease
BENAZEPRIL;rs1799998;Variant;PA448561;Chemical
CANDESARTAN;rs1799998;Variant;PA448765;Chemical
IMIDAPRIL;rs1799998;Variant;PA452640;Chemical
ESSENTIAL HYPERTENSION;rs113095083;Variant;PA447288;Disease
HYDROCHLOROTHIAZIDE;rs113095083;Variant;PA449899;Chemical
IMATINIB;SLC19A1;Gene;PA10804;Chemical
PEMETREXED;SLC19A1;Gene;PA10810;Chemical
FLUOROURACIL;SLC19A1;Gene;PA128406956;Chemical
RALTITREXED;SLC19A1;Gene;PA131625240;Chemical
GASTROINTESTINAL STROMAL TUMORS;SLC19A1;Gene;PA151958383;Disease
PLATINUM COMPOUNDS;SLC19A1;Gene;PA164713176;Chemical
ADVERSE EVENTS;SLC19A1;Gene;PA166151827;Disease
RS1801131;SLC19A1;Gene;PA166153643;Variant
RS1801133;SLC19A1;Gene;PA166153644;Variant
RS4149081;SLC19A1;Gene;PA166154581;Variant
RS11045879;SLC19A1;Gene;PA166154633;Variant
RHEUMATOID ARTHRITIS;SLC19A1;Gene;PA443434;Disease
BURKITT LYMPHOMA;SLC19A1;Gene;PA443580;Disease
NON-SMALL CELL LUNG CARCINOMA;SLC19A1;Gene;PA443622;Disease
UTERINE CERVICAL NEOPLASM;SLC19A1;Gene;PA443685;Disease
DRUG TOXICITY;SLC19A1;Gene;PA443937;Disease
HEART DEFECTS, CONGENITAL;SLC19A1;Gene;PA444367;Disease
LEUKEMIA;SLC19A1;Gene;PA444750;Disease
MESOTHELIOMA;SLC19A1;Gene;PA444937;Disease
NEOPLASMS;SLC19A1;Gene;PA445062;Disease
OSTEOSARCOMA;SLC19A1;Gene;PA445601;Disease
THROMBOSIS;SLC19A1;Gene;PA445850;Disease
COLORECTAL NEOPLASMS;SLC19A1;Gene;PA446108;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;SLC19A1;Gene;PA446155;Disease
LYMPHOMA, T-CELL;SLC19A1;Gene;PA446309;Disease
CARBOPLATIN;SLC19A1;Gene;PA448803;Chemical
CISPLATIN;SLC19A1;Gene;PA449014;Chemical
IRINOTECAN;SLC19A1;Gene;PA450085;Chemical
LEUCOVORIN;SLC19A1;Gene;PA450198;Chemical
METHOTREXATE;SLC19A1;Gene;PA450428;Chemical
CFTR;ivacaftor / lumacaftor;Chemical;PA109;Gene
RS78655421;ivacaftor / lumacaftor;Chemical;PA166157519;Variant
RS113993960;ivacaftor / lumacaftor;Chemical;PA166157525;Variant
RS121909011;ivacaftor / lumacaftor;Chemical;PA166161188;Variant
RS74551128;ivacaftor / lumacaftor;Chemical;PA166162705;Variant
GEMTUZUMAB OZOGAMICIN;rs11231825;Variant;PA164749431;Chemical
LEUKEMIA, MYELOID, ACUTE;rs11231825;Variant;PA444760;Disease
CYTARABINE;rs11231825;Variant;PA449177;Chemical
FLUDARABINE;rs11231825;Variant;PA449655;Chemical
IDARUBICIN;rs11231825;Variant;PA449961;Chemical
PEGASPARGASE;rs12283870;Variant;PA164760860;Chemical
ELEVATED LIVER ENZYMES;rs12283870;Variant;PA166279881;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;rs12283870;Variant;PA446155;Disease
CYCLOPHOSPHAMIDE;rs12283870;Variant;PA449165;Chemical
CYTARABINE;rs12283870;Variant;PA449177;Chemical
DAUNORUBICIN;rs12283870;Variant;PA449212;Chemical
DOXORUBICIN;rs12283870;Variant;PA449412;Chemical
MERCAPTOPURINE;rs12283870;Variant;PA450379;Chemical
METHOTREXATE;rs12283870;Variant;PA450428;Chemical
THIOGUANINE;rs12283870;Variant;PA451663;Chemical
VINCRISTINE;rs12283870;Variant;PA451879;Chemical
ABCC2;tamoxifen;Chemical;PA116;Gene
CYP2B6;tamoxifen;Chemical;PA123;Gene
CYP2C19;tamoxifen;Chemical;PA124;Gene
CYP2C9;tamoxifen;Chemical;PA126;Gene
CYP2D6;tamoxifen;Chemical;PA128;Gene
CYP3A4;tamoxifen;Chemical;PA130;Gene
CYP3A5;tamoxifen;Chemical;PA131;Gene
E2F7;tamoxifen;Chemical;PA134894421;Gene
LRMDA;tamoxifen;Chemical;PA134899373;Gene
ZNF423;tamoxifen;Chemical;PA134903681;Gene
ESR1;tamoxifen;Chemical;PA156;Gene
F2;tamoxifen;Chemical;PA157;Gene
F5;tamoxifen;Chemical;PA159;Gene
FMO1;tamoxifen;Chemical;PA165;Gene
CYP2C19*17;tamoxifen;Chemical;PA165816533;Haplotype
CYP2D6*1;tamoxifen;Chemical;PA165816576;Haplotype
CYP2D6*2;tamoxifen;Chemical;PA165816577;Haplotype
CYP2D6*3;tamoxifen;Chemical;PA165816578;Haplotype
CYP2D6*4;tamoxifen;Chemical;PA165816579;Haplotype
CYP2D6*6;tamoxifen;Chemical;PA165816581;Haplotype
CYP2D6*10;tamoxifen;Chemical;PA165816582;Haplotype
CYP2D6*17;tamoxifen;Chemical;PA165816583;Haplotype
CYP2D6*41;tamoxifen;Chemical;PA165816584;Haplotype
CYP2B6*1;tamoxifen;Chemical;PA165818750;Haplotype
CYP2B6*6;tamoxifen;Chemical;PA165818762;Haplotype
CYP3A4*1;tamoxifen;Chemical;PA165819201;Haplotype
CYP2D6*5;tamoxifen;Chemical;PA165948092;Haplotype
CYP2D6*9;tamoxifen;Chemical;PA165948317;Haplotype
CYP2D6*29;tamoxifen;Chemical;PA165948318;Haplotype
CYP2D6*7;tamoxifen;Chemical;PA165971559;Haplotype
CYP2D6*11;tamoxifen;Chemical;PA165971564;Haplotype
CYP2D6*18;tamoxifen;Chemical;PA165971569;Haplotype
CYP2D6*20;tamoxifen;Chemical;PA165971571;Haplotype
CYP2C19*1;tamoxifen;Chemical;PA165980634;Haplotype
CYP2C19*2;tamoxifen;Chemical;PA165980635;Haplotype
UGT2B15*1;tamoxifen;Chemical;PA165984975;Haplotype
UGT2B15*2;tamoxifen;Chemical;PA165984976;Haplotype
CYP2D6*1XN;tamoxifen;Chemical;PA165988479;Haplotype
CYP2D6*21;tamoxifen;Chemical;PA165988484;Haplotype
CYP2D6*35;tamoxifen;Chemical;PA165988487;Haplotype
CYP2D6*36;tamoxifen;Chemical;PA165988488;Haplotype
FMO3;tamoxifen;Chemical;PA166;Gene
CYP3A4*22;tamoxifen;Chemical;PA166048680;Haplotype
CYP2D6*87;tamoxifen;Chemical;PA166123327;Haplotype
CYP2D6*90;tamoxifen;Chemical;PA166123330;Haplotype
CYP2D6*91;tamoxifen;Chemical;PA166123331;Haplotype
CYP2D6*93;tamoxifen;Chemical;PA166123333;Haplotype
CYP2D6*95;tamoxifen;Chemical;PA166123336;Haplotype
CYP2D6*98;tamoxifen;Chemical;PA166123339;Haplotype
CYP2D6*10X2;tamoxifen;Chemical;PA166123456;Haplotype
CYP3A5*1;tamoxifen;Chemical;PA166128213;Haplotype
CYP3A5*3;tamoxifen;Chemical;PA166128219;Haplotype
RS717620;tamoxifen;Chemical;PA166153953;Variant
RS3740065;tamoxifen;Chemical;PA166154027;Variant
RS10509373;tamoxifen;Chemical;PA166154108;Variant
RS11023197;tamoxifen;Chemical;PA166154443;Variant
RS310786;tamoxifen;Chemical;PA166154495;Variant
RS4986938;tamoxifen;Chemical;PA166154805;Variant
RS4646;tamoxifen;Chemical;PA166154836;Variant
RS8060157;tamoxifen;Chemical;PA166155087;Variant
RS1804645;tamoxifen;Chemical;PA166155648;Variant
RS2011425;tamoxifen;Chemical;PA166155662;Variant
RS10030044;tamoxifen;Chemical;PA166156638;Variant
RS9340799;tamoxifen;Chemical;PA166157143;Variant
RS478437;tamoxifen;Chemical;PA166157258;Variant
RS1045642;tamoxifen;Chemical;PA166157284;Variant
RS2740574;tamoxifen;Chemical;PA166157367;Variant
CYP2D6*14;tamoxifen;Chemical;PA166181185;Haplotype
BRCA1;tamoxifen;Chemical;PA25411;Gene
PGR;tamoxifen;Chemical;PA266;Gene
ABCB1;tamoxifen;Chemical;PA267;Gene
CYP19A1;tamoxifen;Chemical;PA27091;Gene
CYP1A2;tamoxifen;Chemical;PA27093;Gene
ESR2;tamoxifen;Chemical;PA27886;Gene
NCOA1;tamoxifen;Chemical;PA31470;Gene
RRAS2;tamoxifen;Chemical;PA34862;Gene
UGT1A4;tamoxifen;Chemical;PA37179;Gene
UGT2B15;tamoxifen;Chemical;PA37188;Gene
NR1I2;tamoxifen;Chemical;PA378;Gene
CCNA2;tamoxifen;Chemical;PA94;Gene
MEASLES VACCINES;rs3775291;Variant;PA164712887;Chemical
ASTHMA;rs3775291;Variant;PA443450;Disease
ASPIRIN;rs3775291;Variant;PA448497;Chemical
HEROIN DEPENDENCE;rs1491850;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs1491850;Variant;PA445043;Disease
METHADONE;rs1491850;Variant;PA450401;Chemical
LENALIDOMIDE;rs4135385;Variant;PA162363968;Chemical
MULTIPLE MYELOMA;rs4135385;Variant;PA444985;Disease
CYCLOPHOSPHAMIDE;rs4135385;Variant;PA449165;Chemical
DEXAMETHASONE;rs4135385;Variant;PA449247;Chemical
THALIDOMIDE;rs4135385;Variant;PA451644;Chemical
COMT;butorphanol;Chemical;PA117;Gene
RS4633;butorphanol;Chemical;PA166156023;Variant
RS6269;butorphanol;Chemical;PA166156027;Variant
RS702764;butorphanol;Chemical;PA166183555;Variant
OPRK1;butorphanol;Chemical;PA31943;Gene
FASTKD3;Juvenile Rheumatoid Arthritis;Disease;PA145148868;Gene
HLA-DRB1*15:01;Juvenile Rheumatoid Arthritis;Disease;PA165952269;Haplotype
RS1801133;Juvenile Rheumatoid Arthritis;Disease;PA166153644;Variant
RS3763980;Juvenile Rheumatoid Arthritis;Disease;PA166154563;Variant
RS1801394;Juvenile Rheumatoid Arthritis;Disease;PA166156776;Variant
RS1045642;Juvenile Rheumatoid Arthritis;Disease;PA166157284;Variant
MTHFR;Juvenile Rheumatoid Arthritis;Disease;PA245;Gene
ABCB1;Juvenile Rheumatoid Arthritis;Disease;PA267;Gene
MTRR;Juvenile Rheumatoid Arthritis;Disease;PA31277;Gene
HLA-DRB1;Juvenile Rheumatoid Arthritis;Disease;PA35072;Gene
SLC16A7;Juvenile Rheumatoid Arthritis;Disease;PA35819;Gene
ARIPIPRAZOLE;CYP2C9;Gene;PA10026;Chemical
BOSENTAN;CYP2C9;Gene;PA10034;Chemical
DULOXETINE;CYP2C9;Gene;PA10066;Chemical
ESCITALOPRAM;CYP2C9;Gene;PA10074;Chemical
VORICONAZOLE;CYP2C9;Gene;PA10233;Chemical
SULFONAMIDES, UREA DERIVATIVES;CYP2C9;Gene;PA10390;Chemical
GLICLAZIDE;CYP2C9;Gene;PA10892;Chemical
GEFITINIB;CYP2C9;Gene;PA131301952;Chemical
TENOXICAM;CYP2C9;Gene;PA131890625;Chemical
HMG COA REDUCTASE INHIBITORS;CYP2C9;Gene;PA133950441;Chemical
BENZBROMARONE;CYP2C9;Gene;PA134852920;Chemical
PITAVASTATIN;CYP2C9;Gene;PA142650384;Chemical
ANTIEPILEPTICS;CYP2C9;Gene;PA143485705;Chemical
PRASUGREL;CYP2C9;Gene;PA154410481;Chemical
MACULOPAPULAR EXANTHEMA;CYP2C9;Gene;PA162316739;Disease
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;CYP2C9;Gene;PA164712462;Chemical
GLIQUIDONE;CYP2C9;Gene;PA164744895;Chemical
FOSPHENYTOIN;CYP2C9;Gene;PA164746820;Chemical
LUMIRACOXIB;CYP2C9;Gene;PA164769031;Chemical
DIVALPROEX SODIUM;CYP2C9;Gene;PA164783479;Chemical
ETHAMBUTOL;CYP2C9;Gene;PA164784021;Chemical
ACUTE CORONARY SYNDROME;CYP2C9;Gene;PA165108401;Disease
DRUG RESISTANCE;CYP2C9;Gene;PA165111675;Disease
CYP2C9*1;CYP2C9;Gene;PA165816542;Haplotype
CYP2C9*2;CYP2C9;Gene;PA165816543;Haplotype
CYP2C9*3;CYP2C9;Gene;PA165816544;Haplotype
CYP2C9*5;CYP2C9;Gene;PA165816546;Haplotype
CYP2C9*6;CYP2C9;Gene;PA165816547;Haplotype
CYP2C9*8;CYP2C9;Gene;PA165816549;Haplotype
CYP2C9*11;CYP2C9;Gene;PA165816552;Haplotype
KIDNEY TRANSPLANTATION;CYP2C9;Gene;PA165817016;Disease
SLCO1B1*5;CYP2C9;Gene;PA165819255;Haplotype
SLCO1B1*15;CYP2C9;Gene;PA165819265;Haplotype
HYDROXYPHENYTOIN;CYP2C9;Gene;PA165823907;Chemical
HLA-B*15:02;CYP2C9;Gene;PA165954769;Haplotype
LORNOXICAM;CYP2C9;Gene;PA165958395;Chemical
FLUINDIONE;CYP2C9;Gene;PA165980614;Chemical
ACECLOFENAC;CYP2C9;Gene;PA166049185;Chemical
DRUG-INDUCED LIVER INJURY;CYP2C9;Gene;PA166119041;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;CYP2C9;Gene;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;CYP2C9;Gene;PA166120929;Disease
HEMATOPOIETIC STEM CELL TRANSPLANTATION;CYP2C9;Gene;PA166123007;Disease
OVER-ANTICOAGULATION;CYP2C9;Gene;PA166123298;Disease
HEART VALVE REPLACEMENT;CYP2C9;Gene;PA166123431;Disease
PLATELET AGGREGATION;CYP2C9;Gene;PA166123766;Disease
4-HYDROXYTAMOXIFEN;CYP2C9;Gene;PA166127652;Chemical
DIPYRONE;CYP2C9;Gene;PA166128206;Chemical
TIME TO ACHIEVE STABLE DOSE;CYP2C9;Gene;PA166129530;Disease
TIME IN THERAPEUTIC RANGE;CYP2C9;Gene;PA166129531;Disease
TIME TO THERAPEUTIC INR;CYP2C9;Gene;PA166129532;Disease
TIME ABOVE THERAPEUTIC RANGE;CYP2C9;Gene;PA166129534;Disease
TIME BELOW THERAPEUTIC RANGE;CYP2C9;Gene;PA166129562;Disease
4-HYDROXYCYCLOPHOSPHAMIDE;CYP2C9;Gene;PA166131388;Chemical
7-HYDROXY R-WARFARIN;CYP2C9;Gene;PA166131397;Chemical
7-HYDROXY S-WARFARIN;CYP2C9;Gene;PA166131399;Chemical
ADVERSE EVENTS;CYP2C9;Gene;PA166151827;Disease
FLIBANSERIN;CYP2C9;Gene;PA166153431;Chemical
BRIVARACETAM;CYP2C9;Gene;PA166153491;Chemical
RS6025;CYP2C9;Gene;PA166153554;Variant
RS12777823;CYP2C9;Gene;PA166154157;Variant
RS1799963;CYP2C9;Gene;PA166154336;Variant
RS4149056;CYP2C9;Gene;PA166154579;Variant
RS9923231;CYP2C9;Gene;PA166155091;Variant
RS9934438;CYP2C9;Gene;PA166155096;Variant
RS2108622;CYP2C9;Gene;PA166155381;Variant
LESINURAD;CYP2C9;Gene;PA166160006;Chemical
INTERNATIONAL NORMALIZED RATIO VARIABILITY (INR-VAR);CYP2C9;Gene;PA166160459;Disease
AVATROMBOPAG;CYP2C9;Gene;PA166179849;Chemical
ERDAFITINIB;CYP2C9;Gene;PA166182720;Chemical
SIPONIMOD;CYP2C9;Gene;PA166182736;Chemical
OSPEMIFENE;CYP2C9;Gene;PA166182883;Chemical
RIMEGEPANT;CYP2C9;Gene;PA166225041;Chemical
ABROCITINIB;CYP2C9;Gene;PA166272921;Chemical
ETRASIMOD;CYP2C9;Gene;PA166328841;Chemical
DEURUXOLITINIB;CYP2C9;Gene;PA166400021;Chemical
SELADELPAR;CYP2C9;Gene;PA166400041;Chemical
ALCOHOLISM;CYP2C9;Gene;PA443309;Disease
ATRIAL FIBRILLATION;CYP2C9;Gene;PA443459;Disease
ATRIAL FLUTTER;CYP2C9;Gene;PA443460;Disease
BLOOD COAGULATION DISORDERS;CYP2C9;Gene;PA443523;Disease
BREAST NEOPLASMS;CYP2C9;Gene;PA443560;Disease
CARDIOVASCULAR DISEASES;CYP2C9;Gene;PA443635;Disease
CORONARY ARTERY DISEASE;CYP2C9;Gene;PA443796;Disease
DIABETES MELLITUS;CYP2C9;Gene;PA443886;Disease
DIABETES MELLITUS, TYPE 2;CYP2C9;Gene;PA443890;Disease
DRUG TOXICITY;CYP2C9;Gene;PA443937;Disease
DYSPEPSIA;CYP2C9;Gene;PA443965;Disease
EPIDERMAL NECROLYSIS, TOXIC;CYP2C9;Gene;PA444059;Disease
EPILEPSY;CYP2C9;Gene;PA444065;Disease
EXANTHEMA;CYP2C9;Gene;PA444109;Disease
GASTRITIS;CYP2C9;Gene;PA444250;Disease
HEART DISEASES;CYP2C9;Gene;PA444368;Disease
HEMATOMA, SUBDURAL;CYP2C9;Gene;PA444398;Disease
HEMORRHAGE;CYP2C9;Gene;PA444417;Disease
GASTROINTESTINAL HEMORRHAGE;CYP2C9;Gene;PA444418;Disease
HYPERTENSION;CYP2C9;Gene;PA444552;Disease
HYPOGLYCEMIA;CYP2C9;Gene;PA444570;Disease
HYPOTENSION;CYP2C9;Gene;PA444584;Disease
INFLAMMATION;CYP2C9;Gene;PA444620;Disease
KIDNEY DISEASES;CYP2C9;Gene;PA444682;Disease
LEUKOPENIA;CYP2C9;Gene;PA444773;Disease
CARDIOMYOPATHIES;CYP2C9;Gene;PA445018;Disease
NEOPLASMS;CYP2C9;Gene;PA445062;Disease
PAIN;CYP2C9;Gene;PA445208;Disease
PAIN, POSTOPERATIVE;CYP2C9;Gene;PA445210;Disease
PULMONARY EMBOLISM;CYP2C9;Gene;PA445465;Disease
RHEUMATIC HEART DISEASE;CYP2C9;Gene;PA445553;Disease
STEVENS-JOHNSON SYNDROME;CYP2C9;Gene;PA445738;Disease
THROMBOEMBOLISM;CYP2C9;Gene;PA445848;Disease
THYROTOXICOSIS;CYP2C9;Gene;PA445862;Disease
TOBACCO USE DISORDER;CYP2C9;Gene;PA445876;Disease
TUBERCULOSIS;CYP2C9;Gene;PA445941;Disease
VASCULITIS;CYP2C9;Gene;PA446023;Disease
WEGENER GRANULOMATOSIS;CYP2C9;Gene;PA446065;Disease
VENOUS THROMBOSIS;CYP2C9;Gene;PA446969;Disease
STROKE;CYP2C9;Gene;PA447054;Disease
BIPOLAR DISORDER;CYP2C9;Gene;PA447199;Disease
MENTAL DISORDERS;CYP2C9;Gene;PA447208;Disease
PSYCHOTIC DISORDERS;CYP2C9;Gene;PA447215;Disease
HIV INFECTIONS;CYP2C9;Gene;PA447230;Disease
THROMBOSIS OF CEREBRAL VEINS;CYP2C9;Gene;PA447276;Disease
ESSENTIAL HYPERTENSION;CYP2C9;Gene;PA447288;Disease
VENOUS THROMBOEMBOLISM;CYP2C9;Gene;PA447298;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2C9;Gene;PA447321;Disease
AMITRIPTYLINE;CYP2C9;Gene;PA448385;Chemical
ASPIRIN;CYP2C9;Gene;PA448497;Chemical
BUPROPION;CYP2C9;Gene;PA448687;Chemical
BUSPIRONE;CYP2C9;Gene;PA448689;Chemical
BUSULFAN;CYP2C9;Gene;PA448691;Chemical
CARBAMAZEPINE;CYP2C9;Gene;PA448785;Chemical
CELECOXIB;CYP2C9;Gene;PA448871;Chemical
CITALOPRAM;CYP2C9;Gene;PA449015;Chemical
CLOPIDOGREL;CYP2C9;Gene;PA449053;Chemical
CYCLOPHOSPHAMIDE;CYP2C9;Gene;PA449165;Chemical
DIAZEPAM;CYP2C9;Gene;PA449283;Chemical
DICLOFENAC;CYP2C9;Gene;PA449293;Chemical
DOXEPIN;CYP2C9;Gene;PA449409;Chemical
DRONABINOL;CYP2C9;Gene;PA449421;Chemical
FLUCONAZOLE;CYP2C9;Gene;PA449653;Chemical
FLUOXETINE;CYP2C9;Gene;PA449673;Chemical
FLURBIPROFEN;CYP2C9;Gene;PA449683;Chemical
FLUVASTATIN;CYP2C9;Gene;PA449688;Chemical
GLIMEPIRIDE;CYP2C9;Gene;PA449761;Chemical
GLIPIZIDE;CYP2C9;Gene;PA449762;Chemical
GLYBURIDE;CYP2C9;Gene;PA449782;Chemical
IBUPROFEN;CYP2C9;Gene;PA449957;Chemical
INDOMETHACIN;CYP2C9;Gene;PA449982;Chemical
IRBESARTAN;CYP2C9;Gene;PA450084;Chemical
ISONIAZID;CYP2C9;Gene;PA450112;Chemical
KETOPROFEN;CYP2C9;Gene;PA450149;Chemical
KETOROLAC;CYP2C9;Gene;PA450150;Chemical
LAMOTRIGINE;CYP2C9;Gene;PA450164;Chemical
LOSARTAN;CYP2C9;Gene;PA450268;Chemical
MELOXICAM;CYP2C9;Gene;PA450353;Chemical
METHADONE;CYP2C9;Gene;PA450401;Chemical
MIRTAZAPINE;CYP2C9;Gene;PA450522;Chemical
MODAFINIL;CYP2C9;Gene;PA450530;Chemical
NABUMETONE;CYP2C9;Gene;PA450572;Chemical
NAPROXEN;CYP2C9;Gene;PA450595;Chemical
NATEGLINIDE;CYP2C9;Gene;PA450600;Chemical
NEVIRAPINE;CYP2C9;Gene;PA450616;Chemical
NORTRIPTYLINE;CYP2C9;Gene;PA450657;Chemical
OLANZAPINE;CYP2C9;Gene;PA450688;Chemical
OXCARBAZEPINE;CYP2C9;Gene;PA450732;Chemical
PAROXETINE;CYP2C9;Gene;PA450801;Chemical
PHENPROCOUMON;CYP2C9;Gene;PA450921;Chemical
PHENYTOIN;CYP2C9;Gene;PA450947;Chemical
PIOGLITAZONE;CYP2C9;Gene;PA450970;Chemical
PIROXICAM;CYP2C9;Gene;PA450985;Chemical
PROPOFOL;CYP2C9;Gene;PA451141;Chemical
PYRAZINAMIDE;CYP2C9;Gene;PA451182;Chemical
QUETIAPINE;CYP2C9;Gene;PA451201;Chemical
RIFAMPIN;CYP2C9;Gene;PA451250;Chemical
RISPERIDONE;CYP2C9;Gene;PA451257;Chemical
ROSIGLITAZONE;CYP2C9;Gene;PA451283;Chemical
SERTRALINE;CYP2C9;Gene;PA451333;Chemical
SIMVASTATIN;CYP2C9;Gene;PA451363;Chemical
SULFAMETHOXAZOLE;CYP2C9;Gene;PA451544;Chemical
TAMOXIFEN;CYP2C9;Gene;PA451581;Chemical
TOLBUTAMIDE;CYP2C9;Gene;PA451718;Chemical
TRAZODONE;CYP2C9;Gene;PA451744;Chemical
TRIMIPRAMINE;CYP2C9;Gene;PA451791;Chemical
VALPROIC ACID;CYP2C9;Gene;PA451846;Chemical
VENLAFAXINE;CYP2C9;Gene;PA451866;Chemical
WARFARIN;CYP2C9;Gene;PA451906;Chemical
ZAFIRLUKAST;CYP2C9;Gene;PA451949;Chemical
ZIDOVUDINE;CYP2C9;Gene;PA451954;Chemical
ZIPRASIDONE;CYP2C9;Gene;PA451974;Chemical
ACENOCOUMAROL;CYP2C9;Gene;PA452632;Chemical
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;CYP2C9;Gene;PA452637;Chemical
SORAFENIB;CYP2C9;Gene;PA7000;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs1065634;Variant;PA443622;Disease
CARBOPLATIN;rs1065634;Variant;PA448803;Chemical
CISPLATIN;rs1065634;Variant;PA449014;Chemical
GEMCITABINE;rs1065634;Variant;PA449748;Chemical
OPIOID-RELATED DISORDERS;EXOC4;Gene;PA445043;Disease
OPIOIDS;EXOC4;Gene;PA452618;Chemical
WEIGHT GAIN;CNR1;Gene;PA128406954;Disease
AUTISM SPECTRUM DISORDER;CNR1;Gene;PA153906318;Disease
HEROIN DEPENDENCE;CNR1;Gene;PA444460;Disease
OPIOID-RELATED DISORDERS;CNR1;Gene;PA445043;Disease
COCAINE DEPENDENCE;CNR1;Gene;PA446878;Disease
PSYCHOTIC DISORDER;CNR1;Gene;PA447215;Disease
SCHIZOPHRENIA;CNR1;Gene;PA447216;Disease
CLOZAPINE;CNR1;Gene;PA449061;Chemical
COCAINE;CNR1;Gene;PA449072;Chemical
METHADONE;CNR1;Gene;PA450401;Chemical
OLANZAPINE;CNR1;Gene;PA450688;Chemical
RISPERIDONE;CNR1;Gene;PA451257;Chemical
OPIOIDS;CNR1;Gene;PA452618;Chemical
OXALIPLATIN;MT1A;Gene;PA131285527;Chemical
ARSENIC TRIOXIDE;MT1A;Gene;PA448486;Chemical
RETINAL DISEASES;rs2523864;Variant;PA445532;Disease
TRIAMCINOLONE;rs2523864;Variant;PA451749;Chemical
ESCITALOPRAM;rs2069526;Variant;PA10074;Chemical
MAJOR DEPRESSIVE DISORDER;rs2069526;Variant;PA447321;Disease
DIARRHEA;rs4149178;Variant;PA443899;Disease
NEOPLASMS;rs4149178;Variant;PA445062;Disease
CAPECITABINE;rs4149178;Variant;PA448771;Chemical
PTGS2;etodolac;Chemical;PA293;Gene
VALACICLOVIR;etodolac;Chemical;PA451839;Chemical
FLUOROURACIL;TPMT*3B;Haplotype;PA128406956;Chemical
NUDT15;TPMT*3B;Haplotype;PA134963132;Gene
OTOTOXICITY;TPMT*3B;Haplotype;PA162263534;Disease
KIDNEY TRANSPLANTATION;TPMT*3B;Haplotype;PA165817016;Disease
MYELOSUPPRESSION;TPMT*3B;Haplotype;PA165817398;Disease
DOSE REDUCTION;TPMT*3B;Haplotype;PA166159953;Disease
TPMT;TPMT*3B;Haplotype;PA356;Gene
CROHN DISEASE;TPMT*3B;Haplotype;PA443815;Disease
HEAD AND NECK NEOPLASMS;TPMT*3B;Haplotype;PA444352;Disease
LEUKOPENIA;TPMT*3B;Haplotype;PA444773;Disease
NEOPLASMS;TPMT*3B;Haplotype;PA445062;Disease
SKIN NEOPLASMS;TPMT*3B;Haplotype;PA445683;Disease
INFLAMMATORY BOWEL DISEASES;TPMT*3B;Haplotype;PA446116;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;TPMT*3B;Haplotype;PA446155;Disease
AZATHIOPRINE;TPMT*3B;Haplotype;PA448515;Chemical
CISPLATIN;TPMT*3B;Haplotype;PA449014;Chemical
CYCLOSPORINE;TPMT*3B;Haplotype;PA449167;Chemical
MERCAPTOPURINE;TPMT*3B;Haplotype;PA450379;Chemical
METHOTREXATE;TPMT*3B;Haplotype;PA450428;Chemical
THIOGUANINE;TPMT*3B;Haplotype;PA451663;Chemical
PURINE ANALOGUES;TPMT*3B;Haplotype;PA452634;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;HLA-DQB1*02:01;Haplotype;PA164712708;Chemical
TOXIC LIVER DISEASE;HLA-DQB1*02:01;Haplotype;PA164925725;Disease
DRUG-INDUCED LIVER INJURY;HLA-DQB1*02:01;Haplotype;PA166119041;Disease
AGRANULOCYTOSIS;HLA-DQB1*02:01;Haplotype;PA443297;Disease
DRUG HYPERSENSITIVITY;HLA-DQB1*02:01;Haplotype;PA443936;Disease
TUBERCULOSIS;HLA-DQB1*02:01;Haplotype;PA445941;Disease
SCHIZOPHRENIA;HLA-DQB1*02:01;Haplotype;PA447216;Disease
HIV INFECTIONS;HLA-DQB1*02:01;Haplotype;PA447230;Disease
CLOZAPINE;HLA-DQB1*02:01;Haplotype;PA449061;Chemical
NEVIRAPINE;HLA-DQB1*02:01;Haplotype;PA450616;Chemical
INFLIXIMAB;HLA-DQB1*02:01;Haplotype;PA452639;Chemical
DPYD;rs146529561;Variant;PA145;Gene
CAPECITABINE;rs146529561;Variant;PA448771;Chemical
HALOPERIDOL;GRIN2A;Gene;PA449841;Chemical
URTICARIA;HLA-DPB1*13:01;Haplotype;PA445999;Disease
ASPIRIN;HLA-DPB1*13:01;Haplotype;PA448497;Chemical
RS2274567;Paroxysmal nocturnal hemoglobinuria;Disease;PA166153689;Variant
CR1;Paroxysmal nocturnal hemoglobinuria;Disease;PA26855;Gene
DESFLURANE;rs121918593;Variant;PA164749136;Chemical
RYR1;rs121918593;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs121918593;Variant;PA444863;Disease
ENFLURANE;rs121918593;Variant;PA449461;Chemical
HALOTHANE;rs121918593;Variant;PA449845;Chemical
ISOFLURANE;rs121918593;Variant;PA450106;Chemical
METHOXYFLURANE;rs121918593;Variant;PA450434;Chemical
SEVOFLURANE;rs121918593;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs121918593;Variant;PA451522;Chemical
CACNA1S;rs121918593;Variant;PA85;Gene
HLA-B;cabotegravir / rilpivirine;Chemical;PA35056;Gene
UGT1A1;cabotegravir / rilpivirine;Chemical;PA420;Gene
RS1801253;Angiotensin II Antagonists;Chemical;PA166153977;Variant
RS1042713;Angiotensin II Antagonists;Chemical;PA166156748;Variant
RS1799983;Angiotensin II Antagonists;Chemical;PA166157303;Variant
NOS3;Angiotensin II Antagonists;Chemical;PA254;Gene
ADRB1;Angiotensin II Antagonists;Chemical;PA38;Gene
ADRB2;Angiotensin II Antagonists;Chemical;PA39;Gene
FLUOROURACIL;rs1801268;Variant;PA128406956;Chemical
DPYD;rs1801268;Variant;PA145;Gene
CAPECITABINE;rs1801268;Variant;PA448771;Chemical
TEGAFUR;rs1801268;Variant;PA452620;Chemical
ASPIRIN-INDUCED ASTHMA;rs3129294;Variant;PA131285571;Disease
ASTHMA;rs3129294;Variant;PA443450;Disease
ASPIRIN;rs3129294;Variant;PA448497;Chemical
COMT;fluvoxamine;Chemical;PA117;Gene
CYP2C19;fluvoxamine;Chemical;PA124;Gene
CYP2D6;fluvoxamine;Chemical;PA128;Gene
MDGA2;fluvoxamine;Chemical;PA162395090;Gene
CYP2C19*8;fluvoxamine;Chemical;PA165816524;Haplotype
CYP2C19*9;fluvoxamine;Chemical;PA165816525;Haplotype
CYP2C19*11;fluvoxamine;Chemical;PA165816527;Haplotype
CYP2C19*13;fluvoxamine;Chemical;PA165816529;Haplotype
CYP2C19*15;fluvoxamine;Chemical;PA165816531;Haplotype
CYP2C19*18;fluvoxamine;Chemical;PA165816534;Haplotype
CYP2C19*19;fluvoxamine;Chemical;PA165816535;Haplotype
CYP2D6*1;fluvoxamine;Chemical;PA165816576;Haplotype
CYP2D6*4;fluvoxamine;Chemical;PA165816579;Haplotype
CYP2D6*6;fluvoxamine;Chemical;PA165816581;Haplotype
CYP2D6*10;fluvoxamine;Chemical;PA165816582;Haplotype
CYP2D6*5;fluvoxamine;Chemical;PA165948092;Haplotype
CYP2C19*1;fluvoxamine;Chemical;PA165980634;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);fluvoxamine;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);fluvoxamine;Chemical;PA166116466;Haplotype
SLC6A4 L ALLELE-RS25531T;fluvoxamine;Chemical;PA166117146;Haplotype
SLC6A4 L ALLELE-RS25531C;fluvoxamine;Chemical;PA166117147;Haplotype
RS6311;fluvoxamine;Chemical;PA166154673;Variant
RS6313;fluvoxamine;Chemical;PA166154675;Variant
RS1160351;fluvoxamine;Chemical;PA166154774;Variant
RS4680;fluvoxamine;Chemical;PA166156024;Variant
RS1449683;fluvoxamine;Chemical;PA166156513;Variant
RS6295;fluvoxamine;Chemical;PA166156708;Variant
RS1364043;fluvoxamine;Chemical;PA166156760;Variant
RS10042486;fluvoxamine;Chemical;PA166156855;Variant
RS2032583;fluvoxamine;Chemical;PA166157317;Variant
RS2235040;fluvoxamine;Chemical;PA166157338;Variant
CYP2D6 POOR METABOLIZER;fluvoxamine;Chemical;PA166157927;Variant
CYP2D6*14;fluvoxamine;Chemical;PA166181185;Haplotype
HTR1A;fluvoxamine;Chemical;PA192;Gene
HTR2A;fluvoxamine;Chemical;PA193;Gene
ABCB1;fluvoxamine;Chemical;PA267;Gene
CYP1A2;fluvoxamine;Chemical;PA27093;Gene
FGF2;fluvoxamine;Chemical;PA28115;Gene
SLC6A4;fluvoxamine;Chemical;PA312;Gene
CYP2B6;ifosfamide;Chemical;PA123;Gene
NR1I2;ifosfamide;Chemical;PA378;Gene
RECURRENCE FREE SURVIVAL;CYP2D6*10x2;Haplotype;PA166127658;Disease
BREAST NEOPLASMS;CYP2D6*10x2;Haplotype;PA443560;Disease
DEXTROMETHORPHAN;CYP2D6*10x2;Haplotype;PA449273;Chemical
TAMOXIFEN;CYP2D6*10x2;Haplotype;PA451581;Chemical
COLORECTAL NEOPLASMS;GATA2;Gene;PA446108;Disease
OPIOID-RELATED DISORDERS;rs6600893;Variant;PA445043;Disease
METHADONE;rs6600893;Variant;PA450401;Chemical
IMATINIB;rs12505410;Variant;PA10804;Chemical
OSTEOSARCOMA;rs12505410;Variant;PA445601;Disease
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;rs12505410;Variant;PA446171;Disease
METHOTREXATE;rs12505410;Variant;PA450428;Chemical
COUMARIN;CYP2A6*47;Haplotype;PA134521193;Chemical
DEFERASIROX;rs2470890;Variant;PA164760843;Chemical
BETA-THALASSEMIA AND RELATED DISEASES;rs2470890;Variant;PA446432;Disease
MAJOR DEPRESSIVE DISORDER;rs2470890;Variant;PA447321;Disease
PAROXETINE;rs2470890;Variant;PA450801;Chemical
WARFARIN;rs72558189;Variant;PA451906;Chemical
ADALIMUMAB;rs1130864;Variant;PA10004;Chemical
DEFERASIROX;rs1983023;Variant;PA164760843;Chemical
BETA-THALASSEMIA AND RELATED DISEASES;rs1983023;Variant;PA446432;Disease
PEGINTERFERON ALFA-2A;IFNL3 rs12979860T;Haplotype;PA164749390;Chemical
PEGINTERFERON ALFA-2B;IFNL3 rs12979860T;Haplotype;PA164784024;Chemical
RIBAVIRIN;IFNL3 rs12979860T;Haplotype;PA451241;Chemical
CYP2D6;propafenone;Chemical;PA128;Gene
CYP3A4;propafenone;Chemical;PA130;Gene
CYP2D6*1;propafenone;Chemical;PA165816576;Haplotype
CYP2D6*2;propafenone;Chemical;PA165816577;Haplotype
CYP2D6*10;propafenone;Chemical;PA165816582;Haplotype
CYP2D6*41;propafenone;Chemical;PA165816584;Haplotype
CYP2D6*5;propafenone;Chemical;PA165948092;Haplotype
CYP2D6*59;propafenone;Chemical;PA165971614;Haplotype
CYP2D6*62;propafenone;Chemical;PA165971617;Haplotype
CYP2D6*36;propafenone;Chemical;PA165988488;Haplotype
RS16947;propafenone;Chemical;PA166156031;Variant
RS28371725;propafenone;Chemical;PA166156155;Variant
KCNH2;propafenone;Chemical;PA212;Gene
ABCB1;propafenone;Chemical;PA267;Gene
SCN5A;propafenone;Chemical;PA304;Gene
RS3781719;botulinum toxin type a;Chemical;PA166196165;Variant
RS222749;botulinum toxin type a;Chemical;PA166196173;Variant
CALCA;botulinum toxin type a;Chemical;PA26029;Gene
TRPV1;botulinum toxin type a;Chemical;PA37329;Gene
ACE;Pulmonary Disease, Chronic Obstructive;Disease;PA139;Gene
RS1799752;Pulmonary Disease, Chronic Obstructive;Disease;PA166155187;Variant
EPHX1 POOR METABOLIZER;Pulmonary Disease, Chronic Obstructive;Disease;PA166157923;Variant
EPHX1;Pulmonary Disease, Chronic Obstructive;Disease;PA27829;Gene
ACE2;Pulmonary Disease, Chronic Obstructive;Disease;PA425;Gene
CYP2D6;Paracetamol, combinations excl. Psycholeptics (Vicks MediNait Sirup);Chemical;PA128;Gene
G6PD;Paracetamol, combinations excl. Psycholeptics (Vicks MediNait Sirup);Chemical;PA28469;Gene
DULOXETINE;rs12595802;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs12595802;Variant;PA447321;Disease
CFTR;rs121908752;Variant;PA109;Gene
IVACAFTOR;rs121908752;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs121908752;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs121908752;Variant;PA166190041;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs121908752;Variant;PA166362502;Chemical
CYSTIC FIBROSIS;rs121908752;Variant;PA443829;Disease
CORTICOSTEROIDS;HDAC1;Gene;PA10832;Chemical
ASTHMA;HDAC1;Gene;PA443450;Disease
VALPROIC ACID;HDAC1;Gene;PA451846;Chemical
NICOTINE;rs137904044;Variant;PA450626;Chemical
OMEPRAZOLE;rs140278421;Variant;PA450704;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs2235047;Variant;PA130620651;Chemical
NEOPLASMS;rs2235047;Variant;PA445062;Disease
LEUKEMIA, MYELOID, ACUTE;NME4;Gene;PA444760;Disease
CYTARABINE;NME4;Gene;PA449177;Chemical
OMEPRAZOLE;rs1466428833;Variant;PA450704;Chemical
DPYD;rs138545885;Variant;PA145;Gene
CAPECITABINE;rs138545885;Variant;PA448771;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs10426377;Variant;PA130620651;Chemical
NEOPLASMS;rs10426377;Variant;PA445062;Disease
PROSTATIC NEOPLASMS;rs7769719;Variant;PA445425;Disease
DOCETAXEL;rs7769719;Variant;PA449383;Chemical
THALIDOMIDE;rs7769719;Variant;PA451644;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs854555;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs854555;Variant;PA443434;Disease
BRONCHOPULMONARY DYSPLASIA OF NEWBORN;rs35320474;Variant;PA165109162;Disease
APNEA OF PREMATURITY;rs35320474;Variant;PA166248161;Disease
PREMATURE BIRTH;rs35320474;Variant;PA444704;Disease
CAFFEINE;rs35320474;Variant;PA448710;Chemical
IFNL3;Hepatitis B, Chronic;Disease;PA134952671;Gene
IFNL4;Hepatitis B, Chronic;Disease;PA166049147;Gene
RS12979860;Hepatitis B, Chronic;Disease;PA166155468;Variant
RS3077;Hepatitis B, Chronic;Disease;PA166156899;Variant
HLA-DPA1;Hepatitis B, Chronic;Disease;PA35062;Gene
ACETAMINOPHEN;SULT1A4;Gene;PA448015;Chemical
MORPHINE;SULT1A4;Gene;PA450550;Chemical
LUPUS NEPHRITIS;rs3957356;Variant;PA444823;Disease
CYCLOPHOSPHAMIDE;rs3957356;Variant;PA449165;Chemical
FLUOROURACIL;rs67376798;Variant;PA128406956;Chemical
DPYD;rs67376798;Variant;PA145;Gene
NEOPLASMS;rs67376798;Variant;PA445062;Disease
CAPECITABINE;rs67376798;Variant;PA448771;Chemical
TEGAFUR;rs67376798;Variant;PA452620;Chemical
MACULOPAPULAR EXANTHEMA;HLA-B*15:11;Haplotype;PA162316739;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*15:11;Haplotype;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-B*15:11;Haplotype;PA166120929;Disease
HLA-B;HLA-B*15:11;Haplotype;PA35056;Gene
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*15:11;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*15:11;Haplotype;PA445738;Disease
CARBAMAZEPINE;HLA-B*15:11;Haplotype;PA448785;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs10491684;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs10491684;Variant;PA445846;Disease
CARBOPLATIN;rs10491684;Variant;PA448803;Chemical
GEMCITABINE;rs10491684;Variant;PA449748;Chemical
PEGINTERFERON ALFA-2B;rs12819210;Variant;PA164784024;Chemical
HEPATITIS C VIRUS INFECTION;rs12819210;Variant;PA444445;Disease
RIBAVIRIN;rs12819210;Variant;PA451241;Chemical
ENDOXIFEN;rs4386686;Variant;PA166124478;Chemical
CHD4;vorinostat;Chemical;PA26455;Gene
UGT2B17;vorinostat;Chemical;PA37189;Gene
CYP2C9;rs1799963;Variant;PA126;Gene
F2;rs1799963;Variant;PA157;Gene
F5;rs1799963;Variant;PA159;Gene
ETHINYL ESTRADIOL / NORELGESTROMIN;rs1799963;Variant;PA165290929;Chemical
AVATROMBOPAG;rs1799963;Variant;PA166179849;Chemical
LUSUTROMBOPAG;rs1799963;Variant;PA166182748;Chemical
MTHFR;rs1799963;Variant;PA245;Gene
PROC;rs1799963;Variant;PA33799;Gene
PROS1;rs1799963;Variant;PA33809;Gene
SERPINC1;rs1799963;Variant;PA35026;Gene
VENOUS THROMBOSIS;rs1799963;Variant;PA446969;Disease
STROKE;rs1799963;Variant;PA447054;Disease
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;rs1799963;Variant;PA452637;Chemical
CYP2D6;dextromethorphan / quinidine;Chemical;PA128;Gene
AKT1;HNF4A;Gene;PA24684;Gene
ANEMIA;HNF4A;Gene;PA443340;Disease
EPILEPSY;HNF4A;Gene;PA444065;Disease
NASOPHARYNGEAL NEOPLASMS;HNF4A;Gene;PA445046;Disease
HIV INFECTIOUS DISEASE;HNF4A;Gene;PA447230;Disease
CARBAMAZEPINE;HNF4A;Gene;PA448785;Chemical
DOCETAXEL;HNF4A;Gene;PA449383;Chemical
EFAVIRENZ;HNF4A;Gene;PA449441;Chemical
LAMOTRIGINE;HNF4A;Gene;PA450164;Chemical
WARFARIN;HNF4A;Gene;PA451906;Chemical
COMT;Selective serotonin reuptake inhibitors;Chemical;PA117;Gene
CYP2D6;Selective serotonin reuptake inhibitors;Chemical;PA128;Gene
TPH2;Selective serotonin reuptake inhibitors;Chemical;PA128747823;Gene
CYP2D6*1;Selective serotonin reuptake inhibitors;Chemical;PA165816576;Haplotype
CYP2D6*4;Selective serotonin reuptake inhibitors;Chemical;PA165816579;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);Selective serotonin reuptake inhibitors;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);Selective serotonin reuptake inhibitors;Chemical;PA166116466;Haplotype
RS1800544;Selective serotonin reuptake inhibitors;Chemical;PA166153974;Variant
RS948854;Selective serotonin reuptake inhibitors;Chemical;PA166154302;Variant
RS2734833;Selective serotonin reuptake inhibitors;Chemical;PA166154384;Variant
RS4460839;Selective serotonin reuptake inhibitors;Chemical;PA166154408;Variant
RS6311;Selective serotonin reuptake inhibitors;Chemical;PA166154673;Variant
RS10514475;Selective serotonin reuptake inhibitors;Chemical;PA166155100;Variant
RS6108160;Selective serotonin reuptake inhibitors;Chemical;PA166155959;Variant
RS13306278;Selective serotonin reuptake inhibitors;Chemical;PA166156141;Variant
RS6295;Selective serotonin reuptake inhibitors;Chemical;PA166156708;Variant
RS1992647;Selective serotonin reuptake inhibitors;Chemical;PA166156777;Variant
RS10036156;Selective serotonin reuptake inhibitors;Chemical;PA166156853;Variant
RS4713916;Selective serotonin reuptake inhibitors;Chemical;PA166157104;Variant
RS1045642;Selective serotonin reuptake inhibitors;Chemical;PA166157284;Variant
RS301434;Selective serotonin reuptake inhibitors;Chemical;PA166157703;Variant
RS301435;Selective serotonin reuptake inhibitors;Chemical;PA166157704;Variant
RS3087879;Selective serotonin reuptake inhibitors;Chemical;PA166157760;Variant
RS502434;Selective serotonin reuptake inhibitors;Chemical;PA166157853;Variant
RS3761554;Selective serotonin reuptake inhibitors;Chemical;PA166157871;Variant
RS3761555;Selective serotonin reuptake inhibitors;Chemical;PA166157872;Variant
RS7905446;Selective serotonin reuptake inhibitors;Chemical;PA166182096;Variant
HTR1A;Selective serotonin reuptake inhibitors;Chemical;PA192;Gene
HTR2A;Selective serotonin reuptake inhibitors;Chemical;PA193;Gene
ABCB1;Selective serotonin reuptake inhibitors;Chemical;PA267;Gene
DRD2;Selective serotonin reuptake inhibitors;Chemical;PA27478;Gene
FKBP5;Selective serotonin reuptake inhibitors;Chemical;PA28162;Gene
GABRA6;Selective serotonin reuptake inhibitors;Chemical;PA28494;Gene
GABRP;Selective serotonin reuptake inhibitors;Chemical;PA28503;Gene
GAL;Selective serotonin reuptake inhibitors;Chemical;PA28529;Gene
GRIA3;Selective serotonin reuptake inhibitors;Chemical;PA28968;Gene
HTR7;Selective serotonin reuptake inhibitors;Chemical;PA29561;Gene
SLC6A4;Selective serotonin reuptake inhibitors;Chemical;PA312;Gene
BDNF;Selective serotonin reuptake inhibitors;Chemical;PA31891;Gene
PLCB1;Selective serotonin reuptake inhibitors;Chemical;PA33384;Gene
ADRA2A;Selective serotonin reuptake inhibitors;Chemical;PA35;Gene
TPH1;Selective serotonin reuptake inhibitors;Chemical;PA355;Gene
SLC1A1;Selective serotonin reuptake inhibitors;Chemical;PA35826;Gene
ABCB1;mitomycin;Chemical;PA267;Gene
PACLITAXEL;FGD4;Gene;PA450761;Chemical
CYP3A4;vinblastine;Chemical;PA130;Gene
GSTM1 NULL;vinblastine;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;vinblastine;Chemical;PA166048676;Haplotype
GSTM1;vinblastine;Chemical;PA182;Gene
ABCB1;vinblastine;Chemical;PA267;Gene
NR1I2;vinblastine;Chemical;PA378;Gene
GNB4;PLCB3;Gene;PA134864200;Gene
GNAQ;PLCB3;Gene;PA174;Gene
GNB3;PLCB3;Gene;PA176;Gene
CASR;PLCB3;Gene;PA26097;Gene
GNB1;PLCB3;Gene;PA28776;Gene
GNB1L;PLCB3;Gene;PA28777;Gene
GNB2;PLCB3;Gene;PA28778;Gene
GNG2;PLCB3;Gene;PA28784;Gene
GNG3;PLCB3;Gene;PA28785;Gene
GNG4;PLCB3;Gene;PA28786;Gene
GNG5;PLCB3;Gene;PA28787;Gene
GNG7;PLCB3;Gene;PA28789;Gene
PRKCA;PLCB3;Gene;PA33759;Gene
PRKCB;PLCB3;Gene;PA33761;Gene
PRKCG;PLCB3;Gene;PA33766;Gene
PRKCH;PLCB3;Gene;PA33767;Gene
PRKCI;PLCB3;Gene;PA33768;Gene
PRKD1;PLCB3;Gene;PA33771;Gene
PRKCZ;PLCB3;Gene;PA33775;Gene
ADRB2;PLCB3;Gene;PA39;Gene
O-DESMETHYLTRAMADOL;HCN1;Gene;PA166131379;Chemical
TRAMADOL;HCN1;Gene;PA451735;Chemical
GP1BB;COL1A1;Gene;PA179;Gene
ITGA2;COL1A1;Gene;PA204;Gene
CD36;COL1A1;Gene;PA26212;Gene
GP5;COL1A1;Gene;PA28823;Gene
GP6;COL1A1;Gene;PA28824;Gene
GP9;COL1A1;Gene;PA28825;Gene
EPILEPSY;COL1A1;Gene;PA444065;Disease
OSTEOPOROSIS;COL1A1;Gene;PA445190;Disease
SOMATROPIN RECOMBINANT;COL1A1;Gene;PA451446;Chemical
VALPROIC ACID;COL1A1;Gene;PA451846;Chemical
SOMNOLENCE;rs10248420;Variant;PA166185626;Disease
SCHIZOPHRENIA;rs10248420;Variant;PA447216;Disease
DEPRESSION;rs10248420;Variant;PA447278;Disease
AMITRIPTYLINE;rs10248420;Variant;PA448385;Chemical
CITALOPRAM;rs10248420;Variant;PA449015;Chemical
CLOZAPINE;rs10248420;Variant;PA449061;Chemical
OLANZAPINE;rs10248420;Variant;PA450688;Chemical
PAROXETINE;rs10248420;Variant;PA450801;Chemical
VENLAFAXINE;rs10248420;Variant;PA451866;Chemical
QT-PROLONGING DRUGS;KCNE1;Gene;PA1102;Chemical
DIURETICS;KCNE1;Gene;PA151249535;Chemical
ANTIBIOTICS;KCNE1;Gene;PA164712406;Chemical
ACQUIRED LONG QT SYNDROME (ALQTS);KCNE1;Gene;PA447300;Disease
AMIODARONE;KCNE1;Gene;PA448383;Chemical
QUINIDINE;KCNE1;Gene;PA451209;Chemical
SOTALOL;KCNE1;Gene;PA451457;Chemical
ANTIPSYCHOTICS;KCNE1;Gene;PA452233;Chemical
BREAST NEOPLASMS;EPHA5;Gene;PA443560;Disease
OVARIAN NEOPLASMS;EPHA5;Gene;PA445204;Disease
PERIPHERAL NERVOUS SYSTEM DISEASES;EPHA5;Gene;PA445301;Disease
PACLITAXEL;EPHA5;Gene;PA450761;Chemical
ANEMIA;rs9725457;Variant;PA443340;Disease
NASOPHARYNGEAL NEOPLASMS;rs9725457;Variant;PA445046;Disease
DOCETAXEL;rs9725457;Variant;PA449383;Chemical
HEPATOCELLULAR CARCINOMA;rs2257212;Variant;PA444447;Disease
SORAFENIB;rs2257212;Variant;PA7000;Chemical
ALDH1A1;vitamin a;Chemical;PA24692;Gene
FLUOROURACIL;rs371258350;Variant;PA128406956;Chemical
DRUG TOXICITY;rs371258350;Variant;PA443937;Disease
RS6280;Autism Spectrum Disorder;Disease;PA166156277;Variant
RS806378;Autism Spectrum Disorder;Disease;PA166156956;Variant
RS1049353;Autism Spectrum Disorder;Disease;PA166156973;Variant
RS7799039;Autism Spectrum Disorder;Disease;PA166157432;Variant
LEP;Autism Spectrum Disorder;Disease;PA228;Gene
CNR1;Autism Spectrum Disorder;Disease;PA26681;Gene
DRD3;Autism Spectrum Disorder;Disease;PA27479;Gene
ACUTE CORONARY SYNDROME;ZDHHC3;Gene;PA165108401;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);ZDHHC3;Gene;PA166129560;Disease
ASPIRIN;ZDHHC3;Gene;PA448497;Chemical
CLOPIDOGREL;ZDHHC3;Gene;PA449053;Chemical
IMATINIB;rs58818712;Variant;PA10804;Chemical
DASATINIB;rs58818712;Variant;PA162372878;Chemical
NILOTINIB;rs58818712;Variant;PA165958345;Chemical
COMT;Analgesics;Chemical;PA117;Gene
DBH;Analgesics;Chemical;PA136;Gene
RS6265;Analgesics;Chemical;PA166154259;Variant
RS6275;Analgesics;Chemical;PA166154260;Variant
RS6305;Analgesics;Chemical;PA166154672;Variant
RS2070995;Analgesics;Chemical;PA166155996;Variant
RS4680;Analgesics;Chemical;PA166156024;Variant
RS1799971;Analgesics;Chemical;PA166156991;Variant
RS1611115;Analgesics;Chemical;PA166157734;Variant
HTR2A;Analgesics;Chemical;PA193;Gene
DRD2;Analgesics;Chemical;PA27478;Gene
KCNJ6;Analgesics;Chemical;PA30049;Gene
BDNF;Analgesics;Chemical;PA31891;Gene
OPRM1;Analgesics;Chemical;PA31945;Gene
HYPERTENSION;rs340874;Variant;PA444552;Disease
ATENOLOL;rs340874;Variant;PA448499;Chemical
TPMT POOR METABOLIZER;thioguanosine diphosphate;Chemical;PA166157904;Variant
TPMT;thioguanosine diphosphate;Chemical;PA356;Gene
VALPROIC ACID;OGDH;Gene;PA451846;Chemical
PEGINTERFERON ALFA-2B;rs10853728;Variant;PA164784024;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;rs10853728;Variant;PA446863;Disease
RIBAVIRIN;rs10853728;Variant;PA451241;Chemical
RS622342;amantadine;Chemical;PA166156932;Variant
SLC22A1;amantadine;Chemical;PA329;Gene
OPIOID-RELATED DISORDERS;rs4530637;Variant;PA445043;Disease
OPIOIDS;rs4530637;Variant;PA452618;Chemical
HYPERTENSION;NUCB2;Gene;PA444552;Disease
HYDROCHLOROTHIAZIDE;NUCB2;Gene;PA449899;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs9981861;Variant;PA443622;Disease
NEOPLASMS;rs9981861;Variant;PA445062;Disease
CARBOPLATIN;rs9981861;Variant;PA448803;Chemical
PACLITAXEL;rs9981861;Variant;PA450761;Chemical
CYP2C19;atomoxetine;Chemical;PA124;Gene
CYP2D6;atomoxetine;Chemical;PA128;Gene
CYP2D6*1;atomoxetine;Chemical;PA165816576;Haplotype
CYP2D6*2;atomoxetine;Chemical;PA165816577;Haplotype
CYP2D6*3;atomoxetine;Chemical;PA165816578;Haplotype
CYP2D6*4;atomoxetine;Chemical;PA165816579;Haplotype
CYP2D6*6;atomoxetine;Chemical;PA165816581;Haplotype
CYP2D6*10;atomoxetine;Chemical;PA165816582;Haplotype
CYP2D6*17;atomoxetine;Chemical;PA165816583;Haplotype
CYP2D6*41;atomoxetine;Chemical;PA165816584;Haplotype
CYP2D6*5;atomoxetine;Chemical;PA165948092;Haplotype
CYP2D6*9;atomoxetine;Chemical;PA165948317;Haplotype
CYP2D6*29;atomoxetine;Chemical;PA165948318;Haplotype
CYP2C19*1;atomoxetine;Chemical;PA165980634;Haplotype
CYP2C19*2;atomoxetine;Chemical;PA165980635;Haplotype
CYP2D6*87;atomoxetine;Chemical;PA166123327;Haplotype
CYP2D6*88;atomoxetine;Chemical;PA166123328;Haplotype
CYP2D6*89;atomoxetine;Chemical;PA166123329;Haplotype
CYP2D6*90;atomoxetine;Chemical;PA166123330;Haplotype
CYP2D6*91;atomoxetine;Chemical;PA166123331;Haplotype
CYP2D6*92;atomoxetine;Chemical;PA166123332;Haplotype
CYP2D6*93;atomoxetine;Chemical;PA166123333;Haplotype
CYP2D6*95;atomoxetine;Chemical;PA166123336;Haplotype
CYP2D6*96;atomoxetine;Chemical;PA166123337;Haplotype
CYP2D6*97;atomoxetine;Chemical;PA166123338;Haplotype
CYP2D6*98;atomoxetine;Chemical;PA166123339;Haplotype
CYP2D6*4XN;atomoxetine;Chemical;PA166123455;Haplotype
CYP2D6*94;atomoxetine;Chemical;PA166128737;Haplotype
RS3785143;atomoxetine;Chemical;PA166155055;Variant
RS12708954;atomoxetine;Chemical;PA166155113;Variant
CYP2D6 POOR METABOLIZER;atomoxetine;Chemical;PA166157927;Variant
SLC6A2;atomoxetine;Chemical;PA310;Gene
DIHYDROPYRIDINE DERIVATIVES;rs10494366;Variant;PA164712688;Chemical
SHORTENED QT INTERVAL;rs10494366;Variant;PA165818136;Disease
DIABETES MELLITUS, TYPE 2;rs10494366;Variant;PA443890;Disease
HYPOGLYCEMIA;rs10494366;Variant;PA444570;Disease
ACQUIRED LONG QT SYNDROME (ALQTS);rs10494366;Variant;PA447300;Disease
DIGOXIN;rs10494366;Variant;PA449319;Chemical
DOLASETRON;rs10494366;Variant;PA449390;Chemical
GLIMEPIRIDE;rs10494366;Variant;PA449761;Chemical
GLIPIZIDE;rs10494366;Variant;PA449762;Chemical
GLYBURIDE;rs10494366;Variant;PA449782;Chemical
GRANISETRON;rs10494366;Variant;PA449809;Chemical
REPAGLINIDE;rs10494366;Variant;PA451234;Chemical
VERAPAMIL;rs10494366;Variant;PA451868;Chemical
TENOFOVIR;ABCG2;Gene;PA10204;Chemical
IMATINIB;ABCG2;Gene;PA10804;Chemical
FLUOROURACIL;ABCG2;Gene;PA128406956;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;ABCG2;Gene;PA130620651;Chemical
OXALIPLATIN;ABCG2;Gene;PA131285527;Chemical
GEFITINIB;ABCG2;Gene;PA131301952;Chemical
HMG COA REDUCTASE INHIBITORS;ABCG2;Gene;PA133950441;Chemical
ROSUVASTATIN;ABCG2;Gene;PA134308647;Chemical
PITAVASTATIN;ABCG2;Gene;PA142650384;Chemical
GASTROINTESTINAL STROMAL TUMORS;ABCG2;Gene;PA151958383;Disease
CURCUMIN;ABCG2;Gene;PA151958596;Chemical
SUNITINIB;ABCG2;Gene;PA162372840;Chemical
DASATINIB;ABCG2;Gene;PA162372878;Chemical
OPIOID ANESTHETICS;ABCG2;Gene;PA164712948;Chemical
OTHER GENERAL ANESTHETICS;ABCG2;Gene;PA164713083;Chemical
PLATINUM COMPOUNDS;ABCG2;Gene;PA164713176;Chemical
DEFERASIROX;ABCG2;Gene;PA164760843;Chemical
ELACRIDAR;ABCG2;Gene;PA164924562;Chemical
RHODAMINE 123;ABCG2;Gene;PA165110729;Chemical
SN-38;ABCG2;Gene;PA165110775;Chemical
PAZOPANIB;ABCG2;Gene;PA165291492;Chemical
SLCO1B1*5;ABCG2;Gene;PA165819255;Haplotype
SLCO1B1*15;ABCG2;Gene;PA165819265;Haplotype
NILOTINIB;ABCG2;Gene;PA165958345;Chemical
DOLUTEGRAVIR;ABCG2;Gene;PA166114961;Chemical
VOLATILE ANESTHETICS;ABCG2;Gene;PA166131630;Chemical
RS4149056;ABCG2;Gene;PA166154579;Variant
RS2231137;ABCG2;Gene;PA166156543;Variant
RS2231142;ABCG2;Gene;PA166156544;Variant
STATIN-RELATED MYOPATHY;ABCG2;Gene;PA166163391;Disease
APIXABAN;ABCG2;Gene;PA166163740;Chemical
EZETIMIBE / ROSUVASTATIN;ABCG2;Gene;PA166184498;Chemical
RESMETIROM;ABCG2;Gene;PA166353181;Chemical
NR1I2;ABCG2;Gene;PA378;Gene
RHEUMATOID ARTHRITIS;ABCG2;Gene;PA443434;Disease
ATRIAL FIBRILLATION;ABCG2;Gene;PA443459;Disease
BRAIN NEOPLASMS;ABCG2;Gene;PA443557;Disease
BREAST NEOPLASMS;ABCG2;Gene;PA443560;Disease
BURKITT LYMPHOMA;ABCG2;Gene;PA443580;Disease
NON-SMALL CELL LUNG CARCINOMA;ABCG2;Gene;PA443622;Disease
CENTRAL NERVOUS SYSTEM INFECTIOUS DISORDER;ABCG2;Gene;PA443658;Disease
DRUG TOXICITY;ABCG2;Gene;PA443937;Disease
EPILEPSY;ABCG2;Gene;PA444065;Disease
ESOPHAGEAL NEOPLASMS;ABCG2;Gene;PA444101;Disease
GOUT;ABCG2;Gene;PA444318;Disease
HYPERCHOLESTEROLEMIA;ABCG2;Gene;PA444516;Disease
LUNG NEOPLASMS;ABCG2;Gene;PA444818;Disease
MYOCARDIAL INFARCTION;ABCG2;Gene;PA445019;Disease
NEOPLASMS;ABCG2;Gene;PA445062;Disease
PSORIASIS;ABCG2;Gene;PA445451;Disease
OSTEOSARCOMA;ABCG2;Gene;PA445601;Disease
STOMACH NEOPLASMS;ABCG2;Gene;PA445742;Disease
COLORECTAL NEOPLASMS;ABCG2;Gene;PA446108;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;ABCG2;Gene;PA446155;Disease
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;ABCG2;Gene;PA446171;Disease
LYMPHOMA, T-CELL;ABCG2;Gene;PA446309;Disease
BETA-THALASSEMIA AND RELATED DISEASES;ABCG2;Gene;PA446432;Disease
HIV INFECTIOUS DISEASE;ABCG2;Gene;PA447230;Disease
ALLOPURINOL;ABCG2;Gene;PA448320;Chemical
ATORVASTATIN;ABCG2;Gene;PA448500;Chemical
CAPECITABINE;ABCG2;Gene;PA448771;Chemical
CEFTRIAXONE;ABCG2;Gene;PA448866;Chemical
CYCLOPHOSPHAMIDE;ABCG2;Gene;PA449165;Chemical
CYCLOSPORINE;ABCG2;Gene;PA449167;Chemical
DAUNORUBICIN;ABCG2;Gene;PA449212;Chemical
DOCETAXEL;ABCG2;Gene;PA449383;Chemical
DOXORUBICIN;ABCG2;Gene;PA449412;Chemical
EFAVIRENZ;ABCG2;Gene;PA449441;Chemical
FLUVASTATIN;ABCG2;Gene;PA449688;Chemical
GEMCITABINE;ABCG2;Gene;PA449748;Chemical
IRINOTECAN;ABCG2;Gene;PA450085;Chemical
LAMIVUDINE;ABCG2;Gene;PA450163;Chemical
LAMOTRIGINE;ABCG2;Gene;PA450164;Chemical
LEUCOVORIN;ABCG2;Gene;PA450198;Chemical
LOVASTATIN;ABCG2;Gene;PA450272;Chemical
METHOTREXATE;ABCG2;Gene;PA450428;Chemical
PACLITAXEL;ABCG2;Gene;PA450761;Chemical
PRAVASTATIN;ABCG2;Gene;PA451089;Chemical
SIMVASTATIN;ABCG2;Gene;PA451363;Chemical
SULFASALAZINE;ABCG2;Gene;PA451547;Chemical
TELMISARTAN;ABCG2;Gene;PA451605;Chemical
TOPOTECAN;ABCG2;Gene;PA451729;Chemical
ZIDOVUDINE;ABCG2;Gene;PA451954;Chemical
URINARY BLADDER NEOPLASMS;rs10964552;Variant;PA443512;Disease
CISPLATIN;rs10964552;Variant;PA449014;Chemical
ANALGESICS;rs1611115;Variant;PA164712362;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;rs1611115;Variant;PA164712462;Chemical
ERGOT ALKALOIDS;rs1611115;Variant;PA164712741;Chemical
ALCOHOL ABUSE;rs1611115;Variant;PA443309;Disease
SUBSTANCE WITHDRAWAL SYNDROME;rs1611115;Variant;PA445768;Disease
COCAINE DEPENDENCE;rs1611115;Variant;PA446878;Disease
LEVODOPA;rs1611115;Variant;PA450213;Chemical
NALTREXONE;rs1611115;Variant;PA450588;Chemical
SUMATRIPTAN;rs1611115;Variant;PA451566;Chemical
OPIOIDS;rs1611115;Variant;PA452618;Chemical
DULOXETINE;rs17786394;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs17786394;Variant;PA447321;Disease
RS396991;rituximab;Chemical;PA166153571;Variant
RS1801274;rituximab;Chemical;PA166153652;Variant
RS1800470;rituximab;Chemical;PA166155373;Variant
RS1800471;rituximab;Chemical;PA166155374;Variant
RS6822844;rituximab;Chemical;PA166156610;Variant
RS3957357;rituximab;Chemical;PA166157094;Variant
RS2229109;rituximab;Chemical;PA166157334;Variant
RS1801157;rituximab;Chemical;PA166159131;Variant
RS3759467;rituximab;Chemical;PA166160991;Variant
IL2;rituximab;Chemical;PA195;Gene
IL6;rituximab;Chemical;PA198;Gene
ABCB1;rituximab;Chemical;PA267;Gene
FCGR2A;rituximab;Chemical;PA28063;Gene
FCGR3A;rituximab;Chemical;PA28065;Gene
GSTA1;rituximab;Chemical;PA29016;Gene
IL10;rituximab;Chemical;PA29778;Gene
MS4A1;rituximab;Chemical;PA31111;Gene
TGFB1;rituximab;Chemical;PA350;Gene
CXCL13;rituximab;Chemical;PA35570;Gene
CXCL12;rituximab;Chemical;PA35602;Gene
SUBSTANCE-RELATED DISORDERS;rs58801820;Variant;PA446876;Disease
PSYCHOTIC DISORDER;GRIN1;Gene;PA447215;Disease
HALOPERIDOL;GRIN1;Gene;PA449841;Chemical
METHAMPHETAMINE;GRIN1;Gene;PA450403;Chemical
MECP2;trofinetide;Chemical;PA30729;Gene
FXYD2;ARNT;Gene;PA28442;Gene
CARBOCISTEINE;rs138809906;Variant;PA166184060;Chemical
L-PHENYLALANINE;rs138809906;Variant;PA450931;Chemical
ECULIZUMAB;rs56040400;Variant;PA164776637;Chemical
BEVACIZUMAB;KCNAB1;Gene;PA130232992;Chemical
HYPERTENSION;KCNAB1;Gene;PA444552;Disease
TRANSPLANTATION;GSTA1;Gene;PA134850491;Disease
LYMPHOMA, LARGE B-CELL, DIFFUSE;GSTA1;Gene;PA160680212;Disease
ANEMIA;GSTA1;Gene;PA443340;Disease
LUPUS NEPHRITIS;GSTA1;Gene;PA444823;Disease
OVARIAN NEOPLASMS;GSTA1;Gene;PA445204;Disease
SARCOMA;GSTA1;Gene;PA445594;Disease
BUSULFAN;GSTA1;Gene;PA448691;Chemical
CISPLATIN;GSTA1;Gene;PA449014;Chemical
CYCLOPHOSPHAMIDE;GSTA1;Gene;PA449165;Chemical
DOXORUBICIN;GSTA1;Gene;PA449412;Chemical
PREDNISONE;GSTA1;Gene;PA451100;Chemical
RITUXIMAB;GSTA1;Gene;PA451261;Chemical
VINCRISTINE;GSTA1;Gene;PA451879;Chemical
CYP2C8;cerivastatin;Chemical;PA125;Gene
SLCO1B1;cerivastatin;Chemical;PA134865839;Gene
SLCO1B1*5;cerivastatin;Chemical;PA165819255;Haplotype
SLCO1B1*15;cerivastatin;Chemical;PA165819265;Haplotype
CYP2C8*3;cerivastatin;Chemical;PA165958685;Haplotype
CYP2C8*4;cerivastatin;Chemical;PA165958686;Haplotype
SLCO1B1*1;cerivastatin;Chemical;PA165981641;Haplotype
RS2819742;cerivastatin;Chemical;PA166153719;Variant
RS4149056;cerivastatin;Chemical;PA166154579;Variant
CYP2C8*1;cerivastatin;Chemical;PA166242948;Haplotype
RYR2;cerivastatin;Chemical;PA300;Gene
HLA-DRB1*08:02;bucillamine;Chemical;PA165951674;Haplotype
HLA-DQB1*04:02;bucillamine;Chemical;PA165958226;Haplotype
HLA-DQB1;bucillamine;Chemical;PA35068;Gene
HLA-DRB1;bucillamine;Chemical;PA35072;Gene
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs17685420;Variant;PA447197;Disease
METHYLPHENIDATE;rs17685420;Variant;PA450464;Chemical
CYP3A4;darunavir;Chemical;PA130;Gene
ASTHMA;rs1663332;Variant;PA443450;Disease
SALBUTAMOL;rs1663332;Variant;PA448068;Chemical
CYP2B6;duloxetine;Chemical;PA123;Gene
CYP2C19;duloxetine;Chemical;PA124;Gene
CYP2C9;duloxetine;Chemical;PA126;Gene
CYP2D6;duloxetine;Chemical;PA128;Gene
CYP3A4;duloxetine;Chemical;PA130;Gene
CYP3A5;duloxetine;Chemical;PA131;Gene
TEX10;duloxetine;Chemical;PA134991964;Gene
TREML4;duloxetine;Chemical;PA134993202;Gene
SKIC3;duloxetine;Chemical;PA162407226;Gene
ZNF385D;duloxetine;Chemical;PA162410152;Gene
CYP2D6*1;duloxetine;Chemical;PA165816576;Haplotype
CYP2D6*4;duloxetine;Chemical;PA165816579;Haplotype
CYP2D6*5;duloxetine;Chemical;PA165948092;Haplotype
RS167770;duloxetine;Chemical;PA166156279;Variant
RS324023;duloxetine;Chemical;PA166156285;Variant
RS324026;duloxetine;Chemical;PA166156286;Variant
RS963468;duloxetine;Chemical;PA166156301;Variant
RS6700741;duloxetine;Chemical;PA166177102;Variant
RS4971678;duloxetine;Chemical;PA166177103;Variant
RS2933304;duloxetine;Chemical;PA166177104;Variant
RS13093500;duloxetine;Chemical;PA166177107;Variant
RS4261893;duloxetine;Chemical;PA166177108;Variant
RS4334661;duloxetine;Chemical;PA166177109;Variant
RS4858478;duloxetine;Chemical;PA166177110;Variant
RS7616119;duloxetine;Chemical;PA166177112;Variant
RS7625956;duloxetine;Chemical;PA166177113;Variant
RS7653345;duloxetine;Chemical;PA166177114;Variant
RS9310657;duloxetine;Chemical;PA166177115;Variant
RS9310658;duloxetine;Chemical;PA166177116;Variant
RS9819548;duloxetine;Chemical;PA166177117;Variant
RS9824595;duloxetine;Chemical;PA166177118;Variant
RS9873889;duloxetine;Chemical;PA166177119;Variant
RS9879065;duloxetine;Chemical;PA166177120;Variant
RS10007051;duloxetine;Chemical;PA166177121;Variant
RS11933890;duloxetine;Chemical;PA166177122;Variant
RS55881666;duloxetine;Chemical;PA166177123;Variant
RS56229625;duloxetine;Chemical;PA166177124;Variant
RS61692318;duloxetine;Chemical;PA166177125;Variant
RS62319299;duloxetine;Chemical;PA166177126;Variant
RS10123866;duloxetine;Chemical;PA166177127;Variant
RS10124893;duloxetine;Chemical;PA166177128;Variant
RS10989064;duloxetine;Chemical;PA166177130;Variant
RS6479008;duloxetine;Chemical;PA166177131;Variant
RS7035619;duloxetine;Chemical;PA166177132;Variant
RS7472;duloxetine;Chemical;PA166177133;Variant
RS12595802;duloxetine;Chemical;PA166177136;Variant
RS12603700;duloxetine;Chemical;PA166177137;Variant
RS3889402;duloxetine;Chemical;PA166177138;Variant
RS56355515;duloxetine;Chemical;PA166177139;Variant
RS58042962;duloxetine;Chemical;PA166177140;Variant
RS12630569;duloxetine;Chemical;PA166177145;Variant
RS12094644;duloxetine;Chemical;PA166177177;Variant
RS2419128;duloxetine;Chemical;PA166177178;Variant
RS4437856;duloxetine;Chemical;PA166177179;Variant
RS12502866;duloxetine;Chemical;PA166177180;Variant
RS12657120;duloxetine;Chemical;PA166177181;Variant
RS4639250;duloxetine;Chemical;PA166177182;Variant
RS13204353;duloxetine;Chemical;PA166177183;Variant
RS9369266;duloxetine;Chemical;PA166177184;Variant
RS3124955;duloxetine;Chemical;PA166177185;Variant
RS3128624;duloxetine;Chemical;PA166177186;Variant
RS10771997;duloxetine;Chemical;PA166177187;Variant
RS10771998;duloxetine;Chemical;PA166177188;Variant
RS10771999;duloxetine;Chemical;PA166177189;Variant
RS17724452;duloxetine;Chemical;PA166177190;Variant
RS17724464;duloxetine;Chemical;PA166177191;Variant
RS17724494;duloxetine;Chemical;PA166177192;Variant
RS17786394;duloxetine;Chemical;PA166177193;Variant
RS17786400;duloxetine;Chemical;PA166177194;Variant
RS17786412;duloxetine;Chemical;PA166177195;Variant
RS61908402;duloxetine;Chemical;PA166177196;Variant
RS61908403;duloxetine;Chemical;PA166177197;Variant
RS61908404;duloxetine;Chemical;PA166177198;Variant
RS61908405;duloxetine;Chemical;PA166177199;Variant
RS61908406;duloxetine;Chemical;PA166177200;Variant
RS61908407;duloxetine;Chemical;PA166177201;Variant
RS61908408;duloxetine;Chemical;PA166177202;Variant
RS61908409;duloxetine;Chemical;PA166177203;Variant
RS61908410;duloxetine;Chemical;PA166177204;Variant
RS61908411;duloxetine;Chemical;PA166177205;Variant
RS7306991;duloxetine;Chemical;PA166177206;Variant
RS7316769;duloxetine;Chemical;PA166177207;Variant
RS78482393;duloxetine;Chemical;PA166177208;Variant
RS78615940;duloxetine;Chemical;PA166177209;Variant
RS2303377;duloxetine;Chemical;PA166180924;Variant
RS117986340;duloxetine;Chemical;PA166180928;Variant
HTR2A;duloxetine;Chemical;PA193;Gene
HTR2C;duloxetine;Chemical;PA194;Gene
ATP10A;duloxetine;Chemical;PA25097;Gene
ANO2;duloxetine;Chemical;PA25504;Gene
CYP1A2;duloxetine;Chemical;PA27093;Gene
DRD2;duloxetine;Chemical;PA27478;Gene
DRD3;duloxetine;Chemical;PA27479;Gene
FCN2;duloxetine;Chemical;PA28070;Gene
SLC6A4;duloxetine;Chemical;PA312;Gene
NCAM1;duloxetine;Chemical;PA31459;Gene
NRXN1;duloxetine;Chemical;PA31786;Gene
POLG;duloxetine;Chemical;PA33500;Gene
HLA-A;duloxetine;Chemical;PA35055;Gene
HLA-B;duloxetine;Chemical;PA35056;Gene
UGT1A4;duloxetine;Chemical;PA37179;Gene
MIEF2;duloxetine;Chemical;PA38265;Gene
INVS;duloxetine;Chemical;PA38472;Gene
KMT2E;duloxetine;Chemical;PA38568;Gene
XDH;thioxanthine;Chemical;PA37404;Gene
VORICONAZOLE;CYP2C19*23;Haplotype;PA10233;Chemical
ANDROSTENEDIONE;CYP2C19*23;Haplotype;PA166178641;Chemical
16ALPHA-HYDROXYTESTOSTERONE;CYP2C19*23;Haplotype;PA166318241;Chemical
11ALPHA-HYDROXYTESTOSTERONE;CYP2C19*23;Haplotype;PA166318261;Chemical
16ALPHA-HYDROXYPROGESTERONE;CYP2C19*23;Haplotype;PA166318321;Chemical
11A-HYDROXYPROGESTERONE;CYP2C19*23;Haplotype;PA166318342;Chemical
6BETA-HYDROXYPROGESTERONE;CYP2C19*23;Haplotype;PA166318343;Chemical
DESOXYCORTONE;CYP2C19*23;Haplotype;PA166318362;Chemical
CLOPIDOGREL;CYP2C19*23;Haplotype;PA449053;Chemical
HYDROXYPROGESTERONE;CYP2C19*23;Haplotype;PA449932;Chemical
MEPHENYTOIN;CYP2C19*23;Haplotype;PA450373;Chemical
OMEPRAZOLE;CYP2C19*23;Haplotype;PA450704;Chemical
ANEMIA;rs6130615;Variant;PA443340;Disease
NASOPHARYNGEAL NEOPLASMS;rs6130615;Variant;PA445046;Disease
DOCETAXEL;rs6130615;Variant;PA449383;Chemical
RS1042713;methacholine;Chemical;PA166156748;Variant
ADRB2;methacholine;Chemical;PA39;Gene
CYP2A6;Lung Neoplasms;Disease;PA121;Gene
MALAT1;Lung Neoplasms;Disease;PA134935778;Gene
HOTAIR;Lung Neoplasms;Disease;PA162391575;Gene
UGT1A1*1;Lung Neoplasms;Disease;PA166115841;Haplotype
UGT1A1*28;Lung Neoplasms;Disease;PA166115842;Haplotype
UGT1A1*6;Lung Neoplasms;Disease;PA166115858;Haplotype
UGT1A1*27;Lung Neoplasms;Disease;PA166115865;Haplotype
RS324420;Lung Neoplasms;Disease;PA166153569;Variant
RS3740556;Lung Neoplasms;Disease;PA166154030;Variant
RS619586;Lung Neoplasms;Disease;PA166154287;Variant
RS2839698;Lung Neoplasms;Disease;PA166154388;Variant
RS4149117;Lung Neoplasms;Disease;PA166154583;Variant
RS7958904;Lung Neoplasms;Disease;PA166154606;Variant
RS9535826;Lung Neoplasms;Disease;PA166154736;Variant
RS9535828;Lung Neoplasms;Disease;PA166154737;Variant
RS1130214;Lung Neoplasms;Disease;PA166154772;Variant
RS1799782;Lung Neoplasms;Disease;PA166155370;Variant
RS2231142;Lung Neoplasms;Disease;PA166156544;Variant
RS121434569;Lung Neoplasms;Disease;PA166157528;Variant
RS6983267;Lung Neoplasms;Disease;PA166157621;Variant
RS836554;Lung Neoplasms;Disease;PA166160419;Variant
MTHFR;Lung Neoplasms;Disease;PA245;Gene
AKR1C3;Lung Neoplasms;Disease;PA24679;Gene
AKT1;Lung Neoplasms;Disease;PA24684;Gene
ALOX15B;Lung Neoplasms;Disease;PA24725;Gene
EIF3A;Lung Neoplasms;Disease;PA27699;Gene
FAAH;Lung Neoplasms;Disease;PA27955;Gene
H19;Lung Neoplasms;Disease;PA29091;Gene
NQO1;Lung Neoplasms;Disease;PA31744;Gene
SLCO1B3;Lung Neoplasms;Disease;PA35844;Gene
XRCC1;Lung Neoplasms;Disease;PA369;Gene
ABCG2;Lung Neoplasms;Disease;PA390;Gene
UGT1A1;Lung Neoplasms;Disease;PA420;Gene
ATP7B;Lung Neoplasms;Disease;PA73;Gene
EGFR;Lung Neoplasms;Disease;PA7360;Gene
CHLOROCRESOL;rs186983396;Variant;PA166122627;Chemical
MALIGNANT HYPERTHERMIA;rs186983396;Variant;PA444863;Disease
CAFFEINE;rs186983396;Variant;PA448710;Chemical
DEXTROMETHORPHAN;CYP2D6*42;Haplotype;PA449273;Chemical
TUBERCULOSIS;NAT2*6O;Haplotype;PA445941;Disease
ISONIAZID;NAT2*6O;Haplotype;PA450112;Chemical
NICOTINE;rs140471703;Variant;PA450626;Chemical
EPILEPSY;UGT1A4*1b;Haplotype;PA444065;Disease
LAMOTRIGINE;UGT1A4*1b;Haplotype;PA450164;Chemical
PLATINUM COMPOUNDS;rs10510050;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs10510050;Variant;PA443622;Disease
RASAGILINE;rs1076560;Variant;PA164764584;Chemical
HEROIN DEPENDENCE;rs1076560;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs1076560;Variant;PA445043;Disease
PARKINSON DISEASE;rs1076560;Variant;PA445254;Disease
COCAINE DEPENDENCE;rs1076560;Variant;PA446878;Disease
SCHIZOPHRENIA;rs1076560;Variant;PA447216;Disease
COCAINE;rs1076560;Variant;PA449072;Chemical
OLANZAPINE;rs1076560;Variant;PA450688;Chemical
OPIOIDS;rs1076560;Variant;PA452618;Chemical
CYP3A4;Testicular Neoplasms;Disease;PA130;Gene
ERCC1;Testicular Neoplasms;Disease;PA155;Gene
GSTM1 NULL;Testicular Neoplasms;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Testicular Neoplasms;Disease;PA166048676;Haplotype
RS1695;Testicular Neoplasms;Disease;PA166154249;Variant
RS1050565;Testicular Neoplasms;Disease;PA166155175;Variant
RS11615;Testicular Neoplasms;Disease;PA166155342;Variant
RS13181;Testicular Neoplasms;Disease;PA166155343;Variant
RS238406;Testicular Neoplasms;Disease;PA166155349;Variant
RS1799793;Testicular Neoplasms;Disease;PA166155371;Variant
RS3212986;Testicular Neoplasms;Disease;PA166155407;Variant
RS2228001;Testicular Neoplasms;Disease;PA166156345;Variant
RS1045642;Testicular Neoplasms;Disease;PA166157284;Variant
RS2740574;Testicular Neoplasms;Disease;PA166157367;Variant
RS4788863;Testicular Neoplasms;Disease;PA166163715;Variant
GSTM1;Testicular Neoplasms;Disease;PA182;Gene
BLMH;Testicular Neoplasms;Disease;PA25370;Gene
ABCB1;Testicular Neoplasms;Disease;PA267;Gene
ERCC2;Testicular Neoplasms;Disease;PA27848;Gene
GSTP1;Testicular Neoplasms;Disease;PA29028;Gene
SLC16A5;Testicular Neoplasms;Disease;PA35817;Gene
XPC;Testicular Neoplasms;Disease;PA37413;Gene
ADEFOVIR DIPIVOXIL;SLC26A8;Gene;PA10005;Chemical
TENOFOVIR;SLC26A8;Gene;PA10204;Chemical
OXALIPLATIN;rs2233678;Variant;PA131285527;Chemical
COLORECTAL NEOPLASMS;rs2233678;Variant;PA446108;Disease
IRINOTECAN;rs2233678;Variant;PA450085;Chemical
DESFLURANE;rs193922770;Variant;PA164749136;Chemical
RYR1;rs193922770;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs193922770;Variant;PA444863;Disease
CAFFEINE;rs193922770;Variant;PA448710;Chemical
ENFLURANE;rs193922770;Variant;PA449461;Chemical
HALOTHANE;rs193922770;Variant;PA449845;Chemical
ISOFLURANE;rs193922770;Variant;PA450106;Chemical
METHOXYFLURANE;rs193922770;Variant;PA450434;Chemical
SEVOFLURANE;rs193922770;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs193922770;Variant;PA451522;Chemical
CACNA1S;rs193922770;Variant;PA85;Gene
ALZHEIMER DISEASE;ACHE;Gene;PA443319;Disease
RIVASTIGMINE;ACHE;Gene;PA451262;Chemical
HMG COA REDUCTASE INHIBITORS;rs11868035;Variant;PA133950441;Chemical
SCHIZOPHRENIA;rs11868035;Variant;PA447216;Disease
SULFONAMIDES, UREA DERIVATIVES;TCF7L2;Gene;PA10390;Chemical
DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS;TCF7L2;Gene;PA164712689;Chemical
KIDNEY TRANSPLANTATION;TCF7L2;Gene;PA165817016;Disease
DIABETES MELLITUS, TYPE 2;TCF7L2;Gene;PA443890;Disease
HYPERTENSION;TCF7L2;Gene;PA444552;Disease
LIVER TRANSPLANTATION;TCF7L2;Gene;PA447247;Disease
CYCLOSPORINE;TCF7L2;Gene;PA449167;Chemical
HYDROCHLOROTHIAZIDE;TCF7L2;Gene;PA449899;Chemical
REPAGLINIDE;TCF7L2;Gene;PA451234;Chemical
SIROLIMUS;TCF7L2;Gene;PA451365;Chemical
TACROLIMUS;TCF7L2;Gene;PA451578;Chemical
ROZANOLIXIZUMAB;MUSK;Gene;PA166313325;Chemical
ESOMEPRAZOLE;rs1059513;Variant;PA10075;Chemical
EOSINOPHILIC ESOPHAGITIS;rs1059513;Variant;PA166224501;Disease
OLANZAPINE;rs2734841;Variant;PA450688;Chemical
DAUNORUBICIN;rs1143663;Variant;PA449212;Chemical
DOXORUBICIN;rs1143663;Variant;PA449412;Chemical
FLUCLOXACILLIN;HLA-B*57:03;Haplotype;PA164781042;Chemical
DRUG-INDUCED LIVER INJURY;HLA-B*57:03;Haplotype;PA166119041;Disease
BIPOLAR DISORDER;rs6279;Variant;PA447199;Disease
DEPRESSION;rs6279;Variant;PA447278;Disease
OLANZAPINE;rs6279;Variant;PA450688;Chemical
HLA-B;Behcet Syndrome;Disease;PA35056;Gene
CFTR;rs74503330;Variant;PA109;Gene
IVACAFTOR;rs74503330;Variant;PA165950341;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs74503330;Variant;PA166190041;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs74503330;Variant;PA166362502;Chemical
CYSTIC FIBROSIS;rs74503330;Variant;PA443829;Disease
ABCC2;Drugs For Treatment Of Tuberculosis;Chemical;PA116;Gene
CYP2B6;Drugs For Treatment Of Tuberculosis;Chemical;PA123;Gene
CYP2E1;Drugs For Treatment Of Tuberculosis;Chemical;PA129;Gene
RIPOR2;Drugs For Treatment Of Tuberculosis;Chemical;PA162387677;Gene
CYP2E1*1A;Drugs For Treatment Of Tuberculosis;Chemical;PA165948032;Haplotype
CYP2E1*5B;Drugs For Treatment Of Tuberculosis;Chemical;PA165948040;Haplotype
NAT2*4;Drugs For Treatment Of Tuberculosis;Chemical;PA165949098;Haplotype
NAT2*5A;Drugs For Treatment Of Tuberculosis;Chemical;PA165949099;Haplotype
NAT2*12A;Drugs For Treatment Of Tuberculosis;Chemical;PA165949138;Haplotype
HLA-DQA1*01:02;Drugs For Treatment Of Tuberculosis;Chemical;PA165951275;Haplotype
HLA-C*04:01;Drugs For Treatment Of Tuberculosis;Chemical;PA165957046;Haplotype
HLA-DQB1*05:01;Drugs For Treatment Of Tuberculosis;Chemical;PA165958073;Haplotype
HLA-DQB1*05:02;Drugs For Treatment Of Tuberculosis;Chemical;PA165958077;Haplotype
HLA-DQB1*05:03;Drugs For Treatment Of Tuberculosis;Chemical;PA165958080;Haplotype
HLA-DQB1*02:01;Drugs For Treatment Of Tuberculosis;Chemical;PA165958158;Haplotype
NAT2*5;Drugs For Treatment Of Tuberculosis;Chemical;PA165981634;Haplotype
NAT2*6;Drugs For Treatment Of Tuberculosis;Chemical;PA165981635;Haplotype
NAT2*7;Drugs For Treatment Of Tuberculosis;Chemical;PA165981636;Haplotype
NAT2*14;Drugs For Treatment Of Tuberculosis;Chemical;PA165981640;Haplotype
GSTM1 NULL;Drugs For Treatment Of Tuberculosis;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;Drugs For Treatment Of Tuberculosis;Chemical;PA166048676;Haplotype
GSTT1 NULL;Drugs For Treatment Of Tuberculosis;Chemical;PA166048678;Haplotype
GSTT1 NON-NULL;Drugs For Treatment Of Tuberculosis;Chemical;PA166048679;Haplotype
RS2031920;Drugs For Treatment Of Tuberculosis;Chemical;PA166153990;Variant
RS3740065;Drugs For Treatment Of Tuberculosis;Chemical;PA166154027;Variant
RS3745274;Drugs For Treatment Of Tuberculosis;Chemical;PA166155409;Variant
RS1045642;Drugs For Treatment Of Tuberculosis;Chemical;PA166157284;Variant
RS1495741;Drugs For Treatment Of Tuberculosis;Chemical;PA166157560;Variant
RS1799929;Drugs For Treatment Of Tuberculosis;Chemical;PA166157563;Variant
NAT2 SLOW ACETYLATOR;Drugs For Treatment Of Tuberculosis;Chemical;PA166157948;Variant
RS10946737;Drugs For Treatment Of Tuberculosis;Chemical;PA166160680;Variant
RS4430924;Drugs For Treatment Of Tuberculosis;Chemical;PA166186121;Variant
NAT2;Drugs For Treatment Of Tuberculosis;Chemical;PA18;Gene
GSTM1;Drugs For Treatment Of Tuberculosis;Chemical;PA182;Gene
GSTT1;Drugs For Treatment Of Tuberculosis;Chemical;PA183;Gene
ABCB1;Drugs For Treatment Of Tuberculosis;Chemical;PA267;Gene
HLA-C;Drugs For Treatment Of Tuberculosis;Chemical;PA35057;Gene
HLA-DQA1;Drugs For Treatment Of Tuberculosis;Chemical;PA35066;Gene
HLA-DQB1;Drugs For Treatment Of Tuberculosis;Chemical;PA35068;Gene
XPO1;Drugs For Treatment Of Tuberculosis;Chemical;PA37418;Gene
GEMCITABINE;NT5C;Gene;PA449748;Chemical
LAMIVUDINE;NT5C;Gene;PA450163;Chemical
FLUOROURACIL;NT5C1A;Gene;PA128406956;Chemical
CLADRIBINE;NT5C1A;Gene;PA449027;Chemical
GEMCITABINE;NT5C1A;Gene;PA449748;Chemical
COMT;trihexyphenidyl;Chemical;PA117;Gene
RIFAMPIN;rs1803155;Variant;PA451250;Chemical
IMATINIB;RUNDC3B;Gene;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;RUNDC3B;Gene;PA151958383;Disease
DRUG TOXICITY;RUNDC3B;Gene;PA443937;Disease
IMATINIB;rs1061018;Variant;PA10804;Chemical
DASATINIB;rs1061018;Variant;PA162372878;Chemical
NILOTINIB;rs1061018;Variant;PA165958345;Chemical
TOBACCO USE DISORDER;rs1456862;Variant;PA445876;Disease
NICOTINE;rs1456862;Variant;PA450626;Chemical
TPMT;TPMT*15;Haplotype;PA356;Gene
AZATHIOPRINE;TPMT*15;Haplotype;PA448515;Chemical
MERCAPTOPURINE;TPMT*15;Haplotype;PA450379;Chemical
THIOGUANINE;TPMT*15;Haplotype;PA451663;Chemical
MAJOR DEPRESSIVE DISORDER;rs2299267;Variant;PA447321;Disease
ANTIDEPRESSANTS;rs2299267;Variant;PA452229;Chemical
BREAST NEOPLASMS;rs7349683;Variant;PA443560;Disease
OVARIAN NEOPLASMS;rs7349683;Variant;PA445204;Disease
PERIPHERAL NERVOUS SYSTEM DISEASES;rs7349683;Variant;PA445301;Disease
PACLITAXEL;rs7349683;Variant;PA450761;Chemical
RS6275;rizatriptan;Chemical;PA166154260;Variant
DRD2;rizatriptan;Chemical;PA27478;Gene
DESMETHYLNAPROXEN;rs544820732;Variant;PA166163690;Chemical
TAPENTADOL;rs544820732;Variant;PA166179720;Chemical
ACETAMINOPHEN;rs544820732;Variant;PA448015;Chemical
O-DESMETHYLTRAMADOL;rs1293732453;Variant;PA166131379;Chemical
TAPENTADOL;rs1293732453;Variant;PA166179720;Chemical
ACETAMINOPHEN;rs1293732453;Variant;PA448015;Chemical
MORPHINE;rs1293732453;Variant;PA450550;Chemical
TRAMADOL;rs1293732453;Variant;PA451735;Chemical
CYP3A4;clarithromycin;Chemical;PA130;Gene
CYP3A5;clarithromycin;Chemical;PA131;Gene
ABCB1;clarithromycin;Chemical;PA267;Gene
PIMOZIDE;clarithromycin;Chemical;PA450965;Chemical
BETA BLOCKING AGENTS;rs3740563;Variant;PA164712535;Chemical
CORONARY ARTERY DISEASE;rs3740563;Variant;PA443796;Disease
CYP3A4;prednisolone;Chemical;PA130;Gene
DSE;prednisolone;Chemical;PA162384080;Gene
RS1045642;prednisolone;Chemical;PA166157284;Variant
RS2229109;prednisolone;Chemical;PA166157334;Variant
RS738409;prednisolone;Chemical;PA166165078;Variant
RS3828743;prednisolone;Chemical;PA166179651;Variant
ABCB1;prednisolone;Chemical;PA267;Gene
TSPYL1;prednisolone;Chemical;PA37050;Gene
PNPLA3;prednisolone;Chemical;PA38592;Gene
SCHIZOPHRENIA;rs2980976;Variant;PA447216;Disease
RISPERIDONE;rs2980976;Variant;PA451257;Chemical
CYP2D6;pimozide;Chemical;PA128;Gene
CYP3A4;pimozide;Chemical;PA130;Gene
CYP2D6 POOR METABOLIZERS;pimozide;Chemical;PA166157895;Variant
CLARITHROMYCIN;pimozide;Chemical;PA449028;Chemical
SERTRALINE;pimozide;Chemical;PA451333;Chemical
IRINOTECAN;rs6072262;Variant;PA450085;Chemical
CATECHOLAMINES;rs1801253;Variant;PA133822447;Chemical
DIURETICS;rs1801253;Variant;PA151249535;Chemical
MURAGLITAZAR;rs1801253;Variant;PA162356187;Chemical
ACE INHIBITORS, PLAIN;rs1801253;Variant;PA164712308;Chemical
ANGIOTENSIN II ANTAGONISTS;rs1801253;Variant;PA164712372;Chemical
BETA BLOCKING AGENTS;rs1801253;Variant;PA164712535;Chemical
BUCINDOLOL;rs1801253;Variant;PA165945764;Chemical
ATRIAL FIBRILLATION;rs1801253;Variant;PA443459;Disease
CARDIOMYOPATHY, DILATED;rs1801253;Variant;PA443632;Disease
CORONARY ARTERY DISEASE;rs1801253;Variant;PA443796;Disease
DIABETES MELLITUS;rs1801253;Variant;PA443886;Disease
EDEMA;rs1801253;Variant;PA443994;Disease
HEART FAILURE;rs1801253;Variant;PA444370;Disease
HYPERLIPIDEMIAS;rs1801253;Variant;PA444528;Disease
TACHYCARDIA;rs1801253;Variant;PA445802;Disease
ESSENTIAL HYPERTENSION;rs1801253;Variant;PA447288;Disease
ATENOLOL;rs1801253;Variant;PA448499;Chemical
CARVEDILOL;rs1801253;Variant;PA448817;Chemical
DIGOXIN;rs1801253;Variant;PA449319;Chemical
DOBUTAMINE;rs1801253;Variant;PA449381;Chemical
ISOPROTERENOL;rs1801253;Variant;PA450121;Chemical
METOPROLOL;rs1801253;Variant;PA450480;Chemical
SPIRONOLACTONE;rs1801253;Variant;PA451483;Chemical
AKT1;PIK3CG;Gene;PA24684;Gene
ERBB2;PIK3CG;Gene;PA27844;Gene
ERBB3;PIK3CG;Gene;PA27846;Gene
ERBB4;PIK3CG;Gene;PA27847;Gene
FLT1;PIK3CG;Gene;PA28180;Gene
FLT4;PIK3CG;Gene;PA28183;Gene
KDR;PIK3CG;Gene;PA30086;Gene
EGFR;PIK3CG;Gene;PA7360;Gene
URINARY BLADDER NEOPLASMS;CCNE1;Gene;PA443512;Disease
CYP2C9;Psychotic Disorder;Disease;PA126;Gene
CYP2D6;Psychotic Disorder;Disease;PA128;Gene
RABEP1;Psychotic Disorder;Disease;PA134884097;Gene
DAOA;Psychotic Disorder;Disease;PA134924986;Gene
SH2B1;Psychotic Disorder;Disease;PA145148084;Gene
ESR1;Psychotic Disorder;Disease;PA156;Gene
CYP2C9*1;Psychotic Disorder;Disease;PA165816542;Haplotype
CYP2C9*2;Psychotic Disorder;Disease;PA165816543;Haplotype
CYP2C9*3;Psychotic Disorder;Disease;PA165816544;Haplotype
CYP2D6*1;Psychotic Disorder;Disease;PA165816576;Haplotype
CYP2D6*3;Psychotic Disorder;Disease;PA165816578;Haplotype
CYP2D6*4;Psychotic Disorder;Disease;PA165816579;Haplotype
CYP2D6*6;Psychotic Disorder;Disease;PA165816581;Haplotype
CYP2D6*10;Psychotic Disorder;Disease;PA165816582;Haplotype
CYP2D6*41;Psychotic Disorder;Disease;PA165816584;Haplotype
CYP2D6*5;Psychotic Disorder;Disease;PA165948092;Haplotype
CYP2D6*1XN;Psychotic Disorder;Disease;PA165988479;Haplotype
RS324420;Psychotic Disorder;Disease;PA166153569;Variant
RS1801133;Psychotic Disorder;Disease;PA166153644;Variant
RS1799732;Psychotic Disorder;Disease;PA166154334;Variant
RS2514218;Psychotic Disorder;Disease;PA166154375;Variant
RS778293;Psychotic Disorder;Disease;PA166154684;Variant
RS2472297;Psychotic Disorder;Disease;PA166154895;Variant
RS2076369;Psychotic Disorder;Disease;PA166156086;Variant
RS7643645;Psychotic Disorder;Disease;PA166156423;Variant
RS1049353;Psychotic Disorder;Disease;PA166156973;Variant
RS2234693;Psychotic Disorder;Disease;PA166157026;Variant
RS2619538;Psychotic Disorder;Disease;PA166157043;Variant
RS3213207;Psychotic Disorder;Disease;PA166157074;Variant
RS1045642;Psychotic Disorder;Disease;PA166157284;Variant
RS4410790;Psychotic Disorder;Disease;PA166157390;Variant
RS17143212;Psychotic Disorder;Disease;PA166157469;Variant
RS1126442;Psychotic Disorder;Disease;PA166157720;Variant
RS16935279;Psychotic Disorder;Disease;PA166159072;Variant
RS1334802;Psychotic Disorder;Disease;PA166161286;Variant
RS363341;Psychotic Disorder;Disease;PA166161288;Variant
RS1124491;Psychotic Disorder;Disease;PA166161290;Variant
RS9567733;Psychotic Disorder;Disease;PA166161292;Variant
RS3888190;Psychotic Disorder;Disease;PA166165398;Variant
RS1000940;Psychotic Disorder;Disease;PA166165401;Variant
CYP2D6*14;Psychotic Disorder;Disease;PA166181185;Haplotype
HTR2A;Psychotic Disorder;Disease;PA193;Gene
ABCB5;Psychotic Disorder;Disease;PA24387;Gene
MTHFR;Psychotic Disorder;Disease;PA245;Gene
AHR;Psychotic Disorder;Disease;PA24641;Gene
CNR1;Psychotic Disorder;Disease;PA26681;Gene
ABCB1;Psychotic Disorder;Disease;PA267;Gene
CYP1A1;Psychotic Disorder;Disease;PA27092;Gene
DRD2;Psychotic Disorder;Disease;PA27478;Gene
DTNBP1;Psychotic Disorder;Disease;PA27512;Gene
FAAH;Psychotic Disorder;Disease;PA27955;Gene
GRIK3;Psychotic Disorder;Disease;PA28975;Gene
GRIN1;Psychotic Disorder;Disease;PA28978;Gene
SLC18A2;Psychotic Disorder;Disease;PA325;Gene
PICK1;Psychotic Disorder;Disease;PA33760;Gene
NR1I2;Psychotic Disorder;Disease;PA378;Gene
HLA-B*15:02;Neuropathic pain;Disease;PA165954769;Haplotype
HLA-B*15:21;Neuropathic pain;Disease;PA165954809;Haplotype
RS4240803;Neuropathic pain;Disease;PA166155063;Variant
RS1799971;Neuropathic pain;Disease;PA166156991;Variant
RS6318;Neuropathic pain;Disease;PA166157849;Variant
HTR2C;Neuropathic pain;Disease;PA194;Gene
OPRM1;Neuropathic pain;Disease;PA31945;Gene
HLA-B;Neuropathic pain;Disease;PA35056;Gene
SLC7A5;Neuropathic pain;Disease;PA35923;Gene
VITAMIN K;AIFM2;Gene;PA164713404;Chemical
SCHIZOPHRENIA;ITIH3;Gene;PA447216;Disease
CLOZAPINE;ITIH3;Gene;PA449061;Chemical
CYP2B6;Cystitis;Disease;PA123;Gene
RS8192709;Cystitis;Disease;PA166155442;Variant
FLUOROURACIL;rs59086055;Variant;PA128406956;Chemical
DPYD;rs59086055;Variant;PA145;Gene
NEOPLASMS;rs59086055;Variant;PA445062;Disease
CAPECITABINE;rs59086055;Variant;PA448771;Chemical
BIPOLAR DISORDER;rs2284018;Variant;PA447199;Disease
LITHIUM;rs2284018;Variant;PA450243;Chemical
CFTR;rs397508556;Variant;PA109;Gene
IVACAFTOR;rs397508556;Variant;PA165950341;Chemical
NPY1R;PYY;Gene;PA258;Gene
NPY2R;PYY;Gene;PA31741;Gene
BIPOLAR DISORDER;rs8192440;Variant;PA447199;Disease
LITHIUM;rs8192440;Variant;PA450243;Chemical
CYP3A4;cabazitaxel;Chemical;PA130;Gene
RS2298805;mizolastine;Chemical;PA166153699;Variant
FCER1A;mizolastine;Chemical;PA28056;Gene
IMATINIB;SLC22A1;Gene;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;SLC22A1;Gene;PA151958383;Disease
TROPISETRON;SLC22A1;Gene;PA161925594;Chemical
ANTICHOLINERGICS;SLC22A1;Gene;PA164712420;Chemical
ANTIEMETICS AND ANTINAUSEANTS;SLC22A1;Gene;PA164712431;Chemical
DOPAMINE AGONISTS;SLC22A1;Gene;PA164712697;Chemical
GASTROINTESTINAL TOXICITY;SLC22A1;Gene;PA166124386;Disease
SEDATION;SLC22A1;Gene;PA166129521;Disease
O-DESMETHYLTRAMADOL;SLC22A1;Gene;PA166131379;Chemical
DIABETES MELLITUS;SLC22A1;Gene;PA443886;Disease
DIABETES MELLITUS, TYPE 2;SLC22A1;Gene;PA443890;Disease
DIZZINESS;SLC22A1;Gene;PA443928;Disease
DRUG TOXICITY;SLC22A1;Gene;PA443937;Disease
EPILEPSY;SLC22A1;Gene;PA444065;Disease
HEADACHE;SLC22A1;Gene;PA444354;Disease
INFECTION;SLC22A1;Gene;PA444614;Disease
NAUSEA;SLC22A1;Gene;PA445048;Disease
NEOPLASMS;SLC22A1;Gene;PA445062;Disease
PAIN;SLC22A1;Gene;PA445208;Disease
PARKINSON DISEASE;SLC22A1;Gene;PA445254;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;SLC22A1;Gene;PA446155;Disease
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;SLC22A1;Gene;PA446171;Disease
AMANTADINE;SLC22A1;Gene;PA448360;Chemical
CODEINE;SLC22A1;Gene;PA449088;Chemical
LAMIVUDINE;SLC22A1;Gene;PA450163;Chemical
LAMOTRIGINE;SLC22A1;Gene;PA450164;Chemical
LEVODOPA;SLC22A1;Gene;PA450213;Chemical
MERCAPTOPURINE;SLC22A1;Gene;PA450379;Chemical
METFORMIN;SLC22A1;Gene;PA450395;Chemical
MORPHINE;SLC22A1;Gene;PA450550;Chemical
OLANZAPINE;SLC22A1;Gene;PA450688;Chemical
PROGUANIL;SLC22A1;Gene;PA451124;Chemical
RANITIDINE;SLC22A1;Gene;PA451224;Chemical
SELEGILINE;SLC22A1;Gene;PA451316;Chemical
TRAMADOL;SLC22A1;Gene;PA451735;Chemical
SORAFENIB;SLC22A1;Gene;PA7000;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;rs3099844;Variant;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;rs3099844;Variant;PA166120929;Disease
ACQUIRED IMMUNODEFICIENCY SYNDROME;rs3099844;Variant;PA443250;Disease
STEVENS-JOHNSON SYNDROME;rs3099844;Variant;PA445738;Disease
ALLOPURINOL;rs3099844;Variant;PA448320;Chemical
NEVIRAPINE;rs3099844;Variant;PA450616;Chemical
TALAZOPARIB;PALB2;Gene;PA166182740;Chemical
PROSTATIC NEOPLASMS;PALB2;Gene;PA445425;Disease
CYP3A4;Febrile neutropenia;Disease;PA130;Gene
ERCC1;Febrile neutropenia;Disease;PA155;Gene
CYP3A4*22;Febrile neutropenia;Disease;PA166048680;Haplotype
UGT1A1*1;Febrile neutropenia;Disease;PA166115841;Haplotype
UGT1A1*28;Febrile neutropenia;Disease;PA166115842;Haplotype
UGT1A1*6;Febrile neutropenia;Disease;PA166115858;Haplotype
RS11615;Febrile neutropenia;Disease;PA166155342;Variant
UGT1A1;Febrile neutropenia;Disease;PA420;Gene
ANTITHYROID PREPARATIONS;HLA-B*39:01;Haplotype;PA164712499;Chemical
DRUG-INDUCED LIVER INJURY;HLA-B*39:01;Haplotype;PA166119041;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*39:01;Haplotype;PA166120927;Disease
AGRANULOCYTOSIS;HLA-B*39:01;Haplotype;PA443297;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*39:01;Haplotype;PA444059;Disease
GRAVES DISEASE;HLA-B*39:01;Haplotype;PA444329;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*39:01;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-B*39:01;Haplotype;PA450616;Chemical
SULFASALAZINE;HLA-B*39:01;Haplotype;PA451547;Chemical
INFLIXIMAB;HLA-B*39:01;Haplotype;PA452639;Chemical
ASTHMA;CLOCK;Gene;PA443450;Disease
BIPOLAR DISORDER;CLOCK;Gene;PA447199;Disease
SALBUTAMOL;CLOCK;Gene;PA448068;Chemical
LITHIUM;CLOCK;Gene;PA450243;Chemical
WARFARIN;PRSS53;Gene;PA451906;Chemical
SUBSTANCE-RELATED DISORDERS;rs75168521;Variant;PA446876;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs10841753;Variant;PA446155;Disease
METHOTREXATE;rs10841753;Variant;PA450428;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;rs301434;Variant;PA164713257;Chemical
OBSESSIVE-COMPULSIVE DISORDER;rs301434;Variant;PA447211;Disease
G6PD A- 202A_376G;sitamaquine;Chemical;PA165947827;Haplotype
G6PD;sitamaquine;Chemical;PA28469;Gene
OPIOID-RELATED DISORDERS;ZNF804A;Gene;PA445043;Disease
BIPOLAR DISORDER;ZNF804A;Gene;PA447199;Disease
SCHIZOPHRENIA;ZNF804A;Gene;PA447216;Disease
LITHIUM;ZNF804A;Gene;PA450243;Chemical
ANTIPSYCHOTICS;ZNF804A;Gene;PA452233;Chemical
OPIOIDS;ZNF804A;Gene;PA452618;Chemical
FLUOROURACIL;rs56005131;Variant;PA128406956;Chemical
DPYD;rs56005131;Variant;PA145;Gene
CAPECITABINE;rs56005131;Variant;PA448771;Chemical
ACUTE CORONARY SYNDROME;rs17064642;Variant;PA165108401;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);rs17064642;Variant;PA166129560;Disease
ASPIRIN;rs17064642;Variant;PA448497;Chemical
CLOPIDOGREL;rs17064642;Variant;PA449053;Chemical
ASPIRIN-INDUCED ASTHMA;rs1047626;Variant;PA131285571;Disease
ASPIRIN;rs1047626;Variant;PA448497;Chemical
ALLOPURINOL;rs10193126;Variant;PA448320;Chemical
HYPERTENSION;rs932764;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs932764;Variant;PA449899;Chemical
HYPERTENSION;C5orf56;Gene;PA444552;Disease
HYDROCHLOROTHIAZIDE;C5orf56;Gene;PA449899;Chemical
FEBUXOSTAT;rs34650714;Variant;PA165958521;Chemical
GOUT;rs34650714;Variant;PA444318;Disease
ALLOPURINOL;rs34650714;Variant;PA448320;Chemical
EMAPALUMAB;RAB27A;Gene;PA166182763;Chemical
PPP3CA;RELB;Gene;PA33678;Gene
PPP3CB;RELB;Gene;PA33679;Gene
PPP3CC;RELB;Gene;PA33680;Gene
PPP3R1;RELB;Gene;PA33681;Gene
PPP3R2;RELB;Gene;PA33682;Gene
ADALIMUMAB;KLRD1;Gene;PA10004;Chemical
CERTOLIZUMAB PEGOL;KLRD1;Gene;PA165107055;Chemical
RHEUMATOID ARTHRITIS;KLRD1;Gene;PA443434;Disease
ETANERCEPT;KLRD1;Gene;PA449515;Chemical
METHOTREXATE;KLRD1;Gene;PA450428;Chemical
GLUCOCORTICOIDS;KLRD1;Gene;PA452347;Chemical
INFLIXIMAB;KLRD1;Gene;PA452639;Chemical
CYP3A4;4-beta-hydroxycholesterol;Chemical;PA130;Gene
PLATINUM;rs836554;Variant;PA150595617;Chemical
DRUG TOXICITY;rs836554;Variant;PA443937;Disease
LUNG NEOPLASMS;rs836554;Variant;PA444818;Disease
PRIMAQUINE;CYP2D6*34;Haplotype;PA451103;Chemical
ADALIMUMAB;rs1801274;Variant;PA10004;Chemical
CETUXIMAB;rs1801274;Variant;PA10040;Chemical
RHEUMATOID ARTHRITIS;rs1801274;Variant;PA443434;Disease
BREAST NEOPLASMS;rs1801274;Variant;PA443560;Disease
HEAD AND NECK NEOPLASMS;rs1801274;Variant;PA444352;Disease
PSORIASIS;rs1801274;Variant;PA445451;Disease
COLORECTAL NEOPLASMS;rs1801274;Variant;PA446108;Disease
ETANERCEPT;rs1801274;Variant;PA449515;Chemical
RITUXIMAB;rs1801274;Variant;PA451261;Chemical
TRASTUZUMAB;rs1801274;Variant;PA451743;Chemical
INFLIXIMAB;rs1801274;Variant;PA452639;Chemical
OPIOID-RELATED DISORDERS;rs2654754;Variant;PA445043;Disease
OPIOIDS;rs2654754;Variant;PA452618;Chemical
IMATINIB;rs1051266;Variant;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;rs1051266;Variant;PA151958383;Disease
PLATINUM COMPOUNDS;rs1051266;Variant;PA164713176;Chemical
RHEUMATOID ARTHRITIS;rs1051266;Variant;PA443434;Disease
BURKITT LYMPHOMA;rs1051266;Variant;PA443580;Disease
NON-SMALL CELL LUNG CARCINOMA;rs1051266;Variant;PA443622;Disease
DRUG TOXICITY;rs1051266;Variant;PA443937;Disease
LEUKEMIA;rs1051266;Variant;PA444750;Disease
NEOPLASMS;rs1051266;Variant;PA445062;Disease
OSTEOSARCOMA;rs1051266;Variant;PA445601;Disease
COLORECTAL NEOPLASMS;rs1051266;Variant;PA446108;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs1051266;Variant;PA446155;Disease
LYMPHOMA, T-CELL;rs1051266;Variant;PA446309;Disease
IRINOTECAN;rs1051266;Variant;PA450085;Chemical
METHOTREXATE;rs1051266;Variant;PA450428;Chemical
FLUOROURACIL;rs1800566;Variant;PA128406956;Chemical
OXALIPLATIN;rs1800566;Variant;PA131285527;Chemical
PLATINUM COMPOUNDS;rs1800566;Variant;PA164713176;Chemical
BREAST NEOPLASMS;rs1800566;Variant;PA443560;Disease
HEMORRHAGE;rs1800566;Variant;PA444417;Disease
METASTATIC NEOPLASM;rs1800566;Variant;PA445058;Disease
NEOPLASMS;rs1800566;Variant;PA445062;Disease
STOMACH NEOPLASMS;rs1800566;Variant;PA445742;Disease
THROMBOTIC DISEASE;rs1800566;Variant;PA445850;Disease
CYCLOPHOSPHAMIDE;rs1800566;Variant;PA449165;Chemical
EPIRUBICIN;rs1800566;Variant;PA449476;Chemical
WARFARIN;rs1800566;Variant;PA451906;Chemical
BENZENE;rs1800566;Variant;PA451991;Chemical
ASTHMA;rs4271002;Variant;PA443450;Disease
ASPIRIN;rs4271002;Variant;PA448497;Chemical
ABCB1;Actinomycines;Chemical;PA267;Gene
ABCC2;Epilepsy;Disease;PA116;Gene
CYP2A6;Epilepsy;Disease;PA121;Gene
CYP2C19;Epilepsy;Disease;PA124;Gene
CYP2C9;Epilepsy;Disease;PA126;Gene
CYP2D6;Epilepsy;Disease;PA128;Gene
CYP3A4;Epilepsy;Disease;PA130;Gene
CYP3A5;Epilepsy;Disease;PA131;Gene
ANKK1;Epilepsy;Disease;PA134872551;Gene
CYP2C9*1;Epilepsy;Disease;PA165816542;Haplotype
CYP2C9*2;Epilepsy;Disease;PA165816543;Haplotype
CYP2C9*3;Epilepsy;Disease;PA165816544;Haplotype
CYP2C9*5;Epilepsy;Disease;PA165816546;Haplotype
CYP2C9*6;Epilepsy;Disease;PA165816547;Haplotype
CYP2C9*8;Epilepsy;Disease;PA165816549;Haplotype
CYP2C9*11;Epilepsy;Disease;PA165816552;Haplotype
CYP2C9*13;Epilepsy;Disease;PA165816554;Haplotype
CYP2C9*14;Epilepsy;Disease;PA165816555;Haplotype
CYP2C9*16;Epilepsy;Disease;PA165816557;Haplotype
CYP2C9*31;Epilepsy;Disease;PA165816560;Haplotype
CYP2C9*33;Epilepsy;Disease;PA165816561;Haplotype
CYP2C9*29;Epilepsy;Disease;PA165816573;Haplotype
CYP2D6*1;Epilepsy;Disease;PA165816576;Haplotype
CYP2D6*41;Epilepsy;Disease;PA165816584;Haplotype
CYP2A6*1;Epilepsy;Disease;PA165924690;Haplotype
CYP2A6*4;Epilepsy;Disease;PA165924721;Haplotype
HLA-DRB1*04:03;Epilepsy;Disease;PA165951504;Haplotype
HLA-DRB1*07:01;Epilepsy;Disease;PA165951644;Haplotype
HLA-DRB1*16:02;Epilepsy;Disease;PA165952368;Haplotype
HLA-A*02:07;Epilepsy;Disease;PA165952839;Haplotype
HLA-A*11:01;Epilepsy;Disease;PA165953358;Haplotype
HLA-A*24:07;Epilepsy;Disease;PA165953622;Haplotype
HLA-A*31:01;Epilepsy;Disease;PA165954030;Haplotype
HLA-B*13:01;Epilepsy;Disease;PA165954643;Haplotype
HLA-B*13:02;Epilepsy;Disease;PA165954649;Haplotype
HLA-B*15:01;Epilepsy;Disease;PA165954745;Haplotype
HLA-B*15:02;Epilepsy;Disease;PA165954769;Haplotype
HLA-B*15:18;Epilepsy;Disease;PA165954803;Haplotype
HLA-B*15:19;Epilepsy;Disease;PA165954807;Haplotype
HLA-B*15:21;Epilepsy;Disease;PA165954809;Haplotype
HLA-B*15:27;Epilepsy;Disease;PA165954816;Haplotype
HLA-B*27:09;Epilepsy;Disease;PA165955138;Haplotype
HLA-B*37:01;Epilepsy;Disease;PA165955461;Haplotype
HLA-B*40:01;Epilepsy;Disease;PA165955628;Haplotype
HLA-B*40:02;Epilepsy;Disease;PA165955651;Haplotype
HLA-B*44:03;Epilepsy;Disease;PA165955913;Haplotype
HLA-B*46:01;Epilepsy;Disease;PA165956083;Haplotype
HLA-B*48:04;Epilepsy;Disease;PA165956139;Haplotype
HLA-B*51:01;Epilepsy;Disease;PA165956201;Haplotype
HLA-B*51:02;Epilepsy;Disease;PA165956231;Haplotype
HLA-B*54:01;Epilepsy;Disease;PA165956438;Haplotype
HLA-B*59:01;Epilepsy;Disease;PA165956674;Haplotype
HLA-C*03:04;Epilepsy;Disease;PA165956881;Haplotype
HLA-C*07:04;Epilepsy;Disease;PA165957428;Haplotype
HLA-DQB1*03:03;Epilepsy;Disease;PA165958180;Haplotype
CYP2C19*1;Epilepsy;Disease;PA165980634;Haplotype
CYP2C19*2;Epilepsy;Disease;PA165980635;Haplotype
CYP2C19*3;Epilepsy;Disease;PA165980636;Haplotype
HLA-B*58:01;Epilepsy;Disease;PA165987831;Haplotype
CYP2C9*37;Epilepsy;Disease;PA166048683;Haplotype
CYP2C9*39;Epilepsy;Disease;PA166048685;Haplotype
CYP2C9*42;Epilepsy;Disease;PA166048688;Haplotype
CYP2C9*43;Epilepsy;Disease;PA166048689;Haplotype
CYP2C9*45;Epilepsy;Disease;PA166048691;Haplotype
CYP2C9*50;Epilepsy;Disease;PA166048696;Haplotype
CYP2C9*52;Epilepsy;Disease;PA166048698;Haplotype
CYP2C9*55;Epilepsy;Disease;PA166048701;Haplotype
UGT1A4*1A;Epilepsy;Disease;PA166117588;Haplotype
UGT1A4*1B;Epilepsy;Disease;PA166117589;Haplotype
UGT1A4*2;Epilepsy;Disease;PA166117597;Haplotype
UGT1A6*1A;Epilepsy;Disease;PA166117614;Haplotype
UGT1A6*2A;Epilepsy;Disease;PA166117621;Haplotype
UGT1A6*3A;Epilepsy;Disease;PA166117625;Haplotype
UGT1A6*4A;Epilepsy;Disease;PA166117627;Haplotype
UGT1A6*8;Epilepsy;Disease;PA166117633;Haplotype
HLA-C*03:02;Epilepsy;Disease;PA166123425;Haplotype
HLA-C*08:01;Epilepsy;Disease;PA166123426;Haplotype
HLA-A*02:01;Epilepsy;Disease;PA166123427;Haplotype
HLA-A*33:03;Epilepsy;Disease;PA166123428;Haplotype
CYP3A5*1;Epilepsy;Disease;PA166128213;Haplotype
CYP3A5*3;Epilepsy;Disease;PA166128219;Haplotype
RS1051740;Epilepsy;Disease;PA166153612;Variant
RS1137101;Epilepsy;Disease;PA166153626;Variant
RS1801133;Epilepsy;Disease;PA166153644;Variant
RS2234922;Epilepsy;Disease;PA166153680;Variant
RS717620;Epilepsy;Disease;PA166153953;Variant
RS1934969;Epilepsy;Disease;PA166153986;Variant
RS2273697;Epilepsy;Disease;PA166154007;Variant
RS3740066;Epilepsy;Disease;PA166154028;Variant
RS4148386;Epilepsy;Disease;PA166154047;Variant
RS12782374;Epilepsy;Disease;PA166154159;Variant
RS71486745;Epilepsy;Disease;PA166154191;Variant
RS1800497;Epilepsy;Disease;PA166154339;Variant
RS1019385;Epilepsy;Disease;PA166154508;Variant
RS2606345;Epilepsy;Disease;PA166154899;Variant
RS1800012;Epilepsy;Disease;PA166155190;Variant
RS1047891;Epilepsy;Disease;PA166155617;Variant
RS1105879;Epilepsy;Disease;PA166155623;Variant
RS2011425;Epilepsy;Disease;PA166155662;Variant
RS2070959;Epilepsy;Disease;PA166155665;Variant
RS2298771;Epilepsy;Disease;PA166155680;Variant
RS2304016;Epilepsy;Disease;PA166155682;Variant
RS2741049;Epilepsy;Disease;PA166155690;Variant
RS3812718;Epilepsy;Disease;PA166155715;Variant
RS6759892;Epilepsy;Disease;PA166155760;Variant
RS17183814;Epilepsy;Disease;PA166155842;Variant
RS28898617;Epilepsy;Disease;PA166155860;Variant
RS2071197;Epilepsy;Disease;PA166155919;Variant
RS2461817;Epilepsy;Disease;PA166156357;Variant
RS3814055;Epilepsy;Disease;PA166156383;Variant
RS4688040;Epilepsy;Disease;PA166156402;Variant
RS7643645;Epilepsy;Disease;PA166156423;Variant
RS2231142;Epilepsy;Disease;PA166156544;Variant
RS3114020;Epilepsy;Disease;PA166156572;Variant
RS7439366;Epilepsy;Disease;PA166156619;Variant
RS7668258;Epilepsy;Disease;PA166156625;Variant
RS12233719;Epilepsy;Disease;PA166156658;Variant
RS28365063;Epilepsy;Disease;PA166156677;Variant
RS2279020;Epilepsy;Disease;PA166156794;Variant
RS2290732;Epilepsy;Disease;PA166156796;Variant
RS4880;Epilepsy;Disease;PA166156900;Variant
RS628031;Epilepsy;Disease;PA166156933;Variant
RS2227956;Epilepsy;Disease;PA166157023;Variant
RS15524;Epilepsy;Disease;PA166157243;Variant
RS776746;Epilepsy;Disease;PA166157267;Variant
RS1045642;Epilepsy;Disease;PA166157284;Variant
RS1128503;Epilepsy;Disease;PA166157288;Variant
RS2032582;Epilepsy;Disease;PA166157316;Variant
RS2242480;Epilepsy;Disease;PA166157345;Variant
RS2740574;Epilepsy;Disease;PA166157367;Variant
RS3789243;Epilepsy;Disease;PA166157380;Variant
RS4148739;Epilepsy;Disease;PA166157386;Variant
RS4148740;Epilepsy;Disease;PA166157387;Variant
LEPR;Epilepsy;Disease;PA229;Gene
MTHFR;Epilepsy;Disease;PA245;Gene
ABCB1;Epilepsy;Disease;PA267;Gene
CPS1;Epilepsy;Disease;PA26840;Gene
CYP1A1;Epilepsy;Disease;PA27092;Gene
EPHX1;Epilepsy;Disease;PA27829;Gene
GABRA1;Epilepsy;Disease;PA28489;Gene
GRIN2B;Epilepsy;Disease;PA28980;Gene
HNF4A;Epilepsy;Disease;PA29349;Gene
HSPA1L;Epilepsy;Disease;PA29500;Gene
SCN1A;Epilepsy;Disease;PA301;Gene
SLC22A1;Epilepsy;Disease;PA329;Gene
SCN2A;Epilepsy;Disease;PA35004;Gene
COL1A1;Epilepsy;Disease;PA35041;Gene
HLA-A;Epilepsy;Disease;PA35055;Gene
HLA-B;Epilepsy;Disease;PA35056;Gene
HLA-C;Epilepsy;Disease;PA35057;Gene
HLA-DQB1;Epilepsy;Disease;PA35068;Gene
HLA-DRB1;Epilepsy;Disease;PA35072;Gene
SOD2;Epilepsy;Disease;PA36017;Gene
UGT2B7;Epilepsy;Disease;PA361;Gene
UGT1A10;Epilepsy;Disease;PA37174;Gene
UGT1A3;Epilepsy;Disease;PA37178;Gene
UGT1A4;Epilepsy;Disease;PA37179;Gene
UGT1A5;Epilepsy;Disease;PA37180;Gene
UGT1A6;Epilepsy;Disease;PA37181;Gene
UGT1A7;Epilepsy;Disease;PA37182;Gene
UGT1A8;Epilepsy;Disease;PA37183;Gene
NR1I2;Epilepsy;Disease;PA378;Gene
ABCG2;Epilepsy;Disease;PA390;Gene
UGT1A9;Epilepsy;Disease;PA419;Gene
CAMK1D;STAT5B;Gene;PA134992438;Gene
AKT1;STAT5B;Gene;PA24684;Gene
AKT2;STAT5B;Gene;PA24685;Gene
AKT3;STAT5B;Gene;PA24686;Gene
NFKB1;STAT5B;Gene;PA248;Gene
CAMK1;STAT5B;Gene;PA26048;Gene
CAMK1G;STAT5B;Gene;PA26049;Gene
ELK1;STAT5B;Gene;PA27749;Gene
FOS;STAT5B;Gene;PA28212;Gene
MAPK8;STAT5B;Gene;PA283;Gene
RELA;STAT5B;Gene;PA296;Gene
JAK1;STAT5B;Gene;PA29988;Gene
JUN;STAT5B;Gene;PA30006;Gene
MAPK1;STAT5B;Gene;PA30616;Gene
MAPK3;STAT5B;Gene;PA30622;Gene
MYC;STAT5B;Gene;PA31353;Gene
NFKB2;STAT5B;Gene;PA31600;Gene
STAT3;STAT5B;Gene;PA337;Gene
PRKCA;STAT5B;Gene;PA33759;Gene
PRKCB;STAT5B;Gene;PA33761;Gene
PRKCG;STAT5B;Gene;PA33766;Gene
STAT5A;STAT5B;Gene;PA338;Gene
SP1;STAT5B;Gene;PA36042;Gene
STAT1;STAT5B;Gene;PA36183;Gene
STAT2;STAT5B;Gene;PA36184;Gene
STAT4;STAT5B;Gene;PA36185;Gene
CAMK2A;STAT5B;Gene;PA90;Gene
CAMK2B;STAT5B;Gene;PA91;Gene
CAMK2D;STAT5B;Gene;PA92;Gene
CAMK2G;STAT5B;Gene;PA93;Gene
C18ORF56;asparaginase;Chemical;PA134956204;Gene
ATL2;asparaginase;Chemical;PA164716322;Gene
HLA-DRB1*07:01;asparaginase;Chemical;PA165951644;Haplotype
RS3824662;asparaginase;Chemical;PA166154043;Variant
RS7142143;asparaginase;Chemical;PA166154808;Variant
RS45445694;asparaginase;Chemical;PA166155331;Variant
RS6021191;asparaginase;Chemical;PA166155950;Variant
RS4958381;asparaginase;Chemical;PA166156837;Variant
RS4880;asparaginase;Chemical;PA166156900;Variant
RS17885382;asparaginase;Chemical;PA166157195;Variant
RS199695765;asparaginase;Chemical;PA166157535;Variant
RS738409;asparaginase;Chemical;PA166165078;Variant
RS59569490;asparaginase;Chemical;PA166394241;Variant
ASNS;asparaginase;Chemical;PA25052;Gene
CPA2;asparaginase;Chemical;PA26817;Gene
GATA3;asparaginase;Chemical;PA28586;Gene
GRIA1;asparaginase;Chemical;PA28966;Gene
MYBBP1A;asparaginase;Chemical;PA31346;Gene
NFATC2;asparaginase;Chemical;PA31583;Gene
PYGL;asparaginase;Chemical;PA34068;Gene
HLA-DRB1;asparaginase;Chemical;PA35072;Gene
TYMS;asparaginase;Chemical;PA359;Gene
SOD2;asparaginase;Chemical;PA36017;Gene
PNPLA3;asparaginase;Chemical;PA38592;Gene
BIPOLAR DISORDER;rs75222709;Variant;PA447199;Disease
LITHIUM;rs75222709;Variant;PA450243;Chemical
ATOMOXETINE;CYP2D6*17;Haplotype;PA134688071;Chemical
BUFURALOL;CYP2D6*17;Haplotype;PA166110256;Chemical
ENDOXIFEN;CYP2D6*17;Haplotype;PA166124478;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*17;Haplotype;PA166127651;Chemical
SEDATION;CYP2D6*17;Haplotype;PA166129521;Disease
O-DESMETHYLTRAMADOL;CYP2D6*17;Haplotype;PA166131379;Chemical
BREXPIPRAZOLE;CYP2D6*17;Haplotype;PA166160053;Chemical
ANEMIA, SICKLE CELL;CYP2D6*17;Haplotype;PA443355;Disease
BREAST NEOPLASMS;CYP2D6*17;Haplotype;PA443560;Disease
HYPERTENSION;CYP2D6*17;Haplotype;PA444552;Disease
PAIN;CYP2D6*17;Haplotype;PA445208;Disease
PAIN, POSTOPERATIVE;CYP2D6*17;Haplotype;PA445210;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CYP2D6*17;Haplotype;PA447197;Disease
MENTAL DISORDERS;CYP2D6*17;Haplotype;PA447208;Disease
SCHIZOPHRENIA;CYP2D6*17;Haplotype;PA447216;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2D6*17;Haplotype;PA447321;Disease
CITALOPRAM;CYP2D6*17;Haplotype;PA449015;Chemical
CODEINE;CYP2D6*17;Haplotype;PA449088;Chemical
DEXTROMETHORPHAN;CYP2D6*17;Haplotype;PA449273;Chemical
FLUOXETINE;CYP2D6*17;Haplotype;PA449673;Chemical
HALOPERIDOL;CYP2D6*17;Haplotype;PA449841;Chemical
HYDROCODONE;CYP2D6*17;Haplotype;PA449900;Chemical
HYDROMORPHONE;CYP2D6*17;Haplotype;PA449918;Chemical
KETOPROFEN;CYP2D6*17;Haplotype;PA450149;Chemical
METOPROLOL;CYP2D6*17;Haplotype;PA450480;Chemical
NORTRIPTYLINE;CYP2D6*17;Haplotype;PA450657;Chemical
PRIMAQUINE;CYP2D6*17;Haplotype;PA451103;Chemical
TAMOXIFEN;CYP2D6*17;Haplotype;PA451581;Chemical
TRAMADOL;CYP2D6*17;Haplotype;PA451735;Chemical
VENLAFAXINE;CYP2D6*17;Haplotype;PA451866;Chemical
DEBRISOQUINE;CYP2D6*17;Haplotype;PA452616;Chemical
RS1801131;cyanocobalamin;Chemical;PA166153643;Variant
MTHFR;cyanocobalamin;Chemical;PA245;Gene
ABCB1;cyanocobalamin;Chemical;PA267;Gene
DULOXETINE;TEX10;Gene;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;TEX10;Gene;PA447321;Disease
CLDN18;zolbetuximab;Chemical;PA26565;Gene
ERBB2;zolbetuximab;Chemical;PA27844;Gene
RS1050828;chlorproguanil;Chemical;PA166157859;Variant
G6PD;chlorproguanil;Chemical;PA28469;Gene
NR1I2;cefadroxil;Chemical;PA378;Gene
DIABETES MELLITUS, TYPE 2;rs2252281;Variant;PA443890;Disease
POLYCYSTIC OVARY SYNDROME;rs2252281;Variant;PA445376;Disease
METFORMIN;rs2252281;Variant;PA450395;Chemical
GEFITINIB;CYP2D6*2;Haplotype;PA131301952;Chemical
3,4-METHYLENEDIOXYMETHAMPHETAMINE;CYP2D6*2;Haplotype;PA131887008;Chemical
ATOMOXETINE;CYP2D6*2;Haplotype;PA134688071;Chemical
TOXIC LIVER DISEASE;CYP2D6*2;Haplotype;PA164925725;Disease
BUFURALOL;CYP2D6*2;Haplotype;PA166110256;Chemical
PROGRESSION-FREE SURVIVAL;CYP2D6*2;Haplotype;PA166123026;Disease
OVERALL SURVIVAL;CYP2D6*2;Haplotype;PA166123207;Disease
AGITATION;CYP2D6*2;Haplotype;PA166123306;Disease
INSOMNIA;CYP2D6*2;Haplotype;PA166123307;Disease
EVENT-FREE SURVIVAL;CYP2D6*2;Haplotype;PA166123366;Disease
DISCONTINUATION;CYP2D6*2;Haplotype;PA166123507;Disease
ENDOXIFEN;CYP2D6*2;Haplotype;PA166124478;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*2;Haplotype;PA166127651;Chemical
CARDIOTOXICITY;CYP2D6*2;Haplotype;PA166128121;Disease
SEDATION;CYP2D6*2;Haplotype;PA166129521;Disease
O-DESMETHYLTRAMADOL;CYP2D6*2;Haplotype;PA166131379;Chemical
N-DESMETHYLTRAMADOL;CYP2D6*2;Haplotype;PA166131493;Chemical
N,O-DIDESMETHYLTRAMADOL;CYP2D6*2;Haplotype;PA166131494;Chemical
DAPOXETINE;CYP2D6*2;Haplotype;PA166151992;Chemical
BREXPIPRAZOLE;CYP2D6*2;Haplotype;PA166160053;Chemical
EXTRAPYRAMIDAL SYMPTOMS;CYP2D6*2;Haplotype;PA166170367;Disease
CNS DEPRESSION;CYP2D6*2;Haplotype;PA166170668;Disease
MEPHEDRONE;CYP2D6*2;Haplotype;PA166184711;Chemical
ADENOCARCINOMA;CYP2D6*2;Haplotype;PA443265;Disease
ARRHYTHMIAS, CARDIAC;CYP2D6*2;Haplotype;PA443421;Disease
BREAST NEOPLASMS;CYP2D6*2;Haplotype;PA443560;Disease
CARCINOMA, NON-SMALL-CELL LUNG;CYP2D6*2;Haplotype;PA443622;Disease
DEATH;CYP2D6*2;Haplotype;PA443842;Disease
DRUG TOXICITY;CYP2D6*2;Haplotype;PA443937;Disease
EXANTHEMA;CYP2D6*2;Haplotype;PA444109;Disease
HEAD AND NECK NEOPLASMS;CYP2D6*2;Haplotype;PA444352;Disease
HEART DISEASES;CYP2D6*2;Haplotype;PA444368;Disease
HEROIN DEPENDENCE;CYP2D6*2;Haplotype;PA444460;Disease
HYPERTENSION;CYP2D6*2;Haplotype;PA444552;Disease
MALARIA;CYP2D6*2;Haplotype;PA444859;Disease
OPIOID-RELATED DISORDERS;CYP2D6*2;Haplotype;PA445043;Disease
NEOPLASMS;CYP2D6*2;Haplotype;PA445062;Disease
PAIN;CYP2D6*2;Haplotype;PA445208;Disease
PAIN, POSTOPERATIVE;CYP2D6*2;Haplotype;PA445210;Disease
RECURRENCE;CYP2D6*2;Haplotype;PA445506;Disease
TACHYCARDIA;CYP2D6*2;Haplotype;PA445802;Disease
VOMITING;CYP2D6*2;Haplotype;PA446051;Disease
SEROTONIN SYNDROME;CYP2D6*2;Haplotype;PA446956;Disease
AGORAPHOBIA;CYP2D6*2;Haplotype;PA447194;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CYP2D6*2;Haplotype;PA447197;Disease
DEPRESSIVE DISORDER;CYP2D6*2;Haplotype;PA447207;Disease
MENTAL DISORDERS;CYP2D6*2;Haplotype;PA447208;Disease
SCHIZOPHRENIA;CYP2D6*2;Haplotype;PA447216;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2D6*2;Haplotype;PA447321;Disease
ACETAMINOPHEN;CYP2D6*2;Haplotype;PA448015;Chemical
AMITRIPTYLINE;CYP2D6*2;Haplotype;PA448385;Chemical
CARVEDILOL;CYP2D6*2;Haplotype;PA448817;Chemical
CITALOPRAM;CYP2D6*2;Haplotype;PA449015;Chemical
CLOMIPRAMINE;CYP2D6*2;Haplotype;PA449048;Chemical
CODEINE;CYP2D6*2;Haplotype;PA449088;Chemical
DESIPRAMINE;CYP2D6*2;Haplotype;PA449233;Chemical
DEXTROMETHORPHAN;CYP2D6*2;Haplotype;PA449273;Chemical
DOXEPIN;CYP2D6*2;Haplotype;PA449409;Chemical
FLECAINIDE;CYP2D6*2;Haplotype;PA449646;Chemical
FLUOXETINE;CYP2D6*2;Haplotype;PA449673;Chemical
HALOPERIDOL;CYP2D6*2;Haplotype;PA449841;Chemical
HYDROCODONE;CYP2D6*2;Haplotype;PA449900;Chemical
KETOPROFEN;CYP2D6*2;Haplotype;PA450149;Chemical
METHADONE;CYP2D6*2;Haplotype;PA450401;Chemical
METHYLPHENIDATE;CYP2D6*2;Haplotype;PA450464;Chemical
METOPROLOL;CYP2D6*2;Haplotype;PA450480;Chemical
NORTRIPTYLINE;CYP2D6*2;Haplotype;PA450657;Chemical
ONDANSETRON;CYP2D6*2;Haplotype;PA450705;Chemical
OXYCODONE;CYP2D6*2;Haplotype;PA450741;Chemical
PAROXETINE;CYP2D6*2;Haplotype;PA450801;Chemical
PRIMAQUINE;CYP2D6*2;Haplotype;PA451103;Chemical
PROPAFENONE;CYP2D6*2;Haplotype;PA451131;Chemical
RISPERIDONE;CYP2D6*2;Haplotype;PA451257;Chemical
TAMOXIFEN;CYP2D6*2;Haplotype;PA451581;Chemical
TRAMADOL;CYP2D6*2;Haplotype;PA451735;Chemical
VENLAFAXINE;CYP2D6*2;Haplotype;PA451866;Chemical
ANTIDEPRESSANTS;CYP2D6*2;Haplotype;PA452229;Chemical
ANTIPSYCHOTICS;CYP2D6*2;Haplotype;PA452233;Chemical
SPARTEINE;CYP2D6*2;Haplotype;PA452610;Chemical
DEBRISOQUINE;CYP2D6*2;Haplotype;PA452616;Chemical
ANTINEOPLASTIC AGENTS;CYP2D6*2;Haplotype;PA452621;Chemical
BREAST NEOPLASMS;rs10509373;Variant;PA443560;Disease
TAMOXIFEN;rs10509373;Variant;PA451581;Chemical
TOXIC LIVER DISEASE;rs2070401;Variant;PA164925725;Disease
DRUG-INDUCED LIVER INJURY;rs2070401;Variant;PA166119041;Disease
ISONIAZID;rs2070401;Variant;PA450112;Chemical
AUTISM;rs3813928;Variant;PA447198;Disease
RISPERIDONE;rs3813928;Variant;PA451257;Chemical
RHEUMATOID ARTHRITIS;SLC22A11;Gene;PA443434;Disease
METHOTREXATE;SLC22A11;Gene;PA450428;Chemical
ZIDOVUDINE;SLC22A11;Gene;PA451954;Chemical
LAMIVUDINE;CHPT1;Gene;PA450163;Chemical
ADALIMUMAB;ATP5F1E;Gene;PA10004;Chemical
CERTOLIZUMAB PEGOL;ATP5F1E;Gene;PA165107055;Chemical
RHEUMATOID ARTHRITIS;ATP5F1E;Gene;PA443434;Disease
ETANERCEPT;ATP5F1E;Gene;PA449515;Chemical
METHOTREXATE;ATP5F1E;Gene;PA450428;Chemical
GLUCOCORTICOIDS;ATP5F1E;Gene;PA452347;Chemical
INFLIXIMAB;ATP5F1E;Gene;PA452639;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;rs4460839;Variant;PA164713257;Chemical
MAJOR DEPRESSIVE DISORDER;rs4460839;Variant;PA447321;Disease
SULFONAMIDES, UREA DERIVATIVES;KCNJ11;Gene;PA10390;Chemical
GLICLAZIDE;KCNJ11;Gene;PA10892;Chemical
PERSISTENT HYPERINSULINEMIA HYPOGLYCEMIA OF INFANCY;KCNJ11;Gene;PA150527845;Disease
DIABETES, PERMANENT NEONATAL (PNDM);KCNJ11;Gene;PA152530787;Disease
CARDIOVASCULAR DISEASES;KCNJ11;Gene;PA443635;Disease
DIABETES MELLITUS;KCNJ11;Gene;PA443886;Disease
DIABETES MELLITUS, TYPE 2;KCNJ11;Gene;PA443890;Disease
DIAZOXIDE;KCNJ11;Gene;PA449285;Chemical
METFORMIN;KCNJ11;Gene;PA450395;Chemical
REPAGLINIDE;KCNJ11;Gene;PA451234;Chemical
TACROLIMUS;KCNJ11;Gene;PA451578;Chemical
ANTIARRHYTHMICS, CLASS I AND III;KCNJ11;Gene;PA452249;Chemical
CYP3A4;nifedipine;Chemical;PA130;Gene
CYP3A5;nifedipine;Chemical;PA131;Gene
CYP3A4*1;nifedipine;Chemical;PA165819201;Haplotype
CYP3A4*17;nifedipine;Chemical;PA165819239;Haplotype
RS1123617;nifedipine;Chemical;PA166155278;Variant
RS3745009;nifedipine;Chemical;PA166155291;Variant
RS776746;nifedipine;Chemical;PA166157267;Variant
RS28383479;nifedipine;Chemical;PA166157484;Variant
RS41279854;nifedipine;Chemical;PA166157489;Variant
RS55817950;nifedipine;Chemical;PA166157492;Variant
RS72552791;nifedipine;Chemical;PA166157505;Variant
RS1048101;nifedipine;Chemical;PA166157550;Variant
ADRA1A;nifedipine;Chemical;PA34;Gene
SLC14A2;nifedipine;Chemical;PA35811;Gene
NR1I2;nifedipine;Chemical;PA378;Gene
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs4902333;Variant;PA447197;Disease
METHYLPHENIDATE;rs4902333;Variant;PA450464;Chemical
CANNABINOIDS;KAT2B;Gene;PA131890620;Chemical
SUBSTANCE-RELATED DISORDERS;KAT2B;Gene;PA446876;Disease
AMPHETAMINE;KAT2B;Gene;PA448408;Chemical
COCAINE;KAT2B;Gene;PA449072;Chemical
OPIOIDS;KAT2B;Gene;PA452618;Chemical
FLUOROURACIL;PTEN;Gene;PA128406956;Chemical
CAPIVASERTIB;PTEN;Gene;PA166328761;Chemical
PIK3R1;PTEN;Gene;PA33312;Gene
NON-SMALL CELL LUNG CARCINOMA;PTEN;Gene;PA443622;Disease
HAMARTOMA SYNDROME, MULTIPLE;PTEN;Gene;PA444342;Disease
METASTATIC NEOPLASM;PTEN;Gene;PA445058;Disease
PROSTATIC NEOPLASMS;PTEN;Gene;PA445425;Disease
CAPECITABINE;PTEN;Gene;PA448771;Chemical
CARBOPLATIN;PTEN;Gene;PA448803;Chemical
CISPLATIN;PTEN;Gene;PA449014;Chemical
HEROIN DEPENDENCE;DAO;Gene;PA444460;Disease
METHADONE;DAO;Gene;PA450401;Chemical
MYELOSUPPRESSION;TPMT*24;Haplotype;PA165817398;Disease
DISCONTINUATION;TPMT*24;Haplotype;PA166123507;Disease
INFLAMMATION;TPMT*24;Haplotype;PA444620;Disease
LUPUS ERYTHEMATOSUS, SYSTEMIC;TPMT*24;Haplotype;PA444822;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;TPMT*24;Haplotype;PA446155;Disease
AZATHIOPRINE;TPMT*24;Haplotype;PA448515;Chemical
MERCAPTOPURINE;TPMT*24;Haplotype;PA450379;Chemical
SCN5A;Sick Sinus Syndrome;Disease;PA304;Gene
RS396991;cetuximab;Chemical;PA166153571;Variant
RS1801274;cetuximab;Chemical;PA166153652;Variant
RS9344;cetuximab;Chemical;PA166154264;Variant
RS61764370;cetuximab;Chemical;PA166154658;Variant
RS112445441;cetuximab;Chemical;PA166154663;Variant
RS885036;cetuximab;Chemical;PA166155606;Variant
RS1353295;cetuximab;Chemical;PA166156509;Variant
RS4444903;cetuximab;Chemical;PA166156588;Variant
RS9996584;cetuximab;Chemical;PA166156635;Variant
RS11942466;cetuximab;Chemical;PA166156656;Variant
RS13104811;cetuximab;Chemical;PA166156663;Variant
RS144854329;cetuximab;Chemical;PA166157228;Variant
RS712829;cetuximab;Chemical;PA166157262;Variant
RS712830;cetuximab;Chemical;PA166157263;Variant
RS2227983;cetuximab;Chemical;PA166157331;Variant
RS113488022;cetuximab;Chemical;PA166157522;Variant
RS2236947;cetuximab;Chemical;PA166180901;Variant
AREG;cetuximab;Chemical;PA24933;Gene
BRAF;cetuximab;Chemical;PA25408;Gene
BTC;cetuximab;Chemical;PA25442;Gene
HBEGF;cetuximab;Chemical;PA27513;Gene
EGF;cetuximab;Chemical;PA27664;Gene
EREG;cetuximab;Chemical;PA27856;Gene
FCGR2A;cetuximab;Chemical;PA28063;Gene
FCGR3A;cetuximab;Chemical;PA28065;Gene
KRAS;cetuximab;Chemical;PA30196;Gene
MGAT4A;cetuximab;Chemical;PA30782;Gene
NRAS;cetuximab;Chemical;PA31768;Gene
NRG1;cetuximab;Chemical;PA31776;Gene
NRG2;cetuximab;Chemical;PA31777;Gene
NRG3;cetuximab;Chemical;PA31778;Gene
RASSF1;cetuximab;Chemical;PA34245;Gene
TGFA;cetuximab;Chemical;PA36480;Gene
VEGFA;cetuximab;Chemical;PA37302;Gene
EGFR;cetuximab;Chemical;PA7360;Gene
CCND1;cetuximab;Chemical;PA75;Gene
G6PD B (REFERENCE);chloroquine;Chemical;PA165947826;Haplotype
G6PD A- 202A_376G;chloroquine;Chemical;PA165947827;Haplotype
G6PD MEDITERRANEAN HAPLOTYPE;chloroquine;Chemical;PA165947830;Haplotype
G6PD MEDITERRANEAN, DALLAS, PANAMA, SASSARI, CAGLIARI, BIRMINGHAM;chloroquine;Chemical;PA166121127;Haplotype
G6PD DEFICIENCY;chloroquine;Chemical;PA166157959;Variant
G6PD;chloroquine;Chemical;PA28469;Gene
CES1;Attention Deficit Disorder with Hyperactivity;Disease;PA107;Gene
COMT;Attention Deficit Disorder with Hyperactivity;Disease;PA117;Gene
CYP2C19;Attention Deficit Disorder with Hyperactivity;Disease;PA124;Gene
CYP2D6;Attention Deficit Disorder with Hyperactivity;Disease;PA128;Gene
FARP2;Attention Deficit Disorder with Hyperactivity;Disease;PA134873245;Gene
CORO7;Attention Deficit Disorder with Hyperactivity;Disease;PA134910806;Gene
SENP3;Attention Deficit Disorder with Hyperactivity;Disease;PA134933213;Gene
ADGRL3;Attention Deficit Disorder with Hyperactivity;Disease;PA134968284;Gene
ZNF565;Attention Deficit Disorder with Hyperactivity;Disease;PA134970652;Gene
CHURC1;Attention Deficit Disorder with Hyperactivity;Disease;PA134982480;Gene
SPSB2;Attention Deficit Disorder with Hyperactivity;Disease;PA142670872;Gene
ELP5;Attention Deficit Disorder with Hyperactivity;Disease;PA143485405;Gene
DRD1;Attention Deficit Disorder with Hyperactivity;Disease;PA147;Gene
RRP7A;Attention Deficit Disorder with Hyperactivity;Disease;PA162402175;Gene
HTT;Attention Deficit Disorder with Hyperactivity;Disease;PA164741646;Gene
PYROXD2;Attention Deficit Disorder with Hyperactivity;Disease;PA165549043;Gene
PEBP4;Attention Deficit Disorder with Hyperactivity;Disease;PA165585814;Gene
ESYT2;Attention Deficit Disorder with Hyperactivity;Disease;PA165617947;Gene
CYP2D6*1;Attention Deficit Disorder with Hyperactivity;Disease;PA165816576;Haplotype
CYP2D6*2;Attention Deficit Disorder with Hyperactivity;Disease;PA165816577;Haplotype
CYP2D6*3;Attention Deficit Disorder with Hyperactivity;Disease;PA165816578;Haplotype
CYP2D6*4;Attention Deficit Disorder with Hyperactivity;Disease;PA165816579;Haplotype
CYP2D6*6;Attention Deficit Disorder with Hyperactivity;Disease;PA165816581;Haplotype
CYP2D6*10;Attention Deficit Disorder with Hyperactivity;Disease;PA165816582;Haplotype
CYP2D6*17;Attention Deficit Disorder with Hyperactivity;Disease;PA165816583;Haplotype
CYP2D6*41;Attention Deficit Disorder with Hyperactivity;Disease;PA165816584;Haplotype
CYP2D6*5;Attention Deficit Disorder with Hyperactivity;Disease;PA165948092;Haplotype
CYP2D6*9;Attention Deficit Disorder with Hyperactivity;Disease;PA165948317;Haplotype
CYP2D6*29;Attention Deficit Disorder with Hyperactivity;Disease;PA165948318;Haplotype
CYP2C19*1;Attention Deficit Disorder with Hyperactivity;Disease;PA165980634;Haplotype
CYP2C19*2;Attention Deficit Disorder with Hyperactivity;Disease;PA165980635;Haplotype
ARHGEF28;Attention Deficit Disorder with Hyperactivity;Disease;PA166048998;Gene
CYP2D6*92;Attention Deficit Disorder with Hyperactivity;Disease;PA166123332;Haplotype
CYP2D6*96;Attention Deficit Disorder with Hyperactivity;Disease;PA166123337;Haplotype
CYP2D6*4XN;Attention Deficit Disorder with Hyperactivity;Disease;PA166123455;Haplotype
RS1800544;Attention Deficit Disorder with Hyperactivity;Disease;PA166153974;Variant
RS2283265;Attention Deficit Disorder with Hyperactivity;Disease;PA166154364;Variant
RS5569;Attention Deficit Disorder with Hyperactivity;Disease;PA166154972;Variant
RS3785143;Attention Deficit Disorder with Hyperactivity;Disease;PA166155055;Variant
RS12708954;Attention Deficit Disorder with Hyperactivity;Disease;PA166155113;Variant
RS71647871;Attention Deficit Disorder with Hyperactivity;Disease;PA166155135;Variant
RS4680;Attention Deficit Disorder with Hyperactivity;Disease;PA166156024;Variant
RS734644;Attention Deficit Disorder with Hyperactivity;Disease;PA166156491;Variant
RS1355368;Attention Deficit Disorder with Hyperactivity;Disease;PA166156510;Variant
RS1947275;Attention Deficit Disorder with Hyperactivity;Disease;PA166156531;Variant
RS6551665;Attention Deficit Disorder with Hyperactivity;Disease;PA166156602;Variant
RS6813183;Attention Deficit Disorder with Hyperactivity;Disease;PA166156607;Variant
RS4532;Attention Deficit Disorder with Hyperactivity;Disease;PA166156706;Variant
RS2032582;Attention Deficit Disorder with Hyperactivity;Disease;PA166157316;Variant
CYP2D6 POOR METABOLIZER;Attention Deficit Disorder with Hyperactivity;Disease;PA166157927;Variant
RS2295490;Attention Deficit Disorder with Hyperactivity;Disease;PA166163170;Variant
RS2070762;Attention Deficit Disorder with Hyperactivity;Disease;PA166175927;Variant
RS17685420;Attention Deficit Disorder with Hyperactivity;Disease;PA166176933;Variant
RS3210967;Attention Deficit Disorder with Hyperactivity;Disease;PA166176934;Variant
RS10413455;Attention Deficit Disorder with Hyperactivity;Disease;PA166176935;Variant
RS2071421;Attention Deficit Disorder with Hyperactivity;Disease;PA166176936;Variant
RS12302749;Attention Deficit Disorder with Hyperactivity;Disease;PA166176937;Variant
RS10420097;Attention Deficit Disorder with Hyperactivity;Disease;PA166176938;Variant
RS3810818;Attention Deficit Disorder with Hyperactivity;Disease;PA166176939;Variant
RS2886059;Attention Deficit Disorder with Hyperactivity;Disease;PA166176940;Variant
RS9901675;Attention Deficit Disorder with Hyperactivity;Disease;PA166176941;Variant
RS4805162;Attention Deficit Disorder with Hyperactivity;Disease;PA166176942;Variant
RS4562;Attention Deficit Disorder with Hyperactivity;Disease;PA166176943;Variant
RS17712523;Attention Deficit Disorder with Hyperactivity;Disease;PA166176944;Variant
RS2799018;Attention Deficit Disorder with Hyperactivity;Disease;PA166176945;Variant
RS12409352;Attention Deficit Disorder with Hyperactivity;Disease;PA166176946;Variant
RS4902333;Attention Deficit Disorder with Hyperactivity;Disease;PA166176947;Variant
RS4627790;Attention Deficit Disorder with Hyperactivity;Disease;PA166176948;Variant
RS1048786;Attention Deficit Disorder with Hyperactivity;Disease;PA166176949;Variant
RS751655;Attention Deficit Disorder with Hyperactivity;Disease;PA166176951;Variant
RS11559290;Attention Deficit Disorder with Hyperactivity;Disease;PA166176952;Variant
RS7858;Attention Deficit Disorder with Hyperactivity;Disease;PA166176953;Variant
RS929740;Attention Deficit Disorder with Hyperactivity;Disease;PA166176954;Variant
RS9032;Attention Deficit Disorder with Hyperactivity;Disease;PA166176955;Variant
RS11552708;Attention Deficit Disorder with Hyperactivity;Disease;PA166176956;Variant
RS1061735;Attention Deficit Disorder with Hyperactivity;Disease;PA166176957;Variant
RS11553441;Attention Deficit Disorder with Hyperactivity;Disease;PA166176958;Variant
RS362272;Attention Deficit Disorder with Hyperactivity;Disease;PA166176959;Variant
RS757978;Attention Deficit Disorder with Hyperactivity;Disease;PA166176960;Variant
RS17279558;Attention Deficit Disorder with Hyperactivity;Disease;PA166176961;Variant
RS3761372;Attention Deficit Disorder with Hyperactivity;Disease;PA166176962;Variant
RS1061115;Attention Deficit Disorder with Hyperactivity;Disease;PA166176963;Variant
RS2013169;Attention Deficit Disorder with Hyperactivity;Disease;PA166176964;Variant
RS28386840;Attention Deficit Disorder with Hyperactivity;Disease;PA166181222;Variant
RS2159140;Attention Deficit Disorder with Hyperactivity;Disease;PA166185779;Variant
ARHGAP12;Attention Deficit Disorder with Hyperactivity;Disease;PA24957;Gene
ARSA;Attention Deficit Disorder with Hyperactivity;Disease;PA25005;Gene
TRIB3;Attention Deficit Disorder with Hyperactivity;Disease;PA25804;Gene
CDH23;Attention Deficit Disorder with Hyperactivity;Disease;PA26296;Gene
ABCB1;Attention Deficit Disorder with Hyperactivity;Disease;PA267;Gene
DRD2;Attention Deficit Disorder with Hyperactivity;Disease;PA27478;Gene
ETFDH;Attention Deficit Disorder with Hyperactivity;Disease;PA27899;Gene
ALDH1L1;Attention Deficit Disorder with Hyperactivity;Disease;PA28393;Gene
FXR2;Attention Deficit Disorder with Hyperactivity;Disease;PA28440;Gene
MAP2K4;Attention Deficit Disorder with Hyperactivity;Disease;PA30589;Gene
SLC6A2;Attention Deficit Disorder with Hyperactivity;Disease;PA310;Gene
NFIB;Attention Deficit Disorder with Hyperactivity;Disease;PA31591;Gene
OPCML;Attention Deficit Disorder with Hyperactivity;Disease;PA31930;Gene
PDIA2;Attention Deficit Disorder with Hyperactivity;Disease;PA33153;Gene
PURA;Attention Deficit Disorder with Hyperactivity;Disease;PA34045;Gene
ADRA2A;Attention Deficit Disorder with Hyperactivity;Disease;PA35;Gene
TH;Attention Deficit Disorder with Hyperactivity;Disease;PA351;Gene
ZNF134;Attention Deficit Disorder with Hyperactivity;Disease;PA37506;Gene
ZNF211;Attention Deficit Disorder with Hyperactivity;Disease;PA37582;Gene
STRBP;Attention Deficit Disorder with Hyperactivity;Disease;PA38145;Gene
ZDHHC7;Attention Deficit Disorder with Hyperactivity;Disease;PA38335;Gene
PIGM;Attention Deficit Disorder with Hyperactivity;Disease;PA38718;Gene
CMTM8;Attention Deficit Disorder with Hyperactivity;Disease;PA38818;Gene
GGH;Attention Deficit Disorder with Hyperactivity;Disease;PA432;Gene
ZOLEDRONATE;FDPS;Gene;PA10235;Chemical
BISPHOSPHONATES;FDPS;Gene;PA164712563;Chemical
CORONARY DISEASE;FDPS;Gene;PA443797;Disease
NEOPLASMS;FDPS;Gene;PA445062;Disease
OSTEONECROSIS;FDPS;Gene;PA445187;Disease
OSTEOPOROSIS;FDPS;Gene;PA445190;Disease
OSTEOPOROSIS, POSTMENOPAUSAL;FDPS;Gene;PA446214;Disease
ATORVASTATIN;FDPS;Gene;PA448500;Chemical
ARIPIPRAZOLE;DRD2;Gene;PA10026;Chemical
DULOXETINE;DRD2;Gene;PA10066;Chemical
ESCITALOPRAM;DRD2;Gene;PA10074;Chemical
NEMONAPRIDE;DRD2;Gene;PA151186253;Chemical
AMISULPRIDE;DRD2;Gene;PA162565877;Chemical
ANALGESICS;DRD2;Gene;PA164712362;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;DRD2;Gene;PA164712462;Chemical
ERGOT ALKALOIDS;DRD2;Gene;PA164712741;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;DRD2;Gene;PA164713257;Chemical
ROPINIROLE;DRD2;Gene;PA164749035;Chemical
RASAGILINE;DRD2;Gene;PA164764584;Chemical
DIVALPROEX SODIUM;DRD2;Gene;PA164783479;Chemical
BROMPERIDOL;DRD2;Gene;PA165282097;Chemical
SCHIZOAFFECTIVE DISORDER;DRD2;Gene;PA166123368;Disease
ALCOHOL ABUSE;DRD2;Gene;PA443309;Disease
DEATH;DRD2;Gene;PA443842;Disease
HEROIN DEPENDENCE;DRD2;Gene;PA444460;Disease
HYPERPROLACTINEMIA;DRD2;Gene;PA444545;Disease
MIGRAINE WITHOUT AURA;DRD2;Gene;PA444949;Disease
OPIOID-RELATED DISORDERS;DRD2;Gene;PA445043;Disease
NAUSEA;DRD2;Gene;PA445048;Disease
OBESITY;DRD2;Gene;PA445131;Disease
PARKINSON DISEASE;DRD2;Gene;PA445254;Disease
PSYCHOMOTOR AGITATION;DRD2;Gene;PA445452;Disease
TOBACCO USE DISORDER;DRD2;Gene;PA445876;Disease
SUBSTANCE-RELATED DISORDERS;DRD2;Gene;PA446876;Disease
COCAINE DEPENDENCE;DRD2;Gene;PA446878;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DRD2;Gene;PA447197;Disease
AUTISM;DRD2;Gene;PA447198;Disease
BIPOLAR DISORDER;DRD2;Gene;PA447199;Disease
MENTAL DISORDERS;DRD2;Gene;PA447208;Disease
PSYCHOTIC DISORDER;DRD2;Gene;PA447215;Disease
SCHIZOPHRENIA;DRD2;Gene;PA447216;Disease
DEPRESSION;DRD2;Gene;PA447278;Disease
MAJOR DEPRESSIVE DISORDER;DRD2;Gene;PA447321;Disease
ETHANOL;DRD2;Gene;PA448073;Chemical
AMITRIPTYLINE;DRD2;Gene;PA448385;Chemical
AMPHETAMINE;DRD2;Gene;PA448408;Chemical
BUPROPION;DRD2;Gene;PA448687;Chemical
BUSPIRONE;DRD2;Gene;PA448689;Chemical
CABERGOLINE;DRD2;Gene;PA448708;Chemical
CARBAMAZEPINE;DRD2;Gene;PA448785;Chemical
CITALOPRAM;DRD2;Gene;PA449015;Chemical
CLOZAPINE;DRD2;Gene;PA449061;Chemical
COCAINE;DRD2;Gene;PA449072;Chemical
DIAZEPAM;DRD2;Gene;PA449283;Chemical
DISULFIRAM;DRD2;Gene;PA449376;Chemical
FLUOXETINE;DRD2;Gene;PA449673;Chemical
HALOPERIDOL;DRD2;Gene;PA449841;Chemical
LAMOTRIGINE;DRD2;Gene;PA450164;Chemical
LEVODOPA;DRD2;Gene;PA450213;Chemical
METHADONE;DRD2;Gene;PA450401;Chemical
METHYLPHENIDATE;DRD2;Gene;PA450464;Chemical
MIRTAZAPINE;DRD2;Gene;PA450522;Chemical
MODAFINIL;DRD2;Gene;PA450530;Chemical
NALTREXONE;DRD2;Gene;PA450588;Chemical
NICOTINE;DRD2;Gene;PA450626;Chemical
NORTRIPTYLINE;DRD2;Gene;PA450657;Chemical
OLANZAPINE;DRD2;Gene;PA450688;Chemical
OXCARBAZEPINE;DRD2;Gene;PA450732;Chemical
PAROXETINE;DRD2;Gene;PA450801;Chemical
PERGOLIDE;DRD2;Gene;PA450873;Chemical
PHENYTOIN;DRD2;Gene;PA450947;Chemical
PROCHLORPERAZINE;DRD2;Gene;PA451114;Chemical
QUETIAPINE;DRD2;Gene;PA451201;Chemical
RISPERIDONE;DRD2;Gene;PA451257;Chemical
RIZATRIPTAN;DRD2;Gene;PA451264;Chemical
SERTRALINE;DRD2;Gene;PA451333;Chemical
SUMATRIPTAN;DRD2;Gene;PA451566;Chemical
TRAZODONE;DRD2;Gene;PA451744;Chemical
VALPROIC ACID;DRD2;Gene;PA451846;Chemical
VENLAFAXINE;DRD2;Gene;PA451866;Chemical
ZIPRASIDONE;DRD2;Gene;PA451974;Chemical
ANTIPSYCHOTICS;DRD2;Gene;PA452233;Chemical
OPIOIDS;DRD2;Gene;PA452618;Chemical
HEROIN;DRD2;Gene;PA452619;Chemical
ROCURONIUM;rs11045995;Variant;PA164754992;Chemical
DAUNORUBICIN;rs2835285;Variant;PA449212;Chemical
DOXORUBICIN;rs2835285;Variant;PA449412;Chemical
ACE;bumetanide;Chemical;PA139;Gene
NPPA-AS1;bumetanide;Chemical;PA165752124;Gene
RS5063;bumetanide;Chemical;PA166153548;Variant
RS5443;bumetanide;Chemical;PA166154486;Variant
RS1529927;bumetanide;Chemical;PA166155014;Variant
RS1799752;bumetanide;Chemical;PA166155187;Variant
RS4961;bumetanide;Chemical;PA166156480;Variant
GNB3;bumetanide;Chemical;PA176;Gene
ADD1;bumetanide;Chemical;PA31;Gene
SLC12A3;bumetanide;Chemical;PA321;Gene
CREATINE;rs616147;Variant;PA164778930;Chemical
AMYOTROPHIC LATERAL SCLEROSIS;rs616147;Variant;PA443332;Disease
LEUKEMIA, MYELOID, ACUTE;RRM2B;Gene;PA444760;Disease
CLADRIBINE;RRM2B;Gene;PA449027;Chemical
CYTARABINE;RRM2B;Gene;PA449177;Chemical
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-C*07:18;Haplotype;PA166120929;Disease
LAMOTRIGINE;HLA-C*07:18;Haplotype;PA450164;Chemical
NAUSEA;rs41269255;Variant;PA445048;Disease
VOMITING;rs41269255;Variant;PA446051;Disease
OPIOIDS;rs41269255;Variant;PA452618;Chemical
HYPERTENSION;rs9940629;Variant;PA444552;Disease
ATENOLOL;rs9940629;Variant;PA448499;Chemical
COMT;Hyperalgesia;Disease;PA117;Gene
RS4680;Hyperalgesia;Disease;PA166156024;Variant
CD274;tislelizumab;Chemical;PA134915280;Gene
RS121434568;afatinib;Chemical;PA166157527;Variant
EGFR;afatinib;Chemical;PA7360;Gene
BUCILLAMINE;HLA-DRB1*08:02;Haplotype;PA166123566;Chemical
ARTHRITIS, RHEUMATOID;HLA-DRB1*08:02;Haplotype;PA443434;Disease
PROTEINURIA;HLA-DRB1*08:02;Haplotype;PA445431;Disease
COMT;lithium;Chemical;PA117;Gene
RABEP1;lithium;Chemical;PA134884097;Gene
GRAMD1B;lithium;Chemical;PA142671708;Gene
SH2B1;lithium;Chemical;PA145148084;Gene
DRD1;lithium;Chemical;PA147;Gene
FAM177A1;lithium;Chemical;PA162387378;Gene
FAM178B;lithium;Chemical;PA162387456;Gene
ZNF804A;lithium;Chemical;PA162410599;Gene
RS1800532;lithium;Chemical;PA166154340;Variant
RS2499984;lithium;Chemical;PA166154371;Variant
RS16909440;lithium;Chemical;PA166154469;Variant
RS8192440;lithium;Chemical;PA166154610;Variant
RS2071427;lithium;Chemical;PA166155199;Variant
RS2314339;lithium;Chemical;PA166155208;Variant
RS11869731;lithium;Chemical;PA166155249;Variant
RS16973410;lithium;Chemical;PA166155327;Variant
RS2826494;lithium;Chemical;PA166155999;Variant
RS74795342;lithium;Chemical;PA166156018;Variant
RS75222709;lithium;Chemical;PA166156019;Variant
RS78015114;lithium;Chemical;PA166156020;Variant
RS79663003;lithium;Chemical;PA166156021;Variant
RS2284017;lithium;Chemical;PA166156093;Variant
RS2284018;lithium;Chemical;PA166156094;Variant
RS334558;lithium;Chemical;PA166156287;Variant
RS6438552;lithium;Chemical;PA166156406;Variant
RS1801260;lithium;Chemical;PA166156525;Variant
RS4532;lithium;Chemical;PA166156706;Variant
RS130058;lithium;Chemical;PA166156908;Variant
RS1360780;lithium;Chemical;PA166156983;Variant
RS2032582;lithium;Chemical;PA166157316;Variant
RS1387923;lithium;Chemical;PA166157727;Variant
RS2769605;lithium;Chemical;PA166157756;Variant
RS3888190;lithium;Chemical;PA166165398;Variant
RS1000940;lithium;Chemical;PA166165401;Variant
RS324899;lithium;Chemical;PA166171034;Variant
RS6942227;lithium;Chemical;PA166171035;Variant
RS1611259;lithium;Chemical;PA166171037;Variant
RS59724122;lithium;Chemical;PA166171038;Variant
RS61123830;lithium;Chemical;PA166171039;Variant
RS7959663;lithium;Chemical;PA166171040;Variant
RS66486766;lithium;Chemical;PA166171041;Variant
RS7405404;lithium;Chemical;PA166171042;Variant
RS6728642;lithium;Chemical;PA166171043;Variant
RS62200793;lithium;Chemical;PA166171044;Variant
RS7588746;lithium;Chemical;PA166171045;Variant
RS3919583;lithium;Chemical;PA166171046;Variant
RS1611255;lithium;Chemical;PA166171048;Variant
RS209474;lithium;Chemical;PA166171049;Variant
RS1521470;lithium;Chemical;PA166171050;Variant
RS79403677;lithium;Chemical;PA166171051;Variant
ASIC2;lithium;Chemical;PA24433;Gene
ADCY1;lithium;Chemical;PA24560;Gene
CACNG2;lithium;Chemical;PA26016;Gene
CLOCK;lithium;Chemical;PA26609;Gene
ABCB1;lithium;Chemical;PA267;Gene
CREB1;lithium;Chemical;PA26864;Gene
CRY1;lithium;Chemical;PA26904;Gene
EPHX2;lithium;Chemical;PA27830;Gene
FKBP5;lithium;Chemical;PA28162;Gene
GSK3B;lithium;Chemical;PA29009;Gene
HTR1B;lithium;Chemical;PA29549;Gene
SCN5A;lithium;Chemical;PA304;Gene
MYO1H;lithium;Chemical;PA31404;Gene
NR1D1;lithium;Chemical;PA31748;Gene
NTRK2;lithium;Chemical;PA31818;Gene
BDNF;lithium;Chemical;PA31891;Gene
OR52E2;lithium;Chemical;PA32403;Gene
OR52J2P;lithium;Chemical;PA32415;Gene
OR52J3;lithium;Chemical;PA32416;Gene
TPH1;lithium;Chemical;PA355;Gene
THRA;lithium;Chemical;PA36507;Gene
WARFARIN;rs104894539;Variant;PA451906;Chemical
DIARRHEA;WWOX;Gene;PA443899;Disease
SORAFENIB;WWOX;Gene;PA7000;Chemical
HMG COA REDUCTASE INHIBITORS;CFAP44;Gene;PA133950441;Chemical
CYP2E1;Leukemia, Myeloid, Acute;Disease;PA129;Gene
SLCO1B1;Leukemia, Myeloid, Acute;Disease;PA134865839;Gene
DCK;Leukemia, Myeloid, Acute;Disease;PA137;Gene
SLC29A1;Leukemia, Myeloid, Acute;Disease;PA154;Gene
CMPK1;Leukemia, Myeloid, Acute;Disease;PA162382539;Gene
TPMT*1;Leukemia, Myeloid, Acute;Disease;PA165819268;Haplotype
TPMT*3A;Leukemia, Myeloid, Acute;Disease;PA165819270;Haplotype
RS532545;Leukemia, Myeloid, Acute;Disease;PA166153575;Variant
RS1044457;Leukemia, Myeloid, Acute;Disease;PA166153608;Variant
RS3754446;Leukemia, Myeloid, Acute;Disease;PA166153750;Variant
RS2070673;Leukemia, Myeloid, Acute;Disease;PA166153993;Variant
RS2515641;Leukemia, Myeloid, Acute;Disease;PA166154017;Variant
RS1042919;Leukemia, Myeloid, Acute;Disease;PA166154310;Variant
RS1561876;Leukemia, Myeloid, Acute;Disease;PA166154332;Variant
RS2898950;Leukemia, Myeloid, Acute;Disease;PA166154392;Variant
RS11030918;Leukemia, Myeloid, Acute;Disease;PA166154447;Variant
RS11231825;Leukemia, Myeloid, Acute;Disease;PA166154455;Variant
RS2291075;Leukemia, Myeloid, Acute;Disease;PA166154544;Variant
RS4149056;Leukemia, Myeloid, Acute;Disease;PA166154579;Variant
RS2302948;Leukemia, Myeloid, Acute;Disease;PA166155396;Variant
RS1130609;Leukemia, Myeloid, Acute;Disease;PA166155627;Variant
RS5030743;Leukemia, Myeloid, Acute;Disease;PA166155740;Variant
RS1883112;Leukemia, Myeloid, Acute;Disease;PA166156080;Variant
RS13058338;Leukemia, Myeloid, Acute;Disease;PA166156140;Variant
RS2306744;Leukemia, Myeloid, Acute;Disease;PA166156554;Variant
RS80143932;Leukemia, Myeloid, Acute;Disease;PA166156697;Variant
RS1045642;Leukemia, Myeloid, Acute;Disease;PA166157284;Variant
RS1128503;Leukemia, Myeloid, Acute;Disease;PA166157288;Variant
RS1799983;Leukemia, Myeloid, Acute;Disease;PA166157303;Variant
RS2032582;Leukemia, Myeloid, Acute;Disease;PA166157316;Variant
RS3750117;Leukemia, Myeloid, Acute;Disease;PA166157378;Variant
RS1265138;Leukemia, Myeloid, Acute;Disease;PA166157554;Variant
RS4643786;Leukemia, Myeloid, Acute;Disease;PA166160283;Variant
RS35112940;Leukemia, Myeloid, Acute;Disease;PA166161442;Variant
RS17343066;Leukemia, Myeloid, Acute;Disease;PA166181000;Variant
RS2228224;Leukemia, Myeloid, Acute;Disease;PA166337421;Variant
RS2229300;Leukemia, Myeloid, Acute;Disease;PA166337441;Variant
RS10916819;Leukemia, Myeloid, Acute;Disease;PA166412241;Variant
RS17103168;Leukemia, Myeloid, Acute;Disease;PA166412243;Variant
RS2396243;Leukemia, Myeloid, Acute;Disease;PA166412244;Variant
RS5841;Leukemia, Myeloid, Acute;Disease;PA166412262;Variant
GSTM1;Leukemia, Myeloid, Acute;Disease;PA182;Gene
ARHGAP9;Leukemia, Myeloid, Acute;Disease;PA24962;Gene
NOS3;Leukemia, Myeloid, Acute;Disease;PA254;Gene
CD33;Leukemia, Myeloid, Acute;Disease;PA26210;Gene
ABCB1;Leukemia, Myeloid, Acute;Disease;PA267;Gene
GLI1;Leukemia, Myeloid, Acute;Disease;PA28720;Gene
RRM1;Leukemia, Myeloid, Acute;Disease;PA298;Gene
RRM2;Leukemia, Myeloid, Acute;Disease;PA299;Gene
NCF4;Leukemia, Myeloid, Acute;Disease;PA31465;Gene
NME4;Leukemia, Myeloid, Acute;Disease;PA31657;Gene
NRAS;Leukemia, Myeloid, Acute;Disease;PA31768;Gene
NT5C3A;Leukemia, Myeloid, Acute;Disease;PA31802;Gene
RAC2;Leukemia, Myeloid, Acute;Disease;PA34163;Gene
RRM2B;Leukemia, Myeloid, Acute;Disease;PA34866;Gene
TPMT;Leukemia, Myeloid, Acute;Disease;PA356;Gene
SULT2B1;Leukemia, Myeloid, Acute;Disease;PA36249;Gene
SLC22A12;Leukemia, Myeloid, Acute;Disease;PA38478;Gene
SLC28A3;Leukemia, Myeloid, Acute;Disease;PA426;Gene
CDA;Leukemia, Myeloid, Acute;Disease;PA98;Gene
ALCOHOL ABUSE;rs10485057;Variant;PA443309;Disease
TOBACCO USE DISORDER;rs10485057;Variant;PA445876;Disease
ETHANOL;rs10485057;Variant;PA448073;Chemical
NICOTINE;rs10485057;Variant;PA450626;Chemical
MAP2K3;MAP3K7;Gene;PA30588;Gene
MAP2K6;MAP3K7;Gene;PA30591;Gene
WARFARIN;rs2189784;Variant;PA451906;Chemical
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;rs710446;Variant;PA452637;Chemical
TENOFOVIR;rs8187707;Variant;PA10204;Chemical
HIV INFECTIOUS DISEASE;rs8187707;Variant;PA447230;Disease
PEGINTERFERON ALFA-2A;SCARB1;Gene;PA164749390;Chemical
HYPERCHOLESTEROLEMIA;SCARB1;Gene;PA444516;Disease
HYPERTRIGLYCERIDEMIA;SCARB1;Gene;PA446120;Disease
CHRONIC HEPATITIS C VIRUS INFECTION;SCARB1;Gene;PA446863;Disease
ATORVASTATIN;SCARB1;Gene;PA448500;Chemical
FENOFIBRATE;SCARB1;Gene;PA449594;Chemical
RIBAVIRIN;SCARB1;Gene;PA451241;Chemical
RS6311;Diminished ability to concentrate;Disease;PA166154673;Variant
HTR2A;Diminished ability to concentrate;Disease;PA193;Gene
KDR;CSK;Gene;PA30086;Gene
RAF1;CSK;Gene;PA34183;Gene
HYPERTENSION;CSK;Gene;PA444552;Disease
HYDROCHLOROTHIAZIDE;CSK;Gene;PA449899;Chemical
NEOPLASMS;rs60369023;Variant;PA445062;Disease
NEUTROPENIA;rs60369023;Variant;PA445113;Disease
CYTARABINE;rs60369023;Variant;PA449177;Chemical
GEMCITABINE;rs60369023;Variant;PA449748;Chemical
RS4655226;difluorodeoxyuridine;Chemical;PA166153774;Variant
CDA;difluorodeoxyuridine;Chemical;PA98;Gene
BREAST NEOPLASMS;rs1804645;Variant;PA443560;Disease
TAMOXIFEN;rs1804645;Variant;PA451581;Chemical
DIABETES MELLITUS;PAX4;Gene;PA443886;Disease
DIABETES MELLITUS, TYPE 2;PAX4;Gene;PA443890;Disease
REPAGLINIDE;PAX4;Gene;PA451234;Chemical
ROSIGLITAZONE;PAX4;Gene;PA451283;Chemical
PAIN, POSTOPERATIVE;rs2835859;Variant;PA445210;Disease
FENTANYL;rs2835859;Variant;PA449599;Chemical
CYP2C9;ketoprofen;Chemical;PA126;Gene
CYP2D6;ketoprofen;Chemical;PA128;Gene
CYP2C9*1;ketoprofen;Chemical;PA165816542;Haplotype
CYP2C9*2;ketoprofen;Chemical;PA165816543;Haplotype
CYP2C9*3;ketoprofen;Chemical;PA165816544;Haplotype
CYP2D6*1;ketoprofen;Chemical;PA165816576;Haplotype
CYP2D6*2;ketoprofen;Chemical;PA165816577;Haplotype
CYP2D6*3;ketoprofen;Chemical;PA165816578;Haplotype
CYP2D6*4;ketoprofen;Chemical;PA165816579;Haplotype
CYP2D6*6;ketoprofen;Chemical;PA165816581;Haplotype
CYP2D6*10;ketoprofen;Chemical;PA165816582;Haplotype
CYP2D6*17;ketoprofen;Chemical;PA165816583;Haplotype
CYP2D6*41;ketoprofen;Chemical;PA165816584;Haplotype
CYP2D6*5;ketoprofen;Chemical;PA165948092;Haplotype
CYP2D6*9;ketoprofen;Chemical;PA165948317;Haplotype
AKT1;NEUROD1;Gene;PA24684;Gene
DIABETES MELLITUS;NEUROD1;Gene;PA443886;Disease
REPAGLINIDE;NEUROD1;Gene;PA451234;Chemical
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;SLCO1B1*23;Haplotype;PA446155;Disease
METHOTREXATE;SLCO1B1*23;Haplotype;PA450428;Chemical
KALLMANN SYNDROME;ANOS1;Gene;PA446481;Disease
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs10499563;Variant;PA164713366;Chemical
ULCERATIVE COLITIS;rs10499563;Variant;PA443750;Disease
INFLAMMATORY BOWEL DISEASES;rs10499563;Variant;PA446116;Disease
OPIOID-RELATED DISORDERS;rs6090043;Variant;PA445043;Disease
OPIOIDS;rs6090043;Variant;PA452618;Chemical
COMT;tramadol;Chemical;PA117;Gene
CYP2B6;tramadol;Chemical;PA123;Gene
CYP2D6;tramadol;Chemical;PA128;Gene
CYP3A4;tramadol;Chemical;PA130;Gene
CYP3A5;tramadol;Chemical;PA131;Gene
WBP2NL;tramadol;Chemical;PA145147710;Gene
RFPL4B;tramadol;Chemical;PA162401195;Gene
RGL4;tramadol;Chemical;PA162401277;Gene
CYP2D6*1;tramadol;Chemical;PA165816576;Haplotype
CYP2D6*2;tramadol;Chemical;PA165816577;Haplotype
CYP2D6*3;tramadol;Chemical;PA165816578;Haplotype
CYP2D6*4;tramadol;Chemical;PA165816579;Haplotype
CYP2D6*6;tramadol;Chemical;PA165816581;Haplotype
CYP2D6*10;tramadol;Chemical;PA165816582;Haplotype
CYP2D6*17;tramadol;Chemical;PA165816583;Haplotype
CYP2D6*41;tramadol;Chemical;PA165816584;Haplotype
CYP2D6*5;tramadol;Chemical;PA165948092;Haplotype
CYP2D6*9;tramadol;Chemical;PA165948317;Haplotype
CYP2D6*1XN;tramadol;Chemical;PA165988479;Haplotype
CYP2D6*2XN;tramadol;Chemical;PA165988480;Haplotype
RS1045280;tramadol;Chemical;PA166155174;Variant
RS3745274;tramadol;Chemical;PA166155409;Variant
RS4680;tramadol;Chemical;PA166156024;Variant
RS1799971;tramadol;Chemical;PA166156991;Variant
RS12208357;tramadol;Chemical;PA166157178;Variant
RS34130495;tramadol;Chemical;PA166157197;Variant
RS35167514;tramadol;Chemical;PA166157201;Variant
RS1045642;tramadol;Chemical;PA166157284;Variant
RS1128503;tramadol;Chemical;PA166157288;Variant
RS2032582;tramadol;Chemical;PA166157316;Variant
CYP2D6 POOR METABOLIZER;tramadol;Chemical;PA166157927;Variant
RS2234918;tramadol;Chemical;PA166175997;Variant
RS776817009;tramadol;Chemical;PA166179692;Variant
RS767263838;tramadol;Chemical;PA166179693;Variant
RS762151655;tramadol;Chemical;PA166179694;Variant
RS757573592;tramadol;Chemical;PA166179695;Variant
RS750575779;tramadol;Chemical;PA166179696;Variant
RS553050853;tramadol;Chemical;PA166179697;Variant
RS751527244;tramadol;Chemical;PA166179698;Variant
RS1293732453;tramadol;Chemical;PA166179699;Variant
RS1328799050;tramadol;Chemical;PA166179700;Variant
RS184199168;tramadol;Chemical;PA166195561;Variant
RS72732317;tramadol;Chemical;PA166195562;Variant
RS62435418;tramadol;Chemical;PA166195563;Variant
RS79983226;tramadol;Chemical;PA166195564;Variant
RS9384825;tramadol;Chemical;PA166195565;Variant
RS62436463;tramadol;Chemical;PA166257861;Variant
RS739296;tramadol;Chemical;PA166257862;Variant
SEPTIN3;tramadol;Chemical;PA24355;Gene
ABCB1;tramadol;Chemical;PA267;Gene
CYP2A7P1;tramadol;Chemical;PA27103;Gene
ICA1;tramadol;Chemical;PA29591;Gene
OPRD1;tramadol;Chemical;PA31942;Gene
OPRM1;tramadol;Chemical;PA31945;Gene
SLC22A1;tramadol;Chemical;PA329;Gene
SULT1A3;tramadol;Chemical;PA344;Gene
ARRB2;tramadol;Chemical;PA60;Gene
HCN1;tramadol;Chemical;PA77;Gene
HYPERTRIGLYCERIDEMIA;rs2230808;Variant;PA446120;Disease
FENOFIBRATE;rs2230808;Variant;PA449594;Chemical
CYP2D6;Psychomotor Agitation;Disease;PA128;Gene
CYP2D6*1;Psychomotor Agitation;Disease;PA165816576;Haplotype
CYP2D6*4;Psychomotor Agitation;Disease;PA165816579;Haplotype
CYP2D6*41;Psychomotor Agitation;Disease;PA165816584;Haplotype
RS2514218;Psychomotor Agitation;Disease;PA166154375;Variant
DRD2;Psychomotor Agitation;Disease;PA27478;Gene
ALCOHOL ABUSE;rs12749274;Variant;PA443309;Disease
NALTREXONE;rs12749274;Variant;PA450588;Chemical
PIK3R5;AKT1;Gene;PA134890823;Gene
MAFA;AKT1;Gene;PA134963361;Gene
HNF1B;AKT1;Gene;PA162391083;Gene
PDX1;AKT1;Gene;PA162399173;Gene
CAPIVASERTIB;AKT1;Gene;PA166328761;Chemical
NFKB1;AKT1;Gene;PA248;Gene
BAD;AKT1;Gene;PA25236;Gene
NOS3;AKT1;Gene;PA254;Gene
ELK1;AKT1;Gene;PA27749;Gene
FOS;AKT1;Gene;PA28212;Gene
HNF4A;AKT1;Gene;PA29349;Gene
RELA;AKT1;Gene;PA296;Gene
ISL1;AKT1;Gene;PA29932;Gene
JUN;AKT1;Gene;PA30006;Gene
MYC;AKT1;Gene;PA31353;Gene
NEUROD1;AKT1;Gene;PA31564;Gene
NFKB2;AKT1;Gene;PA31600;Gene
PDK1;AKT1;Gene;PA33154;Gene
PIK3C2A;AKT1;Gene;PA33304;Gene
PIK3C2B;AKT1;Gene;PA33305;Gene
PIK3CA;AKT1;Gene;PA33308;Gene
PIK3CB;AKT1;Gene;PA33309;Gene
PIK3CD;AKT1;Gene;PA33310;Gene
PIK3CG;AKT1;Gene;PA33311;Gene
PIK3R1;AKT1;Gene;PA33312;Gene
PIK3R2;AKT1;Gene;PA33313;Gene
PIK3R3;AKT1;Gene;PA33314;Gene
STAT3;AKT1;Gene;PA337;Gene
STAT5A;AKT1;Gene;PA338;Gene
SP1;AKT1;Gene;PA36042;Gene
STAT1;AKT1;Gene;PA36183;Gene
STAT2;AKT1;Gene;PA36184;Gene
STAT4;AKT1;Gene;PA36185;Gene
STAT5B;AKT1;Gene;PA36186;Gene
HNF1A;AKT1;Gene;PA36380;Gene
NON-SMALL CELL LUNG CARCINOMA;AKT1;Gene;PA443622;Disease
LUNG NEOPLASMS;AKT1;Gene;PA444818;Disease
SCHIZOPHRENIA;AKT1;Gene;PA447216;Disease
CARBOPLATIN;AKT1;Gene;PA448803;Chemical
CISPLATIN;AKT1;Gene;PA449014;Chemical
RISPERIDONE;AKT1;Gene;PA451257;Chemical
G6PD DEFICIENCY;mafenide;Chemical;PA166157959;Variant
G6PD;mafenide;Chemical;PA28469;Gene
ALCOHOL ABUSE;FUT2;Gene;PA443309;Disease
ETHANOL;FUT2;Gene;PA448073;Chemical
KIDNEY TRANSPLANTATION;rs17868320;Variant;PA165817016;Disease
NEOPLASMS;rs17868320;Variant;PA445062;Disease
MYCOPHENOLATE MOFETIL;rs17868320;Variant;PA450566;Chemical
SORAFENIB;rs17868320;Variant;PA7000;Chemical
PEGASPARGASE;HLA-DRB1*16:02;Haplotype;PA164760860;Chemical
DRUG HYPERSENSITIVITY;HLA-DRB1*16:02;Haplotype;PA443936;Disease
EPILEPSY;HLA-DRB1*16:02;Haplotype;PA444065;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;HLA-DRB1*16:02;Haplotype;PA446155;Disease
DAPSONE;HLA-DRB1*16:02;Haplotype;PA449211;Chemical
PHENYTOIN;HLA-DRB1*16:02;Haplotype;PA450947;Chemical
TXN;PRDX2;Gene;PA37091;Gene
CYP2D6;yohimbine;Chemical;PA128;Gene
ADRA2A;yohimbine;Chemical;PA35;Gene
ADRA2B;yohimbine;Chemical;PA36;Gene
ADRA2C;yohimbine;Chemical;PA37;Gene
APOA5;MTTP;Gene;PA24888;Gene
CORONARY ARTERY DISEASE;MTTP;Gene;PA443796;Disease
HYPERLIPOPROTEINEMIA TYPE II;MTTP;Gene;PA444517;Disease
ATORVASTATIN;MTTP;Gene;PA448500;Chemical
PRAVASTATIN;MTTP;Gene;PA451089;Chemical
APOB;MTTP;Gene;PA50;Gene
APOC1;MTTP;Gene;PA51;Gene
APOC2;MTTP;Gene;PA52;Gene
APOC3;MTTP;Gene;PA53;Gene
APOE;MTTP;Gene;PA55;Gene
CHEK1;CCNB1;Gene;PA110;Gene
CASP3;CCNB1;Gene;PA26087;Gene
CHEK2;CCNB1;Gene;PA404;Gene
TICAGRELOR;NUP153;Gene;PA165374673;Chemical
HMG COA REDUCTASE INHIBITORS;rs4693075;Variant;PA133950441;Chemical
ROSUVASTATIN;rs4693075;Variant;PA134308647;Chemical
MUSCULAR DISEASES;rs4693075;Variant;PA444997;Disease
ATORVASTATIN;rs4693075;Variant;PA448500;Chemical
GEFITINIB;rs2272733;Variant;PA131301952;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs2272733;Variant;PA443622;Disease
EXANTHEMA;rs2272733;Variant;PA444109;Disease
PARKINSON DISEASE;PARK10;Gene;PA445254;Disease
CRIZANLIZUMAB-TMCA;HBB;Gene;PA166189801;Chemical
VOXELOTOR;HBB;Gene;PA166189802;Chemical
LUSPATERCEPT;HBB;Gene;PA166190001;Chemical
HIV INFECTIOUS DISEASE;rs35303484;Variant;PA447230;Disease
EFAVIRENZ;rs35303484;Variant;PA449441;Chemical
ESCITALOPRAM;rs7905446;Variant;PA10074;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;rs7905446;Variant;PA164713257;Chemical
BIPOLAR DISORDER;rs7905446;Variant;PA447199;Disease
DEPRESSION;rs7905446;Variant;PA447278;Disease
PAROXETINE;rs7905446;Variant;PA450801;Chemical
ANTIDEPRESSANTS;rs7905446;Variant;PA452229;Chemical
CROHN DISEASE;TPMT*23;Haplotype;PA443815;Disease
MERCAPTOPURINE;TPMT*23;Haplotype;PA450379;Chemical
THIOGUANINE;TPMT*23;Haplotype;PA451663;Chemical
ANXIETY DISORDERS;rs5751876;Variant;PA447196;Disease
CAFFEINE;rs5751876;Variant;PA448710;Chemical
OTOTOXICITY;rs1603218569;Variant;PA162263534;Disease
AMINOGLYCOSIDE ANTIBACTERIALS;rs1603218569;Variant;PA452167;Chemical
CFTR;ivacaftor / tezacaftor;Chemical;PA109;Gene
RS75039782;ivacaftor / tezacaftor;Chemical;PA166157514;Variant
RS113993960;ivacaftor / tezacaftor;Chemical;PA166157525;Variant
RS77932196;ivacaftor / tezacaftor;Chemical;PA166161186;Variant
RS80224560;ivacaftor / tezacaftor;Chemical;PA166162698;Variant
RS74551128;ivacaftor / tezacaftor;Chemical;PA166162705;Variant
RS397508256;ivacaftor / tezacaftor;Chemical;PA166164939;Variant
RS368505753;ivacaftor / tezacaftor;Chemical;PA166164940;Variant
RS115545701;ivacaftor / tezacaftor;Chemical;PA166164941;Variant
RS397508537;ivacaftor / tezacaftor;Chemical;PA166164942;Variant
RS113993958;ivacaftor / tezacaftor;Chemical;PA166164943;Variant
RS77834169;ivacaftor / tezacaftor;Chemical;PA166164944;Variant
RS397508759;ivacaftor / tezacaftor;Chemical;PA166164945;Variant
RS121908752;ivacaftor / tezacaftor;Chemical;PA166164946;Variant
RS121908753;ivacaftor / tezacaftor;Chemical;PA166164947;Variant
RS397508288;ivacaftor / tezacaftor;Chemical;PA166164948;Variant
RS397508442;ivacaftor / tezacaftor;Chemical;PA166164949;Variant
RS141033578;ivacaftor / tezacaftor;Chemical;PA166164950;Variant
RS150212784;ivacaftor / tezacaftor;Chemical;PA166164951;Variant
RS397508513;ivacaftor / tezacaftor;Chemical;PA166164952;Variant
RS121909020;ivacaftor / tezacaftor;Chemical;PA166164953;Variant
RS202179988;ivacaftor / tezacaftor;Chemical;PA166164956;Variant
RS186045772;ivacaftor / tezacaftor;Chemical;PA166164957;Variant
RS75541969;ivacaftor / tezacaftor;Chemical;PA166164958;Variant
RS11971167;ivacaftor / tezacaftor;Chemical;PA166164959;Variant
RS76151804;ivacaftor / tezacaftor;Chemical;PA166184909;Variant
RS397508761;ivacaftor / tezacaftor;Chemical;PA166196981;Variant
RS397508387;ivacaftor / tezacaftor;Chemical;PA166196982;Variant
RS35516286;ivacaftor / tezacaftor;Chemical;PA166365261;Variant
AK4;adefovir dipivoxil;Chemical;PA165750325;Gene
RS11568626;adefovir dipivoxil;Chemical;PA166154458;Variant
RS11568634;adefovir dipivoxil;Chemical;PA166181074;Variant
AK2;adefovir dipivoxil;Chemical;PA24656;Gene
NME1;adefovir dipivoxil;Chemical;PA249;Gene
NME2;adefovir dipivoxil;Chemical;PA250;Gene
SLC26A8;adefovir dipivoxil;Chemical;PA37885;Gene
SLC22A6;adefovir dipivoxil;Chemical;PA388;Gene
ABCC4;adefovir dipivoxil;Chemical;PA397;Gene
ALCOHOL ABUSE;MED19;Gene;PA443309;Disease
ETHANOL;MED19;Gene;PA448073;Chemical
DICLOFENAC;CYP2C9*40;Haplotype;PA449293;Chemical
PHENYTOIN;CYP2C9*40;Haplotype;PA450947;Chemical
GIVOSIRAN;HMBS;Gene;PA166190681;Chemical
HMG COA REDUCTASE INHIBITORS;rs9806699;Variant;PA133950441;Chemical
MYOCARDIAL INFARCTION;rs9806699;Variant;PA445019;Disease
SIMVASTATIN;rs9806699;Variant;PA451363;Chemical
COMT;sertraline;Chemical;PA117;Gene
CYP2B6;sertraline;Chemical;PA123;Gene
CYP2C19;sertraline;Chemical;PA124;Gene
CYP2C9;sertraline;Chemical;PA126;Gene
CYP2D6;sertraline;Chemical;PA128;Gene
CYP3A4;sertraline;Chemical;PA130;Gene
CYP3A5;sertraline;Chemical;PA131;Gene
REEP5;sertraline;Chemical;PA134882361;Gene
P3H3;sertraline;Chemical;PA134890414;Gene
ACE;sertraline;Chemical;PA139;Gene
CYP2C19*8;sertraline;Chemical;PA165816524;Haplotype
CYP2C19*9;sertraline;Chemical;PA165816525;Haplotype
CYP2C19*11;sertraline;Chemical;PA165816527;Haplotype
CYP2C19*13;sertraline;Chemical;PA165816529;Haplotype
CYP2C19*14;sertraline;Chemical;PA165816530;Haplotype
CYP2C19*16;sertraline;Chemical;PA165816532;Haplotype
CYP2C19*17;sertraline;Chemical;PA165816533;Haplotype
CYP2C19*19;sertraline;Chemical;PA165816535;Haplotype
CYP2D6*1;sertraline;Chemical;PA165816576;Haplotype
CYP2D6*4;sertraline;Chemical;PA165816579;Haplotype
CYP2B6*1;sertraline;Chemical;PA165818750;Haplotype
CYP2B6*4;sertraline;Chemical;PA165818757;Haplotype
CYP2B6*6;sertraline;Chemical;PA165818762;Haplotype
CYP2B6*9;sertraline;Chemical;PA165818807;Haplotype
HLA-A*33:01;sertraline;Chemical;PA165954144;Haplotype
CYP2C19*1;sertraline;Chemical;PA165980634;Haplotype
CYP2C19*2;sertraline;Chemical;PA165980635;Haplotype
CYP2C19*3;sertraline;Chemical;PA165980636;Haplotype
CYP2C19*4;sertraline;Chemical;PA165980637;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);sertraline;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);sertraline;Chemical;PA166116466;Haplotype
RS6311;sertraline;Chemical;PA166154673;Variant
RS6313;sertraline;Chemical;PA166154675;Variant
RS7997012;sertraline;Chemical;PA166154726;Variant
RS1799752;sertraline;Chemical;PA166155187;Variant
RS13432159;sertraline;Chemical;PA166155835;Variant
RS6295;sertraline;Chemical;PA166156708;Variant
RS153549;sertraline;Chemical;PA166156716;Variant
RS153560;sertraline;Chemical;PA166156717;Variant
RS495794;sertraline;Chemical;PA166156736;Variant
RS2032583;sertraline;Chemical;PA166157317;Variant
RS2235040;sertraline;Chemical;PA166157338;Variant
RS4148739;sertraline;Chemical;PA166157386;Variant
RS28401781;sertraline;Chemical;PA166157485;Variant
RS57098334;sertraline;Chemical;PA166158926;Variant
RS5441;sertraline;Chemical;PA166185647;Variant
GNB3;sertraline;Chemical;PA176;Gene
HTR1A;sertraline;Chemical;PA192;Gene
HTR2A;sertraline;Chemical;PA193;Gene
HTR2C;sertraline;Chemical;PA194;Gene
ABCB1;sertraline;Chemical;PA267;Gene
CYP1A2;sertraline;Chemical;PA27093;Gene
DRD2;sertraline;Chemical;PA27478;Gene
SLC6A4;sertraline;Chemical;PA312;Gene
POLG;sertraline;Chemical;PA33500;Gene
HLA-A;sertraline;Chemical;PA35055;Gene
HLA-B;sertraline;Chemical;PA35056;Gene
SRP19;sertraline;Chemical;PA36124;Gene
UGT1A4;sertraline;Chemical;PA37179;Gene
PIMOZIDE;sertraline;Chemical;PA450965;Chemical
PAIN;rs1277441;Variant;PA445208;Disease
PAIN, POSTOPERATIVE;rs1277441;Variant;PA445210;Disease
MORPHINE;rs1277441;Variant;PA450550;Chemical
OPIOIDS;rs1277441;Variant;PA452618;Chemical
TUBERCULOSIS;rs10946739;Variant;PA445941;Disease
RIFAMPIN;rs10946739;Variant;PA451250;Chemical
GEFITINIB;CYP2D6*98;Haplotype;PA131301952;Chemical
ATOMOXETINE;CYP2D6*98;Haplotype;PA134688071;Chemical
TOLTERODINE;CYP2D6*98;Haplotype;PA164746757;Chemical
BUFURALOL;CYP2D6*98;Haplotype;PA166110256;Chemical
DAPOXETINE;CYP2D6*98;Haplotype;PA166151992;Chemical
AMITRIPTYLINE;CYP2D6*98;Haplotype;PA448385;Chemical
CITALOPRAM;CYP2D6*98;Haplotype;PA449015;Chemical
DEXTROMETHORPHAN;CYP2D6*98;Haplotype;PA449273;Chemical
METHADONE;CYP2D6*98;Haplotype;PA450401;Chemical
RISPERIDONE;CYP2D6*98;Haplotype;PA451257;Chemical
TAMOXIFEN;CYP2D6*98;Haplotype;PA451581;Chemical
VENLAFAXINE;CYP2D6*98;Haplotype;PA451866;Chemical
CFTR;rs397508678;Variant;PA109;Gene
IVACAFTOR;rs397508678;Variant;PA165950341;Chemical
SCHIZOPHRENIA;rs1062613;Variant;PA447216;Disease
CLOZAPINE;rs1062613;Variant;PA449061;Chemical
RS16944;etidronic acid;Chemical;PA166155587;Variant
IL1B;etidronic acid;Chemical;PA29808;Gene
ANALGESICS;rs6275;Variant;PA164712362;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;rs6275;Variant;PA164712462;Chemical
ERGOT ALKALOIDS;rs6275;Variant;PA164712741;Chemical
HEROIN DEPENDENCE;rs6275;Variant;PA444460;Disease
MIGRAINE WITHOUT AURA;rs6275;Variant;PA444949;Disease
BIPOLAR DISORDER;rs6275;Variant;PA447199;Disease
DEPRESSION;rs6275;Variant;PA447278;Disease
METHADONE;rs6275;Variant;PA450401;Chemical
OLANZAPINE;rs6275;Variant;PA450688;Chemical
RIZATRIPTAN;rs6275;Variant;PA451264;Chemical
SUMATRIPTAN;rs6275;Variant;PA451566;Chemical
OPIOIDS;rs6275;Variant;PA452618;Chemical
ANTIEPILEPTICS;SCN2A;Gene;PA143485705;Chemical
EPILEPSY;SCN2A;Gene;PA444065;Disease
CARBAMAZEPINE;SCN2A;Gene;PA448785;Chemical
LAMOTRIGINE;SCN2A;Gene;PA450164;Chemical
OXCARBAZEPINE;SCN2A;Gene;PA450732;Chemical
PHENOBARBITAL;SCN2A;Gene;PA450911;Chemical
PHENYTOIN;SCN2A;Gene;PA450947;Chemical
TOPIRAMATE;SCN2A;Gene;PA451728;Chemical
VALPROIC ACID;SCN2A;Gene;PA451846;Chemical
ECULIZUMAB;CHRNA4;Gene;PA164776637;Chemical
VARENICLINE;CHRNA4;Gene;PA164781343;Chemical
EFGARTIGIMOD ALFA;CHRNA4;Gene;PA166268781;Chemical
RAVULIZUMAB;CHRNA4;Gene;PA166277861;Chemical
ROZANOLIXIZUMAB;CHRNA4;Gene;PA166313325;Chemical
ZILUCOPLAN;CHRNA4;Gene;PA166328901;Chemical
ALCOHOL ABUSE;CHRNA4;Gene;PA443309;Disease
TOBACCO USE DISORDER;CHRNA4;Gene;PA445876;Disease
ETHANOL;CHRNA4;Gene;PA448073;Chemical
NICOTINE;CHRNA4;Gene;PA450626;Chemical
FLUOROURACIL;ABCG1;Gene;PA128406956;Chemical
COLORECTAL NEOPLASMS;ABCG1;Gene;PA446108;Disease
IRINOTECAN;ABCG1;Gene;PA450085;Chemical
LEUCOVORIN;ABCG1;Gene;PA450198;Chemical
OPIOID-RELATED DISORDERS;rs62368105;Variant;PA445043;Disease
BUPRENORPHINE;rs62368105;Variant;PA448685;Chemical
ESCITALOPRAM;rs6318;Variant;PA10074;Chemical
WEIGHT GAIN;rs6318;Variant;PA128406954;Disease
NEUROPATHIC PAIN;rs6318;Variant;PA162263525;Disease
SCHIZOPHRENIA;rs6318;Variant;PA447216;Disease
RISPERIDONE;rs6318;Variant;PA451257;Chemical
RS16944;risedronate;Chemical;PA166155587;Variant
IL1B;risedronate;Chemical;PA29808;Gene
NON-SMALL CELL LUNG CARCINOMA;MUCL3;Gene;PA443622;Disease
THROMBOCYTOPENIA;MUCL3;Gene;PA445846;Disease
CARBOPLATIN;MUCL3;Gene;PA448803;Chemical
GEMCITABINE;MUCL3;Gene;PA449748;Chemical
DRD2;cabergoline;Chemical;PA27478;Gene
FLUOROURACIL;rs2016520;Variant;PA128406956;Chemical
DRUG TOXICITY;rs2016520;Variant;PA443937;Disease
PROSTATIC NEOPLASMS;rs2016520;Variant;PA445425;Disease
CAPECITABINE;rs2016520;Variant;PA448771;Chemical
DOCETAXEL;rs2016520;Variant;PA449383;Chemical
THALIDOMIDE;rs2016520;Variant;PA451644;Chemical
FLUOROURACIL;rs13181;Variant;PA128406956;Chemical
OXALIPLATIN;rs13181;Variant;PA131285527;Chemical
PLATINUM;rs13181;Variant;PA150595617;Chemical
NEPHROTOXICITY;rs13181;Variant;PA162263533;Disease
PLATINUM COMPOUNDS;rs13181;Variant;PA164713176;Chemical
PROGRESSION-FREE SURVIVAL;rs13181;Variant;PA166123026;Disease
ALOPECIA;rs13181;Variant;PA443314;Disease
BREAST NEOPLASMS;rs13181;Variant;PA443560;Disease
NON-SMALL CELL LUNG CARCINOMA;rs13181;Variant;PA443622;Disease
NEOPLASM OF ESOPHAGUS;rs13181;Variant;PA444101;Disease
MESOTHELIOMA;rs13181;Variant;PA444937;Disease
OVARIAN NEOPLASMS;rs13181;Variant;PA445204;Disease
PANCREATIC NEOPLASMS;rs13181;Variant;PA445218;Disease
OSTEOSARCOMA;rs13181;Variant;PA445601;Disease
TESTICULAR NEOPLASMS;rs13181;Variant;PA445828;Disease
COLORECTAL NEOPLASMS;rs13181;Variant;PA446108;Disease
BLEOMYCIN;rs13181;Variant;PA448645;Chemical
CISPLATIN;rs13181;Variant;PA449014;Chemical
DOCETAXEL;rs13181;Variant;PA449383;Chemical
DOXORUBICIN;rs13181;Variant;PA449412;Chemical
ETOPOSIDE;rs13181;Variant;PA449552;Chemical
GEMCITABINE;rs13181;Variant;PA449748;Chemical
LEUCOVORIN;rs13181;Variant;PA450198;Chemical
METHOTREXATE;rs13181;Variant;PA450428;Chemical
ASTHMA;rs1786929;Variant;PA443450;Disease
FLUTICASONE PROPIONATE;rs1786929;Variant;PA449686;Chemical
MONTELUKAST;rs1786929;Variant;PA450546;Chemical
CYP2B6;buspirone;Chemical;PA123;Gene
CYP2C19;buspirone;Chemical;PA124;Gene
CYP2C9;buspirone;Chemical;PA126;Gene
CYP2D6;buspirone;Chemical;PA128;Gene
CYP3A4;buspirone;Chemical;PA130;Gene
CYP3A5;buspirone;Chemical;PA131;Gene
HTR2A;buspirone;Chemical;PA193;Gene
HTR2C;buspirone;Chemical;PA194;Gene
CYP1A2;buspirone;Chemical;PA27093;Gene
DRD2;buspirone;Chemical;PA27478;Gene
SLC6A4;buspirone;Chemical;PA312;Gene
POLG;buspirone;Chemical;PA33500;Gene
HLA-A;buspirone;Chemical;PA35055;Gene
HLA-B;buspirone;Chemical;PA35056;Gene
UGT1A4;buspirone;Chemical;PA37179;Gene
ACE;Calcium channel blockers;Chemical;PA139;Gene
TANC2;Calcium channel blockers;Chemical;PA142670837;Gene
RS588076;Calcium channel blockers;Chemical;PA166154284;Variant
RS10898815;Calcium channel blockers;Chemical;PA166154441;Variant
RS2238032;Calcium channel blockers;Chemical;PA166154533;Variant
RS2239050;Calcium channel blockers;Chemical;PA166154534;Variant
RS2239128;Calcium channel blockers;Chemical;PA166154535;Variant
RS1799752;Calcium channel blockers;Chemical;PA166155187;Variant
RS2429427;Calcium channel blockers;Chemical;PA166155209;Variant
RS1137617;Calcium channel blockers;Chemical;PA166157289;Variant
KCNH2;Calcium channel blockers;Chemical;PA212;Gene
NUMA1;Calcium channel blockers;Chemical;PA31844;Gene
PICALM;Calcium channel blockers;Chemical;PA33287;Gene
CACNA1C;Calcium channel blockers;Chemical;PA83;Gene
SELECTIVE BETA-2-ADRENORECEPTOR AGONISTS;CRHR2;Gene;PA134687887;Chemical
ASTHMA;CRHR2;Gene;PA443450;Disease
MAJOR DEPRESSIVE DISORDER;CRHR2;Gene;PA447321;Disease
SALBUTAMOL;CRHR2;Gene;PA448068;Chemical
CITALOPRAM;CRHR2;Gene;PA449015;Chemical
DRUG TOXICITY;CAPG;Gene;PA443937;Disease
NEUROTOXICITY SYNDROMES;CAPG;Gene;PA446975;Disease
VINCRISTINE;CAPG;Gene;PA451879;Chemical
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;rs56392308;Variant;PA452637;Chemical
CYP2D6;rucaparib;Chemical;PA128;Gene
BRCA1;rucaparib;Chemical;PA25411;Gene
BRCA2;rucaparib;Chemical;PA25412;Gene
CYP1A2;rucaparib;Chemical;PA27093;Gene
ESR1;olaparib;Chemical;PA156;Gene
BRCA1;olaparib;Chemical;PA25411;Gene
BRCA2;olaparib;Chemical;PA25412;Gene
PGR;olaparib;Chemical;PA266;Gene
ERBB2;olaparib;Chemical;PA27844;Gene
ESR2;olaparib;Chemical;PA27886;Gene
PPP2R2A;olaparib;Chemical;PA33668;Gene
OTOTOXICITY;MT-ND1;Gene;PA162263534;Disease
ISEPAMICIN;MT-ND1;Gene;PA166241781;Chemical
MICRONOMICIN;MT-ND1;Gene;PA166241801;Chemical
AMINOGLYCOSIDE ANTIBACTERIALS;MT-ND1;Gene;PA452167;Chemical
ALCOHOL ABUSE;rs7900002;Variant;PA443309;Disease
ETHANOL;rs7900002;Variant;PA448073;Chemical
PEPTIC ULCER DISEASE;EYA1;Gene;PA447240;Disease
ASPIRIN;EYA1;Gene;PA448497;Chemical
UGT1A1*1;tranilast;Chemical;PA166115841;Haplotype
UGT1A1*28;tranilast;Chemical;PA166115842;Haplotype
UGT1A1;tranilast;Chemical;PA420;Gene
DRUGS USED IN ALCOHOL DEPENDENCE;rs13273672;Variant;PA164712718;Chemical
ALCOHOL ABUSE;rs13273672;Variant;PA443309;Disease
CYP2B6;nortriptyline;Chemical;PA123;Gene
CYP2C19;nortriptyline;Chemical;PA124;Gene
CYP2C9;nortriptyline;Chemical;PA126;Gene
CYP2D6;nortriptyline;Chemical;PA128;Gene
CYP3A4;nortriptyline;Chemical;PA130;Gene
CYP3A5;nortriptyline;Chemical;PA131;Gene
SLC39A14;nortriptyline;Chemical;PA134863701;Gene
CYP2D6*1;nortriptyline;Chemical;PA165816576;Haplotype
CYP2D6*2;nortriptyline;Chemical;PA165816577;Haplotype
CYP2D6*3;nortriptyline;Chemical;PA165816578;Haplotype
CYP2D6*4;nortriptyline;Chemical;PA165816579;Haplotype
CYP2D6*6;nortriptyline;Chemical;PA165816581;Haplotype
CYP2D6*10;nortriptyline;Chemical;PA165816582;Haplotype
CYP2D6*17;nortriptyline;Chemical;PA165816583;Haplotype
CYP2D6*41;nortriptyline;Chemical;PA165816584;Haplotype
CYP2D6*5;nortriptyline;Chemical;PA165948092;Haplotype
CYP2C19*1;nortriptyline;Chemical;PA165980634;Haplotype
CYP2C19*2;nortriptyline;Chemical;PA165980635;Haplotype
CYP2C19*3;nortriptyline;Chemical;PA165980636;Haplotype
CYP2D6*1XN;nortriptyline;Chemical;PA165988479;Haplotype
CYP2D6*2XN;nortriptyline;Chemical;PA165988480;Haplotype
CYP2D6*81;nortriptyline;Chemical;PA166123321;Haplotype
RS962369;nortriptyline;Chemical;PA166154303;Variant
RS5443;nortriptyline;Chemical;PA166154486;Variant
RS2500535;nortriptyline;Chemical;PA166157039;Variant
RS1045642;nortriptyline;Chemical;PA166157284;Variant
RS1799983;nortriptyline;Chemical;PA166157303;Variant
RS17060812;nortriptyline;Chemical;PA166157650;Variant
GNB3;nortriptyline;Chemical;PA176;Gene
HTR2A;nortriptyline;Chemical;PA193;Gene
HTR2C;nortriptyline;Chemical;PA194;Gene
NOS3;nortriptyline;Chemical;PA254;Gene
ABCB1;nortriptyline;Chemical;PA267;Gene
CYP1A2;nortriptyline;Chemical;PA27093;Gene
DRD2;nortriptyline;Chemical;PA27478;Gene
SLC6A4;nortriptyline;Chemical;PA312;Gene
BDNF;nortriptyline;Chemical;PA31891;Gene
POLG;nortriptyline;Chemical;PA33500;Gene
HLA-A;nortriptyline;Chemical;PA35055;Gene
HLA-B;nortriptyline;Chemical;PA35056;Gene
UGT1A4;nortriptyline;Chemical;PA37179;Gene
UST;nortriptyline;Chemical;PA38213;Gene
ABCC2;atazanavir;Chemical;PA116;Gene
CYP2C19;atazanavir;Chemical;PA124;Gene
CYP3A4;atazanavir;Chemical;PA130;Gene
CYP3A5;atazanavir;Chemical;PA131;Gene
SORCS2;atazanavir;Chemical;PA134902026;Gene
RALTEGRAVIR;atazanavir;Chemical;PA164888966;Chemical
UGT1A1*1;atazanavir;Chemical;PA166115841;Haplotype
UGT1A1*28;atazanavir;Chemical;PA166115842;Haplotype
UGT1A1*36;atazanavir;Chemical;PA166115843;Haplotype
UGT1A1*37;atazanavir;Chemical;PA166115844;Haplotype
UGT1A1*80;atazanavir;Chemical;PA166115850;Haplotype
UGT1A1*6;atazanavir;Chemical;PA166115858;Haplotype
BILIRUBIN;atazanavir;Chemical;PA166123346;Chemical
CYP3A5*1;atazanavir;Chemical;PA166128213;Haplotype
CYP3A5*3;atazanavir;Chemical;PA166128219;Haplotype
CYP3A5*6;atazanavir;Chemical;PA166128233;Haplotype
CYP3A5*7;atazanavir;Chemical;PA166128234;Haplotype
RS717620;atazanavir;Chemical;PA166153953;Variant
RS8330;atazanavir;Chemical;PA166155584;Variant
RS887829;atazanavir;Chemical;PA166155607;Variant
RS1042640;atazanavir;Chemical;PA166155616;Variant
RS3806596;atazanavir;Chemical;PA166155712;Variant
RS7586110;atazanavir;Chemical;PA166155768;Variant
RS10929303;atazanavir;Chemical;PA166155795;Variant
RS17863778;atazanavir;Chemical;PA166155853;Variant
RS17868323;atazanavir;Chemical;PA166155857;Variant
RS2472677;atazanavir;Chemical;PA166156358;Variant
RS1045642;atazanavir;Chemical;PA166157284;Variant
RS2032582;atazanavir;Chemical;PA166157316;Variant
RS2740574;atazanavir;Chemical;PA166157367;Variant
RS73208473;atazanavir;Chemical;PA166181200;Variant
UGT1A1*80+*28;atazanavir;Chemical;PA166220483;Haplotype
ABCB1;atazanavir;Chemical;PA267;Gene
UGT1A3;atazanavir;Chemical;PA37178;Gene
UGT1A7;atazanavir;Chemical;PA37182;Gene
NR1I2;atazanavir;Chemical;PA378;Gene
UGT1A1;atazanavir;Chemical;PA420;Gene
COLORECTAL NEOPLASMS;rs2302821;Variant;PA446108;Disease
CELECOXIB;rs2302821;Variant;PA448871;Chemical
ACE;Headache Disorders;Disease;PA139;Gene
RS1799752;Headache Disorders;Disease;PA166155187;Variant
LEUKEMIA, MYELOID, ACUTE;rs3750117;Variant;PA444760;Disease
NEOPLASMS;rs3750117;Variant;PA445062;Disease
CYTARABINE;rs3750117;Variant;PA449177;Chemical
GEMCITABINE;rs3750117;Variant;PA449748;Chemical
IDARUBICIN;rs3750117;Variant;PA449961;Chemical
ACQUIRED LONG QT SYNDROME (ALQTS);rs10918594;Variant;PA447300;Disease
VERAPAMIL;rs10918594;Variant;PA451868;Chemical
CFTR;rs397508758;Variant;PA109;Gene
IVACAFTOR;rs397508758;Variant;PA165950341;Chemical
OSTEOSARCOMA;rs4148324;Variant;PA445601;Disease
METHOTREXATE;rs4148324;Variant;PA450428;Chemical
SUBSTANCE-RELATED DISORDERS;rs17552189;Variant;PA446876;Disease
NUDT15;Pancytopenia;Disease;PA134963132;Gene
TPMT*1;Pancytopenia;Disease;PA165819268;Haplotype
TPMT*2;Pancytopenia;Disease;PA165819269;Haplotype
TPMT*3A;Pancytopenia;Disease;PA165819270;Haplotype
TPMT*3C;Pancytopenia;Disease;PA165819272;Haplotype
TPMT*9;Pancytopenia;Disease;PA165819279;Haplotype
RS116855232;Pancytopenia;Disease;PA166154759;Variant
RS746071566;Pancytopenia;Disease;PA166165231;Variant
TPMT;Pancytopenia;Disease;PA356;Gene
PITRAKINRA;rs1029489;Variant;PA165983754;Chemical
ASTHMA;rs1029489;Variant;PA443450;Disease
RS6166;gonadotropin,chorionic;Chemical;PA166155582;Variant
FSHR;gonadotropin,chorionic;Chemical;PA28386;Gene
DULOXETINE;rs56229625;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs56229625;Variant;PA447321;Disease
MAP2K7;MAPK11;Gene;PA284;Gene
MAP2K1;MAPK11;Gene;PA30584;Gene
MAP2K2;MAPK11;Gene;PA30587;Gene
MAP2K3;MAPK11;Gene;PA30588;Gene
MAP2K4;MAPK11;Gene;PA30589;Gene
MAP2K5;MAPK11;Gene;PA30590;Gene
MAP2K6;MAPK11;Gene;PA30591;Gene
SORAFENIB;MAPK11;Gene;PA7000;Chemical
COMT;Pain, Postoperative;Disease;PA117;Gene
CYP2B6;Pain, Postoperative;Disease;PA123;Gene
CYP2C8;Pain, Postoperative;Disease;PA125;Gene
CYP2C9;Pain, Postoperative;Disease;PA126;Gene
CYP2D6;Pain, Postoperative;Disease;PA128;Gene
CYP3A4;Pain, Postoperative;Disease;PA130;Gene
CYP3A5;Pain, Postoperative;Disease;PA131;Gene
TAOK3;Pain, Postoperative;Disease;PA134975064;Gene
CYP2C9*1;Pain, Postoperative;Disease;PA165816542;Haplotype
CYP2C9*2;Pain, Postoperative;Disease;PA165816543;Haplotype
CYP2C9*3;Pain, Postoperative;Disease;PA165816544;Haplotype
CYP2D6*1;Pain, Postoperative;Disease;PA165816576;Haplotype
CYP2D6*2;Pain, Postoperative;Disease;PA165816577;Haplotype
CYP2D6*3;Pain, Postoperative;Disease;PA165816578;Haplotype
CYP2D6*4;Pain, Postoperative;Disease;PA165816579;Haplotype
CYP2D6*6;Pain, Postoperative;Disease;PA165816581;Haplotype
CYP2D6*10;Pain, Postoperative;Disease;PA165816582;Haplotype
CYP2D6*17;Pain, Postoperative;Disease;PA165816583;Haplotype
CYP2D6*41;Pain, Postoperative;Disease;PA165816584;Haplotype
CYP2B6*6;Pain, Postoperative;Disease;PA165818762;Haplotype
CYP3A4*1;Pain, Postoperative;Disease;PA165819201;Haplotype
CYP3A4*18;Pain, Postoperative;Disease;PA165819240;Haplotype
CYP2D6*5;Pain, Postoperative;Disease;PA165948092;Haplotype
CYP2D6*9;Pain, Postoperative;Disease;PA165948317;Haplotype
CYP2C8*2;Pain, Postoperative;Disease;PA165958684;Haplotype
CYP2C8*3;Pain, Postoperative;Disease;PA165958685;Haplotype
CYP2C8*4;Pain, Postoperative;Disease;PA165958686;Haplotype
CYP3A5*1;Pain, Postoperative;Disease;PA166128213;Haplotype
CYP3A5*3;Pain, Postoperative;Disease;PA166128219;Haplotype
CYP3A5*6;Pain, Postoperative;Disease;PA166128233;Haplotype
RS3845446;Pain, Postoperative;Disease;PA166153757;Variant
RS1143634;Pain, Postoperative;Disease;PA166155630;Variant
RS2952768;Pain, Postoperative;Disease;PA166155692;Variant
RS2835859;Pain, Postoperative;Disease;PA166156003;Variant
RS4680;Pain, Postoperative;Disease;PA166156024;Variant
RS6269;Pain, Postoperative;Disease;PA166156027;Variant
RS7439366;Pain, Postoperative;Disease;PA166156619;Variant
RS11959113;Pain, Postoperative;Disease;PA166156872;Variant
RS1799971;Pain, Postoperative;Disease;PA166156991;Variant
RS2275913;Pain, Postoperative;Disease;PA166157030;Variant
RS1045642;Pain, Postoperative;Disease;PA166157284;Variant
RS1128503;Pain, Postoperative;Disease;PA166157288;Variant
RS2032582;Pain, Postoperative;Disease;PA166157316;Variant
RS2242480;Pain, Postoperative;Disease;PA166157345;Variant
RS696;Pain, Postoperative;Disease;PA166159900;Variant
RS3804100;Pain, Postoperative;Disease;PA166176322;Variant
RS4587017;Pain, Postoperative;Disease;PA166180080;Variant
RS10028494;Pain, Postoperative;Disease;PA166180083;Variant
RS7583431;Pain, Postoperative;Disease;PA166180145;Variant
RS9397685;Pain, Postoperative;Disease;PA166180172;Variant
RS13093031;Pain, Postoperative;Disease;PA166180183;Variant
RS6961071;Pain, Postoperative;Disease;PA166180184;Variant
RS795484;Pain, Postoperative;Disease;PA166182407;Variant
RS1277441;Pain, Postoperative;Disease;PA166182408;Variant
RS1718125;Pain, Postoperative;Disease;PA166184626;Variant
RS145837941;Pain, Postoperative;Disease;PA166196166;Variant
RS1800035;Pain, Postoperative;Disease;PA166209221;Variant
RS201376588;Pain, Postoperative;Disease;PA166209222;Variant
RS775887911;Pain, Postoperative;Disease;PA166209223;Variant
CYP2C8*1;Pain, Postoperative;Disease;PA166242948;Haplotype
RS958804;Pain, Postoperative;Disease;PA166254981;Variant
RS7858836;Pain, Postoperative;Disease;PA166254982;Variant
ASTN2;Pain, Postoperative;Disease;PA25076;Gene
ATF2;Pain, Postoperative;Disease;PA25084;Gene
CACNA1E;Pain, Postoperative;Disease;PA26009;Gene
CALCA;Pain, Postoperative;Disease;PA26029;Gene
ABCB1;Pain, Postoperative;Disease;PA267;Gene
IL17A;Pain, Postoperative;Disease;PA29794;Gene
IL1B;Pain, Postoperative;Disease;PA29808;Gene
KCNJ6;Pain, Postoperative;Disease;PA30049;Gene
NFKBIA;Pain, Postoperative;Disease;PA31601;Gene
OPRM1;Pain, Postoperative;Disease;PA31945;Gene
P2RX7;Pain, Postoperative;Disease;PA32866;Gene
ADRA2A;Pain, Postoperative;Disease;PA35;Gene
UGT2B7;Pain, Postoperative;Disease;PA361;Gene
TLR2;Pain, Postoperative;Disease;PA36550;Gene
MAJOR DEPRESSIVE DISORDER;RAPGEF5;Gene;PA447321;Disease
ANTIDEPRESSANTS;RAPGEF5;Gene;PA452229;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs9032;Variant;PA447197;Disease
METHYLPHENIDATE;rs9032;Variant;PA450464;Chemical
BUPROPION;rs374099483;Variant;PA448687;Chemical
EFAVIRENZ;rs374099483;Variant;PA449441;Chemical
HYPERTENSION;rs10792367;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs10792367;Variant;PA449899;Chemical
DEXTROMETHORPHAN;CYP2D6*169;Haplotype;PA449273;Chemical
ADALIMUMAB;IL6;Gene;PA10004;Chemical
CRISPLD2;IL6;Gene;PA142672077;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;IL6;Gene;PA164713366;Chemical
PEGINTERFERON ALFA-2B;IL6;Gene;PA164784024;Chemical
RHEUMATOID ARTHRITIS;IL6;Gene;PA443434;Disease
CARDIOVASCULAR DISEASE;IL6;Gene;PA443635;Disease
ULCERATIVE COLITIS;IL6;Gene;PA443750;Disease
PSORIASIS;IL6;Gene;PA445451;Disease
INFLAMMATORY BOWEL DISEASES;IL6;Gene;PA446116;Disease
CHRONIC HEPATITIS C VIRUS INFECTION;IL6;Gene;PA446863;Disease
ETANERCEPT;IL6;Gene;PA449515;Chemical
FENOFIBRATE;IL6;Gene;PA449594;Chemical
RIBAVIRIN;IL6;Gene;PA451241;Chemical
RITUXIMAB;IL6;Gene;PA451261;Chemical
INFLIXIMAB;IL6;Gene;PA452639;Chemical
DPYD;rs199549923;Variant;PA145;Gene
CAPECITABINE;rs199549923;Variant;PA448771;Chemical
APNEA;rs568724445;Variant;PA443407;Disease
SUCCINYLCHOLINE;rs568724445;Variant;PA451522;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;CYCSP5;Gene;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;CYCSP5;Gene;PA166120929;Disease
ACQUIRED IMMUNODEFICIENCY SYNDROME;CYCSP5;Gene;PA443250;Disease
EPIDERMAL NECROLYSIS, TOXIC;CYCSP5;Gene;PA444059;Disease
STEVENS-JOHNSON SYNDROME;CYCSP5;Gene;PA445738;Disease
ALLOPURINOL;CYCSP5;Gene;PA448320;Chemical
NEVIRAPINE;CYCSP5;Gene;PA450616;Chemical
RASBURICASE;CYB5R3;Gene;PA10176;Chemical
BUPIVACAINE;CYB5R3;Gene;PA135057240;Chemical
SODIUM NITRITE;CYB5R3;Gene;PA166115361;Chemical
LIDOCAINE / PRILOCAINE;CYB5R3;Gene;PA166176018;Chemical
LIDOCAINE AND TETRACAINE;CYB5R3;Gene;PA166182735;Chemical
ARTICAINE / EPINEPHRINE;CYB5R3;Gene;PA166182783;Chemical
OXYMETAZOLINE AND TETRACAINE;CYB5R3;Gene;PA166182885;Chemical
CYB5A;CYB5R3;Gene;PA27068;Gene
KIDNEY FAILURE, CHRONIC;CYB5R3;Gene;PA444684;Disease
METHEMOGLOBINEMIA;CYB5R3;Gene;PA444942;Disease
CEFTRIAXONE;CYB5R3;Gene;PA448866;Chemical
CHLOROPROCAINE;CYB5R3;Gene;PA448946;Chemical
DAPSONE;CYB5R3;Gene;PA449211;Chemical
ISOSORBIDE DINITRATE;CYB5R3;Gene;PA450125;Chemical
ISOSORBIDE MONONITRATE;CYB5R3;Gene;PA450126;Chemical
MELOXICAM;CYB5R3;Gene;PA450353;Chemical
METOCLOPRAMIDE;CYB5R3;Gene;PA450475;Chemical
PRIMAQUINE;CYB5R3;Gene;PA451103;Chemical
ROPIVACAINE;CYB5R3;Gene;PA451271;Chemical
CYP3A5;maraviroc;Chemical;PA131;Gene
CYP3A5*1;maraviroc;Chemical;PA166128213;Haplotype
CYP3A5*3;maraviroc;Chemical;PA166128219;Haplotype
CYP3A5*6;maraviroc;Chemical;PA166128233;Haplotype
CYP3A5*7;maraviroc;Chemical;PA166128234;Haplotype
CCR5;maraviroc;Chemical;PA26170;Gene
FLUOROURACIL;rs11479;Variant;PA128406956;Chemical
NEOPLASMS;rs11479;Variant;PA445062;Disease
CAPECITABINE;rs11479;Variant;PA448771;Chemical
DIABETES MELLITUS, TYPE 2;rs5030868;Variant;PA443890;Disease
GLYBURIDE;rs5030868;Variant;PA449782;Chemical
G6PD;sulfisoxazole;Chemical;PA28469;Gene
NR1I2;sulfisoxazole;Chemical;PA378;Gene
COMT;Panic Disorder;Disease;PA117;Gene
CYP2C19;Panic Disorder;Disease;PA124;Gene
CYP2C19*1;Panic Disorder;Disease;PA165980634;Haplotype
CYP2C19*2;Panic Disorder;Disease;PA165980635;Haplotype
CYP2C19*3;Panic Disorder;Disease;PA165980636;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);Panic Disorder;Disease;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);Panic Disorder;Disease;PA166116466;Haplotype
RS6295;Panic Disorder;Disease;PA166156708;Variant
RS57098334;Panic Disorder;Disease;PA166158926;Variant
HTR1A;Panic Disorder;Disease;PA192;Gene
SLC6A4;Panic Disorder;Disease;PA312;Gene
GNAI1;ADCY7;Gene;PA172;Gene
GNAI3;ADCY7;Gene;PA173;Gene
GNAS;ADCY7;Gene;PA175;Gene
GNAI2;ADCY7;Gene;PA24347;Gene
KIDNEY TRANSPLANTATION;IL3;Gene;PA165817016;Disease
TACROLIMUS;IL3;Gene;PA451578;Chemical
BREAST NEOPLASMS;rs4870061;Variant;PA443560;Disease
LETROZOLE;rs4870061;Variant;PA450196;Chemical
HLA-DRB3*01:01;heparin-induced thrombocytopenia;Disease;PA165952388;Haplotype
HLA-DRB3;heparin-induced thrombocytopenia;Disease;PA35074;Gene
ATAZANAVIR;CYP3A5*7;Haplotype;PA10251;Chemical
CYP2C19;CYP3A5*7;Haplotype;PA124;Gene
MARAVIROC;CYP3A5*7;Haplotype;PA164768835;Chemical
KIDNEY TRANSPLANTATION;CYP3A5*7;Haplotype;PA165817016;Disease
TRANSPLANT REJECTION;CYP3A5*7;Haplotype;PA166114454;Disease
LUNG TRANSPLANTATION;CYP3A5*7;Haplotype;PA166114457;Disease
HEART TRANSPLANTATION;CYP3A5*7;Haplotype;PA166114458;Disease
HEMATOPOIETIC STEM CELL TRANSPLANTATION;CYP3A5*7;Haplotype;PA166123007;Disease
DELAYED GRAFT FUNCTION;CYP3A5*7;Haplotype;PA166123755;Disease
MAVACAMTEN;CYP3A5*7;Haplotype;PA166272922;Chemical
HIV INFECTIONS;CYP3A5*7;Haplotype;PA447230;Disease
LIVER TRANSPLANTATION;CYP3A5*7;Haplotype;PA447247;Disease
AMLODIPINE;CYP3A5*7;Haplotype;PA448388;Chemical
RITONAVIR;CYP3A5*7;Haplotype;PA451260;Chemical
TACROLIMUS;CYP3A5*7;Haplotype;PA451578;Chemical
HLA-A*02:01;tebentafusp;Chemical;PA166123427;Haplotype
HLA-A;tebentafusp;Chemical;PA35055;Gene
PERIPHERAL NERVOUS SYSTEM DISEASES;SAMHD1;Gene;PA445301;Disease
HIV INFECTIOUS DISEASE;SAMHD1;Gene;PA447230;Disease
STAVUDINE;SAMHD1;Gene;PA451494;Chemical
SCN5A;Brugada syndrome;Disease;PA304;Gene
SCHIZOPHRENIA;Brugada syndrome;Disease;PA447216;Disease
ESSENTIAL HYPERTENSION;rs11189015;Variant;PA447288;Disease
HYDROCHLOROTHIAZIDE;rs11189015;Variant;PA449899;Chemical
ESR1;abemaciclib;Chemical;PA156;Gene
PGR;abemaciclib;Chemical;PA266;Gene
ERBB2;abemaciclib;Chemical;PA27844;Gene
ESR2;abemaciclib;Chemical;PA27886;Gene
MKI67;abemaciclib;Chemical;PA30825;Gene
DPYD;rs145773863;Variant;PA145;Gene
CAPECITABINE;rs145773863;Variant;PA448771;Chemical
MYOTONIA;rs80338792;Variant;PA445030;Disease
FLECAINIDE;rs80338792;Variant;PA449646;Chemical
MEXILETINE;rs80338792;Variant;PA450488;Chemical
EPILEPSY;CYP2C9*42;Haplotype;PA444065;Disease
DICLOFENAC;CYP2C9*42;Haplotype;PA449293;Chemical
PHENYTOIN;CYP2C9*42;Haplotype;PA450947;Chemical
ABCB1;hydroxocobalamin;Chemical;PA267;Gene
CYP2B6;busulfan;Chemical;PA123;Gene
CYP2C19;busulfan;Chemical;PA124;Gene
CYP2C9;busulfan;Chemical;PA126;Gene
CYP2B6*1;busulfan;Chemical;PA165818750;Haplotype
CYP2B6*5;busulfan;Chemical;PA165818760;Haplotype
CYP2B6*9;busulfan;Chemical;PA165818807;Haplotype
RS3754446;busulfan;Chemical;PA166153750;Variant
RS1799853;busulfan;Chemical;PA166153972;Variant
RS12248560;busulfan;Chemical;PA166154147;Variant
RS3957357;busulfan;Chemical;PA166157094;Variant
RS1021737;busulfan;Chemical;PA166161880;Variant
GSTM1;busulfan;Chemical;PA182;Gene
ABL1;busulfan;Chemical;PA24413;Gene
BCR;busulfan;Chemical;PA25321;Gene
CTH;busulfan;Chemical;PA27004;Gene
GSTA1;busulfan;Chemical;PA29016;Gene
GSTP1;busulfan;Chemical;PA29028;Gene
TMEM43;Urinary Bladder Neoplasms;Disease;PA134871907;Gene
GALNT18;Urinary Bladder Neoplasms;Disease;PA134950929;Gene
TP63;Urinary Bladder Neoplasms;Disease;PA162406776;Gene
RS2228001;Urinary Bladder Neoplasms;Disease;PA166156345;Variant
RS3814055;Urinary Bladder Neoplasms;Disease;PA166156383;Variant
RS6785049;Urinary Bladder Neoplasms;Disease;PA166156411;Variant
RS1128503;Urinary Bladder Neoplasms;Disease;PA166157288;Variant
RS2032582;Urinary Bladder Neoplasms;Disease;PA166157316;Variant
RS244898;Urinary Bladder Neoplasms;Disease;PA166159488;Variant
RS7937567;Urinary Bladder Neoplasms;Disease;PA166159497;Variant
RS10964552;Urinary Bladder Neoplasms;Disease;PA166159499;Variant
NAT2;Urinary Bladder Neoplasms;Disease;PA18;Gene
ABCB1;Urinary Bladder Neoplasms;Disease;PA267;Gene
CSNK2A3;Urinary Bladder Neoplasms;Disease;PA26958;Gene
FGFR3;Urinary Bladder Neoplasms;Disease;PA28129;Gene
LSP1;Urinary Bladder Neoplasms;Disease;PA30472;Gene
MLLT3;Urinary Bladder Neoplasms;Disease;PA30852;Gene
MSH2;Urinary Bladder Neoplasms;Disease;PA31133;Gene
MYC;Urinary Bladder Neoplasms;Disease;PA31353;Gene
PSCA;Urinary Bladder Neoplasms;Disease;PA33847;Gene
RARS1;Urinary Bladder Neoplasms;Disease;PA34231;Gene
CWC27;Urinary Bladder Neoplasms;Disease;PA35594;Gene
SLC14A1;Urinary Bladder Neoplasms;Disease;PA35810;Gene
TACC3;Urinary Bladder Neoplasms;Disease;PA36301;Gene
XPC;Urinary Bladder Neoplasms;Disease;PA37413;Gene
NR1I2;Urinary Bladder Neoplasms;Disease;PA378;Gene
TOBACCO USE DISORDER;Urinary Bladder Neoplasms;Disease;PA445876;Disease
CCNE1;Urinary Bladder Neoplasms;Disease;PA96;Gene
KIDNEY TRANSPLANTATION;rs72551330;Variant;PA165817016;Disease
MYCOPHENOLATE MOFETIL;rs72551330;Variant;PA450566;Chemical
SULFINPYRAZONE;rs72551330;Variant;PA451550;Chemical
FLT3;midostaurin;Chemical;PA28181;Gene
KIT;midostaurin;Chemical;PA30128;Gene
NPM1;midostaurin;Chemical;PA31712;Gene
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;rs2734583;Variant;PA166120927;Disease
STEVENS-JOHNSON SYNDROME;rs2734583;Variant;PA445738;Disease
ALLOPURINOL;rs2734583;Variant;PA448320;Chemical
CFTR;rs145449046;Variant;PA109;Gene
IVACAFTOR;rs145449046;Variant;PA165950341;Chemical
MAJOR DEPRESSIVE DISORDER;rs17614642;Variant;PA447321;Disease
BUPROPION;rs17614642;Variant;PA448687;Chemical
ARACHIDONIC ACID;rs1292029455;Variant;PA166178659;Chemical
TRANSPLANTATION;TPMT*2;Haplotype;PA134850491;Disease
NUDT15;TPMT*2;Haplotype;PA134963132;Gene
KIDNEY TRANSPLANTATION;TPMT*2;Haplotype;PA165817016;Disease
MYELOSUPPRESSION;TPMT*2;Haplotype;PA165817398;Disease
TRANSPLANT REJECTION;TPMT*2;Haplotype;PA166114454;Disease
HEART TRANSPLANTATION;TPMT*2;Haplotype;PA166114458;Disease
EVENT-FREE SURVIVAL;TPMT*2;Haplotype;PA166123366;Disease
DISCONTINUATION;TPMT*2;Haplotype;PA166123507;Disease
DOSE REDUCTION;TPMT*2;Haplotype;PA166159953;Disease
TPMT;TPMT*2;Haplotype;PA356;Gene
CROHN DISEASE;TPMT*2;Haplotype;PA443815;Disease
DRUG TOXICITY;TPMT*2;Haplotype;PA443937;Disease
INFLAMMATION;TPMT*2;Haplotype;PA444620;Disease
LEUKEMIA;TPMT*2;Haplotype;PA444750;Disease
LEUKOPENIA;TPMT*2;Haplotype;PA444773;Disease
NEOPLASMS;TPMT*2;Haplotype;PA445062;Disease
NEUTROPENIA;TPMT*2;Haplotype;PA445113;Disease
PANCYTOPENIA;TPMT*2;Haplotype;PA445221;Disease
RHEUMATIC DISEASES;TPMT*2;Haplotype;PA445555;Disease
THROMBOCYTOPENIA;TPMT*2;Haplotype;PA445846;Disease
INFLAMMATORY BOWEL DISEASES;TPMT*2;Haplotype;PA446116;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;TPMT*2;Haplotype;PA446155;Disease
AZATHIOPRINE;TPMT*2;Haplotype;PA448515;Chemical
CISPLATIN;TPMT*2;Haplotype;PA449014;Chemical
CYCLOSPORINE;TPMT*2;Haplotype;PA449167;Chemical
MERCAPTOPURINE;TPMT*2;Haplotype;PA450379;Chemical
METHOTREXATE;TPMT*2;Haplotype;PA450428;Chemical
PREDNISONE;TPMT*2;Haplotype;PA451100;Chemical
THIOGUANINE;TPMT*2;Haplotype;PA451663;Chemical
PURINE ANALOGUES;TPMT*2;Haplotype;PA452634;Chemical
NEUTROPENIA;rs471760;Variant;PA445113;Disease
PANCREATIC NEOPLASMS;rs471760;Variant;PA445218;Disease
GEMCITABINE;rs471760;Variant;PA449748;Chemical
AGRANULOCYTOSIS;HLA-DRB5*02:02;Haplotype;PA443297;Disease
SCHIZOPHRENIA;HLA-DRB5*02:02;Haplotype;PA447216;Disease
CLOZAPINE;HLA-DRB5*02:02;Haplotype;PA449061;Chemical
DAUNORUBICIN;AKR7A2;Gene;PA449212;Chemical
DOXORUBICIN;AKR7A2;Gene;PA449412;Chemical
PSYCHOTIC DISORDER;DAOA;Gene;PA447215;Disease
METHAMPHETAMINE;DAOA;Gene;PA450403;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs10782001;Variant;PA164713366;Chemical
PSORIASIS;rs10782001;Variant;PA445451;Disease
HEROIN DEPENDENCE;rs562859;Variant;PA444460;Disease
HEROIN;rs562859;Variant;PA452619;Chemical
CETUXIMAB;CCND1;Gene;PA10040;Chemical
FLUOROURACIL;CCND1;Gene;PA128406956;Chemical
LAPATINIB;CCND1;Gene;PA152241907;Chemical
BREAST NEOPLASMS;CCND1;Gene;PA443560;Disease
COLONIC NEOPLASMS;CCND1;Gene;PA443756;Disease
LYMPHOMA;CCND1;Gene;PA444840;Disease
OSTEOSARCOMA;CCND1;Gene;PA445601;Disease
COLORECTAL NEOPLASMS;CCND1;Gene;PA446108;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;CCND1;Gene;PA446155;Disease
CISPLATIN;CCND1;Gene;PA449014;Chemical
DOXORUBICIN;CCND1;Gene;PA449412;Chemical
METHOTREXATE;CCND1;Gene;PA450428;Chemical
AKT1;BAD;Gene;PA24684;Gene
FLUOROURACIL;TP53;Gene;PA128406956;Chemical
PLATINUM COMPOUNDS;TP53;Gene;PA164713176;Chemical
LI-FRAUMENI SYNDROME;TP53;Gene;PA165108952;Disease
OVERALL SURVIVAL;TP53;Gene;PA166123207;Disease
VENETOCLAX;TP53;Gene;PA166153473;Chemical
ZANUBRUTINIB;TP53;Gene;PA166204001;Chemical
RS387907272;TP53;Gene;PA166224421;Variant
PIRTOBRUTINIB;TP53;Gene;PA166328845;Chemical
MDM2;TP53;Gene;PA30718;Gene
BREAST NEOPLASMS;TP53;Gene;PA443560;Disease
DRUG TOXICITY;TP53;Gene;PA443937;Disease
NEUTROPENIA;TP53;Gene;PA445113;Disease
CYCLOPHOSPHAMIDE;TP53;Gene;PA449165;Chemical
EPIRUBICIN;TP53;Gene;PA449476;Chemical
ANTINEOPLASTIC AGENTS;TP53;Gene;PA452621;Chemical
LORNOXICAM;CYP2C9*13;Haplotype;PA165958395;Chemical
HEART VALVE REPLACEMENT;CYP2C9*13;Haplotype;PA166123431;Disease
ATRIAL FIBRILLATION;CYP2C9*13;Haplotype;PA443459;Disease
EPILEPSY;CYP2C9*13;Haplotype;PA444065;Disease
CELECOXIB;CYP2C9*13;Haplotype;PA448871;Chemical
DICLOFENAC;CYP2C9*13;Haplotype;PA449293;Chemical
LOSARTAN;CYP2C9*13;Haplotype;PA450268;Chemical
MELOXICAM;CYP2C9*13;Haplotype;PA450353;Chemical
PHENYTOIN;CYP2C9*13;Haplotype;PA450947;Chemical
WARFARIN;CYP2C9*13;Haplotype;PA451906;Chemical
ZAFIRLUKAST;CYP2C9*13;Haplotype;PA451949;Chemical
DRUGS USED IN ALCOHOL DEPENDENCE;GATA4;Gene;PA164712718;Chemical
ALCOHOL ABUSE;GATA4;Gene;PA443309;Disease
WARFARIN;GATA4;Gene;PA451906;Chemical
SACROSIDASE;SI;Gene;PA166277821;Chemical
TOXIC LIVER DISEASE;rs11125883;Variant;PA164925725;Disease
DRUG-INDUCED LIVER INJURY;rs11125883;Variant;PA166119041;Disease
ISONIAZID;rs11125883;Variant;PA450112;Chemical
TPMT*1;purine analogues;Chemical;PA165819268;Haplotype
TPMT*2;purine analogues;Chemical;PA165819269;Haplotype
TPMT*3A;purine analogues;Chemical;PA165819270;Haplotype
TPMT*3B;purine analogues;Chemical;PA165819271;Haplotype
TPMT*3C;purine analogues;Chemical;PA165819272;Haplotype
RS1127354;purine analogues;Chemical;PA166155915;Variant
ITPA;purine analogues;Chemical;PA29973;Gene
RAC1;purine analogues;Chemical;PA34162;Gene
TPMT;purine analogues;Chemical;PA356;Gene
ABCC4;purine analogues;Chemical;PA397;Gene
CYP2C19;normeperidine;Chemical;PA124;Gene
CYP2C19*17;normeperidine;Chemical;PA165816533;Haplotype
CYP2C19*1;normeperidine;Chemical;PA165980634;Haplotype
CES1;methylphenidate;Chemical;PA107;Gene
COMT;methylphenidate;Chemical;PA117;Gene
CYP2D6;methylphenidate;Chemical;PA128;Gene
FARP2;methylphenidate;Chemical;PA134873245;Gene
CORO7;methylphenidate;Chemical;PA134910806;Gene
SENP3;methylphenidate;Chemical;PA134933213;Gene
ADGRL3;methylphenidate;Chemical;PA134968284;Gene
ZNF565;methylphenidate;Chemical;PA134970652;Gene
CHURC1;methylphenidate;Chemical;PA134982480;Gene
SPSB2;methylphenidate;Chemical;PA142670872;Gene
ELP5;methylphenidate;Chemical;PA143485405;Gene
DRD1;methylphenidate;Chemical;PA147;Gene
RRP7A;methylphenidate;Chemical;PA162402175;Gene
HTT;methylphenidate;Chemical;PA164741646;Gene
PYROXD2;methylphenidate;Chemical;PA165549043;Gene
PEBP4;methylphenidate;Chemical;PA165585814;Gene
ESYT2;methylphenidate;Chemical;PA165617947;Gene
CYP2D6*2;methylphenidate;Chemical;PA165816577;Haplotype
CYP2D6*4;methylphenidate;Chemical;PA165816579;Haplotype
CYP2D6*10;methylphenidate;Chemical;PA165816582;Haplotype
CYP2D6*5;methylphenidate;Chemical;PA165948092;Haplotype
ARHGEF28;methylphenidate;Chemical;PA166048998;Gene
RS1800544;methylphenidate;Chemical;PA166153974;Variant
RS2283265;methylphenidate;Chemical;PA166154364;Variant
RS5569;methylphenidate;Chemical;PA166154972;Variant
RS71647871;methylphenidate;Chemical;PA166155135;Variant
RS4680;methylphenidate;Chemical;PA166156024;Variant
RS6280;methylphenidate;Chemical;PA166156277;Variant
RS734644;methylphenidate;Chemical;PA166156491;Variant
RS1355368;methylphenidate;Chemical;PA166156510;Variant
RS1947275;methylphenidate;Chemical;PA166156531;Variant
RS6551665;methylphenidate;Chemical;PA166156602;Variant
RS6813183;methylphenidate;Chemical;PA166156607;Variant
RS4532;methylphenidate;Chemical;PA166156706;Variant
RS3836790;methylphenidate;Chemical;PA166156819;Variant
RS2032582;methylphenidate;Chemical;PA166157316;Variant
RS2295490;methylphenidate;Chemical;PA166163170;Variant
RS2070762;methylphenidate;Chemical;PA166175927;Variant
RS17685420;methylphenidate;Chemical;PA166176933;Variant
RS3210967;methylphenidate;Chemical;PA166176934;Variant
RS10413455;methylphenidate;Chemical;PA166176935;Variant
RS2071421;methylphenidate;Chemical;PA166176936;Variant
RS12302749;methylphenidate;Chemical;PA166176937;Variant
RS10420097;methylphenidate;Chemical;PA166176938;Variant
RS3810818;methylphenidate;Chemical;PA166176939;Variant
RS2886059;methylphenidate;Chemical;PA166176940;Variant
RS9901675;methylphenidate;Chemical;PA166176941;Variant
RS4805162;methylphenidate;Chemical;PA166176942;Variant
RS4562;methylphenidate;Chemical;PA166176943;Variant
RS17712523;methylphenidate;Chemical;PA166176944;Variant
RS2799018;methylphenidate;Chemical;PA166176945;Variant
RS12409352;methylphenidate;Chemical;PA166176946;Variant
RS4902333;methylphenidate;Chemical;PA166176947;Variant
RS4627790;methylphenidate;Chemical;PA166176948;Variant
RS1048786;methylphenidate;Chemical;PA166176949;Variant
RS751655;methylphenidate;Chemical;PA166176951;Variant
RS11559290;methylphenidate;Chemical;PA166176952;Variant
RS7858;methylphenidate;Chemical;PA166176953;Variant
RS929740;methylphenidate;Chemical;PA166176954;Variant
RS9032;methylphenidate;Chemical;PA166176955;Variant
RS11552708;methylphenidate;Chemical;PA166176956;Variant
RS1061735;methylphenidate;Chemical;PA166176957;Variant
RS11553441;methylphenidate;Chemical;PA166176958;Variant
RS362272;methylphenidate;Chemical;PA166176959;Variant
RS757978;methylphenidate;Chemical;PA166176960;Variant
RS17279558;methylphenidate;Chemical;PA166176961;Variant
RS3761372;methylphenidate;Chemical;PA166176962;Variant
RS1061115;methylphenidate;Chemical;PA166176963;Variant
RS2013169;methylphenidate;Chemical;PA166176964;Variant
RS28386840;methylphenidate;Chemical;PA166181222;Variant
RS778068631;methylphenidate;Chemical;PA166200921;Variant
ARHGAP12;methylphenidate;Chemical;PA24957;Gene
ARSA;methylphenidate;Chemical;PA25005;Gene
TRIB3;methylphenidate;Chemical;PA25804;Gene
CDH23;methylphenidate;Chemical;PA26296;Gene
ABCB1;methylphenidate;Chemical;PA267;Gene
DRD2;methylphenidate;Chemical;PA27478;Gene
DRD3;methylphenidate;Chemical;PA27479;Gene
ETFDH;methylphenidate;Chemical;PA27899;Gene
ALDH1L1;methylphenidate;Chemical;PA28393;Gene
FXR2;methylphenidate;Chemical;PA28440;Gene
SLC6A2;methylphenidate;Chemical;PA310;Gene
SLC6A3;methylphenidate;Chemical;PA311;Gene
NFIB;methylphenidate;Chemical;PA31591;Gene
OPCML;methylphenidate;Chemical;PA31930;Gene
PDIA2;methylphenidate;Chemical;PA33153;Gene
PURA;methylphenidate;Chemical;PA34045;Gene
ADRA2A;methylphenidate;Chemical;PA35;Gene
TH;methylphenidate;Chemical;PA351;Gene
ZNF134;methylphenidate;Chemical;PA37506;Gene
ZNF211;methylphenidate;Chemical;PA37582;Gene
STRBP;methylphenidate;Chemical;PA38145;Gene
ZDHHC7;methylphenidate;Chemical;PA38335;Gene
PIGM;methylphenidate;Chemical;PA38718;Gene
CMTM8;methylphenidate;Chemical;PA38818;Gene
GGH;methylphenidate;Chemical;PA432;Gene
CARBOCISTEINE;rs62516101;Variant;PA166184060;Chemical
L-PHENYLALANINE;rs62516101;Variant;PA450931;Chemical
COMT;Ergot alkaloids;Chemical;PA117;Gene
DBH;Ergot alkaloids;Chemical;PA136;Gene
RS6265;Ergot alkaloids;Chemical;PA166154259;Variant
RS6275;Ergot alkaloids;Chemical;PA166154260;Variant
RS6305;Ergot alkaloids;Chemical;PA166154672;Variant
RS4680;Ergot alkaloids;Chemical;PA166156024;Variant
RS1799971;Ergot alkaloids;Chemical;PA166156991;Variant
RS1611115;Ergot alkaloids;Chemical;PA166157734;Variant
HTR2A;Ergot alkaloids;Chemical;PA193;Gene
DRD2;Ergot alkaloids;Chemical;PA27478;Gene
BDNF;Ergot alkaloids;Chemical;PA31891;Gene
OPRM1;Ergot alkaloids;Chemical;PA31945;Gene
LIVER TRANSPLANTATION;rs9200;Variant;PA447247;Disease
TACROLIMUS;rs9200;Variant;PA451578;Chemical
CFTR;rs397508300;Variant;PA109;Gene
IVACAFTOR;rs397508300;Variant;PA165950341;Chemical
CYP2C19;adverse cardiovascular events;Disease;PA124;Gene
CYP2C19*1;adverse cardiovascular events;Disease;PA165980634;Haplotype
CYP2C19*2;adverse cardiovascular events;Disease;PA165980635;Haplotype
COMT;Vomiting;Disease;PA117;Gene
SLC31A1;Vomiting;Disease;PA118;Gene
CYP2C19;Vomiting;Disease;PA124;Gene
CYP2D6;Vomiting;Disease;PA128;Gene
ZNF568;Vomiting;Disease;PA134893477;Gene
CLCC1;Vomiting;Disease;PA142672105;Gene
ERCC1;Vomiting;Disease;PA155;Gene
CYP2C19*17;Vomiting;Disease;PA165816533;Haplotype
CYP2D6*1;Vomiting;Disease;PA165816576;Haplotype
CYP2D6*2;Vomiting;Disease;PA165816577;Haplotype
CYP2D6*3;Vomiting;Disease;PA165816578;Haplotype
CYP2D6*4;Vomiting;Disease;PA165816579;Haplotype
CYP2D6*6;Vomiting;Disease;PA165816581;Haplotype
CYP2D6*10;Vomiting;Disease;PA165816582;Haplotype
CYP2D6*5;Vomiting;Disease;PA165948092;Haplotype
CYP2D6*35XN;Vomiting;Disease;PA165971588;Haplotype
CYP2C19*1;Vomiting;Disease;PA165980634;Haplotype
CYP2D6*1XN;Vomiting;Disease;PA165988479;Haplotype
CYP2D6*2XN;Vomiting;Disease;PA165988480;Haplotype
UGT1A1*1;Vomiting;Disease;PA166115841;Haplotype
UGT1A1*28;Vomiting;Disease;PA166115842;Haplotype
UGT1A6*2A;Vomiting;Disease;PA166117621;Haplotype
UGT1A7*3;Vomiting;Disease;PA166117639;Haplotype
CYP2D6*81;Vomiting;Disease;PA166123321;Haplotype
RS6311;Vomiting;Disease;PA166154673;Variant
RS45445694;Vomiting;Disease;PA166155331;Variant
RS3212986;Vomiting;Disease;PA166155407;Variant
RS4680;Vomiting;Disease;PA166156024;Variant
RS1799971;Vomiting;Disease;PA166156991;Variant
RS1045642;Vomiting;Disease;PA166157284;Variant
RS2032582;Vomiting;Disease;PA166157316;Variant
RS699517;Vomiting;Disease;PA166163751;Variant
RS2279199;Vomiting;Disease;PA166163760;Variant
RS540825;Vomiting;Disease;PA166178596;Variant
RS10817464;Vomiting;Disease;PA166179458;Variant
RS9397685;Vomiting;Disease;PA166180172;Variant
RS36024412;Vomiting;Disease;PA166206581;Variant
RS168107;Vomiting;Disease;PA166206601;Variant
RS41269255;Vomiting;Disease;PA166206602;Variant
RS9393888;Vomiting;Disease;PA166206603;Variant
RS12305038;Vomiting;Disease;PA166206604;Variant
RS11882256;Vomiting;Disease;PA166206605;Variant
RS10405238;Vomiting;Disease;PA166206621;Variant
HTR2A;Vomiting;Disease;PA193;Gene
CRYBG2;Vomiting;Disease;PA24650;Gene
ABCB1;Vomiting;Disease;PA267;Gene
MUC16;Vomiting;Disease;PA31314;Gene
OPRM1;Vomiting;Disease;PA31945;Gene
PDE3A;Vomiting;Disease;PA33126;Gene
POM121L2;Vomiting;Disease;PA33524;Gene
TYMS;Vomiting;Disease;PA359;Gene
UMPS;Vomiting;Disease;PA363;Gene
UGT1A6;Vomiting;Disease;PA37181;Gene
UGT1A7;Vomiting;Disease;PA37182;Gene
ZNF165;Vomiting;Disease;PA37535;Gene
UGT1A1;Vomiting;Disease;PA420;Gene
COMT;levomethadone;Chemical;PA117;Gene
OPRM1;levomethadone;Chemical;PA31945;Gene
CACNA1B;PRKACA;Gene;PA26008;Gene
MAPK1;PRKACA;Gene;PA30616;Gene
PPP1R1B;PRKACA;Gene;PA33639;Gene
ARRB1;PRKACA;Gene;PA59;Gene
ARRB2;PRKACA;Gene;PA60;Gene
CACNA1C;PRKACA;Gene;PA83;Gene
CACNA1D;PRKACA;Gene;PA84;Gene
CACNA1S;PRKACA;Gene;PA85;Gene
WARFARIN;rs11676382;Variant;PA451906;Chemical
ACENOCOUMAROL;rs11676382;Variant;PA452632;Chemical
EGFR;mobocertinib;Chemical;PA7360;Gene
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*78:01;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*78:01;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*78:01;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-B*78:01;Haplotype;PA450616;Chemical
REGADENOSON;AMPD1;Gene;PA166129536;Chemical
RHEUMATOID ARTHRITIS;AMPD1;Gene;PA443434;Disease
METHOTREXATE;AMPD1;Gene;PA450428;Chemical
MDM2;nutlin-3;Chemical;PA30718;Gene
COMT;antipsychotics;Chemical;PA117;Gene
CYP2D6;antipsychotics;Chemical;PA128;Gene
INSIG2;antipsychotics;Chemical;PA134890284;Gene
BDNF-AS;antipsychotics;Chemical;PA134953249;Gene
ZNF804A;antipsychotics;Chemical;PA162410599;Gene
CYP2D6*1;antipsychotics;Chemical;PA165816576;Haplotype
CYP2D6*2;antipsychotics;Chemical;PA165816577;Haplotype
CYP2D6*3;antipsychotics;Chemical;PA165816578;Haplotype
CYP2D6*4;antipsychotics;Chemical;PA165816579;Haplotype
CYP2D6*6;antipsychotics;Chemical;PA165816581;Haplotype
CYP2D6*10;antipsychotics;Chemical;PA165816582;Haplotype
CYP2D6*5;antipsychotics;Chemical;PA165948092;Haplotype
CYP2D6*7;antipsychotics;Chemical;PA165971559;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);antipsychotics;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);antipsychotics;Chemical;PA166116466;Haplotype
RS4606;antipsychotics;Chemical;PA166153543;Variant
RS878949;antipsychotics;Chemical;PA166153597;Variant
RS951439;antipsychotics;Chemical;PA166153604;Variant
RS1137101;antipsychotics;Chemical;PA166153626;Variant
RS1801133;antipsychotics;Chemical;PA166153644;Variant
RS2445142;antipsychotics;Chemical;PA166153705;Variant
RS6265;antipsychotics;Chemical;PA166154259;Variant
RS6277;antipsychotics;Chemical;PA166154261;Variant
RS1079598;antipsychotics;Chemical;PA166154316;Variant
RS1799732;antipsychotics;Chemical;PA166154334;Variant
RS2513265;antipsychotics;Chemical;PA166154374;Variant
RS10501087;antipsychotics;Chemical;PA166154431;Variant
RS11030104;antipsychotics;Chemical;PA166154444;Variant
RS6311;antipsychotics;Chemical;PA166154673;Variant
RS762551;antipsychotics;Chemical;PA166154850;Variant
RS2061051;antipsychotics;Chemical;PA166154873;Variant
RS2069514;antipsychotics;Chemical;PA166154874;Variant
RS489693;antipsychotics;Chemical;PA166155269;Variant
RS17782313;antipsychotics;Chemical;PA166155330;Variant
RS16944;antipsychotics;Chemical;PA166155587;Variant
RS1143634;antipsychotics;Chemical;PA166155630;Variant
RS1344706;antipsychotics;Chemical;PA166155631;Variant
RS4849127;antipsychotics;Chemical;PA166155736;Variant
RS10490162;antipsychotics;Chemical;PA166155789;Variant
RS11123469;antipsychotics;Chemical;PA166155798;Variant
RS12467557;antipsychotics;Chemical;PA166155812;Variant
RS17587100;antipsychotics;Chemical;PA166155845;Variant
RS1805128;antipsychotics;Chemical;PA166155994;Variant
RS4680;antipsychotics;Chemical;PA166156024;Variant
RS5030655;antipsychotics;Chemical;PA166156111;Variant
RS1544938;antipsychotics;Chemical;PA166156766;Variant
RS10042486;antipsychotics;Chemical;PA166156855;Variant
RS1799971;antipsychotics;Chemical;PA166156991;Variant
RS9346455;antipsychotics;Chemical;PA166157145;Variant
RS1045642;antipsychotics;Chemical;PA166157284;Variant
RS1468412;antipsychotics;Chemical;PA166157298;Variant
RS2032582;antipsychotics;Chemical;PA166157316;Variant
RS6465084;antipsychotics;Chemical;PA166157411;Variant
RS6977820;antipsychotics;Chemical;PA166157426;Variant
RS7799039;antipsychotics;Chemical;PA166157432;Variant
RS13250975;antipsychotics;Chemical;PA166157643;Variant
RS17716295;antipsychotics;Chemical;PA166157653;Variant
RS3813929;antipsychotics;Chemical;PA166157875;Variant
RS1334802;antipsychotics;Chemical;PA166161286;Variant
RS363341;antipsychotics;Chemical;PA166161288;Variant
RS1124491;antipsychotics;Chemical;PA166161290;Variant
RS9567733;antipsychotics;Chemical;PA166161292;Variant
CYP2D6*14;antipsychotics;Chemical;PA166181185;Haplotype
RS7720513;antipsychotics;Chemical;PA166200021;Variant
RS62097526;antipsychotics;Chemical;PA166200041;Variant
RS1525085;antipsychotics;Chemical;PA166200061;Variant
HTR1A;antipsychotics;Chemical;PA192;Gene
HTR2A;antipsychotics;Chemical;PA193;Gene
HTR2C;antipsychotics;Chemical;PA194;Gene
KCNE1;antipsychotics;Chemical;PA211;Gene
LEP;antipsychotics;Chemical;PA228;Gene
LEPR;antipsychotics;Chemical;PA229;Gene
MTHFR;antipsychotics;Chemical;PA245;Gene
ADCY2;antipsychotics;Chemical;PA24561;Gene
CLCN6;antipsychotics;Chemical;PA26551;Gene
ABCB1;antipsychotics;Chemical;PA267;Gene
CYP1A2;antipsychotics;Chemical;PA27093;Gene
DGKB;antipsychotics;Chemical;PA27311;Gene
DRD2;antipsychotics;Chemical;PA27478;Gene
GABRG3;antipsychotics;Chemical;PA28502;Gene
GRIK3;antipsychotics;Chemical;PA28975;Gene
GRM3;antipsychotics;Chemical;PA28992;Gene
HSPG2;antipsychotics;Chemical;PA29537;Gene
IL1B;antipsychotics;Chemical;PA29808;Gene
MC4R;antipsychotics;Chemical;PA30676;Gene
SLC6A4;antipsychotics;Chemical;PA312;Gene
NRG1;antipsychotics;Chemical;PA31776;Gene
NRXN1;antipsychotics;Chemical;PA31786;Gene
BDNF;antipsychotics;Chemical;PA31891;Gene
OPRM1;antipsychotics;Chemical;PA31945;Gene
SLC18A2;antipsychotics;Chemical;PA325;Gene
RGS2;antipsychotics;Chemical;PA34372;Gene
RGS4;antipsychotics;Chemical;PA34375;Gene
MAPK1;GRK2;Gene;PA30616;Gene
SLC12A1;GRK2;Gene;PA320;Gene
ADRB2;GRK2;Gene;PA39;Gene
ATP1A1;GRK2;Gene;PA62;Gene
PAIN, POSTOPERATIVE;rs145837941;Variant;PA445210;Disease
FENTANYL;rs145837941;Variant;PA449599;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-A*24:02;Haplotype;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-A*24:02;Haplotype;PA166120929;Disease
DRUG HYPERSENSITIVITY;HLA-A*24:02;Haplotype;PA443936;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-A*24:02;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-A*24:02;Haplotype;PA445738;Disease
ACETAMINOPHEN;HLA-A*24:02;Haplotype;PA448015;Chemical
CARBAMAZEPINE;HLA-A*24:02;Haplotype;PA448785;Chemical
DAPSONE;HLA-A*24:02;Haplotype;PA449211;Chemical
PHENYTOIN;HLA-A*24:02;Haplotype;PA450947;Chemical
PLATINUM COMPOUNDS;rs1800975;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs1800975;Variant;PA443622;Disease
GSTM1 NULL;Hodgkin Disease;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Hodgkin Disease;Disease;PA166048676;Haplotype
GSTM1;Hodgkin Disease;Disease;PA182;Gene
N-DESMETHYLTAMOXIFEN;CYP2D6*33;Haplotype;PA166127651;Chemical
PRIMAQUINE;CYP2D6*33;Haplotype;PA451103;Chemical
CYP2D6;nefazodone;Chemical;PA128;Gene
RS130058;nefazodone;Chemical;PA166156908;Variant
RS1360780;nefazodone;Chemical;PA166156983;Variant
RS2032582;nefazodone;Chemical;PA166157316;Variant
ABCB1;nefazodone;Chemical;PA267;Gene
FKBP5;nefazodone;Chemical;PA28162;Gene
HTR1B;nefazodone;Chemical;PA29549;Gene
PPCDC;FEC100;Chemical;PA142671157;Gene
RS147451859;FEC100;Chemical;PA166199721;Variant
RS17587029;FEC100;Chemical;PA166199722;Variant
DPYD;rs61622928;Variant;PA145;Gene
CAPECITABINE;rs61622928;Variant;PA448771;Chemical
RHEUMATOID ARTHRITIS;rs3761422;Variant;PA443434;Disease
ANXIETY DISORDERS;rs3761422;Variant;PA447196;Disease
CAFFEINE;rs3761422;Variant;PA448710;Chemical
METHOTREXATE;rs3761422;Variant;PA450428;Chemical
CONJUGATED ESTROGENS;SULT1A1;Gene;PA164754789;Chemical
DESMETHYLNAPROXEN;SULT1A1;Gene;PA166163690;Chemical
TAPENTADOL;SULT1A1;Gene;PA166179720;Chemical
BREAST NEOPLASMS;SULT1A1;Gene;PA443560;Disease
ESOPHAGEAL NEOPLASMS;SULT1A1;Gene;PA444101;Disease
PAIN;SULT1A1;Gene;PA445208;Disease
PROSTATIC NEOPLASMS;SULT1A1;Gene;PA445425;Disease
COLORECTAL NEOPLASMS;SULT1A1;Gene;PA446108;Disease
ENDOMETRIAL NEOPLASMS;SULT1A1;Gene;PA446411;Disease
ACETAMINOPHEN;SULT1A1;Gene;PA448015;Chemical
ESTROGENS;SULT1A1;Gene;PA449509;Chemical
MINOXIDIL;SULT1A1;Gene;PA450521;Chemical
HYPERTENSION;rs4359;Variant;PA444552;Disease
RAMIPRIL;rs4359;Variant;PA451223;Chemical
CYP2B6;ethambutol;Chemical;PA123;Gene
CYP2C19;ethambutol;Chemical;PA124;Gene
CYP2C9;ethambutol;Chemical;PA126;Gene
CYP2B6*1;ethambutol;Chemical;PA165818750;Haplotype
CYP2B6*6;ethambutol;Chemical;PA165818762;Haplotype
GSTM1 NULL;ethambutol;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;ethambutol;Chemical;PA166048676;Haplotype
GSTT1 NULL;ethambutol;Chemical;PA166048678;Haplotype
GSTT1 NON-NULL;ethambutol;Chemical;PA166048679;Haplotype
RS4986893;ethambutol;Chemical;PA166154070;Variant
RS9332096;ethambutol;Chemical;PA166154097;Variant
RS1800629;ethambutol;Chemical;PA166156997;Variant
RS1041983;ethambutol;Chemical;PA166157549;Variant
RS4646244;ethambutol;Chemical;PA166157603;Variant
NAT2;ethambutol;Chemical;PA18;Gene
GSTM1;ethambutol;Chemical;PA182;Gene
GSTT1;ethambutol;Chemical;PA183;Gene
TNF;ethambutol;Chemical;PA435;Gene
MIDAZOLAM;rs11568820;Variant;PA450496;Chemical
DESFLURANE;rs118192162;Variant;PA164749136;Chemical
RYR1;rs118192162;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs118192162;Variant;PA444863;Disease
ENFLURANE;rs118192162;Variant;PA449461;Chemical
HALOTHANE;rs118192162;Variant;PA449845;Chemical
ISOFLURANE;rs118192162;Variant;PA450106;Chemical
METHOXYFLURANE;rs118192162;Variant;PA450434;Chemical
SEVOFLURANE;rs118192162;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs118192162;Variant;PA451522;Chemical
CACNA1S;rs118192162;Variant;PA85;Gene
CETP;Hypercholesterolemia;Disease;PA108;Gene
ABCC2;Hypercholesterolemia;Disease;PA116;Gene
CYP3A4;Hypercholesterolemia;Disease;PA130;Gene
CYP3A5;Hypercholesterolemia;Disease;PA131;Gene
RHOA;Hypercholesterolemia;Disease;PA134865095;Gene
SLCO1B1;Hypercholesterolemia;Disease;PA134865839;Gene
KIF6;Hypercholesterolemia;Disease;PA134920075;Gene
MYLIP;Hypercholesterolemia;Disease;PA134942677;Gene
SCAP;Hypercholesterolemia;Disease;PA162402461;Gene
CYP3A4*1;Hypercholesterolemia;Disease;PA165819201;Haplotype
SLCO1B1*37;Hypercholesterolemia;Disease;PA165819251;Haplotype
SLCO1B1*5;Hypercholesterolemia;Disease;PA165819255;Haplotype
SLCO1B1*14;Hypercholesterolemia;Disease;PA165819264;Haplotype
SLCO1B1*15;Hypercholesterolemia;Disease;PA165819265;Haplotype
SLCO1B1*1;Hypercholesterolemia;Disease;PA165981641;Haplotype
CYP3A4*22;Hypercholesterolemia;Disease;PA166048680;Haplotype
RS717620;Hypercholesterolemia;Disease;PA166153953;Variant
RS5443;Hypercholesterolemia;Disease;PA166154486;Variant
RS5888;Hypercholesterolemia;Disease;PA166154488;Variant
RS2306283;Hypercholesterolemia;Disease;PA166154547;Variant
RS4149056;Hypercholesterolemia;Disease;PA166154579;Variant
RS11045819;Hypercholesterolemia;Disease;PA166154628;Variant
RS4673;Hypercholesterolemia;Disease;PA166154969;Variant
RS5882;Hypercholesterolemia;Disease;PA166154975;Variant
RS708272;Hypercholesterolemia;Disease;PA166154993;Variant
RS4783961;Hypercholesterolemia;Disease;PA166155066;Variant
RS11887534;Hypercholesterolemia;Disease;PA166155810;Variant
RS11716445;Hypercholesterolemia;Disease;PA166156445;Variant
RS12487736;Hypercholesterolemia;Disease;PA166156447;Variant
RS2231142;Hypercholesterolemia;Disease;PA166156544;Variant
RS17671591;Hypercholesterolemia;Disease;PA166156889;Variant
RS20455;Hypercholesterolemia;Disease;PA166156905;Variant
RS6924995;Hypercholesterolemia;Disease;PA166157118;Variant
RS9370867;Hypercholesterolemia;Disease;PA166157150;Variant
RS662;Hypercholesterolemia;Disease;PA166157238;Variant
RS705379;Hypercholesterolemia;Disease;PA166157261;Variant
RS776746;Hypercholesterolemia;Disease;PA166157267;Variant
RS1045642;Hypercholesterolemia;Disease;PA166157284;Variant
RS1128503;Hypercholesterolemia;Disease;PA166157288;Variant
RS1922242;Hypercholesterolemia;Disease;PA166157312;Variant
RS2032582;Hypercholesterolemia;Disease;PA166157316;Variant
RS17161788;Hypercholesterolemia;Disease;PA166157472;Variant
GNB3;Hypercholesterolemia;Disease;PA176;Gene
HMGCR;Hypercholesterolemia;Disease;PA189;Gene
ABCG8;Hypercholesterolemia;Disease;PA24412;Gene
ABCB1;Hypercholesterolemia;Disease;PA267;Gene
CYBA;Hypercholesterolemia;Disease;PA27075;Gene
PON1;Hypercholesterolemia;Disease;PA33529;Gene
ABCG2;Hypercholesterolemia;Disease;PA390;Gene
SCARB1;Hypercholesterolemia;Disease;PA97;Gene
HYPERPROLACTINEMIA;rs1976391;Variant;PA444545;Disease
OXAZEPAM;rs1976391;Variant;PA450731;Chemical
RISPERIDONE;rs1976391;Variant;PA451257;Chemical
SCHIZOPHRENIA;rs2661319;Variant;PA447216;Disease
RISPERIDONE;rs2661319;Variant;PA451257;Chemical
TRANSPLANTATION;IL18;Gene;PA134850491;Disease
KIDNEY TRANSPLANTATION;IL18;Gene;PA165817016;Disease
LUNG TRANSPLANTATION;IL18;Gene;PA166114457;Disease
CHRONIC HEPATITIS C VIRUS INFECTION;IL18;Gene;PA446863;Disease
RIBAVIRIN;IL18;Gene;PA451241;Chemical
TACROLIMUS;IL18;Gene;PA451578;Chemical
INTERFERONS;IL18;Gene;PA451999;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs929740;Variant;PA447197;Disease
METHYLPHENIDATE;rs929740;Variant;PA450464;Chemical
ATOMOXETINE;CYP2D6*89;Haplotype;PA134688071;Chemical
TOLTERODINE;CYP2D6*89;Haplotype;PA164746757;Chemical
BUFURALOL;CYP2D6*89;Haplotype;PA166110256;Chemical
DAPOXETINE;CYP2D6*89;Haplotype;PA166151992;Chemical
AMITRIPTYLINE;CYP2D6*89;Haplotype;PA448385;Chemical
CITALOPRAM;CYP2D6*89;Haplotype;PA449015;Chemical
DEXTROMETHORPHAN;CYP2D6*89;Haplotype;PA449273;Chemical
METHADONE;CYP2D6*89;Haplotype;PA450401;Chemical
RISPERIDONE;CYP2D6*89;Haplotype;PA451257;Chemical
VENLAFAXINE;CYP2D6*89;Haplotype;PA451866;Chemical
SCHIZOPHRENIA;GCG;Gene;PA447216;Disease
CLOZAPINE;GCG;Gene;PA449061;Chemical
OLANZAPINE;GCG;Gene;PA450688;Chemical
KIDNEY TRANSPLANTATION;rs846908;Variant;PA165817016;Disease
TACROLIMUS;rs846908;Variant;PA451578;Chemical
FLUOROURACIL;RBX1;Gene;PA128406956;Chemical
BREAST NEOPLASMS;RBX1;Gene;PA443560;Disease
NEUTROPENIA;RBX1;Gene;PA445113;Disease
CYCLOPHOSPHAMIDE;RBX1;Gene;PA449165;Chemical
EPIRUBICIN;RBX1;Gene;PA449476;Chemical
CATECHOLAMINES;ADRB1;Gene;PA133822447;Chemical
SELECTIVE BETA-2-ADRENORECEPTOR AGONISTS;ADRB1;Gene;PA134687887;Chemical
DIURETICS;ADRB1;Gene;PA151249535;Chemical
NEBIVOLOL;ADRB1;Gene;PA151958426;Chemical
MURAGLITAZAR;ADRB1;Gene;PA162356187;Chemical
ACE INHIBITORS, PLAIN;ADRB1;Gene;PA164712308;Chemical
ANGIOTENSIN II ANTAGONISTS;ADRB1;Gene;PA164712372;Chemical
BETA BLOCKING AGENTS;ADRB1;Gene;PA164712535;Chemical
BETA BLOCKING AGENTS, NON-SELECTIVE;ADRB1;Gene;PA164712541;Chemical
BETA BLOCKING AGENTS, SELECTIVE;ADRB1;Gene;PA164712547;Chemical
LABETALOL;ADRB1;Gene;PA164743150;Chemical
BUCINDOLOL;ADRB1;Gene;PA165945764;Chemical
MAJOR ADVERSE CARDIAC EVENTS (MACE);ADRB1;Gene;PA166129560;Disease
ALZHEIMER DISEASE;ADRB1;Gene;PA443319;Disease
ANGINA PECTORIS;ADRB1;Gene;PA443362;Disease
ANGINA, UNSTABLE;ADRB1;Gene;PA443364;Disease
ATRIAL FIBRILLATION;ADRB1;Gene;PA443459;Disease
CARDIOMYOPATHY, DILATED;ADRB1;Gene;PA443632;Disease
CARDIOVASCULAR DISEASES;ADRB1;Gene;PA443635;Disease
CORONARY ARTERY DISEASE;ADRB1;Gene;PA443796;Disease
DIABETES MELLITUS;ADRB1;Gene;PA443886;Disease
EDEMA;ADRB1;Gene;PA443994;Disease
HEART FAILURE;ADRB1;Gene;PA444370;Disease
HYPERLIPIDEMIAS;ADRB1;Gene;PA444528;Disease
HYPERTENSION;ADRB1;Gene;PA444552;Disease
ISCHEMIA;ADRB1;Gene;PA444645;Disease
MYOCARDIAL INFARCTION;ADRB1;Gene;PA445019;Disease
OBESITY;ADRB1;Gene;PA445131;Disease
TACHYCARDIA;ADRB1;Gene;PA445802;Disease
MYOCARDIAL ISCHEMIA;ADRB1;Gene;PA446459;Disease
SLEEP APNEA, OBSTRUCTIVE;ADRB1;Gene;PA446916;Disease
DEPRESSION;ADRB1;Gene;PA447278;Disease
ESSENTIAL HYPERTENSION;ADRB1;Gene;PA447288;Disease
ACQUIRED LONG QT SYNDROME (ALQTS);ADRB1;Gene;PA447300;Disease
ACEBUTOLOL;ADRB1;Gene;PA448011;Chemical
ATENOLOL;ADRB1;Gene;PA448499;Chemical
BETAXOLOL;ADRB1;Gene;PA448611;Chemical
BISOPROLOL;ADRB1;Gene;PA448641;Chemical
CARVEDILOL;ADRB1;Gene;PA448817;Chemical
DIGOXIN;ADRB1;Gene;PA449319;Chemical
DOBUTAMINE;ADRB1;Gene;PA449381;Chemical
DOPAMINE;ADRB1;Gene;PA449396;Chemical
EPINEPHRINE;ADRB1;Gene;PA449470;Chemical
ESMOLOL;ADRB1;Gene;PA449500;Chemical
HYDROCHLOROTHIAZIDE;ADRB1;Gene;PA449899;Chemical
ISOPROTERENOL;ADRB1;Gene;PA450121;Chemical
METOPROLOL;ADRB1;Gene;PA450480;Chemical
NADOLOL;ADRB1;Gene;PA450573;Chemical
NOREPINEPHRINE;ADRB1;Gene;PA450649;Chemical
PINDOLOL;ADRB1;Gene;PA450966;Chemical
PROPRANOLOL;ADRB1;Gene;PA451145;Chemical
SOTALOL;ADRB1;Gene;PA451457;Chemical
SPIRONOLACTONE;ADRB1;Gene;PA451483;Chemical
TIMOLOL;ADRB1;Gene;PA451690;Chemical
ANTIDEPRESSANTS;ADRB1;Gene;PA452229;Chemical
XENOBIOTICS;ADRB1;Gene;PA452604;Chemical
ESSENTIAL HYPERTENSION;rs10752271;Variant;PA447288;Disease
LOSARTAN;rs10752271;Variant;PA450268;Chemical
RHEUMATOID ARTHRITIS;rs1476413;Variant;PA443434;Disease
METHOTREXATE;rs1476413;Variant;PA450428;Chemical
CORTICOSTEROIDS;rs2240017;Variant;PA10832;Chemical
ASTHMA;rs2240017;Variant;PA443450;Disease
SLC29A1;trifluridine;Chemical;PA154;Gene
RS760370;trifluridine;Chemical;PA166156947;Variant
RS9394992;trifluridine;Chemical;PA166157157;Variant
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CMTM8;Gene;PA447197;Disease
METHYLPHENIDATE;CMTM8;Gene;PA450464;Chemical
ASTHMA;TBXAS1;Gene;PA443450;Disease
ASPIRIN;TBXAS1;Gene;PA448497;Chemical
CYP2C19;flibanserin;Chemical;PA124;Gene
CYP2C9;flibanserin;Chemical;PA126;Gene
CYP2D6;flibanserin;Chemical;PA128;Gene
CETUXIMAB;TGFA;Gene;PA10040;Chemical
PANITUMUMAB;TGFA;Gene;PA162373091;Chemical
DESFLURANE;rs193922843;Variant;PA164749136;Chemical
RYR1;rs193922843;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs193922843;Variant;PA444863;Disease
ENFLURANE;rs193922843;Variant;PA449461;Chemical
HALOTHANE;rs193922843;Variant;PA449845;Chemical
ISOFLURANE;rs193922843;Variant;PA450106;Chemical
METHOXYFLURANE;rs193922843;Variant;PA450434;Chemical
SEVOFLURANE;rs193922843;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs193922843;Variant;PA451522;Chemical
CACNA1S;rs193922843;Variant;PA85;Gene
HMG COA REDUCTASE INHIBITORS;HLA-DRB1*04:06;Haplotype;PA133950441;Chemical
ROSUVASTATIN;HLA-DRB1*04:06;Haplotype;PA134308647;Chemical
PITAVASTATIN;HLA-DRB1*04:06;Haplotype;PA142650384;Chemical
MUSCULAR DISEASES;HLA-DRB1*04:06;Haplotype;PA444997;Disease
ATORVASTATIN;HLA-DRB1*04:06;Haplotype;PA448500;Chemical
FLUVASTATIN;HLA-DRB1*04:06;Haplotype;PA449688;Chemical
PRAVASTATIN;HLA-DRB1*04:06;Haplotype;PA451089;Chemical
SIMVASTATIN;HLA-DRB1*04:06;Haplotype;PA451363;Chemical
NEUROTOXICITY SYNDROMES;rs1135989;Variant;PA446975;Disease
VINCRISTINE;rs1135989;Variant;PA451879;Chemical
HMG COA REDUCTASE INHIBITORS;rs2306283;Variant;PA133950441;Chemical
SLCO1B1;rs2306283;Variant;PA134865839;Gene
PITAVASTATIN;rs2306283;Variant;PA142650384;Chemical
MYCOPHENOLIC ACID;rs2306283;Variant;PA164748728;Chemical
ROCURONIUM;rs2306283;Variant;PA164754992;Chemical
DYSLIPIDAEMIA;rs2306283;Variant;PA165108110;Disease
KIDNEY TRANSPLANTATION;rs2306283;Variant;PA165817016;Disease
LETERMOVIR;rs2306283;Variant;PA166184379;Chemical
UGT1A1;rs2306283;Variant;PA420;Gene
CORONARY ARTERY DISEASE;rs2306283;Variant;PA443796;Disease
CORONARY DISEASE;rs2306283;Variant;PA443797;Disease
DIABETES MELLITUS;rs2306283;Variant;PA443886;Disease
DIARRHEA;rs2306283;Variant;PA443899;Disease
HYPERCHOLESTEROLEMIA;rs2306283;Variant;PA444516;Disease
HYPERLIPIDEMIAS;rs2306283;Variant;PA444528;Disease
NEOPLASMS;rs2306283;Variant;PA445062;Disease
COLORECTAL NEOPLASMS;rs2306283;Variant;PA446108;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs2306283;Variant;PA446155;Disease
ATORVASTATIN;rs2306283;Variant;PA448500;Chemical
IRINOTECAN;rs2306283;Variant;PA450085;Chemical
METHOTREXATE;rs2306283;Variant;PA450428;Chemical
PRAVASTATIN;rs2306283;Variant;PA451089;Chemical
REPAGLINIDE;rs2306283;Variant;PA451234;Chemical
RIFAMPIN;rs2306283;Variant;PA451250;Chemical
SIMVASTATIN;rs2306283;Variant;PA451363;Chemical
SORAFENIB;rs2306283;Variant;PA7000;Chemical
SUNITINIB;IL13;Gene;PA162372840;Chemical
HEPATITIS VACCINES;IL13;Gene;PA164712789;Chemical
RENAL CELL CARCINOMA;IL13;Gene;PA443624;Disease
MTHFR;Spina Bifida Cystica;Disease;PA245;Gene
CELECOXIB;MMP9;Gene;PA448871;Chemical
DOXORUBICINOL;rs2229540;Variant;PA165291922;Chemical
DAUNORUBICINOL;rs2229540;Variant;PA166248083;Chemical
DPYD;rs3918289;Variant;PA145;Gene
CAPECITABINE;rs3918289;Variant;PA448771;Chemical
CABOZANTINIB;CYP3A4*34;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*34;Haplotype;PA165958362;Chemical
REGORAFENIB;CYP3A4*34;Haplotype;PA166114943;Chemical
VANDETANIB;CYP3A4*34;Haplotype;PA166118341;Chemical
IBRUTINIB;CYP3A4*34;Haplotype;PA166121346;Chemical
BREXPIPRAZOLE;CYP3A4*34;Haplotype;PA166160053;Chemical
MACITENTAN;CYP3A4*34;Haplotype;PA166261201;Chemical
BLONANSERIN;CYP3A4*34;Haplotype;PA166319041;Chemical
AMIODARONE;CYP3A4*34;Haplotype;PA448383;Chemical
IBUPROFEN;CYP3A4*34;Haplotype;PA449957;Chemical
LIDOCAINE;CYP3A4*34;Haplotype;PA450226;Chemical
METHADONE;CYP3A4*34;Haplotype;PA450401;Chemical
OXYCODONE;CYP3A4*34;Haplotype;PA450741;Chemical
TESTOSTERONE;CYP3A4*34;Haplotype;PA451627;Chemical
CLODRONATE;rs1544410;Variant;PA10239;Chemical
PEGINTERFERON ALFA-2A;rs1544410;Variant;PA164749390;Chemical
CONJUGATED ESTROGENS;rs1544410;Variant;PA164754789;Chemical
DEFERASIROX;rs1544410;Variant;PA164760843;Chemical
HEPATITIS C VIRUS INFECTION;rs1544410;Variant;PA444445;Disease
OSTEOPOROSIS;rs1544410;Variant;PA445190;Disease
BETA-THALASSEMIA AND RELATED DISEASES;rs1544410;Variant;PA446432;Disease
ALENDRONATE;rs1544410;Variant;PA448082;Chemical
MEDROXYPROGESTERONE;rs1544410;Variant;PA450344;Chemical
MIDAZOLAM;rs1544410;Variant;PA450496;Chemical
RIBAVIRIN;rs1544410;Variant;PA451241;Chemical
DPYD;rs72975710;Variant;PA145;Gene
CAPECITABINE;rs72975710;Variant;PA448771;Chemical
TOBACCO USE DISORDER;CYP2A6*41;Haplotype;PA445876;Disease
NICOTINE;CYP2A6*41;Haplotype;PA450626;Chemical
SMALL CELL CARCINOMA;rs17574269;Variant;PA446661;Disease
CISPLATIN;rs17574269;Variant;PA449014;Chemical
IRINOTECAN;rs17574269;Variant;PA450085;Chemical
CYP2D6;dextromethorphan hydrobromide / bupropion hydrochloride;Chemical;PA128;Gene
CYP2D6;mianserin;Chemical;PA128;Gene
CYP3A4;mianserin;Chemical;PA130;Gene
CYP2D6*1;mianserin;Chemical;PA165816576;Haplotype
CYP2D6*10;mianserin;Chemical;PA165816582;Haplotype
CYP2D6*5;mianserin;Chemical;PA165948092;Haplotype
CYP2D6*1XN;mianserin;Chemical;PA165988479;Haplotype
CYP2D6*2XN;mianserin;Chemical;PA165988480;Haplotype
LAPATINIB;HLA-DQA1;Gene;PA152241907;Chemical
ANTITHYROID PREPARATIONS;HLA-DQA1;Gene;PA164712499;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;HLA-DQA1;Gene;PA164712708;Chemical
MEASLES VACCINES;HLA-DQA1;Gene;PA164712887;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;HLA-DQA1;Gene;PA164713366;Chemical
PEGASPARGASE;HLA-DQA1;Gene;PA164760860;Chemical
LUMIRACOXIB;HLA-DQA1;Gene;PA164769031;Chemical
FLUCLOXACILLIN;HLA-DQA1;Gene;PA164781042;Chemical
TOXIC LIVER DISEASE;HLA-DQA1;Gene;PA164925725;Disease
HLA-DQA1*02:01;HLA-DQA1;Gene;PA165951292;Haplotype
HLA-DRB1*07:01;HLA-DQA1;Gene;PA165951644;Haplotype
DRUG-INDUCED LIVER INJURY;HLA-DQA1;Gene;PA166119041;Disease
AGRANULOCYTOSIS;HLA-DQA1;Gene;PA443297;Disease
DRUG TOXICITY;HLA-DQA1;Gene;PA443937;Disease
GRAVES DISEASE;HLA-DQA1;Gene;PA444329;Disease
HYPERSENSITIVITY;HLA-DQA1;Gene;PA444546;Disease
PANCREATITIS;HLA-DQA1;Gene;PA445220;Disease
TUBERCULOSIS;HLA-DQA1;Gene;PA445941;Disease
INFLAMMATORY BOWEL DISEASES;HLA-DQA1;Gene;PA446116;Disease
AZATHIOPRINE;HLA-DQA1;Gene;PA448515;Chemical
INTERFERON BETA-1A;HLA-DQA1;Gene;PA450037;Chemical
INTERFERON BETA-1B;HLA-DQA1;Gene;PA450039;Chemical
MERCAPTOPURINE;HLA-DQA1;Gene;PA450379;Chemical
ABIRATERONE;TSPYL1;Gene;PA166123407;Chemical
PROSTATIC NEOPLASMS;TSPYL1;Gene;PA445425;Disease
PREDNISOLONE;TSPYL1;Gene;PA451096;Chemical
PLATINUM;ERCC5;Gene;PA150595617;Chemical
OVARIAN NEOPLASMS;ERCC5;Gene;PA445204;Disease
HYPERLIPIDEMIAS;rs2854116;Variant;PA444528;Disease
HIV INFECTIOUS DISEASE;rs2854116;Variant;PA447230;Disease
RITONAVIR;rs2854116;Variant;PA451260;Chemical
DRUG HYPERSENSITIVITY;ATL2;Gene;PA443936;Disease
NEOPLASMS;ATL2;Gene;PA445062;Disease
ASPARAGINASE;ATL2;Gene;PA448492;Chemical
CYP3A4;blonanserin;Chemical;PA130;Gene
CYP3A4*1;blonanserin;Chemical;PA165819201;Haplotype
CYP3A4*4;blonanserin;Chemical;PA165819222;Haplotype
CYP3A4*5;blonanserin;Chemical;PA165819223;Haplotype
CYP3A4*7;blonanserin;Chemical;PA165819225;Haplotype
CYP3A4*8;blonanserin;Chemical;PA165819226;Haplotype
CYP3A4*9;blonanserin;Chemical;PA165819227;Haplotype
CYP3A4*10;blonanserin;Chemical;PA165819228;Haplotype
CYP3A4*12;blonanserin;Chemical;PA165819230;Haplotype
CYP3A4*13;blonanserin;Chemical;PA165819231;Haplotype
CYP3A4*14;blonanserin;Chemical;PA165819232;Haplotype
CYP3A4*16;blonanserin;Chemical;PA165819236;Haplotype
CYP3A4*17;blonanserin;Chemical;PA165819239;Haplotype
CYP3A4*18;blonanserin;Chemical;PA165819240;Haplotype
CYP3A4*20;blonanserin;Chemical;PA165819244;Haplotype
CYP3A4*23;blonanserin;Chemical;PA166115836;Haplotype
CYP3A4*24;blonanserin;Chemical;PA166115837;Haplotype
CYP3A4*28;blonanserin;Chemical;PA166245584;Haplotype
CYP3A4*29;blonanserin;Chemical;PA166245585;Haplotype
CYP3A4*31;blonanserin;Chemical;PA166245587;Haplotype
CYP3A4*33;blonanserin;Chemical;PA166245589;Haplotype
CYP3A4*34;blonanserin;Chemical;PA166245590;Haplotype
PROSTATIC NEOPLASMS;rs2250242;Variant;PA445425;Disease
DOCETAXEL;rs2250242;Variant;PA449383;Chemical
HYPERTENSION;LRRC15;Gene;PA444552;Disease
ATENOLOL;LRRC15;Gene;PA448499;Chemical
HYDROCHLOROTHIAZIDE;LRRC15;Gene;PA449899;Chemical
METOPROLOL;LRRC15;Gene;PA450480;Chemical
RS5186;angiotensin II;Chemical;PA166156276;Variant
AGTR1;angiotensin II;Chemical;PA43;Gene
COMT;Urinary Retention;Disease;PA117;Gene
CYP2D6;Urinary Retention;Disease;PA128;Gene
RS324420;Urinary Retention;Disease;PA166153569;Variant
RS4680;Urinary Retention;Disease;PA166156024;Variant
RS1799971;Urinary Retention;Disease;PA166156991;Variant
FAAH;Urinary Retention;Disease;PA27955;Gene
OPRM1;Urinary Retention;Disease;PA31945;Gene
MAJOR ADVERSE CARDIAC EVENTS (MACE);rs1330344;Variant;PA166129560;Disease
CLOPIDOGREL;rs1330344;Variant;PA449053;Chemical
ABCC2;Kidney Transplantation;Disease;PA116;Gene
CYP3A7;Kidney Transplantation;Disease;PA122;Gene
CYP2C19;Kidney Transplantation;Disease;PA124;Gene
CYP2C8;Kidney Transplantation;Disease;PA125;Gene
CYP2C9;Kidney Transplantation;Disease;PA126;Gene
CYP3A4;Kidney Transplantation;Disease;PA130;Gene
CYP3A5;Kidney Transplantation;Disease;PA131;Gene
SLCO1B1;Kidney Transplantation;Disease;PA134865839;Gene
ZSCAN25;Kidney Transplantation;Disease;PA134962723;Gene
CYP2C19*17;Kidney Transplantation;Disease;PA165816533;Haplotype
CYP2C9*1;Kidney Transplantation;Disease;PA165816542;Haplotype
CYP2C9*2;Kidney Transplantation;Disease;PA165816543;Haplotype
CYP2C9*3;Kidney Transplantation;Disease;PA165816544;Haplotype
CYP3A4*1;Kidney Transplantation;Disease;PA165819201;Haplotype
CYP3A4*3;Kidney Transplantation;Disease;PA165819221;Haplotype
CYP3A4*18;Kidney Transplantation;Disease;PA165819240;Haplotype
CYP3A4*20;Kidney Transplantation;Disease;PA165819244;Haplotype
TPMT*1;Kidney Transplantation;Disease;PA165819268;Haplotype
TPMT*2;Kidney Transplantation;Disease;PA165819269;Haplotype
TPMT*3A;Kidney Transplantation;Disease;PA165819270;Haplotype
TPMT*3B;Kidney Transplantation;Disease;PA165819271;Haplotype
TPMT*3C;Kidney Transplantation;Disease;PA165819272;Haplotype
CYP3A7*1A;Kidney Transplantation;Disease;PA165948045;Haplotype
CYP3A7*1C;Kidney Transplantation;Disease;PA165948047;Haplotype
CYP2C8*3;Kidney Transplantation;Disease;PA165958685;Haplotype
CYP2C19*1;Kidney Transplantation;Disease;PA165980634;Haplotype
CYP2C19*2;Kidney Transplantation;Disease;PA165980635;Haplotype
CYP2C19*3;Kidney Transplantation;Disease;PA165980636;Haplotype
CYP3A4*22;Kidney Transplantation;Disease;PA166048680;Haplotype
CYP3A5*1;Kidney Transplantation;Disease;PA166128213;Haplotype
CYP3A5*3;Kidney Transplantation;Disease;PA166128219;Haplotype
CYP3A5*6;Kidney Transplantation;Disease;PA166128233;Haplotype
CYP3A5*7;Kidney Transplantation;Disease;PA166128234;Haplotype
RS396991;Kidney Transplantation;Disease;PA166153571;Variant
RS846908;Kidney Transplantation;Disease;PA166153595;Variant
RS846910;Kidney Transplantation;Disease;PA166153596;Variant
RS890293;Kidney Transplantation;Disease;PA166153598;Variant
RS1800871;Kidney Transplantation;Disease;PA166153639;Variant
RS1800872;Kidney Transplantation;Disease;PA166153640;Variant
RS1800896;Kidney Transplantation;Disease;PA166153642;Variant
RS4844880;Kidney Transplantation;Disease;PA166153776;Variant
RS717620;Kidney Transplantation;Disease;PA166153953;Variant
RS3740066;Kidney Transplantation;Disease;PA166154028;Variant
RS7903146;Kidney Transplantation;Disease;PA166154084;Variant
RS11572076;Kidney Transplantation;Disease;PA166154139;Variant
RS1946518;Kidney Transplantation;Disease;PA166154344;Variant
RS2237895;Kidney Transplantation;Disease;PA166154355;Variant
RS2306283;Kidney Transplantation;Disease;PA166154547;Variant
RS4149056;Kidney Transplantation;Disease;PA166154579;Variant
RS4149117;Kidney Transplantation;Disease;PA166154583;Variant
RS7311358;Kidney Transplantation;Disease;PA166154602;Variant
RS11568658;Kidney Transplantation;Disease;PA166154747;Variant
RS2066844;Kidney Transplantation;Disease;PA166155027;Variant
RS231775;Kidney Transplantation;Disease;PA166155589;Variant
RS1042597;Kidney Transplantation;Disease;PA166155614;Variant
RS3832043;Kidney Transplantation;Disease;PA166155718;Variant
RS4553808;Kidney Transplantation;Disease;PA166155730;Variant
RS5030952;Kidney Transplantation;Disease;PA166155741;Variant
RS6714486;Kidney Transplantation;Disease;PA166155748;Variant
RS17868320;Kidney Transplantation;Disease;PA166155855;Variant
RS72551330;Kidney Transplantation;Disease;PA166155900;Variant
RS4253728;Kidney Transplantation;Disease;PA166156105;Variant
RS568408;Kidney Transplantation;Disease;PA166156289;Variant
RS2276707;Kidney Transplantation;Disease;PA166156352;Variant
RS11706052;Kidney Transplantation;Disease;PA166156443;Variant
RS7438135;Kidney Transplantation;Disease;PA166156617;Variant
RS1800629;Kidney Transplantation;Disease;PA166156997;Variant
RS15524;Kidney Transplantation;Disease;PA166157243;Variant
RS776746;Kidney Transplantation;Disease;PA166157267;Variant
RS1045642;Kidney Transplantation;Disease;PA166157284;Variant
RS1057868;Kidney Transplantation;Disease;PA166157286;Variant
RS1128503;Kidney Transplantation;Disease;PA166157288;Variant
RS2032582;Kidney Transplantation;Disease;PA166157316;Variant
RS2229109;Kidney Transplantation;Disease;PA166157334;Variant
RS2242480;Kidney Transplantation;Disease;PA166157345;Variant
RS2278294;Kidney Transplantation;Disease;PA166157351;Variant
RS2740574;Kidney Transplantation;Disease;PA166157367;Variant
RS4646437;Kidney Transplantation;Disease;PA166157391;Variant
RS9282564;Kidney Transplantation;Disease;PA166157435;Variant
RS28371759;Kidney Transplantation;Disease;PA166157481;Variant
RS3761548;Kidney Transplantation;Disease;PA166162248;Variant
RS181781;Kidney Transplantation;Disease;PA166163546;Variant
RS4646450;Kidney Transplantation;Disease;PA166176608;Variant
CYP2C8*1;Kidney Transplantation;Disease;PA166242948;Haplotype
FOXP3;Kidney Transplantation;Disease;PA201094;Gene
KCNQ1;Kidney Transplantation;Disease;PA223;Gene
CAPN10;Kidney Transplantation;Disease;PA26058;Gene
NOD2;Kidney Transplantation;Disease;PA26074;Gene
ABCB1;Kidney Transplantation;Disease;PA267;Gene
CTLA4;Kidney Transplantation;Disease;PA27006;Gene
CYP2J2;Kidney Transplantation;Disease;PA27112;Gene
PPARA;Kidney Transplantation;Disease;PA280;Gene
FCGR3A;Kidney Transplantation;Disease;PA28065;Gene
HSD11B1;Kidney Transplantation;Disease;PA29476;Gene
IL10;Kidney Transplantation;Disease;PA29778;Gene
IL12A;Kidney Transplantation;Disease;PA29784;Gene
IL18;Kidney Transplantation;Disease;PA29802;Gene
IL3;Kidney Transplantation;Disease;PA29830;Gene
IMPDH1;Kidney Transplantation;Disease;PA29862;Gene
IMPDH2;Kidney Transplantation;Disease;PA29863;Gene
POR;Kidney Transplantation;Disease;PA33532;Gene
TPMT;Kidney Transplantation;Disease;PA356;Gene
SLCO1B3;Kidney Transplantation;Disease;PA35844;Gene
UGT2B7;Kidney Transplantation;Disease;PA361;Gene
TCF7L2;Kidney Transplantation;Disease;PA36394;Gene
UGT1A8;Kidney Transplantation;Disease;PA37183;Gene
NR1I2;Kidney Transplantation;Disease;PA378;Gene
ABCC4;Kidney Transplantation;Disease;PA397;Gene
UGT1A9;Kidney Transplantation;Disease;PA419;Gene
TNF;Kidney Transplantation;Disease;PA435;Gene
MAJOR DEPRESSIVE DISORDER;CRH;Gene;PA447321;Disease
ANTIDEPRESSANTS;CRH;Gene;PA452229;Chemical
NAT2;amifampridine;Chemical;PA18;Gene
CES1;Atrial Fibrillation;Disease;PA107;Gene
CYP2C19;Atrial Fibrillation;Disease;PA124;Gene
CYP2C9;Atrial Fibrillation;Disease;PA126;Gene
CACNA2D4;Atrial Fibrillation;Disease;PA130546913;Gene
CYP3A5;Atrial Fibrillation;Disease;PA131;Gene
VKORC1;Atrial Fibrillation;Disease;PA133787052;Gene
MIR21;Atrial Fibrillation;Disease;PA164722590;Gene
CYP2C19*17;Atrial Fibrillation;Disease;PA165816533;Haplotype
CYP2C9*1;Atrial Fibrillation;Disease;PA165816542;Haplotype
CYP2C9*2;Atrial Fibrillation;Disease;PA165816543;Haplotype
CYP2C9*3;Atrial Fibrillation;Disease;PA165816544;Haplotype
CYP2C9*13;Atrial Fibrillation;Disease;PA165816554;Haplotype
CYP2C9*14;Atrial Fibrillation;Disease;PA165816555;Haplotype
CYP2C9*16;Atrial Fibrillation;Disease;PA165816557;Haplotype
CYP4F2*1;Atrial Fibrillation;Disease;PA165860685;Haplotype
CYP4F2*3;Atrial Fibrillation;Disease;PA165860687;Haplotype
CYP2C19*1;Atrial Fibrillation;Disease;PA165980634;Haplotype
CYP2C19*2;Atrial Fibrillation;Disease;PA165980635;Haplotype
CYP2C19*3;Atrial Fibrillation;Disease;PA165980636;Haplotype
CYP2C9*60;Atrial Fibrillation;Disease;PA166128211;Haplotype
RS1801253;Atrial Fibrillation;Disease;PA166153977;Variant
RS2244613;Atrial Fibrillation;Disease;PA166155037;Variant
RS2108622;Atrial Fibrillation;Disease;PA166155381;Variant
RS2592551;Atrial Fibrillation;Disease;PA166155685;Variant
RS2231142;Atrial Fibrillation;Disease;PA166156544;Variant
RS776746;Atrial Fibrillation;Disease;PA166157267;Variant
RS8192935;Atrial Fibrillation;Disease;PA166159104;Variant
RS4148738;Atrial Fibrillation;Disease;PA166159110;Variant
ABCB1;Atrial Fibrillation;Disease;PA267;Gene
CYP4F2;Atrial Fibrillation;Disease;PA27121;Gene
GGCX;Atrial Fibrillation;Disease;PA28660;Gene
ADRB1;Atrial Fibrillation;Disease;PA38;Gene
ABCG2;Atrial Fibrillation;Disease;PA390;Gene
STROKE;Atrial Fibrillation;Disease;PA447054;Disease
CACNB2;Atrial Fibrillation;Disease;PA88;Gene
HLA-B*13:01;Leprosy;Disease;PA165954643;Haplotype
HLA-B;Leprosy;Disease;PA35056;Gene
CES1;oseltamivir;Chemical;PA107;Gene
RS1045642;oseltamivir;Chemical;PA166157284;Variant
RS200707504;oseltamivir;Chemical;PA166170232;Variant
ABCB1;oseltamivir;Chemical;PA267;Gene
HYPERTENSION;rs201279313;Variant;PA444552;Disease
ATENOLOL;rs201279313;Variant;PA448499;Chemical
HYDROCHLOROTHIAZIDE;rs201279313;Variant;PA449899;Chemical
METOPROLOL;rs201279313;Variant;PA450480;Chemical
PPP1R1B;CDK5;Gene;PA33639;Gene
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs10420097;Variant;PA447197;Disease
METHYLPHENIDATE;rs10420097;Variant;PA450464;Chemical
DPYD;rs111858276;Variant;PA145;Gene
CAPECITABINE;rs111858276;Variant;PA448771;Chemical
BREAST NEOPLASMS;ZNF423;Gene;PA443560;Disease
RALOXIFENE;ZNF423;Gene;PA451221;Chemical
TAMOXIFEN;ZNF423;Gene;PA451581;Chemical
SCHIZOPHRENIA;rs9852;Variant;PA447216;Disease
CLOZAPINE;rs9852;Variant;PA449061;Chemical
OLANZAPINE;rs9852;Variant;PA450688;Chemical
LAPATINIB;HLA-DRB1*04:03;Haplotype;PA152241907;Chemical
MACULOPAPULAR EXANTHEMA;HLA-DRB1*04:03;Haplotype;PA162316739;Disease
BREAST NEOPLASMS;HLA-DRB1*04:03;Haplotype;PA443560;Disease
EPILEPSY;HLA-DRB1*04:03;Haplotype;PA444065;Disease
EXANTHEMA;HLA-DRB1*04:03;Haplotype;PA444109;Disease
OXCARBAZEPINE;HLA-DRB1*04:03;Haplotype;PA450732;Chemical
ARIPIPRAZOLE;rs324420;Variant;PA10026;Chemical
CANNABINOIDS;rs324420;Variant;PA131890620;Chemical
SOMNOLENCE;rs324420;Variant;PA166185626;Disease
CONSTIPATION;rs324420;Variant;PA443782;Disease
DELIRIUM;rs324420;Variant;PA443851;Disease
LUNG NEOPLASMS;rs324420;Variant;PA444818;Disease
NAUSEA;rs324420;Variant;PA445048;Disease
PAIN;rs324420;Variant;PA445208;Disease
PRURITUS;rs324420;Variant;PA445437;Disease
RESPIRATORY INSUFFICIENCY;rs324420;Variant;PA445522;Disease
URINARY RETENTION;rs324420;Variant;PA446264;Disease
SUBSTANCE-RELATED DISORDERS;rs324420;Variant;PA446876;Disease
POSTOPERATIVE NAUSEA AND VOMITING;rs324420;Variant;PA446970;Disease
PSYCHOTIC DISORDER;rs324420;Variant;PA447215;Disease
CLOZAPINE;rs324420;Variant;PA449061;Chemical
HALOPERIDOL;rs324420;Variant;PA449841;Chemical
METHAMPHETAMINE;rs324420;Variant;PA450403;Chemical
MORPHINE;rs324420;Variant;PA450550;Chemical
OLANZAPINE;rs324420;Variant;PA450688;Chemical
QUETIAPINE;rs324420;Variant;PA451201;Chemical
RISPERIDONE;rs324420;Variant;PA451257;Chemical
CYB5R3;lidocaine / prilocaine;Chemical;PA27331;Gene
G6PD;lidocaine / prilocaine;Chemical;PA28469;Gene
HYPERTENSION;rs1123617;Variant;PA444552;Disease
NIFEDIPINE;rs1123617;Variant;PA450631;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs3130985;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs3130985;Variant;PA445846;Disease
CARBOPLATIN;rs3130985;Variant;PA448803;Chemical
GEMCITABINE;rs3130985;Variant;PA449748;Chemical
ASS1;sodium phenylbutyrate;Chemical;PA162376926;Gene
CPS1;sodium phenylbutyrate;Chemical;PA26840;Gene
OTC;sodium phenylbutyrate;Chemical;PA32840;Gene
BIPOLAR DISORDER;rs324899;Variant;PA447199;Disease
LITHIUM;rs324899;Variant;PA450243;Chemical
CYP2C8;diclofenac;Chemical;PA125;Gene
CYP2C9;diclofenac;Chemical;PA126;Gene
CYP2C9*1;diclofenac;Chemical;PA165816542;Haplotype
CYP2C9*2;diclofenac;Chemical;PA165816543;Haplotype
CYP2C9*3;diclofenac;Chemical;PA165816544;Haplotype
CYP2C9*8;diclofenac;Chemical;PA165816549;Haplotype
CYP2C9*13;diclofenac;Chemical;PA165816554;Haplotype
CYP2C8*3;diclofenac;Chemical;PA165958685;Haplotype
CYP2C8*4;diclofenac;Chemical;PA165958686;Haplotype
CYP2C9*36;diclofenac;Chemical;PA166048682;Haplotype
CYP2C9*37;diclofenac;Chemical;PA166048683;Haplotype
CYP2C9*38;diclofenac;Chemical;PA166048684;Haplotype
CYP2C9*39;diclofenac;Chemical;PA166048685;Haplotype
CYP2C9*40;diclofenac;Chemical;PA166048686;Haplotype
CYP2C9*42;diclofenac;Chemical;PA166048688;Haplotype
CYP2C9*43;diclofenac;Chemical;PA166048689;Haplotype
CYP2C9*44;diclofenac;Chemical;PA166048690;Haplotype
CYP2C9*45;diclofenac;Chemical;PA166048691;Haplotype
CYP2C9*46;diclofenac;Chemical;PA166048692;Haplotype
CYP2C9*47;diclofenac;Chemical;PA166048693;Haplotype
CYP2C9*48;diclofenac;Chemical;PA166048694;Haplotype
CYP2C9*50;diclofenac;Chemical;PA166048696;Haplotype
CYP2C9*52;diclofenac;Chemical;PA166048698;Haplotype
CYP2C9*53;diclofenac;Chemical;PA166048699;Haplotype
CYP2C9*54;diclofenac;Chemical;PA166048700;Haplotype
CYP2C9*55;diclofenac;Chemical;PA166048701;Haplotype
CYP2C9*59;diclofenac;Chemical;PA166128210;Haplotype
CYP2C9*60;diclofenac;Chemical;PA166128211;Haplotype
RS12746200;diclofenac;Chemical;PA166153862;Variant
RS1057910;diclofenac;Chemical;PA166153959;Variant
RS1805034;diclofenac;Chemical;PA166155281;Variant
RS2228246;diclofenac;Chemical;PA166155921;Variant
RS1800629;diclofenac;Chemical;PA166156997;Variant
CYP2C9*62;diclofenac;Chemical;PA166219782;Haplotype
CYP2C8*1;diclofenac;Chemical;PA166242948;Haplotype
CYP2C9*72;diclofenac;Chemical;PA166257325;Haplotype
CYP2C9*73;diclofenac;Chemical;PA166257326;Haplotype
CYP2C9*74;diclofenac;Chemical;PA166257327;Haplotype
PLA2G4A;diclofenac;Chemical;PA271;Gene
CYP2J2;diclofenac;Chemical;PA27112;Gene
PTGS2;diclofenac;Chemical;PA293;Gene
LTA;diclofenac;Chemical;PA30474;Gene
PLCG1;diclofenac;Chemical;PA33392;Gene
SLC22A7;diclofenac;Chemical;PA35848;Gene
TNFRSF11A;diclofenac;Chemical;PA36601;Gene
UGT2B17;diclofenac;Chemical;PA37189;Gene
LST1;diclofenac;Chemical;PA37856;Gene
TNF;diclofenac;Chemical;PA435;Gene
VALACICLOVIR;diclofenac;Chemical;PA451839;Chemical
APNEA;rs1560022535;Variant;PA443407;Disease
SUCCINYLCHOLINE;rs1560022535;Variant;PA451522;Chemical
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;SUGCT;Gene;PA452637;Chemical
G6PD;chlorpropamide;Chemical;PA28469;Gene
KIDNEY TRANSPLANTATION;rs28371759;Variant;PA165817016;Disease
CYCLOSPORINE;rs28371759;Variant;PA449167;Chemical
KIDNEY TRANSPLANTATION;rs4646450;Variant;PA165817016;Disease
LIVER TRANSPLANTATION;rs4646450;Variant;PA447247;Disease
TACROLIMUS;rs4646450;Variant;PA451578;Chemical
RS2853826;Nucleoside and nucleotide reverse transcriptase inhibitors;Chemical;PA166158911;Variant
CYP3A4;lidocaine;Chemical;PA130;Gene
CYP3A4*1;lidocaine;Chemical;PA165819201;Haplotype
CYP3A4*2;lidocaine;Chemical;PA165819220;Haplotype
CYP3A4*5;lidocaine;Chemical;PA165819223;Haplotype
CYP3A4*9;lidocaine;Chemical;PA165819227;Haplotype
CYP3A4*11;lidocaine;Chemical;PA165819229;Haplotype
CYP3A4*14;lidocaine;Chemical;PA165819232;Haplotype
CYP3A4*15;lidocaine;Chemical;PA165819233;Haplotype
CYP3A4*16;lidocaine;Chemical;PA165819236;Haplotype
CYP3A4*18;lidocaine;Chemical;PA165819240;Haplotype
CYP3A4*19;lidocaine;Chemical;PA165819243;Haplotype
CYP3A4*23;lidocaine;Chemical;PA166115836;Haplotype
CYP3A4*24;lidocaine;Chemical;PA166115837;Haplotype
CYP3A4*29;lidocaine;Chemical;PA166245585;Haplotype
CYP3A4*31;lidocaine;Chemical;PA166245587;Haplotype
CYP3A4*32;lidocaine;Chemical;PA166245588;Haplotype
CYP3A4*34;lidocaine;Chemical;PA166245590;Haplotype
SCN5A;lidocaine;Chemical;PA304;Gene
EVENT-FREE SURVIVAL;CYP2D6*11;Haplotype;PA166123366;Disease
BREAST NEOPLASMS;CYP2D6*11;Haplotype;PA443560;Disease
TAMOXIFEN;CYP2D6*11;Haplotype;PA451581;Chemical
SPARTEINE;CYP2D6*11;Haplotype;PA452610;Chemical
FLUOROURACIL;rs3749438;Variant;PA128406956;Chemical
COLORECTAL NEOPLASMS;rs3749438;Variant;PA446108;Disease
IRINOTECAN;rs3749438;Variant;PA450085;Chemical
LEUCOVORIN;rs3749438;Variant;PA450198;Chemical
PROSTATIC NEOPLASMS;RPL13;Gene;PA445425;Disease
DOCETAXEL;RPL13;Gene;PA449383;Chemical
THALIDOMIDE;RPL13;Gene;PA451644;Chemical
BETA BLOCKING AGENTS;rs4752292;Variant;PA164712535;Chemical
CORONARY ARTERY DISEASE;rs4752292;Variant;PA443796;Disease
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs11938228;Variant;PA164713366;Chemical
PSORIASIS;rs11938228;Variant;PA445451;Disease
INFLAMMATORY BOWEL DISEASES;rs11938228;Variant;PA446116;Disease
SUNITINIB;KDR;Gene;PA162372840;Chemical
BRIVANIB;KDR;Gene;PA164924492;Chemical
AXITINIB;KDR;Gene;PA164924493;Chemical
PAZOPANIB;KDR;Gene;PA165291492;Chemical
HAND-FOOT SYNDROME;KDR;Gene;PA166114377;Disease
REGORAFENIB;KDR;Gene;PA166114943;Chemical
MOTESANIB;KDR;Gene;PA166118340;Chemical
VANDETANIB;KDR;Gene;PA166118341;Chemical
CSK;KDR;Gene;PA26946;Gene
HRAS;KDR;Gene;PA29444;Gene
KRAS;KDR;Gene;PA30196;Gene
NRAS;KDR;Gene;PA31768;Gene
NRP1;KDR;Gene;PA31783;Gene
PIK3C2A;KDR;Gene;PA33304;Gene
PIK3C2B;KDR;Gene;PA33305;Gene
PIK3CA;KDR;Gene;PA33308;Gene
PIK3CB;KDR;Gene;PA33309;Gene
PIK3CD;KDR;Gene;PA33310;Gene
PIK3CG;KDR;Gene;PA33311;Gene
PIK3R1;KDR;Gene;PA33312;Gene
PIK3R2;KDR;Gene;PA33313;Gene
PIK3R3;KDR;Gene;PA33314;Gene
PLCG1;KDR;Gene;PA33392;Gene
PLCG2;KDR;Gene;PA33393;Gene
TIMP3;KDR;Gene;PA36528;Gene
VEGFA;KDR;Gene;PA37302;Gene
VEGFB;KDR;Gene;PA37303;Gene
VEGFC;KDR;Gene;PA37304;Gene
RENAL CELL CARCINOMA;KDR;Gene;PA443624;Disease
DRUG TOXICITY;KDR;Gene;PA443937;Disease
HEPATOCELLULAR CARCINOMA;KDR;Gene;PA444447;Disease
HYPERTENSION;KDR;Gene;PA444552;Disease
KIDNEY NEOPLASMS;KDR;Gene;PA444685;Disease
SORAFENIB;KDR;Gene;PA7000;Chemical
DPYD;rs145112791;Variant;PA145;Gene
CAPECITABINE;rs145112791;Variant;PA448771;Chemical
BREAST NEOPLASMS;rs4550690;Variant;PA443560;Disease
ANASTROZOLE;rs4550690;Variant;PA448432;Chemical
EXEMESTANE;rs4550690;Variant;PA449563;Chemical
ACE INHIBITORS, PLAIN;AGT;Gene;PA164712308;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;AGT;Gene;PA164712462;Chemical
ACUTE CORONARY SYNDROME;AGT;Gene;PA165108401;Disease
CORONARY ARTERY DISEASE;AGT;Gene;PA443796;Disease
HYPERTENSION;AGT;Gene;PA444552;Disease
HYPERTROPHY, LEFT VENTRICULAR;AGT;Gene;PA446479;Disease
AMLODIPINE;AGT;Gene;PA448388;Chemical
ASPIRIN;AGT;Gene;PA448497;Chemical
ATENOLOL;AGT;Gene;PA448499;Chemical
BENAZEPRIL;AGT;Gene;PA448561;Chemical
CHLORTHALIDONE;AGT;Gene;PA448970;Chemical
IRBESARTAN;AGT;Gene;PA450084;Chemical
LISINOPRIL;AGT;Gene;PA450242;Chemical
QUINAPRIL;AGT;Gene;PA451205;Chemical
IMIDAPRIL;AGT;Gene;PA452640;Chemical
RS2369049;estradiol;Chemical;PA166154791;Variant
RS7158782;estradiol;Chemical;PA166154811;Variant
RS7159713;estradiol;Chemical;PA166154812;Variant
RS11849538;estradiol;Chemical;PA166154825;Variant
TCL1A;estradiol;Chemical;PA36400;Gene
3-CYANO-7-ETHOXYCOUMARIN;CYP2C19*16;Haplotype;PA166123047;Chemical
11A-HYDROXYPROGESTERONE;CYP2C19*16;Haplotype;PA166318342;Chemical
CELECOXIB;CYP2C19*16;Haplotype;PA448871;Chemical
CLOPIDOGREL;CYP2C19*16;Haplotype;PA449053;Chemical
FLUOXETINE;CYP2C19*16;Haplotype;PA449673;Chemical
KETOCONAZOLE;CYP2C19*16;Haplotype;PA450146;Chemical
MEPHENYTOIN;CYP2C19*16;Haplotype;PA450373;Chemical
METHYLPHENOBARBITAL;CYP2C19*16;Haplotype;PA450374;Chemical
OMEPRAZOLE;CYP2C19*16;Haplotype;PA450704;Chemical
SERTRALINE;CYP2C19*16;Haplotype;PA451333;Chemical
TICLOPIDINE;CYP2C19*16;Haplotype;PA451686;Chemical
FLT1;motesanib;Chemical;PA28180;Gene
KDR;motesanib;Chemical;PA30086;Gene
DIABETES MELLITUS, TYPE 2;rs1801282;Variant;PA443890;Disease
SCHIZOPHRENIA;rs1801282;Variant;PA447216;Disease
OLANZAPINE;rs1801282;Variant;PA450688;Chemical
PIOGLITAZONE;rs1801282;Variant;PA450970;Chemical
OPIOID-RELATED DISORDERS;RGS19;Gene;PA445043;Disease
OPIOIDS;RGS19;Gene;PA452618;Chemical
MENOPAUSE;rs700518;Variant;PA166048848;Disease
BREAST NEOPLASMS;rs700518;Variant;PA443560;Disease
LETROZOLE;rs700518;Variant;PA450196;Chemical
LEUKOPENIA;rs4948496;Variant;PA444773;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs4948496;Variant;PA446155;Disease
METHOTREXATE;rs4948496;Variant;PA450428;Chemical
RADIOTHERAPY;rs264651;Variant;PA166122986;Chemical
PROSTATIC NEOPLASMS;rs264651;Variant;PA445425;Disease
CYP2C19;6beta-hydroxytestosterone;Chemical;PA124;Gene
CYP2C19*6;6beta-hydroxytestosterone;Chemical;PA165816522;Haplotype
CYP2C19*9;6beta-hydroxytestosterone;Chemical;PA165816525;Haplotype
CYP2C19*10;6beta-hydroxytestosterone;Chemical;PA165816526;Haplotype
CYP2C19*13;6beta-hydroxytestosterone;Chemical;PA165816529;Haplotype
CYP2C19*19;6beta-hydroxytestosterone;Chemical;PA165816535;Haplotype
CYP2C19*1;6beta-hydroxytestosterone;Chemical;PA165980634;Haplotype
CYP2C19*30;6beta-hydroxytestosterone;Chemical;PA166123293;Haplotype
PRANLUKAST;CYSLTR1;Gene;PA134698661;Chemical
MONTELUKAST;CYSLTR1;Gene;PA450546;Chemical
ZAFIRLUKAST;CYSLTR1;Gene;PA451949;Chemical
CYP3A5;Obesity;Disease;PA131;Gene
ANKK1;Obesity;Disease;PA134872551;Gene
CYP3A5*3;Obesity;Disease;PA166128219;Haplotype
RS1800497;Obesity;Disease;PA166154339;Variant
RS5443;Obesity;Disease;PA166154486;Variant
RS6923761;Obesity;Disease;PA166157117;Variant
RS10305420;Obesity;Disease;PA166157167;Variant
GNB3;Obesity;Disease;PA176;Gene
DRD2;Obesity;Disease;PA27478;Gene
GLP1R;Obesity;Disease;PA28725;Gene
ADRB1;Obesity;Disease;PA38;Gene
VARENICLINE;rs1044396;Variant;PA164781343;Chemical
TOBACCO USE DISORDER;rs1044396;Variant;PA445876;Disease
NICOTINE;rs1044396;Variant;PA450626;Chemical
AGRANULOCYTOSIS;HLA-DRB3*02:02;Haplotype;PA443297;Disease
SCHIZOPHRENIA;HLA-DRB3*02:02;Haplotype;PA447216;Disease
CLOZAPINE;HLA-DRB3*02:02;Haplotype;PA449061;Chemical
ATAZANAVIR;rs2472677;Variant;PA10251;Chemical
NEPHROLITHIASIS;rs2472677;Variant;PA162355520;Disease
DOLUTEGRAVIR;rs2472677;Variant;PA166114961;Chemical
DISCONTINUATION;rs2472677;Variant;PA166123507;Disease
ADVERSE EVENTS;rs2472677;Variant;PA166151827;Disease
ACQUIRED IMMUNODEFICIENCY SYNDROME;rs2472677;Variant;PA443250;Disease
HIV INFECTIOUS DISEASE;rs2472677;Variant;PA447230;Disease
RIFAMPIN;rs2472677;Variant;PA451250;Chemical
TPMT*1;dose reduction;Disease;PA165819268;Haplotype
TPMT*2;dose reduction;Disease;PA165819269;Haplotype
TPMT*3A;dose reduction;Disease;PA165819270;Haplotype
TPMT*3B;dose reduction;Disease;PA165819271;Haplotype
TPMT*3C;dose reduction;Disease;PA165819272;Haplotype
TPMT*9;dose reduction;Disease;PA165819279;Haplotype
TPMT;dose reduction;Disease;PA356;Gene
NICOTINE;rs56256500;Variant;PA450626;Chemical
NAT2*4;sulfamethazine;Chemical;PA165949098;Haplotype
NAT2;sulfamethazine;Chemical;PA18;Gene
G6PD;sulfamethazine;Chemical;PA28469;Gene
NR1I2;sulfamethazine;Chemical;PA378;Gene
BIPOLAR DISORDER;rs1387923;Variant;PA447199;Disease
LITHIUM;rs1387923;Variant;PA450243;Chemical
CFTR;rs397508288;Variant;PA109;Gene
IVACAFTOR;rs397508288;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs397508288;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs397508288;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs397508288;Variant;PA443829;Disease
N-DESMETHYLTAMOXIFEN;CYP2D6*46;Haplotype;PA166127651;Chemical
HYPERTENSION;CYP2D6*46;Haplotype;PA444552;Disease
METOPROLOL;CYP2D6*46;Haplotype;PA450480;Chemical
PRIMAQUINE;CYP2D6*46;Haplotype;PA451103;Chemical
HEROIN DEPENDENCE;rs9478495;Variant;PA444460;Disease
HEROIN;rs9478495;Variant;PA452619;Chemical
CYP2A6;pilocarpine;Chemical;PA121;Gene
CYP2A6*4;pilocarpine;Chemical;PA165924721;Haplotype
CYP2A6*7;pilocarpine;Chemical;PA165924731;Haplotype
CYP2A6*10;pilocarpine;Chemical;PA165924735;Haplotype
CYP2A6*9;pilocarpine;Chemical;PA165980914;Haplotype
CYP2C19;benzodiazepine derivatives;Chemical;PA124;Gene
RS948854;benzodiazepine derivatives;Chemical;PA166154302;Variant
RS1799971;benzodiazepine derivatives;Chemical;PA166156991;Variant
GAL;benzodiazepine derivatives;Chemical;PA28529;Gene
OPRM1;benzodiazepine derivatives;Chemical;PA31945;Gene
MARGETUXIMAB;FCGR2B;Gene;PA166235241;Chemical
METHADONE;rs17446819;Variant;PA450401;Chemical
CONJUGATED ESTROGENS;rs1042028;Variant;PA164754789;Chemical
DESMETHYLNAPROXEN;rs1042028;Variant;PA166163690;Chemical
TAPENTADOL;rs1042028;Variant;PA166179720;Chemical
PAIN;rs1042028;Variant;PA445208;Disease
ENDOMETRIAL NEOPLASMS;rs1042028;Variant;PA446411;Disease
ACETAMINOPHEN;rs1042028;Variant;PA448015;Chemical
UGT1A1*1;Asthenia;Disease;PA166115841;Haplotype
UGT1A1*28;Asthenia;Disease;PA166115842;Haplotype
UGT1A1*37;Asthenia;Disease;PA166115844;Haplotype
RS45445694;Asthenia;Disease;PA166155331;Variant
RS4728709;Asthenia;Disease;PA166157398;Variant
RS699517;Asthenia;Disease;PA166163751;Variant
RS4678145;Asthenia;Disease;PA166163762;Variant
ABCB1;Asthenia;Disease;PA267;Gene
TYMS;Asthenia;Disease;PA359;Gene
UMPS;Asthenia;Disease;PA363;Gene
UGT1A1;Asthenia;Disease;PA420;Gene
MERCAPTOPURINE;rs3931660;Variant;PA450379;Chemical
CFTR;elexacaftor;Chemical;PA109;Gene
RS113993960;elexacaftor;Chemical;PA166157525;Variant
RS397508139;elexacaftor;Chemical;PA166178058;Variant
RS758900656;elexacaftor;Chemical;PA166351561;Variant
RS397508609;elexacaftor;Chemical;PA166397581;Variant
RS397508293;elexacaftor;Chemical;PA166415961;Variant
RS1792306355;elexacaftor;Chemical;PA166415982;Variant
ADRA1D;Alpha-adrenoreceptor antagonists;Chemical;PA24597;Gene
ADRA1B;Alpha-adrenoreceptor antagonists;Chemical;PA33;Gene
ADRA1A;Alpha-adrenoreceptor antagonists;Chemical;PA34;Gene
RHEUMATOID ARTHRITIS;rs35592;Variant;PA443434;Disease
PSORIASIS;rs35592;Variant;PA445451;Disease
METHOTREXATE;rs35592;Variant;PA450428;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;rs1800544;Variant;PA164713257;Chemical
MILNACIPRAN;rs1800544;Variant;PA164752812;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs1800544;Variant;PA447197;Disease
DEPRESSIVE DISORDER;rs1800544;Variant;PA447207;Disease
MAJOR DEPRESSIVE DISORDER;rs1800544;Variant;PA447321;Disease
DEXMEDETOMIDINE;rs1800544;Variant;PA449256;Chemical
METHYLPHENIDATE;rs1800544;Variant;PA450464;Chemical
CETP;atorvastatin;Chemical;PA108;Gene
ABCC2;atorvastatin;Chemical;PA116;Gene
CYP2C19;atorvastatin;Chemical;PA124;Gene
CYP2D6;atorvastatin;Chemical;PA128;Gene
CYP3A4;atorvastatin;Chemical;PA130;Gene
CYP3A5;atorvastatin;Chemical;PA131;Gene
CYP7A1;atorvastatin;Chemical;PA132;Gene
SLCO1B1;atorvastatin;Chemical;PA134865839;Gene
KIF6;atorvastatin;Chemical;PA134920075;Gene
MYLIP;atorvastatin;Chemical;PA134942677;Gene
IFNL3;atorvastatin;Chemical;PA134952671;Gene
ACE;atorvastatin;Chemical;PA139;Gene
COQ2;atorvastatin;Chemical;PA142672084;Gene
SCAP;atorvastatin;Chemical;PA162402461;Gene
MTTP;atorvastatin;Chemical;PA164742099;Gene
CYP2D6*1;atorvastatin;Chemical;PA165816576;Haplotype
CYP2D6*3;atorvastatin;Chemical;PA165816578;Haplotype
CYP2D6*4;atorvastatin;Chemical;PA165816579;Haplotype
SLCO1B1*37;atorvastatin;Chemical;PA165819251;Haplotype
SLCO1B1*5;atorvastatin;Chemical;PA165819255;Haplotype
SLCO1B1*15;atorvastatin;Chemical;PA165819265;Haplotype
HLA-DRB1*01:01;atorvastatin;Chemical;PA165951320;Haplotype
HLA-DRB1*04:06;atorvastatin;Chemical;PA165951530;Haplotype
UGT1A3*1;atorvastatin;Chemical;PA165959980;Haplotype
UGT1A3*2;atorvastatin;Chemical;PA165959981;Haplotype
CYP2C19*1;atorvastatin;Chemical;PA165980634;Haplotype
CYP2C19*2;atorvastatin;Chemical;PA165980635;Haplotype
CYP2C19*3;atorvastatin;Chemical;PA165980636;Haplotype
SLCO1B1*1;atorvastatin;Chemical;PA165981641;Haplotype
IFNL4;atorvastatin;Chemical;PA166049147;Gene
CYP3A5*1;atorvastatin;Chemical;PA166128213;Haplotype
CYP3A5*3;atorvastatin;Chemical;PA166128219;Haplotype
RS1805094;atorvastatin;Chemical;PA166153655;Variant
RS2297480;atorvastatin;Chemical;PA166153695;Variant
RS2819742;atorvastatin;Chemical;PA166153719;Variant
RS11264359;atorvastatin;Chemical;PA166153825;Variant
RS717620;atorvastatin;Chemical;PA166153953;Variant
RS1935349;atorvastatin;Chemical;PA166153988;Variant
RS662799;atorvastatin;Chemical;PA166154293;Variant
RS2276307;atorvastatin;Chemical;PA166154360;Variant
RS5888;atorvastatin;Chemical;PA166154488;Variant
RS2306283;atorvastatin;Chemical;PA166154547;Variant
RS4149036;atorvastatin;Chemical;PA166154576;Variant
RS4149056;atorvastatin;Chemical;PA166154579;Variant
RS1799722;atorvastatin;Chemical;PA166154785;Variant
RS708272;atorvastatin;Chemical;PA166154993;Variant
RS1799752;atorvastatin;Chemical;PA166155187;Variant
RS7412;atorvastatin;Chemical;PA166155341;Variant
RS12979860;atorvastatin;Chemical;PA166155468;Variant
RS11887534;atorvastatin;Chemical;PA166155810;Variant
RS5186;atorvastatin;Chemical;PA166156276;Variant
RS12487736;atorvastatin;Chemical;PA166156447;Variant
RS1800591;atorvastatin;Chemical;PA166156523;Variant
RS2231142;atorvastatin;Chemical;PA166156544;Variant
RS4693075;atorvastatin;Chemical;PA166156593;Variant
RS6535454;atorvastatin;Chemical;PA166156601;Variant
RS17238540;atorvastatin;Chemical;PA166156885;Variant
RS17671591;atorvastatin;Chemical;PA166156889;Variant
RS20455;atorvastatin;Chemical;PA166156905;Variant
RS1800629;atorvastatin;Chemical;PA166156997;Variant
RS9370867;atorvastatin;Chemical;PA166157150;Variant
RS662;atorvastatin;Chemical;PA166157238;Variant
RS705379;atorvastatin;Chemical;PA166157261;Variant
RS776746;atorvastatin;Chemical;PA166157267;Variant
RS1045642;atorvastatin;Chemical;PA166157284;Variant
RS1057868;atorvastatin;Chemical;PA166157286;Variant
RS2032582;atorvastatin;Chemical;PA166157316;Variant
RS2242480;atorvastatin;Chemical;PA166157345;Variant
RS2740574;atorvastatin;Chemical;PA166157367;Variant
RS17161788;atorvastatin;Chemical;PA166157472;Variant
RS3808607;atorvastatin;Chemical;PA166157595;Variant
RS2230806;atorvastatin;Chemical;PA166157744;Variant
RS12003906;atorvastatin;Chemical;PA166157834;Variant
HMGCR;atorvastatin;Chemical;PA189;Gene
LDLR;atorvastatin;Chemical;PA227;Gene
LEPR;atorvastatin;Chemical;PA229;Gene
ABCA1;atorvastatin;Chemical;PA24373;Gene
ABCG8;atorvastatin;Chemical;PA24412;Gene
APOA5;atorvastatin;Chemical;PA24888;Gene
ABCB1;atorvastatin;Chemical;PA267;Gene
FDPS;atorvastatin;Chemical;PA28075;Gene
HTR3B;atorvastatin;Chemical;PA29556;Gene
HTR7;atorvastatin;Chemical;PA29561;Gene
RYR2;atorvastatin;Chemical;PA300;Gene
PON1;atorvastatin;Chemical;PA33529;Gene
POR;atorvastatin;Chemical;PA33532;Gene
HLA-DRB1;atorvastatin;Chemical;PA35072;Gene
UGT1A3;atorvastatin;Chemical;PA37178;Gene
NR1I2;atorvastatin;Chemical;PA378;Gene
ABCG2;atorvastatin;Chemical;PA390;Gene
AGTR1;atorvastatin;Chemical;PA43;Gene
TNF;atorvastatin;Chemical;PA435;Gene
APOE;atorvastatin;Chemical;PA55;Gene
BDKRB2;atorvastatin;Chemical;PA80;Gene
SCARB1;atorvastatin;Chemical;PA97;Gene
DRUG HYPERSENSITIVITY;HLA-B*14:02;Haplotype;PA443936;Disease
HIV INFECTIONS;HLA-B*14:02;Haplotype;PA447230;Disease
NEVIRAPINE;HLA-B*14:02;Haplotype;PA450616;Chemical
ABL1;Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative;Disease;PA24413;Gene
DRUG TOXICITY;rs9973653;Variant;PA443937;Disease
SORAFENIB;rs9973653;Variant;PA7000;Chemical
DESFLURANE;rs118192163;Variant;PA164749136;Chemical
RYR1;rs118192163;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs118192163;Variant;PA444863;Disease
ENFLURANE;rs118192163;Variant;PA449461;Chemical
HALOTHANE;rs118192163;Variant;PA449845;Chemical
ISOFLURANE;rs118192163;Variant;PA450106;Chemical
METHOXYFLURANE;rs118192163;Variant;PA450434;Chemical
SEVOFLURANE;rs118192163;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs118192163;Variant;PA451522;Chemical
CACNA1S;rs118192163;Variant;PA85;Gene
MULTIPLE SCLEROSIS;rs10760397;Variant;PA444987;Disease
INTERFERON BETA-1A;rs10760397;Variant;PA450037;Chemical
INTERFERON BETA-1B;rs10760397;Variant;PA450039;Chemical
DIABETES MELLITUS, TYPE 2;NBEA;Gene;PA443890;Disease
MAJOR DEPRESSIVE DISORDER;NBEA;Gene;PA447321;Disease
METFORMIN;NBEA;Gene;PA450395;Chemical
ANTIDEPRESSANTS;NBEA;Gene;PA452229;Chemical
ASTHMA;GALNT17;Gene;PA443450;Disease
MONTELUKAST;GALNT17;Gene;PA450546;Chemical
PLATINUM COMPOUNDS;rs50872;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs50872;Variant;PA443622;Disease
VORICONAZOLE;rs1045642;Variant;PA10233;Chemical
ATAZANAVIR;rs1045642;Variant;PA10251;Chemical
IMATINIB;rs1045642;Variant;PA10804;Chemical
FLUOROURACIL;rs1045642;Variant;PA128406956;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs1045642;Variant;PA130620651;Chemical
OXALIPLATIN;rs1045642;Variant;PA131285527;Chemical
ORGAN TRANSPLANTATION;rs1045642;Variant;PA133888799;Disease
HMG COA REDUCTASE INHIBITORS;rs1045642;Variant;PA133950441;Chemical
TRANSPLANTATION;rs1045642;Variant;PA134850491;Disease
ANTIEPILEPTICS;rs1045642;Variant;PA143485705;Chemical
TALINOLOL;rs1045642;Variant;PA146123005;Chemical
TAXANES;rs1045642;Variant;PA150481189;Chemical
MYALGIA;rs1045642;Variant;PA157379134;Disease
SUNITINIB;rs1045642;Variant;PA162372840;Chemical
ANTIVIRALS FOR TREATMENT OF HIV INFECTIONS, COMBINATIONS;rs1045642;Variant;PA164712505;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;rs1045642;Variant;PA164712708;Chemical
PLATINUM COMPOUNDS;rs1045642;Variant;PA164713176;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;rs1045642;Variant;PA164713257;Chemical
EVEROLIMUS;rs1045642;Variant;PA164746311;Chemical
DICLOXACILLIN;rs1045642;Variant;PA164749649;Chemical
DAPTOMYCIN;rs1045642;Variant;PA164768820;Chemical
TOXIC LIVER DISEASE;rs1045642;Variant;PA164925725;Disease
ACUTE CORONARY SYNDROME;rs1045642;Variant;PA165108401;Disease
DABIGATRAN;rs1045642;Variant;PA165110351;Chemical
RHODAMINE 123;rs1045642;Variant;PA165110729;Chemical
KIDNEY TRANSPLANTATION;rs1045642;Variant;PA165817016;Disease
RIVAROXABAN;rs1045642;Variant;PA165958360;Chemical
AGOMELATINE;rs1045642;Variant;PA165958363;Chemical
HELICOBACTER INFECTIONS;rs1045642;Variant;PA166048740;Disease
MUCOSITIS;rs1045642;Variant;PA166122058;Disease
PLATELET REACTIVITY;rs1045642;Variant;PA166124406;Disease
SILIBININ;rs1045642;Variant;PA166129539;Chemical
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART);rs1045642;Variant;PA166177229;Chemical
JUVENILE RHEUMATOID ARTHRITIS;rs1045642;Variant;PA443433;Disease
RHEUMATOID ARTHRITIS;rs1045642;Variant;PA443434;Disease
BREAST NEOPLASMS;rs1045642;Variant;PA443560;Disease
BURKITT LYMPHOMA;rs1045642;Variant;PA443580;Disease
NON-SMALL CELL LUNG CARCINOMA;rs1045642;Variant;PA443622;Disease
RENAL CELL CARCINOMA;rs1045642;Variant;PA443624;Disease
ULCERATIVE COLITIS;rs1045642;Variant;PA443750;Disease
CORONARY ARTERY DISEASE;rs1045642;Variant;PA443796;Disease
CORONARY DISEASE;rs1045642;Variant;PA443797;Disease
DEATH;rs1045642;Variant;PA443842;Disease
DRUG TOXICITY;rs1045642;Variant;PA443937;Disease
EPILEPSY;rs1045642;Variant;PA444065;Disease
EPILEPSIES, PARTIAL;rs1045642;Variant;PA444066;Disease
EPILEPSY, IDIOPATHIC GENERALIZED;rs1045642;Variant;PA444067;Disease
NEOPLASM OF ESOPHAGUS;rs1045642;Variant;PA444101;Disease
FRACTURES, BONE;rs1045642;Variant;PA444222;Disease
GASTROESOPHAGEAL REFLUX;rs1045642;Variant;PA444255;Disease
HEMORRHAGE;rs1045642;Variant;PA444417;Disease
HEROIN DEPENDENCE;rs1045642;Variant;PA444460;Disease
HYPERCHOLESTEROLEMIA;rs1045642;Variant;PA444516;Disease
HYPERTENSION;rs1045642;Variant;PA444552;Disease
HYPOTENSIVE DISORDER;rs1045642;Variant;PA444584;Disease
HYPOVENTILATION;rs1045642;Variant;PA444591;Disease
LEUKEMIA, MYELOID, ACUTE;rs1045642;Variant;PA444760;Disease
MIGRAINE WITHOUT AURA;rs1045642;Variant;PA444949;Disease
MULTIPLE MYELOMA;rs1045642;Variant;PA444985;Disease
MYOCARDIAL INFARCTION;rs1045642;Variant;PA445019;Disease
NARCOLEPSY;rs1045642;Variant;PA445042;Disease
OPIOID-RELATED DISORDERS;rs1045642;Variant;PA445043;Disease
NEOPLASMS;rs1045642;Variant;PA445062;Disease
NEUTROPENIA;rs1045642;Variant;PA445113;Disease
PAIN;rs1045642;Variant;PA445208;Disease
PAIN, POSTOPERATIVE;rs1045642;Variant;PA445210;Disease
PERIPHERAL NERVOUS SYSTEM DISEASES;rs1045642;Variant;PA445301;Disease
TESTICULAR NEOPLASMS;rs1045642;Variant;PA445828;Disease
TUBERCULOSIS;rs1045642;Variant;PA445941;Disease
VOMITING;rs1045642;Variant;PA446051;Disease
COLORECTAL NEOPLASMS;rs1045642;Variant;PA446108;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs1045642;Variant;PA446155;Disease
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;rs1045642;Variant;PA446171;Disease
LYMPHOMA, T-CELL;rs1045642;Variant;PA446309;Disease
LOW BACK PAIN;rs1045642;Variant;PA446444;Disease
ARTHRALGIA;rs1045642;Variant;PA446761;Disease
SUBSTANCE-RELATED DISORDERS;rs1045642;Variant;PA446876;Disease
POSTOPERATIVE NAUSEA AND VOMITING;rs1045642;Variant;PA446970;Disease
MIGRAINE WITH AURA;rs1045642;Variant;PA447004;Disease
BIPOLAR DISORDER;rs1045642;Variant;PA447199;Disease
DEPRESSIVE DISORDER;rs1045642;Variant;PA447207;Disease
PSYCHOTIC DISORDER;rs1045642;Variant;PA447215;Disease
SCHIZOPHRENIA;rs1045642;Variant;PA447216;Disease
HIV INFECTIOUS DISEASE;rs1045642;Variant;PA447230;Disease
DEPRESSION;rs1045642;Variant;PA447278;Disease
MAJOR DEPRESSIVE DISORDER;rs1045642;Variant;PA447321;Disease
ANASTROZOLE;rs1045642;Variant;PA448432;Chemical
ATORVASTATIN;rs1045642;Variant;PA448500;Chemical
BLEOMYCIN;rs1045642;Variant;PA448645;Chemical
CAPECITABINE;rs1045642;Variant;PA448771;Chemical
CARBAMAZEPINE;rs1045642;Variant;PA448785;Chemical
CISPLATIN;rs1045642;Variant;PA449014;Chemical
CLOPIDOGREL;rs1045642;Variant;PA449053;Chemical
CLOZAPINE;rs1045642;Variant;PA449061;Chemical
CODEINE;rs1045642;Variant;PA449088;Chemical
CYCLOPHOSPHAMIDE;rs1045642;Variant;PA449165;Chemical
CYCLOSPORINE;rs1045642;Variant;PA449167;Chemical
CYTARABINE;rs1045642;Variant;PA449177;Chemical
DEXAMETHASONE;rs1045642;Variant;PA449247;Chemical
DIGOXIN;rs1045642;Variant;PA449319;Chemical
DOCETAXEL;rs1045642;Variant;PA449383;Chemical
DOXORUBICIN;rs1045642;Variant;PA449412;Chemical
EFAVIRENZ;rs1045642;Variant;PA449441;Chemical
ETOPOSIDE;rs1045642;Variant;PA449552;Chemical
FENTANYL;rs1045642;Variant;PA449599;Chemical
FEXOFENADINE;rs1045642;Variant;PA449621;Chemical
GRANISETRON;rs1045642;Variant;PA449809;Chemical
ISONIAZID;rs1045642;Variant;PA450112;Chemical
LANSOPRAZOLE;rs1045642;Variant;PA450180;Chemical
LOSARTAN;rs1045642;Variant;PA450268;Chemical
METHADONE;rs1045642;Variant;PA450401;Chemical
METHOTREXATE;rs1045642;Variant;PA450428;Chemical
METHYLPREDNISOLONE;rs1045642;Variant;PA450466;Chemical
MODAFINIL;rs1045642;Variant;PA450530;Chemical
MORPHINE;rs1045642;Variant;PA450550;Chemical
NELFINAVIR;rs1045642;Variant;PA450606;Chemical
NEVIRAPINE;rs1045642;Variant;PA450616;Chemical
NORTRIPTYLINE;rs1045642;Variant;PA450657;Chemical
OLANZAPINE;rs1045642;Variant;PA450688;Chemical
OMEPRAZOLE;rs1045642;Variant;PA450704;Chemical
ONDANSETRON;rs1045642;Variant;PA450705;Chemical
OSELTAMIVIR;rs1045642;Variant;PA450721;Chemical
OXCARBAZEPINE;rs1045642;Variant;PA450732;Chemical
OXYCODONE;rs1045642;Variant;PA450741;Chemical
PACLITAXEL;rs1045642;Variant;PA450761;Chemical
PANTOPRAZOLE;rs1045642;Variant;PA450774;Chemical
PHENOBARBITAL;rs1045642;Variant;PA450911;Chemical
PHENYTOIN;rs1045642;Variant;PA450947;Chemical
PREDNISOLONE;rs1045642;Variant;PA451096;Chemical
PREDNISONE;rs1045642;Variant;PA451100;Chemical
REMIFENTANIL;rs1045642;Variant;PA451232;Chemical
RISPERIDONE;rs1045642;Variant;PA451257;Chemical
RITONAVIR;rs1045642;Variant;PA451260;Chemical
SIMVASTATIN;rs1045642;Variant;PA451363;Chemical
SIROLIMUS;rs1045642;Variant;PA451365;Chemical
TACROLIMUS;rs1045642;Variant;PA451578;Chemical
TAMOXIFEN;rs1045642;Variant;PA451581;Chemical
TOPIRAMATE;rs1045642;Variant;PA451728;Chemical
TRAMADOL;rs1045642;Variant;PA451735;Chemical
VENLAFAXINE;rs1045642;Variant;PA451866;Chemical
VERAPAMIL;rs1045642;Variant;PA451868;Chemical
VINCRISTINE;rs1045642;Variant;PA451879;Chemical
WARFARIN;rs1045642;Variant;PA451906;Chemical
ANTIPSYCHOTICS;rs1045642;Variant;PA452233;Chemical
OPIOIDS;rs1045642;Variant;PA452618;Chemical
ANTINEOPLASTIC AGENTS;rs1045642;Variant;PA452621;Chemical
SORAFENIB;rs1045642;Variant;PA7000;Chemical
RS34545984;cephalexin;Chemical;PA166257841;Variant
NR1I2;cephalexin;Chemical;PA378;Gene
G6PD;sodium nitrate;Chemical;PA28469;Gene
ZOLBETUXIMAB;CLDN18;Gene;PA166345562;Chemical
CYP2C9;Thromboembolism;Disease;PA126;Gene
VKORC1;Thromboembolism;Disease;PA133787052;Gene
CYP2C9*1;Thromboembolism;Disease;PA165816542;Haplotype
CYP2C9*3;Thromboembolism;Disease;PA165816544;Haplotype
UGT1A1*1;Thromboembolism;Disease;PA166115841;Haplotype
UGT1A1*28;Thromboembolism;Disease;PA166115842;Haplotype
RS9934438;Thromboembolism;Disease;PA166155096;Variant
UGT1A1;Thromboembolism;Disease;PA420;Gene
ROSUVASTATIN;SLCO1B1*14;Haplotype;PA134308647;Chemical
ATRASENTAN;SLCO1B1*14;Haplotype;PA143414738;Chemical
HYPERCHOLESTEROLEMIA;SLCO1B1*14;Haplotype;PA444516;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;SLCO1B1*14;Haplotype;PA446155;Disease
FLUVASTATIN;SLCO1B1*14;Haplotype;PA449688;Chemical
METHOTREXATE;SLCO1B1*14;Haplotype;PA450428;Chemical
CELECOXIB;CACNA1G;Gene;PA448871;Chemical
CYP3A4;testosterone;Chemical;PA130;Gene
CYP3A5;testosterone;Chemical;PA131;Gene
CYP3A4*1;testosterone;Chemical;PA165819201;Haplotype
CYP3A4*2;testosterone;Chemical;PA165819220;Haplotype
CYP3A4*3;testosterone;Chemical;PA165819221;Haplotype
CYP3A4*5;testosterone;Chemical;PA165819223;Haplotype
CYP3A4*10;testosterone;Chemical;PA165819228;Haplotype
CYP3A4*11;testosterone;Chemical;PA165819229;Haplotype
CYP3A4*14;testosterone;Chemical;PA165819232;Haplotype
CYP3A4*15;testosterone;Chemical;PA165819233;Haplotype
CYP3A4*16;testosterone;Chemical;PA165819236;Haplotype
CYP3A4*17;testosterone;Chemical;PA165819239;Haplotype
CYP3A4*23;testosterone;Chemical;PA166115836;Haplotype
CYP3A4*24;testosterone;Chemical;PA166115837;Haplotype
UGT1A4*1A;testosterone;Chemical;PA166117588;Haplotype
UGT1A4*3A;testosterone;Chemical;PA166117598;Haplotype
RS28383479;testosterone;Chemical;PA166157484;Variant
RS35599367;testosterone;Chemical;PA166157487;Variant
RS41279854;testosterone;Chemical;PA166157489;Variant
RS55817950;testosterone;Chemical;PA166157492;Variant
CYP3A4*28;testosterone;Chemical;PA166245584;Haplotype
CYP3A4*29;testosterone;Chemical;PA166245585;Haplotype
CYP3A4*31;testosterone;Chemical;PA166245587;Haplotype
CYP3A4*32;testosterone;Chemical;PA166245588;Haplotype
CYP3A4*33;testosterone;Chemical;PA166245589;Haplotype
CYP3A4*34;testosterone;Chemical;PA166245590;Haplotype
UGT1A4;testosterone;Chemical;PA37179;Gene
RS13273672;Drugs used in alcohol dependence;Chemical;PA166157646;Variant
GATA4;Drugs used in alcohol dependence;Chemical;PA28587;Gene
ASTHMA;SLC6A12;Gene;PA443450;Disease
ASPIRIN;SLC6A12;Gene;PA448497;Chemical
MILNACIPRAN;MDGA2;Gene;PA164752812;Chemical
MAJOR DEPRESSIVE DISORDER;MDGA2;Gene;PA447321;Disease
FLUVOXAMINE;MDGA2;Gene;PA449690;Chemical
PAROXETINE;MDGA2;Gene;PA450801;Chemical
CELECOXIB;CACNA1F;Gene;PA448871;Chemical
VALPROIC ACID;CACNA1F;Gene;PA451846;Chemical
SACUBITRIL;rs71647871;Variant;PA166131580;Chemical
REMIMAZOLAM;rs71647871;Variant;PA166321761;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs71647871;Variant;PA447197;Disease
CLOPIDOGREL;rs71647871;Variant;PA449053;Chemical
ENALAPRIL;rs71647871;Variant;PA449456;Chemical
METHYLPHENIDATE;rs71647871;Variant;PA450464;Chemical
TRANDOLAPRIL;rs71647871;Variant;PA451737;Chemical
HEROIN;rs71647871;Variant;PA452619;Chemical
FLUOROURACIL;rs12248560;Variant;PA128406956;Chemical
HEMATOPOIETIC STEM CELL TRANSPLANTATION;rs12248560;Variant;PA166123007;Disease
PHENAZEPAM;rs12248560;Variant;PA166180939;Chemical
ALCOHOL ABUSE;rs12248560;Variant;PA443309;Disease
BREAST NEOPLASMS;rs12248560;Variant;PA443560;Disease
BUSULFAN;rs12248560;Variant;PA448691;Chemical
CYCLOPHOSPHAMIDE;rs12248560;Variant;PA449165;Chemical
DOXORUBICIN;rs12248560;Variant;PA449412;Chemical
MEPHENYTOIN;rs12248560;Variant;PA450373;Chemical
HEART VALVE REPLACEMENT;STX1B;Gene;PA166123431;Disease
WARFARIN;STX1B;Gene;PA451906;Chemical
PIRTOBRUTINIB;IGH;Gene;PA166328845;Chemical
ALZHEIMER DISEASE;rs2571598;Variant;PA443319;Disease
RIVASTIGMINE;rs2571598;Variant;PA451262;Chemical
OPIOID-RELATED DISORDERS;rs10770140;Variant;PA445043;Disease
OPIOIDS;rs10770140;Variant;PA452618;Chemical
TAXANES;rs879825;Variant;PA150481189;Chemical
OVARIAN NEOPLASMS;rs879825;Variant;PA445204;Disease
CARBOPLATIN;rs879825;Variant;PA448803;Chemical
OPIOID-RELATED DISORDERS;rs1611131;Variant;PA445043;Disease
OPIOIDS;rs1611131;Variant;PA452618;Chemical
CYP3A5;Myalgia;Disease;PA131;Gene
CYP3A5*1;Myalgia;Disease;PA166128213;Haplotype
CYP3A5*3;Myalgia;Disease;PA166128219;Haplotype
RS1935349;Myalgia;Disease;PA166153988;Variant
RS2276307;Myalgia;Disease;PA166154360;Variant
RS776746;Myalgia;Disease;PA166157267;Variant
RS1045642;Myalgia;Disease;PA166157284;Variant
RS2032582;Myalgia;Disease;PA166157316;Variant
ABCB1;Myalgia;Disease;PA267;Gene
HTR3B;Myalgia;Disease;PA29556;Gene
HTR7;Myalgia;Disease;PA29561;Gene
CYP2C9;lornoxicam;Chemical;PA126;Gene
CYP2C9*1;lornoxicam;Chemical;PA165816542;Haplotype
CYP2C9*2;lornoxicam;Chemical;PA165816543;Haplotype
CYP2C9*3;lornoxicam;Chemical;PA165816544;Haplotype
CYP2C9*13;lornoxicam;Chemical;PA165816554;Haplotype
VALACICLOVIR;lornoxicam;Chemical;PA451839;Chemical
ADALIMUMAB;TRAF1;Gene;PA10004;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;TRAF1;Gene;PA164713366;Chemical
RHEUMATOID ARTHRITIS;TRAF1;Gene;PA443434;Disease
ETANERCEPT;TRAF1;Gene;PA449515;Chemical
INFLIXIMAB;TRAF1;Gene;PA452639;Chemical
PEGASPARGASE;HLA-DQB1*02:02;Haplotype;PA164760860;Chemical
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-DQB1*02:02;Haplotype;PA166120929;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-DQB1*02:02;Haplotype;PA444059;Disease
HYPERSENSITIVITY;HLA-DQB1*02:02;Haplotype;PA444546;Disease
STEVENS-JOHNSON SYNDROME;HLA-DQB1*02:02;Haplotype;PA445738;Disease
ACETAMINOPHEN;HLA-DQB1*02:02;Haplotype;PA448015;Chemical
KIDNEY TRANSPLANTATION;rs6714486;Variant;PA165817016;Disease
MYCOPHENOLATE MOFETIL;rs6714486;Variant;PA450566;Chemical
BISPHOSPHONATES;rs17024608;Variant;PA164712563;Chemical
OSTEONECROSIS;rs17024608;Variant;PA445187;Disease
NEOPLASMS;rs602950;Variant;PA445062;Disease
CAPECITABINE;rs602950;Variant;PA448771;Chemical
CYTARABINE;rs602950;Variant;PA449177;Chemical
PLATINUM COMPOUNDS;rs4541111;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs4541111;Variant;PA443622;Disease
CFTR;rs376008630;Variant;PA109;Gene
IVACAFTOR;rs376008630;Variant;PA165950341;Chemical
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-A*24:07;Haplotype;PA166120929;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-A*24:07;Haplotype;PA444059;Disease
EPILEPSY;HLA-A*24:07;Haplotype;PA444065;Disease
STEVENS-JOHNSON SYNDROME;HLA-A*24:07;Haplotype;PA445738;Disease
CARBAMAZEPINE;HLA-A*24:07;Haplotype;PA448785;Chemical
MIDAZOLAM;CYP3A4*39;Haplotype;PA450496;Chemical
RS2472304;erlotinib;Chemical;PA166154898;Variant
RS726501;erlotinib;Chemical;PA166156739;Variant
RS712829;erlotinib;Chemical;PA166157262;Variant
RS121434568;erlotinib;Chemical;PA166157527;Variant
RS121434569;erlotinib;Chemical;PA166157528;Variant
ABCB1;erlotinib;Chemical;PA267;Gene
CYP1A2;erlotinib;Chemical;PA27093;Gene
ERBB2;erlotinib;Chemical;PA27844;Gene
ERBB3;erlotinib;Chemical;PA27846;Gene
ERBB4;erlotinib;Chemical;PA27847;Gene
MAP3K1;erlotinib;Chemical;PA30592;Gene
UGT1A1;erlotinib;Chemical;PA420;Gene
EGFR;erlotinib;Chemical;PA7360;Gene
DEFERASIROX;rs10877012;Variant;PA164760843;Chemical
PEGINTERFERON ALFA-2B;rs10877012;Variant;PA164784024;Chemical
BETA-THALASSEMIA AND RELATED DISEASES;rs10877012;Variant;PA446432;Disease
CHRONIC HEPATITIS C VIRUS INFECTION;rs10877012;Variant;PA446863;Disease
RIBAVIRIN;rs10877012;Variant;PA451241;Chemical
DEXMEDETOMIDINE;rs9922316;Variant;PA449256;Chemical
NAT2;daniquidone;Chemical;PA18;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;TNFRSF10A;Gene;PA164713366;Chemical
ARTHRITIS;TNFRSF10A;Gene;PA443430;Disease
CYP3A5;vardenafil;Chemical;PA131;Gene
RS776746;vardenafil;Chemical;PA166157267;Variant
ASTHMA;rs1364805;Variant;PA443450;Disease
MONTELUKAST;rs1364805;Variant;PA450546;Chemical
PROSTATIC NEOPLASMS;rs2292954;Variant;PA445425;Disease
DOCETAXEL;rs2292954;Variant;PA449383;Chemical
THALIDOMIDE;rs2292954;Variant;PA451644;Chemical
FLUOROURACIL;rs3772810;Variant;PA128406956;Chemical
METASTATIC NEOPLASM;rs3772810;Variant;PA445058;Disease
CAPECITABINE;rs3772810;Variant;PA448771;Chemical
ASPIRIN-INDUCED ASTHMA;SLC30A9;Gene;PA131285571;Disease
ASPIRIN;SLC30A9;Gene;PA448497;Chemical
CAMK1D;STAT4;Gene;PA134992438;Gene
AKT1;STAT4;Gene;PA24684;Gene
AKT2;STAT4;Gene;PA24685;Gene
AKT3;STAT4;Gene;PA24686;Gene
NFKB1;STAT4;Gene;PA248;Gene
CAMK1;STAT4;Gene;PA26048;Gene
CAMK1G;STAT4;Gene;PA26049;Gene
ELK1;STAT4;Gene;PA27749;Gene
FOS;STAT4;Gene;PA28212;Gene
MAPK8;STAT4;Gene;PA283;Gene
RELA;STAT4;Gene;PA296;Gene
JAK1;STAT4;Gene;PA29988;Gene
JUN;STAT4;Gene;PA30006;Gene
MAPK1;STAT4;Gene;PA30616;Gene
MAPK3;STAT4;Gene;PA30622;Gene
MYC;STAT4;Gene;PA31353;Gene
NFKB2;STAT4;Gene;PA31600;Gene
STAT3;STAT4;Gene;PA337;Gene
PRKCA;STAT4;Gene;PA33759;Gene
PRKCB;STAT4;Gene;PA33761;Gene
PRKCG;STAT4;Gene;PA33766;Gene
STAT5A;STAT4;Gene;PA338;Gene
SP1;STAT4;Gene;PA36042;Gene
STAT1;STAT4;Gene;PA36183;Gene
STAT2;STAT4;Gene;PA36184;Gene
STAT5B;STAT4;Gene;PA36186;Gene
RHEUMATOID ARTHRITIS;STAT4;Gene;PA443434;Disease
ETANERCEPT;STAT4;Gene;PA449515;Chemical
CAMK2A;STAT4;Gene;PA90;Gene
CAMK2B;STAT4;Gene;PA91;Gene
CAMK2D;STAT4;Gene;PA92;Gene
CAMK2G;STAT4;Gene;PA93;Gene
AMPHETAMINE;rs2281617;Variant;PA448408;Chemical
BIPOLAR DISORDER;rs16909440;Variant;PA447199;Disease
LITHIUM;rs16909440;Variant;PA450243;Chemical
COMT;Somnolence;Disease;PA117;Gene
CYP3A5;Somnolence;Disease;PA131;Gene
CYP3A5*1;Somnolence;Disease;PA166128213;Haplotype
CYP3A5*3;Somnolence;Disease;PA166128219;Haplotype
RS324420;Somnolence;Disease;PA166153569;Variant
RS4680;Somnolence;Disease;PA166156024;Variant
RS1799971;Somnolence;Disease;PA166156991;Variant
RS10248420;Somnolence;Disease;PA166157440;Variant
ABCB1;Somnolence;Disease;PA267;Gene
FAAH;Somnolence;Disease;PA27955;Gene
OPRM1;Somnolence;Disease;PA31945;Gene
ACE;torasemide;Chemical;PA139;Gene
NPPA-AS1;torasemide;Chemical;PA165752124;Gene
RS5063;torasemide;Chemical;PA166153548;Variant
RS5443;torasemide;Chemical;PA166154486;Variant
RS1529927;torasemide;Chemical;PA166155014;Variant
RS1799752;torasemide;Chemical;PA166155187;Variant
RS4961;torasemide;Chemical;PA166156480;Variant
GNB3;torasemide;Chemical;PA176;Gene
ADD1;torasemide;Chemical;PA31;Gene
SLC12A3;torasemide;Chemical;PA321;Gene
ARIPIPRAZOLE;ANKK1;Gene;PA10026;Chemical
NEMONAPRIDE;ANKK1;Gene;PA151186253;Chemical
ALCOHOL ABUSE;ANKK1;Gene;PA443309;Disease
EPILEPSY;ANKK1;Gene;PA444065;Disease
HEROIN DEPENDENCE;ANKK1;Gene;PA444460;Disease
HYPERPROLACTINEMIA;ANKK1;Gene;PA444545;Disease
OPIOID-RELATED DISORDERS;ANKK1;Gene;PA445043;Disease
NAUSEA;ANKK1;Gene;PA445048;Disease
OBESITY;ANKK1;Gene;PA445131;Disease
TOBACCO USE DISORDER;ANKK1;Gene;PA445876;Disease
COCAINE DEPENDENCE;ANKK1;Gene;PA446878;Disease
AUTISM;ANKK1;Gene;PA447198;Disease
SCHIZOPHRENIA;ANKK1;Gene;PA447216;Disease
ETHANOL;ANKK1;Gene;PA448073;Chemical
BUPROPION;ANKK1;Gene;PA448687;Chemical
DISULFIRAM;ANKK1;Gene;PA449376;Chemical
HALOPERIDOL;ANKK1;Gene;PA449841;Chemical
METHADONE;ANKK1;Gene;PA450401;Chemical
NALTREXONE;ANKK1;Gene;PA450588;Chemical
NICOTINE;ANKK1;Gene;PA450626;Chemical
OLANZAPINE;ANKK1;Gene;PA450688;Chemical
PROCHLORPERAZINE;ANKK1;Gene;PA451114;Chemical
RISPERIDONE;ANKK1;Gene;PA451257;Chemical
VALPROIC ACID;ANKK1;Gene;PA451846;Chemical
OPIOIDS;ANKK1;Gene;PA452618;Chemical
CYP2C19;cilostazol;Chemical;PA124;Gene
CYP3A5;cilostazol;Chemical;PA131;Gene
CYP2C19*1;cilostazol;Chemical;PA165980634;Haplotype
CYP2C19*2;cilostazol;Chemical;PA165980635;Haplotype
CYP2C19*3;cilostazol;Chemical;PA165980636;Haplotype
CYP3A5*1;cilostazol;Chemical;PA166128213;Haplotype
CYP3A5*3;cilostazol;Chemical;PA166128219;Haplotype
HYPERTRIGLYCERIDEMIA;FABP1;Gene;PA446120;Disease
FENOFIBRATE;FABP1;Gene;PA449594;Chemical
SLC22A2;creatinine clearance;Disease;PA331;Gene
WARFARIN;rs17708472;Variant;PA451906;Chemical
HMG COA REDUCTASE INHIBITORS;rs708272;Variant;PA133950441;Chemical
ROSUVASTATIN;rs708272;Variant;PA134308647;Chemical
CORONARY ARTERY DISEASE;rs708272;Variant;PA443796;Disease
HYPERCHOLESTEROLEMIA;rs708272;Variant;PA444516;Disease
HYPERLIPOPROTEINEMIA TYPE II;rs708272;Variant;PA444517;Disease
ATORVASTATIN;rs708272;Variant;PA448500;Chemical
LOVASTATIN;rs708272;Variant;PA450272;Chemical
PRAVASTATIN;rs708272;Variant;PA451089;Chemical
SIMVASTATIN;rs708272;Variant;PA451363;Chemical
CYP2D6;chlorpromazine;Chemical;PA128;Gene
RS1415744;chlorpromazine;Chemical;PA166156984;Variant
ABCB1;chlorpromazine;Chemical;PA267;Gene
EPM2A;chlorpromazine;Chemical;PA27832;Gene
NR1I2;chlorpromazine;Chemical;PA378;Gene
CYP3A4;ripretinib;Chemical;PA130;Gene
ACUTE CORONARY SYNDROME;rs3749187;Variant;PA165108401;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);rs3749187;Variant;PA166129560;Disease
ASPIRIN;rs3749187;Variant;PA448497;Chemical
CLOPIDOGREL;rs3749187;Variant;PA449053;Chemical
CURCUMIN;CFTR;Gene;PA151958596;Chemical
GENISTEIN;CFTR;Gene;PA165109660;Chemical
ROFLUMILAST;CFTR;Gene;PA165948052;Chemical
IVACAFTOR;CFTR;Gene;PA165950341;Chemical
LUMACAFTOR;CFTR;Gene;PA166114483;Chemical
ADVERSE EVENTS;CFTR;Gene;PA166151827;Disease
ATALUREN;CFTR;Gene;PA166151864;Chemical
IVACAFTOR / LUMACAFTOR;CFTR;Gene;PA166152935;Chemical
LATONDUINE A;CFTR;Gene;PA166153449;Chemical
RS74503330;CFTR;Gene;PA166157511;Variant
RS75039782;CFTR;Gene;PA166157514;Variant
RS75527207;CFTR;Gene;PA166157516;Variant
RS78655421;CFTR;Gene;PA166157519;Variant
RS80282562;CFTR;Gene;PA166157521;Variant
RS113993960;CFTR;Gene;PA166157525;Variant
RS121908755;CFTR;Gene;PA166157529;Variant
RS121908757;CFTR;Gene;PA166157530;Variant
RS121909005;CFTR;Gene;PA166157531;Variant
RS121909013;CFTR;Gene;PA166157532;Variant
RS121909041;CFTR;Gene;PA166157533;Variant
RS193922525;CFTR;Gene;PA166157534;Variant
RS267606723;CFTR;Gene;PA166157537;Variant
CORR-4A;CFTR;Gene;PA166158935;Chemical
NPPB;CFTR;Gene;PA166159659;Chemical
RS77932196;CFTR;Gene;PA166161186;Variant
RS80224560;CFTR;Gene;PA166162698;Variant
RS75961395;CFTR;Gene;PA166162699;Variant
RS74551128;CFTR;Gene;PA166162705;Variant
CAVOSONSTAT;CFTR;Gene;PA166163226;Chemical
RS397508256;CFTR;Gene;PA166164939;Variant
RS368505753;CFTR;Gene;PA166164940;Variant
RS115545701;CFTR;Gene;PA166164941;Variant
RS397508537;CFTR;Gene;PA166164942;Variant
RS113993958;CFTR;Gene;PA166164943;Variant
RS77834169;CFTR;Gene;PA166164944;Variant
RS397508759;CFTR;Gene;PA166164945;Variant
RS121908752;CFTR;Gene;PA166164946;Variant
RS121908753;CFTR;Gene;PA166164947;Variant
RS397508288;CFTR;Gene;PA166164948;Variant
RS397508442;CFTR;Gene;PA166164949;Variant
RS141033578;CFTR;Gene;PA166164950;Variant
RS150212784;CFTR;Gene;PA166164951;Variant
RS397508513;CFTR;Gene;PA166164952;Variant
RS121909020;CFTR;Gene;PA166164953;Variant
RS200321110;CFTR;Gene;PA166164954;Variant
RS78769542;CFTR;Gene;PA166164955;Variant
RS202179988;CFTR;Gene;PA166164956;Variant
RS186045772;CFTR;Gene;PA166164957;Variant
RS75541969;CFTR;Gene;PA166164958;Variant
RS11971167;CFTR;Gene;PA166164959;Variant
TEZACAFTOR;CFTR;Gene;PA166175754;Chemical
CYSTIC FIBROSIS PULMONARY EXACERBATION;CFTR;Gene;PA166175756;Disease
RS1800100;CFTR;Gene;PA166178025;Variant
RS1800111;CFTR;Gene;PA166178032;Variant
RS121909019;CFTR;Gene;PA166178049;Variant
RS77409459;CFTR;Gene;PA166178052;Variant
RS397508139;CFTR;Gene;PA166178058;Variant
RS397508510;CFTR;Gene;PA166178060;Variant
RS121908751;CFTR;Gene;PA166178065;Variant
RS36210737;CFTR;Gene;PA166178078;Variant
RS139304906;CFTR;Gene;PA166178080;Variant
RS397508453;CFTR;Gene;PA166178138;Variant
RS397508602;CFTR;Gene;PA166178193;Variant
IVACAFTOR / TEZACAFTOR;CFTR;Gene;PA166179845;Chemical
RS76151804;CFTR;Gene;PA166184909;Variant
ELEXACAFTOR;CFTR;Gene;PA166185161;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;CFTR;Gene;PA166190041;Chemical
RS397508761;CFTR;Gene;PA166196981;Variant
RS397508387;CFTR;Gene;PA166196982;Variant
RS186089140;CFTR;Gene;PA166299361;Variant
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;CFTR;Gene;PA166362502;Chemical
RS35516286;CFTR;Gene;PA166365261;Variant
RS397508783;CFTR;Gene;PA166394302;Variant
RS397508556;CFTR;Gene;PA166394341;Variant
RS2116683801;CFTR;Gene;PA166394421;Variant
RS74571530;CFTR;Gene;PA166394481;Variant
RS397508621;CFTR;Gene;PA166394521;Variant
RS397508573;CFTR;Gene;PA166394541;Variant
RS397508572;CFTR;Gene;PA166394581;Variant
RS397508784;CFTR;Gene;PA166394641;Variant
RS1800076;CFTR;Gene;PA166394661;Variant
RS397508300;CFTR;Gene;PA166394662;Variant
RS397508744;CFTR;Gene;PA166394681;Variant
RS1800103;CFTR;Gene;PA166394701;Variant
RS201958172;CFTR;Gene;PA166394721;Variant
RS769016520;CFTR;Gene;PA166394741;Variant
RS121909021;CFTR;Gene;PA166394761;Variant
RS397508748;CFTR;Gene;PA166394762;Variant
RS1800079;CFTR;Gene;PA166394781;Variant
RS144476686;CFTR;Gene;PA166394801;Variant
RS376008630;CFTR;Gene;PA166394802;Variant
RS1800110;CFTR;Gene;PA166394821;Variant
RS75763344;CFTR;Gene;PA166394841;Variant
RS758818611;CFTR;Gene;PA166394842;Variant
RS140883683;CFTR;Gene;PA166394861;Variant
RS121909044;CFTR;Gene;PA166394862;Variant
RS397508758;CFTR;Gene;PA166394881;Variant
RS397508721;CFTR;Gene;PA166394901;Variant
RS1800097;CFTR;Gene;PA166394921;Variant
RS1800098;CFTR;Gene;PA166394941;Variant
RS151048781;CFTR;Gene;PA166394961;Variant
RS145449046;CFTR;Gene;PA166394981;Variant
RS150157202;CFTR;Gene;PA166394982;Variant
RS201759207;CFTR;Gene;PA166394983;Variant
RS386134230;CFTR;Gene;PA166395001;Variant
RS142773283;CFTR;Gene;PA166395021;Variant
RS397508436;CFTR;Gene;PA166395041;Variant
RS397508616;CFTR;Gene;PA166395061;Variant
RS149279509;CFTR;Gene;PA166395081;Variant
RS397508785;CFTR;Gene;PA166395101;Variant
RS1800120;CFTR;Gene;PA166395102;Variant
RS144055758;CFTR;Gene;PA166395121;Variant
RS397508153;CFTR;Gene;PA166395141;Variant
RS77902683;CFTR;Gene;PA166395161;Variant
RS397508378;CFTR;Gene;PA166395162;Variant
RS397508440;CFTR;Gene;PA166395163;Variant
RS397508678;CFTR;Gene;PA166395181;Variant
RS1800112;CFTR;Gene;PA166395301;Variant
RS121909006;CFTR;Gene;PA166395342;Variant
RS397508533;CFTR;Gene;PA166395502;Variant
CYSTIC FIBROSIS;CFTR;Gene;PA443829;Disease
EXOCRINE PANCREATIC INSUFFICIENCY;CFTR;Gene;PA445217;Disease
CYSTEAMINE;CFTR;Gene;PA449171;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;FBXL19;Gene;PA164713366;Chemical
PSORIASIS;FBXL19;Gene;PA445451;Disease
CYP2C19;fluconazole;Chemical;PA124;Gene
CYP2C9;fluconazole;Chemical;PA126;Gene
CYP2C19*8;fluconazole;Chemical;PA165816524;Haplotype
CYP2C19*9;fluconazole;Chemical;PA165816525;Haplotype
CYP2C19*11;fluconazole;Chemical;PA165816527;Haplotype
CYP2C19*13;fluconazole;Chemical;PA165816529;Haplotype
CYP2C19*14;fluconazole;Chemical;PA165816530;Haplotype
CYP2C9*1;fluconazole;Chemical;PA165816542;Haplotype
CYP2C9*2;fluconazole;Chemical;PA165816543;Haplotype
CYP2C9*3;fluconazole;Chemical;PA165816544;Haplotype
CYP2C19*1;fluconazole;Chemical;PA165980634;Haplotype
ABL1;inotuzumab ozogamicin;Chemical;PA24413;Gene
BCR;inotuzumab ozogamicin;Chemical;PA25321;Gene
KETOCONAZOLE;drospirenone;Chemical;PA450146;Chemical
BREAST NEOPLASMS;E2F7;Gene;PA443560;Disease
TAMOXIFEN;E2F7;Gene;PA451581;Chemical
ABCC2;Breast Neoplasms;Disease;PA116;Gene
COMT;Breast Neoplasms;Disease;PA117;Gene
CYP2A6;Breast Neoplasms;Disease;PA121;Gene
CYP2B6;Breast Neoplasms;Disease;PA123;Gene
CYP2C19;Breast Neoplasms;Disease;PA124;Gene
CYP2C8;Breast Neoplasms;Disease;PA125;Gene
CYP2C9;Breast Neoplasms;Disease;PA126;Gene
CYP2D6;Breast Neoplasms;Disease;PA128;Gene
CYP3A4;Breast Neoplasms;Disease;PA130;Gene
CYP3A5;Breast Neoplasms;Disease;PA131;Gene
SLCO1B1;Breast Neoplasms;Disease;PA134865839;Gene
ECT2L;Breast Neoplasms;Disease;PA134893289;Gene
E2F7;Breast Neoplasms;Disease;PA134894421;Gene
LRMDA;Breast Neoplasms;Disease;PA134899373;Gene
ZNF423;Breast Neoplasms;Disease;PA134903681;Gene
SLC22A16;Breast Neoplasms;Disease;PA134911502;Gene
PERP;Breast Neoplasms;Disease;PA134944221;Gene
GNL3;Breast Neoplasms;Disease;PA134952132;Gene
DHFR;Breast Neoplasms;Disease;PA143;Gene
DPYD;Breast Neoplasms;Disease;PA145;Gene
SLC29A1;Breast Neoplasms;Disease;PA154;Gene
ERCC1;Breast Neoplasms;Disease;PA155;Gene
ESR1;Breast Neoplasms;Disease;PA156;Gene
TP53AIP1;Breast Neoplasms;Disease;PA164726680;Gene
DLG2;Breast Neoplasms;Disease;PA164741388;Gene
RICTOR;Breast Neoplasms;Disease;PA165660455;Gene
CYP2C19*17;Breast Neoplasms;Disease;PA165816533;Haplotype
CYP2D6*1;Breast Neoplasms;Disease;PA165816576;Haplotype
CYP2D6*2;Breast Neoplasms;Disease;PA165816577;Haplotype
CYP2D6*3;Breast Neoplasms;Disease;PA165816578;Haplotype
CYP2D6*4;Breast Neoplasms;Disease;PA165816579;Haplotype
CYP2D6*6;Breast Neoplasms;Disease;PA165816581;Haplotype
CYP2D6*10;Breast Neoplasms;Disease;PA165816582;Haplotype
CYP2D6*17;Breast Neoplasms;Disease;PA165816583;Haplotype
CYP2D6*41;Breast Neoplasms;Disease;PA165816584;Haplotype
CYP2B6*1;Breast Neoplasms;Disease;PA165818750;Haplotype
CYP2B6*5;Breast Neoplasms;Disease;PA165818760;Haplotype
CYP2B6*6;Breast Neoplasms;Disease;PA165818762;Haplotype
CYP2B6*7;Breast Neoplasms;Disease;PA165818765;Haplotype
CYP3A4*1;Breast Neoplasms;Disease;PA165819201;Haplotype
CYP3A4*8;Breast Neoplasms;Disease;PA165819226;Haplotype
CYP3A4*20;Breast Neoplasms;Disease;PA165819244;Haplotype
SLCO1B1*5;Breast Neoplasms;Disease;PA165819255;Haplotype
SLCO1B1*15;Breast Neoplasms;Disease;PA165819265;Haplotype
CYP2A6*1;Breast Neoplasms;Disease;PA165924690;Haplotype
CYP2A6*46;Breast Neoplasms;Disease;PA165924691;Haplotype
CYP2A6*2;Breast Neoplasms;Disease;PA165924719;Haplotype
CYP2A6*4;Breast Neoplasms;Disease;PA165924721;Haplotype
CYP2A6*7;Breast Neoplasms;Disease;PA165924731;Haplotype
CYP2A6*17;Breast Neoplasms;Disease;PA165924744;Haplotype
CYP2A6*20;Breast Neoplasms;Disease;PA165924749;Haplotype
CYP2A6*23;Breast Neoplasms;Disease;PA165924752;Haplotype
CYP2A6*26;Breast Neoplasms;Disease;PA165924756;Haplotype
CYP2D6*5;Breast Neoplasms;Disease;PA165948092;Haplotype
CYP2D6*9;Breast Neoplasms;Disease;PA165948317;Haplotype
CYP2D6*29;Breast Neoplasms;Disease;PA165948318;Haplotype
HLA-DRB1*04:03;Breast Neoplasms;Disease;PA165951504;Haplotype
HLA-DRB1*07:01;Breast Neoplasms;Disease;PA165951644;Haplotype
HLA-A*26:01;Breast Neoplasms;Disease;PA165953825;Haplotype
HLA-C*08:02;Breast Neoplasms;Disease;PA165957658;Haplotype
CYP2C8*2;Breast Neoplasms;Disease;PA165958684;Haplotype
CYP2C8*3;Breast Neoplasms;Disease;PA165958685;Haplotype
CYP2C8*4;Breast Neoplasms;Disease;PA165958686;Haplotype
CYP2D6*7;Breast Neoplasms;Disease;PA165971559;Haplotype
CYP2D6*11;Breast Neoplasms;Disease;PA165971564;Haplotype
CYP2D6*20;Breast Neoplasms;Disease;PA165971571;Haplotype
CYP2C19*1;Breast Neoplasms;Disease;PA165980634;Haplotype
CYP2C19*2;Breast Neoplasms;Disease;PA165980635;Haplotype
CYP2A6*9;Breast Neoplasms;Disease;PA165980914;Haplotype
CYP2A6*12;Breast Neoplasms;Disease;PA165980915;Haplotype
CYP2A6*35;Breast Neoplasms;Disease;PA165980920;Haplotype
SLCO1B1*1;Breast Neoplasms;Disease;PA165981641;Haplotype
UGT2B15*1;Breast Neoplasms;Disease;PA165984975;Haplotype
UGT2B15*2;Breast Neoplasms;Disease;PA165984976;Haplotype
CYP2D6*1XN;Breast Neoplasms;Disease;PA165988479;Haplotype
CYP2D6*2XN;Breast Neoplasms;Disease;PA165988480;Haplotype
CYP2D6*21;Breast Neoplasms;Disease;PA165988484;Haplotype
CYP2D6*35;Breast Neoplasms;Disease;PA165988487;Haplotype
CYP2D6*36;Breast Neoplasms;Disease;PA165988488;Haplotype
GSTM1 NULL;Breast Neoplasms;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Breast Neoplasms;Disease;PA166048676;Haplotype
CYP3A4*22;Breast Neoplasms;Disease;PA166048680;Haplotype
RBFOX1;Breast Neoplasms;Disease;PA166048951;Gene
HLA-B*48:01;Breast Neoplasms;Disease;PA166123429;Haplotype
CYP2D6*10X2;Breast Neoplasms;Disease;PA166123456;Haplotype
CYP3A5*1;Breast Neoplasms;Disease;PA166128213;Haplotype
CYP3A5*3;Breast Neoplasms;Disease;PA166128219;Haplotype
RS396991;Breast Neoplasms;Disease;PA166153571;Variant
RS1563828;Breast Neoplasms;Disease;PA166153633;Variant
RS1801274;Breast Neoplasms;Disease;PA166153652;Variant
RS717620;Breast Neoplasms;Disease;PA166153953;Variant
RS1113129;Breast Neoplasms;Disease;PA166153964;Variant
RS1934951;Breast Neoplasms;Disease;PA166153985;Variant
RS1937840;Breast Neoplasms;Disease;PA166153989;Variant
RS2273697;Breast Neoplasms;Disease;PA166154007;Variant
RS3740065;Breast Neoplasms;Disease;PA166154027;Variant
RS3740066;Breast Neoplasms;Disease;PA166154028;Variant
RS4244285;Breast Neoplasms;Disease;PA166154053;Variant
RS10509373;Breast Neoplasms;Disease;PA166154108;Variant
RS12248560;Breast Neoplasms;Disease;PA166154147;Variant
RS1695;Breast Neoplasms;Disease;PA166154249;Variant
RS9344;Breast Neoplasms;Disease;PA166154264;Variant
RS1042858;Breast Neoplasms;Disease;PA166154309;Variant
RS11023197;Breast Neoplasms;Disease;PA166154443;Variant
RS310786;Breast Neoplasms;Disease;PA166154495;Variant
RS4149056;Breast Neoplasms;Disease;PA166154579;Variant
RS7984870;Breast Neoplasms;Disease;PA166154722;Variant
RS9561778;Breast Neoplasms;Disease;PA166154741;Variant
RS10140457;Breast Neoplasms;Disease;PA166154819;Variant
RS4646;Breast Neoplasms;Disease;PA166154836;Variant
RS10046;Breast Neoplasms;Disease;PA166154837;Variant
RS700518;Breast Neoplasms;Disease;PA166154847;Variant
RS749292;Breast Neoplasms;Disease;PA166154849;Variant
RS934635;Breast Neoplasms;Disease;PA166154853;Variant
RS1008805;Breast Neoplasms;Disease;PA166154854;Variant
RS1048943;Breast Neoplasms;Disease;PA166154855;Variant
RS1062033;Breast Neoplasms;Disease;PA166154858;Variant
RS2289105;Breast Neoplasms;Disease;PA166154884;Variant
RS3759811;Breast Neoplasms;Disease;PA166154903;Variant
RS4775936;Breast Neoplasms;Disease;PA166154912;Variant
RS6493497;Breast Neoplasms;Disease;PA166154917;Variant
RS7176005;Breast Neoplasms;Disease;PA166154921;Variant
RS16964189;Breast Neoplasms;Disease;PA166154937;Variant
RS1800566;Breast Neoplasms;Disease;PA166155017;Variant
RS6500843;Breast Neoplasms;Disease;PA166155075;Variant
RS8060157;Breast Neoplasms;Disease;PA166155087;Variant
RS1136201;Breast Neoplasms;Disease;PA166155183;Variant
RS2228100;Breast Neoplasms;Disease;PA166155201;Variant
RS45445694;Breast Neoplasms;Disease;PA166155331;Variant
RS11615;Breast Neoplasms;Disease;PA166155342;Variant
RS13181;Breast Neoplasms;Disease;PA166155343;Variant
RS25487;Breast Neoplasms;Disease;PA166155346;Variant
RS3211371;Breast Neoplasms;Disease;PA166155405;Variant
RS3212986;Breast Neoplasms;Disease;PA166155407;Variant
RS3745274;Breast Neoplasms;Disease;PA166155409;Variant
RS12721655;Breast Neoplasms;Disease;PA166155467;Variant
RS1056836;Breast Neoplasms;Disease;PA166155621;Variant
RS1804645;Breast Neoplasms;Disease;PA166155648;Variant
RS2011425;Breast Neoplasms;Disease;PA166155662;Variant
RS4550690;Breast Neoplasms;Disease;PA166155729;Variant
RS10485828;Breast Neoplasms;Disease;PA166155965;Variant
RS9024;Breast Neoplasms;Disease;PA166155972;Variant
RS20572;Breast Neoplasms;Disease;PA166155974;Variant
RS8133052;Breast Neoplasms;Disease;PA166156011;Variant
RS2231142;Breast Neoplasms;Disease;PA166156544;Variant
RS7349683;Breast Neoplasms;Disease;PA166156616;Variant
RS10030044;Breast Neoplasms;Disease;PA166156638;Variant
RS351855;Breast Neoplasms;Disease;PA166156731;Variant
RS70991108;Breast Neoplasms;Disease;PA166156893;Variant
RS4880;Breast Neoplasms;Disease;PA166156900;Variant
RS5370;Breast Neoplasms;Disease;PA166156901;Variant
RS699947;Breast Neoplasms;Disease;PA166156938;Variant
RS714368;Breast Neoplasms;Disease;PA166156940;Variant
RS747199;Breast Neoplasms;Disease;PA166156945;Variant
RS1143684;Breast Neoplasms;Disease;PA166156979;Variant
RS1570360;Breast Neoplasms;Disease;PA166156985;Variant
RS2813543;Breast Neoplasms;Disease;PA166157050;Variant
RS3025039;Breast Neoplasms;Disease;PA166157061;Variant
RS4870061;Breast Neoplasms;Disease;PA166157106;Variant
RS6901146;Breast Neoplasms;Disease;PA166157111;Variant
RS6907567;Breast Neoplasms;Disease;PA166157112;Variant
RS9322335;Breast Neoplasms;Disease;PA166157137;Variant
RS11155012;Breast Neoplasms;Disease;PA166157173;Variant
RS12210538;Breast Neoplasms;Disease;PA166157179;Variant
RS13207351;Breast Neoplasms;Disease;PA166157183;Variant
RS35864111;Breast Neoplasms;Disease;PA166157202;Variant
RS144854329;Breast Neoplasms;Disease;PA166157228;Variant
RS1045642;Breast Neoplasms;Disease;PA166157284;Variant
RS1128503;Breast Neoplasms;Disease;PA166157288;Variant
RS1799983;Breast Neoplasms;Disease;PA166157303;Variant
RS2032582;Breast Neoplasms;Disease;PA166157316;Variant
RS2070744;Breast Neoplasms;Disease;PA166157325;Variant
RS2740574;Breast Neoplasms;Disease;PA166157367;Variant
RS2073618;Breast Neoplasms;Disease;PA166157573;Variant
RS6151031;Breast Neoplasms;Disease;PA166157783;Variant
DPYD DEFICIENCY;Breast Neoplasms;Disease;PA166157931;Variant
CYP2D6 NORMAL METABOLIZER AND ULTRARAPID METABOLIZER;Breast Neoplasms;Disease;PA166161134;Variant
RS727479;Breast Neoplasms;Disease;PA166163632;Variant
RS12050587;Breast Neoplasms;Disease;PA166164874;Variant
RS11636687;Breast Neoplasms;Disease;PA166164877;Variant
RS143414470;Breast Neoplasms;Disease;PA166165332;Variant
RS10515074;Breast Neoplasms;Disease;PA166165378;Variant
RS144991623;Breast Neoplasms;Disease;PA166178395;Variant
RS9389568;Breast Neoplasms;Disease;PA166178396;Variant
RS8110364;Breast Neoplasms;Disease;PA166178397;Variant
RS56022120;Breast Neoplasms;Disease;PA166178398;Variant
RS150688309;Breast Neoplasms;Disease;PA166178399;Variant
RS58695150;Breast Neoplasms;Disease;PA166178400;Variant
RS299293;Breast Neoplasms;Disease;PA166178401;Variant
RS138602176;Breast Neoplasms;Disease;PA166178402;Variant
RS148235907;Breast Neoplasms;Disease;PA166178403;Variant
RS117951771;Breast Neoplasms;Disease;PA166178404;Variant
RS299314;Breast Neoplasms;Disease;PA166178405;Variant
RS299313;Breast Neoplasms;Disease;PA166178406;Variant
RS115457081;Breast Neoplasms;Disease;PA166178407;Variant
RS117341846;Breast Neoplasms;Disease;PA166178408;Variant
RS4968187;Breast Neoplasms;Disease;PA166178409;Variant
RS142244113;Breast Neoplasms;Disease;PA166178410;Variant
RS79430272;Breast Neoplasms;Disease;PA166178411;Variant
RS118129530;Breast Neoplasms;Disease;PA166178412;Variant
RS77769901;Breast Neoplasms;Disease;PA166178413;Variant
RS145623321;Breast Neoplasms;Disease;PA166178414;Variant
RS148013902;Breast Neoplasms;Disease;PA166178415;Variant
RS55633228;Breast Neoplasms;Disease;PA166178416;Variant
RS41412545;Breast Neoplasms;Disease;PA166178421;Variant
RS3805945;Breast Neoplasms;Disease;PA166178422;Variant
RS117101815;Breast Neoplasms;Disease;PA166178423;Variant
RS9402944;Breast Neoplasms;Disease;PA166178424;Variant
RS181501757;Breast Neoplasms;Disease;PA166178425;Variant
RS149212925;Breast Neoplasms;Disease;PA166178426;Variant
RS112783657;Breast Neoplasms;Disease;PA166178427;Variant
RS74743371;Breast Neoplasms;Disease;PA166178428;Variant
RS117458836;Breast Neoplasms;Disease;PA166178429;Variant
RS118088833;Breast Neoplasms;Disease;PA166178430;Variant
RS112242273;Breast Neoplasms;Disease;PA166178431;Variant
RS78428806;Breast Neoplasms;Disease;PA166178432;Variant
RS141084494;Breast Neoplasms;Disease;PA166178541;Variant
RS2229046;Breast Neoplasms;Disease;PA166179815;Variant
RS773123;Breast Neoplasms;Disease;PA166179816;Variant
RS2284922;Breast Neoplasms;Disease;PA166179817;Variant
RS2070096;Breast Neoplasms;Disease;PA166179818;Variant
RS1801516;Breast Neoplasms;Disease;PA166180286;Variant
RS11280056;Breast Neoplasms;Disease;PA166180936;Variant
CYP2D6*14;Breast Neoplasms;Disease;PA166181185;Haplotype
RS2449598;Breast Neoplasms;Disease;PA166233301;Variant
RS1437153;Breast Neoplasms;Disease;PA166233321;Variant
RS6981827;Breast Neoplasms;Disease;PA166233341;Variant
RS6990851;Breast Neoplasms;Disease;PA166233521;Variant
RS2024627;Breast Neoplasms;Disease;PA166238104;Variant
CYP2C8*1;Breast Neoplasms;Disease;PA166242948;Haplotype
GSTM1;Breast Neoplasms;Disease;PA182;Gene
INSR;Breast Neoplasms;Disease;PA202;Gene
IRS1;Breast Neoplasms;Disease;PA203;Gene
MTHFR;Breast Neoplasms;Disease;PA245;Gene
AKR1C3;Breast Neoplasms;Disease;PA24679;Gene
ALDH1A1;Breast Neoplasms;Disease;PA24692;Gene
ALDH3A1;Breast Neoplasms;Disease;PA24697;Gene
ANK3;Breast Neoplasms;Disease;PA24800;Gene
NOS1;Breast Neoplasms;Disease;PA252;Gene
BARD1;Breast Neoplasms;Disease;PA25256;Gene
NOS3;Breast Neoplasms;Disease;PA254;Gene
BRCA1;Breast Neoplasms;Disease;PA25411;Gene
CBR1;Breast Neoplasms;Disease;PA26121;Gene
CBR3;Breast Neoplasms;Disease;PA26122;Gene
CCNK;Breast Neoplasms;Disease;PA26161;Gene
ABCB1;Breast Neoplasms;Disease;PA267;Gene
CSMD1;Breast Neoplasms;Disease;PA26947;Gene
CYP19A1;Breast Neoplasms;Disease;PA27091;Gene
CYP1A1;Breast Neoplasms;Disease;PA27092;Gene
CYP1B1;Breast Neoplasms;Disease;PA27094;Gene
EDN1;Breast Neoplasms;Disease;PA27614;Gene
EPHA5;Breast Neoplasms;Disease;PA27821;Gene
ERBB2;Breast Neoplasms;Disease;PA27844;Gene
ERBB3;Breast Neoplasms;Disease;PA27846;Gene
ERCC2;Breast Neoplasms;Disease;PA27848;Gene
ESR2;Breast Neoplasms;Disease;PA27886;Gene
FCGR2A;Breast Neoplasms;Disease;PA28063;Gene
FCGR3A;Breast Neoplasms;Disease;PA28065;Gene
FGFR4;Breast Neoplasms;Disease;PA28130;Gene
FOXO1;Breast Neoplasms;Disease;PA28237;Gene
MTOR;Breast Neoplasms;Disease;PA28360;Gene
GSTP1;Breast Neoplasms;Disease;PA29028;Gene
HMMR;Breast Neoplasms;Disease;PA29340;Gene
RRM1;Breast Neoplasms;Disease;PA298;Gene
MAP4K4;Breast Neoplasms;Disease;PA30612;Gene
MDM4;Breast Neoplasms;Disease;PA30719;Gene
NCOA1;Breast Neoplasms;Disease;PA31470;Gene
NQO1;Breast Neoplasms;Disease;PA31744;Gene
NQO2;Breast Neoplasms;Disease;PA31745;Gene
PIGB;Breast Neoplasms;Disease;PA33290;Gene
PIK3R1;Breast Neoplasms;Disease;PA33312;Gene
PIK3R2;Breast Neoplasms;Disease;PA33313;Gene
PPP2R5D;Breast Neoplasms;Disease;PA33676;Gene
RBX1;Breast Neoplasms;Disease;PA34299;Gene
SULT1A1;Breast Neoplasms;Disease;PA343;Gene
RNF8;Breast Neoplasms;Disease;PA34445;Gene
RRAS2;Breast Neoplasms;Disease;PA34862;Gene
HLA-A;Breast Neoplasms;Disease;PA35055;Gene
HLA-B;Breast Neoplasms;Disease;PA35056;Gene
HLA-C;Breast Neoplasms;Disease;PA35057;Gene
HLA-DRB1;Breast Neoplasms;Disease;PA35072;Gene
TOP2A;Breast Neoplasms;Disease;PA354;Gene
TYMS;Breast Neoplasms;Disease;PA359;Gene
SOD2;Breast Neoplasms;Disease;PA36017;Gene
TNFRSF11B;Breast Neoplasms;Disease;PA36602;Gene
TNFSF11;Breast Neoplasms;Disease;PA36619;Gene
TP53;Breast Neoplasms;Disease;PA36679;Gene
XRCC1;Breast Neoplasms;Disease;PA369;Gene
UGT1A4;Breast Neoplasms;Disease;PA37179;Gene
UGT2B15;Breast Neoplasms;Disease;PA37188;Gene
UGT2B17;Breast Neoplasms;Disease;PA37189;Gene
VDR;Breast Neoplasms;Disease;PA37301;Gene
VEGFA;Breast Neoplasms;Disease;PA37302;Gene
TUBB1;Breast Neoplasms;Disease;PA38100;Gene
ABCG2;Breast Neoplasms;Disease;PA390;Gene
ABCC4;Breast Neoplasms;Disease;PA397;Gene
ATM;Breast Neoplasms;Disease;PA61;Gene
CCND1;Breast Neoplasms;Disease;PA75;Gene
TOBACCO USE DISORDER;rs6090378;Variant;PA445876;Disease
NICOTINE;rs6090378;Variant;PA450626;Chemical
PLATINUM COMPOUNDS;rs73594404;Variant;PA164713176;Chemical
MYELOSUPPRESSION;rs73594404;Variant;PA165817398;Disease
MUCOSITIS;rs73594404;Variant;PA166122058;Disease
RADIOTHERAPY;rs73594404;Variant;PA166122986;Chemical
ANEMIA;rs73594404;Variant;PA443340;Disease
DERMATITIS;rs73594404;Variant;PA443875;Disease
LEUKOPENIA;rs73594404;Variant;PA444773;Disease
NEUTROPENIA;rs73594404;Variant;PA445113;Disease
THROMBOCYTOPENIA;rs73594404;Variant;PA445846;Disease
NFKB1;PPP3R1;Gene;PA248;Gene
RELA;PPP3R1;Gene;PA296;Gene
NFATC1;PPP3R1;Gene;PA31582;Gene
NFATC2;PPP3R1;Gene;PA31583;Gene
NFATC4;PPP3R1;Gene;PA31584;Gene
NFKB2;PPP3R1;Gene;PA31600;Gene
REL;PPP3R1;Gene;PA34321;Gene
RELB;PPP3R1;Gene;PA34322;Gene
G6PD;3-aminopyridine-2-carboxaldehyde thiosemicarbazone;Chemical;PA28469;Gene
PRASUGREL;rs12041331;Variant;PA154410481;Chemical
TICAGRELOR;rs12041331;Variant;PA165374673;Chemical
MYOCARDIAL INFARCTION;rs12041331;Variant;PA445019;Disease
ASPIRIN;rs12041331;Variant;PA448497;Chemical
CLOPIDOGREL;rs12041331;Variant;PA449053;Chemical
CFTR;rs397508153;Variant;PA109;Gene
IVACAFTOR;rs397508153;Variant;PA165950341;Chemical
PSYCHOTIC DISORDER;DTNBP1;Gene;PA447215;Disease
SCHIZOPHRENIA;DTNBP1;Gene;PA447216;Disease
MAJOR DEPRESSIVE DISORDER;DTNBP1;Gene;PA447321;Disease
CITALOPRAM;DTNBP1;Gene;PA449015;Chemical
CLOZAPINE;DTNBP1;Gene;PA449061;Chemical
HALOPERIDOL;DTNBP1;Gene;PA449841;Chemical
METHAMPHETAMINE;DTNBP1;Gene;PA450403;Chemical
FLURBIPROFEN;rs780801862;Variant;PA449683;Chemical
NAPROXEN;rs780801862;Variant;PA450595;Chemical
PHENYTOIN;rs780801862;Variant;PA450947;Chemical
WARFARIN;rs780801862;Variant;PA451906;Chemical
DEPRESSION;rs17060812;Variant;PA447278;Disease
NORTRIPTYLINE;rs17060812;Variant;PA450657;Chemical
CORONARY ARTERY DISEASE;rs20417;Variant;PA443796;Disease
ASPIRIN;rs20417;Variant;PA448497;Chemical
IBUPROFEN;rs20417;Variant;PA449957;Chemical
ROFECOXIB;rs20417;Variant;PA451268;Chemical
GASTROINTESTINAL STROMAL TUMORS;rs4149117;Variant;PA151958383;Disease
SUNITINIB;rs4149117;Variant;PA162372840;Chemical
MYCOPHENOLIC ACID;rs4149117;Variant;PA164748728;Chemical
KIDNEY TRANSPLANTATION;rs4149117;Variant;PA165817016;Disease
TRANSPLANT REJECTION;rs4149117;Variant;PA166114454;Disease
LUNG TRANSPLANTATION;rs4149117;Variant;PA166114457;Disease
OVERALL SURVIVAL;rs4149117;Variant;PA166123207;Disease
CHRONIC LUNG ALLOGRAFT DYSFUNCTION;rs4149117;Variant;PA166195784;Disease
LUNG NEOPLASMS;rs4149117;Variant;PA444818;Disease
CARBOPLATIN;rs4149117;Variant;PA448803;Chemical
MYCOPHENOLATE MOFETIL;rs4149117;Variant;PA450566;Chemical
PACLITAXEL;rs4149117;Variant;PA450761;Chemical
MYALGIA;rs2276307;Variant;PA157379134;Disease
ATORVASTATIN;rs2276307;Variant;PA448500;Chemical
PRAVASTATIN;rs2276307;Variant;PA451089;Chemical
SIMVASTATIN;rs2276307;Variant;PA451363;Chemical
CYP11B2;candesartan;Chemical;PA134;Gene
PLEKHJ1;candesartan;Chemical;PA134936152;Gene
DOT1L;candesartan;Chemical;PA134993717;Gene
SH2B3;candesartan;Chemical;PA145148124;Gene
SULT1C3;candesartan;Chemical;PA162405069;Gene
RS3758785;candesartan;Chemical;PA166154400;Variant
RS3184504;candesartan;Chemical;PA166154560;Variant
RS5186;candesartan;Chemical;PA166156276;Variant
RS1799998;candesartan;Chemical;PA166157566;Variant
RS1275988;candesartan;Chemical;PA166199001;Variant
RS6722745;candesartan;Chemical;PA166199002;Variant
RS740406;candesartan;Chemical;PA166199008;Variant
GPR83;candesartan;Chemical;PA28927;Gene
KCNK3;candesartan;Chemical;PA30060;Gene
AGTR1;candesartan;Chemical;PA43;Gene
LONG QT SYNDROME;rs10800397;Variant;PA444807;Disease
AMIODARONE;rs10800397;Variant;PA448383;Chemical
ABCC2;HIV Infections;Disease;PA116;Gene
CYP2A6;HIV Infections;Disease;PA121;Gene
CYP2B6;HIV Infections;Disease;PA123;Gene
CYP2C19;HIV Infections;Disease;PA124;Gene
CYP2C9;HIV Infections;Disease;PA126;Gene
CYP2D6;HIV Infections;Disease;PA128;Gene
CYP3A4;HIV Infections;Disease;PA130;Gene
CYP3A5;HIV Infections;Disease;PA131;Gene
SLCO1B1;HIV Infections;Disease;PA134865839;Gene
SORCS2;HIV Infections;Disease;PA134902026;Gene
CCHCR1;HIV Infections;Disease;PA134942738;Gene
IFNL3;HIV Infections;Disease;PA134952671;Gene
ZSCAN25;HIV Infections;Disease;PA134962723;Gene
POLR3G;HIV Infections;Disease;PA134986024;Gene
FTO;HIV Infections;Disease;PA152208656;Gene
CYP2C9*2;HIV Infections;Disease;PA165816543;Haplotype
CYP2C9*3;HIV Infections;Disease;PA165816544;Haplotype
CYP2B6*1;HIV Infections;Disease;PA165818750;Haplotype
CYP2B6*2;HIV Infections;Disease;PA165818753;Haplotype
CYP2B6*4;HIV Infections;Disease;PA165818757;Haplotype
CYP2B6*6;HIV Infections;Disease;PA165818762;Haplotype
CYP2B6*11;HIV Infections;Disease;PA165818770;Haplotype
CYP2B6*26;HIV Infections;Disease;PA165818788;Haplotype
CYP2B6*9;HIV Infections;Disease;PA165818807;Haplotype
CYP2B6*18;HIV Infections;Disease;PA165818808;Haplotype
CYP2B6*28;HIV Infections;Disease;PA165818812;Haplotype
CYP3A4*1;HIV Infections;Disease;PA165819201;Haplotype
CYP2A6*2;HIV Infections;Disease;PA165924719;Haplotype
NAT2*4;HIV Infections;Disease;PA165949098;Haplotype
NAT2*5A;HIV Infections;Disease;PA165949099;Haplotype
NAT2*12A;HIV Infections;Disease;PA165949138;Haplotype
HLA-DRB1*01:01;HIV Infections;Disease;PA165951320;Haplotype
HLA-DRB1*01:02;HIV Infections;Disease;PA165951340;Haplotype
HLA-DRB1*07:01;HIV Infections;Disease;PA165951644;Haplotype
HLA-DRB1*15:01;HIV Infections;Disease;PA165952269;Haplotype
HLA-DRB1*15:03;HIV Infections;Disease;PA165952297;Haplotype
HLA-B*14:02;HIV Infections;Disease;PA165954712;Haplotype
HLA-B*35:01;HIV Infections;Disease;PA165955215;Haplotype
HLA-B*35:05;HIV Infections;Disease;PA165955262;Haplotype
HLA-B*40:01;HIV Infections;Disease;PA165955628;Haplotype
HLA-B*58:02;HIV Infections;Disease;PA165956639;Haplotype
HLA-C*02:10;HIV Infections;Disease;PA165956805;Haplotype
HLA-C*04:01;HIV Infections;Disease;PA165957046;Haplotype
HLA-C*08:02;HIV Infections;Disease;PA165957658;Haplotype
HLA-DQB1*05:01;HIV Infections;Disease;PA165958073;Haplotype
HLA-DQB1*06:02;HIV Infections;Disease;PA165958103;Haplotype
HLA-DQB1*06:03;HIV Infections;Disease;PA165958105;Haplotype
HLA-DQB1*06:09;HIV Infections;Disease;PA165958117;Haplotype
HLA-DQB1*02:01;HIV Infections;Disease;PA165958158;Haplotype
HLA-DQB1*03:02;HIV Infections;Disease;PA165958175;Haplotype
HLA-DQB1*03:03;HIV Infections;Disease;PA165958180;Haplotype
NAT2*6;HIV Infections;Disease;PA165981635;Haplotype
NAT2*7;HIV Infections;Disease;PA165981636;Haplotype
HLA-B*57:01;HIV Infections;Disease;PA165987830;Haplotype
HLA-B*58:01;HIV Infections;Disease;PA165987831;Haplotype
GSTM1 NULL;HIV Infections;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;HIV Infections;Disease;PA166048676;Haplotype
CYP3A4*22;HIV Infections;Disease;PA166048680;Haplotype
IFNL4;HIV Infections;Disease;PA166049147;Gene
UGT1A1*1;HIV Infections;Disease;PA166115841;Haplotype
UGT1A1*28;HIV Infections;Disease;PA166115842;Haplotype
UGT1A1*36;HIV Infections;Disease;PA166115843;Haplotype
UGT1A1*37;HIV Infections;Disease;PA166115844;Haplotype
UGT1A1*6;HIV Infections;Disease;PA166115858;Haplotype
CYP2B6*38;HIV Infections;Disease;PA166117278;Haplotype
UGT1A9*3A;HIV Infections;Disease;PA166117680;Haplotype
HLA-C*03:02;HIV Infections;Disease;PA166123425;Haplotype
HLA-C*08:01;HIV Infections;Disease;PA166123426;Haplotype
CYP3A5*1;HIV Infections;Disease;PA166128213;Haplotype
CYP3A5*3;HIV Infections;Disease;PA166128219;Haplotype
CYP3A5*6;HIV Infections;Disease;PA166128233;Haplotype
CYP3A5*7;HIV Infections;Disease;PA166128234;Haplotype
RS1800896;HIV Infections;Disease;PA166153642;Variant
RS2307424;HIV Infections;Disease;PA166153700;Variant
RS3003596;HIV Infections;Disease;PA166153729;Variant
RS717620;HIV Infections;Disease;PA166153953;Variant
RS2273697;HIV Infections;Disease;PA166154007;Variant
RS4244285;HIV Infections;Disease;PA166154053;Variant
RS7917432;HIV Infections;Disease;PA166154090;Variant
RS8187707;HIV Infections;Disease;PA166154093;Variant
RS8187710;HIV Infections;Disease;PA166154094;Variant
RS11191561;HIV Infections;Disease;PA166154132;Variant
RS11598702;HIV Infections;Disease;PA166154142;Variant
RS12768009;HIV Infections;Disease;PA166154155;Variant
RS17222723;HIV Infections;Disease;PA166154163;Variant
RS5128;HIV Infections;Disease;PA166154254;Variant
RS2854116;HIV Infections;Disease;PA166154390;Variant
RS2854117;HIV Infections;Disease;PA166154391;Variant
RS4149056;HIV Infections;Disease;PA166154579;Variant
RS6313;HIV Infections;Disease;PA166154675;Variant
RS899494;HIV Infections;Disease;PA166154688;Variant
RS1059751;HIV Infections;Disease;PA166154694;Variant
RS1751034;HIV Infections;Disease;PA166154702;Variant
RS3742106;HIV Infections;Disease;PA166154713;Variant
RS11568695;HIV Infections;Disease;PA166154749;Variant
RS11854484;HIV Infections;Disease;PA166154934;Variant
RS212091;HIV Infections;Disease;PA166154987;Variant
RS9939609;HIV Infections;Disease;PA166155098;Variant
RS7412;HIV Infections;Disease;PA166155341;Variant
RS14158;HIV Infections;Disease;PA166155344;Variant
RS429358;HIV Infections;Disease;PA166155351;Variant
RS2054675;HIV Infections;Disease;PA166155378;Variant
RS2279345;HIV Infections;Disease;PA166155395;Variant
RS3745274;HIV Infections;Disease;PA166155409;Variant
RS3786547;HIV Infections;Disease;PA166155411;Variant
RS4803217;HIV Infections;Disease;PA166155416;Variant
RS4803419;HIV Infections;Disease;PA166155420;Variant
RS8113007;HIV Infections;Disease;PA166155440;Variant
RS8192719;HIV Infections;Disease;PA166155444;Variant
RS8192726;HIV Infections;Disease;PA166155447;Variant
RS11881222;HIV Infections;Disease;PA166155462;Variant
RS12721646;HIV Infections;Disease;PA166155465;Variant
RS12979860;HIV Infections;Disease;PA166155468;Variant
RS28399433;HIV Infections;Disease;PA166155471;Variant
RS28399454;HIV Infections;Disease;PA166155475;Variant
RS28399499;HIV Infections;Disease;PA166155478;Variant
RS28416813;HIV Infections;Disease;PA166155479;Variant
RS35303484;HIV Infections;Disease;PA166155496;Variant
RS36118214;HIV Infections;Disease;PA166155504;Variant
RS58425034;HIV Infections;Disease;PA166155511;Variant
RS8330;HIV Infections;Disease;PA166155584;Variant
RS887829;HIV Infections;Disease;PA166155607;Variant
RS1042640;HIV Infections;Disease;PA166155616;Variant
RS1429376;HIV Infections;Disease;PA166155636;Variant
RS1594160;HIV Infections;Disease;PA166155638;Variant
RS3806596;HIV Infections;Disease;PA166155712;Variant
RS4148323;HIV Infections;Disease;PA166155721;Variant
RS6545803;HIV Infections;Disease;PA166155746;Variant
RS7586110;HIV Infections;Disease;PA166155768;Variant
RS10929303;HIV Infections;Disease;PA166155795;Variant
RS17863778;HIV Infections;Disease;PA166155853;Variant
RS17868323;HIV Infections;Disease;PA166155857;Variant
RS1884613;HIV Infections;Disease;PA166155918;Variant
RS28371706;HIV Infections;Disease;PA166156151;Variant
RS6280;HIV Infections;Disease;PA166156277;Variant
RS2472677;HIV Infections;Disease;PA166156358;Variant
RS3842689;HIV Infections;Disease;PA166156387;Variant
RS2231142;HIV Infections;Disease;PA166156544;Variant
RS7439366;HIV Infections;Disease;PA166156619;Variant
RS28365062;HIV Infections;Disease;PA166156676;Variant
RS2562519;HIV Infections;Disease;PA166156804;Variant
RS130072;HIV Infections;Disease;PA166156909;Variant
RS746647;HIV Infections;Disease;PA166156944;Variant
RS761142;HIV Infections;Disease;PA166156949;Variant
RS1265112;HIV Infections;Disease;PA166156982;Variant
RS1799964;HIV Infections;Disease;PA166156990;Variant
RS2073724;HIV Infections;Disease;PA166157014;Variant
RS2125739;HIV Infections;Disease;PA166157018;Variant
RS9349256;HIV Infections;Disease;PA166157146;Variant
RS9461684;HIV Infections;Disease;PA166157160;Variant
RS76228616;HIV Infections;Disease;PA166157221;Variant
RS3842;HIV Infections;Disease;PA166157239;Variant
RS757639;HIV Infections;Disease;PA166157265;Variant
RS776746;HIV Infections;Disease;PA166157267;Variant
RS1045642;HIV Infections;Disease;PA166157284;Variant
RS1128503;HIV Infections;Disease;PA166157288;Variant
RS2032582;HIV Infections;Disease;PA166157316;Variant
RS2740574;HIV Infections;Disease;PA166157367;Variant
RS113165732;HIV Infections;Disease;PA166157891;Variant
G6PD DEFICIENCY;HIV Infections;Disease;PA166157959;Variant
RS2853826;HIV Infections;Disease;PA166158911;Variant
RS8175347;HIV Infections;Disease;PA166159020;Variant
RS4646536;HIV Infections;Disease;PA166165040;Variant
RS2248359;HIV Infections;Disease;PA166170863;Variant
RS671531;HIV Infections;Disease;PA166180109;Variant
RS8124728;HIV Infections;Disease;PA166180546;Variant
RS73208473;HIV Infections;Disease;PA166181200;Variant
NAT2;HIV Infections;Disease;PA18;Gene
GSTM1;HIV Infections;Disease;PA182;Gene
HTR2A;HIV Infections;Disease;PA193;Gene
LDLR;HIV Infections;Disease;PA227;Gene
ABCC10;HIV Infections;Disease;PA24392;Gene
ABCC1;HIV Infections;Disease;PA244;Gene
TRAF3IP2;HIV Infections;Disease;PA25938;Gene
ABCB1;HIV Infections;Disease;PA267;Gene
CYP24A1;HIV Infections;Disease;PA27097;Gene
CYP27B1;HIV Infections;Disease;PA27099;Gene
DRD3;HIV Infections;Disease;PA27479;Gene
G6PD;HIV Infections;Disease;PA28469;Gene
GCLC;HIV Infections;Disease;PA28612;Gene
HNF4A;HIV Infections;Disease;PA29349;Gene
IL10;HIV Infections;Disease;PA29778;Gene
NT5C2;HIV Infections;Disease;PA31801;Gene
OCRL;HIV Infections;Disease;PA31896;Gene
OPRM1;HIV Infections;Disease;PA31945;Gene
SAMHD1;HIV Infections;Disease;PA34938;Gene
HLA-B;HIV Infections;Disease;PA35056;Gene
HLA-C;HIV Infections;Disease;PA35057;Gene
HLA-DQB1;HIV Infections;Disease;PA35068;Gene
HLA-DRB1;HIV Infections;Disease;PA35072;Gene
UGT2B7;HIV Infections;Disease;PA361;Gene
TCF19;HIV Infections;Disease;PA36384;Gene
UGT1A3;HIV Infections;Disease;PA37178;Gene
UGT1A7;HIV Infections;Disease;PA37182;Gene
XDH;HIV Infections;Disease;PA37404;Gene
NR1I2;HIV Infections;Disease;PA378;Gene
SLC28A2;HIV Infections;Disease;PA386;Gene
ABCG2;HIV Infections;Disease;PA390;Gene
NR1I3;HIV Infections;Disease;PA391;Gene
ABCC4;HIV Infections;Disease;PA397;Gene
UGT1A9;HIV Infections;Disease;PA419;Gene
UGT1A1;HIV Infections;Disease;PA420;Gene
TNF;HIV Infections;Disease;PA435;Gene
APOC3;HIV Infections;Disease;PA53;Gene
APOE;HIV Infections;Disease;PA55;Gene
ARIPIPRAZOLE;ABCB1;Gene;PA10026;Chemical
ESCITALOPRAM;ABCB1;Gene;PA10074;Chemical
VALGANCICLOVIR;ABCB1;Gene;PA10227;Chemical
VINDESINE;ABCB1;Gene;PA10232;Chemical
VORICONAZOLE;ABCB1;Gene;PA10233;Chemical
ATAZANAVIR;ABCB1;Gene;PA10251;Chemical
FLUPENTHIXOL;ABCB1;Gene;PA10268;Chemical
PHENOTHIAZINES WITH ALIPHATIC SIDE-CHAIN;ABCB1;Gene;PA10478;Chemical
IMATINIB;ABCB1;Gene;PA10804;Chemical
CORTICOSTEROIDS;ABCB1;Gene;PA10832;Chemical
FLUOROURACIL;ABCB1;Gene;PA128406956;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;ABCB1;Gene;PA130620651;Chemical
OXALIPLATIN;ABCB1;Gene;PA131285527;Chemical
GEFITINIB;ABCB1;Gene;PA131301952;Chemical
CALCEIN;ABCB1;Gene;PA132595336;Chemical
ORGAN TRANSPLANTATION;ABCB1;Gene;PA133888799;Disease
HMG COA REDUCTASE INHIBITORS;ABCB1;Gene;PA133950441;Chemical
ERLOTINIB;ABCB1;Gene;PA134687924;Chemical
DOMPERIDONE;ABCB1;Gene;PA134711056;Chemical
TRANSPLANTATION;ABCB1;Gene;PA134850491;Disease
TETRABENAZINE;ABCB1;Gene;PA140222719;Chemical
ANTIEPILEPTICS;ABCB1;Gene;PA143485705;Chemical
ALISKIREN;ABCB1;Gene;PA143487910;Chemical
NITRENDIPINE;ABCB1;Gene;PA146096020;Chemical
TALINOLOL;ABCB1;Gene;PA146123005;Chemical
TAXANES;ABCB1;Gene;PA150481189;Chemical
VALINOMYCIN;ABCB1;Gene;PA151917011;Chemical
GRAPEFRUIT JUICE;ABCB1;Gene;PA151958355;Chemical
GASTROINTESTINAL STROMAL TUMORS;ABCB1;Gene;PA151958383;Disease
CURCUMIN;ABCB1;Gene;PA151958596;Chemical
MYALGIA;ABCB1;Gene;PA157379134;Disease
LENALIDOMIDE;ABCB1;Gene;PA162363968;Chemical
SUNITINIB;ABCB1;Gene;PA162372840;Chemical
AMISULPRIDE;ABCB1;Gene;PA162565877;Chemical
ACTINOMYCINES;ABCB1;Gene;PA164712314;Chemical
ANTIVIRALS FOR TREATMENT OF HIV INFECTIONS, COMBINATIONS;ABCB1;Gene;PA164712505;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;ABCB1;Gene;PA164712708;Chemical
PHENOTHIAZINE DERIVATIVES;ABCB1;Gene;PA164713162;Chemical
PLATINUM COMPOUNDS;ABCB1;Gene;PA164713176;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;ABCB1;Gene;PA164713257;Chemical
PENTAZOCINE;ABCB1;Gene;PA164744326;Chemical
RANOLAZINE;ABCB1;Gene;PA164746007;Chemical
EVEROLIMUS;ABCB1;Gene;PA164746311;Chemical
TEMSIROLIMUS;ABCB1;Gene;PA164746890;Chemical
VECURONIUM;ABCB1;Gene;PA164748865;Chemical
DICLOXACILLIN;ABCB1;Gene;PA164749649;Chemical
BEPRIDIL;ABCB1;Gene;PA164754755;Chemical
ROCURONIUM;ABCB1;Gene;PA164754992;Chemical
HYDROXOCOBALAMIN;ABCB1;Gene;PA164768689;Chemical
DAPTOMYCIN;ABCB1;Gene;PA164768820;Chemical
ALDOSTERONE;ABCB1;Gene;PA164924487;Chemical
BIRICODAR;ABCB1;Gene;PA164924560;Chemical
CELIPROLOL;ABCB1;Gene;PA164924561;Chemical
ELACRIDAR;ABCB1;Gene;PA164924562;Chemical
OC144-093;ABCB1;Gene;PA164924563;Chemical
R101933;ABCB1;Gene;PA164924564;Chemical
VALSPODAR;ABCB1;Gene;PA164924565;Chemical
XR9051;ABCB1;Gene;PA164924566;Chemical
ZOSUQUIDAR;ABCB1;Gene;PA164924567;Chemical
TOXIC LIVER DISEASE;ABCB1;Gene;PA164925725;Disease
ACUTE CORONARY SYNDROME;ABCB1;Gene;PA165108401;Disease
DABIGATRAN;ABCB1;Gene;PA165110351;Chemical
RHODAMINE 123;ABCB1;Gene;PA165110729;Chemical
SN-38;ABCB1;Gene;PA165110775;Chemical
TIPIFARNIB;ABCB1;Gene;PA165110778;Chemical
CREMOPHOR EL;ABCB1;Gene;PA165111677;Chemical
TARIQUIDAR;ABCB1;Gene;PA165282096;Chemical
BROMPERIDOL;ABCB1;Gene;PA165282097;Chemical
KIDNEY TRANSPLANTATION;ABCB1;Gene;PA165817016;Disease
VEMURAFENIB;ABCB1;Gene;PA165946873;Chemical
BOCEPREVIR;ABCB1;Gene;PA165948902;Chemical
RIVAROXABAN;ABCB1;Gene;PA165958360;Chemical
AGOMELATINE;ABCB1;Gene;PA165958363;Chemical
HELICOBACTER INFECTIONS;ABCB1;Gene;PA166048740;Disease
HAND-FOOT SYNDROME;ABCB1;Gene;PA166114377;Disease
LUNG TRANSPLANTATION;ABCB1;Gene;PA166114457;Disease
MUCOSITIS;ABCB1;Gene;PA166122058;Disease
HEMATOPOIETIC STEM CELL TRANSPLANTATION;ABCB1;Gene;PA166123007;Disease
PROGRESSION-FREE SURVIVAL;ABCB1;Gene;PA166123026;Disease
PLATELET REACTIVITY;ABCB1;Gene;PA166124406;Disease
SILIBININ;ABCB1;Gene;PA166129539;Chemical
FLUOXETINE GLUCURONIDE;ABCB1;Gene;PA166131439;Chemical
RS1801131;ABCB1;Gene;PA166153643;Variant
RS1801133;ABCB1;Gene;PA166153644;Variant
RS4149081;ABCB1;Gene;PA166154581;Variant
RS11045879;ABCB1;Gene;PA166154633;Variant
ROMIDEPSIN;ABCB1;Gene;PA166161306;Chemical
APIXABAN;ABCB1;Gene;PA166163740;Chemical
TONSILLECTOMY;ABCB1;Gene;PA166169457;Disease
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART);ABCB1;Gene;PA166177229;Chemical
SOMNOLENCE;ABCB1;Gene;PA166185626;Disease
NR1I2;ABCB1;Gene;PA378;Gene
CARDIAC RHYTHM DISEASE;ABCB1;Gene;PA443421;Disease
JUVENILE RHEUMATOID ARTHRITIS;ABCB1;Gene;PA443433;Disease
RHEUMATOID ARTHRITIS;ABCB1;Gene;PA443434;Disease
ASTHENIA;ABCB1;Gene;PA443448;Disease
ATRIAL FIBRILLATION;ABCB1;Gene;PA443459;Disease
URINARY BLADDER NEOPLASMS;ABCB1;Gene;PA443512;Disease
BREAST NEOPLASMS;ABCB1;Gene;PA443560;Disease
BURKITT LYMPHOMA;ABCB1;Gene;PA443580;Disease
NON-SMALL CELL LUNG CARCINOMA;ABCB1;Gene;PA443622;Disease
RENAL CELL CARCINOMA;ABCB1;Gene;PA443624;Disease
ULCERATIVE COLITIS;ABCB1;Gene;PA443750;Disease
CORONARY ARTERY DISEASE;ABCB1;Gene;PA443796;Disease
CORONARY DISEASE;ABCB1;Gene;PA443797;Disease
CYSTIC FIBROSIS;ABCB1;Gene;PA443829;Disease
DEATH;ABCB1;Gene;PA443842;Disease
DRUG TOXICITY;ABCB1;Gene;PA443937;Disease
EPILEPSY;ABCB1;Gene;PA444065;Disease
EPILEPSIES, PARTIAL;ABCB1;Gene;PA444066;Disease
EPILEPSY, IDIOPATHIC GENERALIZED;ABCB1;Gene;PA444067;Disease
NEOPLASM OF ESOPHAGUS;ABCB1;Gene;PA444101;Disease
FRACTURES, BONE;ABCB1;Gene;PA444222;Disease
GASTROESOPHAGEAL REFLUX;ABCB1;Gene;PA444255;Disease
GLIOMA;ABCB1;Gene;PA444284;Disease
HEMORRHAGE;ABCB1;Gene;PA444417;Disease
HEROIN DEPENDENCE;ABCB1;Gene;PA444460;Disease
HYPERCHOLESTEROLEMIA;ABCB1;Gene;PA444516;Disease
HYPERLIPOPROTEINEMIA TYPE II;ABCB1;Gene;PA444517;Disease
HYPERTENSION;ABCB1;Gene;PA444552;Disease
HYPOTENSIVE DISORDER;ABCB1;Gene;PA444584;Disease
HYPOVENTILATION;ABCB1;Gene;PA444591;Disease
LEUKEMIA, MYELOID, ACUTE;ABCB1;Gene;PA444760;Disease
LYMPHOMA;ABCB1;Gene;PA444840;Disease
NON-HODGKIN LYMPHOMA;ABCB1;Gene;PA444845;Disease
LYMPHOPENIA;ABCB1;Gene;PA444848;Disease
MIGRAINE WITHOUT AURA;ABCB1;Gene;PA444949;Disease
MULTIPLE MYELOMA;ABCB1;Gene;PA444985;Disease
MYASTHENIA GRAVIS;ABCB1;Gene;PA445004;Disease
MYOCARDIAL INFARCTION;ABCB1;Gene;PA445019;Disease
NARCOLEPSY;ABCB1;Gene;PA445042;Disease
OPIOID-RELATED DISORDERS;ABCB1;Gene;PA445043;Disease
METASTATIC NEOPLASM;ABCB1;Gene;PA445058;Disease
NEOPLASMS;ABCB1;Gene;PA445062;Disease
NEPHROTIC SYNDROME;ABCB1;Gene;PA445089;Disease
NEUTROPENIA;ABCB1;Gene;PA445113;Disease
OVARIAN NEOPLASMS;ABCB1;Gene;PA445204;Disease
PAIN;ABCB1;Gene;PA445208;Disease
PAIN, POSTOPERATIVE;ABCB1;Gene;PA445210;Disease
PERIPHERAL NERVOUS SYSTEM DISEASES;ABCB1;Gene;PA445301;Disease
OSTEOSARCOMA;ABCB1;Gene;PA445601;Disease
TESTICULAR NEOPLASMS;ABCB1;Gene;PA445828;Disease
TUBERCULOSIS;ABCB1;Gene;PA445941;Disease
VOMITING;ABCB1;Gene;PA446051;Disease
COLORECTAL NEOPLASMS;ABCB1;Gene;PA446108;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;ABCB1;Gene;PA446155;Disease
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;ABCB1;Gene;PA446171;Disease
LYMPHOMA, T-CELL;ABCB1;Gene;PA446309;Disease
LOW BACK PAIN;ABCB1;Gene;PA446444;Disease
ARTHRALGIA;ABCB1;Gene;PA446761;Disease
SUBSTANCE-RELATED DISORDERS;ABCB1;Gene;PA446876;Disease
POSTOPERATIVE NAUSEA AND VOMITING;ABCB1;Gene;PA446970;Disease
NEUROTOXICITY SYNDROMES;ABCB1;Gene;PA446975;Disease
MIGRAINE WITH AURA;ABCB1;Gene;PA447004;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;ABCB1;Gene;PA447197;Disease
AUTISM;ABCB1;Gene;PA447198;Disease
BIPOLAR DISORDER;ABCB1;Gene;PA447199;Disease
DEPRESSIVE DISORDER;ABCB1;Gene;PA447207;Disease
PSYCHOTIC DISORDER;ABCB1;Gene;PA447215;Disease
SCHIZOPHRENIA;ABCB1;Gene;PA447216;Disease
HIV INFECTIOUS DISEASE;ABCB1;Gene;PA447230;Disease
LIVER TRANSPLANTATION;ABCB1;Gene;PA447247;Disease
DEPRESSION;ABCB1;Gene;PA447278;Disease
MAJOR DEPRESSIVE DISORDER;ABCB1;Gene;PA447321;Disease
AMIODARONE;ABCB1;Gene;PA448383;Chemical
AMITRIPTYLINE;ABCB1;Gene;PA448385;Chemical
AMPRENAVIR;ABCB1;Gene;PA448422;Chemical
ANASTROZOLE;ABCB1;Gene;PA448432;Chemical
ASTEMIZOLE;ABCB1;Gene;PA448498;Chemical
ATENOLOL;ABCB1;Gene;PA448499;Chemical
ATORVASTATIN;ABCB1;Gene;PA448500;Chemical
AZATHIOPRINE;ABCB1;Gene;PA448515;Chemical
BLEOMYCIN;ABCB1;Gene;PA448645;Chemical
CAPECITABINE;ABCB1;Gene;PA448771;Chemical
CARBAMAZEPINE;ABCB1;Gene;PA448785;Chemical
CARVEDILOL;ABCB1;Gene;PA448817;Chemical
CHLORPROMAZINE;ABCB1;Gene;PA448964;Chemical
CIMETIDINE;ABCB1;Gene;PA449001;Chemical
CISPLATIN;ABCB1;Gene;PA449014;Chemical
CITALOPRAM;ABCB1;Gene;PA449015;Chemical
CLARITHROMYCIN;ABCB1;Gene;PA449028;Chemical
CLOMIPRAMINE;ABCB1;Gene;PA449048;Chemical
CLOPIDOGREL;ABCB1;Gene;PA449053;Chemical
CLOZAPINE;ABCB1;Gene;PA449061;Chemical
CODEINE;ABCB1;Gene;PA449088;Chemical
COLCHICINE;ABCB1;Gene;PA449092;Chemical
CYCLOPHOSPHAMIDE;ABCB1;Gene;PA449165;Chemical
CYCLOSPORINE;ABCB1;Gene;PA449167;Chemical
CYTARABINE;ABCB1;Gene;PA449177;Chemical
DAUNORUBICIN;ABCB1;Gene;PA449212;Chemical
DESIPRAMINE;ABCB1;Gene;PA449233;Chemical
DEXAMETHASONE;ABCB1;Gene;PA449247;Chemical
DEXRAZOXANE;ABCB1;Gene;PA449259;Chemical
DIGOXIN;ABCB1;Gene;PA449319;Chemical
DILTIAZEM;ABCB1;Gene;PA449334;Chemical
DIPYRIDAMOLE;ABCB1;Gene;PA449367;Chemical
DISULFIRAM;ABCB1;Gene;PA449376;Chemical
DOCETAXEL;ABCB1;Gene;PA449383;Chemical
DOXORUBICIN;ABCB1;Gene;PA449412;Chemical
DOXYCYCLINE;ABCB1;Gene;PA449415;Chemical
EFAVIRENZ;ABCB1;Gene;PA449441;Chemical
ERYTHROMYCIN;ABCB1;Gene;PA449493;Chemical
ETOPOSIDE;ABCB1;Gene;PA449552;Chemical
FELODIPINE;ABCB1;Gene;PA449591;Chemical
FENTANYL;ABCB1;Gene;PA449599;Chemical
FEXOFENADINE;ABCB1;Gene;PA449621;Chemical
FLUOXETINE;ABCB1;Gene;PA449673;Chemical
FLUPHENAZINE;ABCB1;Gene;PA449676;Chemical
FLUVASTATIN;ABCB1;Gene;PA449688;Chemical
FLUVOXAMINE;ABCB1;Gene;PA449690;Chemical
GRAMICIDIN D;ABCB1;Gene;PA449808;Chemical
GRANISETRON;ABCB1;Gene;PA449809;Chemical
HALOPERIDOL;ABCB1;Gene;PA449841;Chemical
HYDROCORTISONE;ABCB1;Gene;PA449905;Chemical
IDARUBICIN;ABCB1;Gene;PA449961;Chemical
INDINAVIR;ABCB1;Gene;PA449977;Chemical
IRINOTECAN;ABCB1;Gene;PA450085;Chemical
ISONIAZID;ABCB1;Gene;PA450112;Chemical
ITRACONAZOLE;ABCB1;Gene;PA450132;Chemical
IVERMECTIN;ABCB1;Gene;PA450133;Chemical
KETOCONAZOLE;ABCB1;Gene;PA450146;Chemical
LAMIVUDINE;ABCB1;Gene;PA450163;Chemical
LAMOTRIGINE;ABCB1;Gene;PA450164;Chemical
LANSOPRAZOLE;ABCB1;Gene;PA450180;Chemical
LEVETIRACETAM;ABCB1;Gene;PA450206;Chemical
LEVOFLOXACIN;ABCB1;Gene;PA450214;Chemical
LITHIUM;ABCB1;Gene;PA450243;Chemical
LOPERAMIDE;ABCB1;Gene;PA450262;Chemical
LOSARTAN;ABCB1;Gene;PA450268;Chemical
LOVASTATIN;ABCB1;Gene;PA450272;Chemical
MAPROTILINE;ABCB1;Gene;PA450322;Chemical
MEFLOQUINE;ABCB1;Gene;PA450348;Chemical
MELPHALAN;ABCB1;Gene;PA450354;Chemical
METHADONE;ABCB1;Gene;PA450401;Chemical
METHOTREXATE;ABCB1;Gene;PA450428;Chemical
METHYLPHENIDATE;ABCB1;Gene;PA450464;Chemical
METHYLPREDNISOLONE;ABCB1;Gene;PA450466;Chemical
MIDAZOLAM;ABCB1;Gene;PA450496;Chemical
MIFEPRISTONE;ABCB1;Gene;PA450500;Chemical
MITOMYCIN;ABCB1;Gene;PA450524;Chemical
MITOXANTRONE;ABCB1;Gene;PA450526;Chemical
MODAFINIL;ABCB1;Gene;PA450530;Chemical
MORPHINE;ABCB1;Gene;PA450550;Chemical
MYCOPHENOLATE MOFETIL;ABCB1;Gene;PA450566;Chemical
NAPROXEN;ABCB1;Gene;PA450595;Chemical
NEFAZODONE;ABCB1;Gene;PA450603;Chemical
NELFINAVIR;ABCB1;Gene;PA450606;Chemical
NEVIRAPINE;ABCB1;Gene;PA450616;Chemical
NICARDIPINE;ABCB1;Gene;PA450620;Chemical
NORTRIPTYLINE;ABCB1;Gene;PA450657;Chemical
OLANZAPINE;ABCB1;Gene;PA450688;Chemical
OMEPRAZOLE;ABCB1;Gene;PA450704;Chemical
ONDANSETRON;ABCB1;Gene;PA450705;Chemical
OSELTAMIVIR;ABCB1;Gene;PA450721;Chemical
OXCARBAZEPINE;ABCB1;Gene;PA450732;Chemical
OXYCODONE;ABCB1;Gene;PA450741;Chemical
PACLITAXEL;ABCB1;Gene;PA450761;Chemical
PANTOPRAZOLE;ABCB1;Gene;PA450774;Chemical
PAROXETINE;ABCB1;Gene;PA450801;Chemical
PHENOBARBITAL;ABCB1;Gene;PA450911;Chemical
PHENYTOIN;ABCB1;Gene;PA450947;Chemical
PRAVASTATIN;ABCB1;Gene;PA451089;Chemical
PREDNISOLONE;ABCB1;Gene;PA451096;Chemical
PREDNISONE;ABCB1;Gene;PA451100;Chemical
PROGESTERONE;ABCB1;Gene;PA451123;Chemical
PROPAFENONE;ABCB1;Gene;PA451131;Chemical
PROPOFOL;ABCB1;Gene;PA451141;Chemical
PROPRANOLOL;ABCB1;Gene;PA451145;Chemical
QUINIDINE;ABCB1;Gene;PA451209;Chemical
QUININE;ABCB1;Gene;PA451213;Chemical
RANITIDINE;ABCB1;Gene;PA451224;Chemical
REMIFENTANIL;ABCB1;Gene;PA451232;Chemical
RESERPINE;ABCB1;Gene;PA451236;Chemical
RIFAMPIN;ABCB1;Gene;PA451250;Chemical
RISPERIDONE;ABCB1;Gene;PA451257;Chemical
RITONAVIR;ABCB1;Gene;PA451260;Chemical
RITUXIMAB;ABCB1;Gene;PA451261;Chemical
SAQUINAVIR;ABCB1;Gene;PA451305;Chemical
SERTRALINE;ABCB1;Gene;PA451333;Chemical
SEVOFLURANE;ABCB1;Gene;PA451341;Chemical
SIMVASTATIN;ABCB1;Gene;PA451363;Chemical
SIROLIMUS;ABCB1;Gene;PA451365;Chemical
SPARFLOXACIN;ABCB1;Gene;PA451472;Chemical
SPIRONOLACTONE;ABCB1;Gene;PA451483;Chemical
SUFENTANIL;ABCB1;Gene;PA451527;Chemical
TACROLIMUS;ABCB1;Gene;PA451578;Chemical
TAMOXIFEN;ABCB1;Gene;PA451581;Chemical
TEMOZOLOMIDE;ABCB1;Gene;PA451609;Chemical
TENIPOSIDE;ABCB1;Gene;PA451611;Chemical
TERFENADINE;ABCB1;Gene;PA451619;Chemical
TETRACYCLINE;ABCB1;Gene;PA451640;Chemical
TOPIRAMATE;ABCB1;Gene;PA451728;Chemical
TOPOTECAN;ABCB1;Gene;PA451729;Chemical
TRAMADOL;ABCB1;Gene;PA451735;Chemical
VALPROIC ACID;ABCB1;Gene;PA451846;Chemical
VENLAFAXINE;ABCB1;Gene;PA451866;Chemical
VERAPAMIL;ABCB1;Gene;PA451868;Chemical
VINBLASTINE;ABCB1;Gene;PA451877;Chemical
VINCRISTINE;ABCB1;Gene;PA451879;Chemical
CYANOCOBALAMIN;ABCB1;Gene;PA451892;Chemical
VITAMIN E;ABCB1;Gene;PA451900;Chemical
WARFARIN;ABCB1;Gene;PA451906;Chemical
ZIDOVUDINE;ABCB1;Gene;PA451954;Chemical
ANTIDEPRESSANTS;ABCB1;Gene;PA452229;Chemical
ANTIPSYCHOTICS;ABCB1;Gene;PA452233;Chemical
GLUCOCORTICOIDS;ABCB1;Gene;PA452347;Chemical
OPIOIDS;ABCB1;Gene;PA452618;Chemical
ANTINEOPLASTIC AGENTS;ABCB1;Gene;PA452621;Chemical
SORAFENIB;ABCB1;Gene;PA7000;Chemical
PRKAA1;MLYCD;Gene;PA33744;Gene
PRKAA2;MLYCD;Gene;PA33745;Gene
PRKAB1;MLYCD;Gene;PA33746;Gene
PRKAB2;MLYCD;Gene;PA33747;Gene
PRKAG1;MLYCD;Gene;PA33751;Gene
PRKAG2;MLYCD;Gene;PA33752;Gene
PRKAG3;MLYCD;Gene;PA33753;Gene
BREAST NEOPLASMS;rs8060157;Variant;PA443560;Disease
RALOXIFENE;rs8060157;Variant;PA451221;Chemical
TAMOXIFEN;rs8060157;Variant;PA451581;Chemical
DPYD;rs144395748;Variant;PA145;Gene
CAPECITABINE;rs144395748;Variant;PA448771;Chemical
ASTHMA;rs6962291;Variant;PA443450;Disease
ASPIRIN;rs6962291;Variant;PA448497;Chemical
ACE;ramipril;Chemical;PA139;Gene
RS4344;ramipril;Chemical;PA166155148;Variant
RS4359;ramipril;Chemical;PA166155149;Variant
BREAST NEOPLASMS;rs2073618;Variant;PA443560;Disease
ANASTROZOLE;rs2073618;Variant;PA448432;Chemical
LETROZOLE;rs2073618;Variant;PA450196;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs96844;Variant;PA164713366;Chemical
PSORIASIS;rs96844;Variant;PA445451;Disease
CFTR;rs397508510;Variant;PA109;Gene
IVACAFTOR;rs397508510;Variant;PA165950341;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs397508510;Variant;PA166362502;Chemical
CYSTIC FIBROSIS;rs397508510;Variant;PA443829;Disease
MECASERMIN;GH1;Gene;PA164774876;Chemical
BUFURALOL;CYP2D6*54;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*54;Haplotype;PA166127651;Chemical
DEXTROMETHORPHAN;CYP2D6*54;Haplotype;PA449273;Chemical
PRIMAQUINE;CYP2D6*54;Haplotype;PA451103;Chemical
ALCOHOL ABUSE;rs8109485;Variant;PA443309;Disease
ETHANOL;rs8109485;Variant;PA448073;Chemical
GLATIRAMER ACETATE;rs12459996;Variant;PA449760;Chemical
ANAKINRA;NLRP3;Gene;PA10799;Chemical
ESCITALOPRAM;SLC6A4 HTTLPR long form (L allele);Haplotype;PA10074;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;SLC6A4 HTTLPR long form (L allele);Haplotype;PA164713257;Chemical
PEGINTERFERON ALFA-2B;SLC6A4 HTTLPR long form (L allele);Haplotype;PA164784024;Chemical
EVODIAMINE;SLC6A4 HTTLPR long form (L allele);Haplotype;PA165860788;Chemical
BERBERINE;SLC6A4 HTTLPR long form (L allele);Haplotype;PA165860812;Chemical
PREGNANCY;SLC6A4 HTTLPR long form (L allele);Haplotype;PA166048714;Disease
ALCOHOLISM;SLC6A4 HTTLPR long form (L allele);Haplotype;PA443309;Disease
DIZZINESS;SLC6A4 HTTLPR long form (L allele);Haplotype;PA443928;Disease
DRUG TOXICITY;SLC6A4 HTTLPR long form (L allele);Haplotype;PA443937;Disease
HEART DEFECTS, CONGENITAL;SLC6A4 HTTLPR long form (L allele);Haplotype;PA444367;Disease
OPIOID-RELATED DISORDERS;SLC6A4 HTTLPR long form (L allele);Haplotype;PA445043;Disease
TOBACCO USE DISORDER;SLC6A4 HTTLPR long form (L allele);Haplotype;PA445876;Disease
HEPATITIS C, CHRONIC;SLC6A4 HTTLPR long form (L allele);Haplotype;PA446863;Disease
ANXIETY DISORDERS;SLC6A4 HTTLPR long form (L allele);Haplotype;PA447196;Disease
DEPRESSIVE DISORDER;SLC6A4 HTTLPR long form (L allele);Haplotype;PA447207;Disease
MOOD DISORDERS;SLC6A4 HTTLPR long form (L allele);Haplotype;PA447209;Disease
OBSESSIVE-COMPULSIVE DISORDER;SLC6A4 HTTLPR long form (L allele);Haplotype;PA447211;Disease
PANIC DISORDER;SLC6A4 HTTLPR long form (L allele);Haplotype;PA447212;Disease
SCHIZOPHRENIA;SLC6A4 HTTLPR long form (L allele);Haplotype;PA447216;Disease
SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;SLC6A4 HTTLPR long form (L allele);Haplotype;PA447218;Disease
DEPRESSION;SLC6A4 HTTLPR long form (L allele);Haplotype;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;SLC6A4 HTTLPR long form (L allele);Haplotype;PA447321;Disease
ETHANOL;SLC6A4 HTTLPR long form (L allele);Haplotype;PA448073;Chemical
BUPRENORPHINE;SLC6A4 HTTLPR long form (L allele);Haplotype;PA448685;Chemical
BUPROPION;SLC6A4 HTTLPR long form (L allele);Haplotype;PA448687;Chemical
CITALOPRAM;SLC6A4 HTTLPR long form (L allele);Haplotype;PA449015;Chemical
CLOMIPRAMINE;SLC6A4 HTTLPR long form (L allele);Haplotype;PA449048;Chemical
FLUOXETINE;SLC6A4 HTTLPR long form (L allele);Haplotype;PA449673;Chemical
FLUVOXAMINE;SLC6A4 HTTLPR long form (L allele);Haplotype;PA449690;Chemical
HALOPERIDOL;SLC6A4 HTTLPR long form (L allele);Haplotype;PA449841;Chemical
METHADONE;SLC6A4 HTTLPR long form (L allele);Haplotype;PA450401;Chemical
MIRTAZAPINE;SLC6A4 HTTLPR long form (L allele);Haplotype;PA450522;Chemical
OLANZAPINE;SLC6A4 HTTLPR long form (L allele);Haplotype;PA450688;Chemical
ONDANSETRON;SLC6A4 HTTLPR long form (L allele);Haplotype;PA450705;Chemical
PAROXETINE;SLC6A4 HTTLPR long form (L allele);Haplotype;PA450801;Chemical
QUETIAPINE;SLC6A4 HTTLPR long form (L allele);Haplotype;PA451201;Chemical
RIBAVIRIN;SLC6A4 HTTLPR long form (L allele);Haplotype;PA451241;Chemical
RISPERIDONE;SLC6A4 HTTLPR long form (L allele);Haplotype;PA451257;Chemical
SERTRALINE;SLC6A4 HTTLPR long form (L allele);Haplotype;PA451333;Chemical
VENLAFAXINE;SLC6A4 HTTLPR long form (L allele);Haplotype;PA451866;Chemical
ANTIDEPRESSANTS;SLC6A4 HTTLPR long form (L allele);Haplotype;PA452229;Chemical
ANTIPSYCHOTICS;SLC6A4 HTTLPR long form (L allele);Haplotype;PA452233;Chemical
CLOPIDOGREL;CYP2C19*15;Haplotype;PA449053;Chemical
FLUOXETINE;CYP2C19*15;Haplotype;PA449673;Chemical
FLUVOXAMINE;CYP2C19*15;Haplotype;PA449690;Chemical
MEPHENYTOIN;CYP2C19*15;Haplotype;PA450373;Chemical
OMEPRAZOLE;CYP2C19*15;Haplotype;PA450704;Chemical
TRANYLCYPROMINE;CYP2C19*15;Haplotype;PA451741;Chemical
HMG COA REDUCTASE INHIBITORS;HLA-DRB1*01:01;Haplotype;PA133950441;Chemical
ROSUVASTATIN;HLA-DRB1*01:01;Haplotype;PA134308647;Chemical
PITAVASTATIN;HLA-DRB1*01:01;Haplotype;PA142650384;Chemical
MEASLES VACCINES;HLA-DRB1*01:01;Haplotype;PA164712887;Chemical
LUMIRACOXIB;HLA-DRB1*01:01;Haplotype;PA164769031;Chemical
TOXIC LIVER DISEASE;HLA-DRB1*01:01;Haplotype;PA164925725;Disease
AGRANULOCYTOSIS;HLA-DRB1*01:01;Haplotype;PA443297;Disease
DRUG HYPERSENSITIVITY;HLA-DRB1*01:01;Haplotype;PA443936;Disease
DRUG TOXICITY;HLA-DRB1*01:01;Haplotype;PA443937;Disease
EXANTHEMA;HLA-DRB1*01:01;Haplotype;PA444109;Disease
HYPERSENSITIVITY;HLA-DRB1*01:01;Haplotype;PA444546;Disease
MUSCULAR DISEASES;HLA-DRB1*01:01;Haplotype;PA444997;Disease
SCHIZOPHRENIA;HLA-DRB1*01:01;Haplotype;PA447216;Disease
HIV INFECTIONS;HLA-DRB1*01:01;Haplotype;PA447230;Disease
ATORVASTATIN;HLA-DRB1*01:01;Haplotype;PA448500;Chemical
CLOZAPINE;HLA-DRB1*01:01;Haplotype;PA449061;Chemical
EFAVIRENZ;HLA-DRB1*01:01;Haplotype;PA449441;Chemical
FLUVASTATIN;HLA-DRB1*01:01;Haplotype;PA449688;Chemical
NEVIRAPINE;HLA-DRB1*01:01;Haplotype;PA450616;Chemical
PRAVASTATIN;HLA-DRB1*01:01;Haplotype;PA451089;Chemical
SIMVASTATIN;HLA-DRB1*01:01;Haplotype;PA451363;Chemical
DESFLURANE;rs193922768;Variant;PA164749136;Chemical
RYR1;rs193922768;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs193922768;Variant;PA444863;Disease
ENFLURANE;rs193922768;Variant;PA449461;Chemical
HALOTHANE;rs193922768;Variant;PA449845;Chemical
ISOFLURANE;rs193922768;Variant;PA450106;Chemical
METHOXYFLURANE;rs193922768;Variant;PA450434;Chemical
SEVOFLURANE;rs193922768;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs193922768;Variant;PA451522;Chemical
CACNA1S;rs193922768;Variant;PA85;Gene
CFTR;rs769016520;Variant;PA109;Gene
IVACAFTOR;rs769016520;Variant;PA165950341;Chemical
EPILEPSY;CYP2C9*43;Haplotype;PA444065;Disease
DICLOFENAC;CYP2C9*43;Haplotype;PA449293;Chemical
PHENYTOIN;CYP2C9*43;Haplotype;PA450947;Chemical
DIURETICS;ADD1;Gene;PA151249535;Chemical
HYPERTENSION;ADD1;Gene;PA444552;Disease
LIVER CIRRHOSIS;ADD1;Gene;PA444797;Disease
MYOCARDIAL INFARCTION;ADD1;Gene;PA445019;Disease
ESSENTIAL HYPERTENSION;ADD1;Gene;PA447288;Disease
BUMETANIDE;ADD1;Gene;PA448682;Chemical
FUROSEMIDE;ADD1;Gene;PA449719;Chemical
HYDROCHLOROTHIAZIDE;ADD1;Gene;PA449899;Chemical
SPIRONOLACTONE;ADD1;Gene;PA451483;Chemical
TORASEMIDE;ADD1;Gene;PA451733;Chemical
ATP1A1;ADD1;Gene;PA62;Gene
HEART VALVE REPLACEMENT;DNMT3A;Gene;PA166123431;Disease
WARFARIN;DNMT3A;Gene;PA451906;Chemical
NFKB1;CAMK1G;Gene;PA248;Gene
ELK1;CAMK1G;Gene;PA27749;Gene
FOS;CAMK1G;Gene;PA28212;Gene
RELA;CAMK1G;Gene;PA296;Gene
JUN;CAMK1G;Gene;PA30006;Gene
MYC;CAMK1G;Gene;PA31353;Gene
NFKB2;CAMK1G;Gene;PA31600;Gene
STAT3;CAMK1G;Gene;PA337;Gene
STAT5A;CAMK1G;Gene;PA338;Gene
SP1;CAMK1G;Gene;PA36042;Gene
STAT1;CAMK1G;Gene;PA36183;Gene
STAT2;CAMK1G;Gene;PA36184;Gene
STAT4;CAMK1G;Gene;PA36185;Gene
STAT5B;CAMK1G;Gene;PA36186;Gene
NEOPLASMS;rs11141915;Variant;PA445062;Disease
GEMCITABINE;rs11141915;Variant;PA449748;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs4627790;Variant;PA447197;Disease
METHYLPHENIDATE;rs4627790;Variant;PA450464;Chemical
DIURETICS;rs702553;Variant;PA151249535;Chemical
NEPHROSCLEROSIS;rs702553;Variant;PA445086;Disease
KCNIP4;Ace Inhibitors, Plain;Chemical;PA134893552;Gene
ACE;Ace Inhibitors, Plain;Chemical;PA139;Gene
RS699;Ace Inhibitors, Plain;Chemical;PA166153539;Variant
RS11209716;Ace Inhibitors, Plain;Chemical;PA166153821;Variant
RS1801253;Ace Inhibitors, Plain;Chemical;PA166153977;Variant
RS1799722;Ace Inhibitors, Plain;Chemical;PA166154785;Variant
RS8012552;Ace Inhibitors, Plain;Chemical;PA166154814;Variant
RS8016905;Ace Inhibitors, Plain;Chemical;PA166154816;Variant
RS1799752;Ace Inhibitors, Plain;Chemical;PA166155187;Variant
RS4267385;Ace Inhibitors, Plain;Chemical;PA166155220;Variant
RS4459610;Ace Inhibitors, Plain;Chemical;PA166155221;Variant
RS5182;Ace Inhibitors, Plain;Chemical;PA166156275;Variant
RS5186;Ace Inhibitors, Plain;Chemical;PA166156276;Variant
RS2016848;Ace Inhibitors, Plain;Chemical;PA166156337;Variant
RS1495509;Ace Inhibitors, Plain;Chemical;PA166156516;Variant
RS6838116;Ace Inhibitors, Plain;Chemical;PA166156612;Variant
RS7661530;Ace Inhibitors, Plain;Chemical;PA166156620;Variant
RS7675300;Ace Inhibitors, Plain;Chemical;PA166156629;Variant
RS16870989;Ace Inhibitors, Plain;Chemical;PA166156667;Variant
RS145489027;Ace Inhibitors, Plain;Chemical;PA166156701;Variant
RS1042713;Ace Inhibitors, Plain;Chemical;PA166156748;Variant
RS1799983;Ace Inhibitors, Plain;Chemical;PA166157303;Variant
RS495828;Ace Inhibitors, Plain;Chemical;PA166157707;Variant
RS3788853;Ace Inhibitors, Plain;Chemical;PA166220461;Variant
RS71103505;Ace Inhibitors, Plain;Chemical;PA166223161;Variant
RS2253201;Ace Inhibitors, Plain;Chemical;PA166238521;Variant
KCNMA1;Ace Inhibitors, Plain;Chemical;PA220;Gene
ABO;Ace Inhibitors, Plain;Chemical;PA24415;Gene
NOS3;Ace Inhibitors, Plain;Chemical;PA254;Gene
PTGER3;Ace Inhibitors, Plain;Chemical;PA288;Gene
MME;Ace Inhibitors, Plain;Chemical;PA30864;Gene
XPNPEP2;Ace Inhibitors, Plain;Chemical;PA37416;Gene
ADRB1;Ace Inhibitors, Plain;Chemical;PA38;Gene
ADRB2;Ace Inhibitors, Plain;Chemical;PA39;Gene
AGT;Ace Inhibitors, Plain;Chemical;PA42;Gene
AGTR1;Ace Inhibitors, Plain;Chemical;PA43;Gene
BDKRB2;Ace Inhibitors, Plain;Chemical;PA80;Gene
FLUOROURACIL;IRS1;Gene;PA128406956;Chemical
DRUGS USED IN DIABETES;IRS1;Gene;PA164712711;Chemical
BREAST NEOPLASMS;IRS1;Gene;PA443560;Disease
CORONARY ARTERY DISEASE;IRS1;Gene;PA443796;Disease
DIABETES MELLITUS, TYPE 2;IRS1;Gene;PA443890;Disease
NEUTROPENIA;IRS1;Gene;PA445113;Disease
CLOPIDOGREL;IRS1;Gene;PA449053;Chemical
CYCLOPHOSPHAMIDE;IRS1;Gene;PA449165;Chemical
EPIRUBICIN;IRS1;Gene;PA449476;Chemical
FLUOROURACIL;REV3L;Gene;PA128406956;Chemical
METASTATIC NEOPLASM;REV3L;Gene;PA445058;Disease
OSTEOSARCOMA;REV3L;Gene;PA445601;Disease
CAPECITABINE;REV3L;Gene;PA448771;Chemical
CISPLATIN;REV3L;Gene;PA449014;Chemical
COTININE;rs3798676;Variant;PA166114414;Chemical
NICOTINE;rs3798676;Variant;PA450626;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;rs9895420;Variant;PA446155;Disease
METHOTREXATE;rs9895420;Variant;PA450428;Chemical
PANCREATIC NEOPLASMS;SERPINA3;Gene;PA445218;Disease
ANTINEOPLASTIC AGENTS;SERPINA3;Gene;PA452621;Chemical
FEBUXOSTAT;rs75995567;Variant;PA165958521;Chemical
GOUT;rs75995567;Variant;PA444318;Disease
ALLOPURINOL;rs75995567;Variant;PA448320;Chemical
CYP2C19;lung transplantation;Disease;PA124;Gene
CYP3A4;lung transplantation;Disease;PA130;Gene
CYP3A5;lung transplantation;Disease;PA131;Gene
CYP2C19*17;lung transplantation;Disease;PA165816533;Haplotype
CYP3A4*1;lung transplantation;Disease;PA165819201;Haplotype
CYP3A4*18;lung transplantation;Disease;PA165819240;Haplotype
CYP3A4*20;lung transplantation;Disease;PA165819244;Haplotype
CYP2C19*1;lung transplantation;Disease;PA165980634;Haplotype
CYP2C19*2;lung transplantation;Disease;PA165980635;Haplotype
CYP3A4*22;lung transplantation;Disease;PA166048680;Haplotype
CYP3A5*1;lung transplantation;Disease;PA166128213;Haplotype
CYP3A5*3;lung transplantation;Disease;PA166128219;Haplotype
CYP3A5*6;lung transplantation;Disease;PA166128233;Haplotype
CYP3A5*7;lung transplantation;Disease;PA166128234;Haplotype
RS1946518;lung transplantation;Disease;PA166154344;Variant
RS4149117;lung transplantation;Disease;PA166154583;Variant
RS7311358;lung transplantation;Disease;PA166154602;Variant
RS9282564;lung transplantation;Disease;PA166157435;Variant
ABCB1;lung transplantation;Disease;PA267;Gene
IL18;lung transplantation;Disease;PA29802;Gene
SLCO1B3;lung transplantation;Disease;PA35844;Gene
PROSTATIC NEOPLASMS;CYP4B1;Gene;PA445425;Disease
DOCETAXEL;CYP4B1;Gene;PA449383;Chemical
THALIDOMIDE;CYP4B1;Gene;PA451644;Chemical
RADIOTHERAPY;rs264588;Variant;PA166122986;Chemical
PROSTATIC NEOPLASMS;rs264588;Variant;PA445425;Disease
FLT3;quizartinib;Chemical;PA28181;Gene
CYP2D6;sedation;Disease;PA128;Gene
FASTKD3;sedation;Disease;PA145148868;Gene
CYP2D6*1;sedation;Disease;PA165816576;Haplotype
CYP2D6*2;sedation;Disease;PA165816577;Haplotype
CYP2D6*3;sedation;Disease;PA165816578;Haplotype
CYP2D6*4;sedation;Disease;PA165816579;Haplotype
CYP2D6*6;sedation;Disease;PA165816581;Haplotype
CYP2D6*10;sedation;Disease;PA165816582;Haplotype
CYP2D6*17;sedation;Disease;PA165816583;Haplotype
CYP2D6*41;sedation;Disease;PA165816584;Haplotype
CYP2D6*5;sedation;Disease;PA165948092;Haplotype
CYP2D6*9;sedation;Disease;PA165948317;Haplotype
CYP2D6*2XN;sedation;Disease;PA165988480;Haplotype
RS901865;sedation;Disease;PA166156299;Variant
RS1801394;sedation;Disease;PA166156776;Variant
RS6686529;sedation;Disease;PA166285101;Variant
HRH1;sedation;Disease;PA29456;Gene
KCNK2;sedation;Disease;PA30059;Gene
MTRR;sedation;Disease;PA31277;Gene
SLC22A1;sedation;Disease;PA329;Gene
DRUG TOXICITY;rs2244614;Variant;PA443937;Disease
CAPECITABINE;rs2244614;Variant;PA448771;Chemical
MAJOR DEPRESSIVE DISORDER;rs521093;Variant;PA447321;Disease
ANTIDEPRESSANTS;rs521093;Variant;PA452229;Chemical
EFAVIRENZ;rs752695347;Variant;PA449441;Chemical
PROPOFOL;rs752695347;Variant;PA451141;Chemical
DULOXETINE;rs7306991;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs7306991;Variant;PA447321;Disease
RALTEGRAVIR;rs8175347;Variant;PA164888966;Chemical
NILOTINIB;rs8175347;Variant;PA165958345;Chemical
UGT1A1;rs8175347;Variant;PA420;Gene
HIV INFECTIONS;rs8175347;Variant;PA447230;Disease
CFTR;rs1800079;Variant;PA109;Gene
IVACAFTOR;rs1800079;Variant;PA165950341;Chemical
SN-38;rs35621;Variant;PA165110775;Chemical
COLORECTAL NEOPLASMS;rs35621;Variant;PA446108;Disease
CAMK1D;NFKB1;Gene;PA134992438;Gene
AKT1;NFKB1;Gene;PA24684;Gene
AKT2;NFKB1;Gene;PA24685;Gene
AKT3;NFKB1;Gene;PA24686;Gene
CAMK1;NFKB1;Gene;PA26048;Gene
CAMK1G;NFKB1;Gene;PA26049;Gene
MAPK8;NFKB1;Gene;PA283;Gene
MAPK1;NFKB1;Gene;PA30616;Gene
MAPK3;NFKB1;Gene;PA30622;Gene
PPP3CA;NFKB1;Gene;PA33678;Gene
PPP3CB;NFKB1;Gene;PA33679;Gene
PPP3CC;NFKB1;Gene;PA33680;Gene
PPP3R1;NFKB1;Gene;PA33681;Gene
PPP3R2;NFKB1;Gene;PA33682;Gene
STAT3;NFKB1;Gene;PA337;Gene
PRKCA;NFKB1;Gene;PA33759;Gene
PRKCB;NFKB1;Gene;PA33761;Gene
PRKCG;NFKB1;Gene;PA33766;Gene
STAT5A;NFKB1;Gene;PA338;Gene
STAT1;NFKB1;Gene;PA36183;Gene
STAT2;NFKB1;Gene;PA36184;Gene
STAT4;NFKB1;Gene;PA36185;Gene
STAT5B;NFKB1;Gene;PA36186;Gene
PSORIASIS;NFKB1;Gene;PA445451;Disease
ETANERCEPT;NFKB1;Gene;PA449515;Chemical
CAMK2A;NFKB1;Gene;PA90;Gene
CAMK2B;NFKB1;Gene;PA91;Gene
CAMK2D;NFKB1;Gene;PA92;Gene
CAMK2G;NFKB1;Gene;PA93;Gene
ATRIAL FIBRILLATION;CYP2C9*16;Haplotype;PA443459;Disease
EPILEPSY;CYP2C9*16;Haplotype;PA444065;Disease
PHENYTOIN;CYP2C9*16;Haplotype;PA450947;Chemical
WARFARIN;CYP2C9*16;Haplotype;PA451906;Chemical
RHEUMATOID ARTHRITIS;rs1544105;Variant;PA443434;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs1544105;Variant;PA446155;Disease
METHOTREXATE;rs1544105;Variant;PA450428;Chemical
HEROIN DEPENDENCE;rs2236861;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs2236861;Variant;PA445043;Disease
OPIOIDS;rs2236861;Variant;PA452618;Chemical
HEROIN;rs2236861;Variant;PA452619;Chemical
CORONARY ARTERY DISEASE;rs2279238;Variant;PA443796;Disease
HYPERTENSION;rs2279238;Variant;PA444552;Disease
VERAPAMIL;rs2279238;Variant;PA451868;Chemical
RS5030843;l-phenylalanine;Chemical;PA166189122;Variant
RS138809906;l-phenylalanine;Chemical;PA166189123;Variant
RS5030849;l-phenylalanine;Chemical;PA166189124;Variant
RS5030858;l-phenylalanine;Chemical;PA166189125;Variant
RS5030860;l-phenylalanine;Chemical;PA166189126;Variant
RS76394784;l-phenylalanine;Chemical;PA166189141;Variant
RS62516101;l-phenylalanine;Chemical;PA166189142;Variant
PAH;l-phenylalanine;Chemical;PA32911;Gene
SYSTOLIC BLOOD PRESSURE;NPPA;Gene;PA166128188;Disease
CARDIOVASCULAR DISEASE;NPPA;Gene;PA443635;Disease
CORONARY DISEASE;NPPA;Gene;PA443797;Disease
HYPERTENSION;NPPA;Gene;PA444552;Disease
STROKE;NPPA;Gene;PA447054;Disease
AMLODIPINE;NPPA;Gene;PA448388;Chemical
CHLORTHALIDONE;NPPA;Gene;PA448970;Chemical
AMISULPRIDE;HTR1A;Gene;PA162565877;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;HTR1A;Gene;PA164713257;Chemical
MILNACIPRAN;HTR1A;Gene;PA164752812;Chemical
LURASIDONE;HTR1A;Gene;PA166129557;Chemical
GNAI1;HTR1A;Gene;PA172;Gene
GNAI3;HTR1A;Gene;PA173;Gene
GNAI2;HTR1A;Gene;PA24347;Gene
SUBSTANCE-RELATED DISORDERS;HTR1A;Gene;PA446876;Disease
DEPRESSIVE DISORDER;HTR1A;Gene;PA447207;Disease
PANIC DISORDER;HTR1A;Gene;PA447212;Disease
SCHIZOPHRENIA;HTR1A;Gene;PA447216;Disease
MAJOR DEPRESSIVE DISORDER;HTR1A;Gene;PA447321;Disease
CLOZAPINE;HTR1A;Gene;PA449061;Chemical
FLUOXETINE;HTR1A;Gene;PA449673;Chemical
FLUVOXAMINE;HTR1A;Gene;PA449690;Chemical
METHAMPHETAMINE;HTR1A;Gene;PA450403;Chemical
OLANZAPINE;HTR1A;Gene;PA450688;Chemical
PAROXETINE;HTR1A;Gene;PA450801;Chemical
QUETIAPINE;HTR1A;Gene;PA451201;Chemical
RISPERIDONE;HTR1A;Gene;PA451257;Chemical
SERTRALINE;HTR1A;Gene;PA451333;Chemical
ANTIDEPRESSANTS;HTR1A;Gene;PA452229;Chemical
ANTIPSYCHOTICS;HTR1A;Gene;PA452233;Chemical
FEBUXOSTAT;AOX1;Gene;PA165958521;Chemical
XK469;AOX1;Gene;PA166114484;Chemical
GOUT;AOX1;Gene;PA444318;Disease
INFLAMMATORY BOWEL DISEASES;AOX1;Gene;PA446116;Disease
ALLOPURINOL;AOX1;Gene;PA448320;Chemical
AZATHIOPRINE;AOX1;Gene;PA448515;Chemical
ETHANOL;rs648007;Variant;PA448073;Chemical
HMG COA REDUCTASE INHIBITORS;rs1337512;Variant;PA133950441;Chemical
RHABDOMYOLYSIS;rs1337512;Variant;PA445549;Disease
MARALIXIBAT;MYO5B;Gene;PA166268803;Chemical
LDLR;mipomersen;Chemical;PA227;Gene
CYP2C19;norclobazam;Chemical;PA124;Gene
GABRA2;norclobazam;Chemical;PA28490;Gene
SULFONAMIDES, PLAIN;SLC12A1;Gene;PA10741;Chemical
OXSR1;SLC12A1;Gene;PA134973207;Gene
GRK2;SLC12A1;Gene;PA40;Gene
ANTITHYROID PREPARATIONS;HLA-B*08:01;Haplotype;PA164712499;Chemical
MEASLES VACCINES;HLA-B*08:01;Haplotype;PA164712887;Chemical
DRUG-INDUCED LIVER INJURY;HLA-B*08:01;Haplotype;PA166119041;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-B*08:01;Haplotype;PA166120929;Disease
AGRANULOCYTOSIS;HLA-B*08:01;Haplotype;PA443297;Disease
CARBAMAZEPINE;HLA-B*08:01;Haplotype;PA448785;Chemical
INFLIXIMAB;HLA-B*08:01;Haplotype;PA452639;Chemical
PANCREATIC NEOPLASMS;rs944050;Variant;PA445218;Disease
GEMCITABINE;rs944050;Variant;PA449748;Chemical
G6PD;sodium ascorbate;Chemical;PA28469;Gene
OVARIAN NEOPLASMS;rs879207;Variant;PA445204;Disease
CARBOPLATIN;rs879207;Variant;PA448803;Chemical
DOCETAXEL;rs879207;Variant;PA449383;Chemical
PACLITAXEL;rs879207;Variant;PA450761;Chemical
FLUOROURACIL;TP53AIP1;Gene;PA128406956;Chemical
BREAST NEOPLASMS;TP53AIP1;Gene;PA443560;Disease
NEUTROPENIA;TP53AIP1;Gene;PA445113;Disease
CYCLOPHOSPHAMIDE;TP53AIP1;Gene;PA449165;Chemical
EPIRUBICIN;TP53AIP1;Gene;PA449476;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs13393173;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs13393173;Variant;PA443434;Disease
NON-SMALL CELL LUNG CARCINOMA;rs6118;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs6118;Variant;PA445846;Disease
CARBOPLATIN;rs6118;Variant;PA448803;Chemical
GEMCITABINE;rs6118;Variant;PA449748;Chemical
RS34550074;Hyponatremia;Disease;PA166169840;Variant
SLCO2A1;Hyponatremia;Disease;PA35840;Gene
MULTIPLE SCLEROSIS;rs4774388;Variant;PA444987;Disease
INTERFERON BETA-1A;rs4774388;Variant;PA450037;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;PGLYRP4;Gene;PA164713366;Chemical
PSORIASIS;PGLYRP4;Gene;PA445451;Disease
CAFFEINE;rs35060421;Variant;PA448710;Chemical
DRUG-INDUCED LIVER INJURY;HLA-DRB1*04:04;Haplotype;PA166119041;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-DRB1*04:04;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-DRB1*04:04;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-DRB1*04:04;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-DRB1*04:04;Haplotype;PA450616;Chemical
INFLIXIMAB;HLA-DRB1*04:04;Haplotype;PA452639;Chemical
FLUOROURACIL;rs17160359;Variant;PA128406956;Chemical
METASTATIC NEOPLASM;rs17160359;Variant;PA445058;Disease
CAPECITABINE;rs17160359;Variant;PA448771;Chemical
MIRVETUXIMAB SORAVTANSINE;FOLR1;Gene;PA166293721;Chemical
METHOTREXATE;FOLR1;Gene;PA450428;Chemical
ATAZANAVIR;UGT1A3;Gene;PA10251;Chemical
HMG COA REDUCTASE INHIBITORS;UGT1A3;Gene;PA133950441;Chemical
DEFERASIROX;UGT1A3;Gene;PA164760843;Chemical
SN-38;UGT1A3;Gene;PA165110775;Chemical
FEBUXOSTAT;UGT1A3;Gene;PA165958521;Chemical
ASTHMA;UGT1A3;Gene;PA443450;Disease
EPILEPSY;UGT1A3;Gene;PA444065;Disease
GOUT;UGT1A3;Gene;PA444318;Disease
HYPERBILIRUBINEMIA;UGT1A3;Gene;PA444511;Disease
OSTEOSARCOMA;UGT1A3;Gene;PA445601;Disease
BETA-THALASSEMIA AND RELATED DISEASES;UGT1A3;Gene;PA446432;Disease
SCHIZOPHRENIA;UGT1A3;Gene;PA447216;Disease
HIV INFECTIOUS DISEASE;UGT1A3;Gene;PA447230;Disease
ALLOPURINOL;UGT1A3;Gene;PA448320;Chemical
ATORVASTATIN;UGT1A3;Gene;PA448500;Chemical
IBUPROFEN;UGT1A3;Gene;PA449957;Chemical
METHOTREXATE;UGT1A3;Gene;PA450428;Chemical
MONTELUKAST;UGT1A3;Gene;PA450546;Chemical
RISPERIDONE;UGT1A3;Gene;PA451257;Chemical
RITONAVIR;UGT1A3;Gene;PA451260;Chemical
TELMISARTAN;UGT1A3;Gene;PA451605;Chemical
VALPROIC ACID;UGT1A3;Gene;PA451846;Chemical
VITAMIN D AND ANALOGUES;UGT1A3;Gene;PA451899;Chemical
COTININE;rs13253389;Variant;PA166114414;Chemical
SCHIZOPHRENIA;rs10501087;Variant;PA447216;Disease
ANTIPSYCHOTICS;rs10501087;Variant;PA452233;Chemical
ABCB1;OC144-093;Chemical;PA267;Gene
FLUOROURACIL;rs56022120;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs56022120;Variant;PA443560;Disease
NEUTROPENIA;rs56022120;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs56022120;Variant;PA449165;Chemical
EPIRUBICIN;rs56022120;Variant;PA449476;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*65;Haplotype;PA166127651;Chemical
PRIMAQUINE;CYP2D6*65;Haplotype;PA451103;Chemical
CYP2D6;solanidine;Chemical;PA128;Gene
HYPERTENSION;rs3890011;Variant;PA444552;Disease
SPIRONOLACTONE;rs3890011;Variant;PA451483;Chemical
MILNACIPRAN;rs1160351;Variant;PA164752812;Chemical
MAJOR DEPRESSIVE DISORDER;rs1160351;Variant;PA447321;Disease
FLUVOXAMINE;rs1160351;Variant;PA449690;Chemical
PAROXETINE;rs1160351;Variant;PA450801;Chemical
CORONARY ARTERY DISEASE;BDKRB1;Gene;PA443796;Disease
PERINDOPRIL;BDKRB1;Gene;PA450877;Chemical
RHEUMATOID ARTHRITIS;rs3758149;Variant;PA443434;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs3758149;Variant;PA446155;Disease
METHOTREXATE;rs3758149;Variant;PA450428;Chemical
CYP3A4;ivabradine;Chemical;PA130;Gene
FLUOROURACIL;rs3218592;Variant;PA128406956;Chemical
METASTATIC NEOPLASM;rs3218592;Variant;PA445058;Disease
CAPECITABINE;rs3218592;Variant;PA448771;Chemical
OSTEOSARCOMA;rs4148416;Variant;PA445601;Disease
CISPLATIN;rs4148416;Variant;PA449014;Chemical
CYCLOPHOSPHAMIDE;rs4148416;Variant;PA449165;Chemical
DOXORUBICIN;rs4148416;Variant;PA449412;Chemical
METHOTREXATE;rs4148416;Variant;PA450428;Chemical
VINCRISTINE;rs4148416;Variant;PA451879;Chemical
GPAM;PRKAG1;Gene;PA134983031;Gene
CRTC2;PRKAG1;Gene;PA142672073;Gene
HMGCR;PRKAG1;Gene;PA189;Gene
ACACA;PRKAG1;Gene;PA24421;Gene
ACACB;PRKAG1;Gene;PA24422;Gene
MLYCD;PRKAG1;Gene;PA30861;Gene
SREBF1;PRKAG1;Gene;PA335;Gene
SLC2A4;PRKAG1;Gene;PA35879;Gene
STK11;PRKAG1;Gene;PA36198;Gene
MLXIPL;PRKAG1;Gene;PA37353;Gene
SIRT1;PRKAG1;Gene;PA37935;Gene
METFORMIN;PRKAG1;Gene;PA450395;Chemical
ATM;PRKAG1;Gene;PA61;Gene
MAJOR DEPRESSIVE DISORDER;GDNF;Gene;PA447321;Disease
PAROXETINE;GDNF;Gene;PA450801;Chemical
GNB4;PLCB2;Gene;PA134864200;Gene
GNAQ;PLCB2;Gene;PA174;Gene
GNB3;PLCB2;Gene;PA176;Gene
CASR;PLCB2;Gene;PA26097;Gene
GNB1;PLCB2;Gene;PA28776;Gene
GNB1L;PLCB2;Gene;PA28777;Gene
GNB2;PLCB2;Gene;PA28778;Gene
GNG2;PLCB2;Gene;PA28784;Gene
GNG3;PLCB2;Gene;PA28785;Gene
GNG4;PLCB2;Gene;PA28786;Gene
GNG5;PLCB2;Gene;PA28787;Gene
GNG7;PLCB2;Gene;PA28789;Gene
PRKCA;PLCB2;Gene;PA33759;Gene
PRKCB;PLCB2;Gene;PA33761;Gene
PRKCG;PLCB2;Gene;PA33766;Gene
PRKCH;PLCB2;Gene;PA33767;Gene
PRKCI;PLCB2;Gene;PA33768;Gene
PRKD1;PLCB2;Gene;PA33771;Gene
PRKCZ;PLCB2;Gene;PA33775;Gene
ADRB2;PLCB2;Gene;PA39;Gene
UGT1A1*6;Lymphoma, Large B-Cell, Diffuse;Disease;PA166115858;Haplotype
RS3957357;Lymphoma, Large B-Cell, Diffuse;Disease;PA166157094;Variant
GSTA1;Lymphoma, Large B-Cell, Diffuse;Disease;PA29016;Gene
UGT1A1;Lymphoma, Large B-Cell, Diffuse;Disease;PA420;Gene
PPP3CA;REL;Gene;PA33678;Gene
PPP3CB;REL;Gene;PA33679;Gene
PPP3CC;REL;Gene;PA33680;Gene
PPP3R1;REL;Gene;PA33681;Gene
PPP3R2;REL;Gene;PA33682;Gene
GEMCITABINE;SLC29A2;Gene;PA449748;Chemical
OPIOID-RELATED DISORDERS;TACR1;Gene;PA445043;Disease
OPIOIDS;TACR1;Gene;PA452618;Chemical
OTOTOXICITY;rs267606619;Variant;PA162263534;Disease
AMIKACIN;rs267606619;Variant;PA164744372;Chemical
NETILMICIN;rs267606619;Variant;PA164754913;Chemical
PAROMOMYCIN;rs267606619;Variant;PA164784023;Chemical
PLAZOMICIN;rs267606619;Variant;PA166228921;Chemical
MICRONOMICIN;rs267606619;Variant;PA166241801;Chemical
DIBEKACIN;rs267606619;Variant;PA166292901;Chemical
RIBOSTAMYCIN;rs267606619;Variant;PA166292902;Chemical
MT-RNR1;rs267606619;Variant;PA31274;Gene
GENTAMICIN;rs267606619;Variant;PA449753;Chemical
KANAMYCIN;rs267606619;Variant;PA450137;Chemical
NEOMYCIN;rs267606619;Variant;PA450608;Chemical
STREPTOMYCIN;rs267606619;Variant;PA451512;Chemical
TOBRAMYCIN;rs267606619;Variant;PA451704;Chemical
AMINOGLYCOSIDE ANTIBACTERIALS;rs267606619;Variant;PA452167;Chemical
FLUOROURACIL;UMPS;Gene;PA128406956;Chemical
ASTHENIA;UMPS;Gene;PA443448;Disease
DRUG TOXICITY;UMPS;Gene;PA443937;Disease
NAUSEA;UMPS;Gene;PA445048;Disease
METASTATIC NEOPLASM;UMPS;Gene;PA445058;Disease
NEOPLASMS;UMPS;Gene;PA445062;Disease
VOMITING;UMPS;Gene;PA446051;Disease
CAPECITABINE;UMPS;Gene;PA448771;Chemical
TEGAFUR;UMPS;Gene;PA452620;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*32;Haplotype;PA166127651;Chemical
PRIMAQUINE;CYP2D6*32;Haplotype;PA451103;Chemical
DIABETES MELLITUS, TYPE 2;PRPF31;Gene;PA443890;Disease
METFORMIN;PRPF31;Gene;PA450395;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs1143627;Variant;PA164713366;Chemical
USTEKINUMAB;rs1143627;Variant;PA166048654;Chemical
PSORIASIS;rs1143627;Variant;PA445451;Disease
ASPIRIN;rs1143627;Variant;PA448497;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs5569;Variant;PA447197;Disease
METHYLPHENIDATE;rs5569;Variant;PA450464;Chemical
CYP2C19;Angina Pectoris;Disease;PA124;Gene
CYP2D6;Angina Pectoris;Disease;PA128;Gene
P2RY12;Angina Pectoris;Disease;PA134971947;Gene
CYP2C19*17;Angina Pectoris;Disease;PA165816533;Haplotype
CYP2D6*10;Angina Pectoris;Disease;PA165816582;Haplotype
CYP2C19*1;Angina Pectoris;Disease;PA165980634;Haplotype
CYP2C19*2;Angina Pectoris;Disease;PA165980635;Haplotype
CYP2C19*3;Angina Pectoris;Disease;PA165980636;Haplotype
UGT1A1*1;Angina Pectoris;Disease;PA166115841;Haplotype
UGT1A1*28;Angina Pectoris;Disease;PA166115842;Haplotype
RS4148323;Angina Pectoris;Disease;PA166155721;Variant
RS2046934;Angina Pectoris;Disease;PA166156339;Variant
RS662;Angina Pectoris;Disease;PA166157238;Variant
PON1;Angina Pectoris;Disease;PA33529;Gene
ADRB1;Angina Pectoris;Disease;PA38;Gene
UGT1A1;Angina Pectoris;Disease;PA420;Gene
MIGALASTAT;rs727504348;Variant;PA166182881;Chemical
FABRY DISEASE;rs727504348;Variant;PA443367;Disease
BIPOLAR DISORDER;rs6728642;Variant;PA447199;Disease
LITHIUM;rs6728642;Variant;PA450243;Chemical
MACULOPAPULAR EXANTHEMA;HLA-B*40:02;Haplotype;PA162316739;Disease
EPILEPSY;HLA-B*40:02;Haplotype;PA444065;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*40:02;Haplotype;PA445738;Disease
LAMOTRIGINE;HLA-B*40:02;Haplotype;PA450164;Chemical
OXCARBAZEPINE;HLA-B*40:02;Haplotype;PA450732;Chemical
PITAVASTATIN;PCSK9;Gene;PA142650384;Chemical
LOMITAPIDE;PCSK9;Gene;PA166114922;Chemical
FAMILIAL HYPERCHOLESTEROLEMIA;PCSK9;Gene;PA166114942;Disease
INCLISIRAN;PCSK9;Gene;PA166268802;Chemical
RS5272;nimesulide;Chemical;PA166153550;Variant
RS5273;nimesulide;Chemical;PA166153551;Variant
PTGS2;nimesulide;Chemical;PA293;Gene
ROSUVASTATIN;rs20455;Variant;PA134308647;Chemical
CORONARY DISEASE;rs20455;Variant;PA443797;Disease
HYPERCHOLESTEROLEMIA;rs20455;Variant;PA444516;Disease
MYOCARDIAL INFARCTION;rs20455;Variant;PA445019;Disease
ATORVASTATIN;rs20455;Variant;PA448500;Chemical
PRAVASTATIN;rs20455;Variant;PA451089;Chemical
SIMVASTATIN;rs20455;Variant;PA451363;Chemical
ADALIMUMAB;rs9828223;Variant;PA10004;Chemical
CROHN DISEASE;rs9828223;Variant;PA443815;Disease
FLUOROURACIL;rs11615;Variant;PA128406956;Chemical
OXALIPLATIN;rs11615;Variant;PA131285527;Chemical
PLATINUM;rs11615;Variant;PA150595617;Chemical
PLATINUM COMPOUNDS;rs11615;Variant;PA164713176;Chemical
MUCOSITIS;rs11615;Variant;PA166122058;Disease
RADIOTHERAPY;rs11615;Variant;PA166122986;Chemical
FEBRILE NEUTROPENIA;rs11615;Variant;PA166170245;Disease
BREAST NEOPLASMS;rs11615;Variant;PA443560;Disease
NON-SMALL CELL LUNG CARCINOMA;rs11615;Variant;PA443622;Disease
COLONIC NEOPLASMS;rs11615;Variant;PA443756;Disease
DRUG TOXICITY;rs11615;Variant;PA443937;Disease
NEOPLASM OF ESOPHAGUS;rs11615;Variant;PA444101;Disease
NEOPLASMS;rs11615;Variant;PA445062;Disease
OVARIAN NEOPLASMS;rs11615;Variant;PA445204;Disease
PANCREATIC NEOPLASMS;rs11615;Variant;PA445218;Disease
RECTAL NEOPLASMS;rs11615;Variant;PA445503;Disease
OSTEOSARCOMA;rs11615;Variant;PA445601;Disease
STOMACH NEOPLASMS;rs11615;Variant;PA445742;Disease
TESTICULAR NEOPLASMS;rs11615;Variant;PA445828;Disease
COLORECTAL NEOPLASMS;rs11615;Variant;PA446108;Disease
BLEOMYCIN;rs11615;Variant;PA448645;Chemical
CAPECITABINE;rs11615;Variant;PA448771;Chemical
CARBOPLATIN;rs11615;Variant;PA448803;Chemical
CISPLATIN;rs11615;Variant;PA449014;Chemical
CYCLOPHOSPHAMIDE;rs11615;Variant;PA449165;Chemical
DOCETAXEL;rs11615;Variant;PA449383;Chemical
DOXORUBICIN;rs11615;Variant;PA449412;Chemical
ETOPOSIDE;rs11615;Variant;PA449552;Chemical
GEMCITABINE;rs11615;Variant;PA449748;Chemical
LEUCOVORIN;rs11615;Variant;PA450198;Chemical
G6PD;carmustine;Chemical;PA28469;Gene
DPYD;rs150385342;Variant;PA145;Gene
CAPECITABINE;rs150385342;Variant;PA448771;Chemical
ETHANOL;rs7821592;Variant;PA448073;Chemical
TENOFOVIR;rs1751034;Variant;PA10204;Chemical
HIV INFECTIOUS DISEASE;rs1751034;Variant;PA447230;Disease
CD274;avelumab;Chemical;PA134915280;Gene
MYCOPHENOLATE MOFETIL;rs2278293;Variant;PA450566;Chemical
ARNT;FXYD2;Gene;PA24994;Gene
PEMETREXED;GGH;Gene;PA10810;Chemical
BEVACIZUMAB;GGH;Gene;PA130232992;Chemical
RHEUMATOID ARTHRITIS;GGH;Gene;PA443434;Disease
NON-SMALL CELL LUNG CARCINOMA;GGH;Gene;PA443622;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;GGH;Gene;PA446155;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;GGH;Gene;PA447197;Disease
METHOTREXATE;GGH;Gene;PA450428;Chemical
METHYLPHENIDATE;GGH;Gene;PA450464;Chemical
HYPERTENSION;SULT1C3;Gene;PA444552;Disease
CANDESARTAN;SULT1C3;Gene;PA448765;Chemical
ANTIBIOTICS;rs11125;Variant;PA164712406;Chemical
HYPERSENSITIVITY;rs11125;Variant;PA444546;Disease
ASPIRIN-INDUCED ASTHMA;HLA-DQB1*03:02;Haplotype;PA131285571;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-DQB1*03:02;Haplotype;PA166120927;Disease
DRUG HYPERSENSITIVITY;HLA-DQB1*03:02;Haplotype;PA443936;Disease
HIV INFECTIONS;HLA-DQB1*03:02;Haplotype;PA447230;Disease
ASPIRIN;HLA-DQB1*03:02;Haplotype;PA448497;Chemical
NEVIRAPINE;HLA-DQB1*03:02;Haplotype;PA450616;Chemical
DEBRISOQUINE;CYP2D6*36xN;Haplotype;PA452616;Chemical
HYPERTENSION;rs2776546;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs2776546;Variant;PA449899;Chemical
SULFAMETHOXAZOLE / TRIMETHOPRIM;GSTM1;Gene;PA10715;Chemical
FLUOROURACIL;GSTM1;Gene;PA128406956;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;GSTM1;Gene;PA130620651;Chemical
OXALIPLATIN;GSTM1;Gene;PA131285527;Chemical
TAXANES;GSTM1;Gene;PA150481189;Chemical
OTOTOXICITY;GSTM1;Gene;PA162263534;Disease
DRUGS FOR TREATMENT OF TUBERCULOSIS;GSTM1;Gene;PA164712708;Chemical
PLATINUM COMPOUNDS;GSTM1;Gene;PA164713176;Chemical
ETHAMBUTOL;GSTM1;Gene;PA164784021;Chemical
TOXIC LIVER DISEASE;GSTM1;Gene;PA164925725;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;GSTM1;Gene;PA166120929;Disease
RADIOTHERAPY;GSTM1;Gene;PA166122986;Chemical
HEMATOPOIETIC STEM CELL TRANSPLANTATION;GSTM1;Gene;PA166123007;Disease
LAZERTINIB;GSTM1;Gene;PA166314341;Chemical
ACQUIRED IMMUNODEFICIENCY SYNDROME;GSTM1;Gene;PA443250;Disease
ASTHMA;GSTM1;Gene;PA443450;Disease
BREAST NEOPLASMS;GSTM1;Gene;PA443560;Disease
UTERINE CERVICAL NEOPLASMS;GSTM1;Gene;PA443685;Disease
COLITIS, ULCERATIVE;GSTM1;Gene;PA443750;Disease
CROHN DISEASE;GSTM1;Gene;PA443815;Disease
DEAFNESS;GSTM1;Gene;PA443840;Disease
DEATH;GSTM1;Gene;PA443842;Disease
DRUG TOXICITY;GSTM1;Gene;PA443937;Disease
EPIDERMAL NECROLYSIS, TOXIC;GSTM1;Gene;PA444059;Disease
HODGKIN DISEASE;GSTM1;Gene;PA444485;Disease
LEUKEMIA, MYELOID, ACUTE;GSTM1;Gene;PA444760;Disease
CARDIOMYOPATHIES;GSTM1;Gene;PA445018;Disease
NEOPLASMS;GSTM1;Gene;PA445062;Disease
NEUTROPENIA;GSTM1;Gene;PA445113;Disease
OVARIAN NEOPLASMS;GSTM1;Gene;PA445204;Disease
RECURRENCE;GSTM1;Gene;PA445506;Disease
STEVENS-JOHNSON SYNDROME;GSTM1;Gene;PA445738;Disease
TESTICULAR NEOPLASMS;GSTM1;Gene;PA445828;Disease
TUBERCULOSIS;GSTM1;Gene;PA445941;Disease
COLORECTAL NEOPLASMS;GSTM1;Gene;PA446108;Disease
INFLAMMATORY BOWEL DISEASES;GSTM1;Gene;PA446116;Disease
HIV INFECTIONS;GSTM1;Gene;PA447230;Disease
AZATHIOPRINE;GSTM1;Gene;PA448515;Chemical
BLEOMYCIN;GSTM1;Gene;PA448645;Chemical
BUSULFAN;GSTM1;Gene;PA448691;Chemical
CAPECITABINE;GSTM1;Gene;PA448771;Chemical
CISPLATIN;GSTM1;Gene;PA449014;Chemical
CLOZAPINE;GSTM1;Gene;PA449061;Chemical
CYCLOPHOSPHAMIDE;GSTM1;Gene;PA449165;Chemical
DACARBAZINE;GSTM1;Gene;PA449197;Chemical
DOXORUBICIN;GSTM1;Gene;PA449412;Chemical
ISONIAZID;GSTM1;Gene;PA450112;Chemical
NEVIRAPINE;GSTM1;Gene;PA450616;Chemical
PACLITAXEL;GSTM1;Gene;PA450761;Chemical
PYRAZINAMIDE;GSTM1;Gene;PA451182;Chemical
RIFAMPIN;GSTM1;Gene;PA451250;Chemical
STREPTOMYCIN;GSTM1;Gene;PA451512;Chemical
VINBLASTINE;GSTM1;Gene;PA451877;Chemical
VOMITING;CYP2D6*35xN;Haplotype;PA446051;Disease
DOXEPIN;CYP2D6*35xN;Haplotype;PA449409;Chemical
ONDANSETRON;CYP2D6*35xN;Haplotype;PA450705;Chemical
SPARTEINE;CYP2D6*35xN;Haplotype;PA452610;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;HLA-C*04:01;Haplotype;PA164712708;Chemical
PEGINTERFERON ALFA-2B;HLA-C*04:01;Haplotype;PA164784024;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-C*04:01;Haplotype;PA166120927;Disease
DRUG HYPERSENSITIVITY;HLA-C*04:01;Haplotype;PA443936;Disease
DRUG TOXICITY;HLA-C*04:01;Haplotype;PA443937;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-C*04:01;Haplotype;PA444059;Disease
EXANTHEMA;HLA-C*04:01;Haplotype;PA444109;Disease
HEPATITIS C;HLA-C*04:01;Haplotype;PA444445;Disease
HYPERSENSITIVITY;HLA-C*04:01;Haplotype;PA444546;Disease
STEVENS-JOHNSON SYNDROME;HLA-C*04:01;Haplotype;PA445738;Disease
TUBERCULOSIS;HLA-C*04:01;Haplotype;PA445941;Disease
HIV INFECTIONS;HLA-C*04:01;Haplotype;PA447230;Disease
NEVIRAPINE;HLA-C*04:01;Haplotype;PA450616;Chemical
RIBAVIRIN;HLA-C*04:01;Haplotype;PA451241;Chemical
NICOTINE;rs148693084;Variant;PA450626;Chemical
ALCOHOL ABUSE;rs61767420;Variant;PA443309;Disease
ETHANOL;rs61767420;Variant;PA448073;Chemical
CYP2D6;2-hydroxymethyl olanzapine;Chemical;PA128;Gene
PRASUGREL;rs2768759;Variant;PA154410481;Chemical
ASPIRIN;rs2768759;Variant;PA448497;Chemical
PITOLISANT;HRH3;Gene;PA166185163;Chemical
SCHIZOPHRENIA;HRH3;Gene;PA447216;Disease
RISPERIDONE;HRH3;Gene;PA451257;Chemical
FLUOROURACIL;rs17109924;Variant;PA128406956;Chemical
COLONIC NEOPLASMS;rs17109924;Variant;PA443756;Disease
TAXANES;rs1801249;Variant;PA150481189;Chemical
OVARIAN NEOPLASMS;rs1801249;Variant;PA445204;Disease
CARBOPLATIN;rs1801249;Variant;PA448803;Chemical
URINARY BLADDER NEOPLASMS;CWC27;Gene;PA443512;Disease
MULTIPLE SCLEROSIS;FHIT;Gene;PA444987;Disease
MAJOR DEPRESSIVE DISORDER;FHIT;Gene;PA447321;Disease
INTERFERON BETA-1A;FHIT;Gene;PA450037;Chemical
INTERFERON BETA-1B;FHIT;Gene;PA450039;Chemical
ANTIDEPRESSANTS;FHIT;Gene;PA452229;Chemical
CYP2C19;3-cyano-7-ethoxycoumarin;Chemical;PA124;Gene
CYP2C19*8;3-cyano-7-ethoxycoumarin;Chemical;PA165816524;Haplotype
CYP2C19*9;3-cyano-7-ethoxycoumarin;Chemical;PA165816525;Haplotype
CYP2C19*10;3-cyano-7-ethoxycoumarin;Chemical;PA165816526;Haplotype
CYP2C19*16;3-cyano-7-ethoxycoumarin;Chemical;PA165816532;Haplotype
CYP2C19*19;3-cyano-7-ethoxycoumarin;Chemical;PA165816535;Haplotype
CYP2C19*1;3-cyano-7-ethoxycoumarin;Chemical;PA165980634;Haplotype
CFTR;Exocrine Pancreatic Insufficiency;Disease;PA109;Gene
RS113993960;Exocrine Pancreatic Insufficiency;Disease;PA166157525;Variant
BIPOLAR DISORDER;rs79403677;Variant;PA447199;Disease
LITHIUM;rs79403677;Variant;PA450243;Chemical
SCHIZOPHRENIA;rs2494732;Variant;PA447216;Disease
RISPERIDONE;rs2494732;Variant;PA451257;Chemical
MTHFR;Hyperhomocysteinemia;Disease;PA245;Gene
DISCONTINUATION;CYP2B6*9;Haplotype;PA166123507;Disease
S-EDDP;CYP2B6*9;Haplotype;PA166177606;Chemical
(S)-METHADONE;CYP2B6*9;Haplotype;PA166178554;Chemical
R-EDDP;CYP2B6*9;Haplotype;PA166247521;Chemical
SCOLIOSIS;CYP2B6*9;Haplotype;PA445619;Disease
HIV INFECTIONS;CYP2B6*9;Haplotype;PA447230;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2B6*9;Haplotype;PA447321;Disease
BUSULFAN;CYP2B6*9;Haplotype;PA448691;Chemical
EFAVIRENZ;CYP2B6*9;Haplotype;PA449441;Chemical
SERTRALINE;CYP2B6*9;Haplotype;PA451333;Chemical
ARIPIPRAZOLE;CYP2D6*1;Haplotype;PA10026;Chemical
DULOXETINE;CYP2D6*1;Haplotype;PA10066;Chemical
ESCITALOPRAM;CYP2D6*1;Haplotype;PA10074;Chemical
WEIGHT GAIN;CYP2D6*1;Haplotype;PA128406954;Disease
ANTHRACYCLINES AND RELATED SUBSTANCES;CYP2D6*1;Haplotype;PA130620651;Chemical
GEFITINIB;CYP2D6*1;Haplotype;PA131301952;Chemical
3,4-METHYLENEDIOXYMETHAMPHETAMINE;CYP2D6*1;Haplotype;PA131887008;Chemical
ROSUVASTATIN;CYP2D6*1;Haplotype;PA134308647;Chemical
MIANSERIN;CYP2D6*1;Haplotype;PA134687937;Chemical
LEVOMEPROMAZINE;CYP2D6*1;Haplotype;PA134687942;Chemical
ATOMOXETINE;CYP2D6*1;Haplotype;PA134688071;Chemical
OPIPRAMOL;CYP2D6*1;Haplotype;PA144614922;Chemical
TROPISETRON;CYP2D6*1;Haplotype;PA161925594;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;CYP2D6*1;Haplotype;PA164713257;Chemical
TOLTERODINE;CYP2D6*1;Haplotype;PA164746757;Chemical
TOXIC LIVER DISEASE;CYP2D6*1;Haplotype;PA164925725;Disease
BINGE EATING DISORDER;CYP2D6*1;Haplotype;PA165108929;Disease
BERBERINE;CYP2D6*1;Haplotype;PA165860812;Chemical
HYDROXYAMITRIPTYLINE;CYP2D6*1;Haplotype;PA165946747;Chemical
BUFURALOL;CYP2D6*1;Haplotype;PA166110256;Chemical
VORTIOXETINE;CYP2D6*1;Haplotype;PA166122595;Chemical
PROGRESSION-FREE SURVIVAL;CYP2D6*1;Haplotype;PA166123026;Disease
OVERALL SURVIVAL;CYP2D6*1;Haplotype;PA166123207;Disease
AGITATION;CYP2D6*1;Haplotype;PA166123306;Disease
EVENT-FREE SURVIVAL;CYP2D6*1;Haplotype;PA166123366;Disease
SCHIZOAFFECTIVE DISORDER;CYP2D6*1;Haplotype;PA166123368;Disease
DISCONTINUATION;CYP2D6*1;Haplotype;PA166123507;Disease
ENDOXIFEN;CYP2D6*1;Haplotype;PA166124478;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*1;Haplotype;PA166127651;Chemical
4-HYDROXYTAMOXIFEN;CYP2D6*1;Haplotype;PA166127652;Chemical
RECURRENCE FREE SURVIVAL;CYP2D6*1;Haplotype;PA166127658;Disease
CARDIOTOXICITY;CYP2D6*1;Haplotype;PA166128121;Disease
SEDATION;CYP2D6*1;Haplotype;PA166129521;Disease
O-DESMETHYLTRAMADOL;CYP2D6*1;Haplotype;PA166131379;Chemical
N-DESMETHYLTRAMADOL;CYP2D6*1;Haplotype;PA166131493;Chemical
N,O-DIDESMETHYLTRAMADOL;CYP2D6*1;Haplotype;PA166131494;Chemical
ADVERSE EVENTS;CYP2D6*1;Haplotype;PA166151827;Disease
DAPOXETINE;CYP2D6*1;Haplotype;PA166151992;Chemical
TOLPERISONE;CYP2D6*1;Haplotype;PA166152940;Chemical
COPTISINE;CYP2D6*1;Haplotype;PA166153416;Chemical
BREXPIPRAZOLE;CYP2D6*1;Haplotype;PA166160053;Chemical
EXTRAPYRAMIDAL SYMPTOMS;CYP2D6*1;Haplotype;PA166170367;Disease
CNS DEPRESSION;CYP2D6*1;Haplotype;PA166170668;Disease
DIHYDROCODEINE;CYP2D6*1;Haplotype;PA166176885;Chemical
MEPHEDRONE;CYP2D6*1;Haplotype;PA166184711;Chemical
DYSPHORIA;CYP2D6*1;Haplotype;PA166185295;Disease
ETHYLMORPHINE;CYP2D6*1;Haplotype;PA166210801;Chemical
ADENOCARCINOMA;CYP2D6*1;Haplotype;PA443265;Disease
ALZHEIMER DISEASE;CYP2D6*1;Haplotype;PA443319;Disease
ANEMIA, SICKLE CELL;CYP2D6*1;Haplotype;PA443355;Disease
ARRHYTHMIAS, CARDIAC;CYP2D6*1;Haplotype;PA443421;Disease
BACK PAIN;CYP2D6*1;Haplotype;PA443472;Disease
BREAST NEOPLASMS;CYP2D6*1;Haplotype;PA443560;Disease
BURNS;CYP2D6*1;Haplotype;PA443582;Disease
CARCINOMA, NON-SMALL-CELL LUNG;CYP2D6*1;Haplotype;PA443622;Disease
CONSTIPATION;CYP2D6*1;Haplotype;PA443782;Disease
DEATH;CYP2D6*1;Haplotype;PA443842;Disease
DEMENTIA;CYP2D6*1;Haplotype;PA443853;Disease
DIABETIC NEUROPATHIES;CYP2D6*1;Haplotype;PA443894;Disease
DRUG TOXICITY;CYP2D6*1;Haplotype;PA443937;Disease
DYSTONIA;CYP2D6*1;Haplotype;PA443970;Disease
EDEMA;CYP2D6*1;Haplotype;PA443994;Disease
EPILEPSY;CYP2D6*1;Haplotype;PA444065;Disease
EXANTHEMA;CYP2D6*1;Haplotype;PA444109;Disease
GALACTORRHEA;CYP2D6*1;Haplotype;PA444239;Disease
GASTROINTESTINAL NEOPLASMS;CYP2D6*1;Haplotype;PA444257;Disease
HEAD AND NECK NEOPLASMS;CYP2D6*1;Haplotype;PA444352;Disease
HEART DISEASES;CYP2D6*1;Haplotype;PA444368;Disease
HEART FAILURE;CYP2D6*1;Haplotype;PA444370;Disease
HEROIN DEPENDENCE;CYP2D6*1;Haplotype;PA444460;Disease
HYPERTENSION;CYP2D6*1;Haplotype;PA444552;Disease
INAPPROPRIATE ADH SYNDROME;CYP2D6*1;Haplotype;PA444607;Disease
MALARIA;CYP2D6*1;Haplotype;PA444859;Disease
OPIOID-RELATED DISORDERS;CYP2D6*1;Haplotype;PA445043;Disease
NAUSEA;CYP2D6*1;Haplotype;PA445048;Disease
NEOPLASMS;CYP2D6*1;Haplotype;PA445062;Disease
PAIN;CYP2D6*1;Haplotype;PA445208;Disease
PAIN, POSTOPERATIVE;CYP2D6*1;Haplotype;PA445210;Disease
FAMILIAL MEDITERRANEAN FEVER;CYP2D6*1;Haplotype;PA445293;Disease
PSYCHOMOTOR AGITATION;CYP2D6*1;Haplotype;PA445452;Disease
RECURRENCE;CYP2D6*1;Haplotype;PA445506;Disease
RESPIRATORY INSUFFICIENCY;CYP2D6*1;Haplotype;PA445522;Disease
TACHYCARDIA;CYP2D6*1;Haplotype;PA445802;Disease
VOMITING;CYP2D6*1;Haplotype;PA446051;Disease
HOT FLASHES;CYP2D6*1;Haplotype;PA446852;Disease
ALCOHOL-RELATED DISORDERS;CYP2D6*1;Haplotype;PA446879;Disease
POSTOPERATIVE NAUSEA AND VOMITING;CYP2D6*1;Haplotype;PA446970;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CYP2D6*1;Haplotype;PA447197;Disease
AUTISTIC DISORDER;CYP2D6*1;Haplotype;PA447198;Disease
DEPRESSIVE DISORDER;CYP2D6*1;Haplotype;PA447207;Disease
MENTAL DISORDERS;CYP2D6*1;Haplotype;PA447208;Disease
OBSESSIVE-COMPULSIVE DISORDER;CYP2D6*1;Haplotype;PA447211;Disease
PSYCHOTIC DISORDERS;CYP2D6*1;Haplotype;PA447215;Disease
SCHIZOPHRENIA;CYP2D6*1;Haplotype;PA447216;Disease
TARDIVE DYSKINESIA;CYP2D6*1;Haplotype;PA447268;Disease
DEPRESSION;CYP2D6*1;Haplotype;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2D6*1;Haplotype;PA447321;Disease
ACETAMINOPHEN;CYP2D6*1;Haplotype;PA448015;Chemical
AMITRIPTYLINE;CYP2D6*1;Haplotype;PA448385;Chemical
ATORVASTATIN;CYP2D6*1;Haplotype;PA448500;Chemical
CARVEDILOL;CYP2D6*1;Haplotype;PA448817;Chemical
CITALOPRAM;CYP2D6*1;Haplotype;PA449015;Chemical
CLOMIPRAMINE;CYP2D6*1;Haplotype;PA449048;Chemical
CODEINE;CYP2D6*1;Haplotype;PA449088;Chemical
COLCHICINE;CYP2D6*1;Haplotype;PA449092;Chemical
DESIPRAMINE;CYP2D6*1;Haplotype;PA449233;Chemical
DEXTROMETHORPHAN;CYP2D6*1;Haplotype;PA449273;Chemical
DOLASETRON;CYP2D6*1;Haplotype;PA449390;Chemical
DONEPEZIL;CYP2D6*1;Haplotype;PA449394;Chemical
DOXEPIN;CYP2D6*1;Haplotype;PA449409;Chemical
FENTANYL;CYP2D6*1;Haplotype;PA449599;Chemical
FLECAINIDE;CYP2D6*1;Haplotype;PA449646;Chemical
FLUOXETINE;CYP2D6*1;Haplotype;PA449673;Chemical
FLUVASTATIN;CYP2D6*1;Haplotype;PA449688;Chemical
FLUVOXAMINE;CYP2D6*1;Haplotype;PA449690;Chemical
GALANTAMINE;CYP2D6*1;Haplotype;PA449726;Chemical
GRANISETRON;CYP2D6*1;Haplotype;PA449809;Chemical
HALOPERIDOL;CYP2D6*1;Haplotype;PA449841;Chemical
HYDROCODONE;CYP2D6*1;Haplotype;PA449900;Chemical
HYDROMORPHONE;CYP2D6*1;Haplotype;PA449918;Chemical
IMIPRAMINE;CYP2D6*1;Haplotype;PA449969;Chemical
KETOPROFEN;CYP2D6*1;Haplotype;PA450149;Chemical
LOVASTATIN;CYP2D6*1;Haplotype;PA450272;Chemical
MAPROTILINE;CYP2D6*1;Haplotype;PA450322;Chemical
METHADONE;CYP2D6*1;Haplotype;PA450401;Chemical
METOPROLOL;CYP2D6*1;Haplotype;PA450480;Chemical
MIRTAZAPINE;CYP2D6*1;Haplotype;PA450522;Chemical
NORTRIPTYLINE;CYP2D6*1;Haplotype;PA450657;Chemical
OLANZAPINE;CYP2D6*1;Haplotype;PA450688;Chemical
ONDANSETRON;CYP2D6*1;Haplotype;PA450705;Chemical
OXYCODONE;CYP2D6*1;Haplotype;PA450741;Chemical
PAROXETINE;CYP2D6*1;Haplotype;PA450801;Chemical
PHENYTOIN;CYP2D6*1;Haplotype;PA450947;Chemical
PRIMAQUINE;CYP2D6*1;Haplotype;PA451103;Chemical
PROPAFENONE;CYP2D6*1;Haplotype;PA451131;Chemical
PROPRANOLOL;CYP2D6*1;Haplotype;PA451145;Chemical
QUETIAPINE;CYP2D6*1;Haplotype;PA451201;Chemical
RISPERIDONE;CYP2D6*1;Haplotype;PA451257;Chemical
SERTRALINE;CYP2D6*1;Haplotype;PA451333;Chemical
SIMVASTATIN;CYP2D6*1;Haplotype;PA451363;Chemical
TAMOXIFEN;CYP2D6*1;Haplotype;PA451581;Chemical
TIMOLOL;CYP2D6*1;Haplotype;PA451690;Chemical
TRAMADOL;CYP2D6*1;Haplotype;PA451735;Chemical
TRIMIPRAMINE;CYP2D6*1;Haplotype;PA451791;Chemical
VENLAFAXINE;CYP2D6*1;Haplotype;PA451866;Chemical
ANTIPSYCHOTICS;CYP2D6*1;Haplotype;PA452233;Chemical
SPARTEINE;CYP2D6*1;Haplotype;PA452610;Chemical
DEBRISOQUINE;CYP2D6*1;Haplotype;PA452616;Chemical
ANTINEOPLASTIC AGENTS;CYP2D6*1;Haplotype;PA452621;Chemical
ZUCLOPENTHIXOL;CYP2D6*1;Haplotype;PA452629;Chemical
NFKB1;CAMK2B;Gene;PA248;Gene
ELK1;CAMK2B;Gene;PA27749;Gene
FOS;CAMK2B;Gene;PA28212;Gene
RELA;CAMK2B;Gene;PA296;Gene
JUN;CAMK2B;Gene;PA30006;Gene
MYC;CAMK2B;Gene;PA31353;Gene
NFKB2;CAMK2B;Gene;PA31600;Gene
STAT3;CAMK2B;Gene;PA337;Gene
STAT5A;CAMK2B;Gene;PA338;Gene
SP1;CAMK2B;Gene;PA36042;Gene
STAT1;CAMK2B;Gene;PA36183;Gene
STAT2;CAMK2B;Gene;PA36184;Gene
STAT4;CAMK2B;Gene;PA36185;Gene
STAT5B;CAMK2B;Gene;PA36186;Gene
CYP3A4;alprazolam;Chemical;PA130;Gene
CYP3A5;alprazolam;Chemical;PA131;Gene
CYP3A4*1;alprazolam;Chemical;PA165819201;Haplotype
CYP3A4*22;alprazolam;Chemical;PA166048680;Haplotype
RS35599367;alprazolam;Chemical;PA166157487;Variant
NON-SMALL CELL LUNG CARCINOMA;rs6119;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs6119;Variant;PA445846;Disease
CARBOPLATIN;rs6119;Variant;PA448803;Chemical
GEMCITABINE;rs6119;Variant;PA449748;Chemical
MECASERMIN;IGF1;Gene;PA164774876;Chemical
RS1801253;isoproterenol;Chemical;PA166153977;Variant
RS1042713;isoproterenol;Chemical;PA166156748;Variant
ADRA1D;isoproterenol;Chemical;PA24597;Gene
ADRA1B;isoproterenol;Chemical;PA33;Gene
ADRA1A;isoproterenol;Chemical;PA34;Gene
ADRA2A;isoproterenol;Chemical;PA35;Gene
ADRA2B;isoproterenol;Chemical;PA36;Gene
ADRA2C;isoproterenol;Chemical;PA37;Gene
ADRB1;isoproterenol;Chemical;PA38;Gene
ADRB2;isoproterenol;Chemical;PA39;Gene
WARFARIN;rs3814637;Variant;PA451906;Chemical
NIMESULIDE;rs5273;Variant;PA137179528;Chemical
BREAST NEOPLASMS;rs6981827;Variant;PA443560;Disease
ANASTROZOLE;rs6981827;Variant;PA448432;Chemical
WARFARIN;rs72547529;Variant;PA451906;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*51:02;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*51:02;Haplotype;PA444059;Disease
EPILEPSY;HLA-B*51:02;Haplotype;PA444065;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*51:02;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-B*51:02;Haplotype;PA450616;Chemical
PHENYTOIN;HLA-B*51:02;Haplotype;PA450947;Chemical
NEOPLASMS;rs1060896;Variant;PA445062;Disease
GEMCITABINE;rs1060896;Variant;PA449748;Chemical
CFTR;rs121908751;Variant;PA109;Gene
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs121908751;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs121908751;Variant;PA443829;Disease
SIMVASTATIN;rs1346268;Variant;PA451363;Chemical
HIV INFECTIOUS DISEASE;rs2073724;Variant;PA447230;Disease
NEVIRAPINE;rs2073724;Variant;PA450616;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;rs10036156;Variant;PA164713257;Chemical
MAJOR DEPRESSIVE DISORDER;rs10036156;Variant;PA447321;Disease
VENLAFAXINE;rs10036156;Variant;PA451866;Chemical
ANTIDEPRESSANTS;rs10036156;Variant;PA452229;Chemical
DESMETHYLNAPROXEN;rs767487725;Variant;PA166163690;Chemical
TAPENTADOL;rs767487725;Variant;PA166179720;Chemical
ACETAMINOPHEN;rs767487725;Variant;PA448015;Chemical
OPIOID-RELATED DISORDERS;rs6090041;Variant;PA445043;Disease
OPIOIDS;rs6090041;Variant;PA452618;Chemical
COUMARIN;CYP2A6*19;Haplotype;PA134521193;Chemical
NEOPLASMS;CYP2A6*19;Haplotype;PA445062;Disease
TOBACCO USE DISORDER;CYP2A6*19;Haplotype;PA445876;Disease
NICOTINE;CYP2A6*19;Haplotype;PA450626;Chemical
TEGAFUR;CYP2A6*19;Haplotype;PA452620;Chemical
HMG COA REDUCTASE INHIBITORS;RYR1;Gene;PA133950441;Chemical
DESFLURANE;RYR1;Gene;PA164749136;Chemical
CHLOROCRESOL;RYR1;Gene;PA166122627;Chemical
MULTI-CORE CONGENITAL MYOPATHY;RYR1;Gene;PA166128826;Disease
EXERTIONAL RHABDOMYOLYSIS;RYR1;Gene;PA166128827;Disease
VOLATILE ANESTHETICS;RYR1;Gene;PA166131630;Chemical
RS1800559;RYR1;Gene;PA166153638;Variant
RS772226819;RYR1;Gene;PA166153940;Variant
RS1801086;RYR1;Gene;PA166155375;Variant
RS28933396;RYR1;Gene;PA166155481;Variant
RS28933397;RYR1;Gene;PA166155482;Variant
RS63749869;RYR1;Gene;PA166155516;Variant
RS111888148;RYR1;Gene;PA166155524;Variant
RS112563513;RYR1;Gene;PA166155526;Variant
RS118192116;RYR1;Gene;PA166155528;Variant
RS118192122;RYR1;Gene;PA166155529;Variant
RS118192124;RYR1;Gene;PA166155531;Variant
RS118192161;RYR1;Gene;PA166155532;Variant
RS118192162;RYR1;Gene;PA166155533;Variant
RS118192163;RYR1;Gene;PA166155534;Variant
RS118192167;RYR1;Gene;PA166155535;Variant
RS118192170;RYR1;Gene;PA166155536;Variant
RS118192172;RYR1;Gene;PA166155537;Variant
RS118192175;RYR1;Gene;PA166155538;Variant
RS118192176;RYR1;Gene;PA166155539;Variant
RS118192177;RYR1;Gene;PA166155540;Variant
RS118192178;RYR1;Gene;PA166155541;Variant
RS121918592;RYR1;Gene;PA166155543;Variant
RS121918593;RYR1;Gene;PA166155544;Variant
RS121918594;RYR1;Gene;PA166155545;Variant
RS121918595;RYR1;Gene;PA166155546;Variant
RS193922747;RYR1;Gene;PA166155564;Variant
RS193922753;RYR1;Gene;PA166155565;Variant
RS193922770;RYR1;Gene;PA166155567;Variant
RS193922772;RYR1;Gene;PA166155568;Variant
RS193922802;RYR1;Gene;PA166155569;Variant
RS193922803;RYR1;Gene;PA166155570;Variant
RS193922807;RYR1;Gene;PA166155571;Variant
RS193922809;RYR1;Gene;PA166155572;Variant
RS193922816;RYR1;Gene;PA166155573;Variant
RS193922818;RYR1;Gene;PA166155574;Variant
RS193922876;RYR1;Gene;PA166155575;Variant
RS193922878;RYR1;Gene;PA166155576;Variant
RS193922843;RYR1;Gene;PA166163663;Variant
RS193922832;RYR1;Gene;PA166163667;Variant
RS118192168;RYR1;Gene;PA166163669;Variant
RS193922764;RYR1;Gene;PA166176176;Variant
RS121918596;RYR1;Gene;PA166177994;Variant
RS193922748;RYR1;Gene;PA166180322;Variant
RS193922762;RYR1;Gene;PA166180323;Variant
RS193922768;RYR1;Gene;PA166180324;Variant
RS144336148;RYR1;Gene;PA166180325;Variant
SURGERY;RYR1;Gene;PA166314441;Disease
MALIGNANT HYPERTHERMIA;RYR1;Gene;PA444863;Disease
MUSCULAR DISEASES;RYR1;Gene;PA444997;Disease
RHABDOMYOLYSIS;RYR1;Gene;PA445549;Disease
MYOPATHY, CENTRAL CORE;RYR1;Gene;PA447048;Disease
MYOPATHIES, STRUCTURAL, CONGENITAL;RYR1;Gene;PA447109;Disease
CAFFEINE;RYR1;Gene;PA448710;Chemical
DANTROLENE;RYR1;Gene;PA449208;Chemical
ENFLURANE;RYR1;Gene;PA449461;Chemical
HALOPERIDOL;RYR1;Gene;PA449841;Chemical
HALOTHANE;RYR1;Gene;PA449845;Chemical
ISOFLURANE;RYR1;Gene;PA450106;Chemical
METHOXYFLURANE;RYR1;Gene;PA450434;Chemical
SEVOFLURANE;RYR1;Gene;PA451341;Chemical
SUCCINYLCHOLINE;RYR1;Gene;PA451522;Chemical
ASTHMA;UGT1A3*2;Haplotype;PA443450;Disease
ATORVASTATIN;UGT1A3*2;Haplotype;PA448500;Chemical
MONTELUKAST;UGT1A3*2;Haplotype;PA450546;Chemical
TELMISARTAN;UGT1A3*2;Haplotype;PA451605;Chemical
ACE;digoxin;Chemical;PA139;Gene
NOS1AP;digoxin;Chemical;PA142671259;Gene
RS10494366;digoxin;Chemical;PA166153802;Variant
RS1801253;digoxin;Chemical;PA166153977;Variant
RS1799752;digoxin;Chemical;PA166155187;Variant
RS1042713;digoxin;Chemical;PA166156748;Variant
RS1045642;digoxin;Chemical;PA166157284;Variant
RS1128503;digoxin;Chemical;PA166157288;Variant
RS1799983;digoxin;Chemical;PA166157303;Variant
RS2032582;digoxin;Chemical;PA166157316;Variant
NOS3;digoxin;Chemical;PA254;Gene
ABCB1;digoxin;Chemical;PA267;Gene
ADRB1;digoxin;Chemical;PA38;Gene
ADRB2;digoxin;Chemical;PA39;Gene
SCN5A;Heart Block;Disease;PA304;Gene
SLCO1B1;levothyroxine;Chemical;PA134865839;Gene
RS4149056;levothyroxine;Chemical;PA166154579;Variant
NKX2-5;levothyroxine;Chemical;PA24202;Gene
IRS4;levothyroxine;Chemical;PA29923;Gene
PAX8;levothyroxine;Chemical;PA32962;Gene
TBL1X;levothyroxine;Chemical;PA36349;Gene
TSHB;levothyroxine;Chemical;PA37041;Gene
CYP2C19;progesterone;Chemical;PA124;Gene
CYP3A5;progesterone;Chemical;PA131;Gene
CYP2C19*17;progesterone;Chemical;PA165816533;Haplotype
CYP2C19*1;progesterone;Chemical;PA165980634;Haplotype
CYP2C19*2;progesterone;Chemical;PA165980635;Haplotype
ABCB1;progesterone;Chemical;PA267;Gene
NR1I2;progesterone;Chemical;PA378;Gene
DULOXETINE;rs4639250;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs4639250;Variant;PA447321;Disease
CISPLATIN;rs7186128;Variant;PA449014;Chemical
IRINOTECAN;rs7186128;Variant;PA450085;Chemical
ESCITALOPRAM;TSPAN5;Gene;PA10074;Chemical
DEPRESSIVE DISORDER;TSPAN5;Gene;PA447207;Disease
CITALOPRAM;TSPAN5;Gene;PA449015;Chemical
ABCC2;Lymphoma, Non-Hodgkin;Disease;PA116;Gene
CYP2B6;Lymphoma, Non-Hodgkin;Disease;PA123;Gene
CYP2C19;Lymphoma, Non-Hodgkin;Disease;PA124;Gene
CYP3A5;Lymphoma, Non-Hodgkin;Disease;PA131;Gene
CYP2B6*1;Lymphoma, Non-Hodgkin;Disease;PA165818750;Haplotype
CYP2B6*6;Lymphoma, Non-Hodgkin;Disease;PA165818762;Haplotype
CYP2B6*29;Lymphoma, Non-Hodgkin;Disease;PA165818813;Haplotype
CYP2C19*1;Lymphoma, Non-Hodgkin;Disease;PA165980634;Haplotype
CYP2C19*2;Lymphoma, Non-Hodgkin;Disease;PA165980635;Haplotype
CYP2B6*30;Lymphoma, Non-Hodgkin;Disease;PA166117272;Haplotype
CYP3A5*1;Lymphoma, Non-Hodgkin;Disease;PA166128213;Haplotype
CYP3A5*3;Lymphoma, Non-Hodgkin;Disease;PA166128219;Haplotype
RS1801131;Lymphoma, Non-Hodgkin;Disease;PA166153643;Variant
RS8187710;Lymphoma, Non-Hodgkin;Disease;PA166154094;Variant
RS17222723;Lymphoma, Non-Hodgkin;Disease;PA166154163;Variant
RS2236225;Lymphoma, Non-Hodgkin;Disease;PA166154789;Variant
RS45511401;Lymphoma, Non-Hodgkin;Disease;PA166155130;Variant
RS45445694;Lymphoma, Non-Hodgkin;Disease;PA166155331;Variant
RS2229109;Lymphoma, Non-Hodgkin;Disease;PA166157334;Variant
ABCC1;Lymphoma, Non-Hodgkin;Disease;PA244;Gene
MTHFR;Lymphoma, Non-Hodgkin;Disease;PA245;Gene
ABCB1;Lymphoma, Non-Hodgkin;Disease;PA267;Gene
MTHFD1;Lymphoma, Non-Hodgkin;Disease;PA31236;Gene
TYMS;Lymphoma, Non-Hodgkin;Disease;PA359;Gene
LYMPHOMA, T-CELL, CUTANEOUS;Lymphoma, Non-Hodgkin;Disease;PA446320;Disease
RUBELLA VACCINES;HLA-C*15:02;Haplotype;PA164713242;Chemical
PEGINTERFERON ALFA-2B;HLA-C*15:02;Haplotype;PA164784024;Chemical
EPIDERMAL NECROLYSIS, TOXIC;HLA-C*15:02;Haplotype;PA444059;Disease
HEPATITIS C;HLA-C*15:02;Haplotype;PA444445;Disease
STEVENS-JOHNSON SYNDROME;HLA-C*15:02;Haplotype;PA445738;Disease
PHENYTOIN;HLA-C*15:02;Haplotype;PA450947;Chemical
RIBAVIRIN;HLA-C*15:02;Haplotype;PA451241;Chemical
TOLLIP;Pulmonary Fibrosis;Disease;PA134876213;Gene
RS3750920;Pulmonary Fibrosis;Disease;PA166154399;Variant
OVARIAN NEOPLASMS;rs2849380;Variant;PA445204;Disease
CARBOPLATIN;rs2849380;Variant;PA448803;Chemical
DOCETAXEL;rs2849380;Variant;PA449383;Chemical
PACLITAXEL;rs2849380;Variant;PA450761;Chemical
HYPERTENSION;PLEKHJ1;Gene;PA444552;Disease
CANDESARTAN;PLEKHJ1;Gene;PA448765;Chemical
G6PD;Quinolone Antibacterials;Chemical;PA28469;Gene
PAIN, POSTOPERATIVE;rs3804100;Variant;PA445210;Disease
MORPHINE;rs3804100;Variant;PA450550;Chemical
OXALIPLATIN;KLC3;Gene;PA131285527;Chemical
PLATINUM;KLC3;Gene;PA150595617;Chemical
PLATINUM COMPOUNDS;KLC3;Gene;PA164713176;Chemical
NEOPLASM OF ESOPHAGUS;KLC3;Gene;PA444101;Disease
MESOTHELIOMA;KLC3;Gene;PA444937;Disease
OVARIAN NEOPLASMS;KLC3;Gene;PA445204;Disease
PANCREATIC NEOPLASMS;KLC3;Gene;PA445218;Disease
OSTEOSARCOMA;KLC3;Gene;PA445601;Disease
COLORECTAL NEOPLASMS;KLC3;Gene;PA446108;Disease
CISPLATIN;KLC3;Gene;PA449014;Chemical
GEMCITABINE;KLC3;Gene;PA449748;Chemical
S-EDDP;CYP2B6*17;Haplotype;PA166177606;Chemical
R-EDDP;CYP2B6*17;Haplotype;PA166247521;Chemical
TENOFOVIR;rs17222723;Variant;PA10204;Chemical
CARDIAC RHYTHM DISEASE;rs17222723;Variant;PA443421;Disease
DRUG TOXICITY;rs17222723;Variant;PA443937;Disease
LEUKOPENIA;rs17222723;Variant;PA444773;Disease
NON-HODGKIN LYMPHOMA;rs17222723;Variant;PA444845;Disease
OSTEOSARCOMA;rs17222723;Variant;PA445601;Disease
HIV INFECTIOUS DISEASE;rs17222723;Variant;PA447230;Disease
DOXORUBICIN;rs17222723;Variant;PA449412;Chemical
METHOTREXATE;rs17222723;Variant;PA450428;Chemical
OPIOID-RELATED DISORDERS;CYP3A;Gene;PA445043;Disease
METHADONE;CYP3A;Gene;PA450401;Chemical
OPIOIDS;CYP3A;Gene;PA452618;Chemical
MAJOR DEPRESSIVE DISORDER;rs3810651;Variant;PA447321;Disease
VENLAFAXINE;rs3810651;Variant;PA451866;Chemical
RS1800566;benzene;Chemical;PA166155017;Variant
NQO1;benzene;Chemical;PA31744;Gene
CORTICOSTEROIDS;rs4713916;Variant;PA10832;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;rs4713916;Variant;PA164713257;Chemical
CROHN DISEASE;rs4713916;Variant;PA443815;Disease
DEPRESSIVE DISORDER;rs4713916;Variant;PA447207;Disease
MOOD DISORDER;rs4713916;Variant;PA447209;Disease
FLUOXETINE;rs4713916;Variant;PA449673;Chemical
MIRTAZAPINE;rs4713916;Variant;PA450522;Chemical
ANTIDEPRESSANTS;rs4713916;Variant;PA452229;Chemical
PLATINUM COMPOUNDS;rs1042927;Variant;PA164713176;Chemical
MESOTHELIOMA;rs1042927;Variant;PA444937;Disease
GEMCITABINE;rs1042927;Variant;PA449748;Chemical
PENICILLIN V;HLA-B*55:01;Haplotype;PA164745442;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*55:01;Haplotype;PA166120927;Disease
DRUG HYPERSENSITIVITY;HLA-B*55:01;Haplotype;PA443936;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*55:01;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*55:01;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-B*55:01;Haplotype;PA450616;Chemical
PENICILLIN G;HLA-B*55:01;Haplotype;PA450842;Chemical
3-CYANO-7-ETHOXYCOUMARIN;CYP2C19*19;Haplotype;PA166123047;Chemical
6BETA-HYDROXYTESTOSTERONE;CYP2C19*19;Haplotype;PA166318222;Chemical
11A-HYDROXYPROGESTERONE;CYP2C19*19;Haplotype;PA166318342;Chemical
CELECOXIB;CYP2C19*19;Haplotype;PA448871;Chemical
CLOPIDOGREL;CYP2C19*19;Haplotype;PA449053;Chemical
FLUOXETINE;CYP2C19*19;Haplotype;PA449673;Chemical
FLUVOXAMINE;CYP2C19*19;Haplotype;PA449690;Chemical
KETOCONAZOLE;CYP2C19*19;Haplotype;PA450146;Chemical
MEPHENYTOIN;CYP2C19*19;Haplotype;PA450373;Chemical
OMEPRAZOLE;CYP2C19*19;Haplotype;PA450704;Chemical
SERTRALINE;CYP2C19*19;Haplotype;PA451333;Chemical
TICLOPIDINE;CYP2C19*19;Haplotype;PA451686;Chemical
TRANYLCYPROMINE;CYP2C19*19;Haplotype;PA451741;Chemical
RS2027701;Dermatitis;Disease;PA166169891;Variant
RS1059698;Dermatitis;Disease;PA166169893;Variant
RS73594404;Dermatitis;Disease;PA166169897;Variant
RS10132552;Dermatitis;Disease;PA166169901;Variant
MEG3;Dermatitis;Disease;PA30737;Gene
ARIPIPRAZOLE;HTR2C;Gene;PA10026;Chemical
DULOXETINE;HTR2C;Gene;PA10066;Chemical
ESCITALOPRAM;HTR2C;Gene;PA10074;Chemical
WEIGHT GAIN;HTR2C;Gene;PA128406954;Disease
NEUROPATHIC PAIN;HTR2C;Gene;PA162263525;Disease
METABOLIC SYNDROME;HTR2C;Gene;PA162370415;Disease
DIVALPROEX SODIUM;HTR2C;Gene;PA164783479;Chemical
GNAQ;HTR2C;Gene;PA174;Gene
AUTISM;HTR2C;Gene;PA447198;Disease
MENTAL DISORDERS;HTR2C;Gene;PA447208;Disease
SCHIZOPHRENIA;HTR2C;Gene;PA447216;Disease
AMITRIPTYLINE;HTR2C;Gene;PA448385;Chemical
BUPROPION;HTR2C;Gene;PA448687;Chemical
BUSPIRONE;HTR2C;Gene;PA448689;Chemical
CARBAMAZEPINE;HTR2C;Gene;PA448785;Chemical
CITALOPRAM;HTR2C;Gene;PA449015;Chemical
CLOZAPINE;HTR2C;Gene;PA449061;Chemical
DIAZEPAM;HTR2C;Gene;PA449283;Chemical
FLUOXETINE;HTR2C;Gene;PA449673;Chemical
HALOPERIDOL;HTR2C;Gene;PA449841;Chemical
LAMOTRIGINE;HTR2C;Gene;PA450164;Chemical
MIRTAZAPINE;HTR2C;Gene;PA450522;Chemical
MODAFINIL;HTR2C;Gene;PA450530;Chemical
NORTRIPTYLINE;HTR2C;Gene;PA450657;Chemical
OLANZAPINE;HTR2C;Gene;PA450688;Chemical
OXCARBAZEPINE;HTR2C;Gene;PA450732;Chemical
PAROXETINE;HTR2C;Gene;PA450801;Chemical
PHENYTOIN;HTR2C;Gene;PA450947;Chemical
QUETIAPINE;HTR2C;Gene;PA451201;Chemical
RISPERIDONE;HTR2C;Gene;PA451257;Chemical
SERTRALINE;HTR2C;Gene;PA451333;Chemical
TRAZODONE;HTR2C;Gene;PA451744;Chemical
VALPROIC ACID;HTR2C;Gene;PA451846;Chemical
VENLAFAXINE;HTR2C;Gene;PA451866;Chemical
ZIPRASIDONE;HTR2C;Gene;PA451974;Chemical
ANTIPSYCHOTICS;HTR2C;Gene;PA452233;Chemical
EPILEPSY;CYP2C9*33;Haplotype;PA444065;Disease
HYPERTENSION;CYP2C9*33;Haplotype;PA444552;Disease
LOSARTAN;CYP2C9*33;Haplotype;PA450268;Chemical
PHENYTOIN;CYP2C9*33;Haplotype;PA450947;Chemical
PROSTATIC NEOPLASMS;ERG;Gene;PA445425;Disease
PEMETREXED;rs3788189;Variant;PA10810;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs3788189;Variant;PA443622;Disease
MESOTHELIOMA;rs3788189;Variant;PA444937;Disease
RASBURICASE;G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham;Haplotype;PA10176;Chemical
SULFAMETOPYRAZINE;G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham;Haplotype;PA164747038;Chemical
HYPERURICEMIA;G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham;Haplotype;PA166048814;Disease
ANEMIA, HEMOLYTIC;G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham;Haplotype;PA443343;Disease
ARTHRITIS;G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham;Haplotype;PA443430;Disease
HEMOLYSIS;G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham;Haplotype;PA444411;Disease
METHEMOGLOBINEMIA;G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham;Haplotype;PA444942;Disease
NEOPLASMS;G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham;Haplotype;PA445062;Disease
COLORECTAL NEOPLASMS;G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham;Haplotype;PA446108;Disease
ASPIRIN;G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham;Haplotype;PA448497;Chemical
CHLOROQUINE;G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham;Haplotype;PA448948;Chemical
CIPROFLOXACIN;G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham;Haplotype;PA449009;Chemical
DAUNORUBICIN;G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham;Haplotype;PA449212;Chemical
PRIMAQUINE;G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham;Haplotype;PA451103;Chemical
SULFADOXINE;G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham;Haplotype;PA451540;Chemical
MAJOR DEPRESSIVE DISORDER;rs11628713;Variant;PA447321;Disease
CITALOPRAM;rs11628713;Variant;PA449015;Chemical
DULOXETINE;rs11933890;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs11933890;Variant;PA447321;Disease
PLATINUM COMPOUNDS;AXIN2;Gene;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;AXIN2;Gene;PA443622;Disease
ASTHMA;FCER1G;Gene;PA443450;Disease
ASPIRIN;FCER1G;Gene;PA448497;Chemical
HYPERTENSION;rs4815273;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs4815273;Variant;PA449899;Chemical
BUFURALOL;rs1058171;Variant;PA166110256;Chemical
ABCC2;pemetrexed;Chemical;PA116;Gene
CD274;pemetrexed;Chemical;PA134915280;Gene
DHFR;pemetrexed;Chemical;PA143;Gene
RS1801131;pemetrexed;Chemical;PA166153643;Variant
RS1801133;pemetrexed;Chemical;PA166153644;Variant
RS2273697;pemetrexed;Chemical;PA166154007;Variant
RS61734430;pemetrexed;Chemical;PA166154476;Variant
RS914232;pemetrexed;Chemical;PA166155984;Variant
RS1051298;pemetrexed;Chemical;PA166155988;Variant
RS3788189;pemetrexed;Chemical;PA166156005;Variant
RS442767;pemetrexed;Chemical;PA166156733;Variant
RS1650697;pemetrexed;Chemical;PA166156770;Variant
RS3780126;pemetrexed;Chemical;PA166157594;Variant
RS11545078;pemetrexed;Chemical;PA166157634;Variant
RS11280056;pemetrexed;Chemical;PA166180936;Variant
MTHFR;pemetrexed;Chemical;PA245;Gene
ALK;pemetrexed;Chemical;PA24719;Gene
FOLR3;pemetrexed;Chemical;PA28211;Gene
SLC19A1;pemetrexed;Chemical;PA327;Gene
TYMS;pemetrexed;Chemical;PA359;Gene
SLC22A8;pemetrexed;Chemical;PA389;Gene
GGH;pemetrexed;Chemical;PA432;Gene
EGFR;pemetrexed;Chemical;PA7360;Gene
CASR;PLCL1;Gene;PA26097;Gene
PRKCA;PLCL1;Gene;PA33759;Gene
PRKCB;PLCL1;Gene;PA33761;Gene
PRKCG;PLCL1;Gene;PA33766;Gene
PRKCH;PLCL1;Gene;PA33767;Gene
PRKCI;PLCL1;Gene;PA33768;Gene
PRKD1;PLCL1;Gene;PA33771;Gene
PRKCZ;PLCL1;Gene;PA33775;Gene
IMATINIB;rs9561765;Variant;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;rs9561765;Variant;PA151958383;Disease
NAUSEA;CRYBG2;Gene;PA445048;Disease
VOMITING;CRYBG2;Gene;PA446051;Disease
OPIOIDS;CRYBG2;Gene;PA452618;Chemical
FLURBIPROFEN;rs182132442;Variant;PA449683;Chemical
NAPROXEN;rs182132442;Variant;PA450595;Chemical
PHENYTOIN;rs182132442;Variant;PA450947;Chemical
WARFARIN;rs182132442;Variant;PA451906;Chemical
ORGAN TRANSPLANTATION;rs2278294;Variant;PA133888799;Disease
KIDNEY TRANSPLANTATION;rs2278294;Variant;PA165817016;Disease
LEUKOPENIA;rs2278294;Variant;PA444773;Disease
MYCOPHENOLATE MOFETIL;rs2278294;Variant;PA450566;Chemical
ADALIMUMAB;rs767455;Variant;PA10004;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs767455;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs767455;Variant;PA443434;Disease
ARTHRITIS, PSORIATIC;rs767455;Variant;PA446198;Disease
ETANERCEPT;rs767455;Variant;PA449515;Chemical
INFLIXIMAB;rs767455;Variant;PA452639;Chemical
CASR;PLCH2;Gene;PA26097;Gene
PRKCA;PLCH2;Gene;PA33759;Gene
PRKCB;PLCH2;Gene;PA33761;Gene
PRKCG;PLCH2;Gene;PA33766;Gene
PRKCH;PLCH2;Gene;PA33767;Gene
PRKCI;PLCH2;Gene;PA33768;Gene
PRKD1;PLCH2;Gene;PA33771;Gene
PRKCZ;PLCH2;Gene;PA33775;Gene
CYP3A4;nicardipine;Chemical;PA130;Gene
ABCB1;nicardipine;Chemical;PA267;Gene
NR1I2;nicardipine;Chemical;PA378;Gene
RS121434568;osimertinib;Chemical;PA166157527;Variant
RS121434569;osimertinib;Chemical;PA166157528;Variant
EGFR;osimertinib;Chemical;PA7360;Gene
CYP2C19;moclobemide;Chemical;PA124;Gene
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;FARP2;Gene;PA447197;Disease
METHYLPHENIDATE;FARP2;Gene;PA450464;Chemical
BETA BLOCKING AGENTS;rs1801252;Variant;PA164712535;Chemical
MAJOR ADVERSE CARDIAC EVENTS (MACE);rs1801252;Variant;PA166129560;Disease
HYPERTENSION;rs1801252;Variant;PA444552;Disease
CARVEDILOL;rs1801252;Variant;PA448817;Chemical
METOPROLOL;rs1801252;Variant;PA450480;Chemical
TIMOLOL;rs1801252;Variant;PA451690;Chemical
ASTHMA;rs2115819;Variant;PA443450;Disease
MONTELUKAST;rs2115819;Variant;PA450546;Chemical
TAXANES;rs74497159;Variant;PA150481189;Chemical
PERIPHERAL NERVOUS SYSTEM DISEASES;rs74497159;Variant;PA445301;Disease
BUFURALOL;rs745746329;Variant;PA166110256;Chemical
DEXTROMETHORPHAN;rs745746329;Variant;PA449273;Chemical
CESSATION;CYP2A6*28;Haplotype;PA166123046;Disease
TOBACCO USE DISORDER;CYP2A6*28;Haplotype;PA445876;Disease
NICOTINE;CYP2A6*28;Haplotype;PA450626;Chemical
SLC47A1;Polycystic Ovary Syndrome;Disease;PA162403808;Gene
RS2252281;Polycystic Ovary Syndrome;Disease;PA166155204;Variant
RS2289669;Polycystic Ovary Syndrome;Disease;PA166155206;Variant
RS6923761;Polycystic Ovary Syndrome;Disease;PA166157117;Variant
RS10305420;Polycystic Ovary Syndrome;Disease;PA166157167;Variant
GLP1R;Polycystic Ovary Syndrome;Disease;PA28725;Gene
AUTISM SPECTRUM DISORDER;LEP;Gene;PA153906318;Disease
METRELEPTIN;LEP;Gene;PA166235301;Chemical
MOOD DISORDER;LEP;Gene;PA447209;Disease
SCHIZOPHRENIA;LEP;Gene;PA447216;Disease
OLANZAPINE;LEP;Gene;PA450688;Chemical
RISPERIDONE;LEP;Gene;PA451257;Chemical
ANTIPSYCHOTICS;LEP;Gene;PA452233;Chemical
DPYD;rs142619737;Variant;PA145;Gene
CAPECITABINE;rs142619737;Variant;PA448771;Chemical
CLOZAPINE;CYP1A2*8;Haplotype;PA449061;Chemical
DACARBAZINE;CYP1A2*8;Haplotype;PA449197;Chemical
ESCITALOPRAM;TPH1;Gene;PA10074;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;TPH1;Gene;PA164713257;Chemical
BIPOLAR DISORDER;TPH1;Gene;PA447199;Disease
MAJOR DEPRESSIVE DISORDER;TPH1;Gene;PA447321;Disease
CITALOPRAM;TPH1;Gene;PA449015;Chemical
FLUOXETINE;TPH1;Gene;PA449673;Chemical
LITHIUM;TPH1;Gene;PA450243;Chemical
PAROXETINE;TPH1;Gene;PA450801;Chemical
ANTIDEPRESSANTS;TPH1;Gene;PA452229;Chemical
DIABETES MELLITUS, TYPE 2;IGF2BP2;Gene;PA443890;Disease
REPAGLINIDE;IGF2BP2;Gene;PA451234;Chemical
ACETAMINOPHEN;SULT1E1;Gene;PA448015;Chemical
HEPATITIS C VIRUS INFECTION;rs1800477;Variant;PA444445;Disease
RIBAVIRIN;rs1800477;Variant;PA451241;Chemical
INTERFERONS;rs1800477;Variant;PA451999;Chemical
LEUKEMIA, MYELOID, ACUTE;rs2898950;Variant;PA444760;Disease
CLADRIBINE;rs2898950;Variant;PA449027;Chemical
CYTARABINE;rs2898950;Variant;PA449177;Chemical
HMG COA REDUCTASE INHIBITORS;ABCB11;Gene;PA133950441;Chemical
LAPATINIB;ABCB11;Gene;PA152241907;Chemical
MARALIXIBAT;ABCB11;Gene;PA166268803;Chemical
ODEVIXIBAT;ABCB11;Gene;PA166268805;Chemical
RS72549402;ABCB11;Gene;PA166313821;Variant
RS11568372;ABCB11;Gene;PA166313822;Variant
MAJOR DEPRESSIVE DISORDER;RGS17;Gene;PA447321;Disease
ANTIDEPRESSANTS;RGS17;Gene;PA452229;Chemical
CFTR;rs397508616;Variant;PA109;Gene
IVACAFTOR;rs397508616;Variant;PA165950341;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs397508616;Variant;PA166362502;Chemical
PROSTATIC NEOPLASMS;ORM2;Gene;PA445425;Disease
DOCETAXEL;ORM2;Gene;PA449383;Chemical
CASR;Parathyroid Hormones And Analogues;Chemical;PA26097;Gene
ROSUVASTATIN;rs2230806;Variant;PA134308647;Chemical
CORONARY DISEASE;rs2230806;Variant;PA443797;Disease
HYPERTRIGLYCERIDEMIA;rs2230806;Variant;PA446120;Disease
ATORVASTATIN;rs2230806;Variant;PA448500;Chemical
FENOFIBRATE;rs2230806;Variant;PA449594;Chemical
PRAVASTATIN;rs2230806;Variant;PA451089;Chemical
SIMVASTATIN;rs2230806;Variant;PA451363;Chemical
DBH;Substance Withdrawal Syndrome;Disease;PA136;Gene
RS1799971;Substance Withdrawal Syndrome;Disease;PA166156991;Variant
RS1611115;Substance Withdrawal Syndrome;Disease;PA166157734;Variant
OPRM1;Substance Withdrawal Syndrome;Disease;PA31945;Gene
MUCOSITIS;ENOSF1;Gene;PA166122058;Disease
GASTROINTESTINAL TOXICITY;ENOSF1;Gene;PA166124386;Disease
ARTHRITIS, RHEUMATOID;ENOSF1;Gene;PA443434;Disease
NEOPLASMS;ENOSF1;Gene;PA445062;Disease
NEUTROPENIA;ENOSF1;Gene;PA445113;Disease
COLORECTAL NEOPLASMS;ENOSF1;Gene;PA446108;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;ENOSF1;Gene;PA446155;Disease
CAPECITABINE;ENOSF1;Gene;PA448771;Chemical
METHOTREXATE;ENOSF1;Gene;PA450428;Chemical
HYPERTENSION;rs2144300;Variant;PA444552;Disease
ATENOLOL;rs2144300;Variant;PA448499;Chemical
PARKINSON DISEASE;rs4704559;Variant;PA445254;Disease
LEVODOPA;rs4704559;Variant;PA450213;Chemical
FLUOROURACIL;ABCC5;Gene;PA128406956;Chemical
OXALIPLATIN;ABCC5;Gene;PA131285527;Chemical
COLORECTAL NEOPLASMS;ABCC5;Gene;PA446108;Disease
IRINOTECAN;ABCC5;Gene;PA450085;Chemical
LEUCOVORIN;ABCC5;Gene;PA450198;Chemical
ZIDOVUDINE;ABCC5;Gene;PA451954;Chemical
CYP2C8;Peripheral Nervous System Diseases;Disease;PA125;Gene
CYP3A4;Peripheral Nervous System Diseases;Disease;PA130;Gene
CYP3A5;Peripheral Nervous System Diseases;Disease;PA131;Gene
CEP72;Peripheral Nervous System Diseases;Disease;PA142672125;Gene
CYP3A4*1;Peripheral Nervous System Diseases;Disease;PA165819201;Haplotype
CYP3A4*8;Peripheral Nervous System Diseases;Disease;PA165819226;Haplotype
CYP3A4*20;Peripheral Nervous System Diseases;Disease;PA165819244;Haplotype
CYP2C8*2;Peripheral Nervous System Diseases;Disease;PA165958684;Haplotype
CYP2C8*3;Peripheral Nervous System Diseases;Disease;PA165958685;Haplotype
CYP2C8*4;Peripheral Nervous System Diseases;Disease;PA165958686;Haplotype
CYP3A5*1;Peripheral Nervous System Diseases;Disease;PA166128213;Haplotype
CYP3A5*3;Peripheral Nervous System Diseases;Disease;PA166128219;Haplotype
RS7349683;Peripheral Nervous System Diseases;Disease;PA166156616;Variant
RS924607;Peripheral Nervous System Diseases;Disease;PA166156745;Variant
RS1045642;Peripheral Nervous System Diseases;Disease;PA166157284;Variant
RS1128503;Peripheral Nervous System Diseases;Disease;PA166157288;Variant
RS1799735;Peripheral Nervous System Diseases;Disease;PA166159214;Variant
RS8124728;Peripheral Nervous System Diseases;Disease;PA166180546;Variant
RS74497159;Peripheral Nervous System Diseases;Disease;PA166230141;Variant
CYP2C8*1;Peripheral Nervous System Diseases;Disease;PA166242948;Haplotype
ABCB1;Peripheral Nervous System Diseases;Disease;PA267;Gene
EPHA5;Peripheral Nervous System Diseases;Disease;PA27821;Gene
GSTM3;Peripheral Nervous System Diseases;Disease;PA29024;Gene
SAMHD1;Peripheral Nervous System Diseases;Disease;PA34938;Gene
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs11552708;Variant;PA447197;Disease
METHYLPHENIDATE;rs11552708;Variant;PA450464;Chemical
SLCO1B1;ezetimibe / rosuvastatin;Chemical;PA134865839;Gene
RS4149056;ezetimibe / rosuvastatin;Chemical;PA166154579;Variant
RS2231142;ezetimibe / rosuvastatin;Chemical;PA166156544;Variant
ABCG2;ezetimibe / rosuvastatin;Chemical;PA390;Gene
ESCITALOPRAM;rs10975641;Variant;PA10074;Chemical
MAJOR DEPRESSIVE DISORDER;rs10975641;Variant;PA447321;Disease
CITALOPRAM;rs10975641;Variant;PA449015;Chemical
HYDROXYCHLOROQUINE;MTR;Gene;PA164777036;Chemical
AGRANULOCYTOSIS;MTR;Gene;PA443297;Disease
RHEUMATOID ARTHRITIS;MTR;Gene;PA443434;Disease
BRAIN DISEASES;MTR;Gene;PA443553;Disease
DRUG TOXICITY;MTR;Gene;PA443937;Disease
NEOPLASMS;MTR;Gene;PA445062;Disease
OSTEOSARCOMA;MTR;Gene;PA445601;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;MTR;Gene;PA446155;Disease
ESSENTIAL HYPERTENSION;MTR;Gene;PA447288;Disease
BENAZEPRIL;MTR;Gene;PA448561;Chemical
CARBOPLATIN;MTR;Gene;PA448803;Chemical
CISPLATIN;MTR;Gene;PA449014;Chemical
FOLIC ACID;MTR;Gene;PA449692;Chemical
METHOTREXATE;MTR;Gene;PA450428;Chemical
SULFASALAZINE;MTR;Gene;PA451547;Chemical
SEVOFLURANE;rs2307116;Variant;PA451341;Chemical
NR1I2;rifabutin;Chemical;PA378;Gene
ALCOHOL ABUSE;rs1476592;Variant;PA443309;Disease
ETHANOL;rs1476592;Variant;PA448073;Chemical
HEMATOPOIETIC STEM CELL TRANSPLANTATION;NUDT15*4;Haplotype;PA166123007;Disease
PRIMARY GRAFT FAILURE;NUDT15*4;Haplotype;PA166248341;Disease
LEUKOPENIA;NUDT15*4;Haplotype;PA444773;Disease
INFLAMMATORY BOWEL DISEASES;NUDT15*4;Haplotype;PA446116;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;NUDT15*4;Haplotype;PA446155;Disease
ACYCLOVIR;NUDT15*4;Haplotype;PA448045;Chemical
AZATHIOPRINE;NUDT15*4;Haplotype;PA448515;Chemical
MERCAPTOPURINE;NUDT15*4;Haplotype;PA450379;Chemical
BREAST NEOPLASMS;rs12721655;Variant;PA443560;Disease
BUPROPION;rs12721655;Variant;PA448687;Chemical
CYCLOPHOSPHAMIDE;rs12721655;Variant;PA449165;Chemical
DOXORUBICIN;rs12721655;Variant;PA449412;Chemical
EFAVIRENZ;rs12721655;Variant;PA449441;Chemical
NEOPLASMS;rs11211524;Variant;PA445062;Disease
GEMCITABINE;rs11211524;Variant;PA449748;Chemical
OLUTASIDENIB;rs121913499;Variant;PA166293881;Chemical
IDH1;rs121913499;Variant;PA29630;Gene
DIARRHEA;rs2853741;Variant;PA443899;Disease
NEOPLASMS;rs2853741;Variant;PA445062;Disease
CAPECITABINE;rs2853741;Variant;PA448771;Chemical
BEVACIZUMAB;rs11200638;Variant;PA130232992;Chemical
MACULAR DEGENERATION;rs11200638;Variant;PA134850558;Disease
RANIBIZUMAB;rs11200638;Variant;PA164746012;Chemical
AQP4;inebilizumab;Chemical;PA24922;Gene
BRCA1;Breast Neoplasms, Male;Disease;PA25411;Gene
TMSB4X;timbetasin;Chemical;PA36581;Gene
RS616147;Amyotrophic Lateral Sclerosis;Disease;PA166202221;Variant
MOBP;Amyotrophic Lateral Sclerosis;Disease;PA30899;Gene
COTININE;rs510769;Variant;PA166114414;Chemical
HEROIN DEPENDENCE;rs510769;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs510769;Variant;PA445043;Disease
AMPHETAMINE;rs510769;Variant;PA448408;Chemical
NICOTINE;rs510769;Variant;PA450626;Chemical
OPIOIDS;rs510769;Variant;PA452618;Chemical
HEROIN;rs510769;Variant;PA452619;Chemical
SCHIZOPHRENIA;rs8050896;Variant;PA447216;Disease
RISPERIDONE;rs8050896;Variant;PA451257;Chemical
DOCETAXEL;rs12762549;Variant;PA449383;Chemical
CHEK1;ATR;Gene;PA110;Gene
TALAZOPARIB;ATR;Gene;PA166182740;Chemical
CHEK2;ATR;Gene;PA404;Gene
MAP3K1;SHC2;Gene;PA30592;Gene
RAF1;SHC2;Gene;PA34183;Gene
EGFR;SHC2;Gene;PA7360;Gene
ESR1;sacituzumab govitecan;Chemical;PA156;Gene
UGT1A1*1;sacituzumab govitecan;Chemical;PA166115841;Haplotype
UGT1A1*28;sacituzumab govitecan;Chemical;PA166115842;Haplotype
BRCA1;sacituzumab govitecan;Chemical;PA25411;Gene
BRCA2;sacituzumab govitecan;Chemical;PA25412;Gene
ERBB2;sacituzumab govitecan;Chemical;PA27844;Gene
ESR2;sacituzumab govitecan;Chemical;PA27886;Gene
UGT1A1;sacituzumab govitecan;Chemical;PA420;Gene
PLCH1;PRKD1;Gene;PA128394595;Gene
PLCZ1;PRKD1;Gene;PA134875646;Gene
PLCH2;PRKD1;Gene;PA134914471;Gene
PLCB1;PRKD1;Gene;PA33384;Gene
PLCB2;PRKD1;Gene;PA33385;Gene
PLCB3;PRKD1;Gene;PA33386;Gene
PLCB4;PRKD1;Gene;PA33387;Gene
PLCD1;PRKD1;Gene;PA33388;Gene
PLCD3;PRKD1;Gene;PA33389;Gene
PLCD4;PRKD1;Gene;PA33390;Gene
PLCE1;PRKD1;Gene;PA33391;Gene
PLCG1;PRKD1;Gene;PA33392;Gene
PLCG2;PRKD1;Gene;PA33393;Gene
PLCL1;PRKD1;Gene;PA33394;Gene
PLCL2;PRKD1;Gene;PA33395;Gene
CYP2D6;berberine;Chemical;PA128;Gene
CYP2D6*1;berberine;Chemical;PA165816576;Haplotype
CYP2D6*10;berberine;Chemical;PA165816582;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);berberine;Chemical;PA166116465;Haplotype
SLC6A4;berberine;Chemical;PA312;Gene
MAJOR DEPRESSIVE DISORDER;rs4675690;Variant;PA447321;Disease
CITALOPRAM;rs4675690;Variant;PA449015;Chemical
OVERDOSE;rs114077267;Variant;PA446199;Disease
OPIOIDS;rs114077267;Variant;PA452618;Chemical
TALAZOPARIB;FANCA;Gene;PA166182740;Chemical
ABCB1;aliskiren;Chemical;PA267;Gene
TPMT*1;Hepatitis, Autoimmune;Disease;PA165819268;Haplotype
TPMT*3C;Hepatitis, Autoimmune;Disease;PA165819272;Haplotype
TPMT;Hepatitis, Autoimmune;Disease;PA356;Gene
MAPK8;FOSL1;Gene;PA283;Gene
MAPK14;FOSL1;Gene;PA30621;Gene
ALCOHOL ABUSE;rs1044394;Variant;PA443309;Disease
ETHANOL;rs1044394;Variant;PA448073;Chemical
ALCOHOL ABUSE;rs4432372;Variant;PA443309;Disease
ETHANOL;rs4432372;Variant;PA448073;Chemical
SAXAGLIPTIN;CYP3A4*10;Haplotype;PA165958362;Chemical
REGORAFENIB;CYP3A4*10;Haplotype;PA166114943;Chemical
VANDETANIB;CYP3A4*10;Haplotype;PA166118341;Chemical
BREXPIPRAZOLE;CYP3A4*10;Haplotype;PA166160053;Chemical
MACITENTAN;CYP3A4*10;Haplotype;PA166261201;Chemical
BLONANSERIN;CYP3A4*10;Haplotype;PA166319041;Chemical
AMIODARONE;CYP3A4*10;Haplotype;PA448383;Chemical
OXYCODONE;CYP3A4*10;Haplotype;PA450741;Chemical
SILDENAFIL;CYP3A4*10;Haplotype;PA451346;Chemical
TESTOSTERONE;CYP3A4*10;Haplotype;PA451627;Chemical
CORONARY ARTERY DISEASE;rs2301149;Variant;PA443796;Disease
HYPERTENSION;rs2301149;Variant;PA444552;Disease
VERAPAMIL;rs2301149;Variant;PA451868;Chemical
ARTHRITIS, RHEUMATOID;rs3045983;Variant;PA443434;Disease
DRUG TOXICITY;rs3045983;Variant;PA443937;Disease
METHOTREXATE;rs3045983;Variant;PA450428;Chemical
FGFR1;pemigatinib;Chemical;PA28127;Gene
FGFR2;pemigatinib;Chemical;PA28128;Gene
SCHIZOPHRENIA;RGS4;Gene;PA447216;Disease
OLANZAPINE;RGS4;Gene;PA450688;Chemical
PERPHENAZINE;RGS4;Gene;PA450882;Chemical
QUETIAPINE;RGS4;Gene;PA451201;Chemical
RISPERIDONE;RGS4;Gene;PA451257;Chemical
ZIPRASIDONE;RGS4;Gene;PA451974;Chemical
ANTIPSYCHOTICS;RGS4;Gene;PA452233;Chemical
BREAST NEOPLASMS;TNFSF11;Gene;PA443560;Disease
ANASTROZOLE;TNFSF11;Gene;PA448432;Chemical
LETROZOLE;TNFSF11;Gene;PA450196;Chemical
RS3753380;Open-angle glaucoma;Disease;PA166153748;Variant
RS3766355;Open-angle glaucoma;Disease;PA166153751;Variant
RS11568658;Open-angle glaucoma;Disease;PA166154747;Variant
RS10306114;Open-angle glaucoma;Disease;PA166157803;Variant
PTGS1;Open-angle glaucoma;Disease;PA24346;Gene
PTGFR;Open-angle glaucoma;Disease;PA290;Gene
ABCC4;Open-angle glaucoma;Disease;PA397;Gene
SCHIZOPHRENIA;rs813676;Variant;PA447216;Disease
RISPERIDONE;rs813676;Variant;PA451257;Chemical
NASOPHARYNGEAL NEOPLASMS;rs11185648;Variant;PA445046;Disease
DOCETAXEL;rs11185648;Variant;PA449383;Chemical
NR1I2;econazole;Chemical;PA378;Gene
HYPERCHOLESTEROLEMIA;rs17161788;Variant;PA444516;Disease
ATORVASTATIN;rs17161788;Variant;PA448500;Chemical
ELF2;SLC9A3R1;Gene;PA27745;Gene
CYP2C19;Carcinoma, Squamous Cell;Disease;PA124;Gene
CYP2C19*17;Carcinoma, Squamous Cell;Disease;PA165816533;Haplotype
CYP2C19*1;Carcinoma, Squamous Cell;Disease;PA165980634;Haplotype
RS1799782;Carcinoma, Squamous Cell;Disease;PA166155370;Variant
RS3219489;Carcinoma, Squamous Cell;Disease;PA166171088;Variant
RS1760944;Carcinoma, Squamous Cell;Disease;PA166238764;Variant
APEX1;Carcinoma, Squamous Cell;Disease;PA201059;Gene
MUTYH;Carcinoma, Squamous Cell;Disease;PA31328;Gene
OSGEP;Carcinoma, Squamous Cell;Disease;PA32834;Gene
XRCC1;Carcinoma, Squamous Cell;Disease;PA369;Gene
DESMETHYLNAPROXEN;rs765399160;Variant;PA166163690;Chemical
ACETAMINOPHEN;rs765399160;Variant;PA448015;Chemical
HYPERTENSION;rs688;Variant;PA444552;Disease
ATENOLOL;rs688;Variant;PA448499;Chemical
LOVASTATIN;rs688;Variant;PA450272;Chemical
METFORMIN;rs2282143;Variant;PA450395;Chemical
TOBACCO USE DISORDER;rs113288603;Variant;PA445876;Disease
NICOTINE;rs113288603;Variant;PA450626;Chemical
RS1208;Drug interaction with drug;Disease;PA166157540;Variant
RS1041983;Drug interaction with drug;Disease;PA166157549;Variant
RS1799929;Drug interaction with drug;Disease;PA166157563;Variant
RS1799930;Drug interaction with drug;Disease;PA166157564;Variant
RS1799931;Drug interaction with drug;Disease;PA166157565;Variant
RS1801280;Drug interaction with drug;Disease;PA166157570;Variant
NAT2;Drug interaction with drug;Disease;PA18;Gene
MS4A1;ibritumomab;Chemical;PA31111;Gene
BENZODIAZEPINE DERIVATIVES;rs948854;Variant;PA10402;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;rs948854;Variant;PA164713257;Chemical
OPIOID-RELATED DISORDERS;rs948854;Variant;PA445043;Disease
MAJOR DEPRESSIVE DISORDER;rs948854;Variant;PA447321;Disease
MIRTAZAPINE;rs948854;Variant;PA450522;Chemical
ANTIDEPRESSANTS;rs948854;Variant;PA452229;Chemical
OPIOIDS;rs948854;Variant;PA452618;Chemical
ASTHMA;FADS2;Gene;PA443450;Disease
DPYD;rs148799944;Variant;PA145;Gene
CAPECITABINE;rs148799944;Variant;PA448771;Chemical
BSND;CLCNKB;Gene;PA134911659;Gene
BREAST NEOPLASMS;MAP4K4;Gene;PA443560;Disease
ANASTROZOLE;MAP4K4;Gene;PA448432;Chemical
EXEMESTANE;MAP4K4;Gene;PA449563;Chemical
CFTR;rs149279509;Variant;PA109;Gene
IVACAFTOR;rs149279509;Variant;PA165950341;Chemical
LEUKEMIA, MYELOID, ACUTE;rs1265138;Variant;PA444760;Disease
CLADRIBINE;rs1265138;Variant;PA449027;Chemical
CYTARABINE;rs1265138;Variant;PA449177;Chemical
MIGALASTAT;rs398123223;Variant;PA166182881;Chemical
FABRY DISEASE;rs398123223;Variant;PA443367;Disease
CYP2D6;N-desmethyltamoxifen;Chemical;PA128;Gene
CYP3A4;N-desmethyltamoxifen;Chemical;PA130;Gene
CYP2D6*1;N-desmethyltamoxifen;Chemical;PA165816576;Haplotype
CYP2D6*2;N-desmethyltamoxifen;Chemical;PA165816577;Haplotype
CYP2D6*10;N-desmethyltamoxifen;Chemical;PA165816582;Haplotype
CYP2D6*17;N-desmethyltamoxifen;Chemical;PA165816583;Haplotype
CYP3A4*1;N-desmethyltamoxifen;Chemical;PA165819201;Haplotype
CYP2D6*9;N-desmethyltamoxifen;Chemical;PA165948317;Haplotype
CYP2D6*29;N-desmethyltamoxifen;Chemical;PA165948318;Haplotype
CYP2D6*7;N-desmethyltamoxifen;Chemical;PA165971559;Haplotype
CYP2D6*12;N-desmethyltamoxifen;Chemical;PA165971565;Haplotype
CYP2D6*18;N-desmethyltamoxifen;Chemical;PA165971569;Haplotype
CYP2D6*22;N-desmethyltamoxifen;Chemical;PA165971574;Haplotype
CYP2D6*23;N-desmethyltamoxifen;Chemical;PA165971575;Haplotype
CYP2D6*24;N-desmethyltamoxifen;Chemical;PA165971576;Haplotype
CYP2D6*25;N-desmethyltamoxifen;Chemical;PA165971577;Haplotype
CYP2D6*26;N-desmethyltamoxifen;Chemical;PA165971578;Haplotype
CYP2D6*27;N-desmethyltamoxifen;Chemical;PA165971579;Haplotype
CYP2D6*28;N-desmethyltamoxifen;Chemical;PA165971580;Haplotype
CYP2D6*30;N-desmethyltamoxifen;Chemical;PA165971581;Haplotype
CYP2D6*31;N-desmethyltamoxifen;Chemical;PA165971582;Haplotype
CYP2D6*32;N-desmethyltamoxifen;Chemical;PA165971583;Haplotype
CYP2D6*33;N-desmethyltamoxifen;Chemical;PA165971584;Haplotype
CYP2D6*37;N-desmethyltamoxifen;Chemical;PA165971591;Haplotype
CYP2D6*40;N-desmethyltamoxifen;Chemical;PA165971594;Haplotype
CYP2D6*43;N-desmethyltamoxifen;Chemical;PA165971596;Haplotype
CYP2D6*46;N-desmethyltamoxifen;Chemical;PA165971600;Haplotype
CYP2D6*47;N-desmethyltamoxifen;Chemical;PA165971601;Haplotype
CYP2D6*48;N-desmethyltamoxifen;Chemical;PA165971602;Haplotype
CYP2D6*49;N-desmethyltamoxifen;Chemical;PA165971603;Haplotype
CYP2D6*50;N-desmethyltamoxifen;Chemical;PA165971604;Haplotype
CYP2D6*51;N-desmethyltamoxifen;Chemical;PA165971605;Haplotype
CYP2D6*52;N-desmethyltamoxifen;Chemical;PA165971606;Haplotype
CYP2D6*53;N-desmethyltamoxifen;Chemical;PA165971607;Haplotype
CYP2D6*54;N-desmethyltamoxifen;Chemical;PA165971608;Haplotype
CYP2D6*55;N-desmethyltamoxifen;Chemical;PA165971609;Haplotype
CYP2D6*61;N-desmethyltamoxifen;Chemical;PA165971616;Haplotype
CYP2D6*62;N-desmethyltamoxifen;Chemical;PA165971617;Haplotype
CYP2D6*63;N-desmethyltamoxifen;Chemical;PA165971618;Haplotype
CYP2D6*64;N-desmethyltamoxifen;Chemical;PA165971619;Haplotype
CYP2D6*65;N-desmethyltamoxifen;Chemical;PA165971620;Haplotype
CYP2D6*70;N-desmethyltamoxifen;Chemical;PA165971622;Haplotype
CYP2D6*71;N-desmethyltamoxifen;Chemical;PA165971623;Haplotype
CYP2D6*72;N-desmethyltamoxifen;Chemical;PA165971624;Haplotype
CYP2D6*75;N-desmethyltamoxifen;Chemical;PA165971627;Haplotype
CYP2D6*35;N-desmethyltamoxifen;Chemical;PA165988487;Haplotype
CYP2D6*36;N-desmethyltamoxifen;Chemical;PA165988488;Haplotype
CYP2D6*45;N-desmethyltamoxifen;Chemical;PA165988489;Haplotype
CYP2D6*39;N-desmethyltamoxifen;Chemical;PA166001447;Haplotype
CYP3A4*22;N-desmethyltamoxifen;Chemical;PA166048680;Haplotype
CYP2D6*114;N-desmethyltamoxifen;Chemical;PA166181184;Haplotype
CYP2D6*14;N-desmethyltamoxifen;Chemical;PA166181185;Haplotype
G6PD;bisoprolol fumarate / perindopril arginine;Chemical;PA28469;Gene
DIABETES MELLITUS;rs12795437;Variant;PA443886;Disease
HYPERTENSION;rs12795437;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs12795437;Variant;PA449899;Chemical
TPMT POOR METABOLIZER;thioguanosine monophosphate;Chemical;PA166157904;Variant
TPMT;thioguanosine monophosphate;Chemical;PA356;Gene
CASR;PLCD1;Gene;PA26097;Gene
PRKCA;PLCD1;Gene;PA33759;Gene
PRKCB;PLCD1;Gene;PA33761;Gene
PRKCG;PLCD1;Gene;PA33766;Gene
PRKCH;PLCD1;Gene;PA33767;Gene
PRKCI;PLCD1;Gene;PA33768;Gene
PRKD1;PLCD1;Gene;PA33771;Gene
PRKCZ;PLCD1;Gene;PA33775;Gene
OXALIPLATIN;UGT1A7*3;Haplotype;PA131285527;Chemical
TEGAFUR / GIMERACIL / OTERACIL;UGT1A7*3;Haplotype;PA166115442;Chemical
DIARRHEA;UGT1A7*3;Haplotype;PA443899;Disease
NEUTROPENIA;UGT1A7*3;Haplotype;PA445113;Disease
STOMACH NEOPLASMS;UGT1A7*3;Haplotype;PA445742;Disease
VOMITING;UGT1A7*3;Haplotype;PA446051;Disease
COLORECTAL NEOPLASMS;UGT1A7*3;Haplotype;PA446108;Disease
IRINOTECAN;UGT1A7*3;Haplotype;PA450085;Chemical
DOBUTAMINE;rs62205366;Variant;PA449381;Chemical
TAAR6;corticosteroids;Chemical;PA134881141;Gene
DCAF4;corticosteroids;Chemical;PA165478762;Gene
RS1741981;corticosteroids;Chemical;PA166153635;Variant
RS7160796;corticosteroids;Chemical;PA166154813;Variant
RS1876828;corticosteroids;Chemical;PA166155193;Variant
RS2240017;corticosteroids;Chemical;PA166155202;Variant
RS724710;corticosteroids;Chemical;PA166155599;Variant
RS138335;corticosteroids;Chemical;PA166156042;Variant
RS138337;corticosteroids;Chemical;PA166156043;Variant
RS3842689;corticosteroids;Chemical;PA166156387;Variant
RS1042713;corticosteroids;Chemical;PA166156748;Variant
RS4713916;corticosteroids;Chemical;PA166157104;Variant
RS7772821;corticosteroids;Chemical;PA166157130;Variant
RS2241843;corticosteroids;Chemical;PA166176351;Variant
BCL2L11;corticosteroids;Chemical;PA25305;Gene
ABCB1;corticosteroids;Chemical;PA267;Gene
CRHR1;corticosteroids;Chemical;PA26874;Gene
FKBP5;corticosteroids;Chemical;PA28162;Gene
HDAC1;corticosteroids;Chemical;PA29226;Gene
ST13;corticosteroids;Chemical;PA36167;Gene
TBX21;corticosteroids;Chemical;PA36362;Gene
NR1I2;corticosteroids;Chemical;PA378;Gene
ADRB2;corticosteroids;Chemical;PA39;Gene
ALCOHOL ABUSE;rs2066713;Variant;PA443309;Disease
ETHANOL;rs2066713;Variant;PA448073;Chemical
MAJOR DEPRESSIVE DISORDER;rs4737771;Variant;PA447321;Disease
ANTIDEPRESSANTS;rs4737771;Variant;PA452229;Chemical
FLUOROURACIL;rs374825099;Variant;PA128406956;Chemical
DRUG TOXICITY;rs374825099;Variant;PA443937;Disease
DIABETES MELLITUS, TYPE 2;rs2237892;Variant;PA443890;Disease
REPAGLINIDE;rs2237892;Variant;PA451234;Chemical
CFTR;rs141033578;Variant;PA109;Gene
IVACAFTOR;rs141033578;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs141033578;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs141033578;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs141033578;Variant;PA443829;Disease
HIV INFECTIOUS DISEASE;rs746647;Variant;PA447230;Disease
NEVIRAPINE;rs746647;Variant;PA450616;Chemical
BORTEZOMIB;CTLA4;Gene;PA10252;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;CTLA4;Gene;PA164712462;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;CTLA4;Gene;PA164713366;Chemical
KIDNEY TRANSPLANTATION;CTLA4;Gene;PA165817016;Disease
PSORIASIS;CTLA4;Gene;PA445451;Disease
CYCLOSPORINE;CTLA4;Gene;PA449167;Chemical
DEXAMETHASONE;CTLA4;Gene;PA449247;Chemical
MELPHALAN;CTLA4;Gene;PA450354;Chemical
PREDNISONE;CTLA4;Gene;PA451100;Chemical
TACROLIMUS;CTLA4;Gene;PA451578;Chemical
PEGINTERFERON ALFA-2A;rs10846744;Variant;PA164749390;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;rs10846744;Variant;PA446863;Disease
RIBAVIRIN;rs10846744;Variant;PA451241;Chemical
HEARING LOSS;rs1872328;Variant;PA145069467;Disease
OTOTOXICITY;rs1872328;Variant;PA162263534;Disease
BRAIN NEOPLASMS;rs1872328;Variant;PA443557;Disease
CISPLATIN;rs1872328;Variant;PA449014;Chemical
RS267606617;isepamicin;Chemical;PA166159181;Variant
MT-ND1;isepamicin;Chemical;PA31259;Gene
MT-RNR1;isepamicin;Chemical;PA31274;Gene
CYP2C19;lansoprazole;Chemical;PA124;Gene
CYP3A5;lansoprazole;Chemical;PA131;Gene
SLCO1B1;lansoprazole;Chemical;PA134865839;Gene
CYP2C19*8;lansoprazole;Chemical;PA165816524;Haplotype
CYP2C19*9;lansoprazole;Chemical;PA165816525;Haplotype
CYP2C19*17;lansoprazole;Chemical;PA165816533;Haplotype
CYP2C19*1;lansoprazole;Chemical;PA165980634;Haplotype
CYP2C19*2;lansoprazole;Chemical;PA165980635;Haplotype
CYP2C19*3;lansoprazole;Chemical;PA165980636;Haplotype
RS4149056;lansoprazole;Chemical;PA166154579;Variant
RS16944;lansoprazole;Chemical;PA166155587;Variant
RS1045642;lansoprazole;Chemical;PA166157284;Variant
CYP2C19 EXTENSIVE METABOLIZER;lansoprazole;Chemical;PA166161835;Variant
ABCB1;lansoprazole;Chemical;PA267;Gene
CYP1A2;lansoprazole;Chemical;PA27093;Gene
IL1B;lansoprazole;Chemical;PA29808;Gene
NR1I2;lansoprazole;Chemical;PA378;Gene
SLC22A6;lansoprazole;Chemical;PA388;Gene
SLC22A8;lansoprazole;Chemical;PA389;Gene
DULOXETINE;NRXN1;Gene;PA10066;Chemical
SCHIZOPHRENIA;NRXN1;Gene;PA447216;Disease
MAJOR DEPRESSIVE DISORDER;NRXN1;Gene;PA447321;Disease
ANTIPSYCHOTICS;NRXN1;Gene;PA452233;Chemical
PEGINTERFERON ALFA-2A;rs12980275;Variant;PA164749390;Chemical
PEGINTERFERON ALFA-2B;rs12980275;Variant;PA164784024;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;rs12980275;Variant;PA446863;Disease
RIBAVIRIN;rs12980275;Variant;PA451241;Chemical
HYPERTENSION;rs3745009;Variant;PA444552;Disease
NIFEDIPINE;rs3745009;Variant;PA450631;Chemical
WARFARIN;CYP2C9*58;Haplotype;PA451906;Chemical
DIABETES MELLITUS;SLC2A2;Gene;PA443886;Disease
METFORMIN;SLC2A2;Gene;PA450395;Chemical
CYP2A6;letrozole;Chemical;PA121;Gene
ESR1;letrozole;Chemical;PA156;Gene
CYP2A6*1;letrozole;Chemical;PA165924690;Haplotype
CYP2A6*46;letrozole;Chemical;PA165924691;Haplotype
CYP2A6*2;letrozole;Chemical;PA165924719;Haplotype
CYP2A6*4;letrozole;Chemical;PA165924721;Haplotype
CYP2A6*7;letrozole;Chemical;PA165924731;Haplotype
CYP2A6*17;letrozole;Chemical;PA165924744;Haplotype
CYP2A6*20;letrozole;Chemical;PA165924749;Haplotype
CYP2A6*23;letrozole;Chemical;PA165924752;Haplotype
CYP2A6*26;letrozole;Chemical;PA165924756;Haplotype
CYP2A6*9;letrozole;Chemical;PA165980914;Haplotype
CYP2A6*12;letrozole;Chemical;PA165980915;Haplotype
CYP2A6*35;letrozole;Chemical;PA165980920;Haplotype
RS7984870;letrozole;Chemical;PA166154722;Variant
RS10140457;letrozole;Chemical;PA166154819;Variant
RS4646;letrozole;Chemical;PA166154836;Variant
RS10046;letrozole;Chemical;PA166154837;Variant
RS700518;letrozole;Chemical;PA166154847;Variant
RS749292;letrozole;Chemical;PA166154849;Variant
RS1008805;letrozole;Chemical;PA166154854;Variant
RS1062033;letrozole;Chemical;PA166154858;Variant
RS2289105;letrozole;Chemical;PA166154884;Variant
RS3759811;letrozole;Chemical;PA166154903;Variant
RS4775936;letrozole;Chemical;PA166154912;Variant
RS6493497;letrozole;Chemical;PA166154917;Variant
RS2234693;letrozole;Chemical;PA166157026;Variant
RS4870061;letrozole;Chemical;PA166157106;Variant
RS9322335;letrozole;Chemical;PA166157137;Variant
RS9340799;letrozole;Chemical;PA166157143;Variant
RS2073618;letrozole;Chemical;PA166157573;Variant
PGR;letrozole;Chemical;PA266;Gene
CYP19A1;letrozole;Chemical;PA27091;Gene
ESR2;letrozole;Chemical;PA27886;Gene
TNFRSF11B;letrozole;Chemical;PA36602;Gene
TNFSF11;letrozole;Chemical;PA36619;Gene
RADIOTHERAPY;rs7582141;Variant;PA166122986;Chemical
PROSTATIC NEOPLASMS;rs7582141;Variant;PA445425;Disease
BEVACIZUMAB;rs800292;Variant;PA130232992;Chemical
CYP2C9;gefitinib;Chemical;PA126;Gene
CYP2D6;gefitinib;Chemical;PA128;Gene
CYP3A5;gefitinib;Chemical;PA131;Gene
IKBKE;gefitinib;Chemical;PA134962294;Gene
CYP2D6*1;gefitinib;Chemical;PA165816576;Haplotype
CYP2D6*2;gefitinib;Chemical;PA165816577;Haplotype
CYP2D6*3;gefitinib;Chemical;PA165816578;Haplotype
CYP2D6*4;gefitinib;Chemical;PA165816579;Haplotype
CYP2D6*6;gefitinib;Chemical;PA165816581;Haplotype
CYP2D6*10;gefitinib;Chemical;PA165816582;Haplotype
CYP2D6*41;gefitinib;Chemical;PA165816584;Haplotype
CYP2D6*5;gefitinib;Chemical;PA165948092;Haplotype
CYP2D6*87;gefitinib;Chemical;PA166123327;Haplotype
CYP2D6*90;gefitinib;Chemical;PA166123330;Haplotype
CYP2D6*92;gefitinib;Chemical;PA166123332;Haplotype
CYP2D6*93;gefitinib;Chemical;PA166123333;Haplotype
CYP2D6*95;gefitinib;Chemical;PA166123336;Haplotype
CYP2D6*96;gefitinib;Chemical;PA166123337;Haplotype
CYP2D6*98;gefitinib;Chemical;PA166123339;Haplotype
CYP2D6*4XN;gefitinib;Chemical;PA166123455;Haplotype
CYP3A5*1;gefitinib;Chemical;PA166128213;Haplotype
CYP3A5*3;gefitinib;Chemical;PA166128219;Haplotype
RS2231142;gefitinib;Chemical;PA166156544;Variant
RS726501;gefitinib;Chemical;PA166156739;Variant
RS712829;gefitinib;Chemical;PA166157262;Variant
RS1128503;gefitinib;Chemical;PA166157288;Variant
RS2293347;gefitinib;Chemical;PA166157355;Variant
RS121434568;gefitinib;Chemical;PA166157527;Variant
RS121434569;gefitinib;Chemical;PA166157528;Variant
RS11568315;gefitinib;Chemical;PA166158794;Variant
CYP2D6*114;gefitinib;Chemical;PA166181184;Haplotype
CYP2D6*14;gefitinib;Chemical;PA166181185;Haplotype
RS11227247;gefitinib;Chemical;PA166203341;Variant
RS2272733;gefitinib;Chemical;PA166203342;Variant
RS12142086;gefitinib;Chemical;PA166203343;Variant
RS2151222;gefitinib;Chemical;PA166203361;Variant
RS3748022;gefitinib;Chemical;PA166203403;Variant
RS2233406;gefitinib;Chemical;PA166203407;Variant
RS2233407;gefitinib;Chemical;PA166203408;Variant
RS2233409;gefitinib;Chemical;PA166203409;Variant
RS8904;gefitinib;Chemical;PA166203410;Variant
RS2053071;gefitinib;Chemical;PA166203411;Variant
RS2695121;gefitinib;Chemical;PA166203413;Variant
RS577001;gefitinib;Chemical;PA166203424;Variant
RS9694958;gefitinib;Chemical;PA166203441;Variant
ABCB1;gefitinib;Chemical;PA267;Gene
ERBB2;gefitinib;Chemical;PA27844;Gene
ERBB3;gefitinib;Chemical;PA27846;Gene
ERBB4;gefitinib;Chemical;PA27847;Gene
RELA;gefitinib;Chemical;PA296;Gene
IKBKB;gefitinib;Chemical;PA29776;Gene
MAP3K1;gefitinib;Chemical;PA30592;Gene
TAB2;gefitinib;Chemical;PA30605;Gene
NFKBIA;gefitinib;Chemical;PA31601;Gene
NFKBIB;gefitinib;Chemical;PA31602;Gene
NR1H2;gefitinib;Chemical;PA31750;Gene
SIRT2;gefitinib;Chemical;PA35786;Gene
ABCG2;gefitinib;Chemical;PA390;Gene
EGFR;gefitinib;Chemical;PA7360;Gene
ACTA1;Myopathies, Structural, Congenital;Disease;PA24455;Gene
MTM1;Myopathies, Structural, Congenital;Disease;PA31251;Gene
NEB;Myopathies, Structural, Congenital;Disease;PA31530;Gene
RYR1;Myopathies, Structural, Congenital;Disease;PA34896;Gene
TPM3;Myopathies, Structural, Congenital;Disease;PA36692;Gene
SELENON;Myopathies, Structural, Congenital;Disease;PA38079;Gene
CARBOCISTEINE;rs5030858;Variant;PA166184060;Chemical
L-PHENYLALANINE;rs5030858;Variant;PA450931;Chemical
CYP3A4;sunitinib;Chemical;PA130;Gene
CYP3A5;sunitinib;Chemical;PA131;Gene
RS4149117;sunitinib;Chemical;PA166154583;Variant
RS1933437;sunitinib;Chemical;PA166154705;Variant
RS6785049;sunitinib;Chemical;PA166156411;Variant
RS1126647;sunitinib;Chemical;PA166156502;Variant
RS2231142;sunitinib;Chemical;PA166156544;Variant
RS307821;sunitinib;Chemical;PA166156728;Variant
RS307826;sunitinib;Chemical;PA166156730;Variant
RS1800925;sunitinib;Chemical;PA166156774;Variant
RS699947;sunitinib;Chemical;PA166156938;Variant
RS833061;sunitinib;Chemical;PA166156958;Variant
RS776746;sunitinib;Chemical;PA166157267;Variant
RS1045642;sunitinib;Chemical;PA166157284;Variant
RS1057868;sunitinib;Chemical;PA166157286;Variant
RS1128503;sunitinib;Chemical;PA166157288;Variant
RS2032582;sunitinib;Chemical;PA166157316;Variant
IL13;sunitinib;Chemical;PA199;Gene
ABCB1;sunitinib;Chemical;PA267;Gene
FLT1;sunitinib;Chemical;PA28180;Gene
FLT3;sunitinib;Chemical;PA28181;Gene
FLT4;sunitinib;Chemical;PA28183;Gene
CXCL8;sunitinib;Chemical;PA29841;Gene
KDR;sunitinib;Chemical;PA30086;Gene
KIT;sunitinib;Chemical;PA30128;Gene
PDGFRB;sunitinib;Chemical;PA33148;Gene
POR;sunitinib;Chemical;PA33532;Gene
RET;sunitinib;Chemical;PA34335;Gene
SLCO1B3;sunitinib;Chemical;PA35844;Gene
VEGFA;sunitinib;Chemical;PA37302;Gene
NR1I2;sunitinib;Chemical;PA378;Gene
ABCG2;sunitinib;Chemical;PA390;Gene
NR1I3;sunitinib;Chemical;PA391;Gene
ACUTE LYMPHOBLASTIC LEUKEMIA;rs6021191;Variant;PA446155;Disease
ASPARAGINASE;rs6021191;Variant;PA448492;Chemical
ABT-751;rs6431558;Variant;PA166104276;Chemical
NEOPLASMS;rs6431558;Variant;PA445062;Disease
UGT1A1*1;bone density;Disease;PA166115841;Haplotype
UGT1A1*28;bone density;Disease;PA166115842;Haplotype
VDR;bone density;Disease;PA37301;Gene
UGT1A1;bone density;Disease;PA420;Gene
RS731236;Osteitis Deformans;Disease;PA166154500;Variant
RS16944;Osteitis Deformans;Disease;PA166155587;Variant
IL1B;Osteitis Deformans;Disease;PA29808;Gene
VDR;Osteitis Deformans;Disease;PA37301;Gene
BUFURALOL;CYP2D6*64;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*64;Haplotype;PA166127651;Chemical
DEXTROMETHORPHAN;CYP2D6*64;Haplotype;PA449273;Chemical
PRIMAQUINE;CYP2D6*64;Haplotype;PA451103;Chemical
CYP2C9;4-hydroxytamoxifen;Chemical;PA126;Gene
CYP2D6;4-hydroxytamoxifen;Chemical;PA128;Gene
CYP3A4;4-hydroxytamoxifen;Chemical;PA130;Gene
CYP2D6*1;4-hydroxytamoxifen;Chemical;PA165816576;Haplotype
CYP2D6*4;4-hydroxytamoxifen;Chemical;PA165816579;Haplotype
CYP2D6*10;4-hydroxytamoxifen;Chemical;PA165816582;Haplotype
CYP3A4*1;4-hydroxytamoxifen;Chemical;PA165819201;Haplotype
CYP2D6*5;4-hydroxytamoxifen;Chemical;PA165948092;Haplotype
CYP3A4*22;4-hydroxytamoxifen;Chemical;PA166048680;Haplotype
HYPERGLYCEMIA;HMGCS2;Gene;PA444522;Disease
HYPERTENSION;HMGCS2;Gene;PA444552;Disease
CHLOROTHIAZIDE;HMGCS2;Gene;PA448953;Chemical
HYDROCHLOROTHIAZIDE;HMGCS2;Gene;PA449899;Chemical
RASBURICASE;G6PD deficiency;Variant;PA10176;Chemical
SULFAMETHOXAZOLE / TRIMETHOPRIM;G6PD deficiency;Variant;PA10715;Chemical
NALIDIXIC ACID;G6PD deficiency;Variant;PA164746384;Chemical
PHENAZOPYRIDINE;G6PD deficiency;Variant;PA164746899;Chemical
PEGLOTICASE;G6PD deficiency;Variant;PA165963961;Chemical
PREGNANCY;G6PD deficiency;Variant;PA166048714;Disease
HYPERURICEMIA;G6PD deficiency;Variant;PA166048814;Disease
MAFENIDE;G6PD deficiency;Variant;PA166114925;Chemical
PAMAQUINE;G6PD deficiency;Variant;PA166115579;Chemical
ANEMIA, HEMOLYTIC;G6PD deficiency;Variant;PA443343;Disease
BURKITT LYMPHOMA;G6PD deficiency;Variant;PA443580;Disease
COLITIS, ULCERATIVE;G6PD deficiency;Variant;PA443750;Disease
GOUT;G6PD deficiency;Variant;PA444318;Disease
HEMATURIA;G6PD deficiency;Variant;PA444400;Disease
HEMOLYSIS;G6PD deficiency;Variant;PA444411;Disease
HYPERBILIRUBINEMIA;G6PD deficiency;Variant;PA444511;Disease
JAUNDICE;G6PD deficiency;Variant;PA444648;Disease
KIDNEY FAILURE, ACUTE;G6PD deficiency;Variant;PA444683;Disease
LEUKEMIA, LYMPHOID;G6PD deficiency;Variant;PA444756;Disease
MALARIA;G6PD deficiency;Variant;PA444859;Disease
METHEMOGLOBINEMIA;G6PD deficiency;Variant;PA444942;Disease
NEOPLASMS;G6PD deficiency;Variant;PA445062;Disease
TYPHOID FEVER;G6PD deficiency;Variant;PA445970;Disease
TUMOR LYSIS SYNDROME;G6PD deficiency;Variant;PA446126;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;G6PD deficiency;Variant;PA446155;Disease
PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;G6PD deficiency;Variant;PA446166;Disease
MALARIA, VIVAX;G6PD deficiency;Variant;PA446392;Disease
HIV INFECTIONS;G6PD deficiency;Variant;PA447230;Disease
CHLORAMPHENICOL;G6PD deficiency;Variant;PA448927;Chemical
CHLOROQUINE;G6PD deficiency;Variant;PA448948;Chemical
DAPSONE;G6PD deficiency;Variant;PA449211;Chemical
MEFLOQUINE;G6PD deficiency;Variant;PA450348;Chemical
METHYLENE BLUE;G6PD deficiency;Variant;PA450457;Chemical
NITROFURANTOIN;G6PD deficiency;Variant;PA450640;Chemical
PRIMAQUINE;G6PD deficiency;Variant;PA451103;Chemical
QUININE;G6PD deficiency;Variant;PA451213;Chemical
SULFAMETHOXAZOLE;G6PD deficiency;Variant;PA451544;Chemical
SULFANILAMIDE;G6PD deficiency;Variant;PA451545;Chemical
SULFASALAZINE;G6PD deficiency;Variant;PA451547;Chemical
VITAMIN C;G6PD deficiency;Variant;PA451898;Chemical
ESCITALOPRAM;rs11144870;Variant;PA10074;Chemical
DEPRESSIVE DISORDER;rs11144870;Variant;PA447207;Disease
CITALOPRAM;rs11144870;Variant;PA449015;Chemical
TIMBETASIN;TMSB4X;Gene;PA166222901;Chemical
BUPROPION;CYP2B6*47;Haplotype;PA448687;Chemical
EFAVIRENZ;CYP2B6*47;Haplotype;PA449441;Chemical
RS6759892;deferiprone;Chemical;PA166155760;Variant
UGT1A6;deferiprone;Chemical;PA37181;Gene
MACULOPAPULAR EXANTHEMA;HLA-B*15:19;Haplotype;PA162316739;Disease
EPILEPSY;HLA-B*15:19;Haplotype;PA444065;Disease
OXCARBAZEPINE;HLA-B*15:19;Haplotype;PA450732;Chemical
CFTR;rs140883683;Variant;PA109;Gene
IVACAFTOR;rs140883683;Variant;PA165950341;Chemical
FLUOROURACIL;rs1801159;Variant;PA128406956;Chemical
DPYD;rs1801159;Variant;PA145;Gene
NEOPLASMS;rs1801159;Variant;PA445062;Disease
CAPECITABINE;rs1801159;Variant;PA448771;Chemical
ARIPIPRAZOLE;FAAH;Gene;PA10026;Chemical
CANNABINOIDS;FAAH;Gene;PA131890620;Chemical
SOMNOLENCE;FAAH;Gene;PA166185626;Disease
CONSTIPATION;FAAH;Gene;PA443782;Disease
DELIRIUM;FAAH;Gene;PA443851;Disease
LUNG NEOPLASMS;FAAH;Gene;PA444818;Disease
NAUSEA;FAAH;Gene;PA445048;Disease
PAIN;FAAH;Gene;PA445208;Disease
PRURITUS;FAAH;Gene;PA445437;Disease
RESPIRATORY INSUFFICIENCY;FAAH;Gene;PA445522;Disease
URINARY RETENTION;FAAH;Gene;PA446264;Disease
SUBSTANCE-RELATED DISORDERS;FAAH;Gene;PA446876;Disease
POSTOPERATIVE NAUSEA AND VOMITING;FAAH;Gene;PA446970;Disease
PSYCHOTIC DISORDER;FAAH;Gene;PA447215;Disease
CLOZAPINE;FAAH;Gene;PA449061;Chemical
HALOPERIDOL;FAAH;Gene;PA449841;Chemical
IBUPROFEN;FAAH;Gene;PA449957;Chemical
METHAMPHETAMINE;FAAH;Gene;PA450403;Chemical
MORPHINE;FAAH;Gene;PA450550;Chemical
OLANZAPINE;FAAH;Gene;PA450688;Chemical
QUETIAPINE;FAAH;Gene;PA451201;Chemical
RISPERIDONE;FAAH;Gene;PA451257;Chemical
OPIOIDS;FAAH;Gene;PA452618;Chemical
SEVOFLURANE;rs279858;Variant;PA451341;Chemical
CFTR;rs142773283;Variant;PA109;Gene
IVACAFTOR;rs142773283;Variant;PA165950341;Chemical
FEBUXOSTAT;XDH;Gene;PA165958521;Chemical
THIOXANTHINE;XDH;Gene;PA166163264;Chemical
HIV INFECTIOUS DISEASE;XDH;Gene;PA447230;Disease
ALLOPURINOL;XDH;Gene;PA448320;Chemical
DIDANOSINE;XDH;Gene;PA449301;Chemical
KCNH2;droperidol;Chemical;PA212;Gene
BETA BLOCKING AGENTS;rs139945292;Variant;PA164712535;Chemical
SCHIZOPHRENIA;rs3810950;Variant;PA447216;Disease
OLANZAPINE;rs3810950;Variant;PA450688;Chemical
CES1;Stroke;Disease;PA107;Gene
CYP2C19;Stroke;Disease;PA124;Gene
CYP2C9;Stroke;Disease;PA126;Gene
F2;Stroke;Disease;PA157;Gene
F12;Stroke;Disease;PA161;Gene
CYP2C19*6;Stroke;Disease;PA165816522;Haplotype
CYP2C19*8;Stroke;Disease;PA165816524;Haplotype
CYP2C19*17;Stroke;Disease;PA165816533;Haplotype
CYP2C9*1;Stroke;Disease;PA165816542;Haplotype
CYP2C9*2;Stroke;Disease;PA165816543;Haplotype
CYP2C9*3;Stroke;Disease;PA165816544;Haplotype
CYP2C19*1;Stroke;Disease;PA165980634;Haplotype
CYP2C19*2;Stroke;Disease;PA165980635;Haplotype
CYP2C19*3;Stroke;Disease;PA165980636;Haplotype
CYP2C19*4;Stroke;Disease;PA165980637;Haplotype
CYP2C19*5;Stroke;Disease;PA165980638;Haplotype
RS5065;Stroke;Disease;PA166153549;Variant
RS1799963;Stroke;Disease;PA166154336;Variant
RS669;Stroke;Disease;PA166154481;Variant
RS1801020;Stroke;Disease;PA166156775;Variant
RS8192950;Stroke;Disease;PA166162295;Variant
RS35068180;Stroke;Disease;PA166181205;Variant
A2M;Stroke;Disease;PA24357;Gene
NPPA;Stroke;Disease;PA256;Gene
ALDH1L1;Stroke;Disease;PA28393;Gene
PTGS2;Stroke;Disease;PA293;Gene
MMP3;Stroke;Disease;PA30886;Gene
ATRIAL FIBRILLATION;Stroke;Disease;PA443459;Disease
DULOXETINE;rs61908404;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs61908404;Variant;PA447321;Disease
PREGNANCY;CYP1A2 high activity;Variant;PA166048714;Disease
ABORTION, SPONTANEOUS;CYP1A2 high activity;Variant;PA443227;Disease
CAFFEINE;CYP1A2 high activity;Variant;PA448710;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;rs301435;Variant;PA164713257;Chemical
OBSESSIVE-COMPULSIVE DISORDER;rs301435;Variant;PA447211;Disease
OPIOID-RELATED DISORDERS;rs73568641;Variant;PA445043;Disease
METHADONE;rs73568641;Variant;PA450401;Chemical
CYB5R3;bupivacaine;Chemical;PA27331;Gene
G6PD;bupivacaine;Chemical;PA28469;Gene
ALK;Neuroblastoma;Disease;PA24719;Gene
CFTR;rs121909044;Variant;PA109;Gene
IVACAFTOR;rs121909044;Variant;PA165950341;Chemical
ASTHMA;COL22A1;Gene;PA443450;Disease
SALBUTAMOL;COL22A1;Gene;PA448068;Chemical
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA;PKP2;Gene;PA446847;Disease
HIV INFECTIOUS DISEASE;rs76228616;Variant;PA447230;Disease
NEVIRAPINE;rs76228616;Variant;PA450616;Chemical
RHEUMATOID ARTHRITIS;AHRR;Gene;PA443434;Disease
METHOTREXATE;AHRR;Gene;PA450428;Chemical
ACE INHIBITORS, PLAIN;rs7661530;Variant;PA164712308;Chemical
TOBACCO USE DISORDER;rs2229959;Variant;PA445876;Disease
NICOTINE;rs2229959;Variant;PA450626;Chemical
BUTYRYLCHOLINESTERASE DEFICIENCY;rs1803274;Variant;PA166122649;Disease
COGNITIVE DISORDER;rs1803274;Variant;PA166176306;Disease
ALZHEIMER DISEASE;rs1803274;Variant;PA443319;Disease
APNEA;rs1803274;Variant;PA443407;Disease
COCAINE DEPENDENCE;rs1803274;Variant;PA446878;Disease
LEWY BODY DISEASE;rs1803274;Variant;PA447127;Disease
COCAINE;rs1803274;Variant;PA449072;Chemical
DONEPEZIL;rs1803274;Variant;PA449394;Chemical
RIVASTIGMINE;rs1803274;Variant;PA451262;Chemical
SUCCINYLCHOLINE;rs1803274;Variant;PA451522;Chemical
DEXTROMETHORPHAN;CYP2D6*69;Haplotype;PA449273;Chemical
ABL1;omacetaxine;Chemical;PA24413;Gene
BCR;omacetaxine;Chemical;PA25321;Gene
AKT1;PDX1;Gene;PA24684;Gene
PLATINUM COMPOUNDS;rs1143623;Variant;PA164713176;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs1143623;Variant;PA164713366;Chemical
USTEKINUMAB;rs1143623;Variant;PA166048654;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs1143623;Variant;PA443622;Disease
PSORIASIS;rs1143623;Variant;PA445451;Disease
MENOPAUSE;rs10046;Variant;PA166048848;Disease
HDL CHOLESTEROL;rs10046;Variant;PA166129559;Chemical
BREAST NEOPLASMS;rs10046;Variant;PA443560;Disease
LETROZOLE;rs10046;Variant;PA450196;Chemical
TRIGLYCERIDES;rs10046;Variant;PA451776;Chemical
ESSENTIAL HYPERTENSION;GPR83;Gene;PA447288;Disease
CANDESARTAN;GPR83;Gene;PA448765;Chemical
HYDROCHLOROTHIAZIDE;GPR83;Gene;PA449899;Chemical
BEVACIZUMAB;rs5370;Variant;PA130232992;Chemical
MURAGLITAZAR;rs5370;Variant;PA162356187;Chemical
BREAST NEOPLASMS;rs5370;Variant;PA443560;Disease
DIABETES MELLITUS;rs5370;Variant;PA443886;Disease
EDEMA;rs5370;Variant;PA443994;Disease
HYPERLIPIDEMIAS;rs5370;Variant;PA444528;Disease
ESSENTIAL HYPERTENSION;rs5370;Variant;PA447288;Disease
ATENOLOL;rs5370;Variant;PA448499;Chemical
IRBESARTAN;rs5370;Variant;PA450084;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;ZNF211;Gene;PA447197;Disease
METHYLPHENIDATE;ZNF211;Gene;PA450464;Chemical
ZOLEDRONATE;rs2297480;Variant;PA10235;Chemical
BISPHOSPHONATES;rs2297480;Variant;PA164712563;Chemical
CORONARY DISEASE;rs2297480;Variant;PA443797;Disease
NEOPLASMS;rs2297480;Variant;PA445062;Disease
OSTEONECROSIS;rs2297480;Variant;PA445187;Disease
OSTEOPOROSIS;rs2297480;Variant;PA445190;Disease
OSTEOPOROSIS, POSTMENOPAUSAL;rs2297480;Variant;PA446214;Disease
ATORVASTATIN;rs2297480;Variant;PA448500;Chemical
CFTR;rs201958172;Variant;PA109;Gene
IVACAFTOR;rs201958172;Variant;PA165950341;Chemical
TENOFOVIR;rs12979860;Variant;PA10204;Chemical
IFNL3;rs12979860;Variant;PA134952671;Gene
PEGINTERFERON ALFA-2A;rs12979860;Variant;PA164749390;Chemical
PEGINTERFERON ALFA-2B;rs12979860;Variant;PA164784024;Chemical
BOCEPREVIR;rs12979860;Variant;PA165948902;Chemical
TELAPREVIR;rs12979860;Variant;PA165958354;Chemical
IFNL4;rs12979860;Variant;PA166049147;Gene
SIMEPREVIR;rs12979860;Variant;PA166122590;Chemical
SOFOSBUVIR;rs12979860;Variant;PA166122593;Chemical
DELEOBUVIR;rs12979860;Variant;PA166128130;Chemical
FALDAPREVIR;rs12979860;Variant;PA166128132;Chemical
LEDIPASVIR;rs12979860;Variant;PA166128166;Chemical
DACLATASVIR;rs12979860;Variant;PA166128167;Chemical
OMBITASVIR / PARITAPREVIR / RITONAVIR;rs12979860;Variant;PA166163408;Chemical
VELPATASVIR;rs12979860;Variant;PA166163415;Chemical
SOFOSBUVIR / VELPATASVIR;rs12979860;Variant;PA166163416;Chemical
VOXILAPREVIR;rs12979860;Variant;PA166171182;Chemical
HEPATITIS C VIRUS INFECTION;rs12979860;Variant;PA444445;Disease
MYELOPROLIFERATIVE DISORDER;rs12979860;Variant;PA445016;Disease
RECURRENCE;rs12979860;Variant;PA445506;Disease
HEPATITIS B, CHRONIC;rs12979860;Variant;PA446862;Disease
CHRONIC HEPATITIS C VIRUS INFECTION;rs12979860;Variant;PA446863;Disease
HIV INFECTIOUS DISEASE;rs12979860;Variant;PA447230;Disease
ATORVASTATIN;rs12979860;Variant;PA448500;Chemical
RIBAVIRIN;rs12979860;Variant;PA451241;Chemical
INTERFERONS;rs12979860;Variant;PA451999;Chemical
CYP2B6;diazepam;Chemical;PA123;Gene
CYP2C19;diazepam;Chemical;PA124;Gene
CYP2C9;diazepam;Chemical;PA126;Gene
CYP2D6;diazepam;Chemical;PA128;Gene
CYP3A4;diazepam;Chemical;PA130;Gene
CYP3A5;diazepam;Chemical;PA131;Gene
CYP2C9*1;diazepam;Chemical;PA165816542;Haplotype
CYP2C9*2;diazepam;Chemical;PA165816543;Haplotype
CYP2C19*1;diazepam;Chemical;PA165980634;Haplotype
CYP2C19*2;diazepam;Chemical;PA165980635;Haplotype
CYP2C19*3;diazepam;Chemical;PA165980636;Haplotype
HTR2A;diazepam;Chemical;PA193;Gene
HTR2C;diazepam;Chemical;PA194;Gene
CYP1A2;diazepam;Chemical;PA27093;Gene
DRD2;diazepam;Chemical;PA27478;Gene
SLC6A4;diazepam;Chemical;PA312;Gene
POLG;diazepam;Chemical;PA33500;Gene
HLA-A;diazepam;Chemical;PA35055;Gene
HLA-B;diazepam;Chemical;PA35056;Gene
UGT1A4;diazepam;Chemical;PA37179;Gene
NEOPLASMS;rs1901440;Variant;PA445062;Disease
GEMCITABINE;rs1901440;Variant;PA449748;Chemical
CETUXIMAB;rs885036;Variant;PA10040;Chemical
BEVACIZUMAB;rs885036;Variant;PA130232992;Chemical
OXALIPLATIN;rs885036;Variant;PA131285527;Chemical
COLORECTAL NEOPLASMS;rs885036;Variant;PA446108;Disease
CAPECITABINE;rs885036;Variant;PA448771;Chemical
CALCIUM CHANNEL BLOCKERS;NUMA1;Gene;PA10407;Chemical
HYPERTENSION;NUMA1;Gene;PA444552;Disease
ARIPIPRAZOLE;CYP2D6*4xN;Haplotype;PA10026;Chemical
GEFITINIB;CYP2D6*4xN;Haplotype;PA131301952;Chemical
ATOMOXETINE;CYP2D6*4xN;Haplotype;PA134688071;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CYP2D6*4xN;Haplotype;PA447197;Disease
DEXTROMETHORPHAN;CYP2D6*4xN;Haplotype;PA449273;Chemical
DEBRISOQUINE;CYP2D6*4xN;Haplotype;PA452616;Chemical
SALICYLAMIDE;rs6500265;Variant;PA165958416;Chemical
LOXOPROFEN;rs6500265;Variant;PA166049180;Chemical
ACETAMINOPHEN;rs6500265;Variant;PA448015;Chemical
IBUPROFEN;rs6500265;Variant;PA449957;Chemical
FLUOROURACIL;HMMR;Gene;PA128406956;Chemical
BREAST NEOPLASMS;HMMR;Gene;PA443560;Disease
NEUTROPENIA;HMMR;Gene;PA445113;Disease
CYCLOPHOSPHAMIDE;HMMR;Gene;PA449165;Chemical
EPIRUBICIN;HMMR;Gene;PA449476;Chemical
DOFETILIDE;rs36210421;Variant;PA449389;Chemical
CYP2B6;selegiline;Chemical;PA123;Gene
CYP3A4;selegiline;Chemical;PA130;Gene
RS622342;selegiline;Chemical;PA166156932;Variant
SLC22A1;selegiline;Chemical;PA329;Gene
CORONARY DISEASE;rs3732759;Variant;PA443797;Disease
CLOPIDOGREL;rs3732759;Variant;PA449053;Chemical
BIPOLAR DISORDER;rs59724122;Variant;PA447199;Disease
LITHIUM;rs59724122;Variant;PA450243;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs11465996;Variant;PA164713366;Chemical
PSORIASIS;rs11465996;Variant;PA445451;Disease
CESSATION;CYP2A6*25;Haplotype;PA166123046;Disease
TOBACCO USE DISORDER;CYP2A6*25;Haplotype;PA445876;Disease
NICOTINE;CYP2A6*25;Haplotype;PA450626;Chemical
TPMT;deoxy-thioguanosine triphosphate;Chemical;PA356;Gene
CORTICOSTEROIDS;rs138335;Variant;PA10832;Chemical
ASTHMA;rs138335;Variant;PA443450;Disease
ANEMIA;rs11185647;Variant;PA443340;Disease
NASOPHARYNGEAL NEOPLASMS;rs11185647;Variant;PA445046;Disease
NEUTROPENIA;rs11185647;Variant;PA445113;Disease
DOCETAXEL;rs11185647;Variant;PA449383;Chemical
CYP2D6;chlorpheniramine;Chemical;PA128;Gene
CYP3A5;chlorpheniramine;Chemical;PA131;Gene
LDLR;alirocumab;Chemical;PA227;Gene
POMC;alpha-MSH;Chemical;PA33526;Gene
CXCR4;mavorixafor;Chemical;PA27058;Gene
ETHAMBUTOL;rs4646244;Variant;PA164784021;Chemical
TUBERCULOSIS;rs4646244;Variant;PA445941;Disease
ISONIAZID;rs4646244;Variant;PA450112;Chemical
PYRAZINAMIDE;rs4646244;Variant;PA451182;Chemical
RIFAMPIN;rs4646244;Variant;PA451250;Chemical
ARIMOCLOMOL;NPC2;Gene;PA166400062;Chemical
LEVACETYLLEUCINE;NPC2;Gene;PA166400081;Chemical
RYR1;multi-core congenital myopathy;Disease;PA34896;Gene
ZOLEDRONATE;rs1934951;Variant;PA10235;Chemical
BISPHOSPHONATES;rs1934951;Variant;PA164712563;Chemical
BREAST NEOPLASMS;rs1934951;Variant;PA443560;Disease
MULTIPLE MYELOMA;rs1934951;Variant;PA444985;Disease
OSTEONECROSIS;rs1934951;Variant;PA445187;Disease
PACLITAXEL;rs1934951;Variant;PA450761;Chemical
PAMIDRONATE;rs1934951;Variant;PA450767;Chemical
FLUOROURACIL;rs4244285;Variant;PA128406956;Chemical
PRASUGREL;rs4244285;Variant;PA154410481;Chemical
ACUTE CORONARY SYNDROME;rs4244285;Variant;PA165108401;Disease
TICAGRELOR;rs4244285;Variant;PA165374673;Chemical
ETRAVIRINE;rs4244285;Variant;PA166014703;Chemical
BREAST NEOPLASMS;rs4244285;Variant;PA443560;Disease
SYSTEMIC LUPUS ERYTHEMATOSUS;rs4244285;Variant;PA444822;Disease
PANCREATIC NEOPLASMS;rs4244285;Variant;PA445218;Disease
HIV INFECTIOUS DISEASE;rs4244285;Variant;PA447230;Disease
DEPRESSION;rs4244285;Variant;PA447278;Disease
CLOPIDOGREL;rs4244285;Variant;PA449053;Chemical
CYCLOPHOSPHAMIDE;rs4244285;Variant;PA449165;Chemical
DOXORUBICIN;rs4244285;Variant;PA449412;Chemical
NELFINAVIR;rs4244285;Variant;PA450606;Chemical
VENLAFAXINE;rs4244285;Variant;PA451866;Chemical
CALCIUM CHANNEL BLOCKERS;rs10898815;Variant;PA10407;Chemical
HYPERTENSION;rs10898815;Variant;PA444552;Disease
PLCH1;PRKCZ;Gene;PA128394595;Gene
PLCZ1;PRKCZ;Gene;PA134875646;Gene
PLCH2;PRKCZ;Gene;PA134914471;Gene
PLCB1;PRKCZ;Gene;PA33384;Gene
PLCB2;PRKCZ;Gene;PA33385;Gene
PLCB3;PRKCZ;Gene;PA33386;Gene
PLCB4;PRKCZ;Gene;PA33387;Gene
PLCD1;PRKCZ;Gene;PA33388;Gene
PLCD3;PRKCZ;Gene;PA33389;Gene
PLCD4;PRKCZ;Gene;PA33390;Gene
PLCE1;PRKCZ;Gene;PA33391;Gene
PLCG1;PRKCZ;Gene;PA33392;Gene
PLCG2;PRKCZ;Gene;PA33393;Gene
PLCL1;PRKCZ;Gene;PA33394;Gene
PLCL2;PRKCZ;Gene;PA33395;Gene
RAF1;PRKCZ;Gene;PA34183;Gene
ADRB2;PRKCZ;Gene;PA39;Gene
TPMT;TPMT*10;Haplotype;PA356;Gene
CROHN DISEASE;TPMT*10;Haplotype;PA443815;Disease
AZATHIOPRINE;TPMT*10;Haplotype;PA448515;Chemical
MERCAPTOPURINE;TPMT*10;Haplotype;PA450379;Chemical
THIOGUANINE;TPMT*10;Haplotype;PA451663;Chemical
MAJOR DEPRESSIVE DISORDER;rs2742390;Variant;PA447321;Disease
BUPROPION;rs2742390;Variant;PA448687;Chemical
WEIGHT GAIN;rs1525085;Variant;PA128406954;Disease
ANTIPSYCHOTICS;rs1525085;Variant;PA452233;Chemical
IMATINIB;rs3764043;Variant;PA10804;Chemical
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;rs3764043;Variant;PA446171;Disease
PSYCHOTIC DISORDER;rs778293;Variant;PA447215;Disease
METHAMPHETAMINE;rs778293;Variant;PA450403;Chemical
CYP2C9;hydroxyphenytoin;Chemical;PA126;Gene
CYP2C9*1;hydroxyphenytoin;Chemical;PA165816542;Haplotype
CYP2C9*2;hydroxyphenytoin;Chemical;PA165816543;Haplotype
CYP2C9*11;hydroxyphenytoin;Chemical;PA165816552;Haplotype
FGB;eptifibatide;Chemical;PA163;Gene
ITGB3;eptifibatide;Chemical;PA205;Gene
ITGA2B;eptifibatide;Chemical;PA29938;Gene
FGA;eptifibatide;Chemical;PA429;Gene
FGG;eptifibatide;Chemical;PA430;Gene
MET;capmatinib;Chemical;PA30763;Gene
CALCIUM CHANNEL BLOCKERS;TANC2;Gene;PA10407;Chemical
HYPERTENSION;TANC2;Gene;PA444552;Disease
CYP2D6;valbenazine;Chemical;PA128;Gene
ALCOHOL ABUSE;rs2159140;Variant;PA443309;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs2159140;Variant;PA447197;Disease
ETHANOL;rs2159140;Variant;PA448073;Chemical
SLC29A1;tipiracil hydrochloride;Chemical;PA154;Gene
RS760370;tipiracil hydrochloride;Chemical;PA166156947;Variant
RS9394992;tipiracil hydrochloride;Chemical;PA166157157;Variant
HIV INFECTIOUS DISEASE;rs6545803;Variant;PA447230;Disease
NEVIRAPINE;rs6545803;Variant;PA450616;Chemical
CFTR;rs267606723;Variant;PA109;Gene
IVACAFTOR;rs267606723;Variant;PA165950341;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs267606723;Variant;PA166190041;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs267606723;Variant;PA166362502;Chemical
CYSTIC FIBROSIS;rs267606723;Variant;PA443829;Disease
METHYLCHOLANTHRENE;AHR;Gene;PA165816878;Chemical
PSYCHOTIC DISORDER;AHR;Gene;PA447215;Disease
OLANZAPINE;AHR;Gene;PA450688;Chemical
OMEPRAZOLE;AHR;Gene;PA450704;Chemical
XENOBIOTICS;AHR;Gene;PA452604;Chemical
G6PD DEFICIENCY;rs72554665;Variant;PA166048754;Disease
HEMOLYTIC ANEMIA;rs72554665;Variant;PA443343;Disease
GALNT14;Hepatocellular Carcinoma;Disease;PA134920089;Gene
UGT1A1*1;Hepatocellular Carcinoma;Disease;PA166115841;Haplotype
UGT1A1*28;Hepatocellular Carcinoma;Disease;PA166115842;Haplotype
RS7574296;Hepatocellular Carcinoma;Disease;PA166155765;Variant
RS9679162;Hepatocellular Carcinoma;Disease;PA166155774;Variant
RS12613732;Hepatocellular Carcinoma;Disease;PA166155818;Variant
RS1870377;Hepatocellular Carcinoma;Disease;PA166156528;Variant
RS2071559;Hepatocellular Carcinoma;Disease;PA166156537;Variant
RS4604006;Hepatocellular Carcinoma;Disease;PA166156591;Variant
RS1800629;Hepatocellular Carcinoma;Disease;PA166156997;Variant
RS2010963;Hepatocellular Carcinoma;Disease;PA166157006;Variant
RS1799983;Hepatocellular Carcinoma;Disease;PA166157303;Variant
RS2070744;Hepatocellular Carcinoma;Disease;PA166157325;Variant
RS2257212;Hepatocellular Carcinoma;Disease;PA166159807;Variant
RS3025040;Hepatocellular Carcinoma;Disease;PA166159965;Variant
NOS3;Hepatocellular Carcinoma;Disease;PA254;Gene
KDR;Hepatocellular Carcinoma;Disease;PA30086;Gene
SLC15A2;Hepatocellular Carcinoma;Disease;PA35812;Gene
VEGFA;Hepatocellular Carcinoma;Disease;PA37302;Gene
UGT1A9;Hepatocellular Carcinoma;Disease;PA419;Gene
UGT1A1;Hepatocellular Carcinoma;Disease;PA420;Gene
TNF;Hepatocellular Carcinoma;Disease;PA435;Gene
BREAST NEOPLASMS;rs2813543;Variant;PA443560;Disease
EXEMESTANE;rs2813543;Variant;PA449563;Chemical
CYP2D6;quinidine;Chemical;PA128;Gene
CYP3A4;quinidine;Chemical;PA130;Gene
RS1805128;quinidine;Chemical;PA166155994;Variant
RS104894021;quinidine;Chemical;PA166183768;Variant
KCNE1;quinidine;Chemical;PA211;Gene
KCNH2;quinidine;Chemical;PA212;Gene
ABCB1;quinidine;Chemical;PA267;Gene
SCN5A;quinidine;Chemical;PA304;Gene
WARFARIN;quinidine;Chemical;PA451906;Chemical
MMADHC;betaine;Chemical;PA164723053;Gene
MTHFR;betaine;Chemical;PA245;Gene
CBS;betaine;Chemical;PA26123;Gene
BIPOLAR DISORDER;MYO1H;Gene;PA447199;Disease
LITHIUM;MYO1H;Gene;PA450243;Chemical
CHOLIC ACID;DHCR7;Gene;PA166160055;Chemical
ASTHMA;rs2305089;Variant;PA443450;Disease
FLUNISOLIDE;rs2305089;Variant;PA449661;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;rs10514475;Variant;PA164713257;Chemical
DEPRESSION;rs10514475;Variant;PA447278;Disease
PACLITAXEL;rs11572103;Variant;PA450761;Chemical
SEVOFLURANE;rs3733784;Variant;PA451341;Chemical
ACE;Kidney Failure, Chronic;Disease;PA139;Gene
HLA-B*58:01;Kidney Failure, Chronic;Disease;PA165987831;Haplotype
HLA-C*03:02;Kidney Failure, Chronic;Disease;PA166123425;Haplotype
HLA-A*33:03;Kidney Failure, Chronic;Disease;PA166123428;Haplotype
RS1799752;Kidney Failure, Chronic;Disease;PA166155187;Variant
CYB5R3 DEFICIENCY;Kidney Failure, Chronic;Disease;PA166157902;Variant
CYB5R3;Kidney Failure, Chronic;Disease;PA27331;Gene
HLA-A;Kidney Failure, Chronic;Disease;PA35055;Gene
HLA-B;Kidney Failure, Chronic;Disease;PA35056;Gene
HLA-C;Kidney Failure, Chronic;Disease;PA35057;Gene
EFAVIRENZ;CYP2B6*27;Haplotype;PA449441;Chemical
O-DESMETHYLTRAMADOL;rs1328799050;Variant;PA166131379;Chemical
TAPENTADOL;rs1328799050;Variant;PA166179720;Chemical
ACETAMINOPHEN;rs1328799050;Variant;PA448015;Chemical
MORPHINE;rs1328799050;Variant;PA450550;Chemical
TRAMADOL;rs1328799050;Variant;PA451735;Chemical
CHRNA3;zilucoplan;Chemical;PA113;Gene
CHRNA7;zilucoplan;Chemical;PA114;Gene
CHRNA1;zilucoplan;Chemical;PA26487;Gene
CHRNA4;zilucoplan;Chemical;PA26490;Gene
CHRNA5;zilucoplan;Chemical;PA26491;Gene
CHRNA6;zilucoplan;Chemical;PA26492;Gene
CHRNB1;zilucoplan;Chemical;PA26494;Gene
CHRNE;zilucoplan;Chemical;PA26498;Gene
DIABETES MELLITUS;rs11124945;Variant;PA443886;Disease
HYPERTENSION;rs11124945;Variant;PA444552;Disease
ATENOLOL;rs11124945;Variant;PA448499;Chemical
VERAPAMIL;rs11124945;Variant;PA451868;Chemical
ALCOHOL ABUSE;rs10405681;Variant;PA443309;Disease
ETHANOL;rs10405681;Variant;PA448073;Chemical
CFTR;rs151048781;Variant;PA109;Gene
IVACAFTOR;rs151048781;Variant;PA165950341;Chemical
DIABETES MELLITUS, TYPE 2;rs10192566;Variant;PA443890;Disease
ROSIGLITAZONE;rs10192566;Variant;PA451283;Chemical
LYMPHOMA, NON-HODGKIN;CYP2B6*29;Haplotype;PA444845;Disease
CYCLOPHOSPHAMIDE;CYP2B6*29;Haplotype;PA449165;Chemical
TOBACCO USE DISORDER;CYP2A6*1x2;Haplotype;PA445876;Disease
NICOTINE;CYP2A6*1x2;Haplotype;PA450626;Chemical
TOXIC LIVER DISEASE;CYP2A7P1;Gene;PA164925725;Disease
NEONATAL ABSTINENCE SYNDROME;CYP2A7P1;Gene;PA165108809;Disease
DIARRHEA;CYP2A7P1;Gene;PA443899;Disease
DRUG TOXICITY;CYP2A7P1;Gene;PA443937;Disease
INFECTIOUS DISEASE;CYP2A7P1;Gene;PA444614;Disease
LUPUS NEPHRITIS;CYP2A7P1;Gene;PA444823;Disease
OPIOID-RELATED DISORDERS;CYP2A7P1;Gene;PA445043;Disease
CYCLOPHOSPHAMIDE;CYP2A7P1;Gene;PA449165;Chemical
METHADONE;CYP2A7P1;Gene;PA450401;Chemical
TRAMADOL;CYP2A7P1;Gene;PA451735;Chemical
OPIOIDS;CYP2A7P1;Gene;PA452618;Chemical
PRAVASTATIN;rs17244841;Variant;PA451089;Chemical
SIMVASTATIN;rs17244841;Variant;PA451363;Chemical
PONATINIB;rs121913459;Variant;PA165980594;Chemical
ASCIMINIB;rs121913459;Variant;PA166268841;Chemical
ABL1;rs121913459;Variant;PA24413;Gene
BCR;rs121913459;Variant;PA25321;Gene
DIURETICS;NEDD4L;Gene;PA151249535;Chemical
SGK1;NEDD4L;Gene;PA162403013;Gene
SCNN1A;NEDD4L;Gene;PA305;Gene
SCNN1B;NEDD4L;Gene;PA306;Gene
SCNN1G;NEDD4L;Gene;PA307;Gene
SLC12A3;NEDD4L;Gene;PA321;Gene
HYPERTENSION;NEDD4L;Gene;PA444552;Disease
DEPRESSION;NEDD4L;Gene;PA447278;Disease
CITALOPRAM;NEDD4L;Gene;PA449015;Chemical
HYDROCHLOROTHIAZIDE;NEDD4L;Gene;PA449899;Chemical
ATP1A1;NEDD4L;Gene;PA62;Gene
SCHIZOPHRENIA;rs17742120;Variant;PA447216;Disease
QUETIAPINE;rs17742120;Variant;PA451201;Chemical
TOBACCO USE DISORDER;CYP2A6*15;Haplotype;PA445876;Disease
METHOXSALEN;CYP2A6*15;Haplotype;PA450433;Chemical
NICOTINE;CYP2A6*15;Haplotype;PA450626;Chemical
GLUCOCORTICOIDS;NR3C1;Gene;PA452347;Chemical
NR1I2;permethrin;Chemical;PA378;Gene
RS1061622;Spondylitis, Ankylosing;Disease;PA166153618;Variant
RS1799724;Spondylitis, Ankylosing;Disease;PA166156988;Variant
RS1799964;Spondylitis, Ankylosing;Disease;PA166156990;Variant
RS1800629;Spondylitis, Ankylosing;Disease;PA166156997;Variant
HLA-B;Spondylitis, Ankylosing;Disease;PA35056;Gene
TNFRSF1B;Spondylitis, Ankylosing;Disease;PA36610;Gene
TNF;Spondylitis, Ankylosing;Disease;PA435;Gene
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs3810818;Variant;PA447197;Disease
METHYLPHENIDATE;rs3810818;Variant;PA450464;Chemical
CYP2C8;amodiaquine;Chemical;PA125;Gene
CYP2C8*2;amodiaquine;Chemical;PA165958684;Haplotype
CYP2C8*3;amodiaquine;Chemical;PA165958685;Haplotype
RS10509681;amodiaquine;Chemical;PA166154110;Variant
RS11572080;amodiaquine;Chemical;PA166154140;Variant
RS1050828;amodiaquine;Chemical;PA166157859;Variant
CYP1A1;amodiaquine;Chemical;PA27092;Gene
CYP1B1;amodiaquine;Chemical;PA27094;Gene
G6PD;amodiaquine;Chemical;PA28469;Gene
HMG COA REDUCTASE INHIBITORS;rs137852808;Variant;PA133950441;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs2290271;Variant;PA130620651;Chemical
CYP2C19;carisoprodol;Chemical;PA124;Gene
CYP2C19*1;carisoprodol;Chemical;PA165980634;Haplotype
CYP2C19*2;carisoprodol;Chemical;PA165980635;Haplotype
IVACAFTOR;rs397508328;Variant;PA165950341;Chemical
CYSTIC FIBROSIS;rs397508328;Variant;PA443829;Disease
CYP2C9;severe cutaneous adverse reactions;Disease;PA126;Gene
CYCSP5;severe cutaneous adverse reactions;Disease;PA142672032;Gene
CYP2C9*1;severe cutaneous adverse reactions;Disease;PA165816542;Haplotype
CYP2C9*3;severe cutaneous adverse reactions;Disease;PA165816544;Haplotype
NAT2*4;severe cutaneous adverse reactions;Disease;PA165949098;Haplotype
NAT2*5A;severe cutaneous adverse reactions;Disease;PA165949099;Haplotype
HLA-DRB1*07:01;severe cutaneous adverse reactions;Disease;PA165951644;Haplotype
HLA-DRB1*13:01;severe cutaneous adverse reactions;Disease;PA165951968;Haplotype
HLA-DRB1*13:02;severe cutaneous adverse reactions;Disease;PA165951978;Haplotype
HLA-DRB1*15:02;severe cutaneous adverse reactions;Disease;PA165952289;Haplotype
HLA-A*02:07;severe cutaneous adverse reactions;Disease;PA165952839;Haplotype
HLA-A*11:01;severe cutaneous adverse reactions;Disease;PA165953358;Haplotype
HLA-A*24:02;severe cutaneous adverse reactions;Disease;PA165953564;Haplotype
HLA-A*24:07;severe cutaneous adverse reactions;Disease;PA165953622;Haplotype
HLA-A*31:01;severe cutaneous adverse reactions;Disease;PA165954030;Haplotype
HLA-A*68:01;severe cutaneous adverse reactions;Disease;PA165954243;Haplotype
HLA-A*74:01;severe cutaneous adverse reactions;Disease;PA165954348;Haplotype
HLA-B*07:02;severe cutaneous adverse reactions;Disease;PA165954366;Haplotype
HLA-B*08:01;severe cutaneous adverse reactions;Disease;PA165954547;Haplotype
HLA-B*13:01;severe cutaneous adverse reactions;Disease;PA165954643;Haplotype
HLA-B*15:02;severe cutaneous adverse reactions;Disease;PA165954769;Haplotype
HLA-B*15:11;severe cutaneous adverse reactions;Disease;PA165954787;Haplotype
HLA-B*15:21;severe cutaneous adverse reactions;Disease;PA165954809;Haplotype
HLA-B*35:01;severe cutaneous adverse reactions;Disease;PA165955215;Haplotype
HLA-B*40:01;severe cutaneous adverse reactions;Disease;PA165955628;Haplotype
HLA-B*46:01;severe cutaneous adverse reactions;Disease;PA165956083;Haplotype
HLA-B*51:01;severe cutaneous adverse reactions;Disease;PA165956201;Haplotype
HLA-B*56:02;severe cutaneous adverse reactions;Disease;PA165956532;Haplotype
HLA-B*59:01;severe cutaneous adverse reactions;Disease;PA165956674;Haplotype
HLA-C*01:02;severe cutaneous adverse reactions;Disease;PA165956704;Haplotype
HLA-C*03:04;severe cutaneous adverse reactions;Disease;PA165956881;Haplotype
HLA-C*07:18;severe cutaneous adverse reactions;Disease;PA165957448;Haplotype
HLA-DQB1*05:02;severe cutaneous adverse reactions;Disease;PA165958077;Haplotype
HLA-DQB1*06:09;severe cutaneous adverse reactions;Disease;PA165958117;Haplotype
HLA-DQB1*02:02;severe cutaneous adverse reactions;Disease;PA165958162;Haplotype
HLA-DQB1*03:03;severe cutaneous adverse reactions;Disease;PA165958180;Haplotype
NAT2*5;severe cutaneous adverse reactions;Disease;PA165981634;Haplotype
NAT2*6;severe cutaneous adverse reactions;Disease;PA165981635;Haplotype
NAT2*7;severe cutaneous adverse reactions;Disease;PA165981636;Haplotype
NAT2*14;severe cutaneous adverse reactions;Disease;PA165981640;Haplotype
HLA-B*58:01;severe cutaneous adverse reactions;Disease;PA165987831;Haplotype
GSTM1 NULL;severe cutaneous adverse reactions;Disease;PA166048675;Haplotype
HLA-C*03:02;severe cutaneous adverse reactions;Disease;PA166123425;Haplotype
HLA-A*02:01;severe cutaneous adverse reactions;Disease;PA166123427;Haplotype
HLA-A*33:03;severe cutaneous adverse reactions;Disease;PA166123428;Haplotype
HLA-B*48:01;severe cutaneous adverse reactions;Disease;PA166123429;Haplotype
HLA-DRB1*03:01;severe cutaneous adverse reactions;Disease;PA166123430;Haplotype
RS2844665;severe cutaneous adverse reactions;Disease;PA166157053;Variant
RS3094188;severe cutaneous adverse reactions;Disease;PA166157064;Variant
RS3099844;severe cutaneous adverse reactions;Disease;PA166157066;Variant
RS3130501;severe cutaneous adverse reactions;Disease;PA166157069;Variant
RS3130931;severe cutaneous adverse reactions;Disease;PA166157071;Variant
RS3815087;severe cutaneous adverse reactions;Disease;PA166157086;Variant
RS9469003;severe cutaneous adverse reactions;Disease;PA166157162;Variant
RS3131003;severe cutaneous adverse reactions;Disease;PA166176035;Variant
RS367398;severe cutaneous adverse reactions;Disease;PA166176039;Variant
NAT2;severe cutaneous adverse reactions;Disease;PA18;Gene
GSTM1;severe cutaneous adverse reactions;Disease;PA182;Gene
NOTCH4;severe cutaneous adverse reactions;Disease;PA31686;Gene
POU5F1;severe cutaneous adverse reactions;Disease;PA33545;Gene
PSORS1C1;severe cutaneous adverse reactions;Disease;PA33919;Gene
PSORS1C3;severe cutaneous adverse reactions;Disease;PA33921;Gene
HLA-A;severe cutaneous adverse reactions;Disease;PA35055;Gene
HLA-B;severe cutaneous adverse reactions;Disease;PA35056;Gene
HLA-C;severe cutaneous adverse reactions;Disease;PA35057;Gene
HLA-DQB1;severe cutaneous adverse reactions;Disease;PA35068;Gene
HLA-DRB1;severe cutaneous adverse reactions;Disease;PA35072;Gene
CETUXIMAB;rs112445441;Variant;PA10040;Chemical
COLORECTAL NEOPLASMS;rs112445441;Variant;PA446108;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;STRBP;Gene;PA447197;Disease
METHYLPHENIDATE;STRBP;Gene;PA450464;Chemical
TPMT;TPMT*17;Haplotype;PA356;Gene
CROHN DISEASE;TPMT*17;Haplotype;PA443815;Disease
AZATHIOPRINE;TPMT*17;Haplotype;PA448515;Chemical
MERCAPTOPURINE;TPMT*17;Haplotype;PA450379;Chemical
THIOGUANINE;TPMT*17;Haplotype;PA451663;Chemical
CASR;PLCD4;Gene;PA26097;Gene
PRKCA;PLCD4;Gene;PA33759;Gene
PRKCB;PLCD4;Gene;PA33761;Gene
PRKCG;PLCD4;Gene;PA33766;Gene
PRKCH;PLCD4;Gene;PA33767;Gene
PRKCI;PLCD4;Gene;PA33768;Gene
PRKD1;PLCD4;Gene;PA33771;Gene
PRKCZ;PLCD4;Gene;PA33775;Gene
GEMCITABINE;FHL2;Gene;PA449748;Chemical
SCHIZOPHRENIA;CCL2;Gene;PA447216;Disease
RISPERIDONE;CCL2;Gene;PA451257;Chemical
MAJOR DEPRESSIVE DISORDER;rs2245705;Variant;PA447321;Disease
BUPROPION;rs2245705;Variant;PA448687;Chemical
ASTHMA;rs6988229;Variant;PA443450;Disease
SALBUTAMOL;rs6988229;Variant;PA448068;Chemical
HEMATOPOIETIC STEM CELL TRANSPLANTATION;rs1021737;Variant;PA166123007;Disease
BUSULFAN;rs1021737;Variant;PA448691;Chemical
CYCLOPHOSPHAMIDE;rs1021737;Variant;PA449165;Chemical
HYPERCHOLESTEROLEMIA;RHOA;Gene;PA444516;Disease
PRAVASTATIN;RHOA;Gene;PA451089;Chemical
SIMVASTATIN;RHOA;Gene;PA451363;Chemical
PANCREATIC NEOPLASMS;rs12507552;Variant;PA445218;Disease
GEMCITABINE;rs12507552;Variant;PA449748;Chemical
URINARY BLADDER NEOPLASMS;SLC14A1;Gene;PA443512;Disease
DRUGS FOR TREATMENT OF TUBERCULOSIS;rs4430924;Variant;PA164712708;Chemical
DRUG TOXICITY;rs4430924;Variant;PA443937;Disease
TUBERCULOSIS;rs4430924;Variant;PA445941;Disease
CFTR;rs80224560;Variant;PA109;Gene
IVACAFTOR;rs80224560;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs80224560;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs80224560;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs80224560;Variant;PA443829;Disease
CFTR;lumacaftor;Chemical;PA109;Gene
RS113993960;lumacaftor;Chemical;PA166157525;Variant
RS121909047;lumacaftor;Chemical;PA166178088;Variant
FLUOROURACIL;CYP2A6*7;Haplotype;PA128406956;Chemical
OXALIPLATIN;CYP2A6*7;Haplotype;PA131285527;Chemical
COUMARIN;CYP2A6*7;Haplotype;PA134521193;Chemical
TEGAFUR / GIMERACIL / OTERACIL;CYP2A6*7;Haplotype;PA166115442;Chemical
PROGRESSION-FREE SURVIVAL;CYP2A6*7;Haplotype;PA166123026;Disease
OVERALL SURVIVAL;CYP2A6*7;Haplotype;PA166123207;Disease
BILIARY TRACT NEOPLASMS;CYP2A6*7;Haplotype;PA166128807;Disease
BREAST NEOPLASMS;CYP2A6*7;Haplotype;PA443560;Disease
CARCINOMA, NON-SMALL-CELL LUNG;CYP2A6*7;Haplotype;PA443622;Disease
NEOPLASMS;CYP2A6*7;Haplotype;PA445062;Disease
STOMACH NEOPLASMS;CYP2A6*7;Haplotype;PA445742;Disease
TOBACCO USE DISORDER;CYP2A6*7;Haplotype;PA445876;Disease
COLORECTAL NEOPLASMS;CYP2A6*7;Haplotype;PA446108;Disease
CAFFEINE;CYP2A6*7;Haplotype;PA448710;Chemical
IRINOTECAN;CYP2A6*7;Haplotype;PA450085;Chemical
LETROZOLE;CYP2A6*7;Haplotype;PA450196;Chemical
NICOTINE;CYP2A6*7;Haplotype;PA450626;Chemical
PILOCARPINE;CYP2A6*7;Haplotype;PA450962;Chemical
TEGAFUR;CYP2A6*7;Haplotype;PA452620;Chemical
HYPERTENSION;rs740406;Variant;PA444552;Disease
CANDESARTAN;rs740406;Variant;PA448765;Chemical
TRIB2;allopurinol;Chemical;PA128394647;Gene
TBL1XR1;allopurinol;Chemical;PA134928556;Gene
GREM2;allopurinol;Chemical;PA134968998;Gene
CYCSP5;allopurinol;Chemical;PA142672032;Gene
NTNG1;allopurinol;Chemical;PA164742200;Gene
HLA-DRB1*09:01;allopurinol;Chemical;PA165951734;Haplotype
HLA-DRB1*13:02;allopurinol;Chemical;PA165951978;Haplotype
HLA-DRB1*14:01;allopurinol;Chemical;PA165952135;Haplotype
HLA-DRB1*15:02;allopurinol;Chemical;PA165952289;Haplotype
HLA-A*33:01;allopurinol;Chemical;PA165954144;Haplotype
HLA-DQB1*05:02;allopurinol;Chemical;PA165958077;Haplotype
HLA-B*58:01;allopurinol;Chemical;PA165987831;Haplotype
HLA-C*03:02;allopurinol;Chemical;PA166123425;Haplotype
HLA-C*08:01;allopurinol;Chemical;PA166123426;Haplotype
HLA-A*02:01;allopurinol;Chemical;PA166123427;Haplotype
HLA-A*33:03;allopurinol;Chemical;PA166123428;Haplotype
HLA-B*48:01;allopurinol;Chemical;PA166123429;Haplotype
HLA-DRB1*03:01;allopurinol;Chemical;PA166123430;Haplotype
RS2231142;allopurinol;Chemical;PA166156544;Variant
RS4148157;allopurinol;Chemical;PA166156582;Variant
RS10011796;allopurinol;Chemical;PA166156637;Variant
RS2844665;allopurinol;Chemical;PA166157053;Variant
RS3094188;allopurinol;Chemical;PA166157064;Variant
RS3099844;allopurinol;Chemical;PA166157066;Variant
RS3130501;allopurinol;Chemical;PA166157069;Variant
RS3130931;allopurinol;Chemical;PA166157071;Variant
RS3815087;allopurinol;Chemical;PA166157086;Variant
RS9469003;allopurinol;Chemical;PA166157162;Variant
RS2734583;allopurinol;Chemical;PA166161405;Variant
RS9263726;allopurinol;Chemical;PA166161422;Variant
RS3731722;allopurinol;Chemical;PA166161450;Variant
RS75995567;allopurinol;Chemical;PA166161452;Variant
RS34650714;allopurinol;Chemical;PA166161456;Variant
RS3131003;allopurinol;Chemical;PA166176035;Variant
RS367398;allopurinol;Chemical;PA166176039;Variant
RS77567654;allopurinol;Chemical;PA166182330;Variant
RS1934341;allopurinol;Chemical;PA166182332;Variant
RS4148155;allopurinol;Chemical;PA166182334;Variant
RS57449396;allopurinol;Chemical;PA166182335;Variant
RS10802887;allopurinol;Chemical;PA166182336;Variant
RS61816456;allopurinol;Chemical;PA166182337;Variant
RS79663562;allopurinol;Chemical;PA166182338;Variant
RS2725215;allopurinol;Chemical;PA166182339;Variant
RS10193126;allopurinol;Chemical;PA166182350;Variant
RS9366772;allopurinol;Chemical;PA166182351;Variant
RS76979899;allopurinol;Chemical;PA166182352;Variant
RS4659982;allopurinol;Chemical;PA166182353;Variant
AOX1;allopurinol;Chemical;PA24842;Gene
MYT1L;allopurinol;Chemical;PA31427;Gene
NOTCH4;allopurinol;Chemical;PA31686;Gene
PKD2;allopurinol;Chemical;PA33343;Gene
POU5F1;allopurinol;Chemical;PA33545;Gene
PSORS1C1;allopurinol;Chemical;PA33919;Gene
PSORS1C3;allopurinol;Chemical;PA33921;Gene
HLA-A;allopurinol;Chemical;PA35055;Gene
HLA-B;allopurinol;Chemical;PA35056;Gene
HLA-C;allopurinol;Chemical;PA35057;Gene
HLA-DQB1;allopurinol;Chemical;PA35068;Gene
HLA-DRB1;allopurinol;Chemical;PA35072;Gene
UGT1A10;allopurinol;Chemical;PA37174;Gene
UGT1A3;allopurinol;Chemical;PA37178;Gene
UGT1A4;allopurinol;Chemical;PA37179;Gene
UGT1A5;allopurinol;Chemical;PA37180;Gene
UGT1A6;allopurinol;Chemical;PA37181;Gene
UGT1A7;allopurinol;Chemical;PA37182;Gene
UGT1A8;allopurinol;Chemical;PA37183;Gene
XDH;allopurinol;Chemical;PA37404;Gene
ABCG2;allopurinol;Chemical;PA390;Gene
UGT1A9;allopurinol;Chemical;PA419;Gene
UGT1A1;allopurinol;Chemical;PA420;Gene
DULOXETINE;rs61908408;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs61908408;Variant;PA447321;Disease
HEROIN DEPENDENCE;GRM3;Gene;PA444460;Disease
SCHIZOPHRENIA;GRM3;Gene;PA447216;Disease
RISPERIDONE;GRM3;Gene;PA451257;Chemical
ANTIPSYCHOTICS;GRM3;Gene;PA452233;Chemical
HEROIN;GRM3;Gene;PA452619;Chemical
AKT1;MAFA;Gene;PA24684;Gene
MAPK8;MAFA;Gene;PA283;Gene
MAPK14;MAFA;Gene;PA30621;Gene
CYP2B6;ospemifene;Chemical;PA123;Gene
CYP2C9;ospemifene;Chemical;PA126;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;TLR9;Gene;PA164713366;Chemical
CROHN DISEASE;TLR9;Gene;PA443815;Disease
PSORIASIS;TLR9;Gene;PA445451;Disease
INFLAMMATORY BOWEL DISEASES;TLR9;Gene;PA446116;Disease
RYR2;catecholaminergic polymorphic ventricular tachycardia;Disease;PA300;Gene
CARBOPLATIN;rs17661089;Variant;PA448803;Chemical
CISPLATIN;rs17661089;Variant;PA449014;Chemical
DOCETAXEL;rs17661089;Variant;PA449383;Chemical
PACLITAXEL;rs17661089;Variant;PA450761;Chemical
IFNL4;Hepatitis B;Disease;PA166049147;Gene
RS11322783;Hepatitis B;Disease;PA166190881;Variant
SULFAMETHOXAZOLE / TRIMETHOPRIM;NAT2*6;Haplotype;PA10715;Chemical
ANTIVIRALS FOR TREATMENT OF HIV INFECTIONS, COMBINATIONS;NAT2*6;Haplotype;PA164712505;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;NAT2*6;Haplotype;PA164712708;Chemical
TOXIC LIVER DISEASE;NAT2*6;Haplotype;PA164925725;Disease
DRUG-INDUCED LIVER INJURY;NAT2*6;Haplotype;PA166119041;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;NAT2*6;Haplotype;PA166120929;Disease
DIPYRONE;NAT2*6;Haplotype;PA166128206;Chemical
ADVERSE EVENTS;NAT2*6;Haplotype;PA166151827;Disease
SOLITHROMYCIN;NAT2*6;Haplotype;PA166165147;Chemical
HYPERSENSITIVITY;NAT2*6;Haplotype;PA444546;Disease
HYPERTENSION;NAT2*6;Haplotype;PA444552;Disease
TUBERCULOSIS;NAT2*6;Haplotype;PA445941;Disease
HIV INFECTIONS;NAT2*6;Haplotype;PA447230;Disease
HYDRALAZINE;NAT2*6;Haplotype;PA449894;Chemical
ISONIAZID;NAT2*6;Haplotype;PA450112;Chemical
ADORA2A-AS1;Hematologic Neoplasms;Disease;PA165378332;Gene
HLA-DRB1*09:01;Hematologic Neoplasms;Disease;PA165951734;Haplotype
HLA-DRB1*14:01;Hematologic Neoplasms;Disease;PA165952135;Haplotype
HLA-C*08:01;Hematologic Neoplasms;Disease;PA166123426;Haplotype
HLA-B*48:01;Hematologic Neoplasms;Disease;PA166123429;Haplotype
RS2298383;Hematologic Neoplasms;Disease;PA166156099;Variant
ADORA2A;Hematologic Neoplasms;Disease;PA24584;Gene
HLA-B;Hematologic Neoplasms;Disease;PA35056;Gene
HLA-C;Hematologic Neoplasms;Disease;PA35057;Gene
HLA-DRB1;Hematologic Neoplasms;Disease;PA35072;Gene
GRK5;nadolol;Chemical;PA180;Gene
GRK4;nadolol;Chemical;PA28941;Gene
SLCO1A2;nadolol;Chemical;PA328;Gene
ADRA2C;nadolol;Chemical;PA37;Gene
ADRB1;nadolol;Chemical;PA38;Gene
ADRB2;nadolol;Chemical;PA39;Gene
NON-SMALL CELL LUNG CARCINOMA;rs16886403;Variant;PA443622;Disease
CARBOPLATIN;rs16886403;Variant;PA448803;Chemical
CISPLATIN;rs16886403;Variant;PA449014;Chemical
DOCETAXEL;rs16886403;Variant;PA449383;Chemical
PACLITAXEL;rs16886403;Variant;PA450761;Chemical
CESSATION;CYP2A6*35;Haplotype;PA166123046;Disease
BREAST NEOPLASMS;CYP2A6*35;Haplotype;PA443560;Disease
TOBACCO USE DISORDER;CYP2A6*35;Haplotype;PA445876;Disease
LETROZOLE;CYP2A6*35;Haplotype;PA450196;Chemical
NICOTINE;CYP2A6*35;Haplotype;PA450626;Chemical
CYP2C19;topiramate;Chemical;PA124;Gene
RS2306719;topiramate;Chemical;PA166154889;Variant
RS4984241;topiramate;Chemical;PA166154916;Variant
RS2396185;topiramate;Chemical;PA166155398;Variant
RS2304016;topiramate;Chemical;PA166155682;Variant
RS2832407;topiramate;Chemical;PA166156001;Variant
RS1045642;topiramate;Chemical;PA166157284;Variant
INSR;topiramate;Chemical;PA202;Gene
CA12;topiramate;Chemical;PA25987;Gene
ABCB1;topiramate;Chemical;PA267;Gene
GRIK1;topiramate;Chemical;PA28973;Gene
SCN2A;topiramate;Chemical;PA35004;Gene
NR1I2;topiramate;Chemical;PA378;Gene
SLCO1B1;statin-related myopathy;Disease;PA134865839;Gene
SLCO1B1*5;statin-related myopathy;Disease;PA165819255;Haplotype
SLCO1B1*15;statin-related myopathy;Disease;PA165819265;Haplotype
SLCO1B1*1;statin-related myopathy;Disease;PA165981641;Haplotype
RS4149056;statin-related myopathy;Disease;PA166154579;Variant
RS2231142;statin-related myopathy;Disease;PA166156544;Variant
RS1225367412;statin-related myopathy;Disease;PA166180969;Variant
ABCG2;statin-related myopathy;Disease;PA390;Gene
CACNA1S;statin-related myopathy;Disease;PA85;Gene
CYP2B6;propofol;Chemical;PA123;Gene
CYP2C9;propofol;Chemical;PA126;Gene
CYP2C9*1;propofol;Chemical;PA165816542;Haplotype
CYP2C9*2;propofol;Chemical;PA165816543;Haplotype
RS2279343;propofol;Chemical;PA166155393;Variant
RS3745274;propofol;Chemical;PA166155409;Variant
RS58597806;propofol;Chemical;PA166155889;Variant
RS1128503;propofol;Chemical;PA166157288;Variant
RS1042718;propofol;Chemical;PA166160473;Variant
RS1282926098;propofol;Chemical;PA166350825;Variant
RS373442191;propofol;Chemical;PA166350830;Variant
RS1969136524;propofol;Chemical;PA166350832;Variant
RS142421637;propofol;Chemical;PA166350842;Variant
RS752695347;propofol;Chemical;PA166350843;Variant
RS553968231;propofol;Chemical;PA166350862;Variant
RS773494867;propofol;Chemical;PA166350903;Variant
RS1969376664;propofol;Chemical;PA166350922;Variant
RS138264188;propofol;Chemical;PA166350925;Variant
ABCB1;propofol;Chemical;PA267;Gene
ADRB2;propofol;Chemical;PA39;Gene
UGT1A9;propofol;Chemical;PA419;Gene
RS267606618;aminoglycoside antibacterials;Chemical;PA166158908;Variant
RS267606619;aminoglycoside antibacterials;Chemical;PA166158909;Variant
RS267606617;aminoglycoside antibacterials;Chemical;PA166159181;Variant
RS28358572;aminoglycoside antibacterials;Chemical;PA166229181;Variant
RS1556422499;aminoglycoside antibacterials;Chemical;PA166241841;Variant
RS1603218569;aminoglycoside antibacterials;Chemical;PA166241901;Variant
MT-ND1;aminoglycoside antibacterials;Chemical;PA31259;Gene
MT-RNR1;aminoglycoside antibacterials;Chemical;PA31274;Gene
MENOPAUSE;rs2289105;Variant;PA166048848;Disease
HDL CHOLESTEROL;rs2289105;Variant;PA166129559;Chemical
BREAST NEOPLASMS;rs2289105;Variant;PA443560;Disease
LETROZOLE;rs2289105;Variant;PA450196;Chemical
TRIGLYCERIDES;rs2289105;Variant;PA451776;Chemical
MAJOR DEPRESSIVE DISORDER;rs2228479;Variant;PA447321;Disease
DESIPRAMINE;rs2228479;Variant;PA449233;Chemical
DABIGATRAN;rs4148738;Variant;PA165110351;Chemical
APIXABAN;rs4148738;Variant;PA166163740;Chemical
ATRIAL FIBRILLATION;rs4148738;Variant;PA443459;Disease
MTTP;APOC1;Gene;PA164742099;Gene
AUTISTIC DISORDER;MACROD2;Gene;PA447198;Disease
CYB5R3;CYB5A;Gene;PA27331;Gene
GNB4;PLCB1;Gene;PA134864200;Gene
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;PLCB1;Gene;PA164713257;Chemical
GNAQ;PLCB1;Gene;PA174;Gene
GNB3;PLCB1;Gene;PA176;Gene
GP1BB;PLCB1;Gene;PA179;Gene
ITGA2;PLCB1;Gene;PA204;Gene
ITGB3;PLCB1;Gene;PA205;Gene
CASR;PLCB1;Gene;PA26097;Gene
CD36;PLCB1;Gene;PA26212;Gene
PLA2G2A;PLCB1;Gene;PA270;Gene
PLA2G4A;PLCB1;Gene;PA271;Gene
GNA11;PLCB1;Gene;PA28764;Gene
GNA12;PLCB1;Gene;PA28765;Gene
GNA13;PLCB1;Gene;PA28766;Gene
GNA15;PLCB1;Gene;PA28768;Gene
GNB1;PLCB1;Gene;PA28776;Gene
GNB1L;PLCB1;Gene;PA28777;Gene
GNB2;PLCB1;Gene;PA28778;Gene
GNG2;PLCB1;Gene;PA28784;Gene
GNG3;PLCB1;Gene;PA28785;Gene
GNG4;PLCB1;Gene;PA28786;Gene
GNG5;PLCB1;Gene;PA28787;Gene
GNG7;PLCB1;Gene;PA28789;Gene
GP5;PLCB1;Gene;PA28823;Gene
GP6;PLCB1;Gene;PA28824;Gene
GP9;PLCB1;Gene;PA28825;Gene
ITGA2B;PLCB1;Gene;PA29938;Gene
PLA2G4B;PLCB1;Gene;PA33364;Gene
PRKCA;PLCB1;Gene;PA33759;Gene
PRKCB;PLCB1;Gene;PA33761;Gene
PRKCG;PLCB1;Gene;PA33766;Gene
PRKCH;PLCB1;Gene;PA33767;Gene
PRKCI;PLCB1;Gene;PA33768;Gene
PRKD1;PLCB1;Gene;PA33771;Gene
PRKCZ;PLCB1;Gene;PA33775;Gene
ADRB2;PLCB1;Gene;PA39;Gene
DEPRESSION;PLCB1;Gene;PA447278;Disease
PAIN, POSTOPERATIVE;rs13093031;Variant;PA445210;Disease
FENTANYL;rs13093031;Variant;PA449599;Chemical
SCHIZOPHRENIA;rs2975226;Variant;PA447216;Disease
CLOZAPINE;rs2975226;Variant;PA449061;Chemical
TOBACCO USE DISORDER;rs324650;Variant;PA445876;Disease
NICOTINE;rs324650;Variant;PA450626;Chemical
DIABETES MELLITUS, TYPE 2;AQP2;Gene;PA443890;Disease
THIAZOLIDINEDIONES;AQP2;Gene;PA452631;Chemical
ATAZANAVIR;bilirubin;Chemical;PA10251;Chemical
UGT1A1*1;bilirubin;Chemical;PA166115841;Haplotype
UGT1A1*28;bilirubin;Chemical;PA166115842;Haplotype
UGT1A1*6;bilirubin;Chemical;PA166115858;Haplotype
RS11563250;bilirubin;Chemical;PA166155802;Variant
UGT1A;bilirubin;Chemical;PA37173;Gene
UGT1A1;bilirubin;Chemical;PA420;Gene
IRINOTECAN;bilirubin;Chemical;PA450085;Chemical
HYPERTENSION;NR3C2;Gene;PA444552;Disease
ENALAPRIL;NR3C2;Gene;PA449456;Chemical
ANEMIA;GSTM3;Gene;PA443340;Disease
DRUG TOXICITY;GSTM3;Gene;PA443937;Disease
NEOPLASM METASTASIS;GSTM3;Gene;PA445058;Disease
OVARIAN NEOPLASMS;GSTM3;Gene;PA445204;Disease
PERIPHERAL NERVOUS SYSTEM DISEASES;GSTM3;Gene;PA445301;Disease
PROSTATIC NEOPLASMS;GSTM3;Gene;PA445425;Disease
OSTEOSARCOMA;GSTM3;Gene;PA445601;Disease
THROMBOCYTOPENIA;GSTM3;Gene;PA445846;Disease
NEUROTOXICITY SYNDROMES;GSTM3;Gene;PA446975;Disease
CISPLATIN;GSTM3;Gene;PA449014;Chemical
CYCLOPHOSPHAMIDE;GSTM3;Gene;PA449165;Chemical
OLANZAPINE;GSTM3;Gene;PA450688;Chemical
MYCOPHENOLIC ACID;rs11706052;Variant;PA164748728;Chemical
KIDNEY TRANSPLANTATION;rs11706052;Variant;PA165817016;Disease
CYCLOSPORINE;rs11706052;Variant;PA449167;Chemical
MYCOPHENOLATE MOFETIL;rs11706052;Variant;PA450566;Chemical
ATAZANAVIR;raltegravir;Chemical;PA10251;Chemical
UGT1A1*28;raltegravir;Chemical;PA166115842;Haplotype
UGT1A9*3A;raltegravir;Chemical;PA166117680;Haplotype
RS8175347;raltegravir;Chemical;PA166159020;Variant
UGT1A9;raltegravir;Chemical;PA419;Gene
UGT1A1;raltegravir;Chemical;PA420;Gene
CETUXIMAB;HBEGF;Gene;PA10040;Chemical
PANITUMUMAB;HBEGF;Gene;PA162373091;Chemical
ANTIEMETICS AND ANTINAUSEANTS;rs12208357;Variant;PA164712431;Chemical
METFORMIN;rs12208357;Variant;PA450395;Chemical
PROGUANIL;rs12208357;Variant;PA451124;Chemical
TRAMADOL;rs12208357;Variant;PA451735;Chemical
MAJOR DEPRESSIVE DISORDER;rs766127;Variant;PA447321;Disease
ANTIDEPRESSANTS;rs766127;Variant;PA452229;Chemical
COL3A1;GP1BB;Gene;PA26716;Gene
COL4A1;GP1BB;Gene;PA26717;Gene
COL4A2;GP1BB;Gene;PA26718;Gene
PLCB1;GP1BB;Gene;PA33384;Gene
PLCG2;GP1BB;Gene;PA33393;Gene
COL1A1;GP1BB;Gene;PA35041;Gene
COL1A2;GP1BB;Gene;PA35042;Gene
PROSTATIC NEOPLASMS;rs4148943;Variant;PA445425;Disease
DOCETAXEL;rs4148943;Variant;PA449383;Chemical
THALIDOMIDE;rs4148943;Variant;PA451644;Chemical
CELECOXIB;CACNA2D3;Gene;PA448871;Chemical
CETUXIMAB;rs9344;Variant;PA10040;Chemical
FLUOROURACIL;rs9344;Variant;PA128406956;Chemical
LAPATINIB;rs9344;Variant;PA152241907;Chemical
BREAST NEOPLASMS;rs9344;Variant;PA443560;Disease
COLONIC NEOPLASMS;rs9344;Variant;PA443756;Disease
LYMPHOMA;rs9344;Variant;PA444840;Disease
OSTEOSARCOMA;rs9344;Variant;PA445601;Disease
COLORECTAL NEOPLASMS;rs9344;Variant;PA446108;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs9344;Variant;PA446155;Disease
CISPLATIN;rs9344;Variant;PA449014;Chemical
DOXORUBICIN;rs9344;Variant;PA449412;Chemical
METHOTREXATE;rs9344;Variant;PA450428;Chemical
CLOPIDOGREL;rs57731889;Variant;PA449053;Chemical
HYPERTROPHY, LEFT VENTRICULAR;rs1800545;Variant;PA446479;Disease
ATENOLOL;rs1800545;Variant;PA448499;Chemical
CFTR;rs1800110;Variant;PA109;Gene
IVACAFTOR;rs1800110;Variant;PA165950341;Chemical
MACULOPAPULAR EXANTHEMA;HLA-B*15:01;Haplotype;PA162316739;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*15:01;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*15:01;Haplotype;PA444059;Disease
EPILEPSY;HLA-B*15:01;Haplotype;PA444065;Disease
EXANTHEMA;HLA-B*15:01;Haplotype;PA444109;Disease
MULTIPLE SCLEROSIS;HLA-B*15:01;Haplotype;PA444987;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*15:01;Haplotype;PA445738;Disease
INTERFERON BETA-1A;HLA-B*15:01;Haplotype;PA450037;Chemical
NEVIRAPINE;HLA-B*15:01;Haplotype;PA450616;Chemical
OXCARBAZEPINE;HLA-B*15:01;Haplotype;PA450732;Chemical
PHENYTOIN;HLA-B*15:01;Haplotype;PA450947;Chemical
PSYCHOTIC DISORDER;GRIK3;Gene;PA447215;Disease
ANTIPSYCHOTICS;GRIK3;Gene;PA452233;Chemical
PHENPROCOUMON;STX4;Gene;PA450921;Chemical
WARFARIN;STX4;Gene;PA451906;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*43;Haplotype;PA166127651;Chemical
PRIMAQUINE;CYP2D6*43;Haplotype;PA451103;Chemical
C18ORF56;Rectal Neoplasms;Disease;PA134956204;Gene
DPYD;Rectal Neoplasms;Disease;PA145;Gene
ERCC1;Rectal Neoplasms;Disease;PA155;Gene
RS1695;Rectal Neoplasms;Disease;PA166154249;Variant
RS45445694;Rectal Neoplasms;Disease;PA166155331;Variant
RS11615;Rectal Neoplasms;Disease;PA166155342;Variant
RS25487;Rectal Neoplasms;Disease;PA166155346;Variant
RS4444903;Rectal Neoplasms;Disease;PA166156588;Variant
RS11942466;Rectal Neoplasms;Disease;PA166156656;Variant
DPYD DEFICIENCY;Rectal Neoplasms;Disease;PA166157931;Variant
DPYD POOR METABOLIZER;Rectal Neoplasms;Disease;PA166157958;Variant
AREG;Rectal Neoplasms;Disease;PA24933;Gene
EGF;Rectal Neoplasms;Disease;PA27664;Gene
GSTP1;Rectal Neoplasms;Disease;PA29028;Gene
TYMS;Rectal Neoplasms;Disease;PA359;Gene
XRCC1;Rectal Neoplasms;Disease;PA369;Gene
NEOPLASMS;rs2612091;Variant;PA445062;Disease
CAPECITABINE;rs2612091;Variant;PA448771;Chemical
CYP2B6;mitotane;Chemical;PA123;Gene
RS3745274;mitotane;Chemical;PA166155409;Variant
ACUTE LYMPHOBLASTIC LEUKEMIA;rs7992226;Variant;PA446155;Disease
METHOTREXATE;rs7992226;Variant;PA450428;Chemical
RS28933979;eplontersen;Chemical;PA166329081;Variant
TTR;eplontersen;Chemical;PA37069;Gene
FLUOROURACIL;DPYD deficiency;Variant;PA128406956;Chemical
MUCOSITIS;DPYD deficiency;Variant;PA166122058;Disease
BREAST NEOPLASMS;DPYD deficiency;Variant;PA443560;Disease
COLONIC NEOPLASMS;DPYD deficiency;Variant;PA443756;Disease
DEATH;DPYD deficiency;Variant;PA443842;Disease
DRUG TOXICITY;DPYD deficiency;Variant;PA443937;Disease
HEAD AND NECK NEOPLASMS;DPYD deficiency;Variant;PA444352;Disease
NEOPLASMS;DPYD deficiency;Variant;PA445062;Disease
NEUTROPENIA;DPYD deficiency;Variant;PA445113;Disease
RECTAL NEOPLASMS;DPYD deficiency;Variant;PA445503;Disease
NEUROTOXICITY SYNDROMES;DPYD deficiency;Variant;PA446975;Disease
CAPECITABINE;DPYD deficiency;Variant;PA448771;Chemical
CYP2D6;tolperisone;Chemical;PA128;Gene
CYP2D6*1;tolperisone;Chemical;PA165816576;Haplotype
CYP2D6*4;tolperisone;Chemical;PA165816579;Haplotype
CYP2D6*5;tolperisone;Chemical;PA165948092;Haplotype
CYP3A4;therapy-related acute myeloid leukemia (t-ML);Disease;PA130;Gene
GSTM1 NULL;taxanes;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;taxanes;Chemical;PA166048676;Haplotype
RS1061472;taxanes;Chemical;PA166154695;Variant
RS1801249;taxanes;Chemical;PA166154703;Variant
RS9825762;taxanes;Chemical;PA166156430;Variant
RS879825;taxanes;Chemical;PA166156961;Variant
RS6900017;taxanes;Chemical;PA166157110;Variant
RS9369421;taxanes;Chemical;PA166157149;Variant
RS1045642;taxanes;Chemical;PA166157284;Variant
RS2032582;taxanes;Chemical;PA166157316;Variant
RS3594;taxanes;Chemical;PA166157541;Variant
RS74497159;taxanes;Chemical;PA166230141;Variant
GSTM1;taxanes;Chemical;PA182;Gene
ABCB1;taxanes;Chemical;PA267;Gene
GSR;taxanes;Chemical;PA29014;Gene
SCN10A;taxanes;Chemical;PA35000;Gene
VEGFA;taxanes;Chemical;PA37302;Gene
NR1I2;taxanes;Chemical;PA378;Gene
ATP7B;taxanes;Chemical;PA73;Gene
GEFITINIB;CYP2D6*114;Haplotype;PA131301952;Chemical
BUFURALOL;CYP2D6*114;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*114;Haplotype;PA166127651;Chemical
CARCINOMA, NON-SMALL-CELL LUNG;CYP2D6*114;Haplotype;PA443622;Disease
EXANTHEMA;CYP2D6*114;Haplotype;PA444109;Disease
DEXTROMETHORPHAN;CYP2D6*114;Haplotype;PA449273;Chemical
PRIMAQUINE;CYP2D6*114;Haplotype;PA451103;Chemical
CYP2B6;prasugrel;Chemical;PA123;Gene
CYP2C19;prasugrel;Chemical;PA124;Gene
CYP2C9;prasugrel;Chemical;PA126;Gene
CYP3A4;prasugrel;Chemical;PA130;Gene
CYP3A5;prasugrel;Chemical;PA131;Gene
P2RY12;prasugrel;Chemical;PA134971947;Gene
PEAR1;prasugrel;Chemical;PA162399233;Gene
CYP2C19*17;prasugrel;Chemical;PA165816533;Haplotype
CYP2C9*1;prasugrel;Chemical;PA165816542;Haplotype
CYP2C9*2;prasugrel;Chemical;PA165816543;Haplotype
CYP2C19*1;prasugrel;Chemical;PA165980634;Haplotype
CYP2C19*2;prasugrel;Chemical;PA165980635;Haplotype
CYP2C19*3;prasugrel;Chemical;PA165980636;Haplotype
RS822441;prasugrel;Chemical;PA166153591;Variant
RS822442;prasugrel;Chemical;PA166153592;Variant
RS2768759;prasugrel;Chemical;PA166153716;Variant
RS3737224;prasugrel;Chemical;PA166153743;Variant
RS12041331;prasugrel;Chemical;PA166153839;Variant
RS12407843;prasugrel;Chemical;PA166153856;Variant
RS41273215;prasugrel;Chemical;PA166153883;Variant
RS77235035;prasugrel;Chemical;PA166153911;Variant
RS4244285;prasugrel;Chemical;PA166154053;Variant
NTRK1;prasugrel;Chemical;PA31817;Gene
VALPROIC ACID;rs7438284;Variant;PA451846;Chemical
ACE;Beta Blocking Agents;Chemical;PA139;Gene
RS1801252;Beta Blocking Agents;Chemical;PA166153976;Variant
RS1801253;Beta Blocking Agents;Chemical;PA166153977;Variant
RS2230345;Beta Blocking Agents;Chemical;PA166154001;Variant
RS5443;Beta Blocking Agents;Chemical;PA166154486;Variant
RS1799752;Beta Blocking Agents;Chemical;PA166155187;Variant
RS4253778;Beta Blocking Agents;Chemical;PA166156106;Variant
RS61767072;Beta Blocking Agents;Chemical;PA166156691;Variant
RS1042713;Beta Blocking Agents;Chemical;PA166156748;Variant
RS1799983;Beta Blocking Agents;Chemical;PA166157303;Variant
RS36217263;Beta Blocking Agents;Chemical;PA166186681;Variant
RS139945292;Beta Blocking Agents;Chemical;PA166250001;Variant
RS10787959;Beta Blocking Agents;Chemical;PA166274201;Variant
RS3740563;Beta Blocking Agents;Chemical;PA166274202;Variant
RS11198893;Beta Blocking Agents;Chemical;PA166274203;Variant
RS4752292;Beta Blocking Agents;Chemical;PA166274204;Variant
GNB3;Beta Blocking Agents;Chemical;PA176;Gene
GRK5;Beta Blocking Agents;Chemical;PA180;Gene
NOS3;Beta Blocking Agents;Chemical;PA254;Gene
PPARA;Beta Blocking Agents;Chemical;PA280;Gene
KL;Beta Blocking Agents;Chemical;PA30130;Gene
ADRA2C;Beta Blocking Agents;Chemical;PA37;Gene
ADRB1;Beta Blocking Agents;Chemical;PA38;Gene
ADRB2;Beta Blocking Agents;Chemical;PA39;Gene
TRANSIENT ISCHEMIC ATTACK;rs8192950;Variant;PA443672;Disease
CEREBROVASCULAR DISORDERS;rs8192950;Variant;PA443678;Disease
STROKE;rs8192950;Variant;PA447054;Disease
CLOPIDOGREL;rs8192950;Variant;PA449053;Chemical
ACUTE CORONARY SYNDROME;AGAP3;Gene;PA165108401;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);AGAP3;Gene;PA166129560;Disease
ASPIRIN;AGAP3;Gene;PA448497;Chemical
CLOPIDOGREL;AGAP3;Gene;PA449053;Chemical
BUPROPION;rs117872433;Variant;PA448687;Chemical
EFAVIRENZ;rs117872433;Variant;PA449441;Chemical
OTOTOXICITY;rs1142345;Variant;PA162263534;Disease
DRUG TOXICITY;rs1142345;Variant;PA443937;Disease
NEOPLASMS;rs1142345;Variant;PA445062;Disease
OVARIAN NEOPLASMS;rs1142345;Variant;PA445204;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs1142345;Variant;PA446155;Disease
CISPLATIN;rs1142345;Variant;PA449014;Chemical
CYCLOPHOSPHAMIDE;rs1142345;Variant;PA449165;Chemical
MERCAPTOPURINE;rs1142345;Variant;PA450379;Chemical
NIMESULIDE;rs5272;Variant;PA137179528;Chemical
CYP3A5;terazosin;Chemical;PA131;Gene
DEPRESSION;rs11983225;Variant;PA447278;Disease
AMITRIPTYLINE;rs11983225;Variant;PA448385;Chemical
CITALOPRAM;rs11983225;Variant;PA449015;Chemical
PAROXETINE;rs11983225;Variant;PA450801;Chemical
VENLAFAXINE;rs11983225;Variant;PA451866;Chemical
IMATINIB;rs2631367;Variant;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;rs2631367;Variant;PA151958383;Disease
SULFAMETHOXAZOLE / TRIMETHOPRIM;HLA-C*07:02;Haplotype;PA10715;Chemical
RESPIRATORY INSUFFICIENCY;HLA-C*07:02;Haplotype;PA445522;Disease
LUMIRACOXIB;HLA-DQA1*01:01;Haplotype;PA164769031;Chemical
TOXIC LIVER DISEASE;HLA-DQA1*01:01;Haplotype;PA164925725;Disease
HLA-DRB1*04:01;etanercept;Chemical;PA165951493;Haplotype
RS396991;etanercept;Chemical;PA166153571;Variant
RS1061622;etanercept;Chemical;PA166153618;Variant
RS1801274;etanercept;Chemical;PA166153652;Variant
RS6427528;etanercept;Chemical;PA166153781;Variant
RS10919563;etanercept;Chemical;PA166153818;Variant
RS767455;etanercept;Chemical;PA166154502;Variant
RS7574865;etanercept;Chemical;PA166155766;Variant
RS1059150;etanercept;Chemical;PA166155914;Variant
RS1264457;etanercept;Chemical;PA166156981;Variant
RS1800629;etanercept;Chemical;PA166156997;Variant
RS2233945;etanercept;Chemical;PA166157025;Variant
RS1800795;etanercept;Chemical;PA166157304;Variant
RS3761847;etanercept;Chemical;PA166157763;Variant
RS28362491;etanercept;Chemical;PA166159897;Variant
RS2302489;etanercept;Chemical;PA166160715;Variant
RS7301582;etanercept;Chemical;PA166160807;Variant
IL6;etanercept;Chemical;PA198;Gene
NFKB1;etanercept;Chemical;PA248;Gene
ATP5F1E;etanercept;Chemical;PA25128;Gene
CD84;etanercept;Chemical;PA26242;Gene
FCGR2A;etanercept;Chemical;PA28063;Gene
FCGR3A;etanercept;Chemical;PA28065;Gene
KLRC1;etanercept;Chemical;PA30163;Gene
KLRD1;etanercept;Chemical;PA30167;Gene
PSORS1C1;etanercept;Chemical;PA33919;Gene
PTPRC;etanercept;Chemical;PA34011;Gene
HLA-DRB1;etanercept;Chemical;PA35072;Gene
HLA-E;etanercept;Chemical;PA35081;Gene
STAT4;etanercept;Chemical;PA36185;Gene
TNFRSF1A;etanercept;Chemical;PA36609;Gene
TNFRSF1B;etanercept;Chemical;PA36610;Gene
TRAF1;etanercept;Chemical;PA36708;Gene
TNF;etanercept;Chemical;PA435;Gene
HYPERTENSION;SH2B3;Gene;PA444552;Disease
CANDESARTAN;SH2B3;Gene;PA448765;Chemical
ACUTE CORONARY SYNDROME;rs1805094;Variant;PA165108401;Disease
ATORVASTATIN;rs1805094;Variant;PA448500;Chemical
CFTR;rs121908757;Variant;PA109;Gene
IVACAFTOR;rs121908757;Variant;PA165950341;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs121908757;Variant;PA166190041;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs121908757;Variant;PA166362502;Chemical
CYSTIC FIBROSIS;rs121908757;Variant;PA443829;Disease
DEFERASIROX;rs4124874;Variant;PA164760843;Chemical
DRUG TOXICITY;rs4124874;Variant;PA443937;Disease
LYMPHOMA;rs4124874;Variant;PA444840;Disease
NEOPLASMS;rs4124874;Variant;PA445062;Disease
BETA-THALASSEMIA AND RELATED DISEASES;rs4124874;Variant;PA446432;Disease
IRINOTECAN;rs4124874;Variant;PA450085;Chemical
FLUOROURACIL;CYP19A1;Gene;PA128406956;Chemical
HMG COA REDUCTASE INHIBITORS;CYP19A1;Gene;PA133950441;Chemical
ENZYME INHIBITORS;CYP19A1;Gene;PA164712732;Chemical
MENOPAUSE;CYP19A1;Gene;PA166048848;Disease
HDL CHOLESTEROL;CYP19A1;Gene;PA166129559;Chemical
BREAST NEOPLASMS;CYP19A1;Gene;PA443560;Disease
METASTATIC NEOPLASM;CYP19A1;Gene;PA445058;Disease
ANASTROZOLE;CYP19A1;Gene;PA448432;Chemical
CAPECITABINE;CYP19A1;Gene;PA448771;Chemical
EXEMESTANE;CYP19A1;Gene;PA449563;Chemical
LETROZOLE;CYP19A1;Gene;PA450196;Chemical
TAMOXIFEN;CYP19A1;Gene;PA451581;Chemical
TRIGLYCERIDES;CYP19A1;Gene;PA451776;Chemical
CFTR;rs397508785;Variant;PA109;Gene
IVACAFTOR;rs397508785;Variant;PA165950341;Chemical
CDK4;Turner Syndrome;Disease;PA102;Gene
RS2069502;Turner Syndrome;Disease;PA166154525;Variant
BIPOLAR DISORDER;NCOA2;Gene;PA447199;Disease
CARGLUMIC ACID;NAGS;Gene;PA165958402;Chemical
SODIUM BENZOATE / SODIUM PHENYLACETATE;NAGS;Gene;PA166176020;Chemical
GLYCEROL PHENYLBUTYRATE;NAGS;Gene;PA166268801;Chemical
CFTR;rs397508784;Variant;PA109;Gene
IVACAFTOR;rs397508784;Variant;PA165950341;Chemical
NEOPLASMS;KCNQ5;Gene;PA445062;Disease
CELECOXIB;KCNQ5;Gene;PA448871;Chemical
IRINOTECAN;KCNQ5;Gene;PA450085;Chemical
RS4135385;lenalidomide;Chemical;PA166156394;Variant
RS4533622;lenalidomide;Chemical;PA166156399;Variant
RS2229109;lenalidomide;Chemical;PA166157334;Variant
RS308395;lenalidomide;Chemical;PA166163497;Variant
ABCB1;lenalidomide;Chemical;PA267;Gene
CTNNB1;lenalidomide;Chemical;PA27013;Gene
FGF2;lenalidomide;Chemical;PA28115;Gene
TROFINETIDE;MECP2;Gene;PA166313324;Chemical
SEVERE CUTANEOUS ADVERSE REACTIONS;rs3131003;Variant;PA166120929;Disease
ALLOPURINOL;rs3131003;Variant;PA448320;Chemical
SLCO1B1;rs4148323;Variant;PA134865839;Gene
LETERMOVIR;rs4148323;Variant;PA166184379;Chemical
UGT1A1;rs4148323;Variant;PA420;Gene
ANGINA PECTORIS;rs4148323;Variant;PA443362;Disease
HEART FAILURE;rs4148323;Variant;PA444370;Disease
HIV INFECTIOUS DISEASE;rs4148323;Variant;PA447230;Disease
CARVEDILOL;rs4148323;Variant;PA448817;Chemical
INDINAVIR;rs4148323;Variant;PA449977;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs2799018;Variant;PA447197;Disease
METHYLPHENIDATE;rs2799018;Variant;PA450464;Chemical
FLUOROURACIL;rs78428806;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs78428806;Variant;PA443560;Disease
NEUTROPENIA;rs78428806;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs78428806;Variant;PA449165;Chemical
EPIRUBICIN;rs78428806;Variant;PA449476;Chemical
VARENICLINE;rs7164594;Variant;PA164781343;Chemical
TOBACCO USE DISORDER;rs7164594;Variant;PA445876;Disease
LEPR;setmelanotide;Chemical;PA229;Gene
PCSK1;setmelanotide;Chemical;PA33089;Gene
POMC;setmelanotide;Chemical;PA33526;Gene
SCHIZOPHRENIA;rs9606186;Variant;PA447216;Disease
RISPERIDONE;rs9606186;Variant;PA451257;Chemical
FLUOROURACIL;rs748620513;Variant;PA128406956;Chemical
HLA-DRB1*15:01;rilonacept;Chemical;PA165952269;Haplotype
HLA-DRB1;rilonacept;Chemical;PA35072;Gene
NFKB1;PPP3CC;Gene;PA248;Gene
RELA;PPP3CC;Gene;PA296;Gene
NFATC1;PPP3CC;Gene;PA31582;Gene
NFATC2;PPP3CC;Gene;PA31583;Gene
NFATC4;PPP3CC;Gene;PA31584;Gene
NFKB2;PPP3CC;Gene;PA31600;Gene
REL;PPP3CC;Gene;PA34321;Gene
RELB;PPP3CC;Gene;PA34322;Gene
PSYCHOTIC DISORDER;rs363341;Variant;PA447215;Disease
ANTIPSYCHOTICS;rs363341;Variant;PA452233;Chemical
DEXTROMETHORPHAN;CYP2D6*4x2;Haplotype;PA449273;Chemical
RS1800559;halothane;Chemical;PA166153638;Variant
RS772226819;halothane;Chemical;PA166153940;Variant
RS1801086;halothane;Chemical;PA166155375;Variant
RS28933396;halothane;Chemical;PA166155481;Variant
RS28933397;halothane;Chemical;PA166155482;Variant
RS63749869;halothane;Chemical;PA166155516;Variant
RS111888148;halothane;Chemical;PA166155524;Variant
RS112563513;halothane;Chemical;PA166155526;Variant
RS118192116;halothane;Chemical;PA166155528;Variant
RS118192122;halothane;Chemical;PA166155529;Variant
RS118192124;halothane;Chemical;PA166155531;Variant
RS118192161;halothane;Chemical;PA166155532;Variant
RS118192162;halothane;Chemical;PA166155533;Variant
RS118192163;halothane;Chemical;PA166155534;Variant
RS118192167;halothane;Chemical;PA166155535;Variant
RS118192170;halothane;Chemical;PA166155536;Variant
RS118192172;halothane;Chemical;PA166155537;Variant
RS118192175;halothane;Chemical;PA166155538;Variant
RS118192176;halothane;Chemical;PA166155539;Variant
RS118192177;halothane;Chemical;PA166155540;Variant
RS118192178;halothane;Chemical;PA166155541;Variant
RS121918592;halothane;Chemical;PA166155543;Variant
RS121918593;halothane;Chemical;PA166155544;Variant
RS121918594;halothane;Chemical;PA166155545;Variant
RS121918595;halothane;Chemical;PA166155546;Variant
RS193922747;halothane;Chemical;PA166155564;Variant
RS193922753;halothane;Chemical;PA166155565;Variant
RS193922770;halothane;Chemical;PA166155567;Variant
RS193922772;halothane;Chemical;PA166155568;Variant
RS193922802;halothane;Chemical;PA166155569;Variant
RS193922803;halothane;Chemical;PA166155570;Variant
RS193922807;halothane;Chemical;PA166155571;Variant
RS193922809;halothane;Chemical;PA166155572;Variant
RS193922816;halothane;Chemical;PA166155573;Variant
RS193922818;halothane;Chemical;PA166155574;Variant
RS193922876;halothane;Chemical;PA166155575;Variant
RS193922878;halothane;Chemical;PA166155576;Variant
RS193922843;halothane;Chemical;PA166163663;Variant
RS193922832;halothane;Chemical;PA166163667;Variant
RS118192168;halothane;Chemical;PA166163669;Variant
RS193922764;halothane;Chemical;PA166176176;Variant
RS121918596;halothane;Chemical;PA166177994;Variant
RS193922748;halothane;Chemical;PA166180322;Variant
RS193922762;halothane;Chemical;PA166180323;Variant
RS193922768;halothane;Chemical;PA166180324;Variant
RS144336148;halothane;Chemical;PA166180325;Variant
RYR1;halothane;Chemical;PA34896;Gene
CACNA1S;halothane;Chemical;PA85;Gene
RHEUMATOID ARTHRITIS;rs17421511;Variant;PA443434;Disease
METHOTREXATE;rs17421511;Variant;PA450428;Chemical
RS118204085;mitapivat;Chemical;PA166317661;Variant
PKLR;mitapivat;Chemical;PA33352;Gene
CETUXIMAB;NRG2;Gene;PA10040;Chemical
PANITUMUMAB;NRG2;Gene;PA162373091;Chemical
ATOMOXETINE;rs3785143;Variant;PA134688071;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs3785143;Variant;PA447197;Disease
RS1799971;Amplification of sexual behavior;Disease;PA166156991;Variant
OPRM1;Amplification of sexual behavior;Disease;PA31945;Gene
OVERALL SURVIVAL;ARHGAP9;Gene;PA166123207;Disease
RECURRENCE FREE SURVIVAL;ARHGAP9;Gene;PA166127658;Disease
LEUKEMIA, MYELOID, ACUTE;ARHGAP9;Gene;PA444760;Disease
CYTARABINE;ARHGAP9;Gene;PA449177;Chemical
KIDNEY TRANSPLANTATION;rs2276707;Variant;PA165817016;Disease
SUBSTANCE-RELATED DISORDERS;rs2276707;Variant;PA446876;Disease
BIPOLAR DISORDER;rs2276707;Variant;PA447199;Disease
DEPRESSION;rs2276707;Variant;PA447278;Disease
RISPERIDONE;rs2276707;Variant;PA451257;Chemical
TACROLIMUS;rs2276707;Variant;PA451578;Chemical
CES1;Transient Ischemic Attack;Disease;PA107;Gene
CYP2C19;Transient Ischemic Attack;Disease;PA124;Gene
CYP2C19*6;Transient Ischemic Attack;Disease;PA165816522;Haplotype
CYP2C19*8;Transient Ischemic Attack;Disease;PA165816524;Haplotype
CYP2C19*17;Transient Ischemic Attack;Disease;PA165816533;Haplotype
CYP2C19*1;Transient Ischemic Attack;Disease;PA165980634;Haplotype
CYP2C19*2;Transient Ischemic Attack;Disease;PA165980635;Haplotype
CYP2C19*3;Transient Ischemic Attack;Disease;PA165980636;Haplotype
CYP2C19*4;Transient Ischemic Attack;Disease;PA165980637;Haplotype
CYP2C19*5;Transient Ischemic Attack;Disease;PA165980638;Haplotype
RS8192950;Transient Ischemic Attack;Disease;PA166162295;Variant
PYRAZOLONES;PLA2G4A;Gene;PA164713217;Chemical
PLCB1;PLA2G4A;Gene;PA33384;Gene
PLCG2;PLA2G4A;Gene;PA33393;Gene
HYPERTENSION;PLA2G4A;Gene;PA444552;Disease
ACETAMINOPHEN;PLA2G4A;Gene;PA448015;Chemical
ASPIRIN;PLA2G4A;Gene;PA448497;Chemical
ATENOLOL;PLA2G4A;Gene;PA448499;Chemical
DICLOFENAC;PLA2G4A;Gene;PA449293;Chemical
PROPIONIC ACID DERIVATIVES;PLA2G4A;Gene;PA451140;Chemical
FLUOROURACIL;rs6907567;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs6907567;Variant;PA443560;Disease
CYCLOPHOSPHAMIDE;rs6907567;Variant;PA449165;Chemical
DOXORUBICIN;rs6907567;Variant;PA449412;Chemical
HIV INFECTIOUS DISEASE;POLR3G;Gene;PA447230;Disease
NEVIRAPINE;POLR3G;Gene;PA450616;Chemical
CYP3A4;amlodipine;Chemical;PA130;Gene
CYP3A5;amlodipine;Chemical;PA131;Gene
ACE;amlodipine;Chemical;PA139;Gene
CYP3A5*1;amlodipine;Chemical;PA166128213;Haplotype
CYP3A5*3;amlodipine;Chemical;PA166128219;Haplotype
CYP3A5*6;amlodipine;Chemical;PA166128233;Haplotype
CYP3A5*7;amlodipine;Chemical;PA166128234;Haplotype
SIMVASTATIN ACID;amlodipine;Chemical;PA166129446;Chemical
RS5065;amlodipine;Chemical;PA166153549;Variant
RS11122576;amlodipine;Chemical;PA166153819;Variant
RS12143842;amlodipine;Chemical;PA166153854;Variant
RS4291;amlodipine;Chemical;PA166155143;Variant
RS200148;amlodipine;Chemical;PA166156912;Variant
RS2246709;amlodipine;Chemical;PA166157346;Variant
RS2740574;amlodipine;Chemical;PA166157367;Variant
NPPA;amlodipine;Chemical;PA256;Gene
AGT;amlodipine;Chemical;PA42;Gene
USTEKINUMAB;IL23A;Gene;PA166048654;Chemical
CHRM2;Tobacco Use Disorder;Disease;PA111;Gene
CHRNA3;Tobacco Use Disorder;Disease;PA113;Gene
CHRNB2;Tobacco Use Disorder;Disease;PA115;Gene
COMT;Tobacco Use Disorder;Disease;PA117;Gene
CYP2A6;Tobacco Use Disorder;Disease;PA121;Gene
CYP2B6;Tobacco Use Disorder;Disease;PA123;Gene
CYP2C19;Tobacco Use Disorder;Disease;PA124;Gene
CYP2C9;Tobacco Use Disorder;Disease;PA126;Gene
ANKK1;Tobacco Use Disorder;Disease;PA134872551;Gene
ADGRL3;Tobacco Use Disorder;Disease;PA134968284;Gene
DDC;Tobacco Use Disorder;Disease;PA140;Gene
DRD1;Tobacco Use Disorder;Disease;PA147;Gene
HYKK;Tobacco Use Disorder;Disease;PA165478483;Gene
CYP2C19*17;Tobacco Use Disorder;Disease;PA165816533;Haplotype
CYP2C9*1;Tobacco Use Disorder;Disease;PA165816542;Haplotype
CYP2C9*2;Tobacco Use Disorder;Disease;PA165816543;Haplotype
CYP2B6*1;Tobacco Use Disorder;Disease;PA165818750;Haplotype
CYP2B6*4;Tobacco Use Disorder;Disease;PA165818757;Haplotype
CYP2B6*5;Tobacco Use Disorder;Disease;PA165818760;Haplotype
CYP2B6*6;Tobacco Use Disorder;Disease;PA165818762;Haplotype
CYP2B6*18;Tobacco Use Disorder;Disease;PA165818808;Haplotype
CYP2B6*22;Tobacco Use Disorder;Disease;PA165818809;Haplotype
CYP2A6*1;Tobacco Use Disorder;Disease;PA165924690;Haplotype
CYP2A6*46;Tobacco Use Disorder;Disease;PA165924691;Haplotype
CYP2A6*1X2;Tobacco Use Disorder;Disease;PA165924717;Haplotype
CYP2A6*2;Tobacco Use Disorder;Disease;PA165924719;Haplotype
CYP2A6*4;Tobacco Use Disorder;Disease;PA165924721;Haplotype
CYP2A6*7;Tobacco Use Disorder;Disease;PA165924731;Haplotype
CYP2A6*10;Tobacco Use Disorder;Disease;PA165924735;Haplotype
CYP2A6*11;Tobacco Use Disorder;Disease;PA165924736;Haplotype
CYP2A6*13;Tobacco Use Disorder;Disease;PA165924740;Haplotype
CYP2A6*14;Tobacco Use Disorder;Disease;PA165924741;Haplotype
CYP2A6*15;Tobacco Use Disorder;Disease;PA165924742;Haplotype
CYP2A6*17;Tobacco Use Disorder;Disease;PA165924744;Haplotype
CYP2A6*19;Tobacco Use Disorder;Disease;PA165924748;Haplotype
CYP2A6*20;Tobacco Use Disorder;Disease;PA165924749;Haplotype
CYP2A6*23;Tobacco Use Disorder;Disease;PA165924752;Haplotype
CYP2A6*24;Tobacco Use Disorder;Disease;PA165924753;Haplotype
CYP2A6*25;Tobacco Use Disorder;Disease;PA165924755;Haplotype
CYP2A6*26;Tobacco Use Disorder;Disease;PA165924756;Haplotype
CYP2A6*27;Tobacco Use Disorder;Disease;PA165924757;Haplotype
CYP2A6*28;Tobacco Use Disorder;Disease;PA165924758;Haplotype
CYP2C19*1;Tobacco Use Disorder;Disease;PA165980634;Haplotype
CYP2A6*9;Tobacco Use Disorder;Disease;PA165980914;Haplotype
CYP2A6*12;Tobacco Use Disorder;Disease;PA165980915;Haplotype
CYP2A6*35;Tobacco Use Disorder;Disease;PA165980920;Haplotype
FMO3;Tobacco Use Disorder;Disease;PA166;Gene
SLC6A4 HTTLPR LONG FORM (L ALLELE);Tobacco Use Disorder;Disease;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);Tobacco Use Disorder;Disease;PA166116466;Haplotype
CYP2A6*38;Tobacco Use Disorder;Disease;PA166117264;Haplotype
CYP2A6*39;Tobacco Use Disorder;Disease;PA166117265;Haplotype
CYP2A6*41;Tobacco Use Disorder;Disease;PA166117267;Haplotype
RS2072658;Tobacco Use Disorder;Disease;PA166153664;Variant
RS2072660;Tobacco Use Disorder;Disease;PA166153665;Variant
RS2072661;Tobacco Use Disorder;Disease;PA166153666;Variant
RS2266780;Tobacco Use Disorder;Disease;PA166153687;Variant
RS6702335;Tobacco Use Disorder;Disease;PA166153786;Variant
RS1799732;Tobacco Use Disorder;Disease;PA166154334;Variant
RS1800497;Tobacco Use Disorder;Disease;PA166154339;Variant
RS3758987;Tobacco Use Disorder;Disease;PA166154401;Variant
RS578776;Tobacco Use Disorder;Disease;PA166154840;Variant
RS588765;Tobacco Use Disorder;Disease;PA166154841;Variant
RS637137;Tobacco Use Disorder;Disease;PA166154843;Variant
RS660652;Tobacco Use Disorder;Disease;PA166154844;Variant
RS684513;Tobacco Use Disorder;Disease;PA166154846;Variant
RS1051730;Tobacco Use Disorder;Disease;PA166154856;Variant
RS3743078;Tobacco Use Disorder;Disease;PA166154901;Variant
RS3813567;Tobacco Use Disorder;Disease;PA166154904;Variant
RS7170068;Tobacco Use Disorder;Disease;PA166154919;Variant
RS10851907;Tobacco Use Disorder;Disease;PA166154929;Variant
RS16969968;Tobacco Use Disorder;Disease;PA166154938;Variant
RS57064725;Tobacco Use Disorder;Disease;PA166154955;Variant
RS2717162;Tobacco Use Disorder;Disease;PA166155286;Variant
RS2279343;Tobacco Use Disorder;Disease;PA166155393;Variant
RS3211371;Tobacco Use Disorder;Disease;PA166155405;Variant
RS4803381;Tobacco Use Disorder;Disease;PA166155418;Variant
RS12461964;Tobacco Use Disorder;Disease;PA166155464;Variant
RS28399433;Tobacco Use Disorder;Disease;PA166155471;Variant
RS56113850;Tobacco Use Disorder;Disease;PA166155506;Variant
RS72552266;Tobacco Use Disorder;Disease;PA166155522;Variant
RS113288603;Tobacco Use Disorder;Disease;PA166155527;Variant
RS1044396;Tobacco Use Disorder;Disease;PA166155912;Variant
RS1044397;Tobacco Use Disorder;Disease;PA166155913;Variant
RS2229959;Tobacco Use Disorder;Disease;PA166155922;Variant
RS2236196;Tobacco Use Disorder;Disease;PA166155923;Variant
RS4680;Tobacco Use Disorder;Disease;PA166156024;Variant
RS165599;Tobacco Use Disorder;Disease;PA166156046;Variant
RS2056527;Tobacco Use Disorder;Disease;PA166156340;Variant
RS2869950;Tobacco Use Disorder;Disease;PA166156567;Variant
RS77107237;Tobacco Use Disorder;Disease;PA166156696;Variant
RS686;Tobacco Use Disorder;Disease;PA166156705;Variant
RS4532;Tobacco Use Disorder;Disease;PA166156706;Variant
RS3836790;Tobacco Use Disorder;Disease;PA166156819;Variant
RS28363170;Tobacco Use Disorder;Disease;PA166156890;Variant
RS1799971;Tobacco Use Disorder;Disease;PA166156991;Variant
RS324650;Tobacco Use Disorder;Disease;PA166157253;Variant
RS12718541;Tobacco Use Disorder;Disease;PA166157457;Variant
RS10121600;Tobacco Use Disorder;Disease;PA166157802;Variant
RS11788456;Tobacco Use Disorder;Disease;PA166157832;Variant
RS2942857;Tobacco Use Disorder;Disease;PA166163174;Variant
RS503464;Tobacco Use Disorder;Disease;PA166175850;Variant
RS55781567;Tobacco Use Disorder;Disease;PA166175853;Variant
RS3852209;Tobacco Use Disorder;Disease;PA166179948;Variant
RS11606194;Tobacco Use Disorder;Disease;PA166180009;Variant
RS1948;Tobacco Use Disorder;Disease;PA166181364;Variant
RS1709083;Tobacco Use Disorder;Disease;PA166184034;Variant
RS7164594;Tobacco Use Disorder;Disease;PA166184140;Variant
RS8109525;Tobacco Use Disorder;Disease;PA166184141;Variant
RS6090378;Tobacco Use Disorder;Disease;PA166184544;Variant
RS3787138;Tobacco Use Disorder;Disease;PA166184546;Variant
RS3787140;Tobacco Use Disorder;Disease;PA166184548;Variant
RS10485057;Tobacco Use Disorder;Disease;PA166184699;Variant
RS2036527;Tobacco Use Disorder;Disease;PA166185387;Variant
RS3743075;Tobacco Use Disorder;Disease;PA166185407;Variant
RS7178270;Tobacco Use Disorder;Disease;PA166185489;Variant
RS2271339;Tobacco Use Disorder;Disease;PA166185754;Variant
RS1456862;Tobacco Use Disorder;Disease;PA166185755;Variant
CYP2A6*55;Tobacco Use Disorder;Disease;PA166309214;Haplotype
CHRNA4;Tobacco Use Disorder;Disease;PA26490;Gene
CHRNA5;Tobacco Use Disorder;Disease;PA26491;Gene
CHRNB4;Tobacco Use Disorder;Disease;PA26496;Gene
CYP1A2;Tobacco Use Disorder;Disease;PA27093;Gene
CYP2A13;Tobacco Use Disorder;Disease;PA27101;Gene
DRD2;Tobacco Use Disorder;Disease;PA27478;Gene
EPB41;Tobacco Use Disorder;Disease;PA27810;Gene
GALR1;Tobacco Use Disorder;Disease;PA28545;Gene
GRIN3A;Tobacco Use Disorder;Disease;PA28983;Gene
HINT1;Tobacco Use Disorder;Disease;PA29286;Gene
HTR3B;Tobacco Use Disorder;Disease;PA29556;Gene
SLC6A3;Tobacco Use Disorder;Disease;PA311;Gene
SLC6A4;Tobacco Use Disorder;Disease;PA312;Gene
OPRM1;Tobacco Use Disorder;Disease;PA31945;Gene
PSMA4;Tobacco Use Disorder;Disease;PA33878;Gene
UGT2B10;Tobacco Use Disorder;Disease;PA37186;Gene
ACE2;Tobacco Use Disorder;Disease;PA425;Gene
URINARY BLADDER NEOPLASMS;Tobacco Use Disorder;Disease;PA443512;Disease
FENOFIBRATE;rs9626730;Variant;PA449594;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;rs10994982;Variant;PA446155;Disease
METHOTREXATE;rs10994982;Variant;PA450428;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;NFIB;Gene;PA447197;Disease
SCHIZOPHRENIA;NFIB;Gene;PA447216;Disease
CLOZAPINE;NFIB;Gene;PA449061;Chemical
METHYLPHENIDATE;NFIB;Gene;PA450464;Chemical
DPYD;rs139459586;Variant;PA145;Gene
CAPECITABINE;rs139459586;Variant;PA448771;Chemical
CFTR;rs397508387;Variant;PA109;Gene
IVACAFTOR;rs397508387;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs397508387;Variant;PA166179845;Chemical
DESFLURANE;rs1801086;Variant;PA164749136;Chemical
RYR1;rs1801086;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs1801086;Variant;PA444863;Disease
ENFLURANE;rs1801086;Variant;PA449461;Chemical
HALOTHANE;rs1801086;Variant;PA449845;Chemical
ISOFLURANE;rs1801086;Variant;PA450106;Chemical
METHOXYFLURANE;rs1801086;Variant;PA450434;Chemical
SEVOFLURANE;rs1801086;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs1801086;Variant;PA451522;Chemical
CACNA1S;rs1801086;Variant;PA85;Gene
DULOXETINE;rs17724452;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs17724452;Variant;PA447321;Disease
G6PD B (REFERENCE);Lead Poisoning, Nervous System, Childhood;Disease;PA165947826;Haplotype
G6PD A- 202A_376G;Lead Poisoning, Nervous System, Childhood;Disease;PA165947827;Haplotype
G6PD;Lead Poisoning, Nervous System, Childhood;Disease;PA28469;Gene
DRUGS FOR TREATMENT OF TUBERCULOSIS;CYP2E1;Gene;PA164712708;Chemical
MIR570;CYP2E1;Gene;PA164722867;Gene
GEMTUZUMAB OZOGAMICIN;CYP2E1;Gene;PA164749431;Chemical
PYRIDOXAL PHOSPHATE;CYP2E1;Gene;PA164749650;Chemical
TOXIC LIVER DISEASE;CYP2E1;Gene;PA164925725;Disease
DRUG-INDUCED LIVER INJURY;CYP2E1;Gene;PA166119041;Disease
ALCOHOL ABUSE;CYP2E1;Gene;PA443309;Disease
DRUG TOXICITY;CYP2E1;Gene;PA443937;Disease
LEUKEMIA, MYELOID, ACUTE;CYP2E1;Gene;PA444760;Disease
LIVER DISEASES, ALCOHOLIC;CYP2E1;Gene;PA444802;Disease
OVARIAN NEOPLASMS;CYP2E1;Gene;PA445204;Disease
TUBERCULOSIS;CYP2E1;Gene;PA445941;Disease
SCHIZOPHRENIA;CYP2E1;Gene;PA447216;Disease
ACETAMINOPHEN;CYP2E1;Gene;PA448015;Chemical
ETHANOL;CYP2E1;Gene;PA448073;Chemical
CISPLATIN;CYP2E1;Gene;PA449014;Chemical
CYCLOPHOSPHAMIDE;CYP2E1;Gene;PA449165;Chemical
CYTARABINE;CYP2E1;Gene;PA449177;Chemical
FLUDARABINE;CYP2E1;Gene;PA449655;Chemical
IDARUBICIN;CYP2E1;Gene;PA449961;Chemical
ISOFLURANE;CYP2E1;Gene;PA450106;Chemical
ISONIAZID;CYP2E1;Gene;PA450112;Chemical
RISPERIDONE;CYP2E1;Gene;PA451257;Chemical
SEVOFLURANE;CYP2E1;Gene;PA451341;Chemical
ZIDOVUDINE;CYP2E1;Gene;PA451954;Chemical
OVARIAN NEOPLASMS;rs139887;Variant;PA445204;Disease
CARBOPLATIN;rs139887;Variant;PA448803;Chemical
DOCETAXEL;rs139887;Variant;PA449383;Chemical
PACLITAXEL;rs139887;Variant;PA450761;Chemical
ALCOHOL ABUSE;ACSS2;Gene;PA443309;Disease
NON-SMALL CELL LUNG CARCINOMA;ACSS2;Gene;PA443622;Disease
ETHANOL;ACSS2;Gene;PA448073;Chemical
CARBOPLATIN;ACSS2;Gene;PA448803;Chemical
CISPLATIN;ACSS2;Gene;PA449014;Chemical
DOCETAXEL;ACSS2;Gene;PA449383;Chemical
GEMCITABINE;ACSS2;Gene;PA449748;Chemical
PACLITAXEL;ACSS2;Gene;PA450761;Chemical
BIPOLAR DISORDER;rs6942227;Variant;PA447199;Disease
LITHIUM;rs6942227;Variant;PA450243;Chemical
ESCITALOPRAM;CYP2C19*1;Haplotype;PA10074;Chemical
ESOMEPRAZOLE;CYP2C19*1;Haplotype;PA10075;Chemical
VORICONAZOLE;CYP2C19*1;Haplotype;PA10233;Chemical
SULFONAMIDES, UREA DERIVATIVES;CYP2C19*1;Haplotype;PA10390;Chemical
CLOBAZAM;CYP2C19*1;Haplotype;PA10888;Chemical
CYP2C19;CYP2C19*1;Haplotype;PA124;Gene
3,4-METHYLENEDIOXYMETHAMPHETAMINE;CYP2C19*1;Haplotype;PA131887008;Chemical
ROSUVASTATIN;CYP2C19*1;Haplotype;PA134308647;Chemical
ATOMOXETINE;CYP2C19*1;Haplotype;PA134688071;Chemical
NEBIVOLOL;CYP2C19*1;Haplotype;PA151958426;Chemical
PERIPHERAL VASCULAR DISEASES;CYP2C19*1;Haplotype;PA153619833;Disease
PRASUGREL;CYP2C19*1;Haplotype;PA154410481;Chemical
METABOLIC SYNDROME;CYP2C19*1;Haplotype;PA162370415;Disease
LABETALOL;CYP2C19*1;Haplotype;PA164743150;Chemical
CILOSTAZOL;CYP2C19*1;Haplotype;PA164746334;Chemical
ACUTE CORONARY SYNDROME;CYP2C19*1;Haplotype;PA165108401;Disease
SUICIDE;CYP2C19*1;Haplotype;PA165374639;Disease
KIDNEY TRANSPLANTATION;CYP2C19*1;Haplotype;PA165817016;Disease
AMBRISENTAN;CYP2C19*1;Haplotype;PA165860521;Chemical
RIVAROXABAN;CYP2C19*1;Haplotype;PA165958360;Chemical
DESVENLAFAXINE;CYP2C19*1;Haplotype;PA165958374;Chemical
HELICOBACTER INFECTIONS;CYP2C19*1;Haplotype;PA166048740;Disease
DEXLANSOPRAZOLE;CYP2C19*1;Haplotype;PA166110257;Chemical
LUNG TRANSPLANTATION;CYP2C19*1;Haplotype;PA166114457;Disease
ICOTINIB;CYP2C19*1;Haplotype;PA166114460;Chemical
3-CYANO-7-ETHOXYCOUMARIN;CYP2C19*1;Haplotype;PA166123047;Chemical
INTRAGASTRIC PH;CYP2C19*1;Haplotype;PA166123203;Disease
OVERALL SURVIVAL;CYP2C19*1;Haplotype;PA166123207;Disease
EVENT-FREE SURVIVAL;CYP2C19*1;Haplotype;PA166123366;Disease
SCHIZOAFFECTIVE DISORDER;CYP2C19*1;Haplotype;PA166123368;Disease
DISCONTINUATION;CYP2C19*1;Haplotype;PA166123507;Disease
PLATELET AGGREGATION;CYP2C19*1;Haplotype;PA166123766;Disease
PLATELET REACTIVITY;CYP2C19*1;Haplotype;PA166124406;Disease
TREATMENT FAILURE;CYP2C19*1;Haplotype;PA166128095;Disease
CARDIOTOXICITY;CYP2C19*1;Haplotype;PA166128121;Disease
DIPYRONE;CYP2C19*1;Haplotype;PA166128206;Chemical
PLATELET AGGREGATION INHIBITION;CYP2C19*1;Haplotype;PA166128371;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);CYP2C19*1;Haplotype;PA166129560;Disease
DESMETHYL CLOMIPRAMINE;CYP2C19*1;Haplotype;PA166131507;Chemical
ADVERSE EVENTS;CYP2C19*1;Haplotype;PA166151827;Disease
BRIVARACETAM;CYP2C19*1;Haplotype;PA166153491;Chemical
HIGH ON-TREATMENT PLATELET REACTIVITY;CYP2C19*1;Haplotype;PA166163563;Disease
N-DESMETHYLCLOZAPINE;CYP2C19*1;Haplotype;PA166163659;Chemical
ADVERSE CARDIOVASCULAR EVENTS;CYP2C19*1;Haplotype;PA166165020;Disease
ANDROSTENEDIONE;CYP2C19*1;Haplotype;PA166178641;Chemical
PHENAZEPAM;CYP2C19*1;Haplotype;PA166180939;Chemical
NORMEPERIDINE;CYP2C19*1;Haplotype;PA166186301;Chemical
EOSINOPHILIC ESOPHAGITIS;CYP2C19*1;Haplotype;PA166224501;Disease
HYDROXYBUPROPION;CYP2C19*1;Haplotype;PA166226561;Chemical
MAVACAMTEN;CYP2C19*1;Haplotype;PA166272922;Chemical
6BETA-HYDROXYTESTOSTERONE;CYP2C19*1;Haplotype;PA166318222;Chemical
16ALPHA-HYDROXYTESTOSTERONE;CYP2C19*1;Haplotype;PA166318241;Chemical
11ALPHA-HYDROXYTESTOSTERONE;CYP2C19*1;Haplotype;PA166318261;Chemical
16ALPHA-HYDROXYPROGESTERONE;CYP2C19*1;Haplotype;PA166318321;Chemical
11A-HYDROXYPROGESTERONE;CYP2C19*1;Haplotype;PA166318342;Chemical
6BETA-HYDROXYPROGESTERONE;CYP2C19*1;Haplotype;PA166318343;Chemical
DESOXYCORTONE;CYP2C19*1;Haplotype;PA166318362;Chemical
ALCOHOLISM;CYP2C19*1;Haplotype;PA443309;Disease
ANGINA PECTORIS;CYP2C19*1;Haplotype;PA443362;Disease
ARTHRITIS, RHEUMATOID;CYP2C19*1;Haplotype;PA443434;Disease
ASTHMA;CYP2C19*1;Haplotype;PA443450;Disease
ATRIAL FIBRILLATION;CYP2C19*1;Haplotype;PA443459;Disease
BREAST NEOPLASMS;CYP2C19*1;Haplotype;PA443560;Disease
CARCINOMA, SQUAMOUS CELL;CYP2C19*1;Haplotype;PA443626;Disease
CARDIOVASCULAR DISEASES;CYP2C19*1;Haplotype;PA443635;Disease
CAROTID ARTERY DISEASES;CYP2C19*1;Haplotype;PA443636;Disease
ISCHEMIC ATTACK, TRANSIENT;CYP2C19*1;Haplotype;PA443672;Disease
CEREBROVASCULAR DISORDERS;CYP2C19*1;Haplotype;PA443678;Disease
CORONARY ARTERY DISEASE;CYP2C19*1;Haplotype;PA443796;Disease
CORONARY DISEASE;CYP2C19*1;Haplotype;PA443797;Disease
CYSTIC FIBROSIS;CYP2C19*1;Haplotype;PA443829;Disease
DEATH;CYP2C19*1;Haplotype;PA443842;Disease
DIABETES MELLITUS, TYPE 2;CYP2C19*1;Haplotype;PA443890;Disease
DRUG TOXICITY;CYP2C19*1;Haplotype;PA443937;Disease
EDEMA;CYP2C19*1;Haplotype;PA443994;Disease
EPILEPSY;CYP2C19*1;Haplotype;PA444065;Disease
ESOPHAGITIS;CYP2C19*1;Haplotype;PA444104;Disease
GASTROESOPHAGEAL REFLUX;CYP2C19*1;Haplotype;PA444255;Disease
GRANULOMATOUS DISEASE, CHRONIC;CYP2C19*1;Haplotype;PA444327;Disease
HALLUCINATIONS;CYP2C19*1;Haplotype;PA444339;Disease
HEMATOLOGIC DISEASES;CYP2C19*1;Haplotype;PA444395;Disease
HEMORRHAGE;CYP2C19*1;Haplotype;PA444417;Disease
HEPATITIS C;CYP2C19*1;Haplotype;PA444445;Disease
HYPERPROLACTINEMIA;CYP2C19*1;Haplotype;PA444545;Disease
INFLAMMATION;CYP2C19*1;Haplotype;PA444620;Disease
LYMPHOMA;CYP2C19*1;Haplotype;PA444840;Disease
LYMPHOMA, NON-HODGKIN;CYP2C19*1;Haplotype;PA444845;Disease
MALARIA;CYP2C19*1;Haplotype;PA444859;Disease
MYCOSES;CYP2C19*1;Haplotype;PA445009;Disease
MYOCARDIAL INFARCTION;CYP2C19*1;Haplotype;PA445019;Disease
NAUSEA;CYP2C19*1;Haplotype;PA445048;Disease
NEOPLASMS;CYP2C19*1;Haplotype;PA445062;Disease
PANCREATIC NEOPLASMS;CYP2C19*1;Haplotype;PA445218;Disease
RECURRENCE;CYP2C19*1;Haplotype;PA445506;Disease
RESPIRATORY TRACT INFECTIONS;CYP2C19*1;Haplotype;PA445526;Disease
SHOCK, SEPTIC;CYP2C19*1;Haplotype;PA445647;Disease
THROMBOSIS;CYP2C19*1;Haplotype;PA445850;Disease
TOBACCO USE DISORDER;CYP2C19*1;Haplotype;PA445876;Disease
ULCER;CYP2C19*1;Haplotype;PA445973;Disease
VOMITING;CYP2C19*1;Haplotype;PA446051;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;CYP2C19*1;Haplotype;PA446155;Disease
ALCOHOL-RELATED DISORDERS;CYP2C19*1;Haplotype;PA446879;Disease
STROKE;CYP2C19*1;Haplotype;PA447054;Disease
ANXIETY DISORDERS;CYP2C19*1;Haplotype;PA447196;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CYP2C19*1;Haplotype;PA447197;Disease
BIPOLAR DISORDER;CYP2C19*1;Haplotype;PA447199;Disease
DEPRESSIVE DISORDER;CYP2C19*1;Haplotype;PA447207;Disease
MENTAL DISORDERS;CYP2C19*1;Haplotype;PA447208;Disease
OBSESSIVE-COMPULSIVE DISORDER;CYP2C19*1;Haplotype;PA447211;Disease
PANIC DISORDER;CYP2C19*1;Haplotype;PA447212;Disease
SCHIZOPHRENIA;CYP2C19*1;Haplotype;PA447216;Disease
PEPTIC ULCER;CYP2C19*1;Haplotype;PA447240;Disease
DEPRESSION;CYP2C19*1;Haplotype;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2C19*1;Haplotype;PA447321;Disease
CORONARY RESTENOSIS;CYP2C19*1;Haplotype;PA447325;Disease
AMITRIPTYLINE;CYP2C19*1;Haplotype;PA448385;Chemical
AMOXICILLIN;CYP2C19*1;Haplotype;PA448406;Chemical
ASPIRIN;CYP2C19*1;Haplotype;PA448497;Chemical
ATORVASTATIN;CYP2C19*1;Haplotype;PA448500;Chemical
BUPROPION;CYP2C19*1;Haplotype;PA448687;Chemical
CARISOPRODOL;CYP2C19*1;Haplotype;PA448809;Chemical
CELECOXIB;CYP2C19*1;Haplotype;PA448871;Chemical
CITALOPRAM;CYP2C19*1;Haplotype;PA449015;Chemical
CLOMIPRAMINE;CYP2C19*1;Haplotype;PA449048;Chemical
CLOPIDOGREL;CYP2C19*1;Haplotype;PA449053;Chemical
CLOZAPINE;CYP2C19*1;Haplotype;PA449061;Chemical
CYCLOPHOSPHAMIDE;CYP2C19*1;Haplotype;PA449165;Chemical
DIAZEPAM;CYP2C19*1;Haplotype;PA449283;Chemical
DOXEPIN;CYP2C19*1;Haplotype;PA449409;Chemical
EFAVIRENZ;CYP2C19*1;Haplotype;PA449441;Chemical
FLUCONAZOLE;CYP2C19*1;Haplotype;PA449653;Chemical
FLUOXETINE;CYP2C19*1;Haplotype;PA449673;Chemical
FLUVOXAMINE;CYP2C19*1;Haplotype;PA449690;Chemical
HYDROXYPROGESTERONE;CYP2C19*1;Haplotype;PA449932;Chemical
IBUPROFEN;CYP2C19*1;Haplotype;PA449957;Chemical
IMIPRAMINE;CYP2C19*1;Haplotype;PA449969;Chemical
KETOCONAZOLE;CYP2C19*1;Haplotype;PA450146;Chemical
LANSOPRAZOLE;CYP2C19*1;Haplotype;PA450180;Chemical
LEFLUNOMIDE;CYP2C19*1;Haplotype;PA450192;Chemical
MEPHENYTOIN;CYP2C19*1;Haplotype;PA450373;Chemical
METHYLPHENOBARBITAL;CYP2C19*1;Haplotype;PA450374;Chemical
METHADONE;CYP2C19*1;Haplotype;PA450401;Chemical
NELFINAVIR;CYP2C19*1;Haplotype;PA450606;Chemical
NORTRIPTYLINE;CYP2C19*1;Haplotype;PA450657;Chemical
OMEPRAZOLE;CYP2C19*1;Haplotype;PA450704;Chemical
PANTOPRAZOLE;CYP2C19*1;Haplotype;PA450774;Chemical
PROGESTERONE;CYP2C19*1;Haplotype;PA451123;Chemical
PROGUANIL;CYP2C19*1;Haplotype;PA451124;Chemical
QUETIAPINE;CYP2C19*1;Haplotype;PA451201;Chemical
RABEPRAZOLE;CYP2C19*1;Haplotype;PA451216;Chemical
SERTRALINE;CYP2C19*1;Haplotype;PA451333;Chemical
TACROLIMUS;CYP2C19*1;Haplotype;PA451578;Chemical
TAMOXIFEN;CYP2C19*1;Haplotype;PA451581;Chemical
TICLOPIDINE;CYP2C19*1;Haplotype;PA451686;Chemical
TOLBUTAMIDE;CYP2C19*1;Haplotype;PA451718;Chemical
TRANYLCYPROMINE;CYP2C19*1;Haplotype;PA451741;Chemical
TRIMIPRAMINE;CYP2C19*1;Haplotype;PA451791;Chemical
TROGLITAZONE;CYP2C19*1;Haplotype;PA451799;Chemical
VALPROIC ACID;CYP2C19*1;Haplotype;PA451846;Chemical
VENLAFAXINE;CYP2C19*1;Haplotype;PA451866;Chemical
WARFARIN;CYP2C19*1;Haplotype;PA451906;Chemical
ANTIDEPRESSANTS;CYP2C19*1;Haplotype;PA452229;Chemical
ANTINEOPLASTIC AGENTS;CYP2C19*1;Haplotype;PA452621;Chemical
HLA-DRB1*07:01;abacavir;Chemical;PA165951644;Haplotype
HLA-DQB1*03:03;abacavir;Chemical;PA165958180;Haplotype
HLA-B*57:01;abacavir;Chemical;PA165987830;Haplotype
RS3093726;abacavir;Chemical;PA166157063;Variant
ADH1A;abacavir;Chemical;PA24570;Gene
ADH1B;abacavir;Chemical;PA24571;Gene
ADH1C;abacavir;Chemical;PA24572;Gene
ADK;abacavir;Chemical;PA24579;Gene
LTA;abacavir;Chemical;PA30474;Gene
LTB;abacavir;Chemical;PA30475;Gene
HLA-B;abacavir;Chemical;PA35056;Gene
HLA-DQB1;abacavir;Chemical;PA35068;Gene
HLA-DRB1;abacavir;Chemical;PA35072;Gene
LST1;abacavir;Chemical;PA37856;Gene
G6PD;norfloxacin;Chemical;PA28469;Gene
AGRANULOCYTOSIS;rs3768142;Variant;PA443297;Disease
METHOTREXATE;rs3768142;Variant;PA450428;Chemical
CYP3A4;acalabrutinib;Chemical;PA130;Gene
CYP3A4*1;acalabrutinib;Chemical;PA165819201;Haplotype
CYP3A4*2;acalabrutinib;Chemical;PA165819220;Haplotype
CYP3A4*3;acalabrutinib;Chemical;PA165819221;Haplotype
CYP3A4*9;acalabrutinib;Chemical;PA165819227;Haplotype
CYP3A4*11;acalabrutinib;Chemical;PA165819229;Haplotype
CYP3A4*14;acalabrutinib;Chemical;PA165819232;Haplotype
CYP3A4*16;acalabrutinib;Chemical;PA165819236;Haplotype
CYP3A4*19;acalabrutinib;Chemical;PA165819243;Haplotype
CYP3A4*23;acalabrutinib;Chemical;PA166115836;Haplotype
CYP3A4*24;acalabrutinib;Chemical;PA166115837;Haplotype
CYP3A4*28;acalabrutinib;Chemical;PA166245584;Haplotype
CYP3A4*29;acalabrutinib;Chemical;PA166245585;Haplotype
CYP3A4*32;acalabrutinib;Chemical;PA166245588;Haplotype
CYP3A4*33;acalabrutinib;Chemical;PA166245589;Haplotype
BREAST NEOPLASMS;rs1136201;Variant;PA443560;Disease
DRUG TOXICITY;rs1136201;Variant;PA443937;Disease
CARBOPLATIN;rs1136201;Variant;PA448803;Chemical
DOCETAXEL;rs1136201;Variant;PA449383;Chemical
TRASTUZUMAB;rs1136201;Variant;PA451743;Chemical
ATOMOXETINE;CYP2D6*29;Haplotype;PA134688071;Chemical
BUFURALOL;CYP2D6*29;Haplotype;PA166110256;Chemical
ENDOXIFEN;CYP2D6*29;Haplotype;PA166124478;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*29;Haplotype;PA166127651;Chemical
BREXPIPRAZOLE;CYP2D6*29;Haplotype;PA166160053;Chemical
BREAST NEOPLASMS;CYP2D6*29;Haplotype;PA443560;Disease
BURNS;CYP2D6*29;Haplotype;PA443582;Disease
HYPERTENSION;CYP2D6*29;Haplotype;PA444552;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CYP2D6*29;Haplotype;PA447197;Disease
CODEINE;CYP2D6*29;Haplotype;PA449088;Chemical
DEXTROMETHORPHAN;CYP2D6*29;Haplotype;PA449273;Chemical
FENTANYL;CYP2D6*29;Haplotype;PA449599;Chemical
METOPROLOL;CYP2D6*29;Haplotype;PA450480;Chemical
PRIMAQUINE;CYP2D6*29;Haplotype;PA451103;Chemical
TAMOXIFEN;CYP2D6*29;Haplotype;PA451581;Chemical
DEBRISOQUINE;CYP2D6*29;Haplotype;PA452616;Chemical
17BETA-ESTRADIOL GLUCURONIDE;rs142211148;Variant;PA166277182;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;ZNF816;Gene;PA164713366;Chemical
PSORIASIS;ZNF816;Gene;PA445451;Disease
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs3397;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs3397;Variant;PA443434;Disease
SCHIZOPHRENIA;rs6977820;Variant;PA447216;Disease
TARDIVE DYSKINESIA;rs6977820;Variant;PA447268;Disease
ANTIPSYCHOTICS;rs6977820;Variant;PA452233;Chemical
TOCILIZUMAB;CD69;Gene;PA165292659;Chemical
RHEUMATOID ARTHRITIS;CD69;Gene;PA443434;Disease
EPILEPSY;HLA-B*15:18;Haplotype;PA444065;Disease
SEIZURES;HLA-B*15:18;Haplotype;PA445629;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*15:18;Haplotype;PA445738;Disease
CARBAMAZEPINE;HLA-B*15:18;Haplotype;PA448785;Chemical
OXCARBAZEPINE;HLA-B*15:18;Haplotype;PA450732;Chemical
INFLUENZA VACCINES;HLA-DQB1*03:03;Haplotype;PA164712830;Chemical
CLAVULANATE;HLA-DQB1*03:03;Haplotype;PA164742987;Chemical
FLUCLOXACILLIN;HLA-DQB1*03:03;Haplotype;PA164781042;Chemical
DRUG-INDUCED LIVER INJURY;HLA-DQB1*03:03;Haplotype;PA166119041;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-DQB1*03:03;Haplotype;PA166120929;Disease
EPILEPSY;HLA-DQB1*03:03;Haplotype;PA444065;Disease
URTICARIA;HLA-DQB1*03:03;Haplotype;PA445999;Disease
HIV INFECTIONS;HLA-DQB1*03:03;Haplotype;PA447230;Disease
ABACAVIR;HLA-DQB1*03:03;Haplotype;PA448004;Chemical
AMOXICILLIN;HLA-DQB1*03:03;Haplotype;PA448406;Chemical
ASPIRIN;HLA-DQB1*03:03;Haplotype;PA448497;Chemical
CARBAMAZEPINE;HLA-DQB1*03:03;Haplotype;PA448785;Chemical
MUCOSITIS;CYBA;Gene;PA166122058;Disease
ANEMIA;CYBA;Gene;PA443340;Disease
HYPERCHOLESTEROLEMIA;CYBA;Gene;PA444516;Disease
NEOPLASMS;CYBA;Gene;PA445062;Disease
OSTEOSARCOMA;CYBA;Gene;PA445601;Disease
CISPLATIN;CYBA;Gene;PA449014;Chemical
DOXORUBICIN;CYBA;Gene;PA449412;Chemical
IDARUBICIN;CYBA;Gene;PA449961;Chemical
SIMVASTATIN;CYBA;Gene;PA451363;Chemical
BUTORPHANOL;rs702764;Variant;PA164745398;Chemical
DPYD;rs145548112;Variant;PA145;Gene
CAPECITABINE;rs145548112;Variant;PA448771;Chemical
UGT1A1*1;raloxifene 6-glucuronide;Chemical;PA166115841;Haplotype
UGT1A1*28;raloxifene 6-glucuronide;Chemical;PA166115842;Haplotype
UGT1A1;raloxifene 6-glucuronide;Chemical;PA420;Gene
ABCC2;erythromycin;Chemical;PA116;Gene
CYP3A4;erythromycin;Chemical;PA130;Gene
CYP3A5;erythromycin;Chemical;PA131;Gene
RS717620;erythromycin;Chemical;PA166153953;Variant
RS35599367;erythromycin;Chemical;PA166157487;Variant
KCNH2;erythromycin;Chemical;PA212;Gene
ABCB1;erythromycin;Chemical;PA267;Gene
NR1I2;erythromycin;Chemical;PA378;Gene
NEOPLASMS;rs9936750;Variant;PA445062;Disease
CAPECITABINE;rs9936750;Variant;PA448771;Chemical
FLUOROURACIL;rs148013902;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs148013902;Variant;PA443560;Disease
NEUTROPENIA;rs148013902;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs148013902;Variant;PA449165;Chemical
EPIRUBICIN;rs148013902;Variant;PA449476;Chemical
HLA-DQA1*01:03;Graves Disease;Disease;PA165951282;Haplotype
HLA-DRB1*08:03;Graves Disease;Disease;PA165951678;Haplotype
HLA-B*38:02;Graves Disease;Disease;PA165955505;Haplotype
HLA-B*39:01;Graves Disease;Disease;PA165955543;Haplotype
HLA-DQB1*06:01;Graves Disease;Disease;PA165958097;Haplotype
HLA-B;Graves Disease;Disease;PA35056;Gene
HLA-DQA1;Graves Disease;Disease;PA35066;Gene
HLA-DQB1;Graves Disease;Disease;PA35068;Gene
HLA-DRB1;Graves Disease;Disease;PA35072;Gene
CYP2C9;fosphenytoin;Chemical;PA126;Gene
CYP2C9*2;fosphenytoin;Chemical;PA165816543;Haplotype
CYP2C9*3;fosphenytoin;Chemical;PA165816544;Haplotype
HLA-B*15:02;fosphenytoin;Chemical;PA165954769;Haplotype
HLA-B;fosphenytoin;Chemical;PA35056;Gene
DRD2;pergolide;Chemical;PA27478;Gene
TP53;Li-Fraumeni syndrome;Disease;PA36679;Gene
OLANZAPINE;rs2734842;Variant;PA450688;Chemical
MULTIPLE SCLEROSIS;rs2291858;Variant;PA444987;Disease
INTERFERON BETA-1A;rs2291858;Variant;PA450037;Chemical
INTERFERON BETA-1B;rs2291858;Variant;PA450039;Chemical
CD274;nivolumab;Chemical;PA134915280;Gene
RS113488022;nivolumab;Chemical;PA166157522;Variant
ALK;nivolumab;Chemical;PA24719;Gene
BRAF;nivolumab;Chemical;PA25408;Gene
ERBB2;nivolumab;Chemical;PA27844;Gene
EGFR;nivolumab;Chemical;PA7360;Gene
AMISULPRIDE;rs7968606;Variant;PA162565877;Chemical
SCHIZOPHRENIA;rs7968606;Variant;PA447216;Disease
CDKAL1;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA134871999;Gene
MOB3B;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA134886513;Gene
PGLYRP4;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA134902492;Gene
C9ORF72;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA134908144;Gene
FBXL19;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA134911396;Gene
LY96;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA134924906;Gene
CERS6;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA134925480;Gene
IL23R;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA134935109;Gene
GBP6;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA134964409;Gene
CNPY4;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA162382618;Gene
ARAP2;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA164715938;Gene
ZNF816;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA165394953;Gene
RS3397;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166153542;Variant
RS928655;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166153600;Variant
RS983332;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166153605;Variant
RS1061622;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166153618;Variant
RS1061631;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166153620;Variant
RS1800896;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166153642;Variant
RS10919563;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166153818;Variant
RS767455;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166154502;Variant
RS2430561;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166154549;Variant
RS3794271;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166154566;Variant
RS4149570;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166154585;Variant
RS1143623;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166155628;Variant
RS1143627;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166155629;Variant
RS3087243;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166155693;Variant
RS4251961;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166155724;Variant
RS4848306;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166155735;Variant
RS13393173;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166155829;Variant
RS6028945;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166155951;Variant
RS6071980;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166155954;Variant
RS6138150;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166155963;Variant
RS352139;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166156288;Variant
RS437943;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166156488;Variant
RS1816702;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166156526;Variant
RS3804099;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166156580;Variant
RS4696480;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166156596;Variant
RS11938228;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166156654;Variant
RS2569190;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166156805;Variant
RS610604;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166156931;Variant
RS1799724;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166156988;Variant
RS1799964;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166156990;Variant
RS1800629;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166156997;Variant
RS2275913;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166157030;Variant
RS6920220;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166157114;Variant
RS6927172;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166157119;Variant
RS10945919;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166157172;Variant
RS854547;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166157269;Variant
RS854548;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166157270;Variant
RS854555;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166157272;Variant
RS1800795;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166157304;Variant
RS10499563;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166157448;Variant
RS20575;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166157545;Variant
RS774359;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166157714;Variant
RS868856;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166157715;Variant
RS1554973;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166157732;Variant
RS2814707;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166157759;Variant
RS3761847;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166157763;Variant
RS3849942;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166157768;Variant
RS5030728;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166157782;Variant
RS7046653;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166157788;Variant
RS11209026;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166160559;Variant
RS6941263;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166161136;Variant
RS113878252;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166161137;Variant
RS6065221;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166161138;Variant
RS10782001;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166161150;Variant
RS651630;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166161153;Variant
RS2916205;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166161846;Variant
RS9304742;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166161849;Variant
RS11126740;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166161851;Variant
RS2546890;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166161853;Variant
RS96844;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166161855;Variant
RS12191877;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166161857;Variant
RS6908425;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166161859;Variant
RS4819554;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166161868;Variant
RS11541076;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166161875;Variant
RS11465996;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166175796;Variant
RS1051792;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166238462;Variant
HLA-DQA1*05;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166319541;Haplotype
RS1154831;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA166328661;Variant
IL6;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA198;Gene
CD14;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA26188;Gene
CSRP3;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA26971;Gene
CST5;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA26978;Gene
CTLA4;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA27006;Gene
CTNNA2;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA27009;Gene
IFNG;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA29674;Gene
IL12B;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA29785;Gene
IL17A;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA29794;Gene
IL17RA;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA29801;Gene
IL1B;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA29808;Gene
IL1RN;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA29816;Gene
KLRC4;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA30166;Gene
MAFB;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA30535;Gene
MAP3K1;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA30592;Gene
MICA;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA30811;Gene
PON1;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA33529;Gene
PTPRC;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA34011;Gene
HLA-C;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA35057;Gene
HLA-DQA1;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA35066;Gene
SH3BP2;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA35733;Gene
TLR2;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA36550;Gene
TLR4;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA36552;Gene
TNFAIP3;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA36593;Gene
TNFRSF10A;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA36597;Gene
TNFRSF1A;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA36609;Gene
TNFRSF1B;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA36610;Gene
TRAF1;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA36708;Gene
SLCO1C1;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA37815;Gene
SLC12A8;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA37991;Gene
TLR9;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA38010;Gene
TNF;Tumor necrosis factor alpha (TNF-alpha) inhibitors;Chemical;PA435;Gene
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-C*03:04;Haplotype;PA166120929;Disease
DRUG HYPERSENSITIVITY;HLA-C*03:04;Haplotype;PA443936;Disease
EPILEPSY;HLA-C*03:04;Haplotype;PA444065;Disease
STEVENS-JOHNSON SYNDROME;HLA-C*03:04;Haplotype;PA445738;Disease
CARBAMAZEPINE;HLA-C*03:04;Haplotype;PA448785;Chemical
VALPROIC ACID;HLA-C*03:04;Haplotype;PA451846;Chemical
WARFARIN;rs4841588;Variant;PA451906;Chemical
SLC31A1;Neutropenia;Disease;PA118;Gene
CYP2C8;Neutropenia;Disease;PA125;Gene
CYP3A5;Neutropenia;Disease;PA131;Gene
TMEM43;Neutropenia;Disease;PA134871907;Gene
ENOSF1;Neutropenia;Disease;PA134897613;Gene
PERP;Neutropenia;Disease;PA134944221;Gene
GNL3;Neutropenia;Disease;PA134952132;Gene
C18ORF56;Neutropenia;Disease;PA134956204;Gene
NUDT15;Neutropenia;Disease;PA134963132;Gene
DPYD;Neutropenia;Disease;PA145;Gene
FTO;Neutropenia;Disease;PA152208656;Gene
TP53AIP1;Neutropenia;Disease;PA164726680;Gene
TPMT*1;Neutropenia;Disease;PA165819268;Haplotype
TPMT*2;Neutropenia;Disease;PA165819269;Haplotype
TPMT*3A;Neutropenia;Disease;PA165819270;Haplotype
TPMT*3C;Neutropenia;Disease;PA165819272;Haplotype
TPMT*9;Neutropenia;Disease;PA165819279;Haplotype
TPMT*21;Neutropenia;Disease;PA165819291;Haplotype
CYP2C8*2;Neutropenia;Disease;PA165958684;Haplotype
CYP2C8*3;Neutropenia;Disease;PA165958685;Haplotype
CYP2C8*4;Neutropenia;Disease;PA165958686;Haplotype
TPMT*33;Neutropenia;Disease;PA166005224;Haplotype
TPMT*34;Neutropenia;Disease;PA166005225;Haplotype
GSTM1 NULL;Neutropenia;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Neutropenia;Disease;PA166048676;Haplotype
GSTT1 NULL;Neutropenia;Disease;PA166048678;Haplotype
GSTT1 NON-NULL;Neutropenia;Disease;PA166048679;Haplotype
UGT1A1*1;Neutropenia;Disease;PA166115841;Haplotype
UGT1A1*28;Neutropenia;Disease;PA166115842;Haplotype
UGT1A1*37;Neutropenia;Disease;PA166115844;Haplotype
UGT1A1*6;Neutropenia;Disease;PA166115858;Haplotype
UGT1A7*1A;Neutropenia;Disease;PA166117636;Haplotype
UGT1A7*2;Neutropenia;Disease;PA166117638;Haplotype
UGT1A7*3;Neutropenia;Disease;PA166117639;Haplotype
CYP3A5*1;Neutropenia;Disease;PA166128213;Haplotype
CYP3A5*3;Neutropenia;Disease;PA166128219;Haplotype
NUDT15*1;Neutropenia;Disease;PA166131619;Haplotype
NUDT15*2;Neutropenia;Disease;PA166131620;Haplotype
NUDT15*3;Neutropenia;Disease;PA166131621;Haplotype
NUDT15*5;Neutropenia;Disease;PA166131623;Haplotype
NUDT15*6;Neutropenia;Disease;PA166151814;Haplotype
RS1801133;Neutropenia;Disease;PA166153644;Variant
RS60369023;Neutropenia;Disease;PA166153893;Variant
RS75114882;Neutropenia;Disease;PA166153907;Variant
RS1695;Neutropenia;Disease;PA166154249;Variant
RS1933437;Neutropenia;Disease;PA166154705;Variant
RS45445694;Neutropenia;Disease;PA166155331;Variant
RS10929302;Neutropenia;Disease;PA166155794;Variant
RS7270101;Neutropenia;Disease;PA166155964;Variant
RS8133052;Neutropenia;Disease;PA166156011;Variant
RS2228001;Neutropenia;Disease;PA166156345;Variant
RS1045642;Neutropenia;Disease;PA166157284;Variant
RS2032582;Neutropenia;Disease;PA166157316;Variant
RS11185647;Neutropenia;Disease;PA166157831;Variant
DPYD DEFICIENCY;Neutropenia;Disease;PA166157931;Variant
RS16952570;Neutropenia;Disease;PA166160979;Variant
RS12720066;Neutropenia;Disease;PA166161538;Variant
RS17501331;Neutropenia;Disease;PA166161570;Variant
RS149104283;Neutropenia;Disease;PA166162391;Variant
RS12050587;Neutropenia;Disease;PA166164874;Variant
RS11636687;Neutropenia;Disease;PA166164877;Variant
RS2027701;Neutropenia;Disease;PA166169891;Variant
RS1059698;Neutropenia;Disease;PA166169893;Variant
RS73594404;Neutropenia;Disease;PA166169897;Variant
RS10132552;Neutropenia;Disease;PA166169901;Variant
RS144991623;Neutropenia;Disease;PA166178395;Variant
RS9389568;Neutropenia;Disease;PA166178396;Variant
RS8110364;Neutropenia;Disease;PA166178397;Variant
RS56022120;Neutropenia;Disease;PA166178398;Variant
RS150688309;Neutropenia;Disease;PA166178399;Variant
RS58695150;Neutropenia;Disease;PA166178400;Variant
RS299293;Neutropenia;Disease;PA166178401;Variant
RS138602176;Neutropenia;Disease;PA166178402;Variant
RS148235907;Neutropenia;Disease;PA166178403;Variant
RS117951771;Neutropenia;Disease;PA166178404;Variant
RS299314;Neutropenia;Disease;PA166178405;Variant
RS299313;Neutropenia;Disease;PA166178406;Variant
RS115457081;Neutropenia;Disease;PA166178407;Variant
RS117341846;Neutropenia;Disease;PA166178408;Variant
RS4968187;Neutropenia;Disease;PA166178409;Variant
RS142244113;Neutropenia;Disease;PA166178410;Variant
RS79430272;Neutropenia;Disease;PA166178411;Variant
RS118129530;Neutropenia;Disease;PA166178412;Variant
RS77769901;Neutropenia;Disease;PA166178413;Variant
RS145623321;Neutropenia;Disease;PA166178414;Variant
RS148013902;Neutropenia;Disease;PA166178415;Variant
RS55633228;Neutropenia;Disease;PA166178416;Variant
RS41412545;Neutropenia;Disease;PA166178421;Variant
RS3805945;Neutropenia;Disease;PA166178422;Variant
RS117101815;Neutropenia;Disease;PA166178423;Variant
RS9402944;Neutropenia;Disease;PA166178424;Variant
RS181501757;Neutropenia;Disease;PA166178425;Variant
RS149212925;Neutropenia;Disease;PA166178426;Variant
RS112783657;Neutropenia;Disease;PA166178427;Variant
RS74743371;Neutropenia;Disease;PA166178428;Variant
RS117458836;Neutropenia;Disease;PA166178429;Variant
RS118088833;Neutropenia;Disease;PA166178430;Variant
RS112242273;Neutropenia;Disease;PA166178431;Variant
RS78428806;Neutropenia;Disease;PA166178432;Variant
RS141084494;Neutropenia;Disease;PA166178541;Variant
RS10817464;Neutropenia;Disease;PA166179458;Variant
RS11280056;Neutropenia;Disease;PA166180936;Variant
RS3825876;Neutropenia;Disease;PA166182208;Variant
RS471760;Neutropenia;Disease;PA166182211;Variant
RS12148896;Neutropenia;Disease;PA166182212;Variant
CYP2C8*1;Neutropenia;Disease;PA166242948;Haplotype
GSTM1;Neutropenia;Disease;PA182;Gene
GSTT1;Neutropenia;Disease;PA183;Gene
INSR;Neutropenia;Disease;PA202;Gene
IRS1;Neutropenia;Disease;PA203;Gene
ABCC1;Neutropenia;Disease;PA244;Gene
MTHFR;Neutropenia;Disease;PA245;Gene
NOS1;Neutropenia;Disease;PA252;Gene
CBR3;Neutropenia;Disease;PA26122;Gene
CCNK;Neutropenia;Disease;PA26161;Gene
ABCB1;Neutropenia;Disease;PA267;Gene
FLT3;Neutropenia;Disease;PA28181;Gene
FOXO1;Neutropenia;Disease;PA28237;Gene
GSTP1;Neutropenia;Disease;PA29028;Gene
HMMR;Neutropenia;Disease;PA29340;Gene
ITPA;Neutropenia;Disease;PA29973;Gene
MEG3;Neutropenia;Disease;PA30737;Gene
PIGB;Neutropenia;Disease;PA33290;Gene
PIK3R2;Neutropenia;Disease;PA33313;Gene
PPP2R5D;Neutropenia;Disease;PA33676;Gene
RBX1;Neutropenia;Disease;PA34299;Gene
RXRA;Neutropenia;Disease;PA34890;Gene
TOP2A;Neutropenia;Disease;PA354;Gene
TPMT;Neutropenia;Disease;PA356;Gene
TYMS;Neutropenia;Disease;PA359;Gene
TP53;Neutropenia;Disease;PA36679;Gene
UGT1A7;Neutropenia;Disease;PA37182;Gene
XPC;Neutropenia;Disease;PA37413;Gene
SLC28A1;Neutropenia;Disease;PA387;Gene
NR1I3;Neutropenia;Disease;PA391;Gene
ABCC4;Neutropenia;Disease;PA397;Gene
UGT1A1;Neutropenia;Disease;PA420;Gene
CDA;Neutropenia;Disease;PA98;Gene
AUTISM SPECTRUM DISORDER;rs7799039;Variant;PA153906318;Disease
MOOD DISORDER;rs7799039;Variant;PA447209;Disease
RISPERIDONE;rs7799039;Variant;PA451257;Chemical
ANTIPSYCHOTICS;rs7799039;Variant;PA452233;Chemical
DEPRESSIVE DISORDER;rs1954787;Variant;PA447207;Disease
ANTIDEPRESSANTS;rs1954787;Variant;PA452229;Chemical
EPILEPSY;CYP2C9*39;Haplotype;PA444065;Disease
DICLOFENAC;CYP2C9*39;Haplotype;PA449293;Chemical
PHENYTOIN;CYP2C9*39;Haplotype;PA450947;Chemical
KIDNEY TRANSPLANTATION;rs3761548;Variant;PA165817016;Disease
PSORIASIS;rs3761548;Variant;PA445451;Disease
METHOTREXATE;rs3761548;Variant;PA450428;Chemical
TACROLIMUS;rs3761548;Variant;PA451578;Chemical
ASTHMA;GSDMB;Gene;PA443450;Disease
LONAFARNIB;FNTB;Gene;PA166129466;Chemical
OVARIAN NEOPLASMS;FNTB;Gene;PA445204;Disease
CARBOPLATIN;FNTB;Gene;PA448803;Chemical
PACLITAXEL;FNTB;Gene;PA450761;Chemical
LUNG NEOPLASMS;rs3740556;Variant;PA444818;Disease
CARBOPLATIN;rs3740556;Variant;PA448803;Chemical
CISPLATIN;rs3740556;Variant;PA449014;Chemical
WNK4;STK39;Gene;PA134875400;Gene
OXSR1;STK39;Gene;PA134973207;Gene
SLC12A3;STK39;Gene;PA321;Gene
WNK1;STK39;Gene;PA33782;Gene
WNK3;STK39;Gene;PA33784;Gene
LOSARTAN;STK39;Gene;PA450268;Chemical
RS387907272;zanubrutinib;Chemical;PA166224421;Variant
MYD88;zanubrutinib;Chemical;PA31361;Gene
TP53;zanubrutinib;Chemical;PA36679;Gene
RS6166;urofollitropin;Chemical;PA166155582;Variant
FSHR;urofollitropin;Chemical;PA28386;Gene
GNAS;HTR6;Gene;PA175;Gene
DIABETES MELLITUS;rs149711321;Variant;PA443886;Disease
METFORMIN;rs149711321;Variant;PA450395;Chemical
DRUG HYPERSENSITIVITY;LST1;Gene;PA443936;Disease
MIGRAINE WITHOUT AURA;LST1;Gene;PA444949;Disease
ABACAVIR;LST1;Gene;PA448004;Chemical
DICLOFENAC;LST1;Gene;PA449293;Chemical
IBUPROFEN;LST1;Gene;PA449957;Chemical
INDOMETHACIN;LST1;Gene;PA449982;Chemical
KETOROLAC;LST1;Gene;PA450150;Chemical
NAPROXEN;LST1;Gene;PA450595;Chemical
BREAST NEOPLASMS;TNFRSF11B;Gene;PA443560;Disease
ANASTROZOLE;TNFRSF11B;Gene;PA448432;Chemical
LETROZOLE;TNFRSF11B;Gene;PA450196;Chemical
G6PD;Ascorbic acid (vitamin C), plain;Chemical;PA28469;Gene
DULOXETINE;rs7616119;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs7616119;Variant;PA447321;Disease
KRAS;fruquintinib;Chemical;PA30196;Gene
RHEUMATOID ARTHRITIS;rs1800470;Variant;PA443434;Disease
RITUXIMAB;rs1800470;Variant;PA451261;Chemical
MDGA2;milnacipran;Chemical;PA162395090;Gene
RS1800544;milnacipran;Chemical;PA166153974;Variant
RS1160351;milnacipran;Chemical;PA166154774;Variant
RS6295;milnacipran;Chemical;PA166156708;Variant
RS1364043;milnacipran;Chemical;PA166156760;Variant
RS10042486;milnacipran;Chemical;PA166156855;Variant
HTR1A;milnacipran;Chemical;PA192;Gene
HTR2A;milnacipran;Chemical;PA193;Gene
SLC6A4;milnacipran;Chemical;PA312;Gene
ADRA2A;milnacipran;Chemical;PA35;Gene
G6PD;prilocaine;Chemical;PA28469;Gene
TICAGRELOR;SVEP1;Gene;PA165374673;Chemical
PLATINUM COMPOUNDS;XBP1;Gene;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;XBP1;Gene;PA443622;Disease
SLC22A2;fampridine;Chemical;PA331;Gene
HLA-B*35:02;minocycline;Chemical;PA166288241;Haplotype
HLA-B;minocycline;Chemical;PA35056;Gene
NR1I2;minocycline;Chemical;PA378;Gene
BISPHOSPHONATES;CSRNP3;Gene;PA164712563;Chemical
OSTEONECROSIS;CSRNP3;Gene;PA445187;Disease
ZNF423;raloxifene;Chemical;PA134903681;Gene
ESR1;raloxifene;Chemical;PA156;Gene
UGT1A1*1;raloxifene;Chemical;PA166115841;Haplotype
UGT1A1*28;raloxifene;Chemical;PA166115842;Haplotype
UGT1A8*1A;raloxifene;Chemical;PA166117652;Haplotype
UGT1A8*2;raloxifene;Chemical;PA166117654;Haplotype
UGT1A8*3;raloxifene;Chemical;PA166117655;Haplotype
RS8060157;raloxifene;Chemical;PA166155087;Variant
RS1042597;raloxifene;Chemical;PA166155614;Variant
RS10030044;raloxifene;Chemical;PA166156638;Variant
RS11543791;raloxifene;Chemical;PA166160309;Variant
ESR2;raloxifene;Chemical;PA27886;Gene
UGT1A8;raloxifene;Chemical;PA37183;Gene
UGT1A1;raloxifene;Chemical;PA420;Gene
CORONARY ARTERY DISEASE;rs1800591;Variant;PA443796;Disease
HYPERLIPOPROTEINEMIA TYPE II;rs1800591;Variant;PA444517;Disease
ATORVASTATIN;rs1800591;Variant;PA448500;Chemical
PRAVASTATIN;rs1800591;Variant;PA451089;Chemical
CES1;SN-38;Chemical;PA107;Gene
ABCC2;SN-38;Chemical;PA116;Gene
SLCO1B1;SN-38;Chemical;PA134865839;Gene
UGT1A1*1;SN-38;Chemical;PA166115841;Haplotype
UGT1A1*28;SN-38;Chemical;PA166115842;Haplotype
UGT1A1*37;SN-38;Chemical;PA166115844;Haplotype
UGT1A1*60;SN-38;Chemical;PA166115845;Haplotype
UGT1A1*6;SN-38;Chemical;PA166115858;Haplotype
RS4149056;SN-38;Chemical;PA166154579;Variant
RS2741049;SN-38;Chemical;PA166155690;Variant
RS3806598;SN-38;Chemical;PA166155714;Variant
RS3832043;SN-38;Chemical;PA166155718;Variant
RS34993780;SN-38;Chemical;PA166155869;Variant
RS35350960;SN-38;Chemical;PA166155870;Variant
RS72551344;SN-38;Chemical;PA166155902;Variant
RS6498588;SN-38;Chemical;PA166161540;Variant
RS35621;SN-38;Chemical;PA166161543;Variant
ABCC1;SN-38;Chemical;PA244;Gene
BCHE;SN-38;Chemical;PA25294;Gene
ABCB1;SN-38;Chemical;PA267;Gene
TOP1;SN-38;Chemical;PA353;Gene
UGT1A10;SN-38;Chemical;PA37174;Gene
UGT1A3;SN-38;Chemical;PA37178;Gene
UGT1A4;SN-38;Chemical;PA37179;Gene
UGT1A6;SN-38;Chemical;PA37181;Gene
UGT1A8;SN-38;Chemical;PA37183;Gene
CES2;SN-38;Chemical;PA377;Gene
ABCG2;SN-38;Chemical;PA390;Gene
UGT1A9;SN-38;Chemical;PA419;Gene
UGT1A1;SN-38;Chemical;PA420;Gene
PEMETREXED;rs914232;Variant;PA10810;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs914232;Variant;PA443622;Disease
MESOTHELIOMA;rs914232;Variant;PA444937;Disease
BIPOLAR DISORDER;rs1611259;Variant;PA447199;Disease
LITHIUM;rs1611259;Variant;PA450243;Chemical
RHEUMATOID ARTHRITIS;FPGS;Gene;PA443434;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;FPGS;Gene;PA446155;Disease
METHOTREXATE;FPGS;Gene;PA450428;Chemical
WARFARIN;FPGS;Gene;PA451906;Chemical
COUMARIN;CYP2A6*20;Haplotype;PA134521193;Chemical
COTININE;CYP2A6*20;Haplotype;PA166114414;Chemical
CESSATION;CYP2A6*20;Haplotype;PA166123046;Disease
BREAST NEOPLASMS;CYP2A6*20;Haplotype;PA443560;Disease
TOBACCO USE DISORDER;CYP2A6*20;Haplotype;PA445876;Disease
LETROZOLE;CYP2A6*20;Haplotype;PA450196;Chemical
NICOTINE;CYP2A6*20;Haplotype;PA450626;Chemical
CYP3A4;posaconazole;Chemical;PA130;Gene
BUFURALOL;CYP2D6*36;Haplotype;PA166110256;Chemical
EVENT-FREE SURVIVAL;CYP2D6*36;Haplotype;PA166123366;Disease
N-DESMETHYLTAMOXIFEN;CYP2D6*36;Haplotype;PA166127651;Chemical
RECURRENCE FREE SURVIVAL;CYP2D6*36;Haplotype;PA166127658;Disease
ARRHYTHMIAS, CARDIAC;CYP2D6*36;Haplotype;PA443421;Disease
BREAST NEOPLASMS;CYP2D6*36;Haplotype;PA443560;Disease
RECURRENCE;CYP2D6*36;Haplotype;PA445506;Disease
TACHYCARDIA;CYP2D6*36;Haplotype;PA445802;Disease
CODEINE;CYP2D6*36;Haplotype;PA449088;Chemical
DEXTROMETHORPHAN;CYP2D6*36;Haplotype;PA449273;Chemical
FLECAINIDE;CYP2D6*36;Haplotype;PA449646;Chemical
PRIMAQUINE;CYP2D6*36;Haplotype;PA451103;Chemical
PROPAFENONE;CYP2D6*36;Haplotype;PA451131;Chemical
TAMOXIFEN;CYP2D6*36;Haplotype;PA451581;Chemical
ANTINEOPLASTIC AGENTS;CYP2D6*36;Haplotype;PA452621;Chemical
CYP2D6;perphenazine;Chemical;PA128;Gene
RS951439;perphenazine;Chemical;PA166153604;Variant
RS2842030;perphenazine;Chemical;PA166153720;Variant
RS155333;perphenazine;Chemical;PA166252941;Variant
RS6465938;perphenazine;Chemical;PA166252981;Variant
RELN;perphenazine;Chemical;PA34323;Gene
RGS4;perphenazine;Chemical;PA34375;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs6028945;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs6028945;Variant;PA443434;Disease
NEPHROTOXICITY;GATA3;Gene;PA162263533;Disease
PEGASPARGASE;GATA3;Gene;PA164760860;Chemical
GLUCARPIDASE;GATA3;Gene;PA165949771;Chemical
ASPARAGINASE;GATA3;Gene;PA448492;Chemical
CYCLOPHOSPHAMIDE;GATA3;Gene;PA449165;Chemical
CYTARABINE;GATA3;Gene;PA449177;Chemical
DAUNORUBICIN;GATA3;Gene;PA449212;Chemical
DEXAMETHASONE;GATA3;Gene;PA449247;Chemical
DOXORUBICIN;GATA3;Gene;PA449412;Chemical
LEUCOVORIN;GATA3;Gene;PA450198;Chemical
MERCAPTOPURINE;GATA3;Gene;PA450379;Chemical
METHOTREXATE;GATA3;Gene;PA450428;Chemical
PREDNISONE;GATA3;Gene;PA451100;Chemical
THIOGUANINE;GATA3;Gene;PA451663;Chemical
VINCRISTINE;GATA3;Gene;PA451879;Chemical
CYP2B6;trazodone;Chemical;PA123;Gene
CYP2C19;trazodone;Chemical;PA124;Gene
CYP2C9;trazodone;Chemical;PA126;Gene
CYP2D6;trazodone;Chemical;PA128;Gene
CYP3A4;trazodone;Chemical;PA130;Gene
CYP3A5;trazodone;Chemical;PA131;Gene
HTR2A;trazodone;Chemical;PA193;Gene
HTR2C;trazodone;Chemical;PA194;Gene
CYP1A2;trazodone;Chemical;PA27093;Gene
DRD2;trazodone;Chemical;PA27478;Gene
SLC6A4;trazodone;Chemical;PA312;Gene
POLG;trazodone;Chemical;PA33500;Gene
HLA-A;trazodone;Chemical;PA35055;Gene
HLA-B;trazodone;Chemical;PA35056;Gene
UGT1A4;trazodone;Chemical;PA37179;Gene
RS1059150;certolizumab pegol;Chemical;PA166155914;Variant
RS1264457;certolizumab pegol;Chemical;PA166156981;Variant
RS2302489;certolizumab pegol;Chemical;PA166160715;Variant
RS7301582;certolizumab pegol;Chemical;PA166160807;Variant
ATP5F1E;certolizumab pegol;Chemical;PA25128;Gene
KLRC1;certolizumab pegol;Chemical;PA30163;Gene
KLRD1;certolizumab pegol;Chemical;PA30167;Gene
HLA-E;certolizumab pegol;Chemical;PA35081;Gene
MAP3K1;SHC3;Gene;PA30592;Gene
RAF1;SHC3;Gene;PA34183;Gene
EGFR;SHC3;Gene;PA7360;Gene
FLUOROURACIL;ABCC11;Gene;PA128406956;Chemical
LEUKOPENIA;ABCC11;Gene;PA444773;Disease
NEOPLASMS;ABCC11;Gene;PA445062;Disease
LEUKOTRIENE RECEPTOR ANTAGONISTS;CYSLTR2;Gene;PA164712863;Chemical
SODIUM PHENYLBUTYRATE;ASS1;Gene;PA166114316;Chemical
SODIUM BENZOATE / SODIUM PHENYLACETATE;ASS1;Gene;PA166176020;Chemical
GLYCEROL PHENYLBUTYRATE;ASS1;Gene;PA166268801;Chemical
CBS;methionine;Chemical;PA26123;Gene
CPS1;methionine;Chemical;PA26840;Gene
ALDH1L1;methionine;Chemical;PA28393;Gene
GNMT;methionine;Chemical;PA28794;Gene
PSPH;methionine;Chemical;PA33928;Gene
RYR1;dantrolene;Chemical;PA34896;Gene
XK469;rs10931910;Variant;PA166114484;Chemical
SCHIZOPHRENIA;rs6465084;Variant;PA447216;Disease
ANTIPSYCHOTICS;rs6465084;Variant;PA452233;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs9901675;Variant;PA447197;Disease
METHYLPHENIDATE;rs9901675;Variant;PA450464;Chemical
ROSUVASTATIN;rs12422149;Variant;PA134308647;Chemical
ASTHMA;rs12422149;Variant;PA443450;Disease
MONTELUKAST;rs12422149;Variant;PA450546;Chemical
HEROIN DEPENDENCE;rs1051660;Variant;PA444460;Disease
NEOPLASMS;rs1051660;Variant;PA445062;Disease
PAIN;rs1051660;Variant;PA445208;Disease
MORPHINE;rs1051660;Variant;PA450550;Chemical
HEROIN;rs1051660;Variant;PA452619;Chemical
ASTHMA;rs1663330;Variant;PA443450;Disease
SALBUTAMOL;rs1663330;Variant;PA448068;Chemical
IFNL3;voxilaprevir;Chemical;PA134952671;Gene
IFNL4;voxilaprevir;Chemical;PA166049147;Gene
RS12979860;voxilaprevir;Chemical;PA166155468;Variant
ACUTE CORONARY SYNDROME;rs1967309;Variant;PA165108401;Disease
DALCETRAPIB;rs1967309;Variant;PA166131581;Chemical
HYPERCHOLESTEROLEMIA;MYLIP;Gene;PA444516;Disease
ATORVASTATIN;MYLIP;Gene;PA448500;Chemical
RS80338792;Myotonia;Disease;PA166155266;Variant
SCN4A;Myotonia;Disease;PA35006;Gene
CFTR;rs1800120;Variant;PA109;Gene
IVACAFTOR;rs1800120;Variant;PA165950341;Chemical
FLUOROURACIL;KLC1;Gene;PA128406956;Chemical
COLORECTAL NEOPLASMS;KLC1;Gene;PA446108;Disease
IRINOTECAN;KLC1;Gene;PA450085;Chemical
LEUCOVORIN;KLC1;Gene;PA450198;Chemical
NR1H3;SULT2A1;Gene;PA31751;Gene
ACETAMINOPHEN;SULT2A1;Gene;PA448015;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs1056892;Variant;PA130620651;Chemical
HEART FAILURE;rs1056892;Variant;PA444370;Disease
NEOPLASMS;rs1056892;Variant;PA445062;Disease
HMG COA REDUCTASE INHIBITORS;rs646776;Variant;PA133950441;Chemical
S-EDDP;CYP2B6*4;Haplotype;PA166177606;Chemical
R-EDDP;CYP2B6*4;Haplotype;PA166247521;Chemical
HEROIN DEPENDENCE;CYP2B6*4;Haplotype;PA444460;Disease
OPIOID-RELATED DISORDERS;CYP2B6*4;Haplotype;PA445043;Disease
TOBACCO USE DISORDER;CYP2B6*4;Haplotype;PA445876;Disease
HIV INFECTIONS;CYP2B6*4;Haplotype;PA447230;Disease
DEPRESSION;CYP2B6*4;Haplotype;PA447278;Disease
BUPROPION;CYP2B6*4;Haplotype;PA448687;Chemical
EFAVIRENZ;CYP2B6*4;Haplotype;PA449441;Chemical
METHADONE;CYP2B6*4;Haplotype;PA450401;Chemical
MIRTAZAPINE;CYP2B6*4;Haplotype;PA450522;Chemical
NICOTINE;CYP2B6*4;Haplotype;PA450626;Chemical
SERTRALINE;CYP2B6*4;Haplotype;PA451333;Chemical
CYP2D6;tiotropium;Chemical;PA128;Gene
RS1042713;tiotropium;Chemical;PA166156748;Variant
ADRB2;tiotropium;Chemical;PA39;Gene
RHEUMATOID ARTHRITIS;rs246240;Variant;PA443434;Disease
DRUG TOXICITY;rs246240;Variant;PA443937;Disease
PSORIASIS;rs246240;Variant;PA445451;Disease
METHOTREXATE;rs246240;Variant;PA450428;Chemical
RS1045642;Epilepsy, idiopathic generalized;Disease;PA166157284;Variant
ABCB1;Epilepsy, idiopathic generalized;Disease;PA267;Gene
CDKAL1;Psoriasis;Disease;PA134871999;Gene
PGLYRP4;Psoriasis;Disease;PA134902492;Gene
FBXL19;Psoriasis;Disease;PA134911396;Gene
LY96;Psoriasis;Disease;PA134924906;Gene
IL23R;Psoriasis;Disease;PA134935109;Gene
TIRAP;Psoriasis;Disease;PA134972842;Gene
ZNF816;Psoriasis;Disease;PA165394953;Gene
HLA-C*06:02;Psoriasis;Disease;PA165957286;Haplotype
RS396991;Psoriasis;Disease;PA166153571;Variant
RS1801274;Psoriasis;Disease;PA166153652;Variant
RS6427528;Psoriasis;Disease;PA166153781;Variant
RS1695;Psoriasis;Disease;PA166154249;Variant
RS35592;Psoriasis;Disease;PA166154982;Variant
RS246240;Psoriasis;Disease;PA166154991;Variant
RS2238476;Psoriasis;Disease;PA166155034;Variant
RS28364006;Psoriasis;Disease;PA166155126;Variant
RS45445694;Psoriasis;Disease;PA166155331;Variant
RS1143623;Psoriasis;Disease;PA166155628;Variant
RS1143627;Psoriasis;Disease;PA166155629;Variant
RS3087243;Psoriasis;Disease;PA166155693;Variant
RS352139;Psoriasis;Disease;PA166156288;Variant
RS4696480;Psoriasis;Disease;PA166156596;Variant
RS11938228;Psoriasis;Disease;PA166156654;Variant
RS13120400;Psoriasis;Disease;PA166156664;Variant
RS17731538;Psoriasis;Disease;PA166156674;Variant
RS610604;Psoriasis;Disease;PA166156931;Variant
RS1799724;Psoriasis;Disease;PA166156988;Variant
RS1800629;Psoriasis;Disease;PA166156997;Variant
RS6920220;Psoriasis;Disease;PA166157114;Variant
RS1800795;Psoriasis;Disease;PA166157304;Variant
RS28362491;Psoriasis;Disease;PA166159897;Variant
RS3213094;Psoriasis;Disease;PA166160547;Variant
RS11209026;Psoriasis;Disease;PA166160559;Variant
RS10782001;Psoriasis;Disease;PA166161150;Variant
RS651630;Psoriasis;Disease;PA166161153;Variant
RS2916205;Psoriasis;Disease;PA166161846;Variant
RS9304742;Psoriasis;Disease;PA166161849;Variant
RS11126740;Psoriasis;Disease;PA166161851;Variant
RS2546890;Psoriasis;Disease;PA166161853;Variant
RS96844;Psoriasis;Disease;PA166161855;Variant
RS12191877;Psoriasis;Disease;PA166161857;Variant
RS6908425;Psoriasis;Disease;PA166161859;Variant
RS4819554;Psoriasis;Disease;PA166161868;Variant
RS3761548;Psoriasis;Disease;PA166162248;Variant
RS5744174;Psoriasis;Disease;PA166163371;Variant
RS11465996;Psoriasis;Disease;PA166175796;Variant
RS8177374;Psoriasis;Disease;PA166175800;Variant
RS11280056;Psoriasis;Disease;PA166180936;Variant
RS12885713;Psoriasis;Disease;PA166289381;Variant
IL6;Psoriasis;Disease;PA198;Gene
FOXP3;Psoriasis;Disease;PA201094;Gene
ABCC1;Psoriasis;Disease;PA244;Gene
NFKB1;Psoriasis;Disease;PA248;Gene
CALM1;Psoriasis;Disease;PA26035;Gene
CD84;Psoriasis;Disease;PA26242;Gene
CTLA4;Psoriasis;Disease;PA27006;Gene
CTNNA2;Psoriasis;Disease;PA27009;Gene
FCGR2A;Psoriasis;Disease;PA28063;Gene
FCGR3A;Psoriasis;Disease;PA28065;Gene
GSTP1;Psoriasis;Disease;PA29028;Gene
IL12B;Psoriasis;Disease;PA29785;Gene
IL17RA;Psoriasis;Disease;PA29801;Gene
IL1B;Psoriasis;Disease;PA29808;Gene
MAP3K1;Psoriasis;Disease;PA30592;Gene
HLA-C;Psoriasis;Disease;PA35057;Gene
SH3BP2;Psoriasis;Disease;PA35733;Gene
TYMS;Psoriasis;Disease;PA359;Gene
TLR2;Psoriasis;Disease;PA36550;Gene
TLR5;Psoriasis;Disease;PA36553;Gene
TNFAIP3;Psoriasis;Disease;PA36593;Gene
VDR;Psoriasis;Disease;PA37301;Gene
SLC12A8;Psoriasis;Disease;PA37991;Gene
TLR9;Psoriasis;Disease;PA38010;Gene
ABCG2;Psoriasis;Disease;PA390;Gene
TNF;Psoriasis;Disease;PA435;Gene
PLCB1;PLA2G2A;Gene;PA33384;Gene
PLCG2;PLA2G2A;Gene;PA33393;Gene
RHEUMATOID ARTHRITIS;rs6064463;Variant;PA443434;Disease
METHOTREXATE;rs6064463;Variant;PA450428;Chemical
LDLR;lomitapide;Chemical;PA227;Gene
PCSK9;lomitapide;Chemical;PA38617;Gene
APOB;lomitapide;Chemical;PA50;Gene
CLODRONATE;VDR;Gene;PA10239;Chemical
SELECTIVE BETA-2-ADRENORECEPTOR AGONISTS;VDR;Gene;PA134687887;Chemical
CALCIUM;VDR;Gene;PA164712582;Chemical
PEGINTERFERON ALFA-2A;VDR;Gene;PA164749390;Chemical
CONJUGATED ESTROGENS;VDR;Gene;PA164754789;Chemical
DEFERASIROX;VDR;Gene;PA164760843;Chemical
PEGINTERFERON ALFA-2B;VDR;Gene;PA164784024;Chemical
BOCEPREVIR;VDR;Gene;PA165948902;Chemical
BONE DENSITY;VDR;Gene;PA166128365;Disease
ACQUIRED IMMUNODEFICIENCY SYNDROME;VDR;Gene;PA443250;Disease
ASTHMA;VDR;Gene;PA443450;Disease
BREAST NEOPLASMS;VDR;Gene;PA443560;Disease
DIABETES MELLITUS, TYPE 1;VDR;Gene;PA443888;Disease
HEPATITIS C VIRUS INFECTION;VDR;Gene;PA444445;Disease
MYOCARDIAL INFARCTION;VDR;Gene;PA445019;Disease
OSTEITIS DEFORMANS;VDR;Gene;PA445172;Disease
OSTEOPOROSIS;VDR;Gene;PA445190;Disease
PROSTATIC NEOPLASMS;VDR;Gene;PA445425;Disease
PSORIASIS;VDR;Gene;PA445451;Disease
RICKETS;VDR;Gene;PA445566;Disease
TUBERCULOSIS;VDR;Gene;PA445941;Disease
COLORECTAL NEOPLASMS;VDR;Gene;PA446108;Disease
BETA-THALASSEMIA AND RELATED DISEASES;VDR;Gene;PA446432;Disease
CHRONIC HEPATITIS C VIRUS INFECTION;VDR;Gene;PA446863;Disease
ALENDRONATE;VDR;Gene;PA448082;Chemical
CALCIPOTRIOL;VDR;Gene;PA448714;Chemical
CALCITRIOL;VDR;Gene;PA448717;Chemical
DEXAMETHASONE;VDR;Gene;PA449247;Chemical
IRINOTECAN;VDR;Gene;PA450085;Chemical
MEDROXYPROGESTERONE;VDR;Gene;PA450344;Chemical
MIDAZOLAM;VDR;Gene;PA450496;Chemical
RIBAVIRIN;VDR;Gene;PA451241;Chemical
VITAMIN D AND ANALOGUES;VDR;Gene;PA451899;Chemical
WARFARIN;VDR;Gene;PA451906;Chemical
METHOTREXATE;ADA;Gene;PA450428;Chemical
G6PD DEFICIENCY;rs137852330;Variant;PA166048754;Disease
FLUOROURACIL;rs72728438;Variant;PA128406956;Chemical
PSYCHOTIC DISORDER;rs1334802;Variant;PA447215;Disease
ANTIPSYCHOTICS;rs1334802;Variant;PA452233;Chemical
FLUOROURACIL;TOP2A;Gene;PA128406956;Chemical
BREAST NEOPLASMS;TOP2A;Gene;PA443560;Disease
NEUTROPENIA;TOP2A;Gene;PA445113;Disease
CYCLOPHOSPHAMIDE;TOP2A;Gene;PA449165;Chemical
EPIRUBICIN;TOP2A;Gene;PA449476;Chemical
FLUOROURACIL;DPYD c.1129-5923C>G, c.1236G>A (HapB3);Haplotype;PA128406956;Chemical
DPYD;DPYD c.1129-5923C>G, c.1236G>A (HapB3);Haplotype;PA145;Gene
TEGAFUR / GIMERACIL / OTERACIL;DPYD c.1129-5923C>G, c.1236G>A (HapB3);Haplotype;PA166115442;Chemical
DRUG TOXICITY;DPYD c.1129-5923C>G, c.1236G>A (HapB3);Haplotype;PA443937;Disease
NEOPLASMS;DPYD c.1129-5923C>G, c.1236G>A (HapB3);Haplotype;PA445062;Disease
CAPECITABINE;DPYD c.1129-5923C>G, c.1236G>A (HapB3);Haplotype;PA448771;Chemical
TEGAFUR;DPYD c.1129-5923C>G, c.1236G>A (HapB3);Haplotype;PA452620;Chemical
DEPRESSIVE DISORDER;rs7787082;Variant;PA447207;Disease
SCHIZOPHRENIA;rs7787082;Variant;PA447216;Disease
AMITRIPTYLINE;rs7787082;Variant;PA448385;Chemical
CITALOPRAM;rs7787082;Variant;PA449015;Chemical
CLOZAPINE;rs7787082;Variant;PA449061;Chemical
PAROXETINE;rs7787082;Variant;PA450801;Chemical
VENLAFAXINE;rs7787082;Variant;PA451866;Chemical
ADALIMUMAB;rs7301582;Variant;PA10004;Chemical
CERTOLIZUMAB PEGOL;rs7301582;Variant;PA165107055;Chemical
RHEUMATOID ARTHRITIS;rs7301582;Variant;PA443434;Disease
ETANERCEPT;rs7301582;Variant;PA449515;Chemical
METHOTREXATE;rs7301582;Variant;PA450428;Chemical
GLUCOCORTICOIDS;rs7301582;Variant;PA452347;Chemical
INFLIXIMAB;rs7301582;Variant;PA452639;Chemical
SULFAMETHOXAZOLE / TRIMETHOPRIM;NAT2*16;Haplotype;PA10715;Chemical
ANTIVIRALS FOR TREATMENT OF HIV INFECTIONS, COMBINATIONS;NAT2*16;Haplotype;PA164712505;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;NAT2*16;Haplotype;PA164712708;Chemical
TOXIC LIVER DISEASE;NAT2*16;Haplotype;PA164925725;Disease
DRUG-INDUCED LIVER INJURY;NAT2*16;Haplotype;PA166119041;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;NAT2*16;Haplotype;PA166120929;Disease
DIPYRONE;NAT2*16;Haplotype;PA166128206;Chemical
ADVERSE EVENTS;NAT2*16;Haplotype;PA166151827;Disease
HYPERSENSITIVITY;NAT2*16;Haplotype;PA444546;Disease
HYPERTENSION;NAT2*16;Haplotype;PA444552;Disease
TUBERCULOSIS;NAT2*16;Haplotype;PA445941;Disease
HIV INFECTIONS;NAT2*16;Haplotype;PA447230;Disease
HYDRALAZINE;NAT2*16;Haplotype;PA449894;Chemical
ISONIAZID;NAT2*16;Haplotype;PA450112;Chemical
ARIPIPRAZOLE;SH2B1;Gene;PA10026;Chemical
AMISULPRIDE;SH2B1;Gene;PA162565877;Chemical
PALIPERIDONE;SH2B1;Gene;PA163518919;Chemical
SCHIZOAFFECTIVE DISORDER;SH2B1;Gene;PA166123368;Disease
BIPOLAR DISORDER;SH2B1;Gene;PA447199;Disease
DEPRESSIVE DISORDER;SH2B1;Gene;PA447207;Disease
PSYCHOTIC DISORDER;SH2B1;Gene;PA447215;Disease
CLOZAPINE;SH2B1;Gene;PA449061;Chemical
LITHIUM;SH2B1;Gene;PA450243;Chemical
MIRTAZAPINE;SH2B1;Gene;PA450522;Chemical
OLANZAPINE;SH2B1;Gene;PA450688;Chemical
QUETIAPINE;SH2B1;Gene;PA451201;Chemical
RISPERIDONE;SH2B1;Gene;PA451257;Chemical
VALPROIC ACID;SH2B1;Gene;PA451846;Chemical
ARIPIPRAZOLE;CYP3A4;Gene;PA10026;Chemical
DULOXETINE;CYP3A4;Gene;PA10066;Chemical
ESCITALOPRAM;CYP3A4;Gene;PA10074;Chemical
FOSAMPRENAVIR;CYP3A4;Gene;PA10084;Chemical
TELITHROMYCIN;CYP3A4;Gene;PA10202;Chemical
VINDESINE;CYP3A4;Gene;PA10232;Chemical
VORICONAZOLE;CYP3A4;Gene;PA10233;Chemical
ATAZANAVIR;CYP3A4;Gene;PA10251;Chemical
IMATINIB;CYP3A4;Gene;PA10804;Chemical
ORGAN TRANSPLANTATION;CYP3A4;Gene;PA133888799;Disease
HMG COA REDUCTASE INHIBITORS;CYP3A4;Gene;PA133950441;Chemical
ROSUVASTATIN;CYP3A4;Gene;PA134308647;Chemical
MIANSERIN;CYP3A4;Gene;PA134687937;Chemical
TRANSPLANTATION;CYP3A4;Gene;PA134850491;Disease
PITAVASTATIN;CYP3A4;Gene;PA142650384;Chemical
POSACONAZOLE;CYP3A4;Gene;PA151958574;Chemical
DRONEDARONE;CYP3A4;Gene;PA153619853;Chemical
PRASUGREL;CYP3A4;Gene;PA154410481;Chemical
TROPISETRON;CYP3A4;Gene;PA161925594;Chemical
SUNITINIB;CYP3A4;Gene;PA162372840;Chemical
DARUNAVIR;CYP3A4;Gene;PA163522472;Chemical
TIPRANAVIR;CYP3A4;Gene;PA163522473;Chemical
MIR27A;CYP3A4;Gene;PA164722621;Gene
TRIMETHADIONE;CYP3A4;Gene;PA164744924;Chemical
RANOLAZINE;CYP3A4;Gene;PA164746007;Chemical
EVEROLIMUS;CYP3A4;Gene;PA164746311;Chemical
TOLTERODINE;CYP3A4;Gene;PA164746757;Chemical
MYCOPHENOLIC ACID;CYP3A4;Gene;PA164748728;Chemical
DORZOLAMIDE;CYP3A4;Gene;PA164748765;Chemical
DESLORATADINE;CYP3A4;Gene;PA164776964;Chemical
FLUNITRAZEPAM;CYP3A4;Gene;PA164781320;Chemical
DIVALPROEX SODIUM;CYP3A4;Gene;PA164783479;Chemical
SERTINDOLE;CYP3A4;Gene;PA164784002;Chemical
ACUTE CORONARY SYNDROME;CYP3A4;Gene;PA165108401;Disease
ARTEMISININ;CYP3A4;Gene;PA165111696;Chemical
ARTEMETHER;CYP3A4;Gene;PA165111698;Chemical
LUMEFANTRINE;CYP3A4;Gene;PA165111722;Chemical
ARTEETHER;CYP3A4;Gene;PA165260403;Chemical
PAZOPANIB;CYP3A4;Gene;PA165291492;Chemical
TICAGRELOR;CYP3A4;Gene;PA165374673;Chemical
KIDNEY TRANSPLANTATION;CYP3A4;Gene;PA165817016;Disease
CYP3A4*1;CYP3A4;Gene;PA165819201;Haplotype
CYP3A4*6;CYP3A4;Gene;PA165819224;Haplotype
CYP3A4*8;CYP3A4;Gene;PA165819226;Haplotype
CYP3A4*11;CYP3A4;Gene;PA165819229;Haplotype
CYP3A4*12;CYP3A4;Gene;PA165819230;Haplotype
CYP3A4*13;CYP3A4;Gene;PA165819231;Haplotype
CYP3A4*16;CYP3A4;Gene;PA165819236;Haplotype
CYP3A4*17;CYP3A4;Gene;PA165819239;Haplotype
CYP3A4*18;CYP3A4;Gene;PA165819240;Haplotype
CYP3A4*20;CYP3A4;Gene;PA165819244;Haplotype
CABOZANTINIB;CYP3A4;Gene;PA165906891;Chemical
VEMURAFENIB;CYP3A4;Gene;PA165946873;Chemical
NILOTINIB;CYP3A4;Gene;PA165958345;Chemical
RIVAROXABAN;CYP3A4;Gene;PA165958360;Chemical
SAXAGLIPTIN;CYP3A4;Gene;PA165958362;Chemical
VILAZODONE;CYP3A4;Gene;PA165958365;Chemical
FESOTERODINE;CYP3A4;Gene;PA165958376;Chemical
CABAZITAXEL;CYP3A4;Gene;PA165958401;Chemical
CYP3A4*22;CYP3A4;Gene;PA166048680;Haplotype
TRANSPLANT REJECTION;CYP3A4;Gene;PA166114454;Disease
ACUTE CELLULAR REJECTION;CYP3A4;Gene;PA166114455;Disease
LUNG TRANSPLANTATION;CYP3A4;Gene;PA166114457;Disease
REGORAFENIB;CYP3A4;Gene;PA166114943;Chemical
DOLUTEGRAVIR;CYP3A4;Gene;PA166114961;Chemical
VANDETANIB;CYP3A4;Gene;PA166118341;Chemical
IBRUTINIB;CYP3A4;Gene;PA166121346;Chemical
RUXOLITINIB;CYP3A4;Gene;PA166123386;Chemical
IVABRADINE;CYP3A4;Gene;PA166123415;Chemical
TREATMENT MODIFICATION;CYP3A4;Gene;PA166124372;Disease
ENDOXIFEN;CYP3A4;Gene;PA166124478;Chemical
N-DESMETHYLTAMOXIFEN;CYP3A4;Gene;PA166127651;Chemical
4-HYDROXYTAMOXIFEN;CYP3A4;Gene;PA166127652;Chemical
CYP3A5*3;CYP3A4;Gene;PA166128219;Haplotype
PLATELET AGGREGATION INHIBITION;CYP3A4;Gene;PA166128371;Disease
LONAFARNIB;CYP3A4;Gene;PA166129466;Chemical
ADVERSE EVENTS;CYP3A4;Gene;PA166151827;Disease
ALECTINIB;CYP3A4;Gene;PA166160050;Chemical
BREXPIPRAZOLE;CYP3A4;Gene;PA166160053;Chemical
CLOZAPINE N-OXIDE;CYP3A4;Gene;PA166163658;Chemical
N-DESMETHYLCLOZAPINE;CYP3A4;Gene;PA166163659;Chemical
4-BETA-HYDROXYCHOLESTEROL;CYP3A4;Gene;PA166165251;Chemical
LAPAROSCOPIC SLEEVE GASTRECTOMY;CYP3A4;Gene;PA166169562;Disease
FEBRILE NEUTROPENIA;CYP3A4;Gene;PA166170245;Disease
NORFENTANYL;CYP3A4;Gene;PA166179852;Chemical
UMIFENOVIR;CYP3A4;Gene;PA166197241;Chemical
ACALABRUTINIB;CYP3A4;Gene;PA166198581;Chemical
CYP3A4*26;CYP3A4;Gene;PA166245583;Haplotype
MACITENTAN;CYP3A4;Gene;PA166261201;Chemical
RIPRETINIB;CYP3A4;Gene;PA166270781;Chemical
BLONANSERIN;CYP3A4;Gene;PA166319041;Chemical
NR1I2;CYP3A4;Gene;PA378;Gene
NR1I3;CYP3A4;Gene;PA391;Gene
ALCOHOLISM;CYP3A4;Gene;PA443309;Disease
ALOPECIA;CYP3A4;Gene;PA443314;Disease
BREAST NEOPLASMS;CYP3A4;Gene;PA443560;Disease
CARCINOMA, NON-SMALL-CELL LUNG;CYP3A4;Gene;PA443622;Disease
CORONARY ARTERY DISEASE;CYP3A4;Gene;PA443796;Disease
DRUG TOXICITY;CYP3A4;Gene;PA443937;Disease
EPILEPSY;CYP3A4;Gene;PA444065;Disease
EXANTHEMA;CYP3A4;Gene;PA444109;Disease
HEART FAILURE;CYP3A4;Gene;PA444370;Disease
HEROIN DEPENDENCE;CYP3A4;Gene;PA444460;Disease
HYPERCHOLESTEROLEMIA;CYP3A4;Gene;PA444516;Disease
HYPERLIPIDEMIAS;CYP3A4;Gene;PA444528;Disease
HYPERTENSION;CYP3A4;Gene;PA444552;Disease
HYPOVENTILATION;CYP3A4;Gene;PA444591;Disease
KIDNEY NEOPLASMS;CYP3A4;Gene;PA444685;Disease
LIVER CIRRHOSIS;CYP3A4;Gene;PA444797;Disease
MALARIA;CYP3A4;Gene;PA444859;Disease
MYCOSES;CYP3A4;Gene;PA445009;Disease
OPIOID-RELATED DISORDERS;CYP3A4;Gene;PA445043;Disease
NEOPLASMS;CYP3A4;Gene;PA445062;Disease
OVARIAN NEOPLASMS;CYP3A4;Gene;PA445204;Disease
PAIN;CYP3A4;Gene;PA445208;Disease
PAIN, POSTOPERATIVE;CYP3A4;Gene;PA445210;Disease
PERIPHERAL NERVOUS SYSTEM DISEASES;CYP3A4;Gene;PA445301;Disease
PROSTATIC NEOPLASMS;CYP3A4;Gene;PA445425;Disease
PROTEINURIA;CYP3A4;Gene;PA445431;Disease
TESTICULAR NEOPLASMS;CYP3A4;Gene;PA445828;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;CYP3A4;Gene;PA446155;Disease
ENDOMETRIAL NEOPLASMS;CYP3A4;Gene;PA446411;Disease
CARCINOMA, SMALL CELL;CYP3A4;Gene;PA446661;Disease
NEUROENDOCRINE TUMORS;CYP3A4;Gene;PA446713;Disease
HOT FLASHES;CYP3A4;Gene;PA446852;Disease
HEPATITIS C, CHRONIC;CYP3A4;Gene;PA446863;Disease
ANXIETY DISORDERS;CYP3A4;Gene;PA447196;Disease
SCHIZOPHRENIA;CYP3A4;Gene;PA447216;Disease
HIV INFECTIONS;CYP3A4;Gene;PA447230;Disease
LIVER TRANSPLANTATION;CYP3A4;Gene;PA447247;Disease
THERAPY-RELATED ACUTE MYELOID LEUKEMIA (T-ML);CYP3A4;Gene;PA447322;Disease
ACETAMINOPHEN;CYP3A4;Gene;PA448015;Chemical
ALPRAZOLAM;CYP3A4;Gene;PA448333;Chemical
AMIODARONE;CYP3A4;Gene;PA448383;Chemical
AMITRIPTYLINE;CYP3A4;Gene;PA448385;Chemical
AMLODIPINE;CYP3A4;Gene;PA448388;Chemical
ASTEMIZOLE;CYP3A4;Gene;PA448498;Chemical
ATORVASTATIN;CYP3A4;Gene;PA448500;Chemical
BENZPHETAMINE;CYP3A4;Gene;PA448586;Chemical
BLEOMYCIN;CYP3A4;Gene;PA448645;Chemical
BUDESONIDE;CYP3A4;Gene;PA448681;Chemical
BUPRENORPHINE;CYP3A4;Gene;PA448685;Chemical
BUPROPION;CYP3A4;Gene;PA448687;Chemical
BUSPIRONE;CYP3A4;Gene;PA448689;Chemical
CARBAMAZEPINE;CYP3A4;Gene;PA448785;Chemical
CELECOXIB;CYP3A4;Gene;PA448871;Chemical
CHLORZOXAZONE;CYP3A4;Gene;PA448971;Chemical
CISAPRIDE;CYP3A4;Gene;PA449011;Chemical
CISPLATIN;CYP3A4;Gene;PA449014;Chemical
CITALOPRAM;CYP3A4;Gene;PA449015;Chemical
CLARITHROMYCIN;CYP3A4;Gene;PA449028;Chemical
CLOMIPRAMINE;CYP3A4;Gene;PA449048;Chemical
CLONAZEPAM;CYP3A4;Gene;PA449050;Chemical
CLOPIDOGREL;CYP3A4;Gene;PA449053;Chemical
CLOZAPINE;CYP3A4;Gene;PA449061;Chemical
COCAINE;CYP3A4;Gene;PA449072;Chemical
CODEINE;CYP3A4;Gene;PA449088;Chemical
CYCLOPHOSPHAMIDE;CYP3A4;Gene;PA449165;Chemical
CYCLOSPORINE;CYP3A4;Gene;PA449167;Chemical
DAPSONE;CYP3A4;Gene;PA449211;Chemical
DESIPRAMINE;CYP3A4;Gene;PA449233;Chemical
DEXTROMETHORPHAN;CYP3A4;Gene;PA449273;Chemical
DIAZEPAM;CYP3A4;Gene;PA449283;Chemical
DILTIAZEM;CYP3A4;Gene;PA449334;Chemical
DOCETAXEL;CYP3A4;Gene;PA449383;Chemical
DOLASETRON;CYP3A4;Gene;PA449390;Chemical
DOXEPIN;CYP3A4;Gene;PA449409;Chemical
DOXORUBICIN;CYP3A4;Gene;PA449412;Chemical
EFAVIRENZ;CYP3A4;Gene;PA449441;Chemical
ENALAPRIL;CYP3A4;Gene;PA449456;Chemical
ERYTHROMYCIN;CYP3A4;Gene;PA449493;Chemical
ETHOSUXIMIDE;CYP3A4;Gene;PA449533;Chemical
ETOPOSIDE;CYP3A4;Gene;PA449552;Chemical
EXEMESTANE;CYP3A4;Gene;PA449563;Chemical
FELBAMATE;CYP3A4;Gene;PA449590;Chemical
FELODIPINE;CYP3A4;Gene;PA449591;Chemical
FENTANYL;CYP3A4;Gene;PA449599;Chemical
FLUOXETINE;CYP3A4;Gene;PA449673;Chemical
FLUTAMIDE;CYP3A4;Gene;PA449685;Chemical
FLUVASTATIN;CYP3A4;Gene;PA449688;Chemical
GRANISETRON;CYP3A4;Gene;PA449809;Chemical
HYDROCORTISONE;CYP3A4;Gene;PA449905;Chemical
IBUPROFEN;CYP3A4;Gene;PA449957;Chemical
IMIPRAMINE;CYP3A4;Gene;PA449969;Chemical
INDINAVIR;CYP3A4;Gene;PA449977;Chemical
ITRACONAZOLE;CYP3A4;Gene;PA450132;Chemical
KETOCONAZOLE;CYP3A4;Gene;PA450146;Chemical
LAMOTRIGINE;CYP3A4;Gene;PA450164;Chemical
LIDOCAINE;CYP3A4;Gene;PA450226;Chemical
LOPINAVIR;CYP3A4;Gene;PA450264;Chemical
LOSARTAN;CYP3A4;Gene;PA450268;Chemical
LOVASTATIN;CYP3A4;Gene;PA450272;Chemical
MEPHENYTOIN;CYP3A4;Gene;PA450373;Chemical
METHADONE;CYP3A4;Gene;PA450401;Chemical
METHOXYFLURANE;CYP3A4;Gene;PA450434;Chemical
MICONAZOLE;CYP3A4;Gene;PA450494;Chemical
MIDAZOLAM;CYP3A4;Gene;PA450496;Chemical
MIFEPRISTONE;CYP3A4;Gene;PA450500;Chemical
MIRTAZAPINE;CYP3A4;Gene;PA450522;Chemical
MODAFINIL;CYP3A4;Gene;PA450530;Chemical
NATEGLINIDE;CYP3A4;Gene;PA450600;Chemical
NELFINAVIR;CYP3A4;Gene;PA450606;Chemical
NEVIRAPINE;CYP3A4;Gene;PA450616;Chemical
NICARDIPINE;CYP3A4;Gene;PA450620;Chemical
NIFEDIPINE;CYP3A4;Gene;PA450631;Chemical
NORTRIPTYLINE;CYP3A4;Gene;PA450657;Chemical
OLANZAPINE;CYP3A4;Gene;PA450688;Chemical
OMEPRAZOLE;CYP3A4;Gene;PA450704;Chemical
ONDANSETRON;CYP3A4;Gene;PA450705;Chemical
OXAZEPAM;CYP3A4;Gene;PA450731;Chemical
OXCARBAZEPINE;CYP3A4;Gene;PA450732;Chemical
OXYCODONE;CYP3A4;Gene;PA450741;Chemical
PACLITAXEL;CYP3A4;Gene;PA450761;Chemical
PAROXETINE;CYP3A4;Gene;PA450801;Chemical
PHENYTOIN;CYP3A4;Gene;PA450947;Chemical
PIMOZIDE;CYP3A4;Gene;PA450965;Chemical
PRAVASTATIN;CYP3A4;Gene;PA451089;Chemical
PREDNISOLONE;CYP3A4;Gene;PA451096;Chemical
PROGUANIL;CYP3A4;Gene;PA451124;Chemical
PROPAFENONE;CYP3A4;Gene;PA451131;Chemical
QUETIAPINE;CYP3A4;Gene;PA451201;Chemical
QUINIDINE;CYP3A4;Gene;PA451209;Chemical
QUININE;CYP3A4;Gene;PA451213;Chemical
REPAGLINIDE;CYP3A4;Gene;PA451234;Chemical
RIFAMPIN;CYP3A4;Gene;PA451250;Chemical
RISPERIDONE;CYP3A4;Gene;PA451257;Chemical
RITONAVIR;CYP3A4;Gene;PA451260;Chemical
ROPIVACAINE;CYP3A4;Gene;PA451271;Chemical
SAQUINAVIR;CYP3A4;Gene;PA451305;Chemical
SELEGILINE;CYP3A4;Gene;PA451316;Chemical
SERTRALINE;CYP3A4;Gene;PA451333;Chemical
SEVOFLURANE;CYP3A4;Gene;PA451341;Chemical
SILDENAFIL;CYP3A4;Gene;PA451346;Chemical
SIMVASTATIN;CYP3A4;Gene;PA451363;Chemical
SIROLIMUS;CYP3A4;Gene;PA451365;Chemical
SUFENTANIL;CYP3A4;Gene;PA451527;Chemical
SULFADIAZINE;CYP3A4;Gene;PA451539;Chemical
SULFAMETHOXAZOLE;CYP3A4;Gene;PA451544;Chemical
SULFINPYRAZONE;CYP3A4;Gene;PA451550;Chemical
TACROLIMUS;CYP3A4;Gene;PA451578;Chemical
TAMOXIFEN;CYP3A4;Gene;PA451581;Chemical
TAMSULOSIN;CYP3A4;Gene;PA451583;Chemical
TEMAZEPAM;CYP3A4;Gene;PA451608;Chemical
TERFENADINE;CYP3A4;Gene;PA451619;Chemical
TESTOSTERONE;CYP3A4;Gene;PA451627;Chemical
THEOPHYLLINE;CYP3A4;Gene;PA451647;Chemical
TOREMIFENE;CYP3A4;Gene;PA451731;Chemical
TRAMADOL;CYP3A4;Gene;PA451735;Chemical
TRAZODONE;CYP3A4;Gene;PA451744;Chemical
TRIAZOLAM;CYP3A4;Gene;PA451753;Chemical
TRIMETHOPRIM;CYP3A4;Gene;PA451788;Chemical
VALPROIC ACID;CYP3A4;Gene;PA451846;Chemical
VENLAFAXINE;CYP3A4;Gene;PA451866;Chemical
VERAPAMIL;CYP3A4;Gene;PA451868;Chemical
VINBLASTINE;CYP3A4;Gene;PA451877;Chemical
VINCRISTINE;CYP3A4;Gene;PA451879;Chemical
WARFARIN;CYP3A4;Gene;PA451906;Chemical
ZIDOVUDINE;CYP3A4;Gene;PA451954;Chemical
ZIPRASIDONE;CYP3A4;Gene;PA451974;Chemical
ZOLPIDEM;CYP3A4;Gene;PA451976;Chemical
ZONISAMIDE;CYP3A4;Gene;PA451978;Chemical
OPIOIDS;CYP3A4;Gene;PA452618;Chemical
SORAFENIB;CYP3A4;Gene;PA7000;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;rs10757274;Variant;PA164712462;Chemical
ACUTE CORONARY SYNDROME;rs10757274;Variant;PA165108401;Disease
HIV INFECTIOUS DISEASE;rs11191561;Variant;PA447230;Disease
DIDANOSINE;rs11191561;Variant;PA449301;Chemical
CETUXIMAB;NRAS;Gene;PA10040;Chemical
EGFR INHIBITORS;NRAS;Gene;PA153561371;Chemical
PANITUMUMAB;NRAS;Gene;PA162373091;Chemical
VEMURAFENIB;NRAS;Gene;PA165946873;Chemical
DABRAFENIB;NRAS;Gene;PA166114911;Chemical
TRAMETINIB;NRAS;Gene;PA166115364;Chemical
RS113488022;NRAS;Gene;PA166157522;Variant
ENCORAFENIB;NRAS;Gene;PA166179872;Chemical
TUCATINIB;NRAS;Gene;PA166225141;Chemical
ARAF;NRAS;Gene;PA24928;Gene
BRAF;NRAS;Gene;PA25408;Gene
CRK;NRAS;Gene;PA26880;Gene
FGFR1;NRAS;Gene;PA28127;Gene
FLT1;NRAS;Gene;PA28180;Gene
FLT3;NRAS;Gene;PA28181;Gene
FLT4;NRAS;Gene;PA28183;Gene
KDR;NRAS;Gene;PA30086;Gene
KIT;NRAS;Gene;PA30128;Gene
MAP3K1;NRAS;Gene;PA30592;Gene
PDGFRB;NRAS;Gene;PA33148;Gene
RAF1;NRAS;Gene;PA34183;Gene
RET;NRAS;Gene;PA34335;Gene
NON-SMALL CELL LUNG CARCINOMA;NRAS;Gene;PA443622;Disease
LEUKEMIA, MYELOID, ACUTE;NRAS;Gene;PA444760;Disease
MELANOMA;NRAS;Gene;PA444903;Disease
COLORECTAL NEOPLASMS;NRAS;Gene;PA446108;Disease
CARBOPLATIN;NRAS;Gene;PA448803;Chemical
CISPLATIN;NRAS;Gene;PA449014;Chemical
GEMCITABINE;NRAS;Gene;PA449748;Chemical
AZACITIDINE;NRAS;Gene;PA451996;Chemical
EGFR;NRAS;Gene;PA7360;Gene
FLUOROURACIL;C18orf56;Gene;PA128406956;Chemical
PLATINUM;C18orf56;Gene;PA150595617;Chemical
HYDROXYCHLOROQUINE;C18orf56;Gene;PA164777036;Chemical
MYELOSUPPRESSION;C18orf56;Gene;PA165817398;Disease
PROGRESSION-FREE SURVIVAL;C18orf56;Gene;PA166123026;Disease
OVERALL SURVIVAL;C18orf56;Gene;PA166123207;Disease
GASTROESOPHAGEAL CANCER;C18orf56;Gene;PA166153403;Disease
ARTHRITIS, RHEUMATOID;C18orf56;Gene;PA443434;Disease
ESOPHAGEAL NEOPLASMS;C18orf56;Gene;PA444101;Disease
NEUTROPENIA;C18orf56;Gene;PA445113;Disease
RECTAL NEOPLASMS;C18orf56;Gene;PA445503;Disease
STOMACH NEOPLASMS;C18orf56;Gene;PA445742;Disease
COLORECTAL NEOPLASMS;C18orf56;Gene;PA446108;Disease
INFLAMMATORY BOWEL DISEASES;C18orf56;Gene;PA446116;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;C18orf56;Gene;PA446155;Disease
ASPARAGINASE;C18orf56;Gene;PA448492;Chemical
AZATHIOPRINE;C18orf56;Gene;PA448515;Chemical
CAPECITABINE;C18orf56;Gene;PA448771;Chemical
CISPLATIN;C18orf56;Gene;PA449014;Chemical
CYTARABINE;C18orf56;Gene;PA449177;Chemical
DAUNORUBICIN;C18orf56;Gene;PA449212;Chemical
EPIRUBICIN;C18orf56;Gene;PA449476;Chemical
ETOPOSIDE;C18orf56;Gene;PA449552;Chemical
FOLIC ACID;C18orf56;Gene;PA449692;Chemical
IRINOTECAN;C18orf56;Gene;PA450085;Chemical
MERCAPTOPURINE;C18orf56;Gene;PA450379;Chemical
METHOTREXATE;C18orf56;Gene;PA450428;Chemical
PREDNISONE;C18orf56;Gene;PA451100;Chemical
SULFASALAZINE;C18orf56;Gene;PA451547;Chemical
VINCRISTINE;C18orf56;Gene;PA451879;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs1058932;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs1058932;Variant;PA445846;Disease
CARBOPLATIN;rs1058932;Variant;PA448803;Chemical
GEMCITABINE;rs1058932;Variant;PA449748;Chemical
BEVACIZUMAB;rs2010963;Variant;PA130232992;Chemical
OXALIPLATIN;rs2010963;Variant;PA131285527;Chemical
RANIBIZUMAB;rs2010963;Variant;PA164746012;Chemical
PEGAPTANIB;rs2010963;Variant;PA164771236;Chemical
HAND-FOOT SYNDROME;rs2010963;Variant;PA166114377;Disease
RENAL CELL CARCINOMA;rs2010963;Variant;PA443624;Disease
HEPATOCELLULAR CARCINOMA;rs2010963;Variant;PA444447;Disease
PROSTATIC NEOPLASMS;rs2010963;Variant;PA445425;Disease
COLORECTAL NEOPLASMS;rs2010963;Variant;PA446108;Disease
CHOROIDAL NEOVASCULARIZATION;rs2010963;Variant;PA446974;Disease
CAPECITABINE;rs2010963;Variant;PA448771;Chemical
CYCLOPHOSPHAMIDE;rs2010963;Variant;PA449165;Chemical
SORAFENIB;rs2010963;Variant;PA7000;Chemical
ANEMIA;rs10538494;Variant;PA443340;Disease
NASOPHARYNGEAL NEOPLASMS;rs10538494;Variant;PA445046;Disease
DOCETAXEL;rs10538494;Variant;PA449383;Chemical
WARFARIN;rs4917639;Variant;PA451906;Chemical
HEROIN DEPENDENCE;rs1990040;Variant;PA444460;Disease
HEROIN;rs1990040;Variant;PA452619;Chemical
HLA-B*58:01;Hyperuricemia;Disease;PA165987831;Haplotype
G6PD MEDITERRANEAN, DALLAS, PANAMA, SASSARI, CAGLIARI, BIRMINGHAM;Hyperuricemia;Disease;PA166121127;Haplotype
G6PD DEFICIENCY;Hyperuricemia;Disease;PA166157959;Variant
G6PD;Hyperuricemia;Disease;PA28469;Gene
HLA-B;Hyperuricemia;Disease;PA35056;Gene
BREAST NEOPLASMS;rs10030044;Variant;PA443560;Disease
RALOXIFENE;rs10030044;Variant;PA451221;Chemical
TAMOXIFEN;rs10030044;Variant;PA451581;Chemical
ASPIRIN-INDUCED ASTHMA;ALOX5;Gene;PA131285571;Disease
LEUKOTRIENE RECEPTOR ANTAGONISTS;ALOX5;Gene;PA164712863;Chemical
ASTHMA;ALOX5;Gene;PA443450;Disease
COLONIC NEOPLASMS;ALOX5;Gene;PA443756;Disease
CORONARY ARTERY DISEASE;ALOX5;Gene;PA443796;Disease
MONTELUKAST;ALOX5;Gene;PA450546;Chemical
ZILEUTON;ALOX5;Gene;PA451955;Chemical
NASOPHARYNGEAL NEOPLASMS;rs62576288;Variant;PA445046;Disease
DOCETAXEL;rs62576288;Variant;PA449383;Chemical
ABCB1;Biricodar;Chemical;PA267;Gene
CYP3A7;Adrenal Hyperplasia, Congenital;Disease;PA122;Gene
CYP3A7*1A;Adrenal Hyperplasia, Congenital;Disease;PA165948045;Haplotype
CYP3A7*1C;Adrenal Hyperplasia, Congenital;Disease;PA165948047;Haplotype
OPIOID-RELATED DISORDERS;rs1384401;Variant;PA445043;Disease
OPIOIDS;rs1384401;Variant;PA452618;Chemical
BUTORPHANOL;rs6269;Variant;PA164745398;Chemical
NEOPLASMS;rs6269;Variant;PA445062;Disease
PAIN;rs6269;Variant;PA445208;Disease
PAIN, POSTOPERATIVE;rs6269;Variant;PA445210;Disease
SCHIZOPHRENIA;rs6269;Variant;PA447216;Disease
MORPHINE;rs6269;Variant;PA450550;Chemical
QUETIAPINE;rs6269;Variant;PA451201;Chemical
OPIOIDS;rs6269;Variant;PA452618;Chemical
CARDIOVASCULAR DISEASES;ANGPTL3;Gene;PA443635;Disease
SULFASALAZINE;rs72552713;Variant;PA451547;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;rs1992647;Variant;PA164713257;Chemical
MAJOR DEPRESSIVE DISORDER;rs1992647;Variant;PA447321;Disease
VENLAFAXINE;rs1992647;Variant;PA451866;Chemical
ANTIDEPRESSANTS;rs1992647;Variant;PA452229;Chemical
TOBACCO USE DISORDER;rs165599;Variant;PA445876;Disease
SCHIZOPHRENIA;rs165599;Variant;PA447216;Disease
BUPROPION;rs165599;Variant;PA448687;Chemical
RISPERIDONE;rs165599;Variant;PA451257;Chemical
DRUG-INDUCED LIVER INJURY;HLA-DPB1*10:01;Haplotype;PA166119041;Disease
INFLIXIMAB;HLA-DPB1*10:01;Haplotype;PA452639;Chemical
OVARIAN NEOPLASMS;rs2336219;Variant;PA445204;Disease
CISPLATIN;rs2336219;Variant;PA449014;Chemical
VEMURAFENIB;HRAS;Gene;PA165946873;Chemical
DABRAFENIB;HRAS;Gene;PA166114911;Chemical
TRAMETINIB;HRAS;Gene;PA166115364;Chemical
ENCORAFENIB;HRAS;Gene;PA166179872;Chemical
TUCATINIB;HRAS;Gene;PA166225141;Chemical
ARAF;HRAS;Gene;PA24928;Gene
BRAF;HRAS;Gene;PA25408;Gene
CRK;HRAS;Gene;PA26880;Gene
FGFR1;HRAS;Gene;PA28127;Gene
FLT1;HRAS;Gene;PA28180;Gene
FLT3;HRAS;Gene;PA28181;Gene
FLT4;HRAS;Gene;PA28183;Gene
KDR;HRAS;Gene;PA30086;Gene
KIT;HRAS;Gene;PA30128;Gene
MAP3K1;HRAS;Gene;PA30592;Gene
PDGFRB;HRAS;Gene;PA33148;Gene
RAF1;HRAS;Gene;PA34183;Gene
RET;HRAS;Gene;PA34335;Gene
COLORECTAL NEOPLASMS;HRAS;Gene;PA446108;Disease
EGFR;HRAS;Gene;PA7360;Gene
NAT1*4;mesalazine;Chemical;PA165958462;Haplotype
NAT1*3;mesalazine;Chemical;PA165958463;Haplotype
NAT1*10;mesalazine;Chemical;PA165958465;Haplotype
NAT1;mesalazine;Chemical;PA17;Gene
G6PD;mesalazine;Chemical;PA28469;Gene
METRELEPTIN;LMNB2;Gene;PA166235301;Chemical
DPYD;rs140114515;Variant;PA145;Gene
CAPECITABINE;rs140114515;Variant;PA448771;Chemical
CYP2C9;lesinurad;Chemical;PA126;Gene
CYP2C9*1;lesinurad;Chemical;PA165816542;Haplotype
CYP2C9*3;lesinurad;Chemical;PA165816544;Haplotype
OPIOID-RELATED DISORDERS;rs13169373;Variant;PA445043;Disease
BUPRENORPHINE;rs13169373;Variant;PA448685;Chemical
EGFR;amivantamab;Chemical;PA7360;Gene
MTHFR;Abortion, Habitual;Disease;PA245;Gene
G6PD;carbasalate calcium;Chemical;PA28469;Gene
ACUTE CORONARY SYNDROME;rs61361928;Variant;PA165108401;Disease
TICAGRELOR;rs61361928;Variant;PA165374673;Chemical
ACE INHIBITORS, PLAIN;rs1495509;Variant;PA164712308;Chemical
BUPROPION;rs58871670;Variant;PA448687;Chemical
EFAVIRENZ;rs58871670;Variant;PA449441;Chemical
PHENYTOIN;CYP2C9*19;Haplotype;PA450947;Chemical
WARFARIN;rs7196161;Variant;PA451906;Chemical
SUBSTANCE-RELATED DISORDERS;DRD4;Gene;PA446876;Disease
ETHANOL;DRD4;Gene;PA448073;Chemical
NICOTINE;DRD4;Gene;PA450626;Chemical
ATAZANAVIR;rs2032582;Variant;PA10251;Chemical
ANTIEPILEPTICS;rs2032582;Variant;PA143485705;Chemical
TAXANES;rs2032582;Variant;PA150481189;Chemical
MYALGIA;rs2032582;Variant;PA157379134;Disease
SUNITINIB;rs2032582;Variant;PA162372840;Chemical
PLATINUM COMPOUNDS;rs2032582;Variant;PA164713176;Chemical
EVEROLIMUS;rs2032582;Variant;PA164746311;Chemical
TEMSIROLIMUS;rs2032582;Variant;PA164746890;Chemical
DICLOXACILLIN;rs2032582;Variant;PA164749649;Chemical
ACUTE CORONARY SYNDROME;rs2032582;Variant;PA165108401;Disease
DABIGATRAN;rs2032582;Variant;PA165110351;Chemical
KIDNEY TRANSPLANTATION;rs2032582;Variant;PA165817016;Disease
RIVAROXABAN;rs2032582;Variant;PA165958360;Chemical
HAND-FOOT SYNDROME;rs2032582;Variant;PA166114377;Disease
HEMATOPOIETIC STEM CELL TRANSPLANTATION;rs2032582;Variant;PA166123007;Disease
URINARY BLADDER NEOPLASMS;rs2032582;Variant;PA443512;Disease
BREAST NEOPLASMS;rs2032582;Variant;PA443560;Disease
RENAL CELL CARCINOMA;rs2032582;Variant;PA443624;Disease
ULCERATIVE COLITIS;rs2032582;Variant;PA443750;Disease
CORONARY ARTERY DISEASE;rs2032582;Variant;PA443796;Disease
CYSTIC FIBROSIS;rs2032582;Variant;PA443829;Disease
EPILEPSY;rs2032582;Variant;PA444065;Disease
FRACTURES, BONE;rs2032582;Variant;PA444222;Disease
HYPERCHOLESTEROLEMIA;rs2032582;Variant;PA444516;Disease
HYPERLIPOPROTEINEMIA TYPE II;rs2032582;Variant;PA444517;Disease
HYPOVENTILATION;rs2032582;Variant;PA444591;Disease
LEUKEMIA, MYELOID, ACUTE;rs2032582;Variant;PA444760;Disease
LYMPHOPENIA;rs2032582;Variant;PA444848;Disease
MULTIPLE MYELOMA;rs2032582;Variant;PA444985;Disease
NARCOLEPSY;rs2032582;Variant;PA445042;Disease
OPIOID-RELATED DISORDERS;rs2032582;Variant;PA445043;Disease
NEOPLASMS;rs2032582;Variant;PA445062;Disease
NEPHROTIC SYNDROME;rs2032582;Variant;PA445089;Disease
NEUTROPENIA;rs2032582;Variant;PA445113;Disease
OVARIAN NEOPLASMS;rs2032582;Variant;PA445204;Disease
PAIN;rs2032582;Variant;PA445208;Disease
PAIN, POSTOPERATIVE;rs2032582;Variant;PA445210;Disease
VOMITING;rs2032582;Variant;PA446051;Disease
COLORECTAL NEOPLASMS;rs2032582;Variant;PA446108;Disease
POSTOPERATIVE NAUSEA AND VOMITING;rs2032582;Variant;PA446970;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs2032582;Variant;PA447197;Disease
DEPRESSIVE DISORDER;rs2032582;Variant;PA447207;Disease
SCHIZOPHRENIA;rs2032582;Variant;PA447216;Disease
HIV INFECTIOUS DISEASE;rs2032582;Variant;PA447230;Disease
LIVER TRANSPLANTATION;rs2032582;Variant;PA447247;Disease
DEPRESSION;rs2032582;Variant;PA447278;Disease
ANASTROZOLE;rs2032582;Variant;PA448432;Chemical
ATORVASTATIN;rs2032582;Variant;PA448500;Chemical
CAPECITABINE;rs2032582;Variant;PA448771;Chemical
CARBAMAZEPINE;rs2032582;Variant;PA448785;Chemical
CLOMIPRAMINE;rs2032582;Variant;PA449048;Chemical
CLOPIDOGREL;rs2032582;Variant;PA449053;Chemical
CYCLOPHOSPHAMIDE;rs2032582;Variant;PA449165;Chemical
CYCLOSPORINE;rs2032582;Variant;PA449167;Chemical
CYTARABINE;rs2032582;Variant;PA449177;Chemical
DAUNORUBICIN;rs2032582;Variant;PA449212;Chemical
DEXAMETHASONE;rs2032582;Variant;PA449247;Chemical
DEXRAZOXANE;rs2032582;Variant;PA449259;Chemical
DIGOXIN;rs2032582;Variant;PA449319;Chemical
DOXORUBICIN;rs2032582;Variant;PA449412;Chemical
EFAVIRENZ;rs2032582;Variant;PA449441;Chemical
FENTANYL;rs2032582;Variant;PA449599;Chemical
FLUOXETINE;rs2032582;Variant;PA449673;Chemical
IDARUBICIN;rs2032582;Variant;PA449961;Chemical
LITHIUM;rs2032582;Variant;PA450243;Chemical
METHADONE;rs2032582;Variant;PA450401;Chemical
METHYLPHENIDATE;rs2032582;Variant;PA450464;Chemical
MODAFINIL;rs2032582;Variant;PA450530;Chemical
MYCOPHENOLATE MOFETIL;rs2032582;Variant;PA450566;Chemical
NEFAZODONE;rs2032582;Variant;PA450603;Chemical
ONDANSETRON;rs2032582;Variant;PA450705;Chemical
PACLITAXEL;rs2032582;Variant;PA450761;Chemical
PAROXETINE;rs2032582;Variant;PA450801;Chemical
PHENYTOIN;rs2032582;Variant;PA450947;Chemical
PRAVASTATIN;rs2032582;Variant;PA451089;Chemical
RITONAVIR;rs2032582;Variant;PA451260;Chemical
SIMVASTATIN;rs2032582;Variant;PA451363;Chemical
SIROLIMUS;rs2032582;Variant;PA451365;Chemical
SUFENTANIL;rs2032582;Variant;PA451527;Chemical
TACROLIMUS;rs2032582;Variant;PA451578;Chemical
TRAMADOL;rs2032582;Variant;PA451735;Chemical
VALPROIC ACID;rs2032582;Variant;PA451846;Chemical
VENLAFAXINE;rs2032582;Variant;PA451866;Chemical
VERAPAMIL;rs2032582;Variant;PA451868;Chemical
VINCRISTINE;rs2032582;Variant;PA451879;Chemical
ANTIPSYCHOTICS;rs2032582;Variant;PA452233;Chemical
BILIRUBIN;UGT1A;Gene;PA166123346;Chemical
COLORECTAL NEOPLASMS;UGT1A;Gene;PA446108;Disease
LIVER FAILURE, ACUTE;UGT1A;Gene;PA446443;Disease
ACETAMINOPHEN;UGT1A;Gene;PA448015;Chemical
IRINOTECAN;UGT1A;Gene;PA450085;Chemical
WEIGHT GAIN;GNB3;Gene;PA128406954;Disease
HMG COA REDUCTASE INHIBITORS;GNB3;Gene;PA133950441;Chemical
P2RY12;GNB3;Gene;PA134971947;Gene
BETA BLOCKING AGENTS;GNB3;Gene;PA164712535;Chemical
THIAZIDES, PLAIN;GNB3;Gene;PA164713347;Chemical
ADCY3;GNB3;Gene;PA164741137;Gene
HYDRALAZINE / ISOSORBIDE DINITRATE;GNB3;Gene;PA166176017;Chemical
F2R;GNB3;Gene;PA27946;Gene
F2RL3;GNB3;Gene;PA27949;Gene
P2RY1;GNB3;Gene;PA32868;Gene
PLCB1;GNB3;Gene;PA33384;Gene
PLCB2;GNB3;Gene;PA33385;Gene
PLCB3;GNB3;Gene;PA33386;Gene
PLCB4;GNB3;Gene;PA33387;Gene
PLCG2;GNB3;Gene;PA33393;Gene
TBXA2R;GNB3;Gene;PA348;Gene
CLUSTER HEADACHE;GNB3;Gene;PA443742;Disease
DIABETES MELLITUS;GNB3;Gene;PA443886;Disease
HEART FAILURE;GNB3;Gene;PA444370;Disease
HYPERCHOLESTEROLEMIA;GNB3;Gene;PA444516;Disease
ERECTILE DYSFUNCTION;GNB3;Gene;PA444606;Disease
LIVER CIRRHOSIS;GNB3;Gene;PA444797;Disease
MYOCARDIAL INFARCTION;GNB3;Gene;PA445019;Disease
OPIOID-RELATED DISORDERS;GNB3;Gene;PA445043;Disease
OBESITY;GNB3;Gene;PA445131;Disease
SCHIZOPHRENIA;GNB3;Gene;PA447216;Disease
ESSENTIAL HYPERTENSION;GNB3;Gene;PA447288;Disease
MAJOR DEPRESSIVE DISORDER;GNB3;Gene;PA447321;Disease
ATENOLOL;GNB3;Gene;PA448499;Chemical
BUMETANIDE;GNB3;Gene;PA448682;Chemical
CLONIDINE;GNB3;Gene;PA449051;Chemical
FUROSEMIDE;GNB3;Gene;PA449719;Chemical
METHADONE;GNB3;Gene;PA450401;Chemical
NORTRIPTYLINE;GNB3;Gene;PA450657;Chemical
OLANZAPINE;GNB3;Gene;PA450688;Chemical
SERTRALINE;GNB3;Gene;PA451333;Chemical
SIBUTRAMINE;GNB3;Gene;PA451344;Chemical
SILDENAFIL;GNB3;Gene;PA451346;Chemical
SUMATRIPTAN;GNB3;Gene;PA451566;Chemical
TELMISARTAN;GNB3;Gene;PA451605;Chemical
TORASEMIDE;GNB3;Gene;PA451733;Chemical
ANTIDEPRESSANTS;GNB3;Gene;PA452229;Chemical
CORTICOSTEROIDS;rs7772821;Variant;PA10832;Chemical
ASTHMA;rs7772821;Variant;PA443450;Disease
CYP2C9;etrasimod;Chemical;PA126;Gene
CYP2C9*2;etrasimod;Chemical;PA165816543;Haplotype
CYP2C9*3;etrasimod;Chemical;PA165816544;Haplotype
INFLUENZA VACCINES;HLA-DRB1*13:01;Haplotype;PA164712830;Chemical
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-DRB1*13:01;Haplotype;PA166120929;Disease
LAMOTRIGINE;HLA-DRB1*13:01;Haplotype;PA450164;Chemical
CETUXIMAB;BRAF;Gene;PA10040;Chemical
VEMURAFENIB;BRAF;Gene;PA165946873;Chemical
DABRAFENIB;BRAF;Gene;PA166114911;Chemical
TRAMETINIB;BRAF;Gene;PA166115364;Chemical
PEMBROLIZUMAB;BRAF;Gene;PA166124615;Chemical
NIVOLUMAB;BRAF;Gene;PA166129522;Chemical
ATEZOLIZUMAB;BRAF;Gene;PA166129523;Chemical
RS113488022;BRAF;Gene;PA166157522;Variant
COBIMETINIB;BRAF;Gene;PA166160044;Chemical
BINIMETINIB;BRAF;Gene;PA166179867;Chemical
ENCORAFENIB;BRAF;Gene;PA166179872;Chemical
NIVOLUMAB / RELATLIMAB;BRAF;Gene;PA166277902;Chemical
TOVORAFENIB;BRAF;Gene;PA166345561;Chemical
KCNH2;BRAF;Gene;PA212;Gene
HRAS;BRAF;Gene;PA29444;Gene
KRAS;BRAF;Gene;PA30196;Gene
MAP2K1;BRAF;Gene;PA30584;Gene
MAP2K2;BRAF;Gene;PA30587;Gene
MRAS;BRAF;Gene;PA30932;Gene
NRAS;BRAF;Gene;PA31768;Gene
RRAS;BRAF;Gene;PA34861;Gene
MELANOMA;BRAF;Gene;PA444903;Disease
NEOPLASMS;BRAF;Gene;PA445062;Disease
COLORECTAL NEOPLASMS;BRAF;Gene;PA446108;Disease
SORAFENIB;BRAF;Gene;PA7000;Chemical
ETHANOL;rs61667602;Variant;PA448073;Chemical
WARFARIN;CALU;Gene;PA451906;Chemical
ACENOCOUMAROL;CALU;Gene;PA452632;Chemical
DIURETICS;rs4961;Variant;PA151249535;Chemical
HYPERTENSION;rs4961;Variant;PA444552;Disease
LIVER CIRRHOSIS;rs4961;Variant;PA444797;Disease
MYOCARDIAL INFARCTION;rs4961;Variant;PA445019;Disease
ESSENTIAL HYPERTENSION;rs4961;Variant;PA447288;Disease
BUMETANIDE;rs4961;Variant;PA448682;Chemical
FUROSEMIDE;rs4961;Variant;PA449719;Chemical
HYDROCHLOROTHIAZIDE;rs4961;Variant;PA449899;Chemical
SPIRONOLACTONE;rs4961;Variant;PA451483;Chemical
TORASEMIDE;rs4961;Variant;PA451733;Chemical
OPIOID-RELATED DISORDERS;rs6928499;Variant;PA445043;Disease
OPIOIDS;rs6928499;Variant;PA452618;Chemical
CYP2C19;high on-treatment platelet reactivity;Disease;PA124;Gene
CYP2C19*1;high on-treatment platelet reactivity;Disease;PA165980634;Haplotype
CYP2C19*2;high on-treatment platelet reactivity;Disease;PA165980635;Haplotype
CYP2C19*3;high on-treatment platelet reactivity;Disease;PA165980636;Haplotype
DESFLURANE;rs118192176;Variant;PA164749136;Chemical
RYR1;rs118192176;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs118192176;Variant;PA444863;Disease
ENFLURANE;rs118192176;Variant;PA449461;Chemical
HALOTHANE;rs118192176;Variant;PA449845;Chemical
ISOFLURANE;rs118192176;Variant;PA450106;Chemical
METHOXYFLURANE;rs118192176;Variant;PA450434;Chemical
SEVOFLURANE;rs118192176;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs118192176;Variant;PA451522;Chemical
CACNA1S;rs118192176;Variant;PA85;Gene
PEGINTERFERON ALFA-2B;KIR2DS2;Gene;PA164784024;Chemical
TENIPOSIDE;NUP50;Gene;PA451611;Chemical
FLUOROURACIL;rs187713395;Variant;PA128406956;Chemical
DRUG TOXICITY;rs187713395;Variant;PA443937;Disease
RS121913530;sotorasib;Chemical;PA166165415;Variant
KRAS;sotorasib;Chemical;PA30196;Gene
CARBOCISTEINE;rs75193786;Variant;PA166184060;Chemical
PHOTODYNAMIC THERAPY;F13A1;Gene;PA165984462;Chemical
ASTHMA;F13A1;Gene;PA443450;Disease
CHOROIDAL NEOVASCULARIZATION;F13A1;Gene;PA446974;Disease
ASPIRIN;F13A1;Gene;PA448497;Chemical
CYP3A5;Urinary Tract Infections;Disease;PA131;Gene
CYP3A5*1;Urinary Tract Infections;Disease;PA166128213;Haplotype
CYP3A5*3;Urinary Tract Infections;Disease;PA166128219;Haplotype
HYPERTENSION;rs11600347;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs11600347;Variant;PA449899;Chemical
CYP3A4;itraconazole;Chemical;PA130;Gene
CYP3A5;itraconazole;Chemical;PA131;Gene
CYP3A5*1;itraconazole;Chemical;PA166128213;Haplotype
CYP3A5*3;itraconazole;Chemical;PA166128219;Haplotype
ABCB1;itraconazole;Chemical;PA267;Gene
FLUOROURACIL;rs117458836;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs117458836;Variant;PA443560;Disease
NEUTROPENIA;rs117458836;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs117458836;Variant;PA449165;Chemical
EPIRUBICIN;rs117458836;Variant;PA449476;Chemical
NICOTINE;rs111869995;Variant;PA450626;Chemical
LEUKEMIA, MYELOID, ACUTE;rs10916819;Variant;PA444760;Disease
CYTARABINE;rs10916819;Variant;PA449177;Chemical
PEMETREXED;rs11545078;Variant;PA10810;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs11545078;Variant;PA443622;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs11545078;Variant;PA446155;Disease
METHOTREXATE;rs11545078;Variant;PA450428;Chemical
CYP2B6;Transplantation;Disease;PA123;Gene
CYP3A4;Transplantation;Disease;PA130;Gene
CYP3A5;Transplantation;Disease;PA131;Gene
CRTC2;Transplantation;Disease;PA142672073;Gene
CYP3A4*1;Transplantation;Disease;PA165819201;Haplotype
TPMT*1;Transplantation;Disease;PA165819268;Haplotype
TPMT*2;Transplantation;Disease;PA165819269;Haplotype
TPMT*3A;Transplantation;Disease;PA165819270;Haplotype
TPMT*3C;Transplantation;Disease;PA165819272;Haplotype
CYP3A4*22;Transplantation;Disease;PA166048680;Haplotype
CYP3A5*1;Transplantation;Disease;PA166128213;Haplotype
CYP3A5*3;Transplantation;Disease;PA166128219;Haplotype
RS1800896;Transplantation;Disease;PA166153642;Variant
RS5744247;Transplantation;Disease;PA166154416;Variant
RS2279343;Transplantation;Disease;PA166155393;Variant
RS3745274;Transplantation;Disease;PA166155409;Variant
RS8192709;Transplantation;Disease;PA166155442;Variant
RS3957357;Transplantation;Disease;PA166157094;Variant
RS1045642;Transplantation;Disease;PA166157284;Variant
RS1057868;Transplantation;Disease;PA166157286;Variant
RS1128503;Transplantation;Disease;PA166157288;Variant
RS8450;Transplantation;Disease;PA166163444;Variant
ABCB1;Transplantation;Disease;PA267;Gene
GSTA1;Transplantation;Disease;PA29016;Gene
IL10;Transplantation;Disease;PA29778;Gene
IL18;Transplantation;Disease;PA29802;Gene
POR;Transplantation;Disease;PA33532;Gene
TPMT;Transplantation;Disease;PA356;Gene
ASTHMA;rs7572857;Variant;PA443450;Disease
ASPIRIN;rs7572857;Variant;PA448497;Chemical
CYP2D6;Anemia, Sickle Cell;Disease;PA128;Gene
CYP2D6*1;Anemia, Sickle Cell;Disease;PA165816576;Haplotype
CYP2D6*4;Anemia, Sickle Cell;Disease;PA165816579;Haplotype
CYP2D6*6;Anemia, Sickle Cell;Disease;PA165816581;Haplotype
CYP2D6*17;Anemia, Sickle Cell;Disease;PA165816583;Haplotype
CYP2D6*5;Anemia, Sickle Cell;Disease;PA165948092;Haplotype
CYP2D6*40;Anemia, Sickle Cell;Disease;PA165971594;Haplotype
RS7668282;Anemia, Sickle Cell;Disease;PA166156626;Variant
UGT2B7;Anemia, Sickle Cell;Disease;PA361;Gene
PAIN;Anemia, Sickle Cell;Disease;PA445208;Disease
FLUOROURACIL;rs25487;Variant;PA128406956;Chemical
PLATINUM COMPOUNDS;rs25487;Variant;PA164713176;Chemical
BREAST NEOPLASMS;rs25487;Variant;PA443560;Disease
UTERINE CERVICAL NEOPLASM;rs25487;Variant;PA443685;Disease
COLONIC NEOPLASMS;rs25487;Variant;PA443756;Disease
NEOPLASMS;rs25487;Variant;PA445062;Disease
OVARIAN NEOPLASMS;rs25487;Variant;PA445204;Disease
RECTAL NEOPLASMS;rs25487;Variant;PA445503;Disease
COLORECTAL NEOPLASMS;rs25487;Variant;PA446108;Disease
CYCLOPHOSPHAMIDE;rs25487;Variant;PA449165;Chemical
DOXORUBICIN;rs25487;Variant;PA449412;Chemical
BREAST NEOPLASMS;DLG2;Gene;PA443560;Disease
ANASTROZOLE;DLG2;Gene;PA448432;Chemical
NR1I2;cefradine;Chemical;PA378;Gene
OVARIAN NEOPLASMS;rs1052536;Variant;PA445204;Disease
CISPLATIN;rs1052536;Variant;PA449014;Chemical
CYCLOPHOSPHAMIDE;rs1052536;Variant;PA449165;Chemical
PEGINTERFERON ALFA-2A;rs11881222;Variant;PA164749390;Chemical
PEGINTERFERON ALFA-2B;rs11881222;Variant;PA164784024;Chemical
HEPATITIS C VIRUS INFECTION;rs11881222;Variant;PA444445;Disease
HIV INFECTIOUS DISEASE;rs11881222;Variant;PA447230;Disease
RIBAVIRIN;rs11881222;Variant;PA451241;Chemical
PLATINUM COMPOUNDS;rs11030918;Variant;PA164713176;Chemical
LEUKEMIA, MYELOID, ACUTE;rs11030918;Variant;PA444760;Disease
MESOTHELIOMA;rs11030918;Variant;PA444937;Disease
CYTARABINE;rs11030918;Variant;PA449177;Chemical
GEMCITABINE;rs11030918;Variant;PA449748;Chemical
ANASTROZOLE;rs3732219;Variant;PA448432;Chemical
CDKN1A;celecoxib;Chemical;PA104;Gene
CDKN1B;celecoxib;Chemical;PA105;Gene
CYP2C19;celecoxib;Chemical;PA124;Gene
CYP2C9;celecoxib;Chemical;PA126;Gene
CYP2D6;celecoxib;Chemical;PA128;Gene
CYP3A4;celecoxib;Chemical;PA130;Gene
CACNA2D4;celecoxib;Chemical;PA130546913;Gene
CYP3A5;celecoxib;Chemical;PA131;Gene
IL23R;celecoxib;Chemical;PA134935109;Gene
CYP2C19*9;celecoxib;Chemical;PA165816525;Haplotype
CYP2C19*14;celecoxib;Chemical;PA165816530;Haplotype
CYP2C19*16;celecoxib;Chemical;PA165816532;Haplotype
CYP2C19*18;celecoxib;Chemical;PA165816534;Haplotype
CYP2C19*19;celecoxib;Chemical;PA165816535;Haplotype
CYP2C9*1;celecoxib;Chemical;PA165816542;Haplotype
CYP2C9*2;celecoxib;Chemical;PA165816543;Haplotype
CYP2C9*3;celecoxib;Chemical;PA165816544;Haplotype
CYP2C9*13;celecoxib;Chemical;PA165816554;Haplotype
CYP2C19*1;celecoxib;Chemical;PA165980634;Haplotype
RS7518660;celecoxib;Chemical;PA166153789;Variant
RS1057910;celecoxib;Chemical;PA166153959;Variant
RS1799853;celecoxib;Chemical;PA166153972;Variant
RS11078659;celecoxib;Chemical;PA166155244;Variant
RS4133101;celecoxib;Chemical;PA166156824;Variant
RS2302821;celecoxib;Chemical;PA166157751;Variant
KCNQ1;celecoxib;Chemical;PA223;Gene
ATP2A1;celecoxib;Chemical;PA25105;Gene
ATP2A3;celecoxib;Chemical;PA25106;Gene
BCAR1;celecoxib;Chemical;PA25281;Gene
CA12;celecoxib;Chemical;PA25987;Gene
CA9;celecoxib;Chemical;PA25998;Gene
CACNA1A;celecoxib;Chemical;PA26007;Gene
CACNA1B;celecoxib;Chemical;PA26008;Gene
CACNA1E;celecoxib;Chemical;PA26009;Gene
CACNA1F;celecoxib;Chemical;PA26010;Gene
CACNA1I;celecoxib;Chemical;PA26011;Gene
CACNA2D2;celecoxib;Chemical;PA26012;Gene
CACNA2D3;celecoxib;Chemical;PA26013;Gene
CACNB4;celecoxib;Chemical;PA26014;Gene
CASP3;celecoxib;Chemical;PA26087;Gene
CASP9;celecoxib;Chemical;PA26094;Gene
CTNNB1;celecoxib;Chemical;PA27013;Gene
DDIT3;celecoxib;Chemical;PA27193;Gene
PPARG;celecoxib;Chemical;PA281;Gene
PTGER4;celecoxib;Chemical;PA289;Gene
PTGS2;celecoxib;Chemical;PA293;Gene
IGFBP3;celecoxib;Chemical;PA29705;Gene
KCNQ2;celecoxib;Chemical;PA30074;Gene
KCNQ3;celecoxib;Chemical;PA30075;Gene
KCNQ4;celecoxib;Chemical;PA30076;Gene
KCNQ5;celecoxib;Chemical;PA30077;Gene
MMP9;celecoxib;Chemical;PA30889;Gene
PDK1;celecoxib;Chemical;PA33154;Gene
PTGES;celecoxib;Chemical;PA33948;Gene
VEGFA;celecoxib;Chemical;PA37302;Gene
CACNA1H;celecoxib;Chemical;PA380;Gene
CACNA1G;celecoxib;Chemical;PA381;Gene
ASPIRIN;celecoxib;Chemical;PA448497;Chemical
ALOX12;celecoxib;Chemical;PA45;Gene
ATP2A2;celecoxib;Chemical;PA71;Gene
CACNA1C;celecoxib;Chemical;PA83;Gene
CACNA1D;celecoxib;Chemical;PA84;Gene
CACNA1S;celecoxib;Chemical;PA85;Gene
CACNA2D1;celecoxib;Chemical;PA86;Gene
CACNB1;celecoxib;Chemical;PA87;Gene
CACNB2;celecoxib;Chemical;PA88;Gene
CACNB3;celecoxib;Chemical;PA89;Gene
HYPERTENSION;rs1346563;Variant;PA444552;Disease
SORAFENIB;rs1346563;Variant;PA7000;Chemical
RS77375493;ropeginterferon alfa-2b;Chemical;PA166268922;Variant
JAK2;ropeginterferon alfa-2b;Chemical;PA29989;Gene
AMLODIPINE;rs11122576;Variant;PA448388;Chemical
CHLORTHALIDONE;rs11122576;Variant;PA448970;Chemical
LISINOPRIL;rs11122576;Variant;PA450242;Chemical
REMIMAZOLAM;rs151291296;Variant;PA166321761;Chemical
URINARY BLADDER NEOPLASMS;rs244898;Variant;PA443512;Disease
CISPLATIN;rs244898;Variant;PA449014;Chemical
RS1128503;tipifarnib;Chemical;PA166157288;Variant
ABCB1;tipifarnib;Chemical;PA267;Gene
ESR1;ixabepilone;Chemical;PA156;Gene
PGR;ixabepilone;Chemical;PA266;Gene
ERBB2;ixabepilone;Chemical;PA27844;Gene
ESR2;ixabepilone;Chemical;PA27886;Gene
HEROIN DEPENDENCE;NGF;Gene;PA444460;Disease
OPIOID-RELATED DISORDERS;NGF;Gene;PA445043;Disease
METHADONE;NGF;Gene;PA450401;Chemical
BETA BLOCKING AGENTS;rs36217263;Variant;PA164712535;Chemical
RS1045642;Arthralgia;Disease;PA166157284;Variant
ABCB1;Arthralgia;Disease;PA267;Gene
SCHIZOPHRENIA;PMCH;Gene;PA447216;Disease
OLANZAPINE;PMCH;Gene;PA450688;Chemical
PLCB1;GNB1;Gene;PA33384;Gene
PLCB2;GNB1;Gene;PA33385;Gene
PLCB3;GNB1;Gene;PA33386;Gene
PLCB4;GNB1;Gene;PA33387;Gene
OMEPRAZOLE;rs75519181;Variant;PA450704;Chemical
XENOBIOTICS;rs75519181;Variant;PA452604;Chemical
CYP2D6;fluoxetine / olanzapine;Chemical;PA128;Gene
BIPOLAR DISORDER;OR52E2;Gene;PA447199;Disease
LITHIUM;OR52E2;Gene;PA450243;Chemical
MIGALASTAT;GLA;Gene;PA166182881;Chemical
FABRY DISEASE;GLA;Gene;PA443367;Disease
RS5186;nitrendipine;Chemical;PA166156276;Variant
RS1137617;nitrendipine;Chemical;PA166157289;Variant
KCNH2;nitrendipine;Chemical;PA212;Gene
ABCB1;nitrendipine;Chemical;PA267;Gene
AGTR1;nitrendipine;Chemical;PA43;Gene
MS4A1;tositumomab;Chemical;PA31111;Gene
MEPHENYTOIN;rs1187513719;Variant;PA450373;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs6813183;Variant;PA447197;Disease
METHYLPHENIDATE;rs6813183;Variant;PA450464;Chemical
ORGAN TRANSPLANTATION;PPARA;Gene;PA133888799;Disease
BETA BLOCKING AGENTS;PPARA;Gene;PA164712535;Chemical
KIDNEY TRANSPLANTATION;PPARA;Gene;PA165817016;Disease
CORONARY DISEASE;PPARA;Gene;PA443797;Disease
DIABETES MELLITUS;PPARA;Gene;PA443886;Disease
FENOFIBRATE;PPARA;Gene;PA449594;Chemical
METFORMIN;PPARA;Gene;PA450395;Chemical
PHENPROCOUMON;PPARA;Gene;PA450921;Chemical
SIMVASTATIN;PPARA;Gene;PA451363;Chemical
TACROLIMUS;PPARA;Gene;PA451578;Chemical
IMATINIB;rs10517;Variant;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;rs10517;Variant;PA151958383;Disease
WARFARIN;rs10517;Variant;PA451906;Chemical
CYP2C19;drospirenone / ethinyl estradiol;Chemical;PA124;Gene
F5;drospirenone / ethinyl estradiol;Chemical;PA159;Gene
RS6025;drospirenone / ethinyl estradiol;Chemical;PA166153554;Variant
PROC;drospirenone / ethinyl estradiol;Chemical;PA33799;Gene
PROS1;drospirenone / ethinyl estradiol;Chemical;PA33809;Gene
SERPINC1;drospirenone / ethinyl estradiol;Chemical;PA35026;Gene
ALK;ramucirumab;Chemical;PA24719;Gene
KRAS;ramucirumab;Chemical;PA30196;Gene
EGFR;ramucirumab;Chemical;PA7360;Gene
FLUOROURACIL;rs201045130;Variant;PA128406956;Chemical
CLADRIBINE;rs201045130;Variant;PA449027;Chemical
GEMCITABINE;rs201045130;Variant;PA449748;Chemical
FLUOROURACIL;rs1979277;Variant;PA128406956;Chemical
BEVACIZUMAB;rs1979277;Variant;PA130232992;Chemical
COLORECTAL NEOPLASMS;rs1979277;Variant;PA446108;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs1979277;Variant;PA446155;Disease
IRINOTECAN;rs1979277;Variant;PA450085;Chemical
LEUCOVORIN;rs1979277;Variant;PA450198;Chemical
METHOTREXATE;rs1979277;Variant;PA450428;Chemical
HEROIN DEPENDENCE;rs769404;Variant;PA444460;Disease
METHADONE;rs769404;Variant;PA450401;Chemical
CYP2C8;Osteonecrosis;Disease;PA125;Gene
TBC1D32;Osteonecrosis;Disease;PA134871908;Gene
MEX3C;Osteonecrosis;Disease;PA162395821;Gene
CSRNP3;Osteonecrosis;Disease;PA164718184;Gene
LINC00251;Osteonecrosis;Disease;PA165585763;Gene
RS1886629;Osteonecrosis;Disease;PA166153657;Variant
RS1891059;Osteonecrosis;Disease;PA166153658;Variant
RS2297480;Osteonecrosis;Disease;PA166153695;Variant
RS17021408;Osteonecrosis;Disease;PA166153867;Variant
RS80223967;Osteonecrosis;Disease;PA166153915;Variant
RS1934951;Osteonecrosis;Disease;PA166153985;Variant
RS11189381;Osteonecrosis;Disease;PA166154129;Variant
RS1678387;Osteonecrosis;Disease;PA166154701;Variant
RS12903202;Osteonecrosis;Disease;PA166154936;Variant
RS17751934;Osteonecrosis;Disease;PA166155329;Variant
RS7588295;Osteonecrosis;Disease;PA166155769;Variant
RS79085477;Osteonecrosis;Disease;PA166155968;Variant
RS117532069;Osteonecrosis;Disease;PA166155970;Variant
RS17024608;Osteonecrosis;Disease;PA166156462;Variant
RS7740004;Osteonecrosis;Disease;PA166157121;Variant
RS141059755;Osteonecrosis;Disease;PA166157691;Variant
RS1799762;Osteonecrosis;Disease;PA166282801;Variant
ACP1;Osteonecrosis;Disease;PA24446;Gene
ALDH1A2;Osteonecrosis;Disease;PA24693;Gene
BMP7;Osteonecrosis;Disease;PA25384;Gene
DOK5;Osteonecrosis;Disease;PA25724;Gene
SERPINE1;Osteonecrosis;Disease;PA261;Gene
FDPS;Osteonecrosis;Disease;PA28075;Gene
RBMS3;Osteonecrosis;Disease;PA34276;Gene
SFRP5;Osteonecrosis;Disease;PA35695;Gene
KCNT2;Osteonecrosis;Disease;PA38726;Gene
ABCC4;Osteonecrosis;Disease;PA397;Gene
FLUOROURACIL;rs72549303;Variant;PA128406956;Chemical
DPYD;rs72549303;Variant;PA145;Gene
CAPECITABINE;rs72549303;Variant;PA448771;Chemical
TEGAFUR;rs72549303;Variant;PA452620;Chemical
OTOTOXICITY;XPC;Gene;PA162263534;Disease
PLATINUM COMPOUNDS;XPC;Gene;PA164713176;Chemical
GASTROINTESTINAL TOXICITY;XPC;Gene;PA166124386;Disease
URINARY BLADDER NEOPLASMS;XPC;Gene;PA443512;Disease
NON-SMALL CELL LUNG CARCINOMA;XPC;Gene;PA443622;Disease
DRUG TOXICITY;XPC;Gene;PA443937;Disease
HEMATOLOGIC DISORDER;XPC;Gene;PA444395;Disease
INFECTIOUS DISEASE;XPC;Gene;PA444614;Disease
LEUKOPENIA;XPC;Gene;PA444773;Disease
NEOPLASMS;XPC;Gene;PA445062;Disease
NEUTROPENIA;XPC;Gene;PA445113;Disease
OSTEOSARCOMA;XPC;Gene;PA445601;Disease
TESTICULAR NEOPLASMS;XPC;Gene;PA445828;Disease
CISPLATIN;XPC;Gene;PA449014;Chemical
DOXORUBICIN;XPC;Gene;PA449412;Chemical
DEXTROMETHORPHAN;CYP2D6*44;Haplotype;PA449273;Chemical
APNEA;rs201820739;Variant;PA443407;Disease
SUCCINYLCHOLINE;rs201820739;Variant;PA451522;Chemical
PROSTATIC NEOPLASMS;rs1871450;Variant;PA445425;Disease
DOCETAXEL;rs1871450;Variant;PA449383;Chemical
THALIDOMIDE;rs1871450;Variant;PA451644;Chemical
SCHIZOPHRENIA;rs362306;Variant;PA447216;Disease
RISPERIDONE;rs362306;Variant;PA451257;Chemical
WARFARIN;rs28371686;Variant;PA451906;Chemical
DRUG HYPERSENSITIVITY;rs3093726;Variant;PA443936;Disease
ABACAVIR;rs3093726;Variant;PA448004;Chemical
CYP3A4;umifenovir;Chemical;PA130;Gene
TOBACCO USE DISORDER;rs55781567;Variant;PA445876;Disease
NICOTINE;rs55781567;Variant;PA450626;Chemical
HLA-DRB1*15:01;canakinumab;Chemical;PA165952269;Haplotype
HLA-DRB1;canakinumab;Chemical;PA35072;Gene
CYB5R3;lidocaine and tetracaine;Chemical;PA27331;Gene
G6PD;lidocaine and tetracaine;Chemical;PA28469;Gene
CYP3A4;dolutegravir;Chemical;PA130;Gene
CYP3A5;dolutegravir;Chemical;PA131;Gene
UGT1A1*1;dolutegravir;Chemical;PA166115841;Haplotype
UGT1A1*28;dolutegravir;Chemical;PA166115842;Haplotype
UGT1A1*36;dolutegravir;Chemical;PA166115843;Haplotype
UGT1A1*37;dolutegravir;Chemical;PA166115844;Haplotype
UGT1A1*6;dolutegravir;Chemical;PA166115858;Haplotype
RS2472677;dolutegravir;Chemical;PA166156358;Variant
RS2231142;dolutegravir;Chemical;PA166156544;Variant
NR1I2;dolutegravir;Chemical;PA378;Gene
ABCG2;dolutegravir;Chemical;PA390;Gene
UGT1A1;dolutegravir;Chemical;PA420;Gene
SCHIZOPHRENIA;rs11030104;Variant;PA447216;Disease
ANTIPSYCHOTICS;rs11030104;Variant;PA452233;Chemical
NEOPLASMS;rs12948783;Variant;PA445062;Disease
FENTANYL;rs12948783;Variant;PA449599;Chemical
MORPHINE;rs12948783;Variant;PA450550;Chemical
OXYCODONE;rs12948783;Variant;PA450741;Chemical
OPIOIDS;rs12948783;Variant;PA452618;Chemical
EMAPALUMAB;STX11;Gene;PA166182763;Chemical
HEROIN DEPENDENCE;rs4877900;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs4877900;Variant;PA445043;Disease
METHADONE;rs4877900;Variant;PA450401;Chemical
COMT;rs4680;Variant;PA117;Gene
ANALGESICS;rs4680;Variant;PA164712362;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;rs4680;Variant;PA164712462;Chemical
DRUGS USED IN NICOTINE DEPENDENCE;rs4680;Variant;PA164712720;Chemical
ERGOT ALKALOIDS;rs4680;Variant;PA164712741;Chemical
ENTACAPONE;rs4680;Variant;PA164748726;Chemical
TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME;rs4680;Variant;PA165108308;Disease
NEONATAL ABSTINENCE SYNDROME;rs4680;Variant;PA165108809;Disease
METHAMPHETAMINE DEPENDENCE;rs4680;Variant;PA166119022;Disease
SMOKING CESSATION;rs4680;Variant;PA166123046;Disease
ADVERSE EVENTS;rs4680;Variant;PA166151827;Disease
SOMNOLENCE;rs4680;Variant;PA166185626;Disease
FREMANEZUMAB;rs4680;Variant;PA166320903;Chemical
GALCANEZUMAB;rs4680;Variant;PA166320904;Chemical
ERENUMAB;rs4680;Variant;PA166320921;Chemical
CONSTIPATION;rs4680;Variant;PA443782;Disease
DEATH;rs4680;Variant;PA443842;Disease
DELIRIUM;rs4680;Variant;PA443851;Disease
ERYTHEMA;rs4680;Variant;PA444083;Disease
EXANTHEMA;rs4680;Variant;PA444109;Disease
HYPERALGESIA;rs4680;Variant;PA444510;Disease
MIGRAINE WITHOUT AURA;rs4680;Variant;PA444949;Disease
OPIOID-RELATED DISORDERS;rs4680;Variant;PA445043;Disease
NAUSEA;rs4680;Variant;PA445048;Disease
PAIN;rs4680;Variant;PA445208;Disease
PAIN, POSTOPERATIVE;rs4680;Variant;PA445210;Disease
PARKINSON DISEASE;rs4680;Variant;PA445254;Disease
PRURITUS;rs4680;Variant;PA445437;Disease
TOBACCO USE DISORDER;rs4680;Variant;PA445876;Disease
VOMITING;rs4680;Variant;PA446051;Disease
URINARY RETENTION;rs4680;Variant;PA446264;Disease
MIGRAINE WITH AURA;rs4680;Variant;PA447004;Disease
ANXIETY DISORDERS;rs4680;Variant;PA447196;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs4680;Variant;PA447197;Disease
DEPRESSIVE DISORDER;rs4680;Variant;PA447207;Disease
SCHIZOPHRENIA;rs4680;Variant;PA447216;Disease
TARDIVE DYSKINESIA;rs4680;Variant;PA447268;Disease
MAJOR DEPRESSIVE DISORDER;rs4680;Variant;PA447321;Disease
BUPRENORPHINE;rs4680;Variant;PA448685;Chemical
CLOZAPINE;rs4680;Variant;PA449061;Chemical
FENTANYL;rs4680;Variant;PA449599;Chemical
FLUVOXAMINE;rs4680;Variant;PA449690;Chemical
HALOPERIDOL;rs4680;Variant;PA449841;Chemical
METHADONE;rs4680;Variant;PA450401;Chemical
METHYLPHENIDATE;rs4680;Variant;PA450464;Chemical
MODAFINIL;rs4680;Variant;PA450530;Chemical
MORPHINE;rs4680;Variant;PA450550;Chemical
NALOXONE;rs4680;Variant;PA450586;Chemical
NICOTINE;rs4680;Variant;PA450626;Chemical
OXYCODONE;rs4680;Variant;PA450741;Chemical
PAROXETINE;rs4680;Variant;PA450801;Chemical
PROPRANOLOL;rs4680;Variant;PA451145;Chemical
REMIFENTANIL;rs4680;Variant;PA451232;Chemical
RISPERIDONE;rs4680;Variant;PA451257;Chemical
SUFENTANIL;rs4680;Variant;PA451527;Chemical
SUMATRIPTAN;rs4680;Variant;PA451566;Chemical
TRAMADOL;rs4680;Variant;PA451735;Chemical
VENLAFAXINE;rs4680;Variant;PA451866;Chemical
ANTIPSYCHOTICS;rs4680;Variant;PA452233;Chemical
OPIOIDS;rs4680;Variant;PA452618;Chemical
COMT;benztropine;Chemical;PA117;Gene
DPYD;rs150036960;Variant;PA145;Gene
CAPECITABINE;rs150036960;Variant;PA448771;Chemical
ALCOHOL ABUSE;rs2673136;Variant;PA443309;Disease
ETHANOL;rs2673136;Variant;PA448073;Chemical
ESCITALOPRAM;HTR1B;Gene;PA10074;Chemical
KETANSERIN;HTR1B;Gene;PA131053734;Chemical
DIHYDROERGOTAMINE;HTR1B;Gene;PA164743028;Chemical
METHYSERGIDE;HTR1B;Gene;PA164743265;Chemical
LIOTHYRONINE;HTR1B;Gene;PA164778866;Chemical
GNAI1;HTR1B;Gene;PA172;Gene
GNAI3;HTR1B;Gene;PA173;Gene
GNAI2;HTR1B;Gene;PA24347;Gene
ANXIETY DISORDERS;HTR1B;Gene;PA447196;Disease
DEPRESSION;HTR1B;Gene;PA447278;Disease
MAJOR DEPRESSIVE DISORDER;HTR1B;Gene;PA447321;Disease
CITALOPRAM;HTR1B;Gene;PA449015;Chemical
CLOMIPRAMINE;HTR1B;Gene;PA449048;Chemical
FLUOXETINE;HTR1B;Gene;PA449673;Chemical
LITHIUM;HTR1B;Gene;PA450243;Chemical
NEFAZODONE;HTR1B;Gene;PA450603;Chemical
PAROXETINE;HTR1B;Gene;PA450801;Chemical
SUMATRIPTAN;HTR1B;Gene;PA451566;Chemical
VENLAFAXINE;HTR1B;Gene;PA451866;Chemical
DIABETES MELLITUS;rs114202595;Variant;PA443886;Disease
REPAGLINIDE;rs114202595;Variant;PA451234;Chemical
CFTR;rs139304906;Variant;PA109;Gene
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs139304906;Variant;PA166190041;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs139304906;Variant;PA166362502;Chemical
FLUOROURACIL;rs4294451;Variant;PA128406956;Chemical
SCHIZOPHRENIA;rs3803300;Variant;PA447216;Disease
RISPERIDONE;rs3803300;Variant;PA451257;Chemical
KETOROLAC;rs2562456;Variant;PA450150;Chemical
RS1799971;Sleep Disorders;Disease;PA166156991;Variant
OPRM1;Sleep Disorders;Disease;PA31945;Gene
CYP2C19;troglitazone;Chemical;PA124;Gene
SLCO1B1;troglitazone;Chemical;PA134865839;Gene
CYP2C19*8;troglitazone;Chemical;PA165816524;Haplotype
CYP2C19*9;troglitazone;Chemical;PA165816525;Haplotype
CYP2C19*1;troglitazone;Chemical;PA165980634;Haplotype
RS10811661;troglitazone;Chemical;PA166157816;Variant
GSTT1;troglitazone;Chemical;PA183;Gene
NR1I2;troglitazone;Chemical;PA378;Gene
PLATINUM COMPOUNDS;MALAT1;Gene;PA164713176;Chemical
LUNG NEOPLASMS;MALAT1;Gene;PA444818;Disease
DPYD;rs72547602;Variant;PA145;Gene
CAPECITABINE;rs72547602;Variant;PA448771;Chemical
ANTITHYROID PREPARATIONS;HLA-B*27:05;Haplotype;PA164712499;Chemical
AGRANULOCYTOSIS;HLA-B*27:05;Haplotype;PA443297;Disease
HEROIN DEPENDENCE;rs13242038;Variant;PA444460;Disease
HEROIN;rs13242038;Variant;PA452619;Chemical
NEUROTOXICITY SYNDROMES;ACTG1;Gene;PA446975;Disease
VINCRISTINE;ACTG1;Gene;PA451879;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs3210967;Variant;PA447197;Disease
METHYLPHENIDATE;rs3210967;Variant;PA450464;Chemical
RS6166;Infertility disorder;Disease;PA166155582;Variant
FSHR;Infertility disorder;Disease;PA28386;Gene
CYP1A2;albendazole;Chemical;PA27093;Gene
CYP2J2;albendazole;Chemical;PA27112;Gene
PANCREATIC NEOPLASMS;rs274713;Variant;PA445218;Disease
GEMCITABINE;rs274713;Variant;PA449748;Chemical
CYP2C9;Blood Coagulation Disorders;Disease;PA126;Gene
CYP2C9*1;Blood Coagulation Disorders;Disease;PA165816542;Haplotype
CYP2C9*3;Blood Coagulation Disorders;Disease;PA165816544;Haplotype
MACULOPAPULAR EXANTHEMA;HLA-A*33:03;Haplotype;PA162316739;Disease
TOXIC LIVER DISEASE;HLA-A*33:03;Haplotype;PA164925725;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-A*33:03;Haplotype;PA166120929;Disease
DRUG HYPERSENSITIVITY;HLA-A*33:03;Haplotype;PA443936;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-A*33:03;Haplotype;PA444059;Disease
EPILEPSY;HLA-A*33:03;Haplotype;PA444065;Disease
KIDNEY FAILURE, CHRONIC;HLA-A*33:03;Haplotype;PA444684;Disease
STEVENS-JOHNSON SYNDROME;HLA-A*33:03;Haplotype;PA445738;Disease
ALLOPURINOL;HLA-A*33:03;Haplotype;PA448320;Chemical
CARBAMAZEPINE;HLA-A*33:03;Haplotype;PA448785;Chemical
LAMOTRIGINE;HLA-A*33:03;Haplotype;PA450164;Chemical
TICLOPIDINE;HLA-A*33:03;Haplotype;PA451686;Chemical
FLUVASTATIN;rs60282872;Variant;PA449688;Chemical
LEUKEMIA, MYELOID, ACUTE;rs1042919;Variant;PA444760;Disease
CLADRIBINE;rs1042919;Variant;PA449027;Chemical
CYTARABINE;rs1042919;Variant;PA449177;Chemical
DIARRHEA;UGT1A7*2;Haplotype;PA443899;Disease
NEUTROPENIA;UGT1A7*2;Haplotype;PA445113;Disease
STOMACH NEOPLASMS;UGT1A7*2;Haplotype;PA445742;Disease
IRINOTECAN;UGT1A7*2;Haplotype;PA450085;Chemical
TENOFOVIR;rs3742106;Variant;PA10204;Chemical
NEPHROTOXICITY;rs3742106;Variant;PA162263533;Disease
TENOFOVIR DISOPROXIL FUMARATE;rs3742106;Variant;PA166201941;Chemical
HIV INFECTIOUS DISEASE;rs3742106;Variant;PA447230;Disease
NON-SMALL CELL LUNG CARCINOMA;rs73450548;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs73450548;Variant;PA445846;Disease
CARBOPLATIN;rs73450548;Variant;PA448803;Chemical
GEMCITABINE;rs73450548;Variant;PA449748;Chemical
ESR1;fulvestrant;Chemical;PA156;Gene
PGR;fulvestrant;Chemical;PA266;Gene
ERBB2;fulvestrant;Chemical;PA27844;Gene
ESR2;fulvestrant;Chemical;PA27886;Gene
ANASTROZOLE;fulvestrant;Chemical;PA448432;Chemical
ABCC2;Lymphoma;Disease;PA116;Gene
CYP2C19;Lymphoma;Disease;PA124;Gene
SLCO1B1;Lymphoma;Disease;PA134865839;Gene
CYP2C19*1;Lymphoma;Disease;PA165980634;Haplotype
CYP2C19*2;Lymphoma;Disease;PA165980635;Haplotype
RS1801133;Lymphoma;Disease;PA166153644;Variant
RS2072671;Lymphoma;Disease;PA166153667;Variant
RS717620;Lymphoma;Disease;PA166153953;Variant
RS3740065;Lymphoma;Disease;PA166154027;Variant
RS9344;Lymphoma;Disease;PA166154264;Variant
RS11045879;Lymphoma;Disease;PA166154633;Variant
RS4124874;Lymphoma;Disease;PA166155720;Variant
RS1801394;Lymphoma;Disease;PA166156776;Variant
RS1128503;Lymphoma;Disease;PA166157288;Variant
MTHFR;Lymphoma;Disease;PA245;Gene
ABCB1;Lymphoma;Disease;PA267;Gene
MTRR;Lymphoma;Disease;PA31277;Gene
UGT1A1;Lymphoma;Disease;PA420;Gene
CCND1;Lymphoma;Disease;PA75;Gene
CDA;Lymphoma;Disease;PA98;Gene
IFNL3;telaprevir;Chemical;PA134952671;Gene
IFNL4;telaprevir;Chemical;PA166049147;Gene
RS8099917;telaprevir;Chemical;PA166155435;Variant
RS12979860;telaprevir;Chemical;PA166155468;Variant
RS2585428;telaprevir;Chemical;PA166155928;Variant
RS11322783;telaprevir;Chemical;PA166190881;Variant
CYP24A1;telaprevir;Chemical;PA27097;Gene
LUNG NEOPLASMS;ALOX15B;Gene;PA444818;Disease
SELECTIVE BETA-2-ADRENORECEPTOR AGONISTS;rs2284220;Variant;PA134687887;Chemical
ASTHMA;rs2284220;Variant;PA443450;Disease
SALBUTAMOL;rs2284220;Variant;PA448068;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs75549581;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs75549581;Variant;PA443829;Disease
IBRUTINIB;rs387907272;Variant;PA166121346;Chemical
ZANUBRUTINIB;rs387907272;Variant;PA166204001;Chemical
MYD88;rs387907272;Variant;PA31361;Gene
TP53;rs387907272;Variant;PA36679;Gene
CETUXIMAB;EGFR;Gene;PA10040;Chemical
IMATINIB;EGFR;Gene;PA10804;Chemical
PEMETREXED;EGFR;Gene;PA10810;Chemical
FLUOROURACIL;EGFR;Gene;PA128406956;Chemical
GEFITINIB;EGFR;Gene;PA131301952;Chemical
ERLOTINIB;EGFR;Gene;PA134687924;Chemical
SHC3;EGFR;Gene;PA134913435;Gene
SHC2;EGFR;Gene;PA134971076;Gene
TOPOISOMERASE I INHIBITORS;EGFR;Gene;PA150481186;Chemical
GASTROINTESTINAL STROMAL TUMORS;EGFR;Gene;PA151958383;Disease
GELDANAMYCIN;EGFR;Gene;PA152031327;Chemical
LAPATINIB;EGFR;Gene;PA152241907;Chemical
EGFR INHIBITORS;EGFR;Gene;PA153561371;Chemical
PANITUMUMAB;EGFR;Gene;PA162373091;Chemical
ALKYLATING AGENTS;EGFR;Gene;PA164712331;Chemical
PEGINTERFERON ALFA-2A;EGFR;Gene;PA164749390;Chemical
PEGINTERFERON ALFA-2B;EGFR;Gene;PA164784024;Chemical
DRUG RESISTANCE;EGFR;Gene;PA165111675;Disease
NERATINIB;EGFR;Gene;PA165291472;Chemical
AFATINIB;EGFR;Gene;PA165981154;Chemical
VANDETANIB;EGFR;Gene;PA166118341;Chemical
PEMBROLIZUMAB;EGFR;Gene;PA166124615;Chemical
NIVOLUMAB;EGFR;Gene;PA166129522;Chemical
ATEZOLIZUMAB;EGFR;Gene;PA166129523;Chemical
OSIMERTINIB;EGFR;Gene;PA166131626;Chemical
RS113488022;EGFR;Gene;PA166157522;Variant
RS121434568;EGFR;Gene;PA166157527;Variant
RS121434569;EGFR;Gene;PA166157528;Variant
DURVALUMAB;EGFR;Gene;PA166169883;Chemical
DACOMITINIB;EGFR;Gene;PA166182279;Chemical
IPILIMUMAB;EGFR;Gene;PA166182718;Chemical
RAMUCIRUMAB;EGFR;Gene;PA166184558;Chemical
TEPOTINIB;EGFR;Gene;PA166211181;Chemical
CEMIPLIMAB-RWLC;EGFR;Gene;PA166251401;Chemical
MOBOCERTINIB;EGFR;Gene;PA166268804;Chemical
TREMELIMUMAB;EGFR;Gene;PA166293321;Chemical
LAZERTINIB;EGFR;Gene;PA166314341;Chemical
AMIVANTAMAB;EGFR;Gene;PA166321301;Chemical
GRB2;EGFR;Gene;PA28962;Gene
HRAS;EGFR;Gene;PA29444;Gene
JAK1;EGFR;Gene;PA29988;Gene
KRAS;EGFR;Gene;PA30196;Gene
MRAS;EGFR;Gene;PA30932;Gene
NRAS;EGFR;Gene;PA31768;Gene
PIK3CA;EGFR;Gene;PA33308;Gene
PIK3CB;EGFR;Gene;PA33309;Gene
PIK3CD;EGFR;Gene;PA33310;Gene
PIK3CG;EGFR;Gene;PA33311;Gene
PIK3R1;EGFR;Gene;PA33312;Gene
PIK3R2;EGFR;Gene;PA33313;Gene
PIK3R3;EGFR;Gene;PA33314;Gene
PLCG1;EGFR;Gene;PA33392;Gene
PLCG2;EGFR;Gene;PA33393;Gene
RRAS;EGFR;Gene;PA34861;Gene
SHC1;EGFR;Gene;PA35746;Gene
SOS1;EGFR;Gene;PA36024;Gene
ADENOCARCINOMA;EGFR;Gene;PA443265;Disease
NON-SMALL CELL LUNG CARCINOMA;EGFR;Gene;PA443622;Disease
DIARRHEA;EGFR;Gene;PA443899;Disease
HEAD AND NECK NEOPLASMS;EGFR;Gene;PA444352;Disease
HYPERTENSION;EGFR;Gene;PA444552;Disease
LUNG NEOPLASMS;EGFR;Gene;PA444818;Disease
NEOPLASMS;EGFR;Gene;PA445062;Disease
PANCREATIC NEOPLASMS;EGFR;Gene;PA445218;Disease
STOMACH NEOPLASMS;EGFR;Gene;PA445742;Disease
COLORECTAL NEOPLASMS;EGFR;Gene;PA446108;Disease
CHRONIC HEPATITIS C VIRUS INFECTION;EGFR;Gene;PA446863;Disease
IRINOTECAN;EGFR;Gene;PA450085;Chemical
LEUCOVORIN;EGFR;Gene;PA450198;Chemical
RIBAVIRIN;EGFR;Gene;PA451241;Chemical
TEGAFUR;EGFR;Gene;PA452620;Chemical
SORAFENIB;EGFR;Gene;PA7000;Chemical
ESSENTIAL HYPERTENSION;rs2301339;Variant;PA447288;Disease
ATENOLOL;rs2301339;Variant;PA448499;Chemical
MAJOR DEPRESSIVE DISORDER;rs809736;Variant;PA447321;Disease
CITALOPRAM;rs809736;Variant;PA449015;Chemical
CYP2C9;nateglinide;Chemical;PA126;Gene
CYP3A4;nateglinide;Chemical;PA130;Gene
SLCO1B1;nateglinide;Chemical;PA134865839;Gene
CYP2C9*1;nateglinide;Chemical;PA165816542;Haplotype
CYP2C9*3;nateglinide;Chemical;PA165816544;Haplotype
PEMETREXED;DHFR;Gene;PA10810;Chemical
MULTIVITAMINS, PLAIN;DHFR;Gene;PA164712913;Chemical
DRUG-INDUCED LIVER INJURY;DHFR;Gene;PA166119041;Disease
RHEUMATOID ARTHRITIS;DHFR;Gene;PA443434;Disease
BREAST NEOPLASMS;DHFR;Gene;PA443560;Disease
NON-SMALL CELL LUNG CARCINOMA;DHFR;Gene;PA443622;Disease
DRUG TOXICITY;DHFR;Gene;PA443937;Disease
LEUKOPENIA;DHFR;Gene;PA444773;Disease
MESOTHELIOMA;DHFR;Gene;PA444937;Disease
OSTEOSARCOMA;DHFR;Gene;PA445601;Disease
THROMBOCYTOPENIA;DHFR;Gene;PA445846;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;DHFR;Gene;PA446155;Disease
METHOTREXATE;DHFR;Gene;PA450428;Chemical
FLUOROURACIL;rs140039091;Variant;PA128406956;Chemical
DRUG TOXICITY;rs140039091;Variant;PA443937;Disease
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;SH3BP2;Gene;PA164713366;Chemical
PSORIASIS;SH3BP2;Gene;PA445451;Disease
ARTHRITIS, PSORIATIC;SH3BP2;Gene;PA446198;Disease
CEFOTAXIME;rs11568482;Variant;PA448852;Chemical
BETA-THALASSEMIA AND RELATED DISEASES;MAP3K5;Gene;PA446432;Disease
HYDROXYUREA;MAP3K5;Gene;PA449942;Chemical
ANTIEPILEPTICS;rs2304016;Variant;PA143485705;Chemical
EPILEPSY;rs2304016;Variant;PA444065;Disease
CARBAMAZEPINE;rs2304016;Variant;PA448785;Chemical
LAMOTRIGINE;rs2304016;Variant;PA450164;Chemical
OXCARBAZEPINE;rs2304016;Variant;PA450732;Chemical
PHENYTOIN;rs2304016;Variant;PA450947;Chemical
TOPIRAMATE;rs2304016;Variant;PA451728;Chemical
GPAM;PRKAB2;Gene;PA134983031;Gene
CRTC2;PRKAB2;Gene;PA142672073;Gene
HMGCR;PRKAB2;Gene;PA189;Gene
ACACA;PRKAB2;Gene;PA24421;Gene
ACACB;PRKAB2;Gene;PA24422;Gene
MLYCD;PRKAB2;Gene;PA30861;Gene
SREBF1;PRKAB2;Gene;PA335;Gene
SLC2A4;PRKAB2;Gene;PA35879;Gene
STK11;PRKAB2;Gene;PA36198;Gene
MLXIPL;PRKAB2;Gene;PA37353;Gene
SIRT1;PRKAB2;Gene;PA37935;Gene
METFORMIN;PRKAB2;Gene;PA450395;Chemical
ATM;PRKAB2;Gene;PA61;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs2275913;Variant;PA164713366;Chemical
ULCERATIVE COLITIS;rs2275913;Variant;PA443750;Disease
PAIN, POSTOPERATIVE;rs2275913;Variant;PA445210;Disease
INFLAMMATORY BOWEL DISEASES;rs2275913;Variant;PA446116;Disease
OPIOIDS;rs2275913;Variant;PA452618;Chemical
CYP2D6;dihydrocodeine;Chemical;PA128;Gene
CYP2D6*1;dihydrocodeine;Chemical;PA165816576;Haplotype
CYP2D6*4;dihydrocodeine;Chemical;PA165816579;Haplotype
ECULIZUMAB;CR1;Gene;PA164776637;Chemical
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA;CR1;Gene;PA166122772;Disease
IMATINIB;SLCO1A2;Gene;PA10804;Chemical
HMG COA REDUCTASE INHIBITORS;SLCO1A2;Gene;PA133950441;Chemical
ROCURONIUM;SLCO1A2;Gene;PA164754992;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;SLCO1A2;Gene;PA446155;Disease
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;SLCO1A2;Gene;PA446171;Disease
METHOTREXATE;SLCO1A2;Gene;PA450428;Chemical
NADOLOL;SLCO1A2;Gene;PA450573;Chemical
HIV INFECTIOUS DISEASE;GCLC;Gene;PA447230;Disease
SULFAMETHOXAZOLE;GCLC;Gene;PA451544;Chemical
CYP2D6;Brain Neoplasms;Disease;PA128;Gene
CYP2D6*3;Brain Neoplasms;Disease;PA165816578;Haplotype
CYP2D6*4;Brain Neoplasms;Disease;PA165816579;Haplotype
CYP2D6*5;Brain Neoplasms;Disease;PA165948092;Haplotype
RS1872328;Brain Neoplasms;Disease;PA166155651;Variant
RS4148157;Brain Neoplasms;Disease;PA166156582;Variant
ACYP2;Brain Neoplasms;Disease;PA24500;Gene
ABCG2;Brain Neoplasms;Disease;PA390;Gene
RENAL CELL CARCINOMA;rs2239702;Variant;PA443624;Disease
SORAFENIB;rs2239702;Variant;PA7000;Chemical
HNRNPH2;Fabry Disease;Disease;PA162391316;Gene
RS398123212;Fabry Disease;Disease;PA166185903;Variant
RS398123217;Fabry Disease;Disease;PA166185904;Variant
RS397515874;Fabry Disease;Disease;PA166185905;Variant
RS727505292;Fabry Disease;Disease;PA166185906;Variant
RS869312399;Fabry Disease;Disease;PA166185907;Variant
RS104894828;Fabry Disease;Disease;PA166185908;Variant
RS398123226;Fabry Disease;Disease;PA166185909;Variant
RS727504348;Fabry Disease;Disease;PA166185910;Variant
RS869312136;Fabry Disease;Disease;PA166185911;Variant
RS28935195;Fabry Disease;Disease;PA166185912;Variant
RS104894827;Fabry Disease;Disease;PA166185913;Variant
RS869312138;Fabry Disease;Disease;PA166185914;Variant
RS1569304898;Fabry Disease;Disease;PA166185915;Variant
RS372966991;Fabry Disease;Disease;PA166185916;Variant
RS869312146;Fabry Disease;Disease;PA166185917;Variant
RS398123223;Fabry Disease;Disease;PA166185918;Variant
RS190347120;Fabry Disease;Disease;PA166185919;Variant
RS28935490;Fabry Disease;Disease;PA166185920;Variant
RS397515870;Fabry Disease;Disease;PA166185937;Variant
GLA;Fabry Disease;Disease;PA28707;Gene
CYP2B6;Recurrence free survival;Disease;PA123;Gene
CYP2D6;Recurrence free survival;Disease;PA128;Gene
CYP3A5;Recurrence free survival;Disease;PA131;Gene
CYP2D6*1;Recurrence free survival;Disease;PA165816576;Haplotype
CYP2D6*4;Recurrence free survival;Disease;PA165816579;Haplotype
CYP2D6*10;Recurrence free survival;Disease;PA165816582;Haplotype
CYP2D6*41;Recurrence free survival;Disease;PA165816584;Haplotype
CYP2B6*1;Recurrence free survival;Disease;PA165818750;Haplotype
CYP2B6*5;Recurrence free survival;Disease;PA165818760;Haplotype
CYP2B6*6;Recurrence free survival;Disease;PA165818762;Haplotype
CYP2D6*5;Recurrence free survival;Disease;PA165948092;Haplotype
CYP2D6*1XN;Recurrence free survival;Disease;PA165988479;Haplotype
CYP2D6*21;Recurrence free survival;Disease;PA165988484;Haplotype
CYP2D6*36;Recurrence free survival;Disease;PA165988488;Haplotype
UGT1A1*1;Recurrence free survival;Disease;PA166115841;Haplotype
UGT1A1*28;Recurrence free survival;Disease;PA166115842;Haplotype
CYP2D6*10X2;Recurrence free survival;Disease;PA166123456;Haplotype
CYP3A5*1;Recurrence free survival;Disease;PA166128213;Haplotype
CYP3A5*3;Recurrence free survival;Disease;PA166128219;Haplotype
CYP2D6*14;Recurrence free survival;Disease;PA166181185;Haplotype
RS2228224;Recurrence free survival;Disease;PA166337421;Variant
RS2229300;Recurrence free survival;Disease;PA166337441;Variant
ARHGAP9;Recurrence free survival;Disease;PA24962;Gene
GLI1;Recurrence free survival;Disease;PA28720;Gene
UGT1A1;Recurrence free survival;Disease;PA420;Gene
EYS;HMG CoA reductase inhibitors, other combinations;Chemical;PA164719488;Gene
RS9342288;HMG CoA reductase inhibitors, other combinations;Chemical;PA166179568;Variant
BREAST NEOPLASMS;rs9322335;Variant;PA443560;Disease
EXEMESTANE;rs9322335;Variant;PA449563;Chemical
LETROZOLE;rs9322335;Variant;PA450196;Chemical
BUFURALOL;CYP2D6*12;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*12;Haplotype;PA166127651;Chemical
DEXTROMETHORPHAN;CYP2D6*12;Haplotype;PA449273;Chemical
PRIMAQUINE;CYP2D6*12;Haplotype;PA451103;Chemical
SPARTEINE;CYP2D6*12;Haplotype;PA452610;Chemical
SEVERE CUTANEOUS ADVERSE REACTIONS;PSORS1C3;Gene;PA166120929;Disease
EPIDERMAL NECROLYSIS, TOXIC;PSORS1C3;Gene;PA444059;Disease
STEVENS-JOHNSON SYNDROME;PSORS1C3;Gene;PA445738;Disease
ALLOPURINOL;PSORS1C3;Gene;PA448320;Chemical
ACUTE CORONARY SYNDROME;rs113681054;Variant;PA165108401;Disease
TICAGRELOR;rs113681054;Variant;PA165374673;Chemical
SMALL CELL CARCINOMA;rs16950650;Variant;PA446661;Disease
CISPLATIN;rs16950650;Variant;PA449014;Chemical
IRINOTECAN;rs16950650;Variant;PA450085;Chemical
PSORIASIS;CALM1;Gene;PA445451;Disease
CYCLOSPORINE;CALM1;Gene;PA449167;Chemical
MAJOR DEPRESSIVE DISORDER;rs28364032;Variant;PA447321;Disease
ANTIDEPRESSANTS;rs28364032;Variant;PA452229;Chemical
ABCC2;Platinum compounds;Chemical;PA116;Gene
SLC31A1;Platinum compounds;Chemical;PA118;Gene
MALAT1;Platinum compounds;Chemical;PA134935778;Gene
CXXC4;Platinum compounds;Chemical;PA134992016;Gene
KLC3;Platinum compounds;Chemical;PA142671588;Gene
POLR1G;Platinum compounds;Chemical;PA142672156;Gene
ERCC1;Platinum compounds;Chemical;PA155;Gene
HOTAIR;Platinum compounds;Chemical;PA162391575;Gene
TMEM167A;Platinum compounds;Chemical;PA162405909;Gene
APLF;Platinum compounds;Chemical;PA164715842;Gene
GSTM1 NULL;Platinum compounds;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;Platinum compounds;Chemical;PA166048676;Haplotype
RS1801133;Platinum compounds;Chemical;PA166153644;Variant
RS1127687;Platinum compounds;Chemical;PA166153965;Variant
RS1409314;Platinum compounds;Chemical;PA166153968;Variant
RS2227310;Platinum compounds;Chemical;PA166153999;Variant
RS4353229;Platinum compounds;Chemical;PA166154054;Variant
RS4752219;Platinum compounds;Chemical;PA166154059;Variant
RS4752220;Platinum compounds;Chemical;PA166154060;Variant
RS7091672;Platinum compounds;Chemical;PA166154079;Variant
RS7921977;Platinum compounds;Chemical;PA166154092;Variant
RS10510050;Platinum compounds;Chemical;PA166154111;Variant
RS12415607;Platinum compounds;Chemical;PA166154152;Variant
RS1695;Platinum compounds;Chemical;PA166154249;Variant
RS619586;Platinum compounds;Chemical;PA166154287;Variant
RS716274;Platinum compounds;Chemical;PA166154297;Variant
RS1042927;Platinum compounds;Chemical;PA166154311;Variant
RS2839698;Platinum compounds;Chemical;PA166154388;Variant
RS11030918;Platinum compounds;Chemical;PA166154447;Variant
RS12806698;Platinum compounds;Chemical;PA166154468;Variant
RS7958904;Platinum compounds;Chemical;PA166154606;Variant
RS10878232;Platinum compounds;Chemical;PA166154624;Variant
RS12819505;Platinum compounds;Chemical;PA166154645;Variant
RS9535826;Platinum compounds;Chemical;PA166154736;Variant
RS9535828;Platinum compounds;Chemical;PA166154737;Variant
RS861539;Platinum compounds;Chemical;PA166154768;Variant
RS1799801;Platinum compounds;Chemical;PA166155016;Variant
RS1800566;Platinum compounds;Chemical;PA166155017;Variant
RS1042522;Platinum compounds;Chemical;PA166155173;Variant
RS4541111;Platinum compounds;Chemical;PA166155222;Variant
RS11868547;Platinum compounds;Chemical;PA166155248;Variant
RS11615;Platinum compounds;Chemical;PA166155342;Variant
RS13181;Platinum compounds;Chemical;PA166155343;Variant
RS25487;Platinum compounds;Chemical;PA166155346;Variant
RS1052555;Platinum compounds;Chemical;PA166155361;Variant
RS1799782;Platinum compounds;Chemical;PA166155370;Variant
RS1799793;Platinum compounds;Chemical;PA166155371;Variant
RS3212986;Platinum compounds;Chemical;PA166155407;Variant
RS3213239;Platinum compounds;Chemical;PA166155408;Variant
RS1143623;Platinum compounds;Chemical;PA166155628;Variant
RS3738948;Platinum compounds;Chemical;PA166155704;Variant
RS1051266;Platinum compounds;Chemical;PA166155986;Variant
RS2269577;Platinum compounds;Chemical;PA166156092;Variant
RS4413407;Platinum compounds;Chemical;PA166156586;Variant
RS316019;Platinum compounds;Chemical;PA166156913;Variant
RS1045642;Platinum compounds;Chemical;PA166157284;Variant
RS1128503;Platinum compounds;Chemical;PA166157288;Variant
RS1799983;Platinum compounds;Chemical;PA166157303;Variant
RS2032582;Platinum compounds;Chemical;PA166157316;Variant
RS6983267;Platinum compounds;Chemical;PA166157621;Variant
RS430397;Platinum compounds;Chemical;PA166157705;Variant
RS1800975;Platinum compounds;Chemical;PA166157737;Variant
RS50872;Platinum compounds;Chemical;PA166159977;Variant
RS7170924;Platinum compounds;Chemical;PA166159979;Variant
RS1690924;Platinum compounds;Chemical;PA166159981;Variant
RS12621220;Platinum compounds;Chemical;PA166159984;Variant
RS2027701;Platinum compounds;Chemical;PA166169891;Variant
RS1059698;Platinum compounds;Chemical;PA166169893;Variant
RS1829346;Platinum compounds;Chemical;PA166169895;Variant
RS73594404;Platinum compounds;Chemical;PA166169897;Variant
RS36080650;Platinum compounds;Chemical;PA166169899;Variant
RS10132552;Platinum compounds;Chemical;PA166169901;Variant
RS2298881;Platinum compounds;Chemical;PA166169975;Variant
RS10040363;Platinum compounds;Chemical;PA166169977;Variant
RS2075685;Platinum compounds;Chemical;PA166169979;Variant
RS2228000;Platinum compounds;Chemical;PA166171094;Variant
RS4979223;Platinum compounds;Chemical;PA166179445;Variant
RS4978536;Platinum compounds;Chemical;PA166179452;Variant
RS10817464;Platinum compounds;Chemical;PA166179458;Variant
RS10759637;Platinum compounds;Chemical;PA166179462;Variant
RS2233914;Platinum compounds;Chemical;PA166179466;Variant
GSTM1;Platinum compounds;Chemical;PA182;Gene
GSTT1;Platinum compounds;Chemical;PA183;Gene
MTHFR;Platinum compounds;Chemical;PA245;Gene
AXIN2;Platinum compounds;Chemical;PA25196;Gene
NOS3;Platinum compounds;Chemical;PA254;Gene
CASP7;Platinum compounds;Chemical;PA26091;Gene
ABCB1;Platinum compounds;Chemical;PA267;Gene
DYNC2H1;Platinum compounds;Chemical;PA27433;Gene
EIF3A;Platinum compounds;Chemical;PA27699;Gene
ERCC2;Platinum compounds;Chemical;PA27848;Gene
ERCC3;Platinum compounds;Chemical;PA27849;Gene
ERCC4;Platinum compounds;Chemical;PA27850;Gene
GSTP1;Platinum compounds;Chemical;PA29028;Gene
H19;Platinum compounds;Chemical;PA29091;Gene
HSPA5;Platinum compounds;Chemical;PA29504;Gene
IL16;Platinum compounds;Chemical;PA29793;Gene
RRM1;Platinum compounds;Chemical;PA298;Gene
IL1B;Platinum compounds;Chemical;PA29808;Gene
MDM2;Platinum compounds;Chemical;PA30718;Gene
MEG3;Platinum compounds;Chemical;PA30737;Gene
NQO1;Platinum compounds;Chemical;PA31744;Gene
SLC19A1;Platinum compounds;Chemical;PA327;Gene
SLC22A2;Platinum compounds;Chemical;PA331;Gene
PPP1R13L;Platinum compounds;Chemical;PA34195;Gene
TP53;Platinum compounds;Chemical;PA36679;Gene
XPA;Platinum compounds;Chemical;PA368;Gene
XRCC1;Platinum compounds;Chemical;PA369;Gene
XBP1;Platinum compounds;Chemical;PA37400;Gene
XPC;Platinum compounds;Chemical;PA37413;Gene
XRCC3;Platinum compounds;Chemical;PA37422;Gene
XRCC4;Platinum compounds;Chemical;PA37423;Gene
WNT5B;Platinum compounds;Chemical;PA38104;Gene
WIF1;Platinum compounds;Chemical;PA38291;Gene
ABCG2;Platinum compounds;Chemical;PA390;Gene
ATP7A;Platinum compounds;Chemical;PA72;Gene
ATP7B;Platinum compounds;Chemical;PA73;Gene
GEFITINIB;rs3748022;Variant;PA131301952;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs3748022;Variant;PA443622;Disease
EXANTHEMA;rs3748022;Variant;PA444109;Disease
CYP2C9;naproxen;Chemical;PA126;Gene
CYP2C9*1;naproxen;Chemical;PA165816542;Haplotype
CYP2C9*2;naproxen;Chemical;PA165816543;Haplotype
CYP2C9*3;naproxen;Chemical;PA165816544;Haplotype
CYP2C9*29;naproxen;Chemical;PA165816573;Haplotype
RS182132442;naproxen;Chemical;PA166154220;Variant
RS1800629;naproxen;Chemical;PA166156997;Variant
RS780801862;naproxen;Chemical;PA166209781;Variant
ABCB1;naproxen;Chemical;PA267;Gene
PTGS2;naproxen;Chemical;PA293;Gene
LTA;naproxen;Chemical;PA30474;Gene
LST1;naproxen;Chemical;PA37856;Gene
TNF;naproxen;Chemical;PA435;Gene
TMEM43;Arrhythmogenic Right Ventricular Dysplasia;Disease;PA134871907;Gene
DSC2;Arrhythmogenic Right Ventricular Dysplasia;Disease;PA27489;Gene
DSG2;Arrhythmogenic Right Ventricular Dysplasia;Disease;PA27502;Gene
DSP;Arrhythmogenic Right Ventricular Dysplasia;Disease;PA27505;Gene
PKP2;Arrhythmogenic Right Ventricular Dysplasia;Disease;PA33357;Gene
CES1;sacubitril;Chemical;PA107;Gene
RS71647871;sacubitril;Chemical;PA166155135;Variant
CASR;PLCD3;Gene;PA26097;Gene
PRKCA;PLCD3;Gene;PA33759;Gene
PRKCB;PLCD3;Gene;PA33761;Gene
PRKCG;PLCD3;Gene;PA33766;Gene
PRKCH;PLCD3;Gene;PA33767;Gene
PRKCI;PLCD3;Gene;PA33768;Gene
PRKD1;PLCD3;Gene;PA33771;Gene
PRKCZ;PLCD3;Gene;PA33775;Gene
HYPERTENSION;PLCD3;Gene;PA444552;Disease
DILTIAZEM;PLCD3;Gene;PA449334;Chemical
VARENICLINE;CHRFAM7A;Gene;PA164781343;Chemical
UGT1A1*1;raltitrexed;Chemical;PA166115841;Haplotype
UGT1A1*28;raltitrexed;Chemical;PA166115842;Haplotype
RS45445694;raltitrexed;Chemical;PA166155331;Variant
SLC19A1;raltitrexed;Chemical;PA327;Gene
TYMS;raltitrexed;Chemical;PA359;Gene
UGT1A1;raltitrexed;Chemical;PA420;Gene
ALLOPURINOL;rs76979899;Variant;PA448320;Chemical
RS1076560;rasagiline;Chemical;PA166154313;Variant
RS2283265;rasagiline;Chemical;PA166154364;Variant
DRD2;rasagiline;Chemical;PA27478;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;MAFB;Gene;PA164713366;Chemical
MAPK8;MAFB;Gene;PA283;Gene
MAPK14;MAFB;Gene;PA30621;Gene
RHEUMATOID ARTHRITIS;MAFB;Gene;PA443434;Disease
SN-38;rs34993780;Variant;PA165110775;Chemical
HYPERGLYCEMIA;rs9943291;Variant;PA444522;Disease
HYPERTENSION;rs9943291;Variant;PA444552;Disease
CHLOROTHIAZIDE;rs9943291;Variant;PA448953;Chemical
HYDROCHLOROTHIAZIDE;rs9943291;Variant;PA449899;Chemical
CYTARABINE;rs1163075;Variant;PA449177;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs2295490;Variant;PA447197;Disease
METHYLPHENIDATE;rs2295490;Variant;PA450464;Chemical
DEPRESSION;rs7569963;Variant;PA447278;Disease
CITALOPRAM;rs7569963;Variant;PA449015;Chemical
ANTIDEPRESSANTS;rs7569963;Variant;PA452229;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs2494752;Variant;PA443622;Disease
CARBOPLATIN;rs2494752;Variant;PA448803;Chemical
CISPLATIN;rs2494752;Variant;PA449014;Chemical
ERBB2;tucatinib;Chemical;PA27844;Gene
HRAS;tucatinib;Chemical;PA29444;Gene
KRAS;tucatinib;Chemical;PA30196;Gene
NRAS;tucatinib;Chemical;PA31768;Gene
NR1I2;diethylstilbestrol;Chemical;PA378;Gene
EFAVIRENZ;rs70950385;Variant;PA449441;Chemical
PEGINTERFERON ALFA-2A;rs7248668;Variant;PA164749390;Chemical
PEGINTERFERON ALFA-2B;rs7248668;Variant;PA164784024;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;rs7248668;Variant;PA446863;Disease
RIBAVIRIN;rs7248668;Variant;PA451241;Chemical
TOBACCO USE DISORDER;rs3787140;Variant;PA445876;Disease
NICOTINE;rs3787140;Variant;PA450626;Chemical
COLORECTAL NEOPLASMS;rs4133101;Variant;PA446108;Disease
CELECOXIB;rs4133101;Variant;PA448871;Chemical
TIPIRACIL HYDROCHLORIDE;rs9394992;Variant;PA166171170;Chemical
PANCREATIC NEOPLASMS;rs9394992;Variant;PA445218;Disease
COLORECTAL NEOPLASMS;rs9394992;Variant;PA446108;Disease
GEMCITABINE;rs9394992;Variant;PA449748;Chemical
TRIFLURIDINE;rs9394992;Variant;PA451775;Chemical
BUPROPION;CYP2B6*46;Haplotype;PA448687;Chemical
EFAVIRENZ;CYP2B6*46;Haplotype;PA449441;Chemical
ESCITALOPRAM;rs116692768;Variant;PA10074;Chemical
CITALOPRAM;rs116692768;Variant;PA449015;Chemical
COMT;Parkinson Disease;Disease;PA117;Gene
HOMER1;Parkinson Disease;Disease;PA134972608;Gene
RS1076560;Parkinson Disease;Disease;PA166154313;Variant
RS1799732;Parkinson Disease;Disease;PA166154334;Variant
RS2283265;Parkinson Disease;Disease;PA166154364;Variant
RS4680;Parkinson Disease;Disease;PA166156024;Variant
RS6280;Parkinson Disease;Disease;PA166156277;Variant
RS3836790;Parkinson Disease;Disease;PA166156819;Variant
RS4704559;Parkinson Disease;Disease;PA166156833;Variant
RS622342;Parkinson Disease;Disease;PA166156932;Variant
DRD2;Parkinson Disease;Disease;PA27478;Gene
DRD3;Parkinson Disease;Disease;PA27479;Gene
SLC6A3;Parkinson Disease;Disease;PA311;Gene
SLC22A1;Parkinson Disease;Disease;PA329;Gene
PARK10;Parkinson Disease;Disease;PA32941;Gene
CYP2C9;Heart Diseases;Disease;PA126;Gene
CYP2D6;Heart Diseases;Disease;PA128;Gene
VKORC1;Heart Diseases;Disease;PA133787052;Gene
CYP2C9*1;Heart Diseases;Disease;PA165816542;Haplotype
CYP2C9*2;Heart Diseases;Disease;PA165816543;Haplotype
CYP2C9*3;Heart Diseases;Disease;PA165816544;Haplotype
CYP2D6*1;Heart Diseases;Disease;PA165816576;Haplotype
CYP2D6*2;Heart Diseases;Disease;PA165816577;Haplotype
CYP2D6*3;Heart Diseases;Disease;PA165816578;Haplotype
CYP2D6*4;Heart Diseases;Disease;PA165816579;Haplotype
CYP2D6*6;Heart Diseases;Disease;PA165816581;Haplotype
CYP2D6*10;Heart Diseases;Disease;PA165816582;Haplotype
CYP2D6*5;Heart Diseases;Disease;PA165948092;Haplotype
RS2230345;Heart Diseases;Disease;PA166154001;Variant
RS9923231;Heart Diseases;Disease;PA166155091;Variant
GRK5;Heart Diseases;Disease;PA180;Gene
ARTHRITIS, RHEUMATOID;PLB1;Gene;PA443434;Disease
VITAMIN B-COMPLEX, PLAIN;rs1801133;Variant;PA10505;Chemical
PEMETREXED;rs1801133;Variant;PA10810;Chemical
FLUOROURACIL;rs1801133;Variant;PA128406956;Chemical
OXALIPLATIN;rs1801133;Variant;PA131285527;Chemical
SLCO1B1;rs1801133;Variant;PA134865839;Gene
F2;rs1801133;Variant;PA157;Gene
F5;rs1801133;Variant;PA159;Gene
NEPHROTOXICITY;rs1801133;Variant;PA162263533;Disease
PLATINUM COMPOUNDS;rs1801133;Variant;PA164713176;Chemical
VITAMIN B-COMPLEX, INCL. COMBINATIONS;rs1801133;Variant;PA164713398;Chemical
TOXIC LIVER DISEASE;rs1801133;Variant;PA164925725;Disease
ETHINYL ESTRADIOL / NORELGESTROMIN;rs1801133;Variant;PA165290929;Chemical
MYELOSUPPRESSION;rs1801133;Variant;PA165817398;Disease
MUCOSITIS;rs1801133;Variant;PA166122058;Disease
L-METHYLFOLATE;rs1801133;Variant;PA166182939;Chemical
PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA;rs1801133;Variant;PA166252441;Disease
MTHFR;rs1801133;Variant;PA245;Gene
ABCB1;rs1801133;Variant;PA267;Gene
SLC19A1;rs1801133;Variant;PA327;Gene
PROC;rs1801133;Variant;PA33799;Gene
PROS1;rs1801133;Variant;PA33809;Gene
SERPINC1;rs1801133;Variant;PA35026;Gene
JUVENILE RHEUMATOID ARTHRITIS;rs1801133;Variant;PA443433;Disease
RHEUMATOID ARTHRITIS;rs1801133;Variant;PA443434;Disease
BURKITT LYMPHOMA;rs1801133;Variant;PA443580;Disease
NON-SMALL CELL LUNG CARCINOMA;rs1801133;Variant;PA443622;Disease
COLONIC NEOPLASMS;rs1801133;Variant;PA443756;Disease
CORONARY ARTERY DISEASE;rs1801133;Variant;PA443796;Disease
DRUG TOXICITY;rs1801133;Variant;PA443937;Disease
EPILEPSY;rs1801133;Variant;PA444065;Disease
GRAFT VS HOST DISEASE;rs1801133;Variant;PA444320;Disease
HYPERTENSION;rs1801133;Variant;PA444552;Disease
LEUKEMIA;rs1801133;Variant;PA444750;Disease
LEUKOPENIA;rs1801133;Variant;PA444773;Disease
LYMPHOMA;rs1801133;Variant;PA444840;Disease
MESOTHELIOMA;rs1801133;Variant;PA444937;Disease
MYOCARDIAL INFARCTION;rs1801133;Variant;PA445019;Disease
NEOPLASMS;rs1801133;Variant;PA445062;Disease
NEUTROPENIA;rs1801133;Variant;PA445113;Disease
OSTEOSARCOMA;rs1801133;Variant;PA445601;Disease
THROMBOCYTOPENIA;rs1801133;Variant;PA445846;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs1801133;Variant;PA446155;Disease
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;rs1801133;Variant;PA446171;Disease
ARTHRITIS, PSORIATIC;rs1801133;Variant;PA446198;Disease
LYMPHOMA, T-CELL;rs1801133;Variant;PA446309;Disease
COCAINE DEPENDENCE;rs1801133;Variant;PA446878;Disease
PSYCHOTIC DISORDER;rs1801133;Variant;PA447215;Disease
SCHIZOPHRENIA;rs1801133;Variant;PA447216;Disease
MAJOR DEPRESSIVE DISORDER;rs1801133;Variant;PA447321;Disease
BENAZEPRIL;rs1801133;Variant;PA448561;Chemical
CAPECITABINE;rs1801133;Variant;PA448771;Chemical
CISPLATIN;rs1801133;Variant;PA449014;Chemical
DISULFIRAM;rs1801133;Variant;PA449376;Chemical
DOXORUBICIN;rs1801133;Variant;PA449412;Chemical
FOLIC ACID;rs1801133;Variant;PA449692;Chemical
LEUCOVORIN;rs1801133;Variant;PA450198;Chemical
MERCAPTOPURINE;rs1801133;Variant;PA450379;Chemical
METHOTREXATE;rs1801133;Variant;PA450428;Chemical
NITROUS OXIDE;rs1801133;Variant;PA450645;Chemical
PHENOBARBITAL;rs1801133;Variant;PA450911;Chemical
PHENYTOIN;rs1801133;Variant;PA450947;Chemical
PRAVASTATIN;rs1801133;Variant;PA451089;Chemical
ANTIPSYCHOTICS;rs1801133;Variant;PA452233;Chemical
MAPK8;BATF;Gene;PA283;Gene
MAPK14;BATF;Gene;PA30621;Gene
MEPHENYTOIN;rs28399504;Variant;PA450373;Chemical
OPIOID-RELATED DISORDERS;rs1022563;Variant;PA445043;Disease
OPIOIDS;rs1022563;Variant;PA452618;Chemical
IVACAFTOR;rs34911792;Variant;PA165950341;Chemical
CYSTIC FIBROSIS;rs34911792;Variant;PA443829;Disease
HIV INFECTIOUS DISEASE;rs8192719;Variant;PA447230;Disease
EFAVIRENZ;rs8192719;Variant;PA449441;Chemical
EVEROLIMUS;rs2024627;Variant;PA164746311;Chemical
BREAST NEOPLASMS;rs2024627;Variant;PA443560;Disease
KIDNEY NEOPLASMS;rs2024627;Variant;PA444685;Disease
NEUROENDOCRINE TUMORS;rs2024627;Variant;PA446713;Disease
ABCC2;sorafenib;Chemical;PA116;Gene
CYP2B6;sorafenib;Chemical;PA123;Gene
CYP2C8;sorafenib;Chemical;PA125;Gene
CYP2C9;sorafenib;Chemical;PA126;Gene
CYP3A4;sorafenib;Chemical;PA130;Gene
SLCO1B1;sorafenib;Chemical;PA134865839;Gene
PIK3R5;sorafenib;Chemical;PA134890823;Gene
GALNT14;sorafenib;Chemical;PA134920089;Gene
UGT1A1*1;sorafenib;Chemical;PA166115841;Haplotype
UGT1A1*28;sorafenib;Chemical;PA166115842;Haplotype
RS717620;sorafenib;Chemical;PA166153953;Variant
RS2306283;sorafenib;Chemical;PA166154547;Variant
RS4149056;sorafenib;Chemical;PA166154579;Variant
RS3832043;sorafenib;Chemical;PA166155718;Variant
RS7574296;sorafenib;Chemical;PA166155765;Variant
RS9679162;sorafenib;Chemical;PA166155774;Variant
RS17868320;sorafenib;Chemical;PA166155855;Variant
RS1870377;sorafenib;Chemical;PA166156528;Variant
RS2071559;sorafenib;Chemical;PA166156537;Variant
RS2239702;sorafenib;Chemical;PA166156547;Variant
RS4604006;sorafenib;Chemical;PA166156591;Variant
RS1570360;sorafenib;Chemical;PA166156985;Variant
RS1800629;sorafenib;Chemical;PA166156997;Variant
RS2010963;sorafenib;Chemical;PA166157006;Variant
RS1045642;sorafenib;Chemical;PA166157284;Variant
RS1799983;sorafenib;Chemical;PA166157303;Variant
RS2070744;sorafenib;Chemical;PA166157325;Variant
RS2257212;sorafenib;Chemical;PA166159807;Variant
RS11549465;sorafenib;Chemical;PA166159812;Variant
RS3025040;sorafenib;Chemical;PA166159965;Variant
RS444904;sorafenib;Chemical;PA166283281;Variant
RS4864950;sorafenib;Chemical;PA166283282;Variant
RS1346563;sorafenib;Chemical;PA166283381;Variant
RS11125039;sorafenib;Chemical;PA166283383;Variant
RS2330951;sorafenib;Chemical;PA166283401;Variant
RS917881;sorafenib;Chemical;PA166283442;Variant
RS17682789;sorafenib;Chemical;PA166283521;Variant
RS11651488;sorafenib;Chemical;PA166283542;Variant
RS9927200;sorafenib;Chemical;PA166283544;Variant
RS12366035;sorafenib;Chemical;PA166283581;Variant
RS1868089;sorafenib;Chemical;PA166283641;Variant
RS7557402;sorafenib;Chemical;PA166283681;Variant
RS10958704;sorafenib;Chemical;PA166283702;Variant
RS12948059;sorafenib;Chemical;PA166283722;Variant
RS4035887;sorafenib;Chemical;PA166283741;Variant
RS315498;sorafenib;Chemical;PA166283743;Variant
RS9973653;sorafenib;Chemical;PA166283762;Variant
ADAMTS18;sorafenib;Chemical;PA24544;Gene
ARAF;sorafenib;Chemical;PA24928;Gene
NOS3;sorafenib;Chemical;PA254;Gene
BRAF;sorafenib;Chemical;PA25408;Gene
CDH13;sorafenib;Chemical;PA26287;Gene
ABCB1;sorafenib;Chemical;PA267;Gene
EPAS1;sorafenib;Chemical;PA27809;Gene
FGFR1;sorafenib;Chemical;PA28127;Gene
FLT1;sorafenib;Chemical;PA28180;Gene
FLT3;sorafenib;Chemical;PA28181;Gene
FLT4;sorafenib;Chemical;PA28183;Gene
MAPK8;sorafenib;Chemical;PA283;Gene
HIF1A;sorafenib;Chemical;PA29283;Gene
KDR;sorafenib;Chemical;PA30086;Gene
KIT;sorafenib;Chemical;PA30128;Gene
MAP2K6;sorafenib;Chemical;PA30591;Gene
MAPK1;sorafenib;Chemical;PA30616;Gene
MAPK10;sorafenib;Chemical;PA30617;Gene
MAPK11;sorafenib;Chemical;PA30618;Gene
MAPK12;sorafenib;Chemical;PA30619;Gene
MAPK13;sorafenib;Chemical;PA30620;Gene
MAPK14;sorafenib;Chemical;PA30621;Gene
MAPK3;sorafenib;Chemical;PA30622;Gene
MAPK4;sorafenib;Chemical;PA30623;Gene
MAPK6;sorafenib;Chemical;PA30624;Gene
MAPK7;sorafenib;Chemical;PA30625;Gene
MAPK9;sorafenib;Chemical;PA30630;Gene
SLC22A1;sorafenib;Chemical;PA329;Gene
PDGFRB;sorafenib;Chemical;PA33148;Gene
PRKCE;sorafenib;Chemical;PA33765;Gene
RAF1;sorafenib;Chemical;PA34183;Gene
RET;sorafenib;Chemical;PA34335;Gene
SLC15A2;sorafenib;Chemical;PA35812;Gene
VEGFA;sorafenib;Chemical;PA37302;Gene
VEGFB;sorafenib;Chemical;PA37303;Gene
WWOX;sorafenib;Chemical;PA37398;Gene
UGT1A9;sorafenib;Chemical;PA419;Gene
UGT1A1;sorafenib;Chemical;PA420;Gene
TNF;sorafenib;Chemical;PA435;Gene
EGFR;sorafenib;Chemical;PA7360;Gene
CYP11B2;imidapril;Chemical;PA134;Gene
RS5051;imidapril;Chemical;PA166153547;Variant
RS1799722;imidapril;Chemical;PA166154785;Variant
RS1799998;imidapril;Chemical;PA166157566;Variant
AGT;imidapril;Chemical;PA42;Gene
BDKRB2;imidapril;Chemical;PA80;Gene
RS6500265;salicylamide;Chemical;PA166176206;Variant
RS9933632;salicylamide;Chemical;PA166176208;Variant
G6PD;Ascorbic acid (vitamin C), combinations;Chemical;PA28469;Gene
FLUOROURACIL;rs1056836;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs1056836;Variant;PA443560;Disease
CYCLOPHOSPHAMIDE;rs1056836;Variant;PA449165;Chemical
DOXORUBICIN;rs1056836;Variant;PA449412;Chemical
EPIRUBICIN;rs1056836;Variant;PA449476;Chemical
PACLITAXEL;rs1056836;Variant;PA450761;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs10945919;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs10945919;Variant;PA443434;Disease
LEUKEMIA, MYELOID, ACUTE;rs1883112;Variant;PA444760;Disease
NEOPLASMS;rs1883112;Variant;PA445062;Disease
DOXORUBICIN;rs1883112;Variant;PA449412;Chemical
IDARUBICIN;rs1883112;Variant;PA449961;Chemical
ALCOHOL ABUSE;rs61974485;Variant;PA443309;Disease
ETHANOL;rs61974485;Variant;PA448073;Chemical
DIURETICS;rs2273359;Variant;PA151249535;Chemical
THIAZIDES, PLAIN;rs2273359;Variant;PA164713347;Chemical
HYPERTENSION;rs2273359;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs2273359;Variant;PA449899;Chemical
HMG COA REDUCTASE INHIBITORS;rs352046;Variant;PA133950441;Chemical
ACUTE CORONARY SYNDROME;rs352046;Variant;PA165108401;Disease
RS1799971;Sympathomimetics;Chemical;PA166156991;Variant
OPRM1;Sympathomimetics;Chemical;PA31945;Gene
RS1803274;Cognitive disorder;Disease;PA166156332;Variant
BCHE;Cognitive disorder;Disease;PA25294;Gene
IRRITABLE BOWEL SYNDROME;rs79206939;Variant;PA166048887;Disease
LEUKOPENIA;rs79206939;Variant;PA444773;Disease
AZATHIOPRINE;rs79206939;Variant;PA448515;Chemical
MERCAPTOPURINE;rs79206939;Variant;PA450379;Chemical
MAJOR DEPRESSIVE DISORDER;rs2742435;Variant;PA447321;Disease
BUPROPION;rs2742435;Variant;PA448687;Chemical
HIV INFECTIOUS DISEASE;rs36118214;Variant;PA447230;Disease
EFAVIRENZ;rs36118214;Variant;PA449441;Chemical
RS113488022;binimetinib;Chemical;PA166157522;Variant
BRAF;binimetinib;Chemical;PA25408;Gene
UGT1A1;binimetinib;Chemical;PA420;Gene
DULOXETINE;rs10989064;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs10989064;Variant;PA447321;Disease
MENTAL DISORDERS;rs3813929;Variant;PA447208;Disease
SCHIZOPHRENIA;rs3813929;Variant;PA447216;Disease
CLOZAPINE;rs3813929;Variant;PA449061;Chemical
OLANZAPINE;rs3813929;Variant;PA450688;Chemical
RISPERIDONE;rs3813929;Variant;PA451257;Chemical
ANTIPSYCHOTICS;rs3813929;Variant;PA452233;Chemical
GALNS;elosulfase alfa;Chemical;PA28535;Gene
DIABETES MELLITUS;rs12943590;Variant;PA443886;Disease
METFORMIN;rs12943590;Variant;PA450395;Chemical
ESCITALOPRAM;CYP2C19*2;Haplotype;PA10074;Chemical
ESOMEPRAZOLE;CYP2C19*2;Haplotype;PA10075;Chemical
VORICONAZOLE;CYP2C19*2;Haplotype;PA10233;Chemical
SULFONAMIDES, UREA DERIVATIVES;CYP2C19*2;Haplotype;PA10390;Chemical
CLOBAZAM;CYP2C19*2;Haplotype;PA10888;Chemical
CYP2C19;CYP2C19*2;Haplotype;PA124;Gene
3,4-METHYLENEDIOXYMETHAMPHETAMINE;CYP2C19*2;Haplotype;PA131887008;Chemical
ROSUVASTATIN;CYP2C19*2;Haplotype;PA134308647;Chemical
ATOMOXETINE;CYP2C19*2;Haplotype;PA134688071;Chemical
PERIPHERAL VASCULAR DISEASES;CYP2C19*2;Haplotype;PA153619833;Disease
PRASUGREL;CYP2C19*2;Haplotype;PA154410481;Chemical
METABOLIC SYNDROME;CYP2C19*2;Haplotype;PA162370415;Disease
LABETALOL;CYP2C19*2;Haplotype;PA164743150;Chemical
CILOSTAZOL;CYP2C19*2;Haplotype;PA164746334;Chemical
ACUTE CORONARY SYNDROME;CYP2C19*2;Haplotype;PA165108401;Disease
SUICIDE;CYP2C19*2;Haplotype;PA165374639;Disease
KIDNEY TRANSPLANTATION;CYP2C19*2;Haplotype;PA165817016;Disease
AMBRISENTAN;CYP2C19*2;Haplotype;PA165860521;Chemical
DESVENLAFAXINE;CYP2C19*2;Haplotype;PA165958374;Chemical
HELICOBACTER INFECTIONS;CYP2C19*2;Haplotype;PA166048740;Disease
DEXLANSOPRAZOLE;CYP2C19*2;Haplotype;PA166110257;Chemical
LUNG TRANSPLANTATION;CYP2C19*2;Haplotype;PA166114457;Disease
ICOTINIB;CYP2C19*2;Haplotype;PA166114460;Chemical
HEMATOPOIETIC STEM CELL TRANSPLANTATION;CYP2C19*2;Haplotype;PA166123007;Disease
INTRAGASTRIC PH;CYP2C19*2;Haplotype;PA166123203;Disease
OVERALL SURVIVAL;CYP2C19*2;Haplotype;PA166123207;Disease
EVENT-FREE SURVIVAL;CYP2C19*2;Haplotype;PA166123366;Disease
DISCONTINUATION;CYP2C19*2;Haplotype;PA166123507;Disease
PLATELET AGGREGATION;CYP2C19*2;Haplotype;PA166123766;Disease
PLATELET REACTIVITY;CYP2C19*2;Haplotype;PA166124406;Disease
TREATMENT FAILURE;CYP2C19*2;Haplotype;PA166128095;Disease
DIPYRONE;CYP2C19*2;Haplotype;PA166128206;Chemical
MAJOR ADVERSE CARDIAC EVENTS (MACE);CYP2C19*2;Haplotype;PA166129560;Disease
DESMETHYL CLOMIPRAMINE;CYP2C19*2;Haplotype;PA166131507;Chemical
ADVERSE EVENTS;CYP2C19*2;Haplotype;PA166151827;Disease
BRIVARACETAM;CYP2C19*2;Haplotype;PA166153491;Chemical
HIGH ON-TREATMENT PLATELET REACTIVITY;CYP2C19*2;Haplotype;PA166163563;Disease
ADVERSE CARDIOVASCULAR EVENTS;CYP2C19*2;Haplotype;PA166165020;Disease
PHENAZEPAM;CYP2C19*2;Haplotype;PA166180939;Chemical
BELZUTIFAN;CYP2C19*2;Haplotype;PA166268761;Chemical
MAVACAMTEN;CYP2C19*2;Haplotype;PA166272922;Chemical
UGT2B17;CYP2C19*2;Haplotype;PA37189;Gene
ALCOHOLISM;CYP2C19*2;Haplotype;PA443309;Disease
ANGINA PECTORIS;CYP2C19*2;Haplotype;PA443362;Disease
ARTHRITIS, RHEUMATOID;CYP2C19*2;Haplotype;PA443434;Disease
ASTHMA;CYP2C19*2;Haplotype;PA443450;Disease
ATRIAL FIBRILLATION;CYP2C19*2;Haplotype;PA443459;Disease
BREAST NEOPLASMS;CYP2C19*2;Haplotype;PA443560;Disease
CARDIOVASCULAR DISEASES;CYP2C19*2;Haplotype;PA443635;Disease
CAROTID ARTERY DISEASES;CYP2C19*2;Haplotype;PA443636;Disease
ISCHEMIC ATTACK, TRANSIENT;CYP2C19*2;Haplotype;PA443672;Disease
CEREBROVASCULAR DISORDERS;CYP2C19*2;Haplotype;PA443678;Disease
CORONARY ARTERY DISEASE;CYP2C19*2;Haplotype;PA443796;Disease
CORONARY DISEASE;CYP2C19*2;Haplotype;PA443797;Disease
CYSTIC FIBROSIS;CYP2C19*2;Haplotype;PA443829;Disease
DEATH;CYP2C19*2;Haplotype;PA443842;Disease
DIABETES MELLITUS, TYPE 2;CYP2C19*2;Haplotype;PA443890;Disease
DRUG TOXICITY;CYP2C19*2;Haplotype;PA443937;Disease
EPILEPSY;CYP2C19*2;Haplotype;PA444065;Disease
ESOPHAGITIS;CYP2C19*2;Haplotype;PA444104;Disease
GASTROESOPHAGEAL REFLUX;CYP2C19*2;Haplotype;PA444255;Disease
HALLUCINATIONS;CYP2C19*2;Haplotype;PA444339;Disease
HEMATOLOGIC DISEASES;CYP2C19*2;Haplotype;PA444395;Disease
HEMORRHAGE;CYP2C19*2;Haplotype;PA444417;Disease
HEPATITIS C;CYP2C19*2;Haplotype;PA444445;Disease
HYPERPROLACTINEMIA;CYP2C19*2;Haplotype;PA444545;Disease
LYMPHOMA;CYP2C19*2;Haplotype;PA444840;Disease
LYMPHOMA, NON-HODGKIN;CYP2C19*2;Haplotype;PA444845;Disease
MALARIA;CYP2C19*2;Haplotype;PA444859;Disease
MYCOSES;CYP2C19*2;Haplotype;PA445009;Disease
MYOCARDIAL INFARCTION;CYP2C19*2;Haplotype;PA445019;Disease
NEOPLASMS;CYP2C19*2;Haplotype;PA445062;Disease
PANCREATIC NEOPLASMS;CYP2C19*2;Haplotype;PA445218;Disease
RECURRENCE;CYP2C19*2;Haplotype;PA445506;Disease
RESPIRATORY TRACT INFECTIONS;CYP2C19*2;Haplotype;PA445526;Disease
SHOCK, SEPTIC;CYP2C19*2;Haplotype;PA445647;Disease
THROMBOSIS;CYP2C19*2;Haplotype;PA445850;Disease
ULCER;CYP2C19*2;Haplotype;PA445973;Disease
MYOCARDIAL ISCHEMIA;CYP2C19*2;Haplotype;PA446459;Disease
STROKE;CYP2C19*2;Haplotype;PA447054;Disease
ANXIETY DISORDERS;CYP2C19*2;Haplotype;PA447196;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CYP2C19*2;Haplotype;PA447197;Disease
BIPOLAR DISORDER;CYP2C19*2;Haplotype;PA447199;Disease
DEPRESSIVE DISORDER;CYP2C19*2;Haplotype;PA447207;Disease
MENTAL DISORDERS;CYP2C19*2;Haplotype;PA447208;Disease
OBSESSIVE-COMPULSIVE DISORDER;CYP2C19*2;Haplotype;PA447211;Disease
PANIC DISORDER;CYP2C19*2;Haplotype;PA447212;Disease
SCHIZOPHRENIA;CYP2C19*2;Haplotype;PA447216;Disease
PEPTIC ULCER;CYP2C19*2;Haplotype;PA447240;Disease
DEPRESSION;CYP2C19*2;Haplotype;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2C19*2;Haplotype;PA447321;Disease
CORONARY RESTENOSIS;CYP2C19*2;Haplotype;PA447325;Disease
AMITRIPTYLINE;CYP2C19*2;Haplotype;PA448385;Chemical
AMOXICILLIN;CYP2C19*2;Haplotype;PA448406;Chemical
ASPIRIN;CYP2C19*2;Haplotype;PA448497;Chemical
ATORVASTATIN;CYP2C19*2;Haplotype;PA448500;Chemical
BUPROPION;CYP2C19*2;Haplotype;PA448687;Chemical
CARISOPRODOL;CYP2C19*2;Haplotype;PA448809;Chemical
CITALOPRAM;CYP2C19*2;Haplotype;PA449015;Chemical
CLOMIPRAMINE;CYP2C19*2;Haplotype;PA449048;Chemical
CLOPIDOGREL;CYP2C19*2;Haplotype;PA449053;Chemical
CLOZAPINE;CYP2C19*2;Haplotype;PA449061;Chemical
CYCLOPHOSPHAMIDE;CYP2C19*2;Haplotype;PA449165;Chemical
DIAZEPAM;CYP2C19*2;Haplotype;PA449283;Chemical
DOXEPIN;CYP2C19*2;Haplotype;PA449409;Chemical
EFAVIRENZ;CYP2C19*2;Haplotype;PA449441;Chemical
FLUOXETINE;CYP2C19*2;Haplotype;PA449673;Chemical
IMIPRAMINE;CYP2C19*2;Haplotype;PA449969;Chemical
LANSOPRAZOLE;CYP2C19*2;Haplotype;PA450180;Chemical
LEFLUNOMIDE;CYP2C19*2;Haplotype;PA450192;Chemical
MEPHENYTOIN;CYP2C19*2;Haplotype;PA450373;Chemical
METHYLPHENOBARBITAL;CYP2C19*2;Haplotype;PA450374;Chemical
METHADONE;CYP2C19*2;Haplotype;PA450401;Chemical
NELFINAVIR;CYP2C19*2;Haplotype;PA450606;Chemical
NORTRIPTYLINE;CYP2C19*2;Haplotype;PA450657;Chemical
OMEPRAZOLE;CYP2C19*2;Haplotype;PA450704;Chemical
PANTOPRAZOLE;CYP2C19*2;Haplotype;PA450774;Chemical
PHENOBARBITAL;CYP2C19*2;Haplotype;PA450911;Chemical
PHENPROCOUMON;CYP2C19*2;Haplotype;PA450921;Chemical
PHENYTOIN;CYP2C19*2;Haplotype;PA450947;Chemical
PROGESTERONE;CYP2C19*2;Haplotype;PA451123;Chemical
PROGUANIL;CYP2C19*2;Haplotype;PA451124;Chemical
QUETIAPINE;CYP2C19*2;Haplotype;PA451201;Chemical
RABEPRAZOLE;CYP2C19*2;Haplotype;PA451216;Chemical
SERTRALINE;CYP2C19*2;Haplotype;PA451333;Chemical
TACROLIMUS;CYP2C19*2;Haplotype;PA451578;Chemical
TAMOXIFEN;CYP2C19*2;Haplotype;PA451581;Chemical
TRIMIPRAMINE;CYP2C19*2;Haplotype;PA451791;Chemical
VALPROIC ACID;CYP2C19*2;Haplotype;PA451846;Chemical
VENLAFAXINE;CYP2C19*2;Haplotype;PA451866;Chemical
WARFARIN;CYP2C19*2;Haplotype;PA451906;Chemical
ANTIDEPRESSANTS;CYP2C19*2;Haplotype;PA452229;Chemical
ANTINEOPLASTIC AGENTS;CYP2C19*2;Haplotype;PA452621;Chemical
ACENOCOUMAROL;CYP2C19*2;Haplotype;PA452632;Chemical
TIME TO THERAPEUTIC INR;CYP4F2*3;Haplotype;PA166129532;Disease
VITAMIN K1;CYP4F2*3;Haplotype;PA166197681;Chemical
ATRIAL FIBRILLATION;CYP4F2*3;Haplotype;PA443459;Disease
HEMORRHAGE;CYP4F2*3;Haplotype;PA444417;Disease
WARFARIN;CYP4F2*3;Haplotype;PA451906;Chemical
OPIOID-RELATED DISORDERS;TH;Gene;PA445043;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;TH;Gene;PA447197;Disease
METHYLPHENIDATE;TH;Gene;PA450464;Chemical
METYROSINE;TH;Gene;PA450487;Chemical
OPIOIDS;TH;Gene;PA452618;Chemical
UGT1A1*28;Rhabdomyosarcoma, Alveolar;Disease;PA166115842;Haplotype
UGT1A1;Rhabdomyosarcoma, Alveolar;Disease;PA420;Gene
ARIPIPRAZOLE;HLA-B;Gene;PA10026;Chemical
DULOXETINE;HLA-B;Gene;PA10066;Chemical
ESCITALOPRAM;HLA-B;Gene;PA10074;Chemical
SULFAMETHOXAZOLE / TRIMETHOPRIM;HLA-B;Gene;PA10715;Chemical
ANTIEPILEPTICS;HLA-B;Gene;PA143485705;Chemical
LAPATINIB;HLA-B;Gene;PA152241907;Chemical
NEUROPATHIC PAIN;HLA-B;Gene;PA162263525;Disease
MACULOPAPULAR EXANTHEMA;HLA-B;Gene;PA162316739;Disease
ANTITHYROID PREPARATIONS;HLA-B;Gene;PA164712499;Chemical
MEASLES VACCINES;HLA-B;Gene;PA164712887;Chemical
RUBELLA VACCINES;HLA-B;Gene;PA164713242;Chemical
CARBIMAZOLE;HLA-B;Gene;PA164742970;Chemical
CLAVULANATE;HLA-B;Gene;PA164742987;Chemical
PENICILLIN V;HLA-B;Gene;PA164745442;Chemical
FOSPHENYTOIN;HLA-B;Gene;PA164746820;Chemical
PEGINTERFERON ALFA-2A;HLA-B;Gene;PA164749390;Chemical
INTERFERON ALFA-2A, RECOMBINANT;HLA-B;Gene;PA164779048;Chemical
FLUCLOXACILLIN;HLA-B;Gene;PA164781042;Chemical
DIVALPROEX SODIUM;HLA-B;Gene;PA164783479;Chemical
PEGINTERFERON ALFA-2B;HLA-B;Gene;PA164784024;Chemical
TOXIC LIVER DISEASE;HLA-B;Gene;PA164925725;Disease
PAZOPANIB;HLA-B;Gene;PA165291492;Chemical
CYP2C9*2;HLA-B;Gene;PA165816543;Haplotype
CYP2C9*3;HLA-B;Gene;PA165816544;Haplotype
HLA-A*31:01;HLA-B;Gene;PA165954030;Haplotype
HLA-B*15:02;HLA-B;Gene;PA165954769;Haplotype
HLA-B*15:11;HLA-B;Gene;PA165954787;Haplotype
HLA-B*51:01;HLA-B;Gene;PA165956201;Haplotype
HLA-B*57:01;HLA-B;Gene;PA165987830;Haplotype
HLA-B*58:01;HLA-B;Gene;PA165987831;Haplotype
BEHCET SYNDROME;HLA-B;Gene;PA166048807;Disease
HYPERURICEMIA;HLA-B;Gene;PA166048814;Disease
SOFT TISSUE NEOPLASMS;HLA-B;Gene;PA166048850;Disease
TRICHLOROETHYLENE;HLA-B;Gene;PA166115521;Chemical
UGT1A1*28;HLA-B;Gene;PA166115842;Haplotype
DRUG-INDUCED LIVER INJURY;HLA-B;Gene;PA166119041;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B;Gene;PA166120927;Disease
ERYTHEMA EXUDATIVUM MULTIFORME;HLA-B;Gene;PA166120928;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-B;Gene;PA166120929;Disease
SCHIZOAFFECTIVE DISORDER;HLA-B;Gene;PA166123368;Disease
SCHIZENCEPHALY;HLA-B;Gene;PA166152644;Disease
LAMIVUDINE / ABACAVIR;HLA-B;Gene;PA166184501;Chemical
ZIDOVUDINE / LAMIVUDINE / ABACAVIR;HLA-B;Gene;PA166184503;Chemical
DOLUTEGRAVIR / ABACAVIR / LAMIVUDINE;HLA-B;Gene;PA166184505;Chemical
CABOTEGRAVIR / RILPIVIRINE;HLA-B;Gene;PA166251381;Chemical
AGRANULOCYTOSIS;HLA-B;Gene;PA443297;Disease
BREAST NEOPLASMS;HLA-B;Gene;PA443560;Disease
CARCINOMA, RENAL CELL;HLA-B;Gene;PA443624;Disease
DRUG HYPERSENSITIVITY;HLA-B;Gene;PA443936;Disease
DRUG TOXICITY;HLA-B;Gene;PA443937;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B;Gene;PA444059;Disease
EPILEPSY;HLA-B;Gene;PA444065;Disease
EXANTHEMA;HLA-B;Gene;PA444109;Disease
GLAUCOMA;HLA-B;Gene;PA444281;Disease
GRAVES DISEASE;HLA-B;Gene;PA444329;Disease
HEPATITIS C;HLA-B;Gene;PA444445;Disease
HYPERSENSITIVITY;HLA-B;Gene;PA444546;Disease
KIDNEY FAILURE, CHRONIC;HLA-B;Gene;PA444684;Disease
LEPROSY;HLA-B;Gene;PA444745;Disease
MALARIA;HLA-B;Gene;PA444859;Disease
MULTIPLE SCLEROSIS;HLA-B;Gene;PA444987;Disease
OVARIAN NEOPLASMS;HLA-B;Gene;PA445204;Disease
RESPIRATORY INSUFFICIENCY;HLA-B;Gene;PA445522;Disease
SARCOMA;HLA-B;Gene;PA445594;Disease
SEIZURES;HLA-B;Gene;PA445629;Disease
SKIN DISEASES;HLA-B;Gene;PA445676;Disease
SPONDYLITIS, ANKYLOSING;HLA-B;Gene;PA445724;Disease
STEVENS-JOHNSON SYNDROME;HLA-B;Gene;PA445738;Disease
TUBERCULOSIS;HLA-B;Gene;PA445941;Disease
ARTHRITIS, GOUTY;HLA-B;Gene;PA446114;Disease
HEMATOLOGIC NEOPLASMS;HLA-B;Gene;PA446827;Disease
BIPOLAR DISORDER;HLA-B;Gene;PA447199;Disease
MOOD DISORDERS;HLA-B;Gene;PA447209;Disease
SCHIZOPHRENIA;HLA-B;Gene;PA447216;Disease
HIV INFECTIONS;HLA-B;Gene;PA447230;Disease
ABACAVIR;HLA-B;Gene;PA448004;Chemical
ACETAMINOPHEN;HLA-B;Gene;PA448015;Chemical
ACETAZOLAMIDE;HLA-B;Gene;PA448018;Chemical
ALLOPURINOL;HLA-B;Gene;PA448320;Chemical
AMITRIPTYLINE;HLA-B;Gene;PA448385;Chemical
AMOXICILLIN;HLA-B;Gene;PA448406;Chemical
BUPROPION;HLA-B;Gene;PA448687;Chemical
BUSPIRONE;HLA-B;Gene;PA448689;Chemical
CARBAMAZEPINE;HLA-B;Gene;PA448785;Chemical
CITALOPRAM;HLA-B;Gene;PA449015;Chemical
CLINDAMYCIN;HLA-B;Gene;PA449035;Chemical
CLOZAPINE;HLA-B;Gene;PA449061;Chemical
DAPSONE;HLA-B;Gene;PA449211;Chemical
DIAZEPAM;HLA-B;Gene;PA449283;Chemical
FLUOXETINE;HLA-B;Gene;PA449673;Chemical
INTERFERON BETA-1A;HLA-B;Gene;PA450037;Chemical
ISONIAZID;HLA-B;Gene;PA450112;Chemical
LAMIVUDINE;HLA-B;Gene;PA450163;Chemical
LAMOTRIGINE;HLA-B;Gene;PA450164;Chemical
METHAZOLAMIDE;HLA-B;Gene;PA450413;Chemical
METHIMAZOLE;HLA-B;Gene;PA450422;Chemical
MINOCYCLINE;HLA-B;Gene;PA450519;Chemical
MIRTAZAPINE;HLA-B;Gene;PA450522;Chemical
MODAFINIL;HLA-B;Gene;PA450530;Chemical
NEVIRAPINE;HLA-B;Gene;PA450616;Chemical
NORTRIPTYLINE;HLA-B;Gene;PA450657;Chemical
OLANZAPINE;HLA-B;Gene;PA450688;Chemical
OXCARBAZEPINE;HLA-B;Gene;PA450732;Chemical
PAROXETINE;HLA-B;Gene;PA450801;Chemical
PENICILLIN G;HLA-B;Gene;PA450842;Chemical
PHENOBARBITAL;HLA-B;Gene;PA450911;Chemical
PHENYTOIN;HLA-B;Gene;PA450947;Chemical
PROPYLTHIOURACIL;HLA-B;Gene;PA451156;Chemical
QUETIAPINE;HLA-B;Gene;PA451201;Chemical
RIBAVIRIN;HLA-B;Gene;PA451241;Chemical
RISPERIDONE;HLA-B;Gene;PA451257;Chemical
SERTRALINE;HLA-B;Gene;PA451333;Chemical
STAVUDINE;HLA-B;Gene;PA451494;Chemical
SULFASALAZINE;HLA-B;Gene;PA451547;Chemical
TICLOPIDINE;HLA-B;Gene;PA451686;Chemical
TRAZODONE;HLA-B;Gene;PA451744;Chemical
VALPROIC ACID;HLA-B;Gene;PA451846;Chemical
VENLAFAXINE;HLA-B;Gene;PA451866;Chemical
ZIPRASIDONE;HLA-B;Gene;PA451974;Chemical
INTERFERONS;HLA-B;Gene;PA451999;Chemical
INFLIXIMAB;HLA-B;Gene;PA452639;Chemical
ORGAN TRANSPLANTATION;TLR4;Gene;PA133888799;Disease
PERTUSSIS VACCINES;TLR4;Gene;PA164713160;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;TLR4;Gene;PA164713366;Chemical
RHEUMATOID ARTHRITIS;TLR4;Gene;PA443434;Disease
CORONARY ARTERY DISEASE;TLR4;Gene;PA443796;Disease
INFLAMMATORY BOWEL DISEASES;TLR4;Gene;PA446116;Disease
FOLIC ACID;TLR4;Gene;PA449692;Chemical
METHOTREXATE;TLR4;Gene;PA450428;Chemical
PRAVASTATIN;TLR4;Gene;PA451089;Chemical
TACROLIMUS;TLR4;Gene;PA451578;Chemical
SLCO1B1;atrasentan;Chemical;PA134865839;Gene
SLCO1B1*37;atrasentan;Chemical;PA165819251;Haplotype
SLCO1B1*5;atrasentan;Chemical;PA165819255;Haplotype
SLCO1B1*9;atrasentan;Chemical;PA165819259;Haplotype
SLCO1B1*14;atrasentan;Chemical;PA165819264;Haplotype
SLCO1B1*15;atrasentan;Chemical;PA165819265;Haplotype
SLCO1B1*1;atrasentan;Chemical;PA165981641;Haplotype
RS1801278;Drugs Used In Diabetes;Chemical;PA166155646;Variant
IRS1;Drugs Used In Diabetes;Chemical;PA203;Gene
TH;metyrosine;Chemical;PA351;Gene
PAIN, POSTOPERATIVE;rs201376588;Variant;PA445210;Disease
DEXMEDETOMIDINE;rs201376588;Variant;PA449256;Chemical
SUBSTANCE-RELATED DISORDERS;rs2076369;Variant;PA446876;Disease
PSYCHOTIC DISORDER;rs2076369;Variant;PA447215;Disease
METHAMPHETAMINE;rs2076369;Variant;PA450403;Chemical
PEGINTERFERON ALFA-2B;rs3077;Variant;PA164784024;Chemical
HEPATITIS B, CHRONIC;rs3077;Variant;PA446862;Disease
GSTT1 NULL;exacerbation of asthma;Disease;PA166048678;Haplotype
GSTT1 NON-NULL;exacerbation of asthma;Disease;PA166048679;Haplotype
GSTT1;exacerbation of asthma;Disease;PA183;Gene
RHEUMATOID ARTHRITIS;rs1643650;Variant;PA443434;Disease
METHOTREXATE;rs1643650;Variant;PA450428;Chemical
DRUG TOXICITY;rs12948059;Variant;PA443937;Disease
SORAFENIB;rs12948059;Variant;PA7000;Chemical
DULOXETINE;rs9369266;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs9369266;Variant;PA447321;Disease
CLAVULANATE;HLA-B*18:01;Haplotype;PA164742987;Chemical
DRUG-INDUCED LIVER INJURY;HLA-B*18:01;Haplotype;PA166119041;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*18:01;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*18:01;Haplotype;PA445738;Disease
AMOXICILLIN;HLA-B*18:01;Haplotype;PA448406;Chemical
CARBAMAZEPINE;HLA-B*18:01;Haplotype;PA448785;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;SENP3;Gene;PA447197;Disease
METHYLPHENIDATE;SENP3;Gene;PA450464;Chemical
NICOTINE;rs1303839356;Variant;PA450626;Chemical
EFAVIRENZ;rs750671397;Variant;PA449441;Chemical
WARFARIN;CYP2C9*12;Haplotype;PA451906;Chemical
ACUTE CORONARY SYNDROME;rs74569896;Variant;PA165108401;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);rs74569896;Variant;PA166129560;Disease
ASPIRIN;rs74569896;Variant;PA448497;Chemical
CLOPIDOGREL;rs74569896;Variant;PA449053;Chemical
MORPHINE;rs2295632;Variant;PA450550;Chemical
OPIOIDS;rs2295632;Variant;PA452618;Chemical
HMG COA REDUCTASE INHIBITORS;rs1532624;Variant;PA133950441;Chemical
HYPERLIPIDEMIAS;rs1532624;Variant;PA444528;Disease
CYP2C9;erdafitinib;Chemical;PA126;Gene
CYP2C9*3;erdafitinib;Chemical;PA165816544;Haplotype
FGFR3;erdafitinib;Chemical;PA28129;Gene
MIGALASTAT;rs869312399;Variant;PA166182881;Chemical
FABRY DISEASE;rs869312399;Variant;PA443367;Disease
FLUOROURACIL;CYP2A6*4;Haplotype;PA128406956;Chemical
OXALIPLATIN;CYP2A6*4;Haplotype;PA131285527;Chemical
COUMARIN;CYP2A6*4;Haplotype;PA134521193;Chemical
TEGAFUR / GIMERACIL / OTERACIL;CYP2A6*4;Haplotype;PA166115442;Chemical
PROGRESSION-FREE SURVIVAL;CYP2A6*4;Haplotype;PA166123026;Disease
CESSATION;CYP2A6*4;Haplotype;PA166123046;Disease
OVERALL SURVIVAL;CYP2A6*4;Haplotype;PA166123207;Disease
BILIARY TRACT NEOPLASMS;CYP2A6*4;Haplotype;PA166128807;Disease
BREAST NEOPLASMS;CYP2A6*4;Haplotype;PA443560;Disease
CARCINOMA, NON-SMALL-CELL LUNG;CYP2A6*4;Haplotype;PA443622;Disease
EPILEPSY;CYP2A6*4;Haplotype;PA444065;Disease
NEOPLASMS;CYP2A6*4;Haplotype;PA445062;Disease
STOMACH NEOPLASMS;CYP2A6*4;Haplotype;PA445742;Disease
TOBACCO USE DISORDER;CYP2A6*4;Haplotype;PA445876;Disease
COLORECTAL NEOPLASMS;CYP2A6*4;Haplotype;PA446108;Disease
CAFFEINE;CYP2A6*4;Haplotype;PA448710;Chemical
DOCETAXEL;CYP2A6*4;Haplotype;PA449383;Chemical
IRINOTECAN;CYP2A6*4;Haplotype;PA450085;Chemical
LETROZOLE;CYP2A6*4;Haplotype;PA450196;Chemical
NICOTINE;CYP2A6*4;Haplotype;PA450626;Chemical
PILOCARPINE;CYP2A6*4;Haplotype;PA450962;Chemical
VALPROIC ACID;CYP2A6*4;Haplotype;PA451846;Chemical
TEGAFUR;CYP2A6*4;Haplotype;PA452620;Chemical
RS1801131;nitrous oxide;Chemical;PA166153643;Variant
RS1801133;nitrous oxide;Chemical;PA166153644;Variant
MTHFR;nitrous oxide;Chemical;PA245;Gene
NECTIN4;enfortumab vedotin;Chemical;PA134991624;Gene
NEOPLASMS;rs12201199;Variant;PA445062;Disease
CISPLATIN;rs12201199;Variant;PA449014;Chemical
MERCAPTOPURINE;rs12201199;Variant;PA450379;Chemical
DULOXETINE;INVS;Gene;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;INVS;Gene;PA447321;Disease
CYP2C19;6beta-hydroxyprogesterone;Chemical;PA124;Gene
CYP2C19*11;6beta-hydroxyprogesterone;Chemical;PA165816527;Haplotype
CYP2C19*23;6beta-hydroxyprogesterone;Chemical;PA165816537;Haplotype
CYP2C19*1;6beta-hydroxyprogesterone;Chemical;PA165980634;Haplotype
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;ZNF565;Gene;PA447197;Disease
METHYLPHENIDATE;ZNF565;Gene;PA450464;Chemical
CYP2D6;amiodarone;Chemical;PA128;Gene
CYP3A4;amiodarone;Chemical;PA130;Gene
CYP3A5;amiodarone;Chemical;PA131;Gene
NOS1AP;amiodarone;Chemical;PA142671259;Gene
CYP3A4*1;amiodarone;Chemical;PA165819201;Haplotype
CYP3A4*2;amiodarone;Chemical;PA165819220;Haplotype
CYP3A4*9;amiodarone;Chemical;PA165819227;Haplotype
CYP3A4*10;amiodarone;Chemical;PA165819228;Haplotype
CYP3A4*11;amiodarone;Chemical;PA165819229;Haplotype
CYP3A4*16;amiodarone;Chemical;PA165819236;Haplotype
CYP3A4*17;amiodarone;Chemical;PA165819239;Haplotype
CYP3A4*18;amiodarone;Chemical;PA165819240;Haplotype
CYP3A4*19;amiodarone;Chemical;PA165819243;Haplotype
CYP3A4*23;amiodarone;Chemical;PA166115836;Haplotype
CYP3A4*24;amiodarone;Chemical;PA166115837;Haplotype
RS10800397;amiodarone;Chemical;PA166153809;Variant
RS10919035;amiodarone;Chemical;PA166153817;Variant
RS1805128;amiodarone;Chemical;PA166155994;Variant
RS12720441;amiodarone;Chemical;PA166157459;Variant
CYP3A4*29;amiodarone;Chemical;PA166245585;Haplotype
CYP3A4*31;amiodarone;Chemical;PA166245587;Haplotype
CYP3A4*32;amiodarone;Chemical;PA166245588;Haplotype
CYP3A4*34;amiodarone;Chemical;PA166245590;Haplotype
KCNE1;amiodarone;Chemical;PA211;Gene
KCNH2;amiodarone;Chemical;PA212;Gene
ABCB1;amiodarone;Chemical;PA267;Gene
CYP2J2;amiodarone;Chemical;PA27112;Gene
SCN5A;amiodarone;Chemical;PA304;Gene
HEROIN DEPENDENCE;rs3778151;Variant;PA444460;Disease
HEROIN;rs3778151;Variant;PA452619;Chemical
PEGINTERFERON ALFA-2B;HLA-C*01:02;Haplotype;PA164784024;Chemical
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-C*01:02;Haplotype;PA166120929;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-C*01:02;Haplotype;PA444059;Disease
HEPATITIS C;HLA-C*01:02;Haplotype;PA444445;Disease
STEVENS-JOHNSON SYNDROME;HLA-C*01:02;Haplotype;PA445738;Disease
METHAZOLAMIDE;HLA-C*01:02;Haplotype;PA450413;Chemical
RIBAVIRIN;HLA-C*01:02;Haplotype;PA451241;Chemical
UGT1A1*1;Osteoporosis;Disease;PA166115841;Haplotype
UGT1A1*28;Osteoporosis;Disease;PA166115842;Haplotype
RS2297480;Osteoporosis;Disease;PA166153695;Variant
RS11264359;Osteoporosis;Disease;PA166153825;Variant
RS1544410;Osteoporosis;Disease;PA166154516;Variant
RS1800012;Osteoporosis;Disease;PA166155190;Variant
FDPS;Osteoporosis;Disease;PA28075;Gene
COL1A1;Osteoporosis;Disease;PA35041;Gene
VDR;Osteoporosis;Disease;PA37301;Gene
UGT1A1;Osteoporosis;Disease;PA420;Gene
CFTR;rs758818611;Variant;PA109;Gene
IVACAFTOR;rs758818611;Variant;PA165950341;Chemical
CES1;remimazolam;Chemical;PA107;Gene
RS2307240;remimazolam;Chemical;PA166155039;Variant
RS71647871;remimazolam;Chemical;PA166155135;Variant
RS200707504;remimazolam;Chemical;PA166170232;Variant
RS151291296;remimazolam;Chemical;PA166171196;Variant
RS143718310;remimazolam;Chemical;PA166171204;Variant
BREAST NEOPLASMS;RBFOX1;Gene;PA443560;Disease
ANTINEOPLASTIC AGENTS;RBFOX1;Gene;PA452621;Chemical
FGFR1OP;PIK3C2A;Gene;PA134941638;Gene
FGFR1OP2;PIK3C2A;Gene;PA134972108;Gene
AKT1;PIK3C2A;Gene;PA24684;Gene
AKT2;PIK3C2A;Gene;PA24685;Gene
AKT3;PIK3C2A;Gene;PA24686;Gene
FGFR1;PIK3C2A;Gene;PA28127;Gene
FGFR2;PIK3C2A;Gene;PA28128;Gene
FGFR3;PIK3C2A;Gene;PA28129;Gene
FGFR4;PIK3C2A;Gene;PA28130;Gene
FGFR3P1;PIK3C2A;Gene;PA28131;Gene
FGFRL1;PIK3C2A;Gene;PA28132;Gene
FLT1;PIK3C2A;Gene;PA28180;Gene
FLT4;PIK3C2A;Gene;PA28183;Gene
HRH2;PIK3C2A;Gene;PA29457;Gene
KDR;PIK3C2A;Gene;PA30086;Gene
USTEKINUMAB;TLR5;Gene;PA166048654;Chemical
PSORIASIS;TLR5;Gene;PA445451;Disease
CLOBAZAM;SCN1A;Gene;PA10888;Chemical
EPILEPSY;SCN1A;Gene;PA444065;Disease
CARBAMAZEPINE;SCN1A;Gene;PA448785;Chemical
ETHOSUXIMIDE;SCN1A;Gene;PA449533;Chemical
LAMOTRIGINE;SCN1A;Gene;PA450164;Chemical
LEVETIRACETAM;SCN1A;Gene;PA450206;Chemical
OXCARBAZEPINE;SCN1A;Gene;PA450732;Chemical
PHENYTOIN;SCN1A;Gene;PA450947;Chemical
VALPROIC ACID;SCN1A;Gene;PA451846;Chemical
ETHANOL;GHSR;Gene;PA448073;Chemical
NQO1;dicumarol;Chemical;PA31744;Gene
TAMOXIFEN;rs478437;Variant;PA451581;Chemical
RADIOTHERAPY;rs10711;Variant;PA166122986;Chemical
PNEUMONITIS;rs10711;Variant;PA166124223;Disease
CETUXIMAB;AREG;Gene;PA10040;Chemical
PANITUMUMAB;AREG;Gene;PA162373091;Chemical
RADIOTHERAPY;AREG;Gene;PA166122986;Chemical
OVERALL SURVIVAL;AREG;Gene;PA166123207;Disease
ADENOCARCINOMA;AREG;Gene;PA443265;Disease
RECTAL NEOPLASMS;AREG;Gene;PA445503;Disease
COLORECTAL NEOPLASMS;AREG;Gene;PA446108;Disease
CAPECITABINE;AREG;Gene;PA448771;Chemical
IRINOTECAN;AREG;Gene;PA450085;Chemical
EPILEPSY;CYP2C9*45;Haplotype;PA444065;Disease
DICLOFENAC;CYP2C9*45;Haplotype;PA449293;Chemical
PHENYTOIN;CYP2C9*45;Haplotype;PA450947;Chemical
GEFITINIB;CYP2D6*93;Haplotype;PA131301952;Chemical
ATOMOXETINE;CYP2D6*93;Haplotype;PA134688071;Chemical
TOLTERODINE;CYP2D6*93;Haplotype;PA164746757;Chemical
BUFURALOL;CYP2D6*93;Haplotype;PA166110256;Chemical
DAPOXETINE;CYP2D6*93;Haplotype;PA166151992;Chemical
AMITRIPTYLINE;CYP2D6*93;Haplotype;PA448385;Chemical
CITALOPRAM;CYP2D6*93;Haplotype;PA449015;Chemical
DEXTROMETHORPHAN;CYP2D6*93;Haplotype;PA449273;Chemical
FLUOXETINE;CYP2D6*93;Haplotype;PA449673;Chemical
METHADONE;CYP2D6*93;Haplotype;PA450401;Chemical
OLANZAPINE;CYP2D6*93;Haplotype;PA450688;Chemical
RISPERIDONE;CYP2D6*93;Haplotype;PA451257;Chemical
TAMOXIFEN;CYP2D6*93;Haplotype;PA451581;Chemical
VENLAFAXINE;CYP2D6*93;Haplotype;PA451866;Chemical
RS1800559;succinylcholine;Chemical;PA166153638;Variant
RS772226819;succinylcholine;Chemical;PA166153940;Variant
RS1801086;succinylcholine;Chemical;PA166155375;Variant
RS28933396;succinylcholine;Chemical;PA166155481;Variant
RS28933397;succinylcholine;Chemical;PA166155482;Variant
RS63749869;succinylcholine;Chemical;PA166155516;Variant
RS111888148;succinylcholine;Chemical;PA166155524;Variant
RS112563513;succinylcholine;Chemical;PA166155526;Variant
RS118192116;succinylcholine;Chemical;PA166155528;Variant
RS118192122;succinylcholine;Chemical;PA166155529;Variant
RS118192124;succinylcholine;Chemical;PA166155531;Variant
RS118192161;succinylcholine;Chemical;PA166155532;Variant
RS118192162;succinylcholine;Chemical;PA166155533;Variant
RS118192163;succinylcholine;Chemical;PA166155534;Variant
RS118192167;succinylcholine;Chemical;PA166155535;Variant
RS118192170;succinylcholine;Chemical;PA166155536;Variant
RS118192172;succinylcholine;Chemical;PA166155537;Variant
RS118192175;succinylcholine;Chemical;PA166155538;Variant
RS118192176;succinylcholine;Chemical;PA166155539;Variant
RS118192177;succinylcholine;Chemical;PA166155540;Variant
RS118192178;succinylcholine;Chemical;PA166155541;Variant
RS118204423;succinylcholine;Chemical;PA166155542;Variant
RS121918592;succinylcholine;Chemical;PA166155543;Variant
RS121918593;succinylcholine;Chemical;PA166155544;Variant
RS121918594;succinylcholine;Chemical;PA166155545;Variant
RS121918595;succinylcholine;Chemical;PA166155546;Variant
RS193922747;succinylcholine;Chemical;PA166155564;Variant
RS193922753;succinylcholine;Chemical;PA166155565;Variant
RS193922770;succinylcholine;Chemical;PA166155567;Variant
RS193922772;succinylcholine;Chemical;PA166155568;Variant
RS193922802;succinylcholine;Chemical;PA166155569;Variant
RS193922803;succinylcholine;Chemical;PA166155570;Variant
RS193922807;succinylcholine;Chemical;PA166155571;Variant
RS193922809;succinylcholine;Chemical;PA166155572;Variant
RS193922816;succinylcholine;Chemical;PA166155573;Variant
RS193922818;succinylcholine;Chemical;PA166155574;Variant
RS193922876;succinylcholine;Chemical;PA166155575;Variant
RS193922878;succinylcholine;Chemical;PA166155576;Variant
RS1799807;succinylcholine;Chemical;PA166156327;Variant
RS1803274;succinylcholine;Chemical;PA166156332;Variant
RS28933389;succinylcholine;Chemical;PA166156467;Variant
RS28933390;succinylcholine;Chemical;PA166156468;Variant
BCHE DEFICIENCY;succinylcholine;Chemical;PA166157951;Variant
RS193922843;succinylcholine;Chemical;PA166163663;Variant
RS193922832;succinylcholine;Chemical;PA166163667;Variant
RS118192168;succinylcholine;Chemical;PA166163669;Variant
RS193922764;succinylcholine;Chemical;PA166176176;Variant
RS121918596;succinylcholine;Chemical;PA166177994;Variant
RS193922748;succinylcholine;Chemical;PA166180322;Variant
RS193922762;succinylcholine;Chemical;PA166180323;Variant
RS193922768;succinylcholine;Chemical;PA166180324;Variant
RS144336148;succinylcholine;Chemical;PA166180325;Variant
RS193922752;succinylcholine;Chemical;PA166183378;Variant
RS764841347;succinylcholine;Chemical;PA166236401;Variant
RS568724445;succinylcholine;Chemical;PA166236402;Variant
RS1560022535;succinylcholine;Chemical;PA166236481;Variant
RS745364489;succinylcholine;Chemical;PA166236541;Variant
RS531738678;succinylcholine;Chemical;PA166236761;Variant
RS201820739;succinylcholine;Chemical;PA166236822;Variant
RS774072493;succinylcholine;Chemical;PA166249641;Variant
BCHE;succinylcholine;Chemical;PA25294;Gene
RYR1;succinylcholine;Chemical;PA34896;Gene
CACNA1S;succinylcholine;Chemical;PA85;Gene
MAJOR DEPRESSIVE DISORDER;rs10848635;Variant;PA447321;Disease
CITALOPRAM;rs10848635;Variant;PA449015;Chemical
CHOLIC ACID;HSD3B7;Gene;PA166160055;Chemical
BETA-THALASSEMIA AND RELATED DISEASES;rs9376230;Variant;PA446432;Disease
HYDROXYUREA;rs9376230;Variant;PA449942;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;LY96;Gene;PA164713366;Chemical
PSORIASIS;LY96;Gene;PA445451;Disease
RS296766;thiazolidinediones;Chemical;PA166154494;Variant
AQP2;thiazolidinediones;Chemical;PA24920;Gene
CYP2C8;diclofenac acyl glucuronide;Chemical;PA125;Gene
CYP2C8*4;diclofenac acyl glucuronide;Chemical;PA165958686;Haplotype
RS7439366;diclofenac acyl glucuronide;Chemical;PA166156619;Variant
CYP2C8*1;diclofenac acyl glucuronide;Chemical;PA166242948;Haplotype
UGT2B7;diclofenac acyl glucuronide;Chemical;PA361;Gene
NICOTINE;rs4001926;Variant;PA450626;Chemical
ESOMEPRAZOLE;STAT6;Gene;PA10075;Chemical
EOSINOPHILIC ESOPHAGITIS;STAT6;Gene;PA166224501;Disease
PAIN, POSTOPERATIVE;P2RX7;Gene;PA445210;Disease
FENTANYL;P2RX7;Gene;PA449599;Chemical
BREAST NEOPLASMS;rs13207351;Variant;PA443560;Disease
DOCETAXEL;rs13207351;Variant;PA449383;Chemical
CYP2C9;ketorolac;Chemical;PA126;Gene
CYP2D6;ketorolac;Chemical;PA128;Gene
CYP2C9*1;ketorolac;Chemical;PA165816542;Haplotype
CYP2C9*2;ketorolac;Chemical;PA165816543;Haplotype
CYP2C9*3;ketorolac;Chemical;PA165816544;Haplotype
CYP2D6*4;ketorolac;Chemical;PA165816579;Haplotype
RS2562456;ketorolac;Chemical;PA166155399;Variant
RS1800629;ketorolac;Chemical;PA166156997;Variant
LTA;ketorolac;Chemical;PA30474;Gene
LST1;ketorolac;Chemical;PA37856;Gene
TNF;ketorolac;Chemical;PA435;Gene
VALACICLOVIR;ketorolac;Chemical;PA451839;Chemical
CYP2D6;Osteoarthritis;Disease;PA128;Gene
VWA1;Osteoarthritis;Disease;PA142670612;Gene
CYP2D6 POOR METABOLIZER;Osteoarthritis;Disease;PA166157927;Variant
NR1I2;cefaclor;Chemical;PA378;Gene
CFTR;rs1800097;Variant;PA109;Gene
IVACAFTOR;rs1800097;Variant;PA165950341;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs1800097;Variant;PA166362502;Chemical
CYP2C8;montelukast;Chemical;PA125;Gene
CYP3A5;montelukast;Chemical;PA131;Gene
CYP2C8*3;montelukast;Chemical;PA165958685;Haplotype
CYP2C8*4;montelukast;Chemical;PA165958686;Haplotype
UGT1A3*1;montelukast;Chemical;PA165959980;Haplotype
UGT1A3*2;montelukast;Chemical;PA165959981;Haplotype
RS1786929;montelukast;Chemical;PA166153971;Variant
RS2115819;montelukast;Chemical;PA166153996;Variant
RS12422149;montelukast;Chemical;PA166154465;Variant
RS2660845;montelukast;Chemical;PA166154552;Variant
RS953977;montelukast;Chemical;PA166154690;Variant
RS119774;montelukast;Chemical;PA166154984;Variant
RS967676;montelukast;Chemical;PA166155171;Variant
RS1364805;montelukast;Chemical;PA166156511;Variant
RS730012;montelukast;Chemical;PA166156740;Variant
RS7794356;montelukast;Chemical;PA166157431;Variant
RS6475448;montelukast;Chemical;PA166157785;Variant
RS7604115;montelukast;Chemical;PA166179590;Variant
RS704212;montelukast;Chemical;PA166179594;Variant
CYP2C8*1;montelukast;Chemical;PA166242948;Haplotype
LTC4S;montelukast;Chemical;PA235;Gene
LTA4H;montelukast;Chemical;PA24345;Gene
ABCC1;montelukast;Chemical;PA244;Gene
CA10;montelukast;Chemical;PA25985;Gene
MLLT3;montelukast;Chemical;PA30852;Gene
SLCO2B1;montelukast;Chemical;PA35845;Gene
UGT1A3;montelukast;Chemical;PA37178;Gene
GALNT17;montelukast;Chemical;PA38124;Gene
CYSLTR1;montelukast;Chemical;PA38453;Gene
ABCC9;montelukast;Chemical;PA396;Gene
ALOX5;montelukast;Chemical;PA46;Gene
CYP2C19;CYP2C19*8;Haplotype;PA124;Gene
ACUTE CORONARY SYNDROME;CYP2C19*8;Haplotype;PA165108401;Disease
3-CYANO-7-ETHOXYCOUMARIN;CYP2C19*8;Haplotype;PA166123047;Chemical
ASTHMA;CYP2C19*8;Haplotype;PA443450;Disease
CARDIOVASCULAR DISEASES;CYP2C19*8;Haplotype;PA443635;Disease
ISCHEMIC ATTACK, TRANSIENT;CYP2C19*8;Haplotype;PA443672;Disease
CORONARY ARTERY DISEASE;CYP2C19*8;Haplotype;PA443796;Disease
GASTROESOPHAGEAL REFLUX;CYP2C19*8;Haplotype;PA444255;Disease
RESPIRATORY TRACT INFECTIONS;CYP2C19*8;Haplotype;PA445526;Disease
STROKE;CYP2C19*8;Haplotype;PA447054;Disease
CLOPIDOGREL;CYP2C19*8;Haplotype;PA449053;Chemical
FLUCONAZOLE;CYP2C19*8;Haplotype;PA449653;Chemical
FLUOXETINE;CYP2C19*8;Haplotype;PA449673;Chemical
FLUVOXAMINE;CYP2C19*8;Haplotype;PA449690;Chemical
KETOCONAZOLE;CYP2C19*8;Haplotype;PA450146;Chemical
LANSOPRAZOLE;CYP2C19*8;Haplotype;PA450180;Chemical
MEPHENYTOIN;CYP2C19*8;Haplotype;PA450373;Chemical
OMEPRAZOLE;CYP2C19*8;Haplotype;PA450704;Chemical
SERTRALINE;CYP2C19*8;Haplotype;PA451333;Chemical
TICLOPIDINE;CYP2C19*8;Haplotype;PA451686;Chemical
TOLBUTAMIDE;CYP2C19*8;Haplotype;PA451718;Chemical
TRANYLCYPROMINE;CYP2C19*8;Haplotype;PA451741;Chemical
TROGLITAZONE;CYP2C19*8;Haplotype;PA451799;Chemical
NITRENDIPINE;AGTR1;Gene;PA146096020;Chemical
ACE INHIBITORS, PLAIN;AGTR1;Gene;PA164712308;Chemical
THIAZIDES, PLAIN;AGTR1;Gene;PA164713347;Chemical
ANGIOTENSIN II;AGTR1;Gene;PA166109554;Chemical
CORONARY ARTERY DISEASE;AGTR1;Gene;PA443796;Disease
DIABETES MELLITUS, TYPE 2;AGTR1;Gene;PA443890;Disease
HEART FAILURE;AGTR1;Gene;PA444370;Disease
HYPERTENSION;AGTR1;Gene;PA444552;Disease
LIVER CIRRHOSIS;AGTR1;Gene;PA444797;Disease
HYPERTROPHY, LEFT VENTRICULAR;AGTR1;Gene;PA446479;Disease
ATORVASTATIN;AGTR1;Gene;PA448500;Chemical
CANDESARTAN;AGTR1;Gene;PA448765;Chemical
CAPTOPRIL;AGTR1;Gene;PA448780;Chemical
IRBESARTAN;AGTR1;Gene;PA450084;Chemical
LOSARTAN;AGTR1;Gene;PA450268;Chemical
PERINDOPRIL;AGTR1;Gene;PA450877;Chemical
BEVACIZUMAB;rs9381299;Variant;PA130232992;Chemical
HYPERTENSION;rs9381299;Variant;PA444552;Disease
BEVACIZUMAB;rs3025039;Variant;PA130232992;Chemical
BREAST NEOPLASMS;rs3025039;Variant;PA443560;Disease
COLORECTAL NEOPLASMS;rs3025039;Variant;PA446108;Disease
ACETALDEHYDE;PGM1;Gene;PA166186245;Chemical
RS1045642;rhodamine 123;Chemical;PA166157284;Variant
ABCB1;rhodamine 123;Chemical;PA267;Gene
ABCG2;rhodamine 123;Chemical;PA390;Gene
17BETA-ESTRADIOL GLUCURONIDE;rs11568644;Variant;PA166277182;Chemical
PYRAZOLONES;rs1805034;Variant;PA164713217;Chemical
ACETAMINOPHEN;rs1805034;Variant;PA448015;Chemical
ASPIRIN;rs1805034;Variant;PA448497;Chemical
DICLOFENAC;rs1805034;Variant;PA449293;Chemical
PROPIONIC ACID DERIVATIVES;rs1805034;Variant;PA451140;Chemical
ABCC2;Central Nervous System Infectious Disorder;Disease;PA116;Gene
RS2273697;Central Nervous System Infectious Disorder;Disease;PA166154007;Variant
RS13120400;Central Nervous System Infectious Disorder;Disease;PA166156664;Variant
ABCG2;Central Nervous System Infectious Disorder;Disease;PA390;Gene
ARIPIPRAZOLE;CYP2B6;Gene;PA10026;Chemical
DULOXETINE;CYP2B6;Gene;PA10066;Chemical
ESCITALOPRAM;CYP2B6;Gene;PA10074;Chemical
IMATINIB;CYP2B6;Gene;PA10804;Chemical
3,4-METHYLENEDIOXYMETHAMPHETAMINE;CYP2B6;Gene;PA131887008;Chemical
TRANSPLANTATION;CYP2B6;Gene;PA134850491;Disease
PRASUGREL;CYP2B6;Gene;PA154410481;Chemical
ANTIVIRALS FOR TREATMENT OF HIV INFECTIONS, COMBINATIONS;CYP2B6;Gene;PA164712505;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;CYP2B6;Gene;PA164712708;Chemical
MITOTANE;CYP2B6;Gene;PA164746157;Chemical
DIVALPROEX SODIUM;CYP2B6;Gene;PA164783479;Chemical
ETHAMBUTOL;CYP2B6;Gene;PA164784021;Chemical
TOXIC LIVER DISEASE;CYP2B6;Gene;PA164925725;Disease
NEONATAL ABSTINENCE SYNDROME;CYP2B6;Gene;PA165108809;Disease
ARTEMISININ;CYP2B6;Gene;PA165111696;Chemical
ARTEMETHER;CYP2B6;Gene;PA165111698;Chemical
ARTEETHER;CYP2B6;Gene;PA165260403;Chemical
CYP2B6*1;CYP2B6;Gene;PA165818750;Haplotype
CYP2B6*5;CYP2B6;Gene;PA165818760;Haplotype
CYP2B6*6;CYP2B6;Gene;PA165818762;Haplotype
CYP2B6*18;CYP2B6;Gene;PA165818808;Haplotype
PREGNANCY;CYP2B6;Gene;PA166048714;Disease
COTININE;CYP2B6;Gene;PA166114414;Chemical
DRUG-INDUCED LIVER INJURY;CYP2B6;Gene;PA166119041;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;CYP2B6;Gene;PA166120927;Disease
DISCONTINUATION;CYP2B6;Gene;PA166123507;Disease
RECURRENCE FREE SURVIVAL;CYP2B6;Gene;PA166127658;Disease
RS3745274;CYP2B6;Gene;PA166155409;Variant
EFAVIRENZ / EMTRICITABINE / TENOFOVIR DISOPROXIL;CYP2B6;Gene;PA166176033;Chemical
S-EDDP;CYP2B6;Gene;PA166177606;Chemical
(S)-METHADONE;CYP2B6;Gene;PA166178554;Chemical
OSPEMIFENE;CYP2B6;Gene;PA166182883;Chemical
HYDROXYBUPROPION;CYP2B6;Gene;PA166226561;Chemical
R-EDDP;CYP2B6;Gene;PA166247521;Chemical
NR1I2;CYP2B6;Gene;PA378;Gene
NR1I3;CYP2B6;Gene;PA391;Gene
BREAST NEOPLASMS;CYP2B6;Gene;PA443560;Disease
CENTRAL NERVOUS SYSTEM DISEASES;CYP2B6;Gene;PA443657;Disease
CYSTITIS;CYP2B6;Gene;PA443833;Disease
DIARRHEA;CYP2B6;Gene;PA443899;Disease
DRUG TOXICITY;CYP2B6;Gene;PA443937;Disease
EPIDERMAL NECROLYSIS, TOXIC;CYP2B6;Gene;PA444059;Disease
HEPATIC VENO-OCCLUSIVE DISEASE;CYP2B6;Gene;PA444434;Disease
HEROIN DEPENDENCE;CYP2B6;Gene;PA444460;Disease
INFECTIOUS DISEASE;CYP2B6;Gene;PA444614;Disease
LONG QT SYNDROME;CYP2B6;Gene;PA444807;Disease
LUPUS ERYTHEMATOSUS;CYP2B6;Gene;PA444819;Disease
LUPUS NEPHRITIS;CYP2B6;Gene;PA444823;Disease
LYMPHOMA, NON-HODGKIN;CYP2B6;Gene;PA444845;Disease
OPIOID-RELATED DISORDERS;CYP2B6;Gene;PA445043;Disease
NEOPLASMS;CYP2B6;Gene;PA445062;Disease
PAIN;CYP2B6;Gene;PA445208;Disease
PAIN, POSTOPERATIVE;CYP2B6;Gene;PA445210;Disease
SCOLIOSIS;CYP2B6;Gene;PA445619;Disease
STEVENS-JOHNSON SYNDROME;CYP2B6;Gene;PA445738;Disease
TOBACCO USE DISORDER;CYP2B6;Gene;PA445876;Disease
TUBERCULOSIS;CYP2B6;Gene;PA445941;Disease
LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;CYP2B6;Gene;PA446169;Disease
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;CYP2B6;Gene;PA446171;Disease
LYMPHOMA, B-CELL;CYP2B6;Gene;PA446304;Disease
ADRENOCORTICAL CARCINOMA;CYP2B6;Gene;PA446644;Disease
NEUROTOXICITY SYNDROMES;CYP2B6;Gene;PA446975;Disease
HIV INFECTIONS;CYP2B6;Gene;PA447230;Disease
DEPRESSION;CYP2B6;Gene;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2B6;Gene;PA447321;Disease
AMITRIPTYLINE;CYP2B6;Gene;PA448385;Chemical
BUPROPION;CYP2B6;Gene;PA448687;Chemical
BUSPIRONE;CYP2B6;Gene;PA448689;Chemical
BUSULFAN;CYP2B6;Gene;PA448691;Chemical
CARBAMAZEPINE;CYP2B6;Gene;PA448785;Chemical
CITALOPRAM;CYP2B6;Gene;PA449015;Chemical
CLOPIDOGREL;CYP2B6;Gene;PA449053;Chemical
CYCLOPHOSPHAMIDE;CYP2B6;Gene;PA449165;Chemical
DIAZEPAM;CYP2B6;Gene;PA449283;Chemical
DOXORUBICIN;CYP2B6;Gene;PA449412;Chemical
EFAVIRENZ;CYP2B6;Gene;PA449441;Chemical
ETHINYL ESTRADIOL;CYP2B6;Gene;PA449527;Chemical
FLUDARABINE;CYP2B6;Gene;PA449655;Chemical
FLUOXETINE;CYP2B6;Gene;PA449673;Chemical
IFOSFAMIDE;CYP2B6;Gene;PA449964;Chemical
ISONIAZID;CYP2B6;Gene;PA450112;Chemical
KETAMINE;CYP2B6;Gene;PA450144;Chemical
LAMIVUDINE;CYP2B6;Gene;PA450163;Chemical
LAMOTRIGINE;CYP2B6;Gene;PA450164;Chemical
MEPERIDINE;CYP2B6;Gene;PA450369;Chemical
MEPHENYTOIN;CYP2B6;Gene;PA450373;Chemical
METHADONE;CYP2B6;Gene;PA450401;Chemical
METHOTREXATE;CYP2B6;Gene;PA450428;Chemical
MIDAZOLAM;CYP2B6;Gene;PA450496;Chemical
MIRTAZAPINE;CYP2B6;Gene;PA450522;Chemical
MODAFINIL;CYP2B6;Gene;PA450530;Chemical
NEVIRAPINE;CYP2B6;Gene;PA450616;Chemical
NICOTINE;CYP2B6;Gene;PA450626;Chemical
NORTRIPTYLINE;CYP2B6;Gene;PA450657;Chemical
OLANZAPINE;CYP2B6;Gene;PA450688;Chemical
OXCARBAZEPINE;CYP2B6;Gene;PA450732;Chemical
PAROXETINE;CYP2B6;Gene;PA450801;Chemical
PHENOBARBITAL;CYP2B6;Gene;PA450911;Chemical
PHENYTOIN;CYP2B6;Gene;PA450947;Chemical
PROPOFOL;CYP2B6;Gene;PA451141;Chemical
PYRAZINAMIDE;CYP2B6;Gene;PA451182;Chemical
QUETIAPINE;CYP2B6;Gene;PA451201;Chemical
RIFAMPIN;CYP2B6;Gene;PA451250;Chemical
RISPERIDONE;CYP2B6;Gene;PA451257;Chemical
SELEGILINE;CYP2B6;Gene;PA451316;Chemical
SERTRALINE;CYP2B6;Gene;PA451333;Chemical
STAVUDINE;CYP2B6;Gene;PA451494;Chemical
TAMOXIFEN;CYP2B6;Gene;PA451581;Chemical
THIOTEPA;CYP2B6;Gene;PA451668;Chemical
TICLOPIDINE;CYP2B6;Gene;PA451686;Chemical
TRAMADOL;CYP2B6;Gene;PA451735;Chemical
TRAZODONE;CYP2B6;Gene;PA451744;Chemical
VALPROIC ACID;CYP2B6;Gene;PA451846;Chemical
VENLAFAXINE;CYP2B6;Gene;PA451866;Chemical
ZIDOVUDINE;CYP2B6;Gene;PA451954;Chemical
ZIPRASIDONE;CYP2B6;Gene;PA451974;Chemical
AFLATOXIN B1;CYP2B6;Gene;PA452609;Chemical
OPIOIDS;CYP2B6;Gene;PA452618;Chemical
SORAFENIB;CYP2B6;Gene;PA7000;Chemical
OPIOID-RELATED DISORDERS;rs4292394;Variant;PA445043;Disease
METHADONE;rs4292394;Variant;PA450401;Chemical
FLUOROURACIL;rs536577604;Variant;PA128406956;Chemical
DRUG TOXICITY;rs536577604;Variant;PA443937;Disease
COMT;etoposide catechol;Chemical;PA117;Gene
PSYCHOTIC DISORDER;rs2619538;Variant;PA447215;Disease
METHAMPHETAMINE;rs2619538;Variant;PA450403;Chemical
O-DESMETHYLTRAMADOL;rs751527244;Variant;PA166131379;Chemical
TAPENTADOL;rs751527244;Variant;PA166179720;Chemical
ACETAMINOPHEN;rs751527244;Variant;PA448015;Chemical
MORPHINE;rs751527244;Variant;PA450550;Chemical
TRAMADOL;rs751527244;Variant;PA451735;Chemical
FLUOROURACIL;rs11636687;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs11636687;Variant;PA443560;Disease
LEUKOPENIA;rs11636687;Variant;PA444773;Disease
NEUTROPENIA;rs11636687;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs11636687;Variant;PA449165;Chemical
EPIRUBICIN;rs11636687;Variant;PA449476;Chemical
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-A*11:01;Haplotype;PA166120929;Disease
ADVERSE EVENTS;HLA-A*11:01;Haplotype;PA166151827;Disease
DRUG TOXICITY;HLA-A*11:01;Haplotype;PA443937;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-A*11:01;Haplotype;PA444059;Disease
EPILEPSY;HLA-A*11:01;Haplotype;PA444065;Disease
STEVENS-JOHNSON SYNDROME;HLA-A*11:01;Haplotype;PA445738;Disease
CARBAMAZEPINE;HLA-A*11:01;Haplotype;PA448785;Chemical
LEVETIRACETAM;HLA-A*11:01;Haplotype;PA450206;Chemical
FLUOROURACIL;rs115632870;Variant;PA128406956;Chemical
ZEB1;ATP1A1;Gene;PA162409589;Gene
EPLERENONE;ATP1A1;Gene;PA164749044;Chemical
MAPK1;ATP1A1;Gene;PA30616;Gene
MAPK3;ATP1A1;Gene;PA30622;Gene
ADD1;ATP1A1;Gene;PA31;Gene
NEDD4L;ATP1A1;Gene;PA31534;Gene
PPP2CA;ATP1A1;Gene;PA33663;Gene
PRKAA2;ATP1A1;Gene;PA33745;Gene
PRKCE;ATP1A1;Gene;PA33765;Gene
GRK2;ATP1A1;Gene;PA40;Gene
GRK3;ATP1A1;Gene;PA41;Gene
ARRB2;ATP1A1;Gene;PA60;Gene
CRIZOTINIB;MET;Gene;PA165946122;Chemical
TEPOTINIB;MET;Gene;PA166211181;Chemical
CAPMATINIB;MET;Gene;PA166224201;Chemical
CORTICOSTEROIDS;DCAF4;Gene;PA10832;Chemical
ASTHMA;DCAF4;Gene;PA443450;Disease
ALPHA-ADRENORECEPTOR ANTAGONISTS;ADRA1A;Gene;PA164712344;Chemical
HYPERTENSION;ADRA1A;Gene;PA444552;Disease
DOPAMINE;ADRA1A;Gene;PA449396;Chemical
EPINEPHRINE;ADRA1A;Gene;PA449470;Chemical
ISOPROTERENOL;ADRA1A;Gene;PA450121;Chemical
METHOXAMINE;ADRA1A;Gene;PA450431;Chemical
NIFEDIPINE;ADRA1A;Gene;PA450631;Chemical
NOREPINEPHRINE;ADRA1A;Gene;PA450649;Chemical
PHENYLEPHRINE;ADRA1A;Gene;PA450935;Chemical
PERIPHERAL NERVOUS SYSTEM DISEASES;CEP72;Gene;PA445301;Disease
VINCRISTINE;CEP72;Gene;PA451879;Chemical
DEXTROMETHORPHAN;PHETA2;Gene;PA449273;Chemical
O-DESMETHYLTRAMADOL;rs750575779;Variant;PA166131379;Chemical
TAPENTADOL;rs750575779;Variant;PA166179720;Chemical
ACETAMINOPHEN;rs750575779;Variant;PA448015;Chemical
TRAMADOL;rs750575779;Variant;PA451735;Chemical
WARFARIN;rs1131873;Variant;PA451906;Chemical
CYP2C8;Ovarian Neoplasms;Disease;PA125;Gene
CYP2E1;Ovarian Neoplasms;Disease;PA129;Gene
CYP3A4;Ovarian Neoplasms;Disease;PA130;Gene
CYP3A5;Ovarian Neoplasms;Disease;PA131;Gene
KLC3;Ovarian Neoplasms;Disease;PA142671588;Gene
POLR1G;Ovarian Neoplasms;Disease;PA142672156;Gene
ERCC1;Ovarian Neoplasms;Disease;PA155;Gene
CYP3A4*1;Ovarian Neoplasms;Disease;PA165819201;Haplotype
CYP3A4*8;Ovarian Neoplasms;Disease;PA165819226;Haplotype
CYP3A4*20;Ovarian Neoplasms;Disease;PA165819244;Haplotype
CYP2C8*3;Ovarian Neoplasms;Disease;PA165958685;Haplotype
HLA-B*57:01;Ovarian Neoplasms;Disease;PA165987830;Haplotype
GSTM1 NULL;Ovarian Neoplasms;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Ovarian Neoplasms;Disease;PA166048676;Haplotype
CYP3A4*22;Ovarian Neoplasms;Disease;PA166048680;Haplotype
UGT1A1*1;Ovarian Neoplasms;Disease;PA166115841;Haplotype
UGT1A1*28;Ovarian Neoplasms;Disease;PA166115842;Haplotype
CYP3A5*1;Ovarian Neoplasms;Disease;PA166128213;Haplotype
CYP3A5*3;Ovarian Neoplasms;Disease;PA166128219;Haplotype
RS1051740;Ovarian Neoplasms;Disease;PA166153612;Variant
RS3219484;Ovarian Neoplasms;Disease;PA166153742;Variant
RS2070676;Ovarian Neoplasms;Disease;PA166153994;Variant
RS6413432;Ovarian Neoplasms;Disease;PA166154073;Variant
RS1695;Ovarian Neoplasms;Disease;PA166154249;Variant
RS11226;Ovarian Neoplasms;Disease;PA166154490;Variant
RS17655;Ovarian Neoplasms;Disease;PA166154677;Variant
RS1061472;Ovarian Neoplasms;Disease;PA166154695;Variant
RS1801249;Ovarian Neoplasms;Disease;PA166154703;Variant
RS11623866;Ovarian Neoplasms;Disease;PA166154823;Variant
RS879207;Ovarian Neoplasms;Disease;PA166155169;Variant
RS1052536;Ovarian Neoplasms;Disease;PA166155177;Variant
RS2849380;Ovarian Neoplasms;Disease;PA166155289;Variant
RS11615;Ovarian Neoplasms;Disease;PA166155342;Variant
RS13181;Ovarian Neoplasms;Disease;PA166155343;Variant
RS25487;Ovarian Neoplasms;Disease;PA166155346;Variant
RS3212986;Ovarian Neoplasms;Disease;PA166155407;Variant
RS139887;Ovarian Neoplasms;Disease;PA166156044;Variant
RS9825762;Ovarian Neoplasms;Disease;PA166156430;Variant
RS698;Ovarian Neoplasms;Disease;PA166156476;Variant
RS7349683;Ovarian Neoplasms;Disease;PA166156616;Variant
RS544093;Ovarian Neoplasms;Disease;PA166156925;Variant
RS879825;Ovarian Neoplasms;Disease;PA166156961;Variant
RS1142345;Ovarian Neoplasms;Disease;PA166156978;Variant
RS3957357;Ovarian Neoplasms;Disease;PA166157094;Variant
RS6900017;Ovarian Neoplasms;Disease;PA166157110;Variant
RS9369421;Ovarian Neoplasms;Disease;PA166157149;Variant
RS1799983;Ovarian Neoplasms;Disease;PA166157303;Variant
RS1801368;Ovarian Neoplasms;Disease;PA166157307;Variant
RS2032582;Ovarian Neoplasms;Disease;PA166157316;Variant
RS3594;Ovarian Neoplasms;Disease;PA166157541;Variant
RS1801280;Ovarian Neoplasms;Disease;PA166157570;Variant
RS1799735;Ovarian Neoplasms;Disease;PA166159214;Variant
RS36120609;Ovarian Neoplasms;Disease;PA166211543;Variant
RS2336219;Ovarian Neoplasms;Disease;PA166253284;Variant
RS3212980;Ovarian Neoplasms;Disease;PA166253286;Variant
NAT2;Ovarian Neoplasms;Disease;PA18;Gene
GSTM1;Ovarian Neoplasms;Disease;PA182;Gene
MTHFR;Ovarian Neoplasms;Disease;PA245;Gene
ADH1C;Ovarian Neoplasms;Disease;PA24572;Gene
BCL2;Ovarian Neoplasms;Disease;PA25302;Gene
NOS3;Ovarian Neoplasms;Disease;PA254;Gene
BRCA1;Ovarian Neoplasms;Disease;PA25411;Gene
ABCB1;Ovarian Neoplasms;Disease;PA267;Gene
EPHA5;Ovarian Neoplasms;Disease;PA27821;Gene
EPHX1;Ovarian Neoplasms;Disease;PA27829;Gene
ERCC2;Ovarian Neoplasms;Disease;PA27848;Gene
ERCC5;Ovarian Neoplasms;Disease;PA27851;Gene
FNTB;Ovarian Neoplasms;Disease;PA28202;Gene
FOXO1;Ovarian Neoplasms;Disease;PA28237;Gene
GSR;Ovarian Neoplasms;Disease;PA29014;Gene
GSTA1;Ovarian Neoplasms;Disease;PA29016;Gene
GSTM3;Ovarian Neoplasms;Disease;PA29024;Gene
GSTP1;Ovarian Neoplasms;Disease;PA29028;Gene
LIG3;Ovarian Neoplasms;Disease;PA30374;Gene
MUTYH;Ovarian Neoplasms;Disease;PA31328;Gene
OPRM1;Ovarian Neoplasms;Disease;PA31945;Gene
RAD52;Ovarian Neoplasms;Disease;PA34180;Gene
PPP1R13L;Ovarian Neoplasms;Disease;PA34195;Gene
SCN10A;Ovarian Neoplasms;Disease;PA35000;Gene
HLA-B;Ovarian Neoplasms;Disease;PA35056;Gene
TPMT;Ovarian Neoplasms;Disease;PA356;Gene
SOX10;Ovarian Neoplasms;Disease;PA36027;Gene
XRCC1;Ovarian Neoplasms;Disease;PA369;Gene
MAD1L1;Ovarian Neoplasms;Disease;PA372;Gene
VEGFA;Ovarian Neoplasms;Disease;PA37302;Gene
NR1I2;Ovarian Neoplasms;Disease;PA378;Gene
UGT1A1;Ovarian Neoplasms;Disease;PA420;Gene
ATP7B;Ovarian Neoplasms;Disease;PA73;Gene
ACUTE LYMPHOBLASTIC LEUKEMIA;rs10948059;Variant;PA446155;Disease
MERCAPTOPURINE;rs10948059;Variant;PA450379;Chemical
ARACHIDONIC ACID;rs114396708;Variant;PA166178659;Chemical
DRUG TOXICITY;rs2270860;Variant;PA443937;Disease
NEOPLASMS;rs2270860;Variant;PA445062;Disease
CAPECITABINE;rs2270860;Variant;PA448771;Chemical
HYPERPROLACTINEMIA;rs10929302;Variant;PA444545;Disease
NEUTROPENIA;rs10929302;Variant;PA445113;Disease
IRINOTECAN;rs10929302;Variant;PA450085;Chemical
RISPERIDONE;rs10929302;Variant;PA451257;Chemical
CFTR;rs115545701;Variant;PA109;Gene
IVACAFTOR;rs115545701;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs115545701;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs115545701;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs115545701;Variant;PA443829;Disease
ALCOHOL ABUSE;rs738409;Variant;PA443309;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs738409;Variant;PA446155;Disease
ETHANOL;rs738409;Variant;PA448073;Chemical
ASPARAGINASE;rs738409;Variant;PA448492;Chemical
CYCLOPHOSPHAMIDE;rs738409;Variant;PA449165;Chemical
DAUNORUBICIN;rs738409;Variant;PA449212;Chemical
PREDNISOLONE;rs738409;Variant;PA451096;Chemical
VINCRISTINE;rs738409;Variant;PA451879;Chemical
FLUOROURACIL;DPYD c.2846A>T;Haplotype;PA128406956;Chemical
DPYD;DPYD c.2846A>T;Haplotype;PA145;Gene
TEGAFUR / GIMERACIL / OTERACIL;DPYD c.2846A>T;Haplotype;PA166115442;Chemical
FOLFOX;DPYD c.2846A>T;Haplotype;PA166182862;Chemical
DRUG TOXICITY;DPYD c.2846A>T;Haplotype;PA443937;Disease
COLORECTAL NEOPLASMS;DPYD c.2846A>T;Haplotype;PA446108;Disease
CAPECITABINE;DPYD c.2846A>T;Haplotype;PA448771;Chemical
TEGAFUR;DPYD c.2846A>T;Haplotype;PA452620;Chemical
LAPATINIB;PGR;Gene;PA152241907;Chemical
FULVESTRANT;PGR;Gene;PA164747170;Chemical
GOSERELIN;PGR;Gene;PA164747674;Chemical
OLAPARIB;PGR;Gene;PA164920420;Chemical
IXABEPILONE;PGR;Gene;PA165110439;Chemical
PERTUZUMAB;PGR;Gene;PA165290933;Chemical
NERATINIB;PGR;Gene;PA165291472;Chemical
PALBOCICLIB;PGR;Gene;PA166153469;Chemical
RIBOCICLIB;PGR;Gene;PA166153470;Chemical
ABEMACICLIB;PGR;Gene;PA166153471;Chemical
ERIBULIN;PGR;Gene;PA166182723;Chemical
ANASTROZOLE;PGR;Gene;PA448432;Chemical
DOCETAXEL;PGR;Gene;PA449383;Chemical
EXEMESTANE;PGR;Gene;PA449563;Chemical
LETROZOLE;PGR;Gene;PA450196;Chemical
TAMOXIFEN;PGR;Gene;PA451581;Chemical
TRASTUZUMAB;PGR;Gene;PA451743;Chemical
TANC1;radiotherapy;Chemical;PA142670838;Gene
ERCC1;radiotherapy;Chemical;PA155;Gene
TMEM167A;radiotherapy;Chemical;PA162405909;Gene
GSTM1 NULL;radiotherapy;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;radiotherapy;Chemical;PA166048676;Haplotype
RS10711;radiotherapy;Chemical;PA166153941;Variant
RS11615;radiotherapy;Chemical;PA166155342;Variant
RS1799782;radiotherapy;Chemical;PA166155370;Variant
RS264588;radiotherapy;Chemical;PA166155590;Variant
RS264631;radiotherapy;Chemical;PA166155591;Variant
RS264651;radiotherapy;Chemical;PA166155592;Variant
RS264663;radiotherapy;Chemical;PA166155593;Variant
RS6432512;radiotherapy;Chemical;PA166155744;Variant
RS7582141;radiotherapy;Chemical;PA166155767;Variant
RS10497203;radiotherapy;Chemical;PA166155791;Variant
RS11125035;radiotherapy;Chemical;PA166155799;Variant
RS11942466;radiotherapy;Chemical;PA166156656;Variant
RS2027701;radiotherapy;Chemical;PA166169891;Variant
RS1059698;radiotherapy;Chemical;PA166169893;Variant
RS1829346;radiotherapy;Chemical;PA166169895;Variant
RS73594404;radiotherapy;Chemical;PA166169897;Variant
RS36080650;radiotherapy;Chemical;PA166169899;Variant
RS10132552;radiotherapy;Chemical;PA166169901;Variant
RS2298881;radiotherapy;Chemical;PA166169975;Variant
RS10040363;radiotherapy;Chemical;PA166169977;Variant
RS2075685;radiotherapy;Chemical;PA166169979;Variant
RS3219489;radiotherapy;Chemical;PA166171088;Variant
RS1760944;radiotherapy;Chemical;PA166238764;Variant
GSTM1;radiotherapy;Chemical;PA182;Gene
APEX1;radiotherapy;Chemical;PA201059;Gene
AREG;radiotherapy;Chemical;PA24933;Gene
MEG3;radiotherapy;Chemical;PA30737;Gene
MUTYH;radiotherapy;Chemical;PA31328;Gene
OSGEP;radiotherapy;Chemical;PA32834;Gene
PRKCE;radiotherapy;Chemical;PA33765;Gene
XRCC1;radiotherapy;Chemical;PA369;Gene
XRCC4;radiotherapy;Chemical;PA37423;Gene
CDK1;radiotherapy;Chemical;PA99;Gene
PANCREATITIS;rs199695765;Variant;PA445220;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs199695765;Variant;PA446155;Disease
ASPARAGINASE;rs199695765;Variant;PA448492;Chemical
RS1799807;Butyrylcholinesterase deficiency;Disease;PA166156327;Variant
RS1803274;Butyrylcholinesterase deficiency;Disease;PA166156332;Variant
RS28933389;Butyrylcholinesterase deficiency;Disease;PA166156467;Variant
RS28933390;Butyrylcholinesterase deficiency;Disease;PA166156468;Variant
BCHE;Butyrylcholinesterase deficiency;Disease;PA25294;Gene
ASPARAGINASE;MYBBP1A;Gene;PA448492;Chemical
CYP3A5;apixaban;Chemical;PA131;Gene
RS2231142;apixaban;Chemical;PA166156544;Variant
RS776746;apixaban;Chemical;PA166157267;Variant
RS4148738;apixaban;Chemical;PA166159110;Variant
ABCB1;apixaban;Chemical;PA267;Gene
ABCG2;apixaban;Chemical;PA390;Gene
FLUOROURACIL;RGS5;Gene;PA128406956;Chemical
BEVACIZUMAB;RGS5;Gene;PA130232992;Chemical
COLORECTAL NEOPLASMS;RGS5;Gene;PA446108;Disease
IRINOTECAN;RGS5;Gene;PA450085;Chemical
LEUCOVORIN;RGS5;Gene;PA450198;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs28386840;Variant;PA447197;Disease
METHYLPHENIDATE;rs28386840;Variant;PA450464;Chemical
NPY;NPY2R;Gene;PA255;Gene
PYY;NPY2R;Gene;PA34090;Gene
ETOPOSIDE;rs446112;Variant;PA449552;Chemical
DESMETHYLNAPROXEN;rs1042008;Variant;PA166163690;Chemical
TAPENTADOL;rs1042008;Variant;PA166179720;Chemical
ACETAMINOPHEN;rs1042008;Variant;PA448015;Chemical
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;rs2289252;Variant;PA452637;Chemical
BUTYRYLCHOLINESTERASE DEFICIENCY;rs28933390;Variant;PA166122649;Disease
APNEA;rs28933390;Variant;PA443407;Disease
SUCCINYLCHOLINE;rs28933390;Variant;PA451522;Chemical
CENTRAL NERVOUS SYSTEM DISEASES;CYP2B6*2;Haplotype;PA443657;Disease
HIV INFECTIONS;CYP2B6*2;Haplotype;PA447230;Disease
EFAVIRENZ;CYP2B6*2;Haplotype;PA449441;Chemical
NEOPLASMS;rs1800460;Variant;PA445062;Disease
CISPLATIN;rs1800460;Variant;PA449014;Chemical
ETEPLIRSEN;DMD;Gene;PA166163432;Chemical
GOLODIRSEN;DMD;Gene;PA166190721;Chemical
VILTOLARSEN;DMD;Gene;PA166236421;Chemical
CASIMERSEN;DMD;Gene;PA166251541;Chemical
BUCILLAMINE;HLA-DQB1*04:02;Haplotype;PA166123566;Chemical
ARTHRITIS, RHEUMATOID;HLA-DQB1*04:02;Haplotype;PA443434;Disease
PROTEINURIA;HLA-DQB1*04:02;Haplotype;PA445431;Disease
CES1;capecitabine;Chemical;PA107;Gene
ENOSF1;capecitabine;Chemical;PA134897613;Gene
CES1P1;capecitabine;Chemical;PA134906523;Gene
C18ORF56;capecitabine;Chemical;PA134956204;Gene
DPYD;capecitabine;Chemical;PA145;Gene
DPYS;capecitabine;Chemical;PA146;Gene
ERCC1;capecitabine;Chemical;PA155;Gene
TYMP;capecitabine;Chemical;PA162407502;Gene
MIR27A;capecitabine;Chemical;PA164722621;Gene
GSTM1 NULL;capecitabine;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;capecitabine;Chemical;PA166048676;Haplotype
UGT1A1*1;capecitabine;Chemical;PA166115841;Haplotype
UGT1A1*28;capecitabine;Chemical;PA166115842;Haplotype
RS5275;capecitabine;Chemical;PA166153552;Variant
RS602950;capecitabine;Chemical;PA166153581;Variant
RS1047840;capecitabine;Chemical;PA166153609;Variant
RS1048977;capecitabine;Chemical;PA166153610;Variant
RS1801131;capecitabine;Chemical;PA166153643;Variant
RS1801133;capecitabine;Chemical;PA166153644;Variant
RS1801158;capecitabine;Chemical;PA166153645;Variant
RS1801159;capecitabine;Chemical;PA166153646;Variant
RS1801160;capecitabine;Chemical;PA166153647;Variant
RS1801265;capecitabine;Chemical;PA166153648;Variant
RS1801266;capecitabine;Chemical;PA166153649;Variant
RS1801267;capecitabine;Chemical;PA166153650;Variant
RS1801268;capecitabine;Chemical;PA166153651;Variant
RS2072671;capecitabine;Chemical;PA166153667;Variant
RS2297595;capecitabine;Chemical;PA166153696;Variant
RS3215400;capecitabine;Chemical;PA166153738;Variant
RS3917412;capecitabine;Chemical;PA166153758;Variant
RS3918290;capecitabine;Chemical;PA166153760;Variant
RS12022243;capecitabine;Chemical;PA166153837;Variant
RS12132152;capecitabine;Chemical;PA166153852;Variant
RS17376848;capecitabine;Chemical;PA166153874;Variant
RS45589337;capecitabine;Chemical;PA166153885;Variant
RS55674432;capecitabine;Chemical;PA166153886;Variant
RS55886062;capecitabine;Chemical;PA166153888;Variant
RS56038477;capecitabine;Chemical;PA166153889;Variant
RS59086055;capecitabine;Chemical;PA166153891;Variant
RS60139309;capecitabine;Chemical;PA166153892;Variant
RS67376798;capecitabine;Chemical;PA166153895;Variant
RS72547601;capecitabine;Chemical;PA166153896;Variant
RS72549303;capecitabine;Chemical;PA166153897;Variant
RS72549304;capecitabine;Chemical;PA166153898;Variant
RS72549306;capecitabine;Chemical;PA166153899;Variant
RS72549307;capecitabine;Chemical;PA166153900;Variant
RS72549308;capecitabine;Chemical;PA166153901;Variant
RS72549309;capecitabine;Chemical;PA166153902;Variant
RS75017182;capecitabine;Chemical;PA166153906;Variant
RS76387818;capecitabine;Chemical;PA166153910;Variant
RS78060119;capecitabine;Chemical;PA166153913;Variant
RS80081766;capecitabine;Chemical;PA166153914;Variant
RS111858276;capecitabine;Chemical;PA166153916;Variant
RS112766203;capecitabine;Chemical;PA166153917;Variant
RS114096998;capecitabine;Chemical;PA166153918;Variant
RS115232898;capecitabine;Chemical;PA166153919;Variant
RS137999090;capecitabine;Chemical;PA166153921;Variant
RS138616379;capecitabine;Chemical;PA166153922;Variant
RS141044036;capecitabine;Chemical;PA166153923;Variant
RS143154602;capecitabine;Chemical;PA166153925;Variant
RS145773863;capecitabine;Chemical;PA166153927;Variant
RS146356975;capecitabine;Chemical;PA166153928;Variant
RS147545709;capecitabine;Chemical;PA166153929;Variant
RS147601618;capecitabine;Chemical;PA166153930;Variant
RS183385770;capecitabine;Chemical;PA166153932;Variant
RS186169810;capecitabine;Chemical;PA166153933;Variant
RS200687447;capecitabine;Chemical;PA166153936;Variant
RS2289310;capecitabine;Chemical;PA166154010;Variant
RS17431184;capecitabine;Chemical;PA166154164;Variant
RS1695;capecitabine;Chemical;PA166154249;Variant
RS1048943;capecitabine;Chemical;PA166154855;Variant
RS2236722;capecitabine;Chemical;PA166154880;Variant
RS2244613;capecitabine;Chemical;PA166155037;Variant
RS9936750;capecitabine;Chemical;PA166155097;Variant
RS2612091;capecitabine;Chemical;PA166155285;Variant
RS2741171;capecitabine;Chemical;PA166155287;Variant
RS45445694;capecitabine;Chemical;PA166155331;Variant
RS183205964;capecitabine;Chemical;PA166155336;Variant
RS11615;capecitabine;Chemical;PA166155342;Variant
RS895819;capecitabine;Chemical;PA166155357;Variant
RS885036;capecitabine;Chemical;PA166155606;Variant
RS11479;capecitabine;Chemical;PA166156029;Variant
RS2291078;capecitabine;Chemical;PA166156353;Variant
RS3772809;capecitabine;Chemical;PA166156378;Variant
RS3772810;capecitabine;Chemical;PA166156379;Variant
RS2231142;capecitabine;Chemical;PA166156544;Variant
RS11942466;capecitabine;Chemical;PA166156656;Variant
RS4702484;capecitabine;Chemical;PA166156831;Variant
RS699947;capecitabine;Chemical;PA166156938;Variant
RS2010963;capecitabine;Chemical;PA166157006;Variant
RS2016520;capecitabine;Chemical;PA166157007;Variant
RS3218592;capecitabine;Chemical;PA166157075;Variant
RS4149178;capecitabine;Chemical;PA166157095;Variant
RS9380142;capecitabine;Chemical;PA166157153;Variant
RS17179108;capecitabine;Chemical;PA166157191;Variant
RS371194629;capecitabine;Chemical;PA166157235;Variant
RS1045642;capecitabine;Chemical;PA166157284;Variant
RS1128503;capecitabine;Chemical;PA166157288;Variant
RS2032582;capecitabine;Chemical;PA166157316;Variant
RS17160359;capecitabine;Chemical;PA166157471;Variant
DPYD DEFICIENCY;capecitabine;Chemical;PA166157931;Variant
RS367619008;capecitabine;Chemical;PA166159539;Variant
RS61622928;capecitabine;Chemical;PA166159638;Variant
RS72549310;capecitabine;Chemical;PA166159712;Variant
RS150036960;capecitabine;Chemical;PA166159767;Variant
RS150385342;capecitabine;Chemical;PA166159768;Variant
RS141462178;capecitabine;Chemical;PA166159769;Variant
RS200562975;capecitabine;Chemical;PA166159770;Variant
RS139834141;capecitabine;Chemical;PA166159771;Variant
RS150437414;capecitabine;Chemical;PA166159772;Variant
RS145112791;capecitabine;Chemical;PA166159773;Variant
RS201018345;capecitabine;Chemical;PA166159774;Variant
RS72549305;capecitabine;Chemical;PA166159775;Variant
RS143815742;capecitabine;Chemical;PA166159776;Variant
RS140602333;capecitabine;Chemical;PA166159777;Variant
RS200064537;capecitabine;Chemical;PA166159778;Variant
RS142512579;capecitabine;Chemical;PA166159779;Variant
RS72975710;capecitabine;Chemical;PA166159780;Variant
RS144395748;capecitabine;Chemical;PA166159781;Variant
RS199549923;capecitabine;Chemical;PA166159782;Variant
RS138391898;capecitabine;Chemical;PA166159783;Variant
RS148994843;capecitabine;Chemical;PA166159784;Variant
RS190951787;capecitabine;Chemical;PA166159785;Variant
RS142619737;capecitabine;Chemical;PA166159786;Variant
RS201615754;capecitabine;Chemical;PA166159787;Variant
RS3918289;capecitabine;Chemical;PA166159788;Variant
RS55971861;capecitabine;Chemical;PA166159789;Variant
RS138545885;capecitabine;Chemical;PA166159790;Variant
RS145548112;capecitabine;Chemical;PA166159791;Variant
RS146529561;capecitabine;Chemical;PA166159792;Variant
RS60511679;capecitabine;Chemical;PA166159793;Variant
RS199634007;capecitabine;Chemical;PA166159794;Variant
RS201035051;capecitabine;Chemical;PA166159796;Variant
RS145529148;capecitabine;Chemical;PA166159797;Variant
RS72547602;capecitabine;Chemical;PA166159798;Variant
RS139459586;capecitabine;Chemical;PA166159799;Variant
RS202144771;capecitabine;Chemical;PA166159800;Variant
RS140114515;capecitabine;Chemical;PA166159801;Variant
RS148799944;capecitabine;Chemical;PA166159802;Variant
RS3217164;capecitabine;Chemical;PA166163239;Variant
RS2244614;capecitabine;Chemical;PA166163241;Variant
RS11861118;capecitabine;Chemical;PA166163244;Variant
RS7187684;capecitabine;Chemical;PA166163246;Variant
RS12119882;capecitabine;Chemical;PA166163749;Variant
RS699517;capecitabine;Chemical;PA166163751;Variant
RS2270860;capecitabine;Chemical;PA166163754;Variant
RS2853741;capecitabine;Chemical;PA166163757;Variant
RS2279199;capecitabine;Chemical;PA166163760;Variant
RS4678145;capecitabine;Chemical;PA166163762;Variant
RS143414470;capecitabine;Chemical;PA166165332;Variant
DPYD C.1905+1G>A (*2A);capecitabine;Chemical;PA166171117;Haplotype
DPYD C.1679T>G (*13);capecitabine;Chemical;PA166171118;Haplotype
DPYD C.2846A>T;capecitabine;Chemical;PA166171119;Haplotype
DPYD C.1129-5923C>G, C.1236G>A (HAPB3);capecitabine;Chemical;PA166171120;Haplotype
RS56005131;capecitabine;Chemical;PA166179517;Variant
RS11280056;capecitabine;Chemical;PA166180936;Variant
RS6670886;capecitabine;Chemical;PA166192821;Variant
RS764666241;capecitabine;Chemical;PA166192822;Variant
RS57918000;capecitabine;Chemical;PA166192823;Variant
DPYD C.2194G>A (*6);capecitabine;Chemical;PA166194413;Haplotype
RS755416212;capecitabine;Chemical;PA166320941;Variant
RS143004875;capecitabine;Chemical;PA166321181;Variant
GSTM1;capecitabine;Chemical;PA182;Gene
MTHFR;capecitabine;Chemical;PA245;Gene
ADCY2;capecitabine;Chemical;PA24561;Gene
ANK3;capecitabine;Chemical;PA24800;Gene
AREG;capecitabine;Chemical;PA24933;Gene
ABCB1;capecitabine;Chemical;PA267;Gene
CYP19A1;capecitabine;Chemical;PA27091;Gene
CYP1A1;capecitabine;Chemical;PA27092;Gene
DLG5;capecitabine;Chemical;PA27360;Gene
ERBB2;capecitabine;Chemical;PA27844;Gene
EXO1;capecitabine;Chemical;PA27923;Gene
GSTP1;capecitabine;Chemical;PA29028;Gene
PTGS2;capecitabine;Chemical;PA293;Gene
MGAT4A;capecitabine;Chemical;PA30782;Gene
PPARD;capecitabine;Chemical;PA33557;Gene
PTEN;capecitabine;Chemical;PA33942;Gene
REV3L;capecitabine;Chemical;PA34337;Gene
HLA-G;capecitabine;Chemical;PA35083;Gene
SELE;capecitabine;Chemical;PA35640;Gene
SLC22A7;capecitabine;Chemical;PA35848;Gene
TYMS;capecitabine;Chemical;PA359;Gene
UMPS;capecitabine;Chemical;PA363;Gene
VEGFA;capecitabine;Chemical;PA37302;Gene
ABCG2;capecitabine;Chemical;PA390;Gene
UGT1A1;capecitabine;Chemical;PA420;Gene
CDA;capecitabine;Chemical;PA98;Gene
MAJOR DEPRESSIVE DISORDER;rs1969624;Variant;PA447321;Disease
BUPROPION;rs1969624;Variant;PA448687;Chemical
PRAVASTATIN;rs328;Variant;PA451089;Chemical
ALCOHOL ABUSE;PIP5K1C;Gene;PA443309;Disease
ETHANOL;PIP5K1C;Gene;PA448073;Chemical
AIFM2;Vitamin K;Chemical;PA162376150;Gene
RS2108622;Vitamin K;Chemical;PA166155381;Variant
CYP4F2;Vitamin K;Chemical;PA27121;Gene
G6PD;Vitamin K;Chemical;PA28469;Gene
WARFARIN;Vitamin K;Chemical;PA451906;Chemical
ABCC2;vincristine;Chemical;PA116;Gene
CYP3A4;vincristine;Chemical;PA130;Gene
CYP3A5;vincristine;Chemical;PA131;Gene
C18ORF56;vincristine;Chemical;PA134956204;Gene
DROSHA;vincristine;Chemical;PA142671060;Gene
CEP72;vincristine;Chemical;PA142672125;Gene
LINC00251;vincristine;Chemical;PA165585763;Gene
CYP3A5*1;vincristine;Chemical;PA166128213;Haplotype
CYP3A5*3;vincristine;Chemical;PA166128219;Haplotype
RS1891059;vincristine;Chemical;PA166153658;Variant
RS17021408;vincristine;Chemical;PA166153867;Variant
RS80223967;vincristine;Chemical;PA166153915;Variant
RS3824662;vincristine;Chemical;PA166154043;Variant
RS1135989;vincristine;Chemical;PA166155182;Variant
RS4148416;vincristine;Chemical;PA166155219;Variant
RS45445694;vincristine;Chemical;PA166155331;Variant
RS3770102;vincristine;Chemical;PA166155709;Variant
RS79085477;vincristine;Chemical;PA166155968;Variant
RS117532069;vincristine;Chemical;PA166155970;Variant
RS639174;vincristine;Chemical;PA166156737;Variant
RS924607;vincristine;Chemical;PA166156745;Variant
RS3957357;vincristine;Chemical;PA166157094;Variant
RS1045642;vincristine;Chemical;PA166157284;Variant
RS1128503;vincristine;Chemical;PA166157288;Variant
RS2032582;vincristine;Chemical;PA166157316;Variant
RS2229109;vincristine;Chemical;PA166157334;Variant
RS4148737;vincristine;Chemical;PA166157385;Variant
RS4728709;vincristine;Chemical;PA166157398;Variant
RS141059755;vincristine;Chemical;PA166157691;Variant
RS1801157;vincristine;Chemical;PA166159131;Variant
RS738409;vincristine;Chemical;PA166165078;Variant
RS12283870;vincristine;Chemical;PA166285621;Variant
RS1247117;vincristine;Chemical;PA166289281;Variant
RS533334893;vincristine;Chemical;PA166307621;Variant
ABCC10;vincristine;Chemical;PA24392;Gene
ABCC1;vincristine;Chemical;PA244;Gene
ABL1;vincristine;Chemical;PA24413;Gene
ACTG1;vincristine;Chemical;PA24468;Gene
BCL2;vincristine;Chemical;PA25302;Gene
BCR;vincristine;Chemical;PA25321;Gene
BMP7;vincristine;Chemical;PA25384;Gene
DOK5;vincristine;Chemical;PA25724;Gene
CAPG;vincristine;Chemical;PA26056;Gene
ABCB1;vincristine;Chemical;PA267;Gene
CPT1A;vincristine;Chemical;PA26847;Gene
GATA3;vincristine;Chemical;PA28586;Gene
GSTA1;vincristine;Chemical;PA29016;Gene
IGHMBP2;vincristine;Chemical;PA29731;Gene
RALBP1;vincristine;Chemical;PA34199;Gene
CXCL12;vincristine;Chemical;PA35602;Gene
TYMS;vincristine;Chemical;PA359;Gene
ABCC3;vincristine;Chemical;PA376;Gene
NR1I2;vincristine;Chemical;PA378;Gene
PNPLA3;vincristine;Chemical;PA38592;Gene
FENOTEROL;ADRB2;Gene;PA10079;Chemical
CORTICOSTEROIDS;ADRB2;Gene;PA10832;Chemical
SELECTIVE BETA-2-ADRENORECEPTOR AGONISTS;ADRB2;Gene;PA134687887;Chemical
FORMOTEROL;ADRB2;Gene;PA134687907;Chemical
DIURETICS;ADRB2;Gene;PA151249535;Chemical
ACE INHIBITORS, PLAIN;ADRB2;Gene;PA164712308;Chemical
ANGIOTENSIN II ANTAGONISTS;ADRB2;Gene;PA164712372;Chemical
BETA BLOCKING AGENTS;ADRB2;Gene;PA164712535;Chemical
BETA BLOCKING AGENTS, NON-SELECTIVE;ADRB2;Gene;PA164712541;Chemical
LABETALOL;ADRB2;Gene;PA164743150;Chemical
TIOTROPIUM;ADRB2;Gene;PA164769056;Chemical
ACUTE CORONARY SYNDROME;ADRB2;Gene;PA165108401;Disease
METHACHOLINE;ADRB2;Gene;PA165958382;Chemical
GNAI1;ADRB2;Gene;PA172;Gene
GNAI3;ADRB2;Gene;PA173;Gene
GNAS;ADRB2;Gene;PA175;Gene
GNAI2;ADRB2;Gene;PA24347;Gene
ELF2;ADRB2;Gene;PA27745;Gene
PLCB1;ADRB2;Gene;PA33384;Gene
PLCB2;ADRB2;Gene;PA33385;Gene
PLCB3;ADRB2;Gene;PA33386;Gene
PLCB4;ADRB2;Gene;PA33387;Gene
PRKCA;ADRB2;Gene;PA33759;Gene
PRKCB;ADRB2;Gene;PA33761;Gene
PRKCD;ADRB2;Gene;PA33763;Gene
CAVIN3;ADRB2;Gene;PA33764;Gene
PRKCE;ADRB2;Gene;PA33765;Gene
PRKCG;ADRB2;Gene;PA33766;Gene
PRKCH;ADRB2;Gene;PA33767;Gene
PRKCQ;ADRB2;Gene;PA33773;Gene
PRKCZ;ADRB2;Gene;PA33775;Gene
GRK2;ADRB2;Gene;PA40;Gene
GRK3;ADRB2;Gene;PA41;Gene
ASTHMA;ADRB2;Gene;PA443450;Disease
CARDIOMYOPATHY, DILATED;ADRB2;Gene;PA443632;Disease
CORONARY ARTERY DISEASE;ADRB2;Gene;PA443796;Disease
HEART FAILURE;ADRB2;Gene;PA444370;Disease
HYPERTENSION;ADRB2;Gene;PA444552;Disease
HYPOTENSIVE DISORDER;ADRB2;Gene;PA444584;Disease
LIVER CIRRHOSIS;ADRB2;Gene;PA444797;Disease
TACHYCARDIA;ADRB2;Gene;PA445802;Disease
HYPERTROPHY, LEFT VENTRICULAR;ADRB2;Gene;PA446479;Disease
SCHIZOPHRENIA;ADRB2;Gene;PA447216;Disease
ESSENTIAL HYPERTENSION;ADRB2;Gene;PA447288;Disease
SALBUTAMOL;ADRB2;Gene;PA448068;Chemical
ATENOLOL;ADRB2;Gene;PA448499;Chemical
BENAZEPRIL;ADRB2;Gene;PA448561;Chemical
CARVEDILOL;ADRB2;Gene;PA448817;Chemical
DIGOXIN;ADRB2;Gene;PA449319;Chemical
ENALAPRIL;ADRB2;Gene;PA449456;Chemical
EPHEDRINE;ADRB2;Gene;PA449466;Chemical
EPINEPHRINE;ADRB2;Gene;PA449470;Chemical
FENTANYL;ADRB2;Gene;PA449599;Chemical
ISOPROTERENOL;ADRB2;Gene;PA450121;Chemical
ORCIPRENALINE;ADRB2;Gene;PA450390;Chemical
METOPROLOL;ADRB2;Gene;PA450480;Chemical
NADOLOL;ADRB2;Gene;PA450573;Chemical
PHENYLEPHRINE;ADRB2;Gene;PA450935;Chemical
PINDOLOL;ADRB2;Gene;PA450966;Chemical
PROPOFOL;ADRB2;Gene;PA451141;Chemical
PROPRANOLOL;ADRB2;Gene;PA451145;Chemical
REMIFENTANIL;ADRB2;Gene;PA451232;Chemical
RISPERIDONE;ADRB2;Gene;PA451257;Chemical
RITODRINE;ADRB2;Gene;PA451258;Chemical
SALMETEROL;ADRB2;Gene;PA451300;Chemical
SEVOFLURANE;ADRB2;Gene;PA451341;Chemical
SOTALOL;ADRB2;Gene;PA451457;Chemical
SPIRONOLACTONE;ADRB2;Gene;PA451483;Chemical
TERBUTALINE;ADRB2;Gene;PA451616;Chemical
ARRB1;ADRB2;Gene;PA59;Gene
ARRB2;ADRB2;Gene;PA60;Gene
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs2013169;Variant;PA447197;Disease
METHYLPHENIDATE;rs2013169;Variant;PA450464;Chemical
DEPRESSIVE DISORDER;rs2235015;Variant;PA447207;Disease
DEPRESSION;rs2235015;Variant;PA447278;Disease
MAJOR DEPRESSIVE DISORDER;rs2235015;Variant;PA447321;Disease
AMITRIPTYLINE;rs2235015;Variant;PA448385;Chemical
CITALOPRAM;rs2235015;Variant;PA449015;Chemical
PAROXETINE;rs2235015;Variant;PA450801;Chemical
VENLAFAXINE;rs2235015;Variant;PA451866;Chemical
ANTIDEPRESSANTS;rs2235015;Variant;PA452229;Chemical
GNAI1;ADCY2;Gene;PA172;Gene
GNAI3;ADCY2;Gene;PA173;Gene
GNAS;ADCY2;Gene;PA175;Gene
GNAI2;ADCY2;Gene;PA24347;Gene
COLORECTAL NEOPLASMS;ADCY2;Gene;PA446108;Disease
SCHIZOPHRENIA;ADCY2;Gene;PA447216;Disease
CAPECITABINE;ADCY2;Gene;PA448771;Chemical
ANTIPSYCHOTICS;ADCY2;Gene;PA452233;Chemical
BIPOLAR DISORDER;rs1611255;Variant;PA447199;Disease
LITHIUM;rs1611255;Variant;PA450243;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs2072671;Variant;PA443622;Disease
LEUKEMIA;rs2072671;Variant;PA444750;Disease
LYMPHOMA;rs2072671;Variant;PA444840;Disease
MESOTHELIOMA;rs2072671;Variant;PA444937;Disease
NAUSEA;rs2072671;Variant;PA445048;Disease
NEOPLASMS;rs2072671;Variant;PA445062;Disease
PANCREATIC NEOPLASMS;rs2072671;Variant;PA445218;Disease
CAPECITABINE;rs2072671;Variant;PA448771;Chemical
CYTARABINE;rs2072671;Variant;PA449177;Chemical
GEMCITABINE;rs2072671;Variant;PA449748;Chemical
PACLITAXEL;rs2072671;Variant;PA450761;Chemical
IFNL3;sofosbuvir;Chemical;PA134952671;Gene
IFNL4;sofosbuvir;Chemical;PA166049147;Gene
RS8099917;sofosbuvir;Chemical;PA166155435;Variant
RS12979860;sofosbuvir;Chemical;PA166155468;Variant
RS11322783;sofosbuvir;Chemical;PA166190881;Variant
SUBSTANCE-RELATED DISORDERS;rs713729;Variant;PA446876;Disease
METHAMPHETAMINE;rs713729;Variant;PA450403;Chemical
BRIVANIB;FGFR1OP2;Gene;PA164924492;Chemical
CRK;FGFR1OP2;Gene;PA26880;Gene
FGF2;FGFR1OP2;Gene;PA28115;Gene
PIK3C2A;FGFR1OP2;Gene;PA33304;Gene
PIK3C2B;FGFR1OP2;Gene;PA33305;Gene
HMG COA REDUCTASE INHIBITORS;rs11045819;Variant;PA133950441;Chemical
HYPERCHOLESTEROLEMIA;rs11045819;Variant;PA444516;Disease
FLUVASTATIN;rs11045819;Variant;PA449688;Chemical
RIFAMPIN;rs11045819;Variant;PA451250;Chemical
ALCOHOL ABUSE;rs72768626;Variant;PA443309;Disease
ETHANOL;rs72768626;Variant;PA448073;Chemical
ARIPIPRAZOLE;CYP2D6;Gene;PA10026;Chemical
BROMAZEPAM;CYP2D6;Gene;PA10035;Chemical
DULOXETINE;CYP2D6;Gene;PA10066;Chemical
ESCITALOPRAM;CYP2D6;Gene;PA10074;Chemical
FLUPENTHIXOL;CYP2D6;Gene;PA10268;Chemical
PALONOSETRON;CYP2D6;Gene;PA10352;Chemical
WEIGHT GAIN;CYP2D6;Gene;PA128406954;Disease
PERHEXILINE;CYP2D6;Gene;PA130150436;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;CYP2D6;Gene;PA130620651;Chemical
GEFITINIB;CYP2D6;Gene;PA131301952;Chemical
3,4-METHYLENEDIOXYMETHAMPHETAMINE;CYP2D6;Gene;PA131887008;Chemical
HMG COA REDUCTASE INHIBITORS;CYP2D6;Gene;PA133950441;Chemical
ROSUVASTATIN;CYP2D6;Gene;PA134308647;Chemical
FORMOTEROL;CYP2D6;Gene;PA134687907;Chemical
MIANSERIN;CYP2D6;Gene;PA134687937;Chemical
LEVOMEPROMAZINE;CYP2D6;Gene;PA134687942;Chemical
ELETRIPTAN;CYP2D6;Gene;PA134687947;Chemical
ATOMOXETINE;CYP2D6;Gene;PA134688071;Chemical
TETRABENAZINE;CYP2D6;Gene;PA140222719;Chemical
OPIPRAMOL;CYP2D6;Gene;PA144614922;Chemical
NEBIVOLOL;CYP2D6;Gene;PA151958426;Chemical
DRONEDARONE;CYP2D6;Gene;PA153619853;Chemical
ILOPERIDONE;CYP2D6;Gene;PA161199368;Chemical
TROPISETRON;CYP2D6;Gene;PA161925594;Chemical
PALIPERIDONE;CYP2D6;Gene;PA163518919;Chemical
OPIUM DERIVATIVES AND EXPECTORANTS;CYP2D6;Gene;PA164712951;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;CYP2D6;Gene;PA164713257;Chemical
ARFORMOTEROL;CYP2D6;Gene;PA164743977;Chemical
LOFEXIDINE;CYP2D6;Gene;PA164744510;Chemical
RANOLAZINE;CYP2D6;Gene;PA164746007;Chemical
TOLTERODINE;CYP2D6;Gene;PA164746757;Chemical
CEVIMELINE;CYP2D6;Gene;PA164754754;Chemical
BEPRIDIL;CYP2D6;Gene;PA164754755;Chemical
TIOTROPIUM;CYP2D6;Gene;PA164769056;Chemical
DARIFENACIN;CYP2D6;Gene;PA164774901;Chemical
DIVALPROEX SODIUM;CYP2D6;Gene;PA164783479;Chemical
SERTINDOLE;CYP2D6;Gene;PA164784002;Chemical
TOXIC LIVER DISEASE;CYP2D6;Gene;PA164925725;Disease
BINGE EATING DISORDER;CYP2D6;Gene;PA165108929;Disease
SUICIDE;CYP2D6;Gene;PA165374639;Disease
BERBERINE;CYP2D6;Gene;PA165860812;Chemical
HYDROXYAMITRIPTYLINE;CYP2D6;Gene;PA165946747;Chemical
DESVENLAFAXINE;CYP2D6;Gene;PA165958374;Chemical
FESOTERODINE;CYP2D6;Gene;PA165958376;Chemical
CYP2D6*1XN;CYP2D6;Gene;PA165988479;Haplotype
CYP2D6*2XN;CYP2D6;Gene;PA165988480;Haplotype
ELDERLY ADULT;CYP2D6;Gene;PA166048829;Disease
BUFURALOL;CYP2D6;Gene;PA166110256;Chemical
DRY MOUTH;CYP2D6;Gene;PA166115462;Disease
IBRUTINIB;CYP2D6;Gene;PA166121346;Chemical
VORTIOXETINE;CYP2D6;Gene;PA166122595;Chemical
PROGRESSION-FREE SURVIVAL;CYP2D6;Gene;PA166123026;Disease
OVERALL SURVIVAL;CYP2D6;Gene;PA166123207;Disease
AGITATION;CYP2D6;Gene;PA166123306;Disease
INSOMNIA;CYP2D6;Gene;PA166123307;Disease
EVENT-FREE SURVIVAL;CYP2D6;Gene;PA166123366;Disease
SCHIZOAFFECTIVE DISORDER;CYP2D6;Gene;PA166123368;Disease
ELIGLUSTAT;CYP2D6;Gene;PA166123486;Chemical
DISCONTINUATION;CYP2D6;Gene;PA166123507;Disease
ENDOXIFEN;CYP2D6;Gene;PA166124478;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6;Gene;PA166127651;Chemical
4-HYDROXYTAMOXIFEN;CYP2D6;Gene;PA166127652;Chemical
RECURRENCE FREE SURVIVAL;CYP2D6;Gene;PA166127658;Disease
CARDIOTOXICITY;CYP2D6;Gene;PA166128121;Disease
SEDATION;CYP2D6;Gene;PA166129521;Disease
NOROXYCODONE;CYP2D6;Gene;PA166131342;Chemical
O-DESMETHYLTRAMADOL;CYP2D6;Gene;PA166131379;Chemical
N-DESMETHYLTRAMADOL;CYP2D6;Gene;PA166131493;Chemical
N,O-DIDESMETHYLTRAMADOL;CYP2D6;Gene;PA166131494;Chemical
DESMETHYL CLOMIPRAMINE;CYP2D6;Gene;PA166131507;Chemical
ADVERSE EVENTS;CYP2D6;Gene;PA166151827;Disease
DAPOXETINE;CYP2D6;Gene;PA166151992;Chemical
TOLPERISONE;CYP2D6;Gene;PA166152940;Chemical
COPTISINE;CYP2D6;Gene;PA166153416;Chemical
FLIBANSERIN;CYP2D6;Gene;PA166153431;Chemical
BREXPIPRAZOLE;CYP2D6;Gene;PA166160053;Chemical
ARIPIPRAZOLE LAUROXIL;CYP2D6;Gene;PA166161216;Chemical
RUCAPARIB;CYP2D6;Gene;PA166163418;Chemical
2-HYDROXYMETHYL OLANZAPINE;CYP2D6;Gene;PA166164917;Chemical
DEUTETRABENAZINE;CYP2D6;Gene;PA166169881;Chemical
VALBENAZINE;CYP2D6;Gene;PA166170051;Chemical
EXTRAPYRAMIDAL SYMPTOMS;CYP2D6;Gene;PA166170367;Disease
CNS DEPRESSION;CYP2D6;Gene;PA166170668;Disease
DEXTROMETHORPHAN / QUINIDINE;CYP2D6;Gene;PA166175998;Chemical
FLUOXETINE / OLANZAPINE;CYP2D6;Gene;PA166176027;Chemical
DIHYDROCODEINE;CYP2D6;Gene;PA166176885;Chemical
CARIPRAZINE;CYP2D6;Gene;PA166177476;Chemical
MIRABEGRON;CYP2D6;Gene;PA166177513;Chemical
UMECLIDINIUM;CYP2D6;Gene;PA166177519;Chemical
ACETAMINOPHEN / CODEINE;CYP2D6;Gene;PA166184061;Chemical
VERNAKALANT;CYP2D6;Gene;PA166184233;Chemical
UMECLIDINIUM / VILANTEROL;CYP2D6;Gene;PA166184235;Chemical
PARACETAMOL, COMBINATIONS EXCL. PSYCHOLEPTICS (VICKS MEDINAIT SIRUP);CYP2D6;Gene;PA166184497;Chemical
MEPHEDRONE;CYP2D6;Gene;PA166184711;Chemical
PITOLISANT;CYP2D6;Gene;PA166185163;Chemical
DYSPHORIA;CYP2D6;Gene;PA166185295;Disease
UPADACITINIB;CYP2D6;Gene;PA166189803;Chemical
ETHYLMORPHINE;CYP2D6;Gene;PA166210801;Chemical
OLICERIDINE;CYP2D6;Gene;PA166223601;Chemical
CYP2D6*2X2;CYP2D6;Gene;PA166228161;Haplotype
ACETAMINOPHEN / CAFFEINE / DIHYDROCODEINE;CYP2D6;Gene;PA166246281;Chemical
VILOXAZINE;CYP2D6;Gene;PA166251581;Chemical
DEXTROMETHORPHAN HYDROBROMIDE / BUPROPION HYDROCHLORIDE;CYP2D6;Gene;PA166278341;Chemical
SOLANIDINE;CYP2D6;Gene;PA166289881;Chemical
XANOMELINE / TROSPIUM;CYP2D6;Gene;PA166353841;Chemical
ADENOCARCINOMA;CYP2D6;Gene;PA443265;Disease
ALZHEIMER DISEASE;CYP2D6;Gene;PA443319;Disease
ANEMIA, SICKLE CELL;CYP2D6;Gene;PA443355;Disease
ANGINA PECTORIS;CYP2D6;Gene;PA443362;Disease
ARRHYTHMIAS, CARDIAC;CYP2D6;Gene;PA443421;Disease
BACK PAIN;CYP2D6;Gene;PA443472;Disease
BRADYCARDIA;CYP2D6;Gene;PA443548;Disease
BRAIN NEOPLASMS;CYP2D6;Gene;PA443557;Disease
BREAST NEOPLASMS;CYP2D6;Gene;PA443560;Disease
BURNS;CYP2D6;Gene;PA443582;Disease
CARCINOMA, NON-SMALL-CELL LUNG;CYP2D6;Gene;PA443622;Disease
CONSTIPATION;CYP2D6;Gene;PA443782;Disease
DEATH;CYP2D6;Gene;PA443842;Disease
DEMENTIA;CYP2D6;Gene;PA443853;Disease
DIABETIC NEUROPATHIES;CYP2D6;Gene;PA443894;Disease
DIZZINESS;CYP2D6;Gene;PA443928;Disease
DRUG TOXICITY;CYP2D6;Gene;PA443937;Disease
DUCTUS ARTERIOSUS, PATENT;CYP2D6;Gene;PA443940;Disease
DYSTONIA;CYP2D6;Gene;PA443970;Disease
EDEMA;CYP2D6;Gene;PA443994;Disease
EPILEPSY;CYP2D6;Gene;PA444065;Disease
EXANTHEMA;CYP2D6;Gene;PA444109;Disease
FATIGUE;CYP2D6;Gene;PA444153;Disease
GALACTORRHEA;CYP2D6;Gene;PA444239;Disease
GASTROINTESTINAL NEOPLASMS;CYP2D6;Gene;PA444257;Disease
GAUCHER DISEASE;CYP2D6;Gene;PA444258;Disease
HEAD AND NECK NEOPLASMS;CYP2D6;Gene;PA444352;Disease
HEART DISEASES;CYP2D6;Gene;PA444368;Disease
HEART FAILURE;CYP2D6;Gene;PA444370;Disease
HEROIN DEPENDENCE;CYP2D6;Gene;PA444460;Disease
HYPERTENSION;CYP2D6;Gene;PA444552;Disease
INAPPROPRIATE ADH SYNDROME;CYP2D6;Gene;PA444607;Disease
MALARIA;CYP2D6;Gene;PA444859;Disease
OPIOID-RELATED DISORDERS;CYP2D6;Gene;PA445043;Disease
NAUSEA;CYP2D6;Gene;PA445048;Disease
NEOPLASMS;CYP2D6;Gene;PA445062;Disease
OSTEOARTHRITIS;CYP2D6;Gene;PA445174;Disease
PAIN;CYP2D6;Gene;PA445208;Disease
PAIN, POSTOPERATIVE;CYP2D6;Gene;PA445210;Disease
FAMILIAL MEDITERRANEAN FEVER;CYP2D6;Gene;PA445293;Disease
POISONING;CYP2D6;Gene;PA445371;Disease
PSYCHOMOTOR AGITATION;CYP2D6;Gene;PA445452;Disease
RECURRENCE;CYP2D6;Gene;PA445506;Disease
RESPIRATORY INSUFFICIENCY;CYP2D6;Gene;PA445522;Disease
SEIZURES;CYP2D6;Gene;PA445629;Disease
TACHYCARDIA;CYP2D6;Gene;PA445802;Disease
VOMITING;CYP2D6;Gene;PA446051;Disease
URINARY RETENTION;CYP2D6;Gene;PA446264;Disease
LOW BACK PAIN;CYP2D6;Gene;PA446444;Disease
HOT FLASHES;CYP2D6;Gene;PA446852;Disease
ALCOHOL-RELATED DISORDERS;CYP2D6;Gene;PA446879;Disease
SEROTONIN SYNDROME;CYP2D6;Gene;PA446956;Disease
POSTOPERATIVE NAUSEA AND VOMITING;CYP2D6;Gene;PA446970;Disease
AGORAPHOBIA;CYP2D6;Gene;PA447194;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CYP2D6;Gene;PA447197;Disease
AUTISTIC DISORDER;CYP2D6;Gene;PA447198;Disease
DEPRESSIVE DISORDER;CYP2D6;Gene;PA447207;Disease
MENTAL DISORDERS;CYP2D6;Gene;PA447208;Disease
MOOD DISORDERS;CYP2D6;Gene;PA447209;Disease
OBSESSIVE-COMPULSIVE DISORDER;CYP2D6;Gene;PA447211;Disease
PSYCHOTIC DISORDERS;CYP2D6;Gene;PA447215;Disease
SCHIZOPHRENIA;CYP2D6;Gene;PA447216;Disease
HIV INFECTIOUS DISEASE;CYP2D6;Gene;PA447230;Disease
TARDIVE DYSKINESIA;CYP2D6;Gene;PA447268;Disease
DEPRESSION;CYP2D6;Gene;PA447278;Disease
VISION DISORDERS;CYP2D6;Gene;PA447310;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2D6;Gene;PA447321;Disease
ACEBUTOLOL;CYP2D6;Gene;PA448011;Chemical
ACETAMINOPHEN;CYP2D6;Gene;PA448015;Chemical
ETHANOL;CYP2D6;Gene;PA448073;Chemical
AMIODARONE;CYP2D6;Gene;PA448383;Chemical
AMITRIPTYLINE;CYP2D6;Gene;PA448385;Chemical
AMOXAPINE;CYP2D6;Gene;PA448405;Chemical
AMPHETAMINE;CYP2D6;Gene;PA448408;Chemical
ASPIRIN;CYP2D6;Gene;PA448497;Chemical
ATENOLOL;CYP2D6;Gene;PA448499;Chemical
ATORVASTATIN;CYP2D6;Gene;PA448500;Chemical
BETAXOLOL;CYP2D6;Gene;PA448611;Chemical
BISOPROLOL;CYP2D6;Gene;PA448641;Chemical
BUPROPION;CYP2D6;Gene;PA448687;Chemical
BUSPIRONE;CYP2D6;Gene;PA448689;Chemical
CARBAMAZEPINE;CYP2D6;Gene;PA448785;Chemical
CARVEDILOL;CYP2D6;Gene;PA448817;Chemical
CELECOXIB;CYP2D6;Gene;PA448871;Chemical
CHLORPHENIRAMINE;CYP2D6;Gene;PA448960;Chemical
CHLORPROMAZINE;CYP2D6;Gene;PA448964;Chemical
CIPROFLOXACIN;CYP2D6;Gene;PA449009;Chemical
CITALOPRAM;CYP2D6;Gene;PA449015;Chemical
CLOMIPRAMINE;CYP2D6;Gene;PA449048;Chemical
CLONIDINE;CYP2D6;Gene;PA449051;Chemical
CLOZAPINE;CYP2D6;Gene;PA449061;Chemical
CODEINE;CYP2D6;Gene;PA449088;Chemical
COLCHICINE;CYP2D6;Gene;PA449092;Chemical
DESIPRAMINE;CYP2D6;Gene;PA449233;Chemical
DEXTROMETHORPHAN;CYP2D6;Gene;PA449273;Chemical
DIAZEPAM;CYP2D6;Gene;PA449283;Chemical
DISOPYRAMIDE;CYP2D6;Gene;PA449373;Chemical
DOLASETRON;CYP2D6;Gene;PA449390;Chemical
DONEPEZIL;CYP2D6;Gene;PA449394;Chemical
DOXEPIN;CYP2D6;Gene;PA449409;Chemical
FENTANYL;CYP2D6;Gene;PA449599;Chemical
FLECAINIDE;CYP2D6;Gene;PA449646;Chemical
FLUOXETINE;CYP2D6;Gene;PA449673;Chemical
FLUPHENAZINE;CYP2D6;Gene;PA449676;Chemical
FLUVASTATIN;CYP2D6;Gene;PA449688;Chemical
FLUVOXAMINE;CYP2D6;Gene;PA449690;Chemical
GALANTAMINE;CYP2D6;Gene;PA449726;Chemical
GRANISETRON;CYP2D6;Gene;PA449809;Chemical
HALOPERIDOL;CYP2D6;Gene;PA449841;Chemical
HYDROCODONE;CYP2D6;Gene;PA449900;Chemical
HYDROMORPHONE;CYP2D6;Gene;PA449918;Chemical
IMIPRAMINE;CYP2D6;Gene;PA449969;Chemical
KETOPROFEN;CYP2D6;Gene;PA450149;Chemical
KETOROLAC;CYP2D6;Gene;PA450150;Chemical
LAMOTRIGINE;CYP2D6;Gene;PA450164;Chemical
LOVASTATIN;CYP2D6;Gene;PA450272;Chemical
MAPROTILINE;CYP2D6;Gene;PA450322;Chemical
MECLIZINE;CYP2D6;Gene;PA450338;Chemical
METHADONE;CYP2D6;Gene;PA450401;Chemical
METHYLPHENIDATE;CYP2D6;Gene;PA450464;Chemical
METOCLOPRAMIDE;CYP2D6;Gene;PA450475;Chemical
METOPROLOL;CYP2D6;Gene;PA450480;Chemical
MEXILETINE;CYP2D6;Gene;PA450488;Chemical
MIRTAZAPINE;CYP2D6;Gene;PA450522;Chemical
MODAFINIL;CYP2D6;Gene;PA450530;Chemical
MORPHINE;CYP2D6;Gene;PA450550;Chemical
NEFAZODONE;CYP2D6;Gene;PA450603;Chemical
NEVIRAPINE;CYP2D6;Gene;PA450616;Chemical
NICOTINE;CYP2D6;Gene;PA450626;Chemical
NORTRIPTYLINE;CYP2D6;Gene;PA450657;Chemical
OLANZAPINE;CYP2D6;Gene;PA450688;Chemical
ONDANSETRON;CYP2D6;Gene;PA450705;Chemical
OXCARBAZEPINE;CYP2D6;Gene;PA450732;Chemical
OXYCODONE;CYP2D6;Gene;PA450741;Chemical
PAROXETINE;CYP2D6;Gene;PA450801;Chemical
PERPHENAZINE;CYP2D6;Gene;PA450882;Chemical
PHENYTOIN;CYP2D6;Gene;PA450947;Chemical
PIMOZIDE;CYP2D6;Gene;PA450965;Chemical
PRIMAQUINE;CYP2D6;Gene;PA451103;Chemical
PROMETHAZINE;CYP2D6;Gene;PA451128;Chemical
PROPAFENONE;CYP2D6;Gene;PA451131;Chemical
PROPRANOLOL;CYP2D6;Gene;PA451145;Chemical
PROTRIPTYLINE;CYP2D6;Gene;PA451168;Chemical
QUETIAPINE;CYP2D6;Gene;PA451201;Chemical
QUINIDINE;CYP2D6;Gene;PA451209;Chemical
QUININE;CYP2D6;Gene;PA451213;Chemical
RISPERIDONE;CYP2D6;Gene;PA451257;Chemical
RITONAVIR;CYP2D6;Gene;PA451260;Chemical
SERTRALINE;CYP2D6;Gene;PA451333;Chemical
SIMVASTATIN;CYP2D6;Gene;PA451363;Chemical
SOTALOL;CYP2D6;Gene;PA451457;Chemical
SULFASALAZINE;CYP2D6;Gene;PA451547;Chemical
TAMOXIFEN;CYP2D6;Gene;PA451581;Chemical
TAMSULOSIN;CYP2D6;Gene;PA451583;Chemical
TERBINAFINE;CYP2D6;Gene;PA451614;Chemical
THIORIDAZINE;CYP2D6;Gene;PA451666;Chemical
TIMOLOL;CYP2D6;Gene;PA451690;Chemical
TOREMIFENE;CYP2D6;Gene;PA451731;Chemical
TRAMADOL;CYP2D6;Gene;PA451735;Chemical
TRAZODONE;CYP2D6;Gene;PA451744;Chemical
TRIMIPRAMINE;CYP2D6;Gene;PA451791;Chemical
VALPROIC ACID;CYP2D6;Gene;PA451846;Chemical
VENLAFAXINE;CYP2D6;Gene;PA451866;Chemical
YOHIMBINE;CYP2D6;Gene;PA451946;Chemical
ZIPRASIDONE;CYP2D6;Gene;PA451974;Chemical
ANTIDEPRESSANTS;CYP2D6;Gene;PA452229;Chemical
ANTIPSYCHOTICS;CYP2D6;Gene;PA452233;Chemical
SPARTEINE;CYP2D6;Gene;PA452610;Chemical
DEBRISOQUINE;CYP2D6;Gene;PA452616;Chemical
OPIOIDS;CYP2D6;Gene;PA452618;Chemical
ANTINEOPLASTIC AGENTS;CYP2D6;Gene;PA452621;Chemical
ZUCLOPENTHIXOL;CYP2D6;Gene;PA452629;Chemical
WARFARIN;rs61162043;Variant;PA451906;Chemical
TOBACCO USE DISORDER;rs8109525;Variant;PA445876;Disease
BUPROPION;rs8109525;Variant;PA448687;Chemical
FLUOROURACIL;XRCC3;Gene;PA128406956;Chemical
PLATINUM COMPOUNDS;XRCC3;Gene;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;XRCC3;Gene;PA443622;Disease
COLORECTAL NEOPLASMS;XRCC3;Gene;PA446108;Disease
IRINOTECAN;XRCC3;Gene;PA450085;Chemical
LEUCOVORIN;XRCC3;Gene;PA450198;Chemical
TOLBUTAMIDE;rs762081829;Variant;PA451718;Chemical
ANALGESICS;DBH;Gene;PA164712362;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;DBH;Gene;PA164712462;Chemical
ERGOT ALKALOIDS;DBH;Gene;PA164712741;Chemical
ALCOHOL ABUSE;DBH;Gene;PA443309;Disease
HEROIN DEPENDENCE;DBH;Gene;PA444460;Disease
MEMORY IMPAIRMENT;DBH;Gene;PA444910;Disease
OPIOID-RELATED DISORDERS;DBH;Gene;PA445043;Disease
SUBSTANCE WITHDRAWAL SYNDROME;DBH;Gene;PA445768;Disease
COCAINE DEPENDENCE;DBH;Gene;PA446878;Disease
MAJOR DEPRESSIVE DISORDER;DBH;Gene;PA447321;Disease
BUPROPION;DBH;Gene;PA448687;Chemical
DISULFIRAM;DBH;Gene;PA449376;Chemical
LEVODOPA;DBH;Gene;PA450213;Chemical
NALTREXONE;DBH;Gene;PA450588;Chemical
SUMATRIPTAN;DBH;Gene;PA451566;Chemical
OPIOIDS;DBH;Gene;PA452618;Chemical
HEROIN;DBH;Gene;PA452619;Chemical
3,4-METHYLENEDIOXYMETHAMPHETAMINE;CYP2D6*9;Haplotype;PA131887008;Chemical
ATOMOXETINE;CYP2D6*9;Haplotype;PA134688071;Chemical
BUFURALOL;CYP2D6*9;Haplotype;PA166110256;Chemical
EVENT-FREE SURVIVAL;CYP2D6*9;Haplotype;PA166123366;Disease
ENDOXIFEN;CYP2D6*9;Haplotype;PA166124478;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*9;Haplotype;PA166127651;Chemical
SEDATION;CYP2D6*9;Haplotype;PA166129521;Disease
O-DESMETHYLTRAMADOL;CYP2D6*9;Haplotype;PA166131379;Chemical
N,O-DIDESMETHYLTRAMADOL;CYP2D6*9;Haplotype;PA166131494;Chemical
BREXPIPRAZOLE;CYP2D6*9;Haplotype;PA166160053;Chemical
MEPHEDRONE;CYP2D6*9;Haplotype;PA166184711;Chemical
BREAST NEOPLASMS;CYP2D6*9;Haplotype;PA443560;Disease
BURNS;CYP2D6*9;Haplotype;PA443582;Disease
HYPERTENSION;CYP2D6*9;Haplotype;PA444552;Disease
MALARIA;CYP2D6*9;Haplotype;PA444859;Disease
PAIN, POSTOPERATIVE;CYP2D6*9;Haplotype;PA445210;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CYP2D6*9;Haplotype;PA447197;Disease
MENTAL DISORDERS;CYP2D6*9;Haplotype;PA447208;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2D6*9;Haplotype;PA447321;Disease
AMITRIPTYLINE;CYP2D6*9;Haplotype;PA448385;Chemical
DESIPRAMINE;CYP2D6*9;Haplotype;PA449233;Chemical
DOXEPIN;CYP2D6*9;Haplotype;PA449409;Chemical
FENTANYL;CYP2D6*9;Haplotype;PA449599;Chemical
KETOPROFEN;CYP2D6*9;Haplotype;PA450149;Chemical
METOPROLOL;CYP2D6*9;Haplotype;PA450480;Chemical
PAROXETINE;CYP2D6*9;Haplotype;PA450801;Chemical
PRIMAQUINE;CYP2D6*9;Haplotype;PA451103;Chemical
TAMOXIFEN;CYP2D6*9;Haplotype;PA451581;Chemical
TRAMADOL;CYP2D6*9;Haplotype;PA451735;Chemical
VENLAFAXINE;CYP2D6*9;Haplotype;PA451866;Chemical
SPARTEINE;CYP2D6*9;Haplotype;PA452610;Chemical
DEBRISOQUINE;CYP2D6*9;Haplotype;PA452616;Chemical
ANTINEOPLASTIC AGENTS;CYP2D6*9;Haplotype;PA452621;Chemical
OPIOID-RELATED DISORDERS;rs2760118;Variant;PA445043;Disease
METHADONE;rs2760118;Variant;PA450401;Chemical
MIGALASTAT;rs869312138;Variant;PA166182881;Chemical
FABRY DISEASE;rs869312138;Variant;PA443367;Disease
CYP2C19;mavacamten;Chemical;PA124;Gene
CYP2C19*17;mavacamten;Chemical;PA165816533;Haplotype
CYP3A4*20;mavacamten;Chemical;PA165819244;Haplotype
CYP2C19*1;mavacamten;Chemical;PA165980634;Haplotype
CYP2C19*2;mavacamten;Chemical;PA165980635;Haplotype
CYP2C19*3;mavacamten;Chemical;PA165980636;Haplotype
CYP3A4*22;mavacamten;Chemical;PA166048680;Haplotype
CYP3A5*3;mavacamten;Chemical;PA166128219;Haplotype
CYP3A5*6;mavacamten;Chemical;PA166128233;Haplotype
CYP3A5*7;mavacamten;Chemical;PA166128234;Haplotype
DEXTROMETHORPHAN;CYP2D6*134;Haplotype;PA449273;Chemical
DESFLURANE;rs193922832;Variant;PA164749136;Chemical
RYR1;rs193922832;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs193922832;Variant;PA444863;Disease
ENFLURANE;rs193922832;Variant;PA449461;Chemical
HALOTHANE;rs193922832;Variant;PA449845;Chemical
ISOFLURANE;rs193922832;Variant;PA450106;Chemical
METHOXYFLURANE;rs193922832;Variant;PA450434;Chemical
SEVOFLURANE;rs193922832;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs193922832;Variant;PA451522;Chemical
CACNA1S;rs193922832;Variant;PA85;Gene
GNAI1;RGS1;Gene;PA172;Gene
GNAI3;RGS1;Gene;PA173;Gene
GNAS;RGS1;Gene;PA175;Gene
GNAI2;RGS1;Gene;PA24347;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs3087243;Variant;PA164713366;Chemical
PSORIASIS;rs3087243;Variant;PA445451;Disease
ALCOHOL ABUSE;rs10055255;Variant;PA443309;Disease
ETHANOL;rs10055255;Variant;PA448073;Chemical
LUTETIUM (177LU) OXODOTREOTIDE;SSTR4;Gene;PA166224981;Chemical
COMT;sufentanil;Chemical;PA117;Gene
CYP3A4;sufentanil;Chemical;PA130;Gene
CYP3A5;sufentanil;Chemical;PA131;Gene
CYP3A5*1;sufentanil;Chemical;PA166128213;Haplotype
CYP3A5*3;sufentanil;Chemical;PA166128219;Haplotype
RS4680;sufentanil;Chemical;PA166156024;Variant
RS1799971;sufentanil;Chemical;PA166156991;Variant
RS1128503;sufentanil;Chemical;PA166157288;Variant
RS2032582;sufentanil;Chemical;PA166157316;Variant
RS2242480;sufentanil;Chemical;PA166157345;Variant
RS696;sufentanil;Chemical;PA166159900;Variant
RS1323040;sufentanil;Chemical;PA166185653;Variant
ABCB1;sufentanil;Chemical;PA267;Gene
NFKBIA;sufentanil;Chemical;PA31601;Gene
OPRM1;sufentanil;Chemical;PA31945;Gene
DESFLURANE;rs118192122;Variant;PA164749136;Chemical
RYR1;rs118192122;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs118192122;Variant;PA444863;Disease
ENFLURANE;rs118192122;Variant;PA449461;Chemical
HALOTHANE;rs118192122;Variant;PA449845;Chemical
ISOFLURANE;rs118192122;Variant;PA450106;Chemical
METHOXYFLURANE;rs118192122;Variant;PA450434;Chemical
SEVOFLURANE;rs118192122;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs118192122;Variant;PA451522;Chemical
CACNA1S;rs118192122;Variant;PA85;Gene
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*39:05;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*39:05;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*39:05;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-B*39:05;Haplotype;PA450616;Chemical
RS1128503;temozolomide;Chemical;PA166157288;Variant
RS2229109;temozolomide;Chemical;PA166157334;Variant
MGMT;temozolomide;Chemical;PA239;Gene
ABCB1;temozolomide;Chemical;PA267;Gene
HDAC4;temozolomide;Chemical;PA29229;Gene
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs17712523;Variant;PA447197;Disease
METHYLPHENIDATE;rs17712523;Variant;PA450464;Chemical
SCNN1A;triamterene;Chemical;PA305;Gene
SCNN1B;triamterene;Chemical;PA306;Gene
SCNN1G;triamterene;Chemical;PA307;Gene
ADVERSE EVENTS;rs62436463;Variant;PA166151827;Disease
CODEINE;rs62436463;Variant;PA449088;Chemical
HYDROCODONE;rs62436463;Variant;PA449900;Chemical
OXYCODONE;rs62436463;Variant;PA450741;Chemical
TRAMADOL;rs62436463;Variant;PA451735;Chemical
DULOXETINE;rs17786400;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs17786400;Variant;PA447321;Disease
BRIVANIB;FGFR3P1;Gene;PA164924492;Chemical
CRK;FGFR3P1;Gene;PA26880;Gene
FGF2;FGFR3P1;Gene;PA28115;Gene
PIK3C2A;FGFR3P1;Gene;PA33304;Gene
PIK3C2B;FGFR3P1;Gene;PA33305;Gene
IMATINIB;CYP3A4*3;Haplotype;PA10804;Chemical
ORGAN TRANSPLANTATION;CYP3A4*3;Haplotype;PA133888799;Disease
TICAGRELOR;CYP3A4*3;Haplotype;PA165374673;Chemical
KIDNEY TRANSPLANTATION;CYP3A4*3;Haplotype;PA165817016;Disease
CABOZANTINIB;CYP3A4*3;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*3;Haplotype;PA165958362;Chemical
FESOTERODINE;CYP3A4*3;Haplotype;PA165958376;Chemical
REGORAFENIB;CYP3A4*3;Haplotype;PA166114943;Chemical
VANDETANIB;CYP3A4*3;Haplotype;PA166118341;Chemical
IBRUTINIB;CYP3A4*3;Haplotype;PA166121346;Chemical
BREXPIPRAZOLE;CYP3A4*3;Haplotype;PA166160053;Chemical
ACALABRUTINIB;CYP3A4*3;Haplotype;PA166198581;Chemical
MACITENTAN;CYP3A4*3;Haplotype;PA166261201;Chemical
FENTANYL;CYP3A4*3;Haplotype;PA449599;Chemical
METHADONE;CYP3A4*3;Haplotype;PA450401;Chemical
OXYCODONE;CYP3A4*3;Haplotype;PA450741;Chemical
QUETIAPINE;CYP3A4*3;Haplotype;PA451201;Chemical
SILDENAFIL;CYP3A4*3;Haplotype;PA451346;Chemical
TACROLIMUS;CYP3A4*3;Haplotype;PA451578;Chemical
TESTOSTERONE;CYP3A4*3;Haplotype;PA451627;Chemical
CYP2C19;Coronary Restenosis;Disease;PA124;Gene
CYP2C19*1;Coronary Restenosis;Disease;PA165980634;Haplotype
CYP2C19*2;Coronary Restenosis;Disease;PA165980635;Haplotype
ALCOHOL ABUSE;rs56722963;Variant;PA443309;Disease
ETHANOL;rs56722963;Variant;PA448073;Chemical
ACUTE CORONARY SYNDROME;ECHS1;Gene;PA165108401;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);ECHS1;Gene;PA166129560;Disease
ASPIRIN;ECHS1;Gene;PA448497;Chemical
CLOPIDOGREL;ECHS1;Gene;PA449053;Chemical
ADEFOVIR DIPIVOXIL;SLC22A6;Gene;PA10005;Chemical
TENOFOVIR;SLC22A6;Gene;PA10204;Chemical
HMG COA REDUCTASE INHIBITORS;SLC22A6;Gene;PA133950441;Chemical
CIDOFOVIR;SLC22A6;Gene;PA448997;Chemical
LANSOPRAZOLE;SLC22A6;Gene;PA450180;Chemical
METHOTREXATE;SLC22A6;Gene;PA450428;Chemical
OMEPRAZOLE;SLC22A6;Gene;PA450704;Chemical
PANTOPRAZOLE;SLC22A6;Gene;PA450774;Chemical
ZIDOVUDINE;SLC22A6;Gene;PA451954;Chemical
FLUOROURACIL;rs55633228;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs55633228;Variant;PA443560;Disease
NEUTROPENIA;rs55633228;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs55633228;Variant;PA449165;Chemical
EPIRUBICIN;rs55633228;Variant;PA449476;Chemical
APOA4;PLTP;Gene;PA24887;Gene
APOA1;PLTP;Gene;PA49;Gene
LEUKEMIA, MYELOID, ACUTE;rs3754446;Variant;PA444760;Disease
BUSULFAN;rs3754446;Variant;PA448691;Chemical
GLIOBLASTOMA;TERT;Gene;PA444283;Disease
N-DESMETHYLTAMOXIFEN;CYP2D6*31;Haplotype;PA166127651;Chemical
HYPERTENSION;CYP2D6*31;Haplotype;PA444552;Disease
DEXTROMETHORPHAN;CYP2D6*31;Haplotype;PA449273;Chemical
METOPROLOL;CYP2D6*31;Haplotype;PA450480;Chemical
PRIMAQUINE;CYP2D6*31;Haplotype;PA451103;Chemical
DEBRISOQUINE;CYP2D6*31;Haplotype;PA452616;Chemical
TENOFOVIR;OCRL;Gene;PA10204;Chemical
HIV INFECTIOUS DISEASE;OCRL;Gene;PA447230;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs4562;Variant;PA447197;Disease
METHYLPHENIDATE;rs4562;Variant;PA450464;Chemical
FLUOROURACIL;rs1799983;Variant;PA128406956;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs1799983;Variant;PA130620651;Chemical
OXALIPLATIN;rs1799983;Variant;PA131285527;Chemical
HMG COA REDUCTASE INHIBITORS;rs1799983;Variant;PA133950441;Chemical
DIURETICS;rs1799983;Variant;PA151249535;Chemical
ACE INHIBITORS, PLAIN;rs1799983;Variant;PA164712308;Chemical
ANGIOTENSIN II ANTAGONISTS;rs1799983;Variant;PA164712372;Chemical
BETA BLOCKING AGENTS;rs1799983;Variant;PA164712535;Chemical
PLATINUM COMPOUNDS;rs1799983;Variant;PA164713176;Chemical
SALVIANOLIC ACID B;rs1799983;Variant;PA166128370;Chemical
BREAST NEOPLASMS;rs1799983;Variant;PA443560;Disease
CORONARY ARTERY DISEASE;rs1799983;Variant;PA443796;Disease
CORONARY DISEASE;rs1799983;Variant;PA443797;Disease
HEART FAILURE;rs1799983;Variant;PA444370;Disease
HEPATOCELLULAR CARCINOMA;rs1799983;Variant;PA444447;Disease
LEUKEMIA, MYELOID, ACUTE;rs1799983;Variant;PA444760;Disease
MIGRAINE WITHOUT AURA;rs1799983;Variant;PA444949;Disease
NEOPLASMS;rs1799983;Variant;PA445062;Disease
OVARIAN NEOPLASMS;rs1799983;Variant;PA445204;Disease
STOMACH NEOPLASMS;rs1799983;Variant;PA445742;Disease
MIGRAINE WITH AURA;rs1799983;Variant;PA447004;Disease
ASPIRIN;rs1799983;Variant;PA448497;Chemical
CLOPIDOGREL;rs1799983;Variant;PA449053;Chemical
CYCLOPHOSPHAMIDE;rs1799983;Variant;PA449165;Chemical
DAUNORUBICIN;rs1799983;Variant;PA449212;Chemical
DIGOXIN;rs1799983;Variant;PA449319;Chemical
DOXORUBICIN;rs1799983;Variant;PA449412;Chemical
EPIRUBICIN;rs1799983;Variant;PA449476;Chemical
METHOTREXATE;rs1799983;Variant;PA450428;Chemical
NORTRIPTYLINE;rs1799983;Variant;PA450657;Chemical
SPIRONOLACTONE;rs1799983;Variant;PA451483;Chemical
SORAFENIB;rs1799983;Variant;PA7000;Chemical
RALOXIFENE;UGT1A8*1a;Haplotype;PA451221;Chemical
PROC;synthetic conjugated estrogens, A;Chemical;PA33799;Gene
PROS1;synthetic conjugated estrogens, A;Chemical;PA33809;Gene
SERPINC1;synthetic conjugated estrogens, A;Chemical;PA35026;Gene
AZATHIOPRINE;MOCOS;Gene;PA448515;Chemical
G6PD B (REFERENCE);Protein Deficiency;Disease;PA165947826;Haplotype
G6PD A- 202A_376G;Protein Deficiency;Disease;PA165947827;Haplotype
G6PD;Protein Deficiency;Disease;PA28469;Gene
DIABETES MELLITUS;rs10747673;Variant;PA443886;Disease
METFORMIN;rs10747673;Variant;PA450395;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-DRB1*10:01;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-DRB1*10:01;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-DRB1*10:01;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-DRB1*10:01;Haplotype;PA450616;Chemical
WEIGHT GAIN;HRH1;Gene;PA128406954;Disease
DESLORATADINE;HRH1;Gene;PA164776964;Chemical
SEDATION;HRH1;Gene;PA166129521;Disease
URTICARIA;HRH1;Gene;PA445999;Disease
BEVACIZUMAB;rs6770663;Variant;PA130232992;Chemical
HYPERTENSION;rs6770663;Variant;PA444552;Disease
CFTR;elexacaftor / tezacaftor / ivacaftor;Chemical;PA109;Gene
RS74503330;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166157511;Variant
RS75039782;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166157514;Variant
RS75527207;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166157516;Variant
RS78655421;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166157519;Variant
RS80282562;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166157521;Variant
RS113993960;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166157525;Variant
RS121908755;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166157529;Variant
RS121908757;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166157530;Variant
RS121909005;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166157531;Variant
RS121909013;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166157532;Variant
RS121909041;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166157533;Variant
RS193922525;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166157534;Variant
RS267606723;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166157537;Variant
RS77932196;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166161186;Variant
RS121909011;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166161188;Variant
RS80034486;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166162695;Variant
RS80224560;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166162698;Variant
RS75961395;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166162699;Variant
RS74551128;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166162705;Variant
RS397508256;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164939;Variant
RS368505753;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164940;Variant
RS115545701;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164941;Variant
RS397508537;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164942;Variant
RS113993958;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164943;Variant
RS77834169;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164944;Variant
RS397508759;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164945;Variant
RS121908752;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164946;Variant
RS121908753;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164947;Variant
RS397508288;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164948;Variant
RS397508442;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164949;Variant
RS141033578;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164950;Variant
RS150212784;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164951;Variant
RS397508513;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164952;Variant
RS121909020;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164953;Variant
RS200321110;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164954;Variant
RS78769542;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164955;Variant
RS202179988;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164956;Variant
RS186045772;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164957;Variant
RS75541969;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164958;Variant
RS11971167;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166164959;Variant
RS121909019;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166178049;Variant
RS121908751;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166178065;Variant
RS36210737;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166178078;Variant
RS139304906;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166178080;Variant
RS121909036;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166178084;Variant
RS121909047;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166178088;Variant
RS75549581;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166178090;Variant
RS186089140;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166299361;Variant
RS35516286;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166365261;Variant
RS397508166;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166366421;Variant
RS397508573;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166394541;Variant
RS397508572;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166394581;Variant
RS1800076;elexacaftor / tezacaftor / ivacaftor;Chemical;PA166394661;Variant
BREAST NEOPLASMS;rs7176005;Variant;PA443560;Disease
EXEMESTANE;rs7176005;Variant;PA449563;Chemical
ESCITALOPRAM;CYP2C19*17;Haplotype;PA10074;Chemical
ESOMEPRAZOLE;CYP2C19*17;Haplotype;PA10075;Chemical
VORICONAZOLE;CYP2C19*17;Haplotype;PA10233;Chemical
CYP2C19;CYP2C19*17;Haplotype;PA124;Gene
3,4-METHYLENEDIOXYMETHAMPHETAMINE;CYP2C19*17;Haplotype;PA131887008;Chemical
PRASUGREL;CYP2C19*17;Haplotype;PA154410481;Chemical
ACUTE CORONARY SYNDROME;CYP2C19*17;Haplotype;PA165108401;Disease
KIDNEY TRANSPLANTATION;CYP2C19*17;Haplotype;PA165817016;Disease
AMBRISENTAN;CYP2C19*17;Haplotype;PA165860521;Chemical
RIVAROXABAN;CYP2C19*17;Haplotype;PA165958360;Chemical
HELICOBACTER INFECTIONS;CYP2C19*17;Haplotype;PA166048740;Disease
LUNG TRANSPLANTATION;CYP2C19*17;Haplotype;PA166114457;Disease
SCHIZOAFFECTIVE DISORDER;CYP2C19*17;Haplotype;PA166123368;Disease
DISCONTINUATION;CYP2C19*17;Haplotype;PA166123507;Disease
PLATELET AGGREGATION;CYP2C19*17;Haplotype;PA166123766;Disease
PLATELET REACTIVITY;CYP2C19*17;Haplotype;PA166124406;Disease
TREATMENT FAILURE;CYP2C19*17;Haplotype;PA166128095;Disease
CARDIOTOXICITY;CYP2C19*17;Haplotype;PA166128121;Disease
PLATELET AGGREGATION INHIBITION;CYP2C19*17;Haplotype;PA166128371;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);CYP2C19*17;Haplotype;PA166129560;Disease
N-DESMETHYLCLOZAPINE;CYP2C19*17;Haplotype;PA166163659;Chemical
PHENAZEPAM;CYP2C19*17;Haplotype;PA166180939;Chemical
NORMEPERIDINE;CYP2C19*17;Haplotype;PA166186301;Chemical
EOSINOPHILIC ESOPHAGITIS;CYP2C19*17;Haplotype;PA166224501;Disease
HYDROXYBUPROPION;CYP2C19*17;Haplotype;PA166226561;Chemical
MAVACAMTEN;CYP2C19*17;Haplotype;PA166272922;Chemical
ALCOHOLISM;CYP2C19*17;Haplotype;PA443309;Disease
ANGINA PECTORIS;CYP2C19*17;Haplotype;PA443362;Disease
ARTHRITIS, RHEUMATOID;CYP2C19*17;Haplotype;PA443434;Disease
ATRIAL FIBRILLATION;CYP2C19*17;Haplotype;PA443459;Disease
BREAST NEOPLASMS;CYP2C19*17;Haplotype;PA443560;Disease
CARCINOMA, SQUAMOUS CELL;CYP2C19*17;Haplotype;PA443626;Disease
CARDIOVASCULAR DISEASES;CYP2C19*17;Haplotype;PA443635;Disease
ISCHEMIC ATTACK, TRANSIENT;CYP2C19*17;Haplotype;PA443672;Disease
CORONARY ARTERY DISEASE;CYP2C19*17;Haplotype;PA443796;Disease
CYSTIC FIBROSIS;CYP2C19*17;Haplotype;PA443829;Disease
DIABETES MELLITUS;CYP2C19*17;Haplotype;PA443886;Disease
EDEMA;CYP2C19*17;Haplotype;PA443994;Disease
GASTROESOPHAGEAL REFLUX;CYP2C19*17;Haplotype;PA444255;Disease
GRANULOMATOUS DISEASE, CHRONIC;CYP2C19*17;Haplotype;PA444327;Disease
HEMATOLOGIC DISEASES;CYP2C19*17;Haplotype;PA444395;Disease
HEMORRHAGE;CYP2C19*17;Haplotype;PA444417;Disease
INFLAMMATION;CYP2C19*17;Haplotype;PA444620;Disease
MYCOSES;CYP2C19*17;Haplotype;PA445009;Disease
MYOCARDIAL INFARCTION;CYP2C19*17;Haplotype;PA445019;Disease
NAUSEA;CYP2C19*17;Haplotype;PA445048;Disease
NEOPLASMS;CYP2C19*17;Haplotype;PA445062;Disease
THROMBOSIS;CYP2C19*17;Haplotype;PA445850;Disease
TOBACCO USE DISORDER;CYP2C19*17;Haplotype;PA445876;Disease
VOMITING;CYP2C19*17;Haplotype;PA446051;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;CYP2C19*17;Haplotype;PA446155;Disease
SEVERE COMBINED IMMUNODEFICIENCY;CYP2C19*17;Haplotype;PA446336;Disease
ALCOHOL-RELATED DISORDERS;CYP2C19*17;Haplotype;PA446879;Disease
STROKE;CYP2C19*17;Haplotype;PA447054;Disease
ANXIETY DISORDERS;CYP2C19*17;Haplotype;PA447196;Disease
BIPOLAR DISORDER;CYP2C19*17;Haplotype;PA447199;Disease
DEPRESSIVE DISORDER;CYP2C19*17;Haplotype;PA447207;Disease
MENTAL DISORDERS;CYP2C19*17;Haplotype;PA447208;Disease
OBSESSIVE-COMPULSIVE DISORDER;CYP2C19*17;Haplotype;PA447211;Disease
SCHIZOPHRENIA;CYP2C19*17;Haplotype;PA447216;Disease
PEPTIC ULCER;CYP2C19*17;Haplotype;PA447240;Disease
DEPRESSION;CYP2C19*17;Haplotype;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2C19*17;Haplotype;PA447321;Disease
AMITRIPTYLINE;CYP2C19*17;Haplotype;PA448385;Chemical
ASPIRIN;CYP2C19*17;Haplotype;PA448497;Chemical
BUPROPION;CYP2C19*17;Haplotype;PA448687;Chemical
CITALOPRAM;CYP2C19*17;Haplotype;PA449015;Chemical
CLOMIPRAMINE;CYP2C19*17;Haplotype;PA449048;Chemical
CLOPIDOGREL;CYP2C19*17;Haplotype;PA449053;Chemical
CLOZAPINE;CYP2C19*17;Haplotype;PA449061;Chemical
FLUOXETINE;CYP2C19*17;Haplotype;PA449673;Chemical
IMIPRAMINE;CYP2C19*17;Haplotype;PA449969;Chemical
LANSOPRAZOLE;CYP2C19*17;Haplotype;PA450180;Chemical
LEFLUNOMIDE;CYP2C19*17;Haplotype;PA450192;Chemical
OMEPRAZOLE;CYP2C19*17;Haplotype;PA450704;Chemical
PANTOPRAZOLE;CYP2C19*17;Haplotype;PA450774;Chemical
PROGESTERONE;CYP2C19*17;Haplotype;PA451123;Chemical
RABEPRAZOLE;CYP2C19*17;Haplotype;PA451216;Chemical
SERTRALINE;CYP2C19*17;Haplotype;PA451333;Chemical
TAMOXIFEN;CYP2C19*17;Haplotype;PA451581;Chemical
VENLAFAXINE;CYP2C19*17;Haplotype;PA451866;Chemical
MULTIPLE SCLEROSIS;rs4278350;Variant;PA444987;Disease
INTERFERON BETA-1A;rs4278350;Variant;PA450037;Chemical
INTERFERON BETA-1B;rs4278350;Variant;PA450039;Chemical
IL23R;azathioprine;Chemical;PA134935109;Gene
C18ORF56;azathioprine;Chemical;PA134956204;Gene
NUDT15;azathioprine;Chemical;PA134963132;Gene
MOCOS;azathioprine;Chemical;PA134964534;Gene
FTO;azathioprine;Chemical;PA152208656;Gene
DDRGK1;azathioprine;Chemical;PA164718734;Gene
TPMT*1;azathioprine;Chemical;PA165819268;Haplotype
TPMT*2;azathioprine;Chemical;PA165819269;Haplotype
TPMT*3A;azathioprine;Chemical;PA165819270;Haplotype
TPMT*3B;azathioprine;Chemical;PA165819271;Haplotype
TPMT*3C;azathioprine;Chemical;PA165819272;Haplotype
TPMT*4;azathioprine;Chemical;PA165819274;Haplotype
TPMT*5;azathioprine;Chemical;PA165819275;Haplotype
TPMT*6;azathioprine;Chemical;PA165819276;Haplotype
TPMT*7;azathioprine;Chemical;PA165819277;Haplotype
TPMT*8;azathioprine;Chemical;PA165819278;Haplotype
TPMT*9;azathioprine;Chemical;PA165819279;Haplotype
TPMT*10;azathioprine;Chemical;PA165819280;Haplotype
TPMT*11;azathioprine;Chemical;PA165819281;Haplotype
TPMT*12;azathioprine;Chemical;PA165819282;Haplotype
TPMT*13;azathioprine;Chemical;PA165819283;Haplotype
TPMT*14;azathioprine;Chemical;PA165819284;Haplotype
TPMT*15;azathioprine;Chemical;PA165819285;Haplotype
TPMT*16;azathioprine;Chemical;PA165819286;Haplotype
TPMT*17;azathioprine;Chemical;PA165819287;Haplotype
TPMT*18;azathioprine;Chemical;PA165819288;Haplotype
TPMT*24;azathioprine;Chemical;PA165819295;Haplotype
HLA-DQA1*02:01;azathioprine;Chemical;PA165951292;Haplotype
HLA-DRB1*07:01;azathioprine;Chemical;PA165951644;Haplotype
GSTM1 NULL;azathioprine;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;azathioprine;Chemical;PA166048676;Haplotype
NUDT15*1;azathioprine;Chemical;PA166131619;Haplotype
NUDT15*2;azathioprine;Chemical;PA166131620;Haplotype
NUDT15*3;azathioprine;Chemical;PA166131621;Haplotype
NUDT15*4;azathioprine;Chemical;PA166131622;Haplotype
NUDT15*5;azathioprine;Chemical;PA166131623;Haplotype
NUDT15*6;azathioprine;Chemical;PA166151814;Haplotype
RS3765534;azathioprine;Chemical;PA166154714;Variant
RS116855232;azathioprine;Chemical;PA166154759;Variant
RS45445694;azathioprine;Chemical;PA166155331;Variant
RS55754655;azathioprine;Chemical;PA166155879;Variant
RS1127354;azathioprine;Chemical;PA166155915;Variant
RS7270101;azathioprine;Chemical;PA166155964;Variant
RS2413739;azathioprine;Chemical;PA166156100;Variant
RS2647087;azathioprine;Chemical;PA166157045;Variant
RS79206939;azathioprine;Chemical;PA166160976;Variant
RS16952570;azathioprine;Chemical;PA166160979;Variant
TPMT LOW ACTIVITY;azathioprine;Chemical;PA166161836;Variant
RS746071566;azathioprine;Chemical;PA166165231;Variant
RS11969064;azathioprine;Chemical;PA166184136;Variant
GSTM1;azathioprine;Chemical;PA182;Gene
AOX1;azathioprine;Chemical;PA24842;Gene
CASP9;azathioprine;Chemical;PA26094;Gene
ABCB1;azathioprine;Chemical;PA267;Gene
ITPA;azathioprine;Chemical;PA29973;Gene
PACSIN2;azathioprine;Chemical;PA32897;Gene
RAC1;azathioprine;Chemical;PA34162;Gene
HLA-DQA1;azathioprine;Chemical;PA35066;Gene
HLA-DRB1;azathioprine;Chemical;PA35072;Gene
TPMT;azathioprine;Chemical;PA356;Gene
TYMS;azathioprine;Chemical;PA359;Gene
ABCC4;azathioprine;Chemical;PA397;Gene
DULOXETINE;rs2419128;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs2419128;Variant;PA447321;Disease
ADRB2;fenoterol;Chemical;PA39;Gene
RS1801253;bucindolol;Chemical;PA166153977;Variant
RS61767072;bucindolol;Chemical;PA166156691;Variant
ADRA2C;bucindolol;Chemical;PA37;Gene
ADRB1;bucindolol;Chemical;PA38;Gene
CYP2B6;Lymphoma, B-Cell;Disease;PA123;Gene
CYP2B6*1;Lymphoma, B-Cell;Disease;PA165818750;Haplotype
CYP2B6*6;Lymphoma, B-Cell;Disease;PA165818762;Haplotype
MULTIPLE SCLEROSIS;rs3133084;Variant;PA444987;Disease
INTERFERON BETA-1A;rs3133084;Variant;PA450037;Chemical
INTERFERON BETA-1B;rs3133084;Variant;PA450039;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs3794271;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs3794271;Variant;PA443434;Disease
ARTHRITIS, PSORIATIC;rs3794271;Variant;PA446198;Disease
FLUOROURACIL;rs2228100;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs2228100;Variant;PA443560;Disease
CYCLOPHOSPHAMIDE;rs2228100;Variant;PA449165;Chemical
DOXORUBICIN;rs2228100;Variant;PA449412;Chemical
NEPHROTOXICITY;rs10908521;Variant;PA162263533;Disease
GLUCARPIDASE;rs10908521;Variant;PA165949771;Chemical
HALOPERIDOL;HTR3E;Gene;PA449841;Chemical
MIGALASTAT;rs1569304898;Variant;PA166182881;Chemical
FABRY DISEASE;rs1569304898;Variant;PA443367;Disease
THIOGUANOSINE MONOPHOSPHATE;TPMT poor metabolizer;Variant;PA166160623;Chemical
THIOGUANOSINE DIPHOSPHATE;TPMT poor metabolizer;Variant;PA166160632;Chemical
THIOGUANOSINE TRIPHOSPHATE;TPMT poor metabolizer;Variant;PA166160633;Chemical
INFLAMMATORY BOWEL DISEASES;TPMT poor metabolizer;Variant;PA446116;Disease
MERCAPTOPURINE;TPMT poor metabolizer;Variant;PA450379;Chemical
DULOXETINE;rs3124955;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs3124955;Variant;PA447321;Disease
ALCOHOL ABUSE;rs511435;Variant;PA443309;Disease
HEROIN DEPENDENCE;rs511435;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs511435;Variant;PA445043;Disease
ETHANOL;rs511435;Variant;PA448073;Chemical
OPIOIDS;rs511435;Variant;PA452618;Chemical
HEROIN;rs511435;Variant;PA452619;Chemical
CYP3A4;indinavir;Chemical;PA130;Gene
UGT1A1*1;indinavir;Chemical;PA166115841;Haplotype
UGT1A1*28;indinavir;Chemical;PA166115842;Haplotype
UGT1A1*6;indinavir;Chemical;PA166115858;Haplotype
RS4148323;indinavir;Chemical;PA166155721;Variant
RS2740574;indinavir;Chemical;PA166157367;Variant
ABCB1;indinavir;Chemical;PA267;Gene
UGT1A1;indinavir;Chemical;PA420;Gene
CYP2C19;schizoaffective disorder;Disease;PA124;Gene
CYP2D6;schizoaffective disorder;Disease;PA128;Gene
CYP3A5;schizoaffective disorder;Disease;PA131;Gene
RABEP1;schizoaffective disorder;Disease;PA134884097;Gene
SH2B1;schizoaffective disorder;Disease;PA145148084;Gene
CYP2C19*17;schizoaffective disorder;Disease;PA165816533;Haplotype
CYP2D6*1;schizoaffective disorder;Disease;PA165816576;Haplotype
CYP2D6*4;schizoaffective disorder;Disease;PA165816579;Haplotype
CYP2D6*6;schizoaffective disorder;Disease;PA165816581;Haplotype
CYP2D6*10;schizoaffective disorder;Disease;PA165816582;Haplotype
CYP2D6*41;schizoaffective disorder;Disease;PA165816584;Haplotype
CYP1A2*7;schizoaffective disorder;Disease;PA165819184;Haplotype
CYP2D6*5;schizoaffective disorder;Disease;PA165948092;Haplotype
HLA-B*38:01;schizoaffective disorder;Disease;PA165955500;Haplotype
CYP2C19*1;schizoaffective disorder;Disease;PA165980634;Haplotype
CYP3A5*1;schizoaffective disorder;Disease;PA166128213;Haplotype
CYP3A5*3;schizoaffective disorder;Disease;PA166128219;Haplotype
RS1801131;schizoaffective disorder;Disease;PA166153643;Variant
RS1799732;schizoaffective disorder;Disease;PA166154334;Variant
RS2514218;schizoaffective disorder;Disease;PA166154375;Variant
RS489693;schizoaffective disorder;Disease;PA166155269;Variant
CYP2D6 POOR METABOLIZER;schizoaffective disorder;Disease;PA166157927;Variant
RS3888190;schizoaffective disorder;Disease;PA166165398;Variant
RS1000940;schizoaffective disorder;Disease;PA166165401;Variant
MTHFR;schizoaffective disorder;Disease;PA245;Gene
CYP1A2;schizoaffective disorder;Disease;PA27093;Gene
DRD2;schizoaffective disorder;Disease;PA27478;Gene
MC4R;schizoaffective disorder;Disease;PA30676;Gene
HLA-B;schizoaffective disorder;Disease;PA35056;Gene
ANTIHYPERTENSIVES;rs6487504;Variant;PA164712445;Chemical
HYPERTENSION;rs6487504;Variant;PA444552;Disease
ATRIAL FIBRILLATION;MIR21;Gene;PA443459;Disease
CHOLANGIOCARCINOMA;MIR21;Gene;PA446654;Disease
CELECOXIB;CDKN1B;Gene;PA448871;Chemical
DRUG TOXICITY;rs315498;Variant;PA443937;Disease
SORAFENIB;rs315498;Variant;PA7000;Chemical
APNEA;rs764841347;Variant;PA443407;Disease
SUCCINYLCHOLINE;rs764841347;Variant;PA451522;Chemical
CYP3A4;Endometrial Neoplasms;Disease;PA130;Gene
RS1042028;Endometrial Neoplasms;Disease;PA166186146;Variant
MTHFR;Endometrial Neoplasms;Disease;PA245;Gene
SULT1A1;Endometrial Neoplasms;Disease;PA343;Gene
NR1I2;Endometrial Neoplasms;Disease;PA378;Gene
COTININE;CYP2A6*2;Haplotype;PA166114414;Chemical
CESSATION;CYP2A6*2;Haplotype;PA166123046;Disease
BREAST NEOPLASMS;CYP2A6*2;Haplotype;PA443560;Disease
TOBACCO USE DISORDER;CYP2A6*2;Haplotype;PA445876;Disease
HIV INFECTIONS;CYP2A6*2;Haplotype;PA447230;Disease
EFAVIRENZ;CYP2A6*2;Haplotype;PA449441;Chemical
LETROZOLE;CYP2A6*2;Haplotype;PA450196;Chemical
METRONIDAZOLE;CYP2A6*2;Haplotype;PA450484;Chemical
NICOTINE;CYP2A6*2;Haplotype;PA450626;Chemical
TOCILIZUMAB;rs11265618;Variant;PA165292659;Chemical
RHEUMATOID ARTHRITIS;rs11265618;Variant;PA443434;Disease
MAPK8;JDP2;Gene;PA283;Gene
MAPK14;JDP2;Gene;PA30621;Gene
TPMT POOR METABOLIZER;thioguanosine triphosphate;Chemical;PA166157904;Variant
TPMT;thioguanosine triphosphate;Chemical;PA356;Gene
TALAZOPARIB;NBN;Gene;PA166182740;Chemical
JUVENILE RHEUMATOID ARTHRITIS;SLC16A7;Gene;PA443433;Disease
METHOTREXATE;SLC16A7;Gene;PA450428;Chemical
CYP2D6;cevimeline;Chemical;PA128;Gene
EPILEPSY;rs28365063;Variant;PA444065;Disease
CARBAMAZEPINE;rs28365063;Variant;PA448785;Chemical
LAMOTRIGINE;rs28365063;Variant;PA450164;Chemical
PLATINUM COMPOUNDS;rs12806698;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs12806698;Variant;PA443622;Disease
MESOTHELIOMA;rs12806698;Variant;PA444937;Disease
GEMCITABINE;rs12806698;Variant;PA449748;Chemical
BREAST NEOPLASMS;RRAS2;Gene;PA443560;Disease
TAMOXIFEN;RRAS2;Gene;PA451581;Chemical
HLA-B*15:02;schizencephaly;Disease;PA165954769;Haplotype
HLA-B;schizencephaly;Disease;PA35056;Gene
NON-SMALL CELL LUNG CARCINOMA;rs12118636;Variant;PA443622;Disease
CARBOPLATIN;rs12118636;Variant;PA448803;Chemical
CISPLATIN;rs12118636;Variant;PA449014;Chemical
GEMCITABINE;rs12118636;Variant;PA449748;Chemical
MS4A1;ofatumumab;Chemical;PA31111;Gene
CFTR;rs121909021;Variant;PA109;Gene
IVACAFTOR;rs121909021;Variant;PA165950341;Chemical
GEFITINIB;IKBKE;Gene;PA131301952;Chemical
NON-SMALL CELL LUNG CARCINOMA;IKBKE;Gene;PA443622;Disease
DIARRHEA;IKBKE;Gene;PA443899;Disease
EXANTHEMA;IKBKE;Gene;PA444109;Disease
F2R;GNA12;Gene;PA27946;Gene
F2RL3;GNA12;Gene;PA27949;Gene
P2RY1;GNA12;Gene;PA32868;Gene
PLCB1;GNA12;Gene;PA33384;Gene
PLCG2;GNA12;Gene;PA33393;Gene
TBXA2R;GNA12;Gene;PA348;Gene
SCHIZOPHRENIA;rs4436578;Variant;PA447216;Disease
CLOZAPINE;rs4436578;Variant;PA449061;Chemical
OLANZAPINE;rs4436578;Variant;PA450688;Chemical
RISPERIDONE;rs4436578;Variant;PA451257;Chemical
NICOTINE;rs7877;Variant;PA450626;Chemical
OLANZAPINE;rs7877;Variant;PA450688;Chemical
CESSATION;CYP2A6*27;Haplotype;PA166123046;Disease
TOBACCO USE DISORDER;CYP2A6*27;Haplotype;PA445876;Disease
NICOTINE;CYP2A6*27;Haplotype;PA450626;Chemical
INFLIXIMAB;rs7195994;Variant;PA452639;Chemical
RHEUMATOID ARTHRITIS;rs2234693;Variant;PA443434;Disease
NEOPLASMS;rs2234693;Variant;PA445062;Disease
PSYCHOTIC DISORDER;rs2234693;Variant;PA447215;Disease
ANASTROZOLE;rs2234693;Variant;PA448432;Chemical
LEFLUNOMIDE;rs2234693;Variant;PA450192;Chemical
LETROZOLE;rs2234693;Variant;PA450196;Chemical
METHAMPHETAMINE;rs2234693;Variant;PA450403;Chemical
WILMS TUMOR;WT1;Gene;PA445084;Disease
TALAZOPARIB;MLH1;Gene;PA166182740;Chemical
COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS;MLH1;Gene;PA443761;Disease
PROSTATIC NEOPLASMS;MLH1;Gene;PA445425;Disease
PLATINUM COMPOUNDS;rs1042522;Variant;PA164713176;Chemical
OVERALL SURVIVAL;rs1042522;Variant;PA166123207;Disease
DRUG TOXICITY;rs1042522;Variant;PA443937;Disease
ANTINEOPLASTIC AGENTS;rs1042522;Variant;PA452621;Chemical
BREAST NEOPLASMS;rs1563828;Variant;PA443560;Disease
DOCETAXEL;rs1563828;Variant;PA449383;Chemical
EPIRUBICIN;rs1563828;Variant;PA449476;Chemical
PHENYTOIN;CYP2C9*56;Haplotype;PA450947;Chemical
BUFURALOL;CYP2D6*53;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*53;Haplotype;PA166127651;Chemical
PRIMAQUINE;CYP2D6*53;Haplotype;PA451103;Chemical
CARBAMAZEPINE;rs750332;Variant;PA448785;Chemical
ALLOPURINOL;PKD2;Gene;PA448320;Chemical
HMG COA REDUCTASE INHIBITORS;rs13064411;Variant;PA133950441;Chemical
BIPOLAR DISORDER;CRY1;Gene;PA447199;Disease
LITHIUM;CRY1;Gene;PA450243;Chemical
BREAST NEOPLASMS;LRMDA;Gene;PA443560;Disease
TAMOXIFEN;LRMDA;Gene;PA451581;Chemical
MERCAPTOPURINE;rs73189762;Variant;PA450379;Chemical
CESSATION;CYP2A6*26;Haplotype;PA166123046;Disease
BREAST NEOPLASMS;CYP2A6*26;Haplotype;PA443560;Disease
TOBACCO USE DISORDER;CYP2A6*26;Haplotype;PA445876;Disease
LETROZOLE;CYP2A6*26;Haplotype;PA450196;Chemical
NICOTINE;CYP2A6*26;Haplotype;PA450626;Chemical
MULTIPLE SCLEROSIS;CD58;Gene;PA444987;Disease
INTERFERON BETA-1A;CD58;Gene;PA450037;Chemical
INTERFERON BETA-1B;CD58;Gene;PA450039;Chemical
DESFLURANE;rs121918594;Variant;PA164749136;Chemical
RYR1;rs121918594;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs121918594;Variant;PA444863;Disease
ENFLURANE;rs121918594;Variant;PA449461;Chemical
HALOTHANE;rs121918594;Variant;PA449845;Chemical
ISOFLURANE;rs121918594;Variant;PA450106;Chemical
METHOXYFLURANE;rs121918594;Variant;PA450434;Chemical
SEVOFLURANE;rs121918594;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs121918594;Variant;PA451522;Chemical
CACNA1S;rs121918594;Variant;PA85;Gene
RHEUMATOID ARTHRITIS;ADORA2A-AS1;Gene;PA443434;Disease
HEMATOLOGIC NEOPLASMS;ADORA2A-AS1;Gene;PA446827;Disease
METHOTREXATE;ADORA2A-AS1;Gene;PA450428;Chemical
BISPHOSPHONATES;TBC1D32;Gene;PA164712563;Chemical
OSTEONECROSIS;TBC1D32;Gene;PA445187;Disease
HYPERTENSION;rs11739136;Variant;PA444552;Disease
VERAPAMIL;rs11739136;Variant;PA451868;Chemical
DRUG TOXICITY;rs1801019;Variant;PA443937;Disease
TEGAFUR;rs1801019;Variant;PA452620;Chemical
IMATINIB;FIP1L1;Gene;PA10804;Chemical
ADVERSE EVENTS;FIP1L1;Gene;PA166151827;Disease
MEPOLIZUMAB;FIP1L1;Gene;PA166313323;Chemical
MEPERIDINE;FIP1L1;Gene;PA450369;Chemical
DIABETES MELLITUS, TYPE 2;LPIN1;Gene;PA443890;Disease
ROSIGLITAZONE;LPIN1;Gene;PA451283;Chemical
KCNJ11;Persistent Hyperinsulinemia Hypoglycemia of Infancy;Disease;PA217;Gene
DRUG INTERACTION WITH DRUG;rs1208;Variant;PA165108622;Disease
DRUG TOXICITY;rs1208;Variant;PA443937;Disease
ISONIAZID;rs1208;Variant;PA450112;Chemical
PHENYTOIN;rs1208;Variant;PA450947;Chemical
MIGALASTAT;rs869312146;Variant;PA166182881;Chemical
FABRY DISEASE;rs869312146;Variant;PA443367;Disease
COLORECTAL NEOPLASMS;rs4702484;Variant;PA446108;Disease
CAPECITABINE;rs4702484;Variant;PA448771;Chemical
HYPERTENSION;rs2144297;Variant;PA444552;Disease
ATENOLOL;rs2144297;Variant;PA448499;Chemical
CD274;cosibelimab;Chemical;PA134915280;Gene
IMATINIB;rs11249454;Variant;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;rs11249454;Variant;PA151958383;Disease
THYROTROPIN ALFA;FSHR;Gene;PA164746560;Chemical
MENOTROPINS;FSHR;Gene;PA164749406;Chemical
OVARIAN HYPERSTIMULATION SYNDROME;FSHR;Gene;PA165108853;Disease
INFERTILITY DISORDER;FSHR;Gene;PA444617;Disease
INFERTILITY, FEMALE;FSHR;Gene;PA444618;Disease
FOLLITROPIN BETA;FSHR;Gene;PA449693;Chemical
GONADOTROPIN,CHORIONIC;FSHR;Gene;PA449804;Chemical
UROFOLLITROPIN;FSHR;Gene;PA451835;Chemical
CYP2B6;Heroin Dependence;Disease;PA123;Gene
CYP2D6;Heroin Dependence;Disease;PA128;Gene
ANKS1B;Heroin Dependence;Disease;PA128394692;Gene
TPH2;Heroin Dependence;Disease;PA128747823;Gene
CYP3A4;Heroin Dependence;Disease;PA130;Gene
ANKK1;Heroin Dependence;Disease;PA134872551;Gene
BDNF-AS;Heroin Dependence;Disease;PA134953249;Gene
DBH;Heroin Dependence;Disease;PA136;Gene
DRD1;Heroin Dependence;Disease;PA147;Gene
NGF;Heroin Dependence;Disease;PA162397475;Gene
CYP2D6*1;Heroin Dependence;Disease;PA165816576;Haplotype
CYP2D6*2;Heroin Dependence;Disease;PA165816577;Haplotype
CYP2D6*3;Heroin Dependence;Disease;PA165816578;Haplotype
CYP2D6*4;Heroin Dependence;Disease;PA165816579;Haplotype
CYP2D6*6;Heroin Dependence;Disease;PA165816581;Haplotype
CYP2B6*1;Heroin Dependence;Disease;PA165818750;Haplotype
CYP2B6*4;Heroin Dependence;Disease;PA165818757;Haplotype
CYP2B6*6;Heroin Dependence;Disease;PA165818762;Haplotype
CYP2B6*18;Heroin Dependence;Disease;PA165818808;Haplotype
CYP2D6*1XN;Heroin Dependence;Disease;PA165988479;Haplotype
CYP2D6*2XN;Heroin Dependence;Disease;PA165988480;Haplotype
RS2236861;Heroin Dependence;Disease;PA166153682;Variant
RS2239622;Heroin Dependence;Disease;PA166153683;Variant
RS4654327;Heroin Dependence;Disease;PA166153773;Variant
RS6275;Heroin Dependence;Disease;PA166154260;Variant
RS1076560;Heroin Dependence;Disease;PA166154313;Variant
RS1491850;Heroin Dependence;Disease;PA166154329;Variant
RS1799978;Heroin Dependence;Disease;PA166154337;Variant
RS2283265;Heroin Dependence;Disease;PA166154364;Variant
RS3758987;Heroin Dependence;Disease;PA166154401;Variant
RS7118900;Heroin Dependence;Disease;PA166154420;Variant
RS7934165;Heroin Dependence;Disease;PA166154427;Variant
RS10835210;Heroin Dependence;Disease;PA166154437;Variant
RS12364283;Heroin Dependence;Disease;PA166154464;Variant
RS671;Heroin Dependence;Disease;PA166154482;Variant
RS2279343;Heroin Dependence;Disease;PA166155393;Variant
RS3745274;Heroin Dependence;Disease;PA166155409;Variant
RS2070995;Heroin Dependence;Disease;PA166155996;Variant
RS1534891;Heroin Dependence;Disease;PA166156078;Variant
RS5326;Heroin Dependence;Disease;PA166156707;Variant
RS510769;Heroin Dependence;Disease;PA166156924;Variant
RS558025;Heroin Dependence;Disease;PA166156928;Variant
RS806368;Heroin Dependence;Disease;PA166156953;Variant
RS1799971;Heroin Dependence;Disease;PA166156991;Variant
RS2075572;Heroin Dependence;Disease;PA166157015;Variant
RS3778151;Heroin Dependence;Disease;PA166157079;Variant
RS9479757;Heroin Dependence;Disease;PA166157164;Variant
RS274618;Heroin Dependence;Disease;PA166157251;Variant
RS274622;Heroin Dependence;Disease;PA166157252;Variant
RS724226;Heroin Dependence;Disease;PA166157264;Variant
RS1045642;Heroin Dependence;Disease;PA166157284;Variant
RS1128503;Heroin Dependence;Disease;PA166157288;Variant
RS1990040;Heroin Dependence;Disease;PA166157314;Variant
RS2189814;Heroin Dependence;Disease;PA166157328;Variant
RS2242480;Heroin Dependence;Disease;PA166157345;Variant
RS2246709;Heroin Dependence;Disease;PA166157346;Variant
RS3735451;Heroin Dependence;Disease;PA166157375;Variant
RS4646437;Heroin Dependence;Disease;PA166157391;Variant
RS4646440;Heroin Dependence;Disease;PA166157393;Variant
RS13242038;Heroin Dependence;Disease;PA166157465;Variant
RS1051660;Heroin Dependence;Disease;PA166157551;Variant
RS1948308;Heroin Dependence;Disease;PA166157739;Variant
RS2120266;Heroin Dependence;Disease;PA166157742;Variant
RS2289658;Heroin Dependence;Disease;PA166157749;Variant
RS2378676;Heroin Dependence;Disease;PA166157752;Variant
RS4358872;Heroin Dependence;Disease;PA166157773;Variant
RS4877900;Heroin Dependence;Disease;PA166157779;Variant
RS963549;Heroin Dependence;Disease;PA166176247;Variant
RS2229205;Heroin Dependence;Disease;PA166177058;Variant
RS2758339;Heroin Dependence;Disease;PA166177621;Variant
RS5746136;Heroin Dependence;Disease;PA166177622;Variant
RS495491;Heroin Dependence;Disease;PA166177792;Variant
RS62638690;Heroin Dependence;Disease;PA166177955;Variant
RS2236857;Heroin Dependence;Disease;PA166179883;Variant
RS562859;Heroin Dependence;Disease;PA166179966;Variant
RS3192723;Heroin Dependence;Disease;PA166182126;Variant
RS511435;Heroin Dependence;Disease;PA166183701;Variant
RS524731;Heroin Dependence;Disease;PA166183702;Variant
RS3823010;Heroin Dependence;Disease;PA166183703;Variant
RS6473797;Heroin Dependence;Disease;PA166183884;Variant
RS694066;Heroin Dependence;Disease;PA166183887;Variant
RS3766951;Heroin Dependence;Disease;PA166183890;Variant
RS2236855;Heroin Dependence;Disease;PA166184206;Variant
RS2298897;Heroin Dependence;Disease;PA166184208;Variant
RS508448;Heroin Dependence;Disease;PA166184212;Variant
RS9478495;Heroin Dependence;Disease;PA166184665;Variant
RS3778150;Heroin Dependence;Disease;PA166184666;Variant
RS9384169;Heroin Dependence;Disease;PA166184667;Variant
RS16917234;Heroin Dependence;Disease;PA166185222;Variant
RS2133896;Heroin Dependence;Disease;PA166200161;Variant
RS3762555;Heroin Dependence;Disease;PA166205741;Variant
RS3762556;Heroin Dependence;Disease;PA166205742;Variant
RS3749034;Heroin Dependence;Disease;PA166205744;Variant
RS769404;Heroin Dependence;Disease;PA166205843;Variant
RS3802279;Heroin Dependence;Disease;PA166206202;Variant
RS3802281;Heroin Dependence;Disease;PA166206221;Variant
RS16974799;Heroin Dependence;Disease;PA166232202;Variant
RS1386493;Heroin Dependence;Disease;PA166232221;Variant
RS1611114;Heroin Dependence;Disease;PA166233886;Variant
RS55944529;Heroin Dependence;Disease;PA166263684;Variant
ALDH2;Heroin Dependence;Disease;PA24696;Gene
CNR1;Heroin Dependence;Disease;PA26681;Gene
ABCB1;Heroin Dependence;Disease;PA267;Gene
CSNK1E;Heroin Dependence;Disease;PA26953;Gene
DAO;Heroin Dependence;Disease;PA27139;Gene
DRD2;Heroin Dependence;Disease;PA27478;Gene
GAD1;Heroin Dependence;Disease;PA28507;Gene
GAL;Heroin Dependence;Disease;PA28529;Gene
GRM3;Heroin Dependence;Disease;PA28992;Gene
HTR3B;Heroin Dependence;Disease;PA29556;Gene
KCNJ6;Heroin Dependence;Disease;PA30049;Gene
NTRK2;Heroin Dependence;Disease;PA31818;Gene
BDNF;Heroin Dependence;Disease;PA31891;Gene
OPRD1;Heroin Dependence;Disease;PA31942;Gene
OPRK1;Heroin Dependence;Disease;PA31943;Gene
OPRL1;Heroin Dependence;Disease;PA31944;Gene
OPRM1;Heroin Dependence;Disease;PA31945;Gene
SOD2;Heroin Dependence;Disease;PA36017;Gene
PLCH1;PRKCA;Gene;PA128394595;Gene
BEVACIZUMAB;PRKCA;Gene;PA130232992;Chemical
PLCZ1;PRKCA;Gene;PA134875646;Gene
PLCH2;PRKCA;Gene;PA134914471;Gene
NFKB1;PRKCA;Gene;PA248;Gene
ELK1;PRKCA;Gene;PA27749;Gene
FOS;PRKCA;Gene;PA28212;Gene
RELA;PRKCA;Gene;PA296;Gene
JUN;PRKCA;Gene;PA30006;Gene
MYC;PRKCA;Gene;PA31353;Gene
NFKB2;PRKCA;Gene;PA31600;Gene
PLCB1;PRKCA;Gene;PA33384;Gene
PLCB2;PRKCA;Gene;PA33385;Gene
PLCB3;PRKCA;Gene;PA33386;Gene
PLCB4;PRKCA;Gene;PA33387;Gene
PLCD1;PRKCA;Gene;PA33388;Gene
PLCD3;PRKCA;Gene;PA33389;Gene
PLCD4;PRKCA;Gene;PA33390;Gene
PLCE1;PRKCA;Gene;PA33391;Gene
PLCG1;PRKCA;Gene;PA33392;Gene
PLCG2;PRKCA;Gene;PA33393;Gene
PLCL1;PRKCA;Gene;PA33394;Gene
PLCL2;PRKCA;Gene;PA33395;Gene
STAT3;PRKCA;Gene;PA337;Gene
STAT5A;PRKCA;Gene;PA338;Gene
RAF1;PRKCA;Gene;PA34183;Gene
SP1;PRKCA;Gene;PA36042;Gene
STAT1;PRKCA;Gene;PA36183;Gene
STAT2;PRKCA;Gene;PA36184;Gene
STAT4;PRKCA;Gene;PA36185;Gene
STAT5B;PRKCA;Gene;PA36186;Gene
ADRB2;PRKCA;Gene;PA39;Gene
HYPERTENSION;PRKCA;Gene;PA444552;Disease
HYDROCHLOROTHIAZIDE;PRKCA;Gene;PA449899;Chemical
MYOCARDIAL ISCHEMIA;rs3917643;Variant;PA446459;Disease
SIMVASTATIN;rs3917643;Variant;PA451363;Chemical
TTR;tafamidis;Chemical;PA37069;Gene
NR1I2;troleandomycin;Chemical;PA378;Gene
PROSTATIC NEOPLASMS;HOXB13;Gene;PA445425;Disease
VDR;Rickets;Disease;PA37301;Gene
TRIHEPTANOIN;ACADVL;Gene;PA166350462;Chemical
BREAST NEOPLASMS;rs2284922;Variant;PA443560;Disease
CARBOPLATIN;rs2284922;Variant;PA448803;Chemical
DOCETAXEL;rs2284922;Variant;PA449383;Chemical
TRASTUZUMAB;rs2284922;Variant;PA451743;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*24;Haplotype;PA166127651;Chemical
CODEINE;CYP2D6*24;Haplotype;PA449088;Chemical
DEXTROMETHORPHAN;CYP2D6*24;Haplotype;PA449273;Chemical
CYP2D6;carvedilol;Chemical;PA128;Gene
SLCO1B1;carvedilol;Chemical;PA134865839;Gene
CYP2D6*1;carvedilol;Chemical;PA165816576;Haplotype
CYP2D6*2;carvedilol;Chemical;PA165816577;Haplotype
CYP2D6*3;carvedilol;Chemical;PA165816578;Haplotype
CYP2D6*4;carvedilol;Chemical;PA165816579;Haplotype
CYP2D6*6;carvedilol;Chemical;PA165816581;Haplotype
CYP2D6*10;carvedilol;Chemical;PA165816582;Haplotype
CYP2D6*5;carvedilol;Chemical;PA165948092;Haplotype
UGT1A1*1;carvedilol;Chemical;PA166115841;Haplotype
UGT1A1*28;carvedilol;Chemical;PA166115842;Haplotype
RS1801252;carvedilol;Chemical;PA166153976;Variant
RS1801253;carvedilol;Chemical;PA166153977;Variant
RS4149056;carvedilol;Chemical;PA166154579;Variant
RS4148323;carvedilol;Chemical;PA166155721;Variant
RS1042714;carvedilol;Chemical;PA166156749;Variant
GRK5;carvedilol;Chemical;PA180;Gene
ABCB1;carvedilol;Chemical;PA267;Gene
GRK4;carvedilol;Chemical;PA28941;Gene
ADRA2C;carvedilol;Chemical;PA37;Gene
ADRB1;carvedilol;Chemical;PA38;Gene
ADRB2;carvedilol;Chemical;PA39;Gene
UGT1A1;carvedilol;Chemical;PA420;Gene
FLUOROURACIL;rs2847153;Variant;PA128406956;Chemical
PANCREATIC NEOPLASMS;rs2847153;Variant;PA445218;Disease
OPIOID-RELATED DISORDERS;GABRB3;Gene;PA445043;Disease
OPIOIDS;GABRB3;Gene;PA452618;Chemical
IMATINIB;rs1202283;Variant;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;rs1202283;Variant;PA151958383;Disease
PLATINUM COMPOUNDS;ERCC4;Gene;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;ERCC4;Gene;PA443622;Disease
DRUGS FOR TREATMENT OF TUBERCULOSIS;HLA-DQA1*01:02;Haplotype;PA164712708;Chemical
LUMIRACOXIB;HLA-DQA1*01:02;Haplotype;PA164769031;Chemical
TOXIC LIVER DISEASE;HLA-DQA1*01:02;Haplotype;PA164925725;Disease
TUBERCULOSIS;HLA-DQA1*01:02;Haplotype;PA445941;Disease
UGT1A1*1;FOLFIRINOX;Chemical;PA166115841;Haplotype
UGT1A1*28;FOLFIRINOX;Chemical;PA166115842;Haplotype
UGT1A1*6;FOLFIRINOX;Chemical;PA166115858;Haplotype
UGT1A1;FOLFIRINOX;Chemical;PA420;Gene
RHEUMATOID ARTHRITIS;rs17004921;Variant;PA443434;Disease
METHOTREXATE;rs17004921;Variant;PA450428;Chemical
KIDNEY TRANSPLANTATION;rs1800872;Variant;PA165817016;Disease
LIVER TRANSPLANTATION;rs1800872;Variant;PA447247;Disease
CYCLOSPORINE;rs1800872;Variant;PA449167;Chemical
MYCOPHENOLATE MOFETIL;rs1800872;Variant;PA450566;Chemical
TACROLIMUS;rs1800872;Variant;PA451578;Chemical
OPIOID-RELATED DISORDERS;rs6600880;Variant;PA445043;Disease
METHADONE;rs6600880;Variant;PA450401;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs720106;Variant;PA443622;Disease
CISPLATIN;rs720106;Variant;PA449014;Chemical
GEMCITABINE;rs720106;Variant;PA449748;Chemical
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-A*74:01;Haplotype;PA166120929;Disease
CARBAMAZEPINE;HLA-A*74:01;Haplotype;PA448785;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;ADRA2A;Gene;PA164713257;Chemical
MILNACIPRAN;ADRA2A;Gene;PA164752812;Chemical
PAIN, POSTOPERATIVE;ADRA2A;Gene;PA445210;Disease
HYPERTROPHY, LEFT VENTRICULAR;ADRA2A;Gene;PA446479;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;ADRA2A;Gene;PA447197;Disease
DEPRESSIVE DISORDER;ADRA2A;Gene;PA447207;Disease
MAJOR DEPRESSIVE DISORDER;ADRA2A;Gene;PA447321;Disease
ATENOLOL;ADRA2A;Gene;PA448499;Chemical
BRIMONIDINE;ADRA2A;Gene;PA448665;Chemical
CLONIDINE;ADRA2A;Gene;PA449051;Chemical
DEXMEDETOMIDINE;ADRA2A;Gene;PA449256;Chemical
DOPAMINE;ADRA2A;Gene;PA449396;Chemical
EPINEPHRINE;ADRA2A;Gene;PA449470;Chemical
ISOPROTERENOL;ADRA2A;Gene;PA450121;Chemical
METHYLPHENIDATE;ADRA2A;Gene;PA450464;Chemical
NOREPINEPHRINE;ADRA2A;Gene;PA450649;Chemical
YOHIMBINE;ADRA2A;Gene;PA451946;Chemical
TUBERCULOSIS;AGBL4;Gene;PA445941;Disease
RIFAMPIN;AGBL4;Gene;PA451250;Chemical
OTOTOXICITY;MT-RNR1;Gene;PA162263534;Disease
AMIKACIN;MT-RNR1;Gene;PA164744372;Chemical
NETILMICIN;MT-RNR1;Gene;PA164754913;Chemical
PAROMOMYCIN;MT-RNR1;Gene;PA164784023;Chemical
RS267606618;MT-RNR1;Gene;PA166158908;Variant
RS267606619;MT-RNR1;Gene;PA166158909;Variant
RS267606617;MT-RNR1;Gene;PA166159181;Variant
PLAZOMICIN;MT-RNR1;Gene;PA166228921;Chemical
ISEPAMICIN;MT-RNR1;Gene;PA166241781;Chemical
MICRONOMICIN;MT-RNR1;Gene;PA166241801;Chemical
HYGROMYCIN B;MT-RNR1;Gene;PA166242401;Chemical
DIHYDROSTREPTOMYCIN;MT-RNR1;Gene;PA166242461;Chemical
DIBEKACIN;MT-RNR1;Gene;PA166292901;Chemical
RIBOSTAMYCIN;MT-RNR1;Gene;PA166292902;Chemical
DEAFNESS;MT-RNR1;Gene;PA443840;Disease
GENTAMICIN;MT-RNR1;Gene;PA449753;Chemical
KANAMYCIN;MT-RNR1;Gene;PA450137;Chemical
NEOMYCIN;MT-RNR1;Gene;PA450608;Chemical
STREPTOMYCIN;MT-RNR1;Gene;PA451512;Chemical
TOBRAMYCIN;MT-RNR1;Gene;PA451704;Chemical
AMINOGLYCOSIDE ANTIBACTERIALS;MT-RNR1;Gene;PA452167;Chemical
FLUOROURACIL;rs1047840;Variant;PA128406956;Chemical
METASTATIC NEOPLASM;rs1047840;Variant;PA445058;Disease
CAPECITABINE;rs1047840;Variant;PA448771;Chemical
MIDAZOLAM;CYP3A4*42;Haplotype;PA450496;Chemical
FLUOROURACIL;rs7699188;Variant;PA128406956;Chemical
COLORECTAL NEOPLASMS;rs7699188;Variant;PA446108;Disease
IRINOTECAN;rs7699188;Variant;PA450085;Chemical
LEUCOVORIN;rs7699188;Variant;PA450198;Chemical
DPYD;rs72549305;Variant;PA145;Gene
CAPECITABINE;rs72549305;Variant;PA448771;Chemical
ACUTE CORONARY SYNDROME;rs201441480;Variant;PA165108401;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);rs201441480;Variant;PA166129560;Disease
ASPIRIN;rs201441480;Variant;PA448497;Chemical
CLOPIDOGREL;rs201441480;Variant;PA449053;Chemical
ESR1;doxycycline;Chemical;PA156;Gene
ABCB1;doxycycline;Chemical;PA267;Gene
NR1I2;doxycycline;Chemical;PA378;Gene
OSTEOSARCOMA;rs4148737;Variant;PA445601;Disease
CISPLATIN;rs4148737;Variant;PA449014;Chemical
CYCLOPHOSPHAMIDE;rs4148737;Variant;PA449165;Chemical
DOXORUBICIN;rs4148737;Variant;PA449412;Chemical
METHOTREXATE;rs4148737;Variant;PA450428;Chemical
VINCRISTINE;rs4148737;Variant;PA451879;Chemical
OTOTOXICITY;rs267606618;Variant;PA162263534;Disease
AMIKACIN;rs267606618;Variant;PA164744372;Chemical
NETILMICIN;rs267606618;Variant;PA164754913;Chemical
PAROMOMYCIN;rs267606618;Variant;PA164784023;Chemical
PLAZOMICIN;rs267606618;Variant;PA166228921;Chemical
DIBEKACIN;rs267606618;Variant;PA166292901;Chemical
RIBOSTAMYCIN;rs267606618;Variant;PA166292902;Chemical
MT-RNR1;rs267606618;Variant;PA31274;Gene
GENTAMICIN;rs267606618;Variant;PA449753;Chemical
KANAMYCIN;rs267606618;Variant;PA450137;Chemical
NEOMYCIN;rs267606618;Variant;PA450608;Chemical
STREPTOMYCIN;rs267606618;Variant;PA451512;Chemical
TOBRAMYCIN;rs267606618;Variant;PA451704;Chemical
AMINOGLYCOSIDE ANTIBACTERIALS;rs267606618;Variant;PA452167;Chemical
GSTM1 NULL;Uterine Cervical Neoplasms;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Uterine Cervical Neoplasms;Disease;PA166048676;Haplotype
RS25487;Uterine Cervical Neoplasms;Disease;PA166155346;Variant
RS12659;Uterine Cervical Neoplasms;Disease;PA166155973;Variant
GSTM1;Uterine Cervical Neoplasms;Disease;PA182;Gene
MTHFR;Uterine Cervical Neoplasms;Disease;PA245;Gene
BRCA1;Uterine Cervical Neoplasms;Disease;PA25411;Gene
SLC19A1;Uterine Cervical Neoplasms;Disease;PA327;Gene
XRCC1;Uterine Cervical Neoplasms;Disease;PA369;Gene
HYPERTENSION;rs1126742;Variant;PA444552;Disease
AMILORIDE;rs1126742;Variant;PA448368;Chemical
SPIRONOLACTONE;rs1126742;Variant;PA451483;Chemical
DPYS;Hyperglycemia;Disease;PA146;Gene
RS11649514;Hyperglycemia;Disease;PA166155107;Variant
RS2669429;Hyperglycemia;Disease;PA166157579;Variant
RS10515074;Hyperglycemia;Disease;PA166165378;Variant
RS9943291;Hyperglycemia;Disease;PA166177889;Variant
RS61824877;Hyperglycemia;Disease;PA166177898;Variant
HMGCS2;Hyperglycemia;Disease;PA29338;Gene
PIK3R1;Hyperglycemia;Disease;PA33312;Gene
PRKCB;Hyperglycemia;Disease;PA33761;Gene
PLATINUM COMPOUNDS;rs2269577;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs2269577;Variant;PA443622;Disease
MACULOPAPULAR EXANTHEMA;HLA-DRB1*03:01;Haplotype;PA162316739;Disease
MEASLES VACCINES;HLA-DRB1*03:01;Haplotype;PA164712887;Chemical
DRUG-INDUCED LIVER INJURY;HLA-DRB1*03:01;Haplotype;PA166119041;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-DRB1*03:01;Haplotype;PA166120929;Disease
ALLOPURINOL;HLA-DRB1*03:01;Haplotype;PA448320;Chemical
CARBAMAZEPINE;HLA-DRB1*03:01;Haplotype;PA448785;Chemical
INFLIXIMAB;HLA-DRB1*03:01;Haplotype;PA452639;Chemical
BUFURALOL;CYP2D6*40;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*40;Haplotype;PA166127651;Chemical
ANEMIA, SICKLE CELL;CYP2D6*40;Haplotype;PA443355;Disease
PAIN;CYP2D6*40;Haplotype;PA445208;Disease
CODEINE;CYP2D6*40;Haplotype;PA449088;Chemical
DEXTROMETHORPHAN;CYP2D6*40;Haplotype;PA449273;Chemical
PRIMAQUINE;CYP2D6*40;Haplotype;PA451103;Chemical
ACE INHIBITORS, PLAIN;BDKRB2;Gene;PA164712308;Chemical
ANGIOEDEMA;BDKRB2;Gene;PA443371;Disease
COUGH;BDKRB2;Gene;PA443803;Disease
HYPERTENSION;BDKRB2;Gene;PA444552;Disease
ESSENTIAL HYPERTENSION;BDKRB2;Gene;PA447288;Disease
ATORVASTATIN;BDKRB2;Gene;PA448500;Chemical
ENALAPRIL;BDKRB2;Gene;PA449456;Chemical
LISINOPRIL;BDKRB2;Gene;PA450242;Chemical
IMIDAPRIL;BDKRB2;Gene;PA452640;Chemical
SULFAMETHOXAZOLE / TRIMETHOPRIM;HLA-B*15:02;Haplotype;PA10715;Chemical
CYP2C9;HLA-B*15:02;Haplotype;PA126;Gene
ANTIEPILEPTICS;HLA-B*15:02;Haplotype;PA143485705;Chemical
NEUROPATHIC PAIN;HLA-B*15:02;Haplotype;PA162263525;Disease
MACULOPAPULAR EXANTHEMA;HLA-B*15:02;Haplotype;PA162316739;Disease
FOSPHENYTOIN;HLA-B*15:02;Haplotype;PA164746820;Chemical
PAZOPANIB;HLA-B*15:02;Haplotype;PA165291492;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*15:02;Haplotype;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-B*15:02;Haplotype;PA166120929;Disease
SCHIZENCEPHALY;HLA-B*15:02;Haplotype;PA166152644;Disease
HLA-A;HLA-B*15:02;Haplotype;PA35055;Gene
HLA-B;HLA-B*15:02;Haplotype;PA35056;Gene
DRUG HYPERSENSITIVITY;HLA-B*15:02;Haplotype;PA443936;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*15:02;Haplotype;PA444059;Disease
EPILEPSY;HLA-B*15:02;Haplotype;PA444065;Disease
EXANTHEMA;HLA-B*15:02;Haplotype;PA444109;Disease
SEIZURES;HLA-B*15:02;Haplotype;PA445629;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*15:02;Haplotype;PA445738;Disease
BIPOLAR DISORDER;HLA-B*15:02;Haplotype;PA447199;Disease
CARBAMAZEPINE;HLA-B*15:02;Haplotype;PA448785;Chemical
DAPSONE;HLA-B*15:02;Haplotype;PA449211;Chemical
LAMOTRIGINE;HLA-B*15:02;Haplotype;PA450164;Chemical
OXCARBAZEPINE;HLA-B*15:02;Haplotype;PA450732;Chemical
PHENOBARBITAL;HLA-B*15:02;Haplotype;PA450911;Chemical
PHENYTOIN;HLA-B*15:02;Haplotype;PA450947;Chemical
TENOFOVIR;rs2273697;Variant;PA10204;Chemical
IMATINIB;rs2273697;Variant;PA10804;Chemical
PEMETREXED;rs2273697;Variant;PA10810;Chemical
FLUOROURACIL;rs2273697;Variant;PA128406956;Chemical
ANTIEPILEPTICS;rs2273697;Variant;PA143485705;Chemical
TALINOLOL;rs2273697;Variant;PA146123005;Chemical
GASTROINTESTINAL STROMAL TUMORS;rs2273697;Variant;PA151958383;Disease
DEFERASIROX;rs2273697;Variant;PA164760843;Chemical
RHEUMATOID ARTHRITIS;rs2273697;Variant;PA443434;Disease
BREAST NEOPLASMS;rs2273697;Variant;PA443560;Disease
CENTRAL NERVOUS SYSTEM INFECTIOUS DISORDER;rs2273697;Variant;PA443658;Disease
EPILEPSY;rs2273697;Variant;PA444065;Disease
KIDNEY DISORDER;rs2273697;Variant;PA444682;Disease
MESOTHELIOMA;rs2273697;Variant;PA444937;Disease
COLORECTAL NEOPLASMS;rs2273697;Variant;PA446108;Disease
BETA-THALASSEMIA AND RELATED DISEASES;rs2273697;Variant;PA446432;Disease
HIV INFECTIOUS DISEASE;rs2273697;Variant;PA447230;Disease
CARBAMAZEPINE;rs2273697;Variant;PA448785;Chemical
CEFTRIAXONE;rs2273697;Variant;PA448866;Chemical
CISPLATIN;rs2273697;Variant;PA449014;Chemical
CYCLOPHOSPHAMIDE;rs2273697;Variant;PA449165;Chemical
DOXORUBICIN;rs2273697;Variant;PA449412;Chemical
IRINOTECAN;rs2273697;Variant;PA450085;Chemical
METHOTREXATE;rs2273697;Variant;PA450428;Chemical
OXCARBAZEPINE;rs2273697;Variant;PA450732;Chemical
ABCC2;oxaliplatin;Chemical;PA116;Gene
CYP2A6;oxaliplatin;Chemical;PA121;Gene
KLC3;oxaliplatin;Chemical;PA142671588;Gene
ERCC1;oxaliplatin;Chemical;PA155;Gene
PARD3B;oxaliplatin;Chemical;PA162398721;Gene
CYP2A6*1;oxaliplatin;Chemical;PA165924690;Haplotype
CYP2A6*4;oxaliplatin;Chemical;PA165924721;Haplotype
CYP2A6*7;oxaliplatin;Chemical;PA165924731;Haplotype
CYP2A6*9;oxaliplatin;Chemical;PA165980914;Haplotype
GSTM1 NULL;oxaliplatin;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;oxaliplatin;Chemical;PA166048676;Haplotype
UGT1A1*1;oxaliplatin;Chemical;PA166115841;Haplotype
UGT1A1*28;oxaliplatin;Chemical;PA166115842;Haplotype
UGT1A1*60;oxaliplatin;Chemical;PA166115845;Haplotype
UGT1A6*2A;oxaliplatin;Chemical;PA166117621;Haplotype
UGT1A7*3;oxaliplatin;Chemical;PA166117639;Haplotype
RS5275;oxaliplatin;Chemical;PA166153552;Variant
RS1801131;oxaliplatin;Chemical;PA166153643;Variant
RS1801133;oxaliplatin;Chemical;PA166153644;Variant
RS3917412;oxaliplatin;Chemical;PA166153758;Variant
RS717620;oxaliplatin;Chemical;PA166153953;Variant
RS1695;oxaliplatin;Chemical;PA166154249;Variant
RS7325568;oxaliplatin;Chemical;PA166154720;Variant
RS1800566;oxaliplatin;Chemical;PA166155017;Variant
RS45445694;oxaliplatin;Chemical;PA166155331;Variant
RS11615;oxaliplatin;Chemical;PA166155342;Variant
RS13181;oxaliplatin;Chemical;PA166155343;Variant
RS885036;oxaliplatin;Chemical;PA166155606;Variant
RS17626122;oxaliplatin;Chemical;PA166155846;Variant
RS2231142;oxaliplatin;Chemical;PA166156544;Variant
RS25648;oxaliplatin;Chemical;PA166156906;Variant
RS699947;oxaliplatin;Chemical;PA166156938;Variant
RS2010963;oxaliplatin;Chemical;PA166157006;Variant
RS662;oxaliplatin;Chemical;PA166157238;Variant
RS1045642;oxaliplatin;Chemical;PA166157284;Variant
RS1128503;oxaliplatin;Chemical;PA166157288;Variant
RS1799983;oxaliplatin;Chemical;PA166157303;Variant
RS2233678;oxaliplatin;Chemical;PA166181044;Variant
GSTM1;oxaliplatin;Chemical;PA182;Gene
MTHFR;oxaliplatin;Chemical;PA245;Gene
NOS3;oxaliplatin;Chemical;PA254;Gene
ABCB1;oxaliplatin;Chemical;PA267;Gene
CSMD1;oxaliplatin;Chemical;PA26947;Gene
ERCC2;oxaliplatin;Chemical;PA27848;Gene
GNA13;oxaliplatin;Chemical;PA28766;Gene
GSTP1;oxaliplatin;Chemical;PA29028;Gene
PTGS2;oxaliplatin;Chemical;PA293;Gene
MGAT4A;oxaliplatin;Chemical;PA30782;Gene
MT1A;oxaliplatin;Chemical;PA31198;Gene
NQO1;oxaliplatin;Chemical;PA31744;Gene
PIN1;oxaliplatin;Chemical;PA33320;Gene
PON1;oxaliplatin;Chemical;PA33529;Gene
SELE;oxaliplatin;Chemical;PA35640;Gene
TYMS;oxaliplatin;Chemical;PA359;Gene
UGT1A6;oxaliplatin;Chemical;PA37181;Gene
UGT1A7;oxaliplatin;Chemical;PA37182;Gene
VEGFA;oxaliplatin;Chemical;PA37302;Gene
ABCG2;oxaliplatin;Chemical;PA390;Gene
ABCC5;oxaliplatin;Chemical;PA395;Gene
UGT1A1;oxaliplatin;Chemical;PA420;Gene
ABCC2;talinolol;Chemical;PA116;Gene
RS2273697;talinolol;Chemical;PA166154007;Variant
RS1045642;talinolol;Chemical;PA166157284;Variant
ABCB1;talinolol;Chemical;PA267;Gene
IBUPROFEN;CYP2C19*35;Haplotype;PA449957;Chemical
TOXIC LIVER DISEASE;HLA-DRB1*01:02;Haplotype;PA164925725;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-DRB1*01:02;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-DRB1*01:02;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-DRB1*01:02;Haplotype;PA445738;Disease
HIV INFECTIONS;HLA-DRB1*01:02;Haplotype;PA447230;Disease
NEVIRAPINE;HLA-DRB1*01:02;Haplotype;PA450616;Chemical
AUTISM SPECTRUM DISORDER;rs806378;Variant;PA153906318;Disease
SCHIZOPHRENIA;rs806378;Variant;PA447216;Disease
CLOZAPINE;rs806378;Variant;PA449061;Chemical
OLANZAPINE;rs806378;Variant;PA450688;Chemical
RISPERIDONE;rs806378;Variant;PA451257;Chemical
HMG COA REDUCTASE INHIBITORS;rs1063320;Variant;PA133950441;Chemical
ASTHMA;rs1063320;Variant;PA443450;Disease
COTININE;NAT1;Gene;PA166114414;Chemical
COLITIS, ULCERATIVE;NAT1;Gene;PA443750;Disease
CROHN DISEASE;NAT1;Gene;PA443815;Disease
INFLAMMATORY BOWEL DISEASES;NAT1;Gene;PA446116;Disease
MESALAZINE;NAT1;Gene;PA450384;Chemical
THIOGUANINE;NAT1;Gene;PA451663;Chemical
BETA BLOCKING AGENTS;rs10787959;Variant;PA164712535;Chemical
CORONARY ARTERY DISEASE;rs10787959;Variant;PA443796;Disease
CYP2C19;n-desmethylclozapine;Chemical;PA124;Gene
CYP3A4;n-desmethylclozapine;Chemical;PA130;Gene
CYP2C19*17;n-desmethylclozapine;Chemical;PA165816533;Haplotype
CYP2C19*1;n-desmethylclozapine;Chemical;PA165980634;Haplotype
CYP1A2*35;n-desmethylclozapine;Chemical;PA166363479;Haplotype
CYP1A2;n-desmethylclozapine;Chemical;PA27093;Gene
DEFERASIROX;rs927650;Variant;PA164760843;Chemical
BETA-THALASSEMIA AND RELATED DISEASES;rs927650;Variant;PA446432;Disease
KCNJ1;WNK4;Gene;PA213;Gene
SCNN1A;WNK4;Gene;PA305;Gene
SCNN1B;WNK4;Gene;PA306;Gene
SCNN1G;WNK4;Gene;PA307;Gene
SLC12A3;WNK4;Gene;PA321;Gene
WNK1;WNK4;Gene;PA33782;Gene
STK39;WNK4;Gene;PA38243;Gene
PLATINUM COMPOUNDS;ATP7A;Gene;PA164713176;Chemical
PROSTATIC NEOPLASMS;ATP7A;Gene;PA445425;Disease
DOCETAXEL;ATP7A;Gene;PA449383;Chemical
THALIDOMIDE;ATP7A;Gene;PA451644;Chemical
CELECOXIB;BCAR1;Gene;PA448871;Chemical
CYP2D6;lofexidine;Chemical;PA128;Gene
PEGASPARGASE;CPT1A;Gene;PA164760860;Chemical
ELEVATED LIVER ENZYMES;CPT1A;Gene;PA166279881;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;CPT1A;Gene;PA446155;Disease
CYCLOPHOSPHAMIDE;CPT1A;Gene;PA449165;Chemical
CYTARABINE;CPT1A;Gene;PA449177;Chemical
DAUNORUBICIN;CPT1A;Gene;PA449212;Chemical
DOXORUBICIN;CPT1A;Gene;PA449412;Chemical
MERCAPTOPURINE;CPT1A;Gene;PA450379;Chemical
METHOTREXATE;CPT1A;Gene;PA450428;Chemical
THIOGUANINE;CPT1A;Gene;PA451663;Chemical
VINCRISTINE;CPT1A;Gene;PA451879;Chemical
WEIGHT GAIN;rs518147;Variant;PA128406954;Disease
SCHIZOPHRENIA;rs518147;Variant;PA447216;Disease
OLANZAPINE;rs518147;Variant;PA450688;Chemical
ALCOHOL ABUSE;rs10516440;Variant;PA443309;Disease
ETHANOL;rs10516440;Variant;PA448073;Chemical
ASTHMA;rs881152;Variant;PA443450;Disease
SALBUTAMOL;rs881152;Variant;PA448068;Chemical
HEROIN DEPENDENCE;rs12364283;Variant;PA444460;Disease
AMPHETAMINE;rs12364283;Variant;PA448408;Chemical
HEROIN;rs12364283;Variant;PA452619;Chemical
CYP2C19;Malaria;Disease;PA124;Gene
CYP2D6;Malaria;Disease;PA128;Gene
CYP3A4;Malaria;Disease;PA130;Gene
CYP3A5;Malaria;Disease;PA131;Gene
ZSCAN25;Malaria;Disease;PA134962723;Gene
CYP2D6*1;Malaria;Disease;PA165816576;Haplotype
CYP2D6*2;Malaria;Disease;PA165816577;Haplotype
CYP2D6*4;Malaria;Disease;PA165816579;Haplotype
CYP2D6*6;Malaria;Disease;PA165816581;Haplotype
CYP2D6*10;Malaria;Disease;PA165816582;Haplotype
CYP2D6*41;Malaria;Disease;PA165816584;Haplotype
G6PD B (REFERENCE);Malaria;Disease;PA165947826;Haplotype
G6PD A- 202A_376G;Malaria;Disease;PA165947827;Haplotype
CYP2D6*5;Malaria;Disease;PA165948092;Haplotype
CYP2D6*9;Malaria;Disease;PA165948317;Haplotype
CYP2C19*1;Malaria;Disease;PA165980634;Haplotype
CYP2C19*2;Malaria;Disease;PA165980635;Haplotype
CYP2C19*3;Malaria;Disease;PA165980636;Haplotype
RS776746;Malaria;Disease;PA166157267;Variant
RS2740574;Malaria;Disease;PA166157367;Variant
RS10264272;Malaria;Disease;PA166157441;Variant
RS41303343;Malaria;Disease;PA166157490;Variant
RS1050828;Malaria;Disease;PA166157859;Variant
G6PD DEFICIENCY;Malaria;Disease;PA166157959;Variant
RS62103056;Malaria;Disease;PA166216422;Variant
G6PD;Malaria;Disease;PA28469;Gene
HLA-B;Malaria;Disease;PA35056;Gene
CYP2D6;Heart Failure;Disease;PA128;Gene
CYP3A4;Heart Failure;Disease;PA130;Gene
ACE;Heart Failure;Disease;PA139;Gene
CYP2D6*1;Heart Failure;Disease;PA165816576;Haplotype
CYP2D6*3;Heart Failure;Disease;PA165816578;Haplotype
CYP2D6*4;Heart Failure;Disease;PA165816579;Haplotype
CYP2D6*6;Heart Failure;Disease;PA165816581;Haplotype
CYP2D6*10;Heart Failure;Disease;PA165816582;Haplotype
CYP3A4*1;Heart Failure;Disease;PA165819201;Haplotype
CYP2D6*5;Heart Failure;Disease;PA165948092;Haplotype
CYP3A4*22;Heart Failure;Disease;PA166048680;Haplotype
RS1801253;Heart Failure;Disease;PA166153977;Variant
RS2230345;Heart Failure;Disease;PA166154001;Variant
RS5443;Heart Failure;Disease;PA166154486;Variant
RS1799752;Heart Failure;Disease;PA166155187;Variant
RS4148323;Heart Failure;Disease;PA166155721;Variant
RS1056892;Heart Failure;Disease;PA166155989;Variant
RS5186;Heart Failure;Disease;PA166156276;Variant
RS61767072;Heart Failure;Disease;PA166156691;Variant
RS1042713;Heart Failure;Disease;PA166156748;Variant
RS1042714;Heart Failure;Disease;PA166156749;Variant
RS1799983;Heart Failure;Disease;PA166157303;Variant
RS17268282;Heart Failure;Disease;PA166161197;Variant
GNB3;Heart Failure;Disease;PA176;Gene
GRK5;Heart Failure;Disease;PA180;Gene
NOS3;Heart Failure;Disease;PA254;Gene
CBR3;Heart Failure;Disease;PA26122;Gene
ADRA2C;Heart Failure;Disease;PA37;Gene
ADRB1;Heart Failure;Disease;PA38;Gene
ADRB2;Heart Failure;Disease;PA39;Gene
ABCC4;Heart Failure;Disease;PA397;Gene
UGT1A1;Heart Failure;Disease;PA420;Gene
AGTR1;Heart Failure;Disease;PA43;Gene
SCHIZOPHRENIA;rs2445142;Variant;PA447216;Disease
ANTIPSYCHOTICS;rs2445142;Variant;PA452233;Chemical
HMG COA REDUCTASE INHIBITORS;rs10455872;Variant;PA133950441;Chemical
ROSUVASTATIN;rs10455872;Variant;PA134308647;Chemical
CORONARY ARTERY DISEASE;rs10455872;Variant;PA443796;Disease
PEGINTERFERON ALFA-2A;ITPA;Gene;PA164749390;Chemical
INTERFERON ALFA-2B, RECOMBINANT;ITPA;Gene;PA164783990;Chemical
PEGINTERFERON ALFA-2B;ITPA;Gene;PA164784024;Chemical
MYELOSUPPRESSION;ITPA;Gene;PA165817398;Disease
TRANSPLANT REJECTION;ITPA;Gene;PA166114454;Disease
ANEMIA;ITPA;Gene;PA443340;Disease
RHEUMATOID ARTHRITIS;ITPA;Gene;PA443434;Disease
HEPATITIS C VIRUS INFECTION;ITPA;Gene;PA444445;Disease
LEUKOPENIA;ITPA;Gene;PA444773;Disease
SYSTEMIC LUPUS ERYTHEMATOSUS;ITPA;Gene;PA444822;Disease
NEUTROPENIA;ITPA;Gene;PA445113;Disease
INFLAMMATORY BOWEL DISEASES;ITPA;Gene;PA446116;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;ITPA;Gene;PA446155;Disease
CHRONIC HEPATITIS C VIRUS INFECTION;ITPA;Gene;PA446863;Disease
LIVER TRANSPLANTATION;ITPA;Gene;PA447247;Disease
AZATHIOPRINE;ITPA;Gene;PA448515;Chemical
MERCAPTOPURINE;ITPA;Gene;PA450379;Chemical
METHOTREXATE;ITPA;Gene;PA450428;Chemical
RIBAVIRIN;ITPA;Gene;PA451241;Chemical
PURINE ANALOGUES;ITPA;Gene;PA452634;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs868856;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs868856;Variant;PA443434;Disease
CYP2D6;Tachycardia;Disease;PA128;Gene
CYP2D6*1;Tachycardia;Disease;PA165816576;Haplotype
CYP2D6*2;Tachycardia;Disease;PA165816577;Haplotype
CYP2D6*3;Tachycardia;Disease;PA165816578;Haplotype
CYP2D6*4;Tachycardia;Disease;PA165816579;Haplotype
CYP2D6*6;Tachycardia;Disease;PA165816581;Haplotype
CYP2D6*10;Tachycardia;Disease;PA165816582;Haplotype
CYP2D6*5;Tachycardia;Disease;PA165948092;Haplotype
CYP2D6*36;Tachycardia;Disease;PA165988488;Haplotype
CYP2D6*81;Tachycardia;Disease;PA166123321;Haplotype
RS1801253;Tachycardia;Disease;PA166153977;Variant
RS1042713;Tachycardia;Disease;PA166156748;Variant
RS1042714;Tachycardia;Disease;PA166156749;Variant
ADRB1;Tachycardia;Disease;PA38;Gene
ADRB2;Tachycardia;Disease;PA39;Gene
FLUOROURACIL;rs3772809;Variant;PA128406956;Chemical
METASTATIC NEOPLASM;rs3772809;Variant;PA445058;Disease
CAPECITABINE;rs3772809;Variant;PA448771;Chemical
HYPERTRIGLYCERIDEMIA;rs3135506;Variant;PA446120;Disease
FENOFIBRATE;rs3135506;Variant;PA449594;Chemical
ALCOHOL ABUSE;rs4251417;Variant;PA443309;Disease
ETHANOL;rs4251417;Variant;PA448073;Chemical
FLUOROURACIL;rs12613732;Variant;PA128406956;Chemical
HEPATOCELLULAR CARCINOMA;rs12613732;Variant;PA444447;Disease
CISPLATIN;rs12613732;Variant;PA449014;Chemical
MITOXANTRONE;rs12613732;Variant;PA450526;Chemical
CYP3A5;Graft vs Host Disease;Disease;PA131;Gene
GSTT1 NULL;Graft vs Host Disease;Disease;PA166048678;Haplotype
GSTT1 NON-NULL;Graft vs Host Disease;Disease;PA166048679;Haplotype
CYP3A5*1;Graft vs Host Disease;Disease;PA166128213;Haplotype
CYP3A5*3;Graft vs Host Disease;Disease;PA166128219;Haplotype
RS1801133;Graft vs Host Disease;Disease;PA166153644;Variant
GSTT1;Graft vs Host Disease;Disease;PA183;Gene
MTHFR;Graft vs Host Disease;Disease;PA245;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs2814707;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs2814707;Variant;PA443434;Disease
CARDIOTOXICITY;RNF144A;Gene;PA166128121;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs1061115;Variant;PA447197;Disease
METHYLPHENIDATE;rs1061115;Variant;PA450464;Chemical
DRUG HYPERSENSITIVITY;HLA-DQB1*06:03;Haplotype;PA443936;Disease
HIV INFECTIONS;HLA-DQB1*06:03;Haplotype;PA447230;Disease
NEVIRAPINE;HLA-DQB1*06:03;Haplotype;PA450616;Chemical
TOXIC LIVER DISEASE;rs3087374;Variant;PA164925725;Disease
VALPROIC ACID;rs3087374;Variant;PA451846;Chemical
FLUOROURACIL;rs56038477;Variant;PA128406956;Chemical
DPYD;rs56038477;Variant;PA145;Gene
NEOPLASMS;rs56038477;Variant;PA445062;Disease
CAPECITABINE;rs56038477;Variant;PA448771;Chemical
TEGAFUR;rs56038477;Variant;PA452620;Chemical
NEOPLASMS;rs2291767;Variant;PA445062;Disease
CISPLATIN;rs2291767;Variant;PA449014;Chemical
3,4-METHYLENEDIOXYMETHAMPHETAMINE;rs36029;Variant;PA131887008;Chemical
CYP2C9;Gastritis;Disease;PA126;Gene
CYP2C9*1;Gastritis;Disease;PA165816542;Haplotype
CYP2C9*3;Gastritis;Disease;PA165816544;Haplotype
MULTIPLE SCLEROSIS;rs12044852;Variant;PA444987;Disease
INTERFERON BETA-1A;rs12044852;Variant;PA450037;Chemical
INTERFERON BETA-1B;rs12044852;Variant;PA450039;Chemical
G6PD;probenecid;Chemical;PA28469;Gene
NON-SMALL CELL LUNG CARCINOMA;HCP5;Gene;PA443622;Disease
THROMBOCYTOPENIA;HCP5;Gene;PA445846;Disease
CARBOPLATIN;HCP5;Gene;PA448803;Chemical
GEMCITABINE;HCP5;Gene;PA449748;Chemical
NEVIRAPINE;HCP5;Gene;PA450616;Chemical
TNFSF13B;belimumab;Chemical;PA434;Gene
CFTR;rs75541969;Variant;PA109;Gene
IVACAFTOR;rs75541969;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs75541969;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs75541969;Variant;PA166190041;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs75541969;Variant;PA166362502;Chemical
CYSTIC FIBROSIS;rs75541969;Variant;PA443829;Disease
SIMVASTATIN;rs2003569;Variant;PA451363;Chemical
MAJOR DEPRESSIVE DISORDER;rs9361233;Variant;PA447321;Disease
FLUOXETINE;rs9361233;Variant;PA449673;Chemical
ARIPIPRAZOLE;rs6465938;Variant;PA10026;Chemical
SCHIZOPHRENIA;rs6465938;Variant;PA447216;Disease
OLANZAPINE;rs6465938;Variant;PA450688;Chemical
PERPHENAZINE;rs6465938;Variant;PA450882;Chemical
QUETIAPINE;rs6465938;Variant;PA451201;Chemical
RISPERIDONE;rs6465938;Variant;PA451257;Chemical
PLATINUM COMPOUNDS;rs1059698;Variant;PA164713176;Chemical
MYELOSUPPRESSION;rs1059698;Variant;PA165817398;Disease
MUCOSITIS;rs1059698;Variant;PA166122058;Disease
RADIOTHERAPY;rs1059698;Variant;PA166122986;Chemical
ANEMIA;rs1059698;Variant;PA443340;Disease
DERMATITIS;rs1059698;Variant;PA443875;Disease
NASOPHARYNGEAL NEOPLASMS;rs1059698;Variant;PA445046;Disease
NEUTROPENIA;rs1059698;Variant;PA445113;Disease
THROMBOCYTOPENIA;rs1059698;Variant;PA445846;Disease
CYP2C9;Atrial Flutter;Disease;PA126;Gene
CYP2C9*1;Atrial Flutter;Disease;PA165816542;Haplotype
CYP2C9*3;Atrial Flutter;Disease;PA165816544;Haplotype
ALLOPURINOL;TBL1XR1;Gene;PA448320;Chemical
PERTUSSIS VACCINES;rs4986790;Variant;PA164713160;Chemical
RHEUMATOID ARTHRITIS;rs4986790;Variant;PA443434;Disease
CORONARY ARTERY DISEASE;rs4986790;Variant;PA443796;Disease
FOLIC ACID;rs4986790;Variant;PA449692;Chemical
METHOTREXATE;rs4986790;Variant;PA450428;Chemical
PRAVASTATIN;rs4986790;Variant;PA451089;Chemical
OSTEOSARCOMA;rs1650723;Variant;PA445601;Disease
METHOTREXATE;rs1650723;Variant;PA450428;Chemical
HEROIN DEPENDENCE;rs274622;Variant;PA444460;Disease
HEROIN;rs274622;Variant;PA452619;Chemical
PLATINUM COMPOUNDS;ERCC3;Gene;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;ERCC3;Gene;PA443622;Disease
CYP2C8;repaglinide;Chemical;PA125;Gene
IGF2BP2;repaglinide;Chemical;PA128394577;Gene
CYP3A4;repaglinide;Chemical;PA130;Gene
SLCO1B1;repaglinide;Chemical;PA134865839;Gene
SLC30A8;repaglinide;Chemical;PA134915546;Gene
NOS1AP;repaglinide;Chemical;PA142671259;Gene
SLCO1B1*37;repaglinide;Chemical;PA165819251;Haplotype
SLCO1B1*5;repaglinide;Chemical;PA165819255;Haplotype
SLCO1B1*15;repaglinide;Chemical;PA165819265;Haplotype
CYP2C8*3;repaglinide;Chemical;PA165958685;Haplotype
SLCO1B1*1;repaglinide;Chemical;PA165981641;Haplotype
RS10494366;repaglinide;Chemical;PA166153802;Variant
RS290487;repaglinide;Chemical;PA166153946;Variant
RS10509681;repaglinide;Chemical;PA166154110;Variant
RS11572080;repaglinide;Chemical;PA166154140;Variant
RS5219;repaglinide;Chemical;PA166154256;Variant
RS2237892;repaglinide;Chemical;PA166154354;Variant
RS2237895;repaglinide;Chemical;PA166154355;Variant
RS2306283;repaglinide;Chemical;PA166154547;Variant
RS4149056;repaglinide;Chemical;PA166154579;Variant
RS1801262;repaglinide;Chemical;PA166155645;Variant
RS1470579;repaglinide;Chemical;PA166156318;Variant
RS2276706;repaglinide;Chemical;PA166156351;Variant
RS3814058;repaglinide;Chemical;PA166156385;Variant
RS4402960;repaglinide;Chemical;PA166156398;Variant
RS114202595;repaglinide;Chemical;PA166157526;Variant
RS13266634;repaglinide;Chemical;PA166157645;Variant
KCNJ11;repaglinide;Chemical;PA217;Gene
KCNQ1;repaglinide;Chemical;PA223;Gene
NEUROD1;repaglinide;Chemical;PA31564;Gene
PAX4;repaglinide;Chemical;PA32958;Gene
TCF7L2;repaglinide;Chemical;PA36394;Gene
NR1I2;repaglinide;Chemical;PA378;Gene
IRBESARTAN;repaglinide;Chemical;PA450084;Chemical
C18ORF56;Myelosuppression;Disease;PA134956204;Gene
NUDT15;Myelosuppression;Disease;PA134963132;Gene
TPMT*1;Myelosuppression;Disease;PA165819268;Haplotype
TPMT*2;Myelosuppression;Disease;PA165819269;Haplotype
TPMT*3A;Myelosuppression;Disease;PA165819270;Haplotype
TPMT*3B;Myelosuppression;Disease;PA165819271;Haplotype
TPMT*3C;Myelosuppression;Disease;PA165819272;Haplotype
TPMT*6;Myelosuppression;Disease;PA165819276;Haplotype
TPMT*8;Myelosuppression;Disease;PA165819278;Haplotype
TPMT*9;Myelosuppression;Disease;PA165819279;Haplotype
TPMT*12;Myelosuppression;Disease;PA165819282;Haplotype
TPMT*24;Myelosuppression;Disease;PA165819295;Haplotype
NUDT15*1;Myelosuppression;Disease;PA166131619;Haplotype
NUDT15*2;Myelosuppression;Disease;PA166131620;Haplotype
NUDT15*3;Myelosuppression;Disease;PA166131621;Haplotype
RS1801133;Myelosuppression;Disease;PA166153644;Variant
RS1933437;Myelosuppression;Disease;PA166154705;Variant
RS116855232;Myelosuppression;Disease;PA166154759;Variant
RS45445694;Myelosuppression;Disease;PA166155331;Variant
RS1127354;Myelosuppression;Disease;PA166155915;Variant
RS3814055;Myelosuppression;Disease;PA166156383;Variant
RS6785049;Myelosuppression;Disease;PA166156411;Variant
RS746071566;Myelosuppression;Disease;PA166165231;Variant
RS2027701;Myelosuppression;Disease;PA166169891;Variant
RS1059698;Myelosuppression;Disease;PA166169893;Variant
RS73594404;Myelosuppression;Disease;PA166169897;Variant
RS10132552;Myelosuppression;Disease;PA166169901;Variant
RS11969064;Myelosuppression;Disease;PA166184136;Variant
MTHFR;Myelosuppression;Disease;PA245;Gene
FLT3;Myelosuppression;Disease;PA28181;Gene
ITPA;Myelosuppression;Disease;PA29973;Gene
MEG3;Myelosuppression;Disease;PA30737;Gene
TPMT;Myelosuppression;Disease;PA356;Gene
TYMS;Myelosuppression;Disease;PA359;Gene
NR1I2;Myelosuppression;Disease;PA378;Gene
CARDIOVASCULAR DISEASES;CYP2C9*4;Haplotype;PA443635;Disease
WARFARIN;CYP2C9*4;Haplotype;PA451906;Chemical
RS396991;Neuromyelitis Optica;Disease;PA166153571;Variant
FCGR3A;Neuromyelitis Optica;Disease;PA28065;Gene
CAMK1D;ELK1;Gene;PA134992438;Gene
AKT1;ELK1;Gene;PA24684;Gene
AKT2;ELK1;Gene;PA24685;Gene
AKT3;ELK1;Gene;PA24686;Gene
CAMK1;ELK1;Gene;PA26048;Gene
CAMK1G;ELK1;Gene;PA26049;Gene
MAPK8;ELK1;Gene;PA283;Gene
MAPK1;ELK1;Gene;PA30616;Gene
MAPK3;ELK1;Gene;PA30622;Gene
STAT3;ELK1;Gene;PA337;Gene
PRKCA;ELK1;Gene;PA33759;Gene
PRKCB;ELK1;Gene;PA33761;Gene
PRKCG;ELK1;Gene;PA33766;Gene
STAT5A;ELK1;Gene;PA338;Gene
STAT1;ELK1;Gene;PA36183;Gene
STAT2;ELK1;Gene;PA36184;Gene
STAT4;ELK1;Gene;PA36185;Gene
STAT5B;ELK1;Gene;PA36186;Gene
CAMK2A;ELK1;Gene;PA90;Gene
CAMK2B;ELK1;Gene;PA91;Gene
CAMK2D;ELK1;Gene;PA92;Gene
CAMK2G;ELK1;Gene;PA93;Gene
MAJOR DEPRESSIVE DISORDER;rs2742417;Variant;PA447321;Disease
BUPROPION;rs2742417;Variant;PA448687;Chemical
TOBACCO USE DISORDER;CHRNB2;Gene;PA445876;Disease
NICOTINE;CHRNB2;Gene;PA450626;Chemical
BEVACIZUMAB;rs3025000;Variant;PA130232992;Chemical
MACULAR DEGENERATION;rs3025000;Variant;PA134850558;Disease
RANIBIZUMAB;rs3025000;Variant;PA164746012;Chemical
ABCC2;Toxic liver disease;Disease;PA116;Gene
CYP2B6;Toxic liver disease;Disease;PA123;Gene
CYP2C8;Toxic liver disease;Disease;PA125;Gene
CYP2D6;Toxic liver disease;Disease;PA128;Gene
CYP2E1;Toxic liver disease;Disease;PA129;Gene
CYP3A5;Toxic liver disease;Disease;PA131;Gene
NOS2;Toxic liver disease;Disease;PA164724093;Gene
CYP2D6*1;Toxic liver disease;Disease;PA165816576;Haplotype
CYP2D6*2;Toxic liver disease;Disease;PA165816577;Haplotype
CYP2D6*10;Toxic liver disease;Disease;PA165816582;Haplotype
CYP2B6*1;Toxic liver disease;Disease;PA165818750;Haplotype
CYP2B6*6;Toxic liver disease;Disease;PA165818762;Haplotype
CYP2B6*7;Toxic liver disease;Disease;PA165818765;Haplotype
CYP2E1*1A;Toxic liver disease;Disease;PA165948032;Haplotype
CYP2E1*5B;Toxic liver disease;Disease;PA165948040;Haplotype
CYP2D6*5;Toxic liver disease;Disease;PA165948092;Haplotype
NAT2*4;Toxic liver disease;Disease;PA165949098;Haplotype
NAT2*16;Toxic liver disease;Disease;PA165949099;Haplotype
NAT2*1;Toxic liver disease;Disease;PA165949138;Haplotype
HLA-DQA1*01:01;Toxic liver disease;Disease;PA165951273;Haplotype
HLA-DQA1*01:02;Toxic liver disease;Disease;PA165951275;Haplotype
HLA-DQA1*02:01;Toxic liver disease;Disease;PA165951292;Haplotype
HLA-DRB1*01:01;Toxic liver disease;Disease;PA165951320;Haplotype
HLA-DRB1*01:02;Toxic liver disease;Disease;PA165951340;Haplotype
HLA-DRB1*07:01;Toxic liver disease;Disease;PA165951644;Haplotype
HLA-DRB1*13:02;Toxic liver disease;Disease;PA165951978;Haplotype
HLA-DRB1*15:01;Toxic liver disease;Disease;PA165952269;Haplotype
HLA-B*44:03;Toxic liver disease;Disease;PA165955913;Haplotype
HLA-B*58:02;Toxic liver disease;Disease;PA165956639;Haplotype
HLA-C*02:10;Toxic liver disease;Disease;PA165956805;Haplotype
HLA-C*14:03;Toxic liver disease;Disease;PA165957827;Haplotype
HLA-DQB1*06:02;Toxic liver disease;Disease;PA165958103;Haplotype
HLA-DQB1*06:04;Toxic liver disease;Disease;PA165958107;Haplotype
HLA-DQB1*02:01;Toxic liver disease;Disease;PA165958158;Haplotype
CYP2C8*2;Toxic liver disease;Disease;PA165958684;Haplotype
CYP2C8*3;Toxic liver disease;Disease;PA165958685;Haplotype
CYP2C8*4;Toxic liver disease;Disease;PA165958686;Haplotype
NAT2*5;Toxic liver disease;Disease;PA165981634;Haplotype
NAT2*6;Toxic liver disease;Disease;PA165981635;Haplotype
NAT2*7;Toxic liver disease;Disease;PA165981636;Haplotype
NAT2*14;Toxic liver disease;Disease;PA165981640;Haplotype
HLA-B*57:01;Toxic liver disease;Disease;PA165987830;Haplotype
HLA-B*58:01;Toxic liver disease;Disease;PA165987831;Haplotype
GSTM1 NULL;Toxic liver disease;Disease;PA166048675;Haplotype
GSTT1 NULL;Toxic liver disease;Disease;PA166048678;Haplotype
HLA-A*33:03;Toxic liver disease;Disease;PA166123428;Haplotype
CYP3A5*1;Toxic liver disease;Disease;PA166128213;Haplotype
CYP3A5*3;Toxic liver disease;Disease;PA166128219;Haplotype
RS1801133;Toxic liver disease;Disease;PA166153644;Variant
RS3740065;Toxic liver disease;Disease;PA166154027;Variant
RS2236225;Toxic liver disease;Disease;PA166154789;Variant
RS3087374;Toxic liver disease;Disease;PA166154900;Variant
RS11080344;Toxic liver disease;Disease;PA166155245;Variant
RS3745274;Toxic liver disease;Disease;PA166155409;Variant
RS11125883;Toxic liver disease;Disease;PA166155800;Variant
RS2070401;Toxic liver disease;Disease;PA166155995;Variant
RS3814055;Toxic liver disease;Disease;PA166156383;Variant
RS1800629;Toxic liver disease;Disease;PA166156997;Variant
RS776746;Toxic liver disease;Disease;PA166157267;Variant
RS1045642;Toxic liver disease;Disease;PA166157284;Variant
RS4720833;Toxic liver disease;Disease;PA166157396;Variant
RS1041983;Toxic liver disease;Disease;PA166157549;Variant
NAT2 SLOW ACETYLATOR;Toxic liver disease;Disease;PA166157948;Variant
RS11280056;Toxic liver disease;Disease;PA166180936;Variant
CYP2D6*14;Toxic liver disease;Disease;PA166181185;Haplotype
RS11227247;Toxic liver disease;Disease;PA166203341;Variant
RS2233407;Toxic liver disease;Disease;PA166203408;Variant
RS2053071;Toxic liver disease;Disease;PA166203411;Variant
CYP2C8*1;Toxic liver disease;Disease;PA166242948;Haplotype
NAT2;Toxic liver disease;Disease;PA18;Gene
GSTM1;Toxic liver disease;Disease;PA182;Gene
GSTT1;Toxic liver disease;Disease;PA183;Gene
MTHFR;Toxic liver disease;Disease;PA245;Gene
BACH1;Toxic liver disease;Disease;PA25234;Gene
ABCB1;Toxic liver disease;Disease;PA267;Gene
CYP2A7P1;Toxic liver disease;Disease;PA27103;Gene
RELA;Toxic liver disease;Disease;PA296;Gene
MAFK;Toxic liver disease;Disease;PA30540;Gene
MTHFD1;Toxic liver disease;Disease;PA31236;Gene
NFKBIA;Toxic liver disease;Disease;PA31601;Gene
NFKBIB;Toxic liver disease;Disease;PA31602;Gene
POLG;Toxic liver disease;Disease;PA33500;Gene
HLA-A;Toxic liver disease;Disease;PA35055;Gene
HLA-B;Toxic liver disease;Disease;PA35056;Gene
HLA-C;Toxic liver disease;Disease;PA35057;Gene
HLA-DQA1;Toxic liver disease;Disease;PA35066;Gene
HLA-DQB1;Toxic liver disease;Disease;PA35068;Gene
HLA-DRB1;Toxic liver disease;Disease;PA35072;Gene
SIRT2;Toxic liver disease;Disease;PA35786;Gene
TYMS;Toxic liver disease;Disease;PA359;Gene
XPO1;Toxic liver disease;Disease;PA37418;Gene
NR1I2;Toxic liver disease;Disease;PA378;Gene
TNF;Toxic liver disease;Disease;PA435;Gene
RHEUMATOID ARTHRITIS;TGFB1;Gene;PA443434;Disease
PROSTATIC NEOPLASMS;TGFB1;Gene;PA445425;Disease
COLORECTAL NEOPLASMS;TGFB1;Gene;PA446108;Disease
ASPIRIN;TGFB1;Gene;PA448497;Chemical
IRINOTECAN;TGFB1;Gene;PA450085;Chemical
RITUXIMAB;TGFB1;Gene;PA451261;Chemical
METHOTREXATE;rs168201;Variant;PA450428;Chemical
CYP3A4;telithromycin;Chemical;PA130;Gene
KCNH2;telithromycin;Chemical;PA212;Gene
VASCULAR DISEASES;rs1433099;Variant;PA446021;Disease
PRAVASTATIN;rs1433099;Variant;PA451089;Chemical
TOBACCO USE DISORDER;CHRM2;Gene;PA445876;Disease
NICOTINE;CHRM2;Gene;PA450626;Chemical
BIPOLAR DISORDER;ITPR2;Gene;PA447199;Disease
PRAVASTATIN;rs113646094;Variant;PA451089;Chemical
CYP3A4;hydrocortisone;Chemical;PA130;Gene
ABCB1;hydrocortisone;Chemical;PA267;Gene
NR1I2;hydrocortisone;Chemical;PA378;Gene
CYP2D6;meclizine;Chemical;PA128;Gene
FLUOROURACIL;rs538336580;Variant;PA128406956;Chemical
DRUG TOXICITY;rs538336580;Variant;PA443937;Disease
NEONATAL ABSTINENCE SYNDROME;PNOC;Gene;PA165108809;Disease
BUPRENORPHINE;PNOC;Gene;PA448685;Chemical
METHADONE;PNOC;Gene;PA450401;Chemical
NEPHROTOXICITY;rs4646536;Variant;PA162263533;Disease
TENOFOVIR DISOPROXIL FUMARATE;rs4646536;Variant;PA166201941;Chemical
HIV INFECTIOUS DISEASE;rs4646536;Variant;PA447230;Disease
CHRNA3;efgartigimod alfa;Chemical;PA113;Gene
CHRNA7;efgartigimod alfa;Chemical;PA114;Gene
CHRNA1;efgartigimod alfa;Chemical;PA26487;Gene
CHRNA4;efgartigimod alfa;Chemical;PA26490;Gene
CHRNA5;efgartigimod alfa;Chemical;PA26491;Gene
CHRNA6;efgartigimod alfa;Chemical;PA26492;Gene
CHRNB1;efgartigimod alfa;Chemical;PA26494;Gene
CHRNE;efgartigimod alfa;Chemical;PA26498;Gene
CYP3A4;cabozantinib;Chemical;PA130;Gene
CYP3A4*1;cabozantinib;Chemical;PA165819201;Haplotype
CYP3A4*2;cabozantinib;Chemical;PA165819220;Haplotype
CYP3A4*3;cabozantinib;Chemical;PA165819221;Haplotype
CYP3A4*4;cabozantinib;Chemical;PA165819222;Haplotype
CYP3A4*5;cabozantinib;Chemical;PA165819223;Haplotype
CYP3A4*7;cabozantinib;Chemical;PA165819225;Haplotype
CYP3A4*8;cabozantinib;Chemical;PA165819226;Haplotype
CYP3A4*9;cabozantinib;Chemical;PA165819227;Haplotype
CYP3A4*11;cabozantinib;Chemical;PA165819229;Haplotype
CYP3A4*12;cabozantinib;Chemical;PA165819230;Haplotype
CYP3A4*13;cabozantinib;Chemical;PA165819231;Haplotype
CYP3A4*14;cabozantinib;Chemical;PA165819232;Haplotype
CYP3A4*15;cabozantinib;Chemical;PA165819233;Haplotype
CYP3A4*16;cabozantinib;Chemical;PA165819236;Haplotype
CYP3A4*17;cabozantinib;Chemical;PA165819239;Haplotype
CYP3A4*18;cabozantinib;Chemical;PA165819240;Haplotype
CYP3A4*19;cabozantinib;Chemical;PA165819243;Haplotype
CYP3A4*23;cabozantinib;Chemical;PA166115836;Haplotype
CYP3A4*24;cabozantinib;Chemical;PA166115837;Haplotype
CYP3A4*28;cabozantinib;Chemical;PA166245584;Haplotype
CYP3A4*29;cabozantinib;Chemical;PA166245585;Haplotype
CYP3A4*31;cabozantinib;Chemical;PA166245587;Haplotype
CYP3A4*32;cabozantinib;Chemical;PA166245588;Haplotype
CYP3A4*33;cabozantinib;Chemical;PA166245589;Haplotype
CYP3A4*34;cabozantinib;Chemical;PA166245590;Haplotype
RET;cabozantinib;Chemical;PA34335;Gene
VITAMIN B-COMPLEX, PLAIN;MTHFR;Gene;PA10505;Chemical
PEMETREXED;MTHFR;Gene;PA10810;Chemical
WEIGHT GAIN;MTHFR;Gene;PA128406954;Disease
FLUOROURACIL;MTHFR;Gene;PA128406956;Chemical
BEVACIZUMAB;MTHFR;Gene;PA130232992;Chemical
OXALIPLATIN;MTHFR;Gene;PA131285527;Chemical
HOMOCYSTEINEMIA;MTHFR;Gene;PA150516584;Disease
NEPHROTOXICITY;MTHFR;Gene;PA162263533;Disease
PLATINUM COMPOUNDS;MTHFR;Gene;PA164713176;Chemical
VITAMIN B-COMPLEX, INCL. COMBINATIONS;MTHFR;Gene;PA164713398;Chemical
TOXIC LIVER DISEASE;MTHFR;Gene;PA164925725;Disease
ETHINYL ESTRADIOL / NORELGESTROMIN;MTHFR;Gene;PA165290929;Chemical
MYELOSUPPRESSION;MTHFR;Gene;PA165817398;Disease
MUCOSITIS;MTHFR;Gene;PA166122058;Disease
SCHIZOAFFECTIVE DISORDER;MTHFR;Gene;PA166123368;Disease
RS1801131;MTHFR;Gene;PA166153643;Variant
RS1801133;MTHFR;Gene;PA166153644;Variant
RS1799963;MTHFR;Gene;PA166154336;Variant
RS4149081;MTHFR;Gene;PA166154581;Variant
RS11045879;MTHFR;Gene;PA166154633;Variant
L-METHYLFOLATE;MTHFR;Gene;PA166182939;Chemical
PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA;MTHFR;Gene;PA166252441;Disease
ABORTION, HABITUAL;MTHFR;Gene;PA443228;Disease
ALZHEIMER DISEASE;MTHFR;Gene;PA443319;Disease
ARTERIOSCLEROSIS;MTHFR;Gene;PA443425;Disease
JUVENILE RHEUMATOID ARTHRITIS;MTHFR;Gene;PA443433;Disease
RHEUMATOID ARTHRITIS;MTHFR;Gene;PA443434;Disease
BREAST NEOPLASMS;MTHFR;Gene;PA443560;Disease
BURKITT LYMPHOMA;MTHFR;Gene;PA443580;Disease
NON-SMALL CELL LUNG CARCINOMA;MTHFR;Gene;PA443622;Disease
CARDIOVASCULAR DISEASES;MTHFR;Gene;PA443635;Disease
UTERINE CERVICAL NEOPLASMS;MTHFR;Gene;PA443685;Disease
CLEFT LIP;MTHFR;Gene;PA443736;Disease
CLEFT PALATE;MTHFR;Gene;PA443737;Disease
COLONIC NEOPLASMS;MTHFR;Gene;PA443756;Disease
CORONARY ARTERY DISEASE;MTHFR;Gene;PA443796;Disease
DOWN SYNDROME;MTHFR;Gene;PA443933;Disease
DRUG TOXICITY;MTHFR;Gene;PA443937;Disease
EPILEPSY;MTHFR;Gene;PA444065;Disease
GRAFT VS HOST DISEASE;MTHFR;Gene;PA444320;Disease
HYPERTENSION;MTHFR;Gene;PA444552;Disease
LEUKEMIA;MTHFR;Gene;PA444750;Disease
LEUKOPENIA;MTHFR;Gene;PA444773;Disease
LUNG NEOPLASMS;MTHFR;Gene;PA444818;Disease
LYMPHOMA;MTHFR;Gene;PA444840;Disease
NON-HODGKIN LYMPHOMA;MTHFR;Gene;PA444845;Disease
MESOTHELIOMA;MTHFR;Gene;PA444937;Disease
MYOCARDIAL INFARCTION;MTHFR;Gene;PA445019;Disease
NEOPLASMS;MTHFR;Gene;PA445062;Disease
NEURAL TUBE DEFECTS;MTHFR;Gene;PA445095;Disease
NEUTROPENIA;MTHFR;Gene;PA445113;Disease
OVARIAN NEOPLASMS;MTHFR;Gene;PA445204;Disease
PRE-ECLAMPSIA;MTHFR;Gene;PA445398;Disease
PREGNANCY COMPLICATIONS;MTHFR;Gene;PA445403;Disease
OSTEOSARCOMA;MTHFR;Gene;PA445601;Disease
THROMBOCYTOPENIA;MTHFR;Gene;PA445846;Disease
COLORECTAL NEOPLASMS;MTHFR;Gene;PA446108;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;MTHFR;Gene;PA446155;Disease
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;MTHFR;Gene;PA446171;Disease
ARTHRITIS, PSORIATIC;MTHFR;Gene;PA446198;Disease
SPINA BIFIDA CYSTICA;MTHFR;Gene;PA446286;Disease
LYMPHOMA, T-CELL;MTHFR;Gene;PA446309;Disease
ENDOMETRIAL NEOPLASMS;MTHFR;Gene;PA446411;Disease
COCAINE DEPENDENCE;MTHFR;Gene;PA446878;Disease
HYPERHOMOCYSTEINEMIA;MTHFR;Gene;PA446892;Disease
PSYCHOTIC DISORDER;MTHFR;Gene;PA447215;Disease
SCHIZOPHRENIA;MTHFR;Gene;PA447216;Disease
DEPRESSION;MTHFR;Gene;PA447278;Disease
VENOUS THROMBOEMBOLISM;MTHFR;Gene;PA447298;Disease
MAJOR DEPRESSIVE DISORDER;MTHFR;Gene;PA447321;Disease
BENAZEPRIL;MTHFR;Gene;PA448561;Chemical
BETAINE;MTHFR;Gene;PA448603;Chemical
CAPECITABINE;MTHFR;Gene;PA448771;Chemical
CARBAMAZEPINE;MTHFR;Gene;PA448785;Chemical
CARBIDOPA;MTHFR;Gene;PA448794;Chemical
CARBOPLATIN;MTHFR;Gene;PA448803;Chemical
CISPLATIN;MTHFR;Gene;PA449014;Chemical
CLOZAPINE;MTHFR;Gene;PA449061;Chemical
DISULFIRAM;MTHFR;Gene;PA449376;Chemical
DOXORUBICIN;MTHFR;Gene;PA449412;Chemical
FOLIC ACID;MTHFR;Gene;PA449692;Chemical
LEUCOVORIN;MTHFR;Gene;PA450198;Chemical
LEVODOPA;MTHFR;Gene;PA450213;Chemical
MERCAPTOPURINE;MTHFR;Gene;PA450379;Chemical
METHOTREXATE;MTHFR;Gene;PA450428;Chemical
NITROUS OXIDE;MTHFR;Gene;PA450645;Chemical
OLANZAPINE;MTHFR;Gene;PA450688;Chemical
PHENOBARBITAL;MTHFR;Gene;PA450911;Chemical
PHENYTOIN;MTHFR;Gene;PA450947;Chemical
PRAVASTATIN;MTHFR;Gene;PA451089;Chemical
SULFASALAZINE;MTHFR;Gene;PA451547;Chemical
VALPROIC ACID;MTHFR;Gene;PA451846;Chemical
CYANOCOBALAMIN;MTHFR;Gene;PA451892;Chemical
ANTIPSYCHOTICS;MTHFR;Gene;PA452233;Chemical
CYP2D6;Fatigue;Disease;PA128;Gene
TPMT*1;Fatigue;Disease;PA165819268;Haplotype
TPMT*3A;Fatigue;Disease;PA165819270;Haplotype
TPMT*3C;Fatigue;Disease;PA165819272;Haplotype
UGT1A1*1;Fatigue;Disease;PA166115841;Haplotype
UGT1A1*28;Fatigue;Disease;PA166115842;Haplotype
TPMT;Fatigue;Disease;PA356;Gene
UGT2B17;Fatigue;Disease;PA37189;Gene
UGT1A1;Fatigue;Disease;PA420;Gene
NFKB1;MAPK3;Gene;PA248;Gene
ELK1;MAPK3;Gene;PA27749;Gene
ETS1;MAPK3;Gene;PA27902;Gene
FOS;MAPK3;Gene;PA28212;Gene
MAP2K7;MAPK3;Gene;PA284;Gene
RELA;MAPK3;Gene;PA296;Gene
JUN;MAPK3;Gene;PA30006;Gene
MAP2K1;MAPK3;Gene;PA30584;Gene
MAP2K2;MAPK3;Gene;PA30587;Gene
MAP2K3;MAPK3;Gene;PA30588;Gene
MAP2K4;MAPK3;Gene;PA30589;Gene
MAP2K5;MAPK3;Gene;PA30590;Gene
MAP2K6;MAPK3;Gene;PA30591;Gene
MYC;MAPK3;Gene;PA31353;Gene
NFKB2;MAPK3;Gene;PA31600;Gene
STAT3;MAPK3;Gene;PA337;Gene
STAT5A;MAPK3;Gene;PA338;Gene
SP1;MAPK3;Gene;PA36042;Gene
STAT1;MAPK3;Gene;PA36183;Gene
STAT2;MAPK3;Gene;PA36184;Gene
STAT4;MAPK3;Gene;PA36185;Gene
STAT5B;MAPK3;Gene;PA36186;Gene
ATP1A1;MAPK3;Gene;PA62;Gene
SORAFENIB;MAPK3;Gene;PA7000;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;GBP6;Gene;PA164713366;Chemical
RHEUMATOID ARTHRITIS;GBP6;Gene;PA443434;Disease
TOBACCO USE DISORDER;rs56113850;Variant;PA445876;Disease
NICOTINE;rs56113850;Variant;PA450626;Chemical
ARTESUNATE;rs1050828;Variant;PA165111697;Chemical
CHLORPROGUANIL;rs1050828;Variant;PA165857067;Chemical
MALARIA;rs1050828;Variant;PA444859;Disease
MALARIA, FALCIPARUM;rs1050828;Variant;PA446390;Disease
AMODIAQUINE;rs1050828;Variant;PA448404;Chemical
DAPSONE;rs1050828;Variant;PA449211;Chemical
PRIMAQUINE;rs1050828;Variant;PA451103;Chemical
PYRIMETHAMINE;rs1050828;Variant;PA451193;Chemical
SULFADOXINE;rs1050828;Variant;PA451540;Chemical
ADALIMUMAB;rs2071303;Variant;PA10004;Chemical
CROHN DISEASE;rs2071303;Variant;PA443815;Disease
ADVERSE EVENTS;IL7;Gene;PA166151827;Disease
PD-1/PDL-1 (PROGRAMMED CELL DEATH PROTEIN 1/DEATH LIGAND 1) INHIBITORS;IL7;Gene;PA166305982;Chemical
ETHANOL;SRPRB;Gene;PA448073;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;CST5;Gene;PA164713366;Chemical
RHEUMATOID ARTHRITIS;CST5;Gene;PA443434;Disease
CHRNA3;Alcoholism;Disease;PA113;Gene
CYP2C19;Alcoholism;Disease;PA124;Gene
CYP2C9;Alcoholism;Disease;PA126;Gene
ANKS1B;Alcoholism;Disease;PA128394692;Gene
CYP2E1;Alcoholism;Disease;PA129;Gene
CYP3A4;Alcoholism;Disease;PA130;Gene
ANKK1;Alcoholism;Disease;PA134872551;Gene
MED19;Alcoholism;Disease;PA134926032;Gene
SLC39A8;Alcoholism;Disease;PA134931507;Gene
RABGAP1L;Alcoholism;Disease;PA134940645;Gene
DBH;Alcoholism;Disease;PA136;Gene
KLB;Alcoholism;Disease;PA142671586;Gene
FTO;Alcoholism;Disease;PA152208656;Gene
CADM2;Alcoholism;Disease;PA162380882;Gene
THSD7B;Alcoholism;Disease;PA162405776;Gene
TMX2;Alcoholism;Disease;PA164726611;Gene
CYP2C19*17;Alcoholism;Disease;PA165816533;Haplotype
CYP2C9*1;Alcoholism;Disease;PA165816542;Haplotype
CYP2C9*2;Alcoholism;Disease;PA165816543;Haplotype
CYP2C9*3;Alcoholism;Disease;PA165816544;Haplotype
CYP3A4*1;Alcoholism;Disease;PA165819201;Haplotype
CYP2C19*1;Alcoholism;Disease;PA165980634;Haplotype
CYP2C19*2;Alcoholism;Disease;PA165980635;Haplotype
CYP3A4*22;Alcoholism;Disease;PA166048680;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);Alcoholism;Disease;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);Alcoholism;Disease;PA166116466;Haplotype
RS4654327;Alcoholism;Disease;PA166153773;Variant
RS2031920;Alcoholism;Disease;PA166153990;Variant
RS12248560;Alcoholism;Disease;PA166154147;Variant
RS1001179;Alcoholism;Disease;PA166154306;Variant
RS1799732;Alcoholism;Disease;PA166154334;Variant
RS1800497;Alcoholism;Disease;PA166154339;Variant
RS671;Alcoholism;Disease;PA166154482;Variant
RS2058878;Alcoholism;Disease;PA166154524;Variant
RS578776;Alcoholism;Disease;PA166154840;Variant
RS615470;Alcoholism;Disease;PA166154842;Variant
RS1051730;Alcoholism;Disease;PA166154856;Variant
RS16969968;Alcoholism;Disease;PA166154938;Variant
RS25531;Alcoholism;Disease;PA166155159;Variant
RS1042173;Alcoholism;Disease;PA166155172;Variant
RS698;Alcoholism;Disease;PA166156476;Variant
RS1229984;Alcoholism;Disease;PA166156507;Variant
RS2066702;Alcoholism;Disease;PA166156533;Variant
RS28363170;Alcoholism;Disease;PA166156890;Variant
RS1799971;Alcoholism;Disease;PA166156991;Variant
RS846664;Alcoholism;Disease;PA166157268;Variant
RS13273672;Alcoholism;Disease;PA166157646;Variant
RS1611115;Alcoholism;Disease;PA166157734;Variant
RS738409;Alcoholism;Disease;PA166165078;Variant
RS495491;Alcoholism;Disease;PA166177792;Variant
RS1260326;Alcoholism;Disease;PA166177970;Variant
RS11940694;Alcoholism;Disease;PA166177971;Variant
RS4251417;Alcoholism;Disease;PA166181168;Variant
RS1044394;Alcoholism;Disease;PA166183681;Variant
RS511435;Alcoholism;Disease;PA166183701;Variant
RS524731;Alcoholism;Disease;PA166183702;Variant
RS3823010;Alcoholism;Disease;PA166183703;Variant
RS1381376;Alcoholism;Disease;PA166183704;Variant
RS3778156;Alcoholism;Disease;PA166183705;Variant
RS6473797;Alcoholism;Disease;PA166183884;Variant
RS10055255;Alcoholism;Disease;PA166183982;Variant
RS2066713;Alcoholism;Disease;PA166184026;Variant
RS10485057;Alcoholism;Disease;PA166184699;Variant
RS6088638;Alcoholism;Disease;PA166185175;Variant
RS4807493;Alcoholism;Disease;PA166185410;Variant
RS10405681;Alcoholism;Disease;PA166185412;Variant
RS2074957;Alcoholism;Disease;PA166185417;Variant
RS10432303;Alcoholism;Disease;PA166185418;Variant
RS8109485;Alcoholism;Disease;PA166185420;Variant
RS1476592;Alcoholism;Disease;PA166185422;Variant
RS10419980;Alcoholism;Disease;PA166185423;Variant
RS4432372;Alcoholism;Disease;PA166185425;Variant
RS10516440;Alcoholism;Disease;PA166185686;Variant
RS2159140;Alcoholism;Disease;PA166185779;Variant
RS61826952;Alcoholism;Disease;PA166197261;Variant
RS2133896;Alcoholism;Disease;PA166200161;Variant
RS1034936;Alcoholism;Disease;PA166202881;Variant
RS6421482;Alcoholism;Disease;PA166210001;Variant
RS61767420;Alcoholism;Disease;PA166210002;Variant
RS494904;Alcoholism;Disease;PA166210003;Variant
RS1402398;Alcoholism;Disease;PA166210004;Variant
RS2673136;Alcoholism;Disease;PA166210005;Variant
RS13129401;Alcoholism;Disease;PA166210006;Variant
RS13125415;Alcoholism;Disease;PA166210007;Variant
RS13135092;Alcoholism;Disease;PA166210008;Variant
RS2533200;Alcoholism;Disease;PA166210009;Variant
RS2582405;Alcoholism;Disease;PA166210010;Variant
RS576859;Alcoholism;Disease;PA166210013;Variant
RS1783835;Alcoholism;Disease;PA166210014;Variant
RS12296477;Alcoholism;Disease;PA166210015;Variant
RS61974485;Alcoholism;Disease;PA166210016;Variant
RS72768626;Alcoholism;Disease;PA166210017;Variant
RS492602;Alcoholism;Disease;PA166210018;Variant
RS9679319;Alcoholism;Disease;PA166210021;Variant
RS13382553;Alcoholism;Disease;PA166210022;Variant
RS62250713;Alcoholism;Disease;PA166210023;Variant
RS7900002;Alcoholism;Disease;PA166210024;Variant
RS75967634;Alcoholism;Disease;PA166210041;Variant
RS56722963;Alcoholism;Disease;PA166210042;Variant
RS6589386;Alcoholism;Disease;PA166210044;Variant
RS8008020;Alcoholism;Disease;PA166210045;Variant
RS9937709;Alcoholism;Disease;PA166210046;Variant
RS12749274;Alcoholism;Disease;PA166258761;Variant
RS77583603;Alcoholism;Disease;PA166258781;Variant
ACSS2;Alcoholism;Disease;PA24429;Gene
ADH1A;Alcoholism;Disease;PA24570;Gene
ADH1B;Alcoholism;Disease;PA24571;Gene
ADH1C;Alcoholism;Disease;PA24572;Gene
ALDH1A1;Alcoholism;Disease;PA24692;Gene
ALDH2;Alcoholism;Disease;PA24696;Gene
CAT;Alcoholism;Disease;PA26099;Gene
CHRNA4;Alcoholism;Disease;PA26490;Gene
CHRNA5;Alcoholism;Disease;PA26491;Gene
CRHBP;Alcoholism;Disease;PA26873;Gene
DPP6;Alcoholism;Disease;PA27468;Gene
DRD2;Alcoholism;Disease;PA27478;Gene
FUT2;Alcoholism;Disease;PA28429;Gene
GATA4;Alcoholism;Disease;PA28587;Gene
GCKR;Alcoholism;Disease;PA28611;Gene
GRIN2B;Alcoholism;Disease;PA28980;Gene
MAP2K4;Alcoholism;Disease;PA30589;Gene
SLC6A3;Alcoholism;Disease;PA311;Gene
SLC6A4;Alcoholism;Disease;PA312;Gene
OPRD1;Alcoholism;Disease;PA31942;Gene
OPRK1;Alcoholism;Disease;PA31943;Gene
OPRM1;Alcoholism;Disease;PA31945;Gene
PDE4B;Alcoholism;Disease;PA33129;Gene
PIP5K1C;Alcoholism;Disease;PA33329;Gene
ARID4A;Alcoholism;Disease;PA34249;Gene
SLC4A8;Alcoholism;Disease;PA35900;Gene
TNRC6A;Alcoholism;Disease;PA36656;Gene
TAS2R16;Alcoholism;Disease;PA37931;Gene
PNPLA3;Alcoholism;Disease;PA38592;Gene
CACNA1C;Alcoholism;Disease;PA83;Gene
SN-38;rs2741049;Variant;PA165110775;Chemical
EPILEPSY;rs2741049;Variant;PA444065;Disease
SEIZURES;rs2741049;Variant;PA445629;Disease
OXCARBAZEPINE;rs2741049;Variant;PA450732;Chemical
ESSENTIAL HYPERTENSION;rs9590353;Variant;PA447288;Disease
HYDROCHLOROTHIAZIDE;rs9590353;Variant;PA449899;Chemical
ANEMIA;rs2273618;Variant;PA443340;Disease
NASOPHARYNGEAL NEOPLASMS;rs2273618;Variant;PA445046;Disease
DOCETAXEL;rs2273618;Variant;PA449383;Chemical
HLA-B*55:02;methazolamide;Chemical;PA165956471;Haplotype
HLA-B*59:01;methazolamide;Chemical;PA165956674;Haplotype
HLA-C*01:02;methazolamide;Chemical;PA165956704;Haplotype
HLA-B;methazolamide;Chemical;PA35056;Gene
HLA-C;methazolamide;Chemical;PA35057;Gene
CFTR;rs80282562;Variant;PA109;Gene
IVACAFTOR;rs80282562;Variant;PA165950341;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs80282562;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs80282562;Variant;PA443829;Disease
SNORD68;thalidomide;Chemical;PA145007789;Gene
ERCC1;thalidomide;Chemical;PA155;Gene
SULT1C4;thalidomide;Chemical;PA162405070;Gene
RS4646487;thalidomide;Chemical;PA166153768;Variant
RS12418;thalidomide;Chemical;PA166153942;Variant
RS730720;thalidomide;Chemical;PA166153954;Variant
RS1871450;thalidomide;Chemical;PA166153978;Variant
RS4148943;thalidomide;Chemical;PA166154049;Variant
RS4148945;thalidomide;Chemical;PA166154050;Variant
RS4148947;thalidomide;Chemical;PA166154051;Variant
RS4148950;thalidomide;Chemical;PA166154052;Variant
RS2301159;thalidomide;Chemical;PA166154711;Variant
RS12960;thalidomide;Chemical;PA166154981;Variant
RS2238472;thalidomide;Chemical;PA166155033;Variant
RS2292954;thalidomide;Chemical;PA166155038;Variant
RS735482;thalidomide;Chemical;PA166155356;Variant
RS1051685;thalidomide;Chemical;PA166155619;Variant
RS1402467;thalidomide;Chemical;PA166155635;Variant
RS4630;thalidomide;Chemical;PA166156022;Variant
RS4135385;thalidomide;Chemical;PA166156394;Variant
RS4533622;thalidomide;Chemical;PA166156399;Variant
RS1883322;thalidomide;Chemical;PA166157003;Variant
RS2016520;thalidomide;Chemical;PA166157007;Variant
RS3734254;thalidomide;Chemical;PA166157077;Variant
RS6922548;thalidomide;Chemical;PA166157116;Variant
RS7769719;thalidomide;Chemical;PA166157128;Variant
RS1799931;thalidomide;Chemical;PA166157565;Variant
RS2227291;thalidomide;Chemical;PA166157866;Variant
RS308395;thalidomide;Chemical;PA166163497;Variant
NAT2;thalidomide;Chemical;PA18;Gene
GSTT1;thalidomide;Chemical;PA183;Gene
CHST3;thalidomide;Chemical;PA26503;Gene
CTNNB1;thalidomide;Chemical;PA27013;Gene
CYP4B1;thalidomide;Chemical;PA27119;Gene
FGF2;thalidomide;Chemical;PA28115;Gene
SLC10A2;thalidomide;Chemical;PA318;Gene
PPARD;thalidomide;Chemical;PA33557;Gene
RPL13;thalidomide;Chemical;PA34670;Gene
SPG7;thalidomide;Chemical;PA36067;Gene
XRCC5;thalidomide;Chemical;PA37425;Gene
ABCC6;thalidomide;Chemical;PA58;Gene
ATP7A;thalidomide;Chemical;PA72;Gene
MERCAPTOPURINE;MED4;Gene;PA450379;Chemical
DRUG TOXICITY;rs11861118;Variant;PA443937;Disease
CAPECITABINE;rs11861118;Variant;PA448771;Chemical
ALCOHOL ABUSE;OPRD1;Gene;PA443309;Disease
HEROIN DEPENDENCE;OPRD1;Gene;PA444460;Disease
OPIOID-RELATED DISORDERS;OPRD1;Gene;PA445043;Disease
COCAINE DEPENDENCE;OPRD1;Gene;PA446878;Disease
PHYSIOLOGICAL SEXUAL DISORDER;OPRD1;Gene;PA447218;Disease
BUPRENORPHINE;OPRD1;Gene;PA448685;Chemical
COCAINE;OPRD1;Gene;PA449072;Chemical
DISULFIRAM;OPRD1;Gene;PA449376;Chemical
FENTANYL;OPRD1;Gene;PA449599;Chemical
METHADONE;OPRD1;Gene;PA450401;Chemical
NALTREXONE;OPRD1;Gene;PA450588;Chemical
OXYCODONE;OPRD1;Gene;PA450741;Chemical
TRAMADOL;OPRD1;Gene;PA451735;Chemical
OPIOIDS;OPRD1;Gene;PA452618;Chemical
HEROIN;OPRD1;Gene;PA452619;Chemical
SIMVASTATIN;ZNF542P;Gene;PA451363;Chemical
TOCILIZUMAB;rs4329505;Variant;PA165292659;Chemical
RHEUMATOID ARTHRITIS;rs4329505;Variant;PA443434;Disease
BIPOLAR DISORDER;rs167771;Variant;PA447199;Disease
SCHIZOPHRENIA;rs167771;Variant;PA447216;Disease
RISPERIDONE;rs167771;Variant;PA451257;Chemical
CYP3A4;alectinib;Chemical;PA130;Gene
CYP3A4*1;alectinib;Chemical;PA165819201;Haplotype
CYP3A4*4;alectinib;Chemical;PA165819222;Haplotype
CYP3A4*7;alectinib;Chemical;PA165819225;Haplotype
CYP3A4*8;alectinib;Chemical;PA165819226;Haplotype
CYP3A4*12;alectinib;Chemical;PA165819230;Haplotype
CYP3A4*14;alectinib;Chemical;PA165819232;Haplotype
CYP3A4*16;alectinib;Chemical;PA165819236;Haplotype
CYP3A4*17;alectinib;Chemical;PA165819239;Haplotype
CYP3A4*18;alectinib;Chemical;PA165819240;Haplotype
CYP3A4*19;alectinib;Chemical;PA165819243;Haplotype
CYP3A4*20;alectinib;Chemical;PA165819244;Haplotype
CYP3A4*23;alectinib;Chemical;PA166115836;Haplotype
CYP3A4*24;alectinib;Chemical;PA166115837;Haplotype
CYP3A4*29;alectinib;Chemical;PA166245585;Haplotype
ALK;alectinib;Chemical;PA24719;Gene
TUBEROUS SCLEROSIS;TSC2;Gene;PA445965;Disease
GALNT14;Liver cancer;Disease;PA134920089;Gene
RS9679162;Liver cancer;Disease;PA166155774;Variant
RS6025211;Liver cancer;Disease;PA166201322;Variant
LAMIVUDINE;PCYT1A;Gene;PA450163;Chemical
DEPRESSIVE DISORDER;GRIK4;Gene;PA447207;Disease
HALOPERIDOL;GRIK4;Gene;PA449841;Chemical
ANTIDEPRESSANTS;GRIK4;Gene;PA452229;Chemical
HYPERTENSION;rs2229437;Variant;PA444552;Disease
BENAZEPRIL;rs2229437;Variant;PA448561;Chemical
CYP2C9;sulfamethoxazole;Chemical;PA126;Gene
CYP3A4;sulfamethoxazole;Chemical;PA130;Gene
CYP2C9*2;sulfamethoxazole;Chemical;PA165816543;Haplotype
CYP2C9*3;sulfamethoxazole;Chemical;PA165816544;Haplotype
G6PD B (REFERENCE);sulfamethoxazole;Chemical;PA165947826;Haplotype
G6PD CANTON, TAIWAN-HAKKA, GIFU-LIKE, AGRIGENTO-LIKE;sulfamethoxazole;Chemical;PA166121153;Haplotype
RS761142;sulfamethoxazole;Chemical;PA166156949;Variant
G6PD DEFICIENCY;sulfamethoxazole;Chemical;PA166157959;Variant
NAT2;sulfamethoxazole;Chemical;PA18;Gene
G6PD;sulfamethoxazole;Chemical;PA28469;Gene
GCLC;sulfamethoxazole;Chemical;PA28612;Gene
ALKYLATING AGENTS;rs2207396;Variant;PA164712331;Chemical
NEOPLASMS;rs2207396;Variant;PA445062;Disease
CISPLATIN;rs2207396;Variant;PA449014;Chemical
17BETA-ESTRADIOL GLUCURONIDE;rs11568681;Variant;PA166277182;Chemical
HALOPERIDOL;ZIC4;Gene;PA449841;Chemical
SELECTIVE BETA-2-ADRENORECEPTOR AGONISTS;ARG1;Gene;PA134687887;Chemical
SODIUM BENZOATE / SODIUM PHENYLACETATE;ARG1;Gene;PA166176020;Chemical
GLYCEROL PHENYLBUTYRATE;ARG1;Gene;PA166268801;Chemical
ASTHMA;ARG1;Gene;PA443450;Disease
SILDENAFIL;ARG1;Gene;PA451346;Chemical
HYPERTENSION;rs1367094;Variant;PA444552;Disease
ATENOLOL;rs1367094;Variant;PA448499;Chemical
NEOPLASMS;LRP2;Gene;PA445062;Disease
CISPLATIN;LRP2;Gene;PA449014;Chemical
LIOTHYRONINE;rs130058;Variant;PA164778866;Chemical
DEPRESSION;rs130058;Variant;PA447278;Disease
CLOMIPRAMINE;rs130058;Variant;PA449048;Chemical
LITHIUM;rs130058;Variant;PA450243;Chemical
NEFAZODONE;rs130058;Variant;PA450603;Chemical
PAROXETINE;rs130058;Variant;PA450801;Chemical
VENLAFAXINE;rs130058;Variant;PA451866;Chemical
PAIN, POSTOPERATIVE;rs1718125;Variant;PA445210;Disease
FENTANYL;rs1718125;Variant;PA449599;Chemical
MULTIPLE SCLEROSIS;GAPVD1;Gene;PA444987;Disease
INTERFERON BETA-1A;GAPVD1;Gene;PA450037;Chemical
INTERFERON BETA-1B;GAPVD1;Gene;PA450039;Chemical
MYCOPHENOLIC ACID;HPRT1;Gene;PA164748728;Chemical
ARIPIPRAZOLE;CYP2D6*3;Haplotype;PA10026;Chemical
WEIGHT GAIN;CYP2D6*3;Haplotype;PA128406954;Disease
GEFITINIB;CYP2D6*3;Haplotype;PA131301952;Chemical
3,4-METHYLENEDIOXYMETHAMPHETAMINE;CYP2D6*3;Haplotype;PA131887008;Chemical
ROSUVASTATIN;CYP2D6*3;Haplotype;PA134308647;Chemical
ATOMOXETINE;CYP2D6*3;Haplotype;PA134688071;Chemical
TROPISETRON;CYP2D6*3;Haplotype;PA161925594;Chemical
TOLTERODINE;CYP2D6*3;Haplotype;PA164746757;Chemical
PROGRESSION-FREE SURVIVAL;CYP2D6*3;Haplotype;PA166123026;Disease
OVERALL SURVIVAL;CYP2D6*3;Haplotype;PA166123207;Disease
AGITATION;CYP2D6*3;Haplotype;PA166123306;Disease
EVENT-FREE SURVIVAL;CYP2D6*3;Haplotype;PA166123366;Disease
ENDOXIFEN;CYP2D6*3;Haplotype;PA166124478;Chemical
CARDIOTOXICITY;CYP2D6*3;Haplotype;PA166128121;Disease
SEDATION;CYP2D6*3;Haplotype;PA166129521;Disease
O-DESMETHYLTRAMADOL;CYP2D6*3;Haplotype;PA166131379;Chemical
N,O-DIDESMETHYLTRAMADOL;CYP2D6*3;Haplotype;PA166131494;Chemical
CNS DEPRESSION;CYP2D6*3;Haplotype;PA166170668;Disease
MEPHEDRONE;CYP2D6*3;Haplotype;PA166184711;Chemical
DYSPHORIA;CYP2D6*3;Haplotype;PA166185295;Disease
ALZHEIMER DISEASE;CYP2D6*3;Haplotype;PA443319;Disease
BRAIN NEOPLASMS;CYP2D6*3;Haplotype;PA443557;Disease
BREAST NEOPLASMS;CYP2D6*3;Haplotype;PA443560;Disease
DEATH;CYP2D6*3;Haplotype;PA443842;Disease
DEMENTIA;CYP2D6*3;Haplotype;PA443853;Disease
DRUG TOXICITY;CYP2D6*3;Haplotype;PA443937;Disease
DYSTONIA;CYP2D6*3;Haplotype;PA443970;Disease
EDEMA;CYP2D6*3;Haplotype;PA443994;Disease
HEART DISEASES;CYP2D6*3;Haplotype;PA444368;Disease
HEART FAILURE;CYP2D6*3;Haplotype;PA444370;Disease
HEROIN DEPENDENCE;CYP2D6*3;Haplotype;PA444460;Disease
HYPERTENSION;CYP2D6*3;Haplotype;PA444552;Disease
OPIOID-RELATED DISORDERS;CYP2D6*3;Haplotype;PA445043;Disease
NAUSEA;CYP2D6*3;Haplotype;PA445048;Disease
NEOPLASMS;CYP2D6*3;Haplotype;PA445062;Disease
PAIN;CYP2D6*3;Haplotype;PA445208;Disease
PAIN, POSTOPERATIVE;CYP2D6*3;Haplotype;PA445210;Disease
POISONING;CYP2D6*3;Haplotype;PA445371;Disease
RECURRENCE;CYP2D6*3;Haplotype;PA445506;Disease
TACHYCARDIA;CYP2D6*3;Haplotype;PA445802;Disease
VOMITING;CYP2D6*3;Haplotype;PA446051;Disease
ALCOHOL-RELATED DISORDERS;CYP2D6*3;Haplotype;PA446879;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CYP2D6*3;Haplotype;PA447197;Disease
DEPRESSIVE DISORDER;CYP2D6*3;Haplotype;PA447207;Disease
MENTAL DISORDERS;CYP2D6*3;Haplotype;PA447208;Disease
OBSESSIVE-COMPULSIVE DISORDER;CYP2D6*3;Haplotype;PA447211;Disease
PSYCHOTIC DISORDERS;CYP2D6*3;Haplotype;PA447215;Disease
SCHIZOPHRENIA;CYP2D6*3;Haplotype;PA447216;Disease
TARDIVE DYSKINESIA;CYP2D6*3;Haplotype;PA447268;Disease
DEPRESSION;CYP2D6*3;Haplotype;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2D6*3;Haplotype;PA447321;Disease
AMITRIPTYLINE;CYP2D6*3;Haplotype;PA448385;Chemical
ASPIRIN;CYP2D6*3;Haplotype;PA448497;Chemical
ATORVASTATIN;CYP2D6*3;Haplotype;PA448500;Chemical
CARVEDILOL;CYP2D6*3;Haplotype;PA448817;Chemical
CITALOPRAM;CYP2D6*3;Haplotype;PA449015;Chemical
CLOMIPRAMINE;CYP2D6*3;Haplotype;PA449048;Chemical
CODEINE;CYP2D6*3;Haplotype;PA449088;Chemical
DESIPRAMINE;CYP2D6*3;Haplotype;PA449233;Chemical
DEXTROMETHORPHAN;CYP2D6*3;Haplotype;PA449273;Chemical
DONEPEZIL;CYP2D6*3;Haplotype;PA449394;Chemical
DOXEPIN;CYP2D6*3;Haplotype;PA449409;Chemical
FLUOXETINE;CYP2D6*3;Haplotype;PA449673;Chemical
GALANTAMINE;CYP2D6*3;Haplotype;PA449726;Chemical
HALOPERIDOL;CYP2D6*3;Haplotype;PA449841;Chemical
HYDROCODONE;CYP2D6*3;Haplotype;PA449900;Chemical
IMIPRAMINE;CYP2D6*3;Haplotype;PA449969;Chemical
KETOPROFEN;CYP2D6*3;Haplotype;PA450149;Chemical
METHADONE;CYP2D6*3;Haplotype;PA450401;Chemical
METOPROLOL;CYP2D6*3;Haplotype;PA450480;Chemical
MIRTAZAPINE;CYP2D6*3;Haplotype;PA450522;Chemical
NORTRIPTYLINE;CYP2D6*3;Haplotype;PA450657;Chemical
OLANZAPINE;CYP2D6*3;Haplotype;PA450688;Chemical
OXYCODONE;CYP2D6*3;Haplotype;PA450741;Chemical
PAROXETINE;CYP2D6*3;Haplotype;PA450801;Chemical
RISPERIDONE;CYP2D6*3;Haplotype;PA451257;Chemical
SIMVASTATIN;CYP2D6*3;Haplotype;PA451363;Chemical
SULFASALAZINE;CYP2D6*3;Haplotype;PA451547;Chemical
TAMOXIFEN;CYP2D6*3;Haplotype;PA451581;Chemical
TIMOLOL;CYP2D6*3;Haplotype;PA451690;Chemical
TRAMADOL;CYP2D6*3;Haplotype;PA451735;Chemical
TRIMIPRAMINE;CYP2D6*3;Haplotype;PA451791;Chemical
VENLAFAXINE;CYP2D6*3;Haplotype;PA451866;Chemical
ANTIPSYCHOTICS;CYP2D6*3;Haplotype;PA452233;Chemical
SPARTEINE;CYP2D6*3;Haplotype;PA452610;Chemical
DEBRISOQUINE;CYP2D6*3;Haplotype;PA452616;Chemical
ANTINEOPLASTIC AGENTS;CYP2D6*3;Haplotype;PA452621;Chemical
ZUCLOPENTHIXOL;CYP2D6*3;Haplotype;PA452629;Chemical
CORONARY DISEASE;rs1137101;Variant;PA443797;Disease
EPILEPSY;rs1137101;Variant;PA444065;Disease
HYPERLIPIDEMIAS;rs1137101;Variant;PA444528;Disease
SIMVASTATIN;rs1137101;Variant;PA451363;Chemical
VALPROIC ACID;rs1137101;Variant;PA451846;Chemical
ANTIPSYCHOTICS;rs1137101;Variant;PA452233;Chemical
MYOTONIC DISORDERS;rs121908547;Variant;PA447130;Disease
FLECAINIDE;rs121908547;Variant;PA449646;Chemical
MEXILETINE;rs121908547;Variant;PA450488;Chemical
ALCOHOLISM;rs28363170;Variant;PA443309;Disease
TOBACCO USE DISORDER;rs28363170;Variant;PA445876;Disease
COCAINE-RELATED DISORDERS;rs28363170;Variant;PA446878;Disease
ETHANOL;rs28363170;Variant;PA448073;Chemical
DISULFIRAM;rs28363170;Variant;PA449376;Chemical
CANNABINOIDS;rs9829896;Variant;PA131890620;Chemical
SUBSTANCE-RELATED DISORDERS;rs9829896;Variant;PA446876;Disease
AMPHETAMINE;rs9829896;Variant;PA448408;Chemical
COCAINE;rs9829896;Variant;PA449072;Chemical
OPIOIDS;rs9829896;Variant;PA452618;Chemical
BOSUTINIB;CAMK2G;Gene;PA166114906;Chemical
NFKB1;CAMK2G;Gene;PA248;Gene
ELK1;CAMK2G;Gene;PA27749;Gene
FOS;CAMK2G;Gene;PA28212;Gene
RELA;CAMK2G;Gene;PA296;Gene
JUN;CAMK2G;Gene;PA30006;Gene
MYC;CAMK2G;Gene;PA31353;Gene
NFKB2;CAMK2G;Gene;PA31600;Gene
STAT3;CAMK2G;Gene;PA337;Gene
STAT5A;CAMK2G;Gene;PA338;Gene
SP1;CAMK2G;Gene;PA36042;Gene
STAT1;CAMK2G;Gene;PA36183;Gene
STAT2;CAMK2G;Gene;PA36184;Gene
STAT4;CAMK2G;Gene;PA36185;Gene
STAT5B;CAMK2G;Gene;PA36186;Gene
ASPIRIN-INDUCED ASTHMA;HLA-DPB1*03:01;Haplotype;PA131285571;Disease
ASTHMA;HLA-DPB1*03:01;Haplotype;PA443450;Disease
URTICARIA;HLA-DPB1*03:01;Haplotype;PA445999;Disease
ASPIRIN;HLA-DPB1*03:01;Haplotype;PA448497;Chemical
DROTRECOGIN ALFA;DRD1;Gene;PA131548935;Chemical
HEROIN DEPENDENCE;DRD1;Gene;PA444460;Disease
TOBACCO USE DISORDER;DRD1;Gene;PA445876;Disease
SEPSIS;DRD1;Gene;PA446771;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DRD1;Gene;PA447197;Disease
BIPOLAR DISORDER;DRD1;Gene;PA447199;Disease
SCHIZOPHRENIA;DRD1;Gene;PA447216;Disease
BUPROPION;DRD1;Gene;PA448687;Chemical
CLOZAPINE;DRD1;Gene;PA449061;Chemical
DEXTROAMPHETAMINE;DRD1;Gene;PA449269;Chemical
HALOPERIDOL;DRD1;Gene;PA449841;Chemical
LITHIUM;DRD1;Gene;PA450243;Chemical
METHADONE;DRD1;Gene;PA450401;Chemical
METHYLPHENIDATE;DRD1;Gene;PA450464;Chemical
NICOTINE;DRD1;Gene;PA450626;Chemical
ATAZANAVIR;SORCS2;Gene;PA10251;Chemical
HIV INFECTIOUS DISEASE;SORCS2;Gene;PA447230;Disease
BREAST NEOPLASMS;rs2229046;Variant;PA443560;Disease
CARBOPLATIN;rs2229046;Variant;PA448803;Chemical
DOCETAXEL;rs2229046;Variant;PA449383;Chemical
TRASTUZUMAB;rs2229046;Variant;PA451743;Chemical
EPILEPSY;rs1019385;Variant;PA444065;Disease
VALPROIC ACID;rs1019385;Variant;PA451846;Chemical
CRP;adalimumab;Chemical;PA120;Gene
ATG16L1;adalimumab;Chemical;PA134902949;Gene
HLA-DRB1*04:01;adalimumab;Chemical;PA165951493;Haplotype
RS396991;adalimumab;Chemical;PA166153571;Variant
RS1130864;adalimumab;Chemical;PA166153624;Variant
RS1801274;adalimumab;Chemical;PA166153652;Variant
RS10919563;adalimumab;Chemical;PA166153818;Variant
RS767455;adalimumab;Chemical;PA166154502;Variant
RS10210302;adalimumab;Chemical;PA166155785;Variant
RS1059150;adalimumab;Chemical;PA166155914;Variant
RS1799852;adalimumab;Chemical;PA166156328;Variant
RS510432;adalimumab;Chemical;PA166156923;Variant
RS1264457;adalimumab;Chemical;PA166156981;Variant
RS2071303;adalimumab;Chemical;PA166157009;Variant
RS9373839;adalimumab;Chemical;PA166157151;Variant
RS1800795;adalimumab;Chemical;PA166157304;Variant
RS3761847;adalimumab;Chemical;PA166157763;Variant
RS2302489;adalimumab;Chemical;PA166160715;Variant
RS7301582;adalimumab;Chemical;PA166160807;Variant
RS9828223;adalimumab;Chemical;PA166196821;Variant
IL6;adalimumab;Chemical;PA198;Gene
ATG5;adalimumab;Chemical;PA24880;Gene
ATP5F1E;adalimumab;Chemical;PA25128;Gene
FCGR2A;adalimumab;Chemical;PA28063;Gene
FCGR3A;adalimumab;Chemical;PA28065;Gene
HFE;adalimumab;Chemical;PA29263;Gene
KLRC1;adalimumab;Chemical;PA30163;Gene
KLRD1;adalimumab;Chemical;PA30167;Gene
PTPRC;adalimumab;Chemical;PA34011;Gene
HLA-DRB1;adalimumab;Chemical;PA35072;Gene
HLA-E;adalimumab;Chemical;PA35081;Gene
TF;adalimumab;Chemical;PA36457;Gene
TNFRSF1A;adalimumab;Chemical;PA36609;Gene
TRAF1;adalimumab;Chemical;PA36708;Gene
CFTR;rs2116683801;Variant;PA109;Gene
IVACAFTOR;rs2116683801;Variant;PA165950341;Chemical
ATAZANAVIR;UGT1A1*6;Haplotype;PA10251;Chemical
LYMPHOMA, LARGE B-CELL, DIFFUSE;UGT1A1*6;Haplotype;PA160680212;Disease
LABETALOL;UGT1A1*6;Haplotype;PA164743150;Chemical
SN-38;UGT1A1*6;Haplotype;PA165110775;Chemical
PAZOPANIB;UGT1A1*6;Haplotype;PA165291492;Chemical
NILOTINIB;UGT1A1*6;Haplotype;PA165958345;Chemical
DOLUTEGRAVIR;UGT1A1*6;Haplotype;PA166114961;Chemical
PROGRESSION-FREE SURVIVAL;UGT1A1*6;Haplotype;PA166123026;Disease
OVERALL SURVIVAL;UGT1A1*6;Haplotype;PA166123207;Disease
BILIRUBIN;UGT1A1*6;Haplotype;PA166123346;Chemical
BILIARY TRACT NEOPLASMS;UGT1A1*6;Haplotype;PA166128807;Disease
FEBRILE NEUTROPENIA;UGT1A1*6;Haplotype;PA166170245;Disease
ATAZANAVIR / RITONAVIR;UGT1A1*6;Haplotype;PA166182624;Chemical
FOLFIRI;UGT1A1*6;Haplotype;PA166182863;Chemical
FOLFIRINOX;UGT1A1*6;Haplotype;PA166240141;Chemical
UGT1A1;UGT1A1*6;Haplotype;PA420;Gene
CARCINOMA, RENAL CELL;UGT1A1*6;Haplotype;PA443624;Disease
DIARRHEA;UGT1A1*6;Haplotype;PA443899;Disease
DRUG TOXICITY;UGT1A1*6;Haplotype;PA443937;Disease
HYPERBILIRUBINEMIA;UGT1A1*6;Haplotype;PA444511;Disease
LEUKOPENIA;UGT1A1*6;Haplotype;PA444773;Disease
LUNG NEOPLASMS;UGT1A1*6;Haplotype;PA444818;Disease
NEOPLASM METASTASIS;UGT1A1*6;Haplotype;PA445058;Disease
NEOPLASMS;UGT1A1*6;Haplotype;PA445062;Disease
NEUTROPENIA;UGT1A1*6;Haplotype;PA445113;Disease
PANCREATIC NEOPLASMS;UGT1A1*6;Haplotype;PA445218;Disease
STOMACH NEOPLASMS;UGT1A1*6;Haplotype;PA445742;Disease
COLORECTAL NEOPLASMS;UGT1A1*6;Haplotype;PA446108;Disease
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;UGT1A1*6;Haplotype;PA446171;Disease
HIV INFECTIONS;UGT1A1*6;Haplotype;PA447230;Disease
CARBOPLATIN;UGT1A1*6;Haplotype;PA448803;Chemical
DEXAMETHASONE;UGT1A1*6;Haplotype;PA449247;Chemical
ETOPOSIDE;UGT1A1*6;Haplotype;PA449552;Chemical
INDINAVIR;UGT1A1*6;Haplotype;PA449977;Chemical
IRINOTECAN;UGT1A1*6;Haplotype;PA450085;Chemical
NON-SMALL CELL LUNG CARCINOMA;CDSN;Gene;PA443622;Disease
THROMBOCYTOPENIA;CDSN;Gene;PA445846;Disease
CARBOPLATIN;CDSN;Gene;PA448803;Chemical
GEMCITABINE;CDSN;Gene;PA449748;Chemical
G6PD;Vitamin B-complex with vitamin C;Chemical;PA28469;Gene
ATAZANAVIR;rs7586110;Variant;PA10251;Chemical
HYPERBILIRUBINEMIA;rs7586110;Variant;PA444511;Disease
HIV INFECTIOUS DISEASE;rs7586110;Variant;PA447230;Disease
RITONAVIR;rs7586110;Variant;PA451260;Chemical
ACE INHIBITORS, PLAIN;rs11209716;Variant;PA164712308;Chemical
COUGH;rs11209716;Variant;PA443803;Disease
HYPERTENSION;rs11209716;Variant;PA444552;Disease
FLUOROURACIL;rs17179108;Variant;PA128406956;Chemical
COLORECTAL NEOPLASMS;rs17179108;Variant;PA446108;Disease
CAPECITABINE;rs17179108;Variant;PA448771;Chemical
CFTR;rs1800098;Variant;PA109;Gene
IVACAFTOR;rs1800098;Variant;PA165950341;Chemical
ALK;ceritinib;Chemical;PA24719;Gene
MAPK1;ETS1;Gene;PA30616;Gene
MAPK3;ETS1;Gene;PA30622;Gene
DIABETES MELLITUS;AMHR2;Gene;PA443886;Disease
METFORMIN;AMHR2;Gene;PA450395;Chemical
OVERDOSE;rs115208233;Variant;PA446199;Disease
OPIOIDS;rs115208233;Variant;PA452618;Chemical
MULTIPLE SCLEROSIS;rs10494227;Variant;PA444987;Disease
INTERFERON BETA-1A;rs10494227;Variant;PA450037;Chemical
INTERFERON BETA-1B;rs10494227;Variant;PA450039;Chemical
HEPATOCELLULAR CARCINOMA;rs4604006;Variant;PA444447;Disease
SORAFENIB;rs4604006;Variant;PA7000;Chemical
SUNITINIB;rs1933437;Variant;PA162372840;Chemical
MYELOSUPPRESSION;rs1933437;Variant;PA165817398;Disease
LEUKOPENIA;rs1933437;Variant;PA444773;Disease
NEUTROPENIA;rs1933437;Variant;PA445113;Disease
THROMBOCYTOPENIA;rs1933437;Variant;PA445846;Disease
IRRITABLE BOWEL SYNDROME;rs16952570;Variant;PA166048887;Disease
ULCERATIVE COLITIS;rs16952570;Variant;PA443750;Disease
CROHN DISEASE;rs16952570;Variant;PA443815;Disease
LEUKOPENIA;rs16952570;Variant;PA444773;Disease
NEUTROPENIA;rs16952570;Variant;PA445113;Disease
AZATHIOPRINE;rs16952570;Variant;PA448515;Chemical
MERCAPTOPURINE;rs16952570;Variant;PA450379;Chemical
PSYCHOTIC DISORDER;rs2472297;Variant;PA447215;Disease
OLANZAPINE;rs2472297;Variant;PA450688;Chemical
ACUTE CORONARY SYNDROME;rs2046934;Variant;PA165108401;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);rs2046934;Variant;PA166129560;Disease
ANGINA PECTORIS;rs2046934;Variant;PA443362;Disease
CLOPIDOGREL;rs2046934;Variant;PA449053;Chemical
L-TRYPTOPHAN;rs316019;Variant;PA10323;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs316019;Variant;PA130620651;Chemical
OTOTOXICITY;rs316019;Variant;PA162263534;Disease
PLATINUM COMPOUNDS;rs316019;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs316019;Variant;PA443622;Disease
NEOPLASMS;rs316019;Variant;PA445062;Disease
CISPLATIN;rs316019;Variant;PA449014;Chemical
METFORMIN;rs316019;Variant;PA450395;Chemical
COMT;Smoking Cessation;Disease;PA117;Gene
CYP2A6;Smoking Cessation;Disease;PA121;Gene
CYP2A6*1;Smoking Cessation;Disease;PA165924690;Haplotype
CYP2A6*46;Smoking Cessation;Disease;PA165924691;Haplotype
CYP2A6*2;Smoking Cessation;Disease;PA165924719;Haplotype
CYP2A6*4;Smoking Cessation;Disease;PA165924721;Haplotype
CYP2A6*17;Smoking Cessation;Disease;PA165924744;Haplotype
CYP2A6*20;Smoking Cessation;Disease;PA165924749;Haplotype
CYP2A6*23;Smoking Cessation;Disease;PA165924752;Haplotype
CYP2A6*24;Smoking Cessation;Disease;PA165924753;Haplotype
CYP2A6*25;Smoking Cessation;Disease;PA165924755;Haplotype
CYP2A6*26;Smoking Cessation;Disease;PA165924756;Haplotype
CYP2A6*27;Smoking Cessation;Disease;PA165924757;Haplotype
CYP2A6*28;Smoking Cessation;Disease;PA165924758;Haplotype
CYP2A6*9;Smoking Cessation;Disease;PA165980914;Haplotype
CYP2A6*12;Smoking Cessation;Disease;PA165980915;Haplotype
CYP2A6*35;Smoking Cessation;Disease;PA165980920;Haplotype
RS4680;Smoking Cessation;Disease;PA166156024;Variant
RS3852209;Smoking Cessation;Disease;PA166179948;Variant
HINT1;Smoking Cessation;Disease;PA29286;Gene
MAJOR ADVERSE CARDIAC EVENTS (MACE);N6AMT1;Gene;PA166129560;Disease
CLOPIDOGREL;N6AMT1;Gene;PA449053;Chemical
RS3814055;temsirolimus;Chemical;PA166156383;Variant
RS6785049;temsirolimus;Chemical;PA166156411;Variant
RS1128503;temsirolimus;Chemical;PA166157288;Variant
RS2032582;temsirolimus;Chemical;PA166157316;Variant
ABCB1;temsirolimus;Chemical;PA267;Gene
NR1I2;temsirolimus;Chemical;PA378;Gene
OXALIPLATIN;CSMD1;Gene;PA131285527;Chemical
BREAST NEOPLASMS;CSMD1;Gene;PA443560;Disease
DIABETES MELLITUS;CSMD1;Gene;PA443886;Disease
ESSENTIAL HYPERTENSION;CSMD1;Gene;PA447288;Disease
ANASTROZOLE;CSMD1;Gene;PA448432;Chemical
HYDROCHLOROTHIAZIDE;CSMD1;Gene;PA449899;Chemical
METFORMIN;CSMD1;Gene;PA450395;Chemical
FLUOROURACIL;rs662;Variant;PA128406956;Chemical
OXALIPLATIN;rs662;Variant;PA131285527;Chemical
ANGINA PECTORIS;rs662;Variant;PA443362;Disease
CORONARY ARTERY DISEASE;rs662;Variant;PA443796;Disease
HYPERCHOLESTEROLEMIA;rs662;Variant;PA444516;Disease
MYOCARDIAL INFARCTION;rs662;Variant;PA445019;Disease
NEOPLASMS;rs662;Variant;PA445062;Disease
STOMACH NEOPLASMS;rs662;Variant;PA445742;Disease
THROMBOTIC DISEASE;rs662;Variant;PA445850;Disease
MYOCARDIAL ISCHEMIA;rs662;Variant;PA446459;Disease
ATORVASTATIN;rs662;Variant;PA448500;Chemical
CLOPIDOGREL;rs662;Variant;PA449053;Chemical
EPIRUBICIN;rs662;Variant;PA449476;Chemical
SIMVASTATIN;rs662;Variant;PA451363;Chemical
CYP2C9;international normalized ratio variability (inr-var);Disease;PA126;Gene
CYP2C9*1;international normalized ratio variability (inr-var);Disease;PA165816542;Haplotype
CYP2C9*11;international normalized ratio variability (inr-var);Disease;PA165816552;Haplotype
OPIOID-RELATED DISORDERS;PDYN;Gene;PA445043;Disease
OPIOIDS;PDYN;Gene;PA452618;Chemical
DRUG HYPERSENSITIVITY;HLA-DRB1*14:01;Haplotype;PA443936;Disease
HEMATOLOGIC NEOPLASMS;HLA-DRB1*14:01;Haplotype;PA446827;Disease
ALLOPURINOL;HLA-DRB1*14:01;Haplotype;PA448320;Chemical
ANEMIA;rs2234753;Variant;PA443340;Disease
NASOPHARYNGEAL NEOPLASMS;rs2234753;Variant;PA445046;Disease
DOCETAXEL;rs2234753;Variant;PA449383;Chemical
KDR;TIMP3;Gene;PA30086;Gene
SLCO1B1;elagolix;Chemical;PA134865839;Gene
RS4149056;elagolix;Chemical;PA166154579;Variant
KCNH2;probucol;Chemical;PA212;Gene
ATALUREN;rs113993959;Variant;PA166151864;Chemical
CYSTIC FIBROSIS;rs113993959;Variant;PA443829;Disease
CES1;Acute coronary syndrome;Disease;PA107;Gene
CYP2C19;Acute coronary syndrome;Disease;PA124;Gene
CYP2C9;Acute coronary syndrome;Disease;PA126;Gene
CYP3A4;Acute coronary syndrome;Disease;PA130;Gene
SLCO1B1;Acute coronary syndrome;Disease;PA134865839;Gene
WDR24;Acute coronary syndrome;Disease;PA134918496;Gene
KRTAP10-4;Acute coronary syndrome;Disease;PA134942730;Gene
P2RY12;Acute coronary syndrome;Disease;PA134971947;Gene
EFR3A;Acute coronary syndrome;Disease;PA162384422;Gene
JMJD8;Acute coronary syndrome;Disease;PA162392531;Gene
NECAB1;Acute coronary syndrome;Disease;PA162397411;Gene
CDKN2B-AS1;Acute coronary syndrome;Disease;PA164717802;Gene
CYP2C19*6;Acute coronary syndrome;Disease;PA165816522;Haplotype
CYP2C19*8;Acute coronary syndrome;Disease;PA165816524;Haplotype
CYP2C19*17;Acute coronary syndrome;Disease;PA165816533;Haplotype
CYP2C9*1;Acute coronary syndrome;Disease;PA165816542;Haplotype
CYP2C9*2;Acute coronary syndrome;Disease;PA165816543;Haplotype
CYP2C9*3;Acute coronary syndrome;Disease;PA165816544;Haplotype
CYP2C19*1;Acute coronary syndrome;Disease;PA165980634;Haplotype
CYP2C19*2;Acute coronary syndrome;Disease;PA165980635;Haplotype
CYP2C19*3;Acute coronary syndrome;Disease;PA165980636;Haplotype
CYP2C19*4;Acute coronary syndrome;Disease;PA165980637;Haplotype
CYP2C19*5;Acute coronary syndrome;Disease;PA165980638;Haplotype
RS943580;Acute coronary syndrome;Disease;PA166153602;Variant
RS1805094;Acute coronary syndrome;Disease;PA166153655;Variant
RS4244285;Acute coronary syndrome;Disease;PA166154053;Variant
RS4149056;Acute coronary syndrome;Disease;PA166154579;Variant
RS113681054;Acute coronary syndrome;Disease;PA166154664;Variant
RS1967309;Acute coronary syndrome;Disease;PA166155024;Variant
RS2307240;Acute coronary syndrome;Disease;PA166155039;Variant
RS5918;Acute coronary syndrome;Disease;PA166155152;Variant
RS2108622;Acute coronary syndrome;Disease;PA166155381;Variant
RS2046934;Acute coronary syndrome;Disease;PA166156339;Variant
RS352046;Acute coronary syndrome;Disease;PA166156487;Variant
RS61361928;Acute coronary syndrome;Disease;PA166156689;Variant
RS61767072;Acute coronary syndrome;Disease;PA166156691;Variant
RS1800629;Acute coronary syndrome;Disease;PA166156997;Variant
RS1045642;Acute coronary syndrome;Disease;PA166157284;Variant
RS2032582;Acute coronary syndrome;Disease;PA166157316;Variant
RS56324128;Acute coronary syndrome;Disease;PA166157496;Variant
RS62471956;Acute coronary syndrome;Disease;PA166157501;Variant
RS10306135;Acute coronary syndrome;Disease;PA166157804;Variant
RS10757274;Acute coronary syndrome;Disease;PA166157810;Variant
RS11640115;Acute coronary syndrome;Disease;PA166268441;Variant
RS74569896;Acute coronary syndrome;Disease;PA166268442;Variant
RS4736529;Acute coronary syndrome;Disease;PA166268443;Variant
RS75750968;Acute coronary syndrome;Disease;PA166268444;Variant
RS3749187;Acute coronary syndrome;Disease;PA166268445;Variant
RS140410716;Acute coronary syndrome;Disease;PA166268446;Variant
RS201441480;Acute coronary syndrome;Disease;PA166268447;Variant
RS17064642;Acute coronary syndrome;Disease;PA166268981;Variant
ITGB3;Acute coronary syndrome;Disease;PA205;Gene
LEPR;Acute coronary syndrome;Disease;PA229;Gene
PTGS1;Acute coronary syndrome;Disease;PA24346;Gene
TSPEAR;Acute coronary syndrome;Disease;PA25824;Gene
AGAP3;Acute coronary syndrome;Disease;PA26413;Gene
ABCB1;Acute coronary syndrome;Disease;PA267;Gene
CYP4F2;Acute coronary syndrome;Disease;PA27121;Gene
ECHS1;Acute coronary syndrome;Disease;PA27597;Gene
ADCY9;Acute coronary syndrome;Disease;PA30;Gene
MYOM2;Acute coronary syndrome;Disease;PA31419;Gene
CXCL5;Acute coronary syndrome;Disease;PA35573;Gene
UGT2B7;Acute coronary syndrome;Disease;PA361;Gene
ADRA2C;Acute coronary syndrome;Disease;PA37;Gene
ZDHHC3;Acute coronary syndrome;Disease;PA38544;Gene
ADRB2;Acute coronary syndrome;Disease;PA39;Gene
AGT;Acute coronary syndrome;Disease;PA42;Gene
CYP3A43;Acute coronary syndrome;Disease;PA427;Gene
TNF;Acute coronary syndrome;Disease;PA435;Gene
CHRNA7;rivastigmine;Chemical;PA114;Gene
RS2177370;rivastigmine;Chemical;PA166153998;Variant
RS3793790;rivastigmine;Chemical;PA166154034;Variant
RS6494223;rivastigmine;Chemical;PA166154918;Variant
RS1803274;rivastigmine;Chemical;PA166156332;Variant
RS2571598;rivastigmine;Chemical;PA166157364;Variant
ACHE;rivastigmine;Chemical;PA20;Gene
BCHE;rivastigmine;Chemical;PA25294;Gene
CHAT;rivastigmine;Chemical;PA26448;Gene
CYP2C19;Hemorrhage;Disease;PA124;Gene
CYP2C9;Hemorrhage;Disease;PA126;Gene
VKORC1;Hemorrhage;Disease;PA133787052;Gene
CYP2C19*17;Hemorrhage;Disease;PA165816533;Haplotype
CYP2C9*1;Hemorrhage;Disease;PA165816542;Haplotype
CYP2C9*2;Hemorrhage;Disease;PA165816543;Haplotype
CYP2C9*3;Hemorrhage;Disease;PA165816544;Haplotype
CYP2C9*5;Hemorrhage;Disease;PA165816546;Haplotype
CYP2C9*6;Hemorrhage;Disease;PA165816547;Haplotype
CYP2C9*11;Hemorrhage;Disease;PA165816552;Haplotype
CYP4F2*1;Hemorrhage;Disease;PA165860685;Haplotype
CYP4F2*3;Hemorrhage;Disease;PA165860687;Haplotype
CYP2C19*1;Hemorrhage;Disease;PA165980634;Haplotype
CYP2C19*2;Hemorrhage;Disease;PA165980635;Haplotype
CYP2C19*3;Hemorrhage;Disease;PA165980636;Haplotype
RS11568732;Hemorrhage;Disease;PA166154138;Variant
RS1800566;Hemorrhage;Disease;PA166155017;Variant
RS9923231;Hemorrhage;Disease;PA166155091;Variant
RS429358;Hemorrhage;Disease;PA166155351;Variant
RS1367117;Hemorrhage;Disease;PA166155632;Variant
RS1045642;Hemorrhage;Disease;PA166157284;Variant
RS679899;Hemorrhage;Disease;PA166197882;Variant
RS78132896;Hemorrhage;Disease;PA166223623;Variant
ABCB1;Hemorrhage;Disease;PA267;Gene
CYP4F2;Hemorrhage;Disease;PA27121;Gene
EPHA7;Hemorrhage;Disease;PA27822;Gene
GGCX;Hemorrhage;Disease;PA28660;Gene
NQO1;Hemorrhage;Disease;PA31744;Gene
APOB;Hemorrhage;Disease;PA50;Gene
APOE;Hemorrhage;Disease;PA55;Gene
OPIOID-RELATED DISORDERS;rs1079596;Variant;PA445043;Disease
OPIOIDS;rs1079596;Variant;PA452618;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs17583889;Variant;PA130620651;Chemical
NEOPLASMS;rs17583889;Variant;PA445062;Disease
HEROIN DEPENDENCE;rs1948308;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs1948308;Variant;PA445043;Disease
METHADONE;rs1948308;Variant;PA450401;Chemical
ROCURONIUM;rs3834939;Variant;PA164754992;Chemical
MAPK8;FOSB;Gene;PA283;Gene
MAPK14;FOSB;Gene;PA30621;Gene
PSYCHOTIC DISORDER;rs4410790;Variant;PA447215;Disease
OLANZAPINE;rs4410790;Variant;PA450688;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;MICA;Gene;PA164713366;Chemical
RHEUMATOID ARTHRITIS;MICA;Gene;PA443434;Disease
SPONDYLARTHROPATHIES;MICA;Gene;PA447163;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;SLCO1B1*31;Haplotype;PA446155;Disease
METHOTREXATE;SLCO1B1*31;Haplotype;PA450428;Chemical
RS2108622;vitamin e;Chemical;PA166155381;Variant
RS3093105;vitamin e;Chemical;PA166155402;Variant
ABCB1;vitamin e;Chemical;PA267;Gene
CYP4F2;vitamin e;Chemical;PA27121;Gene
ASTHMA;RAP1GAP2;Gene;PA443450;Disease
HYPERLIPIDEMIAS;rs2854117;Variant;PA444528;Disease
HIV INFECTIOUS DISEASE;rs2854117;Variant;PA447230;Disease
RITONAVIR;rs2854117;Variant;PA451260;Chemical
COL3A1;ITGA2;Gene;PA26716;Gene
COL4A1;ITGA2;Gene;PA26717;Gene
COL4A2;ITGA2;Gene;PA26718;Gene
PLCB1;ITGA2;Gene;PA33384;Gene
PLCG2;ITGA2;Gene;PA33393;Gene
COL1A1;ITGA2;Gene;PA35041;Gene
COL1A2;ITGA2;Gene;PA35042;Gene
CORONARY ARTERY DISEASE;ITGA2;Gene;PA443796;Disease
CORONARY DISEASE;ITGA2;Gene;PA443797;Disease
MYOCARDIAL INFARCTION;ITGA2;Gene;PA445019;Disease
ASPIRIN;ITGA2;Gene;PA448497;Chemical
CLOPIDOGREL;ITGA2;Gene;PA449053;Chemical
APNEA;rs531738678;Variant;PA443407;Disease
SUCCINYLCHOLINE;rs531738678;Variant;PA451522;Chemical
TPMT*1;Stomatitis;Disease;PA165819268;Haplotype
TPMT*3A;Stomatitis;Disease;PA165819270;Haplotype
RS45445694;Stomatitis;Disease;PA166155331;Variant
TPMT;Stomatitis;Disease;PA356;Gene
TYMS;Stomatitis;Disease;PA359;Gene
COMT;sumatriptan;Chemical;PA117;Gene
DBH;sumatriptan;Chemical;PA136;Gene
RS6265;sumatriptan;Chemical;PA166154259;Variant
RS6275;sumatriptan;Chemical;PA166154260;Variant
RS5443;sumatriptan;Chemical;PA166154486;Variant
RS6305;sumatriptan;Chemical;PA166154672;Variant
RS4680;sumatriptan;Chemical;PA166156024;Variant
RS1799971;sumatriptan;Chemical;PA166156991;Variant
RS1611115;sumatriptan;Chemical;PA166157734;Variant
RS130060;sumatriptan;Chemical;PA166184004;Variant
GNB3;sumatriptan;Chemical;PA176;Gene
HTR2A;sumatriptan;Chemical;PA193;Gene
DRD2;sumatriptan;Chemical;PA27478;Gene
HTR1B;sumatriptan;Chemical;PA29549;Gene
BDNF;sumatriptan;Chemical;PA31891;Gene
OPRM1;sumatriptan;Chemical;PA31945;Gene
ANEMIA;rs6413517;Variant;PA443340;Disease
NASOPHARYNGEAL NEOPLASMS;rs6413517;Variant;PA445046;Disease
DOCETAXEL;rs6413517;Variant;PA449383;Chemical
CYP3A4;lumefantrine;Chemical;PA130;Gene
CYP3A5;lumefantrine;Chemical;PA131;Gene
ZSCAN25;lumefantrine;Chemical;PA134962723;Gene
RS776746;lumefantrine;Chemical;PA166157267;Variant
RS2740574;lumefantrine;Chemical;PA166157367;Variant
RS10264272;lumefantrine;Chemical;PA166157441;Variant
RS41303343;lumefantrine;Chemical;PA166157490;Variant
PLATINUM COMPOUNDS;rs1127687;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs1127687;Variant;PA443622;Disease
GEMCITABINE;rs1127687;Variant;PA449748;Chemical
PACLITAXEL;rs1127687;Variant;PA450761;Chemical
COUMARIN;rs1801272;Variant;PA134521193;Chemical
TOXIC LIVER DISEASE;HLA-DQB1*06:04;Haplotype;PA164925725;Disease
URTICARIA;HLA-DQB1*06:04;Haplotype;PA445999;Disease
ASPIRIN;HLA-DQB1*06:04;Haplotype;PA448497;Chemical
TICLOPIDINE;HLA-DQB1*06:04;Haplotype;PA451686;Chemical
ATRIAL FIBRILLATION;CACNB2;Gene;PA443459;Disease
CELECOXIB;CACNB2;Gene;PA448871;Chemical
NON-SMALL CELL LUNG CARCINOMA;C8orf34;Gene;PA443622;Disease
IRINOTECAN;C8orf34;Gene;PA450085;Chemical
PANCREATIC NEOPLASMS;TENT4A;Gene;PA445218;Disease
GEMCITABINE;TENT4A;Gene;PA449748;Chemical
DPYD;rs72549307;Variant;PA145;Gene
CAPECITABINE;rs72549307;Variant;PA448771;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs6920220;Variant;PA164713366;Chemical
PSORIASIS;rs6920220;Variant;PA445451;Disease
ARTHRITIS, PSORIATIC;rs6920220;Variant;PA446198;Disease
METHOTREXATE;rs6920220;Variant;PA450428;Chemical
STAT2;SOCS3;Gene;PA36184;Gene
SLC31A1;carboplatin;Chemical;PA118;Gene
CYP2C8;carboplatin;Chemical;PA125;Gene
CYP3A5;carboplatin;Chemical;PA131;Gene
C6ORF15;carboplatin;Chemical;PA134866404;Gene
PPP1R18;carboplatin;Chemical;PA134918172;Gene
DOCK8;carboplatin;Chemical;PA134918866;Gene
MUCL3;carboplatin;Chemical;PA134926573;Gene
ATAT1;carboplatin;Chemical;PA134948212;Gene
HCP5;carboplatin;Chemical;PA134951826;Gene
ERCC1;carboplatin;Chemical;PA155;Gene
UGT1A1*6;carboplatin;Chemical;PA166115858;Haplotype
CYP3A5*1;carboplatin;Chemical;PA166128213;Haplotype
CYP3A5*3;carboplatin;Chemical;PA166128219;Haplotype
RS1065634;carboplatin;Chemical;PA166153621;Variant
RS1801131;carboplatin;Chemical;PA166153643;Variant
RS1805087;carboplatin;Chemical;PA166153654;Variant
RS12118636;carboplatin;Chemical;PA166153850;Variant
RS2299939;carboplatin;Chemical;PA166154011;Variant
RS3740556;carboplatin;Chemical;PA166154030;Variant
RS4149117;carboplatin;Chemical;PA166154583;Variant
RS7311358;carboplatin;Chemical;PA166154602;Variant
RS1061472;carboplatin;Chemical;PA166154695;Variant
RS1801249;carboplatin;Chemical;PA166154703;Variant
RS6113;carboplatin;Chemical;PA166154763;Variant
RS1130214;carboplatin;Chemical;PA166154772;Variant
RS2494752;carboplatin;Chemical;PA166154795;Variant
RS2498804;carboplatin;Chemical;PA166154797;Variant
RS11623866;carboplatin;Chemical;PA166154823;Variant
RS879207;carboplatin;Chemical;PA166155169;Variant
RS1136201;carboplatin;Chemical;PA166155183;Variant
RS2849380;carboplatin;Chemical;PA166155289;Variant
RS11615;carboplatin;Chemical;PA166155342;Variant
RS17309872;carboplatin;Chemical;PA166155966;Variant
RS12659;carboplatin;Chemical;PA166155973;Variant
RS9981861;carboplatin;Chemical;PA166156013;Variant
RS139887;carboplatin;Chemical;PA166156044;Variant
RS2699887;carboplatin;Chemical;PA166156362;Variant
RS9825762;carboplatin;Chemical;PA166156430;Variant
RS11710163;carboplatin;Chemical;PA166156444;Variant
RS726501;carboplatin;Chemical;PA166156739;Variant
RS16886403;carboplatin;Chemical;PA166156882;Variant
RS17661089;carboplatin;Chemical;PA166156888;Variant
RS451774;carboplatin;Chemical;PA166156918;Variant
RS544093;carboplatin;Chemical;PA166156925;Variant
RS879825;carboplatin;Chemical;PA166156961;Variant
RS1800629;carboplatin;Chemical;PA166156997;Variant
RS6900017;carboplatin;Chemical;PA166157110;Variant
RS9369421;carboplatin;Chemical;PA166157149;Variant
RS1801368;carboplatin;Chemical;PA166157307;Variant
RS3594;carboplatin;Chemical;PA166157541;Variant
RS6151031;carboplatin;Chemical;PA166157783;Variant
RS7851395;carboplatin;Chemical;PA166157789;Variant
RS2229046;carboplatin;Chemical;PA166179815;Variant
RS773123;carboplatin;Chemical;PA166179816;Variant
RS2284922;carboplatin;Chemical;PA166179817;Variant
RS2070096;carboplatin;Chemical;PA166179818;Variant
RS11280056;carboplatin;Chemical;PA166180936;Variant
RS5877;carboplatin;Chemical;PA166201501;Variant
RS3094086;carboplatin;Chemical;PA166201502;Variant
RS1049709;carboplatin;Chemical;PA166201503;Variant
RS10885;carboplatin;Chemical;PA166201504;Variant
RS3115672;carboplatin;Chemical;PA166201505;Variant
RS9262132;carboplatin;Chemical;PA166201521;Variant
RS9262143;carboplatin;Chemical;PA166201522;Variant
RS886424;carboplatin;Chemical;PA166201523;Variant
RS886423;carboplatin;Chemical;PA166201524;Variant
RS2233980;carboplatin;Chemical;PA166201525;Variant
RS3130985;carboplatin;Chemical;PA166201526;Variant
RS3130907;carboplatin;Chemical;PA166201527;Variant
RS11229;carboplatin;Chemical;PA166201528;Variant
RS10491684;carboplatin;Chemical;PA166201541;Variant
RS1058932;carboplatin;Chemical;PA166201542;Variant
RS11572078;carboplatin;Chemical;PA166201543;Variant
RS6118;carboplatin;Chemical;PA166201545;Variant
RS6119;carboplatin;Chemical;PA166201546;Variant
RS6504649;carboplatin;Chemical;PA166201547;Variant
RS73450548;carboplatin;Chemical;PA166201561;Variant
GSTT1;carboplatin;Chemical;PA183;Gene
ACSS2;carboplatin;Chemical;PA24429;Gene
MTHFR;carboplatin;Chemical;PA245;Gene
AKT1;carboplatin;Chemical;PA24684;Gene
ALDH1A1;carboplatin;Chemical;PA24692;Gene
BARD1;carboplatin;Chemical;PA25256;Gene
PRRC2A;carboplatin;Chemical;PA25263;Gene
BCL2;carboplatin;Chemical;PA25302;Gene
CDSN;carboplatin;Chemical;PA26348;Gene
DSCAM;carboplatin;Chemical;PA27491;Gene
EIF3A;carboplatin;Chemical;PA27699;Gene
ERBB2;carboplatin;Chemical;PA27844;Gene
ERBB3;carboplatin;Chemical;PA27846;Gene
ETS2;carboplatin;Chemical;PA27903;Gene
FNTB;carboplatin;Chemical;PA28202;Gene
GPX5;carboplatin;Chemical;PA28953;Gene
GSR;carboplatin;Chemical;PA29014;Gene
MAP3K1;carboplatin;Chemical;PA30592;Gene
MSH5;carboplatin;Chemical;PA31136;Gene
MTR;carboplatin;Chemical;PA31272;Gene
NRAS;carboplatin;Chemical;PA31768;Gene
OPRM1;carboplatin;Chemical;PA31945;Gene
SLC19A1;carboplatin;Chemical;PA327;Gene
PIK3CA;carboplatin;Chemical;PA33308;Gene
PSORS1C1;carboplatin;Chemical;PA33919;Gene
PTEN;carboplatin;Chemical;PA33942;Gene
RAF1;carboplatin;Chemical;PA34183;Gene
RNF8;carboplatin;Chemical;PA34445;Gene
SCN10A;carboplatin;Chemical;PA35000;Gene
SERPINC1;carboplatin;Chemical;PA35026;Gene
HLA-C;carboplatin;Chemical;PA35057;Gene
SERPINA5;carboplatin;Chemical;PA35505;Gene
SLCO1B3;carboplatin;Chemical;PA35844;Gene
TYMS;carboplatin;Chemical;PA359;Gene
SOX10;carboplatin;Chemical;PA36027;Gene
MAD1L1;carboplatin;Chemical;PA372;Gene
VEGFA;carboplatin;Chemical;PA37302;Gene
XYLT2;carboplatin;Chemical;PA37974;Gene
UGT1A1;carboplatin;Chemical;PA420;Gene
TNF;carboplatin;Chemical;PA435;Gene
ATP7B;carboplatin;Chemical;PA73;Gene
SUFENTANIL;rs1323040;Variant;PA451527;Chemical
PERTUSSIS VACCINES;rs2770150;Variant;PA164713160;Chemical
SLCO1B1;Gastrointestinal toxicity;Disease;PA134865839;Gene
ENOSF1;Gastrointestinal toxicity;Disease;PA134897613;Gene
RS11045879;Gastrointestinal toxicity;Disease;PA166154633;Variant
RS6280;Gastrointestinal toxicity;Disease;PA166156277;Variant
RS3814055;Gastrointestinal toxicity;Disease;PA166156383;Variant
RS6785049;Gastrointestinal toxicity;Disease;PA166156411;Variant
RS628031;Gastrointestinal toxicity;Disease;PA166156933;Variant
RS2228000;Gastrointestinal toxicity;Disease;PA166171094;Variant
RS11280056;Gastrointestinal toxicity;Disease;PA166180936;Variant
DRD3;Gastrointestinal toxicity;Disease;PA27479;Gene
SLC22A1;Gastrointestinal toxicity;Disease;PA329;Gene
TYMS;Gastrointestinal toxicity;Disease;PA359;Gene
XPC;Gastrointestinal toxicity;Disease;PA37413;Gene
NR1I2;Gastrointestinal toxicity;Disease;PA378;Gene
ASTHMA;rs2228079;Variant;PA443450;Disease
ASPIRIN;rs2228079;Variant;PA448497;Chemical
ESTRADIOL;rs7159713;Variant;PA449503;Chemical
RS1057519045;futibatinib;Chemical;PA166317621;Variant
RS1057519797;futibatinib;Chemical;PA166317622;Variant
FGFR2;futibatinib;Chemical;PA28128;Gene
HALOPERIDOL;RTKN2;Gene;PA449841;Chemical
CFTR;rs397508621;Variant;PA109;Gene
IVACAFTOR;rs397508621;Variant;PA165950341;Chemical
COCAINE DEPENDENCE;rs11503014;Variant;PA446878;Disease
COCAINE;rs11503014;Variant;PA449072;Chemical
OVARIAN NEOPLASMS;rs6413432;Variant;PA445204;Disease
CISPLATIN;rs6413432;Variant;PA449014;Chemical
CYCLOPHOSPHAMIDE;rs6413432;Variant;PA449165;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs1061735;Variant;PA447197;Disease
METHYLPHENIDATE;rs1061735;Variant;PA450464;Chemical
MAJOR DEPRESSIVE DISORDER;rs7103411;Variant;PA447321;Disease
CITALOPRAM;rs7103411;Variant;PA449015;Chemical
MAJOR DEPRESSIVE DISORDER;rs2112460;Variant;PA447321;Disease
ANTIDEPRESSANTS;rs2112460;Variant;PA452229;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs9262132;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs9262132;Variant;PA445846;Disease
CARBOPLATIN;rs9262132;Variant;PA448803;Chemical
GEMCITABINE;rs9262132;Variant;PA449748;Chemical
3-CYANO-7-ETHOXYCOUMARIN;CYP2C19*10;Haplotype;PA166123047;Chemical
6BETA-HYDROXYTESTOSTERONE;CYP2C19*10;Haplotype;PA166318222;Chemical
11A-HYDROXYPROGESTERONE;CYP2C19*10;Haplotype;PA166318342;Chemical
GASTROESOPHAGEAL REFLUX;CYP2C19*10;Haplotype;PA444255;Disease
CLOPIDOGREL;CYP2C19*10;Haplotype;PA449053;Chemical
FLUOXETINE;CYP2C19*10;Haplotype;PA449673;Chemical
MEPHENYTOIN;CYP2C19*10;Haplotype;PA450373;Chemical
OMEPRAZOLE;CYP2C19*10;Haplotype;PA450704;Chemical
WNK4;SCNN1A;Gene;PA134875400;Gene
NEDD4L;SCNN1A;Gene;PA31534;Gene
WNK1;SCNN1A;Gene;PA33782;Gene
AMILORIDE;SCNN1A;Gene;PA448368;Chemical
TRIAMTERENE;SCNN1A;Gene;PA451752;Chemical
TOXIC LIVER DISEASE;NOS2;Gene;PA164925725;Disease
TUBERCULOSIS;NOS2;Gene;PA445941;Disease
IBUPROFEN;NOS2;Gene;PA449957;Chemical
ISONIAZID;NOS2;Gene;PA450112;Chemical
RIFAMPIN;NOS2;Gene;PA451250;Chemical
REGADENOSON;rs17602729;Variant;PA166129536;Chemical
RHEUMATOID ARTHRITIS;rs17602729;Variant;PA443434;Disease
METHOTREXATE;rs17602729;Variant;PA450428;Chemical
ALLOPURINOL;TRIB2;Gene;PA448320;Chemical
CYP2C19;Granulomatous Disease, Chronic;Disease;PA124;Gene
CYP2C19*17;Granulomatous Disease, Chronic;Disease;PA165816533;Haplotype
CYP2C19*1;Granulomatous Disease, Chronic;Disease;PA165980634;Haplotype
PEGASPARGASE;rs141059755;Variant;PA164760860;Chemical
OSTEONECROSIS;rs141059755;Variant;PA445187;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs141059755;Variant;PA446155;Disease
CYCLOPHOSPHAMIDE;rs141059755;Variant;PA449165;Chemical
CYTARABINE;rs141059755;Variant;PA449177;Chemical
DAUNORUBICIN;rs141059755;Variant;PA449212;Chemical
DEXAMETHASONE;rs141059755;Variant;PA449247;Chemical
DOXORUBICIN;rs141059755;Variant;PA449412;Chemical
METHOTREXATE;rs141059755;Variant;PA450428;Chemical
PREDNISONE;rs141059755;Variant;PA451100;Chemical
THIOGUANINE;rs141059755;Variant;PA451663;Chemical
VINCRISTINE;rs141059755;Variant;PA451879;Chemical
MSH6;Colorectal Neoplasms, Hereditary Nonpolyposis;Disease;PA184;Gene
MLH1;Colorectal Neoplasms, Hereditary Nonpolyposis;Disease;PA240;Gene
MSH2;Colorectal Neoplasms, Hereditary Nonpolyposis;Disease;PA31133;Gene
PMS2;Colorectal Neoplasms, Hereditary Nonpolyposis;Disease;PA33448;Gene
MERCAPTOPURINE;TPMT*31;Haplotype;PA450379;Chemical
OPIOID-RELATED DISORDERS;rs2366929;Variant;PA445043;Disease
OPIOIDS;rs2366929;Variant;PA452618;Chemical
NEPHROTOXICITY;CYP24A1;Gene;PA162263533;Disease
DEFERASIROX;CYP24A1;Gene;PA164760843;Chemical
TELAPREVIR;CYP24A1;Gene;PA165958354;Chemical
TENOFOVIR DISOPROXIL FUMARATE;CYP24A1;Gene;PA166201941;Chemical
HEPATITIS C VIRUS INFECTION;CYP24A1;Gene;PA444445;Disease
BETA-THALASSEMIA AND RELATED DISEASES;CYP24A1;Gene;PA446432;Disease
HIV INFECTIOUS DISEASE;CYP24A1;Gene;PA447230;Disease
ADALIMUMAB;HLA-DRB1;Gene;PA10004;Chemical
ANAKINRA;HLA-DRB1;Gene;PA10799;Chemical
HMG COA REDUCTASE INHIBITORS;HLA-DRB1;Gene;PA133950441;Chemical
ROSUVASTATIN;HLA-DRB1;Gene;PA134308647;Chemical
PITAVASTATIN;HLA-DRB1;Gene;PA142650384;Chemical
LAPATINIB;HLA-DRB1;Gene;PA152241907;Chemical
MACULOPAPULAR EXANTHEMA;HLA-DRB1;Gene;PA162316739;Disease
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;HLA-DRB1;Gene;PA164712462;Chemical
ANTITHYROID PREPARATIONS;HLA-DRB1;Gene;PA164712499;Chemical
HEPATITIS VACCINES;HLA-DRB1;Gene;PA164712789;Chemical
INFLUENZA VACCINES;HLA-DRB1;Gene;PA164712830;Chemical
MEASLES VACCINES;HLA-DRB1;Gene;PA164712887;Chemical
CARBIMAZOLE;HLA-DRB1;Gene;PA164742970;Chemical
CLAVULANATE;HLA-DRB1;Gene;PA164742987;Chemical
PEGASPARGASE;HLA-DRB1;Gene;PA164760860;Chemical
LUMIRACOXIB;HLA-DRB1;Gene;PA164769031;Chemical
FLUCLOXACILLIN;HLA-DRB1;Gene;PA164781042;Chemical
TOXIC LIVER DISEASE;HLA-DRB1;Gene;PA164925725;Disease
TOCILIZUMAB;HLA-DRB1;Gene;PA165292659;Chemical
HLA-DQA1*02:01;HLA-DRB1;Gene;PA165951292;Haplotype
HLA-DRB1*07:01;HLA-DRB1;Gene;PA165951644;Haplotype
CANAKINUMAB;HLA-DRB1;Gene;PA165958358;Chemical
DABRAFENIB;HLA-DRB1;Gene;PA166114911;Chemical
DRUG-INDUCED LIVER INJURY;HLA-DRB1;Gene;PA166119041;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-DRB1;Gene;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-DRB1;Gene;PA166120929;Disease
BUCILLAMINE;HLA-DRB1;Gene;PA166123566;Chemical
FLUPIRTINE;HLA-DRB1;Gene;PA166152829;Chemical
RILONACEPT;HLA-DRB1;Gene;PA166256441;Chemical
AGRANULOCYTOSIS;HLA-DRB1;Gene;PA443297;Disease
ANAPHYLAXIS;HLA-DRB1;Gene;PA443335;Disease
ARTHRITIS, JUVENILE RHEUMATOID;HLA-DRB1;Gene;PA443433;Disease
ARTHRITIS, RHEUMATOID;HLA-DRB1;Gene;PA443434;Disease
BREAST NEOPLASMS;HLA-DRB1;Gene;PA443560;Disease
DRUG HYPERSENSITIVITY;HLA-DRB1;Gene;PA443936;Disease
DRUG TOXICITY;HLA-DRB1;Gene;PA443937;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-DRB1;Gene;PA444059;Disease
EPILEPSY;HLA-DRB1;Gene;PA444065;Disease
EXANTHEMA;HLA-DRB1;Gene;PA444109;Disease
FEVER;HLA-DRB1;Gene;PA444178;Disease
GRAVES DISEASE;HLA-DRB1;Gene;PA444329;Disease
HEPATITIS;HLA-DRB1;Gene;PA444435;Disease
HYPERSENSITIVITY;HLA-DRB1;Gene;PA444546;Disease
HYPERTENSION;HLA-DRB1;Gene;PA444552;Disease
INFECTION;HLA-DRB1;Gene;PA444614;Disease
JAUNDICE;HLA-DRB1;Gene;PA444648;Disease
MELANOMA;HLA-DRB1;Gene;PA444903;Disease
MULTIPLE SCLEROSIS;HLA-DRB1;Gene;PA444987;Disease
MUSCULAR DISEASES;HLA-DRB1;Gene;PA444997;Disease
PANCREATITIS;HLA-DRB1;Gene;PA445220;Disease
PROTEINURIA;HLA-DRB1;Gene;PA445431;Disease
STEVENS-JOHNSON SYNDROME;HLA-DRB1;Gene;PA445738;Disease
URTICARIA;HLA-DRB1;Gene;PA445999;Disease
INFLAMMATORY BOWEL DISEASES;HLA-DRB1;Gene;PA446116;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;HLA-DRB1;Gene;PA446155;Disease
STILL'S DISEASE, ADULT-ONSET;HLA-DRB1;Gene;PA446366;Disease
HEMATOLOGIC NEOPLASMS;HLA-DRB1;Gene;PA446827;Disease
SCHIZOPHRENIA;HLA-DRB1;Gene;PA447216;Disease
HIV INFECTIONS;HLA-DRB1;Gene;PA447230;Disease
ABACAVIR;HLA-DRB1;Gene;PA448004;Chemical
ACETAMINOPHEN;HLA-DRB1;Gene;PA448015;Chemical
ALLOPURINOL;HLA-DRB1;Gene;PA448320;Chemical
AMOXICILLIN;HLA-DRB1;Gene;PA448406;Chemical
ASPARAGINASE;HLA-DRB1;Gene;PA448492;Chemical
ASPIRIN;HLA-DRB1;Gene;PA448497;Chemical
ATORVASTATIN;HLA-DRB1;Gene;PA448500;Chemical
AZATHIOPRINE;HLA-DRB1;Gene;PA448515;Chemical
CARBAMAZEPINE;HLA-DRB1;Gene;PA448785;Chemical
CLOZAPINE;HLA-DRB1;Gene;PA449061;Chemical
DAPSONE;HLA-DRB1;Gene;PA449211;Chemical
EFAVIRENZ;HLA-DRB1;Gene;PA449441;Chemical
ETANERCEPT;HLA-DRB1;Gene;PA449515;Chemical
FLUVASTATIN;HLA-DRB1;Gene;PA449688;Chemical
GLATIRAMER ACETATE;HLA-DRB1;Gene;PA449760;Chemical
HYDRALAZINE;HLA-DRB1;Gene;PA449894;Chemical
INTERFERON BETA-1A;HLA-DRB1;Gene;PA450037;Chemical
LAMOTRIGINE;HLA-DRB1;Gene;PA450164;Chemical
MERCAPTOPURINE;HLA-DRB1;Gene;PA450379;Chemical
METHIMAZOLE;HLA-DRB1;Gene;PA450422;Chemical
NEVIRAPINE;HLA-DRB1;Gene;PA450616;Chemical
OXCARBAZEPINE;HLA-DRB1;Gene;PA450732;Chemical
PHENYTOIN;HLA-DRB1;Gene;PA450947;Chemical
PRAVASTATIN;HLA-DRB1;Gene;PA451089;Chemical
PROPYLTHIOURACIL;HLA-DRB1;Gene;PA451156;Chemical
SIMVASTATIN;HLA-DRB1;Gene;PA451363;Chemical
TICLOPIDINE;HLA-DRB1;Gene;PA451686;Chemical
INFLIXIMAB;HLA-DRB1;Gene;PA452639;Chemical
CYP3A5;medroxyprogesterone;Chemical;PA131;Gene
ESR1;medroxyprogesterone;Chemical;PA156;Gene
RS1544410;medroxyprogesterone;Chemical;PA166154516;Variant
RS9340799;medroxyprogesterone;Chemical;PA166157143;Variant
ESR2;medroxyprogesterone;Chemical;PA27886;Gene
VDR;medroxyprogesterone;Chemical;PA37301;Gene
SUNITINIB;FLT4;Gene;PA162372840;Chemical
HRAS;FLT4;Gene;PA29444;Gene
KRAS;FLT4;Gene;PA30196;Gene
NRAS;FLT4;Gene;PA31768;Gene
PIK3C2A;FLT4;Gene;PA33304;Gene
PIK3C2B;FLT4;Gene;PA33305;Gene
PIK3CA;FLT4;Gene;PA33308;Gene
PIK3CB;FLT4;Gene;PA33309;Gene
PIK3CD;FLT4;Gene;PA33310;Gene
PIK3CG;FLT4;Gene;PA33311;Gene
PIK3R1;FLT4;Gene;PA33312;Gene
PIK3R2;FLT4;Gene;PA33313;Gene
PIK3R3;FLT4;Gene;PA33314;Gene
RENAL CELL CARCINOMA;FLT4;Gene;PA443624;Disease
SORAFENIB;FLT4;Gene;PA7000;Chemical
CYP2C19;formoterol;Chemical;PA124;Gene
CYP2D6;formoterol;Chemical;PA128;Gene
ADRB2;formoterol;Chemical;PA39;Gene
WARFARIN;rs7200749;Variant;PA451906;Chemical
ACENOCOUMAROL;rs7200749;Variant;PA452632;Chemical
ASTHMA;rs1353411;Variant;PA443450;Disease
ASPIRIN;rs1353411;Variant;PA448497;Chemical
EPILEPSY;HLA-C*07:04;Haplotype;PA444065;Disease
STEVENS-JOHNSON SYNDROME;HLA-C*07:04;Haplotype;PA445738;Disease
CARBAMAZEPINE;HLA-C*07:04;Haplotype;PA448785;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;rs1051296;Variant;PA446155;Disease
METHOTREXATE;rs1051296;Variant;PA450428;Chemical
CYP2C9;gliclazide;Chemical;PA126;Gene
CYP2C9*1;gliclazide;Chemical;PA165816542;Haplotype
CYP2C9*2;gliclazide;Chemical;PA165816543;Haplotype
CYP2C9*3;gliclazide;Chemical;PA165816544;Haplotype
RS5219;gliclazide;Chemical;PA166154256;Variant
KCNJ11;gliclazide;Chemical;PA217;Gene
G6PD;gliclazide;Chemical;PA28469;Gene
GLUCOCORTICOIDS;NLRP1;Gene;PA452347;Chemical
CYP2C9;dronabinol;Chemical;PA126;Gene
TOBACCO USE DISORDER;rs2236196;Variant;PA445876;Disease
NICOTINE;rs2236196;Variant;PA450626;Chemical
EPILEPSY;rs28898617;Variant;PA444065;Disease
VALPROIC ACID;rs28898617;Variant;PA451846;Chemical
ESCITALOPRAM;IL11;Gene;PA10074;Chemical
DEPRESSION;IL11;Gene;PA447278;Disease
CITALOPRAM;IL11;Gene;PA449015;Chemical
ARIPIPRAZOLE;rs155333;Variant;PA10026;Chemical
SCHIZOPHRENIA;rs155333;Variant;PA447216;Disease
OLANZAPINE;rs155333;Variant;PA450688;Chemical
PERPHENAZINE;rs155333;Variant;PA450882;Chemical
QUETIAPINE;rs155333;Variant;PA451201;Chemical
RISPERIDONE;rs155333;Variant;PA451257;Chemical
SCHIZOPHRENIA;rs17716295;Variant;PA447216;Disease
ANTIPSYCHOTICS;rs17716295;Variant;PA452233;Chemical
PYRAZOLONES;PLCG1;Gene;PA164713217;Chemical
CASR;PLCG1;Gene;PA26097;Gene
ERBB2;PLCG1;Gene;PA27844;Gene
ERBB3;PLCG1;Gene;PA27846;Gene
ERBB4;PLCG1;Gene;PA27847;Gene
KDR;PLCG1;Gene;PA30086;Gene
PRKCA;PLCG1;Gene;PA33759;Gene
PRKCB;PLCG1;Gene;PA33761;Gene
PRKCD;PLCG1;Gene;PA33763;Gene
PRKCE;PLCG1;Gene;PA33765;Gene
PRKCG;PLCG1;Gene;PA33766;Gene
PRKCH;PLCG1;Gene;PA33767;Gene
PRKCI;PLCG1;Gene;PA33768;Gene
PRKD1;PLCG1;Gene;PA33771;Gene
PRKCQ;PLCG1;Gene;PA33773;Gene
PRKCZ;PLCG1;Gene;PA33775;Gene
ACETAMINOPHEN;PLCG1;Gene;PA448015;Chemical
ASPIRIN;PLCG1;Gene;PA448497;Chemical
DICLOFENAC;PLCG1;Gene;PA449293;Chemical
PROPIONIC ACID DERIVATIVES;PLCG1;Gene;PA451140;Chemical
EGFR;PLCG1;Gene;PA7360;Gene
CYP3A4;verapamil;Chemical;PA130;Gene
PLEKHH2;verapamil;Chemical;PA134912826;Gene
NOS1AP;verapamil;Chemical;PA142671259;Gene
RS10494366;verapamil;Chemical;PA166153802;Variant
RS10918594;verapamil;Chemical;PA166153816;Variant
RS2279238;verapamil;Chemical;PA166154362;Variant
RS11039149;verapamil;Chemical;PA166154448;Variant
RS12221497;verapamil;Chemical;PA166154461;Variant
RS1051375;verapamil;Chemical;PA166154509;Variant
RS1024323;verapamil;Chemical;PA166156499;Variant
RS2301149;verapamil;Chemical;PA166156798;Variant
RS11739136;verapamil;Chemical;PA166156869;Variant
RS1045642;verapamil;Chemical;PA166157284;Variant
RS2032582;verapamil;Chemical;PA166157316;Variant
RS4742610;verapamil;Chemical;PA166157776;Variant
RS11124945;verapamil;Chemical;PA166161873;Variant
KCNMB1;verapamil;Chemical;PA221;Gene
ABCB1;verapamil;Chemical;PA267;Gene
GRK4;verapamil;Chemical;PA28941;Gene
KCNIP1;verapamil;Chemical;PA30041;Gene
NR1H3;verapamil;Chemical;PA31751;Gene
PTPRD;verapamil;Chemical;PA34013;Gene
CACNA1C;verapamil;Chemical;PA83;Gene
DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS;rs7756992;Variant;PA164712689;Chemical
DIABETES MELLITUS;rs7756992;Variant;PA443886;Disease
CYP2D6;Familial Mediterranean Fever;Disease;PA128;Gene
CYP2D6*1;Familial Mediterranean Fever;Disease;PA165816576;Haplotype
CYP2D6*4;Familial Mediterranean Fever;Disease;PA165816579;Haplotype
ARIMOCLOMOL;NPC1;Gene;PA166400062;Chemical
LEVACETYLLEUCINE;NPC1;Gene;PA166400081;Chemical
FLUOROURACIL;WNT5B;Gene;PA128406956;Chemical
PLATINUM COMPOUNDS;WNT5B;Gene;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;WNT5B;Gene;PA443622;Disease
COLONIC NEOPLASMS;WNT5B;Gene;PA443756;Disease
DEFERASIROX;CYP1A1;Gene;PA164760843;Chemical
HEART VALVE REPLACEMENT;CYP1A1;Gene;PA166123431;Disease
BREAST NEOPLASMS;CYP1A1;Gene;PA443560;Disease
EPILEPSY;CYP1A1;Gene;PA444065;Disease
BETA-THALASSEMIA AND RELATED DISEASES;CYP1A1;Gene;PA446432;Disease
PSYCHOTIC DISORDER;CYP1A1;Gene;PA447215;Disease
AMODIAQUINE;CYP1A1;Gene;PA448404;Chemical
CAPECITABINE;CYP1A1;Gene;PA448771;Chemical
CARBAMAZEPINE;CYP1A1;Gene;PA448785;Chemical
DACARBAZINE;CYP1A1;Gene;PA449197;Chemical
DOCETAXEL;CYP1A1;Gene;PA449383;Chemical
GRANISETRON;CYP1A1;Gene;PA449809;Chemical
OLANZAPINE;CYP1A1;Gene;PA450688;Chemical
PHENOBARBITAL;CYP1A1;Gene;PA450911;Chemical
PHENYTOIN;CYP1A1;Gene;PA450947;Chemical
VALPROIC ACID;CYP1A1;Gene;PA451846;Chemical
WARFARIN;CYP1A1;Gene;PA451906;Chemical
F2R;GNA15;Gene;PA27946;Gene
F2RL3;GNA15;Gene;PA27949;Gene
P2RY1;GNA15;Gene;PA32868;Gene
PLCB1;GNA15;Gene;PA33384;Gene
PLCG2;GNA15;Gene;PA33393;Gene
TBXA2R;GNA15;Gene;PA348;Gene
CYP3A5;Kidney Failure;Disease;PA131;Gene
RS776746;Kidney Failure;Disease;PA166157267;Variant
DIABETES MELLITUS, TYPE 2;rs6467136;Variant;PA443890;Disease
ROSIGLITAZONE;rs6467136;Variant;PA451283;Chemical
RS1801131;l-methylfolate;Chemical;PA166153643;Variant
RS1801133;l-methylfolate;Chemical;PA166153644;Variant
MTHFR;l-methylfolate;Chemical;PA245;Gene
O-DESMETHYLTRAMADOL;ICA1;Gene;PA166131379;Chemical
TRAMADOL;ICA1;Gene;PA451735;Chemical
BREAST NEOPLASMS;TUBB1;Gene;PA443560;Disease
ANASTROZOLE;TUBB1;Gene;PA448432;Chemical
EXEMESTANE;TUBB1;Gene;PA449563;Chemical
ETHINYL ESTRADIOL / NORELGESTROMIN;F2;Gene;PA165290929;Chemical
CYP2C9*2;F2;Gene;PA165816543;Haplotype
CYP2C9*3;F2;Gene;PA165816544;Haplotype
RS6025;F2;Gene;PA166153554;Variant
RS1801131;F2;Gene;PA166153643;Variant
RS1801133;F2;Gene;PA166153644;Variant
RS1799963;F2;Gene;PA166154336;Variant
AVATROMBOPAG;F2;Gene;PA166179849;Chemical
LUSUTROMBOPAG;F2;Gene;PA166182748;Chemical
F2R;F2;Gene;PA27946;Gene
F2RL3;F2;Gene;PA27949;Gene
VENOUS THROMBOSIS;F2;Gene;PA446969;Disease
STROKE;F2;Gene;PA447054;Disease
TAMOXIFEN;F2;Gene;PA451581;Chemical
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;F2;Gene;PA452637;Chemical
WNK4;SLC12A3;Gene;PA134875400;Gene
THIAZIDES, PLAIN;SLC12A3;Gene;PA164713347;Chemical
NEDD4L;SLC12A3;Gene;PA31534;Gene
WNK3;SLC12A3;Gene;PA33784;Gene
STK39;SLC12A3;Gene;PA38243;Gene
ESSENTIAL HYPERTENSION;SLC12A3;Gene;PA447288;Disease
BUMETANIDE;SLC12A3;Gene;PA448682;Chemical
FUROSEMIDE;SLC12A3;Gene;PA449719;Chemical
TORASEMIDE;SLC12A3;Gene;PA451733;Chemical
COLORECTAL NEOPLASMS;rs3743527;Variant;PA446108;Disease
IRINOTECAN;rs3743527;Variant;PA450085;Chemical
RS1799807;Apnea;Disease;PA166156327;Variant
RS1803274;Apnea;Disease;PA166156332;Variant
RS28933389;Apnea;Disease;PA166156467;Variant
RS28933390;Apnea;Disease;PA166156468;Variant
RS764841347;Apnea;Disease;PA166236401;Variant
RS568724445;Apnea;Disease;PA166236402;Variant
RS1560022535;Apnea;Disease;PA166236481;Variant
RS745364489;Apnea;Disease;PA166236541;Variant
RS531738678;Apnea;Disease;PA166236761;Variant
RS201820739;Apnea;Disease;PA166236822;Variant
RS774072493;Apnea;Disease;PA166249641;Variant
BCHE;Apnea;Disease;PA25294;Gene
MAJOR DEPRESSIVE DISORDER;rs153560;Variant;PA447321;Disease
CITALOPRAM;rs153560;Variant;PA449015;Chemical
FLUOXETINE;rs153560;Variant;PA449673;Chemical
PAROXETINE;rs153560;Variant;PA450801;Chemical
SERTRALINE;rs153560;Variant;PA451333;Chemical
ALZHEIMER DISEASE;rs4291;Variant;PA443319;Disease
ASTHMA;rs4291;Variant;PA443450;Disease
HYPERTENSION;rs4291;Variant;PA444552;Disease
AMLODIPINE;rs4291;Variant;PA448388;Chemical
ASPIRIN;rs4291;Variant;PA448497;Chemical
CAPTOPRIL;rs4291;Variant;PA448780;Chemical
CHLORTHALIDONE;rs4291;Variant;PA448970;Chemical
LISINOPRIL;rs4291;Variant;PA450242;Chemical
NEOPLASMS;DAPK1;Gene;PA445062;Disease
GEMCITABINE;DAPK1;Gene;PA449748;Chemical
CFTR;rs113993958;Variant;PA109;Gene
IVACAFTOR;rs113993958;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs113993958;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs113993958;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs113993958;Variant;PA443829;Disease
ESCITALOPRAM;GRK5;Gene;PA10074;Chemical
NEBIVOLOL;GRK5;Gene;PA151958426;Chemical
ANTIHYPERTENSIVES;GRK5;Gene;PA164712445;Chemical
BETA BLOCKING AGENTS;GRK5;Gene;PA164712535;Chemical
LABETALOL;GRK5;Gene;PA164743150;Chemical
CORONARY ARTERY DISEASE;GRK5;Gene;PA443796;Disease
HEART DISEASES;GRK5;Gene;PA444368;Disease
HEART FAILURE;GRK5;Gene;PA444370;Disease
DEPRESSIVE DISORDER;GRK5;Gene;PA447207;Disease
ACEBUTOLOL;GRK5;Gene;PA448011;Chemical
ATENOLOL;GRK5;Gene;PA448499;Chemical
BETAXOLOL;GRK5;Gene;PA448611;Chemical
BISOPROLOL;GRK5;Gene;PA448641;Chemical
CARVEDILOL;GRK5;Gene;PA448817;Chemical
CITALOPRAM;GRK5;Gene;PA449015;Chemical
ESMOLOL;GRK5;Gene;PA449500;Chemical
METOPROLOL;GRK5;Gene;PA450480;Chemical
NADOLOL;GRK5;Gene;PA450573;Chemical
PINDOLOL;GRK5;Gene;PA450966;Chemical
PROPRANOLOL;GRK5;Gene;PA451145;Chemical
SOTALOL;GRK5;Gene;PA451457;Chemical
SCHIZOPHRENIA;rs4483927;Variant;PA447216;Disease
RISPERIDONE;rs4483927;Variant;PA451257;Chemical
PIK3CA;MIR10A;Gene;PA33308;Gene
DEPRESSION;SLC39A14;Gene;PA447278;Disease
NORTRIPTYLINE;SLC39A14;Gene;PA450657;Chemical
PANCREATIC NEOPLASMS;CDC5L;Gene;PA445218;Disease
GEMCITABINE;CDC5L;Gene;PA449748;Chemical
ANEMIA;rs3732359;Variant;PA443340;Disease
NASOPHARYNGEAL NEOPLASMS;rs3732359;Variant;PA445046;Disease
DOCETAXEL;rs3732359;Variant;PA449383;Chemical
CORONARY ARTERY DISEASE;KCNIP1;Gene;PA443796;Disease
HYPERTENSION;KCNIP1;Gene;PA444552;Disease
VERAPAMIL;KCNIP1;Gene;PA451868;Chemical
METOPROLOL;rs3892097;Variant;PA450480;Chemical
COMT;Antiinflammatory agents, non-steroids;Chemical;PA117;Gene
CYP2C9;Antiinflammatory agents, non-steroids;Chemical;PA126;Gene
DBH;Antiinflammatory agents, non-steroids;Chemical;PA136;Gene
CDKN2B-AS1;Antiinflammatory agents, non-steroids;Chemical;PA164717802;Gene
CYP2C9*3;Antiinflammatory agents, non-steroids;Chemical;PA165816544;Haplotype
HLA-DRB1*11:01;Antiinflammatory agents, non-steroids;Chemical;PA165951763;Haplotype
RS699;Antiinflammatory agents, non-steroids;Chemical;PA166153539;Variant
RS943580;Antiinflammatory agents, non-steroids;Chemical;PA166153602;Variant
RS1800896;Antiinflammatory agents, non-steroids;Chemical;PA166153642;Variant
RS1057910;Antiinflammatory agents, non-steroids;Chemical;PA166153959;Variant
RS6265;Antiinflammatory agents, non-steroids;Chemical;PA166154259;Variant
RS6275;Antiinflammatory agents, non-steroids;Chemical;PA166154260;Variant
RS2965667;Antiinflammatory agents, non-steroids;Chemical;PA166154559;Variant
RS6305;Antiinflammatory agents, non-steroids;Chemical;PA166154672;Variant
RS16973225;Antiinflammatory agents, non-steroids;Chemical;PA166154939;Variant
RS231775;Antiinflammatory agents, non-steroids;Chemical;PA166155589;Variant
RS4680;Antiinflammatory agents, non-steroids;Chemical;PA166156024;Variant
RS1799971;Antiinflammatory agents, non-steroids;Chemical;PA166156991;Variant
RS1611115;Antiinflammatory agents, non-steroids;Chemical;PA166157734;Variant
RS10306135;Antiinflammatory agents, non-steroids;Chemical;PA166157804;Variant
RS10757274;Antiinflammatory agents, non-steroids;Chemical;PA166157810;Variant
HTR2A;Antiinflammatory agents, non-steroids;Chemical;PA193;Gene
PTGS1;Antiinflammatory agents, non-steroids;Chemical;PA24346;Gene
CTLA4;Antiinflammatory agents, non-steroids;Chemical;PA27006;Gene
DRD2;Antiinflammatory agents, non-steroids;Chemical;PA27478;Gene
PTGS2;Antiinflammatory agents, non-steroids;Chemical;PA293;Gene
IL10;Antiinflammatory agents, non-steroids;Chemical;PA29778;Gene
BDNF;Antiinflammatory agents, non-steroids;Chemical;PA31891;Gene
OPRM1;Antiinflammatory agents, non-steroids;Chemical;PA31945;Gene
HLA-DRB1;Antiinflammatory agents, non-steroids;Chemical;PA35072;Gene
AGT;Antiinflammatory agents, non-steroids;Chemical;PA42;Gene
OMEPRAZOLE;rs1431015009;Variant;PA450704;Chemical
OTOTOXICITY;rs4788863;Variant;PA162263534;Disease
NEOPLASMS;rs4788863;Variant;PA445062;Disease
TESTICULAR NEOPLASMS;rs4788863;Variant;PA445828;Disease
CISPLATIN;rs4788863;Variant;PA449014;Chemical
PSORIASIS;rs28362491;Variant;PA445451;Disease
ETANERCEPT;rs28362491;Variant;PA449515;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CHURC1;Gene;PA447197;Disease
METHYLPHENIDATE;CHURC1;Gene;PA450464;Chemical
ACE INHIBITORS, PLAIN;KCNIP4;Gene;PA164712308;Chemical
BIPOLAR DISORDER;rs66486766;Variant;PA447199;Disease
LITHIUM;rs66486766;Variant;PA450243;Chemical
ABCC2;Mesothelioma;Disease;PA116;Gene
KLC3;Mesothelioma;Disease;PA142671588;Gene
POLR1G;Mesothelioma;Disease;PA142672156;Gene
DHFR;Mesothelioma;Disease;PA143;Gene
ERCC1;Mesothelioma;Disease;PA155;Gene
RS1801133;Mesothelioma;Disease;PA166153644;Variant
RS2072671;Mesothelioma;Disease;PA166153667;Variant
RS2273697;Mesothelioma;Disease;PA166154007;Variant
RS1042927;Mesothelioma;Disease;PA166154311;Variant
RS11030918;Mesothelioma;Disease;PA166154447;Variant
RS12806698;Mesothelioma;Disease;PA166154468;Variant
RS61734430;Mesothelioma;Disease;PA166154476;Variant
RS2236225;Mesothelioma;Disease;PA166154789;Variant
RS13181;Mesothelioma;Disease;PA166155343;Variant
RS3212986;Mesothelioma;Disease;PA166155407;Variant
RS914232;Mesothelioma;Disease;PA166155984;Variant
RS1051298;Mesothelioma;Disease;PA166155988;Variant
RS3788189;Mesothelioma;Disease;PA166156005;Variant
RS1650697;Mesothelioma;Disease;PA166156770;Variant
RS11280056;Mesothelioma;Disease;PA166180936;Variant
RS1049305;Mesothelioma;Disease;PA166186213;Variant
MTHFR;Mesothelioma;Disease;PA245;Gene
AQP1;Mesothelioma;Disease;PA24918;Gene
ERCC2;Mesothelioma;Disease;PA27848;Gene
FOLR3;Mesothelioma;Disease;PA28211;Gene
RRM1;Mesothelioma;Disease;PA298;Gene
MTHFD1;Mesothelioma;Disease;PA31236;Gene
SLC19A1;Mesothelioma;Disease;PA327;Gene
PPP1R13L;Mesothelioma;Disease;PA34195;Gene
TYMS;Mesothelioma;Disease;PA359;Gene
CDA;Mesothelioma;Disease;PA98;Gene
NEOPLASMS;rs11598702;Variant;PA445062;Disease
HIV INFECTIOUS DISEASE;rs11598702;Variant;PA447230;Disease
DIDANOSINE;rs11598702;Variant;PA449301;Chemical
GEMCITABINE;rs11598702;Variant;PA449748;Chemical
ADVERSE EVENTS;SERINC5;Gene;PA166151827;Disease
MEPERIDINE;SERINC5;Gene;PA450369;Chemical
DULOXETINE;rs17786412;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs17786412;Variant;PA447321;Disease
EMAPALUMAB;UNC13D;Gene;PA166182763;Chemical
CYP2C8;Calcineurin inhibitors;Chemical;PA125;Gene
CYP2C8*3;Calcineurin inhibitors;Chemical;PA165958685;Haplotype
CYP2C8*1;Calcineurin inhibitors;Chemical;PA166242948;Haplotype
MYOPATHIES, STRUCTURAL, CONGENITAL;ACTA1;Gene;PA447109;Disease
SULFAMETHOXAZOLE / TRIMETHOPRIM;HLA-C*07:27;Haplotype;PA10715;Chemical
EPIDERMAL NECROLYSIS, TOXIC;HLA-C*07:27;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-C*07:27;Haplotype;PA445738;Disease
SLFN11;topoisomerase I inhibitors;Chemical;PA144596358;Gene
RS712829;topoisomerase I inhibitors;Chemical;PA166157262;Variant
EGFR;topoisomerase I inhibitors;Chemical;PA7360;Gene
DAUNORUBICIN;rs17134592;Variant;PA449212;Chemical
NALTREXONE;rs17134592;Variant;PA450588;Chemical
OPIOID-RELATED DISORDERS;rs529520;Variant;PA445043;Disease
BUPRENORPHINE;rs529520;Variant;PA448685;Chemical
NAT2*4;solithromycin;Chemical;PA165949098;Haplotype
NAT2*5;solithromycin;Chemical;PA165981634;Haplotype
NAT2*6;solithromycin;Chemical;PA165981635;Haplotype
NAT2*7;solithromycin;Chemical;PA165981636;Haplotype
NAT2*14;solithromycin;Chemical;PA165981640;Haplotype
NAT2;solithromycin;Chemical;PA18;Gene
ADVERSE EVENTS;rs2838956;Variant;PA166151827;Disease
RHEUMATOID ARTHRITIS;rs2838956;Variant;PA443434;Disease
METHOTREXATE;rs2838956;Variant;PA450428;Chemical
SUNITINIB;rs307826;Variant;PA162372840;Chemical
RENAL CELL CARCINOMA;rs307826;Variant;PA443624;Disease
DESFLURANE;rs121918592;Variant;PA164749136;Chemical
RYR1;rs121918592;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs121918592;Variant;PA444863;Disease
CAFFEINE;rs121918592;Variant;PA448710;Chemical
ENFLURANE;rs121918592;Variant;PA449461;Chemical
HALOTHANE;rs121918592;Variant;PA449845;Chemical
ISOFLURANE;rs121918592;Variant;PA450106;Chemical
METHOXYFLURANE;rs121918592;Variant;PA450434;Chemical
SEVOFLURANE;rs121918592;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs121918592;Variant;PA451522;Chemical
CACNA1S;rs121918592;Variant;PA85;Gene
HMG COA REDUCTASE INHIBITORS;rs3857532;Variant;PA133950441;Chemical
RHABDOMYOLYSIS;rs3857532;Variant;PA445549;Disease
PLCB1;GNG5;Gene;PA33384;Gene
PLCB2;GNG5;Gene;PA33385;Gene
PLCB3;GNG5;Gene;PA33386;Gene
PLCB4;GNG5;Gene;PA33387;Gene
HYPERTENSION;rs2330951;Variant;PA444552;Disease
SORAFENIB;rs2330951;Variant;PA7000;Chemical
MALIGNANT HYPERTHERMIA;STAC3;Gene;PA444863;Disease
DESFLURANE;rs118192161;Variant;PA164749136;Chemical
RYR1;rs118192161;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs118192161;Variant;PA444863;Disease
CAFFEINE;rs118192161;Variant;PA448710;Chemical
ENFLURANE;rs118192161;Variant;PA449461;Chemical
HALOTHANE;rs118192161;Variant;PA449845;Chemical
ISOFLURANE;rs118192161;Variant;PA450106;Chemical
METHOXYFLURANE;rs118192161;Variant;PA450434;Chemical
SEVOFLURANE;rs118192161;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs118192161;Variant;PA451522;Chemical
CACNA1S;rs118192161;Variant;PA85;Gene
PLATINUM COMPOUNDS;MDM2;Gene;PA164713176;Chemical
NUTLIN-3;MDM2;Gene;PA165290931;Chemical
TP53;MDM2;Gene;PA36679;Gene
NON-SMALL CELL LUNG CARCINOMA;MDM2;Gene;PA443622;Disease
NEOPLASMS;MDM2;Gene;PA445062;Disease
PHENPROCOUMON;rs10871454;Variant;PA450921;Chemical
WARFARIN;rs10871454;Variant;PA451906;Chemical
CDKAL1;Dipeptidyl peptidase 4 (DPP-4) inhibitors;Chemical;PA134871999;Gene
RS7754840;Dipeptidyl peptidase 4 (DPP-4) inhibitors;Chemical;PA166157125;Variant
RS7756992;Dipeptidyl peptidase 4 (DPP-4) inhibitors;Chemical;PA166157126;Variant
TCF7L2;Dipeptidyl peptidase 4 (DPP-4) inhibitors;Chemical;PA36394;Gene
MORPHINE;rs3766246;Variant;PA450550;Chemical
RS1045642;highly active antiretroviral therapy (haart);Chemical;PA166157284;Variant
RS671531;highly active antiretroviral therapy (haart);Chemical;PA166180109;Variant
ABCB1;highly active antiretroviral therapy (haart);Chemical;PA267;Gene
OPRM1;highly active antiretroviral therapy (haart);Chemical;PA31945;Gene
GNAI1;ADCY1;Gene;PA172;Gene
GNAI3;ADCY1;Gene;PA173;Gene
GNAS;ADCY1;Gene;PA175;Gene
GNAI2;ADCY1;Gene;PA24347;Gene
BIPOLAR DISORDER;ADCY1;Gene;PA447199;Disease
LITHIUM;ADCY1;Gene;PA450243;Chemical
CETUXIMAB;rs144854329;Variant;PA10040;Chemical
BREAST NEOPLASMS;rs144854329;Variant;PA443560;Disease
COLORECTAL NEOPLASMS;rs144854329;Variant;PA446108;Disease
DOCETAXEL;rs144854329;Variant;PA449383;Chemical
BREAST NEOPLASMS;rs6500843;Variant;PA443560;Disease
ANTINEOPLASTIC AGENTS;rs6500843;Variant;PA452621;Chemical
CYP2D6;Vision Disorders;Disease;PA128;Gene
HMG COA REDUCTASE INHIBITORS;rs2900478;Variant;PA133950441;Chemical
METHYLENE BLUE;BLVRB;Gene;PA450457;Chemical
WNK4;SCNN1B;Gene;PA134875400;Gene
FARGLITAZAR;SCNN1B;Gene;PA165815771;Chemical
NEDD4L;SCNN1B;Gene;PA31534;Gene
WNK1;SCNN1B;Gene;PA33782;Gene
DIABETES MELLITUS, TYPE 2;SCNN1B;Gene;PA443890;Disease
AMILORIDE;SCNN1B;Gene;PA448368;Chemical
GLYBURIDE;SCNN1B;Gene;PA449782;Chemical
TRIAMTERENE;SCNN1B;Gene;PA451752;Chemical
ATENOLOL;apple juice;Chemical;PA448499;Chemical
IMATINIB;GSTT1 non-null;Haplotype;PA10804;Chemical
OTOTOXICITY;GSTT1 non-null;Haplotype;PA162263534;Disease
DRUGS FOR TREATMENT OF TUBERCULOSIS;GSTT1 non-null;Haplotype;PA164712708;Chemical
ETHAMBUTOL;GSTT1 non-null;Haplotype;PA164784021;Chemical
HEMATOPOIETIC STEM CELL TRANSPLANTATION;GSTT1 non-null;Haplotype;PA166123007;Disease
PROGRESSION-FREE SURVIVAL;GSTT1 non-null;Haplotype;PA166123026;Disease
EXACERBATION OF ASTHMA;GSTT1 non-null;Haplotype;PA166179129;Disease
ASTHMA;GSTT1 non-null;Haplotype;PA443450;Disease
DEAFNESS;GSTT1 non-null;Haplotype;PA443840;Disease
GRAFT VS HOST DISEASE;GSTT1 non-null;Haplotype;PA444320;Disease
NEOPLASMS;GSTT1 non-null;Haplotype;PA445062;Disease
NEUTROPENIA;GSTT1 non-null;Haplotype;PA445113;Disease
OSTEOSARCOMA;GSTT1 non-null;Haplotype;PA445601;Disease
TUBERCULOSIS;GSTT1 non-null;Haplotype;PA445941;Disease
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;GSTT1 non-null;Haplotype;PA446171;Disease
CISPLATIN;GSTT1 non-null;Haplotype;PA449014;Chemical
CLOZAPINE;GSTT1 non-null;Haplotype;PA449061;Chemical
CYCLOPHOSPHAMIDE;GSTT1 non-null;Haplotype;PA449165;Chemical
DOXORUBICIN;GSTT1 non-null;Haplotype;PA449412;Chemical
ISONIAZID;GSTT1 non-null;Haplotype;PA450112;Chemical
METHOTREXATE;GSTT1 non-null;Haplotype;PA450428;Chemical
PYRAZINAMIDE;GSTT1 non-null;Haplotype;PA451182;Chemical
RIFAMPIN;GSTT1 non-null;Haplotype;PA451250;Chemical
STREPTOMYCIN;GSTT1 non-null;Haplotype;PA451512;Chemical
SMOKING CESSATION;HINT1;Gene;PA166123046;Disease
TOBACCO USE DISORDER;HINT1;Gene;PA445876;Disease
NICOTINE;HINT1;Gene;PA450626;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;rs10946737;Variant;PA164712708;Chemical
TUBERCULOSIS;rs10946737;Variant;PA445941;Disease
RIFAMPIN;rs10946737;Variant;PA451250;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs451774;Variant;PA443622;Disease
CARBOPLATIN;rs451774;Variant;PA448803;Chemical
CISPLATIN;rs451774;Variant;PA449014;Chemical
GEMCITABINE;rs451774;Variant;PA449748;Chemical
ABCC2;methotrexate;Chemical;PA116;Gene
CYP2B6;methotrexate;Chemical;PA123;Gene
SLCO1B1;methotrexate;Chemical;PA134865839;Gene
ENOSF1;methotrexate;Chemical;PA134897613;Gene
ARID5B;methotrexate;Chemical;PA134943193;Gene
C18ORF56;methotrexate;Chemical;PA134956204;Gene
DROSHA;methotrexate;Chemical;PA142671060;Gene
DHFR;methotrexate;Chemical;PA143;Gene
FASTKD3;methotrexate;Chemical;PA145148868;Gene
NALCN;methotrexate;Chemical;PA162396840;Gene
SLC46A1;methotrexate;Chemical;PA162403775;Gene
SPECC1L;methotrexate;Chemical;PA164718673;Gene
ADORA2A-AS1;methotrexate;Chemical;PA165378332;Gene
LINC00251;methotrexate;Chemical;PA165585763;Gene
SLCO1B1*37;methotrexate;Chemical;PA165819251;Haplotype
SLCO1B1*5;methotrexate;Chemical;PA165819255;Haplotype
SLCO1B1*14;methotrexate;Chemical;PA165819264;Haplotype
SLCO1B1*15;methotrexate;Chemical;PA165819265;Haplotype
TPMT*1;methotrexate;Chemical;PA165819268;Haplotype
TPMT*2;methotrexate;Chemical;PA165819269;Haplotype
TPMT*3A;methotrexate;Chemical;PA165819270;Haplotype
TPMT*3B;methotrexate;Chemical;PA165819271;Haplotype
TPMT*3C;methotrexate;Chemical;PA165819272;Haplotype
TPMT*12;methotrexate;Chemical;PA165819282;Haplotype
SLCO1B1*23;methotrexate;Chemical;PA165947864;Haplotype
SLCO1B1*31;methotrexate;Chemical;PA165947872;Haplotype
HLA-C*06:02;methotrexate;Chemical;PA165957286;Haplotype
SLCO1B1*1;methotrexate;Chemical;PA165981641;Haplotype
SLCO1B1*20;methotrexate;Chemical;PA165988676;Haplotype
GSTT1 NULL;methotrexate;Chemical;PA166048678;Haplotype
GSTT1 NON-NULL;methotrexate;Chemical;PA166048679;Haplotype
RS1476413;methotrexate;Chemical;PA166153631;Variant
RS1801131;methotrexate;Chemical;PA166153643;Variant
RS1801133;methotrexate;Chemical;PA166153644;Variant
RS1805087;methotrexate;Chemical;PA166153654;Variant
RS1891059;methotrexate;Chemical;PA166153658;Variant
RS3768142;methotrexate;Chemical;PA166153752;Variant
RS4846051;methotrexate;Chemical;PA166153777;Variant
RS17021408;methotrexate;Chemical;PA166153867;Variant
RS17421511;methotrexate;Chemical;PA166153875;Variant
RS17602729;methotrexate;Chemical;PA166153876;Variant
RS80223967;methotrexate;Chemical;PA166153915;Variant
RS717620;methotrexate;Chemical;PA166153953;Variant
RS1901633;methotrexate;Chemical;PA166153982;Variant
RS2273697;methotrexate;Chemical;PA166154007;Variant
RS3740065;methotrexate;Chemical;PA166154027;Variant
RS3824662;methotrexate;Chemical;PA166154043;Variant
RS4948496;methotrexate;Chemical;PA166154069;Variant
RS10821936;methotrexate;Chemical;PA166154117;Variant
RS10994982;methotrexate;Chemical;PA166154120;Variant
RS17222723;methotrexate;Chemical;PA166154163;Variant
RS1695;methotrexate;Chemical;PA166154249;Variant
RS9344;methotrexate;Chemical;PA166154264;Variant
RS11231809;methotrexate;Chemical;PA166154454;Variant
RS61886492;methotrexate;Chemical;PA166154477;Variant
RS2306283;methotrexate;Chemical;PA166154547;Variant
RS3763980;methotrexate;Chemical;PA166154563;Variant
RS4149056;methotrexate;Chemical;PA166154579;Variant
RS4149081;methotrexate;Chemical;PA166154581;Variant
RS11045821;methotrexate;Chemical;PA166154629;Variant
RS11045872;methotrexate;Chemical;PA166154632;Variant
RS11045879;methotrexate;Chemical;PA166154633;Variant
RS7317112;methotrexate;Chemical;PA166154718;Variant
RS7992226;methotrexate;Chemical;PA166154723;Variant
RS9516519;methotrexate;Chemical;PA166154734;Variant
RS2236225;methotrexate;Chemical;PA166154789;Variant
RS4982133;methotrexate;Chemical;PA166154803;Variant
RS7142143;methotrexate;Chemical;PA166154808;Variant
RS1703794;methotrexate;Chemical;PA166154866;Variant
RS35592;methotrexate;Chemical;PA166154982;Variant
RS246240;methotrexate;Chemical;PA166154991;Variant
RS2238476;methotrexate;Chemical;PA166155034;Variant
RS3784864;methotrexate;Chemical;PA166155054;Variant
RS4888024;methotrexate;Chemical;PA166155071;Variant
RS28364006;methotrexate;Chemical;PA166155126;Variant
RS1979277;methotrexate;Chemical;PA166155196;Variant
RS4148416;methotrexate;Chemical;PA166155219;Variant
RS9895420;methotrexate;Chemical;PA166155237;Variant
RS2853539;methotrexate;Chemical;PA166155290;Variant
RS6506569;methotrexate;Chemical;PA166155301;Variant
RS45445694;methotrexate;Chemical;PA166155331;Variant
RS13181;methotrexate;Chemical;PA166155343;Variant
RS4803418;methotrexate;Chemical;PA166155419;Variant
RS4803419;methotrexate;Chemical;PA166155420;Variant
RS2372536;methotrexate;Chemical;PA166155684;Variant
RS4673993;methotrexate;Chemical;PA166155733;Variant
RS10197559;methotrexate;Chemical;PA166155781;Variant
RS16853826;methotrexate;Chemical;PA166155836;Variant
RS1059150;methotrexate;Chemical;PA166155914;Variant
RS1127354;methotrexate;Chemical;PA166155915;Variant
RS2650972;methotrexate;Chemical;PA166155929;Variant
RS6064463;methotrexate;Chemical;PA166155953;Variant
RS7270101;methotrexate;Chemical;PA166155964;Variant
RS79085477;methotrexate;Chemical;PA166155968;Variant
RS117532069;methotrexate;Chemical;PA166155970;Variant
RS1051266;methotrexate;Chemical;PA166155986;Variant
RS1051296;methotrexate;Chemical;PA166155987;Variant
RS2838956;methotrexate;Chemical;PA166156004;Variant
RS9977268;methotrexate;Chemical;PA166156012;Variant
RS2236624;methotrexate;Chemical;PA166156088;Variant
RS2267076;methotrexate;Chemical;PA166156091;Variant
RS2298383;methotrexate;Chemical;PA166156099;Variant
RS2413739;methotrexate;Chemical;PA166156100;Variant
RS3761422;methotrexate;Chemical;PA166156103;Variant
RS5760410;methotrexate;Chemical;PA166156121;Variant
RS7624766;methotrexate;Chemical;PA166156420;Variant
RS2231135;methotrexate;Chemical;PA166156542;Variant
RS2231142;methotrexate;Chemical;PA166156544;Variant
RS12505410;methotrexate;Chemical;PA166156659;Variant
RS13120400;methotrexate;Chemical;PA166156664;Variant
RS17731538;methotrexate;Chemical;PA166156674;Variant
RS7387;methotrexate;Chemical;PA166156710;Variant
RS351855;methotrexate;Chemical;PA166156731;Variant
RS408626;methotrexate;Chemical;PA166156732;Variant
RS442767;methotrexate;Chemical;PA166156733;Variant
RS639174;methotrexate;Chemical;PA166156737;Variant
RS1053129;methotrexate;Chemical;PA166156751;Variant
RS1105525;methotrexate;Chemical;PA166156754;Variant
RS1643650;methotrexate;Chemical;PA166156768;Variant
RS1650723;methotrexate;Chemical;PA166156771;Variant
RS1801394;methotrexate;Chemical;PA166156776;Variant
RS70991108;methotrexate;Chemical;PA166156893;Variant
RS4880;methotrexate;Chemical;PA166156900;Variant
RS1264457;methotrexate;Chemical;PA166156981;Variant
RS6920220;methotrexate;Chemical;PA166157114;Variant
RS9345389;methotrexate;Chemical;PA166157144;Variant
RS371194629;methotrexate;Chemical;PA166157235;Variant
RS1045642;methotrexate;Chemical;PA166157284;Variant
RS1128503;methotrexate;Chemical;PA166157288;Variant
RS1799983;methotrexate;Chemical;PA166157303;Variant
RS2070744;methotrexate;Chemical;PA166157325;Variant
RS2229109;methotrexate;Chemical;PA166157334;Variant
RS4148737;methotrexate;Chemical;PA166157385;Variant
RS719235;methotrexate;Chemical;PA166157548;Variant
RS1800909;methotrexate;Chemical;PA166157567;Variant
RS3758149;methotrexate;Chemical;PA166157593;Variant
RS11545077;methotrexate;Chemical;PA166157633;Variant
RS11545078;methotrexate;Chemical;PA166157634;Variant
RS141059755;methotrexate;Chemical;PA166157691;Variant
RS1544105;methotrexate;Chemical;PA166157731;Variant
RS4986790;methotrexate;Chemical;PA166157780;Variant
RS3045983;methotrexate;Chemical;PA166160497;Variant
RS2302489;methotrexate;Chemical;PA166160715;Variant
RS7301582;methotrexate;Chemical;PA166160807;Variant
RS3761548;methotrexate;Chemical;PA166162248;Variant
RS2838958;methotrexate;Chemical;PA166170682;Variant
RS10841753;methotrexate;Chemical;PA166170701;Variant
RS11280056;methotrexate;Chemical;PA166180936;Variant
RS168201;methotrexate;Chemical;PA166181038;Variant
RS13137622;methotrexate;Chemical;PA166181277;Variant
RS4148324;methotrexate;Chemical;PA166181287;Variant
RS17004921;methotrexate;Chemical;PA166238642;Variant
RS4149009;methotrexate;Chemical;PA166252581;Variant
RS11545076;methotrexate;Chemical;PA166253503;Variant
RS2292596;methotrexate;Chemical;PA166271161;Variant
RS12283870;methotrexate;Chemical;PA166285621;Variant
FPGS;methotrexate;Chemical;PA167;Gene
GSTT1;methotrexate;Chemical;PA183;Gene
FOXP3;methotrexate;Chemical;PA201094;Gene
ABCC1;methotrexate;Chemical;PA244;Gene
MTHFR;methotrexate;Chemical;PA245;Gene
ADA;methotrexate;Chemical;PA24503;Gene
ADORA2A;methotrexate;Chemical;PA24584;Gene
AHRR;methotrexate;Chemical;PA24639;Gene
AMPD1;methotrexate;Chemical;PA24776;Gene
ATIC;methotrexate;Chemical;PA25094;Gene
ATP5F1E;methotrexate;Chemical;PA25128;Gene
BMP7;methotrexate;Chemical;PA25384;Gene
NOS3;methotrexate;Chemical;PA254;Gene
DOK5;methotrexate;Chemical;PA25724;Gene
CLCN6;methotrexate;Chemical;PA26551;Gene
ABCB1;methotrexate;Chemical;PA267;Gene
CPT1A;methotrexate;Chemical;PA26847;Gene
ERCC2;methotrexate;Chemical;PA27848;Gene
FGFR4;methotrexate;Chemical;PA28130;Gene
FOLH1;methotrexate;Chemical;PA28205;Gene
FOLR1;methotrexate;Chemical;PA28207;Gene
GATA3;methotrexate;Chemical;PA28586;Gene
GSTP1;methotrexate;Chemical;PA29028;Gene
IGHMBP2;methotrexate;Chemical;PA29731;Gene
ITPA;methotrexate;Chemical;PA29973;Gene
KIR2DS4;methotrexate;Chemical;PA30121;Gene
KLRC1;methotrexate;Chemical;PA30163;Gene
KLRD1;methotrexate;Chemical;PA30167;Gene
MSH3;methotrexate;Chemical;PA31134;Gene
MTHFD1;methotrexate;Chemical;PA31236;Gene
MTR;methotrexate;Chemical;PA31272;Gene
MTRR;methotrexate;Chemical;PA31277;Gene
SLC19A1;methotrexate;Chemical;PA327;Gene
SLCO1A2;methotrexate;Chemical;PA328;Gene
PACSIN2;methotrexate;Chemical;PA32897;Gene
PTPRM;methotrexate;Chemical;PA34020;Gene
PYGL;methotrexate;Chemical;PA34068;Gene
HLA-C;methotrexate;Chemical;PA35057;Gene
HLA-E;methotrexate;Chemical;PA35081;Gene
HLA-G;methotrexate;Chemical;PA35083;Gene
TPMT;methotrexate;Chemical;PA356;Gene
SHMT1;methotrexate;Chemical;PA35753;Gene
SLC16A7;methotrexate;Chemical;PA35819;Gene
SLCO1B3;methotrexate;Chemical;PA35844;Gene
TYMS;methotrexate;Chemical;PA359;Gene
SOD2;methotrexate;Chemical;PA36017;Gene
TLR4;methotrexate;Chemical;PA36552;Gene
TNFAIP3;methotrexate;Chemical;PA36593;Gene
UGT1A10;methotrexate;Chemical;PA37174;Gene
UGT1A3;methotrexate;Chemical;PA37178;Gene
UGT1A4;methotrexate;Chemical;PA37179;Gene
UGT1A5;methotrexate;Chemical;PA37180;Gene
UGT1A6;methotrexate;Chemical;PA37181;Gene
UGT1A7;methotrexate;Chemical;PA37182;Gene
UGT1A8;methotrexate;Chemical;PA37183;Gene
ABCC3;methotrexate;Chemical;PA376;Gene
SLC22A9;methotrexate;Chemical;PA38102;Gene
SLC22A11;methotrexate;Chemical;PA38295;Gene
SLC22A6;methotrexate;Chemical;PA388;Gene
SLC22A8;methotrexate;Chemical;PA389;Gene
ABCG2;methotrexate;Chemical;PA390;Gene
ABCC4;methotrexate;Chemical;PA397;Gene
UGT1A9;methotrexate;Chemical;PA419;Gene
UGT1A1;methotrexate;Chemical;PA420;Gene
GGH;methotrexate;Chemical;PA432;Gene
IBUPROFEN;methotrexate;Chemical;PA449957;Chemical
CCND1;methotrexate;Chemical;PA75;Gene
ALCOHOL ABUSE;SLC39A8;Gene;PA443309;Disease
ETHANOL;SLC39A8;Gene;PA448073;Chemical
BISPHOSPHONATES;rs11264359;Variant;PA164712563;Chemical
CORONARY DISEASE;rs11264359;Variant;PA443797;Disease
OSTEOPOROSIS;rs11264359;Variant;PA445190;Disease
ATORVASTATIN;rs11264359;Variant;PA448500;Chemical
ABCB1;Tariquidar;Chemical;PA267;Gene
ACE INHIBITORS, PLAIN;rs4267385;Variant;PA164712308;Chemical
COUGH;rs4267385;Variant;PA443803;Disease
O-DESMETHYLTRAMADOL;rs79983226;Variant;PA166131379;Chemical
TRAMADOL;rs79983226;Variant;PA451735;Chemical
ADRA2A;brimonidine;Chemical;PA35;Gene
ADRA2B;brimonidine;Chemical;PA36;Gene
ADRA2C;brimonidine;Chemical;PA37;Gene
RS2011425;desmethylclozapine glucuronide;Chemical;PA166155662;Variant
UGT1A4;desmethylclozapine glucuronide;Chemical;PA37179;Gene
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs362272;Variant;PA447197;Disease
METHYLPHENIDATE;rs362272;Variant;PA450464;Chemical
LIVER TRANSPLANTATION;SUMO4;Gene;PA447247;Disease
TACROLIMUS;SUMO4;Gene;PA451578;Chemical
SLFN11;Sarcoma, Ewing's;Disease;PA144596358;Gene
PEGINTERFERON ALFA-2B;rs2228570;Variant;PA164784024;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;rs2228570;Variant;PA446863;Disease
RIBAVIRIN;rs2228570;Variant;PA451241;Chemical
GEFITINIB;CYP2D6*95;Haplotype;PA131301952;Chemical
ATOMOXETINE;CYP2D6*95;Haplotype;PA134688071;Chemical
TOLTERODINE;CYP2D6*95;Haplotype;PA164746757;Chemical
BUFURALOL;CYP2D6*95;Haplotype;PA166110256;Chemical
DAPOXETINE;CYP2D6*95;Haplotype;PA166151992;Chemical
AMITRIPTYLINE;CYP2D6*95;Haplotype;PA448385;Chemical
DEXTROMETHORPHAN;CYP2D6*95;Haplotype;PA449273;Chemical
METHADONE;CYP2D6*95;Haplotype;PA450401;Chemical
OLANZAPINE;CYP2D6*95;Haplotype;PA450688;Chemical
RISPERIDONE;CYP2D6*95;Haplotype;PA451257;Chemical
TAMOXIFEN;CYP2D6*95;Haplotype;PA451581;Chemical
VENLAFAXINE;CYP2D6*95;Haplotype;PA451866;Chemical
MAJOR DEPRESSIVE DISORDER;CTNNA3;Gene;PA447321;Disease
ANTIDEPRESSANTS;CTNNA3;Gene;PA452229;Chemical
CYP2C9;glyburide;Chemical;PA126;Gene
NOS1AP;glyburide;Chemical;PA142671259;Gene
CYP2C9*1;glyburide;Chemical;PA165816542;Haplotype
CYP2C9*2;glyburide;Chemical;PA165816543;Haplotype
CYP2C9*3;glyburide;Chemical;PA165816544;Haplotype
G6PD B (REFERENCE);glyburide;Chemical;PA165947826;Haplotype
G6PD A- 202A_376G;glyburide;Chemical;PA165947827;Haplotype
RS10494366;glyburide;Chemical;PA166153802;Variant
RS889299;glyburide;Chemical;PA166154998;Variant
RS5030868;glyburide;Chemical;PA166157880;Variant
G6PD;glyburide;Chemical;PA28469;Gene
SCNN1B;glyburide;Chemical;PA306;Gene
NR1I2;glyburide;Chemical;PA378;Gene
FLUOROURACIL;rs45445694;Variant;PA128406956;Chemical
BEVACIZUMAB;rs45445694;Variant;PA130232992;Chemical
OXALIPLATIN;rs45445694;Variant;PA131285527;Chemical
RALTITREXED;rs45445694;Variant;PA131625240;Chemical
PLATINUM;rs45445694;Variant;PA150595617;Chemical
HYDROXYCHLOROQUINE;rs45445694;Variant;PA164777036;Chemical
MYELOSUPPRESSION;rs45445694;Variant;PA165817398;Disease
HAND-FOOT SYNDROME;rs45445694;Variant;PA166114377;Disease
PROGRESSION-FREE SURVIVAL;rs45445694;Variant;PA166123026;Disease
OVERALL SURVIVAL;rs45445694;Variant;PA166123207;Disease
DISCONTINUATION;rs45445694;Variant;PA166123507;Disease
ADVERSE EVENTS;rs45445694;Variant;PA166151827;Disease
GASTROESOPHAGEAL CANCER;rs45445694;Variant;PA166153403;Disease
FOLFOX;rs45445694;Variant;PA166182862;Chemical
FOLFIRI;rs45445694;Variant;PA166182863;Chemical
XELOX;rs45445694;Variant;PA166182864;Chemical
TYMS;rs45445694;Variant;PA359;Gene
ADENOCARCINOMA;rs45445694;Variant;PA443265;Disease
ANEMIA;rs45445694;Variant;PA443340;Disease
ARTHRITIS, RHEUMATOID;rs45445694;Variant;PA443434;Disease
ASTHENIA;rs45445694;Variant;PA443448;Disease
BREAST NEOPLASMS;rs45445694;Variant;PA443560;Disease
DIARRHEA;rs45445694;Variant;PA443899;Disease
DRUG TOXICITY;rs45445694;Variant;PA443937;Disease
ESOPHAGEAL NEOPLASMS;rs45445694;Variant;PA444101;Disease
GASTROINTESTINAL NEOPLASMS;rs45445694;Variant;PA444257;Disease
LYMPHOMA, NON-HODGKIN;rs45445694;Variant;PA444845;Disease
CARDIOMYOPATHIES;rs45445694;Variant;PA445018;Disease
NEOPLASMS;rs45445694;Variant;PA445062;Disease
NEUTROPENIA;rs45445694;Variant;PA445113;Disease
PANCREATIC NEOPLASMS;rs45445694;Variant;PA445218;Disease
PSORIASIS;rs45445694;Variant;PA445451;Disease
RECTAL NEOPLASMS;rs45445694;Variant;PA445503;Disease
STOMACH NEOPLASMS;rs45445694;Variant;PA445742;Disease
STOMATITIS;rs45445694;Variant;PA445746;Disease
VOMITING;rs45445694;Variant;PA446051;Disease
COLORECTAL NEOPLASMS;rs45445694;Variant;PA446108;Disease
INFLAMMATORY BOWEL DISEASES;rs45445694;Variant;PA446116;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;rs45445694;Variant;PA446155;Disease
HYPERAMMONEMIA;rs45445694;Variant;PA447146;Disease
ASPARAGINASE;rs45445694;Variant;PA448492;Chemical
AZATHIOPRINE;rs45445694;Variant;PA448515;Chemical
CAPECITABINE;rs45445694;Variant;PA448771;Chemical
CISPLATIN;rs45445694;Variant;PA449014;Chemical
CYTARABINE;rs45445694;Variant;PA449177;Chemical
DAUNORUBICIN;rs45445694;Variant;PA449212;Chemical
DOCETAXEL;rs45445694;Variant;PA449383;Chemical
EPIRUBICIN;rs45445694;Variant;PA449476;Chemical
ETOPOSIDE;rs45445694;Variant;PA449552;Chemical
FOLIC ACID;rs45445694;Variant;PA449692;Chemical
IRINOTECAN;rs45445694;Variant;PA450085;Chemical
LEUCOVORIN;rs45445694;Variant;PA450198;Chemical
MERCAPTOPURINE;rs45445694;Variant;PA450379;Chemical
METHOTREXATE;rs45445694;Variant;PA450428;Chemical
PREDNISONE;rs45445694;Variant;PA451100;Chemical
SULFASALAZINE;rs45445694;Variant;PA451547;Chemical
TRASTUZUMAB;rs45445694;Variant;PA451743;Chemical
VINCRISTINE;rs45445694;Variant;PA451879;Chemical
TEGAFUR;rs45445694;Variant;PA452620;Chemical
AGXT;lumasiran;Chemical;PA24633;Gene
PROSTATIC NEOPLASMS;rs730720;Variant;PA445425;Disease
DOCETAXEL;rs730720;Variant;PA449383;Chemical
THALIDOMIDE;rs730720;Variant;PA451644;Chemical
TICAGRELOR;CYP3A4*14;Haplotype;PA165374673;Chemical
CABOZANTINIB;CYP3A4*14;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*14;Haplotype;PA165958362;Chemical
REGORAFENIB;CYP3A4*14;Haplotype;PA166114943;Chemical
VANDETANIB;CYP3A4*14;Haplotype;PA166118341;Chemical
IBRUTINIB;CYP3A4*14;Haplotype;PA166121346;Chemical
ALECTINIB;CYP3A4*14;Haplotype;PA166160050;Chemical
BREXPIPRAZOLE;CYP3A4*14;Haplotype;PA166160053;Chemical
ACALABRUTINIB;CYP3A4*14;Haplotype;PA166198581;Chemical
BLONANSERIN;CYP3A4*14;Haplotype;PA166319041;Chemical
LIDOCAINE;CYP3A4*14;Haplotype;PA450226;Chemical
METHADONE;CYP3A4*14;Haplotype;PA450401;Chemical
OXYCODONE;CYP3A4*14;Haplotype;PA450741;Chemical
SILDENAFIL;CYP3A4*14;Haplotype;PA451346;Chemical
TESTOSTERONE;CYP3A4*14;Haplotype;PA451627;Chemical
RADIOTHERAPY;rs264631;Variant;PA166122986;Chemical
PROSTATIC NEOPLASMS;rs264631;Variant;PA445425;Disease
MAJOR DEPRESSIVE DISORDER;rs2500535;Variant;PA447321;Disease
NORTRIPTYLINE;rs2500535;Variant;PA450657;Chemical
TEZACAFTOR;rs397508609;Variant;PA166175754;Chemical
ELEXACAFTOR;rs397508609;Variant;PA166185161;Chemical
IMATINIB;rs41282401;Variant;PA10804;Chemical
DASATINIB;rs41282401;Variant;PA162372878;Chemical
NILOTINIB;rs41282401;Variant;PA165958345;Chemical
ACE;salvianolic acid b;Chemical;PA139;Gene
RS1799752;salvianolic acid b;Chemical;PA166155187;Variant
RS1799983;salvianolic acid b;Chemical;PA166157303;Variant
NOS3;salvianolic acid b;Chemical;PA254;Gene
CYCSP5;Acquired Immunodeficiency Syndrome;Disease;PA142672032;Gene
GSTM1 NULL;Acquired Immunodeficiency Syndrome;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Acquired Immunodeficiency Syndrome;Disease;PA166048676;Haplotype
UGT1A1*1;Acquired Immunodeficiency Syndrome;Disease;PA166115841;Haplotype
UGT1A1*28;Acquired Immunodeficiency Syndrome;Disease;PA166115842;Haplotype
RS2472677;Acquired Immunodeficiency Syndrome;Disease;PA166156358;Variant
RS3099844;Acquired Immunodeficiency Syndrome;Disease;PA166157066;Variant
GSTM1;Acquired Immunodeficiency Syndrome;Disease;PA182;Gene
G6PD;Acquired Immunodeficiency Syndrome;Disease;PA28469;Gene
VDR;Acquired Immunodeficiency Syndrome;Disease;PA37301;Gene
NR1I2;Acquired Immunodeficiency Syndrome;Disease;PA378;Gene
UGT1A1;Acquired Immunodeficiency Syndrome;Disease;PA420;Gene
PSORIASIS;rs2238476;Variant;PA445451;Disease
METHOTREXATE;rs2238476;Variant;PA450428;Chemical
CYP4F2*1;Vitamin K1;Chemical;PA165860685;Haplotype
CYP4F2*3;Vitamin K1;Chemical;PA165860687;Haplotype
CYP4F2;Vitamin K1;Chemical;PA27121;Gene
ARMS2;Macular Degeneration;Disease;PA162376896;Gene
RS1061170;Macular Degeneration;Disease;PA166153617;Variant
RS2070296;Macular Degeneration;Disease;PA166153991;Variant
RS10490924;Macular Degeneration;Disease;PA166154107;Variant
RS11200638;Macular Degeneration;Disease;PA166154135;Variant
RS4073;Macular Degeneration;Disease;PA166156478;Variant
RS699947;Macular Degeneration;Disease;PA166156938;Variant
RS833069;Macular Degeneration;Disease;PA166156960;Variant
RS3025000;Macular Degeneration;Disease;PA166157058;Variant
CNGB3;Macular Degeneration;Disease;PA26663;Gene
CFH;Macular Degeneration;Disease;PA29261;Gene
CXCL8;Macular Degeneration;Disease;PA29841;Gene
NRP1;Macular Degeneration;Disease;PA31783;Gene
HTRA1;Macular Degeneration;Disease;PA33829;Gene
VEGFA;Macular Degeneration;Disease;PA37302;Gene
PACLITAXEL;rs1058930;Variant;PA450761;Chemical
HYPERCHOLESTEROLEMIA;rs5888;Variant;PA444516;Disease
ATORVASTATIN;rs5888;Variant;PA448500;Chemical
BREAST NEOPLASMS;rs35864111;Variant;PA443560;Disease
DOCETAXEL;rs35864111;Variant;PA449383;Chemical
CFTR;rs78769542;Variant;PA109;Gene
IVACAFTOR;rs78769542;Variant;PA165950341;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs78769542;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs78769542;Variant;PA443829;Disease
FLUOROURACIL;rs1335150891;Variant;PA128406956;Chemical
WARFARIN;rs28371685;Variant;PA451906;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;ESYT2;Gene;PA447197;Disease
METHYLPHENIDATE;ESYT2;Gene;PA450464;Chemical
CYP2C19;antineoplastic agents;Chemical;PA124;Gene
CYP2D6;antineoplastic agents;Chemical;PA128;Gene
DPYD;antineoplastic agents;Chemical;PA145;Gene
CYP2D6*1;antineoplastic agents;Chemical;PA165816576;Haplotype
CYP2D6*2;antineoplastic agents;Chemical;PA165816577;Haplotype
CYP2D6*3;antineoplastic agents;Chemical;PA165816578;Haplotype
CYP2D6*4;antineoplastic agents;Chemical;PA165816579;Haplotype
CYP2D6*6;antineoplastic agents;Chemical;PA165816581;Haplotype
CYP2D6*10;antineoplastic agents;Chemical;PA165816582;Haplotype
CYP2D6*41;antineoplastic agents;Chemical;PA165816584;Haplotype
CYP2D6*5;antineoplastic agents;Chemical;PA165948092;Haplotype
CYP2D6*9;antineoplastic agents;Chemical;PA165948317;Haplotype
CYP2D6*20;antineoplastic agents;Chemical;PA165971571;Haplotype
CYP2C19*1;antineoplastic agents;Chemical;PA165980634;Haplotype
CYP2C19*2;antineoplastic agents;Chemical;PA165980635;Haplotype
UGT2B15*1;antineoplastic agents;Chemical;PA165984975;Haplotype
UGT2B15*2;antineoplastic agents;Chemical;PA165984976;Haplotype
CYP2D6*1XN;antineoplastic agents;Chemical;PA165988479;Haplotype
CYP2D6*35;antineoplastic agents;Chemical;PA165988487;Haplotype
CYP2D6*36;antineoplastic agents;Chemical;PA165988488;Haplotype
RBFOX1;antineoplastic agents;Chemical;PA166048951;Gene
RS1760217;antineoplastic agents;Chemical;PA166153636;Variant
RS17091162;antineoplastic agents;Chemical;PA166154830;Variant
RS6500843;antineoplastic agents;Chemical;PA166155075;Variant
RS1042522;antineoplastic agents;Chemical;PA166155173;Variant
RS1045642;antineoplastic agents;Chemical;PA166157284;Variant
RS11280056;antineoplastic agents;Chemical;PA166180936;Variant
ABCB1;antineoplastic agents;Chemical;PA267;Gene
SERPINA3;antineoplastic agents;Chemical;PA35020;Gene
TYMS;antineoplastic agents;Chemical;PA359;Gene
TP53;antineoplastic agents;Chemical;PA36679;Gene
UGT2B15;antineoplastic agents;Chemical;PA37188;Gene
FLUOROURACIL;rs10040363;Variant;PA128406956;Chemical
PLATINUM COMPOUNDS;rs10040363;Variant;PA164713176;Chemical
RADIOTHERAPY;rs10040363;Variant;PA166122986;Chemical
STOMACH NEOPLASMS;rs10040363;Variant;PA445742;Disease
FLUOROURACIL;rs6025211;Variant;PA128406956;Chemical
LIVER CANCER;rs6025211;Variant;PA444804;Disease
CISPLATIN;rs6025211;Variant;PA449014;Chemical
MITOXANTRONE;rs6025211;Variant;PA450526;Chemical
CYP2C8;epirubicin;Chemical;PA125;Gene
SLCO1B1;epirubicin;Chemical;PA134865839;Gene
PERP;epirubicin;Chemical;PA134944221;Gene
GNL3;epirubicin;Chemical;PA134952132;Gene
C18ORF56;epirubicin;Chemical;PA134956204;Gene
TP53AIP1;epirubicin;Chemical;PA164726680;Gene
CYP2C8*4;epirubicin;Chemical;PA165958686;Haplotype
RS1563828;epirubicin;Chemical;PA166153633;Variant
RS1695;epirubicin;Chemical;PA166154249;Variant
RS4149056;epirubicin;Chemical;PA166154579;Variant
RS1800566;epirubicin;Chemical;PA166155017;Variant
RS45445694;epirubicin;Chemical;PA166155331;Variant
RS1056836;epirubicin;Chemical;PA166155621;Variant
RS662;epirubicin;Chemical;PA166157238;Variant
RS1799983;epirubicin;Chemical;PA166157303;Variant
RS12050587;epirubicin;Chemical;PA166164874;Variant
RS11636687;epirubicin;Chemical;PA166164877;Variant
RS144991623;epirubicin;Chemical;PA166178395;Variant
RS9389568;epirubicin;Chemical;PA166178396;Variant
RS8110364;epirubicin;Chemical;PA166178397;Variant
RS56022120;epirubicin;Chemical;PA166178398;Variant
RS150688309;epirubicin;Chemical;PA166178399;Variant
RS58695150;epirubicin;Chemical;PA166178400;Variant
RS299293;epirubicin;Chemical;PA166178401;Variant
RS138602176;epirubicin;Chemical;PA166178402;Variant
RS148235907;epirubicin;Chemical;PA166178403;Variant
RS117951771;epirubicin;Chemical;PA166178404;Variant
RS299314;epirubicin;Chemical;PA166178405;Variant
RS299313;epirubicin;Chemical;PA166178406;Variant
RS115457081;epirubicin;Chemical;PA166178407;Variant
RS117341846;epirubicin;Chemical;PA166178408;Variant
RS4968187;epirubicin;Chemical;PA166178409;Variant
RS142244113;epirubicin;Chemical;PA166178410;Variant
RS79430272;epirubicin;Chemical;PA166178411;Variant
RS118129530;epirubicin;Chemical;PA166178412;Variant
RS77769901;epirubicin;Chemical;PA166178413;Variant
RS145623321;epirubicin;Chemical;PA166178414;Variant
RS148013902;epirubicin;Chemical;PA166178415;Variant
RS55633228;epirubicin;Chemical;PA166178416;Variant
RS41412545;epirubicin;Chemical;PA166178421;Variant
RS3805945;epirubicin;Chemical;PA166178422;Variant
RS117101815;epirubicin;Chemical;PA166178423;Variant
RS9402944;epirubicin;Chemical;PA166178424;Variant
RS181501757;epirubicin;Chemical;PA166178425;Variant
RS149212925;epirubicin;Chemical;PA166178426;Variant
RS112783657;epirubicin;Chemical;PA166178427;Variant
RS74743371;epirubicin;Chemical;PA166178428;Variant
RS117458836;epirubicin;Chemical;PA166178429;Variant
RS118088833;epirubicin;Chemical;PA166178430;Variant
RS112242273;epirubicin;Chemical;PA166178431;Variant
RS78428806;epirubicin;Chemical;PA166178432;Variant
RS141084494;epirubicin;Chemical;PA166178541;Variant
CYP2C8*1;epirubicin;Chemical;PA166242948;Haplotype
INSR;epirubicin;Chemical;PA202;Gene
IRS1;epirubicin;Chemical;PA203;Gene
NOS1;epirubicin;Chemical;PA252;Gene
NOS3;epirubicin;Chemical;PA254;Gene
CBR3;epirubicin;Chemical;PA26122;Gene
CCNK;epirubicin;Chemical;PA26161;Gene
CYP1B1;epirubicin;Chemical;PA27094;Gene
FOXO1;epirubicin;Chemical;PA28237;Gene
GSTP1;epirubicin;Chemical;PA29028;Gene
HMMR;epirubicin;Chemical;PA29340;Gene
MDM4;epirubicin;Chemical;PA30719;Gene
NQO1;epirubicin;Chemical;PA31744;Gene
PIGB;epirubicin;Chemical;PA33290;Gene
PIK3R2;epirubicin;Chemical;PA33313;Gene
PON1;epirubicin;Chemical;PA33529;Gene
PPP2R5D;epirubicin;Chemical;PA33676;Gene
RBX1;epirubicin;Chemical;PA34299;Gene
TOP2A;epirubicin;Chemical;PA354;Gene
TYMS;epirubicin;Chemical;PA359;Gene
TP53;epirubicin;Chemical;PA36679;Gene
OLAPARIB;BRCA1;Gene;PA164920420;Chemical
NIRAPARIB;BRCA1;Gene;PA166131610;Chemical
RUCAPARIB;BRCA1;Gene;PA166163418;Chemical
TALAZOPARIB;BRCA1;Gene;PA166182740;Chemical
SACITUZUMAB GOVITECAN;BRCA1;Gene;PA166225061;Chemical
BREAST NEOPLASMS;BRCA1;Gene;PA443560;Disease
UTERINE CERVICAL NEOPLASMS;BRCA1;Gene;PA443685;Disease
COLONIC NEOPLASMS;BRCA1;Gene;PA443756;Disease
FALLOPIAN TUBE NEOPLASMS;BRCA1;Gene;PA444144;Disease
OVARIAN NEOPLASMS;BRCA1;Gene;PA445204;Disease
PANCREATIC NEOPLASMS;BRCA1;Gene;PA445218;Disease
PROSTATIC NEOPLASMS;BRCA1;Gene;PA445425;Disease
STOMACH NEOPLASMS;BRCA1;Gene;PA445742;Disease
UTERINE NEOPLASMS;BRCA1;Gene;PA446004;Disease
BREAST NEOPLASMS, MALE;BRCA1;Gene;PA446745;Disease
TAMOXIFEN;BRCA1;Gene;PA451581;Chemical
RS1556422499;dihydrostreptomycin;Chemical;PA166241841;Variant
MT-RNR1;dihydrostreptomycin;Chemical;PA31274;Gene
CYP2C19;nebivolol;Chemical;PA124;Gene
CYP2D6;nebivolol;Chemical;PA128;Gene
CYP2C19*6;nebivolol;Chemical;PA165816522;Haplotype
CYP2C19*18;nebivolol;Chemical;PA165816534;Haplotype
CYP2C19*1;nebivolol;Chemical;PA165980634;Haplotype
CYP2C19*30;nebivolol;Chemical;PA166123293;Haplotype
CYP2C19*31;nebivolol;Chemical;PA166123294;Haplotype
CYP2C19*32;nebivolol;Chemical;PA166123295;Haplotype
CYP2C19*33;nebivolol;Chemical;PA166123296;Haplotype
GRK5;nebivolol;Chemical;PA180;Gene
GRK4;nebivolol;Chemical;PA28941;Gene
ADRA2C;nebivolol;Chemical;PA37;Gene
ADRB1;nebivolol;Chemical;PA38;Gene
MALIGNANT HYPERTHERMIA;SCN4A;Gene;PA444863;Disease
MYOTONIA;SCN4A;Gene;PA445030;Disease
HYPOKALEMIC PERIODIC PARALYSIS;SCN4A;Gene;PA447050;Disease
MYOTONIC DISORDERS;SCN4A;Gene;PA447130;Disease
FLECAINIDE;SCN4A;Gene;PA449646;Chemical
MEXILETINE;SCN4A;Gene;PA450488;Chemical
MAP2K7;MAPK12;Gene;PA284;Gene
MAP2K1;MAPK12;Gene;PA30584;Gene
MAP2K2;MAPK12;Gene;PA30587;Gene
MAP2K3;MAPK12;Gene;PA30588;Gene
MAP2K4;MAPK12;Gene;PA30589;Gene
MAP2K5;MAPK12;Gene;PA30590;Gene
MAP2K6;MAPK12;Gene;PA30591;Gene
SORAFENIB;MAPK12;Gene;PA7000;Chemical
VORICONAZOLE;CYP3A4*22;Haplotype;PA10233;Chemical
IMATINIB;CYP3A4*22;Haplotype;PA10804;Chemical
CYP2C19;CYP3A4*22;Haplotype;PA124;Gene
CYP3A4;CYP3A4*22;Haplotype;PA130;Gene
CYP3A5;CYP3A4*22;Haplotype;PA131;Gene
ORGAN TRANSPLANTATION;CYP3A4*22;Haplotype;PA133888799;Disease
TRANSPLANTATION;CYP3A4*22;Haplotype;PA134850491;Disease
EVEROLIMUS;CYP3A4*22;Haplotype;PA164746311;Chemical
TICAGRELOR;CYP3A4*22;Haplotype;PA165374673;Chemical
KIDNEY TRANSPLANTATION;CYP3A4*22;Haplotype;PA165817016;Disease
FESOTERODINE;CYP3A4*22;Haplotype;PA165958376;Chemical
TRANSPLANT REJECTION;CYP3A4*22;Haplotype;PA166114454;Disease
LUNG TRANSPLANTATION;CYP3A4*22;Haplotype;PA166114457;Disease
ENDOXIFEN;CYP3A4*22;Haplotype;PA166124478;Chemical
N-DESMETHYLTAMOXIFEN;CYP3A4*22;Haplotype;PA166127651;Chemical
4-HYDROXYTAMOXIFEN;CYP3A4*22;Haplotype;PA166127652;Chemical
PLATELET AGGREGATION INHIBITION;CYP3A4*22;Haplotype;PA166128371;Disease
ADVERSE EVENTS;CYP3A4*22;Haplotype;PA166151827;Disease
LAPAROSCOPIC SLEEVE GASTRECTOMY;CYP3A4*22;Haplotype;PA166169562;Disease
FEBRILE NEUTROPENIA;CYP3A4*22;Haplotype;PA166170245;Disease
MAVACAMTEN;CYP3A4*22;Haplotype;PA166272922;Chemical
ALCOHOLISM;CYP3A4*22;Haplotype;PA443309;Disease
BREAST NEOPLASMS;CYP3A4*22;Haplotype;PA443560;Disease
DRUG TOXICITY;CYP3A4*22;Haplotype;PA443937;Disease
EXANTHEMA;CYP3A4*22;Haplotype;PA444109;Disease
HEART FAILURE;CYP3A4*22;Haplotype;PA444370;Disease
HYPERCHOLESTEROLEMIA;CYP3A4*22;Haplotype;PA444516;Disease
KIDNEY NEOPLASMS;CYP3A4*22;Haplotype;PA444685;Disease
LIVER CIRRHOSIS;CYP3A4*22;Haplotype;PA444797;Disease
NEOPLASMS;CYP3A4*22;Haplotype;PA445062;Disease
OVARIAN NEOPLASMS;CYP3A4*22;Haplotype;PA445204;Disease
NEUROENDOCRINE TUMORS;CYP3A4*22;Haplotype;PA446713;Disease
HOT FLASHES;CYP3A4*22;Haplotype;PA446852;Disease
ANXIETY DISORDERS;CYP3A4*22;Haplotype;PA447196;Disease
HIV INFECTIONS;CYP3A4*22;Haplotype;PA447230;Disease
LIVER TRANSPLANTATION;CYP3A4*22;Haplotype;PA447247;Disease
ALPRAZOLAM;CYP3A4*22;Haplotype;PA448333;Chemical
CYCLOSPORINE;CYP3A4*22;Haplotype;PA449167;Chemical
DOCETAXEL;CYP3A4*22;Haplotype;PA449383;Chemical
EXEMESTANE;CYP3A4*22;Haplotype;PA449563;Chemical
FENTANYL;CYP3A4*22;Haplotype;PA449599;Chemical
LOPINAVIR;CYP3A4*22;Haplotype;PA450264;Chemical
MIDAZOLAM;CYP3A4*22;Haplotype;PA450496;Chemical
OXYCODONE;CYP3A4*22;Haplotype;PA450741;Chemical
PACLITAXEL;CYP3A4*22;Haplotype;PA450761;Chemical
QUETIAPINE;CYP3A4*22;Haplotype;PA451201;Chemical
SILDENAFIL;CYP3A4*22;Haplotype;PA451346;Chemical
SIMVASTATIN;CYP3A4*22;Haplotype;PA451363;Chemical
SIROLIMUS;CYP3A4*22;Haplotype;PA451365;Chemical
TACROLIMUS;CYP3A4*22;Haplotype;PA451578;Chemical
TAMOXIFEN;CYP3A4*22;Haplotype;PA451581;Chemical
PLATINUM COMPOUNDS;rs3213239;Variant;PA164713176;Chemical
CARCINOMA, NON-SMALL-CELL LUNG;rs3213239;Variant;PA443622;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;PYROXD2;Gene;PA447197;Disease
METHYLPHENIDATE;PYROXD2;Gene;PA450464;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;rs4888024;Variant;PA446155;Disease
RESIDUAL NEOPLASM;rs4888024;Variant;PA446714;Disease
METHOTREXATE;rs4888024;Variant;PA450428;Chemical
FLUOROURACIL;PON1;Gene;PA128406956;Chemical
OXALIPLATIN;PON1;Gene;PA131285527;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;PON1;Gene;PA164713366;Chemical
ANGINA PECTORIS;PON1;Gene;PA443362;Disease
RHEUMATOID ARTHRITIS;PON1;Gene;PA443434;Disease
CARDIOVASCULAR DISEASES;PON1;Gene;PA443635;Disease
CORONARY ARTERY DISEASE;PON1;Gene;PA443796;Disease
HYPERCHOLESTEROLEMIA;PON1;Gene;PA444516;Disease
MYOCARDIAL INFARCTION;PON1;Gene;PA445019;Disease
NEOPLASMS;PON1;Gene;PA445062;Disease
STOMACH NEOPLASMS;PON1;Gene;PA445742;Disease
THROMBOTIC DISEASE;PON1;Gene;PA445850;Disease
MYOCARDIAL ISCHEMIA;PON1;Gene;PA446459;Disease
ATORVASTATIN;PON1;Gene;PA448500;Chemical
CLOPIDOGREL;PON1;Gene;PA449053;Chemical
EPIRUBICIN;PON1;Gene;PA449476;Chemical
SIMVASTATIN;PON1;Gene;PA451363;Chemical
DPYD;Metabolism, Inborn Errors;Disease;PA145;Gene
DPYD;rs55674432;Variant;PA145;Gene
CAPECITABINE;rs55674432;Variant;PA448771;Chemical
GEFITINIB;NR1H2;Gene;PA131301952;Chemical
NON-SMALL CELL LUNG CARCINOMA;NR1H2;Gene;PA443622;Disease
DIARRHEA;NR1H2;Gene;PA443899;Disease
SCHIZOPHRENIA;EIF2AK4;Gene;PA447216;Disease
HALOPERIDOL;EIF2AK4;Gene;PA449841;Chemical
OLANZAPINE;EIF2AK4;Gene;PA450688;Chemical
QUETIAPINE;EIF2AK4;Gene;PA451201;Chemical
RISPERIDONE;EIF2AK4;Gene;PA451257;Chemical
ZIPRASIDONE;EIF2AK4;Gene;PA451974;Chemical
BISPHOSPHONATES;rs7740004;Variant;PA164712563;Chemical
OSTEONECROSIS;rs7740004;Variant;PA445187;Disease
PROSTATIC NEOPLASMS;rs2227291;Variant;PA445425;Disease
DOCETAXEL;rs2227291;Variant;PA449383;Chemical
THALIDOMIDE;rs2227291;Variant;PA451644;Chemical
SCHIZOPHRENIA;rs6688363;Variant;PA447216;Disease
OLANZAPINE;rs6688363;Variant;PA450688;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs80034486;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs80034486;Variant;PA443829;Disease
DESIPRAMINE;CYP2D6 poor metabolizers;Variant;PA449233;Chemical
PIMOZIDE;CYP2D6 poor metabolizers;Variant;PA450965;Chemical
DACARBAZINE;CYP1A1*2C;Haplotype;PA449197;Chemical
PAIN, POSTOPERATIVE;rs775887911;Variant;PA445210;Disease
DEXMEDETOMIDINE;rs775887911;Variant;PA449256;Chemical
HIV INFECTIOUS DISEASE;rs11568695;Variant;PA447230;Disease
ZIDOVUDINE;rs11568695;Variant;PA451954;Chemical
RASBURICASE;CYB5R4;Gene;PA10176;Chemical
ISOSORBIDE DINITRATE;CYB5R4;Gene;PA450125;Chemical
ISOSORBIDE MONONITRATE;CYB5R4;Gene;PA450126;Chemical
METOCLOPRAMIDE;CYB5R4;Gene;PA450475;Chemical
PRIMAQUINE;CYB5R4;Gene;PA451103;Chemical
HMG COA REDUCTASE INHIBITORS;ADAMTS1;Gene;PA133950441;Chemical
CORONARY DISEASE;ADAMTS1;Gene;PA443797;Disease
MYOCARDIAL INFARCTION;ADAMTS1;Gene;PA445019;Disease
PRAVASTATIN;ADAMTS1;Gene;PA451089;Chemical
HEROIN DEPENDENCE;rs62638690;Variant;PA444460;Disease
COCAINE DEPENDENCE;rs62638690;Variant;PA446878;Disease
COCAINE;rs62638690;Variant;PA449072;Chemical
HEROIN;rs62638690;Variant;PA452619;Chemical
HEMATOPOIETIC STEM CELL TRANSPLANTATION;NUDT15*5;Haplotype;PA166123007;Disease
PRIMARY GRAFT FAILURE;NUDT15*5;Haplotype;PA166248341;Disease
LEUKOPENIA;NUDT15*5;Haplotype;PA444773;Disease
NEUTROPENIA;NUDT15*5;Haplotype;PA445113;Disease
INFLAMMATORY BOWEL DISEASES;NUDT15*5;Haplotype;PA446116;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;NUDT15*5;Haplotype;PA446155;Disease
ACYCLOVIR;NUDT15*5;Haplotype;PA448045;Chemical
AZATHIOPRINE;NUDT15*5;Haplotype;PA448515;Chemical
MERCAPTOPURINE;NUDT15*5;Haplotype;PA450379;Chemical
CASR;PLCZ1;Gene;PA26097;Gene
PRKCA;PLCZ1;Gene;PA33759;Gene
PRKCB;PLCZ1;Gene;PA33761;Gene
PRKCG;PLCZ1;Gene;PA33766;Gene
PRKCH;PLCZ1;Gene;PA33767;Gene
PRKCI;PLCZ1;Gene;PA33768;Gene
PRKD1;PLCZ1;Gene;PA33771;Gene
PRKCZ;PLCZ1;Gene;PA33775;Gene
ABCB1;R101933;Chemical;PA267;Gene
HYPERTENSION;rs4742610;Variant;PA444552;Disease
TRANDOLAPRIL;rs4742610;Variant;PA451737;Chemical
VERAPAMIL;rs4742610;Variant;PA451868;Chemical
CYP2E1;Liver Diseases, Alcoholic;Disease;PA129;Gene
CYP2E1*5B;Liver Diseases, Alcoholic;Disease;PA165948040;Haplotype
CYP2E1*1;Liver Diseases, Alcoholic;Disease;PA165981617;Haplotype
ADH1B;Liver Diseases, Alcoholic;Disease;PA24571;Gene
MAP3K1;SOS1;Gene;PA30592;Gene
RAF1;SOS1;Gene;PA34183;Gene
EGFR;SOS1;Gene;PA7360;Gene
CYP3A5;tretinoin;Chemical;PA131;Gene
PML;tretinoin;Chemical;PA33439;Gene
RARA;tretinoin;Chemical;PA34225;Gene
TEGAFUR;rs8192720;Variant;PA452620;Chemical
LYMPHOMA, NON-HODGKIN;CYP2B6*30;Haplotype;PA444845;Disease
BUPROPION;CYP2B6*30;Haplotype;PA448687;Chemical
CYCLOPHOSPHAMIDE;CYP2B6*30;Haplotype;PA449165;Chemical
LUNG NEOPLASMS;rs1130214;Variant;PA444818;Disease
CARBOPLATIN;rs1130214;Variant;PA448803;Chemical
CISPLATIN;rs1130214;Variant;PA449014;Chemical
VEGFA;aflibercept;Chemical;PA37302;Gene
VEGFB;aflibercept;Chemical;PA37303;Gene
VEGFC;aflibercept;Chemical;PA37304;Gene
HLA-DRB1*08:03;carbimazole;Chemical;PA165951678;Haplotype
HLA-B*38:02;carbimazole;Chemical;PA165955505;Haplotype
HLA-B;carbimazole;Chemical;PA35056;Gene
HLA-DRB1;carbimazole;Chemical;PA35072;Gene
SCHIZOPHRENIA;rs17382202;Variant;PA447216;Disease
QUETIAPINE;rs17382202;Variant;PA451201;Chemical
MENTAL DISORDERS;rs2440390;Variant;PA447208;Disease
OLANZAPINE;rs2440390;Variant;PA450688;Chemical
THIORIDAZINE;rs1080985;Variant;PA451666;Chemical
DEBRISOQUINE;rs1080985;Variant;PA452616;Chemical
PROSTATIC NEOPLASMS;rs4646487;Variant;PA445425;Disease
DOCETAXEL;rs4646487;Variant;PA449383;Chemical
THALIDOMIDE;rs4646487;Variant;PA451644;Chemical
MAJOR DEPRESSIVE DISORDER;PAPLN;Gene;PA447321;Disease
CITALOPRAM;PAPLN;Gene;PA449015;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs3094086;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs3094086;Variant;PA445846;Disease
CARBOPLATIN;rs3094086;Variant;PA448803;Chemical
GEMCITABINE;rs3094086;Variant;PA449748;Chemical
GIVOSIRAN;CPOX;Gene;PA166190681;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;RARG;Gene;PA130620651;Chemical
CARDIOTOXICITY;RARG;Gene;PA166128121;Disease
RS2229774;RARG;Gene;PA166154532;Variant
RS17863783;RARG;Gene;PA166155854;Variant
RS7853758;RARG;Gene;PA166157790;Variant
NEOPLASMS;RARG;Gene;PA445062;Disease
DAUNORUBICIN;RARG;Gene;PA449212;Chemical
DOXORUBICIN;RARG;Gene;PA449412;Chemical
ADALIMUMAB;rs9373839;Variant;PA10004;Chemical
INFLAMMATORY BOWEL DISEASES;rs9373839;Variant;PA446116;Disease
DICLOFENAC ACYL GLUCURONIDE;rs7439366;Variant;PA166163692;Chemical
S-EDDP;rs7439366;Variant;PA166177606;Chemical
(R)-METHADONE;rs7439366;Variant;PA166178312;Chemical
BUPRENORPHINE / NALOXONE;rs7439366;Variant;PA166182641;Chemical
EPILEPSY;rs7439366;Variant;PA444065;Disease
OPIOID-RELATED DISORDERS;rs7439366;Variant;PA445043;Disease
PAIN;rs7439366;Variant;PA445208;Disease
PAIN, POSTOPERATIVE;rs7439366;Variant;PA445210;Disease
HIV INFECTIOUS DISEASE;rs7439366;Variant;PA447230;Disease
CODEINE;rs7439366;Variant;PA449088;Chemical
EFAVIRENZ;rs7439366;Variant;PA449441;Chemical
FENTANYL;rs7439366;Variant;PA449599;Chemical
FLURBIPROFEN;rs7439366;Variant;PA449683;Chemical
METHADONE;rs7439366;Variant;PA450401;Chemical
MORPHINE;rs7439366;Variant;PA450550;Chemical
OXCARBAZEPINE;rs7439366;Variant;PA450732;Chemical
OXYCODONE;rs7439366;Variant;PA450741;Chemical
VALPROIC ACID;rs7439366;Variant;PA451846;Chemical
HEROIN DEPENDENCE;rs5746136;Variant;PA444460;Disease
HEROIN;rs5746136;Variant;PA452619;Chemical
COUMARIN;CYP2A6*12;Haplotype;PA134521193;Chemical
CESSATION;CYP2A6*12;Haplotype;PA166123046;Disease
3-HYDROXYCOTININE;CYP2A6*12;Haplotype;PA166131262;Chemical
BREAST NEOPLASMS;CYP2A6*12;Haplotype;PA443560;Disease
TOBACCO USE DISORDER;CYP2A6*12;Haplotype;PA445876;Disease
LETROZOLE;CYP2A6*12;Haplotype;PA450196;Chemical
NICOTINE;CYP2A6*12;Haplotype;PA450626;Chemical
TAXANES;rs9825762;Variant;PA150481189;Chemical
OVARIAN NEOPLASMS;rs9825762;Variant;PA445204;Disease
CARBOPLATIN;rs9825762;Variant;PA448803;Chemical
MUCOSITIS;rs4673;Variant;PA166122058;Disease
ANEMIA;rs4673;Variant;PA443340;Disease
HYPERCHOLESTEROLEMIA;rs4673;Variant;PA444516;Disease
NEOPLASMS;rs4673;Variant;PA445062;Disease
OSTEOSARCOMA;rs4673;Variant;PA445601;Disease
CISPLATIN;rs4673;Variant;PA449014;Chemical
DOXORUBICIN;rs4673;Variant;PA449412;Chemical
IDARUBICIN;rs4673;Variant;PA449961;Chemical
SIMVASTATIN;rs4673;Variant;PA451363;Chemical
ABCIXIMAB;FGG;Gene;PA448006;Chemical
EPTIFIBATIDE;FGG;Gene;PA449483;Chemical
TIROFIBAN;FGG;Gene;PA451698;Chemical
IMATINIB;rs305968;Variant;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;rs305968;Variant;PA151958383;Disease
DULOXETINE;rs7472;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs7472;Variant;PA447321;Disease
DPYD;rs186169810;Variant;PA145;Gene
CAPECITABINE;rs186169810;Variant;PA448771;Chemical
LAPATINIB;HLA-DQA1*02:01;Haplotype;PA152241907;Chemical
MEASLES VACCINES;HLA-DQA1*02:01;Haplotype;PA164712887;Chemical
PEGASPARGASE;HLA-DQA1*02:01;Haplotype;PA164760860;Chemical
FLUCLOXACILLIN;HLA-DQA1*02:01;Haplotype;PA164781042;Chemical
TOXIC LIVER DISEASE;HLA-DQA1*02:01;Haplotype;PA164925725;Disease
DRUG-INDUCED LIVER INJURY;HLA-DQA1*02:01;Haplotype;PA166119041;Disease
HLA-DQA1;HLA-DQA1*02:01;Haplotype;PA35066;Gene
HLA-DRB1;HLA-DQA1*02:01;Haplotype;PA35072;Gene
DRUG TOXICITY;HLA-DQA1*02:01;Haplotype;PA443937;Disease
HYPERSENSITIVITY;HLA-DQA1*02:01;Haplotype;PA444546;Disease
PANCREATITIS;HLA-DQA1*02:01;Haplotype;PA445220;Disease
INFLAMMATORY BOWEL DISEASES;HLA-DQA1*02:01;Haplotype;PA446116;Disease
AZATHIOPRINE;HLA-DQA1*02:01;Haplotype;PA448515;Chemical
MERCAPTOPURINE;HLA-DQA1*02:01;Haplotype;PA450379;Chemical
HEROIN DEPENDENCE;rs2236855;Variant;PA444460;Disease
HEROIN;rs2236855;Variant;PA452619;Chemical
O-DESMETHYLTRAMADOL;rs72732317;Variant;PA166131379;Chemical
TRAMADOL;rs72732317;Variant;PA451735;Chemical
WARFARIN;rs7856096;Variant;PA451906;Chemical
TOLBUTAMIDE;rs761895497;Variant;PA451718;Chemical
GPAM;PRKAB1;Gene;PA134983031;Gene
CRTC2;PRKAB1;Gene;PA142672073;Gene
HMGCR;PRKAB1;Gene;PA189;Gene
ACACA;PRKAB1;Gene;PA24421;Gene
ACACB;PRKAB1;Gene;PA24422;Gene
MLYCD;PRKAB1;Gene;PA30861;Gene
SREBF1;PRKAB1;Gene;PA335;Gene
SLC2A4;PRKAB1;Gene;PA35879;Gene
STK11;PRKAB1;Gene;PA36198;Gene
MLXIPL;PRKAB1;Gene;PA37353;Gene
SIRT1;PRKAB1;Gene;PA37935;Gene
METFORMIN;PRKAB1;Gene;PA450395;Chemical
ATM;PRKAB1;Gene;PA61;Gene
MYOPATHIES, STRUCTURAL, CONGENITAL;MTM1;Gene;PA447109;Disease
DROTRECOGIN ALFA;F5;Gene;PA131548935;Chemical
DROSPIRENONE / ETHINYL ESTRADIOL;F5;Gene;PA165290928;Chemical
ETHINYL ESTRADIOL / NORELGESTROMIN;F5;Gene;PA165290929;Chemical
CYP2C9*2;F5;Gene;PA165816543;Haplotype
CYP2C9*3;F5;Gene;PA165816544;Haplotype
RIVAROXABAN;F5;Gene;PA165958360;Chemical
ELTROMBOPAG;F5;Gene;PA165981594;Chemical
RS6025;F5;Gene;PA166153554;Variant
RS1801131;F5;Gene;PA166153643;Variant
RS1801133;F5;Gene;PA166153644;Variant
RS1799963;F5;Gene;PA166154336;Variant
AVATROMBOPAG;F5;Gene;PA166179849;Chemical
LUSUTROMBOPAG;F5;Gene;PA166182748;Chemical
RELUGOLIX / ESTRADIOL / NORETHINDRONE ACETATE;F5;Gene;PA166397682;Chemical
THROMBOTIC DISEASE;F5;Gene;PA445850;Disease
SEPSIS;F5;Gene;PA446771;Disease
VENOUS THROMBOEMBOLISM;F5;Gene;PA447298;Disease
ESTROGENS;F5;Gene;PA449509;Chemical
TAMOXIFEN;F5;Gene;PA451581;Chemical
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;F5;Gene;PA452637;Chemical
CARBAMAZEPINE;RALBP1;Gene;PA448785;Chemical
VINCRISTINE;RALBP1;Gene;PA451879;Chemical
COL3A1;CD36;Gene;PA26716;Gene
COL4A1;CD36;Gene;PA26717;Gene
COL4A2;CD36;Gene;PA26718;Gene
PLCB1;CD36;Gene;PA33384;Gene
PLCG2;CD36;Gene;PA33393;Gene
COL1A1;CD36;Gene;PA35041;Gene
COL1A2;CD36;Gene;PA35042;Gene
CYP2C19;amoxicillin;Chemical;PA124;Gene
HLA-DPB1*01:01;amoxicillin;Chemical;PA165951121;Haplotype
HLA-DRB1*07:01;amoxicillin;Chemical;PA165951644;Haplotype
HLA-DRB1*15:01;amoxicillin;Chemical;PA165952269;Haplotype
HLA-DRB5*01:01;amoxicillin;Chemical;PA165952460;Haplotype
HLA-A*01:01;amoxicillin;Chemical;PA165952609;Haplotype
HLA-A*30:02;amoxicillin;Chemical;PA165953969;Haplotype
HLA-B*18:01;amoxicillin;Chemical;PA165955030;Haplotype
HLA-C*06:02;amoxicillin;Chemical;PA165957286;Haplotype
HLA-DQB1*06:02;amoxicillin;Chemical;PA165958103;Haplotype
HLA-DQB1*03:03;amoxicillin;Chemical;PA165958180;Haplotype
CYP2C19*1;amoxicillin;Chemical;PA165980634;Haplotype
CYP2C19*2;amoxicillin;Chemical;PA165980635;Haplotype
CYP2C19*3;amoxicillin;Chemical;PA165980636;Haplotype
HLA-B*57:01;amoxicillin;Chemical;PA165987830;Haplotype
HLA-B*58:01;amoxicillin;Chemical;PA165987831;Haplotype
HLA-C*03:02;amoxicillin;Chemical;PA166123425;Haplotype
RS9274407;amoxicillin;Chemical;PA166157135;Variant
GSTT1;amoxicillin;Chemical;PA183;Gene
HLA-A;amoxicillin;Chemical;PA35055;Gene
HLA-B;amoxicillin;Chemical;PA35056;Gene
HLA-C;amoxicillin;Chemical;PA35057;Gene
HLA-DPB1;amoxicillin;Chemical;PA35064;Gene
HLA-DQB1;amoxicillin;Chemical;PA35068;Gene
HLA-DRB1;amoxicillin;Chemical;PA35072;Gene
HLA-DRB5;amoxicillin;Chemical;PA35076;Gene
NR1I2;amoxicillin;Chemical;PA378;Gene
CYP3A4;CYP3A4*17;Haplotype;PA130;Gene
TICAGRELOR;CYP3A4*17;Haplotype;PA165374673;Chemical
CABOZANTINIB;CYP3A4*17;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*17;Haplotype;PA165958362;Chemical
REGORAFENIB;CYP3A4*17;Haplotype;PA166114943;Chemical
VANDETANIB;CYP3A4*17;Haplotype;PA166118341;Chemical
IBRUTINIB;CYP3A4*17;Haplotype;PA166121346;Chemical
ALECTINIB;CYP3A4*17;Haplotype;PA166160050;Chemical
BREXPIPRAZOLE;CYP3A4*17;Haplotype;PA166160053;Chemical
MACITENTAN;CYP3A4*17;Haplotype;PA166261201;Chemical
BLONANSERIN;CYP3A4*17;Haplotype;PA166319041;Chemical
AMIODARONE;CYP3A4*17;Haplotype;PA448383;Chemical
METHADONE;CYP3A4*17;Haplotype;PA450401;Chemical
NIFEDIPINE;CYP3A4*17;Haplotype;PA450631;Chemical
OXYCODONE;CYP3A4*17;Haplotype;PA450741;Chemical
QUETIAPINE;CYP3A4*17;Haplotype;PA451201;Chemical
TESTOSTERONE;CYP3A4*17;Haplotype;PA451627;Chemical
ADH1B;Fetal Alcohol Syndrome;Disease;PA24571;Gene
COTININE;PSMA4;Gene;PA166114414;Chemical
TOBACCO USE DISORDER;PSMA4;Gene;PA445876;Disease
MEASLES VACCINES;HLA-DQA1*01:04;Haplotype;PA164712887;Chemical
CYP3A4;saquinavir;Chemical;PA130;Gene
ABCB1;saquinavir;Chemical;PA267;Gene
NR1I2;saquinavir;Chemical;PA378;Gene
PPP3CA;NFATC2;Gene;PA33678;Gene
PPP3CB;NFATC2;Gene;PA33679;Gene
PPP3CC;NFATC2;Gene;PA33680;Gene
PPP3R1;NFATC2;Gene;PA33681;Gene
PPP3R2;NFATC2;Gene;PA33682;Gene
ACUTE LYMPHOBLASTIC LEUKEMIA;NFATC2;Gene;PA446155;Disease
ASPARAGINASE;NFATC2;Gene;PA448492;Chemical
CYP2C9;glimepiride;Chemical;PA126;Gene
NOS1AP;glimepiride;Chemical;PA142671259;Gene
CYP2C9*1;glimepiride;Chemical;PA165816542;Haplotype
CYP2C9*2;glimepiride;Chemical;PA165816543;Haplotype
CYP2C9*3;glimepiride;Chemical;PA165816544;Haplotype
RS10494366;glimepiride;Chemical;PA166153802;Variant
G6PD;glimepiride;Chemical;PA28469;Gene
ABT-751;rs6755571;Variant;PA166104276;Chemical
NEOPLASMS;rs6755571;Variant;PA445062;Disease
CYP3A5;loratadine;Chemical;PA131;Gene
RS762551;Abortion, Spontaneous;Disease;PA166154850;Variant
CYP1A2 HIGH ACTIVITY;Abortion, Spontaneous;Disease;PA166157954;Variant
CYP1A2;Abortion, Spontaneous;Disease;PA27093;Gene
DPYD;rs72549304;Variant;PA145;Gene
CAPECITABINE;rs72549304;Variant;PA448771;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;HLA-DQA1*05;Haplotype;PA164713366;Chemical
INFLAMMATORY BOWEL DISEASES;HLA-DQA1*05;Haplotype;PA446116;Disease
CYP2C19;phenprocoumon;Chemical;PA124;Gene
CYP2C9;phenprocoumon;Chemical;PA126;Gene
VKORC1;phenprocoumon;Chemical;PA133787052;Gene
CYP2C9*1;phenprocoumon;Chemical;PA165816542;Haplotype
CYP2C9*2;phenprocoumon;Chemical;PA165816543;Haplotype
CYP2C9*3;phenprocoumon;Chemical;PA165816544;Haplotype
CYP2C19*2;phenprocoumon;Chemical;PA165980635;Haplotype
CYP2C19*3;phenprocoumon;Chemical;PA165980636;Haplotype
RS1051740;phenprocoumon;Chemical;PA166153612;Variant
RS4086116;phenprocoumon;Chemical;PA166154045;Variant
RS7294;phenprocoumon;Chemical;PA166154977;Variant
RS9923231;phenprocoumon;Chemical;PA166155091;Variant
RS9934438;phenprocoumon;Chemical;PA166155096;Variant
RS10871454;phenprocoumon;Chemical;PA166155102;Variant
RS2108622;phenprocoumon;Chemical;PA166155381;Variant
RS1799808;phenprocoumon;Chemical;PA166155641;Variant
RS4253728;phenprocoumon;Chemical;PA166156105;Variant
CYP4F2;phenprocoumon;Chemical;PA27121;Gene
EPHX1;phenprocoumon;Chemical;PA27829;Gene
PPARA;phenprocoumon;Chemical;PA280;Gene
PROC;phenprocoumon;Chemical;PA33799;Gene
STX4;phenprocoumon;Chemical;PA36236;Gene
MAJOR DEPRESSIVE DISORDER;SACM1L;Gene;PA447321;Disease
BUPROPION;SACM1L;Gene;PA448687;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs3130907;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs3130907;Variant;PA445846;Disease
CARBOPLATIN;rs3130907;Variant;PA448803;Chemical
GEMCITABINE;rs3130907;Variant;PA449748;Chemical
IVACAFTOR;SLC26A9;Gene;PA165950341;Chemical
CYSTIC FIBROSIS;SLC26A9;Gene;PA443829;Disease
COMT;valproic acid;Chemical;PA117;Gene
CYP2A6;valproic acid;Chemical;PA121;Gene
CYP2B6;valproic acid;Chemical;PA123;Gene
CYP2C19;valproic acid;Chemical;PA124;Gene
CYP2C9;valproic acid;Chemical;PA126;Gene
CYP2D6;valproic acid;Chemical;PA128;Gene
CYP3A4;valproic acid;Chemical;PA130;Gene
CYP3A5;valproic acid;Chemical;PA131;Gene
ANKK1;valproic acid;Chemical;PA134872551;Gene
RABEP1;valproic acid;Chemical;PA134884097;Gene
SH2B1;valproic acid;Chemical;PA145148084;Gene
MEROPENEM;valproic acid;Chemical;PA164764445;Chemical
CYP2C9*1;valproic acid;Chemical;PA165816542;Haplotype
CYP2C9*2;valproic acid;Chemical;PA165816543;Haplotype
CYP2C9*3;valproic acid;Chemical;PA165816544;Haplotype
CYP2A6*1;valproic acid;Chemical;PA165924690;Haplotype
CYP2A6*4;valproic acid;Chemical;PA165924721;Haplotype
HLA-C*03:04;valproic acid;Chemical;PA165956881;Haplotype
CYP2C19*1;valproic acid;Chemical;PA165980634;Haplotype
CYP2C19*2;valproic acid;Chemical;PA165980635;Haplotype
CYP2C19*3;valproic acid;Chemical;PA165980636;Haplotype
UGT1A6*1A;valproic acid;Chemical;PA166117614;Haplotype
UGT1A6*2A;valproic acid;Chemical;PA166117621;Haplotype
UGT1A6*3A;valproic acid;Chemical;PA166117625;Haplotype
UGT1A6*4A;valproic acid;Chemical;PA166117627;Haplotype
UGT1A6*8;valproic acid;Chemical;PA166117633;Haplotype
HLA-A*02:01;valproic acid;Chemical;PA166123427;Haplotype
RS1137101;valproic acid;Chemical;PA166153626;Variant
RS1057910;valproic acid;Chemical;PA166153959;Variant
RS1799853;valproic acid;Chemical;PA166153972;Variant
RS1800497;valproic acid;Chemical;PA166154339;Variant
RS1019385;valproic acid;Chemical;PA166154508;Variant
RS2606345;valproic acid;Chemical;PA166154899;Variant
RS3087374;valproic acid;Chemical;PA166154900;Variant
RS1800012;valproic acid;Chemical;PA166155190;Variant
RS1047891;valproic acid;Chemical;PA166155617;Variant
RS1105879;valproic acid;Chemical;PA166155623;Variant
RS2070959;valproic acid;Chemical;PA166155665;Variant
RS2298771;valproic acid;Chemical;PA166155680;Variant
RS6759892;valproic acid;Chemical;PA166155760;Variant
RS17183814;valproic acid;Chemical;PA166155842;Variant
RS28898617;valproic acid;Chemical;PA166155860;Variant
RS7438284;valproic acid;Chemical;PA166156618;Variant
RS7439366;valproic acid;Chemical;PA166156619;Variant
RS7668258;valproic acid;Chemical;PA166156625;Variant
RS12233719;valproic acid;Chemical;PA166156658;Variant
RS2279020;valproic acid;Chemical;PA166156794;Variant
RS4880;valproic acid;Chemical;PA166156900;Variant
RS2032582;valproic acid;Chemical;PA166157316;Variant
RS2769605;valproic acid;Chemical;PA166157756;Variant
RS3888190;valproic acid;Chemical;PA166165398;Variant
RS1000940;valproic acid;Chemical;PA166165401;Variant
HTR2A;valproic acid;Chemical;PA193;Gene
HTR2C;valproic acid;Chemical;PA194;Gene
LEPR;valproic acid;Chemical;PA229;Gene
ABAT;valproic acid;Chemical;PA24372;Gene
MTHFR;valproic acid;Chemical;PA245;Gene
ALDH5A1;valproic acid;Chemical;PA24702;Gene
CACNA1F;valproic acid;Chemical;PA26010;Gene
ABCB1;valproic acid;Chemical;PA267;Gene
CPS1;valproic acid;Chemical;PA26840;Gene
CYP1A1;valproic acid;Chemical;PA27092;Gene
CYP1A2;valproic acid;Chemical;PA27093;Gene
DRD2;valproic acid;Chemical;PA27478;Gene
GABRA1;valproic acid;Chemical;PA28489;Gene
GRIN2B;valproic acid;Chemical;PA28980;Gene
HDAC1;valproic acid;Chemical;PA29226;Gene
SCN1A;valproic acid;Chemical;PA301;Gene
SLC6A4;valproic acid;Chemical;PA312;Gene
OGDH;valproic acid;Chemical;PA31910;Gene
OTC;valproic acid;Chemical;PA32840;Gene
POLG;valproic acid;Chemical;PA33500;Gene
SCN2A;valproic acid;Chemical;PA35004;Gene
COL1A1;valproic acid;Chemical;PA35041;Gene
HLA-A;valproic acid;Chemical;PA35055;Gene
HLA-B;valproic acid;Chemical;PA35056;Gene
HLA-C;valproic acid;Chemical;PA35057;Gene
SOD2;valproic acid;Chemical;PA36017;Gene
UGT2B7;valproic acid;Chemical;PA361;Gene
UGT1A10;valproic acid;Chemical;PA37174;Gene
UGT1A3;valproic acid;Chemical;PA37178;Gene
UGT1A4;valproic acid;Chemical;PA37179;Gene
UGT1A5;valproic acid;Chemical;PA37180;Gene
UGT1A6;valproic acid;Chemical;PA37181;Gene
UGT1A7;valproic acid;Chemical;PA37182;Gene
UGT1A8;valproic acid;Chemical;PA37183;Gene
NR1I2;valproic acid;Chemical;PA378;Gene
HDAC9;valproic acid;Chemical;PA38377;Gene
HDAC11;valproic acid;Chemical;PA38793;Gene
UGT1A9;valproic acid;Chemical;PA419;Gene
CACNA1C;valproic acid;Chemical;PA83;Gene
CACNA1D;valproic acid;Chemical;PA84;Gene
TOBACCO USE DISORDER;rs1948;Variant;PA445876;Disease
NICOTINE;rs1948;Variant;PA450626;Chemical
HEMATOPOIETIC STEM CELL TRANSPLANTATION;rs1799853;Variant;PA166123007;Disease
BUSULFAN;rs1799853;Variant;PA448691;Chemical
CELECOXIB;rs1799853;Variant;PA448871;Chemical
IRBESARTAN;rs1799853;Variant;PA450084;Chemical
VALPROIC ACID;rs1799853;Variant;PA451846;Chemical
WARFARIN;rs1799853;Variant;PA451906;Chemical
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;rs1799853;Variant;PA452637;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs854548;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs854548;Variant;PA443434;Disease
TPMT;TPMT*11;Haplotype;PA356;Gene
AZATHIOPRINE;TPMT*11;Haplotype;PA448515;Chemical
MERCAPTOPURINE;TPMT*11;Haplotype;PA450379;Chemical
THIOGUANINE;TPMT*11;Haplotype;PA451663;Chemical
PLATINUM COMPOUNDS;rs7091672;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs7091672;Variant;PA443622;Disease
CYP2D6;brexpiprazole;Chemical;PA128;Gene
CYP3A4;brexpiprazole;Chemical;PA130;Gene
CYP2D6*1;brexpiprazole;Chemical;PA165816576;Haplotype
CYP2D6*2;brexpiprazole;Chemical;PA165816577;Haplotype
CYP2D6*10;brexpiprazole;Chemical;PA165816582;Haplotype
CYP2D6*17;brexpiprazole;Chemical;PA165816583;Haplotype
CYP2D6*41;brexpiprazole;Chemical;PA165816584;Haplotype
CYP3A4*1;brexpiprazole;Chemical;PA165819201;Haplotype
CYP3A4*2;brexpiprazole;Chemical;PA165819220;Haplotype
CYP3A4*3;brexpiprazole;Chemical;PA165819221;Haplotype
CYP3A4*4;brexpiprazole;Chemical;PA165819222;Haplotype
CYP3A4*5;brexpiprazole;Chemical;PA165819223;Haplotype
CYP3A4*7;brexpiprazole;Chemical;PA165819225;Haplotype
CYP3A4*8;brexpiprazole;Chemical;PA165819226;Haplotype
CYP3A4*9;brexpiprazole;Chemical;PA165819227;Haplotype
CYP3A4*10;brexpiprazole;Chemical;PA165819228;Haplotype
CYP3A4*11;brexpiprazole;Chemical;PA165819229;Haplotype
CYP3A4*12;brexpiprazole;Chemical;PA165819230;Haplotype
CYP3A4*13;brexpiprazole;Chemical;PA165819231;Haplotype
CYP3A4*14;brexpiprazole;Chemical;PA165819232;Haplotype
CYP3A4*15;brexpiprazole;Chemical;PA165819233;Haplotype
CYP3A4*16;brexpiprazole;Chemical;PA165819236;Haplotype
CYP3A4*17;brexpiprazole;Chemical;PA165819239;Haplotype
CYP3A4*18;brexpiprazole;Chemical;PA165819240;Haplotype
CYP3A4*20;brexpiprazole;Chemical;PA165819244;Haplotype
CYP2D6*9;brexpiprazole;Chemical;PA165948317;Haplotype
CYP2D6*29;brexpiprazole;Chemical;PA165948318;Haplotype
CYP3A4*23;brexpiprazole;Chemical;PA166115836;Haplotype
CYP2D6*14;brexpiprazole;Chemical;PA166181185;Haplotype
CYP3A4*29;brexpiprazole;Chemical;PA166245585;Haplotype
CYP3A4*31;brexpiprazole;Chemical;PA166245587;Haplotype
CYP3A4*32;brexpiprazole;Chemical;PA166245588;Haplotype
CYP3A4*33;brexpiprazole;Chemical;PA166245589;Haplotype
CYP3A4*34;brexpiprazole;Chemical;PA166245590;Haplotype
6BETA-HYDROXYTESTOSTERONE;CYP2C19*13;Haplotype;PA166318222;Chemical
11A-HYDROXYPROGESTERONE;CYP2C19*13;Haplotype;PA166318342;Chemical
CLOPIDOGREL;CYP2C19*13;Haplotype;PA449053;Chemical
FLUCONAZOLE;CYP2C19*13;Haplotype;PA449653;Chemical
FLUVOXAMINE;CYP2C19*13;Haplotype;PA449690;Chemical
MEPHENYTOIN;CYP2C19*13;Haplotype;PA450373;Chemical
SERTRALINE;CYP2C19*13;Haplotype;PA451333;Chemical
BREAST NEOPLASMS;rs6901146;Variant;PA443560;Disease
ANASTROZOLE;rs6901146;Variant;PA448432;Chemical
EXEMESTANE;rs6901146;Variant;PA449563;Chemical
ATL2;Drug Hypersensitivity;Disease;PA164716322;Gene
HLA-DRB1*01:01;Drug Hypersensitivity;Disease;PA165951320;Haplotype
HLA-DRB1*07:01;Drug Hypersensitivity;Disease;PA165951644;Haplotype
HLA-DRB1*09:01;Drug Hypersensitivity;Disease;PA165951734;Haplotype
HLA-DRB1*13:02;Drug Hypersensitivity;Disease;PA165951978;Haplotype
HLA-DRB1*14:01;Drug Hypersensitivity;Disease;PA165952135;Haplotype
HLA-DRB1*15:01;Drug Hypersensitivity;Disease;PA165952269;Haplotype
HLA-DRB1*15:02;Drug Hypersensitivity;Disease;PA165952289;Haplotype
HLA-DRB1*16:02;Drug Hypersensitivity;Disease;PA165952368;Haplotype
HLA-A*02:06;Drug Hypersensitivity;Disease;PA165952829;Haplotype
HLA-A*24:02;Drug Hypersensitivity;Disease;PA165953564;Haplotype
HLA-A*31:01;Drug Hypersensitivity;Disease;PA165954030;Haplotype
HLA-A*33:01;Drug Hypersensitivity;Disease;PA165954144;Haplotype
HLA-B*13:01;Drug Hypersensitivity;Disease;PA165954643;Haplotype
HLA-B*14:02;Drug Hypersensitivity;Disease;PA165954712;Haplotype
HLA-B*15:02;Drug Hypersensitivity;Disease;PA165954769;Haplotype
HLA-B*35:01;Drug Hypersensitivity;Disease;PA165955215;Haplotype
HLA-B*44:02;Drug Hypersensitivity;Disease;PA165955891;Haplotype
HLA-B*44:03;Drug Hypersensitivity;Disease;PA165955913;Haplotype
HLA-B*51:01;Drug Hypersensitivity;Disease;PA165956201;Haplotype
HLA-B*55:01;Drug Hypersensitivity;Disease;PA165956463;Haplotype
HLA-C*03:04;Drug Hypersensitivity;Disease;PA165956881;Haplotype
HLA-C*04:01;Drug Hypersensitivity;Disease;PA165957046;Haplotype
HLA-C*08:02;Drug Hypersensitivity;Disease;PA165957658;Haplotype
HLA-DQB1*05:01;Drug Hypersensitivity;Disease;PA165958073;Haplotype
HLA-DQB1*05:02;Drug Hypersensitivity;Disease;PA165958077;Haplotype
HLA-DQB1*06:02;Drug Hypersensitivity;Disease;PA165958103;Haplotype
HLA-DQB1*06:03;Drug Hypersensitivity;Disease;PA165958105;Haplotype
HLA-DQB1*06:09;Drug Hypersensitivity;Disease;PA165958117;Haplotype
HLA-DQB1*02:01;Drug Hypersensitivity;Disease;PA165958158;Haplotype
HLA-DQB1*03:02;Drug Hypersensitivity;Disease;PA165958175;Haplotype
HLA-B*57:01;Drug Hypersensitivity;Disease;PA165987830;Haplotype
HLA-B*58:01;Drug Hypersensitivity;Disease;PA165987831;Haplotype
HLA-C*03:02;Drug Hypersensitivity;Disease;PA166123425;Haplotype
HLA-C*08:01;Drug Hypersensitivity;Disease;PA166123426;Haplotype
HLA-A*02:01;Drug Hypersensitivity;Disease;PA166123427;Haplotype
HLA-A*33:03;Drug Hypersensitivity;Disease;PA166123428;Haplotype
HLA-B*48:01;Drug Hypersensitivity;Disease;PA166123429;Haplotype
RS3093726;Drug Hypersensitivity;Disease;PA166157063;Variant
RS201929247;Drug Hypersensitivity;Disease;PA166181039;Variant
RS701829;Drug Hypersensitivity;Disease;PA166181040;Variant
RS17211071;Drug Hypersensitivity;Disease;PA166181041;Variant
RS59569490;Drug Hypersensitivity;Disease;PA166394241;Variant
LTA;Drug Hypersensitivity;Disease;PA30474;Gene
LTB;Drug Hypersensitivity;Disease;PA30475;Gene
HLA-A;Drug Hypersensitivity;Disease;PA35055;Gene
HLA-B;Drug Hypersensitivity;Disease;PA35056;Gene
HLA-C;Drug Hypersensitivity;Disease;PA35057;Gene
HLA-DQB1;Drug Hypersensitivity;Disease;PA35068;Gene
HLA-DRB1;Drug Hypersensitivity;Disease;PA35072;Gene
LST1;Drug Hypersensitivity;Disease;PA37856;Gene
HYPERTENSION;ADAMTS18;Gene;PA444552;Disease
SORAFENIB;ADAMTS18;Gene;PA7000;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;CTNNA2;Gene;PA164713366;Chemical
PSORIASIS;CTNNA2;Gene;PA445451;Disease
CONJUGATED ESTROGENS;SLCO1B1*13;Haplotype;PA164754789;Chemical
PLCB1;ITGA2B;Gene;PA33384;Gene
PLCG2;ITGA2B;Gene;PA33393;Gene
ABCIXIMAB;ITGA2B;Gene;PA448006;Chemical
EPTIFIBATIDE;ITGA2B;Gene;PA449483;Chemical
TIROFIBAN;ITGA2B;Gene;PA451698;Chemical
TOBACCO USE DISORDER;CYP2B6*22;Haplotype;PA445876;Disease
BUPROPION;CYP2B6*22;Haplotype;PA448687;Chemical
FLUOROURACIL;rs9380142;Variant;PA128406956;Chemical
COLORECTAL NEOPLASMS;rs9380142;Variant;PA446108;Disease
CAPECITABINE;rs9380142;Variant;PA448771;Chemical
FLUOROURACIL;TPMT*3C;Haplotype;PA128406956;Chemical
TRANSPLANTATION;TPMT*3C;Haplotype;PA134850491;Disease
NUDT15;TPMT*3C;Haplotype;PA134963132;Gene
OTOTOXICITY;TPMT*3C;Haplotype;PA162263534;Disease
KIDNEY TRANSPLANTATION;TPMT*3C;Haplotype;PA165817016;Disease
MYELOSUPPRESSION;TPMT*3C;Haplotype;PA165817398;Disease
TRANSPLANT REJECTION;TPMT*3C;Haplotype;PA166114454;Disease
HEART TRANSPLANTATION;TPMT*3C;Haplotype;PA166114458;Disease
EVENT-FREE SURVIVAL;TPMT*3C;Haplotype;PA166123366;Disease
DISCONTINUATION;TPMT*3C;Haplotype;PA166123507;Disease
DOSE REDUCTION;TPMT*3C;Haplotype;PA166159953;Disease
TPMT;TPMT*3C;Haplotype;PA356;Gene
CROHN DISEASE;TPMT*3C;Haplotype;PA443815;Disease
DIZZINESS;TPMT*3C;Haplotype;PA443928;Disease
FATIGUE;TPMT*3C;Haplotype;PA444153;Disease
HEAD AND NECK NEOPLASMS;TPMT*3C;Haplotype;PA444352;Disease
INFLAMMATION;TPMT*3C;Haplotype;PA444620;Disease
LEUKEMIA;TPMT*3C;Haplotype;PA444750;Disease
LEUKOPENIA;TPMT*3C;Haplotype;PA444773;Disease
NEOPLASMS;TPMT*3C;Haplotype;PA445062;Disease
NEUTROPENIA;TPMT*3C;Haplotype;PA445113;Disease
PANCYTOPENIA;TPMT*3C;Haplotype;PA445221;Disease
SKIN NEOPLASMS;TPMT*3C;Haplotype;PA445683;Disease
THROMBOCYTOPENIA;TPMT*3C;Haplotype;PA445846;Disease
INFLAMMATORY BOWEL DISEASES;TPMT*3C;Haplotype;PA446116;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;TPMT*3C;Haplotype;PA446155;Disease
HEPATITIS, AUTOIMMUNE;TPMT*3C;Haplotype;PA446861;Disease
AZATHIOPRINE;TPMT*3C;Haplotype;PA448515;Chemical
CISPLATIN;TPMT*3C;Haplotype;PA449014;Chemical
CYCLOSPORINE;TPMT*3C;Haplotype;PA449167;Chemical
MERCAPTOPURINE;TPMT*3C;Haplotype;PA450379;Chemical
METHOTREXATE;TPMT*3C;Haplotype;PA450428;Chemical
OLANZAPINE;TPMT*3C;Haplotype;PA450688;Chemical
PREDNISONE;TPMT*3C;Haplotype;PA451100;Chemical
THIOGUANINE;TPMT*3C;Haplotype;PA451663;Chemical
PURINE ANALOGUES;TPMT*3C;Haplotype;PA452634;Chemical
MAP2K3;MAP3K11;Gene;PA30588;Gene
MAP2K6;MAP3K11;Gene;PA30591;Gene
EPILEPSY;rs2290732;Variant;PA444065;Disease
CARBAMAZEPINE;rs2290732;Variant;PA448785;Chemical
IRRITABLE BOWEL SYNDROME;rs2413739;Variant;PA166048887;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs2413739;Variant;PA446155;Disease
AZATHIOPRINE;rs2413739;Variant;PA448515;Chemical
MERCAPTOPURINE;rs2413739;Variant;PA450379;Chemical
METHOTREXATE;rs2413739;Variant;PA450428;Chemical
CYP3A4;sulfinpyrazone;Chemical;PA130;Gene
RS72551330;sulfinpyrazone;Chemical;PA166155900;Variant
NR1I2;sulfinpyrazone;Chemical;PA378;Gene
UGT1A9;sulfinpyrazone;Chemical;PA419;Gene
IMATINIB;GSTT1;Gene;PA10804;Chemical
OTOTOXICITY;GSTT1;Gene;PA162263534;Disease
DRUGS FOR TREATMENT OF TUBERCULOSIS;GSTT1;Gene;PA164712708;Chemical
PLATINUM COMPOUNDS;GSTT1;Gene;PA164713176;Chemical
ETHAMBUTOL;GSTT1;Gene;PA164784021;Chemical
TOXIC LIVER DISEASE;GSTT1;Gene;PA164925725;Disease
HEMATOPOIETIC STEM CELL TRANSPLANTATION;GSTT1;Gene;PA166123007;Disease
PROGRESSION-FREE SURVIVAL;GSTT1;Gene;PA166123026;Disease
EXACERBATION OF ASTHMA;GSTT1;Gene;PA166179129;Disease
ASTHMA;GSTT1;Gene;PA443450;Disease
DEAFNESS;GSTT1;Gene;PA443840;Disease
EXANTHEMA;GSTT1;Gene;PA444109;Disease
GRAFT VS HOST DISEASE;GSTT1;Gene;PA444320;Disease
MULTIPLE MYELOMA;GSTT1;Gene;PA444985;Disease
NEOPLASMS;GSTT1;Gene;PA445062;Disease
NEUTROPENIA;GSTT1;Gene;PA445113;Disease
OSTEOSARCOMA;GSTT1;Gene;PA445601;Disease
TUBERCULOSIS;GSTT1;Gene;PA445941;Disease
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;GSTT1;Gene;PA446171;Disease
AMOXICILLIN;GSTT1;Gene;PA448406;Chemical
CARBOPLATIN;GSTT1;Gene;PA448803;Chemical
CISPLATIN;GSTT1;Gene;PA449014;Chemical
CLOZAPINE;GSTT1;Gene;PA449061;Chemical
CYCLOPHOSPHAMIDE;GSTT1;Gene;PA449165;Chemical
DOXORUBICIN;GSTT1;Gene;PA449412;Chemical
ETOPOSIDE;GSTT1;Gene;PA449552;Chemical
ISONIAZID;GSTT1;Gene;PA450112;Chemical
METHOTREXATE;GSTT1;Gene;PA450428;Chemical
PYRAZINAMIDE;GSTT1;Gene;PA451182;Chemical
RIFAMPIN;GSTT1;Gene;PA451250;Chemical
STREPTOMYCIN;GSTT1;Gene;PA451512;Chemical
THALIDOMIDE;GSTT1;Gene;PA451644;Chemical
TROGLITAZONE;GSTT1;Gene;PA451799;Chemical
XENOBIOTICS;GSTT1;Gene;PA452604;Chemical
TOXIC LIVER DISEASE;MTHFD1;Gene;PA164925725;Disease
MUCOSITIS;MTHFD1;Gene;PA166122058;Disease
ANEMIA;MTHFD1;Gene;PA443340;Disease
LEUKOPENIA;MTHFD1;Gene;PA444773;Disease
NON-HODGKIN LYMPHOMA;MTHFD1;Gene;PA444845;Disease
MESOTHELIOMA;MTHFD1;Gene;PA444937;Disease
OSTEOSARCOMA;MTHFD1;Gene;PA445601;Disease
THROMBOCYTOPENIA;MTHFD1;Gene;PA445846;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;MTHFD1;Gene;PA446155;Disease
CISPLATIN;MTHFD1;Gene;PA449014;Chemical
DOXORUBICIN;MTHFD1;Gene;PA449412;Chemical
METHOTREXATE;MTHFD1;Gene;PA450428;Chemical
LATANOPROST;rs3766355;Variant;PA164774763;Chemical
OPEN-ANGLE GLAUCOMA;rs3766355;Variant;PA444282;Disease
GNAI1;ADCY4;Gene;PA172;Gene
GNAI3;ADCY4;Gene;PA173;Gene
GNAS;ADCY4;Gene;PA175;Gene
GNAI2;ADCY4;Gene;PA24347;Gene
DIABETES MELLITUS, TYPE 2;rs4402960;Variant;PA443890;Disease
REPAGLINIDE;rs4402960;Variant;PA451234;Chemical
VOLATILE ANESTHETICS;rs118204423;Variant;PA166131630;Chemical
MALIGNANT HYPERTHERMIA;rs118204423;Variant;PA444863;Disease
SUCCINYLCHOLINE;rs118204423;Variant;PA451522;Chemical
RS1045642;silibinin;Chemical;PA166157284;Variant
ABCB1;silibinin;Chemical;PA267;Gene
DRUG INTERACTION WITH DRUG;rs1801280;Variant;PA165108622;Disease
DRUG TOXICITY;rs1801280;Variant;PA443937;Disease
OVARIAN NEOPLASMS;rs1801280;Variant;PA445204;Disease
CISPLATIN;rs1801280;Variant;PA449014;Chemical
CYCLOPHOSPHAMIDE;rs1801280;Variant;PA449165;Chemical
ISONIAZID;rs1801280;Variant;PA450112;Chemical
PHENYTOIN;rs1801280;Variant;PA450947;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*22;Haplotype;PA166127651;Chemical
PRIMAQUINE;CYP2D6*22;Haplotype;PA451103;Chemical
ADEFOVIR DIPIVOXIL;AK2;Gene;PA10005;Chemical
TENOFOVIR;AK2;Gene;PA10204;Chemical
ELF2;SLC9A3;Gene;PA27745;Gene
CYP2D6;darifenacin;Chemical;PA128;Gene
RS3781719;Migraine disorder;Disease;PA166196165;Variant
RS222749;Migraine disorder;Disease;PA166196173;Variant
CALCA;Migraine disorder;Disease;PA26029;Gene
TRPV1;Migraine disorder;Disease;PA37329;Gene
3,4-METHYLENEDIOXYMETHAMPHETAMINE;SLC6A2;Gene;PA131887008;Chemical
ATOMOXETINE;SLC6A2;Gene;PA134688071;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;SLC6A2;Gene;PA447197;Disease
MAJOR DEPRESSIVE DISORDER;SLC6A2;Gene;PA447321;Disease
DESIPRAMINE;SLC6A2;Gene;PA449233;Chemical
METHYLPHENIDATE;SLC6A2;Gene;PA450464;Chemical
VENLAFAXINE;SLC6A2;Gene;PA451866;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;CYP2E1*5B;Haplotype;PA164712708;Chemical
TOXIC LIVER DISEASE;CYP2E1*5B;Haplotype;PA164925725;Disease
LIVER DISEASES, ALCOHOLIC;CYP2E1*5B;Haplotype;PA444802;Disease
TUBERCULOSIS;CYP2E1*5B;Haplotype;PA445941;Disease
ACETAMINOPHEN;CYP2E1*5B;Haplotype;PA448015;Chemical
CYP3A4;Kidney Neoplasms;Disease;PA130;Gene
CYP3A5;Kidney Neoplasms;Disease;PA131;Gene
CYP3A4*1;Kidney Neoplasms;Disease;PA165819201;Haplotype
CYP3A4*22;Kidney Neoplasms;Disease;PA166048680;Haplotype
CYP3A5*1;Kidney Neoplasms;Disease;PA166128213;Haplotype
CYP3A5*3;Kidney Neoplasms;Disease;PA166128219;Haplotype
RS34231037;Kidney Neoplasms;Disease;PA166156679;Variant
RS2024627;Kidney Neoplasms;Disease;PA166238104;Variant
MTOR;Kidney Neoplasms;Disease;PA28360;Gene
KDR;Kidney Neoplasms;Disease;PA30086;Gene
ADRA1D;epinephrine;Chemical;PA24597;Gene
ADRA1B;epinephrine;Chemical;PA33;Gene
ADRA1A;epinephrine;Chemical;PA34;Gene
ADRA2A;epinephrine;Chemical;PA35;Gene
ADRA2B;epinephrine;Chemical;PA36;Gene
ADRA2C;epinephrine;Chemical;PA37;Gene
ADRB1;epinephrine;Chemical;PA38;Gene
ADRB2;epinephrine;Chemical;PA39;Gene
OVARIAN NEOPLASMS;rs1801368;Variant;PA445204;Disease
CARBOPLATIN;rs1801368;Variant;PA448803;Chemical
PACLITAXEL;rs1801368;Variant;PA450761;Chemical
HYPERTENSION;rs11125039;Variant;PA444552;Disease
SORAFENIB;rs11125039;Variant;PA7000;Chemical
ASTHMA;rs1131882;Variant;PA443450;Disease
DIABETES MELLITUS, TYPE 2;rs1131882;Variant;PA443890;Disease
ASPIRIN;rs1131882;Variant;PA448497;Chemical
DICLOFENAC;CYP2C9*36;Haplotype;PA449293;Chemical
PHENYTOIN;CYP2C9*36;Haplotype;PA450947;Chemical
CYP2D6;ciprofloxacin;Chemical;PA128;Gene
CYP2D6*6;ciprofloxacin;Chemical;PA165816581;Haplotype
G6PD B (REFERENCE);ciprofloxacin;Chemical;PA165947826;Haplotype
G6PD MEDITERRANEAN HAPLOTYPE;ciprofloxacin;Chemical;PA165947830;Haplotype
G6PD MEDITERRANEAN, DALLAS, PANAMA, SASSARI, CAGLIARI, BIRMINGHAM;ciprofloxacin;Chemical;PA166121127;Haplotype
G6PD;ciprofloxacin;Chemical;PA28469;Gene
ECULIZUMAB;rs2274567;Variant;PA164776637;Chemical
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA;rs2274567;Variant;PA166122772;Disease
MITOXANTRONE;C10orf67;Gene;PA450526;Chemical
G6PD;Jaundice, Neonatal;Disease;PA28469;Gene
AZACITIDINE;CBL;Gene;PA451996;Chemical
TENOFOVIR;rs8187710;Variant;PA10204;Chemical
CALCEIN;rs8187710;Variant;PA132595336;Chemical
DEFERASIROX;rs8187710;Variant;PA164760843;Chemical
FANCONI RENOTUBULAR SYNDROME;rs8187710;Variant;PA444145;Disease
NON-HODGKIN LYMPHOMA;rs8187710;Variant;PA444845;Disease
BETA-THALASSEMIA AND RELATED DISEASES;rs8187710;Variant;PA446432;Disease
HIV INFECTIOUS DISEASE;rs8187710;Variant;PA447230;Disease
DOXORUBICIN;rs8187710;Variant;PA449412;Chemical
LOPINAVIR;rs8187710;Variant;PA450264;Chemical
SLC12A1;sulfonamides, plain;Chemical;PA320;Gene
CYP2C19;intragastric ph;Disease;PA124;Gene
CYP2C19*1;intragastric ph;Disease;PA165980634;Haplotype
CYP2C19*2;intragastric ph;Disease;PA165980635;Haplotype
CYP2C19*3;intragastric ph;Disease;PA165980636;Haplotype
CYP2C19 EXTENSIVE METABOLIZER;intragastric ph;Disease;PA166161835;Variant
OSTEOARTHRITIS;VWA1;Gene;PA445174;Disease
CYP2C8;rosiglitazone;Chemical;PA125;Gene
CYP2C9;rosiglitazone;Chemical;PA126;Gene
SLCO1B1;rosiglitazone;Chemical;PA134865839;Gene
CYP2C8*3;rosiglitazone;Chemical;PA165958685;Haplotype
RS4149056;rosiglitazone;Chemical;PA166154579;Variant
RS10192566;rosiglitazone;Chemical;PA166155779;Variant
RS6467136;rosiglitazone;Chemical;PA166157413;Variant
RS894160;rosiglitazone;Chemical;PA166183759;Variant
CYP2C8*1;rosiglitazone;Chemical;PA166242948;Haplotype
LPIN1;rosiglitazone;Chemical;PA30436;Gene
PAX4;rosiglitazone;Chemical;PA32958;Gene
PLIN1;rosiglitazone;Chemical;PA33409;Gene
NR1I2;rosiglitazone;Chemical;PA378;Gene
FLUOROURACIL;rs75017182;Variant;PA128406956;Chemical
NEOPLASMS;rs75017182;Variant;PA445062;Disease
CAPECITABINE;rs75017182;Variant;PA448771;Chemical
COQ8B;Immunoglobulins;Chemical;PA134988974;Gene
RS28493229;Immunoglobulins;Chemical;PA166155480;Variant
ITPKC;Immunoglobulins;Chemical;PA29977;Gene
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;ETFDH;Gene;PA447197;Disease
METHYLPHENIDATE;ETFDH;Gene;PA450464;Chemical
MYCN;eflornithine;Chemical;PA31359;Gene
CES1;enalapril;Chemical;PA107;Gene
CYP3A4;enalapril;Chemical;PA130;Gene
SLCO1B1;enalapril;Chemical;PA134865839;Gene
ACE;enalapril;Chemical;PA139;Gene
RS4149056;enalapril;Chemical;PA166154579;Variant
RS1799722;enalapril;Chemical;PA166154785;Variant
RS71647871;enalapril;Chemical;PA166155135;Variant
RS1799752;enalapril;Chemical;PA166155187;Variant
RS5522;enalapril;Chemical;PA166156481;Variant
RS1042714;enalapril;Chemical;PA166156749;Variant
RS699947;enalapril;Chemical;PA166156938;Variant
RS2070744;enalapril;Chemical;PA166157325;Variant
RS495828;enalapril;Chemical;PA166157707;Variant
NR3C2;enalapril;Chemical;PA242;Gene
NOS3;enalapril;Chemical;PA254;Gene
VEGFA;enalapril;Chemical;PA37302;Gene
ADRB2;enalapril;Chemical;PA39;Gene
BDKRB2;enalapril;Chemical;PA80;Gene
FLUOROURACIL;rs3805945;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs3805945;Variant;PA443560;Disease
NEUTROPENIA;rs3805945;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs3805945;Variant;PA449165;Chemical
EPIRUBICIN;rs3805945;Variant;PA449476;Chemical
PLATINUM COMPOUNDS;rs3738948;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs3738948;Variant;PA443622;Disease
NEONATAL ABSTINENCE SYNDROME;rs4732636;Variant;PA165108809;Disease
BUPRENORPHINE;rs4732636;Variant;PA448685;Chemical
METHADONE;rs4732636;Variant;PA450401;Chemical
GNAI1;ADCY6;Gene;PA172;Gene
GNAI3;ADCY6;Gene;PA173;Gene
GNAS;ADCY6;Gene;PA175;Gene
GNAI2;ADCY6;Gene;PA24347;Gene
SCHIZOPHRENIA;rs1072388;Variant;PA447216;Disease
CLOZAPINE;rs1072388;Variant;PA449061;Chemical
ASPARAGINASE;ASNS;Gene;PA448492;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;TNF;Gene;PA164713366;Chemical
ETHAMBUTOL;TNF;Gene;PA164784021;Chemical
TOXIC LIVER DISEASE;TNF;Gene;PA164925725;Disease
ACUTE CORONARY SYNDROME;TNF;Gene;PA165108401;Disease
KIDNEY TRANSPLANTATION;TNF;Gene;PA165817016;Disease
HAND-FOOT SYNDROME;TNF;Gene;PA166114377;Disease
RHEUMATOID ARTHRITIS;TNF;Gene;PA443434;Disease
NON-SMALL CELL LUNG CARCINOMA;TNF;Gene;PA443622;Disease
CROHN DISEASE;TNF;Gene;PA443815;Disease
HEPATOCELLULAR CARCINOMA;TNF;Gene;PA444447;Disease
HYPERSENSITIVITY;TNF;Gene;PA444546;Disease
INFLAMMATION;TNF;Gene;PA444620;Disease
MIGRAINE WITHOUT AURA;TNF;Gene;PA444949;Disease
PSORIASIS;TNF;Gene;PA445451;Disease
SPONDYLITIS, ANKYLOSING;TNF;Gene;PA445724;Disease
THROMBOCYTOPENIA;TNF;Gene;PA445846;Disease
TUBERCULOSIS;TNF;Gene;PA445941;Disease
ARTHRITIS, PSORIATIC;TNF;Gene;PA446198;Disease
HIV INFECTIOUS DISEASE;TNF;Gene;PA447230;Disease
ASPIRIN;TNF;Gene;PA448497;Chemical
ATORVASTATIN;TNF;Gene;PA448500;Chemical
CARBAMAZEPINE;TNF;Gene;PA448785;Chemical
CARBOPLATIN;TNF;Gene;PA448803;Chemical
CYCLOSPORINE;TNF;Gene;PA449167;Chemical
DICLOFENAC;TNF;Gene;PA449293;Chemical
ETANERCEPT;TNF;Gene;PA449515;Chemical
GEMCITABINE;TNF;Gene;PA449748;Chemical
IBUPROFEN;TNF;Gene;PA449957;Chemical
INDOMETHACIN;TNF;Gene;PA449982;Chemical
ISONIAZID;TNF;Gene;PA450112;Chemical
KETOROLAC;TNF;Gene;PA450150;Chemical
MYCOPHENOLATE MOFETIL;TNF;Gene;PA450566;Chemical
NAPROXEN;TNF;Gene;PA450595;Chemical
PYRAZINAMIDE;TNF;Gene;PA451182;Chemical
RIFAMPIN;TNF;Gene;PA451250;Chemical
STAVUDINE;TNF;Gene;PA451494;Chemical
GLUCOCORTICOIDS;TNF;Gene;PA452347;Chemical
INFLIXIMAB;TNF;Gene;PA452639;Chemical
SORAFENIB;TNF;Gene;PA7000;Chemical
HMG COA REDUCTASE INHIBITORS;rs429358;Variant;PA133950441;Chemical
ANTIVIRALS FOR TREATMENT OF HIV INFECTIONS, COMBINATIONS;rs429358;Variant;PA164712505;Chemical
LECANEMAB;rs429358;Variant;PA166313301;Chemical
ADUCANUMAB;rs429358;Variant;PA166350685;Chemical
ALZHEIMER DISEASE;rs429358;Variant;PA443319;Disease
HEMORRHAGE;rs429358;Variant;PA444417;Disease
HYPERLIPIDEMIAS;rs429358;Variant;PA444528;Disease
MYOCARDIAL INFARCTION;rs429358;Variant;PA445019;Disease
HIV INFECTIOUS DISEASE;rs429358;Variant;PA447230;Disease
VENOUS THROMBOEMBOLISM;rs429358;Variant;PA447298;Disease
RITONAVIR;rs429358;Variant;PA451260;Chemical
SIMVASTATIN;rs429358;Variant;PA451363;Chemical
WARFARIN;rs429358;Variant;PA451906;Chemical
ACENOCOUMAROL;rs429358;Variant;PA452632;Chemical
APOE;rs429358;Variant;PA55;Gene
MENOPAUSE;rs749292;Variant;PA166048848;Disease
BREAST NEOPLASMS;rs749292;Variant;PA443560;Disease
LETROZOLE;rs749292;Variant;PA450196;Chemical
NR1I2;metyrapone;Chemical;PA378;Gene
CYP2B6;Lupus erythematosus;Disease;PA123;Gene
RS4802101;Lupus erythematosus;Disease;PA166155415;Variant
RS7254579;Lupus erythematosus;Disease;PA166155433;Variant
NAT2;Lupus erythematosus;Disease;PA18;Gene
AUTISM SPECTRUM DISORDER;rs6280;Variant;PA153906318;Disease
PRAMIPEXOLE;rs6280;Variant;PA164742949;Chemical
GASTROINTESTINAL TOXICITY;rs6280;Variant;PA166124386;Disease
HALLUCINATIONS;rs6280;Variant;PA444339;Disease
OPIOID-RELATED DISORDERS;rs6280;Variant;PA445043;Disease
PARKINSON DISEASE;rs6280;Variant;PA445254;Disease
AUTISM;rs6280;Variant;PA447198;Disease
SCHIZOPHRENIA;rs6280;Variant;PA447216;Disease
HIV INFECTIOUS DISEASE;rs6280;Variant;PA447230;Disease
MAJOR DEPRESSIVE DISORDER;rs6280;Variant;PA447321;Disease
CLOZAPINE;rs6280;Variant;PA449061;Chemical
LEVODOPA;rs6280;Variant;PA450213;Chemical
METHAMPHETAMINE;rs6280;Variant;PA450403;Chemical
METHYLPHENIDATE;rs6280;Variant;PA450464;Chemical
OLANZAPINE;rs6280;Variant;PA450688;Chemical
PAROXETINE;rs6280;Variant;PA450801;Chemical
QUETIAPINE;rs6280;Variant;PA451201;Chemical
RISPERIDONE;rs6280;Variant;PA451257;Chemical
OPIOIDS;rs6280;Variant;PA452618;Chemical
ARRB1;PDE4C;Gene;PA59;Gene
ARRB2;PDE4C;Gene;PA60;Gene
METHOTREXATE;rs4803418;Variant;PA450428;Chemical
CYP3A4;tipranavir;Chemical;PA130;Gene
EPILEPSY;rs4148386;Variant;PA444065;Disease
CARBAMAZEPINE;rs4148386;Variant;PA448785;Chemical
COTININE;rs77107237;Variant;PA166114414;Chemical
TOBACCO USE DISORDER;rs77107237;Variant;PA445876;Disease
PLATINUM COMPOUNDS;WIF1;Gene;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;WIF1;Gene;PA443622;Disease
FLUOROURACIL;rs3740066;Variant;PA128406956;Chemical
ORGAN TRANSPLANTATION;rs3740066;Variant;PA133888799;Disease
ANTIEPILEPTICS;rs3740066;Variant;PA143485705;Chemical
MYCOPHENOLIC ACID;rs3740066;Variant;PA164748728;Chemical
KIDNEY TRANSPLANTATION;rs3740066;Variant;PA165817016;Disease
BREAST NEOPLASMS;rs3740066;Variant;PA443560;Disease
NON-SMALL CELL LUNG CARCINOMA;rs3740066;Variant;PA443622;Disease
EPILEPSY;rs3740066;Variant;PA444065;Disease
CARBAMAZEPINE;rs3740066;Variant;PA448785;Chemical
CYCLOPHOSPHAMIDE;rs3740066;Variant;PA449165;Chemical
DOXORUBICIN;rs3740066;Variant;PA449412;Chemical
IRINOTECAN;rs3740066;Variant;PA450085;Chemical
TACROLIMUS;rs3740066;Variant;PA451578;Chemical
BOSENTAN;CYP2C9*1;Haplotype;PA10034;Chemical
VORICONAZOLE;CYP2C9*1;Haplotype;PA10233;Chemical
SULFONAMIDES, UREA DERIVATIVES;CYP2C9*1;Haplotype;PA10390;Chemical
GLICLAZIDE;CYP2C9*1;Haplotype;PA10892;Chemical
CYP2C9;CYP2C9*1;Haplotype;PA126;Gene
TENOXICAM;CYP2C9*1;Haplotype;PA131890625;Chemical
VKORC1;CYP2C9*1;Haplotype;PA133787052;Gene
BENZBROMARONE;CYP2C9*1;Haplotype;PA134852920;Chemical
PITAVASTATIN;CYP2C9*1;Haplotype;PA142650384;Chemical
ANTIEPILEPTICS;CYP2C9*1;Haplotype;PA143485705;Chemical
PRASUGREL;CYP2C9*1;Haplotype;PA154410481;Chemical
MACULOPAPULAR EXANTHEMA;CYP2C9*1;Haplotype;PA162316739;Disease
GLIQUIDONE;CYP2C9*1;Haplotype;PA164744895;Chemical
ACUTE CORONARY SYNDROME;CYP2C9*1;Haplotype;PA165108401;Disease
DRUG RESISTANCE;CYP2C9*1;Haplotype;PA165111675;Disease
KIDNEY TRANSPLANTATION;CYP2C9*1;Haplotype;PA165817016;Disease
HYDROXYPHENYTOIN;CYP2C9*1;Haplotype;PA165823907;Chemical
LORNOXICAM;CYP2C9*1;Haplotype;PA165958395;Chemical
ACECLOFENAC;CYP2C9*1;Haplotype;PA166049185;Chemical
DRUG-INDUCED LIVER INJURY;CYP2C9*1;Haplotype;PA166119041;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;CYP2C9*1;Haplotype;PA166120929;Disease
OVER-ANTICOAGULATION;CYP2C9*1;Haplotype;PA166123298;Disease
HEART VALVE REPLACEMENT;CYP2C9*1;Haplotype;PA166123431;Disease
PLATELET AGGREGATION;CYP2C9*1;Haplotype;PA166123766;Disease
DIPYRONE;CYP2C9*1;Haplotype;PA166128206;Chemical
TIME TO ACHIEVE STABLE DOSE;CYP2C9*1;Haplotype;PA166129530;Disease
TIME IN THERAPEUTIC RANGE;CYP2C9*1;Haplotype;PA166129531;Disease
TIME TO THERAPEUTIC INR;CYP2C9*1;Haplotype;PA166129532;Disease
TIME ABOVE THERAPEUTIC RANGE;CYP2C9*1;Haplotype;PA166129534;Disease
TIME BELOW THERAPEUTIC RANGE;CYP2C9*1;Haplotype;PA166129562;Disease
ADVERSE EVENTS;CYP2C9*1;Haplotype;PA166151827;Disease
LESINURAD;CYP2C9*1;Haplotype;PA166160006;Chemical
INTERNATIONAL NORMALIZED RATIO VARIABILITY (INR-VAR);CYP2C9*1;Haplotype;PA166160459;Disease
SIPONIMOD;CYP2C9*1;Haplotype;PA166182736;Chemical
ALCOHOLISM;CYP2C9*1;Haplotype;PA443309;Disease
ATRIAL FIBRILLATION;CYP2C9*1;Haplotype;PA443459;Disease
ATRIAL FLUTTER;CYP2C9*1;Haplotype;PA443460;Disease
BLOOD COAGULATION DISORDERS;CYP2C9*1;Haplotype;PA443523;Disease
CARDIOVASCULAR DISEASES;CYP2C9*1;Haplotype;PA443635;Disease
CORONARY ARTERY DISEASE;CYP2C9*1;Haplotype;PA443796;Disease
DIABETES MELLITUS;CYP2C9*1;Haplotype;PA443886;Disease
DIABETES MELLITUS, TYPE 2;CYP2C9*1;Haplotype;PA443890;Disease
DRUG TOXICITY;CYP2C9*1;Haplotype;PA443937;Disease
DYSPEPSIA;CYP2C9*1;Haplotype;PA443965;Disease
EPIDERMAL NECROLYSIS, TOXIC;CYP2C9*1;Haplotype;PA444059;Disease
EPILEPSY;CYP2C9*1;Haplotype;PA444065;Disease
EXANTHEMA;CYP2C9*1;Haplotype;PA444109;Disease
GASTRITIS;CYP2C9*1;Haplotype;PA444250;Disease
HEART DISEASES;CYP2C9*1;Haplotype;PA444368;Disease
HEMATOMA, SUBDURAL;CYP2C9*1;Haplotype;PA444398;Disease
HEMORRHAGE;CYP2C9*1;Haplotype;PA444417;Disease
GASTROINTESTINAL HEMORRHAGE;CYP2C9*1;Haplotype;PA444418;Disease
HYPERTENSION;CYP2C9*1;Haplotype;PA444552;Disease
HYPOGLYCEMIA;CYP2C9*1;Haplotype;PA444570;Disease
HYPOTENSION;CYP2C9*1;Haplotype;PA444584;Disease
INFLAMMATION;CYP2C9*1;Haplotype;PA444620;Disease
KIDNEY DISEASES;CYP2C9*1;Haplotype;PA444682;Disease
CARDIOMYOPATHIES;CYP2C9*1;Haplotype;PA445018;Disease
NEOPLASMS;CYP2C9*1;Haplotype;PA445062;Disease
PAIN;CYP2C9*1;Haplotype;PA445208;Disease
PAIN, POSTOPERATIVE;CYP2C9*1;Haplotype;PA445210;Disease
PULMONARY EMBOLISM;CYP2C9*1;Haplotype;PA445465;Disease
RHEUMATIC HEART DISEASE;CYP2C9*1;Haplotype;PA445553;Disease
STEVENS-JOHNSON SYNDROME;CYP2C9*1;Haplotype;PA445738;Disease
THROMBOEMBOLISM;CYP2C9*1;Haplotype;PA445848;Disease
THYROTOXICOSIS;CYP2C9*1;Haplotype;PA445862;Disease
TOBACCO USE DISORDER;CYP2C9*1;Haplotype;PA445876;Disease
TUBERCULOSIS;CYP2C9*1;Haplotype;PA445941;Disease
VENOUS THROMBOSIS;CYP2C9*1;Haplotype;PA446969;Disease
STROKE;CYP2C9*1;Haplotype;PA447054;Disease
BIPOLAR DISORDER;CYP2C9*1;Haplotype;PA447199;Disease
MENTAL DISORDERS;CYP2C9*1;Haplotype;PA447208;Disease
PSYCHOTIC DISORDERS;CYP2C9*1;Haplotype;PA447215;Disease
THROMBOSIS OF CEREBRAL VEINS;CYP2C9*1;Haplotype;PA447276;Disease
VENOUS THROMBOEMBOLISM;CYP2C9*1;Haplotype;PA447298;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2C9*1;Haplotype;PA447321;Disease
ASPIRIN;CYP2C9*1;Haplotype;PA448497;Chemical
CELECOXIB;CYP2C9*1;Haplotype;PA448871;Chemical
CLOPIDOGREL;CYP2C9*1;Haplotype;PA449053;Chemical
DIAZEPAM;CYP2C9*1;Haplotype;PA449283;Chemical
DICLOFENAC;CYP2C9*1;Haplotype;PA449293;Chemical
DOXEPIN;CYP2C9*1;Haplotype;PA449409;Chemical
FLUCONAZOLE;CYP2C9*1;Haplotype;PA449653;Chemical
FLUOXETINE;CYP2C9*1;Haplotype;PA449673;Chemical
FLURBIPROFEN;CYP2C9*1;Haplotype;PA449683;Chemical
FLUVASTATIN;CYP2C9*1;Haplotype;PA449688;Chemical
GLIMEPIRIDE;CYP2C9*1;Haplotype;PA449761;Chemical
GLIPIZIDE;CYP2C9*1;Haplotype;PA449762;Chemical
GLYBURIDE;CYP2C9*1;Haplotype;PA449782;Chemical
IBUPROFEN;CYP2C9*1;Haplotype;PA449957;Chemical
INDOMETHACIN;CYP2C9*1;Haplotype;PA449982;Chemical
KETOPROFEN;CYP2C9*1;Haplotype;PA450149;Chemical
KETOROLAC;CYP2C9*1;Haplotype;PA450150;Chemical
LOSARTAN;CYP2C9*1;Haplotype;PA450268;Chemical
MELOXICAM;CYP2C9*1;Haplotype;PA450353;Chemical
METHADONE;CYP2C9*1;Haplotype;PA450401;Chemical
NAPROXEN;CYP2C9*1;Haplotype;PA450595;Chemical
NATEGLINIDE;CYP2C9*1;Haplotype;PA450600;Chemical
OLANZAPINE;CYP2C9*1;Haplotype;PA450688;Chemical
PHENPROCOUMON;CYP2C9*1;Haplotype;PA450921;Chemical
PHENYTOIN;CYP2C9*1;Haplotype;PA450947;Chemical
PIOGLITAZONE;CYP2C9*1;Haplotype;PA450970;Chemical
PIROXICAM;CYP2C9*1;Haplotype;PA450985;Chemical
PROPOFOL;CYP2C9*1;Haplotype;PA451141;Chemical
RIFAMPIN;CYP2C9*1;Haplotype;PA451250;Chemical
SIMVASTATIN;CYP2C9*1;Haplotype;PA451363;Chemical
TOLBUTAMIDE;CYP2C9*1;Haplotype;PA451718;Chemical
TRIMIPRAMINE;CYP2C9*1;Haplotype;PA451791;Chemical
VALPROIC ACID;CYP2C9*1;Haplotype;PA451846;Chemical
WARFARIN;CYP2C9*1;Haplotype;PA451906;Chemical
ZAFIRLUKAST;CYP2C9*1;Haplotype;PA451949;Chemical
ACENOCOUMAROL;CYP2C9*1;Haplotype;PA452632;Chemical
HAND-FOOT SYNDROME;rs7574296;Variant;PA166114377;Disease
HEPATOCELLULAR CARCINOMA;rs7574296;Variant;PA444447;Disease
SORAFENIB;rs7574296;Variant;PA7000;Chemical
CYP1A2*6;dacarbazine;Chemical;PA165819183;Haplotype
CYP1A2*8;dacarbazine;Chemical;PA165819185;Haplotype
CYP1A1*1;dacarbazine;Chemical;PA165860672;Haplotype
CYP1A1*2C;dacarbazine;Chemical;PA165860675;Haplotype
CYP1A1*4;dacarbazine;Chemical;PA165860677;Haplotype
GSTM1 NULL;dacarbazine;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;dacarbazine;Chemical;PA166048676;Haplotype
GEMCITABINE TRIPHOSPHATE;dacarbazine;Chemical;PA166131567;Chemical
GSTM1;dacarbazine;Chemical;PA182;Gene
CYP1A1;dacarbazine;Chemical;PA27092;Gene
CYP1A2;dacarbazine;Chemical;PA27093;Gene
CYP2D6;maprotiline;Chemical;PA128;Gene
CYP2D6*1;maprotiline;Chemical;PA165816576;Haplotype
CYP2D6*4;maprotiline;Chemical;PA165816579;Haplotype
ABCB1;maprotiline;Chemical;PA267;Gene
PROSTATIC NEOPLASMS;rs2238472;Variant;PA445425;Disease
DOCETAXEL;rs2238472;Variant;PA449383;Chemical
THALIDOMIDE;rs2238472;Variant;PA451644;Chemical
NEUROPATHIC PAIN;SLC7A5;Gene;PA162263525;Disease
PREGABALIN;SLC7A5;Gene;PA164754814;Chemical
ADVERSE EVENTS;SLC7A5;Gene;PA166151827;Disease
MULTIPLE MYELOMA;SLC7A5;Gene;PA444985;Disease
GABAPENTIN;SLC7A5;Gene;PA449720;Chemical
MELPHALAN;SLC7A5;Gene;PA450354;Chemical
COMT;opioids;Chemical;PA117;Gene
CYP2B6;opioids;Chemical;PA123;Gene
CYP2D6;opioids;Chemical;PA128;Gene
CYP3A4;opioids;Chemical;PA130;Gene
CYP3A5;opioids;Chemical;PA131;Gene
ANKK1;opioids;Chemical;PA134872551;Gene
ZNF568;opioids;Chemical;PA134893477;Gene
CNIH3;opioids;Chemical;PA134929862;Gene
EXOC4;opioids;Chemical;PA134944654;Gene
BDNF-AS;opioids;Chemical;PA134953249;Gene
ADGRV1;opioids;Chemical;PA134960779;Gene
ZSCAN25;opioids;Chemical;PA134962723;Gene
TAOK3;opioids;Chemical;PA134975064;Gene
RHBDF2;opioids;Chemical;PA134980674;Gene
DBH;opioids;Chemical;PA136;Gene
CLCC1;opioids;Chemical;PA142672105;Gene
LKAAEAR1;opioids;Chemical;PA162378956;Gene
KAT2B;opioids;Chemical;PA162392705;Gene
ZNF804A;opioids;Chemical;PA162410599;Gene
CYP2D6*4;opioids;Chemical;PA165816579;Haplotype
RS2236861;opioids;Chemical;PA166153682;Variant
RS2295632;opioids;Chemical;PA166153693;Variant
RS6265;opioids;Chemical;PA166154259;Variant
RS6275;opioids;Chemical;PA166154260;Variant
RS948854;opioids;Chemical;PA166154302;Variant
RS1076560;opioids;Chemical;PA166154313;Variant
RS1125394;opioids;Chemical;PA166154319;Variant
RS1800497;opioids;Chemical;PA166154339;Variant
RS10770141;opioids;Chemical;PA166154434;Variant
RS6305;opioids;Chemical;PA166154672;Variant
RS2069514;opioids;Chemical;PA166154874;Variant
RS12948783;opioids;Chemical;PA166155254;Variant
RS3745274;opioids;Chemical;PA166155409;Variant
RS2952768;opioids;Chemical;PA166155692;Variant
RS4633;opioids;Chemical;PA166156023;Variant
RS4680;opioids;Chemical;PA166156024;Variant
RS4818;opioids;Chemical;PA166156025;Variant
RS6269;opioids;Chemical;PA166156027;Variant
RS1065852;opioids;Chemical;PA166156062;Variant
RS6280;opioids;Chemical;PA166156277;Variant
RS2654754;opioids;Chemical;PA166156360;Variant
RS9288993;opioids;Chemical;PA166156428;Variant
RS510769;opioids;Chemical;PA166156924;Variant
RS1799971;opioids;Chemical;PA166156991;Variant
RS2275913;opioids;Chemical;PA166157030;Variant
RS9479757;opioids;Chemical;PA166157164;Variant
RS15524;opioids;Chemical;PA166157243;Variant
RS776746;opioids;Chemical;PA166157267;Variant
RS1045642;opioids;Chemical;PA166157284;Variant
RS2740574;opioids;Chemical;PA166157367;Variant
RS9282564;opioids;Chemical;PA166157435;Variant
RS1611115;opioids;Chemical;PA166157734;Variant
RS1611131;opioids;Chemical;PA166175925;Variant
RS2070762;opioids;Chemical;PA166175927;Variant
RS648893;opioids;Chemical;PA166176243;Variant
RS6090041;opioids;Chemical;PA166177052;Variant
RS6090043;opioids;Chemical;PA166177053;Variant
RS1799972;opioids;Chemical;PA166177739;Variant
RS495491;opioids;Chemical;PA166177792;Variant
RS10457090;opioids;Chemical;PA166177793;Variant
RS589046;opioids;Chemical;PA166177794;Variant
RS1997794;opioids;Chemical;PA166177932;Variant
RS1022563;opioids;Chemical;PA166177933;Variant
RS910080;opioids;Chemical;PA166177939;Variant
RS548646;opioids;Chemical;PA166179967;Variant
RS6517442;opioids;Chemical;PA166182219;Variant
RS795484;opioids;Chemical;PA166182407;Variant
RS1277441;opioids;Chemical;PA166182408;Variant
RS511435;opioids;Chemical;PA166183701;Variant
RS524731;opioids;Chemical;PA166183702;Variant
RS3823010;opioids;Chemical;PA166183703;Variant
RS3778156;opioids;Chemical;PA166183705;Variant
RS609148;opioids;Chemical;PA166183707;Variant
RS1079596;opioids;Chemical;PA166183998;Variant
RS6928499;opioids;Chemical;PA166184035;Variant
RS9829896;opioids;Chemical;PA166184842;Variant
RS997917;opioids;Chemical;PA166198164;Variant
RS115208233;opioids;Chemical;PA166199581;Variant
RS116181528;opioids;Chemical;PA166199582;Variant
RS114077267;opioids;Chemical;PA166199601;Variant
RS2366929;opioids;Chemical;PA166205161;Variant
RS36024412;opioids;Chemical;PA166206581;Variant
RS168107;opioids;Chemical;PA166206601;Variant
RS41269255;opioids;Chemical;PA166206602;Variant
RS9393888;opioids;Chemical;PA166206603;Variant
RS12305038;opioids;Chemical;PA166206604;Variant
RS11882256;opioids;Chemical;PA166206605;Variant
RS10405238;opioids;Chemical;PA166206621;Variant
RS10770140;opioids;Chemical;PA166208983;Variant
RS11030096;opioids;Chemical;PA166235681;Variant
RS4906902;opioids;Chemical;PA166235724;Variant
RS735668;opioids;Chemical;PA166235762;Variant
RS7597593;opioids;Chemical;PA166235764;Variant
RS2023239;opioids;Chemical;PA166235801;Variant
RS324029;opioids;Chemical;PA166235844;Variant
RS718656;opioids;Chemical;PA166235847;Variant
RS1384401;opioids;Chemical;PA166235849;Variant
RS4530637;opioids;Chemical;PA166235850;Variant
RS10799590;opioids;Chemical;PA166252261;Variant
HTR2A;opioids;Chemical;PA193;Gene
CRYBG2;opioids;Chemical;PA24650;Gene
CNR1;opioids;Chemical;PA26681;Gene
ABCB1;opioids;Chemical;PA267;Gene
CYP1A2;opioids;Chemical;PA27093;Gene
CYP2A7P1;opioids;Chemical;PA27103;Gene
CYP3A;opioids;Chemical;PA27114;Gene
DRD2;opioids;Chemical;PA27478;Gene
DRD3;opioids;Chemical;PA27479;Gene
FAAH;opioids;Chemical;PA27955;Gene
GABRB3;opioids;Chemical;PA28497;Gene
GAL;opioids;Chemical;PA28529;Gene
IL17A;opioids;Chemical;PA29794;Gene
KCNJ6;opioids;Chemical;PA30049;Gene
MCOLN1;opioids;Chemical;PA30699;Gene
MUC16;opioids;Chemical;PA31314;Gene
BDNF;opioids;Chemical;PA31891;Gene
OPRD1;opioids;Chemical;PA31942;Gene
OPRK1;opioids;Chemical;PA31943;Gene
OPRL1;opioids;Chemical;PA31944;Gene
OPRM1;opioids;Chemical;PA31945;Gene
PDE3A;opioids;Chemical;PA33126;Gene
PDYN;opioids;Chemical;PA33163;Gene
POM121L2;opioids;Chemical;PA33524;Gene
RGS19;opioids;Chemical;PA34370;Gene
TH;opioids;Chemical;PA351;Gene
TACR1;opioids;Chemical;PA36302;Gene
TACR3;opioids;Chemical;PA36304;Gene
HNF1A;opioids;Chemical;PA36380;Gene
ZNF165;opioids;Chemical;PA37535;Gene
DIABETES MELLITUS, TYPE 2;rs2289669;Variant;PA443890;Disease
POLYCYSTIC OVARY SYNDROME;rs2289669;Variant;PA445376;Disease
METFORMIN;rs2289669;Variant;PA450395;Chemical
ACETALDEHYDE;rs1229976;Variant;PA166186245;Chemical
RS9376230;hydroxyurea;Chemical;PA166157152;Variant
RS9483947;hydroxyurea;Chemical;PA166157165;Variant
MAP3K5;hydroxyurea;Chemical;PA30601;Gene
GEFITINIB;MAP3K1;Gene;PA131301952;Chemical
ERLOTINIB;MAP3K1;Gene;PA134687924;Chemical
SHC3;MAP3K1;Gene;PA134913435;Gene
SHC2;MAP3K1;Gene;PA134971076;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;MAP3K1;Gene;PA164713366;Chemical
MAP2K7;MAP3K1;Gene;PA284;Gene
GRB2;MAP3K1;Gene;PA28962;Gene
HRAS;MAP3K1;Gene;PA29444;Gene
KRAS;MAP3K1;Gene;PA30196;Gene
MAP2K4;MAP3K1;Gene;PA30589;Gene
MRAS;MAP3K1;Gene;PA30932;Gene
NRAS;MAP3K1;Gene;PA31768;Gene
RRAS;MAP3K1;Gene;PA34861;Gene
SHC1;MAP3K1;Gene;PA35746;Gene
SOS1;MAP3K1;Gene;PA36024;Gene
NON-SMALL CELL LUNG CARCINOMA;MAP3K1;Gene;PA443622;Disease
PSORIASIS;MAP3K1;Gene;PA445451;Disease
CARBOPLATIN;MAP3K1;Gene;PA448803;Chemical
CISPLATIN;MAP3K1;Gene;PA449014;Chemical
DOCETAXEL;MAP3K1;Gene;PA449383;Chemical
PACLITAXEL;MAP3K1;Gene;PA450761;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs518329;Variant;PA443622;Disease
DOCETAXEL;rs518329;Variant;PA449383;Chemical
CETP;hmg coa reductase inhibitors;Chemical;PA108;Gene
ABCC2;hmg coa reductase inhibitors;Chemical;PA116;Gene
CYP2C19;hmg coa reductase inhibitors;Chemical;PA124;Gene
CYP2C8;hmg coa reductase inhibitors;Chemical;PA125;Gene
CYP2C9;hmg coa reductase inhibitors;Chemical;PA126;Gene
CYP2D6;hmg coa reductase inhibitors;Chemical;PA128;Gene
CYP3A4;hmg coa reductase inhibitors;Chemical;PA130;Gene
CYP3A5;hmg coa reductase inhibitors;Chemical;PA131;Gene
SLCO1B1;hmg coa reductase inhibitors;Chemical;PA134865839;Gene
CFAP44;hmg coa reductase inhibitors;Chemical;PA134928828;Gene
COQ2;hmg coa reductase inhibitors;Chemical;PA142672084;Gene
EYS;hmg coa reductase inhibitors;Chemical;PA164719488;Gene
HLA-DRB1*01:01;hmg coa reductase inhibitors;Chemical;PA165951320;Haplotype
HLA-DRB1*04:06;hmg coa reductase inhibitors;Chemical;PA165951530;Haplotype
UGT1A1*28;hmg coa reductase inhibitors;Chemical;PA166115842;Haplotype
RS646776;hmg coa reductase inhibitors;Chemical;PA166153583;Variant
RS1935349;hmg coa reductase inhibitors;Chemical;PA166153988;Variant
RS5443;hmg coa reductase inhibitors;Chemical;PA166154486;Variant
RS2306283;hmg coa reductase inhibitors;Chemical;PA166154547;Variant
RS2900478;hmg coa reductase inhibitors;Chemical;PA166154557;Variant
RS4149056;hmg coa reductase inhibitors;Chemical;PA166154579;Variant
RS11045819;hmg coa reductase inhibitors;Chemical;PA166154628;Variant
RS1008805;hmg coa reductase inhibitors;Chemical;PA166154854;Variant
RS1062033;hmg coa reductase inhibitors;Chemical;PA166154858;Variant
RS1719247;hmg coa reductase inhibitors;Chemical;PA166154867;Variant
RS9806699;hmg coa reductase inhibitors;Chemical;PA166154927;Variant
RS247616;hmg coa reductase inhibitors;Chemical;PA166154992;Variant
RS708272;hmg coa reductase inhibitors;Chemical;PA166154993;Variant
RS1532624;hmg coa reductase inhibitors;Chemical;PA166155015;Variant
RS11868035;hmg coa reductase inhibitors;Chemical;PA166155247;Variant
RS429358;hmg coa reductase inhibitors;Chemical;PA166155351;Variant
RS445925;hmg coa reductase inhibitors;Chemical;PA166155352;Variant
RS118192172;hmg coa reductase inhibitors;Chemical;PA166155537;Variant
RS137852808;hmg coa reductase inhibitors;Chemical;PA166155904;Variant
RS402007;hmg coa reductase inhibitors;Chemical;PA166155979;Variant
RS13064411;hmg coa reductase inhibitors;Chemical;PA166156455;Variant
RS352046;hmg coa reductase inhibitors;Chemical;PA166156487;Variant
RS4693075;hmg coa reductase inhibitors;Chemical;PA166156593;Variant
RS6535454;hmg coa reductase inhibitors;Chemical;PA166156601;Variant
RS12654264;hmg coa reductase inhibitors;Chemical;PA166156878;Variant
RS17238540;hmg coa reductase inhibitors;Chemical;PA166156885;Variant
RS1063320;hmg coa reductase inhibitors;Chemical;PA166156976;Variant
RS10455872;hmg coa reductase inhibitors;Chemical;PA166157168;Variant
RS1045642;hmg coa reductase inhibitors;Chemical;PA166157284;Variant
RS1128503;hmg coa reductase inhibitors;Chemical;PA166157288;Variant
RS1799983;hmg coa reductase inhibitors;Chemical;PA166157303;Variant
RS3857532;hmg coa reductase inhibitors;Chemical;PA166179565;Variant
RS1337512;hmg coa reductase inhibitors;Chemical;PA166179571;Variant
RS13210472;hmg coa reductase inhibitors;Chemical;PA166266481;Variant
GNB3;hmg coa reductase inhibitors;Chemical;PA176;Gene
HMGCR;hmg coa reductase inhibitors;Chemical;PA189;Gene
ADAMTS1;hmg coa reductase inhibitors;Chemical;PA24536;Gene
NOS3;hmg coa reductase inhibitors;Chemical;PA254;Gene
CELSR2;hmg coa reductase inhibitors;Chemical;PA26394;Gene
CHRNA1;hmg coa reductase inhibitors;Chemical;PA26487;Gene
ABCB1;hmg coa reductase inhibitors;Chemical;PA267;Gene
CYP19A1;hmg coa reductase inhibitors;Chemical;PA27091;Gene
GATM;hmg coa reductase inhibitors;Chemical;PA28590;Gene
HTR7;hmg coa reductase inhibitors;Chemical;PA29561;Gene
LPA;hmg coa reductase inhibitors;Chemical;PA30432;Gene
SLC15A1;hmg coa reductase inhibitors;Chemical;PA323;Gene
SLCO1A2;hmg coa reductase inhibitors;Chemical;PA328;Gene
SREBF1;hmg coa reductase inhibitors;Chemical;PA335;Gene
RYR1;hmg coa reductase inhibitors;Chemical;PA34896;Gene
HLA-DRB1;hmg coa reductase inhibitors;Chemical;PA35072;Gene
HLA-G;hmg coa reductase inhibitors;Chemical;PA35083;Gene
CXCL5;hmg coa reductase inhibitors;Chemical;PA35573;Gene
SLCO1B3;hmg coa reductase inhibitors;Chemical;PA35844;Gene
SLCO2B1;hmg coa reductase inhibitors;Chemical;PA35845;Gene
UGT2B7;hmg coa reductase inhibitors;Chemical;PA361;Gene
UGT1A3;hmg coa reductase inhibitors;Chemical;PA37178;Gene
ABCB11;hmg coa reductase inhibitors;Chemical;PA374;Gene
SLC22A6;hmg coa reductase inhibitors;Chemical;PA388;Gene
SLC22A8;hmg coa reductase inhibitors;Chemical;PA389;Gene
ABCG2;hmg coa reductase inhibitors;Chemical;PA390;Gene
UGT1A1;hmg coa reductase inhibitors;Chemical;PA420;Gene
APOE;hmg coa reductase inhibitors;Chemical;PA55;Gene
LEUKEMIA, MYELOID, ACUTE;rs2306744;Variant;PA444760;Disease
CYTARABINE;rs2306744;Variant;PA449177;Chemical
IDARUBICIN;rs2306744;Variant;PA449961;Chemical
FARGLITAZAR;rs889299;Variant;PA165815771;Chemical
DIABETES MELLITUS, TYPE 2;rs889299;Variant;PA443890;Disease
GLYBURIDE;rs889299;Variant;PA449782;Chemical
BREAST NEOPLASMS;MDM4;Gene;PA443560;Disease
DOCETAXEL;MDM4;Gene;PA449383;Chemical
EPIRUBICIN;MDM4;Gene;PA449476;Chemical
NR1I2;cefuroxime;Chemical;PA378;Gene
SETMELANOTIDE;PCSK1;Gene;PA166235341;Chemical
CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA;RYR2;Gene;PA166123311;Disease
CARDIOVASCULAR DISEASE;RYR2;Gene;PA443635;Disease
RHABDOMYOLYSIS;RYR2;Gene;PA445549;Disease
ATORVASTATIN;RYR2;Gene;PA448500;Chemical
CERIVASTATIN;RYR2;Gene;PA448897;Chemical
SIMVASTATIN;RYR2;Gene;PA451363;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs1517114;Variant;PA443622;Disease
IRINOTECAN;rs1517114;Variant;PA450085;Chemical
SCHIZOPHRENIA;rs1778929;Variant;PA447216;Disease
CLOZAPINE;rs1778929;Variant;PA449061;Chemical
CYP2B6;aflatoxin b1;Chemical;PA123;Gene
CHRNA3;Pregnancy;Disease;PA113;Gene
CYP2B6;Pregnancy;Disease;PA123;Gene
CYP3A5;Pregnancy;Disease;PA131;Gene
CYP2B6*1;Pregnancy;Disease;PA165818750;Haplotype
CYP2B6*6;Pregnancy;Disease;PA165818762;Haplotype
UGT1A1*1;Pregnancy;Disease;PA166115841;Haplotype
UGT1A1*28;Pregnancy;Disease;PA166115842;Haplotype
UGT1A1*36;Pregnancy;Disease;PA166115843;Haplotype
UGT1A1*37;Pregnancy;Disease;PA166115844;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);Pregnancy;Disease;PA166116465;Haplotype
RS1051730;Pregnancy;Disease;PA166154856;Variant
RS776746;Pregnancy;Disease;PA166157267;Variant
CYP1A2 HIGH ACTIVITY;Pregnancy;Disease;PA166157954;Variant
G6PD DEFICIENCY;Pregnancy;Disease;PA166157959;Variant
CYP1A2 LOW ACTIVITY;Pregnancy;Disease;PA166157966;Variant
CYP1A2;Pregnancy;Disease;PA27093;Gene
G6PD;Pregnancy;Disease;PA28469;Gene
SLC6A4;Pregnancy;Disease;PA312;Gene
UGT1A1;Pregnancy;Disease;PA420;Gene
ASTHMA;NAGA;Gene;PA443450;Disease
NEUROPATHIC PAIN;rs4240803;Variant;PA162263525;Disease
PREGABALIN;rs4240803;Variant;PA164754814;Chemical
ADVERSE EVENTS;rs4240803;Variant;PA166151827;Disease
MULTIPLE MYELOMA;rs4240803;Variant;PA444985;Disease
GABAPENTIN;rs4240803;Variant;PA449720;Chemical
MELPHALAN;rs4240803;Variant;PA450354;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;HLA-DQB1*05:02;Haplotype;PA164712708;Chemical
DRUG-INDUCED LIVER INJURY;HLA-DQB1*05:02;Haplotype;PA166119041;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-DQB1*05:02;Haplotype;PA166120929;Disease
FLUPIRTINE;HLA-DQB1*05:02;Haplotype;PA166152829;Chemical
AGRANULOCYTOSIS;HLA-DQB1*05:02;Haplotype;PA443297;Disease
DRUG HYPERSENSITIVITY;HLA-DQB1*05:02;Haplotype;PA443936;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-DQB1*05:02;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-DQB1*05:02;Haplotype;PA445738;Disease
TUBERCULOSIS;HLA-DQB1*05:02;Haplotype;PA445941;Disease
SCHIZOPHRENIA;HLA-DQB1*05:02;Haplotype;PA447216;Disease
ALLOPURINOL;HLA-DQB1*05:02;Haplotype;PA448320;Chemical
CLOZAPINE;HLA-DQB1*05:02;Haplotype;PA449061;Chemical
NON-SMALL CELL LUNG CARCINOMA;PPP1R18;Gene;PA443622;Disease
THROMBOCYTOPENIA;PPP1R18;Gene;PA445846;Disease
CARBOPLATIN;PPP1R18;Gene;PA448803;Chemical
GEMCITABINE;PPP1R18;Gene;PA449748;Chemical
VARDENAFIL;rs776746;Variant;PA10229;Chemical
IMATINIB;rs776746;Variant;PA10804;Chemical
ROSUVASTATIN;rs776746;Variant;PA134308647;Chemical
MYALGIA;rs776746;Variant;PA157379134;Disease
SUNITINIB;rs776746;Variant;PA162372840;Chemical
TOXIC LIVER DISEASE;rs776746;Variant;PA164925725;Disease
LUMEFANTRINE;rs776746;Variant;PA165111722;Chemical
KIDNEY TRANSPLANTATION;rs776746;Variant;PA165817016;Disease
PREGNANCY;rs776746;Variant;PA166048714;Disease
TRANSPLANT REJECTION;rs776746;Variant;PA166114454;Disease
APIXABAN;rs776746;Variant;PA166163740;Chemical
ARTERIOSCLEROSIS;rs776746;Variant;PA443425;Disease
ATRIAL FIBRILLATION;rs776746;Variant;PA443459;Disease
RENAL CELL CARCINOMA;rs776746;Variant;PA443624;Disease
ULCERATIVE COLITIS;rs776746;Variant;PA443750;Disease
DRUG TOXICITY;rs776746;Variant;PA443937;Disease
EPILEPSY;rs776746;Variant;PA444065;Disease
HYPERCHOLESTEROLEMIA;rs776746;Variant;PA444516;Disease
HYPERLIPIDEMIAS;rs776746;Variant;PA444528;Disease
HYPERTENSION;rs776746;Variant;PA444552;Disease
INFECTIOUS DISEASE;rs776746;Variant;PA444614;Disease
MALARIA;rs776746;Variant;PA444859;Disease
MYOCARDIAL INFARCTION;rs776746;Variant;PA445019;Disease
OPIOID-RELATED DISORDERS;rs776746;Variant;PA445043;Disease
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;rs776746;Variant;PA446171;Disease
KIDNEY FAILURE;rs776746;Variant;PA446438;Disease
NEUROTOXICITY SYNDROMES;rs776746;Variant;PA446975;Disease
HIV INFECTIOUS DISEASE;rs776746;Variant;PA447230;Disease
LIVER TRANSPLANTATION;rs776746;Variant;PA447247;Disease
ATORVASTATIN;rs776746;Variant;PA448500;Chemical
CARBAMAZEPINE;rs776746;Variant;PA448785;Chemical
CYCLOSPORINE;rs776746;Variant;PA449167;Chemical
EFAVIRENZ;rs776746;Variant;PA449441;Chemical
LOPINAVIR;rs776746;Variant;PA450264;Chemical
LOVASTATIN;rs776746;Variant;PA450272;Chemical
NEVIRAPINE;rs776746;Variant;PA450616;Chemical
NIFEDIPINE;rs776746;Variant;PA450631;Chemical
ONDANSETRON;rs776746;Variant;PA450705;Chemical
QUETIAPINE;rs776746;Variant;PA451201;Chemical
SIMVASTATIN;rs776746;Variant;PA451363;Chemical
TACROLIMUS;rs776746;Variant;PA451578;Chemical
OPIOIDS;rs776746;Variant;PA452618;Chemical
CYP2C9;Gastrointestinal Hemorrhage;Disease;PA126;Gene
CYP2C9*1;Gastrointestinal Hemorrhage;Disease;PA165816542;Haplotype
CYP2C9*2;Gastrointestinal Hemorrhage;Disease;PA165816543;Haplotype
CYP2C9*3;Gastrointestinal Hemorrhage;Disease;PA165816544;Haplotype
HGFAC;Gastrointestinal Hemorrhage;Disease;PA29270;Gene
DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS;rs7754840;Variant;PA164712689;Chemical
DIABETES MELLITUS;rs7754840;Variant;PA443886;Disease
CYP2C9;bosentan;Chemical;PA126;Gene
SLCO1B1;bosentan;Chemical;PA134865839;Gene
CYP2C9*1;bosentan;Chemical;PA165816542;Haplotype
CYP2C9*2;bosentan;Chemical;PA165816543;Haplotype
CYP2C9*3;bosentan;Chemical;PA165816544;Haplotype
NR1I2;bosentan;Chemical;PA378;Gene
HMG COA REDUCTASE INHIBITORS;rs118192172;Variant;PA133950441;Chemical
DESFLURANE;rs118192172;Variant;PA164749136;Chemical
RYR1;rs118192172;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs118192172;Variant;PA444863;Disease
MUSCULAR DISEASES;rs118192172;Variant;PA444997;Disease
CAFFEINE;rs118192172;Variant;PA448710;Chemical
ENFLURANE;rs118192172;Variant;PA449461;Chemical
HALOTHANE;rs118192172;Variant;PA449845;Chemical
ISOFLURANE;rs118192172;Variant;PA450106;Chemical
METHOXYFLURANE;rs118192172;Variant;PA450434;Chemical
SEVOFLURANE;rs118192172;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs118192172;Variant;PA451522;Chemical
CACNA1S;rs118192172;Variant;PA85;Gene
SULFAMETHOXAZOLE / TRIMETHOPRIM;NAT2*4;Haplotype;PA10715;Chemical
ANTIVIRALS FOR TREATMENT OF HIV INFECTIONS, COMBINATIONS;NAT2*4;Haplotype;PA164712505;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;NAT2*4;Haplotype;PA164712708;Chemical
TOXIC LIVER DISEASE;NAT2*4;Haplotype;PA164925725;Disease
DRUG-INDUCED LIVER INJURY;NAT2*4;Haplotype;PA166119041;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;NAT2*4;Haplotype;PA166120929;Disease
DIPYRONE;NAT2*4;Haplotype;PA166128206;Chemical
ADVERSE EVENTS;NAT2*4;Haplotype;PA166151827;Disease
SOLITHROMYCIN;NAT2*4;Haplotype;PA166165147;Chemical
HYPERSENSITIVITY;NAT2*4;Haplotype;PA444546;Disease
HYPERTENSION;NAT2*4;Haplotype;PA444552;Disease
TUBERCULOSIS;NAT2*4;Haplotype;PA445941;Disease
HIV INFECTIONS;NAT2*4;Haplotype;PA447230;Disease
CAFFEINE;NAT2*4;Haplotype;PA448710;Chemical
HYDRALAZINE;NAT2*4;Haplotype;PA449894;Chemical
ISONIAZID;NAT2*4;Haplotype;PA450112;Chemical
RIFAMPIN;NAT2*4;Haplotype;PA451250;Chemical
SULFAMETHAZINE;NAT2*4;Haplotype;PA451542;Chemical
TUBERCULOSIS;rs2279345;Variant;PA445941;Disease
HIV INFECTIOUS DISEASE;rs2279345;Variant;PA447230;Disease
EFAVIRENZ;rs2279345;Variant;PA449441;Chemical
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;SLCO1B1*20;Haplotype;PA446155;Disease
METHOTREXATE;SLCO1B1*20;Haplotype;PA450428;Chemical
CES1;Drug Toxicity;Disease;PA107;Gene
ABCC2;Drug Toxicity;Disease;PA116;Gene
COMT;Drug Toxicity;Disease;PA117;Gene
SLC31A1;Drug Toxicity;Disease;PA118;Gene
CYP2B6;Drug Toxicity;Disease;PA123;Gene
CYP2C19;Drug Toxicity;Disease;PA124;Gene
CYP2C8;Drug Toxicity;Disease;PA125;Gene
CYP2C9;Drug Toxicity;Disease;PA126;Gene
CYP2D6;Drug Toxicity;Disease;PA128;Gene
CYP2E1;Drug Toxicity;Disease;PA129;Gene
CYP3A4;Drug Toxicity;Disease;PA130;Gene
CYP3A5;Drug Toxicity;Disease;PA131;Gene
SLCO1B1;Drug Toxicity;Disease;PA134865839;Gene
TMEM43;Drug Toxicity;Disease;PA134871907;Gene
CES1P1;Drug Toxicity;Disease;PA134906523;Gene
ZSCAN25;Drug Toxicity;Disease;PA134962723;Gene
DHFR;Drug Toxicity;Disease;PA143;Gene
DPYD;Drug Toxicity;Disease;PA145;Gene
DPYS;Drug Toxicity;Disease;PA146;Gene
ERCC1;Drug Toxicity;Disease;PA155;Gene
PARD3B;Drug Toxicity;Disease;PA162398721;Gene
RUNDC3B;Drug Toxicity;Disease;PA162402278;Gene
CYP2C9*1;Drug Toxicity;Disease;PA165816542;Haplotype
CYP2C9*2;Drug Toxicity;Disease;PA165816543;Haplotype
CYP2C9*3;Drug Toxicity;Disease;PA165816544;Haplotype
CYP2D6*1;Drug Toxicity;Disease;PA165816576;Haplotype
CYP2D6*2;Drug Toxicity;Disease;PA165816577;Haplotype
CYP2D6*3;Drug Toxicity;Disease;PA165816578;Haplotype
CYP2D6*4;Drug Toxicity;Disease;PA165816579;Haplotype
CYP2D6*6;Drug Toxicity;Disease;PA165816581;Haplotype
CYP2D6*10;Drug Toxicity;Disease;PA165816582;Haplotype
CYP2D6*41;Drug Toxicity;Disease;PA165816584;Haplotype
CYP2B6*1;Drug Toxicity;Disease;PA165818750;Haplotype
CYP2B6*6;Drug Toxicity;Disease;PA165818762;Haplotype
SLCO1B1*5;Drug Toxicity;Disease;PA165819255;Haplotype
TPMT*1;Drug Toxicity;Disease;PA165819268;Haplotype
TPMT*2;Drug Toxicity;Disease;PA165819269;Haplotype
TPMT*3A;Drug Toxicity;Disease;PA165819270;Haplotype
TPMT*12;Drug Toxicity;Disease;PA165819282;Haplotype
CYP2D6*5;Drug Toxicity;Disease;PA165948092;Haplotype
HLA-DQA1*02:01;Drug Toxicity;Disease;PA165951292;Haplotype
HLA-DRB1*01:01;Drug Toxicity;Disease;PA165951320;Haplotype
HLA-DRB1*07:01;Drug Toxicity;Disease;PA165951644;Haplotype
HLA-A*11:01;Drug Toxicity;Disease;PA165953358;Haplotype
HLA-B*15:27;Drug Toxicity;Disease;PA165954816;Haplotype
HLA-B*35:01;Drug Toxicity;Disease;PA165955215;Haplotype
HLA-B*51:01;Drug Toxicity;Disease;PA165956201;Haplotype
HLA-C*04:01;Drug Toxicity;Disease;PA165957046;Haplotype
CYP2C8*2;Drug Toxicity;Disease;PA165958684;Haplotype
CYP2C8*3;Drug Toxicity;Disease;PA165958685;Haplotype
CYP2C8*4;Drug Toxicity;Disease;PA165958686;Haplotype
CYP2C19*1;Drug Toxicity;Disease;PA165980634;Haplotype
CYP2C19*2;Drug Toxicity;Disease;PA165980635;Haplotype
SLCO1B1*1;Drug Toxicity;Disease;PA165981641;Haplotype
CYP2D6*1XN;Drug Toxicity;Disease;PA165988479;Haplotype
CYP2D6*2XN;Drug Toxicity;Disease;PA165988480;Haplotype
GSTM1 NULL;Drug Toxicity;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Drug Toxicity;Disease;PA166048676;Haplotype
CYP3A4*22;Drug Toxicity;Disease;PA166048680;Haplotype
UGT1A1*1;Drug Toxicity;Disease;PA166115841;Haplotype
UGT1A1*28;Drug Toxicity;Disease;PA166115842;Haplotype
UGT1A1*6;Drug Toxicity;Disease;PA166115858;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);Drug Toxicity;Disease;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);Drug Toxicity;Disease;PA166116466;Haplotype
CYP2D6*81;Drug Toxicity;Disease;PA166123321;Haplotype
HLA-A*02:01;Drug Toxicity;Disease;PA166123427;Haplotype
CYP3A5*1;Drug Toxicity;Disease;PA166128213;Haplotype
CYP3A5*3;Drug Toxicity;Disease;PA166128219;Haplotype
RS1801133;Drug Toxicity;Disease;PA166153644;Variant
RS1805087;Drug Toxicity;Disease;PA166153654;Variant
RS3215400;Drug Toxicity;Disease;PA166153738;Variant
RS4846051;Drug Toxicity;Disease;PA166153777;Variant
RS3740065;Drug Toxicity;Disease;PA166154027;Variant
RS10509681;Drug Toxicity;Disease;PA166154110;Variant
RS11572080;Drug Toxicity;Disease;PA166154140;Variant
RS17222723;Drug Toxicity;Disease;PA166154163;Variant
RS1695;Drug Toxicity;Disease;PA166154249;Variant
RS1806201;Drug Toxicity;Disease;PA166154519;Variant
RS6313;Drug Toxicity;Disease;PA166154675;Variant
RS899494;Drug Toxicity;Disease;PA166154688;Variant
RS9561778;Drug Toxicity;Disease;PA166154741;Variant
RS246240;Drug Toxicity;Disease;PA166154991;Variant
RS2244613;Drug Toxicity;Disease;PA166155037;Variant
RS45511401;Drug Toxicity;Disease;PA166155130;Variant
RS1042522;Drug Toxicity;Disease;PA166155173;Variant
RS1051640;Drug Toxicity;Disease;PA166155176;Variant
RS1136201;Drug Toxicity;Disease;PA166155183;Variant
RS45445694;Drug Toxicity;Disease;PA166155331;Variant
RS11615;Drug Toxicity;Disease;PA166155342;Variant
RS3745274;Drug Toxicity;Disease;PA166155409;Variant
RS3770102;Drug Toxicity;Disease;PA166155709;Variant
RS3832043;Drug Toxicity;Disease;PA166155718;Variant
RS4124874;Drug Toxicity;Disease;PA166155720;Variant
RS10932125;Drug Toxicity;Disease;PA166155797;Variant
RS17626122;Drug Toxicity;Disease;PA166155846;Variant
RS1051266;Drug Toxicity;Disease;PA166155986;Variant
RS4646316;Drug Toxicity;Disease;PA166156108;Variant
RS9332377;Drug Toxicity;Disease;PA166156133;Variant
RS1801019;Drug Toxicity;Disease;PA166156330;Variant
RS2228001;Drug Toxicity;Disease;PA166156345;Variant
RS2231137;Drug Toxicity;Disease;PA166156543;Variant
RS2231142;Drug Toxicity;Disease;PA166156544;Variant
RS1801394;Drug Toxicity;Disease;PA166156776;Variant
RS1142345;Drug Toxicity;Disease;PA166156978;Variant
RS2016520;Drug Toxicity;Disease;PA166157007;Variant
RS2647087;Drug Toxicity;Disease;PA166157045;Variant
RS9274407;Drug Toxicity;Disease;PA166157135;Variant
RS776746;Drug Toxicity;Disease;PA166157267;Variant
RS1045642;Drug Toxicity;Disease;PA166157284;Variant
RS1208;Drug Toxicity;Disease;PA166157540;Variant
RS1041983;Drug Toxicity;Disease;PA166157549;Variant
RS1799929;Drug Toxicity;Disease;PA166157563;Variant
RS1799930;Drug Toxicity;Disease;PA166157564;Variant
RS1799931;Drug Toxicity;Disease;PA166157565;Variant
RS1801280;Drug Toxicity;Disease;PA166157570;Variant
RS770063251;Drug Toxicity;Disease;PA166157694;Variant
RS6151031;Drug Toxicity;Disease;PA166157783;Variant
CYP2C19 INTERMEDIATE METABOLIZER;Drug Toxicity;Disease;PA166157913;Variant
DPYD DEFICIENCY;Drug Toxicity;Disease;PA166157931;Variant
RS376073289;Drug Toxicity;Disease;PA166159507;Variant
RS367619008;Drug Toxicity;Disease;PA166159539;Variant
RS836554;Drug Toxicity;Disease;PA166160419;Variant
RS3045983;Drug Toxicity;Disease;PA166160497;Variant
RS3217164;Drug Toxicity;Disease;PA166163239;Variant
RS2244614;Drug Toxicity;Disease;PA166163241;Variant
RS11861118;Drug Toxicity;Disease;PA166163244;Variant
RS7187684;Drug Toxicity;Disease;PA166163246;Variant
RS2270860;Drug Toxicity;Disease;PA166163754;Variant
DPYD C.2846A>T;Drug Toxicity;Disease;PA166171119;Haplotype
DPYD C.1129-5923C>G, C.1236G>A (HAPB3);Drug Toxicity;Disease;PA166171120;Haplotype
RS544027339;Drug Toxicity;Disease;PA166179353;Variant
RS1029359343;Drug Toxicity;Disease;PA166179355;Variant
RS2233914;Drug Toxicity;Disease;PA166179466;Variant
RS11280056;Drug Toxicity;Disease;PA166180936;Variant
RS28656907;Drug Toxicity;Disease;PA166185792;Variant
RS4430924;Drug Toxicity;Disease;PA166186121;Variant
RS36120609;Drug Toxicity;Disease;PA166211543;Variant
CYP2C8*1;Drug Toxicity;Disease;PA166242948;Haplotype
RS4864950;Drug Toxicity;Disease;PA166283282;Variant
RS12366035;Drug Toxicity;Disease;PA166283581;Variant
RS1868089;Drug Toxicity;Disease;PA166283641;Variant
RS7557402;Drug Toxicity;Disease;PA166283681;Variant
RS10958704;Drug Toxicity;Disease;PA166283702;Variant
RS12948059;Drug Toxicity;Disease;PA166283722;Variant
RS4035887;Drug Toxicity;Disease;PA166283741;Variant
RS315498;Drug Toxicity;Disease;PA166283743;Variant
RS9973653;Drug Toxicity;Disease;PA166283762;Variant
RS533334893;Drug Toxicity;Disease;PA166307621;Variant
RS374825099;Drug Toxicity;Disease;PA166319205;Variant
RS372307932;Drug Toxicity;Disease;PA166319207;Variant
RS369103276;Drug Toxicity;Disease;PA166319222;Variant
RS374527058;Drug Toxicity;Disease;PA166319223;Variant
RS371258350;Drug Toxicity;Disease;PA166319224;Variant
RS368146607;Drug Toxicity;Disease;PA166319225;Variant
RS140039091;Drug Toxicity;Disease;PA166319421;Variant
RS187713395;Drug Toxicity;Disease;PA166319422;Variant
RS758649719;Drug Toxicity;Disease;PA166319424;Variant
RS570122671;Drug Toxicity;Disease;PA166319461;Variant
RS201268750;Drug Toxicity;Disease;PA166319463;Variant
RS527580106;Drug Toxicity;Disease;PA166319465;Variant
RS528152707;Drug Toxicity;Disease;PA166319467;Variant
RS536577604;Drug Toxicity;Disease;PA166319501;Variant
RS558354142;Drug Toxicity;Disease;PA166319622;Variant
RS538703919;Drug Toxicity;Disease;PA166319642;Variant
RS568367673;Drug Toxicity;Disease;PA166319644;Variant
RS140989814;Drug Toxicity;Disease;PA166319662;Variant
RS538336580;Drug Toxicity;Disease;PA166319664;Variant
RS548783838;Drug Toxicity;Disease;PA166319703;Variant
RS575853463;Drug Toxicity;Disease;PA166319705;Variant
RS569661196;Drug Toxicity;Disease;PA166319721;Variant
RS755416212;Drug Toxicity;Disease;PA166320941;Variant
RS143004875;Drug Toxicity;Disease;PA166321181;Variant
NAT2;Drug Toxicity;Disease;PA18;Gene
GSTM1;Drug Toxicity;Disease;PA182;Gene
HTR2A;Drug Toxicity;Disease;PA193;Gene
ABCC1;Drug Toxicity;Disease;PA244;Gene
MTHFR;Drug Toxicity;Disease;PA245;Gene
ALDH1A1;Drug Toxicity;Disease;PA24692;Gene
CAPG;Drug Toxicity;Disease;PA26056;Gene
ABCB1;Drug Toxicity;Disease;PA267;Gene
CYP2A7P1;Drug Toxicity;Disease;PA27103;Gene
EPAS1;Drug Toxicity;Disease;PA27809;Gene
ERBB2;Drug Toxicity;Disease;PA27844;Gene
GRIN2B;Drug Toxicity;Disease;PA28980;Gene
GSTM3;Drug Toxicity;Disease;PA29024;Gene
GSTP1;Drug Toxicity;Disease;PA29028;Gene
KDR;Drug Toxicity;Disease;PA30086;Gene
MAP2K6;Drug Toxicity;Disease;PA30591;Gene
SLC6A4;Drug Toxicity;Disease;PA312;Gene
MTR;Drug Toxicity;Disease;PA31272;Gene
MTRR;Drug Toxicity;Disease;PA31277;Gene
NRP2;Drug Toxicity;Disease;PA31784;Gene
SLC19A1;Drug Toxicity;Disease;PA327;Gene
SLC22A1;Drug Toxicity;Disease;PA329;Gene
PPARD;Drug Toxicity;Disease;PA33557;Gene
HLA-A;Drug Toxicity;Disease;PA35055;Gene
HLA-B;Drug Toxicity;Disease;PA35056;Gene
HLA-C;Drug Toxicity;Disease;PA35057;Gene
HLA-DQA1;Drug Toxicity;Disease;PA35066;Gene
HLA-DQB1;Drug Toxicity;Disease;PA35068;Gene
HLA-DRB1;Drug Toxicity;Disease;PA35072;Gene
TPMT;Drug Toxicity;Disease;PA356;Gene
SLC22A7;Drug Toxicity;Disease;PA35848;Gene
TYMS;Drug Toxicity;Disease;PA359;Gene
UMPS;Drug Toxicity;Disease;PA363;Gene
TP53;Drug Toxicity;Disease;PA36679;Gene
VEGFB;Drug Toxicity;Disease;PA37303;Gene
XPC;Drug Toxicity;Disease;PA37413;Gene
XPO1;Drug Toxicity;Disease;PA37418;Gene
ABCC3;Drug Toxicity;Disease;PA376;Gene
ABCG2;Drug Toxicity;Disease;PA390;Gene
ABCC4;Drug Toxicity;Disease;PA397;Gene
UGT1A9;Drug Toxicity;Disease;PA419;Gene
UGT1A1;Drug Toxicity;Disease;PA420;Gene
CDA;Drug Toxicity;Disease;PA98;Gene
MAJOR DEPRESSIVE DISORDER;rs6127921;Variant;PA447321;Disease
CITALOPRAM;rs6127921;Variant;PA449015;Chemical
G6PD B (REFERENCE);sulfamethoxazole / trimethoprim;Chemical;PA165947826;Haplotype
NAT2*4;sulfamethoxazole / trimethoprim;Chemical;PA165949098;Haplotype
NAT2*5A;sulfamethoxazole / trimethoprim;Chemical;PA165949099;Haplotype
HLA-B*07:02;sulfamethoxazole / trimethoprim;Chemical;PA165954366;Haplotype
HLA-B*13:01;sulfamethoxazole / trimethoprim;Chemical;PA165954643;Haplotype
HLA-B*15:02;sulfamethoxazole / trimethoprim;Chemical;PA165954769;Haplotype
HLA-B*38:02;sulfamethoxazole / trimethoprim;Chemical;PA165955505;Haplotype
HLA-C*06:02;sulfamethoxazole / trimethoprim;Chemical;PA165957286;Haplotype
HLA-C*07:02;sulfamethoxazole / trimethoprim;Chemical;PA165957396;Haplotype
HLA-C*07:27;sulfamethoxazole / trimethoprim;Chemical;PA165957457;Haplotype
NAT2*5;sulfamethoxazole / trimethoprim;Chemical;PA165981634;Haplotype
NAT2*6;sulfamethoxazole / trimethoprim;Chemical;PA165981635;Haplotype
NAT2*7;sulfamethoxazole / trimethoprim;Chemical;PA165981636;Haplotype
NAT2*14;sulfamethoxazole / trimethoprim;Chemical;PA165981640;Haplotype
GSTM1 NULL;sulfamethoxazole / trimethoprim;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;sulfamethoxazole / trimethoprim;Chemical;PA166048676;Haplotype
G6PD CANTON, TAIWAN-HAKKA, GIFU-LIKE, AGRIGENTO-LIKE;sulfamethoxazole / trimethoprim;Chemical;PA166121153;Haplotype
HLA-C*08:01;sulfamethoxazole / trimethoprim;Chemical;PA166123426;Haplotype
RS1799930;sulfamethoxazole / trimethoprim;Chemical;PA166157564;Variant
RS1799931;sulfamethoxazole / trimethoprim;Chemical;PA166157565;Variant
G6PD DEFICIENCY;sulfamethoxazole / trimethoprim;Chemical;PA166157959;Variant
NAT2;sulfamethoxazole / trimethoprim;Chemical;PA18;Gene
GSTM1;sulfamethoxazole / trimethoprim;Chemical;PA182;Gene
G6PD;sulfamethoxazole / trimethoprim;Chemical;PA28469;Gene
HLA-B;sulfamethoxazole / trimethoprim;Chemical;PA35056;Gene
HLA-C;sulfamethoxazole / trimethoprim;Chemical;PA35057;Gene
CYB5R4;isosorbide mononitrate;Chemical;PA134904907;Gene
CYB5R1;isosorbide mononitrate;Chemical;PA134979668;Gene
CYB5R2;isosorbide mononitrate;Chemical;PA142672060;Gene
CYB5R3;isosorbide mononitrate;Chemical;PA27331;Gene
CYP2C9;CYP2C9*8;Haplotype;PA126;Gene
VKORC1;CYP2C9*8;Haplotype;PA133787052;Gene
SIPONIMOD;CYP2C9*8;Haplotype;PA166182736;Chemical
CYP4F2;CYP2C9*8;Haplotype;PA27121;Gene
CARDIOVASCULAR DISEASES;CYP2C9*8;Haplotype;PA443635;Disease
EPILEPSY;CYP2C9*8;Haplotype;PA444065;Disease
DICLOFENAC;CYP2C9*8;Haplotype;PA449293;Chemical
LOSARTAN;CYP2C9*8;Haplotype;PA450268;Chemical
PHENYTOIN;CYP2C9*8;Haplotype;PA450947;Chemical
WARFARIN;CYP2C9*8;Haplotype;PA451906;Chemical
ACENOCOUMAROL;CYP2C9*8;Haplotype;PA452632;Chemical
ARTHRITIS, RHEUMATOID;SPP1;Gene;PA443434;Disease
VORICONAZOLE;CYP2C19*18;Haplotype;PA10233;Chemical
NEBIVOLOL;CYP2C19*18;Haplotype;PA151958426;Chemical
CELECOXIB;CYP2C19*18;Haplotype;PA448871;Chemical
CLOPIDOGREL;CYP2C19*18;Haplotype;PA449053;Chemical
FLUOXETINE;CYP2C19*18;Haplotype;PA449673;Chemical
FLUVOXAMINE;CYP2C19*18;Haplotype;PA449690;Chemical
KETOCONAZOLE;CYP2C19*18;Haplotype;PA450146;Chemical
MEPHENYTOIN;CYP2C19*18;Haplotype;PA450373;Chemical
OMEPRAZOLE;CYP2C19*18;Haplotype;PA450704;Chemical
TICLOPIDINE;CYP2C19*18;Haplotype;PA451686;Chemical
CYP3A4;vandetanib;Chemical;PA130;Gene
CYP3A4*1;vandetanib;Chemical;PA165819201;Haplotype
CYP3A4*2;vandetanib;Chemical;PA165819220;Haplotype
CYP3A4*3;vandetanib;Chemical;PA165819221;Haplotype
CYP3A4*5;vandetanib;Chemical;PA165819223;Haplotype
CYP3A4*6;vandetanib;Chemical;PA165819224;Haplotype
CYP3A4*7;vandetanib;Chemical;PA165819225;Haplotype
CYP3A4*8;vandetanib;Chemical;PA165819226;Haplotype
CYP3A4*9;vandetanib;Chemical;PA165819227;Haplotype
CYP3A4*10;vandetanib;Chemical;PA165819228;Haplotype
CYP3A4*11;vandetanib;Chemical;PA165819229;Haplotype
CYP3A4*12;vandetanib;Chemical;PA165819230;Haplotype
CYP3A4*13;vandetanib;Chemical;PA165819231;Haplotype
CYP3A4*14;vandetanib;Chemical;PA165819232;Haplotype
CYP3A4*15;vandetanib;Chemical;PA165819233;Haplotype
CYP3A4*16;vandetanib;Chemical;PA165819236;Haplotype
CYP3A4*17;vandetanib;Chemical;PA165819239;Haplotype
CYP3A4*18;vandetanib;Chemical;PA165819240;Haplotype
CYP3A4*19;vandetanib;Chemical;PA165819243;Haplotype
CYP3A4*20;vandetanib;Chemical;PA165819244;Haplotype
CYP3A4*23;vandetanib;Chemical;PA166115836;Haplotype
CYP3A4*24;vandetanib;Chemical;PA166115837;Haplotype
CYP3A4*29;vandetanib;Chemical;PA166245585;Haplotype
CYP3A4*30;vandetanib;Chemical;PA166245586;Haplotype
CYP3A4*31;vandetanib;Chemical;PA166245587;Haplotype
CYP3A4*32;vandetanib;Chemical;PA166245588;Haplotype
CYP3A4*33;vandetanib;Chemical;PA166245589;Haplotype
CYP3A4*34;vandetanib;Chemical;PA166245590;Haplotype
KDR;vandetanib;Chemical;PA30086;Gene
RET;vandetanib;Chemical;PA34335;Gene
EGFR;vandetanib;Chemical;PA7360;Gene
CYP2E1;pyridoxal phosphate;Chemical;PA129;Gene
CYP2E1*1A;pyridoxal phosphate;Chemical;PA165948032;Haplotype
VANCOMYCIN;rs2789047;Variant;PA451850;Chemical
ALDH2;nitroglycerin;Chemical;PA24696;Gene
G6PD;nitroglycerin;Chemical;PA28469;Gene
MAFA;MAPK14;Gene;PA134963361;Gene
JDP2;MAPK14;Gene;PA162392499;Gene
ATF2;MAPK14;Gene;PA25084;Gene
ATF3;MAPK14;Gene;PA25085;Gene
BATF;MAPK14;Gene;PA25268;Gene
FOS;MAPK14;Gene;PA28212;Gene
FOSB;MAPK14;Gene;PA28213;Gene
FOSL1;MAPK14;Gene;PA28214;Gene
FOSL2;MAPK14;Gene;PA28215;Gene
MAP2K7;MAPK14;Gene;PA284;Gene
JUN;MAPK14;Gene;PA30006;Gene
JUNB;MAPK14;Gene;PA30007;Gene
JUND;MAPK14;Gene;PA30008;Gene
MAF;MAPK14;Gene;PA30534;Gene
MAFB;MAPK14;Gene;PA30535;Gene
MAFF;MAPK14;Gene;PA30538;Gene
MAFG;MAPK14;Gene;PA30539;Gene
MAFK;MAPK14;Gene;PA30540;Gene
MAP2K1;MAPK14;Gene;PA30584;Gene
MAP2K2;MAPK14;Gene;PA30587;Gene
MAP2K3;MAPK14;Gene;PA30588;Gene
MAP2K4;MAPK14;Gene;PA30589;Gene
MAP2K5;MAPK14;Gene;PA30590;Gene
MAP2K6;MAPK14;Gene;PA30591;Gene
NRL;MAPK14;Gene;PA31781;Gene
SORAFENIB;MAPK14;Gene;PA7000;Chemical
C18ORF56;Esophageal Neoplasms;Disease;PA134956204;Gene
KLC3;Esophageal Neoplasms;Disease;PA142671588;Gene
ERCC1;Esophageal Neoplasms;Disease;PA155;Gene
RS45445694;Esophageal Neoplasms;Disease;PA166155331;Variant
RS11615;Esophageal Neoplasms;Disease;PA166155342;Variant
RS13181;Esophageal Neoplasms;Disease;PA166155343;Variant
RS3212986;Esophageal Neoplasms;Disease;PA166155407;Variant
RS1045642;Esophageal Neoplasms;Disease;PA166157284;Variant
ABCB1;Esophageal Neoplasms;Disease;PA267;Gene
ERCC2;Esophageal Neoplasms;Disease;PA27848;Gene
SULT1A1;Esophageal Neoplasms;Disease;PA343;Gene
TYMS;Esophageal Neoplasms;Disease;PA359;Gene
ABCG2;Esophageal Neoplasms;Disease;PA390;Gene
DOXORUBICINOL;rs6690497;Variant;PA165291922;Chemical
DAUNORUBICINOL;rs6690497;Variant;PA166248083;Chemical
WARFARIN;CYP2C9*57;Haplotype;PA451906;Chemical
ACENOCOUMAROL;CYP2C9*57;Haplotype;PA452632;Chemical
HYPERTENSION;PDE3A;Gene;PA444552;Disease
NAUSEA;PDE3A;Gene;PA445048;Disease
VOMITING;PDE3A;Gene;PA446051;Disease
HYDROCHLOROTHIAZIDE;PDE3A;Gene;PA449899;Chemical
OPIOIDS;PDE3A;Gene;PA452618;Chemical
COLITIS, ULCERATIVE;NAT1*4;Haplotype;PA443750;Disease
CROHN DISEASE;NAT1*4;Haplotype;PA443815;Disease
INFLAMMATORY BOWEL DISEASES;NAT1*4;Haplotype;PA446116;Disease
MESALAZINE;NAT1*4;Haplotype;PA450384;Chemical
THIOGUANINE;NAT1*4;Haplotype;PA451663;Chemical
ALPHA-MSH;POMC;Gene;PA166170627;Chemical
SETMELANOTIDE;POMC;Gene;PA166235341;Chemical
ASTHMA;TAPBP;Gene;PA443450;Disease
ASPIRIN;TAPBP;Gene;PA448497;Chemical
FLUOROURACIL;rs2291078;Variant;PA128406956;Chemical
METASTATIC NEOPLASM;rs2291078;Variant;PA445058;Disease
CAPECITABINE;rs2291078;Variant;PA448771;Chemical
CYP3A4;dapsone;Chemical;PA130;Gene
G6PD A- 202A_376G;dapsone;Chemical;PA165947827;Haplotype
HLA-DRB1*15:01;dapsone;Chemical;PA165952269;Haplotype
HLA-DRB1*16:02;dapsone;Chemical;PA165952368;Haplotype
HLA-A*24:02;dapsone;Chemical;PA165953564;Haplotype
HLA-B*13:01;dapsone;Chemical;PA165954643;Haplotype
HLA-B*15:02;dapsone;Chemical;PA165954769;Haplotype
RS1050828;dapsone;Chemical;PA166157859;Variant
G6PD DEFICIENCY;dapsone;Chemical;PA166157959;Variant
RS201929247;dapsone;Chemical;PA166181039;Variant
RS701829;dapsone;Chemical;PA166181040;Variant
RS17211071;dapsone;Chemical;PA166181041;Variant
CYB5R3;dapsone;Chemical;PA27331;Gene
G6PD;dapsone;Chemical;PA28469;Gene
HLA-A;dapsone;Chemical;PA35055;Gene
HLA-B;dapsone;Chemical;PA35056;Gene
HLA-DRB1;dapsone;Chemical;PA35072;Gene
ARTHRITIS, PSORIATIC;IFIH1;Gene;PA446198;Disease
PEMETREXED;CD274;Gene;PA10810;Chemical
PEMBROLIZUMAB;CD274;Gene;PA166124615;Chemical
NIVOLUMAB;CD274;Gene;PA166129522;Chemical
ATEZOLIZUMAB;CD274;Gene;PA166129523;Chemical
RS113488022;CD274;Gene;PA166157522;Variant
AVELUMAB;CD274;Gene;PA166169875;Chemical
DURVALUMAB;CD274;Gene;PA166169883;Chemical
IPILIMUMAB;CD274;Gene;PA166182718;Chemical
CEMIPLIMAB-RWLC;CD274;Gene;PA166251401;Chemical
NIVOLUMAB / RELATLIMAB;CD274;Gene;PA166277902;Chemical
TREMELIMUMAB;CD274;Gene;PA166293321;Chemical
TISLELIZUMAB;CD274;Gene;PA166353221;Chemical
COSIBELIMAB;CD274;Gene;PA166400162;Chemical
RS11280056;Myelodysplastic Syndromes;Disease;PA166180936;Variant
TYMS;Myelodysplastic Syndromes;Disease;PA359;Gene
MARALIXIBAT;ATP8B1;Gene;PA166268803;Chemical
ODEVIXIBAT;ATP8B1;Gene;PA166268805;Chemical
RS72549402;ATP8B1;Gene;PA166313821;Variant
RS11568372;ATP8B1;Gene;PA166313822;Variant
DULOXETINE;rs9310658;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs9310658;Variant;PA447321;Disease
HLA-DPB1*04:01;Agranulocytosis;Disease;PA165951133;Haplotype
HLA-DQA1*01:03;Agranulocytosis;Disease;PA165951282;Haplotype
HLA-DRB1*01:01;Agranulocytosis;Disease;PA165951320;Haplotype
HLA-DRB1*04:02;Agranulocytosis;Disease;PA165951501;Haplotype
HLA-DRB1*08:03;Agranulocytosis;Disease;PA165951678;Haplotype
HLA-DRB3*02:02;Agranulocytosis;Disease;PA165952408;Haplotype
HLA-DRB5*02:02;Agranulocytosis;Disease;PA165952475;Haplotype
HLA-B*08:01;Agranulocytosis;Disease;PA165954547;Haplotype
HLA-B*27:05;Agranulocytosis;Disease;PA165955118;Haplotype
HLA-B*38:01;Agranulocytosis;Disease;PA165955500;Haplotype
HLA-B*38:02;Agranulocytosis;Disease;PA165955505;Haplotype
HLA-B*39:01;Agranulocytosis;Disease;PA165955543;Haplotype
HLA-B*59:01;Agranulocytosis;Disease;PA165956674;Haplotype
HLA-C*07:01;Agranulocytosis;Disease;PA165957372;Haplotype
HLA-DQB1*05:02;Agranulocytosis;Disease;PA165958077;Haplotype
HLA-DQB1*06:01;Agranulocytosis;Disease;PA165958097;Haplotype
HLA-DQB1*02:01;Agranulocytosis;Disease;PA165958158;Haplotype
RS3768142;Agranulocytosis;Disease;PA166153752;Variant
RS652888;Agranulocytosis;Disease;PA166170338;Variant
RS199564443;Agranulocytosis;Disease;PA166170340;Variant
RS1071816;Agranulocytosis;Disease;PA166170341;Variant
RS111618861;Agranulocytosis;Disease;PA166170342;Variant
EHMT2;Agranulocytosis;Disease;PA25267;Gene
FOXF2;Agranulocytosis;Disease;PA28227;Gene
MTR;Agranulocytosis;Disease;PA31272;Gene
HLA-B;Agranulocytosis;Disease;PA35056;Gene
HLA-C;Agranulocytosis;Disease;PA35057;Gene
HLA-DPB1;Agranulocytosis;Disease;PA35064;Gene
HLA-DQA1;Agranulocytosis;Disease;PA35066;Gene
HLA-DQB1;Agranulocytosis;Disease;PA35068;Gene
HLA-DRB1;Agranulocytosis;Disease;PA35072;Gene
HLA-DRB3;Agranulocytosis;Disease;PA35074;Gene
HLA-DRB5;Agranulocytosis;Disease;PA35076;Gene
MYOPATHIES, STRUCTURAL, CONGENITAL;SELENON;Gene;PA447109;Disease
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs983332;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs983332;Variant;PA443434;Disease
FLUOROURACIL;APEX1;Gene;PA128406956;Chemical
RADIOTHERAPY;APEX1;Gene;PA166122986;Chemical
OVERALL SURVIVAL;APEX1;Gene;PA166123207;Disease
CARCINOMA, SQUAMOUS CELL;APEX1;Gene;PA443626;Disease
CISPLATIN;APEX1;Gene;PA449014;Chemical
ALCOHOL ABUSE;rs492602;Variant;PA443309;Disease
ETHANOL;rs492602;Variant;PA448073;Chemical
MAJOR DEPRESSIVE DISORDER;MC1R;Gene;PA447321;Disease
DESIPRAMINE;MC1R;Gene;PA449233;Chemical
ISOFLURANE;MC1R;Gene;PA450106;Chemical
CYP2B6;amitriptyline;Chemical;PA123;Gene
CYP2C19;amitriptyline;Chemical;PA124;Gene
CYP2C9;amitriptyline;Chemical;PA126;Gene
CYP2D6;amitriptyline;Chemical;PA128;Gene
CYP3A4;amitriptyline;Chemical;PA130;Gene
CYP3A5;amitriptyline;Chemical;PA131;Gene
CYP2C19*17;amitriptyline;Chemical;PA165816533;Haplotype
CYP2D6*1;amitriptyline;Chemical;PA165816576;Haplotype
CYP2D6*2;amitriptyline;Chemical;PA165816577;Haplotype
CYP2D6*3;amitriptyline;Chemical;PA165816578;Haplotype
CYP2D6*4;amitriptyline;Chemical;PA165816579;Haplotype
CYP2D6*6;amitriptyline;Chemical;PA165816581;Haplotype
CYP2D6*10;amitriptyline;Chemical;PA165816582;Haplotype
CYP2D6*41;amitriptyline;Chemical;PA165816584;Haplotype
CYP2D6*5;amitriptyline;Chemical;PA165948092;Haplotype
CYP2D6*9;amitriptyline;Chemical;PA165948317;Haplotype
CYP2C19*1;amitriptyline;Chemical;PA165980634;Haplotype
CYP2C19*2;amitriptyline;Chemical;PA165980635;Haplotype
CYP2C19*3;amitriptyline;Chemical;PA165980636;Haplotype
CYP2D6*1XN;amitriptyline;Chemical;PA165988479;Haplotype
CYP2D6*2XN;amitriptyline;Chemical;PA165988480;Haplotype
CYP2D6*87;amitriptyline;Chemical;PA166123327;Haplotype
CYP2D6*88;amitriptyline;Chemical;PA166123328;Haplotype
CYP2D6*89;amitriptyline;Chemical;PA166123329;Haplotype
CYP2D6*90;amitriptyline;Chemical;PA166123330;Haplotype
CYP2D6*91;amitriptyline;Chemical;PA166123331;Haplotype
CYP2D6*93;amitriptyline;Chemical;PA166123333;Haplotype
CYP2D6*95;amitriptyline;Chemical;PA166123336;Haplotype
CYP2D6*97;amitriptyline;Chemical;PA166123338;Haplotype
CYP2D6*98;amitriptyline;Chemical;PA166123339;Haplotype
CYP2D6*94;amitriptyline;Chemical;PA166128737;Haplotype
RS2032583;amitriptyline;Chemical;PA166157317;Variant
RS2235015;amitriptyline;Chemical;PA166157336;Variant
RS2235040;amitriptyline;Chemical;PA166157338;Variant
RS2235067;amitriptyline;Chemical;PA166157341;Variant
RS4148739;amitriptyline;Chemical;PA166157386;Variant
RS4148740;amitriptyline;Chemical;PA166157387;Variant
RS7787082;amitriptyline;Chemical;PA166157428;Variant
RS10248420;amitriptyline;Chemical;PA166157440;Variant
RS10280101;amitriptyline;Chemical;PA166157445;Variant
RS11983225;amitriptyline;Chemical;PA166157453;Variant
RS12720067;amitriptyline;Chemical;PA166157458;Variant
HTR2A;amitriptyline;Chemical;PA193;Gene
HTR2C;amitriptyline;Chemical;PA194;Gene
ABCB1;amitriptyline;Chemical;PA267;Gene
CYP1A2;amitriptyline;Chemical;PA27093;Gene
DRD2;amitriptyline;Chemical;PA27478;Gene
SLC6A4;amitriptyline;Chemical;PA312;Gene
POLG;amitriptyline;Chemical;PA33500;Gene
HLA-A;amitriptyline;Chemical;PA35055;Gene
HLA-B;amitriptyline;Chemical;PA35056;Gene
UGT1A4;amitriptyline;Chemical;PA37179;Gene
HEROIN DEPENDENCE;rs3735451;Variant;PA444460;Disease
METHADONE;rs3735451;Variant;PA450401;Chemical
TAXANES;rs9369421;Variant;PA150481189;Chemical
OVARIAN NEOPLASMS;rs9369421;Variant;PA445204;Disease
CARBOPLATIN;rs9369421;Variant;PA448803;Chemical
SLCO1B1;lovastatin acid;Chemical;PA134865839;Gene
SLCO1B1*5;lovastatin acid;Chemical;PA165819255;Haplotype
SLCO1B1*15;lovastatin acid;Chemical;PA165819265;Haplotype
SLCO1B1*1;lovastatin acid;Chemical;PA165981641;Haplotype
RS4149056;lovastatin acid;Chemical;PA166154579;Variant
CYP2C19;Myocardial Ischemia;Disease;PA124;Gene
F3;Myocardial Ischemia;Disease;PA158;Gene
CYP2C19*2;Myocardial Ischemia;Disease;PA165980635;Haplotype
UGT1A1*1;Myocardial Ischemia;Disease;PA166115841;Haplotype
UGT1A1*28;Myocardial Ischemia;Disease;PA166115842;Haplotype
RS3917643;Myocardial Ischemia;Disease;PA166153759;Variant
RS662;Myocardial Ischemia;Disease;PA166157238;Variant
PON1;Myocardial Ischemia;Disease;PA33529;Gene
ADRB1;Myocardial Ischemia;Disease;PA38;Gene
UGT1A1;Myocardial Ischemia;Disease;PA420;Gene
PEGINTERFERON ALFA-2A;rs3828913;Variant;PA164749390;Chemical
PEGINTERFERON ALFA-2B;rs3828913;Variant;PA164784024;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;rs3828913;Variant;PA446863;Disease
RIBAVIRIN;rs3828913;Variant;PA451241;Chemical
CYP3A4;vindesine;Chemical;PA130;Gene
RS2229109;vindesine;Chemical;PA166157334;Variant
ABCB1;vindesine;Chemical;PA267;Gene
TTR;vutrisiran;Chemical;PA37069;Gene
FEBUXOSTAT;rs3731722;Variant;PA165958521;Chemical
GOUT;rs3731722;Variant;PA444318;Disease
ALLOPURINOL;rs3731722;Variant;PA448320;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs4492666;Variant;PA443622;Disease
CISPLATIN;rs4492666;Variant;PA449014;Chemical
GEMCITABINE;rs4492666;Variant;PA449748;Chemical
CYP3A4;terfenadine;Chemical;PA130;Gene
KCNH2;terfenadine;Chemical;PA212;Gene
ABCB1;terfenadine;Chemical;PA267;Gene
CYP2J2;terfenadine;Chemical;PA27112;Gene
DEPRESSION;TGFBR3;Gene;PA447278;Disease
ANTIDEPRESSANTS;TGFBR3;Gene;PA452229;Chemical
ROSUVASTATIN;rs199654337;Variant;PA134308647;Chemical
ESTRONE SULFATE;rs199654337;Variant;PA166185957;Chemical
WNK4;SCNN1G;Gene;PA134875400;Gene
NEDD4L;SCNN1G;Gene;PA31534;Gene
WNK1;SCNN1G;Gene;PA33782;Gene
AMILORIDE;SCNN1G;Gene;PA448368;Chemical
TRIAMTERENE;SCNN1G;Gene;PA451752;Chemical
HYPERTENSION;rs12521868;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs12521868;Variant;PA449899;Chemical
HLA-DRB1*07:01;Hepatitis vaccines;Chemical;PA165951644;Haplotype
RS1805015;Hepatitis vaccines;Chemical;PA166155023;Variant
RS1295686;Hepatitis vaccines;Chemical;PA166156759;Variant
IL13;Hepatitis vaccines;Chemical;PA199;Gene
IL4R;Hepatitis vaccines;Chemical;PA29832;Gene
HLA-DRB1;Hepatitis vaccines;Chemical;PA35072;Gene
THIOGUANINE;TPMT*20;Haplotype;PA451663;Chemical
WEIGHT GAIN;NPY;Gene;PA128406954;Disease
NPY1R;NPY;Gene;PA258;Gene
NPY2R;NPY;Gene;PA31741;Gene
RS622342;Dopamine agonists;Chemical;PA166156932;Variant
SLC22A1;Dopamine agonists;Chemical;PA329;Gene
ASPIRIN-INDUCED ASTHMA;rs3097671;Variant;PA131285571;Disease
ASPIRIN;rs3097671;Variant;PA448497;Chemical
CFTR;curcumin;Chemical;PA109;Gene
RS77010898;curcumin;Chemical;PA166157518;Variant
ABCB1;curcumin;Chemical;PA267;Gene
ABCG2;curcumin;Chemical;PA390;Gene
PANCREATIC NEOPLASMS;rs4694362;Variant;PA445218;Disease
GEMCITABINE;rs4694362;Variant;PA449748;Chemical
ADAGRASIB;rs121913530;Variant;PA166246421;Chemical
SOTORASIB;rs121913530;Variant;PA166246441;Chemical
KRAS;rs121913530;Variant;PA30196;Gene
CYP3A4;sirolimus;Chemical;PA130;Gene
CYP3A5;sirolimus;Chemical;PA131;Gene
CYP3A4*1;sirolimus;Chemical;PA165819201;Haplotype
CYP3A4*22;sirolimus;Chemical;PA166048680;Haplotype
CYP3A5*1;sirolimus;Chemical;PA166128213;Haplotype
CYP3A5*3;sirolimus;Chemical;PA166128219;Haplotype
RS1800896;sirolimus;Chemical;PA166153642;Variant
RS7903146;sirolimus;Chemical;PA166154084;Variant
RS1042597;sirolimus;Chemical;PA166155614;Variant
RS3814055;sirolimus;Chemical;PA166156383;Variant
RS6785049;sirolimus;Chemical;PA166156411;Variant
RS1045642;sirolimus;Chemical;PA166157284;Variant
RS1057868;sirolimus;Chemical;PA166157286;Variant
RS1128503;sirolimus;Chemical;PA166157288;Variant
RS2032582;sirolimus;Chemical;PA166157316;Variant
RS2740574;sirolimus;Chemical;PA166157367;Variant
ABCB1;sirolimus;Chemical;PA267;Gene
IL10;sirolimus;Chemical;PA29778;Gene
POR;sirolimus;Chemical;PA33532;Gene
TCF7L2;sirolimus;Chemical;PA36394;Gene
UGT1A8;sirolimus;Chemical;PA37183;Gene
NR1I2;sirolimus;Chemical;PA378;Gene
CFTR;rs202179988;Variant;PA109;Gene
IVACAFTOR;rs202179988;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs202179988;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs202179988;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs202179988;Variant;PA443829;Disease
EVEROLIMUS;PIK3R1;Gene;PA164746311;Chemical
LENIOLISIB;PIK3R1;Gene;PA166313326;Chemical
AKT1;PIK3R1;Gene;PA24684;Gene
ERBB2;PIK3R1;Gene;PA27844;Gene
ERBB3;PIK3R1;Gene;PA27846;Gene
ERBB4;PIK3R1;Gene;PA27847;Gene
FLT1;PIK3R1;Gene;PA28180;Gene
FLT4;PIK3R1;Gene;PA28183;Gene
KDR;PIK3R1;Gene;PA30086;Gene
PIK3CA;PIK3R1;Gene;PA33308;Gene
PTEN;PIK3R1;Gene;PA33942;Gene
BREAST NEOPLASMS;PIK3R1;Gene;PA443560;Disease
HYPERGLYCEMIA;PIK3R1;Gene;PA444522;Disease
LEUKOPENIA;PIK3R1;Gene;PA444773;Disease
NEOPLASMS;PIK3R1;Gene;PA445062;Disease
EGFR;PIK3R1;Gene;PA7360;Gene
MAJOR DEPRESSIVE DISORDER;REEP5;Gene;PA447321;Disease
CITALOPRAM;REEP5;Gene;PA449015;Chemical
FLUOXETINE;REEP5;Gene;PA449673;Chemical
PAROXETINE;REEP5;Gene;PA450801;Chemical
SERTRALINE;REEP5;Gene;PA451333;Chemical
ATAZANAVIR;rs887829;Variant;PA10251;Chemical
DEFERASIROX;rs887829;Variant;PA164760843;Chemical
HEART VALVE REPLACEMENT;rs887829;Variant;PA166123431;Disease
HYPERPROLACTINEMIA;rs887829;Variant;PA444545;Disease
BETA-THALASSEMIA AND RELATED DISEASES;rs887829;Variant;PA446432;Disease
HIV INFECTIOUS DISEASE;rs887829;Variant;PA447230;Disease
RISPERIDONE;rs887829;Variant;PA451257;Chemical
WARFARIN;rs887829;Variant;PA451906;Chemical
GPR182;ADM;Gene;PA162390165;Gene
MAJOR DEPRESSIVE DISORDER;ADM;Gene;PA447321;Disease
PAROXETINE;ADM;Gene;PA450801;Chemical
ASPIRIN-INDUCED ASTHMA;HLA-DPB1;Gene;PA131285571;Disease
DRUG-INDUCED LIVER INJURY;HLA-DPB1;Gene;PA166119041;Disease
AGRANULOCYTOSIS;HLA-DPB1;Gene;PA443297;Disease
ASTHMA;HLA-DPB1;Gene;PA443450;Disease
URTICARIA;HLA-DPB1;Gene;PA445999;Disease
SCHIZOPHRENIA;HLA-DPB1;Gene;PA447216;Disease
AMOXICILLIN;HLA-DPB1;Gene;PA448406;Chemical
ASPIRIN;HLA-DPB1;Gene;PA448497;Chemical
CLOZAPINE;HLA-DPB1;Gene;PA449061;Chemical
INFLIXIMAB;HLA-DPB1;Gene;PA452639;Chemical
STEVENS-JOHNSON SYNDROME;HLA-A*23:01;Haplotype;PA445738;Disease
LAMOTRIGINE;HLA-A*23:01;Haplotype;PA450164;Chemical
ORGAN TRANSPLANTATION;rs2228075;Variant;PA133888799;Disease
MYCOPHENOLATE MOFETIL;rs2228075;Variant;PA450566;Chemical
CYP2C19;Shock, Septic;Disease;PA124;Gene
CYP2C19*1;Shock, Septic;Disease;PA165980634;Haplotype
CYP2C19*2;Shock, Septic;Disease;PA165980635;Haplotype
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;CD14;Gene;PA164713366;Chemical
ULCERATIVE COLITIS;CD14;Gene;PA443750;Disease
CYP3A4;miconazole;Chemical;PA130;Gene
NR1I2;miconazole;Chemical;PA378;Gene
GEMCITABINE;rs642990;Variant;PA449748;Chemical
AGRANULOCYTOSIS;HLA-DRB3;Gene;PA443297;Disease
SCHIZOPHRENIA;HLA-DRB3;Gene;PA447216;Disease
HEPARIN-INDUCED THROMBOCYTOPENIA;HLA-DRB3;Gene;PA447264;Disease
CLOZAPINE;HLA-DRB3;Gene;PA449061;Chemical
HEPARIN;HLA-DRB3;Gene;PA449855;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;ELP5;Gene;PA447197;Disease
METHYLPHENIDATE;ELP5;Gene;PA450464;Chemical
SMN1;risdiplam;Chemical;PA35966;Gene
SMN2;risdiplam;Chemical;PA35967;Gene
FLUOROURACIL;rs143004875;Variant;PA128406956;Chemical
DRUG TOXICITY;rs143004875;Variant;PA443937;Disease
CAPECITABINE;rs143004875;Variant;PA448771;Chemical
NEPHROTOXICITY;rs10821936;Variant;PA162263533;Disease
GLUCARPIDASE;rs10821936;Variant;PA165949771;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;rs10821936;Variant;PA446155;Disease
METHOTREXATE;rs10821936;Variant;PA450428;Chemical
GNAQ;P2RY1;Gene;PA174;Gene
GNB3;P2RY1;Gene;PA176;Gene
GNA11;P2RY1;Gene;PA28764;Gene
GNA12;P2RY1;Gene;PA28765;Gene
GNA13;P2RY1;Gene;PA28766;Gene
GNA15;P2RY1;Gene;PA28768;Gene
MYOCARDIAL INFARCTION;P2RY1;Gene;PA445019;Disease
ASPIRIN;P2RY1;Gene;PA448497;Chemical
MAP3K1;GRB2;Gene;PA30592;Gene
RAF1;GRB2;Gene;PA34183;Gene
EGFR;GRB2;Gene;PA7360;Gene
PAIN, POSTOPERATIVE;CACNA1E;Gene;PA445210;Disease
CELECOXIB;CACNA1E;Gene;PA448871;Chemical
FENTANYL;CACNA1E;Gene;PA449599;Chemical
PRKAA1;ACACB;Gene;PA33744;Gene
PRKAA2;ACACB;Gene;PA33745;Gene
PRKAB1;ACACB;Gene;PA33746;Gene
PRKAB2;ACACB;Gene;PA33747;Gene
PRKAG1;ACACB;Gene;PA33751;Gene
PRKAG2;ACACB;Gene;PA33752;Gene
PRKAG3;ACACB;Gene;PA33753;Gene
HLA-B*57:01;dolutegravir / abacavir / lamivudine;Chemical;PA165987830;Haplotype
HLA-B;dolutegravir / abacavir / lamivudine;Chemical;PA35056;Gene
FLUOROURACIL;rs183205964;Variant;PA128406956;Chemical
NEOPLASMS;rs183205964;Variant;PA445062;Disease
CAPECITABINE;rs183205964;Variant;PA448771;Chemical
TEGAFUR;rs183205964;Variant;PA452620;Chemical
RASAGILINE;rs2283265;Variant;PA164764584;Chemical
HEROIN DEPENDENCE;rs2283265;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs2283265;Variant;PA445043;Disease
PARKINSON DISEASE;rs2283265;Variant;PA445254;Disease
COCAINE DEPENDENCE;rs2283265;Variant;PA446878;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs2283265;Variant;PA447197;Disease
COCAINE;rs2283265;Variant;PA449072;Chemical
DISULFIRAM;rs2283265;Variant;PA449376;Chemical
METHADONE;rs2283265;Variant;PA450401;Chemical
METHYLPHENIDATE;rs2283265;Variant;PA450464;Chemical
FLUNITRAZEPAM;GABRG1;Gene;PA164781320;Chemical
DULOXETINE;rs7316769;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs7316769;Variant;PA447321;Disease
COLORECTAL NEOPLASMS;TGFBR2;Gene;PA446108;Disease
IRINOTECAN;TGFBR2;Gene;PA450085;Chemical
TELITHROMYCIN;KCNH2;Gene;PA10202;Chemical
CALCIUM CHANNEL BLOCKERS;KCNH2;Gene;PA10407;Chemical
NITRENDIPINE;KCNH2;Gene;PA146096020;Chemical
SERTINDOLE;KCNH2;Gene;PA164784002;Chemical
PRENYLAMINE;KCNH2;Gene;PA165817938;Chemical
PYRILAMINE;KCNH2;Gene;PA165817939;Chemical
TERODILINE;KCNH2;Gene;PA165817950;Chemical
LIDOFLAZINE;KCNH2;Gene;PA165818137;Chemical
SHORT QT SYNDROME 1;KCNH2;Gene;PA166183774;Disease
BRAF;KCNH2;Gene;PA25408;Gene
LONG QT SYNDROME;KCNH2;Gene;PA444807;Disease
TORSADES DE POINTES;KCNH2;Gene;PA446294;Disease
ESSENTIAL HYPERTENSION;KCNH2;Gene;PA447288;Disease
ACQUIRED LONG QT SYNDROME (ALQTS);KCNH2;Gene;PA447300;Disease
AMIODARONE;KCNH2;Gene;PA448383;Chemical
ASTEMIZOLE;KCNH2;Gene;PA448498;Chemical
CISAPRIDE;KCNH2;Gene;PA449011;Chemical
DISOPYRAMIDE;KCNH2;Gene;PA449373;Chemical
DOFETILIDE;KCNH2;Gene;PA449389;Chemical
DOXEPIN;KCNH2;Gene;PA449409;Chemical
DROPERIDOL;KCNH2;Gene;PA449422;Chemical
ERYTHROMYCIN;KCNH2;Gene;PA449493;Chemical
FLUOXETINE;KCNH2;Gene;PA449673;Chemical
GREPAFLOXACIN;KCNH2;Gene;PA449812;Chemical
HALOPERIDOL;KCNH2;Gene;PA449841;Chemical
HYDROXYZINE;KCNH2;Gene;PA449943;Chemical
LEVOMETHADYL ACETATE;KCNH2;Gene;PA450215;Chemical
METHADONE;KCNH2;Gene;PA450401;Chemical
MIBEFRADIL;KCNH2;Gene;PA450492;Chemical
MOXIFLOXACIN;KCNH2;Gene;PA450555;Chemical
PROBUCOL;KCNH2;Gene;PA451107;Chemical
PROPAFENONE;KCNH2;Gene;PA451131;Chemical
QUINIDINE;KCNH2;Gene;PA451209;Chemical
TERFENADINE;KCNH2;Gene;PA451619;Chemical
THIORIDAZINE;KCNH2;Gene;PA451666;Chemical
ABCC2;imatinib;Chemical;PA116;Gene
CYP2B6;imatinib;Chemical;PA123;Gene
CYP3A4;imatinib;Chemical;PA130;Gene
CYP3A5;imatinib;Chemical;PA131;Gene
FIP1L1;imatinib;Chemical;PA134875694;Gene
ULK3;imatinib;Chemical;PA134908392;Gene
RUNDC3B;imatinib;Chemical;PA162402278;Gene
CYP3A4*1;imatinib;Chemical;PA165819201;Haplotype
CYP3A4*3;imatinib;Chemical;PA165819221;Haplotype
CYP3A4*20;imatinib;Chemical;PA165819244;Haplotype
GSTT1 NULL;imatinib;Chemical;PA166048678;Haplotype
GSTT1 NON-NULL;imatinib;Chemical;PA166048679;Haplotype
CYP3A4*22;imatinib;Chemical;PA166048680;Haplotype
RS2273697;imatinib;Chemical;PA166154007;Variant
RS3764043;imatinib;Chemical;PA166154564;Variant
RS9561765;imatinib;Chemical;PA166154740;Variant
RS762551;imatinib;Chemical;PA166154850;Variant
RS2290573;imatinib;Chemical;PA166154887;Variant
RS10517;imatinib;Chemical;PA166154980;Variant
RS3745274;imatinib;Chemical;PA166155409;Variant
RS724710;imatinib;Chemical;PA166155599;Variant
RS12659;imatinib;Chemical;PA166155973;Variant
RS1051266;imatinib;Chemical;PA166155986;Variant
RS1061018;imatinib;Chemical;PA166156501;Variant
RS2231137;imatinib;Chemical;PA166156543;Variant
RS2231142;imatinib;Chemical;PA166156544;Variant
RS2725252;imatinib;Chemical;PA166156565;Variant
RS12505410;imatinib;Chemical;PA166156659;Variant
RS13120400;imatinib;Chemical;PA166156664;Variant
RS41282401;imatinib;Chemical;PA166156685;Variant
RS45605536;imatinib;Chemical;PA166156686;Variant
RS58818712;imatinib;Chemical;PA166156688;Variant
RS121913512;imatinib;Chemical;PA166156700;Variant
RS1050152;imatinib;Chemical;PA166156750;Variant
RS2631367;imatinib;Chemical;PA166156807;Variant
RS2631372;imatinib;Chemical;PA166156808;Variant
RS628031;imatinib;Chemical;PA166156933;Variant
RS683369;imatinib;Chemical;PA166156936;Variant
RS776746;imatinib;Chemical;PA166157267;Variant
RS1045642;imatinib;Chemical;PA166157284;Variant
RS1128503;imatinib;Chemical;PA166157288;Variant
RS2235040;imatinib;Chemical;PA166157338;Variant
RS10258429;imatinib;Chemical;PA166176775;Variant
RS274558;imatinib;Chemical;PA166176780;Variant
RS1202283;imatinib;Chemical;PA166182161;Variant
RS9787901;imatinib;Chemical;PA166182188;Variant
RS305968;imatinib;Chemical;PA166182189;Variant
RS11249454;imatinib;Chemical;PA166182190;Variant
RS28656907;imatinib;Chemical;PA166185792;Variant
GSTT1;imatinib;Chemical;PA183;Gene
ABL1;imatinib;Chemical;PA24413;Gene
BCL2L11;imatinib;Chemical;PA25305;Gene
BCR;imatinib;Chemical;PA25321;Gene
CHST1;imatinib;Chemical;PA26501;Gene
ABCB1;imatinib;Chemical;PA267;Gene
ABCB4;imatinib;Chemical;PA268;Gene
CYP1A2;imatinib;Chemical;PA27093;Gene
CYP2F1;imatinib;Chemical;PA27109;Gene
KIT;imatinib;Chemical;PA30128;Gene
NQO1;imatinib;Chemical;PA31744;Gene
SLC19A1;imatinib;Chemical;PA327;Gene
SLCO1A2;imatinib;Chemical;PA328;Gene
SLC22A1;imatinib;Chemical;PA329;Gene
PDGFRA;imatinib;Chemical;PA33147;Gene
PDGFRB;imatinib;Chemical;PA33148;Gene
SLC22A4;imatinib;Chemical;PA332;Gene
SLC22A5;imatinib;Chemical;PA333;Gene
UGT2A1;imatinib;Chemical;PA37184;Gene
ABCG2;imatinib;Chemical;PA390;Gene
ABCC4;imatinib;Chemical;PA397;Gene
CYCLOSPORINE;imatinib;Chemical;PA449167;Chemical
EGFR;imatinib;Chemical;PA7360;Gene
FLUOROURACIL;rs368146607;Variant;PA128406956;Chemical
DRUG TOXICITY;rs368146607;Variant;PA443937;Disease
CYP3A4;Hypoventilation;Disease;PA130;Gene
RS1045642;Hypoventilation;Disease;PA166157284;Variant
RS1128503;Hypoventilation;Disease;PA166157288;Variant
RS2032582;Hypoventilation;Disease;PA166157316;Variant
RS2242480;Hypoventilation;Disease;PA166157345;Variant
ABCB1;Hypoventilation;Disease;PA267;Gene
SN-38;BCHE;Gene;PA165110775;Chemical
BUTYRYLCHOLINESTERASE DEFICIENCY;BCHE;Gene;PA166122649;Disease
COGNITIVE DISORDER;BCHE;Gene;PA166176306;Disease
OXYMETAZOLINE AND TETRACAINE;BCHE;Gene;PA166182885;Chemical
ALZHEIMER DISEASE;BCHE;Gene;PA443319;Disease
APNEA;BCHE;Gene;PA443407;Disease
COCAINE DEPENDENCE;BCHE;Gene;PA446878;Disease
LEWY BODY DISEASE;BCHE;Gene;PA447127;Disease
CHLOROPROCAINE;BCHE;Gene;PA448946;Chemical
COCAINE;BCHE;Gene;PA449072;Chemical
DONEPEZIL;BCHE;Gene;PA449394;Chemical
IRINOTECAN;BCHE;Gene;PA450085;Chemical
MIVACURIUM;BCHE;Gene;PA450528;Chemical
RIVASTIGMINE;BCHE;Gene;PA451262;Chemical
SUCCINYLCHOLINE;BCHE;Gene;PA451522;Chemical
FUTIBATINIB;rs1057519797;Variant;PA166293381;Chemical
FGFR2;rs1057519797;Variant;PA28128;Gene
CHRM2;nicotine;Chemical;PA111;Gene
CHRNA3;nicotine;Chemical;PA113;Gene
CHRNA7;nicotine;Chemical;PA114;Gene
CHRNB2;nicotine;Chemical;PA115;Gene
COMT;nicotine;Chemical;PA117;Gene
CYP2A6;nicotine;Chemical;PA121;Gene
CYP2B6;nicotine;Chemical;PA123;Gene
CYP2D6;nicotine;Chemical;PA128;Gene
ANKK1;nicotine;Chemical;PA134872551;Gene
ADGRL3;nicotine;Chemical;PA134968284;Gene
DDC;nicotine;Chemical;PA140;Gene
DRD1;nicotine;Chemical;PA147;Gene
FMO1;nicotine;Chemical;PA165;Gene
CYP2B6*1;nicotine;Chemical;PA165818750;Haplotype
CYP2B6*4;nicotine;Chemical;PA165818757;Haplotype
CYP2B6*6;nicotine;Chemical;PA165818762;Haplotype
CYP2A6*1;nicotine;Chemical;PA165924690;Haplotype
CYP2A6*46;nicotine;Chemical;PA165924691;Haplotype
CYP2A6*1X2;nicotine;Chemical;PA165924717;Haplotype
CYP2A6*2;nicotine;Chemical;PA165924719;Haplotype
CYP2A6*4;nicotine;Chemical;PA165924721;Haplotype
CYP2A6*7;nicotine;Chemical;PA165924731;Haplotype
CYP2A6*10;nicotine;Chemical;PA165924735;Haplotype
CYP2A6*11;nicotine;Chemical;PA165924736;Haplotype
CYP2A6*13;nicotine;Chemical;PA165924740;Haplotype
CYP2A6*14;nicotine;Chemical;PA165924741;Haplotype
CYP2A6*15;nicotine;Chemical;PA165924742;Haplotype
CYP2A6*17;nicotine;Chemical;PA165924744;Haplotype
CYP2A6*19;nicotine;Chemical;PA165924748;Haplotype
CYP2A6*20;nicotine;Chemical;PA165924749;Haplotype
CYP2A6*23;nicotine;Chemical;PA165924752;Haplotype
CYP2A6*24;nicotine;Chemical;PA165924753;Haplotype
CYP2A6*25;nicotine;Chemical;PA165924755;Haplotype
CYP2A6*26;nicotine;Chemical;PA165924756;Haplotype
CYP2A6*27;nicotine;Chemical;PA165924757;Haplotype
CYP2A6*28;nicotine;Chemical;PA165924758;Haplotype
CYP2A6*9;nicotine;Chemical;PA165980914;Haplotype
CYP2A6*12;nicotine;Chemical;PA165980915;Haplotype
CYP2A6*35;nicotine;Chemical;PA165980920;Haplotype
FMO3;nicotine;Chemical;PA166;Gene
CYP2A6*38;nicotine;Chemical;PA166117264;Haplotype
CYP2A6*39;nicotine;Chemical;PA166117265;Haplotype
CYP2A6*41;nicotine;Chemical;PA166117267;Haplotype
RS7877;nicotine;Chemical;PA166153558;Variant
RS2072658;nicotine;Chemical;PA166153664;Variant
RS2072660;nicotine;Chemical;PA166153665;Variant
RS2072661;nicotine;Chemical;PA166153666;Variant
RS2266780;nicotine;Chemical;PA166153687;Variant
RS6702335;nicotine;Chemical;PA166153786;Variant
RS10912675;nicotine;Chemical;PA166153813;Variant
RS6277;nicotine;Chemical;PA166154261;Variant
RS1799732;nicotine;Chemical;PA166154334;Variant
RS1800497;nicotine;Chemical;PA166154339;Variant
RS3758987;nicotine;Chemical;PA166154401;Variant
RS578776;nicotine;Chemical;PA166154840;Variant
RS588765;nicotine;Chemical;PA166154841;Variant
RS637137;nicotine;Chemical;PA166154843;Variant
RS660652;nicotine;Chemical;PA166154844;Variant
RS684513;nicotine;Chemical;PA166154846;Variant
RS1051730;nicotine;Chemical;PA166154856;Variant
RS3743078;nicotine;Chemical;PA166154901;Variant
RS3813567;nicotine;Chemical;PA166154904;Variant
RS16969968;nicotine;Chemical;PA166154938;Variant
RS2717162;nicotine;Chemical;PA166155286;Variant
RS2279343;nicotine;Chemical;PA166155393;Variant
RS4803381;nicotine;Chemical;PA166155418;Variant
RS5031016;nicotine;Chemical;PA166155422;Variant
RS12461964;nicotine;Chemical;PA166155464;Variant
RS28399433;nicotine;Chemical;PA166155471;Variant
RS28399454;nicotine;Chemical;PA166155475;Variant
RS28399468;nicotine;Chemical;PA166155477;Variant
RS56113850;nicotine;Chemical;PA166155506;Variant
RS56256500;nicotine;Chemical;PA166155507;Variant
RS72549435;nicotine;Chemical;PA166155521;Variant
RS72552266;nicotine;Chemical;PA166155522;Variant
RS113288603;nicotine;Chemical;PA166155527;Variant
RS140471703;nicotine;Chemical;PA166155551;Variant
RS148044792;nicotine;Chemical;PA166155560;Variant
RS376817657;nicotine;Chemical;PA166155579;Variant
RS1044396;nicotine;Chemical;PA166155912;Variant
RS1044397;nicotine;Chemical;PA166155913;Variant
RS2229959;nicotine;Chemical;PA166155922;Variant
RS2236196;nicotine;Chemical;PA166155923;Variant
RS4680;nicotine;Chemical;PA166156024;Variant
RS2056527;nicotine;Chemical;PA166156340;Variant
RS2869950;nicotine;Chemical;PA166156567;Variant
RS61750900;nicotine;Chemical;PA166156690;Variant
RS112561475;nicotine;Chemical;PA166156698;Variant
RS686;nicotine;Chemical;PA166156705;Variant
RS4532;nicotine;Chemical;PA166156706;Variant
RS2168631;nicotine;Chemical;PA166156786;Variant
RS11746641;nicotine;Chemical;PA166156870;Variant
RS11749035;nicotine;Chemical;PA166156871;Variant
RS510769;nicotine;Chemical;PA166156924;Variant
RS1799971;nicotine;Chemical;PA166156991;Variant
RS2075572;nicotine;Chemical;PA166157015;Variant
RS324650;nicotine;Chemical;PA166157253;Variant
RS1057868;nicotine;Chemical;PA166157286;Variant
RS12718541;nicotine;Chemical;PA166157457;Variant
RS10121600;nicotine;Chemical;PA166157802;Variant
RS11788456;nicotine;Chemical;PA166157832;Variant
RS12459249;nicotine;Chemical;PA166170354;Variant
RS503464;nicotine;Chemical;PA166175850;Variant
RS55781567;nicotine;Chemical;PA166175853;Variant
RS1799972;nicotine;Chemical;PA166177739;Variant
RS1074287;nicotine;Chemical;PA166177785;Variant
RS6912029;nicotine;Chemical;PA166177786;Variant
RS12209447;nicotine;Chemical;PA166177787;Variant
RS3798676;nicotine;Chemical;PA166177788;Variant
RS553202;nicotine;Chemical;PA166177789;Variant
RS7748401;nicotine;Chemical;PA166177791;Variant
RS495491;nicotine;Chemical;PA166177792;Variant
RS10457090;nicotine;Chemical;PA166177793;Variant
RS589046;nicotine;Chemical;PA166177794;Variant
RS3778152;nicotine;Chemical;PA166177795;Variant
RS563649;nicotine;Chemical;PA166177796;Variant
RS3852209;nicotine;Chemical;PA166179948;Variant
RS11606194;nicotine;Chemical;PA166180009;Variant
RS1948;nicotine;Chemical;PA166181364;Variant
RS2337980;nicotine;Chemical;PA166183950;Variant
RS1709083;nicotine;Chemical;PA166184034;Variant
RS6090378;nicotine;Chemical;PA166184544;Variant
RS3787138;nicotine;Chemical;PA166184546;Variant
RS3787140;nicotine;Chemical;PA166184548;Variant
RS10485057;nicotine;Chemical;PA166184699;Variant
RS4001926;nicotine;Chemical;PA166184886;Variant
RS7247903;nicotine;Chemical;PA166184887;Variant
RS2036527;nicotine;Chemical;PA166185387;Variant
RS3743075;nicotine;Chemical;PA166185407;Variant
RS7178270;nicotine;Chemical;PA166185489;Variant
RS2271339;nicotine;Chemical;PA166185754;Variant
RS1456862;nicotine;Chemical;PA166185755;Variant
RS145014075;nicotine;Chemical;PA166238001;Variant
RS571335587;nicotine;Chemical;PA166261982;Variant
RS768416963;nicotine;Chemical;PA166261983;Variant
RS1302192284;nicotine;Chemical;PA166261984;Variant
RS111869995;nicotine;Chemical;PA166261985;Variant
RS199515342;nicotine;Chemical;PA166262001;Variant
RS61605570;nicotine;Chemical;PA166262002;Variant
RS137904044;nicotine;Chemical;PA166262003;Variant
RS200554095;nicotine;Chemical;PA166262004;Variant
RS772964366;nicotine;Chemical;PA166262005;Variant
RS758479488;nicotine;Chemical;PA166262008;Variant
RS145157460;nicotine;Chemical;PA166262009;Variant
RS148693084;nicotine;Chemical;PA166262022;Variant
RS1303839356;nicotine;Chemical;PA166262041;Variant
RS778019189;nicotine;Chemical;PA166262042;Variant
RS374515279;nicotine;Chemical;PA166262043;Variant
RS145308399;nicotine;Chemical;PA166262061;Variant
RS777098658;nicotine;Chemical;PA166262062;Variant
CYP2A6*55;nicotine;Chemical;PA166309214;Haplotype
CHRNA4;nicotine;Chemical;PA26490;Gene
CHRNA5;nicotine;Chemical;PA26491;Gene
CHRNB4;nicotine;Chemical;PA26496;Gene
CYP2A13;nicotine;Chemical;PA27101;Gene
DRD2;nicotine;Chemical;PA27478;Gene
DRD4;nicotine;Chemical;PA27480;Gene
EPB41;nicotine;Chemical;PA27810;Gene
GALR1;nicotine;Chemical;PA28545;Gene
GRIN3A;nicotine;Chemical;PA28983;Gene
HINT1;nicotine;Chemical;PA29286;Gene
HTR3B;nicotine;Chemical;PA29556;Gene
SLC6A3;nicotine;Chemical;PA311;Gene
OPRM1;nicotine;Chemical;PA31945;Gene
POR;nicotine;Chemical;PA33532;Gene
UGT2B10;nicotine;Chemical;PA37186;Gene
TOBACCO USE DISORDER;rs3813567;Variant;PA445876;Disease
NICOTINE;rs3813567;Variant;PA450626;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs20575;Variant;PA164713366;Chemical
ARTHRITIS;rs20575;Variant;PA443430;Disease
RS2011425;clozapine 5-N-glucuronide;Chemical;PA166155662;Variant
UGT1A4;clozapine 5-N-glucuronide;Chemical;PA37179;Gene
NICOTINE;rs28399468;Variant;PA450626;Chemical
DESFLURANE;rs121918596;Variant;PA164749136;Chemical
CHLOROCRESOL;rs121918596;Variant;PA166122627;Chemical
RYR1;rs121918596;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs121918596;Variant;PA444863;Disease
ENFLURANE;rs121918596;Variant;PA449461;Chemical
HALOTHANE;rs121918596;Variant;PA449845;Chemical
ISOFLURANE;rs121918596;Variant;PA450106;Chemical
METHOXYFLURANE;rs121918596;Variant;PA450434;Chemical
SEVOFLURANE;rs121918596;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs121918596;Variant;PA451522;Chemical
CACNA1S;rs121918596;Variant;PA85;Gene
OPIOID-RELATED DISORDERS;rs7205113;Variant;PA445043;Disease
BUPRENORPHINE;rs7205113;Variant;PA448685;Chemical
CYP2B6;Leukemia, Lymphocytic, Chronic, B-Cell;Disease;PA123;Gene
CYP2B6*1;Leukemia, Lymphocytic, Chronic, B-Cell;Disease;PA165818750;Haplotype
CYP2B6*6;Leukemia, Lymphocytic, Chronic, B-Cell;Disease;PA165818762;Haplotype
RS1801157;Leukemia, Lymphocytic, Chronic, B-Cell;Disease;PA166159131;Variant
CXCL12;Leukemia, Lymphocytic, Chronic, B-Cell;Disease;PA35602;Gene
HYPERTENSION;rs2269879;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs2269879;Variant;PA449899;Chemical
ARRB1;PDE4A;Gene;PA59;Gene
ARRB2;PDE4A;Gene;PA60;Gene
FIP1L1;mepolizumab;Chemical;PA134875694;Gene
PDGFRA;mepolizumab;Chemical;PA33147;Gene
HYPERLIPIDEMIAS;rs5128;Variant;PA444528;Disease
HIV INFECTIOUS DISEASE;rs5128;Variant;PA447230;Disease
OLANZAPINE;rs5128;Variant;PA450688;Chemical
RITONAVIR;rs5128;Variant;PA451260;Chemical
PULMONARY FIBROSIS;rs3750920;Variant;PA445468;Disease
ACETYLCYSTEINE;rs3750920;Variant;PA448033;Chemical
MYCOPHENOLIC ACID;CES2;Gene;PA164748728;Chemical
SN-38;CES2;Gene;PA165110775;Chemical
IRINOTECAN;CES2;Gene;PA450085;Chemical
MYCOPHENOLATE MOFETIL;CES2;Gene;PA450566;Chemical
ASTHENIA;rs4728709;Variant;PA443448;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs4728709;Variant;PA446155;Disease
OLANZAPINE;rs4728709;Variant;PA450688;Chemical
VINCRISTINE;rs4728709;Variant;PA451879;Chemical
BETA BLOCKING AGENTS;rs11198893;Variant;PA164712535;Chemical
CORONARY ARTERY DISEASE;rs11198893;Variant;PA443796;Disease
CONJUGATED ESTROGENS;rs9340799;Variant;PA164754789;Chemical
RHEUMATOID ARTHRITIS;rs9340799;Variant;PA443434;Disease
NEOPLASMS;rs9340799;Variant;PA445062;Disease
ANASTROZOLE;rs9340799;Variant;PA448432;Chemical
LEFLUNOMIDE;rs9340799;Variant;PA450192;Chemical
LETROZOLE;rs9340799;Variant;PA450196;Chemical
MEDROXYPROGESTERONE;rs9340799;Variant;PA450344;Chemical
TAMOXIFEN;rs9340799;Variant;PA451581;Chemical
RS396991;antithymocyte globulin;Chemical;PA166153571;Variant
FCGR3A;antithymocyte globulin;Chemical;PA28065;Gene
RHEUMATOID ARTHRITIS;rs2650972;Variant;PA443434;Disease
METHOTREXATE;rs2650972;Variant;PA450428;Chemical
SYSTOLIC BLOOD PRESSURE;rs5065;Variant;PA166128188;Disease
CARDIOVASCULAR DISEASE;rs5065;Variant;PA443635;Disease
CORONARY DISEASE;rs5065;Variant;PA443797;Disease
HYPERTENSION;rs5065;Variant;PA444552;Disease
STROKE;rs5065;Variant;PA447054;Disease
AMLODIPINE;rs5065;Variant;PA448388;Chemical
CHLORTHALIDONE;rs5065;Variant;PA448970;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*46:01;Haplotype;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-B*46:01;Haplotype;PA166120929;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*46:01;Haplotype;PA444059;Disease
EPILEPSY;HLA-B*46:01;Haplotype;PA444065;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*46:01;Haplotype;PA445738;Disease
CARBAMAZEPINE;HLA-B*46:01;Haplotype;PA448785;Chemical
PHENYTOIN;HLA-B*46:01;Haplotype;PA450947;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs1061622;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs1061622;Variant;PA443434;Disease
SPONDYLITIS, ANKYLOSING;rs1061622;Variant;PA445724;Disease
ETANERCEPT;rs1061622;Variant;PA449515;Chemical
INFLIXIMAB;rs1061622;Variant;PA452639;Chemical
CYP2R1;calcidiol;Chemical;PA134986407;Gene
ABCC2;lamivudine;Chemical;PA116;Gene
CYP2B6;lamivudine;Chemical;PA123;Gene
DCK;lamivudine;Chemical;PA137;Gene
CMPK1;lamivudine;Chemical;PA162382539;Gene
CYP2B6*1;lamivudine;Chemical;PA165818750;Haplotype
CYP2B6*6;lamivudine;Chemical;PA165818762;Haplotype
HLA-B*35:05;lamivudine;Chemical;PA165955262;Haplotype
HLA-B*40:01;lamivudine;Chemical;PA165955628;Haplotype
UGT1A1*1;lamivudine;Chemical;PA166115841;Haplotype
UGT1A1*28;lamivudine;Chemical;PA166115842;Haplotype
UGT1A1*36;lamivudine;Chemical;PA166115843;Haplotype
UGT1A1*37;lamivudine;Chemical;PA166115844;Haplotype
RS212091;lamivudine;Chemical;PA166154987;Variant
ABCC1;lamivudine;Chemical;PA244;Gene
NME1;lamivudine;Chemical;PA249;Gene
NME2;lamivudine;Chemical;PA250;Gene
CHPT1;lamivudine;Chemical;PA26477;Gene
ABCB1;lamivudine;Chemical;PA267;Gene
NT5C;lamivudine;Chemical;PA31798;Gene
SLC22A1;lamivudine;Chemical;PA329;Gene
SLC22A3;lamivudine;Chemical;PA330;Gene
PCYT1A;lamivudine;Chemical;PA33099;Gene
SLC22A2;lamivudine;Chemical;PA331;Gene
PCYT2;lamivudine;Chemical;PA33101;Gene
PGK1;lamivudine;Chemical;PA33234;Gene
HLA-B;lamivudine;Chemical;PA35056;Gene
ABCC3;lamivudine;Chemical;PA376;Gene
ABCG2;lamivudine;Chemical;PA390;Gene
ABCC4;lamivudine;Chemical;PA397;Gene
UGT1A1;lamivudine;Chemical;PA420;Gene
DULOXETINE;ATP10A;Gene;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;ATP10A;Gene;PA447321;Disease
EGFR INHIBITORS;HLA-A*02:01;Haplotype;PA153561371;Chemical
MACULOPAPULAR EXANTHEMA;HLA-A*02:01;Haplotype;PA162316739;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-A*02:01;Haplotype;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-A*02:01;Haplotype;PA166120929;Disease
IPILIMUMAB;HLA-A*02:01;Haplotype;PA166182718;Chemical
TEBENTAFUSP;HLA-A*02:01;Haplotype;PA166277741;Chemical
HLA-A;HLA-A*02:01;Haplotype;PA35055;Gene
DRUG HYPERSENSITIVITY;HLA-A*02:01;Haplotype;PA443936;Disease
DRUG TOXICITY;HLA-A*02:01;Haplotype;PA443937;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-A*02:01;Haplotype;PA444059;Disease
EPILEPSY;HLA-A*02:01;Haplotype;PA444065;Disease
EXANTHEMA;HLA-A*02:01;Haplotype;PA444109;Disease
NEOPLASMS;HLA-A*02:01;Haplotype;PA445062;Disease
STEVENS-JOHNSON SYNDROME;HLA-A*02:01;Haplotype;PA445738;Disease
ALLOPURINOL;HLA-A*02:01;Haplotype;PA448320;Chemical
CARBAMAZEPINE;HLA-A*02:01;Haplotype;PA448785;Chemical
PHENYTOIN;HLA-A*02:01;Haplotype;PA450947;Chemical
VALPROIC ACID;HLA-A*02:01;Haplotype;PA451846;Chemical
TOPIRAMATE;rs4984241;Variant;PA451728;Chemical
ZONISAMIDE;rs4984241;Variant;PA451978;Chemical
ALCOHOL ABUSE;TMX2;Gene;PA443309;Disease
ETHANOL;TMX2;Gene;PA448073;Chemical
MACULOPAPULAR EXANTHEMA;CFHR4;Gene;PA162316739;Disease
PHENYTOIN;CFHR4;Gene;PA450947;Chemical
CYP3A4;fosamprenavir;Chemical;PA130;Gene
INTERFERON ALFA-2B, RECOMBINANT;rs1127354;Variant;PA164783990;Chemical
PEGINTERFERON ALFA-2B;rs1127354;Variant;PA164784024;Chemical
MYELOSUPPRESSION;rs1127354;Variant;PA165817398;Disease
TRANSPLANT REJECTION;rs1127354;Variant;PA166114454;Disease
ANEMIA;rs1127354;Variant;PA443340;Disease
RHEUMATOID ARTHRITIS;rs1127354;Variant;PA443434;Disease
SYSTEMIC LUPUS ERYTHEMATOSUS;rs1127354;Variant;PA444822;Disease
INFLAMMATORY BOWEL DISEASES;rs1127354;Variant;PA446116;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs1127354;Variant;PA446155;Disease
CHRONIC HEPATITIS C VIRUS INFECTION;rs1127354;Variant;PA446863;Disease
LIVER TRANSPLANTATION;rs1127354;Variant;PA447247;Disease
AZATHIOPRINE;rs1127354;Variant;PA448515;Chemical
MERCAPTOPURINE;rs1127354;Variant;PA450379;Chemical
METHOTREXATE;rs1127354;Variant;PA450428;Chemical
RIBAVIRIN;rs1127354;Variant;PA451241;Chemical
PURINE ANALOGUES;rs1127354;Variant;PA452634;Chemical
BREAST NEOPLASMS;NCOA1;Gene;PA443560;Disease
TAMOXIFEN;NCOA1;Gene;PA451581;Chemical
ARIPIPRAZOLE;MC4R;Gene;PA10026;Chemical
WEIGHT GAIN;MC4R;Gene;PA128406954;Disease
AMISULPRIDE;MC4R;Gene;PA162565877;Chemical
PALIPERIDONE;MC4R;Gene;PA163518919;Chemical
SCHIZOAFFECTIVE DISORDER;MC4R;Gene;PA166123368;Disease
HYPERTRIGLYCERIDEMIA;MC4R;Gene;PA446120;Disease
SCHIZOPHRENIA;MC4R;Gene;PA447216;Disease
CLOZAPINE;MC4R;Gene;PA449061;Chemical
HALOPERIDOL;MC4R;Gene;PA449841;Chemical
OLANZAPINE;MC4R;Gene;PA450688;Chemical
QUETIAPINE;MC4R;Gene;PA451201;Chemical
RISPERIDONE;MC4R;Gene;PA451257;Chemical
ANTIPSYCHOTICS;MC4R;Gene;PA452233;Chemical
BUFURALOL;rs750996195;Variant;PA166110256;Chemical
DEXTROMETHORPHAN;rs750996195;Variant;PA449273;Chemical
BREAST NEOPLASMS;BARD1;Gene;PA443560;Disease
CARBOPLATIN;BARD1;Gene;PA448803;Chemical
DOCETAXEL;BARD1;Gene;PA449383;Chemical
TRASTUZUMAB;BARD1;Gene;PA451743;Chemical
ARIPIPRAZOLE;CYP2D6*6;Haplotype;PA10026;Chemical
GEFITINIB;CYP2D6*6;Haplotype;PA131301952;Chemical
3,4-METHYLENEDIOXYMETHAMPHETAMINE;CYP2D6*6;Haplotype;PA131887008;Chemical
ATOMOXETINE;CYP2D6*6;Haplotype;PA134688071;Chemical
TROPISETRON;CYP2D6*6;Haplotype;PA161925594;Chemical
AGITATION;CYP2D6*6;Haplotype;PA166123306;Disease
EVENT-FREE SURVIVAL;CYP2D6*6;Haplotype;PA166123366;Disease
SCHIZOAFFECTIVE DISORDER;CYP2D6*6;Haplotype;PA166123368;Disease
ENDOXIFEN;CYP2D6*6;Haplotype;PA166124478;Chemical
CARDIOTOXICITY;CYP2D6*6;Haplotype;PA166128121;Disease
SEDATION;CYP2D6*6;Haplotype;PA166129521;Disease
O-DESMETHYLTRAMADOL;CYP2D6*6;Haplotype;PA166131379;Chemical
ADVERSE EVENTS;CYP2D6*6;Haplotype;PA166151827;Disease
EXTRAPYRAMIDAL SYMPTOMS;CYP2D6*6;Haplotype;PA166170367;Disease
CNS DEPRESSION;CYP2D6*6;Haplotype;PA166170668;Disease
DYSPHORIA;CYP2D6*6;Haplotype;PA166185295;Disease
ALZHEIMER DISEASE;CYP2D6*6;Haplotype;PA443319;Disease
ANEMIA, SICKLE CELL;CYP2D6*6;Haplotype;PA443355;Disease
BREAST NEOPLASMS;CYP2D6*6;Haplotype;PA443560;Disease
DEMENTIA;CYP2D6*6;Haplotype;PA443853;Disease
DRUG TOXICITY;CYP2D6*6;Haplotype;PA443937;Disease
DYSTONIA;CYP2D6*6;Haplotype;PA443970;Disease
EDEMA;CYP2D6*6;Haplotype;PA443994;Disease
HEART DISEASES;CYP2D6*6;Haplotype;PA444368;Disease
HEART FAILURE;CYP2D6*6;Haplotype;PA444370;Disease
HEROIN DEPENDENCE;CYP2D6*6;Haplotype;PA444460;Disease
HYPERTENSION;CYP2D6*6;Haplotype;PA444552;Disease
MALARIA;CYP2D6*6;Haplotype;PA444859;Disease
OPIOID-RELATED DISORDERS;CYP2D6*6;Haplotype;PA445043;Disease
NAUSEA;CYP2D6*6;Haplotype;PA445048;Disease
NEOPLASMS;CYP2D6*6;Haplotype;PA445062;Disease
PAIN;CYP2D6*6;Haplotype;PA445208;Disease
PAIN, POSTOPERATIVE;CYP2D6*6;Haplotype;PA445210;Disease
TACHYCARDIA;CYP2D6*6;Haplotype;PA445802;Disease
VOMITING;CYP2D6*6;Haplotype;PA446051;Disease
ALCOHOL-RELATED DISORDERS;CYP2D6*6;Haplotype;PA446879;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CYP2D6*6;Haplotype;PA447197;Disease
DEPRESSIVE DISORDER;CYP2D6*6;Haplotype;PA447207;Disease
MENTAL DISORDERS;CYP2D6*6;Haplotype;PA447208;Disease
OBSESSIVE-COMPULSIVE DISORDER;CYP2D6*6;Haplotype;PA447211;Disease
PSYCHOTIC DISORDERS;CYP2D6*6;Haplotype;PA447215;Disease
SCHIZOPHRENIA;CYP2D6*6;Haplotype;PA447216;Disease
TARDIVE DYSKINESIA;CYP2D6*6;Haplotype;PA447268;Disease
DEPRESSION;CYP2D6*6;Haplotype;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2D6*6;Haplotype;PA447321;Disease
AMITRIPTYLINE;CYP2D6*6;Haplotype;PA448385;Chemical
CARVEDILOL;CYP2D6*6;Haplotype;PA448817;Chemical
CIPROFLOXACIN;CYP2D6*6;Haplotype;PA449009;Chemical
CLOMIPRAMINE;CYP2D6*6;Haplotype;PA449048;Chemical
CODEINE;CYP2D6*6;Haplotype;PA449088;Chemical
DESIPRAMINE;CYP2D6*6;Haplotype;PA449233;Chemical
DEXTROMETHORPHAN;CYP2D6*6;Haplotype;PA449273;Chemical
DONEPEZIL;CYP2D6*6;Haplotype;PA449394;Chemical
FLUOXETINE;CYP2D6*6;Haplotype;PA449673;Chemical
FLUVOXAMINE;CYP2D6*6;Haplotype;PA449690;Chemical
GALANTAMINE;CYP2D6*6;Haplotype;PA449726;Chemical
HALOPERIDOL;CYP2D6*6;Haplotype;PA449841;Chemical
HYDROCODONE;CYP2D6*6;Haplotype;PA449900;Chemical
IMIPRAMINE;CYP2D6*6;Haplotype;PA449969;Chemical
KETOPROFEN;CYP2D6*6;Haplotype;PA450149;Chemical
METHADONE;CYP2D6*6;Haplotype;PA450401;Chemical
METOPROLOL;CYP2D6*6;Haplotype;PA450480;Chemical
MIRTAZAPINE;CYP2D6*6;Haplotype;PA450522;Chemical
NORTRIPTYLINE;CYP2D6*6;Haplotype;PA450657;Chemical
OXYCODONE;CYP2D6*6;Haplotype;PA450741;Chemical
PAROXETINE;CYP2D6*6;Haplotype;PA450801;Chemical
PRIMAQUINE;CYP2D6*6;Haplotype;PA451103;Chemical
RISPERIDONE;CYP2D6*6;Haplotype;PA451257;Chemical
TAMOXIFEN;CYP2D6*6;Haplotype;PA451581;Chemical
TRAMADOL;CYP2D6*6;Haplotype;PA451735;Chemical
TRIMIPRAMINE;CYP2D6*6;Haplotype;PA451791;Chemical
VENLAFAXINE;CYP2D6*6;Haplotype;PA451866;Chemical
ANTIPSYCHOTICS;CYP2D6*6;Haplotype;PA452233;Chemical
SPARTEINE;CYP2D6*6;Haplotype;PA452610;Chemical
DEBRISOQUINE;CYP2D6*6;Haplotype;PA452616;Chemical
ANTINEOPLASTIC AGENTS;CYP2D6*6;Haplotype;PA452621;Chemical
DAB2IP;EZH2;Gene;PA27133;Gene
ALCOHOL ABUSE;TNRC6A;Gene;PA443309;Disease
ETHANOL;TNRC6A;Gene;PA448073;Chemical
TICAGRELOR;CYP3A4*9;Haplotype;PA165374673;Chemical
CABOZANTINIB;CYP3A4*9;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*9;Haplotype;PA165958362;Chemical
REGORAFENIB;CYP3A4*9;Haplotype;PA166114943;Chemical
VANDETANIB;CYP3A4*9;Haplotype;PA166118341;Chemical
IBRUTINIB;CYP3A4*9;Haplotype;PA166121346;Chemical
BREXPIPRAZOLE;CYP3A4*9;Haplotype;PA166160053;Chemical
ACALABRUTINIB;CYP3A4*9;Haplotype;PA166198581;Chemical
MACITENTAN;CYP3A4*9;Haplotype;PA166261201;Chemical
BLONANSERIN;CYP3A4*9;Haplotype;PA166319041;Chemical
AMIODARONE;CYP3A4*9;Haplotype;PA448383;Chemical
LIDOCAINE;CYP3A4*9;Haplotype;PA450226;Chemical
OXYCODONE;CYP3A4*9;Haplotype;PA450741;Chemical
CYP2B6;stavudine;Chemical;PA123;Gene
CYP2B6*1;stavudine;Chemical;PA165818750;Haplotype
CYP2B6*6;stavudine;Chemical;PA165818762;Haplotype
HLA-B*35:05;stavudine;Chemical;PA165955262;Haplotype
HLA-B*40:01;stavudine;Chemical;PA165955628;Haplotype
RS1799964;stavudine;Chemical;PA166156990;Variant
RS8124728;stavudine;Chemical;PA166180546;Variant
SAMHD1;stavudine;Chemical;PA34938;Gene
HLA-B;stavudine;Chemical;PA35056;Gene
TNF;stavudine;Chemical;PA435;Gene
CYP2D6;oliceridine;Chemical;PA128;Gene
HEART VALVE REPLACEMENT;rs2304429;Variant;PA166123431;Disease
WARFARIN;rs2304429;Variant;PA451906;Chemical
PRKACA;CACNA1D;Gene;PA33748;Gene
PRKACB;CACNA1D;Gene;PA33749;Gene
PRKACG;CACNA1D;Gene;PA33750;Gene
CELECOXIB;CACNA1D;Gene;PA448871;Chemical
VALPROIC ACID;CACNA1D;Gene;PA451846;Chemical
DULOXETINE;rs58042962;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs58042962;Variant;PA447321;Disease
RHEUMATOID ARTHRITIS;ATIC;Gene;PA443434;Disease
METHOTREXATE;ATIC;Gene;PA450428;Chemical
ACE INHIBITORS, PLAIN;rs71103505;Variant;PA164712308;Chemical
ANGIOEDEMA;rs71103505;Variant;PA443371;Disease
COUGH;rs71103505;Variant;PA443803;Disease
VALPROIC ACID;HDAC9;Gene;PA451846;Chemical
ANEMIA;rs2502815;Variant;PA443340;Disease
NASOPHARYNGEAL NEOPLASMS;rs2502815;Variant;PA445046;Disease
DOCETAXEL;rs2502815;Variant;PA449383;Chemical
KIDNEY TRANSPLANTATION;rs9282564;Variant;PA165817016;Disease
LUNG TRANSPLANTATION;rs9282564;Variant;PA166114457;Disease
DEATH;rs9282564;Variant;PA443842;Disease
OPIOID-RELATED DISORDERS;rs9282564;Variant;PA445043;Disease
METHADONE;rs9282564;Variant;PA450401;Chemical
MORPHINE;rs9282564;Variant;PA450550;Chemical
PACLITAXEL;rs9282564;Variant;PA450761;Chemical
TACROLIMUS;rs9282564;Variant;PA451578;Chemical
OPIOIDS;rs9282564;Variant;PA452618;Chemical
DIABETES MELLITUS;FMO5;Gene;PA443886;Disease
METFORMIN;FMO5;Gene;PA450395;Chemical
CARDIAC RHYTHM DISEASE;rs45511401;Variant;PA443421;Disease
DRUG TOXICITY;rs45511401;Variant;PA443937;Disease
NON-HODGKIN LYMPHOMA;rs45511401;Variant;PA444845;Disease
DOXORUBICIN;rs45511401;Variant;PA449412;Chemical
NEPHROTOXICITY;rs9332377;Variant;PA162263533;Disease
OTOTOXICITY;rs9332377;Variant;PA162263534;Disease
DRUG TOXICITY;rs9332377;Variant;PA443937;Disease
NEOPLASMS;rs9332377;Variant;PA445062;Disease
CISPLATIN;rs9332377;Variant;PA449014;Chemical
RS12208357;Antiemetics And Antinauseants;Chemical;PA166157178;Variant
RS34059508;Antiemetics And Antinauseants;Chemical;PA166157196;Variant
RS34130495;Antiemetics And Antinauseants;Chemical;PA166157197;Variant
RS35167514;Antiemetics And Antinauseants;Chemical;PA166157201;Variant
RS55918055;Antiemetics And Antinauseants;Chemical;PA166157206;Variant
SLC22A1;Antiemetics And Antinauseants;Chemical;PA329;Gene
BISPHOSPHONATES;ALDH1A2;Gene;PA164712563;Chemical
HYPERTENSION;ALDH1A2;Gene;PA444552;Disease
OSTEONECROSIS;ALDH1A2;Gene;PA445187;Disease
ATENOLOL;ALDH1A2;Gene;PA448499;Chemical
HYDROCHLOROTHIAZIDE;ALDH1A2;Gene;PA449899;Chemical
DESFLURANE;rs28933397;Variant;PA164749136;Chemical
RYR1;rs28933397;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs28933397;Variant;PA444863;Disease
ENFLURANE;rs28933397;Variant;PA449461;Chemical
HALOTHANE;rs28933397;Variant;PA449845;Chemical
ISOFLURANE;rs28933397;Variant;PA450106;Chemical
METHOXYFLURANE;rs28933397;Variant;PA450434;Chemical
SEVOFLURANE;rs28933397;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs28933397;Variant;PA451522;Chemical
CACNA1S;rs28933397;Variant;PA85;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs3849942;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs3849942;Variant;PA443434;Disease
NEUROFIBROMATOSIS 2;NF2;Gene;PA446338;Disease
ACE INHIBITORS, PLAIN;XPNPEP2;Gene;PA164712308;Chemical
ANGIOEDEMA;XPNPEP2;Gene;PA443371;Disease
FLUOROURACIL;rs138602176;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs138602176;Variant;PA443560;Disease
NEUTROPENIA;rs138602176;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs138602176;Variant;PA449165;Chemical
EPIRUBICIN;rs138602176;Variant;PA449476;Chemical
VITAMIN E;rs3093105;Variant;PA451900;Chemical
ADRB1;Ischemia;Disease;PA38;Gene
CELECOXIB;CDKN1A;Gene;PA448871;Chemical
PHENYTOIN;CYP2C9*41;Haplotype;PA450947;Chemical
TICAGRELOR;CYP3A4*28;Haplotype;PA165374673;Chemical
CABOZANTINIB;CYP3A4*28;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*28;Haplotype;PA165958362;Chemical
REGORAFENIB;CYP3A4*28;Haplotype;PA166114943;Chemical
IBRUTINIB;CYP3A4*28;Haplotype;PA166121346;Chemical
ACALABRUTINIB;CYP3A4*28;Haplotype;PA166198581;Chemical
MACITENTAN;CYP3A4*28;Haplotype;PA166261201;Chemical
BLONANSERIN;CYP3A4*28;Haplotype;PA166319041;Chemical
IBUPROFEN;CYP3A4*28;Haplotype;PA449957;Chemical
OXYCODONE;CYP3A4*28;Haplotype;PA450741;Chemical
SILDENAFIL;CYP3A4*28;Haplotype;PA451346;Chemical
TESTOSTERONE;CYP3A4*28;Haplotype;PA451627;Chemical
FLUOROURACIL;rs225440;Variant;PA128406956;Chemical
COLORECTAL NEOPLASMS;rs225440;Variant;PA446108;Disease
IRINOTECAN;rs225440;Variant;PA450085;Chemical
LEUCOVORIN;rs225440;Variant;PA450198;Chemical
TENOFOVIR;rs2231142;Variant;PA10204;Chemical
IMATINIB;rs2231142;Variant;PA10804;Chemical
FLUOROURACIL;rs2231142;Variant;PA128406956;Chemical
OXALIPLATIN;rs2231142;Variant;PA131285527;Chemical
GEFITINIB;rs2231142;Variant;PA131301952;Chemical
ROSUVASTATIN;rs2231142;Variant;PA134308647;Chemical
SLCO1B1;rs2231142;Variant;PA134865839;Gene
SUNITINIB;rs2231142;Variant;PA162372840;Chemical
DASATINIB;rs2231142;Variant;PA162372878;Chemical
OPIOID ANESTHETICS;rs2231142;Variant;PA164712948;Chemical
OTHER GENERAL ANESTHETICS;rs2231142;Variant;PA164713083;Chemical
NILOTINIB;rs2231142;Variant;PA165958345;Chemical
DOLUTEGRAVIR;rs2231142;Variant;PA166114961;Chemical
VOLATILE ANESTHETICS;rs2231142;Variant;PA166131630;Chemical
STATIN-RELATED MYOPATHY;rs2231142;Variant;PA166163391;Disease
APIXABAN;rs2231142;Variant;PA166163740;Chemical
EZETIMIBE / ROSUVASTATIN;rs2231142;Variant;PA166184498;Chemical
RESMETIROM;rs2231142;Variant;PA166353181;Chemical
ABCG2;rs2231142;Variant;PA390;Gene
RHEUMATOID ARTHRITIS;rs2231142;Variant;PA443434;Disease
ATRIAL FIBRILLATION;rs2231142;Variant;PA443459;Disease
BREAST NEOPLASMS;rs2231142;Variant;PA443560;Disease
BURKITT LYMPHOMA;rs2231142;Variant;PA443580;Disease
NON-SMALL CELL LUNG CARCINOMA;rs2231142;Variant;PA443622;Disease
DRUG TOXICITY;rs2231142;Variant;PA443937;Disease
EPILEPSY;rs2231142;Variant;PA444065;Disease
GOUT;rs2231142;Variant;PA444318;Disease
HYPERCHOLESTEROLEMIA;rs2231142;Variant;PA444516;Disease
LUNG NEOPLASMS;rs2231142;Variant;PA444818;Disease
MYOCARDIAL INFARCTION;rs2231142;Variant;PA445019;Disease
NEOPLASMS;rs2231142;Variant;PA445062;Disease
OSTEOSARCOMA;rs2231142;Variant;PA445601;Disease
COLORECTAL NEOPLASMS;rs2231142;Variant;PA446108;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs2231142;Variant;PA446155;Disease
LYMPHOMA, T-CELL;rs2231142;Variant;PA446309;Disease
HIV INFECTIOUS DISEASE;rs2231142;Variant;PA447230;Disease
ALLOPURINOL;rs2231142;Variant;PA448320;Chemical
ATORVASTATIN;rs2231142;Variant;PA448500;Chemical
CAPECITABINE;rs2231142;Variant;PA448771;Chemical
CYCLOPHOSPHAMIDE;rs2231142;Variant;PA449165;Chemical
DOXORUBICIN;rs2231142;Variant;PA449412;Chemical
EFAVIRENZ;rs2231142;Variant;PA449441;Chemical
FLUVASTATIN;rs2231142;Variant;PA449688;Chemical
GEMCITABINE;rs2231142;Variant;PA449748;Chemical
LAMOTRIGINE;rs2231142;Variant;PA450164;Chemical
LEUCOVORIN;rs2231142;Variant;PA450198;Chemical
METHOTREXATE;rs2231142;Variant;PA450428;Chemical
SIMVASTATIN;rs2231142;Variant;PA451363;Chemical
SULFASALAZINE;rs2231142;Variant;PA451547;Chemical
IMATINIB;rs724710;Variant;PA10804;Chemical
CORTICOSTEROIDS;rs724710;Variant;PA10832;Chemical
NEOPLASMS;rs724710;Variant;PA445062;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs724710;Variant;PA446155;Disease
PIK3R5;HRH2;Gene;PA134890823;Gene
GNAS;HRH2;Gene;PA175;Gene
PIK3C2A;HRH2;Gene;PA33304;Gene
PIK3C2B;HRH2;Gene;PA33305;Gene
OPIOID-RELATED DISORDERS;rs4906902;Variant;PA445043;Disease
OPIOIDS;rs4906902;Variant;PA452618;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs774359;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs774359;Variant;PA443434;Disease
BENZODIAZEPINE DERIVATIVES;OPRM1;Gene;PA10402;Chemical
CANNABINOIDS;OPRM1;Gene;PA131890620;Chemical
NEUROPATHIC PAIN;OPRM1;Gene;PA162263525;Disease
ANALGESICS;OPRM1;Gene;PA164712362;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;OPRM1;Gene;PA164712462;Chemical
DRUGS USED IN NICOTINE DEPENDENCE;OPRM1;Gene;PA164712720;Chemical
ERGOT ALKALOIDS;OPRM1;Gene;PA164712741;Chemical
OPIOID ANESTHETICS;OPRM1;Gene;PA164712948;Chemical
OTHER GENERAL ANESTHETICS;OPRM1;Gene;PA164713083;Chemical
SYMPATHOMIMETICS;OPRM1;Gene;PA164713301;Chemical
NEONATAL ABSTINENCE SYNDROME;OPRM1;Gene;PA165108809;Disease
COTININE;OPRM1;Gene;PA166114414;Chemical
DRY MOUTH;OPRM1;Gene;PA166115462;Disease
METHAMPHETAMINE DEPENDENCE;OPRM1;Gene;PA166119022;Disease
VOLATILE ANESTHETICS;OPRM1;Gene;PA166131630;Chemical
ADVERSE EVENTS;OPRM1;Gene;PA166151827;Disease
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART);OPRM1;Gene;PA166177229;Chemical
SOMNOLENCE;OPRM1;Gene;PA166185626;Disease
SUICIDAL IDEATION;OPRM1;Gene;PA166186039;Disease
TIANEPTINE;OPRM1;Gene;PA166186040;Chemical
LEVOMETHADONE;OPRM1;Gene;PA166227621;Chemical
AMPLIFICATION OF SEXUAL BEHAVIOR;OPRM1;Gene;PA166232141;Disease
ALCOHOL ABUSE;OPRM1;Gene;PA443309;Disease
MARIJUANA ABUSE;OPRM1;Gene;PA443602;Disease
CONSTIPATION;OPRM1;Gene;PA443782;Disease
DELIRIUM;OPRM1;Gene;PA443851;Disease
DIZZINESS;OPRM1;Gene;PA443928;Disease
ERYTHEMA;OPRM1;Gene;PA444083;Disease
CARDIAC ARREST;OPRM1;Gene;PA444365;Disease
HEROIN DEPENDENCE;OPRM1;Gene;PA444460;Disease
OPIOID-RELATED DISORDERS;OPRM1;Gene;PA445043;Disease
NAUSEA;OPRM1;Gene;PA445048;Disease
OVARIAN NEOPLASMS;OPRM1;Gene;PA445204;Disease
PAIN;OPRM1;Gene;PA445208;Disease
PAIN, POSTOPERATIVE;OPRM1;Gene;PA445210;Disease
PRURITUS;OPRM1;Gene;PA445437;Disease
RESPIRATORY INSUFFICIENCY;OPRM1;Gene;PA445522;Disease
SLEEP APNEA SYNDROMES;OPRM1;Gene;PA445687;Disease
SLEEP DISORDERS;OPRM1;Gene;PA445689;Disease
SUBSTANCE WITHDRAWAL SYNDROME;OPRM1;Gene;PA445768;Disease
TOBACCO USE DISORDER;OPRM1;Gene;PA445876;Disease
VOMITING;OPRM1;Gene;PA446051;Disease
OVERDOSE;OPRM1;Gene;PA446199;Disease
URINARY RETENTION;OPRM1;Gene;PA446264;Disease
SUBSTANCE-RELATED DISORDERS;OPRM1;Gene;PA446876;Disease
COCAINE DEPENDENCE;OPRM1;Gene;PA446878;Disease
POSTOPERATIVE NAUSEA AND VOMITING;OPRM1;Gene;PA446970;Disease
HIV INFECTIOUS DISEASE;OPRM1;Gene;PA447230;Disease
MAJOR DEPRESSIVE DISORDER;OPRM1;Gene;PA447321;Disease
ACETAMINOPHEN;OPRM1;Gene;PA448015;Chemical
ETHANOL;OPRM1;Gene;PA448073;Chemical
ALFENTANIL;OPRM1;Gene;PA448084;Chemical
AMPHETAMINE;OPRM1;Gene;PA448408;Chemical
BUPRENORPHINE;OPRM1;Gene;PA448685;Chemical
CARBOPLATIN;OPRM1;Gene;PA448803;Chemical
COCAINE;OPRM1;Gene;PA449072;Chemical
CODEINE;OPRM1;Gene;PA449088;Chemical
DOCETAXEL;OPRM1;Gene;PA449383;Chemical
FENTANYL;OPRM1;Gene;PA449599;Chemical
HYDROCODONE;OPRM1;Gene;PA449900;Chemical
HYDROMORPHONE;OPRM1;Gene;PA449918;Chemical
METHADONE;OPRM1;Gene;PA450401;Chemical
METHAMPHETAMINE;OPRM1;Gene;PA450403;Chemical
MORPHINE;OPRM1;Gene;PA450550;Chemical
NALOXONE;OPRM1;Gene;PA450586;Chemical
NALTREXONE;OPRM1;Gene;PA450588;Chemical
NICOTINE;OPRM1;Gene;PA450626;Chemical
OXYCODONE;OPRM1;Gene;PA450741;Chemical
PACLITAXEL;OPRM1;Gene;PA450761;Chemical
REMIFENTANIL;OPRM1;Gene;PA451232;Chemical
SUFENTANIL;OPRM1;Gene;PA451527;Chemical
SUMATRIPTAN;OPRM1;Gene;PA451566;Chemical
TRAMADOL;OPRM1;Gene;PA451735;Chemical
ANTIDEPRESSANTS;OPRM1;Gene;PA452229;Chemical
ANTIPSYCHOTICS;OPRM1;Gene;PA452233;Chemical
OPIOIDS;OPRM1;Gene;PA452618;Chemical
HEROIN;OPRM1;Gene;PA452619;Chemical
DRUG HYPERSENSITIVITY;rs59569490;Variant;PA443936;Disease
NEOPLASMS;rs59569490;Variant;PA445062;Disease
ASPARAGINASE;rs59569490;Variant;PA448492;Chemical
SLCO1B1;Dyslipidaemia;Disease;PA134865839;Gene
RS2306283;Dyslipidaemia;Disease;PA166154547;Variant
RS4149056;Dyslipidaemia;Disease;PA166154579;Variant
SCHIZOPHRENIA;rs2636697;Variant;PA447216;Disease
RISPERIDONE;rs2636697;Variant;PA451257;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;PDIA2;Gene;PA447197;Disease
METHYLPHENIDATE;PDIA2;Gene;PA450464;Chemical
RS4149117;Chronic lung allograft dysfunction;Disease;PA166154583;Variant
RS7311358;Chronic lung allograft dysfunction;Disease;PA166154602;Variant
SLCO1B3;Chronic lung allograft dysfunction;Disease;PA35844;Gene
IMATINIB;rs13120400;Variant;PA10804;Chemical
DEFERASIROX;rs13120400;Variant;PA164760843;Chemical
CENTRAL NERVOUS SYSTEM INFECTIOUS DISORDER;rs13120400;Variant;PA443658;Disease
PSORIASIS;rs13120400;Variant;PA445451;Disease
OSTEOSARCOMA;rs13120400;Variant;PA445601;Disease
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;rs13120400;Variant;PA446171;Disease
BETA-THALASSEMIA AND RELATED DISEASES;rs13120400;Variant;PA446432;Disease
CEFTRIAXONE;rs13120400;Variant;PA448866;Chemical
METHOTREXATE;rs13120400;Variant;PA450428;Chemical
UGT1A1*1;FOLFIRI;Chemical;PA166115841;Haplotype
UGT1A1*28;FOLFIRI;Chemical;PA166115842;Haplotype
UGT1A1*6;FOLFIRI;Chemical;PA166115858;Haplotype
RS45445694;FOLFIRI;Chemical;PA166155331;Variant
TYMS;FOLFIRI;Chemical;PA359;Gene
UGT1A1;FOLFIRI;Chemical;PA420;Gene
CYP2D6;perhexiline;Chemical;PA128;Gene
TOBACCO USE DISORDER;rs4532;Variant;PA445876;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs4532;Variant;PA447197;Disease
BIPOLAR DISORDER;rs4532;Variant;PA447199;Disease
DEXTROAMPHETAMINE;rs4532;Variant;PA449269;Chemical
LITHIUM;rs4532;Variant;PA450243;Chemical
METHYLPHENIDATE;rs4532;Variant;PA450464;Chemical
NICOTINE;rs4532;Variant;PA450626;Chemical
MAJOR DEPRESSIVE DISORDER;rs2235067;Variant;PA447321;Disease
AMITRIPTYLINE;rs2235067;Variant;PA448385;Chemical
CITALOPRAM;rs2235067;Variant;PA449015;Chemical
PAROXETINE;rs2235067;Variant;PA450801;Chemical
VENLAFAXINE;rs2235067;Variant;PA451866;Chemical
PEGINTERFERON ALFA-2B;HLA-C*14:02;Haplotype;PA164784024;Chemical
EPIDERMAL NECROLYSIS, TOXIC;HLA-C*14:02;Haplotype;PA444059;Disease
HEPATITIS C;HLA-C*14:02;Haplotype;PA444445;Disease
STEVENS-JOHNSON SYNDROME;HLA-C*14:02;Haplotype;PA445738;Disease
PHENYTOIN;HLA-C*14:02;Haplotype;PA450947;Chemical
RIBAVIRIN;HLA-C*14:02;Haplotype;PA451241;Chemical
ESCITALOPRAM;rs9316233;Variant;PA10074;Chemical
DEPRESSIVE DISORDER;rs9316233;Variant;PA447207;Disease
TTR;inotersen;Chemical;PA37069;Gene
ALCOHOL ABUSE;rs13382553;Variant;PA443309;Disease
ETHANOL;rs13382553;Variant;PA448073;Chemical
ESR1;Menopause;Disease;PA156;Gene
RS4646;Menopause;Disease;PA166154836;Variant
RS10046;Menopause;Disease;PA166154837;Variant
RS700518;Menopause;Disease;PA166154847;Variant
RS749292;Menopause;Disease;PA166154849;Variant
RS1008805;Menopause;Disease;PA166154854;Variant
RS1062033;Menopause;Disease;PA166154858;Variant
RS2289105;Menopause;Disease;PA166154884;Variant
RS3759811;Menopause;Disease;PA166154903;Variant
RS4775936;Menopause;Disease;PA166154912;Variant
RS1042597;Menopause;Disease;PA166155614;Variant
RS11543791;Menopause;Disease;PA166160309;Variant
CYP19A1;Menopause;Disease;PA27091;Gene
UGT1A8;Menopause;Disease;PA37183;Gene
RS4553808;bortezomib;Chemical;PA166155730;Variant
CTLA4;bortezomib;Chemical;PA27006;Gene
CELECOXIB;CACNB3;Gene;PA448871;Chemical
DRUGS USED IN NICOTINE DEPENDENCE;rs588765;Variant;PA164712720;Chemical
VARENICLINE;rs588765;Variant;PA164781343;Chemical
TOBACCO USE DISORDER;rs588765;Variant;PA445876;Disease
COCAINE DEPENDENCE;rs588765;Variant;PA446878;Disease
COCAINE;rs588765;Variant;PA449072;Chemical
NICOTINE;rs588765;Variant;PA450626;Chemical
DRUGS USED IN NICOTINE DEPENDENCE;rs16969968;Variant;PA164712720;Chemical
OPIUM ALKALOIDS AND DERIVATIVES;rs16969968;Variant;PA164712950;Chemical
VARENICLINE;rs16969968;Variant;PA164781343;Chemical
COTININE;rs16969968;Variant;PA166114414;Chemical
ALCOHOL ABUSE;rs16969968;Variant;PA443309;Disease
PAIN;rs16969968;Variant;PA445208;Disease
TOBACCO USE DISORDER;rs16969968;Variant;PA445876;Disease
COCAINE DEPENDENCE;rs16969968;Variant;PA446878;Disease
ETHANOL;rs16969968;Variant;PA448073;Chemical
BUPROPION;rs16969968;Variant;PA448687;Chemical
COCAINE;rs16969968;Variant;PA449072;Chemical
NICOTINE;rs16969968;Variant;PA450626;Chemical
VHL;von Hippel-Lindau Disease;Disease;PA37307;Gene
CYP3A4;clonazepam;Chemical;PA130;Gene
NAT2;clonazepam;Chemical;PA18;Gene
HEROIN DEPENDENCE;CSNK1E;Gene;PA444460;Disease
HEROIN;CSNK1E;Gene;PA452619;Chemical
ALDOPHOSPHAMIDE;ALDH1A1;Gene;PA166131270;Chemical
CHLOROACETALDEHYDE;ALDH1A1;Gene;PA166131319;Chemical
ALCOHOLISM;ALDH1A1;Gene;PA443309;Disease
BREAST NEOPLASMS;ALDH1A1;Gene;PA443560;Disease
DRUG TOXICITY;ALDH1A1;Gene;PA443937;Disease
NEOPLASMS;ALDH1A1;Gene;PA445062;Disease
ETHANOL;ALDH1A1;Gene;PA448073;Chemical
CARBOPLATIN;ALDH1A1;Gene;PA448803;Chemical
CYCLOPHOSPHAMIDE;ALDH1A1;Gene;PA449165;Chemical
DOXORUBICIN;ALDH1A1;Gene;PA449412;Chemical
THIOTEPA;ALDH1A1;Gene;PA451668;Chemical
VITAMIN A;ALDH1A1;Gene;PA451884;Chemical
NUDT15;acyclovir;Chemical;PA134963132;Gene
NUDT15*1;acyclovir;Chemical;PA166131619;Haplotype
NUDT15*2;acyclovir;Chemical;PA166131620;Haplotype
NUDT15*3;acyclovir;Chemical;PA166131621;Haplotype
NUDT15*4;acyclovir;Chemical;PA166131622;Haplotype
NUDT15*5;acyclovir;Chemical;PA166131623;Haplotype
UGT1A1*1;belinostat;Chemical;PA166115841;Haplotype
UGT1A1*28;belinostat;Chemical;PA166115842;Haplotype
UGT1A1*60;belinostat;Chemical;PA166115845;Haplotype
UGT1A1;belinostat;Chemical;PA420;Gene
FLUOROURACIL;rs299313;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs299313;Variant;PA443560;Disease
NEUTROPENIA;rs299313;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs299313;Variant;PA449165;Chemical
EPIRUBICIN;rs299313;Variant;PA449476;Chemical
ORGAN TRANSPLANTATION;rs35599367;Variant;PA133888799;Disease
NEOPLASMS;rs35599367;Variant;PA445062;Disease
ALPRAZOLAM;rs35599367;Variant;PA448333;Chemical
CYCLOSPORINE;rs35599367;Variant;PA449167;Chemical
DEXTROMETHORPHAN;rs35599367;Variant;PA449273;Chemical
ERYTHROMYCIN;rs35599367;Variant;PA449493;Chemical
MIDAZOLAM;rs35599367;Variant;PA450496;Chemical
SIMVASTATIN;rs35599367;Variant;PA451363;Chemical
TESTOSTERONE;rs35599367;Variant;PA451627;Chemical
CFTR;Cystic Fibrosis;Disease;PA109;Gene
CYP2C19;Cystic Fibrosis;Disease;PA124;Gene
CYP2C19*17;Cystic Fibrosis;Disease;PA165816533;Haplotype
CYP2C19*1;Cystic Fibrosis;Disease;PA165980634;Haplotype
CYP2C19*2;Cystic Fibrosis;Disease;PA165980635;Haplotype
RS2032582;Cystic Fibrosis;Disease;PA166157316;Variant
RS74503330;Cystic Fibrosis;Disease;PA166157511;Variant
RS75039782;Cystic Fibrosis;Disease;PA166157514;Variant
RS75527207;Cystic Fibrosis;Disease;PA166157516;Variant
RS77010898;Cystic Fibrosis;Disease;PA166157518;Variant
RS78655421;Cystic Fibrosis;Disease;PA166157519;Variant
RS80282562;Cystic Fibrosis;Disease;PA166157521;Variant
RS113993959;Cystic Fibrosis;Disease;PA166157524;Variant
RS113993960;Cystic Fibrosis;Disease;PA166157525;Variant
RS121908755;Cystic Fibrosis;Disease;PA166157529;Variant
RS121908757;Cystic Fibrosis;Disease;PA166157530;Variant
RS121909005;Cystic Fibrosis;Disease;PA166157531;Variant
RS121909013;Cystic Fibrosis;Disease;PA166157532;Variant
RS121909041;Cystic Fibrosis;Disease;PA166157533;Variant
RS193922525;Cystic Fibrosis;Disease;PA166157534;Variant
RS267606723;Cystic Fibrosis;Disease;PA166157537;Variant
RS77932196;Cystic Fibrosis;Disease;PA166161186;Variant
RS121909011;Cystic Fibrosis;Disease;PA166161188;Variant
RS80034486;Cystic Fibrosis;Disease;PA166162695;Variant
RS80224560;Cystic Fibrosis;Disease;PA166162698;Variant
RS75961395;Cystic Fibrosis;Disease;PA166162699;Variant
RS74551128;Cystic Fibrosis;Disease;PA166162705;Variant
RS7512462;Cystic Fibrosis;Disease;PA166162981;Variant
RS397508256;Cystic Fibrosis;Disease;PA166164939;Variant
RS368505753;Cystic Fibrosis;Disease;PA166164940;Variant
RS115545701;Cystic Fibrosis;Disease;PA166164941;Variant
RS397508537;Cystic Fibrosis;Disease;PA166164942;Variant
RS113993958;Cystic Fibrosis;Disease;PA166164943;Variant
RS77834169;Cystic Fibrosis;Disease;PA166164944;Variant
RS397508759;Cystic Fibrosis;Disease;PA166164945;Variant
RS121908752;Cystic Fibrosis;Disease;PA166164946;Variant
RS121908753;Cystic Fibrosis;Disease;PA166164947;Variant
RS397508288;Cystic Fibrosis;Disease;PA166164948;Variant
RS397508442;Cystic Fibrosis;Disease;PA166164949;Variant
RS141033578;Cystic Fibrosis;Disease;PA166164950;Variant
RS150212784;Cystic Fibrosis;Disease;PA166164951;Variant
RS397508513;Cystic Fibrosis;Disease;PA166164952;Variant
RS121909020;Cystic Fibrosis;Disease;PA166164953;Variant
RS78769542;Cystic Fibrosis;Disease;PA166164955;Variant
RS202179988;Cystic Fibrosis;Disease;PA166164956;Variant
RS186045772;Cystic Fibrosis;Disease;PA166164957;Variant
RS75541969;Cystic Fibrosis;Disease;PA166164958;Variant
RS11971167;Cystic Fibrosis;Disease;PA166164959;Variant
RS34911792;Cystic Fibrosis;Disease;PA166178021;Variant
RS1800100;Cystic Fibrosis;Disease;PA166178025;Variant
RS1800111;Cystic Fibrosis;Disease;PA166178032;Variant
RS121909019;Cystic Fibrosis;Disease;PA166178049;Variant
RS77409459;Cystic Fibrosis;Disease;PA166178052;Variant
RS397508139;Cystic Fibrosis;Disease;PA166178058;Variant
RS397508510;Cystic Fibrosis;Disease;PA166178060;Variant
RS397508328;Cystic Fibrosis;Disease;PA166178063;Variant
RS121908751;Cystic Fibrosis;Disease;PA166178065;Variant
RS397508435;Cystic Fibrosis;Disease;PA166178067;Variant
RS36210737;Cystic Fibrosis;Disease;PA166178078;Variant
RS121909047;Cystic Fibrosis;Disease;PA166178088;Variant
RS75549581;Cystic Fibrosis;Disease;PA166178090;Variant
RS397508453;Cystic Fibrosis;Disease;PA166178138;Variant
RS397508602;Cystic Fibrosis;Disease;PA166178193;Variant
RS186089140;Cystic Fibrosis;Disease;PA166299361;Variant
RS35516286;Cystic Fibrosis;Disease;PA166365261;Variant
RS397508573;Cystic Fibrosis;Disease;PA166394541;Variant
RS397508572;Cystic Fibrosis;Disease;PA166394581;Variant
RS1800076;Cystic Fibrosis;Disease;PA166394661;Variant
ABCB1;Cystic Fibrosis;Disease;PA267;Gene
SLC26A9;Cystic Fibrosis;Disease;PA37886;Gene
ESR1;UGT2B15;Gene;PA156;Gene
SIPOGLITAZAR;UGT2B15;Gene;PA166114434;Chemical
EVENT-FREE SURVIVAL;UGT2B15;Gene;PA166123366;Disease
BREAST NEOPLASMS;UGT2B15;Gene;PA443560;Disease
PAIN;UGT2B15;Gene;PA445208;Disease
ACETAMINOPHEN;UGT2B15;Gene;PA448015;Chemical
LORAZEPAM;UGT2B15;Gene;PA450267;Chemical
OXAZEPAM;UGT2B15;Gene;PA450731;Chemical
PHENOBARBITAL;UGT2B15;Gene;PA450911;Chemical
PHENYTOIN;UGT2B15;Gene;PA450947;Chemical
TAMOXIFEN;UGT2B15;Gene;PA451581;Chemical
ANTINEOPLASTIC AGENTS;UGT2B15;Gene;PA452621;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs886424;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs886424;Variant;PA445846;Disease
CARBOPLATIN;rs886424;Variant;PA448803;Chemical
GEMCITABINE;rs886424;Variant;PA449748;Chemical
ARIPIPRAZOLE;CYP2C19;Gene;PA10026;Chemical
DULOXETINE;CYP2C19;Gene;PA10066;Chemical
ESCITALOPRAM;CYP2C19;Gene;PA10074;Chemical
ESOMEPRAZOLE;CYP2C19;Gene;PA10075;Chemical
VORICONAZOLE;CYP2C19;Gene;PA10233;Chemical
ATAZANAVIR;CYP2C19;Gene;PA10251;Chemical
SULFONAMIDES, UREA DERIVATIVES;CYP2C19;Gene;PA10390;Chemical
BENZODIAZEPINE DERIVATIVES;CYP2C19;Gene;PA10402;Chemical
CLOBAZAM;CYP2C19;Gene;PA10888;Chemical
FLUOROURACIL;CYP2C19;Gene;PA128406956;Chemical
3,4-METHYLENEDIOXYMETHAMPHETAMINE;CYP2C19;Gene;PA131887008;Chemical
HMG COA REDUCTASE INHIBITORS;CYP2C19;Gene;PA133950441;Chemical
ROSUVASTATIN;CYP2C19;Gene;PA134308647;Chemical
FORMOTEROL;CYP2C19;Gene;PA134687907;Chemical
ATOMOXETINE;CYP2C19;Gene;PA134688071;Chemical
NEBIVOLOL;CYP2C19;Gene;PA151958426;Chemical
PERIPHERAL VASCULAR DISEASES;CYP2C19;Gene;PA153619833;Disease
PRASUGREL;CYP2C19;Gene;PA154410481;Chemical
MACULOPAPULAR EXANTHEMA;CYP2C19;Gene;PA162316739;Disease
METABOLIC SYNDROME;CYP2C19;Gene;PA162370415;Disease
PROTON PUMP INHIBITORS;CYP2C19;Gene;PA164713207;Chemical
LABETALOL;CYP2C19;Gene;PA164743150;Chemical
CILOSTAZOL;CYP2C19;Gene;PA164746334;Chemical
FLUNITRAZEPAM;CYP2C19;Gene;PA164781320;Chemical
DIVALPROEX SODIUM;CYP2C19;Gene;PA164783479;Chemical
ETHAMBUTOL;CYP2C19;Gene;PA164784021;Chemical
AXITINIB;CYP2C19;Gene;PA164924493;Chemical
ACUTE CORONARY SYNDROME;CYP2C19;Gene;PA165108401;Disease
DROSPIRENONE / ETHINYL ESTRADIOL;CYP2C19;Gene;PA165290928;Chemical
SUICIDE;CYP2C19;Gene;PA165374639;Disease
TICAGRELOR;CYP2C19;Gene;PA165374673;Chemical
CYP2C19*6;CYP2C19;Gene;PA165816522;Haplotype
CYP2C19*7;CYP2C19;Gene;PA165816523;Haplotype
CYP2C19*8;CYP2C19;Gene;PA165816524;Haplotype
CYP2C19*17;CYP2C19;Gene;PA165816533;Haplotype
CYP2C9*3;CYP2C19;Gene;PA165816544;Haplotype
KIDNEY TRANSPLANTATION;CYP2C19;Gene;PA165817016;Disease
CYP3A4*20;CYP2C19;Gene;PA165819244;Haplotype
AMBRISENTAN;CYP2C19;Gene;PA165860521;Chemical
RIVAROXABAN;CYP2C19;Gene;PA165958360;Chemical
DESVENLAFAXINE;CYP2C19;Gene;PA165958374;Chemical
CYP2C19*1;CYP2C19;Gene;PA165980634;Haplotype
CYP2C19*2;CYP2C19;Gene;PA165980635;Haplotype
CYP2C19*3;CYP2C19;Gene;PA165980636;Haplotype
CYP2C19*4;CYP2C19;Gene;PA165980637;Haplotype
CYP2C19*5;CYP2C19;Gene;PA165980638;Haplotype
ETRAVIRINE;CYP2C19;Gene;PA166014703;Chemical
CYP3A4*22;CYP2C19;Gene;PA166048680;Haplotype
HELICOBACTER INFECTIONS;CYP2C19;Gene;PA166048740;Disease
ELDERLY ADULT;CYP2C19;Gene;PA166048829;Disease
DEXLANSOPRAZOLE;CYP2C19;Gene;PA166110257;Chemical
LUNG TRANSPLANTATION;CYP2C19;Gene;PA166114457;Disease
ICOTINIB;CYP2C19;Gene;PA166114460;Chemical
HEMATOPOIETIC STEM CELL TRANSPLANTATION;CYP2C19;Gene;PA166123007;Disease
3-CYANO-7-ETHOXYCOUMARIN;CYP2C19;Gene;PA166123047;Chemical
INTRAGASTRIC PH;CYP2C19;Gene;PA166123203;Disease
OVERALL SURVIVAL;CYP2C19;Gene;PA166123207;Disease
EVENT-FREE SURVIVAL;CYP2C19;Gene;PA166123366;Disease
SCHIZOAFFECTIVE DISORDER;CYP2C19;Gene;PA166123368;Disease
DISCONTINUATION;CYP2C19;Gene;PA166123507;Disease
PLATELET AGGREGATION;CYP2C19;Gene;PA166123766;Disease
PLATELET REACTIVITY;CYP2C19;Gene;PA166124406;Disease
TREATMENT FAILURE;CYP2C19;Gene;PA166128095;Disease
CARDIOTOXICITY;CYP2C19;Gene;PA166128121;Disease
DIPYRONE;CYP2C19;Gene;PA166128206;Chemical
CYP3A5*3;CYP2C19;Gene;PA166128219;Haplotype
CYP3A5*6;CYP2C19;Gene;PA166128233;Haplotype
CYP3A5*7;CYP2C19;Gene;PA166128234;Haplotype
PLATELET AGGREGATION INHIBITION;CYP2C19;Gene;PA166128371;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);CYP2C19;Gene;PA166129560;Disease
CLOPIDOGREL THIOL METABOLITE H4;CYP2C19;Gene;PA166131260;Chemical
DESMETHYL CLOMIPRAMINE;CYP2C19;Gene;PA166131507;Chemical
ADVERSE EVENTS;CYP2C19;Gene;PA166151827;Disease
FLIBANSERIN;CYP2C19;Gene;PA166153431;Chemical
BRIVARACETAM;CYP2C19;Gene;PA166153491;Chemical
LACOSAMIDE;CYP2C19;Gene;PA166160048;Chemical
HIGH ON-TREATMENT PLATELET REACTIVITY;CYP2C19;Gene;PA166163563;Disease
N-DESMETHYLCLOZAPINE;CYP2C19;Gene;PA166163659;Chemical
ADVERSE CARDIOVASCULAR EVENTS;CYP2C19;Gene;PA166165020;Disease
NORCLOBAZAM;CYP2C19;Gene;PA166169929;Chemical
ANDROSTENEDIONE;CYP2C19;Gene;PA166178641;Chemical
PHENAZEPAM;CYP2C19;Gene;PA166180939;Chemical
NORMEPERIDINE;CYP2C19;Gene;PA166186301;Chemical
EOSINOPHILIC ESOPHAGITIS;CYP2C19;Gene;PA166224501;Disease
HYDROXYBUPROPION;CYP2C19;Gene;PA166226561;Chemical
BELZUTIFAN;CYP2C19;Gene;PA166268761;Chemical
ABROCITINIB;CYP2C19;Gene;PA166272921;Chemical
MAVACAMTEN;CYP2C19;Gene;PA166272922;Chemical
6BETA-HYDROXYTESTOSTERONE;CYP2C19;Gene;PA166318222;Chemical
16ALPHA-HYDROXYTESTOSTERONE;CYP2C19;Gene;PA166318241;Chemical
11ALPHA-HYDROXYTESTOSTERONE;CYP2C19;Gene;PA166318261;Chemical
16ALPHA-HYDROXYPROGESTERONE;CYP2C19;Gene;PA166318321;Chemical
11A-HYDROXYPROGESTERONE;CYP2C19;Gene;PA166318342;Chemical
6BETA-HYDROXYPROGESTERONE;CYP2C19;Gene;PA166318343;Chemical
DESOXYCORTONE;CYP2C19;Gene;PA166318362;Chemical
ALCOHOLISM;CYP2C19;Gene;PA443309;Disease
ANGINA PECTORIS;CYP2C19;Gene;PA443362;Disease
ARTHRITIS, RHEUMATOID;CYP2C19;Gene;PA443434;Disease
ASTHMA;CYP2C19;Gene;PA443450;Disease
ATRIAL FIBRILLATION;CYP2C19;Gene;PA443459;Disease
BREAST NEOPLASMS;CYP2C19;Gene;PA443560;Disease
CARCINOMA, SQUAMOUS CELL;CYP2C19;Gene;PA443626;Disease
CARDIOVASCULAR DISEASES;CYP2C19;Gene;PA443635;Disease
CAROTID ARTERY DISEASES;CYP2C19;Gene;PA443636;Disease
ISCHEMIC ATTACK, TRANSIENT;CYP2C19;Gene;PA443672;Disease
CEREBROVASCULAR DISORDERS;CYP2C19;Gene;PA443678;Disease
CORONARY ARTERY DISEASE;CYP2C19;Gene;PA443796;Disease
CORONARY DISEASE;CYP2C19;Gene;PA443797;Disease
CYSTIC FIBROSIS;CYP2C19;Gene;PA443829;Disease
DEATH;CYP2C19;Gene;PA443842;Disease
DIABETES MELLITUS;CYP2C19;Gene;PA443886;Disease
DIABETES MELLITUS, TYPE 2;CYP2C19;Gene;PA443890;Disease
DRUG TOXICITY;CYP2C19;Gene;PA443937;Disease
EDEMA;CYP2C19;Gene;PA443994;Disease
EPILEPSY;CYP2C19;Gene;PA444065;Disease
ESOPHAGITIS;CYP2C19;Gene;PA444104;Disease
GASTROESOPHAGEAL REFLUX;CYP2C19;Gene;PA444255;Disease
GRANULOMATOUS DISEASE, CHRONIC;CYP2C19;Gene;PA444327;Disease
HALLUCINATIONS;CYP2C19;Gene;PA444339;Disease
HEMATOLOGIC DISEASES;CYP2C19;Gene;PA444395;Disease
HEMORRHAGE;CYP2C19;Gene;PA444417;Disease
HEPATITIS C;CYP2C19;Gene;PA444445;Disease
HYPERPROLACTINEMIA;CYP2C19;Gene;PA444545;Disease
INFLAMMATION;CYP2C19;Gene;PA444620;Disease
SYSTEMIC LUPUS ERYTHEMATOSUS;CYP2C19;Gene;PA444822;Disease
LYMPHOMA;CYP2C19;Gene;PA444840;Disease
LYMPHOMA, NON-HODGKIN;CYP2C19;Gene;PA444845;Disease
MALARIA;CYP2C19;Gene;PA444859;Disease
MYCOSES;CYP2C19;Gene;PA445009;Disease
MYOCARDIAL INFARCTION;CYP2C19;Gene;PA445019;Disease
NAUSEA;CYP2C19;Gene;PA445048;Disease
NEOPLASMS;CYP2C19;Gene;PA445062;Disease
PANCREATIC NEOPLASMS;CYP2C19;Gene;PA445218;Disease
RECURRENCE;CYP2C19;Gene;PA445506;Disease
RESPIRATORY TRACT INFECTIONS;CYP2C19;Gene;PA445526;Disease
SHOCK, SEPTIC;CYP2C19;Gene;PA445647;Disease
THROMBOSIS;CYP2C19;Gene;PA445850;Disease
TOBACCO USE DISORDER;CYP2C19;Gene;PA445876;Disease
TUBERCULOSIS;CYP2C19;Gene;PA445941;Disease
ULCER;CYP2C19;Gene;PA445973;Disease
VOMITING;CYP2C19;Gene;PA446051;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;CYP2C19;Gene;PA446155;Disease
SEVERE COMBINED IMMUNODEFICIENCY;CYP2C19;Gene;PA446336;Disease
MYOCARDIAL ISCHEMIA;CYP2C19;Gene;PA446459;Disease
ALCOHOL-RELATED DISORDERS;CYP2C19;Gene;PA446879;Disease
STROKE;CYP2C19;Gene;PA447054;Disease
ANXIETY DISORDERS;CYP2C19;Gene;PA447196;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CYP2C19;Gene;PA447197;Disease
BIPOLAR DISORDER;CYP2C19;Gene;PA447199;Disease
DEPRESSIVE DISORDER;CYP2C19;Gene;PA447207;Disease
MENTAL DISORDERS;CYP2C19;Gene;PA447208;Disease
OBSESSIVE-COMPULSIVE DISORDER;CYP2C19;Gene;PA447211;Disease
PANIC DISORDER;CYP2C19;Gene;PA447212;Disease
SCHIZOPHRENIA;CYP2C19;Gene;PA447216;Disease
HIV INFECTIOUS DISEASE;CYP2C19;Gene;PA447230;Disease
PEPTIC ULCER;CYP2C19;Gene;PA447240;Disease
DEPRESSION;CYP2C19;Gene;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2C19;Gene;PA447321;Disease
CORONARY RESTENOSIS;CYP2C19;Gene;PA447325;Disease
AMITRIPTYLINE;CYP2C19;Gene;PA448385;Chemical
AMOXICILLIN;CYP2C19;Gene;PA448406;Chemical
ASPIRIN;CYP2C19;Gene;PA448497;Chemical
ATORVASTATIN;CYP2C19;Gene;PA448500;Chemical
BUPROPION;CYP2C19;Gene;PA448687;Chemical
BUSPIRONE;CYP2C19;Gene;PA448689;Chemical
BUSULFAN;CYP2C19;Gene;PA448691;Chemical
CARBAMAZEPINE;CYP2C19;Gene;PA448785;Chemical
CARISOPRODOL;CYP2C19;Gene;PA448809;Chemical
CELECOXIB;CYP2C19;Gene;PA448871;Chemical
CHLORAMPHENICOL;CYP2C19;Gene;PA448927;Chemical
CIMETIDINE;CYP2C19;Gene;PA449001;Chemical
CITALOPRAM;CYP2C19;Gene;PA449015;Chemical
CLOMIPRAMINE;CYP2C19;Gene;PA449048;Chemical
CLOPIDOGREL;CYP2C19;Gene;PA449053;Chemical
CLOZAPINE;CYP2C19;Gene;PA449061;Chemical
CYCLOPHOSPHAMIDE;CYP2C19;Gene;PA449165;Chemical
DESIPRAMINE;CYP2C19;Gene;PA449233;Chemical
DIAZEPAM;CYP2C19;Gene;PA449283;Chemical
DOXEPIN;CYP2C19;Gene;PA449409;Chemical
DOXORUBICIN;CYP2C19;Gene;PA449412;Chemical
EFAVIRENZ;CYP2C19;Gene;PA449441;Chemical
FELBAMATE;CYP2C19;Gene;PA449590;Chemical
FLUCONAZOLE;CYP2C19;Gene;PA449653;Chemical
FLUOXETINE;CYP2C19;Gene;PA449673;Chemical
FLUVOXAMINE;CYP2C19;Gene;PA449690;Chemical
HYDROXYPROGESTERONE;CYP2C19;Gene;PA449932;Chemical
IBUPROFEN;CYP2C19;Gene;PA449957;Chemical
IMIPRAMINE;CYP2C19;Gene;PA449969;Chemical
INDOMETHACIN;CYP2C19;Gene;PA449982;Chemical
ISONIAZID;CYP2C19;Gene;PA450112;Chemical
KETOCONAZOLE;CYP2C19;Gene;PA450146;Chemical
LAMOTRIGINE;CYP2C19;Gene;PA450164;Chemical
LANSOPRAZOLE;CYP2C19;Gene;PA450180;Chemical
LEFLUNOMIDE;CYP2C19;Gene;PA450192;Chemical
MEPHENYTOIN;CYP2C19;Gene;PA450373;Chemical
METHYLPHENOBARBITAL;CYP2C19;Gene;PA450374;Chemical
METHADONE;CYP2C19;Gene;PA450401;Chemical
MIRTAZAPINE;CYP2C19;Gene;PA450522;Chemical
MODAFINIL;CYP2C19;Gene;PA450530;Chemical
NELFINAVIR;CYP2C19;Gene;PA450606;Chemical
NEVIRAPINE;CYP2C19;Gene;PA450616;Chemical
NORETHINDRONE;CYP2C19;Gene;PA450651;Chemical
NORTRIPTYLINE;CYP2C19;Gene;PA450657;Chemical
OLANZAPINE;CYP2C19;Gene;PA450688;Chemical
OMEPRAZOLE;CYP2C19;Gene;PA450704;Chemical
OXAZEPAM;CYP2C19;Gene;PA450731;Chemical
OXCARBAZEPINE;CYP2C19;Gene;PA450732;Chemical
OXYCODONE;CYP2C19;Gene;PA450741;Chemical
PANTOPRAZOLE;CYP2C19;Gene;PA450774;Chemical
PAROXETINE;CYP2C19;Gene;PA450801;Chemical
PHENOBARBITAL;CYP2C19;Gene;PA450911;Chemical
PHENPROCOUMON;CYP2C19;Gene;PA450921;Chemical
PHENYTOIN;CYP2C19;Gene;PA450947;Chemical
PREDNISONE;CYP2C19;Gene;PA451100;Chemical
PROGESTERONE;CYP2C19;Gene;PA451123;Chemical
PROGUANIL;CYP2C19;Gene;PA451124;Chemical
PYRAZINAMIDE;CYP2C19;Gene;PA451182;Chemical
QUETIAPINE;CYP2C19;Gene;PA451201;Chemical
RABEPRAZOLE;CYP2C19;Gene;PA451216;Chemical
RIFAMPIN;CYP2C19;Gene;PA451250;Chemical
RISPERIDONE;CYP2C19;Gene;PA451257;Chemical
SERTRALINE;CYP2C19;Gene;PA451333;Chemical
TACROLIMUS;CYP2C19;Gene;PA451578;Chemical
TAMOXIFEN;CYP2C19;Gene;PA451581;Chemical
TEMAZEPAM;CYP2C19;Gene;PA451608;Chemical
TICLOPIDINE;CYP2C19;Gene;PA451686;Chemical
TOLBUTAMIDE;CYP2C19;Gene;PA451718;Chemical
TOPIRAMATE;CYP2C19;Gene;PA451728;Chemical
TRANYLCYPROMINE;CYP2C19;Gene;PA451741;Chemical
TRAZODONE;CYP2C19;Gene;PA451744;Chemical
TRIMIPRAMINE;CYP2C19;Gene;PA451791;Chemical
TROGLITAZONE;CYP2C19;Gene;PA451799;Chemical
VALPROIC ACID;CYP2C19;Gene;PA451846;Chemical
VENLAFAXINE;CYP2C19;Gene;PA451866;Chemical
WARFARIN;CYP2C19;Gene;PA451906;Chemical
ZIPRASIDONE;CYP2C19;Gene;PA451974;Chemical
ANTIDEPRESSANTS;CYP2C19;Gene;PA452229;Chemical
MOCLOBEMIDE;CYP2C19;Gene;PA452615;Chemical
ANTINEOPLASTIC AGENTS;CYP2C19;Gene;PA452621;Chemical
ACENOCOUMAROL;CYP2C19;Gene;PA452632;Chemical
MAPK8;JUND;Gene;PA283;Gene
MAPK14;JUND;Gene;PA30621;Gene
DIABETES MELLITUS, TYPE 2;ALDH3B1;Gene;PA443890;Disease
RS200858900;17beta-estradiol glucuronide;Chemical;PA166268321;Variant
RS11568644;17beta-estradiol glucuronide;Chemical;PA166268341;Variant
RS11568681;17beta-estradiol glucuronide;Chemical;PA166277183;Variant
RS142211148;17beta-estradiol glucuronide;Chemical;PA166277184;Variant
ABCC4;17beta-estradiol glucuronide;Chemical;PA397;Gene
DPYD;rs201615754;Variant;PA145;Gene
CAPECITABINE;rs201615754;Variant;PA448771;Chemical
EPIDERMAL NECROLYSIS, TOXIC;HLA-DRB1*12:02;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-DRB1*12:02;Haplotype;PA445738;Disease
ACETAMINOPHEN;HLA-DRB1*12:02;Haplotype;PA448015;Chemical
CHOLIC ACID;AMACR;Gene;PA166160055;Chemical
IBUPROFEN;AMACR;Gene;PA449957;Chemical
ALCOHOL ABUSE;rs12296477;Variant;PA443309;Disease
ETHANOL;rs12296477;Variant;PA448073;Chemical
OPIOID-RELATED DISORDERS;ADAMTSL2;Gene;PA445043;Disease
BUPRENORPHINE;ADAMTSL2;Gene;PA448685;Chemical
CFTR;rs397508537;Variant;PA109;Gene
IVACAFTOR;rs397508537;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs397508537;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs397508537;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs397508537;Variant;PA443829;Disease
ESCITALOPRAM;rs2069521;Variant;PA10074;Chemical
MAJOR DEPRESSIVE DISORDER;rs2069521;Variant;PA447321;Disease
ACE;Cough;Disease;PA139;Gene
RS11209716;Cough;Disease;PA166153821;Variant
RS1799722;Cough;Disease;PA166154785;Variant
RS8012552;Cough;Disease;PA166154814;Variant
RS8016905;Cough;Disease;PA166154816;Variant
RS1799752;Cough;Disease;PA166155187;Variant
RS4267385;Cough;Disease;PA166155220;Variant
RS4459610;Cough;Disease;PA166155221;Variant
RS2016848;Cough;Disease;PA166156337;Variant
RS71103505;Cough;Disease;PA166223161;Variant
PTGER3;Cough;Disease;PA288;Gene
MME;Cough;Disease;PA30864;Gene
BDKRB2;Cough;Disease;PA80;Gene
FUTIBATINIB;rs1057519045;Variant;PA166293381;Chemical
FGFR2;rs1057519045;Variant;PA28128;Gene
NAUSEA;rs2279199;Variant;PA445048;Disease
VOMITING;rs2279199;Variant;PA446051;Disease
CAPECITABINE;rs2279199;Variant;PA448771;Chemical
ADALIMUMAB;rs510432;Variant;PA10004;Chemical
INFLAMMATORY BOWEL DISEASES;rs510432;Variant;PA446116;Disease
RS10931910;XK469;Chemical;PA166155796;Variant
AOX1;XK469;Chemical;PA24842;Gene
TAXANES;ATP7B;Gene;PA150481189;Chemical
PLATINUM COMPOUNDS;ATP7B;Gene;PA164713176;Chemical
LUNG NEOPLASMS;ATP7B;Gene;PA444818;Disease
OVARIAN NEOPLASMS;ATP7B;Gene;PA445204;Disease
CARBOPLATIN;ATP7B;Gene;PA448803;Chemical
DAUNORUBICIN;ATP7B;Gene;PA449212;Chemical
RS186983396;chlorocresol;Chemical;PA166177045;Variant
RS121918596;chlorocresol;Chemical;PA166177994;Variant
RYR1;chlorocresol;Chemical;PA34896;Gene
SCHIZOPHRENIA;rs1880676;Variant;PA447216;Disease
OLANZAPINE;rs1880676;Variant;PA450688;Chemical
CDKN2A;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA106;Gene
ABCC2;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA116;Gene
CYP2C19;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA124;Gene
CYP3A4;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA130;Gene
CYP3A5;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA131;Gene
SLCO1B1;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA134865839;Gene
ENOSF1;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA134897613;Gene
ARID5B;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA134943193;Gene
C18ORF56;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA134956204;Gene
NUDT15;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA134963132;Gene
DROSHA;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA142671060;Gene
DHFR;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA143;Gene
NALCN;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA162396840;Gene
LINC00251;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165585763;Gene
CYP2C19*17;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165816533;Haplotype
SLCO1B1*37;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165819251;Haplotype
SLCO1B1*5;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165819255;Haplotype
SLCO1B1*14;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165819264;Haplotype
SLCO1B1*15;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165819265;Haplotype
TPMT*1;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165819268;Haplotype
TPMT*2;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165819269;Haplotype
TPMT*3A;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165819270;Haplotype
TPMT*3B;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165819271;Haplotype
TPMT*3C;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165819272;Haplotype
TPMT*9;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165819279;Haplotype
TPMT*12;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165819282;Haplotype
TPMT*21;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165819291;Haplotype
TPMT*24;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165819295;Haplotype
TPMT*25;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165819296;Haplotype
SLCO1B1*23;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165947864;Haplotype
SLCO1B1*31;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165947872;Haplotype
HLA-DRB1*07:01;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165951644;Haplotype
HLA-DRB1*16:02;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165952368;Haplotype
CYP2C19*1;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165980634;Haplotype
SLCO1B1*1;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165981641;Haplotype
SLCO1B1*20;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA165988676;Haplotype
TPMT*32;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166005223;Haplotype
TPMT*33;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166005224;Haplotype
TPMT*34;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166005225;Haplotype
TPMT*37;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166119185;Haplotype
CYP3A5*1;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166128213;Haplotype
CYP3A5*3;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166128219;Haplotype
NUDT15*1;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166131619;Haplotype
NUDT15*2;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166131620;Haplotype
NUDT15*3;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166131621;Haplotype
NUDT15*4;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166131622;Haplotype
NUDT15*5;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166131623;Haplotype
NUDT15*6;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166151814;Haplotype
RS1801131;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166153643;Variant
RS1801133;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166153644;Variant
RS1805087;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166153654;Variant
RS1891059;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166153658;Variant
RS17021408;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166153867;Variant
RS80223967;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166153915;Variant
RS717620;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166153953;Variant
RS3740065;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166154027;Variant
RS4948496;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166154069;Variant
RS10821936;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166154117;Variant
RS10994982;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166154120;Variant
RS1695;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166154249;Variant
RS9344;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166154264;Variant
RS10836235;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166154438;Variant
RS61886492;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166154477;Variant
RS2306283;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166154547;Variant
RS4149056;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166154579;Variant
RS4149081;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166154581;Variant
RS11045821;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166154629;Variant
RS11045872;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166154632;Variant
RS11045879;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166154633;Variant
RS7317112;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166154718;Variant
RS7992226;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166154723;Variant
RS2236225;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166154789;Variant
RS7142143;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166154808;Variant
RS4888024;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166155071;Variant
RS1979277;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166155196;Variant
RS9895420;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166155237;Variant
RS45445694;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166155331;Variant
RS724710;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166155599;Variant
RS1127354;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166155915;Variant
RS6021191;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166155950;Variant
RS7270101;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166155964;Variant
RS79085477;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166155968;Variant
RS117532069;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166155970;Variant
RS1051266;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166155986;Variant
RS1051296;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166155987;Variant
RS2413739;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166156100;Variant
RS2231142;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166156544;Variant
RS408626;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166156732;Variant
RS442767;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166156733;Variant
RS639174;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166156737;Variant
RS1105525;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166156754;Variant
RS1801394;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166156776;Variant
RS4958381;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166156837;Variant
RS70991108;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166156893;Variant
RS4880;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166156900;Variant
RS1142345;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166156978;Variant
RS9345389;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166157144;Variant
RS17885382;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166157195;Variant
RS72552763;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166157216;Variant
RS6092;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166157240;Variant
RS1045642;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166157284;Variant
RS1128503;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166157288;Variant
RS2229109;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166157334;Variant
RS4728709;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166157398;Variant
RS199695765;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166157535;Variant
RS3758149;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166157593;Variant
RS11545077;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166157633;Variant
RS11545078;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166157634;Variant
RS141059755;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166157691;Variant
RS1544105;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166157731;Variant
G6PD DEFICIENCY;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166157959;Variant
RS10948059;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166159951;Variant
TPMT INTERMEDIATE ACTIVITY;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166161831;Variant
RS738409;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166165078;Variant
RS766023281;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166165228;Variant
RS746071566;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166165231;Variant
RS2838958;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166170682;Variant
RS10841753;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166170701;Variant
RS2241843;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166176351;Variant
RS11280056;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166180936;Variant
RS4149009;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166252581;Variant
RS11545076;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166253503;Variant
RS12283870;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166285621;Variant
RS533334893;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166307621;Variant
FPGS;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA167;Gene
MTHFR;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA245;Gene
BCL2L11;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA25305;Gene
BMP7;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA25384;Gene
DOK5;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA25724;Gene
CAT;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA26099;Gene
SERPINE1;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA261;Gene
ABCB1;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA267;Gene
CPA2;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA26817;Gene
CPT1A;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA26847;Gene
ETV6;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA27909;Gene
FOLH1;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA28205;Gene
G6PD;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA28469;Gene
GNMT;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA28794;Gene
GRIA1;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA28966;Gene
GSTP1;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA29028;Gene
IGHMBP2;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA29731;Gene
ITPA;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA29973;Gene
MSH3;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA31134;Gene
MTHFD1;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA31236;Gene
MTR;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA31272;Gene
MTRR;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA31277;Gene
NFATC2;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA31583;Gene
SLC19A1;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA327;Gene
SLCO1A2;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA328;Gene
PACSIN2;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA32897;Gene
SLC22A1;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA329;Gene
PYGL;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA34068;Gene
HLA-DRB1;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA35072;Gene
TPMT;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA356;Gene
SHMT1;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA35753;Gene
TYMS;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA359;Gene
SOD2;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA36017;Gene
ABCC3;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA376;Gene
PNPLA3;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA38592;Gene
ABCG2;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA390;Gene
ABCC4;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA397;Gene
GGH;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA432;Gene
CCND1;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA75;Gene
IMATINIB;rs10258429;Variant;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;rs10258429;Variant;PA151958383;Disease
FLUOROURACIL;NOS1;Gene;PA128406956;Chemical
BREAST NEOPLASMS;NOS1;Gene;PA443560;Disease
NEUTROPENIA;NOS1;Gene;PA445113;Disease
CYCLOPHOSPHAMIDE;NOS1;Gene;PA449165;Chemical
EPIRUBICIN;NOS1;Gene;PA449476;Chemical
IBUPROFEN;NOS1;Gene;PA449957;Chemical
IFNL4;direct acting antivirals;Chemical;PA166049147;Gene
RS11322783;direct acting antivirals;Chemical;PA166190881;Variant
LAPATINIB;PIK3CA;Gene;PA152241907;Chemical
MIR10A;PIK3CA;Gene;PA164722345;Gene
ALPELISIB;PIK3CA;Gene;PA166184523;Chemical
CAPIVASERTIB;PIK3CA;Gene;PA166328761;Chemical
INAVOLISIB;PIK3CA;Gene;PA166400101;Chemical
AKT1;PIK3CA;Gene;PA24684;Gene
ERBB2;PIK3CA;Gene;PA27844;Gene
ERBB3;PIK3CA;Gene;PA27846;Gene
ERBB4;PIK3CA;Gene;PA27847;Gene
FLT1;PIK3CA;Gene;PA28180;Gene
FLT4;PIK3CA;Gene;PA28183;Gene
KDR;PIK3CA;Gene;PA30086;Gene
PIK3R1;PIK3CA;Gene;PA33312;Gene
NON-SMALL CELL LUNG CARCINOMA;PIK3CA;Gene;PA443622;Disease
CARBOPLATIN;PIK3CA;Gene;PA448803;Chemical
CISPLATIN;PIK3CA;Gene;PA449014;Chemical
DOCETAXEL;PIK3CA;Gene;PA449383;Chemical
TRASTUZUMAB;PIK3CA;Gene;PA451743;Chemical
EGFR;PIK3CA;Gene;PA7360;Gene
RS1872328;Hearing Loss;Disease;PA166155651;Variant
ACYP2;Hearing Loss;Disease;PA24500;Gene
OXYCODONE;CYP3A4*21;Haplotype;PA450741;Chemical
OPIOID-RELATED DISORDERS;rs1129844;Variant;PA445043;Disease
METHADONE;rs1129844;Variant;PA450401;Chemical
HYPERTENSION;YEATS4;Gene;PA444552;Disease
ESSENTIAL HYPERTENSION;YEATS4;Gene;PA447288;Disease
HYDROCHLOROTHIAZIDE;YEATS4;Gene;PA449899;Chemical
CYTARABINE;rs11191612;Variant;PA449177;Chemical
LEUKEMIA, MYELOID, ACUTE;RAC2;Gene;PA444760;Disease
NEOPLASMS;RAC2;Gene;PA445062;Disease
DOXORUBICIN;RAC2;Gene;PA449412;Chemical
IDARUBICIN;RAC2;Gene;PA449961;Chemical
ACE;COVID-19;Disease;PA139;Gene
RS1799752;COVID-19;Disease;PA166155187;Variant
G6PD;COVID-19;Disease;PA28469;Gene
ACE2;COVID-19;Disease;PA425;Gene
MUCOCUTANEOUS LYMPH NODE SYNDROME;COVID-19;Disease;PA444977;Disease
FLUOROURACIL;rs41412545;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs41412545;Variant;PA443560;Disease
NEUTROPENIA;rs41412545;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs41412545;Variant;PA449165;Chemical
EPIRUBICIN;rs41412545;Variant;PA449476;Chemical
CHRNA3;ravulizumab;Chemical;PA113;Gene
CHRNA7;ravulizumab;Chemical;PA114;Gene
AQP4;ravulizumab;Chemical;PA24922;Gene
CHRNA1;ravulizumab;Chemical;PA26487;Gene
CHRNA4;ravulizumab;Chemical;PA26490;Gene
CHRNA5;ravulizumab;Chemical;PA26491;Gene
CHRNA6;ravulizumab;Chemical;PA26492;Gene
CHRNB1;ravulizumab;Chemical;PA26494;Gene
CHRNE;ravulizumab;Chemical;PA26498;Gene
C18ORF56;gastroesophageal cancer;Disease;PA134956204;Gene
RS45445694;gastroesophageal cancer;Disease;PA166155331;Variant
TYMS;gastroesophageal cancer;Disease;PA359;Gene
CETUXIMAB;EREG;Gene;PA10040;Chemical
PANITUMUMAB;EREG;Gene;PA162373091;Chemical
DESFLURANE;rs63749869;Variant;PA164749136;Chemical
RYR1;rs63749869;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs63749869;Variant;PA444863;Disease
ENFLURANE;rs63749869;Variant;PA449461;Chemical
HALOTHANE;rs63749869;Variant;PA449845;Chemical
ISOFLURANE;rs63749869;Variant;PA450106;Chemical
METHOXYFLURANE;rs63749869;Variant;PA450434;Chemical
SEVOFLURANE;rs63749869;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs63749869;Variant;PA451522;Chemical
CACNA1S;rs63749869;Variant;PA85;Gene
VALDECOXIB;PTGS2;Gene;PA10226;Chemical
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS;PTGS2;Gene;PA10384;Chemical
OXALIPLATIN;PTGS2;Gene;PA131285527;Chemical
NIMESULIDE;PTGS2;Gene;PA137179528;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;PTGS2;Gene;PA164712462;Chemical
COXIBS;PTGS2;Gene;PA164712669;Chemical
LUMIRACOXIB;PTGS2;Gene;PA164769031;Chemical
ETORICOXIB;PTGS2;Gene;PA164776853;Chemical
CARDIOVASCULAR DISEASES;PTGS2;Gene;PA443635;Disease
CORONARY ARTERY DISEASE;PTGS2;Gene;PA443796;Disease
CORONARY DISEASE;PTGS2;Gene;PA443797;Disease
HYPERTENSION;PTGS2;Gene;PA444552;Disease
MYOCARDIAL INFARCTION;PTGS2;Gene;PA445019;Disease
NEOPLASMS;PTGS2;Gene;PA445062;Disease
PROSTATIC NEOPLASMS;PTGS2;Gene;PA445425;Disease
COLORECTAL NEOPLASMS;PTGS2;Gene;PA446108;Disease
STROKE;PTGS2;Gene;PA447054;Disease
ASPIRIN;PTGS2;Gene;PA448497;Chemical
ATENOLOL;PTGS2;Gene;PA448499;Chemical
CAPECITABINE;PTGS2;Gene;PA448771;Chemical
CELECOXIB;PTGS2;Gene;PA448871;Chemical
DICLOFENAC;PTGS2;Gene;PA449293;Chemical
ETODOLAC;PTGS2;Gene;PA449550;Chemical
IBUPROFEN;PTGS2;Gene;PA449957;Chemical
INDOMETHACIN;PTGS2;Gene;PA449982;Chemical
MELOXICAM;PTGS2;Gene;PA450353;Chemical
NAPROXEN;PTGS2;Gene;PA450595;Chemical
ROFECOXIB;PTGS2;Gene;PA451268;Chemical
CYP2C19;omeprazole;Chemical;PA124;Gene
CYP3A4;omeprazole;Chemical;PA130;Gene
CYP3A5;omeprazole;Chemical;PA131;Gene
CYP2C19*8;omeprazole;Chemical;PA165816524;Haplotype
CYP2C19*9;omeprazole;Chemical;PA165816525;Haplotype
CYP2C19*10;omeprazole;Chemical;PA165816526;Haplotype
CYP2C19*15;omeprazole;Chemical;PA165816531;Haplotype
CYP2C19*16;omeprazole;Chemical;PA165816532;Haplotype
CYP2C19*17;omeprazole;Chemical;PA165816533;Haplotype
CYP2C19*18;omeprazole;Chemical;PA165816534;Haplotype
CYP2C19*19;omeprazole;Chemical;PA165816535;Haplotype
CYP2C19*23;omeprazole;Chemical;PA165816537;Haplotype
CYP2C19*24;omeprazole;Chemical;PA165816538;Haplotype
CYP2C19*26;omeprazole;Chemical;PA165816540;Haplotype
CYP2C19*1;omeprazole;Chemical;PA165980634;Haplotype
CYP2C19*2;omeprazole;Chemical;PA165980635;Haplotype
CYP2C19*3;omeprazole;Chemical;PA165980636;Haplotype
CYP2C19*29;omeprazole;Chemical;PA166123292;Haplotype
CYP2C19*30;omeprazole;Chemical;PA166123293;Haplotype
CYP2C19*31;omeprazole;Chemical;PA166123294;Haplotype
CYP2C19*33;omeprazole;Chemical;PA166123296;Haplotype
RS140278421;omeprazole;Chemical;PA166154212;Variant
RS16944;omeprazole;Chemical;PA166155587;Variant
RS1045642;omeprazole;Chemical;PA166157284;Variant
RS75519181;omeprazole;Chemical;PA166157515;Variant
CYP2C19 POOR METABOLIZERS;omeprazole;Chemical;PA166157897;Variant
RS148247410;omeprazole;Chemical;PA166208261;Variant
RS1466428833;omeprazole;Chemical;PA166403561;Variant
RS1361528097;omeprazole;Chemical;PA166410301;Variant
RS1431015009;omeprazole;Chemical;PA166410323;Variant
RS1393133490;omeprazole;Chemical;PA166410325;Variant
AHR;omeprazole;Chemical;PA24641;Gene
ABCB1;omeprazole;Chemical;PA267;Gene
CYP1A2;omeprazole;Chemical;PA27093;Gene
IL1B;omeprazole;Chemical;PA29808;Gene
NR1I2;omeprazole;Chemical;PA378;Gene
SLC22A6;omeprazole;Chemical;PA388;Gene
SLC22A8;omeprazole;Chemical;PA389;Gene
CLOPIDOGREL;omeprazole;Chemical;PA449053;Chemical
CYP2D6;dysphoria;Disease;PA128;Gene
CYP2D6*1;dysphoria;Disease;PA165816576;Haplotype
CYP2D6*3;dysphoria;Disease;PA165816578;Haplotype
CYP2D6*4;dysphoria;Disease;PA165816579;Haplotype
CYP2D6*6;dysphoria;Disease;PA165816581;Haplotype
CYP2D6*5;dysphoria;Disease;PA165948092;Haplotype
CYP2D6*81;dysphoria;Disease;PA166123321;Haplotype
ITOPRIDE;rs2266780;Variant;PA152432599;Chemical
TOBACCO USE DISORDER;rs2266780;Variant;PA445876;Disease
NICOTINE;rs2266780;Variant;PA450626;Chemical
OLANZAPINE;rs2266780;Variant;PA450688;Chemical
SULINDAC;rs2266780;Variant;PA451565;Chemical
HLA-DRB1*15:01;Hepatitis;Disease;PA165952269;Haplotype
HLA-DRB5*01:01;Hepatitis;Disease;PA165952460;Haplotype
HLA-DQB1*06:02;Hepatitis;Disease;PA165958103;Haplotype
HLA-DQB1;Hepatitis;Disease;PA35068;Gene
HLA-DRB1;Hepatitis;Disease;PA35072;Gene
HLA-DRB5;Hepatitis;Disease;PA35076;Gene
GP1BB;COL4A2;Gene;PA179;Gene
ITGA2;COL4A2;Gene;PA204;Gene
CD36;COL4A2;Gene;PA26212;Gene
GP5;COL4A2;Gene;PA28823;Gene
GP6;COL4A2;Gene;PA28824;Gene
GP9;COL4A2;Gene;PA28825;Gene
BEVACIZUMAB;rs3734704;Variant;PA130232992;Chemical
HYPERTENSION;rs3734704;Variant;PA444552;Disease
PLATINUM COMPOUNDS;rs4978536;Variant;PA164713176;Chemical
THROMBOCYTOPENIA;rs4978536;Variant;PA445846;Disease
RS1128503;Glioma;Disease;PA166157288;Variant
RS2229109;Glioma;Disease;PA166157334;Variant
ABCB1;Glioma;Disease;PA267;Gene
G6PD DEFICIENCY;Hematuria;Disease;PA166157959;Variant
G6PD;Hematuria;Disease;PA28469;Gene
IFNL4;complete early virological response;Disease;PA166049147;Gene
RS11322783;complete early virological response;Disease;PA166190881;Variant
RS16906115;PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors;Chemical;PA166344461;Variant
IL7;PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors;Chemical;PA29839;Gene
ESTRADIOL;rs11849538;Variant;PA449503;Chemical
ABCC2;leucovorin;Chemical;PA116;Gene
DPYD;leucovorin;Chemical;PA145;Gene
ERCC1;leucovorin;Chemical;PA155;Gene
KLC1;leucovorin;Chemical;PA162393424;Gene
RS1056515;leucovorin;Chemical;PA166153615;Variant
RS1801131;leucovorin;Chemical;PA166153643;Variant
RS1801133;leucovorin;Chemical;PA166153644;Variant
RS3917412;leucovorin;Chemical;PA166153758;Variant
RS717620;leucovorin;Chemical;PA166153953;Variant
RS3824662;leucovorin;Chemical;PA166154043;Variant
RS1695;leucovorin;Chemical;PA166154249;Variant
RS861539;leucovorin;Chemical;PA166154768;Variant
RS1979277;leucovorin;Chemical;PA166155196;Variant
RS45445694;leucovorin;Chemical;PA166155331;Variant
RS11615;leucovorin;Chemical;PA166155342;Variant
RS13181;leucovorin;Chemical;PA166155343;Variant
RS225440;leucovorin;Chemical;PA166155976;Variant
RS2292997;leucovorin;Chemical;PA166156354;Variant
RS3749438;leucovorin;Chemical;PA166156376;Variant
RS10937158;leucovorin;Chemical;PA166156440;Variant
RS2231142;leucovorin;Chemical;PA166156544;Variant
RS7699188;leucovorin;Chemical;PA166156632;Variant
RS699947;leucovorin;Chemical;PA166156938;Variant
RS712830;leucovorin;Chemical;PA166157263;Variant
ABCG1;leucovorin;Chemical;PA24408;Gene
MTHFR;leucovorin;Chemical;PA245;Gene
ERCC2;leucovorin;Chemical;PA27848;Gene
GATA3;leucovorin;Chemical;PA28586;Gene
GSTP1;leucovorin;Chemical;PA29028;Gene
SLC19A1;leucovorin;Chemical;PA327;Gene
RGS5;leucovorin;Chemical;PA34376;Gene
SELE;leucovorin;Chemical;PA35640;Gene
SHMT1;leucovorin;Chemical;PA35753;Gene
TYMS;leucovorin;Chemical;PA359;Gene
VEGFA;leucovorin;Chemical;PA37302;Gene
XRCC3;leucovorin;Chemical;PA37422;Gene
ABCG2;leucovorin;Chemical;PA390;Gene
ABCC5;leucovorin;Chemical;PA395;Gene
EGFR;leucovorin;Chemical;PA7360;Gene
APOE;donanemab;Chemical;PA55;Gene
NFKB1;CAMK2A;Gene;PA248;Gene
ELK1;CAMK2A;Gene;PA27749;Gene
FOS;CAMK2A;Gene;PA28212;Gene
RELA;CAMK2A;Gene;PA296;Gene
JUN;CAMK2A;Gene;PA30006;Gene
MYC;CAMK2A;Gene;PA31353;Gene
NFKB2;CAMK2A;Gene;PA31600;Gene
STAT3;CAMK2A;Gene;PA337;Gene
STAT5A;CAMK2A;Gene;PA338;Gene
SP1;CAMK2A;Gene;PA36042;Gene
STAT1;CAMK2A;Gene;PA36183;Gene
STAT2;CAMK2A;Gene;PA36184;Gene
STAT4;CAMK2A;Gene;PA36185;Gene
STAT5B;CAMK2A;Gene;PA36186;Gene
ISATUXIMAB;CD38;Gene;PA166224941;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;ZDHHC7;Gene;PA447197;Disease
METHYLPHENIDATE;ZDHHC7;Gene;PA450464;Chemical
LEUKEMIA, MYELOID, ACUTE;NT5C3A;Gene;PA444760;Disease
NEOPLASMS;NT5C3A;Gene;PA445062;Disease
CYTARABINE;NT5C3A;Gene;PA449177;Chemical
GEMCITABINE;NT5C3A;Gene;PA449748;Chemical
IDARUBICIN;NT5C3A;Gene;PA449961;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;IL23R;Gene;PA164713366;Chemical
PSORIASIS;IL23R;Gene;PA445451;Disease
COLORECTAL NEOPLASMS;IL23R;Gene;PA446108;Disease
AZATHIOPRINE;IL23R;Gene;PA448515;Chemical
CELECOXIB;IL23R;Gene;PA448871;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs9262143;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs9262143;Variant;PA445846;Disease
CARBOPLATIN;rs9262143;Variant;PA448803;Chemical
GEMCITABINE;rs9262143;Variant;PA449748;Chemical
MAP2K7;MAPK7;Gene;PA284;Gene
MAP2K1;MAPK7;Gene;PA30584;Gene
MAP2K2;MAPK7;Gene;PA30587;Gene
MAP2K3;MAPK7;Gene;PA30588;Gene
MAP2K4;MAPK7;Gene;PA30589;Gene
MAP2K5;MAPK7;Gene;PA30590;Gene
MAP2K6;MAPK7;Gene;PA30591;Gene
SORAFENIB;MAPK7;Gene;PA7000;Chemical
ASPIRIN-INDUCED ASTHMA;CHIA;Gene;PA131285571;Disease
ASPIRIN;CHIA;Gene;PA448497;Chemical
CES1;dabigatran;Chemical;PA107;Gene
CYP3A5;dabigatran;Chemical;PA131;Gene
CYP3A5*1;dabigatran;Chemical;PA166128213;Haplotype
CYP3A5*3;dabigatran;Chemical;PA166128219;Haplotype
RS2244613;dabigatran;Chemical;PA166155037;Variant
RS1045642;dabigatran;Chemical;PA166157284;Variant
RS2032582;dabigatran;Chemical;PA166157316;Variant
RS8192935;dabigatran;Chemical;PA166159104;Variant
RS4148738;dabigatran;Chemical;PA166159110;Variant
ABCB1;dabigatran;Chemical;PA267;Gene
DULOXETINE;rs167770;Variant;PA10066;Chemical
ANXIETY DISORDERS;rs167770;Variant;PA447196;Disease
PSORIASIS;rs28364006;Variant;PA445451;Disease
METHOTREXATE;rs28364006;Variant;PA450428;Chemical
MARALIXIBAT;JAG1;Gene;PA166268803;Chemical
ODEVIXIBAT;JAG1;Gene;PA166268805;Chemical
REVUMENIB;KMT2A;Gene;PA166400121;Chemical
NICOTINE;rs2337980;Variant;PA450626;Chemical
CYP2D6;toremifene;Chemical;PA128;Gene
CYP3A4;toremifene;Chemical;PA130;Gene
ESR1;toremifene;Chemical;PA156;Gene
CYP2D6*10;toremifene;Chemical;PA165816582;Haplotype
ESR2;toremifene;Chemical;PA27886;Gene
PLATINUM COMPOUNDS;rs9535826;Variant;PA164713176;Chemical
LUNG NEOPLASMS;rs9535826;Variant;PA444818;Disease
ACE;Erectile Dysfunction;Disease;PA139;Gene
RS5443;Erectile Dysfunction;Disease;PA166154486;Variant
RS4343;Erectile Dysfunction;Disease;PA166155147;Variant
RS699947;Erectile Dysfunction;Disease;PA166156938;Variant
RS2070744;Erectile Dysfunction;Disease;PA166157325;Variant
GNB3;Erectile Dysfunction;Disease;PA176;Gene
NOS3;Erectile Dysfunction;Disease;PA254;Gene
VEGFA;Erectile Dysfunction;Disease;PA37302;Gene
DPYD;rs143815742;Variant;PA145;Gene
CAPECITABINE;rs143815742;Variant;PA448771;Chemical
HLA-DRB1*15:01;glatiramer acetate;Chemical;PA165952269;Haplotype
RS333;glatiramer acetate;Chemical;PA166156273;Variant
RS12459996;glatiramer acetate;Chemical;PA166170234;Variant
RS75041078;glatiramer acetate;Chemical;PA166170236;Variant
RS1056854;glatiramer acetate;Chemical;PA166170237;Variant
CCR5;glatiramer acetate;Chemical;PA26170;Gene
HLA-DRB1;glatiramer acetate;Chemical;PA35072;Gene
IL6;CRISPLD2;Gene;PA198;Gene
IL8;CRISPLD2;Gene;PA29841;Gene
DEXAMETHASONE;CRISPLD2;Gene;PA449247;Chemical
CORONARY ARTERY DISEASE;rs342293;Variant;PA443796;Disease
CLOPIDOGREL;rs342293;Variant;PA449053;Chemical
AMISULPRIDE;rs10042486;Variant;PA162565877;Chemical
MILNACIPRAN;rs10042486;Variant;PA164752812;Chemical
SCHIZOPHRENIA;rs10042486;Variant;PA447216;Disease
MAJOR DEPRESSIVE DISORDER;rs10042486;Variant;PA447321;Disease
FLUVOXAMINE;rs10042486;Variant;PA449690;Chemical
OLANZAPINE;rs10042486;Variant;PA450688;Chemical
PAROXETINE;rs10042486;Variant;PA450801;Chemical
QUETIAPINE;rs10042486;Variant;PA451201;Chemical
RISPERIDONE;rs10042486;Variant;PA451257;Chemical
ANTIPSYCHOTICS;rs10042486;Variant;PA452233;Chemical
ASTHMA;rs3856806;Variant;PA443450;Disease
ASPIRIN;rs3856806;Variant;PA448497;Chemical
NR1I2;phenylbutazone;Chemical;PA378;Gene
COUMARIN;CYP2A6*10;Haplotype;PA134521193;Chemical
TEGAFUR / GIMERACIL / OTERACIL;CYP2A6*10;Haplotype;PA166115442;Chemical
PROGRESSION-FREE SURVIVAL;CYP2A6*10;Haplotype;PA166123026;Disease
OVERALL SURVIVAL;CYP2A6*10;Haplotype;PA166123207;Disease
BILIARY TRACT NEOPLASMS;CYP2A6*10;Haplotype;PA166128807;Disease
NEOPLASMS;CYP2A6*10;Haplotype;PA445062;Disease
STOMACH NEOPLASMS;CYP2A6*10;Haplotype;PA445742;Disease
TOBACCO USE DISORDER;CYP2A6*10;Haplotype;PA445876;Disease
CAFFEINE;CYP2A6*10;Haplotype;PA448710;Chemical
NICOTINE;CYP2A6*10;Haplotype;PA450626;Chemical
PILOCARPINE;CYP2A6*10;Haplotype;PA450962;Chemical
TEGAFUR;CYP2A6*10;Haplotype;PA452620;Chemical
PAZOPANIB;rs34231037;Variant;PA165291492;Chemical
KIDNEY NEOPLASMS;rs34231037;Variant;PA444685;Disease
COMT;Constipation;Disease;PA117;Gene
CYP2D6;Constipation;Disease;PA128;Gene
CYP2D6*1;Constipation;Disease;PA165816576;Haplotype
CYP2D6*4;Constipation;Disease;PA165816579;Haplotype
CYP2D6*10;Constipation;Disease;PA165816582;Haplotype
CYP2D6*41;Constipation;Disease;PA165816584;Haplotype
CYP2D6*5;Constipation;Disease;PA165948092;Haplotype
RS324420;Constipation;Disease;PA166153569;Variant
RS4680;Constipation;Disease;PA166156024;Variant
RS1799971;Constipation;Disease;PA166156991;Variant
FAAH;Constipation;Disease;PA27955;Gene
OPRM1;Constipation;Disease;PA31945;Gene
RS889299;farglitazar;Chemical;PA166154998;Variant
SCNN1B;farglitazar;Chemical;PA306;Gene
PEGINTERFERON ALFA-2A;rs28416813;Variant;PA164749390;Chemical
PEGINTERFERON ALFA-2B;rs28416813;Variant;PA164784024;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;rs28416813;Variant;PA446863;Disease
HIV INFECTIOUS DISEASE;rs28416813;Variant;PA447230;Disease
RIBAVIRIN;rs28416813;Variant;PA451241;Chemical
DEXTROMETHORPHAN;CYP2D6*15;Haplotype;PA449273;Chemical
DEBRISOQUINE;CYP2D6*15;Haplotype;PA452616;Chemical
LENALIDOMIDE;rs308395;Variant;PA162363968;Chemical
MULTIPLE MYELOMA;rs308395;Variant;PA444985;Disease
THALIDOMIDE;rs308395;Variant;PA451644;Chemical
ABCIXIMAB;FGB;Gene;PA448006;Chemical
EPTIFIBATIDE;FGB;Gene;PA449483;Chemical
TIROFIBAN;FGB;Gene;PA451698;Chemical
SCHIZOPHRENIA;HTR3A;Gene;PA447216;Disease
CLOZAPINE;HTR3A;Gene;PA449061;Chemical
HALOPERIDOL;HTR3A;Gene;PA449841;Chemical
ADVERSE EVENTS;rs10774053;Variant;PA166151827;Disease
PREMATURE BIRTH;rs10774053;Variant;PA444704;Disease
RITODRINE;rs10774053;Variant;PA451258;Chemical
BUTYRYLCHOLINESTERASE DEFICIENCY;rs1799807;Variant;PA166122649;Disease
APNEA;rs1799807;Variant;PA443407;Disease
SUCCINYLCHOLINE;rs1799807;Variant;PA451522;Chemical
HEROIN DEPENDENCE;rs7934165;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs7934165;Variant;PA445043;Disease
METHADONE;rs7934165;Variant;PA450401;Chemical
CES1;clopidogrel;Chemical;PA107;Gene
CYP2B6;clopidogrel;Chemical;PA123;Gene
CYP2C19;clopidogrel;Chemical;PA124;Gene
CYP2C8;clopidogrel;Chemical;PA125;Gene
CYP2C9;clopidogrel;Chemical;PA126;Gene
CYP3A4;clopidogrel;Chemical;PA130;Gene
CYP3A5;clopidogrel;Chemical;PA131;Gene
MED12L;clopidogrel;Chemical;PA134884590;Gene
CES1P1;clopidogrel;Chemical;PA134906523;Gene
WDR24;clopidogrel;Chemical;PA134918496;Gene
KRTAP10-4;clopidogrel;Chemical;PA134942730;Gene
P2RY12;clopidogrel;Chemical;PA134971947;Gene
EFR3A;clopidogrel;Chemical;PA162384422;Gene
JMJD8;clopidogrel;Chemical;PA162392531;Gene
N6AMT1;clopidogrel;Chemical;PA162396656;Gene
NECAB1;clopidogrel;Chemical;PA162397411;Gene
PEAR1;clopidogrel;Chemical;PA162399233;Gene
CYP2C19*6;clopidogrel;Chemical;PA165816522;Haplotype
CYP2C19*7;clopidogrel;Chemical;PA165816523;Haplotype
CYP2C19*8;clopidogrel;Chemical;PA165816524;Haplotype
CYP2C19*9;clopidogrel;Chemical;PA165816525;Haplotype
CYP2C19*10;clopidogrel;Chemical;PA165816526;Haplotype
CYP2C19*13;clopidogrel;Chemical;PA165816529;Haplotype
CYP2C19*14;clopidogrel;Chemical;PA165816530;Haplotype
CYP2C19*15;clopidogrel;Chemical;PA165816531;Haplotype
CYP2C19*16;clopidogrel;Chemical;PA165816532;Haplotype
CYP2C19*17;clopidogrel;Chemical;PA165816533;Haplotype
CYP2C19*18;clopidogrel;Chemical;PA165816534;Haplotype
CYP2C19*19;clopidogrel;Chemical;PA165816535;Haplotype
CYP2C19*22;clopidogrel;Chemical;PA165816536;Haplotype
CYP2C19*23;clopidogrel;Chemical;PA165816537;Haplotype
CYP2C19*24;clopidogrel;Chemical;PA165816538;Haplotype
CYP2C19*25;clopidogrel;Chemical;PA165816539;Haplotype
CYP2C19*26;clopidogrel;Chemical;PA165816540;Haplotype
CYP2C9*1;clopidogrel;Chemical;PA165816542;Haplotype
CYP2C9*2;clopidogrel;Chemical;PA165816543;Haplotype
CYP2C9*3;clopidogrel;Chemical;PA165816544;Haplotype
CYP2B6*1;clopidogrel;Chemical;PA165818750;Haplotype
CYP2B6*5;clopidogrel;Chemical;PA165818760;Haplotype
CYP2C19*1;clopidogrel;Chemical;PA165980634;Haplotype
CYP2C19*2;clopidogrel;Chemical;PA165980635;Haplotype
CYP2C19*3;clopidogrel;Chemical;PA165980636;Haplotype
CYP2C19*4;clopidogrel;Chemical;PA165980637;Haplotype
CYP2C19*5;clopidogrel;Chemical;PA165980638;Haplotype
CYP2C19*28;clopidogrel;Chemical;PA166115675;Haplotype
CYP3A5*1;clopidogrel;Chemical;PA166128213;Haplotype
CYP3A5*3;clopidogrel;Chemical;PA166128219;Haplotype
RS12041331;clopidogrel;Chemical;PA166153839;Variant
RS41273215;clopidogrel;Chemical;PA166153883;Variant
RS4244285;clopidogrel;Chemical;PA166154053;Variant
RS11568732;clopidogrel;Chemical;PA166154138;Variant
RS762551;clopidogrel;Chemical;PA166154850;Variant
RS2307240;clopidogrel;Chemical;PA166155039;Variant
RS3785161;clopidogrel;Chemical;PA166155056;Variant
RS71647871;clopidogrel;Chemical;PA166155135;Variant
RS5918;clopidogrel;Chemical;PA166155152;Variant
RS2108622;clopidogrel;Chemical;PA166155381;Variant
RS13431554;clopidogrel;Chemical;PA166155834;Variant
RS2046934;clopidogrel;Chemical;PA166156339;Variant
RS5853517;clopidogrel;Chemical;PA166156405;Variant
RS6785930;clopidogrel;Chemical;PA166156412;Variant
RS6787801;clopidogrel;Chemical;PA166156413;Variant
RS6809699;clopidogrel;Chemical;PA166156418;Variant
RS1062535;clopidogrel;Chemical;PA166156753;Variant
RS1126643;clopidogrel;Chemical;PA166156755;Variant
RS662;clopidogrel;Chemical;PA166157238;Variant
RS342293;clopidogrel;Chemical;PA166157255;Variant
RS1045642;clopidogrel;Chemical;PA166157284;Variant
RS1128503;clopidogrel;Chemical;PA166157288;Variant
RS1799983;clopidogrel;Chemical;PA166157303;Variant
RS2032582;clopidogrel;Chemical;PA166157316;Variant
RS2242480;clopidogrel;Chemical;PA166157345;Variant
RS10306114;clopidogrel;Chemical;PA166157803;Variant
CYP2C19 POOR METABOLIZER AND INTERMEDIATE METABOLIZER GENOTYPES;clopidogrel;Chemical;PA166157960;Variant
RS1330344;clopidogrel;Chemical;PA166159656;Variant
RS1061781;clopidogrel;Chemical;PA166160428;Variant
RS8192950;clopidogrel;Chemical;PA166162295;Variant
RS3732759;clopidogrel;Chemical;PA166163134;Variant
RS57731889;clopidogrel;Chemical;PA166163566;Variant
RS2254638;clopidogrel;Chemical;PA166164927;Variant
RS778068631;clopidogrel;Chemical;PA166200921;Variant
RS11640115;clopidogrel;Chemical;PA166268441;Variant
RS74569896;clopidogrel;Chemical;PA166268442;Variant
RS4736529;clopidogrel;Chemical;PA166268443;Variant
RS75750968;clopidogrel;Chemical;PA166268444;Variant
RS3749187;clopidogrel;Chemical;PA166268445;Variant
RS140410716;clopidogrel;Chemical;PA166268446;Variant
RS201441480;clopidogrel;Chemical;PA166268447;Variant
RS17064642;clopidogrel;Chemical;PA166268981;Variant
IRS1;clopidogrel;Chemical;PA203;Gene
ITGA2;clopidogrel;Chemical;PA204;Gene
ITGB3;clopidogrel;Chemical;PA205;Gene
PTGS1;clopidogrel;Chemical;PA24346;Gene
B4GALT2;clopidogrel;Chemical;PA25224;Gene
NOS3;clopidogrel;Chemical;PA254;Gene
TSPEAR;clopidogrel;Chemical;PA25824;Gene
AGAP3;clopidogrel;Chemical;PA26413;Gene
ABCB1;clopidogrel;Chemical;PA267;Gene
CYP1A2;clopidogrel;Chemical;PA27093;Gene
CYP4F2;clopidogrel;Chemical;PA27121;Gene
ECHS1;clopidogrel;Chemical;PA27597;Gene
MYOM2;clopidogrel;Chemical;PA31419;Gene
PON1;clopidogrel;Chemical;PA33529;Gene
ZDHHC3;clopidogrel;Chemical;PA38544;Gene
OMEPRAZOLE;clopidogrel;Chemical;PA450704;Chemical
BIPOLAR DISORDER;rs11869731;Variant;PA447199;Disease
LITHIUM;rs11869731;Variant;PA450243;Chemical
ETHANOL;rs2291317;Variant;PA448073;Chemical
ADALIMUMAB;rs1799852;Variant;PA10004;Chemical
CROHN DISEASE;rs1799852;Variant;PA443815;Disease
FLUOROURACIL;MUTYH;Gene;PA128406956;Chemical
RADIOTHERAPY;MUTYH;Gene;PA166122986;Chemical
PROGRESSION-FREE SURVIVAL;MUTYH;Gene;PA166123026;Disease
CARCINOMA, SQUAMOUS CELL;MUTYH;Gene;PA443626;Disease
OVARIAN NEOPLASMS;MUTYH;Gene;PA445204;Disease
PROSTATIC NEOPLASMS;MUTYH;Gene;PA445425;Disease
CISPLATIN;MUTYH;Gene;PA449014;Chemical
CYCLOPHOSPHAMIDE;MUTYH;Gene;PA449165;Chemical
ATAZANAVIR;CYP3A5*1;Haplotype;PA10251;Chemical
CYP3A5;CYP3A5*1;Haplotype;PA131;Gene
GEFITINIB;CYP3A5*1;Haplotype;PA131301952;Chemical
ORGAN TRANSPLANTATION;CYP3A5*1;Haplotype;PA133888799;Disease
TRANSPLANTATION;CYP3A5*1;Haplotype;PA134850491;Disease
MYALGIA UNSPECIFIED;CYP3A5*1;Haplotype;PA157379134;Disease
NEPHROTOXICITY;CYP3A5*1;Haplotype;PA162263533;Disease
EVEROLIMUS;CYP3A5*1;Haplotype;PA164746311;Chemical
CILOSTAZOL;CYP3A5*1;Haplotype;PA164746334;Chemical
MARAVIROC;CYP3A5*1;Haplotype;PA164768835;Chemical
TOXIC LIVER DISEASE;CYP3A5*1;Haplotype;PA164925725;Disease
DABIGATRAN;CYP3A5*1;Haplotype;PA165110351;Chemical
KIDNEY TRANSPLANTATION;CYP3A5*1;Haplotype;PA165817016;Disease
TRANSPLANT REJECTION;CYP3A5*1;Haplotype;PA166114454;Disease
LUNG TRANSPLANTATION;CYP3A5*1;Haplotype;PA166114457;Disease
HEART TRANSPLANTATION;CYP3A5*1;Haplotype;PA166114458;Disease
DRUG-INDUCED LIVER INJURY;CYP3A5*1;Haplotype;PA166119041;Disease
HEMATOPOIETIC STEM CELL TRANSPLANTATION;CYP3A5*1;Haplotype;PA166123007;Disease
SCHIZOAFFECTIVE DISORDER;CYP3A5*1;Haplotype;PA166123368;Disease
DELAYED GRAFT FUNCTION;CYP3A5*1;Haplotype;PA166123755;Disease
RECURRENCE FREE SURVIVAL;CYP3A5*1;Haplotype;PA166127658;Disease
ADVERSE EVENTS;CYP3A5*1;Haplotype;PA166151827;Disease
LAPAROSCOPIC SLEEVE GASTRECTOMY;CYP3A5*1;Haplotype;PA166169562;Disease
S-EDDP;CYP3A5*1;Haplotype;PA166177606;Chemical
DEXTROPROPOXYPHENE;CYP3A5*1;Haplotype;PA166183939;Chemical
SOMNOLENCE;CYP3A5*1;Haplotype;PA166185626;Disease
3,4-DEHYDROCILOSTAZOL;CYP3A5*1;Haplotype;PA166254461;Chemical
ARTHRITIS, RHEUMATOID;CYP3A5*1;Haplotype;PA443434;Disease
AUTOIMMUNE DISEASES;CYP3A5*1;Haplotype;PA443464;Disease
BREAST NEOPLASMS;CYP3A5*1;Haplotype;PA443560;Disease
CARCINOMA, NON-SMALL-CELL LUNG;CYP3A5*1;Haplotype;PA443622;Disease
CEREBRAL INFARCTION;CYP3A5*1;Haplotype;PA443670;Disease
COLITIS, ULCERATIVE;CYP3A5*1;Haplotype;PA443750;Disease
CORONARY ARTERY DISEASE;CYP3A5*1;Haplotype;PA443796;Disease
DIABETES MELLITUS;CYP3A5*1;Haplotype;PA443886;Disease
DRUG TOXICITY;CYP3A5*1;Haplotype;PA443937;Disease
EPILEPSY;CYP3A5*1;Haplotype;PA444065;Disease
GASTROINTESTINAL NEOPLASMS;CYP3A5*1;Haplotype;PA444257;Disease
GRAFT VS HOST DISEASE;CYP3A5*1;Haplotype;PA444320;Disease
INFECTION;CYP3A5*1;Haplotype;PA444614;Disease
KIDNEY NEOPLASMS;CYP3A5*1;Haplotype;PA444685;Disease
LEUKEMIA;CYP3A5*1;Haplotype;PA444750;Disease
LEUKOPENIA;CYP3A5*1;Haplotype;PA444773;Disease
LUPUS ERYTHEMATOSUS, SYSTEMIC;CYP3A5*1;Haplotype;PA444822;Disease
LUPUS NEPHRITIS;CYP3A5*1;Haplotype;PA444823;Disease
LYMPHOMA, NON-HODGKIN;CYP3A5*1;Haplotype;PA444845;Disease
MUSCULAR DISEASES;CYP3A5*1;Haplotype;PA444997;Disease
MYASTHENIA GRAVIS;CYP3A5*1;Haplotype;PA445004;Disease
NEOPLASMS;CYP3A5*1;Haplotype;PA445062;Disease
NEPHROTIC SYNDROME;CYP3A5*1;Haplotype;PA445089;Disease
NEUTROPENIA;CYP3A5*1;Haplotype;PA445113;Disease
OVARIAN NEOPLASMS;CYP3A5*1;Haplotype;PA445204;Disease
PAIN;CYP3A5*1;Haplotype;PA445208;Disease
PAIN, POSTOPERATIVE;CYP3A5*1;Haplotype;PA445210;Disease
PERIPHERAL NERVOUS SYSTEM DISEASES;CYP3A5*1;Haplotype;PA445301;Disease
URINARY TRACT INFECTIONS;CYP3A5*1;Haplotype;PA445992;Disease
VIRUS DISEASES;CYP3A5*1;Haplotype;PA446038;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;CYP3A5*1;Haplotype;PA446155;Disease
NEUROENDOCRINE TUMORS;CYP3A5*1;Haplotype;PA446713;Disease
NEUROTOXICITY SYNDROMES;CYP3A5*1;Haplotype;PA446975;Disease
ANXIETY DISORDERS;CYP3A5*1;Haplotype;PA447196;Disease
SCHIZOPHRENIA;CYP3A5*1;Haplotype;PA447216;Disease
HIV INFECTIONS;CYP3A5*1;Haplotype;PA447230;Disease
LIVER TRANSPLANTATION;CYP3A5*1;Haplotype;PA447247;Disease
DEPRESSION;CYP3A5*1;Haplotype;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;CYP3A5*1;Haplotype;PA447321;Disease
AMLODIPINE;CYP3A5*1;Haplotype;PA448388;Chemical
ATORVASTATIN;CYP3A5*1;Haplotype;PA448500;Chemical
CARBAMAZEPINE;CYP3A5*1;Haplotype;PA448785;Chemical
CARBOPLATIN;CYP3A5*1;Haplotype;PA448803;Chemical
CLOMIPRAMINE;CYP3A5*1;Haplotype;PA449048;Chemical
CLOPIDOGREL;CYP3A5*1;Haplotype;PA449053;Chemical
CLOZAPINE;CYP3A5*1;Haplotype;PA449061;Chemical
CYCLOPHOSPHAMIDE;CYP3A5*1;Haplotype;PA449165;Chemical
CYCLOSPORINE;CYP3A5*1;Haplotype;PA449167;Chemical
FELODIPINE;CYP3A5*1;Haplotype;PA449591;Chemical
FENTANYL;CYP3A5*1;Haplotype;PA449599;Chemical
FLECAINIDE;CYP3A5*1;Haplotype;PA449646;Chemical
FLUOXETINE;CYP3A5*1;Haplotype;PA449673;Chemical
GRANISETRON;CYP3A5*1;Haplotype;PA449809;Chemical
ITRACONAZOLE;CYP3A5*1;Haplotype;PA450132;Chemical
KETOCONAZOLE;CYP3A5*1;Haplotype;PA450146;Chemical
METHADONE;CYP3A5*1;Haplotype;PA450401;Chemical
MIDAZOLAM;CYP3A5*1;Haplotype;PA450496;Chemical
NIMODIPINE;CYP3A5*1;Haplotype;PA450633;Chemical
OLANZAPINE;CYP3A5*1;Haplotype;PA450688;Chemical
OXYCODONE;CYP3A5*1;Haplotype;PA450741;Chemical
PACLITAXEL;CYP3A5*1;Haplotype;PA450761;Chemical
RITONAVIR;CYP3A5*1;Haplotype;PA451260;Chemical
SIMVASTATIN;CYP3A5*1;Haplotype;PA451363;Chemical
SIROLIMUS;CYP3A5*1;Haplotype;PA451365;Chemical
SUFENTANIL;CYP3A5*1;Haplotype;PA451527;Chemical
TACROLIMUS;CYP3A5*1;Haplotype;PA451578;Chemical
TAMOXIFEN;CYP3A5*1;Haplotype;PA451581;Chemical
VINCRISTINE;CYP3A5*1;Haplotype;PA451879;Chemical
SURGERY;rs193922852;Variant;PA166314441;Disease
MALIGNANT HYPERTHERMIA;rs193922852;Variant;PA444863;Disease
SEVOFLURANE;rs193922852;Variant;PA451341;Chemical
SLCO1B1;mercaptopurine;Chemical;PA134865839;Gene
MED4;mercaptopurine;Chemical;PA134877001;Gene
C18ORF56;mercaptopurine;Chemical;PA134956204;Gene
NUDT15;mercaptopurine;Chemical;PA134963132;Gene
DROSHA;mercaptopurine;Chemical;PA142671060;Gene
FTO;mercaptopurine;Chemical;PA152208656;Gene
TPMT*1;mercaptopurine;Chemical;PA165819268;Haplotype
TPMT*2;mercaptopurine;Chemical;PA165819269;Haplotype
TPMT*3A;mercaptopurine;Chemical;PA165819270;Haplotype
TPMT*3B;mercaptopurine;Chemical;PA165819271;Haplotype
TPMT*3C;mercaptopurine;Chemical;PA165819272;Haplotype
TPMT*4;mercaptopurine;Chemical;PA165819274;Haplotype
TPMT*5;mercaptopurine;Chemical;PA165819275;Haplotype
TPMT*6;mercaptopurine;Chemical;PA165819276;Haplotype
TPMT*7;mercaptopurine;Chemical;PA165819277;Haplotype
TPMT*8;mercaptopurine;Chemical;PA165819278;Haplotype
TPMT*9;mercaptopurine;Chemical;PA165819279;Haplotype
TPMT*10;mercaptopurine;Chemical;PA165819280;Haplotype
TPMT*11;mercaptopurine;Chemical;PA165819281;Haplotype
TPMT*12;mercaptopurine;Chemical;PA165819282;Haplotype
TPMT*13;mercaptopurine;Chemical;PA165819283;Haplotype
TPMT*14;mercaptopurine;Chemical;PA165819284;Haplotype
TPMT*15;mercaptopurine;Chemical;PA165819285;Haplotype
TPMT*16;mercaptopurine;Chemical;PA165819286;Haplotype
TPMT*17;mercaptopurine;Chemical;PA165819287;Haplotype
TPMT*18;mercaptopurine;Chemical;PA165819288;Haplotype
TPMT*21;mercaptopurine;Chemical;PA165819291;Haplotype
TPMT*23;mercaptopurine;Chemical;PA165819293;Haplotype
TPMT*24;mercaptopurine;Chemical;PA165819295;Haplotype
TPMT*25;mercaptopurine;Chemical;PA165819296;Haplotype
HLA-DQA1*02:01;mercaptopurine;Chemical;PA165951292;Haplotype
HLA-DRB1*07:01;mercaptopurine;Chemical;PA165951644;Haplotype
TPMT*26;mercaptopurine;Chemical;PA166005217;Haplotype
TPMT*31;mercaptopurine;Chemical;PA166005222;Haplotype
TPMT*32;mercaptopurine;Chemical;PA166005223;Haplotype
TPMT*33;mercaptopurine;Chemical;PA166005224;Haplotype
TPMT*34;mercaptopurine;Chemical;PA166005225;Haplotype
TPMT*37;mercaptopurine;Chemical;PA166119185;Haplotype
NUDT15*1;mercaptopurine;Chemical;PA166131619;Haplotype
NUDT15*2;mercaptopurine;Chemical;PA166131620;Haplotype
NUDT15*3;mercaptopurine;Chemical;PA166131621;Haplotype
NUDT15*4;mercaptopurine;Chemical;PA166131622;Haplotype
NUDT15*5;mercaptopurine;Chemical;PA166131623;Haplotype
NUDT15*6;mercaptopurine;Chemical;PA166151814;Haplotype
RS1801133;mercaptopurine;Chemical;PA166153644;Variant
RS3824662;mercaptopurine;Chemical;PA166154043;Variant
RS1695;mercaptopurine;Chemical;PA166154249;Variant
RS61886492;mercaptopurine;Chemical;PA166154477;Variant
RS4149056;mercaptopurine;Chemical;PA166154579;Variant
RS11045879;mercaptopurine;Chemical;PA166154633;Variant
RS3765534;mercaptopurine;Chemical;PA166154714;Variant
RS116855232;mercaptopurine;Chemical;PA166154759;Variant
RS45445694;mercaptopurine;Chemical;PA166155331;Variant
RS1127354;mercaptopurine;Chemical;PA166155915;Variant
RS7270101;mercaptopurine;Chemical;PA166155964;Variant
RS2413739;mercaptopurine;Chemical;PA166156100;Variant
RS639174;mercaptopurine;Chemical;PA166156737;Variant
RS1142345;mercaptopurine;Chemical;PA166156978;Variant
RS2647087;mercaptopurine;Chemical;PA166157045;Variant
RS3931660;mercaptopurine;Chemical;PA166157092;Variant
RS12201199;mercaptopurine;Chemical;PA166157177;Variant
RS17839843;mercaptopurine;Chemical;PA166157194;Variant
RS72552763;mercaptopurine;Chemical;PA166157216;Variant
TPMT POOR METABOLIZER;mercaptopurine;Chemical;PA166157904;Variant
RS10948059;mercaptopurine;Chemical;PA166159951;Variant
RS79206939;mercaptopurine;Chemical;PA166160976;Variant
RS16952570;mercaptopurine;Chemical;PA166160979;Variant
TPMT INTERMEDIATE ACTIVITY;mercaptopurine;Chemical;PA166161831;Variant
TPMT LOW ACTIVITY;mercaptopurine;Chemical;PA166161836;Variant
RS766023281;mercaptopurine;Chemical;PA166165228;Variant
RS746071566;mercaptopurine;Chemical;PA166165231;Variant
RS11969064;mercaptopurine;Chemical;PA166184136;Variant
RS73189762;mercaptopurine;Chemical;PA166267001;Variant
RS12283870;mercaptopurine;Chemical;PA166285621;Variant
MTHFR;mercaptopurine;Chemical;PA245;Gene
CPT1A;mercaptopurine;Chemical;PA26847;Gene
FOLH1;mercaptopurine;Chemical;PA28205;Gene
GATA3;mercaptopurine;Chemical;PA28586;Gene
GNMT;mercaptopurine;Chemical;PA28794;Gene
GSTP1;mercaptopurine;Chemical;PA29028;Gene
IGHMBP2;mercaptopurine;Chemical;PA29731;Gene
ITPA;mercaptopurine;Chemical;PA29973;Gene
NT5C2;mercaptopurine;Chemical;PA31801;Gene
PACSIN2;mercaptopurine;Chemical;PA32897;Gene
SLC22A1;mercaptopurine;Chemical;PA329;Gene
HLA-DQA1;mercaptopurine;Chemical;PA35066;Gene
HLA-DRB1;mercaptopurine;Chemical;PA35072;Gene
TPMT;mercaptopurine;Chemical;PA356;Gene
TYMS;mercaptopurine;Chemical;PA359;Gene
ABCC4;mercaptopurine;Chemical;PA397;Gene
ZNF697;interferon beta-1b;Chemical;PA142670495;Gene
GAPVD1;interferon beta-1b;Chemical;PA142671748;Gene
RS4278350;interferon beta-1b;Chemical;PA166153763;Variant
RS10494227;interferon beta-1b;Chemical;PA166153801;Variant
RS12044852;interferon beta-1b;Chemical;PA166153841;Variant
RS3133084;interferon beta-1b;Chemical;PA166154394;Variant
RS760316;interferon beta-1b;Chemical;PA166156293;Variant
RS9272105;interferon beta-1b;Chemical;PA166157134;Variant
RS1448673;interferon beta-1b;Chemical;PA166157296;Variant
RS2291858;interferon beta-1b;Chemical;PA166157750;Variant
RS10760397;interferon beta-1b;Chemical;PA166157811;Variant
RS10819043;interferon beta-1b;Chemical;PA166157818;Variant
RS2205986;interferon beta-1b;Chemical;PA166179805;Variant
CD58;interferon beta-1b;Chemical;PA26227;Gene
FHIT;interferon beta-1b;Chemical;PA28140;Gene
IRF6;interferon beta-1b;Chemical;PA29920;Gene
HLA-DQA1;interferon beta-1b;Chemical;PA35066;Gene
VARENICLINE;rs503464;Variant;PA164781343;Chemical
TOBACCO USE DISORDER;rs503464;Variant;PA445876;Disease
BUPROPION;rs503464;Variant;PA448687;Chemical
NICOTINE;rs503464;Variant;PA450626;Chemical
NUBPL;Acquired Long QT Syndrome (aLQTS);Disease;PA134907818;Gene
ACN9;Acquired Long QT Syndrome (aLQTS);Disease;PA134976380;Gene
CERKL;Acquired Long QT Syndrome (aLQTS);Disease;PA134984780;Gene
NOS1AP;Acquired Long QT Syndrome (aLQTS);Disease;PA142671259;Gene
RS10494366;Acquired Long QT Syndrome (aLQTS);Disease;PA166153802;Variant
RS10918594;Acquired Long QT Syndrome (aLQTS);Disease;PA166153816;Variant
RS4933824;Acquired Long QT Syndrome (aLQTS);Disease;PA166154068;Variant
RS7142881;Acquired Long QT Syndrome (aLQTS);Disease;PA166154809;Variant
RS4799915;Acquired Long QT Syndrome (aLQTS);Disease;PA166155297;Variant
RS993648;Acquired Long QT Syndrome (aLQTS);Disease;PA166155611;Variant
RS1805128;Acquired Long QT Syndrome (aLQTS);Disease;PA166155994;Variant
KCNE1;Acquired Long QT Syndrome (aLQTS);Disease;PA211;Gene
KCNH2;Acquired Long QT Syndrome (aLQTS);Disease;PA212;Gene
CELF4;Acquired Long QT Syndrome (aLQTS);Disease;PA25428;Gene
NRG3;Acquired Long QT Syndrome (aLQTS);Disease;PA31778;Gene
ADRB1;Acquired Long QT Syndrome (aLQTS);Disease;PA38;Gene
ABCB1;loperamide;Chemical;PA267;Gene
PEGINTERFERON ALFA-2B;rs7270101;Variant;PA164784024;Chemical
ANEMIA;rs7270101;Variant;PA443340;Disease
LEUKOPENIA;rs7270101;Variant;PA444773;Disease
NEUTROPENIA;rs7270101;Variant;PA445113;Disease
INFLAMMATORY BOWEL DISEASES;rs7270101;Variant;PA446116;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs7270101;Variant;PA446155;Disease
CHRONIC HEPATITIS C VIRUS INFECTION;rs7270101;Variant;PA446863;Disease
AZATHIOPRINE;rs7270101;Variant;PA448515;Chemical
MERCAPTOPURINE;rs7270101;Variant;PA450379;Chemical
METHOTREXATE;rs7270101;Variant;PA450428;Chemical
RIBAVIRIN;rs7270101;Variant;PA451241;Chemical
ATRIAL FIBRILLATION;CACNA2D4;Gene;PA443459;Disease
CELECOXIB;CACNA2D4;Gene;PA448871;Chemical
ANKK1;disulfiram;Chemical;PA134872551;Gene
DBH;disulfiram;Chemical;PA136;Gene
SLC6A4 HTTLPR SHORT FORM (S ALLELE);disulfiram;Chemical;PA166116466;Haplotype
SLC6A4 L ALLELE-RS25531T;disulfiram;Chemical;PA166117146;Haplotype
SLC6A4 L ALLELE-RS25531C;disulfiram;Chemical;PA166117147;Haplotype
RS1801133;disulfiram;Chemical;PA166153644;Variant
RS1800497;disulfiram;Chemical;PA166154339;Variant
RS2283265;disulfiram;Chemical;PA166154364;Variant
RS28363170;disulfiram;Chemical;PA166156890;Variant
RS678849;disulfiram;Chemical;PA166175994;Variant
MTHFR;disulfiram;Chemical;PA245;Gene
ABCB1;disulfiram;Chemical;PA267;Gene
DRD2;disulfiram;Chemical;PA27478;Gene
SLC6A3;disulfiram;Chemical;PA311;Gene
SLC6A4;disulfiram;Chemical;PA312;Gene
OPRD1;disulfiram;Chemical;PA31942;Gene
NAT2 DEFICIENCY;Insulin Resistance;Disease;PA166157911;Variant
NAT2;Insulin Resistance;Disease;PA18;Gene
G6PD;Insulin Resistance;Disease;PA28469;Gene
RS1805128;qt-prolonging drugs;Chemical;PA166155994;Variant
KCNE1;qt-prolonging drugs;Chemical;PA211;Gene
EPILEPSY;rs1800012;Variant;PA444065;Disease
OSTEOPOROSIS;rs1800012;Variant;PA445190;Disease
SOMATROPIN RECOMBINANT;rs1800012;Variant;PA451446;Chemical
VALPROIC ACID;rs1800012;Variant;PA451846;Chemical
ERECTILE DYSFUNCTION;rs4343;Variant;PA444606;Disease
SILDENAFIL;rs4343;Variant;PA451346;Chemical
SPIRONOLACTONE;rs4343;Variant;PA451483;Chemical
IMATINIB;rs2290573;Variant;PA10804;Chemical
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;rs2290573;Variant;PA446171;Disease
ANTHRACYCLINES AND RELATED SUBSTANCES;rs7853758;Variant;PA130620651;Chemical
CARDIOTOXICITY;rs7853758;Variant;PA166128121;Disease
RARG;rs7853758;Variant;PA34227;Gene
UGT1A6;rs7853758;Variant;PA37181;Gene
SLC28A3;rs7853758;Variant;PA426;Gene
DAUNORUBICIN;rs7853758;Variant;PA449212;Chemical
DOXORUBICIN;rs7853758;Variant;PA449412;Chemical
CYP3A5;Colitis, Ulcerative;Disease;PA131;Gene
FTO;Colitis, Ulcerative;Disease;PA152208656;Gene
TPMT*3A;Colitis, Ulcerative;Disease;PA165819270;Haplotype
NAT1*4;Colitis, Ulcerative;Disease;PA165958462;Haplotype
NAT1*3;Colitis, Ulcerative;Disease;PA165958463;Haplotype
NAT1*10;Colitis, Ulcerative;Disease;PA165958465;Haplotype
GSTM1 NULL;Colitis, Ulcerative;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Colitis, Ulcerative;Disease;PA166048676;Haplotype
CYP3A5*1;Colitis, Ulcerative;Disease;PA166128213;Haplotype
CYP3A5*3;Colitis, Ulcerative;Disease;PA166128219;Haplotype
RS4251961;Colitis, Ulcerative;Disease;PA166155724;Variant
RS4848306;Colitis, Ulcerative;Disease;PA166155735;Variant
RS4696480;Colitis, Ulcerative;Disease;PA166156596;Variant
RS2569190;Colitis, Ulcerative;Disease;PA166156805;Variant
RS2275913;Colitis, Ulcerative;Disease;PA166157030;Variant
RS6927172;Colitis, Ulcerative;Disease;PA166157119;Variant
RS776746;Colitis, Ulcerative;Disease;PA166157267;Variant
RS1045642;Colitis, Ulcerative;Disease;PA166157284;Variant
RS1128503;Colitis, Ulcerative;Disease;PA166157288;Variant
RS2032582;Colitis, Ulcerative;Disease;PA166157316;Variant
RS10499563;Colitis, Ulcerative;Disease;PA166157448;Variant
G6PD DEFICIENCY;Colitis, Ulcerative;Disease;PA166157959;Variant
RS16952570;Colitis, Ulcerative;Disease;PA166160979;Variant
NAT1;Colitis, Ulcerative;Disease;PA17;Gene
GSTM1;Colitis, Ulcerative;Disease;PA182;Gene
IL6;Colitis, Ulcerative;Disease;PA198;Gene
CD14;Colitis, Ulcerative;Disease;PA26188;Gene
ABCB1;Colitis, Ulcerative;Disease;PA267;Gene
G6PD;Colitis, Ulcerative;Disease;PA28469;Gene
IL17A;Colitis, Ulcerative;Disease;PA29794;Gene
IL1B;Colitis, Ulcerative;Disease;PA29808;Gene
IL1RN;Colitis, Ulcerative;Disease;PA29816;Gene
TPMT;Colitis, Ulcerative;Disease;PA356;Gene
TLR2;Colitis, Ulcerative;Disease;PA36550;Gene
TNFAIP3;Colitis, Ulcerative;Disease;PA36593;Gene
NR1I2;Colitis, Ulcerative;Disease;PA378;Gene
CYP3A4;CYP3A4*6;Haplotype;PA130;Gene
VANDETANIB;CYP3A4*6;Haplotype;PA166118341;Chemical
OXYCODONE;CYP3A4*6;Haplotype;PA450741;Chemical
QUETIAPINE;CYP3A4*6;Haplotype;PA451201;Chemical
AMISULPRIDE;rs1079597;Variant;PA162565877;Chemical
NAUSEA;rs1079597;Variant;PA445048;Disease
SCHIZOPHRENIA;rs1079597;Variant;PA447216;Disease
PROCHLORPERAZINE;rs1079597;Variant;PA451114;Chemical
CYP3A4;CYP3A4*16;Haplotype;PA130;Gene
TICAGRELOR;CYP3A4*16;Haplotype;PA165374673;Chemical
CABOZANTINIB;CYP3A4*16;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*16;Haplotype;PA165958362;Chemical
VANDETANIB;CYP3A4*16;Haplotype;PA166118341;Chemical
IBRUTINIB;CYP3A4*16;Haplotype;PA166121346;Chemical
ALECTINIB;CYP3A4*16;Haplotype;PA166160050;Chemical
BREXPIPRAZOLE;CYP3A4*16;Haplotype;PA166160053;Chemical
ACALABRUTINIB;CYP3A4*16;Haplotype;PA166198581;Chemical
MACITENTAN;CYP3A4*16;Haplotype;PA166261201;Chemical
BLONANSERIN;CYP3A4*16;Haplotype;PA166319041;Chemical
AMIODARONE;CYP3A4*16;Haplotype;PA448383;Chemical
LIDOCAINE;CYP3A4*16;Haplotype;PA450226;Chemical
METHADONE;CYP3A4*16;Haplotype;PA450401;Chemical
OXYCODONE;CYP3A4*16;Haplotype;PA450741;Chemical
QUETIAPINE;CYP3A4*16;Haplotype;PA451201;Chemical
TESTOSTERONE;CYP3A4*16;Haplotype;PA451627;Chemical
BREAST NEOPLASMS;rs11023197;Variant;PA443560;Disease
TAMOXIFEN;rs11023197;Variant;PA451581;Chemical
DIABETES MELLITUS;SLC47A2;Gene;PA443886;Disease
METFORMIN;SLC47A2;Gene;PA450395;Chemical
HMG COA REDUCTASE INHIBITORS;rs402007;Variant;PA133950441;Chemical
CYP3A4;norfentanyl;Chemical;PA130;Gene
ABCC2;Burkitt Lymphoma;Disease;PA116;Gene
G6PD A- 202A_376G;Burkitt Lymphoma;Disease;PA165947827;Haplotype
RS1801131;Burkitt Lymphoma;Disease;PA166153643;Variant
RS1801133;Burkitt Lymphoma;Disease;PA166153644;Variant
RS3740065;Burkitt Lymphoma;Disease;PA166154027;Variant
RS9516519;Burkitt Lymphoma;Disease;PA166154734;Variant
RS1051266;Burkitt Lymphoma;Disease;PA166155986;Variant
RS2231142;Burkitt Lymphoma;Disease;PA166156544;Variant
RS1045642;Burkitt Lymphoma;Disease;PA166157284;Variant
G6PD DEFICIENCY;Burkitt Lymphoma;Disease;PA166157959;Variant
MTHFR;Burkitt Lymphoma;Disease;PA245;Gene
ABCB1;Burkitt Lymphoma;Disease;PA267;Gene
G6PD;Burkitt Lymphoma;Disease;PA28469;Gene
SLC19A1;Burkitt Lymphoma;Disease;PA327;Gene
ABCG2;Burkitt Lymphoma;Disease;PA390;Gene
ABCC4;Burkitt Lymphoma;Disease;PA397;Gene
ADVERSE EVENTS;rs11049274;Variant;PA166151827;Disease
MEPERIDINE;rs11049274;Variant;PA450369;Chemical
UGT1A1*1;Purpura, Thrombocytopenic, Idiopathic;Disease;PA166115841;Haplotype
UGT1A1*28;Purpura, Thrombocytopenic, Idiopathic;Disease;PA166115842;Haplotype
UGT1A1;Purpura, Thrombocytopenic, Idiopathic;Disease;PA420;Gene
CYP2C9;irbesartan;Chemical;PA126;Gene
ACE;irbesartan;Chemical;PA139;Gene
RS699;irbesartan;Chemical;PA166153539;Variant
RS4762;irbesartan;Chemical;PA166153545;Variant
RS1057910;irbesartan;Chemical;PA166153959;Variant
RS1799853;irbesartan;Chemical;PA166153972;Variant
RS72558187;irbesartan;Chemical;PA166154194;Variant
RS1799752;irbesartan;Chemical;PA166155187;Variant
RS1367117;irbesartan;Chemical;PA166155632;Variant
RS1801701;irbesartan;Chemical;PA166155647;Variant
RS5186;irbesartan;Chemical;PA166156276;Variant
RS5370;irbesartan;Chemical;PA166156901;Variant
EDN1;irbesartan;Chemical;PA27614;Gene
AGT;irbesartan;Chemical;PA42;Gene
AGTR1;irbesartan;Chemical;PA43;Gene
REPAGLINIDE;irbesartan;Chemical;PA451234;Chemical
APOB;irbesartan;Chemical;PA50;Gene
APC;nirogacestat;Chemical;PA24875;Gene
CTNNB1;nirogacestat;Chemical;PA27013;Gene
CYP2C9;Thrombosis of cerebral veins;Disease;PA126;Gene
CYP2C9*1;Thrombosis of cerebral veins;Disease;PA165816542;Haplotype
CYP2C9*2;Thrombosis of cerebral veins;Disease;PA165816543;Haplotype
CYP2C9*3;Thrombosis of cerebral veins;Disease;PA165816544;Haplotype
COLITIS, ULCERATIVE;NAT1*3;Haplotype;PA443750;Disease
CROHN DISEASE;NAT1*3;Haplotype;PA443815;Disease
INFLAMMATORY BOWEL DISEASES;NAT1*3;Haplotype;PA446116;Disease
MESALAZINE;NAT1*3;Haplotype;PA450384;Chemical
THIOGUANINE;NAT1*3;Haplotype;PA451663;Chemical
HYPERBILIRUBINEMIA;rs1048977;Variant;PA444511;Disease
NEOPLASMS;rs1048977;Variant;PA445062;Disease
CAPECITABINE;rs1048977;Variant;PA448771;Chemical
GEMCITABINE;rs1048977;Variant;PA449748;Chemical
FLUVASTATIN;rs1800588;Variant;PA449688;Chemical
PRAVASTATIN;rs1800588;Variant;PA451089;Chemical
SIMVASTATIN;rs1800588;Variant;PA451363;Chemical
CFTR;rs75961395;Variant;PA109;Gene
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs75961395;Variant;PA166190041;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs75961395;Variant;PA166362502;Chemical
CYSTIC FIBROSIS;rs75961395;Variant;PA443829;Disease
COTININE;rs563649;Variant;PA166114414;Chemical
NICOTINE;rs563649;Variant;PA450626;Chemical
GEFITINIB;CYP2D6*87;Haplotype;PA131301952;Chemical
ATOMOXETINE;CYP2D6*87;Haplotype;PA134688071;Chemical
TOLTERODINE;CYP2D6*87;Haplotype;PA164746757;Chemical
BUFURALOL;CYP2D6*87;Haplotype;PA166110256;Chemical
DAPOXETINE;CYP2D6*87;Haplotype;PA166151992;Chemical
AMITRIPTYLINE;CYP2D6*87;Haplotype;PA448385;Chemical
CITALOPRAM;CYP2D6*87;Haplotype;PA449015;Chemical
DEXTROMETHORPHAN;CYP2D6*87;Haplotype;PA449273;Chemical
FLUOXETINE;CYP2D6*87;Haplotype;PA449673;Chemical
METHADONE;CYP2D6*87;Haplotype;PA450401;Chemical
OLANZAPINE;CYP2D6*87;Haplotype;PA450688;Chemical
RISPERIDONE;CYP2D6*87;Haplotype;PA451257;Chemical
TAMOXIFEN;CYP2D6*87;Haplotype;PA451581;Chemical
VENLAFAXINE;CYP2D6*87;Haplotype;PA451866;Chemical
ACE;Hypertrophy, Left Ventricular;Disease;PA139;Gene
RS699;Hypertrophy, Left Ventricular;Disease;PA166153539;Variant
RS4762;Hypertrophy, Left Ventricular;Disease;PA166153545;Variant
RS1800545;Hypertrophy, Left Ventricular;Disease;PA166153975;Variant
RS1799752;Hypertrophy, Left Ventricular;Disease;PA166155187;Variant
RS1801701;Hypertrophy, Left Ventricular;Disease;PA166155647;Variant
RS5186;Hypertrophy, Left Ventricular;Disease;PA166156276;Variant
RS1042714;Hypertrophy, Left Ventricular;Disease;PA166156749;Variant
ADRA2A;Hypertrophy, Left Ventricular;Disease;PA35;Gene
ADRB2;Hypertrophy, Left Ventricular;Disease;PA39;Gene
AGT;Hypertrophy, Left Ventricular;Disease;PA42;Gene
AGTR1;Hypertrophy, Left Ventricular;Disease;PA43;Gene
APOB;Hypertrophy, Left Ventricular;Disease;PA50;Gene
RS1128503;tonsillectomy;Disease;PA166157288;Variant
ABCB1;tonsillectomy;Disease;PA267;Gene
CYP2C9;Cardiomyopathies;Disease;PA126;Gene
ACE;Cardiomyopathies;Disease;PA139;Gene
CYP2C9*1;Cardiomyopathies;Disease;PA165816542;Haplotype
CYP2C9*2;Cardiomyopathies;Disease;PA165816543;Haplotype
CYP2C9*24;Cardiomyopathies;Disease;PA165816569;Haplotype
GSTM1 NULL;Cardiomyopathies;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Cardiomyopathies;Disease;PA166048676;Haplotype
RS2232228;Cardiomyopathies;Disease;PA166155032;Variant
RS45445694;Cardiomyopathies;Disease;PA166155331;Variant
RS9024;Cardiomyopathies;Disease;PA166155972;Variant
GSTM1;Cardiomyopathies;Disease;PA182;Gene
CBR1;Cardiomyopathies;Disease;PA26121;Gene
HAS3;Cardiomyopathies;Disease;PA29196;Gene
TYMS;Cardiomyopathies;Disease;PA359;Gene
METOPROLOL;rs5030655;Variant;PA450480;Chemical
ANTIPSYCHOTICS;rs5030655;Variant;PA452233;Chemical
HIV INFECTIOUS DISEASE;rs2054675;Variant;PA447230;Disease
NEVIRAPINE;rs2054675;Variant;PA450616;Chemical
DULOXETINE;rs7653345;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs7653345;Variant;PA447321;Disease
DEXTROMETHORPHAN;rs1062753;Variant;PA449273;Chemical
ABCB1;romidepsin;Chemical;PA267;Gene
NON-SMALL CELL LUNG CARCINOMA;rs6504649;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs6504649;Variant;PA445846;Disease
CARBOPLATIN;rs6504649;Variant;PA448803;Chemical
GEMCITABINE;rs6504649;Variant;PA449748;Chemical
BEVACIZUMAB;CXCL8;Gene;PA130232992;Chemical
MACULAR DEGENERATION;CXCL8;Gene;PA134850558;Disease
CRISPLD2;CXCL8;Gene;PA142672077;Gene
SUNITINIB;CXCL8;Gene;PA162372840;Chemical
PAZOPANIB;CXCL8;Gene;PA165291492;Chemical
RENAL CELL CARCINOMA;CXCL8;Gene;PA443624;Disease
DURVALUMAB;PDCD1;Gene;PA166169883;Chemical
KIDNEY TRANSPLANTATION;rs181781;Variant;PA165817016;Disease
TACROLIMUS;rs181781;Variant;PA451578;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs4148350;Variant;PA130620651;Chemical
NEOPLASMS;rs4148350;Variant;PA445062;Disease
PLCH1;PRKCI;Gene;PA128394595;Gene
PLCZ1;PRKCI;Gene;PA134875646;Gene
PLCH2;PRKCI;Gene;PA134914471;Gene
PLCB1;PRKCI;Gene;PA33384;Gene
PLCB2;PRKCI;Gene;PA33385;Gene
PLCB3;PRKCI;Gene;PA33386;Gene
PLCB4;PRKCI;Gene;PA33387;Gene
PLCD1;PRKCI;Gene;PA33388;Gene
PLCD3;PRKCI;Gene;PA33389;Gene
PLCD4;PRKCI;Gene;PA33390;Gene
PLCE1;PRKCI;Gene;PA33391;Gene
PLCG1;PRKCI;Gene;PA33392;Gene
PLCG2;PRKCI;Gene;PA33393;Gene
PLCL1;PRKCI;Gene;PA33394;Gene
PLCL2;PRKCI;Gene;PA33395;Gene
RAF1;PRKCI;Gene;PA34183;Gene
ADALIMUMAB;HLA-E;Gene;PA10004;Chemical
CERTOLIZUMAB PEGOL;HLA-E;Gene;PA165107055;Chemical
RHEUMATOID ARTHRITIS;HLA-E;Gene;PA443434;Disease
ETANERCEPT;HLA-E;Gene;PA449515;Chemical
METHOTREXATE;HLA-E;Gene;PA450428;Chemical
GLUCOCORTICOIDS;HLA-E;Gene;PA452347;Chemical
INFLIXIMAB;HLA-E;Gene;PA452639;Chemical
PLCB1;GNG4;Gene;PA33384;Gene
PLCB2;GNG4;Gene;PA33385;Gene
PLCB3;GNG4;Gene;PA33386;Gene
PLCB4;GNG4;Gene;PA33387;Gene
HYPERCHOLESTEROLEMIA;SCAP;Gene;PA444516;Disease
ATORVASTATIN;SCAP;Gene;PA448500;Chemical
SIMVASTATIN;SCAP;Gene;PA451363;Chemical
COLORECTAL NEOPLASMS;rs11078659;Variant;PA446108;Disease
CELECOXIB;rs11078659;Variant;PA448871;Chemical
FLUOROURACIL;rs861539;Variant;PA128406956;Chemical
PLATINUM COMPOUNDS;rs861539;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs861539;Variant;PA443622;Disease
COLORECTAL NEOPLASMS;rs861539;Variant;PA446108;Disease
IRINOTECAN;rs861539;Variant;PA450085;Chemical
LEUCOVORIN;rs861539;Variant;PA450198;Chemical
CD274;pembrolizumab;Chemical;PA134915280;Gene
RS113488022;pembrolizumab;Chemical;PA166157522;Variant
ALK;pembrolizumab;Chemical;PA24719;Gene
BRAF;pembrolizumab;Chemical;PA25408;Gene
ERBB2;pembrolizumab;Chemical;PA27844;Gene
EGFR;pembrolizumab;Chemical;PA7360;Gene
SCHIZOPHRENIA;rs4606;Variant;PA447216;Disease
ANTIPSYCHOTICS;rs4606;Variant;PA452233;Chemical
CYP2D6;quinine;Chemical;PA128;Gene
CYP3A4;quinine;Chemical;PA130;Gene
G6PD DEFICIENCY;quinine;Chemical;PA166157959;Variant
ABCB1;quinine;Chemical;PA267;Gene
G6PD;quinine;Chemical;PA28469;Gene
ADRENERGICS, INHALANTS;rs34548976;Variant;PA10405;Chemical
ASTHMA;rs34548976;Variant;PA443450;Disease
MAP2K7;MAPK9;Gene;PA284;Gene
MAP2K1;MAPK9;Gene;PA30584;Gene
MAP2K2;MAPK9;Gene;PA30587;Gene
MAP2K3;MAPK9;Gene;PA30588;Gene
MAP2K4;MAPK9;Gene;PA30589;Gene
MAP2K5;MAPK9;Gene;PA30590;Gene
MAP2K6;MAPK9;Gene;PA30591;Gene
SORAFENIB;MAPK9;Gene;PA7000;Chemical
CYP3A4;diltiazem;Chemical;PA130;Gene
SLCO1B1;diltiazem;Chemical;PA134865839;Gene
RS4149056;diltiazem;Chemical;PA166154579;Variant
RS12946454;diltiazem;Chemical;PA166155253;Variant
ABCB1;diltiazem;Chemical;PA267;Gene
PLCD3;diltiazem;Chemical;PA33389;Gene
ATAZANAVIR;UGT1A1*36;Haplotype;PA10251;Chemical
PREGNANCY;UGT1A1*36;Haplotype;PA166048714;Disease
DOLUTEGRAVIR;UGT1A1*36;Haplotype;PA166114961;Chemical
ATAZANAVIR / RITONAVIR;UGT1A1*36;Haplotype;PA166182624;Chemical
UGT1A1;UGT1A1*36;Haplotype;PA420;Gene
HYPERBILIRUBINEMIA;UGT1A1*36;Haplotype;PA444511;Disease
JAUNDICE;UGT1A1*36;Haplotype;PA444648;Disease
TUBERCULOSIS;UGT1A1*36;Haplotype;PA445941;Disease
HIV INFECTIONS;UGT1A1*36;Haplotype;PA447230;Disease
LAMIVUDINE;UGT1A1*36;Haplotype;PA450163;Chemical
MOXIFLOXACIN;UGT1A1*36;Haplotype;PA450555;Chemical
ZIDOVUDINE;UGT1A1*36;Haplotype;PA451954;Chemical
OVARIAN NEOPLASMS;rs3219484;Variant;PA445204;Disease
CISPLATIN;rs3219484;Variant;PA449014;Chemical
CYCLOPHOSPHAMIDE;rs3219484;Variant;PA449165;Chemical
EPILEPSY;UGT1A4*1a;Haplotype;PA444065;Disease
LAMOTRIGINE;UGT1A4*1a;Haplotype;PA450164;Chemical
OLANZAPINE;UGT1A4*1a;Haplotype;PA450688;Chemical
TESTOSTERONE;UGT1A4*1a;Haplotype;PA451627;Chemical
HYPERTENSION;rs7297610;Variant;PA444552;Disease
ESSENTIAL HYPERTENSION;rs7297610;Variant;PA447288;Disease
HYDROCHLOROTHIAZIDE;rs7297610;Variant;PA449899;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs1736557;Variant;PA130620651;Chemical
ROSUVASTATIN;rs1736557;Variant;PA134308647;Chemical
NEOPLASMS;rs1736557;Variant;PA445062;Disease
NAUSEA;POM121L2;Gene;PA445048;Disease
VOMITING;POM121L2;Gene;PA446051;Disease
OPIOIDS;POM121L2;Gene;PA452618;Chemical
FLT3;ABCB6;Gene;PA28181;Gene
HEPARIN-INDUCED THROMBOCYTOPENIA;HLA-DRB3*01:01;Haplotype;PA447264;Disease
HEPARIN;HLA-DRB3*01:01;Haplotype;PA449855;Chemical
HYPERGLYCEMIA;rs11649514;Variant;PA444522;Disease
ATENOLOL;rs11649514;Variant;PA448499;Chemical
HLA-DQB1;Diabetic Retinopathy;Disease;PA35068;Gene
HYPERTENSION;rs261316;Variant;PA444552;Disease
ATENOLOL;rs261316;Variant;PA448499;Chemical
HYDROCHLOROTHIAZIDE;rs261316;Variant;PA449899;Chemical
COMT;risperidone;Chemical;PA117;Gene
CYP2B6;risperidone;Chemical;PA123;Gene
CYP2C19;risperidone;Chemical;PA124;Gene
CYP2C9;risperidone;Chemical;PA126;Gene
CYP2D6;risperidone;Chemical;PA128;Gene
CYP2E1;risperidone;Chemical;PA129;Gene
CYP3A4;risperidone;Chemical;PA130;Gene
CCL2;risperidone;Chemical;PA130413151;Gene
CYP3A5;risperidone;Chemical;PA131;Gene
ANKK1;risperidone;Chemical;PA134872551;Gene
RABEP1;risperidone;Chemical;PA134884097;Gene
EIF2AK4;risperidone;Chemical;PA134947616;Gene
HRH4;risperidone;Chemical;PA134982275;Gene
PPA2;risperidone;Chemical;PA142671159;Gene
SH2B1;risperidone;Chemical;PA145148084;Gene
MSANTD1;risperidone;Chemical;PA162379942;Gene
HTT;risperidone;Chemical;PA164741646;Gene
CYP2D6*1;risperidone;Chemical;PA165816576;Haplotype
CYP2D6*2;risperidone;Chemical;PA165816577;Haplotype
CYP2D6*3;risperidone;Chemical;PA165816578;Haplotype
CYP2D6*4;risperidone;Chemical;PA165816579;Haplotype
CYP2D6*6;risperidone;Chemical;PA165816581;Haplotype
CYP2D6*10;risperidone;Chemical;PA165816582;Haplotype
CYP2D6*41;risperidone;Chemical;PA165816584;Haplotype
CYP2D6*5;risperidone;Chemical;PA165948092;Haplotype
CYP2D6*1XN;risperidone;Chemical;PA165988479;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);risperidone;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);risperidone;Chemical;PA166116466;Haplotype
CYP2D6*87;risperidone;Chemical;PA166123327;Haplotype
CYP2D6*88;risperidone;Chemical;PA166123328;Haplotype
CYP2D6*89;risperidone;Chemical;PA166123329;Haplotype
CYP2D6*90;risperidone;Chemical;PA166123330;Haplotype
CYP2D6*91;risperidone;Chemical;PA166123331;Haplotype
CYP2D6*93;risperidone;Chemical;PA166123333;Haplotype
CYP2D6*95;risperidone;Chemical;PA166123336;Haplotype
CYP2D6*97;risperidone;Chemical;PA166123338;Haplotype
CYP2D6*98;risperidone;Chemical;PA166123339;Haplotype
CYP2D6*94;risperidone;Chemical;PA166128737;Haplotype
RS324420;risperidone;Chemical;PA166153569;Variant
RS951439;risperidone;Chemical;PA166153604;Variant
RS1805054;risperidone;Chemical;PA166153653;Variant
RS2661319;risperidone;Chemical;PA166153715;Variant
RS2842030;risperidone;Chemical;PA166153720;Variant
RS10917670;risperidone;Chemical;PA166153815;Variant
RS2515641;risperidone;Chemical;PA166154017;Variant
RS7912580;risperidone;Chemical;PA166154088;Variant
RS1799732;risperidone;Chemical;PA166154334;Variant
RS1799978;risperidone;Chemical;PA166154337;Variant
RS1800497;risperidone;Chemical;PA166154339;Variant
RS2514218;risperidone;Chemical;PA166154375;Variant
RS4436578;risperidone;Chemical;PA166154407;Variant
RS1806201;risperidone;Chemical;PA166154519;Variant
RS6311;risperidone;Chemical;PA166154673;Variant
RS6313;risperidone;Chemical;PA166154675;Variant
RS2494732;risperidone;Chemical;PA166154793;Variant
RS3803300;risperidone;Chemical;PA166154801;Variant
RS2412459;risperidone;Chemical;PA166154891;Variant
RS4586;risperidone;Chemical;PA166155151;Variant
RS2857657;risperidone;Chemical;PA166155210;Variant
RS4795893;risperidone;Chemical;PA166155227;Variant
RS489693;risperidone;Chemical;PA166155269;Variant
RS4483927;risperidone;Chemical;PA166155296;Variant
RS17782313;risperidone;Chemical;PA166155330;Variant
RS10012;risperidone;Chemical;PA166155586;Variant
RS887829;risperidone;Chemical;PA166155607;Variant
RS1056827;risperidone;Chemical;PA166155620;Variant
RS6706232;risperidone;Chemical;PA166155747;Variant
RS10929302;risperidone;Chemical;PA166155794;Variant
RS3787429;risperidone;Chemical;PA166155940;Variant
RS3787430;risperidone;Chemical;PA166155941;Variant
RS4633;risperidone;Chemical;PA166156023;Variant
RS4680;risperidone;Chemical;PA166156024;Variant
RS4818;risperidone;Chemical;PA166156025;Variant
RS165599;risperidone;Chemical;PA166156046;Variant
RS9606186;risperidone;Chemical;PA166156134;Variant
RS6280;risperidone;Chemical;PA166156277;Variant
RS167771;risperidone;Chemical;PA166156280;Variant
RS1523130;risperidone;Chemical;PA166156323;Variant
RS2069062;risperidone;Chemical;PA166156341;Variant
RS2276707;risperidone;Chemical;PA166156352;Variant
RS7643645;risperidone;Chemical;PA166156423;Variant
RS1875705;risperidone;Chemical;PA166156529;Variant
RS1042713;risperidone;Chemical;PA166156748;Variant
RS10042486;risperidone;Chemical;PA166156855;Variant
RS806378;risperidone;Chemical;PA166156956;Variant
RS1049353;risperidone;Chemical;PA166156973;Variant
RS1415744;risperidone;Chemical;PA166156984;Variant
RS724226;risperidone;Chemical;PA166157264;Variant
RS1045642;risperidone;Chemical;PA166157284;Variant
RS1128503;risperidone;Chemical;PA166157288;Variant
RS2229109;risperidone;Chemical;PA166157334;Variant
RS7799039;risperidone;Chemical;PA166157432;Variant
RS6318;risperidone;Chemical;PA166157849;Variant
RS1414334;risperidone;Chemical;PA166157862;Variant
RS3813928;risperidone;Chemical;PA166157874;Variant
RS3813929;risperidone;Chemical;PA166157875;Variant
CYP2D6 POOR METABOLIZER;risperidone;Chemical;PA166157927;Variant
RS3888190;risperidone;Chemical;PA166165398;Variant
RS1000940;risperidone;Chemical;PA166165401;Variant
RS1976391;risperidone;Chemical;PA166179207;Variant
CYP2D6*14;risperidone;Chemical;PA166181185;Haplotype
RS8050896;risperidone;Chemical;PA166184306;Variant
RS2980976;risperidone;Chemical;PA166184307;Variant
RS2636697;risperidone;Chemical;PA166184308;Variant
RS2636719;risperidone;Chemical;PA166184309;Variant
RS7395555;risperidone;Chemical;PA166184310;Variant
RS711355;risperidone;Chemical;PA166184316;Variant
RS785423;risperidone;Chemical;PA166184317;Variant
RS813676;risperidone;Chemical;PA166184318;Variant
RS362267;risperidone;Chemical;PA166185304;Variant
RS362306;risperidone;Chemical;PA166185306;Variant
RS155333;risperidone;Chemical;PA166252941;Variant
RS6465938;risperidone;Chemical;PA166252981;Variant
HTR1A;risperidone;Chemical;PA192;Gene
HTR2A;risperidone;Chemical;PA193;Gene
HTR2C;risperidone;Chemical;PA194;Gene
LEP;risperidone;Chemical;PA228;Gene
AKT1;risperidone;Chemical;PA24684;Gene
CNR1;risperidone;Chemical;PA26681;Gene
ABCB1;risperidone;Chemical;PA267;Gene
CYP1A2;risperidone;Chemical;PA27093;Gene
CYP1B1;risperidone;Chemical;PA27094;Gene
DRD2;risperidone;Chemical;PA27478;Gene
DRD3;risperidone;Chemical;PA27479;Gene
EPM2A;risperidone;Chemical;PA27832;Gene
FAAH;risperidone;Chemical;PA27955;Gene
GRID2;risperidone;Chemical;PA28971;Gene
GRIN2B;risperidone;Chemical;PA28980;Gene
GRM3;risperidone;Chemical;PA28992;Gene
GRM7;risperidone;Chemical;PA28996;Gene
HRH3;risperidone;Chemical;PA29458;Gene
MC4R;risperidone;Chemical;PA30676;Gene
SLC6A4;risperidone;Chemical;PA312;Gene
POLG;risperidone;Chemical;PA33500;Gene
RELN;risperidone;Chemical;PA34323;Gene
RGS4;risperidone;Chemical;PA34375;Gene
HLA-A;risperidone;Chemical;PA35055;Gene
HLA-B;risperidone;Chemical;PA35056;Gene
TJP1;risperidone;Chemical;PA36532;Gene
TNFRSF11A;risperidone;Chemical;PA36601;Gene
UGT1A10;risperidone;Chemical;PA37174;Gene
UGT1A3;risperidone;Chemical;PA37178;Gene
UGT1A4;risperidone;Chemical;PA37179;Gene
UGT1A5;risperidone;Chemical;PA37180;Gene
UGT1A6;risperidone;Chemical;PA37181;Gene
UGT1A7;risperidone;Chemical;PA37182;Gene
UGT1A8;risperidone;Chemical;PA37183;Gene
NR1I2;risperidone;Chemical;PA378;Gene
ADRB2;risperidone;Chemical;PA39;Gene
UGT1A9;risperidone;Chemical;PA419;Gene
UGT1A1;risperidone;Chemical;PA420;Gene
CLOZAPINE;rs72547516;Variant;PA449061;Chemical
CYP2A6;Recurrence;Disease;PA121;Gene
CYP2C19;Recurrence;Disease;PA124;Gene
CYP2D6;Recurrence;Disease;PA128;Gene
IFNL3;Recurrence;Disease;PA134952671;Gene
CYP2D6*1;Recurrence;Disease;PA165816576;Haplotype
CYP2D6*2;Recurrence;Disease;PA165816577;Haplotype
CYP2D6*3;Recurrence;Disease;PA165816578;Haplotype
CYP2D6*4;Recurrence;Disease;PA165816579;Haplotype
CYP2D6*10;Recurrence;Disease;PA165816582;Haplotype
CYP2D6*41;Recurrence;Disease;PA165816584;Haplotype
CYP2D6*5;Recurrence;Disease;PA165948092;Haplotype
CYP2C19*1;Recurrence;Disease;PA165980634;Haplotype
CYP2C19*2;Recurrence;Disease;PA165980635;Haplotype
CYP2D6*21;Recurrence;Disease;PA165988484;Haplotype
CYP2D6*35;Recurrence;Disease;PA165988487;Haplotype
CYP2D6*36;Recurrence;Disease;PA165988488;Haplotype
GSTM1 NULL;Recurrence;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Recurrence;Disease;PA166048676;Haplotype
IFNL4;Recurrence;Disease;PA166049147;Gene
RS12979860;Recurrence;Disease;PA166155468;Variant
CYP2D6*14;Recurrence;Disease;PA166181185;Haplotype
GSTM1;Recurrence;Disease;PA182;Gene
ROSUVASTATIN;rs1205;Variant;PA134308647;Chemical
CORONARY DISEASE;rs1205;Variant;PA443797;Disease
DIARRHEA;rs917881;Variant;PA443899;Disease
SORAFENIB;rs917881;Variant;PA7000;Chemical
ABCC2;Leukopenia;Disease;PA116;Gene
SLC31A1;Leukopenia;Disease;PA118;Gene
CYP2C9;Leukopenia;Disease;PA126;Gene
CYP3A5;Leukopenia;Disease;PA131;Gene
ARID5B;Leukopenia;Disease;PA134943193;Gene
NUDT15;Leukopenia;Disease;PA134963132;Gene
POLR1G;Leukopenia;Disease;PA142672156;Gene
DHFR;Leukopenia;Disease;PA143;Gene
FTO;Leukopenia;Disease;PA152208656;Gene
ERCC1;Leukopenia;Disease;PA155;Gene
TPMT*1;Leukopenia;Disease;PA165819268;Haplotype
TPMT*2;Leukopenia;Disease;PA165819269;Haplotype
TPMT*3A;Leukopenia;Disease;PA165819270;Haplotype
TPMT*3B;Leukopenia;Disease;PA165819271;Haplotype
TPMT*3C;Leukopenia;Disease;PA165819272;Haplotype
TPMT*6;Leukopenia;Disease;PA165819276;Haplotype
UGT1A1*1;Leukopenia;Disease;PA166115841;Haplotype
UGT1A1*28;Leukopenia;Disease;PA166115842;Haplotype
UGT1A1*6;Leukopenia;Disease;PA166115858;Haplotype
UGT1A1*27;Leukopenia;Disease;PA166115865;Haplotype
CYP3A5*1;Leukopenia;Disease;PA166128213;Haplotype
CYP3A5*3;Leukopenia;Disease;PA166128219;Haplotype
NUDT15*1;Leukopenia;Disease;PA166131619;Haplotype
NUDT15*2;Leukopenia;Disease;PA166131620;Haplotype
NUDT15*3;Leukopenia;Disease;PA166131621;Haplotype
NUDT15*4;Leukopenia;Disease;PA166131622;Haplotype
NUDT15*5;Leukopenia;Disease;PA166131623;Haplotype
NUDT15*6;Leukopenia;Disease;PA166151814;Haplotype
RS1801133;Leukopenia;Disease;PA166153644;Variant
RS12046844;Leukopenia;Disease;PA166153842;Variant
RS4948496;Leukopenia;Disease;PA166154069;Variant
RS17222723;Leukopenia;Disease;PA166154163;Variant
RS1695;Leukopenia;Disease;PA166154249;Variant
RS1933437;Leukopenia;Disease;PA166154705;Variant
RS2236225;Leukopenia;Disease;PA166154789;Variant
RS7194667;Leukopenia;Disease;PA166155078;Variant
RS238406;Leukopenia;Disease;PA166155349;Variant
RS3212986;Leukopenia;Disease;PA166155407;Variant
RS7270101;Leukopenia;Disease;PA166155964;Variant
RS70991108;Leukopenia;Disease;PA166156893;Variant
RS2278294;Leukopenia;Disease;PA166157351;Variant
CYP2C9 POOR METABOLIZER;Leukopenia;Disease;PA166157932;Variant
RS79206939;Leukopenia;Disease;PA166160976;Variant
RS16952570;Leukopenia;Disease;PA166160979;Variant
RS12050587;Leukopenia;Disease;PA166164874;Variant
RS11636687;Leukopenia;Disease;PA166164877;Variant
RS746071566;Leukopenia;Disease;PA166165231;Variant
RS10515074;Leukopenia;Disease;PA166165378;Variant
RS2027701;Leukopenia;Disease;PA166169891;Variant
RS73594404;Leukopenia;Disease;PA166169897;Variant
RS10132552;Leukopenia;Disease;PA166169901;Variant
RS2228000;Leukopenia;Disease;PA166171094;Variant
RS10817464;Leukopenia;Disease;PA166179458;Variant
RS1049305;Leukopenia;Disease;PA166186213;Variant
ABCC11;Leukopenia;Disease;PA24393;Gene
MTHFR;Leukopenia;Disease;PA245;Gene
AQP1;Leukopenia;Disease;PA24918;Gene
ERCC2;Leukopenia;Disease;PA27848;Gene
FLT3;Leukopenia;Disease;PA28181;Gene
GSTP1;Leukopenia;Disease;PA29028;Gene
IMPDH1;Leukopenia;Disease;PA29862;Gene
ITPA;Leukopenia;Disease;PA29973;Gene
MEG3;Leukopenia;Disease;PA30737;Gene
MSH3;Leukopenia;Disease;PA31134;Gene
MTHFD1;Leukopenia;Disease;PA31236;Gene
PIGB;Leukopenia;Disease;PA33290;Gene
PIK3R1;Leukopenia;Disease;PA33312;Gene
PPP1R13L;Leukopenia;Disease;PA34195;Gene
TPMT;Leukopenia;Disease;PA356;Gene
XPC;Leukopenia;Disease;PA37413;Gene
UGT1A1;Leukopenia;Disease;PA420;Gene
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;ARHGEF28;Gene;PA447197;Disease
METHYLPHENIDATE;ARHGEF28;Gene;PA450464;Chemical
F2;lusutrombopag;Chemical;PA157;Gene
F5;lusutrombopag;Chemical;PA159;Gene
RS6025;lusutrombopag;Chemical;PA166153554;Variant
RS1799963;lusutrombopag;Chemical;PA166154336;Variant
PROC;lusutrombopag;Chemical;PA33799;Gene
PROS1;lusutrombopag;Chemical;PA33809;Gene
SERPINC1;lusutrombopag;Chemical;PA35026;Gene
CYP3A5;eszopiclone;Chemical;PA131;Gene
IFNL3;interferons;Chemical;PA134952671;Gene
IFNL4;interferons;Chemical;PA166049147;Gene
RS187238;interferons;Chemical;PA166154270;Variant
RS1946518;interferons;Chemical;PA166154344;Variant
RS4796793;interferons;Chemical;PA166155228;Variant
RS1800477;interferons;Chemical;PA166155280;Variant
RS8099917;interferons;Chemical;PA166155435;Variant
RS12979860;interferons;Chemical;PA166155468;Variant
BCL2;interferons;Chemical;PA25302;Gene
IL18;interferons;Chemical;PA29802;Gene
STAT3;interferons;Chemical;PA337;Gene
HLA-B;interferons;Chemical;PA35056;Gene
ACUTE CORONARY SYNDROME;KRTAP10-4;Gene;PA165108401;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);KRTAP10-4;Gene;PA166129560;Disease
ASPIRIN;KRTAP10-4;Gene;PA448497;Chemical
CLOPIDOGREL;KRTAP10-4;Gene;PA449053;Chemical
OPIOID-RELATED DISORDERS;rs548646;Variant;PA445043;Disease
ETHANOL;rs548646;Variant;PA448073;Chemical
OPIOIDS;rs548646;Variant;PA452618;Chemical
RHEUMATOID ARTHRITIS;rs3213422;Variant;PA443434;Disease
LEFLUNOMIDE;rs3213422;Variant;PA450192;Chemical
OMEPRAZOLE;CYP2C19 poor metabolizers;Variant;PA450704;Chemical
DULOXETINE;rs78615940;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs78615940;Variant;PA447321;Disease
ASTHMA;ADORA1;Gene;PA443450;Disease
ASPIRIN;ADORA1;Gene;PA448497;Chemical
ANEMIA;rs3746574;Variant;PA443340;Disease
NASOPHARYNGEAL NEOPLASMS;rs3746574;Variant;PA445046;Disease
DOCETAXEL;rs3746574;Variant;PA449383;Chemical
SCHIZOPHRENIA;rs1056827;Variant;PA447216;Disease
RISPERIDONE;rs1056827;Variant;PA451257;Chemical
PRKACA;CACNA1B;Gene;PA33748;Gene
PRKACB;CACNA1B;Gene;PA33749;Gene
PRKACG;CACNA1B;Gene;PA33750;Gene
CELECOXIB;CACNA1B;Gene;PA448871;Chemical
CFTR;rs144476686;Variant;PA109;Gene
IVACAFTOR;rs144476686;Variant;PA165950341;Chemical
ANTITHYROID PREPARATIONS;rs111618861;Variant;PA164712499;Chemical
AGRANULOCYTOSIS;rs111618861;Variant;PA443297;Disease
CYP2C9;time to therapeutic inr;Disease;PA126;Gene
VKORC1;time to therapeutic inr;Disease;PA133787052;Gene
CYP2C9*1;time to therapeutic inr;Disease;PA165816542;Haplotype
CYP2C9*2;time to therapeutic inr;Disease;PA165816543;Haplotype
CYP2C9*3;time to therapeutic inr;Disease;PA165816544;Haplotype
CYP4F2*1;time to therapeutic inr;Disease;PA165860685;Haplotype
CYP4F2*3;time to therapeutic inr;Disease;PA165860687;Haplotype
RS9923231;time to therapeutic inr;Disease;PA166155091;Variant
CYP4F2;time to therapeutic inr;Disease;PA27121;Gene
CYP2A13;nnk;Chemical;PA27101;Gene
HYPERTENSION;SLC4A1;Gene;PA444552;Disease
ATENOLOL;SLC4A1;Gene;PA448499;Chemical
METOPROLOL;SLC4A1;Gene;PA450480;Chemical
COMT;Neoplasms;Disease;PA117;Gene
CYP2A6;Neoplasms;Disease;PA121;Gene
CYP2B6;Neoplasms;Disease;PA123;Gene
CYP2C19;Neoplasms;Disease;PA124;Gene
CYP2C8;Neoplasms;Disease;PA125;Gene
CYP2C9;Neoplasms;Disease;PA126;Gene
CYP2D6;Neoplasms;Disease;PA128;Gene
CYP3A4;Neoplasms;Disease;PA130;Gene
CYP3A5;Neoplasms;Disease;PA131;Gene
SLCO1B1;Neoplasms;Disease;PA134865839;Gene
ENOSF1;Neoplasms;Disease;PA134897613;Gene
OTOS;Neoplasms;Disease;PA134906408;Gene
RHBDF2;Neoplasms;Disease;PA134980674;Gene
DPYD;Neoplasms;Disease;PA145;Gene
DPYS;Neoplasms;Disease;PA146;Gene
SLC29A1;Neoplasms;Disease;PA154;Gene
ERCC1;Neoplasms;Disease;PA155;Gene
ESR1;Neoplasms;Disease;PA156;Gene
CMPK1;Neoplasms;Disease;PA162382539;Gene
TYMP;Neoplasms;Disease;PA162407502;Gene
ATL2;Neoplasms;Disease;PA164716322;Gene
MIR27A;Neoplasms;Disease;PA164722621;Gene
CYP2C19*17;Neoplasms;Disease;PA165816533;Haplotype
CYP2C9*1;Neoplasms;Disease;PA165816542;Haplotype
CYP2C9*2;Neoplasms;Disease;PA165816543;Haplotype
CYP2C9*3;Neoplasms;Disease;PA165816544;Haplotype
CYP2D6*1;Neoplasms;Disease;PA165816576;Haplotype
CYP2D6*2;Neoplasms;Disease;PA165816577;Haplotype
CYP2D6*3;Neoplasms;Disease;PA165816578;Haplotype
CYP2D6*4;Neoplasms;Disease;PA165816579;Haplotype
CYP2D6*6;Neoplasms;Disease;PA165816581;Haplotype
CYP2B6*1;Neoplasms;Disease;PA165818750;Haplotype
CYP2B6*6;Neoplasms;Disease;PA165818762;Haplotype
CYP3A4*1;Neoplasms;Disease;PA165819201;Haplotype
TPMT*1;Neoplasms;Disease;PA165819268;Haplotype
TPMT*2;Neoplasms;Disease;PA165819269;Haplotype
TPMT*3A;Neoplasms;Disease;PA165819270;Haplotype
TPMT*3B;Neoplasms;Disease;PA165819271;Haplotype
TPMT*3C;Neoplasms;Disease;PA165819272;Haplotype
TPMT*9;Neoplasms;Disease;PA165819279;Haplotype
CYP2A6*1;Neoplasms;Disease;PA165924690;Haplotype
CYP2A6*46;Neoplasms;Disease;PA165924691;Haplotype
CYP2A6*4;Neoplasms;Disease;PA165924721;Haplotype
CYP2A6*7;Neoplasms;Disease;PA165924731;Haplotype
CYP2A6*10;Neoplasms;Disease;PA165924735;Haplotype
CYP2A6*11;Neoplasms;Disease;PA165924736;Haplotype
CYP2A6*19;Neoplasms;Disease;PA165924748;Haplotype
HLA-A*03:01;Neoplasms;Disease;PA165953186;Haplotype
CYP2C8*3;Neoplasms;Disease;PA165958685;Haplotype
CYP2C8*4;Neoplasms;Disease;PA165958686;Haplotype
CYP2C19*1;Neoplasms;Disease;PA165980634;Haplotype
CYP2C19*2;Neoplasms;Disease;PA165980635;Haplotype
CYP2A6*9;Neoplasms;Disease;PA165980914;Haplotype
CYP2A6*18;Neoplasms;Disease;PA165980916;Haplotype
CYP2D6*1XN;Neoplasms;Disease;PA165988479;Haplotype
FMO3;Neoplasms;Disease;PA166;Gene
GSTM1 NULL;Neoplasms;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Neoplasms;Disease;PA166048676;Haplotype
GSTT1 NULL;Neoplasms;Disease;PA166048678;Haplotype
GSTT1 NON-NULL;Neoplasms;Disease;PA166048679;Haplotype
CYP3A4*22;Neoplasms;Disease;PA166048680;Haplotype
UGT1A1*1;Neoplasms;Disease;PA166115841;Haplotype
UGT1A1*28;Neoplasms;Disease;PA166115842;Haplotype
UGT1A1*37;Neoplasms;Disease;PA166115844;Haplotype
UGT1A1*60;Neoplasms;Disease;PA166115845;Haplotype
UGT1A1*6;Neoplasms;Disease;PA166115858;Haplotype
G6PD MEDITERRANEAN, DALLAS, PANAMA, SASSARI, CAGLIARI, BIRMINGHAM;Neoplasms;Disease;PA166121127;Haplotype
HLA-A*02:01;Neoplasms;Disease;PA166123427;Haplotype
CYP3A5*1;Neoplasms;Disease;PA166128213;Haplotype
CYP3A5*3;Neoplasms;Disease;PA166128219;Haplotype
RS396991;Neoplasms;Disease;PA166153571;Variant
RS532545;Neoplasms;Disease;PA166153575;Variant
RS602950;Neoplasms;Disease;PA166153581;Variant
RS1044457;Neoplasms;Disease;PA166153608;Variant
RS1048977;Neoplasms;Disease;PA166153610;Variant
RS1736557;Neoplasms;Disease;PA166153634;Variant
RS1801131;Neoplasms;Disease;PA166153643;Variant
RS1801133;Neoplasms;Disease;PA166153644;Variant
RS1801158;Neoplasms;Disease;PA166153645;Variant
RS1801159;Neoplasms;Disease;PA166153646;Variant
RS1801160;Neoplasms;Disease;PA166153647;Variant
RS1801265;Neoplasms;Disease;PA166153648;Variant
RS1805087;Neoplasms;Disease;PA166153654;Variant
RS2072671;Neoplasms;Disease;PA166153667;Variant
RS2297480;Neoplasms;Disease;PA166153695;Variant
RS2297595;Neoplasms;Disease;PA166153696;Variant
RS3215400;Neoplasms;Disease;PA166153738;Variant
RS3918290;Neoplasms;Disease;PA166153760;Variant
RS4655226;Neoplasms;Disease;PA166153774;Variant
RS11211524;Neoplasms;Disease;PA166153822;Variant
RS12046844;Neoplasms;Disease;PA166153842;Variant
RS17376848;Neoplasms;Disease;PA166153874;Variant
RS55886062;Neoplasms;Disease;PA166153888;Variant
RS56038477;Neoplasms;Disease;PA166153889;Variant
RS59086055;Neoplasms;Disease;PA166153891;Variant
RS60369023;Neoplasms;Disease;PA166153893;Variant
RS67376798;Neoplasms;Disease;PA166153895;Variant
RS75017182;Neoplasms;Disease;PA166153906;Variant
RS78060119;Neoplasms;Disease;PA166153913;Variant
RS115232898;Neoplasms;Disease;PA166153919;Variant
RS11598702;Neoplasms;Disease;PA166154142;Variant
RS1695;Neoplasms;Disease;PA166154249;Variant
RS9937;Neoplasms;Disease;PA166154265;Variant
RS183484;Neoplasms;Disease;PA166154269;Variant
RS1138272;Neoplasms;Disease;PA166154320;Variant
RS2229774;Neoplasms;Disease;PA166154532;Variant
RS2306283;Neoplasms;Disease;PA166154547;Variant
RS4149056;Neoplasms;Disease;PA166154579;Variant
RS11045585;Neoplasms;Disease;PA166154626;Variant
RS11045879;Neoplasms;Disease;PA166154633;Variant
RS61764370;Neoplasms;Disease;PA166154658;Variant
RS7319981;Neoplasms;Disease;PA166154719;Variant
RS9514091;Neoplasms;Disease;PA166154733;Variant
RS9561778;Neoplasms;Disease;PA166154741;Variant
RS1060896;Neoplasms;Disease;PA166154857;Variant
RS2305364;Neoplasms;Disease;PA166154888;Variant
RS4673;Neoplasms;Disease;PA166154969;Variant
RS1800566;Neoplasms;Disease;PA166155017;Variant
RS2019604;Neoplasms;Disease;PA166155026;Variant
RS4148350;Neoplasms;Disease;PA166155060;Variant
RS7194667;Neoplasms;Disease;PA166155078;Variant
RS9936750;Neoplasms;Disease;PA166155097;Variant
RS1051640;Neoplasms;Disease;PA166155176;Variant
RS12948783;Neoplasms;Disease;PA166155254;Variant
RS2612091;Neoplasms;Disease;PA166155285;Variant
RS45445694;Neoplasms;Disease;PA166155331;Variant
RS183205964;Neoplasms;Disease;PA166155336;Variant
RS11615;Neoplasms;Disease;PA166155342;Variant
RS25487;Neoplasms;Disease;PA166155346;Variant
RS895819;Neoplasms;Disease;PA166155357;Variant
RS1799793;Neoplasms;Disease;PA166155371;Variant
RS2108623;Neoplasms;Disease;PA166155382;Variant
RS3212986;Neoplasms;Disease;PA166155407;Variant
RS10426377;Neoplasms;Disease;PA166155454;Variant
RS724710;Neoplasms;Disease;PA166155599;Variant
RS1901440;Neoplasms;Disease;PA166155653;Variant
RS2075252;Neoplasms;Disease;PA166155666;Variant
RS2228171;Neoplasms;Disease;PA166155671;Variant
RS2291767;Neoplasms;Disease;PA166155679;Variant
RS4124874;Neoplasms;Disease;PA166155720;Variant
RS4261716;Neoplasms;Disease;PA166155725;Variant
RS6431558;Neoplasms;Disease;PA166155742;Variant
RS6755571;Neoplasms;Disease;PA166155759;Variant
RS17583889;Neoplasms;Disease;PA166155844;Variant
RS17645700;Neoplasms;Disease;PA166155847;Variant
RS17863783;Neoplasms;Disease;PA166155854;Variant
RS17868320;Neoplasms;Disease;PA166155855;Variant
RS9024;Neoplasms;Disease;PA166155972;Variant
RS1051266;Neoplasms;Disease;PA166155986;Variant
RS1056892;Neoplasms;Disease;PA166155989;Variant
RS9981861;Neoplasms;Disease;PA166156013;Variant
RS6269;Neoplasms;Disease;PA166156027;Variant
RS11479;Neoplasms;Disease;PA166156029;Variant
RS1883112;Neoplasms;Disease;PA166156080;Variant
RS4646316;Neoplasms;Disease;PA166156108;Variant
RS9332377;Neoplasms;Disease;PA166156133;Variant
RS13058338;Neoplasms;Disease;PA166156140;Variant
RS2228001;Neoplasms;Disease;PA166156345;Variant
RS6785049;Neoplasms;Disease;PA166156411;Variant
RS11719165;Neoplasms;Disease;PA166156446;Variant
RS2231142;Neoplasms;Disease;PA166156544;Variant
RS316019;Neoplasms;Disease;PA166156913;Variant
RS628031;Neoplasms;Disease;PA166156933;Variant
RS760370;Neoplasms;Disease;PA166156947;Variant
RS1142345;Neoplasms;Disease;PA166156978;Variant
RS1800460;Neoplasms;Disease;PA166156992;Variant
RS2207396;Neoplasms;Disease;PA166157022;Variant
RS2234693;Neoplasms;Disease;PA166157026;Variant
RS4149178;Neoplasms;Disease;PA166157095;Variant
RS9340799;Neoplasms;Disease;PA166157143;Variant
RS9351963;Neoplasms;Disease;PA166157147;Variant
RS12201199;Neoplasms;Disease;PA166157177;Variant
RS662;Neoplasms;Disease;PA166157238;Variant
RS712829;Neoplasms;Disease;PA166157262;Variant
RS1045642;Neoplasms;Disease;PA166157284;Variant
RS1128503;Neoplasms;Disease;PA166157288;Variant
RS1149222;Neoplasms;Disease;PA166157290;Variant
RS1799983;Neoplasms;Disease;PA166157303;Variant
RS2032582;Neoplasms;Disease;PA166157316;Variant
RS2227983;Neoplasms;Disease;PA166157331;Variant
RS2235047;Neoplasms;Disease;PA166157339;Variant
RS2740574;Neoplasms;Disease;PA166157367;Variant
RS3750117;Neoplasms;Disease;PA166157378;Variant
RS4148808;Neoplasms;Disease;PA166157388;Variant
RS12721627;Neoplasms;Disease;PA166157460;Variant
RS35599367;Neoplasms;Disease;PA166157487;Variant
RS1051660;Neoplasms;Disease;PA166157551;Variant
RS770063251;Neoplasms;Disease;PA166157694;Variant
RS885004;Neoplasms;Disease;PA166157716;Variant
RS4877847;Neoplasms;Disease;PA166157778;Variant
RS6151031;Neoplasms;Disease;PA166157783;Variant
RS7867504;Neoplasms;Disease;PA166157795;Variant
RS11141915;Neoplasms;Disease;PA166157828;Variant
DPYD DEFICIENCY;Neoplasms;Disease;PA166157931;Variant
G6PD DEFICIENCY;Neoplasms;Disease;PA166157959;Variant
RS4788863;Neoplasms;Disease;PA166163715;Variant
RS12119882;Neoplasms;Disease;PA166163749;Variant
RS699517;Neoplasms;Disease;PA166163751;Variant
RS2270860;Neoplasms;Disease;PA166163754;Variant
RS2853741;Neoplasms;Disease;PA166163757;Variant
RS4678145;Neoplasms;Disease;PA166163762;Variant
RS143414470;Neoplasms;Disease;PA166165332;Variant
DPYD C.1129-5923C>G, C.1236G>A (HAPB3);Neoplasms;Disease;PA166171120;Haplotype
RS11280056;Neoplasms;Disease;PA166180936;Variant
CYP2C8*1;Neoplasms;Disease;PA166242948;Haplotype
RS13210472;Neoplasms;Disease;PA166266481;Variant
RS59569490;Neoplasms;Disease;PA166394241;Variant
NAT2;Neoplasms;Disease;PA18;Gene
GSTM1;Neoplasms;Disease;PA182;Gene
GSTT1;Neoplasms;Disease;PA183;Gene
HNMT;Neoplasms;Disease;PA190;Gene
ABCC11;Neoplasms;Disease;PA24393;Gene
ABCC1;Neoplasms;Disease;PA244;Gene
ABL1;Neoplasms;Disease;PA24413;Gene
MTHFR;Neoplasms;Disease;PA245;Gene
ALDH1A1;Neoplasms;Disease;PA24692;Gene
ANK3;Neoplasms;Disease;PA24800;Gene
BCL2L11;Neoplasms;Disease;PA25305;Gene
NOS3;Neoplasms;Disease;PA254;Gene
BRAF;Neoplasms;Disease;PA25408;Gene
CBR1;Neoplasms;Disease;PA26121;Gene
CBR3;Neoplasms;Disease;PA26122;Gene
ABCB1;Neoplasms;Disease;PA267;Gene
ABCB4;Neoplasms;Disease;PA268;Gene
CYBA;Neoplasms;Disease;PA27075;Gene
CYP4F2;Neoplasms;Disease;PA27121;Gene
DAPK1;Neoplasms;Disease;PA27142;Gene
DSCAM;Neoplasms;Disease;PA27491;Gene
ERCC2;Neoplasms;Disease;PA27848;Gene
FCGR3A;Neoplasms;Disease;PA28065;Gene
FDPS;Neoplasms;Disease;PA28075;Gene
G6PD;Neoplasms;Disease;PA28469;Gene
GSTP1;Neoplasms;Disease;PA29028;Gene
PTGS2;Neoplasms;Disease;PA293;Gene
RRM1;Neoplasms;Disease;PA298;Gene
KCNQ5;Neoplasms;Disease;PA30077;Gene
KRAS;Neoplasms;Disease;PA30196;Gene
LRP2;Neoplasms;Disease;PA30452;Gene
MDM2;Neoplasms;Disease;PA30718;Gene
MTR;Neoplasms;Disease;PA31272;Gene
NCF4;Neoplasms;Disease;PA31465;Gene
NQO1;Neoplasms;Disease;PA31744;Gene
SLC10A2;Neoplasms;Disease;PA318;Gene
NT5C2;Neoplasms;Disease;PA31801;Gene
NT5C3A;Neoplasms;Disease;PA31802;Gene
OPRK1;Neoplasms;Disease;PA31943;Gene
SLC19A1;Neoplasms;Disease;PA327;Gene
SLC22A1;Neoplasms;Disease;PA329;Gene
SLC22A2;Neoplasms;Disease;PA331;Gene
PIK3R1;Neoplasms;Disease;PA33312;Gene
PON1;Neoplasms;Disease;PA33529;Gene
RAC2;Neoplasms;Disease;PA34163;Gene
RARG;Neoplasms;Disease;PA34227;Gene
HLA-A;Neoplasms;Disease;PA35055;Gene
TPMT;Neoplasms;Disease;PA356;Gene
SLC16A5;Neoplasms;Disease;PA35817;Gene
SLCO1B3;Neoplasms;Disease;PA35844;Gene
SLC22A7;Neoplasms;Disease;PA35848;Gene
TYMS;Neoplasms;Disease;PA359;Gene
SPG7;Neoplasms;Disease;PA36067;Gene
SULT2B1;Neoplasms;Disease;PA36249;Gene
UMPS;Neoplasms;Disease;PA363;Gene
XRCC1;Neoplasms;Disease;PA369;Gene
UGT1A4;Neoplasms;Disease;PA37179;Gene
UGT1A6;Neoplasms;Disease;PA37181;Gene
UGT1A8;Neoplasms;Disease;PA37183;Gene
XPC;Neoplasms;Disease;PA37413;Gene
ABCC3;Neoplasms;Disease;PA376;Gene
NR1I2;Neoplasms;Disease;PA378;Gene
SLC28A2;Neoplasms;Disease;PA386;Gene
SLC28A1;Neoplasms;Disease;PA387;Gene
ABCG2;Neoplasms;Disease;PA390;Gene
ABCC4;Neoplasms;Disease;PA397;Gene
UGT1A9;Neoplasms;Disease;PA419;Gene
UGT1A1;Neoplasms;Disease;PA420;Gene
SLC28A3;Neoplasms;Disease;PA426;Gene
EGFR;Neoplasms;Disease;PA7360;Gene
CDA;Neoplasms;Disease;PA98;Gene
BREAST NEOPLASMS;rs8133052;Variant;PA443560;Disease
NEUTROPENIA;rs8133052;Variant;PA445113;Disease
DOXORUBICIN;rs8133052;Variant;PA449412;Chemical
FLUOROURACIL;rs371194629;Variant;PA128406956;Chemical
ARTHRITIS, RHEUMATOID;rs371194629;Variant;PA443434;Disease
COLORECTAL NEOPLASMS;rs371194629;Variant;PA446108;Disease
CAPECITABINE;rs371194629;Variant;PA448771;Chemical
METHOTREXATE;rs371194629;Variant;PA450428;Chemical
OPIOID-RELATED DISORDERS;rs4554144;Variant;PA445043;Disease
METHADONE;rs4554144;Variant;PA450401;Chemical
LAROPIPRANT;PTGDR;Gene;PA166129564;Chemical
GNAS;PTGDR;Gene;PA175;Gene
DEXAMETHASONE;PTGDR;Gene;PA449247;Chemical
DULOXETINE;rs324026;Variant;PA10066;Chemical
ANXIETY DISORDERS;rs324026;Variant;PA447196;Disease
CYP3A4;acute cellular rejection;Disease;PA130;Gene
RS2242480;acute cellular rejection;Disease;PA166157345;Variant
COMT;Anxiety Disorders;Disease;PA117;Gene
CYP2C19;Anxiety Disorders;Disease;PA124;Gene
CYP3A4;Anxiety Disorders;Disease;PA130;Gene
CYP3A5;Anxiety Disorders;Disease;PA131;Gene
CYP2C19*17;Anxiety Disorders;Disease;PA165816533;Haplotype
CYP3A4*1;Anxiety Disorders;Disease;PA165819201;Haplotype
CYP2C19*1;Anxiety Disorders;Disease;PA165980634;Haplotype
CYP2C19*2;Anxiety Disorders;Disease;PA165980635;Haplotype
CYP3A4*22;Anxiety Disorders;Disease;PA166048680;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);Anxiety Disorders;Disease;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);Anxiety Disorders;Disease;PA166116466;Haplotype
SLC6A4 L ALLELE-RS25531T;Anxiety Disorders;Disease;PA166117146;Haplotype
CYP3A5*1;Anxiety Disorders;Disease;PA166128213;Haplotype
CYP3A5*3;Anxiety Disorders;Disease;PA166128219;Haplotype
RS6311;Anxiety Disorders;Disease;PA166154673;Variant
RS6313;Anxiety Disorders;Disease;PA166154675;Variant
RS7997012;Anxiety Disorders;Disease;PA166154726;Variant
RS242941;Anxiety Disorders;Disease;PA166155163;Variant
RS4680;Anxiety Disorders;Disease;PA166156024;Variant
RS3761422;Anxiety Disorders;Disease;PA166156103;Variant
RS5751876;Anxiety Disorders;Disease;PA166156118;Variant
RS167770;Anxiety Disorders;Disease;PA166156279;Variant
RS324023;Anxiety Disorders;Disease;PA166156285;Variant
RS324026;Anxiety Disorders;Disease;PA166156286;Variant
RS963468;Anxiety Disorders;Disease;PA166156301;Variant
RS6296;Anxiety Disorders;Disease;PA166156903;Variant
RS11568817;Anxiety Disorders;Disease;PA166157174;Variant
HTR2A;Anxiety Disorders;Disease;PA193;Gene
ADORA2A;Anxiety Disorders;Disease;PA24584;Gene
CRHR1;Anxiety Disorders;Disease;PA26874;Gene
DRD3;Anxiety Disorders;Disease;PA27479;Gene
HTR1B;Anxiety Disorders;Disease;PA29549;Gene
SLC6A4;Anxiety Disorders;Disease;PA312;Gene
ETHANOL;rs77804065;Variant;PA448073;Chemical
PLATINUM COMPOUNDS;rs4413407;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs4413407;Variant;PA443622;Disease
INFLAMMATORY BOWEL DISEASES;DDRGK1;Gene;PA446116;Disease
AZATHIOPRINE;DDRGK1;Gene;PA448515;Chemical
CYP2B6;efavirenz / emtricitabine / tenofovir disoproxil;Chemical;PA123;Gene
CYP2B6*6;efavirenz / emtricitabine / tenofovir disoproxil;Chemical;PA165818762;Haplotype
RS3745274;efavirenz / emtricitabine / tenofovir disoproxil;Chemical;PA166155409;Variant
ACE INHIBITORS, PLAIN;rs2016848;Variant;PA164712308;Chemical
COUGH;rs2016848;Variant;PA443803;Disease
HYPERTENSION;rs2016848;Variant;PA444552;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*15:35;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*15:35;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*15:35;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-B*15:35;Haplotype;PA450616;Chemical
CFTR;cysteamine;Chemical;PA109;Gene
RS113993960;cysteamine;Chemical;PA166157525;Variant
LPL;olezarsen;Chemical;PA232;Gene
TOBACCO USE DISORDER;rs684513;Variant;PA445876;Disease
COCAINE DEPENDENCE;rs684513;Variant;PA446878;Disease
COCAINE;rs684513;Variant;PA449072;Chemical
NICOTINE;rs684513;Variant;PA450626;Chemical
DIARRHEA;CDH13;Gene;PA443899;Disease
SORAFENIB;CDH13;Gene;PA7000;Chemical
MACULAR DEGENERATION;NRP1;Gene;PA134850558;Disease
RANIBIZUMAB;NRP1;Gene;PA164746012;Chemical
KDR;NRP1;Gene;PA30086;Gene
VEGFA;NRP1;Gene;PA37302;Gene
VEGFB;NRP1;Gene;PA37303;Gene
VEGFC;NRP1;Gene;PA37304;Gene
BELIMUMAB;TNFSF13B;Gene;PA166114904;Chemical
ARACHIDONIC ACID;rs550261161;Variant;PA166178659;Chemical
RS712829;geldanamycin;Chemical;PA166157262;Variant
EGFR;geldanamycin;Chemical;PA7360;Gene
ROCURONIUM;rs7967354;Variant;PA164754992;Chemical
CYP2B6;meperidine;Chemical;PA123;Gene
CYP3A5;meperidine;Chemical;PA131;Gene
FIP1L1;meperidine;Chemical;PA134875694;Gene
RS11049274;meperidine;Chemical;PA166257863;Variant
RS113100019;meperidine;Chemical;PA166257864;Variant
RS185462714;meperidine;Chemical;PA166257865;Variant
SERINC5;meperidine;Chemical;PA38698;Gene
CARBAMAZEPINE;HSPA1A;Gene;PA448785;Chemical
CFTR;rs74571530;Variant;PA109;Gene
IVACAFTOR;rs74571530;Variant;PA165950341;Chemical
SCHIZOPHRENIA;rs13250975;Variant;PA447216;Disease
ANTIPSYCHOTICS;rs13250975;Variant;PA452233;Chemical
NICOTINE;rs758479488;Variant;PA450626;Chemical
HYPERTENSION;rs7184292;Variant;PA444552;Disease
ATENOLOL;rs7184292;Variant;PA448499;Chemical
COTININE;rs10851907;Variant;PA166114414;Chemical
TOBACCO USE DISORDER;rs10851907;Variant;PA445876;Disease
TRANSPLANTATION;TPMT*3A;Haplotype;PA134850491;Disease
NUDT15;TPMT*3A;Haplotype;PA134963132;Gene
OTOTOXICITY;TPMT*3A;Haplotype;PA162263534;Disease
KIDNEY TRANSPLANTATION;TPMT*3A;Haplotype;PA165817016;Disease
MYELOSUPPRESSION;TPMT*3A;Haplotype;PA165817398;Disease
TRANSPLANT REJECTION;TPMT*3A;Haplotype;PA166114454;Disease
HEART TRANSPLANTATION;TPMT*3A;Haplotype;PA166114458;Disease
EVENT-FREE SURVIVAL;TPMT*3A;Haplotype;PA166123366;Disease
DISCONTINUATION;TPMT*3A;Haplotype;PA166123507;Disease
DOSE REDUCTION;TPMT*3A;Haplotype;PA166159953;Disease
TPMT;TPMT*3A;Haplotype;PA356;Gene
ARTHRITIS, RHEUMATOID;TPMT*3A;Haplotype;PA443434;Disease
COLITIS, ULCERATIVE;TPMT*3A;Haplotype;PA443750;Disease
CROHN DISEASE;TPMT*3A;Haplotype;PA443815;Disease
DIZZINESS;TPMT*3A;Haplotype;PA443928;Disease
DRUG TOXICITY;TPMT*3A;Haplotype;PA443937;Disease
FATIGUE;TPMT*3A;Haplotype;PA444153;Disease
HEMATOLOGIC DISEASES;TPMT*3A;Haplotype;PA444395;Disease
INFECTION;TPMT*3A;Haplotype;PA444614;Disease
INFLAMMATION;TPMT*3A;Haplotype;PA444620;Disease
LEUKEMIA;TPMT*3A;Haplotype;PA444750;Disease
LEUKEMIA, MYELOID, ACUTE;TPMT*3A;Haplotype;PA444760;Disease
LEUKOPENIA;TPMT*3A;Haplotype;PA444773;Disease
NEOPLASMS;TPMT*3A;Haplotype;PA445062;Disease
NEUTROPENIA;TPMT*3A;Haplotype;PA445113;Disease
PANCYTOPENIA;TPMT*3A;Haplotype;PA445221;Disease
RHEUMATIC DISEASES;TPMT*3A;Haplotype;PA445555;Disease
SKIN NEOPLASMS;TPMT*3A;Haplotype;PA445683;Disease
STOMATITIS;TPMT*3A;Haplotype;PA445746;Disease
THROMBOCYTOPENIA;TPMT*3A;Haplotype;PA445846;Disease
INFLAMMATORY BOWEL DISEASES;TPMT*3A;Haplotype;PA446116;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;TPMT*3A;Haplotype;PA446155;Disease
LIVER TRANSPLANTATION;TPMT*3A;Haplotype;PA447247;Disease
AZATHIOPRINE;TPMT*3A;Haplotype;PA448515;Chemical
CISPLATIN;TPMT*3A;Haplotype;PA449014;Chemical
CYCLOSPORINE;TPMT*3A;Haplotype;PA449167;Chemical
MERCAPTOPURINE;TPMT*3A;Haplotype;PA450379;Chemical
METHOTREXATE;TPMT*3A;Haplotype;PA450428;Chemical
OLANZAPINE;TPMT*3A;Haplotype;PA450688;Chemical
PREDNISONE;TPMT*3A;Haplotype;PA451100;Chemical
THIOGUANINE;TPMT*3A;Haplotype;PA451663;Chemical
PURINE ANALOGUES;TPMT*3A;Haplotype;PA452634;Chemical
ESCITALOPRAM;rs962369;Variant;PA10074;Chemical
MAJOR DEPRESSIVE DISORDER;rs962369;Variant;PA447321;Disease
NORTRIPTYLINE;rs962369;Variant;PA450657;Chemical
ALCOHOL-RELATED DISORDERS;GRIK1;Gene;PA446879;Disease
TOPIRAMATE;GRIK1;Gene;PA451728;Chemical
TENOFOVIR;rs1059751;Variant;PA10204;Chemical
HIV INFECTIOUS DISEASE;rs1059751;Variant;PA447230;Disease
DOXORUBICIN;rs4987121;Variant;PA449412;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs12302749;Variant;PA447197;Disease
METHYLPHENIDATE;rs12302749;Variant;PA450464;Chemical
CYP2C19;tolbutamide;Chemical;PA124;Gene
CYP2C9;tolbutamide;Chemical;PA126;Gene
CYP2C19*8;tolbutamide;Chemical;PA165816524;Haplotype
CYP2C9*1;tolbutamide;Chemical;PA165816542;Haplotype
CYP2C9*2;tolbutamide;Chemical;PA165816543;Haplotype
CYP2C9*3;tolbutamide;Chemical;PA165816544;Haplotype
CYP2C19*1;tolbutamide;Chemical;PA165980634;Haplotype
CYP2C19*5;tolbutamide;Chemical;PA165980638;Haplotype
CYP2C9*59;tolbutamide;Chemical;PA166128210;Haplotype
CYP2C9*60;tolbutamide;Chemical;PA166128211;Haplotype
RS9332239;tolbutamide;Chemical;PA166154106;Variant
RS41291556;tolbutamide;Chemical;PA166154179;Variant
RS762081829;tolbutamide;Chemical;PA166186014;Variant
RS771237265;tolbutamide;Chemical;PA166186015;Variant
RS761895497;tolbutamide;Chemical;PA166186016;Variant
CYP2C9*62;tolbutamide;Chemical;PA166219782;Haplotype
CYP2C9*72;tolbutamide;Chemical;PA166257325;Haplotype
CYP2C9*74;tolbutamide;Chemical;PA166257327;Haplotype
G6PD;tolbutamide;Chemical;PA28469;Gene
MULTIPLE SCLEROSIS;rs333;Variant;PA444987;Disease
GLATIRAMER ACETATE;rs333;Variant;PA449760;Chemical
TSC1;Tuberous Sclerosis;Disease;PA37034;Gene
TSC2;Tuberous Sclerosis;Disease;PA37035;Gene
MACULAR DEGENERATION;rs2070296;Variant;PA134850558;Disease
RANIBIZUMAB;rs2070296;Variant;PA164746012;Chemical
CASR;PLCH1;Gene;PA26097;Gene
PRKCA;PLCH1;Gene;PA33759;Gene
PRKCB;PLCH1;Gene;PA33761;Gene
PRKCG;PLCH1;Gene;PA33766;Gene
PRKCH;PLCH1;Gene;PA33767;Gene
PRKCI;PLCH1;Gene;PA33768;Gene
PRKD1;PLCH1;Gene;PA33771;Gene
PRKCZ;PLCH1;Gene;PA33775;Gene
GEFITINIB;rs121434569;Variant;PA131301952;Chemical
ERLOTINIB;rs121434569;Variant;PA134687924;Chemical
DRUG RESISTANCE;rs121434569;Variant;PA165111675;Disease
OSIMERTINIB;rs121434569;Variant;PA166131626;Chemical
ADENOCARCINOMA;rs121434569;Variant;PA443265;Disease
NON-SMALL CELL LUNG CARCINOMA;rs121434569;Variant;PA443622;Disease
LUNG NEOPLASMS;rs121434569;Variant;PA444818;Disease
EGFR;rs121434569;Variant;PA7360;Gene
LUPUS ERYTHEMATOSUS;rs7254579;Variant;PA444819;Disease
CYCLOPHOSPHAMIDE;rs7254579;Variant;PA449165;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;CDKN2B-AS1;Gene;PA164712462;Chemical
ACUTE CORONARY SYNDROME;CDKN2B-AS1;Gene;PA165108401;Disease
ZOLEDRONATE;rs17587029;Variant;PA10235;Chemical
FEC100;rs17587029;Variant;PA166185677;Chemical
AMENORRHEA;rs17587029;Variant;PA443324;Disease
DOCETAXEL;rs17587029;Variant;PA449383;Chemical
GEMCITABINE;rs17587029;Variant;PA449748;Chemical
TRASTUZUMAB;rs17587029;Variant;PA451743;Chemical
FLUOROURACIL;rs201268750;Variant;PA128406956;Chemical
DRUG TOXICITY;rs201268750;Variant;PA443937;Disease
HEART VALVE REPLACEMENT;rs72800847;Variant;PA166123431;Disease
WARFARIN;rs72800847;Variant;PA451906;Chemical
CLAVULANATE;HLA-B*57:01;Haplotype;PA164742987;Chemical
FLUCLOXACILLIN;HLA-B*57:01;Haplotype;PA164781042;Chemical
TOXIC LIVER DISEASE;HLA-B*57:01;Haplotype;PA164925725;Disease
PAZOPANIB;HLA-B*57:01;Haplotype;PA165291492;Chemical
SOFT TISSUE NEOPLASMS;HLA-B*57:01;Haplotype;PA166048850;Disease
DRUG-INDUCED LIVER INJURY;HLA-B*57:01;Haplotype;PA166119041;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*57:01;Haplotype;PA166120927;Disease
LAMIVUDINE / ABACAVIR;HLA-B*57:01;Haplotype;PA166184501;Chemical
ZIDOVUDINE / LAMIVUDINE / ABACAVIR;HLA-B*57:01;Haplotype;PA166184503;Chemical
DOLUTEGRAVIR / ABACAVIR / LAMIVUDINE;HLA-B*57:01;Haplotype;PA166184505;Chemical
HLA-B;HLA-B*57:01;Haplotype;PA35056;Gene
UGT1A1;HLA-B*57:01;Haplotype;PA420;Gene
CARCINOMA, RENAL CELL;HLA-B*57:01;Haplotype;PA443624;Disease
DRUG HYPERSENSITIVITY;HLA-B*57:01;Haplotype;PA443936;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*57:01;Haplotype;PA444059;Disease
OVARIAN NEOPLASMS;HLA-B*57:01;Haplotype;PA445204;Disease
SARCOMA;HLA-B*57:01;Haplotype;PA445594;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*57:01;Haplotype;PA445738;Disease
HIV INFECTIONS;HLA-B*57:01;Haplotype;PA447230;Disease
ABACAVIR;HLA-B*57:01;Haplotype;PA448004;Chemical
AMOXICILLIN;HLA-B*57:01;Haplotype;PA448406;Chemical
LAMOTRIGINE;HLA-B*57:01;Haplotype;PA450164;Chemical
NEVIRAPINE;HLA-B*57:01;Haplotype;PA450616;Chemical
MOCS1;fosdenopterin;Chemical;PA30900;Gene
EPILEPSY;GABRA1;Gene;PA444065;Disease
CARBAMAZEPINE;GABRA1;Gene;PA448785;Chemical
PHENYTOIN;GABRA1;Gene;PA450947;Chemical
VALPROIC ACID;GABRA1;Gene;PA451846;Chemical
DPYD;rs80081766;Variant;PA145;Gene
CAPECITABINE;rs80081766;Variant;PA448771;Chemical
NIFEDIPINE;rs41279854;Variant;PA450631;Chemical
TESTOSTERONE;rs41279854;Variant;PA451627;Chemical
CFTR;rs193922525;Variant;PA109;Gene
IVACAFTOR;rs193922525;Variant;PA165950341;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs193922525;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs193922525;Variant;PA443829;Disease
NAT2*4;hydralazine;Chemical;PA165949098;Haplotype
NAT2*5A;hydralazine;Chemical;PA165949099;Haplotype
NAT2*12A;hydralazine;Chemical;PA165949138;Haplotype
HLA-DRB1*04:01;hydralazine;Chemical;PA165951493;Haplotype
NAT2*5;hydralazine;Chemical;PA165981634;Haplotype
NAT2*6;hydralazine;Chemical;PA165981635;Haplotype
NAT2*7;hydralazine;Chemical;PA165981636;Haplotype
NAT2*14;hydralazine;Chemical;PA165981640;Haplotype
NAT2;hydralazine;Chemical;PA18;Gene
HLA-DRB1;hydralazine;Chemical;PA35072;Gene
CFTR;rs121909041;Variant;PA109;Gene
IVACAFTOR;rs121909041;Variant;PA165950341;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs121909041;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs121909041;Variant;PA443829;Disease
CFTR;rs201759207;Variant;PA109;Gene
IVACAFTOR;rs201759207;Variant;PA165950341;Chemical
NEUROPATHIC PAIN;HLA-B*15:21;Haplotype;PA162263525;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*15:21;Haplotype;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-B*15:21;Haplotype;PA166120929;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*15:21;Haplotype;PA444059;Disease
EPILEPSY;HLA-B*15:21;Haplotype;PA444065;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*15:21;Haplotype;PA445738;Disease
MOOD DISORDERS;HLA-B*15:21;Haplotype;PA447209;Disease
CARBAMAZEPINE;HLA-B*15:21;Haplotype;PA448785;Chemical
CYP2D6;protriptyline;Chemical;PA128;Gene
PEGINTERFERON ALFA-2B;HLA-C*03:02;Haplotype;PA164784024;Chemical
DRUG-INDUCED LIVER INJURY;HLA-C*03:02;Haplotype;PA166119041;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-C*03:02;Haplotype;PA166120929;Disease
DRUG HYPERSENSITIVITY;HLA-C*03:02;Haplotype;PA443936;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-C*03:02;Haplotype;PA444059;Disease
EPILEPSY;HLA-C*03:02;Haplotype;PA444065;Disease
EXANTHEMA;HLA-C*03:02;Haplotype;PA444109;Disease
HEPATITIS C;HLA-C*03:02;Haplotype;PA444445;Disease
KIDNEY FAILURE, CHRONIC;HLA-C*03:02;Haplotype;PA444684;Disease
STEVENS-JOHNSON SYNDROME;HLA-C*03:02;Haplotype;PA445738;Disease
HIV INFECTIONS;HLA-C*03:02;Haplotype;PA447230;Disease
ALLOPURINOL;HLA-C*03:02;Haplotype;PA448320;Chemical
AMOXICILLIN;HLA-C*03:02;Haplotype;PA448406;Chemical
CARBAMAZEPINE;HLA-C*03:02;Haplotype;PA448785;Chemical
NEVIRAPINE;HLA-C*03:02;Haplotype;PA450616;Chemical
RIBAVIRIN;HLA-C*03:02;Haplotype;PA451241;Chemical
CYP2J2;mesoridazine;Chemical;PA27112;Gene
FLUOROURACIL;rs1801160;Variant;PA128406956;Chemical
DPYD;rs1801160;Variant;PA145;Gene
NEOPLASMS;rs1801160;Variant;PA445062;Disease
CAPECITABINE;rs1801160;Variant;PA448771;Chemical
RS12746200;Pyrazolones;Chemical;PA166153862;Variant
RS1805034;Pyrazolones;Chemical;PA166155281;Variant
RS2228246;Pyrazolones;Chemical;PA166155921;Variant
PLA2G4A;Pyrazolones;Chemical;PA271;Gene
PLCG1;Pyrazolones;Chemical;PA33392;Gene
TNFRSF11A;Pyrazolones;Chemical;PA36601;Gene
VITAMIN B-COMPLEX, PLAIN;rs1801394;Variant;PA10505;Chemical
SEDATION;rs1801394;Variant;PA166129521;Disease
JUVENILE RHEUMATOID ARTHRITIS;rs1801394;Variant;PA443433;Disease
RHEUMATOID ARTHRITIS;rs1801394;Variant;PA443434;Disease
DRUG TOXICITY;rs1801394;Variant;PA443937;Disease
LYMPHOMA;rs1801394;Variant;PA444840;Disease
OSTEOSARCOMA;rs1801394;Variant;PA445601;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs1801394;Variant;PA446155;Disease
MIGRAINE WITH AURA;rs1801394;Variant;PA447004;Disease
FOLIC ACID;rs1801394;Variant;PA449692;Chemical
METHOTREXATE;rs1801394;Variant;PA450428;Chemical
SEVOFLURANE;rs1801394;Variant;PA451341;Chemical
RYR1;Myopathy, Central Core;Disease;PA34896;Gene
HEROIN DEPENDENCE;OPRL1;Gene;PA444460;Disease
OPIOID-RELATED DISORDERS;OPRL1;Gene;PA445043;Disease
METHADONE;OPRL1;Gene;PA450401;Chemical
OPIOIDS;OPRL1;Gene;PA452618;Chemical
ALCOHOL ABUSE;THSD7B;Gene;PA443309;Disease
ETHANOL;THSD7B;Gene;PA448073;Chemical
CELECOXIB;ATP2A3;Gene;PA448871;Chemical
ALCOHOL ABUSE;SLC4A8;Gene;PA443309;Disease
ETHANOL;SLC4A8;Gene;PA448073;Chemical
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART);rs671531;Variant;PA166177229;Chemical
HIV INFECTIOUS DISEASE;rs671531;Variant;PA447230;Disease
HLA-B*59:01;acetazolamide;Chemical;PA165956674;Haplotype
HLA-B;acetazolamide;Chemical;PA35056;Gene
CYP2C9;Pulmonary Embolism;Disease;PA126;Gene
CYP2C9*1;Pulmonary Embolism;Disease;PA165816542;Haplotype
CYP2C9*3;Pulmonary Embolism;Disease;PA165816544;Haplotype
TAMOXIFEN;CCNA2;Gene;PA451581;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;TRIB3;Gene;PA447197;Disease
METHYLPHENIDATE;TRIB3;Gene;PA450464;Chemical
TOXIC LIVER DISEASE;HLA-C*14:03;Haplotype;PA164925725;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-C*14:03;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-C*14:03;Haplotype;PA445738;Disease
ACETAMINOPHEN;HLA-C*14:03;Haplotype;PA448015;Chemical
TICLOPIDINE;HLA-C*14:03;Haplotype;PA451686;Chemical
CYP2D6;colchicine;Chemical;PA128;Gene
CYP2D6*1;colchicine;Chemical;PA165816576;Haplotype
CYP2D6*4;colchicine;Chemical;PA165816579;Haplotype
ABCB1;colchicine;Chemical;PA267;Gene
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-A*68:01;Haplotype;PA166120929;Disease
LAMOTRIGINE;HLA-A*68:01;Haplotype;PA450164;Chemical
PLATINUM COMPOUNDS;rs11868547;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs11868547;Variant;PA443622;Disease
UGT1A1*1;Unconsciousness;Disease;PA166115841;Haplotype
UGT1A1*28;Unconsciousness;Disease;PA166115842;Haplotype
UGT1A1;Unconsciousness;Disease;PA420;Gene
DIABETES MELLITUS, TYPE 2;rs594709;Variant;PA443890;Disease
METFORMIN;rs594709;Variant;PA450395;Chemical
EPILEPSY;CYP2C9*37;Haplotype;PA444065;Disease
DICLOFENAC;CYP2C9*37;Haplotype;PA449293;Chemical
PHENYTOIN;CYP2C9*37;Haplotype;PA450947;Chemical
RS113488022;trametinib;Chemical;PA166157522;Variant
BRAF;trametinib;Chemical;PA25408;Gene
G6PD;trametinib;Chemical;PA28469;Gene
HRAS;trametinib;Chemical;PA29444;Gene
KRAS;trametinib;Chemical;PA30196;Gene
NRAS;trametinib;Chemical;PA31768;Gene
TOLBUTAMIDE;rs9332239;Variant;PA451718;Chemical
PYRAZOLONES;rs2228246;Variant;PA164713217;Chemical
ACETAMINOPHEN;rs2228246;Variant;PA448015;Chemical
ASPIRIN;rs2228246;Variant;PA448497;Chemical
DICLOFENAC;rs2228246;Variant;PA449293;Chemical
PROPIONIC ACID DERIVATIVES;rs2228246;Variant;PA451140;Chemical
NEPHROTOXICITY;rs3824662;Variant;PA162263533;Disease
PEGASPARGASE;rs3824662;Variant;PA164760860;Chemical
GLUCARPIDASE;rs3824662;Variant;PA165949771;Chemical
ASPARAGINASE;rs3824662;Variant;PA448492;Chemical
CYCLOPHOSPHAMIDE;rs3824662;Variant;PA449165;Chemical
CYTARABINE;rs3824662;Variant;PA449177;Chemical
DAUNORUBICIN;rs3824662;Variant;PA449212;Chemical
DEXAMETHASONE;rs3824662;Variant;PA449247;Chemical
DOXORUBICIN;rs3824662;Variant;PA449412;Chemical
LEUCOVORIN;rs3824662;Variant;PA450198;Chemical
MERCAPTOPURINE;rs3824662;Variant;PA450379;Chemical
METHOTREXATE;rs3824662;Variant;PA450428;Chemical
PREDNISONE;rs3824662;Variant;PA451100;Chemical
THIOGUANINE;rs3824662;Variant;PA451663;Chemical
VINCRISTINE;rs3824662;Variant;PA451879;Chemical
RS2070744;Antihypertensives And Diuretics In Combination;Chemical;PA166157325;Variant
NOS3;Antihypertensives And Diuretics In Combination;Chemical;PA254;Gene
BREAST NEOPLASMS;rs6151031;Variant;PA443560;Disease
DRUG TOXICITY;rs6151031;Variant;PA443937;Disease
NEOPLASMS;rs6151031;Variant;PA445062;Disease
CARBOPLATIN;rs6151031;Variant;PA448803;Chemical
CYCLOPHOSPHAMIDE;rs6151031;Variant;PA449165;Chemical
DOXORUBICIN;rs6151031;Variant;PA449412;Chemical
THIOTEPA;rs6151031;Variant;PA451668;Chemical
TOXIC LIVER DISEASE;HLA-C*02:10;Haplotype;PA164925725;Disease
HIV INFECTIONS;HLA-C*02:10;Haplotype;PA447230;Disease
NEVIRAPINE;HLA-C*02:10;Haplotype;PA450616;Chemical
SCHIZOPHRENIA;rs28379954;Variant;PA447216;Disease
CLOZAPINE;rs28379954;Variant;PA449061;Chemical
COMT;Ototoxicity;Disease;PA117;Gene
TPMT*1;Ototoxicity;Disease;PA165819268;Haplotype
TPMT*3A;Ototoxicity;Disease;PA165819270;Haplotype
TPMT*3B;Ototoxicity;Disease;PA165819271;Haplotype
TPMT*3C;Ototoxicity;Disease;PA165819272;Haplotype
GSTM1 NULL;Ototoxicity;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Ototoxicity;Disease;PA166048676;Haplotype
GSTT1 NULL;Ototoxicity;Disease;PA166048678;Haplotype
GSTT1 NON-NULL;Ototoxicity;Disease;PA166048679;Haplotype
RS1695;Ototoxicity;Disease;PA166154249;Variant
RS1051640;Ototoxicity;Disease;PA166155176;Variant
RS1872328;Ototoxicity;Disease;PA166155651;Variant
RS4646316;Ototoxicity;Disease;PA166156108;Variant
RS9332377;Ototoxicity;Disease;PA166156133;Variant
RS2228001;Ototoxicity;Disease;PA166156345;Variant
RS316019;Ototoxicity;Disease;PA166156913;Variant
RS1142345;Ototoxicity;Disease;PA166156978;Variant
RS267606618;Ototoxicity;Disease;PA166158908;Variant
RS267606619;Ototoxicity;Disease;PA166158909;Variant
RS28358569;Ototoxicity;Disease;PA166158910;Variant
RS267606617;Ototoxicity;Disease;PA166159181;Variant
RS4788863;Ototoxicity;Disease;PA166163715;Variant
RS28358571;Ototoxicity;Disease;PA166229161;Variant
RS28358572;Ototoxicity;Disease;PA166229181;Variant
RS1556422499;Ototoxicity;Disease;PA166241841;Variant
RS1603218569;Ototoxicity;Disease;PA166241901;Variant
GSTM1;Ototoxicity;Disease;PA182;Gene
GSTT1;Ototoxicity;Disease;PA183;Gene
ACYP2;Ototoxicity;Disease;PA24500;Gene
GSTP1;Ototoxicity;Disease;PA29028;Gene
MT-ND1;Ototoxicity;Disease;PA31259;Gene
MT-RNR1;Ototoxicity;Disease;PA31274;Gene
SLC22A2;Ototoxicity;Disease;PA331;Gene
TPMT;Ototoxicity;Disease;PA356;Gene
SLC16A5;Ototoxicity;Disease;PA35817;Gene
XPC;Ototoxicity;Disease;PA37413;Gene
ABCC3;Ototoxicity;Disease;PA376;Gene
GEFITINIB;rs8904;Variant;PA131301952;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs8904;Variant;PA443622;Disease
EXANTHEMA;rs8904;Variant;PA444109;Disease
DEPRESSIVE DISORDER;rs2032583;Variant;PA447207;Disease
DEPRESSION;rs2032583;Variant;PA447278;Disease
MAJOR DEPRESSIVE DISORDER;rs2032583;Variant;PA447321;Disease
AMITRIPTYLINE;rs2032583;Variant;PA448385;Chemical
CITALOPRAM;rs2032583;Variant;PA449015;Chemical
FLUVOXAMINE;rs2032583;Variant;PA449690;Chemical
PAROXETINE;rs2032583;Variant;PA450801;Chemical
SERTRALINE;rs2032583;Variant;PA451333;Chemical
VENLAFAXINE;rs2032583;Variant;PA451866;Chemical
ANTIDEPRESSANTS;rs2032583;Variant;PA452229;Chemical
RS2770150;Pertussis vaccines;Chemical;PA166157757;Variant
RS4986790;Pertussis vaccines;Chemical;PA166157780;Variant
TLR4;Pertussis vaccines;Chemical;PA36552;Gene
CYP2C9;over-anticoagulation;Disease;PA126;Gene
VKORC1;over-anticoagulation;Disease;PA133787052;Gene
CYP2C9*1;over-anticoagulation;Disease;PA165816542;Haplotype
CYP2C9*2;over-anticoagulation;Disease;PA165816543;Haplotype
CYP2C9*3;over-anticoagulation;Disease;PA165816544;Haplotype
CYP2C9*5;over-anticoagulation;Disease;PA165816546;Haplotype
CYP2C9*6;over-anticoagulation;Disease;PA165816547;Haplotype
CYP2C9*11;over-anticoagulation;Disease;PA165816552;Haplotype
RS9923231;over-anticoagulation;Disease;PA166155091;Variant
RS2108622;over-anticoagulation;Disease;PA166155381;Variant
CYP4F2;over-anticoagulation;Disease;PA27121;Gene
CYP3A4;bleomycin;Chemical;PA130;Gene
ERCC1;bleomycin;Chemical;PA155;Gene
GSTM1 NULL;bleomycin;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;bleomycin;Chemical;PA166048676;Haplotype
RS1695;bleomycin;Chemical;PA166154249;Variant
RS1050565;bleomycin;Chemical;PA166155175;Variant
RS11615;bleomycin;Chemical;PA166155342;Variant
RS13181;bleomycin;Chemical;PA166155343;Variant
RS238406;bleomycin;Chemical;PA166155349;Variant
RS1799793;bleomycin;Chemical;PA166155371;Variant
RS3212986;bleomycin;Chemical;PA166155407;Variant
RS1045642;bleomycin;Chemical;PA166157284;Variant
RS2229109;bleomycin;Chemical;PA166157334;Variant
RS2740574;bleomycin;Chemical;PA166157367;Variant
GSTM1;bleomycin;Chemical;PA182;Gene
BLMH;bleomycin;Chemical;PA25370;Gene
ABCB1;bleomycin;Chemical;PA267;Gene
ERCC2;bleomycin;Chemical;PA27848;Gene
GSTP1;bleomycin;Chemical;PA29028;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;IL12B;Gene;PA164713366;Chemical
USTEKINUMAB;IL12B;Gene;PA166048654;Chemical
PSORIASIS;IL12B;Gene;PA445451;Disease
SMN2;nusinersen;Chemical;PA35967;Gene
CYP2D6;palonosetron;Chemical;PA128;Gene
ERCC1;palonosetron;Chemical;PA155;Gene
RS3212986;palonosetron;Chemical;PA166155407;Variant
NEOPLASMS;rs2228171;Variant;PA445062;Disease
CISPLATIN;rs2228171;Variant;PA449014;Chemical
ABCC2;cyclophosphamide;Chemical;PA116;Gene
CYP2B6;cyclophosphamide;Chemical;PA123;Gene
CYP2C19;cyclophosphamide;Chemical;PA124;Gene
CYP2C8;cyclophosphamide;Chemical;PA125;Gene
CYP2C9;cyclophosphamide;Chemical;PA126;Gene
CYP2E1;cyclophosphamide;Chemical;PA129;Gene
CYP3A4;cyclophosphamide;Chemical;PA130;Gene
CYP3A5;cyclophosphamide;Chemical;PA131;Gene
SLCO1B1;cyclophosphamide;Chemical;PA134865839;Gene
SLC22A16;cyclophosphamide;Chemical;PA134911502;Gene
PERP;cyclophosphamide;Chemical;PA134944221;Gene
GNL3;cyclophosphamide;Chemical;PA134952132;Gene
DROSHA;cyclophosphamide;Chemical;PA142671060;Gene
ERCC1;cyclophosphamide;Chemical;PA155;Gene
TP53AIP1;cyclophosphamide;Chemical;PA164726680;Gene
LINC00251;cyclophosphamide;Chemical;PA165585763;Gene
CYP2B6*1;cyclophosphamide;Chemical;PA165818750;Haplotype
CYP2B6*5;cyclophosphamide;Chemical;PA165818760;Haplotype
CYP2B6*6;cyclophosphamide;Chemical;PA165818762;Haplotype
CYP2B6*7;cyclophosphamide;Chemical;PA165818765;Haplotype
CYP2B6*29;cyclophosphamide;Chemical;PA165818813;Haplotype
CYP2C8*4;cyclophosphamide;Chemical;PA165958686;Haplotype
CYP2C19*1;cyclophosphamide;Chemical;PA165980634;Haplotype
CYP2C19*2;cyclophosphamide;Chemical;PA165980635;Haplotype
GSTM1 NULL;cyclophosphamide;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;cyclophosphamide;Chemical;PA166048676;Haplotype
GSTT1 NULL;cyclophosphamide;Chemical;PA166048678;Haplotype
GSTT1 NON-NULL;cyclophosphamide;Chemical;PA166048679;Haplotype
CYP2B6*30;cyclophosphamide;Chemical;PA166117272;Haplotype
CYP3A5*1;cyclophosphamide;Chemical;PA166128213;Haplotype
CYP3A5*3;cyclophosphamide;Chemical;PA166128219;Haplotype
RS1051740;cyclophosphamide;Chemical;PA166153612;Variant
RS1891059;cyclophosphamide;Chemical;PA166153658;Variant
RS3219484;cyclophosphamide;Chemical;PA166153742;Variant
RS17021408;cyclophosphamide;Chemical;PA166153867;Variant
RS80223967;cyclophosphamide;Chemical;PA166153915;Variant
RS2070676;cyclophosphamide;Chemical;PA166153994;Variant
RS2273697;cyclophosphamide;Chemical;PA166154007;Variant
RS3740066;cyclophosphamide;Chemical;PA166154028;Variant
RS3824662;cyclophosphamide;Chemical;PA166154043;Variant
RS4244285;cyclophosphamide;Chemical;PA166154053;Variant
RS6413432;cyclophosphamide;Chemical;PA166154073;Variant
RS12248560;cyclophosphamide;Chemical;PA166154147;Variant
RS1695;cyclophosphamide;Chemical;PA166154249;Variant
RS11226;cyclophosphamide;Chemical;PA166154490;Variant
RS4149056;cyclophosphamide;Chemical;PA166154579;Variant
RS9561778;cyclophosphamide;Chemical;PA166154741;Variant
RS1800566;cyclophosphamide;Chemical;PA166155017;Variant
RS1052536;cyclophosphamide;Chemical;PA166155177;Variant
RS2228100;cyclophosphamide;Chemical;PA166155201;Variant
RS4148416;cyclophosphamide;Chemical;PA166155219;Variant
RS11615;cyclophosphamide;Chemical;PA166155342;Variant
RS25487;cyclophosphamide;Chemical;PA166155346;Variant
RS2279343;cyclophosphamide;Chemical;PA166155393;Variant
RS3211371;cyclophosphamide;Chemical;PA166155405;Variant
RS3212986;cyclophosphamide;Chemical;PA166155407;Variant
RS3745274;cyclophosphamide;Chemical;PA166155409;Variant
RS4802101;cyclophosphamide;Chemical;PA166155415;Variant
RS7254579;cyclophosphamide;Chemical;PA166155433;Variant
RS8192709;cyclophosphamide;Chemical;PA166155442;Variant
RS12721655;cyclophosphamide;Chemical;PA166155467;Variant
RS1056836;cyclophosphamide;Chemical;PA166155621;Variant
RS79085477;cyclophosphamide;Chemical;PA166155968;Variant
RS117532069;cyclophosphamide;Chemical;PA166155970;Variant
RS20572;cyclophosphamide;Chemical;PA166155974;Variant
RS4135385;cyclophosphamide;Chemical;PA166156394;Variant
RS698;cyclophosphamide;Chemical;PA166156476;Variant
RS2231142;cyclophosphamide;Chemical;PA166156544;Variant
RS351855;cyclophosphamide;Chemical;PA166156731;Variant
RS639174;cyclophosphamide;Chemical;PA166156737;Variant
RS4880;cyclophosphamide;Chemical;PA166156900;Variant
RS714368;cyclophosphamide;Chemical;PA166156940;Variant
RS723685;cyclophosphamide;Chemical;PA166156941;Variant
RS1142345;cyclophosphamide;Chemical;PA166156978;Variant
RS1143684;cyclophosphamide;Chemical;PA166156979;Variant
RS1570360;cyclophosphamide;Chemical;PA166156985;Variant
RS2010963;cyclophosphamide;Chemical;PA166157006;Variant
RS3957356;cyclophosphamide;Chemical;PA166157093;Variant
RS3957357;cyclophosphamide;Chemical;PA166157094;Variant
RS6907567;cyclophosphamide;Chemical;PA166157112;Variant
RS12210538;cyclophosphamide;Chemical;PA166157179;Variant
RS1045642;cyclophosphamide;Chemical;PA166157284;Variant
RS1128503;cyclophosphamide;Chemical;PA166157288;Variant
RS1799983;cyclophosphamide;Chemical;PA166157303;Variant
RS2032582;cyclophosphamide;Chemical;PA166157316;Variant
RS2070744;cyclophosphamide;Chemical;PA166157325;Variant
RS2229109;cyclophosphamide;Chemical;PA166157334;Variant
RS2740574;cyclophosphamide;Chemical;PA166157367;Variant
RS4148737;cyclophosphamide;Chemical;PA166157385;Variant
RS1801280;cyclophosphamide;Chemical;PA166157570;Variant
RS141059755;cyclophosphamide;Chemical;PA166157691;Variant
RS6151031;cyclophosphamide;Chemical;PA166157783;Variant
CYP2C9 POOR METABOLIZER;cyclophosphamide;Chemical;PA166157932;Variant
RS1801157;cyclophosphamide;Chemical;PA166159131;Variant
RS1799735;cyclophosphamide;Chemical;PA166159214;Variant
RS1021737;cyclophosphamide;Chemical;PA166161880;Variant
RS12050587;cyclophosphamide;Chemical;PA166164874;Variant
RS11636687;cyclophosphamide;Chemical;PA166164877;Variant
RS738409;cyclophosphamide;Chemical;PA166165078;Variant
RS144991623;cyclophosphamide;Chemical;PA166178395;Variant
RS9389568;cyclophosphamide;Chemical;PA166178396;Variant
RS8110364;cyclophosphamide;Chemical;PA166178397;Variant
RS56022120;cyclophosphamide;Chemical;PA166178398;Variant
RS150688309;cyclophosphamide;Chemical;PA166178399;Variant
RS58695150;cyclophosphamide;Chemical;PA166178400;Variant
RS299293;cyclophosphamide;Chemical;PA166178401;Variant
RS138602176;cyclophosphamide;Chemical;PA166178402;Variant
RS148235907;cyclophosphamide;Chemical;PA166178403;Variant
RS117951771;cyclophosphamide;Chemical;PA166178404;Variant
RS299314;cyclophosphamide;Chemical;PA166178405;Variant
RS299313;cyclophosphamide;Chemical;PA166178406;Variant
RS115457081;cyclophosphamide;Chemical;PA166178407;Variant
RS117341846;cyclophosphamide;Chemical;PA166178408;Variant
RS4968187;cyclophosphamide;Chemical;PA166178409;Variant
RS142244113;cyclophosphamide;Chemical;PA166178410;Variant
RS79430272;cyclophosphamide;Chemical;PA166178411;Variant
RS118129530;cyclophosphamide;Chemical;PA166178412;Variant
RS77769901;cyclophosphamide;Chemical;PA166178413;Variant
RS145623321;cyclophosphamide;Chemical;PA166178414;Variant
RS148013902;cyclophosphamide;Chemical;PA166178415;Variant
RS55633228;cyclophosphamide;Chemical;PA166178416;Variant
RS41412545;cyclophosphamide;Chemical;PA166178421;Variant
RS3805945;cyclophosphamide;Chemical;PA166178422;Variant
RS117101815;cyclophosphamide;Chemical;PA166178423;Variant
RS9402944;cyclophosphamide;Chemical;PA166178424;Variant
RS181501757;cyclophosphamide;Chemical;PA166178425;Variant
RS149212925;cyclophosphamide;Chemical;PA166178426;Variant
RS112783657;cyclophosphamide;Chemical;PA166178427;Variant
RS74743371;cyclophosphamide;Chemical;PA166178428;Variant
RS117458836;cyclophosphamide;Chemical;PA166178429;Variant
RS118088833;cyclophosphamide;Chemical;PA166178430;Variant
RS112242273;cyclophosphamide;Chemical;PA166178431;Variant
RS78428806;cyclophosphamide;Chemical;PA166178432;Variant
RS141084494;cyclophosphamide;Chemical;PA166178541;Variant
RS1801516;cyclophosphamide;Chemical;PA166180286;Variant
RS36120609;cyclophosphamide;Chemical;PA166211543;Variant
CYP2C8*1;cyclophosphamide;Chemical;PA166242948;Haplotype
RS12283870;cyclophosphamide;Chemical;PA166285621;Variant
NAT2;cyclophosphamide;Chemical;PA18;Gene
GSTM1;cyclophosphamide;Chemical;PA182;Gene
GSTT1;cyclophosphamide;Chemical;PA183;Gene
INSR;cyclophosphamide;Chemical;PA202;Gene
IRS1;cyclophosphamide;Chemical;PA203;Gene
ADH1C;cyclophosphamide;Chemical;PA24572;Gene
ALDH1A1;cyclophosphamide;Chemical;PA24692;Gene
ALDH3A1;cyclophosphamide;Chemical;PA24697;Gene
NOS1;cyclophosphamide;Chemical;PA252;Gene
BMP7;cyclophosphamide;Chemical;PA25384;Gene
NOS3;cyclophosphamide;Chemical;PA254;Gene
DOK5;cyclophosphamide;Chemical;PA25724;Gene
CBR1;cyclophosphamide;Chemical;PA26121;Gene
CBR3;cyclophosphamide;Chemical;PA26122;Gene
CCNK;cyclophosphamide;Chemical;PA26161;Gene
ABCB1;cyclophosphamide;Chemical;PA267;Gene
CPT1A;cyclophosphamide;Chemical;PA26847;Gene
CTH;cyclophosphamide;Chemical;PA27004;Gene
CTNNB1;cyclophosphamide;Chemical;PA27013;Gene
CYP1B1;cyclophosphamide;Chemical;PA27094;Gene
CYP2A7P1;cyclophosphamide;Chemical;PA27103;Gene
EPHX1;cyclophosphamide;Chemical;PA27829;Gene
FGFR4;cyclophosphamide;Chemical;PA28130;Gene
FOXO1;cyclophosphamide;Chemical;PA28237;Gene
GATA3;cyclophosphamide;Chemical;PA28586;Gene
GSTA1;cyclophosphamide;Chemical;PA29016;Gene
GSTM3;cyclophosphamide;Chemical;PA29024;Gene
GSTP1;cyclophosphamide;Chemical;PA29028;Gene
HMMR;cyclophosphamide;Chemical;PA29340;Gene
IGHMBP2;cyclophosphamide;Chemical;PA29731;Gene
LIG3;cyclophosphamide;Chemical;PA30374;Gene
MUTYH;cyclophosphamide;Chemical;PA31328;Gene
NQO1;cyclophosphamide;Chemical;PA31744;Gene
NQO2;cyclophosphamide;Chemical;PA31745;Gene
PIGB;cyclophosphamide;Chemical;PA33290;Gene
PIK3R2;cyclophosphamide;Chemical;PA33313;Gene
PPP2R5D;cyclophosphamide;Chemical;PA33676;Gene
RAD52;cyclophosphamide;Chemical;PA34180;Gene
RBX1;cyclophosphamide;Chemical;PA34299;Gene
TOP2A;cyclophosphamide;Chemical;PA354;Gene
TPMT;cyclophosphamide;Chemical;PA356;Gene
CXCL12;cyclophosphamide;Chemical;PA35602;Gene
SOD2;cyclophosphamide;Chemical;PA36017;Gene
TP53;cyclophosphamide;Chemical;PA36679;Gene
XRCC1;cyclophosphamide;Chemical;PA369;Gene
VEGFA;cyclophosphamide;Chemical;PA37302;Gene
ABCC3;cyclophosphamide;Chemical;PA376;Gene
NR1I2;cyclophosphamide;Chemical;PA378;Gene
PNPLA3;cyclophosphamide;Chemical;PA38592;Gene
ABCG2;cyclophosphamide;Chemical;PA390;Gene
ABCC4;cyclophosphamide;Chemical;PA397;Gene
ATM;cyclophosphamide;Chemical;PA61;Gene
ESR1;elacestrant;Chemical;PA156;Gene
ERBB2;elacestrant;Chemical;PA27844;Gene
HEROIN DEPENDENCE;rs7118900;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs7118900;Variant;PA445043;Disease
METHADONE;rs7118900;Variant;PA450401;Chemical
METABOLIC SYNDROME;C3;Gene;PA162370415;Disease
CLOZAPINE;C3;Gene;PA449061;Chemical
MIDAZOLAM;CYP3A4*41;Haplotype;PA450496;Chemical
ADALIMUMAB;FCGR2A;Gene;PA10004;Chemical
CETUXIMAB;FCGR2A;Gene;PA10040;Chemical
MARGETUXIMAB;FCGR2A;Gene;PA166235241;Chemical
RHEUMATOID ARTHRITIS;FCGR2A;Gene;PA443434;Disease
BREAST NEOPLASMS;FCGR2A;Gene;PA443560;Disease
HEAD AND NECK NEOPLASMS;FCGR2A;Gene;PA444352;Disease
PSORIASIS;FCGR2A;Gene;PA445451;Disease
COLORECTAL NEOPLASMS;FCGR2A;Gene;PA446108;Disease
ETANERCEPT;FCGR2A;Gene;PA449515;Chemical
RITUXIMAB;FCGR2A;Gene;PA451261;Chemical
TRASTUZUMAB;FCGR2A;Gene;PA451743;Chemical
INFLIXIMAB;FCGR2A;Gene;PA452639;Chemical
TRANSPLANTATION;rs5744247;Variant;PA134850491;Disease
TACROLIMUS;rs5744247;Variant;PA451578;Chemical
CYP2C19;belzutifan;Chemical;PA124;Gene
CYP2C19*2;belzutifan;Chemical;PA165980635;Haplotype
CYP2C19*3;belzutifan;Chemical;PA165980636;Haplotype
UGT2B17;belzutifan;Chemical;PA37189;Gene
VHL;belzutifan;Chemical;PA37307;Gene
FLUOROURACIL;rs376073289;Variant;PA128406956;Chemical
DRUG TOXICITY;rs376073289;Variant;PA443937;Disease
CYP3A4;vemurafenib;Chemical;PA130;Gene
RS113488022;vemurafenib;Chemical;PA166157522;Variant
BRAF;vemurafenib;Chemical;PA25408;Gene
ABCB1;vemurafenib;Chemical;PA267;Gene
CYP1A2;vemurafenib;Chemical;PA27093;Gene
HRAS;vemurafenib;Chemical;PA29444;Gene
KRAS;vemurafenib;Chemical;PA30196;Gene
NRAS;vemurafenib;Chemical;PA31768;Gene
DIARRHEA;rs9927200;Variant;PA443899;Disease
SORAFENIB;rs9927200;Variant;PA7000;Chemical
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;F11;Gene;PA452637;Chemical
RS1045642;methylprednisolone;Chemical;PA166157284;Variant
RS1799762;methylprednisolone;Chemical;PA166282801;Variant
SERPINE1;methylprednisolone;Chemical;PA261;Gene
ABCB1;methylprednisolone;Chemical;PA267;Gene
RHEUMATOID ARTHRITIS;rs7624766;Variant;PA443434;Disease
METHOTREXATE;rs7624766;Variant;PA450428;Chemical
METFORMIN;rs34834489;Variant;PA450395;Chemical
CETUXIMAB;KRAS;Gene;PA10040;Chemical
PANITUMUMAB;KRAS;Gene;PA162373091;Chemical
VEMURAFENIB;KRAS;Gene;PA165946873;Chemical
DABRAFENIB;KRAS;Gene;PA166114911;Chemical
REGORAFENIB;KRAS;Gene;PA166114943;Chemical
TRAMETINIB;KRAS;Gene;PA166115364;Chemical
RS113488022;KRAS;Gene;PA166157522;Variant
RS121913530;KRAS;Gene;PA166165415;Variant
ENCORAFENIB;KRAS;Gene;PA166179872;Chemical
RAMUCIRUMAB;KRAS;Gene;PA166184558;Chemical
TIPIRACIL / TRIFLURIDINE;KRAS;Gene;PA166184566;Chemical
TUCATINIB;KRAS;Gene;PA166225141;Chemical
ADAGRASIB;KRAS;Gene;PA166246421;Chemical
SOTORASIB;KRAS;Gene;PA166246441;Chemical
FRUQUINTINIB;KRAS;Gene;PA166328842;Chemical
ARAF;KRAS;Gene;PA24928;Gene
BRAF;KRAS;Gene;PA25408;Gene
CRK;KRAS;Gene;PA26880;Gene
FGFR1;KRAS;Gene;PA28127;Gene
FLT1;KRAS;Gene;PA28180;Gene
FLT3;KRAS;Gene;PA28181;Gene
FLT4;KRAS;Gene;PA28183;Gene
KDR;KRAS;Gene;PA30086;Gene
KIT;KRAS;Gene;PA30128;Gene
MAP3K1;KRAS;Gene;PA30592;Gene
PDGFRB;KRAS;Gene;PA33148;Gene
RAF1;KRAS;Gene;PA34183;Gene
RET;KRAS;Gene;PA34335;Gene
CARCINOMA, NON-SMALL-CELL LUNG;KRAS;Gene;PA443622;Disease
NEOPLASMS;KRAS;Gene;PA445062;Disease
STOMACH NEOPLASMS;KRAS;Gene;PA445742;Disease
COLORECTAL NEOPLASMS;KRAS;Gene;PA446108;Disease
AZACITIDINE;KRAS;Gene;PA451996;Chemical
EGFR;KRAS;Gene;PA7360;Gene
ADRB1;Angina, Unstable;Disease;PA38;Gene
CYP2C19;trimipramine;Chemical;PA124;Gene
CYP2C9;trimipramine;Chemical;PA126;Gene
CYP2D6;trimipramine;Chemical;PA128;Gene
CYP2C9*1;trimipramine;Chemical;PA165816542;Haplotype
CYP2C9*3;trimipramine;Chemical;PA165816544;Haplotype
CYP2D6*1;trimipramine;Chemical;PA165816576;Haplotype
CYP2D6*3;trimipramine;Chemical;PA165816578;Haplotype
CYP2D6*4;trimipramine;Chemical;PA165816579;Haplotype
CYP2D6*6;trimipramine;Chemical;PA165816581;Haplotype
CYP2D6*5;trimipramine;Chemical;PA165948092;Haplotype
CYP2C19*1;trimipramine;Chemical;PA165980634;Haplotype
CYP2C19*2;trimipramine;Chemical;PA165980635;Haplotype
CYP2D6*2XN;trimipramine;Chemical;PA165988480;Haplotype
BTK;pirtobrutinib;Chemical;PA25454;Gene
IGH;pirtobrutinib;Chemical;PA35106;Gene
TP53;pirtobrutinib;Chemical;PA36679;Gene
DEXTROMETHORPHAN;CYP2D6*56;Haplotype;PA449273;Chemical
GASTROESOPHAGEAL REFLUX;CYP2C19*24;Haplotype;PA444255;Disease
CLOPIDOGREL;CYP2C19*24;Haplotype;PA449053;Chemical
MEPHENYTOIN;CYP2C19*24;Haplotype;PA450373;Chemical
OMEPRAZOLE;CYP2C19*24;Haplotype;PA450704;Chemical
ESTRADIOL;rs2369049;Variant;PA449503;Chemical
SKELETAL DYSPLASIA;FGFR3;Gene;PA162373099;Disease
BRIVANIB;FGFR3;Gene;PA164924492;Chemical
ERDAFITINIB;FGFR3;Gene;PA166182720;Chemical
CRK;FGFR3;Gene;PA26880;Gene
FGF2;FGFR3;Gene;PA28115;Gene
PIK3C2A;FGFR3;Gene;PA33304;Gene
PIK3C2B;FGFR3;Gene;PA33305;Gene
URINARY BLADDER NEOPLASMS;FGFR3;Gene;PA443512;Disease
DULOXETINE;rs13093500;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs13093500;Variant;PA447321;Disease
HYPERTENSION;ACY3;Gene;PA444552;Disease
BISOPROLOL;ACY3;Gene;PA448641;Chemical
TAXANES;rs6900017;Variant;PA150481189;Chemical
OVARIAN NEOPLASMS;rs6900017;Variant;PA445204;Disease
CARBOPLATIN;rs6900017;Variant;PA448803;Chemical
SELECTIVE BETA-2-ADRENORECEPTOR AGONISTS;rs2267715;Variant;PA134687887;Chemical
ASTHMA;rs2267715;Variant;PA443450;Disease
SALBUTAMOL;rs2267715;Variant;PA448068;Chemical
MACULOPAPULAR EXANTHEMA;rs78239784;Variant;PA162316739;Disease
PHENYTOIN;rs78239784;Variant;PA450947;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs2232228;Variant;PA130620651;Chemical
CARDIOMYOPATHIES;rs2232228;Variant;PA445018;Disease
PANCREATITIS;CPA2;Gene;PA445220;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;CPA2;Gene;PA446155;Disease
ASPARAGINASE;CPA2;Gene;PA448492;Chemical
NON-SMALL CELL LUNG CARCINOMA;PRRC2A;Gene;PA443622;Disease
THROMBOCYTOPENIA;PRRC2A;Gene;PA445846;Disease
CARBAMAZEPINE;PRRC2A;Gene;PA448785;Chemical
CARBOPLATIN;PRRC2A;Gene;PA448803;Chemical
GEMCITABINE;PRRC2A;Gene;PA449748;Chemical
OVERDOSE;rs116181528;Variant;PA446199;Disease
OPIOIDS;rs116181528;Variant;PA452618;Chemical
DPYD;rs72547601;Variant;PA145;Gene
CAPECITABINE;rs72547601;Variant;PA448771;Chemical
DRUG HYPERSENSITIVITY;LTB;Gene;PA443936;Disease
ABACAVIR;LTB;Gene;PA448004;Chemical
BEVACIZUMAB;VEGFB;Gene;PA130232992;Chemical
AFLIBERCEPT;VEGFB;Gene;PA166118342;Chemical
FLT1;VEGFB;Gene;PA28180;Gene
KDR;VEGFB;Gene;PA30086;Gene
NRP1;VEGFB;Gene;PA31783;Gene
DRUG TOXICITY;VEGFB;Gene;PA443937;Disease
SORAFENIB;VEGFB;Gene;PA7000;Chemical
PANCREATIC NEOPLASMS;DCTD;Gene;PA445218;Disease
GEMCITABINE;DCTD;Gene;PA449748;Chemical
ADVERSE EVENTS;rs76103438;Variant;PA166151827;Disease
SIMVASTATIN;rs76103438;Variant;PA451363;Chemical
ACE;Diabetes Mellitus, Type 1;Disease;PA139;Gene
RS1799752;Diabetes Mellitus, Type 1;Disease;PA166155187;Variant
VDR;Diabetes Mellitus, Type 1;Disease;PA37301;Gene
HYPOTHYROIDISM;Diabetes Mellitus, Type 1;Disease;PA444589;Disease
LDLR;evinacumab;Chemical;PA227;Gene
NR1I2;cyproterone;Chemical;PA378;Gene
SCHIZOPHRENIA;rs2412459;Variant;PA447216;Disease
HALOPERIDOL;rs2412459;Variant;PA449841;Chemical
OLANZAPINE;rs2412459;Variant;PA450688;Chemical
QUETIAPINE;rs2412459;Variant;PA451201;Chemical
RISPERIDONE;rs2412459;Variant;PA451257;Chemical
ZIPRASIDONE;rs2412459;Variant;PA451974;Chemical
FMO3;sulindac;Chemical;PA166;Gene
RS2266780;sulindac;Chemical;PA166153687;Variant
RS2266782;sulindac;Chemical;PA166153688;Variant
ABCC2;tacrolimus;Chemical;PA116;Gene
CYP3A7;tacrolimus;Chemical;PA122;Gene
CYP2C19;tacrolimus;Chemical;PA124;Gene
CYP2C8;tacrolimus;Chemical;PA125;Gene
CYP3A4;tacrolimus;Chemical;PA130;Gene
CYP3A5;tacrolimus;Chemical;PA131;Gene
ZSCAN25;tacrolimus;Chemical;PA134962723;Gene
SUMO4;tacrolimus;Chemical;PA134979206;Gene
CRTC2;tacrolimus;Chemical;PA142672073;Gene
CYP3A4*1;tacrolimus;Chemical;PA165819201;Haplotype
CYP3A4*3;tacrolimus;Chemical;PA165819221;Haplotype
CYP3A4*18;tacrolimus;Chemical;PA165819240;Haplotype
CYP3A4*20;tacrolimus;Chemical;PA165819244;Haplotype
CYP3A7*1A;tacrolimus;Chemical;PA165948045;Haplotype
CYP3A7*1C;tacrolimus;Chemical;PA165948047;Haplotype
CYP2C8*3;tacrolimus;Chemical;PA165958685;Haplotype
CYP2C19*1;tacrolimus;Chemical;PA165980634;Haplotype
CYP2C19*2;tacrolimus;Chemical;PA165980635;Haplotype
CYP3A4*22;tacrolimus;Chemical;PA166048680;Haplotype
CYP3A5*1;tacrolimus;Chemical;PA166128213;Haplotype
CYP3A5*3;tacrolimus;Chemical;PA166128219;Haplotype
CYP3A5*6;tacrolimus;Chemical;PA166128233;Haplotype
CYP3A5*7;tacrolimus;Chemical;PA166128234;Haplotype
RS846908;tacrolimus;Chemical;PA166153595;Variant
RS846910;tacrolimus;Chemical;PA166153596;Variant
RS890293;tacrolimus;Chemical;PA166153598;Variant
RS1800871;tacrolimus;Chemical;PA166153639;Variant
RS1800872;tacrolimus;Chemical;PA166153640;Variant
RS1800896;tacrolimus;Chemical;PA166153642;Variant
RS4844880;tacrolimus;Chemical;PA166153776;Variant
RS11265572;tacrolimus;Chemical;PA166153827;Variant
RS290487;tacrolimus;Chemical;PA166153946;Variant
RS717620;tacrolimus;Chemical;PA166153953;Variant
RS3740066;tacrolimus;Chemical;PA166154028;Variant
RS7903146;tacrolimus;Chemical;PA166154084;Variant
RS5219;tacrolimus;Chemical;PA166154256;Variant
RS1946518;tacrolimus;Chemical;PA166154344;Variant
RS2237895;tacrolimus;Chemical;PA166154355;Variant
RS5744247;tacrolimus;Chemical;PA166154416;Variant
RS2066844;tacrolimus;Chemical;PA166155027;Variant
RS1042597;tacrolimus;Chemical;PA166155614;Variant
RS4553808;tacrolimus;Chemical;PA166155730;Variant
RS5030952;tacrolimus;Chemical;PA166155741;Variant
RS4253728;tacrolimus;Chemical;PA166156105;Variant
RS4823613;tacrolimus;Chemical;PA166156110;Variant
RS2276707;tacrolimus;Chemical;PA166156352;Variant
RS3814055;tacrolimus;Chemical;PA166156383;Variant
RS15524;tacrolimus;Chemical;PA166157243;Variant
RS776746;tacrolimus;Chemical;PA166157267;Variant
RS1045642;tacrolimus;Chemical;PA166157284;Variant
RS1057868;tacrolimus;Chemical;PA166157286;Variant
RS1128503;tacrolimus;Chemical;PA166157288;Variant
RS2032582;tacrolimus;Chemical;PA166157316;Variant
RS2229109;tacrolimus;Chemical;PA166157334;Variant
RS2242480;tacrolimus;Chemical;PA166157345;Variant
RS2740574;tacrolimus;Chemical;PA166157367;Variant
RS4646437;tacrolimus;Chemical;PA166157391;Variant
RS9282564;tacrolimus;Chemical;PA166157435;Variant
RS1927907;tacrolimus;Chemical;PA166157738;Variant
RS3761548;tacrolimus;Chemical;PA166162248;Variant
RS8450;tacrolimus;Chemical;PA166163444;Variant
RS181781;tacrolimus;Chemical;PA166163546;Variant
RS9200;tacrolimus;Chemical;PA166169844;Variant
RS10052999;tacrolimus;Chemical;PA166169847;Variant
RS4646450;tacrolimus;Chemical;PA166176608;Variant
RS237025;tacrolimus;Chemical;PA166176908;Variant
CYP2C8*1;tacrolimus;Chemical;PA166242948;Haplotype
FOXP3;tacrolimus;Chemical;PA201094;Gene
KCNJ11;tacrolimus;Chemical;PA217;Gene
KCNQ1;tacrolimus;Chemical;PA223;Gene
C6;tacrolimus;Chemical;PA25921;Gene
CAPN10;tacrolimus;Chemical;PA26058;Gene
NOD2;tacrolimus;Chemical;PA26074;Gene
ABCB1;tacrolimus;Chemical;PA267;Gene
CTLA4;tacrolimus;Chemical;PA27006;Gene
CYP2J2;tacrolimus;Chemical;PA27112;Gene
PPARA;tacrolimus;Chemical;PA280;Gene
HSD11B1;tacrolimus;Chemical;PA29476;Gene
IL10;tacrolimus;Chemical;PA29778;Gene
IL18;tacrolimus;Chemical;PA29802;Gene
IL3;tacrolimus;Chemical;PA29830;Gene
POR;tacrolimus;Chemical;PA33532;Gene
TCF7L2;tacrolimus;Chemical;PA36394;Gene
TLR4;tacrolimus;Chemical;PA36552;Gene
UGT1A8;tacrolimus;Chemical;PA37183;Gene
NR1I2;tacrolimus;Chemical;PA378;Gene
RS267606619;micronomicin;Chemical;PA166158909;Variant
MT-ND1;micronomicin;Chemical;PA31259;Gene
MT-RNR1;micronomicin;Chemical;PA31274;Gene
CYP2B6;hydroxybupropion;Chemical;PA123;Gene
CYP2C19;hydroxybupropion;Chemical;PA124;Gene
CYP2C19*17;hydroxybupropion;Chemical;PA165816533;Haplotype
CYP2B6*1;hydroxybupropion;Chemical;PA165818750;Haplotype
CYP2B6*6;hydroxybupropion;Chemical;PA165818762;Haplotype
CYP2C19*1;hydroxybupropion;Chemical;PA165980634;Haplotype
ELF2;SLC9A4;Gene;PA27745;Gene
METHOTREXATE;SLC46A1;Gene;PA450428;Chemical
DIABETES MELLITUS;rs658903;Variant;PA443886;Disease
HYPERTENSION;rs658903;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs658903;Variant;PA449899;Chemical
MACULOPAPULAR EXANTHEMA;HLA-B*44:03;Haplotype;PA162316739;Disease
TOXIC LIVER DISEASE;HLA-B*44:03;Haplotype;PA164925725;Disease
TRICHLOROETHYLENE;HLA-B*44:03;Haplotype;PA166115521;Chemical
DRUG HYPERSENSITIVITY;HLA-B*44:03;Haplotype;PA443936;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*44:03;Haplotype;PA444059;Disease
EPILEPSY;HLA-B*44:03;Haplotype;PA444065;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*44:03;Haplotype;PA445738;Disease
ACETAMINOPHEN;HLA-B*44:03;Haplotype;PA448015;Chemical
LAMOTRIGINE;HLA-B*44:03;Haplotype;PA450164;Chemical
TICLOPIDINE;HLA-B*44:03;Haplotype;PA451686;Chemical
PAIN;rs1902023;Variant;PA445208;Disease
ACETAMINOPHEN;rs1902023;Variant;PA448015;Chemical
LORAZEPAM;rs1902023;Variant;PA450267;Chemical
OXAZEPAM;rs1902023;Variant;PA450731;Chemical
DESFLURANE;rs193922772;Variant;PA164749136;Chemical
RYR1;rs193922772;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs193922772;Variant;PA444863;Disease
CAFFEINE;rs193922772;Variant;PA448710;Chemical
ENFLURANE;rs193922772;Variant;PA449461;Chemical
HALOTHANE;rs193922772;Variant;PA449845;Chemical
ISOFLURANE;rs193922772;Variant;PA450106;Chemical
METHOXYFLURANE;rs193922772;Variant;PA450434;Chemical
SEVOFLURANE;rs193922772;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs193922772;Variant;PA451522;Chemical
CACNA1S;rs193922772;Variant;PA85;Gene
CHOLIC ACID;CYP7A1;Gene;PA166160055;Chemical
ATORVASTATIN;CYP7A1;Gene;PA448500;Chemical
TUBERCULOSIS;rs393994;Variant;PA445941;Disease
RIFAMPIN;rs393994;Variant;PA451250;Chemical
GEMCITABINE;rs66878317;Variant;PA449748;Chemical
ESCITALOPRAM;rs9380524;Variant;PA10074;Chemical
MAJOR DEPRESSIVE DISORDER;rs9380524;Variant;PA447321;Disease
CITALOPRAM;rs9380524;Variant;PA449015;Chemical
RS10046;hdl cholesterol;Chemical;PA166154837;Variant
RS2289105;hdl cholesterol;Chemical;PA166154884;Variant
CYP19A1;hdl cholesterol;Chemical;PA27091;Gene
HYPERTENSION;rs12595985;Variant;PA444552;Disease
ATENOLOL;rs12595985;Variant;PA448499;Chemical
COMT;clozapine;Chemical;PA117;Gene
CYP2C19;clozapine;Chemical;PA124;Gene
CYP2D6;clozapine;Chemical;PA128;Gene
CYP3A4;clozapine;Chemical;PA130;Gene
CYP3A5;clozapine;Chemical;PA131;Gene
RABEP1;clozapine;Chemical;PA134884097;Gene
SH2B1;clozapine;Chemical;PA145148084;Gene
DRD1;clozapine;Chemical;PA147;Gene
CYP2C19*17;clozapine;Chemical;PA165816533;Haplotype
CYP1A2*3;clozapine;Chemical;PA165819181;Haplotype
CYP1A2*4;clozapine;Chemical;PA165819182;Haplotype
CYP1A2*6;clozapine;Chemical;PA165819183;Haplotype
CYP1A2*7;clozapine;Chemical;PA165819184;Haplotype
CYP1A2*8;clozapine;Chemical;PA165819185;Haplotype
HLA-DPB1*04:01;clozapine;Chemical;PA165951133;Haplotype
HLA-DRB1*01:01;clozapine;Chemical;PA165951320;Haplotype
HLA-DRB1*04:02;clozapine;Chemical;PA165951501;Haplotype
HLA-DRB3*02:02;clozapine;Chemical;PA165952408;Haplotype
HLA-DRB5*02:02;clozapine;Chemical;PA165952475;Haplotype
HLA-B*38:01;clozapine;Chemical;PA165955500;Haplotype
HLA-B*59:01;clozapine;Chemical;PA165956674;Haplotype
HLA-C*07:01;clozapine;Chemical;PA165957372;Haplotype
HLA-DQB1*05:02;clozapine;Chemical;PA165958077;Haplotype
HLA-DQB1*02:01;clozapine;Chemical;PA165958158;Haplotype
CYP2C19*1;clozapine;Chemical;PA165980634;Haplotype
CYP2C19*2;clozapine;Chemical;PA165980635;Haplotype
GSTM1 NULL;clozapine;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;clozapine;Chemical;PA166048676;Haplotype
GSTT1 NULL;clozapine;Chemical;PA166048678;Haplotype
GSTT1 NON-NULL;clozapine;Chemical;PA166048679;Haplotype
UGT1A1*1;clozapine;Chemical;PA166115841;Haplotype
UGT1A1*28;clozapine;Chemical;PA166115842;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);clozapine;Chemical;PA166116466;Haplotype
SLC6A4 L ALLELE-RS25531T;clozapine;Chemical;PA166117146;Haplotype
SLC6A4 L ALLELE-RS25531C;clozapine;Chemical;PA166117147;Haplotype
CYP3A5*1;clozapine;Chemical;PA166128213;Haplotype
CYP3A5*3;clozapine;Chemical;PA166128219;Haplotype
RS324420;clozapine;Chemical;PA166153569;Variant
RS1801131;clozapine;Chemical;PA166153643;Variant
RS6277;clozapine;Chemical;PA166154261;Variant
RS1062613;clozapine;Chemical;PA166154312;Variant
RS1079598;clozapine;Chemical;PA166154316;Variant
RS1150226;clozapine;Chemical;PA166154321;Variant
RS2276302;clozapine;Chemical;PA166154358;Variant
RS4436578;clozapine;Chemical;PA166154407;Variant
RS1072388;clozapine;Chemical;PA166154510;Variant
RS762551;clozapine;Chemical;PA166154850;Variant
RS72547516;clozapine;Chemical;PA166154962;Variant
RS11872992;clozapine;Chemical;PA166155319;Variant
RS13429709;clozapine;Chemical;PA166155833;Variant
RS4680;clozapine;Chemical;PA166156024;Variant
RS6280;clozapine;Chemical;PA166156277;Variant
RS9852;clozapine;Chemical;PA166156482;Variant
RS6295;clozapine;Chemical;PA166156708;Variant
RS265976;clozapine;Chemical;PA166156722;Variant
RS2975226;clozapine;Chemical;PA166156812;Variant
RS742105;clozapine;Chemical;PA166156943;Variant
RS806378;clozapine;Chemical;PA166156956;Variant
RS1360780;clozapine;Chemical;PA166156983;Variant
RS1415744;clozapine;Chemical;PA166156984;Variant
RS2268639;clozapine;Chemical;PA166157028;Variant
RS1045642;clozapine;Chemical;PA166157284;Variant
RS7787082;clozapine;Chemical;PA166157428;Variant
RS10248420;clozapine;Chemical;PA166157440;Variant
RS1778929;clozapine;Chemical;PA166157736;Variant
RS10465180;clozapine;Chemical;PA166157805;Variant
RS1414334;clozapine;Chemical;PA166157862;Variant
RS3813929;clozapine;Chemical;PA166157875;Variant
RS2535629;clozapine;Chemical;PA166159627;Variant
RS149104283;clozapine;Chemical;PA166162391;Variant
RS2277984;clozapine;Chemical;PA166163394;Variant
RS3888190;clozapine;Chemical;PA166165398;Variant
RS1000940;clozapine;Chemical;PA166165401;Variant
RS28379954;clozapine;Chemical;PA166232961;Variant
CYP1A2*1;clozapine;Chemical;PA166363465;Haplotype
CYP1A2*30;clozapine;Chemical;PA166363474;Haplotype
CYP1A2*35;clozapine;Chemical;PA166363479;Haplotype
GSTM1;clozapine;Chemical;PA182;Gene
GSTT1;clozapine;Chemical;PA183;Gene
HTR1A;clozapine;Chemical;PA192;Gene
HTR2A;clozapine;Chemical;PA193;Gene
HTR2C;clozapine;Chemical;PA194;Gene
MTHFR;clozapine;Chemical;PA245;Gene
C3;clozapine;Chemical;PA25897;Gene
CNR1;clozapine;Chemical;PA26681;Gene
ABCB1;clozapine;Chemical;PA267;Gene
CYP1A2;clozapine;Chemical;PA27093;Gene
DRD2;clozapine;Chemical;PA27478;Gene
DRD3;clozapine;Chemical;PA27479;Gene
DTNBP1;clozapine;Chemical;PA27512;Gene
EPM2A;clozapine;Chemical;PA27832;Gene
FAAH;clozapine;Chemical;PA27955;Gene
FKBP5;clozapine;Chemical;PA28162;Gene
GCG;clozapine;Chemical;PA28606;Gene
GLP1R;clozapine;Chemical;PA28725;Gene
GRIN2B;clozapine;Chemical;PA28980;Gene
HTR3A;clozapine;Chemical;PA29555;Gene
ITIH3;clozapine;Chemical;PA29966;Gene
MC4R;clozapine;Chemical;PA30676;Gene
SLC6A3;clozapine;Chemical;PA311;Gene
SLC6A4;clozapine;Chemical;PA312;Gene
NFIB;clozapine;Chemical;PA31591;Gene
NQO2;clozapine;Chemical;PA31745;Gene
NTRK2;clozapine;Chemical;PA31818;Gene
HLA-B;clozapine;Chemical;PA35056;Gene
HLA-C;clozapine;Chemical;PA35057;Gene
HLA-DPB1;clozapine;Chemical;PA35064;Gene
HLA-DQB1;clozapine;Chemical;PA35068;Gene
HLA-DRB1;clozapine;Chemical;PA35072;Gene
HLA-DRB3;clozapine;Chemical;PA35074;Gene
HLA-DRB5;clozapine;Chemical;PA35076;Gene
TBC1D1;clozapine;Chemical;PA36342;Gene
UGT1A1;clozapine;Chemical;PA420;Gene
CAFFEINE;clozapine;Chemical;PA448710;Chemical
HIV INFECTIOUS DISEASE;rs2562519;Variant;PA447230;Disease
NEVIRAPINE;rs2562519;Variant;PA450616;Chemical
GNAI1;ADCY3;Gene;PA172;Gene
GNAI3;ADCY3;Gene;PA173;Gene
GNAS;ADCY3;Gene;PA175;Gene
GNB3;ADCY3;Gene;PA176;Gene
GNAI2;ADCY3;Gene;PA24347;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs2569190;Variant;PA164713366;Chemical
ULCERATIVE COLITIS;rs2569190;Variant;PA443750;Disease
CYP3A5;propoxyphene;Chemical;PA131;Gene
GEFITINIB;rs577001;Variant;PA131301952;Chemical
DIARRHEA;rs577001;Variant;PA443899;Disease
DIABETES MELLITUS;NPC1L1;Gene;PA443886;Disease
HYPERTENSION;NPC1L1;Gene;PA444552;Disease
VASCULAR DISEASES;NPC1L1;Gene;PA446021;Disease
PRAVASTATIN;NPC1L1;Gene;PA451089;Chemical
BIPOLAR DISORDER;EPHX2;Gene;PA447199;Disease
LITHIUM;EPHX2;Gene;PA450243;Chemical
DIABETES MELLITUS, TYPE 2;C11orf65;Gene;PA443890;Disease
METFORMIN;C11orf65;Gene;PA450395;Chemical
CFTR;rs121908753;Variant;PA109;Gene
IVACAFTOR;rs121908753;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs121908753;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs121908753;Variant;PA166190041;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs121908753;Variant;PA166362502;Chemical
CYSTIC FIBROSIS;rs121908753;Variant;PA443829;Disease
HEROIN DEPENDENCE;rs9479757;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs9479757;Variant;PA445043;Disease
OPIOIDS;rs9479757;Variant;PA452618;Chemical
HEROIN;rs9479757;Variant;PA452619;Chemical
AXITINIB;HIF1A;Gene;PA164924493;Chemical
SORAFENIB;HIF1A;Gene;PA7000;Chemical
RS5443;Cluster Headache;Disease;PA166154486;Variant
GNB3;Cluster Headache;Disease;PA176;Gene
LATANOPROST;rs10306114;Variant;PA164774763;Chemical
CORONARY ARTERY DISEASE;rs10306114;Variant;PA443796;Disease
OPEN-ANGLE GLAUCOMA;rs10306114;Variant;PA444282;Disease
MYOCARDIAL INFARCTION;rs10306114;Variant;PA445019;Disease
ASPIRIN;rs10306114;Variant;PA448497;Chemical
CLOPIDOGREL;rs10306114;Variant;PA449053;Chemical
IFNL3;deleobuvir;Chemical;PA134952671;Gene
IFNL4;deleobuvir;Chemical;PA166049147;Gene
RS12979860;deleobuvir;Chemical;PA166155468;Variant
BREAST NEOPLASMS;rs1042858;Variant;PA443560;Disease
GEMCITABINE;rs1042858;Variant;PA449748;Chemical
CYP3A4;ethosuximide;Chemical;PA130;Gene
RS2298771;ethosuximide;Chemical;PA166155680;Variant
SCN1A;ethosuximide;Chemical;PA301;Gene
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;PIGM;Gene;PA447197;Disease
METHYLPHENIDATE;PIGM;Gene;PA450464;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs11559290;Variant;PA447197;Disease
METHYLPHENIDATE;rs11559290;Variant;PA450464;Chemical
DEXTROMETHORPHAN;rs1807493;Variant;PA449273;Chemical
MIGALASTAT;rs28935195;Variant;PA166182881;Chemical
FABRY DISEASE;rs28935195;Variant;PA443367;Disease
CYP2D6;dextromethorphan;Chemical;PA128;Gene
CYP3A4;dextromethorphan;Chemical;PA130;Gene
PHETA2;dextromethorphan;Chemical;PA143485467;Gene
WBP2NL;dextromethorphan;Chemical;PA145147710;Gene
SMDT1;dextromethorphan;Chemical;PA145149451;Gene
CYP2D6*1;dextromethorphan;Chemical;PA165816576;Haplotype
CYP2D6*2;dextromethorphan;Chemical;PA165816577;Haplotype
CYP2D6*3;dextromethorphan;Chemical;PA165816578;Haplotype
CYP2D6*4;dextromethorphan;Chemical;PA165816579;Haplotype
CYP2D6*6;dextromethorphan;Chemical;PA165816581;Haplotype
CYP2D6*10;dextromethorphan;Chemical;PA165816582;Haplotype
CYP2D6*17;dextromethorphan;Chemical;PA165816583;Haplotype
CYP2D6*41;dextromethorphan;Chemical;PA165816584;Haplotype
CYP2D6*5;dextromethorphan;Chemical;PA165948092;Haplotype
CYP2D6*29;dextromethorphan;Chemical;PA165948318;Haplotype
CYP2D6*7;dextromethorphan;Chemical;PA165971559;Haplotype
CYP2D6*12;dextromethorphan;Chemical;PA165971565;Haplotype
CYP2D6*15;dextromethorphan;Chemical;PA165971568;Haplotype
CYP2D6*18;dextromethorphan;Chemical;PA165971569;Haplotype
CYP2D6*24;dextromethorphan;Chemical;PA165971576;Haplotype
CYP2D6*26;dextromethorphan;Chemical;PA165971578;Haplotype
CYP2D6*31;dextromethorphan;Chemical;PA165971582;Haplotype
CYP2D6*37;dextromethorphan;Chemical;PA165971591;Haplotype
CYP2D6*40;dextromethorphan;Chemical;PA165971594;Haplotype
CYP2D6*42;dextromethorphan;Chemical;PA165971595;Haplotype
CYP2D6*44;dextromethorphan;Chemical;PA165971597;Haplotype
CYP2D6*47;dextromethorphan;Chemical;PA165971601;Haplotype
CYP2D6*49;dextromethorphan;Chemical;PA165971603;Haplotype
CYP2D6*50;dextromethorphan;Chemical;PA165971604;Haplotype
CYP2D6*51;dextromethorphan;Chemical;PA165971605;Haplotype
CYP2D6*52;dextromethorphan;Chemical;PA165971606;Haplotype
CYP2D6*54;dextromethorphan;Chemical;PA165971608;Haplotype
CYP2D6*55;dextromethorphan;Chemical;PA165971609;Haplotype
CYP2D6*59;dextromethorphan;Chemical;PA165971614;Haplotype
CYP2D6*62;dextromethorphan;Chemical;PA165971617;Haplotype
CYP2D6*64;dextromethorphan;Chemical;PA165971619;Haplotype
CYP2D6*69;dextromethorphan;Chemical;PA165971621;Haplotype
CYP2D6*71;dextromethorphan;Chemical;PA165971623;Haplotype
CYP2D6*72;dextromethorphan;Chemical;PA165971624;Haplotype
CYP2D6*75;dextromethorphan;Chemical;PA165971627;Haplotype
CYP2D6*13;dextromethorphan;Chemical;PA165988481;Haplotype
CYP2D6*21;dextromethorphan;Chemical;PA165988484;Haplotype
CYP2D6*36;dextromethorphan;Chemical;PA165988488;Haplotype
CYP2D6*56;dextromethorphan;Chemical;PA165988494;Haplotype
CYP2D6*84;dextromethorphan;Chemical;PA166123324;Haplotype
CYP2D6*87;dextromethorphan;Chemical;PA166123327;Haplotype
CYP2D6*89;dextromethorphan;Chemical;PA166123329;Haplotype
CYP2D6*90;dextromethorphan;Chemical;PA166123330;Haplotype
CYP2D6*91;dextromethorphan;Chemical;PA166123331;Haplotype
CYP2D6*92;dextromethorphan;Chemical;PA166123332;Haplotype
CYP2D6*93;dextromethorphan;Chemical;PA166123333;Haplotype
CYP2D6*95;dextromethorphan;Chemical;PA166123336;Haplotype
CYP2D6*96;dextromethorphan;Chemical;PA166123337;Haplotype
CYP2D6*97;dextromethorphan;Chemical;PA166123338;Haplotype
CYP2D6*98;dextromethorphan;Chemical;PA166123339;Haplotype
CYP2D6*100;dextromethorphan;Chemical;PA166123340;Haplotype
CYP2D6*101;dextromethorphan;Chemical;PA166123341;Haplotype
CYP2D6*4XN;dextromethorphan;Chemical;PA166123455;Haplotype
CYP2D6*10X2;dextromethorphan;Chemical;PA166123456;Haplotype
CYP2D6*94;dextromethorphan;Chemical;PA166128737;Haplotype
RS138417770;dextromethorphan;Chemical;PA166156205;Variant
RS371793722;dextromethorphan;Chemical;PA166156250;Variant
RS745746329;dextromethorphan;Chemical;PA166156263;Variant
RS750996195;dextromethorphan;Chemical;PA166156265;Variant
RS777560972;dextromethorphan;Chemical;PA166156272;Variant
RS35599367;dextromethorphan;Chemical;PA166157487;Variant
CYP2D6*114;dextromethorphan;Chemical;PA166181184;Haplotype
CYP2D6*14;dextromethorphan;Chemical;PA166181185;Haplotype
CYP2D6*134;dextromethorphan;Chemical;PA166183240;Haplotype
CYP2D6*153;dextromethorphan;Chemical;PA166274898;Haplotype
CYP2D6*169;dextromethorphan;Chemical;PA166281715;Haplotype
CYP2D6*4X2;dextromethorphan;Chemical;PA166299961;Haplotype
RS1807493;dextromethorphan;Chemical;PA166322981;Variant
RS1062753;dextromethorphan;Chemical;PA166323061;Variant
RS4073010;dextromethorphan;Chemical;PA166323063;Variant
RS729559;dextromethorphan;Chemical;PA166323065;Variant
SEPTIN3;dextromethorphan;Chemical;PA24355;Gene
NEUROTOXICITY SYNDROMES;CYP2B6*38;Haplotype;PA446975;Disease
HIV INFECTIONS;CYP2B6*38;Haplotype;PA447230;Disease
EFAVIRENZ;CYP2B6*38;Haplotype;PA449441;Chemical
EPILEPSY;rs12233719;Variant;PA444065;Disease
VALPROIC ACID;rs12233719;Variant;PA451846;Chemical
MENOPAUSE;rs4646;Variant;PA166048848;Disease
BREAST NEOPLASMS;rs4646;Variant;PA443560;Disease
LETROZOLE;rs4646;Variant;PA450196;Chemical
TAMOXIFEN;rs4646;Variant;PA451581;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs11209026;Variant;PA164713366;Chemical
PSORIASIS;rs11209026;Variant;PA445451;Disease
G6PD;Anemia, Hemolytic, Congenital Nonspherocytic;Disease;PA28469;Gene
RS35320474;Bronchopulmonary dysplasia of newborn;Disease;PA166156166;Variant
ADORA2A;Bronchopulmonary dysplasia of newborn;Disease;PA24584;Gene
HIV INFECTIOUS DISEASE;rs130072;Variant;PA447230;Disease
NEVIRAPINE;rs130072;Variant;PA450616;Chemical
CYP2D6;umeclidinium / vilanterol;Chemical;PA128;Gene
TICAGRELOR;CYP3A4*15;Haplotype;PA165374673;Chemical
CABOZANTINIB;CYP3A4*15;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*15;Haplotype;PA165958362;Chemical
REGORAFENIB;CYP3A4*15;Haplotype;PA166114943;Chemical
VANDETANIB;CYP3A4*15;Haplotype;PA166118341;Chemical
IBRUTINIB;CYP3A4*15;Haplotype;PA166121346;Chemical
BREXPIPRAZOLE;CYP3A4*15;Haplotype;PA166160053;Chemical
MACITENTAN;CYP3A4*15;Haplotype;PA166261201;Chemical
LIDOCAINE;CYP3A4*15;Haplotype;PA450226;Chemical
METHADONE;CYP3A4*15;Haplotype;PA450401;Chemical
OXYCODONE;CYP3A4*15;Haplotype;PA450741;Chemical
TESTOSTERONE;CYP3A4*15;Haplotype;PA451627;Chemical
ASTHMA;rs953977;Variant;PA443450;Disease
MONTELUKAST;rs953977;Variant;PA450546;Chemical
CYP3A5;Muscular Diseases;Disease;PA131;Gene
SLCO1B1;Muscular Diseases;Disease;PA134865839;Gene
COQ2;Muscular Diseases;Disease;PA142672084;Gene
HLA-DRB1*01:01;Muscular Diseases;Disease;PA165951320;Haplotype
HLA-DRB1*04:06;Muscular Diseases;Disease;PA165951530;Haplotype
CYP3A5*1;Muscular Diseases;Disease;PA166128213;Haplotype
CYP3A5*3;Muscular Diseases;Disease;PA166128219;Haplotype
RS4363657;Muscular Diseases;Disease;PA166154590;Variant
RS118192172;Muscular Diseases;Disease;PA166155537;Variant
RS4693075;Muscular Diseases;Disease;PA166156593;Variant
RS6535454;Muscular Diseases;Disease;PA166156601;Variant
RS1799762;Muscular Diseases;Disease;PA166282801;Variant
SERPINE1;Muscular Diseases;Disease;PA261;Gene
RYR1;Muscular Diseases;Disease;PA34896;Gene
HLA-DRB1;Muscular Diseases;Disease;PA35072;Gene
MEASLES VACCINES;HLA-B*51:01;Haplotype;PA164712887;Chemical
PAZOPANIB;HLA-B*51:01;Haplotype;PA165291492;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*51:01;Haplotype;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-B*51:01;Haplotype;PA166120929;Disease
HLA-B;HLA-B*51:01;Haplotype;PA35056;Gene
DRUG HYPERSENSITIVITY;HLA-B*51:01;Haplotype;PA443936;Disease
DRUG TOXICITY;HLA-B*51:01;Haplotype;PA443937;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*51:01;Haplotype;PA444059;Disease
EPILEPSY;HLA-B*51:01;Haplotype;PA444065;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*51:01;Haplotype;PA445738;Disease
CARBAMAZEPINE;HLA-B*51:01;Haplotype;PA448785;Chemical
CLINDAMYCIN;HLA-B*51:01;Haplotype;PA449035;Chemical
NEVIRAPINE;HLA-B*51:01;Haplotype;PA450616;Chemical
PHENOBARBITAL;HLA-B*51:01;Haplotype;PA450911;Chemical
PHENYTOIN;HLA-B*51:01;Haplotype;PA450947;Chemical
RS1805128;Antibiotics;Chemical;PA166155994;Variant
RS11125;Antibiotics;Chemical;PA166160641;Variant
KCNE1;Antibiotics;Chemical;PA211;Gene
LGALS3;Antibiotics;Chemical;PA30340;Gene
IFNL3;faldaprevir;Chemical;PA134952671;Gene
IFNL4;faldaprevir;Chemical;PA166049147;Gene
RS12979860;faldaprevir;Chemical;PA166155468;Variant
COUMARIN;CYP2A13;Gene;PA134521193;Chemical
NNK;CYP2A13;Gene;PA166181759;Chemical
TOBACCO USE DISORDER;CYP2A13;Gene;PA445876;Disease
NICOTINE;CYP2A13;Gene;PA450626;Chemical
SULFAMETHOXAZOLE / TRIMETHOPRIM;G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like;Haplotype;PA10715;Chemical
ANEMIA, HEMOLYTIC;G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like;Haplotype;PA443343;Disease
HEMOLYSIS;G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like;Haplotype;PA444411;Disease
SULFAMETHOXAZOLE;G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like;Haplotype;PA451544;Chemical
PSORIASIS;rs17731538;Variant;PA445451;Disease
METHOTREXATE;rs17731538;Variant;PA450428;Chemical
LEUKEMIA, MYELOID, ACUTE;DCK;Gene;PA444760;Disease
PANCREATIC NEOPLASMS;DCK;Gene;PA445218;Disease
CYTARABINE;DCK;Gene;PA449177;Chemical
DAUNORUBICIN;DCK;Gene;PA449212;Chemical
GEMCITABINE;DCK;Gene;PA449748;Chemical
IDARUBICIN;DCK;Gene;PA449961;Chemical
LAMIVUDINE;DCK;Gene;PA450163;Chemical
CES1;mycophenolate mofetil;Chemical;PA107;Gene
ABCC2;mycophenolate mofetil;Chemical;PA116;Gene
CYP2C8;mycophenolate mofetil;Chemical;PA125;Gene
SLCO1B1;mycophenolate mofetil;Chemical;PA134865839;Gene
RS1800872;mycophenolate mofetil;Chemical;PA166153640;Variant
RS11572076;mycophenolate mofetil;Chemical;PA166154139;Variant
RS4149056;mycophenolate mofetil;Chemical;PA166154579;Variant
RS4149117;mycophenolate mofetil;Chemical;PA166154583;Variant
RS7311358;mycophenolate mofetil;Chemical;PA166154602;Variant
RS1042597;mycophenolate mofetil;Chemical;PA166155614;Variant
RS3832043;mycophenolate mofetil;Chemical;PA166155718;Variant
RS6714486;mycophenolate mofetil;Chemical;PA166155748;Variant
RS17868320;mycophenolate mofetil;Chemical;PA166155855;Variant
RS72551330;mycophenolate mofetil;Chemical;PA166155900;Variant
RS568408;mycophenolate mofetil;Chemical;PA166156289;Variant
RS11706052;mycophenolate mofetil;Chemical;PA166156443;Variant
RS7438135;mycophenolate mofetil;Chemical;PA166156617;Variant
RS1800629;mycophenolate mofetil;Chemical;PA166156997;Variant
RS2032582;mycophenolate mofetil;Chemical;PA166157316;Variant
RS2228075;mycophenolate mofetil;Chemical;PA166157332;Variant
RS2278293;mycophenolate mofetil;Chemical;PA166157350;Variant
RS2278294;mycophenolate mofetil;Chemical;PA166157351;Variant
ABCB1;mycophenolate mofetil;Chemical;PA267;Gene
IL10;mycophenolate mofetil;Chemical;PA29778;Gene
IL12A;mycophenolate mofetil;Chemical;PA29784;Gene
IMPDH1;mycophenolate mofetil;Chemical;PA29862;Gene
IMPDH2;mycophenolate mofetil;Chemical;PA29863;Gene
SLCO1B3;mycophenolate mofetil;Chemical;PA35844;Gene
UGT2B7;mycophenolate mofetil;Chemical;PA361;Gene
UGT1A7;mycophenolate mofetil;Chemical;PA37182;Gene
UGT1A8;mycophenolate mofetil;Chemical;PA37183;Gene
CES2;mycophenolate mofetil;Chemical;PA377;Gene
UGT1A9;mycophenolate mofetil;Chemical;PA419;Gene
TNF;mycophenolate mofetil;Chemical;PA435;Gene
FLUOROURACIL;rs1212037891;Variant;PA128406956;Chemical
ALZHEIMER DISEASE;rs6494223;Variant;PA443319;Disease
DONEPEZIL;rs6494223;Variant;PA449394;Chemical
GALANTAMINE;rs6494223;Variant;PA449726;Chemical
RIVASTIGMINE;rs6494223;Variant;PA451262;Chemical
CYP2A6;caffeine;Chemical;PA121;Gene
CYP2A6*1;caffeine;Chemical;PA165924690;Haplotype
CYP2A6*4;caffeine;Chemical;PA165924721;Haplotype
CYP2A6*7;caffeine;Chemical;PA165924731;Haplotype
CYP2A6*10;caffeine;Chemical;PA165924735;Haplotype
CYP2A6*11;caffeine;Chemical;PA165924736;Haplotype
NAT2*4;caffeine;Chemical;PA165949098;Haplotype
CYP2A6*9;caffeine;Chemical;PA165980914;Haplotype
RS762551;caffeine;Chemical;PA166154850;Variant
RS2069514;caffeine;Chemical;PA166154874;Variant
RS118192161;caffeine;Chemical;PA166155532;Variant
RS118192172;caffeine;Chemical;PA166155537;Variant
RS121918592;caffeine;Chemical;PA166155543;Variant
RS193922747;caffeine;Chemical;PA166155564;Variant
RS193922770;caffeine;Chemical;PA166155567;Variant
RS193922772;caffeine;Chemical;PA166155568;Variant
RS193922802;caffeine;Chemical;PA166155569;Variant
RS2298383;caffeine;Chemical;PA166156099;Variant
RS3761422;caffeine;Chemical;PA166156103;Variant
RS5751876;caffeine;Chemical;PA166156118;Variant
RS35320474;caffeine;Chemical;PA166156166;Variant
CYP1A2 HIGH ACTIVITY;caffeine;Chemical;PA166157954;Variant
CYP1A2 LOW ACTIVITY;caffeine;Chemical;PA166157966;Variant
RS186983396;caffeine;Chemical;PA166177045;Variant
RS35060421;caffeine;Chemical;PA166215001;Variant
NAT2;caffeine;Chemical;PA18;Gene
ADORA2A;caffeine;Chemical;PA24584;Gene
CYP1A2;caffeine;Chemical;PA27093;Gene
RYR1;caffeine;Chemical;PA34896;Gene
CLOZAPINE;caffeine;Chemical;PA449061;Chemical
CACNA1S;caffeine;Chemical;PA85;Gene
IFNL3;ledipasvir / sofosbuvir;Chemical;PA134952671;Gene
CFTR;rs77409459;Variant;PA109;Gene
IVACAFTOR;rs77409459;Variant;PA165950341;Chemical
CYSTIC FIBROSIS;rs77409459;Variant;PA443829;Disease
ACE;Multiple Sclerosis;Disease;PA139;Gene
ZNF697;Multiple Sclerosis;Disease;PA142670495;Gene
GAPVD1;Multiple Sclerosis;Disease;PA142671748;Gene
HLA-DRB1*04:01;Multiple Sclerosis;Disease;PA165951493;Haplotype
HLA-DRB1*15:01;Multiple Sclerosis;Disease;PA165952269;Haplotype
HLA-B*15:01;Multiple Sclerosis;Disease;PA165954745;Haplotype
RS4278350;Multiple Sclerosis;Disease;PA166153763;Variant
RS10494227;Multiple Sclerosis;Disease;PA166153801;Variant
RS12044852;Multiple Sclerosis;Disease;PA166153841;Variant
RS3133084;Multiple Sclerosis;Disease;PA166154394;Variant
RS1799752;Multiple Sclerosis;Disease;PA166155187;Variant
RS333;Multiple Sclerosis;Disease;PA166156273;Variant
RS760316;Multiple Sclerosis;Disease;PA166156293;Variant
RS1448673;Multiple Sclerosis;Disease;PA166157296;Variant
RS2291858;Multiple Sclerosis;Disease;PA166157750;Variant
RS10760397;Multiple Sclerosis;Disease;PA166157811;Variant
RS10819043;Multiple Sclerosis;Disease;PA166157818;Variant
RS2205986;Multiple Sclerosis;Disease;PA166179805;Variant
RS4774388;Multiple Sclerosis;Disease;PA166203235;Variant
CCR5;Multiple Sclerosis;Disease;PA26170;Gene
CD58;Multiple Sclerosis;Disease;PA26227;Gene
FHIT;Multiple Sclerosis;Disease;PA28140;Gene
IRF6;Multiple Sclerosis;Disease;PA29920;Gene
RORA;Multiple Sclerosis;Disease;PA34630;Gene
HLA-B;Multiple Sclerosis;Disease;PA35056;Gene
HLA-DRB1;Multiple Sclerosis;Disease;PA35072;Gene
NEUTROPENIA;rs149104283;Variant;PA445113;Disease
CLOZAPINE;rs149104283;Variant;PA449061;Chemical
PIK3CD;leniolisib;Chemical;PA33310;Gene
PIK3R1;leniolisib;Chemical;PA33312;Gene
PANCREATIC NEOPLASMS;rs17091162;Variant;PA445218;Disease
ANTINEOPLASTIC AGENTS;rs17091162;Variant;PA452621;Chemical
EVENT-FREE SURVIVAL;TPMT*33;Haplotype;PA166123366;Disease
LUPUS ERYTHEMATOSUS, SYSTEMIC;TPMT*33;Haplotype;PA444822;Disease
NEUTROPENIA;TPMT*33;Haplotype;PA445113;Disease
THROMBOCYTOPENIA;TPMT*33;Haplotype;PA445846;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;TPMT*33;Haplotype;PA446155;Disease
MERCAPTOPURINE;TPMT*33;Haplotype;PA450379;Chemical
THIOGUANINE;TPMT*33;Haplotype;PA451663;Chemical
MEPHENYTOIN;rs144928727;Variant;PA450373;Chemical
MTHFR;Cleft Palate;Disease;PA245;Gene
RS113488022;cobimetinib;Chemical;PA166157522;Variant
BRAF;cobimetinib;Chemical;PA25408;Gene
FLUOROURACIL;rs7325568;Variant;PA128406956;Chemical
OXALIPLATIN;rs7325568;Variant;PA131285527;Chemical
COLORECTAL NEOPLASMS;rs7325568;Variant;PA446108;Disease
SCHIZOPHRENIA;rs12467557;Variant;PA447216;Disease
ANTIPSYCHOTICS;rs12467557;Variant;PA452233;Chemical
STAT1;PIAS1;Gene;PA36183;Gene
BETA BLOCKING AGENTS;rs4253778;Variant;PA164712535;Chemical
CORONARY DISEASE;rs4253778;Variant;PA443797;Disease
DIABETES MELLITUS;rs4253778;Variant;PA443886;Disease
FENOFIBRATE;rs4253778;Variant;PA449594;Chemical
LEUKEMIA, MYELOID, ACUTE;RRM2;Gene;PA444760;Disease
CLADRIBINE;RRM2;Gene;PA449027;Chemical
CYTARABINE;RRM2;Gene;PA449177;Chemical
ABCC2;Colonic Neoplasms;Disease;PA116;Gene
CYP2W1;Colonic Neoplasms;Disease;PA134992665;Gene
DPYD;Colonic Neoplasms;Disease;PA145;Gene
ERCC1;Colonic Neoplasms;Disease;PA155;Gene
UGT1A1*1;Colonic Neoplasms;Disease;PA166115841;Haplotype
UGT1A1*28;Colonic Neoplasms;Disease;PA166115842;Haplotype
RS1801133;Colonic Neoplasms;Disease;PA166153644;Variant
RS3917412;Colonic Neoplasms;Disease;PA166153758;Variant
RS717620;Colonic Neoplasms;Disease;PA166153953;Variant
RS9344;Colonic Neoplasms;Disease;PA166154264;Variant
RS2010851;Colonic Neoplasms;Disease;PA166154523;Variant
RS17109924;Colonic Neoplasms;Disease;PA166154646;Variant
RS11615;Colonic Neoplasms;Disease;PA166155342;Variant
RS25487;Colonic Neoplasms;Disease;PA166155346;Variant
RS1105879;Colonic Neoplasms;Disease;PA166155623;Variant
RS2070959;Colonic Neoplasms;Disease;PA166155665;Variant
RS12654264;Colonic Neoplasms;Disease;PA166156878;Variant
DPYD DEFICIENCY;Colonic Neoplasms;Disease;PA166157931;Variant
RS10934498;Colonic Neoplasms;Disease;PA166159102;Variant
HMGCR;Colonic Neoplasms;Disease;PA189;Gene
MTHFR;Colonic Neoplasms;Disease;PA245;Gene
BRCA1;Colonic Neoplasms;Disease;PA25411;Gene
LGR5;Colonic Neoplasms;Disease;PA28894;Gene
SELE;Colonic Neoplasms;Disease;PA35640;Gene
XRCC1;Colonic Neoplasms;Disease;PA369;Gene
UGT1A6;Colonic Neoplasms;Disease;PA37181;Gene
NR1I2;Colonic Neoplasms;Disease;PA378;Gene
WNT5B;Colonic Neoplasms;Disease;PA38104;Gene
UGT1A1;Colonic Neoplasms;Disease;PA420;Gene
ALOX5;Colonic Neoplasms;Disease;PA46;Gene
CCND1;Colonic Neoplasms;Disease;PA75;Gene
ANTHRACYCLINES AND RELATED SUBSTANCES;rs885004;Variant;PA130620651;Chemical
NEOPLASMS;rs885004;Variant;PA445062;Disease
ABCC2;lopinavir;Chemical;PA116;Gene
CYP3A4;lopinavir;Chemical;PA130;Gene
CYP3A5;lopinavir;Chemical;PA131;Gene
SLCO1B1;lopinavir;Chemical;PA134865839;Gene
ZSCAN25;lopinavir;Chemical;PA134962723;Gene
CYP3A4*1;lopinavir;Chemical;PA165819201;Haplotype
CYP3A4*22;lopinavir;Chemical;PA166048680;Haplotype
RS717620;lopinavir;Chemical;PA166153953;Variant
RS8187710;lopinavir;Chemical;PA166154094;Variant
RS4149056;lopinavir;Chemical;PA166154579;Variant
RS212091;lopinavir;Chemical;PA166154987;Variant
RS776746;lopinavir;Chemical;PA166157267;Variant
RS2853826;lopinavir;Chemical;PA166158911;Variant
ABCC1;lopinavir;Chemical;PA244;Gene
CETUXIMAB;BTC;Gene;PA10040;Chemical
PANITUMUMAB;BTC;Gene;PA162373091;Chemical
SCHIZOPHRENIA;rs4849127;Variant;PA447216;Disease
ANTIPSYCHOTICS;rs4849127;Variant;PA452233;Chemical
OPIOID-RELATED DISORDERS;rs997917;Variant;PA445043;Disease
COCAINE DEPENDENCE;rs997917;Variant;PA446878;Disease
COCAINE;rs997917;Variant;PA449072;Chemical
OPIOIDS;rs997917;Variant;PA452618;Chemical
PERIPHERAL NERVOUS SYSTEM DISEASES;rs924607;Variant;PA445301;Disease
VINCRISTINE;rs924607;Variant;PA451879;Chemical
ESSENTIAL HYPERTENSION;DIAPH3;Gene;PA447288;Disease
HYDROCHLOROTHIAZIDE;DIAPH3;Gene;PA449899;Chemical
GNAS;HTR4;Gene;PA175;Gene
BONE DISEASES;MVK;Gene;PA443532;Disease
ALENDRONATE;MVK;Gene;PA448082;Chemical
DESFLURANE;rs193922764;Variant;PA164749136;Chemical
RYR1;rs193922764;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs193922764;Variant;PA444863;Disease
ENFLURANE;rs193922764;Variant;PA449461;Chemical
HALOTHANE;rs193922764;Variant;PA449845;Chemical
ISOFLURANE;rs193922764;Variant;PA450106;Chemical
METHOXYFLURANE;rs193922764;Variant;PA450434;Chemical
SEVOFLURANE;rs193922764;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs193922764;Variant;PA451522;Chemical
CACNA1S;rs193922764;Variant;PA85;Gene
O-DESMETHYLTRAMADOL;rs776817009;Variant;PA166131379;Chemical
TAPENTADOL;rs776817009;Variant;PA166179720;Chemical
ACETAMINOPHEN;rs776817009;Variant;PA448015;Chemical
TRAMADOL;rs776817009;Variant;PA451735;Chemical
HYPERTENSION;rs12946454;Variant;PA444552;Disease
DILTIAZEM;rs12946454;Variant;PA449334;Chemical
GPAM;PRKAG3;Gene;PA134983031;Gene
CRTC2;PRKAG3;Gene;PA142672073;Gene
HMGCR;PRKAG3;Gene;PA189;Gene
ACACA;PRKAG3;Gene;PA24421;Gene
ACACB;PRKAG3;Gene;PA24422;Gene
MLYCD;PRKAG3;Gene;PA30861;Gene
SREBF1;PRKAG3;Gene;PA335;Gene
SLC2A4;PRKAG3;Gene;PA35879;Gene
STK11;PRKAG3;Gene;PA36198;Gene
MLXIPL;PRKAG3;Gene;PA37353;Gene
SIRT1;PRKAG3;Gene;PA37935;Gene
METFORMIN;PRKAG3;Gene;PA450395;Chemical
ATM;PRKAG3;Gene;PA61;Gene
RS3215400;azacitidine;Chemical;PA166153738;Variant
RS11280056;azacitidine;Chemical;PA166180936;Variant
CBL;azacitidine;Chemical;PA26115;Gene
KRAS;azacitidine;Chemical;PA30196;Gene
NRAS;azacitidine;Chemical;PA31768;Gene
PTPN11;azacitidine;Chemical;PA33986;Gene
TYMS;azacitidine;Chemical;PA359;Gene
CDA;azacitidine;Chemical;PA98;Gene
CFTR;genistein;Chemical;PA109;Gene
NASOPHARYNGEAL NEOPLASMS;rs1536475;Variant;PA445046;Disease
DOCETAXEL;rs1536475;Variant;PA449383;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs1554973;Variant;PA164713366;Chemical
INFLAMMATORY BOWEL DISEASES;rs1554973;Variant;PA446116;Disease
DULOXETINE;rs10771999;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs10771999;Variant;PA447321;Disease
PEGINTERFERON ALFA-2B;HLA-C*17:01;Haplotype;PA164784024;Chemical
HEPATITIS C;HLA-C*17:01;Haplotype;PA444445;Disease
RIBAVIRIN;HLA-C*17:01;Haplotype;PA451241;Chemical
NR1I2;ampicillin;Chemical;PA378;Gene
CYP2C9;time to achieve stable dose;Disease;PA126;Gene
CYP2C9*1;time to achieve stable dose;Disease;PA165816542;Haplotype
CYP2C9*2;time to achieve stable dose;Disease;PA165816543;Haplotype
CYP2C9*3;time to achieve stable dose;Disease;PA165816544;Haplotype
ATM;CHEK1;Gene;PA61;Gene
ATR;CHEK1;Gene;PA74;Gene
CCNB1;CHEK1;Gene;PA95;Gene
CORONARY ARTERY DISEASE;MMP3;Gene;PA443796;Disease
HYPERTENSION;MMP3;Gene;PA444552;Disease
STROKE;MMP3;Gene;PA447054;Disease
CHLORTHALIDONE;MMP3;Gene;PA448970;Chemical
LISINOPRIL;MMP3;Gene;PA450242;Chemical
PRAVASTATIN;MMP3;Gene;PA451089;Chemical
P2RY12;GNAI2;Gene;PA134971947;Gene
ADCY3;GNAI2;Gene;PA164741137;Gene
HTR1A;GNAI2;Gene;PA192;Gene
ADCY1;GNAI2;Gene;PA24560;Gene
ADCY2;GNAI2;Gene;PA24561;Gene
ADCY4;GNAI2;Gene;PA24562;Gene
ADCY5;GNAI2;Gene;PA24563;Gene
ADCY6;GNAI2;Gene;PA27;Gene
ADCY7;GNAI2;Gene;PA28;Gene
ADCY8;GNAI2;Gene;PA29;Gene
HTR1B;GNAI2;Gene;PA29549;Gene
HTR1D;GNAI2;Gene;PA29550;Gene
HTR1E;GNAI2;Gene;PA29552;Gene
HTR1F;GNAI2;Gene;PA29553;Gene
ADCY9;GNAI2;Gene;PA30;Gene
RGS1;GNAI2;Gene;PA34361;Gene
ADRB2;GNAI2;Gene;PA39;Gene
PEGINTERFERON ALFA-2B;rs8113007;Variant;PA164784024;Chemical
HEPATITIS C VIRUS INFECTION;rs8113007;Variant;PA444445;Disease
HIV INFECTIOUS DISEASE;rs8113007;Variant;PA447230;Disease
RIBAVIRIN;rs8113007;Variant;PA451241;Chemical
DULOXETINE;rs61908405;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs61908405;Variant;PA447321;Disease
MACULOPAPULAR EXANTHEMA;HLA-DRB1*14:05;Haplotype;PA162316739;Disease
CARBAMAZEPINE;HLA-DRB1*14:05;Haplotype;PA448785;Chemical
METFORMIN;SLC29A4;Gene;PA450395;Chemical
ASPIRIN-INDUCED ASTHMA;HLA-DQB1;Gene;PA131285571;Disease
ANTITHYROID PREPARATIONS;HLA-DQB1;Gene;PA164712499;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;HLA-DQB1;Gene;PA164712708;Chemical
INFLUENZA VACCINES;HLA-DQB1;Gene;PA164712830;Chemical
CLAVULANATE;HLA-DQB1;Gene;PA164742987;Chemical
PEGASPARGASE;HLA-DQB1;Gene;PA164760860;Chemical
LUMIRACOXIB;HLA-DQB1;Gene;PA164769031;Chemical
FLUCLOXACILLIN;HLA-DQB1;Gene;PA164781042;Chemical
TOXIC LIVER DISEASE;HLA-DQB1;Gene;PA164925725;Disease
DRUG-INDUCED LIVER INJURY;HLA-DQB1;Gene;PA166119041;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-DQB1;Gene;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-DQB1;Gene;PA166120929;Disease
BUCILLAMINE;HLA-DQB1;Gene;PA166123566;Chemical
FLUPIRTINE;HLA-DQB1;Gene;PA166152829;Chemical
AGRANULOCYTOSIS;HLA-DQB1;Gene;PA443297;Disease
ARTHRITIS, RHEUMATOID;HLA-DQB1;Gene;PA443434;Disease
DIABETIC RETINOPATHY;HLA-DQB1;Gene;PA443895;Disease
DRUG HYPERSENSITIVITY;HLA-DQB1;Gene;PA443936;Disease
DRUG TOXICITY;HLA-DQB1;Gene;PA443937;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-DQB1;Gene;PA444059;Disease
EPILEPSY;HLA-DQB1;Gene;PA444065;Disease
GRAVES DISEASE;HLA-DQB1;Gene;PA444329;Disease
HEPATITIS;HLA-DQB1;Gene;PA444435;Disease
HYPERSENSITIVITY;HLA-DQB1;Gene;PA444546;Disease
HYPERTENSION;HLA-DQB1;Gene;PA444552;Disease
INFECTION;HLA-DQB1;Gene;PA444614;Disease
NARCOLEPSY;HLA-DQB1;Gene;PA445042;Disease
PROTEINURIA;HLA-DQB1;Gene;PA445431;Disease
STEVENS-JOHNSON SYNDROME;HLA-DQB1;Gene;PA445738;Disease
TUBERCULOSIS;HLA-DQB1;Gene;PA445941;Disease
URTICARIA;HLA-DQB1;Gene;PA445999;Disease
SCHIZOPHRENIA;HLA-DQB1;Gene;PA447216;Disease
HIV INFECTIONS;HLA-DQB1;Gene;PA447230;Disease
ABACAVIR;HLA-DQB1;Gene;PA448004;Chemical
ACETAMINOPHEN;HLA-DQB1;Gene;PA448015;Chemical
ALLOPURINOL;HLA-DQB1;Gene;PA448320;Chemical
AMOXICILLIN;HLA-DQB1;Gene;PA448406;Chemical
ASPIRIN;HLA-DQB1;Gene;PA448497;Chemical
CARBAMAZEPINE;HLA-DQB1;Gene;PA448785;Chemical
CLOZAPINE;HLA-DQB1;Gene;PA449061;Chemical
LAMOTRIGINE;HLA-DQB1;Gene;PA450164;Chemical
NEVIRAPINE;HLA-DQB1;Gene;PA450616;Chemical
TICLOPIDINE;HLA-DQB1;Gene;PA451686;Chemical
INFLIXIMAB;HLA-DQB1;Gene;PA452639;Chemical
SUBSTANCE-RELATED DISORDERS;rs4790694;Variant;PA446876;Disease
METHAMPHETAMINE;rs4790694;Variant;PA450403;Chemical
MIGALASTAT;rs397515870;Variant;PA166182881;Chemical
FABRY DISEASE;rs397515870;Variant;PA443367;Disease
NPC1;arimoclomol;Chemical;PA31698;Gene
NPC2;arimoclomol;Chemical;PA31700;Gene
RS1801157;alemtuzumab;Chemical;PA166159131;Variant
CXCL12;alemtuzumab;Chemical;PA35602;Gene
LENALIDOMIDE;rs4533622;Variant;PA162363968;Chemical
MULTIPLE MYELOMA;rs4533622;Variant;PA444985;Disease
THALIDOMIDE;rs4533622;Variant;PA451644;Chemical
ETOPOSIDE;PLA2G6;Gene;PA449552;Chemical
HBB;voxelotor;Chemical;PA29202;Gene
DESFLURANE;rs118192178;Variant;PA164749136;Chemical
RYR1;rs118192178;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs118192178;Variant;PA444863;Disease
ENFLURANE;rs118192178;Variant;PA449461;Chemical
HALOTHANE;rs118192178;Variant;PA449845;Chemical
ISOFLURANE;rs118192178;Variant;PA450106;Chemical
METHOXYFLURANE;rs118192178;Variant;PA450434;Chemical
SEVOFLURANE;rs118192178;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs118192178;Variant;PA451522;Chemical
CACNA1S;rs118192178;Variant;PA85;Gene
PPP1R1B;PPP1CA;Gene;PA33639;Gene
DROSPIRENONE / ETHINYL ESTRADIOL;PROC;Gene;PA165290928;Chemical
ETHINYL ESTRADIOL / NORELGESTROMIN;PROC;Gene;PA165290929;Chemical
CYP2C9*2;PROC;Gene;PA165816543;Haplotype
CYP2C9*3;PROC;Gene;PA165816544;Haplotype
RS6025;PROC;Gene;PA166153554;Variant
RS1801131;PROC;Gene;PA166153643;Variant
RS1801133;PROC;Gene;PA166153644;Variant
RS1799963;PROC;Gene;PA166154336;Variant
AVATROMBOPAG;PROC;Gene;PA166179849;Chemical
LUSUTROMBOPAG;PROC;Gene;PA166182748;Chemical
ESTRADIOL / PROGESTERONE;PROC;Gene;PA166190221;Chemical
SYNTHETIC CONJUGATED ESTROGENS, A;PROC;Gene;PA166238763;Chemical
RELUGOLIX / ESTRADIOL / NORETHINDRONE ACETATE;PROC;Gene;PA166397682;Chemical
PHENPROCOUMON;PROC;Gene;PA450921;Chemical
WARFARIN;PROC;Gene;PA451906;Chemical
HYPERTENSION;CYP11B2;Gene;PA444552;Disease
ESSENTIAL HYPERTENSION;CYP11B2;Gene;PA447288;Disease
BENAZEPRIL;CYP11B2;Gene;PA448561;Chemical
CANDESARTAN;CYP11B2;Gene;PA448765;Chemical
IMIDAPRIL;CYP11B2;Gene;PA452640;Chemical
CYP2C9;piroxicam;Chemical;PA126;Gene
CYP2C9*1;piroxicam;Chemical;PA165816542;Haplotype
CYP2C9*2;piroxicam;Chemical;PA165816543;Haplotype
CYP2C9*3;piroxicam;Chemical;PA165816544;Haplotype
VALACICLOVIR;piroxicam;Chemical;PA451839;Chemical
PLATINUM COMPOUNDS;rs4979223;Variant;PA164713176;Chemical
OVERALL SURVIVAL;rs4979223;Variant;PA166123207;Disease
THROMBOCYTOPENIA;rs4979223;Variant;PA445846;Disease
CYP2C8;CYP2C8*4;Haplotype;PA125;Gene
TOXIC LIVER DISEASE;CYP2C8*4;Haplotype;PA164925725;Disease
DICLOFENAC ACYL GLUCURONIDE;CYP2C8*4;Haplotype;PA166163692;Chemical
ASTHMA;CYP2C8*4;Haplotype;PA443450;Disease
BREAST NEOPLASMS;CYP2C8*4;Haplotype;PA443560;Disease
DRUG TOXICITY;CYP2C8*4;Haplotype;PA443937;Disease
NEOPLASMS;CYP2C8*4;Haplotype;PA445062;Disease
NEUTROPENIA;CYP2C8*4;Haplotype;PA445113;Disease
PAIN, POSTOPERATIVE;CYP2C8*4;Haplotype;PA445210;Disease
PERIPHERAL NERVOUS SYSTEM DISEASES;CYP2C8*4;Haplotype;PA445301;Disease
CERIVASTATIN;CYP2C8*4;Haplotype;PA448897;Chemical
CYCLOPHOSPHAMIDE;CYP2C8*4;Haplotype;PA449165;Chemical
DICLOFENAC;CYP2C8*4;Haplotype;PA449293;Chemical
EPIRUBICIN;CYP2C8*4;Haplotype;PA449476;Chemical
IBUPROFEN;CYP2C8*4;Haplotype;PA449957;Chemical
MONTELUKAST;CYP2C8*4;Haplotype;PA450546;Chemical
PACLITAXEL;CYP2C8*4;Haplotype;PA450761;Chemical
EVENT-FREE SURVIVAL;CYP2D6*20;Haplotype;PA166123366;Disease
BREAST NEOPLASMS;CYP2D6*20;Haplotype;PA443560;Disease
TAMOXIFEN;CYP2D6*20;Haplotype;PA451581;Chemical
ANTINEOPLASTIC AGENTS;CYP2D6*20;Haplotype;PA452621;Chemical
KIDNEY TRANSPLANTATION;FOXP3;Gene;PA165817016;Disease
PSORIASIS;FOXP3;Gene;PA445451;Disease
METHOTREXATE;FOXP3;Gene;PA450428;Chemical
TACROLIMUS;FOXP3;Gene;PA451578;Chemical
CETUXIMAB;NRG1;Gene;PA10040;Chemical
PANITUMUMAB;NRG1;Gene;PA162373091;Chemical
ZENOCUTUZUMAB;NRG1;Gene;PA166400161;Chemical
SCHIZOPHRENIA;NRG1;Gene;PA447216;Disease
ANTIPSYCHOTICS;NRG1;Gene;PA452233;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;rs766023281;Variant;PA446155;Disease
MERCAPTOPURINE;rs766023281;Variant;PA450379;Chemical
TOBACCO USE DISORDER;rs3787138;Variant;PA445876;Disease
NICOTINE;rs3787138;Variant;PA450626;Chemical
CALCIUM CHANNEL BLOCKERS;rs2238032;Variant;PA10407;Chemical
HYPERTENSION;rs2238032;Variant;PA444552;Disease
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;TNFAIP3;Gene;PA164713366;Chemical
USTEKINUMAB;TNFAIP3;Gene;PA166048654;Chemical
ULCERATIVE COLITIS;TNFAIP3;Gene;PA443750;Disease
PSORIASIS;TNFAIP3;Gene;PA445451;Disease
INFLAMMATORY BOWEL DISEASES;TNFAIP3;Gene;PA446116;Disease
ARTHRITIS, PSORIATIC;TNFAIP3;Gene;PA446198;Disease
METHOTREXATE;TNFAIP3;Gene;PA450428;Chemical
DRUG-INDUCED LIVER INJURY;HLA-DRB1*16:01;Haplotype;PA166119041;Disease
FLUPIRTINE;HLA-DRB1*16:01;Haplotype;PA166152829;Chemical
RADIOTHERAPY;rs11125035;Variant;PA166122986;Chemical
DRUG TOXICITY;rs10932125;Variant;PA443937;Disease
DAUNORUBICIN;rs10932125;Variant;PA449212;Chemical
DAUNORUBICIN;rs41557318;Variant;PA449212;Chemical
DOXORUBICIN;rs41557318;Variant;PA449412;Chemical
OTOTOXICITY;rs1556422499;Variant;PA162263534;Disease
DIHYDROSTREPTOMYCIN;rs1556422499;Variant;PA166242461;Chemical
STREPTOMYCIN;rs1556422499;Variant;PA451512;Chemical
AMINOGLYCOSIDE ANTIBACTERIALS;rs1556422499;Variant;PA452167;Chemical
CYP2C19;flunitrazepam;Chemical;PA124;Gene
CYP3A4;flunitrazepam;Chemical;PA130;Gene
GABRG1;flunitrazepam;Chemical;PA28500;Gene
RS1801058;hypertensive nephrosclerosis;Disease;PA166156524;Variant
GRK4;hypertensive nephrosclerosis;Disease;PA28941;Gene
FLUOROURACIL;rs1695;Variant;PA128406956;Chemical
OXALIPLATIN;rs1695;Variant;PA131285527;Chemical
PLATINUM;rs1695;Variant;PA150595617;Chemical
OTOTOXICITY;rs1695;Variant;PA162263534;Disease
PLATINUM COMPOUNDS;rs1695;Variant;PA164713176;Chemical
DRUG-INDUCED LIVER INJURY;rs1695;Variant;PA166119041;Disease
CARDIOTOXICITY;rs1695;Variant;PA166128121;Disease
DIMETHYL FUMARATE;rs1695;Variant;PA166152838;Chemical
BREAST NEOPLASMS;rs1695;Variant;PA443560;Disease
NON-SMALL CELL LUNG CARCINOMA;rs1695;Variant;PA443622;Disease
DRUG TOXICITY;rs1695;Variant;PA443937;Disease
GASTROINTESTINAL NEOPLASMS;rs1695;Variant;PA444257;Disease
INFECTIOUS DISEASE;rs1695;Variant;PA444614;Disease
LEUKOPENIA;rs1695;Variant;PA444773;Disease
MEDULLOBLASTOMA;rs1695;Variant;PA444898;Disease
NAUSEA;rs1695;Variant;PA445048;Disease
NEOPLASMS;rs1695;Variant;PA445062;Disease
NEUTROPENIA;rs1695;Variant;PA445113;Disease
OVARIAN NEOPLASMS;rs1695;Variant;PA445204;Disease
PSORIASIS;rs1695;Variant;PA445451;Disease
RECTAL NEOPLASMS;rs1695;Variant;PA445503;Disease
OSTEOSARCOMA;rs1695;Variant;PA445601;Disease
TESTICULAR NEOPLASMS;rs1695;Variant;PA445828;Disease
TUBERCULOSIS;rs1695;Variant;PA445941;Disease
COLORECTAL NEOPLASMS;rs1695;Variant;PA446108;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs1695;Variant;PA446155;Disease
BLEOMYCIN;rs1695;Variant;PA448645;Chemical
CAPECITABINE;rs1695;Variant;PA448771;Chemical
CISPLATIN;rs1695;Variant;PA449014;Chemical
CYCLOPHOSPHAMIDE;rs1695;Variant;PA449165;Chemical
DOXORUBICIN;rs1695;Variant;PA449412;Chemical
EPIRUBICIN;rs1695;Variant;PA449476;Chemical
ETOPOSIDE;rs1695;Variant;PA449552;Chemical
ISONIAZID;rs1695;Variant;PA450112;Chemical
LEUCOVORIN;rs1695;Variant;PA450198;Chemical
MERCAPTOPURINE;rs1695;Variant;PA450379;Chemical
METHOTREXATE;rs1695;Variant;PA450428;Chemical
RIFAMPIN;rs1695;Variant;PA451250;Chemical
ESCITALOPRAM;CYP2C19*3;Haplotype;PA10074;Chemical
ESOMEPRAZOLE;CYP2C19*3;Haplotype;PA10075;Chemical
VORICONAZOLE;CYP2C19*3;Haplotype;PA10233;Chemical
SULFONAMIDES, UREA DERIVATIVES;CYP2C19*3;Haplotype;PA10390;Chemical
CLOBAZAM;CYP2C19*3;Haplotype;PA10888;Chemical
CYP2C19;CYP2C19*3;Haplotype;PA124;Gene
ROSUVASTATIN;CYP2C19*3;Haplotype;PA134308647;Chemical
PRASUGREL;CYP2C19*3;Haplotype;PA154410481;Chemical
CILOSTAZOL;CYP2C19*3;Haplotype;PA164746334;Chemical
ACUTE CORONARY SYNDROME;CYP2C19*3;Haplotype;PA165108401;Disease
KIDNEY TRANSPLANTATION;CYP2C19*3;Haplotype;PA165817016;Disease
AMBRISENTAN;CYP2C19*3;Haplotype;PA165860521;Chemical
HELICOBACTER INFECTIONS;CYP2C19*3;Haplotype;PA166048740;Disease
DEXLANSOPRAZOLE;CYP2C19*3;Haplotype;PA166110257;Chemical
ICOTINIB;CYP2C19*3;Haplotype;PA166114460;Chemical
INTRAGASTRIC PH;CYP2C19*3;Haplotype;PA166123203;Disease
PLATELET REACTIVITY;CYP2C19*3;Haplotype;PA166124406;Disease
TREATMENT FAILURE;CYP2C19*3;Haplotype;PA166128095;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);CYP2C19*3;Haplotype;PA166129560;Disease
BRIVARACETAM;CYP2C19*3;Haplotype;PA166153491;Chemical
HIGH ON-TREATMENT PLATELET REACTIVITY;CYP2C19*3;Haplotype;PA166163563;Disease
BELZUTIFAN;CYP2C19*3;Haplotype;PA166268761;Chemical
MAVACAMTEN;CYP2C19*3;Haplotype;PA166272922;Chemical
UGT2B17;CYP2C19*3;Haplotype;PA37189;Gene
ANGINA PECTORIS;CYP2C19*3;Haplotype;PA443362;Disease
ASTHMA;CYP2C19*3;Haplotype;PA443450;Disease
ATRIAL FIBRILLATION;CYP2C19*3;Haplotype;PA443459;Disease
CARDIOVASCULAR DISEASES;CYP2C19*3;Haplotype;PA443635;Disease
ISCHEMIC ATTACK, TRANSIENT;CYP2C19*3;Haplotype;PA443672;Disease
CORONARY ARTERY DISEASE;CYP2C19*3;Haplotype;PA443796;Disease
CORONARY DISEASE;CYP2C19*3;Haplotype;PA443797;Disease
DEATH;CYP2C19*3;Haplotype;PA443842;Disease
DIABETES MELLITUS, TYPE 2;CYP2C19*3;Haplotype;PA443890;Disease
EPILEPSY;CYP2C19*3;Haplotype;PA444065;Disease
ESOPHAGITIS;CYP2C19*3;Haplotype;PA444104;Disease
GASTROESOPHAGEAL REFLUX;CYP2C19*3;Haplotype;PA444255;Disease
HEMATOLOGIC DISEASES;CYP2C19*3;Haplotype;PA444395;Disease
HEMORRHAGE;CYP2C19*3;Haplotype;PA444417;Disease
MALARIA;CYP2C19*3;Haplotype;PA444859;Disease
MYCOSES;CYP2C19*3;Haplotype;PA445009;Disease
MYOCARDIAL INFARCTION;CYP2C19*3;Haplotype;PA445019;Disease
RESPIRATORY TRACT INFECTIONS;CYP2C19*3;Haplotype;PA445526;Disease
THROMBOSIS;CYP2C19*3;Haplotype;PA445850;Disease
ULCER;CYP2C19*3;Haplotype;PA445973;Disease
STROKE;CYP2C19*3;Haplotype;PA447054;Disease
DEPRESSIVE DISORDER;CYP2C19*3;Haplotype;PA447207;Disease
MENTAL DISORDERS;CYP2C19*3;Haplotype;PA447208;Disease
OBSESSIVE-COMPULSIVE DISORDER;CYP2C19*3;Haplotype;PA447211;Disease
PANIC DISORDER;CYP2C19*3;Haplotype;PA447212;Disease
PEPTIC ULCER;CYP2C19*3;Haplotype;PA447240;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2C19*3;Haplotype;PA447321;Disease
AMITRIPTYLINE;CYP2C19*3;Haplotype;PA448385;Chemical
AMOXICILLIN;CYP2C19*3;Haplotype;PA448406;Chemical
ASPIRIN;CYP2C19*3;Haplotype;PA448497;Chemical
ATORVASTATIN;CYP2C19*3;Haplotype;PA448500;Chemical
CITALOPRAM;CYP2C19*3;Haplotype;PA449015;Chemical
CLOMIPRAMINE;CYP2C19*3;Haplotype;PA449048;Chemical
CLOPIDOGREL;CYP2C19*3;Haplotype;PA449053;Chemical
DIAZEPAM;CYP2C19*3;Haplotype;PA449283;Chemical
EFAVIRENZ;CYP2C19*3;Haplotype;PA449441;Chemical
IBUPROFEN;CYP2C19*3;Haplotype;PA449957;Chemical
IMIPRAMINE;CYP2C19*3;Haplotype;PA449969;Chemical
LANSOPRAZOLE;CYP2C19*3;Haplotype;PA450180;Chemical
MEPHENYTOIN;CYP2C19*3;Haplotype;PA450373;Chemical
METHADONE;CYP2C19*3;Haplotype;PA450401;Chemical
NORTRIPTYLINE;CYP2C19*3;Haplotype;PA450657;Chemical
OMEPRAZOLE;CYP2C19*3;Haplotype;PA450704;Chemical
PANTOPRAZOLE;CYP2C19*3;Haplotype;PA450774;Chemical
PHENPROCOUMON;CYP2C19*3;Haplotype;PA450921;Chemical
PHENYTOIN;CYP2C19*3;Haplotype;PA450947;Chemical
PROGUANIL;CYP2C19*3;Haplotype;PA451124;Chemical
RABEPRAZOLE;CYP2C19*3;Haplotype;PA451216;Chemical
SERTRALINE;CYP2C19*3;Haplotype;PA451333;Chemical
VALPROIC ACID;CYP2C19*3;Haplotype;PA451846;Chemical
WARFARIN;CYP2C19*3;Haplotype;PA451906;Chemical
ACENOCOUMAROL;CYP2C19*3;Haplotype;PA452632;Chemical
OLAPARIB;PPP2R2A;Gene;PA164920420;Chemical
ESCITALOPRAM;BMP5;Gene;PA10074;Chemical
MAJOR DEPRESSIVE DISORDER;BMP5;Gene;PA447321;Disease
GEFITINIB;rs2695121;Variant;PA131301952;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs2695121;Variant;PA443622;Disease
DIARRHEA;rs2695121;Variant;PA443899;Disease
IMATINIB;rs2631372;Variant;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;rs2631372;Variant;PA151958383;Disease
PAIN, POSTOPERATIVE;rs2952768;Variant;PA445210;Disease
FENTANYL;rs2952768;Variant;PA449599;Chemical
OPIOIDS;rs2952768;Variant;PA452618;Chemical
RS121913459;ponatinib;Chemical;PA166157848;Variant
ABL1;ponatinib;Chemical;PA24413;Gene
BCR;ponatinib;Chemical;PA25321;Gene
HCG22;Retinal Diseases;Disease;PA134876212;Gene
RS2523864;Retinal Diseases;Disease;PA166159310;Variant
RS3873352;Retinal Diseases;Disease;PA166159319;Variant
MYELOSUPPRESSION;NUDT15*1;Haplotype;PA165817398;Disease
HEMATOPOIETIC STEM CELL TRANSPLANTATION;NUDT15*1;Haplotype;PA166123007;Disease
DISCONTINUATION;NUDT15*1;Haplotype;PA166123507;Disease
PRIMARY GRAFT FAILURE;NUDT15*1;Haplotype;PA166248341;Disease
INFLAMMATION;NUDT15*1;Haplotype;PA444620;Disease
LEUKOPENIA;NUDT15*1;Haplotype;PA444773;Disease
NEUTROPENIA;NUDT15*1;Haplotype;PA445113;Disease
INFLAMMATORY BOWEL DISEASES;NUDT15*1;Haplotype;PA446116;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;NUDT15*1;Haplotype;PA446155;Disease
ACYCLOVIR;NUDT15*1;Haplotype;PA448045;Chemical
AZATHIOPRINE;NUDT15*1;Haplotype;PA448515;Chemical
MERCAPTOPURINE;NUDT15*1;Haplotype;PA450379;Chemical
BEVACIZUMAB;rs4073;Variant;PA130232992;Chemical
MACULAR DEGENERATION;rs4073;Variant;PA134850558;Disease
GIVOSIRAN;PPOX;Gene;PA166190681;Chemical
HEROIN DEPENDENCE;rs806368;Variant;PA444460;Disease
COCAINE DEPENDENCE;rs806368;Variant;PA446878;Disease
COCAINE;rs806368;Variant;PA449072;Chemical
METHADONE;rs806368;Variant;PA450401;Chemical
METHOTREXATE;SLC22A9;Gene;PA450428;Chemical
ASTHMA;TERC;Gene;PA443450;Disease
ABCB1;tetracycline;Chemical;PA267;Gene
NR1I2;tetracycline;Chemical;PA378;Gene
BUTORPHANOL;rs4633;Variant;PA164745398;Chemical
DIZZINESS;rs4633;Variant;PA443928;Disease
PAIN;rs4633;Variant;PA445208;Disease
SCHIZOPHRENIA;rs4633;Variant;PA447216;Disease
PHYSIOLOGICAL SEXUAL DISORDER;rs4633;Variant;PA447218;Disease
RISPERIDONE;rs4633;Variant;PA451257;Chemical
OPIOIDS;rs4633;Variant;PA452618;Chemical
WEIGHT GAIN;rs7720513;Variant;PA128406954;Disease
ANTIPSYCHOTICS;rs7720513;Variant;PA452233;Chemical
FLUOROURACIL;PERP;Gene;PA128406956;Chemical
BREAST NEOPLASMS;PERP;Gene;PA443560;Disease
NEUTROPENIA;PERP;Gene;PA445113;Disease
CYCLOPHOSPHAMIDE;PERP;Gene;PA449165;Chemical
EPIRUBICIN;PERP;Gene;PA449476;Chemical
SCHIZOPHRENIA;rs2842030;Variant;PA447216;Disease
OLANZAPINE;rs2842030;Variant;PA450688;Chemical
PERPHENAZINE;rs2842030;Variant;PA450882;Chemical
RISPERIDONE;rs2842030;Variant;PA451257;Chemical
SCHIZOPHRENIA;MSANTD1;Gene;PA447216;Disease
RISPERIDONE;MSANTD1;Gene;PA451257;Chemical
OPIOID-RELATED DISORDERS;rs2070762;Variant;PA445043;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs2070762;Variant;PA447197;Disease
METHYLPHENIDATE;rs2070762;Variant;PA450464;Chemical
OPIOIDS;rs2070762;Variant;PA452618;Chemical
L-TRYPTOPHAN;SLC22A2;Gene;PA10323;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;SLC22A2;Gene;PA130620651;Chemical
OTOTOXICITY;SLC22A2;Gene;PA162263534;Disease
PLATINUM COMPOUNDS;SLC22A2;Gene;PA164713176;Chemical
FAMPRIDINE;SLC22A2;Gene;PA166123389;Chemical
CREATININE CLEARANCE;SLC22A2;Gene;PA166123756;Disease
NON-SMALL CELL LUNG CARCINOMA;SLC22A2;Gene;PA443622;Disease
NEOPLASMS;SLC22A2;Gene;PA445062;Disease
CISPLATIN;SLC22A2;Gene;PA449014;Chemical
LAMIVUDINE;SLC22A2;Gene;PA450163;Chemical
METFORMIN;SLC22A2;Gene;PA450395;Chemical
HEROIN DEPENDENCE;rs3766951;Variant;PA444460;Disease
HEROIN;rs3766951;Variant;PA452619;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs6759892;Variant;PA130620651;Chemical
DEFERIPRONE;rs6759892;Variant;PA166118041;Chemical
EPILEPSY;rs6759892;Variant;PA444065;Disease
BETA-THALASSEMIA AND RELATED DISEASES;rs6759892;Variant;PA446432;Disease
VALPROIC ACID;rs6759892;Variant;PA451846;Chemical
VELAGLUCERASE ALFA;GBA;Gene;PA166115366;Chemical
CEREBRAL INFARCTION;PTGIS;Gene;PA443670;Disease
HYPERTENSION;PTGIS;Gene;PA444552;Disease
MYOCARDIAL INFARCTION;PTGIS;Gene;PA445019;Disease
LEUKEMIA, MYELOID, ACUTE;rs5841;Variant;PA444760;Disease
CYTARABINE;rs5841;Variant;PA449177;Chemical
GEFITINIB;ERBB4;Gene;PA131301952;Chemical
ERLOTINIB;ERBB4;Gene;PA134687924;Chemical
LAPATINIB;ERBB4;Gene;PA152241907;Chemical
PALIPERIDONE;ERBB4;Gene;PA163518919;Chemical
JAK1;ERBB4;Gene;PA29988;Gene
PIK3CA;ERBB4;Gene;PA33308;Gene
PIK3CB;ERBB4;Gene;PA33309;Gene
PIK3CD;ERBB4;Gene;PA33310;Gene
PIK3CG;ERBB4;Gene;PA33311;Gene
PIK3R1;ERBB4;Gene;PA33312;Gene
PIK3R2;ERBB4;Gene;PA33313;Gene
PIK3R3;ERBB4;Gene;PA33314;Gene
PLCG1;ERBB4;Gene;PA33392;Gene
PLCG2;ERBB4;Gene;PA33393;Gene
DPYD;rs143154602;Variant;PA145;Gene
CAPECITABINE;rs143154602;Variant;PA448771;Chemical
SCHIZOPHRENIA;rs2535629;Variant;PA447216;Disease
CLOZAPINE;rs2535629;Variant;PA449061;Chemical
CYP2C9;rs6025;Variant;PA126;Gene
F2;rs6025;Variant;PA157;Gene
F5;rs6025;Variant;PA159;Gene
DROSPIRENONE / ETHINYL ESTRADIOL;rs6025;Variant;PA165290928;Chemical
ETHINYL ESTRADIOL / NORELGESTROMIN;rs6025;Variant;PA165290929;Chemical
ELTROMBOPAG;rs6025;Variant;PA165981594;Chemical
AVATROMBOPAG;rs6025;Variant;PA166179849;Chemical
LUSUTROMBOPAG;rs6025;Variant;PA166182748;Chemical
RELUGOLIX / ESTRADIOL / NORETHINDRONE ACETATE;rs6025;Variant;PA166397682;Chemical
PROC;rs6025;Variant;PA33799;Gene
PROS1;rs6025;Variant;PA33809;Gene
SERPINC1;rs6025;Variant;PA35026;Gene
THROMBOTIC DISEASE;rs6025;Variant;PA445850;Disease
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;rs6025;Variant;PA452637;Chemical
PEMETREXED;rs442767;Variant;PA10810;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs442767;Variant;PA443622;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs442767;Variant;PA446155;Disease
METHOTREXATE;rs442767;Variant;PA450428;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;HAS3;Gene;PA130620651;Chemical
CARDIOMYOPATHIES;HAS3;Gene;PA445018;Disease
CYP3A5;Cerebral Infarction;Disease;PA131;Gene
CYP3A5*1;Cerebral Infarction;Disease;PA166128213;Haplotype
CYP3A5*3;Cerebral Infarction;Disease;PA166128219;Haplotype
PTGIS;Cerebral Infarction;Disease;PA292;Gene
WARFARIN;NEDD4;Gene;PA451906;Chemical
ARACHIDONIC ACID;rs753169154;Variant;PA166178659;Chemical
G6PD B (REFERENCE);phenazopyridine;Chemical;PA165947826;Haplotype
G6PD MEDITERRANEAN HAPLOTYPE;phenazopyridine;Chemical;PA165947830;Haplotype
G6PD DEFICIENCY;phenazopyridine;Chemical;PA166157959;Variant
G6PD;phenazopyridine;Chemical;PA28469;Gene
REN;vitamin d and analogues;Chemical;PA297;Gene
UGT1A3;vitamin d and analogues;Chemical;PA37178;Gene
UGT1A4;vitamin d and analogues;Chemical;PA37179;Gene
VDR;vitamin d and analogues;Chemical;PA37301;Gene
RIFAMPIN;vitamin d and analogues;Chemical;PA451250;Chemical
IFNL3;simeprevir;Chemical;PA134952671;Gene
IFNL4;simeprevir;Chemical;PA166049147;Gene
RS8099917;simeprevir;Chemical;PA166155435;Variant
RS12979860;simeprevir;Chemical;PA166155468;Variant
RS11322783;simeprevir;Chemical;PA166190881;Variant
COTININE GLUCURONIDE;rs12471326;Variant;PA166131561;Chemical
ABCC2;fluorouracil;Chemical;PA116;Gene
CYP2A6;fluorouracil;Chemical;PA121;Gene
CYP2C19;fluorouracil;Chemical;PA124;Gene
CYP2C8;fluorouracil;Chemical;PA125;Gene
SLCO1B1;fluorouracil;Chemical;PA134865839;Gene
SLC22A16;fluorouracil;Chemical;PA134911502;Gene
GALNT14;fluorouracil;Chemical;PA134920089;Gene
PERP;fluorouracil;Chemical;PA134944221;Gene
GNL3;fluorouracil;Chemical;PA134952132;Gene
C18ORF56;fluorouracil;Chemical;PA134956204;Gene
MEGF11;fluorouracil;Chemical;PA144596411;Gene
DPYD;fluorouracil;Chemical;PA145;Gene
DPYS;fluorouracil;Chemical;PA146;Gene
ERCC1;fluorouracil;Chemical;PA155;Gene
KLC1;fluorouracil;Chemical;PA162393424;Gene
PARD3B;fluorouracil;Chemical;PA162398721;Gene
TMEM167A;fluorouracil;Chemical;PA162405909;Gene
TYMP;fluorouracil;Chemical;PA162407502;Gene
MIR27A;fluorouracil;Chemical;PA164722621;Gene
TP53AIP1;fluorouracil;Chemical;PA164726680;Gene
TPMT*1;fluorouracil;Chemical;PA165819268;Haplotype
TPMT*3B;fluorouracil;Chemical;PA165819271;Haplotype
TPMT*3C;fluorouracil;Chemical;PA165819272;Haplotype
CYP2A6*1;fluorouracil;Chemical;PA165924690;Haplotype
CYP2A6*4;fluorouracil;Chemical;PA165924721;Haplotype
CYP2A6*7;fluorouracil;Chemical;PA165924731;Haplotype
CYP2A6*9;fluorouracil;Chemical;PA165980914;Haplotype
GSTM1 NULL;fluorouracil;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;fluorouracil;Chemical;PA166048676;Haplotype
RS1047840;fluorouracil;Chemical;PA166153609;Variant
RS1056515;fluorouracil;Chemical;PA166153615;Variant
RS1801131;fluorouracil;Chemical;PA166153643;Variant
RS1801133;fluorouracil;Chemical;PA166153644;Variant
RS1801158;fluorouracil;Chemical;PA166153645;Variant
RS1801159;fluorouracil;Chemical;PA166153646;Variant
RS1801160;fluorouracil;Chemical;PA166153647;Variant
RS1801265;fluorouracil;Chemical;PA166153648;Variant
RS1801266;fluorouracil;Chemical;PA166153649;Variant
RS1801268;fluorouracil;Chemical;PA166153651;Variant
RS2297595;fluorouracil;Chemical;PA166153696;Variant
RS3917412;fluorouracil;Chemical;PA166153758;Variant
RS3918290;fluorouracil;Chemical;PA166153760;Variant
RS17376848;fluorouracil;Chemical;PA166153874;Variant
RS55886062;fluorouracil;Chemical;PA166153888;Variant
RS56038477;fluorouracil;Chemical;PA166153889;Variant
RS59086055;fluorouracil;Chemical;PA166153891;Variant
RS67376798;fluorouracil;Chemical;PA166153895;Variant
RS72549303;fluorouracil;Chemical;PA166153897;Variant
RS72549306;fluorouracil;Chemical;PA166153899;Variant
RS72549309;fluorouracil;Chemical;PA166153902;Variant
RS72728438;fluorouracil;Chemical;PA166153903;Variant
RS75017182;fluorouracil;Chemical;PA166153906;Variant
RS78060119;fluorouracil;Chemical;PA166153913;Variant
RS115232898;fluorouracil;Chemical;PA166153919;Variant
RS115632870;fluorouracil;Chemical;PA166153920;Variant
RS188052243;fluorouracil;Chemical;PA166153934;Variant
RS201045130;fluorouracil;Chemical;PA166153937;Variant
RS370457585;fluorouracil;Chemical;PA166153938;Variant
RS374150125;fluorouracil;Chemical;PA166153939;Variant
RS717620;fluorouracil;Chemical;PA166153953;Variant
RS2273697;fluorouracil;Chemical;PA166154007;Variant
RS2289310;fluorouracil;Chemical;PA166154010;Variant
RS3740066;fluorouracil;Chemical;PA166154028;Variant
RS4244285;fluorouracil;Chemical;PA166154053;Variant
RS12248560;fluorouracil;Chemical;PA166154147;Variant
RS17431184;fluorouracil;Chemical;PA166154164;Variant
RS1695;fluorouracil;Chemical;PA166154249;Variant
RS9344;fluorouracil;Chemical;PA166154264;Variant
RS2010851;fluorouracil;Chemical;PA166154523;Variant
RS4149056;fluorouracil;Chemical;PA166154579;Variant
RS17109924;fluorouracil;Chemical;PA166154646;Variant
RS7325568;fluorouracil;Chemical;PA166154720;Variant
RS9561778;fluorouracil;Chemical;PA166154741;Variant
RS861539;fluorouracil;Chemical;PA166154768;Variant
RS2236722;fluorouracil;Chemical;PA166154880;Variant
RS1800566;fluorouracil;Chemical;PA166155017;Variant
RS7194667;fluorouracil;Chemical;PA166155078;Variant
RS1979277;fluorouracil;Chemical;PA166155196;Variant
RS2228100;fluorouracil;Chemical;PA166155201;Variant
RS2847153;fluorouracil;Chemical;PA166155288;Variant
RS45445694;fluorouracil;Chemical;PA166155331;Variant
RS183205964;fluorouracil;Chemical;PA166155336;Variant
RS11615;fluorouracil;Chemical;PA166155342;Variant
RS13181;fluorouracil;Chemical;PA166155343;Variant
RS25487;fluorouracil;Chemical;PA166155346;Variant
RS895819;fluorouracil;Chemical;PA166155357;Variant
RS1799782;fluorouracil;Chemical;PA166155370;Variant
RS3212986;fluorouracil;Chemical;PA166155407;Variant
RS1056836;fluorouracil;Chemical;PA166155621;Variant
RS9679162;fluorouracil;Chemical;PA166155774;Variant
RS12613732;fluorouracil;Chemical;PA166155818;Variant
RS17626122;fluorouracil;Chemical;PA166155846;Variant
RS12659;fluorouracil;Chemical;PA166155973;Variant
RS20572;fluorouracil;Chemical;PA166155974;Variant
RS225440;fluorouracil;Chemical;PA166155976;Variant
RS11479;fluorouracil;Chemical;PA166156029;Variant
RS2291078;fluorouracil;Chemical;PA166156353;Variant
RS2292997;fluorouracil;Chemical;PA166156354;Variant
RS3749438;fluorouracil;Chemical;PA166156376;Variant
RS3772809;fluorouracil;Chemical;PA166156378;Variant
RS3772810;fluorouracil;Chemical;PA166156379;Variant
RS10937158;fluorouracil;Chemical;PA166156440;Variant
RS2231142;fluorouracil;Chemical;PA166156544;Variant
RS7699188;fluorouracil;Chemical;PA166156632;Variant
RS351855;fluorouracil;Chemical;PA166156731;Variant
RS25648;fluorouracil;Chemical;PA166156906;Variant
RS699947;fluorouracil;Chemical;PA166156938;Variant
RS714368;fluorouracil;Chemical;PA166156940;Variant
RS2016520;fluorouracil;Chemical;PA166157007;Variant
RS3218592;fluorouracil;Chemical;PA166157075;Variant
RS6907567;fluorouracil;Chemical;PA166157112;Variant
RS9380142;fluorouracil;Chemical;PA166157153;Variant
RS17179108;fluorouracil;Chemical;PA166157191;Variant
RS371194629;fluorouracil;Chemical;PA166157235;Variant
RS662;fluorouracil;Chemical;PA166157238;Variant
RS1045642;fluorouracil;Chemical;PA166157284;Variant
RS1799983;fluorouracil;Chemical;PA166157303;Variant
RS2070744;fluorouracil;Chemical;PA166157325;Variant
RS2293347;fluorouracil;Chemical;PA166157355;Variant
RS2854744;fluorouracil;Chemical;PA166157368;Variant
RS2960436;fluorouracil;Chemical;PA166157371;Variant
RS17160359;fluorouracil;Chemical;PA166157471;Variant
RS770063251;fluorouracil;Chemical;PA166157694;Variant
DPYD DEFICIENCY;fluorouracil;Chemical;PA166157931;Variant
DPYD POOR METABOLIZER;fluorouracil;Chemical;PA166157958;Variant
RS376073289;fluorouracil;Chemical;PA166159507;Variant
RS367619008;fluorouracil;Chemical;PA166159539;Variant
RS148994843;fluorouracil;Chemical;PA166159784;Variant
RS12050587;fluorouracil;Chemical;PA166164874;Variant
RS11636687;fluorouracil;Chemical;PA166164877;Variant
RS2298881;fluorouracil;Chemical;PA166169975;Variant
RS10040363;fluorouracil;Chemical;PA166169977;Variant
RS2075685;fluorouracil;Chemical;PA166169979;Variant
RS3219489;fluorouracil;Chemical;PA166171088;Variant
DPYD C.1905+1G>A (*2A);fluorouracil;Chemical;PA166171117;Haplotype
DPYD C.1679T>G (*13);fluorouracil;Chemical;PA166171118;Haplotype
DPYD C.2846A>T;fluorouracil;Chemical;PA166171119;Haplotype
DPYD C.1129-5923C>G, C.1236G>A (HAPB3);fluorouracil;Chemical;PA166171120;Haplotype
RS144991623;fluorouracil;Chemical;PA166178395;Variant
RS9389568;fluorouracil;Chemical;PA166178396;Variant
RS8110364;fluorouracil;Chemical;PA166178397;Variant
RS56022120;fluorouracil;Chemical;PA166178398;Variant
RS150688309;fluorouracil;Chemical;PA166178399;Variant
RS58695150;fluorouracil;Chemical;PA166178400;Variant
RS299293;fluorouracil;Chemical;PA166178401;Variant
RS138602176;fluorouracil;Chemical;PA166178402;Variant
RS148235907;fluorouracil;Chemical;PA166178403;Variant
RS117951771;fluorouracil;Chemical;PA166178404;Variant
RS299314;fluorouracil;Chemical;PA166178405;Variant
RS299313;fluorouracil;Chemical;PA166178406;Variant
RS115457081;fluorouracil;Chemical;PA166178407;Variant
RS117341846;fluorouracil;Chemical;PA166178408;Variant
RS4968187;fluorouracil;Chemical;PA166178409;Variant
RS142244113;fluorouracil;Chemical;PA166178410;Variant
RS79430272;fluorouracil;Chemical;PA166178411;Variant
RS118129530;fluorouracil;Chemical;PA166178412;Variant
RS77769901;fluorouracil;Chemical;PA166178413;Variant
RS145623321;fluorouracil;Chemical;PA166178414;Variant
RS148013902;fluorouracil;Chemical;PA166178415;Variant
RS55633228;fluorouracil;Chemical;PA166178416;Variant
RS41412545;fluorouracil;Chemical;PA166178421;Variant
RS3805945;fluorouracil;Chemical;PA166178422;Variant
RS117101815;fluorouracil;Chemical;PA166178423;Variant
RS9402944;fluorouracil;Chemical;PA166178424;Variant
RS181501757;fluorouracil;Chemical;PA166178425;Variant
RS149212925;fluorouracil;Chemical;PA166178426;Variant
RS112783657;fluorouracil;Chemical;PA166178427;Variant
RS74743371;fluorouracil;Chemical;PA166178428;Variant
RS117458836;fluorouracil;Chemical;PA166178429;Variant
RS118088833;fluorouracil;Chemical;PA166178430;Variant
RS112242273;fluorouracil;Chemical;PA166178431;Variant
RS78428806;fluorouracil;Chemical;PA166178432;Variant
RS141084494;fluorouracil;Chemical;PA166178541;Variant
RS143879757;fluorouracil;Chemical;PA166179507;Variant
RS1184321568;fluorouracil;Chemical;PA166179510;Variant
RS748620513;fluorouracil;Chemical;PA166179513;Variant
RS56005131;fluorouracil;Chemical;PA166179517;Variant
RS1335150891;fluorouracil;Chemical;PA166179519;Variant
RS1212037891;fluorouracil;Chemical;PA166179525;Variant
RS1801516;fluorouracil;Chemical;PA166180286;Variant
RS11280056;fluorouracil;Chemical;PA166180936;Variant
DPYD C.2194G>A (*6);fluorouracil;Chemical;PA166194413;Haplotype
RS6025211;fluorouracil;Chemical;PA166201322;Variant
RS1760944;fluorouracil;Chemical;PA166238764;Variant
RS374825099;fluorouracil;Chemical;PA166319205;Variant
RS372307932;fluorouracil;Chemical;PA166319207;Variant
RS369103276;fluorouracil;Chemical;PA166319222;Variant
RS374527058;fluorouracil;Chemical;PA166319223;Variant
RS371258350;fluorouracil;Chemical;PA166319224;Variant
RS368146607;fluorouracil;Chemical;PA166319225;Variant
RS140039091;fluorouracil;Chemical;PA166319421;Variant
RS187713395;fluorouracil;Chemical;PA166319422;Variant
RS758649719;fluorouracil;Chemical;PA166319424;Variant
RS570122671;fluorouracil;Chemical;PA166319461;Variant
RS201268750;fluorouracil;Chemical;PA166319463;Variant
RS527580106;fluorouracil;Chemical;PA166319465;Variant
RS528152707;fluorouracil;Chemical;PA166319467;Variant
RS536577604;fluorouracil;Chemical;PA166319501;Variant
RS558354142;fluorouracil;Chemical;PA166319622;Variant
RS538703919;fluorouracil;Chemical;PA166319642;Variant
RS568367673;fluorouracil;Chemical;PA166319644;Variant
RS140989814;fluorouracil;Chemical;PA166319662;Variant
RS538336580;fluorouracil;Chemical;PA166319664;Variant
RS548783838;fluorouracil;Chemical;PA166319703;Variant
RS575853463;fluorouracil;Chemical;PA166319705;Variant
RS569661196;fluorouracil;Chemical;PA166319721;Variant
RS755416212;fluorouracil;Chemical;PA166320941;Variant
RS143004875;fluorouracil;Chemical;PA166321181;Variant
RS4294451;fluorouracil;Chemical;PA166336961;Variant
GSTM1;fluorouracil;Chemical;PA182;Gene
APEX1;fluorouracil;Chemical;PA201059;Gene
INSR;fluorouracil;Chemical;PA202;Gene
IRS1;fluorouracil;Chemical;PA203;Gene
ABCC11;fluorouracil;Chemical;PA24393;Gene
ABCG1;fluorouracil;Chemical;PA24408;Gene
MTHFR;fluorouracil;Chemical;PA245;Gene
ALDH3A1;fluorouracil;Chemical;PA24697;Gene
NOS1;fluorouracil;Chemical;PA252;Gene
NOS3;fluorouracil;Chemical;PA254;Gene
CBR1;fluorouracil;Chemical;PA26121;Gene
CBR3;fluorouracil;Chemical;PA26122;Gene
CCNK;fluorouracil;Chemical;PA26161;Gene
CHN2;fluorouracil;Chemical;PA26474;Gene
ABCB1;fluorouracil;Chemical;PA267;Gene
CYP19A1;fluorouracil;Chemical;PA27091;Gene
CYP1B1;fluorouracil;Chemical;PA27094;Gene
DLG5;fluorouracil;Chemical;PA27360;Gene
ERCC2;fluorouracil;Chemical;PA27848;Gene
EXO1;fluorouracil;Chemical;PA27923;Gene
FGFR4;fluorouracil;Chemical;PA28130;Gene
FOXO1;fluorouracil;Chemical;PA28237;Gene
LGR5;fluorouracil;Chemical;PA28894;Gene
GSTP1;fluorouracil;Chemical;PA29028;Gene
HMMR;fluorouracil;Chemical;PA29340;Gene
IGFBP3;fluorouracil;Chemical;PA29705;Gene
MUTYH;fluorouracil;Chemical;PA31328;Gene
NQO1;fluorouracil;Chemical;PA31744;Gene
NT5C1A;fluorouracil;Chemical;PA31799;Gene
SLC19A1;fluorouracil;Chemical;PA327;Gene
OSGEP;fluorouracil;Chemical;PA32834;Gene
PIGB;fluorouracil;Chemical;PA33290;Gene
PIK3R2;fluorouracil;Chemical;PA33313;Gene
PON1;fluorouracil;Chemical;PA33529;Gene
PPARD;fluorouracil;Chemical;PA33557;Gene
PPP2R5D;fluorouracil;Chemical;PA33676;Gene
PTEN;fluorouracil;Chemical;PA33942;Gene
RBX1;fluorouracil;Chemical;PA34299;Gene
REV3L;fluorouracil;Chemical;PA34337;Gene
RGS5;fluorouracil;Chemical;PA34376;Gene
HLA-G;fluorouracil;Chemical;PA35083;Gene
TOP2A;fluorouracil;Chemical;PA354;Gene
TPMT;fluorouracil;Chemical;PA356;Gene
SELE;fluorouracil;Chemical;PA35640;Gene
SHMT1;fluorouracil;Chemical;PA35753;Gene
TYMS;fluorouracil;Chemical;PA359;Gene
UMPS;fluorouracil;Chemical;PA363;Gene
TP53;fluorouracil;Chemical;PA36679;Gene
XRCC1;fluorouracil;Chemical;PA369;Gene
TWIST1;fluorouracil;Chemical;PA37088;Gene
VEGFA;fluorouracil;Chemical;PA37302;Gene
XRCC3;fluorouracil;Chemical;PA37422;Gene
XRCC4;fluorouracil;Chemical;PA37423;Gene
WNT5B;fluorouracil;Chemical;PA38104;Gene
ABCG2;fluorouracil;Chemical;PA390;Gene
ABCC5;fluorouracil;Chemical;PA395;Gene
ABCC4;fluorouracil;Chemical;PA397;Gene
ATM;fluorouracil;Chemical;PA61;Gene
EGFR;fluorouracil;Chemical;PA7360;Gene
CCND1;fluorouracil;Chemical;PA75;Gene
RS72554665;G6PD Deficiency;Disease;PA166157888;Variant
RS137852330;G6PD Deficiency;Disease;PA166161055;Variant
G6PD;G6PD Deficiency;Disease;PA28469;Gene
PAIN;rs224534;Variant;PA445208;Disease
ACETAMINOPHEN;rs224534;Variant;PA448015;Chemical
CYP2C19;cimetidine;Chemical;PA124;Gene
ABCB1;cimetidine;Chemical;PA267;Gene
ADVERSE EVENTS;rs115346678;Variant;PA166151827;Disease
ASPIRIN;rs115346678;Variant;PA448497;Chemical
WARFARIN;rs7089580;Variant;PA451906;Chemical
DPYD;rs150437414;Variant;PA145;Gene
CAPECITABINE;rs150437414;Variant;PA448771;Chemical
ACENOCOUMAROL;CYP2C18;Gene;PA452632;Chemical
CFTR;roflumilast;Chemical;PA109;Gene
RS121909011;roflumilast;Chemical;PA166161188;Variant
BCHE;mivacurium;Chemical;PA25294;Gene
COMT;Schizophrenia;Disease;PA117;Gene
CRP;Schizophrenia;Disease;PA120;Gene
CYP2C19;Schizophrenia;Disease;PA124;Gene
CYP2D6;Schizophrenia;Disease;PA128;Gene
ANKS1B;Schizophrenia;Disease;PA128394692;Gene
CYP2E1;Schizophrenia;Disease;PA129;Gene
CYP3A4;Schizophrenia;Disease;PA130;Gene
CCL2;Schizophrenia;Disease;PA130413151;Gene
CYP3A5;Schizophrenia;Disease;PA131;Gene
ANKK1;Schizophrenia;Disease;PA134872551;Gene
TAAR6;Schizophrenia;Disease;PA134881141;Gene
SV2C;Schizophrenia;Disease;PA134888452;Gene
INSIG2;Schizophrenia;Disease;PA134890284;Gene
EIF2AK4;Schizophrenia;Disease;PA134947616;Gene
BDNF-AS;Schizophrenia;Disease;PA134953249;Gene
HRH4;Schizophrenia;Disease;PA134982275;Gene
PPA2;Schizophrenia;Disease;PA142671159;Gene
DRD1;Schizophrenia;Disease;PA147;Gene
ESR1;Schizophrenia;Disease;PA156;Gene
BRUGADA SYNDROME;Schizophrenia;Disease;PA159018367;Disease
MSANTD1;Schizophrenia;Disease;PA162379942;Gene
SPOPL;Schizophrenia;Disease;PA162404650;Gene
ZNF804A;Schizophrenia;Disease;PA162410599;Gene
MIR582;Schizophrenia;Disease;PA164722879;Gene
HTT;Schizophrenia;Disease;PA164741646;Gene
CYP2C19*17;Schizophrenia;Disease;PA165816533;Haplotype
CYP2D6*1;Schizophrenia;Disease;PA165816576;Haplotype
CYP2D6*2;Schizophrenia;Disease;PA165816577;Haplotype
CYP2D6*3;Schizophrenia;Disease;PA165816578;Haplotype
CYP2D6*4;Schizophrenia;Disease;PA165816579;Haplotype
CYP2D6*6;Schizophrenia;Disease;PA165816581;Haplotype
CYP2D6*10;Schizophrenia;Disease;PA165816582;Haplotype
CYP2D6*17;Schizophrenia;Disease;PA165816583;Haplotype
CYP2D6*41;Schizophrenia;Disease;PA165816584;Haplotype
CYP2D6*5;Schizophrenia;Disease;PA165948092;Haplotype
HLA-DPB1*04:01;Schizophrenia;Disease;PA165951133;Haplotype
HLA-DRB1*01:01;Schizophrenia;Disease;PA165951320;Haplotype
HLA-DRB1*04:02;Schizophrenia;Disease;PA165951501;Haplotype
HLA-DRB3*02:02;Schizophrenia;Disease;PA165952408;Haplotype
HLA-DRB5*02:02;Schizophrenia;Disease;PA165952475;Haplotype
HLA-A*31:01;Schizophrenia;Disease;PA165954030;Haplotype
HLA-B*38:01;Schizophrenia;Disease;PA165955500;Haplotype
HLA-B*59:01;Schizophrenia;Disease;PA165956674;Haplotype
HLA-C*07:01;Schizophrenia;Disease;PA165957372;Haplotype
HLA-DQB1*05:02;Schizophrenia;Disease;PA165958077;Haplotype
HLA-DQB1*02:01;Schizophrenia;Disease;PA165958158;Haplotype
CYP2D6*7;Schizophrenia;Disease;PA165971559;Haplotype
CYP2C19*1;Schizophrenia;Disease;PA165980634;Haplotype
CYP2C19*2;Schizophrenia;Disease;PA165980635;Haplotype
CYP2D6*1XN;Schizophrenia;Disease;PA165988479;Haplotype
UGT1A1*28;Schizophrenia;Disease;PA166115842;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);Schizophrenia;Disease;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);Schizophrenia;Disease;PA166116466;Haplotype
SLC6A4 L ALLELE-RS25531T;Schizophrenia;Disease;PA166117146;Haplotype
SLC6A4 L ALLELE-RS25531C;Schizophrenia;Disease;PA166117147;Haplotype
CYP3A5*1;Schizophrenia;Disease;PA166128213;Haplotype
CYP3A5*3;Schizophrenia;Disease;PA166128219;Haplotype
RS4606;Schizophrenia;Disease;PA166153543;Variant
RS878949;Schizophrenia;Disease;PA166153597;Variant
RS951439;Schizophrenia;Disease;PA166153604;Variant
RS1801131;Schizophrenia;Disease;PA166153643;Variant
RS1801133;Schizophrenia;Disease;PA166153644;Variant
RS1805054;Schizophrenia;Disease;PA166153653;Variant
RS2445142;Schizophrenia;Disease;PA166153705;Variant
RS2661319;Schizophrenia;Disease;PA166153715;Variant
RS2842030;Schizophrenia;Disease;PA166153720;Variant
RS10917670;Schizophrenia;Disease;PA166153815;Variant
RS1880676;Schizophrenia;Disease;PA166153979;Variant
RS2515641;Schizophrenia;Disease;PA166154017;Variant
RS3810950;Schizophrenia;Disease;PA166154040;Variant
RS7912580;Schizophrenia;Disease;PA166154088;Variant
RS6265;Schizophrenia;Disease;PA166154259;Variant
RS6277;Schizophrenia;Disease;PA166154261;Variant
RS1062613;Schizophrenia;Disease;PA166154312;Variant
RS1076560;Schizophrenia;Disease;PA166154313;Variant
RS1079597;Schizophrenia;Disease;PA166154315;Variant
RS1079598;Schizophrenia;Disease;PA166154316;Variant
RS1150226;Schizophrenia;Disease;PA166154321;Variant
RS1799732;Schizophrenia;Disease;PA166154334;Variant
RS1799978;Schizophrenia;Disease;PA166154337;Variant
RS1800497;Schizophrenia;Disease;PA166154339;Variant
RS2276302;Schizophrenia;Disease;PA166154358;Variant
RS2298826;Schizophrenia;Disease;PA166154366;Variant
RS2513265;Schizophrenia;Disease;PA166154374;Variant
RS2514218;Schizophrenia;Disease;PA166154375;Variant
RS4436578;Schizophrenia;Disease;PA166154407;Variant
RS10501087;Schizophrenia;Disease;PA166154431;Variant
RS11030104;Schizophrenia;Disease;PA166154444;Variant
RS5443;Schizophrenia;Disease;PA166154486;Variant
RS1072388;Schizophrenia;Disease;PA166154510;Variant
RS7973796;Schizophrenia;Disease;PA166154607;Variant
RS6313;Schizophrenia;Disease;PA166154675;Variant
RS6314;Schizophrenia;Disease;PA166154676;Variant
RS2494732;Schizophrenia;Disease;PA166154793;Variant
RS3803300;Schizophrenia;Disease;PA166154801;Variant
RS762551;Schizophrenia;Disease;PA166154850;Variant
RS2061051;Schizophrenia;Disease;PA166154873;Variant
RS2069514;Schizophrenia;Disease;PA166154874;Variant
RS2412459;Schizophrenia;Disease;PA166154891;Variant
RS4586;Schizophrenia;Disease;PA166155151;Variant
RS2857657;Schizophrenia;Disease;PA166155210;Variant
RS4795893;Schizophrenia;Disease;PA166155227;Variant
RS11868035;Schizophrenia;Disease;PA166155247;Variant
RS489693;Schizophrenia;Disease;PA166155269;Variant
RS4483927;Schizophrenia;Disease;PA166155296;Variant
RS11872992;Schizophrenia;Disease;PA166155319;Variant
RS10423928;Schizophrenia;Disease;PA166155453;Variant
RS10012;Schizophrenia;Disease;PA166155586;Variant
RS16944;Schizophrenia;Disease;PA166155587;Variant
RS1042597;Schizophrenia;Disease;PA166155614;Variant
RS1056827;Schizophrenia;Disease;PA166155620;Variant
RS1143634;Schizophrenia;Disease;PA166155630;Variant
RS1344706;Schizophrenia;Disease;PA166155631;Variant
RS4849127;Schizophrenia;Disease;PA166155736;Variant
RS6706232;Schizophrenia;Disease;PA166155747;Variant
RS10490162;Schizophrenia;Disease;PA166155789;Variant
RS11123469;Schizophrenia;Disease;PA166155798;Variant
RS11677416;Schizophrenia;Disease;PA166155806;Variant
RS12467557;Schizophrenia;Disease;PA166155812;Variant
RS13429709;Schizophrenia;Disease;PA166155833;Variant
RS17587100;Schizophrenia;Disease;PA166155845;Variant
RS3787429;Schizophrenia;Disease;PA166155940;Variant
RS3787430;Schizophrenia;Disease;PA166155941;Variant
RS4633;Schizophrenia;Disease;PA166156023;Variant
RS4680;Schizophrenia;Disease;PA166156024;Variant
RS4818;Schizophrenia;Disease;PA166156025;Variant
RS6269;Schizophrenia;Disease;PA166156027;Variant
RS165599;Schizophrenia;Disease;PA166156046;Variant
RS1065852;Schizophrenia;Disease;PA166156062;Variant
RS9606186;Schizophrenia;Disease;PA166156134;Variant
RS6280;Schizophrenia;Disease;PA166156277;Variant
RS167771;Schizophrenia;Disease;PA166156280;Variant
RS1801282;Schizophrenia;Disease;PA166156331;Variant
RS9852;Schizophrenia;Disease;PA166156482;Variant
RS6295;Schizophrenia;Disease;PA166156708;Variant
RS265976;Schizophrenia;Disease;PA166156722;Variant
RS1042713;Schizophrenia;Disease;PA166156748;Variant
RS1544938;Schizophrenia;Disease;PA166156766;Variant
RS2975226;Schizophrenia;Disease;PA166156812;Variant
RS10042486;Schizophrenia;Disease;PA166156855;Variant
RS11960832;Schizophrenia;Disease;PA166156873;Variant
RS742105;Schizophrenia;Disease;PA166156943;Variant
RS806378;Schizophrenia;Disease;PA166156956;Variant
RS909706;Schizophrenia;Disease;PA166156964;Variant
RS1360780;Schizophrenia;Disease;PA166156983;Variant
RS1415744;Schizophrenia;Disease;PA166156984;Variant
RS2268639;Schizophrenia;Disease;PA166157028;Variant
RS4305746;Schizophrenia;Disease;PA166157100;Variant
RS9346455;Schizophrenia;Disease;PA166157145;Variant
RS472660;Schizophrenia;Disease;PA166157257;Variant
RS724226;Schizophrenia;Disease;PA166157264;Variant
RS1045642;Schizophrenia;Disease;PA166157284;Variant
RS1468412;Schizophrenia;Disease;PA166157298;Variant
RS2032582;Schizophrenia;Disease;PA166157316;Variant
RS4731426;Schizophrenia;Disease;PA166157400;Variant
RS6465084;Schizophrenia;Disease;PA166157411;Variant
RS6977820;Schizophrenia;Disease;PA166157426;Variant
RS7787082;Schizophrenia;Disease;PA166157428;Variant
RS10248420;Schizophrenia;Disease;PA166157440;Variant
RS4994;Schizophrenia;Disease;PA166157543;Variant
RS13250975;Schizophrenia;Disease;PA166157643;Variant
RS17716295;Schizophrenia;Disease;PA166157653;Variant
RS1778929;Schizophrenia;Disease;PA166157736;Variant
RS10465180;Schizophrenia;Disease;PA166157805;Variant
RS6318;Schizophrenia;Disease;PA166157849;Variant
RS518147;Schizophrenia;Disease;PA166157854;Variant
RS1414334;Schizophrenia;Disease;PA166157862;Variant
RS3813929;Schizophrenia;Disease;PA166157875;Variant
CYP2D6 POOR METABOLIZER;Schizophrenia;Disease;PA166157927;Variant
RS16935279;Schizophrenia;Disease;PA166159072;Variant
RS2535629;Schizophrenia;Disease;PA166159627;Variant
RS11543791;Schizophrenia;Disease;PA166160309;Variant
RS5993883;Schizophrenia;Disease;PA166161174;Variant
RS7968606;Schizophrenia;Disease;PA166163521;Variant
CYP2D6*14;Schizophrenia;Disease;PA166181185;Haplotype
RS6688363;Schizophrenia;Disease;PA166184305;Variant
RS8050896;Schizophrenia;Disease;PA166184306;Variant
RS2980976;Schizophrenia;Disease;PA166184307;Variant
RS2636697;Schizophrenia;Disease;PA166184308;Variant
RS2636719;Schizophrenia;Disease;PA166184309;Variant
RS7395555;Schizophrenia;Disease;PA166184310;Variant
RS10170310;Schizophrenia;Disease;PA166184311;Variant
RS17382202;Schizophrenia;Disease;PA166184312;Variant
RS17742120;Schizophrenia;Disease;PA166184313;Variant
RS2164660;Schizophrenia;Disease;PA166184314;Variant
RS711355;Schizophrenia;Disease;PA166184316;Variant
RS785423;Schizophrenia;Disease;PA166184317;Variant
RS813676;Schizophrenia;Disease;PA166184318;Variant
RS362267;Schizophrenia;Disease;PA166185304;Variant
RS362306;Schizophrenia;Disease;PA166185306;Variant
RS28379954;Schizophrenia;Disease;PA166232961;Variant
RS155333;Schizophrenia;Disease;PA166252941;Variant
RS6465938;Schizophrenia;Disease;PA166252981;Variant
CYP1A2*35;Schizophrenia;Disease;PA166363479;Haplotype
GNB3;Schizophrenia;Disease;PA176;Gene
HTR1A;Schizophrenia;Disease;PA192;Gene
HTR2A;Schizophrenia;Disease;PA193;Gene
HTR2C;Schizophrenia;Disease;PA194;Gene
LEP;Schizophrenia;Disease;PA228;Gene
MTHFR;Schizophrenia;Disease;PA245;Gene
ADCY2;Schizophrenia;Disease;PA24561;Gene
ADRB3;Schizophrenia;Disease;PA24598;Gene
AKT1;Schizophrenia;Disease;PA24684;Gene
CHAT;Schizophrenia;Disease;PA26448;Gene
CLCN6;Schizophrenia;Disease;PA26551;Gene
CNR1;Schizophrenia;Disease;PA26681;Gene
ABCB1;Schizophrenia;Disease;PA267;Gene
CYP1A2;Schizophrenia;Disease;PA27093;Gene
CYP1B1;Schizophrenia;Disease;PA27094;Gene
DRD2;Schizophrenia;Disease;PA27478;Gene
DRD3;Schizophrenia;Disease;PA27479;Gene
DTNBP1;Schizophrenia;Disease;PA27512;Gene
EPM2A;Schizophrenia;Disease;PA27832;Gene
PPARG;Schizophrenia;Disease;PA281;Gene
FKBP5;Schizophrenia;Disease;PA28162;Gene
GABRG3;Schizophrenia;Disease;PA28502;Gene
GCG;Schizophrenia;Disease;PA28606;Gene
GIPR;Schizophrenia;Disease;PA28682;Gene
GLP1R;Schizophrenia;Disease;PA28725;Gene
GRIN2B;Schizophrenia;Disease;PA28980;Gene
GRM3;Schizophrenia;Disease;PA28992;Gene
HRH3;Schizophrenia;Disease;PA29458;Gene
HSPG2;Schizophrenia;Disease;PA29537;Gene
HTR3A;Schizophrenia;Disease;PA29555;Gene
IL1A;Schizophrenia;Disease;PA29807;Gene
IL1B;Schizophrenia;Disease;PA29808;Gene
ITIH3;Schizophrenia;Disease;PA29966;Gene
MC4R;Schizophrenia;Disease;PA30676;Gene
ATP1A2;Schizophrenia;Disease;PA30796;Gene
SLC6A3;Schizophrenia;Disease;PA311;Gene
SLC6A4;Schizophrenia;Disease;PA312;Gene
NFIB;Schizophrenia;Disease;PA31591;Gene
NRG1;Schizophrenia;Disease;PA31776;Gene
NRXN1;Schizophrenia;Disease;PA31786;Gene
NTRK2;Schizophrenia;Disease;PA31818;Gene
BDNF;Schizophrenia;Disease;PA31891;Gene
PDE4D;Schizophrenia;Disease;PA33130;Gene
PMCH;Schizophrenia;Disease;PA33435;Gene
SREBF1;Schizophrenia;Disease;PA335;Gene
RELN;Schizophrenia;Disease;PA34323;Gene
RGS2;Schizophrenia;Disease;PA34372;Gene
RGS4;Schizophrenia;Disease;PA34375;Gene
HLA-A;Schizophrenia;Disease;PA35055;Gene
HLA-B;Schizophrenia;Disease;PA35056;Gene
HLA-C;Schizophrenia;Disease;PA35057;Gene
HLA-DPB1;Schizophrenia;Disease;PA35064;Gene
HLA-DQB1;Schizophrenia;Disease;PA35068;Gene
HLA-DRB1;Schizophrenia;Disease;PA35072;Gene
HLA-DRB3;Schizophrenia;Disease;PA35074;Gene
HLA-DRB5;Schizophrenia;Disease;PA35076;Gene
SLC6A5;Schizophrenia;Disease;PA35911;Gene
TBC1D1;Schizophrenia;Disease;PA36342;Gene
TJP1;Schizophrenia;Disease;PA36532;Gene
TNFRSF11A;Schizophrenia;Disease;PA36601;Gene
UGT1A10;Schizophrenia;Disease;PA37174;Gene
UGT1A3;Schizophrenia;Disease;PA37178;Gene
UGT1A4;Schizophrenia;Disease;PA37179;Gene
UGT1A5;Schizophrenia;Disease;PA37180;Gene
UGT1A6;Schizophrenia;Disease;PA37181;Gene
UGT1A7;Schizophrenia;Disease;PA37182;Gene
UGT1A8;Schizophrenia;Disease;PA37183;Gene
ADRB2;Schizophrenia;Disease;PA39;Gene
UGT1A9;Schizophrenia;Disease;PA419;Gene
UGT1A1;Schizophrenia;Disease;PA420;Gene
CYP3A43;Schizophrenia;Disease;PA427;Gene
ARTHRITIS, RHEUMATOID;Schizophrenia;Disease;PA443434;Disease
CARDIOVASCULAR DISEASES;Schizophrenia;Disease;PA443635;Disease
BUFURALOL;CYP2D6*48;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*48;Haplotype;PA166127651;Chemical
PRIMAQUINE;CYP2D6*48;Haplotype;PA451103;Chemical
ACUTE CORONARY SYNDROME;rs5918;Variant;PA165108401;Disease
CORONARY ARTERY DISEASE;rs5918;Variant;PA443796;Disease
MYOCARDIAL INFARCTION;rs5918;Variant;PA445019;Disease
ASPIRIN;rs5918;Variant;PA448497;Chemical
CLOPIDOGREL;rs5918;Variant;PA449053;Chemical
METFORMIN;SLC19A3;Gene;PA450395;Chemical
CYP2C19;imipramine;Chemical;PA124;Gene
CYP2D6;imipramine;Chemical;PA128;Gene
CYP3A4;imipramine;Chemical;PA130;Gene
CYP2C19*17;imipramine;Chemical;PA165816533;Haplotype
CYP2D6*1;imipramine;Chemical;PA165816576;Haplotype
CYP2D6*3;imipramine;Chemical;PA165816578;Haplotype
CYP2D6*4;imipramine;Chemical;PA165816579;Haplotype
CYP2D6*6;imipramine;Chemical;PA165816581;Haplotype
CYP2D6*5;imipramine;Chemical;PA165948092;Haplotype
CYP2C19*1;imipramine;Chemical;PA165980634;Haplotype
CYP2C19*2;imipramine;Chemical;PA165980635;Haplotype
CYP2C19*3;imipramine;Chemical;PA165980636;Haplotype
CYP2D6*1XN;imipramine;Chemical;PA165988479;Haplotype
CYP2D6*2XN;imipramine;Chemical;PA165988480;Haplotype
CYP1A2;imipramine;Chemical;PA27093;Gene
TOXIC LIVER DISEASE;HLA-DRB1*13:02;Haplotype;PA164925725;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-DRB1*13:02;Haplotype;PA166120929;Disease
DRUG HYPERSENSITIVITY;HLA-DRB1*13:02;Haplotype;PA443936;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-DRB1*13:02;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-DRB1*13:02;Haplotype;PA445738;Disease
URTICARIA;HLA-DRB1*13:02;Haplotype;PA445999;Disease
ALLOPURINOL;HLA-DRB1*13:02;Haplotype;PA448320;Chemical
ASPIRIN;HLA-DRB1*13:02;Haplotype;PA448497;Chemical
TICLOPIDINE;HLA-DRB1*13:02;Haplotype;PA451686;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*15:05;Haplotype;PA166120927;Disease
SULFASALAZINE;HLA-B*15:05;Haplotype;PA451547;Chemical
CYP2C19;phenazepam;Chemical;PA124;Gene
CYP2C19*17;phenazepam;Chemical;PA165816533;Haplotype
CYP2C19*1;phenazepam;Chemical;PA165980634;Haplotype
CYP2C19*2;phenazepam;Chemical;PA165980635;Haplotype
RS12248560;phenazepam;Chemical;PA166154147;Variant
ACUTE CORONARY SYNDROME;rs56324128;Variant;PA165108401;Disease
TICAGRELOR;rs56324128;Variant;PA165374673;Chemical
ADALIMUMAB;FCGR3A;Gene;PA10004;Chemical
CETUXIMAB;FCGR3A;Gene;PA10040;Chemical
ANTITHYMOCYTE GLOBULIN;FCGR3A;Gene;PA164743704;Chemical
TOCILIZUMAB;FCGR3A;Gene;PA165292659;Chemical
KIDNEY TRANSPLANTATION;FCGR3A;Gene;PA165817016;Disease
MARGETUXIMAB;FCGR3A;Gene;PA166235241;Chemical
RHEUMATOID ARTHRITIS;FCGR3A;Gene;PA443434;Disease
BREAST NEOPLASMS;FCGR3A;Gene;PA443560;Disease
NEOPLASMS;FCGR3A;Gene;PA445062;Disease
NEUROMYELITIS OPTICA;FCGR3A;Gene;PA445109;Disease
PSORIASIS;FCGR3A;Gene;PA445451;Disease
ETANERCEPT;FCGR3A;Gene;PA449515;Chemical
RITUXIMAB;FCGR3A;Gene;PA451261;Chemical
TRASTUZUMAB;FCGR3A;Gene;PA451743;Chemical
INFLIXIMAB;FCGR3A;Gene;PA452639;Chemical
PROSTATIC NEOPLASMS;rs875858;Variant;PA445425;Disease
DOCETAXEL;rs875858;Variant;PA449383;Chemical
OPIOID-RELATED DISORDERS;rs1125394;Variant;PA445043;Disease
COCAINE DEPENDENCE;rs1125394;Variant;PA446878;Disease
COCAINE;rs1125394;Variant;PA449072;Chemical
OPIOIDS;rs1125394;Variant;PA452618;Chemical
DULOXETINE;rs12094644;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs12094644;Variant;PA447321;Disease
SUBSTANCE-RELATED DISORDERS;rs2036657;Variant;PA446876;Disease
METHAMPHETAMINE;rs2036657;Variant;PA450403;Chemical
ZOLEDRONATE;CYP2C8;Gene;PA10235;Chemical
WEIGHT GAIN;CYP2C8;Gene;PA128406954;Disease
FLUOROURACIL;CYP2C8;Gene;PA128406956;Chemical
HMG COA REDUCTASE INHIBITORS;CYP2C8;Gene;PA133950441;Chemical
BISPHOSPHONATES;CYP2C8;Gene;PA164712563;Chemical
CALCINEURIN INHIBITORS;CYP2C8;Gene;PA164712580;Chemical
MYCOPHENOLIC ACID;CYP2C8;Gene;PA164748728;Chemical
TOXIC LIVER DISEASE;CYP2C8;Gene;PA164925725;Disease
PAZOPANIB;CYP2C8;Gene;PA165291492;Chemical
KIDNEY TRANSPLANTATION;CYP2C8;Gene;PA165817016;Disease
CYP2C8*3;CYP2C8;Gene;PA165958685;Haplotype
CYP2C8*4;CYP2C8;Gene;PA165958686;Haplotype
DELAYED GRAFT FUNCTION;CYP2C8;Gene;PA166123755;Disease
DICLOFENAC ACYL GLUCURONIDE;CYP2C8;Gene;PA166163692;Chemical
NR1I2;CYP2C8;Gene;PA378;Gene
ASTHMA;CYP2C8;Gene;PA443450;Disease
BREAST NEOPLASMS;CYP2C8;Gene;PA443560;Disease
NON-SMALL CELL LUNG CARCINOMA;CYP2C8;Gene;PA443622;Disease
DIABETES MELLITUS;CYP2C8;Gene;PA443886;Disease
DIABETES MELLITUS, TYPE 2;CYP2C8;Gene;PA443890;Disease
DRUG TOXICITY;CYP2C8;Gene;PA443937;Disease
EDEMA;CYP2C8;Gene;PA443994;Disease
KIDNEY DISEASES;CYP2C8;Gene;PA444682;Disease
MULTIPLE MYELOMA;CYP2C8;Gene;PA444985;Disease
NEOPLASMS;CYP2C8;Gene;PA445062;Disease
NEUTROPENIA;CYP2C8;Gene;PA445113;Disease
OSTEONECROSIS;CYP2C8;Gene;PA445187;Disease
OVARIAN NEOPLASMS;CYP2C8;Gene;PA445204;Disease
PAIN, POSTOPERATIVE;CYP2C8;Gene;PA445210;Disease
PERIPHERAL NERVOUS SYSTEM DISEASES;CYP2C8;Gene;PA445301;Disease
THROMBOCYTOPENIA;CYP2C8;Gene;PA445846;Disease
NEUROTOXICITY SYNDROMES;CYP2C8;Gene;PA446975;Disease
LIVER TRANSPLANTATION;CYP2C8;Gene;PA447247;Disease
AMODIAQUINE;CYP2C8;Gene;PA448404;Chemical
CARBAMAZEPINE;CYP2C8;Gene;PA448785;Chemical
CARBOPLATIN;CYP2C8;Gene;PA448803;Chemical
CERIVASTATIN;CYP2C8;Gene;PA448897;Chemical
CLOPIDOGREL;CYP2C8;Gene;PA449053;Chemical
CYCLOPHOSPHAMIDE;CYP2C8;Gene;PA449165;Chemical
CYCLOSPORINE;CYP2C8;Gene;PA449167;Chemical
DICLOFENAC;CYP2C8;Gene;PA449293;Chemical
EPIRUBICIN;CYP2C8;Gene;PA449476;Chemical
GEMCITABINE;CYP2C8;Gene;PA449748;Chemical
IBUPROFEN;CYP2C8;Gene;PA449957;Chemical
MONTELUKAST;CYP2C8;Gene;PA450546;Chemical
MYCOPHENOLATE MOFETIL;CYP2C8;Gene;PA450566;Chemical
PACLITAXEL;CYP2C8;Gene;PA450761;Chemical
PAMIDRONATE;CYP2C8;Gene;PA450767;Chemical
PIOGLITAZONE;CYP2C8;Gene;PA450970;Chemical
REPAGLINIDE;CYP2C8;Gene;PA451234;Chemical
ROSIGLITAZONE;CYP2C8;Gene;PA451283;Chemical
SIMVASTATIN;CYP2C8;Gene;PA451363;Chemical
TACROLIMUS;CYP2C8;Gene;PA451578;Chemical
SORAFENIB;CYP2C8;Gene;PA7000;Chemical
ALCOHOL ABUSE;rs615470;Variant;PA443309;Disease
ETHANOL;rs615470;Variant;PA448073;Chemical
MACULOPAPULAR EXANTHEMA;HLA-B*15:27;Haplotype;PA162316739;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*15:27;Haplotype;PA166120927;Disease
DRUG TOXICITY;HLA-B*15:27;Haplotype;PA443937;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*15:27;Haplotype;PA444059;Disease
EPILEPSY;HLA-B*15:27;Haplotype;PA444065;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*15:27;Haplotype;PA445738;Disease
CLINDAMYCIN;HLA-B*15:27;Haplotype;PA449035;Chemical
NEVIRAPINE;HLA-B*15:27;Haplotype;PA450616;Chemical
OXCARBAZEPINE;HLA-B*15:27;Haplotype;PA450732;Chemical
MULTIPLE ENDOCRINE NEOPLASIA TYPE 1;MEN1;Gene;PA446760;Disease
CYP2C19;axitinib;Chemical;PA124;Gene
CYP3A5;axitinib;Chemical;PA131;Gene
RS11549465;axitinib;Chemical;PA166159812;Variant
FLT1;axitinib;Chemical;PA28180;Gene
HIF1A;axitinib;Chemical;PA29283;Gene
KDR;axitinib;Chemical;PA30086;Gene
UGT1A1;axitinib;Chemical;PA420;Gene
RHEUMATOID ARTHRITIS;rs1800909;Variant;PA443434;Disease
METHOTREXATE;rs1800909;Variant;PA450428;Chemical
WEIGHT GAIN;CYP2C8*1;Haplotype;PA128406954;Disease
CALCINEURIN INHIBITORS;CYP2C8*1;Haplotype;PA164712580;Chemical
TOXIC LIVER DISEASE;CYP2C8*1;Haplotype;PA164925725;Disease
KIDNEY TRANSPLANTATION;CYP2C8*1;Haplotype;PA165817016;Disease
DELAYED GRAFT FUNCTION;CYP2C8*1;Haplotype;PA166123755;Disease
DICLOFENAC ACYL GLUCURONIDE;CYP2C8*1;Haplotype;PA166163692;Chemical
ASTHMA;CYP2C8*1;Haplotype;PA443450;Disease
BREAST NEOPLASMS;CYP2C8*1;Haplotype;PA443560;Disease
DIABETES MELLITUS;CYP2C8*1;Haplotype;PA443886;Disease
DIABETES MELLITUS, TYPE 2;CYP2C8*1;Haplotype;PA443890;Disease
DRUG TOXICITY;CYP2C8*1;Haplotype;PA443937;Disease
KIDNEY DISEASES;CYP2C8*1;Haplotype;PA444682;Disease
NEOPLASMS;CYP2C8*1;Haplotype;PA445062;Disease
NEUTROPENIA;CYP2C8*1;Haplotype;PA445113;Disease
PAIN, POSTOPERATIVE;CYP2C8*1;Haplotype;PA445210;Disease
PERIPHERAL NERVOUS SYSTEM DISEASES;CYP2C8*1;Haplotype;PA445301;Disease
LIVER TRANSPLANTATION;CYP2C8*1;Haplotype;PA447247;Disease
CERIVASTATIN;CYP2C8*1;Haplotype;PA448897;Chemical
CYCLOPHOSPHAMIDE;CYP2C8*1;Haplotype;PA449165;Chemical
CYCLOSPORINE;CYP2C8*1;Haplotype;PA449167;Chemical
DICLOFENAC;CYP2C8*1;Haplotype;PA449293;Chemical
EPIRUBICIN;CYP2C8*1;Haplotype;PA449476;Chemical
IBUPROFEN;CYP2C8*1;Haplotype;PA449957;Chemical
MONTELUKAST;CYP2C8*1;Haplotype;PA450546;Chemical
PACLITAXEL;CYP2C8*1;Haplotype;PA450761;Chemical
PIOGLITAZONE;CYP2C8*1;Haplotype;PA450970;Chemical
ROSIGLITAZONE;CYP2C8*1;Haplotype;PA451283;Chemical
TACROLIMUS;CYP2C8*1;Haplotype;PA451578;Chemical
BIPOLAR DISORDER;DTNA;Gene;PA447199;Disease
LEUKOPENIA;NUDT15*6;Haplotype;PA444773;Disease
NEUTROPENIA;NUDT15*6;Haplotype;PA445113;Disease
INFLAMMATORY BOWEL DISEASES;NUDT15*6;Haplotype;PA446116;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;NUDT15*6;Haplotype;PA446155;Disease
AZATHIOPRINE;NUDT15*6;Haplotype;PA448515;Chemical
MERCAPTOPURINE;NUDT15*6;Haplotype;PA450379;Chemical
COLONIC NEOPLASMS;rs10934498;Variant;PA443756;Disease
IRINOTECAN;rs10934498;Variant;PA450085;Chemical
ILOPERIDONE;CERKL;Gene;PA161199368;Chemical
ACQUIRED LONG QT SYNDROME (ALQTS);CERKL;Gene;PA447300;Disease
DMD;eteplirsen;Chemical;PA27378;Gene
CATECHOLAMINES;SLC22A3;Gene;PA133822447;Chemical
CORONARY ARTERY DISEASE;SLC22A3;Gene;PA443796;Disease
LAMIVUDINE;SLC22A3;Gene;PA450163;Chemical
METFORMIN;SLC22A3;Gene;PA450395;Chemical
CFTR;rs397508744;Variant;PA109;Gene
IVACAFTOR;rs397508744;Variant;PA165950341;Chemical
MACULOPAPULAR EXANTHEMA;HLA-B*35:01;Haplotype;PA162316739;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-B*35:01;Haplotype;PA166120929;Disease
DRUG HYPERSENSITIVITY;HLA-B*35:01;Haplotype;PA443936;Disease
DRUG TOXICITY;HLA-B*35:01;Haplotype;PA443937;Disease
HIV INFECTIONS;HLA-B*35:01;Haplotype;PA447230;Disease
CARBAMAZEPINE;HLA-B*35:01;Haplotype;PA448785;Chemical
NEVIRAPINE;HLA-B*35:01;Haplotype;PA450616;Chemical
DIABETES MELLITUS, TYPE 2;rs57081354;Variant;PA443890;Disease
METFORMIN;rs57081354;Variant;PA450395;Chemical
ANTIBIOTICS;LGALS3;Gene;PA164712406;Chemical
HYPERSENSITIVITY;LGALS3;Gene;PA444546;Disease
METHOXSALEN;CYP2A6*22;Haplotype;PA450433;Chemical
ATP1A1;PPP2CA;Gene;PA62;Gene
H2AFX;PRKDC;Gene;PA29116;Gene
NFKB1;PPP3CA;Gene;PA248;Gene
RELA;PPP3CA;Gene;PA296;Gene
NFATC1;PPP3CA;Gene;PA31582;Gene
NFATC2;PPP3CA;Gene;PA31583;Gene
NFATC4;PPP3CA;Gene;PA31584;Gene
NFKB2;PPP3CA;Gene;PA31600;Gene
REL;PPP3CA;Gene;PA34321;Gene
RELB;PPP3CA;Gene;PA34322;Gene
CYP2C9;CYP2C9*6;Haplotype;PA126;Gene
VKORC1;CYP2C9*6;Haplotype;PA133787052;Gene
OVER-ANTICOAGULATION;CYP2C9*6;Haplotype;PA166123298;Disease
SIPONIMOD;CYP2C9*6;Haplotype;PA166182736;Chemical
CYP4F2;CYP2C9*6;Haplotype;PA27121;Gene
CARDIOVASCULAR DISEASES;CYP2C9*6;Haplotype;PA443635;Disease
EPILEPSY;CYP2C9*6;Haplotype;PA444065;Disease
HEMORRHAGE;CYP2C9*6;Haplotype;PA444417;Disease
HYPOTENSION;CYP2C9*6;Haplotype;PA444584;Disease
LOSARTAN;CYP2C9*6;Haplotype;PA450268;Chemical
OLANZAPINE;CYP2C9*6;Haplotype;PA450688;Chemical
PHENYTOIN;CYP2C9*6;Haplotype;PA450947;Chemical
WARFARIN;CYP2C9*6;Haplotype;PA451906;Chemical
ASTHMA;rs7551789;Variant;PA443450;Disease
ASPIRIN;rs7551789;Variant;PA448497;Chemical
CALCIUM CHANNEL BLOCKERS;rs2429427;Variant;PA10407;Chemical
HYPERTENSION;rs2429427;Variant;PA444552;Disease
CURCUMIN;rs77010898;Variant;PA151958596;Chemical
IVACAFTOR;rs77010898;Variant;PA165950341;Chemical
ATALUREN;rs77010898;Variant;PA166151864;Chemical
CYSTIC FIBROSIS;rs77010898;Variant;PA443829;Disease
SCHIZOPHRENIA;rs2298826;Variant;PA447216;Disease
HALOPERIDOL;rs2298826;Variant;PA449841;Chemical
ESCITALOPRAM;rs11947402;Variant;PA10074;Chemical
DEPRESSIVE DISORDER;rs11947402;Variant;PA447207;Disease
CITALOPRAM;rs11947402;Variant;PA449015;Chemical
MYOCARDIAL ISCHEMIA;F3;Gene;PA446459;Disease
SIMVASTATIN;F3;Gene;PA451363;Chemical
CYP2C19;desoxycortone;Chemical;PA124;Gene
CYP2C19*9;desoxycortone;Chemical;PA165816525;Haplotype
CYP2C19*11;desoxycortone;Chemical;PA165816527;Haplotype
CYP2C19*23;desoxycortone;Chemical;PA165816537;Haplotype
CYP2C19*1;desoxycortone;Chemical;PA165980634;Haplotype
ALCOHOL ABUSE;rs494904;Variant;PA443309;Disease
ETHANOL;rs494904;Variant;PA448073;Chemical
ARIPIPRAZOLE;UGT1A4;Gene;PA10026;Chemical
DULOXETINE;UGT1A4;Gene;PA10066;Chemical
ESCITALOPRAM;UGT1A4;Gene;PA10074;Chemical
DIVALPROEX SODIUM;UGT1A4;Gene;PA164783479;Chemical
SN-38;UGT1A4;Gene;PA165110775;Chemical
FEBUXOSTAT;UGT1A4;Gene;PA165958521;Chemical
ABT-751;UGT1A4;Gene;PA166104276;Chemical
TAMOXIFEN-N-GLUCURONIDE;UGT1A4;Gene;PA166131338;Chemical
CLOZAPINE 5-N-GLUCURONIDE;UGT1A4;Gene;PA166213001;Chemical
DESMETHYLCLOZAPINE GLUCURONIDE;UGT1A4;Gene;PA166264701;Chemical
BREAST NEOPLASMS;UGT1A4;Gene;PA443560;Disease
EPILEPSY;UGT1A4;Gene;PA444065;Disease
GOUT;UGT1A4;Gene;PA444318;Disease
NEOPLASMS;UGT1A4;Gene;PA445062;Disease
OSTEOSARCOMA;UGT1A4;Gene;PA445601;Disease
SCHIZOPHRENIA;UGT1A4;Gene;PA447216;Disease
ALLOPURINOL;UGT1A4;Gene;PA448320;Chemical
AMITRIPTYLINE;UGT1A4;Gene;PA448385;Chemical
ANASTROZOLE;UGT1A4;Gene;PA448432;Chemical
BUPROPION;UGT1A4;Gene;PA448687;Chemical
BUSPIRONE;UGT1A4;Gene;PA448689;Chemical
CARBAMAZEPINE;UGT1A4;Gene;PA448785;Chemical
CITALOPRAM;UGT1A4;Gene;PA449015;Chemical
DIAZEPAM;UGT1A4;Gene;PA449283;Chemical
FLUOXETINE;UGT1A4;Gene;PA449673;Chemical
LAMOTRIGINE;UGT1A4;Gene;PA450164;Chemical
METHOTREXATE;UGT1A4;Gene;PA450428;Chemical
MIDAZOLAM;UGT1A4;Gene;PA450496;Chemical
MIRTAZAPINE;UGT1A4;Gene;PA450522;Chemical
MODAFINIL;UGT1A4;Gene;PA450530;Chemical
NORTRIPTYLINE;UGT1A4;Gene;PA450657;Chemical
OLANZAPINE;UGT1A4;Gene;PA450688;Chemical
OXCARBAZEPINE;UGT1A4;Gene;PA450732;Chemical
PAROXETINE;UGT1A4;Gene;PA450801;Chemical
PHENYTOIN;UGT1A4;Gene;PA450947;Chemical
QUETIAPINE;UGT1A4;Gene;PA451201;Chemical
RISPERIDONE;UGT1A4;Gene;PA451257;Chemical
SERTRALINE;UGT1A4;Gene;PA451333;Chemical
TAMOXIFEN;UGT1A4;Gene;PA451581;Chemical
TESTOSTERONE;UGT1A4;Gene;PA451627;Chemical
TRAZODONE;UGT1A4;Gene;PA451744;Chemical
VALPROIC ACID;UGT1A4;Gene;PA451846;Chemical
VENLAFAXINE;UGT1A4;Gene;PA451866;Chemical
VITAMIN D AND ANALOGUES;UGT1A4;Gene;PA451899;Chemical
ZIPRASIDONE;UGT1A4;Gene;PA451974;Chemical
TOBACCO USE DISORDER;rs2271339;Variant;PA445876;Disease
NICOTINE;rs2271339;Variant;PA450626;Chemical
TRANSPLANTATION;rs1057868;Variant;PA134850491;Disease
GASTROINTESTINAL STROMAL TUMORS;rs1057868;Variant;PA151958383;Disease
SUNITINIB;rs1057868;Variant;PA162372840;Chemical
KIDNEY TRANSPLANTATION;rs1057868;Variant;PA165817016;Disease
FAMILIAL HYPERCHOLESTEROLEMIA;rs1057868;Variant;PA166114942;Disease
ATORVASTATIN;rs1057868;Variant;PA448500;Chemical
CYCLOSPORINE;rs1057868;Variant;PA449167;Chemical
MIDAZOLAM;rs1057868;Variant;PA450496;Chemical
NICOTINE;rs1057868;Variant;PA450626;Chemical
SIROLIMUS;rs1057868;Variant;PA451365;Chemical
TACROLIMUS;rs1057868;Variant;PA451578;Chemical
ADALIMUMAB;rs1264457;Variant;PA10004;Chemical
CERTOLIZUMAB PEGOL;rs1264457;Variant;PA165107055;Chemical
RHEUMATOID ARTHRITIS;rs1264457;Variant;PA443434;Disease
ETANERCEPT;rs1264457;Variant;PA449515;Chemical
METHOTREXATE;rs1264457;Variant;PA450428;Chemical
GLUCOCORTICOIDS;rs1264457;Variant;PA452347;Chemical
INFLIXIMAB;rs1264457;Variant;PA452639;Chemical
FLUOROURACIL;OSGEP;Gene;PA128406956;Chemical
RADIOTHERAPY;OSGEP;Gene;PA166122986;Chemical
OVERALL SURVIVAL;OSGEP;Gene;PA166123207;Disease
CARCINOMA, SQUAMOUS CELL;OSGEP;Gene;PA443626;Disease
CISPLATIN;OSGEP;Gene;PA449014;Chemical
CYP2C9;Thyrotoxicosis;Disease;PA126;Gene
CYP2C9*1;Thyrotoxicosis;Disease;PA165816542;Haplotype
CYP2C9*3;Thyrotoxicosis;Disease;PA165816544;Haplotype
CFTR;rs397508573;Variant;PA109;Gene
IVACAFTOR;rs397508573;Variant;PA165950341;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs397508573;Variant;PA166190041;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs397508573;Variant;PA166362502;Chemical
CYSTIC FIBROSIS;rs397508573;Variant;PA443829;Disease
CETUXIMAB;rs61764370;Variant;PA10040;Chemical
PANITUMUMAB;rs61764370;Variant;PA162373091;Chemical
NEOPLASMS;rs61764370;Variant;PA445062;Disease
NAUSEA;rs12305038;Variant;PA445048;Disease
VOMITING;rs12305038;Variant;PA446051;Disease
OPIOIDS;rs12305038;Variant;PA452618;Chemical
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;EPHX1 poor metabolizer;Variant;PA447178;Disease
ACETYLCYSTEINE;EPHX1 poor metabolizer;Variant;PA448033;Chemical
SCHIZOPHRENIA;rs2164660;Variant;PA447216;Disease
QUETIAPINE;rs2164660;Variant;PA451201;Chemical
ACETALDEHYDE;rs671;Variant;PA166186245;Chemical
ALCOHOL ABUSE;rs671;Variant;PA443309;Disease
HEROIN DEPENDENCE;rs671;Variant;PA444460;Disease
ETHANOL;rs671;Variant;PA448073;Chemical
NALTREXONE;rs671;Variant;PA450588;Chemical
HEROIN;rs671;Variant;PA452619;Chemical
WARFARIN;CYP2C9*10;Haplotype;PA451906;Chemical
3,4-METHYLENEDIOXYMETHAMPHETAMINE;rs1861647;Variant;PA131887008;Chemical
HEROIN DEPENDENCE;rs3762556;Variant;PA444460;Disease
METHADONE;rs3762556;Variant;PA450401;Chemical
TOBACCO USE DISORDER;rs7178270;Variant;PA445876;Disease
NICOTINE;rs7178270;Variant;PA450626;Chemical
CYP2B6;rifampin;Chemical;PA123;Gene
CYP2C19;rifampin;Chemical;PA124;Gene
CYP2C9;rifampin;Chemical;PA126;Gene
CYP3A4;rifampin;Chemical;PA130;Gene
CYP3A5;rifampin;Chemical;PA131;Gene
SLCO1B1;rifampin;Chemical;PA134865839;Gene
AGBL4;rifampin;Chemical;PA142672636;Gene
CUX2;rifampin;Chemical;PA162382977;Gene
RIPOR2;rifampin;Chemical;PA162387677;Gene
NOS2;rifampin;Chemical;PA164724093;Gene
CYP2C9*1;rifampin;Chemical;PA165816542;Haplotype
CYP2C9*2;rifampin;Chemical;PA165816543;Haplotype
CYP2C9*3;rifampin;Chemical;PA165816544;Haplotype
CYP2C9*11;rifampin;Chemical;PA165816552;Haplotype
CYP2B6*1;rifampin;Chemical;PA165818750;Haplotype
CYP2B6*6;rifampin;Chemical;PA165818762;Haplotype
SLCO1B1*15;rifampin;Chemical;PA165819265;Haplotype
NAT2*4;rifampin;Chemical;PA165949098;Haplotype
SLCO1B1*1;rifampin;Chemical;PA165981641;Haplotype
GSTM1 NULL;rifampin;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;rifampin;Chemical;PA166048676;Haplotype
GSTT1 NULL;rifampin;Chemical;PA166048678;Haplotype
GSTT1 NON-NULL;rifampin;Chemical;PA166048679;Haplotype
RS4986893;rifampin;Chemical;PA166154070;Variant
RS9332096;rifampin;Chemical;PA166154097;Variant
RS1695;rifampin;Chemical;PA166154249;Variant
RS2306283;rifampin;Chemical;PA166154547;Variant
RS4149032;rifampin;Chemical;PA166154575;Variant
RS4149056;rifampin;Chemical;PA166154579;Variant
RS11045819;rifampin;Chemical;PA166154628;Variant
RS11080344;rifampin;Chemical;PA166155245;Variant
RS2472677;rifampin;Chemical;PA166156358;Variant
RS1800629;rifampin;Chemical;PA166156997;Variant
RS1041983;rifampin;Chemical;PA166157549;Variant
RS4646244;rifampin;Chemical;PA166157603;Variant
RS319952;rifampin;Chemical;PA166160678;Variant
RS10946737;rifampin;Chemical;PA166160680;Variant
RS10946739;rifampin;Chemical;PA166160685;Variant
RS393994;rifampin;Chemical;PA166160687;Variant
RS320003;rifampin;Chemical;PA166160689;Variant
RS7958375;rifampin;Chemical;PA166160694;Variant
RS1803155;rifampin;Chemical;PA166246042;Variant
NAT2;rifampin;Chemical;PA18;Gene
GSTM1;rifampin;Chemical;PA182;Gene
GSTT1;rifampin;Chemical;PA183;Gene
AADAC;rifampin;Chemical;PA24363;Gene
ABCB1;rifampin;Chemical;PA267;Gene
GSTP1;rifampin;Chemical;PA29028;Gene
NR1I2;rifampin;Chemical;PA378;Gene
TNF;rifampin;Chemical;PA435;Gene
EFAVIRENZ;rifampin;Chemical;PA449441;Chemical
VITAMIN D AND ANALOGUES;rifampin;Chemical;PA451899;Chemical
SULFAMETHOXAZOLE / TRIMETHOPRIM;NAT2*7;Haplotype;PA10715;Chemical
ANTIVIRALS FOR TREATMENT OF HIV INFECTIONS, COMBINATIONS;NAT2*7;Haplotype;PA164712505;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;NAT2*7;Haplotype;PA164712708;Chemical
TOXIC LIVER DISEASE;NAT2*7;Haplotype;PA164925725;Disease
DRUG-INDUCED LIVER INJURY;NAT2*7;Haplotype;PA166119041;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;NAT2*7;Haplotype;PA166120929;Disease
DIPYRONE;NAT2*7;Haplotype;PA166128206;Chemical
ADVERSE EVENTS;NAT2*7;Haplotype;PA166151827;Disease
SOLITHROMYCIN;NAT2*7;Haplotype;PA166165147;Chemical
HYPERSENSITIVITY;NAT2*7;Haplotype;PA444546;Disease
HYPERTENSION;NAT2*7;Haplotype;PA444552;Disease
TUBERCULOSIS;NAT2*7;Haplotype;PA445941;Disease
HIV INFECTIONS;NAT2*7;Haplotype;PA447230;Disease
HYDRALAZINE;NAT2*7;Haplotype;PA449894;Chemical
ISONIAZID;NAT2*7;Haplotype;PA450112;Chemical
FLUOROURACIL;rs372307932;Variant;PA128406956;Chemical
DRUG TOXICITY;rs372307932;Variant;PA443937;Disease
SN-38;TOP1;Gene;PA165110775;Chemical
IRINOTECAN;TOP1;Gene;PA450085;Chemical
NICOTINE;rs7247903;Variant;PA450626;Chemical
SCHIZOPHRENIA;rs909706;Variant;PA447216;Disease
HALOPERIDOL;rs909706;Variant;PA449841;Chemical
COCAINE DEPENDENCE;SYT1;Gene;PA446878;Disease
COCAINE;SYT1;Gene;PA449072;Chemical
IRRITABLE BOWEL SYNDROME;PACSIN2;Gene;PA166048887;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;PACSIN2;Gene;PA446155;Disease
AZATHIOPRINE;PACSIN2;Gene;PA448515;Chemical
MERCAPTOPURINE;PACSIN2;Gene;PA450379;Chemical
METHOTREXATE;PACSIN2;Gene;PA450428;Chemical
RS130060;methysergide;Chemical;PA166184004;Variant
HTR1B;methysergide;Chemical;PA29549;Gene
SYSTEMIC LUPUS ERYTHEMATOSUS;rs6822844;Variant;PA444822;Disease
RITUXIMAB;rs6822844;Variant;PA451261;Chemical
ALLOPURINOL;rs61816456;Variant;PA448320;Chemical
DICLOFENAC;CYP2C9*53;Haplotype;PA449293;Chemical
PHENYTOIN;CYP2C9*53;Haplotype;PA450947;Chemical
URINARY BLADDER NEOPLASMS;PSCA;Gene;PA443512;Disease
CETP;pravastatin;Chemical;PA108;Gene
ABCC2;pravastatin;Chemical;PA116;Gene
CYP3A4;pravastatin;Chemical;PA130;Gene
CYP3A5;pravastatin;Chemical;PA131;Gene
RHOA;pravastatin;Chemical;PA134865095;Gene
SLCO1B1;pravastatin;Chemical;PA134865839;Gene
KIF6;pravastatin;Chemical;PA134920075;Gene
ACE;pravastatin;Chemical;PA139;Gene
MTTP;pravastatin;Chemical;PA164742099;Gene
SLCO1B1*37;pravastatin;Chemical;PA165819251;Haplotype
SLCO1B1*5;pravastatin;Chemical;PA165819255;Haplotype
SLCO1B1*15;pravastatin;Chemical;PA165819265;Haplotype
HLA-DRB1*01:01;pravastatin;Chemical;PA165951320;Haplotype
HLA-DRB1*04:06;pravastatin;Chemical;PA165951530;Haplotype
SLCO1B1*1;pravastatin;Chemical;PA165981641;Haplotype
RS1801133;pravastatin;Chemical;PA166153644;Variant
RS1935349;pravastatin;Chemical;PA166153988;Variant
RS113646094;pravastatin;Chemical;PA166154205;Variant
RS2276307;pravastatin;Chemical;PA166154360;Variant
RS2306283;pravastatin;Chemical;PA166154547;Variant
RS4149015;pravastatin;Chemical;PA166154574;Variant
RS4149056;pravastatin;Chemical;PA166154579;Variant
RS1800588;pravastatin;Chemical;PA166154870;Variant
RS708272;pravastatin;Chemical;PA166154993;Variant
RS4341;pravastatin;Chemical;PA166155146;Variant
RS1799752;pravastatin;Chemical;PA166155187;Variant
RS7412;pravastatin;Chemical;PA166155341;Variant
RS1433099;pravastatin;Chemical;PA166155367;Variant
RS2738466;pravastatin;Chemical;PA166155400;Variant
RS16944;pravastatin;Chemical;PA166155587;Variant
RS428785;pravastatin;Chemical;PA166155981;Variant
RS11716445;pravastatin;Chemical;PA166156445;Variant
RS1800591;pravastatin;Chemical;PA166156523;Variant
RS17238540;pravastatin;Chemical;PA166156885;Variant
RS17244841;pravastatin;Chemical;PA166156886;Variant
RS20455;pravastatin;Chemical;PA166156905;Variant
RS2032582;pravastatin;Chemical;PA166157316;Variant
RS17655652;pravastatin;Chemical;PA166157478;Variant
RS328;pravastatin;Chemical;PA166157539;Variant
RS2230806;pravastatin;Chemical;PA166157744;Variant
RS4986790;pravastatin;Chemical;PA166157780;Variant
RS12003906;pravastatin;Chemical;PA166157834;Variant
RS35068180;pravastatin;Chemical;PA166181205;Variant
HMGCR;pravastatin;Chemical;PA189;Gene
LDLR;pravastatin;Chemical;PA227;Gene
LIPC;pravastatin;Chemical;PA230;Gene
LPL;pravastatin;Chemical;PA232;Gene
ABCA1;pravastatin;Chemical;PA24373;Gene
MTHFR;pravastatin;Chemical;PA245;Gene
ADAMTS1;pravastatin;Chemical;PA24536;Gene
ABCB1;pravastatin;Chemical;PA267;Gene
HTR3B;pravastatin;Chemical;PA29556;Gene
HTR7;pravastatin;Chemical;PA29561;Gene
IL1B;pravastatin;Chemical;PA29808;Gene
MMP3;pravastatin;Chemical;PA30886;Gene
NPC1L1;pravastatin;Chemical;PA31699;Gene
HLA-DRB1;pravastatin;Chemical;PA35072;Gene
SLCO1B3;pravastatin;Chemical;PA35844;Gene
TLR4;pravastatin;Chemical;PA36552;Gene
ABCG2;pravastatin;Chemical;PA390;Gene
IBUPROFEN;pravastatin;Chemical;PA449957;Chemical
APOE;pravastatin;Chemical;PA55;Gene
HYPERTENSION;rs880054;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs880054;Variant;PA449899;Chemical
AKT1;ISL1;Gene;PA24684;Gene
NEBIVOLOL;ADRA2C;Gene;PA151958426;Chemical
BETA BLOCKING AGENTS;ADRA2C;Gene;PA164712535;Chemical
LABETALOL;ADRA2C;Gene;PA164743150;Chemical
ACUTE CORONARY SYNDROME;ADRA2C;Gene;PA165108401;Disease
BUCINDOLOL;ADRA2C;Gene;PA165945764;Chemical
CARDIOMYOPATHY, DILATED;ADRA2C;Gene;PA443632;Disease
DEATH;ADRA2C;Gene;PA443842;Disease
HEART FAILURE;ADRA2C;Gene;PA444370;Disease
LIVER CIRRHOSIS;ADRA2C;Gene;PA444797;Disease
ACEBUTOLOL;ADRA2C;Gene;PA448011;Chemical
ATENOLOL;ADRA2C;Gene;PA448499;Chemical
BETAXOLOL;ADRA2C;Gene;PA448611;Chemical
BISOPROLOL;ADRA2C;Gene;PA448641;Chemical
BRIMONIDINE;ADRA2C;Gene;PA448665;Chemical
CARVEDILOL;ADRA2C;Gene;PA448817;Chemical
CLONIDINE;ADRA2C;Gene;PA449051;Chemical
DOPAMINE;ADRA2C;Gene;PA449396;Chemical
EPINEPHRINE;ADRA2C;Gene;PA449470;Chemical
ESMOLOL;ADRA2C;Gene;PA449500;Chemical
ISOPROTERENOL;ADRA2C;Gene;PA450121;Chemical
METOPROLOL;ADRA2C;Gene;PA450480;Chemical
NADOLOL;ADRA2C;Gene;PA450573;Chemical
NOREPINEPHRINE;ADRA2C;Gene;PA450649;Chemical
PINDOLOL;ADRA2C;Gene;PA450966;Chemical
PROPRANOLOL;ADRA2C;Gene;PA451145;Chemical
SOTALOL;ADRA2C;Gene;PA451457;Chemical
YOHIMBINE;ADRA2C;Gene;PA451946;Chemical
CYP2C19;Inflammation;Disease;PA124;Gene
CYP2C9;Inflammation;Disease;PA126;Gene
NUDT15;Inflammation;Disease;PA134963132;Gene
CYP2C19*17;Inflammation;Disease;PA165816533;Haplotype
CYP2C9*1;Inflammation;Disease;PA165816542;Haplotype
CYP2C9*2;Inflammation;Disease;PA165816543;Haplotype
TPMT*1;Inflammation;Disease;PA165819268;Haplotype
TPMT*2;Inflammation;Disease;PA165819269;Haplotype
TPMT*3A;Inflammation;Disease;PA165819270;Haplotype
TPMT*3C;Inflammation;Disease;PA165819272;Haplotype
TPMT*8;Inflammation;Disease;PA165819278;Haplotype
TPMT*9;Inflammation;Disease;PA165819279;Haplotype
TPMT*12;Inflammation;Disease;PA165819282;Haplotype
TPMT*24;Inflammation;Disease;PA165819295;Haplotype
CYP2C19*1;Inflammation;Disease;PA165980634;Haplotype
NUDT15*1;Inflammation;Disease;PA166131619;Haplotype
NUDT15*2;Inflammation;Disease;PA166131620;Haplotype
NUDT15*3;Inflammation;Disease;PA166131621;Haplotype
RS1800629;Inflammation;Disease;PA166156997;Variant
TPMT;Inflammation;Disease;PA356;Gene
TNF;Inflammation;Disease;PA435;Gene
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*56:06;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*56:06;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*56:06;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-B*56:06;Haplotype;PA450616;Chemical
LENIOLISIB;PIK3CD;Gene;PA166313326;Chemical
CAPIVASERTIB;PIK3CD;Gene;PA166328761;Chemical
AKT1;PIK3CD;Gene;PA24684;Gene
ERBB2;PIK3CD;Gene;PA27844;Gene
ERBB3;PIK3CD;Gene;PA27846;Gene
ERBB4;PIK3CD;Gene;PA27847;Gene
FLT1;PIK3CD;Gene;PA28180;Gene
FLT4;PIK3CD;Gene;PA28183;Gene
KDR;PIK3CD;Gene;PA30086;Gene
EGFR;PIK3CD;Gene;PA7360;Gene
MAJOR DEPRESSIVE DISORDER;rs2433320;Variant;PA447321;Disease
FLUOXETINE;rs2433320;Variant;PA449673;Chemical
ALCOHOL ABUSE;CADM2;Gene;PA443309;Disease
ETHANOL;CADM2;Gene;PA448073;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs651630;Variant;PA164713366;Chemical
PSORIASIS;rs651630;Variant;PA445451;Disease
PEGINTERFERON ALFA-2A;CXCL10;Gene;PA164749390;Chemical
PEGINTERFERON ALFA-2B;CXCL10;Gene;PA164784024;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;CXCL10;Gene;PA446863;Disease
PATENT DUCTUS ARTERIOSUS;rs2069514;Variant;PA443940;Disease
OPIOID-RELATED DISORDERS;rs2069514;Variant;PA445043;Disease
SCHIZOPHRENIA;rs2069514;Variant;PA447216;Disease
ACETAMINOPHEN;rs2069514;Variant;PA448015;Chemical
CAFFEINE;rs2069514;Variant;PA448710;Chemical
ANTIPSYCHOTICS;rs2069514;Variant;PA452233;Chemical
OPIOIDS;rs2069514;Variant;PA452618;Chemical
CELECOXIB;ATP2A1;Gene;PA448871;Chemical
IFNL3;sofosbuvir / velpatasvir;Chemical;PA134952671;Gene
RS12979860;sofosbuvir / velpatasvir;Chemical;PA166155468;Variant
GEMCITABINE;ALG10;Gene;PA449748;Chemical
ASTHMA;rs119774;Variant;PA443450;Disease
MONTELUKAST;rs119774;Variant;PA450546;Chemical
SCHIZOPHRENIA;rs265976;Variant;PA447216;Disease
CLOZAPINE;rs265976;Variant;PA449061;Chemical
ACE;nitroprusside;Chemical;PA139;Gene
RS1799752;nitroprusside;Chemical;PA166155187;Variant
MAPK8;MAF;Gene;PA283;Gene
MAPK14;MAF;Gene;PA30621;Gene
ALCOHOL ABUSE;rs1260326;Variant;PA443309;Disease
ETHANOL;rs1260326;Variant;PA448073;Chemical
PHENYTOIN;CYP2C9*51;Haplotype;PA450947;Chemical
RS1805087;Brain Diseases;Disease;PA166153654;Variant
MTR;Brain Diseases;Disease;PA31272;Gene
LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN;FOLH1;Gene;PA166278141;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;FOLH1;Gene;PA446155;Disease
MERCAPTOPURINE;FOLH1;Gene;PA450379;Chemical
METHOTREXATE;FOLH1;Gene;PA450428;Chemical
PLATINUM COMPOUNDS;EIF3A;Gene;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;EIF3A;Gene;PA443622;Disease
LUNG NEOPLASMS;EIF3A;Gene;PA444818;Disease
CARBOPLATIN;EIF3A;Gene;PA448803;Chemical
CISPLATIN;EIF3A;Gene;PA449014;Chemical
OPIOID-RELATED DISORDERS;rs7597593;Variant;PA445043;Disease
OPIOIDS;rs7597593;Variant;PA452618;Chemical
DIABETES MELLITUS;rs1801262;Variant;PA443886;Disease
REPAGLINIDE;rs1801262;Variant;PA451234;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-C*05:09;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-C*05:09;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-C*05:09;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-C*05:09;Haplotype;PA450616;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;NAT2 slow acetylator;Variant;PA164712708;Chemical
TOXIC LIVER DISEASE;NAT2 slow acetylator;Variant;PA164925725;Disease
ARTHRITIS, RHEUMATOID;NAT2 slow acetylator;Variant;PA443434;Disease
TUBERCULOSIS;NAT2 slow acetylator;Variant;PA445941;Disease
ISONIAZID;NAT2 slow acetylator;Variant;PA450112;Chemical
SULFASALAZINE;NAT2 slow acetylator;Variant;PA451547;Chemical
GEMTUZUMAB OZOGAMICIN;rs35112940;Variant;PA164749431;Chemical
LEUKEMIA, MYELOID, ACUTE;rs35112940;Variant;PA444760;Disease
REMIMAZOLAM;rs200707504;Variant;PA166321761;Chemical
OSELTAMIVIR;rs200707504;Variant;PA450721;Chemical
BIPOLAR DISORDER;rs3919583;Variant;PA447199;Disease
LITHIUM;rs3919583;Variant;PA450243;Chemical
INSULIN RECOMBINANT;rs13266634;Variant;PA164744571;Chemical
DIABETES MELLITUS, TYPE 2;rs13266634;Variant;PA443890;Disease
REPAGLINIDE;rs13266634;Variant;PA451234;Chemical
ZINC ACETATE;rs13266634;Variant;PA451961;Chemical
CHRNA3;Cocaine dependence;Disease;PA113;Gene
ANKK1;Cocaine dependence;Disease;PA134872551;Gene
DBH;Cocaine dependence;Disease;PA136;Gene
SLC6A4 HTTLPR SHORT FORM (S ALLELE);Cocaine dependence;Disease;PA166116466;Haplotype
SLC6A4 L ALLELE-RS25531T;Cocaine dependence;Disease;PA166117146;Haplotype
SLC6A4 L ALLELE-RS25531C;Cocaine dependence;Disease;PA166117147;Haplotype
RS1801133;Cocaine dependence;Disease;PA166153644;Variant
RS1076560;Cocaine dependence;Disease;PA166154313;Variant
RS1125394;Cocaine dependence;Disease;PA166154319;Variant
RS1800497;Cocaine dependence;Disease;PA166154339;Variant
RS2283265;Cocaine dependence;Disease;PA166154364;Variant
RS588765;Cocaine dependence;Disease;PA166154841;Variant
RS684513;Cocaine dependence;Disease;PA166154846;Variant
RS16969968;Cocaine dependence;Disease;PA166154938;Variant
RS1803274;Cocaine dependence;Disease;PA166156332;Variant
RS3836790;Cocaine dependence;Disease;PA166156819;Variant
RS28363170;Cocaine dependence;Disease;PA166156890;Variant
RS806368;Cocaine dependence;Disease;PA166156953;Variant
RS1799971;Cocaine dependence;Disease;PA166156991;Variant
RS6454674;Cocaine dependence;Disease;PA166157108;Variant
RS1611115;Cocaine dependence;Disease;PA166157734;Variant
RS11503014;Cocaine dependence;Disease;PA166169464;Variant
RS678849;Cocaine dependence;Disease;PA166175994;Variant
RS495491;Cocaine dependence;Disease;PA166177792;Variant
RS62638690;Cocaine dependence;Disease;PA166177955;Variant
RS2236256;Cocaine dependence;Disease;PA166182127;Variant
RS524731;Cocaine dependence;Disease;PA166183702;Variant
RS3823010;Cocaine dependence;Disease;PA166183703;Variant
RS3778156;Cocaine dependence;Disease;PA166183705;Variant
RS2251214;Cocaine dependence;Disease;PA166196881;Variant
RS997917;Cocaine dependence;Disease;PA166198164;Variant
RS10111937;Cocaine dependence;Disease;PA166260384;Variant
MTHFR;Cocaine dependence;Disease;PA245;Gene
BCHE;Cocaine dependence;Disease;PA25294;Gene
CHRNA5;Cocaine dependence;Disease;PA26491;Gene
CNR1;Cocaine dependence;Disease;PA26681;Gene
DRD2;Cocaine dependence;Disease;PA27478;Gene
GABRA2;Cocaine dependence;Disease;PA28490;Gene
SLC6A3;Cocaine dependence;Disease;PA311;Gene
SLC6A4;Cocaine dependence;Disease;PA312;Gene
OPRD1;Cocaine dependence;Disease;PA31942;Gene
OPRK1;Cocaine dependence;Disease;PA31943;Gene
OPRM1;Cocaine dependence;Disease;PA31945;Gene
SYT1;Cocaine dependence;Disease;PA36290;Gene
KCNH2;grepafloxacin;Chemical;PA212;Gene
FLUOROURACIL;rs148235907;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs148235907;Variant;PA443560;Disease
NEUTROPENIA;rs148235907;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs148235907;Variant;PA449165;Chemical
EPIRUBICIN;rs148235907;Variant;PA449476;Chemical
O-DESMETHYLTRAMADOL;rs9384825;Variant;PA166131379;Chemical
TRAMADOL;rs9384825;Variant;PA451735;Chemical
DRUG HYPERSENSITIVITY;rs701829;Variant;PA443936;Disease
DAPSONE;rs701829;Variant;PA449211;Chemical
CYP2C9;Vasculitis;Disease;PA126;Gene
CYP2C9 POOR METABOLIZER;Vasculitis;Disease;PA166157932;Variant
RS3759467;Vasculitis;Disease;PA166160991;Variant
DRUG HYPERSENSITIVITY;LTA;Gene;PA443936;Disease
HYPERSENSITIVITY;LTA;Gene;PA444546;Disease
MIGRAINE WITHOUT AURA;LTA;Gene;PA444949;Disease
ABACAVIR;LTA;Gene;PA448004;Chemical
CARBAMAZEPINE;LTA;Gene;PA448785;Chemical
DICLOFENAC;LTA;Gene;PA449293;Chemical
IBUPROFEN;LTA;Gene;PA449957;Chemical
INDOMETHACIN;LTA;Gene;PA449982;Chemical
KETOROLAC;LTA;Gene;PA450150;Chemical
NAPROXEN;LTA;Gene;PA450595;Chemical
FLUOROURACIL;rs1801265;Variant;PA128406956;Chemical
DPYD;rs1801265;Variant;PA145;Gene
NEOPLASMS;rs1801265;Variant;PA445062;Disease
CAPECITABINE;rs1801265;Variant;PA448771;Chemical
SCHIZOPHRENIA;rs7973796;Variant;PA447216;Disease
OLANZAPINE;rs7973796;Variant;PA450688;Chemical
MAJOR DEPRESSIVE DISORDER;SRP19;Gene;PA447321;Disease
CITALOPRAM;SRP19;Gene;PA449015;Chemical
FLUOXETINE;SRP19;Gene;PA449673;Chemical
PAROXETINE;SRP19;Gene;PA450801;Chemical
SERTRALINE;SRP19;Gene;PA451333;Chemical
CYP2C8;Multiple Myeloma;Disease;PA125;Gene
ERCC1;Multiple Myeloma;Disease;PA155;Gene
RS1934951;Multiple Myeloma;Disease;PA166153985;Variant
RS4240803;Multiple Myeloma;Disease;PA166155063;Variant
RS735482;Multiple Myeloma;Disease;PA166155356;Variant
RS1051685;Multiple Myeloma;Disease;PA166155619;Variant
RS4630;Multiple Myeloma;Disease;PA166156022;Variant
RS4135385;Multiple Myeloma;Disease;PA166156394;Variant
RS4533622;Multiple Myeloma;Disease;PA166156399;Variant
RS1045642;Multiple Myeloma;Disease;PA166157284;Variant
RS2032582;Multiple Myeloma;Disease;PA166157316;Variant
RS2229109;Multiple Myeloma;Disease;PA166157334;Variant
RS308395;Multiple Myeloma;Disease;PA166163497;Variant
GSTT1;Multiple Myeloma;Disease;PA183;Gene
ABCB1;Multiple Myeloma;Disease;PA267;Gene
CTNNB1;Multiple Myeloma;Disease;PA27013;Gene
FGF2;Multiple Myeloma;Disease;PA28115;Gene
SLC7A5;Multiple Myeloma;Disease;PA35923;Gene
XRCC5;Multiple Myeloma;Disease;PA37425;Gene
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*39:10;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*39:10;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*39:10;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-B*39:10;Haplotype;PA450616;Chemical
SLCO1B1;ezetimibe / simvastatin;Chemical;PA134865839;Gene
RS4149056;ezetimibe / simvastatin;Chemical;PA166154579;Variant
HYPERTENSION;rs8068318;Variant;PA444552;Disease
ATENOLOL;rs8068318;Variant;PA448499;Chemical
COLORECTAL NEOPLASMS;rs12022243;Variant;PA446108;Disease
CAPECITABINE;rs12022243;Variant;PA448771;Chemical
IFNL3;ribavirin;Chemical;PA134952671;Gene
CYP2R1;ribavirin;Chemical;PA134986407;Gene
FTO;ribavirin;Chemical;PA152208656;Gene
SLC29A1;ribavirin;Chemical;PA154;Gene
HLA-A*01:01;ribavirin;Chemical;PA165952609;Haplotype
HLA-B*38:01;ribavirin;Chemical;PA165955500;Haplotype
HLA-B*44:02;ribavirin;Chemical;PA165955891;Haplotype
HLA-C*01:02;ribavirin;Chemical;PA165956704;Haplotype
HLA-C*02:02;ribavirin;Chemical;PA165956777;Haplotype
HLA-C*04:01;ribavirin;Chemical;PA165957046;Haplotype
HLA-C*05:01;ribavirin;Chemical;PA165957192;Haplotype
HLA-C*06:02;ribavirin;Chemical;PA165957286;Haplotype
HLA-C*07:01;ribavirin;Chemical;PA165957372;Haplotype
HLA-C*12:02;ribavirin;Chemical;PA165957722;Haplotype
HLA-C*14:02;ribavirin;Chemical;PA165957818;Haplotype
HLA-C*15:02;ribavirin;Chemical;PA165957859;Haplotype
HLA-C*16:01;ribavirin;Chemical;PA165957927;Haplotype
HLA-C*17:01;ribavirin;Chemical;PA165957985;Haplotype
IFNL4;ribavirin;Chemical;PA166049147;Gene
SLC6A4 HTTLPR LONG FORM (L ALLELE);ribavirin;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);ribavirin;Chemical;PA166116466;Haplotype
HLA-C*03:02;ribavirin;Chemical;PA166123425;Haplotype
HLA-C*08:01;ribavirin;Chemical;PA166123426;Haplotype
IFNL3 RS12979860 REFERENCE (C);ribavirin;Chemical;PA166129427;Haplotype
IFNL3 RS12979860T;ribavirin;Chemical;PA166129428;Haplotype
RS187238;ribavirin;Chemical;PA166154270;Variant
RS1946518;ribavirin;Chemical;PA166154344;Variant
RS1544410;ribavirin;Chemical;PA166154516;Variant
RS2228570;ribavirin;Chemical;PA166154531;Variant
RS10877012;ribavirin;Chemical;PA166154623;Variant
RS12819210;ribavirin;Chemical;PA166154644;Variant
RS11854484;ribavirin;Chemical;PA166154934;Variant
RS9939609;ribavirin;Chemical;PA166155098;Variant
RS1800477;ribavirin;Chemical;PA166155280;Variant
RS14158;ribavirin;Chemical;PA166155344;Variant
RS4803217;ribavirin;Chemical;PA166155416;Variant
RS4803219;ribavirin;Chemical;PA166155417;Variant
RS7248668;ribavirin;Chemical;PA166155429;Variant
RS8099917;ribavirin;Chemical;PA166155435;Variant
RS8103142;ribavirin;Chemical;PA166155437;Variant
RS8105790;ribavirin;Chemical;PA166155438;Variant
RS8113007;ribavirin;Chemical;PA166155440;Variant
RS10853728;ribavirin;Chemical;PA166155456;Variant
RS11881222;ribavirin;Chemical;PA166155462;Variant
RS12979860;ribavirin;Chemical;PA166155468;Variant
RS12980275;ribavirin;Chemical;PA166155469;Variant
RS28416813;ribavirin;Chemical;PA166155479;Variant
RS1127354;ribavirin;Chemical;PA166155915;Variant
RS6051702;ribavirin;Chemical;PA166155952;Variant
RS7270101;ribavirin;Chemical;PA166155964;Variant
RS760370;ribavirin;Chemical;PA166156947;Variant
RS3828913;ribavirin;Chemical;PA166157089;Variant
RS1800795;ribavirin;Chemical;PA166157304;Variant
RS10846744;ribavirin;Chemical;PA166160587;Variant
RS117648444;ribavirin;Chemical;PA166160628;Variant
RS4273729;ribavirin;Chemical;PA166160738;Variant
RS10741657;ribavirin;Chemical;PA166163255;Variant
RS11506105;ribavirin;Chemical;PA166165309;Variant
RS11322783;ribavirin;Chemical;PA166190881;Variant
IL6;ribavirin;Chemical;PA198;Gene
LDLR;ribavirin;Chemical;PA227;Gene
BCL2;ribavirin;Chemical;PA25302;Gene
CYP27B1;ribavirin;Chemical;PA27099;Gene
IL18;ribavirin;Chemical;PA29802;Gene
ITPA;ribavirin;Chemical;PA29973;Gene
MICB;ribavirin;Chemical;PA30812;Gene
SLC6A4;ribavirin;Chemical;PA312;Gene
OASL;ribavirin;Chemical;PA31879;Gene
HLA-A;ribavirin;Chemical;PA35055;Gene
HLA-B;ribavirin;Chemical;PA35056;Gene
HLA-C;ribavirin;Chemical;PA35057;Gene
VDR;ribavirin;Chemical;PA37301;Gene
SLC28A2;ribavirin;Chemical;PA386;Gene
EGFR;ribavirin;Chemical;PA7360;Gene
SCARB1;ribavirin;Chemical;PA97;Gene
CELECOXIB;CYP2C19*14;Haplotype;PA448871;Chemical
CLOPIDOGREL;CYP2C19*14;Haplotype;PA449053;Chemical
FLUCONAZOLE;CYP2C19*14;Haplotype;PA449653;Chemical
FLUOXETINE;CYP2C19*14;Haplotype;PA449673;Chemical
MEPHENYTOIN;CYP2C19*14;Haplotype;PA450373;Chemical
SERTRALINE;CYP2C19*14;Haplotype;PA451333;Chemical
BREAST NEOPLASMS;rs10485828;Variant;PA443560;Disease
ANASTROZOLE;rs10485828;Variant;PA448432;Chemical
EXEMESTANE;rs10485828;Variant;PA449563;Chemical
PEGINTERFERON ALFA-2A;IFNL3 rs12979860 reference (C);Haplotype;PA164749390;Chemical
PEGINTERFERON ALFA-2B;IFNL3 rs12979860 reference (C);Haplotype;PA164784024;Chemical
RIBAVIRIN;IFNL3 rs12979860 reference (C);Haplotype;PA451241;Chemical
ALCOHOL ABUSE;rs698;Variant;PA443309;Disease
OVARIAN NEOPLASMS;rs698;Variant;PA445204;Disease
CISPLATIN;rs698;Variant;PA449014;Chemical
CYCLOPHOSPHAMIDE;rs698;Variant;PA449165;Chemical
NALTREXONE;rs698;Variant;PA450588;Chemical
UGT1A3*1;telmisartan;Chemical;PA165959980;Haplotype
UGT1A3*2;telmisartan;Chemical;PA165959981;Haplotype
UGT1A3*3;telmisartan;Chemical;PA165959982;Haplotype
RS5443;telmisartan;Chemical;PA166154486;Variant
RS60140950;telmisartan;Chemical;PA166230183;Variant
GNB3;telmisartan;Chemical;PA176;Gene
SLCO1B3;telmisartan;Chemical;PA35844;Gene
UGT1A3;telmisartan;Chemical;PA37178;Gene
ABCG2;telmisartan;Chemical;PA390;Gene
MYOTONIC DISORDERS;rs886043595;Variant;PA447130;Disease
MEXILETINE;rs886043595;Variant;PA450488;Chemical
MIGALASTAT;rs397515874;Variant;PA166182881;Chemical
FABRY DISEASE;rs397515874;Variant;PA443367;Disease
DIABETES MELLITUS, TYPE 2;rs784888;Variant;PA443890;Disease
METFORMIN;rs784888;Variant;PA450395;Chemical
ACUTE CORONARY SYNDROME;rs11640115;Variant;PA165108401;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);rs11640115;Variant;PA166129560;Disease
ASPIRIN;rs11640115;Variant;PA448497;Chemical
CLOPIDOGREL;rs11640115;Variant;PA449053;Chemical
PPCDC;Amenorrhea;Disease;PA142671157;Gene
RS147451859;Amenorrhea;Disease;PA166199721;Variant
RS17587029;Amenorrhea;Disease;PA166199722;Variant
RS8330;Nephrolithiasis;Disease;PA166155584;Variant
RS1042640;Nephrolithiasis;Disease;PA166155616;Variant
RS10929303;Nephrolithiasis;Disease;PA166155795;Variant
RS2472677;Nephrolithiasis;Disease;PA166156358;Variant
NR1I2;Nephrolithiasis;Disease;PA378;Gene
UGT1A1;Nephrolithiasis;Disease;PA420;Gene
CLNK;Antihypertensives;Chemical;PA164718067;Gene
RS2230345;Antihypertensives;Chemical;PA166154001;Variant
RS12817819;Antihypertensives;Chemical;PA166154643;Variant
RS2070744;Antihypertensives;Chemical;PA166157325;Variant
RS13144136;Antihypertensives;Chemical;PA166163480;Variant
RS6487504;Antihypertensives;Chemical;PA166195021;Variant
RS11749255;Antihypertensives;Chemical;PA166195022;Variant
RS324498;Antihypertensives;Chemical;PA166195023;Variant
GRK5;Antihypertensives;Chemical;PA180;Gene
ATP2B1;Antihypertensives;Chemical;PA25107;Gene
NOS3;Antihypertensives;Chemical;PA254;Gene
PTPRD;Antihypertensives;Chemical;PA34013;Gene
CLCNKA;BSND;Gene;PA26553;Gene
CLCNKB;BSND;Gene;PA26554;Gene
CYP2C19;Hepatitis C;Disease;PA124;Gene
GALNT14;Hepatitis C;Disease;PA134920089;Gene
IFNL3;Hepatitis C;Disease;PA134952671;Gene
HLA-A*01:01;Hepatitis C;Disease;PA165952609;Haplotype
HLA-B*38:01;Hepatitis C;Disease;PA165955500;Haplotype
HLA-B*44:02;Hepatitis C;Disease;PA165955891;Haplotype
HLA-C*01:02;Hepatitis C;Disease;PA165956704;Haplotype
HLA-C*02:02;Hepatitis C;Disease;PA165956777;Haplotype
HLA-C*04:01;Hepatitis C;Disease;PA165957046;Haplotype
HLA-C*05:01;Hepatitis C;Disease;PA165957192;Haplotype
HLA-C*06:02;Hepatitis C;Disease;PA165957286;Haplotype
HLA-C*07:01;Hepatitis C;Disease;PA165957372;Haplotype
HLA-C*12:02;Hepatitis C;Disease;PA165957722;Haplotype
HLA-C*14:02;Hepatitis C;Disease;PA165957818;Haplotype
HLA-C*15:02;Hepatitis C;Disease;PA165957859;Haplotype
HLA-C*16:01;Hepatitis C;Disease;PA165957927;Haplotype
HLA-C*17:01;Hepatitis C;Disease;PA165957985;Haplotype
CYP2C19*1;Hepatitis C;Disease;PA165980634;Haplotype
CYP2C19*2;Hepatitis C;Disease;PA165980635;Haplotype
IFNL4;Hepatitis C;Disease;PA166049147;Gene
HLA-C*03:02;Hepatitis C;Disease;PA166123425;Haplotype
HLA-C*08:01;Hepatitis C;Disease;PA166123426;Haplotype
RS1544410;Hepatitis C;Disease;PA166154516;Variant
RS12819210;Hepatitis C;Disease;PA166154644;Variant
RS11854484;Hepatitis C;Disease;PA166154934;Variant
RS1800477;Hepatitis C;Disease;PA166155280;Variant
RS4803217;Hepatitis C;Disease;PA166155416;Variant
RS8099917;Hepatitis C;Disease;PA166155435;Variant
RS8103142;Hepatitis C;Disease;PA166155437;Variant
RS8113007;Hepatitis C;Disease;PA166155440;Variant
RS11881222;Hepatitis C;Disease;PA166155462;Variant
RS12979860;Hepatitis C;Disease;PA166155468;Variant
RS9679162;Hepatitis C;Disease;PA166155774;Variant
RS2585428;Hepatitis C;Disease;PA166155928;Variant
RS6051702;Hepatitis C;Disease;PA166155952;Variant
RS11322783;Hepatitis C;Disease;PA166190881;Variant
BCL2;Hepatitis C;Disease;PA25302;Gene
CYP24A1;Hepatitis C;Disease;PA27097;Gene
ITPA;Hepatitis C;Disease;PA29973;Gene
OASL;Hepatitis C;Disease;PA31879;Gene
HLA-A;Hepatitis C;Disease;PA35055;Gene
HLA-B;Hepatitis C;Disease;PA35056;Gene
HLA-C;Hepatitis C;Disease;PA35057;Gene
VDR;Hepatitis C;Disease;PA37301;Gene
SLC28A2;Hepatitis C;Disease;PA386;Gene
G6PD;nicorandil;Chemical;PA28469;Gene
CYP2D6;bisoprolol;Chemical;PA128;Gene
ACY3;bisoprolol;Chemical;PA134936640;Gene
RS12346562;bisoprolol;Chemical;PA166157835;Variant
RS2514036;bisoprolol;Chemical;PA166159082;Variant
GRK5;bisoprolol;Chemical;PA180;Gene
GRK4;bisoprolol;Chemical;PA28941;Gene
ADRA2C;bisoprolol;Chemical;PA37;Gene
ADRB1;bisoprolol;Chemical;PA38;Gene
CYP2C19;11alpha-hydroxytestosterone;Chemical;PA124;Gene
CYP2C19*9;11alpha-hydroxytestosterone;Chemical;PA165816525;Haplotype
CYP2C19*11;11alpha-hydroxytestosterone;Chemical;PA165816527;Haplotype
CYP2C19*23;11alpha-hydroxytestosterone;Chemical;PA165816537;Haplotype
CYP2C19*1;11alpha-hydroxytestosterone;Chemical;PA165980634;Haplotype
TRANSPLANTATION;rs8192709;Variant;PA134850491;Disease
CYSTITIS;rs8192709;Variant;PA443833;Disease
CYCLOPHOSPHAMIDE;rs8192709;Variant;PA449165;Chemical
EFAVIRENZ;rs8192709;Variant;PA449441;Chemical
METHADONE;rs8192709;Variant;PA450401;Chemical
CYP3A4;zolpidem;Chemical;PA130;Gene
CYP3A5;zolpidem;Chemical;PA131;Gene
NR1I2;nafcillin;Chemical;PA378;Gene
PERIPHERAL NERVOUS SYSTEM DISEASES;rs8124728;Variant;PA445301;Disease
HIV INFECTIOUS DISEASE;rs8124728;Variant;PA447230;Disease
STAVUDINE;rs8124728;Variant;PA451494;Chemical
DESFLURANE;rs193922747;Variant;PA164749136;Chemical
RYR1;rs193922747;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs193922747;Variant;PA444863;Disease
CAFFEINE;rs193922747;Variant;PA448710;Chemical
ENFLURANE;rs193922747;Variant;PA449461;Chemical
HALOTHANE;rs193922747;Variant;PA449845;Chemical
ISOFLURANE;rs193922747;Variant;PA450106;Chemical
METHOXYFLURANE;rs193922747;Variant;PA450434;Chemical
SEVOFLURANE;rs193922747;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs193922747;Variant;PA451522;Chemical
CACNA1S;rs193922747;Variant;PA85;Gene
ERBB2;trastuzumab emtansine;Chemical;PA27844;Gene
TAXANES;rs1061472;Variant;PA150481189;Chemical
OVARIAN NEOPLASMS;rs1061472;Variant;PA445204;Disease
CARBOPLATIN;rs1061472;Variant;PA448803;Chemical
CABOZANTINIB;CYP3A4*7;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*7;Haplotype;PA165958362;Chemical
REGORAFENIB;CYP3A4*7;Haplotype;PA166114943;Chemical
VANDETANIB;CYP3A4*7;Haplotype;PA166118341;Chemical
ALECTINIB;CYP3A4*7;Haplotype;PA166160050;Chemical
BREXPIPRAZOLE;CYP3A4*7;Haplotype;PA166160053;Chemical
BLONANSERIN;CYP3A4*7;Haplotype;PA166319041;Chemical
OXYCODONE;CYP3A4*7;Haplotype;PA450741;Chemical
CYP3A4;saxagliptin;Chemical;PA130;Gene
CYP3A4*1;saxagliptin;Chemical;PA165819201;Haplotype
CYP3A4*2;saxagliptin;Chemical;PA165819220;Haplotype
CYP3A4*3;saxagliptin;Chemical;PA165819221;Haplotype
CYP3A4*4;saxagliptin;Chemical;PA165819222;Haplotype
CYP3A4*5;saxagliptin;Chemical;PA165819223;Haplotype
CYP3A4*7;saxagliptin;Chemical;PA165819225;Haplotype
CYP3A4*8;saxagliptin;Chemical;PA165819226;Haplotype
CYP3A4*9;saxagliptin;Chemical;PA165819227;Haplotype
CYP3A4*10;saxagliptin;Chemical;PA165819228;Haplotype
CYP3A4*11;saxagliptin;Chemical;PA165819229;Haplotype
CYP3A4*12;saxagliptin;Chemical;PA165819230;Haplotype
CYP3A4*13;saxagliptin;Chemical;PA165819231;Haplotype
CYP3A4*14;saxagliptin;Chemical;PA165819232;Haplotype
CYP3A4*15;saxagliptin;Chemical;PA165819233;Haplotype
CYP3A4*16;saxagliptin;Chemical;PA165819236;Haplotype
CYP3A4*17;saxagliptin;Chemical;PA165819239;Haplotype
CYP3A4*18;saxagliptin;Chemical;PA165819240;Haplotype
CYP3A4*19;saxagliptin;Chemical;PA165819243;Haplotype
CYP3A4*20;saxagliptin;Chemical;PA165819244;Haplotype
CYP3A4*23;saxagliptin;Chemical;PA166115836;Haplotype
CYP3A4*24;saxagliptin;Chemical;PA166115837;Haplotype
CYP3A4*28;saxagliptin;Chemical;PA166245584;Haplotype
CYP3A4*29;saxagliptin;Chemical;PA166245585;Haplotype
CYP3A4*31;saxagliptin;Chemical;PA166245587;Haplotype
CYP3A4*32;saxagliptin;Chemical;PA166245588;Haplotype
CYP3A4*34;saxagliptin;Chemical;PA166245590;Haplotype
SCHIZOPHRENIA;rs1805054;Variant;PA447216;Disease
RISPERIDONE;rs1805054;Variant;PA451257;Chemical
ASTHMA;rs7793837;Variant;PA443450;Disease
SALBUTAMOL;rs7793837;Variant;PA448068;Chemical
EVENT-FREE SURVIVAL;TPMT*32;Haplotype;PA166123366;Disease
LUPUS ERYTHEMATOSUS, SYSTEMIC;TPMT*32;Haplotype;PA444822;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;TPMT*32;Haplotype;PA446155;Disease
MERCAPTOPURINE;TPMT*32;Haplotype;PA450379;Chemical
THIOGUANINE;TPMT*32;Haplotype;PA451663;Chemical
ROSUVASTATIN;rs1009122956;Variant;PA134308647;Chemical
ESTRONE SULFATE;rs1009122956;Variant;PA166185957;Chemical
CORTICOSTEROIDS;rs7160796;Variant;PA10832;Chemical
ASTHMA;rs7160796;Variant;PA443450;Disease
CYP3A5;Autoimmune Diseases;Disease;PA131;Gene
NUDT15;Autoimmune Diseases;Disease;PA134963132;Gene
CYP3A5*1;Autoimmune Diseases;Disease;PA166128213;Haplotype
CYP3A5*3;Autoimmune Diseases;Disease;PA166128219;Haplotype
RS746071566;Autoimmune Diseases;Disease;PA166165231;Variant
CYP3A4;exemestane;Chemical;PA130;Gene
ESR1;exemestane;Chemical;PA156;Gene
CYP3A4*1;exemestane;Chemical;PA165819201;Haplotype
CYP3A4*22;exemestane;Chemical;PA166048680;Haplotype
RS11253043;exemestane;Chemical;PA166154137;Variant
RS62621365;exemestane;Chemical;PA166154188;Variant
RS934635;exemestane;Chemical;PA166154853;Variant
RS6493497;exemestane;Chemical;PA166154917;Variant
RS7176005;exemestane;Chemical;PA166154921;Variant
RS16964189;exemestane;Chemical;PA166154937;Variant
RS4550690;exemestane;Chemical;PA166155729;Variant
RS10485828;exemestane;Chemical;PA166155965;Variant
RS2813543;exemestane;Chemical;PA166157050;Variant
RS6901146;exemestane;Chemical;PA166157111;Variant
RS9322335;exemestane;Chemical;PA166157137;Variant
AKR1C3;exemestane;Chemical;PA24679;Gene
AKR1C4;exemestane;Chemical;PA24680;Gene
PGR;exemestane;Chemical;PA266;Gene
CYP19A1;exemestane;Chemical;PA27091;Gene
ESR2;exemestane;Chemical;PA27886;Gene
MAP4K4;exemestane;Chemical;PA30612;Gene
UGT2B17;exemestane;Chemical;PA37189;Gene
TUBB1;exemestane;Chemical;PA38100;Gene
CYP2C9;rs9934438;Variant;PA126;Gene
VKORC1;rs9934438;Variant;PA133787052;Gene
FLUINDIONE;rs9934438;Variant;PA165980614;Chemical
THROMBOEMBOLISM;rs9934438;Variant;PA445848;Disease
PHENPROCOUMON;rs9934438;Variant;PA450921;Chemical
WARFARIN;rs9934438;Variant;PA451906;Chemical
ACENOCOUMAROL;rs9934438;Variant;PA452632;Chemical
BISPHOSPHONATES;RBMS3;Gene;PA164712563;Chemical
OSTEONECROSIS;RBMS3;Gene;PA445187;Disease
BUFURALOL;CYP2D6*50;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*50;Haplotype;PA166127651;Chemical
DEXTROMETHORPHAN;CYP2D6*50;Haplotype;PA449273;Chemical
PRIMAQUINE;CYP2D6*50;Haplotype;PA451103;Chemical
METRELEPTIN;AGPAT2;Gene;PA166235301;Chemical
NAUSEA;CLCC1;Gene;PA445048;Disease
VOMITING;CLCC1;Gene;PA446051;Disease
OPIOIDS;CLCC1;Gene;PA452618;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs928655;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs928655;Variant;PA443434;Disease
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;IL1RN;Gene;PA164713366;Chemical
ULCERATIVE COLITIS;IL1RN;Gene;PA443750;Disease
HALOPERIDOL;IL1RN;Gene;PA449841;Chemical
HEPARIN;IL1RN;Gene;PA449855;Chemical
MULTIPLE MYELOMA;rs735482;Variant;PA444985;Disease
THALIDOMIDE;rs735482;Variant;PA451644;Chemical
CESSATION;CYP2A6*46;Haplotype;PA166123046;Disease
BREAST NEOPLASMS;CYP2A6*46;Haplotype;PA443560;Disease
NEOPLASMS;CYP2A6*46;Haplotype;PA445062;Disease
TOBACCO USE DISORDER;CYP2A6*46;Haplotype;PA445876;Disease
LETROZOLE;CYP2A6*46;Haplotype;PA450196;Chemical
NICOTINE;CYP2A6*46;Haplotype;PA450626;Chemical
TEGAFUR;CYP2A6*46;Haplotype;PA452620;Chemical
DPYD;rs147601618;Variant;PA145;Gene
CAPECITABINE;rs147601618;Variant;PA448771;Chemical
PLATINUM COMPOUNDS;rs2228000;Variant;PA164713176;Chemical
GASTROINTESTINAL TOXICITY;rs2228000;Variant;PA166124386;Disease
NON-SMALL CELL LUNG CARCINOMA;rs2228000;Variant;PA443622;Disease
HEMATOLOGIC DISORDER;rs2228000;Variant;PA444395;Disease
LEUKOPENIA;rs2228000;Variant;PA444773;Disease
ERBB2;margetuximab;Chemical;PA27844;Gene
FCGR2A;margetuximab;Chemical;PA28063;Gene
FCGR2B;margetuximab;Chemical;PA28064;Gene
FCGR3A;margetuximab;Chemical;PA28065;Gene
NON-SMALL CELL LUNG CARCINOMA;rs2498804;Variant;PA443622;Disease
CARBOPLATIN;rs2498804;Variant;PA448803;Chemical
CISPLATIN;rs2498804;Variant;PA449014;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;rs2734833;Variant;PA164713257;Chemical
MAJOR DEPRESSIVE DISORDER;rs2734833;Variant;PA447321;Disease
ATOMOXETINE;CYP2D6*94;Haplotype;PA134688071;Chemical
TOLTERODINE;CYP2D6*94;Haplotype;PA164746757;Chemical
BUFURALOL;CYP2D6*94;Haplotype;PA166110256;Chemical
DAPOXETINE;CYP2D6*94;Haplotype;PA166151992;Chemical
AMITRIPTYLINE;CYP2D6*94;Haplotype;PA448385;Chemical
DEXTROMETHORPHAN;CYP2D6*94;Haplotype;PA449273;Chemical
RISPERIDONE;CYP2D6*94;Haplotype;PA451257;Chemical
VENLAFAXINE;CYP2D6*94;Haplotype;PA451866;Chemical
IMATINIB;cyclosporine;Chemical;PA10804;Chemical
CYP2C8;cyclosporine;Chemical;PA125;Gene
CYP3A4;cyclosporine;Chemical;PA130;Gene
CYP3A5;cyclosporine;Chemical;PA131;Gene
CRTC2;cyclosporine;Chemical;PA142672073;Gene
CYP3A4*1;cyclosporine;Chemical;PA165819201;Haplotype
CYP3A4*18;cyclosporine;Chemical;PA165819240;Haplotype
TPMT*1;cyclosporine;Chemical;PA165819268;Haplotype
TPMT*2;cyclosporine;Chemical;PA165819269;Haplotype
TPMT*3A;cyclosporine;Chemical;PA165819270;Haplotype
TPMT*3B;cyclosporine;Chemical;PA165819271;Haplotype
TPMT*3C;cyclosporine;Chemical;PA165819272;Haplotype
CYP2C8*3;cyclosporine;Chemical;PA165958685;Haplotype
CYP3A4*22;cyclosporine;Chemical;PA166048680;Haplotype
CYP3A5*1;cyclosporine;Chemical;PA166128213;Haplotype
CYP3A5*3;cyclosporine;Chemical;PA166128219;Haplotype
RS1800872;cyclosporine;Chemical;PA166153640;Variant
RS7903146;cyclosporine;Chemical;PA166154084;Variant
RS231775;cyclosporine;Chemical;PA166155589;Variant
RS1042597;cyclosporine;Chemical;PA166155614;Variant
RS11706052;cyclosporine;Chemical;PA166156443;Variant
RS1800629;cyclosporine;Chemical;PA166156997;Variant
RS776746;cyclosporine;Chemical;PA166157267;Variant
RS1045642;cyclosporine;Chemical;PA166157284;Variant
RS1057868;cyclosporine;Chemical;PA166157286;Variant
RS1128503;cyclosporine;Chemical;PA166157288;Variant
RS2032582;cyclosporine;Chemical;PA166157316;Variant
RS2740574;cyclosporine;Chemical;PA166157367;Variant
RS4646437;cyclosporine;Chemical;PA166157391;Variant
RS28371759;cyclosporine;Chemical;PA166157481;Variant
RS35599367;cyclosporine;Chemical;PA166157487;Variant
RS8450;cyclosporine;Chemical;PA166163444;Variant
CYP2C8*1;cyclosporine;Chemical;PA166242948;Haplotype
RS12885713;cyclosporine;Chemical;PA166289381;Variant
RS2874116;cyclosporine;Chemical;PA166289401;Variant
CALM1;cyclosporine;Chemical;PA26035;Gene
ABCB1;cyclosporine;Chemical;PA267;Gene
CTLA4;cyclosporine;Chemical;PA27006;Gene
IL10;cyclosporine;Chemical;PA29778;Gene
IMPDH2;cyclosporine;Chemical;PA29863;Gene
POR;cyclosporine;Chemical;PA33532;Gene
TPMT;cyclosporine;Chemical;PA356;Gene
TCF7L2;cyclosporine;Chemical;PA36394;Gene
UGT1A8;cyclosporine;Chemical;PA37183;Gene
NR1I2;cyclosporine;Chemical;PA378;Gene
ABCG2;cyclosporine;Chemical;PA390;Gene
TNF;cyclosporine;Chemical;PA435;Gene
CELECOXIB;CACNA2D2;Gene;PA448871;Chemical
REMIFENTANIL;CACNA2D2;Gene;PA451232;Chemical
GPAM;PRKAG2;Gene;PA134983031;Gene
CRTC2;PRKAG2;Gene;PA142672073;Gene
HMGCR;PRKAG2;Gene;PA189;Gene
ACACA;PRKAG2;Gene;PA24421;Gene
ACACB;PRKAG2;Gene;PA24422;Gene
MLYCD;PRKAG2;Gene;PA30861;Gene
SREBF1;PRKAG2;Gene;PA335;Gene
SLC2A4;PRKAG2;Gene;PA35879;Gene
STK11;PRKAG2;Gene;PA36198;Gene
MLXIPL;PRKAG2;Gene;PA37353;Gene
SIRT1;PRKAG2;Gene;PA37935;Gene
HYPERTENSION;PRKAG2;Gene;PA444552;Disease
HYDROCHLOROTHIAZIDE;PRKAG2;Gene;PA449899;Chemical
METFORMIN;PRKAG2;Gene;PA450395;Chemical
ATM;PRKAG2;Gene;PA61;Gene
CACNA1B;PRKACG;Gene;PA26008;Gene
MAPK1;PRKACG;Gene;PA30616;Gene
ARRB1;PRKACG;Gene;PA59;Gene
ARRB2;PRKACG;Gene;PA60;Gene
CACNA1C;PRKACG;Gene;PA83;Gene
CACNA1D;PRKACG;Gene;PA84;Gene
CACNA1S;PRKACG;Gene;PA85;Gene
UGT1A1*1;treatment interruptions;Disease;PA166115841;Haplotype
UGT1A1*28;treatment interruptions;Disease;PA166115842;Haplotype
UGT1A1;treatment interruptions;Disease;PA420;Gene
ACUTE CORONARY SYNDROME;TSPEAR;Gene;PA165108401;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);TSPEAR;Gene;PA166129560;Disease
ASPIRIN;TSPEAR;Gene;PA448497;Chemical
CLOPIDOGREL;TSPEAR;Gene;PA449053;Chemical
MEPHENYTOIN;rs145119820;Variant;PA450373;Chemical
SCHIZOPHRENIA;rs2857657;Variant;PA447216;Disease
RISPERIDONE;rs2857657;Variant;PA451257;Chemical
FLUOROURACIL;GALNT14;Gene;PA128406956;Chemical
HEPATITIS C VIRUS INFECTION;GALNT14;Gene;PA444445;Disease
HEPATOCELLULAR CARCINOMA;GALNT14;Gene;PA444447;Disease
LIVER CANCER;GALNT14;Gene;PA444804;Disease
CISPLATIN;GALNT14;Gene;PA449014;Chemical
MITOXANTRONE;GALNT14;Gene;PA450526;Chemical
SORAFENIB;GALNT14;Gene;PA7000;Chemical
PEGINTERFERON ALFA-2B;HLA-C*07:01;Haplotype;PA164784024;Chemical
AGRANULOCYTOSIS;HLA-C*07:01;Haplotype;PA443297;Disease
HEPATITIS C;HLA-C*07:01;Haplotype;PA444445;Disease
SCHIZOPHRENIA;HLA-C*07:01;Haplotype;PA447216;Disease
CLOZAPINE;HLA-C*07:01;Haplotype;PA449061;Chemical
RIBAVIRIN;HLA-C*07:01;Haplotype;PA451241;Chemical
ALLOPURINOL;rs10802887;Variant;PA448320;Chemical
HEROIN DEPENDENCE;rs3802281;Variant;PA444460;Disease
METHADONE;rs3802281;Variant;PA450401;Chemical
CYP2D6;sertindole;Chemical;PA128;Gene
CYP3A4;sertindole;Chemical;PA130;Gene
KCNH2;sertindole;Chemical;PA212;Gene
SUBSTANCE-RELATED DISORDERS;rs78886294;Variant;PA446876;Disease
KHK;fructose;Chemical;PA30095;Gene
NEOPLASMS;OTOS;Gene;PA445062;Disease
CISPLATIN;OTOS;Gene;PA449014;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs4848306;Variant;PA164713366;Chemical
ULCERATIVE COLITIS;rs4848306;Variant;PA443750;Disease
INFLAMMATORY BOWEL DISEASES;rs4848306;Variant;PA446116;Disease
ETOPOSIDE;rs6539870;Variant;PA449552;Chemical
RS2010963;pegaptanib;Chemical;PA166157006;Variant
VEGFA;pegaptanib;Chemical;PA37302;Gene
CYP1A2;CYP1A2*3;Haplotype;PA27093;Gene
CLOZAPINE;CYP1A2*3;Haplotype;PA449061;Chemical
SCHIZOPHRENIA;rs10490162;Variant;PA447216;Disease
ANTIPSYCHOTICS;rs10490162;Variant;PA452233;Chemical
HYPERTENSION;rs7606603;Variant;PA444552;Disease
ATENOLOL;rs7606603;Variant;PA448499;Chemical
OPIOID-RELATED DISORDERS;rs581111;Variant;PA445043;Disease
BUPRENORPHINE;rs581111;Variant;PA448685;Chemical
OXYCODONE;rs581111;Variant;PA450741;Chemical
SEDATION;rs6686529;Variant;PA166129521;Disease
SEVOFLURANE;rs6686529;Variant;PA451341;Chemical
CORONARY DISEASE;CES1P1;Gene;PA443797;Disease
DRUG TOXICITY;CES1P1;Gene;PA443937;Disease
CAPECITABINE;CES1P1;Gene;PA448771;Chemical
CLOPIDOGREL;CES1P1;Gene;PA449053;Chemical
CYP2D6;thioridazine;Chemical;PA128;Gene
RS1080985;thioridazine;Chemical;PA166156064;Variant
KCNH2;thioridazine;Chemical;PA212;Gene
CYP2J2;thioridazine;Chemical;PA27112;Gene
CYP2C19;lacosamide;Chemical;PA124;Gene
LEUKEMIA, MYELOID, ACUTE;rs80143932;Variant;PA444760;Disease
CYTARABINE;rs80143932;Variant;PA449177;Chemical
IDARUBICIN;rs80143932;Variant;PA449961;Chemical
GBA;velaglucerase alfa;Chemical;PA28591;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs6138150;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs6138150;Variant;PA443434;Disease
HYPERTENSION;rs1446468;Variant;PA444552;Disease
METOPROLOL;rs1446468;Variant;PA450480;Chemical
ANEMIA;rs36120609;Variant;PA443340;Disease
DRUG TOXICITY;rs36120609;Variant;PA443937;Disease
NEOPLASM METASTASIS;rs36120609;Variant;PA445058;Disease
OVARIAN NEOPLASMS;rs36120609;Variant;PA445204;Disease
OSTEOSARCOMA;rs36120609;Variant;PA445601;Disease
THROMBOCYTOPENIA;rs36120609;Variant;PA445846;Disease
NEUROTOXICITY SYNDROMES;rs36120609;Variant;PA446975;Disease
CISPLATIN;rs36120609;Variant;PA449014;Chemical
CYCLOPHOSPHAMIDE;rs36120609;Variant;PA449165;Chemical
OLANZAPINE;rs36120609;Variant;PA450688;Chemical
HYDROCHLOROTHIAZIDE;uric acid;Chemical;PA449899;Chemical
MAJOR DEPRESSIVE DISORDER;rs7124442;Variant;PA447321;Disease
CITALOPRAM;rs7124442;Variant;PA449015;Chemical
DICLOFENAC;CYP2C9*46;Haplotype;PA449293;Chemical
WARFARIN;CYP2C9*46;Haplotype;PA451906;Chemical
MTHFR;Cleft Lip;Disease;PA245;Gene
ALEMTUZUMAB;rs1801157;Variant;PA164783958;Chemical
LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;rs1801157;Variant;PA446169;Disease
CHLORAMBUCIL;rs1801157;Variant;PA448926;Chemical
CYCLOPHOSPHAMIDE;rs1801157;Variant;PA449165;Chemical
FLUDARABINE;rs1801157;Variant;PA449655;Chemical
PREDNISONE;rs1801157;Variant;PA451100;Chemical
RITUXIMAB;rs1801157;Variant;PA451261;Chemical
VINCRISTINE;rs1801157;Variant;PA451879;Chemical
HMG COA REDUCTASE INHIBITORS;rs445925;Variant;PA133950441;Chemical
BISPHOSPHONATES;rs17751934;Variant;PA164712563;Chemical
OSTEONECROSIS;rs17751934;Variant;PA445187;Disease
CAMK1D;STAT3;Gene;PA134992438;Gene
AKT1;STAT3;Gene;PA24684;Gene
AKT2;STAT3;Gene;PA24685;Gene
AKT3;STAT3;Gene;PA24686;Gene
NFKB1;STAT3;Gene;PA248;Gene
CAMK1;STAT3;Gene;PA26048;Gene
CAMK1G;STAT3;Gene;PA26049;Gene
ELK1;STAT3;Gene;PA27749;Gene
FOS;STAT3;Gene;PA28212;Gene
MAPK8;STAT3;Gene;PA283;Gene
RELA;STAT3;Gene;PA296;Gene
JAK1;STAT3;Gene;PA29988;Gene
JUN;STAT3;Gene;PA30006;Gene
MAPK1;STAT3;Gene;PA30616;Gene
MAPK3;STAT3;Gene;PA30622;Gene
MYC;STAT3;Gene;PA31353;Gene
NFKB2;STAT3;Gene;PA31600;Gene
PRKCA;STAT3;Gene;PA33759;Gene
PRKCB;STAT3;Gene;PA33761;Gene
PRKCG;STAT3;Gene;PA33766;Gene
STAT5A;STAT3;Gene;PA338;Gene
SP1;STAT3;Gene;PA36042;Gene
STAT1;STAT3;Gene;PA36183;Gene
STAT2;STAT3;Gene;PA36184;Gene
STAT4;STAT3;Gene;PA36185;Gene
STAT5B;STAT3;Gene;PA36186;Gene
RENAL CELL CARCINOMA;STAT3;Gene;PA443624;Disease
INTERFERONS;STAT3;Gene;PA451999;Chemical
CAMK2A;STAT3;Gene;PA90;Gene
CAMK2B;STAT3;Gene;PA91;Gene
CAMK2D;STAT3;Gene;PA92;Gene
CAMK2G;STAT3;Gene;PA93;Gene
HEROIN DEPENDENCE;rs1799978;Variant;PA444460;Disease
HYPERPROLACTINEMIA;rs1799978;Variant;PA444545;Disease
SCHIZOPHRENIA;rs1799978;Variant;PA447216;Disease
METHADONE;rs1799978;Variant;PA450401;Chemical
OLANZAPINE;rs1799978;Variant;PA450688;Chemical
RISPERIDONE;rs1799978;Variant;PA451257;Chemical
SUBSTANCE-RELATED DISORDERS;rs34214870;Variant;PA446876;Disease
TOXIC LIVER DISEASE;BACH1;Gene;PA164925725;Disease
DRUG-INDUCED LIVER INJURY;BACH1;Gene;PA166119041;Disease
ISONIAZID;BACH1;Gene;PA450112;Chemical
CYP3A5;Renal Cell Carcinoma;Disease;PA131;Gene
HLA-B*57:01;Renal Cell Carcinoma;Disease;PA165987830;Haplotype
UGT1A1*1;Renal Cell Carcinoma;Disease;PA166115841;Haplotype
UGT1A1*28;Renal Cell Carcinoma;Disease;PA166115842;Haplotype
UGT1A1*37;Renal Cell Carcinoma;Disease;PA166115844;Haplotype
UGT1A1*6;Renal Cell Carcinoma;Disease;PA166115858;Haplotype
RS4796793;Renal Cell Carcinoma;Disease;PA166155228;Variant
RS1126647;Renal Cell Carcinoma;Disease;PA166156502;Variant
RS2071559;Renal Cell Carcinoma;Disease;PA166156537;Variant
RS2239702;Renal Cell Carcinoma;Disease;PA166156547;Variant
RS307821;Renal Cell Carcinoma;Disease;PA166156728;Variant
RS307826;Renal Cell Carcinoma;Disease;PA166156730;Variant
RS1800925;Renal Cell Carcinoma;Disease;PA166156774;Variant
RS1570360;Renal Cell Carcinoma;Disease;PA166156985;Variant
RS2010963;Renal Cell Carcinoma;Disease;PA166157006;Variant
RS776746;Renal Cell Carcinoma;Disease;PA166157267;Variant
RS1045642;Renal Cell Carcinoma;Disease;PA166157284;Variant
RS1128503;Renal Cell Carcinoma;Disease;PA166157288;Variant
RS2032582;Renal Cell Carcinoma;Disease;PA166157316;Variant
IL13;Renal Cell Carcinoma;Disease;PA199;Gene
ABCB1;Renal Cell Carcinoma;Disease;PA267;Gene
FLT4;Renal Cell Carcinoma;Disease;PA28183;Gene
CXCL8;Renal Cell Carcinoma;Disease;PA29841;Gene
KDR;Renal Cell Carcinoma;Disease;PA30086;Gene
STAT3;Renal Cell Carcinoma;Disease;PA337;Gene
HLA-B;Renal Cell Carcinoma;Disease;PA35056;Gene
VEGFA;Renal Cell Carcinoma;Disease;PA37302;Gene
UGT1A1;Renal Cell Carcinoma;Disease;PA420;Gene
FLUOROURACIL;rs770063251;Variant;PA128406956;Chemical
DRUG TOXICITY;rs770063251;Variant;PA443937;Disease
NEOPLASMS;rs770063251;Variant;PA445062;Disease
DICLOFENAC;CYP2C9*44;Haplotype;PA449293;Chemical
INOTERSEN;TTR;Gene;PA166182756;Chemical
PATISIRAN;TTR;Gene;PA166182884;Chemical
TAFAMIDIS;TTR;Gene;PA166184562;Chemical
VUTRISIRAN;TTR;Gene;PA166277621;Chemical
EPLONTERSEN;TTR;Gene;PA166328821;Chemical
RS28933979;TTR;Gene;PA166329081;Variant
ALCOHOL ABUSE;rs6589386;Variant;PA443309;Disease
ETHANOL;rs6589386;Variant;PA448073;Chemical
FLUOROURACIL;rs374527058;Variant;PA128406956;Chemical
DRUG TOXICITY;rs374527058;Variant;PA443937;Disease
RS11568658;valganciclovir;Chemical;PA166154747;Variant
RS2229109;valganciclovir;Chemical;PA166157334;Variant
ABCB1;valganciclovir;Chemical;PA267;Gene
ABCC4;valganciclovir;Chemical;PA397;Gene
HAND-FOOT SYNDROME;rs1870377;Variant;PA166114377;Disease
HEPATOCELLULAR CARCINOMA;rs1870377;Variant;PA444447;Disease
HYPERTENSION;rs1870377;Variant;PA444552;Disease
SORAFENIB;rs1870377;Variant;PA7000;Chemical
ALLOPURINOL;rs4659982;Variant;PA448320;Chemical
CYP3A4;zonisamide;Chemical;PA130;Gene
HLA-A*02:07;zonisamide;Chemical;PA165952839;Haplotype
RS2306719;zonisamide;Chemical;PA166154889;Variant
RS4984241;zonisamide;Chemical;PA166154916;Variant
CA12;zonisamide;Chemical;PA25987;Gene
HLA-A;zonisamide;Chemical;PA35055;Gene
CLOBAZAM;rs2298771;Variant;PA10888;Chemical
EPILEPSY;rs2298771;Variant;PA444065;Disease
CARBAMAZEPINE;rs2298771;Variant;PA448785;Chemical
ETHOSUXIMIDE;rs2298771;Variant;PA449533;Chemical
LAMOTRIGINE;rs2298771;Variant;PA450164;Chemical
LEVETIRACETAM;rs2298771;Variant;PA450206;Chemical
OXCARBAZEPINE;rs2298771;Variant;PA450732;Chemical
VALPROIC ACID;rs2298771;Variant;PA451846;Chemical
FLUOROURACIL;DPYD;Gene;PA128406956;Chemical
TEGAFUR / GIMERACIL / OTERACIL;DPYD;Gene;PA166115442;Chemical
MUCOSITIS;DPYD;Gene;PA166122058;Disease
TREATMENT MODIFICATION;DPYD;Gene;PA166124372;Disease
RS1801158;DPYD;Gene;PA166153645;Variant
RS1801159;DPYD;Gene;PA166153646;Variant
RS1801160;DPYD;Gene;PA166153647;Variant
RS1801265;DPYD;Gene;PA166153648;Variant
RS1801266;DPYD;Gene;PA166153649;Variant
RS1801267;DPYD;Gene;PA166153650;Variant
RS1801268;DPYD;Gene;PA166153651;Variant
RS2297595;DPYD;Gene;PA166153696;Variant
RS3918290;DPYD;Gene;PA166153760;Variant
RS17376848;DPYD;Gene;PA166153874;Variant
RS45589337;DPYD;Gene;PA166153885;Variant
RS55674432;DPYD;Gene;PA166153886;Variant
RS55886062;DPYD;Gene;PA166153888;Variant
RS56038477;DPYD;Gene;PA166153889;Variant
RS59086055;DPYD;Gene;PA166153891;Variant
RS60139309;DPYD;Gene;PA166153892;Variant
RS67376798;DPYD;Gene;PA166153895;Variant
RS72547601;DPYD;Gene;PA166153896;Variant
RS72549303;DPYD;Gene;PA166153897;Variant
RS72549304;DPYD;Gene;PA166153898;Variant
RS72549306;DPYD;Gene;PA166153899;Variant
RS72549307;DPYD;Gene;PA166153900;Variant
RS72549308;DPYD;Gene;PA166153901;Variant
RS72549309;DPYD;Gene;PA166153902;Variant
RS78060119;DPYD;Gene;PA166153913;Variant
RS80081766;DPYD;Gene;PA166153914;Variant
RS111858276;DPYD;Gene;PA166153916;Variant
RS112766203;DPYD;Gene;PA166153917;Variant
RS114096998;DPYD;Gene;PA166153918;Variant
RS115232898;DPYD;Gene;PA166153919;Variant
RS137999090;DPYD;Gene;PA166153921;Variant
RS138616379;DPYD;Gene;PA166153922;Variant
RS141044036;DPYD;Gene;PA166153923;Variant
RS143154602;DPYD;Gene;PA166153925;Variant
RS145773863;DPYD;Gene;PA166153927;Variant
RS146356975;DPYD;Gene;PA166153928;Variant
RS147545709;DPYD;Gene;PA166153929;Variant
RS147601618;DPYD;Gene;PA166153930;Variant
RS183385770;DPYD;Gene;PA166153932;Variant
RS186169810;DPYD;Gene;PA166153933;Variant
RS200687447;DPYD;Gene;PA166153936;Variant
RS61622928;DPYD;Gene;PA166159638;Variant
RS72549310;DPYD;Gene;PA166159712;Variant
RS150036960;DPYD;Gene;PA166159767;Variant
RS150385342;DPYD;Gene;PA166159768;Variant
RS141462178;DPYD;Gene;PA166159769;Variant
RS200562975;DPYD;Gene;PA166159770;Variant
RS139834141;DPYD;Gene;PA166159771;Variant
RS150437414;DPYD;Gene;PA166159772;Variant
RS145112791;DPYD;Gene;PA166159773;Variant
RS201018345;DPYD;Gene;PA166159774;Variant
RS72549305;DPYD;Gene;PA166159775;Variant
RS143815742;DPYD;Gene;PA166159776;Variant
RS140602333;DPYD;Gene;PA166159777;Variant
RS200064537;DPYD;Gene;PA166159778;Variant
RS142512579;DPYD;Gene;PA166159779;Variant
RS72975710;DPYD;Gene;PA166159780;Variant
RS144395748;DPYD;Gene;PA166159781;Variant
RS199549923;DPYD;Gene;PA166159782;Variant
RS138391898;DPYD;Gene;PA166159783;Variant
RS148994843;DPYD;Gene;PA166159784;Variant
RS190951787;DPYD;Gene;PA166159785;Variant
RS142619737;DPYD;Gene;PA166159786;Variant
RS201615754;DPYD;Gene;PA166159787;Variant
RS3918289;DPYD;Gene;PA166159788;Variant
RS55971861;DPYD;Gene;PA166159789;Variant
RS138545885;DPYD;Gene;PA166159790;Variant
RS145548112;DPYD;Gene;PA166159791;Variant
RS146529561;DPYD;Gene;PA166159792;Variant
RS60511679;DPYD;Gene;PA166159793;Variant
RS199634007;DPYD;Gene;PA166159794;Variant
RS201035051;DPYD;Gene;PA166159796;Variant
RS145529148;DPYD;Gene;PA166159797;Variant
RS72547602;DPYD;Gene;PA166159798;Variant
RS139459586;DPYD;Gene;PA166159799;Variant
RS202144771;DPYD;Gene;PA166159800;Variant
RS140114515;DPYD;Gene;PA166159801;Variant
RS148799944;DPYD;Gene;PA166159802;Variant
DPYD C.1905+1G>A (*2A);DPYD;Gene;PA166171117;Haplotype
DPYD C.1679T>G (*13);DPYD;Gene;PA166171118;Haplotype
DPYD C.2846A>T;DPYD;Gene;PA166171119;Haplotype
DPYD C.1129-5923C>G, C.1236G>A (HAPB3);DPYD;Gene;PA166171120;Haplotype
RS56005131;DPYD;Gene;PA166179517;Variant
FOLFOX;DPYD;Gene;PA166182862;Chemical
XELOX;DPYD;Gene;PA166182864;Chemical
FLUOROURACIL / SALICYLIC ACID;DPYD;Gene;PA166183787;Chemical
RS6670886;DPYD;Gene;PA166192821;Variant
RS764666241;DPYD;Gene;PA166192822;Variant
RS57918000;DPYD;Gene;PA166192823;Variant
DPYD C.2194G>A (*6);DPYD;Gene;PA166194413;Haplotype
BREAST NEOPLASMS;DPYD;Gene;PA443560;Disease
COLONIC NEOPLASMS;DPYD;Gene;PA443756;Disease
DEATH;DPYD;Gene;PA443842;Disease
DRUG TOXICITY;DPYD;Gene;PA443937;Disease
GASTROINTESTINAL NEOPLASMS;DPYD;Gene;PA444257;Disease
HEAD AND NECK NEOPLASMS;DPYD;Gene;PA444352;Disease
HYPERBILIRUBINEMIA;DPYD;Gene;PA444511;Disease
MENTAL RETARDATION;DPYD;Gene;PA444929;Disease
METABOLIC DISEASES;DPYD;Gene;PA444938;Disease
METABOLISM, INBORN ERRORS;DPYD;Gene;PA444939;Disease
NEOPLASMS;DPYD;Gene;PA445062;Disease
NEUTROPENIA;DPYD;Gene;PA445113;Disease
PANCREATIC NEOPLASMS;DPYD;Gene;PA445218;Disease
PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS;DPYD;Gene;PA445476;Disease
RECTAL NEOPLASMS;DPYD;Gene;PA445503;Disease
SEIZURES;DPYD;Gene;PA445629;Disease
COLORECTAL NEOPLASMS;DPYD;Gene;PA446108;Disease
NEUROTOXICITY SYNDROMES;DPYD;Gene;PA446975;Disease
CAPECITABINE;DPYD;Gene;PA448771;Chemical
FLUCYTOSINE;DPYD;Gene;PA449654;Chemical
IRINOTECAN;DPYD;Gene;PA450085;Chemical
LEUCOVORIN;DPYD;Gene;PA450198;Chemical
TEGAFUR;DPYD;Gene;PA452620;Chemical
ANTINEOPLASTIC AGENTS;DPYD;Gene;PA452621;Chemical
WARFARIN;rs699664;Variant;PA451906;Chemical
RHEUMATOID ARTHRITIS;rs4673993;Variant;PA443434;Disease
METHOTREXATE;rs4673993;Variant;PA450428;Chemical
BIPOLAR DISORDER;NR1D1;Gene;PA447199;Disease
LITHIUM;NR1D1;Gene;PA450243;Chemical
CYP2D6;debrisoquine;Chemical;PA128;Gene
CYP2D6*1;debrisoquine;Chemical;PA165816576;Haplotype
CYP2D6*2;debrisoquine;Chemical;PA165816577;Haplotype
CYP2D6*3;debrisoquine;Chemical;PA165816578;Haplotype
CYP2D6*4;debrisoquine;Chemical;PA165816579;Haplotype
CYP2D6*6;debrisoquine;Chemical;PA165816581;Haplotype
CYP2D6*10;debrisoquine;Chemical;PA165816582;Haplotype
CYP2D6*17;debrisoquine;Chemical;PA165816583;Haplotype
CYP2D6*5;debrisoquine;Chemical;PA165948092;Haplotype
CYP2D6*9;debrisoquine;Chemical;PA165948317;Haplotype
CYP2D6*29;debrisoquine;Chemical;PA165948318;Haplotype
CYP2D6*8;debrisoquine;Chemical;PA165971560;Haplotype
CYP2D6*15;debrisoquine;Chemical;PA165971568;Haplotype
CYP2D6*18;debrisoquine;Chemical;PA165971569;Haplotype
CYP2D6*31;debrisoquine;Chemical;PA165971582;Haplotype
CYP2D6*36XN;debrisoquine;Chemical;PA165971589;Haplotype
CYP2D6*38;debrisoquine;Chemical;PA165971592;Haplotype
CYP2D6*75;debrisoquine;Chemical;PA165971627;Haplotype
CYP2D6*2XN;debrisoquine;Chemical;PA165988480;Haplotype
CYP2D6*21;debrisoquine;Chemical;PA165988484;Haplotype
CYP2D6*4XN;debrisoquine;Chemical;PA166123455;Haplotype
RS1080985;debrisoquine;Chemical;PA166156064;Variant
LEUKEMIA, MYELOID, ACUTE;rs4643786;Variant;PA444760;Disease
CYTARABINE;rs4643786;Variant;PA449177;Chemical
NICOTINE;rs200554095;Variant;PA450626;Chemical
ACE INHIBITORS, PLAIN;rs7675300;Variant;PA164712308;Chemical
PROSTATIC NEOPLASMS;ABCC6;Gene;PA445425;Disease
DOCETAXEL;ABCC6;Gene;PA449383;Chemical
THALIDOMIDE;ABCC6;Gene;PA451644;Chemical
DEFERASIROX;GC;Gene;PA164760843;Chemical
BETA-THALASSEMIA AND RELATED DISEASES;GC;Gene;PA446432;Disease
CYP2A6;biliary tract neoplasms;Disease;PA121;Gene
CYP2A6*1;biliary tract neoplasms;Disease;PA165924690;Haplotype
CYP2A6*4;biliary tract neoplasms;Disease;PA165924721;Haplotype
CYP2A6*7;biliary tract neoplasms;Disease;PA165924731;Haplotype
CYP2A6*10;biliary tract neoplasms;Disease;PA165924735;Haplotype
CYP2A6*9;biliary tract neoplasms;Disease;PA165980914;Haplotype
UGT1A1*1;biliary tract neoplasms;Disease;PA166115841;Haplotype
UGT1A1*28;biliary tract neoplasms;Disease;PA166115842;Haplotype
UGT1A1*6;biliary tract neoplasms;Disease;PA166115858;Haplotype
UGT1A1;biliary tract neoplasms;Disease;PA420;Gene
TEGAFUR;rs8192725;Variant;PA452620;Chemical
CYP3A5;Myasthenia Gravis;Disease;PA131;Gene
CYP3A5*1;Myasthenia Gravis;Disease;PA166128213;Haplotype
CYP3A5*3;Myasthenia Gravis;Disease;PA166128219;Haplotype
RS1128503;Myasthenia Gravis;Disease;PA166157288;Variant
ABCB1;Myasthenia Gravis;Disease;PA267;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;IL17RA;Gene;PA164713366;Chemical
PSORIASIS;IL17RA;Gene;PA445451;Disease
HAND-FOOT SYNDROME;ANK3;Gene;PA166114377;Disease
BREAST NEOPLASMS;ANK3;Gene;PA443560;Disease
NEOPLASMS;ANK3;Gene;PA445062;Disease
COLORECTAL NEOPLASMS;ANK3;Gene;PA446108;Disease
CAPECITABINE;ANK3;Gene;PA448771;Chemical
METHOTREXATE;KIR2DS4;Gene;PA450428;Chemical
MARAVIROC;CCR5;Gene;PA164768835;Chemical
MULTIPLE SCLEROSIS;CCR5;Gene;PA444987;Disease
GLATIRAMER ACETATE;CCR5;Gene;PA449760;Chemical
HLA-DPB1*03:01;Urticaria;Disease;PA165951131;Haplotype
HLA-DPB1*05:01;Urticaria;Disease;PA165951139;Haplotype
HLA-DPB1*13:01;Urticaria;Disease;PA165951184;Haplotype
HLA-DRB1*09:01;Urticaria;Disease;PA165951734;Haplotype
HLA-DRB1*13:02;Urticaria;Disease;PA165951978;Haplotype
HLA-DQB1*06:04;Urticaria;Disease;PA165958107;Haplotype
HLA-DQB1*06:09;Urticaria;Disease;PA165958117;Haplotype
HLA-DQB1*03:03;Urticaria;Disease;PA165958180;Haplotype
RS2298805;Urticaria;Disease;PA166153699;Variant
RS901865;Urticaria;Disease;PA166156299;Variant
RS730012;Urticaria;Disease;PA166156740;Variant
LTC4S;Urticaria;Disease;PA235;Gene
FCER1A;Urticaria;Disease;PA28056;Gene
HRH1;Urticaria;Disease;PA29456;Gene
HLA-DPB1;Urticaria;Disease;PA35064;Gene
HLA-DQB1;Urticaria;Disease;PA35068;Gene
HLA-DRB1;Urticaria;Disease;PA35072;Gene
CYP2A6;methoxsalen;Chemical;PA121;Gene
CYP2A6*1;methoxsalen;Chemical;PA165924690;Haplotype
CYP2A6*15;methoxsalen;Chemical;PA165924742;Haplotype
CYP2A6*21;methoxsalen;Chemical;PA165924750;Haplotype
CYP2A6*22;methoxsalen;Chemical;PA165924751;Haplotype
COMT;Pruritus;Disease;PA117;Gene
NECTIN4;Pruritus;Disease;PA134991624;Gene
RS324420;Pruritus;Disease;PA166153569;Variant
RS4680;Pruritus;Disease;PA166156024;Variant
RS1799971;Pruritus;Disease;PA166156991;Variant
RS11265549;Pruritus;Disease;PA166233022;Variant
FAAH;Pruritus;Disease;PA27955;Gene
OPRM1;Pruritus;Disease;PA31945;Gene
HLA-B*13:01;Skin Diseases;Disease;PA165954643;Haplotype
HLA-B;Skin Diseases;Disease;PA35056;Gene
ALLOPURINOL;rs1934341;Variant;PA448320;Chemical
HEMATOPOIETIC STEM CELL TRANSPLANTATION;CTH;Gene;PA166123007;Disease
BUSULFAN;CTH;Gene;PA448691;Chemical
CYCLOPHOSPHAMIDE;CTH;Gene;PA449165;Chemical
DPYD;Purine-Pyrimidine Metabolism, Inborn Errors;Disease;PA145;Gene
RS72549309;Purine-Pyrimidine Metabolism, Inborn Errors;Disease;PA166153902;Variant
SLCO1B1;Arsenic compounds;Chemical;PA134865839;Gene
RASBURICASE;G6PD;Gene;PA10176;Chemical
SULFAMETHOXAZOLE / TRIMETHOPRIM;G6PD;Gene;PA10715;Chemical
GLICLAZIDE;G6PD;Gene;PA10892;Chemical
BUPIVACAINE;G6PD;Gene;PA135057240;Chemical
METABOLIC SYNDROME;G6PD;Gene;PA162370415;Disease
ASCORBIC ACID (VITAMIN C), COMBINATIONS;G6PD;Gene;PA164712515;Chemical
ASCORBIC ACID (VITAMIN C), PLAIN;G6PD;Gene;PA164712516;Chemical
QUINOLONE ANTIBACTERIALS;G6PD;Gene;PA164713229;Chemical
VITAMIN B-COMPLEX WITH VITAMIN C;G6PD;Gene;PA164713397;Chemical
VITAMIN K AND ANALOGUES;G6PD;Gene;PA164713404;Chemical
QUINACRINE;G6PD;Gene;PA164745551;Chemical
NALIDIXIC ACID;G6PD;Gene;PA164746384;Chemical
FURAZOLIDONE;G6PD;Gene;PA164746760;Chemical
PHENAZOPYRIDINE;G6PD;Gene;PA164746899;Chemical
SULFAMETOPYRAZINE;G6PD;Gene;PA164747038;Chemical
MEPIVACAINE;G6PD;Gene;PA164748741;Chemical
SULFISOXAZOLE;G6PD;Gene;PA164748964;Chemical
NITROFURAZONE;G6PD;Gene;PA164754877;Chemical
TOLAZAMIDE;G6PD;Gene;PA164774902;Chemical
HYDROXYCHLOROQUINE;G6PD;Gene;PA164777036;Chemical
FAVISM;G6PD;Gene;PA165108889;Disease
ARTESUNATE;G6PD;Gene;PA165111697;Chemical
ANEMIA, HEMOLYTIC, CONGENITAL NONSPHEROCYTIC;G6PD;Gene;PA165857066;Disease
CHLORPROGUANIL;G6PD;Gene;PA165857067;Chemical
3-AMINOPYRIDINE-2-CARBOXALDEHYDE THIOSEMICARBAZONE;G6PD;Gene;PA165858618;Chemical
DIMERCAPROL;G6PD;Gene;PA165958406;Chemical
PEGLOTICASE;G6PD;Gene;PA165963961;Chemical
PREGNANCY;G6PD;Gene;PA166048714;Disease
G6PD DEFICIENCY;G6PD;Gene;PA166048754;Disease
HYPERURICEMIA;G6PD;Gene;PA166048814;Disease
LEAD POISONING, NERVOUS SYSTEM, CHILDHOOD;G6PD;Gene;PA166048926;Disease
DABRAFENIB;G6PD;Gene;PA166114911;Chemical
MAFENIDE;G6PD;Gene;PA166114925;Chemical
SODIUM NITRITE;G6PD;Gene;PA166115361;Chemical
TRAMETINIB;G6PD;Gene;PA166115364;Chemical
PAMAQUINE;G6PD;Gene;PA166115579;Chemical
TAFENOQUINE;G6PD;Gene;PA166115580;Chemical
SITAMAQUINE;G6PD;Gene;PA166115581;Chemical
RS4149056;G6PD;Gene;PA166154579;Variant
MOVIPREP;G6PD;Gene;PA166163260;Chemical
SODIUM ASCORBATE;G6PD;Gene;PA166163262;Chemical
ERYTHROMYCIN ETHYLSUCCINATE / SULFISOXAZOLE ACETYL;G6PD;Gene;PA166176008;Chemical
LIDOCAINE / PRILOCAINE;G6PD;Gene;PA166176018;Chemical
LIDOCAINE AND TETRACAINE;G6PD;Gene;PA166182735;Chemical
ARTICAINE / EPINEPHRINE;G6PD;Gene;PA166182783;Chemical
OXYMETAZOLINE AND TETRACAINE;G6PD;Gene;PA166182885;Chemical
AMLODIPINE / ATORVASTATIN / PERINDOPRIL ARGININE;G6PD;Gene;PA166183785;Chemical
METABUTETHAMINE;G6PD;Gene;PA166183788;Chemical
BISOPROLOL FUMARATE / PERINDOPRIL ARGININE;G6PD;Gene;PA166184057;Chemical
CARBASALATE CALCIUM;G6PD;Gene;PA166184059;Chemical
ACETAMINOPHEN / CODEINE;G6PD;Gene;PA166184061;Chemical
NICORANDIL;G6PD;Gene;PA166184081;Chemical
ACETAMINOPHEN / TRAMADOL;G6PD;Gene;PA166184496;Chemical
PARACETAMOL, COMBINATIONS EXCL. PSYCHOLEPTICS (VICKS MEDINAIT SIRUP);G6PD;Gene;PA166184497;Chemical
COVID-19;G6PD;Gene;PA166197121;Disease
TOLUIDINE BLUE;G6PD;Gene;PA166268821;Chemical
SODIUM NITRATE;G6PD;Gene;PA166279461;Chemical
ACQUIRED IMMUNODEFICIENCY SYNDROME;G6PD;Gene;PA443250;Disease
ANEMIA;G6PD;Gene;PA443340;Disease
ANEMIA, HEMOLYTIC;G6PD;Gene;PA443343;Disease
ARTERIOSCLEROSIS;G6PD;Gene;PA443425;Disease
ARTHRITIS;G6PD;Gene;PA443430;Disease
BURKITT LYMPHOMA;G6PD;Gene;PA443580;Disease
BURNS;G6PD;Gene;PA443582;Disease
CARDIOVASCULAR DISEASES;G6PD;Gene;PA443635;Disease
COLITIS, ULCERATIVE;G6PD;Gene;PA443750;Disease
DIABETES MELLITUS, TYPE 2;G6PD;Gene;PA443890;Disease
GOUT;G6PD;Gene;PA444318;Disease
HEMATURIA;G6PD;Gene;PA444400;Disease
HEMOLYSIS;G6PD;Gene;PA444411;Disease
HYPERBILIRUBINEMIA;G6PD;Gene;PA444511;Disease
INSULIN RESISTANCE;G6PD;Gene;PA444626;Disease
JAUNDICE;G6PD;Gene;PA444648;Disease
JAUNDICE, NEONATAL;G6PD;Gene;PA444650;Disease
KIDNEY FAILURE, ACUTE;G6PD;Gene;PA444683;Disease
LEUKEMIA, LYMPHOID;G6PD;Gene;PA444756;Disease
MALARIA;G6PD;Gene;PA444859;Disease
METHEMOGLOBINEMIA;G6PD;Gene;PA444942;Disease
NEOPLASMS;G6PD;Gene;PA445062;Disease
PROTEIN DEFICIENCY;G6PD;Gene;PA445428;Disease
SYNCOPE;G6PD;Gene;PA445787;Disease
TYPHOID FEVER;G6PD;Gene;PA445970;Disease
COLORECTAL NEOPLASMS;G6PD;Gene;PA446108;Disease
TUMOR LYSIS SYNDROME;G6PD;Gene;PA446126;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;G6PD;Gene;PA446155;Disease
PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;G6PD;Gene;PA446166;Disease
MALARIA, FALCIPARUM;G6PD;Gene;PA446390;Disease
MALARIA, VIVAX;G6PD;Gene;PA446392;Disease
HIV INFECTIONS;G6PD;Gene;PA447230;Disease
ACETAMINOPHEN;G6PD;Gene;PA448015;Chemical
AMINOSALICYLIC ACID;G6PD;Gene;PA448382;Chemical
AMODIAQUINE;G6PD;Gene;PA448404;Chemical
ASPIRIN;G6PD;Gene;PA448497;Chemical
CARMUSTINE;G6PD;Gene;PA448810;Chemical
CEFTRIAXONE;G6PD;Gene;PA448866;Chemical
CHLORAMPHENICOL;G6PD;Gene;PA448927;Chemical
CHLOROPROCAINE;G6PD;Gene;PA448946;Chemical
CHLOROQUINE;G6PD;Gene;PA448948;Chemical
CHLORPROPAMIDE;G6PD;Gene;PA448966;Chemical
CIPROFLOXACIN;G6PD;Gene;PA449009;Chemical
DAPSONE;G6PD;Gene;PA449211;Chemical
DAUNORUBICIN;G6PD;Gene;PA449212;Chemical
DOXORUBICIN;G6PD;Gene;PA449412;Chemical
FLUTAMIDE;G6PD;Gene;PA449685;Chemical
GLIMEPIRIDE;G6PD;Gene;PA449761;Chemical
GLIPIZIDE;G6PD;Gene;PA449762;Chemical
GLYBURIDE;G6PD;Gene;PA449782;Chemical
MEFLOQUINE;G6PD;Gene;PA450348;Chemical
MELOXICAM;G6PD;Gene;PA450353;Chemical
MESALAZINE;G6PD;Gene;PA450384;Chemical
METHYLENE BLUE;G6PD;Gene;PA450457;Chemical
METOCLOPRAMIDE;G6PD;Gene;PA450475;Chemical
MOXIFLOXACIN;G6PD;Gene;PA450555;Chemical
NITROFURANTOIN;G6PD;Gene;PA450640;Chemical
NITROGLYCERIN;G6PD;Gene;PA450644;Chemical
NORFLOXACIN;G6PD;Gene;PA450654;Chemical
OFLOXACIN;G6PD;Gene;PA450684;Chemical
PERINDOPRIL;G6PD;Gene;PA450877;Chemical
PIOGLITAZONE;G6PD;Gene;PA450970;Chemical
PRILOCAINE;G6PD;Gene;PA451101;Chemical
PRIMAQUINE;G6PD;Gene;PA451103;Chemical
PROBENECID;G6PD;Gene;PA451106;Chemical
PYRIMETHAMINE;G6PD;Gene;PA451193;Chemical
QUININE;G6PD;Gene;PA451213;Chemical
ROPIVACAINE;G6PD;Gene;PA451271;Chemical
SUCCIMER;G6PD;Gene;PA451521;Chemical
SULFACETAMIDE;G6PD;Gene;PA451536;Chemical
SULFADIAZINE;G6PD;Gene;PA451539;Chemical
SULFADOXINE;G6PD;Gene;PA451540;Chemical
SULFAMETHAZINE;G6PD;Gene;PA451542;Chemical
SULFAMETHOXAZOLE;G6PD;Gene;PA451544;Chemical
SULFANILAMIDE;G6PD;Gene;PA451545;Chemical
SULFASALAZINE;G6PD;Gene;PA451547;Chemical
TOLBUTAMIDE;G6PD;Gene;PA451718;Chemical
VITAMIN C;G6PD;Gene;PA451898;Chemical
ANTITHROMBOTIC AGENTS;G6PD;Gene;PA452200;Chemical
ZOLEDRONATE;rs147451859;Variant;PA10235;Chemical
FEC100;rs147451859;Variant;PA166185677;Chemical
AMENORRHEA;rs147451859;Variant;PA443324;Disease
DOCETAXEL;rs147451859;Variant;PA449383;Chemical
GEMCITABINE;rs147451859;Variant;PA449748;Chemical
TRASTUZUMAB;rs147451859;Variant;PA451743;Chemical
CDK5;PPP1R1B;Gene;PA26310;Gene
PPP1CA;PPP1R1B;Gene;PA33609;Gene
PRKACA;PPP1R1B;Gene;PA33748;Gene
PEMETREXED;FOLR3;Gene;PA10810;Chemical
NON-SMALL CELL LUNG CARCINOMA;FOLR3;Gene;PA443622;Disease
MESOTHELIOMA;FOLR3;Gene;PA444937;Disease
DRUG HYPERSENSITIVITY;HLA-A*02:06;Haplotype;PA443936;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-A*02:06;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-A*02:06;Haplotype;PA445738;Disease
ACETAMINOPHEN;HLA-A*02:06;Haplotype;PA448015;Chemical
TETANUS ANTITOXIN;HLA-A*02:06;Haplotype;PA451632;Chemical
METFORMIN;rs578427;Variant;PA450395;Chemical
RS1050828;pyrimethamine;Chemical;PA166157859;Variant
G6PD;pyrimethamine;Chemical;PA28469;Gene
GSTP1;pyrimethamine;Chemical;PA29028;Gene
IKBKG;pyrimethamine;Chemical;PA29777;Gene
ALK;brentuximab vedotin;Chemical;PA24719;Gene
TNFRSF8;brentuximab vedotin;Chemical;PA36616;Gene
LEVOTHYROXINE;TBL1X;Gene;PA450221;Chemical
PLCG1;PRKCQ;Gene;PA33392;Gene
PLCG2;PRKCQ;Gene;PA33393;Gene
RAF1;PRKCQ;Gene;PA34183;Gene
ADRB2;PRKCQ;Gene;PA39;Gene
SUICIDE;rs4825476;Variant;PA165374639;Disease
DEPRESSION;rs4825476;Variant;PA447278;Disease
CITALOPRAM;rs4825476;Variant;PA449015;Chemical
CYP3A4;flutamide;Chemical;PA130;Gene
G6PD;flutamide;Chemical;PA28469;Gene
NR1I2;flutamide;Chemical;PA378;Gene
BREAST NEOPLASMS;rs7984870;Variant;PA443560;Disease
ANASTROZOLE;rs7984870;Variant;PA448432;Chemical
LETROZOLE;rs7984870;Variant;PA450196;Chemical
RS4240803;melphalan;Chemical;PA166155063;Variant
RS4553808;melphalan;Chemical;PA166155730;Variant
ABCB1;melphalan;Chemical;PA267;Gene
CTLA4;melphalan;Chemical;PA27006;Gene
SLC7A5;melphalan;Chemical;PA35923;Gene
SCHIZOPHRENIA;rs11960832;Variant;PA447216;Disease
OLANZAPINE;rs11960832;Variant;PA450688;Chemical
PEGASPARGASE;BMP7;Gene;PA164760860;Chemical
OSTEONECROSIS;BMP7;Gene;PA445187;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;BMP7;Gene;PA446155;Disease
CYCLOPHOSPHAMIDE;BMP7;Gene;PA449165;Chemical
CYTARABINE;BMP7;Gene;PA449177;Chemical
DAUNORUBICIN;BMP7;Gene;PA449212;Chemical
DEXAMETHASONE;BMP7;Gene;PA449247;Chemical
DOXORUBICIN;BMP7;Gene;PA449412;Chemical
METHOTREXATE;BMP7;Gene;PA450428;Chemical
PREDNISONE;BMP7;Gene;PA451100;Chemical
THIOGUANINE;BMP7;Gene;PA451663;Chemical
VINCRISTINE;BMP7;Gene;PA451879;Chemical
ALCOHOL ABUSE;rs6473797;Variant;PA443309;Disease
HEROIN DEPENDENCE;rs6473797;Variant;PA444460;Disease
ETHANOL;rs6473797;Variant;PA448073;Chemical
HEROIN;rs6473797;Variant;PA452619;Chemical
HLA-B*13:01;trichloroethylene;Chemical;PA165954643;Haplotype
HLA-B*44:02;trichloroethylene;Chemical;PA165955891;Haplotype
HLA-B*44:03;trichloroethylene;Chemical;PA165955913;Haplotype
HLA-B;trichloroethylene;Chemical;PA35056;Gene
CYP2D6;sotalol;Chemical;PA128;Gene
RS1805128;sotalol;Chemical;PA166155994;Variant
GRK5;sotalol;Chemical;PA180;Gene
KCNE1;sotalol;Chemical;PA211;Gene
GRK4;sotalol;Chemical;PA28941;Gene
ADRA2C;sotalol;Chemical;PA37;Gene
ADRB1;sotalol;Chemical;PA38;Gene
ADRB2;sotalol;Chemical;PA39;Gene
HEROIN DEPENDENCE;rs2120266;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs2120266;Variant;PA445043;Disease
METHADONE;rs2120266;Variant;PA450401;Chemical
HIV INFECTIOUS DISEASE;rs28365062;Variant;PA447230;Disease
EFAVIRENZ;rs28365062;Variant;PA449441;Chemical
ZIDOVUDINE;rs28365062;Variant;PA451954;Chemical
NEPHROTOXICITY;rs1353327;Variant;PA162263533;Disease
GLUCARPIDASE;rs1353327;Variant;PA165949771;Chemical
ESCITALOPRAM;ERICH3;Gene;PA10074;Chemical
DEPRESSIVE DISORDER;ERICH3;Gene;PA447207;Disease
CITALOPRAM;ERICH3;Gene;PA449015;Chemical
ANTIDEPRESSANTS;ERICH3;Gene;PA452229;Chemical
BRCA1;niraparib;Chemical;PA25411;Gene
BRCA2;niraparib;Chemical;PA25412;Gene
ACUTE LYMPHOBLASTIC LEUKEMIA;rs7142143;Variant;PA446155;Disease
ASPARAGINASE;rs7142143;Variant;PA448492;Chemical
DEXAMETHASONE;rs7142143;Variant;PA449247;Chemical
METHOTREXATE;rs7142143;Variant;PA450428;Chemical
CYP2B6;R-EDDP;Chemical;PA123;Gene
CYP2B6*1;R-EDDP;Chemical;PA165818750;Haplotype
CYP2B6*4;R-EDDP;Chemical;PA165818757;Haplotype
CYP2B6*5;R-EDDP;Chemical;PA165818760;Haplotype
CYP2B6*6;R-EDDP;Chemical;PA165818762;Haplotype
CYP2B6*7;R-EDDP;Chemical;PA165818765;Haplotype
CYP2B6*17;R-EDDP;Chemical;PA165818781;Haplotype
CYP2B6*19;R-EDDP;Chemical;PA165818784;Haplotype
CYP2B6*26;R-EDDP;Chemical;PA165818788;Haplotype
CYP2B6*9;R-EDDP;Chemical;PA165818807;Haplotype
CYP2B6*18;R-EDDP;Chemical;PA165818808;Haplotype
DPYD;rs57918000;Variant;PA145;Gene
CAPECITABINE;rs57918000;Variant;PA448771;Chemical
WEIGHT GAIN;rs2497538;Variant;PA128406954;Disease
OLANZAPINE;rs2497538;Variant;PA450688;Chemical
TPMT;TPMT*13;Haplotype;PA356;Gene
CROHN DISEASE;TPMT*13;Haplotype;PA443815;Disease
AZATHIOPRINE;TPMT*13;Haplotype;PA448515;Chemical
MERCAPTOPURINE;TPMT*13;Haplotype;PA450379;Chemical
THIOGUANINE;TPMT*13;Haplotype;PA451663;Chemical
PROPOFOL;rs138264188;Variant;PA451141;Chemical
COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS;PMS2;Gene;PA443761;Disease
PROSTATIC NEOPLASMS;PMS2;Gene;PA445425;Disease
CFTR;rs75527207;Variant;PA109;Gene
IVACAFTOR;rs75527207;Variant;PA165950341;Chemical
NPPB;rs75527207;Variant;PA166159659;Chemical
TEZACAFTOR;rs75527207;Variant;PA166175754;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs75527207;Variant;PA166190041;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs75527207;Variant;PA166362502;Chemical
CYSTIC FIBROSIS;rs75527207;Variant;PA443829;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs61886492;Variant;PA446155;Disease
MERCAPTOPURINE;rs61886492;Variant;PA450379;Chemical
METHOTREXATE;rs61886492;Variant;PA450428;Chemical
HLA-DRB1*16:01;flupirtine;Chemical;PA165952366;Haplotype
HLA-DQB1*05:02;flupirtine;Chemical;PA165958077;Haplotype
HLA-DQB1;flupirtine;Chemical;PA35068;Gene
HLA-DRB1;flupirtine;Chemical;PA35072;Gene
GNB4;PLCB4;Gene;PA134864200;Gene
GNAQ;PLCB4;Gene;PA174;Gene
GNB3;PLCB4;Gene;PA176;Gene
CASR;PLCB4;Gene;PA26097;Gene
GNB1;PLCB4;Gene;PA28776;Gene
GNB1L;PLCB4;Gene;PA28777;Gene
GNB2;PLCB4;Gene;PA28778;Gene
GNG2;PLCB4;Gene;PA28784;Gene
GNG3;PLCB4;Gene;PA28785;Gene
GNG4;PLCB4;Gene;PA28786;Gene
GNG5;PLCB4;Gene;PA28787;Gene
GNG7;PLCB4;Gene;PA28789;Gene
PRKCA;PLCB4;Gene;PA33759;Gene
PRKCB;PLCB4;Gene;PA33761;Gene
PRKCG;PLCB4;Gene;PA33766;Gene
PRKCH;PLCB4;Gene;PA33767;Gene
PRKCI;PLCB4;Gene;PA33768;Gene
PRKD1;PLCB4;Gene;PA33771;Gene
PRKCZ;PLCB4;Gene;PA33775;Gene
ADRB2;PLCB4;Gene;PA39;Gene
CYP2E1;sevoflurane;Chemical;PA129;Gene
CYP3A4;sevoflurane;Chemical;PA130;Gene
FASTKD3;sevoflurane;Chemical;PA145148868;Gene
RS1800559;sevoflurane;Chemical;PA166153638;Variant
RS772226819;sevoflurane;Chemical;PA166153940;Variant
RS2031920;sevoflurane;Chemical;PA166153990;Variant
RS3813867;sevoflurane;Chemical;PA166154041;Variant
RS1806201;sevoflurane;Chemical;PA166154519;Variant
RS1801086;sevoflurane;Chemical;PA166155375;Variant
RS28933396;sevoflurane;Chemical;PA166155481;Variant
RS28933397;sevoflurane;Chemical;PA166155482;Variant
RS63749869;sevoflurane;Chemical;PA166155516;Variant
RS111888148;sevoflurane;Chemical;PA166155524;Variant
RS112563513;sevoflurane;Chemical;PA166155526;Variant
RS118192116;sevoflurane;Chemical;PA166155528;Variant
RS118192122;sevoflurane;Chemical;PA166155529;Variant
RS118192124;sevoflurane;Chemical;PA166155531;Variant
RS118192161;sevoflurane;Chemical;PA166155532;Variant
RS118192162;sevoflurane;Chemical;PA166155533;Variant
RS118192163;sevoflurane;Chemical;PA166155534;Variant
RS118192167;sevoflurane;Chemical;PA166155535;Variant
RS118192170;sevoflurane;Chemical;PA166155536;Variant
RS118192172;sevoflurane;Chemical;PA166155537;Variant
RS118192175;sevoflurane;Chemical;PA166155538;Variant
RS118192176;sevoflurane;Chemical;PA166155539;Variant
RS118192177;sevoflurane;Chemical;PA166155540;Variant
RS118192178;sevoflurane;Chemical;PA166155541;Variant
RS121918592;sevoflurane;Chemical;PA166155543;Variant
RS121918593;sevoflurane;Chemical;PA166155544;Variant
RS121918594;sevoflurane;Chemical;PA166155545;Variant
RS121918595;sevoflurane;Chemical;PA166155546;Variant
RS193922747;sevoflurane;Chemical;PA166155564;Variant
RS193922753;sevoflurane;Chemical;PA166155565;Variant
RS193922770;sevoflurane;Chemical;PA166155567;Variant
RS193922772;sevoflurane;Chemical;PA166155568;Variant
RS193922802;sevoflurane;Chemical;PA166155569;Variant
RS193922803;sevoflurane;Chemical;PA166155570;Variant
RS193922807;sevoflurane;Chemical;PA166155571;Variant
RS193922809;sevoflurane;Chemical;PA166155572;Variant
RS193922816;sevoflurane;Chemical;PA166155573;Variant
RS193922818;sevoflurane;Chemical;PA166155574;Variant
RS193922876;sevoflurane;Chemical;PA166155575;Variant
RS193922878;sevoflurane;Chemical;PA166155576;Variant
RS1801394;sevoflurane;Chemical;PA166156776;Variant
RS1128503;sevoflurane;Chemical;PA166157288;Variant
RS1042718;sevoflurane;Chemical;PA166160473;Variant
RS193922843;sevoflurane;Chemical;PA166163663;Variant
RS193922832;sevoflurane;Chemical;PA166163667;Variant
RS118192168;sevoflurane;Chemical;PA166163669;Variant
RS193922764;sevoflurane;Chemical;PA166176176;Variant
RS121918596;sevoflurane;Chemical;PA166177994;Variant
RS193922748;sevoflurane;Chemical;PA166180322;Variant
RS193922762;sevoflurane;Chemical;PA166180323;Variant
RS193922768;sevoflurane;Chemical;PA166180324;Variant
RS144336148;sevoflurane;Chemical;PA166180325;Variant
RS193922852;sevoflurane;Chemical;PA166183392;Variant
RS1275988;sevoflurane;Chemical;PA166199001;Variant
RS6686529;sevoflurane;Chemical;PA166285101;Variant
RS3733784;sevoflurane;Chemical;PA166285102;Variant
RS279858;sevoflurane;Chemical;PA166285103;Variant
RS2307116;sevoflurane;Chemical;PA166285121;Variant
ABCB1;sevoflurane;Chemical;PA267;Gene
DUX1;sevoflurane;Chemical;PA27535;Gene
GABRA2;sevoflurane;Chemical;PA28490;Gene
GRIN2B;sevoflurane;Chemical;PA28980;Gene
GSTP1;sevoflurane;Chemical;PA29028;Gene
KCNK2;sevoflurane;Chemical;PA30059;Gene
KCNK3;sevoflurane;Chemical;PA30060;Gene
MTRR;sevoflurane;Chemical;PA31277;Gene
RYR1;sevoflurane;Chemical;PA34896;Gene
ADRB2;sevoflurane;Chemical;PA39;Gene
CACNA1S;sevoflurane;Chemical;PA85;Gene
KALLMANN SYNDROME;rs137852517;Variant;PA446481;Disease
RS179008;Basal Cell Carcinoma;Disease;PA166157851;Variant
TLR7;Basal Cell Carcinoma;Disease;PA38008;Gene
BISPHOSPHONATES;rs12903202;Variant;PA164712563;Chemical
OSTEONECROSIS;rs12903202;Variant;PA445187;Disease
HIV INFECTIONS;rs58425034;Variant;PA447230;Disease
NEVIRAPINE;rs58425034;Variant;PA450616;Chemical
RS12720461;xenobiotics;Chemical;PA166154935;Variant
RS75519181;xenobiotics;Chemical;PA166157515;Variant
GSTT1;xenobiotics;Chemical;PA183;Gene
AHR;xenobiotics;Chemical;PA24641;Gene
CYP1A2;xenobiotics;Chemical;PA27093;Gene
NR1I2;xenobiotics;Chemical;PA378;Gene
ADRB1;xenobiotics;Chemical;PA38;Gene
EPILEPSY;rs2279020;Variant;PA444065;Disease
CARBAMAZEPINE;rs2279020;Variant;PA448785;Chemical
PHENYTOIN;rs2279020;Variant;PA450947;Chemical
VALPROIC ACID;rs2279020;Variant;PA451846;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs10413455;Variant;PA447197;Disease
METHYLPHENIDATE;rs10413455;Variant;PA450464;Chemical
CYP2B6;aripiprazole;Chemical;PA123;Gene
CYP2C19;aripiprazole;Chemical;PA124;Gene
CYP2C9;aripiprazole;Chemical;PA126;Gene
CYP2D6;aripiprazole;Chemical;PA128;Gene
CYP3A4;aripiprazole;Chemical;PA130;Gene
CYP3A5;aripiprazole;Chemical;PA131;Gene
ANKK1;aripiprazole;Chemical;PA134872551;Gene
TAAR6;aripiprazole;Chemical;PA134881141;Gene
RABEP1;aripiprazole;Chemical;PA134884097;Gene
SH2B1;aripiprazole;Chemical;PA145148084;Gene
CYP2D6*1;aripiprazole;Chemical;PA165816576;Haplotype
CYP2D6*3;aripiprazole;Chemical;PA165816578;Haplotype
CYP2D6*4;aripiprazole;Chemical;PA165816579;Haplotype
CYP2D6*6;aripiprazole;Chemical;PA165816581;Haplotype
CYP2D6*10;aripiprazole;Chemical;PA165816582;Haplotype
CYP2D6*41;aripiprazole;Chemical;PA165816584;Haplotype
CYP2D6*5;aripiprazole;Chemical;PA165948092;Haplotype
CYP2D6*1XN;aripiprazole;Chemical;PA165988479;Haplotype
CYP2D6*21;aripiprazole;Chemical;PA165988484;Haplotype
CYP2D6*4XN;aripiprazole;Chemical;PA166123455;Haplotype
RS324420;aripiprazole;Chemical;PA166153569;Variant
RS6277;aripiprazole;Chemical;PA166154261;Variant
RS1799732;aripiprazole;Chemical;PA166154334;Variant
RS1800497;aripiprazole;Chemical;PA166154339;Variant
RS2514218;aripiprazole;Chemical;PA166154375;Variant
RS489693;aripiprazole;Chemical;PA166155269;Variant
RS4305746;aripiprazole;Chemical;PA166157100;Variant
RS1128503;aripiprazole;Chemical;PA166157288;Variant
RS2229109;aripiprazole;Chemical;PA166157334;Variant
CYP2D6 POOR METABOLIZER;aripiprazole;Chemical;PA166157927;Variant
RS3888190;aripiprazole;Chemical;PA166165398;Variant
RS1000940;aripiprazole;Chemical;PA166165401;Variant
RS155333;aripiprazole;Chemical;PA166252941;Variant
RS6465938;aripiprazole;Chemical;PA166252981;Variant
HTR2A;aripiprazole;Chemical;PA193;Gene
HTR2C;aripiprazole;Chemical;PA194;Gene
ABCB1;aripiprazole;Chemical;PA267;Gene
CYP1A2;aripiprazole;Chemical;PA27093;Gene
DRD2;aripiprazole;Chemical;PA27478;Gene
FAAH;aripiprazole;Chemical;PA27955;Gene
MC4R;aripiprazole;Chemical;PA30676;Gene
SLC6A4;aripiprazole;Chemical;PA312;Gene
POLG;aripiprazole;Chemical;PA33500;Gene
RELN;aripiprazole;Chemical;PA34323;Gene
HLA-A;aripiprazole;Chemical;PA35055;Gene
HLA-B;aripiprazole;Chemical;PA35056;Gene
UGT1A4;aripiprazole;Chemical;PA37179;Gene
CORONARY DISEASE;rs428785;Variant;PA443797;Disease
MYOCARDIAL INFARCTION;rs428785;Variant;PA445019;Disease
PRAVASTATIN;rs428785;Variant;PA451089;Chemical
CYP2C19;sulfonamides, urea derivatives;Chemical;PA124;Gene
CYP2C9;sulfonamides, urea derivatives;Chemical;PA126;Gene
FIBRATES;sulfonamides, urea derivatives;Chemical;PA164712760;Chemical
CYP2C9*1;sulfonamides, urea derivatives;Chemical;PA165816542;Haplotype
CYP2C9*2;sulfonamides, urea derivatives;Chemical;PA165816543;Haplotype
CYP2C9*3;sulfonamides, urea derivatives;Chemical;PA165816544;Haplotype
CYP2C19*1;sulfonamides, urea derivatives;Chemical;PA165980634;Haplotype
CYP2C19*2;sulfonamides, urea derivatives;Chemical;PA165980635;Haplotype
CYP2C19*3;sulfonamides, urea derivatives;Chemical;PA165980636;Haplotype
RS7903146;sulfonamides, urea derivatives;Chemical;PA166154084;Variant
RS12255372;sulfonamides, urea derivatives;Chemical;PA166154148;Variant
RS5219;sulfonamides, urea derivatives;Chemical;PA166154256;Variant
RS757110;sulfonamides, urea derivatives;Chemical;PA166154301;Variant
KCNJ11;sulfonamides, urea derivatives;Chemical;PA217;Gene
ABCC8;sulfonamides, urea derivatives;Chemical;PA24395;Gene
TCF7L2;sulfonamides, urea derivatives;Chemical;PA36394;Gene
COMT;norepinephrine;Chemical;PA117;Gene
ADRA1D;norepinephrine;Chemical;PA24597;Gene
ADRA1B;norepinephrine;Chemical;PA33;Gene
ADRA1A;norepinephrine;Chemical;PA34;Gene
ADRA2A;norepinephrine;Chemical;PA35;Gene
ADRA2B;norepinephrine;Chemical;PA36;Gene
ADRA2C;norepinephrine;Chemical;PA37;Gene
ADRB1;norepinephrine;Chemical;PA38;Gene
EPILEPSY;rs3812718;Variant;PA444065;Disease
CARBAMAZEPINE;rs3812718;Variant;PA448785;Chemical
LAMOTRIGINE;rs3812718;Variant;PA450164;Chemical
PHENYTOIN;rs3812718;Variant;PA450947;Chemical
SCHIZOPHRENIA;rs1079598;Variant;PA447216;Disease
CLOZAPINE;rs1079598;Variant;PA449061;Chemical
OLANZAPINE;rs1079598;Variant;PA450688;Chemical
ANTIPSYCHOTICS;rs1079598;Variant;PA452233;Chemical
COMT;hydromorphone;Chemical;PA117;Gene
CYP2D6;hydromorphone;Chemical;PA128;Gene
CYP3A5;hydromorphone;Chemical;PA131;Gene
CYP2D6*1;hydromorphone;Chemical;PA165816576;Haplotype
CYP2D6*4;hydromorphone;Chemical;PA165816579;Haplotype
CYP2D6*17;hydromorphone;Chemical;PA165816583;Haplotype
CYP2D6*5;hydromorphone;Chemical;PA165948092;Haplotype
OPRM1;hydromorphone;Chemical;PA31945;Gene
RS1415744;trifluoperazine;Chemical;PA166156984;Variant
EPM2A;trifluoperazine;Chemical;PA27832;Gene
ANTIDEPRESSANTS;ACSS3;Gene;PA452229;Chemical
BIPOLAR DISORDER;rs16973410;Variant;PA447199;Disease
LITHIUM;rs16973410;Variant;PA450243;Chemical
BRIVANIB;FGFR1;Gene;PA164924492;Chemical
PEMIGATINIB;FGFR1;Gene;PA166248041;Chemical
CRK;FGFR1;Gene;PA26880;Gene
FGF2;FGFR1;Gene;PA28115;Gene
HRAS;FGFR1;Gene;PA29444;Gene
KRAS;FGFR1;Gene;PA30196;Gene
NRAS;FGFR1;Gene;PA31768;Gene
PIK3C2A;FGFR1;Gene;PA33304;Gene
PIK3C2B;FGFR1;Gene;PA33305;Gene
SORAFENIB;FGFR1;Gene;PA7000;Chemical
SCHIZOPHRENIA;rs7912580;Variant;PA447216;Disease
HALOPERIDOL;rs7912580;Variant;PA449841;Chemical
OLANZAPINE;rs7912580;Variant;PA450688;Chemical
QUETIAPINE;rs7912580;Variant;PA451201;Chemical
RISPERIDONE;rs7912580;Variant;PA451257;Chemical
ZIPRASIDONE;rs7912580;Variant;PA451974;Chemical
TRANSPLANTATION;rs8450;Variant;PA134850491;Disease
CYCLOSPORINE;rs8450;Variant;PA449167;Chemical
TACROLIMUS;rs8450;Variant;PA451578;Chemical
PEGASPARGASE;DOK5;Gene;PA164760860;Chemical
OSTEONECROSIS;DOK5;Gene;PA445187;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;DOK5;Gene;PA446155;Disease
CYCLOPHOSPHAMIDE;DOK5;Gene;PA449165;Chemical
CYTARABINE;DOK5;Gene;PA449177;Chemical
DAUNORUBICIN;DOK5;Gene;PA449212;Chemical
DEXAMETHASONE;DOK5;Gene;PA449247;Chemical
DOXORUBICIN;DOK5;Gene;PA449412;Chemical
METHOTREXATE;DOK5;Gene;PA450428;Chemical
PREDNISONE;DOK5;Gene;PA451100;Chemical
THIOGUANINE;DOK5;Gene;PA451663;Chemical
VINCRISTINE;DOK5;Gene;PA451879;Chemical
METHOXSALEN;CYP2A6*21;Haplotype;PA450433;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-DRB1*01:03;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-DRB1*01:03;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-DRB1*01:03;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-DRB1*01:03;Haplotype;PA450616;Chemical
CYP2C19;Diabetes Mellitus;Disease;PA124;Gene
CYP2C8;Diabetes Mellitus;Disease;PA125;Gene
CYP2C9;Diabetes Mellitus;Disease;PA126;Gene
CYP3A5;Diabetes Mellitus;Disease;PA131;Gene
SLCO1B1;Diabetes Mellitus;Disease;PA134865839;Gene
CDKAL1;Diabetes Mellitus;Disease;PA134871999;Gene
PLEKHH2;Diabetes Mellitus;Disease;PA134912826;Gene
ADIPOQ;Diabetes Mellitus;Disease;PA134933118;Gene
ACE;Diabetes Mellitus;Disease;PA139;Gene
SLC47A2;Diabetes Mellitus;Disease;PA162403847;Gene
CYP2C19*17;Diabetes Mellitus;Disease;PA165816533;Haplotype
CYP2C9*1;Diabetes Mellitus;Disease;PA165816542;Haplotype
CYP2C9*2;Diabetes Mellitus;Disease;PA165816543;Haplotype
CYP2C9*3;Diabetes Mellitus;Disease;PA165816544;Haplotype
CYP2C8*3;Diabetes Mellitus;Disease;PA165958685;Haplotype
CYP3A5*1;Diabetes Mellitus;Disease;PA166128213;Haplotype
CYP3A5*3;Diabetes Mellitus;Disease;PA166128219;Haplotype
RS2368564;Diabetes Mellitus;Disease;PA166153701;Variant
RS7541245;Diabetes Mellitus;Disease;PA166153791;Variant
RS1801253;Diabetes Mellitus;Disease;PA166153977;Variant
RS5219;Diabetes Mellitus;Disease;PA166154256;Variant
RS658903;Diabetes Mellitus;Disease;PA166154290;Variant
RS757110;Diabetes Mellitus;Disease;PA166154301;Variant
RS12795437;Diabetes Mellitus;Disease;PA166154466;Variant
RS5443;Diabetes Mellitus;Disease;PA166154486;Variant
RS784892;Diabetes Mellitus;Disease;PA166154504;Variant
RS2306283;Diabetes Mellitus;Disease;PA166154547;Variant
RS2683511;Diabetes Mellitus;Disease;PA166154554;Variant
RS10747673;Diabetes Mellitus;Disease;PA166154613;Variant
RS4341;Diabetes Mellitus;Disease;PA166155146;Variant
RS1799752;Diabetes Mellitus;Disease;PA166155187;Variant
RS12943590;Diabetes Mellitus;Disease;PA166155251;Variant
RS1801262;Diabetes Mellitus;Disease;PA166155645;Variant
RS3792269;Diabetes Mellitus;Disease;PA166155711;Variant
RS4253778;Diabetes Mellitus;Disease;PA166156106;Variant
RS149711321;Diabetes Mellitus;Disease;PA166156212;Variant
RS2241766;Diabetes Mellitus;Disease;PA166156347;Variant
RS5370;Diabetes Mellitus;Disease;PA166156901;Variant
RS622342;Diabetes Mellitus;Disease;PA166156932;Variant
RS7754840;Diabetes Mellitus;Disease;PA166157125;Variant
RS7756992;Diabetes Mellitus;Disease;PA166157126;Variant
RS17655652;Diabetes Mellitus;Disease;PA166157478;Variant
RS114202595;Diabetes Mellitus;Disease;PA166157526;Variant
RS8192675;Diabetes Mellitus;Disease;PA166159968;Variant
RS2954625;Diabetes Mellitus;Disease;PA166160922;Variant
RS11124945;Diabetes Mellitus;Disease;PA166161873;Variant
CYP2C8*1;Diabetes Mellitus;Disease;PA166242948;Haplotype
GNB3;Diabetes Mellitus;Disease;PA176;Gene
KCNJ1;Diabetes Mellitus;Disease;PA213;Gene
KCNJ11;Diabetes Mellitus;Disease;PA217;Gene
ABCC8;Diabetes Mellitus;Disease;PA24395;Gene
AMHR2;Diabetes Mellitus;Disease;PA24770;Gene
CAPN10;Diabetes Mellitus;Disease;PA26058;Gene
CSMD1;Diabetes Mellitus;Disease;PA26947;Gene
EDN1;Diabetes Mellitus;Disease;PA27614;Gene
PPARA;Diabetes Mellitus;Disease;PA280;Gene
FMO5;Diabetes Mellitus;Disease;PA28189;Gene
REN;Diabetes Mellitus;Disease;PA297;Gene
NEUROD1;Diabetes Mellitus;Disease;PA31564;Gene
NPC1L1;Diabetes Mellitus;Disease;PA31699;Gene
SLC22A1;Diabetes Mellitus;Disease;PA329;Gene
PAX4;Diabetes Mellitus;Disease;PA32958;Gene
SLC2A2;Diabetes Mellitus;Disease;PA35876;Gene
SP1;Diabetes Mellitus;Disease;PA36042;Gene
ADRB1;Diabetes Mellitus;Disease;PA38;Gene
SLCO1B1;dulaglutide;Chemical;PA134865839;Gene
RS4149056;dulaglutide;Chemical;PA166154579;Variant
CFTR;cavosonstat;Chemical;PA109;Gene
RS113993960;cavosonstat;Chemical;PA166157525;Variant
SULFAMETHOXAZOLE / TRIMETHOPRIM;HLA-C*06:02;Haplotype;PA10715;Chemical
CLAVULANATE;HLA-C*06:02;Haplotype;PA164742987;Chemical
FLUCLOXACILLIN;HLA-C*06:02;Haplotype;PA164781042;Chemical
PEGINTERFERON ALFA-2B;HLA-C*06:02;Haplotype;PA164784024;Chemical
USTEKINUMAB;HLA-C*06:02;Haplotype;PA166048654;Chemical
DRUG-INDUCED LIVER INJURY;HLA-C*06:02;Haplotype;PA166119041;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-C*06:02;Haplotype;PA444059;Disease
HEPATITIS C;HLA-C*06:02;Haplotype;PA444445;Disease
PSORIASIS;HLA-C*06:02;Haplotype;PA445451;Disease
STEVENS-JOHNSON SYNDROME;HLA-C*06:02;Haplotype;PA445738;Disease
AMOXICILLIN;HLA-C*06:02;Haplotype;PA448406;Chemical
METHOTREXATE;HLA-C*06:02;Haplotype;PA450428;Chemical
RIBAVIRIN;HLA-C*06:02;Haplotype;PA451241;Chemical
HEROIN DEPENDENCE;rs55944529;Variant;PA444460;Disease
METHADONE;rs55944529;Variant;PA450401;Chemical
DEXTROMETHORPHAN;rs4073010;Variant;PA449273;Chemical
CYP2A6;artesunate;Chemical;PA121;Gene
RS1050828;artesunate;Chemical;PA166157859;Variant
G6PD;artesunate;Chemical;PA28469;Gene
IKBKG;artesunate;Chemical;PA29777;Gene
OMEPRAZOLE;rs1361528097;Variant;PA450704;Chemical
CRTC2;SIRT1;Gene;PA142672073;Gene
SREBF1;SIRT1;Gene;PA335;Gene
PPARGC1A;SIRT1;Gene;PA33558;Gene
PRKAA1;SIRT1;Gene;PA33744;Gene
PRKAA2;SIRT1;Gene;PA33745;Gene
PRKAB1;SIRT1;Gene;PA33746;Gene
PRKAB2;SIRT1;Gene;PA33747;Gene
PRKAG1;SIRT1;Gene;PA33751;Gene
PRKAG2;SIRT1;Gene;PA33752;Gene
PRKAG3;SIRT1;Gene;PA33753;Gene
BIPOLAR DISORDER;rs74795342;Variant;PA447199;Disease
LITHIUM;rs74795342;Variant;PA450243;Chemical
ACE;lisinopril;Chemical;PA139;Gene
RS11122576;lisinopril;Chemical;PA166153819;Variant
RS12143842;lisinopril;Chemical;PA166153854;Variant
RS1799722;lisinopril;Chemical;PA166154785;Variant
RS4291;lisinopril;Chemical;PA166155143;Variant
RS1799752;lisinopril;Chemical;PA166155187;Variant
RS200148;lisinopril;Chemical;PA166156912;Variant
RS35068180;lisinopril;Chemical;PA166181205;Variant
MMP3;lisinopril;Chemical;PA30886;Gene
AGT;lisinopril;Chemical;PA42;Gene
BDKRB2;lisinopril;Chemical;PA80;Gene
DRUG-INDUCED LIVER INJURY;HLA-DRB1*15:03;Haplotype;PA166119041;Disease
HIV INFECTIONS;HLA-DRB1*15:03;Haplotype;PA447230;Disease
NEVIRAPINE;HLA-DRB1*15:03;Haplotype;PA450616;Chemical
BUMETANIDE;rs1529927;Variant;PA448682;Chemical
FUROSEMIDE;rs1529927;Variant;PA449719;Chemical
TORASEMIDE;rs1529927;Variant;PA451733;Chemical
PROSTATIC NEOPLASMS;rs3734254;Variant;PA445425;Disease
DOCETAXEL;rs3734254;Variant;PA449383;Chemical
THALIDOMIDE;rs3734254;Variant;PA451644;Chemical
ACE;Cardiomyopathy, Dilated;Disease;PA139;Gene
RS1801253;Cardiomyopathy, Dilated;Disease;PA166153977;Variant
RS61767072;Cardiomyopathy, Dilated;Disease;PA166156691;Variant
RS1042713;Cardiomyopathy, Dilated;Disease;PA166156748;Variant
ADRA2C;Cardiomyopathy, Dilated;Disease;PA37;Gene
ADRB1;Cardiomyopathy, Dilated;Disease;PA38;Gene
ADRB2;Cardiomyopathy, Dilated;Disease;PA39;Gene
ASPIRIN;rs1050891;Variant;PA448497;Chemical
SIPOGLITAZAR;UGT2B15*2;Haplotype;PA166114434;Chemical
EVENT-FREE SURVIVAL;UGT2B15*2;Haplotype;PA166123366;Disease
BREAST NEOPLASMS;UGT2B15*2;Haplotype;PA443560;Disease
ACETAMINOPHEN;UGT2B15*2;Haplotype;PA448015;Chemical
TAMOXIFEN;UGT2B15*2;Haplotype;PA451581;Chemical
ANTINEOPLASTIC AGENTS;UGT2B15*2;Haplotype;PA452621;Chemical
OTOTOXICITY;SLC16A5;Gene;PA162263534;Disease
NEOPLASMS;SLC16A5;Gene;PA445062;Disease
TESTICULAR NEOPLASMS;SLC16A5;Gene;PA445828;Disease
CISPLATIN;SLC16A5;Gene;PA449014;Chemical
ABCB1;levofloxacin;Chemical;PA267;Gene
HMG COA REDUCTASE INHIBITORS;LPA;Gene;PA133950441;Chemical
ROSUVASTATIN;LPA;Gene;PA134308647;Chemical
CORONARY ARTERY DISEASE;LPA;Gene;PA443796;Disease
RS622342;Anticholinergics;Chemical;PA166156932;Variant
SLC22A1;Anticholinergics;Chemical;PA329;Gene
ALCOHOL ABUSE;rs61826952;Variant;PA443309;Disease
ETHANOL;rs61826952;Variant;PA448073;Chemical
FLUOROURACIL;rs2298881;Variant;PA128406956;Chemical
PLATINUM COMPOUNDS;rs2298881;Variant;PA164713176;Chemical
RADIOTHERAPY;rs2298881;Variant;PA166122986;Chemical
STOMACH NEOPLASMS;rs2298881;Variant;PA445742;Disease
PANCREATIC NEOPLASMS;rs992160;Variant;PA445218;Disease
GEMCITABINE;rs992160;Variant;PA449748;Chemical
CYP2B6;Stevens-Johnson Syndrome;Disease;PA123;Gene
CYP2C9;Stevens-Johnson Syndrome;Disease;PA126;Gene
CYCSP5;Stevens-Johnson Syndrome;Disease;PA142672032;Gene
CYP2C9*1;Stevens-Johnson Syndrome;Disease;PA165816542;Haplotype
CYP2C9*3;Stevens-Johnson Syndrome;Disease;PA165816544;Haplotype
HLA-DRB1*01:02;Stevens-Johnson Syndrome;Disease;PA165951340;Haplotype
HLA-DRB1*01:03;Stevens-Johnson Syndrome;Disease;PA165951348;Haplotype
HLA-DRB1*04:04;Stevens-Johnson Syndrome;Disease;PA165951511;Haplotype
HLA-DRB1*08:01;Stevens-Johnson Syndrome;Disease;PA165951669;Haplotype
HLA-DRB1*08:03;Stevens-Johnson Syndrome;Disease;PA165951678;Haplotype
HLA-DRB1*10:01;Stevens-Johnson Syndrome;Disease;PA165951757;Haplotype
HLA-DRB1*12:02;Stevens-Johnson Syndrome;Disease;PA165951930;Haplotype
HLA-DRB1*13:02;Stevens-Johnson Syndrome;Disease;PA165951978;Haplotype
HLA-DRB1*15:02;Stevens-Johnson Syndrome;Disease;PA165952289;Haplotype
HLA-A*02:06;Stevens-Johnson Syndrome;Disease;PA165952829;Haplotype
HLA-A*02:07;Stevens-Johnson Syndrome;Disease;PA165952839;Haplotype
HLA-A*11:01;Stevens-Johnson Syndrome;Disease;PA165953358;Haplotype
HLA-A*23:01;Stevens-Johnson Syndrome;Disease;PA165953507;Haplotype
HLA-A*24:02;Stevens-Johnson Syndrome;Disease;PA165953564;Haplotype
HLA-A*24:07;Stevens-Johnson Syndrome;Disease;PA165953622;Haplotype
HLA-A*31:01;Stevens-Johnson Syndrome;Disease;PA165954030;Haplotype
HLA-B*07:02;Stevens-Johnson Syndrome;Disease;PA165954366;Haplotype
HLA-B*13:01;Stevens-Johnson Syndrome;Disease;PA165954643;Haplotype
HLA-B*13:02;Stevens-Johnson Syndrome;Disease;PA165954649;Haplotype
HLA-B*15:01;Stevens-Johnson Syndrome;Disease;PA165954745;Haplotype
HLA-B*15:02;Stevens-Johnson Syndrome;Disease;PA165954769;Haplotype
HLA-B*15:11;Stevens-Johnson Syndrome;Disease;PA165954787;Haplotype
HLA-B*15:12;Stevens-Johnson Syndrome;Disease;PA165954792;Haplotype
HLA-B*15:13;Stevens-Johnson Syndrome;Disease;PA165954793;Haplotype
HLA-B*15:18;Stevens-Johnson Syndrome;Disease;PA165954803;Haplotype
HLA-B*15:21;Stevens-Johnson Syndrome;Disease;PA165954809;Haplotype
HLA-B*15:24;Stevens-Johnson Syndrome;Disease;PA165954811;Haplotype
HLA-B*15:25;Stevens-Johnson Syndrome;Disease;PA165954812;Haplotype
HLA-B*15:27;Stevens-Johnson Syndrome;Disease;PA165954816;Haplotype
HLA-B*15:32;Stevens-Johnson Syndrome;Disease;PA165954823;Haplotype
HLA-B*15:35;Stevens-Johnson Syndrome;Disease;PA165954826;Haplotype
HLA-B*18:01;Stevens-Johnson Syndrome;Disease;PA165955030;Haplotype
HLA-B*35:10;Stevens-Johnson Syndrome;Disease;PA165955274;Haplotype
HLA-B*38:01;Stevens-Johnson Syndrome;Disease;PA165955500;Haplotype
HLA-B*38:02;Stevens-Johnson Syndrome;Disease;PA165955505;Haplotype
HLA-B*39:01;Stevens-Johnson Syndrome;Disease;PA165955543;Haplotype
HLA-B*39:05;Stevens-Johnson Syndrome;Disease;PA165955559;Haplotype
HLA-B*39:06;Stevens-Johnson Syndrome;Disease;PA165955561;Haplotype
HLA-B*39:09;Stevens-Johnson Syndrome;Disease;PA165955565;Haplotype
HLA-B*39:10;Stevens-Johnson Syndrome;Disease;PA165955566;Haplotype
HLA-B*40:01;Stevens-Johnson Syndrome;Disease;PA165955628;Haplotype
HLA-B*40:02;Stevens-Johnson Syndrome;Disease;PA165955651;Haplotype
HLA-B*44:03;Stevens-Johnson Syndrome;Disease;PA165955913;Haplotype
HLA-B*46:01;Stevens-Johnson Syndrome;Disease;PA165956083;Haplotype
HLA-B*51:01;Stevens-Johnson Syndrome;Disease;PA165956201;Haplotype
HLA-B*51:02;Stevens-Johnson Syndrome;Disease;PA165956231;Haplotype
HLA-B*52:01;Stevens-Johnson Syndrome;Disease;PA165956366;Haplotype
HLA-B*54:01;Stevens-Johnson Syndrome;Disease;PA165956438;Haplotype
HLA-B*55:01;Stevens-Johnson Syndrome;Disease;PA165956463;Haplotype
HLA-B*55:02;Stevens-Johnson Syndrome;Disease;PA165956471;Haplotype
HLA-B*56:01;Stevens-Johnson Syndrome;Disease;PA165956528;Haplotype
HLA-B*56:02;Stevens-Johnson Syndrome;Disease;PA165956532;Haplotype
HLA-B*56:06;Stevens-Johnson Syndrome;Disease;PA165956537;Haplotype
HLA-B*59:01;Stevens-Johnson Syndrome;Disease;PA165956674;Haplotype
HLA-B*67:01;Stevens-Johnson Syndrome;Disease;PA165956680;Haplotype
HLA-B*78:01;Stevens-Johnson Syndrome;Disease;PA165956686;Haplotype
HLA-C*01:02;Stevens-Johnson Syndrome;Disease;PA165956704;Haplotype
HLA-C*03:04;Stevens-Johnson Syndrome;Disease;PA165956881;Haplotype
HLA-C*04:01;Stevens-Johnson Syndrome;Disease;PA165957046;Haplotype
HLA-C*04:03;Stevens-Johnson Syndrome;Disease;PA165957085;Haplotype
HLA-C*04:06;Stevens-Johnson Syndrome;Disease;PA165957089;Haplotype
HLA-C*04:07;Stevens-Johnson Syndrome;Disease;PA165957090;Haplotype
HLA-C*05:01;Stevens-Johnson Syndrome;Disease;PA165957192;Haplotype
HLA-C*05:09;Stevens-Johnson Syndrome;Disease;PA165957217;Haplotype
HLA-C*06:02;Stevens-Johnson Syndrome;Disease;PA165957286;Haplotype
HLA-C*07:04;Stevens-Johnson Syndrome;Disease;PA165957428;Haplotype
HLA-C*07:27;Stevens-Johnson Syndrome;Disease;PA165957457;Haplotype
HLA-C*14:02;Stevens-Johnson Syndrome;Disease;PA165957818;Haplotype
HLA-C*14:03;Stevens-Johnson Syndrome;Disease;PA165957827;Haplotype
HLA-C*15:02;Stevens-Johnson Syndrome;Disease;PA165957859;Haplotype
HLA-C*18:01;Stevens-Johnson Syndrome;Disease;PA165958003;Haplotype
HLA-DQB1*05:01;Stevens-Johnson Syndrome;Disease;PA165958073;Haplotype
HLA-DQB1*05:02;Stevens-Johnson Syndrome;Disease;PA165958077;Haplotype
HLA-DQB1*02:02;Stevens-Johnson Syndrome;Disease;PA165958162;Haplotype
HLA-B*57:01;Stevens-Johnson Syndrome;Disease;PA165987830;Haplotype
HLA-B*58:01;Stevens-Johnson Syndrome;Disease;PA165987831;Haplotype
GSTM1 NULL;Stevens-Johnson Syndrome;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Stevens-Johnson Syndrome;Disease;PA166048676;Haplotype
HLA-C*03:02;Stevens-Johnson Syndrome;Disease;PA166123425;Haplotype
HLA-C*08:01;Stevens-Johnson Syndrome;Disease;PA166123426;Haplotype
HLA-A*02:01;Stevens-Johnson Syndrome;Disease;PA166123427;Haplotype
HLA-A*33:03;Stevens-Johnson Syndrome;Disease;PA166123428;Haplotype
RS3745274;Stevens-Johnson Syndrome;Disease;PA166155409;Variant
RS28399499;Stevens-Johnson Syndrome;Disease;PA166155478;Variant
RS2844665;Stevens-Johnson Syndrome;Disease;PA166157053;Variant
RS3094188;Stevens-Johnson Syndrome;Disease;PA166157064;Variant
RS3099844;Stevens-Johnson Syndrome;Disease;PA166157066;Variant
RS3130501;Stevens-Johnson Syndrome;Disease;PA166157069;Variant
RS3130931;Stevens-Johnson Syndrome;Disease;PA166157071;Variant
RS3815087;Stevens-Johnson Syndrome;Disease;PA166157086;Variant
RS9469003;Stevens-Johnson Syndrome;Disease;PA166157162;Variant
RS2734583;Stevens-Johnson Syndrome;Disease;PA166161405;Variant
RS9263726;Stevens-Johnson Syndrome;Disease;PA166161422;Variant
GSTM1;Stevens-Johnson Syndrome;Disease;PA182;Gene
POU5F1;Stevens-Johnson Syndrome;Disease;PA33545;Gene
PSORS1C1;Stevens-Johnson Syndrome;Disease;PA33919;Gene
PSORS1C3;Stevens-Johnson Syndrome;Disease;PA33921;Gene
HLA-A;Stevens-Johnson Syndrome;Disease;PA35055;Gene
HLA-B;Stevens-Johnson Syndrome;Disease;PA35056;Gene
HLA-C;Stevens-Johnson Syndrome;Disease;PA35057;Gene
HLA-DQB1;Stevens-Johnson Syndrome;Disease;PA35068;Gene
HLA-DRB1;Stevens-Johnson Syndrome;Disease;PA35072;Gene
TALAZOPARIB;RAD51C;Gene;PA166182740;Chemical
ACETALDEHYDE;ADH1B;Gene;PA166186245;Chemical
ALCOHOL ABUSE;ADH1B;Gene;PA443309;Disease
ASTHMA;ADH1B;Gene;PA443450;Disease
CARDIOVASCULAR DISEASES;ADH1B;Gene;PA443635;Disease
FETAL ALCOHOL SYNDROME;ADH1B;Gene;PA444167;Disease
GOUT;ADH1B;Gene;PA444318;Disease
LIVER DISEASES, ALCOHOLIC;ADH1B;Gene;PA444802;Disease
OROPHARYNGEAL NEOPLASMS;ADH1B;Gene;PA445168;Disease
ABACAVIR;ADH1B;Gene;PA448004;Chemical
ETHANOL;ADH1B;Gene;PA448073;Chemical
NALTREXONE;ADH1B;Gene;PA450588;Chemical
OPIOID-RELATED DISORDERS;CCL11;Gene;PA445043;Disease
METHADONE;CCL11;Gene;PA450401;Chemical
EPILEPSY;rs2227956;Variant;PA444065;Disease
CARBAMAZEPINE;rs2227956;Variant;PA448785;Chemical
HYPERTENSION;PROX1;Gene;PA444552;Disease
ATENOLOL;PROX1;Gene;PA448499;Chemical
DRUG-INDUCED LIVER INJURY;HLA-A*33:01;Haplotype;PA166119041;Disease
DRUG HYPERSENSITIVITY;HLA-A*33:01;Haplotype;PA443936;Disease
ALLOPURINOL;HLA-A*33:01;Haplotype;PA448320;Chemical
FENOFIBRATE;HLA-A*33:01;Haplotype;PA449594;Chemical
SERTRALINE;HLA-A*33:01;Haplotype;PA451333;Chemical
TERBINAFINE;HLA-A*33:01;Haplotype;PA451614;Chemical
TICLOPIDINE;HLA-A*33:01;Haplotype;PA451686;Chemical
PRKDC;H2AFX;Gene;PA33776;Gene
XRCC4;H2AFX;Gene;PA37423;Gene
METHADONE;H2AFX;Gene;PA450401;Chemical
NOS1AP;Dihydropyridine derivatives;Chemical;PA142671259;Gene
RS10494366;Dihydropyridine derivatives;Chemical;PA166153802;Variant
HYPERTENSION;rs5522;Variant;PA444552;Disease
ENALAPRIL;rs5522;Variant;PA449456;Chemical
PLATINUM COMPOUNDS;rs10878232;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs10878232;Variant;PA443622;Disease
DAUNORUBICIN;AKR1C4;Gene;PA449212;Chemical
EXEMESTANE;AKR1C4;Gene;PA449563;Chemical
NALTREXONE;AKR1C4;Gene;PA450588;Chemical
CARBOCISTEINE;PAH;Gene;PA166184060;Chemical
L-PHENYLALANINE;PAH;Gene;PA450931;Chemical
ATOMOXETINE;CYP2D6*91;Haplotype;PA134688071;Chemical
TOLTERODINE;CYP2D6*91;Haplotype;PA164746757;Chemical
BUFURALOL;CYP2D6*91;Haplotype;PA166110256;Chemical
DAPOXETINE;CYP2D6*91;Haplotype;PA166151992;Chemical
AMITRIPTYLINE;CYP2D6*91;Haplotype;PA448385;Chemical
CITALOPRAM;CYP2D6*91;Haplotype;PA449015;Chemical
DEXTROMETHORPHAN;CYP2D6*91;Haplotype;PA449273;Chemical
OLANZAPINE;CYP2D6*91;Haplotype;PA450688;Chemical
RISPERIDONE;CYP2D6*91;Haplotype;PA451257;Chemical
TAMOXIFEN;CYP2D6*91;Haplotype;PA451581;Chemical
VENLAFAXINE;CYP2D6*91;Haplotype;PA451866;Chemical
COMT;Methyldopa;Chemical;PA117;Gene
COMT;olanzapine;Chemical;PA117;Gene
CYP2B6;olanzapine;Chemical;PA123;Gene
CYP2C19;olanzapine;Chemical;PA124;Gene
CYP2C9;olanzapine;Chemical;PA126;Gene
CYP2D6;olanzapine;Chemical;PA128;Gene
CYP3A4;olanzapine;Chemical;PA130;Gene
CYP3A5;olanzapine;Chemical;PA131;Gene
ANKK1;olanzapine;Chemical;PA134872551;Gene
RABEP1;olanzapine;Chemical;PA134884097;Gene
SV2C;olanzapine;Chemical;PA134888452;Gene
EIF2AK4;olanzapine;Chemical;PA134947616;Gene
SH2B1;olanzapine;Chemical;PA145148084;Gene
SPOPL;olanzapine;Chemical;PA162404650;Gene
FMO1;olanzapine;Chemical;PA165;Gene
CYP2C9*1;olanzapine;Chemical;PA165816542;Haplotype
CYP2C9*2;olanzapine;Chemical;PA165816543;Haplotype
CYP2C9*3;olanzapine;Chemical;PA165816544;Haplotype
CYP2C9*6;olanzapine;Chemical;PA165816547;Haplotype
CYP2D6*1;olanzapine;Chemical;PA165816576;Haplotype
CYP2D6*3;olanzapine;Chemical;PA165816578;Haplotype
CYP2D6*4;olanzapine;Chemical;PA165816579;Haplotype
CYP2D6*10;olanzapine;Chemical;PA165816582;Haplotype
TPMT*1;olanzapine;Chemical;PA165819268;Haplotype
TPMT*3A;olanzapine;Chemical;PA165819270;Haplotype
TPMT*3C;olanzapine;Chemical;PA165819272;Haplotype
FMO3;olanzapine;Chemical;PA166;Gene
UGT1A1*1;olanzapine;Chemical;PA166115841;Haplotype
UGT1A1*28;olanzapine;Chemical;PA166115842;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);olanzapine;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);olanzapine;Chemical;PA166116466;Haplotype
UGT1A4*1A;olanzapine;Chemical;PA166117588;Haplotype
UGT1A4*3A;olanzapine;Chemical;PA166117598;Haplotype
CYP2D6*87;olanzapine;Chemical;PA166123327;Haplotype
CYP2D6*88;olanzapine;Chemical;PA166123328;Haplotype
CYP2D6*90;olanzapine;Chemical;PA166123330;Haplotype
CYP2D6*91;olanzapine;Chemical;PA166123331;Haplotype
CYP2D6*92;olanzapine;Chemical;PA166123332;Haplotype
CYP2D6*93;olanzapine;Chemical;PA166123333;Haplotype
CYP2D6*95;olanzapine;Chemical;PA166123336;Haplotype
CYP2D6*96;olanzapine;Chemical;PA166123337;Haplotype
CYP2D6*97;olanzapine;Chemical;PA166123338;Haplotype
CYP3A5*1;olanzapine;Chemical;PA166128213;Haplotype
CYP3A5*3;olanzapine;Chemical;PA166128219;Haplotype
RS7877;olanzapine;Chemical;PA166153558;Variant
RS324420;olanzapine;Chemical;PA166153569;Variant
RS951439;olanzapine;Chemical;PA166153604;Variant
RS1801131;olanzapine;Chemical;PA166153643;Variant
RS2266780;olanzapine;Chemical;PA166153687;Variant
RS2842030;olanzapine;Chemical;PA166153720;Variant
RS12720462;olanzapine;Chemical;PA166153860;Variant
RS1880676;olanzapine;Chemical;PA166153979;Variant
RS3810950;olanzapine;Chemical;PA166154040;Variant
RS7912580;olanzapine;Chemical;PA166154088;Variant
RS5128;olanzapine;Chemical;PA166154254;Variant
RS6265;olanzapine;Chemical;PA166154259;Variant
RS6275;olanzapine;Chemical;PA166154260;Variant
RS6277;olanzapine;Chemical;PA166154261;Variant
RS6279;olanzapine;Chemical;PA166154262;Variant
RS1076560;olanzapine;Chemical;PA166154313;Variant
RS1079598;olanzapine;Chemical;PA166154316;Variant
RS1124493;olanzapine;Chemical;PA166154318;Variant
RS1799732;olanzapine;Chemical;PA166154334;Variant
RS1799978;olanzapine;Chemical;PA166154337;Variant
RS1800497;olanzapine;Chemical;PA166154339;Variant
RS2440390;olanzapine;Chemical;PA166154369;Variant
RS2734841;olanzapine;Chemical;PA166154385;Variant
RS2734842;olanzapine;Chemical;PA166154386;Variant
RS4436578;olanzapine;Chemical;PA166154407;Variant
RS5443;olanzapine;Chemical;PA166154486;Variant
RS7973796;olanzapine;Chemical;PA166154607;Variant
RS6313;olanzapine;Chemical;PA166154675;Variant
RS6314;olanzapine;Chemical;PA166154676;Variant
RS7997012;olanzapine;Chemical;PA166154726;Variant
RS762551;olanzapine;Chemical;PA166154850;Variant
RS2412459;olanzapine;Chemical;PA166154891;Variant
RS2472297;olanzapine;Chemical;PA166154895;Variant
RS11872992;olanzapine;Chemical;PA166155319;Variant
RS10423928;olanzapine;Chemical;PA166155453;Variant
RS11677416;olanzapine;Chemical;PA166155806;Variant
RS13429709;olanzapine;Chemical;PA166155833;Variant
RS6280;olanzapine;Chemical;PA166156277;Variant
RS1801282;olanzapine;Chemical;PA166156331;Variant
RS9852;olanzapine;Chemical;PA166156482;Variant
RS10042486;olanzapine;Chemical;PA166156855;Variant
RS11960832;olanzapine;Chemical;PA166156873;Variant
RS806378;olanzapine;Chemical;PA166156956;Variant
RS1415744;olanzapine;Chemical;PA166156984;Variant
RS2268639;olanzapine;Chemical;PA166157028;Variant
RS34059508;olanzapine;Chemical;PA166157196;Variant
RS3842;olanzapine;Chemical;PA166157239;Variant
RS472660;olanzapine;Chemical;PA166157257;Variant
RS1045642;olanzapine;Chemical;PA166157284;Variant
RS2229109;olanzapine;Chemical;PA166157334;Variant
RS4410790;olanzapine;Chemical;PA166157390;Variant
RS4728709;olanzapine;Chemical;PA166157398;Variant
RS4731426;olanzapine;Chemical;PA166157400;Variant
RS10248420;olanzapine;Chemical;PA166157440;Variant
RS4994;olanzapine;Chemical;PA166157543;Variant
RS518147;olanzapine;Chemical;PA166157854;Variant
RS1414334;olanzapine;Chemical;PA166157862;Variant
RS2497538;olanzapine;Chemical;PA166157870;Variant
RS3813929;olanzapine;Chemical;PA166157875;Variant
RS1799735;olanzapine;Chemical;PA166159214;Variant
RS3888190;olanzapine;Chemical;PA166165398;Variant
RS1000940;olanzapine;Chemical;PA166165401;Variant
RS6688363;olanzapine;Chemical;PA166184305;Variant
RS10170310;olanzapine;Chemical;PA166184311;Variant
RS36120609;olanzapine;Chemical;PA166211543;Variant
RS155333;olanzapine;Chemical;PA166252941;Variant
RS6465938;olanzapine;Chemical;PA166252981;Variant
GNB3;olanzapine;Chemical;PA176;Gene
HTR1A;olanzapine;Chemical;PA192;Gene
HTR2A;olanzapine;Chemical;PA193;Gene
HTR2C;olanzapine;Chemical;PA194;Gene
LEP;olanzapine;Chemical;PA228;Gene
MTHFR;olanzapine;Chemical;PA245;Gene
ADRB3;olanzapine;Chemical;PA24598;Gene
AHR;olanzapine;Chemical;PA24641;Gene
CHAT;olanzapine;Chemical;PA26448;Gene
CNR1;olanzapine;Chemical;PA26681;Gene
ABCB1;olanzapine;Chemical;PA267;Gene
CYP1A1;olanzapine;Chemical;PA27092;Gene
CYP1A2;olanzapine;Chemical;PA27093;Gene
DRD2;olanzapine;Chemical;PA27478;Gene
DRD3;olanzapine;Chemical;PA27479;Gene
EPM2A;olanzapine;Chemical;PA27832;Gene
FAAH;olanzapine;Chemical;PA27955;Gene
PPARG;olanzapine;Chemical;PA281;Gene
GCG;olanzapine;Chemical;PA28606;Gene
GIPR;olanzapine;Chemical;PA28682;Gene
GLP1R;olanzapine;Chemical;PA28725;Gene
GSTM3;olanzapine;Chemical;PA29024;Gene
IL1A;olanzapine;Chemical;PA29807;Gene
MC4R;olanzapine;Chemical;PA30676;Gene
ATP1A2;olanzapine;Chemical;PA30796;Gene
SLC6A4;olanzapine;Chemical;PA312;Gene
BDNF;olanzapine;Chemical;PA31891;Gene
SLC22A1;olanzapine;Chemical;PA329;Gene
PMCH;olanzapine;Chemical;PA33435;Gene
POLG;olanzapine;Chemical;PA33500;Gene
RELN;olanzapine;Chemical;PA34323;Gene
RGS4;olanzapine;Chemical;PA34375;Gene
HLA-A;olanzapine;Chemical;PA35055;Gene
HLA-B;olanzapine;Chemical;PA35056;Gene
TPMT;olanzapine;Chemical;PA356;Gene
TBC1D1;olanzapine;Chemical;PA36342;Gene
UGT1A4;olanzapine;Chemical;PA37179;Gene
UGT1A1;olanzapine;Chemical;PA420;Gene
CYP3A43;olanzapine;Chemical;PA427;Gene
APOC3;olanzapine;Chemical;PA53;Gene
RS267606618;paromomycin;Chemical;PA166158908;Variant
RS267606619;paromomycin;Chemical;PA166158909;Variant
RS267606617;paromomycin;Chemical;PA166159181;Variant
MT-RNR1;paromomycin;Chemical;PA31274;Gene
MAPK8;MAP2K6;Gene;PA283;Gene
MAP3K11;MAP2K6;Gene;PA30594;Gene
MAP3K7;MAP2K6;Gene;PA30603;Gene
MAPK1;MAP2K6;Gene;PA30616;Gene
MAPK10;MAP2K6;Gene;PA30617;Gene
MAPK11;MAP2K6;Gene;PA30618;Gene
MAPK12;MAP2K6;Gene;PA30619;Gene
MAPK13;MAP2K6;Gene;PA30620;Gene
MAPK14;MAP2K6;Gene;PA30621;Gene
MAPK3;MAP2K6;Gene;PA30622;Gene
MAPK4;MAP2K6;Gene;PA30623;Gene
MAPK6;MAP2K6;Gene;PA30624;Gene
MAPK7;MAP2K6;Gene;PA30625;Gene
MAPK9;MAP2K6;Gene;PA30630;Gene
RAF1;MAP2K6;Gene;PA34183;Gene
DIARRHEA;MAP2K6;Gene;PA443899;Disease
DRUG TOXICITY;MAP2K6;Gene;PA443937;Disease
SORAFENIB;MAP2K6;Gene;PA7000;Chemical
MACULOPAPULAR EXANTHEMA;rs9332096;Variant;PA162316739;Disease
ETHAMBUTOL;rs9332096;Variant;PA164784021;Chemical
TUBERCULOSIS;rs9332096;Variant;PA445941;Disease
ISONIAZID;rs9332096;Variant;PA450112;Chemical
PYRAZINAMIDE;rs9332096;Variant;PA451182;Chemical
RIFAMPIN;rs9332096;Variant;PA451250;Chemical
WARFARIN;rs9332096;Variant;PA451906;Chemical
MAJOR DEPRESSIVE DISORDER;rs10997242;Variant;PA447321;Disease
ANTIDEPRESSANTS;rs10997242;Variant;PA452229;Chemical
VORICONAZOLE;CYP2C19 ultrarapid metabolizer;Variant;PA10233;Chemical
MYCOSES;CYP2C19 ultrarapid metabolizer;Variant;PA445009;Disease
ABCB1;phenothiazines with aliphatic side-chain;Chemical;PA267;Gene
CYP2D6;zuclopenthixol;Chemical;PA128;Gene
CYP2D6*1;zuclopenthixol;Chemical;PA165816576;Haplotype
CYP2D6*3;zuclopenthixol;Chemical;PA165816578;Haplotype
CYP2D6*4;zuclopenthixol;Chemical;PA165816579;Haplotype
CHRNA7;Alzheimer Disease;Disease;PA114;Gene
CYP2D6;Alzheimer Disease;Disease;PA128;Gene
ACE;Alzheimer Disease;Disease;PA139;Gene
CYP2D6*1;Alzheimer Disease;Disease;PA165816576;Haplotype
CYP2D6*3;Alzheimer Disease;Disease;PA165816578;Haplotype
CYP2D6*4;Alzheimer Disease;Disease;PA165816579;Haplotype
CYP2D6*6;Alzheimer Disease;Disease;PA165816581;Haplotype
CYP2D6*5;Alzheimer Disease;Disease;PA165948092;Haplotype
CYP2D6*1XN;Alzheimer Disease;Disease;PA165988479;Haplotype
RS2177370;Alzheimer Disease;Disease;PA166153998;Variant
RS3793790;Alzheimer Disease;Disease;PA166154034;Variant
RS6313;Alzheimer Disease;Disease;PA166154675;Variant
RS6494223;Alzheimer Disease;Disease;PA166154918;Variant
RS4291;Alzheimer Disease;Disease;PA166155143;Variant
RS429358;Alzheimer Disease;Disease;PA166155351;Variant
RS1803274;Alzheimer Disease;Disease;PA166156332;Variant
RS2571598;Alzheimer Disease;Disease;PA166157364;Variant
CYP2D6 POOR METABOLIZER;Alzheimer Disease;Disease;PA166157927;Variant
HTR2A;Alzheimer Disease;Disease;PA193;Gene
ACHE;Alzheimer Disease;Disease;PA20;Gene
MTHFR;Alzheimer Disease;Disease;PA245;Gene
BCHE;Alzheimer Disease;Disease;PA25294;Gene
CHAT;Alzheimer Disease;Disease;PA26448;Gene
IGHV1-67;Alzheimer Disease;Disease;PA35158;Gene
ADRB1;Alzheimer Disease;Disease;PA38;Gene
TP53INP1;Alzheimer Disease;Disease;PA38278;Gene
APOE;Alzheimer Disease;Disease;PA55;Gene
DRD1;dextroamphetamine;Chemical;PA147;Gene
RS4532;dextroamphetamine;Chemical;PA166156706;Variant
NICOTINE;rs72549435;Variant;PA450626;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*28;Haplotype;PA166127651;Chemical
PRIMAQUINE;CYP2D6*28;Haplotype;PA451103;Chemical
ASTHMA;rs1059288;Variant;PA443450;Disease
ASPIRIN;rs1059288;Variant;PA448497;Chemical
SLC6A4 HTTLPR LONG FORM (L ALLELE);Heart Defects, Congenital;Disease;PA166116465;Haplotype
SLC6A4;Heart Defects, Congenital;Disease;PA312;Gene
SLC19A1;Heart Defects, Congenital;Disease;PA327;Gene
PEGASPARGASE;rs117532069;Variant;PA164760860;Chemical
OSTEONECROSIS;rs117532069;Variant;PA445187;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs117532069;Variant;PA446155;Disease
CYCLOPHOSPHAMIDE;rs117532069;Variant;PA449165;Chemical
CYTARABINE;rs117532069;Variant;PA449177;Chemical
DAUNORUBICIN;rs117532069;Variant;PA449212;Chemical
DEXAMETHASONE;rs117532069;Variant;PA449247;Chemical
DOXORUBICIN;rs117532069;Variant;PA449412;Chemical
METHOTREXATE;rs117532069;Variant;PA450428;Chemical
PREDNISONE;rs117532069;Variant;PA451100;Chemical
THIOGUANINE;rs117532069;Variant;PA451663;Chemical
VINCRISTINE;rs117532069;Variant;PA451879;Chemical
AGXT;nedosiran;Chemical;PA24633;Gene
ROCURONIUM;IAPP;Gene;PA164754992;Chemical
SULFAMETHOXAZOLE / TRIMETHOPRIM;HLA-C;Gene;PA10715;Chemical
LAPATINIB;HLA-C;Gene;PA152241907;Chemical
MACULOPAPULAR EXANTHEMA;HLA-C;Gene;PA162316739;Disease
DRUGS FOR TREATMENT OF TUBERCULOSIS;HLA-C;Gene;PA164712708;Chemical
RUBELLA VACCINES;HLA-C;Gene;PA164713242;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;HLA-C;Gene;PA164713366;Chemical
CLAVULANATE;HLA-C;Gene;PA164742987;Chemical
FLUCLOXACILLIN;HLA-C;Gene;PA164781042;Chemical
PEGINTERFERON ALFA-2B;HLA-C;Gene;PA164784024;Chemical
TOXIC LIVER DISEASE;HLA-C;Gene;PA164925725;Disease
USTEKINUMAB;HLA-C;Gene;PA166048654;Chemical
DRUG-INDUCED LIVER INJURY;HLA-C;Gene;PA166119041;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-C;Gene;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-C;Gene;PA166120929;Disease
AGRANULOCYTOSIS;HLA-C;Gene;PA443297;Disease
BREAST NEOPLASMS;HLA-C;Gene;PA443560;Disease
NON-SMALL CELL LUNG CARCINOMA;HLA-C;Gene;PA443622;Disease
DRUG HYPERSENSITIVITY;HLA-C;Gene;PA443936;Disease
DRUG TOXICITY;HLA-C;Gene;PA443937;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-C;Gene;PA444059;Disease
EPILEPSY;HLA-C;Gene;PA444065;Disease
EXANTHEMA;HLA-C;Gene;PA444109;Disease
HEPATITIS C;HLA-C;Gene;PA444445;Disease
HYPERSENSITIVITY;HLA-C;Gene;PA444546;Disease
KIDNEY FAILURE, CHRONIC;HLA-C;Gene;PA444684;Disease
PSORIASIS;HLA-C;Gene;PA445451;Disease
RESPIRATORY INSUFFICIENCY;HLA-C;Gene;PA445522;Disease
STEVENS-JOHNSON SYNDROME;HLA-C;Gene;PA445738;Disease
THROMBOCYTOPENIA;HLA-C;Gene;PA445846;Disease
TUBERCULOSIS;HLA-C;Gene;PA445941;Disease
HEMATOLOGIC NEOPLASMS;HLA-C;Gene;PA446827;Disease
SCHIZOPHRENIA;HLA-C;Gene;PA447216;Disease
HIV INFECTIONS;HLA-C;Gene;PA447230;Disease
ACETAMINOPHEN;HLA-C;Gene;PA448015;Chemical
ALLOPURINOL;HLA-C;Gene;PA448320;Chemical
AMOXICILLIN;HLA-C;Gene;PA448406;Chemical
CARBAMAZEPINE;HLA-C;Gene;PA448785;Chemical
CARBOPLATIN;HLA-C;Gene;PA448803;Chemical
CLOZAPINE;HLA-C;Gene;PA449061;Chemical
GEMCITABINE;HLA-C;Gene;PA449748;Chemical
LAMOTRIGINE;HLA-C;Gene;PA450164;Chemical
METHAZOLAMIDE;HLA-C;Gene;PA450413;Chemical
METHOTREXATE;HLA-C;Gene;PA450428;Chemical
NEVIRAPINE;HLA-C;Gene;PA450616;Chemical
PHENYTOIN;HLA-C;Gene;PA450947;Chemical
RIBAVIRIN;HLA-C;Gene;PA451241;Chemical
TICLOPIDINE;HLA-C;Gene;PA451686;Chemical
VALPROIC ACID;HLA-C;Gene;PA451846;Chemical
INFLIXIMAB;HLA-C;Gene;PA452639;Chemical
RASBURICASE;CYB5R2;Gene;PA10176;Chemical
ISOSORBIDE DINITRATE;CYB5R2;Gene;PA450125;Chemical
ISOSORBIDE MONONITRATE;CYB5R2;Gene;PA450126;Chemical
METOCLOPRAMIDE;CYB5R2;Gene;PA450475;Chemical
PRIMAQUINE;CYB5R2;Gene;PA451103;Chemical
ARHGAP28;pegaspargase;Chemical;PA134915320;Gene
LINC00251;pegaspargase;Chemical;PA165585763;Gene
HLA-DQA1*02:01;pegaspargase;Chemical;PA165951292;Haplotype
HLA-DRB1*07:01;pegaspargase;Chemical;PA165951644;Haplotype
HLA-DRB1*16:02;pegaspargase;Chemical;PA165952368;Haplotype
HLA-DQB1*02:02;pegaspargase;Chemical;PA165958162;Haplotype
RS1891059;pegaspargase;Chemical;PA166153658;Variant
RS17021408;pegaspargase;Chemical;PA166153867;Variant
RS80223967;pegaspargase;Chemical;PA166153915;Variant
RS3824662;pegaspargase;Chemical;PA166154043;Variant
RS79085477;pegaspargase;Chemical;PA166155968;Variant
RS117532069;pegaspargase;Chemical;PA166155970;Variant
RS141059755;pegaspargase;Chemical;PA166157691;Variant
RS9958628;pegaspargase;Chemical;PA166250701;Variant
RS12283870;pegaspargase;Chemical;PA166285621;Variant
BMP7;pegaspargase;Chemical;PA25384;Gene
DOK5;pegaspargase;Chemical;PA25724;Gene
CPT1A;pegaspargase;Chemical;PA26847;Gene
GATA3;pegaspargase;Chemical;PA28586;Gene
IGHMBP2;pegaspargase;Chemical;PA29731;Gene
HLA-DQA1;pegaspargase;Chemical;PA35066;Gene
HLA-DQB1;pegaspargase;Chemical;PA35068;Gene
HLA-DRB1;pegaspargase;Chemical;PA35072;Gene
BENZODIAZEPINE DERIVATIVES;rs1799971;Variant;PA10402;Chemical
CANNABINOIDS;rs1799971;Variant;PA131890620;Chemical
NEUROPATHIC PAIN;rs1799971;Variant;PA162263525;Disease
ANALGESICS;rs1799971;Variant;PA164712362;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;rs1799971;Variant;PA164712462;Chemical
DRUGS USED IN NICOTINE DEPENDENCE;rs1799971;Variant;PA164712720;Chemical
ERGOT ALKALOIDS;rs1799971;Variant;PA164712741;Chemical
OPIOID ANESTHETICS;rs1799971;Variant;PA164712948;Chemical
OTHER GENERAL ANESTHETICS;rs1799971;Variant;PA164713083;Chemical
SYMPATHOMIMETICS;rs1799971;Variant;PA164713301;Chemical
NEONATAL ABSTINENCE SYNDROME;rs1799971;Variant;PA165108809;Disease
COTININE;rs1799971;Variant;PA166114414;Chemical
DRY MOUTH;rs1799971;Variant;PA166115462;Disease
VOLATILE ANESTHETICS;rs1799971;Variant;PA166131630;Chemical
ADVERSE EVENTS;rs1799971;Variant;PA166151827;Disease
SOMNOLENCE;rs1799971;Variant;PA166185626;Disease
SUICIDAL IDEATION;rs1799971;Variant;PA166186039;Disease
TIANEPTINE;rs1799971;Variant;PA166186040;Chemical
AMPLIFICATION OF SEXUAL BEHAVIOR;rs1799971;Variant;PA166232141;Disease
ALCOHOL ABUSE;rs1799971;Variant;PA443309;Disease
MARIJUANA ABUSE;rs1799971;Variant;PA443602;Disease
CONSTIPATION;rs1799971;Variant;PA443782;Disease
DELIRIUM;rs1799971;Variant;PA443851;Disease
DIZZINESS;rs1799971;Variant;PA443928;Disease
ERYTHEMA;rs1799971;Variant;PA444083;Disease
CARDIAC ARREST;rs1799971;Variant;PA444365;Disease
HEROIN DEPENDENCE;rs1799971;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs1799971;Variant;PA445043;Disease
NAUSEA;rs1799971;Variant;PA445048;Disease
PAIN;rs1799971;Variant;PA445208;Disease
PAIN, POSTOPERATIVE;rs1799971;Variant;PA445210;Disease
PRURITUS;rs1799971;Variant;PA445437;Disease
RESPIRATORY INSUFFICIENCY;rs1799971;Variant;PA445522;Disease
SLEEP APNEA SYNDROMES;rs1799971;Variant;PA445687;Disease
SLEEP DISORDERS;rs1799971;Variant;PA445689;Disease
SUBSTANCE WITHDRAWAL SYNDROME;rs1799971;Variant;PA445768;Disease
TOBACCO USE DISORDER;rs1799971;Variant;PA445876;Disease
VOMITING;rs1799971;Variant;PA446051;Disease
OVERDOSE;rs1799971;Variant;PA446199;Disease
URINARY RETENTION;rs1799971;Variant;PA446264;Disease
SUBSTANCE-RELATED DISORDERS;rs1799971;Variant;PA446876;Disease
COCAINE DEPENDENCE;rs1799971;Variant;PA446878;Disease
POSTOPERATIVE NAUSEA AND VOMITING;rs1799971;Variant;PA446970;Disease
MAJOR DEPRESSIVE DISORDER;rs1799971;Variant;PA447321;Disease
ACETAMINOPHEN;rs1799971;Variant;PA448015;Chemical
ETHANOL;rs1799971;Variant;PA448073;Chemical
ALFENTANIL;rs1799971;Variant;PA448084;Chemical
BUPRENORPHINE;rs1799971;Variant;PA448685;Chemical
COCAINE;rs1799971;Variant;PA449072;Chemical
CODEINE;rs1799971;Variant;PA449088;Chemical
FENTANYL;rs1799971;Variant;PA449599;Chemical
HYDROCODONE;rs1799971;Variant;PA449900;Chemical
METHADONE;rs1799971;Variant;PA450401;Chemical
MORPHINE;rs1799971;Variant;PA450550;Chemical
NALOXONE;rs1799971;Variant;PA450586;Chemical
NALTREXONE;rs1799971;Variant;PA450588;Chemical
NICOTINE;rs1799971;Variant;PA450626;Chemical
OXYCODONE;rs1799971;Variant;PA450741;Chemical
SUFENTANIL;rs1799971;Variant;PA451527;Chemical
SUMATRIPTAN;rs1799971;Variant;PA451566;Chemical
TRAMADOL;rs1799971;Variant;PA451735;Chemical
ANTIDEPRESSANTS;rs1799971;Variant;PA452229;Chemical
ANTIPSYCHOTICS;rs1799971;Variant;PA452233;Chemical
OPIOIDS;rs1799971;Variant;PA452618;Chemical
HEROIN;rs1799971;Variant;PA452619;Chemical
BISPHOSPHONATES;SFRP5;Gene;PA164712563;Chemical
OSTEONECROSIS;SFRP5;Gene;PA445187;Disease
ABCC2;Osteosarcoma;Disease;PA116;Gene
SLCO1B1;Osteosarcoma;Disease;PA134865839;Gene
TMEM43;Osteosarcoma;Disease;PA134871907;Gene
KLC3;Osteosarcoma;Disease;PA142671588;Gene
POLR1G;Osteosarcoma;Disease;PA142672156;Gene
DHFR;Osteosarcoma;Disease;PA143;Gene
ERCC1;Osteosarcoma;Disease;PA155;Gene
REV1;Osteosarcoma;Disease;PA162401120;Gene
GSTT1 NULL;Osteosarcoma;Disease;PA166048678;Haplotype
GSTT1 NON-NULL;Osteosarcoma;Disease;PA166048679;Haplotype
RS1801133;Osteosarcoma;Disease;PA166153644;Variant
RS1805087;Osteosarcoma;Disease;PA166153654;Variant
RS717620;Osteosarcoma;Disease;PA166153953;Variant
RS3740065;Osteosarcoma;Disease;PA166154027;Variant
RS17222723;Osteosarcoma;Disease;PA166154163;Variant
RS1695;Osteosarcoma;Disease;PA166154249;Variant
RS9344;Osteosarcoma;Disease;PA166154264;Variant
RS4149056;Osteosarcoma;Disease;PA166154579;Variant
RS4149081;Osteosarcoma;Disease;PA166154581;Variant
RS11045879;Osteosarcoma;Disease;PA166154633;Variant
RS2236225;Osteosarcoma;Disease;PA166154789;Variant
RS4673;Osteosarcoma;Disease;PA166154969;Variant
RS4148416;Osteosarcoma;Disease;PA166155219;Variant
RS11615;Osteosarcoma;Disease;PA166155342;Variant
RS13181;Osteosarcoma;Disease;PA166155343;Variant
RS3212986;Osteosarcoma;Disease;PA166155407;Variant
RS3087403;Osteosarcoma;Disease;PA166155696;Variant
RS1051266;Osteosarcoma;Disease;PA166155986;Variant
RS2228001;Osteosarcoma;Disease;PA166156345;Variant
RS2231135;Osteosarcoma;Disease;PA166156542;Variant
RS2231142;Osteosarcoma;Disease;PA166156544;Variant
RS12505410;Osteosarcoma;Disease;PA166156659;Variant
RS13120400;Osteosarcoma;Disease;PA166156664;Variant
RS1053129;Osteosarcoma;Disease;PA166156751;Variant
RS1650723;Osteosarcoma;Disease;PA166156771;Variant
RS1801394;Osteosarcoma;Disease;PA166156776;Variant
RS462779;Osteosarcoma;Disease;PA166156920;Variant
RS1128503;Osteosarcoma;Disease;PA166157288;Variant
RS4148737;Osteosarcoma;Disease;PA166157385;Variant
RS13137622;Osteosarcoma;Disease;PA166181277;Variant
RS4148324;Osteosarcoma;Disease;PA166181287;Variant
RS36120609;Osteosarcoma;Disease;PA166211543;Variant
GSTT1;Osteosarcoma;Disease;PA183;Gene
MTHFR;Osteosarcoma;Disease;PA245;Gene
CLCN6;Osteosarcoma;Disease;PA26551;Gene
ABCB1;Osteosarcoma;Disease;PA267;Gene
CYBA;Osteosarcoma;Disease;PA27075;Gene
ERCC2;Osteosarcoma;Disease;PA27848;Gene
GSTM3;Osteosarcoma;Disease;PA29024;Gene
GSTP1;Osteosarcoma;Disease;PA29028;Gene
MTHFD1;Osteosarcoma;Disease;PA31236;Gene
MTR;Osteosarcoma;Disease;PA31272;Gene
MTRR;Osteosarcoma;Disease;PA31277;Gene
SLC19A1;Osteosarcoma;Disease;PA327;Gene
PPP1R13L;Osteosarcoma;Disease;PA34195;Gene
REV3L;Osteosarcoma;Disease;PA34337;Gene
UGT1A10;Osteosarcoma;Disease;PA37174;Gene
UGT1A3;Osteosarcoma;Disease;PA37178;Gene
UGT1A4;Osteosarcoma;Disease;PA37179;Gene
UGT1A5;Osteosarcoma;Disease;PA37180;Gene
UGT1A6;Osteosarcoma;Disease;PA37181;Gene
UGT1A7;Osteosarcoma;Disease;PA37182;Gene
UGT1A8;Osteosarcoma;Disease;PA37183;Gene
XPC;Osteosarcoma;Disease;PA37413;Gene
ABCC3;Osteosarcoma;Disease;PA376;Gene
NR1I2;Osteosarcoma;Disease;PA378;Gene
ABCG2;Osteosarcoma;Disease;PA390;Gene
UGT1A9;Osteosarcoma;Disease;PA419;Gene
UGT1A1;Osteosarcoma;Disease;PA420;Gene
CCND1;Osteosarcoma;Disease;PA75;Gene
NF2;Neurofibromatosis 2;Disease;PA31580;Gene
CYP2B6;Central Nervous System Diseases;Disease;PA123;Gene
CYP2B6*1;Central Nervous System Diseases;Disease;PA165818750;Haplotype
CYP2B6*2;Central Nervous System Diseases;Disease;PA165818753;Haplotype
CYP2C19;Hyperprolactinemia;Disease;PA124;Gene
ANKK1;Hyperprolactinemia;Disease;PA134872551;Gene
CYP2C19*1;Hyperprolactinemia;Disease;PA165980634;Haplotype
CYP2C19*2;Hyperprolactinemia;Disease;PA165980635;Haplotype
CYP2C19*4;Hyperprolactinemia;Disease;PA165980637;Haplotype
RS1799978;Hyperprolactinemia;Disease;PA166154337;Variant
RS1800497;Hyperprolactinemia;Disease;PA166154339;Variant
RS887829;Hyperprolactinemia;Disease;PA166155607;Variant
RS10929302;Hyperprolactinemia;Disease;PA166155794;Variant
RS1976391;Hyperprolactinemia;Disease;PA166179207;Variant
DRD2;Hyperprolactinemia;Disease;PA27478;Gene
UGT1A1;Hyperprolactinemia;Disease;PA420;Gene
ACUTE LYMPHOBLASTIC LEUKEMIA;rs4149009;Variant;PA446155;Disease
METHOTREXATE;rs4149009;Variant;PA450428;Chemical
TRANSPLANTATION;CRTC2;Gene;PA134850491;Disease
PRKAA1;CRTC2;Gene;PA33744;Gene
PRKAA2;CRTC2;Gene;PA33745;Gene
PRKAB1;CRTC2;Gene;PA33746;Gene
PRKAB2;CRTC2;Gene;PA33747;Gene
PRKAG1;CRTC2;Gene;PA33751;Gene
PRKAG2;CRTC2;Gene;PA33752;Gene
PRKAG3;CRTC2;Gene;PA33753;Gene
SIRT1;CRTC2;Gene;PA37935;Gene
CYCLOSPORINE;CRTC2;Gene;PA449167;Chemical
TACROLIMUS;CRTC2;Gene;PA451578;Chemical
LIRAGLUTIDE;rs10305420;Variant;PA165958364;Chemical
OBESITY;rs10305420;Variant;PA445131;Disease
POLYCYSTIC OVARY SYNDROME;rs10305420;Variant;PA445376;Disease
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs11126740;Variant;PA164713366;Chemical
PSORIASIS;rs11126740;Variant;PA445451;Disease
ABCC2;calcein;Chemical;PA116;Gene
RS8187710;calcein;Chemical;PA166154094;Variant
ABCB1;calcein;Chemical;PA267;Gene
BOTULINUM TOXIN TYPE A;rs3781719;Variant;PA164754825;Chemical
MIGRAINE DISORDER;rs3781719;Variant;PA165108779;Disease
PLATINUM COMPOUNDS;HSPA5;Gene;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;HSPA5;Gene;PA443622;Disease
CYP2C19;voriconazole;Chemical;PA124;Gene
CYP2C9;voriconazole;Chemical;PA126;Gene
CYP3A4;voriconazole;Chemical;PA130;Gene
CYP2C19*6;voriconazole;Chemical;PA165816522;Haplotype
CYP2C19*17;voriconazole;Chemical;PA165816533;Haplotype
CYP2C19*18;voriconazole;Chemical;PA165816534;Haplotype
CYP2C19*23;voriconazole;Chemical;PA165816537;Haplotype
CYP2C9*1;voriconazole;Chemical;PA165816542;Haplotype
CYP2C9*2;voriconazole;Chemical;PA165816543;Haplotype
CYP2C9*3;voriconazole;Chemical;PA165816544;Haplotype
CYP3A4*1;voriconazole;Chemical;PA165819201;Haplotype
CYP2C19*1;voriconazole;Chemical;PA165980634;Haplotype
CYP2C19*2;voriconazole;Chemical;PA165980635;Haplotype
CYP2C19*3;voriconazole;Chemical;PA165980636;Haplotype
CYP3A4*22;voriconazole;Chemical;PA166048680;Haplotype
CYP2C19*29;voriconazole;Chemical;PA166123292;Haplotype
CYP2C19*30;voriconazole;Chemical;PA166123293;Haplotype
CYP2C19*31;voriconazole;Chemical;PA166123294;Haplotype
CYP2C19*32;voriconazole;Chemical;PA166123295;Haplotype
CYP2C19*33;voriconazole;Chemical;PA166123296;Haplotype
RS1045642;voriconazole;Chemical;PA166157284;Variant
RS4646437;voriconazole;Chemical;PA166157391;Variant
CYP2C19 POOR METABOLIZERS AND INTERMEDIATE METABOLIZERS;voriconazole;Chemical;PA166157901;Variant
CYP2C19 INTERMEDIATE METABOLIZER;voriconazole;Chemical;PA166157913;Variant
CYP2C19 POOR METABOLIZER;voriconazole;Chemical;PA166157938;Variant
CYP2C19 ULTRARAPID METABOLIZER;voriconazole;Chemical;PA166157942;Variant
RS3781727;voriconazole;Chemical;PA166238581;Variant
ABCB1;voriconazole;Chemical;PA267;Gene
SLCO2B1;voriconazole;Chemical;PA35845;Gene
TOLLIP;acetylcysteine;Chemical;PA134876213;Gene
RS3750920;acetylcysteine;Chemical;PA166154399;Variant
EPHX1 POOR METABOLIZER;acetylcysteine;Chemical;PA166157923;Variant
EPHX1;acetylcysteine;Chemical;PA27829;Gene
ACETAMINOPHEN;acetylcysteine;Chemical;PA448015;Chemical
DEFERASIROX;rs7041;Variant;PA164760843;Chemical
BETA-THALASSEMIA AND RELATED DISEASES;rs7041;Variant;PA446432;Disease
MIDAZOLAM;rs4516035;Variant;PA450496;Chemical
TOBACCO USE DISORDER;rs686;Variant;PA445876;Disease
NICOTINE;rs686;Variant;PA450626;Chemical
FLUOROURACIL;CYP1B1;Gene;PA128406956;Chemical
4-HYDROXYESTRADIOL;CYP1B1;Gene;PA166178986;Chemical
BREAST NEOPLASMS;CYP1B1;Gene;PA443560;Disease
SCHIZOPHRENIA;CYP1B1;Gene;PA447216;Disease
AMODIAQUINE;CYP1B1;Gene;PA448404;Chemical
CYCLOPHOSPHAMIDE;CYP1B1;Gene;PA449165;Chemical
DOCETAXEL;CYP1B1;Gene;PA449383;Chemical
DOXORUBICIN;CYP1B1;Gene;PA449412;Chemical
EPIRUBICIN;CYP1B1;Gene;PA449476;Chemical
PACLITAXEL;CYP1B1;Gene;PA450761;Chemical
RISPERIDONE;CYP1B1;Gene;PA451257;Chemical
RS6923761;sitagliptin;Chemical;PA166157117;Variant
GLP1R;sitagliptin;Chemical;PA28725;Gene
CYP2D6;anthracyclines and related substances;Chemical;PA128;Gene
ECT2L;anthracyclines and related substances;Chemical;PA134893289;Gene
CYP2D6*1;anthracyclines and related substances;Chemical;PA165816576;Haplotype
CYP2D6*4;anthracyclines and related substances;Chemical;PA165816579;Haplotype
FMO3;anthracyclines and related substances;Chemical;PA166;Gene
GSTM1 NULL;anthracyclines and related substances;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;anthracyclines and related substances;Chemical;PA166048676;Haplotype
RS1736557;anthracyclines and related substances;Chemical;PA166153634;Variant
RS10836235;anthracyclines and related substances;Chemical;PA166154438;Variant
RS2229774;anthracyclines and related substances;Chemical;PA166154532;Variant
RS7319981;anthracyclines and related substances;Chemical;PA166154719;Variant
RS9514091;anthracyclines and related substances;Chemical;PA166154733;Variant
RS2290271;anthracyclines and related substances;Chemical;PA166154885;Variant
RS2305364;anthracyclines and related substances;Chemical;PA166154888;Variant
RS2019604;anthracyclines and related substances;Chemical;PA166155026;Variant
RS2232228;anthracyclines and related substances;Chemical;PA166155032;Variant
RS4148350;anthracyclines and related substances;Chemical;PA166155060;Variant
RS2108623;anthracyclines and related substances;Chemical;PA166155382;Variant
RS10426377;anthracyclines and related substances;Chemical;PA166155454;Variant
RS4261716;anthracyclines and related substances;Chemical;PA166155725;Variant
RS6759892;anthracyclines and related substances;Chemical;PA166155760;Variant
RS17583889;anthracyclines and related substances;Chemical;PA166155844;Variant
RS17645700;anthracyclines and related substances;Chemical;PA166155847;Variant
RS17863783;anthracyclines and related substances;Chemical;PA166155854;Variant
RS9024;anthracyclines and related substances;Chemical;PA166155972;Variant
RS1056892;anthracyclines and related substances;Chemical;PA166155989;Variant
RS729147;anthracyclines and related substances;Chemical;PA166156490;Variant
RS316019;anthracyclines and related substances;Chemical;PA166156913;Variant
RS11155012;anthracyclines and related substances;Chemical;PA166157173;Variant
RS1045642;anthracyclines and related substances;Chemical;PA166157284;Variant
RS1149222;anthracyclines and related substances;Chemical;PA166157290;Variant
RS1799983;anthracyclines and related substances;Chemical;PA166157303;Variant
RS2235047;anthracyclines and related substances;Chemical;PA166157339;Variant
RS4148808;anthracyclines and related substances;Chemical;PA166157388;Variant
RS885004;anthracyclines and related substances;Chemical;PA166157716;Variant
RS4877847;anthracyclines and related substances;Chemical;PA166157778;Variant
RS7853758;anthracyclines and related substances;Chemical;PA166157790;Variant
GSTM1;anthracyclines and related substances;Chemical;PA182;Gene
HNMT;anthracyclines and related substances;Chemical;PA190;Gene
ABCC1;anthracyclines and related substances;Chemical;PA244;Gene
ADH7;anthracyclines and related substances;Chemical;PA24577;Gene
NOS3;anthracyclines and related substances;Chemical;PA254;Gene
CAT;anthracyclines and related substances;Chemical;PA26099;Gene
CBR1;anthracyclines and related substances;Chemical;PA26121;Gene
CBR3;anthracyclines and related substances;Chemical;PA26122;Gene
ABCB1;anthracyclines and related substances;Chemical;PA267;Gene
ABCB4;anthracyclines and related substances;Chemical;PA268;Gene
CYP4F2;anthracyclines and related substances;Chemical;PA27121;Gene
HAS3;anthracyclines and related substances;Chemical;PA29196;Gene
SLC10A2;anthracyclines and related substances;Chemical;PA318;Gene
SLC22A2;anthracyclines and related substances;Chemical;PA331;Gene
RARG;anthracyclines and related substances;Chemical;PA34227;Gene
SPG7;anthracyclines and related substances;Chemical;PA36067;Gene
SULT2B1;anthracyclines and related substances;Chemical;PA36249;Gene
UGT1A6;anthracyclines and related substances;Chemical;PA37181;Gene
SLC28A1;anthracyclines and related substances;Chemical;PA387;Gene
ABCG2;anthracyclines and related substances;Chemical;PA390;Gene
SLC28A3;anthracyclines and related substances;Chemical;PA426;Gene
CYP3A5;tadalafil;Chemical;PA131;Gene
HEMORRHAGE;rs78132896;Variant;PA444417;Disease
WARFARIN;rs78132896;Variant;PA451906;Chemical
PEGINTERFERON ALFA-2B;HLA-C*05:01;Haplotype;PA164784024;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-C*05:01;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-C*05:01;Haplotype;PA444059;Disease
HEPATITIS C;HLA-C*05:01;Haplotype;PA444445;Disease
STEVENS-JOHNSON SYNDROME;HLA-C*05:01;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-C*05:01;Haplotype;PA450616;Chemical
RIBAVIRIN;HLA-C*05:01;Haplotype;PA451241;Chemical
CYP2C19;16alpha-hydroxytestosterone;Chemical;PA124;Gene
CYP2C19*11;16alpha-hydroxytestosterone;Chemical;PA165816527;Haplotype
CYP2C19*23;16alpha-hydroxytestosterone;Chemical;PA165816537;Haplotype
CYP2C19*1;16alpha-hydroxytestosterone;Chemical;PA165980634;Haplotype
ALCOHOL ABUSE;rs62250713;Variant;PA443309;Disease
ETHANOL;rs62250713;Variant;PA448073;Chemical
KIT;HOXB4;Gene;PA30128;Gene
SLCO1B1;lorazepam;Chemical;PA134865839;Gene
RS4149056;lorazepam;Chemical;PA166154579;Variant
RS1902023;lorazepam;Chemical;PA166156530;Variant
UGT2B15;lorazepam;Chemical;PA37188;Gene
CYP2C9;glipizide;Chemical;PA126;Gene
NOS1AP;glipizide;Chemical;PA142671259;Gene
CYP2C9*1;glipizide;Chemical;PA165816542;Haplotype
CYP2C9*2;glipizide;Chemical;PA165816543;Haplotype
CYP2C9*3;glipizide;Chemical;PA165816544;Haplotype
RS10494366;glipizide;Chemical;PA166153802;Variant
G6PD;glipizide;Chemical;PA28469;Gene
RS3788853;Angioedema;Disease;PA166220461;Variant
RS71103505;Angioedema;Disease;PA166223161;Variant
RS2253201;Angioedema;Disease;PA166238521;Variant
KCNMA1;Angioedema;Disease;PA220;Gene
XPNPEP2;Angioedema;Disease;PA37416;Gene
BDKRB2;Angioedema;Disease;PA80;Gene
MAJOR DEPRESSIVE DISORDER;rs9315310;Variant;PA447321;Disease
ANTIDEPRESSANTS;rs9315310;Variant;PA452229;Chemical
BUPRENORPHINE / NALOXONE;rs7662029;Variant;PA166182641;Chemical
OPIOID-RELATED DISORDERS;rs7662029;Variant;PA445043;Disease
METHADONE;rs7662029;Variant;PA450401;Chemical
COTININE;rs57064725;Variant;PA166114414;Chemical
TOBACCO USE DISORDER;rs57064725;Variant;PA445876;Disease
OPIOID-RELATED DISORDERS;rs648893;Variant;PA445043;Disease
OPIOIDS;rs648893;Variant;PA452618;Chemical
CFTR;rs75763344;Variant;PA109;Gene
IVACAFTOR;rs75763344;Variant;PA165950341;Chemical
HEROIN DEPENDENCE;rs963549;Variant;PA444460;Disease
METHADONE;rs963549;Variant;PA450401;Chemical
GEMTUZUMAB OZOGAMICIN;rs2302948;Variant;PA164749431;Chemical
LEUKEMIA, MYELOID, ACUTE;rs2302948;Variant;PA444760;Disease
CYTARABINE;rs2302948;Variant;PA449177;Chemical
FLUDARABINE;rs2302948;Variant;PA449655;Chemical
IDARUBICIN;rs2302948;Variant;PA449961;Chemical
MAJOR DEPRESSIVE DISORDER;rs16965962;Variant;PA447321;Disease
CITALOPRAM;rs16965962;Variant;PA449015;Chemical
WARFARIN;ASPH;Gene;PA451906;Chemical
TOBACCO USE DISORDER;rs12461964;Variant;PA445876;Disease
NICOTINE;rs12461964;Variant;PA450626;Chemical
APNEA;rs745364489;Variant;PA443407;Disease
SUCCINYLCHOLINE;rs745364489;Variant;PA451522;Chemical
NEONATAL ABSTINENCE SYNDROME;rs740603;Variant;PA165108809;Disease
BUPRENORPHINE;rs740603;Variant;PA448685;Chemical
METHADONE;rs740603;Variant;PA450401;Chemical
CFTR;rs77932196;Variant;PA109;Gene
IVACAFTOR;rs77932196;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs77932196;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs77932196;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs77932196;Variant;PA443829;Disease
FLUOROURACIL;rs2960436;Variant;PA128406956;Chemical
STOMACH NEOPLASMS;rs2960436;Variant;PA445742;Disease
DEPRESSION;rs3800373;Variant;PA447278;Disease
ANTIDEPRESSANTS;rs3800373;Variant;PA452229;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs1800629;Variant;PA164713366;Chemical
ETHAMBUTOL;rs1800629;Variant;PA164784021;Chemical
TOXIC LIVER DISEASE;rs1800629;Variant;PA164925725;Disease
ACUTE CORONARY SYNDROME;rs1800629;Variant;PA165108401;Disease
KIDNEY TRANSPLANTATION;rs1800629;Variant;PA165817016;Disease
HAND-FOOT SYNDROME;rs1800629;Variant;PA166114377;Disease
RHEUMATOID ARTHRITIS;rs1800629;Variant;PA443434;Disease
NON-SMALL CELL LUNG CARCINOMA;rs1800629;Variant;PA443622;Disease
CROHN DISEASE;rs1800629;Variant;PA443815;Disease
HEPATOCELLULAR CARCINOMA;rs1800629;Variant;PA444447;Disease
HYPERSENSITIVITY;rs1800629;Variant;PA444546;Disease
INFLAMMATION;rs1800629;Variant;PA444620;Disease
MIGRAINE WITHOUT AURA;rs1800629;Variant;PA444949;Disease
PSORIASIS;rs1800629;Variant;PA445451;Disease
SPONDYLITIS, ANKYLOSING;rs1800629;Variant;PA445724;Disease
THROMBOCYTOPENIA;rs1800629;Variant;PA445846;Disease
TUBERCULOSIS;rs1800629;Variant;PA445941;Disease
ARTHRITIS, PSORIATIC;rs1800629;Variant;PA446198;Disease
ASPIRIN;rs1800629;Variant;PA448497;Chemical
ATORVASTATIN;rs1800629;Variant;PA448500;Chemical
CARBAMAZEPINE;rs1800629;Variant;PA448785;Chemical
CARBOPLATIN;rs1800629;Variant;PA448803;Chemical
CYCLOSPORINE;rs1800629;Variant;PA449167;Chemical
DICLOFENAC;rs1800629;Variant;PA449293;Chemical
ETANERCEPT;rs1800629;Variant;PA449515;Chemical
GEMCITABINE;rs1800629;Variant;PA449748;Chemical
IBUPROFEN;rs1800629;Variant;PA449957;Chemical
INDOMETHACIN;rs1800629;Variant;PA449982;Chemical
ISONIAZID;rs1800629;Variant;PA450112;Chemical
KETOROLAC;rs1800629;Variant;PA450150;Chemical
MYCOPHENOLATE MOFETIL;rs1800629;Variant;PA450566;Chemical
NAPROXEN;rs1800629;Variant;PA450595;Chemical
PYRAZINAMIDE;rs1800629;Variant;PA451182;Chemical
RIFAMPIN;rs1800629;Variant;PA451250;Chemical
SORAFENIB;rs1800629;Variant;PA7000;Chemical
FLUOROURACIL;rs3219489;Variant;PA128406956;Chemical
RADIOTHERAPY;rs3219489;Variant;PA166122986;Chemical
PROGRESSION-FREE SURVIVAL;rs3219489;Variant;PA166123026;Disease
CARCINOMA, SQUAMOUS CELL;rs3219489;Variant;PA443626;Disease
CISPLATIN;rs3219489;Variant;PA449014;Chemical
CETP;rosuvastatin;Chemical;PA108;Gene
CRP;rosuvastatin;Chemical;PA120;Gene
CYP2C19;rosuvastatin;Chemical;PA124;Gene
CYP2D6;rosuvastatin;Chemical;PA128;Gene
CYP3A4;rosuvastatin;Chemical;PA130;Gene
CYP3A5;rosuvastatin;Chemical;PA131;Gene
SLCO1B1;rosuvastatin;Chemical;PA134865839;Gene
KIF6;rosuvastatin;Chemical;PA134920075;Gene
COQ2;rosuvastatin;Chemical;PA142672084;Gene
CYP2D6*1;rosuvastatin;Chemical;PA165816576;Haplotype
CYP2D6*3;rosuvastatin;Chemical;PA165816578;Haplotype
CYP2D6*4;rosuvastatin;Chemical;PA165816579;Haplotype
SLCO1B1*37;rosuvastatin;Chemical;PA165819251;Haplotype
SLCO1B1*5;rosuvastatin;Chemical;PA165819255;Haplotype
SLCO1B1*9;rosuvastatin;Chemical;PA165819259;Haplotype
SLCO1B1*14;rosuvastatin;Chemical;PA165819264;Haplotype
SLCO1B1*15;rosuvastatin;Chemical;PA165819265;Haplotype
HLA-DRB1*01:01;rosuvastatin;Chemical;PA165951320;Haplotype
HLA-DRB1*04:06;rosuvastatin;Chemical;PA165951530;Haplotype
CYP2C19*1;rosuvastatin;Chemical;PA165980634;Haplotype
CYP2C19*2;rosuvastatin;Chemical;PA165980635;Haplotype
CYP2C19*3;rosuvastatin;Chemical;PA165980636;Haplotype
SLCO1B1*1;rosuvastatin;Chemical;PA165981641;Haplotype
FMO3;rosuvastatin;Chemical;PA166;Gene
RS1205;rosuvastatin;Chemical;PA166153541;Variant
RS1736557;rosuvastatin;Chemical;PA166153634;Variant
RS2808630;rosuvastatin;Chemical;PA166153717;Variant
RS12422149;rosuvastatin;Chemical;PA166154465;Variant
RS4149056;rosuvastatin;Chemical;PA166154579;Variant
RS4149081;rosuvastatin;Chemical;PA166154581;Variant
RS5882;rosuvastatin;Chemical;PA166154975;Variant
RS708272;rosuvastatin;Chemical;PA166154993;Variant
RS2231142;rosuvastatin;Chemical;PA166156544;Variant
RS4693075;rosuvastatin;Chemical;PA166156593;Variant
RS6535454;rosuvastatin;Chemical;PA166156601;Variant
RS20455;rosuvastatin;Chemical;PA166156905;Variant
RS10455872;rosuvastatin;Chemical;PA166157168;Variant
RS776746;rosuvastatin;Chemical;PA166157267;Variant
RS2230806;rosuvastatin;Chemical;PA166157744;Variant
RS2199936;rosuvastatin;Chemical;PA166343601;Variant
RS1009122956;rosuvastatin;Chemical;PA166396181;Variant
RS1621378;rosuvastatin;Chemical;PA166396182;Variant
RS199654337;rosuvastatin;Chemical;PA166396241;Variant
HMGCR;rosuvastatin;Chemical;PA189;Gene
LDLR;rosuvastatin;Chemical;PA227;Gene
ABCA1;rosuvastatin;Chemical;PA24373;Gene
LPA;rosuvastatin;Chemical;PA30432;Gene
HLA-DRB1;rosuvastatin;Chemical;PA35072;Gene
SLCO2B1;rosuvastatin;Chemical;PA35845;Gene
ABCG2;rosuvastatin;Chemical;PA390;Gene
ABCC2;Gastrointestinal Stromal Tumors;Disease;PA116;Gene
RUNDC3B;Gastrointestinal Stromal Tumors;Disease;PA162402278;Gene
RS2273697;Gastrointestinal Stromal Tumors;Disease;PA166154007;Variant
RS4149117;Gastrointestinal Stromal Tumors;Disease;PA166154583;Variant
RS9561765;Gastrointestinal Stromal Tumors;Disease;PA166154740;Variant
RS762551;Gastrointestinal Stromal Tumors;Disease;PA166154850;Variant
RS10517;Gastrointestinal Stromal Tumors;Disease;PA166154980;Variant
RS12659;Gastrointestinal Stromal Tumors;Disease;PA166155973;Variant
RS1051266;Gastrointestinal Stromal Tumors;Disease;PA166155986;Variant
RS2231137;Gastrointestinal Stromal Tumors;Disease;PA166156543;Variant
RS1050152;Gastrointestinal Stromal Tumors;Disease;PA166156750;Variant
RS2631367;Gastrointestinal Stromal Tumors;Disease;PA166156807;Variant
RS2631372;Gastrointestinal Stromal Tumors;Disease;PA166156808;Variant
RS683369;Gastrointestinal Stromal Tumors;Disease;PA166156936;Variant
RS1057868;Gastrointestinal Stromal Tumors;Disease;PA166157286;Variant
RS2235040;Gastrointestinal Stromal Tumors;Disease;PA166157338;Variant
RS10258429;Gastrointestinal Stromal Tumors;Disease;PA166176775;Variant
RS274558;Gastrointestinal Stromal Tumors;Disease;PA166176780;Variant
RS1202283;Gastrointestinal Stromal Tumors;Disease;PA166182161;Variant
RS9787901;Gastrointestinal Stromal Tumors;Disease;PA166182188;Variant
RS305968;Gastrointestinal Stromal Tumors;Disease;PA166182189;Variant
RS11249454;Gastrointestinal Stromal Tumors;Disease;PA166182190;Variant
RS28656907;Gastrointestinal Stromal Tumors;Disease;PA166185792;Variant
CHST1;Gastrointestinal Stromal Tumors;Disease;PA26501;Gene
ABCB1;Gastrointestinal Stromal Tumors;Disease;PA267;Gene
ABCB4;Gastrointestinal Stromal Tumors;Disease;PA268;Gene
CYP1A2;Gastrointestinal Stromal Tumors;Disease;PA27093;Gene
CYP2F1;Gastrointestinal Stromal Tumors;Disease;PA27109;Gene
KIT;Gastrointestinal Stromal Tumors;Disease;PA30128;Gene
NQO1;Gastrointestinal Stromal Tumors;Disease;PA31744;Gene
SLC19A1;Gastrointestinal Stromal Tumors;Disease;PA327;Gene
SLC22A1;Gastrointestinal Stromal Tumors;Disease;PA329;Gene
PDGFRA;Gastrointestinal Stromal Tumors;Disease;PA33147;Gene
SLC22A4;Gastrointestinal Stromal Tumors;Disease;PA332;Gene
SLC22A5;Gastrointestinal Stromal Tumors;Disease;PA333;Gene
POR;Gastrointestinal Stromal Tumors;Disease;PA33532;Gene
SLCO1B3;Gastrointestinal Stromal Tumors;Disease;PA35844;Gene
UGT2A1;Gastrointestinal Stromal Tumors;Disease;PA37184;Gene
ABCG2;Gastrointestinal Stromal Tumors;Disease;PA390;Gene
ABCC4;Gastrointestinal Stromal Tumors;Disease;PA397;Gene
EGFR;Gastrointestinal Stromal Tumors;Disease;PA7360;Gene
NAT2*4;Hypersensitivity;Disease;PA165949098;Haplotype
NAT2*5A;Hypersensitivity;Disease;PA165949099;Haplotype
HLA-DQA1*02:01;Hypersensitivity;Disease;PA165951292;Haplotype
HLA-DRB1*01:01;Hypersensitivity;Disease;PA165951320;Haplotype
HLA-DRB1*07:01;Hypersensitivity;Disease;PA165951644;Haplotype
HLA-A*31:01;Hypersensitivity;Disease;PA165954030;Haplotype
HLA-C*04:01;Hypersensitivity;Disease;PA165957046;Haplotype
HLA-DQB1*02:02;Hypersensitivity;Disease;PA165958162;Haplotype
NAT2*5;Hypersensitivity;Disease;PA165981634;Haplotype
NAT2*6;Hypersensitivity;Disease;PA165981635;Haplotype
NAT2*7;Hypersensitivity;Disease;PA165981636;Haplotype
NAT2*14;Hypersensitivity;Disease;PA165981640;Haplotype
HLA-C*08:01;Hypersensitivity;Disease;PA166123426;Haplotype
RS1800629;Hypersensitivity;Disease;PA166156997;Variant
RS1799930;Hypersensitivity;Disease;PA166157564;Variant
RS1799931;Hypersensitivity;Disease;PA166157565;Variant
RS11125;Hypersensitivity;Disease;PA166160641;Variant
NAT2;Hypersensitivity;Disease;PA18;Gene
LGALS3;Hypersensitivity;Disease;PA30340;Gene
LTA;Hypersensitivity;Disease;PA30474;Gene
HLA-A;Hypersensitivity;Disease;PA35055;Gene
HLA-B;Hypersensitivity;Disease;PA35056;Gene
HLA-C;Hypersensitivity;Disease;PA35057;Gene
HLA-DQA1;Hypersensitivity;Disease;PA35066;Gene
HLA-DQB1;Hypersensitivity;Disease;PA35068;Gene
HLA-DRB1;Hypersensitivity;Disease;PA35072;Gene
TNF;Hypersensitivity;Disease;PA435;Gene
COTININE;rs3778152;Variant;PA166114414;Chemical
NICOTINE;rs3778152;Variant;PA450626;Chemical
CLOPIDOGREL;rs6785930;Variant;PA449053;Chemical
NUSINERSEN;SMN2;Gene;PA166182882;Chemical
RISDIPLAM;SMN2;Gene;PA166235322;Chemical
NPY;NPY1R;Gene;PA255;Gene
PYY;NPY1R;Gene;PA34090;Gene
ALCOHOL ABUSE;rs8008020;Variant;PA443309;Disease
ETHANOL;rs8008020;Variant;PA448073;Chemical
CYP3A4;Alopecia;Disease;PA130;Gene
RS1050565;Alopecia;Disease;PA166155175;Variant
RS13181;Alopecia;Disease;PA166155343;Variant
RS3832043;Alopecia;Disease;PA166155718;Variant
RS2740574;Alopecia;Disease;PA166157367;Variant
RS1049305;Alopecia;Disease;PA166186213;Variant
AQP1;Alopecia;Disease;PA24918;Gene
BLMH;Alopecia;Disease;PA25370;Gene
ERCC2;Alopecia;Disease;PA27848;Gene
UGT1A9;Alopecia;Disease;PA419;Gene
CYP2B6;phenobarbital;Chemical;PA123;Gene
CYP2C19;phenobarbital;Chemical;PA124;Gene
HLA-B*13:01;phenobarbital;Chemical;PA165954643;Haplotype
HLA-B*15:02;phenobarbital;Chemical;PA165954769;Haplotype
HLA-B*51:01;phenobarbital;Chemical;PA165956201;Haplotype
CYP2C19*2;phenobarbital;Chemical;PA165980635;Haplotype
RS1801133;phenobarbital;Chemical;PA166153644;Variant
RS2606345;phenobarbital;Chemical;PA166154899;Variant
RS17183814;phenobarbital;Chemical;PA166155842;Variant
RS1045642;phenobarbital;Chemical;PA166157284;Variant
MTHFR;phenobarbital;Chemical;PA245;Gene
ABCB1;phenobarbital;Chemical;PA267;Gene
CYP1A1;phenobarbital;Chemical;PA27092;Gene
SCN2A;phenobarbital;Chemical;PA35004;Gene
HLA-B;phenobarbital;Chemical;PA35056;Gene
UGT1A6;phenobarbital;Chemical;PA37181;Gene
UGT2B15;phenobarbital;Chemical;PA37188;Gene
NR1I2;phenobarbital;Chemical;PA378;Gene
UGT1A9;phenobarbital;Chemical;PA419;Gene
ACETAMINOPHEN;phenobarbital;Chemical;PA448015;Chemical
MAPK8;MAP2K5;Gene;PA283;Gene
MAPK1;MAP2K5;Gene;PA30616;Gene
MAPK10;MAP2K5;Gene;PA30617;Gene
MAPK11;MAP2K5;Gene;PA30618;Gene
MAPK12;MAP2K5;Gene;PA30619;Gene
MAPK13;MAP2K5;Gene;PA30620;Gene
MAPK14;MAP2K5;Gene;PA30621;Gene
MAPK3;MAP2K5;Gene;PA30622;Gene
MAPK4;MAP2K5;Gene;PA30623;Gene
MAPK6;MAP2K5;Gene;PA30624;Gene
MAPK7;MAP2K5;Gene;PA30625;Gene
MAPK9;MAP2K5;Gene;PA30630;Gene
RAF1;MAP2K5;Gene;PA34183;Gene
OPIOID-RELATED DISORDERS;rs10485058;Variant;PA445043;Disease
METHADONE;rs10485058;Variant;PA450401;Chemical
DEPRESSION;rs12082710;Variant;PA447278;Disease
ANTIDEPRESSANTS;rs12082710;Variant;PA452229;Chemical
PREGNENOLONE;rs527454384;Variant;PA166334121;Chemical
PRKAA1;SLC2A4;Gene;PA33744;Gene
PRKAA2;SLC2A4;Gene;PA33745;Gene
PRKAB1;SLC2A4;Gene;PA33746;Gene
PRKAB2;SLC2A4;Gene;PA33747;Gene
PRKAG1;SLC2A4;Gene;PA33751;Gene
PRKAG2;SLC2A4;Gene;PA33752;Gene
PRKAG3;SLC2A4;Gene;PA33753;Gene
OPIOID-RELATED DISORDERS;rs609148;Variant;PA445043;Disease
OPIOIDS;rs609148;Variant;PA452618;Chemical
ANKK1;prochlorperazine;Chemical;PA134872551;Gene
RS1079597;prochlorperazine;Chemical;PA166154315;Variant
RS1800497;prochlorperazine;Chemical;PA166154339;Variant
DRD2;prochlorperazine;Chemical;PA27478;Gene
TAXANES;SCN10A;Gene;PA150481189;Chemical
OVARIAN NEOPLASMS;SCN10A;Gene;PA445204;Disease
CARBOPLATIN;SCN10A;Gene;PA448803;Chemical
TUBERCULOSIS;rs320003;Variant;PA445941;Disease
RIFAMPIN;rs320003;Variant;PA451250;Chemical
DESFLURANE;rs28933396;Variant;PA164749136;Chemical
RYR1;rs28933396;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs28933396;Variant;PA444863;Disease
ENFLURANE;rs28933396;Variant;PA449461;Chemical
HALOTHANE;rs28933396;Variant;PA449845;Chemical
ISOFLURANE;rs28933396;Variant;PA450106;Chemical
METHOXYFLURANE;rs28933396;Variant;PA450434;Chemical
SEVOFLURANE;rs28933396;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs28933396;Variant;PA451522;Chemical
CACNA1S;rs28933396;Variant;PA85;Gene
IFNL3;dasabuvir / ombitasvir / paritaprevir / ritonavir;Chemical;PA134952671;Gene
OSTEOSARCOMA;rs1053129;Variant;PA445601;Disease
METHOTREXATE;rs1053129;Variant;PA450428;Chemical
DESFLURANE;rs118192167;Variant;PA164749136;Chemical
RYR1;rs118192167;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs118192167;Variant;PA444863;Disease
ENFLURANE;rs118192167;Variant;PA449461;Chemical
HALOTHANE;rs118192167;Variant;PA449845;Chemical
ISOFLURANE;rs118192167;Variant;PA450106;Chemical
METHOXYFLURANE;rs118192167;Variant;PA450434;Chemical
SEVOFLURANE;rs118192167;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs118192167;Variant;PA451522;Chemical
CACNA1S;rs118192167;Variant;PA85;Gene
COLORECTAL NEOPLASMS;rs3087465;Variant;PA446108;Disease
IRINOTECAN;rs3087465;Variant;PA450085;Chemical
NPM1;ABCA5;Gene;PA31712;Gene
ASTHMA;rs7794356;Variant;PA443450;Disease
MONTELUKAST;rs7794356;Variant;PA450546;Chemical
N-DESMETHYLCLOZAPINE;CYP1A2*35;Haplotype;PA166163659;Chemical
SCHIZOPHRENIA;CYP1A2*35;Haplotype;PA447216;Disease
CLOZAPINE;CYP1A2*35;Haplotype;PA449061;Chemical
NPIPB8;desmethylnaproxen;Chemical;PA166123718;Gene
RS28374453;desmethylnaproxen;Chemical;PA166155127;Variant
RS544820732;desmethylnaproxen;Chemical;PA166186134;Variant
RS765399160;desmethylnaproxen;Chemical;PA166186135;Variant
RS1042008;desmethylnaproxen;Chemical;PA166186136;Variant
RS767487725;desmethylnaproxen;Chemical;PA166186137;Variant
RS552524124;desmethylnaproxen;Chemical;PA166186138;Variant
RS758145522;desmethylnaproxen;Chemical;PA166186139;Variant
RS72547527;desmethylnaproxen;Chemical;PA166186140;Variant
RS1042028;desmethylnaproxen;Chemical;PA166186146;Variant
SULT1A1;desmethylnaproxen;Chemical;PA343;Gene
CYP2B6;divalproex sodium;Chemical;PA123;Gene
CYP2C19;divalproex sodium;Chemical;PA124;Gene
CYP2C9;divalproex sodium;Chemical;PA126;Gene
CYP2D6;divalproex sodium;Chemical;PA128;Gene
CYP3A4;divalproex sodium;Chemical;PA130;Gene
CYP3A5;divalproex sodium;Chemical;PA131;Gene
HTR2A;divalproex sodium;Chemical;PA193;Gene
HTR2C;divalproex sodium;Chemical;PA194;Gene
CYP1A2;divalproex sodium;Chemical;PA27093;Gene
DRD2;divalproex sodium;Chemical;PA27478;Gene
SLC6A4;divalproex sodium;Chemical;PA312;Gene
POLG;divalproex sodium;Chemical;PA33500;Gene
HLA-A;divalproex sodium;Chemical;PA35055;Gene
HLA-B;divalproex sodium;Chemical;PA35056;Gene
UGT1A4;divalproex sodium;Chemical;PA37179;Gene
PITRAKINRA;rs8832;Variant;PA165983754;Chemical
ASTHMA;rs8832;Variant;PA443450;Disease
RS3753380;latanoprost;Chemical;PA166153748;Variant
RS3766355;latanoprost;Chemical;PA166153751;Variant
RS11568658;latanoprost;Chemical;PA166154747;Variant
RS10306114;latanoprost;Chemical;PA166157803;Variant
PTGS1;latanoprost;Chemical;PA24346;Gene
PTGFR;latanoprost;Chemical;PA290;Gene
ABCC4;latanoprost;Chemical;PA397;Gene
RS1051740;Congenital Abnormalities;Disease;PA166153612;Variant
RS2234922;Congenital Abnormalities;Disease;PA166153680;Variant
EPHX1;Congenital Abnormalities;Disease;PA27829;Gene
PANCREATIC NEOPLASMS;rs35687416;Variant;PA445218;Disease
GEMCITABINE;rs35687416;Variant;PA449748;Chemical
SCHIZOPHRENIA;rs2636719;Variant;PA447216;Disease
RISPERIDONE;rs2636719;Variant;PA451257;Chemical
ADM;GPR182;Gene;PA24580;Gene
OVARIAN NEOPLASMS;rs544093;Variant;PA445204;Disease
CARBOPLATIN;rs544093;Variant;PA448803;Chemical
DOCETAXEL;rs544093;Variant;PA449383;Chemical
PACLITAXEL;rs544093;Variant;PA450761;Chemical
CYP2C19;Hallucinations;Disease;PA124;Gene
CYP2C19*1;Hallucinations;Disease;PA165980634;Haplotype
CYP2C19*2;Hallucinations;Disease;PA165980635;Haplotype
RS6280;Hallucinations;Disease;PA166156277;Variant
DRD3;Hallucinations;Disease;PA27479;Gene
IMATINIB;CYP2F1;Gene;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;CYP2F1;Gene;PA151958383;Disease
CYP2D6;bufuralol;Chemical;PA128;Gene
CYP2D6*1;bufuralol;Chemical;PA165816576;Haplotype
CYP2D6*2;bufuralol;Chemical;PA165816577;Haplotype
CYP2D6*10;bufuralol;Chemical;PA165816582;Haplotype
CYP2D6*17;bufuralol;Chemical;PA165816583;Haplotype
CYP2D6*9;bufuralol;Chemical;PA165948317;Haplotype
CYP2D6*29;bufuralol;Chemical;PA165948318;Haplotype
CYP2D6*7;bufuralol;Chemical;PA165971559;Haplotype
CYP2D6*12;bufuralol;Chemical;PA165971565;Haplotype
CYP2D6*18;bufuralol;Chemical;PA165971569;Haplotype
CYP2D6*27;bufuralol;Chemical;PA165971579;Haplotype
CYP2D6*37;bufuralol;Chemical;PA165971591;Haplotype
CYP2D6*40;bufuralol;Chemical;PA165971594;Haplotype
CYP2D6*47;bufuralol;Chemical;PA165971601;Haplotype
CYP2D6*48;bufuralol;Chemical;PA165971602;Haplotype
CYP2D6*49;bufuralol;Chemical;PA165971603;Haplotype
CYP2D6*50;bufuralol;Chemical;PA165971604;Haplotype
CYP2D6*51;bufuralol;Chemical;PA165971605;Haplotype
CYP2D6*53;bufuralol;Chemical;PA165971607;Haplotype
CYP2D6*54;bufuralol;Chemical;PA165971608;Haplotype
CYP2D6*55;bufuralol;Chemical;PA165971609;Haplotype
CYP2D6*62;bufuralol;Chemical;PA165971617;Haplotype
CYP2D6*64;bufuralol;Chemical;PA165971619;Haplotype
CYP2D6*71;bufuralol;Chemical;PA165971623;Haplotype
CYP2D6*72;bufuralol;Chemical;PA165971624;Haplotype
CYP2D6*75;bufuralol;Chemical;PA165971627;Haplotype
CYP2D6*36;bufuralol;Chemical;PA165988488;Haplotype
CYP2D6*39;bufuralol;Chemical;PA166001447;Haplotype
CYP2D6*87;bufuralol;Chemical;PA166123327;Haplotype
CYP2D6*88;bufuralol;Chemical;PA166123328;Haplotype
CYP2D6*89;bufuralol;Chemical;PA166123329;Haplotype
CYP2D6*90;bufuralol;Chemical;PA166123330;Haplotype
CYP2D6*91;bufuralol;Chemical;PA166123331;Haplotype
CYP2D6*92;bufuralol;Chemical;PA166123332;Haplotype
CYP2D6*93;bufuralol;Chemical;PA166123333;Haplotype
CYP2D6*95;bufuralol;Chemical;PA166123336;Haplotype
CYP2D6*96;bufuralol;Chemical;PA166123337;Haplotype
CYP2D6*97;bufuralol;Chemical;PA166123338;Haplotype
CYP2D6*98;bufuralol;Chemical;PA166123339;Haplotype
CYP2D6*94;bufuralol;Chemical;PA166128737;Haplotype
RS1065852;bufuralol;Chemical;PA166156062;Variant
RS138417770;bufuralol;Chemical;PA166156205;Variant
RS371793722;bufuralol;Chemical;PA166156250;Variant
RS745746329;bufuralol;Chemical;PA166156263;Variant
RS750996195;bufuralol;Chemical;PA166156265;Variant
RS777560972;bufuralol;Chemical;PA166156272;Variant
CYP2D6*114;bufuralol;Chemical;PA166181184;Haplotype
CYP2D6*14;bufuralol;Chemical;PA166181185;Haplotype
RS1230912765;bufuralol;Chemical;PA166410361;Variant
RS1058171;bufuralol;Chemical;PA166410382;Variant
BCHE;chloroprocaine;Chemical;PA25294;Gene
CYB5R3;chloroprocaine;Chemical;PA27331;Gene
G6PD;chloroprocaine;Chemical;PA28469;Gene
GNAI1;HTR1D;Gene;PA172;Gene
GNAI3;HTR1D;Gene;PA173;Gene
GNAI2;HTR1D;Gene;PA24347;Gene
VORICONAZOLE;rs3781727;Variant;PA10233;Chemical
SN-38;rs3806598;Variant;PA165110775;Chemical
ESCITALOPRAM;RFK;Gene;PA10074;Chemical
DEPRESSIVE DISORDER;RFK;Gene;PA447207;Disease
CITALOPRAM;RFK;Gene;PA449015;Chemical
PTGDR;laropiprant;Chemical;PA285;Gene
CAMK1D;MYC;Gene;PA134992438;Gene
POLATUZUMAB VEDOTIN;MYC;Gene;PA166313341;Chemical
AKT1;MYC;Gene;PA24684;Gene
AKT2;MYC;Gene;PA24685;Gene
AKT3;MYC;Gene;PA24686;Gene
CAMK1;MYC;Gene;PA26048;Gene
CAMK1G;MYC;Gene;PA26049;Gene
MAPK8;MYC;Gene;PA283;Gene
MAPK1;MYC;Gene;PA30616;Gene
MAPK3;MYC;Gene;PA30622;Gene
STAT3;MYC;Gene;PA337;Gene
PRKCA;MYC;Gene;PA33759;Gene
PRKCB;MYC;Gene;PA33761;Gene
PRKCG;MYC;Gene;PA33766;Gene
STAT5A;MYC;Gene;PA338;Gene
STAT1;MYC;Gene;PA36183;Gene
STAT2;MYC;Gene;PA36184;Gene
STAT4;MYC;Gene;PA36185;Gene
STAT5B;MYC;Gene;PA36186;Gene
URINARY BLADDER NEOPLASMS;MYC;Gene;PA443512;Disease
CAMK2A;MYC;Gene;PA90;Gene
CAMK2B;MYC;Gene;PA91;Gene
CAMK2D;MYC;Gene;PA92;Gene
CAMK2G;MYC;Gene;PA93;Gene
G6PD A- 202A_376G;vitamin c;Chemical;PA165947827;Haplotype
G6PD DEFICIENCY;vitamin c;Chemical;PA166157959;Variant
G6PD;vitamin c;Chemical;PA28469;Gene
TXNRD1;vitamin c;Chemical;PA37093;Gene
CORONARY ARTERY DISEASE;rs1051375;Variant;PA443796;Disease
HYPERTENSION;rs1051375;Variant;PA444552;Disease
ATENOLOL;rs1051375;Variant;PA448499;Chemical
VERAPAMIL;rs1051375;Variant;PA451868;Chemical
PLATINUM COMPOUNDS;POLR1G;Gene;PA164713176;Chemical
INFECTIOUS DISEASE;POLR1G;Gene;PA444614;Disease
LEUKOPENIA;POLR1G;Gene;PA444773;Disease
MESOTHELIOMA;POLR1G;Gene;PA444937;Disease
OVARIAN NEOPLASMS;POLR1G;Gene;PA445204;Disease
OSTEOSARCOMA;POLR1G;Gene;PA445601;Disease
CISPLATIN;POLR1G;Gene;PA449014;Chemical
DOXORUBICIN;POLR1G;Gene;PA449412;Chemical
GEMCITABINE;POLR1G;Gene;PA449748;Chemical
DPYD;rs183385770;Variant;PA145;Gene
CAPECITABINE;rs183385770;Variant;PA448771;Chemical
CFTR;rs121909005;Variant;PA109;Gene
IVACAFTOR;rs121909005;Variant;PA165950341;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs121909005;Variant;PA166190041;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs121909005;Variant;PA166362502;Chemical
CYSTIC FIBROSIS;rs121909005;Variant;PA443829;Disease
TOLBUTAMIDE;rs771237265;Variant;PA451718;Chemical
SUNITINIB;rs833061;Variant;PA162372840;Chemical
ADVERSE EVENTS;rs2236624;Variant;PA166151827;Disease
RHEUMATOID ARTHRITIS;rs2236624;Variant;PA443434;Disease
METHOTREXATE;rs2236624;Variant;PA450428;Chemical
RHEUMATOID ARTHRITIS;rs7387;Variant;PA443434;Disease
METHOTREXATE;rs7387;Variant;PA450428;Chemical
HEROIN DEPENDENCE;rs2239622;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs2239622;Variant;PA445043;Disease
METHADONE;rs2239622;Variant;PA450401;Chemical
CLOPIDOGREL;rs1061781;Variant;PA449053;Chemical
CYP2D6;cns depression;Disease;PA128;Gene
CYP2D6*1;cns depression;Disease;PA165816576;Haplotype
CYP2D6*2;cns depression;Disease;PA165816577;Haplotype
CYP2D6*3;cns depression;Disease;PA165816578;Haplotype
CYP2D6*4;cns depression;Disease;PA165816579;Haplotype
CYP2D6*6;cns depression;Disease;PA165816581;Haplotype
CYP2D6*2XN;cns depression;Disease;PA165988480;Haplotype
COLONIC NEOPLASMS;rs2070959;Variant;PA443756;Disease
EPILEPSY;rs2070959;Variant;PA444065;Disease
COLORECTAL NEOPLASMS;rs2070959;Variant;PA446108;Disease
ASPIRIN;rs2070959;Variant;PA448497;Chemical
IRINOTECAN;rs2070959;Variant;PA450085;Chemical
VALPROIC ACID;rs2070959;Variant;PA451846;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;rs502434;Variant;PA164713257;Chemical
MAJOR DEPRESSIVE DISORDER;rs502434;Variant;PA447321;Disease
VENLAFAXINE;rs502434;Variant;PA451866;Chemical
ANTIDEPRESSANTS;rs502434;Variant;PA452229;Chemical
SCHIZOPHRENIA;rs3787429;Variant;PA447216;Disease
RISPERIDONE;rs3787429;Variant;PA451257;Chemical
DESFLURANE;rs193922802;Variant;PA164749136;Chemical
RYR1;rs193922802;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs193922802;Variant;PA444863;Disease
CAFFEINE;rs193922802;Variant;PA448710;Chemical
ENFLURANE;rs193922802;Variant;PA449461;Chemical
HALOTHANE;rs193922802;Variant;PA449845;Chemical
ISOFLURANE;rs193922802;Variant;PA450106;Chemical
METHOXYFLURANE;rs193922802;Variant;PA450434;Chemical
SEVOFLURANE;rs193922802;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs193922802;Variant;PA451522;Chemical
CACNA1S;rs193922802;Variant;PA85;Gene
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs17279558;Variant;PA447197;Disease
METHYLPHENIDATE;rs17279558;Variant;PA450464;Chemical
DULOXETINE;rs12603700;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs12603700;Variant;PA447321;Disease
BISPHOSPHONATES;KCNT2;Gene;PA164712563;Chemical
OSTEONECROSIS;KCNT2;Gene;PA445187;Disease
PPP3CA;NFATC4;Gene;PA33678;Gene
PPP3CB;NFATC4;Gene;PA33679;Gene
PPP3CC;NFATC4;Gene;PA33680;Gene
PPP3R1;NFATC4;Gene;PA33681;Gene
PPP3R2;NFATC4;Gene;PA33682;Gene
OPIOID-RELATED DISORDERS;rs1799972;Variant;PA445043;Disease
SUBSTANCE-RELATED DISORDERS;rs1799972;Variant;PA446876;Disease
ETHANOL;rs1799972;Variant;PA448073;Chemical
COCAINE;rs1799972;Variant;PA449072;Chemical
NICOTINE;rs1799972;Variant;PA450626;Chemical
OPIOIDS;rs1799972;Variant;PA452618;Chemical
ABCB1;Zosuquidar;Chemical;PA267;Gene
HMG COA REDUCTASE INHIBITORS;rs247616;Variant;PA133950441;Chemical
HLA-DRB1*07:01;dabrafenib;Chemical;PA165951644;Haplotype
RS113488022;dabrafenib;Chemical;PA166157522;Variant
BRAF;dabrafenib;Chemical;PA25408;Gene
G6PD;dabrafenib;Chemical;PA28469;Gene
HRAS;dabrafenib;Chemical;PA29444;Gene
KRAS;dabrafenib;Chemical;PA30196;Gene
NRAS;dabrafenib;Chemical;PA31768;Gene
HLA-DRB1;dabrafenib;Chemical;PA35072;Gene
WEIGHT GAIN;DGKB;Gene;PA128406954;Disease
ANTIPSYCHOTICS;DGKB;Gene;PA452233;Chemical
SCHIZOPHRENIA;SLC6A5;Gene;PA447216;Disease
HALOPERIDOL;SLC6A5;Gene;PA449841;Chemical
ACE INHIBITORS, PLAIN;rs3788853;Variant;PA164712308;Chemical
ANGIOEDEMA;rs3788853;Variant;PA443371;Disease
17BETA-ESTRADIOL GLUCURONIDE;rs200858900;Variant;PA166277182;Chemical
PREGNENOLONE;rs774212320;Variant;PA166334121;Chemical
HLA-DRB1*07:01;Melanoma;Disease;PA165951644;Haplotype
GNAQ;Melanoma;Disease;PA174;Gene
BAP1;Melanoma;Disease;PA25254;Gene
BRAF;Melanoma;Disease;PA25408;Gene
EIF1AX;Melanoma;Disease;PA27684;Gene
GNA11;Melanoma;Disease;PA28764;Gene
NRAS;Melanoma;Disease;PA31768;Gene
HLA-DRB1;Melanoma;Disease;PA35072;Gene
SF3B1;Melanoma;Disease;PA35686;Gene
IMATINIB;UGT2A1;Gene;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;UGT2A1;Gene;PA151958383;Disease
BRAIN NEOPLASMS;rs4148157;Variant;PA443557;Disease
ALLOPURINOL;rs4148157;Variant;PA448320;Chemical
TOPOTECAN;rs4148157;Variant;PA451729;Chemical
SUNITINIB;FLT1;Gene;PA162372840;Chemical
AXITINIB;FLT1;Gene;PA164924493;Chemical
MOTESANIB;FLT1;Gene;PA166118340;Chemical
HRAS;FLT1;Gene;PA29444;Gene
KRAS;FLT1;Gene;PA30196;Gene
NRAS;FLT1;Gene;PA31768;Gene
PIK3C2A;FLT1;Gene;PA33304;Gene
PIK3C2B;FLT1;Gene;PA33305;Gene
PIK3CA;FLT1;Gene;PA33308;Gene
PIK3CB;FLT1;Gene;PA33309;Gene
PIK3CD;FLT1;Gene;PA33310;Gene
PIK3CG;FLT1;Gene;PA33311;Gene
PIK3R1;FLT1;Gene;PA33312;Gene
PIK3R2;FLT1;Gene;PA33313;Gene
PIK3R3;FLT1;Gene;PA33314;Gene
VEGFA;FLT1;Gene;PA37302;Gene
VEGFB;FLT1;Gene;PA37303;Gene
VEGFC;FLT1;Gene;PA37304;Gene
SORAFENIB;FLT1;Gene;PA7000;Chemical
DUBIN-JOHNSON SYNDROME;rs533334893;Variant;PA166307601;Disease
DRUG TOXICITY;rs533334893;Variant;PA443937;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs533334893;Variant;PA446155;Disease
VINCRISTINE;rs533334893;Variant;PA451879;Chemical
DRUG TOXICITY;rs10509681;Variant;PA443937;Disease
AMODIAQUINE;rs10509681;Variant;PA448404;Chemical
PACLITAXEL;rs10509681;Variant;PA450761;Chemical
REPAGLINIDE;rs10509681;Variant;PA451234;Chemical
THIOGUANINE;TPMT*30;Haplotype;PA451663;Chemical
ALLOPURINOL;rs2725215;Variant;PA448320;Chemical
DULOXETINE;rs2303377;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs2303377;Variant;PA447321;Disease
O-DESMETHYLTRAMADOL;rs553050853;Variant;PA166131379;Chemical
TAPENTADOL;rs553050853;Variant;PA166179720;Chemical
ACETAMINOPHEN;rs553050853;Variant;PA448015;Chemical
MORPHINE;rs553050853;Variant;PA450550;Chemical
TRAMADOL;rs553050853;Variant;PA451735;Chemical
MACULOPAPULAR EXANTHEMA;HLA-A*31:01;Haplotype;PA162316739;Disease
ERYTHEMA MULTIFORME NOS;HLA-A*31:01;Haplotype;PA165108357;Disease
DRUG-INDUCED LIVER INJURY;HLA-A*31:01;Haplotype;PA166119041;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-A*31:01;Haplotype;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-A*31:01;Haplotype;PA166120929;Disease
HLA-A;HLA-A*31:01;Haplotype;PA35055;Gene
HLA-B;HLA-A*31:01;Haplotype;PA35056;Gene
DRUG HYPERSENSITIVITY;HLA-A*31:01;Haplotype;PA443936;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-A*31:01;Haplotype;PA444059;Disease
EPILEPSY;HLA-A*31:01;Haplotype;PA444065;Disease
EXANTHEMA;HLA-A*31:01;Haplotype;PA444109;Disease
HYPERSENSITIVITY;HLA-A*31:01;Haplotype;PA444546;Disease
NEURALGIA;HLA-A*31:01;Haplotype;PA445096;Disease
STEVENS-JOHNSON SYNDROME;HLA-A*31:01;Haplotype;PA445738;Disease
BIPOLAR DISORDER;HLA-A*31:01;Haplotype;PA447199;Disease
SCHIZOPHRENIA;HLA-A*31:01;Haplotype;PA447216;Disease
CARBAMAZEPINE;HLA-A*31:01;Haplotype;PA448785;Chemical
OXCARBAZEPINE;HLA-A*31:01;Haplotype;PA450732;Chemical
PYRAZOLONES;rs12746200;Variant;PA164713217;Chemical
ACETAMINOPHEN;rs12746200;Variant;PA448015;Chemical
ASPIRIN;rs12746200;Variant;PA448497;Chemical
DICLOFENAC;rs12746200;Variant;PA449293;Chemical
PROPIONIC ACID DERIVATIVES;rs12746200;Variant;PA451140;Chemical
ATAZANAVIR;rs17863778;Variant;PA10251;Chemical
HYPERBILIRUBINEMIA;rs17863778;Variant;PA444511;Disease
HIV INFECTIOUS DISEASE;rs17863778;Variant;PA447230;Disease
RITONAVIR;rs17863778;Variant;PA451260;Chemical
C18ORF56;platinum;Chemical;PA134956204;Gene
KLC3;platinum;Chemical;PA142671588;Gene
ERCC1;platinum;Chemical;PA155;Gene
HNF1B;platinum;Chemical;PA162391083;Gene
RS1695;platinum;Chemical;PA166154249;Variant
RS17655;platinum;Chemical;PA166154677;Variant
RS45445694;platinum;Chemical;PA166155331;Variant
RS11615;platinum;Chemical;PA166155342;Variant
RS13181;platinum;Chemical;PA166155343;Variant
RS836554;platinum;Chemical;PA166160419;Variant
ERCC2;platinum;Chemical;PA27848;Gene
ERCC5;platinum;Chemical;PA27851;Gene
GSTP1;platinum;Chemical;PA29028;Gene
TYMS;platinum;Chemical;PA359;Gene
MARALIXIBAT;TJP2;Gene;PA166268803;Chemical
ALK;tepotinib;Chemical;PA24719;Gene
MET;tepotinib;Chemical;PA30763;Gene
EGFR;tepotinib;Chemical;PA7360;Gene
CYP2C19;16alpha-hydroxyprogesterone;Chemical;PA124;Gene
CYP2C19*11;16alpha-hydroxyprogesterone;Chemical;PA165816527;Haplotype
CYP2C19*23;16alpha-hydroxyprogesterone;Chemical;PA165816537;Haplotype
CYP2C19*1;16alpha-hydroxyprogesterone;Chemical;PA165980634;Haplotype
CYP2C19*33;16alpha-hydroxyprogesterone;Chemical;PA166123296;Haplotype
DPYD;XELOX;Chemical;PA145;Gene
RS45445694;XELOX;Chemical;PA166155331;Variant
RS367619008;XELOX;Chemical;PA166159539;Variant
TYMS;XELOX;Chemical;PA359;Gene
SEDATION;FASTKD3;Gene;PA166129521;Disease
JUVENILE RHEUMATOID ARTHRITIS;FASTKD3;Gene;PA443433;Disease
RHEUMATOID ARTHRITIS;FASTKD3;Gene;PA443434;Disease
METHOTREXATE;FASTKD3;Gene;PA450428;Chemical
SEVOFLURANE;FASTKD3;Gene;PA451341;Chemical
BREAST NEOPLASMS;rs1937840;Variant;PA443560;Disease
DOCETAXEL;rs1937840;Variant;PA449383;Chemical
DOXORUBICIN;rs1937840;Variant;PA449412;Chemical
LEUKOTRIENE RECEPTOR ANTAGONISTS;LTA4H;Gene;PA164712863;Chemical
ASTHMA;LTA4H;Gene;PA443450;Disease
MONTELUKAST;LTA4H;Gene;PA450546;Chemical
MAP2K7;MAPK10;Gene;PA284;Gene
MAP2K1;MAPK10;Gene;PA30584;Gene
MAP2K2;MAPK10;Gene;PA30587;Gene
MAP2K3;MAPK10;Gene;PA30588;Gene
MAP2K4;MAPK10;Gene;PA30589;Gene
MAP2K5;MAPK10;Gene;PA30590;Gene
MAP2K6;MAPK10;Gene;PA30591;Gene
SORAFENIB;MAPK10;Gene;PA7000;Chemical
OPIOID-RELATED DISORDERS;rs756770;Variant;PA445043;Disease
BUPRENORPHINE;rs756770;Variant;PA448685;Chemical
KIDNEY TRANSPLANTATION;NOD2;Gene;PA165817016;Disease
TACROLIMUS;NOD2;Gene;PA451578;Chemical
DESLORATADINE;FCER1A;Gene;PA164776964;Chemical
MIZOLASTINE;FCER1A;Gene;PA166129535;Chemical
URTICARIA;FCER1A;Gene;PA445999;Disease
CFTR;rs121909020;Variant;PA109;Gene
IVACAFTOR;rs121909020;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs121909020;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs121909020;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs121909020;Variant;PA443829;Disease
COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS;MSH6;Gene;PA443761;Disease
PROSTATIC NEOPLASMS;MSH6;Gene;PA445425;Disease
IFNL4;rapid virological response (rvr);Disease;PA166049147;Gene
RS11322783;rapid virological response (rvr);Disease;PA166190881;Variant
ALCOHOL ABUSE;rs2582405;Variant;PA443309;Disease
ETHANOL;rs2582405;Variant;PA448073;Chemical
UGT1A1*1;Oliguria;Disease;PA166115841;Haplotype
UGT1A1*28;Oliguria;Disease;PA166115842;Haplotype
UGT1A1;Oliguria;Disease;PA420;Gene
SEVERE CUTANEOUS ADVERSE REACTIONS;POU5F1;Gene;PA166120929;Disease
EPIDERMAL NECROLYSIS, TOXIC;POU5F1;Gene;PA444059;Disease
STEVENS-JOHNSON SYNDROME;POU5F1;Gene;PA445738;Disease
ALLOPURINOL;POU5F1;Gene;PA448320;Chemical
HIV INFECTIOUS DISEASE;rs761142;Variant;PA447230;Disease
SULFAMETHOXAZOLE;rs761142;Variant;PA451544;Chemical
MAVS;IRF7;Gene;PA164722208;Gene
DPYD;rs200064537;Variant;PA145;Gene
CAPECITABINE;rs200064537;Variant;PA448771;Chemical
DULOXETINE;rs12502866;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs12502866;Variant;PA447321;Disease
CALCIUM CHANNEL BLOCKERS;rs2239050;Variant;PA10407;Chemical
HYPERTENSION;rs2239050;Variant;PA444552;Disease
NIMODIPINE;rs2239050;Variant;PA450633;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs17309872;Variant;PA443622;Disease
CARBOPLATIN;rs17309872;Variant;PA448803;Chemical
CISPLATIN;rs17309872;Variant;PA449014;Chemical
DOCETAXEL;rs17309872;Variant;PA449383;Chemical
GEMCITABINE;rs17309872;Variant;PA449748;Chemical
PACLITAXEL;rs17309872;Variant;PA450761;Chemical
SULFAMETHOXAZOLE / TRIMETHOPRIM;HLA-B*13:01;Haplotype;PA10715;Chemical
MACULOPAPULAR EXANTHEMA;HLA-B*13:01;Haplotype;PA162316739;Disease
MEASLES VACCINES;HLA-B*13:01;Haplotype;PA164712887;Chemical
TRICHLOROETHYLENE;HLA-B*13:01;Haplotype;PA166115521;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*13:01;Haplotype;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-B*13:01;Haplotype;PA166120929;Disease
DRUG HYPERSENSITIVITY;HLA-B*13:01;Haplotype;PA443936;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*13:01;Haplotype;PA444059;Disease
EPILEPSY;HLA-B*13:01;Haplotype;PA444065;Disease
LEPROSY;HLA-B*13:01;Haplotype;PA444745;Disease
SKIN DISEASES;HLA-B*13:01;Haplotype;PA445676;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*13:01;Haplotype;PA445738;Disease
ACETAMINOPHEN;HLA-B*13:01;Haplotype;PA448015;Chemical
CARBAMAZEPINE;HLA-B*13:01;Haplotype;PA448785;Chemical
DAPSONE;HLA-B*13:01;Haplotype;PA449211;Chemical
PHENOBARBITAL;HLA-B*13:01;Haplotype;PA450911;Chemical
PHENYTOIN;HLA-B*13:01;Haplotype;PA450947;Chemical
SULFASALAZINE;HLA-B*13:01;Haplotype;PA451547;Chemical
BUFURALOL;CYP2D6*71;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*71;Haplotype;PA166127651;Chemical
DEXTROMETHORPHAN;CYP2D6*71;Haplotype;PA449273;Chemical
PRIMAQUINE;CYP2D6*71;Haplotype;PA451103;Chemical
HYPERTENSION;NFAT5;Gene;PA444552;Disease
ASPIRIN-INDUCED ASTHMA;HLA-DPB2;Gene;PA131285571;Disease
ASTHMA;HLA-DPB2;Gene;PA443450;Disease
ASPIRIN;HLA-DPB2;Gene;PA448497;Chemical
RS777924668;pregnenolone;Chemical;PA166334141;Variant
RS527454384;pregnenolone;Chemical;PA166334144;Variant
RS777140014;pregnenolone;Chemical;PA166334146;Variant
RS746398875;pregnenolone;Chemical;PA166334161;Variant
RS762765702;pregnenolone;Chemical;PA166334162;Variant
RS774212320;pregnenolone;Chemical;PA166334163;Variant
SULT2B1;pregnenolone;Chemical;PA36249;Gene
TAXANES;GSR;Gene;PA150481189;Chemical
OVARIAN NEOPLASMS;GSR;Gene;PA445204;Disease
CARBOPLATIN;GSR;Gene;PA448803;Chemical
RS3742106;tenofovir disoproxil fumarate;Chemical;PA166154713;Variant
RS11854484;tenofovir disoproxil fumarate;Chemical;PA166154934;Variant
RS9349256;tenofovir disoproxil fumarate;Chemical;PA166157146;Variant
RS4646536;tenofovir disoproxil fumarate;Chemical;PA166165040;Variant
RS2248359;tenofovir disoproxil fumarate;Chemical;PA166170863;Variant
ABCC10;tenofovir disoproxil fumarate;Chemical;PA24392;Gene
CYP24A1;tenofovir disoproxil fumarate;Chemical;PA27097;Gene
CYP27B1;tenofovir disoproxil fumarate;Chemical;PA27099;Gene
SLC28A2;tenofovir disoproxil fumarate;Chemical;PA386;Gene
ABCC4;tenofovir disoproxil fumarate;Chemical;PA397;Gene
MAJOR DEPRESSIVE DISORDER;rs2742423;Variant;PA447321;Disease
BUPROPION;rs2742423;Variant;PA448687;Chemical
ASTHMA;rs1419555;Variant;PA443450;Disease
SALBUTAMOL;rs1419555;Variant;PA448068;Chemical
CFTR;ataluren;Chemical;PA109;Gene
RS75039782;ataluren;Chemical;PA166157514;Variant
RS77010898;ataluren;Chemical;PA166157518;Variant
RS113993959;ataluren;Chemical;PA166157524;Variant
ADRB1;Sleep Apnea, Obstructive;Disease;PA38;Gene
BUFURALOL;rs371793722;Variant;PA166110256;Chemical
DEXTROMETHORPHAN;rs371793722;Variant;PA449273;Chemical
ASTHMA;rs2660845;Variant;PA443450;Disease
MONTELUKAST;rs2660845;Variant;PA450546;Chemical
VORINOSTAT;CHD4;Gene;PA164748224;Chemical
LONAFARNIB;rs11623866;Variant;PA166129466;Chemical
OVARIAN NEOPLASMS;rs11623866;Variant;PA445204;Disease
CARBOPLATIN;rs11623866;Variant;PA448803;Chemical
PACLITAXEL;rs11623866;Variant;PA450761;Chemical
PAIN, POSTOPERATIVE;rs1800035;Variant;PA445210;Disease
DEXMEDETOMIDINE;rs1800035;Variant;PA449256;Chemical
VORICONAZOLE;CYP2C19*32;Haplotype;PA10233;Chemical
NEBIVOLOL;CYP2C19*32;Haplotype;PA151958426;Chemical
FLUOXETINE;CYP2C19*32;Haplotype;PA449673;Chemical
IBUPROFEN;CYP2C19*32;Haplotype;PA449957;Chemical
MEPHENYTOIN;CYP2C19*32;Haplotype;PA450373;Chemical
METHADONE;CYP2C19*32;Haplotype;PA450401;Chemical
DEPRESSION;rs520210;Variant;PA447278;Disease
CITALOPRAM;rs520210;Variant;PA449015;Chemical
RS731236;calcium;Chemical;PA166154500;Variant
VDR;calcium;Chemical;PA37301;Gene
CYP2C19;icotinib;Chemical;PA124;Gene
CYP2C19*1;icotinib;Chemical;PA165980634;Haplotype
CYP2C19*2;icotinib;Chemical;PA165980635;Haplotype
CYP2C19*3;icotinib;Chemical;PA165980636;Haplotype
FLUOROURACIL;rs145623321;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs145623321;Variant;PA443560;Disease
NEUTROPENIA;rs145623321;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs145623321;Variant;PA449165;Chemical
EPIRUBICIN;rs145623321;Variant;PA449476;Chemical
FLUOROURACIL;rs299314;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs299314;Variant;PA443560;Disease
NEUTROPENIA;rs299314;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs299314;Variant;PA449165;Chemical
EPIRUBICIN;rs299314;Variant;PA449476;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs17863783;Variant;PA130620651;Chemical
RARG;rs17863783;Variant;PA34227;Gene
UGT1A6;rs17863783;Variant;PA37181;Gene
SLC28A3;rs17863783;Variant;PA426;Gene
NEOPLASMS;rs17863783;Variant;PA445062;Disease
DAUNORUBICIN;rs17863783;Variant;PA449212;Chemical
DOXORUBICIN;rs17863783;Variant;PA449412;Chemical
HYPERTRIGLYCERIDEMIA;rs964184;Variant;PA446120;Disease
FENOFIBRATE;rs964184;Variant;PA449594;Chemical
KCNJ11;diazoxide;Chemical;PA217;Gene
CYP2E1;gemtuzumab ozogamicin;Chemical;PA129;Gene
SLCO1B1;gemtuzumab ozogamicin;Chemical;PA134865839;Gene
RS2070673;gemtuzumab ozogamicin;Chemical;PA166153993;Variant
RS2515641;gemtuzumab ozogamicin;Chemical;PA166154017;Variant
RS11231825;gemtuzumab ozogamicin;Chemical;PA166154455;Variant
RS4149056;gemtuzumab ozogamicin;Chemical;PA166154579;Variant
RS2302948;gemtuzumab ozogamicin;Chemical;PA166155396;Variant
RS35112940;gemtuzumab ozogamicin;Chemical;PA166161442;Variant
CD33;gemtuzumab ozogamicin;Chemical;PA26210;Gene
SULT2B1;gemtuzumab ozogamicin;Chemical;PA36249;Gene
SLC22A12;gemtuzumab ozogamicin;Chemical;PA38478;Gene
ABCB1;sparfloxacin;Chemical;PA267;Gene
VORICONAZOLE;CYP3A4*1;Haplotype;PA10233;Chemical
IMATINIB;CYP3A4*1;Haplotype;PA10804;Chemical
CYP3A4;CYP3A4*1;Haplotype;PA130;Gene
ORGAN TRANSPLANTATION;CYP3A4*1;Haplotype;PA133888799;Disease
TRANSPLANTATION;CYP3A4*1;Haplotype;PA134850491;Disease
EVEROLIMUS;CYP3A4*1;Haplotype;PA164746311;Chemical
TICAGRELOR;CYP3A4*1;Haplotype;PA165374673;Chemical
KIDNEY TRANSPLANTATION;CYP3A4*1;Haplotype;PA165817016;Disease
CABOZANTINIB;CYP3A4*1;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*1;Haplotype;PA165958362;Chemical
FESOTERODINE;CYP3A4*1;Haplotype;PA165958376;Chemical
TRANSPLANT REJECTION;CYP3A4*1;Haplotype;PA166114454;Disease
LUNG TRANSPLANTATION;CYP3A4*1;Haplotype;PA166114457;Disease
REGORAFENIB;CYP3A4*1;Haplotype;PA166114943;Chemical
VANDETANIB;CYP3A4*1;Haplotype;PA166118341;Chemical
IBRUTINIB;CYP3A4*1;Haplotype;PA166121346;Chemical
TREATMENT MODIFICATION;CYP3A4*1;Haplotype;PA166124372;Disease
ENDOXIFEN;CYP3A4*1;Haplotype;PA166124478;Chemical
N-DESMETHYLTAMOXIFEN;CYP3A4*1;Haplotype;PA166127651;Chemical
4-HYDROXYTAMOXIFEN;CYP3A4*1;Haplotype;PA166127652;Chemical
PLATELET AGGREGATION INHIBITION;CYP3A4*1;Haplotype;PA166128371;Disease
ADVERSE EVENTS;CYP3A4*1;Haplotype;PA166151827;Disease
ALECTINIB;CYP3A4*1;Haplotype;PA166160050;Chemical
BREXPIPRAZOLE;CYP3A4*1;Haplotype;PA166160053;Chemical
LAPAROSCOPIC SLEEVE GASTRECTOMY;CYP3A4*1;Haplotype;PA166169562;Disease
ACALABRUTINIB;CYP3A4*1;Haplotype;PA166198581;Chemical
MACITENTAN;CYP3A4*1;Haplotype;PA166261201;Chemical
BLONANSERIN;CYP3A4*1;Haplotype;PA166319041;Chemical
ALCOHOLISM;CYP3A4*1;Haplotype;PA443309;Disease
BREAST NEOPLASMS;CYP3A4*1;Haplotype;PA443560;Disease
EXANTHEMA;CYP3A4*1;Haplotype;PA444109;Disease
HEART FAILURE;CYP3A4*1;Haplotype;PA444370;Disease
HYPERCHOLESTEROLEMIA;CYP3A4*1;Haplotype;PA444516;Disease
HYPERLIPIDEMIAS;CYP3A4*1;Haplotype;PA444528;Disease
KIDNEY NEOPLASMS;CYP3A4*1;Haplotype;PA444685;Disease
NEOPLASMS;CYP3A4*1;Haplotype;PA445062;Disease
OVARIAN NEOPLASMS;CYP3A4*1;Haplotype;PA445204;Disease
PAIN, POSTOPERATIVE;CYP3A4*1;Haplotype;PA445210;Disease
PERIPHERAL NERVOUS SYSTEM DISEASES;CYP3A4*1;Haplotype;PA445301;Disease
NEUROENDOCRINE TUMORS;CYP3A4*1;Haplotype;PA446713;Disease
HOT FLASHES;CYP3A4*1;Haplotype;PA446852;Disease
ANXIETY DISORDERS;CYP3A4*1;Haplotype;PA447196;Disease
HIV INFECTIONS;CYP3A4*1;Haplotype;PA447230;Disease
LIVER TRANSPLANTATION;CYP3A4*1;Haplotype;PA447247;Disease
ALPRAZOLAM;CYP3A4*1;Haplotype;PA448333;Chemical
AMIODARONE;CYP3A4*1;Haplotype;PA448383;Chemical
CYCLOSPORINE;CYP3A4*1;Haplotype;PA449167;Chemical
EXEMESTANE;CYP3A4*1;Haplotype;PA449563;Chemical
FENTANYL;CYP3A4*1;Haplotype;PA449599;Chemical
IBUPROFEN;CYP3A4*1;Haplotype;PA449957;Chemical
LIDOCAINE;CYP3A4*1;Haplotype;PA450226;Chemical
LOPINAVIR;CYP3A4*1;Haplotype;PA450264;Chemical
METHADONE;CYP3A4*1;Haplotype;PA450401;Chemical
MIDAZOLAM;CYP3A4*1;Haplotype;PA450496;Chemical
NIFEDIPINE;CYP3A4*1;Haplotype;PA450631;Chemical
OXYCODONE;CYP3A4*1;Haplotype;PA450741;Chemical
PACLITAXEL;CYP3A4*1;Haplotype;PA450761;Chemical
QUETIAPINE;CYP3A4*1;Haplotype;PA451201;Chemical
SILDENAFIL;CYP3A4*1;Haplotype;PA451346;Chemical
SIMVASTATIN;CYP3A4*1;Haplotype;PA451363;Chemical
SIROLIMUS;CYP3A4*1;Haplotype;PA451365;Chemical
TACROLIMUS;CYP3A4*1;Haplotype;PA451578;Chemical
TAMOXIFEN;CYP3A4*1;Haplotype;PA451581;Chemical
TESTOSTERONE;CYP3A4*1;Haplotype;PA451627;Chemical
CYP2B6;lamotrigine;Chemical;PA123;Gene
CYP2C19;lamotrigine;Chemical;PA124;Gene
CYP2C9;lamotrigine;Chemical;PA126;Gene
CYP2D6;lamotrigine;Chemical;PA128;Gene
CYP3A4;lamotrigine;Chemical;PA130;Gene
CYP3A5;lamotrigine;Chemical;PA131;Gene
HLA-DRB1*13:01;lamotrigine;Chemical;PA165951968;Haplotype
HLA-A*02:07;lamotrigine;Chemical;PA165952839;Haplotype
HLA-A*23:01;lamotrigine;Chemical;PA165953507;Haplotype
HLA-A*30:01;lamotrigine;Chemical;PA165953964;Haplotype
HLA-A*68:01;lamotrigine;Chemical;PA165954243;Haplotype
HLA-B*13:02;lamotrigine;Chemical;PA165954649;Haplotype
HLA-B*15:02;lamotrigine;Chemical;PA165954769;Haplotype
HLA-B*38:01;lamotrigine;Chemical;PA165955500;Haplotype
HLA-B*40:02;lamotrigine;Chemical;PA165955651;Haplotype
HLA-B*44:03;lamotrigine;Chemical;PA165955913;Haplotype
HLA-C*07:18;lamotrigine;Chemical;PA165957448;Haplotype
HLA-DQB1*06:09;lamotrigine;Chemical;PA165958117;Haplotype
HLA-B*57:01;lamotrigine;Chemical;PA165987830;Haplotype
HLA-B*58:01;lamotrigine;Chemical;PA165987831;Haplotype
UGT1A4*1A;lamotrigine;Chemical;PA166117588;Haplotype
UGT1A4*1B;lamotrigine;Chemical;PA166117589;Haplotype
UGT1A4*2;lamotrigine;Chemical;PA166117597;Haplotype
UGT1A4*3A;lamotrigine;Chemical;PA166117598;Haplotype
HLA-A*33:03;lamotrigine;Chemical;PA166123428;Haplotype
RS2011425;lamotrigine;Chemical;PA166155662;Variant
RS2298771;lamotrigine;Chemical;PA166155680;Variant
RS2304016;lamotrigine;Chemical;PA166155682;Variant
RS3812718;lamotrigine;Chemical;PA166155715;Variant
RS2071197;lamotrigine;Chemical;PA166155919;Variant
RS2231142;lamotrigine;Chemical;PA166156544;Variant
RS3114020;lamotrigine;Chemical;PA166156572;Variant
RS7668258;lamotrigine;Chemical;PA166156625;Variant
RS28365063;lamotrigine;Chemical;PA166156677;Variant
RS628031;lamotrigine;Chemical;PA166156933;Variant
HTR2A;lamotrigine;Chemical;PA193;Gene
HTR2C;lamotrigine;Chemical;PA194;Gene
ABCB1;lamotrigine;Chemical;PA267;Gene
CYP1A2;lamotrigine;Chemical;PA27093;Gene
DRD2;lamotrigine;Chemical;PA27478;Gene
HNF4A;lamotrigine;Chemical;PA29349;Gene
SCN1A;lamotrigine;Chemical;PA301;Gene
SLC6A4;lamotrigine;Chemical;PA312;Gene
SLC22A1;lamotrigine;Chemical;PA329;Gene
POLG;lamotrigine;Chemical;PA33500;Gene
SCN2A;lamotrigine;Chemical;PA35004;Gene
HLA-A;lamotrigine;Chemical;PA35055;Gene
HLA-B;lamotrigine;Chemical;PA35056;Gene
HLA-C;lamotrigine;Chemical;PA35057;Gene
HLA-DQB1;lamotrigine;Chemical;PA35068;Gene
HLA-DRB1;lamotrigine;Chemical;PA35072;Gene
UGT2B7;lamotrigine;Chemical;PA361;Gene
UGT1A4;lamotrigine;Chemical;PA37179;Gene
ABCG2;lamotrigine;Chemical;PA390;Gene
GNAS;PTGIR;Gene;PA175;Gene
ASTHMA;PTGIR;Gene;PA443450;Disease
CARDIOVASCULAR DISEASES;PTGIR;Gene;PA443635;Disease
ASPIRIN;PTGIR;Gene;PA448497;Chemical
CERLIPONASE ALFA;TPP1;Gene;PA166169879;Chemical
ESR1;inavolisib;Chemical;PA156;Gene
ERBB2;inavolisib;Chemical;PA27844;Gene
ESR2;inavolisib;Chemical;PA27886;Gene
PIK3CA;inavolisib;Chemical;PA33308;Gene
CYP2C9;flurbiprofen;Chemical;PA126;Gene
CYP2C9*1;flurbiprofen;Chemical;PA165816542;Haplotype
CYP2C9*2;flurbiprofen;Chemical;PA165816543;Haplotype
CYP2C9*3;flurbiprofen;Chemical;PA165816544;Haplotype
CYP2C9*29;flurbiprofen;Chemical;PA165816573;Haplotype
RS182132442;flurbiprofen;Chemical;PA166154220;Variant
RS7439366;flurbiprofen;Chemical;PA166156619;Variant
RS780801862;flurbiprofen;Chemical;PA166209781;Variant
UGT2B7;flurbiprofen;Chemical;PA361;Gene
ATAZANAVIR;CYP3A5*6;Haplotype;PA10251;Chemical
CYP2C19;CYP3A5*6;Haplotype;PA124;Gene
MARAVIROC;CYP3A5*6;Haplotype;PA164768835;Chemical
KIDNEY TRANSPLANTATION;CYP3A5*6;Haplotype;PA165817016;Disease
TRANSPLANT REJECTION;CYP3A5*6;Haplotype;PA166114454;Disease
LUNG TRANSPLANTATION;CYP3A5*6;Haplotype;PA166114457;Disease
HEART TRANSPLANTATION;CYP3A5*6;Haplotype;PA166114458;Disease
HEMATOPOIETIC STEM CELL TRANSPLANTATION;CYP3A5*6;Haplotype;PA166123007;Disease
DELAYED GRAFT FUNCTION;CYP3A5*6;Haplotype;PA166123755;Disease
MAVACAMTEN;CYP3A5*6;Haplotype;PA166272922;Chemical
PAIN;CYP3A5*6;Haplotype;PA445208;Disease
PAIN, POSTOPERATIVE;CYP3A5*6;Haplotype;PA445210;Disease
HIV INFECTIONS;CYP3A5*6;Haplotype;PA447230;Disease
LIVER TRANSPLANTATION;CYP3A5*6;Haplotype;PA447247;Disease
AMLODIPINE;CYP3A5*6;Haplotype;PA448388;Chemical
FENTANYL;CYP3A5*6;Haplotype;PA449599;Chemical
RITONAVIR;CYP3A5*6;Haplotype;PA451260;Chemical
TACROLIMUS;CYP3A5*6;Haplotype;PA451578;Chemical
ERBB2;tipiracil / trifluridine;Chemical;PA27844;Gene
KRAS;tipiracil / trifluridine;Chemical;PA30196;Gene
ABCB1;celiprolol;Chemical;PA267;Gene
MAJOR DEPRESSIVE DISORDER;rs1006737;Variant;PA447321;Disease
CITALOPRAM;rs1006737;Variant;PA449015;Chemical
PEMETREXED;rs3780126;Variant;PA10810;Chemical
BEVACIZUMAB;rs3780126;Variant;PA130232992;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs3780126;Variant;PA443622;Disease
TORSADES DE POINTES;rs12720441;Variant;PA446294;Disease
AMIODARONE;rs12720441;Variant;PA448383;Chemical
CYP2D6;Adenocarcinoma;Disease;PA128;Gene
CYP2D6*1;Adenocarcinoma;Disease;PA165816576;Haplotype
CYP2D6*2;Adenocarcinoma;Disease;PA165816577;Haplotype
CYP2D6*10;Adenocarcinoma;Disease;PA165816582;Haplotype
CYP2D6*5;Adenocarcinoma;Disease;PA165948092;Haplotype
UGT1A1*1;Adenocarcinoma;Disease;PA166115841;Haplotype
UGT1A1*28;Adenocarcinoma;Disease;PA166115842;Haplotype
RS45445694;Adenocarcinoma;Disease;PA166155331;Variant
RS1615111;Adenocarcinoma;Disease;PA166156518;Variant
RS121434569;Adenocarcinoma;Disease;PA166157528;Variant
AREG;Adenocarcinoma;Disease;PA24933;Gene
TYMS;Adenocarcinoma;Disease;PA359;Gene
UGT1A1;Adenocarcinoma;Disease;PA420;Gene
EGFR;Adenocarcinoma;Disease;PA7360;Gene
TRANSPLANTATION;IL10;Gene;PA134850491;Disease
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;IL10;Gene;PA164712462;Chemical
KIDNEY TRANSPLANTATION;IL10;Gene;PA165817016;Disease
HIV INFECTIOUS DISEASE;IL10;Gene;PA447230;Disease
LIVER TRANSPLANTATION;IL10;Gene;PA447247;Disease
CYCLOSPORINE;IL10;Gene;PA449167;Chemical
EFAVIRENZ;IL10;Gene;PA449441;Chemical
MYCOPHENOLATE MOFETIL;IL10;Gene;PA450566;Chemical
RITUXIMAB;IL10;Gene;PA451261;Chemical
SIROLIMUS;IL10;Gene;PA451365;Chemical
TACROLIMUS;IL10;Gene;PA451578;Chemical
FLUOROURACIL;rs569661196;Variant;PA128406956;Chemical
DRUG TOXICITY;rs569661196;Variant;PA443937;Disease
FLUOROURACIL;TMEM167A;Gene;PA128406956;Chemical
PLATINUM COMPOUNDS;TMEM167A;Gene;PA164713176;Chemical
RADIOTHERAPY;TMEM167A;Gene;PA166122986;Chemical
STOMACH NEOPLASMS;TMEM167A;Gene;PA445742;Disease
TOBACCO USE DISORDER;ADGRL3;Gene;PA445876;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;ADGRL3;Gene;PA447197;Disease
METHYLPHENIDATE;ADGRL3;Gene;PA450464;Chemical
NICOTINE;ADGRL3;Gene;PA450626;Chemical
CYP2D6;CYP2D6*2xN;Haplotype;PA128;Gene
MIANSERIN;CYP2D6*2xN;Haplotype;PA134687937;Chemical
TROPISETRON;CYP2D6*2xN;Haplotype;PA161925594;Chemical
SUICIDE;CYP2D6*2xN;Haplotype;PA165374639;Disease
DISCONTINUATION;CYP2D6*2xN;Haplotype;PA166123507;Disease
ENDOXIFEN;CYP2D6*2xN;Haplotype;PA166124478;Chemical
CARDIOTOXICITY;CYP2D6*2xN;Haplotype;PA166128121;Disease
SEDATION;CYP2D6*2xN;Haplotype;PA166129521;Disease
CNS DEPRESSION;CYP2D6*2xN;Haplotype;PA166170668;Disease
BREAST NEOPLASMS;CYP2D6*2xN;Haplotype;PA443560;Disease
DEATH;CYP2D6*2xN;Haplotype;PA443842;Disease
DRUG TOXICITY;CYP2D6*2xN;Haplotype;PA443937;Disease
HEROIN DEPENDENCE;CYP2D6*2xN;Haplotype;PA444460;Disease
OPIOID-RELATED DISORDERS;CYP2D6*2xN;Haplotype;PA445043;Disease
PAIN;CYP2D6*2xN;Haplotype;PA445208;Disease
VOMITING;CYP2D6*2xN;Haplotype;PA446051;Disease
DEPRESSIVE DISORDER;CYP2D6*2xN;Haplotype;PA447207;Disease
MENTAL DISORDERS;CYP2D6*2xN;Haplotype;PA447208;Disease
MOOD DISORDERS;CYP2D6*2xN;Haplotype;PA447209;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2D6*2xN;Haplotype;PA447321;Disease
AMITRIPTYLINE;CYP2D6*2xN;Haplotype;PA448385;Chemical
CITALOPRAM;CYP2D6*2xN;Haplotype;PA449015;Chemical
CODEINE;CYP2D6*2xN;Haplotype;PA449088;Chemical
DESIPRAMINE;CYP2D6*2xN;Haplotype;PA449233;Chemical
DOXEPIN;CYP2D6*2xN;Haplotype;PA449409;Chemical
FLUOXETINE;CYP2D6*2xN;Haplotype;PA449673;Chemical
HYDROCODONE;CYP2D6*2xN;Haplotype;PA449900;Chemical
IMIPRAMINE;CYP2D6*2xN;Haplotype;PA449969;Chemical
METHADONE;CYP2D6*2xN;Haplotype;PA450401;Chemical
MIRTAZAPINE;CYP2D6*2xN;Haplotype;PA450522;Chemical
NORTRIPTYLINE;CYP2D6*2xN;Haplotype;PA450657;Chemical
ONDANSETRON;CYP2D6*2xN;Haplotype;PA450705;Chemical
OXYCODONE;CYP2D6*2xN;Haplotype;PA450741;Chemical
PAROXETINE;CYP2D6*2xN;Haplotype;PA450801;Chemical
TRAMADOL;CYP2D6*2xN;Haplotype;PA451735;Chemical
TRIMIPRAMINE;CYP2D6*2xN;Haplotype;PA451791;Chemical
VENLAFAXINE;CYP2D6*2xN;Haplotype;PA451866;Chemical
ANTIDEPRESSANTS;CYP2D6*2xN;Haplotype;PA452229;Chemical
SPARTEINE;CYP2D6*2xN;Haplotype;PA452610;Chemical
DEBRISOQUINE;CYP2D6*2xN;Haplotype;PA452616;Chemical
PLATINUM COMPOUNDS;rs1799793;Variant;PA164713176;Chemical
PNEUMONITIS;rs1799793;Variant;PA166124223;Disease
ADVERSE EVENTS;rs1799793;Variant;PA166151827;Disease
ANEMIA;rs1799793;Variant;PA443340;Disease
NON-SMALL CELL LUNG CARCINOMA;rs1799793;Variant;PA443622;Disease
NEOPLASMS;rs1799793;Variant;PA445062;Disease
TESTICULAR NEOPLASMS;rs1799793;Variant;PA445828;Disease
BLEOMYCIN;rs1799793;Variant;PA448645;Chemical
CISPLATIN;rs1799793;Variant;PA449014;Chemical
ETOPOSIDE;rs1799793;Variant;PA449552;Chemical
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-B*59:01;Haplotype;PA166120929;Disease
AGRANULOCYTOSIS;HLA-B*59:01;Haplotype;PA443297;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*59:01;Haplotype;PA444059;Disease
EPILEPSY;HLA-B*59:01;Haplotype;PA444065;Disease
GLAUCOMA;HLA-B*59:01;Haplotype;PA444281;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*59:01;Haplotype;PA445738;Disease
SCHIZOPHRENIA;HLA-B*59:01;Haplotype;PA447216;Disease
ACETAZOLAMIDE;HLA-B*59:01;Haplotype;PA448018;Chemical
CARBAMAZEPINE;HLA-B*59:01;Haplotype;PA448785;Chemical
CLOZAPINE;HLA-B*59:01;Haplotype;PA449061;Chemical
METHAZOLAMIDE;HLA-B*59:01;Haplotype;PA450413;Chemical
SLCO1B1;daunorubicin;Chemical;PA134865839;Gene
C18ORF56;daunorubicin;Chemical;PA134956204;Gene
DCK;daunorubicin;Chemical;PA137;Gene
DROSHA;daunorubicin;Chemical;PA142671060;Gene
LINC00251;daunorubicin;Chemical;PA165585763;Gene
G6PD A- 202A_376G;daunorubicin;Chemical;PA165947827;Haplotype
FMO3;daunorubicin;Chemical;PA166;Gene
G6PD MEDITERRANEAN, DALLAS, PANAMA, SASSARI, CAGLIARI, BIRMINGHAM;daunorubicin;Chemical;PA166121127;Haplotype
RS1891059;daunorubicin;Chemical;PA166153658;Variant
RS17021408;daunorubicin;Chemical;PA166153867;Variant
RS80223967;daunorubicin;Chemical;PA166153915;Variant
RS3824662;daunorubicin;Chemical;PA166154043;Variant
RS2229774;daunorubicin;Chemical;PA166154532;Variant
RS2291075;daunorubicin;Chemical;PA166154544;Variant
RS45445694;daunorubicin;Chemical;PA166155331;Variant
RS10932125;daunorubicin;Chemical;PA166155797;Variant
RS17863783;daunorubicin;Chemical;PA166155854;Variant
RS79085477;daunorubicin;Chemical;PA166155968;Variant
RS117532069;daunorubicin;Chemical;PA166155970;Variant
RS1143663;daunorubicin;Chemical;PA166155991;Variant
RS2835285;daunorubicin;Chemical;PA166156002;Variant
RS41557318;daunorubicin;Chemical;PA166156017;Variant
RS639174;daunorubicin;Chemical;PA166156737;Variant
RS1799983;daunorubicin;Chemical;PA166157303;Variant
RS2032582;daunorubicin;Chemical;PA166157316;Variant
RS141059755;daunorubicin;Chemical;PA166157691;Variant
RS7853758;daunorubicin;Chemical;PA166157790;Variant
RS17134592;daunorubicin;Chemical;PA166161792;Variant
RS1043657;daunorubicin;Chemical;PA166161794;Variant
RS738409;daunorubicin;Chemical;PA166165078;Variant
RS4987102;daunorubicin;Chemical;PA166170184;Variant
RS35575889;daunorubicin;Chemical;PA166170186;Variant
RS34186955;daunorubicin;Chemical;PA166170188;Variant
RS12283870;daunorubicin;Chemical;PA166285621;Variant
AKR1C3;daunorubicin;Chemical;PA24679;Gene
AKR1C4;daunorubicin;Chemical;PA24680;Gene
AKR7A2;daunorubicin;Chemical;PA24682;Gene
BMP7;daunorubicin;Chemical;PA25384;Gene
NOS3;daunorubicin;Chemical;PA254;Gene
DOK5;daunorubicin;Chemical;PA25724;Gene
SETD4;daunorubicin;Chemical;PA25814;Gene
CBR1;daunorubicin;Chemical;PA26121;Gene
CBR3;daunorubicin;Chemical;PA26122;Gene
ABCB1;daunorubicin;Chemical;PA267;Gene
CPT1A;daunorubicin;Chemical;PA26847;Gene
G6PD;daunorubicin;Chemical;PA28469;Gene
GATA3;daunorubicin;Chemical;PA28586;Gene
GSTP1;daunorubicin;Chemical;PA29028;Gene
IGHMBP2;daunorubicin;Chemical;PA29731;Gene
NRP2;daunorubicin;Chemical;PA31784;Gene
RARG;daunorubicin;Chemical;PA34227;Gene
TYMS;daunorubicin;Chemical;PA359;Gene
UGT1A6;daunorubicin;Chemical;PA37181;Gene
PNPLA3;daunorubicin;Chemical;PA38592;Gene
ABCG2;daunorubicin;Chemical;PA390;Gene
SLC28A3;daunorubicin;Chemical;PA426;Gene
ATP7B;daunorubicin;Chemical;PA73;Gene
GEFITINIB;TAB2;Gene;PA131301952;Chemical
DIARRHEA;TAB2;Gene;PA443899;Disease
CYP2C19;Suicide;Disease;PA124;Gene
CYP2D6;Suicide;Disease;PA128;Gene
CYP2C19*1;Suicide;Disease;PA165980634;Haplotype
CYP2C19*2;Suicide;Disease;PA165980635;Haplotype
CYP2D6*1XN;Suicide;Disease;PA165988479;Haplotype
CYP2D6*2XN;Suicide;Disease;PA165988480;Haplotype
RS4825476;Suicide;Disease;PA166157876;Variant
GRIA3;Suicide;Disease;PA28968;Gene
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*67:01;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*67:01;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*67:01;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-B*67:01;Haplotype;PA450616;Chemical
COTININE;rs10457090;Variant;PA166114414;Chemical
OPIOID-RELATED DISORDERS;rs10457090;Variant;PA445043;Disease
NICOTINE;rs10457090;Variant;PA450626;Chemical
OPIOIDS;rs10457090;Variant;PA452618;Chemical
HYPERTENSION;HOXC@;Gene;PA444552;Disease
ECULIZUMAB;CHRNB1;Gene;PA164776637;Chemical
EFGARTIGIMOD ALFA;CHRNB1;Gene;PA166268781;Chemical
RAVULIZUMAB;CHRNB1;Gene;PA166277861;Chemical
ROZANOLIXIZUMAB;CHRNB1;Gene;PA166313325;Chemical
ZILUCOPLAN;CHRNB1;Gene;PA166328901;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs2546890;Variant;PA164713366;Chemical
PSORIASIS;rs2546890;Variant;PA445451;Disease
OVERALL SURVIVAL;rs2229300;Variant;PA166123207;Disease
RECURRENCE FREE SURVIVAL;rs2229300;Variant;PA166127658;Disease
LEUKEMIA, MYELOID, ACUTE;rs2229300;Variant;PA444760;Disease
CYTARABINE;rs2229300;Variant;PA449177;Chemical
ACE;diuretics;Chemical;PA139;Gene
RS1801253;diuretics;Chemical;PA166153977;Variant
RS1799752;diuretics;Chemical;PA166155187;Variant
RS4149601;diuretics;Chemical;PA166155293;Variant
RS2273359;diuretics;Chemical;PA166155924;Variant
RS1805128;diuretics;Chemical;PA166155994;Variant
RS4961;diuretics;Chemical;PA166156480;Variant
RS702553;diuretics;Chemical;PA166156738;Variant
RS1042713;diuretics;Chemical;PA166156748;Variant
RS1799983;diuretics;Chemical;PA166157303;Variant
RS2070744;diuretics;Chemical;PA166157325;Variant
KCNE1;diuretics;Chemical;PA211;Gene
NOS3;diuretics;Chemical;PA254;Gene
ADD1;diuretics;Chemical;PA31;Gene
NEDD4L;diuretics;Chemical;PA31534;Gene
PDE4D;diuretics;Chemical;PA33130;Gene
ADRB1;diuretics;Chemical;PA38;Gene
NELFCD;diuretics;Chemical;PA38055;Gene
ADRB2;diuretics;Chemical;PA39;Gene
MYCOPHENOLIC ACID;IMPDH2;Gene;PA164748728;Chemical
KIDNEY TRANSPLANTATION;IMPDH2;Gene;PA165817016;Disease
CYCLOSPORINE;IMPDH2;Gene;PA449167;Chemical
MYCOPHENOLATE MOFETIL;IMPDH2;Gene;PA450566;Chemical
ARIPIPRAZOLE;rs1128503;Variant;PA10026;Chemical
IMATINIB;rs1128503;Variant;PA10804;Chemical
OXALIPLATIN;rs1128503;Variant;PA131285527;Chemical
GEFITINIB;rs1128503;Variant;PA131301952;Chemical
HMG COA REDUCTASE INHIBITORS;rs1128503;Variant;PA133950441;Chemical
TRANSPLANTATION;rs1128503;Variant;PA134850491;Disease
ANTIEPILEPTICS;rs1128503;Variant;PA143485705;Chemical
SUNITINIB;rs1128503;Variant;PA162372840;Chemical
PLATINUM COMPOUNDS;rs1128503;Variant;PA164713176;Chemical
TEMSIROLIMUS;rs1128503;Variant;PA164746890;Chemical
ROCURONIUM;rs1128503;Variant;PA164754992;Chemical
TIPIFARNIB;rs1128503;Variant;PA165110778;Chemical
KIDNEY TRANSPLANTATION;rs1128503;Variant;PA165817016;Disease
MUCOSITIS;rs1128503;Variant;PA166122058;Disease
HEMATOPOIETIC STEM CELL TRANSPLANTATION;rs1128503;Variant;PA166123007;Disease
TONSILLECTOMY;rs1128503;Variant;PA166169457;Disease
RHEUMATOID ARTHRITIS;rs1128503;Variant;PA443434;Disease
URINARY BLADDER NEOPLASMS;rs1128503;Variant;PA443512;Disease
BREAST NEOPLASMS;rs1128503;Variant;PA443560;Disease
NON-SMALL CELL LUNG CARCINOMA;rs1128503;Variant;PA443622;Disease
RENAL CELL CARCINOMA;rs1128503;Variant;PA443624;Disease
ULCERATIVE COLITIS;rs1128503;Variant;PA443750;Disease
EPILEPSY;rs1128503;Variant;PA444065;Disease
GLIOMA;rs1128503;Variant;PA444284;Disease
HEROIN DEPENDENCE;rs1128503;Variant;PA444460;Disease
HYPERCHOLESTEROLEMIA;rs1128503;Variant;PA444516;Disease
HYPOVENTILATION;rs1128503;Variant;PA444591;Disease
LEUKEMIA, MYELOID, ACUTE;rs1128503;Variant;PA444760;Disease
LYMPHOMA;rs1128503;Variant;PA444840;Disease
MYASTHENIA GRAVIS;rs1128503;Variant;PA445004;Disease
NARCOLEPSY;rs1128503;Variant;PA445042;Disease
OPIOID-RELATED DISORDERS;rs1128503;Variant;PA445043;Disease
NEOPLASMS;rs1128503;Variant;PA445062;Disease
NEPHROTIC SYNDROME;rs1128503;Variant;PA445089;Disease
PAIN;rs1128503;Variant;PA445208;Disease
PAIN, POSTOPERATIVE;rs1128503;Variant;PA445210;Disease
PERIPHERAL NERVOUS SYSTEM DISEASES;rs1128503;Variant;PA445301;Disease
OSTEOSARCOMA;rs1128503;Variant;PA445601;Disease
COLORECTAL NEOPLASMS;rs1128503;Variant;PA446108;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs1128503;Variant;PA446155;Disease
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;rs1128503;Variant;PA446171;Disease
NEUROTOXICITY SYNDROMES;rs1128503;Variant;PA446975;Disease
AUTISM;rs1128503;Variant;PA447198;Disease
HIV INFECTIOUS DISEASE;rs1128503;Variant;PA447230;Disease
MAJOR DEPRESSIVE DISORDER;rs1128503;Variant;PA447321;Disease
CAPECITABINE;rs1128503;Variant;PA448771;Chemical
CARBAMAZEPINE;rs1128503;Variant;PA448785;Chemical
CISPLATIN;rs1128503;Variant;PA449014;Chemical
CLOPIDOGREL;rs1128503;Variant;PA449053;Chemical
CODEINE;rs1128503;Variant;PA449088;Chemical
CYCLOPHOSPHAMIDE;rs1128503;Variant;PA449165;Chemical
CYCLOSPORINE;rs1128503;Variant;PA449167;Chemical
CYTARABINE;rs1128503;Variant;PA449177;Chemical
DIGOXIN;rs1128503;Variant;PA449319;Chemical
DOXORUBICIN;rs1128503;Variant;PA449412;Chemical
EFAVIRENZ;rs1128503;Variant;PA449441;Chemical
FENTANYL;rs1128503;Variant;PA449599;Chemical
METHADONE;rs1128503;Variant;PA450401;Chemical
METHOTREXATE;rs1128503;Variant;PA450428;Chemical
MODAFINIL;rs1128503;Variant;PA450530;Chemical
MORPHINE;rs1128503;Variant;PA450550;Chemical
PACLITAXEL;rs1128503;Variant;PA450761;Chemical
PHENYTOIN;rs1128503;Variant;PA450947;Chemical
PROPOFOL;rs1128503;Variant;PA451141;Chemical
REMIFENTANIL;rs1128503;Variant;PA451232;Chemical
RISPERIDONE;rs1128503;Variant;PA451257;Chemical
SEVOFLURANE;rs1128503;Variant;PA451341;Chemical
SIMVASTATIN;rs1128503;Variant;PA451363;Chemical
SIROLIMUS;rs1128503;Variant;PA451365;Chemical
SUFENTANIL;rs1128503;Variant;PA451527;Chemical
TACROLIMUS;rs1128503;Variant;PA451578;Chemical
TEMOZOLOMIDE;rs1128503;Variant;PA451609;Chemical
TRAMADOL;rs1128503;Variant;PA451735;Chemical
VINCRISTINE;rs1128503;Variant;PA451879;Chemical
ANTIDEPRESSANTS;rs1128503;Variant;PA452229;Chemical
ALLOPURINOL;MYT1L;Gene;PA448320;Chemical
MAJOR DEPRESSIVE DISORDER;P3H3;Gene;PA447321;Disease
SERTRALINE;P3H3;Gene;PA451333;Chemical
SCHIZOPHRENIA;rs17587100;Variant;PA447216;Disease
ANTIPSYCHOTICS;rs17587100;Variant;PA452233;Chemical
FLUOROURACIL;rs112783657;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs112783657;Variant;PA443560;Disease
NEUTROPENIA;rs112783657;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs112783657;Variant;PA449165;Chemical
EPIRUBICIN;rs112783657;Variant;PA449476;Chemical
CYP2D6;Hot Flashes;Disease;PA128;Gene
CYP3A4;Hot Flashes;Disease;PA130;Gene
CYP2D6*1;Hot Flashes;Disease;PA165816576;Haplotype
CYP2D6*4;Hot Flashes;Disease;PA165816579;Haplotype
CYP3A4*1;Hot Flashes;Disease;PA165819201;Haplotype
CYP3A4*22;Hot Flashes;Disease;PA166048680;Haplotype
UGT2B17;Hot Flashes;Disease;PA37189;Gene
DULOXETINE;ANO2;Gene;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;ANO2;Gene;PA447321;Disease
PSYCHOTIC DISORDER;rs1124491;Variant;PA447215;Disease
ANTIPSYCHOTICS;rs1124491;Variant;PA452233;Chemical
PEGASPARGASE;LINC00251;Gene;PA164760860;Chemical
OSTEONECROSIS;LINC00251;Gene;PA445187;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;LINC00251;Gene;PA446155;Disease
CYCLOPHOSPHAMIDE;LINC00251;Gene;PA449165;Chemical
CYTARABINE;LINC00251;Gene;PA449177;Chemical
DAUNORUBICIN;LINC00251;Gene;PA449212;Chemical
DEXAMETHASONE;LINC00251;Gene;PA449247;Chemical
DOXORUBICIN;LINC00251;Gene;PA449412;Chemical
METHOTREXATE;LINC00251;Gene;PA450428;Chemical
PREDNISONE;LINC00251;Gene;PA451100;Chemical
THIOGUANINE;LINC00251;Gene;PA451663;Chemical
VINCRISTINE;LINC00251;Gene;PA451879;Chemical
FLUOROURACIL;rs20572;Variant;PA128406956;Chemical
DOXORUBICINOL;rs20572;Variant;PA165291922;Chemical
BREAST NEOPLASMS;rs20572;Variant;PA443560;Disease
CYCLOPHOSPHAMIDE;rs20572;Variant;PA449165;Chemical
DOXORUBICIN;rs20572;Variant;PA449412;Chemical
USTEKINUMAB;rs3213094;Variant;PA166048654;Chemical
PSORIASIS;rs3213094;Variant;PA445451;Disease
NR1I2;bexarotene;Chemical;PA378;Gene
HIV INFECTIOUS DISEASE;rs28399454;Variant;PA447230;Disease
EFAVIRENZ;rs28399454;Variant;PA449441;Chemical
NICOTINE;rs28399454;Variant;PA450626;Chemical
CHRNA7;galantamine;Chemical;PA114;Gene
CYP2D6;galantamine;Chemical;PA128;Gene
CYP2D6*1;galantamine;Chemical;PA165816576;Haplotype
CYP2D6*3;galantamine;Chemical;PA165816578;Haplotype
CYP2D6*4;galantamine;Chemical;PA165816579;Haplotype
CYP2D6*6;galantamine;Chemical;PA165816581;Haplotype
CYP2D6*41;galantamine;Chemical;PA165816584;Haplotype
CYP2D6*5;galantamine;Chemical;PA165948092;Haplotype
CYP2D6*1XN;galantamine;Chemical;PA165988479;Haplotype
RS2177370;galantamine;Chemical;PA166153998;Variant
RS3793790;galantamine;Chemical;PA166154034;Variant
RS6494223;galantamine;Chemical;PA166154918;Variant
CHAT;galantamine;Chemical;PA26448;Gene
NOS3;l-arginine;Chemical;PA254;Gene
THIAZIDES, PLAIN;SLCO2A1;Gene;PA164713347;Chemical
HYPERTENSION;SLCO2A1;Gene;PA444552;Disease
HYPONATREMIA;SLCO2A1;Gene;PA444575;Disease
DULOXETINE;FCN2;Gene;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;FCN2;Gene;PA447321;Disease
ESCITALOPRAM;BDNF;Gene;PA10074;Chemical
WEIGHT GAIN;BDNF;Gene;PA128406954;Disease
ANALGESICS;BDNF;Gene;PA164712362;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;BDNF;Gene;PA164712462;Chemical
ERGOT ALKALOIDS;BDNF;Gene;PA164712741;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;BDNF;Gene;PA164713257;Chemical
METHAMPHETAMINE DEPENDENCE;BDNF;Gene;PA166119022;Disease
HEROIN DEPENDENCE;BDNF;Gene;PA444460;Disease
OPIOID-RELATED DISORDERS;BDNF;Gene;PA445043;Disease
SUBSTANCE-RELATED DISORDERS;BDNF;Gene;PA446876;Disease
DEPRESSIVE DISORDER;BDNF;Gene;PA447207;Disease
SCHIZOPHRENIA;BDNF;Gene;PA447216;Disease
DEPRESSION;BDNF;Gene;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;BDNF;Gene;PA447321;Disease
CITALOPRAM;BDNF;Gene;PA449015;Chemical
DESIPRAMINE;BDNF;Gene;PA449233;Chemical
FLUOXETINE;BDNF;Gene;PA449673;Chemical
LITHIUM;BDNF;Gene;PA450243;Chemical
METHADONE;BDNF;Gene;PA450401;Chemical
METHAMPHETAMINE;BDNF;Gene;PA450403;Chemical
NORTRIPTYLINE;BDNF;Gene;PA450657;Chemical
OLANZAPINE;BDNF;Gene;PA450688;Chemical
PAROXETINE;BDNF;Gene;PA450801;Chemical
SUMATRIPTAN;BDNF;Gene;PA451566;Chemical
ANTIDEPRESSANTS;BDNF;Gene;PA452229;Chemical
ANTIPSYCHOTICS;BDNF;Gene;PA452233;Chemical
OPIOIDS;BDNF;Gene;PA452618;Chemical
HEROIN;BDNF;Gene;PA452619;Chemical
FLUOROURACIL;rs140989814;Variant;PA128406956;Chemical
DRUG TOXICITY;rs140989814;Variant;PA443937;Disease
ANTHRACYCLINES AND RELATED SUBSTANCES;CYP4F2;Gene;PA130620651;Chemical
VITAMIN K AND ANALOGUES;CYP4F2;Gene;PA164713404;Chemical
ACUTE CORONARY SYNDROME;CYP4F2;Gene;PA165108401;Disease
CYP2C9*2;CYP4F2;Gene;PA165816543;Haplotype
CYP2C9*3;CYP4F2;Gene;PA165816544;Haplotype
CYP2C9*5;CYP4F2;Gene;PA165816546;Haplotype
CYP2C9*6;CYP4F2;Gene;PA165816547;Haplotype
CYP2C9*8;CYP4F2;Gene;PA165816549;Haplotype
CYP2C9*11;CYP4F2;Gene;PA165816552;Haplotype
DB-289;CYP4F2;Gene;PA166122486;Chemical
OVER-ANTICOAGULATION;CYP4F2;Gene;PA166123298;Disease
TIME TO THERAPEUTIC INR;CYP4F2;Gene;PA166129532;Disease
RS12777823;CYP4F2;Gene;PA166154157;Variant
RS9923231;CYP4F2;Gene;PA166155091;Variant
RS2108622;CYP4F2;Gene;PA166155381;Variant
ARACHIDONIC ACID;CYP4F2;Gene;PA166178659;Chemical
VITAMIN K1;CYP4F2;Gene;PA166197681;Chemical
ATRIAL FIBRILLATION;CYP4F2;Gene;PA443459;Disease
HEMORRHAGE;CYP4F2;Gene;PA444417;Disease
NEOPLASMS;CYP4F2;Gene;PA445062;Disease
ESSENTIAL HYPERTENSION;CYP4F2;Gene;PA447288;Disease
ASPIRIN;CYP4F2;Gene;PA448497;Chemical
CLOFIBRATE;CYP4F2;Gene;PA449045;Chemical
CLOPIDOGREL;CYP4F2;Gene;PA449053;Chemical
KETOCONAZOLE;CYP4F2;Gene;PA450146;Chemical
LOVASTATIN;CYP4F2;Gene;PA450272;Chemical
PHENPROCOUMON;CYP4F2;Gene;PA450921;Chemical
VITAMIN E;CYP4F2;Gene;PA451900;Chemical
WARFARIN;CYP4F2;Gene;PA451906;Chemical
ACENOCOUMAROL;CYP4F2;Gene;PA452632;Chemical
HLA-DRB1*07:01;clavulanate;Chemical;PA165951644;Haplotype
HLA-DRB1*15:01;clavulanate;Chemical;PA165952269;Haplotype
HLA-DRB5*01:01;clavulanate;Chemical;PA165952460;Haplotype
HLA-A*30:02;clavulanate;Chemical;PA165953969;Haplotype
HLA-B*18:01;clavulanate;Chemical;PA165955030;Haplotype
HLA-C*06:02;clavulanate;Chemical;PA165957286;Haplotype
HLA-DQB1*06:02;clavulanate;Chemical;PA165958103;Haplotype
HLA-DQB1*03:03;clavulanate;Chemical;PA165958180;Haplotype
HLA-B*57:01;clavulanate;Chemical;PA165987830;Haplotype
RS9274407;clavulanate;Chemical;PA166157135;Variant
HLA-A;clavulanate;Chemical;PA35055;Gene
HLA-B;clavulanate;Chemical;PA35056;Gene
HLA-C;clavulanate;Chemical;PA35057;Gene
HLA-DQB1;clavulanate;Chemical;PA35068;Gene
HLA-DRB1;clavulanate;Chemical;PA35072;Gene
HLA-DRB5;clavulanate;Chemical;PA35076;Gene
CYP2B6;midazolam;Chemical;PA123;Gene
CYP3A4;midazolam;Chemical;PA130;Gene
CYP3A5;midazolam;Chemical;PA131;Gene
CYP3A4*1;midazolam;Chemical;PA165819201;Haplotype
CYP3A4*20;midazolam;Chemical;PA165819244;Haplotype
CYP3A4*22;midazolam;Chemical;PA166048680;Haplotype
CYP3A5*1;midazolam;Chemical;PA166128213;Haplotype
CYP3A5*3;midazolam;Chemical;PA166128219;Haplotype
RS1544410;midazolam;Chemical;PA166154516;Variant
RS4516035;midazolam;Chemical;PA166154592;Variant
RS11568820;midazolam;Chemical;PA166154640;Variant
RS1057868;midazolam;Chemical;PA166157286;Variant
RS12721627;midazolam;Chemical;PA166157460;Variant
RS35599367;midazolam;Chemical;PA166157487;Variant
CYP3A4*39;midazolam;Chemical;PA166313069;Haplotype
CYP3A4*40;midazolam;Chemical;PA166313070;Haplotype
CYP3A4*41;midazolam;Chemical;PA166313071;Haplotype
CYP3A4*42;midazolam;Chemical;PA166313072;Haplotype
CYP3A4*43;midazolam;Chemical;PA166313073;Haplotype
CYP3A4*44;midazolam;Chemical;PA166313074;Haplotype
CYP3A4*46;midazolam;Chemical;PA166313076;Haplotype
ABCB1;midazolam;Chemical;PA267;Gene
POR;midazolam;Chemical;PA33532;Gene
UGT1A4;midazolam;Chemical;PA37179;Gene
VDR;midazolam;Chemical;PA37301;Gene
RS4148157;topotecan;Chemical;PA166156582;Variant
ABCB1;topotecan;Chemical;PA267;Gene
DDO;topotecan;Chemical;PA27194;Gene
ABCG2;topotecan;Chemical;PA390;Gene
OTOTOXICITY;rs1051640;Variant;PA162263534;Disease
DRUG TOXICITY;rs1051640;Variant;PA443937;Disease
NEOPLASMS;rs1051640;Variant;PA445062;Disease
CISPLATIN;rs1051640;Variant;PA449014;Chemical
PLATINUM COMPOUNDS;rs10759637;Variant;PA164713176;Chemical
OVERALL SURVIVAL;rs10759637;Variant;PA166123207;Disease
THROMBOCYTOPENIA;rs10759637;Variant;PA445846;Disease
RS2231137;resmetirom;Chemical;PA166156543;Variant
RS2231142;resmetirom;Chemical;PA166156544;Variant
ABCG2;resmetirom;Chemical;PA390;Gene
MAPK8;MAFF;Gene;PA283;Gene
MAPK14;MAFF;Gene;PA30621;Gene
ARIPIPRAZOLE;rs1799732;Variant;PA10026;Chemical
NEMONAPRIDE;rs1799732;Variant;PA151186253;Chemical
BROMPERIDOL;rs1799732;Variant;PA165282097;Chemical
SCHIZOAFFECTIVE DISORDER;rs1799732;Variant;PA166123368;Disease
ALCOHOL ABUSE;rs1799732;Variant;PA443309;Disease
PARKINSON DISEASE;rs1799732;Variant;PA445254;Disease
TOBACCO USE DISORDER;rs1799732;Variant;PA445876;Disease
PSYCHOTIC DISORDER;rs1799732;Variant;PA447215;Disease
SCHIZOPHRENIA;rs1799732;Variant;PA447216;Disease
ETHANOL;rs1799732;Variant;PA448073;Chemical
BUPROPION;rs1799732;Variant;PA448687;Chemical
LEVODOPA;rs1799732;Variant;PA450213;Chemical
NICOTINE;rs1799732;Variant;PA450626;Chemical
OLANZAPINE;rs1799732;Variant;PA450688;Chemical
RISPERIDONE;rs1799732;Variant;PA451257;Chemical
ANTIPSYCHOTICS;rs1799732;Variant;PA452233;Chemical
LOSARTAN;CYP2C9*75;Haplotype;PA450268;Chemical
CETUXIMAB;rs2227983;Variant;PA10040;Chemical
EGFR INHIBITORS;rs2227983;Variant;PA153561371;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs2227983;Variant;PA443622;Disease
HEAD AND NECK NEOPLASMS;rs2227983;Variant;PA444352;Disease
NEOPLASMS;rs2227983;Variant;PA445062;Disease
PANCREATIC NEOPLASMS;rs2227983;Variant;PA445218;Disease
COLORECTAL NEOPLASMS;rs2227983;Variant;PA446108;Disease
GPAM;PRKAA2;Gene;PA134983031;Gene
CRTC2;PRKAA2;Gene;PA142672073;Gene
HMGCR;PRKAA2;Gene;PA189;Gene
ACACA;PRKAA2;Gene;PA24421;Gene
ACACB;PRKAA2;Gene;PA24422;Gene
MLYCD;PRKAA2;Gene;PA30861;Gene
SREBF1;PRKAA2;Gene;PA335;Gene
SLC2A4;PRKAA2;Gene;PA35879;Gene
STK11;PRKAA2;Gene;PA36198;Gene
MLXIPL;PRKAA2;Gene;PA37353;Gene
SIRT1;PRKAA2;Gene;PA37935;Gene
METFORMIN;PRKAA2;Gene;PA450395;Chemical
ATM;PRKAA2;Gene;PA61;Gene
ATP1A1;PRKAA2;Gene;PA62;Gene
SULFONAMIDES, UREA DERIVATIVES;Fibrates;Chemical;PA10390;Chemical
NON-SMALL CELL LUNG CARCINOMA;DSCAM;Gene;PA443622;Disease
NEOPLASMS;DSCAM;Gene;PA445062;Disease
CARBOPLATIN;DSCAM;Gene;PA448803;Chemical
PACLITAXEL;DSCAM;Gene;PA450761;Chemical
CYP2D6;disopyramide;Chemical;PA128;Gene
RS104894021;disopyramide;Chemical;PA166183768;Variant
KCNH2;disopyramide;Chemical;PA212;Gene
SCN5A;disopyramide;Chemical;PA304;Gene
CYP2C19;Systemic lupus erythematosus;Disease;PA124;Gene
CYP3A5;Systemic lupus erythematosus;Disease;PA131;Gene
TPMT*1;Systemic lupus erythematosus;Disease;PA165819268;Haplotype
TPMT*21;Systemic lupus erythematosus;Disease;PA165819291;Haplotype
TPMT*24;Systemic lupus erythematosus;Disease;PA165819295;Haplotype
TPMT*25;Systemic lupus erythematosus;Disease;PA165819296;Haplotype
TPMT*32;Systemic lupus erythematosus;Disease;PA166005223;Haplotype
TPMT*33;Systemic lupus erythematosus;Disease;PA166005224;Haplotype
TPMT*34;Systemic lupus erythematosus;Disease;PA166005225;Haplotype
TPMT*37;Systemic lupus erythematosus;Disease;PA166119185;Haplotype
CYP3A5*1;Systemic lupus erythematosus;Disease;PA166128213;Haplotype
CYP3A5*3;Systemic lupus erythematosus;Disease;PA166128219;Haplotype
RS4244285;Systemic lupus erythematosus;Disease;PA166154053;Variant
RS1127354;Systemic lupus erythematosus;Disease;PA166155915;Variant
RS6822844;Systemic lupus erythematosus;Disease;PA166156610;Variant
IL2;Systemic lupus erythematosus;Disease;PA195;Gene
ITPA;Systemic lupus erythematosus;Disease;PA29973;Gene
TPMT;Systemic lupus erythematosus;Disease;PA356;Gene
SLC29A4;metformin;Chemical;PA134976472;Gene
C11ORF65;metformin;Chemical;PA144596484;Gene
SLC47A1;metformin;Chemical;PA162403808;Gene
SLC47A2;metformin;Chemical;PA162403847;Gene
RS7541245;metformin;Chemical;PA166153791;Variant
RS5219;metformin;Chemical;PA166154256;Variant
RS11212617;metformin;Chemical;PA166154450;Variant
RS784888;metformin;Chemical;PA166154503;Variant
RS784892;metformin;Chemical;PA166154504;Variant
RS2683511;metformin;Chemical;PA166154554;Variant
RS10747673;metformin;Chemical;PA166154613;Variant
RS2252281;metformin;Chemical;PA166155204;Variant
RS2289669;metformin;Chemical;PA166155206;Variant
RS12943590;metformin;Chemical;PA166155251;Variant
RS34834489;metformin;Chemical;PA166155262;Variant
RS3792269;metformin;Chemical;PA166155711;Variant
RS149711321;metformin;Chemical;PA166156212;Variant
RS316019;metformin;Chemical;PA166156913;Variant
RS578427;metformin;Chemical;PA166156929;Variant
RS594709;metformin;Chemical;PA166156930;Variant
RS622342;metformin;Chemical;PA166156932;Variant
RS628031;metformin;Chemical;PA166156933;Variant
RS2076828;metformin;Chemical;PA166157016;Variant
RS2282143;metformin;Chemical;PA166157032;Variant
RS8187725;metformin;Chemical;PA166157132;Variant
RS12208357;metformin;Chemical;PA166157178;Variant
RS36056065;metformin;Chemical;PA166157203;Variant
RS72552763;metformin;Chemical;PA166157216;Variant
RS8192675;metformin;Chemical;PA166159968;Variant
RS2954625;metformin;Chemical;PA166160922;Variant
RS254271;metformin;Chemical;PA166178547;Variant
RS57081354;metformin;Chemical;PA166178579;Variant
RS2162145;metformin;Chemical;PA166178583;Variant
KCNJ11;metformin;Chemical;PA217;Gene
AMHR2;metformin;Chemical;PA24770;Gene
CAPN10;metformin;Chemical;PA26058;Gene
CSMD1;metformin;Chemical;PA26947;Gene
PPARA;metformin;Chemical;PA280;Gene
FMO5;metformin;Chemical;PA28189;Gene
NBEA;metformin;Chemical;PA31454;Gene
SLC22A1;metformin;Chemical;PA329;Gene
SLC22A3;metformin;Chemical;PA330;Gene
SLC22A2;metformin;Chemical;PA331;Gene
PRKAA1;metformin;Chemical;PA33744;Gene
PRKAA2;metformin;Chemical;PA33745;Gene
PRKAB1;metformin;Chemical;PA33746;Gene
PRKAB2;metformin;Chemical;PA33747;Gene
PRKAG1;metformin;Chemical;PA33751;Gene
PRKAG2;metformin;Chemical;PA33752;Gene
PRKAG3;metformin;Chemical;PA33753;Gene
PRPF31;metformin;Chemical;PA33814;Gene
SLC2A2;metformin;Chemical;PA35876;Gene
SP1;metformin;Chemical;PA36042;Gene
NR1I2;metformin;Chemical;PA378;Gene
SLC19A3;metformin;Chemical;PA38397;Gene
CPA6;metformin;Chemical;PA38444;Gene
ATM;metformin;Chemical;PA61;Gene
ESCITALOPRAM;SLC6A4 HTTLPR short form (S allele);Haplotype;PA10074;Chemical
WEIGHT GAIN;SLC6A4 HTTLPR short form (S allele);Haplotype;PA128406954;Disease
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;SLC6A4 HTTLPR short form (S allele);Haplotype;PA164713257;Chemical
PEGINTERFERON ALFA-2B;SLC6A4 HTTLPR short form (S allele);Haplotype;PA164784024;Chemical
ALCOHOLISM;SLC6A4 HTTLPR short form (S allele);Haplotype;PA443309;Disease
DEMENTIA;SLC6A4 HTTLPR short form (S allele);Haplotype;PA443853;Disease
DIZZINESS;SLC6A4 HTTLPR short form (S allele);Haplotype;PA443928;Disease
DRUG TOXICITY;SLC6A4 HTTLPR short form (S allele);Haplotype;PA443937;Disease
OPIOID-RELATED DISORDERS;SLC6A4 HTTLPR short form (S allele);Haplotype;PA445043;Disease
TOBACCO USE DISORDER;SLC6A4 HTTLPR short form (S allele);Haplotype;PA445876;Disease
HEPATITIS C, CHRONIC;SLC6A4 HTTLPR short form (S allele);Haplotype;PA446863;Disease
COCAINE-RELATED DISORDERS;SLC6A4 HTTLPR short form (S allele);Haplotype;PA446878;Disease
ANXIETY DISORDERS;SLC6A4 HTTLPR short form (S allele);Haplotype;PA447196;Disease
DEPRESSIVE DISORDER;SLC6A4 HTTLPR short form (S allele);Haplotype;PA447207;Disease
MOOD DISORDERS;SLC6A4 HTTLPR short form (S allele);Haplotype;PA447209;Disease
OBSESSIVE-COMPULSIVE DISORDER;SLC6A4 HTTLPR short form (S allele);Haplotype;PA447211;Disease
PANIC DISORDER;SLC6A4 HTTLPR short form (S allele);Haplotype;PA447212;Disease
SCHIZOPHRENIA;SLC6A4 HTTLPR short form (S allele);Haplotype;PA447216;Disease
SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;SLC6A4 HTTLPR short form (S allele);Haplotype;PA447218;Disease
DEPRESSION;SLC6A4 HTTLPR short form (S allele);Haplotype;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;SLC6A4 HTTLPR short form (S allele);Haplotype;PA447321;Disease
ETHANOL;SLC6A4 HTTLPR short form (S allele);Haplotype;PA448073;Chemical
BUPRENORPHINE;SLC6A4 HTTLPR short form (S allele);Haplotype;PA448685;Chemical
BUPROPION;SLC6A4 HTTLPR short form (S allele);Haplotype;PA448687;Chemical
CITALOPRAM;SLC6A4 HTTLPR short form (S allele);Haplotype;PA449015;Chemical
CLOMIPRAMINE;SLC6A4 HTTLPR short form (S allele);Haplotype;PA449048;Chemical
CLOZAPINE;SLC6A4 HTTLPR short form (S allele);Haplotype;PA449061;Chemical
DISULFIRAM;SLC6A4 HTTLPR short form (S allele);Haplotype;PA449376;Chemical
FLUOXETINE;SLC6A4 HTTLPR short form (S allele);Haplotype;PA449673;Chemical
FLUVOXAMINE;SLC6A4 HTTLPR short form (S allele);Haplotype;PA449690;Chemical
HALOPERIDOL;SLC6A4 HTTLPR short form (S allele);Haplotype;PA449841;Chemical
METHADONE;SLC6A4 HTTLPR short form (S allele);Haplotype;PA450401;Chemical
MIRTAZAPINE;SLC6A4 HTTLPR short form (S allele);Haplotype;PA450522;Chemical
OLANZAPINE;SLC6A4 HTTLPR short form (S allele);Haplotype;PA450688;Chemical
ONDANSETRON;SLC6A4 HTTLPR short form (S allele);Haplotype;PA450705;Chemical
PAROXETINE;SLC6A4 HTTLPR short form (S allele);Haplotype;PA450801;Chemical
QUETIAPINE;SLC6A4 HTTLPR short form (S allele);Haplotype;PA451201;Chemical
RIBAVIRIN;SLC6A4 HTTLPR short form (S allele);Haplotype;PA451241;Chemical
RISPERIDONE;SLC6A4 HTTLPR short form (S allele);Haplotype;PA451257;Chemical
SERTRALINE;SLC6A4 HTTLPR short form (S allele);Haplotype;PA451333;Chemical
VENLAFAXINE;SLC6A4 HTTLPR short form (S allele);Haplotype;PA451866;Chemical
ANTIDEPRESSANTS;SLC6A4 HTTLPR short form (S allele);Haplotype;PA452229;Chemical
ANTIPSYCHOTICS;SLC6A4 HTTLPR short form (S allele);Haplotype;PA452233;Chemical
DSE;abiraterone;Chemical;PA162384080;Gene
RS3828743;abiraterone;Chemical;PA166179651;Variant
RS523349;abiraterone;Chemical;PA166263961;Variant
CYP17A1;abiraterone;Chemical;PA27090;Gene
SRD5A2;abiraterone;Chemical;PA36113;Gene
TSPYL1;abiraterone;Chemical;PA37050;Gene
RS6166;menotropins;Chemical;PA166155582;Variant
FSHR;menotropins;Chemical;PA28386;Gene
CYP3A5;sibutramine;Chemical;PA131;Gene
RS5443;sibutramine;Chemical;PA166154486;Variant
GNB3;sibutramine;Chemical;PA176;Gene
EPILEPSY;UGT1A6*3a;Haplotype;PA444065;Disease
VALPROIC ACID;UGT1A6*3a;Haplotype;PA451846;Chemical
CFTR;rs200321110;Variant;PA109;Gene
IVACAFTOR;rs200321110;Variant;PA165950341;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs200321110;Variant;PA166190041;Chemical
CYP3A5;Virus Diseases;Disease;PA131;Gene
CYP3A5*1;Virus Diseases;Disease;PA166128213;Haplotype
CYP3A5*3;Virus Diseases;Disease;PA166128219;Haplotype
CFTR;rs121908755;Variant;PA109;Gene
IVACAFTOR;rs121908755;Variant;PA165950341;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs121908755;Variant;PA166190041;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs121908755;Variant;PA166362502;Chemical
CYSTIC FIBROSIS;rs121908755;Variant;PA443829;Disease
C18ORF56;hydroxychloroquine;Chemical;PA134956204;Gene
RS1805087;hydroxychloroquine;Chemical;PA166153654;Variant
RS45445694;hydroxychloroquine;Chemical;PA166155331;Variant
RS11280056;hydroxychloroquine;Chemical;PA166180936;Variant
G6PD;hydroxychloroquine;Chemical;PA28469;Gene
MTR;hydroxychloroquine;Chemical;PA31272;Gene
TYMS;hydroxychloroquine;Chemical;PA359;Gene
CFTR;adverse events;Disease;PA109;Gene
COMT;adverse events;Disease;PA117;Gene
CYP2C19;adverse events;Disease;PA124;Gene
CYP2C9;adverse events;Disease;PA126;Gene
CYP2D6;adverse events;Disease;PA128;Gene
CYP3A4;adverse events;Disease;PA130;Gene
CYP3A5;adverse events;Disease;PA131;Gene
FIP1L1;adverse events;Disease;PA134875694;Gene
WBP2NL;adverse events;Disease;PA145147710;Gene
CYP2C9*1;adverse events;Disease;PA165816542;Haplotype
CYP2C9*2;adverse events;Disease;PA165816543;Haplotype
CYP2C9*3;adverse events;Disease;PA165816544;Haplotype
CYP2D6*1;adverse events;Disease;PA165816576;Haplotype
CYP2D6*4;adverse events;Disease;PA165816579;Haplotype
CYP2D6*6;adverse events;Disease;PA165816581;Haplotype
CYP3A4*1;adverse events;Disease;PA165819201;Haplotype
NAT2*4;adverse events;Disease;PA165949098;Haplotype
NAT2*5A;adverse events;Disease;PA165949099;Haplotype
HLA-A*11:01;adverse events;Disease;PA165953358;Haplotype
CYP2C19*1;adverse events;Disease;PA165980634;Haplotype
CYP2C19*2;adverse events;Disease;PA165980635;Haplotype
NAT2*5;adverse events;Disease;PA165981634;Haplotype
NAT2*6;adverse events;Disease;PA165981635;Haplotype
NAT2*7;adverse events;Disease;PA165981636;Haplotype
NAT2*14;adverse events;Disease;PA165981640;Haplotype
CYP3A4*22;adverse events;Disease;PA166048680;Haplotype
UGT1A1*1;adverse events;Disease;PA166115841;Haplotype
UGT1A1*28;adverse events;Disease;PA166115842;Haplotype
CYP3A5*1;adverse events;Disease;PA166128213;Haplotype
CYP3A5*3;adverse events;Disease;PA166128219;Haplotype
RS6311;adverse events;Disease;PA166154673;Variant
RS6313;adverse events;Disease;PA166154675;Variant
RS4240803;adverse events;Disease;PA166155063;Variant
RS1045280;adverse events;Disease;PA166155174;Variant
RS45445694;adverse events;Disease;PA166155331;Variant
RS1799793;adverse events;Disease;PA166155371;Variant
RS2838956;adverse events;Disease;PA166156004;Variant
RS4680;adverse events;Disease;PA166156024;Variant
RS2236624;adverse events;Disease;PA166156088;Variant
RS2472677;adverse events;Disease;PA166156358;Variant
RS3814055;adverse events;Disease;PA166156383;Variant
RS1799971;adverse events;Disease;PA166156991;Variant
RS113993960;adverse events;Disease;PA166157525;Variant
RS1799930;adverse events;Disease;PA166157564;Variant
RS1799931;adverse events;Disease;PA166157565;Variant
RS10774053;adverse events;Disease;PA166163612;Variant
RS115346678;adverse events;Disease;PA166257821;Variant
RS9620007;adverse events;Disease;PA166257822;Variant
RS34545984;adverse events;Disease;PA166257841;Variant
RS62436463;adverse events;Disease;PA166257861;Variant
RS739296;adverse events;Disease;PA166257862;Variant
RS11049274;adverse events;Disease;PA166257863;Variant
RS113100019;adverse events;Disease;PA166257864;Variant
RS185462714;adverse events;Disease;PA166257865;Variant
RS115200108;adverse events;Disease;PA166257881;Variant
RS76103438;adverse events;Disease;PA166257882;Variant
RS16906115;adverse events;Disease;PA166344461;Variant
NAT2;adverse events;Disease;PA18;Gene
HTR2A;adverse events;Disease;PA193;Gene
SEPTIN3;adverse events;Disease;PA24355;Gene
ADORA2A;adverse events;Disease;PA24584;Gene
ERCC2;adverse events;Disease;PA27848;Gene
IL7;adverse events;Disease;PA29839;Gene
OPRM1;adverse events;Disease;PA31945;Gene
SLC19A1;adverse events;Disease;PA327;Gene
HLA-A;adverse events;Disease;PA35055;Gene
TYMS;adverse events;Disease;PA359;Gene
SLC7A5;adverse events;Disease;PA35923;Gene
NR1I2;adverse events;Disease;PA378;Gene
SERINC5;adverse events;Disease;PA38698;Gene
UGT1A1;adverse events;Disease;PA420;Gene
ARRB2;adverse events;Disease;PA60;Gene
CACNA1C;adverse events;Disease;PA83;Gene
PLATINUM COMPOUNDS;IL16;Gene;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;IL16;Gene;PA443622;Disease
CELECOXIB;DDIT3;Gene;PA448871;Chemical
NON-SMALL CELL LUNG CARCINOMA;SLC29A3;Gene;PA443622;Disease
GEMCITABINE;SLC29A3;Gene;PA449748;Chemical
UGT1A1*1;raloxifene-4ƒ?ý-glucuronide;Chemical;PA166115841;Haplotype
UGT1A1*28;raloxifene-4ƒ?ý-glucuronide;Chemical;PA166115842;Haplotype
UGT1A1;raloxifene-4ƒ?ý-glucuronide;Chemical;PA420;Gene
PROSTATIC NEOPLASMS;rs1402467;Variant;PA445425;Disease
DOCETAXEL;rs1402467;Variant;PA449383;Chemical
THALIDOMIDE;rs1402467;Variant;PA451644;Chemical
MAJOR DEPRESSIVE DISORDER;rs2227631;Variant;PA447321;Disease
CITALOPRAM;rs2227631;Variant;PA449015;Chemical
FLUOXETINE;rs2227631;Variant;PA449673;Chemical
ANTIDEPRESSANTS;rs2227631;Variant;PA452229;Chemical
GP1BB;COL4A1;Gene;PA179;Gene
ITGA2;COL4A1;Gene;PA204;Gene
CD36;COL4A1;Gene;PA26212;Gene
GP5;COL4A1;Gene;PA28823;Gene
GP6;COL4A1;Gene;PA28824;Gene
GP9;COL4A1;Gene;PA28825;Gene
CARDIOVASCULAR DISEASES;COL4A1;Gene;PA443635;Disease
PLCH1;CASR;Gene;PA128394595;Gene
PLCZ1;CASR;Gene;PA134875646;Gene
PLCH2;CASR;Gene;PA134914471;Gene
PARATHYROID HORMONES AND ANALOGUES;CASR;Gene;PA164713150;Chemical
PLCB1;CASR;Gene;PA33384;Gene
PLCB2;CASR;Gene;PA33385;Gene
PLCB3;CASR;Gene;PA33386;Gene
PLCB4;CASR;Gene;PA33387;Gene
PLCD1;CASR;Gene;PA33388;Gene
PLCD3;CASR;Gene;PA33389;Gene
PLCD4;CASR;Gene;PA33390;Gene
PLCE1;CASR;Gene;PA33391;Gene
PLCG1;CASR;Gene;PA33392;Gene
PLCG2;CASR;Gene;PA33393;Gene
PLCL1;CASR;Gene;PA33394;Gene
PLCL2;CASR;Gene;PA33395;Gene
CASP9;CASP3;Gene;PA26094;Gene
CELECOXIB;CASP3;Gene;PA448871;Chemical
CCNB1;CASP3;Gene;PA95;Gene
CYP2D6;Dementia;Disease;PA128;Gene
CYP2D6*1;Dementia;Disease;PA165816576;Haplotype
CYP2D6*3;Dementia;Disease;PA165816578;Haplotype
CYP2D6*4;Dementia;Disease;PA165816579;Haplotype
CYP2D6*6;Dementia;Disease;PA165816581;Haplotype
CYP2D6*41;Dementia;Disease;PA165816584;Haplotype
CYP2D6*5;Dementia;Disease;PA165948092;Haplotype
CYP2D6*1XN;Dementia;Disease;PA165988479;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);Dementia;Disease;PA166116466;Haplotype
SLC6A4 L ALLELE-RS25531T;Dementia;Disease;PA166117146;Haplotype
SLC6A4 L ALLELE-RS25531C;Dementia;Disease;PA166117147;Haplotype
RS1523130;Dementia;Disease;PA166156323;Variant
SLC6A4;Dementia;Disease;PA312;Gene
NR1I2;Dementia;Disease;PA378;Gene
ADALIMUMAB;KLRC1;Gene;PA10004;Chemical
CERTOLIZUMAB PEGOL;KLRC1;Gene;PA165107055;Chemical
RHEUMATOID ARTHRITIS;KLRC1;Gene;PA443434;Disease
ETANERCEPT;KLRC1;Gene;PA449515;Chemical
METHOTREXATE;KLRC1;Gene;PA450428;Chemical
GLUCOCORTICOIDS;KLRC1;Gene;PA452347;Chemical
INFLIXIMAB;KLRC1;Gene;PA452639;Chemical
PTEN;Hamartoma Syndrome, Multiple;Disease;PA33942;Gene
ATG16L1;Crohn Disease;Disease;PA134902949;Gene
FTO;Crohn Disease;Disease;PA152208656;Gene
TPMT*1;Crohn Disease;Disease;PA165819268;Haplotype
TPMT*2;Crohn Disease;Disease;PA165819269;Haplotype
TPMT*3A;Crohn Disease;Disease;PA165819270;Haplotype
TPMT*3B;Crohn Disease;Disease;PA165819271;Haplotype
TPMT*3C;Crohn Disease;Disease;PA165819272;Haplotype
TPMT*7;Crohn Disease;Disease;PA165819277;Haplotype
TPMT*9;Crohn Disease;Disease;PA165819279;Haplotype
TPMT*10;Crohn Disease;Disease;PA165819280;Haplotype
TPMT*12;Crohn Disease;Disease;PA165819282;Haplotype
TPMT*13;Crohn Disease;Disease;PA165819283;Haplotype
TPMT*16;Crohn Disease;Disease;PA165819286;Haplotype
TPMT*17;Crohn Disease;Disease;PA165819287;Haplotype
TPMT*18;Crohn Disease;Disease;PA165819288;Haplotype
TPMT*23;Crohn Disease;Disease;PA165819293;Haplotype
NAT1*4;Crohn Disease;Disease;PA165958462;Haplotype
NAT1*3;Crohn Disease;Disease;PA165958463;Haplotype
NAT1*10;Crohn Disease;Disease;PA165958465;Haplotype
GSTM1 NULL;Crohn Disease;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Crohn Disease;Disease;PA166048676;Haplotype
RS2430561;Crohn Disease;Disease;PA166154549;Variant
RS4149570;Crohn Disease;Disease;PA166154585;Variant
RS1143634;Crohn Disease;Disease;PA166155630;Variant
RS10210302;Crohn Disease;Disease;PA166155785;Variant
RS352139;Crohn Disease;Disease;PA166156288;Variant
RS1799852;Crohn Disease;Disease;PA166156328;Variant
RS1816702;Crohn Disease;Disease;PA166156526;Variant
RS1799724;Crohn Disease;Disease;PA166156988;Variant
RS1800629;Crohn Disease;Disease;PA166156997;Variant
RS2071303;Crohn Disease;Disease;PA166157009;Variant
RS4713916;Crohn Disease;Disease;PA166157104;Variant
RS16952570;Crohn Disease;Disease;PA166160979;Variant
RS9828223;Crohn Disease;Disease;PA166196821;Variant
NAT1;Crohn Disease;Disease;PA17;Gene
GSTM1;Crohn Disease;Disease;PA182;Gene
FKBP5;Crohn Disease;Disease;PA28162;Gene
HFE;Crohn Disease;Disease;PA29263;Gene
IFNG;Crohn Disease;Disease;PA29674;Gene
IL1B;Crohn Disease;Disease;PA29808;Gene
TPMT;Crohn Disease;Disease;PA356;Gene
TF;Crohn Disease;Disease;PA36457;Gene
TLR2;Crohn Disease;Disease;PA36550;Gene
TNFRSF1A;Crohn Disease;Disease;PA36609;Gene
NR1I2;Crohn Disease;Disease;PA378;Gene
TLR9;Crohn Disease;Disease;PA38010;Gene
TNF;Crohn Disease;Disease;PA435;Gene
SCHIZOPHRENIA;rs785423;Variant;PA447216;Disease
RISPERIDONE;rs785423;Variant;PA451257;Chemical
CETP;Hyperlipoproteinemia Type II;Disease;PA108;Gene
MTTP;Hyperlipoproteinemia Type II;Disease;PA164742099;Gene
RS708272;Hyperlipoproteinemia Type II;Disease;PA166154993;Variant
RS1800591;Hyperlipoproteinemia Type II;Disease;PA166156523;Variant
RS2032582;Hyperlipoproteinemia Type II;Disease;PA166157316;Variant
ABCB1;Hyperlipoproteinemia Type II;Disease;PA267;Gene
MYELOSUPPRESSION;TPMT*12;Haplotype;PA165817398;Disease
DISCONTINUATION;TPMT*12;Haplotype;PA166123507;Disease
TPMT;TPMT*12;Haplotype;PA356;Gene
CROHN DISEASE;TPMT*12;Haplotype;PA443815;Disease
DRUG TOXICITY;TPMT*12;Haplotype;PA443937;Disease
INFLAMMATION;TPMT*12;Haplotype;PA444620;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;TPMT*12;Haplotype;PA446155;Disease
AZATHIOPRINE;TPMT*12;Haplotype;PA448515;Chemical
MERCAPTOPURINE;TPMT*12;Haplotype;PA450379;Chemical
METHOTREXATE;TPMT*12;Haplotype;PA450428;Chemical
THIOGUANINE;TPMT*12;Haplotype;PA451663;Chemical
SEVERE CUTANEOUS ADVERSE REACTIONS;rs2844665;Variant;PA166120929;Disease
EPIDERMAL NECROLYSIS, TOXIC;rs2844665;Variant;PA444059;Disease
STEVENS-JOHNSON SYNDROME;rs2844665;Variant;PA445738;Disease
ALLOPURINOL;rs2844665;Variant;PA448320;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;rs11045872;Variant;PA446155;Disease
METHOTREXATE;rs11045872;Variant;PA450428;Chemical
ILOPERIDONE;CELF4;Gene;PA161199368;Chemical
ACQUIRED LONG QT SYNDROME (ALQTS);CELF4;Gene;PA447300;Disease
CFTR;rs121909019;Variant;PA109;Gene
IVACAFTOR;rs121909019;Variant;PA165950341;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs121909019;Variant;PA166190041;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs121909019;Variant;PA166362502;Chemical
CYSTIC FIBROSIS;rs121909019;Variant;PA443829;Disease
G6PD;toluidine blue;Chemical;PA28469;Gene
DRD1;Sepsis;Disease;PA147;Gene
F5;Sepsis;Disease;PA159;Gene
RS7725278;Sepsis;Disease;PA166156848;Variant
BIPOLAR DISORDER;GSK3B;Gene;PA447199;Disease
MAJOR DEPRESSIVE DISORDER;GSK3B;Gene;PA447321;Disease
CITALOPRAM;GSK3B;Gene;PA449015;Chemical
FLUOXETINE;GSK3B;Gene;PA449673;Chemical
LITHIUM;GSK3B;Gene;PA450243;Chemical
FLUOROURACIL;rs3918290;Variant;PA128406956;Chemical
DPYD;rs3918290;Variant;PA145;Gene
NEOPLASMS;rs3918290;Variant;PA445062;Disease
CAPECITABINE;rs3918290;Variant;PA448771;Chemical
TEGAFUR;rs3918290;Variant;PA452620;Chemical
CARDIOVASCULAR DISEASE;rs3846662;Variant;PA443635;Disease
SIMVASTATIN;rs3846662;Variant;PA451363;Chemical
CYP2D6;flecainide;Chemical;PA128;Gene
CYP3A5;flecainide;Chemical;PA131;Gene
CYP2D6*1;flecainide;Chemical;PA165816576;Haplotype
CYP2D6*2;flecainide;Chemical;PA165816577;Haplotype
CYP2D6*4;flecainide;Chemical;PA165816579;Haplotype
CYP2D6*10;flecainide;Chemical;PA165816582;Haplotype
CYP2D6*5;flecainide;Chemical;PA165948092;Haplotype
CYP2D6*21;flecainide;Chemical;PA165988484;Haplotype
CYP2D6*36;flecainide;Chemical;PA165988488;Haplotype
CYP3A5*1;flecainide;Chemical;PA166128213;Haplotype
CYP3A5*3;flecainide;Chemical;PA166128219;Haplotype
RS80338792;flecainide;Chemical;PA166155266;Variant
RS1567817380;flecainide;Chemical;PA166185728;Variant
RS121908547;flecainide;Chemical;PA166185729;Variant
SCN5A;flecainide;Chemical;PA304;Gene
SCN4A;flecainide;Chemical;PA35006;Gene
ORGAN TRANSPLANTATION;rs4823613;Variant;PA133888799;Disease
SIMVASTATIN;rs4823613;Variant;PA451363;Chemical
TACROLIMUS;rs4823613;Variant;PA451578;Chemical
CELECOXIB;ATP2A2;Gene;PA448871;Chemical
BREAST NEOPLASMS;rs1143684;Variant;PA443560;Disease
CYCLOPHOSPHAMIDE;rs1143684;Variant;PA449165;Chemical
DOXORUBICIN;rs1143684;Variant;PA449412;Chemical
CABOZANTINIB;CYP3A4*23;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*23;Haplotype;PA165958362;Chemical
REGORAFENIB;CYP3A4*23;Haplotype;PA166114943;Chemical
VANDETANIB;CYP3A4*23;Haplotype;PA166118341;Chemical
ALECTINIB;CYP3A4*23;Haplotype;PA166160050;Chemical
BREXPIPRAZOLE;CYP3A4*23;Haplotype;PA166160053;Chemical
ACALABRUTINIB;CYP3A4*23;Haplotype;PA166198581;Chemical
MACITENTAN;CYP3A4*23;Haplotype;PA166261201;Chemical
BLONANSERIN;CYP3A4*23;Haplotype;PA166319041;Chemical
AMIODARONE;CYP3A4*23;Haplotype;PA448383;Chemical
IBUPROFEN;CYP3A4*23;Haplotype;PA449957;Chemical
LIDOCAINE;CYP3A4*23;Haplotype;PA450226;Chemical
OXYCODONE;CYP3A4*23;Haplotype;PA450741;Chemical
TESTOSTERONE;CYP3A4*23;Haplotype;PA451627;Chemical
SUNITINIB;rs6785049;Variant;PA162372840;Chemical
TEMSIROLIMUS;rs6785049;Variant;PA164746890;Chemical
MYELOSUPPRESSION;rs6785049;Variant;PA165817398;Disease
GASTROINTESTINAL TOXICITY;rs6785049;Variant;PA166124386;Disease
URINARY BLADDER NEOPLASMS;rs6785049;Variant;PA443512;Disease
NEOPLASMS;rs6785049;Variant;PA445062;Disease
SIROLIMUS;rs6785049;Variant;PA451365;Chemical
MAP3K1;SHC1;Gene;PA30592;Gene
RAF1;SHC1;Gene;PA34183;Gene
EGFR;SHC1;Gene;PA7360;Gene
DENILEUKIN DIFTITOX;IL2RA;Gene;PA164750594;Chemical
BOTULINUM TOXIN TYPE A;TRPV1;Gene;PA164754825;Chemical
MIGRAINE DISORDER;TRPV1;Gene;PA165108779;Disease
PAIN;TRPV1;Gene;PA445208;Disease
ACETAMINOPHEN;TRPV1;Gene;PA448015;Chemical
HLA-DPB1*10:01;infliximab;Chemical;PA165951154;Haplotype
HLA-DRB1*04:01;infliximab;Chemical;PA165951493;Haplotype
HLA-DRB1*04:04;infliximab;Chemical;PA165951511;Haplotype
HLA-B*08:01;infliximab;Chemical;PA165954547;Haplotype
HLA-B*39:01;infliximab;Chemical;PA165955543;Haplotype
HLA-C*12:03;infliximab;Chemical;PA165957729;Haplotype
HLA-DQB1*02:01;infliximab;Chemical;PA165958158;Haplotype
HLA-DRB1*03:01;infliximab;Chemical;PA166123430;Haplotype
RS396991;infliximab;Chemical;PA166153571;Variant
RS1061622;infliximab;Chemical;PA166153618;Variant
RS1801274;infliximab;Chemical;PA166153652;Variant
RS10919563;infliximab;Chemical;PA166153818;Variant
RS767455;infliximab;Chemical;PA166154502;Variant
RS1143634;infliximab;Chemical;PA166155630;Variant
RS1059150;infliximab;Chemical;PA166155914;Variant
RS361525;infliximab;Chemical;PA166156915;Variant
RS1264457;infliximab;Chemical;PA166156981;Variant
RS1800795;infliximab;Chemical;PA166157304;Variant
RS3761847;infliximab;Chemical;PA166157763;Variant
RS2302489;infliximab;Chemical;PA166160715;Variant
RS7301582;infliximab;Chemical;PA166160807;Variant
RS7195994;infliximab;Chemical;PA166182152;Variant
RS2097432;infliximab;Chemical;PA166299601;Variant
IL6;infliximab;Chemical;PA198;Gene
ATP5F1E;infliximab;Chemical;PA25128;Gene
FCGR2A;infliximab;Chemical;PA28063;Gene
FCGR3A;infliximab;Chemical;PA28065;Gene
IL1B;infliximab;Chemical;PA29808;Gene
KLRC1;infliximab;Chemical;PA30163;Gene
KLRD1;infliximab;Chemical;PA30167;Gene
PTPRC;infliximab;Chemical;PA34011;Gene
HLA-B;infliximab;Chemical;PA35056;Gene
HLA-C;infliximab;Chemical;PA35057;Gene
HLA-DPB1;infliximab;Chemical;PA35064;Gene
HLA-DQB1;infliximab;Chemical;PA35068;Gene
HLA-DRB1;infliximab;Chemical;PA35072;Gene
HLA-E;infliximab;Chemical;PA35081;Gene
TNFRSF1A;infliximab;Chemical;PA36609;Gene
TNFRSF1B;infliximab;Chemical;PA36610;Gene
TRAF1;infliximab;Chemical;PA36708;Gene
TNF;infliximab;Chemical;PA435;Gene
DEPRESSIVE DISORDER;rs1449683;Variant;PA447207;Disease
FLUVOXAMINE;rs1449683;Variant;PA449690;Chemical
MYOTONIC DISORDERS;rs1567817380;Variant;PA447130;Disease
FLECAINIDE;rs1567817380;Variant;PA449646;Chemical
MEXILETINE;rs1567817380;Variant;PA450488;Chemical
FLUOROURACIL;rs150688309;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs150688309;Variant;PA443560;Disease
NEUTROPENIA;rs150688309;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs150688309;Variant;PA449165;Chemical
EPIRUBICIN;rs150688309;Variant;PA449476;Chemical
RS3832043;Thyroid Neoplasms;Disease;PA166155718;Variant
NTRK1;Thyroid Neoplasms;Disease;PA31817;Gene
RET;Thyroid Neoplasms;Disease;PA34335;Gene
UGT1A9;Thyroid Neoplasms;Disease;PA419;Gene
CYP2C19;desvenlafaxine;Chemical;PA124;Gene
CYP2D6;desvenlafaxine;Chemical;PA128;Gene
CYP2D6*4;desvenlafaxine;Chemical;PA165816579;Haplotype
CYP2C19*1;desvenlafaxine;Chemical;PA165980634;Haplotype
CYP2C19*2;desvenlafaxine;Chemical;PA165980635;Haplotype
CYP2D6*99;desvenlafaxine;Chemical;PA166169821;Haplotype
HTR2A;desvenlafaxine;Chemical;PA193;Gene
SLC6A4;desvenlafaxine;Chemical;PA312;Gene
UGT1A1;desvenlafaxine;Chemical;PA420;Gene
FLUOROURACIL;rs143879757;Variant;PA128406956;Chemical
RHEUMATOID ARTHRITIS;rs11231809;Variant;PA443434;Disease
METHOTREXATE;rs11231809;Variant;PA450428;Chemical
DULOXETINE;rs4971678;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs4971678;Variant;PA447321;Disease
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;CNPY4;Gene;PA164713366;Chemical
INFLAMMATORY BOWEL DISEASES;CNPY4;Gene;PA446116;Disease
CFTR;rs76151804;Variant;PA109;Gene
IVACAFTOR;rs76151804;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs76151804;Variant;PA166179845;Chemical
ASPIRIN;GP1BA;Gene;PA448497;Chemical
TALAZOPARIB;CHEK2;Gene;PA166182740;Chemical
PROSTATIC NEOPLASMS;CHEK2;Gene;PA445425;Disease
ATM;CHEK2;Gene;PA61;Gene
ATR;CHEK2;Gene;PA74;Gene
CCNB1;CHEK2;Gene;PA95;Gene
CYP2C19;Edema;Disease;PA124;Gene
CYP2C8;Edema;Disease;PA125;Gene
CYP2D6;Edema;Disease;PA128;Gene
CYP2C19*17;Edema;Disease;PA165816533;Haplotype
CYP2D6*1;Edema;Disease;PA165816576;Haplotype
CYP2D6*3;Edema;Disease;PA165816578;Haplotype
CYP2D6*4;Edema;Disease;PA165816579;Haplotype
CYP2D6*6;Edema;Disease;PA165816581;Haplotype
CYP2D6*5;Edema;Disease;PA165948092;Haplotype
CYP2C8*3;Edema;Disease;PA165958685;Haplotype
CYP2C19*1;Edema;Disease;PA165980634;Haplotype
CYP2D6*81;Edema;Disease;PA166123321;Haplotype
RS2368564;Edema;Disease;PA166153701;Variant
RS1801253;Edema;Disease;PA166153977;Variant
RS5370;Edema;Disease;PA166156901;Variant
EDN1;Edema;Disease;PA27614;Gene
REN;Edema;Disease;PA297;Gene
ADRB1;Edema;Disease;PA38;Gene
URINARY BLADDER NEOPLASMS;TMEM43;Gene;PA443512;Disease
DRUG TOXICITY;TMEM43;Gene;PA443937;Disease
INFECTIOUS DISEASE;TMEM43;Gene;PA444614;Disease
NEUTROPENIA;TMEM43;Gene;PA445113;Disease
OSTEOSARCOMA;TMEM43;Gene;PA445601;Disease
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA;TMEM43;Gene;PA446847;Disease
CISPLATIN;TMEM43;Gene;PA449014;Chemical
DOXORUBICIN;TMEM43;Gene;PA449412;Chemical
ANEMIA;rs3814058;Variant;PA443340;Disease
NASOPHARYNGEAL NEOPLASMS;rs3814058;Variant;PA445046;Disease
DOCETAXEL;rs3814058;Variant;PA449383;Chemical
REPAGLINIDE;rs3814058;Variant;PA451234;Chemical
ANTITHYROID PREPARATIONS;HLA-DQA1*01:03;Haplotype;PA164712499;Chemical
AGRANULOCYTOSIS;HLA-DQA1*01:03;Haplotype;PA443297;Disease
GRAVES DISEASE;HLA-DQA1*01:03;Haplotype;PA444329;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-A*32:01;Haplotype;PA166120927;Disease
VANCOMYCIN;HLA-A*32:01;Haplotype;PA451850;Chemical
CETUXIMAB;rs9996584;Variant;PA10040;Chemical
PANITUMUMAB;rs9996584;Variant;PA162373091;Chemical
COLORECTAL NEOPLASMS;rs9996584;Variant;PA446108;Disease
IRINOTECAN;rs9996584;Variant;PA450085;Chemical
UGT2B7;aprepitant;Chemical;PA361;Gene
HYDROXYCHLOROQUINE;rs1805087;Variant;PA164777036;Chemical
RHEUMATOID ARTHRITIS;rs1805087;Variant;PA443434;Disease
BRAIN DISEASES;rs1805087;Variant;PA443553;Disease
DRUG TOXICITY;rs1805087;Variant;PA443937;Disease
NEOPLASMS;rs1805087;Variant;PA445062;Disease
OSTEOSARCOMA;rs1805087;Variant;PA445601;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs1805087;Variant;PA446155;Disease
ESSENTIAL HYPERTENSION;rs1805087;Variant;PA447288;Disease
BENAZEPRIL;rs1805087;Variant;PA448561;Chemical
CARBOPLATIN;rs1805087;Variant;PA448803;Chemical
CISPLATIN;rs1805087;Variant;PA449014;Chemical
FOLIC ACID;rs1805087;Variant;PA449692;Chemical
METHOTREXATE;rs1805087;Variant;PA450428;Chemical
SULFASALAZINE;rs1805087;Variant;PA451547;Chemical
ALCOHOL ABUSE;rs13129401;Variant;PA443309;Disease
ETHANOL;rs13129401;Variant;PA448073;Chemical
CYP2C9;gliquidone;Chemical;PA126;Gene
CYP2C9*1;gliquidone;Chemical;PA165816542;Haplotype
CYP2C9*2;gliquidone;Chemical;PA165816543;Haplotype
CYP2C9*3;gliquidone;Chemical;PA165816544;Haplotype
BASAL CELL CARCINOMA;rs179008;Variant;PA443613;Disease
IMIQUIMOD;rs179008;Variant;PA449972;Chemical
MTTP;APOC2;Gene;PA164742099;Gene
ACUTE LYMPHOBLASTIC LEUKEMIA;rs17885382;Variant;PA446155;Disease
ASPARAGINASE;rs17885382;Variant;PA448492;Chemical
PLATINUM COMPOUNDS;PPP1R13L;Gene;PA164713176;Chemical
INFECTIOUS DISEASE;PPP1R13L;Gene;PA444614;Disease
LEUKOPENIA;PPP1R13L;Gene;PA444773;Disease
MESOTHELIOMA;PPP1R13L;Gene;PA444937;Disease
OVARIAN NEOPLASMS;PPP1R13L;Gene;PA445204;Disease
OSTEOSARCOMA;PPP1R13L;Gene;PA445601;Disease
CISPLATIN;PPP1R13L;Gene;PA449014;Chemical
DOXORUBICIN;PPP1R13L;Gene;PA449412;Chemical
GEMCITABINE;PPP1R13L;Gene;PA449748;Chemical
SLCO1B1;estrone sulfate;Chemical;PA134865839;Gene
SLCO1B1*5;estrone sulfate;Chemical;PA165819255;Haplotype
SLCO1B1*1;estrone sulfate;Chemical;PA165981641;Haplotype
RS2306168;estrone sulfate;Chemical;PA166154367;Variant
RS1009122956;estrone sulfate;Chemical;PA166396181;Variant
RS1621378;estrone sulfate;Chemical;PA166396182;Variant
RS199654337;estrone sulfate;Chemical;PA166396241;Variant
SLCO2B1;estrone sulfate;Chemical;PA35845;Gene
INFLAMMATORY BOWEL DISEASES;rs3765534;Variant;PA446116;Disease
AZATHIOPRINE;rs3765534;Variant;PA448515;Chemical
MERCAPTOPURINE;rs3765534;Variant;PA450379;Chemical
PLATINUM COMPOUNDS;rs9535828;Variant;PA164713176;Chemical
LUNG NEOPLASMS;rs9535828;Variant;PA444818;Disease
HIV INFECTIONS;CYP2B6*28;Haplotype;PA447230;Disease
EFAVIRENZ;CYP2B6*28;Haplotype;PA449441;Chemical
LUMEFANTRINE;rs10264272;Variant;PA165111722;Chemical
MALARIA;rs10264272;Variant;PA444859;Disease
HLA-B*57:01;zidovudine / lamivudine / abacavir;Chemical;PA165987830;Haplotype
HLA-B;zidovudine / lamivudine / abacavir;Chemical;PA35056;Gene
DIHYDROPYRIDINE DERIVATIVES;NOS1AP;Gene;PA164712688;Chemical
SHORTENED QT INTERVAL;NOS1AP;Gene;PA165818136;Disease
DIABETES MELLITUS, TYPE 2;NOS1AP;Gene;PA443890;Disease
HYPOGLYCEMIA;NOS1AP;Gene;PA444570;Disease
LONG QT SYNDROME;NOS1AP;Gene;PA444807;Disease
ACQUIRED LONG QT SYNDROME (ALQTS);NOS1AP;Gene;PA447300;Disease
AMIODARONE;NOS1AP;Gene;PA448383;Chemical
DIGOXIN;NOS1AP;Gene;PA449319;Chemical
DOLASETRON;NOS1AP;Gene;PA449390;Chemical
GLIMEPIRIDE;NOS1AP;Gene;PA449761;Chemical
GLIPIZIDE;NOS1AP;Gene;PA449762;Chemical
GLYBURIDE;NOS1AP;Gene;PA449782;Chemical
GRANISETRON;NOS1AP;Gene;PA449809;Chemical
REPAGLINIDE;NOS1AP;Gene;PA451234;Chemical
VERAPAMIL;NOS1AP;Gene;PA451868;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;PEBP4;Gene;PA447197;Disease
METHYLPHENIDATE;PEBP4;Gene;PA450464;Chemical
ASPIRIN-INDUCED ASTHMA;rs3818822;Variant;PA131285571;Disease
ASPIRIN;rs3818822;Variant;PA448497;Chemical
CLOZAPINE;CYP1A2*1;Haplotype;PA449061;Chemical
RHEUMATOID ARTHRITIS;DHODH;Gene;PA443434;Disease
LEFLUNOMIDE;DHODH;Gene;PA450192;Chemical
BIPOLAR DISORDER;rs7405404;Variant;PA447199;Disease
LITHIUM;rs7405404;Variant;PA450243;Chemical
BIPOLAR DISORDER;OR52J2P;Gene;PA447199;Disease
LITHIUM;OR52J2P;Gene;PA450243;Chemical
HYPERCHOLESTEROLEMIA;rs705379;Variant;PA444516;Disease
ATORVASTATIN;rs705379;Variant;PA448500;Chemical
SIMVASTATIN;rs705379;Variant;PA451363;Chemical
IMATINIB;rs683369;Variant;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;rs683369;Variant;PA151958383;Disease
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;rs683369;Variant;PA446171;Disease
RS12283870;elevated liver enzymes;Disease;PA166285621;Variant
CPT1A;elevated liver enzymes;Disease;PA26847;Gene
IGHMBP2;elevated liver enzymes;Disease;PA29731;Gene
MAPK8;MAP2K7;Gene;PA283;Gene
MAP3K1;MAP2K7;Gene;PA30592;Gene
MAPK1;MAP2K7;Gene;PA30616;Gene
MAPK10;MAP2K7;Gene;PA30617;Gene
MAPK11;MAP2K7;Gene;PA30618;Gene
MAPK12;MAP2K7;Gene;PA30619;Gene
MAPK13;MAP2K7;Gene;PA30620;Gene
MAPK14;MAP2K7;Gene;PA30621;Gene
MAPK3;MAP2K7;Gene;PA30622;Gene
MAPK4;MAP2K7;Gene;PA30623;Gene
MAPK6;MAP2K7;Gene;PA30624;Gene
MAPK7;MAP2K7;Gene;PA30625;Gene
MAPK9;MAP2K7;Gene;PA30630;Gene
RAF1;MAP2K7;Gene;PA34183;Gene
MAVS;IRF3;Gene;PA164722208;Gene
NR1I2;demeclocycline;Chemical;PA378;Gene
NEOPLASMS;rs1138272;Variant;PA445062;Disease
CISPLATIN;rs1138272;Variant;PA449014;Chemical
THIOTEPA;rs1138272;Variant;PA451668;Chemical
CRISPLD2;dexamethasone;Chemical;PA142672077;Gene
LINC00251;dexamethasone;Chemical;PA165585763;Gene
UGT1A1*6;dexamethasone;Chemical;PA166115858;Haplotype
RS1891059;dexamethasone;Chemical;PA166153658;Variant
RS17021408;dexamethasone;Chemical;PA166153867;Variant
RS80223967;dexamethasone;Chemical;PA166153915;Variant
RS3824662;dexamethasone;Chemical;PA166154043;Variant
RS7142143;dexamethasone;Chemical;PA166154808;Variant
RS4553808;dexamethasone;Chemical;PA166155730;Variant
RS79085477;dexamethasone;Chemical;PA166155968;Variant
RS117532069;dexamethasone;Chemical;PA166155970;Variant
RS4135385;dexamethasone;Chemical;PA166156394;Variant
RS6092;dexamethasone;Chemical;PA166157240;Variant
RS1045642;dexamethasone;Chemical;PA166157284;Variant
RS2032582;dexamethasone;Chemical;PA166157316;Variant
RS2229109;dexamethasone;Chemical;PA166157334;Variant
RS141059755;dexamethasone;Chemical;PA166157691;Variant
BMP7;dexamethasone;Chemical;PA25384;Gene
DOK5;dexamethasone;Chemical;PA25724;Gene
SERPINE1;dexamethasone;Chemical;PA261;Gene
ABCB1;dexamethasone;Chemical;PA267;Gene
CTLA4;dexamethasone;Chemical;PA27006;Gene
CTNNB1;dexamethasone;Chemical;PA27013;Gene
PTGDR;dexamethasone;Chemical;PA285;Gene
GATA3;dexamethasone;Chemical;PA28586;Gene
PYGL;dexamethasone;Chemical;PA34068;Gene
VDR;dexamethasone;Chemical;PA37301;Gene
NR1I2;dexamethasone;Chemical;PA378;Gene
UGT1A1;dexamethasone;Chemical;PA420;Gene
TOBACCO USE DISORDER;rs637137;Variant;PA445876;Disease
NICOTINE;rs637137;Variant;PA450626;Chemical
ADVERSE EVENTS;SEPTIN3;Gene;PA166151827;Disease
CODEINE;SEPTIN3;Gene;PA449088;Chemical
DEXTROMETHORPHAN;SEPTIN3;Gene;PA449273;Chemical
HYDROCODONE;SEPTIN3;Gene;PA449900;Chemical
OXYCODONE;SEPTIN3;Gene;PA450741;Chemical
TRAMADOL;SEPTIN3;Gene;PA451735;Chemical
HEROIN DEPENDENCE;rs724226;Variant;PA444460;Disease
SCHIZOPHRENIA;rs724226;Variant;PA447216;Disease
RISPERIDONE;rs724226;Variant;PA451257;Chemical
HEROIN;rs724226;Variant;PA452619;Chemical
SCHIZOPHRENIA;rs6314;Variant;PA447216;Disease
MAJOR DEPRESSIVE DISORDER;rs6314;Variant;PA447321;Disease
OLANZAPINE;rs6314;Variant;PA450688;Chemical
ANTIDEPRESSANTS;rs6314;Variant;PA452229;Chemical
CYP2A6;acetaminophen;Chemical;PA121;Gene
CYP2D6;acetaminophen;Chemical;PA128;Gene
CYP2E1;acetaminophen;Chemical;PA129;Gene
CYP3A4;acetaminophen;Chemical;PA130;Gene
SULT1A4;acetaminophen;Chemical;PA142670856;Gene
CYP2D6*1;acetaminophen;Chemical;PA165816576;Haplotype
CYP2D6*2;acetaminophen;Chemical;PA165816577;Haplotype
CYP2D6*10;acetaminophen;Chemical;PA165816582;Haplotype
CYP2E1*5B;acetaminophen;Chemical;PA165948040;Haplotype
HLA-DRB1*08:03;acetaminophen;Chemical;PA165951678;Haplotype
HLA-DRB1*12:02;acetaminophen;Chemical;PA165951930;Haplotype
HLA-A*02:06;acetaminophen;Chemical;PA165952829;Haplotype
HLA-A*24:02;acetaminophen;Chemical;PA165953564;Haplotype
HLA-B*13:01;acetaminophen;Chemical;PA165954643;Haplotype
HLA-B*44:03;acetaminophen;Chemical;PA165955913;Haplotype
HLA-C*14:03;acetaminophen;Chemical;PA165957827;Haplotype
HLA-DQB1*02:02;acetaminophen;Chemical;PA165958162;Haplotype
CYP2E1*1;acetaminophen;Chemical;PA165981617;Haplotype
UGT2B15*1;acetaminophen;Chemical;PA165984975;Haplotype
UGT2B15*2;acetaminophen;Chemical;PA165984976;Haplotype
UGT1A6*1A;acetaminophen;Chemical;PA166117614;Haplotype
UGT1A6*2A;acetaminophen;Chemical;PA166117621;Haplotype
NPIPB8;acetaminophen;Chemical;PA166123718;Gene
RS12746200;acetaminophen;Chemical;PA166153862;Variant
RS2069514;acetaminophen;Chemical;PA166154874;Variant
RS28374453;acetaminophen;Chemical;PA166155127;Variant
RS1805034;acetaminophen;Chemical;PA166155281;Variant
RS8330;acetaminophen;Chemical;PA166155584;Variant
RS1042640;acetaminophen;Chemical;PA166155616;Variant
RS10929303;acetaminophen;Chemical;PA166155795;Variant
RS2228246;acetaminophen;Chemical;PA166155921;Variant
RS1902023;acetaminophen;Chemical;PA166156530;Variant
RS1799971;acetaminophen;Chemical;PA166156991;Variant
RS6500265;acetaminophen;Chemical;PA166176206;Variant
RS9933632;acetaminophen;Chemical;PA166176208;Variant
RS776817009;acetaminophen;Chemical;PA166179692;Variant
RS767263838;acetaminophen;Chemical;PA166179693;Variant
RS762151655;acetaminophen;Chemical;PA166179694;Variant
RS757573592;acetaminophen;Chemical;PA166179695;Variant
RS750575779;acetaminophen;Chemical;PA166179696;Variant
RS553050853;acetaminophen;Chemical;PA166179697;Variant
RS751527244;acetaminophen;Chemical;PA166179698;Variant
RS1293732453;acetaminophen;Chemical;PA166179699;Variant
RS1328799050;acetaminophen;Chemical;PA166179700;Variant
RS224534;acetaminophen;Chemical;PA166182236;Variant
RS544820732;acetaminophen;Chemical;PA166186134;Variant
RS765399160;acetaminophen;Chemical;PA166186135;Variant
RS1042008;acetaminophen;Chemical;PA166186136;Variant
RS767487725;acetaminophen;Chemical;PA166186137;Variant
RS552524124;acetaminophen;Chemical;PA166186138;Variant
RS758145522;acetaminophen;Chemical;PA166186139;Variant
RS72547527;acetaminophen;Chemical;PA166186140;Variant
RS1042028;acetaminophen;Chemical;PA166186146;Variant
CYP1A2;acetaminophen;Chemical;PA27093;Gene
PLA2G4A;acetaminophen;Chemical;PA271;Gene
G6PD;acetaminophen;Chemical;PA28469;Gene
OPRM1;acetaminophen;Chemical;PA31945;Gene
PLCG1;acetaminophen;Chemical;PA33392;Gene
SULT1E1;acetaminophen;Chemical;PA340;Gene
SULT1A1;acetaminophen;Chemical;PA343;Gene
SULT1A3;acetaminophen;Chemical;PA344;Gene
SULT2A1;acetaminophen;Chemical;PA346;Gene
HLA-A;acetaminophen;Chemical;PA35055;Gene
HLA-B;acetaminophen;Chemical;PA35056;Gene
HLA-C;acetaminophen;Chemical;PA35057;Gene
HLA-DQB1;acetaminophen;Chemical;PA35068;Gene
HLA-DRB1;acetaminophen;Chemical;PA35072;Gene
TNFRSF11A;acetaminophen;Chemical;PA36601;Gene
UGT1A;acetaminophen;Chemical;PA37173;Gene
UGT1A6;acetaminophen;Chemical;PA37181;Gene
UGT2B15;acetaminophen;Chemical;PA37188;Gene
TRPV1;acetaminophen;Chemical;PA37329;Gene
UGT1A9;acetaminophen;Chemical;PA419;Gene
UGT1A1;acetaminophen;Chemical;PA420;Gene
ACETYLCYSTEINE;acetaminophen;Chemical;PA448033;Chemical
PHENOBARBITAL;acetaminophen;Chemical;PA450911;Chemical
PHENYTOIN;acetaminophen;Chemical;PA450947;Chemical
ABCC2;doxorubicin;Chemical;PA116;Gene
CYP2B6;doxorubicin;Chemical;PA123;Gene
CYP2C19;doxorubicin;Chemical;PA124;Gene
CYP3A4;doxorubicin;Chemical;PA130;Gene
SLCO1B1;doxorubicin;Chemical;PA134865839;Gene
TMEM43;doxorubicin;Chemical;PA134871907;Gene
SLC22A16;doxorubicin;Chemical;PA134911502;Gene
POLR1G;doxorubicin;Chemical;PA142672156;Gene
ERCC1;doxorubicin;Chemical;PA155;Gene
LINC00251;doxorubicin;Chemical;PA165585763;Gene
GSTM1 NULL;doxorubicin;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;doxorubicin;Chemical;PA166048676;Haplotype
GSTT1 NULL;doxorubicin;Chemical;PA166048678;Haplotype
GSTT1 NON-NULL;doxorubicin;Chemical;PA166048679;Haplotype
RS1801133;doxorubicin;Chemical;PA166153644;Variant
RS1891059;doxorubicin;Chemical;PA166153658;Variant
RS17021408;doxorubicin;Chemical;PA166153867;Variant
RS80223967;doxorubicin;Chemical;PA166153915;Variant
RS717620;doxorubicin;Chemical;PA166153953;Variant
RS1937840;doxorubicin;Chemical;PA166153989;Variant
RS2273697;doxorubicin;Chemical;PA166154007;Variant
RS3740066;doxorubicin;Chemical;PA166154028;Variant
RS3824662;doxorubicin;Chemical;PA166154043;Variant
RS4244285;doxorubicin;Chemical;PA166154053;Variant
RS8187710;doxorubicin;Chemical;PA166154094;Variant
RS12248560;doxorubicin;Chemical;PA166154147;Variant
RS17222723;doxorubicin;Chemical;PA166154163;Variant
RS1695;doxorubicin;Chemical;PA166154249;Variant
RS9344;doxorubicin;Chemical;PA166154264;Variant
RS2229774;doxorubicin;Chemical;PA166154532;Variant
RS4149056;doxorubicin;Chemical;PA166154579;Variant
RS9561778;doxorubicin;Chemical;PA166154741;Variant
RS2236225;doxorubicin;Chemical;PA166154789;Variant
RS4673;doxorubicin;Chemical;PA166154969;Variant
RS45511401;doxorubicin;Chemical;PA166155130;Variant
RS2228100;doxorubicin;Chemical;PA166155201;Variant
RS4148416;doxorubicin;Chemical;PA166155219;Variant
RS11615;doxorubicin;Chemical;PA166155342;Variant
RS13181;doxorubicin;Chemical;PA166155343;Variant
RS25487;doxorubicin;Chemical;PA166155346;Variant
RS3211371;doxorubicin;Chemical;PA166155405;Variant
RS3212986;doxorubicin;Chemical;PA166155407;Variant
RS3745274;doxorubicin;Chemical;PA166155409;Variant
RS12721655;doxorubicin;Chemical;PA166155467;Variant
RS1056836;doxorubicin;Chemical;PA166155621;Variant
RS17863783;doxorubicin;Chemical;PA166155854;Variant
RS79085477;doxorubicin;Chemical;PA166155968;Variant
RS117532069;doxorubicin;Chemical;PA166155970;Variant
RS9024;doxorubicin;Chemical;PA166155972;Variant
RS20572;doxorubicin;Chemical;PA166155974;Variant
RS1143663;doxorubicin;Chemical;PA166155991;Variant
RS2835285;doxorubicin;Chemical;PA166156002;Variant
RS4987121;doxorubicin;Chemical;PA166156009;Variant
RS8133052;doxorubicin;Chemical;PA166156011;Variant
RS41557318;doxorubicin;Chemical;PA166156017;Variant
RS1883112;doxorubicin;Chemical;PA166156080;Variant
RS13058338;doxorubicin;Chemical;PA166156140;Variant
RS2228001;doxorubicin;Chemical;PA166156345;Variant
RS2231142;doxorubicin;Chemical;PA166156544;Variant
RS714368;doxorubicin;Chemical;PA166156940;Variant
RS723685;doxorubicin;Chemical;PA166156941;Variant
RS1143684;doxorubicin;Chemical;PA166156979;Variant
RS3957357;doxorubicin;Chemical;PA166157094;Variant
RS6907567;doxorubicin;Chemical;PA166157112;Variant
RS12210538;doxorubicin;Chemical;PA166157179;Variant
RS1045642;doxorubicin;Chemical;PA166157284;Variant
RS1128503;doxorubicin;Chemical;PA166157288;Variant
RS1799983;doxorubicin;Chemical;PA166157303;Variant
RS2032582;doxorubicin;Chemical;PA166157316;Variant
RS2070744;doxorubicin;Chemical;PA166157325;Variant
RS2229109;doxorubicin;Chemical;PA166157334;Variant
RS4148737;doxorubicin;Chemical;PA166157385;Variant
RS141059755;doxorubicin;Chemical;PA166157691;Variant
RS6151031;doxorubicin;Chemical;PA166157783;Variant
RS7853758;doxorubicin;Chemical;PA166157790;Variant
RS1043657;doxorubicin;Chemical;PA166161794;Variant
RS35575889;doxorubicin;Chemical;PA166170186;Variant
RS34186955;doxorubicin;Chemical;PA166170188;Variant
RS1801516;doxorubicin;Chemical;PA166180286;Variant
RS12283870;doxorubicin;Chemical;PA166285621;Variant
RS11140490;doxorubicin;Chemical;PA166353341;Variant
GSTM1;doxorubicin;Chemical;PA182;Gene
GSTT1;doxorubicin;Chemical;PA183;Gene
ABCC1;doxorubicin;Chemical;PA244;Gene
MTHFR;doxorubicin;Chemical;PA245;Gene
AKR1C3;doxorubicin;Chemical;PA24679;Gene
AKR7A2;doxorubicin;Chemical;PA24682;Gene
ALDH1A1;doxorubicin;Chemical;PA24692;Gene
ALDH3A1;doxorubicin;Chemical;PA24697;Gene
BMP7;doxorubicin;Chemical;PA25384;Gene
NOS3;doxorubicin;Chemical;PA254;Gene
DOK5;doxorubicin;Chemical;PA25724;Gene
SETD4;doxorubicin;Chemical;PA25814;Gene
CBR1;doxorubicin;Chemical;PA26121;Gene
CBR3;doxorubicin;Chemical;PA26122;Gene
CLCN6;doxorubicin;Chemical;PA26551;Gene
ABCB1;doxorubicin;Chemical;PA267;Gene
CPT1A;doxorubicin;Chemical;PA26847;Gene
CYBA;doxorubicin;Chemical;PA27075;Gene
CYP1B1;doxorubicin;Chemical;PA27094;Gene
ERCC2;doxorubicin;Chemical;PA27848;Gene
G6PD;doxorubicin;Chemical;PA28469;Gene
GATA3;doxorubicin;Chemical;PA28586;Gene
GSTA1;doxorubicin;Chemical;PA29016;Gene
GSTP1;doxorubicin;Chemical;PA29028;Gene
IGHMBP2;doxorubicin;Chemical;PA29731;Gene
MTHFD1;doxorubicin;Chemical;PA31236;Gene
NCF4;doxorubicin;Chemical;PA31465;Gene
NQO1;doxorubicin;Chemical;PA31744;Gene
NQO2;doxorubicin;Chemical;PA31745;Gene
RAC2;doxorubicin;Chemical;PA34163;Gene
PPP1R13L;doxorubicin;Chemical;PA34195;Gene
RARG;doxorubicin;Chemical;PA34227;Gene
XRCC1;doxorubicin;Chemical;PA369;Gene
UGT1A6;doxorubicin;Chemical;PA37181;Gene
XPC;doxorubicin;Chemical;PA37413;Gene
ABCC3;doxorubicin;Chemical;PA376;Gene
NR1I2;doxorubicin;Chemical;PA378;Gene
ABCG2;doxorubicin;Chemical;PA390;Gene
ABCC4;doxorubicin;Chemical;PA397;Gene
SLC28A3;doxorubicin;Chemical;PA426;Gene
ATM;doxorubicin;Chemical;PA61;Gene
CCND1;doxorubicin;Chemical;PA75;Gene
G6PD MEDITERRANEAN, DALLAS, PANAMA, SASSARI, CAGLIARI, BIRMINGHAM;Arthritis;Disease;PA166121127;Haplotype
RS20575;Arthritis;Disease;PA166157545;Variant
G6PD;Arthritis;Disease;PA28469;Gene
TNFRSF10A;Arthritis;Disease;PA36597;Gene
ACE;spironolactone;Chemical;PA139;Gene
RS1126742;spironolactone;Chemical;PA166153623;Variant
RS1801253;spironolactone;Chemical;PA166153977;Variant
RS4343;spironolactone;Chemical;PA166155147;Variant
RS1799752;spironolactone;Chemical;PA166155187;Variant
RS4961;spironolactone;Chemical;PA166156480;Variant
RS1042713;spironolactone;Chemical;PA166156748;Variant
RS1799983;spironolactone;Chemical;PA166157303;Variant
RS3890011;spironolactone;Chemical;PA166184563;Variant
NOS3;spironolactone;Chemical;PA254;Gene
ABCB1;spironolactone;Chemical;PA267;Gene
CYP4A11;spironolactone;Chemical;PA27118;Gene
ADD1;spironolactone;Chemical;PA31;Gene
NR1I2;spironolactone;Chemical;PA378;Gene
ADRB1;spironolactone;Chemical;PA38;Gene
ADRB2;spironolactone;Chemical;PA39;Gene
ACAMPROSATE;rs2058878;Variant;PA10344;Chemical
ALCOHOL ABUSE;rs2058878;Variant;PA443309;Disease
ALK;EML4;Gene;PA24719;Gene
RS45445694;Hyperammonemia;Disease;PA166155331;Variant
RS1047891;Hyperammonemia;Disease;PA166155617;Variant
RS11280056;Hyperammonemia;Disease;PA166180936;Variant
CPS1;Hyperammonemia;Disease;PA26840;Gene
TYMS;Hyperammonemia;Disease;PA359;Gene
EVEROLIMUS;RPTOR;Gene;PA164746311;Chemical
PROGRESSION-FREE SURVIVAL;RPTOR;Gene;PA166123026;Disease
PNEUMONITIS;RPTOR;Gene;PA166124223;Disease
RS1967309;dalcetrapib;Chemical;PA166155024;Variant
ADCY9;dalcetrapib;Chemical;PA30;Gene
NEDD4L;SGK1;Gene;PA31534;Gene
ANTHRACYCLINES AND RELATED SUBSTANCES;SULT2B1;Gene;PA130620651;Chemical
GEMTUZUMAB OZOGAMICIN;SULT2B1;Gene;PA164749431;Chemical
PREGNENOLONE;SULT2B1;Gene;PA166334121;Chemical
LEUKEMIA, MYELOID, ACUTE;SULT2B1;Gene;PA444760;Disease
NEOPLASMS;SULT2B1;Gene;PA445062;Disease
CYTARABINE;SULT2B1;Gene;PA449177;Chemical
FLUDARABINE;SULT2B1;Gene;PA449655;Chemical
IDARUBICIN;SULT2B1;Gene;PA449961;Chemical
OPIOID-RELATED DISORDERS;TXNRD2;Gene;PA445043;Disease
METHADONE;TXNRD2;Gene;PA450401;Chemical
CYP2D6;Dry mouth;Disease;PA128;Gene
CYP2D6*10;Dry mouth;Disease;PA165816582;Haplotype
CYP2D6*5;Dry mouth;Disease;PA165948092;Haplotype
RS1799971;Dry mouth;Disease;PA166156991;Variant
OPRM1;Dry mouth;Disease;PA31945;Gene
CLOPIDOGREL;CYP2C19*22;Haplotype;PA449053;Chemical
MEPHENYTOIN;CYP2C19*22;Haplotype;PA450373;Chemical
CYP2D6;o-desmethyltramadol;Chemical;PA128;Gene
RFPL4B;o-desmethyltramadol;Chemical;PA162401195;Gene
RGL4;o-desmethyltramadol;Chemical;PA162401277;Gene
CYP2D6*1;o-desmethyltramadol;Chemical;PA165816576;Haplotype
CYP2D6*2;o-desmethyltramadol;Chemical;PA165816577;Haplotype
CYP2D6*3;o-desmethyltramadol;Chemical;PA165816578;Haplotype
CYP2D6*4;o-desmethyltramadol;Chemical;PA165816579;Haplotype
CYP2D6*6;o-desmethyltramadol;Chemical;PA165816581;Haplotype
CYP2D6*10;o-desmethyltramadol;Chemical;PA165816582;Haplotype
CYP2D6*17;o-desmethyltramadol;Chemical;PA165816583;Haplotype
CYP2D6*41;o-desmethyltramadol;Chemical;PA165816584;Haplotype
CYP2D6*5;o-desmethyltramadol;Chemical;PA165948092;Haplotype
CYP2D6*9;o-desmethyltramadol;Chemical;PA165948317;Haplotype
CYP2D6*35;o-desmethyltramadol;Chemical;PA165988487;Haplotype
CYP2D6 POOR METABOLIZER;o-desmethyltramadol;Chemical;PA166157927;Variant
RS776817009;o-desmethyltramadol;Chemical;PA166179692;Variant
RS767263838;o-desmethyltramadol;Chemical;PA166179693;Variant
RS762151655;o-desmethyltramadol;Chemical;PA166179694;Variant
RS757573592;o-desmethyltramadol;Chemical;PA166179695;Variant
RS750575779;o-desmethyltramadol;Chemical;PA166179696;Variant
RS553050853;o-desmethyltramadol;Chemical;PA166179697;Variant
RS751527244;o-desmethyltramadol;Chemical;PA166179698;Variant
RS1293732453;o-desmethyltramadol;Chemical;PA166179699;Variant
RS1328799050;o-desmethyltramadol;Chemical;PA166179700;Variant
RS184199168;o-desmethyltramadol;Chemical;PA166195561;Variant
RS72732317;o-desmethyltramadol;Chemical;PA166195562;Variant
RS62435418;o-desmethyltramadol;Chemical;PA166195563;Variant
RS79983226;o-desmethyltramadol;Chemical;PA166195564;Variant
RS9384825;o-desmethyltramadol;Chemical;PA166195565;Variant
ICA1;o-desmethyltramadol;Chemical;PA29591;Gene
SLC22A1;o-desmethyltramadol;Chemical;PA329;Gene
SULT1A3;o-desmethyltramadol;Chemical;PA344;Gene
HCN1;o-desmethyltramadol;Chemical;PA77;Gene
CHRNA3;Pain;Disease;PA113;Gene
COMT;Pain;Disease;PA117;Gene
CYP2B6;Pain;Disease;PA123;Gene
CYP2C9;Pain;Disease;PA126;Gene
CYP2D6;Pain;Disease;PA128;Gene
CYP3A4;Pain;Disease;PA130;Gene
CYP3A5;Pain;Disease;PA131;Gene
TAOK3;Pain;Disease;PA134975064;Gene
CYP2C9*1;Pain;Disease;PA165816542;Haplotype
CYP2C9*3;Pain;Disease;PA165816544;Haplotype
CYP2D6*1;Pain;Disease;PA165816576;Haplotype
CYP2D6*2;Pain;Disease;PA165816577;Haplotype
CYP2D6*3;Pain;Disease;PA165816578;Haplotype
CYP2D6*4;Pain;Disease;PA165816579;Haplotype
CYP2D6*6;Pain;Disease;PA165816581;Haplotype
CYP2D6*10;Pain;Disease;PA165816582;Haplotype
CYP2D6*17;Pain;Disease;PA165816583;Haplotype
CYP2B6*1;Pain;Disease;PA165818750;Haplotype
CYP2B6*6;Pain;Disease;PA165818762;Haplotype
CYP2D6*5;Pain;Disease;PA165948092;Haplotype
CYP2D6*7;Pain;Disease;PA165971559;Haplotype
CYP2D6*40;Pain;Disease;PA165971594;Haplotype
CYP2D6*1XN;Pain;Disease;PA165988479;Haplotype
CYP2D6*2XN;Pain;Disease;PA165988480;Haplotype
CYP3A5*1;Pain;Disease;PA166128213;Haplotype
CYP3A5*3;Pain;Disease;PA166128219;Haplotype
CYP3A5*6;Pain;Disease;PA166128233;Haplotype
RS324420;Pain;Disease;PA166153569;Variant
RS660652;Pain;Disease;PA166154844;Variant
RS1051730;Pain;Disease;PA166154856;Variant
RS16969968;Pain;Disease;PA166154938;Variant
RS1042173;Pain;Disease;PA166155172;Variant
RS1050565;Pain;Disease;PA166155175;Variant
RS4793665;Pain;Disease;PA166155225;Variant
RS2070995;Pain;Disease;PA166155996;Variant
RS4633;Pain;Disease;PA166156023;Variant
RS4680;Pain;Disease;PA166156024;Variant
RS4818;Pain;Disease;PA166156025;Variant
RS6269;Pain;Disease;PA166156027;Variant
RS1902023;Pain;Disease;PA166156530;Variant
RS7439366;Pain;Disease;PA166156619;Variant
RS1799971;Pain;Disease;PA166156991;Variant
RS1045642;Pain;Disease;PA166157284;Variant
RS1128503;Pain;Disease;PA166157288;Variant
RS2032582;Pain;Disease;PA166157316;Variant
RS2242480;Pain;Disease;PA166157345;Variant
RS2740574;Pain;Disease;PA166157367;Variant
RS1051660;Pain;Disease;PA166157551;Variant
CYP2D6 POOR METABOLIZER;Pain;Disease;PA166157927;Variant
RS6517442;Pain;Disease;PA166182219;Variant
RS224534;Pain;Disease;PA166182236;Variant
RS795484;Pain;Disease;PA166182407;Variant
RS1277441;Pain;Disease;PA166182408;Variant
RS1042028;Pain;Disease;PA166186146;Variant
BLMH;Pain;Disease;PA25370;Gene
CHRNA5;Pain;Disease;PA26491;Gene
ABCB1;Pain;Disease;PA267;Gene
FAAH;Pain;Disease;PA27955;Gene
KCNJ6;Pain;Disease;PA30049;Gene
SLC6A4;Pain;Disease;PA312;Gene
OPRK1;Pain;Disease;PA31943;Gene
OPRM1;Pain;Disease;PA31945;Gene
SLC22A1;Pain;Disease;PA329;Gene
SULT1A1;Pain;Disease;PA343;Gene
UGT2B7;Pain;Disease;PA361;Gene
UGT2B15;Pain;Disease;PA37188;Gene
TRPV1;Pain;Disease;PA37329;Gene
ABCC3;Pain;Disease;PA376;Gene
ANEMIA, SICKLE CELL;Pain;Disease;PA443355;Disease
RS10046;triglycerides;Chemical;PA166154837;Variant
RS2289105;triglycerides;Chemical;PA166154884;Variant
CYP19A1;triglycerides;Chemical;PA27091;Gene
ESSENTIAL HYPERTENSION;rs10737062;Variant;PA447288;Disease
LOSARTAN;rs10737062;Variant;PA450268;Chemical
HLA-DRB1*11:01;Anaphylaxis;Disease;PA165951763;Haplotype
HLA-DRB1;Anaphylaxis;Disease;PA35072;Gene
CYP2D6;bromazepam;Chemical;PA128;Gene
CYP1A2;bromazepam;Chemical;PA27093;Gene
DESMETHYLNAPROXEN;rs72547527;Variant;PA166163690;Chemical
TAPENTADOL;rs72547527;Variant;PA166179720;Chemical
ACETAMINOPHEN;rs72547527;Variant;PA448015;Chemical
ADALIMUMAB;rs10210302;Variant;PA10004;Chemical
CROHN DISEASE;rs10210302;Variant;PA443815;Disease
BIPOLAR DISORDER;FAM178B;Gene;PA447199;Disease
LITHIUM;FAM178B;Gene;PA450243;Chemical
DPYD;flucytosine;Chemical;PA145;Gene
SUNITINIB;rs1126647;Variant;PA162372840;Chemical
RENAL CELL CARCINOMA;rs1126647;Variant;PA443624;Disease
CFTR;rs121909013;Variant;PA109;Gene
IVACAFTOR;rs121909013;Variant;PA165950341;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs121909013;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs121909013;Variant;PA443829;Disease
PEGASPARGASE;rs80223967;Variant;PA164760860;Chemical
OSTEONECROSIS;rs80223967;Variant;PA445187;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs80223967;Variant;PA446155;Disease
CYCLOPHOSPHAMIDE;rs80223967;Variant;PA449165;Chemical
CYTARABINE;rs80223967;Variant;PA449177;Chemical
DAUNORUBICIN;rs80223967;Variant;PA449212;Chemical
DEXAMETHASONE;rs80223967;Variant;PA449247;Chemical
DOXORUBICIN;rs80223967;Variant;PA449412;Chemical
METHOTREXATE;rs80223967;Variant;PA450428;Chemical
PREDNISONE;rs80223967;Variant;PA451100;Chemical
THIOGUANINE;rs80223967;Variant;PA451663;Chemical
VINCRISTINE;rs80223967;Variant;PA451879;Chemical
ABCC2;Dubin-Johnson syndrome;Disease;PA116;Gene
RS533334893;Dubin-Johnson syndrome;Disease;PA166307621;Variant
PAIN;rs4793665;Variant;PA445208;Disease
MORPHINE;rs4793665;Variant;PA450550;Chemical
FLUOROURACIL;rs527580106;Variant;PA128406956;Chemical
DRUG TOXICITY;rs527580106;Variant;PA443937;Disease
HMG COA REDUCTASE INHIBITORS;EYS;Gene;PA133950441;Chemical
HMG COA REDUCTASE INHIBITORS, OTHER COMBINATIONS;EYS;Gene;PA164712781;Chemical
CARDIOVASCULAR DISEASE;EYS;Gene;PA443635;Disease
RHABDOMYOLYSIS;EYS;Gene;PA445549;Disease
SCHIZOPHRENIA;rs1415744;Variant;PA447216;Disease
CHLORPROMAZINE;rs1415744;Variant;PA448964;Chemical
CLOZAPINE;rs1415744;Variant;PA449061;Chemical
HALOPERIDOL;rs1415744;Variant;PA449841;Chemical
OLANZAPINE;rs1415744;Variant;PA450688;Chemical
QUETIAPINE;rs1415744;Variant;PA451201;Chemical
RISPERIDONE;rs1415744;Variant;PA451257;Chemical
TRIFLUOPERAZINE;rs1415744;Variant;PA451771;Chemical
CYP2C8;Bisphosphonates;Chemical;PA125;Gene
TBC1D32;Bisphosphonates;Chemical;PA134871908;Gene
MEX3C;Bisphosphonates;Chemical;PA162395821;Gene
CSRNP3;Bisphosphonates;Chemical;PA164718184;Gene
RS1886629;Bisphosphonates;Chemical;PA166153657;Variant
RS2297480;Bisphosphonates;Chemical;PA166153695;Variant
RS11264359;Bisphosphonates;Chemical;PA166153825;Variant
RS1934951;Bisphosphonates;Chemical;PA166153985;Variant
RS11189381;Bisphosphonates;Chemical;PA166154129;Variant
RS1678387;Bisphosphonates;Chemical;PA166154701;Variant
RS12903202;Bisphosphonates;Chemical;PA166154936;Variant
RS17751934;Bisphosphonates;Chemical;PA166155329;Variant
RS16944;Bisphosphonates;Chemical;PA166155587;Variant
RS7588295;Bisphosphonates;Chemical;PA166155769;Variant
RS17024608;Bisphosphonates;Chemical;PA166156462;Variant
RS7740004;Bisphosphonates;Chemical;PA166157121;Variant
RS2736308;Bisphosphonates;Chemical;PA166256641;Variant
ALDH1A2;Bisphosphonates;Chemical;PA24693;Gene
FDPS;Bisphosphonates;Chemical;PA28075;Gene
IL1B;Bisphosphonates;Chemical;PA29808;Gene
RBMS3;Bisphosphonates;Chemical;PA34276;Gene
SFRP5;Bisphosphonates;Chemical;PA35695;Gene
KCNT2;Bisphosphonates;Chemical;PA38726;Gene
ABCC4;Bisphosphonates;Chemical;PA397;Gene
TOBACCO USE DISORDER;CYP2A6*55;Haplotype;PA445876;Disease
NICOTINE;CYP2A6*55;Haplotype;PA450626;Chemical
DULOXETINE;rs17724494;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs17724494;Variant;PA447321;Disease
HEMORRHAGE;EPHA7;Gene;PA444417;Disease
WARFARIN;EPHA7;Gene;PA451906;Chemical
DPYD;rs72549308;Variant;PA145;Gene
CAPECITABINE;rs72549308;Variant;PA448771;Chemical
HEART FAILURE;rs17268282;Variant;PA444370;Disease
FUROSEMIDE;rs17268282;Variant;PA449719;Chemical
HLA-DRB3*01:01;heparin;Chemical;PA165952388;Haplotype
IL1RN;heparin;Chemical;PA29816;Gene
HLA-DRB3;heparin;Chemical;PA35074;Gene
SCHIZOPHRENIA;MIR582;Gene;PA447216;Disease
QUETIAPINE;MIR582;Gene;PA451201;Chemical
ASTHMA;rs967676;Variant;PA443450;Disease
FLUTICASONE PROPIONATE;rs967676;Variant;PA449686;Chemical
MONTELUKAST;rs967676;Variant;PA450546;Chemical
CYP2C19;ketoconazole;Chemical;PA124;Gene
CYP3A4;ketoconazole;Chemical;PA130;Gene
CYP3A5;ketoconazole;Chemical;PA131;Gene
DROSPIRENONE;ketoconazole;Chemical;PA164749409;Chemical
PAZOPANIB;ketoconazole;Chemical;PA165291492;Chemical
CYP2C19*8;ketoconazole;Chemical;PA165816524;Haplotype
CYP2C19*9;ketoconazole;Chemical;PA165816525;Haplotype
CYP2C19*16;ketoconazole;Chemical;PA165816532;Haplotype
CYP2C19*18;ketoconazole;Chemical;PA165816534;Haplotype
CYP2C19*19;ketoconazole;Chemical;PA165816535;Haplotype
CYP2C19*1;ketoconazole;Chemical;PA165980634;Haplotype
CYP3A5*1;ketoconazole;Chemical;PA166128213;Haplotype
CYP3A5*3;ketoconazole;Chemical;PA166128219;Haplotype
ABCB1;ketoconazole;Chemical;PA267;Gene
CYP4F2;ketoconazole;Chemical;PA27121;Gene
ALCOHOL ABUSE;ARID4A;Gene;PA443309;Disease
ETHANOL;ARID4A;Gene;PA448073;Chemical
ATAZANAVIR;UGT1A1*1;Haplotype;PA10251;Chemical
OXALIPLATIN;UGT1A1*1;Haplotype;PA131285527;Chemical
RALTITREXED;UGT1A1*1;Haplotype;PA131625240;Chemical
TRANILAST;UGT1A1*1;Haplotype;PA131890628;Chemical
ANTIVIRALS FOR TREATMENT OF HIV INFECTIONS, COMBINATIONS;UGT1A1*1;Haplotype;PA164712505;Chemical
LABETALOL;UGT1A1*1;Haplotype;PA164743150;Chemical
DEFERASIROX;UGT1A1*1;Haplotype;PA164760843;Chemical
SN-38;UGT1A1*1;Haplotype;PA165110775;Chemical
PAZOPANIB;UGT1A1*1;Haplotype;PA165291492;Chemical
NILOTINIB;UGT1A1*1;Haplotype;PA165958345;Chemical
BELINOSTAT;UGT1A1*1;Haplotype;PA165971474;Chemical
ELTROMBOPAG;UGT1A1*1;Haplotype;PA165981594;Chemical
PREGNANCY;UGT1A1*1;Haplotype;PA166048714;Disease
PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;UGT1A1*1;Haplotype;PA166048851;Disease
DOLUTEGRAVIR;UGT1A1*1;Haplotype;PA166114961;Chemical
OVERALL SURVIVAL;UGT1A1*1;Haplotype;PA166123207;Disease
BILIRUBIN;UGT1A1*1;Haplotype;PA166123346;Chemical
DISCONTINUATION;UGT1A1*1;Haplotype;PA166123507;Disease
RECURRENCE FREE SURVIVAL;UGT1A1*1;Haplotype;PA166127658;Disease
BONE DENSITY;UGT1A1*1;Haplotype;PA166128365;Disease
BILIARY TRACT NEOPLASMS;UGT1A1*1;Haplotype;PA166128807;Disease
ADVERSE EVENTS;UGT1A1*1;Haplotype;PA166151827;Disease
TREATMENT INTERRUPTIONS;UGT1A1*1;Haplotype;PA166159284;Disease
FEBRILE NEUTROPENIA;UGT1A1*1;Haplotype;PA166170245;Disease
ATAZANAVIR / RITONAVIR;UGT1A1*1;Haplotype;PA166182624;Chemical
FOLFIRI;UGT1A1*1;Haplotype;PA166182863;Chemical
RALOXIFENE-4??Ý-GLUCURONIDE;UGT1A1*1;Haplotype;PA166213481;Chemical
RALOXIFENE 6-GLUCURONIDE;UGT1A1*1;Haplotype;PA166213482;Chemical
SACITUZUMAB GOVITECAN;UGT1A1*1;Haplotype;PA166225061;Chemical
FOLFIRINOX;UGT1A1*1;Haplotype;PA166240141;Chemical
UGT1A1;UGT1A1*1;Haplotype;PA420;Gene
ACQUIRED IMMUNODEFICIENCY SYNDROME;UGT1A1*1;Haplotype;PA443250;Disease
ADENOCARCINOMA;UGT1A1*1;Haplotype;PA443265;Disease
ANEMIA;UGT1A1*1;Haplotype;PA443340;Disease
ANGINA PECTORIS;UGT1A1*1;Haplotype;PA443362;Disease
ASTHENIA;UGT1A1*1;Haplotype;PA443448;Disease
CARCINOMA, RENAL CELL;UGT1A1*1;Haplotype;PA443624;Disease
COLONIC NEOPLASMS;UGT1A1*1;Haplotype;PA443756;Disease
DEATH;UGT1A1*1;Haplotype;PA443842;Disease
DIARRHEA;UGT1A1*1;Haplotype;PA443899;Disease
DRUG TOXICITY;UGT1A1*1;Haplotype;PA443937;Disease
FATIGUE;UGT1A1*1;Haplotype;PA444153;Disease
GASTROINTESTINAL NEOPLASMS;UGT1A1*1;Haplotype;PA444257;Disease
CARCINOMA, HEPATOCELLULAR;UGT1A1*1;Haplotype;PA444447;Disease
HYPERBILIRUBINEMIA;UGT1A1*1;Haplotype;PA444511;Disease
JAUNDICE;UGT1A1*1;Haplotype;PA444648;Disease
LEUKOPENIA;UGT1A1*1;Haplotype;PA444773;Disease
LUNG NEOPLASMS;UGT1A1*1;Haplotype;PA444818;Disease
NEOPLASM METASTASIS;UGT1A1*1;Haplotype;PA445058;Disease
NEOPLASMS;UGT1A1*1;Haplotype;PA445062;Disease
NEUTROPENIA;UGT1A1*1;Haplotype;PA445113;Disease
OLIGURIA;UGT1A1*1;Haplotype;PA445146;Disease
OSTEOPOROSIS;UGT1A1*1;Haplotype;PA445190;Disease
OVARIAN NEOPLASMS;UGT1A1*1;Haplotype;PA445204;Disease
PANCREATIC NEOPLASMS;UGT1A1*1;Haplotype;PA445218;Disease
STOMACH NEOPLASMS;UGT1A1*1;Haplotype;PA445742;Disease
THROMBOCYTOPENIA;UGT1A1*1;Haplotype;PA445846;Disease
THROMBOEMBOLISM;UGT1A1*1;Haplotype;PA445848;Disease
TUBERCULOSIS;UGT1A1*1;Haplotype;PA445941;Disease
UNCONSCIOUSNESS;UGT1A1*1;Haplotype;PA445975;Disease
VOMITING;UGT1A1*1;Haplotype;PA446051;Disease
COLORECTAL NEOPLASMS;UGT1A1*1;Haplotype;PA446108;Disease
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;UGT1A1*1;Haplotype;PA446171;Disease
MYOCARDIAL ISCHEMIA;UGT1A1*1;Haplotype;PA446459;Disease
HIV INFECTIONS;UGT1A1*1;Haplotype;PA447230;Disease
CAPECITABINE;UGT1A1*1;Haplotype;PA448771;Chemical
CARVEDILOL;UGT1A1*1;Haplotype;PA448817;Chemical
CISPLATIN;UGT1A1*1;Haplotype;PA449014;Chemical
CLOZAPINE;UGT1A1*1;Haplotype;PA449061;Chemical
INDINAVIR;UGT1A1*1;Haplotype;PA449977;Chemical
IRINOTECAN;UGT1A1*1;Haplotype;PA450085;Chemical
LAMIVUDINE;UGT1A1*1;Haplotype;PA450163;Chemical
MOXIFLOXACIN;UGT1A1*1;Haplotype;PA450555;Chemical
OLANZAPINE;UGT1A1*1;Haplotype;PA450688;Chemical
RALOXIFENE;UGT1A1*1;Haplotype;PA451221;Chemical
RITONAVIR;UGT1A1*1;Haplotype;PA451260;Chemical
WARFARIN;UGT1A1*1;Haplotype;PA451906;Chemical
ZIDOVUDINE;UGT1A1*1;Haplotype;PA451954;Chemical
SORAFENIB;UGT1A1*1;Haplotype;PA7000;Chemical
KAT2B;Substance-Related Disorders;Disease;PA162392705;Gene
RS324420;Substance-Related Disorders;Disease;PA166153569;Variant
RS6265;Substance-Related Disorders;Disease;PA166154259;Variant
RS6277;Substance-Related Disorders;Disease;PA166154261;Variant
RS1800497;Substance-Related Disorders;Disease;PA166154339;Variant
RS1045280;Substance-Related Disorders;Disease;PA166155174;Variant
RS2036657;Substance-Related Disorders;Disease;PA166155198;Variant
RS4790694;Substance-Related Disorders;Disease;PA166155223;Variant
RS713729;Substance-Related Disorders;Disease;PA166156054;Variant
RS2076369;Substance-Related Disorders;Disease;PA166156086;Variant
RS1523130;Substance-Related Disorders;Disease;PA166156323;Variant
RS2276707;Substance-Related Disorders;Disease;PA166156352;Variant
RS878567;Substance-Related Disorders;Disease;PA166156743;Variant
RS1799971;Substance-Related Disorders;Disease;PA166156991;Variant
RS1045642;Substance-Related Disorders;Disease;PA166157284;Variant
RS1799972;Substance-Related Disorders;Disease;PA166177739;Variant
RS9829896;Substance-Related Disorders;Disease;PA166184842;Variant
RS9891146;Substance-Related Disorders;Disease;PA166184845;Variant
RS17552189;Substance-Related Disorders;Disease;PA166184846;Variant
RS2381356;Substance-Related Disorders;Disease;PA166184847;Variant
RS34066662;Substance-Related Disorders;Disease;PA166197641;Variant
RS58801820;Substance-Related Disorders;Disease;PA166197642;Variant
RS75168521;Substance-Related Disorders;Disease;PA166197643;Variant
RS78886294;Substance-Related Disorders;Disease;PA166197644;Variant
RS1890881;Substance-Related Disorders;Disease;PA166197645;Variant
RS74611272;Substance-Related Disorders;Disease;PA166197646;Variant
RS34214870;Substance-Related Disorders;Disease;PA166197661;Variant
HTR1A;Substance-Related Disorders;Disease;PA192;Gene
ABCB1;Substance-Related Disorders;Disease;PA267;Gene
DRD2;Substance-Related Disorders;Disease;PA27478;Gene
DRD4;Substance-Related Disorders;Disease;PA27480;Gene
FAAH;Substance-Related Disorders;Disease;PA27955;Gene
BDNF;Substance-Related Disorders;Disease;PA31891;Gene
OPRM1;Substance-Related Disorders;Disease;PA31945;Gene
PICK1;Substance-Related Disorders;Disease;PA33760;Gene
NR1I2;Substance-Related Disorders;Disease;PA378;Gene
ARRB2;Substance-Related Disorders;Disease;PA60;Gene
PRORP;zileuton;Chemical;PA134879499;Gene
RS12436663;zileuton;Chemical;PA166161141;Variant
ALOX5;zileuton;Chemical;PA46;Gene
CETUXIMAB;NRG3;Gene;PA10040;Chemical
ILOPERIDONE;NRG3;Gene;PA161199368;Chemical
PANITUMUMAB;NRG3;Gene;PA162373091;Chemical
ACQUIRED LONG QT SYNDROME (ALQTS);NRG3;Gene;PA447300;Disease
ABCC2;Leukemia;Disease;PA116;Gene
CYP3A5;Leukemia;Disease;PA131;Gene
TPMT*1;Leukemia;Disease;PA165819268;Haplotype
TPMT*2;Leukemia;Disease;PA165819269;Haplotype
TPMT*3A;Leukemia;Disease;PA165819270;Haplotype
TPMT*3C;Leukemia;Disease;PA165819272;Haplotype
CYP3A5*1;Leukemia;Disease;PA166128213;Haplotype
CYP3A5*3;Leukemia;Disease;PA166128219;Haplotype
RS1801133;Leukemia;Disease;PA166153644;Variant
RS2072671;Leukemia;Disease;PA166153667;Variant
RS3215400;Leukemia;Disease;PA166153738;Variant
RS717620;Leukemia;Disease;PA166153953;Variant
RS1051266;Leukemia;Disease;PA166155986;Variant
MTHFR;Leukemia;Disease;PA245;Gene
NQO1;Leukemia;Disease;PA31744;Gene
SLC19A1;Leukemia;Disease;PA327;Gene
TPMT;Leukemia;Disease;PA356;Gene
CDA;Leukemia;Disease;PA98;Gene
HYPERTENSION;CDK6;Gene;PA444552;Disease
DEPRESSIVE DISORDER;rs585719;Variant;PA447207;Disease
CITALOPRAM;rs585719;Variant;PA449015;Chemical
DEPRESSION;rs1487278;Variant;PA447278;Disease
MIRTAZAPINE;rs1487278;Variant;PA450522;Chemical
VENLAFAXINE;rs1487278;Variant;PA451866;Chemical
PALBOCICLIB;rs759922342;Variant;PA166153469;Chemical
LATANOPROST;rs3753380;Variant;PA164774763;Chemical
OPEN-ANGLE GLAUCOMA;rs3753380;Variant;PA444282;Disease
DESFLURANE;rs193922818;Variant;PA164749136;Chemical
RYR1;rs193922818;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs193922818;Variant;PA444863;Disease
ENFLURANE;rs193922818;Variant;PA449461;Chemical
HALOTHANE;rs193922818;Variant;PA449845;Chemical
ISOFLURANE;rs193922818;Variant;PA450106;Chemical
METHOXYFLURANE;rs193922818;Variant;PA450434;Chemical
SEVOFLURANE;rs193922818;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs193922818;Variant;PA451522;Chemical
CACNA1S;rs193922818;Variant;PA85;Gene
RADIOTHERAPY;TANC1;Gene;PA166122986;Chemical
PROSTATIC NEOPLASMS;TANC1;Gene;PA445425;Disease
ALZHEIMER DISEASE;rs2177370;Variant;PA443319;Disease
DONEPEZIL;rs2177370;Variant;PA449394;Chemical
GALANTAMINE;rs2177370;Variant;PA449726;Chemical
RIVASTIGMINE;rs2177370;Variant;PA451262;Chemical
HYPERTENSION;TXNDC11;Gene;PA444552;Disease
HYDROCHLOROTHIAZIDE;TXNDC11;Gene;PA449899;Chemical
COL3A1;GP5;Gene;PA26716;Gene
COL4A1;GP5;Gene;PA26717;Gene
COL4A2;GP5;Gene;PA26718;Gene
PLCB1;GP5;Gene;PA33384;Gene
PLCG2;GP5;Gene;PA33393;Gene
COL1A1;GP5;Gene;PA35041;Gene
COL1A2;GP5;Gene;PA35042;Gene
HMG COA REDUCTASE INHIBITORS;CETP;Gene;PA133950441;Chemical
ROSUVASTATIN;CETP;Gene;PA134308647;Chemical
CORONARY ARTERY DISEASE;CETP;Gene;PA443796;Disease
HYPERCHOLESTEROLEMIA;CETP;Gene;PA444516;Disease
HYPERLIPOPROTEINEMIA TYPE II;CETP;Gene;PA444517;Disease
HYPERLIPIDEMIAS;CETP;Gene;PA444528;Disease
ATORVASTATIN;CETP;Gene;PA448500;Chemical
FLUVASTATIN;CETP;Gene;PA449688;Chemical
LOVASTATIN;CETP;Gene;PA450272;Chemical
PRAVASTATIN;CETP;Gene;PA451089;Chemical
SIMVASTATIN;CETP;Gene;PA451363;Chemical
ALOPECIA;rs1050565;Variant;PA443314;Disease
PAIN;rs1050565;Variant;PA445208;Disease
TESTICULAR NEOPLASMS;rs1050565;Variant;PA445828;Disease
BLEOMYCIN;rs1050565;Variant;PA448645;Chemical
CISPLATIN;rs1050565;Variant;PA449014;Chemical
ETOPOSIDE;rs1050565;Variant;PA449552;Chemical
MTTP;APOA5;Gene;PA164742099;Gene
HYPERLIPIDEMIAS;APOA5;Gene;PA444528;Disease
HYPERTRIGLYCERIDEMIA;APOA5;Gene;PA446120;Disease
ATORVASTATIN;APOA5;Gene;PA448500;Chemical
FENOFIBRATE;APOA5;Gene;PA449594;Chemical
LOVASTATIN;APOA5;Gene;PA450272;Chemical
SIMVASTATIN;APOA5;Gene;PA451363;Chemical
PEGINTERFERON ALFA-2A;rs4273729;Variant;PA164749390;Chemical
PEGINTERFERON ALFA-2B;rs4273729;Variant;PA164784024;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;rs4273729;Variant;PA446863;Disease
RIBAVIRIN;rs4273729;Variant;PA451241;Chemical
PEGINTERFERON ALFA-2A;MICB;Gene;PA164749390;Chemical
PEGINTERFERON ALFA-2B;MICB;Gene;PA164784024;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;MICB;Gene;PA446863;Disease
RIBAVIRIN;MICB;Gene;PA451241;Chemical
PLATINUM COMPOUNDS;APLF;Gene;PA164713176;Chemical
CARCINOMA, NON-SMALL-CELL LUNG;APLF;Gene;PA443622;Disease
AZACITIDINE;PTPN11;Gene;PA451996;Chemical
ESCITALOPRAM;RPP30;Gene;PA10074;Chemical
BIPOLAR DISORDER;RPP30;Gene;PA447199;Disease
DEPRESSION;RPP30;Gene;PA447278;Disease
PAROXETINE;RPP30;Gene;PA450801;Chemical
ANTIDEPRESSANTS;RPP30;Gene;PA452229;Chemical
HLA-DQA1*01:03;Antithyroid Preparations;Chemical;PA165951282;Haplotype
HLA-DRB1*08:03;Antithyroid Preparations;Chemical;PA165951678;Haplotype
HLA-B*08:01;Antithyroid Preparations;Chemical;PA165954547;Haplotype
HLA-B*27:05;Antithyroid Preparations;Chemical;PA165955118;Haplotype
HLA-B*38:02;Antithyroid Preparations;Chemical;PA165955505;Haplotype
HLA-B*39:01;Antithyroid Preparations;Chemical;PA165955543;Haplotype
HLA-DQB1*06:01;Antithyroid Preparations;Chemical;PA165958097;Haplotype
RS652888;Antithyroid Preparations;Chemical;PA166170338;Variant
RS199564443;Antithyroid Preparations;Chemical;PA166170340;Variant
RS1071816;Antithyroid Preparations;Chemical;PA166170341;Variant
RS111618861;Antithyroid Preparations;Chemical;PA166170342;Variant
EHMT2;Antithyroid Preparations;Chemical;PA25267;Gene
FOXF2;Antithyroid Preparations;Chemical;PA28227;Gene
HLA-B;Antithyroid Preparations;Chemical;PA35056;Gene
HLA-DQA1;Antithyroid Preparations;Chemical;PA35066;Gene
HLA-DQB1;Antithyroid Preparations;Chemical;PA35068;Gene
HLA-DRB1;Antithyroid Preparations;Chemical;PA35072;Gene
ROSUVASTATIN;KIF6;Gene;PA134308647;Chemical
CORONARY DISEASE;KIF6;Gene;PA443797;Disease
HYPERCHOLESTEROLEMIA;KIF6;Gene;PA444516;Disease
MYOCARDIAL INFARCTION;KIF6;Gene;PA445019;Disease
ATORVASTATIN;KIF6;Gene;PA448500;Chemical
PRAVASTATIN;KIF6;Gene;PA451089;Chemical
SIMVASTATIN;KIF6;Gene;PA451363;Chemical
CYP2C19;labetalol;Chemical;PA124;Gene
CYP2C19*1;labetalol;Chemical;PA165980634;Haplotype
CYP2C19*2;labetalol;Chemical;PA165980635;Haplotype
UGT1A1*1;labetalol;Chemical;PA166115841;Haplotype
UGT1A1*28;labetalol;Chemical;PA166115842;Haplotype
UGT1A1*60;labetalol;Chemical;PA166115845;Haplotype
UGT1A1*6;labetalol;Chemical;PA166115858;Haplotype
GRK5;labetalol;Chemical;PA180;Gene
GRK4;labetalol;Chemical;PA28941;Gene
ADRA2C;labetalol;Chemical;PA37;Gene
ADRB1;labetalol;Chemical;PA38;Gene
ADRB2;labetalol;Chemical;PA39;Gene
UGT1A1;labetalol;Chemical;PA420;Gene
BREAST NEOPLASMS;rs1113129;Variant;PA443560;Disease
PACLITAXEL;rs1113129;Variant;PA450761;Chemical
GRANISETRON;CYP1A1*2A;Haplotype;PA449809;Chemical
NAGS;sodium benzoate / sodium phenylacetate;Chemical;PA134968729;Gene
ASS1;sodium benzoate / sodium phenylacetate;Chemical;PA162376926;Gene
ARG1;sodium benzoate / sodium phenylacetate;Chemical;PA24947;Gene
ASL;sodium benzoate / sodium phenylacetate;Chemical;PA25046;Gene
CPS1;sodium benzoate / sodium phenylacetate;Chemical;PA26840;Gene
OTC;sodium benzoate / sodium phenylacetate;Chemical;PA32840;Gene
GEFITINIB;SIRT2;Gene;PA131301952;Chemical
TOXIC LIVER DISEASE;SIRT2;Gene;PA164925725;Disease
PLCG1;PRKCD;Gene;PA33392;Gene
PLCG2;PRKCD;Gene;PA33393;Gene
RAF1;PRKCD;Gene;PA34183;Gene
ADRB2;PRKCD;Gene;PA39;Gene
CYP2D6;Mood Disorder;Disease;PA128;Gene
HLA-B*15:21;Mood Disorder;Disease;PA165954809;Haplotype
CYP2D6*1XN;Mood Disorder;Disease;PA165988479;Haplotype
CYP2D6*2XN;Mood Disorder;Disease;PA165988480;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);Mood Disorder;Disease;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);Mood Disorder;Disease;PA166116466;Haplotype
SLC6A4 L ALLELE-RS25531T;Mood Disorder;Disease;PA166117146;Haplotype
SLC6A4 L ALLELE-RS25531C;Mood Disorder;Disease;PA166117147;Haplotype
RS4713916;Mood Disorder;Disease;PA166157104;Variant
RS7799039;Mood Disorder;Disease;PA166157432;Variant
LEP;Mood Disorder;Disease;PA228;Gene
FKBP5;Mood Disorder;Disease;PA28162;Gene
SLC6A4;Mood Disorder;Disease;PA312;Gene
HLA-B;Mood Disorder;Disease;PA35056;Gene
TRANSPLANTATION;rs2279343;Variant;PA134850491;Disease
NEONATAL ABSTINENCE SYNDROME;rs2279343;Variant;PA165108809;Disease
HEROIN DEPENDENCE;rs2279343;Variant;PA444460;Disease
TOBACCO USE DISORDER;rs2279343;Variant;PA445876;Disease
BUPROPION;rs2279343;Variant;PA448687;Chemical
CYCLOPHOSPHAMIDE;rs2279343;Variant;PA449165;Chemical
EFAVIRENZ;rs2279343;Variant;PA449441;Chemical
METHADONE;rs2279343;Variant;PA450401;Chemical
NICOTINE;rs2279343;Variant;PA450626;Chemical
PROPOFOL;rs2279343;Variant;PA451141;Chemical
HMG COA REDUCTASE INHIBITORS;SREBF1;Gene;PA133950441;Chemical
PRKAA1;SREBF1;Gene;PA33744;Gene
PRKAA2;SREBF1;Gene;PA33745;Gene
PRKAB1;SREBF1;Gene;PA33746;Gene
PRKAB2;SREBF1;Gene;PA33747;Gene
PRKAG1;SREBF1;Gene;PA33751;Gene
PRKAG2;SREBF1;Gene;PA33752;Gene
PRKAG3;SREBF1;Gene;PA33753;Gene
SIRT1;SREBF1;Gene;PA37935;Gene
SCHIZOPHRENIA;SREBF1;Gene;PA447216;Disease
FLUVASTATIN;SREBF1;Gene;PA449688;Chemical
DIABETES MELLITUS;rs2954625;Variant;PA443886;Disease
METFORMIN;rs2954625;Variant;PA450395;Chemical
ANTIVIRALS FOR TREATMENT OF HIV INFECTIONS, COMBINATIONS;rs7412;Variant;PA164712505;Chemical
LECANEMAB;rs7412;Variant;PA166313301;Chemical
ADUCANUMAB;rs7412;Variant;PA166350685;Chemical
CORONARY DISEASE;rs7412;Variant;PA443797;Disease
HYPERLIPIDEMIAS;rs7412;Variant;PA444528;Disease
HYPERTRIGLYCERIDEMIA;rs7412;Variant;PA446120;Disease
HIV INFECTIOUS DISEASE;rs7412;Variant;PA447230;Disease
ATORVASTATIN;rs7412;Variant;PA448500;Chemical
FENOFIBRATE;rs7412;Variant;PA449594;Chemical
FLUVASTATIN;rs7412;Variant;PA449688;Chemical
PRAVASTATIN;rs7412;Variant;PA451089;Chemical
RITONAVIR;rs7412;Variant;PA451260;Chemical
WARFARIN;rs7412;Variant;PA451906;Chemical
APOE;rs7412;Variant;PA55;Gene
ANTHRACYCLINES AND RELATED SUBSTANCES;rs729147;Variant;PA130620651;Chemical
ANTIEMETICS AND ANTINAUSEANTS;rs35167514;Variant;PA164712431;Chemical
TRAMADOL;rs35167514;Variant;PA451735;Chemical
CYP2B6;fluoxetine;Chemical;PA123;Gene
CYP2C19;fluoxetine;Chemical;PA124;Gene
CYP2C9;fluoxetine;Chemical;PA126;Gene
CYP2D6;fluoxetine;Chemical;PA128;Gene
CYP3A4;fluoxetine;Chemical;PA130;Gene
CYP3A5;fluoxetine;Chemical;PA131;Gene
SLCO1B1;fluoxetine;Chemical;PA134865839;Gene
REEP5;fluoxetine;Chemical;PA134882361;Gene
ACE;fluoxetine;Chemical;PA139;Gene
CYP2C19*8;fluoxetine;Chemical;PA165816524;Haplotype
CYP2C19*9;fluoxetine;Chemical;PA165816525;Haplotype
CYP2C19*10;fluoxetine;Chemical;PA165816526;Haplotype
CYP2C19*14;fluoxetine;Chemical;PA165816530;Haplotype
CYP2C19*15;fluoxetine;Chemical;PA165816531;Haplotype
CYP2C19*16;fluoxetine;Chemical;PA165816532;Haplotype
CYP2C19*17;fluoxetine;Chemical;PA165816533;Haplotype
CYP2C19*18;fluoxetine;Chemical;PA165816534;Haplotype
CYP2C19*19;fluoxetine;Chemical;PA165816535;Haplotype
CYP2C9*1;fluoxetine;Chemical;PA165816542;Haplotype
CYP2C9*2;fluoxetine;Chemical;PA165816543;Haplotype
CYP2C9*3;fluoxetine;Chemical;PA165816544;Haplotype
CYP2D6*1;fluoxetine;Chemical;PA165816576;Haplotype
CYP2D6*2;fluoxetine;Chemical;PA165816577;Haplotype
CYP2D6*3;fluoxetine;Chemical;PA165816578;Haplotype
CYP2D6*4;fluoxetine;Chemical;PA165816579;Haplotype
CYP2D6*6;fluoxetine;Chemical;PA165816581;Haplotype
CYP2D6*10;fluoxetine;Chemical;PA165816582;Haplotype
CYP2D6*17;fluoxetine;Chemical;PA165816583;Haplotype
CYP2D6*5;fluoxetine;Chemical;PA165948092;Haplotype
CYP2C19*1;fluoxetine;Chemical;PA165980634;Haplotype
CYP2C19*2;fluoxetine;Chemical;PA165980635;Haplotype
CYP2D6*1XN;fluoxetine;Chemical;PA165988479;Haplotype
CYP2D6*2XN;fluoxetine;Chemical;PA165988480;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);fluoxetine;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);fluoxetine;Chemical;PA166116466;Haplotype
CYP2C19*29;fluoxetine;Chemical;PA166123292;Haplotype
CYP2C19*31;fluoxetine;Chemical;PA166123294;Haplotype
CYP2C19*32;fluoxetine;Chemical;PA166123295;Haplotype
CYP2D6*87;fluoxetine;Chemical;PA166123327;Haplotype
CYP2D6*92;fluoxetine;Chemical;PA166123332;Haplotype
CYP2D6*93;fluoxetine;Chemical;PA166123333;Haplotype
CYP2D6*96;fluoxetine;Chemical;PA166123337;Haplotype
CYP3A5*1;fluoxetine;Chemical;PA166128213;Haplotype
CYP3A5*3;fluoxetine;Chemical;PA166128219;Haplotype
RS6265;fluoxetine;Chemical;PA166154259;Variant
RS1800532;fluoxetine;Chemical;PA166154340;Variant
RS61888800;fluoxetine;Chemical;PA166154478;Variant
RS4149056;fluoxetine;Chemical;PA166154579;Variant
RS6311;fluoxetine;Chemical;PA166154673;Variant
RS6313;fluoxetine;Chemical;PA166154675;Variant
RS7997012;fluoxetine;Chemical;PA166154726;Variant
RS25531;fluoxetine;Chemical;PA166155159;Variant
RS242941;fluoxetine;Chemical;PA166155163;Variant
RS1799752;fluoxetine;Chemical;PA166155187;Variant
RS334558;fluoxetine;Chemical;PA166156287;Variant
RS2433320;fluoxetine;Chemical;PA166156558;Variant
RS6295;fluoxetine;Chemical;PA166156708;Variant
RS153549;fluoxetine;Chemical;PA166156716;Variant
RS153560;fluoxetine;Chemical;PA166156717;Variant
RS495794;fluoxetine;Chemical;PA166156736;Variant
RS4713916;fluoxetine;Chemical;PA166157104;Variant
RS1799889;fluoxetine;Chemical;PA166157302;Variant
RS2032582;fluoxetine;Chemical;PA166157316;Variant
RS2227631;fluoxetine;Chemical;PA166157329;Variant
RS4148739;fluoxetine;Chemical;PA166157386;Variant
RS28401781;fluoxetine;Chemical;PA166157485;Variant
CYP2D6 POOR METABOLIZER;fluoxetine;Chemical;PA166157927;Variant
RS57098334;fluoxetine;Chemical;PA166158926;Variant
RS9361233;fluoxetine;Chemical;PA166163186;Variant
HTR1A;fluoxetine;Chemical;PA192;Gene
HTR2A;fluoxetine;Chemical;PA193;Gene
HTR2C;fluoxetine;Chemical;PA194;Gene
KCNH2;fluoxetine;Chemical;PA212;Gene
SERPINE1;fluoxetine;Chemical;PA261;Gene
ABCB1;fluoxetine;Chemical;PA267;Gene
CRHR1;fluoxetine;Chemical;PA26874;Gene
CYP1A2;fluoxetine;Chemical;PA27093;Gene
DRD2;fluoxetine;Chemical;PA27478;Gene
FKBP5;fluoxetine;Chemical;PA28162;Gene
GSK3B;fluoxetine;Chemical;PA29009;Gene
HTR1B;fluoxetine;Chemical;PA29549;Gene
SLC6A4;fluoxetine;Chemical;PA312;Gene
BDNF;fluoxetine;Chemical;PA31891;Gene
POLG;fluoxetine;Chemical;PA33500;Gene
HLA-A;fluoxetine;Chemical;PA35055;Gene
HLA-B;fluoxetine;Chemical;PA35056;Gene
TPH1;fluoxetine;Chemical;PA355;Gene
SRP19;fluoxetine;Chemical;PA36124;Gene
UGT1A4;fluoxetine;Chemical;PA37179;Gene
SIPOGLITAZAR;UGT2B15*1;Haplotype;PA166114434;Chemical
EVENT-FREE SURVIVAL;UGT2B15*1;Haplotype;PA166123366;Disease
BREAST NEOPLASMS;UGT2B15*1;Haplotype;PA443560;Disease
ACETAMINOPHEN;UGT2B15*1;Haplotype;PA448015;Chemical
TAMOXIFEN;UGT2B15*1;Haplotype;PA451581;Chemical
ANTINEOPLASTIC AGENTS;UGT2B15*1;Haplotype;PA452621;Chemical
FLUOROURACIL;rs12050587;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs12050587;Variant;PA443560;Disease
LEUKOPENIA;rs12050587;Variant;PA444773;Disease
NEUTROPENIA;rs12050587;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs12050587;Variant;PA449165;Chemical
EPIRUBICIN;rs12050587;Variant;PA449476;Chemical
3-CYANO-7-ETHOXYCOUMARIN;CYP2C19*9;Haplotype;PA166123047;Chemical
ANDROSTENEDIONE;CYP2C19*9;Haplotype;PA166178641;Chemical
6BETA-HYDROXYTESTOSTERONE;CYP2C19*9;Haplotype;PA166318222;Chemical
11ALPHA-HYDROXYTESTOSTERONE;CYP2C19*9;Haplotype;PA166318261;Chemical
11A-HYDROXYPROGESTERONE;CYP2C19*9;Haplotype;PA166318342;Chemical
DESOXYCORTONE;CYP2C19*9;Haplotype;PA166318362;Chemical
ASTHMA;CYP2C19*9;Haplotype;PA443450;Disease
GASTROESOPHAGEAL REFLUX;CYP2C19*9;Haplotype;PA444255;Disease
RESPIRATORY TRACT INFECTIONS;CYP2C19*9;Haplotype;PA445526;Disease
CELECOXIB;CYP2C19*9;Haplotype;PA448871;Chemical
CLOPIDOGREL;CYP2C19*9;Haplotype;PA449053;Chemical
FLUCONAZOLE;CYP2C19*9;Haplotype;PA449653;Chemical
FLUOXETINE;CYP2C19*9;Haplotype;PA449673;Chemical
FLUVOXAMINE;CYP2C19*9;Haplotype;PA449690;Chemical
KETOCONAZOLE;CYP2C19*9;Haplotype;PA450146;Chemical
LANSOPRAZOLE;CYP2C19*9;Haplotype;PA450180;Chemical
MEPHENYTOIN;CYP2C19*9;Haplotype;PA450373;Chemical
OMEPRAZOLE;CYP2C19*9;Haplotype;PA450704;Chemical
SERTRALINE;CYP2C19*9;Haplotype;PA451333;Chemical
TROGLITAZONE;CYP2C19*9;Haplotype;PA451799;Chemical
ATAZANAVIR;UGT1A1;Gene;PA10251;Chemical
OXALIPLATIN;UGT1A1;Gene;PA131285527;Chemical
RALTITREXED;UGT1A1;Gene;PA131625240;Chemical
TRANILAST;UGT1A1;Gene;PA131890628;Chemical
HMG COA REDUCTASE INHIBITORS;UGT1A1;Gene;PA133950441;Chemical
ERLOTINIB;UGT1A1;Gene;PA134687924;Chemical
LYMPHOMA, LARGE B-CELL, DIFFUSE;UGT1A1;Gene;PA160680212;Disease
NEPHROLITHIASIS;UGT1A1;Gene;PA162355520;Disease
ANTIVIRALS FOR TREATMENT OF HIV INFECTIONS, COMBINATIONS;UGT1A1;Gene;PA164712505;Chemical
LABETALOL;UGT1A1;Gene;PA164743150;Chemical
ARFORMOTEROL;UGT1A1;Gene;PA164743977;Chemical
DEFERASIROX;UGT1A1;Gene;PA164760843;Chemical
RALTEGRAVIR;UGT1A1;Gene;PA164888966;Chemical
AXITINIB;UGT1A1;Gene;PA164924493;Chemical
SN-38;UGT1A1;Gene;PA165110775;Chemical
PAZOPANIB;UGT1A1;Gene;PA165291492;Chemical
NILOTINIB;UGT1A1;Gene;PA165958345;Chemical
INDACATEROL;UGT1A1;Gene;PA165958348;Chemical
DESVENLAFAXINE;UGT1A1;Gene;PA165958374;Chemical
FEBUXOSTAT;UGT1A1;Gene;PA165958521;Chemical
BELINOSTAT;UGT1A1;Gene;PA165971474;Chemical
ELTROMBOPAG;UGT1A1;Gene;PA165981594;Chemical
HLA-B*57:01;UGT1A1;Gene;PA165987830;Haplotype
PREGNANCY;UGT1A1;Gene;PA166048714;Disease
PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;UGT1A1;Gene;PA166048851;Disease
DOLUTEGRAVIR;UGT1A1;Gene;PA166114961;Chemical
TEGAFUR / GIMERACIL / OTERACIL;UGT1A1;Gene;PA166115442;Chemical
UGT1A1*1;UGT1A1;Gene;PA166115841;Haplotype
UGT1A1*28;UGT1A1;Gene;PA166115842;Haplotype
UGT1A1*36;UGT1A1;Gene;PA166115843;Haplotype
UGT1A1*37;UGT1A1;Gene;PA166115844;Haplotype
UGT1A1*80;UGT1A1;Gene;PA166115850;Haplotype
UGT1A1*6;UGT1A1;Gene;PA166115858;Haplotype
PROGRESSION-FREE SURVIVAL;UGT1A1;Gene;PA166123026;Disease
OVERALL SURVIVAL;UGT1A1;Gene;PA166123207;Disease
BILIRUBIN;UGT1A1;Gene;PA166123346;Chemical
HEART VALVE REPLACEMENT;UGT1A1;Gene;PA166123431;Disease
DISCONTINUATION;UGT1A1;Gene;PA166123507;Disease
RECURRENCE FREE SURVIVAL;UGT1A1;Gene;PA166127658;Disease
BONE DENSITY;UGT1A1;Gene;PA166128365;Disease
BILIARY TRACT NEOPLASMS;UGT1A1;Gene;PA166128807;Disease
ADVERSE EVENTS;UGT1A1;Gene;PA166151827;Disease
RS2306283;UGT1A1;Gene;PA166154547;Variant
RS4149032;UGT1A1;Gene;PA166154575;Variant
RS4149056;UGT1A1;Gene;PA166154579;Variant
RS4148323;UGT1A1;Gene;PA166155721;Variant
RS8175347;UGT1A1;Gene;PA166159020;Variant
TREATMENT INTERRUPTIONS;UGT1A1;Gene;PA166159284;Disease
FEBRILE NEUTROPENIA;UGT1A1;Gene;PA166170245;Disease
BINIMETINIB;UGT1A1;Gene;PA166179867;Chemical
ATAZANAVIR / RITONAVIR;UGT1A1;Gene;PA166182624;Chemical
FOLFIRI;UGT1A1;Gene;PA166182863;Chemical
LETERMOVIR;UGT1A1;Gene;PA166184379;Chemical
RALOXIFENE-4??Ý-GLUCURONIDE;UGT1A1;Gene;PA166213481;Chemical
RALOXIFENE 6-GLUCURONIDE;UGT1A1;Gene;PA166213482;Chemical
UGT1A1*80+*28;UGT1A1;Gene;PA166220483;Haplotype
SACITUZUMAB GOVITECAN;UGT1A1;Gene;PA166225061;Chemical
FOLFIRINOX;UGT1A1;Gene;PA166240141;Chemical
CABOTEGRAVIR / RILPIVIRINE;UGT1A1;Gene;PA166251381;Chemical
ACQUIRED IMMUNODEFICIENCY SYNDROME;UGT1A1;Gene;PA443250;Disease
ADENOCARCINOMA;UGT1A1;Gene;PA443265;Disease
ANEMIA;UGT1A1;Gene;PA443340;Disease
ANGINA PECTORIS;UGT1A1;Gene;PA443362;Disease
ASTHENIA;UGT1A1;Gene;PA443448;Disease
CARCINOMA, RENAL CELL;UGT1A1;Gene;PA443624;Disease
COLONIC NEOPLASMS;UGT1A1;Gene;PA443756;Disease
CRIGLER-NAJJAR SYNDROME;UGT1A1;Gene;PA443813;Disease
DEATH;UGT1A1;Gene;PA443842;Disease
DIARRHEA;UGT1A1;Gene;PA443899;Disease
DRUG TOXICITY;UGT1A1;Gene;PA443937;Disease
FATIGUE;UGT1A1;Gene;PA444153;Disease
GASTROINTESTINAL NEOPLASMS;UGT1A1;Gene;PA444257;Disease
GOUT;UGT1A1;Gene;PA444318;Disease
HEART FAILURE;UGT1A1;Gene;PA444370;Disease
CARCINOMA, HEPATOCELLULAR;UGT1A1;Gene;PA444447;Disease
HYPERBILIRUBINEMIA;UGT1A1;Gene;PA444511;Disease
HYPERLIPIDEMIAS;UGT1A1;Gene;PA444528;Disease
HYPERPROLACTINEMIA;UGT1A1;Gene;PA444545;Disease
JAUNDICE;UGT1A1;Gene;PA444648;Disease
LEUKOPENIA;UGT1A1;Gene;PA444773;Disease
LUNG NEOPLASMS;UGT1A1;Gene;PA444818;Disease
LYMPHOMA;UGT1A1;Gene;PA444840;Disease
NEOPLASM METASTASIS;UGT1A1;Gene;PA445058;Disease
NEOPLASMS;UGT1A1;Gene;PA445062;Disease
NEUTROPENIA;UGT1A1;Gene;PA445113;Disease
OLIGURIA;UGT1A1;Gene;PA445146;Disease
OSTEOPOROSIS;UGT1A1;Gene;PA445190;Disease
OVARIAN NEOPLASMS;UGT1A1;Gene;PA445204;Disease
PANCREATIC NEOPLASMS;UGT1A1;Gene;PA445218;Disease
OSTEOSARCOMA;UGT1A1;Gene;PA445601;Disease
STOMACH NEOPLASMS;UGT1A1;Gene;PA445742;Disease
THROMBOCYTOPENIA;UGT1A1;Gene;PA445846;Disease
THROMBOEMBOLISM;UGT1A1;Gene;PA445848;Disease
TUBERCULOSIS;UGT1A1;Gene;PA445941;Disease
UNCONSCIOUSNESS;UGT1A1;Gene;PA445975;Disease
VOMITING;UGT1A1;Gene;PA446051;Disease
COLORECTAL NEOPLASMS;UGT1A1;Gene;PA446108;Disease
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;UGT1A1;Gene;PA446171;Disease
BETA-THALASSEMIA AND RELATED DISEASES;UGT1A1;Gene;PA446432;Disease
MYOCARDIAL ISCHEMIA;UGT1A1;Gene;PA446459;Disease
RHABDOMYOSARCOMA, ALVEOLAR;UGT1A1;Gene;PA446615;Disease
SCHIZOPHRENIA;UGT1A1;Gene;PA447216;Disease
HIV INFECTIONS;UGT1A1;Gene;PA447230;Disease
ACETAMINOPHEN;UGT1A1;Gene;PA448015;Chemical
ALLOPURINOL;UGT1A1;Gene;PA448320;Chemical
CAPECITABINE;UGT1A1;Gene;PA448771;Chemical
CARBOPLATIN;UGT1A1;Gene;PA448803;Chemical
CARVEDILOL;UGT1A1;Gene;PA448817;Chemical
CISPLATIN;UGT1A1;Gene;PA449014;Chemical
CLOZAPINE;UGT1A1;Gene;PA449061;Chemical
DEXAMETHASONE;UGT1A1;Gene;PA449247;Chemical
EFAVIRENZ;UGT1A1;Gene;PA449441;Chemical
ETOPOSIDE;UGT1A1;Gene;PA449552;Chemical
INDINAVIR;UGT1A1;Gene;PA449977;Chemical
IRINOTECAN;UGT1A1;Gene;PA450085;Chemical
LAMIVUDINE;UGT1A1;Gene;PA450163;Chemical
LOSARTAN;UGT1A1;Gene;PA450268;Chemical
METHOTREXATE;UGT1A1;Gene;PA450428;Chemical
MOXIFLOXACIN;UGT1A1;Gene;PA450555;Chemical
OLANZAPINE;UGT1A1;Gene;PA450688;Chemical
RALOXIFENE;UGT1A1;Gene;PA451221;Chemical
RISPERIDONE;UGT1A1;Gene;PA451257;Chemical
RITONAVIR;UGT1A1;Gene;PA451260;Chemical
WARFARIN;UGT1A1;Gene;PA451906;Chemical
ZIDOVUDINE;UGT1A1;Gene;PA451954;Chemical
SORAFENIB;UGT1A1;Gene;PA7000;Chemical
DMD;casimersen;Chemical;PA27378;Gene
ACE;acetylcholine;Chemical;PA139;Gene
RS1799752;acetylcholine;Chemical;PA166155187;Variant
WARFARIN;rs4889606;Variant;PA451906;Chemical
ASPIRIN-INDUCED ASTHMA;TSC1;Gene;PA131285571;Disease
ASTHMA;TSC1;Gene;PA443450;Disease
TUBEROUS SCLEROSIS;TSC1;Gene;PA445965;Disease
ASPIRIN;TSC1;Gene;PA448497;Chemical
BUFURALOL;rs1230912765;Variant;PA166110256;Chemical
HYPERTENSIVE NEPHROSCLEROSIS;rs1801058;Variant;PA166152848;Disease
METOPROLOL;rs1801058;Variant;PA450480;Chemical
RS4888024;Residual Neoplasm;Disease;PA166155071;Variant
RS9345389;Residual Neoplasm;Disease;PA166157144;Variant
DIABETES MELLITUS, TYPE 2;rs36056065;Variant;PA443890;Disease
METFORMIN;rs36056065;Variant;PA450395;Chemical
STAC3;Malignant Hyperthermia;Disease;PA134877600;Gene
RS1800559;Malignant Hyperthermia;Disease;PA166153638;Variant
RS772226819;Malignant Hyperthermia;Disease;PA166153940;Variant
RS1801086;Malignant Hyperthermia;Disease;PA166155375;Variant
RS28933396;Malignant Hyperthermia;Disease;PA166155481;Variant
RS28933397;Malignant Hyperthermia;Disease;PA166155482;Variant
RS63749869;Malignant Hyperthermia;Disease;PA166155516;Variant
RS111888148;Malignant Hyperthermia;Disease;PA166155524;Variant
RS112563513;Malignant Hyperthermia;Disease;PA166155526;Variant
RS118192116;Malignant Hyperthermia;Disease;PA166155528;Variant
RS118192122;Malignant Hyperthermia;Disease;PA166155529;Variant
RS118192124;Malignant Hyperthermia;Disease;PA166155531;Variant
RS118192161;Malignant Hyperthermia;Disease;PA166155532;Variant
RS118192162;Malignant Hyperthermia;Disease;PA166155533;Variant
RS118192163;Malignant Hyperthermia;Disease;PA166155534;Variant
RS118192167;Malignant Hyperthermia;Disease;PA166155535;Variant
RS118192170;Malignant Hyperthermia;Disease;PA166155536;Variant
RS118192172;Malignant Hyperthermia;Disease;PA166155537;Variant
RS118192175;Malignant Hyperthermia;Disease;PA166155538;Variant
RS118192176;Malignant Hyperthermia;Disease;PA166155539;Variant
RS118192177;Malignant Hyperthermia;Disease;PA166155540;Variant
RS118192178;Malignant Hyperthermia;Disease;PA166155541;Variant
RS118204423;Malignant Hyperthermia;Disease;PA166155542;Variant
RS121918592;Malignant Hyperthermia;Disease;PA166155543;Variant
RS121918593;Malignant Hyperthermia;Disease;PA166155544;Variant
RS121918594;Malignant Hyperthermia;Disease;PA166155545;Variant
RS121918595;Malignant Hyperthermia;Disease;PA166155546;Variant
RS193922747;Malignant Hyperthermia;Disease;PA166155564;Variant
RS193922753;Malignant Hyperthermia;Disease;PA166155565;Variant
RS193922770;Malignant Hyperthermia;Disease;PA166155567;Variant
RS193922772;Malignant Hyperthermia;Disease;PA166155568;Variant
RS193922802;Malignant Hyperthermia;Disease;PA166155569;Variant
RS193922803;Malignant Hyperthermia;Disease;PA166155570;Variant
RS193922807;Malignant Hyperthermia;Disease;PA166155571;Variant
RS193922809;Malignant Hyperthermia;Disease;PA166155572;Variant
RS193922816;Malignant Hyperthermia;Disease;PA166155573;Variant
RS193922818;Malignant Hyperthermia;Disease;PA166155574;Variant
RS193922876;Malignant Hyperthermia;Disease;PA166155575;Variant
RS193922878;Malignant Hyperthermia;Disease;PA166155576;Variant
RS193922843;Malignant Hyperthermia;Disease;PA166163663;Variant
RS193922832;Malignant Hyperthermia;Disease;PA166163667;Variant
RS118192168;Malignant Hyperthermia;Disease;PA166163669;Variant
RS193922764;Malignant Hyperthermia;Disease;PA166176176;Variant
RS186983396;Malignant Hyperthermia;Disease;PA166177045;Variant
RS121918596;Malignant Hyperthermia;Disease;PA166177994;Variant
RS193922748;Malignant Hyperthermia;Disease;PA166180322;Variant
RS193922762;Malignant Hyperthermia;Disease;PA166180323;Variant
RS193922768;Malignant Hyperthermia;Disease;PA166180324;Variant
RS144336148;Malignant Hyperthermia;Disease;PA166180325;Variant
RS193922752;Malignant Hyperthermia;Disease;PA166183378;Variant
RS193922852;Malignant Hyperthermia;Disease;PA166183392;Variant
RYR1;Malignant Hyperthermia;Disease;PA34896;Gene
SCN4A;Malignant Hyperthermia;Disease;PA35006;Gene
CACNA1S;Malignant Hyperthermia;Disease;PA85;Gene
BEVACIZUMAB;ARMS2;Gene;PA130232992;Chemical
MACULAR DEGENERATION;ARMS2;Gene;PA134850558;Disease
RANIBIZUMAB;ARMS2;Gene;PA164746012;Chemical
FLUOROURACIL;CHN2;Gene;PA128406956;Chemical
IFNL3;boceprevir;Chemical;PA134952671;Gene
IFNL4;boceprevir;Chemical;PA166049147;Gene
RS12979860;boceprevir;Chemical;PA166155468;Variant
RS11322783;boceprevir;Chemical;PA166190881;Variant
ABCB1;boceprevir;Chemical;PA267;Gene
VDR;boceprevir;Chemical;PA37301;Gene
SLC28A2;boceprevir;Chemical;PA386;Gene
RS1045642;dicloxacillin;Chemical;PA166157284;Variant
RS2032582;dicloxacillin;Chemical;PA166157316;Variant
ABCB1;dicloxacillin;Chemical;PA267;Gene
NR1I2;dicloxacillin;Chemical;PA378;Gene
SULFONAMIDES, UREA DERIVATIVES;ABCC8;Gene;PA10390;Chemical
DIABETES MELLITUS;ABCC8;Gene;PA443886;Disease
N-DESMETHYLTAMOXIFEN;CYP2D6*63;Haplotype;PA166127651;Chemical
PRIMAQUINE;CYP2D6*63;Haplotype;PA451103;Chemical
MYOCARDIAL INFARCTION;rs1062535;Variant;PA445019;Disease
ASPIRIN;rs1062535;Variant;PA448497;Chemical
CLOPIDOGREL;rs1062535;Variant;PA449053;Chemical
TURNER SYNDROME;CDK4;Gene;PA445968;Disease
SOMATROPIN RECOMBINANT;CDK4;Gene;PA451446;Chemical
ANTIEPILEPTICS;HLA-B*58:01;Haplotype;PA143485705;Chemical
MACULOPAPULAR EXANTHEMA;HLA-B*58:01;Haplotype;PA162316739;Disease
TOXIC LIVER DISEASE;HLA-B*58:01;Haplotype;PA164925725;Disease
HYPERURICEMIA;HLA-B*58:01;Haplotype;PA166048814;Disease
DRUG-INDUCED LIVER INJURY;HLA-B*58:01;Haplotype;PA166119041;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*58:01;Haplotype;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-B*58:01;Haplotype;PA166120929;Disease
HLA-B;HLA-B*58:01;Haplotype;PA35056;Gene
DRUG HYPERSENSITIVITY;HLA-B*58:01;Haplotype;PA443936;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*58:01;Haplotype;PA444059;Disease
EPILEPSY;HLA-B*58:01;Haplotype;PA444065;Disease
KIDNEY FAILURE, CHRONIC;HLA-B*58:01;Haplotype;PA444684;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*58:01;Haplotype;PA445738;Disease
ARTHRITIS, GOUTY;HLA-B*58:01;Haplotype;PA446114;Disease
HIV INFECTIONS;HLA-B*58:01;Haplotype;PA447230;Disease
ALLOPURINOL;HLA-B*58:01;Haplotype;PA448320;Chemical
AMOXICILLIN;HLA-B*58:01;Haplotype;PA448406;Chemical
CARBAMAZEPINE;HLA-B*58:01;Haplotype;PA448785;Chemical
LAMOTRIGINE;HLA-B*58:01;Haplotype;PA450164;Chemical
NEVIRAPINE;HLA-B*58:01;Haplotype;PA450616;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs1154831;Variant;PA164713366;Chemical
SPONDYLARTHROPATHIES;rs1154831;Variant;PA447163;Disease
MAJOR DEPRESSIVE DISORDER;rs11042725;Variant;PA447321;Disease
PAROXETINE;rs11042725;Variant;PA450801;Chemical
DPYD;rs764666241;Variant;PA145;Gene
CAPECITABINE;rs764666241;Variant;PA448771;Chemical
VARENICLINE;HYKK;Gene;PA164781343;Chemical
TOBACCO USE DISORDER;HYKK;Gene;PA445876;Disease
CYP2B6;Neurotoxicity Syndromes;Disease;PA123;Gene
CYP2C8;Neurotoxicity Syndromes;Disease;PA125;Gene
CYP3A5;Neurotoxicity Syndromes;Disease;PA131;Gene
DPYD;Neurotoxicity Syndromes;Disease;PA145;Gene
CYP2B6*1;Neurotoxicity Syndromes;Disease;PA165818750;Haplotype
CYP2B6*6;Neurotoxicity Syndromes;Disease;PA165818762;Haplotype
CYP2B6*38;Neurotoxicity Syndromes;Disease;PA166117278;Haplotype
CYP3A5*1;Neurotoxicity Syndromes;Disease;PA166128213;Haplotype
CYP3A5*3;Neurotoxicity Syndromes;Disease;PA166128219;Haplotype
RS11572080;Neurotoxicity Syndromes;Disease;PA166154140;Variant
RS1135989;Neurotoxicity Syndromes;Disease;PA166155182;Variant
RS3770102;Neurotoxicity Syndromes;Disease;PA166155709;Variant
RS776746;Neurotoxicity Syndromes;Disease;PA166157267;Variant
RS1128503;Neurotoxicity Syndromes;Disease;PA166157288;Variant
DPYD DEFICIENCY;Neurotoxicity Syndromes;Disease;PA166157931;Variant
RS11280056;Neurotoxicity Syndromes;Disease;PA166180936;Variant
RS36120609;Neurotoxicity Syndromes;Disease;PA166211543;Variant
ACTG1;Neurotoxicity Syndromes;Disease;PA24468;Gene
CAPG;Neurotoxicity Syndromes;Disease;PA26056;Gene
ABCB1;Neurotoxicity Syndromes;Disease;PA267;Gene
GSTM3;Neurotoxicity Syndromes;Disease;PA29024;Gene
TYMS;Neurotoxicity Syndromes;Disease;PA359;Gene
NASOPHARYNGEAL NEOPLASMS;rs75114882;Variant;PA445046;Disease
NEUTROPENIA;rs75114882;Variant;PA445113;Disease
DOCETAXEL;rs75114882;Variant;PA449383;Chemical
HYPERTENSION;rs238;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs238;Variant;PA449899;Chemical
RALOXIFENE;UGT1A8*3;Haplotype;PA451221;Chemical
LAMIVUDINE;PGK1;Gene;PA450163;Chemical
PSYCHOTIC DISORDER;rs3213207;Variant;PA447215;Disease
METHAMPHETAMINE;rs3213207;Variant;PA450403;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;OPCML;Gene;PA447197;Disease
METHYLPHENIDATE;OPCML;Gene;PA450464;Chemical
SALBUTAMOL;rs1800888;Variant;PA448068;Chemical
CYP2C9;avatrombopag;Chemical;PA126;Gene
F2;avatrombopag;Chemical;PA157;Gene
F5;avatrombopag;Chemical;PA159;Gene
CYP2C9*2;avatrombopag;Chemical;PA165816543;Haplotype
CYP2C9*3;avatrombopag;Chemical;PA165816544;Haplotype
RS6025;avatrombopag;Chemical;PA166153554;Variant
RS1799963;avatrombopag;Chemical;PA166154336;Variant
PROC;avatrombopag;Chemical;PA33799;Gene
PROS1;avatrombopag;Chemical;PA33809;Gene
SERPINC1;avatrombopag;Chemical;PA35026;Gene
MAPK8;FOSL2;Gene;PA283;Gene
MAPK14;FOSL2;Gene;PA30621;Gene
MEPHENYTOIN;rs183701923;Variant;PA450373;Chemical
RS201045130;cladribine;Chemical;PA166153937;Variant
RS370457585;cladribine;Chemical;PA166153938;Variant
RS374150125;cladribine;Chemical;PA166153939;Variant
RS1042919;cladribine;Chemical;PA166154310;Variant
RS1561876;cladribine;Chemical;PA166154332;Variant
RS2898950;cladribine;Chemical;PA166154392;Variant
RS1130609;cladribine;Chemical;PA166155627;Variant
RS5030743;cladribine;Chemical;PA166155740;Variant
RS1265138;cladribine;Chemical;PA166157554;Variant
RRM1;cladribine;Chemical;PA298;Gene
RRM2;cladribine;Chemical;PA299;Gene
NT5C1A;cladribine;Chemical;PA31799;Gene
RRM2B;cladribine;Chemical;PA34866;Gene
ESR1;pertuzumab;Chemical;PA156;Gene
PGR;pertuzumab;Chemical;PA266;Gene
ERBB2;pertuzumab;Chemical;PA27844;Gene
ESR2;pertuzumab;Chemical;PA27886;Gene
ANALGESICS;rs2070995;Variant;PA164712362;Chemical
HEROIN DEPENDENCE;rs2070995;Variant;PA444460;Disease
PAIN;rs2070995;Variant;PA445208;Disease
METHADONE;rs2070995;Variant;PA450401;Chemical
WT1;Wilms Tumor;Disease;PA37395;Gene
NON-SMALL CELL LUNG CARCINOMA;rs10981694;Variant;PA443622;Disease
CISPLATIN;rs10981694;Variant;PA449014;Chemical
RS6280;pramipexole;Chemical;PA166156277;Variant
DRD3;pramipexole;Chemical;PA27479;Gene
TICAGRELOR;rs4661012;Variant;PA165374673;Chemical
DRD1;drotrecogin alfa;Chemical;PA147;Gene
F5;drotrecogin alfa;Chemical;PA159;Gene
RS7725278;drotrecogin alfa;Chemical;PA166156848;Variant
AVAPRITINIB;rs121908585;Variant;PA166223903;Chemical
PDGFRA;rs121908585;Variant;PA33147;Gene
DEPRESSION;METTL21A;Gene;PA447278;Disease
CITALOPRAM;METTL21A;Gene;PA449015;Chemical
ANTIDEPRESSANTS;METTL21A;Gene;PA452229;Chemical
HALOPERIDOL;PLEKHA6;Gene;PA449841;Chemical
ASTHMA;rs11252394;Variant;PA443450;Disease
SALBUTAMOL;rs11252394;Variant;PA448068;Chemical
ETHANOL;rs1360983;Variant;PA448073;Chemical
HIV INFECTIOUS DISEASE;rs2125739;Variant;PA447230;Disease
NEVIRAPINE;rs2125739;Variant;PA450616;Chemical
BUFURALOL;CYP2D6*7;Haplotype;PA166110256;Chemical
EVENT-FREE SURVIVAL;CYP2D6*7;Haplotype;PA166123366;Disease
N-DESMETHYLTAMOXIFEN;CYP2D6*7;Haplotype;PA166127651;Chemical
BREAST NEOPLASMS;CYP2D6*7;Haplotype;PA443560;Disease
DYSTONIA;CYP2D6*7;Haplotype;PA443970;Disease
PAIN;CYP2D6*7;Haplotype;PA445208;Disease
SCHIZOPHRENIA;CYP2D6*7;Haplotype;PA447216;Disease
TARDIVE DYSKINESIA;CYP2D6*7;Haplotype;PA447268;Disease
DEXTROMETHORPHAN;CYP2D6*7;Haplotype;PA449273;Chemical
OXYCODONE;CYP2D6*7;Haplotype;PA450741;Chemical
PRIMAQUINE;CYP2D6*7;Haplotype;PA451103;Chemical
TAMOXIFEN;CYP2D6*7;Haplotype;PA451581;Chemical
ANTIPSYCHOTICS;CYP2D6*7;Haplotype;PA452233;Chemical
SPARTEINE;CYP2D6*7;Haplotype;PA452610;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;SPG7;Gene;PA130620651;Chemical
NEOPLASMS;SPG7;Gene;PA445062;Disease
PROSTATIC NEOPLASMS;SPG7;Gene;PA445425;Disease
DOCETAXEL;SPG7;Gene;PA449383;Chemical
THALIDOMIDE;SPG7;Gene;PA451644;Chemical
CYCLOSPORINE;rs2874116;Variant;PA449167;Chemical
ACE INHIBITORS, PLAIN;rs699;Variant;PA164712308;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;rs699;Variant;PA164712462;Chemical
CORONARY ARTERY DISEASE;rs699;Variant;PA443796;Disease
HYPERTENSION;rs699;Variant;PA444552;Disease
HYPERTROPHY, LEFT VENTRICULAR;rs699;Variant;PA446479;Disease
ATENOLOL;rs699;Variant;PA448499;Chemical
IRBESARTAN;rs699;Variant;PA450084;Chemical
QUINAPRIL;rs699;Variant;PA451205;Chemical
ARIPIPRAZOLE;rs3888190;Variant;PA10026;Chemical
AMISULPRIDE;rs3888190;Variant;PA162565877;Chemical
PALIPERIDONE;rs3888190;Variant;PA163518919;Chemical
SCHIZOAFFECTIVE DISORDER;rs3888190;Variant;PA166123368;Disease
BIPOLAR DISORDER;rs3888190;Variant;PA447199;Disease
DEPRESSIVE DISORDER;rs3888190;Variant;PA447207;Disease
PSYCHOTIC DISORDER;rs3888190;Variant;PA447215;Disease
CLOZAPINE;rs3888190;Variant;PA449061;Chemical
LITHIUM;rs3888190;Variant;PA450243;Chemical
MIRTAZAPINE;rs3888190;Variant;PA450522;Chemical
OLANZAPINE;rs3888190;Variant;PA450688;Chemical
QUETIAPINE;rs3888190;Variant;PA451201;Chemical
RISPERIDONE;rs3888190;Variant;PA451257;Chemical
VALPROIC ACID;rs3888190;Variant;PA451846;Chemical
SCHIZOPHRENIA;HSPG2;Gene;PA447216;Disease
HALOPERIDOL;HSPG2;Gene;PA449841;Chemical
ANTIPSYCHOTICS;HSPG2;Gene;PA452233;Chemical
CYP2C9;Hypotensive disorder;Disease;PA126;Gene
CYP2C9*1;Hypotensive disorder;Disease;PA165816542;Haplotype
CYP2C9*2;Hypotensive disorder;Disease;PA165816543;Haplotype
CYP2C9*3;Hypotensive disorder;Disease;PA165816544;Haplotype
CYP2C9*6;Hypotensive disorder;Disease;PA165816547;Haplotype
RS1045642;Hypotensive disorder;Disease;PA166157284;Variant
RS1042718;Hypotensive disorder;Disease;PA166160473;Variant
ABCB1;Hypotensive disorder;Disease;PA267;Gene
ADRB2;Hypotensive disorder;Disease;PA39;Gene
EFAVIRENZ;rs772413158;Variant;PA449441;Chemical
COMT;venlafaxine;Chemical;PA117;Gene
CYP2B6;venlafaxine;Chemical;PA123;Gene
CYP2C19;venlafaxine;Chemical;PA124;Gene
CYP2C9;venlafaxine;Chemical;PA126;Gene
CYP2D6;venlafaxine;Chemical;PA128;Gene
TPH2;venlafaxine;Chemical;PA128747823;Gene
CYP3A4;venlafaxine;Chemical;PA130;Gene
CYP3A5;venlafaxine;Chemical;PA131;Gene
CYP2C19*17;venlafaxine;Chemical;PA165816533;Haplotype
CYP2D6*1;venlafaxine;Chemical;PA165816576;Haplotype
CYP2D6*2;venlafaxine;Chemical;PA165816577;Haplotype
CYP2D6*3;venlafaxine;Chemical;PA165816578;Haplotype
CYP2D6*4;venlafaxine;Chemical;PA165816579;Haplotype
CYP2D6*6;venlafaxine;Chemical;PA165816581;Haplotype
CYP2D6*10;venlafaxine;Chemical;PA165816582;Haplotype
CYP2D6*17;venlafaxine;Chemical;PA165816583;Haplotype
CYP2D6*41;venlafaxine;Chemical;PA165816584;Haplotype
CYP2D6*5;venlafaxine;Chemical;PA165948092;Haplotype
CYP2D6*9;venlafaxine;Chemical;PA165948317;Haplotype
CYP2C19*1;venlafaxine;Chemical;PA165980634;Haplotype
CYP2C19*2;venlafaxine;Chemical;PA165980635;Haplotype
CYP2D6*1XN;venlafaxine;Chemical;PA165988479;Haplotype
CYP2D6*2XN;venlafaxine;Chemical;PA165988480;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);venlafaxine;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);venlafaxine;Chemical;PA166116466;Haplotype
SLC6A4 L ALLELE-RS25531T;venlafaxine;Chemical;PA166117146;Haplotype
CYP2D6*81;venlafaxine;Chemical;PA166123321;Haplotype
CYP2D6*87;venlafaxine;Chemical;PA166123327;Haplotype
CYP2D6*88;venlafaxine;Chemical;PA166123328;Haplotype
CYP2D6*89;venlafaxine;Chemical;PA166123329;Haplotype
CYP2D6*90;venlafaxine;Chemical;PA166123330;Haplotype
CYP2D6*91;venlafaxine;Chemical;PA166123331;Haplotype
CYP2D6*93;venlafaxine;Chemical;PA166123333;Haplotype
CYP2D6*95;venlafaxine;Chemical;PA166123336;Haplotype
CYP2D6*97;venlafaxine;Chemical;PA166123338;Haplotype
CYP2D6*98;venlafaxine;Chemical;PA166123339;Haplotype
CYP2D6*94;venlafaxine;Chemical;PA166128737;Haplotype
RS4244285;venlafaxine;Chemical;PA166154053;Variant
RS1487278;venlafaxine;Chemical;PA166154514;Variant
RS10879346;venlafaxine;Chemical;PA166154625;Variant
RS6311;venlafaxine;Chemical;PA166154673;Variant
RS6313;venlafaxine;Chemical;PA166154675;Variant
RS7997012;venlafaxine;Chemical;PA166154726;Variant
RS2242446;venlafaxine;Chemical;PA166155036;Variant
RS4680;venlafaxine;Chemical;PA166156024;Variant
RS1992647;venlafaxine;Chemical;PA166156777;Variant
RS10036156;venlafaxine;Chemical;PA166156853;Variant
RS130058;venlafaxine;Chemical;PA166156908;Variant
RS1360780;venlafaxine;Chemical;PA166156983;Variant
RS1045642;venlafaxine;Chemical;PA166157284;Variant
RS2032582;venlafaxine;Chemical;PA166157316;Variant
RS2032583;venlafaxine;Chemical;PA166157317;Variant
RS2235015;venlafaxine;Chemical;PA166157336;Variant
RS2235040;venlafaxine;Chemical;PA166157338;Variant
RS2235067;venlafaxine;Chemical;PA166157341;Variant
RS4148739;venlafaxine;Chemical;PA166157386;Variant
RS4148740;venlafaxine;Chemical;PA166157387;Variant
RS7787082;venlafaxine;Chemical;PA166157428;Variant
RS10248420;venlafaxine;Chemical;PA166157440;Variant
RS10280101;venlafaxine;Chemical;PA166157445;Variant
RS11983225;venlafaxine;Chemical;PA166157453;Variant
RS12720067;venlafaxine;Chemical;PA166157458;Variant
RS502434;venlafaxine;Chemical;PA166157853;Variant
RS3761554;venlafaxine;Chemical;PA166157871;Variant
RS3761555;venlafaxine;Chemical;PA166157872;Variant
RS3810651;venlafaxine;Chemical;PA166157873;Variant
HTR2A;venlafaxine;Chemical;PA193;Gene
HTR2C;venlafaxine;Chemical;PA194;Gene
ABCB1;venlafaxine;Chemical;PA267;Gene
CYP1A2;venlafaxine;Chemical;PA27093;Gene
DRD2;venlafaxine;Chemical;PA27478;Gene
FKBP5;venlafaxine;Chemical;PA28162;Gene
GABRA6;venlafaxine;Chemical;PA28494;Gene
GABRP;venlafaxine;Chemical;PA28503;Gene
GABRQ;venlafaxine;Chemical;PA28504;Gene
GRIA3;venlafaxine;Chemical;PA28968;Gene
HTR1B;venlafaxine;Chemical;PA29549;Gene
SLC6A2;venlafaxine;Chemical;PA310;Gene
SLC6A4;venlafaxine;Chemical;PA312;Gene
POLG;venlafaxine;Chemical;PA33500;Gene
HLA-A;venlafaxine;Chemical;PA35055;Gene
HLA-B;venlafaxine;Chemical;PA35056;Gene
UGT1A4;venlafaxine;Chemical;PA37179;Gene
RITUXIMAB;CXCL13;Gene;PA451261;Chemical
SLCO1B1;valsartan;Chemical;PA134865839;Gene
ARACHIDONIC ACID;rs754533672;Variant;PA166178659;Chemical
PAIN, POSTOPERATIVE;rs958804;Variant;PA445210;Disease
FENTANYL;rs958804;Variant;PA449599;Chemical
ABACAVIR;ADK;Gene;PA448004;Chemical
COMT;remifentanil;Chemical;PA117;Gene
RS4680;remifentanil;Chemical;PA166156024;Variant
RS1045642;remifentanil;Chemical;PA166157284;Variant
RS1128503;remifentanil;Chemical;PA166157288;Variant
RS1042718;remifentanil;Chemical;PA166160473;Variant
RS79910351;remifentanil;Chemical;PA166231401;Variant
CACNA2D2;remifentanil;Chemical;PA26012;Gene
ABCB1;remifentanil;Chemical;PA267;Gene
OPRM1;remifentanil;Chemical;PA31945;Gene
ADRB2;remifentanil;Chemical;PA39;Gene
PLATINUM COMPOUNDS;rs4752220;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs4752220;Variant;PA443622;Disease
ARIPIPRAZOLE;CYP2D6*41;Haplotype;PA10026;Chemical
ESCITALOPRAM;CYP2D6*41;Haplotype;PA10074;Chemical
WEIGHT GAIN;CYP2D6*41;Haplotype;PA128406954;Disease
GEFITINIB;CYP2D6*41;Haplotype;PA131301952;Chemical
3,4-METHYLENEDIOXYMETHAMPHETAMINE;CYP2D6*41;Haplotype;PA131887008;Chemical
ATOMOXETINE;CYP2D6*41;Haplotype;PA134688071;Chemical
BINGE EATING DISORDER;CYP2D6*41;Haplotype;PA165108929;Disease
PROGRESSION-FREE SURVIVAL;CYP2D6*41;Haplotype;PA166123026;Disease
OVERALL SURVIVAL;CYP2D6*41;Haplotype;PA166123207;Disease
EVENT-FREE SURVIVAL;CYP2D6*41;Haplotype;PA166123366;Disease
SCHIZOAFFECTIVE DISORDER;CYP2D6*41;Haplotype;PA166123368;Disease
ENDOXIFEN;CYP2D6*41;Haplotype;PA166124478;Chemical
RECURRENCE FREE SURVIVAL;CYP2D6*41;Haplotype;PA166127658;Disease
SEDATION;CYP2D6*41;Haplotype;PA166129521;Disease
O-DESMETHYLTRAMADOL;CYP2D6*41;Haplotype;PA166131379;Chemical
N,O-DIDESMETHYLTRAMADOL;CYP2D6*41;Haplotype;PA166131494;Chemical
DESMETHYL CLOMIPRAMINE;CYP2D6*41;Haplotype;PA166131507;Chemical
BREXPIPRAZOLE;CYP2D6*41;Haplotype;PA166160053;Chemical
EXTRAPYRAMIDAL SYMPTOMS;CYP2D6*41;Haplotype;PA166170367;Disease
MEPHEDRONE;CYP2D6*41;Haplotype;PA166184711;Chemical
BREAST NEOPLASMS;CYP2D6*41;Haplotype;PA443560;Disease
CONSTIPATION;CYP2D6*41;Haplotype;PA443782;Disease
DEATH;CYP2D6*41;Haplotype;PA443842;Disease
DEMENTIA;CYP2D6*41;Haplotype;PA443853;Disease
DRUG TOXICITY;CYP2D6*41;Haplotype;PA443937;Disease
DYSTONIA;CYP2D6*41;Haplotype;PA443970;Disease
EPILEPSY;CYP2D6*41;Haplotype;PA444065;Disease
GALACTORRHEA;CYP2D6*41;Haplotype;PA444239;Disease
HYPERTENSION;CYP2D6*41;Haplotype;PA444552;Disease
MALARIA;CYP2D6*41;Haplotype;PA444859;Disease
PAIN, POSTOPERATIVE;CYP2D6*41;Haplotype;PA445210;Disease
PSYCHOMOTOR AGITATION;CYP2D6*41;Haplotype;PA445452;Disease
RECURRENCE;CYP2D6*41;Haplotype;PA445506;Disease
SEROTONIN SYNDROME;CYP2D6*41;Haplotype;PA446956;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CYP2D6*41;Haplotype;PA447197;Disease
AUTISTIC DISORDER;CYP2D6*41;Haplotype;PA447198;Disease
DEPRESSIVE DISORDER;CYP2D6*41;Haplotype;PA447207;Disease
MENTAL DISORDERS;CYP2D6*41;Haplotype;PA447208;Disease
PSYCHOTIC DISORDERS;CYP2D6*41;Haplotype;PA447215;Disease
SCHIZOPHRENIA;CYP2D6*41;Haplotype;PA447216;Disease
DEPRESSION;CYP2D6*41;Haplotype;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2D6*41;Haplotype;PA447321;Disease
AMITRIPTYLINE;CYP2D6*41;Haplotype;PA448385;Chemical
CITALOPRAM;CYP2D6*41;Haplotype;PA449015;Chemical
CLOMIPRAMINE;CYP2D6*41;Haplotype;PA449048;Chemical
CODEINE;CYP2D6*41;Haplotype;PA449088;Chemical
DESIPRAMINE;CYP2D6*41;Haplotype;PA449233;Chemical
DEXTROMETHORPHAN;CYP2D6*41;Haplotype;PA449273;Chemical
DOXEPIN;CYP2D6*41;Haplotype;PA449409;Chemical
GALANTAMINE;CYP2D6*41;Haplotype;PA449726;Chemical
HYDROCODONE;CYP2D6*41;Haplotype;PA449900;Chemical
KETOPROFEN;CYP2D6*41;Haplotype;PA450149;Chemical
METOPROLOL;CYP2D6*41;Haplotype;PA450480;Chemical
NORTRIPTYLINE;CYP2D6*41;Haplotype;PA450657;Chemical
OXYCODONE;CYP2D6*41;Haplotype;PA450741;Chemical
PAROXETINE;CYP2D6*41;Haplotype;PA450801;Chemical
PHENYTOIN;CYP2D6*41;Haplotype;PA450947;Chemical
PRIMAQUINE;CYP2D6*41;Haplotype;PA451103;Chemical
PROPAFENONE;CYP2D6*41;Haplotype;PA451131;Chemical
QUETIAPINE;CYP2D6*41;Haplotype;PA451201;Chemical
RISPERIDONE;CYP2D6*41;Haplotype;PA451257;Chemical
TAMOXIFEN;CYP2D6*41;Haplotype;PA451581;Chemical
TRAMADOL;CYP2D6*41;Haplotype;PA451735;Chemical
VENLAFAXINE;CYP2D6*41;Haplotype;PA451866;Chemical
SPARTEINE;CYP2D6*41;Haplotype;PA452610;Chemical
ANTINEOPLASTIC AGENTS;CYP2D6*41;Haplotype;PA452621;Chemical
PLATINUM COMPOUNDS;HOTAIR;Gene;PA164713176;Chemical
LUNG NEOPLASMS;HOTAIR;Gene;PA444818;Disease
ATOMOXETINE;CYP2D6*97;Haplotype;PA134688071;Chemical
TOLTERODINE;CYP2D6*97;Haplotype;PA164746757;Chemical
BUFURALOL;CYP2D6*97;Haplotype;PA166110256;Chemical
DAPOXETINE;CYP2D6*97;Haplotype;PA166151992;Chemical
AMITRIPTYLINE;CYP2D6*97;Haplotype;PA448385;Chemical
DEXTROMETHORPHAN;CYP2D6*97;Haplotype;PA449273;Chemical
METHADONE;CYP2D6*97;Haplotype;PA450401;Chemical
OLANZAPINE;CYP2D6*97;Haplotype;PA450688;Chemical
RISPERIDONE;CYP2D6*97;Haplotype;PA451257;Chemical
VENLAFAXINE;CYP2D6*97;Haplotype;PA451866;Chemical
HEPATITIS VACCINES;IL4R;Gene;PA164712789;Chemical
PITRAKINRA;IL4R;Gene;PA165983754;Chemical
ASTHMA;IL4R;Gene;PA443450;Disease
RS1799971;Marijuana Abuse;Disease;PA166156991;Variant
OPRM1;Marijuana Abuse;Disease;PA31945;Gene
HNRNPH2;migalastat;Chemical;PA162391316;Gene
RS398123212;migalastat;Chemical;PA166185903;Variant
RS398123217;migalastat;Chemical;PA166185904;Variant
RS397515874;migalastat;Chemical;PA166185905;Variant
RS727505292;migalastat;Chemical;PA166185906;Variant
RS869312399;migalastat;Chemical;PA166185907;Variant
RS104894828;migalastat;Chemical;PA166185908;Variant
RS398123226;migalastat;Chemical;PA166185909;Variant
RS727504348;migalastat;Chemical;PA166185910;Variant
RS869312136;migalastat;Chemical;PA166185911;Variant
RS28935195;migalastat;Chemical;PA166185912;Variant
RS104894827;migalastat;Chemical;PA166185913;Variant
RS869312138;migalastat;Chemical;PA166185914;Variant
RS1569304898;migalastat;Chemical;PA166185915;Variant
RS372966991;migalastat;Chemical;PA166185916;Variant
RS869312146;migalastat;Chemical;PA166185917;Variant
RS398123223;migalastat;Chemical;PA166185918;Variant
RS190347120;migalastat;Chemical;PA166185919;Variant
RS28935490;migalastat;Chemical;PA166185920;Variant
RS397515870;migalastat;Chemical;PA166185937;Variant
GLA;migalastat;Chemical;PA28707;Gene
ORGAN TRANSPLANTATION;IMPDH1;Gene;PA133888799;Disease
MYCOPHENOLIC ACID;IMPDH1;Gene;PA164748728;Chemical
KIDNEY TRANSPLANTATION;IMPDH1;Gene;PA165817016;Disease
LEUKOPENIA;IMPDH1;Gene;PA444773;Disease
MYCOPHENOLATE MOFETIL;IMPDH1;Gene;PA450566;Chemical
COMT;modafinil;Chemical;PA117;Gene
CYP2B6;modafinil;Chemical;PA123;Gene
CYP2C19;modafinil;Chemical;PA124;Gene
CYP2C9;modafinil;Chemical;PA126;Gene
CYP2D6;modafinil;Chemical;PA128;Gene
CYP3A4;modafinil;Chemical;PA130;Gene
CYP3A5;modafinil;Chemical;PA131;Gene
RS4680;modafinil;Chemical;PA166156024;Variant
RS1045642;modafinil;Chemical;PA166157284;Variant
RS1128503;modafinil;Chemical;PA166157288;Variant
RS2032582;modafinil;Chemical;PA166157316;Variant
HTR2A;modafinil;Chemical;PA193;Gene
HTR2C;modafinil;Chemical;PA194;Gene
ABCB1;modafinil;Chemical;PA267;Gene
CYP1A2;modafinil;Chemical;PA27093;Gene
DRD2;modafinil;Chemical;PA27478;Gene
SLC6A4;modafinil;Chemical;PA312;Gene
POLG;modafinil;Chemical;PA33500;Gene
HLA-A;modafinil;Chemical;PA35055;Gene
HLA-B;modafinil;Chemical;PA35056;Gene
UGT1A4;modafinil;Chemical;PA37179;Gene
NR1I2;modafinil;Chemical;PA378;Gene
WEIGHT GAIN;rs894160;Variant;PA128406954;Disease
DIABETES MELLITUS, TYPE 2;rs894160;Variant;PA443890;Disease
ROSIGLITAZONE;rs894160;Variant;PA451283;Chemical
CYP3A4;budesonide;Chemical;PA130;Gene
RS37973;budesonide;Chemical;PA166157244;Variant
RS2392165;budesonide;Chemical;PA166200821;Variant
NR1I2;budesonide;Chemical;PA378;Gene
GLCCI1;budesonide;Chemical;PA38657;Gene
SYSTEMIC LUPUS ERYTHEMATOSUS;IL2;Gene;PA444822;Disease
RITUXIMAB;IL2;Gene;PA451261;Chemical
HYPERTENSION;rs12221497;Variant;PA444552;Disease
VERAPAMIL;rs12221497;Variant;PA451868;Chemical
DULOXETINE;rs61908406;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs61908406;Variant;PA447321;Disease
AZATHIOPRINE;RAC1;Gene;PA448515;Chemical
PURINE ANALOGUES;RAC1;Gene;PA452634;Chemical
CRIZANLIZUMAB-TMCA;SELP;Gene;PA166189801;Chemical
PEGINTERFERON ALFA-2A;rs117648444;Variant;PA164749390;Chemical
PEGINTERFERON ALFA-2B;rs117648444;Variant;PA164784024;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;rs117648444;Variant;PA446863;Disease
RIBAVIRIN;rs117648444;Variant;PA451241;Chemical
CYP2D6;opipramol;Chemical;PA128;Gene
CYP2D6*1;opipramol;Chemical;PA165816576;Haplotype
CYP2D6*4;opipramol;Chemical;PA165816579;Haplotype
MEASLES VACCINES;TLR3;Gene;PA164712887;Chemical
ASTHMA;TLR3;Gene;PA443450;Disease
ASPIRIN;TLR3;Gene;PA448497;Chemical
CES1;trandolapril;Chemical;PA107;Gene
RS71647871;trandolapril;Chemical;PA166155135;Variant
RS4742610;trandolapril;Chemical;PA166157776;Variant
RS778068631;trandolapril;Chemical;PA166200921;Variant
PTPRD;trandolapril;Chemical;PA34013;Gene
ATOMOXETINE;CYP2D6*88;Haplotype;PA134688071;Chemical
TOLTERODINE;CYP2D6*88;Haplotype;PA164746757;Chemical
BUFURALOL;CYP2D6*88;Haplotype;PA166110256;Chemical
DAPOXETINE;CYP2D6*88;Haplotype;PA166151992;Chemical
AMITRIPTYLINE;CYP2D6*88;Haplotype;PA448385;Chemical
CITALOPRAM;CYP2D6*88;Haplotype;PA449015;Chemical
OLANZAPINE;CYP2D6*88;Haplotype;PA450688;Chemical
RISPERIDONE;CYP2D6*88;Haplotype;PA451257;Chemical
VENLAFAXINE;CYP2D6*88;Haplotype;PA451866;Chemical
MAJOR DEPRESSIVE DISORDER;rs49411;Variant;PA447321;Disease
ANTIDEPRESSANTS;rs49411;Variant;PA452229;Chemical
DESFLURANE;CACNA1S;Gene;PA164749136;Chemical
RS1800559;CACNA1S;Gene;PA166153638;Variant
RS772226819;CACNA1S;Gene;PA166153940;Variant
RS1801086;CACNA1S;Gene;PA166155375;Variant
RS28933396;CACNA1S;Gene;PA166155481;Variant
RS28933397;CACNA1S;Gene;PA166155482;Variant
RS63749869;CACNA1S;Gene;PA166155516;Variant
RS111888148;CACNA1S;Gene;PA166155524;Variant
RS112563513;CACNA1S;Gene;PA166155526;Variant
RS118192116;CACNA1S;Gene;PA166155528;Variant
RS118192122;CACNA1S;Gene;PA166155529;Variant
RS118192124;CACNA1S;Gene;PA166155531;Variant
RS118192161;CACNA1S;Gene;PA166155532;Variant
RS118192162;CACNA1S;Gene;PA166155533;Variant
RS118192163;CACNA1S;Gene;PA166155534;Variant
RS118192167;CACNA1S;Gene;PA166155535;Variant
RS118192170;CACNA1S;Gene;PA166155536;Variant
RS118192172;CACNA1S;Gene;PA166155537;Variant
RS118192175;CACNA1S;Gene;PA166155538;Variant
RS118192176;CACNA1S;Gene;PA166155539;Variant
RS118192177;CACNA1S;Gene;PA166155540;Variant
RS118192178;CACNA1S;Gene;PA166155541;Variant
RS121918592;CACNA1S;Gene;PA166155543;Variant
RS121918593;CACNA1S;Gene;PA166155544;Variant
RS121918594;CACNA1S;Gene;PA166155545;Variant
RS121918595;CACNA1S;Gene;PA166155546;Variant
RS193922747;CACNA1S;Gene;PA166155564;Variant
RS193922753;CACNA1S;Gene;PA166155565;Variant
RS193922770;CACNA1S;Gene;PA166155567;Variant
RS193922772;CACNA1S;Gene;PA166155568;Variant
RS193922802;CACNA1S;Gene;PA166155569;Variant
RS193922803;CACNA1S;Gene;PA166155570;Variant
RS193922807;CACNA1S;Gene;PA166155571;Variant
RS193922809;CACNA1S;Gene;PA166155572;Variant
RS193922816;CACNA1S;Gene;PA166155573;Variant
RS193922818;CACNA1S;Gene;PA166155574;Variant
RS193922876;CACNA1S;Gene;PA166155575;Variant
RS193922878;CACNA1S;Gene;PA166155576;Variant
STATIN-RELATED MYOPATHY;CACNA1S;Gene;PA166163391;Disease
RS193922843;CACNA1S;Gene;PA166163663;Variant
RS193922832;CACNA1S;Gene;PA166163667;Variant
RS118192168;CACNA1S;Gene;PA166163669;Variant
RS193922764;CACNA1S;Gene;PA166176176;Variant
RS121918596;CACNA1S;Gene;PA166177994;Variant
RS193922748;CACNA1S;Gene;PA166180322;Variant
RS193922762;CACNA1S;Gene;PA166180323;Variant
RS193922768;CACNA1S;Gene;PA166180324;Variant
RS144336148;CACNA1S;Gene;PA166180325;Variant
PRKACA;CACNA1S;Gene;PA33748;Gene
PRKACB;CACNA1S;Gene;PA33749;Gene
PRKACG;CACNA1S;Gene;PA33750;Gene
HYPERTENSION;CACNA1S;Gene;PA444552;Disease
KIDNEY DISEASES;CACNA1S;Gene;PA444682;Disease
LIVER DISEASES;CACNA1S;Gene;PA444801;Disease
MALIGNANT HYPERTHERMIA;CACNA1S;Gene;PA444863;Disease
RHABDOMYOLYSIS;CACNA1S;Gene;PA445549;Disease
CAFFEINE;CACNA1S;Gene;PA448710;Chemical
CELECOXIB;CACNA1S;Gene;PA448871;Chemical
ENFLURANE;CACNA1S;Gene;PA449461;Chemical
HALOTHANE;CACNA1S;Gene;PA449845;Chemical
ISOFLURANE;CACNA1S;Gene;PA450106;Chemical
METHOXYFLURANE;CACNA1S;Gene;PA450434;Chemical
SEVOFLURANE;CACNA1S;Gene;PA451341;Chemical
SIMVASTATIN;CACNA1S;Gene;PA451363;Chemical
SUCCINYLCHOLINE;CACNA1S;Gene;PA451522;Chemical
OXALIPLATIN;GNA13;Gene;PA131285527;Chemical
F2R;GNA13;Gene;PA27946;Gene
F2RL3;GNA13;Gene;PA27949;Gene
P2RY1;GNA13;Gene;PA32868;Gene
PLCB1;GNA13;Gene;PA33384;Gene
PLCG2;GNA13;Gene;PA33393;Gene
TBXA2R;GNA13;Gene;PA348;Gene
HIV INFECTIOUS DISEASE;rs1594160;Variant;PA447230;Disease
DIDANOSINE;rs1594160;Variant;PA449301;Chemical
ATAZANAVIR;UGT1A1*80+*28;Haplotype;PA10251;Chemical
UGT1A1;UGT1A1*80+*28;Haplotype;PA420;Gene
CFTR;rs397508759;Variant;PA109;Gene
IVACAFTOR;rs397508759;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs397508759;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs397508759;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs397508759;Variant;PA443829;Disease
HEROIN DEPENDENCE;rs9384169;Variant;PA444460;Disease
HEROIN;rs9384169;Variant;PA452619;Chemical
CYP2D6;timolol;Chemical;PA128;Gene
CYP2D6*1;timolol;Chemical;PA165816576;Haplotype
CYP2D6*3;timolol;Chemical;PA165816578;Haplotype
CYP2D6*4;timolol;Chemical;PA165816579;Haplotype
CYP2D6*5;timolol;Chemical;PA165948092;Haplotype
RS1801252;timolol;Chemical;PA166153976;Variant
RS16947;timolol;Chemical;PA166156031;Variant
CYP2D6 POOR METABOLIZER;timolol;Chemical;PA166157927;Variant
ADRB1;timolol;Chemical;PA38;Gene
PEGASPARGASE;rs17021408;Variant;PA164760860;Chemical
OSTEONECROSIS;rs17021408;Variant;PA445187;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs17021408;Variant;PA446155;Disease
CYCLOPHOSPHAMIDE;rs17021408;Variant;PA449165;Chemical
CYTARABINE;rs17021408;Variant;PA449177;Chemical
DAUNORUBICIN;rs17021408;Variant;PA449212;Chemical
DEXAMETHASONE;rs17021408;Variant;PA449247;Chemical
DOXORUBICIN;rs17021408;Variant;PA449412;Chemical
METHOTREXATE;rs17021408;Variant;PA450428;Chemical
PREDNISONE;rs17021408;Variant;PA451100;Chemical
THIOGUANINE;rs17021408;Variant;PA451663;Chemical
VINCRISTINE;rs17021408;Variant;PA451879;Chemical
FTO;interferon alfa-2a, recombinant;Chemical;PA152208656;Gene
HLA-B*44:02;interferon alfa-2a, recombinant;Chemical;PA165955891;Haplotype
RS9939609;interferon alfa-2a, recombinant;Chemical;PA166155098;Variant
RS9657182;interferon alfa-2a, recombinant;Chemical;PA166157627;Variant
IDO1;interferon alfa-2a, recombinant;Chemical;PA29869;Gene
HLA-B;interferon alfa-2a, recombinant;Chemical;PA35056;Gene
COMT;oxycodone;Chemical;PA117;Gene
CYP2C19;oxycodone;Chemical;PA124;Gene
CYP2D6;oxycodone;Chemical;PA128;Gene
CYP3A4;oxycodone;Chemical;PA130;Gene
CYP3A5;oxycodone;Chemical;PA131;Gene
RHBDF2;oxycodone;Chemical;PA134980674;Gene
WBP2NL;oxycodone;Chemical;PA145147710;Gene
CYP2D6*1;oxycodone;Chemical;PA165816576;Haplotype
CYP2D6*2;oxycodone;Chemical;PA165816577;Haplotype
CYP2D6*3;oxycodone;Chemical;PA165816578;Haplotype
CYP2D6*4;oxycodone;Chemical;PA165816579;Haplotype
CYP2D6*6;oxycodone;Chemical;PA165816581;Haplotype
CYP2D6*41;oxycodone;Chemical;PA165816584;Haplotype
CYP3A4*1;oxycodone;Chemical;PA165819201;Haplotype
CYP3A4*2;oxycodone;Chemical;PA165819220;Haplotype
CYP3A4*3;oxycodone;Chemical;PA165819221;Haplotype
CYP3A4*4;oxycodone;Chemical;PA165819222;Haplotype
CYP3A4*5;oxycodone;Chemical;PA165819223;Haplotype
CYP3A4*6;oxycodone;Chemical;PA165819224;Haplotype
CYP3A4*7;oxycodone;Chemical;PA165819225;Haplotype
CYP3A4*8;oxycodone;Chemical;PA165819226;Haplotype
CYP3A4*9;oxycodone;Chemical;PA165819227;Haplotype
CYP3A4*10;oxycodone;Chemical;PA165819228;Haplotype
CYP3A4*11;oxycodone;Chemical;PA165819229;Haplotype
CYP3A4*12;oxycodone;Chemical;PA165819230;Haplotype
CYP3A4*13;oxycodone;Chemical;PA165819231;Haplotype
CYP3A4*14;oxycodone;Chemical;PA165819232;Haplotype
CYP3A4*15;oxycodone;Chemical;PA165819233;Haplotype
CYP3A4*16;oxycodone;Chemical;PA165819236;Haplotype
CYP3A4*17;oxycodone;Chemical;PA165819239;Haplotype
CYP3A4*18;oxycodone;Chemical;PA165819240;Haplotype
CYP3A4*19;oxycodone;Chemical;PA165819243;Haplotype
CYP3A4*20;oxycodone;Chemical;PA165819244;Haplotype
CYP2D6*5;oxycodone;Chemical;PA165948092;Haplotype
CYP2D6*7;oxycodone;Chemical;PA165971559;Haplotype
CYP2D6*1XN;oxycodone;Chemical;PA165988479;Haplotype
CYP2D6*2XN;oxycodone;Chemical;PA165988480;Haplotype
CYP3A4*22;oxycodone;Chemical;PA166048680;Haplotype
CYP3A4*21;oxycodone;Chemical;PA166115835;Haplotype
CYP3A4*23;oxycodone;Chemical;PA166115836;Haplotype
CYP3A4*24;oxycodone;Chemical;PA166115837;Haplotype
CYP3A5*1;oxycodone;Chemical;PA166128213;Haplotype
CYP3A5*3;oxycodone;Chemical;PA166128219;Haplotype
RS581111;oxycodone;Chemical;PA166153578;Variant
RS12948783;oxycodone;Chemical;PA166155254;Variant
RS4680;oxycodone;Chemical;PA166156024;Variant
RS7439366;oxycodone;Chemical;PA166156619;Variant
RS1799971;oxycodone;Chemical;PA166156991;Variant
RS1045642;oxycodone;Chemical;PA166157284;Variant
RS6848893;oxycodone;Chemical;PA166184876;Variant
CYP3A4*26;oxycodone;Chemical;PA166245583;Haplotype
CYP3A4*28;oxycodone;Chemical;PA166245584;Haplotype
CYP3A4*29;oxycodone;Chemical;PA166245585;Haplotype
CYP3A4*30;oxycodone;Chemical;PA166245586;Haplotype
CYP3A4*31;oxycodone;Chemical;PA166245587;Haplotype
CYP3A4*32;oxycodone;Chemical;PA166245588;Haplotype
CYP3A4*33;oxycodone;Chemical;PA166245589;Haplotype
CYP3A4*34;oxycodone;Chemical;PA166245590;Haplotype
RS62436463;oxycodone;Chemical;PA166257861;Variant
RS739296;oxycodone;Chemical;PA166257862;Variant
SEPTIN3;oxycodone;Chemical;PA24355;Gene
ABCB1;oxycodone;Chemical;PA267;Gene
OPRD1;oxycodone;Chemical;PA31942;Gene
OPRM1;oxycodone;Chemical;PA31945;Gene
UGT2B7;oxycodone;Chemical;PA361;Gene
TICAGRELOR;CYP3A4*31;Haplotype;PA165374673;Chemical
CABOZANTINIB;CYP3A4*31;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*31;Haplotype;PA165958362;Chemical
REGORAFENIB;CYP3A4*31;Haplotype;PA166114943;Chemical
VANDETANIB;CYP3A4*31;Haplotype;PA166118341;Chemical
IBRUTINIB;CYP3A4*31;Haplotype;PA166121346;Chemical
BREXPIPRAZOLE;CYP3A4*31;Haplotype;PA166160053;Chemical
BLONANSERIN;CYP3A4*31;Haplotype;PA166319041;Chemical
AMIODARONE;CYP3A4*31;Haplotype;PA448383;Chemical
IBUPROFEN;CYP3A4*31;Haplotype;PA449957;Chemical
LIDOCAINE;CYP3A4*31;Haplotype;PA450226;Chemical
METHADONE;CYP3A4*31;Haplotype;PA450401;Chemical
OXYCODONE;CYP3A4*31;Haplotype;PA450741;Chemical
TESTOSTERONE;CYP3A4*31;Haplotype;PA451627;Chemical
RPTOR;Pneumonitis;Disease;PA165432629;Gene
RS10711;Pneumonitis;Disease;PA166153941;Variant
RS1799793;Pneumonitis;Disease;PA166155371;Variant
RS9906827;Pneumonitis;Disease;PA166165381;Variant
NAT2;Pneumonitis;Disease;PA18;Gene
ERCC2;Pneumonitis;Disease;PA27848;Gene
CDK1;Pneumonitis;Disease;PA99;Gene
SCHIZOPHRENIA;rs10423928;Variant;PA447216;Disease
OLANZAPINE;rs10423928;Variant;PA450688;Chemical
PALB2;talazoparib;Chemical;PA162398608;Gene
CDK12;talazoparib;Chemical;PA165431656;Gene
MLH1;talazoparib;Chemical;PA240;Gene
BRCA1;talazoparib;Chemical;PA25411;Gene
BRCA2;talazoparib;Chemical;PA25412;Gene
ERBB2;talazoparib;Chemical;PA27844;Gene
FANCA;talazoparib;Chemical;PA27995;Gene
MRE11;talazoparib;Chemical;PA30934;Gene
NBN;talazoparib;Chemical;PA31457;Gene
RAD51C;talazoparib;Chemical;PA34177;Gene
CHEK2;talazoparib;Chemical;PA404;Gene
ATM;talazoparib;Chemical;PA61;Gene
ATR;talazoparib;Chemical;PA74;Gene
CFTR;rs397508256;Variant;PA109;Gene
IVACAFTOR;rs397508256;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs397508256;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs397508256;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs397508256;Variant;PA443829;Disease
ALLOPURINOL;GREM2;Gene;PA448320;Chemical
MAJOR DEPRESSIVE DISORDER;rs153549;Variant;PA447321;Disease
CITALOPRAM;rs153549;Variant;PA449015;Chemical
FLUOXETINE;rs153549;Variant;PA449673;Chemical
PAROXETINE;rs153549;Variant;PA450801;Chemical
SERTRALINE;rs153549;Variant;PA451333;Chemical
ABCB1;Cremophor EL;Chemical;PA267;Gene
TOBACCO USE DISORDER;GRIN3A;Gene;PA445876;Disease
NICOTINE;GRIN3A;Gene;PA450626;Chemical
CRP;Metabolic Syndrome;Disease;PA120;Gene
CYP2C19;Metabolic Syndrome;Disease;PA124;Gene
INSIG2;Metabolic Syndrome;Disease;PA134890284;Gene
CYP2C19*1;Metabolic Syndrome;Disease;PA165980634;Haplotype
CYP2C19*2;Metabolic Syndrome;Disease;PA165980635;Haplotype
RS1417938;Metabolic Syndrome;Disease;PA166153630;Variant
RS3091244;Metabolic Syndrome;Disease;PA166153735;Variant
RS11123469;Metabolic Syndrome;Disease;PA166155798;Variant
RS1414334;Metabolic Syndrome;Disease;PA166157862;Variant
RS2277984;Metabolic Syndrome;Disease;PA166163394;Variant
HTR2C;Metabolic Syndrome;Disease;PA194;Gene
C3;Metabolic Syndrome;Disease;PA25897;Gene
G6PD;Metabolic Syndrome;Disease;PA28469;Gene
CYP2D6;mexiletine;Chemical;PA128;Gene
RS80338792;mexiletine;Chemical;PA166155266;Variant
RS121908560;mexiletine;Chemical;PA166185726;Variant
RS886043595;mexiletine;Chemical;PA166185727;Variant
RS1567817380;mexiletine;Chemical;PA166185728;Variant
RS121908547;mexiletine;Chemical;PA166185729;Variant
SCN5A;mexiletine;Chemical;PA304;Gene
SCN4A;mexiletine;Chemical;PA35006;Gene
HEROIN DEPENDENCE;rs558025;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs558025;Variant;PA445043;Disease
METHADONE;rs558025;Variant;PA450401;Chemical
WARFARIN;CYP2C9*9;Haplotype;PA451906;Chemical
ACENOCOUMAROL;CYP2C9*9;Haplotype;PA452632;Chemical
COMT;methadone;Chemical;PA117;Gene
CYP2B6;methadone;Chemical;PA123;Gene
CYP2C19;methadone;Chemical;PA124;Gene
CYP2C9;methadone;Chemical;PA126;Gene
CYP2D6;methadone;Chemical;PA128;Gene
TPH2;methadone;Chemical;PA128747823;Gene
CYP3A4;methadone;Chemical;PA130;Gene
CYP3A5;methadone;Chemical;PA131;Gene
ANKK1;methadone;Chemical;PA134872551;Gene
NECTIN4;methadone;Chemical;PA134991624;Gene
DRD1;methadone;Chemical;PA147;Gene
NGF;methadone;Chemical;PA162397475;Gene
CYP2C9*1;methadone;Chemical;PA165816542;Haplotype
CYP2C9*2;methadone;Chemical;PA165816543;Haplotype
CYP2C9*3;methadone;Chemical;PA165816544;Haplotype
CYP2D6*1;methadone;Chemical;PA165816576;Haplotype
CYP2D6*2;methadone;Chemical;PA165816577;Haplotype
CYP2D6*3;methadone;Chemical;PA165816578;Haplotype
CYP2D6*4;methadone;Chemical;PA165816579;Haplotype
CYP2D6*6;methadone;Chemical;PA165816581;Haplotype
CYP2D6*10;methadone;Chemical;PA165816582;Haplotype
CYP2B6*1;methadone;Chemical;PA165818750;Haplotype
CYP2B6*4;methadone;Chemical;PA165818757;Haplotype
CYP2B6*5;methadone;Chemical;PA165818760;Haplotype
CYP2B6*6;methadone;Chemical;PA165818762;Haplotype
CYP2B6*7;methadone;Chemical;PA165818765;Haplotype
CYP2B6*18;methadone;Chemical;PA165818808;Haplotype
CYP3A4*1;methadone;Chemical;PA165819201;Haplotype
CYP3A4*2;methadone;Chemical;PA165819220;Haplotype
CYP3A4*3;methadone;Chemical;PA165819221;Haplotype
CYP3A4*5;methadone;Chemical;PA165819223;Haplotype
CYP3A4*11;methadone;Chemical;PA165819229;Haplotype
CYP3A4*14;methadone;Chemical;PA165819232;Haplotype
CYP3A4*15;methadone;Chemical;PA165819233;Haplotype
CYP3A4*16;methadone;Chemical;PA165819236;Haplotype
CYP3A4*17;methadone;Chemical;PA165819239;Haplotype
CYP3A4*18;methadone;Chemical;PA165819240;Haplotype
CYP3A4*19;methadone;Chemical;PA165819243;Haplotype
CYP2C19*1;methadone;Chemical;PA165980634;Haplotype
CYP2C19*2;methadone;Chemical;PA165980635;Haplotype
CYP2C19*3;methadone;Chemical;PA165980636;Haplotype
CYP2D6*1XN;methadone;Chemical;PA165988479;Haplotype
CYP2D6*2XN;methadone;Chemical;PA165988480;Haplotype
CYP3A4*24;methadone;Chemical;PA166115837;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);methadone;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);methadone;Chemical;PA166116466;Haplotype
CYP2C19*29;methadone;Chemical;PA166123292;Haplotype
CYP2C19*30;methadone;Chemical;PA166123293;Haplotype
CYP2C19*31;methadone;Chemical;PA166123294;Haplotype
CYP2C19*32;methadone;Chemical;PA166123295;Haplotype
CYP2C19*33;methadone;Chemical;PA166123296;Haplotype
CYP2D6*87;methadone;Chemical;PA166123327;Haplotype
CYP2D6*89;methadone;Chemical;PA166123329;Haplotype
CYP2D6*90;methadone;Chemical;PA166123330;Haplotype
CYP2D6*93;methadone;Chemical;PA166123333;Haplotype
CYP2D6*95;methadone;Chemical;PA166123336;Haplotype
CYP2D6*97;methadone;Chemical;PA166123338;Haplotype
CYP2D6*98;methadone;Chemical;PA166123339;Haplotype
CYP3A5*1;methadone;Chemical;PA166128213;Haplotype
CYP3A5*3;methadone;Chemical;PA166128219;Haplotype
RS2239622;methadone;Chemical;PA166153683;Variant
RS6275;methadone;Chemical;PA166154260;Variant
RS6277;methadone;Chemical;PA166154261;Variant
RS1491850;methadone;Chemical;PA166154329;Variant
RS1799978;methadone;Chemical;PA166154337;Variant
RS2283265;methadone;Chemical;PA166154364;Variant
RS7118900;methadone;Chemical;PA166154420;Variant
RS7934165;methadone;Chemical;PA166154427;Variant
RS10835210;methadone;Chemical;PA166154437;Variant
RS5443;methadone;Chemical;PA166154486;Variant
RS2279343;methadone;Chemical;PA166155393;Variant
RS3211371;methadone;Chemical;PA166155405;Variant
RS3745274;methadone;Chemical;PA166155409;Variant
RS8192709;methadone;Chemical;PA166155442;Variant
RS2070995;methadone;Chemical;PA166155996;Variant
RS4680;methadone;Chemical;PA166156024;Variant
RS740603;methadone;Chemical;PA166156057;Variant
RS933271;methadone;Chemical;PA166156059;Variant
RS4292394;methadone;Chemical;PA166156584;Variant
RS4554144;methadone;Chemical;PA166156589;Variant
RS6600879;methadone;Chemical;PA166156603;Variant
RS6600880;methadone;Chemical;PA166156604;Variant
RS6600893;methadone;Chemical;PA166156605;Variant
RS7438135;methadone;Chemical;PA166156617;Variant
RS7439366;methadone;Chemical;PA166156619;Variant
RS7662029;methadone;Chemical;PA166156621;Variant
RS7668258;methadone;Chemical;PA166156625;Variant
RS11940316;methadone;Chemical;PA166156655;Variant
RS5326;methadone;Chemical;PA166156707;Variant
RS558025;methadone;Chemical;PA166156928;Variant
RS806368;methadone;Chemical;PA166156953;Variant
RS1799971;methadone;Chemical;PA166156991;Variant
RS2075572;methadone;Chemical;PA166157015;Variant
RS2760118;methadone;Chemical;PA166157047;Variant
RS1045642;methadone;Chemical;PA166157284;Variant
RS1128503;methadone;Chemical;PA166157288;Variant
RS2032582;methadone;Chemical;PA166157316;Variant
RS2242480;methadone;Chemical;PA166157345;Variant
RS2246709;methadone;Chemical;PA166157346;Variant
RS3735451;methadone;Chemical;PA166157375;Variant
RS4646437;methadone;Chemical;PA166157391;Variant
RS4646440;methadone;Chemical;PA166157393;Variant
RS9282564;methadone;Chemical;PA166157435;Variant
RS1948308;methadone;Chemical;PA166157739;Variant
RS2120266;methadone;Chemical;PA166157742;Variant
RS2289658;methadone;Chemical;PA166157749;Variant
RS2378676;methadone;Chemical;PA166157752;Variant
RS4358872;methadone;Chemical;PA166157773;Variant
RS4877900;methadone;Chemical;PA166157779;Variant
RS17180299;methadone;Chemical;PA166159971;Variant
RS10485058;methadone;Chemical;PA166161944;Variant
RS8094439;methadone;Chemical;PA166170277;Variant
RS17446819;methadone;Chemical;PA166170278;Variant
RS1129844;methadone;Chemical;PA166175942;Variant
RS678849;methadone;Chemical;PA166175994;Variant
RS963549;methadone;Chemical;PA166176247;Variant
RS2229205;methadone;Chemical;PA166177058;Variant
RS3192723;methadone;Chemical;PA166182126;Variant
RS204047;methadone;Chemical;PA166184204;Variant
RS3762555;methadone;Chemical;PA166205741;Variant
RS3762556;methadone;Chemical;PA166205742;Variant
RS3749034;methadone;Chemical;PA166205744;Variant
RS769404;methadone;Chemical;PA166205843;Variant
RS797397;methadone;Chemical;PA166206021;Variant
RS3802279;methadone;Chemical;PA166206202;Variant
RS3802281;methadone;Chemical;PA166206221;Variant
RS4732636;methadone;Chemical;PA166218621;Variant
RS351776;methadone;Chemical;PA166218661;Variant
RS16974799;methadone;Chemical;PA166232202;Variant
RS1386493;methadone;Chemical;PA166232221;Variant
RS11265549;methadone;Chemical;PA166233022;Variant
CYP3A4*29;methadone;Chemical;PA166245585;Haplotype
CYP3A4*31;methadone;Chemical;PA166245587;Haplotype
CYP3A4*32;methadone;Chemical;PA166245588;Haplotype
CYP3A4*34;methadone;Chemical;PA166245590;Haplotype
RS73568641;methadone;Chemical;PA166263562;Variant
RS55944529;methadone;Chemical;PA166263684;Variant
GNB3;methadone;Chemical;PA176;Gene
KCNH2;methadone;Chemical;PA212;Gene
ALDH5A1;methadone;Chemical;PA24702;Gene
CDH2;methadone;Chemical;PA26293;Gene
CNR1;methadone;Chemical;PA26681;Gene
ABCB1;methadone;Chemical;PA267;Gene
CYP2A7P1;methadone;Chemical;PA27103;Gene
CYP3A;methadone;Chemical;PA27114;Gene
DAO;methadone;Chemical;PA27139;Gene
DRD2;methadone;Chemical;PA27478;Gene
GAD1;methadone;Chemical;PA28507;Gene
H2AFX;methadone;Chemical;PA29116;Gene
KCNJ6;methadone;Chemical;PA30049;Gene
SLC6A4;methadone;Chemical;PA312;Gene
NTRK2;methadone;Chemical;PA31818;Gene
BDNF;methadone;Chemical;PA31891;Gene
OPRD1;methadone;Chemical;PA31942;Gene
OPRK1;methadone;Chemical;PA31943;Gene
OPRL1;methadone;Chemical;PA31944;Gene
OPRM1;methadone;Chemical;PA31945;Gene
PNOC;methadone;Chemical;PA33485;Gene
CCL11;methadone;Chemical;PA35543;Gene
UGT2B7;methadone;Chemical;PA361;Gene
NR1I2;methadone;Chemical;PA378;Gene
TXNRD2;methadone;Chemical;PA38302;Gene
MTHFR;Pre-Eclampsia;Disease;PA245;Gene
ABCB1;vecuronium;Chemical;PA267;Gene
ESR1;Alkylating Agents;Chemical;PA156;Gene
RS2207396;Alkylating Agents;Chemical;PA166157022;Variant
RS712829;Alkylating Agents;Chemical;PA166157262;Variant
EGFR;Alkylating Agents;Chemical;PA7360;Gene
OTOTOXICITY;rs28358571;Variant;PA162263534;Disease
KANAMYCIN;rs28358571;Variant;PA450137;Chemical
STREPTOMYCIN;rs28358571;Variant;PA451512;Chemical
ALLOPURINOL;rs10011796;Variant;PA448320;Chemical
GP1BB;COL1A2;Gene;PA179;Gene
ITGA2;COL1A2;Gene;PA204;Gene
CD36;COL1A2;Gene;PA26212;Gene
GP5;COL1A2;Gene;PA28823;Gene
GP6;COL1A2;Gene;PA28824;Gene
GP9;COL1A2;Gene;PA28825;Gene
WARFARIN;rs4918758;Variant;PA451906;Chemical
IBRUTINIB;BTK;Gene;PA166121346;Chemical
PIRTOBRUTINIB;BTK;Gene;PA166328845;Chemical
KIDNEY TRANSPLANTATION;rs890293;Variant;PA165817016;Disease
TACROLIMUS;rs890293;Variant;PA451578;Chemical
RS1799971;tianeptine;Chemical;PA166156991;Variant
OPRM1;tianeptine;Chemical;PA31945;Gene
SLCO1B1;mitoxantrone;Chemical;PA134865839;Gene
C10ORF67;mitoxantrone;Chemical;PA134915530;Gene
GALNT14;mitoxantrone;Chemical;PA134920089;Gene
RS2291075;mitoxantrone;Chemical;PA166154544;Variant
RS9679162;mitoxantrone;Chemical;PA166155774;Variant
RS12613732;mitoxantrone;Chemical;PA166155818;Variant
RS6025211;mitoxantrone;Chemical;PA166201322;Variant
ABCB1;mitoxantrone;Chemical;PA267;Gene
INFLAMMATORY BOWEL DISEASES;rs2097432;Variant;PA446116;Disease
INFLIXIMAB;rs2097432;Variant;PA452639;Chemical
FENOFIBRATE;rs135550;Variant;PA449594;Chemical
FLUOROURACIL;rs74743371;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs74743371;Variant;PA443560;Disease
NEUTROPENIA;rs74743371;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs74743371;Variant;PA449165;Chemical
EPIRUBICIN;rs74743371;Variant;PA449476;Chemical
FLUOROURACIL;DPYD c.2194G>A (*6);Haplotype;PA128406956;Chemical
DPYD;DPYD c.2194G>A (*6);Haplotype;PA145;Gene
CAPECITABINE;DPYD c.2194G>A (*6);Haplotype;PA448771;Chemical
TEGAFUR;DPYD c.2194G>A (*6);Haplotype;PA452620;Chemical
URINARY BLADDER NEOPLASMS;MSH2;Gene;PA443512;Disease
COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS;MSH2;Gene;PA443761;Disease
PROSTATIC NEOPLASMS;MSH2;Gene;PA445425;Disease
ADVERSE EVENTS;rs9620007;Variant;PA166151827;Disease
CODEINE;rs9620007;Variant;PA449088;Chemical
RHEUMATOID ARTHRITIS;rs2292596;Variant;PA443434;Disease
METHOTREXATE;rs2292596;Variant;PA450428;Chemical
NON-SMALL CELL LUNG CARCINOMA;CMPK1;Gene;PA443622;Disease
LEUKEMIA, MYELOID, ACUTE;CMPK1;Gene;PA444760;Disease
NEOPLASMS;CMPK1;Gene;PA445062;Disease
PANCREATIC NEOPLASMS;CMPK1;Gene;PA445218;Disease
CISPLATIN;CMPK1;Gene;PA449014;Chemical
CYTARABINE;CMPK1;Gene;PA449177;Chemical
GEMCITABINE;CMPK1;Gene;PA449748;Chemical
LAMIVUDINE;CMPK1;Gene;PA450163;Chemical
WARFARIN;rs17886199;Variant;PA451906;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*45;Haplotype;PA166127651;Chemical
HYPERTENSION;CYP2D6*45;Haplotype;PA444552;Disease
METOPROLOL;CYP2D6*45;Haplotype;PA450480;Chemical
PRIMAQUINE;CYP2D6*45;Haplotype;PA451103;Chemical
RS121913530;adagrasib;Chemical;PA166165415;Variant
KRAS;adagrasib;Chemical;PA30196;Gene
THIAZIDES, PLAIN;rs34550074;Variant;PA164713347;Chemical
HYPERTENSION;rs34550074;Variant;PA444552;Disease
HYPONATREMIA;rs34550074;Variant;PA444575;Disease
N-DESMETHYLTAMOXIFEN;CYP2D6*26;Haplotype;PA166127651;Chemical
DEXTROMETHORPHAN;CYP2D6*26;Haplotype;PA449273;Chemical
PRIMAQUINE;CYP2D6*26;Haplotype;PA451103;Chemical
SUBSTANCE-RELATED DISORDERS;rs74611272;Variant;PA446876;Disease
HYPERTENSION;rs2106809;Variant;PA444552;Disease
CAPTOPRIL;rs2106809;Variant;PA448780;Chemical
CORONARY ARTERY DISEASE;rs12050217;Variant;PA443796;Disease
PERINDOPRIL;rs12050217;Variant;PA450877;Chemical
ANTITHYROID PREPARATIONS;HLA-DQB1*06:01;Haplotype;PA164712499;Chemical
AGRANULOCYTOSIS;HLA-DQB1*06:01;Haplotype;PA443297;Disease
GRAVES DISEASE;HLA-DQB1*06:01;Haplotype;PA444329;Disease
DESFLURANE;rs118192177;Variant;PA164749136;Chemical
RYR1;rs118192177;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs118192177;Variant;PA444863;Disease
ENFLURANE;rs118192177;Variant;PA449461;Chemical
HALOTHANE;rs118192177;Variant;PA449845;Chemical
ISOFLURANE;rs118192177;Variant;PA450106;Chemical
METHOXYFLURANE;rs118192177;Variant;PA450434;Chemical
SEVOFLURANE;rs118192177;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs118192177;Variant;PA451522;Chemical
CACNA1S;rs118192177;Variant;PA85;Gene
CHRNA3;Opium alkaloids and derivatives;Chemical;PA113;Gene
RS660652;Opium alkaloids and derivatives;Chemical;PA166154844;Variant
RS1051730;Opium alkaloids and derivatives;Chemical;PA166154856;Variant
RS16969968;Opium alkaloids and derivatives;Chemical;PA166154938;Variant
CHRNA5;Opium alkaloids and derivatives;Chemical;PA26491;Gene
ADVERSE EVENTS;rs16906115;Variant;PA166151827;Disease
PD-1/PDL-1 (PROGRAMMED CELL DEATH PROTEIN 1/DEATH LIGAND 1) INHIBITORS;rs16906115;Variant;PA166305982;Chemical
ACE INHIBITORS, PLAIN;rs495828;Variant;PA164712308;Chemical
HYPERTENSION;rs495828;Variant;PA444552;Disease
ENALAPRIL;rs495828;Variant;PA449456;Chemical
DULOXETINE;rs117986340;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs117986340;Variant;PA447321;Disease
BCL2;polatuzumab vedotin;Chemical;PA25302;Gene
BCL6;polatuzumab vedotin;Chemical;PA25312;Gene
MYC;polatuzumab vedotin;Chemical;PA31353;Gene
ASTHMA;rs1047303;Variant;PA443450;Disease
GLUCOCORTICOIDS;rs1047303;Variant;PA452347;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;rs11545077;Variant;PA446155;Disease
METHOTREXATE;rs11545077;Variant;PA450428;Chemical
CYP3A4;chlorzoxazone;Chemical;PA130;Gene
TOBACCO USE DISORDER;CYP2A6*14;Haplotype;PA445876;Disease
NICOTINE;CYP2A6*14;Haplotype;PA450626;Chemical
ANTITHYROID PREPARATIONS;FOXF2;Gene;PA164712499;Chemical
AGRANULOCYTOSIS;FOXF2;Gene;PA443297;Disease
NEOPLASMS;rs9351963;Variant;PA445062;Disease
IRINOTECAN;rs9351963;Variant;PA450085;Chemical
CELECOXIB;CA12;Gene;PA448871;Chemical
TOPIRAMATE;CA12;Gene;PA451728;Chemical
ZONISAMIDE;CA12;Gene;PA451978;Chemical
ALCOHOLISM;SLC6A3;Gene;PA443309;Disease
DEATH;SLC6A3;Gene;PA443842;Disease
PARKINSON DISEASE;SLC6A3;Gene;PA445254;Disease
TOBACCO USE DISORDER;SLC6A3;Gene;PA445876;Disease
COCAINE-RELATED DISORDERS;SLC6A3;Gene;PA446878;Disease
SCHIZOPHRENIA;SLC6A3;Gene;PA447216;Disease
ETHANOL;SLC6A3;Gene;PA448073;Chemical
BUPRENORPHINE;SLC6A3;Gene;PA448685;Chemical
CLOZAPINE;SLC6A3;Gene;PA449061;Chemical
COCAINE;SLC6A3;Gene;PA449072;Chemical
DISULFIRAM;SLC6A3;Gene;PA449376;Chemical
HALOPERIDOL;SLC6A3;Gene;PA449841;Chemical
LEVODOPA;SLC6A3;Gene;PA450213;Chemical
METHYLPHENIDATE;SLC6A3;Gene;PA450464;Chemical
NICOTINE;SLC6A3;Gene;PA450626;Chemical
BEVACIZUMAB;CFH;Gene;PA130232992;Chemical
MACULAR DEGENERATION;CFH;Gene;PA134850558;Disease
RANIBIZUMAB;CFH;Gene;PA164746012;Chemical
ECULIZUMAB;CFH;Gene;PA164776637;Chemical
PHOTODYNAMIC THERAPY;CFH;Gene;PA165984462;Chemical
BISPHOSPHONATES;rs7588295;Variant;PA164712563;Chemical
OSTEONECROSIS;rs7588295;Variant;PA445187;Disease
HEROIN DEPENDENCE;rs1611114;Variant;PA444460;Disease
MEMORY IMPAIRMENT;rs1611114;Variant;PA444910;Disease
HEROIN;rs1611114;Variant;PA452619;Chemical
ASTHMA;rs704212;Variant;PA443450;Disease
MONTELUKAST;rs704212;Variant;PA450546;Chemical
PEGINTERFERON ALFA-2A;rs6051702;Variant;PA164749390;Chemical
HEPATITIS C VIRUS INFECTION;rs6051702;Variant;PA444445;Disease
RIBAVIRIN;rs6051702;Variant;PA451241;Chemical
PLATINUM COMPOUNDS;rs10132552;Variant;PA164713176;Chemical
MYELOSUPPRESSION;rs10132552;Variant;PA165817398;Disease
MUCOSITIS;rs10132552;Variant;PA166122058;Disease
RADIOTHERAPY;rs10132552;Variant;PA166122986;Chemical
ANEMIA;rs10132552;Variant;PA443340;Disease
DERMATITIS;rs10132552;Variant;PA443875;Disease
LEUKOPENIA;rs10132552;Variant;PA444773;Disease
NEUTROPENIA;rs10132552;Variant;PA445113;Disease
THROMBOCYTOPENIA;rs10132552;Variant;PA445846;Disease
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS;PTGS1;Gene;PA10384;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;PTGS1;Gene;PA164712462;Chemical
LATANOPROST;PTGS1;Gene;PA164774763;Chemical
ACUTE CORONARY SYNDROME;PTGS1;Gene;PA165108401;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);PTGS1;Gene;PA166129560;Disease
CORONARY ARTERY DISEASE;PTGS1;Gene;PA443796;Disease
OPEN-ANGLE GLAUCOMA;PTGS1;Gene;PA444282;Disease
MYOCARDIAL INFARCTION;PTGS1;Gene;PA445019;Disease
ASPIRIN;PTGS1;Gene;PA448497;Chemical
CLOPIDOGREL;PTGS1;Gene;PA449053;Chemical
IBUPROFEN;PTGS1;Gene;PA449957;Chemical
BETA BLOCKING AGENTS, SELECTIVE;BST1;Gene;PA164712547;Chemical
HYPERTENSION;BST1;Gene;PA444552;Disease
NEOPLASMS;rs2075252;Variant;PA445062;Disease
CISPLATIN;rs2075252;Variant;PA449014;Chemical
G6PD B (REFERENCE);nitrofurantoin;Chemical;PA165947826;Haplotype
G6PD A- 202A_376G;nitrofurantoin;Chemical;PA165947827;Haplotype
G6PD DEFICIENCY;nitrofurantoin;Chemical;PA166157959;Variant
G6PD;nitrofurantoin;Chemical;PA28469;Gene
BUPROPION;rs535039125;Variant;PA448687;Chemical
EFAVIRENZ;rs535039125;Variant;PA449441;Chemical
BEVACIZUMAB;rs10490924;Variant;PA130232992;Chemical
MACULAR DEGENERATION;rs10490924;Variant;PA134850558;Disease
ADALIMUMAB;rs1059150;Variant;PA10004;Chemical
CERTOLIZUMAB PEGOL;rs1059150;Variant;PA165107055;Chemical
RHEUMATOID ARTHRITIS;rs1059150;Variant;PA443434;Disease
ETANERCEPT;rs1059150;Variant;PA449515;Chemical
METHOTREXATE;rs1059150;Variant;PA450428;Chemical
GLUCOCORTICOIDS;rs1059150;Variant;PA452347;Chemical
INFLIXIMAB;rs1059150;Variant;PA452639;Chemical
HEROIN DEPENDENCE;rs2229205;Variant;PA444460;Disease
METHADONE;rs2229205;Variant;PA450401;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*15:25;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*15:25;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*15:25;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-B*15:25;Haplotype;PA450616;Chemical
ARIPIPRAZOLE;CYP3A5;Gene;PA10026;Chemical
DULOXETINE;CYP3A5;Gene;PA10066;Chemical
ESCITALOPRAM;CYP3A5;Gene;PA10074;Chemical
ESOMEPRAZOLE;CYP3A5;Gene;PA10075;Chemical
VARDENAFIL;CYP3A5;Gene;PA10229;Chemical
ATAZANAVIR;CYP3A5;Gene;PA10251;Chemical
TADALAFIL;CYP3A5;Gene;PA10333;Chemical
IMATINIB;CYP3A5;Gene;PA10804;Chemical
GEFITINIB;CYP3A5;Gene;PA131301952;Chemical
ORGAN TRANSPLANTATION;CYP3A5;Gene;PA133888799;Disease
HMG COA REDUCTASE INHIBITORS;CYP3A5;Gene;PA133950441;Chemical
ROSUVASTATIN;CYP3A5;Gene;PA134308647;Chemical
TRANSPLANTATION;CYP3A5;Gene;PA134850491;Disease
PITAVASTATIN;CYP3A5;Gene;PA142650384;Chemical
PRASUGREL;CYP3A5;Gene;PA154410481;Chemical
MYALGIA UNSPECIFIED;CYP3A5;Gene;PA157379134;Disease
NEPHROTOXICITY;CYP3A5;Gene;PA162263533;Disease
SUNITINIB;CYP3A5;Gene;PA162372840;Chemical
ESZOPICLONE;CYP3A5;Gene;PA162630444;Chemical
EVEROLIMUS;CYP3A5;Gene;PA164746311;Chemical
CILOSTAZOL;CYP3A5;Gene;PA164746334;Chemical
MYCOPHENOLIC ACID;CYP3A5;Gene;PA164748728;Chemical
MARAVIROC;CYP3A5;Gene;PA164768835;Chemical
DIVALPROEX SODIUM;CYP3A5;Gene;PA164783479;Chemical
AXITINIB;CYP3A5;Gene;PA164924493;Chemical
TOXIC LIVER DISEASE;CYP3A5;Gene;PA164925725;Disease
DABIGATRAN;CYP3A5;Gene;PA165110351;Chemical
ARTEMETHER;CYP3A5;Gene;PA165111698;Chemical
LUMEFANTRINE;CYP3A5;Gene;PA165111722;Chemical
ARTEETHER;CYP3A5;Gene;PA165260403;Chemical
KIDNEY TRANSPLANTATION;CYP3A5;Gene;PA165817016;Disease
CYP3A4*22;CYP3A5;Gene;PA166048680;Haplotype
PREGNANCY;CYP3A5;Gene;PA166048714;Disease
TRANSPLANT REJECTION;CYP3A5;Gene;PA166114454;Disease
LUNG TRANSPLANTATION;CYP3A5;Gene;PA166114457;Disease
HEART TRANSPLANTATION;CYP3A5;Gene;PA166114458;Disease
DOLUTEGRAVIR;CYP3A5;Gene;PA166114961;Chemical
DRUG-INDUCED LIVER INJURY;CYP3A5;Gene;PA166119041;Disease
HEMATOPOIETIC STEM CELL TRANSPLANTATION;CYP3A5;Gene;PA166123007;Disease
SCHIZOAFFECTIVE DISORDER;CYP3A5;Gene;PA166123368;Disease
DELAYED GRAFT FUNCTION;CYP3A5;Gene;PA166123755;Disease
RECURRENCE FREE SURVIVAL;CYP3A5;Gene;PA166127658;Disease
CYP3A5*1;CYP3A5;Gene;PA166128213;Haplotype
CYP3A5*3;CYP3A5;Gene;PA166128219;Haplotype
ADVERSE EVENTS;CYP3A5;Gene;PA166151827;Disease
APIXABAN;CYP3A5;Gene;PA166163740;Chemical
LAPAROSCOPIC SLEEVE GASTRECTOMY;CYP3A5;Gene;PA166169562;Disease
S-EDDP;CYP3A5;Gene;PA166177606;Chemical
DEXTROPROPOXYPHENE;CYP3A5;Gene;PA166183939;Chemical
SOMNOLENCE;CYP3A5;Gene;PA166185626;Disease
3,4-DEHYDROCILOSTAZOL;CYP3A5;Gene;PA166254461;Chemical
ARTERIOSCLEROSIS;CYP3A5;Gene;PA443425;Disease
ARTHRITIS, RHEUMATOID;CYP3A5;Gene;PA443434;Disease
ATRIAL FIBRILLATION;CYP3A5;Gene;PA443459;Disease
AUTOIMMUNE DISEASES;CYP3A5;Gene;PA443464;Disease
BRADYCARDIA;CYP3A5;Gene;PA443548;Disease
BREAST NEOPLASMS;CYP3A5;Gene;PA443560;Disease
CARCINOMA, NON-SMALL-CELL LUNG;CYP3A5;Gene;PA443622;Disease
CARCINOMA, RENAL CELL;CYP3A5;Gene;PA443624;Disease
CARDIOVASCULAR DISEASES;CYP3A5;Gene;PA443635;Disease
CEREBRAL INFARCTION;CYP3A5;Gene;PA443670;Disease
COLITIS, ULCERATIVE;CYP3A5;Gene;PA443750;Disease
CORONARY ARTERY DISEASE;CYP3A5;Gene;PA443796;Disease
DIABETES MELLITUS;CYP3A5;Gene;PA443886;Disease
DIARRHEA;CYP3A5;Gene;PA443899;Disease
DRUG TOXICITY;CYP3A5;Gene;PA443937;Disease
EPILEPSY;CYP3A5;Gene;PA444065;Disease
GASTROINTESTINAL NEOPLASMS;CYP3A5;Gene;PA444257;Disease
GRAFT VS HOST DISEASE;CYP3A5;Gene;PA444320;Disease
HYPERCHOLESTEROLEMIA;CYP3A5;Gene;PA444516;Disease
HYPERLIPIDEMIAS;CYP3A5;Gene;PA444528;Disease
HYPERTENSION;CYP3A5;Gene;PA444552;Disease
INFECTION;CYP3A5;Gene;PA444614;Disease
KIDNEY NEOPLASMS;CYP3A5;Gene;PA444685;Disease
LEUKEMIA;CYP3A5;Gene;PA444750;Disease
LEUKOPENIA;CYP3A5;Gene;PA444773;Disease
LUPUS ERYTHEMATOSUS, SYSTEMIC;CYP3A5;Gene;PA444822;Disease
LUPUS NEPHRITIS;CYP3A5;Gene;PA444823;Disease
LYMPHOMA, NON-HODGKIN;CYP3A5;Gene;PA444845;Disease
MALARIA;CYP3A5;Gene;PA444859;Disease
MUSCULAR DISEASES;CYP3A5;Gene;PA444997;Disease
MYASTHENIA GRAVIS;CYP3A5;Gene;PA445004;Disease
MYOCARDIAL INFARCTION;CYP3A5;Gene;PA445019;Disease
OPIOID-RELATED DISORDERS;CYP3A5;Gene;PA445043;Disease
NEOPLASMS;CYP3A5;Gene;PA445062;Disease
NEPHROTIC SYNDROME;CYP3A5;Gene;PA445089;Disease
NEUTROPENIA;CYP3A5;Gene;PA445113;Disease
OBESITY;CYP3A5;Gene;PA445131;Disease
OVARIAN NEOPLASMS;CYP3A5;Gene;PA445204;Disease
PAIN;CYP3A5;Gene;PA445208;Disease
PAIN, POSTOPERATIVE;CYP3A5;Gene;PA445210;Disease
PERIPHERAL NERVOUS SYSTEM DISEASES;CYP3A5;Gene;PA445301;Disease
URINARY TRACT INFECTIONS;CYP3A5;Gene;PA445992;Disease
VIRUS DISEASES;CYP3A5;Gene;PA446038;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;CYP3A5;Gene;PA446155;Disease
PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;CYP3A5;Gene;PA446166;Disease
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;CYP3A5;Gene;PA446171;Disease
KIDNEY FAILURE;CYP3A5;Gene;PA446438;Disease
NEUROENDOCRINE TUMORS;CYP3A5;Gene;PA446713;Disease
NEUROTOXICITY SYNDROMES;CYP3A5;Gene;PA446975;Disease
ANXIETY DISORDERS;CYP3A5;Gene;PA447196;Disease
SCHIZOPHRENIA;CYP3A5;Gene;PA447216;Disease
HIV INFECTIONS;CYP3A5;Gene;PA447230;Disease
LIVER TRANSPLANTATION;CYP3A5;Gene;PA447247;Disease
DEPRESSION;CYP3A5;Gene;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;CYP3A5;Gene;PA447321;Disease
ALPRAZOLAM;CYP3A5;Gene;PA448333;Chemical
AMIODARONE;CYP3A5;Gene;PA448383;Chemical
AMITRIPTYLINE;CYP3A5;Gene;PA448385;Chemical
AMLODIPINE;CYP3A5;Gene;PA448388;Chemical
ATORVASTATIN;CYP3A5;Gene;PA448500;Chemical
BUPRENORPHINE;CYP3A5;Gene;PA448685;Chemical
BUPROPION;CYP3A5;Gene;PA448687;Chemical
BUSPIRONE;CYP3A5;Gene;PA448689;Chemical
CARBAMAZEPINE;CYP3A5;Gene;PA448785;Chemical
CARBOPLATIN;CYP3A5;Gene;PA448803;Chemical
CELECOXIB;CYP3A5;Gene;PA448871;Chemical
CHLORPHENIRAMINE;CYP3A5;Gene;PA448960;Chemical
CITALOPRAM;CYP3A5;Gene;PA449015;Chemical
CLARITHROMYCIN;CYP3A5;Gene;PA449028;Chemical
CLINDAMYCIN;CYP3A5;Gene;PA449035;Chemical
CLOMIPRAMINE;CYP3A5;Gene;PA449048;Chemical
CLOPIDOGREL;CYP3A5;Gene;PA449053;Chemical
CLOZAPINE;CYP3A5;Gene;PA449061;Chemical
CYCLOBENZAPRINE;CYP3A5;Gene;PA449160;Chemical
CYCLOPHOSPHAMIDE;CYP3A5;Gene;PA449165;Chemical
CYCLOSPORINE;CYP3A5;Gene;PA449167;Chemical
DIAZEPAM;CYP3A5;Gene;PA449283;Chemical
DOCETAXEL;CYP3A5;Gene;PA449383;Chemical
DONEPEZIL;CYP3A5;Gene;PA449394;Chemical
EFAVIRENZ;CYP3A5;Gene;PA449441;Chemical
ERYTHROMYCIN;CYP3A5;Gene;PA449493;Chemical
ETHINYL ESTRADIOL;CYP3A5;Gene;PA449527;Chemical
FELODIPINE;CYP3A5;Gene;PA449591;Chemical
FENOFIBRATE;CYP3A5;Gene;PA449594;Chemical
FENTANYL;CYP3A5;Gene;PA449599;Chemical
FLECAINIDE;CYP3A5;Gene;PA449646;Chemical
FLUOXETINE;CYP3A5;Gene;PA449673;Chemical
FLUTICASONE PROPIONATE;CYP3A5;Gene;PA449686;Chemical
FLUVASTATIN;CYP3A5;Gene;PA449688;Chemical
GRANISETRON;CYP3A5;Gene;PA449809;Chemical
HALOPERIDOL;CYP3A5;Gene;PA449841;Chemical
HYDROCODONE;CYP3A5;Gene;PA449900;Chemical
HYDROMORPHONE;CYP3A5;Gene;PA449918;Chemical
HYDROXYZINE;CYP3A5;Gene;PA449943;Chemical
ISOTRETINOIN;CYP3A5;Gene;PA450128;Chemical
ITRACONAZOLE;CYP3A5;Gene;PA450132;Chemical
KETOCONAZOLE;CYP3A5;Gene;PA450146;Chemical
LAMOTRIGINE;CYP3A5;Gene;PA450164;Chemical
LANSOPRAZOLE;CYP3A5;Gene;PA450180;Chemical
LOPINAVIR;CYP3A5;Gene;PA450264;Chemical
LORATADINE;CYP3A5;Gene;PA450266;Chemical
LOSARTAN;CYP3A5;Gene;PA450268;Chemical
LOVASTATIN;CYP3A5;Gene;PA450272;Chemical
MEDROXYPROGESTERONE;CYP3A5;Gene;PA450344;Chemical
MELOXICAM;CYP3A5;Gene;PA450353;Chemical
MEPERIDINE;CYP3A5;Gene;PA450369;Chemical
METHADONE;CYP3A5;Gene;PA450401;Chemical
MIDAZOLAM;CYP3A5;Gene;PA450496;Chemical
MIRTAZAPINE;CYP3A5;Gene;PA450522;Chemical
MODAFINIL;CYP3A5;Gene;PA450530;Chemical
MONTELUKAST;CYP3A5;Gene;PA450546;Chemical
NELFINAVIR;CYP3A5;Gene;PA450606;Chemical
NEVIRAPINE;CYP3A5;Gene;PA450616;Chemical
NIFEDIPINE;CYP3A5;Gene;PA450631;Chemical
NIMODIPINE;CYP3A5;Gene;PA450633;Chemical
NORTRIPTYLINE;CYP3A5;Gene;PA450657;Chemical
OLANZAPINE;CYP3A5;Gene;PA450688;Chemical
OMEPRAZOLE;CYP3A5;Gene;PA450704;Chemical
ONDANSETRON;CYP3A5;Gene;PA450705;Chemical
OXCARBAZEPINE;CYP3A5;Gene;PA450732;Chemical
OXYCODONE;CYP3A5;Gene;PA450741;Chemical
PACLITAXEL;CYP3A5;Gene;PA450761;Chemical
PANTOPRAZOLE;CYP3A5;Gene;PA450774;Chemical
PAROXETINE;CYP3A5;Gene;PA450801;Chemical
PHENYTOIN;CYP3A5;Gene;PA450947;Chemical
PIOGLITAZONE;CYP3A5;Gene;PA450970;Chemical
PRAVASTATIN;CYP3A5;Gene;PA451089;Chemical
PROGESTERONE;CYP3A5;Gene;PA451123;Chemical
PROPOXYPHENE;CYP3A5;Gene;PA451142;Chemical
QUETIAPINE;CYP3A5;Gene;PA451201;Chemical
RIFAMPIN;CYP3A5;Gene;PA451250;Chemical
RISPERIDONE;CYP3A5;Gene;PA451257;Chemical
RITONAVIR;CYP3A5;Gene;PA451260;Chemical
SALMETEROL;CYP3A5;Gene;PA451300;Chemical
SERTRALINE;CYP3A5;Gene;PA451333;Chemical
SIBUTRAMINE;CYP3A5;Gene;PA451344;Chemical
SILDENAFIL;CYP3A5;Gene;PA451346;Chemical
SIMVASTATIN;CYP3A5;Gene;PA451363;Chemical
SIROLIMUS;CYP3A5;Gene;PA451365;Chemical
SUFENTANIL;CYP3A5;Gene;PA451527;Chemical
TACROLIMUS;CYP3A5;Gene;PA451578;Chemical
TAMOXIFEN;CYP3A5;Gene;PA451581;Chemical
TAMSULOSIN;CYP3A5;Gene;PA451583;Chemical
TERAZOSIN;CYP3A5;Gene;PA451612;Chemical
TESTOSTERONE;CYP3A5;Gene;PA451627;Chemical
TRAMADOL;CYP3A5;Gene;PA451735;Chemical
TRAZODONE;CYP3A5;Gene;PA451744;Chemical
TRETINOIN;CYP3A5;Gene;PA451746;Chemical
TRIAZOLAM;CYP3A5;Gene;PA451753;Chemical
VALPROIC ACID;CYP3A5;Gene;PA451846;Chemical
VENLAFAXINE;CYP3A5;Gene;PA451866;Chemical
VINCRISTINE;CYP3A5;Gene;PA451879;Chemical
WARFARIN;CYP3A5;Gene;PA451906;Chemical
ZIPRASIDONE;CYP3A5;Gene;PA451974;Chemical
ZOLPIDEM;CYP3A5;Gene;PA451976;Chemical
OPIOIDS;CYP3A5;Gene;PA452618;Chemical
SLCO1B1;rocuronium;Chemical;PA134865839;Gene
RS2306283;rocuronium;Chemical;PA166154547;Variant
RS1128503;rocuronium;Chemical;PA166157288;Variant
RS3834939;rocuronium;Chemical;PA166163600;Variant
RS7967354;rocuronium;Chemical;PA166236261;Variant
RS11045995;rocuronium;Chemical;PA166236262;Variant
ABCB1;rocuronium;Chemical;PA267;Gene
IAPP;rocuronium;Chemical;PA29579;Gene
SLCO1A2;rocuronium;Chemical;PA328;Gene
CYP2C9;Essential hypertension;Disease;PA126;Gene
CYP11B2;Essential hypertension;Disease;PA134;Gene
SLCO1B1;Essential hypertension;Disease;PA134865839;Gene
FBXL17;Essential hypertension;Disease;PA134920563;Gene
CAMK1D;Essential hypertension;Disease;PA134992438;Gene
YEATS4;Essential hypertension;Disease;PA134992686;Gene
ACE;Essential hypertension;Disease;PA139;Gene
ANKFN1;Essential hypertension;Disease;PA142672624;Gene
TET2;Essential hypertension;Disease;PA162405634;Gene
RS1805087;Essential hypertension;Disease;PA166153654;Variant
RS1057910;Essential hypertension;Disease;PA166153959;Variant
RS1801253;Essential hypertension;Disease;PA166153977;Variant
RS10737062;Essential hypertension;Disease;PA166154112;Variant
RS10752271;Essential hypertension;Disease;PA166154113;Variant
RS11189015;Essential hypertension;Disease;PA166154128;Variant
RS3758785;Essential hypertension;Disease;PA166154400;Variant
RS5443;Essential hypertension;Disease;PA166154486;Variant
RS2301339;Essential hypertension;Disease;PA166154545;Variant
RS4149056;Essential hypertension;Disease;PA166154579;Variant
RS7297610;Essential hypertension;Disease;PA166154598;Variant
RS11064426;Essential hypertension;Disease;PA166154636;Variant
RS9590353;Essential hypertension;Disease;PA166154744;Variant
RS77876672;Essential hypertension;Disease;PA166154758;Variant
RS1799722;Essential hypertension;Disease;PA166154785;Variant
RS13306673;Essential hypertension;Disease;PA166155114;Variant
RS1799752;Essential hypertension;Disease;PA166155187;Variant
RS9915451;Essential hypertension;Disease;PA166155242;Variant
RS113095083;Essential hypertension;Disease;PA166155903;Variant
RS4961;Essential hypertension;Disease;PA166156480;Variant
RS12505746;Essential hypertension;Disease;PA166156660;Variant
RS1042713;Essential hypertension;Disease;PA166156748;Variant
RS4431329;Essential hypertension;Disease;PA166156827;Variant
RS7706429;Essential hypertension;Disease;PA166156846;Variant
RS9285669;Essential hypertension;Disease;PA166156850;Variant
RS5370;Essential hypertension;Disease;PA166156901;Variant
RS1137617;Essential hypertension;Disease;PA166157289;Variant
RS1799998;Essential hypertension;Disease;PA166157566;Variant
RS7387065;Essential hypertension;Disease;PA166157626;Variant
RS11993031;Essential hypertension;Disease;PA166157638;Variant
GNB3;Essential hypertension;Disease;PA176;Gene
KCNH2;Essential hypertension;Disease;PA212;Gene
CSMD1;Essential hypertension;Disease;PA26947;Gene
CYP4F2;Essential hypertension;Disease;PA27121;Gene
DIAPH3;Essential hypertension;Disease;PA27335;Gene
EDN1;Essential hypertension;Disease;PA27614;Gene
GPR83;Essential hypertension;Disease;PA28927;Gene
ILKAP;Essential hypertension;Disease;PA29856;Gene
ADD1;Essential hypertension;Disease;PA31;Gene
MTR;Essential hypertension;Disease;PA31272;Gene
SLC12A3;Essential hypertension;Disease;PA321;Gene
SLIT1;Essential hypertension;Disease;PA35938;Gene
ADRB1;Essential hypertension;Disease;PA38;Gene
UGGT2;Essential hypertension;Disease;PA38015;Gene
ADRB2;Essential hypertension;Disease;PA39;Gene
BDKRB2;Essential hypertension;Disease;PA80;Gene
ARIPIPRAZOLE;rs6277;Variant;PA10026;Chemical
SUBSTANCE-RELATED DISORDERS;rs6277;Variant;PA446876;Disease
SCHIZOPHRENIA;rs6277;Variant;PA447216;Disease
CLOZAPINE;rs6277;Variant;PA449061;Chemical
METHADONE;rs6277;Variant;PA450401;Chemical
NICOTINE;rs6277;Variant;PA450626;Chemical
OLANZAPINE;rs6277;Variant;PA450688;Chemical
ANTIPSYCHOTICS;rs6277;Variant;PA452233;Chemical
BRCA1;Uterine Neoplasms;Disease;PA25411;Gene
ACUTE LYMPHOBLASTIC LEUKEMIA;rs2838958;Variant;PA446155;Disease
METHOTREXATE;rs2838958;Variant;PA450428;Chemical
ASTHMA;rs557881;Variant;PA443450;Disease
ASPIRIN;rs557881;Variant;PA448497;Chemical
CYP2B6;escitalopram;Chemical;PA123;Gene
CYP2C19;escitalopram;Chemical;PA124;Gene
CYP2C9;escitalopram;Chemical;PA126;Gene
CYP2D6;escitalopram;Chemical;PA128;Gene
CYP3A4;escitalopram;Chemical;PA130;Gene
CYP3A5;escitalopram;Chemical;PA131;Gene
TSPAN5;escitalopram;Chemical;PA134864098;Gene
RPP30;escitalopram;Chemical;PA134876345;Gene
RFK;escitalopram;Chemical;PA134916697;Gene
ERICH3;escitalopram;Chemical;PA142672422;Gene
CYP2C19*17;escitalopram;Chemical;PA165816533;Haplotype
CYP2D6*1;escitalopram;Chemical;PA165816576;Haplotype
CYP2D6*4;escitalopram;Chemical;PA165816579;Haplotype
CYP2D6*10;escitalopram;Chemical;PA165816582;Haplotype
CYP2D6*41;escitalopram;Chemical;PA165816584;Haplotype
CYP2D6*5;escitalopram;Chemical;PA165948092;Haplotype
CYP2C19*1;escitalopram;Chemical;PA165980634;Haplotype
CYP2C19*2;escitalopram;Chemical;PA165980635;Haplotype
CYP2C19*3;escitalopram;Chemical;PA165980636;Haplotype
CYP2C19*4;escitalopram;Chemical;PA165980637;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);escitalopram;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);escitalopram;Chemical;PA166116466;Haplotype
RS696692;escitalopram;Chemical;PA166153586;Variant
RS915120;escitalopram;Chemical;PA166153956;Variant
RS962369;escitalopram;Chemical;PA166154303;Variant
RS1800532;escitalopram;Chemical;PA166154340;Variant
RS6311;escitalopram;Chemical;PA166154673;Variant
RS6313;escitalopram;Chemical;PA166154675;Variant
RS7997012;escitalopram;Chemical;PA166154726;Variant
RS9316233;escitalopram;Chemical;PA166154732;Variant
RS2069521;escitalopram;Chemical;PA166154875;Variant
RS2069526;escitalopram;Chemical;PA166154877;Variant
RS4646425;escitalopram;Chemical;PA166154909;Variant
RS4646427;escitalopram;Chemical;PA166154910;Variant
RS1126757;escitalopram;Chemical;PA166155364;Variant
RS1065852;escitalopram;Chemical;PA166156062;Variant
RS11947402;escitalopram;Chemical;PA166156657;Variant
RS12054895;escitalopram;Chemical;PA166156874;Variant
RS9380524;escitalopram;Chemical;PA166157154;Variant
RS11568817;escitalopram;Chemical;PA166157174;Variant
RS41271330;escitalopram;Chemical;PA166157204;Variant
RS352428;escitalopram;Chemical;PA166157546;Variant
RS10975641;escitalopram;Chemical;PA166157824;Variant
RS11144870;escitalopram;Chemical;PA166157829;Variant
RS6318;escitalopram;Chemical;PA166157849;Variant
RS116692768;escitalopram;Chemical;PA166176886;Variant
RS76191705;escitalopram;Chemical;PA166176887;Variant
RS7905446;escitalopram;Chemical;PA166182096;Variant
GRK5;escitalopram;Chemical;PA180;Gene
HTR2A;escitalopram;Chemical;PA193;Gene
HTR2C;escitalopram;Chemical;PA194;Gene
BMP5;escitalopram;Chemical;PA25382;Gene
ABCB1;escitalopram;Chemical;PA267;Gene
CYP1A2;escitalopram;Chemical;PA27093;Gene
DRD2;escitalopram;Chemical;PA27478;Gene
FKBP5;escitalopram;Chemical;PA28162;Gene
GLDC;escitalopram;Chemical;PA28716;Gene
HTR1B;escitalopram;Chemical;PA29549;Gene
HTR7;escitalopram;Chemical;PA29561;Gene
IL11;escitalopram;Chemical;PA29781;Gene
SLC6A4;escitalopram;Chemical;PA312;Gene
BDNF;escitalopram;Chemical;PA31891;Gene
POLG;escitalopram;Chemical;PA33500;Gene
HLA-A;escitalopram;Chemical;PA35055;Gene
HLA-B;escitalopram;Chemical;PA35056;Gene
TPH1;escitalopram;Chemical;PA355;Gene
UGT1A4;escitalopram;Chemical;PA37179;Gene
ETHANOL;escitalopram;Chemical;PA448073;Chemical
URINARY BLADDER NEOPLASMS;TP63;Gene;PA443512;Disease
INTERFERON BETA-1A;rs9272105;Variant;PA450037;Chemical
INTERFERON BETA-1B;rs9272105;Variant;PA450039;Chemical
CYP3A4;Prostatic Neoplasms;Disease;PA130;Gene
BRIP1;Prostatic Neoplasms;Disease;PA134906421;Gene
VAC14;Prostatic Neoplasms;Disease;PA142670633;Gene
TANC1;Prostatic Neoplasms;Disease;PA142670838;Gene
SNORD68;Prostatic Neoplasms;Disease;PA145007789;Gene
DSE;Prostatic Neoplasms;Disease;PA162384080;Gene
PALB2;Prostatic Neoplasms;Disease;PA162398608;Gene
SULT1C4;Prostatic Neoplasms;Disease;PA162405070;Gene
RS4646487;Prostatic Neoplasms;Disease;PA166153768;Variant
RS12042763;Prostatic Neoplasms;Disease;PA166153840;Variant
RS12418;Prostatic Neoplasms;Disease;PA166153942;Variant
RS730720;Prostatic Neoplasms;Disease;PA166153954;Variant
RS1871450;Prostatic Neoplasms;Disease;PA166153978;Variant
RS4148943;Prostatic Neoplasms;Disease;PA166154049;Variant
RS4148945;Prostatic Neoplasms;Disease;PA166154050;Variant
RS4148947;Prostatic Neoplasms;Disease;PA166154051;Variant
RS4148950;Prostatic Neoplasms;Disease;PA166154052;Variant
RS2301159;Prostatic Neoplasms;Disease;PA166154711;Variant
RS12960;Prostatic Neoplasms;Disease;PA166154981;Variant
RS875858;Prostatic Neoplasms;Disease;PA166154996;Variant
RS2238472;Prostatic Neoplasms;Disease;PA166155033;Variant
RS2292954;Prostatic Neoplasms;Disease;PA166155038;Variant
RS264588;Prostatic Neoplasms;Disease;PA166155590;Variant
RS264631;Prostatic Neoplasms;Disease;PA166155591;Variant
RS264651;Prostatic Neoplasms;Disease;PA166155592;Variant
RS264663;Prostatic Neoplasms;Disease;PA166155593;Variant
RS1402467;Prostatic Neoplasms;Disease;PA166155635;Variant
RS6432512;Prostatic Neoplasms;Disease;PA166155744;Variant
RS7582141;Prostatic Neoplasms;Disease;PA166155767;Variant
RS10497203;Prostatic Neoplasms;Disease;PA166155791;Variant
RS1570360;Prostatic Neoplasms;Disease;PA166156985;Variant
RS1883322;Prostatic Neoplasms;Disease;PA166157003;Variant
RS2010963;Prostatic Neoplasms;Disease;PA166157006;Variant
RS2016520;Prostatic Neoplasms;Disease;PA166157007;Variant
RS3734254;Prostatic Neoplasms;Disease;PA166157077;Variant
RS6922548;Prostatic Neoplasms;Disease;PA166157116;Variant
RS7769719;Prostatic Neoplasms;Disease;PA166157128;Variant
RS1799931;Prostatic Neoplasms;Disease;PA166157565;Variant
RS2250242;Prostatic Neoplasms;Disease;PA166157747;Variant
RS2227291;Prostatic Neoplasms;Disease;PA166157866;Variant
RS3828743;Prostatic Neoplasms;Disease;PA166179651;Variant
RS523349;Prostatic Neoplasms;Disease;PA166263961;Variant
NAT2;Prostatic Neoplasms;Disease;PA18;Gene
MSH6;Prostatic Neoplasms;Disease;PA184;Gene
MLH1;Prostatic Neoplasms;Disease;PA240;Gene
BRCA1;Prostatic Neoplasms;Disease;PA25411;Gene
BRCA2;Prostatic Neoplasms;Disease;PA25412;Gene
CHST3;Prostatic Neoplasms;Disease;PA26503;Gene
CYP4B1;Prostatic Neoplasms;Disease;PA27119;Gene
EGF;Prostatic Neoplasms;Disease;PA27664;Gene
ERG;Prostatic Neoplasms;Disease;PA27858;Gene
GSTM3;Prostatic Neoplasms;Disease;PA29024;Gene
PTGS2;Prostatic Neoplasms;Disease;PA293;Gene
HOXB13;Prostatic Neoplasms;Disease;PA29388;Gene
MLH3;Prostatic Neoplasms;Disease;PA30845;Gene
MSH2;Prostatic Neoplasms;Disease;PA31133;Gene
MUTYH;Prostatic Neoplasms;Disease;PA31328;Gene
SLC10A2;Prostatic Neoplasms;Disease;PA318;Gene
ORM2;Prostatic Neoplasms;Disease;PA32818;Gene
PMS2;Prostatic Neoplasms;Disease;PA33448;Gene
PPARD;Prostatic Neoplasms;Disease;PA33557;Gene
PTEN;Prostatic Neoplasms;Disease;PA33942;Gene
SULT1A1;Prostatic Neoplasms;Disease;PA343;Gene
RPL13;Prostatic Neoplasms;Disease;PA34670;Gene
TGFB1;Prostatic Neoplasms;Disease;PA350;Gene
SPG7;Prostatic Neoplasms;Disease;PA36067;Gene
SRD5A2;Prostatic Neoplasms;Disease;PA36113;Gene
TMPRSS2;Prostatic Neoplasms;Disease;PA36577;Gene
TSPYL1;Prostatic Neoplasms;Disease;PA37050;Gene
VDR;Prostatic Neoplasms;Disease;PA37301;Gene
VEGFA;Prostatic Neoplasms;Disease;PA37302;Gene
NR1I2;Prostatic Neoplasms;Disease;PA378;Gene
CHEK2;Prostatic Neoplasms;Disease;PA404;Gene
VITAMIN D DEFICIENCY;Prostatic Neoplasms;Disease;PA446044;Disease
ABCC6;Prostatic Neoplasms;Disease;PA58;Gene
ATM;Prostatic Neoplasms;Disease;PA61;Gene
ATP7A;Prostatic Neoplasms;Disease;PA72;Gene
CYP3A4;trimethadione;Chemical;PA130;Gene
SLCO1B1;Inflammatory Bowel Diseases;Disease;PA134865839;Gene
C18ORF56;Inflammatory Bowel Diseases;Disease;PA134956204;Gene
NUDT15;Inflammatory Bowel Diseases;Disease;PA134963132;Gene
CNPY4;Inflammatory Bowel Diseases;Disease;PA162382618;Gene
DDRGK1;Inflammatory Bowel Diseases;Disease;PA164718734;Gene
SLCO1B1*15;Inflammatory Bowel Diseases;Disease;PA165819265;Haplotype
TPMT*1;Inflammatory Bowel Diseases;Disease;PA165819268;Haplotype
TPMT*2;Inflammatory Bowel Diseases;Disease;PA165819269;Haplotype
TPMT*3A;Inflammatory Bowel Diseases;Disease;PA165819270;Haplotype
TPMT*3B;Inflammatory Bowel Diseases;Disease;PA165819271;Haplotype
TPMT*3C;Inflammatory Bowel Diseases;Disease;PA165819272;Haplotype
HLA-DQA1*02:01;Inflammatory Bowel Diseases;Disease;PA165951292;Haplotype
HLA-DRB1*07:01;Inflammatory Bowel Diseases;Disease;PA165951644;Haplotype
NAT1*4;Inflammatory Bowel Diseases;Disease;PA165958462;Haplotype
NAT1*3;Inflammatory Bowel Diseases;Disease;PA165958463;Haplotype
NAT1*10;Inflammatory Bowel Diseases;Disease;PA165958465;Haplotype
GSTM1 NULL;Inflammatory Bowel Diseases;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Inflammatory Bowel Diseases;Disease;PA166048676;Haplotype
NUDT15*1;Inflammatory Bowel Diseases;Disease;PA166131619;Haplotype
NUDT15*2;Inflammatory Bowel Diseases;Disease;PA166131620;Haplotype
NUDT15*3;Inflammatory Bowel Diseases;Disease;PA166131621;Haplotype
NUDT15*4;Inflammatory Bowel Diseases;Disease;PA166131622;Haplotype
NUDT15*5;Inflammatory Bowel Diseases;Disease;PA166131623;Haplotype
NUDT15*6;Inflammatory Bowel Diseases;Disease;PA166151814;Haplotype
RS2430561;Inflammatory Bowel Diseases;Disease;PA166154549;Variant
RS4149570;Inflammatory Bowel Diseases;Disease;PA166154585;Variant
RS3765534;Inflammatory Bowel Diseases;Disease;PA166154714;Variant
RS116855232;Inflammatory Bowel Diseases;Disease;PA166154759;Variant
RS45445694;Inflammatory Bowel Diseases;Disease;PA166155331;Variant
RS4848306;Inflammatory Bowel Diseases;Disease;PA166155735;Variant
RS55754655;Inflammatory Bowel Diseases;Disease;PA166155879;Variant
RS1127354;Inflammatory Bowel Diseases;Disease;PA166155915;Variant
RS7270101;Inflammatory Bowel Diseases;Disease;PA166155964;Variant
RS352139;Inflammatory Bowel Diseases;Disease;PA166156288;Variant
RS3804099;Inflammatory Bowel Diseases;Disease;PA166156580;Variant
RS11938228;Inflammatory Bowel Diseases;Disease;PA166156654;Variant
RS510432;Inflammatory Bowel Diseases;Disease;PA166156923;Variant
RS2275913;Inflammatory Bowel Diseases;Disease;PA166157030;Variant
RS2647087;Inflammatory Bowel Diseases;Disease;PA166157045;Variant
RS6927172;Inflammatory Bowel Diseases;Disease;PA166157119;Variant
RS9373839;Inflammatory Bowel Diseases;Disease;PA166157151;Variant
RS10499563;Inflammatory Bowel Diseases;Disease;PA166157448;Variant
RS1554973;Inflammatory Bowel Diseases;Disease;PA166157732;Variant
RS5030728;Inflammatory Bowel Diseases;Disease;PA166157782;Variant
TPMT POOR METABOLIZER;Inflammatory Bowel Diseases;Disease;PA166157904;Variant
RS746071566;Inflammatory Bowel Diseases;Disease;PA166165231;Variant
RS11969064;Inflammatory Bowel Diseases;Disease;PA166184136;Variant
RS2097432;Inflammatory Bowel Diseases;Disease;PA166299601;Variant
HLA-DQA1*05;Inflammatory Bowel Diseases;Disease;PA166319541;Haplotype
NAT1;Inflammatory Bowel Diseases;Disease;PA17;Gene
GSTM1;Inflammatory Bowel Diseases;Disease;PA182;Gene
IL6;Inflammatory Bowel Diseases;Disease;PA198;Gene
AOX1;Inflammatory Bowel Diseases;Disease;PA24842;Gene
ATG5;Inflammatory Bowel Diseases;Disease;PA24880;Gene
IFNG;Inflammatory Bowel Diseases;Disease;PA29674;Gene
IL17A;Inflammatory Bowel Diseases;Disease;PA29794;Gene
IL1B;Inflammatory Bowel Diseases;Disease;PA29808;Gene
ITPA;Inflammatory Bowel Diseases;Disease;PA29973;Gene
HLA-DQA1;Inflammatory Bowel Diseases;Disease;PA35066;Gene
HLA-DRB1;Inflammatory Bowel Diseases;Disease;PA35072;Gene
TPMT;Inflammatory Bowel Diseases;Disease;PA356;Gene
TYMS;Inflammatory Bowel Diseases;Disease;PA359;Gene
TLR2;Inflammatory Bowel Diseases;Disease;PA36550;Gene
TLR4;Inflammatory Bowel Diseases;Disease;PA36552;Gene
TNFAIP3;Inflammatory Bowel Diseases;Disease;PA36593;Gene
TNFRSF1A;Inflammatory Bowel Diseases;Disease;PA36609;Gene
NR1I2;Inflammatory Bowel Diseases;Disease;PA378;Gene
TLR9;Inflammatory Bowel Diseases;Disease;PA38010;Gene
ABCC4;Inflammatory Bowel Diseases;Disease;PA397;Gene
ESR1;ribociclib;Chemical;PA156;Gene
PGR;ribociclib;Chemical;PA266;Gene
ERBB2;ribociclib;Chemical;PA27844;Gene
ESR2;ribociclib;Chemical;PA27886;Gene
CFTR;rs75039782;Variant;PA109;Gene
IVACAFTOR;rs75039782;Variant;PA165950341;Chemical
ATALUREN;rs75039782;Variant;PA166151864;Chemical
IVACAFTOR / TEZACAFTOR;rs75039782;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs75039782;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs75039782;Variant;PA443829;Disease
COTININE;rs589046;Variant;PA166114414;Chemical
OPIOID-RELATED DISORDERS;rs589046;Variant;PA445043;Disease
NICOTINE;rs589046;Variant;PA450626;Chemical
OPIOIDS;rs589046;Variant;PA452618;Chemical
DRUG TOXICITY;NRP2;Gene;PA443937;Disease
DAUNORUBICIN;NRP2;Gene;PA449212;Chemical
CYP2D6;Seizures;Disease;PA128;Gene
ADGRV1;Seizures;Disease;PA134960779;Gene
DPYD;Seizures;Disease;PA145;Gene
HLA-B*15:02;Seizures;Disease;PA165954769;Haplotype
HLA-B*15:18;Seizures;Disease;PA165954803;Haplotype
HLA-B*40:01;Seizures;Disease;PA165955628;Haplotype
RS762551;Seizures;Disease;PA166154850;Variant
RS2741049;Seizures;Disease;PA166155690;Variant
CYP1A2;Seizures;Disease;PA27093;Gene
HLA-B;Seizures;Disease;PA35056;Gene
UGT1A10;Seizures;Disease;PA37174;Gene
UGT1A7;Seizures;Disease;PA37182;Gene
UGT1A8;Seizures;Disease;PA37183;Gene
UGT1A9;Seizures;Disease;PA419;Gene
CLODRONATE;rs16944;Variant;PA10239;Chemical
BISPHOSPHONATES;rs16944;Variant;PA164712563;Chemical
HELICOBACTER INFECTIONS;rs16944;Variant;PA166048740;Disease
OSTEITIS DEFORMANS;rs16944;Variant;PA445172;Disease
SCHIZOPHRENIA;rs16944;Variant;PA447216;Disease
ETIDRONIC ACID;rs16944;Variant;PA449548;Chemical
LANSOPRAZOLE;rs16944;Variant;PA450180;Chemical
OMEPRAZOLE;rs16944;Variant;PA450704;Chemical
PRAVASTATIN;rs16944;Variant;PA451089;Chemical
RABEPRAZOLE;rs16944;Variant;PA451216;Chemical
RISEDRONATE;rs16944;Variant;PA451255;Chemical
TILUDRONATE;rs16944;Variant;PA451688;Chemical
ANTIPSYCHOTICS;rs16944;Variant;PA452233;Chemical
ABCC2;cisplatin;Chemical;PA116;Gene
COMT;cisplatin;Chemical;PA117;Gene
SLC31A1;cisplatin;Chemical;PA118;Gene
CYP2E1;cisplatin;Chemical;PA129;Gene
CYP3A4;cisplatin;Chemical;PA130;Gene
TMEM43;cisplatin;Chemical;PA134871907;Gene
DCBLD1;cisplatin;Chemical;PA134903108;Gene
OTOS;cisplatin;Chemical;PA134906408;Gene
GALNT14;cisplatin;Chemical;PA134920089;Gene
GALNT18;cisplatin;Chemical;PA134950929;Gene
C18ORF56;cisplatin;Chemical;PA134956204;Gene
KLC3;cisplatin;Chemical;PA142671588;Gene
POLR1G;cisplatin;Chemical;PA142672156;Gene
ERCC1;cisplatin;Chemical;PA155;Gene
ESR1;cisplatin;Chemical;PA156;Gene
CMPK1;cisplatin;Chemical;PA162382539;Gene
REV1;cisplatin;Chemical;PA162401120;Gene
TPMT*1;cisplatin;Chemical;PA165819268;Haplotype
TPMT*2;cisplatin;Chemical;PA165819269;Haplotype
TPMT*3A;cisplatin;Chemical;PA165819270;Haplotype
TPMT*3B;cisplatin;Chemical;PA165819271;Haplotype
TPMT*3C;cisplatin;Chemical;PA165819272;Haplotype
GSTM1 NULL;cisplatin;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;cisplatin;Chemical;PA166048676;Haplotype
GSTT1 NULL;cisplatin;Chemical;PA166048678;Haplotype
GSTT1 NON-NULL;cisplatin;Chemical;PA166048679;Haplotype
UGT1A1*1;cisplatin;Chemical;PA166115841;Haplotype
UGT1A1*28;cisplatin;Chemical;PA166115842;Haplotype
GEMCITABINE TRIPHOSPHATE;cisplatin;Chemical;PA166131567;Chemical
RS1051740;cisplatin;Chemical;PA166153612;Variant
RS1065634;cisplatin;Chemical;PA166153621;Variant
RS1801131;cisplatin;Chemical;PA166153643;Variant
RS1801133;cisplatin;Chemical;PA166153644;Variant
RS1805087;cisplatin;Chemical;PA166153654;Variant
RS3219484;cisplatin;Chemical;PA166153742;Variant
RS4492666;cisplatin;Chemical;PA166153766;Variant
RS12118636;cisplatin;Chemical;PA166153850;Variant
RS717620;cisplatin;Chemical;PA166153953;Variant
RS2070676;cisplatin;Chemical;PA166153994;Variant
RS2273697;cisplatin;Chemical;PA166154007;Variant
RS2299939;cisplatin;Chemical;PA166154011;Variant
RS3740556;cisplatin;Chemical;PA166154030;Variant
RS6413432;cisplatin;Chemical;PA166154073;Variant
RS1695;cisplatin;Chemical;PA166154249;Variant
RS9344;cisplatin;Chemical;PA166154264;Variant
RS232043;cisplatin;Chemical;PA166154271;Variant
RS720106;cisplatin;Chemical;PA166154298;Variant
RS1138272;cisplatin;Chemical;PA166154320;Variant
RS2284449;cisplatin;Chemical;PA166154365;Variant
RS11226;cisplatin;Chemical;PA166154490;Variant
RS16950650;cisplatin;Chemical;PA166154751;Variant
RS1130214;cisplatin;Chemical;PA166154772;Variant
RS2236225;cisplatin;Chemical;PA166154789;Variant
RS2494752;cisplatin;Chemical;PA166154795;Variant
RS2498804;cisplatin;Chemical;PA166154797;Variant
RS4673;cisplatin;Chemical;PA166154969;Variant
RS9597;cisplatin;Chemical;PA166154979;Variant
RS7186128;cisplatin;Chemical;PA166155076;Variant
RS1050565;cisplatin;Chemical;PA166155175;Variant
RS1051640;cisplatin;Chemical;PA166155176;Variant
RS1052536;cisplatin;Chemical;PA166155177;Variant
RS4148416;cisplatin;Chemical;PA166155219;Variant
RS45445694;cisplatin;Chemical;PA166155331;Variant
RS11615;cisplatin;Chemical;PA166155342;Variant
RS13181;cisplatin;Chemical;PA166155343;Variant
RS238406;cisplatin;Chemical;PA166155349;Variant
RS1799782;cisplatin;Chemical;PA166155370;Variant
RS1799793;cisplatin;Chemical;PA166155371;Variant
RS3212986;cisplatin;Chemical;PA166155407;Variant
RS1872328;cisplatin;Chemical;PA166155651;Variant
RS2075252;cisplatin;Chemical;PA166155666;Variant
RS2228171;cisplatin;Chemical;PA166155671;Variant
RS2291767;cisplatin;Chemical;PA166155679;Variant
RS3087403;cisplatin;Chemical;PA166155696;Variant
RS9679162;cisplatin;Chemical;PA166155774;Variant
RS12613732;cisplatin;Chemical;PA166155818;Variant
RS17309872;cisplatin;Chemical;PA166155966;Variant
RS12659;cisplatin;Chemical;PA166155973;Variant
RS4646316;cisplatin;Chemical;PA166156108;Variant
RS9332377;cisplatin;Chemical;PA166156133;Variant
RS2228001;cisplatin;Chemical;PA166156345;Variant
RS2699887;cisplatin;Chemical;PA166156362;Variant
RS11710163;cisplatin;Chemical;PA166156444;Variant
RS698;cisplatin;Chemical;PA166156476;Variant
RS726501;cisplatin;Chemical;PA166156739;Variant
RS16886403;cisplatin;Chemical;PA166156882;Variant
RS17661089;cisplatin;Chemical;PA166156888;Variant
RS25648;cisplatin;Chemical;PA166156906;Variant
RS316019;cisplatin;Chemical;PA166156913;Variant
RS451774;cisplatin;Chemical;PA166156918;Variant
RS462779;cisplatin;Chemical;PA166156920;Variant
RS1142345;cisplatin;Chemical;PA166156978;Variant
RS1800460;cisplatin;Chemical;PA166156992;Variant
RS2207396;cisplatin;Chemical;PA166157022;Variant
RS3957357;cisplatin;Chemical;PA166157094;Variant
RS12201199;cisplatin;Chemical;PA166157177;Variant
RS17574269;cisplatin;Chemical;PA166157193;Variant
RS1045642;cisplatin;Chemical;PA166157284;Variant
RS1128503;cisplatin;Chemical;PA166157288;Variant
RS2740574;cisplatin;Chemical;PA166157367;Variant
RS4148737;cisplatin;Chemical;PA166157385;Variant
RS1801280;cisplatin;Chemical;PA166157570;Variant
RS7851395;cisplatin;Chemical;PA166157789;Variant
RS10981694;cisplatin;Chemical;PA166157825;Variant
RS1799735;cisplatin;Chemical;PA166159214;Variant
RS244898;cisplatin;Chemical;PA166159488;Variant
RS7937567;cisplatin;Chemical;PA166159497;Variant
RS10964552;cisplatin;Chemical;PA166159499;Variant
RS4788863;cisplatin;Chemical;PA166163715;Variant
RS3219489;cisplatin;Chemical;PA166171088;Variant
RS28362731;cisplatin;Chemical;PA166186212;Variant
RS1049305;cisplatin;Chemical;PA166186213;Variant
RS6025211;cisplatin;Chemical;PA166201322;Variant
RS36120609;cisplatin;Chemical;PA166211543;Variant
RS1760944;cisplatin;Chemical;PA166238764;Variant
RS2336219;cisplatin;Chemical;PA166253284;Variant
RS3212980;cisplatin;Chemical;PA166253286;Variant
NAT2;cisplatin;Chemical;PA18;Gene
GSTM1;cisplatin;Chemical;PA182;Gene
GSTT1;cisplatin;Chemical;PA183;Gene
APEX1;cisplatin;Chemical;PA201059;Gene
ACSS2;cisplatin;Chemical;PA24429;Gene
MTHFR;cisplatin;Chemical;PA245;Gene
ACYP2;cisplatin;Chemical;PA24500;Gene
ADH1C;cisplatin;Chemical;PA24572;Gene
AKT1;cisplatin;Chemical;PA24684;Gene
AQP1;cisplatin;Chemical;PA24918;Gene
BLMH;cisplatin;Chemical;PA25370;Gene
CLCN6;cisplatin;Chemical;PA26551;Gene
ABCB1;cisplatin;Chemical;PA267;Gene
CSNK2A3;cisplatin;Chemical;PA26958;Gene
CYBA;cisplatin;Chemical;PA27075;Gene
EIF3A;cisplatin;Chemical;PA27699;Gene
EPHX1;cisplatin;Chemical;PA27829;Gene
ERCC2;cisplatin;Chemical;PA27848;Gene
GPX5;cisplatin;Chemical;PA28953;Gene
GSTA1;cisplatin;Chemical;PA29016;Gene
GSTM3;cisplatin;Chemical;PA29024;Gene
GSTP1;cisplatin;Chemical;PA29028;Gene
RRM1;cisplatin;Chemical;PA298;Gene
LIG3;cisplatin;Chemical;PA30374;Gene
LRP2;cisplatin;Chemical;PA30452;Gene
MAP3K1;cisplatin;Chemical;PA30592;Gene
MLLT3;cisplatin;Chemical;PA30852;Gene
MTHFD1;cisplatin;Chemical;PA31236;Gene
MTR;cisplatin;Chemical;PA31272;Gene
MUTYH;cisplatin;Chemical;PA31328;Gene
NQO1;cisplatin;Chemical;PA31744;Gene
NRAS;cisplatin;Chemical;PA31768;Gene
SLC19A1;cisplatin;Chemical;PA327;Gene
OSGEP;cisplatin;Chemical;PA32834;Gene
SLC22A2;cisplatin;Chemical;PA331;Gene
PIK3CA;cisplatin;Chemical;PA33308;Gene
PTEN;cisplatin;Chemical;PA33942;Gene
RAD52;cisplatin;Chemical;PA34180;Gene
RAF1;cisplatin;Chemical;PA34183;Gene
PPP1R13L;cisplatin;Chemical;PA34195;Gene
RARS1;cisplatin;Chemical;PA34231;Gene
REV3L;cisplatin;Chemical;PA34337;Gene
TPMT;cisplatin;Chemical;PA356;Gene
SLC16A5;cisplatin;Chemical;PA35817;Gene
TYMS;cisplatin;Chemical;PA359;Gene
XRCC1;cisplatin;Chemical;PA369;Gene
UBE2I;cisplatin;Chemical;PA37134;Gene
VEGFA;cisplatin;Chemical;PA37302;Gene
XPC;cisplatin;Chemical;PA37413;Gene
ABCC3;cisplatin;Chemical;PA376;Gene
NR1I2;cisplatin;Chemical;PA378;Gene
ABCC4;cisplatin;Chemical;PA397;Gene
UGT1A1;cisplatin;Chemical;PA420;Gene
CCND1;cisplatin;Chemical;PA75;Gene
ALOPECIA;BLMH;Gene;PA443314;Disease
PAIN;BLMH;Gene;PA445208;Disease
TESTICULAR NEOPLASMS;BLMH;Gene;PA445828;Disease
BLEOMYCIN;BLMH;Gene;PA448645;Chemical
CISPLATIN;BLMH;Gene;PA449014;Chemical
ETOPOSIDE;BLMH;Gene;PA449552;Chemical
ATAZANAVIR;rs10929303;Variant;PA10251;Chemical
NEPHROLITHIASIS;rs10929303;Variant;PA162355520;Disease
LIVER FAILURE, ACUTE;rs10929303;Variant;PA446443;Disease
HIV INFECTIOUS DISEASE;rs10929303;Variant;PA447230;Disease
ACETAMINOPHEN;rs10929303;Variant;PA448015;Chemical
RITONAVIR;rs10929303;Variant;PA451260;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;HNMT;Gene;PA130620651;Chemical
NEOPLASMS;HNMT;Gene;PA445062;Disease
ASPIRIN;HNMT;Gene;PA448497;Chemical
BREAST NEOPLASMS;rs10140457;Variant;PA443560;Disease
LETROZOLE;rs10140457;Variant;PA450196;Chemical
ABIRATERONE;rs523349;Variant;PA166123407;Chemical
PROSTATIC NEOPLASMS;rs523349;Variant;PA445425;Disease
BUFURALOL;CYP2D6*39;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*39;Haplotype;PA166127651;Chemical
PRIMAQUINE;CYP2D6*39;Haplotype;PA451103;Chemical
G6PD DEFICIENCY;Malaria, Vivax;Disease;PA166157959;Variant
G6PD;Malaria, Vivax;Disease;PA28469;Gene
EPIDERMAL NECROLYSIS, TOXIC;rs28399499;Variant;PA444059;Disease
STEVENS-JOHNSON SYNDROME;rs28399499;Variant;PA445738;Disease
HIV INFECTIOUS DISEASE;rs28399499;Variant;PA447230;Disease
NEVIRAPINE;rs28399499;Variant;PA450616;Chemical
DEMENTIA;SLC6A4 L allele-rs25531T;Haplotype;PA443853;Disease
COCAINE-RELATED DISORDERS;SLC6A4 L allele-rs25531T;Haplotype;PA446878;Disease
ANXIETY DISORDERS;SLC6A4 L allele-rs25531T;Haplotype;PA447196;Disease
MOOD DISORDERS;SLC6A4 L allele-rs25531T;Haplotype;PA447209;Disease
SCHIZOPHRENIA;SLC6A4 L allele-rs25531T;Haplotype;PA447216;Disease
DEPRESSION;SLC6A4 L allele-rs25531T;Haplotype;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;SLC6A4 L allele-rs25531T;Haplotype;PA447321;Disease
CITALOPRAM;SLC6A4 L allele-rs25531T;Haplotype;PA449015;Chemical
CLOZAPINE;SLC6A4 L allele-rs25531T;Haplotype;PA449061;Chemical
DISULFIRAM;SLC6A4 L allele-rs25531T;Haplotype;PA449376;Chemical
FLUVOXAMINE;SLC6A4 L allele-rs25531T;Haplotype;PA449690;Chemical
PAROXETINE;SLC6A4 L allele-rs25531T;Haplotype;PA450801;Chemical
VENLAFAXINE;SLC6A4 L allele-rs25531T;Haplotype;PA451866;Chemical
CYP1B1;4-hydroxyestradiol;Chemical;PA27094;Gene
ACAMPROSATE;GRIN2B;Gene;PA10344;Chemical
ALCOHOL ABUSE;GRIN2B;Gene;PA443309;Disease
DRUG TOXICITY;GRIN2B;Gene;PA443937;Disease
EPILEPSY;GRIN2B;Gene;PA444065;Disease
SCHIZOPHRENIA;GRIN2B;Gene;PA447216;Disease
CLOZAPINE;GRIN2B;Gene;PA449061;Chemical
HALOPERIDOL;GRIN2B;Gene;PA449841;Chemical
QUETIAPINE;GRIN2B;Gene;PA451201;Chemical
RISPERIDONE;GRIN2B;Gene;PA451257;Chemical
SEVOFLURANE;GRIN2B;Gene;PA451341;Chemical
VALPROIC ACID;GRIN2B;Gene;PA451846;Chemical
CYP2B6;CYP2B6*5;Haplotype;PA123;Gene
RECURRENCE FREE SURVIVAL;CYP2B6*5;Haplotype;PA166127658;Disease
S-EDDP;CYP2B6*5;Haplotype;PA166177606;Chemical
(S)-METHADONE;CYP2B6*5;Haplotype;PA166178554;Chemical
R-EDDP;CYP2B6*5;Haplotype;PA166247521;Chemical
BREAST NEOPLASMS;CYP2B6*5;Haplotype;PA443560;Disease
OPIOID-RELATED DISORDERS;CYP2B6*5;Haplotype;PA445043;Disease
TOBACCO USE DISORDER;CYP2B6*5;Haplotype;PA445876;Disease
DEPRESSION;CYP2B6*5;Haplotype;PA447278;Disease
BUPROPION;CYP2B6*5;Haplotype;PA448687;Chemical
BUSULFAN;CYP2B6*5;Haplotype;PA448691;Chemical
CLOPIDOGREL;CYP2B6*5;Haplotype;PA449053;Chemical
CYCLOPHOSPHAMIDE;CYP2B6*5;Haplotype;PA449165;Chemical
EFAVIRENZ;CYP2B6*5;Haplotype;PA449441;Chemical
METHADONE;CYP2B6*5;Haplotype;PA450401;Chemical
MIRTAZAPINE;CYP2B6*5;Haplotype;PA450522;Chemical
RS1695;Medulloblastoma;Disease;PA166154249;Variant
GSTP1;Medulloblastoma;Disease;PA29028;Gene
ESSENTIAL HYPERTENSION;TET2;Gene;PA447288;Disease
HYDROCHLOROTHIAZIDE;TET2;Gene;PA449899;Chemical
DULOXETINE;rs10771997;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs10771997;Variant;PA447321;Disease
OXALIPLATIN;PIN1;Gene;PA131285527;Chemical
COLORECTAL NEOPLASMS;PIN1;Gene;PA446108;Disease
IRINOTECAN;PIN1;Gene;PA450085;Chemical
TPP1;cerliponase alfa;Chemical;PA26600;Gene
RS1523130;memantine;Chemical;PA166156323;Variant
NR1I2;memantine;Chemical;PA378;Gene
RS1799971;Sleep Apnea Syndromes;Disease;PA166156991;Variant
OPRM1;Sleep Apnea Syndromes;Disease;PA31945;Gene
HEROIN DEPENDENCE;rs3778150;Variant;PA444460;Disease
ETHANOL;rs3778150;Variant;PA448073;Chemical
HEROIN;rs3778150;Variant;PA452619;Chemical
EFAVIRENZ;rs773494867;Variant;PA449441;Chemical
PROPOFOL;rs773494867;Variant;PA451141;Chemical
ALPHA-ADRENORECEPTOR ANTAGONISTS;ADRA1B;Gene;PA164712344;Chemical
DOPAMINE;ADRA1B;Gene;PA449396;Chemical
EPINEPHRINE;ADRA1B;Gene;PA449470;Chemical
ISOPROTERENOL;ADRA1B;Gene;PA450121;Chemical
METHOXAMINE;ADRA1B;Gene;PA450431;Chemical
NOREPINEPHRINE;ADRA1B;Gene;PA450649;Chemical
PHENYLEPHRINE;ADRA1B;Gene;PA450935;Chemical
LEUKEMIA, MYELOID, ACUTE;rs5030743;Variant;PA444760;Disease
CLADRIBINE;rs5030743;Variant;PA449027;Chemical
CYTARABINE;rs5030743;Variant;PA449177;Chemical
SEVERE CUTANEOUS ADVERSE REACTIONS;rs9469003;Variant;PA166120929;Disease
EPIDERMAL NECROLYSIS, TOXIC;rs9469003;Variant;PA444059;Disease
STEVENS-JOHNSON SYNDROME;rs9469003;Variant;PA445738;Disease
ALLOPURINOL;rs9469003;Variant;PA448320;Chemical
FLUOROURACIL;rs55886062;Variant;PA128406956;Chemical
DPYD;rs55886062;Variant;PA145;Gene
NEOPLASMS;rs55886062;Variant;PA445062;Disease
CAPECITABINE;rs55886062;Variant;PA448771;Chemical
TEGAFUR;rs55886062;Variant;PA452620;Chemical
ROSUVASTATIN;ABCA1;Gene;PA134308647;Chemical
CORONARY DISEASE;ABCA1;Gene;PA443797;Disease
HYPERLIPIDEMIAS;ABCA1;Gene;PA444528;Disease
HYPERTRIGLYCERIDEMIA;ABCA1;Gene;PA446120;Disease
ATORVASTATIN;ABCA1;Gene;PA448500;Chemical
FENOFIBRATE;ABCA1;Gene;PA449594;Chemical
PRAVASTATIN;ABCA1;Gene;PA451089;Chemical
SIMVASTATIN;ABCA1;Gene;PA451363;Chemical
G6PD B (REFERENCE);sulfametopyrazine;Chemical;PA165947826;Haplotype
G6PD MEDITERRANEAN, DALLAS, PANAMA, SASSARI, CAGLIARI, BIRMINGHAM;sulfametopyrazine;Chemical;PA166121127;Haplotype
G6PD;sulfametopyrazine;Chemical;PA28469;Gene
DOXORUBICIN;rs11140490;Variant;PA449412;Chemical
ARIPIPRAZOLE;rs489693;Variant;PA10026;Chemical
WEIGHT GAIN;rs489693;Variant;PA128406954;Disease
AMISULPRIDE;rs489693;Variant;PA162565877;Chemical
PALIPERIDONE;rs489693;Variant;PA163518919;Chemical
SCHIZOAFFECTIVE DISORDER;rs489693;Variant;PA166123368;Disease
HYPERTRIGLYCERIDEMIA;rs489693;Variant;PA446120;Disease
SCHIZOPHRENIA;rs489693;Variant;PA447216;Disease
HALOPERIDOL;rs489693;Variant;PA449841;Chemical
QUETIAPINE;rs489693;Variant;PA451201;Chemical
RISPERIDONE;rs489693;Variant;PA451257;Chemical
ANTIPSYCHOTICS;rs489693;Variant;PA452233;Chemical
GEFITINIB;rs11568315;Variant;PA131301952;Chemical
CARCINOMA, NON-SMALL-CELL LUNG;rs11568315;Variant;PA443622;Disease
CALCIDIOL;CYP2R1;Gene;PA164745614;Chemical
PEGINTERFERON ALFA-2B;CYP2R1;Gene;PA164784024;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;CYP2R1;Gene;PA446863;Disease
RIBAVIRIN;CYP2R1;Gene;PA451241;Chemical
CORONARY DISEASE;rs2738466;Variant;PA443797;Disease
VASCULAR DISEASES;rs2738466;Variant;PA446021;Disease
PRAVASTATIN;rs2738466;Variant;PA451089;Chemical
TOBACCO USE DISORDER;rs2072658;Variant;PA445876;Disease
NICOTINE;rs2072658;Variant;PA450626;Chemical
DPYD;rs6670886;Variant;PA145;Gene
CAPECITABINE;rs6670886;Variant;PA448771;Chemical
NEUTROPENIA;rs12720066;Variant;PA445113;Disease
COLORECTAL NEOPLASMS;rs12720066;Variant;PA446108;Disease
IRINOTECAN;rs12720066;Variant;PA450085;Chemical
DULOXETINE;rs61908402;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs61908402;Variant;PA447321;Disease
TICAGRELOR;CYP3A4*2;Haplotype;PA165374673;Chemical
CABOZANTINIB;CYP3A4*2;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*2;Haplotype;PA165958362;Chemical
REGORAFENIB;CYP3A4*2;Haplotype;PA166114943;Chemical
VANDETANIB;CYP3A4*2;Haplotype;PA166118341;Chemical
IBRUTINIB;CYP3A4*2;Haplotype;PA166121346;Chemical
BREXPIPRAZOLE;CYP3A4*2;Haplotype;PA166160053;Chemical
ACALABRUTINIB;CYP3A4*2;Haplotype;PA166198581;Chemical
AMIODARONE;CYP3A4*2;Haplotype;PA448383;Chemical
LIDOCAINE;CYP3A4*2;Haplotype;PA450226;Chemical
METHADONE;CYP3A4*2;Haplotype;PA450401;Chemical
OXYCODONE;CYP3A4*2;Haplotype;PA450741;Chemical
SILDENAFIL;CYP3A4*2;Haplotype;PA451346;Chemical
TESTOSTERONE;CYP3A4*2;Haplotype;PA451627;Chemical
TUBERCULOSIS;CYP2B6*11;Haplotype;PA445941;Disease
HIV INFECTIONS;CYP2B6*11;Haplotype;PA447230;Disease
EFAVIRENZ;CYP2B6*11;Haplotype;PA449441;Chemical
G6PD;metabutethamine;Chemical;PA28469;Gene
ASTHMA;TBXT;Gene;PA443450;Disease
FLUNISOLIDE;TBXT;Gene;PA449661;Chemical
MIDAZOLAM;CYP3A4*40;Haplotype;PA450496;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs437943;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs437943;Variant;PA443434;Disease
ANTIHYPERTENSIVES;rs12817819;Variant;PA164712445;Chemical
CORONARY ARTERY DISEASE;rs12817819;Variant;PA443796;Disease
HYPERTENSION;rs12817819;Variant;PA444552;Disease
COMT;catecholamines;Chemical;PA117;Gene
RS1801253;catecholamines;Chemical;PA166153977;Variant
RS8187725;catecholamines;Chemical;PA166157132;Variant
SLC22A3;catecholamines;Chemical;PA330;Gene
ADRB1;catecholamines;Chemical;PA38;Gene
ANIFROLUMAB;IFNAR1;Gene;PA166277641;Chemical
NTRK1;entrectinib;Chemical;PA31817;Gene
NTRK2;entrectinib;Chemical;PA31818;Gene
NTRK3;entrectinib;Chemical;PA31819;Gene
ROS1;entrectinib;Chemical;PA34633;Gene
UGT1A1;Crigler-Najjar Syndrome;Disease;PA420;Gene
APC;Adenomatous Polyposis Coli;Disease;PA24875;Gene
RS4240803;pregabalin;Chemical;PA166155063;Variant
SLC7A5;pregabalin;Chemical;PA35923;Gene
HYPERTENSION;rs34717272;Variant;PA444552;Disease
RS267606618;netilmicin;Chemical;PA166158908;Variant
RS267606619;netilmicin;Chemical;PA166158909;Variant
RS267606617;netilmicin;Chemical;PA166159181;Variant
MT-RNR1;netilmicin;Chemical;PA31274;Gene
LUPUS ERYTHEMATOSUS;rs4802101;Variant;PA444819;Disease
CYCLOPHOSPHAMIDE;rs4802101;Variant;PA449165;Chemical
G6PD;Favism;Disease;PA28469;Gene
ANTIEPILEPTICS;rs1047891;Variant;PA143485705;Chemical
EPILEPSY;rs1047891;Variant;PA444065;Disease
HYPERAMMONEMIA;rs1047891;Variant;PA447146;Disease
VALPROIC ACID;rs1047891;Variant;PA451846;Chemical
NUDT15;TPMT*4;Haplotype;PA134963132;Gene
TPMT;TPMT*4;Haplotype;PA356;Gene
AZATHIOPRINE;TPMT*4;Haplotype;PA448515;Chemical
MERCAPTOPURINE;TPMT*4;Haplotype;PA450379;Chemical
THIOGUANINE;TPMT*4;Haplotype;PA451663;Chemical
CLOPIDOGREL;CYP2C19*25;Haplotype;PA449053;Chemical
MEPHENYTOIN;CYP2C19*25;Haplotype;PA450373;Chemical
ACE;Thiazides, plain;Chemical;PA139;Gene
RS5443;Thiazides, plain;Chemical;PA166154486;Variant
RS13306673;Thiazides, plain;Chemical;PA166155114;Variant
RS4341;Thiazides, plain;Chemical;PA166155146;Variant
RS2273359;Thiazides, plain;Chemical;PA166155924;Variant
RS5186;Thiazides, plain;Chemical;PA166156276;Variant
RS34550074;Thiazides, plain;Chemical;PA166169840;Variant
GNB3;Thiazides, plain;Chemical;PA176;Gene
SLC12A3;Thiazides, plain;Chemical;PA321;Gene
SLCO2A1;Thiazides, plain;Chemical;PA35840;Gene
NELFCD;Thiazides, plain;Chemical;PA38055;Gene
AGTR1;Thiazides, plain;Chemical;PA43;Gene
CLODRONATE;IL1B;Gene;PA10239;Chemical
BISPHOSPHONATES;IL1B;Gene;PA164712563;Chemical
PLATINUM COMPOUNDS;IL1B;Gene;PA164713176;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;IL1B;Gene;PA164713366;Chemical
USTEKINUMAB;IL1B;Gene;PA166048654;Chemical
HELICOBACTER INFECTIONS;IL1B;Gene;PA166048740;Disease
NON-SMALL CELL LUNG CARCINOMA;IL1B;Gene;PA443622;Disease
ULCERATIVE COLITIS;IL1B;Gene;PA443750;Disease
CROHN DISEASE;IL1B;Gene;PA443815;Disease
OSTEITIS DEFORMANS;IL1B;Gene;PA445172;Disease
PAIN, POSTOPERATIVE;IL1B;Gene;PA445210;Disease
PSORIASIS;IL1B;Gene;PA445451;Disease
INFLAMMATORY BOWEL DISEASES;IL1B;Gene;PA446116;Disease
SCHIZOPHRENIA;IL1B;Gene;PA447216;Disease
ASPIRIN;IL1B;Gene;PA448497;Chemical
ETIDRONIC ACID;IL1B;Gene;PA449548;Chemical
LANSOPRAZOLE;IL1B;Gene;PA450180;Chemical
MORPHINE;IL1B;Gene;PA450550;Chemical
OMEPRAZOLE;IL1B;Gene;PA450704;Chemical
PRAVASTATIN;IL1B;Gene;PA451089;Chemical
RABEPRAZOLE;IL1B;Gene;PA451216;Chemical
RISEDRONATE;IL1B;Gene;PA451255;Chemical
TILUDRONATE;IL1B;Gene;PA451688;Chemical
ANTIPSYCHOTICS;IL1B;Gene;PA452233;Chemical
INFLIXIMAB;IL1B;Gene;PA452639;Chemical
COLORECTAL NEOPLASMS;rs2741171;Variant;PA446108;Disease
CAPECITABINE;rs2741171;Variant;PA448771;Chemical
RS2306168;fexofenadine;Chemical;PA166154367;Variant
RS1045642;fexofenadine;Chemical;PA166157284;Variant
ABCB1;fexofenadine;Chemical;PA267;Gene
SLCO2B1;fexofenadine;Chemical;PA35845;Gene
WARFARIN;rs1042580;Variant;PA451906;Chemical
ALCOHOL ABUSE;rs6088638;Variant;PA443309;Disease
ETHANOL;rs6088638;Variant;PA448073;Chemical
G6PD B (REFERENCE);Methemoglobinemia;Disease;PA165947826;Haplotype
G6PD A- 202A_376G;Methemoglobinemia;Disease;PA165947827;Haplotype
G6PD MEDITERRANEAN, DALLAS, PANAMA, SASSARI, CAGLIARI, BIRMINGHAM;Methemoglobinemia;Disease;PA166121127;Haplotype
CYB5R3 DEFICIENCY;Methemoglobinemia;Disease;PA166157902;Variant
G6PD DEFICIENCY;Methemoglobinemia;Disease;PA166157959;Variant
CYB5R3;Methemoglobinemia;Disease;PA27331;Gene
G6PD;Methemoglobinemia;Disease;PA28469;Gene
RS130060;ketanserin;Chemical;PA166184004;Variant
HTR1B;ketanserin;Chemical;PA29549;Gene
IFNL3;peginterferon alfa-2b;Chemical;PA134952671;Gene
CYP2R1;peginterferon alfa-2b;Chemical;PA134986407;Gene
SLC29A1;peginterferon alfa-2b;Chemical;PA154;Gene
HLA-A*01:01;peginterferon alfa-2b;Chemical;PA165952609;Haplotype
HLA-B*38:01;peginterferon alfa-2b;Chemical;PA165955500;Haplotype
HLA-C*01:02;peginterferon alfa-2b;Chemical;PA165956704;Haplotype
HLA-C*02:02;peginterferon alfa-2b;Chemical;PA165956777;Haplotype
HLA-C*04:01;peginterferon alfa-2b;Chemical;PA165957046;Haplotype
HLA-C*05:01;peginterferon alfa-2b;Chemical;PA165957192;Haplotype
HLA-C*06:02;peginterferon alfa-2b;Chemical;PA165957286;Haplotype
HLA-C*07:01;peginterferon alfa-2b;Chemical;PA165957372;Haplotype
HLA-C*12:02;peginterferon alfa-2b;Chemical;PA165957722;Haplotype
HLA-C*14:02;peginterferon alfa-2b;Chemical;PA165957818;Haplotype
HLA-C*15:02;peginterferon alfa-2b;Chemical;PA165957859;Haplotype
HLA-C*16:01;peginterferon alfa-2b;Chemical;PA165957927;Haplotype
HLA-C*17:01;peginterferon alfa-2b;Chemical;PA165957985;Haplotype
IFNL4;peginterferon alfa-2b;Chemical;PA166049147;Gene
SLC6A4 HTTLPR LONG FORM (L ALLELE);peginterferon alfa-2b;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);peginterferon alfa-2b;Chemical;PA166116466;Haplotype
HLA-C*03:02;peginterferon alfa-2b;Chemical;PA166123425;Haplotype
HLA-C*08:01;peginterferon alfa-2b;Chemical;PA166123426;Haplotype
IFNL3 RS12979860 REFERENCE (C);peginterferon alfa-2b;Chemical;PA166129427;Haplotype
IFNL3 RS12979860T;peginterferon alfa-2b;Chemical;PA166129428;Haplotype
RS2228570;peginterferon alfa-2b;Chemical;PA166154531;Variant
RS10877012;peginterferon alfa-2b;Chemical;PA166154623;Variant
RS12819210;peginterferon alfa-2b;Chemical;PA166154644;Variant
RS11854484;peginterferon alfa-2b;Chemical;PA166154934;Variant
RS14158;peginterferon alfa-2b;Chemical;PA166155344;Variant
RS4803217;peginterferon alfa-2b;Chemical;PA166155416;Variant
RS4803219;peginterferon alfa-2b;Chemical;PA166155417;Variant
RS7248668;peginterferon alfa-2b;Chemical;PA166155429;Variant
RS8099917;peginterferon alfa-2b;Chemical;PA166155435;Variant
RS8103142;peginterferon alfa-2b;Chemical;PA166155437;Variant
RS8105790;peginterferon alfa-2b;Chemical;PA166155438;Variant
RS8113007;peginterferon alfa-2b;Chemical;PA166155440;Variant
RS10853728;peginterferon alfa-2b;Chemical;PA166155456;Variant
RS11881222;peginterferon alfa-2b;Chemical;PA166155462;Variant
RS12979860;peginterferon alfa-2b;Chemical;PA166155468;Variant
RS12980275;peginterferon alfa-2b;Chemical;PA166155469;Variant
RS28416813;peginterferon alfa-2b;Chemical;PA166155479;Variant
RS1127354;peginterferon alfa-2b;Chemical;PA166155915;Variant
RS7270101;peginterferon alfa-2b;Chemical;PA166155964;Variant
RS56061981;peginterferon alfa-2b;Chemical;PA166156687;Variant
RS3077;peginterferon alfa-2b;Chemical;PA166156899;Variant
RS760370;peginterferon alfa-2b;Chemical;PA166156947;Variant
RS3828913;peginterferon alfa-2b;Chemical;PA166157089;Variant
RS1800795;peginterferon alfa-2b;Chemical;PA166157304;Variant
RS9657182;peginterferon alfa-2b;Chemical;PA166157627;Variant
RS117648444;peginterferon alfa-2b;Chemical;PA166160628;Variant
RS4273729;peginterferon alfa-2b;Chemical;PA166160738;Variant
RS10741657;peginterferon alfa-2b;Chemical;PA166163255;Variant
RS11506105;peginterferon alfa-2b;Chemical;PA166165309;Variant
RS11322783;peginterferon alfa-2b;Chemical;PA166190881;Variant
IL6;peginterferon alfa-2b;Chemical;PA198;Gene
LDLR;peginterferon alfa-2b;Chemical;PA227;Gene
CYP27B1;peginterferon alfa-2b;Chemical;PA27099;Gene
IDO1;peginterferon alfa-2b;Chemical;PA29869;Gene
ITPA;peginterferon alfa-2b;Chemical;PA29973;Gene
KIR2DS2;peginterferon alfa-2b;Chemical;PA30119;Gene
MICB;peginterferon alfa-2b;Chemical;PA30812;Gene
SLC6A4;peginterferon alfa-2b;Chemical;PA312;Gene
OASL;peginterferon alfa-2b;Chemical;PA31879;Gene
HLA-A;peginterferon alfa-2b;Chemical;PA35055;Gene
HLA-B;peginterferon alfa-2b;Chemical;PA35056;Gene
HLA-C;peginterferon alfa-2b;Chemical;PA35057;Gene
HLA-DPA1;peginterferon alfa-2b;Chemical;PA35062;Gene
CXCL10;peginterferon alfa-2b;Chemical;PA35568;Gene
VDR;peginterferon alfa-2b;Chemical;PA37301;Gene
SLC28A2;peginterferon alfa-2b;Chemical;PA386;Gene
EGFR;peginterferon alfa-2b;Chemical;PA7360;Gene
MEMANTINE;rs1523130;Variant;PA10364;Chemical
DEMENTIA;rs1523130;Variant;PA443853;Disease
SUBSTANCE-RELATED DISORDERS;rs1523130;Variant;PA446876;Disease
BIPOLAR DISORDER;rs1523130;Variant;PA447199;Disease
DEPRESSION;rs1523130;Variant;PA447278;Disease
RISPERIDONE;rs1523130;Variant;PA451257;Chemical
G6PD;nitrofurazone;Chemical;PA28469;Gene
PROSTATIC NEOPLASMS;rs6922548;Variant;PA445425;Disease
DOCETAXEL;rs6922548;Variant;PA449383;Chemical
THALIDOMIDE;rs6922548;Variant;PA451644;Chemical
NON-SMALL CELL LUNG CARCINOMA;C6orf15;Gene;PA443622;Disease
THROMBOCYTOPENIA;C6orf15;Gene;PA445846;Disease
CARBOPLATIN;C6orf15;Gene;PA448803;Chemical
GEMCITABINE;C6orf15;Gene;PA449748;Chemical
CYP2B6;thiotepa;Chemical;PA123;Gene
RS1138272;thiotepa;Chemical;PA166154320;Variant
RS6151031;thiotepa;Chemical;PA166157783;Variant
ALDH1A1;thiotepa;Chemical;PA24692;Gene
GSTP1;thiotepa;Chemical;PA29028;Gene
PSORIASIS;rs12885713;Variant;PA445451;Disease
CYCLOSPORINE;rs12885713;Variant;PA449167;Chemical
CYP3A5;Arteriosclerosis;Disease;PA131;Gene
ACE;Arteriosclerosis;Disease;PA139;Gene
RS1799752;Arteriosclerosis;Disease;PA166155187;Variant
RS776746;Arteriosclerosis;Disease;PA166157267;Variant
MTHFR;Arteriosclerosis;Disease;PA245;Gene
G6PD;Arteriosclerosis;Disease;PA28469;Gene
HRAS;ARAF;Gene;PA29444;Gene
KRAS;ARAF;Gene;PA30196;Gene
MAP2K1;ARAF;Gene;PA30584;Gene
MAP2K2;ARAF;Gene;PA30587;Gene
MRAS;ARAF;Gene;PA30932;Gene
NRAS;ARAF;Gene;PA31768;Gene
RRAS;ARAF;Gene;PA34861;Gene
SORAFENIB;ARAF;Gene;PA7000;Chemical
CYP3A4;etoposide;Chemical;PA130;Gene
SLCO1B1;etoposide;Chemical;PA134865839;Gene
C18ORF56;etoposide;Chemical;PA134956204;Gene
ERCC1;etoposide;Chemical;PA155;Gene
UGT1A1*6;etoposide;Chemical;PA166115858;Haplotype
RS2784917;etoposide;Chemical;PA166154018;Variant
RS1695;etoposide;Chemical;PA166154249;Variant
RS716274;etoposide;Chemical;PA166154297;Variant
RS2291075;etoposide;Chemical;PA166154544;Variant
RS6539870;etoposide;Chemical;PA166154595;Variant
RS1050565;etoposide;Chemical;PA166155175;Variant
RS45445694;etoposide;Chemical;PA166155331;Variant
RS11615;etoposide;Chemical;PA166155342;Variant
RS13181;etoposide;Chemical;PA166155343;Variant
RS238406;etoposide;Chemical;PA166155349;Variant
RS1799793;etoposide;Chemical;PA166155371;Variant
RS3212986;etoposide;Chemical;PA166155407;Variant
RS446112;etoposide;Chemical;PA166155909;Variant
RS1045642;etoposide;Chemical;PA166157284;Variant
RS2740574;etoposide;Chemical;PA166157367;Variant
GSTT1;etoposide;Chemical;PA183;Gene
BLMH;etoposide;Chemical;PA25370;Gene
ABCB1;etoposide;Chemical;PA267;Gene
DYNC2H1;etoposide;Chemical;PA27433;Gene
ERCC2;etoposide;Chemical;PA27848;Gene
GSTP1;etoposide;Chemical;PA29028;Gene
PLA2G6;etoposide;Chemical;PA33367;Gene
TYMS;etoposide;Chemical;PA359;Gene
SLIT1;etoposide;Chemical;PA35938;Gene
UGT1A1;etoposide;Chemical;PA420;Gene
G6PD A- 202A_376G;Kidney Failure, Acute;Disease;PA165947827;Haplotype
G6PD DEFICIENCY;Kidney Failure, Acute;Disease;PA166157959;Variant
G6PD;Kidney Failure, Acute;Disease;PA28469;Gene
VORICONAZOLE;SLCO2B1;Gene;PA10233;Chemical
HMG COA REDUCTASE INHIBITORS;SLCO2B1;Gene;PA133950441;Chemical
ROSUVASTATIN;SLCO2B1;Gene;PA134308647;Chemical
LEUKOTRIENE RECEPTOR ANTAGONISTS;SLCO2B1;Gene;PA164712863;Chemical
ESTRONE SULFATE;SLCO2B1;Gene;PA166185957;Chemical
ASTHMA;SLCO2B1;Gene;PA443450;Disease
FEXOFENADINE;SLCO2B1;Gene;PA449621;Chemical
MONTELUKAST;SLCO2B1;Gene;PA450546;Chemical
SIMVASTATIN;SLCO2B1;Gene;PA451363;Chemical
PLCB1;GNB4;Gene;PA33384;Gene
PLCB2;GNB4;Gene;PA33385;Gene
PLCB3;GNB4;Gene;PA33386;Gene
PLCB4;GNB4;Gene;PA33387;Gene
ABCC2;paclitaxel;Chemical;PA116;Gene
CYP2C8;paclitaxel;Chemical;PA125;Gene
CYP3A4;paclitaxel;Chemical;PA130;Gene
CYP3A5;paclitaxel;Chemical;PA131;Gene
SLCO1B1;paclitaxel;Chemical;PA134865839;Gene
FGD4;paclitaxel;Chemical;PA134907925;Gene
SLC29A1;paclitaxel;Chemical;PA154;Gene
ERCC1;paclitaxel;Chemical;PA155;Gene
CYP3A4*1;paclitaxel;Chemical;PA165819201;Haplotype
CYP3A4*8;paclitaxel;Chemical;PA165819226;Haplotype
CYP3A4*20;paclitaxel;Chemical;PA165819244;Haplotype
SLCO1B1*5;paclitaxel;Chemical;PA165819255;Haplotype
SLCO1B1*15;paclitaxel;Chemical;PA165819265;Haplotype
CYP2C8*2;paclitaxel;Chemical;PA165958684;Haplotype
CYP2C8*3;paclitaxel;Chemical;PA165958685;Haplotype
CYP2C8*4;paclitaxel;Chemical;PA165958686;Haplotype
GSTM1 NULL;paclitaxel;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;paclitaxel;Chemical;PA166048676;Haplotype
CYP3A4*22;paclitaxel;Chemical;PA166048680;Haplotype
CYP3A5*1;paclitaxel;Chemical;PA166128213;Haplotype
CYP3A5*3;paclitaxel;Chemical;PA166128219;Haplotype
RS2072671;paclitaxel;Chemical;PA166153667;Variant
RS1058930;paclitaxel;Chemical;PA166153961;Variant
RS1113129;paclitaxel;Chemical;PA166153964;Variant
RS1127687;paclitaxel;Chemical;PA166153965;Variant
RS1934951;paclitaxel;Chemical;PA166153985;Variant
RS2227310;paclitaxel;Chemical;PA166153999;Variant
RS4353229;paclitaxel;Chemical;PA166154054;Variant
RS7921977;paclitaxel;Chemical;PA166154092;Variant
RS10509681;paclitaxel;Chemical;PA166154110;Variant
RS11572080;paclitaxel;Chemical;PA166154140;Variant
RS11572103;paclitaxel;Chemical;PA166154141;Variant
RS12415607;paclitaxel;Chemical;PA166154152;Variant
RS66501115;paclitaxel;Chemical;PA166154189;Variant
RS4149117;paclitaxel;Chemical;PA166154583;Variant
RS7311358;paclitaxel;Chemical;PA166154602;Variant
RS10771973;paclitaxel;Chemical;PA166154614;Variant
RS11623866;paclitaxel;Chemical;PA166154823;Variant
RS879207;paclitaxel;Chemical;PA166155169;Variant
RS2849380;paclitaxel;Chemical;PA166155289;Variant
RS3212986;paclitaxel;Chemical;PA166155407;Variant
RS1056836;paclitaxel;Chemical;PA166155621;Variant
RS17309872;paclitaxel;Chemical;PA166155966;Variant
RS9981861;paclitaxel;Chemical;PA166156013;Variant
RS139887;paclitaxel;Chemical;PA166156044;Variant
RS11710163;paclitaxel;Chemical;PA166156444;Variant
RS7349683;paclitaxel;Chemical;PA166156616;Variant
RS726501;paclitaxel;Chemical;PA166156739;Variant
RS16886403;paclitaxel;Chemical;PA166156882;Variant
RS17661089;paclitaxel;Chemical;PA166156888;Variant
RS4880;paclitaxel;Chemical;PA166156900;Variant
RS544093;paclitaxel;Chemical;PA166156925;Variant
RS747199;paclitaxel;Chemical;PA166156945;Variant
RS1045642;paclitaxel;Chemical;PA166157284;Variant
RS1128503;paclitaxel;Chemical;PA166157288;Variant
RS1801368;paclitaxel;Chemical;PA166157307;Variant
RS2032582;paclitaxel;Chemical;PA166157316;Variant
RS2229109;paclitaxel;Chemical;PA166157334;Variant
RS9282564;paclitaxel;Chemical;PA166157435;Variant
RS12721627;paclitaxel;Chemical;PA166157460;Variant
RS72552784;paclitaxel;Chemical;PA166157504;Variant
RS11280056;paclitaxel;Chemical;PA166180936;Variant
CYP2C8*1;paclitaxel;Chemical;PA166242948;Haplotype
GSTM1;paclitaxel;Chemical;PA182;Gene
ABCC1;paclitaxel;Chemical;PA244;Gene
ACSS2;paclitaxel;Chemical;PA24429;Gene
BCL2;paclitaxel;Chemical;PA25302;Gene
CASP7;paclitaxel;Chemical;PA26091;Gene
ABCB1;paclitaxel;Chemical;PA267;Gene
CYP1B1;paclitaxel;Chemical;PA27094;Gene
DSCAM;paclitaxel;Chemical;PA27491;Gene
EPHA5;paclitaxel;Chemical;PA27821;Gene
FNTB;paclitaxel;Chemical;PA28202;Gene
MAP3K1;paclitaxel;Chemical;PA30592;Gene
OPRM1;paclitaxel;Chemical;PA31945;Gene
RAF1;paclitaxel;Chemical;PA34183;Gene
SLCO1B3;paclitaxel;Chemical;PA35844;Gene
TYMS;paclitaxel;Chemical;PA359;Gene
SOD2;paclitaxel;Chemical;PA36017;Gene
SOX10;paclitaxel;Chemical;PA36027;Gene
MAD1L1;paclitaxel;Chemical;PA372;Gene
NR1I2;paclitaxel;Chemical;PA378;Gene
SPATA5;paclitaxel;Chemical;PA38294;Gene
ABCG2;paclitaxel;Chemical;PA390;Gene
CDA;paclitaxel;Chemical;PA98;Gene
CYP2C19;rivaroxaban;Chemical;PA124;Gene
CYP3A4;rivaroxaban;Chemical;PA130;Gene
F5;rivaroxaban;Chemical;PA159;Gene
CYP2C19*17;rivaroxaban;Chemical;PA165816533;Haplotype
CYP2C19*1;rivaroxaban;Chemical;PA165980634;Haplotype
RS1045642;rivaroxaban;Chemical;PA166157284;Variant
RS2032582;rivaroxaban;Chemical;PA166157316;Variant
ABCB1;rivaroxaban;Chemical;PA267;Gene
STATIN-RELATED MYOPATHY;rs1225367412;Variant;PA166163391;Disease
HYPERTENSION;rs1225367412;Variant;PA444552;Disease
KIDNEY DISEASES;rs1225367412;Variant;PA444682;Disease
LIVER DISEASES;rs1225367412;Variant;PA444801;Disease
RHABDOMYOLYSIS;rs1225367412;Variant;PA445549;Disease
SIMVASTATIN;rs1225367412;Variant;PA451363;Chemical
DRUG TOXICITY;rs7187684;Variant;PA443937;Disease
CAPECITABINE;rs7187684;Variant;PA448771;Chemical
DPYD;Metabolic Diseases;Disease;PA145;Gene
ACE;ACE2;Gene;PA139;Gene
COVID-19;ACE2;Gene;PA166197121;Disease
HYPERTENSION;ACE2;Gene;PA444552;Disease
TOBACCO USE DISORDER;ACE2;Gene;PA445876;Disease
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;ACE2;Gene;PA447178;Disease
CAPTOPRIL;ACE2;Gene;PA448780;Chemical
CYP2C8;pioglitazone;Chemical;PA125;Gene
CYP2C9;pioglitazone;Chemical;PA126;Gene
CYP3A5;pioglitazone;Chemical;PA131;Gene
ADIPOQ;pioglitazone;Chemical;PA134933118;Gene
CYP2C9*1;pioglitazone;Chemical;PA165816542;Haplotype
CYP2C9*3;pioglitazone;Chemical;PA165816544;Haplotype
CYP2C8*2;pioglitazone;Chemical;PA165958684;Haplotype
CYP2C8*3;pioglitazone;Chemical;PA165958685;Haplotype
RS1801282;pioglitazone;Chemical;PA166156331;Variant
RS2241766;pioglitazone;Chemical;PA166156347;Variant
RS17584499;pioglitazone;Chemical;PA166184298;Variant
CYP2C8*1;pioglitazone;Chemical;PA166242948;Haplotype
PPARG;pioglitazone;Chemical;PA281;Gene
G6PD;pioglitazone;Chemical;PA28469;Gene
PTPRD;pioglitazone;Chemical;PA34013;Gene
NR1I2;pioglitazone;Chemical;PA378;Gene
HYPERTENSION;TBX2;Gene;PA444552;Disease
ATENOLOL;TBX2;Gene;PA448499;Chemical
ATAZANAVIR;rs17868323;Variant;PA10251;Chemical
HYPERBILIRUBINEMIA;rs17868323;Variant;PA444511;Disease
HIV INFECTIOUS DISEASE;rs17868323;Variant;PA447230;Disease
RITONAVIR;rs17868323;Variant;PA451260;Chemical
CYP2B6;CYP2B6*6;Haplotype;PA123;Gene
ETHAMBUTOL;CYP2B6*6;Haplotype;PA164784021;Chemical
TOXIC LIVER DISEASE;CYP2B6*6;Haplotype;PA164925725;Disease
ARTEMETHER;CYP2B6*6;Haplotype;PA165111698;Chemical
PREGNANCY;CYP2B6*6;Haplotype;PA166048714;Disease
COTININE;CYP2B6*6;Haplotype;PA166114414;Chemical
DRUG-INDUCED LIVER INJURY;CYP2B6*6;Haplotype;PA166119041;Disease
RECURRENCE FREE SURVIVAL;CYP2B6*6;Haplotype;PA166127658;Disease
EFAVIRENZ / EMTRICITABINE / TENOFOVIR DISOPROXIL;CYP2B6*6;Haplotype;PA166176033;Chemical
S-EDDP;CYP2B6*6;Haplotype;PA166177606;Chemical
(S)-METHADONE;CYP2B6*6;Haplotype;PA166178554;Chemical
HYDROXYBUPROPION;CYP2B6*6;Haplotype;PA166226561;Chemical
R-EDDP;CYP2B6*6;Haplotype;PA166247521;Chemical
BREAST NEOPLASMS;CYP2B6*6;Haplotype;PA443560;Disease
DRUG TOXICITY;CYP2B6*6;Haplotype;PA443937;Disease
HEROIN DEPENDENCE;CYP2B6*6;Haplotype;PA444460;Disease
LONG QT SYNDROME;CYP2B6*6;Haplotype;PA444807;Disease
LYMPHOMA, NON-HODGKIN;CYP2B6*6;Haplotype;PA444845;Disease
OPIOID-RELATED DISORDERS;CYP2B6*6;Haplotype;PA445043;Disease
NEOPLASMS;CYP2B6*6;Haplotype;PA445062;Disease
PAIN;CYP2B6*6;Haplotype;PA445208;Disease
PAIN, POSTOPERATIVE;CYP2B6*6;Haplotype;PA445210;Disease
SCOLIOSIS;CYP2B6*6;Haplotype;PA445619;Disease
TOBACCO USE DISORDER;CYP2B6*6;Haplotype;PA445876;Disease
TUBERCULOSIS;CYP2B6*6;Haplotype;PA445941;Disease
LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;CYP2B6*6;Haplotype;PA446169;Disease
LYMPHOMA, B-CELL;CYP2B6*6;Haplotype;PA446304;Disease
NEUROTOXICITY SYNDROMES;CYP2B6*6;Haplotype;PA446975;Disease
HIV INFECTIONS;CYP2B6*6;Haplotype;PA447230;Disease
DEPRESSION;CYP2B6*6;Haplotype;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2B6*6;Haplotype;PA447321;Disease
BUPROPION;CYP2B6*6;Haplotype;PA448687;Chemical
CYCLOPHOSPHAMIDE;CYP2B6*6;Haplotype;PA449165;Chemical
EFAVIRENZ;CYP2B6*6;Haplotype;PA449441;Chemical
FLUDARABINE;CYP2B6*6;Haplotype;PA449655;Chemical
ISONIAZID;CYP2B6*6;Haplotype;PA450112;Chemical
KETAMINE;CYP2B6*6;Haplotype;PA450144;Chemical
LAMIVUDINE;CYP2B6*6;Haplotype;PA450163;Chemical
METHADONE;CYP2B6*6;Haplotype;PA450401;Chemical
MIRTAZAPINE;CYP2B6*6;Haplotype;PA450522;Chemical
NEVIRAPINE;CYP2B6*6;Haplotype;PA450616;Chemical
NICOTINE;CYP2B6*6;Haplotype;PA450626;Chemical
PYRAZINAMIDE;CYP2B6*6;Haplotype;PA451182;Chemical
RIFAMPIN;CYP2B6*6;Haplotype;PA451250;Chemical
SERTRALINE;CYP2B6*6;Haplotype;PA451333;Chemical
STAVUDINE;CYP2B6*6;Haplotype;PA451494;Chemical
TAMOXIFEN;CYP2B6*6;Haplotype;PA451581;Chemical
ZIDOVUDINE;CYP2B6*6;Haplotype;PA451954;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*15:13;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*15:13;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*15:13;Haplotype;PA445738;Disease
PHENYTOIN;HLA-B*15:13;Haplotype;PA450947;Chemical
MIGALASTAT;rs398123217;Variant;PA166182881;Chemical
FABRY DISEASE;rs398123217;Variant;PA443367;Disease
DULOXETINE;rs2933304;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs2933304;Variant;PA447321;Disease
TIRAP;ustekinumab;Chemical;PA134972842;Gene
HLA-C*06:02;ustekinumab;Chemical;PA165957286;Haplotype
RS1143623;ustekinumab;Chemical;PA166155628;Variant
RS1143627;ustekinumab;Chemical;PA166155629;Variant
RS610604;ustekinumab;Chemical;PA166156931;Variant
RS3213094;ustekinumab;Chemical;PA166160547;Variant
RS5744174;ustekinumab;Chemical;PA166163371;Variant
RS8177374;ustekinumab;Chemical;PA166175800;Variant
IL12A;ustekinumab;Chemical;PA29784;Gene
IL12B;ustekinumab;Chemical;PA29785;Gene
IL1B;ustekinumab;Chemical;PA29808;Gene
IL23A;ustekinumab;Chemical;PA29824;Gene
HLA-C;ustekinumab;Chemical;PA35057;Gene
TLR5;ustekinumab;Chemical;PA36553;Gene
TNFAIP3;ustekinumab;Chemical;PA36593;Gene
PLATINUM COMPOUNDS;rs7170924;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs7170924;Variant;PA443622;Disease
ALCOHOL ABUSE;rs2074957;Variant;PA443309;Disease
ETHANOL;rs2074957;Variant;PA448073;Chemical
NICOTINE;rs1302192284;Variant;PA450626;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;TNFRSF1B;Gene;PA164713366;Chemical
RHEUMATOID ARTHRITIS;TNFRSF1B;Gene;PA443434;Disease
SPONDYLITIS, ANKYLOSING;TNFRSF1B;Gene;PA445724;Disease
ETANERCEPT;TNFRSF1B;Gene;PA449515;Chemical
INFLIXIMAB;TNFRSF1B;Gene;PA452639;Chemical
PREGNENOLONE;rs746398875;Variant;PA166334121;Chemical
ADEFOVIR DIPIVOXIL;NME1;Gene;PA10005;Chemical
TENOFOVIR;NME1;Gene;PA10204;Chemical
LAMIVUDINE;NME1;Gene;PA450163;Chemical
ZIDOVUDINE;NME1;Gene;PA451954;Chemical
ALCOHOL ABUSE;rs25531;Variant;PA443309;Disease
MAJOR DEPRESSIVE DISORDER;rs25531;Variant;PA447321;Disease
ETHANOL;rs25531;Variant;PA448073;Chemical
CITALOPRAM;rs25531;Variant;PA449015;Chemical
FLUOXETINE;rs25531;Variant;PA449673;Chemical
HYPERTENSION;rs3184504;Variant;PA444552;Disease
CANDESARTAN;rs3184504;Variant;PA448765;Chemical
PEMETREXED;rs1051298;Variant;PA10810;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs1051298;Variant;PA443622;Disease
MESOTHELIOMA;rs1051298;Variant;PA444937;Disease
MAJOR DEPRESSIVE DISORDER;rs672170;Variant;PA447321;Disease
ANTIDEPRESSANTS;rs672170;Variant;PA452229;Chemical
LAPATINIB;ESR2;Gene;PA152241907;Chemical
EVEROLIMUS;ESR2;Gene;PA164746311;Chemical
FULVESTRANT;ESR2;Gene;PA164747170;Chemical
GOSERELIN;ESR2;Gene;PA164747674;Chemical
OLAPARIB;ESR2;Gene;PA164920420;Chemical
IXABEPILONE;ESR2;Gene;PA165110439;Chemical
PERTUZUMAB;ESR2;Gene;PA165290933;Chemical
NERATINIB;ESR2;Gene;PA165291472;Chemical
PALBOCICLIB;ESR2;Gene;PA166153469;Chemical
RIBOCICLIB;ESR2;Gene;PA166153470;Chemical
ABEMACICLIB;ESR2;Gene;PA166153471;Chemical
ERIBULIN;ESR2;Gene;PA166182723;Chemical
ALPELISIB;ESR2;Gene;PA166184523;Chemical
TRASTUZUMAB DERUXTECAN;ESR2;Gene;PA166190621;Chemical
SACITUZUMAB GOVITECAN;ESR2;Gene;PA166225061;Chemical
CAPIVASERTIB;ESR2;Gene;PA166328761;Chemical
INAVOLISIB;ESR2;Gene;PA166400101;Chemical
BREAST NEOPLASMS;ESR2;Gene;PA443560;Disease
PANCREATIC NEOPLASMS;ESR2;Gene;PA445218;Disease
ANASTROZOLE;ESR2;Gene;PA448432;Chemical
DOCETAXEL;ESR2;Gene;PA449383;Chemical
EXEMESTANE;ESR2;Gene;PA449563;Chemical
GEMCITABINE;ESR2;Gene;PA449748;Chemical
LETROZOLE;ESR2;Gene;PA450196;Chemical
MEDROXYPROGESTERONE;ESR2;Gene;PA450344;Chemical
RALOXIFENE;ESR2;Gene;PA451221;Chemical
TAMOXIFEN;ESR2;Gene;PA451581;Chemical
TOREMIFENE;ESR2;Gene;PA451731;Chemical
TRASTUZUMAB;ESR2;Gene;PA451743;Chemical
ALGLUCOSIDASE ALFA;GAA;Gene;PA164754753;Chemical
VORICONAZOLE;CYP2C19*30;Haplotype;PA10233;Chemical
NEBIVOLOL;CYP2C19*30;Haplotype;PA151958426;Chemical
6BETA-HYDROXYTESTOSTERONE;CYP2C19*30;Haplotype;PA166318222;Chemical
11A-HYDROXYPROGESTERONE;CYP2C19*30;Haplotype;PA166318342;Chemical
IBUPROFEN;CYP2C19*30;Haplotype;PA449957;Chemical
MEPHENYTOIN;CYP2C19*30;Haplotype;PA450373;Chemical
METHADONE;CYP2C19*30;Haplotype;PA450401;Chemical
OMEPRAZOLE;CYP2C19*30;Haplotype;PA450704;Chemical
HYPERTENSION;CYP4A11;Gene;PA444552;Disease
AMILORIDE;CYP4A11;Gene;PA448368;Chemical
SPIRONOLACTONE;CYP4A11;Gene;PA451483;Chemical
SMALL CELL CARCINOMA;DCBLD1;Gene;PA446661;Disease
CISPLATIN;DCBLD1;Gene;PA449014;Chemical
IRINOTECAN;DCBLD1;Gene;PA450085;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs2233980;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs2233980;Variant;PA445846;Disease
CARBOPLATIN;rs2233980;Variant;PA448803;Chemical
GEMCITABINE;rs2233980;Variant;PA449748;Chemical
FLUOROURACIL;PIGB;Gene;PA128406956;Chemical
BREAST NEOPLASMS;PIGB;Gene;PA443560;Disease
LEUKOPENIA;PIGB;Gene;PA444773;Disease
NEUTROPENIA;PIGB;Gene;PA445113;Disease
CYCLOPHOSPHAMIDE;PIGB;Gene;PA449165;Chemical
EPIRUBICIN;PIGB;Gene;PA449476;Chemical
NFKB1;AKT2;Gene;PA248;Gene
NOS3;AKT2;Gene;PA254;Gene
ELK1;AKT2;Gene;PA27749;Gene
FOS;AKT2;Gene;PA28212;Gene
RELA;AKT2;Gene;PA296;Gene
JUN;AKT2;Gene;PA30006;Gene
MYC;AKT2;Gene;PA31353;Gene
NFKB2;AKT2;Gene;PA31600;Gene
PIK3C2A;AKT2;Gene;PA33304;Gene
PIK3C2B;AKT2;Gene;PA33305;Gene
STAT3;AKT2;Gene;PA337;Gene
STAT5A;AKT2;Gene;PA338;Gene
SP1;AKT2;Gene;PA36042;Gene
STAT1;AKT2;Gene;PA36183;Gene
STAT2;AKT2;Gene;PA36184;Gene
STAT4;AKT2;Gene;PA36185;Gene
STAT5B;AKT2;Gene;PA36186;Gene
G6PD B (REFERENCE);Hemolysis;Disease;PA165947826;Haplotype
G6PD A- 202A_376G;Hemolysis;Disease;PA165947827;Haplotype
G6PD MEDITERRANEAN HAPLOTYPE;Hemolysis;Disease;PA165947830;Haplotype
G6PD MEDITERRANEAN, DALLAS, PANAMA, SASSARI, CAGLIARI, BIRMINGHAM;Hemolysis;Disease;PA166121127;Haplotype
G6PD CANTON, TAIWAN-HAKKA, GIFU-LIKE, AGRIGENTO-LIKE;Hemolysis;Disease;PA166121153;Haplotype
G6PD DEFICIENCY;Hemolysis;Disease;PA166157959;Variant
G6PD;Hemolysis;Disease;PA28469;Gene
ACE INHIBITORS, PLAIN;rs1799722;Variant;PA164712308;Chemical
COUGH;rs1799722;Variant;PA443803;Disease
ESSENTIAL HYPERTENSION;rs1799722;Variant;PA447288;Disease
ATORVASTATIN;rs1799722;Variant;PA448500;Chemical
ENALAPRIL;rs1799722;Variant;PA449456;Chemical
LISINOPRIL;rs1799722;Variant;PA450242;Chemical
IMIDAPRIL;rs1799722;Variant;PA452640;Chemical
RS1045642;Fractures, Bone;Disease;PA166157284;Variant
RS2032582;Fractures, Bone;Disease;PA166157316;Variant
ABCB1;Fractures, Bone;Disease;PA267;Gene
EPILEPSY;rs12782374;Variant;PA444065;Disease
PHENYTOIN;rs12782374;Variant;PA450947;Chemical
RS964184;Hypertriglyceridemia;Disease;PA166154304;Variant
RS2727786;Hypertriglyceridemia;Disease;PA166154383;Variant
RS3135506;Hypertriglyceridemia;Disease;PA166154395;Variant
RS4238001;Hypertriglyceridemia;Disease;PA166154586;Variant
RS489693;Hypertriglyceridemia;Disease;PA166155269;Variant
RS7412;Hypertriglyceridemia;Disease;PA166155341;Variant
RS676210;Hypertriglyceridemia;Disease;PA166155597;Variant
RS2241883;Hypertriglyceridemia;Disease;PA166155674;Variant
RS320;Hypertriglyceridemia;Disease;PA166157538;Variant
RS2230806;Hypertriglyceridemia;Disease;PA166157744;Variant
RS2230808;Hypertriglyceridemia;Disease;PA166157745;Variant
LPL;Hypertriglyceridemia;Disease;PA232;Gene
ABCA1;Hypertriglyceridemia;Disease;PA24373;Gene
APOA5;Hypertriglyceridemia;Disease;PA24888;Gene
FABP1;Hypertriglyceridemia;Disease;PA27956;Gene
MC4R;Hypertriglyceridemia;Disease;PA30676;Gene
APOA1;Hypertriglyceridemia;Disease;PA49;Gene
APOB;Hypertriglyceridemia;Disease;PA50;Gene
APOE;Hypertriglyceridemia;Disease;PA55;Gene
SCARB1;Hypertriglyceridemia;Disease;PA97;Gene
RHEUMATOID ARTHRITIS;rs4982133;Variant;PA443434;Disease
METHOTREXATE;rs4982133;Variant;PA450428;Chemical
RS130060;dihydroergotamine;Chemical;PA166184004;Variant
HTR1B;dihydroergotamine;Chemical;PA29549;Gene
DRUGS USED IN NICOTINE DEPENDENCE;rs1051730;Variant;PA164712720;Chemical
OPIUM ALKALOIDS AND DERIVATIVES;rs1051730;Variant;PA164712950;Chemical
PREGNANCY;rs1051730;Variant;PA166048714;Disease
ALCOHOL ABUSE;rs1051730;Variant;PA443309;Disease
PAIN;rs1051730;Variant;PA445208;Disease
TOBACCO USE DISORDER;rs1051730;Variant;PA445876;Disease
ETHANOL;rs1051730;Variant;PA448073;Chemical
NICOTINE;rs1051730;Variant;PA450626;Chemical
GEFITINIB;CYP2D6*90;Haplotype;PA131301952;Chemical
ATOMOXETINE;CYP2D6*90;Haplotype;PA134688071;Chemical
TOLTERODINE;CYP2D6*90;Haplotype;PA164746757;Chemical
BUFURALOL;CYP2D6*90;Haplotype;PA166110256;Chemical
DAPOXETINE;CYP2D6*90;Haplotype;PA166151992;Chemical
AMITRIPTYLINE;CYP2D6*90;Haplotype;PA448385;Chemical
CITALOPRAM;CYP2D6*90;Haplotype;PA449015;Chemical
DEXTROMETHORPHAN;CYP2D6*90;Haplotype;PA449273;Chemical
METHADONE;CYP2D6*90;Haplotype;PA450401;Chemical
OLANZAPINE;CYP2D6*90;Haplotype;PA450688;Chemical
RISPERIDONE;CYP2D6*90;Haplotype;PA451257;Chemical
TAMOXIFEN;CYP2D6*90;Haplotype;PA451581;Chemical
VENLAFAXINE;CYP2D6*90;Haplotype;PA451866;Chemical
DEXTROMETHORPHAN;CYP2D6*100;Haplotype;PA449273;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-C*04:03;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-C*04:03;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-C*04:03;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-C*04:03;Haplotype;PA450616;Chemical
ANKS1B;methamphetamine;Chemical;PA128394692;Gene
DAOA;methamphetamine;Chemical;PA134924986;Gene
ESR1;methamphetamine;Chemical;PA156;Gene
RS324420;methamphetamine;Chemical;PA166153569;Variant
RS6265;methamphetamine;Chemical;PA166154259;Variant
RS778293;methamphetamine;Chemical;PA166154684;Variant
RS1045280;methamphetamine;Chemical;PA166155174;Variant
RS2036657;methamphetamine;Chemical;PA166155198;Variant
RS4790694;methamphetamine;Chemical;PA166155223;Variant
RS713729;methamphetamine;Chemical;PA166156054;Variant
RS2076369;methamphetamine;Chemical;PA166156086;Variant
RS6280;methamphetamine;Chemical;PA166156277;Variant
RS878567;methamphetamine;Chemical;PA166156743;Variant
RS2075572;methamphetamine;Chemical;PA166157015;Variant
RS2234693;methamphetamine;Chemical;PA166157026;Variant
RS2619538;methamphetamine;Chemical;PA166157043;Variant
RS3213207;methamphetamine;Chemical;PA166157074;Variant
RS1126442;methamphetamine;Chemical;PA166157720;Variant
RS2133896;methamphetamine;Chemical;PA166200161;Variant
HTR1A;methamphetamine;Chemical;PA192;Gene
DRD3;methamphetamine;Chemical;PA27479;Gene
DTNBP1;methamphetamine;Chemical;PA27512;Gene
FAAH;methamphetamine;Chemical;PA27955;Gene
GRIN1;methamphetamine;Chemical;PA28978;Gene
BDNF;methamphetamine;Chemical;PA31891;Gene
OPRM1;methamphetamine;Chemical;PA31945;Gene
PICK1;methamphetamine;Chemical;PA33760;Gene
ARRB2;methamphetamine;Chemical;PA60;Gene
PANCREATIC NEOPLASMS;rs1760217;Variant;PA445218;Disease
ANTINEOPLASTIC AGENTS;rs1760217;Variant;PA452621;Chemical
HLA-A*32:01;vancomycin;Chemical;PA165954097;Haplotype
RS2789047;vancomycin;Chemical;PA166157049;Variant
HLA-A;vancomycin;Chemical;PA35055;Gene
CARBOCISTEINE;rs76394784;Variant;PA166184060;Chemical
L-PHENYLALANINE;rs76394784;Variant;PA450931;Chemical
CFTR;rs397508436;Variant;PA109;Gene
IVACAFTOR;rs397508436;Variant;PA165950341;Chemical
GEFITINIB;CYP2D6*92;Haplotype;PA131301952;Chemical
ATOMOXETINE;CYP2D6*92;Haplotype;PA134688071;Chemical
TOLTERODINE;CYP2D6*92;Haplotype;PA164746757;Chemical
BUFURALOL;CYP2D6*92;Haplotype;PA166110256;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CYP2D6*92;Haplotype;PA447197;Disease
DEXTROMETHORPHAN;CYP2D6*92;Haplotype;PA449273;Chemical
FLUOXETINE;CYP2D6*92;Haplotype;PA449673;Chemical
OLANZAPINE;CYP2D6*92;Haplotype;PA450688;Chemical
MTHFR;Pregnancy Complications;Disease;PA245;Gene
BUFURALOL;CYP2D6*72;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*72;Haplotype;PA166127651;Chemical
DEXTROMETHORPHAN;CYP2D6*72;Haplotype;PA449273;Chemical
PRIMAQUINE;CYP2D6*72;Haplotype;PA451103;Chemical
SLC30A8;insulin recombinant;Chemical;PA134915546;Gene
RS13266634;insulin recombinant;Chemical;PA166157645;Variant
G6PD B (REFERENCE);dimercaprol;Chemical;PA165947826;Haplotype
G6PD A- 202A_376G;dimercaprol;Chemical;PA165947827;Haplotype
G6PD;dimercaprol;Chemical;PA28469;Gene
NUDT15;thioguanine;Chemical;PA134963132;Gene
LINC00251;thioguanine;Chemical;PA165585763;Gene
TPMT*1;thioguanine;Chemical;PA165819268;Haplotype
TPMT*2;thioguanine;Chemical;PA165819269;Haplotype
TPMT*3A;thioguanine;Chemical;PA165819270;Haplotype
TPMT*3B;thioguanine;Chemical;PA165819271;Haplotype
TPMT*3C;thioguanine;Chemical;PA165819272;Haplotype
TPMT*4;thioguanine;Chemical;PA165819274;Haplotype
TPMT*5;thioguanine;Chemical;PA165819275;Haplotype
TPMT*6;thioguanine;Chemical;PA165819276;Haplotype
TPMT*7;thioguanine;Chemical;PA165819277;Haplotype
TPMT*8;thioguanine;Chemical;PA165819278;Haplotype
TPMT*9;thioguanine;Chemical;PA165819279;Haplotype
TPMT*10;thioguanine;Chemical;PA165819280;Haplotype
TPMT*11;thioguanine;Chemical;PA165819281;Haplotype
TPMT*12;thioguanine;Chemical;PA165819282;Haplotype
TPMT*13;thioguanine;Chemical;PA165819283;Haplotype
TPMT*14;thioguanine;Chemical;PA165819284;Haplotype
TPMT*15;thioguanine;Chemical;PA165819285;Haplotype
TPMT*16;thioguanine;Chemical;PA165819286;Haplotype
TPMT*17;thioguanine;Chemical;PA165819287;Haplotype
TPMT*18;thioguanine;Chemical;PA165819288;Haplotype
TPMT*20;thioguanine;Chemical;PA165819290;Haplotype
TPMT*21;thioguanine;Chemical;PA165819291;Haplotype
TPMT*22;thioguanine;Chemical;PA165819292;Haplotype
TPMT*23;thioguanine;Chemical;PA165819293;Haplotype
NAT1*4;thioguanine;Chemical;PA165958462;Haplotype
NAT1*3;thioguanine;Chemical;PA165958463;Haplotype
NAT1*10;thioguanine;Chemical;PA165958465;Haplotype
TPMT*19;thioguanine;Chemical;PA166005216;Haplotype
TPMT*27;thioguanine;Chemical;PA166005218;Haplotype
TPMT*30;thioguanine;Chemical;PA166005221;Haplotype
TPMT*32;thioguanine;Chemical;PA166005223;Haplotype
TPMT*33;thioguanine;Chemical;PA166005224;Haplotype
TPMT*34;thioguanine;Chemical;PA166005225;Haplotype
RS1891059;thioguanine;Chemical;PA166153658;Variant
RS17021408;thioguanine;Chemical;PA166153867;Variant
RS80223967;thioguanine;Chemical;PA166153915;Variant
RS3824662;thioguanine;Chemical;PA166154043;Variant
RS116855232;thioguanine;Chemical;PA166154759;Variant
RS79085477;thioguanine;Chemical;PA166155968;Variant
RS117532069;thioguanine;Chemical;PA166155970;Variant
RS141059755;thioguanine;Chemical;PA166157691;Variant
RS746071566;thioguanine;Chemical;PA166165231;Variant
RS11969064;thioguanine;Chemical;PA166184136;Variant
RS12283870;thioguanine;Chemical;PA166285621;Variant
NAT1;thioguanine;Chemical;PA17;Gene
BMP7;thioguanine;Chemical;PA25384;Gene
DOK5;thioguanine;Chemical;PA25724;Gene
CPT1A;thioguanine;Chemical;PA26847;Gene
GATA3;thioguanine;Chemical;PA28586;Gene
IGHMBP2;thioguanine;Chemical;PA29731;Gene
TPMT;thioguanine;Chemical;PA356;Gene
ANTHRACYCLINES AND RELATED SUBSTANCES;rs11155012;Variant;PA130620651;Chemical
BREAST NEOPLASMS;rs11155012;Variant;PA443560;Disease
COMT;Migraine with Aura;Disease;PA117;Gene
ACE;Migraine with Aura;Disease;PA139;Gene
RS1799752;Migraine with Aura;Disease;PA166155187;Variant
RS4680;Migraine with Aura;Disease;PA166156024;Variant
RS1801394;Migraine with Aura;Disease;PA166156776;Variant
RS1045642;Migraine with Aura;Disease;PA166157284;Variant
RS1799983;Migraine with Aura;Disease;PA166157303;Variant
RS12615320;Migraine with Aura;Disease;PA166349381;Variant
NOS3;Migraine with Aura;Disease;PA254;Gene
ABCB1;Migraine with Aura;Disease;PA267;Gene
MTRR;Migraine with Aura;Disease;PA31277;Gene
HEART VALVE REPLACEMENT;CYP2C9*14;Haplotype;PA166123431;Disease
ATRIAL FIBRILLATION;CYP2C9*14;Haplotype;PA443459;Disease
EPILEPSY;CYP2C9*14;Haplotype;PA444065;Disease
PHENYTOIN;CYP2C9*14;Haplotype;PA450947;Chemical
WARFARIN;CYP2C9*14;Haplotype;PA451906;Chemical
PRASUGREL;rs3737224;Variant;PA154410481;Chemical
PLCH1;PRKCH;Gene;PA128394595;Gene
PLCZ1;PRKCH;Gene;PA134875646;Gene
PLCH2;PRKCH;Gene;PA134914471;Gene
PLCB1;PRKCH;Gene;PA33384;Gene
PLCB2;PRKCH;Gene;PA33385;Gene
PLCB3;PRKCH;Gene;PA33386;Gene
PLCB4;PRKCH;Gene;PA33387;Gene
PLCD1;PRKCH;Gene;PA33388;Gene
PLCD3;PRKCH;Gene;PA33389;Gene
PLCD4;PRKCH;Gene;PA33390;Gene
PLCE1;PRKCH;Gene;PA33391;Gene
PLCG1;PRKCH;Gene;PA33392;Gene
PLCG2;PRKCH;Gene;PA33393;Gene
PLCL1;PRKCH;Gene;PA33394;Gene
PLCL2;PRKCH;Gene;PA33395;Gene
RAF1;PRKCH;Gene;PA34183;Gene
ADRB2;PRKCH;Gene;PA39;Gene
PLATINUM COMPOUNDS;rs1829346;Variant;PA164713176;Chemical
RADIOTHERAPY;rs1829346;Variant;PA166122986;Chemical
NASOPHARYNGEAL NEOPLASMS;rs1829346;Variant;PA445046;Disease
FLUOROURACIL;CYP2A6*1;Haplotype;PA128406956;Chemical
OXALIPLATIN;CYP2A6*1;Haplotype;PA131285527;Chemical
COUMARIN;CYP2A6*1;Haplotype;PA134521193;Chemical
COTININE;CYP2A6*1;Haplotype;PA166114414;Chemical
TEGAFUR / GIMERACIL / OTERACIL;CYP2A6*1;Haplotype;PA166115442;Chemical
PROGRESSION-FREE SURVIVAL;CYP2A6*1;Haplotype;PA166123026;Disease
CESSATION;CYP2A6*1;Haplotype;PA166123046;Disease
OVERALL SURVIVAL;CYP2A6*1;Haplotype;PA166123207;Disease
BILIARY TRACT NEOPLASMS;CYP2A6*1;Haplotype;PA166128807;Disease
3-HYDROXYCOTININE;CYP2A6*1;Haplotype;PA166131262;Chemical
BREAST NEOPLASMS;CYP2A6*1;Haplotype;PA443560;Disease
CARCINOMA, NON-SMALL-CELL LUNG;CYP2A6*1;Haplotype;PA443622;Disease
EPILEPSY;CYP2A6*1;Haplotype;PA444065;Disease
NEOPLASMS;CYP2A6*1;Haplotype;PA445062;Disease
STOMACH NEOPLASMS;CYP2A6*1;Haplotype;PA445742;Disease
TOBACCO USE DISORDER;CYP2A6*1;Haplotype;PA445876;Disease
COLORECTAL NEOPLASMS;CYP2A6*1;Haplotype;PA446108;Disease
CAFFEINE;CYP2A6*1;Haplotype;PA448710;Chemical
DOCETAXEL;CYP2A6*1;Haplotype;PA449383;Chemical
IRINOTECAN;CYP2A6*1;Haplotype;PA450085;Chemical
LETROZOLE;CYP2A6*1;Haplotype;PA450196;Chemical
METHOXSALEN;CYP2A6*1;Haplotype;PA450433;Chemical
METRONIDAZOLE;CYP2A6*1;Haplotype;PA450484;Chemical
NICOTINE;CYP2A6*1;Haplotype;PA450626;Chemical
VALPROIC ACID;CYP2A6*1;Haplotype;PA451846;Chemical
TEGAFUR;CYP2A6*1;Haplotype;PA452620;Chemical
DESFLURANE;rs1800559;Variant;PA164749136;Chemical
RYR1;rs1800559;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs1800559;Variant;PA444863;Disease
ENFLURANE;rs1800559;Variant;PA449461;Chemical
HALOTHANE;rs1800559;Variant;PA449845;Chemical
ISOFLURANE;rs1800559;Variant;PA450106;Chemical
METHOXYFLURANE;rs1800559;Variant;PA450434;Chemical
SEVOFLURANE;rs1800559;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs1800559;Variant;PA451522;Chemical
CACNA1S;rs1800559;Variant;PA85;Gene
PREGNANCY;CYP1A2 low activity;Variant;PA166048714;Disease
CAFFEINE;CYP1A2 low activity;Variant;PA448710;Chemical
TOCILIZUMAB;IL6R;Gene;PA165292659;Chemical
SATRALIZUMAB;IL6R;Gene;PA166235323;Chemical
RHEUMATOID ARTHRITIS;IL6R;Gene;PA443434;Disease
DULOXETINE;rs61908403;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs61908403;Variant;PA447321;Disease
CYP2D6;vernakalant;Chemical;PA128;Gene
SCN5A;non-selective monoamine reuptake inhibitors;Chemical;PA304;Gene
FENOFIBRATE;rs135543;Variant;PA449594;Chemical
BIPOLAR DISORDER;LSAMP;Gene;PA447199;Disease
RS267606618;amikacin;Chemical;PA166158908;Variant
RS267606619;amikacin;Chemical;PA166158909;Variant
RS267606617;amikacin;Chemical;PA166159181;Variant
MT-RNR1;amikacin;Chemical;PA31274;Gene
IFNL4;sustained virological response (svr);Disease;PA166049147;Gene
RS11322783;sustained virological response (svr);Disease;PA166190881;Variant
SUBSTANCE-RELATED DISORDERS;rs1890881;Variant;PA446876;Disease
DESFLURANE;rs193922809;Variant;PA164749136;Chemical
RYR1;rs193922809;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs193922809;Variant;PA444863;Disease
ENFLURANE;rs193922809;Variant;PA449461;Chemical
HALOTHANE;rs193922809;Variant;PA449845;Chemical
ISOFLURANE;rs193922809;Variant;PA450106;Chemical
METHOXYFLURANE;rs193922809;Variant;PA450434;Chemical
SEVOFLURANE;rs193922809;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs193922809;Variant;PA451522;Chemical
CACNA1S;rs193922809;Variant;PA85;Gene
NIFEDIPINE;rs55817950;Variant;PA450631;Chemical
TESTOSTERONE;rs55817950;Variant;PA451627;Chemical
EZH2;DAB2IP;Gene;PA27939;Gene
HMG COA REDUCTASE INHIBITORS;HMGCR;Gene;PA133950441;Chemical
ROSUVASTATIN;HMGCR;Gene;PA134308647;Chemical
PITAVASTATIN;HMGCR;Gene;PA142650384;Chemical
PRKAA1;HMGCR;Gene;PA33744;Gene
PRKAA2;HMGCR;Gene;PA33745;Gene
PRKAB1;HMGCR;Gene;PA33746;Gene
PRKAB2;HMGCR;Gene;PA33747;Gene
PRKAG1;HMGCR;Gene;PA33751;Gene
PRKAG2;HMGCR;Gene;PA33752;Gene
PRKAG3;HMGCR;Gene;PA33753;Gene
CARDIOVASCULAR DISEASE;HMGCR;Gene;PA443635;Disease
COLONIC NEOPLASMS;HMGCR;Gene;PA443756;Disease
HYPERCHOLESTEROLEMIA;HMGCR;Gene;PA444516;Disease
ATORVASTATIN;HMGCR;Gene;PA448500;Chemical
FLUVASTATIN;HMGCR;Gene;PA449688;Chemical
LOVASTATIN;HMGCR;Gene;PA450272;Chemical
PRAVASTATIN;HMGCR;Gene;PA451089;Chemical
SIMVASTATIN;HMGCR;Gene;PA451363;Chemical
FRUCTOSE;KHK;Gene;PA449716;Chemical
ASTHMA;rs9552679;Variant;PA443450;Disease
SALBUTAMOL;rs9552679;Variant;PA448068;Chemical
CETUXIMAB;rs712829;Variant;PA10040;Chemical
GEFITINIB;rs712829;Variant;PA131301952;Chemical
ERLOTINIB;rs712829;Variant;PA134687924;Chemical
TOPOISOMERASE I INHIBITORS;rs712829;Variant;PA150481186;Chemical
GELDANAMYCIN;rs712829;Variant;PA152031327;Chemical
EGFR INHIBITORS;rs712829;Variant;PA153561371;Chemical
PANITUMUMAB;rs712829;Variant;PA162373091;Chemical
ALKYLATING AGENTS;rs712829;Variant;PA164712331;Chemical
NEOPLASMS;rs712829;Variant;PA445062;Disease
COLORECTAL NEOPLASMS;rs712829;Variant;PA446108;Disease
IRINOTECAN;rs712829;Variant;PA450085;Chemical
MAFA;MAPK8;Gene;PA134963361;Gene
JDP2;MAPK8;Gene;PA162392499;Gene
NFKB1;MAPK8;Gene;PA248;Gene
ATF2;MAPK8;Gene;PA25084;Gene
ATF3;MAPK8;Gene;PA25085;Gene
BATF;MAPK8;Gene;PA25268;Gene
ELK1;MAPK8;Gene;PA27749;Gene
FOS;MAPK8;Gene;PA28212;Gene
FOSB;MAPK8;Gene;PA28213;Gene
FOSL1;MAPK8;Gene;PA28214;Gene
FOSL2;MAPK8;Gene;PA28215;Gene
MAP2K7;MAPK8;Gene;PA284;Gene
RELA;MAPK8;Gene;PA296;Gene
JUN;MAPK8;Gene;PA30006;Gene
JUNB;MAPK8;Gene;PA30007;Gene
JUND;MAPK8;Gene;PA30008;Gene
MAF;MAPK8;Gene;PA30534;Gene
MAFB;MAPK8;Gene;PA30535;Gene
MAFF;MAPK8;Gene;PA30538;Gene
MAFG;MAPK8;Gene;PA30539;Gene
MAFK;MAPK8;Gene;PA30540;Gene
MAP2K1;MAPK8;Gene;PA30584;Gene
MAP2K2;MAPK8;Gene;PA30587;Gene
MAP2K3;MAPK8;Gene;PA30588;Gene
MAP2K4;MAPK8;Gene;PA30589;Gene
MAP2K5;MAPK8;Gene;PA30590;Gene
MAP2K6;MAPK8;Gene;PA30591;Gene
MYC;MAPK8;Gene;PA31353;Gene
NFKB2;MAPK8;Gene;PA31600;Gene
NRL;MAPK8;Gene;PA31781;Gene
STAT3;MAPK8;Gene;PA337;Gene
STAT5A;MAPK8;Gene;PA338;Gene
SP1;MAPK8;Gene;PA36042;Gene
STAT1;MAPK8;Gene;PA36183;Gene
STAT2;MAPK8;Gene;PA36184;Gene
STAT4;MAPK8;Gene;PA36185;Gene
STAT5B;MAPK8;Gene;PA36186;Gene
SORAFENIB;MAPK8;Gene;PA7000;Chemical
SLCO1B1;Glucarpidase;Chemical;PA134865839;Gene
ARID5B;Glucarpidase;Chemical;PA134943193;Gene
RS3824662;Glucarpidase;Chemical;PA166154043;Variant
RS10821936;Glucarpidase;Chemical;PA166154117;Variant
RS4149056;Glucarpidase;Chemical;PA166154579;Variant
RS7317112;Glucarpidase;Chemical;PA166154718;Variant
RS9345389;Glucarpidase;Chemical;PA166157144;Variant
RS10908521;Glucarpidase;Chemical;PA166266702;Variant
RS1353327;Glucarpidase;Chemical;PA166266704;Variant
GATA3;Glucarpidase;Chemical;PA28586;Gene
INSRR;Glucarpidase;Chemical;PA29899;Gene
NTRK1;Glucarpidase;Chemical;PA31817;Gene
ABCC4;Glucarpidase;Chemical;PA397;Gene
HEROIN DEPENDENCE;rs4358872;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs4358872;Variant;PA445043;Disease
METHADONE;rs4358872;Variant;PA450401;Chemical
AKT1;PIK3R5;Gene;PA24684;Gene
AKT3;PIK3R5;Gene;PA24686;Gene
HRH2;PIK3R5;Gene;PA29457;Gene
HYPERTENSION;PIK3R5;Gene;PA444552;Disease
SORAFENIB;PIK3R5;Gene;PA7000;Chemical
MAJOR DEPRESSIVE DISORDER;rs889895;Variant;PA447321;Disease
ANTIDEPRESSANTS;rs889895;Variant;PA452229;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;rs408626;Variant;PA446155;Disease
METHOTREXATE;rs408626;Variant;PA450428;Chemical
CYP3A4;Carcinoma, Small Cell;Disease;PA130;Gene
DCBLD1;Carcinoma, Small Cell;Disease;PA134903108;Gene
RS16950650;Carcinoma, Small Cell;Disease;PA166154751;Variant
RS17574269;Carcinoma, Small Cell;Disease;PA166157193;Variant
ABCC4;Carcinoma, Small Cell;Disease;PA397;Gene
ETHAMBUTOL;rs1041983;Variant;PA164784021;Chemical
TOXIC LIVER DISEASE;rs1041983;Variant;PA164925725;Disease
DRUG INTERACTION WITH DRUG;rs1041983;Variant;PA165108622;Disease
DRUG TOXICITY;rs1041983;Variant;PA443937;Disease
TUBERCULOSIS;rs1041983;Variant;PA445941;Disease
ISONIAZID;rs1041983;Variant;PA450112;Chemical
PHENYTOIN;rs1041983;Variant;PA450947;Chemical
PYRAZINAMIDE;rs1041983;Variant;PA451182;Chemical
RIFAMPIN;rs1041983;Variant;PA451250;Chemical
DRUG TOXICITY;rs4035887;Variant;PA443937;Disease
SORAFENIB;rs4035887;Variant;PA7000;Chemical
LEUKOPENIA;CYP2C9 poor metabolizer;Variant;PA444773;Disease
VASCULITIS;CYP2C9 poor metabolizer;Variant;PA446023;Disease
WEGENER GRANULOMATOSIS;CYP2C9 poor metabolizer;Variant;PA446065;Disease
CYCLOPHOSPHAMIDE;CYP2C9 poor metabolizer;Variant;PA449165;Chemical
CYP2D6;Burns;Disease;PA128;Gene
CYP2D6*1;Burns;Disease;PA165816576;Haplotype
G6PD A- 202A_376G;Burns;Disease;PA165947827;Haplotype
CYP2D6*9;Burns;Disease;PA165948317;Haplotype
CYP2D6*29;Burns;Disease;PA165948318;Haplotype
G6PD;Burns;Disease;PA28469;Gene
KMT2A;revumenib;Chemical;PA241;Gene
ASTHMA;rs17701271;Variant;PA443450;Disease
SALBUTAMOL;rs17701271;Variant;PA448068;Chemical
F2R;GNA11;Gene;PA27946;Gene
F2RL3;GNA11;Gene;PA27949;Gene
P2RY1;GNA11;Gene;PA32868;Gene
PLCB1;GNA11;Gene;PA33384;Gene
PLCG2;GNA11;Gene;PA33393;Gene
TBXA2R;GNA11;Gene;PA348;Gene
MELANOMA;GNA11;Gene;PA444903;Disease
COTININE;CHRNB4;Gene;PA166114414;Chemical
TOBACCO USE DISORDER;CHRNB4;Gene;PA445876;Disease
NICOTINE;CHRNB4;Gene;PA450626;Chemical
RS61764370;panitumumab;Chemical;PA166154658;Variant
RS1353295;panitumumab;Chemical;PA166156509;Variant
RS9996584;panitumumab;Chemical;PA166156635;Variant
RS11942466;panitumumab;Chemical;PA166156656;Variant
RS13104811;panitumumab;Chemical;PA166156663;Variant
RS712829;panitumumab;Chemical;PA166157262;Variant
AREG;panitumumab;Chemical;PA24933;Gene
BTC;panitumumab;Chemical;PA25442;Gene
HBEGF;panitumumab;Chemical;PA27513;Gene
EGF;panitumumab;Chemical;PA27664;Gene
EREG;panitumumab;Chemical;PA27856;Gene
KRAS;panitumumab;Chemical;PA30196;Gene
NRAS;panitumumab;Chemical;PA31768;Gene
NRG1;panitumumab;Chemical;PA31776;Gene
NRG2;panitumumab;Chemical;PA31777;Gene
NRG3;panitumumab;Chemical;PA31778;Gene
TGFA;panitumumab;Chemical;PA36480;Gene
EGFR;panitumumab;Chemical;PA7360;Gene
HYPERLIPIDEMIAS;rs662799;Variant;PA444528;Disease
ATORVASTATIN;rs662799;Variant;PA448500;Chemical
LOVASTATIN;rs662799;Variant;PA450272;Chemical
SIMVASTATIN;rs662799;Variant;PA451363;Chemical
CYP4F2;db-289;Chemical;PA27121;Gene
NFKB1;CAMK1D;Gene;PA248;Gene
ELK1;CAMK1D;Gene;PA27749;Gene
FOS;CAMK1D;Gene;PA28212;Gene
RELA;CAMK1D;Gene;PA296;Gene
JUN;CAMK1D;Gene;PA30006;Gene
MYC;CAMK1D;Gene;PA31353;Gene
NFKB2;CAMK1D;Gene;PA31600;Gene
STAT3;CAMK1D;Gene;PA337;Gene
STAT5A;CAMK1D;Gene;PA338;Gene
SP1;CAMK1D;Gene;PA36042;Gene
STAT1;CAMK1D;Gene;PA36183;Gene
STAT2;CAMK1D;Gene;PA36184;Gene
STAT4;CAMK1D;Gene;PA36185;Gene
STAT5B;CAMK1D;Gene;PA36186;Gene
ESSENTIAL HYPERTENSION;CAMK1D;Gene;PA447288;Disease
LOSARTAN;CAMK1D;Gene;PA450268;Chemical
URINARY BLADDER NEOPLASMS;RARS1;Gene;PA443512;Disease
CISPLATIN;RARS1;Gene;PA449014;Chemical
DPYD;rs147545709;Variant;PA145;Gene
CAPECITABINE;rs147545709;Variant;PA448771;Chemical
CYP2D6;fesoterodine;Chemical;PA128;Gene
CYP3A4;fesoterodine;Chemical;PA130;Gene
CYP3A4*1;fesoterodine;Chemical;PA165819201;Haplotype
CYP3A4*3;fesoterodine;Chemical;PA165819221;Haplotype
CYP3A4*20;fesoterodine;Chemical;PA165819244;Haplotype
CYP3A4*22;fesoterodine;Chemical;PA166048680;Haplotype
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;rs4379368;Variant;PA452637;Chemical
WARFARIN;CYP4F11;Gene;PA451906;Chemical
KIDNEY TRANSPLANTATION;rs5030952;Variant;PA165817016;Disease
TACROLIMUS;rs5030952;Variant;PA451578;Chemical
NEOPLASMS;rs183484;Variant;PA445062;Disease
GEMCITABINE;rs183484;Variant;PA449748;Chemical
ROSUVASTATIN;SLCO1B1*37;Haplotype;PA134308647;Chemical
PITAVASTATIN;SLCO1B1*37;Haplotype;PA142650384;Chemical
ATRASENTAN;SLCO1B1*37;Haplotype;PA143414738;Chemical
OLMESARTAN;SLCO1B1*37;Haplotype;PA164742950;Chemical
HYPERCHOLESTEROLEMIA;SLCO1B1*37;Haplotype;PA444516;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;SLCO1B1*37;Haplotype;PA446155;Disease
ATORVASTATIN;SLCO1B1*37;Haplotype;PA448500;Chemical
METHOTREXATE;SLCO1B1*37;Haplotype;PA450428;Chemical
PRAVASTATIN;SLCO1B1*37;Haplotype;PA451089;Chemical
REPAGLINIDE;SLCO1B1*37;Haplotype;PA451234;Chemical
RS1042713;ephedrine;Chemical;PA166156748;Variant
ADRB2;ephedrine;Chemical;PA39;Gene
RHEUMATOID ARTHRITIS;SPECC1L;Gene;PA443434;Disease
METHOTREXATE;SPECC1L;Gene;PA450428;Chemical
GEMTUZUMAB OZOGAMICIN;rs2070673;Variant;PA164749431;Chemical
LEUKEMIA, MYELOID, ACUTE;rs2070673;Variant;PA444760;Disease
CYTARABINE;rs2070673;Variant;PA449177;Chemical
FLUDARABINE;rs2070673;Variant;PA449655;Chemical
IDARUBICIN;rs2070673;Variant;PA449961;Chemical
CAMK1D;FOS;Gene;PA134992438;Gene
AKT1;FOS;Gene;PA24684;Gene
AKT2;FOS;Gene;PA24685;Gene
AKT3;FOS;Gene;PA24686;Gene
CAMK1;FOS;Gene;PA26048;Gene
CAMK1G;FOS;Gene;PA26049;Gene
MAPK8;FOS;Gene;PA283;Gene
MAPK1;FOS;Gene;PA30616;Gene
MAPK14;FOS;Gene;PA30621;Gene
MAPK3;FOS;Gene;PA30622;Gene
STAT3;FOS;Gene;PA337;Gene
PRKCA;FOS;Gene;PA33759;Gene
PRKCB;FOS;Gene;PA33761;Gene
PRKCG;FOS;Gene;PA33766;Gene
STAT5A;FOS;Gene;PA338;Gene
STAT1;FOS;Gene;PA36183;Gene
STAT2;FOS;Gene;PA36184;Gene
STAT4;FOS;Gene;PA36185;Gene
STAT5B;FOS;Gene;PA36186;Gene
CAMK2A;FOS;Gene;PA90;Gene
CAMK2B;FOS;Gene;PA91;Gene
CAMK2D;FOS;Gene;PA92;Gene
CAMK2G;FOS;Gene;PA93;Gene
ABCC2;Arthritis, Rheumatoid;Disease;PA116;Gene
CYP2C19;Arthritis, Rheumatoid;Disease;PA124;Gene
CYP3A5;Arthritis, Rheumatoid;Disease;PA131;Gene
MOB3B;Arthritis, Rheumatoid;Disease;PA134886513;Gene
PLB1;Arthritis, Rheumatoid;Disease;PA134891309;Gene
ENOSF1;Arthritis, Rheumatoid;Disease;PA134897613;Gene
C9ORF72;Arthritis, Rheumatoid;Disease;PA134908144;Gene
CERS6;Arthritis, Rheumatoid;Disease;PA134925480;Gene
GALNT18;Arthritis, Rheumatoid;Disease;PA134950929;Gene
C18ORF56;Arthritis, Rheumatoid;Disease;PA134956204;Gene
GBP6;Arthritis, Rheumatoid;Disease;PA134964409;Gene
DHFR;Arthritis, Rheumatoid;Disease;PA143;Gene
FASTKD3;Arthritis, Rheumatoid;Disease;PA145148868;Gene
ESR1;Arthritis, Rheumatoid;Disease;PA156;Gene
ARAP2;Arthritis, Rheumatoid;Disease;PA164715938;Gene
SPECC1L;Arthritis, Rheumatoid;Disease;PA164718673;Gene
ADORA2A-AS1;Arthritis, Rheumatoid;Disease;PA165378332;Gene
CYP2C19*17;Arthritis, Rheumatoid;Disease;PA165816533;Haplotype
TPMT*1;Arthritis, Rheumatoid;Disease;PA165819268;Haplotype
TPMT*3A;Arthritis, Rheumatoid;Disease;PA165819270;Haplotype
HLA-DRB1*04:01;Arthritis, Rheumatoid;Disease;PA165951493;Haplotype
HLA-DRB1*08:02;Arthritis, Rheumatoid;Disease;PA165951674;Haplotype
HLA-DQB1*04:02;Arthritis, Rheumatoid;Disease;PA165958226;Haplotype
CYP2C19*1;Arthritis, Rheumatoid;Disease;PA165980634;Haplotype
CYP2C19*2;Arthritis, Rheumatoid;Disease;PA165980635;Haplotype
CYP3A5*1;Arthritis, Rheumatoid;Disease;PA166128213;Haplotype
CYP3A5*3;Arthritis, Rheumatoid;Disease;PA166128219;Haplotype
RS3397;Arthritis, Rheumatoid;Disease;PA166153542;Variant
RS396991;Arthritis, Rheumatoid;Disease;PA166153571;Variant
RS928655;Arthritis, Rheumatoid;Disease;PA166153600;Variant
RS983332;Arthritis, Rheumatoid;Disease;PA166153605;Variant
RS1061622;Arthritis, Rheumatoid;Disease;PA166153618;Variant
RS1061631;Arthritis, Rheumatoid;Disease;PA166153620;Variant
RS1476413;Arthritis, Rheumatoid;Disease;PA166153631;Variant
RS1801131;Arthritis, Rheumatoid;Disease;PA166153643;Variant
RS1801133;Arthritis, Rheumatoid;Disease;PA166153644;Variant
RS1801274;Arthritis, Rheumatoid;Disease;PA166153652;Variant
RS1805087;Arthritis, Rheumatoid;Disease;PA166153654;Variant
RS4329505;Arthritis, Rheumatoid;Disease;PA166153765;Variant
RS4846051;Arthritis, Rheumatoid;Disease;PA166153777;Variant
RS6427528;Arthritis, Rheumatoid;Disease;PA166153781;Variant
RS10919563;Arthritis, Rheumatoid;Disease;PA166153818;Variant
RS12083537;Arthritis, Rheumatoid;Disease;PA166153848;Variant
RS17421511;Arthritis, Rheumatoid;Disease;PA166153875;Variant
RS17602729;Arthritis, Rheumatoid;Disease;PA166153876;Variant
RS1901633;Arthritis, Rheumatoid;Disease;PA166153982;Variant
RS2273697;Arthritis, Rheumatoid;Disease;PA166154007;Variant
RS11231809;Arthritis, Rheumatoid;Disease;PA166154454;Variant
RS767455;Arthritis, Rheumatoid;Disease;PA166154502;Variant
RS3794271;Arthritis, Rheumatoid;Disease;PA166154566;Variant
RS4982133;Arthritis, Rheumatoid;Disease;PA166154803;Variant
RS762551;Arthritis, Rheumatoid;Disease;PA166154850;Variant
RS1703794;Arthritis, Rheumatoid;Disease;PA166154866;Variant
RS35592;Arthritis, Rheumatoid;Disease;PA166154982;Variant
RS246240;Arthritis, Rheumatoid;Disease;PA166154991;Variant
RS3213422;Arthritis, Rheumatoid;Disease;PA166155048;Variant
RS3784864;Arthritis, Rheumatoid;Disease;PA166155054;Variant
RS2853539;Arthritis, Rheumatoid;Disease;PA166155290;Variant
RS6506569;Arthritis, Rheumatoid;Disease;PA166155301;Variant
RS45445694;Arthritis, Rheumatoid;Disease;PA166155331;Variant
RS1800470;Arthritis, Rheumatoid;Disease;PA166155373;Variant
RS1800471;Arthritis, Rheumatoid;Disease;PA166155374;Variant
RS2372536;Arthritis, Rheumatoid;Disease;PA166155684;Variant
RS4673993;Arthritis, Rheumatoid;Disease;PA166155733;Variant
RS7574865;Arthritis, Rheumatoid;Disease;PA166155766;Variant
RS10197559;Arthritis, Rheumatoid;Disease;PA166155781;Variant
RS13393173;Arthritis, Rheumatoid;Disease;PA166155829;Variant
RS16853826;Arthritis, Rheumatoid;Disease;PA166155836;Variant
RS1059150;Arthritis, Rheumatoid;Disease;PA166155914;Variant
RS1127354;Arthritis, Rheumatoid;Disease;PA166155915;Variant
RS2650972;Arthritis, Rheumatoid;Disease;PA166155929;Variant
RS6028945;Arthritis, Rheumatoid;Disease;PA166155951;Variant
RS6064463;Arthritis, Rheumatoid;Disease;PA166155953;Variant
RS6071980;Arthritis, Rheumatoid;Disease;PA166155954;Variant
RS6138150;Arthritis, Rheumatoid;Disease;PA166155963;Variant
RS1051266;Arthritis, Rheumatoid;Disease;PA166155986;Variant
RS2838956;Arthritis, Rheumatoid;Disease;PA166156004;Variant
RS9977268;Arthritis, Rheumatoid;Disease;PA166156012;Variant
RS2236624;Arthritis, Rheumatoid;Disease;PA166156088;Variant
RS2267076;Arthritis, Rheumatoid;Disease;PA166156091;Variant
RS2298383;Arthritis, Rheumatoid;Disease;PA166156099;Variant
RS3761422;Arthritis, Rheumatoid;Disease;PA166156103;Variant
RS5760410;Arthritis, Rheumatoid;Disease;PA166156121;Variant
RS7624766;Arthritis, Rheumatoid;Disease;PA166156420;Variant
RS437943;Arthritis, Rheumatoid;Disease;PA166156488;Variant
RS2231142;Arthritis, Rheumatoid;Disease;PA166156544;Variant
RS7387;Arthritis, Rheumatoid;Disease;PA166156710;Variant
RS1643650;Arthritis, Rheumatoid;Disease;PA166156768;Variant
RS1801394;Arthritis, Rheumatoid;Disease;PA166156776;Variant
RS1264457;Arthritis, Rheumatoid;Disease;PA166156981;Variant
RS1799724;Arthritis, Rheumatoid;Disease;PA166156988;Variant
RS1800629;Arthritis, Rheumatoid;Disease;PA166156997;Variant
RS2233945;Arthritis, Rheumatoid;Disease;PA166157025;Variant
RS2234693;Arthritis, Rheumatoid;Disease;PA166157026;Variant
RS9340799;Arthritis, Rheumatoid;Disease;PA166157143;Variant
RS10945919;Arthritis, Rheumatoid;Disease;PA166157172;Variant
RS371194629;Arthritis, Rheumatoid;Disease;PA166157235;Variant
RS854547;Arthritis, Rheumatoid;Disease;PA166157269;Variant
RS854548;Arthritis, Rheumatoid;Disease;PA166157270;Variant
RS854555;Arthritis, Rheumatoid;Disease;PA166157272;Variant
RS1045642;Arthritis, Rheumatoid;Disease;PA166157284;Variant
RS1128503;Arthritis, Rheumatoid;Disease;PA166157288;Variant
RS1800795;Arthritis, Rheumatoid;Disease;PA166157304;Variant
RS719235;Arthritis, Rheumatoid;Disease;PA166157548;Variant
RS1800909;Arthritis, Rheumatoid;Disease;PA166157567;Variant
RS3758149;Arthritis, Rheumatoid;Disease;PA166157593;Variant
RS774359;Arthritis, Rheumatoid;Disease;PA166157714;Variant
RS868856;Arthritis, Rheumatoid;Disease;PA166157715;Variant
RS1544105;Arthritis, Rheumatoid;Disease;PA166157731;Variant
RS2814707;Arthritis, Rheumatoid;Disease;PA166157759;Variant
RS3761847;Arthritis, Rheumatoid;Disease;PA166157763;Variant
RS3849942;Arthritis, Rheumatoid;Disease;PA166157768;Variant
RS4986790;Arthritis, Rheumatoid;Disease;PA166157780;Variant
RS7046653;Arthritis, Rheumatoid;Disease;PA166157788;Variant
NAT2 SLOW ACETYLATOR;Arthritis, Rheumatoid;Disease;PA166157948;Variant
RS4910008;Arthritis, Rheumatoid;Disease;PA166159490;Variant
RS11052877;Arthritis, Rheumatoid;Disease;PA166159492;Variant
RS3045983;Arthritis, Rheumatoid;Disease;PA166160497;Variant
RS2302489;Arthritis, Rheumatoid;Disease;PA166160715;Variant
RS7301582;Arthritis, Rheumatoid;Disease;PA166160807;Variant
RS11265618;Arthritis, Rheumatoid;Disease;PA166161950;Variant
RS11280056;Arthritis, Rheumatoid;Disease;PA166180936;Variant
RS1051792;Arthritis, Rheumatoid;Disease;PA166238462;Variant
RS17004921;Arthritis, Rheumatoid;Disease;PA166238642;Variant
RS2292596;Arthritis, Rheumatoid;Disease;PA166271161;Variant
FPGS;Arthritis, Rheumatoid;Disease;PA167;Gene
NAT2;Arthritis, Rheumatoid;Disease;PA18;Gene
IL6;Arthritis, Rheumatoid;Disease;PA198;Gene
ABCC1;Arthritis, Rheumatoid;Disease;PA244;Gene
MTHFR;Arthritis, Rheumatoid;Disease;PA245;Gene
ADORA2A;Arthritis, Rheumatoid;Disease;PA24584;Gene
AHRR;Arthritis, Rheumatoid;Disease;PA24639;Gene
AMPD1;Arthritis, Rheumatoid;Disease;PA24776;Gene
ATIC;Arthritis, Rheumatoid;Disease;PA25094;Gene
ATP5F1E;Arthritis, Rheumatoid;Disease;PA25128;Gene
CD69;Arthritis, Rheumatoid;Disease;PA26233;Gene
CD84;Arthritis, Rheumatoid;Disease;PA26242;Gene
ABCB1;Arthritis, Rheumatoid;Disease;PA267;Gene
CSRP3;Arthritis, Rheumatoid;Disease;PA26971;Gene
CST5;Arthritis, Rheumatoid;Disease;PA26978;Gene
CYP1A2;Arthritis, Rheumatoid;Disease;PA27093;Gene
DHODH;Arthritis, Rheumatoid;Disease;PA27327;Gene
FCGR2A;Arthritis, Rheumatoid;Disease;PA28063;Gene
FCGR3A;Arthritis, Rheumatoid;Disease;PA28065;Gene
FCGR3B;Arthritis, Rheumatoid;Disease;PA28066;Gene
IL6R;Arthritis, Rheumatoid;Disease;PA29835;Gene
ITPA;Arthritis, Rheumatoid;Disease;PA29973;Gene
KLRC1;Arthritis, Rheumatoid;Disease;PA30163;Gene
KLRD1;Arthritis, Rheumatoid;Disease;PA30167;Gene
MAFB;Arthritis, Rheumatoid;Disease;PA30535;Gene
MICA;Arthritis, Rheumatoid;Disease;PA30811;Gene
MTR;Arthritis, Rheumatoid;Disease;PA31272;Gene
MTRR;Arthritis, Rheumatoid;Disease;PA31277;Gene
SLC19A1;Arthritis, Rheumatoid;Disease;PA327;Gene
PON1;Arthritis, Rheumatoid;Disease;PA33529;Gene
PSORS1C1;Arthritis, Rheumatoid;Disease;PA33919;Gene
PTPRC;Arthritis, Rheumatoid;Disease;PA34011;Gene
PTPRM;Arthritis, Rheumatoid;Disease;PA34020;Gene
TGFB1;Arthritis, Rheumatoid;Disease;PA350;Gene
HLA-DQB1;Arthritis, Rheumatoid;Disease;PA35068;Gene
HLA-DRB1;Arthritis, Rheumatoid;Disease;PA35072;Gene
HLA-E;Arthritis, Rheumatoid;Disease;PA35081;Gene
HLA-G;Arthritis, Rheumatoid;Disease;PA35083;Gene
TPMT;Arthritis, Rheumatoid;Disease;PA356;Gene
TYMS;Arthritis, Rheumatoid;Disease;PA359;Gene
SPP1;Arthritis, Rheumatoid;Disease;PA36085;Gene
STAT4;Arthritis, Rheumatoid;Disease;PA36185;Gene
TLR4;Arthritis, Rheumatoid;Disease;PA36552;Gene
TNFRSF1A;Arthritis, Rheumatoid;Disease;PA36609;Gene
TNFRSF1B;Arthritis, Rheumatoid;Disease;PA36610;Gene
TRAF1;Arthritis, Rheumatoid;Disease;PA36708;Gene
SLCO1C1;Arthritis, Rheumatoid;Disease;PA37815;Gene
SLC22A11;Arthritis, Rheumatoid;Disease;PA38295;Gene
ABCG2;Arthritis, Rheumatoid;Disease;PA390;Gene
GGH;Arthritis, Rheumatoid;Disease;PA432;Gene
TNF;Arthritis, Rheumatoid;Disease;PA435;Gene
SCHIZOPHRENIA;Arthritis, Rheumatoid;Disease;PA447216;Disease
SHORT QT SYNDROME 1;rs104894021;Variant;PA166183774;Disease
DISOPYRAMIDE;rs104894021;Variant;PA449373;Chemical
QUINIDINE;rs104894021;Variant;PA451209;Chemical
ACQUIRED LONG QT SYNDROME (ALQTS);SDHAF3;Gene;PA447300;Disease
ASPIRIN-INDUCED ASTHMA;THRA;Gene;PA131285571;Disease
ASTHMA;THRA;Gene;PA443450;Disease
BIPOLAR DISORDER;THRA;Gene;PA447199;Disease
ASPIRIN;THRA;Gene;PA448497;Chemical
LITHIUM;THRA;Gene;PA450243;Chemical
CYP2C19;Helicobacter Infections;Disease;PA124;Gene
CYP2C19*17;Helicobacter Infections;Disease;PA165816533;Haplotype
CYP2C19*1;Helicobacter Infections;Disease;PA165980634;Haplotype
CYP2C19*2;Helicobacter Infections;Disease;PA165980635;Haplotype
CYP2C19*3;Helicobacter Infections;Disease;PA165980636;Haplotype
RS16944;Helicobacter Infections;Disease;PA166155587;Variant
RS1045642;Helicobacter Infections;Disease;PA166157284;Variant
ABCB1;Helicobacter Infections;Disease;PA267;Gene
IL1B;Helicobacter Infections;Disease;PA29808;Gene
PANCREATIC NEOPLASMS;rs10916852;Variant;PA445218;Disease
GEMCITABINE;rs10916852;Variant;PA449748;Chemical
ANTIHYPERTENSIVES;rs2230345;Variant;PA164712445;Chemical
BETA BLOCKING AGENTS;rs2230345;Variant;PA164712535;Chemical
HEART DISEASES;rs2230345;Variant;PA444368;Disease
HEART FAILURE;rs2230345;Variant;PA444370;Disease
ANTIVIRALS FOR TREATMENT OF HIV INFECTIONS, COMBINATIONS;NAT2*1;Haplotype;PA164712505;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;NAT2*1;Haplotype;PA164712708;Chemical
TOXIC LIVER DISEASE;NAT2*1;Haplotype;PA164925725;Disease
DRUG-INDUCED LIVER INJURY;NAT2*1;Haplotype;PA166119041;Disease
HYPERTENSION;NAT2*1;Haplotype;PA444552;Disease
TUBERCULOSIS;NAT2*1;Haplotype;PA445941;Disease
HIV INFECTIONS;NAT2*1;Haplotype;PA447230;Disease
HYDRALAZINE;NAT2*1;Haplotype;PA449894;Chemical
ISONIAZID;NAT2*1;Haplotype;PA450112;Chemical
ATP1A1;eplerenone;Chemical;PA62;Gene
RS2297480;Osteoporosis, Postmenopausal;Disease;PA166153695;Variant
FDPS;Osteoporosis, Postmenopausal;Disease;PA28075;Gene
ESCITALOPRAM;rs12054895;Variant;PA10074;Chemical
MAJOR DEPRESSIVE DISORDER;rs12054895;Variant;PA447321;Disease
CITALOPRAM;rs12054895;Variant;PA449015;Chemical
PHENYTOIN;CYP2C9*49;Haplotype;PA450947;Chemical
CYP2C19;clobazam;Chemical;PA124;Gene
CYP2C19*1;clobazam;Chemical;PA165980634;Haplotype
CYP2C19*2;clobazam;Chemical;PA165980635;Haplotype
CYP2C19*3;clobazam;Chemical;PA165980636;Haplotype
RS2298771;clobazam;Chemical;PA166155680;Variant
SCN1A;clobazam;Chemical;PA301;Gene
POR;clobazam;Chemical;PA33532;Gene
URINARY BLADDER NEOPLASMS;LSP1;Gene;PA443512;Disease
MYOCARDIAL INFARCTION;rs1065776;Variant;PA445019;Disease
ASPIRIN;rs1065776;Variant;PA448497;Chemical
CYP2A6;Stomach Neoplasms;Disease;PA121;Gene
C18ORF56;Stomach Neoplasms;Disease;PA134956204;Gene
ERCC1;Stomach Neoplasms;Disease;PA155;Gene
TMEM167A;Stomach Neoplasms;Disease;PA162405909;Gene
CYP2A6*1;Stomach Neoplasms;Disease;PA165924690;Haplotype
CYP2A6*4;Stomach Neoplasms;Disease;PA165924721;Haplotype
CYP2A6*7;Stomach Neoplasms;Disease;PA165924731;Haplotype
CYP2A6*10;Stomach Neoplasms;Disease;PA165924735;Haplotype
CYP2A6*11;Stomach Neoplasms;Disease;PA165924736;Haplotype
CYP2A6*9;Stomach Neoplasms;Disease;PA165980914;Haplotype
UGT1A1*1;Stomach Neoplasms;Disease;PA166115841;Haplotype
UGT1A1*6;Stomach Neoplasms;Disease;PA166115858;Haplotype
UGT1A7*1A;Stomach Neoplasms;Disease;PA166117636;Haplotype
UGT1A7*2;Stomach Neoplasms;Disease;PA166117638;Haplotype
UGT1A7*3;Stomach Neoplasms;Disease;PA166117639;Haplotype
RS1800566;Stomach Neoplasms;Disease;PA166155017;Variant
RS45445694;Stomach Neoplasms;Disease;PA166155331;Variant
RS11615;Stomach Neoplasms;Disease;PA166155342;Variant
RS3212986;Stomach Neoplasms;Disease;PA166155407;Variant
RS25648;Stomach Neoplasms;Disease;PA166156906;Variant
RS662;Stomach Neoplasms;Disease;PA166157238;Variant
RS1799983;Stomach Neoplasms;Disease;PA166157303;Variant
RS2293347;Stomach Neoplasms;Disease;PA166157355;Variant
RS2854744;Stomach Neoplasms;Disease;PA166157368;Variant
RS2960436;Stomach Neoplasms;Disease;PA166157371;Variant
RS2298881;Stomach Neoplasms;Disease;PA166169975;Variant
RS10040363;Stomach Neoplasms;Disease;PA166169977;Variant
RS2075685;Stomach Neoplasms;Disease;PA166169979;Variant
RS11280056;Stomach Neoplasms;Disease;PA166180936;Variant
NOS3;Stomach Neoplasms;Disease;PA254;Gene
BRCA1;Stomach Neoplasms;Disease;PA25411;Gene
IGFBP3;Stomach Neoplasms;Disease;PA29705;Gene
KRAS;Stomach Neoplasms;Disease;PA30196;Gene
NQO1;Stomach Neoplasms;Disease;PA31744;Gene
PON1;Stomach Neoplasms;Disease;PA33529;Gene
TYMS;Stomach Neoplasms;Disease;PA359;Gene
UGT1A7;Stomach Neoplasms;Disease;PA37182;Gene
VEGFA;Stomach Neoplasms;Disease;PA37302;Gene
XRCC4;Stomach Neoplasms;Disease;PA37423;Gene
ABCG2;Stomach Neoplasms;Disease;PA390;Gene
UGT1A1;Stomach Neoplasms;Disease;PA420;Gene
EGFR;Stomach Neoplasms;Disease;PA7360;Gene
METHADONE;CDH2;Gene;PA450401;Chemical
BIPOLAR DISORDER;OR52J3;Gene;PA447199;Disease
LITHIUM;OR52J3;Gene;PA450243;Chemical
ADALIMUMAB;rs2302489;Variant;PA10004;Chemical
CERTOLIZUMAB PEGOL;rs2302489;Variant;PA165107055;Chemical
RHEUMATOID ARTHRITIS;rs2302489;Variant;PA443434;Disease
ETANERCEPT;rs2302489;Variant;PA449515;Chemical
METHOTREXATE;rs2302489;Variant;PA450428;Chemical
GLUCOCORTICOIDS;rs2302489;Variant;PA452347;Chemical
INFLIXIMAB;rs2302489;Variant;PA452639;Chemical
DULOXETINE;rs61908407;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs61908407;Variant;PA447321;Disease
DICLOFENAC;CYP2C9*72;Haplotype;PA449293;Chemical
LOSARTAN;CYP2C9*72;Haplotype;PA450268;Chemical
TOLBUTAMIDE;CYP2C9*72;Haplotype;PA451718;Chemical
PAIN;TAOK3;Gene;PA445208;Disease
PAIN, POSTOPERATIVE;TAOK3;Gene;PA445210;Disease
MORPHINE;TAOK3;Gene;PA450550;Chemical
OPIOIDS;TAOK3;Gene;PA452618;Chemical
ABCB1;gramicidin d;Chemical;PA267;Gene
CFTR;tezacaftor;Chemical;PA109;Gene
RS75527207;tezacaftor;Chemical;PA166157516;Variant
RS113993960;tezacaftor;Chemical;PA166157525;Variant
RS397508139;tezacaftor;Chemical;PA166178058;Variant
RS758900656;tezacaftor;Chemical;PA166351561;Variant
RS397508609;tezacaftor;Chemical;PA166397581;Variant
RS397508293;tezacaftor;Chemical;PA166415961;Variant
RS1792306355;tezacaftor;Chemical;PA166415982;Variant
ESSENTIAL HYPERTENSION;SLIT1;Gene;PA447288;Disease
ETOPOSIDE;SLIT1;Gene;PA449552;Chemical
HYDROCHLOROTHIAZIDE;SLIT1;Gene;PA449899;Chemical
CYP2D6;flupenthixol;Chemical;PA128;Gene
ABCB1;flupenthixol;Chemical;PA267;Gene
KCNH2;prenylamine;Chemical;PA212;Gene
ABCB1;domperidone;Chemical;PA267;Gene
KAT2B;cannabinoids;Chemical;PA162392705;Gene
RS324420;cannabinoids;Chemical;PA166153569;Variant
RS1799971;cannabinoids;Chemical;PA166156991;Variant
RS9829896;cannabinoids;Chemical;PA166184842;Variant
FAAH;cannabinoids;Chemical;PA27955;Gene
OPRM1;cannabinoids;Chemical;PA31945;Gene
HEROIN DEPENDENCE;rs10835210;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs10835210;Variant;PA445043;Disease
METHADONE;rs10835210;Variant;PA450401;Chemical
PLCH1;PRKCG;Gene;PA128394595;Gene
PLCZ1;PRKCG;Gene;PA134875646;Gene
PLCH2;PRKCG;Gene;PA134914471;Gene
NFKB1;PRKCG;Gene;PA248;Gene
ELK1;PRKCG;Gene;PA27749;Gene
FOS;PRKCG;Gene;PA28212;Gene
RELA;PRKCG;Gene;PA296;Gene
JUN;PRKCG;Gene;PA30006;Gene
MYC;PRKCG;Gene;PA31353;Gene
NFKB2;PRKCG;Gene;PA31600;Gene
PLCB1;PRKCG;Gene;PA33384;Gene
PLCB2;PRKCG;Gene;PA33385;Gene
PLCB3;PRKCG;Gene;PA33386;Gene
PLCB4;PRKCG;Gene;PA33387;Gene
PLCD1;PRKCG;Gene;PA33388;Gene
PLCD3;PRKCG;Gene;PA33389;Gene
PLCD4;PRKCG;Gene;PA33390;Gene
PLCE1;PRKCG;Gene;PA33391;Gene
PLCG1;PRKCG;Gene;PA33392;Gene
PLCG2;PRKCG;Gene;PA33393;Gene
PLCL1;PRKCG;Gene;PA33394;Gene
PLCL2;PRKCG;Gene;PA33395;Gene
STAT3;PRKCG;Gene;PA337;Gene
STAT5A;PRKCG;Gene;PA338;Gene
RAF1;PRKCG;Gene;PA34183;Gene
SP1;PRKCG;Gene;PA36042;Gene
STAT1;PRKCG;Gene;PA36183;Gene
STAT2;PRKCG;Gene;PA36184;Gene
STAT4;PRKCG;Gene;PA36185;Gene
STAT5B;PRKCG;Gene;PA36186;Gene
ADRB2;PRKCG;Gene;PA39;Gene
MAJOR DEPRESSIVE DISORDER;rs2251954;Variant;PA447321;Disease
BUPROPION;rs2251954;Variant;PA448687;Chemical
TXN;TXNRD1;Gene;PA37091;Gene
VITAMIN C;TXNRD1;Gene;PA451898;Chemical
OPIOID-RELATED DISORDERS;rs2023239;Variant;PA445043;Disease
OPIOIDS;rs2023239;Variant;PA452618;Chemical
MACULAR DEGENERATION;CNGB3;Gene;PA134850558;Disease
EPILEPSY;rs4688040;Variant;PA444065;Disease
CARBAMAZEPINE;rs4688040;Variant;PA448785;Chemical
ELF2;SLC9A6;Gene;PA27745;Gene
THIAZIDES, PLAIN;rs4341;Variant;PA164713347;Chemical
DIABETES MELLITUS;rs4341;Variant;PA443886;Disease
PRAVASTATIN;rs4341;Variant;PA451089;Chemical
HYPERTENSION;rs4132670;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs4132670;Variant;PA449899;Chemical
NON-SMALL CELL LUNG CARCINOMA;PRDX4;Gene;PA443622;Disease
DOCETAXEL;PRDX4;Gene;PA449383;Chemical
DEXTROMETHORPHAN;CYP2D6*101;Haplotype;PA449273;Chemical
ABCC2;carbamazepine;Chemical;PA116;Gene
CYP2B6;carbamazepine;Chemical;PA123;Gene
CYP2C19;carbamazepine;Chemical;PA124;Gene
CYP2C8;carbamazepine;Chemical;PA125;Gene
CYP2C9;carbamazepine;Chemical;PA126;Gene
CYP2D6;carbamazepine;Chemical;PA128;Gene
CYP3A4;carbamazepine;Chemical;PA130;Gene
CYP3A5;carbamazepine;Chemical;PA131;Gene
HLA-DRB1*07:01;carbamazepine;Chemical;PA165951644;Haplotype
HLA-DRB1*14:05;carbamazepine;Chemical;PA165952142;Haplotype
HLA-A*01:01;carbamazepine;Chemical;PA165952609;Haplotype
HLA-A*11:01;carbamazepine;Chemical;PA165953358;Haplotype
HLA-A*24:02;carbamazepine;Chemical;PA165953564;Haplotype
HLA-A*24:07;carbamazepine;Chemical;PA165953622;Haplotype
HLA-A*31:01;carbamazepine;Chemical;PA165954030;Haplotype
HLA-A*74:01;carbamazepine;Chemical;PA165954348;Haplotype
HLA-B*07:02;carbamazepine;Chemical;PA165954366;Haplotype
HLA-B*08:01;carbamazepine;Chemical;PA165954547;Haplotype
HLA-B*13:01;carbamazepine;Chemical;PA165954643;Haplotype
HLA-B*15:02;carbamazepine;Chemical;PA165954769;Haplotype
HLA-B*15:11;carbamazepine;Chemical;PA165954787;Haplotype
HLA-B*15:18;carbamazepine;Chemical;PA165954803;Haplotype
HLA-B*15:21;carbamazepine;Chemical;PA165954809;Haplotype
HLA-B*18:01;carbamazepine;Chemical;PA165955030;Haplotype
HLA-B*35:01;carbamazepine;Chemical;PA165955215;Haplotype
HLA-B*40:01;carbamazepine;Chemical;PA165955628;Haplotype
HLA-B*46:01;carbamazepine;Chemical;PA165956083;Haplotype
HLA-B*51:01;carbamazepine;Chemical;PA165956201;Haplotype
HLA-B*59:01;carbamazepine;Chemical;PA165956674;Haplotype
HLA-C*03:04;carbamazepine;Chemical;PA165956881;Haplotype
HLA-C*07:04;carbamazepine;Chemical;PA165957428;Haplotype
HLA-DQB1*03:03;carbamazepine;Chemical;PA165958180;Haplotype
HLA-B*58:01;carbamazepine;Chemical;PA165987831;Haplotype
HLA-C*03:02;carbamazepine;Chemical;PA166123425;Haplotype
HLA-C*08:01;carbamazepine;Chemical;PA166123426;Haplotype
HLA-A*02:01;carbamazepine;Chemical;PA166123427;Haplotype
HLA-A*33:03;carbamazepine;Chemical;PA166123428;Haplotype
HLA-B*48:01;carbamazepine;Chemical;PA166123429;Haplotype
HLA-DRB1*03:01;carbamazepine;Chemical;PA166123430;Haplotype
CYP3A5*1;carbamazepine;Chemical;PA166128213;Haplotype
CYP3A5*3;carbamazepine;Chemical;PA166128219;Haplotype
RS1051740;carbamazepine;Chemical;PA166153612;Variant
RS2234922;carbamazepine;Chemical;PA166153680;Variant
RS2273697;carbamazepine;Chemical;PA166154007;Variant
RS3740066;carbamazepine;Chemical;PA166154028;Variant
RS4148386;carbamazepine;Chemical;PA166154047;Variant
RS762551;carbamazepine;Chemical;PA166154850;Variant
RS2606345;carbamazepine;Chemical;PA166154899;Variant
RS2298771;carbamazepine;Chemical;PA166155680;Variant
RS2304016;carbamazepine;Chemical;PA166155682;Variant
RS3812718;carbamazepine;Chemical;PA166155715;Variant
RS17183814;carbamazepine;Chemical;PA166155842;Variant
RS2071197;carbamazepine;Chemical;PA166155919;Variant
RS2461817;carbamazepine;Chemical;PA166156357;Variant
RS3814055;carbamazepine;Chemical;PA166156383;Variant
RS4688040;carbamazepine;Chemical;PA166156402;Variant
RS7643645;carbamazepine;Chemical;PA166156423;Variant
RS28365063;carbamazepine;Chemical;PA166156677;Variant
RS2279020;carbamazepine;Chemical;PA166156794;Variant
RS2290732;carbamazepine;Chemical;PA166156796;Variant
RS750332;carbamazepine;Chemical;PA166156946;Variant
RS1043620;carbamazepine;Chemical;PA166156972;Variant
RS1800629;carbamazepine;Chemical;PA166156997;Variant
RS2227956;carbamazepine;Chemical;PA166157023;Variant
RS15524;carbamazepine;Chemical;PA166157243;Variant
RS776746;carbamazepine;Chemical;PA166157267;Variant
RS1045642;carbamazepine;Chemical;PA166157284;Variant
RS1128503;carbamazepine;Chemical;PA166157288;Variant
RS2032582;carbamazepine;Chemical;PA166157316;Variant
RS2242480;carbamazepine;Chemical;PA166157345;Variant
RS2740574;carbamazepine;Chemical;PA166157367;Variant
RS4148739;carbamazepine;Chemical;PA166157386;Variant
RS4148740;carbamazepine;Chemical;PA166157387;Variant
HTR2A;carbamazepine;Chemical;PA193;Gene
HTR2C;carbamazepine;Chemical;PA194;Gene
MTHFR;carbamazepine;Chemical;PA245;Gene
PRRC2A;carbamazepine;Chemical;PA25263;Gene
BAG6;carbamazepine;Chemical;PA25264;Gene
ABCB1;carbamazepine;Chemical;PA267;Gene
CYP1A1;carbamazepine;Chemical;PA27092;Gene
CYP1A2;carbamazepine;Chemical;PA27093;Gene
DRD2;carbamazepine;Chemical;PA27478;Gene
EPHX1;carbamazepine;Chemical;PA27829;Gene
GABRA1;carbamazepine;Chemical;PA28489;Gene
HNF4A;carbamazepine;Chemical;PA29349;Gene
HSPA1A;carbamazepine;Chemical;PA29498;Gene
HSPA1L;carbamazepine;Chemical;PA29500;Gene
SCN1A;carbamazepine;Chemical;PA301;Gene
LTA;carbamazepine;Chemical;PA30474;Gene
SLC6A4;carbamazepine;Chemical;PA312;Gene
POLG;carbamazepine;Chemical;PA33500;Gene
RALBP1;carbamazepine;Chemical;PA34199;Gene
SCN2A;carbamazepine;Chemical;PA35004;Gene
HLA-A;carbamazepine;Chemical;PA35055;Gene
HLA-B;carbamazepine;Chemical;PA35056;Gene
HLA-C;carbamazepine;Chemical;PA35057;Gene
HLA-DQB1;carbamazepine;Chemical;PA35068;Gene
HLA-DRB1;carbamazepine;Chemical;PA35072;Gene
UGT2B7;carbamazepine;Chemical;PA361;Gene
UGT1A4;carbamazepine;Chemical;PA37179;Gene
NR1I2;carbamazepine;Chemical;PA378;Gene
NR1I3;carbamazepine;Chemical;PA391;Gene
TNF;carbamazepine;Chemical;PA435;Gene
MIDAZOLAM;CYP3A4*46;Haplotype;PA450496;Chemical
ETHANOL;rs7931459;Variant;PA448073;Chemical
MAJOR DEPRESSIVE DISORDER;GABRQ;Gene;PA447321;Disease
VENLAFAXINE;GABRQ;Gene;PA451866;Chemical
BOSENTAN;SLCO1B1;Gene;PA10034;Chemical
EZETIMIBE;SLCO1B1;Gene;PA10816;Chemical
FLUOROURACIL;SLCO1B1;Gene;PA128406956;Chemical
HMG COA REDUCTASE INHIBITORS;SLCO1B1;Gene;PA133950441;Chemical
ROSUVASTATIN;SLCO1B1;Gene;PA134308647;Chemical
PITAVASTATIN;SLCO1B1;Gene;PA142650384;Chemical
ATRASENTAN;SLCO1B1;Gene;PA143414738;Chemical
NEPHROTOXICITY;SLCO1B1;Gene;PA162263533;Disease
ARSENIC COMPOUNDS;SLCO1B1;Gene;PA164712509;Chemical
OLMESARTAN;SLCO1B1;Gene;PA164742950;Chemical
CASPOFUNGIN;SLCO1B1;Gene;PA164743013;Chemical
MYCOPHENOLIC ACID;SLCO1B1;Gene;PA164748728;Chemical
GEMTUZUMAB OZOGAMICIN;SLCO1B1;Gene;PA164749431;Chemical
CONJUGATED ESTROGENS;SLCO1B1;Gene;PA164754789;Chemical
ROCURONIUM;SLCO1B1;Gene;PA164754992;Chemical
DYSLIPIDAEMIA;SLCO1B1;Gene;PA165108110;Disease
ACUTE CORONARY SYNDROME;SLCO1B1;Gene;PA165108401;Disease
SN-38;SLCO1B1;Gene;PA165110775;Chemical
TICAGRELOR;SLCO1B1;Gene;PA165374673;Chemical
CYP2C9*2;SLCO1B1;Gene;PA165816543;Haplotype
CYP2C9*3;SLCO1B1;Gene;PA165816544;Haplotype
KIDNEY TRANSPLANTATION;SLCO1B1;Gene;PA165817016;Disease
SLCO1B1*5;SLCO1B1;Gene;PA165819255;Haplotype
SLCO1B1*15;SLCO1B1;Gene;PA165819265;Haplotype
GLUCARPIDASE;SLCO1B1;Gene;PA165949771;Chemical
FAMILIAL HYPERCHOLESTEROLEMIA;SLCO1B1;Gene;PA166114942;Disease
UGT1A1*28;SLCO1B1;Gene;PA166115842;Haplotype
DRUG-INDUCED LIVER INJURY;SLCO1B1;Gene;PA166119041;Disease
DISCONTINUATION;SLCO1B1;Gene;PA166123507;Disease
GASTROINTESTINAL TOXICITY;SLCO1B1;Gene;PA166124386;Disease
SIMVASTATIN ACID;SLCO1B1;Gene;PA166129446;Chemical
RS1801131;SLCO1B1;Gene;PA166153643;Variant
RS1801133;SLCO1B1;Gene;PA166153644;Variant
RS2306283;SLCO1B1;Gene;PA166154547;Variant
RS4149032;SLCO1B1;Gene;PA166154575;Variant
RS4149056;SLCO1B1;Gene;PA166154579;Variant
RS4149081;SLCO1B1;Gene;PA166154581;Variant
RS11045879;SLCO1B1;Gene;PA166154633;Variant
RS4148323;SLCO1B1;Gene;PA166155721;Variant
RS2231142;SLCO1B1;Gene;PA166156544;Variant
LOVASTATIN ACID;SLCO1B1;Gene;PA166163161;Chemical
STATIN-RELATED MYOPATHY;SLCO1B1;Gene;PA166163391;Disease
ELAGOLIX;SLCO1B1;Gene;PA166182348;Chemical
AMLODIPINE / ATORVASTATIN / PERINDOPRIL ARGININE;SLCO1B1;Gene;PA166183785;Chemical
LETERMOVIR;SLCO1B1;Gene;PA166184379;Chemical
EZETIMIBE / SIMVASTATIN;SLCO1B1;Gene;PA166184495;Chemical
EZETIMIBE / ROSUVASTATIN;SLCO1B1;Gene;PA166184498;Chemical
ESTRONE SULFATE;SLCO1B1;Gene;PA166185957;Chemical
VILOXAZINE;SLCO1B1;Gene;PA166251581;Chemical
DULAGLUTIDE;SLCO1B1;Gene;PA166285081;Chemical
BREAST NEOPLASMS;SLCO1B1;Gene;PA443560;Disease
NON-SMALL CELL LUNG CARCINOMA;SLCO1B1;Gene;PA443622;Disease
CARDIOVASCULAR DISEASE;SLCO1B1;Gene;PA443635;Disease
CORONARY ARTERY DISEASE;SLCO1B1;Gene;PA443796;Disease
CORONARY DISEASE;SLCO1B1;Gene;PA443797;Disease
DIABETES MELLITUS;SLCO1B1;Gene;PA443886;Disease
DIABETES MELLITUS, TYPE 2;SLCO1B1;Gene;PA443890;Disease
DIARRHEA;SLCO1B1;Gene;PA443899;Disease
DRUG TOXICITY;SLCO1B1;Gene;PA443937;Disease
HYPERCHOLESTEROLEMIA;SLCO1B1;Gene;PA444516;Disease
HYPERLIPIDEMIAS;SLCO1B1;Gene;PA444528;Disease
LEUKEMIA, MYELOID, ACUTE;SLCO1B1;Gene;PA444760;Disease
LYMPHOMA;SLCO1B1;Gene;PA444840;Disease
MUSCULAR DISEASES;SLCO1B1;Gene;PA444997;Disease
NAUSEA;SLCO1B1;Gene;PA445048;Disease
NEOPLASMS;SLCO1B1;Gene;PA445062;Disease
RHABDOMYOLYSIS;SLCO1B1;Gene;PA445549;Disease
OSTEOSARCOMA;SLCO1B1;Gene;PA445601;Disease
THROMBOCYTOPENIA;SLCO1B1;Gene;PA445846;Disease
TUBERCULOSIS;SLCO1B1;Gene;PA445941;Disease
COLORECTAL NEOPLASMS;SLCO1B1;Gene;PA446108;Disease
INFLAMMATORY BOWEL DISEASES;SLCO1B1;Gene;PA446116;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;SLCO1B1;Gene;PA446155;Disease
HIV INFECTIOUS DISEASE;SLCO1B1;Gene;PA447230;Disease
ESSENTIAL HYPERTENSION;SLCO1B1;Gene;PA447288;Disease
AMPRENAVIR;SLCO1B1;Gene;PA448422;Chemical
ATORVASTATIN;SLCO1B1;Gene;PA448500;Chemical
CARVEDILOL;SLCO1B1;Gene;PA448817;Chemical
CERIVASTATIN;SLCO1B1;Gene;PA448897;Chemical
CYCLOPHOSPHAMIDE;SLCO1B1;Gene;PA449165;Chemical
CYTARABINE;SLCO1B1;Gene;PA449177;Chemical
DAUNORUBICIN;SLCO1B1;Gene;PA449212;Chemical
DILTIAZEM;SLCO1B1;Gene;PA449334;Chemical
DOCETAXEL;SLCO1B1;Gene;PA449383;Chemical
DOXORUBICIN;SLCO1B1;Gene;PA449412;Chemical
ENALAPRIL;SLCO1B1;Gene;PA449456;Chemical
EPIRUBICIN;SLCO1B1;Gene;PA449476;Chemical
ESTRONE;SLCO1B1;Gene;PA449512;Chemical
ETOPOSIDE;SLCO1B1;Gene;PA449552;Chemical
FENOFIBRATE;SLCO1B1;Gene;PA449594;Chemical
FLUDARABINE;SLCO1B1;Gene;PA449655;Chemical
FLUOXETINE;SLCO1B1;Gene;PA449673;Chemical
FLUVASTATIN;SLCO1B1;Gene;PA449688;Chemical
FUROSEMIDE;SLCO1B1;Gene;PA449719;Chemical
IDARUBICIN;SLCO1B1;Gene;PA449961;Chemical
IRINOTECAN;SLCO1B1;Gene;PA450085;Chemical
LANSOPRAZOLE;SLCO1B1;Gene;PA450180;Chemical
LEVOTHYROXINE;SLCO1B1;Gene;PA450221;Chemical
LOPINAVIR;SLCO1B1;Gene;PA450264;Chemical
LORAZEPAM;SLCO1B1;Gene;PA450267;Chemical
LOVASTATIN;SLCO1B1;Gene;PA450272;Chemical
MERCAPTOPURINE;SLCO1B1;Gene;PA450379;Chemical
METHOTREXATE;SLCO1B1;Gene;PA450428;Chemical
MITOXANTRONE;SLCO1B1;Gene;PA450526;Chemical
MYCOPHENOLATE MOFETIL;SLCO1B1;Gene;PA450566;Chemical
NATEGLINIDE;SLCO1B1;Gene;PA450600;Chemical
PACLITAXEL;SLCO1B1;Gene;PA450761;Chemical
PRAVASTATIN;SLCO1B1;Gene;PA451089;Chemical
REPAGLINIDE;SLCO1B1;Gene;PA451234;Chemical
RIFAMPIN;SLCO1B1;Gene;PA451250;Chemical
ROSIGLITAZONE;SLCO1B1;Gene;PA451283;Chemical
SIMVASTATIN;SLCO1B1;Gene;PA451363;Chemical
TROGLITAZONE;SLCO1B1;Gene;PA451799;Chemical
VALSARTAN;SLCO1B1;Gene;PA451848;Chemical
WARFARIN;SLCO1B1;Gene;PA451906;Chemical
SORAFENIB;SLCO1B1;Gene;PA7000;Chemical
MEPHENYTOIN;rs41291556;Variant;PA450373;Chemical
TOLBUTAMIDE;rs41291556;Variant;PA451718;Chemical
ESR1;goserelin;Chemical;PA156;Gene
PGR;goserelin;Chemical;PA266;Gene
ESR2;goserelin;Chemical;PA27886;Gene
KIDNEY TRANSPLANTATION;rs1800871;Variant;PA165817016;Disease
LIVER TRANSPLANTATION;rs1800871;Variant;PA447247;Disease
TACROLIMUS;rs1800871;Variant;PA451578;Chemical
ACE;Glomerulonephritis, IGA;Disease;PA139;Gene
RS1799752;Glomerulonephritis, IGA;Disease;PA166155187;Variant
ACE;perindopril;Chemical;PA139;Gene
RS12050217;perindopril;Chemical;PA166154826;Variant
RS1799752;perindopril;Chemical;PA166155187;Variant
RS5182;perindopril;Chemical;PA166156275;Variant
RS5186;perindopril;Chemical;PA166156276;Variant
RS275651;perindopril;Chemical;PA166156283;Variant
G6PD;perindopril;Chemical;PA28469;Gene
AGTR1;perindopril;Chemical;PA43;Gene
BDKRB1;perindopril;Chemical;PA79;Gene
ATAZANAVIR;rs1042640;Variant;PA10251;Chemical
NEPHROLITHIASIS;rs1042640;Variant;PA162355520;Disease
LIVER FAILURE, ACUTE;rs1042640;Variant;PA446443;Disease
HIV INFECTIOUS DISEASE;rs1042640;Variant;PA447230;Disease
ACETAMINOPHEN;rs1042640;Variant;PA448015;Chemical
RITONAVIR;rs1042640;Variant;PA451260;Chemical
CES1;2-oxo-clopidogrel;Chemical;PA107;Gene
RS778068631;2-oxo-clopidogrel;Chemical;PA166200921;Variant
MAJOR DEPRESSIVE DISORDER;rs2831440;Variant;PA447321;Disease
ANTIDEPRESSANTS;rs2831440;Variant;PA452229;Chemical
ACE INHIBITORS, PLAIN;rs8016905;Variant;PA164712308;Chemical
COUGH;rs8016905;Variant;PA443803;Disease
BREAST NEOPLASMS;rs2449598;Variant;PA443560;Disease
ANASTROZOLE;rs2449598;Variant;PA448432;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*15:24;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*15:24;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*15:24;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-B*15:24;Haplotype;PA450616;Chemical
CYP2B6;Epidermal Necrolysis, Toxic;Disease;PA123;Gene
CYP2C9;Epidermal Necrolysis, Toxic;Disease;PA126;Gene
CYCSP5;Epidermal Necrolysis, Toxic;Disease;PA142672032;Gene
CYP2C9*1;Epidermal Necrolysis, Toxic;Disease;PA165816542;Haplotype
CYP2C9*3;Epidermal Necrolysis, Toxic;Disease;PA165816544;Haplotype
HLA-DRB1*01:02;Epidermal Necrolysis, Toxic;Disease;PA165951340;Haplotype
HLA-DRB1*01:03;Epidermal Necrolysis, Toxic;Disease;PA165951348;Haplotype
HLA-DRB1*04:04;Epidermal Necrolysis, Toxic;Disease;PA165951511;Haplotype
HLA-DRB1*08:01;Epidermal Necrolysis, Toxic;Disease;PA165951669;Haplotype
HLA-DRB1*08:03;Epidermal Necrolysis, Toxic;Disease;PA165951678;Haplotype
HLA-DRB1*10:01;Epidermal Necrolysis, Toxic;Disease;PA165951757;Haplotype
HLA-DRB1*12:02;Epidermal Necrolysis, Toxic;Disease;PA165951930;Haplotype
HLA-DRB1*13:02;Epidermal Necrolysis, Toxic;Disease;PA165951978;Haplotype
HLA-DRB1*15:02;Epidermal Necrolysis, Toxic;Disease;PA165952289;Haplotype
HLA-A*02:06;Epidermal Necrolysis, Toxic;Disease;PA165952829;Haplotype
HLA-A*02:07;Epidermal Necrolysis, Toxic;Disease;PA165952839;Haplotype
HLA-A*11:01;Epidermal Necrolysis, Toxic;Disease;PA165953358;Haplotype
HLA-A*24:02;Epidermal Necrolysis, Toxic;Disease;PA165953564;Haplotype
HLA-A*24:07;Epidermal Necrolysis, Toxic;Disease;PA165953622;Haplotype
HLA-A*31:01;Epidermal Necrolysis, Toxic;Disease;PA165954030;Haplotype
HLA-B*13:01;Epidermal Necrolysis, Toxic;Disease;PA165954643;Haplotype
HLA-B*13:02;Epidermal Necrolysis, Toxic;Disease;PA165954649;Haplotype
HLA-B*15:01;Epidermal Necrolysis, Toxic;Disease;PA165954745;Haplotype
HLA-B*15:02;Epidermal Necrolysis, Toxic;Disease;PA165954769;Haplotype
HLA-B*15:11;Epidermal Necrolysis, Toxic;Disease;PA165954787;Haplotype
HLA-B*15:12;Epidermal Necrolysis, Toxic;Disease;PA165954792;Haplotype
HLA-B*15:13;Epidermal Necrolysis, Toxic;Disease;PA165954793;Haplotype
HLA-B*15:21;Epidermal Necrolysis, Toxic;Disease;PA165954809;Haplotype
HLA-B*15:24;Epidermal Necrolysis, Toxic;Disease;PA165954811;Haplotype
HLA-B*15:25;Epidermal Necrolysis, Toxic;Disease;PA165954812;Haplotype
HLA-B*15:27;Epidermal Necrolysis, Toxic;Disease;PA165954816;Haplotype
HLA-B*15:32;Epidermal Necrolysis, Toxic;Disease;PA165954823;Haplotype
HLA-B*15:35;Epidermal Necrolysis, Toxic;Disease;PA165954826;Haplotype
HLA-B*18:01;Epidermal Necrolysis, Toxic;Disease;PA165955030;Haplotype
HLA-B*35:10;Epidermal Necrolysis, Toxic;Disease;PA165955274;Haplotype
HLA-B*38:01;Epidermal Necrolysis, Toxic;Disease;PA165955500;Haplotype
HLA-B*38:02;Epidermal Necrolysis, Toxic;Disease;PA165955505;Haplotype
HLA-B*39:01;Epidermal Necrolysis, Toxic;Disease;PA165955543;Haplotype
HLA-B*39:05;Epidermal Necrolysis, Toxic;Disease;PA165955559;Haplotype
HLA-B*39:06;Epidermal Necrolysis, Toxic;Disease;PA165955561;Haplotype
HLA-B*39:09;Epidermal Necrolysis, Toxic;Disease;PA165955565;Haplotype
HLA-B*39:10;Epidermal Necrolysis, Toxic;Disease;PA165955566;Haplotype
HLA-B*40:01;Epidermal Necrolysis, Toxic;Disease;PA165955628;Haplotype
HLA-B*44:03;Epidermal Necrolysis, Toxic;Disease;PA165955913;Haplotype
HLA-B*46:01;Epidermal Necrolysis, Toxic;Disease;PA165956083;Haplotype
HLA-B*51:01;Epidermal Necrolysis, Toxic;Disease;PA165956201;Haplotype
HLA-B*51:02;Epidermal Necrolysis, Toxic;Disease;PA165956231;Haplotype
HLA-B*52:01;Epidermal Necrolysis, Toxic;Disease;PA165956366;Haplotype
HLA-B*54:01;Epidermal Necrolysis, Toxic;Disease;PA165956438;Haplotype
HLA-B*55:01;Epidermal Necrolysis, Toxic;Disease;PA165956463;Haplotype
HLA-B*55:02;Epidermal Necrolysis, Toxic;Disease;PA165956471;Haplotype
HLA-B*56:01;Epidermal Necrolysis, Toxic;Disease;PA165956528;Haplotype
HLA-B*56:02;Epidermal Necrolysis, Toxic;Disease;PA165956532;Haplotype
HLA-B*56:06;Epidermal Necrolysis, Toxic;Disease;PA165956537;Haplotype
HLA-B*59:01;Epidermal Necrolysis, Toxic;Disease;PA165956674;Haplotype
HLA-B*67:01;Epidermal Necrolysis, Toxic;Disease;PA165956680;Haplotype
HLA-B*78:01;Epidermal Necrolysis, Toxic;Disease;PA165956686;Haplotype
HLA-C*01:02;Epidermal Necrolysis, Toxic;Disease;PA165956704;Haplotype
HLA-C*04:01;Epidermal Necrolysis, Toxic;Disease;PA165957046;Haplotype
HLA-C*04:03;Epidermal Necrolysis, Toxic;Disease;PA165957085;Haplotype
HLA-C*04:06;Epidermal Necrolysis, Toxic;Disease;PA165957089;Haplotype
HLA-C*04:07;Epidermal Necrolysis, Toxic;Disease;PA165957090;Haplotype
HLA-C*05:01;Epidermal Necrolysis, Toxic;Disease;PA165957192;Haplotype
HLA-C*05:09;Epidermal Necrolysis, Toxic;Disease;PA165957217;Haplotype
HLA-C*06:02;Epidermal Necrolysis, Toxic;Disease;PA165957286;Haplotype
HLA-C*07:27;Epidermal Necrolysis, Toxic;Disease;PA165957457;Haplotype
HLA-C*14:02;Epidermal Necrolysis, Toxic;Disease;PA165957818;Haplotype
HLA-C*14:03;Epidermal Necrolysis, Toxic;Disease;PA165957827;Haplotype
HLA-C*15:02;Epidermal Necrolysis, Toxic;Disease;PA165957859;Haplotype
HLA-C*18:01;Epidermal Necrolysis, Toxic;Disease;PA165958003;Haplotype
HLA-DQB1*05:01;Epidermal Necrolysis, Toxic;Disease;PA165958073;Haplotype
HLA-DQB1*05:02;Epidermal Necrolysis, Toxic;Disease;PA165958077;Haplotype
HLA-DQB1*02:02;Epidermal Necrolysis, Toxic;Disease;PA165958162;Haplotype
HLA-B*57:01;Epidermal Necrolysis, Toxic;Disease;PA165987830;Haplotype
HLA-B*58:01;Epidermal Necrolysis, Toxic;Disease;PA165987831;Haplotype
GSTM1 NULL;Epidermal Necrolysis, Toxic;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Epidermal Necrolysis, Toxic;Disease;PA166048676;Haplotype
HLA-C*03:02;Epidermal Necrolysis, Toxic;Disease;PA166123425;Haplotype
HLA-C*08:01;Epidermal Necrolysis, Toxic;Disease;PA166123426;Haplotype
HLA-A*02:01;Epidermal Necrolysis, Toxic;Disease;PA166123427;Haplotype
HLA-A*33:03;Epidermal Necrolysis, Toxic;Disease;PA166123428;Haplotype
RS28399499;Epidermal Necrolysis, Toxic;Disease;PA166155478;Variant
RS2844665;Epidermal Necrolysis, Toxic;Disease;PA166157053;Variant
RS3094188;Epidermal Necrolysis, Toxic;Disease;PA166157064;Variant
RS3130501;Epidermal Necrolysis, Toxic;Disease;PA166157069;Variant
RS3130931;Epidermal Necrolysis, Toxic;Disease;PA166157071;Variant
RS3815087;Epidermal Necrolysis, Toxic;Disease;PA166157086;Variant
RS9469003;Epidermal Necrolysis, Toxic;Disease;PA166157162;Variant
GSTM1;Epidermal Necrolysis, Toxic;Disease;PA182;Gene
POU5F1;Epidermal Necrolysis, Toxic;Disease;PA33545;Gene
PSORS1C1;Epidermal Necrolysis, Toxic;Disease;PA33919;Gene
PSORS1C3;Epidermal Necrolysis, Toxic;Disease;PA33921;Gene
HLA-A;Epidermal Necrolysis, Toxic;Disease;PA35055;Gene
HLA-B;Epidermal Necrolysis, Toxic;Disease;PA35056;Gene
HLA-C;Epidermal Necrolysis, Toxic;Disease;PA35057;Gene
HLA-DQB1;Epidermal Necrolysis, Toxic;Disease;PA35068;Gene
HLA-DRB1;Epidermal Necrolysis, Toxic;Disease;PA35072;Gene
CYP2D6;promethazine;Chemical;PA128;Gene
CYP2D6*4;promethazine;Chemical;PA165816579;Haplotype
GEFITINIB;CYP2D6*14;Haplotype;PA131301952;Chemical
TOXIC LIVER DISEASE;CYP2D6*14;Haplotype;PA164925725;Disease
BUFURALOL;CYP2D6*14;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*14;Haplotype;PA166127651;Chemical
RECURRENCE FREE SURVIVAL;CYP2D6*14;Haplotype;PA166127658;Disease
BREXPIPRAZOLE;CYP2D6*14;Haplotype;PA166160053;Chemical
BREAST NEOPLASMS;CYP2D6*14;Haplotype;PA443560;Disease
CARCINOMA, NON-SMALL-CELL LUNG;CYP2D6*14;Haplotype;PA443622;Disease
DYSTONIA;CYP2D6*14;Haplotype;PA443970;Disease
RECURRENCE;CYP2D6*14;Haplotype;PA445506;Disease
DEPRESSIVE DISORDER;CYP2D6*14;Haplotype;PA447207;Disease
PSYCHOTIC DISORDERS;CYP2D6*14;Haplotype;PA447215;Disease
SCHIZOPHRENIA;CYP2D6*14;Haplotype;PA447216;Disease
TARDIVE DYSKINESIA;CYP2D6*14;Haplotype;PA447268;Disease
DEXTROMETHORPHAN;CYP2D6*14;Haplotype;PA449273;Chemical
FLUVOXAMINE;CYP2D6*14;Haplotype;PA449690;Chemical
PAROXETINE;CYP2D6*14;Haplotype;PA450801;Chemical
PRIMAQUINE;CYP2D6*14;Haplotype;PA451103;Chemical
RISPERIDONE;CYP2D6*14;Haplotype;PA451257;Chemical
SIMVASTATIN;CYP2D6*14;Haplotype;PA451363;Chemical
TAMOXIFEN;CYP2D6*14;Haplotype;PA451581;Chemical
ANTIPSYCHOTICS;CYP2D6*14;Haplotype;PA452233;Chemical
SULFAMETHOXAZOLE / TRIMETHOPRIM;NAT2;Gene;PA10715;Chemical
ANTIVIRALS FOR TREATMENT OF HIV INFECTIONS, COMBINATIONS;NAT2;Gene;PA164712505;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;NAT2;Gene;PA164712708;Chemical
RIFAPENTINE;NAT2;Gene;PA164783809;Chemical
ETHAMBUTOL;NAT2;Gene;PA164784021;Chemical
TOXIC LIVER DISEASE;NAT2;Gene;PA164925725;Disease
DRUG INTERACTION WITH DRUG;NAT2;Gene;PA165108622;Disease
DRUG-INDUCED LIVER INJURY;NAT2;Gene;PA166119041;Disease
DANIQUIDONE;NAT2;Gene;PA166119201;Chemical
SEVERE CUTANEOUS ADVERSE REACTIONS;NAT2;Gene;PA166120929;Disease
PNEUMONITIS;NAT2;Gene;PA166124223;Disease
DIPYRONE;NAT2;Gene;PA166128206;Chemical
ADVERSE EVENTS;NAT2;Gene;PA166151827;Disease
SOLITHROMYCIN;NAT2;Gene;PA166165147;Chemical
HYDRALAZINE / ISOSORBIDE DINITRATE;NAT2;Gene;PA166176017;Chemical
ISONIAZID / PYRAZINAMIDE / RIFAMPIN;NAT2;Gene;PA166176022;Chemical
AMIFAMPRIDINE PHOSPHATE;NAT2;Gene;PA166182002;Chemical
AMIFAMPRIDINE;NAT2;Gene;PA166185150;Chemical
DRUG-INDUCED LUPUS ERYTHEMATOSUS DUE TO HYDRALAZINE;NAT2;Gene;PA166205041;Disease
ARTHRITIS, RHEUMATOID;NAT2;Gene;PA443434;Disease
ASTHMA;NAT2;Gene;PA443450;Disease
URINARY BLADDER NEOPLASMS;NAT2;Gene;PA443512;Disease
DRUG TOXICITY;NAT2;Gene;PA443937;Disease
HYPERSENSITIVITY;NAT2;Gene;PA444546;Disease
HYPERTENSION;NAT2;Gene;PA444552;Disease
INSULIN RESISTANCE;NAT2;Gene;PA444626;Disease
LUPUS ERYTHEMATOSUS;NAT2;Gene;PA444819;Disease
NEOPLASMS;NAT2;Gene;PA445062;Disease
OVARIAN NEOPLASMS;NAT2;Gene;PA445204;Disease
PROSTATIC NEOPLASMS;NAT2;Gene;PA445425;Disease
TUBERCULOSIS;NAT2;Gene;PA445941;Disease
HIV INFECTIONS;NAT2;Gene;PA447230;Disease
ASPIRIN;NAT2;Gene;PA448497;Chemical
CAFFEINE;NAT2;Gene;PA448710;Chemical
CISPLATIN;NAT2;Gene;PA449014;Chemical
CLONAZEPAM;NAT2;Gene;PA449050;Chemical
CYCLOPHOSPHAMIDE;NAT2;Gene;PA449165;Chemical
DOCETAXEL;NAT2;Gene;PA449383;Chemical
EFAVIRENZ;NAT2;Gene;PA449441;Chemical
HYDRALAZINE;NAT2;Gene;PA449894;Chemical
ISONIAZID;NAT2;Gene;PA450112;Chemical
NEVIRAPINE;NAT2;Gene;PA450616;Chemical
PHENYTOIN;NAT2;Gene;PA450947;Chemical
PROCAINAMIDE;NAT2;Gene;PA451108;Chemical
PYRAZINAMIDE;NAT2;Gene;PA451182;Chemical
RIFAMPIN;NAT2;Gene;PA451250;Chemical
SULFAMETHAZINE;NAT2;Gene;PA451542;Chemical
SULFAMETHOXAZOLE;NAT2;Gene;PA451544;Chemical
SULFASALAZINE;NAT2;Gene;PA451547;Chemical
THALIDOMIDE;NAT2;Gene;PA451644;Chemical
HLA-B*55:01;penicillin g;Chemical;PA165956463;Haplotype
RS115200108;penicillin g;Chemical;PA166257881;Variant
HLA-B;penicillin g;Chemical;PA35056;Gene
VDR;calcipotriol;Chemical;PA37301;Gene
ALCOHOL ABUSE;TAS2R16;Gene;PA443309;Disease
ETHANOL;TAS2R16;Gene;PA448073;Chemical
ASTHMA;rs17495520;Variant;PA443450;Disease
SALBUTAMOL;rs17495520;Variant;PA448068;Chemical
AKT1;PIK3CB;Gene;PA24684;Gene
ERBB2;PIK3CB;Gene;PA27844;Gene
ERBB3;PIK3CB;Gene;PA27846;Gene
ERBB4;PIK3CB;Gene;PA27847;Gene
FLT1;PIK3CB;Gene;PA28180;Gene
FLT4;PIK3CB;Gene;PA28183;Gene
KDR;PIK3CB;Gene;PA30086;Gene
EGFR;PIK3CB;Gene;PA7360;Gene
TOBACCO USE DISORDER;rs12718541;Variant;PA445876;Disease
NICOTINE;rs12718541;Variant;PA450626;Chemical
PITRAKINRA;rs1110470;Variant;PA165983754;Chemical
ASTHMA;rs1110470;Variant;PA443450;Disease
CFTR;rs150157202;Variant;PA109;Gene
IVACAFTOR;rs150157202;Variant;PA165950341;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs150157202;Variant;PA166362502;Chemical
GEMCITABINE;rs1155463;Variant;PA449748;Chemical
CYP2B6;S-EDDP;Chemical;PA123;Gene
CYP3A5;S-EDDP;Chemical;PA131;Gene
CYP2B6*1;S-EDDP;Chemical;PA165818750;Haplotype
CYP2B6*4;S-EDDP;Chemical;PA165818757;Haplotype
CYP2B6*5;S-EDDP;Chemical;PA165818760;Haplotype
CYP2B6*6;S-EDDP;Chemical;PA165818762;Haplotype
CYP2B6*7;S-EDDP;Chemical;PA165818765;Haplotype
CYP2B6*17;S-EDDP;Chemical;PA165818781;Haplotype
CYP2B6*19;S-EDDP;Chemical;PA165818784;Haplotype
CYP2B6*26;S-EDDP;Chemical;PA165818788;Haplotype
CYP2B6*9;S-EDDP;Chemical;PA165818807;Haplotype
CYP2B6*18;S-EDDP;Chemical;PA165818808;Haplotype
CYP3A5*1;S-EDDP;Chemical;PA166128213;Haplotype
CYP3A5*3;S-EDDP;Chemical;PA166128219;Haplotype
RS7439366;S-EDDP;Chemical;PA166156619;Variant
UGT2B7;S-EDDP;Chemical;PA361;Gene
KCNJ11;antiarrhythmics, class i and iii;Chemical;PA217;Gene
RHEUMATOID ARTHRITIS;rs2853539;Variant;PA443434;Disease
METHOTREXATE;rs2853539;Variant;PA450428;Chemical
MIGALASTAT;rs104894827;Variant;PA166182881;Chemical
FABRY DISEASE;rs104894827;Variant;PA443367;Disease
KIDNEY TRANSPLANTATION;rs15524;Variant;PA165817016;Disease
EPILEPSY;rs15524;Variant;PA444065;Disease
OPIOID-RELATED DISORDERS;rs15524;Variant;PA445043;Disease
LIVER TRANSPLANTATION;rs15524;Variant;PA447247;Disease
CARBAMAZEPINE;rs15524;Variant;PA448785;Chemical
TACROLIMUS;rs15524;Variant;PA451578;Chemical
OPIOIDS;rs15524;Variant;PA452618;Chemical
BUTORPHANOL;OPRK1;Gene;PA164745398;Chemical
ALCOHOL ABUSE;OPRK1;Gene;PA443309;Disease
HEROIN DEPENDENCE;OPRK1;Gene;PA444460;Disease
OPIOID-RELATED DISORDERS;OPRK1;Gene;PA445043;Disease
NEOPLASMS;OPRK1;Gene;PA445062;Disease
PAIN;OPRK1;Gene;PA445208;Disease
COCAINE DEPENDENCE;OPRK1;Gene;PA446878;Disease
ETHANOL;OPRK1;Gene;PA448073;Chemical
COCAINE;OPRK1;Gene;PA449072;Chemical
METHADONE;OPRK1;Gene;PA450401;Chemical
MORPHINE;OPRK1;Gene;PA450550;Chemical
OPIOIDS;OPRK1;Gene;PA452618;Chemical
HEROIN;OPRK1;Gene;PA452619;Chemical
F2;F2RL3;Gene;PA157;Gene
GNAQ;F2RL3;Gene;PA174;Gene
GNB3;F2RL3;Gene;PA176;Gene
GNA11;F2RL3;Gene;PA28764;Gene
GNA12;F2RL3;Gene;PA28765;Gene
GNA13;F2RL3;Gene;PA28766;Gene
GNA15;F2RL3;Gene;PA28768;Gene
LEUKEMIA, MYELOID, ACUTE;rs13058338;Variant;PA444760;Disease
NEOPLASMS;rs13058338;Variant;PA445062;Disease
DOXORUBICIN;rs13058338;Variant;PA449412;Chemical
IDARUBICIN;rs13058338;Variant;PA449961;Chemical
DULOXETINE;rs9819548;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs9819548;Variant;PA447321;Disease
PROSTATIC NEOPLASMS;VAC14;Gene;PA445425;Disease
DOCETAXEL;VAC14;Gene;PA449383;Chemical
CYP2C19;esomeprazole;Chemical;PA124;Gene
CYP3A5;esomeprazole;Chemical;PA131;Gene
DASATINIB;esomeprazole;Chemical;PA162372878;Chemical
PAZOPANIB;esomeprazole;Chemical;PA165291492;Chemical
CYP2C19*17;esomeprazole;Chemical;PA165816533;Haplotype
CYP2C19*1;esomeprazole;Chemical;PA165980634;Haplotype
CYP2C19*2;esomeprazole;Chemical;PA165980635;Haplotype
CYP2C19*3;esomeprazole;Chemical;PA165980636;Haplotype
RS1059513;esomeprazole;Chemical;PA166224541;Variant
STAT6;esomeprazole;Chemical;PA339;Gene
CYP2C9;SLCO1B1*5;Haplotype;PA126;Gene
ROSUVASTATIN;SLCO1B1*5;Haplotype;PA134308647;Chemical
SLCO1B1;SLCO1B1*5;Haplotype;PA134865839;Gene
PITAVASTATIN;SLCO1B1*5;Haplotype;PA142650384;Chemical
ATRASENTAN;SLCO1B1*5;Haplotype;PA143414738;Chemical
DISCONTINUATION;SLCO1B1*5;Haplotype;PA166123507;Disease
SIMVASTATIN ACID;SLCO1B1*5;Haplotype;PA166129446;Chemical
LOVASTATIN ACID;SLCO1B1*5;Haplotype;PA166163161;Chemical
STATIN-RELATED MYOPATHY;SLCO1B1*5;Haplotype;PA166163391;Disease
ESTRONE SULFATE;SLCO1B1*5;Haplotype;PA166185957;Chemical
ABCG2;SLCO1B1*5;Haplotype;PA390;Gene
BREAST NEOPLASMS;SLCO1B1*5;Haplotype;PA443560;Disease
DRUG TOXICITY;SLCO1B1*5;Haplotype;PA443937;Disease
HYPERCHOLESTEROLEMIA;SLCO1B1*5;Haplotype;PA444516;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;SLCO1B1*5;Haplotype;PA446155;Disease
ATORVASTATIN;SLCO1B1*5;Haplotype;PA448500;Chemical
CERIVASTATIN;SLCO1B1*5;Haplotype;PA448897;Chemical
ESTRONE;SLCO1B1*5;Haplotype;PA449512;Chemical
FLUVASTATIN;SLCO1B1*5;Haplotype;PA449688;Chemical
LOVASTATIN;SLCO1B1*5;Haplotype;PA450272;Chemical
METHOTREXATE;SLCO1B1*5;Haplotype;PA450428;Chemical
PACLITAXEL;SLCO1B1*5;Haplotype;PA450761;Chemical
PRAVASTATIN;SLCO1B1*5;Haplotype;PA451089;Chemical
REPAGLINIDE;SLCO1B1*5;Haplotype;PA451234;Chemical
SIMVASTATIN;SLCO1B1*5;Haplotype;PA451363;Chemical
MTHFR;Homocysteinemia;Disease;PA245;Gene
RS11191561;didanosine;Chemical;PA166154132;Variant
RS11598702;didanosine;Chemical;PA166154142;Variant
RS1429376;didanosine;Chemical;PA166155636;Variant
RS1594160;didanosine;Chemical;PA166155638;Variant
NT5C2;didanosine;Chemical;PA31801;Gene
XDH;didanosine;Chemical;PA37404;Gene
DRUGS FOR TREATMENT OF TUBERCULOSIS;HLA-DQB1*05:01;Haplotype;PA164712708;Chemical
DRUG-INDUCED LIVER INJURY;HLA-DQB1*05:01;Haplotype;PA166119041;Disease
DRUG HYPERSENSITIVITY;HLA-DQB1*05:01;Haplotype;PA443936;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-DQB1*05:01;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-DQB1*05:01;Haplotype;PA445738;Disease
TUBERCULOSIS;HLA-DQB1*05:01;Haplotype;PA445941;Disease
HIV INFECTIONS;HLA-DQB1*05:01;Haplotype;PA447230;Disease
NEVIRAPINE;HLA-DQB1*05:01;Haplotype;PA450616;Chemical
ARIPIPRAZOLE;rs1000940;Variant;PA10026;Chemical
AMISULPRIDE;rs1000940;Variant;PA162565877;Chemical
PALIPERIDONE;rs1000940;Variant;PA163518919;Chemical
SCHIZOAFFECTIVE DISORDER;rs1000940;Variant;PA166123368;Disease
BIPOLAR DISORDER;rs1000940;Variant;PA447199;Disease
DEPRESSIVE DISORDER;rs1000940;Variant;PA447207;Disease
PSYCHOTIC DISORDER;rs1000940;Variant;PA447215;Disease
CLOZAPINE;rs1000940;Variant;PA449061;Chemical
LITHIUM;rs1000940;Variant;PA450243;Chemical
MIRTAZAPINE;rs1000940;Variant;PA450522;Chemical
OLANZAPINE;rs1000940;Variant;PA450688;Chemical
QUETIAPINE;rs1000940;Variant;PA451201;Chemical
RISPERIDONE;rs1000940;Variant;PA451257;Chemical
VALPROIC ACID;rs1000940;Variant;PA451846;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;rs1105525;Variant;PA446155;Disease
METHOTREXATE;rs1105525;Variant;PA450428;Chemical
G6PD;antithrombotic agents;Chemical;PA28469;Gene
ESR1;trastuzumab deruxtecan;Chemical;PA156;Gene
ERBB2;trastuzumab deruxtecan;Chemical;PA27844;Gene
ESR2;trastuzumab deruxtecan;Chemical;PA27886;Gene
MYCOPHENOLIC ACID;UGT1A9;Gene;PA164748728;Chemical
RALTEGRAVIR;UGT1A9;Gene;PA164888966;Chemical
SN-38;UGT1A9;Gene;PA165110775;Chemical
KIDNEY TRANSPLANTATION;UGT1A9;Gene;PA165817016;Disease
FEBUXOSTAT;UGT1A9;Gene;PA165958521;Chemical
HAND-FOOT SYNDROME;UGT1A9;Gene;PA166114377;Disease
DRUG-INDUCED LIVER INJURY;UGT1A9;Gene;PA166119041;Disease
MUCOSITIS;UGT1A9;Gene;PA166122058;Disease
COTININE GLUCURONIDE;UGT1A9;Gene;PA166131561;Chemical
ALOPECIA;UGT1A9;Gene;PA443314;Disease
NON-SMALL CELL LUNG CARCINOMA;UGT1A9;Gene;PA443622;Disease
DRUG TOXICITY;UGT1A9;Gene;PA443937;Disease
EPILEPSY;UGT1A9;Gene;PA444065;Disease
GOUT;UGT1A9;Gene;PA444318;Disease
HEPATOCELLULAR CARCINOMA;UGT1A9;Gene;PA444447;Disease
NEOPLASMS;UGT1A9;Gene;PA445062;Disease
OSTEOSARCOMA;UGT1A9;Gene;PA445601;Disease
SEIZURES;UGT1A9;Gene;PA445629;Disease
THYROID NEOPLASMS;UGT1A9;Gene;PA445857;Disease
COLORECTAL NEOPLASMS;UGT1A9;Gene;PA446108;Disease
LIVER FAILURE, ACUTE;UGT1A9;Gene;PA446443;Disease
SCHIZOPHRENIA;UGT1A9;Gene;PA447216;Disease
HIV INFECTIONS;UGT1A9;Gene;PA447230;Disease
ACETAMINOPHEN;UGT1A9;Gene;PA448015;Chemical
ALLOPURINOL;UGT1A9;Gene;PA448320;Chemical
IBUPROFEN;UGT1A9;Gene;PA449957;Chemical
IRINOTECAN;UGT1A9;Gene;PA450085;Chemical
METHOTREXATE;UGT1A9;Gene;PA450428;Chemical
MYCOPHENOLATE MOFETIL;UGT1A9;Gene;PA450566;Chemical
OXAZEPAM;UGT1A9;Gene;PA450731;Chemical
OXCARBAZEPINE;UGT1A9;Gene;PA450732;Chemical
PHENOBARBITAL;UGT1A9;Gene;PA450911;Chemical
PHENYTOIN;UGT1A9;Gene;PA450947;Chemical
PROPOFOL;UGT1A9;Gene;PA451141;Chemical
RISPERIDONE;UGT1A9;Gene;PA451257;Chemical
SIMVASTATIN;UGT1A9;Gene;PA451363;Chemical
SULFINPYRAZONE;UGT1A9;Gene;PA451550;Chemical
VALPROIC ACID;UGT1A9;Gene;PA451846;Chemical
SORAFENIB;UGT1A9;Gene;PA7000;Chemical
CETP;Hyperlipidemias;Disease;PA108;Gene
CYP3A4;Hyperlipidemias;Disease;PA130;Gene
CYP3A5;Hyperlipidemias;Disease;PA131;Gene
SLCO1B1;Hyperlipidemias;Disease;PA134865839;Gene
CYP3A4*1;Hyperlipidemias;Disease;PA165819201;Haplotype
CYP3A4*4;Hyperlipidemias;Disease;PA165819222;Haplotype
UGT1A1*28;Hyperlipidemias;Disease;PA166115842;Haplotype
RS1137101;Hyperlipidemias;Disease;PA166153626;Variant
RS2368564;Hyperlipidemias;Disease;PA166153701;Variant
RS1801253;Hyperlipidemias;Disease;PA166153977;Variant
RS5128;Hyperlipidemias;Disease;PA166154254;Variant
RS662799;Hyperlipidemias;Disease;PA166154293;Variant
RS2854116;Hyperlipidemias;Disease;PA166154390;Variant
RS2854117;Hyperlipidemias;Disease;PA166154391;Variant
RS2306283;Hyperlipidemias;Disease;PA166154547;Variant
RS4149056;Hyperlipidemias;Disease;PA166154579;Variant
RS1532624;Hyperlipidemias;Disease;PA166155015;Variant
RS7412;Hyperlipidemias;Disease;PA166155341;Variant
RS429358;Hyperlipidemias;Disease;PA166155351;Variant
RS5370;Hyperlipidemias;Disease;PA166156901;Variant
RS776746;Hyperlipidemias;Disease;PA166157267;Variant
RS2242480;Hyperlipidemias;Disease;PA166157345;Variant
RS12003906;Hyperlipidemias;Disease;PA166157834;Variant
LEPR;Hyperlipidemias;Disease;PA229;Gene
ABCA1;Hyperlipidemias;Disease;PA24373;Gene
APOA5;Hyperlipidemias;Disease;PA24888;Gene
EDN1;Hyperlipidemias;Disease;PA27614;Gene
REN;Hyperlipidemias;Disease;PA297;Gene
ADRB1;Hyperlipidemias;Disease;PA38;Gene
UGT1A1;Hyperlipidemias;Disease;PA420;Gene
APOC3;Hyperlipidemias;Disease;PA53;Gene
APOE;Hyperlipidemias;Disease;PA55;Gene
COMT;buprenorphine;Chemical;PA117;Gene
CYP3A4;buprenorphine;Chemical;PA130;Gene
CYP3A5;buprenorphine;Chemical;PA131;Gene
ADAMTSL2;buprenorphine;Chemical;PA134920655;Gene
SLC6A4 HTTLPR LONG FORM (L ALLELE);buprenorphine;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);buprenorphine;Chemical;PA166116466;Haplotype
RS529520;buprenorphine;Chemical;PA166153574;Variant
RS581111;buprenorphine;Chemical;PA166153578;Variant
RS1045280;buprenorphine;Chemical;PA166155174;Variant
RS4680;buprenorphine;Chemical;PA166156024;Variant
RS740603;buprenorphine;Chemical;PA166156057;Variant
RS1799971;buprenorphine;Chemical;PA166156991;Variant
RS2740574;buprenorphine;Chemical;PA166157367;Variant
RS678849;buprenorphine;Chemical;PA166175994;Variant
RS2234918;buprenorphine;Chemical;PA166175997;Variant
RS4732636;buprenorphine;Chemical;PA166218621;Variant
RS351776;buprenorphine;Chemical;PA166218661;Variant
RS62368105;buprenorphine;Chemical;PA166259901;Variant
RS6973474;buprenorphine;Chemical;PA166259902;Variant
RS756770;buprenorphine;Chemical;PA166259903;Variant
RS7205113;buprenorphine;Chemical;PA166259904;Variant
RS13169373;buprenorphine;Chemical;PA166259921;Variant
RS11782370;buprenorphine;Chemical;PA166259922;Variant
SLC6A3;buprenorphine;Chemical;PA311;Gene
SLC6A4;buprenorphine;Chemical;PA312;Gene
OPRD1;buprenorphine;Chemical;PA31942;Gene
OPRM1;buprenorphine;Chemical;PA31945;Gene
PNOC;buprenorphine;Chemical;PA33485;Gene
UGT2B7;buprenorphine;Chemical;PA361;Gene
ARRB2;buprenorphine;Chemical;PA60;Gene
PSYCHOTIC DISORDER;SLC18A2;Gene;PA447215;Disease
MAJOR DEPRESSIVE DISORDER;SLC18A2;Gene;PA447321;Disease
BUPROPION;SLC18A2;Gene;PA448687;Chemical
ANTIPSYCHOTICS;SLC18A2;Gene;PA452233;Chemical
DIABETES MELLITUS;ADIPOQ;Gene;PA443886;Disease
PIOGLITAZONE;ADIPOQ;Gene;PA450970;Chemical
VINCRISTINE;rs1247117;Variant;PA451879;Chemical
TUBERCULOSIS;NAT2*6J;Haplotype;PA445941;Disease
ISONIAZID;NAT2*6J;Haplotype;PA450112;Chemical
WARFARIN;rs2645400;Variant;PA451906;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs11541076;Variant;PA164713366;Chemical
ABCB1;Valspodar;Chemical;PA267;Gene
NON-SMALL CELL LUNG CARCINOMA;SEMA3C;Gene;PA443622;Disease
IRINOTECAN;SEMA3C;Gene;PA450085;Chemical
ACE INHIBITORS, PLAIN;rs16870989;Variant;PA164712308;Chemical
ASPIRIN-INDUCED ASTHMA;rs1042136;Variant;PA131285571;Disease
ASTHMA;rs1042136;Variant;PA443450;Disease
ASPIRIN;rs1042136;Variant;PA448497;Chemical
ZIDOVUDINE;DTYMK;Gene;PA451954;Chemical
CYP3A4;vilazodone;Chemical;PA130;Gene
HTR2A;vilazodone;Chemical;PA193;Gene
SLC6A4;vilazodone;Chemical;PA312;Gene
PHENYTOIN;CYP2C9*27;Haplotype;PA450947;Chemical
OSTEOSARCOMA;rs13137622;Variant;PA445601;Disease
METHOTREXATE;rs13137622;Variant;PA450428;Chemical
DULOXETINE;rs10007051;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs10007051;Variant;PA447321;Disease
BIPOLAR DISORDER;rs2499984;Variant;PA447199;Disease
LITHIUM;rs2499984;Variant;PA450243;Chemical
BREAST NEOPLASMS;rs1570360;Variant;PA443560;Disease
RENAL CELL CARCINOMA;rs1570360;Variant;PA443624;Disease
PROSTATIC NEOPLASMS;rs1570360;Variant;PA445425;Disease
CYCLOPHOSPHAMIDE;rs1570360;Variant;PA449165;Chemical
DOCETAXEL;rs1570360;Variant;PA449383;Chemical
SORAFENIB;rs1570360;Variant;PA7000;Chemical
RHEUMATOID ARTHRITIS;rs10197559;Variant;PA443434;Disease
METHOTREXATE;rs10197559;Variant;PA450428;Chemical
LOSARTAN;rs12721226;Variant;PA450268;Chemical
NAT2;rifapentine;Chemical;PA18;Gene
NR1I2;rifapentine;Chemical;PA378;Gene
MENOPAUSE;rs11543791;Variant;PA166048848;Disease
SCHIZOPHRENIA;rs11543791;Variant;PA447216;Disease
RALOXIFENE;rs11543791;Variant;PA451221;Chemical
RS37973;nedocromil;Chemical;PA166157244;Variant
GLCCI1;nedocromil;Chemical;PA38657;Gene
CYP4F2;clofibrate;Chemical;PA27121;Gene
COTININE;rs12209447;Variant;PA166114414;Chemical
NICOTINE;rs12209447;Variant;PA450626;Chemical
PRASUGREL;P2RY12;Gene;PA154410481;Chemical
ACUTE CORONARY SYNDROME;P2RY12;Gene;PA165108401;Disease
TICAGRELOR;P2RY12;Gene;PA165374673;Chemical
CANGRELOR;P2RY12;Gene;PA165945763;Chemical
PLATELET AGGREGATION;P2RY12;Gene;PA166123766;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);P2RY12;Gene;PA166129560;Disease
GNAI1;P2RY12;Gene;PA172;Gene
GNAI3;P2RY12;Gene;PA173;Gene
GNB3;P2RY12;Gene;PA176;Gene
GNAI2;P2RY12;Gene;PA24347;Gene
ANGINA PECTORIS;P2RY12;Gene;PA443362;Disease
CARDIOVASCULAR DISEASES;P2RY12;Gene;PA443635;Disease
CORONARY ARTERY DISEASE;P2RY12;Gene;PA443796;Disease
CORONARY DISEASE;P2RY12;Gene;PA443797;Disease
CLOPIDOGREL;P2RY12;Gene;PA449053;Chemical
CYTARABINE;P2RY12;Gene;PA449177;Chemical
TICLOPIDINE;P2RY12;Gene;PA451686;Chemical
COLORECTAL NEOPLASMS;rs76387818;Variant;PA446108;Disease
CAPECITABINE;rs76387818;Variant;PA448771;Chemical
SCHIZOPHRENIA;rs10012;Variant;PA447216;Disease
RISPERIDONE;rs10012;Variant;PA451257;Chemical
ESSENTIAL HYPERTENSION;rs11064426;Variant;PA447288;Disease
ATENOLOL;rs11064426;Variant;PA448499;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs9514091;Variant;PA130620651;Chemical
NEOPLASMS;rs9514091;Variant;PA445062;Disease
SCHIZOPHRENIA;rs1344706;Variant;PA447216;Disease
ANTIPSYCHOTICS;rs1344706;Variant;PA452233;Chemical
EPILEPSY;CYP2C9*52;Haplotype;PA444065;Disease
DICLOFENAC;CYP2C9*52;Haplotype;PA449293;Chemical
PHENYTOIN;CYP2C9*52;Haplotype;PA450947;Chemical
ELF2;SLC9A5;Gene;PA27745;Gene
FLUOROURACIL;IGFBP3;Gene;PA128406956;Chemical
STOMACH NEOPLASMS;IGFBP3;Gene;PA445742;Disease
CELECOXIB;IGFBP3;Gene;PA448871;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;HLA-DRB1*11:01;Haplotype;PA164712462;Chemical
ANAPHYLAXIS;HLA-DRB1*11:01;Haplotype;PA443335;Disease
O-DESMETHYLTRAMADOL;rs184199168;Variant;PA166131379;Chemical
TRAMADOL;rs184199168;Variant;PA451735;Chemical
PRKAA1;GPAM;Gene;PA33744;Gene
PRKAA2;GPAM;Gene;PA33745;Gene
PRKAB1;GPAM;Gene;PA33746;Gene
PRKAB2;GPAM;Gene;PA33747;Gene
PRKAG1;GPAM;Gene;PA33751;Gene
PRKAG2;GPAM;Gene;PA33752;Gene
PRKAG3;GPAM;Gene;PA33753;Gene
FLUOROURACIL;rs2854744;Variant;PA128406956;Chemical
STOMACH NEOPLASMS;rs2854744;Variant;PA445742;Disease
HYPERTENSION;rs4344;Variant;PA444552;Disease
RAMIPRIL;rs4344;Variant;PA451223;Chemical
CHEK1;ATM;Gene;PA110;Gene
FLUOROURACIL;ATM;Gene;PA128406956;Chemical
TALAZOPARIB;ATM;Gene;PA166182740;Chemical
PRKAA1;ATM;Gene;PA33744;Gene
PRKAA2;ATM;Gene;PA33745;Gene
PRKAB1;ATM;Gene;PA33746;Gene
PRKAB2;ATM;Gene;PA33747;Gene
PRKAG1;ATM;Gene;PA33751;Gene
PRKAG2;ATM;Gene;PA33752;Gene
PRKAG3;ATM;Gene;PA33753;Gene
CHEK2;ATM;Gene;PA404;Gene
BREAST NEOPLASMS;ATM;Gene;PA443560;Disease
DIABETES MELLITUS, TYPE 2;ATM;Gene;PA443890;Disease
PROSTATIC NEOPLASMS;ATM;Gene;PA445425;Disease
CYCLOPHOSPHAMIDE;ATM;Gene;PA449165;Chemical
DOXORUBICIN;ATM;Gene;PA449412;Chemical
METFORMIN;ATM;Gene;PA450395;Chemical
TOXIC LIVER DISEASE;rs11080344;Variant;PA164925725;Disease
TUBERCULOSIS;rs11080344;Variant;PA445941;Disease
ISONIAZID;rs11080344;Variant;PA450112;Chemical
RIFAMPIN;rs11080344;Variant;PA451250;Chemical
WARFARIN;DDHD1;Gene;PA451906;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs4149570;Variant;PA164713366;Chemical
CROHN DISEASE;rs4149570;Variant;PA443815;Disease
INFLAMMATORY BOWEL DISEASES;rs4149570;Variant;PA446116;Disease
ACE INHIBITORS, PLAIN;rs5182;Variant;PA164712308;Chemical
CORONARY ARTERY DISEASE;rs5182;Variant;PA443796;Disease
HYPERTENSION;rs5182;Variant;PA444552;Disease
PERINDOPRIL;rs5182;Variant;PA450877;Chemical
SCHIZOPHRENIA;HRH4;Gene;PA447216;Disease
RISPERIDONE;HRH4;Gene;PA451257;Chemical
ASPIRIN-INDUCED ASTHMA;ZBTB22;Gene;PA131285571;Disease
ASTHMA;ZBTB22;Gene;PA443450;Disease
ASPIRIN;ZBTB22;Gene;PA448497;Chemical
CELECOXIB;KCNQ4;Gene;PA448871;Chemical
BETA BLOCKING AGENTS, SELECTIVE;rs28404156;Variant;PA164712547;Chemical
HYPERTENSION;rs28404156;Variant;PA444552;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*39:06;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*39:06;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*39:06;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-B*39:06;Haplotype;PA450616;Chemical
WEIGHT GAIN;FTO;Gene;PA128406954;Disease
INTERFERON ALFA-2A, RECOMBINANT;FTO;Gene;PA164779048;Chemical
INTERFERON ALFA-2B, RECOMBINANT;FTO;Gene;PA164783990;Chemical
IRRITABLE BOWEL SYNDROME;FTO;Gene;PA166048887;Disease
ALCOHOL ABUSE;FTO;Gene;PA443309;Disease
ULCERATIVE COLITIS;FTO;Gene;PA443750;Disease
CROHN DISEASE;FTO;Gene;PA443815;Disease
HYPERTENSION;FTO;Gene;PA444552;Disease
LEUKOPENIA;FTO;Gene;PA444773;Disease
NEUTROPENIA;FTO;Gene;PA445113;Disease
CHRONIC HEPATITIS C VIRUS INFECTION;FTO;Gene;PA446863;Disease
HIV INFECTIOUS DISEASE;FTO;Gene;PA447230;Disease
ETHANOL;FTO;Gene;PA448073;Chemical
ATENOLOL;FTO;Gene;PA448499;Chemical
AZATHIOPRINE;FTO;Gene;PA448515;Chemical
MERCAPTOPURINE;FTO;Gene;PA450379;Chemical
RIBAVIRIN;FTO;Gene;PA451241;Chemical
PITRAKINRA;rs2239347;Variant;PA165983754;Chemical
ASTHMA;rs2239347;Variant;PA443450;Disease
BOSENTAN;CYP2C9*2;Haplotype;PA10034;Chemical
VORICONAZOLE;CYP2C9*2;Haplotype;PA10233;Chemical
SULFONAMIDES, UREA DERIVATIVES;CYP2C9*2;Haplotype;PA10390;Chemical
GLICLAZIDE;CYP2C9*2;Haplotype;PA10892;Chemical
CYP2C9;CYP2C9*2;Haplotype;PA126;Gene
TENOXICAM;CYP2C9*2;Haplotype;PA131890625;Chemical
VKORC1;CYP2C9*2;Haplotype;PA133787052;Gene
SLCO1B1;CYP2C9*2;Haplotype;PA134865839;Gene
PRASUGREL;CYP2C9*2;Haplotype;PA154410481;Chemical
F2;CYP2C9*2;Haplotype;PA157;Gene
F5;CYP2C9*2;Haplotype;PA159;Gene
GLIQUIDONE;CYP2C9*2;Haplotype;PA164744895;Chemical
FOSPHENYTOIN;CYP2C9*2;Haplotype;PA164746820;Chemical
ACUTE CORONARY SYNDROME;CYP2C9*2;Haplotype;PA165108401;Disease
KIDNEY TRANSPLANTATION;CYP2C9*2;Haplotype;PA165817016;Disease
HYDROXYPHENYTOIN;CYP2C9*2;Haplotype;PA165823907;Chemical
LORNOXICAM;CYP2C9*2;Haplotype;PA165958395;Chemical
FLUINDIONE;CYP2C9*2;Haplotype;PA165980614;Chemical
ACECLOFENAC;CYP2C9*2;Haplotype;PA166049185;Chemical
DRUG-INDUCED LIVER INJURY;CYP2C9*2;Haplotype;PA166119041;Disease
OVER-ANTICOAGULATION;CYP2C9*2;Haplotype;PA166123298;Disease
HEART VALVE REPLACEMENT;CYP2C9*2;Haplotype;PA166123431;Disease
PLATELET AGGREGATION;CYP2C9*2;Haplotype;PA166123766;Disease
TIME TO ACHIEVE STABLE DOSE;CYP2C9*2;Haplotype;PA166129530;Disease
TIME IN THERAPEUTIC RANGE;CYP2C9*2;Haplotype;PA166129531;Disease
TIME TO THERAPEUTIC INR;CYP2C9*2;Haplotype;PA166129532;Disease
TIME ABOVE THERAPEUTIC RANGE;CYP2C9*2;Haplotype;PA166129534;Disease
TIME BELOW THERAPEUTIC RANGE;CYP2C9*2;Haplotype;PA166129562;Disease
ADVERSE EVENTS;CYP2C9*2;Haplotype;PA166151827;Disease
AVATROMBOPAG;CYP2C9*2;Haplotype;PA166179849;Chemical
SIPONIMOD;CYP2C9*2;Haplotype;PA166182736;Chemical
RIMEGEPANT;CYP2C9*2;Haplotype;PA166225041;Chemical
ETRASIMOD;CYP2C9*2;Haplotype;PA166328841;Chemical
CYP4F2;CYP2C9*2;Haplotype;PA27121;Gene
PROC;CYP2C9*2;Haplotype;PA33799;Gene
PROS1;CYP2C9*2;Haplotype;PA33809;Gene
SERPINC1;CYP2C9*2;Haplotype;PA35026;Gene
HLA-B;CYP2C9*2;Haplotype;PA35056;Gene
ALCOHOLISM;CYP2C9*2;Haplotype;PA443309;Disease
ATRIAL FIBRILLATION;CYP2C9*2;Haplotype;PA443459;Disease
CARDIOVASCULAR DISEASES;CYP2C9*2;Haplotype;PA443635;Disease
CORONARY ARTERY DISEASE;CYP2C9*2;Haplotype;PA443796;Disease
DIABETES MELLITUS;CYP2C9*2;Haplotype;PA443886;Disease
DIABETES MELLITUS, TYPE 2;CYP2C9*2;Haplotype;PA443890;Disease
DRUG TOXICITY;CYP2C9*2;Haplotype;PA443937;Disease
DYSPEPSIA;CYP2C9*2;Haplotype;PA443965;Disease
EPILEPSY;CYP2C9*2;Haplotype;PA444065;Disease
HEART DISEASES;CYP2C9*2;Haplotype;PA444368;Disease
HEMORRHAGE;CYP2C9*2;Haplotype;PA444417;Disease
GASTROINTESTINAL HEMORRHAGE;CYP2C9*2;Haplotype;PA444418;Disease
HYPERTENSION;CYP2C9*2;Haplotype;PA444552;Disease
HYPOGLYCEMIA;CYP2C9*2;Haplotype;PA444570;Disease
HYPOTENSION;CYP2C9*2;Haplotype;PA444584;Disease
INFLAMMATION;CYP2C9*2;Haplotype;PA444620;Disease
KIDNEY DISEASES;CYP2C9*2;Haplotype;PA444682;Disease
CARDIOMYOPATHIES;CYP2C9*2;Haplotype;PA445018;Disease
NEOPLASMS;CYP2C9*2;Haplotype;PA445062;Disease
PAIN, POSTOPERATIVE;CYP2C9*2;Haplotype;PA445210;Disease
RHEUMATIC HEART DISEASE;CYP2C9*2;Haplotype;PA445553;Disease
TOBACCO USE DISORDER;CYP2C9*2;Haplotype;PA445876;Disease
TUBERCULOSIS;CYP2C9*2;Haplotype;PA445941;Disease
STROKE;CYP2C9*2;Haplotype;PA447054;Disease
BIPOLAR DISORDER;CYP2C9*2;Haplotype;PA447199;Disease
MENTAL DISORDERS;CYP2C9*2;Haplotype;PA447208;Disease
PSYCHOTIC DISORDERS;CYP2C9*2;Haplotype;PA447215;Disease
HIV INFECTIONS;CYP2C9*2;Haplotype;PA447230;Disease
THROMBOSIS OF CEREBRAL VEINS;CYP2C9*2;Haplotype;PA447276;Disease
VENOUS THROMBOEMBOLISM;CYP2C9*2;Haplotype;PA447298;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2C9*2;Haplotype;PA447321;Disease
ASPIRIN;CYP2C9*2;Haplotype;PA448497;Chemical
CELECOXIB;CYP2C9*2;Haplotype;PA448871;Chemical
CLOPIDOGREL;CYP2C9*2;Haplotype;PA449053;Chemical
DIAZEPAM;CYP2C9*2;Haplotype;PA449283;Chemical
DICLOFENAC;CYP2C9*2;Haplotype;PA449293;Chemical
FLUCONAZOLE;CYP2C9*2;Haplotype;PA449653;Chemical
FLUOXETINE;CYP2C9*2;Haplotype;PA449673;Chemical
FLURBIPROFEN;CYP2C9*2;Haplotype;PA449683;Chemical
FLUVASTATIN;CYP2C9*2;Haplotype;PA449688;Chemical
GLIMEPIRIDE;CYP2C9*2;Haplotype;PA449761;Chemical
GLIPIZIDE;CYP2C9*2;Haplotype;PA449762;Chemical
GLYBURIDE;CYP2C9*2;Haplotype;PA449782;Chemical
IBUPROFEN;CYP2C9*2;Haplotype;PA449957;Chemical
INDOMETHACIN;CYP2C9*2;Haplotype;PA449982;Chemical
KETOPROFEN;CYP2C9*2;Haplotype;PA450149;Chemical
KETOROLAC;CYP2C9*2;Haplotype;PA450150;Chemical
LOSARTAN;CYP2C9*2;Haplotype;PA450268;Chemical
MELOXICAM;CYP2C9*2;Haplotype;PA450353;Chemical
METHADONE;CYP2C9*2;Haplotype;PA450401;Chemical
NAPROXEN;CYP2C9*2;Haplotype;PA450595;Chemical
OLANZAPINE;CYP2C9*2;Haplotype;PA450688;Chemical
PHENPROCOUMON;CYP2C9*2;Haplotype;PA450921;Chemical
PHENYTOIN;CYP2C9*2;Haplotype;PA450947;Chemical
PIROXICAM;CYP2C9*2;Haplotype;PA450985;Chemical
PROPOFOL;CYP2C9*2;Haplotype;PA451141;Chemical
RIFAMPIN;CYP2C9*2;Haplotype;PA451250;Chemical
SULFAMETHOXAZOLE;CYP2C9*2;Haplotype;PA451544;Chemical
TOLBUTAMIDE;CYP2C9*2;Haplotype;PA451718;Chemical
VALPROIC ACID;CYP2C9*2;Haplotype;PA451846;Chemical
WARFARIN;CYP2C9*2;Haplotype;PA451906;Chemical
ACENOCOUMAROL;CYP2C9*2;Haplotype;PA452632;Chemical
ANTIEMETICS AND ANTINAUSEANTS;rs34130495;Variant;PA164712431;Chemical
PROGUANIL;rs34130495;Variant;PA451124;Chemical
TRAMADOL;rs34130495;Variant;PA451735;Chemical
CYP2D6;cariprazine;Chemical;PA128;Gene
ASTHMA;rs4292;Variant;PA443450;Disease
ASPIRIN;rs4292;Variant;PA448497;Chemical
CYP2B6;CYP2B6*1;Haplotype;PA123;Gene
ETHAMBUTOL;CYP2B6*1;Haplotype;PA164784021;Chemical
TOXIC LIVER DISEASE;CYP2B6*1;Haplotype;PA164925725;Disease
ARTEMETHER;CYP2B6*1;Haplotype;PA165111698;Chemical
PREGNANCY;CYP2B6*1;Haplotype;PA166048714;Disease
COTININE;CYP2B6*1;Haplotype;PA166114414;Chemical
DRUG-INDUCED LIVER INJURY;CYP2B6*1;Haplotype;PA166119041;Disease
DISCONTINUATION;CYP2B6*1;Haplotype;PA166123507;Disease
RECURRENCE FREE SURVIVAL;CYP2B6*1;Haplotype;PA166127658;Disease
S-EDDP;CYP2B6*1;Haplotype;PA166177606;Chemical
(S)-METHADONE;CYP2B6*1;Haplotype;PA166178554;Chemical
HYDROXYBUPROPION;CYP2B6*1;Haplotype;PA166226561;Chemical
R-EDDP;CYP2B6*1;Haplotype;PA166247521;Chemical
BREAST NEOPLASMS;CYP2B6*1;Haplotype;PA443560;Disease
CENTRAL NERVOUS SYSTEM DISEASES;CYP2B6*1;Haplotype;PA443657;Disease
DRUG TOXICITY;CYP2B6*1;Haplotype;PA443937;Disease
HEROIN DEPENDENCE;CYP2B6*1;Haplotype;PA444460;Disease
LONG QT SYNDROME;CYP2B6*1;Haplotype;PA444807;Disease
LYMPHOMA, NON-HODGKIN;CYP2B6*1;Haplotype;PA444845;Disease
OPIOID-RELATED DISORDERS;CYP2B6*1;Haplotype;PA445043;Disease
NEOPLASMS;CYP2B6*1;Haplotype;PA445062;Disease
PAIN;CYP2B6*1;Haplotype;PA445208;Disease
SCOLIOSIS;CYP2B6*1;Haplotype;PA445619;Disease
TOBACCO USE DISORDER;CYP2B6*1;Haplotype;PA445876;Disease
TUBERCULOSIS;CYP2B6*1;Haplotype;PA445941;Disease
LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;CYP2B6*1;Haplotype;PA446169;Disease
LYMPHOMA, B-CELL;CYP2B6*1;Haplotype;PA446304;Disease
NEUROTOXICITY SYNDROMES;CYP2B6*1;Haplotype;PA446975;Disease
HIV INFECTIONS;CYP2B6*1;Haplotype;PA447230;Disease
DEPRESSION;CYP2B6*1;Haplotype;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2B6*1;Haplotype;PA447321;Disease
BUPROPION;CYP2B6*1;Haplotype;PA448687;Chemical
BUSULFAN;CYP2B6*1;Haplotype;PA448691;Chemical
CLOPIDOGREL;CYP2B6*1;Haplotype;PA449053;Chemical
CYCLOPHOSPHAMIDE;CYP2B6*1;Haplotype;PA449165;Chemical
EFAVIRENZ;CYP2B6*1;Haplotype;PA449441;Chemical
FLUDARABINE;CYP2B6*1;Haplotype;PA449655;Chemical
ISONIAZID;CYP2B6*1;Haplotype;PA450112;Chemical
KETAMINE;CYP2B6*1;Haplotype;PA450144;Chemical
LAMIVUDINE;CYP2B6*1;Haplotype;PA450163;Chemical
METHADONE;CYP2B6*1;Haplotype;PA450401;Chemical
MIRTAZAPINE;CYP2B6*1;Haplotype;PA450522;Chemical
NEVIRAPINE;CYP2B6*1;Haplotype;PA450616;Chemical
NICOTINE;CYP2B6*1;Haplotype;PA450626;Chemical
PYRAZINAMIDE;CYP2B6*1;Haplotype;PA451182;Chemical
RIFAMPIN;CYP2B6*1;Haplotype;PA451250;Chemical
SERTRALINE;CYP2B6*1;Haplotype;PA451333;Chemical
STAVUDINE;CYP2B6*1;Haplotype;PA451494;Chemical
TAMOXIFEN;CYP2B6*1;Haplotype;PA451581;Chemical
ZIDOVUDINE;CYP2B6*1;Haplotype;PA451954;Chemical
HEROIN DEPENDENCE;rs1534891;Variant;PA444460;Disease
HEROIN;rs1534891;Variant;PA452619;Chemical
NFKB1;MAPK1;Gene;PA248;Gene
ELK1;MAPK1;Gene;PA27749;Gene
ETS1;MAPK1;Gene;PA27902;Gene
FOS;MAPK1;Gene;PA28212;Gene
MAP2K7;MAPK1;Gene;PA284;Gene
RELA;MAPK1;Gene;PA296;Gene
JUN;MAPK1;Gene;PA30006;Gene
MAP2K1;MAPK1;Gene;PA30584;Gene
MAP2K2;MAPK1;Gene;PA30587;Gene
MAP2K3;MAPK1;Gene;PA30588;Gene
MAP2K4;MAPK1;Gene;PA30589;Gene
MAP2K5;MAPK1;Gene;PA30590;Gene
MAP2K6;MAPK1;Gene;PA30591;Gene
MYC;MAPK1;Gene;PA31353;Gene
NFKB2;MAPK1;Gene;PA31600;Gene
STAT3;MAPK1;Gene;PA337;Gene
PRKACA;MAPK1;Gene;PA33748;Gene
PRKACB;MAPK1;Gene;PA33749;Gene
PRKACG;MAPK1;Gene;PA33750;Gene
STAT5A;MAPK1;Gene;PA338;Gene
SP1;MAPK1;Gene;PA36042;Gene
SRC;MAPK1;Gene;PA36111;Gene
STAT1;MAPK1;Gene;PA36183;Gene
STAT2;MAPK1;Gene;PA36184;Gene
STAT4;MAPK1;Gene;PA36185;Gene
STAT5B;MAPK1;Gene;PA36186;Gene
GRK2;MAPK1;Gene;PA40;Gene
GRK3;MAPK1;Gene;PA41;Gene
ARRB1;MAPK1;Gene;PA59;Gene
ARRB2;MAPK1;Gene;PA60;Gene
ATP1A1;MAPK1;Gene;PA62;Gene
SORAFENIB;MAPK1;Gene;PA7000;Chemical
ELF2;SLC9A2;Gene;PA27745;Gene
ARAF;RRAS;Gene;PA24928;Gene
BRAF;RRAS;Gene;PA25408;Gene
MAP3K1;RRAS;Gene;PA30592;Gene
RAF1;RRAS;Gene;PA34183;Gene
EGFR;RRAS;Gene;PA7360;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs9304742;Variant;PA164713366;Chemical
PSORIASIS;rs9304742;Variant;PA445451;Disease
HEART VALVE REPLACEMENT;rs3826041;Variant;PA166123431;Disease
WARFARIN;rs3826041;Variant;PA451906;Chemical
GEFITINIB;rs11227247;Variant;PA131301952;Chemical
TOXIC LIVER DISEASE;rs11227247;Variant;PA164925725;Disease
NON-SMALL CELL LUNG CARCINOMA;rs11227247;Variant;PA443622;Disease
GEMTUZUMAB OZOGAMICIN;rs2515641;Variant;PA164749431;Chemical
LEUKEMIA, MYELOID, ACUTE;rs2515641;Variant;PA444760;Disease
SCHIZOPHRENIA;rs2515641;Variant;PA447216;Disease
CYTARABINE;rs2515641;Variant;PA449177;Chemical
FLUDARABINE;rs2515641;Variant;PA449655;Chemical
IDARUBICIN;rs2515641;Variant;PA449961;Chemical
RISPERIDONE;rs2515641;Variant;PA451257;Chemical
ESSENTIAL HYPERTENSION;FBXL17;Gene;PA447288;Disease
HYDROCHLOROTHIAZIDE;FBXL17;Gene;PA449899;Chemical
FLUOROURACIL;rs188052243;Variant;PA128406956;Chemical
RS1051792;Spondylarthropathies;Disease;PA166238462;Variant
RS1154831;Spondylarthropathies;Disease;PA166328661;Variant
KLRC4;Spondylarthropathies;Disease;PA30166;Gene
MICA;Spondylarthropathies;Disease;PA30811;Gene
ALCOHOL ABUSE;rs9679319;Variant;PA443309;Disease
ETHANOL;rs9679319;Variant;PA448073;Chemical
ARIPIPRAZOLE;rs1800497;Variant;PA10026;Chemical
NEMONAPRIDE;rs1800497;Variant;PA151186253;Chemical
ALCOHOL ABUSE;rs1800497;Variant;PA443309;Disease
DEATH;rs1800497;Variant;PA443842;Disease
EPILEPSY;rs1800497;Variant;PA444065;Disease
HYPERPROLACTINEMIA;rs1800497;Variant;PA444545;Disease
OPIOID-RELATED DISORDERS;rs1800497;Variant;PA445043;Disease
NAUSEA;rs1800497;Variant;PA445048;Disease
OBESITY;rs1800497;Variant;PA445131;Disease
TOBACCO USE DISORDER;rs1800497;Variant;PA445876;Disease
SUBSTANCE-RELATED DISORDERS;rs1800497;Variant;PA446876;Disease
COCAINE DEPENDENCE;rs1800497;Variant;PA446878;Disease
AUTISM;rs1800497;Variant;PA447198;Disease
SCHIZOPHRENIA;rs1800497;Variant;PA447216;Disease
ETHANOL;rs1800497;Variant;PA448073;Chemical
BUPROPION;rs1800497;Variant;PA448687;Chemical
DISULFIRAM;rs1800497;Variant;PA449376;Chemical
NALTREXONE;rs1800497;Variant;PA450588;Chemical
NICOTINE;rs1800497;Variant;PA450626;Chemical
OLANZAPINE;rs1800497;Variant;PA450688;Chemical
PROCHLORPERAZINE;rs1800497;Variant;PA451114;Chemical
RISPERIDONE;rs1800497;Variant;PA451257;Chemical
VALPROIC ACID;rs1800497;Variant;PA451846;Chemical
OPIOIDS;rs1800497;Variant;PA452618;Chemical
FLUOROURACIL;rs758649719;Variant;PA128406956;Chemical
DRUG TOXICITY;rs758649719;Variant;PA443937;Disease
FLUOROURACIL;ALDH3A1;Gene;PA128406956;Chemical
BREAST NEOPLASMS;ALDH3A1;Gene;PA443560;Disease
CYCLOPHOSPHAMIDE;ALDH3A1;Gene;PA449165;Chemical
DOXORUBICIN;ALDH3A1;Gene;PA449412;Chemical
CESSATION;CYP2A6*24;Haplotype;PA166123046;Disease
TOBACCO USE DISORDER;CYP2A6*24;Haplotype;PA445876;Disease
NICOTINE;CYP2A6*24;Haplotype;PA450626;Chemical
PROSTATIC NEOPLASMS;SNORD68;Gene;PA445425;Disease
DOCETAXEL;SNORD68;Gene;PA449383;Chemical
THALIDOMIDE;SNORD68;Gene;PA451644;Chemical
MAJOR DEPRESSIVE DISORDER;rs2532560;Variant;PA447321;Disease
ANTIDEPRESSANTS;rs2532560;Variant;PA452229;Chemical
IFNL3;elbasvir / grazoprevir;Chemical;PA134952671;Gene
KIDNEY TRANSPLANTATION;rs7438135;Variant;PA165817016;Disease
OPIOID-RELATED DISORDERS;rs7438135;Variant;PA445043;Disease
METHADONE;rs7438135;Variant;PA450401;Chemical
MORPHINE;rs7438135;Variant;PA450550;Chemical
MYCOPHENOLATE MOFETIL;rs7438135;Variant;PA450566;Chemical
CYP2C9;Hypoglycemia;Disease;PA126;Gene
NOS1AP;Hypoglycemia;Disease;PA142671259;Gene
CYP2C9*1;Hypoglycemia;Disease;PA165816542;Haplotype
CYP2C9*2;Hypoglycemia;Disease;PA165816543;Haplotype
CYP2C9*3;Hypoglycemia;Disease;PA165816544;Haplotype
RS10494366;Hypoglycemia;Disease;PA166153802;Variant
RS2736308;Osteonecrosis of the jaw;Disease;PA166256641;Variant
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs2886059;Variant;PA447197;Disease
METHYLPHENIDATE;rs2886059;Variant;PA450464;Chemical
BREAST NEOPLASMS;rs4880;Variant;PA443560;Disease
EPILEPSY;rs4880;Variant;PA444065;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs4880;Variant;PA446155;Disease
ASPARAGINASE;rs4880;Variant;PA448492;Chemical
CYCLOPHOSPHAMIDE;rs4880;Variant;PA449165;Chemical
METHOTREXATE;rs4880;Variant;PA450428;Chemical
PACLITAXEL;rs4880;Variant;PA450761;Chemical
VALPROIC ACID;rs4880;Variant;PA451846;Chemical
ASTHMA;rs11587213;Variant;PA443450;Disease
ASPIRIN;rs11587213;Variant;PA448497;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs2916205;Variant;PA164713366;Chemical
PSORIASIS;rs2916205;Variant;PA445451;Disease
MYELOSUPPRESSION;TPMT*8;Haplotype;PA165817398;Disease
DISCONTINUATION;TPMT*8;Haplotype;PA166123507;Disease
TPMT;TPMT*8;Haplotype;PA356;Gene
INFLAMMATION;TPMT*8;Haplotype;PA444620;Disease
AZATHIOPRINE;TPMT*8;Haplotype;PA448515;Chemical
MERCAPTOPURINE;TPMT*8;Haplotype;PA450379;Chemical
THIOGUANINE;TPMT*8;Haplotype;PA451663;Chemical
MIDAZOLAM;CYP3A4*44;Haplotype;PA450496;Chemical
KETANSERIN;rs130060;Variant;PA131053734;Chemical
DIHYDROERGOTAMINE;rs130060;Variant;PA164743028;Chemical
METHYSERGIDE;rs130060;Variant;PA164743265;Chemical
SUMATRIPTAN;rs130060;Variant;PA451566;Chemical
SCHIZOPHRENIA;rs13429709;Variant;PA447216;Disease
CLOZAPINE;rs13429709;Variant;PA449061;Chemical
OLANZAPINE;rs13429709;Variant;PA450688;Chemical
RS2231142;Other general anesthetics;Chemical;PA166156544;Variant
RS1799971;Other general anesthetics;Chemical;PA166156991;Variant
OPRM1;Other general anesthetics;Chemical;PA31945;Gene
ABCG2;Other general anesthetics;Chemical;PA390;Gene
CYP2C9;aceclofenac;Chemical;PA126;Gene
CYP2C9*1;aceclofenac;Chemical;PA165816542;Haplotype
CYP2C9*2;aceclofenac;Chemical;PA165816543;Haplotype
CYP2C9*3;aceclofenac;Chemical;PA165816544;Haplotype
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-C*04:07;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-C*04:07;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-C*04:07;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-C*04:07;Haplotype;PA450616;Chemical
CYP2D6;pitolisant;Chemical;PA128;Gene
HRH3;pitolisant;Chemical;PA29458;Gene
DULOXETINE;rs4437856;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs4437856;Variant;PA447321;Disease
ANEMIA;RXRA;Gene;PA443340;Disease
NASOPHARYNGEAL NEOPLASMS;RXRA;Gene;PA445046;Disease
NEUTROPENIA;RXRA;Gene;PA445113;Disease
DOCETAXEL;RXRA;Gene;PA449383;Chemical
KIDNEY TRANSPLANTATION;rs2066844;Variant;PA165817016;Disease
TACROLIMUS;rs2066844;Variant;PA451578;Chemical
ALCOHOL ABUSE;KLB;Gene;PA443309;Disease
ETHANOL;KLB;Gene;PA448073;Chemical
CRIZOTINIB;crizotinib M10;Chemical;PA165946122;Chemical
FOLH1;lutetium (177lu) vipivotide tetraxetan;Chemical;PA28205;Gene
DRUG TOXICITY;rs2647087;Variant;PA443937;Disease
PANCREATITIS;rs2647087;Variant;PA445220;Disease
INFLAMMATORY BOWEL DISEASES;rs2647087;Variant;PA446116;Disease
AZATHIOPRINE;rs2647087;Variant;PA448515;Chemical
MERCAPTOPURINE;rs2647087;Variant;PA450379;Chemical
PEGINTERFERON ALFA-2A;rs8103142;Variant;PA164749390;Chemical
PEGINTERFERON ALFA-2B;rs8103142;Variant;PA164784024;Chemical
HEPATITIS C VIRUS INFECTION;rs8103142;Variant;PA444445;Disease
RIBAVIRIN;rs8103142;Variant;PA451241;Chemical
IFNL3;sofosbuvir / velpatasvir / voxilaprevir;Chemical;PA134952671;Gene
HLA-A*31:01;Erythema multiforme NOS;Disease;PA165954030;Haplotype
HLA-A;Erythema multiforme NOS;Disease;PA35055;Gene
FLUOROURACIL;rs77769901;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs77769901;Variant;PA443560;Disease
NEUTROPENIA;rs77769901;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs77769901;Variant;PA449165;Chemical
EPIRUBICIN;rs77769901;Variant;PA449476;Chemical
TRIHEPTANOIN;HADHA;Gene;PA166350462;Chemical
ASPIRIN-INDUCED ASTHMA;rs11819745;Variant;PA131285571;Disease
ASTHMA;rs11819745;Variant;PA443450;Disease
ASPIRIN;rs11819745;Variant;PA448497;Chemical
CYP2D6;aripiprazole lauroxil;Chemical;PA128;Gene
PROSTATIC NEOPLASMS;BRIP1;Gene;PA445425;Disease
CYP3A4;mifepristone;Chemical;PA130;Gene
ABCB1;mifepristone;Chemical;PA267;Gene
CYP2B6;pyrazinamide;Chemical;PA123;Gene
CYP2C19;pyrazinamide;Chemical;PA124;Gene
CYP2C9;pyrazinamide;Chemical;PA126;Gene
CYP2B6*1;pyrazinamide;Chemical;PA165818750;Haplotype
CYP2B6*6;pyrazinamide;Chemical;PA165818762;Haplotype
GSTM1 NULL;pyrazinamide;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;pyrazinamide;Chemical;PA166048676;Haplotype
GSTT1 NULL;pyrazinamide;Chemical;PA166048678;Haplotype
GSTT1 NON-NULL;pyrazinamide;Chemical;PA166048679;Haplotype
RS4986893;pyrazinamide;Chemical;PA166154070;Variant
RS9332096;pyrazinamide;Chemical;PA166154097;Variant
RS1800629;pyrazinamide;Chemical;PA166156997;Variant
RS1041983;pyrazinamide;Chemical;PA166157549;Variant
RS4646244;pyrazinamide;Chemical;PA166157603;Variant
NAT2;pyrazinamide;Chemical;PA18;Gene
GSTM1;pyrazinamide;Chemical;PA182;Gene
GSTT1;pyrazinamide;Chemical;PA183;Gene
TNF;pyrazinamide;Chemical;PA435;Gene
ECULIZUMAB;AQP4;Gene;PA164776637;Chemical
INEBILIZUMAB;AQP4;Gene;PA166224921;Chemical
SATRALIZUMAB;AQP4;Gene;PA166235323;Chemical
RAVULIZUMAB;AQP4;Gene;PA166277861;Chemical
CYP2A6;varenicline;Chemical;PA121;Gene
HYKK;varenicline;Chemical;PA165478483;Gene
RS588765;varenicline;Chemical;PA166154841;Variant
RS16969968;varenicline;Chemical;PA166154938;Variant
RS1044396;varenicline;Chemical;PA166155912;Variant
RS503464;varenicline;Chemical;PA166175850;Variant
RS7164594;varenicline;Chemical;PA166184140;Variant
RS2036527;varenicline;Chemical;PA166185387;Variant
CHRFAM7A;varenicline;Chemical;PA26483;Gene
CHRNA4;varenicline;Chemical;PA26490;Gene
CHRNA5;varenicline;Chemical;PA26491;Gene
ARIPIPRAZOLE;POLG;Gene;PA10026;Chemical
DULOXETINE;POLG;Gene;PA10066;Chemical
ESCITALOPRAM;POLG;Gene;PA10074;Chemical
DIVALPROEX SODIUM;POLG;Gene;PA164783479;Chemical
TOXIC LIVER DISEASE;POLG;Gene;PA164925725;Disease
AMITRIPTYLINE;POLG;Gene;PA448385;Chemical
BUPROPION;POLG;Gene;PA448687;Chemical
BUSPIRONE;POLG;Gene;PA448689;Chemical
CARBAMAZEPINE;POLG;Gene;PA448785;Chemical
CITALOPRAM;POLG;Gene;PA449015;Chemical
DIAZEPAM;POLG;Gene;PA449283;Chemical
FLUOXETINE;POLG;Gene;PA449673;Chemical
LAMOTRIGINE;POLG;Gene;PA450164;Chemical
MIRTAZAPINE;POLG;Gene;PA450522;Chemical
MODAFINIL;POLG;Gene;PA450530;Chemical
NORTRIPTYLINE;POLG;Gene;PA450657;Chemical
OLANZAPINE;POLG;Gene;PA450688;Chemical
OXCARBAZEPINE;POLG;Gene;PA450732;Chemical
PAROXETINE;POLG;Gene;PA450801;Chemical
PHENYTOIN;POLG;Gene;PA450947;Chemical
QUETIAPINE;POLG;Gene;PA451201;Chemical
RISPERIDONE;POLG;Gene;PA451257;Chemical
SERTRALINE;POLG;Gene;PA451333;Chemical
TRAZODONE;POLG;Gene;PA451744;Chemical
VALPROIC ACID;POLG;Gene;PA451846;Chemical
VENLAFAXINE;POLG;Gene;PA451866;Chemical
ZIPRASIDONE;POLG;Gene;PA451974;Chemical
CYP2C9;deuruxolitinib;Chemical;PA126;Gene
BUFURALOL;CYP2D6*47;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*47;Haplotype;PA166127651;Chemical
DEXTROMETHORPHAN;CYP2D6*47;Haplotype;PA449273;Chemical
PRIMAQUINE;CYP2D6*47;Haplotype;PA451103;Chemical
DEXTROMETHORPHAN;CYP2D6*59;Haplotype;PA449273;Chemical
PROPAFENONE;CYP2D6*59;Haplotype;PA451131;Chemical
SPARTEINE;CYP2D6*59;Haplotype;PA452610;Chemical
RHEUMATOID ARTHRITIS;rs1901633;Variant;PA443434;Disease
METHOTREXATE;rs1901633;Variant;PA450428;Chemical
ESCITALOPRAM;FKBP5;Gene;PA10074;Chemical
CORTICOSTEROIDS;FKBP5;Gene;PA10832;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;FKBP5;Gene;PA164713257;Chemical
CROHN DISEASE;FKBP5;Gene;PA443815;Disease
DEPRESSIVE DISORDER;FKBP5;Gene;PA447207;Disease
MOOD DISORDER;FKBP5;Gene;PA447209;Disease
SCHIZOPHRENIA;FKBP5;Gene;PA447216;Disease
DEPRESSION;FKBP5;Gene;PA447278;Disease
MAJOR DEPRESSIVE DISORDER;FKBP5;Gene;PA447321;Disease
BUPROPION;FKBP5;Gene;PA448687;Chemical
CITALOPRAM;FKBP5;Gene;PA449015;Chemical
CLOMIPRAMINE;FKBP5;Gene;PA449048;Chemical
CLOZAPINE;FKBP5;Gene;PA449061;Chemical
FLUOXETINE;FKBP5;Gene;PA449673;Chemical
GEMCITABINE;FKBP5;Gene;PA449748;Chemical
LITHIUM;FKBP5;Gene;PA450243;Chemical
MIRTAZAPINE;FKBP5;Gene;PA450522;Chemical
NEFAZODONE;FKBP5;Gene;PA450603;Chemical
PAROXETINE;FKBP5;Gene;PA450801;Chemical
VENLAFAXINE;FKBP5;Gene;PA451866;Chemical
ANTIDEPRESSANTS;FKBP5;Gene;PA452229;Chemical
GLUCOCORTICOIDS;FKBP5;Gene;PA452347;Chemical
FTO;Irritable Bowel Syndrome;Disease;PA152208656;Gene
RS2413739;Irritable Bowel Syndrome;Disease;PA166156100;Variant
RS79206939;Irritable Bowel Syndrome;Disease;PA166160976;Variant
RS16952570;Irritable Bowel Syndrome;Disease;PA166160979;Variant
PACSIN2;Irritable Bowel Syndrome;Disease;PA32897;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;IL17A;Gene;PA164713366;Chemical
ULCERATIVE COLITIS;IL17A;Gene;PA443750;Disease
PAIN, POSTOPERATIVE;IL17A;Gene;PA445210;Disease
INFLAMMATORY BOWEL DISEASES;IL17A;Gene;PA446116;Disease
OPIOIDS;IL17A;Gene;PA452618;Chemical
G6PD DEFICIENCY;nalidixic acid;Chemical;PA166157959;Variant
G6PD;nalidixic acid;Chemical;PA28469;Gene
MURAGLITAZAR;rs2368564;Variant;PA162356187;Chemical
DIABETES MELLITUS;rs2368564;Variant;PA443886;Disease
EDEMA;rs2368564;Variant;PA443994;Disease
HYPERLIPIDEMIAS;rs2368564;Variant;PA444528;Disease
CYP2D6;granisetron;Chemical;PA128;Gene
CYP3A4;granisetron;Chemical;PA130;Gene
CYP3A5;granisetron;Chemical;PA131;Gene
NOS1AP;granisetron;Chemical;PA142671259;Gene
ERCC1;granisetron;Chemical;PA155;Gene
CYP2D6*1;granisetron;Chemical;PA165816576;Haplotype
CYP1A1*1;granisetron;Chemical;PA165860672;Haplotype
CYP1A1*2A;granisetron;Chemical;PA165860673;Haplotype
CYP2D6*1XN;granisetron;Chemical;PA165988479;Haplotype
CYP3A5*1;granisetron;Chemical;PA166128213;Haplotype
CYP3A5*3;granisetron;Chemical;PA166128219;Haplotype
RS10494366;granisetron;Chemical;PA166153802;Variant
RS3212986;granisetron;Chemical;PA166155407;Variant
RS1045642;granisetron;Chemical;PA166157284;Variant
ABCB1;granisetron;Chemical;PA267;Gene
CYP1A1;granisetron;Chemical;PA27092;Gene
OMEPRAZOLE;rs1393133490;Variant;PA450704;Chemical
HYPERTENSION;rs10995;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs10995;Variant;PA449899;Chemical
MAJOR DEPRESSIVE DISORDER;rs2973049;Variant;PA447321;Disease
PAROXETINE;rs2973049;Variant;PA450801;Chemical
BENZODIAZEPINE DERIVATIVES;GAL;Gene;PA10402;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;GAL;Gene;PA164713257;Chemical
HEROIN DEPENDENCE;GAL;Gene;PA444460;Disease
OPIOID-RELATED DISORDERS;GAL;Gene;PA445043;Disease
MAJOR DEPRESSIVE DISORDER;GAL;Gene;PA447321;Disease
MIRTAZAPINE;GAL;Gene;PA450522;Chemical
ANTIDEPRESSANTS;GAL;Gene;PA452229;Chemical
OPIOIDS;GAL;Gene;PA452618;Chemical
HEROIN;GAL;Gene;PA452619;Chemical
G6PD;moviprep;Chemical;PA28469;Gene
REPAGLINIDE;rs2276706;Variant;PA451234;Chemical
DIABETES MELLITUS, TYPE 2;CHKA;Gene;PA443890;Disease
ABCB1;XR9051;Chemical;PA267;Gene
PLATINUM COMPOUNDS;rs1690924;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs1690924;Variant;PA443622;Disease
HYPERTENSION;ZMAT4;Gene;PA444552;Disease
ATENOLOL;ZMAT4;Gene;PA448499;Chemical
ABIRATERONE;CYP17A1;Gene;PA166123407;Chemical
GLUCOCORTICOIDS;CYP17A1;Gene;PA452347;Chemical
CABOZANTINIB;CYP3A4*32;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*32;Haplotype;PA165958362;Chemical
REGORAFENIB;CYP3A4*32;Haplotype;PA166114943;Chemical
VANDETANIB;CYP3A4*32;Haplotype;PA166118341;Chemical
IBRUTINIB;CYP3A4*32;Haplotype;PA166121346;Chemical
BREXPIPRAZOLE;CYP3A4*32;Haplotype;PA166160053;Chemical
ACALABRUTINIB;CYP3A4*32;Haplotype;PA166198581;Chemical
AMIODARONE;CYP3A4*32;Haplotype;PA448383;Chemical
IBUPROFEN;CYP3A4*32;Haplotype;PA449957;Chemical
LIDOCAINE;CYP3A4*32;Haplotype;PA450226;Chemical
METHADONE;CYP3A4*32;Haplotype;PA450401;Chemical
OXYCODONE;CYP3A4*32;Haplotype;PA450741;Chemical
SILDENAFIL;CYP3A4*32;Haplotype;PA451346;Chemical
TESTOSTERONE;CYP3A4*32;Haplotype;PA451627;Chemical
HEROIN DEPENDENCE;rs3762555;Variant;PA444460;Disease
METHADONE;rs3762555;Variant;PA450401;Chemical
CYP2C19;dipyrone;Chemical;PA124;Gene
CYP2C9;dipyrone;Chemical;PA126;Gene
CYP2C9*1;dipyrone;Chemical;PA165816542;Haplotype
CYP2C9*3;dipyrone;Chemical;PA165816544;Haplotype
NAT2*4;dipyrone;Chemical;PA165949098;Haplotype
NAT2*5A;dipyrone;Chemical;PA165949099;Haplotype
CYP2C19*1;dipyrone;Chemical;PA165980634;Haplotype
CYP2C19*2;dipyrone;Chemical;PA165980635;Haplotype
NAT2*6;dipyrone;Chemical;PA165981635;Haplotype
NAT2*7;dipyrone;Chemical;PA165981636;Haplotype
NAT2*14;dipyrone;Chemical;PA165981640;Haplotype
NAT2;dipyrone;Chemical;PA18;Gene
COLORECTAL NEOPLASMS;rs12132152;Variant;PA446108;Disease
CAPECITABINE;rs12132152;Variant;PA448771;Chemical
DULOXETINE;rs55881666;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs55881666;Variant;PA447321;Disease
NON-SMALL CELL LUNG CARCINOMA;DOCK8;Gene;PA443622;Disease
THROMBOCYTOPENIA;DOCK8;Gene;PA445846;Disease
CARBOPLATIN;DOCK8;Gene;PA448803;Chemical
GEMCITABINE;DOCK8;Gene;PA449748;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*40:01;Haplotype;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-B*40:01;Haplotype;PA166120929;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*40:01;Haplotype;PA444059;Disease
EPILEPSY;HLA-B*40:01;Haplotype;PA444065;Disease
SEIZURES;HLA-B*40:01;Haplotype;PA445629;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*40:01;Haplotype;PA445738;Disease
HIV INFECTIONS;HLA-B*40:01;Haplotype;PA447230;Disease
CARBAMAZEPINE;HLA-B*40:01;Haplotype;PA448785;Chemical
LAMIVUDINE;HLA-B*40:01;Haplotype;PA450163;Chemical
NEVIRAPINE;HLA-B*40:01;Haplotype;PA450616;Chemical
OXCARBAZEPINE;HLA-B*40:01;Haplotype;PA450732;Chemical
STAVUDINE;HLA-B*40:01;Haplotype;PA451494;Chemical
DRUG TOXICITY;rs1868089;Variant;PA443937;Disease
SORAFENIB;rs1868089;Variant;PA7000;Chemical
ASTHMA;rs7179742;Variant;PA443450;Disease
ASPIRIN;rs7179742;Variant;PA448497;Chemical
CYCS;CASP9;Gene;PA134981636;Gene
CASP3;CASP9;Gene;PA26087;Gene
AZATHIOPRINE;CASP9;Gene;PA448515;Chemical
CELECOXIB;CASP9;Gene;PA448871;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;rs2965667;Variant;PA164712462;Chemical
COLORECTAL NEOPLASMS;rs2965667;Variant;PA446108;Disease
ASPIRIN;rs2965667;Variant;PA448497;Chemical
RS3215400;Hand-foot syndrome;Disease;PA166153738;Variant
RS45445694;Hand-foot syndrome;Disease;PA166155331;Variant
RS3832043;Hand-foot syndrome;Disease;PA166155718;Variant
RS7574296;Hand-foot syndrome;Disease;PA166155765;Variant
RS1870377;Hand-foot syndrome;Disease;PA166156528;Variant
RS1800629;Hand-foot syndrome;Disease;PA166156997;Variant
RS2010963;Hand-foot syndrome;Disease;PA166157006;Variant
RS2032582;Hand-foot syndrome;Disease;PA166157316;Variant
RS3025040;Hand-foot syndrome;Disease;PA166159965;Variant
RS143414470;Hand-foot syndrome;Disease;PA166165332;Variant
ANK3;Hand-foot syndrome;Disease;PA24800;Gene
ABCB1;Hand-foot syndrome;Disease;PA267;Gene
KDR;Hand-foot syndrome;Disease;PA30086;Gene
TYMS;Hand-foot syndrome;Disease;PA359;Gene
VEGFA;Hand-foot syndrome;Disease;PA37302;Gene
UGT1A9;Hand-foot syndrome;Disease;PA419;Gene
TNF;Hand-foot syndrome;Disease;PA435;Gene
CDA;Hand-foot syndrome;Disease;PA98;Gene
PLCB1;GNB2;Gene;PA33384;Gene
PLCB2;GNB2;Gene;PA33385;Gene
PLCB3;GNB2;Gene;PA33386;Gene
PLCB4;GNB2;Gene;PA33387;Gene
DRUG TOXICITY;rs12366035;Variant;PA443937;Disease
SORAFENIB;rs12366035;Variant;PA7000;Chemical
CYP3A4;astemizole;Chemical;PA130;Gene
KCNH2;astemizole;Chemical;PA212;Gene
ABCB1;astemizole;Chemical;PA267;Gene
CYP2J2;astemizole;Chemical;PA27112;Gene
METRELEPTIN;BSCL2;Gene;PA166235301;Chemical
ALCOHOL ABUSE;rs13135092;Variant;PA443309;Disease
ETHANOL;rs13135092;Variant;PA448073;Chemical
SODIUM BENZOATE / SODIUM PHENYLACETATE;ASL;Gene;PA166176020;Chemical
GLYCEROL PHENYLBUTYRATE;ASL;Gene;PA166268801;Chemical
METABOLIC SYNDROME;rs3091244;Variant;PA162370415;Disease
FENOFIBRATE;rs3091244;Variant;PA449594;Chemical
RS1024323;Nephrosclerosis;Disease;PA166156499;Variant
RS702553;Nephrosclerosis;Disease;PA166156738;Variant
GRK4;Nephrosclerosis;Disease;PA28941;Gene
PDE4D;Nephrosclerosis;Disease;PA33130;Gene
CFTR;rs1800112;Variant;PA109;Gene
IVACAFTOR;rs1800112;Variant;PA165950341;Chemical
CYP3A4;lonafarnib;Chemical;PA130;Gene
RS11623866;lonafarnib;Chemical;PA166154823;Variant
LMNA;lonafarnib;Chemical;PA231;Gene
FNTB;lonafarnib;Chemical;PA28202;Gene
ZMPSTE24;lonafarnib;Chemical;PA37466;Gene
ASTHMA;rs2392165;Variant;PA443450;Disease
BUDESONIDE;rs2392165;Variant;PA448681;Chemical
MAPK1;GRK3;Gene;PA30616;Gene
ADRB2;GRK3;Gene;PA39;Gene
ATP1A1;GRK3;Gene;PA62;Gene
DIFLUORODEOXYURIDINE;rs4655226;Variant;PA166131569;Chemical
NEOPLASMS;rs4655226;Variant;PA445062;Disease
F2;ethinyl estradiol / norelgestromin;Chemical;PA157;Gene
F5;ethinyl estradiol / norelgestromin;Chemical;PA159;Gene
RS6025;ethinyl estradiol / norelgestromin;Chemical;PA166153554;Variant
RS1801131;ethinyl estradiol / norelgestromin;Chemical;PA166153643;Variant
RS1801133;ethinyl estradiol / norelgestromin;Chemical;PA166153644;Variant
RS1799963;ethinyl estradiol / norelgestromin;Chemical;PA166154336;Variant
MTHFR;ethinyl estradiol / norelgestromin;Chemical;PA245;Gene
PROC;ethinyl estradiol / norelgestromin;Chemical;PA33799;Gene
PROS1;ethinyl estradiol / norelgestromin;Chemical;PA33809;Gene
SERPINC1;ethinyl estradiol / norelgestromin;Chemical;PA35026;Gene
PLATELET AGGREGATION;MED12L;Gene;PA166123766;Disease
CLOPIDOGREL;MED12L;Gene;PA449053;Chemical
CYTARABINE;MED12L;Gene;PA449177;Chemical
ESCITALOPRAM;rs696692;Variant;PA10074;Chemical
DEPRESSIVE DISORDER;rs696692;Variant;PA447207;Disease
CITALOPRAM;rs696692;Variant;PA449015;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;UGT1A6;Gene;PA130620651;Chemical
OXALIPLATIN;UGT1A6;Gene;PA131285527;Chemical
SN-38;UGT1A6;Gene;PA165110775;Chemical
FEBUXOSTAT;UGT1A6;Gene;PA165958521;Chemical
TEGAFUR / GIMERACIL / OTERACIL;UGT1A6;Gene;PA166115442;Chemical
DEFERIPRONE;UGT1A6;Gene;PA166118041;Chemical
RS2229774;UGT1A6;Gene;PA166154532;Variant
RS17863783;UGT1A6;Gene;PA166155854;Variant
RS7853758;UGT1A6;Gene;PA166157790;Variant
COLONIC NEOPLASMS;UGT1A6;Gene;PA443756;Disease
EPILEPSY;UGT1A6;Gene;PA444065;Disease
GOUT;UGT1A6;Gene;PA444318;Disease
NEOPLASMS;UGT1A6;Gene;PA445062;Disease
OSTEOSARCOMA;UGT1A6;Gene;PA445601;Disease
VOMITING;UGT1A6;Gene;PA446051;Disease
COLORECTAL NEOPLASMS;UGT1A6;Gene;PA446108;Disease
BETA-THALASSEMIA;UGT1A6;Gene;PA446432;Disease
SCHIZOPHRENIA;UGT1A6;Gene;PA447216;Disease
ACETAMINOPHEN;UGT1A6;Gene;PA448015;Chemical
ALLOPURINOL;UGT1A6;Gene;PA448320;Chemical
ASPIRIN;UGT1A6;Gene;PA448497;Chemical
DAUNORUBICIN;UGT1A6;Gene;PA449212;Chemical
DOXORUBICIN;UGT1A6;Gene;PA449412;Chemical
IRINOTECAN;UGT1A6;Gene;PA450085;Chemical
METHOTREXATE;UGT1A6;Gene;PA450428;Chemical
PHENOBARBITAL;UGT1A6;Gene;PA450911;Chemical
PHENYTOIN;UGT1A6;Gene;PA450947;Chemical
RISPERIDONE;UGT1A6;Gene;PA451257;Chemical
VALPROIC ACID;UGT1A6;Gene;PA451846;Chemical
TENOFOVIR;rs9349256;Variant;PA10204;Chemical
NEPHROTOXICITY;rs9349256;Variant;PA162263533;Disease
TENOFOVIR DISOPROXIL FUMARATE;rs9349256;Variant;PA166201941;Chemical
HIV INFECTIOUS DISEASE;rs9349256;Variant;PA447230;Disease
TPMT;TPMT*16;Haplotype;PA356;Gene
CROHN DISEASE;TPMT*16;Haplotype;PA443815;Disease
AZATHIOPRINE;TPMT*16;Haplotype;PA448515;Chemical
MERCAPTOPURINE;TPMT*16;Haplotype;PA450379;Chemical
THIOGUANINE;TPMT*16;Haplotype;PA451663;Chemical
CETUXIMAB;MGAT4A;Gene;PA10040;Chemical
BEVACIZUMAB;MGAT4A;Gene;PA130232992;Chemical
OXALIPLATIN;MGAT4A;Gene;PA131285527;Chemical
COLORECTAL NEOPLASMS;MGAT4A;Gene;PA446108;Disease
CAPECITABINE;MGAT4A;Gene;PA448771;Chemical
FLUOROURACIL;CYP2A6;Gene;PA128406956;Chemical
OXALIPLATIN;CYP2A6;Gene;PA131285527;Chemical
COUMARIN;CYP2A6;Gene;PA134521193;Chemical
DRUGS USED IN NICOTINE DEPENDENCE;CYP2A6;Gene;PA164712720;Chemical
VARENICLINE;CYP2A6;Gene;PA164781343;Chemical
ARTEMISININ;CYP2A6;Gene;PA165111696;Chemical
ARTESUNATE;CYP2A6;Gene;PA165111697;Chemical
3,5-DIMETHYL-2-(3-PYRIDYL)THIAZOLIDIN-4-ONE;CYP2A6;Gene;PA165958321;Chemical
COTININE;CYP2A6;Gene;PA166114414;Chemical
TEGAFUR / GIMERACIL / OTERACIL;CYP2A6;Gene;PA166115442;Chemical
PROGRESSION-FREE SURVIVAL;CYP2A6;Gene;PA166123026;Disease
CESSATION;CYP2A6;Gene;PA166123046;Disease
OVERALL SURVIVAL;CYP2A6;Gene;PA166123207;Disease
BILIARY TRACT NEOPLASMS;CYP2A6;Gene;PA166128807;Disease
3-HYDROXYCOTININE;CYP2A6;Gene;PA166131262;Chemical
BREAST NEOPLASMS;CYP2A6;Gene;PA443560;Disease
CARCINOMA, NON-SMALL-CELL LUNG;CYP2A6;Gene;PA443622;Disease
EPILEPSY;CYP2A6;Gene;PA444065;Disease
LUNG NEOPLASMS;CYP2A6;Gene;PA444818;Disease
NEOPLASMS;CYP2A6;Gene;PA445062;Disease
RECURRENCE;CYP2A6;Gene;PA445506;Disease
STOMACH NEOPLASMS;CYP2A6;Gene;PA445742;Disease
TOBACCO USE DISORDER;CYP2A6;Gene;PA445876;Disease
COLORECTAL NEOPLASMS;CYP2A6;Gene;PA446108;Disease
HIV INFECTIONS;CYP2A6;Gene;PA447230;Disease
ACETAMINOPHEN;CYP2A6;Gene;PA448015;Chemical
BUPROPION;CYP2A6;Gene;PA448687;Chemical
CAFFEINE;CYP2A6;Gene;PA448710;Chemical
DOCETAXEL;CYP2A6;Gene;PA449383;Chemical
EFAVIRENZ;CYP2A6;Gene;PA449441;Chemical
IRINOTECAN;CYP2A6;Gene;PA450085;Chemical
LETROZOLE;CYP2A6;Gene;PA450196;Chemical
METHOXSALEN;CYP2A6;Gene;PA450433;Chemical
METRONIDAZOLE;CYP2A6;Gene;PA450484;Chemical
NICOTINE;CYP2A6;Gene;PA450626;Chemical
PILOCARPINE;CYP2A6;Gene;PA450962;Chemical
VALPROIC ACID;CYP2A6;Gene;PA451846;Chemical
ZIDOVUDINE;CYP2A6;Gene;PA451954;Chemical
TEGAFUR;CYP2A6;Gene;PA452620;Chemical
CFTR;rs113993960;Variant;PA109;Gene
IVACAFTOR;rs113993960;Variant;PA165950341;Chemical
LUMACAFTOR;rs113993960;Variant;PA166114483;Chemical
ADVERSE EVENTS;rs113993960;Variant;PA166151827;Disease
IVACAFTOR / LUMACAFTOR;rs113993960;Variant;PA166152935;Chemical
LATONDUINE A;rs113993960;Variant;PA166153449;Chemical
CORR-4A;rs113993960;Variant;PA166158935;Chemical
CAVOSONSTAT;rs113993960;Variant;PA166163226;Chemical
TEZACAFTOR;rs113993960;Variant;PA166175754;Chemical
CYSTIC FIBROSIS PULMONARY EXACERBATION;rs113993960;Variant;PA166175756;Disease
IVACAFTOR / TEZACAFTOR;rs113993960;Variant;PA166179845;Chemical
ELEXACAFTOR;rs113993960;Variant;PA166185161;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs113993960;Variant;PA166190041;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs113993960;Variant;PA166362502;Chemical
CYSTIC FIBROSIS;rs113993960;Variant;PA443829;Disease
EXOCRINE PANCREATIC INSUFFICIENCY;rs113993960;Variant;PA445217;Disease
CYSTEAMINE;rs113993960;Variant;PA449171;Chemical
ALCOHOL ABUSE;rs1381376;Variant;PA443309;Disease
ETHANOL;rs1381376;Variant;PA448073;Chemical
RADIOTHERAPY;rs6432512;Variant;PA166122986;Chemical
PROSTATIC NEOPLASMS;rs6432512;Variant;PA445425;Disease
EPILEPSY;rs2071197;Variant;PA444065;Disease
CARBAMAZEPINE;rs2071197;Variant;PA448785;Chemical
LAMOTRIGINE;rs2071197;Variant;PA450164;Chemical
FLUOROURACIL;rs1760944;Variant;PA128406956;Chemical
RADIOTHERAPY;rs1760944;Variant;PA166122986;Chemical
OVERALL SURVIVAL;rs1760944;Variant;PA166123207;Disease
CARCINOMA, SQUAMOUS CELL;rs1760944;Variant;PA443626;Disease
CISPLATIN;rs1760944;Variant;PA449014;Chemical
ACE INHIBITORS, PLAIN;rs145489027;Variant;PA164712308;Chemical
BREAST NEOPLASMS;rs3211371;Variant;PA443560;Disease
TOBACCO USE DISORDER;rs3211371;Variant;PA445876;Disease
BUPROPION;rs3211371;Variant;PA448687;Chemical
CYCLOPHOSPHAMIDE;rs3211371;Variant;PA449165;Chemical
DOXORUBICIN;rs3211371;Variant;PA449412;Chemical
EFAVIRENZ;rs3211371;Variant;PA449441;Chemical
METHADONE;rs3211371;Variant;PA450401;Chemical
TPMT*1;Skin Neoplasms;Disease;PA165819268;Haplotype
TPMT*3A;Skin Neoplasms;Disease;PA165819270;Haplotype
TPMT*3B;Skin Neoplasms;Disease;PA165819271;Haplotype
TPMT*3C;Skin Neoplasms;Disease;PA165819272;Haplotype
TPMT;Skin Neoplasms;Disease;PA356;Gene
DICLOFENAC;CYP2C9*59;Haplotype;PA449293;Chemical
LOSARTAN;CYP2C9*59;Haplotype;PA450268;Chemical
TOLBUTAMIDE;CYP2C9*59;Haplotype;PA451718;Chemical
WARFARIN;CYP2C9*59;Haplotype;PA451906;Chemical
PLATINUM COMPOUNDS;rs7958904;Variant;PA164713176;Chemical
LUNG NEOPLASMS;rs7958904;Variant;PA444818;Disease
HYPERTENSION;rs12346562;Variant;PA444552;Disease
ATENOLOL;rs12346562;Variant;PA448499;Chemical
BISOPROLOL;rs12346562;Variant;PA448641;Chemical
HYDROCHLOROTHIAZIDE;rs12346562;Variant;PA449899;Chemical
HMG COA REDUCTASE INHIBITORS;rs1062033;Variant;PA133950441;Chemical
MENOPAUSE;rs1062033;Variant;PA166048848;Disease
BREAST NEOPLASMS;rs1062033;Variant;PA443560;Disease
LETROZOLE;rs1062033;Variant;PA450196;Chemical
PROSTATIC NEOPLASMS;rs12418;Variant;PA445425;Disease
DOCETAXEL;rs12418;Variant;PA449383;Chemical
THALIDOMIDE;rs12418;Variant;PA451644;Chemical
RS121913459;asciminib;Chemical;PA166157848;Variant
ABL1;asciminib;Chemical;PA24413;Gene
BCR;asciminib;Chemical;PA25321;Gene
G6PD B (REFERENCE);sulfadoxine;Chemical;PA165947826;Haplotype
G6PD MEDITERRANEAN, DALLAS, PANAMA, SASSARI, CAGLIARI, BIRMINGHAM;sulfadoxine;Chemical;PA166121127;Haplotype
RS1050828;sulfadoxine;Chemical;PA166157859;Variant
G6PD;sulfadoxine;Chemical;PA28469;Gene
IKBKG;sulfadoxine;Chemical;PA29777;Gene
ESCITALOPRAM;rs4646427;Variant;PA10074;Chemical
MAJOR DEPRESSIVE DISORDER;rs4646427;Variant;PA447321;Disease
PAROXETINE;rs4646427;Variant;PA450801;Chemical
NON-SMALL CELL LUNG CARCINOMA;POLR2A;Gene;PA443622;Disease
GEMCITABINE;POLR2A;Gene;PA449748;Chemical
NUDT1;8-oxo-dGTP;Chemical;PA31830;Gene
CFTR;rs36210737;Variant;PA109;Gene
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs36210737;Variant;PA166190041;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs36210737;Variant;PA166362502;Chemical
CYSTIC FIBROSIS;rs36210737;Variant;PA443829;Disease
HYPERTENSION;RGS2;Gene;PA444552;Disease
SCHIZOPHRENIA;RGS2;Gene;PA447216;Disease
HALOPERIDOL;RGS2;Gene;PA449841;Chemical
ANTIPSYCHOTICS;RGS2;Gene;PA452233;Chemical
PROSTATIC NEOPLASMS;rs12960;Variant;PA445425;Disease
DOCETAXEL;rs12960;Variant;PA449383;Chemical
THALIDOMIDE;rs12960;Variant;PA451644;Chemical
ASPIRIN;rs10279545;Variant;PA448497;Chemical
ASTHMA;IRF1;Gene;PA443450;Disease
FGFR1OP;PIK3C2B;Gene;PA134941638;Gene
FGFR1OP2;PIK3C2B;Gene;PA134972108;Gene
AKT1;PIK3C2B;Gene;PA24684;Gene
AKT2;PIK3C2B;Gene;PA24685;Gene
AKT3;PIK3C2B;Gene;PA24686;Gene
FGFR1;PIK3C2B;Gene;PA28127;Gene
FGFR2;PIK3C2B;Gene;PA28128;Gene
FGFR3;PIK3C2B;Gene;PA28129;Gene
FGFR4;PIK3C2B;Gene;PA28130;Gene
FGFR3P1;PIK3C2B;Gene;PA28131;Gene
FGFRL1;PIK3C2B;Gene;PA28132;Gene
FLT1;PIK3C2B;Gene;PA28180;Gene
FLT4;PIK3C2B;Gene;PA28183;Gene
HRH2;PIK3C2B;Gene;PA29457;Gene
KDR;PIK3C2B;Gene;PA30086;Gene
TOBACCO USE DISORDER;rs2717162;Variant;PA445876;Disease
BUPROPION;rs2717162;Variant;PA448687;Chemical
NICOTINE;rs2717162;Variant;PA450626;Chemical
MULTIPLE MYELOMA;rs4630;Variant;PA444985;Disease
THALIDOMIDE;rs4630;Variant;PA451644;Chemical
HMG COA REDUCTASE INHIBITORS;rs12654264;Variant;PA133950441;Chemical
COLONIC NEOPLASMS;rs12654264;Variant;PA443756;Disease
BIPOLAR DISORDER;rs1521470;Variant;PA447199;Disease
LITHIUM;rs1521470;Variant;PA450243;Chemical
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-DQB1*06:09;Haplotype;PA166120929;Disease
DRUG HYPERSENSITIVITY;HLA-DQB1*06:09;Haplotype;PA443936;Disease
URTICARIA;HLA-DQB1*06:09;Haplotype;PA445999;Disease
HIV INFECTIONS;HLA-DQB1*06:09;Haplotype;PA447230;Disease
ASPIRIN;HLA-DQB1*06:09;Haplotype;PA448497;Chemical
LAMOTRIGINE;HLA-DQB1*06:09;Haplotype;PA450164;Chemical
NEVIRAPINE;HLA-DQB1*06:09;Haplotype;PA450616;Chemical
COMT;naloxone;Chemical;PA117;Gene
RS4680;naloxone;Chemical;PA166156024;Variant
RS1799971;naloxone;Chemical;PA166156991;Variant
OPRM1;naloxone;Chemical;PA31945;Gene
G6PD DEFICIENCY;sulfanilamide;Chemical;PA166157959;Variant
G6PD;sulfanilamide;Chemical;PA28469;Gene
CLODRONATE;rs731236;Variant;PA10239;Chemical
CALCIUM;rs731236;Variant;PA164712582;Chemical
DEFERASIROX;rs731236;Variant;PA164760843;Chemical
OSTEITIS DEFORMANS;rs731236;Variant;PA445172;Disease
BETA-THALASSEMIA AND RELATED DISEASES;rs731236;Variant;PA446432;Disease
PAIN, POSTOPERATIVE;rs6961071;Variant;PA445210;Disease
FENTANYL;rs6961071;Variant;PA449599;Chemical
ARMS2;ranibizumab;Chemical;PA162376896;Gene
RS1061170;ranibizumab;Chemical;PA166153617;Variant
RS2070296;ranibizumab;Chemical;PA166153991;Variant
RS11200638;ranibizumab;Chemical;PA166154135;Variant
RS699947;ranibizumab;Chemical;PA166156938;Variant
RS833069;ranibizumab;Chemical;PA166156960;Variant
RS2010963;ranibizumab;Chemical;PA166157006;Variant
RS3025000;ranibizumab;Chemical;PA166157058;Variant
CFH;ranibizumab;Chemical;PA29261;Gene
NRP1;ranibizumab;Chemical;PA31783;Gene
HTRA1;ranibizumab;Chemical;PA33829;Gene
VEGFA;ranibizumab;Chemical;PA37302;Gene
ELOSULFASE ALFA;GALNS;Gene;PA166159062;Chemical
SCHIZOPHRENIA;rs2061051;Variant;PA447216;Disease
ANTIPSYCHOTICS;rs2061051;Variant;PA452233;Chemical
MAJOR DEPRESSIVE DISORDER;rs2228478;Variant;PA447321;Disease
DESIPRAMINE;rs2228478;Variant;PA449233;Chemical
ODEVIXIBAT;NOTCH2;Gene;PA166268805;Chemical
DESFLURANE;rs112563513;Variant;PA164749136;Chemical
RYR1;rs112563513;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs112563513;Variant;PA444863;Disease
ENFLURANE;rs112563513;Variant;PA449461;Chemical
HALOTHANE;rs112563513;Variant;PA449845;Chemical
ISOFLURANE;rs112563513;Variant;PA450106;Chemical
METHOXYFLURANE;rs112563513;Variant;PA450434;Chemical
SEVOFLURANE;rs112563513;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs112563513;Variant;PA451522;Chemical
CACNA1S;rs112563513;Variant;PA85;Gene
PEGINTERFERON ALFA-2A;rs11506105;Variant;PA164749390;Chemical
PEGINTERFERON ALFA-2B;rs11506105;Variant;PA164784024;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;rs11506105;Variant;PA446863;Disease
RIBAVIRIN;rs11506105;Variant;PA451241;Chemical
BONE DISEASES;rs10161126;Variant;PA443532;Disease
ALENDRONATE;rs10161126;Variant;PA448082;Chemical
VOLATILE ANESTHETICS;rs193922752;Variant;PA166131630;Chemical
MALIGNANT HYPERTHERMIA;rs193922752;Variant;PA444863;Disease
SUCCINYLCHOLINE;rs193922752;Variant;PA451522;Chemical
MYELOSUPPRESSION;rs746071566;Variant;PA165817398;Disease
AUTOIMMUNE DISEASES;rs746071566;Variant;PA443464;Disease
LEUKOPENIA;rs746071566;Variant;PA444773;Disease
PANCYTOPENIA;rs746071566;Variant;PA445221;Disease
THROMBOCYTOPENIA;rs746071566;Variant;PA445846;Disease
INFLAMMATORY BOWEL DISEASES;rs746071566;Variant;PA446116;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;rs746071566;Variant;PA446155;Disease
AZATHIOPRINE;rs746071566;Variant;PA448515;Chemical
MERCAPTOPURINE;rs746071566;Variant;PA450379;Chemical
THIOGUANINE;rs746071566;Variant;PA451663;Chemical
BUPROPION;rs201500445;Variant;PA448687;Chemical
EFAVIRENZ;rs201500445;Variant;PA449441;Chemical
ALLOPURINOL;rs4148155;Variant;PA448320;Chemical
ANXIETY DISORDERS;rs6296;Variant;PA447196;Disease
MAJOR DEPRESSIVE DISORDER;rs6296;Variant;PA447321;Disease
CITALOPRAM;rs6296;Variant;PA449015;Chemical
MAP2K7;MAPK4;Gene;PA284;Gene
MAP2K1;MAPK4;Gene;PA30584;Gene
MAP2K2;MAPK4;Gene;PA30587;Gene
MAP2K3;MAPK4;Gene;PA30588;Gene
MAP2K4;MAPK4;Gene;PA30589;Gene
MAP2K5;MAPK4;Gene;PA30590;Gene
MAP2K6;MAPK4;Gene;PA30591;Gene
SORAFENIB;MAPK4;Gene;PA7000;Chemical
SLC22A1;Headache;Disease;PA329;Gene
ABCB1;elacridar;Chemical;PA267;Gene
ABCG2;elacridar;Chemical;PA390;Gene
FLUOROURACIL;rs2292997;Variant;PA128406956;Chemical
COLORECTAL NEOPLASMS;rs2292997;Variant;PA446108;Disease
IRINOTECAN;rs2292997;Variant;PA450085;Chemical
LEUCOVORIN;rs2292997;Variant;PA450198;Chemical
MAPK1;SRC;Gene;PA30616;Gene
ARRB1;SRC;Gene;PA59;Gene
ARRB2;SRC;Gene;PA60;Gene
ASTHMA;rs6475448;Variant;PA443450;Disease
MONTELUKAST;rs6475448;Variant;PA450546;Chemical
ESR1;capivasertib;Chemical;PA156;Gene
AKT1;capivasertib;Chemical;PA24684;Gene
ERBB2;capivasertib;Chemical;PA27844;Gene
ESR2;capivasertib;Chemical;PA27886;Gene
PIK3CA;capivasertib;Chemical;PA33308;Gene
PIK3CD;capivasertib;Chemical;PA33310;Gene
PTEN;capivasertib;Chemical;PA33942;Gene
HMG COA REDUCTASE INHIBITORS;CHRNA1;Gene;PA133950441;Chemical
ECULIZUMAB;CHRNA1;Gene;PA164776637;Chemical
EFGARTIGIMOD ALFA;CHRNA1;Gene;PA166268781;Chemical
RAVULIZUMAB;CHRNA1;Gene;PA166277861;Chemical
ROZANOLIXIZUMAB;CHRNA1;Gene;PA166313325;Chemical
ZILUCOPLAN;CHRNA1;Gene;PA166328901;Chemical
CARDIOMYOPATHIES;CYP2C9*24;Haplotype;PA445018;Disease
WARFARIN;CYP2C9*24;Haplotype;PA451906;Chemical
HYPERTENSION;rs12579720;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs12579720;Variant;PA449899;Chemical
BASAL CELL CARCINOMA;TLR7;Gene;PA443613;Disease
IMIQUIMOD;TLR7;Gene;PA449972;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-C*18:01;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-C*18:01;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-C*18:01;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-C*18:01;Haplotype;PA450616;Chemical
DULOXETINE;rs9824595;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs9824595;Variant;PA447321;Disease
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;rs3761555;Variant;PA164713257;Chemical
MAJOR DEPRESSIVE DISORDER;rs3761555;Variant;PA447321;Disease
VENLAFAXINE;rs3761555;Variant;PA451866;Chemical
ANTIDEPRESSANTS;rs3761555;Variant;PA452229;Chemical
PLATINUM COMPOUNDS;rs10817464;Variant;PA164713176;Chemical
ANEMIA;rs10817464;Variant;PA443340;Disease
LEUKOPENIA;rs10817464;Variant;PA444773;Disease
NAUSEA;rs10817464;Variant;PA445048;Disease
NEUTROPENIA;rs10817464;Variant;PA445113;Disease
THROMBOCYTOPENIA;rs10817464;Variant;PA445846;Disease
VOMITING;rs10817464;Variant;PA446051;Disease
DEBRISOQUINE;CYP2D6*38;Haplotype;PA452616;Chemical
TOBACCO USE DISORDER;rs2072660;Variant;PA445876;Disease
NICOTINE;rs2072660;Variant;PA450626;Chemical
IMMUNOGLOBULINS;COQ8B;Gene;PA164712817;Chemical
MUCOCUTANEOUS LYMPH NODE SYNDROME;COQ8B;Gene;PA444977;Disease
NUDT15;primary graft failure;Disease;PA134963132;Gene
NUDT15*1;primary graft failure;Disease;PA166131619;Haplotype
NUDT15*2;primary graft failure;Disease;PA166131620;Haplotype
NUDT15*3;primary graft failure;Disease;PA166131621;Haplotype
NUDT15*4;primary graft failure;Disease;PA166131622;Haplotype
NUDT15*5;primary graft failure;Disease;PA166131623;Haplotype
RHEUMATOID ARTHRITIS;rs3784864;Variant;PA443434;Disease
METHOTREXATE;rs3784864;Variant;PA450428;Chemical
DEATH;rs3836790;Variant;PA443842;Disease
PARKINSON DISEASE;rs3836790;Variant;PA445254;Disease
TOBACCO USE DISORDER;rs3836790;Variant;PA445876;Disease
COCAINE-RELATED DISORDERS;rs3836790;Variant;PA446878;Disease
COCAINE;rs3836790;Variant;PA449072;Chemical
LEVODOPA;rs3836790;Variant;PA450213;Chemical
METHYLPHENIDATE;rs3836790;Variant;PA450464;Chemical
ABCC2;pitavastatin;Chemical;PA116;Gene
CYP2C9;pitavastatin;Chemical;PA126;Gene
CYP3A4;pitavastatin;Chemical;PA130;Gene
CYP3A5;pitavastatin;Chemical;PA131;Gene
SLCO1B1;pitavastatin;Chemical;PA134865839;Gene
CYP2C9*1;pitavastatin;Chemical;PA165816542;Haplotype
CYP2C9*3;pitavastatin;Chemical;PA165816544;Haplotype
SLCO1B1*37;pitavastatin;Chemical;PA165819251;Haplotype
SLCO1B1*5;pitavastatin;Chemical;PA165819255;Haplotype
SLCO1B1*15;pitavastatin;Chemical;PA165819265;Haplotype
HLA-DRB1*01:01;pitavastatin;Chemical;PA165951320;Haplotype
HLA-DRB1*04:06;pitavastatin;Chemical;PA165951530;Haplotype
SLCO1B1*1;pitavastatin;Chemical;PA165981641;Haplotype
RS717620;pitavastatin;Chemical;PA166153953;Variant
RS2306283;pitavastatin;Chemical;PA166154547;Variant
RS4149056;pitavastatin;Chemical;PA166154579;Variant
HMGCR;pitavastatin;Chemical;PA189;Gene
LDLR;pitavastatin;Chemical;PA227;Gene
HLA-DRB1;pitavastatin;Chemical;PA35072;Gene
PCSK9;pitavastatin;Chemical;PA38617;Gene
ABCG2;pitavastatin;Chemical;PA390;Gene
APOB;pitavastatin;Chemical;PA50;Gene
EFAVIRENZ;rs1969136524;Variant;PA449441;Chemical
PROPOFOL;rs1969136524;Variant;PA451141;Chemical
RHEUMATOID ARTHRITIS;rs719235;Variant;PA443434;Disease
METHOTREXATE;rs719235;Variant;PA450428;Chemical
COMT;naltrexone;Chemical;PA117;Gene
ANKK1;naltrexone;Chemical;PA134872551;Gene
DBH;naltrexone;Chemical;PA136;Gene
RS4654327;naltrexone;Chemical;PA166153773;Variant
RS1800497;naltrexone;Chemical;PA166154339;Variant
RS671;naltrexone;Chemical;PA166154482;Variant
RS698;naltrexone;Chemical;PA166156476;Variant
RS2066702;naltrexone;Chemical;PA166156533;Variant
RS1799971;naltrexone;Chemical;PA166156991;Variant
RS1611115;naltrexone;Chemical;PA166157734;Variant
RS17134592;naltrexone;Chemical;PA166161792;Variant
RS12749274;naltrexone;Chemical;PA166258761;Variant
RS3829125;naltrexone;Chemical;PA166260301;Variant
ADH1B;naltrexone;Chemical;PA24571;Gene
ADH1C;naltrexone;Chemical;PA24572;Gene
AKR1C4;naltrexone;Chemical;PA24680;Gene
ALDH2;naltrexone;Chemical;PA24696;Gene
DRD2;naltrexone;Chemical;PA27478;Gene
OPRD1;naltrexone;Chemical;PA31942;Gene
OPRM1;naltrexone;Chemical;PA31945;Gene
WARFARIN;rs12714145;Variant;PA451906;Chemical
ADALIMUMAB;TNFRSF1A;Gene;PA10004;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;TNFRSF1A;Gene;PA164713366;Chemical
RHEUMATOID ARTHRITIS;TNFRSF1A;Gene;PA443434;Disease
CROHN DISEASE;TNFRSF1A;Gene;PA443815;Disease
INFLAMMATORY BOWEL DISEASES;TNFRSF1A;Gene;PA446116;Disease
ARTHRITIS, PSORIATIC;TNFRSF1A;Gene;PA446198;Disease
ETANERCEPT;TNFRSF1A;Gene;PA449515;Chemical
INFLIXIMAB;TNFRSF1A;Gene;PA452639;Chemical
HEROIN DEPENDENCE;rs2189814;Variant;PA444460;Disease
HEROIN;rs2189814;Variant;PA452619;Chemical
ACE;interferon beta-1a;Chemical;PA139;Gene
ZNF697;interferon beta-1a;Chemical;PA142670495;Gene
GAPVD1;interferon beta-1a;Chemical;PA142671748;Gene
HLA-DRB1*04:01;interferon beta-1a;Chemical;PA165951493;Haplotype
HLA-B*15:01;interferon beta-1a;Chemical;PA165954745;Haplotype
RS4278350;interferon beta-1a;Chemical;PA166153763;Variant
RS10494227;interferon beta-1a;Chemical;PA166153801;Variant
RS12044852;interferon beta-1a;Chemical;PA166153841;Variant
RS3133084;interferon beta-1a;Chemical;PA166154394;Variant
RS1799752;interferon beta-1a;Chemical;PA166155187;Variant
RS760316;interferon beta-1a;Chemical;PA166156293;Variant
RS9272105;interferon beta-1a;Chemical;PA166157134;Variant
RS1448673;interferon beta-1a;Chemical;PA166157296;Variant
RS2291858;interferon beta-1a;Chemical;PA166157750;Variant
RS10760397;interferon beta-1a;Chemical;PA166157811;Variant
RS10819043;interferon beta-1a;Chemical;PA166157818;Variant
RS2205986;interferon beta-1a;Chemical;PA166179805;Variant
RS4774388;interferon beta-1a;Chemical;PA166203235;Variant
CD58;interferon beta-1a;Chemical;PA26227;Gene
FHIT;interferon beta-1a;Chemical;PA28140;Gene
IRF6;interferon beta-1a;Chemical;PA29920;Gene
RORA;interferon beta-1a;Chemical;PA34630;Gene
HLA-B;interferon beta-1a;Chemical;PA35056;Gene
HLA-DQA1;interferon beta-1a;Chemical;PA35066;Gene
HLA-DRB1;interferon beta-1a;Chemical;PA35072;Gene
TOCILIZUMAB;rs4910008;Variant;PA165292659;Chemical
RHEUMATOID ARTHRITIS;rs4910008;Variant;PA443434;Disease
ALCOHOL ABUSE;rs2533200;Variant;PA443309;Disease
ETHANOL;rs2533200;Variant;PA448073;Chemical
OTOTOXICITY;rs28358572;Variant;PA162263534;Disease
AMINOGLYCOSIDE ANTIBACTERIALS;rs28358572;Variant;PA452167;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs4877847;Variant;PA130620651;Chemical
NEOPLASMS;rs4877847;Variant;PA445062;Disease
DIARRHEA;rs17682789;Variant;PA443899;Disease
SORAFENIB;rs17682789;Variant;PA7000;Chemical
SLC31A1;overall survival;Disease;PA118;Gene
CYP2A6;overall survival;Disease;PA121;Gene
CYP2C19;overall survival;Disease;PA124;Gene
CYP2D6;overall survival;Disease;PA128;Gene
C18ORF56;overall survival;Disease;PA134956204;Gene
CYP2D6*1;overall survival;Disease;PA165816576;Haplotype
CYP2D6*2;overall survival;Disease;PA165816577;Haplotype
CYP2D6*3;overall survival;Disease;PA165816578;Haplotype
CYP2D6*4;overall survival;Disease;PA165816579;Haplotype
CYP2D6*10;overall survival;Disease;PA165816582;Haplotype
CYP2D6*41;overall survival;Disease;PA165816584;Haplotype
CYP2A6*1;overall survival;Disease;PA165924690;Haplotype
CYP2A6*4;overall survival;Disease;PA165924721;Haplotype
CYP2A6*7;overall survival;Disease;PA165924731;Haplotype
CYP2A6*10;overall survival;Disease;PA165924735;Haplotype
CYP2D6*5;overall survival;Disease;PA165948092;Haplotype
CYP2C19*1;overall survival;Disease;PA165980634;Haplotype
CYP2C19*2;overall survival;Disease;PA165980635;Haplotype
CYP2A6*9;overall survival;Disease;PA165980914;Haplotype
CYP2D6*35;overall survival;Disease;PA165988487;Haplotype
UGT1A1*1;overall survival;Disease;PA166115841;Haplotype
UGT1A1*28;overall survival;Disease;PA166115842;Haplotype
UGT1A1*6;overall survival;Disease;PA166115858;Haplotype
RS4149117;overall survival;Disease;PA166154583;Variant
RS7311358;overall survival;Disease;PA166154602;Variant
RS1042522;overall survival;Disease;PA166155173;Variant
RS45445694;overall survival;Disease;PA166155331;Variant
RS1799782;overall survival;Disease;PA166155370;Variant
RS1615111;overall survival;Disease;PA166156518;Variant
RS4979223;overall survival;Disease;PA166179445;Variant
RS10759637;overall survival;Disease;PA166179462;Variant
RS2233914;overall survival;Disease;PA166179466;Variant
RS11280056;overall survival;Disease;PA166180936;Variant
RS1760944;overall survival;Disease;PA166238764;Variant
RS2229300;overall survival;Disease;PA166337441;Variant
APEX1;overall survival;Disease;PA201059;Gene
AREG;overall survival;Disease;PA24933;Gene
ARHGAP9;overall survival;Disease;PA24962;Gene
GLI1;overall survival;Disease;PA28720;Gene
OSGEP;overall survival;Disease;PA32834;Gene
SLCO1B3;overall survival;Disease;PA35844;Gene
TYMS;overall survival;Disease;PA359;Gene
TP53;overall survival;Disease;PA36679;Gene
XRCC1;overall survival;Disease;PA369;Gene
UGT1A1;overall survival;Disease;PA420;Gene
HLA-DRB1*15:01;anakinra;Chemical;PA165952269;Haplotype
NLRP3;anakinra;Chemical;PA26512;Gene
HLA-DRB1;anakinra;Chemical;PA35072;Gene
CYP2D6;n,o-didesmethyltramadol;Chemical;PA128;Gene
CYP2D6*1;n,o-didesmethyltramadol;Chemical;PA165816576;Haplotype
CYP2D6*2;n,o-didesmethyltramadol;Chemical;PA165816577;Haplotype
CYP2D6*3;n,o-didesmethyltramadol;Chemical;PA165816578;Haplotype
CYP2D6*4;n,o-didesmethyltramadol;Chemical;PA165816579;Haplotype
CYP2D6*10;n,o-didesmethyltramadol;Chemical;PA165816582;Haplotype
CYP2D6*41;n,o-didesmethyltramadol;Chemical;PA165816584;Haplotype
CYP2D6*5;n,o-didesmethyltramadol;Chemical;PA165948092;Haplotype
CYP2D6*9;n,o-didesmethyltramadol;Chemical;PA165948317;Haplotype
CYP2D6*35;n,o-didesmethyltramadol;Chemical;PA165988487;Haplotype
WEIGHT GAIN;rs11872992;Variant;PA128406954;Disease
SCHIZOPHRENIA;rs11872992;Variant;PA447216;Disease
CLOZAPINE;rs11872992;Variant;PA449061;Chemical
OLANZAPINE;rs11872992;Variant;PA450688;Chemical
PRKAA1;STK11;Gene;PA33744;Gene
PRKAA2;STK11;Gene;PA33745;Gene
PRKAB1;STK11;Gene;PA33746;Gene
PRKAB2;STK11;Gene;PA33747;Gene
PRKAG1;STK11;Gene;PA33751;Gene
PRKAG2;STK11;Gene;PA33752;Gene
PRKAG3;STK11;Gene;PA33753;Gene
PEUTZ-JEGHERS SYNDROME;STK11;Gene;PA445307;Disease
BIPOLAR DISORDER;rs2826494;Variant;PA447199;Disease
LITHIUM;rs2826494;Variant;PA450243;Chemical
CYP2C9;hormonal contraceptives for systemic use;Chemical;PA126;Gene
F2;hormonal contraceptives for systemic use;Chemical;PA157;Gene
F5;hormonal contraceptives for systemic use;Chemical;PA159;Gene
RS6025;hormonal contraceptives for systemic use;Chemical;PA166153554;Variant
RS1799853;hormonal contraceptives for systemic use;Chemical;PA166153972;Variant
RS1799963;hormonal contraceptives for systemic use;Chemical;PA166154336;Variant
RS8176719;hormonal contraceptives for systemic use;Chemical;PA166170086;Variant
RS2289252;hormonal contraceptives for systemic use;Chemical;PA166170089;Variant
RS56392308;hormonal contraceptives for systemic use;Chemical;PA166170092;Variant
RS4379368;hormonal contraceptives for systemic use;Chemical;PA166170093;Variant
RS710446;hormonal contraceptives for systemic use;Chemical;PA166170094;Variant
KNG1;hormonal contraceptives for systemic use;Chemical;PA225;Gene
ABO;hormonal contraceptives for systemic use;Chemical;PA24415;Gene
SUGCT;hormonal contraceptives for systemic use;Chemical;PA25942;Gene
F11;hormonal contraceptives for systemic use;Chemical;PA27941;Gene
FLUOROURACIL;rs115232898;Variant;PA128406956;Chemical
DPYD;rs115232898;Variant;PA145;Gene
NEOPLASMS;rs115232898;Variant;PA445062;Disease
CAPECITABINE;rs115232898;Variant;PA448771;Chemical
TEGAFUR;rs115232898;Variant;PA452620;Chemical
TRIHEPTANOIN;HADHB;Gene;PA166350462;Chemical
G6PD A- 202A_376G;pegloticase;Chemical;PA165947827;Haplotype
G6PD DEFICIENCY;pegloticase;Chemical;PA166157959;Variant
G6PD;pegloticase;Chemical;PA28469;Gene
RS1801131;Vitamin B-complex, Incl. Combinations;Chemical;PA166153643;Variant
RS1801133;Vitamin B-complex, Incl. Combinations;Chemical;PA166153644;Variant
MTHFR;Vitamin B-complex, Incl. Combinations;Chemical;PA245;Gene
PEGINTERFERON ALFA-2A;rs8105790;Variant;PA164749390;Chemical
PEGINTERFERON ALFA-2B;rs8105790;Variant;PA164784024;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;rs8105790;Variant;PA446863;Disease
RIBAVIRIN;rs8105790;Variant;PA451241;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;GRIA3;Gene;PA164713257;Chemical
SUICIDE;GRIA3;Gene;PA165374639;Disease
DEPRESSION;GRIA3;Gene;PA447278;Disease
MAJOR DEPRESSIVE DISORDER;GRIA3;Gene;PA447321;Disease
CITALOPRAM;GRIA3;Gene;PA449015;Chemical
VENLAFAXINE;GRIA3;Gene;PA451866;Chemical
ANTIDEPRESSANTS;GRIA3;Gene;PA452229;Chemical
PRALSETINIB;rs74799832;Variant;PA166235321;Chemical
RET;rs74799832;Variant;PA34335;Gene
CRIZOTINIB;ROS1;Gene;PA165946122;Chemical
LORLATINIB;ROS1;Gene;PA166182743;Chemical
ENTRECTINIB;ROS1;Gene;PA166190161;Chemical
CEMIPLIMAB-RWLC;ROS1;Gene;PA166251401;Chemical
REPOTRECTINIB;ROS1;Gene;PA166328881;Chemical
ALK;ROS1;Gene;PA24719;Gene
CARCINOMA, NON-SMALL-CELL LUNG;ROS1;Gene;PA443622;Disease
ITOPRIDE;rs2266782;Variant;PA152432599;Chemical
SULINDAC;rs2266782;Variant;PA451565;Chemical
ANTIEPILEPTICS;CPS1;Gene;PA143485705;Chemical
SODIUM PHENYLBUTYRATE;CPS1;Gene;PA166114316;Chemical
SODIUM BENZOATE / SODIUM PHENYLACETATE;CPS1;Gene;PA166176020;Chemical
GLYCEROL PHENYLBUTYRATE;CPS1;Gene;PA166268801;Chemical
EPILEPSY;CPS1;Gene;PA444065;Disease
HYPERAMMONEMIA;CPS1;Gene;PA447146;Disease
L-METHIONINE;CPS1;Gene;PA450423;Chemical
VALPROIC ACID;CPS1;Gene;PA451846;Chemical
ALCOHOL ABUSE;PDE4B;Gene;PA443309;Disease
ETHANOL;PDE4B;Gene;PA448073;Chemical
ARRB1;PDE4B;Gene;PA59;Gene
ARRB2;PDE4B;Gene;PA60;Gene
BREAST NEOPLASMS;rs747199;Variant;PA443560;Disease
GEMCITABINE;rs747199;Variant;PA449748;Chemical
PACLITAXEL;rs747199;Variant;PA450761;Chemical
SCHIZOPHRENIA;rs10917670;Variant;PA447216;Disease
RISPERIDONE;rs10917670;Variant;PA451257;Chemical
HYPERTENSION;rs4387287;Variant;PA444552;Disease
ATENOLOL;rs4387287;Variant;PA448499;Chemical
KIDNEY TRANSPLANTATION;rs846910;Variant;PA165817016;Disease
TACROLIMUS;rs846910;Variant;PA451578;Chemical
IMATINIB;BCL2L11;Gene;PA10804;Chemical
CORTICOSTEROIDS;BCL2L11;Gene;PA10832;Chemical
NEOPLASMS;BCL2L11;Gene;PA445062;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;BCL2L11;Gene;PA446155;Disease
FLUOROURACIL;rs3917412;Variant;PA128406956;Chemical
OXALIPLATIN;rs3917412;Variant;PA131285527;Chemical
COLONIC NEOPLASMS;rs3917412;Variant;PA443756;Disease
CAPECITABINE;rs3917412;Variant;PA448771;Chemical
LEUCOVORIN;rs3917412;Variant;PA450198;Chemical
RS6500265;loxoprofen;Chemical;PA166176206;Variant
RS9933632;loxoprofen;Chemical;PA166176208;Variant
VALACICLOVIR;loxoprofen;Chemical;PA451839;Chemical
FLUOROURACIL;rs9389568;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs9389568;Variant;PA443560;Disease
NEUTROPENIA;rs9389568;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs9389568;Variant;PA449165;Chemical
EPIRUBICIN;rs9389568;Variant;PA449476;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs17645700;Variant;PA130620651;Chemical
NEOPLASMS;rs17645700;Variant;PA445062;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs1947275;Variant;PA447197;Disease
METHYLPHENIDATE;rs1947275;Variant;PA450464;Chemical
RUBELLA VACCINES;HLA-B*35:03;Haplotype;PA164713242;Chemical
ESCITALOPRAM;rs352428;Variant;PA10074;Chemical
MAJOR DEPRESSIVE DISORDER;rs352428;Variant;PA447321;Disease
CITALOPRAM;rs352428;Variant;PA449015;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;rs639174;Variant;PA446155;Disease
CYCLOPHOSPHAMIDE;rs639174;Variant;PA449165;Chemical
CYTARABINE;rs639174;Variant;PA449177;Chemical
DAUNORUBICIN;rs639174;Variant;PA449212;Chemical
MERCAPTOPURINE;rs639174;Variant;PA450379;Chemical
METHOTREXATE;rs639174;Variant;PA450428;Chemical
PREDNISONE;rs639174;Variant;PA451100;Chemical
VINCRISTINE;rs639174;Variant;PA451879;Chemical
ANKS1B;amisulpride;Chemical;PA128394692;Gene
RABEP1;amisulpride;Chemical;PA134884097;Gene
SH2B1;amisulpride;Chemical;PA145148084;Gene
RS1079597;amisulpride;Chemical;PA166154315;Variant
RS489693;amisulpride;Chemical;PA166155269;Variant
RS17782313;amisulpride;Chemical;PA166155330;Variant
RS10042486;amisulpride;Chemical;PA166156855;Variant
RS2229109;amisulpride;Chemical;PA166157334;Variant
RS7968606;amisulpride;Chemical;PA166163521;Variant
RS3888190;amisulpride;Chemical;PA166165398;Variant
RS1000940;amisulpride;Chemical;PA166165401;Variant
HTR1A;amisulpride;Chemical;PA192;Gene
ABCB1;amisulpride;Chemical;PA267;Gene
DRD2;amisulpride;Chemical;PA27478;Gene
MC4R;amisulpride;Chemical;PA30676;Gene
CFTR;corr-4a;Chemical;PA109;Gene
RS113993960;corr-4a;Chemical;PA166157525;Variant
HLA-DRB1*15:01;Jaundice;Disease;PA165952269;Haplotype
UGT1A1*1;Jaundice;Disease;PA166115841;Haplotype
UGT1A1*28;Jaundice;Disease;PA166115842;Haplotype
UGT1A1*36;Jaundice;Disease;PA166115843;Haplotype
G6PD DEFICIENCY;Jaundice;Disease;PA166157959;Variant
G6PD;Jaundice;Disease;PA28469;Gene
HLA-DRB1;Jaundice;Disease;PA35072;Gene
UGT1A1;Jaundice;Disease;PA420;Gene
INSULIN RECOMBINANT;SLC30A8;Gene;PA164744571;Chemical
DIABETES MELLITUS, TYPE 2;SLC30A8;Gene;PA443890;Disease
REPAGLINIDE;SLC30A8;Gene;PA451234;Chemical
ZINC ACETATE;SLC30A8;Gene;PA451961;Chemical
CYP2C19;Proton pump inhibitors;Chemical;PA124;Gene
CYP2C19;nelfinavir;Chemical;PA124;Gene
CYP3A4;nelfinavir;Chemical;PA130;Gene
CYP3A5;nelfinavir;Chemical;PA131;Gene
CYP2C19*1;nelfinavir;Chemical;PA165980634;Haplotype
CYP2C19*2;nelfinavir;Chemical;PA165980635;Haplotype
RS4244285;nelfinavir;Chemical;PA166154053;Variant
RS1045642;nelfinavir;Chemical;PA166157284;Variant
ABCB1;nelfinavir;Chemical;PA267;Gene
ALCOHOL ABUSE;rs1001179;Variant;PA443309;Disease
ETHANOL;rs1001179;Variant;PA448073;Chemical
ABL1;blinatumomab;Chemical;PA24413;Gene
BCR;blinatumomab;Chemical;PA25321;Gene
CD19;blinatumomab;Chemical;PA26192;Gene
EPILEPSY;CYP2C9*55;Haplotype;PA444065;Disease
DICLOFENAC;CYP2C9*55;Haplotype;PA449293;Chemical
PHENYTOIN;CYP2C9*55;Haplotype;PA450947;Chemical
HIV INFECTIOUS DISEASE;rs8192726;Variant;PA447230;Disease
EFAVIRENZ;rs8192726;Variant;PA449441;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*61;Haplotype;PA166127651;Chemical
PRIMAQUINE;CYP2D6*61;Haplotype;PA451103;Chemical
MAPK8;MAFG;Gene;PA283;Gene
MAPK14;MAFG;Gene;PA30621;Gene
NORCLOBAZAM;GABRA2;Gene;PA166169929;Chemical
COCAINE DEPENDENCE;GABRA2;Gene;PA446878;Disease
COCAINE;GABRA2;Gene;PA449072;Chemical
SEVOFLURANE;GABRA2;Gene;PA451341;Chemical
CYP2C19;ambrisentan;Chemical;PA124;Gene
CYP2C19*17;ambrisentan;Chemical;PA165816533;Haplotype
CYP2C19*1;ambrisentan;Chemical;PA165980634;Haplotype
CYP2C19*2;ambrisentan;Chemical;PA165980635;Haplotype
CYP2C19*3;ambrisentan;Chemical;PA165980636;Haplotype
CYP2C19*4;ambrisentan;Chemical;PA165980637;Haplotype
TOBACCO USE DISORDER;CYP2A6*39;Haplotype;PA445876;Disease
NICOTINE;CYP2A6*39;Haplotype;PA450626;Chemical
ECULIZUMAB;CHRNA7;Gene;PA164776637;Chemical
EFGARTIGIMOD ALFA;CHRNA7;Gene;PA166268781;Chemical
RAVULIZUMAB;CHRNA7;Gene;PA166277861;Chemical
ROZANOLIXIZUMAB;CHRNA7;Gene;PA166313325;Chemical
ZILUCOPLAN;CHRNA7;Gene;PA166328901;Chemical
ALZHEIMER DISEASE;CHRNA7;Gene;PA443319;Disease
DONEPEZIL;CHRNA7;Gene;PA449394;Chemical
GALANTAMINE;CHRNA7;Gene;PA449726;Chemical
NICOTINE;CHRNA7;Gene;PA450626;Chemical
RIVASTIGMINE;CHRNA7;Gene;PA451262;Chemical
CYP3A4;dorzolamide;Chemical;PA130;Gene
TOBACCO USE DISORDER;rs3743078;Variant;PA445876;Disease
NICOTINE;rs3743078;Variant;PA450626;Chemical
L-METHIONINE;PSPH;Gene;PA450423;Chemical
CES1;irinotecan;Chemical;PA107;Gene
ABCC2;irinotecan;Chemical;PA116;Gene
CYP2A6;irinotecan;Chemical;PA121;Gene
SLCO1B1;irinotecan;Chemical;PA134865839;Gene
DCBLD1;irinotecan;Chemical;PA134903108;Gene
C18ORF56;irinotecan;Chemical;PA134956204;Gene
C8ORF34;irinotecan;Chemical;PA142672353;Gene
DPYD;irinotecan;Chemical;PA145;Gene
KLC1;irinotecan;Chemical;PA162393424;Gene
CYP2A6*1;irinotecan;Chemical;PA165924690;Haplotype
CYP2A6*4;irinotecan;Chemical;PA165924721;Haplotype
CYP2A6*7;irinotecan;Chemical;PA165924731;Haplotype
CYP2A6*9;irinotecan;Chemical;PA165980914;Haplotype
UGT1A1*1;irinotecan;Chemical;PA166115841;Haplotype
UGT1A1*28;irinotecan;Chemical;PA166115842;Haplotype
UGT1A1*37;irinotecan;Chemical;PA166115844;Haplotype
UGT1A1*60;irinotecan;Chemical;PA166115845;Haplotype
UGT1A1*6;irinotecan;Chemical;PA166115858;Haplotype
UGT1A1*27;irinotecan;Chemical;PA166115865;Haplotype
UGT1A6*2A;irinotecan;Chemical;PA166117621;Haplotype
UGT1A7*1A;irinotecan;Chemical;PA166117636;Haplotype
UGT1A7*2;irinotecan;Chemical;PA166117638;Haplotype
UGT1A7*3;irinotecan;Chemical;PA166117639;Haplotype
BILIRUBIN;irinotecan;Chemical;PA166123346;Chemical
RS1056515;irinotecan;Chemical;PA166153615;Variant
RS2273697;irinotecan;Chemical;PA166154007;Variant
RS3740066;irinotecan;Chemical;PA166154028;Variant
RS2306283;irinotecan;Chemical;PA166154547;Variant
RS4149015;irinotecan;Chemical;PA166154574;Variant
RS4149056;irinotecan;Chemical;PA166154579;Variant
RS16950650;irinotecan;Chemical;PA166154751;Variant
RS861539;irinotecan;Chemical;PA166154768;Variant
RS9597;irinotecan;Chemical;PA166154979;Variant
RS3743527;irinotecan;Chemical;PA166155049;Variant
RS7186128;irinotecan;Chemical;PA166155076;Variant
RS1979277;irinotecan;Chemical;PA166155196;Variant
RS45445694;irinotecan;Chemical;PA166155331;Variant
RS1800469;irinotecan;Chemical;PA166155372;Variant
RS2070959;irinotecan;Chemical;PA166155665;Variant
RS3832043;irinotecan;Chemical;PA166155718;Variant
RS4124874;irinotecan;Chemical;PA166155720;Variant
RS10929302;irinotecan;Chemical;PA166155794;Variant
RS11563250;irinotecan;Chemical;PA166155802;Variant
RS11692021;irinotecan;Chemical;PA166155809;Variant
RS6072262;irinotecan;Chemical;PA166155955;Variant
RS225440;irinotecan;Chemical;PA166155976;Variant
RS1051266;irinotecan;Chemical;PA166155986;Variant
RS2292997;irinotecan;Chemical;PA166156354;Variant
RS3749438;irinotecan;Chemical;PA166156376;Variant
RS10937158;irinotecan;Chemical;PA166156440;Variant
RS1353295;irinotecan;Chemical;PA166156509;Variant
RS2231137;irinotecan;Chemical;PA166156543;Variant
RS7699188;irinotecan;Chemical;PA166156632;Variant
RS9996584;irinotecan;Chemical;PA166156635;Variant
RS11942466;irinotecan;Chemical;PA166156656;Variant
RS13104811;irinotecan;Chemical;PA166156663;Variant
RS699947;irinotecan;Chemical;PA166156938;Variant
RS9351963;irinotecan;Chemical;PA166157147;Variant
RS17574269;irinotecan;Chemical;PA166157193;Variant
RS712829;irinotecan;Chemical;PA166157262;Variant
RS712830;irinotecan;Chemical;PA166157263;Variant
RS7779029;irinotecan;Chemical;PA166157427;Variant
RS1517114;irinotecan;Chemical;PA166157561;Variant
RS10934498;irinotecan;Chemical;PA166159102;Variant
RS3087465;irinotecan;Chemical;PA166161126;Variant
RS12720066;irinotecan;Chemical;PA166161538;Variant
RS17501331;irinotecan;Chemical;PA166161570;Variant
RS11574077;irinotecan;Chemical;PA166179077;Variant
RS2233678;irinotecan;Chemical;PA166181044;Variant
ABCC1;irinotecan;Chemical;PA244;Gene
ABCG1;irinotecan;Chemical;PA24408;Gene
AREG;irinotecan;Chemical;PA24933;Gene
BCHE;irinotecan;Chemical;PA25294;Gene
ABCB1;irinotecan;Chemical;PA267;Gene
KCNQ5;irinotecan;Chemical;PA30077;Gene
SLC19A1;irinotecan;Chemical;PA327;Gene
PIN1;irinotecan;Chemical;PA33320;Gene
RGS5;irinotecan;Chemical;PA34376;Gene
TGFB1;irinotecan;Chemical;PA350;Gene
TOP1;irinotecan;Chemical;PA353;Gene
SEMA3C;irinotecan;Chemical;PA35647;Gene
SHMT1;irinotecan;Chemical;PA35753;Gene
TYMS;irinotecan;Chemical;PA359;Gene
TGFBR2;irinotecan;Chemical;PA36486;Gene
UBE2I;irinotecan;Chemical;PA37134;Gene
UGT1A;irinotecan;Chemical;PA37173;Gene
UGT1A6;irinotecan;Chemical;PA37181;Gene
UGT1A7;irinotecan;Chemical;PA37182;Gene
VDR;irinotecan;Chemical;PA37301;Gene
VEGFA;irinotecan;Chemical;PA37302;Gene
XRCC3;irinotecan;Chemical;PA37422;Gene
CES2;irinotecan;Chemical;PA377;Gene
NR1I2;irinotecan;Chemical;PA378;Gene
ABCG2;irinotecan;Chemical;PA390;Gene
ABCC5;irinotecan;Chemical;PA395;Gene
ABCC4;irinotecan;Chemical;PA397;Gene
UGT1A9;irinotecan;Chemical;PA419;Gene
UGT1A1;irinotecan;Chemical;PA420;Gene
EGFR;irinotecan;Chemical;PA7360;Gene
TOBACCO USE DISORDER;rs11788456;Variant;PA445876;Disease
NICOTINE;rs11788456;Variant;PA450626;Chemical
COMT;codeine;Chemical;PA117;Gene
CYP2D6;codeine;Chemical;PA128;Gene
CYP3A4;codeine;Chemical;PA130;Gene
WBP2NL;codeine;Chemical;PA145147710;Gene
CYP2D6*1;codeine;Chemical;PA165816576;Haplotype
CYP2D6*2;codeine;Chemical;PA165816577;Haplotype
CYP2D6*3;codeine;Chemical;PA165816578;Haplotype
CYP2D6*4;codeine;Chemical;PA165816579;Haplotype
CYP2D6*6;codeine;Chemical;PA165816581;Haplotype
CYP2D6*10;codeine;Chemical;PA165816582;Haplotype
CYP2D6*17;codeine;Chemical;PA165816583;Haplotype
CYP2D6*41;codeine;Chemical;PA165816584;Haplotype
CYP2D6*5;codeine;Chemical;PA165948092;Haplotype
CYP2D6*29;codeine;Chemical;PA165948318;Haplotype
CYP2D6*24;codeine;Chemical;PA165971576;Haplotype
CYP2D6*40;codeine;Chemical;PA165971594;Haplotype
CYP2D6*1XN;codeine;Chemical;PA165988479;Haplotype
CYP2D6*2XN;codeine;Chemical;PA165988480;Haplotype
CYP2D6*36;codeine;Chemical;PA165988488;Haplotype
RS7439366;codeine;Chemical;PA166156619;Variant
RS1799971;codeine;Chemical;PA166156991;Variant
RS1045642;codeine;Chemical;PA166157284;Variant
RS1128503;codeine;Chemical;PA166157288;Variant
CYP2D6 POOR METABOLIZER;codeine;Chemical;PA166157927;Variant
CYP2D6*2X2;codeine;Chemical;PA166228161;Haplotype
RS9620007;codeine;Chemical;PA166257822;Variant
RS62436463;codeine;Chemical;PA166257861;Variant
RS739296;codeine;Chemical;PA166257862;Variant
SEPTIN3;codeine;Chemical;PA24355;Gene
ABCB1;codeine;Chemical;PA267;Gene
OPRM1;codeine;Chemical;PA31945;Gene
SLC22A1;codeine;Chemical;PA329;Gene
UGT2B7;codeine;Chemical;PA361;Gene
MAJOR DEPRESSIVE DISORDER;rs1439050;Variant;PA447321;Disease
ANTIDEPRESSANTS;rs1439050;Variant;PA452229;Chemical
SCN5A;Sudden Infant Death;Disease;PA304;Gene
RS267606618;dibekacin;Chemical;PA166158908;Variant
RS267606619;dibekacin;Chemical;PA166158909;Variant
RS267606617;dibekacin;Chemical;PA166159181;Variant
MT-RNR1;dibekacin;Chemical;PA31274;Gene
BEVACIZUMAB;CXCR4;Gene;PA130232992;Chemical
MAVORIXAFOR;CXCR4;Gene;PA166353004;Chemical
COLORECTAL NEOPLASMS;CXCR4;Gene;PA446108;Disease
KIDNEY TRANSPLANTATION;rs1042597;Variant;PA165817016;Disease
MENOPAUSE;rs1042597;Variant;PA166048848;Disease
SCHIZOPHRENIA;rs1042597;Variant;PA447216;Disease
CYCLOSPORINE;rs1042597;Variant;PA449167;Chemical
MYCOPHENOLATE MOFETIL;rs1042597;Variant;PA450566;Chemical
RALOXIFENE;rs1042597;Variant;PA451221;Chemical
SIROLIMUS;rs1042597;Variant;PA451365;Chemical
TACROLIMUS;rs1042597;Variant;PA451578;Chemical
CETP;lovastatin;Chemical;PA108;Gene
CYP2D6;lovastatin;Chemical;PA128;Gene
CYP3A4;lovastatin;Chemical;PA130;Gene
CYP3A5;lovastatin;Chemical;PA131;Gene
SLCO1B1;lovastatin;Chemical;PA134865839;Gene
CYP2D6*1;lovastatin;Chemical;PA165816576;Haplotype
CYP2D6*10;lovastatin;Chemical;PA165816582;Haplotype
SLCO1B1*5;lovastatin;Chemical;PA165819255;Haplotype
SLCO1B1*15;lovastatin;Chemical;PA165819265;Haplotype
CYP2D6*5;lovastatin;Chemical;PA165948092;Haplotype
SLCO1B1*1;lovastatin;Chemical;PA165981641;Haplotype
RS662799;lovastatin;Chemical;PA166154293;Variant
RS2291073;lovastatin;Chemical;PA166154543;Variant
RS4149056;lovastatin;Chemical;PA166154579;Variant
RS708272;lovastatin;Chemical;PA166154993;Variant
RS688;lovastatin;Chemical;PA166155337;Variant
RS5925;lovastatin;Chemical;PA166155340;Variant
RS17238540;lovastatin;Chemical;PA166156885;Variant
RS776746;lovastatin;Chemical;PA166157267;Variant
HMGCR;lovastatin;Chemical;PA189;Gene
LDLR;lovastatin;Chemical;PA227;Gene
APOA5;lovastatin;Chemical;PA24888;Gene
ABCB1;lovastatin;Chemical;PA267;Gene
CYP4F2;lovastatin;Chemical;PA27121;Gene
NR1I2;lovastatin;Chemical;PA378;Gene
ABCG2;lovastatin;Chemical;PA390;Gene
G6PD DEFICIENCY;Tumor Lysis Syndrome;Disease;PA166157959;Variant
G6PD;Tumor Lysis Syndrome;Disease;PA28469;Gene
OPIOID-RELATED DISORDERS;rs910080;Variant;PA445043;Disease
OPIOIDS;rs910080;Variant;PA452618;Chemical
KIDNEY TRANSPLANTATION;rs2242480;Variant;PA165817016;Disease
ACUTE CELLULAR REJECTION;rs2242480;Variant;PA166114455;Disease
CORONARY ARTERY DISEASE;rs2242480;Variant;PA443796;Disease
EPILEPSY;rs2242480;Variant;PA444065;Disease
HEROIN DEPENDENCE;rs2242480;Variant;PA444460;Disease
HYPERLIPIDEMIAS;rs2242480;Variant;PA444528;Disease
HYPOVENTILATION;rs2242480;Variant;PA444591;Disease
PAIN;rs2242480;Variant;PA445208;Disease
PAIN, POSTOPERATIVE;rs2242480;Variant;PA445210;Disease
LIVER TRANSPLANTATION;rs2242480;Variant;PA447247;Disease
ATORVASTATIN;rs2242480;Variant;PA448500;Chemical
CARBAMAZEPINE;rs2242480;Variant;PA448785;Chemical
CLOPIDOGREL;rs2242480;Variant;PA449053;Chemical
FENTANYL;rs2242480;Variant;PA449599;Chemical
METHADONE;rs2242480;Variant;PA450401;Chemical
SUFENTANIL;rs2242480;Variant;PA451527;Chemical
TACROLIMUS;rs2242480;Variant;PA451578;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*35:10;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*35:10;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*35:10;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-B*35:10;Haplotype;PA450616;Chemical
EVEROLIMUS;rs10515074;Variant;PA164746311;Chemical
BREAST NEOPLASMS;rs10515074;Variant;PA443560;Disease
HYPERGLYCEMIA;rs10515074;Variant;PA444522;Disease
LEUKOPENIA;rs10515074;Variant;PA444773;Disease
SCHIZOPHRENIA;rs742105;Variant;PA447216;Disease
CLOZAPINE;rs742105;Variant;PA449061;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*56:02;Haplotype;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-B*56:02;Haplotype;PA166120929;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*56:02;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*56:02;Haplotype;PA445738;Disease
PHENYTOIN;HLA-B*56:02;Haplotype;PA450947;Chemical
ARIPIPRAZOLE;TAAR6;Gene;PA10026;Chemical
CORTICOSTEROIDS;TAAR6;Gene;PA10832;Chemical
ASTHMA;TAAR6;Gene;PA443450;Disease
SCHIZOPHRENIA;TAAR6;Gene;PA447216;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs4805162;Variant;PA447197;Disease
METHYLPHENIDATE;rs4805162;Variant;PA450464;Chemical
DESFLURANE;rs193922816;Variant;PA164749136;Chemical
RYR1;rs193922816;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs193922816;Variant;PA444863;Disease
ENFLURANE;rs193922816;Variant;PA449461;Chemical
HALOTHANE;rs193922816;Variant;PA449845;Chemical
ISOFLURANE;rs193922816;Variant;PA450106;Chemical
METHOXYFLURANE;rs193922816;Variant;PA450434;Chemical
SEVOFLURANE;rs193922816;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs193922816;Variant;PA451522;Chemical
CACNA1S;rs193922816;Variant;PA85;Gene
ANASTROZOLE;rs3732218;Variant;PA448432;Chemical
CAMK1D;SP1;Gene;PA134992438;Gene
AKT1;SP1;Gene;PA24684;Gene
AKT2;SP1;Gene;PA24685;Gene
AKT3;SP1;Gene;PA24686;Gene
CAMK1;SP1;Gene;PA26048;Gene
CAMK1G;SP1;Gene;PA26049;Gene
MAPK8;SP1;Gene;PA283;Gene
MAPK1;SP1;Gene;PA30616;Gene
MAPK3;SP1;Gene;PA30622;Gene
STAT3;SP1;Gene;PA337;Gene
PRKCA;SP1;Gene;PA33759;Gene
PRKCB;SP1;Gene;PA33761;Gene
PRKCG;SP1;Gene;PA33766;Gene
STAT5A;SP1;Gene;PA338;Gene
STAT1;SP1;Gene;PA36183;Gene
STAT2;SP1;Gene;PA36184;Gene
STAT4;SP1;Gene;PA36185;Gene
STAT5B;SP1;Gene;PA36186;Gene
DIABETES MELLITUS;SP1;Gene;PA443886;Disease
DIABETES MELLITUS, TYPE 2;SP1;Gene;PA443890;Disease
METFORMIN;SP1;Gene;PA450395;Chemical
CAMK2A;SP1;Gene;PA90;Gene
CAMK2B;SP1;Gene;PA91;Gene
CAMK2D;SP1;Gene;PA92;Gene
CAMK2G;SP1;Gene;PA93;Gene
DRUG HYPERSENSITIVITY;HLA-DRB1*09:01;Haplotype;PA443936;Disease
URTICARIA;HLA-DRB1*09:01;Haplotype;PA445999;Disease
HEMATOLOGIC NEOPLASMS;HLA-DRB1*09:01;Haplotype;PA446827;Disease
ALLOPURINOL;HLA-DRB1*09:01;Haplotype;PA448320;Chemical
ASPIRIN;HLA-DRB1*09:01;Haplotype;PA448497;Chemical
DULOXETINE;rs6700741;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs6700741;Variant;PA447321;Disease
ESCITALOPRAM;rs76191705;Variant;PA10074;Chemical
CITALOPRAM;rs76191705;Variant;PA449015;Chemical
IMATINIB;rs9787901;Variant;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;rs9787901;Variant;PA151958383;Disease
NUDT15;NUDT15*2;Haplotype;PA134963132;Gene
MYELOSUPPRESSION;NUDT15*2;Haplotype;PA165817398;Disease
HEMATOPOIETIC STEM CELL TRANSPLANTATION;NUDT15*2;Haplotype;PA166123007;Disease
DISCONTINUATION;NUDT15*2;Haplotype;PA166123507;Disease
PRIMARY GRAFT FAILURE;NUDT15*2;Haplotype;PA166248341;Disease
TPMT;NUDT15*2;Haplotype;PA356;Gene
INFLAMMATION;NUDT15*2;Haplotype;PA444620;Disease
LEUKOPENIA;NUDT15*2;Haplotype;PA444773;Disease
NEUTROPENIA;NUDT15*2;Haplotype;PA445113;Disease
INFLAMMATORY BOWEL DISEASES;NUDT15*2;Haplotype;PA446116;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;NUDT15*2;Haplotype;PA446155;Disease
ACYCLOVIR;NUDT15*2;Haplotype;PA448045;Chemical
AZATHIOPRINE;NUDT15*2;Haplotype;PA448515;Chemical
MERCAPTOPURINE;NUDT15*2;Haplotype;PA450379;Chemical
FLUOROURACIL;rs2289310;Variant;PA128406956;Chemical
METASTATIC NEOPLASM;rs2289310;Variant;PA445058;Disease
CAPECITABINE;rs2289310;Variant;PA448771;Chemical
PEMETREXED;SLC22A8;Gene;PA10810;Chemical
HMG COA REDUCTASE INHIBITORS;SLC22A8;Gene;PA133950441;Chemical
CEFOTAXIME;SLC22A8;Gene;PA448852;Chemical
LANSOPRAZOLE;SLC22A8;Gene;PA450180;Chemical
METHOTREXATE;SLC22A8;Gene;PA450428;Chemical
OMEPRAZOLE;SLC22A8;Gene;PA450704;Chemical
PANTOPRAZOLE;SLC22A8;Gene;PA450774;Chemical
ZIDOVUDINE;SLC22A8;Gene;PA451954;Chemical
HEROIN DEPENDENCE;rs694066;Variant;PA444460;Disease
HEROIN;rs694066;Variant;PA452619;Chemical
ANKK1;nemonapride;Chemical;PA134872551;Gene
RS1799732;nemonapride;Chemical;PA166154334;Variant
RS1800497;nemonapride;Chemical;PA166154339;Variant
DRD2;nemonapride;Chemical;PA27478;Gene
UGT1A1*28;indacaterol;Chemical;PA166115842;Haplotype
UGT1A1;indacaterol;Chemical;PA420;Gene
PLCB1;GNG7;Gene;PA33384;Gene
PLCB2;GNG7;Gene;PA33385;Gene
PLCB3;GNG7;Gene;PA33386;Gene
PLCB4;GNG7;Gene;PA33387;Gene
CYP2D6;viloxazine;Chemical;PA128;Gene
SLCO1B1;viloxazine;Chemical;PA134865839;Gene
STAT2;USP18;Gene;PA36184;Gene
CYP3A4;ropivacaine;Chemical;PA130;Gene
CYB5R3;ropivacaine;Chemical;PA27331;Gene
G6PD;ropivacaine;Chemical;PA28469;Gene
LAPATINIB;HLA-DRB1*07:01;Haplotype;PA152241907;Chemical
HEPATITIS VACCINES;HLA-DRB1*07:01;Haplotype;PA164712789;Chemical
INFLUENZA VACCINES;HLA-DRB1*07:01;Haplotype;PA164712830;Chemical
CLAVULANATE;HLA-DRB1*07:01;Haplotype;PA164742987;Chemical
PEGASPARGASE;HLA-DRB1*07:01;Haplotype;PA164760860;Chemical
FLUCLOXACILLIN;HLA-DRB1*07:01;Haplotype;PA164781042;Chemical
TOXIC LIVER DISEASE;HLA-DRB1*07:01;Haplotype;PA164925725;Disease
DABRAFENIB;HLA-DRB1*07:01;Haplotype;PA166114911;Chemical
DRUG-INDUCED LIVER INJURY;HLA-DRB1*07:01;Haplotype;PA166119041;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-DRB1*07:01;Haplotype;PA166120929;Disease
HLA-DQA1;HLA-DRB1*07:01;Haplotype;PA35066;Gene
HLA-DRB1;HLA-DRB1*07:01;Haplotype;PA35072;Gene
BREAST NEOPLASMS;HLA-DRB1*07:01;Haplotype;PA443560;Disease
DRUG HYPERSENSITIVITY;HLA-DRB1*07:01;Haplotype;PA443936;Disease
DRUG TOXICITY;HLA-DRB1*07:01;Haplotype;PA443937;Disease
EPILEPSY;HLA-DRB1*07:01;Haplotype;PA444065;Disease
FEVER;HLA-DRB1*07:01;Haplotype;PA444178;Disease
HYPERSENSITIVITY;HLA-DRB1*07:01;Haplotype;PA444546;Disease
MELANOMA;HLA-DRB1*07:01;Haplotype;PA444903;Disease
PANCREATITIS;HLA-DRB1*07:01;Haplotype;PA445220;Disease
INFLAMMATORY BOWEL DISEASES;HLA-DRB1*07:01;Haplotype;PA446116;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;HLA-DRB1*07:01;Haplotype;PA446155;Disease
HIV INFECTIONS;HLA-DRB1*07:01;Haplotype;PA447230;Disease
ABACAVIR;HLA-DRB1*07:01;Haplotype;PA448004;Chemical
AMOXICILLIN;HLA-DRB1*07:01;Haplotype;PA448406;Chemical
ASPARAGINASE;HLA-DRB1*07:01;Haplotype;PA448492;Chemical
AZATHIOPRINE;HLA-DRB1*07:01;Haplotype;PA448515;Chemical
CARBAMAZEPINE;HLA-DRB1*07:01;Haplotype;PA448785;Chemical
MERCAPTOPURINE;HLA-DRB1*07:01;Haplotype;PA450379;Chemical
CASP9;CYCS;Gene;PA26094;Gene
HYPERTENSION;CYP2C9*30;Haplotype;PA444552;Disease
LOSARTAN;CYP2C9*30;Haplotype;PA450268;Chemical
CYP2C19;clomipramine;Chemical;PA124;Gene
CYP2D6;clomipramine;Chemical;PA128;Gene
CYP3A4;clomipramine;Chemical;PA130;Gene
CYP3A5;clomipramine;Chemical;PA131;Gene
CYP2C19*17;clomipramine;Chemical;PA165816533;Haplotype
CYP2D6*1;clomipramine;Chemical;PA165816576;Haplotype
CYP2D6*2;clomipramine;Chemical;PA165816577;Haplotype
CYP2D6*3;clomipramine;Chemical;PA165816578;Haplotype
CYP2D6*4;clomipramine;Chemical;PA165816579;Haplotype
CYP2D6*6;clomipramine;Chemical;PA165816581;Haplotype
CYP2D6*10;clomipramine;Chemical;PA165816582;Haplotype
CYP2D6*41;clomipramine;Chemical;PA165816584;Haplotype
CYP2D6*5;clomipramine;Chemical;PA165948092;Haplotype
CYP2C19*1;clomipramine;Chemical;PA165980634;Haplotype
CYP2C19*2;clomipramine;Chemical;PA165980635;Haplotype
CYP2C19*3;clomipramine;Chemical;PA165980636;Haplotype
CYP2D6*1XN;clomipramine;Chemical;PA165988479;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);clomipramine;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);clomipramine;Chemical;PA166116466;Haplotype
CYP3A5*1;clomipramine;Chemical;PA166128213;Haplotype
CYP3A5*3;clomipramine;Chemical;PA166128219;Haplotype
RS130058;clomipramine;Chemical;PA166156908;Variant
RS1360780;clomipramine;Chemical;PA166156983;Variant
RS2032582;clomipramine;Chemical;PA166157316;Variant
CYP2D6 POOR METABOLIZER;clomipramine;Chemical;PA166157927;Variant
ABCB1;clomipramine;Chemical;PA267;Gene
CYP1A2;clomipramine;Chemical;PA27093;Gene
FKBP5;clomipramine;Chemical;PA28162;Gene
HTR1B;clomipramine;Chemical;PA29549;Gene
SLC6A4;clomipramine;Chemical;PA312;Gene
FLUOROURACIL;rs9679162;Variant;PA128406956;Chemical
HEPATITIS C VIRUS INFECTION;rs9679162;Variant;PA444445;Disease
HEPATOCELLULAR CARCINOMA;rs9679162;Variant;PA444447;Disease
LIVER CANCER;rs9679162;Variant;PA444804;Disease
CISPLATIN;rs9679162;Variant;PA449014;Chemical
MITOXANTRONE;rs9679162;Variant;PA450526;Chemical
SORAFENIB;rs9679162;Variant;PA7000;Chemical
HMG COA REDUCTASE INHIBITORS;rs1719247;Variant;PA133950441;Chemical
PREGNENOLONE;rs777140014;Variant;PA166334121;Chemical
CHRNA3;cocaine;Chemical;PA113;Gene
CYP3A4;cocaine;Chemical;PA130;Gene
KAT2B;cocaine;Chemical;PA162392705;Gene
RS1076560;cocaine;Chemical;PA166154313;Variant
RS1125394;cocaine;Chemical;PA166154319;Variant
RS2283265;cocaine;Chemical;PA166154364;Variant
RS588765;cocaine;Chemical;PA166154841;Variant
RS684513;cocaine;Chemical;PA166154846;Variant
RS16969968;cocaine;Chemical;PA166154938;Variant
RS1803274;cocaine;Chemical;PA166156332;Variant
RS3836790;cocaine;Chemical;PA166156819;Variant
RS806368;cocaine;Chemical;PA166156953;Variant
RS1799971;cocaine;Chemical;PA166156991;Variant
RS6454674;cocaine;Chemical;PA166157108;Variant
RS11503014;cocaine;Chemical;PA166169464;Variant
RS678849;cocaine;Chemical;PA166175994;Variant
RS1799972;cocaine;Chemical;PA166177739;Variant
RS495491;cocaine;Chemical;PA166177792;Variant
RS62638690;cocaine;Chemical;PA166177955;Variant
RS2236256;cocaine;Chemical;PA166182127;Variant
RS524731;cocaine;Chemical;PA166183702;Variant
RS3823010;cocaine;Chemical;PA166183703;Variant
RS3778156;cocaine;Chemical;PA166183705;Variant
RS9829896;cocaine;Chemical;PA166184842;Variant
RS2251214;cocaine;Chemical;PA166196881;Variant
RS997917;cocaine;Chemical;PA166198164;Variant
RS10111937;cocaine;Chemical;PA166260384;Variant
BCHE;cocaine;Chemical;PA25294;Gene
CHRNA5;cocaine;Chemical;PA26491;Gene
CNR1;cocaine;Chemical;PA26681;Gene
DRD2;cocaine;Chemical;PA27478;Gene
GABRA2;cocaine;Chemical;PA28490;Gene
SCN5A;cocaine;Chemical;PA304;Gene
SLC6A3;cocaine;Chemical;PA311;Gene
OPRD1;cocaine;Chemical;PA31942;Gene
OPRK1;cocaine;Chemical;PA31943;Gene
OPRM1;cocaine;Chemical;PA31945;Gene
SYT1;cocaine;Chemical;PA36290;Gene
CYP2D6;vortioxetine;Chemical;PA128;Gene
CYP2D6*1;vortioxetine;Chemical;PA165816576;Haplotype
CYP2D6*4;vortioxetine;Chemical;PA165816579;Haplotype
CYP2D6*10;vortioxetine;Chemical;PA165816582;Haplotype
HTR2A;vortioxetine;Chemical;PA193;Gene
SLC6A4;vortioxetine;Chemical;PA312;Gene
SUBSTANCE-RELATED DISORDERS;rs878567;Variant;PA446876;Disease
METHAMPHETAMINE;rs878567;Variant;PA450403;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CORO7;Gene;PA447197;Disease
METHYLPHENIDATE;CORO7;Gene;PA450464;Chemical
DRUG TOXICITY;rs11572080;Variant;PA443937;Disease
NEUROTOXICITY SYNDROMES;rs11572080;Variant;PA446975;Disease
AMODIAQUINE;rs11572080;Variant;PA448404;Chemical
PACLITAXEL;rs11572080;Variant;PA450761;Chemical
REPAGLINIDE;rs11572080;Variant;PA451234;Chemical
HYPERCHOLESTEROLEMIA;rs11716445;Variant;PA444516;Disease
PRAVASTATIN;rs11716445;Variant;PA451089;Chemical
SIMVASTATIN;rs11716445;Variant;PA451363;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs11710163;Variant;PA443622;Disease
CARBOPLATIN;rs11710163;Variant;PA448803;Chemical
CISPLATIN;rs11710163;Variant;PA449014;Chemical
DOCETAXEL;rs11710163;Variant;PA449383;Chemical
GEMCITABINE;rs11710163;Variant;PA449748;Chemical
PACLITAXEL;rs11710163;Variant;PA450761;Chemical
ARIPIPRAZOLE;CYP2D6 poor metabolizer;Variant;PA10026;Chemical
ATOMOXETINE;CYP2D6 poor metabolizer;Variant;PA134688071;Chemical
SCHIZOAFFECTIVE DISORDER;CYP2D6 poor metabolizer;Variant;PA166123368;Disease
O-DESMETHYLTRAMADOL;CYP2D6 poor metabolizer;Variant;PA166131379;Chemical
ALZHEIMER DISEASE;CYP2D6 poor metabolizer;Variant;PA443319;Disease
OSTEOARTHRITIS;CYP2D6 poor metabolizer;Variant;PA445174;Disease
PAIN;CYP2D6 poor metabolizer;Variant;PA445208;Disease
LOW BACK PAIN;CYP2D6 poor metabolizer;Variant;PA446444;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CYP2D6 poor metabolizer;Variant;PA447197;Disease
SCHIZOPHRENIA;CYP2D6 poor metabolizer;Variant;PA447216;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2D6 poor metabolizer;Variant;PA447321;Disease
CITALOPRAM;CYP2D6 poor metabolizer;Variant;PA449015;Chemical
CLOMIPRAMINE;CYP2D6 poor metabolizer;Variant;PA449048;Chemical
CODEINE;CYP2D6 poor metabolizer;Variant;PA449088;Chemical
DONEPEZIL;CYP2D6 poor metabolizer;Variant;PA449394;Chemical
FLUOXETINE;CYP2D6 poor metabolizer;Variant;PA449673;Chemical
FLUVOXAMINE;CYP2D6 poor metabolizer;Variant;PA449690;Chemical
RISPERIDONE;CYP2D6 poor metabolizer;Variant;PA451257;Chemical
TIMOLOL;CYP2D6 poor metabolizer;Variant;PA451690;Chemical
TRAMADOL;CYP2D6 poor metabolizer;Variant;PA451735;Chemical
ANTIHYPERTENSIVES;rs11749255;Variant;PA164712445;Chemical
HYPERTENSION;rs11749255;Variant;PA444552;Disease
NON-SMALL CELL LUNG CARCINOMA;ETS2;Gene;PA443622;Disease
THROMBOCYTOPENIA;ETS2;Gene;PA445846;Disease
CARBOPLATIN;ETS2;Gene;PA448803;Chemical
GEMCITABINE;ETS2;Gene;PA449748;Chemical
BEVACIZUMAB;HTRA1;Gene;PA130232992;Chemical
MACULAR DEGENERATION;HTRA1;Gene;PA134850558;Disease
RANIBIZUMAB;HTRA1;Gene;PA164746012;Chemical
NR1I2;griseofulvin;Chemical;PA378;Gene
WARFARIN;rs11168293;Variant;PA451906;Chemical
GEFITINIB;rs726501;Variant;PA131301952;Chemical
ERLOTINIB;rs726501;Variant;PA134687924;Chemical
CARBOPLATIN;rs726501;Variant;PA448803;Chemical
CISPLATIN;rs726501;Variant;PA449014;Chemical
DOCETAXEL;rs726501;Variant;PA449383;Chemical
PACLITAXEL;rs726501;Variant;PA450761;Chemical
HYPERTENSION;rs10267099;Variant;PA444552;Disease
ATENOLOL;rs10267099;Variant;PA448499;Chemical
CRP;fenofibrate;Chemical;PA120;Gene
CYP3A5;fenofibrate;Chemical;PA131;Gene
SLCO1B1;fenofibrate;Chemical;PA134865839;Gene
HLA-A*33:01;fenofibrate;Chemical;PA165954144;Haplotype
RS1417938;fenofibrate;Chemical;PA166153630;Variant
RS3091244;fenofibrate;Chemical;PA166153735;Variant
RS964184;fenofibrate;Chemical;PA166154304;Variant
RS2727786;fenofibrate;Chemical;PA166154383;Variant
RS3135506;fenofibrate;Chemical;PA166154395;Variant
RS4149056;fenofibrate;Chemical;PA166154579;Variant
RS4238001;fenofibrate;Chemical;PA166154586;Variant
RS7412;fenofibrate;Chemical;PA166155341;Variant
RS676210;fenofibrate;Chemical;PA166155597;Variant
RS2241883;fenofibrate;Chemical;PA166155674;Variant
RS135543;fenofibrate;Chemical;PA166156032;Variant
RS135550;fenofibrate;Chemical;PA166156033;Variant
RS4253778;fenofibrate;Chemical;PA166156106;Variant
RS9626730;fenofibrate;Chemical;PA166156137;Variant
RS1800795;fenofibrate;Chemical;PA166157304;Variant
RS320;fenofibrate;Chemical;PA166157538;Variant
RS2230806;fenofibrate;Chemical;PA166157744;Variant
RS2230808;fenofibrate;Chemical;PA166157745;Variant
IL6;fenofibrate;Chemical;PA198;Gene
LPL;fenofibrate;Chemical;PA232;Gene
ABCA1;fenofibrate;Chemical;PA24373;Gene
APOA5;fenofibrate;Chemical;PA24888;Gene
FABP1;fenofibrate;Chemical;PA27956;Gene
PPARA;fenofibrate;Chemical;PA280;Gene
HLA-A;fenofibrate;Chemical;PA35055;Gene
APOA1;fenofibrate;Chemical;PA49;Gene
APOB;fenofibrate;Chemical;PA50;Gene
APOE;fenofibrate;Chemical;PA55;Gene
SCARB1;fenofibrate;Chemical;PA97;Gene
RS1540339;selective beta-2-adrenoreceptor agonists;Chemical;PA166154515;Variant
RS2239179;selective beta-2-adrenoreceptor agonists;Chemical;PA166154536;Variant
RS1042713;selective beta-2-adrenoreceptor agonists;Chemical;PA166156748;Variant
RS2781659;selective beta-2-adrenoreceptor agonists;Chemical;PA166157048;Variant
RS255100;selective beta-2-adrenoreceptor agonists;Chemical;PA166157250;Variant
RS2267715;selective beta-2-adrenoreceptor agonists;Chemical;PA166157348;Variant
RS2284220;selective beta-2-adrenoreceptor agonists;Chemical;PA166157353;Variant
ARG1;selective beta-2-adrenoreceptor agonists;Chemical;PA24947;Gene
CRHR2;selective beta-2-adrenoreceptor agonists;Chemical;PA26875;Gene
VDR;selective beta-2-adrenoreceptor agonists;Chemical;PA37301;Gene
ADRB1;selective beta-2-adrenoreceptor agonists;Chemical;PA38;Gene
ADRB2;selective beta-2-adrenoreceptor agonists;Chemical;PA39;Gene
ECULIZUMAB;C5;Gene;PA164776637;Chemical
ANALGESICS;rs6305;Variant;PA164712362;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;rs6305;Variant;PA164712462;Chemical
ERGOT ALKALOIDS;rs6305;Variant;PA164712741;Chemical
SUMATRIPTAN;rs6305;Variant;PA451566;Chemical
OPIOIDS;rs6305;Variant;PA452618;Chemical
RS6166;thyrotropin alfa;Chemical;PA166155582;Variant
FSHR;thyrotropin alfa;Chemical;PA28386;Gene
CDKN2A;palbociclib;Chemical;PA106;Gene
ESR1;palbociclib;Chemical;PA156;Gene
RS759922342;palbociclib;Chemical;PA166266941;Variant
PGR;palbociclib;Chemical;PA266;Gene
ERBB2;palbociclib;Chemical;PA27844;Gene
ESR2;palbociclib;Chemical;PA27886;Gene
TOBACCO USE DISORDER;rs1709083;Variant;PA445876;Disease
NICOTINE;rs1709083;Variant;PA450626;Chemical
CYP2D6;amoxapine;Chemical;PA128;Gene
RASBURICASE;CYB5R1;Gene;PA10176;Chemical
ISOSORBIDE DINITRATE;CYB5R1;Gene;PA450125;Chemical
ISOSORBIDE MONONITRATE;CYB5R1;Gene;PA450126;Chemical
METOCLOPRAMIDE;CYB5R1;Gene;PA450475;Chemical
PRIMAQUINE;CYB5R1;Gene;PA451103;Chemical
MYOPATHIES, STRUCTURAL, CONGENITAL;TPM3;Gene;PA447109;Disease
TOBACCO USE DISORDER;CYP2A6*13;Haplotype;PA445876;Disease
NICOTINE;CYP2A6*13;Haplotype;PA450626;Chemical
SELECTIVE BETA-2-ADRENORECEPTOR AGONISTS;rs255100;Variant;PA134687887;Chemical
ASTHMA;rs255100;Variant;PA443450;Disease
SALBUTAMOL;rs255100;Variant;PA448068;Chemical
HLA-B*59:01;Glaucoma;Disease;PA165956674;Haplotype
HLA-B;Glaucoma;Disease;PA35056;Gene
DPYD;rs60139309;Variant;PA145;Gene
CAPECITABINE;rs60139309;Variant;PA448771;Chemical
GRK5;esmolol;Chemical;PA180;Gene
GRK4;esmolol;Chemical;PA28941;Gene
ADRA2C;esmolol;Chemical;PA37;Gene
ADRB1;esmolol;Chemical;PA38;Gene
DROSPIRENONE / ETHINYL ESTRADIOL;PROS1;Gene;PA165290928;Chemical
ETHINYL ESTRADIOL / NORELGESTROMIN;PROS1;Gene;PA165290929;Chemical
CYP2C9*2;PROS1;Gene;PA165816543;Haplotype
CYP2C9*3;PROS1;Gene;PA165816544;Haplotype
RS6025;PROS1;Gene;PA166153554;Variant
RS1801131;PROS1;Gene;PA166153643;Variant
RS1801133;PROS1;Gene;PA166153644;Variant
RS1799963;PROS1;Gene;PA166154336;Variant
AVATROMBOPAG;PROS1;Gene;PA166179849;Chemical
LUSUTROMBOPAG;PROS1;Gene;PA166182748;Chemical
ESTRADIOL / PROGESTERONE;PROS1;Gene;PA166190221;Chemical
SYNTHETIC CONJUGATED ESTROGENS, A;PROS1;Gene;PA166238763;Chemical
RELUGOLIX / ESTRADIOL / NORETHINDRONE ACETATE;PROS1;Gene;PA166397682;Chemical
WARFARIN;PROS1;Gene;PA451906;Chemical
PLATINUM COMPOUNDS;rs4752219;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs4752219;Variant;PA443622;Disease
HTR2A;levomilnacipran;Chemical;PA193;Gene
SLC6A4;levomilnacipran;Chemical;PA312;Gene
CYP2C9;siponimod;Chemical;PA126;Gene
CYP2C9*1;siponimod;Chemical;PA165816542;Haplotype
CYP2C9*2;siponimod;Chemical;PA165816543;Haplotype
CYP2C9*3;siponimod;Chemical;PA165816544;Haplotype
CYP2C9*5;siponimod;Chemical;PA165816546;Haplotype
CYP2C9*6;siponimod;Chemical;PA165816547;Haplotype
CYP2C9*8;siponimod;Chemical;PA165816549;Haplotype
CYP2C9*11;siponimod;Chemical;PA165816552;Haplotype
CYP2C9;Drug Resistance;Disease;PA126;Gene
CYP2C9*1;Drug Resistance;Disease;PA165816542;Haplotype
CYP2C9*3;Drug Resistance;Disease;PA165816544;Haplotype
RS121434569;Drug Resistance;Disease;PA166157528;Variant
EGFR;Drug Resistance;Disease;PA7360;Gene
LEUKEMIA, MYELOID, ACUTE;rs17103168;Variant;PA444760;Disease
CYTARABINE;rs17103168;Variant;PA449177;Chemical
INTERFERON ALFA-2A, RECOMBINANT;rs9657182;Variant;PA164779048;Chemical
PEGINTERFERON ALFA-2B;rs9657182;Variant;PA164784024;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;rs9657182;Variant;PA446863;Disease
BUPROPION;rs11749035;Variant;PA448687;Chemical
NICOTINE;rs11749035;Variant;PA450626;Chemical
DESMETHYLNAPROXEN;NPIPB8;Gene;PA166163690;Chemical
TAPENTADOL;NPIPB8;Gene;PA166179720;Chemical
ACETAMINOPHEN;NPIPB8;Gene;PA448015;Chemical
FLUOROURACIL;rs117951771;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs117951771;Variant;PA443560;Disease
NEUTROPENIA;rs117951771;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs117951771;Variant;PA449165;Chemical
EPIRUBICIN;rs117951771;Variant;PA449476;Chemical
PREGNENOLONE;rs777924668;Variant;PA166334121;Chemical
HLA-B*57:01;Soft Tissue Neoplasms;Disease;PA165987830;Haplotype
HLA-B;Soft Tissue Neoplasms;Disease;PA35056;Gene
KCNH2;levomethadyl acetate;Chemical;PA212;Gene
DPYD;fluorouracil / salicylic acid;Chemical;PA145;Gene
TENOFOVIR;ABCC10;Gene;PA10204;Chemical
NEPHROTOXICITY;ABCC10;Gene;PA162263533;Disease
TENOFOVIR DISOPROXIL FUMARATE;ABCC10;Gene;PA166201941;Chemical
HIV INFECTIOUS DISEASE;ABCC10;Gene;PA447230;Disease
NEVIRAPINE;ABCC10;Gene;PA450616;Chemical
VINCRISTINE;ABCC10;Gene;PA451879;Chemical
CYCLOPHOSPHAMIDE;rs723685;Variant;PA449165;Chemical
DOXORUBICIN;rs723685;Variant;PA449412;Chemical
DPYD;rs201035051;Variant;PA145;Gene
CAPECITABINE;rs201035051;Variant;PA448771;Chemical
DIURETICS;rs4149601;Variant;PA151249535;Chemical
HYPERTENSION;rs4149601;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs4149601;Variant;PA449899;Chemical
DESFLURANE;rs193922753;Variant;PA164749136;Chemical
RYR1;rs193922753;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs193922753;Variant;PA444863;Disease
ENFLURANE;rs193922753;Variant;PA449461;Chemical
HALOTHANE;rs193922753;Variant;PA449845;Chemical
ISOFLURANE;rs193922753;Variant;PA450106;Chemical
METHOXYFLURANE;rs193922753;Variant;PA450434;Chemical
SEVOFLURANE;rs193922753;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs193922753;Variant;PA451522;Chemical
CACNA1S;rs193922753;Variant;PA85;Gene
EMAPALUMAB;SH2D1A;Gene;PA166182763;Chemical
IFNL3;dasabuvir;Chemical;PA134952671;Gene
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs121909036;Variant;PA166190041;Chemical
TOBACCO USE DISORDER;rs2072661;Variant;PA445876;Disease
NICOTINE;rs2072661;Variant;PA450626;Chemical
ATRIAL FIBRILLATION;rs2592551;Variant;PA443459;Disease
WARFARIN;rs2592551;Variant;PA451906;Chemical
RS1045642;Epilepsies, Partial;Disease;PA166157284;Variant
ABCB1;Epilepsies, Partial;Disease;PA267;Gene
ELF2;SLC9A1;Gene;PA27745;Gene
ALCOHOL-RELATED DISORDERS;rs2832407;Variant;PA446879;Disease
TOPIRAMATE;rs2832407;Variant;PA451728;Chemical
INTRAGASTRIC PH;CYP2C19 extensive metabolizer;Variant;PA166123203;Disease
LANSOPRAZOLE;CYP2C19 extensive metabolizer;Variant;PA450180;Chemical
ADVERSE EVENTS;WBP2NL;Gene;PA166151827;Disease
CODEINE;WBP2NL;Gene;PA449088;Chemical
DEXTROMETHORPHAN;WBP2NL;Gene;PA449273;Chemical
HYDROCODONE;WBP2NL;Gene;PA449900;Chemical
OXYCODONE;WBP2NL;Gene;PA450741;Chemical
TRAMADOL;WBP2NL;Gene;PA451735;Chemical
RS1801133;Primary central nervous system lymphoma;Disease;PA166153644;Variant
MTHFR;Primary central nervous system lymphoma;Disease;PA245;Gene
ABCC2;Exanthema;Disease;PA116;Gene
COMT;Exanthema;Disease;PA117;Gene
CYP2C9;Exanthema;Disease;PA126;Gene
CYP2D6;Exanthema;Disease;PA128;Gene
CYP3A4;Exanthema;Disease;PA130;Gene
IKBKE;Exanthema;Disease;PA134962294;Gene
CYP2C9*1;Exanthema;Disease;PA165816542;Haplotype
CYP2C9*3;Exanthema;Disease;PA165816544;Haplotype
CYP2D6*1;Exanthema;Disease;PA165816576;Haplotype
CYP2D6*2;Exanthema;Disease;PA165816577;Haplotype
CYP2D6*10;Exanthema;Disease;PA165816582;Haplotype
CYP3A4*1;Exanthema;Disease;PA165819201;Haplotype
CYP2D6*5;Exanthema;Disease;PA165948092;Haplotype
HLA-DRB1*01:01;Exanthema;Disease;PA165951320;Haplotype
HLA-DRB1*04:03;Exanthema;Disease;PA165951504;Haplotype
HLA-A*03:01;Exanthema;Disease;PA165953186;Haplotype
HLA-A*26:01;Exanthema;Disease;PA165953825;Haplotype
HLA-A*31:01;Exanthema;Disease;PA165954030;Haplotype
HLA-B*15:01;Exanthema;Disease;PA165954745;Haplotype
HLA-B*15:02;Exanthema;Disease;PA165954769;Haplotype
HLA-B*35:05;Exanthema;Disease;PA165955262;Haplotype
HLA-C*04:01;Exanthema;Disease;PA165957046;Haplotype
HLA-C*08:02;Exanthema;Disease;PA165957658;Haplotype
CYP3A4*22;Exanthema;Disease;PA166048680;Haplotype
HLA-C*03:02;Exanthema;Disease;PA166123425;Haplotype
HLA-A*02:01;Exanthema;Disease;PA166123427;Haplotype
HLA-B*48:01;Exanthema;Disease;PA166123429;Haplotype
RS717620;Exanthema;Disease;PA166153953;Variant
RS4680;Exanthema;Disease;PA166156024;Variant
CYP2D6*114;Exanthema;Disease;PA166181184;Haplotype
RS2272733;Exanthema;Disease;PA166203342;Variant
RS12142086;Exanthema;Disease;PA166203343;Variant
RS3748022;Exanthema;Disease;PA166203403;Variant
RS8904;Exanthema;Disease;PA166203410;Variant
RS9694958;Exanthema;Disease;PA166203441;Variant
GSTT1;Exanthema;Disease;PA183;Gene
IKBKB;Exanthema;Disease;PA29776;Gene
NFKBIA;Exanthema;Disease;PA31601;Gene
HLA-A;Exanthema;Disease;PA35055;Gene
HLA-B;Exanthema;Disease;PA35056;Gene
HLA-C;Exanthema;Disease;PA35057;Gene
HLA-DRB1;Exanthema;Disease;PA35072;Gene
PEGINTERFERON ALFA-2B;OASL;Gene;PA164784024;Chemical
HEPATITIS C VIRUS INFECTION;OASL;Gene;PA444445;Disease
RIBAVIRIN;OASL;Gene;PA451241;Chemical
ARSENIC TRIOXIDE;RARA;Gene;PA448486;Chemical
TRETINOIN;RARA;Gene;PA451746;Chemical
COUMARIN;CYP2A6*17;Haplotype;PA134521193;Chemical
COTININE;CYP2A6*17;Haplotype;PA166114414;Chemical
CESSATION;CYP2A6*17;Haplotype;PA166123046;Disease
BREAST NEOPLASMS;CYP2A6*17;Haplotype;PA443560;Disease
TOBACCO USE DISORDER;CYP2A6*17;Haplotype;PA445876;Disease
LETROZOLE;CYP2A6*17;Haplotype;PA450196;Chemical
METRONIDAZOLE;CYP2A6*17;Haplotype;PA450484;Chemical
NICOTINE;CYP2A6*17;Haplotype;PA450626;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs3761372;Variant;PA447197;Disease
METHYLPHENIDATE;rs3761372;Variant;PA450464;Chemical
UGT1A1*1;atazanavir / ritonavir;Chemical;PA166115841;Haplotype
UGT1A1*28;atazanavir / ritonavir;Chemical;PA166115842;Haplotype
UGT1A1*36;atazanavir / ritonavir;Chemical;PA166115843;Haplotype
UGT1A1*37;atazanavir / ritonavir;Chemical;PA166115844;Haplotype
UGT1A1*6;atazanavir / ritonavir;Chemical;PA166115858;Haplotype
UGT1A1;atazanavir / ritonavir;Chemical;PA420;Gene
MAJOR DEPRESSIVE DISORDER;rs363226;Variant;PA447321;Disease
BUPROPION;rs363226;Variant;PA448687;Chemical
METHADONE;rs204047;Variant;PA450401;Chemical
PSYCHOTIC DISORDER;rs9567733;Variant;PA447215;Disease
ANTIPSYCHOTICS;rs9567733;Variant;PA452233;Chemical
ALCOHOL ABUSE;rs75967634;Variant;PA443309;Disease
ETHANOL;rs75967634;Variant;PA448073;Chemical
ALLOPURINOL;NTNG1;Gene;PA448320;Chemical
BREAST NEOPLASMS;rs727479;Variant;PA443560;Disease
ANASTROZOLE;rs727479;Variant;PA448432;Chemical
ABCC2;Colorectal Neoplasms;Disease;PA116;Gene
CYP2A6;Colorectal Neoplasms;Disease;PA121;Gene
SLCO1B1;Colorectal Neoplasms;Disease;PA134865839;Gene
ENOSF1;Colorectal Neoplasms;Disease;PA134897613;Gene
IL23R;Colorectal Neoplasms;Disease;PA134935109;Gene
C18ORF56;Colorectal Neoplasms;Disease;PA134956204;Gene
KLC3;Colorectal Neoplasms;Disease;PA142671588;Gene
DPYD;Colorectal Neoplasms;Disease;PA145;Gene
SLC29A1;Colorectal Neoplasms;Disease;PA154;Gene
ERCC1;Colorectal Neoplasms;Disease;PA155;Gene
KLC1;Colorectal Neoplasms;Disease;PA162393424;Gene
PARD3B;Colorectal Neoplasms;Disease;PA162398721;Gene
CYP2A6*1;Colorectal Neoplasms;Disease;PA165924690;Haplotype
CYP2A6*4;Colorectal Neoplasms;Disease;PA165924721;Haplotype
CYP2A6*7;Colorectal Neoplasms;Disease;PA165924731;Haplotype
CYP2A6*9;Colorectal Neoplasms;Disease;PA165980914;Haplotype
GSTM1 NULL;Colorectal Neoplasms;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Colorectal Neoplasms;Disease;PA166048676;Haplotype
UGT1A1*1;Colorectal Neoplasms;Disease;PA166115841;Haplotype
UGT1A1*28;Colorectal Neoplasms;Disease;PA166115842;Haplotype
UGT1A1*37;Colorectal Neoplasms;Disease;PA166115844;Haplotype
UGT1A1*60;Colorectal Neoplasms;Disease;PA166115845;Haplotype
UGT1A1*6;Colorectal Neoplasms;Disease;PA166115858;Haplotype
UGT1A6*2A;Colorectal Neoplasms;Disease;PA166117621;Haplotype
UGT1A7*3;Colorectal Neoplasms;Disease;PA166117639;Haplotype
G6PD MEDITERRANEAN, DALLAS, PANAMA, SASSARI, CAGLIARI, BIRMINGHAM;Colorectal Neoplasms;Disease;PA166121127;Haplotype
RS5275;Colorectal Neoplasms;Disease;PA166153552;Variant
RS1056515;Colorectal Neoplasms;Disease;PA166153615;Variant
RS1801274;Colorectal Neoplasms;Disease;PA166153652;Variant
RS7518660;Colorectal Neoplasms;Disease;PA166153789;Variant
RS12022243;Colorectal Neoplasms;Disease;PA166153837;Variant
RS12132152;Colorectal Neoplasms;Disease;PA166153852;Variant
RS76387818;Colorectal Neoplasms;Disease;PA166153910;Variant
RS717620;Colorectal Neoplasms;Disease;PA166153953;Variant
RS2273697;Colorectal Neoplasms;Disease;PA166154007;Variant
RS1695;Colorectal Neoplasms;Disease;PA166154249;Variant
RS9344;Colorectal Neoplasms;Disease;PA166154264;Variant
RS2306283;Colorectal Neoplasms;Disease;PA166154547;Variant
RS2965667;Colorectal Neoplasms;Disease;PA166154559;Variant
RS112445441;Colorectal Neoplasms;Disease;PA166154663;Variant
RS7325568;Colorectal Neoplasms;Disease;PA166154720;Variant
RS861539;Colorectal Neoplasms;Disease;PA166154768;Variant
RS16973225;Colorectal Neoplasms;Disease;PA166154939;Variant
RS3743527;Colorectal Neoplasms;Disease;PA166155049;Variant
RS1979277;Colorectal Neoplasms;Disease;PA166155196;Variant
RS11078659;Colorectal Neoplasms;Disease;PA166155244;Variant
RS2741171;Colorectal Neoplasms;Disease;PA166155287;Variant
RS45445694;Colorectal Neoplasms;Disease;PA166155331;Variant
RS11615;Colorectal Neoplasms;Disease;PA166155342;Variant
RS13181;Colorectal Neoplasms;Disease;PA166155343;Variant
RS25487;Colorectal Neoplasms;Disease;PA166155346;Variant
RS1800469;Colorectal Neoplasms;Disease;PA166155372;Variant
RS885036;Colorectal Neoplasms;Disease;PA166155606;Variant
RS2070959;Colorectal Neoplasms;Disease;PA166155665;Variant
RS11563250;Colorectal Neoplasms;Disease;PA166155802;Variant
RS11692021;Colorectal Neoplasms;Disease;PA166155809;Variant
RS17626122;Colorectal Neoplasms;Disease;PA166155846;Variant
RS225440;Colorectal Neoplasms;Disease;PA166155976;Variant
RS1051266;Colorectal Neoplasms;Disease;PA166155986;Variant
RS2292997;Colorectal Neoplasms;Disease;PA166156354;Variant
RS3749438;Colorectal Neoplasms;Disease;PA166156376;Variant
RS10937158;Colorectal Neoplasms;Disease;PA166156440;Variant
RS1353295;Colorectal Neoplasms;Disease;PA166156509;Variant
RS2231142;Colorectal Neoplasms;Disease;PA166156544;Variant
RS4444903;Colorectal Neoplasms;Disease;PA166156588;Variant
RS7699188;Colorectal Neoplasms;Disease;PA166156632;Variant
RS9996584;Colorectal Neoplasms;Disease;PA166156635;Variant
RS11942466;Colorectal Neoplasms;Disease;PA166156656;Variant
RS13104811;Colorectal Neoplasms;Disease;PA166156663;Variant
RS4133101;Colorectal Neoplasms;Disease;PA166156824;Variant
RS4702484;Colorectal Neoplasms;Disease;PA166156831;Variant
RS699947;Colorectal Neoplasms;Disease;PA166156938;Variant
RS760370;Colorectal Neoplasms;Disease;PA166156947;Variant
RS2010963;Colorectal Neoplasms;Disease;PA166157006;Variant
RS3025039;Colorectal Neoplasms;Disease;PA166157061;Variant
RS9380142;Colorectal Neoplasms;Disease;PA166157153;Variant
RS9394992;Colorectal Neoplasms;Disease;PA166157157;Variant
RS17179108;Colorectal Neoplasms;Disease;PA166157191;Variant
RS144854329;Colorectal Neoplasms;Disease;PA166157228;Variant
RS371194629;Colorectal Neoplasms;Disease;PA166157235;Variant
RS712829;Colorectal Neoplasms;Disease;PA166157262;Variant
RS712830;Colorectal Neoplasms;Disease;PA166157263;Variant
RS1045642;Colorectal Neoplasms;Disease;PA166157284;Variant
RS1128503;Colorectal Neoplasms;Disease;PA166157288;Variant
RS2032582;Colorectal Neoplasms;Disease;PA166157316;Variant
RS2227983;Colorectal Neoplasms;Disease;PA166157331;Variant
RS2302821;Colorectal Neoplasms;Disease;PA166157751;Variant
DPYD POOR METABOLIZER;Colorectal Neoplasms;Disease;PA166157958;Variant
RS3087465;Colorectal Neoplasms;Disease;PA166161126;Variant
RS2228014;Colorectal Neoplasms;Disease;PA166161516;Variant
RS12720066;Colorectal Neoplasms;Disease;PA166161538;Variant
RS6498588;Colorectal Neoplasms;Disease;PA166161540;Variant
RS35621;Colorectal Neoplasms;Disease;PA166161543;Variant
RS17501331;Colorectal Neoplasms;Disease;PA166161570;Variant
RS143414470;Colorectal Neoplasms;Disease;PA166165332;Variant
DPYD C.2846A>T;Colorectal Neoplasms;Disease;PA166171119;Haplotype
RS11574077;Colorectal Neoplasms;Disease;PA166179077;Variant
RS2236947;Colorectal Neoplasms;Disease;PA166180901;Variant
RS11280056;Colorectal Neoplasms;Disease;PA166180936;Variant
RS2233678;Colorectal Neoplasms;Disease;PA166181044;Variant
GSTM1;Colorectal Neoplasms;Disease;PA182;Gene
ABCC1;Colorectal Neoplasms;Disease;PA244;Gene
ABCG1;Colorectal Neoplasms;Disease;PA24408;Gene
MTHFR;Colorectal Neoplasms;Disease;PA245;Gene
ADCY2;Colorectal Neoplasms;Disease;PA24561;Gene
ANK3;Colorectal Neoplasms;Disease;PA24800;Gene
AREG;Colorectal Neoplasms;Disease;PA24933;Gene
BRAF;Colorectal Neoplasms;Disease;PA25408;Gene
ABCB1;Colorectal Neoplasms;Disease;PA267;Gene
CXCR4;Colorectal Neoplasms;Disease;PA27058;Gene
EGF;Colorectal Neoplasms;Disease;PA27664;Gene
ERCC2;Colorectal Neoplasms;Disease;PA27848;Gene
FCGR2A;Colorectal Neoplasms;Disease;PA28063;Gene
G6PD;Colorectal Neoplasms;Disease;PA28469;Gene
GATA2;Colorectal Neoplasms;Disease;PA28585;Gene
PTGER4;Colorectal Neoplasms;Disease;PA289;Gene
GSTP1;Colorectal Neoplasms;Disease;PA29028;Gene
PTGS2;Colorectal Neoplasms;Disease;PA293;Gene
HRAS;Colorectal Neoplasms;Disease;PA29444;Gene
KRAS;Colorectal Neoplasms;Disease;PA30196;Gene
MGAT4A;Colorectal Neoplasms;Disease;PA30782;Gene
NRAS;Colorectal Neoplasms;Disease;PA31768;Gene
SLC19A1;Colorectal Neoplasms;Disease;PA327;Gene
PIN1;Colorectal Neoplasms;Disease;PA33320;Gene
PTGES;Colorectal Neoplasms;Disease;PA33948;Gene
RASSF1;Colorectal Neoplasms;Disease;PA34245;Gene
SULT1A1;Colorectal Neoplasms;Disease;PA343;Gene
RGS5;Colorectal Neoplasms;Disease;PA34376;Gene
TGFB1;Colorectal Neoplasms;Disease;PA350;Gene
HLA-G;Colorectal Neoplasms;Disease;PA35083;Gene
SHMT1;Colorectal Neoplasms;Disease;PA35753;Gene
TYMS;Colorectal Neoplasms;Disease;PA359;Gene
TGFBR2;Colorectal Neoplasms;Disease;PA36486;Gene
XRCC1;Colorectal Neoplasms;Disease;PA369;Gene
UGT1A;Colorectal Neoplasms;Disease;PA37173;Gene
UGT1A6;Colorectal Neoplasms;Disease;PA37181;Gene
UGT1A7;Colorectal Neoplasms;Disease;PA37182;Gene
VDR;Colorectal Neoplasms;Disease;PA37301;Gene
VEGFA;Colorectal Neoplasms;Disease;PA37302;Gene
XRCC3;Colorectal Neoplasms;Disease;PA37422;Gene
ABCG2;Colorectal Neoplasms;Disease;PA390;Gene
ABCC5;Colorectal Neoplasms;Disease;PA395;Gene
UGT1A9;Colorectal Neoplasms;Disease;PA419;Gene
UGT1A1;Colorectal Neoplasms;Disease;PA420;Gene
ALOX12;Colorectal Neoplasms;Disease;PA45;Gene
EGFR;Colorectal Neoplasms;Disease;PA7360;Gene
CCND1;Colorectal Neoplasms;Disease;PA75;Gene
EXANTHEMA;HLA-B*35:05;Haplotype;PA444109;Disease
HIV INFECTIONS;HLA-B*35:05;Haplotype;PA447230;Disease
LAMIVUDINE;HLA-B*35:05;Haplotype;PA450163;Chemical
NEVIRAPINE;HLA-B*35:05;Haplotype;PA450616;Chemical
STAVUDINE;HLA-B*35:05;Haplotype;PA451494;Chemical
RYR1;exertional rhabdomyolysis;Disease;PA34896;Gene
CETP;simvastatin;Chemical;PA108;Gene
ABCC2;simvastatin;Chemical;PA116;Gene
CYP2C8;simvastatin;Chemical;PA125;Gene
CYP2C9;simvastatin;Chemical;PA126;Gene
CYP2D6;simvastatin;Chemical;PA128;Gene
CYP3A4;simvastatin;Chemical;PA130;Gene
CYP3A5;simvastatin;Chemical;PA131;Gene
RHOA;simvastatin;Chemical;PA134865095;Gene
SLCO1B1;simvastatin;Chemical;PA134865839;Gene
KIF6;simvastatin;Chemical;PA134920075;Gene
F3;simvastatin;Chemical;PA158;Gene
SCAP;simvastatin;Chemical;PA162402461;Gene
CYP2C9*1;simvastatin;Chemical;PA165816542;Haplotype
CYP2C9*3;simvastatin;Chemical;PA165816544;Haplotype
CYP2D6*1;simvastatin;Chemical;PA165816576;Haplotype
CYP2D6*3;simvastatin;Chemical;PA165816578;Haplotype
CYP2D6*4;simvastatin;Chemical;PA165816579;Haplotype
CYP3A4*1;simvastatin;Chemical;PA165819201;Haplotype
CYP3A4*4;simvastatin;Chemical;PA165819222;Haplotype
SLCO1B1*5;simvastatin;Chemical;PA165819255;Haplotype
SLCO1B1*15;simvastatin;Chemical;PA165819265;Haplotype
HLA-DRB1*01:01;simvastatin;Chemical;PA165951320;Haplotype
HLA-DRB1*04:06;simvastatin;Chemical;PA165951530;Haplotype
CYP2C8*3;simvastatin;Chemical;PA165958685;Haplotype
SLCO1B1*1;simvastatin;Chemical;PA165981641;Haplotype
CYP3A4*22;simvastatin;Chemical;PA166048680;Haplotype
CYP3A5*1;simvastatin;Chemical;PA166128213;Haplotype
CYP3A5*3;simvastatin;Chemical;PA166128219;Haplotype
RS1137101;simvastatin;Chemical;PA166153626;Variant
RS2819742;simvastatin;Chemical;PA166153719;Variant
RS3917643;simvastatin;Chemical;PA166153759;Variant
RS717620;simvastatin;Chemical;PA166153953;Variant
RS1935349;simvastatin;Chemical;PA166153988;Variant
RS662799;simvastatin;Chemical;PA166154293;Variant
RS2276307;simvastatin;Chemical;PA166154360;Variant
RS2306283;simvastatin;Chemical;PA166154547;Variant
RS4149056;simvastatin;Chemical;PA166154579;Variant
RS4149081;simvastatin;Chemical;PA166154581;Variant
RS4363657;simvastatin;Chemical;PA166154590;Variant
RS1346268;simvastatin;Chemical;PA166154860;Variant
RS1800588;simvastatin;Chemical;PA166154870;Variant
RS9806699;simvastatin;Chemical;PA166154927;Variant
RS4673;simvastatin;Chemical;PA166154969;Variant
RS5882;simvastatin;Chemical;PA166154975;Variant
RS708272;simvastatin;Chemical;PA166154993;Variant
RS429358;simvastatin;Chemical;PA166155351;Variant
RS2003569;simvastatin;Chemical;PA166155657;Variant
RS4253728;simvastatin;Chemical;PA166156105;Variant
RS4823613;simvastatin;Chemical;PA166156110;Variant
RS11716445;simvastatin;Chemical;PA166156445;Variant
RS12487736;simvastatin;Chemical;PA166156447;Variant
RS2231142;simvastatin;Chemical;PA166156544;Variant
RS3846662;simvastatin;Chemical;PA166156820;Variant
RS17238540;simvastatin;Chemical;PA166156885;Variant
RS17244841;simvastatin;Chemical;PA166156886;Variant
RS20455;simvastatin;Chemical;PA166156905;Variant
RS6924995;simvastatin;Chemical;PA166157118;Variant
RS662;simvastatin;Chemical;PA166157238;Variant
RS705379;simvastatin;Chemical;PA166157261;Variant
RS776746;simvastatin;Chemical;PA166157267;Variant
RS1045642;simvastatin;Chemical;PA166157284;Variant
RS1128503;simvastatin;Chemical;PA166157288;Variant
RS2032582;simvastatin;Chemical;PA166157316;Variant
RS2740574;simvastatin;Chemical;PA166157367;Variant
RS35599367;simvastatin;Chemical;PA166157487;Variant
RS2230806;simvastatin;Chemical;PA166157744;Variant
RS12003906;simvastatin;Chemical;PA166157834;Variant
ZNF542P;simvastatin;Chemical;PA166180259;Gene
RS1225367412;simvastatin;Chemical;PA166180969;Variant
CYP2D6*14;simvastatin;Chemical;PA166181185;Haplotype
RS76103438;simvastatin;Chemical;PA166257882;Variant
HMGCR;simvastatin;Chemical;PA189;Gene
LEPR;simvastatin;Chemical;PA229;Gene
LIPC;simvastatin;Chemical;PA230;Gene
ABCA1;simvastatin;Chemical;PA24373;Gene
APOA5;simvastatin;Chemical;PA24888;Gene
ABCB1;simvastatin;Chemical;PA267;Gene
CYBA;simvastatin;Chemical;PA27075;Gene
PPARA;simvastatin;Chemical;PA280;Gene
GATM;simvastatin;Chemical;PA28590;Gene
HTR3B;simvastatin;Chemical;PA29556;Gene
HTR7;simvastatin;Chemical;PA29561;Gene
RYR2;simvastatin;Chemical;PA300;Gene
PON1;simvastatin;Chemical;PA33529;Gene
HLA-DRB1;simvastatin;Chemical;PA35072;Gene
SLCO2B1;simvastatin;Chemical;PA35845;Gene
NR1I2;simvastatin;Chemical;PA378;Gene
ABCG2;simvastatin;Chemical;PA390;Gene
UGT1A9;simvastatin;Chemical;PA419;Gene
APOE;simvastatin;Chemical;PA55;Gene
CACNA1S;simvastatin;Chemical;PA85;Gene
FLUOROURACIL;rs2070744;Variant;PA128406956;Chemical
DIURETICS;rs2070744;Variant;PA151249535;Chemical
ANTIHYPERTENSIVES;rs2070744;Variant;PA164712445;Chemical
ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;rs2070744;Variant;PA164712446;Chemical
BREAST NEOPLASMS;rs2070744;Variant;PA443560;Disease
HEPATOCELLULAR CARCINOMA;rs2070744;Variant;PA444447;Disease
HYPERTENSION;rs2070744;Variant;PA444552;Disease
ERECTILE DYSFUNCTION;rs2070744;Variant;PA444606;Disease
CYCLOPHOSPHAMIDE;rs2070744;Variant;PA449165;Chemical
DOXORUBICIN;rs2070744;Variant;PA449412;Chemical
ENALAPRIL;rs2070744;Variant;PA449456;Chemical
METHOTREXATE;rs2070744;Variant;PA450428;Chemical
SILDENAFIL;rs2070744;Variant;PA451346;Chemical
SORAFENIB;rs2070744;Variant;PA7000;Chemical
NICOTINE;rs145308399;Variant;PA450626;Chemical
HEROIN DEPENDENCE;rs3192723;Variant;PA444460;Disease
METHADONE;rs3192723;Variant;PA450401;Chemical
MT1A;arsenic trioxide;Chemical;PA31198;Gene
PML;arsenic trioxide;Chemical;PA33439;Gene
RARA;arsenic trioxide;Chemical;PA34225;Gene
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;GABRA6;Gene;PA164713257;Chemical
MAJOR DEPRESSIVE DISORDER;GABRA6;Gene;PA447321;Disease
VENLAFAXINE;GABRA6;Gene;PA451866;Chemical
ANTIDEPRESSANTS;GABRA6;Gene;PA452229;Chemical
TICAGRELOR;CYP3A4*33;Haplotype;PA165374673;Chemical
CABOZANTINIB;CYP3A4*33;Haplotype;PA165906891;Chemical
REGORAFENIB;CYP3A4*33;Haplotype;PA166114943;Chemical
VANDETANIB;CYP3A4*33;Haplotype;PA166118341;Chemical
BREXPIPRAZOLE;CYP3A4*33;Haplotype;PA166160053;Chemical
ACALABRUTINIB;CYP3A4*33;Haplotype;PA166198581;Chemical
MACITENTAN;CYP3A4*33;Haplotype;PA166261201;Chemical
BLONANSERIN;CYP3A4*33;Haplotype;PA166319041;Chemical
IBUPROFEN;CYP3A4*33;Haplotype;PA449957;Chemical
OXYCODONE;CYP3A4*33;Haplotype;PA450741;Chemical
TESTOSTERONE;CYP3A4*33;Haplotype;PA451627;Chemical
IDH1;ivosidenib;Chemical;PA29630;Gene
CASR;PLCE1;Gene;PA26097;Gene
PRKCA;PLCE1;Gene;PA33759;Gene
PRKCB;PLCE1;Gene;PA33761;Gene
PRKCG;PLCE1;Gene;PA33766;Gene
PRKCH;PLCE1;Gene;PA33767;Gene
PRKCI;PLCE1;Gene;PA33768;Gene
PRKD1;PLCE1;Gene;PA33771;Gene
PRKCZ;PLCE1;Gene;PA33775;Gene
HYPERTENSION;PLCE1;Gene;PA444552;Disease
HYDROCHLOROTHIAZIDE;PLCE1;Gene;PA449899;Chemical
FLUOROURACIL;DPYS;Gene;PA128406956;Chemical
DRUG TOXICITY;DPYS;Gene;PA443937;Disease
HYPERGLYCEMIA;DPYS;Gene;PA444522;Disease
HYPERTENSION;DPYS;Gene;PA444552;Disease
NEOPLASMS;DPYS;Gene;PA445062;Disease
ATENOLOL;DPYS;Gene;PA448499;Chemical
CAPECITABINE;DPYS;Gene;PA448771;Chemical
SCHIZOAFFECTIVE DISORDER;CYP1A2*7;Haplotype;PA166123368;Disease
CYP1A2;CYP1A2*7;Haplotype;PA27093;Gene
CLOZAPINE;CYP1A2*7;Haplotype;PA449061;Chemical
CYP2C19;Diabetes Mellitus, Type 2;Disease;PA124;Gene
CYP2C8;Diabetes Mellitus, Type 2;Disease;PA125;Gene
CYP2C9;Diabetes Mellitus, Type 2;Disease;PA126;Gene
IGF2BP2;Diabetes Mellitus, Type 2;Disease;PA128394577;Gene
SLCO1B1;Diabetes Mellitus, Type 2;Disease;PA134865839;Gene
SLC30A8;Diabetes Mellitus, Type 2;Disease;PA134915546;Gene
ACE;Diabetes Mellitus, Type 2;Disease;PA139;Gene
NOS1AP;Diabetes Mellitus, Type 2;Disease;PA142671259;Gene
C11ORF65;Diabetes Mellitus, Type 2;Disease;PA144596484;Gene
SLC47A1;Diabetes Mellitus, Type 2;Disease;PA162403808;Gene
CYP2C9*1;Diabetes Mellitus, Type 2;Disease;PA165816542;Haplotype
CYP2C9*2;Diabetes Mellitus, Type 2;Disease;PA165816543;Haplotype
CYP2C9*3;Diabetes Mellitus, Type 2;Disease;PA165816544;Haplotype
G6PD A- 202A_376G;Diabetes Mellitus, Type 2;Disease;PA165947827;Haplotype
CYP2C8*3;Diabetes Mellitus, Type 2;Disease;PA165958685;Haplotype
CYP2C19*1;Diabetes Mellitus, Type 2;Disease;PA165980634;Haplotype
CYP2C19*2;Diabetes Mellitus, Type 2;Disease;PA165980635;Haplotype
CYP2C19*3;Diabetes Mellitus, Type 2;Disease;PA165980636;Haplotype
RS10494366;Diabetes Mellitus, Type 2;Disease;PA166153802;Variant
RS290487;Diabetes Mellitus, Type 2;Disease;PA166153946;Variant
RS12255372;Diabetes Mellitus, Type 2;Disease;PA166154148;Variant
RS5219;Diabetes Mellitus, Type 2;Disease;PA166154256;Variant
RS2237892;Diabetes Mellitus, Type 2;Disease;PA166154354;Variant
RS2237895;Diabetes Mellitus, Type 2;Disease;PA166154355;Variant
RS11212617;Diabetes Mellitus, Type 2;Disease;PA166154450;Variant
RS296766;Diabetes Mellitus, Type 2;Disease;PA166154494;Variant
RS784888;Diabetes Mellitus, Type 2;Disease;PA166154503;Variant
RS4149056;Diabetes Mellitus, Type 2;Disease;PA166154579;Variant
RS889299;Diabetes Mellitus, Type 2;Disease;PA166154998;Variant
RS1799752;Diabetes Mellitus, Type 2;Disease;PA166155187;Variant
RS2252281;Diabetes Mellitus, Type 2;Disease;PA166155204;Variant
RS2289669;Diabetes Mellitus, Type 2;Disease;PA166155206;Variant
RS1131882;Diabetes Mellitus, Type 2;Disease;PA166155365;Variant
RS1801278;Diabetes Mellitus, Type 2;Disease;PA166155646;Variant
RS10192566;Diabetes Mellitus, Type 2;Disease;PA166155779;Variant
RS13431554;Diabetes Mellitus, Type 2;Disease;PA166155834;Variant
RS5186;Diabetes Mellitus, Type 2;Disease;PA166156276;Variant
RS1470579;Diabetes Mellitus, Type 2;Disease;PA166156318;Variant
RS1801282;Diabetes Mellitus, Type 2;Disease;PA166156331;Variant
RS4402960;Diabetes Mellitus, Type 2;Disease;PA166156398;Variant
RS594709;Diabetes Mellitus, Type 2;Disease;PA166156930;Variant
RS628031;Diabetes Mellitus, Type 2;Disease;PA166156933;Variant
RS6923761;Diabetes Mellitus, Type 2;Disease;PA166157117;Variant
RS36056065;Diabetes Mellitus, Type 2;Disease;PA166157203;Variant
RS72552763;Diabetes Mellitus, Type 2;Disease;PA166157216;Variant
RS6467136;Diabetes Mellitus, Type 2;Disease;PA166157413;Variant
RS13266634;Diabetes Mellitus, Type 2;Disease;PA166157645;Variant
RS10811661;Diabetes Mellitus, Type 2;Disease;PA166157816;Variant
RS5030868;Diabetes Mellitus, Type 2;Disease;PA166157880;Variant
RS254271;Diabetes Mellitus, Type 2;Disease;PA166178547;Variant
RS57081354;Diabetes Mellitus, Type 2;Disease;PA166178579;Variant
RS2162145;Diabetes Mellitus, Type 2;Disease;PA166178583;Variant
RS894160;Diabetes Mellitus, Type 2;Disease;PA166183759;Variant
RS17584499;Diabetes Mellitus, Type 2;Disease;PA166184298;Variant
CYP2C8*1;Diabetes Mellitus, Type 2;Disease;PA166242948;Haplotype
IRS1;Diabetes Mellitus, Type 2;Disease;PA203;Gene
KCNJ11;Diabetes Mellitus, Type 2;Disease;PA217;Gene
KCNQ1;Diabetes Mellitus, Type 2;Disease;PA223;Gene
ALDH3B1;Diabetes Mellitus, Type 2;Disease;PA24699;Gene
AQP2;Diabetes Mellitus, Type 2;Disease;PA24920;Gene
CHKA;Diabetes Mellitus, Type 2;Disease;PA26468;Gene
PPARG;Diabetes Mellitus, Type 2;Disease;PA281;Gene
G6PD;Diabetes Mellitus, Type 2;Disease;PA28469;Gene
GLP1R;Diabetes Mellitus, Type 2;Disease;PA28725;Gene
LPIN1;Diabetes Mellitus, Type 2;Disease;PA30436;Gene
SCNN1B;Diabetes Mellitus, Type 2;Disease;PA306;Gene
NBEA;Diabetes Mellitus, Type 2;Disease;PA31454;Gene
SLC22A1;Diabetes Mellitus, Type 2;Disease;PA329;Gene
PAX4;Diabetes Mellitus, Type 2;Disease;PA32958;Gene
PLIN1;Diabetes Mellitus, Type 2;Disease;PA33409;Gene
PRPF31;Diabetes Mellitus, Type 2;Disease;PA33814;Gene
PTPRD;Diabetes Mellitus, Type 2;Disease;PA34013;Gene
TBXA2R;Diabetes Mellitus, Type 2;Disease;PA348;Gene
SP1;Diabetes Mellitus, Type 2;Disease;PA36042;Gene
TCF7L2;Diabetes Mellitus, Type 2;Disease;PA36394;Gene
TCIRG1;Diabetes Mellitus, Type 2;Disease;PA36399;Gene
CPA6;Diabetes Mellitus, Type 2;Disease;PA38444;Gene
AGTR1;Diabetes Mellitus, Type 2;Disease;PA43;Gene
ATM;Diabetes Mellitus, Type 2;Disease;PA61;Gene
ALZHEIMER DISEASE;rs3793790;Variant;PA443319;Disease
DONEPEZIL;rs3793790;Variant;PA449394;Chemical
GALANTAMINE;rs3793790;Variant;PA449726;Chemical
RIVASTIGMINE;rs3793790;Variant;PA451262;Chemical
DESVENLAFAXINE;CYP2D6*99;Haplotype;PA165958374;Chemical
ACADVL;triheptanoin;Chemical;PA24428;Gene
CPT2;triheptanoin;Chemical;PA26849;Gene
HADHA;triheptanoin;Chemical;PA29175;Gene
HADHB;triheptanoin;Chemical;PA29177;Gene
DRUG-INDUCED LIVER INJURY;HLA-B*52:01;Haplotype;PA166119041;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*52:01;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*52:01;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*52:01;Haplotype;PA445738;Disease
TUBERCULOSIS;HLA-B*52:01;Haplotype;PA445941;Disease
ISONIAZID;HLA-B*52:01;Haplotype;PA450112;Chemical
NEVIRAPINE;HLA-B*52:01;Haplotype;PA450616;Chemical
EVEROLIMUS;rs9906827;Variant;PA164746311;Chemical
PROGRESSION-FREE SURVIVAL;rs9906827;Variant;PA166123026;Disease
PNEUMONITIS;rs9906827;Variant;PA166124223;Disease
UGT1A4;tamoxifen-n-glucuronide;Chemical;PA37179;Gene
BREAST NEOPLASMS;AKR1C3;Gene;PA443560;Disease
LUNG NEOPLASMS;AKR1C3;Gene;PA444818;Disease
DAUNORUBICIN;AKR1C3;Gene;PA449212;Chemical
DOCETAXEL;AKR1C3;Gene;PA449383;Chemical
DOXORUBICIN;AKR1C3;Gene;PA449412;Chemical
EXEMESTANE;AKR1C3;Gene;PA449563;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;PYGL;Gene;PA446155;Disease
ASPARAGINASE;PYGL;Gene;PA448492;Chemical
DEXAMETHASONE;PYGL;Gene;PA449247;Chemical
METHOTREXATE;PYGL;Gene;PA450428;Chemical
MORPHINE;rs7824175;Variant;PA450550;Chemical
DULOXETINE;rs61692318;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs61692318;Variant;PA447321;Disease
RS1045642;daptomycin;Chemical;PA166157284;Variant
ABCB1;daptomycin;Chemical;PA267;Gene
BURKITT LYMPHOMA;rs9516519;Variant;PA443580;Disease
METHOTREXATE;rs9516519;Variant;PA450428;Chemical
ANTITHYROID PREPARATIONS;rs652888;Variant;PA164712499;Chemical
AGRANULOCYTOSIS;rs652888;Variant;PA443297;Disease
FLUOROURACIL;rs115457081;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs115457081;Variant;PA443560;Disease
NEUTROPENIA;rs115457081;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs115457081;Variant;PA449165;Chemical
EPIRUBICIN;rs115457081;Variant;PA449476;Chemical
MENOPAUSE;rs3759811;Variant;PA166048848;Disease
BREAST NEOPLASMS;rs3759811;Variant;PA443560;Disease
LETROZOLE;rs3759811;Variant;PA450196;Chemical
FLUOROURACIL;rs2010851;Variant;PA128406956;Chemical
COLONIC NEOPLASMS;rs2010851;Variant;PA443756;Disease
CYP11B2;benazepril;Chemical;PA134;Gene
ACE;benazepril;Chemical;PA139;Gene
RS5051;benazepril;Chemical;PA166153547;Variant
RS7079;benazepril;Chemical;PA166153556;Variant
RS1801133;benazepril;Chemical;PA166153644;Variant
RS1805087;benazepril;Chemical;PA166153654;Variant
RS2229437;benazepril;Chemical;PA166154352;Variant
RS1799752;benazepril;Chemical;PA166155187;Variant
RS1042713;benazepril;Chemical;PA166156748;Variant
RS1799998;benazepril;Chemical;PA166157566;Variant
MTHFR;benazepril;Chemical;PA245;Gene
MTR;benazepril;Chemical;PA31272;Gene
PRCP;benazepril;Chemical;PA33705;Gene
ADRB2;benazepril;Chemical;PA39;Gene
AGT;benazepril;Chemical;PA42;Gene
PEGINTERFERON ALFA-2A;rs4803219;Variant;PA164749390;Chemical
PEGINTERFERON ALFA-2B;rs4803219;Variant;PA164784024;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;rs4803219;Variant;PA446863;Disease
RIBAVIRIN;rs4803219;Variant;PA451241;Chemical
RS1799971;suicidal ideation;Disease;PA166156991;Variant
OPRM1;suicidal ideation;Disease;PA31945;Gene
FLUOROURACIL;TYMP;Gene;PA128406956;Chemical
NEOPLASMS;TYMP;Gene;PA445062;Disease
CAPECITABINE;TYMP;Gene;PA448771;Chemical
IDH1;vorasidenib;Chemical;PA29630;Gene
IDH2;vorasidenib;Chemical;PA29631;Gene
OTOTOXICITY;rs267606617;Variant;PA162263534;Disease
AMIKACIN;rs267606617;Variant;PA164744372;Chemical
NETILMICIN;rs267606617;Variant;PA164754913;Chemical
PAROMOMYCIN;rs267606617;Variant;PA164784023;Chemical
PLAZOMICIN;rs267606617;Variant;PA166228921;Chemical
ISEPAMICIN;rs267606617;Variant;PA166241781;Chemical
HYGROMYCIN B;rs267606617;Variant;PA166242401;Chemical
DIBEKACIN;rs267606617;Variant;PA166292901;Chemical
RIBOSTAMYCIN;rs267606617;Variant;PA166292902;Chemical
MT-RNR1;rs267606617;Variant;PA31274;Gene
GENTAMICIN;rs267606617;Variant;PA449753;Chemical
KANAMYCIN;rs267606617;Variant;PA450137;Chemical
NEOMYCIN;rs267606617;Variant;PA450608;Chemical
STREPTOMYCIN;rs267606617;Variant;PA451512;Chemical
TOBRAMYCIN;rs267606617;Variant;PA451704;Chemical
AMINOGLYCOSIDE ANTIBACTERIALS;rs267606617;Variant;PA452167;Chemical
CYP2B6;Long QT Syndrome;Disease;PA123;Gene
NOS1AP;Long QT Syndrome;Disease;PA142671259;Gene
CYP2B6*1;Long QT Syndrome;Disease;PA165818750;Haplotype
CYP2B6*6;Long QT Syndrome;Disease;PA165818762;Haplotype
RS10800397;Long QT Syndrome;Disease;PA166153809;Variant
RS10919035;Long QT Syndrome;Disease;PA166153817;Variant
KCNH2;Long QT Syndrome;Disease;PA212;Gene
SCN5A;Long QT Syndrome;Disease;PA304;Gene
ALLOPURINOL;rs79663562;Variant;PA448320;Chemical
MACULOPAPULAR EXANTHEMA;HLA-A*02:07;Haplotype;PA162316739;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-A*02:07;Haplotype;PA166120929;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-A*02:07;Haplotype;PA444059;Disease
EPILEPSY;HLA-A*02:07;Haplotype;PA444065;Disease
STEVENS-JOHNSON SYNDROME;HLA-A*02:07;Haplotype;PA445738;Disease
LAMOTRIGINE;HLA-A*02:07;Haplotype;PA450164;Chemical
ZONISAMIDE;HLA-A*02:07;Haplotype;PA451978;Chemical
RIFAMPIN;AADAC;Gene;PA451250;Chemical
SLC9A3;ELF2;Gene;PA316;Gene
SLC9A1;ELF2;Gene;PA35928;Gene
SLC9A2;ELF2;Gene;PA35929;Gene
SLC9A3P1;ELF2;Gene;PA35930;Gene
SLC9A3R1;ELF2;Gene;PA35931;Gene
SLC9A3R2;ELF2;Gene;PA35932;Gene
SLC9A4;ELF2;Gene;PA35933;Gene
SLC9A5;ELF2;Gene;PA35934;Gene
SLC9A6;ELF2;Gene;PA35935;Gene
ADRB2;ELF2;Gene;PA39;Gene
IMATINIB;rs3745274;Variant;PA10804;Chemical
CYP2B6;rs3745274;Variant;PA123;Gene
3,4-METHYLENEDIOXYMETHAMPHETAMINE;rs3745274;Variant;PA131887008;Chemical
TRANSPLANTATION;rs3745274;Variant;PA134850491;Disease
ANTIVIRALS FOR TREATMENT OF HIV INFECTIONS, COMBINATIONS;rs3745274;Variant;PA164712505;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;rs3745274;Variant;PA164712708;Chemical
MITOTANE;rs3745274;Variant;PA164746157;Chemical
TOXIC LIVER DISEASE;rs3745274;Variant;PA164925725;Disease
NEONATAL ABSTINENCE SYNDROME;rs3745274;Variant;PA165108809;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;rs3745274;Variant;PA166120927;Disease
EFAVIRENZ / EMTRICITABINE / TENOFOVIR DISOPROXIL;rs3745274;Variant;PA166176033;Chemical
BREAST NEOPLASMS;rs3745274;Variant;PA443560;Disease
DIARRHEA;rs3745274;Variant;PA443899;Disease
DRUG TOXICITY;rs3745274;Variant;PA443937;Disease
HEPATIC VENO-OCCLUSIVE DISEASE;rs3745274;Variant;PA444434;Disease
HEROIN DEPENDENCE;rs3745274;Variant;PA444460;Disease
INFECTIOUS DISEASE;rs3745274;Variant;PA444614;Disease
LUPUS NEPHRITIS;rs3745274;Variant;PA444823;Disease
OPIOID-RELATED DISORDERS;rs3745274;Variant;PA445043;Disease
STEVENS-JOHNSON SYNDROME;rs3745274;Variant;PA445738;Disease
TUBERCULOSIS;rs3745274;Variant;PA445941;Disease
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;rs3745274;Variant;PA446171;Disease
ADRENOCORTICAL CARCINOMA;rs3745274;Variant;PA446644;Disease
HIV INFECTIOUS DISEASE;rs3745274;Variant;PA447230;Disease
CYCLOPHOSPHAMIDE;rs3745274;Variant;PA449165;Chemical
DOXORUBICIN;rs3745274;Variant;PA449412;Chemical
EFAVIRENZ;rs3745274;Variant;PA449441;Chemical
METHADONE;rs3745274;Variant;PA450401;Chemical
NEVIRAPINE;rs3745274;Variant;PA450616;Chemical
PROPOFOL;rs3745274;Variant;PA451141;Chemical
TRAMADOL;rs3745274;Variant;PA451735;Chemical
OPIOIDS;rs3745274;Variant;PA452618;Chemical
CYP2B6;Discontinuation;Disease;PA123;Gene
CYP2C19;Discontinuation;Disease;PA124;Gene
CYP2D6;Discontinuation;Disease;PA128;Gene
SLCO1B1;Discontinuation;Disease;PA134865839;Gene
NUDT15;Discontinuation;Disease;PA134963132;Gene
CYP2C19*17;Discontinuation;Disease;PA165816533;Haplotype
CYP2D6*1;Discontinuation;Disease;PA165816576;Haplotype
CYP2D6*2;Discontinuation;Disease;PA165816577;Haplotype
CYP2B6*1;Discontinuation;Disease;PA165818750;Haplotype
CYP2B6*9;Discontinuation;Disease;PA165818807;Haplotype
SLCO1B1*5;Discontinuation;Disease;PA165819255;Haplotype
TPMT*1;Discontinuation;Disease;PA165819268;Haplotype
TPMT*2;Discontinuation;Disease;PA165819269;Haplotype
TPMT*3A;Discontinuation;Disease;PA165819270;Haplotype
TPMT*3C;Discontinuation;Disease;PA165819272;Haplotype
TPMT*8;Discontinuation;Disease;PA165819278;Haplotype
TPMT*9;Discontinuation;Disease;PA165819279;Haplotype
TPMT*12;Discontinuation;Disease;PA165819282;Haplotype
TPMT*24;Discontinuation;Disease;PA165819295;Haplotype
CYP2C19*1;Discontinuation;Disease;PA165980634;Haplotype
CYP2C19*2;Discontinuation;Disease;PA165980635;Haplotype
SLCO1B1*1;Discontinuation;Disease;PA165981641;Haplotype
CYP2D6*1XN;Discontinuation;Disease;PA165988479;Haplotype
CYP2D6*2XN;Discontinuation;Disease;PA165988480;Haplotype
UGT1A1*1;Discontinuation;Disease;PA166115841;Haplotype
UGT1A1*28;Discontinuation;Disease;PA166115842;Haplotype
NUDT15*1;Discontinuation;Disease;PA166131619;Haplotype
NUDT15*2;Discontinuation;Disease;PA166131620;Haplotype
NUDT15*3;Discontinuation;Disease;PA166131621;Haplotype
RS45445694;Discontinuation;Disease;PA166155331;Variant
RS2472677;Discontinuation;Disease;PA166156358;Variant
RS351855;Discontinuation;Disease;PA166156731;Variant
FGFR4;Discontinuation;Disease;PA28130;Gene
TPMT;Discontinuation;Disease;PA356;Gene
TYMS;Discontinuation;Disease;PA359;Gene
NR1I2;Discontinuation;Disease;PA378;Gene
UGT1A1;Discontinuation;Disease;PA420;Gene
SLCO1B1;Rhabdomyolysis;Disease;PA134865839;Gene
EYS;Rhabdomyolysis;Disease;PA164719488;Gene
RS2819742;Rhabdomyolysis;Disease;PA166153719;Variant
RS4149056;Rhabdomyolysis;Disease;PA166154579;Variant
RS3857532;Rhabdomyolysis;Disease;PA166179565;Variant
RS9342288;Rhabdomyolysis;Disease;PA166179568;Variant
RS1337512;Rhabdomyolysis;Disease;PA166179571;Variant
RS1225367412;Rhabdomyolysis;Disease;PA166180969;Variant
RYR2;Rhabdomyolysis;Disease;PA300;Gene
RYR1;Rhabdomyolysis;Disease;PA34896;Gene
CACNA1S;Rhabdomyolysis;Disease;PA85;Gene
ESSENTIAL HYPERTENSION;rs7387065;Variant;PA447288;Disease
HYDROCHLOROTHIAZIDE;rs7387065;Variant;PA449899;Chemical
COMT;nephrotoxicity;Disease;PA117;Gene
CYP3A5;nephrotoxicity;Disease;PA131;Gene
SLCO1B1;nephrotoxicity;Disease;PA134865839;Gene
ARID5B;nephrotoxicity;Disease;PA134943193;Gene
CYP3A5*1;nephrotoxicity;Disease;PA166128213;Haplotype
CYP3A5*3;nephrotoxicity;Disease;PA166128219;Haplotype
RS1801133;nephrotoxicity;Disease;PA166153644;Variant
RS3824662;nephrotoxicity;Disease;PA166154043;Variant
RS10821936;nephrotoxicity;Disease;PA166154117;Variant
RS4149056;nephrotoxicity;Disease;PA166154579;Variant
RS3742106;nephrotoxicity;Disease;PA166154713;Variant
RS7317112;nephrotoxicity;Disease;PA166154718;Variant
RS11854484;nephrotoxicity;Disease;PA166154934;Variant
RS13181;nephrotoxicity;Disease;PA166155343;Variant
RS4646316;nephrotoxicity;Disease;PA166156108;Variant
RS9332377;nephrotoxicity;Disease;PA166156133;Variant
RS9345389;nephrotoxicity;Disease;PA166157144;Variant
RS9349256;nephrotoxicity;Disease;PA166157146;Variant
RS4646536;nephrotoxicity;Disease;PA166165040;Variant
RS2248359;nephrotoxicity;Disease;PA166170863;Variant
RS10908521;nephrotoxicity;Disease;PA166266702;Variant
RS1353327;nephrotoxicity;Disease;PA166266704;Variant
ABCC10;nephrotoxicity;Disease;PA24392;Gene
MTHFR;nephrotoxicity;Disease;PA245;Gene
CLCN6;nephrotoxicity;Disease;PA26551;Gene
CYP24A1;nephrotoxicity;Disease;PA27097;Gene
CYP27B1;nephrotoxicity;Disease;PA27099;Gene
ERCC2;nephrotoxicity;Disease;PA27848;Gene
GATA3;nephrotoxicity;Disease;PA28586;Gene
INSRR;nephrotoxicity;Disease;PA29899;Gene
NTRK1;nephrotoxicity;Disease;PA31817;Gene
SLC28A2;nephrotoxicity;Disease;PA386;Gene
ABCC4;nephrotoxicity;Disease;PA397;Gene
KIDNEY TRANSPLANTATION;CAPN10;Gene;PA165817016;Disease
DIABETES MELLITUS;CAPN10;Gene;PA443886;Disease
METFORMIN;CAPN10;Gene;PA450395;Chemical
TACROLIMUS;CAPN10;Gene;PA451578;Chemical
GEFITINIB;rs2233406;Variant;PA131301952;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs2233406;Variant;PA443622;Disease
DIARRHEA;rs2233406;Variant;PA443899;Disease
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;ARAP2;Gene;PA164713366;Chemical
RHEUMATOID ARTHRITIS;ARAP2;Gene;PA443434;Disease
DEXTROMETHORPHAN;rs729559;Variant;PA449273;Chemical
MULTIPLE SCLEROSIS;ZNF697;Gene;PA444987;Disease
INTERFERON BETA-1A;ZNF697;Gene;PA450037;Chemical
INTERFERON BETA-1B;ZNF697;Gene;PA450039;Chemical
EPILEPSY;rs3114020;Variant;PA444065;Disease
LAMOTRIGINE;rs3114020;Variant;PA450164;Chemical
HLA-A*03:01;egfr inhibitors;Chemical;PA165953186;Haplotype
HLA-A*02:01;egfr inhibitors;Chemical;PA166123427;Haplotype
RS712829;egfr inhibitors;Chemical;PA166157262;Variant
RS2227983;egfr inhibitors;Chemical;PA166157331;Variant
NRAS;egfr inhibitors;Chemical;PA31768;Gene
HLA-A;egfr inhibitors;Chemical;PA35055;Gene
EGFR;egfr inhibitors;Chemical;PA7360;Gene
ABCC2;Organ Transplantation;Disease;PA116;Gene
CYP3A4;Organ Transplantation;Disease;PA130;Gene
CYP3A5;Organ Transplantation;Disease;PA131;Gene
CYP3A4*1;Organ Transplantation;Disease;PA165819201;Haplotype
CYP3A4*3;Organ Transplantation;Disease;PA165819221;Haplotype
CYP3A4*20;Organ Transplantation;Disease;PA165819244;Haplotype
CYP3A4*22;Organ Transplantation;Disease;PA166048680;Haplotype
CYP3A5*1;Organ Transplantation;Disease;PA166128213;Haplotype
CYP3A5*3;Organ Transplantation;Disease;PA166128219;Haplotype
RS3740066;Organ Transplantation;Disease;PA166154028;Variant
RS4823613;Organ Transplantation;Disease;PA166156110;Variant
RS1045642;Organ Transplantation;Disease;PA166157284;Variant
RS2228075;Organ Transplantation;Disease;PA166157332;Variant
RS2278294;Organ Transplantation;Disease;PA166157351;Variant
RS35599367;Organ Transplantation;Disease;PA166157487;Variant
RS1927907;Organ Transplantation;Disease;PA166157738;Variant
ABCB1;Organ Transplantation;Disease;PA267;Gene
PPARA;Organ Transplantation;Disease;PA280;Gene
IMPDH1;Organ Transplantation;Disease;PA29862;Gene
TLR4;Organ Transplantation;Disease;PA36552;Gene
SSTR1;lutetium (177Lu) oxodotreotide;Chemical;PA36154;Gene
SSTR2;lutetium (177Lu) oxodotreotide;Chemical;PA36155;Gene
SSTR3;lutetium (177Lu) oxodotreotide;Chemical;PA36156;Gene
SSTR4;lutetium (177Lu) oxodotreotide;Chemical;PA36157;Gene
SSTR5;lutetium (177Lu) oxodotreotide;Chemical;PA36158;Gene
APNEA;rs774072493;Variant;PA443407;Disease
SUCCINYLCHOLINE;rs774072493;Variant;PA451522;Chemical
TOBACCO USE DISORDER;rs10121600;Variant;PA445876;Disease
NICOTINE;rs10121600;Variant;PA450626;Chemical
CFTR;rs1800100;Variant;PA109;Gene
IVACAFTOR;rs1800100;Variant;PA165950341;Chemical
CYSTIC FIBROSIS;rs1800100;Variant;PA443829;Disease
FLUOROURACIL;rs2075685;Variant;PA128406956;Chemical
PLATINUM COMPOUNDS;rs2075685;Variant;PA164713176;Chemical
RADIOTHERAPY;rs2075685;Variant;PA166122986;Chemical
STOMACH NEOPLASMS;rs2075685;Variant;PA445742;Disease
CFTR;rs386134230;Variant;PA109;Gene
IVACAFTOR;rs386134230;Variant;PA165950341;Chemical
SCHIZOPHRENIA;rs878949;Variant;PA447216;Disease
ANTIPSYCHOTICS;rs878949;Variant;PA452233;Chemical
TOBACCO USE DISORDER;rs72552266;Variant;PA445876;Disease
NICOTINE;rs72552266;Variant;PA450626;Chemical
CALCIUM CHANNEL BLOCKERS;rs1799752;Variant;PA10407;Chemical
ANTIEPILEPTICS;rs1799752;Variant;PA143485705;Chemical
DIURETICS;rs1799752;Variant;PA151249535;Chemical
ACE INHIBITORS, PLAIN;rs1799752;Variant;PA164712308;Chemical
BETA BLOCKING AGENTS;rs1799752;Variant;PA164712535;Chemical
SALVIANOLIC ACID B;rs1799752;Variant;PA166128370;Chemical
COVID-19;rs1799752;Variant;PA166197121;Disease
ARTERIOSCLEROSIS;rs1799752;Variant;PA443425;Disease
CORONARY ARTERY DISEASE;rs1799752;Variant;PA443796;Disease
CORONARY DISEASE;rs1799752;Variant;PA443797;Disease
COUGH;rs1799752;Variant;PA443803;Disease
DEATH;rs1799752;Variant;PA443842;Disease
DIABETES MELLITUS;rs1799752;Variant;PA443886;Disease
DIABETES MELLITUS, TYPE 1;rs1799752;Variant;PA443888;Disease
DIABETES MELLITUS, TYPE 2;rs1799752;Variant;PA443890;Disease
GLOMERULONEPHRITIS, IGA;rs1799752;Variant;PA444288;Disease
HEART FAILURE;rs1799752;Variant;PA444370;Disease
HYPERTENSION;rs1799752;Variant;PA444552;Disease
KIDNEY DISORDER;rs1799752;Variant;PA444682;Disease
KIDNEY FAILURE, CHRONIC;rs1799752;Variant;PA444684;Disease
MIGRAINE WITHOUT AURA;rs1799752;Variant;PA444949;Disease
MULTIPLE SCLEROSIS;rs1799752;Variant;PA444987;Disease
HYPERTROPHY, LEFT VENTRICULAR;rs1799752;Variant;PA446479;Disease
MIGRAINE WITH AURA;rs1799752;Variant;PA447004;Disease
HEADACHE DISORDERS;rs1799752;Variant;PA447076;Disease
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;rs1799752;Variant;PA447178;Disease
DEPRESSIVE DISORDER;rs1799752;Variant;PA447207;Disease
ESSENTIAL HYPERTENSION;rs1799752;Variant;PA447288;Disease
ACETYLCHOLINE;rs1799752;Variant;PA448031;Chemical
ATENOLOL;rs1799752;Variant;PA448499;Chemical
ATORVASTATIN;rs1799752;Variant;PA448500;Chemical
BENAZEPRIL;rs1799752;Variant;PA448561;Chemical
BUMETANIDE;rs1799752;Variant;PA448682;Chemical
CAPTOPRIL;rs1799752;Variant;PA448780;Chemical
DIGOXIN;rs1799752;Variant;PA449319;Chemical
ENALAPRIL;rs1799752;Variant;PA449456;Chemical
FLUOXETINE;rs1799752;Variant;PA449673;Chemical
FLUVASTATIN;rs1799752;Variant;PA449688;Chemical
FUROSEMIDE;rs1799752;Variant;PA449719;Chemical
HYDROCHLOROTHIAZIDE;rs1799752;Variant;PA449899;Chemical
INTERFERON BETA-1A;rs1799752;Variant;PA450037;Chemical
IRBESARTAN;rs1799752;Variant;PA450084;Chemical
LISINOPRIL;rs1799752;Variant;PA450242;Chemical
LOSARTAN;rs1799752;Variant;PA450268;Chemical
PERINDOPRIL;rs1799752;Variant;PA450877;Chemical
PRAVASTATIN;rs1799752;Variant;PA451089;Chemical
QUINAPRIL;rs1799752;Variant;PA451205;Chemical
SERTRALINE;rs1799752;Variant;PA451333;Chemical
NITROPRUSSIDE;rs1799752;Variant;PA451406;Chemical
SPIRONOLACTONE;rs1799752;Variant;PA451483;Chemical
TORASEMIDE;rs1799752;Variant;PA451733;Chemical
ANTIDEPRESSANTS;rs1799752;Variant;PA452229;Chemical
ADALIMUMAB;ATG16L1;Gene;PA10004;Chemical
CROHN DISEASE;ATG16L1;Gene;PA443815;Disease
WEIGHT GAIN;rs4994;Variant;PA128406954;Disease
SCHIZOPHRENIA;rs4994;Variant;PA447216;Disease
OLANZAPINE;rs4994;Variant;PA450688;Chemical
CYP3A4;nilotinib;Chemical;PA130;Gene
UGT1A1*1;nilotinib;Chemical;PA166115841;Haplotype
UGT1A1*28;nilotinib;Chemical;PA166115842;Haplotype
UGT1A1*6;nilotinib;Chemical;PA166115858;Haplotype
UGT1A1*27;nilotinib;Chemical;PA166115865;Haplotype
RS1061018;nilotinib;Chemical;PA166156501;Variant
RS2231137;nilotinib;Chemical;PA166156543;Variant
RS2231142;nilotinib;Chemical;PA166156544;Variant
RS41282401;nilotinib;Chemical;PA166156685;Variant
RS58818712;nilotinib;Chemical;PA166156688;Variant
RS8175347;nilotinib;Chemical;PA166159020;Variant
ABL1;nilotinib;Chemical;PA24413;Gene
BCR;nilotinib;Chemical;PA25321;Gene
ABCG2;nilotinib;Chemical;PA390;Gene
UGT1A1;nilotinib;Chemical;PA420;Gene
CYP2C19;prednisone;Chemical;PA124;Gene
C18ORF56;prednisone;Chemical;PA134956204;Gene
DROSHA;prednisone;Chemical;PA142671060;Gene
LINC00251;prednisone;Chemical;PA165585763;Gene
TPMT*1;prednisone;Chemical;PA165819268;Haplotype
TPMT*2;prednisone;Chemical;PA165819269;Haplotype
TPMT*3A;prednisone;Chemical;PA165819270;Haplotype
TPMT*3C;prednisone;Chemical;PA165819272;Haplotype
RS1891059;prednisone;Chemical;PA166153658;Variant
RS17021408;prednisone;Chemical;PA166153867;Variant
RS80223967;prednisone;Chemical;PA166153915;Variant
RS3824662;prednisone;Chemical;PA166154043;Variant
RS45445694;prednisone;Chemical;PA166155331;Variant
RS4553808;prednisone;Chemical;PA166155730;Variant
RS79085477;prednisone;Chemical;PA166155968;Variant
RS117532069;prednisone;Chemical;PA166155970;Variant
RS639174;prednisone;Chemical;PA166156737;Variant
RS3957357;prednisone;Chemical;PA166157094;Variant
RS1045642;prednisone;Chemical;PA166157284;Variant
RS2229109;prednisone;Chemical;PA166157334;Variant
RS141059755;prednisone;Chemical;PA166157691;Variant
RS1801157;prednisone;Chemical;PA166159131;Variant
BMP7;prednisone;Chemical;PA25384;Gene
DOK5;prednisone;Chemical;PA25724;Gene
ABCB1;prednisone;Chemical;PA267;Gene
CTLA4;prednisone;Chemical;PA27006;Gene
GATA3;prednisone;Chemical;PA28586;Gene
GSTA1;prednisone;Chemical;PA29016;Gene
TPMT;prednisone;Chemical;PA356;Gene
CXCL12;prednisone;Chemical;PA35602;Gene
TYMS;prednisone;Chemical;PA359;Gene
HYDROCHLOROTHIAZIDE;rs292449;Variant;PA449899;Chemical
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;KNG1;Gene;PA452637;Chemical
EVENT-FREE SURVIVAL;TPMT*34;Haplotype;PA166123366;Disease
LUPUS ERYTHEMATOSUS, SYSTEMIC;TPMT*34;Haplotype;PA444822;Disease
NEUTROPENIA;TPMT*34;Haplotype;PA445113;Disease
THROMBOCYTOPENIA;TPMT*34;Haplotype;PA445846;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;TPMT*34;Haplotype;PA446155;Disease
MERCAPTOPURINE;TPMT*34;Haplotype;PA450379;Chemical
THIOGUANINE;TPMT*34;Haplotype;PA451663;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs7851395;Variant;PA443622;Disease
CARBOPLATIN;rs7851395;Variant;PA448803;Chemical
CISPLATIN;rs7851395;Variant;PA449014;Chemical
RS6295;lurasidone;Chemical;PA166156708;Variant
HTR1A;lurasidone;Chemical;PA192;Gene
DESFLURANE;rs111888148;Variant;PA164749136;Chemical
RYR1;rs111888148;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs111888148;Variant;PA444863;Disease
ENFLURANE;rs111888148;Variant;PA449461;Chemical
HALOTHANE;rs111888148;Variant;PA449845;Chemical
ISOFLURANE;rs111888148;Variant;PA450106;Chemical
METHOXYFLURANE;rs111888148;Variant;PA450434;Chemical
SEVOFLURANE;rs111888148;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs111888148;Variant;PA451522;Chemical
CACNA1S;rs111888148;Variant;PA85;Gene
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs1355368;Variant;PA447197;Disease
METHYLPHENIDATE;rs1355368;Variant;PA450464;Chemical
FLUOROURACIL;XRCC4;Gene;PA128406956;Chemical
PLATINUM COMPOUNDS;XRCC4;Gene;PA164713176;Chemical
RADIOTHERAPY;XRCC4;Gene;PA166122986;Chemical
H2AFX;XRCC4;Gene;PA29116;Gene
NON-SMALL CELL LUNG CARCINOMA;XRCC4;Gene;PA443622;Disease
STOMACH NEOPLASMS;XRCC4;Gene;PA445742;Disease
DOCETAXEL;XRCC4;Gene;PA449383;Chemical
RS11854484;protease inhibitors;Chemical;PA166154934;Variant
SLC28A2;protease inhibitors;Chemical;PA386;Gene
HLA-B;erythema exudativum multiforme;Disease;PA35056;Gene
VORICONAZOLE;CYP2C19 intermediate metabolizer;Variant;PA10233;Chemical
DRUG TOXICITY;CYP2C19 intermediate metabolizer;Variant;PA443937;Disease
IMATINIB;SLC22A5;Gene;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;SLC22A5;Gene;PA151958383;Disease
TEZACAFTOR;rs1792306355;Variant;PA166175754;Chemical
ELEXACAFTOR;rs1792306355;Variant;PA166185161;Chemical
BOSENTAN;CYP2C9*3;Haplotype;PA10034;Chemical
VORICONAZOLE;CYP2C9*3;Haplotype;PA10233;Chemical
SULFONAMIDES, UREA DERIVATIVES;CYP2C9*3;Haplotype;PA10390;Chemical
GLICLAZIDE;CYP2C9*3;Haplotype;PA10892;Chemical
CYP2C19;CYP2C9*3;Haplotype;PA124;Gene
CYP2C9;CYP2C9*3;Haplotype;PA126;Gene
TENOXICAM;CYP2C9*3;Haplotype;PA131890625;Chemical
VKORC1;CYP2C9*3;Haplotype;PA133787052;Gene
BENZBROMARONE;CYP2C9*3;Haplotype;PA134852920;Chemical
SLCO1B1;CYP2C9*3;Haplotype;PA134865839;Gene
PITAVASTATIN;CYP2C9*3;Haplotype;PA142650384;Chemical
ANTIEPILEPTICS;CYP2C9*3;Haplotype;PA143485705;Chemical
F2;CYP2C9*3;Haplotype;PA157;Gene
F5;CYP2C9*3;Haplotype;PA159;Gene
MACULOPAPULAR EXANTHEMA;CYP2C9*3;Haplotype;PA162316739;Disease
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;CYP2C9*3;Haplotype;PA164712462;Chemical
GLIQUIDONE;CYP2C9*3;Haplotype;PA164744895;Chemical
FOSPHENYTOIN;CYP2C9*3;Haplotype;PA164746820;Chemical
ACUTE CORONARY SYNDROME;CYP2C9*3;Haplotype;PA165108401;Disease
DRUG RESISTANCE;CYP2C9*3;Haplotype;PA165111675;Disease
KIDNEY TRANSPLANTATION;CYP2C9*3;Haplotype;PA165817016;Disease
LORNOXICAM;CYP2C9*3;Haplotype;PA165958395;Chemical
FLUINDIONE;CYP2C9*3;Haplotype;PA165980614;Chemical
ACECLOFENAC;CYP2C9*3;Haplotype;PA166049185;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;CYP2C9*3;Haplotype;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;CYP2C9*3;Haplotype;PA166120929;Disease
OVER-ANTICOAGULATION;CYP2C9*3;Haplotype;PA166123298;Disease
HEART VALVE REPLACEMENT;CYP2C9*3;Haplotype;PA166123431;Disease
DIPYRONE;CYP2C9*3;Haplotype;PA166128206;Chemical
TIME TO ACHIEVE STABLE DOSE;CYP2C9*3;Haplotype;PA166129530;Disease
TIME IN THERAPEUTIC RANGE;CYP2C9*3;Haplotype;PA166129531;Disease
TIME TO THERAPEUTIC INR;CYP2C9*3;Haplotype;PA166129532;Disease
TIME ABOVE THERAPEUTIC RANGE;CYP2C9*3;Haplotype;PA166129534;Disease
TIME BELOW THERAPEUTIC RANGE;CYP2C9*3;Haplotype;PA166129562;Disease
ADVERSE EVENTS;CYP2C9*3;Haplotype;PA166151827;Disease
LESINURAD;CYP2C9*3;Haplotype;PA166160006;Chemical
AVATROMBOPAG;CYP2C9*3;Haplotype;PA166179849;Chemical
ERDAFITINIB;CYP2C9*3;Haplotype;PA166182720;Chemical
SIPONIMOD;CYP2C9*3;Haplotype;PA166182736;Chemical
RIMEGEPANT;CYP2C9*3;Haplotype;PA166225041;Chemical
ETRASIMOD;CYP2C9*3;Haplotype;PA166328841;Chemical
CYP4F2;CYP2C9*3;Haplotype;PA27121;Gene
PROC;CYP2C9*3;Haplotype;PA33799;Gene
PROS1;CYP2C9*3;Haplotype;PA33809;Gene
SERPINC1;CYP2C9*3;Haplotype;PA35026;Gene
HLA-B;CYP2C9*3;Haplotype;PA35056;Gene
ALCOHOLISM;CYP2C9*3;Haplotype;PA443309;Disease
ATRIAL FIBRILLATION;CYP2C9*3;Haplotype;PA443459;Disease
ATRIAL FLUTTER;CYP2C9*3;Haplotype;PA443460;Disease
BLOOD COAGULATION DISORDERS;CYP2C9*3;Haplotype;PA443523;Disease
CARDIOVASCULAR DISEASES;CYP2C9*3;Haplotype;PA443635;Disease
CORONARY ARTERY DISEASE;CYP2C9*3;Haplotype;PA443796;Disease
DIABETES MELLITUS;CYP2C9*3;Haplotype;PA443886;Disease
DIABETES MELLITUS, TYPE 2;CYP2C9*3;Haplotype;PA443890;Disease
DRUG TOXICITY;CYP2C9*3;Haplotype;PA443937;Disease
EPIDERMAL NECROLYSIS, TOXIC;CYP2C9*3;Haplotype;PA444059;Disease
EPILEPSY;CYP2C9*3;Haplotype;PA444065;Disease
EXANTHEMA;CYP2C9*3;Haplotype;PA444109;Disease
GASTRITIS;CYP2C9*3;Haplotype;PA444250;Disease
HEART DISEASES;CYP2C9*3;Haplotype;PA444368;Disease
HEMATOMA, SUBDURAL;CYP2C9*3;Haplotype;PA444398;Disease
HEMORRHAGE;CYP2C9*3;Haplotype;PA444417;Disease
GASTROINTESTINAL HEMORRHAGE;CYP2C9*3;Haplotype;PA444418;Disease
HYPERTENSION;CYP2C9*3;Haplotype;PA444552;Disease
HYPOGLYCEMIA;CYP2C9*3;Haplotype;PA444570;Disease
HYPOTENSION;CYP2C9*3;Haplotype;PA444584;Disease
KIDNEY DISEASES;CYP2C9*3;Haplotype;PA444682;Disease
NEOPLASMS;CYP2C9*3;Haplotype;PA445062;Disease
PAIN;CYP2C9*3;Haplotype;PA445208;Disease
PAIN, POSTOPERATIVE;CYP2C9*3;Haplotype;PA445210;Disease
PULMONARY EMBOLISM;CYP2C9*3;Haplotype;PA445465;Disease
RHEUMATIC HEART DISEASE;CYP2C9*3;Haplotype;PA445553;Disease
STEVENS-JOHNSON SYNDROME;CYP2C9*3;Haplotype;PA445738;Disease
THROMBOEMBOLISM;CYP2C9*3;Haplotype;PA445848;Disease
THYROTOXICOSIS;CYP2C9*3;Haplotype;PA445862;Disease
TUBERCULOSIS;CYP2C9*3;Haplotype;PA445941;Disease
VENOUS THROMBOSIS;CYP2C9*3;Haplotype;PA446969;Disease
STROKE;CYP2C9*3;Haplotype;PA447054;Disease
BIPOLAR DISORDER;CYP2C9*3;Haplotype;PA447199;Disease
MENTAL DISORDERS;CYP2C9*3;Haplotype;PA447208;Disease
PSYCHOTIC DISORDERS;CYP2C9*3;Haplotype;PA447215;Disease
HIV INFECTIONS;CYP2C9*3;Haplotype;PA447230;Disease
THROMBOSIS OF CEREBRAL VEINS;CYP2C9*3;Haplotype;PA447276;Disease
VENOUS THROMBOEMBOLISM;CYP2C9*3;Haplotype;PA447298;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2C9*3;Haplotype;PA447321;Disease
ASPIRIN;CYP2C9*3;Haplotype;PA448497;Chemical
CELECOXIB;CYP2C9*3;Haplotype;PA448871;Chemical
CLOPIDOGREL;CYP2C9*3;Haplotype;PA449053;Chemical
DICLOFENAC;CYP2C9*3;Haplotype;PA449293;Chemical
DOXEPIN;CYP2C9*3;Haplotype;PA449409;Chemical
FLUCONAZOLE;CYP2C9*3;Haplotype;PA449653;Chemical
FLUOXETINE;CYP2C9*3;Haplotype;PA449673;Chemical
FLURBIPROFEN;CYP2C9*3;Haplotype;PA449683;Chemical
FLUVASTATIN;CYP2C9*3;Haplotype;PA449688;Chemical
GLIMEPIRIDE;CYP2C9*3;Haplotype;PA449761;Chemical
GLIPIZIDE;CYP2C9*3;Haplotype;PA449762;Chemical
GLYBURIDE;CYP2C9*3;Haplotype;PA449782;Chemical
IBUPROFEN;CYP2C9*3;Haplotype;PA449957;Chemical
INDOMETHACIN;CYP2C9*3;Haplotype;PA449982;Chemical
KETOPROFEN;CYP2C9*3;Haplotype;PA450149;Chemical
KETOROLAC;CYP2C9*3;Haplotype;PA450150;Chemical
LOSARTAN;CYP2C9*3;Haplotype;PA450268;Chemical
MELOXICAM;CYP2C9*3;Haplotype;PA450353;Chemical
METHADONE;CYP2C9*3;Haplotype;PA450401;Chemical
NAPROXEN;CYP2C9*3;Haplotype;PA450595;Chemical
NATEGLINIDE;CYP2C9*3;Haplotype;PA450600;Chemical
OLANZAPINE;CYP2C9*3;Haplotype;PA450688;Chemical
PHENPROCOUMON;CYP2C9*3;Haplotype;PA450921;Chemical
PHENYTOIN;CYP2C9*3;Haplotype;PA450947;Chemical
PIOGLITAZONE;CYP2C9*3;Haplotype;PA450970;Chemical
PIROXICAM;CYP2C9*3;Haplotype;PA450985;Chemical
RIFAMPIN;CYP2C9*3;Haplotype;PA451250;Chemical
SIMVASTATIN;CYP2C9*3;Haplotype;PA451363;Chemical
SULFAMETHOXAZOLE;CYP2C9*3;Haplotype;PA451544;Chemical
TOLBUTAMIDE;CYP2C9*3;Haplotype;PA451718;Chemical
TRIMIPRAMINE;CYP2C9*3;Haplotype;PA451791;Chemical
VALPROIC ACID;CYP2C9*3;Haplotype;PA451846;Chemical
WARFARIN;CYP2C9*3;Haplotype;PA451906;Chemical
ZAFIRLUKAST;CYP2C9*3;Haplotype;PA451949;Chemical
ACENOCOUMAROL;CYP2C9*3;Haplotype;PA452632;Chemical
SULFONAMIDES, UREA DERIVATIVES;rs5219;Variant;PA10390;Chemical
GLICLAZIDE;rs5219;Variant;PA10892;Chemical
DIABETES MELLITUS;rs5219;Variant;PA443886;Disease
DIABETES MELLITUS, TYPE 2;rs5219;Variant;PA443890;Disease
METFORMIN;rs5219;Variant;PA450395;Chemical
REPAGLINIDE;rs5219;Variant;PA451234;Chemical
TACROLIMUS;rs5219;Variant;PA451578;Chemical
ARIPIPRAZOLE;rs2229109;Variant;PA10026;Chemical
VALGANCICLOVIR;rs2229109;Variant;PA10227;Chemical
VINDESINE;rs2229109;Variant;PA10232;Chemical
LENALIDOMIDE;rs2229109;Variant;PA162363968;Chemical
AMISULPRIDE;rs2229109;Variant;PA162565877;Chemical
KIDNEY TRANSPLANTATION;rs2229109;Variant;PA165817016;Disease
PROGRESSION-FREE SURVIVAL;rs2229109;Variant;PA166123026;Disease
GLIOMA;rs2229109;Variant;PA444284;Disease
NON-HODGKIN LYMPHOMA;rs2229109;Variant;PA444845;Disease
MULTIPLE MYELOMA;rs2229109;Variant;PA444985;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs2229109;Variant;PA446155;Disease
BLEOMYCIN;rs2229109;Variant;PA448645;Chemical
CYCLOPHOSPHAMIDE;rs2229109;Variant;PA449165;Chemical
DEXAMETHASONE;rs2229109;Variant;PA449247;Chemical
DOXORUBICIN;rs2229109;Variant;PA449412;Chemical
METHOTREXATE;rs2229109;Variant;PA450428;Chemical
OLANZAPINE;rs2229109;Variant;PA450688;Chemical
PACLITAXEL;rs2229109;Variant;PA450761;Chemical
PREDNISOLONE;rs2229109;Variant;PA451096;Chemical
PREDNISONE;rs2229109;Variant;PA451100;Chemical
RISPERIDONE;rs2229109;Variant;PA451257;Chemical
RITUXIMAB;rs2229109;Variant;PA451261;Chemical
TACROLIMUS;rs2229109;Variant;PA451578;Chemical
TEMOZOLOMIDE;rs2229109;Variant;PA451609;Chemical
VINCRISTINE;rs2229109;Variant;PA451879;Chemical
NON-SMALL CELL LUNG CARCINOMA;UBE2I;Gene;PA443622;Disease
CISPLATIN;UBE2I;Gene;PA449014;Chemical
IRINOTECAN;UBE2I;Gene;PA450085;Chemical
COLORECTAL NEOPLASMS;PTGER4;Gene;PA446108;Disease
CELECOXIB;PTGER4;Gene;PA448871;Chemical
SULFAMETHOXAZOLE / TRIMETHOPRIM;HLA-B*07:02;Haplotype;PA10715;Chemical
MEASLES VACCINES;HLA-B*07:02;Haplotype;PA164712887;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*07:02;Haplotype;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-B*07:02;Haplotype;PA166120929;Disease
RESPIRATORY INSUFFICIENCY;HLA-B*07:02;Haplotype;PA445522;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*07:02;Haplotype;PA445738;Disease
CARBAMAZEPINE;HLA-B*07:02;Haplotype;PA448785;Chemical
PHENYTOIN;HLA-B*07:02;Haplotype;PA450947;Chemical
CALCIUM CHANNEL BLOCKERS;rs588076;Variant;PA10407;Chemical
HYPERTENSION;rs588076;Variant;PA444552;Disease
HALOPERIDOL;NTS;Gene;PA449841;Chemical
SLCO1B1;estrone;Chemical;PA134865839;Gene
SLCO1B1*5;estrone;Chemical;PA165819255;Haplotype
SLCO1B1*1;estrone;Chemical;PA165981641;Haplotype
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs3804099;Variant;PA164713366;Chemical
INFLAMMATORY BOWEL DISEASES;rs3804099;Variant;PA446116;Disease
ERLOTINIB;rs2472304;Variant;PA134687924;Chemical
MAJOR DEPRESSIVE DISORDER;rs2472304;Variant;PA447321;Disease
PAROXETINE;rs2472304;Variant;PA450801;Chemical
SCN5A;Ventricular Fibrillation;Disease;PA304;Gene
CPOX;givosiran;Chemical;PA134979958;Gene
HMBS;givosiran;Chemical;PA29317;Gene
PPOX;givosiran;Chemical;PA33608;Gene
RS11568626;cidofovir;Chemical;PA166154458;Variant
SLC22A6;cidofovir;Chemical;PA388;Gene
FOLR1;mirvetuximab soravtansine;Chemical;PA28207;Gene
CLAVULANATE;HLA-DRB5;Gene;PA164742987;Chemical
AGRANULOCYTOSIS;HLA-DRB5;Gene;PA443297;Disease
HEPATITIS;HLA-DRB5;Gene;PA444435;Disease
INFECTION;HLA-DRB5;Gene;PA444614;Disease
SCHIZOPHRENIA;HLA-DRB5;Gene;PA447216;Disease
AMOXICILLIN;HLA-DRB5;Gene;PA448406;Chemical
CLOZAPINE;HLA-DRB5;Gene;PA449061;Chemical
BOTULINUM TOXIN TYPE A;CALCA;Gene;PA164754825;Chemical
MIGRAINE DISORDER;CALCA;Gene;PA165108779;Disease
PAIN, POSTOPERATIVE;CALCA;Gene;PA445210;Disease
FENTANYL;CALCA;Gene;PA449599;Chemical
CYP2D6;Back Pain;Disease;PA128;Gene
CYP2D6*1;Back Pain;Disease;PA165816576;Haplotype
CYP2D6;coptisine;Chemical;PA128;Gene
CYP2D6*1;coptisine;Chemical;PA165816576;Haplotype
CYP2D6*10;coptisine;Chemical;PA165816582;Haplotype
EFAVIRENZ;rs1969376664;Variant;PA449441;Chemical
PROPOFOL;rs1969376664;Variant;PA451141;Chemical
RS113488022;tovorafenib;Chemical;PA166157522;Variant
BRAF;tovorafenib;Chemical;PA25408;Gene
LAROTRECTINIB;NTRK2;Gene;PA166182733;Chemical
ENTRECTINIB;NTRK2;Gene;PA166190161;Chemical
REPOTRECTINIB;NTRK2;Gene;PA166328881;Chemical
HEROIN DEPENDENCE;NTRK2;Gene;PA444460;Disease
OPIOID-RELATED DISORDERS;NTRK2;Gene;PA445043;Disease
BIPOLAR DISORDER;NTRK2;Gene;PA447199;Disease
SCHIZOPHRENIA;NTRK2;Gene;PA447216;Disease
MAJOR DEPRESSIVE DISORDER;NTRK2;Gene;PA447321;Disease
CLOZAPINE;NTRK2;Gene;PA449061;Chemical
LITHIUM;NTRK2;Gene;PA450243;Chemical
METHADONE;NTRK2;Gene;PA450401;Chemical
ANTIDEPRESSANTS;NTRK2;Gene;PA452229;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;ARSA;Gene;PA447197;Disease
METHYLPHENIDATE;ARSA;Gene;PA450464;Chemical
CYP2C9;time below therapeutic range;Disease;PA126;Gene
CYP2C9*1;time below therapeutic range;Disease;PA165816542;Haplotype
CYP2C9*2;time below therapeutic range;Disease;PA165816543;Haplotype
CYP2C9*3;time below therapeutic range;Disease;PA165816544;Haplotype
CYP2C19;clopidogrel thiol metabolite H4;Chemical;PA124;Gene
ILOPERIDONE;rs7142881;Variant;PA161199368;Chemical
ACQUIRED LONG QT SYNDROME (ALQTS);rs7142881;Variant;PA447300;Disease
S-EDDP;CYP2B6*26;Haplotype;PA166177606;Chemical
R-EDDP;CYP2B6*26;Haplotype;PA166247521;Chemical
HIV INFECTIONS;CYP2B6*26;Haplotype;PA447230;Disease
EFAVIRENZ;CYP2B6*26;Haplotype;PA449441;Chemical
DIARRHEA;UGT1A7*1a;Haplotype;PA443899;Disease
NEUTROPENIA;UGT1A7*1a;Haplotype;PA445113;Disease
STOMACH NEOPLASMS;UGT1A7*1a;Haplotype;PA445742;Disease
IRINOTECAN;UGT1A7*1a;Haplotype;PA450085;Chemical
FLUOROURACIL;rs9561778;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs9561778;Variant;PA443560;Disease
DRUG TOXICITY;rs9561778;Variant;PA443937;Disease
NEOPLASMS;rs9561778;Variant;PA445062;Disease
CYCLOPHOSPHAMIDE;rs9561778;Variant;PA449165;Chemical
DOXORUBICIN;rs9561778;Variant;PA449412;Chemical
MAJOR DEPRESSIVE DISORDER;rs495794;Variant;PA447321;Disease
CITALOPRAM;rs495794;Variant;PA449015;Chemical
FLUOXETINE;rs495794;Variant;PA449673;Chemical
PAROXETINE;rs495794;Variant;PA450801;Chemical
SERTRALINE;rs495794;Variant;PA451333;Chemical
MENOPAUSE;rs4775936;Variant;PA166048848;Disease
BREAST NEOPLASMS;rs4775936;Variant;PA443560;Disease
LETROZOLE;rs4775936;Variant;PA450196;Chemical
BUPROPION;rs200238771;Variant;PA448687;Chemical
EFAVIRENZ;rs200238771;Variant;PA449441;Chemical
BRONCHOPULMONARY DYSPLASIA OF NEWBORN;ADORA2A;Gene;PA165109162;Disease
ADVERSE EVENTS;ADORA2A;Gene;PA166151827;Disease
APNEA OF PREMATURITY;ADORA2A;Gene;PA166248161;Disease
RHEUMATOID ARTHRITIS;ADORA2A;Gene;PA443434;Disease
PREMATURE BIRTH;ADORA2A;Gene;PA444704;Disease
HEMATOLOGIC NEOPLASMS;ADORA2A;Gene;PA446827;Disease
ANXIETY DISORDERS;ADORA2A;Gene;PA447196;Disease
CAFFEINE;ADORA2A;Gene;PA448710;Chemical
METHOTREXATE;ADORA2A;Gene;PA450428;Chemical
MAJOR DEPRESSIVE DISORDER;rs2873804;Variant;PA447321;Disease
BUPROPION;rs2873804;Variant;PA448687;Chemical
RS6166;follitropin beta;Chemical;PA166155582;Variant
FSHR;follitropin beta;Chemical;PA28386;Gene
EPILEPSY;rs2461817;Variant;PA444065;Disease
CARBAMAZEPINE;rs2461817;Variant;PA448785;Chemical
NICOTINE;rs10912675;Variant;PA450626;Chemical
ALCOHOL ABUSE;rs524731;Variant;PA443309;Disease
HEROIN DEPENDENCE;rs524731;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs524731;Variant;PA445043;Disease
COCAINE DEPENDENCE;rs524731;Variant;PA446878;Disease
ETHANOL;rs524731;Variant;PA448073;Chemical
COCAINE;rs524731;Variant;PA449072;Chemical
OPIOIDS;rs524731;Variant;PA452618;Chemical
HEROIN;rs524731;Variant;PA452619;Chemical
HYPERTROPHY, LEFT VENTRICULAR;rs1801701;Variant;PA446479;Disease
IRBESARTAN;rs1801701;Variant;PA450084;Chemical
GEMCITABINE;rs1705772;Variant;PA449748;Chemical
CES1;Cerebrovascular Disorders;Disease;PA107;Gene
CYP2C19;Cerebrovascular Disorders;Disease;PA124;Gene
CYP2C19*1;Cerebrovascular Disorders;Disease;PA165980634;Haplotype
CYP2C19*2;Cerebrovascular Disorders;Disease;PA165980635;Haplotype
RS8192950;Cerebrovascular Disorders;Disease;PA166162295;Variant
PLATINUM COMPOUNDS;rs430397;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs430397;Variant;PA443622;Disease
CYP2C19;platelet aggregation inhibition;Disease;PA124;Gene
CYP3A4;platelet aggregation inhibition;Disease;PA130;Gene
CYP2C19*17;platelet aggregation inhibition;Disease;PA165816533;Haplotype
CYP3A4*1;platelet aggregation inhibition;Disease;PA165819201;Haplotype
CYP2C19*1;platelet aggregation inhibition;Disease;PA165980634;Haplotype
CYP3A4*22;platelet aggregation inhibition;Disease;PA166048680;Haplotype
ANTICHOLINERGICS;rs622342;Variant;PA164712420;Chemical
DOPAMINE AGONISTS;rs622342;Variant;PA164712697;Chemical
DIABETES MELLITUS;rs622342;Variant;PA443886;Disease
PARKINSON DISEASE;rs622342;Variant;PA445254;Disease
AMANTADINE;rs622342;Variant;PA448360;Chemical
LEVODOPA;rs622342;Variant;PA450213;Chemical
METFORMIN;rs622342;Variant;PA450395;Chemical
SELEGILINE;rs622342;Variant;PA451316;Chemical
ODEVIXIBAT;rs11568372;Variant;PA166268805;Chemical
ATP8B1;rs11568372;Variant;PA265;Gene
ABCB11;rs11568372;Variant;PA374;Gene
CARDIAC RHYTHM DISEASE;rs3842;Variant;PA443421;Disease
HIV INFECTIOUS DISEASE;rs3842;Variant;PA447230;Disease
EFAVIRENZ;rs3842;Variant;PA449441;Chemical
OLANZAPINE;rs3842;Variant;PA450688;Chemical
FLUOROURACIL;rs2297595;Variant;PA128406956;Chemical
DPYD;rs2297595;Variant;PA145;Gene
NEOPLASMS;rs2297595;Variant;PA445062;Disease
CAPECITABINE;rs2297595;Variant;PA448771;Chemical
CYP2D6;acetaminophen / codeine;Chemical;PA128;Gene
G6PD;acetaminophen / codeine;Chemical;PA28469;Gene
HYPERTENSION;rs3213619;Variant;PA444552;Disease
ATENOLOL;rs3213619;Variant;PA448499;Chemical
COLITIS, ULCERATIVE;NAT1*10;Haplotype;PA443750;Disease
CROHN DISEASE;NAT1*10;Haplotype;PA443815;Disease
INFLAMMATORY BOWEL DISEASES;NAT1*10;Haplotype;PA446116;Disease
MESALAZINE;NAT1*10;Haplotype;PA450384;Chemical
THIOGUANINE;NAT1*10;Haplotype;PA451663;Chemical
VORINOSTAT;UGT2B17;Gene;PA164748224;Chemical
CYP2C19*2;UGT2B17;Gene;PA165980635;Haplotype
CYP2C19*3;UGT2B17;Gene;PA165980636;Haplotype
BELZUTIFAN;UGT2B17;Gene;PA166268761;Chemical
BREAST NEOPLASMS;UGT2B17;Gene;PA443560;Disease
FATIGUE;UGT2B17;Gene;PA444153;Disease
HOT FLASHES;UGT2B17;Gene;PA446852;Disease
DICLOFENAC;UGT2B17;Gene;PA449293;Chemical
EXEMESTANE;UGT2B17;Gene;PA449563;Chemical
IBUPROFEN;UGT2B17;Gene;PA449957;Chemical
CYP2C19;Peptic Ulcer;Disease;PA124;Gene
CYP2C19*17;Peptic Ulcer;Disease;PA165816533;Haplotype
CYP2C19*1;Peptic Ulcer;Disease;PA165980634;Haplotype
CYP2C19*2;Peptic Ulcer;Disease;PA165980635;Haplotype
CYP2C19*3;Peptic Ulcer;Disease;PA165980636;Haplotype
RS12678747;Peptic Ulcer;Disease;PA166260501;Variant
EYA1;Peptic Ulcer;Disease;PA27931;Gene
COMT;quetiapine;Chemical;PA117;Gene
CYP2B6;quetiapine;Chemical;PA123;Gene
CYP2C19;quetiapine;Chemical;PA124;Gene
CYP2C9;quetiapine;Chemical;PA126;Gene
CYP2D6;quetiapine;Chemical;PA128;Gene
CYP3A4;quetiapine;Chemical;PA130;Gene
CYP3A5;quetiapine;Chemical;PA131;Gene
RABEP1;quetiapine;Chemical;PA134884097;Gene
EIF2AK4;quetiapine;Chemical;PA134947616;Gene
SH2B1;quetiapine;Chemical;PA145148084;Gene
MIR582;quetiapine;Chemical;PA164722879;Gene
CYP2D6*1;quetiapine;Chemical;PA165816576;Haplotype
CYP2D6*4;quetiapine;Chemical;PA165816579;Haplotype
CYP2D6*41;quetiapine;Chemical;PA165816584;Haplotype
CYP3A4*1;quetiapine;Chemical;PA165819201;Haplotype
CYP3A4*3;quetiapine;Chemical;PA165819221;Haplotype
CYP3A4*6;quetiapine;Chemical;PA165819224;Haplotype
CYP3A4*8;quetiapine;Chemical;PA165819226;Haplotype
CYP3A4*11;quetiapine;Chemical;PA165819229;Haplotype
CYP3A4*12;quetiapine;Chemical;PA165819230;Haplotype
CYP3A4*13;quetiapine;Chemical;PA165819231;Haplotype
CYP3A4*16;quetiapine;Chemical;PA165819236;Haplotype
CYP3A4*17;quetiapine;Chemical;PA165819239;Haplotype
CYP3A4*18;quetiapine;Chemical;PA165819240;Haplotype
CYP3A4*20;quetiapine;Chemical;PA165819244;Haplotype
CYP2C19*1;quetiapine;Chemical;PA165980634;Haplotype
CYP2C19*2;quetiapine;Chemical;PA165980635;Haplotype
CYP2C19*4;quetiapine;Chemical;PA165980637;Haplotype
CYP3A4*22;quetiapine;Chemical;PA166048680;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);quetiapine;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);quetiapine;Chemical;PA166116466;Haplotype
RS324420;quetiapine;Chemical;PA166153569;Variant
RS951439;quetiapine;Chemical;PA166153604;Variant
RS7912580;quetiapine;Chemical;PA166154088;Variant
RS1806201;quetiapine;Chemical;PA166154519;Variant
RS2412459;quetiapine;Chemical;PA166154891;Variant
RS489693;quetiapine;Chemical;PA166155269;Variant
RS17782313;quetiapine;Chemical;PA166155330;Variant
RS4818;quetiapine;Chemical;PA166156025;Variant
RS6269;quetiapine;Chemical;PA166156027;Variant
RS6280;quetiapine;Chemical;PA166156277;Variant
RS10042486;quetiapine;Chemical;PA166156855;Variant
RS1415744;quetiapine;Chemical;PA166156984;Variant
RS776746;quetiapine;Chemical;PA166157267;Variant
RS5993883;quetiapine;Chemical;PA166161174;Variant
RS3888190;quetiapine;Chemical;PA166165398;Variant
RS1000940;quetiapine;Chemical;PA166165401;Variant
RS17382202;quetiapine;Chemical;PA166184312;Variant
RS17742120;quetiapine;Chemical;PA166184313;Variant
RS2164660;quetiapine;Chemical;PA166184314;Variant
CYP3A4*26;quetiapine;Chemical;PA166245583;Haplotype
RS155333;quetiapine;Chemical;PA166252941;Variant
RS6465938;quetiapine;Chemical;PA166252981;Variant
HTR1A;quetiapine;Chemical;PA192;Gene
HTR2A;quetiapine;Chemical;PA193;Gene
HTR2C;quetiapine;Chemical;PA194;Gene
CYP1A2;quetiapine;Chemical;PA27093;Gene
DRD2;quetiapine;Chemical;PA27478;Gene
DRD3;quetiapine;Chemical;PA27479;Gene
EPM2A;quetiapine;Chemical;PA27832;Gene
FAAH;quetiapine;Chemical;PA27955;Gene
GRIN2B;quetiapine;Chemical;PA28980;Gene
MC4R;quetiapine;Chemical;PA30676;Gene
SLC6A4;quetiapine;Chemical;PA312;Gene
PDE4D;quetiapine;Chemical;PA33130;Gene
POLG;quetiapine;Chemical;PA33500;Gene
RELN;quetiapine;Chemical;PA34323;Gene
RGS4;quetiapine;Chemical;PA34375;Gene
HLA-A;quetiapine;Chemical;PA35055;Gene
HLA-B;quetiapine;Chemical;PA35056;Gene
UGT1A4;quetiapine;Chemical;PA37179;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs5030728;Variant;PA164713366;Chemical
INFLAMMATORY BOWEL DISEASES;rs5030728;Variant;PA446116;Disease
BREAST NEOPLASMS;rs16964189;Variant;PA443560;Disease
EXEMESTANE;rs16964189;Variant;PA449563;Chemical
NON-SMALL CELL LUNG CARCINOMA;MSH5;Gene;PA443622;Disease
THROMBOCYTOPENIA;MSH5;Gene;PA445846;Disease
CARBOPLATIN;MSH5;Gene;PA448803;Chemical
GEMCITABINE;MSH5;Gene;PA449748;Chemical
SUBSTANCE-RELATED DISORDERS;PICK1;Gene;PA446876;Disease
PSYCHOTIC DISORDER;PICK1;Gene;PA447215;Disease
METHAMPHETAMINE;PICK1;Gene;PA450403;Chemical
ABCC2;Mucositis;Disease;PA116;Gene
ENOSF1;Mucositis;Disease;PA134897613;Gene
DPYD;Mucositis;Disease;PA145;Gene
ERCC1;Mucositis;Disease;PA155;Gene
RS1801133;Mucositis;Disease;PA166153644;Variant
RS3740065;Mucositis;Disease;PA166154027;Variant
RS2236225;Mucositis;Disease;PA166154789;Variant
RS4673;Mucositis;Disease;PA166154969;Variant
RS11615;Mucositis;Disease;PA166155342;Variant
RS3832043;Mucositis;Disease;PA166155718;Variant
RS1045642;Mucositis;Disease;PA166157284;Variant
RS1128503;Mucositis;Disease;PA166157288;Variant
DPYD DEFICIENCY;Mucositis;Disease;PA166157931;Variant
RS2027701;Mucositis;Disease;PA166169891;Variant
RS1059698;Mucositis;Disease;PA166169893;Variant
RS73594404;Mucositis;Disease;PA166169897;Variant
RS10132552;Mucositis;Disease;PA166169901;Variant
RS11280056;Mucositis;Disease;PA166180936;Variant
MTHFR;Mucositis;Disease;PA245;Gene
ABCB1;Mucositis;Disease;PA267;Gene
CYBA;Mucositis;Disease;PA27075;Gene
MEG3;Mucositis;Disease;PA30737;Gene
MTHFD1;Mucositis;Disease;PA31236;Gene
TYMS;Mucositis;Disease;PA359;Gene
UGT1A9;Mucositis;Disease;PA419;Gene
HIV INFECTIOUS DISEASE;rs1265112;Variant;PA447230;Disease
NEVIRAPINE;rs1265112;Variant;PA450616;Chemical
TURNER SYNDROME;rs2069502;Variant;PA445968;Disease
SOMATROPIN RECOMBINANT;rs2069502;Variant;PA451446;Chemical
ANALGESICS;rs6265;Variant;PA164712362;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;rs6265;Variant;PA164712462;Chemical
ERGOT ALKALOIDS;rs6265;Variant;PA164712741;Chemical
METHAMPHETAMINE DEPENDENCE;rs6265;Variant;PA166119022;Disease
SUBSTANCE-RELATED DISORDERS;rs6265;Variant;PA446876;Disease
DEPRESSIVE DISORDER;rs6265;Variant;PA447207;Disease
SCHIZOPHRENIA;rs6265;Variant;PA447216;Disease
DEPRESSIVE DISORDER, MAJOR;rs6265;Variant;PA447321;Disease
CITALOPRAM;rs6265;Variant;PA449015;Chemical
FLUOXETINE;rs6265;Variant;PA449673;Chemical
METHAMPHETAMINE;rs6265;Variant;PA450403;Chemical
OLANZAPINE;rs6265;Variant;PA450688;Chemical
PAROXETINE;rs6265;Variant;PA450801;Chemical
SUMATRIPTAN;rs6265;Variant;PA451566;Chemical
ANTIDEPRESSANTS;rs6265;Variant;PA452229;Chemical
ANTIPSYCHOTICS;rs6265;Variant;PA452233;Chemical
OPIOIDS;rs6265;Variant;PA452618;Chemical
HEROIN;rs6265;Variant;PA452619;Chemical
GEFITINIB;NFKBIB;Gene;PA131301952;Chemical
TOXIC LIVER DISEASE;NFKBIB;Gene;PA164925725;Disease
ATAZANAVIR;UGT1A1*37;Haplotype;PA10251;Chemical
SN-38;UGT1A1*37;Haplotype;PA165110775;Chemical
PAZOPANIB;UGT1A1*37;Haplotype;PA165291492;Chemical
PREGNANCY;UGT1A1*37;Haplotype;PA166048714;Disease
DOLUTEGRAVIR;UGT1A1*37;Haplotype;PA166114961;Chemical
ATAZANAVIR / RITONAVIR;UGT1A1*37;Haplotype;PA166182624;Chemical
UGT1A1;UGT1A1*37;Haplotype;PA420;Gene
ASTHENIA;UGT1A1*37;Haplotype;PA443448;Disease
CARCINOMA, RENAL CELL;UGT1A1*37;Haplotype;PA443624;Disease
DIARRHEA;UGT1A1*37;Haplotype;PA443899;Disease
HYPERBILIRUBINEMIA;UGT1A1*37;Haplotype;PA444511;Disease
NEOPLASMS;UGT1A1*37;Haplotype;PA445062;Disease
NEUTROPENIA;UGT1A1*37;Haplotype;PA445113;Disease
TUBERCULOSIS;UGT1A1*37;Haplotype;PA445941;Disease
COLORECTAL NEOPLASMS;UGT1A1*37;Haplotype;PA446108;Disease
HIV INFECTIONS;UGT1A1*37;Haplotype;PA447230;Disease
IRINOTECAN;UGT1A1*37;Haplotype;PA450085;Chemical
LAMIVUDINE;UGT1A1*37;Haplotype;PA450163;Chemical
MOXIFLOXACIN;UGT1A1*37;Haplotype;PA450555;Chemical
ZIDOVUDINE;UGT1A1*37;Haplotype;PA451954;Chemical
CYP2D6;paliperidone;Chemical;PA128;Gene
RABEP1;paliperidone;Chemical;PA134884097;Gene
SH2B1;paliperidone;Chemical;PA145148084;Gene
RS489693;paliperidone;Chemical;PA166155269;Variant
RS17782313;paliperidone;Chemical;PA166155330;Variant
RS3888190;paliperidone;Chemical;PA166165398;Variant
RS1000940;paliperidone;Chemical;PA166165401;Variant
ERBB4;paliperidone;Chemical;PA27847;Gene
MC4R;paliperidone;Chemical;PA30676;Gene
ATAZANAVIR;rs3806596;Variant;PA10251;Chemical
DEFERASIROX;rs3806596;Variant;PA164760843;Chemical
HYPERBILIRUBINEMIA;rs3806596;Variant;PA444511;Disease
BETA-THALASSEMIA AND RELATED DISEASES;rs3806596;Variant;PA446432;Disease
HIV INFECTIOUS DISEASE;rs3806596;Variant;PA447230;Disease
RITONAVIR;rs3806596;Variant;PA451260;Chemical
HEROIN DEPENDENCE;rs16917234;Variant;PA444460;Disease
HEROIN;rs16917234;Variant;PA452619;Chemical
MYELOSUPPRESSION;NUDT15;Gene;PA165817398;Disease
TPMT*2;NUDT15;Gene;PA165819269;Haplotype
TPMT*3A;NUDT15;Gene;PA165819270;Haplotype
TPMT*3B;NUDT15;Gene;PA165819271;Haplotype
TPMT*3C;NUDT15;Gene;PA165819272;Haplotype
TPMT*4;NUDT15;Gene;PA165819274;Haplotype
HEMATOPOIETIC STEM CELL TRANSPLANTATION;NUDT15;Gene;PA166123007;Disease
DISCONTINUATION;NUDT15;Gene;PA166123507;Disease
NUDT15*2;NUDT15;Gene;PA166131620;Haplotype
NUDT15*3;NUDT15;Gene;PA166131621;Haplotype
RS116855232;NUDT15;Gene;PA166154759;Variant
PRIMARY GRAFT FAILURE;NUDT15;Gene;PA166248341;Disease
AUTOIMMUNE DISEASES;NUDT15;Gene;PA443464;Disease
INFLAMMATION;NUDT15;Gene;PA444620;Disease
LEUKOPENIA;NUDT15;Gene;PA444773;Disease
NEUTROPENIA;NUDT15;Gene;PA445113;Disease
PANCYTOPENIA;NUDT15;Gene;PA445221;Disease
THROMBOCYTOPENIA;NUDT15;Gene;PA445846;Disease
INFLAMMATORY BOWEL DISEASES;NUDT15;Gene;PA446116;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;NUDT15;Gene;PA446155;Disease
ACYCLOVIR;NUDT15;Gene;PA448045;Chemical
AZATHIOPRINE;NUDT15;Gene;PA448515;Chemical
MERCAPTOPURINE;NUDT15;Gene;PA450379;Chemical
THIOGUANINE;NUDT15;Gene;PA451663;Chemical
BUPROPION;rs200458614;Variant;PA448687;Chemical
EFAVIRENZ;rs200458614;Variant;PA449441;Chemical
COL3A1;GP9;Gene;PA26716;Gene
COL4A1;GP9;Gene;PA26717;Gene
COL4A2;GP9;Gene;PA26718;Gene
PLCB1;GP9;Gene;PA33384;Gene
PLCG2;GP9;Gene;PA33393;Gene
COL1A1;GP9;Gene;PA35041;Gene
COL1A2;GP9;Gene;PA35042;Gene
NON-SMALL CELL LUNG CARCINOMA;rs12721627;Variant;PA443622;Disease
NEOPLASMS;rs12721627;Variant;PA445062;Disease
MIDAZOLAM;rs12721627;Variant;PA450496;Chemical
PACLITAXEL;rs12721627;Variant;PA450761;Chemical
ANEMIA, SICKLE CELL;rs7668282;Variant;PA443355;Disease
MORPHINE;rs7668282;Variant;PA450550;Chemical
CETUXIMAB;rs712830;Variant;PA10040;Chemical
COLORECTAL NEOPLASMS;rs712830;Variant;PA446108;Disease
IRINOTECAN;rs712830;Variant;PA450085;Chemical
LEUCOVORIN;rs712830;Variant;PA450198;Chemical
TEGAFUR;rs712830;Variant;PA452620;Chemical
ESCITALOPRAM;rs11568817;Variant;PA10074;Chemical
ANXIETY DISORDERS;rs11568817;Variant;PA447196;Disease
G6PD A- 202A_376G;pamaquine;Chemical;PA165947827;Haplotype
G6PD DEFICIENCY;pamaquine;Chemical;PA166157959;Variant
G6PD;pamaquine;Chemical;PA28469;Gene
PLATINUM COMPOUNDS;rs1052555;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs1052555;Variant;PA443622;Disease
CYP2C19;Respiratory Tract Infections;Disease;PA124;Gene
CYP2C19*8;Respiratory Tract Infections;Disease;PA165816524;Haplotype
CYP2C19*9;Respiratory Tract Infections;Disease;PA165816525;Haplotype
CYP2C19*1;Respiratory Tract Infections;Disease;PA165980634;Haplotype
CYP2C19*2;Respiratory Tract Infections;Disease;PA165980635;Haplotype
CYP2C19*3;Respiratory Tract Infections;Disease;PA165980636;Haplotype
ANTITHYROID PREPARATIONS;HLA-DRB1*08:03;Haplotype;PA164712499;Chemical
CARBIMAZOLE;HLA-DRB1*08:03;Haplotype;PA164742970;Chemical
AGRANULOCYTOSIS;HLA-DRB1*08:03;Haplotype;PA443297;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-DRB1*08:03;Haplotype;PA444059;Disease
GRAVES DISEASE;HLA-DRB1*08:03;Haplotype;PA444329;Disease
STEVENS-JOHNSON SYNDROME;HLA-DRB1*08:03;Haplotype;PA445738;Disease
ACETAMINOPHEN;HLA-DRB1*08:03;Haplotype;PA448015;Chemical
METHIMAZOLE;HLA-DRB1*08:03;Haplotype;PA450422;Chemical
PROPYLTHIOURACIL;HLA-DRB1*08:03;Haplotype;PA451156;Chemical
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;TPMT intermediate activity;Variant;PA446155;Disease
MERCAPTOPURINE;TPMT intermediate activity;Variant;PA450379;Chemical
ESCITALOPRAM;rs1126757;Variant;PA10074;Chemical
DEPRESSION;rs1126757;Variant;PA447278;Disease
BEVACIZUMAB;HSP90AB1;Gene;PA130232992;Chemical
HYPERTENSION;HSP90AB1;Gene;PA444552;Disease
ABCC2;Kidney Diseases;Disease;PA116;Gene
CYP2C8;Kidney Diseases;Disease;PA125;Gene
CYP2C9;Kidney Diseases;Disease;PA126;Gene
ACE;Kidney Diseases;Disease;PA139;Gene
CYP2C9*1;Kidney Diseases;Disease;PA165816542;Haplotype
CYP2C9*2;Kidney Diseases;Disease;PA165816543;Haplotype
CYP2C9*3;Kidney Diseases;Disease;PA165816544;Haplotype
CYP2C8*3;Kidney Diseases;Disease;PA165958685;Haplotype
RS2273697;Kidney Diseases;Disease;PA166154007;Variant
RS1799752;Kidney Diseases;Disease;PA166155187;Variant
RS1024323;Kidney Diseases;Disease;PA166156499;Variant
RS1225367412;Kidney Diseases;Disease;PA166180969;Variant
CYP2C8*1;Kidney Diseases;Disease;PA166242948;Haplotype
GRK4;Kidney Diseases;Disease;PA28941;Gene
CACNA1S;Kidney Diseases;Disease;PA85;Gene
CYP3A4;sildenafil;Chemical;PA130;Gene
CYP3A5;sildenafil;Chemical;PA131;Gene
ACE;sildenafil;Chemical;PA139;Gene
CYP3A4*1;sildenafil;Chemical;PA165819201;Haplotype
CYP3A4*2;sildenafil;Chemical;PA165819220;Haplotype
CYP3A4*3;sildenafil;Chemical;PA165819221;Haplotype
CYP3A4*5;sildenafil;Chemical;PA165819223;Haplotype
CYP3A4*10;sildenafil;Chemical;PA165819228;Haplotype
CYP3A4*14;sildenafil;Chemical;PA165819232;Haplotype
CYP3A4*22;sildenafil;Chemical;PA166048680;Haplotype
CYP3A4*24;sildenafil;Chemical;PA166115837;Haplotype
RS5443;sildenafil;Chemical;PA166154486;Variant
RS4343;sildenafil;Chemical;PA166155147;Variant
RS699947;sildenafil;Chemical;PA166156938;Variant
RS2070744;sildenafil;Chemical;PA166157325;Variant
CYP3A4*28;sildenafil;Chemical;PA166245584;Haplotype
CYP3A4*29;sildenafil;Chemical;PA166245585;Haplotype
CYP3A4*32;sildenafil;Chemical;PA166245588;Haplotype
GNB3;sildenafil;Chemical;PA176;Gene
ARG1;sildenafil;Chemical;PA24947;Gene
NOS3;sildenafil;Chemical;PA254;Gene
VEGFA;sildenafil;Chemical;PA37302;Gene
EFAVIRENZ;rs1248477767;Variant;PA449441;Chemical
ESCITALOPRAM;rs915120;Variant;PA10074;Chemical
DEPRESSIVE DISORDER;rs915120;Variant;PA447207;Disease
CITALOPRAM;rs915120;Variant;PA449015;Chemical
CYP3A4;CYP3A4*26;Haplotype;PA130;Gene
OXYCODONE;CYP3A4*26;Haplotype;PA450741;Chemical
QUETIAPINE;CYP3A4*26;Haplotype;PA451201;Chemical
HYPERTENSION;FBN1;Gene;PA444552;Disease
BUFURALOL;CYP2D6*49;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*49;Haplotype;PA166127651;Chemical
DEXTROMETHORPHAN;CYP2D6*49;Haplotype;PA449273;Chemical
PRIMAQUINE;CYP2D6*49;Haplotype;PA451103;Chemical
ZOLEDRONATE;PPCDC;Gene;PA10235;Chemical
FEC100;PPCDC;Gene;PA166185677;Chemical
AMENORRHEA;PPCDC;Gene;PA443324;Disease
DOCETAXEL;PPCDC;Gene;PA449383;Chemical
GEMCITABINE;PPCDC;Gene;PA449748;Chemical
TRASTUZUMAB;PPCDC;Gene;PA451743;Chemical
LEUKEMIA, MYELOID, ACUTE;rs1561876;Variant;PA444760;Disease
CLADRIBINE;rs1561876;Variant;PA449027;Chemical
CYTARABINE;rs1561876;Variant;PA449177;Chemical
IMATINIB;CHST1;Gene;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;CHST1;Gene;PA151958383;Disease
TOXIC LIVER DISEASE;CYP2B6*7;Haplotype;PA164925725;Disease
S-EDDP;CYP2B6*7;Haplotype;PA166177606;Chemical
(S)-METHADONE;CYP2B6*7;Haplotype;PA166178554;Chemical
R-EDDP;CYP2B6*7;Haplotype;PA166247521;Chemical
BREAST NEOPLASMS;CYP2B6*7;Haplotype;PA443560;Disease
OPIOID-RELATED DISORDERS;CYP2B6*7;Haplotype;PA445043;Disease
SCOLIOSIS;CYP2B6*7;Haplotype;PA445619;Disease
DEPRESSION;CYP2B6*7;Haplotype;PA447278;Disease
CYCLOPHOSPHAMIDE;CYP2B6*7;Haplotype;PA449165;Chemical
METHADONE;CYP2B6*7;Haplotype;PA450401;Chemical
MIRTAZAPINE;CYP2B6*7;Haplotype;PA450522;Chemical
MELANOMA;EIF1AX;Gene;PA444903;Disease
BIPOLAR DISORDER;rs334558;Variant;PA447199;Disease
MAJOR DEPRESSIVE DISORDER;rs334558;Variant;PA447321;Disease
CITALOPRAM;rs334558;Variant;PA449015;Chemical
FLUOXETINE;rs334558;Variant;PA449673;Chemical
LITHIUM;rs334558;Variant;PA450243;Chemical
CYP2B6;phenytoin;Chemical;PA123;Gene
CYP2C19;phenytoin;Chemical;PA124;Gene
CYP2C9;phenytoin;Chemical;PA126;Gene
CYP2D6;phenytoin;Chemical;PA128;Gene
CYP3A4;phenytoin;Chemical;PA130;Gene
CYP3A5;phenytoin;Chemical;PA131;Gene
CFHR4;phenytoin;Chemical;PA134960382;Gene
CYP2C9*1;phenytoin;Chemical;PA165816542;Haplotype
CYP2C9*2;phenytoin;Chemical;PA165816543;Haplotype
CYP2C9*3;phenytoin;Chemical;PA165816544;Haplotype
CYP2C9*5;phenytoin;Chemical;PA165816546;Haplotype
CYP2C9*6;phenytoin;Chemical;PA165816547;Haplotype
CYP2C9*8;phenytoin;Chemical;PA165816549;Haplotype
CYP2C9*11;phenytoin;Chemical;PA165816552;Haplotype
CYP2C9*13;phenytoin;Chemical;PA165816554;Haplotype
CYP2C9*14;phenytoin;Chemical;PA165816555;Haplotype
CYP2C9*16;phenytoin;Chemical;PA165816557;Haplotype
CYP2C9*31;phenytoin;Chemical;PA165816560;Haplotype
CYP2C9*33;phenytoin;Chemical;PA165816561;Haplotype
CYP2C9*19;phenytoin;Chemical;PA165816564;Haplotype
CYP2C9*27;phenytoin;Chemical;PA165816571;Haplotype
CYP2C9*29;phenytoin;Chemical;PA165816573;Haplotype
CYP2D6*1;phenytoin;Chemical;PA165816576;Haplotype
CYP2D6*41;phenytoin;Chemical;PA165816584;Haplotype
HLA-DRB1*16:02;phenytoin;Chemical;PA165952368;Haplotype
HLA-A*24:02;phenytoin;Chemical;PA165953564;Haplotype
HLA-B*07:02;phenytoin;Chemical;PA165954366;Haplotype
HLA-B*13:01;phenytoin;Chemical;PA165954643;Haplotype
HLA-B*15:01;phenytoin;Chemical;PA165954745;Haplotype
HLA-B*15:02;phenytoin;Chemical;PA165954769;Haplotype
HLA-B*15:13;phenytoin;Chemical;PA165954793;Haplotype
HLA-B*37:01;phenytoin;Chemical;PA165955461;Haplotype
HLA-B*38:02;phenytoin;Chemical;PA165955505;Haplotype
HLA-B*46:01;phenytoin;Chemical;PA165956083;Haplotype
HLA-B*51:01;phenytoin;Chemical;PA165956201;Haplotype
HLA-B*51:02;phenytoin;Chemical;PA165956231;Haplotype
HLA-B*54:01;phenytoin;Chemical;PA165956438;Haplotype
HLA-B*56:02;phenytoin;Chemical;PA165956532;Haplotype
HLA-C*14:02;phenytoin;Chemical;PA165957818;Haplotype
HLA-C*15:02;phenytoin;Chemical;PA165957859;Haplotype
CYP2C19*2;phenytoin;Chemical;PA165980635;Haplotype
CYP2C19*3;phenytoin;Chemical;PA165980636;Haplotype
CYP2C9*36;phenytoin;Chemical;PA166048682;Haplotype
CYP2C9*37;phenytoin;Chemical;PA166048683;Haplotype
CYP2C9*39;phenytoin;Chemical;PA166048685;Haplotype
CYP2C9*40;phenytoin;Chemical;PA166048686;Haplotype
CYP2C9*41;phenytoin;Chemical;PA166048687;Haplotype
CYP2C9*42;phenytoin;Chemical;PA166048688;Haplotype
CYP2C9*43;phenytoin;Chemical;PA166048689;Haplotype
CYP2C9*45;phenytoin;Chemical;PA166048691;Haplotype
CYP2C9*47;phenytoin;Chemical;PA166048693;Haplotype
CYP2C9*49;phenytoin;Chemical;PA166048695;Haplotype
CYP2C9*50;phenytoin;Chemical;PA166048696;Haplotype
CYP2C9*51;phenytoin;Chemical;PA166048697;Haplotype
CYP2C9*52;phenytoin;Chemical;PA166048698;Haplotype
CYP2C9*53;phenytoin;Chemical;PA166048699;Haplotype
CYP2C9*54;phenytoin;Chemical;PA166048700;Haplotype
CYP2C9*55;phenytoin;Chemical;PA166048701;Haplotype
CYP2C9*56;phenytoin;Chemical;PA166048702;Haplotype
HLA-C*08:01;phenytoin;Chemical;PA166123426;Haplotype
HLA-A*02:01;phenytoin;Chemical;PA166123427;Haplotype
RS1051740;phenytoin;Chemical;PA166153612;Variant
RS1801133;phenytoin;Chemical;PA166153644;Variant
RS2234922;phenytoin;Chemical;PA166153680;Variant
RS1057910;phenytoin;Chemical;PA166153959;Variant
RS1934969;phenytoin;Chemical;PA166153986;Variant
RS4986893;phenytoin;Chemical;PA166154070;Variant
RS12782374;phenytoin;Chemical;PA166154159;Variant
RS71486745;phenytoin;Chemical;PA166154191;Variant
RS182132442;phenytoin;Chemical;PA166154220;Variant
RS2606345;phenytoin;Chemical;PA166154899;Variant
RS2304016;phenytoin;Chemical;PA166155682;Variant
RS3812718;phenytoin;Chemical;PA166155715;Variant
RS17183814;phenytoin;Chemical;PA166155842;Variant
RS2279020;phenytoin;Chemical;PA166156794;Variant
RS1045642;phenytoin;Chemical;PA166157284;Variant
RS1128503;phenytoin;Chemical;PA166157288;Variant
RS2032582;phenytoin;Chemical;PA166157316;Variant
RS1208;phenytoin;Chemical;PA166157540;Variant
RS1041983;phenytoin;Chemical;PA166157549;Variant
RS1799929;phenytoin;Chemical;PA166157563;Variant
RS1799930;phenytoin;Chemical;PA166157564;Variant
RS1799931;phenytoin;Chemical;PA166157565;Variant
RS1801280;phenytoin;Chemical;PA166157570;Variant
RS544027339;phenytoin;Chemical;PA166179353;Variant
RS1029359343;phenytoin;Chemical;PA166179355;Variant
RS78239784;phenytoin;Chemical;PA166182420;Variant
RS780801862;phenytoin;Chemical;PA166209781;Variant
NAT2;phenytoin;Chemical;PA18;Gene
HTR2A;phenytoin;Chemical;PA193;Gene
HTR2C;phenytoin;Chemical;PA194;Gene
MTHFR;phenytoin;Chemical;PA245;Gene
ABCB1;phenytoin;Chemical;PA267;Gene
CYP1A1;phenytoin;Chemical;PA27092;Gene
CYP1A2;phenytoin;Chemical;PA27093;Gene
DRD2;phenytoin;Chemical;PA27478;Gene
EPHX1;phenytoin;Chemical;PA27829;Gene
GABRA1;phenytoin;Chemical;PA28489;Gene
SCN1A;phenytoin;Chemical;PA301;Gene
SLC6A4;phenytoin;Chemical;PA312;Gene
POLG;phenytoin;Chemical;PA33500;Gene
SCN2A;phenytoin;Chemical;PA35004;Gene
HLA-A;phenytoin;Chemical;PA35055;Gene
HLA-B;phenytoin;Chemical;PA35056;Gene
HLA-C;phenytoin;Chemical;PA35057;Gene
HLA-DRB1;phenytoin;Chemical;PA35072;Gene
UGT1A4;phenytoin;Chemical;PA37179;Gene
UGT1A6;phenytoin;Chemical;PA37181;Gene
UGT2B15;phenytoin;Chemical;PA37188;Gene
NR1I2;phenytoin;Chemical;PA378;Gene
UGT1A9;phenytoin;Chemical;PA419;Gene
ACETAMINOPHEN;phenytoin;Chemical;PA448015;Chemical
BREAST NEOPLASMS;rs2070096;Variant;PA443560;Disease
CARBOPLATIN;rs2070096;Variant;PA448803;Chemical
DOCETAXEL;rs2070096;Variant;PA449383;Chemical
TRASTUZUMAB;rs2070096;Variant;PA451743;Chemical
FLUOROURACIL;ERCC2;Gene;PA128406956;Chemical
OXALIPLATIN;ERCC2;Gene;PA131285527;Chemical
PLATINUM;ERCC2;Gene;PA150595617;Chemical
NEPHROTOXICITY;ERCC2;Gene;PA162263533;Disease
PLATINUM COMPOUNDS;ERCC2;Gene;PA164713176;Chemical
PROGRESSION-FREE SURVIVAL;ERCC2;Gene;PA166123026;Disease
PNEUMONITIS;ERCC2;Gene;PA166124223;Disease
ADVERSE EVENTS;ERCC2;Gene;PA166151827;Disease
ALOPECIA;ERCC2;Gene;PA443314;Disease
ANEMIA;ERCC2;Gene;PA443340;Disease
BREAST NEOPLASMS;ERCC2;Gene;PA443560;Disease
NON-SMALL CELL LUNG CARCINOMA;ERCC2;Gene;PA443622;Disease
NEOPLASM OF ESOPHAGUS;ERCC2;Gene;PA444101;Disease
LEUKOPENIA;ERCC2;Gene;PA444773;Disease
MESOTHELIOMA;ERCC2;Gene;PA444937;Disease
NEOPLASMS;ERCC2;Gene;PA445062;Disease
OVARIAN NEOPLASMS;ERCC2;Gene;PA445204;Disease
PANCREATIC NEOPLASMS;ERCC2;Gene;PA445218;Disease
OSTEOSARCOMA;ERCC2;Gene;PA445601;Disease
TESTICULAR NEOPLASMS;ERCC2;Gene;PA445828;Disease
COLORECTAL NEOPLASMS;ERCC2;Gene;PA446108;Disease
BLEOMYCIN;ERCC2;Gene;PA448645;Chemical
CISPLATIN;ERCC2;Gene;PA449014;Chemical
DOCETAXEL;ERCC2;Gene;PA449383;Chemical
DOXORUBICIN;ERCC2;Gene;PA449412;Chemical
ETOPOSIDE;ERCC2;Gene;PA449552;Chemical
GEMCITABINE;ERCC2;Gene;PA449748;Chemical
LEUCOVORIN;ERCC2;Gene;PA450198;Chemical
METHOTREXATE;ERCC2;Gene;PA450428;Chemical
METFORMIN;rs2076828;Variant;PA450395;Chemical
EVENT-FREE SURVIVAL;TPMT*21;Haplotype;PA166123366;Disease
LUPUS ERYTHEMATOSUS, SYSTEMIC;TPMT*21;Haplotype;PA444822;Disease
NEUTROPENIA;TPMT*21;Haplotype;PA445113;Disease
THROMBOCYTOPENIA;TPMT*21;Haplotype;PA445846;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;TPMT*21;Haplotype;PA446155;Disease
MERCAPTOPURINE;TPMT*21;Haplotype;PA450379;Chemical
THIOGUANINE;TPMT*21;Haplotype;PA451663;Chemical
FLUOROURACIL;PPARD;Gene;PA128406956;Chemical
DRUG TOXICITY;PPARD;Gene;PA443937;Disease
PROSTATIC NEOPLASMS;PPARD;Gene;PA445425;Disease
CAPECITABINE;PPARD;Gene;PA448771;Chemical
DOCETAXEL;PPARD;Gene;PA449383;Chemical
THALIDOMIDE;PPARD;Gene;PA451644;Chemical
CD274;cemiplimab-rwlc;Chemical;PA134915280;Gene
ALK;cemiplimab-rwlc;Chemical;PA24719;Gene
ROS1;cemiplimab-rwlc;Chemical;PA34633;Gene
EGFR;cemiplimab-rwlc;Chemical;PA7360;Gene
ASTHMA;rs730012;Variant;PA443450;Disease
URTICARIA;rs730012;Variant;PA445999;Disease
ASPIRIN;rs730012;Variant;PA448497;Chemical
MONTELUKAST;rs730012;Variant;PA450546;Chemical
PHENPROCOUMON;rs4086116;Variant;PA450921;Chemical
ACENOCOUMAROL;rs4086116;Variant;PA452632;Chemical
HYPERTENSION;XIRP2;Gene;PA444552;Disease
ATENOLOL;XIRP2;Gene;PA448499;Chemical
WARFARIN;rs104894540;Variant;PA451906;Chemical
OSTEOSARCOMA;rs2231135;Variant;PA445601;Disease
METHOTREXATE;rs2231135;Variant;PA450428;Chemical
PLATINUM COMPOUNDS;rs12819505;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs12819505;Variant;PA443622;Disease
PITAVASTATIN;APOB;Gene;PA142650384;Chemical
MTTP;APOB;Gene;PA164742099;Gene
LOMITAPIDE;APOB;Gene;PA166114922;Chemical
FAMILIAL HYPERCHOLESTEROLEMIA;APOB;Gene;PA166114942;Disease
HEART VALVE REPLACEMENT;APOB;Gene;PA166123431;Disease
INCLISIRAN;APOB;Gene;PA166268802;Chemical
HEMORRHAGE;APOB;Gene;PA444417;Disease
HYPERTENSION;APOB;Gene;PA444552;Disease
HYPERTRIGLYCERIDEMIA;APOB;Gene;PA446120;Disease
HYPERTROPHY, LEFT VENTRICULAR;APOB;Gene;PA446479;Disease
FENOFIBRATE;APOB;Gene;PA449594;Chemical
IRBESARTAN;APOB;Gene;PA450084;Chemical
WARFARIN;APOB;Gene;PA451906;Chemical
NEOPLASMS;CYP2A6*11;Haplotype;PA445062;Disease
STOMACH NEOPLASMS;CYP2A6*11;Haplotype;PA445742;Disease
TOBACCO USE DISORDER;CYP2A6*11;Haplotype;PA445876;Disease
CAFFEINE;CYP2A6*11;Haplotype;PA448710;Chemical
NICOTINE;CYP2A6*11;Haplotype;PA450626;Chemical
TEGAFUR;CYP2A6*11;Haplotype;PA452620;Chemical
BUFURALOL;CYP2D6*37;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*37;Haplotype;PA166127651;Chemical
DEXTROMETHORPHAN;CYP2D6*37;Haplotype;PA449273;Chemical
PRIMAQUINE;CYP2D6*37;Haplotype;PA451103;Chemical
CAMK1D;NFKB2;Gene;PA134992438;Gene
AKT1;NFKB2;Gene;PA24684;Gene
AKT2;NFKB2;Gene;PA24685;Gene
AKT3;NFKB2;Gene;PA24686;Gene
CAMK1;NFKB2;Gene;PA26048;Gene
CAMK1G;NFKB2;Gene;PA26049;Gene
MAPK8;NFKB2;Gene;PA283;Gene
MAPK1;NFKB2;Gene;PA30616;Gene
MAPK3;NFKB2;Gene;PA30622;Gene
PPP3CA;NFKB2;Gene;PA33678;Gene
PPP3CB;NFKB2;Gene;PA33679;Gene
PPP3CC;NFKB2;Gene;PA33680;Gene
PPP3R1;NFKB2;Gene;PA33681;Gene
PPP3R2;NFKB2;Gene;PA33682;Gene
STAT3;NFKB2;Gene;PA337;Gene
PRKCA;NFKB2;Gene;PA33759;Gene
PRKCB;NFKB2;Gene;PA33761;Gene
PRKCG;NFKB2;Gene;PA33766;Gene
STAT5A;NFKB2;Gene;PA338;Gene
STAT1;NFKB2;Gene;PA36183;Gene
STAT2;NFKB2;Gene;PA36184;Gene
STAT4;NFKB2;Gene;PA36185;Gene
STAT5B;NFKB2;Gene;PA36186;Gene
CAMK2A;NFKB2;Gene;PA90;Gene
CAMK2B;NFKB2;Gene;PA91;Gene
CAMK2D;NFKB2;Gene;PA92;Gene
CAMK2G;NFKB2;Gene;PA93;Gene
PLATINUM COMPOUNDS;rs2027701;Variant;PA164713176;Chemical
MYELOSUPPRESSION;rs2027701;Variant;PA165817398;Disease
MUCOSITIS;rs2027701;Variant;PA166122058;Disease
RADIOTHERAPY;rs2027701;Variant;PA166122986;Chemical
ANEMIA;rs2027701;Variant;PA443340;Disease
DERMATITIS;rs2027701;Variant;PA443875;Disease
LEUKOPENIA;rs2027701;Variant;PA444773;Disease
NEUTROPENIA;rs2027701;Variant;PA445113;Disease
THROMBOCYTOPENIA;rs2027701;Variant;PA445846;Disease
PIK3R5;AKT3;Gene;PA134890823;Gene
NFKB1;AKT3;Gene;PA248;Gene
NOS3;AKT3;Gene;PA254;Gene
ELK1;AKT3;Gene;PA27749;Gene
FOS;AKT3;Gene;PA28212;Gene
RELA;AKT3;Gene;PA296;Gene
JUN;AKT3;Gene;PA30006;Gene
MYC;AKT3;Gene;PA31353;Gene
NFKB2;AKT3;Gene;PA31600;Gene
PIK3C2A;AKT3;Gene;PA33304;Gene
PIK3C2B;AKT3;Gene;PA33305;Gene
STAT3;AKT3;Gene;PA337;Gene
STAT5A;AKT3;Gene;PA338;Gene
SP1;AKT3;Gene;PA36042;Gene
STAT1;AKT3;Gene;PA36183;Gene
STAT2;AKT3;Gene;PA36184;Gene
STAT4;AKT3;Gene;PA36185;Gene
STAT5B;AKT3;Gene;PA36186;Gene
FLUOROURACIL;SLC22A16;Gene;PA128406956;Chemical
DOXORUBICINOL;SLC22A16;Gene;PA165291922;Chemical
BREAST NEOPLASMS;SLC22A16;Gene;PA443560;Disease
CYCLOPHOSPHAMIDE;SLC22A16;Gene;PA449165;Chemical
DOXORUBICIN;SLC22A16;Gene;PA449412;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs4148808;Variant;PA130620651;Chemical
NEOPLASMS;rs4148808;Variant;PA445062;Disease
HYPERGLYCEMIA;rs61824877;Variant;PA444522;Disease
HYPERTENSION;rs61824877;Variant;PA444552;Disease
CHLOROTHIAZIDE;rs61824877;Variant;PA448953;Chemical
HYDROCHLOROTHIAZIDE;rs61824877;Variant;PA449899;Chemical
RS731236;clodronate;Chemical;PA166154500;Variant
RS1544410;clodronate;Chemical;PA166154516;Variant
RS16944;clodronate;Chemical;PA166155587;Variant
IL1B;clodronate;Chemical;PA29808;Gene
VDR;clodronate;Chemical;PA37301;Gene
LYMPHOMA, NON-HODGKIN;Lymphoma, T-Cell, Cutaneous;Disease;PA444845;Disease
ALLOPURINOL;rs77567654;Variant;PA448320;Chemical
CD274;durvalumab;Chemical;PA134915280;Gene
ALK;durvalumab;Chemical;PA24719;Gene
PDCD1;durvalumab;Chemical;PA33110;Gene
EGFR;durvalumab;Chemical;PA7360;Gene
ASTHMA;rs2071888;Variant;PA443450;Disease
ASPIRIN;rs2071888;Variant;PA448497;Chemical
DROSPIRENONE / ETHINYL ESTRADIOL;SERPINC1;Gene;PA165290928;Chemical
ETHINYL ESTRADIOL / NORELGESTROMIN;SERPINC1;Gene;PA165290929;Chemical
CYP2C9*2;SERPINC1;Gene;PA165816543;Haplotype
CYP2C9*3;SERPINC1;Gene;PA165816544;Haplotype
ELTROMBOPAG;SERPINC1;Gene;PA165981594;Chemical
RS6025;SERPINC1;Gene;PA166153554;Variant
RS1801131;SERPINC1;Gene;PA166153643;Variant
RS1801133;SERPINC1;Gene;PA166153644;Variant
RS1799963;SERPINC1;Gene;PA166154336;Variant
AVATROMBOPAG;SERPINC1;Gene;PA166179849;Chemical
LUSUTROMBOPAG;SERPINC1;Gene;PA166182748;Chemical
ESTRADIOL / PROGESTERONE;SERPINC1;Gene;PA166190221;Chemical
SYNTHETIC CONJUGATED ESTROGENS, A;SERPINC1;Gene;PA166238763;Chemical
RELUGOLIX / ESTRADIOL / NORETHINDRONE ACETATE;SERPINC1;Gene;PA166397682;Chemical
NON-SMALL CELL LUNG CARCINOMA;SERPINC1;Gene;PA443622;Disease
THROMBOCYTOPENIA;SERPINC1;Gene;PA445846;Disease
CARBOPLATIN;SERPINC1;Gene;PA448803;Chemical
GEMCITABINE;SERPINC1;Gene;PA449748;Chemical
DESFLURANE;rs772226819;Variant;PA164749136;Chemical
RYR1;rs772226819;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs772226819;Variant;PA444863;Disease
ENFLURANE;rs772226819;Variant;PA449461;Chemical
HALOTHANE;rs772226819;Variant;PA449845;Chemical
ISOFLURANE;rs772226819;Variant;PA450106;Chemical
METHOXYFLURANE;rs772226819;Variant;PA450434;Chemical
SEVOFLURANE;rs772226819;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs772226819;Variant;PA451522;Chemical
CACNA1S;rs772226819;Variant;PA85;Gene
PROSTATIC NEOPLASMS;rs2301159;Variant;PA445425;Disease
DOCETAXEL;rs2301159;Variant;PA449383;Chemical
THALIDOMIDE;rs2301159;Variant;PA451644;Chemical
DPYD;rs146356975;Variant;PA145;Gene
CAPECITABINE;rs146356975;Variant;PA448771;Chemical
RS267606618;neomycin;Chemical;PA166158908;Variant
RS267606619;neomycin;Chemical;PA166158909;Variant
RS267606617;neomycin;Chemical;PA166159181;Variant
MT-RNR1;neomycin;Chemical;PA31274;Gene
ERBB2;JAK1;Gene;PA27844;Gene
ERBB3;JAK1;Gene;PA27846;Gene
ERBB4;JAK1;Gene;PA27847;Gene
STAT3;JAK1;Gene;PA337;Gene
STAT5A;JAK1;Gene;PA338;Gene
STAT1;JAK1;Gene;PA36183;Gene
STAT2;JAK1;Gene;PA36184;Gene
STAT4;JAK1;Gene;PA36185;Gene
STAT5B;JAK1;Gene;PA36186;Gene
EGFR;JAK1;Gene;PA7360;Gene
CYP2E1;cytarabine;Chemical;PA129;Gene
SLCO1B1;cytarabine;Chemical;PA134865839;Gene
MED12L;cytarabine;Chemical;PA134884590;Gene
C18ORF56;cytarabine;Chemical;PA134956204;Gene
P2RY12;cytarabine;Chemical;PA134971947;Gene
DCK;cytarabine;Chemical;PA137;Gene
DROSHA;cytarabine;Chemical;PA142671060;Gene
SLC29A1;cytarabine;Chemical;PA154;Gene
CMPK1;cytarabine;Chemical;PA162382539;Gene
LINC00251;cytarabine;Chemical;PA165585763;Gene
RS532545;cytarabine;Chemical;PA166153575;Variant
RS602950;cytarabine;Chemical;PA166153581;Variant
RS1044457;cytarabine;Chemical;PA166153608;Variant
RS1891059;cytarabine;Chemical;PA166153658;Variant
RS2072671;cytarabine;Chemical;PA166153667;Variant
RS3215400;cytarabine;Chemical;PA166153738;Variant
RS17021408;cytarabine;Chemical;PA166153867;Variant
RS60369023;cytarabine;Chemical;PA166153893;Variant
RS80223967;cytarabine;Chemical;PA166153915;Variant
RS2070673;cytarabine;Chemical;PA166153993;Variant
RS2515641;cytarabine;Chemical;PA166154017;Variant
RS3824662;cytarabine;Chemical;PA166154043;Variant
RS1042919;cytarabine;Chemical;PA166154310;Variant
RS1561876;cytarabine;Chemical;PA166154332;Variant
RS2898950;cytarabine;Chemical;PA166154392;Variant
RS11030918;cytarabine;Chemical;PA166154447;Variant
RS11231825;cytarabine;Chemical;PA166154455;Variant
RS2291075;cytarabine;Chemical;PA166154544;Variant
RS4149056;cytarabine;Chemical;PA166154579;Variant
RS45445694;cytarabine;Chemical;PA166155331;Variant
RS2302948;cytarabine;Chemical;PA166155396;Variant
RS1130609;cytarabine;Chemical;PA166155627;Variant
RS5030743;cytarabine;Chemical;PA166155740;Variant
RS79085477;cytarabine;Chemical;PA166155968;Variant
RS117532069;cytarabine;Chemical;PA166155970;Variant
RS2306744;cytarabine;Chemical;PA166156554;Variant
RS80143932;cytarabine;Chemical;PA166156697;Variant
RS639174;cytarabine;Chemical;PA166156737;Variant
RS1045642;cytarabine;Chemical;PA166157284;Variant
RS1128503;cytarabine;Chemical;PA166157288;Variant
RS2032582;cytarabine;Chemical;PA166157316;Variant
RS3750117;cytarabine;Chemical;PA166157378;Variant
RS1265138;cytarabine;Chemical;PA166157554;Variant
RS141059755;cytarabine;Chemical;PA166157691;Variant
RS4643786;cytarabine;Chemical;PA166160283;Variant
RS1163075;cytarabine;Chemical;PA166160434;Variant
RS11191612;cytarabine;Chemical;PA166160446;Variant
RS17343066;cytarabine;Chemical;PA166181000;Variant
RS12283870;cytarabine;Chemical;PA166285621;Variant
RS2228224;cytarabine;Chemical;PA166337421;Variant
RS2229300;cytarabine;Chemical;PA166337441;Variant
RS10916819;cytarabine;Chemical;PA166412241;Variant
RS17103168;cytarabine;Chemical;PA166412243;Variant
RS2396243;cytarabine;Chemical;PA166412244;Variant
RS5841;cytarabine;Chemical;PA166412262;Variant
ARHGAP9;cytarabine;Chemical;PA24962;Gene
BMP7;cytarabine;Chemical;PA25384;Gene
DOK5;cytarabine;Chemical;PA25724;Gene
ABCB1;cytarabine;Chemical;PA267;Gene
CPT1A;cytarabine;Chemical;PA26847;Gene
GATA3;cytarabine;Chemical;PA28586;Gene
GLI1;cytarabine;Chemical;PA28720;Gene
IGHMBP2;cytarabine;Chemical;PA29731;Gene
RRM1;cytarabine;Chemical;PA298;Gene
RRM2;cytarabine;Chemical;PA299;Gene
NME4;cytarabine;Chemical;PA31657;Gene
NT5C2;cytarabine;Chemical;PA31801;Gene
NT5C3A;cytarabine;Chemical;PA31802;Gene
RRM2B;cytarabine;Chemical;PA34866;Gene
TYMS;cytarabine;Chemical;PA359;Gene
SULT2B1;cytarabine;Chemical;PA36249;Gene
SLC22A12;cytarabine;Chemical;PA38478;Gene
ABCC4;cytarabine;Chemical;PA397;Gene
SLC28A3;cytarabine;Chemical;PA426;Gene
CDA;cytarabine;Chemical;PA98;Gene
CYP2D6;amphetamine;Chemical;PA128;Gene
KAT2B;amphetamine;Chemical;PA162392705;Gene
RS12364283;amphetamine;Chemical;PA166154464;Variant
RS510769;amphetamine;Chemical;PA166156924;Variant
RS2281617;amphetamine;Chemical;PA166157031;Variant
RS9829896;amphetamine;Chemical;PA166184842;Variant
DRD2;amphetamine;Chemical;PA27478;Gene
OPRM1;amphetamine;Chemical;PA31945;Gene
EPILEPSY;rs4148739;Variant;PA444065;Disease
DEPRESSION;rs4148739;Variant;PA447278;Disease
MAJOR DEPRESSIVE DISORDER;rs4148739;Variant;PA447321;Disease
AMITRIPTYLINE;rs4148739;Variant;PA448385;Chemical
CARBAMAZEPINE;rs4148739;Variant;PA448785;Chemical
CITALOPRAM;rs4148739;Variant;PA449015;Chemical
FLUOXETINE;rs4148739;Variant;PA449673;Chemical
PAROXETINE;rs4148739;Variant;PA450801;Chemical
SERTRALINE;rs4148739;Variant;PA451333;Chemical
VENLAFAXINE;rs4148739;Variant;PA451866;Chemical
CYP2C9;time in therapeutic range;Disease;PA126;Gene
VKORC1;time in therapeutic range;Disease;PA133787052;Gene
CYP2C9*1;time in therapeutic range;Disease;PA165816542;Haplotype
CYP2C9*2;time in therapeutic range;Disease;PA165816543;Haplotype
CYP2C9*3;time in therapeutic range;Disease;PA165816544;Haplotype
RS9923231;time in therapeutic range;Disease;PA166155091;Variant
DIABETES MELLITUS, TYPE 2;rs1470579;Variant;PA443890;Disease
REPAGLINIDE;rs1470579;Variant;PA451234;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-C*04:06;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-C*04:06;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-C*04:06;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-C*04:06;Haplotype;PA450616;Chemical
DEXTROMETHORPHAN;SMDT1;Gene;PA449273;Chemical
DULOXETINE;KMT2E;Gene;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;KMT2E;Gene;PA447321;Disease
IFNL3;velpatasvir;Chemical;PA134952671;Gene
IFNL4;velpatasvir;Chemical;PA166049147;Gene
RS12979860;velpatasvir;Chemical;PA166155468;Variant
RS7412;aducanumab;Chemical;PA166155341;Variant
RS429358;aducanumab;Chemical;PA166155351;Variant
APOE;aducanumab;Chemical;PA55;Gene
BETAINE;CBS;Gene;PA448603;Chemical
L-METHIONINE;CBS;Gene;PA450423;Chemical
ESR1;alpelisib;Chemical;PA156;Gene
ERBB2;alpelisib;Chemical;PA27844;Gene
ESR2;alpelisib;Chemical;PA27886;Gene
PIK3CA;alpelisib;Chemical;PA33308;Gene
VITAMIN B-COMPLEX, PLAIN;MTRR;Gene;PA10505;Chemical
SEDATION;MTRR;Gene;PA166129521;Disease
JUVENILE RHEUMATOID ARTHRITIS;MTRR;Gene;PA443433;Disease
RHEUMATOID ARTHRITIS;MTRR;Gene;PA443434;Disease
DRUG TOXICITY;MTRR;Gene;PA443937;Disease
LYMPHOMA;MTRR;Gene;PA444840;Disease
OSTEOSARCOMA;MTRR;Gene;PA445601;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;MTRR;Gene;PA446155;Disease
MIGRAINE WITH AURA;MTRR;Gene;PA447004;Disease
FOLIC ACID;MTRR;Gene;PA449692;Chemical
METHOTREXATE;MTRR;Gene;PA450428;Chemical
SEVOFLURANE;MTRR;Gene;PA451341;Chemical
FLUOROURACIL;CCNK;Gene;PA128406956;Chemical
BREAST NEOPLASMS;CCNK;Gene;PA443560;Disease
NEUTROPENIA;CCNK;Gene;PA445113;Disease
CYCLOPHOSPHAMIDE;CCNK;Gene;PA449165;Chemical
EPIRUBICIN;CCNK;Gene;PA449476;Chemical
ASPIRIN;rs4523;Variant;PA448497;Chemical
FLUOROURACIL;rs112242273;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs112242273;Variant;PA443560;Disease
NEUTROPENIA;rs112242273;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs112242273;Variant;PA449165;Chemical
EPIRUBICIN;rs112242273;Variant;PA449476;Chemical
CHRNA7;donepezil;Chemical;PA114;Gene
CYP2D6;donepezil;Chemical;PA128;Gene
CYP3A5;donepezil;Chemical;PA131;Gene
CYP2D6*1;donepezil;Chemical;PA165816576;Haplotype
CYP2D6*3;donepezil;Chemical;PA165816578;Haplotype
CYP2D6*4;donepezil;Chemical;PA165816579;Haplotype
CYP2D6*6;donepezil;Chemical;PA165816581;Haplotype
CYP2D6*5;donepezil;Chemical;PA165948092;Haplotype
CYP2D6*1XN;donepezil;Chemical;PA165988479;Haplotype
RS2177370;donepezil;Chemical;PA166153998;Variant
RS3793790;donepezil;Chemical;PA166154034;Variant
RS6494223;donepezil;Chemical;PA166154918;Variant
RS1803274;donepezil;Chemical;PA166156332;Variant
CYP2D6 POOR METABOLIZER;donepezil;Chemical;PA166157927;Variant
BCHE;donepezil;Chemical;PA25294;Gene
CHAT;donepezil;Chemical;PA26448;Gene
HEART FAILURE;rs1042714;Variant;PA444370;Disease
HYPERTENSION;rs1042714;Variant;PA444552;Disease
TACHYCARDIA;rs1042714;Variant;PA445802;Disease
HYPERTROPHY, LEFT VENTRICULAR;rs1042714;Variant;PA446479;Disease
ATENOLOL;rs1042714;Variant;PA448499;Chemical
CARVEDILOL;rs1042714;Variant;PA448817;Chemical
ENALAPRIL;rs1042714;Variant;PA449456;Chemical
METOPROLOL;rs1042714;Variant;PA450480;Chemical
TERBUTALINE;rs1042714;Variant;PA451616;Chemical
ANDROSTENEDIONE;CYP2C19*11;Haplotype;PA166178641;Chemical
16ALPHA-HYDROXYTESTOSTERONE;CYP2C19*11;Haplotype;PA166318241;Chemical
11ALPHA-HYDROXYTESTOSTERONE;CYP2C19*11;Haplotype;PA166318261;Chemical
16ALPHA-HYDROXYPROGESTERONE;CYP2C19*11;Haplotype;PA166318321;Chemical
11A-HYDROXYPROGESTERONE;CYP2C19*11;Haplotype;PA166318342;Chemical
6BETA-HYDROXYPROGESTERONE;CYP2C19*11;Haplotype;PA166318343;Chemical
DESOXYCORTONE;CYP2C19*11;Haplotype;PA166318362;Chemical
FLUCONAZOLE;CYP2C19*11;Haplotype;PA449653;Chemical
FLUVOXAMINE;CYP2C19*11;Haplotype;PA449690;Chemical
HYDROXYPROGESTERONE;CYP2C19*11;Haplotype;PA449932;Chemical
MEPHENYTOIN;CYP2C19*11;Haplotype;PA450373;Chemical
SERTRALINE;CYP2C19*11;Haplotype;PA451333;Chemical
HYPERTENSION;rs10157410;Variant;PA444552;Disease
ATENOLOL;rs10157410;Variant;PA448499;Chemical
CYP2C19;indomethacin;Chemical;PA124;Gene
CYP2C9;indomethacin;Chemical;PA126;Gene
CYP2C9*1;indomethacin;Chemical;PA165816542;Haplotype
CYP2C9*2;indomethacin;Chemical;PA165816543;Haplotype
CYP2C9*3;indomethacin;Chemical;PA165816544;Haplotype
RS1800629;indomethacin;Chemical;PA166156997;Variant
PTGS2;indomethacin;Chemical;PA293;Gene
LTA;indomethacin;Chemical;PA30474;Gene
LST1;indomethacin;Chemical;PA37856;Gene
TNF;indomethacin;Chemical;PA435;Gene
CFTR;rs397508378;Variant;PA109;Gene
IVACAFTOR;rs397508378;Variant;PA165950341;Chemical
DRD2;ropinirole;Chemical;PA27478;Gene
MITAPIVAT;rs118204085;Variant;PA166278021;Chemical
PKLR;rs118204085;Variant;PA33352;Gene
PEMETREXED;rs61734430;Variant;PA10810;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs61734430;Variant;PA443622;Disease
MESOTHELIOMA;rs61734430;Variant;PA444937;Disease
ACENOCOUMAROL;rs1043550;Variant;PA452632;Chemical
NIFEDIPINE;rs28383479;Variant;PA450631;Chemical
TESTOSTERONE;rs28383479;Variant;PA451627;Chemical
RS35320474;Premature Birth;Disease;PA166156166;Variant
RS10774053;Premature Birth;Disease;PA166163612;Variant
ADORA2A;Premature Birth;Disease;PA24584;Gene
CACNA1C;Premature Birth;Disease;PA83;Gene
LUMEFANTRINE;rs41303343;Variant;PA165111722;Chemical
MALARIA;rs41303343;Variant;PA444859;Disease
G6PD;aminosalicylic acid;Chemical;PA28469;Gene
ARIPIPRAZOLE;CYP2D6*4;Haplotype;PA10026;Chemical
DULOXETINE;CYP2D6*4;Haplotype;PA10066;Chemical
ESCITALOPRAM;CYP2D6*4;Haplotype;PA10074;Chemical
WEIGHT GAIN;CYP2D6*4;Haplotype;PA128406954;Disease
ANTHRACYCLINES AND RELATED SUBSTANCES;CYP2D6*4;Haplotype;PA130620651;Chemical
GEFITINIB;CYP2D6*4;Haplotype;PA131301952;Chemical
3,4-METHYLENEDIOXYMETHAMPHETAMINE;CYP2D6*4;Haplotype;PA131887008;Chemical
ROSUVASTATIN;CYP2D6*4;Haplotype;PA134308647;Chemical
ATOMOXETINE;CYP2D6*4;Haplotype;PA134688071;Chemical
OPIPRAMOL;CYP2D6*4;Haplotype;PA144614922;Chemical
TROPISETRON;CYP2D6*4;Haplotype;PA161925594;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;CYP2D6*4;Haplotype;PA164713257;Chemical
TOLTERODINE;CYP2D6*4;Haplotype;PA164746757;Chemical
BINGE EATING DISORDER;CYP2D6*4;Haplotype;PA165108929;Disease
DESVENLAFAXINE;CYP2D6*4;Haplotype;PA165958374;Chemical
VORTIOXETINE;CYP2D6*4;Haplotype;PA166122595;Chemical
PROGRESSION-FREE SURVIVAL;CYP2D6*4;Haplotype;PA166123026;Disease
OVERALL SURVIVAL;CYP2D6*4;Haplotype;PA166123207;Disease
AGITATION;CYP2D6*4;Haplotype;PA166123306;Disease
EVENT-FREE SURVIVAL;CYP2D6*4;Haplotype;PA166123366;Disease
SCHIZOAFFECTIVE DISORDER;CYP2D6*4;Haplotype;PA166123368;Disease
ENDOXIFEN;CYP2D6*4;Haplotype;PA166124478;Chemical
4-HYDROXYTAMOXIFEN;CYP2D6*4;Haplotype;PA166127652;Chemical
RECURRENCE FREE SURVIVAL;CYP2D6*4;Haplotype;PA166127658;Disease
CARDIOTOXICITY;CYP2D6*4;Haplotype;PA166128121;Disease
SEDATION;CYP2D6*4;Haplotype;PA166129521;Disease
O-DESMETHYLTRAMADOL;CYP2D6*4;Haplotype;PA166131379;Chemical
N,O-DIDESMETHYLTRAMADOL;CYP2D6*4;Haplotype;PA166131494;Chemical
DESMETHYL CLOMIPRAMINE;CYP2D6*4;Haplotype;PA166131507;Chemical
ADVERSE EVENTS;CYP2D6*4;Haplotype;PA166151827;Disease
TOLPERISONE;CYP2D6*4;Haplotype;PA166152940;Chemical
EXTRAPYRAMIDAL SYMPTOMS;CYP2D6*4;Haplotype;PA166170367;Disease
CNS DEPRESSION;CYP2D6*4;Haplotype;PA166170668;Disease
DIHYDROCODEINE;CYP2D6*4;Haplotype;PA166176885;Chemical
MEPHEDRONE;CYP2D6*4;Haplotype;PA166184711;Chemical
DYSPHORIA;CYP2D6*4;Haplotype;PA166185295;Disease
ETHYLMORPHINE;CYP2D6*4;Haplotype;PA166210801;Chemical
ALZHEIMER DISEASE;CYP2D6*4;Haplotype;PA443319;Disease
ANEMIA, SICKLE CELL;CYP2D6*4;Haplotype;PA443355;Disease
ARRHYTHMIAS, CARDIAC;CYP2D6*4;Haplotype;PA443421;Disease
BRADYCARDIA;CYP2D6*4;Haplotype;PA443548;Disease
BRAIN NEOPLASMS;CYP2D6*4;Haplotype;PA443557;Disease
BREAST NEOPLASMS;CYP2D6*4;Haplotype;PA443560;Disease
CONSTIPATION;CYP2D6*4;Haplotype;PA443782;Disease
DEATH;CYP2D6*4;Haplotype;PA443842;Disease
DEMENTIA;CYP2D6*4;Haplotype;PA443853;Disease
DRUG TOXICITY;CYP2D6*4;Haplotype;PA443937;Disease
DYSTONIA;CYP2D6*4;Haplotype;PA443970;Disease
EDEMA;CYP2D6*4;Haplotype;PA443994;Disease
GALACTORRHEA;CYP2D6*4;Haplotype;PA444239;Disease
HEART DISEASES;CYP2D6*4;Haplotype;PA444368;Disease
HEART FAILURE;CYP2D6*4;Haplotype;PA444370;Disease
HEROIN DEPENDENCE;CYP2D6*4;Haplotype;PA444460;Disease
HYPERTENSION;CYP2D6*4;Haplotype;PA444552;Disease
MALARIA;CYP2D6*4;Haplotype;PA444859;Disease
OPIOID-RELATED DISORDERS;CYP2D6*4;Haplotype;PA445043;Disease
NAUSEA;CYP2D6*4;Haplotype;PA445048;Disease
NEOPLASMS;CYP2D6*4;Haplotype;PA445062;Disease
PAIN;CYP2D6*4;Haplotype;PA445208;Disease
PAIN, POSTOPERATIVE;CYP2D6*4;Haplotype;PA445210;Disease
FAMILIAL MEDITERRANEAN FEVER;CYP2D6*4;Haplotype;PA445293;Disease
POISONING;CYP2D6*4;Haplotype;PA445371;Disease
PSYCHOMOTOR AGITATION;CYP2D6*4;Haplotype;PA445452;Disease
RECURRENCE;CYP2D6*4;Haplotype;PA445506;Disease
TACHYCARDIA;CYP2D6*4;Haplotype;PA445802;Disease
VOMITING;CYP2D6*4;Haplotype;PA446051;Disease
HOT FLASHES;CYP2D6*4;Haplotype;PA446852;Disease
ALCOHOL-RELATED DISORDERS;CYP2D6*4;Haplotype;PA446879;Disease
SEROTONIN SYNDROME;CYP2D6*4;Haplotype;PA446956;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CYP2D6*4;Haplotype;PA447197;Disease
AUTISTIC DISORDER;CYP2D6*4;Haplotype;PA447198;Disease
DEPRESSIVE DISORDER;CYP2D6*4;Haplotype;PA447207;Disease
MENTAL DISORDERS;CYP2D6*4;Haplotype;PA447208;Disease
OBSESSIVE-COMPULSIVE DISORDER;CYP2D6*4;Haplotype;PA447211;Disease
PSYCHOTIC DISORDERS;CYP2D6*4;Haplotype;PA447215;Disease
SCHIZOPHRENIA;CYP2D6*4;Haplotype;PA447216;Disease
TARDIVE DYSKINESIA;CYP2D6*4;Haplotype;PA447268;Disease
DEPRESSION;CYP2D6*4;Haplotype;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2D6*4;Haplotype;PA447321;Disease
AMITRIPTYLINE;CYP2D6*4;Haplotype;PA448385;Chemical
ASPIRIN;CYP2D6*4;Haplotype;PA448497;Chemical
ATORVASTATIN;CYP2D6*4;Haplotype;PA448500;Chemical
CARVEDILOL;CYP2D6*4;Haplotype;PA448817;Chemical
CITALOPRAM;CYP2D6*4;Haplotype;PA449015;Chemical
CLOMIPRAMINE;CYP2D6*4;Haplotype;PA449048;Chemical
CODEINE;CYP2D6*4;Haplotype;PA449088;Chemical
COLCHICINE;CYP2D6*4;Haplotype;PA449092;Chemical
DESIPRAMINE;CYP2D6*4;Haplotype;PA449233;Chemical
DEXTROMETHORPHAN;CYP2D6*4;Haplotype;PA449273;Chemical
DONEPEZIL;CYP2D6*4;Haplotype;PA449394;Chemical
DOXEPIN;CYP2D6*4;Haplotype;PA449409;Chemical
FLECAINIDE;CYP2D6*4;Haplotype;PA449646;Chemical
FLUOXETINE;CYP2D6*4;Haplotype;PA449673;Chemical
FLUVASTATIN;CYP2D6*4;Haplotype;PA449688;Chemical
FLUVOXAMINE;CYP2D6*4;Haplotype;PA449690;Chemical
GALANTAMINE;CYP2D6*4;Haplotype;PA449726;Chemical
HALOPERIDOL;CYP2D6*4;Haplotype;PA449841;Chemical
HYDROCODONE;CYP2D6*4;Haplotype;PA449900;Chemical
HYDROMORPHONE;CYP2D6*4;Haplotype;PA449918;Chemical
IMIPRAMINE;CYP2D6*4;Haplotype;PA449969;Chemical
KETOPROFEN;CYP2D6*4;Haplotype;PA450149;Chemical
KETOROLAC;CYP2D6*4;Haplotype;PA450150;Chemical
MAPROTILINE;CYP2D6*4;Haplotype;PA450322;Chemical
METHADONE;CYP2D6*4;Haplotype;PA450401;Chemical
METHYLPHENIDATE;CYP2D6*4;Haplotype;PA450464;Chemical
METOPROLOL;CYP2D6*4;Haplotype;PA450480;Chemical
MIRTAZAPINE;CYP2D6*4;Haplotype;PA450522;Chemical
MORPHINE;CYP2D6*4;Haplotype;PA450550;Chemical
NORTRIPTYLINE;CYP2D6*4;Haplotype;PA450657;Chemical
OLANZAPINE;CYP2D6*4;Haplotype;PA450688;Chemical
ONDANSETRON;CYP2D6*4;Haplotype;PA450705;Chemical
OXYCODONE;CYP2D6*4;Haplotype;PA450741;Chemical
PAROXETINE;CYP2D6*4;Haplotype;PA450801;Chemical
PRIMAQUINE;CYP2D6*4;Haplotype;PA451103;Chemical
PROMETHAZINE;CYP2D6*4;Haplotype;PA451128;Chemical
QUETIAPINE;CYP2D6*4;Haplotype;PA451201;Chemical
RISPERIDONE;CYP2D6*4;Haplotype;PA451257;Chemical
SERTRALINE;CYP2D6*4;Haplotype;PA451333;Chemical
SIMVASTATIN;CYP2D6*4;Haplotype;PA451363;Chemical
SULFASALAZINE;CYP2D6*4;Haplotype;PA451547;Chemical
TAMOXIFEN;CYP2D6*4;Haplotype;PA451581;Chemical
TIMOLOL;CYP2D6*4;Haplotype;PA451690;Chemical
TRAMADOL;CYP2D6*4;Haplotype;PA451735;Chemical
TRIMIPRAMINE;CYP2D6*4;Haplotype;PA451791;Chemical
VENLAFAXINE;CYP2D6*4;Haplotype;PA451866;Chemical
ANTIPSYCHOTICS;CYP2D6*4;Haplotype;PA452233;Chemical
SPARTEINE;CYP2D6*4;Haplotype;PA452610;Chemical
DEBRISOQUINE;CYP2D6*4;Haplotype;PA452616;Chemical
OPIOIDS;CYP2D6*4;Haplotype;PA452618;Chemical
ANTINEOPLASTIC AGENTS;CYP2D6*4;Haplotype;PA452621;Chemical
ZUCLOPENTHIXOL;CYP2D6*4;Haplotype;PA452629;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs232043;Variant;PA443622;Disease
CISPLATIN;rs232043;Variant;PA449014;Chemical
GEMCITABINE;rs232043;Variant;PA449748;Chemical
DRUG-INDUCED LIVER INJURY;HLA-DPB1*01:01;Haplotype;PA166119041;Disease
AMOXICILLIN;HLA-DPB1*01:01;Haplotype;PA448406;Chemical
LOVASTATIN;rs5925;Variant;PA450272;Chemical
COLORECTAL NEOPLASMS;PTGES;Gene;PA446108;Disease
CELECOXIB;PTGES;Gene;PA448871;Chemical
DULOXETINE;rs4334661;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs4334661;Variant;PA447321;Disease
HEROIN DEPENDENCE;rs2246709;Variant;PA444460;Disease
HYPERTENSION;rs2246709;Variant;PA444552;Disease
AMLODIPINE;rs2246709;Variant;PA448388;Chemical
METHADONE;rs2246709;Variant;PA450401;Chemical
CLAVULANATE;HLA-A*30:02;Haplotype;PA164742987;Chemical
DRUG-INDUCED LIVER INJURY;HLA-A*30:02;Haplotype;PA166119041;Disease
AMOXICILLIN;HLA-A*30:02;Haplotype;PA448406;Chemical
RS1225367412;Liver Diseases;Disease;PA166180969;Variant
CACNA1S;Liver Diseases;Disease;PA85;Gene
EGFR INHIBITORS;HLA-A*03:01;Haplotype;PA153561371;Chemical
EXANTHEMA;HLA-A*03:01;Haplotype;PA444109;Disease
NEOPLASMS;HLA-A*03:01;Haplotype;PA445062;Disease
CYP2J2;danazol;Chemical;PA27112;Gene
MAPK8;ATF3;Gene;PA283;Gene
MAPK14;ATF3;Gene;PA30621;Gene
HMG COA REDUCTASE INHIBITORS;rs6535454;Variant;PA133950441;Chemical
ROSUVASTATIN;rs6535454;Variant;PA134308647;Chemical
MUSCULAR DISEASES;rs6535454;Variant;PA444997;Disease
ATORVASTATIN;rs6535454;Variant;PA448500;Chemical
CHRNA3;Drugs used in nicotine dependence;Chemical;PA113;Gene
COMT;Drugs used in nicotine dependence;Chemical;PA117;Gene
CYP2A6;Drugs used in nicotine dependence;Chemical;PA121;Gene
RS588765;Drugs used in nicotine dependence;Chemical;PA166154841;Variant
RS1051730;Drugs used in nicotine dependence;Chemical;PA166154856;Variant
RS16969968;Drugs used in nicotine dependence;Chemical;PA166154938;Variant
RS4803381;Drugs used in nicotine dependence;Chemical;PA166155418;Variant
RS4680;Drugs used in nicotine dependence;Chemical;PA166156024;Variant
RS1799971;Drugs used in nicotine dependence;Chemical;PA166156991;Variant
CHRNA5;Drugs used in nicotine dependence;Chemical;PA26491;Gene
OPRM1;Drugs used in nicotine dependence;Chemical;PA31945;Gene
ANALGESICS;KCNJ6;Gene;PA164712362;Chemical
HEROIN DEPENDENCE;KCNJ6;Gene;PA444460;Disease
PAIN;KCNJ6;Gene;PA445208;Disease
PAIN, POSTOPERATIVE;KCNJ6;Gene;PA445210;Disease
LOW BACK PAIN;KCNJ6;Gene;PA446444;Disease
FENTANYL;KCNJ6;Gene;PA449599;Chemical
METHADONE;KCNJ6;Gene;PA450401;Chemical
MORPHINE;KCNJ6;Gene;PA450550;Chemical
OPIOIDS;KCNJ6;Gene;PA452618;Chemical
DACARBAZINE;CYP1A1*4;Haplotype;PA449197;Chemical
TOCILIZUMAB;rs11052877;Variant;PA165292659;Chemical
RHEUMATOID ARTHRITIS;rs11052877;Variant;PA443434;Disease
OSTEONECROSIS;ACP1;Gene;PA445187;Disease
HYPERTRIGLYCERIDEMIA;rs2727786;Variant;PA446120;Disease
FENOFIBRATE;rs2727786;Variant;PA449594;Chemical
MEPHENYTOIN;rs11188072;Variant;PA450373;Chemical
BREAST NEOPLASMS;rs12210538;Variant;PA443560;Disease
CYCLOPHOSPHAMIDE;rs12210538;Variant;PA449165;Chemical
DOXORUBICIN;rs12210538;Variant;PA449412;Chemical
RETINOBLASTOMA;RB1;Gene;PA445538;Disease
NON-SMALL CELL LUNG CARCINOMA;rs5877;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs5877;Variant;PA445846;Disease
CARBOPLATIN;rs5877;Variant;PA448803;Chemical
GEMCITABINE;rs5877;Variant;PA449748;Chemical
MACULOPAPULAR EXANTHEMA;HLA-A*01:01;Haplotype;PA162316739;Disease
PEGINTERFERON ALFA-2A;HLA-A*01:01;Haplotype;PA164749390;Chemical
FLUCLOXACILLIN;HLA-A*01:01;Haplotype;PA164781042;Chemical
PEGINTERFERON ALFA-2B;HLA-A*01:01;Haplotype;PA164784024;Chemical
DRUG-INDUCED LIVER INJURY;HLA-A*01:01;Haplotype;PA166119041;Disease
HEPATITIS C;HLA-A*01:01;Haplotype;PA444445;Disease
AMOXICILLIN;HLA-A*01:01;Haplotype;PA448406;Chemical
CARBAMAZEPINE;HLA-A*01:01;Haplotype;PA448785;Chemical
RIBAVIRIN;HLA-A*01:01;Haplotype;PA451241;Chemical
PLATINUM COMPOUNDS;SLC31A1;Gene;PA164713176;Chemical
OVERALL SURVIVAL;SLC31A1;Gene;PA166123207;Disease
ANEMIA;SLC31A1;Gene;PA443340;Disease
NON-SMALL CELL LUNG CARCINOMA;SLC31A1;Gene;PA443622;Disease
DRUG TOXICITY;SLC31A1;Gene;PA443937;Disease
LEUKOPENIA;SLC31A1;Gene;PA444773;Disease
NAUSEA;SLC31A1;Gene;PA445048;Disease
NEUTROPENIA;SLC31A1;Gene;PA445113;Disease
THROMBOCYTOPENIA;SLC31A1;Gene;PA445846;Disease
VOMITING;SLC31A1;Gene;PA446051;Disease
CARBOPLATIN;SLC31A1;Gene;PA448803;Chemical
CISPLATIN;SLC31A1;Gene;PA449014;Chemical
SCHIZOPHRENIA;rs7395555;Variant;PA447216;Disease
RISPERIDONE;rs7395555;Variant;PA451257;Chemical
CYP2C19;Peripheral Vascular Diseases;Disease;PA124;Gene
CYP2C19*1;Peripheral Vascular Diseases;Disease;PA165980634;Haplotype
CYP2C19*2;Peripheral Vascular Diseases;Disease;PA165980635;Haplotype
COLONIC NEOPLASMS;CYP2W1;Gene;PA443756;Disease
CYP2C19;Hematologic Disorder;Disease;PA124;Gene
CYP2C19*17;Hematologic Disorder;Disease;PA165816533;Haplotype
TPMT*1;Hematologic Disorder;Disease;PA165819268;Haplotype
TPMT*3A;Hematologic Disorder;Disease;PA165819270;Haplotype
CYP2C19*1;Hematologic Disorder;Disease;PA165980634;Haplotype
CYP2C19*2;Hematologic Disorder;Disease;PA165980635;Haplotype
CYP2C19*3;Hematologic Disorder;Disease;PA165980636;Haplotype
RS2228000;Hematologic Disorder;Disease;PA166171094;Variant
TPMT;Hematologic Disorder;Disease;PA356;Gene
XPC;Hematologic Disorder;Disease;PA37413;Gene
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CDH23;Gene;PA447197;Disease
METHYLPHENIDATE;CDH23;Gene;PA450464;Chemical
DPYD;FOLFOX;Chemical;PA145;Gene
RS45445694;FOLFOX;Chemical;PA166155331;Variant
DPYD C.2846A>T;FOLFOX;Chemical;PA166171119;Haplotype
RS11280056;FOLFOX;Chemical;PA166180936;Variant
TYMS;FOLFOX;Chemical;PA359;Gene
ACE;quinapril;Chemical;PA139;Gene
RS699;quinapril;Chemical;PA166153539;Variant
RS1799752;quinapril;Chemical;PA166155187;Variant
AGT;quinapril;Chemical;PA42;Gene
CYP2D6;xanomeline / trospium;Chemical;PA128;Gene
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs7858;Variant;PA447197;Disease
METHYLPHENIDATE;rs7858;Variant;PA450464;Chemical
ABEMACICLIB;MKI67;Gene;PA166153471;Chemical
CYP2B6;Infectious disease;Disease;PA123;Gene
CYP3A5;Infectious disease;Disease;PA131;Gene
TMEM43;Infectious disease;Disease;PA134871907;Gene
POLR1G;Infectious disease;Disease;PA142672156;Gene
ERCC1;Infectious disease;Disease;PA155;Gene
TPMT*1;Infectious disease;Disease;PA165819268;Haplotype
TPMT*3A;Infectious disease;Disease;PA165819270;Haplotype
HLA-DRB1*15:01;Infectious disease;Disease;PA165952269;Haplotype
HLA-DRB5*01:01;Infectious disease;Disease;PA165952460;Haplotype
HLA-DQB1*06:02;Infectious disease;Disease;PA165958103;Haplotype
CYP3A5*1;Infectious disease;Disease;PA166128213;Haplotype
CYP3A5*3;Infectious disease;Disease;PA166128219;Haplotype
RS1695;Infectious disease;Disease;PA166154249;Variant
RS3212986;Infectious disease;Disease;PA166155407;Variant
RS3745274;Infectious disease;Disease;PA166155409;Variant
RS2228001;Infectious disease;Disease;PA166156345;Variant
RS72552763;Infectious disease;Disease;PA166157216;Variant
RS776746;Infectious disease;Disease;PA166157267;Variant
CYP2A7P1;Infectious disease;Disease;PA27103;Gene
GSTP1;Infectious disease;Disease;PA29028;Gene
SLC22A1;Infectious disease;Disease;PA329;Gene
PPP1R13L;Infectious disease;Disease;PA34195;Gene
HLA-DQB1;Infectious disease;Disease;PA35068;Gene
HLA-DRB1;Infectious disease;Disease;PA35072;Gene
HLA-DRB5;Infectious disease;Disease;PA35076;Gene
TPMT;Infectious disease;Disease;PA356;Gene
XPC;Infectious disease;Disease;PA37413;Gene
DEXTROMETHORPHAN;CYP2D6*13;Haplotype;PA449273;Chemical
RISPERIDONE;rs1875705;Variant;PA451257;Chemical
HALOPERIDOL;AKAP13;Gene;PA449841;Chemical
ALZHEIMER DISEASE;TP53INP1;Gene;PA443319;Disease
CYP2D6;Bradycardia;Disease;PA128;Gene
CYP3A5;Bradycardia;Disease;PA131;Gene
CYP2D6*4;Bradycardia;Disease;PA165816579;Haplotype
CYP3A5*3;Bradycardia;Disease;PA166128219;Haplotype
RS16947;Bradycardia;Disease;PA166156031;Variant
PEGASPARGASE;rs9958628;Variant;PA164760860;Chemical
HLA-DQA1*02:01;flucloxacillin;Chemical;PA165951292;Haplotype
HLA-DRB1*07:01;flucloxacillin;Chemical;PA165951644;Haplotype
HLA-DRB1*15:01;flucloxacillin;Chemical;PA165952269;Haplotype
HLA-A*01:01;flucloxacillin;Chemical;PA165952609;Haplotype
HLA-B*57:03;flucloxacillin;Chemical;PA165956579;Haplotype
HLA-C*06:02;flucloxacillin;Chemical;PA165957286;Haplotype
HLA-DQB1*06:02;flucloxacillin;Chemical;PA165958103;Haplotype
HLA-DQB1*03:03;flucloxacillin;Chemical;PA165958180;Haplotype
HLA-B*57:01;flucloxacillin;Chemical;PA165987830;Haplotype
RS3814055;flucloxacillin;Chemical;PA166156383;Variant
HLA-A;flucloxacillin;Chemical;PA35055;Gene
HLA-B;flucloxacillin;Chemical;PA35056;Gene
HLA-C;flucloxacillin;Chemical;PA35057;Gene
HLA-DQA1;flucloxacillin;Chemical;PA35066;Gene
HLA-DQB1;flucloxacillin;Chemical;PA35068;Gene
HLA-DRB1;flucloxacillin;Chemical;PA35072;Gene
ST6GAL1;flucloxacillin;Chemical;PA35762;Gene
NR1I2;flucloxacillin;Chemical;PA378;Gene
ALCOHOL ABUSE;rs6421482;Variant;PA443309;Disease
ETHANOL;rs6421482;Variant;PA448073;Chemical
EPILEPSY;HSPA1L;Gene;PA444065;Disease
CARBAMAZEPINE;HSPA1L;Gene;PA448785;Chemical
ADALIMUMAB;rs396991;Variant;PA10004;Chemical
CETUXIMAB;rs396991;Variant;PA10040;Chemical
ANTITHYMOCYTE GLOBULIN;rs396991;Variant;PA164743704;Chemical
TOCILIZUMAB;rs396991;Variant;PA165292659;Chemical
KIDNEY TRANSPLANTATION;rs396991;Variant;PA165817016;Disease
RHEUMATOID ARTHRITIS;rs396991;Variant;PA443434;Disease
BREAST NEOPLASMS;rs396991;Variant;PA443560;Disease
NEOPLASMS;rs396991;Variant;PA445062;Disease
NEUROMYELITIS OPTICA;rs396991;Variant;PA445109;Disease
PSORIASIS;rs396991;Variant;PA445451;Disease
ETANERCEPT;rs396991;Variant;PA449515;Chemical
RITUXIMAB;rs396991;Variant;PA451261;Chemical
TRASTUZUMAB;rs396991;Variant;PA451743;Chemical
INFLIXIMAB;rs396991;Variant;PA452639;Chemical
OVARIAN NEOPLASMS;rs3212980;Variant;PA445204;Disease
CISPLATIN;rs3212980;Variant;PA449014;Chemical
CYP2C19;platelet aggregation;Disease;PA124;Gene
CYP2C9;platelet aggregation;Disease;PA126;Gene
MED12L;platelet aggregation;Disease;PA134884590;Gene
P2RY12;platelet aggregation;Disease;PA134971947;Gene
CYP2C19*17;platelet aggregation;Disease;PA165816533;Haplotype
CYP2C9*1;platelet aggregation;Disease;PA165816542;Haplotype
CYP2C9*2;platelet aggregation;Disease;PA165816543;Haplotype
CYP2C19*1;platelet aggregation;Disease;PA165980634;Haplotype
CYP2C19*2;platelet aggregation;Disease;PA165980635;Haplotype
RS5853517;platelet aggregation;Disease;PA166156405;Variant
WEIGHT GAIN;rs62097526;Variant;PA128406954;Disease
ANTIPSYCHOTICS;rs62097526;Variant;PA452233;Chemical
NICOTINE;rs376817657;Variant;PA450626;Chemical
PEGASPARGASE;rs1891059;Variant;PA164760860;Chemical
OSTEONECROSIS;rs1891059;Variant;PA445187;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs1891059;Variant;PA446155;Disease
CYCLOPHOSPHAMIDE;rs1891059;Variant;PA449165;Chemical
CYTARABINE;rs1891059;Variant;PA449177;Chemical
DAUNORUBICIN;rs1891059;Variant;PA449212;Chemical
DEXAMETHASONE;rs1891059;Variant;PA449247;Chemical
DOXORUBICIN;rs1891059;Variant;PA449412;Chemical
METHOTREXATE;rs1891059;Variant;PA450428;Chemical
PREDNISONE;rs1891059;Variant;PA451100;Chemical
THIOGUANINE;rs1891059;Variant;PA451663;Chemical
VINCRISTINE;rs1891059;Variant;PA451879;Chemical
CYP2C19;pantoprazole;Chemical;PA124;Gene
CYP3A5;pantoprazole;Chemical;PA131;Gene
CYP2C19*17;pantoprazole;Chemical;PA165816533;Haplotype
CYP2C19*1;pantoprazole;Chemical;PA165980634;Haplotype
CYP2C19*2;pantoprazole;Chemical;PA165980635;Haplotype
CYP2C19*3;pantoprazole;Chemical;PA165980636;Haplotype
RS1045642;pantoprazole;Chemical;PA166157284;Variant
ABCB1;pantoprazole;Chemical;PA267;Gene
SLC22A6;pantoprazole;Chemical;PA388;Gene
SLC22A8;pantoprazole;Chemical;PA389;Gene
SUNITINIB;RET;Gene;PA162372840;Chemical
CABOZANTINIB;RET;Gene;PA165906891;Chemical
VANDETANIB;RET;Gene;PA166118341;Chemical
SELPERCATINIB;RET;Gene;PA166225084;Chemical
PRALSETINIB;RET;Gene;PA166235321;Chemical
RS77709286;RET;Gene;PA166235961;Variant
RS74799832;RET;Gene;PA166235962;Variant
HRAS;RET;Gene;PA29444;Gene
KRAS;RET;Gene;PA30196;Gene
NRAS;RET;Gene;PA31768;Gene
THYROID NEOPLASMS;RET;Gene;PA445857;Disease
SORAFENIB;RET;Gene;PA7000;Chemical
MAP2K7;MAPK13;Gene;PA284;Gene
MAP2K1;MAPK13;Gene;PA30584;Gene
MAP2K2;MAPK13;Gene;PA30587;Gene
MAP2K3;MAPK13;Gene;PA30588;Gene
MAP2K4;MAPK13;Gene;PA30589;Gene
MAP2K5;MAPK13;Gene;PA30590;Gene
MAP2K6;MAPK13;Gene;PA30591;Gene
SORAFENIB;MAPK13;Gene;PA7000;Chemical
CYP2B6;Scoliosis;Disease;PA123;Gene
CYP2B6*1;Scoliosis;Disease;PA165818750;Haplotype
CYP2B6*6;Scoliosis;Disease;PA165818762;Haplotype
CYP2B6*7;Scoliosis;Disease;PA165818765;Haplotype
CYP2B6*9;Scoliosis;Disease;PA165818807;Haplotype
CYP2B6*18;Scoliosis;Disease;PA165818808;Haplotype
COCAINE DEPENDENCE;rs2236256;Variant;PA446878;Disease
COCAINE;rs2236256;Variant;PA449072;Chemical
WARFARIN;rs104894541;Variant;PA451906;Chemical
NAUSEA;rs11882256;Variant;PA445048;Disease
VOMITING;rs11882256;Variant;PA446051;Disease
OPIOIDS;rs11882256;Variant;PA452618;Chemical
PEGINTERFERON ALFA-2B;HLA-C*12:02;Haplotype;PA164784024;Chemical
HEPATITIS C;HLA-C*12:02;Haplotype;PA444445;Disease
RIBAVIRIN;HLA-C*12:02;Haplotype;PA451241;Chemical
WARFARIN;rs11150606;Variant;PA451906;Chemical
DIABETES MELLITUS, TYPE 2;SLC47A1;Gene;PA443890;Disease
POLYCYSTIC OVARY SYNDROME;SLC47A1;Gene;PA445376;Disease
METFORMIN;SLC47A1;Gene;PA450395;Chemical
GLIOBLASTOMA;MGMT;Gene;PA444283;Disease
TEMOZOLOMIDE;MGMT;Gene;PA451609;Chemical
EPILEPSY;CYP2C9*31;Haplotype;PA444065;Disease
PHENYTOIN;CYP2C9*31;Haplotype;PA450947;Chemical
HLA-DQA1*02:01;Pancreatitis;Disease;PA165951292;Haplotype
HLA-DRB1*07:01;Pancreatitis;Disease;PA165951644;Haplotype
RS2647087;Pancreatitis;Disease;PA166157045;Variant
RS199695765;Pancreatitis;Disease;PA166157535;Variant
CPA2;Pancreatitis;Disease;PA26817;Gene
HLA-DQA1;Pancreatitis;Disease;PA35066;Gene
HLA-DRB1;Pancreatitis;Disease;PA35072;Gene
CYP2C9;tenoxicam;Chemical;PA126;Gene
CYP2C9*1;tenoxicam;Chemical;PA165816542;Haplotype
CYP2C9*2;tenoxicam;Chemical;PA165816543;Haplotype
CYP2C9*3;tenoxicam;Chemical;PA165816544;Haplotype
CARBAMAZEPINE;rs1043620;Variant;PA448785;Chemical
ALEMTUZUMAB;CXCL12;Gene;PA164783958;Chemical
LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;CXCL12;Gene;PA446169;Disease
CHLORAMBUCIL;CXCL12;Gene;PA448926;Chemical
CYCLOPHOSPHAMIDE;CXCL12;Gene;PA449165;Chemical
FLUDARABINE;CXCL12;Gene;PA449655;Chemical
PREDNISONE;CXCL12;Gene;PA451100;Chemical
RITUXIMAB;CXCL12;Gene;PA451261;Chemical
VINCRISTINE;CXCL12;Gene;PA451879;Chemical
CYP2B6;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA123;Gene
CYP3A5;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA131;Gene
ULK3;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA134908392;Gene
GSTT1 NULL;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA166048678;Haplotype
GSTT1 NON-NULL;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA166048679;Haplotype
UGT1A1*1;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA166115841;Haplotype
UGT1A1*28;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA166115842;Haplotype
UGT1A1*6;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA166115858;Haplotype
UGT1A1*27;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA166115865;Haplotype
RS1801133;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA166153644;Variant
RS3764043;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA166154564;Variant
RS2290573;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA166154887;Variant
RS3745274;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA166155409;Variant
RS2725252;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA166156565;Variant
RS12505410;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA166156659;Variant
RS13120400;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA166156664;Variant
RS1050152;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA166156750;Variant
RS683369;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA166156936;Variant
RS776746;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA166157267;Variant
RS1045642;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA166157284;Variant
RS1128503;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA166157288;Variant
GSTT1;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA183;Gene
ABL1;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA24413;Gene
MTHFR;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA245;Gene
BCR;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA25321;Gene
ABCB1;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA267;Gene
SLCO1A2;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA328;Gene
SLC22A1;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA329;Gene
SLC22A4;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA332;Gene
ABCG2;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA390;Gene
UGT1A1;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA420;Gene
PHILADELPHIA CHROMOSOME;Chronic myelogenous leukemia, BCR-ABL1 positive;Disease;PA445316;Disease
NR1I2;clotrimazole;Chemical;PA378;Gene
HYPERTRIGLYCERIDEMIA;rs4238001;Variant;PA446120;Disease
FENOFIBRATE;rs4238001;Variant;PA449594;Chemical
CELECOXIB;CACNA1I;Gene;PA448871;Chemical
CD274;nivolumab / relatlimab;Chemical;PA134915280;Gene
RS113488022;nivolumab / relatlimab;Chemical;PA166157522;Variant
BRAF;nivolumab / relatlimab;Chemical;PA25408;Gene
LAG3;nivolumab / relatlimab;Chemical;PA30265;Gene
CYP2D6;ethylmorphine;Chemical;PA128;Gene
CYP2D6*1;ethylmorphine;Chemical;PA165816576;Haplotype
CYP2D6*4;ethylmorphine;Chemical;PA165816579;Haplotype
MAJOR DEPRESSIVE DISORDER;MTRF1L;Gene;PA447321;Disease
ANTIDEPRESSANTS;MTRF1L;Gene;PA452229;Chemical
RS1799971;Cardiac Arrest;Disease;PA166156991;Variant
OPRM1;Cardiac Arrest;Disease;PA31945;Gene
ESR1;neratinib;Chemical;PA156;Gene
PGR;neratinib;Chemical;PA266;Gene
ERBB2;neratinib;Chemical;PA27844;Gene
ESR2;neratinib;Chemical;PA27886;Gene
EGFR;neratinib;Chemical;PA7360;Gene
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;rs13306278;Variant;PA164713257;Chemical
MAJOR DEPRESSIVE DISORDER;rs13306278;Variant;PA447321;Disease
ASTHMA;rs6002674;Variant;PA443450;Disease
SALBUTAMOL;rs6002674;Variant;PA448068;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;PURA;Gene;PA447197;Disease
METHYLPHENIDATE;PURA;Gene;PA450464;Chemical
LUTETIUM (177LU) OXODOTREOTIDE;SSTR2;Gene;PA166224981;Chemical
CYP2D6;sulfasalazine;Chemical;PA128;Gene
C18ORF56;sulfasalazine;Chemical;PA134956204;Gene
CYP2D6*3;sulfasalazine;Chemical;PA165816578;Haplotype
CYP2D6*4;sulfasalazine;Chemical;PA165816579;Haplotype
G6PD B (REFERENCE);sulfasalazine;Chemical;PA165947826;Haplotype
G6PD A- 202A_376G;sulfasalazine;Chemical;PA165947827;Haplotype
CYP2D6*5;sulfasalazine;Chemical;PA165948092;Haplotype
HLA-B*13:01;sulfasalazine;Chemical;PA165954643;Haplotype
HLA-B*15:05;sulfasalazine;Chemical;PA165954778;Haplotype
HLA-B*39:01;sulfasalazine;Chemical;PA165955543;Haplotype
RS1805087;sulfasalazine;Chemical;PA166153654;Variant
RS45445694;sulfasalazine;Chemical;PA166155331;Variant
RS2231142;sulfasalazine;Chemical;PA166156544;Variant
RS72552713;sulfasalazine;Chemical;PA166156694;Variant
NAT2 SLOW ACETYLATOR;sulfasalazine;Chemical;PA166157948;Variant
G6PD DEFICIENCY;sulfasalazine;Chemical;PA166157959;Variant
RS11280056;sulfasalazine;Chemical;PA166180936;Variant
NAT2;sulfasalazine;Chemical;PA18;Gene
MTHFR;sulfasalazine;Chemical;PA245;Gene
G6PD;sulfasalazine;Chemical;PA28469;Gene
MTR;sulfasalazine;Chemical;PA31272;Gene
HLA-B;sulfasalazine;Chemical;PA35056;Gene
TYMS;sulfasalazine;Chemical;PA359;Gene
ABCG2;sulfasalazine;Chemical;PA390;Gene
ACE INHIBITORS, PLAIN;KCNMA1;Gene;PA164712308;Chemical
ANGIOEDEMA;KCNMA1;Gene;PA443371;Disease
DIARRHEA;SLC22A7;Gene;PA443899;Disease
DRUG TOXICITY;SLC22A7;Gene;PA443937;Disease
NEOPLASMS;SLC22A7;Gene;PA445062;Disease
CAPECITABINE;SLC22A7;Gene;PA448771;Chemical
DICLOFENAC;SLC22A7;Gene;PA449293;Chemical
ZIDOVUDINE;SLC22A7;Gene;PA451954;Chemical
RS113488022;LAG3;Gene;PA166157522;Variant
NIVOLUMAB / RELATLIMAB;LAG3;Gene;PA166277902;Chemical
COL3A1;Ehlers-Danlos Syndrome;Disease;PA26716;Gene
DESMETHYLNAPROXEN;rs552524124;Variant;PA166163690;Chemical
TAPENTADOL;rs552524124;Variant;PA166179720;Chemical
ACETAMINOPHEN;rs552524124;Variant;PA448015;Chemical
MEPHENYTOIN;rs61311738;Variant;PA450373;Chemical
CYP3A4;CYP3A4*13;Haplotype;PA130;Gene
CABOZANTINIB;CYP3A4*13;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*13;Haplotype;PA165958362;Chemical
REGORAFENIB;CYP3A4*13;Haplotype;PA166114943;Chemical
VANDETANIB;CYP3A4*13;Haplotype;PA166118341;Chemical
BREXPIPRAZOLE;CYP3A4*13;Haplotype;PA166160053;Chemical
MACITENTAN;CYP3A4*13;Haplotype;PA166261201;Chemical
BLONANSERIN;CYP3A4*13;Haplotype;PA166319041;Chemical
OXYCODONE;CYP3A4*13;Haplotype;PA450741;Chemical
QUETIAPINE;CYP3A4*13;Haplotype;PA451201;Chemical
HIV INFECTIOUS DISEASE;rs1429376;Variant;PA447230;Disease
DIDANOSINE;rs1429376;Variant;PA449301;Chemical
NAUSEA;ZNF568;Gene;PA445048;Disease
VOMITING;ZNF568;Gene;PA446051;Disease
OPIOIDS;ZNF568;Gene;PA452618;Chemical
WARFARIN;rs1060467;Variant;PA451906;Chemical
BLINATUMOMAB;CD19;Gene;PA166129524;Chemical
QT-PROLONGING DRUGS;rs1805128;Variant;PA1102;Chemical
DIURETICS;rs1805128;Variant;PA151249535;Chemical
ANTIBIOTICS;rs1805128;Variant;PA164712406;Chemical
ACQUIRED LONG QT SYNDROME (ALQTS);rs1805128;Variant;PA447300;Disease
AMIODARONE;rs1805128;Variant;PA448383;Chemical
QUINIDINE;rs1805128;Variant;PA451209;Chemical
SOTALOL;rs1805128;Variant;PA451457;Chemical
ANTIPSYCHOTICS;rs1805128;Variant;PA452233;Chemical
OLAPARIB;BRCA2;Gene;PA164920420;Chemical
NIRAPARIB;BRCA2;Gene;PA166131610;Chemical
RUCAPARIB;BRCA2;Gene;PA166163418;Chemical
TALAZOPARIB;BRCA2;Gene;PA166182740;Chemical
SACITUZUMAB GOVITECAN;BRCA2;Gene;PA166225061;Chemical
PROSTATIC NEOPLASMS;BRCA2;Gene;PA445425;Disease
CYP2D6;Serotonin Syndrome;Disease;PA128;Gene
CYP2D6*2;Serotonin Syndrome;Disease;PA165816577;Haplotype
CYP2D6*4;Serotonin Syndrome;Disease;PA165816579;Haplotype
CYP2D6*41;Serotonin Syndrome;Disease;PA165816584;Haplotype
DESFLURANE;rs193922748;Variant;PA164749136;Chemical
RYR1;rs193922748;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs193922748;Variant;PA444863;Disease
ENFLURANE;rs193922748;Variant;PA449461;Chemical
HALOTHANE;rs193922748;Variant;PA449845;Chemical
ISOFLURANE;rs193922748;Variant;PA450106;Chemical
METHOXYFLURANE;rs193922748;Variant;PA450434;Chemical
SEVOFLURANE;rs193922748;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs193922748;Variant;PA451522;Chemical
CACNA1S;rs193922748;Variant;PA85;Gene
CYP2C9;rs2108622;Variant;PA126;Gene
VKORC1;rs2108622;Variant;PA133787052;Gene
VITAMIN K AND ANALOGUES;rs2108622;Variant;PA164713404;Chemical
ACUTE CORONARY SYNDROME;rs2108622;Variant;PA165108401;Disease
OVER-ANTICOAGULATION;rs2108622;Variant;PA166123298;Disease
ARACHIDONIC ACID;rs2108622;Variant;PA166178659;Chemical
CYP4F2;rs2108622;Variant;PA27121;Gene
ATRIAL FIBRILLATION;rs2108622;Variant;PA443459;Disease
ASPIRIN;rs2108622;Variant;PA448497;Chemical
CLOPIDOGREL;rs2108622;Variant;PA449053;Chemical
PHENPROCOUMON;rs2108622;Variant;PA450921;Chemical
VITAMIN E;rs2108622;Variant;PA451900;Chemical
WARFARIN;rs2108622;Variant;PA451906;Chemical
ACENOCOUMAROL;rs2108622;Variant;PA452632;Chemical
CFTR;rs11971167;Variant;PA109;Gene
IVACAFTOR;rs11971167;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs11971167;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs11971167;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs11971167;Variant;PA443829;Disease
WARFARIN;rs104894542;Variant;PA451906;Chemical
ACENOCOUMAROL;rs104894542;Variant;PA452632;Chemical
KIDNEY TRANSPLANTATION;IL12A;Gene;PA165817016;Disease
USTEKINUMAB;IL12A;Gene;PA166048654;Chemical
MYCOPHENOLATE MOFETIL;IL12A;Gene;PA450566;Chemical
PLTP;APOA1;Gene;PA273;Gene
HYPERTRIGLYCERIDEMIA;APOA1;Gene;PA446120;Disease
FENOFIBRATE;APOA1;Gene;PA449594;Chemical
NEOPLASMS;NT5C2;Gene;PA445062;Disease
HIV INFECTIOUS DISEASE;NT5C2;Gene;PA447230;Disease
CYTARABINE;NT5C2;Gene;PA449177;Chemical
DIDANOSINE;NT5C2;Gene;PA449301;Chemical
GEMCITABINE;NT5C2;Gene;PA449748;Chemical
MERCAPTOPURINE;NT5C2;Gene;PA450379;Chemical
SEVERE CUTANEOUS ADVERSE REACTIONS;NOTCH4;Gene;PA166120929;Disease
ALLOPURINOL;NOTCH4;Gene;PA448320;Chemical
SLC31A1;Thrombocytopenia;Disease;PA118;Gene
CYP2C8;Thrombocytopenia;Disease;PA125;Gene
SLCO1B1;Thrombocytopenia;Disease;PA134865839;Gene
C6ORF15;Thrombocytopenia;Disease;PA134866404;Gene
PPP1R18;Thrombocytopenia;Disease;PA134918172;Gene
DOCK8;Thrombocytopenia;Disease;PA134918866;Gene
MUCL3;Thrombocytopenia;Disease;PA134926573;Gene
ATAT1;Thrombocytopenia;Disease;PA134948212;Gene
HCP5;Thrombocytopenia;Disease;PA134951826;Gene
NUDT15;Thrombocytopenia;Disease;PA134963132;Gene
DHFR;Thrombocytopenia;Disease;PA143;Gene
TPMT*1;Thrombocytopenia;Disease;PA165819268;Haplotype
TPMT*2;Thrombocytopenia;Disease;PA165819269;Haplotype
TPMT*3A;Thrombocytopenia;Disease;PA165819270;Haplotype
TPMT*3C;Thrombocytopenia;Disease;PA165819272;Haplotype
TPMT*9;Thrombocytopenia;Disease;PA165819279;Haplotype
TPMT*21;Thrombocytopenia;Disease;PA165819291;Haplotype
TPMT*33;Thrombocytopenia;Disease;PA166005224;Haplotype
TPMT*34;Thrombocytopenia;Disease;PA166005225;Haplotype
UGT1A1*1;Thrombocytopenia;Disease;PA166115841;Haplotype
UGT1A1*28;Thrombocytopenia;Disease;PA166115842;Haplotype
UGT1A1*60;Thrombocytopenia;Disease;PA166115845;Haplotype
RS1801133;Thrombocytopenia;Disease;PA166153644;Variant
RS4149056;Thrombocytopenia;Disease;PA166154579;Variant
RS1933437;Thrombocytopenia;Disease;PA166154705;Variant
RS116855232;Thrombocytopenia;Disease;PA166154759;Variant
RS6113;Thrombocytopenia;Disease;PA166154763;Variant
RS2236225;Thrombocytopenia;Disease;PA166154789;Variant
RS70991108;Thrombocytopenia;Disease;PA166156893;Variant
RS1800629;Thrombocytopenia;Disease;PA166156997;Variant
RS1799735;Thrombocytopenia;Disease;PA166159214;Variant
RS746071566;Thrombocytopenia;Disease;PA166165231;Variant
RS2027701;Thrombocytopenia;Disease;PA166169891;Variant
RS1059698;Thrombocytopenia;Disease;PA166169893;Variant
RS73594404;Thrombocytopenia;Disease;PA166169897;Variant
RS10132552;Thrombocytopenia;Disease;PA166169901;Variant
RS4979223;Thrombocytopenia;Disease;PA166179445;Variant
RS4978536;Thrombocytopenia;Disease;PA166179452;Variant
RS10817464;Thrombocytopenia;Disease;PA166179458;Variant
RS10759637;Thrombocytopenia;Disease;PA166179462;Variant
RS11280056;Thrombocytopenia;Disease;PA166180936;Variant
RS28362731;Thrombocytopenia;Disease;PA166186212;Variant
RS1049305;Thrombocytopenia;Disease;PA166186213;Variant
RS5877;Thrombocytopenia;Disease;PA166201501;Variant
RS3094086;Thrombocytopenia;Disease;PA166201502;Variant
RS1049709;Thrombocytopenia;Disease;PA166201503;Variant
RS10885;Thrombocytopenia;Disease;PA166201504;Variant
RS3115672;Thrombocytopenia;Disease;PA166201505;Variant
RS9262132;Thrombocytopenia;Disease;PA166201521;Variant
RS9262143;Thrombocytopenia;Disease;PA166201522;Variant
RS886424;Thrombocytopenia;Disease;PA166201523;Variant
RS886423;Thrombocytopenia;Disease;PA166201524;Variant
RS2233980;Thrombocytopenia;Disease;PA166201525;Variant
RS3130985;Thrombocytopenia;Disease;PA166201526;Variant
RS3130907;Thrombocytopenia;Disease;PA166201527;Variant
RS11229;Thrombocytopenia;Disease;PA166201528;Variant
RS10491684;Thrombocytopenia;Disease;PA166201541;Variant
RS1058932;Thrombocytopenia;Disease;PA166201542;Variant
RS11572078;Thrombocytopenia;Disease;PA166201543;Variant
RS6118;Thrombocytopenia;Disease;PA166201545;Variant
RS6119;Thrombocytopenia;Disease;PA166201546;Variant
RS6504649;Thrombocytopenia;Disease;PA166201547;Variant
RS73450548;Thrombocytopenia;Disease;PA166201561;Variant
RS36120609;Thrombocytopenia;Disease;PA166211543;Variant
MTHFR;Thrombocytopenia;Disease;PA245;Gene
AQP1;Thrombocytopenia;Disease;PA24918;Gene
PRRC2A;Thrombocytopenia;Disease;PA25263;Gene
CDSN;Thrombocytopenia;Disease;PA26348;Gene
ETS2;Thrombocytopenia;Disease;PA27903;Gene
FLT3;Thrombocytopenia;Disease;PA28181;Gene
GSTM3;Thrombocytopenia;Disease;PA29024;Gene
MEG3;Thrombocytopenia;Disease;PA30737;Gene
MSH5;Thrombocytopenia;Disease;PA31136;Gene
MTHFD1;Thrombocytopenia;Disease;PA31236;Gene
PSORS1C1;Thrombocytopenia;Disease;PA33919;Gene
SERPINC1;Thrombocytopenia;Disease;PA35026;Gene
HLA-C;Thrombocytopenia;Disease;PA35057;Gene
SERPINA5;Thrombocytopenia;Disease;PA35505;Gene
TPMT;Thrombocytopenia;Disease;PA356;Gene
TYMS;Thrombocytopenia;Disease;PA359;Gene
XYLT2;Thrombocytopenia;Disease;PA37974;Gene
UGT1A1;Thrombocytopenia;Disease;PA420;Gene
TNF;Thrombocytopenia;Disease;PA435;Gene
IMATINIB;ABL1;Gene;PA10804;Chemical
DASATINIB;ABL1;Gene;PA162372878;Chemical
NILOTINIB;ABL1;Gene;PA165958345;Chemical
PONATINIB;ABL1;Gene;PA165980594;Chemical
BOSUTINIB;ABL1;Gene;PA166114906;Chemical
OMACETAXINE;ABL1;Gene;PA166114929;Chemical
BLINATUMOMAB;ABL1;Gene;PA166129524;Chemical
RS121913459;ABL1;Gene;PA166157848;Variant
INOTUZUMAB OZOGAMICIN;ABL1;Gene;PA166177510;Chemical
ASCIMINIB;ABL1;Gene;PA166268841;Chemical
NEOPLASMS;ABL1;Gene;PA445062;Disease
PHILADELPHIA CHROMOSOME;ABL1;Gene;PA445316;Disease
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;ABL1;Gene;PA446171;Disease
LEUKEMIA, MYELOID, CHRONIC, ATYPICAL, BCR-ABL NEGATIVE;ABL1;Gene;PA446175;Disease
BUSULFAN;ABL1;Gene;PA448691;Chemical
VINCRISTINE;ABL1;Gene;PA451879;Chemical
TICAGRELOR;CYP3A4*29;Haplotype;PA165374673;Chemical
CABOZANTINIB;CYP3A4*29;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*29;Haplotype;PA165958362;Chemical
VANDETANIB;CYP3A4*29;Haplotype;PA166118341;Chemical
IBRUTINIB;CYP3A4*29;Haplotype;PA166121346;Chemical
ALECTINIB;CYP3A4*29;Haplotype;PA166160050;Chemical
BREXPIPRAZOLE;CYP3A4*29;Haplotype;PA166160053;Chemical
ACALABRUTINIB;CYP3A4*29;Haplotype;PA166198581;Chemical
MACITENTAN;CYP3A4*29;Haplotype;PA166261201;Chemical
BLONANSERIN;CYP3A4*29;Haplotype;PA166319041;Chemical
AMIODARONE;CYP3A4*29;Haplotype;PA448383;Chemical
IBUPROFEN;CYP3A4*29;Haplotype;PA449957;Chemical
LIDOCAINE;CYP3A4*29;Haplotype;PA450226;Chemical
METHADONE;CYP3A4*29;Haplotype;PA450401;Chemical
OXYCODONE;CYP3A4*29;Haplotype;PA450741;Chemical
SILDENAFIL;CYP3A4*29;Haplotype;PA451346;Chemical
TESTOSTERONE;CYP3A4*29;Haplotype;PA451627;Chemical
G6PD;tolazamide;Chemical;PA28469;Gene
TUBERCULOSIS;CUX2;Gene;PA445941;Disease
RIFAMPIN;CUX2;Gene;PA451250;Chemical
DULOXETINE;rs12657120;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs12657120;Variant;PA447321;Disease
EXEMESTANE;rs11253043;Variant;PA449563;Chemical
NFKB1;PPP3CB;Gene;PA248;Gene
RELA;PPP3CB;Gene;PA296;Gene
NFATC1;PPP3CB;Gene;PA31582;Gene
NFATC2;PPP3CB;Gene;PA31583;Gene
NFATC4;PPP3CB;Gene;PA31584;Gene
NFKB2;PPP3CB;Gene;PA31600;Gene
REL;PPP3CB;Gene;PA34321;Gene
RELB;PPP3CB;Gene;PA34322;Gene
ADVERSE EVENTS;ARRB2;Gene;PA166151827;Disease
PDE4C;ARRB2;Gene;PA264;Gene
MAPK1;ARRB2;Gene;PA30616;Gene
PDE4A;ARRB2;Gene;PA33128;Gene
PDE4B;ARRB2;Gene;PA33129;Gene
PDE4D;ARRB2;Gene;PA33130;Gene
PRKACA;ARRB2;Gene;PA33748;Gene
PRKACB;ARRB2;Gene;PA33749;Gene
PRKACG;ARRB2;Gene;PA33750;Gene
SRC;ARRB2;Gene;PA36111;Gene
ADRB2;ARRB2;Gene;PA39;Gene
OPIOID-RELATED DISORDERS;ARRB2;Gene;PA445043;Disease
SUBSTANCE-RELATED DISORDERS;ARRB2;Gene;PA446876;Disease
BUPRENORPHINE;ARRB2;Gene;PA448685;Chemical
FENTANYL;ARRB2;Gene;PA449599;Chemical
METHAMPHETAMINE;ARRB2;Gene;PA450403;Chemical
TRAMADOL;ARRB2;Gene;PA451735;Chemical
ATP1A1;ARRB2;Gene;PA62;Gene
ESR1;anastrozole;Chemical;PA156;Gene
DLG2;anastrozole;Chemical;PA164741388;Gene
FULVESTRANT;anastrozole;Chemical;PA164747170;Chemical
RS7984870;anastrozole;Chemical;PA166154722;Variant
RS1008805;anastrozole;Chemical;PA166154854;Variant
RS6493497;anastrozole;Chemical;PA166154917;Variant
RS3732218;anastrozole;Chemical;PA166155700;Variant
RS3732219;anastrozole;Chemical;PA166155701;Variant
RS4550690;anastrozole;Chemical;PA166155729;Variant
RS10485828;anastrozole;Chemical;PA166155965;Variant
RS2234693;anastrozole;Chemical;PA166157026;Variant
RS6901146;anastrozole;Chemical;PA166157111;Variant
RS9340799;anastrozole;Chemical;PA166157143;Variant
RS1045642;anastrozole;Chemical;PA166157284;Variant
RS2032582;anastrozole;Chemical;PA166157316;Variant
RS2073618;anastrozole;Chemical;PA166157573;Variant
RS727479;anastrozole;Chemical;PA166163632;Variant
RS2449598;anastrozole;Chemical;PA166233301;Variant
RS1437153;anastrozole;Chemical;PA166233321;Variant
RS6981827;anastrozole;Chemical;PA166233341;Variant
RS6990851;anastrozole;Chemical;PA166233521;Variant
PGR;anastrozole;Chemical;PA266;Gene
ABCB1;anastrozole;Chemical;PA267;Gene
CSMD1;anastrozole;Chemical;PA26947;Gene
CYP19A1;anastrozole;Chemical;PA27091;Gene
ESR2;anastrozole;Chemical;PA27886;Gene
MAP4K4;anastrozole;Chemical;PA30612;Gene
TNFRSF11B;anastrozole;Chemical;PA36602;Gene
TNFSF11;anastrozole;Chemical;PA36619;Gene
UGT1A4;anastrozole;Chemical;PA37179;Gene
TUBB1;anastrozole;Chemical;PA38100;Gene
CYP3A4;macitentan;Chemical;PA130;Gene
CYP3A4*1;macitentan;Chemical;PA165819201;Haplotype
CYP3A4*3;macitentan;Chemical;PA165819221;Haplotype
CYP3A4*4;macitentan;Chemical;PA165819222;Haplotype
CYP3A4*5;macitentan;Chemical;PA165819223;Haplotype
CYP3A4*9;macitentan;Chemical;PA165819227;Haplotype
CYP3A4*10;macitentan;Chemical;PA165819228;Haplotype
CYP3A4*11;macitentan;Chemical;PA165819229;Haplotype
CYP3A4*12;macitentan;Chemical;PA165819230;Haplotype
CYP3A4*13;macitentan;Chemical;PA165819231;Haplotype
CYP3A4*15;macitentan;Chemical;PA165819233;Haplotype
CYP3A4*16;macitentan;Chemical;PA165819236;Haplotype
CYP3A4*17;macitentan;Chemical;PA165819239;Haplotype
CYP3A4*20;macitentan;Chemical;PA165819244;Haplotype
CYP3A4*23;macitentan;Chemical;PA166115836;Haplotype
CYP3A4*24;macitentan;Chemical;PA166115837;Haplotype
CYP3A4*28;macitentan;Chemical;PA166245584;Haplotype
CYP3A4*29;macitentan;Chemical;PA166245585;Haplotype
CYP3A4*33;macitentan;Chemical;PA166245589;Haplotype
CYP3A4*34;macitentan;Chemical;PA166245590;Haplotype
HMG COA REDUCTASE INHIBITORS, OTHER COMBINATIONS;rs9342288;Variant;PA164712781;Chemical
CARDIOVASCULAR DISEASE;rs9342288;Variant;PA443635;Disease
RHABDOMYOLYSIS;rs9342288;Variant;PA445549;Disease
TOBACCO USE DISORDER;CYP2A6*38;Haplotype;PA445876;Disease
NICOTINE;CYP2A6*38;Haplotype;PA450626;Chemical
HYPERTENSION;PDE1A;Gene;PA444552;Disease
ETHANOL;rs1577857;Variant;PA448073;Chemical
CRH;antidepressants;Chemical;PA119;Gene
CYP2C19;antidepressants;Chemical;PA124;Gene
CYP2D6;antidepressants;Chemical;PA128;Gene
TPH2;antidepressants;Chemical;PA128747823;Gene
MTRF1L;antidepressants;Chemical;PA134870441;Gene
RPP30;antidepressants;Chemical;PA134876345;Gene
RAPGEF5;antidepressants;Chemical;PA134902361;Gene
ACE;antidepressants;Chemical;PA139;Gene
ERICH3;antidepressants;Chemical;PA142672422;Gene
METTL21A;antidepressants;Chemical;PA145008433;Gene
ACSS3;antidepressants;Chemical;PA162375534;Gene
CYP2D6*2;antidepressants;Chemical;PA165816577;Haplotype
CYP2C19*1;antidepressants;Chemical;PA165980634;Haplotype
CYP2C19*2;antidepressants;Chemical;PA165980635;Haplotype
CYP2D6*2XN;antidepressants;Chemical;PA165988480;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);antidepressants;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);antidepressants;Chemical;PA166116466;Haplotype
RS521093;antidepressants;Chemical;PA166153573;Variant
RS11580409;antidepressants;Chemical;PA166153829;Variant
RS12082710;antidepressants;Chemical;PA166153847;Variant
RS10997242;antidepressants;Chemical;PA166154121;Variant
RS6265;antidepressants;Chemical;PA166154259;Variant
RS948854;antidepressants;Chemical;PA166154302;Variant
RS1800532;antidepressants;Chemical;PA166154340;Variant
RS1954787;antidepressants;Chemical;PA166154345;Variant
RS12800734;antidepressants;Chemical;PA166154467;Variant
RS61888800;antidepressants;Chemical;PA166154478;Variant
RS5443;antidepressants;Chemical;PA166154486;Variant
RS2532560;antidepressants;Chemical;PA166154551;Variant
RS10879346;antidepressants;Chemical;PA166154625;Variant
RS6311;antidepressants;Chemical;PA166154673;Variant
RS6313;antidepressants;Chemical;PA166154675;Variant
RS6314;antidepressants;Chemical;PA166154676;Variant
RS7997012;antidepressants;Chemical;PA166154726;Variant
RS9315310;antidepressants;Chemical;PA166154730;Variant
RS1799752;antidepressants;Chemical;PA166155187;Variant
RS28364032;antidepressants;Chemical;PA166155259;Variant
RS2112460;antidepressants;Chemical;PA166155383;Variant
RS889895;antidepressants;Chemical;PA166155608;Variant
RS7569963;antidepressants;Chemical;PA166155763;Variant
RS2831440;antidepressants;Chemical;PA166156000;Variant
RS49411;antidepressants;Chemical;PA166156278;Variant
RS6295;antidepressants;Chemical;PA166156708;Variant
RS1992647;antidepressants;Chemical;PA166156777;Variant
RS10036156;antidepressants;Chemical;PA166156853;Variant
RS672170;antidepressants;Chemical;PA166156935;Variant
RS766127;antidepressants;Chemical;PA166156951;Variant
RS1360780;antidepressants;Chemical;PA166156983;Variant
RS1799971;antidepressants;Chemical;PA166156991;Variant
RS3800373;antidepressants;Chemical;PA166157083;Variant
RS4713916;antidepressants;Chemical;PA166157104;Variant
RS1128503;antidepressants;Chemical;PA166157288;Variant
RS1799889;antidepressants;Chemical;PA166157302;Variant
RS2032583;antidepressants;Chemical;PA166157317;Variant
RS2227631;antidepressants;Chemical;PA166157329;Variant
RS2235015;antidepressants;Chemical;PA166157336;Variant
RS2235040;antidepressants;Chemical;PA166157338;Variant
RS2299267;antidepressants;Chemical;PA166157359;Variant
RS16873129;antidepressants;Chemical;PA166157467;Variant
RS4737771;antidepressants;Chemical;PA166157606;Variant
RS502434;antidepressants;Chemical;PA166157853;Variant
RS3761554;antidepressants;Chemical;PA166157871;Variant
RS3761555;antidepressants;Chemical;PA166157872;Variant
RS57098334;antidepressants;Chemical;PA166158926;Variant
RS1439050;antidepressants;Chemical;PA166161252;Variant
RS7905446;antidepressants;Chemical;PA166182096;Variant
GNB3;antidepressants;Chemical;PA176;Gene
HTR1A;antidepressants;Chemical;PA192;Gene
HTR2A;antidepressants;Chemical;PA193;Gene
PARP11;antidepressants;Chemical;PA25507;Gene
CACNA1A;antidepressants;Chemical;PA26007;Gene
SERPINE1;antidepressants;Chemical;PA261;Gene
ABCB1;antidepressants;Chemical;PA267;Gene
CREB1;antidepressants;Chemical;PA26864;Gene
CRHR1;antidepressants;Chemical;PA26874;Gene
CTNNA3;antidepressants;Chemical;PA27010;Gene
FHIT;antidepressants;Chemical;PA28140;Gene
FKBP5;antidepressants;Chemical;PA28162;Gene
GABRA6;antidepressants;Chemical;PA28494;Gene
GABRP;antidepressants;Chemical;PA28503;Gene
GAL;antidepressants;Chemical;PA28529;Gene
GRIA3;antidepressants;Chemical;PA28968;Gene
GRIK4;antidepressants;Chemical;PA28976;Gene
HTR7;antidepressants;Chemical;PA29561;Gene
SLC6A4;antidepressants;Chemical;PA312;Gene
NBEA;antidepressants;Chemical;PA31454;Gene
NTRK2;antidepressants;Chemical;PA31818;Gene
BDNF;antidepressants;Chemical;PA31891;Gene
OPRM1;antidepressants;Chemical;PA31945;Gene
PON2;antidepressants;Chemical;PA33530;Gene
RGS17;antidepressants;Chemical;PA34368;Gene
TPH1;antidepressants;Chemical;PA355;Gene
TGFBR3;antidepressants;Chemical;PA36487;Gene
ADRB1;antidepressants;Chemical;PA38;Gene
TOPIRAMATE;rs2306719;Variant;PA451728;Chemical
ZONISAMIDE;rs2306719;Variant;PA451978;Chemical
VKORC1;Coagulation Protein Disorders;Disease;PA133787052;Gene
COMT;Delirium;Disease;PA117;Gene
RS324420;Delirium;Disease;PA166153569;Variant
RS4680;Delirium;Disease;PA166156024;Variant
RS1799971;Delirium;Disease;PA166156991;Variant
FAAH;Delirium;Disease;PA27955;Gene
OPRM1;Delirium;Disease;PA31945;Gene
GEFITINIB;CYP2D6*96;Haplotype;PA131301952;Chemical
ATOMOXETINE;CYP2D6*96;Haplotype;PA134688071;Chemical
TOLTERODINE;CYP2D6*96;Haplotype;PA164746757;Chemical
BUFURALOL;CYP2D6*96;Haplotype;PA166110256;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CYP2D6*96;Haplotype;PA447197;Disease
DEXTROMETHORPHAN;CYP2D6*96;Haplotype;PA449273;Chemical
FLUOXETINE;CYP2D6*96;Haplotype;PA449673;Chemical
OLANZAPINE;CYP2D6*96;Haplotype;PA450688;Chemical
WEIGHT GAIN;rs17782313;Variant;PA128406954;Disease
AMISULPRIDE;rs17782313;Variant;PA162565877;Chemical
PALIPERIDONE;rs17782313;Variant;PA163518919;Chemical
QUETIAPINE;rs17782313;Variant;PA451201;Chemical
RISPERIDONE;rs17782313;Variant;PA451257;Chemical
ANTIPSYCHOTICS;rs17782313;Variant;PA452233;Chemical
IMATINIB;ABCB4;Gene;PA10804;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;ABCB4;Gene;PA130620651;Chemical
GASTROINTESTINAL STROMAL TUMORS;ABCB4;Gene;PA151958383;Disease
MARALIXIBAT;ABCB4;Gene;PA166268803;Chemical
NEOPLASMS;ABCB4;Gene;PA445062;Disease
FLUOROURACIL;CYP2A6*9;Haplotype;PA128406956;Chemical
OXALIPLATIN;CYP2A6*9;Haplotype;PA131285527;Chemical
COUMARIN;CYP2A6*9;Haplotype;PA134521193;Chemical
COTININE;CYP2A6*9;Haplotype;PA166114414;Chemical
TEGAFUR / GIMERACIL / OTERACIL;CYP2A6*9;Haplotype;PA166115442;Chemical
PROGRESSION-FREE SURVIVAL;CYP2A6*9;Haplotype;PA166123026;Disease
CESSATION;CYP2A6*9;Haplotype;PA166123046;Disease
OVERALL SURVIVAL;CYP2A6*9;Haplotype;PA166123207;Disease
BILIARY TRACT NEOPLASMS;CYP2A6*9;Haplotype;PA166128807;Disease
BREAST NEOPLASMS;CYP2A6*9;Haplotype;PA443560;Disease
CARCINOMA, NON-SMALL-CELL LUNG;CYP2A6*9;Haplotype;PA443622;Disease
NEOPLASMS;CYP2A6*9;Haplotype;PA445062;Disease
STOMACH NEOPLASMS;CYP2A6*9;Haplotype;PA445742;Disease
TOBACCO USE DISORDER;CYP2A6*9;Haplotype;PA445876;Disease
COLORECTAL NEOPLASMS;CYP2A6*9;Haplotype;PA446108;Disease
CAFFEINE;CYP2A6*9;Haplotype;PA448710;Chemical
IRINOTECAN;CYP2A6*9;Haplotype;PA450085;Chemical
LETROZOLE;CYP2A6*9;Haplotype;PA450196;Chemical
METRONIDAZOLE;CYP2A6*9;Haplotype;PA450484;Chemical
NICOTINE;CYP2A6*9;Haplotype;PA450626;Chemical
PILOCARPINE;CYP2A6*9;Haplotype;PA450962;Chemical
TEGAFUR;CYP2A6*9;Haplotype;PA452620;Chemical
LEUKEMIA, MYELOID, ACUTE;rs532545;Variant;PA444760;Disease
LEUKEMIA, MYELOID;rs532545;Variant;PA444761;Disease
NEOPLASMS;rs532545;Variant;PA445062;Disease
CYTARABINE;rs532545;Variant;PA449177;Chemical
AMISULPRIDE;ANKS1B;Gene;PA162565877;Chemical
METHAMPHETAMINE DEPENDENCE;ANKS1B;Gene;PA166119022;Disease
ALCOHOL ABUSE;ANKS1B;Gene;PA443309;Disease
HEROIN DEPENDENCE;ANKS1B;Gene;PA444460;Disease
SCHIZOPHRENIA;ANKS1B;Gene;PA447216;Disease
ETHANOL;ANKS1B;Gene;PA448073;Chemical
METHAMPHETAMINE;ANKS1B;Gene;PA450403;Chemical
HEROIN;ANKS1B;Gene;PA452619;Chemical
ADRB1;Beta blocking agents, non-selective;Chemical;PA38;Gene
ADRB2;Beta blocking agents, non-selective;Chemical;PA39;Gene
BIPOLAR DISORDER;rs209474;Variant;PA447199;Disease
LITHIUM;rs209474;Variant;PA450243;Chemical
COMT;Obsessive-Compulsive Disorder;Disease;PA117;Gene
CYP2C19;Obsessive-Compulsive Disorder;Disease;PA124;Gene
CYP2D6;Obsessive-Compulsive Disorder;Disease;PA128;Gene
CYP2C19*17;Obsessive-Compulsive Disorder;Disease;PA165816533;Haplotype
CYP2D6*1;Obsessive-Compulsive Disorder;Disease;PA165816576;Haplotype
CYP2D6*3;Obsessive-Compulsive Disorder;Disease;PA165816578;Haplotype
CYP2D6*4;Obsessive-Compulsive Disorder;Disease;PA165816579;Haplotype
CYP2D6*6;Obsessive-Compulsive Disorder;Disease;PA165816581;Haplotype
CYP2D6*10;Obsessive-Compulsive Disorder;Disease;PA165816582;Haplotype
CYP2D6*5;Obsessive-Compulsive Disorder;Disease;PA165948092;Haplotype
CYP2C19*1;Obsessive-Compulsive Disorder;Disease;PA165980634;Haplotype
CYP2C19*2;Obsessive-Compulsive Disorder;Disease;PA165980635;Haplotype
CYP2C19*3;Obsessive-Compulsive Disorder;Disease;PA165980636;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);Obsessive-Compulsive Disorder;Disease;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);Obsessive-Compulsive Disorder;Disease;PA166116466;Haplotype
CYP2D6*81;Obsessive-Compulsive Disorder;Disease;PA166123321;Haplotype
RS6311;Obsessive-Compulsive Disorder;Disease;PA166154673;Variant
RS301434;Obsessive-Compulsive Disorder;Disease;PA166157703;Variant
RS301435;Obsessive-Compulsive Disorder;Disease;PA166157704;Variant
RS3087879;Obsessive-Compulsive Disorder;Disease;PA166157760;Variant
HTR2A;Obsessive-Compulsive Disorder;Disease;PA193;Gene
SLC6A4;Obsessive-Compulsive Disorder;Disease;PA312;Gene
SLC1A1;Obsessive-Compulsive Disorder;Disease;PA35826;Gene
EPILEPSY;CYP2C9*29;Haplotype;PA444065;Disease
FLURBIPROFEN;CYP2C9*29;Haplotype;PA449683;Chemical
NAPROXEN;CYP2C9*29;Haplotype;PA450595;Chemical
PHENYTOIN;CYP2C9*29;Haplotype;PA450947;Chemical
WARFARIN;CYP2C9*29;Haplotype;PA451906;Chemical
MAPK8;MAP2K3;Gene;PA283;Gene
MAP3K11;MAP2K3;Gene;PA30594;Gene
MAP3K7;MAP2K3;Gene;PA30603;Gene
MAPK1;MAP2K3;Gene;PA30616;Gene
MAPK10;MAP2K3;Gene;PA30617;Gene
MAPK11;MAP2K3;Gene;PA30618;Gene
MAPK12;MAP2K3;Gene;PA30619;Gene
MAPK13;MAP2K3;Gene;PA30620;Gene
MAPK14;MAP2K3;Gene;PA30621;Gene
MAPK3;MAP2K3;Gene;PA30622;Gene
MAPK4;MAP2K3;Gene;PA30623;Gene
MAPK6;MAP2K3;Gene;PA30624;Gene
MAPK7;MAP2K3;Gene;PA30625;Gene
MAPK9;MAP2K3;Gene;PA30630;Gene
RAF1;MAP2K3;Gene;PA34183;Gene
COLORECTAL NEOPLASMS;rs11574077;Variant;PA446108;Disease
IRINOTECAN;rs11574077;Variant;PA450085;Chemical
MITAPIVAT;PKLR;Gene;PA166278021;Chemical
RS118204085;PKLR;Gene;PA166317661;Variant
DEPRESSIVE DISORDER;rs4570625;Variant;PA447207;Disease
CITALOPRAM;rs4570625;Variant;PA449015;Chemical
G6PD;sulfacetamide;Chemical;PA28469;Gene
CFTR;rs186089140;Variant;PA109;Gene
IVACAFTOR;rs186089140;Variant;PA165950341;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs186089140;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs186089140;Variant;PA443829;Disease
CYP2C9;benzbromarone;Chemical;PA126;Gene
CYP2C9*1;benzbromarone;Chemical;PA165816542;Haplotype
CYP2C9*3;benzbromarone;Chemical;PA165816544;Haplotype
URINARY BLADDER NEOPLASMS;rs7937567;Variant;PA443512;Disease
CISPLATIN;rs7937567;Variant;PA449014;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs4149015;Variant;PA443622;Disease
IRINOTECAN;rs4149015;Variant;PA450085;Chemical
PRAVASTATIN;rs4149015;Variant;PA451089;Chemical
F8;desmopressin;Chemical;PA27952;Gene
COCAINE DEPENDENCE;rs6454674;Variant;PA446878;Disease
COCAINE;rs6454674;Variant;PA449072;Chemical
DIABETES MELLITUS;rs2683511;Variant;PA443886;Disease
METFORMIN;rs2683511;Variant;PA450395;Chemical
LIVER TRANSPLANTATION;C6;Gene;PA447247;Disease
TACROLIMUS;C6;Gene;PA451578;Chemical
COMT;Tardive Dyskinesia;Disease;PA117;Gene
CYP2D6;Tardive Dyskinesia;Disease;PA128;Gene
CYP2D6*1;Tardive Dyskinesia;Disease;PA165816576;Haplotype
CYP2D6*3;Tardive Dyskinesia;Disease;PA165816578;Haplotype
CYP2D6*4;Tardive Dyskinesia;Disease;PA165816579;Haplotype
CYP2D6*6;Tardive Dyskinesia;Disease;PA165816581;Haplotype
CYP2D6*10;Tardive Dyskinesia;Disease;PA165816582;Haplotype
CYP2D6*5;Tardive Dyskinesia;Disease;PA165948092;Haplotype
CYP2D6*7;Tardive Dyskinesia;Disease;PA165971559;Haplotype
RS6311;Tardive Dyskinesia;Disease;PA166154673;Variant
RS4680;Tardive Dyskinesia;Disease;PA166156024;Variant
RS6977820;Tardive Dyskinesia;Disease;PA166157426;Variant
CYP2D6*14;Tardive Dyskinesia;Disease;PA166181185;Haplotype
HTR2A;Tardive Dyskinesia;Disease;PA193;Gene
ASTHENIA;rs699517;Variant;PA443448;Disease
NAUSEA;rs699517;Variant;PA445048;Disease
NEOPLASMS;rs699517;Variant;PA445062;Disease
VOMITING;rs699517;Variant;PA446051;Disease
CAPECITABINE;rs699517;Variant;PA448771;Chemical
FLUOROURACIL;SHMT1;Gene;PA128406956;Chemical
BEVACIZUMAB;SHMT1;Gene;PA130232992;Chemical
COLORECTAL NEOPLASMS;SHMT1;Gene;PA446108;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;SHMT1;Gene;PA446155;Disease
IRINOTECAN;SHMT1;Gene;PA450085;Chemical
LEUCOVORIN;SHMT1;Gene;PA450198;Chemical
METHOTREXATE;SHMT1;Gene;PA450428;Chemical
CETP;fluvastatin;Chemical;PA108;Gene
CYP2C9;fluvastatin;Chemical;PA126;Gene
CYP2D6;fluvastatin;Chemical;PA128;Gene
CYP3A4;fluvastatin;Chemical;PA130;Gene
CYP3A5;fluvastatin;Chemical;PA131;Gene
SLCO1B1;fluvastatin;Chemical;PA134865839;Gene
ACE;fluvastatin;Chemical;PA139;Gene
CYP2C9*1;fluvastatin;Chemical;PA165816542;Haplotype
CYP2C9*2;fluvastatin;Chemical;PA165816543;Haplotype
CYP2C9*3;fluvastatin;Chemical;PA165816544;Haplotype
CYP2D6*1;fluvastatin;Chemical;PA165816576;Haplotype
CYP2D6*4;fluvastatin;Chemical;PA165816579;Haplotype
SLCO1B1*5;fluvastatin;Chemical;PA165819255;Haplotype
SLCO1B1*14;fluvastatin;Chemical;PA165819264;Haplotype
SLCO1B1*15;fluvastatin;Chemical;PA165819265;Haplotype
HLA-DRB1*01:01;fluvastatin;Chemical;PA165951320;Haplotype
HLA-DRB1*04:06;fluvastatin;Chemical;PA165951530;Haplotype
SLCO1B1*1;fluvastatin;Chemical;PA165981641;Haplotype
RS4149056;fluvastatin;Chemical;PA166154579;Variant
RS11045819;fluvastatin;Chemical;PA166154628;Variant
RS1800588;fluvastatin;Chemical;PA166154870;Variant
RS5882;fluvastatin;Chemical;PA166154975;Variant
RS4783961;fluvastatin;Chemical;PA166155066;Variant
RS1799752;fluvastatin;Chemical;PA166155187;Variant
RS60282872;fluvastatin;Chemical;PA166155265;Variant
RS7412;fluvastatin;Chemical;PA166155341;Variant
RS2231142;fluvastatin;Chemical;PA166156544;Variant
RS17238540;fluvastatin;Chemical;PA166156885;Variant
RS1922242;fluvastatin;Chemical;PA166157312;Variant
RS4986910;fluvastatin;Chemical;PA166157405;Variant
HMGCR;fluvastatin;Chemical;PA189;Gene
LIPC;fluvastatin;Chemical;PA230;Gene
ABCB1;fluvastatin;Chemical;PA267;Gene
SREBF1;fluvastatin;Chemical;PA335;Gene
HLA-DRB1;fluvastatin;Chemical;PA35072;Gene
NR1I2;fluvastatin;Chemical;PA378;Gene
ABCG2;fluvastatin;Chemical;PA390;Gene
APOE;fluvastatin;Chemical;PA55;Gene
HIV INFECTIOUS DISEASE;rs28371706;Variant;PA447230;Disease
NEVIRAPINE;rs28371706;Variant;PA450616;Chemical
PLATINUM COMPOUNDS;MEG3;Gene;PA164713176;Chemical
MYELOSUPPRESSION;MEG3;Gene;PA165817398;Disease
MUCOSITIS;MEG3;Gene;PA166122058;Disease
RADIOTHERAPY;MEG3;Gene;PA166122986;Chemical
ANEMIA;MEG3;Gene;PA443340;Disease
DERMATITIS;MEG3;Gene;PA443875;Disease
LEUKOPENIA;MEG3;Gene;PA444773;Disease
NEUTROPENIA;MEG3;Gene;PA445113;Disease
THROMBOCYTOPENIA;MEG3;Gene;PA445846;Disease
PLATINUM COMPOUNDS;rs7921977;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs7921977;Variant;PA443622;Disease
DOCETAXEL;rs7921977;Variant;PA449383;Chemical
GEMCITABINE;rs7921977;Variant;PA449748;Chemical
PACLITAXEL;rs7921977;Variant;PA450761;Chemical
VINORELBINE;rs7921977;Variant;PA451881;Chemical
BIPOLAR DISORDER;rs2769605;Variant;PA447199;Disease
LITHIUM;rs2769605;Variant;PA450243;Chemical
VALPROIC ACID;rs2769605;Variant;PA451846;Chemical
ANTIHYPERTENSIVES;PTPRD;Gene;PA164712445;Chemical
DIABETES MELLITUS, TYPE 2;PTPRD;Gene;PA443890;Disease
HYPERTENSION;PTPRD;Gene;PA444552;Disease
PIOGLITAZONE;PTPRD;Gene;PA450970;Chemical
TRANDOLAPRIL;PTPRD;Gene;PA451737;Chemical
VERAPAMIL;PTPRD;Gene;PA451868;Chemical
SCN4A;Hypokalemic Periodic Paralysis;Disease;PA35006;Gene
NICOTINE;rs768416963;Variant;PA450626;Chemical
G6PD;Syncope;Disease;PA28469;Gene
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;ETV6;Gene;PA446155;Disease
TOXIC LIVER DISEASE;rs4720833;Variant;PA164925725;Disease
DRUG-INDUCED LIVER INJURY;rs4720833;Variant;PA166119041;Disease
ISONIAZID;rs4720833;Variant;PA450112;Chemical
NEOPLASMS;rs11719165;Variant;PA445062;Disease
GEMCITABINE;rs11719165;Variant;PA449748;Chemical
OPIOID-RELATED DISORDERS;rs9288993;Variant;PA445043;Disease
OPIOIDS;rs9288993;Variant;PA452618;Chemical
METABOLIC SYNDROME;rs2277984;Variant;PA162370415;Disease
CLOZAPINE;rs2277984;Variant;PA449061;Chemical
TENOFOVIR;rs757639;Variant;PA10204;Chemical
HIV INFECTIOUS DISEASE;rs757639;Variant;PA447230;Disease
CASR;PLCL2;Gene;PA26097;Gene
PRKCA;PLCL2;Gene;PA33759;Gene
PRKCB;PLCL2;Gene;PA33761;Gene
PRKCG;PLCL2;Gene;PA33766;Gene
PRKCH;PLCL2;Gene;PA33767;Gene
PRKCI;PLCL2;Gene;PA33768;Gene
PRKD1;PLCL2;Gene;PA33771;Gene
PRKCZ;PLCL2;Gene;PA33775;Gene
FLUOROURACIL;rs2236722;Variant;PA128406956;Chemical
METASTATIC NEOPLASM;rs2236722;Variant;PA445058;Disease
CAPECITABINE;rs2236722;Variant;PA448771;Chemical
SN-38;rs35350960;Variant;PA165110775;Chemical
CYP2A6;Progression-free survival;Disease;PA121;Gene
CYP2D6;Progression-free survival;Disease;PA128;Gene
C18ORF56;Progression-free survival;Disease;PA134956204;Gene
RPTOR;Progression-free survival;Disease;PA165432629;Gene
CYP2D6*1;Progression-free survival;Disease;PA165816576;Haplotype
CYP2D6*2;Progression-free survival;Disease;PA165816577;Haplotype
CYP2D6*3;Progression-free survival;Disease;PA165816578;Haplotype
CYP2D6*4;Progression-free survival;Disease;PA165816579;Haplotype
CYP2D6*10;Progression-free survival;Disease;PA165816582;Haplotype
CYP2D6*41;Progression-free survival;Disease;PA165816584;Haplotype
CYP2A6*1;Progression-free survival;Disease;PA165924690;Haplotype
CYP2A6*4;Progression-free survival;Disease;PA165924721;Haplotype
CYP2A6*7;Progression-free survival;Disease;PA165924731;Haplotype
CYP2A6*10;Progression-free survival;Disease;PA165924735;Haplotype
CYP2D6*5;Progression-free survival;Disease;PA165948092;Haplotype
CYP2A6*9;Progression-free survival;Disease;PA165980914;Haplotype
CYP2D6*35;Progression-free survival;Disease;PA165988487;Haplotype
GSTT1 NULL;Progression-free survival;Disease;PA166048678;Haplotype
GSTT1 NON-NULL;Progression-free survival;Disease;PA166048679;Haplotype
UGT1A1*6;Progression-free survival;Disease;PA166115858;Haplotype
RS45445694;Progression-free survival;Disease;PA166155331;Variant
RS13181;Progression-free survival;Disease;PA166155343;Variant
RS2229109;Progression-free survival;Disease;PA166157334;Variant
RS9906827;Progression-free survival;Disease;PA166165381;Variant
RS3219489;Progression-free survival;Disease;PA166171088;Variant
RS11280056;Progression-free survival;Disease;PA166180936;Variant
GSTT1;Progression-free survival;Disease;PA183;Gene
ABCB1;Progression-free survival;Disease;PA267;Gene
ERCC2;Progression-free survival;Disease;PA27848;Gene
MUTYH;Progression-free survival;Disease;PA31328;Gene
TYMS;Progression-free survival;Disease;PA359;Gene
UGT1A1;Progression-free survival;Disease;PA420;Gene
CYP3A5;dextropropoxyphene;Chemical;PA131;Gene
CYP3A5*1;dextropropoxyphene;Chemical;PA166128213;Haplotype
CYP3A5*3;dextropropoxyphene;Chemical;PA166128219;Haplotype
CFTR;rs397508533;Variant;PA109;Gene
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs397508533;Variant;PA166362502;Chemical
HYPERTENSION;rs9306160;Variant;PA444552;Disease
ATENOLOL;rs9306160;Variant;PA448499;Chemical
OPIOID-RELATED DISORDERS;rs10770141;Variant;PA445043;Disease
OPIOIDS;rs10770141;Variant;PA452618;Chemical
NEUTROPENIA;rs17501331;Variant;PA445113;Disease
COLORECTAL NEOPLASMS;rs17501331;Variant;PA446108;Disease
IRINOTECAN;rs17501331;Variant;PA450085;Chemical
CYP2C19;aspirin;Chemical;PA124;Gene
CYP2C9;aspirin;Chemical;PA126;Gene
CYP2D6;aspirin;Chemical;PA128;Gene
COL26A1;aspirin;Chemical;PA134887081;Gene
WDR24;aspirin;Chemical;PA134918496;Gene
KRTAP10-4;aspirin;Chemical;PA134942730;Gene
CEP68;aspirin;Chemical;PA134991391;Gene
ACE;aspirin;Chemical;PA139;Gene
FSIP1;aspirin;Chemical;PA142671750;Gene
CHIA;aspirin;Chemical;PA142672117;Gene
F13A1;aspirin;Chemical;PA162;Gene
EFR3A;aspirin;Chemical;PA162384422;Gene
JMJD8;aspirin;Chemical;PA162392531;Gene
NECAB1;aspirin;Chemical;PA162397411;Gene
PEAR1;aspirin;Chemical;PA162399233;Gene
CYP2C19*17;aspirin;Chemical;PA165816533;Haplotype
CYP2C9*1;aspirin;Chemical;PA165816542;Haplotype
CYP2C9*2;aspirin;Chemical;PA165816543;Haplotype
CYP2C9*3;aspirin;Chemical;PA165816544;Haplotype
CYP2D6*3;aspirin;Chemical;PA165816578;Haplotype
CYP2D6*4;aspirin;Chemical;PA165816579;Haplotype
G6PD B (REFERENCE);aspirin;Chemical;PA165947826;Haplotype
CYP2D6*5;aspirin;Chemical;PA165948092;Haplotype
HLA-DPB1*03:01;aspirin;Chemical;PA165951131;Haplotype
HLA-DPB1*04:01;aspirin;Chemical;PA165951133;Haplotype
HLA-DPB1*05:01;aspirin;Chemical;PA165951139;Haplotype
HLA-DPB1*13:01;aspirin;Chemical;PA165951184;Haplotype
HLA-DRB1*09:01;aspirin;Chemical;PA165951734;Haplotype
HLA-DRB1*13:02;aspirin;Chemical;PA165951978;Haplotype
HLA-DQB1*06:04;aspirin;Chemical;PA165958107;Haplotype
HLA-DQB1*06:09;aspirin;Chemical;PA165958117;Haplotype
HLA-DQB1*03:02;aspirin;Chemical;PA165958175;Haplotype
HLA-DQB1*03:03;aspirin;Chemical;PA165958180;Haplotype
CYP2C19*1;aspirin;Chemical;PA165980634;Haplotype
CYP2C19*2;aspirin;Chemical;PA165980635;Haplotype
CYP2C19*3;aspirin;Chemical;PA165980636;Haplotype
G6PD MEDITERRANEAN, DALLAS, PANAMA, SASSARI, CAGLIARI, BIRMINGHAM;aspirin;Chemical;PA166121127;Haplotype
RS5050;aspirin;Chemical;PA166153546;Variant
RS20417;aspirin;Chemical;PA166153559;Variant
RS2228079;aspirin;Chemical;PA166153677;Variant
RS2768759;aspirin;Chemical;PA166153716;Variant
RS3818822;aspirin;Chemical;PA166153756;Variant
RS7551789;aspirin;Chemical;PA166153796;Variant
RS11587213;aspirin;Chemical;PA166153832;Variant
RS12041331;aspirin;Chemical;PA166153839;Variant
RS12042763;aspirin;Chemical;PA166153840;Variant
RS12746200;aspirin;Chemical;PA166153862;Variant
RS16851030;aspirin;Chemical;PA166153865;Variant
RS11819745;aspirin;Chemical;PA166154143;Variant
RS557881;aspirin;Chemical;PA166154498;Variant
RS2965667;aspirin;Chemical;PA166154559;Variant
RS1353411;aspirin;Chemical;PA166154781;Variant
RS2075797;aspirin;Chemical;PA166154788;Variant
RS7179742;aspirin;Chemical;PA166154922;Variant
RS16973225;aspirin;Chemical;PA166154939;Variant
RS4291;aspirin;Chemical;PA166155143;Variant
RS4292;aspirin;Chemical;PA166155144;Variant
RS5918;aspirin;Chemical;PA166155152;Variant
RS6065;aspirin;Chemical;PA166155153;Variant
RS1805034;aspirin;Chemical;PA166155281;Variant
RS4523;aspirin;Chemical;PA166155338;Variant
RS1126510;aspirin;Chemical;PA166155363;Variant
RS1131882;aspirin;Chemical;PA166155365;Variant
RS1613662;aspirin;Chemical;PA166155368;Variant
RS1800469;aspirin;Chemical;PA166155372;Variant
RS2108622;aspirin;Chemical;PA166155381;Variant
RS1050891;aspirin;Chemical;PA166155618;Variant
RS1105879;aspirin;Chemical;PA166155623;Variant
RS1143627;aspirin;Chemical;PA166155629;Variant
RS2070959;aspirin;Chemical;PA166155665;Variant
RS7572857;aspirin;Chemical;PA166155764;Variant
RS2228246;aspirin;Chemical;PA166155921;Variant
RS28360521;aspirin;Chemical;PA166156143;Variant
RS1065776;aspirin;Chemical;PA166156310;Variant
RS3856806;aspirin;Chemical;PA166156388;Variant
RS1047626;aspirin;Chemical;PA166156500;Variant
RS3775291;aspirin;Chemical;PA166156579;Variant
RS730012;aspirin;Chemical;PA166156740;Variant
RS1062535;aspirin;Chemical;PA166156753;Variant
RS1126643;aspirin;Chemical;PA166156755;Variant
RS2243250;aspirin;Chemical;PA166156792;Variant
RS5985;aspirin;Chemical;PA166156902;Variant
RS1042136;aspirin;Chemical;PA166156970;Variant
RS1042151;aspirin;Chemical;PA166156971;Variant
RS1059288;aspirin;Chemical;PA166156974;Variant
RS1800629;aspirin;Chemical;PA166156997;Variant
RS2071888;aspirin;Chemical;PA166157012;Variant
RS3097671;aspirin;Chemical;PA166157065;Variant
RS3129294;aspirin;Chemical;PA166157067;Variant
RS3130100;aspirin;Chemical;PA166157068;Variant
RS1074373;aspirin;Chemical;PA166157287;Variant
RS1799983;aspirin;Chemical;PA166157303;Variant
RS6962291;aspirin;Chemical;PA166157423;Variant
RS10279545;aspirin;Chemical;PA166157444;Variant
RS4271002;aspirin;Chemical;PA166157597;Variant
RS7862221;aspirin;Chemical;PA166157794;Variant
RS10306114;aspirin;Chemical;PA166157803;Variant
RS115346678;aspirin;Chemical;PA166257821;Variant
RS12678747;aspirin;Chemical;PA166260501;Variant
RS11640115;aspirin;Chemical;PA166268441;Variant
RS74569896;aspirin;Chemical;PA166268442;Variant
RS4736529;aspirin;Chemical;PA166268443;Variant
RS75750968;aspirin;Chemical;PA166268444;Variant
RS3749187;aspirin;Chemical;PA166268445;Variant
RS140410716;aspirin;Chemical;PA166268446;Variant
RS201441480;aspirin;Chemical;PA166268447;Variant
RS17064642;aspirin;Chemical;PA166268981;Variant
GP1BA;aspirin;Chemical;PA178;Gene
NAT2;aspirin;Chemical;PA18;Gene
HNMT;aspirin;Chemical;PA190;Gene
IL4;aspirin;Chemical;PA197;Gene
ITGA2;aspirin;Chemical;PA204;Gene
ITGB3;aspirin;Chemical;PA205;Gene
LTC4S;aspirin;Chemical;PA235;Gene
PTGS1;aspirin;Chemical;PA24346;Gene
ADORA1;aspirin;Chemical;PA24583;Gene
NOS3;aspirin;Chemical;PA254;Gene
TSPEAR;aspirin;Chemical;PA25824;Gene
SLC30A9;aspirin;Chemical;PA25909;Gene
AGAP3;aspirin;Chemical;PA26413;Gene
PLA2G4A;aspirin;Chemical;PA271;Gene
CYP4F2;aspirin;Chemical;PA27121;Gene
ECHS1;aspirin;Chemical;PA27597;Gene
EYA1;aspirin;Chemical;PA27931;Gene
FCER1G;aspirin;Chemical;PA28057;Gene
PPARG;aspirin;Chemical;PA281;Gene
G6PD;aspirin;Chemical;PA28469;Gene
PTGER2;aspirin;Chemical;PA287;Gene
PTGER3;aspirin;Chemical;PA288;Gene
GP6;aspirin;Chemical;PA28824;Gene
PTGIR;aspirin;Chemical;PA291;Gene
PTGS2;aspirin;Chemical;PA293;Gene
IL1B;aspirin;Chemical;PA29808;Gene
MYOM2;aspirin;Chemical;PA31419;Gene
NTRK1;aspirin;Chemical;PA31817;Gene
P2RY1;aspirin;Chemical;PA32868;Gene
PLCG1;aspirin;Chemical;PA33392;Gene
TBXA2R;aspirin;Chemical;PA348;Gene
TBXAS1;aspirin;Chemical;PA349;Gene
TGFB1;aspirin;Chemical;PA350;Gene
HLA-DPB1;aspirin;Chemical;PA35064;Gene
HLA-DPB2;aspirin;Chemical;PA35065;Gene
HLA-DQB1;aspirin;Chemical;PA35068;Gene
HLA-DRB1;aspirin;Chemical;PA35072;Gene
SLC6A12;aspirin;Chemical;PA35908;Gene
TAPBP;aspirin;Chemical;PA36331;Gene
THRA;aspirin;Chemical;PA36507;Gene
TLR3;aspirin;Chemical;PA36551;Gene
TNFRSF11A;aspirin;Chemical;PA36601;Gene
TSC1;aspirin;Chemical;PA37034;Gene
UGT1A6;aspirin;Chemical;PA37181;Gene
ZBTB22;aspirin;Chemical;PA37661;Gene
ZDHHC3;aspirin;Chemical;PA38544;Gene
AGT;aspirin;Chemical;PA42;Gene
TNF;aspirin;Chemical;PA435;Gene
CELECOXIB;aspirin;Chemical;PA448871;Chemical
CYP2D6;acebutolol;Chemical;PA128;Gene
GRK5;acebutolol;Chemical;PA180;Gene
GRK4;acebutolol;Chemical;PA28941;Gene
ADRA2C;acebutolol;Chemical;PA37;Gene
ADRB1;acebutolol;Chemical;PA38;Gene
N-DESMETHYLTAMOXIFEN;CYP2D6*30;Haplotype;PA166127651;Chemical
PRIMAQUINE;CYP2D6*30;Haplotype;PA451103;Chemical
SOD1;tofersen;Chemical;PA334;Gene
TELMISARTAN;rs60140950;Variant;PA451605;Chemical
PTGS2;valdecoxib;Chemical;PA293;Gene
ALCOHOL ABUSE;rs11940694;Variant;PA443309;Disease
ETHANOL;rs11940694;Variant;PA448073;Chemical
ETHANOL;rs1461773;Variant;PA448073;Chemical
DESFLURANE;rs193922803;Variant;PA164749136;Chemical
RYR1;rs193922803;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs193922803;Variant;PA444863;Disease
ENFLURANE;rs193922803;Variant;PA449461;Chemical
HALOTHANE;rs193922803;Variant;PA449845;Chemical
ISOFLURANE;rs193922803;Variant;PA450106;Chemical
METHOXYFLURANE;rs193922803;Variant;PA450434;Chemical
SEVOFLURANE;rs193922803;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs193922803;Variant;PA451522;Chemical
CACNA1S;rs193922803;Variant;PA85;Gene
BRIVANIB;FGFR2;Gene;PA164924492;Chemical
PEMIGATINIB;FGFR2;Gene;PA166248041;Chemical
INFIGRATINIB;FGFR2;Gene;PA166252061;Chemical
FUTIBATINIB;FGFR2;Gene;PA166293381;Chemical
RS1057519045;FGFR2;Gene;PA166317621;Variant
RS1057519797;FGFR2;Gene;PA166317622;Variant
CRK;FGFR2;Gene;PA26880;Gene
FGF2;FGFR2;Gene;PA28115;Gene
PIK3C2A;FGFR2;Gene;PA33304;Gene
PIK3C2B;FGFR2;Gene;PA33305;Gene
RETINAL DISEASES;rs3873352;Variant;PA445532;Disease
TRIAMCINOLONE;rs3873352;Variant;PA451749;Chemical
GEFITINIB;rs2233409;Variant;PA131301952;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs2233409;Variant;PA443622;Disease
DIARRHEA;rs2233409;Variant;PA443899;Disease
CYP2C9;seladelpar;Chemical;PA126;Gene
HLA-DRB1*15:01;Still's Disease, Adult-Onset;Disease;PA165952269;Haplotype
HLA-DRB1;Still's Disease, Adult-Onset;Disease;PA35072;Gene
CYP2C19;etravirine;Chemical;PA124;Gene
RS4244285;etravirine;Chemical;PA166154053;Variant
RS2058878;acamprosate;Chemical;PA166154524;Variant
RS77583603;acamprosate;Chemical;PA166258781;Variant
GRIN2B;acamprosate;Chemical;PA28980;Gene
RS28404156;Beta blocking agents, selective;Chemical;PA166199981;Variant
BST1;Beta blocking agents, selective;Chemical;PA25435;Gene
ADRB1;Beta blocking agents, selective;Chemical;PA38;Gene
PRASUGREL;NTRK1;Gene;PA154410481;Chemical
NEPHROTOXICITY;NTRK1;Gene;PA162263533;Disease
GLUCARPIDASE;NTRK1;Gene;PA165949771;Chemical
LAROTRECTINIB;NTRK1;Gene;PA166182733;Chemical
ENTRECTINIB;NTRK1;Gene;PA166190161;Chemical
REPOTRECTINIB;NTRK1;Gene;PA166328881;Chemical
THYROID NEOPLASMS;NTRK1;Gene;PA445857;Disease
ASPIRIN;NTRK1;Gene;PA448497;Chemical
CFTR;cystic fibrosis pulmonary exacerbation;Disease;PA109;Gene
RS113993960;cystic fibrosis pulmonary exacerbation;Disease;PA166157525;Variant
DULOXETINE;DRD3;Gene;PA10066;Chemical
AUTISM SPECTRUM DISORDER;DRD3;Gene;PA153906318;Disease
PRAMIPEXOLE;DRD3;Gene;PA164742949;Chemical
GASTROINTESTINAL TOXICITY;DRD3;Gene;PA166124386;Disease
HALLUCINATIONS;DRD3;Gene;PA444339;Disease
OPIOID-RELATED DISORDERS;DRD3;Gene;PA445043;Disease
PARKINSON DISEASE;DRD3;Gene;PA445254;Disease
ANXIETY DISORDERS;DRD3;Gene;PA447196;Disease
AUTISM;DRD3;Gene;PA447198;Disease
BIPOLAR DISORDER;DRD3;Gene;PA447199;Disease
SCHIZOPHRENIA;DRD3;Gene;PA447216;Disease
HIV INFECTIOUS DISEASE;DRD3;Gene;PA447230;Disease
MAJOR DEPRESSIVE DISORDER;DRD3;Gene;PA447321;Disease
CLOZAPINE;DRD3;Gene;PA449061;Chemical
LEVODOPA;DRD3;Gene;PA450213;Chemical
METHAMPHETAMINE;DRD3;Gene;PA450403;Chemical
METHYLPHENIDATE;DRD3;Gene;PA450464;Chemical
OLANZAPINE;DRD3;Gene;PA450688;Chemical
PAROXETINE;DRD3;Gene;PA450801;Chemical
QUETIAPINE;DRD3;Gene;PA451201;Chemical
RISPERIDONE;DRD3;Gene;PA451257;Chemical
OPIOIDS;DRD3;Gene;PA452618;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;rs16973225;Variant;PA164712462;Chemical
COLORECTAL NEOPLASMS;rs16973225;Variant;PA446108;Disease
ASPIRIN;rs16973225;Variant;PA448497;Chemical
CATECHOLAMINES;rs8187725;Variant;PA133822447;Chemical
METFORMIN;rs8187725;Variant;PA450395;Chemical
COMT;Nausea;Disease;PA117;Gene
SLC31A1;Nausea;Disease;PA118;Gene
CYP2C19;Nausea;Disease;PA124;Gene
CYP2D6;Nausea;Disease;PA128;Gene
SLCO1B1;Nausea;Disease;PA134865839;Gene
ANKK1;Nausea;Disease;PA134872551;Gene
ZNF568;Nausea;Disease;PA134893477;Gene
CLCC1;Nausea;Disease;PA142672105;Gene
ERCC1;Nausea;Disease;PA155;Gene
CYP2C19*17;Nausea;Disease;PA165816533;Haplotype
CYP2D6*1;Nausea;Disease;PA165816576;Haplotype
CYP2D6*3;Nausea;Disease;PA165816578;Haplotype
CYP2D6*4;Nausea;Disease;PA165816579;Haplotype
CYP2D6*6;Nausea;Disease;PA165816581;Haplotype
SLCO1B1*15;Nausea;Disease;PA165819265;Haplotype
CYP2D6*5;Nausea;Disease;PA165948092;Haplotype
CYP2C19*1;Nausea;Disease;PA165980634;Haplotype
CYP2D6*81;Nausea;Disease;PA166123321;Haplotype
RS324420;Nausea;Disease;PA166153569;Variant
RS2072671;Nausea;Disease;PA166153667;Variant
RS1695;Nausea;Disease;PA166154249;Variant
RS1079597;Nausea;Disease;PA166154315;Variant
RS1800497;Nausea;Disease;PA166154339;Variant
RS6311;Nausea;Disease;PA166154673;Variant
RS3212986;Nausea;Disease;PA166155407;Variant
RS4680;Nausea;Disease;PA166156024;Variant
RS1799971;Nausea;Disease;PA166156991;Variant
RS699517;Nausea;Disease;PA166163751;Variant
RS2279199;Nausea;Disease;PA166163760;Variant
RS10817464;Nausea;Disease;PA166179458;Variant
RS9397685;Nausea;Disease;PA166180172;Variant
RS36024412;Nausea;Disease;PA166206581;Variant
RS168107;Nausea;Disease;PA166206601;Variant
RS41269255;Nausea;Disease;PA166206602;Variant
RS9393888;Nausea;Disease;PA166206603;Variant
RS12305038;Nausea;Disease;PA166206604;Variant
RS11882256;Nausea;Disease;PA166206605;Variant
RS10405238;Nausea;Disease;PA166206621;Variant
HTR2A;Nausea;Disease;PA193;Gene
CRYBG2;Nausea;Disease;PA24650;Gene
DRD2;Nausea;Disease;PA27478;Gene
FAAH;Nausea;Disease;PA27955;Gene
GSTP1;Nausea;Disease;PA29028;Gene
MUC16;Nausea;Disease;PA31314;Gene
OPRM1;Nausea;Disease;PA31945;Gene
SLC22A1;Nausea;Disease;PA329;Gene
PDE3A;Nausea;Disease;PA33126;Gene
POM121L2;Nausea;Disease;PA33524;Gene
TYMS;Nausea;Disease;PA359;Gene
UMPS;Nausea;Disease;PA363;Gene
ZNF165;Nausea;Disease;PA37535;Gene
CDA;Nausea;Disease;PA98;Gene
ARAF;MAP2K1;Gene;PA24928;Gene
BRAF;MAP2K1;Gene;PA25408;Gene
MAPK8;MAP2K1;Gene;PA283;Gene
MAPK1;MAP2K1;Gene;PA30616;Gene
MAPK10;MAP2K1;Gene;PA30617;Gene
MAPK11;MAP2K1;Gene;PA30618;Gene
MAPK12;MAP2K1;Gene;PA30619;Gene
MAPK13;MAP2K1;Gene;PA30620;Gene
MAPK14;MAP2K1;Gene;PA30621;Gene
MAPK3;MAP2K1;Gene;PA30622;Gene
MAPK4;MAP2K1;Gene;PA30623;Gene
MAPK6;MAP2K1;Gene;PA30624;Gene
MAPK7;MAP2K1;Gene;PA30625;Gene
MAPK9;MAP2K1;Gene;PA30630;Gene
RAF1;MAP2K1;Gene;PA34183;Gene
PEGINTERFERON ALFA-2B;rs10741657;Variant;PA164784024;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;rs10741657;Variant;PA446863;Disease
RIBAVIRIN;rs10741657;Variant;PA451241;Chemical
NICOTINE;rs374515279;Variant;PA450626;Chemical
WNK4;KCNJ1;Gene;PA134875400;Gene
WNK1;KCNJ1;Gene;PA33782;Gene
DIABETES MELLITUS;KCNJ1;Gene;PA443886;Disease
HYPERTENSION;KCNJ1;Gene;PA444552;Disease
HYDROCHLOROTHIAZIDE;KCNJ1;Gene;PA449899;Chemical
TALAZOPARIB;CDK12;Gene;PA166182740;Chemical
PTGS1;antiinflammatory and antirheumatic products, non-steroids;Chemical;PA24346;Gene
PTGS2;antiinflammatory and antirheumatic products, non-steroids;Chemical;PA293;Gene
ACETALDEHYDE;rs4643;Variant;PA166186245;Chemical
ABCB1;grapefruit juice;Chemical;PA267;Gene
MAJOR DEPRESSIVE DISORDER;rs16873129;Variant;PA447321;Disease
ANTIDEPRESSANTS;rs16873129;Variant;PA452229;Chemical
NAGS;carglumic acid;Chemical;PA134968729;Gene
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;rs1057910;Variant;PA164712462;Chemical
ESSENTIAL HYPERTENSION;rs1057910;Variant;PA447288;Disease
CELECOXIB;rs1057910;Variant;PA448871;Chemical
DICLOFENAC;rs1057910;Variant;PA449293;Chemical
IRBESARTAN;rs1057910;Variant;PA450084;Chemical
LOSARTAN;rs1057910;Variant;PA450268;Chemical
PHENYTOIN;rs1057910;Variant;PA450947;Chemical
VALPROIC ACID;rs1057910;Variant;PA451846;Chemical
WARFARIN;rs1057910;Variant;PA451906;Chemical
BIPOLAR DISORDER;FAM177A1;Gene;PA447199;Disease
LITHIUM;FAM177A1;Gene;PA450243;Chemical
WARFARIN;rs2359612;Variant;PA451906;Chemical
SULFAMETHOXAZOLE / TRIMETHOPRIM;GSTM1 null;Haplotype;PA10715;Chemical
FLUOROURACIL;GSTM1 null;Haplotype;PA128406956;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;GSTM1 null;Haplotype;PA130620651;Chemical
OXALIPLATIN;GSTM1 null;Haplotype;PA131285527;Chemical
TAXANES;GSTM1 null;Haplotype;PA150481189;Chemical
OTOTOXICITY;GSTM1 null;Haplotype;PA162263534;Disease
DRUGS FOR TREATMENT OF TUBERCULOSIS;GSTM1 null;Haplotype;PA164712708;Chemical
PLATINUM COMPOUNDS;GSTM1 null;Haplotype;PA164713176;Chemical
ETHAMBUTOL;GSTM1 null;Haplotype;PA164784021;Chemical
TOXIC LIVER DISEASE;GSTM1 null;Haplotype;PA164925725;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;GSTM1 null;Haplotype;PA166120929;Disease
RADIOTHERAPY;GSTM1 null;Haplotype;PA166122986;Chemical
HEMATOPOIETIC STEM CELL TRANSPLANTATION;GSTM1 null;Haplotype;PA166123007;Disease
ACQUIRED IMMUNODEFICIENCY SYNDROME;GSTM1 null;Haplotype;PA443250;Disease
ASTHMA;GSTM1 null;Haplotype;PA443450;Disease
BREAST NEOPLASMS;GSTM1 null;Haplotype;PA443560;Disease
UTERINE CERVICAL NEOPLASMS;GSTM1 null;Haplotype;PA443685;Disease
COLITIS, ULCERATIVE;GSTM1 null;Haplotype;PA443750;Disease
CROHN DISEASE;GSTM1 null;Haplotype;PA443815;Disease
DEAFNESS;GSTM1 null;Haplotype;PA443840;Disease
DEATH;GSTM1 null;Haplotype;PA443842;Disease
DRUG TOXICITY;GSTM1 null;Haplotype;PA443937;Disease
EPIDERMAL NECROLYSIS, TOXIC;GSTM1 null;Haplotype;PA444059;Disease
HODGKIN DISEASE;GSTM1 null;Haplotype;PA444485;Disease
CARDIOMYOPATHIES;GSTM1 null;Haplotype;PA445018;Disease
NEOPLASMS;GSTM1 null;Haplotype;PA445062;Disease
NEUTROPENIA;GSTM1 null;Haplotype;PA445113;Disease
OVARIAN NEOPLASMS;GSTM1 null;Haplotype;PA445204;Disease
RECURRENCE;GSTM1 null;Haplotype;PA445506;Disease
STEVENS-JOHNSON SYNDROME;GSTM1 null;Haplotype;PA445738;Disease
TESTICULAR NEOPLASMS;GSTM1 null;Haplotype;PA445828;Disease
TUBERCULOSIS;GSTM1 null;Haplotype;PA445941;Disease
COLORECTAL NEOPLASMS;GSTM1 null;Haplotype;PA446108;Disease
INFLAMMATORY BOWEL DISEASES;GSTM1 null;Haplotype;PA446116;Disease
HIV INFECTIONS;GSTM1 null;Haplotype;PA447230;Disease
AZATHIOPRINE;GSTM1 null;Haplotype;PA448515;Chemical
BLEOMYCIN;GSTM1 null;Haplotype;PA448645;Chemical
CAPECITABINE;GSTM1 null;Haplotype;PA448771;Chemical
CISPLATIN;GSTM1 null;Haplotype;PA449014;Chemical
CLOZAPINE;GSTM1 null;Haplotype;PA449061;Chemical
CYCLOPHOSPHAMIDE;GSTM1 null;Haplotype;PA449165;Chemical
DACARBAZINE;GSTM1 null;Haplotype;PA449197;Chemical
DOXORUBICIN;GSTM1 null;Haplotype;PA449412;Chemical
ISONIAZID;GSTM1 null;Haplotype;PA450112;Chemical
NEVIRAPINE;GSTM1 null;Haplotype;PA450616;Chemical
PACLITAXEL;GSTM1 null;Haplotype;PA450761;Chemical
PYRAZINAMIDE;GSTM1 null;Haplotype;PA451182;Chemical
RIFAMPIN;GSTM1 null;Haplotype;PA451250;Chemical
STREPTOMYCIN;GSTM1 null;Haplotype;PA451512;Chemical
VINBLASTINE;GSTM1 null;Haplotype;PA451877;Chemical
CESSATION;CYP2A6*23;Haplotype;PA166123046;Disease
BREAST NEOPLASMS;CYP2A6*23;Haplotype;PA443560;Disease
TOBACCO USE DISORDER;CYP2A6*23;Haplotype;PA445876;Disease
LETROZOLE;CYP2A6*23;Haplotype;PA450196;Chemical
NICOTINE;CYP2A6*23;Haplotype;PA450626;Chemical
COTININE;rs6912029;Variant;PA166114414;Chemical
NICOTINE;rs6912029;Variant;PA450626;Chemical
BEVACIZUMAB;rs834576;Variant;PA130232992;Chemical
HYPERTENSION;rs834576;Variant;PA444552;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*15:12;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*15:12;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*15:12;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-B*15:12;Haplotype;PA450616;Chemical
SEVERE CUTANEOUS ADVERSE REACTIONS;rs3130931;Variant;PA166120929;Disease
EPIDERMAL NECROLYSIS, TOXIC;rs3130931;Variant;PA444059;Disease
STEVENS-JOHNSON SYNDROME;rs3130931;Variant;PA445738;Disease
ALLOPURINOL;rs3130931;Variant;PA448320;Chemical
GEMTUZUMAB OZOGAMICIN;SLC22A12;Gene;PA164749431;Chemical
LEUKEMIA, MYELOID, ACUTE;SLC22A12;Gene;PA444760;Disease
CYTARABINE;SLC22A12;Gene;PA449177;Chemical
FLUDARABINE;SLC22A12;Gene;PA449655;Chemical
IDARUBICIN;SLC22A12;Gene;PA449961;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;IFNG;Gene;PA164713366;Chemical
CROHN DISEASE;IFNG;Gene;PA443815;Disease
INFLAMMATORY BOWEL DISEASES;IFNG;Gene;PA446116;Disease
MULTIPLE SCLEROSIS;rs760316;Variant;PA444987;Disease
INTERFERON BETA-1A;rs760316;Variant;PA450037;Chemical
INTERFERON BETA-1B;rs760316;Variant;PA450039;Chemical
ALCOHOL ABUSE;rs578776;Variant;PA443309;Disease
TOBACCO USE DISORDER;rs578776;Variant;PA445876;Disease
ETHANOL;rs578776;Variant;PA448073;Chemical
NICOTINE;rs578776;Variant;PA450626;Chemical
FGB;abciximab;Chemical;PA163;Gene
ITGB3;abciximab;Chemical;PA205;Gene
ITGA2B;abciximab;Chemical;PA29938;Gene
FGA;abciximab;Chemical;PA429;Gene
FGG;abciximab;Chemical;PA430;Gene
ASTHMA;rs1126510;Variant;PA443450;Disease
ASPIRIN;rs1126510;Variant;PA448497;Chemical
RB1;Retinoblastoma;Disease;PA295;Gene
CYP2D6;fluphenazine;Chemical;PA128;Gene
ABCB1;fluphenazine;Chemical;PA267;Gene
EFAVIRENZ;rs373442191;Variant;PA449441;Chemical
PROPOFOL;rs373442191;Variant;PA451141;Chemical
ABCC2;Tuberculosis;Disease;PA116;Gene
CYP2B6;Tuberculosis;Disease;PA123;Gene
CYP2C19;Tuberculosis;Disease;PA124;Gene
CYP2C9;Tuberculosis;Disease;PA126;Gene
CYP2E1;Tuberculosis;Disease;PA129;Gene
SLCO1B1;Tuberculosis;Disease;PA134865839;Gene
AGBL4;Tuberculosis;Disease;PA142672636;Gene
CUX2;Tuberculosis;Disease;PA162382977;Gene
RIPOR2;Tuberculosis;Disease;PA162387677;Gene
NOS2;Tuberculosis;Disease;PA164724093;Gene
CYP2C9*1;Tuberculosis;Disease;PA165816542;Haplotype
CYP2C9*2;Tuberculosis;Disease;PA165816543;Haplotype
CYP2C9*3;Tuberculosis;Disease;PA165816544;Haplotype
CYP2C9*11;Tuberculosis;Disease;PA165816552;Haplotype
CYP2B6*1;Tuberculosis;Disease;PA165818750;Haplotype
CYP2B6*6;Tuberculosis;Disease;PA165818762;Haplotype
CYP2B6*11;Tuberculosis;Disease;PA165818770;Haplotype
CYP2E1*1A;Tuberculosis;Disease;PA165948032;Haplotype
CYP2E1*5B;Tuberculosis;Disease;PA165948040;Haplotype
NAT2*4;Tuberculosis;Disease;PA165949098;Haplotype
NAT2*5A;Tuberculosis;Disease;PA165949099;Haplotype
NAT2*6J;Tuberculosis;Disease;PA165949124;Haplotype
NAT2*6O;Tuberculosis;Disease;PA165949129;Haplotype
NAT2*12A;Tuberculosis;Disease;PA165949138;Haplotype
HLA-DQA1*01:02;Tuberculosis;Disease;PA165951275;Haplotype
HLA-B*52:01;Tuberculosis;Disease;PA165956366;Haplotype
HLA-C*04:01;Tuberculosis;Disease;PA165957046;Haplotype
HLA-DQB1*05:01;Tuberculosis;Disease;PA165958073;Haplotype
HLA-DQB1*05:02;Tuberculosis;Disease;PA165958077;Haplotype
HLA-DQB1*05:03;Tuberculosis;Disease;PA165958080;Haplotype
HLA-DQB1*02:01;Tuberculosis;Disease;PA165958158;Haplotype
NAT2*5;Tuberculosis;Disease;PA165981634;Haplotype
NAT2*6;Tuberculosis;Disease;PA165981635;Haplotype
NAT2*7;Tuberculosis;Disease;PA165981636;Haplotype
NAT2*14;Tuberculosis;Disease;PA165981640;Haplotype
GSTM1 NULL;Tuberculosis;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Tuberculosis;Disease;PA166048676;Haplotype
GSTT1 NULL;Tuberculosis;Disease;PA166048678;Haplotype
GSTT1 NON-NULL;Tuberculosis;Disease;PA166048679;Haplotype
NAT2*7G;Tuberculosis;Disease;PA166115839;Haplotype
UGT1A1*1;Tuberculosis;Disease;PA166115841;Haplotype
UGT1A1*28;Tuberculosis;Disease;PA166115842;Haplotype
UGT1A1*36;Tuberculosis;Disease;PA166115843;Haplotype
UGT1A1*37;Tuberculosis;Disease;PA166115844;Haplotype
RS2031920;Tuberculosis;Disease;PA166153990;Variant
RS3740065;Tuberculosis;Disease;PA166154027;Variant
RS4986893;Tuberculosis;Disease;PA166154070;Variant
RS9332096;Tuberculosis;Disease;PA166154097;Variant
RS1695;Tuberculosis;Disease;PA166154249;Variant
RS4149032;Tuberculosis;Disease;PA166154575;Variant
RS11080344;Tuberculosis;Disease;PA166155245;Variant
RS2279345;Tuberculosis;Disease;PA166155395;Variant
RS3745274;Tuberculosis;Disease;PA166155409;Variant
RS1800629;Tuberculosis;Disease;PA166156997;Variant
RS1045642;Tuberculosis;Disease;PA166157284;Variant
RS1041983;Tuberculosis;Disease;PA166157549;Variant
RS1495741;Tuberculosis;Disease;PA166157560;Variant
RS1799929;Tuberculosis;Disease;PA166157563;Variant
RS4646244;Tuberculosis;Disease;PA166157603;Variant
NAT2 SLOW ACETYLATOR;Tuberculosis;Disease;PA166157948;Variant
RS319952;Tuberculosis;Disease;PA166160678;Variant
RS10946737;Tuberculosis;Disease;PA166160680;Variant
RS10946739;Tuberculosis;Disease;PA166160685;Variant
RS393994;Tuberculosis;Disease;PA166160687;Variant
RS320003;Tuberculosis;Disease;PA166160689;Variant
RS7958375;Tuberculosis;Disease;PA166160694;Variant
RS4430924;Tuberculosis;Disease;PA166186121;Variant
NAT2;Tuberculosis;Disease;PA18;Gene
GSTM1;Tuberculosis;Disease;PA182;Gene
GSTT1;Tuberculosis;Disease;PA183;Gene
ABCB1;Tuberculosis;Disease;PA267;Gene
GSTP1;Tuberculosis;Disease;PA29028;Gene
HLA-B;Tuberculosis;Disease;PA35056;Gene
HLA-C;Tuberculosis;Disease;PA35057;Gene
HLA-DQA1;Tuberculosis;Disease;PA35066;Gene
HLA-DQB1;Tuberculosis;Disease;PA35068;Gene
VDR;Tuberculosis;Disease;PA37301;Gene
XPO1;Tuberculosis;Disease;PA37418;Gene
UGT1A1;Tuberculosis;Disease;PA420;Gene
TNF;Tuberculosis;Disease;PA435;Gene
MAJOR DEPRESSIVE DISORDER;rs2742421;Variant;PA447321;Disease
BUPROPION;rs2742421;Variant;PA448687;Chemical
SULFONAMIDES, UREA DERIVATIVES;rs7903146;Variant;PA10390;Chemical
KIDNEY TRANSPLANTATION;rs7903146;Variant;PA165817016;Disease
LIVER TRANSPLANTATION;rs7903146;Variant;PA447247;Disease
CYCLOSPORINE;rs7903146;Variant;PA449167;Chemical
SIROLIMUS;rs7903146;Variant;PA451365;Chemical
TACROLIMUS;rs7903146;Variant;PA451578;Chemical
CYP2D6;atenolol;Chemical;PA128;Gene
PLEKHH2;atenolol;Chemical;PA134912826;Gene
LRRC15;atenolol;Chemical;PA134956867;Gene
STN1;atenolol;Chemical;PA134987118;Gene
ACE;atenolol;Chemical;PA139;Gene
ZMAT4;atenolol;Chemical;PA142670525;Gene
SLC25A31;atenolol;Chemical;PA142670904;Gene
DPYS;atenolol;Chemical;PA146;Gene
FTO;atenolol;Chemical;PA152208656;Gene
RRP1B;atenolol;Chemical;PA162402138;Gene
XIRP2;atenolol;Chemical;PA162409337;Gene
RS699;atenolol;Chemical;PA166153539;Variant
RS5051;atenolol;Chemical;PA166153547;Variant
RS340874;atenolol;Chemical;PA166153570;Variant
RS2144297;atenolol;Chemical;PA166153673;Variant
RS2144300;atenolol;Chemical;PA166153674;Variant
RS4648287;atenolol;Chemical;PA166153771;Variant
RS10157410;atenolol;Chemical;PA166153799;Variant
RS1800545;atenolol;Chemical;PA166153975;Variant
RS1801253;atenolol;Chemical;PA166153977;Variant
RS11039149;atenolol;Chemical;PA166154448;Variant
RS5443;atenolol;Chemical;PA166154486;Variant
RS1051375;atenolol;Chemical;PA166154509;Variant
RS2301339;atenolol;Chemical;PA166154545;Variant
RS11064426;atenolol;Chemical;PA166154636;Variant
RS9940629;atenolol;Chemical;PA166155099;Variant
RS11649514;atenolol;Chemical;PA166155107;Variant
RS12595985;atenolol;Chemical;PA166155112;Variant
RS1799752;atenolol;Chemical;PA166155187;Variant
RS688;atenolol;Chemical;PA166155337;Variant
RS11313667;atenolol;Chemical;PA166156442;Variant
RS1024323;atenolol;Chemical;PA166156499;Variant
RS201279313;atenolol;Chemical;PA166156703;Variant
RS1042713;atenolol;Chemical;PA166156748;Variant
RS1042714;atenolol;Chemical;PA166156749;Variant
RS5370;atenolol;Chemical;PA166156901;Variant
RS3213619;atenolol;Chemical;PA166157373;Variant
RS10267099;atenolol;Chemical;PA166157442;Variant
RS1367094;atenolol;Chemical;PA166157555;Variant
RS2669429;atenolol;Chemical;PA166157579;Variant
RS1104514;atenolol;Chemical;PA166157719;Variant
RS10739150;atenolol;Chemical;PA166157809;Variant
RS12346562;atenolol;Chemical;PA166157835;Variant
RS11124945;atenolol;Chemical;PA166161873;Variant
RS261316;atenolol;Chemical;PA166179574;Variant
RS35123024;atenolol;Chemical;PA166179575;Variant
APPLE JUICE;atenolol;Chemical;PA166183406;Chemical
RS7184292;atenolol;Chemical;PA166185404;Variant
RS7606603;atenolol;Chemical;PA166185405;Variant
RS16872401;atenolol;Chemical;PA166185406;Variant
RS294610;atenolol;Chemical;PA166196761;Variant
RS45545233;atenolol;Chemical;PA166196763;Variant
RS4387287;atenolol;Chemical;PA166199004;Variant
RS8068318;atenolol;Chemical;PA166199006;Variant
RS9306160;atenolol;Chemical;PA166199042;Variant
GNB3;atenolol;Chemical;PA176;Gene
GRK5;atenolol;Chemical;PA180;Gene
LDLR;atenolol;Chemical;PA227;Gene
ALDH1A2;atenolol;Chemical;PA24693;Gene
ABCB1;atenolol;Chemical;PA267;Gene
PLA2G4A;atenolol;Chemical;PA271;Gene
EDN1;atenolol;Chemical;PA27614;Gene
GALNT2;atenolol;Chemical;PA28537;Gene
GRK4;atenolol;Chemical;PA28941;Gene
PTGS2;atenolol;Chemical;PA293;Gene
NR1H3;atenolol;Chemical;PA31751;Gene
PRKCB;atenolol;Chemical;PA33761;Gene
PROX1;atenolol;Chemical;PA33812;Gene
ADRA2A;atenolol;Chemical;PA35;Gene
SLC4A1;atenolol;Chemical;PA35895;Gene
TBX2;atenolol;Chemical;PA36360;Gene
ADRA2C;atenolol;Chemical;PA37;Gene
ADRB1;atenolol;Chemical;PA38;Gene
ADRB2;atenolol;Chemical;PA39;Gene
AGT;atenolol;Chemical;PA42;Gene
CACNA1C;atenolol;Chemical;PA83;Gene
ESSENTIAL HYPERTENSION;rs7706429;Variant;PA447288;Disease
HYDROCHLOROTHIAZIDE;rs7706429;Variant;PA449899;Chemical
CHOLIC ACID;AKR1D1;Gene;PA166160055;Chemical
PLATINUM;rs17655;Variant;PA150595617;Chemical
OVARIAN NEOPLASMS;rs17655;Variant;PA445204;Disease
NTRK1;larotrectinib;Chemical;PA31817;Gene
NTRK2;larotrectinib;Chemical;PA31818;Gene
NTRK3;larotrectinib;Chemical;PA31819;Gene
MAJOR DEPRESSIVE DISORDER;rs1799889;Variant;PA447321;Disease
CITALOPRAM;rs1799889;Variant;PA449015;Chemical
FLUOXETINE;rs1799889;Variant;PA449673;Chemical
ANTIDEPRESSANTS;rs1799889;Variant;PA452229;Chemical
VANDETANIB;CYP3A4*30;Haplotype;PA166118341;Chemical
OXYCODONE;CYP3A4*30;Haplotype;PA450741;Chemical
WARFARIN;rs9332131;Variant;PA451906;Chemical
NEPHROTOXICITY;SLC28A2;Gene;PA162263533;Disease
PEGINTERFERON ALFA-2B;SLC28A2;Gene;PA164784024;Chemical
BOCEPREVIR;SLC28A2;Gene;PA165948902;Chemical
TENOFOVIR DISOPROXIL FUMARATE;SLC28A2;Gene;PA166201941;Chemical
NON-SMALL CELL LUNG CARCINOMA;SLC28A2;Gene;PA443622;Disease
HEPATITIS C VIRUS INFECTION;SLC28A2;Gene;PA444445;Disease
NEOPLASMS;SLC28A2;Gene;PA445062;Disease
HIV INFECTIOUS DISEASE;SLC28A2;Gene;PA447230;Disease
GEMCITABINE;SLC28A2;Gene;PA449748;Chemical
PROTEASE INHIBITORS;SLC28A2;Gene;PA451159;Chemical
RIBAVIRIN;SLC28A2;Gene;PA451241;Chemical
DACARBAZINE;CYP1A1*1;Haplotype;PA449197;Chemical
GRANISETRON;CYP1A1*1;Haplotype;PA449809;Chemical
DABIGATRAN;rs8192935;Variant;PA165110351;Chemical
ATRIAL FIBRILLATION;rs8192935;Variant;PA443459;Disease
SULFAMETHOXAZOLE / TRIMETHOPRIM;HLA-B*38:02;Haplotype;PA10715;Chemical
MACULOPAPULAR EXANTHEMA;HLA-B*38:02;Haplotype;PA162316739;Disease
ANTITHYROID PREPARATIONS;HLA-B*38:02;Haplotype;PA164712499;Chemical
CARBIMAZOLE;HLA-B*38:02;Haplotype;PA164742970;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*38:02;Haplotype;PA166120927;Disease
AGRANULOCYTOSIS;HLA-B*38:02;Haplotype;PA443297;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*38:02;Haplotype;PA444059;Disease
GRAVES DISEASE;HLA-B*38:02;Haplotype;PA444329;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*38:02;Haplotype;PA445738;Disease
METHIMAZOLE;HLA-B*38:02;Haplotype;PA450422;Chemical
NEVIRAPINE;HLA-B*38:02;Haplotype;PA450616;Chemical
OXCARBAZEPINE;HLA-B*38:02;Haplotype;PA450732;Chemical
PHENYTOIN;HLA-B*38:02;Haplotype;PA450947;Chemical
PROPYLTHIOURACIL;HLA-B*38:02;Haplotype;PA451156;Chemical
BISPHOSPHONATES;rs2736308;Variant;PA164712563;Chemical
OSTEONECROSIS OF THE JAW;rs2736308;Variant;PA166256642;Disease
COMT;galcanezumab;Chemical;PA117;Gene
RS4680;galcanezumab;Chemical;PA166156024;Variant
RS12615320;galcanezumab;Chemical;PA166349381;Variant
FLUOROURACIL;TWIST1;Gene;PA128406956;Chemical
DPYD;rs114096998;Variant;PA145;Gene
CAPECITABINE;rs114096998;Variant;PA448771;Chemical
CYP2E1;isoflurane;Chemical;PA129;Gene
RS1800559;isoflurane;Chemical;PA166153638;Variant
RS772226819;isoflurane;Chemical;PA166153940;Variant
RS1801086;isoflurane;Chemical;PA166155375;Variant
RS28933396;isoflurane;Chemical;PA166155481;Variant
RS28933397;isoflurane;Chemical;PA166155482;Variant
RS63749869;isoflurane;Chemical;PA166155516;Variant
RS111888148;isoflurane;Chemical;PA166155524;Variant
RS112563513;isoflurane;Chemical;PA166155526;Variant
RS118192116;isoflurane;Chemical;PA166155528;Variant
RS118192122;isoflurane;Chemical;PA166155529;Variant
RS118192124;isoflurane;Chemical;PA166155531;Variant
RS118192161;isoflurane;Chemical;PA166155532;Variant
RS118192162;isoflurane;Chemical;PA166155533;Variant
RS118192163;isoflurane;Chemical;PA166155534;Variant
RS118192167;isoflurane;Chemical;PA166155535;Variant
RS118192170;isoflurane;Chemical;PA166155536;Variant
RS118192172;isoflurane;Chemical;PA166155537;Variant
RS118192175;isoflurane;Chemical;PA166155538;Variant
RS118192176;isoflurane;Chemical;PA166155539;Variant
RS118192177;isoflurane;Chemical;PA166155540;Variant
RS118192178;isoflurane;Chemical;PA166155541;Variant
RS121918592;isoflurane;Chemical;PA166155543;Variant
RS121918593;isoflurane;Chemical;PA166155544;Variant
RS121918594;isoflurane;Chemical;PA166155545;Variant
RS121918595;isoflurane;Chemical;PA166155546;Variant
RS193922747;isoflurane;Chemical;PA166155564;Variant
RS193922753;isoflurane;Chemical;PA166155565;Variant
RS193922770;isoflurane;Chemical;PA166155567;Variant
RS193922772;isoflurane;Chemical;PA166155568;Variant
RS193922802;isoflurane;Chemical;PA166155569;Variant
RS193922803;isoflurane;Chemical;PA166155570;Variant
RS193922807;isoflurane;Chemical;PA166155571;Variant
RS193922809;isoflurane;Chemical;PA166155572;Variant
RS193922816;isoflurane;Chemical;PA166155573;Variant
RS193922818;isoflurane;Chemical;PA166155574;Variant
RS193922876;isoflurane;Chemical;PA166155575;Variant
RS193922878;isoflurane;Chemical;PA166155576;Variant
RS193922843;isoflurane;Chemical;PA166163663;Variant
RS193922832;isoflurane;Chemical;PA166163667;Variant
RS118192168;isoflurane;Chemical;PA166163669;Variant
RS193922764;isoflurane;Chemical;PA166176176;Variant
RS121918596;isoflurane;Chemical;PA166177994;Variant
RS193922748;isoflurane;Chemical;PA166180322;Variant
RS193922762;isoflurane;Chemical;PA166180323;Variant
RS193922768;isoflurane;Chemical;PA166180324;Variant
RS144336148;isoflurane;Chemical;PA166180325;Variant
MC1R;isoflurane;Chemical;PA30673;Gene
RYR1;isoflurane;Chemical;PA34896;Gene
CACNA1S;isoflurane;Chemical;PA85;Gene
DEFERASIROX;rs2606345;Variant;PA164760843;Chemical
EPILEPSY;rs2606345;Variant;PA444065;Disease
BETA-THALASSEMIA AND RELATED DISEASES;rs2606345;Variant;PA446432;Disease
CARBAMAZEPINE;rs2606345;Variant;PA448785;Chemical
PHENOBARBITAL;rs2606345;Variant;PA450911;Chemical
PHENYTOIN;rs2606345;Variant;PA450947;Chemical
VALPROIC ACID;rs2606345;Variant;PA451846;Chemical
IRBESARTAN;rs72558187;Variant;PA450084;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;rs231775;Variant;PA164712462;Chemical
KIDNEY TRANSPLANTATION;rs231775;Variant;PA165817016;Disease
CYCLOSPORINE;rs231775;Variant;PA449167;Chemical
HYPERTENSION;VCL;Gene;PA444552;Disease
CELECOXIB;CACNB4;Gene;PA448871;Chemical
FLUOROURACIL;DLG5;Gene;PA128406956;Chemical
METASTATIC NEOPLASM;DLG5;Gene;PA445058;Disease
CAPECITABINE;DLG5;Gene;PA448771;Chemical
CYP2C19;Alcohol-Related Disorders;Disease;PA124;Gene
CYP2D6;Alcohol-Related Disorders;Disease;PA128;Gene
CYP2C19*17;Alcohol-Related Disorders;Disease;PA165816533;Haplotype
CYP2D6*1;Alcohol-Related Disorders;Disease;PA165816576;Haplotype
CYP2D6*3;Alcohol-Related Disorders;Disease;PA165816578;Haplotype
CYP2D6*4;Alcohol-Related Disorders;Disease;PA165816579;Haplotype
CYP2D6*6;Alcohol-Related Disorders;Disease;PA165816581;Haplotype
CYP2D6*5;Alcohol-Related Disorders;Disease;PA165948092;Haplotype
CYP2C19*1;Alcohol-Related Disorders;Disease;PA165980634;Haplotype
CYP2D6*81;Alcohol-Related Disorders;Disease;PA166123321;Haplotype
RS2832407;Alcohol-Related Disorders;Disease;PA166156001;Variant
GRIK1;Alcohol-Related Disorders;Disease;PA28973;Gene
CYP2B6;mephenytoin;Chemical;PA123;Gene
CYP2C19;mephenytoin;Chemical;PA124;Gene
CYP3A4;mephenytoin;Chemical;PA130;Gene
CYP2C19*6;mephenytoin;Chemical;PA165816522;Haplotype
CYP2C19*7;mephenytoin;Chemical;PA165816523;Haplotype
CYP2C19*8;mephenytoin;Chemical;PA165816524;Haplotype
CYP2C19*9;mephenytoin;Chemical;PA165816525;Haplotype
CYP2C19*10;mephenytoin;Chemical;PA165816526;Haplotype
CYP2C19*11;mephenytoin;Chemical;PA165816527;Haplotype
CYP2C19*13;mephenytoin;Chemical;PA165816529;Haplotype
CYP2C19*14;mephenytoin;Chemical;PA165816530;Haplotype
CYP2C19*15;mephenytoin;Chemical;PA165816531;Haplotype
CYP2C19*16;mephenytoin;Chemical;PA165816532;Haplotype
CYP2C19*18;mephenytoin;Chemical;PA165816534;Haplotype
CYP2C19*19;mephenytoin;Chemical;PA165816535;Haplotype
CYP2C19*22;mephenytoin;Chemical;PA165816536;Haplotype
CYP2C19*23;mephenytoin;Chemical;PA165816537;Haplotype
CYP2C19*24;mephenytoin;Chemical;PA165816538;Haplotype
CYP2C19*25;mephenytoin;Chemical;PA165816539;Haplotype
CYP2C19*26;mephenytoin;Chemical;PA165816540;Haplotype
CYP2C19*1;mephenytoin;Chemical;PA165980634;Haplotype
CYP2C19*2;mephenytoin;Chemical;PA165980635;Haplotype
CYP2C19*3;mephenytoin;Chemical;PA165980636;Haplotype
CYP2C19*5;mephenytoin;Chemical;PA165980638;Haplotype
CYP2C19*29;mephenytoin;Chemical;PA166123292;Haplotype
CYP2C19*30;mephenytoin;Chemical;PA166123293;Haplotype
CYP2C19*31;mephenytoin;Chemical;PA166123294;Haplotype
CYP2C19*32;mephenytoin;Chemical;PA166123295;Haplotype
CYP2C19*33;mephenytoin;Chemical;PA166123296;Haplotype
RS11188072;mephenytoin;Chemical;PA166154127;Variant
RS12248560;mephenytoin;Chemical;PA166154147;Variant
RS28399504;mephenytoin;Chemical;PA166154177;Variant
RS41291556;mephenytoin;Chemical;PA166154179;Variant
RS145119820;mephenytoin;Chemical;PA166154217;Variant
RS144928727;mephenytoin;Chemical;PA166186018;Variant
RS61311738;mephenytoin;Chemical;PA166186019;Variant
RS183701923;mephenytoin;Chemical;PA166186020;Variant
RS1187513719;mephenytoin;Chemical;PA166186021;Variant
CYSLTR1;pranlukast;Chemical;PA38453;Gene
COUMARIN;CYP2A6*18;Haplotype;PA134521193;Chemical
NEOPLASMS;CYP2A6*18;Haplotype;PA445062;Disease
TEGAFUR;CYP2A6*18;Haplotype;PA452620;Chemical
RS5443;hydralazine / isosorbide dinitrate;Chemical;PA166154486;Variant
GNB3;hydralazine / isosorbide dinitrate;Chemical;PA176;Gene
NAT2;hydralazine / isosorbide dinitrate;Chemical;PA18;Gene
CYP3A4;triazolam;Chemical;PA130;Gene
CYP3A5;triazolam;Chemical;PA131;Gene
DICLOFENAC;CYP2C9*73;Haplotype;PA449293;Chemical
LOSARTAN;CYP2C9*73;Haplotype;PA450268;Chemical
ANTIEMETICS AND ANTINAUSEANTS;rs55918055;Variant;PA164712431;Chemical
PROGUANIL;rs55918055;Variant;PA451124;Chemical
RANITIDINE;rs55918055;Variant;PA451224;Chemical
SCHIZOPHRENIA;SV2C;Gene;PA447216;Disease
OLANZAPINE;SV2C;Gene;PA450688;Chemical
DEPRESSION;CREB1;Gene;PA447278;Disease
MAJOR DEPRESSIVE DISORDER;CREB1;Gene;PA447321;Disease
CITALOPRAM;CREB1;Gene;PA449015;Chemical
LITHIUM;CREB1;Gene;PA450243;Chemical
ANTIDEPRESSANTS;CREB1;Gene;PA452229;Chemical
DMD;viltolarsen;Chemical;PA27378;Gene
CYP2A6;tegafur / gimeracil / oteracil;Chemical;PA121;Gene
DPYD;tegafur / gimeracil / oteracil;Chemical;PA145;Gene
CYP2A6*1;tegafur / gimeracil / oteracil;Chemical;PA165924690;Haplotype
CYP2A6*4;tegafur / gimeracil / oteracil;Chemical;PA165924721;Haplotype
CYP2A6*7;tegafur / gimeracil / oteracil;Chemical;PA165924731;Haplotype
CYP2A6*10;tegafur / gimeracil / oteracil;Chemical;PA165924735;Haplotype
CYP2A6*9;tegafur / gimeracil / oteracil;Chemical;PA165980914;Haplotype
UGT1A1*28;tegafur / gimeracil / oteracil;Chemical;PA166115842;Haplotype
UGT1A1*60;tegafur / gimeracil / oteracil;Chemical;PA166115845;Haplotype
UGT1A6*2A;tegafur / gimeracil / oteracil;Chemical;PA166117621;Haplotype
UGT1A7*3;tegafur / gimeracil / oteracil;Chemical;PA166117639;Haplotype
DPYD C.1905+1G>A (*2A);tegafur / gimeracil / oteracil;Chemical;PA166171117;Haplotype
DPYD C.1679T>G (*13);tegafur / gimeracil / oteracil;Chemical;PA166171118;Haplotype
DPYD C.2846A>T;tegafur / gimeracil / oteracil;Chemical;PA166171119;Haplotype
DPYD C.1129-5923C>G, C.1236G>A (HAPB3);tegafur / gimeracil / oteracil;Chemical;PA166171120;Haplotype
UGT1A6;tegafur / gimeracil / oteracil;Chemical;PA37181;Gene
UGT1A7;tegafur / gimeracil / oteracil;Chemical;PA37182;Gene
UGT1A1;tegafur / gimeracil / oteracil;Chemical;PA420;Gene
SLCO1B1;amlodipine / atorvastatin / perindopril arginine;Chemical;PA134865839;Gene
RS4149056;amlodipine / atorvastatin / perindopril arginine;Chemical;PA166154579;Variant
G6PD;amlodipine / atorvastatin / perindopril arginine;Chemical;PA28469;Gene
CYP1A2;CYP1A2*6;Haplotype;PA27093;Gene
CLOZAPINE;CYP1A2*6;Haplotype;PA449061;Chemical
DACARBAZINE;CYP1A2*6;Haplotype;PA449197;Chemical
FLUOROURACIL;rs558354142;Variant;PA128406956;Chemical
DRUG TOXICITY;rs558354142;Variant;PA443937;Disease
ANTIHYPERTENSIVES;rs13144136;Variant;PA164712445;Chemical
HYPERTENSION;rs13144136;Variant;PA444552;Disease
CORONARY ARTERY DISEASE;rs1024323;Variant;PA443796;Disease
HYPERTENSION;rs1024323;Variant;PA444552;Disease
KIDNEY DISORDER;rs1024323;Variant;PA444682;Disease
NEPHROSCLEROSIS;rs1024323;Variant;PA445086;Disease
ATENOLOL;rs1024323;Variant;PA448499;Chemical
METOPROLOL;rs1024323;Variant;PA450480;Chemical
VERAPAMIL;rs1024323;Variant;PA451868;Chemical
WARFARIN;rs3212198;Variant;PA451906;Chemical
TOCILIZUMAB;GALNT18;Gene;PA165292659;Chemical
RHEUMATOID ARTHRITIS;GALNT18;Gene;PA443434;Disease
URINARY BLADDER NEOPLASMS;GALNT18;Gene;PA443512;Disease
CISPLATIN;GALNT18;Gene;PA449014;Chemical
LEUKEMIA, MYELOID, ACUTE;rs1130609;Variant;PA444760;Disease
CLADRIBINE;rs1130609;Variant;PA449027;Chemical
CYTARABINE;rs1130609;Variant;PA449177;Chemical
CORTICOSTEROIDS;rs138337;Variant;PA10832;Chemical
ASTHMA;rs138337;Variant;PA443450;Disease
ACE INHIBITORS, PLAIN;rs4459610;Variant;PA164712308;Chemical
COUGH;rs4459610;Variant;PA443803;Disease
ASTHMA;rs37973;Variant;PA443450;Disease
BUDESONIDE;rs37973;Variant;PA448681;Chemical
FLUNISOLIDE;rs37973;Variant;PA449661;Chemical
FLUTICASONE PROPIONATE;rs37973;Variant;PA449686;Chemical
NEDOCROMIL;rs37973;Variant;PA450601;Chemical
TRIAMCINOLONE;rs37973;Variant;PA451749;Chemical
GLUCOCORTICOIDS;rs37973;Variant;PA452347;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;HTT;Gene;PA447197;Disease
SCHIZOPHRENIA;HTT;Gene;PA447216;Disease
METHYLPHENIDATE;HTT;Gene;PA450464;Chemical
RISPERIDONE;HTT;Gene;PA451257;Chemical
FLUOROURACIL;INSR;Gene;PA128406956;Chemical
BREAST NEOPLASMS;INSR;Gene;PA443560;Disease
NEUTROPENIA;INSR;Gene;PA445113;Disease
CYCLOPHOSPHAMIDE;INSR;Gene;PA449165;Chemical
EPIRUBICIN;INSR;Gene;PA449476;Chemical
TOPIRAMATE;INSR;Gene;PA451728;Chemical
FLUOROURACIL;rs78060119;Variant;PA128406956;Chemical
DPYD;rs78060119;Variant;PA145;Gene
NEOPLASMS;rs78060119;Variant;PA445062;Disease
CAPECITABINE;rs78060119;Variant;PA448771;Chemical
TEGAFUR;rs78060119;Variant;PA452620;Chemical
ASTHMA;UGT1A3*1;Haplotype;PA443450;Disease
ATORVASTATIN;UGT1A3*1;Haplotype;PA448500;Chemical
MONTELUKAST;UGT1A3*1;Haplotype;PA450546;Chemical
TELMISARTAN;UGT1A3*1;Haplotype;PA451605;Chemical
FLUOROURACIL;rs72549309;Variant;PA128406956;Chemical
DPYD;rs72549309;Variant;PA145;Gene
PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS;rs72549309;Variant;PA445476;Disease
CAPECITABINE;rs72549309;Variant;PA448771;Chemical
TEGAFUR;rs72549309;Variant;PA452620;Chemical
AGITATION;CYP2D6*81;Haplotype;PA166123306;Disease
CARDIOTOXICITY;CYP2D6*81;Haplotype;PA166128121;Disease
DYSPHORIA;CYP2D6*81;Haplotype;PA166185295;Disease
DRUG TOXICITY;CYP2D6*81;Haplotype;PA443937;Disease
EDEMA;CYP2D6*81;Haplotype;PA443994;Disease
NAUSEA;CYP2D6*81;Haplotype;PA445048;Disease
TACHYCARDIA;CYP2D6*81;Haplotype;PA445802;Disease
VOMITING;CYP2D6*81;Haplotype;PA446051;Disease
ALCOHOL-RELATED DISORDERS;CYP2D6*81;Haplotype;PA446879;Disease
DEPRESSIVE DISORDER;CYP2D6*81;Haplotype;PA447207;Disease
OBSESSIVE-COMPULSIVE DISORDER;CYP2D6*81;Haplotype;PA447211;Disease
DEPRESSION;CYP2D6*81;Haplotype;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2D6*81;Haplotype;PA447321;Disease
NORTRIPTYLINE;CYP2D6*81;Haplotype;PA450657;Chemical
VENLAFAXINE;CYP2D6*81;Haplotype;PA451866;Chemical
RS2305089;flunisolide;Chemical;PA166157033;Variant
RS37973;flunisolide;Chemical;PA166157244;Variant
TBXT;flunisolide;Chemical;PA36296;Gene
GLCCI1;flunisolide;Chemical;PA38657;Gene
GASTROESOPHAGEAL REFLUX;CYP2C19*26;Haplotype;PA444255;Disease
CLOPIDOGREL;CYP2C19*26;Haplotype;PA449053;Chemical
MEPHENYTOIN;CYP2C19*26;Haplotype;PA450373;Chemical
OMEPRAZOLE;CYP2C19*26;Haplotype;PA450704;Chemical
IMATINIB;CYP3A4*20;Haplotype;PA10804;Chemical
CYP2C19;CYP3A4*20;Haplotype;PA124;Gene
CYP3A4;CYP3A4*20;Haplotype;PA130;Gene
ORGAN TRANSPLANTATION;CYP3A4*20;Haplotype;PA133888799;Disease
KIDNEY TRANSPLANTATION;CYP3A4*20;Haplotype;PA165817016;Disease
SAXAGLIPTIN;CYP3A4*20;Haplotype;PA165958362;Chemical
FESOTERODINE;CYP3A4*20;Haplotype;PA165958376;Chemical
LUNG TRANSPLANTATION;CYP3A4*20;Haplotype;PA166114457;Disease
REGORAFENIB;CYP3A4*20;Haplotype;PA166114943;Chemical
VANDETANIB;CYP3A4*20;Haplotype;PA166118341;Chemical
TREATMENT MODIFICATION;CYP3A4*20;Haplotype;PA166124372;Disease
ALECTINIB;CYP3A4*20;Haplotype;PA166160050;Chemical
BREXPIPRAZOLE;CYP3A4*20;Haplotype;PA166160053;Chemical
LAPAROSCOPIC SLEEVE GASTRECTOMY;CYP3A4*20;Haplotype;PA166169562;Disease
MACITENTAN;CYP3A4*20;Haplotype;PA166261201;Chemical
MAVACAMTEN;CYP3A4*20;Haplotype;PA166272922;Chemical
BLONANSERIN;CYP3A4*20;Haplotype;PA166319041;Chemical
BREAST NEOPLASMS;CYP3A4*20;Haplotype;PA443560;Disease
OVARIAN NEOPLASMS;CYP3A4*20;Haplotype;PA445204;Disease
PERIPHERAL NERVOUS SYSTEM DISEASES;CYP3A4*20;Haplotype;PA445301;Disease
LIVER TRANSPLANTATION;CYP3A4*20;Haplotype;PA447247;Disease
FENTANYL;CYP3A4*20;Haplotype;PA449599;Chemical
MIDAZOLAM;CYP3A4*20;Haplotype;PA450496;Chemical
OXYCODONE;CYP3A4*20;Haplotype;PA450741;Chemical
PACLITAXEL;CYP3A4*20;Haplotype;PA450761;Chemical
QUETIAPINE;CYP3A4*20;Haplotype;PA451201;Chemical
TACROLIMUS;CYP3A4*20;Haplotype;PA451578;Chemical
ALK;ensartinib;Chemical;PA24719;Gene
ROSUVASTATIN;rs4149081;Variant;PA134308647;Chemical
SLCO1B1;rs4149081;Variant;PA134865839;Gene
MTHFR;rs4149081;Variant;PA245;Gene
ABCB1;rs4149081;Variant;PA267;Gene
SLC19A1;rs4149081;Variant;PA327;Gene
CORONARY DISEASE;rs4149081;Variant;PA443797;Disease
OSTEOSARCOMA;rs4149081;Variant;PA445601;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs4149081;Variant;PA446155;Disease
METHOTREXATE;rs4149081;Variant;PA450428;Chemical
SIMVASTATIN;rs4149081;Variant;PA451363;Chemical
BREAST NEOPLASMS;rs310786;Variant;PA443560;Disease
TAMOXIFEN;rs310786;Variant;PA451581;Chemical
CHOLIC ACID;CYP27A1;Gene;PA166160055;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs4819554;Variant;PA164713366;Chemical
PSORIASIS;rs4819554;Variant;PA445451;Disease
CALCIUM CHANNEL BLOCKERS;rs2239128;Variant;PA10407;Chemical
HYPERTENSION;rs2239128;Variant;PA444552;Disease
NIMODIPINE;rs2239128;Variant;PA450633;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;KLRC4;Gene;PA164713366;Chemical
SPONDYLARTHROPATHIES;KLRC4;Gene;PA447163;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;ARHGAP12;Gene;PA447197;Disease
METHYLPHENIDATE;ARHGAP12;Gene;PA450464;Chemical
CORTICOSTEROIDS;rs1876828;Variant;PA10832;Chemical
ASTHMA;rs1876828;Variant;PA443450;Disease
TICAGRELOR;CYP3A4*4;Haplotype;PA165374673;Chemical
CABOZANTINIB;CYP3A4*4;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*4;Haplotype;PA165958362;Chemical
REGORAFENIB;CYP3A4*4;Haplotype;PA166114943;Chemical
IBRUTINIB;CYP3A4*4;Haplotype;PA166121346;Chemical
ALECTINIB;CYP3A4*4;Haplotype;PA166160050;Chemical
BREXPIPRAZOLE;CYP3A4*4;Haplotype;PA166160053;Chemical
MACITENTAN;CYP3A4*4;Haplotype;PA166261201;Chemical
BLONANSERIN;CYP3A4*4;Haplotype;PA166319041;Chemical
HYPERLIPIDEMIAS;CYP3A4*4;Haplotype;PA444528;Disease
IBUPROFEN;CYP3A4*4;Haplotype;PA449957;Chemical
OXYCODONE;CYP3A4*4;Haplotype;PA450741;Chemical
SIMVASTATIN;CYP3A4*4;Haplotype;PA451363;Chemical
CYP2D6;mirabegron;Chemical;PA128;Gene
ATORVASTATIN;rs4149036;Variant;PA448500;Chemical
CYP2C19;brivaracetam;Chemical;PA124;Gene
CYP2C9;brivaracetam;Chemical;PA126;Gene
CYP2C19*1;brivaracetam;Chemical;PA165980634;Haplotype
CYP2C19*2;brivaracetam;Chemical;PA165980635;Haplotype
CYP2C19*3;brivaracetam;Chemical;PA165980636;Haplotype
DIABETES MELLITUS;rs784892;Variant;PA443886;Disease
METFORMIN;rs784892;Variant;PA450395;Chemical
VALPROIC ACID;HDAC11;Gene;PA451846;Chemical
LENALIDOMIDE;CTNNB1;Gene;PA162363968;Chemical
NIROGACESTAT;CTNNB1;Gene;PA166328844;Chemical
MULTIPLE MYELOMA;CTNNB1;Gene;PA444985;Disease
CELECOXIB;CTNNB1;Gene;PA448871;Chemical
CYCLOPHOSPHAMIDE;CTNNB1;Gene;PA449165;Chemical
DEXAMETHASONE;CTNNB1;Gene;PA449247;Chemical
THALIDOMIDE;CTNNB1;Gene;PA451644;Chemical
NAT2;procainamide;Chemical;PA18;Gene
SCN5A;procainamide;Chemical;PA304;Gene
RALOXIFENE;UGT1A8*2;Haplotype;PA451221;Chemical
S-EDDP;CYP2B6*19;Haplotype;PA166177606;Chemical
R-EDDP;CYP2B6*19;Haplotype;PA166247521;Chemical
RS118204423;volatile anesthetics;Chemical;PA166155542;Variant
RS2231142;volatile anesthetics;Chemical;PA166156544;Variant
RS1799971;volatile anesthetics;Chemical;PA166156991;Variant
RS193922752;volatile anesthetics;Chemical;PA166183378;Variant
OPRM1;volatile anesthetics;Chemical;PA31945;Gene
RYR1;volatile anesthetics;Chemical;PA34896;Gene
ABCG2;volatile anesthetics;Chemical;PA390;Gene
LUTETIUM (177LU) OXODOTREOTIDE;SSTR3;Gene;PA166224981;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;rs3087879;Variant;PA164713257;Chemical
OBSESSIVE-COMPULSIVE DISORDER;rs3087879;Variant;PA447211;Disease
HEROIN DEPENDENCE;rs2289658;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs2289658;Variant;PA445043;Disease
METHADONE;rs2289658;Variant;PA450401;Chemical
CYP2C19;Maculopapular Exanthema;Disease;PA124;Gene
CYP2C9;Maculopapular Exanthema;Disease;PA126;Gene
CFHR4;Maculopapular Exanthema;Disease;PA134960382;Gene
CYP2C9*1;Maculopapular Exanthema;Disease;PA165816542;Haplotype
CYP2C9*3;Maculopapular Exanthema;Disease;PA165816544;Haplotype
HLA-DRB1*04:03;Maculopapular Exanthema;Disease;PA165951504;Haplotype
HLA-DRB1*14:05;Maculopapular Exanthema;Disease;PA165952142;Haplotype
HLA-A*01:01;Maculopapular Exanthema;Disease;PA165952609;Haplotype
HLA-A*02:07;Maculopapular Exanthema;Disease;PA165952839;Haplotype
HLA-A*30:01;Maculopapular Exanthema;Disease;PA165953964;Haplotype
HLA-A*31:01;Maculopapular Exanthema;Disease;PA165954030;Haplotype
HLA-B*13:01;Maculopapular Exanthema;Disease;PA165954643;Haplotype
HLA-B*13:02;Maculopapular Exanthema;Disease;PA165954649;Haplotype
HLA-B*15:01;Maculopapular Exanthema;Disease;PA165954745;Haplotype
HLA-B*15:02;Maculopapular Exanthema;Disease;PA165954769;Haplotype
HLA-B*15:11;Maculopapular Exanthema;Disease;PA165954787;Haplotype
HLA-B*15:19;Maculopapular Exanthema;Disease;PA165954807;Haplotype
HLA-B*15:27;Maculopapular Exanthema;Disease;PA165954816;Haplotype
HLA-B*27:09;Maculopapular Exanthema;Disease;PA165955138;Haplotype
HLA-B*35:01;Maculopapular Exanthema;Disease;PA165955215;Haplotype
HLA-B*38:02;Maculopapular Exanthema;Disease;PA165955505;Haplotype
HLA-B*40:02;Maculopapular Exanthema;Disease;PA165955651;Haplotype
HLA-B*44:03;Maculopapular Exanthema;Disease;PA165955913;Haplotype
HLA-B*48:04;Maculopapular Exanthema;Disease;PA165956139;Haplotype
HLA-B*58:01;Maculopapular Exanthema;Disease;PA165987831;Haplotype
HLA-C*08:01;Maculopapular Exanthema;Disease;PA166123426;Haplotype
HLA-A*02:01;Maculopapular Exanthema;Disease;PA166123427;Haplotype
HLA-A*33:03;Maculopapular Exanthema;Disease;PA166123428;Haplotype
HLA-DRB1*03:01;Maculopapular Exanthema;Disease;PA166123430;Haplotype
RS4986893;Maculopapular Exanthema;Disease;PA166154070;Variant
RS9332096;Maculopapular Exanthema;Disease;PA166154097;Variant
RS78239784;Maculopapular Exanthema;Disease;PA166182420;Variant
HLA-A;Maculopapular Exanthema;Disease;PA35055;Gene
HLA-B;Maculopapular Exanthema;Disease;PA35056;Gene
HLA-C;Maculopapular Exanthema;Disease;PA35057;Gene
HLA-DRB1;Maculopapular Exanthema;Disease;PA35072;Gene
ASPIRIN;rs6065;Variant;PA448497;Chemical
CYP2E1;idarubicin;Chemical;PA129;Gene
SLCO1B1;idarubicin;Chemical;PA134865839;Gene
DCK;idarubicin;Chemical;PA137;Gene
RS2070673;idarubicin;Chemical;PA166153993;Variant
RS2515641;idarubicin;Chemical;PA166154017;Variant
RS11231825;idarubicin;Chemical;PA166154455;Variant
RS4149056;idarubicin;Chemical;PA166154579;Variant
RS4673;idarubicin;Chemical;PA166154969;Variant
RS2302948;idarubicin;Chemical;PA166155396;Variant
RS1883112;idarubicin;Chemical;PA166156080;Variant
RS13058338;idarubicin;Chemical;PA166156140;Variant
RS2306744;idarubicin;Chemical;PA166156554;Variant
RS80143932;idarubicin;Chemical;PA166156697;Variant
RS2032582;idarubicin;Chemical;PA166157316;Variant
RS3750117;idarubicin;Chemical;PA166157378;Variant
ABCB1;idarubicin;Chemical;PA267;Gene
CYBA;idarubicin;Chemical;PA27075;Gene
NCF4;idarubicin;Chemical;PA31465;Gene
NT5C3A;idarubicin;Chemical;PA31802;Gene
RAC2;idarubicin;Chemical;PA34163;Gene
SULT2B1;idarubicin;Chemical;PA36249;Gene
SLC22A12;idarubicin;Chemical;PA38478;Gene
HEART VALVE REPLACEMENT;rs679899;Variant;PA166123431;Disease
HEMORRHAGE;rs679899;Variant;PA444417;Disease
WARFARIN;rs679899;Variant;PA451906;Chemical
MYOPATHIES, STRUCTURAL, CONGENITAL;NEB;Gene;PA447109;Disease
BIPOLAR DISORDER;NPAS3;Gene;PA447199;Disease
FLUVASTATIN;rs4986910;Variant;PA449688;Chemical
HMG COA REDUCTASE INHIBITORS;SLCO1B3;Gene;PA133950441;Chemical
GASTROINTESTINAL STROMAL TUMORS;SLCO1B3;Gene;PA151958383;Disease
SUNITINIB;SLCO1B3;Gene;PA162372840;Chemical
MYCOPHENOLIC ACID;SLCO1B3;Gene;PA164748728;Chemical
KIDNEY TRANSPLANTATION;SLCO1B3;Gene;PA165817016;Disease
TRANSPLANT REJECTION;SLCO1B3;Gene;PA166114454;Disease
LUNG TRANSPLANTATION;SLCO1B3;Gene;PA166114457;Disease
OVERALL SURVIVAL;SLCO1B3;Gene;PA166123207;Disease
CHRONIC LUNG ALLOGRAFT DYSFUNCTION;SLCO1B3;Gene;PA166195784;Disease
NON-SMALL CELL LUNG CARCINOMA;SLCO1B3;Gene;PA443622;Disease
LUNG NEOPLASMS;SLCO1B3;Gene;PA444818;Disease
NASOPHARYNGEAL NEOPLASMS;SLCO1B3;Gene;PA445046;Disease
NEOPLASMS;SLCO1B3;Gene;PA445062;Disease
CARBOPLATIN;SLCO1B3;Gene;PA448803;Chemical
DOCETAXEL;SLCO1B3;Gene;PA449383;Chemical
METHOTREXATE;SLCO1B3;Gene;PA450428;Chemical
MYCOPHENOLATE MOFETIL;SLCO1B3;Gene;PA450566;Chemical
PACLITAXEL;SLCO1B3;Gene;PA450761;Chemical
PRAVASTATIN;SLCO1B3;Gene;PA451089;Chemical
TELMISARTAN;SLCO1B3;Gene;PA451605;Chemical
INFLAMMATORY BOWEL DISEASES;rs55754655;Variant;PA446116;Disease
AZATHIOPRINE;rs55754655;Variant;PA448515;Chemical
LUMASIRAN;AGXT;Gene;PA166235281;Chemical
NEDOSIRAN;AGXT;Gene;PA166328843;Chemical
NEPHROTOXICITY;CYP27B1;Gene;PA162263533;Disease
DEFERASIROX;CYP27B1;Gene;PA164760843;Chemical
PEGINTERFERON ALFA-2B;CYP27B1;Gene;PA164784024;Chemical
TENOFOVIR DISOPROXIL FUMARATE;CYP27B1;Gene;PA166201941;Chemical
BETA-THALASSEMIA AND RELATED DISEASES;CYP27B1;Gene;PA446432;Disease
CHRONIC HEPATITIS C VIRUS INFECTION;CYP27B1;Gene;PA446863;Disease
HIV INFECTIOUS DISEASE;CYP27B1;Gene;PA447230;Disease
RIBAVIRIN;CYP27B1;Gene;PA451241;Chemical
ANTIEMETICS AND ANTINAUSEANTS;rs34059508;Variant;PA164712431;Chemical
OLANZAPINE;rs34059508;Variant;PA450688;Chemical
PROGUANIL;rs34059508;Variant;PA451124;Chemical
RANITIDINE;rs34059508;Variant;PA451224;Chemical
AUTISM SPECTRUM DISORDER;rs1049353;Variant;PA153906318;Disease
PSYCHOTIC DISORDER;rs1049353;Variant;PA447215;Disease
RISPERIDONE;rs1049353;Variant;PA451257;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;SLC12A8;Gene;PA164713366;Chemical
PSORIASIS;SLC12A8;Gene;PA445451;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;PSORS1C1;Gene;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;PSORS1C1;Gene;PA166120929;Disease
RHEUMATOID ARTHRITIS;PSORS1C1;Gene;PA443434;Disease
NON-SMALL CELL LUNG CARCINOMA;PSORS1C1;Gene;PA443622;Disease
EPIDERMAL NECROLYSIS, TOXIC;PSORS1C1;Gene;PA444059;Disease
STEVENS-JOHNSON SYNDROME;PSORS1C1;Gene;PA445738;Disease
THROMBOCYTOPENIA;PSORS1C1;Gene;PA445846;Disease
ALLOPURINOL;PSORS1C1;Gene;PA448320;Chemical
CARBOPLATIN;PSORS1C1;Gene;PA448803;Chemical
ETANERCEPT;PSORS1C1;Gene;PA449515;Chemical
GEMCITABINE;PSORS1C1;Gene;PA449748;Chemical
SUNITINIB;FLT3;Gene;PA162372840;Chemical
MYELOSUPPRESSION;FLT3;Gene;PA165817398;Disease
VENETOCLAX;FLT3;Gene;PA166153473;Chemical
MIDOSTAURIN;FLT3;Gene;PA166169917;Chemical
GILTERITINIB;FLT3;Gene;PA166182767;Chemical
QUIZARTINIB;FLT3;Gene;PA166328862;Chemical
ABCB6;FLT3;Gene;PA24388;Gene
HRAS;FLT3;Gene;PA29444;Gene
KRAS;FLT3;Gene;PA30196;Gene
NRAS;FLT3;Gene;PA31768;Gene
LEUKOPENIA;FLT3;Gene;PA444773;Disease
NEUTROPENIA;FLT3;Gene;PA445113;Disease
THROMBOCYTOPENIA;FLT3;Gene;PA445846;Disease
SORAFENIB;FLT3;Gene;PA7000;Chemical
BRCA1;Fallopian Tube Neoplasms;Disease;PA25411;Gene
UGT1A1*1;Metastatic neoplasm;Disease;PA166115841;Haplotype
UGT1A1*28;Metastatic neoplasm;Disease;PA166115842;Haplotype
UGT1A1*6;Metastatic neoplasm;Disease;PA166115858;Haplotype
RS1047840;Metastatic neoplasm;Disease;PA166153609;Variant
RS2289310;Metastatic neoplasm;Disease;PA166154010;Variant
RS17431184;Metastatic neoplasm;Disease;PA166154164;Variant
RS2236722;Metastatic neoplasm;Disease;PA166154880;Variant
RS1800566;Metastatic neoplasm;Disease;PA166155017;Variant
RS2291078;Metastatic neoplasm;Disease;PA166156353;Variant
RS3772809;Metastatic neoplasm;Disease;PA166156378;Variant
RS3772810;Metastatic neoplasm;Disease;PA166156379;Variant
RS3218592;Metastatic neoplasm;Disease;PA166157075;Variant
RS17160359;Metastatic neoplasm;Disease;PA166157471;Variant
RS36120609;Metastatic neoplasm;Disease;PA166211543;Variant
ABCB1;Metastatic neoplasm;Disease;PA267;Gene
CYP19A1;Metastatic neoplasm;Disease;PA27091;Gene
DLG5;Metastatic neoplasm;Disease;PA27360;Gene
EXO1;Metastatic neoplasm;Disease;PA27923;Gene
GSTM3;Metastatic neoplasm;Disease;PA29024;Gene
NQO1;Metastatic neoplasm;Disease;PA31744;Gene
PTEN;Metastatic neoplasm;Disease;PA33942;Gene
REV3L;Metastatic neoplasm;Disease;PA34337;Gene
UMPS;Metastatic neoplasm;Disease;PA363;Gene
UGT1A1;Metastatic neoplasm;Disease;PA420;Gene
ARIPIPRAZOLE;SLC6A4;Gene;PA10026;Chemical
DULOXETINE;SLC6A4;Gene;PA10066;Chemical
ESCITALOPRAM;SLC6A4;Gene;PA10074;Chemical
WEIGHT GAIN;SLC6A4;Gene;PA128406954;Disease
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;SLC6A4;Gene;PA164713257;Chemical
MILNACIPRAN;SLC6A4;Gene;PA164752812;Chemical
DIVALPROEX SODIUM;SLC6A4;Gene;PA164783479;Chemical
PEGINTERFERON ALFA-2B;SLC6A4;Gene;PA164784024;Chemical
EVODIAMINE;SLC6A4;Gene;PA165860788;Chemical
BERBERINE;SLC6A4;Gene;PA165860812;Chemical
VILAZODONE;SLC6A4;Gene;PA165958365;Chemical
DESVENLAFAXINE;SLC6A4;Gene;PA165958374;Chemical
PREGNANCY;SLC6A4;Gene;PA166048714;Disease
VORTIOXETINE;SLC6A4;Gene;PA166122595;Chemical
LEVOMILNACIPRAN;SLC6A4;Gene;PA166182150;Chemical
ALCOHOLISM;SLC6A4;Gene;PA443309;Disease
DEMENTIA;SLC6A4;Gene;PA443853;Disease
DIZZINESS;SLC6A4;Gene;PA443928;Disease
DRUG TOXICITY;SLC6A4;Gene;PA443937;Disease
HEART DEFECTS, CONGENITAL;SLC6A4;Gene;PA444367;Disease
OPIOID-RELATED DISORDERS;SLC6A4;Gene;PA445043;Disease
PAIN;SLC6A4;Gene;PA445208;Disease
TOBACCO USE DISORDER;SLC6A4;Gene;PA445876;Disease
HEPATITIS C, CHRONIC;SLC6A4;Gene;PA446863;Disease
COCAINE-RELATED DISORDERS;SLC6A4;Gene;PA446878;Disease
ANXIETY DISORDERS;SLC6A4;Gene;PA447196;Disease
DEPRESSIVE DISORDER;SLC6A4;Gene;PA447207;Disease
MOOD DISORDERS;SLC6A4;Gene;PA447209;Disease
OBSESSIVE-COMPULSIVE DISORDER;SLC6A4;Gene;PA447211;Disease
PANIC DISORDER;SLC6A4;Gene;PA447212;Disease
SCHIZOPHRENIA;SLC6A4;Gene;PA447216;Disease
SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;SLC6A4;Gene;PA447218;Disease
DEPRESSION;SLC6A4;Gene;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;SLC6A4;Gene;PA447321;Disease
ETHANOL;SLC6A4;Gene;PA448073;Chemical
AMITRIPTYLINE;SLC6A4;Gene;PA448385;Chemical
BUPRENORPHINE;SLC6A4;Gene;PA448685;Chemical
BUPROPION;SLC6A4;Gene;PA448687;Chemical
BUSPIRONE;SLC6A4;Gene;PA448689;Chemical
CARBAMAZEPINE;SLC6A4;Gene;PA448785;Chemical
CITALOPRAM;SLC6A4;Gene;PA449015;Chemical
CLOMIPRAMINE;SLC6A4;Gene;PA449048;Chemical
CLOZAPINE;SLC6A4;Gene;PA449061;Chemical
DIAZEPAM;SLC6A4;Gene;PA449283;Chemical
DISULFIRAM;SLC6A4;Gene;PA449376;Chemical
FLUOXETINE;SLC6A4;Gene;PA449673;Chemical
FLUVOXAMINE;SLC6A4;Gene;PA449690;Chemical
HALOPERIDOL;SLC6A4;Gene;PA449841;Chemical
LAMOTRIGINE;SLC6A4;Gene;PA450164;Chemical
METHADONE;SLC6A4;Gene;PA450401;Chemical
MIRTAZAPINE;SLC6A4;Gene;PA450522;Chemical
MODAFINIL;SLC6A4;Gene;PA450530;Chemical
MORPHINE;SLC6A4;Gene;PA450550;Chemical
NORTRIPTYLINE;SLC6A4;Gene;PA450657;Chemical
OLANZAPINE;SLC6A4;Gene;PA450688;Chemical
ONDANSETRON;SLC6A4;Gene;PA450705;Chemical
OXCARBAZEPINE;SLC6A4;Gene;PA450732;Chemical
PAROXETINE;SLC6A4;Gene;PA450801;Chemical
PHENYTOIN;SLC6A4;Gene;PA450947;Chemical
QUETIAPINE;SLC6A4;Gene;PA451201;Chemical
RIBAVIRIN;SLC6A4;Gene;PA451241;Chemical
RISPERIDONE;SLC6A4;Gene;PA451257;Chemical
SERTRALINE;SLC6A4;Gene;PA451333;Chemical
TRAZODONE;SLC6A4;Gene;PA451744;Chemical
VALPROIC ACID;SLC6A4;Gene;PA451846;Chemical
VENLAFAXINE;SLC6A4;Gene;PA451866;Chemical
ZIPRASIDONE;SLC6A4;Gene;PA451974;Chemical
ANTIDEPRESSANTS;SLC6A4;Gene;PA452229;Chemical
ANTIPSYCHOTICS;SLC6A4;Gene;PA452233;Chemical
CYP2D6;tropisetron;Chemical;PA128;Gene
CYP3A4;tropisetron;Chemical;PA130;Gene
CYP2D6*1;tropisetron;Chemical;PA165816576;Haplotype
CYP2D6*3;tropisetron;Chemical;PA165816578;Haplotype
CYP2D6*4;tropisetron;Chemical;PA165816579;Haplotype
CYP2D6*6;tropisetron;Chemical;PA165816581;Haplotype
CYP2D6*10;tropisetron;Chemical;PA165816582;Haplotype
CYP2D6*5;tropisetron;Chemical;PA165948092;Haplotype
CYP2D6*1XN;tropisetron;Chemical;PA165988479;Haplotype
CYP2D6*2XN;tropisetron;Chemical;PA165988480;Haplotype
SLC22A1;tropisetron;Chemical;PA329;Gene
MACULOPAPULAR EXANTHEMA;HLA-A*30:01;Haplotype;PA162316739;Disease
LAMOTRIGINE;HLA-A*30:01;Haplotype;PA450164;Chemical
HMG COA REDUCTASE INHIBITORS;GATM;Gene;PA133950441;Chemical
MYOCARDIAL INFARCTION;GATM;Gene;PA445019;Disease
SIMVASTATIN;GATM;Gene;PA451363;Chemical
JUVENILE RHEUMATOID ARTHRITIS;rs3763980;Variant;PA443433;Disease
METHOTREXATE;rs3763980;Variant;PA450428;Chemical
PEGINTERFERON ALFA-2A;rs4803217;Variant;PA164749390;Chemical
PEGINTERFERON ALFA-2B;rs4803217;Variant;PA164784024;Chemical
HEPATITIS C VIRUS INFECTION;rs4803217;Variant;PA444445;Disease
HIV INFECTIOUS DISEASE;rs4803217;Variant;PA447230;Disease
RIBAVIRIN;rs4803217;Variant;PA451241;Chemical
RHEUMATOID ARTHRITIS;rs2372536;Variant;PA443434;Disease
METHOTREXATE;rs2372536;Variant;PA450428;Chemical
BUFURALOL;CYP2D6*27;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*27;Haplotype;PA166127651;Chemical
PRIMAQUINE;CYP2D6*27;Haplotype;PA451103;Chemical
RS2227310;vinorelbine;Chemical;PA166153999;Variant
RS4353229;vinorelbine;Chemical;PA166154054;Variant
RS7921977;vinorelbine;Chemical;PA166154092;Variant
RS12415607;vinorelbine;Chemical;PA166154152;Variant
CASP7;vinorelbine;Chemical;PA26091;Gene
O-DESMETHYLTRAMADOL;RGL4;Gene;PA166131379;Chemical
TRAMADOL;RGL4;Gene;PA451735;Chemical
OPIOID-RELATED DISORDERS;TACR3;Gene;PA445043;Disease
OPIOIDS;TACR3;Gene;PA452618;Chemical
FLUOROURACIL;rs1801158;Variant;PA128406956;Chemical
DPYD;rs1801158;Variant;PA145;Gene
NEOPLASMS;rs1801158;Variant;PA445062;Disease
CAPECITABINE;rs1801158;Variant;PA448771;Chemical
CHRNA3;eculizumab;Chemical;PA113;Gene
CHRNA7;eculizumab;Chemical;PA114;Gene
RS2274567;eculizumab;Chemical;PA166153689;Variant
RS56040400;eculizumab;Chemical;PA166157844;Variant
AQP4;eculizumab;Chemical;PA24922;Gene
C5;eculizumab;Chemical;PA25911;Gene
CHRNA1;eculizumab;Chemical;PA26487;Gene
CHRNA4;eculizumab;Chemical;PA26490;Gene
CHRNA5;eculizumab;Chemical;PA26491;Gene
CHRNA6;eculizumab;Chemical;PA26492;Gene
CHRNB1;eculizumab;Chemical;PA26494;Gene
CHRNE;eculizumab;Chemical;PA26498;Gene
CR1;eculizumab;Chemical;PA26855;Gene
CFH;eculizumab;Chemical;PA29261;Gene
SCHIZOPHRENIA;rs10465180;Variant;PA447216;Disease
CLOZAPINE;rs10465180;Variant;PA449061;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;MOB3B;Gene;PA164713366;Chemical
RHEUMATOID ARTHRITIS;MOB3B;Gene;PA443434;Disease
FLUOROURACIL;rs755416212;Variant;PA128406956;Chemical
DRUG TOXICITY;rs755416212;Variant;PA443937;Disease
CAPECITABINE;rs755416212;Variant;PA448771;Chemical
ESCITALOPRAM;HTR7;Gene;PA10074;Chemical
HMG COA REDUCTASE INHIBITORS;HTR7;Gene;PA133950441;Chemical
MYALGIA;HTR7;Gene;PA157379134;Disease
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;HTR7;Gene;PA164713257;Chemical
GNAS;HTR7;Gene;PA175;Gene
BIPOLAR DISORDER;HTR7;Gene;PA447199;Disease
DEPRESSION;HTR7;Gene;PA447278;Disease
ATORVASTATIN;HTR7;Gene;PA448500;Chemical
PAROXETINE;HTR7;Gene;PA450801;Chemical
PRAVASTATIN;HTR7;Gene;PA451089;Chemical
SIMVASTATIN;HTR7;Gene;PA451363;Chemical
ANTIDEPRESSANTS;HTR7;Gene;PA452229;Chemical
PROSTATIC NEOPLASMS;Vitamin D Deficiency;Disease;PA445425;Disease
MIGALASTAT;rs727505292;Variant;PA166182881;Chemical
FABRY DISEASE;rs727505292;Variant;PA443367;Disease
CLOZAPINE 5-N-GLUCURONIDE;rs2011425;Variant;PA166213001;Chemical
DESMETHYLCLOZAPINE GLUCURONIDE;rs2011425;Variant;PA166264701;Chemical
BREAST NEOPLASMS;rs2011425;Variant;PA443560;Disease
EPILEPSY;rs2011425;Variant;PA444065;Disease
LAMOTRIGINE;rs2011425;Variant;PA450164;Chemical
TAMOXIFEN;rs2011425;Variant;PA451581;Chemical
PLATINUM COMPOUNDS;rs4353229;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs4353229;Variant;PA443622;Disease
DOCETAXEL;rs4353229;Variant;PA449383;Chemical
GEMCITABINE;rs4353229;Variant;PA449748;Chemical
PACLITAXEL;rs4353229;Variant;PA450761;Chemical
VINORELBINE;rs4353229;Variant;PA451881;Chemical
ATAZANAVIR;UGT1A1*28;Haplotype;PA10251;Chemical
OXALIPLATIN;UGT1A1*28;Haplotype;PA131285527;Chemical
RALTITREXED;UGT1A1*28;Haplotype;PA131625240;Chemical
TRANILAST;UGT1A1*28;Haplotype;PA131890628;Chemical
HMG COA REDUCTASE INHIBITORS;UGT1A1*28;Haplotype;PA133950441;Chemical
SLCO1B1;UGT1A1*28;Haplotype;PA134865839;Gene
ANTIVIRALS FOR TREATMENT OF HIV INFECTIONS, COMBINATIONS;UGT1A1*28;Haplotype;PA164712505;Chemical
LABETALOL;UGT1A1*28;Haplotype;PA164743150;Chemical
DEFERASIROX;UGT1A1*28;Haplotype;PA164760843;Chemical
RALTEGRAVIR;UGT1A1*28;Haplotype;PA164888966;Chemical
SN-38;UGT1A1*28;Haplotype;PA165110775;Chemical
PAZOPANIB;UGT1A1*28;Haplotype;PA165291492;Chemical
NILOTINIB;UGT1A1*28;Haplotype;PA165958345;Chemical
INDACATEROL;UGT1A1*28;Haplotype;PA165958348;Chemical
BELINOSTAT;UGT1A1*28;Haplotype;PA165971474;Chemical
ELTROMBOPAG;UGT1A1*28;Haplotype;PA165981594;Chemical
PREGNANCY;UGT1A1*28;Haplotype;PA166048714;Disease
PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;UGT1A1*28;Haplotype;PA166048851;Disease
DOLUTEGRAVIR;UGT1A1*28;Haplotype;PA166114961;Chemical
TEGAFUR / GIMERACIL / OTERACIL;UGT1A1*28;Haplotype;PA166115442;Chemical
OVERALL SURVIVAL;UGT1A1*28;Haplotype;PA166123207;Disease
BILIRUBIN;UGT1A1*28;Haplotype;PA166123346;Chemical
DISCONTINUATION;UGT1A1*28;Haplotype;PA166123507;Disease
RECURRENCE FREE SURVIVAL;UGT1A1*28;Haplotype;PA166127658;Disease
BONE DENSITY;UGT1A1*28;Haplotype;PA166128365;Disease
BILIARY TRACT NEOPLASMS;UGT1A1*28;Haplotype;PA166128807;Disease
ADVERSE EVENTS;UGT1A1*28;Haplotype;PA166151827;Disease
TREATMENT INTERRUPTIONS;UGT1A1*28;Haplotype;PA166159284;Disease
FEBRILE NEUTROPENIA;UGT1A1*28;Haplotype;PA166170245;Disease
ATAZANAVIR / RITONAVIR;UGT1A1*28;Haplotype;PA166182624;Chemical
FOLFIRI;UGT1A1*28;Haplotype;PA166182863;Chemical
LETERMOVIR;UGT1A1*28;Haplotype;PA166184379;Chemical
RALOXIFENE-4??Ý-GLUCURONIDE;UGT1A1*28;Haplotype;PA166213481;Chemical
RALOXIFENE 6-GLUCURONIDE;UGT1A1*28;Haplotype;PA166213482;Chemical
SACITUZUMAB GOVITECAN;UGT1A1*28;Haplotype;PA166225061;Chemical
FOLFIRINOX;UGT1A1*28;Haplotype;PA166240141;Chemical
HLA-B;UGT1A1*28;Haplotype;PA35056;Gene
UGT1A1;UGT1A1*28;Haplotype;PA420;Gene
ACQUIRED IMMUNODEFICIENCY SYNDROME;UGT1A1*28;Haplotype;PA443250;Disease
ADENOCARCINOMA;UGT1A1*28;Haplotype;PA443265;Disease
ANEMIA;UGT1A1*28;Haplotype;PA443340;Disease
ANGINA PECTORIS;UGT1A1*28;Haplotype;PA443362;Disease
ASTHENIA;UGT1A1*28;Haplotype;PA443448;Disease
CARCINOMA, RENAL CELL;UGT1A1*28;Haplotype;PA443624;Disease
COLONIC NEOPLASMS;UGT1A1*28;Haplotype;PA443756;Disease
DEATH;UGT1A1*28;Haplotype;PA443842;Disease
DIARRHEA;UGT1A1*28;Haplotype;PA443899;Disease
DRUG TOXICITY;UGT1A1*28;Haplotype;PA443937;Disease
FATIGUE;UGT1A1*28;Haplotype;PA444153;Disease
GASTROINTESTINAL NEOPLASMS;UGT1A1*28;Haplotype;PA444257;Disease
CARCINOMA, HEPATOCELLULAR;UGT1A1*28;Haplotype;PA444447;Disease
HYPERBILIRUBINEMIA;UGT1A1*28;Haplotype;PA444511;Disease
HYPERLIPIDEMIAS;UGT1A1*28;Haplotype;PA444528;Disease
JAUNDICE;UGT1A1*28;Haplotype;PA444648;Disease
LEUKOPENIA;UGT1A1*28;Haplotype;PA444773;Disease
LUNG NEOPLASMS;UGT1A1*28;Haplotype;PA444818;Disease
NEOPLASM METASTASIS;UGT1A1*28;Haplotype;PA445058;Disease
NEOPLASMS;UGT1A1*28;Haplotype;PA445062;Disease
NEUTROPENIA;UGT1A1*28;Haplotype;PA445113;Disease
OLIGURIA;UGT1A1*28;Haplotype;PA445146;Disease
OSTEOPOROSIS;UGT1A1*28;Haplotype;PA445190;Disease
OVARIAN NEOPLASMS;UGT1A1*28;Haplotype;PA445204;Disease
PANCREATIC NEOPLASMS;UGT1A1*28;Haplotype;PA445218;Disease
THROMBOCYTOPENIA;UGT1A1*28;Haplotype;PA445846;Disease
THROMBOEMBOLISM;UGT1A1*28;Haplotype;PA445848;Disease
TUBERCULOSIS;UGT1A1*28;Haplotype;PA445941;Disease
UNCONSCIOUSNESS;UGT1A1*28;Haplotype;PA445975;Disease
VOMITING;UGT1A1*28;Haplotype;PA446051;Disease
COLORECTAL NEOPLASMS;UGT1A1*28;Haplotype;PA446108;Disease
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;UGT1A1*28;Haplotype;PA446171;Disease
MYOCARDIAL ISCHEMIA;UGT1A1*28;Haplotype;PA446459;Disease
RHABDOMYOSARCOMA, ALVEOLAR;UGT1A1*28;Haplotype;PA446615;Disease
SCHIZOPHRENIA;UGT1A1*28;Haplotype;PA447216;Disease
HIV INFECTIONS;UGT1A1*28;Haplotype;PA447230;Disease
CAPECITABINE;UGT1A1*28;Haplotype;PA448771;Chemical
CARVEDILOL;UGT1A1*28;Haplotype;PA448817;Chemical
CISPLATIN;UGT1A1*28;Haplotype;PA449014;Chemical
CLOZAPINE;UGT1A1*28;Haplotype;PA449061;Chemical
INDINAVIR;UGT1A1*28;Haplotype;PA449977;Chemical
IRINOTECAN;UGT1A1*28;Haplotype;PA450085;Chemical
LAMIVUDINE;UGT1A1*28;Haplotype;PA450163;Chemical
MOXIFLOXACIN;UGT1A1*28;Haplotype;PA450555;Chemical
OLANZAPINE;UGT1A1*28;Haplotype;PA450688;Chemical
RALOXIFENE;UGT1A1*28;Haplotype;PA451221;Chemical
RITONAVIR;UGT1A1*28;Haplotype;PA451260;Chemical
WARFARIN;UGT1A1*28;Haplotype;PA451906;Chemical
ZIDOVUDINE;UGT1A1*28;Haplotype;PA451954;Chemical
SORAFENIB;UGT1A1*28;Haplotype;PA7000;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs610604;Variant;PA164713366;Chemical
USTEKINUMAB;rs610604;Variant;PA166048654;Chemical
PSORIASIS;rs610604;Variant;PA445451;Disease
ARTHRITIS, PSORIATIC;rs610604;Variant;PA446198;Disease
CETUXIMAB;rs1353295;Variant;PA10040;Chemical
PANITUMUMAB;rs1353295;Variant;PA162373091;Chemical
COLORECTAL NEOPLASMS;rs1353295;Variant;PA446108;Disease
IRINOTECAN;rs1353295;Variant;PA450085;Chemical
ARTESUNATE;IKBKG;Gene;PA165111697;Chemical
PRIMAQUINE;IKBKG;Gene;PA451103;Chemical
PYRIMETHAMINE;IKBKG;Gene;PA451193;Chemical
SULFADOXINE;IKBKG;Gene;PA451540;Chemical
HYPERCHOLESTEROLEMIA;rs9370867;Variant;PA444516;Disease
ATORVASTATIN;rs9370867;Variant;PA448500;Chemical
CYP2B6;ziprasidone;Chemical;PA123;Gene
CYP2C19;ziprasidone;Chemical;PA124;Gene
CYP2C9;ziprasidone;Chemical;PA126;Gene
CYP2D6;ziprasidone;Chemical;PA128;Gene
CYP3A4;ziprasidone;Chemical;PA130;Gene
CYP3A5;ziprasidone;Chemical;PA131;Gene
EIF2AK4;ziprasidone;Chemical;PA134947616;Gene
RS951439;ziprasidone;Chemical;PA166153604;Variant
RS7912580;ziprasidone;Chemical;PA166154088;Variant
RS2412459;ziprasidone;Chemical;PA166154891;Variant
HTR2A;ziprasidone;Chemical;PA193;Gene
HTR2C;ziprasidone;Chemical;PA194;Gene
CYP1A2;ziprasidone;Chemical;PA27093;Gene
DRD2;ziprasidone;Chemical;PA27478;Gene
SLC6A4;ziprasidone;Chemical;PA312;Gene
POLG;ziprasidone;Chemical;PA33500;Gene
RGS4;ziprasidone;Chemical;PA34375;Gene
HLA-A;ziprasidone;Chemical;PA35055;Gene
HLA-B;ziprasidone;Chemical;PA35056;Gene
UGT1A4;ziprasidone;Chemical;PA37179;Gene
ESSENTIAL HYPERTENSION;rs9285669;Variant;PA447288;Disease
HYDROCHLOROTHIAZIDE;rs9285669;Variant;PA449899;Chemical
BETA BLOCKING AGENTS;rs61767072;Variant;PA164712535;Chemical
ACUTE CORONARY SYNDROME;rs61767072;Variant;PA165108401;Disease
BUCINDOLOL;rs61767072;Variant;PA165945764;Chemical
CARDIOMYOPATHY, DILATED;rs61767072;Variant;PA443632;Disease
DEATH;rs61767072;Variant;PA443842;Disease
HEART FAILURE;rs61767072;Variant;PA444370;Disease
METOPROLOL;rs61767072;Variant;PA450480;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs2699887;Variant;PA443622;Disease
CARBOPLATIN;rs2699887;Variant;PA448803;Chemical
CISPLATIN;rs2699887;Variant;PA449014;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs2071421;Variant;PA447197;Disease
METHYLPHENIDATE;rs2071421;Variant;PA450464;Chemical
VDR;calcitriol;Chemical;PA37301;Gene
NON-SMALL CELL LUNG CARCINOMA;GPX5;Gene;PA443622;Disease
CARBOPLATIN;GPX5;Gene;PA448803;Chemical
CISPLATIN;GPX5;Gene;PA449014;Chemical
GEMCITABINE;GPX5;Gene;PA449748;Chemical
DULOXETINE;rs9879065;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs9879065;Variant;PA447321;Disease
RHEUMATOID ARTHRITIS;rs7574865;Variant;PA443434;Disease
ETANERCEPT;rs7574865;Variant;PA449515;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs1048786;Variant;PA447197;Disease
METHYLPHENIDATE;rs1048786;Variant;PA450464;Chemical
BREAST NEOPLASMS;NQO2;Gene;PA443560;Disease
CLOZAPINE;NQO2;Gene;PA449061;Chemical
CYCLOPHOSPHAMIDE;NQO2;Gene;PA449165;Chemical
DOXORUBICIN;NQO2;Gene;PA449412;Chemical
RS12471326;cotinine glucuronide;Chemical;PA166238022;Variant
UGT1A9;cotinine glucuronide;Chemical;PA419;Gene
ATAZANAVIR;UGT1A7;Gene;PA10251;Chemical
OXALIPLATIN;UGT1A7;Gene;PA131285527;Chemical
MYCOPHENOLIC ACID;UGT1A7;Gene;PA164748728;Chemical
FEBUXOSTAT;UGT1A7;Gene;PA165958521;Chemical
TEGAFUR / GIMERACIL / OTERACIL;UGT1A7;Gene;PA166115442;Chemical
DIARRHEA;UGT1A7;Gene;PA443899;Disease
EPILEPSY;UGT1A7;Gene;PA444065;Disease
GOUT;UGT1A7;Gene;PA444318;Disease
HYPERBILIRUBINEMIA;UGT1A7;Gene;PA444511;Disease
NEUTROPENIA;UGT1A7;Gene;PA445113;Disease
OSTEOSARCOMA;UGT1A7;Gene;PA445601;Disease
SEIZURES;UGT1A7;Gene;PA445629;Disease
STOMACH NEOPLASMS;UGT1A7;Gene;PA445742;Disease
VOMITING;UGT1A7;Gene;PA446051;Disease
COLORECTAL NEOPLASMS;UGT1A7;Gene;PA446108;Disease
SCHIZOPHRENIA;UGT1A7;Gene;PA447216;Disease
HIV INFECTIOUS DISEASE;UGT1A7;Gene;PA447230;Disease
ALLOPURINOL;UGT1A7;Gene;PA448320;Chemical
IRINOTECAN;UGT1A7;Gene;PA450085;Chemical
METHOTREXATE;UGT1A7;Gene;PA450428;Chemical
MYCOPHENOLATE MOFETIL;UGT1A7;Gene;PA450566;Chemical
OXCARBAZEPINE;UGT1A7;Gene;PA450732;Chemical
RISPERIDONE;UGT1A7;Gene;PA451257;Chemical
RITONAVIR;UGT1A7;Gene;PA451260;Chemical
VALPROIC ACID;UGT1A7;Gene;PA451846;Chemical
GEFITINIB;rs2151222;Variant;PA131301952;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs2151222;Variant;PA443622;Disease
DIARRHEA;rs2151222;Variant;PA443899;Disease
RS6923761;liraglutide;Chemical;PA166157117;Variant
RS10305420;liraglutide;Chemical;PA166157167;Variant
GLP1R;liraglutide;Chemical;PA28725;Gene
LEUKEMIA, MYELOID, ACUTE;NCF4;Gene;PA444760;Disease
NEOPLASMS;NCF4;Gene;PA445062;Disease
DOXORUBICIN;NCF4;Gene;PA449412;Chemical
IDARUBICIN;NCF4;Gene;PA449961;Chemical
FLUOROURACIL;rs7194667;Variant;PA128406956;Chemical
LEUKOPENIA;rs7194667;Variant;PA444773;Disease
NEOPLASMS;rs7194667;Variant;PA445062;Disease
MACULOPAPULAR EXANTHEMA;HLA-B*27:09;Haplotype;PA162316739;Disease
EPILEPSY;HLA-B*27:09;Haplotype;PA444065;Disease
OXCARBAZEPINE;HLA-B*27:09;Haplotype;PA450732;Chemical
REGORAFENIB;rs4864950;Variant;PA166114943;Chemical
DRUG TOXICITY;rs4864950;Variant;PA443937;Disease
SORAFENIB;rs4864950;Variant;PA7000;Chemical
HMG COA REDUCTASE INHIBITORS;COQ2;Gene;PA133950441;Chemical
ROSUVASTATIN;COQ2;Gene;PA134308647;Chemical
MUSCULAR DISEASES;COQ2;Gene;PA444997;Disease
ATORVASTATIN;COQ2;Gene;PA448500;Chemical
PLATINUM COMPOUNDS;rs12415607;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs12415607;Variant;PA443622;Disease
DOCETAXEL;rs12415607;Variant;PA449383;Chemical
GEMCITABINE;rs12415607;Variant;PA449748;Chemical
PACLITAXEL;rs12415607;Variant;PA450761;Chemical
VINORELBINE;rs12415607;Variant;PA451881;Chemical
ERBB2;zanidatamab;Chemical;PA27844;Gene
NON-SMALL CELL LUNG CARCINOMA;rs1049709;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs1049709;Variant;PA445846;Disease
CARBOPLATIN;rs1049709;Variant;PA448803;Chemical
GEMCITABINE;rs1049709;Variant;PA449748;Chemical
FLUOROURACIL;MIR27A;Gene;PA128406956;Chemical
CYP3A4;MIR27A;Gene;PA130;Gene
NEOPLASMS;MIR27A;Gene;PA445062;Disease
CAPECITABINE;MIR27A;Gene;PA448771;Chemical
HYPERCHOLESTEROLEMIA;rs17671591;Variant;PA444516;Disease
ATORVASTATIN;rs17671591;Variant;PA448500;Chemical
COUMARIN;rs148044792;Variant;PA134521193;Chemical
NICOTINE;rs148044792;Variant;PA450626;Chemical
LEP;metreleptin;Chemical;PA228;Gene
AGPAT2;metreleptin;Chemical;PA24622;Gene
BSCL2;metreleptin;Chemical;PA25432;Gene
LMNB2;metreleptin;Chemical;PA30404;Gene
DPYD;rs72549310;Variant;PA145;Gene
CAPECITABINE;rs72549310;Variant;PA448771;Chemical
RISDIPLAM;SMN1;Gene;PA166235322;Chemical
WARFARIN;rs4072879;Variant;PA451906;Chemical
TRANSPLANTATION;rs1800896;Variant;PA134850491;Disease
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;rs1800896;Variant;PA164712462;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs1800896;Variant;PA164713366;Chemical
KIDNEY TRANSPLANTATION;rs1800896;Variant;PA165817016;Disease
HIV INFECTIOUS DISEASE;rs1800896;Variant;PA447230;Disease
LIVER TRANSPLANTATION;rs1800896;Variant;PA447247;Disease
EFAVIRENZ;rs1800896;Variant;PA449441;Chemical
SIROLIMUS;rs1800896;Variant;PA451365;Chemical
TACROLIMUS;rs1800896;Variant;PA451578;Chemical
AKT1;PIK3R3;Gene;PA24684;Gene
ERBB2;PIK3R3;Gene;PA27844;Gene
ERBB3;PIK3R3;Gene;PA27846;Gene
ERBB4;PIK3R3;Gene;PA27847;Gene
FLT1;PIK3R3;Gene;PA28180;Gene
FLT4;PIK3R3;Gene;PA28183;Gene
KDR;PIK3R3;Gene;PA30086;Gene
EGFR;PIK3R3;Gene;PA7360;Gene
CFTR;rs186045772;Variant;PA109;Gene
IVACAFTOR;rs186045772;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs186045772;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs186045772;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs186045772;Variant;PA443829;Disease
ACENOCOUMAROL;rs55894764;Variant;PA452632;Chemical
FGFR1OP;CRK;Gene;PA134941638;Gene
FGFR1OP2;CRK;Gene;PA134972108;Gene
FGFR1;CRK;Gene;PA28127;Gene
FGFR2;CRK;Gene;PA28128;Gene
FGFR3;CRK;Gene;PA28129;Gene
FGFR4;CRK;Gene;PA28130;Gene
FGFR3P1;CRK;Gene;PA28131;Gene
FGFRL1;CRK;Gene;PA28132;Gene
HRAS;CRK;Gene;PA29444;Gene
KRAS;CRK;Gene;PA30196;Gene
NRAS;CRK;Gene;PA31768;Gene
CYP2B6;isoniazid;Chemical;PA123;Gene
CYP2C19;isoniazid;Chemical;PA124;Gene
CYP2C9;isoniazid;Chemical;PA126;Gene
CYP2E1;isoniazid;Chemical;PA129;Gene
NOS2;isoniazid;Chemical;PA164724093;Gene
CYP2B6*1;isoniazid;Chemical;PA165818750;Haplotype
CYP2B6*6;isoniazid;Chemical;PA165818762;Haplotype
CYP2E1*1A;isoniazid;Chemical;PA165948032;Haplotype
NAT2*4;isoniazid;Chemical;PA165949098;Haplotype
NAT2*5A;isoniazid;Chemical;PA165949099;Haplotype
NAT2*6J;isoniazid;Chemical;PA165949124;Haplotype
NAT2*6O;isoniazid;Chemical;PA165949129;Haplotype
NAT2*12A;isoniazid;Chemical;PA165949138;Haplotype
HLA-B*52:01;isoniazid;Chemical;PA165956366;Haplotype
NAT2*5;isoniazid;Chemical;PA165981634;Haplotype
NAT2*6;isoniazid;Chemical;PA165981635;Haplotype
NAT2*7;isoniazid;Chemical;PA165981636;Haplotype
NAT2*14;isoniazid;Chemical;PA165981640;Haplotype
GSTM1 NULL;isoniazid;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;isoniazid;Chemical;PA166048676;Haplotype
GSTT1 NULL;isoniazid;Chemical;PA166048678;Haplotype
GSTT1 NON-NULL;isoniazid;Chemical;PA166048679;Haplotype
NAT2*7G;isoniazid;Chemical;PA166115839;Haplotype
RS4986893;isoniazid;Chemical;PA166154070;Variant
RS9332096;isoniazid;Chemical;PA166154097;Variant
RS1695;isoniazid;Chemical;PA166154249;Variant
RS11080344;isoniazid;Chemical;PA166155245;Variant
RS11125883;isoniazid;Chemical;PA166155800;Variant
RS2070401;isoniazid;Chemical;PA166155995;Variant
RS1800629;isoniazid;Chemical;PA166156997;Variant
RS1045642;isoniazid;Chemical;PA166157284;Variant
RS4720833;isoniazid;Chemical;PA166157396;Variant
RS1208;isoniazid;Chemical;PA166157540;Variant
RS1041983;isoniazid;Chemical;PA166157549;Variant
RS1799929;isoniazid;Chemical;PA166157563;Variant
RS1799930;isoniazid;Chemical;PA166157564;Variant
RS1799931;isoniazid;Chemical;PA166157565;Variant
RS1801280;isoniazid;Chemical;PA166157570;Variant
RS4646244;isoniazid;Chemical;PA166157603;Variant
NAT2 SLOW ACETYLATOR;isoniazid;Chemical;PA166157948;Variant
NAT2;isoniazid;Chemical;PA18;Gene
GSTM1;isoniazid;Chemical;PA182;Gene
GSTT1;isoniazid;Chemical;PA183;Gene
BACH1;isoniazid;Chemical;PA25234;Gene
ABCB1;isoniazid;Chemical;PA267;Gene
GSTP1;isoniazid;Chemical;PA29028;Gene
MAFK;isoniazid;Chemical;PA30540;Gene
HLA-B;isoniazid;Chemical;PA35056;Gene
XPO1;isoniazid;Chemical;PA37418;Gene
NR1I2;isoniazid;Chemical;PA378;Gene
TNF;isoniazid;Chemical;PA435;Gene
DPYD;rs201018345;Variant;PA145;Gene
CAPECITABINE;rs201018345;Variant;PA448771;Chemical
PACLITAXEL;rs72552784;Variant;PA450761;Chemical
CYP2D6;primaquine;Chemical;PA128;Gene
CYB5R4;primaquine;Chemical;PA134904907;Gene
CYB5R1;primaquine;Chemical;PA134979668;Gene
CYB5R2;primaquine;Chemical;PA142672060;Gene
CYP2D6*1;primaquine;Chemical;PA165816576;Haplotype
CYP2D6*2;primaquine;Chemical;PA165816577;Haplotype
CYP2D6*4;primaquine;Chemical;PA165816579;Haplotype
CYP2D6*6;primaquine;Chemical;PA165816581;Haplotype
CYP2D6*10;primaquine;Chemical;PA165816582;Haplotype
CYP2D6*17;primaquine;Chemical;PA165816583;Haplotype
CYP2D6*41;primaquine;Chemical;PA165816584;Haplotype
G6PD B (REFERENCE);primaquine;Chemical;PA165947826;Haplotype
G6PD A- 202A_376G;primaquine;Chemical;PA165947827;Haplotype
CYP2D6*5;primaquine;Chemical;PA165948092;Haplotype
CYP2D6*9;primaquine;Chemical;PA165948317;Haplotype
CYP2D6*29;primaquine;Chemical;PA165948318;Haplotype
CYP2D6*7;primaquine;Chemical;PA165971559;Haplotype
CYP2D6*12;primaquine;Chemical;PA165971565;Haplotype
CYP2D6*18;primaquine;Chemical;PA165971569;Haplotype
CYP2D6*22;primaquine;Chemical;PA165971574;Haplotype
CYP2D6*25;primaquine;Chemical;PA165971577;Haplotype
CYP2D6*26;primaquine;Chemical;PA165971578;Haplotype
CYP2D6*27;primaquine;Chemical;PA165971579;Haplotype
CYP2D6*28;primaquine;Chemical;PA165971580;Haplotype
CYP2D6*30;primaquine;Chemical;PA165971581;Haplotype
CYP2D6*31;primaquine;Chemical;PA165971582;Haplotype
CYP2D6*32;primaquine;Chemical;PA165971583;Haplotype
CYP2D6*33;primaquine;Chemical;PA165971584;Haplotype
CYP2D6*34;primaquine;Chemical;PA165971585;Haplotype
CYP2D6*37;primaquine;Chemical;PA165971591;Haplotype
CYP2D6*40;primaquine;Chemical;PA165971594;Haplotype
CYP2D6*43;primaquine;Chemical;PA165971596;Haplotype
CYP2D6*46;primaquine;Chemical;PA165971600;Haplotype
CYP2D6*47;primaquine;Chemical;PA165971601;Haplotype
CYP2D6*48;primaquine;Chemical;PA165971602;Haplotype
CYP2D6*49;primaquine;Chemical;PA165971603;Haplotype
CYP2D6*50;primaquine;Chemical;PA165971604;Haplotype
CYP2D6*51;primaquine;Chemical;PA165971605;Haplotype
CYP2D6*52;primaquine;Chemical;PA165971606;Haplotype
CYP2D6*53;primaquine;Chemical;PA165971607;Haplotype
CYP2D6*54;primaquine;Chemical;PA165971608;Haplotype
CYP2D6*55;primaquine;Chemical;PA165971609;Haplotype
CYP2D6*61;primaquine;Chemical;PA165971616;Haplotype
CYP2D6*63;primaquine;Chemical;PA165971618;Haplotype
CYP2D6*64;primaquine;Chemical;PA165971619;Haplotype
CYP2D6*65;primaquine;Chemical;PA165971620;Haplotype
CYP2D6*70;primaquine;Chemical;PA165971622;Haplotype
CYP2D6*71;primaquine;Chemical;PA165971623;Haplotype
CYP2D6*72;primaquine;Chemical;PA165971624;Haplotype
CYP2D6*75;primaquine;Chemical;PA165971627;Haplotype
CYP2D6*35;primaquine;Chemical;PA165988487;Haplotype
CYP2D6*36;primaquine;Chemical;PA165988488;Haplotype
CYP2D6*45;primaquine;Chemical;PA165988489;Haplotype
CYP2D6*39;primaquine;Chemical;PA166001447;Haplotype
G6PD MEDITERRANEAN, DALLAS, PANAMA, SASSARI, CAGLIARI, BIRMINGHAM;primaquine;Chemical;PA166121127;Haplotype
RS1050828;primaquine;Chemical;PA166157859;Variant
G6PD DEFICIENCY;primaquine;Chemical;PA166157959;Variant
CYP2D6*114;primaquine;Chemical;PA166181184;Haplotype
CYP2D6*14;primaquine;Chemical;PA166181185;Haplotype
CYP1A2;primaquine;Chemical;PA27093;Gene
CYB5R3;primaquine;Chemical;PA27331;Gene
G6PD;primaquine;Chemical;PA28469;Gene
IKBKG;primaquine;Chemical;PA29777;Gene
NAUSEA;ZNF165;Gene;PA445048;Disease
VOMITING;ZNF165;Gene;PA446051;Disease
OPIOIDS;ZNF165;Gene;PA452618;Chemical
HYPERCHOLESTEROLEMIA;rs4783961;Variant;PA444516;Disease
FLUVASTATIN;rs4783961;Variant;PA449688;Chemical
PLATINUM COMPOUNDS;rs2839698;Variant;PA164713176;Chemical
LUNG NEOPLASMS;rs2839698;Variant;PA444818;Disease
CORTICOSTEROIDS;rs1042713;Variant;PA10832;Chemical
SELECTIVE BETA-2-ADRENORECEPTOR AGONISTS;rs1042713;Variant;PA134687887;Chemical
DIURETICS;rs1042713;Variant;PA151249535;Chemical
ACE INHIBITORS, PLAIN;rs1042713;Variant;PA164712308;Chemical
ANGIOTENSIN II ANTAGONISTS;rs1042713;Variant;PA164712372;Chemical
BETA BLOCKING AGENTS;rs1042713;Variant;PA164712535;Chemical
TIOTROPIUM;rs1042713;Variant;PA164769056;Chemical
METHACHOLINE;rs1042713;Variant;PA165958382;Chemical
ASTHMA;rs1042713;Variant;PA443450;Disease
CARDIOMYOPATHY, DILATED;rs1042713;Variant;PA443632;Disease
HEART FAILURE;rs1042713;Variant;PA444370;Disease
LIVER CIRRHOSIS;rs1042713;Variant;PA444797;Disease
TACHYCARDIA;rs1042713;Variant;PA445802;Disease
SCHIZOPHRENIA;rs1042713;Variant;PA447216;Disease
ESSENTIAL HYPERTENSION;rs1042713;Variant;PA447288;Disease
SALBUTAMOL;rs1042713;Variant;PA448068;Chemical
ATENOLOL;rs1042713;Variant;PA448499;Chemical
BENAZEPRIL;rs1042713;Variant;PA448561;Chemical
DIGOXIN;rs1042713;Variant;PA449319;Chemical
EPHEDRINE;rs1042713;Variant;PA449466;Chemical
ISOPROTERENOL;rs1042713;Variant;PA450121;Chemical
METOPROLOL;rs1042713;Variant;PA450480;Chemical
PHENYLEPHRINE;rs1042713;Variant;PA450935;Chemical
PROPRANOLOL;rs1042713;Variant;PA451145;Chemical
RISPERIDONE;rs1042713;Variant;PA451257;Chemical
SALMETEROL;rs1042713;Variant;PA451300;Chemical
SPIRONOLACTONE;rs1042713;Variant;PA451483;Chemical
SCHIZOPHRENIA;ATP1A2;Gene;PA447216;Disease
OLANZAPINE;ATP1A2;Gene;PA450688;Chemical
RECURRENCE FREE SURVIVAL;rs2228224;Variant;PA166127658;Disease
LEUKEMIA, MYELOID, ACUTE;rs2228224;Variant;PA444760;Disease
CYTARABINE;rs2228224;Variant;PA449177;Chemical
CYP2C19;11a-hydroxyprogesterone;Chemical;PA124;Gene
CYP2C19*9;11a-hydroxyprogesterone;Chemical;PA165816525;Haplotype
CYP2C19*10;11a-hydroxyprogesterone;Chemical;PA165816526;Haplotype
CYP2C19*11;11a-hydroxyprogesterone;Chemical;PA165816527;Haplotype
CYP2C19*13;11a-hydroxyprogesterone;Chemical;PA165816529;Haplotype
CYP2C19*16;11a-hydroxyprogesterone;Chemical;PA165816532;Haplotype
CYP2C19*19;11a-hydroxyprogesterone;Chemical;PA165816535;Haplotype
CYP2C19*23;11a-hydroxyprogesterone;Chemical;PA165816537;Haplotype
CYP2C19*1;11a-hydroxyprogesterone;Chemical;PA165980634;Haplotype
CYP2C19*30;11a-hydroxyprogesterone;Chemical;PA166123293;Haplotype
CYP2C19*33;11a-hydroxyprogesterone;Chemical;PA166123296;Haplotype
COMT;Physiological sexual disorder;Disease;PA117;Gene
SLC6A4 HTTLPR LONG FORM (L ALLELE);Physiological sexual disorder;Disease;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);Physiological sexual disorder;Disease;PA166116466;Haplotype
RS6311;Physiological sexual disorder;Disease;PA166154673;Variant
RS6313;Physiological sexual disorder;Disease;PA166154675;Variant
RS4633;Physiological sexual disorder;Disease;PA166156023;Variant
RS2234918;Physiological sexual disorder;Disease;PA166175997;Variant
HTR2A;Physiological sexual disorder;Disease;PA193;Gene
SLC6A4;Physiological sexual disorder;Disease;PA312;Gene
OPRD1;Physiological sexual disorder;Disease;PA31942;Gene
GNAI1;HTR1F;Gene;PA172;Gene
GNAI3;HTR1F;Gene;PA173;Gene
GNAI2;HTR1F;Gene;PA24347;Gene
ESTRADIOL;TCL1A;Gene;PA449503;Chemical
TEZACAFTOR;rs758900656;Variant;PA166175754;Chemical
ELEXACAFTOR;rs758900656;Variant;PA166185161;Chemical
OTOTOXICITY;rs2228001;Variant;PA162263534;Disease
URINARY BLADDER NEOPLASMS;rs2228001;Variant;PA443512;Disease
DRUG TOXICITY;rs2228001;Variant;PA443937;Disease
INFECTIOUS DISEASE;rs2228001;Variant;PA444614;Disease
NEOPLASMS;rs2228001;Variant;PA445062;Disease
NEUTROPENIA;rs2228001;Variant;PA445113;Disease
OSTEOSARCOMA;rs2228001;Variant;PA445601;Disease
TESTICULAR NEOPLASMS;rs2228001;Variant;PA445828;Disease
CISPLATIN;rs2228001;Variant;PA449014;Chemical
DOXORUBICIN;rs2228001;Variant;PA449412;Chemical
ALZHEIMER DISEASE;CHAT;Gene;PA443319;Disease
SCHIZOPHRENIA;CHAT;Gene;PA447216;Disease
DONEPEZIL;CHAT;Gene;PA449394;Chemical
GALANTAMINE;CHAT;Gene;PA449726;Chemical
OLANZAPINE;CHAT;Gene;PA450688;Chemical
RIVASTIGMINE;CHAT;Gene;PA451262;Chemical
IBRUTINIB;MYD88;Gene;PA166121346;Chemical
ZANUBRUTINIB;MYD88;Gene;PA166204001;Chemical
RS387907272;MYD88;Gene;PA166224421;Variant
FENTANYL;MYD88;Gene;PA449599;Chemical
DESFLURANE;rs118192124;Variant;PA164749136;Chemical
RYR1;rs118192124;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs118192124;Variant;PA444863;Disease
ENFLURANE;rs118192124;Variant;PA449461;Chemical
HALOTHANE;rs118192124;Variant;PA449845;Chemical
ISOFLURANE;rs118192124;Variant;PA450106;Chemical
METHOXYFLURANE;rs118192124;Variant;PA450434;Chemical
SEVOFLURANE;rs118192124;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs118192124;Variant;PA451522;Chemical
CACNA1S;rs118192124;Variant;PA85;Gene
TXNDC11;hydrochlorothiazide;Chemical;PA134915251;Gene
FBXL17;hydrochlorothiazide;Chemical;PA134920563;Gene
LRRC15;hydrochlorothiazide;Chemical;PA134956867;Gene
YEATS4;hydrochlorothiazide;Chemical;PA134992686;Gene
DOT1L;hydrochlorothiazide;Chemical;PA134993717;Gene
ACE;hydrochlorothiazide;Chemical;PA139;Gene
SLC25A31;hydrochlorothiazide;Chemical;PA142670904;Gene
ANKFN1;hydrochlorothiazide;Chemical;PA142672624;Gene
ADO;hydrochlorothiazide;Chemical;PA162375713;Gene
TET2;hydrochlorothiazide;Chemical;PA162405634;Gene
C5ORF56;hydrochlorothiazide;Chemical;PA165660191;Gene
RS4132670;hydrochlorothiazide;Chemical;PA166154046;Variant
RS4506565;hydrochlorothiazide;Chemical;PA166154056;Variant
RS7917983;hydrochlorothiazide;Chemical;PA166154091;Variant
RS11189015;hydrochlorothiazide;Chemical;PA166154128;Variant
RS658903;hydrochlorothiazide;Chemical;PA166154290;Variant
RS3758785;hydrochlorothiazide;Chemical;PA166154400;Variant
RS10792367;hydrochlorothiazide;Chemical;PA166154436;Variant
RS11600347;hydrochlorothiazide;Chemical;PA166154459;Variant
RS12795437;hydrochlorothiazide;Chemical;PA166154466;Variant
RS880054;hydrochlorothiazide;Chemical;PA166154506;Variant
RS7297610;hydrochlorothiazide;Chemical;PA166154598;Variant
RS9590353;hydrochlorothiazide;Chemical;PA166154744;Variant
RS77876672;hydrochlorothiazide;Chemical;PA166154758;Variant
RS2776546;hydrochlorothiazide;Chemical;PA166154798;Variant
RS1378942;hydrochlorothiazide;Chemical;PA166154861;Variant
RS1799752;hydrochlorothiazide;Chemical;PA166155187;Variant
RS4791040;hydrochlorothiazide;Chemical;PA166155224;Variant
RS9915451;hydrochlorothiazide;Chemical;PA166155242;Variant
RS16960228;hydrochlorothiazide;Chemical;PA166155256;Variant
RS292449;hydrochlorothiazide;Chemical;PA166155267;Variant
RS4149601;hydrochlorothiazide;Chemical;PA166155293;Variant
RS2269879;hydrochlorothiazide;Chemical;PA166155390;Variant
RS113095083;hydrochlorothiazide;Chemical;PA166155903;Variant
RS2273359;hydrochlorothiazide;Chemical;PA166155924;Variant
RS4815273;hydrochlorothiazide;Chemical;PA166155948;Variant
RS11313667;hydrochlorothiazide;Chemical;PA166156442;Variant
RS4961;hydrochlorothiazide;Chemical;PA166156480;Variant
RS12505746;hydrochlorothiazide;Chemical;PA166156660;Variant
RS201279313;hydrochlorothiazide;Chemical;PA166156703;Variant
RS4431329;hydrochlorothiazide;Chemical;PA166156827;Variant
RS7706429;hydrochlorothiazide;Chemical;PA166156846;Variant
RS9285669;hydrochlorothiazide;Chemical;PA166156850;Variant
RS7387065;hydrochlorothiazide;Chemical;PA166157626;Variant
RS11993031;hydrochlorothiazide;Chemical;PA166157638;Variant
RS238;hydrochlorothiazide;Chemical;PA166157695;Variant
RS12346562;hydrochlorothiazide;Chemical;PA166157835;Variant
RS10995;hydrochlorothiazide;Chemical;PA166162510;Variant
RS9943291;hydrochlorothiazide;Chemical;PA166177889;Variant
RS61824877;hydrochlorothiazide;Chemical;PA166177898;Variant
URIC ACID;hydrochlorothiazide;Chemical;PA166178378;Chemical
RS11065987;hydrochlorothiazide;Chemical;PA166179453;Variant
RS261316;hydrochlorothiazide;Chemical;PA166179574;Variant
RS35123024;hydrochlorothiazide;Chemical;PA166179575;Variant
RS3784921;hydrochlorothiazide;Chemical;PA166185466;Variant
RS12579720;hydrochlorothiazide;Chemical;PA166199003;Variant
RS10995311;hydrochlorothiazide;Chemical;PA166199005;Variant
RS932764;hydrochlorothiazide;Chemical;PA166199007;Variant
RS10224002;hydrochlorothiazide;Chemical;PA166199021;Variant
RS12521868;hydrochlorothiazide;Chemical;PA166199022;Variant
RS757081;hydrochlorothiazide;Chemical;PA166199041;Variant
KCNJ1;hydrochlorothiazide;Chemical;PA213;Gene
ALDH1A2;hydrochlorothiazide;Chemical;PA24693;Gene
CSK;hydrochlorothiazide;Chemical;PA26946;Gene
CSMD1;hydrochlorothiazide;Chemical;PA26947;Gene
DIAPH3;hydrochlorothiazide;Chemical;PA27335;Gene
GPR83;hydrochlorothiazide;Chemical;PA28927;Gene
HMGCS2;hydrochlorothiazide;Chemical;PA29338;Gene
ILKAP;hydrochlorothiazide;Chemical;PA29856;Gene
ADD1;hydrochlorothiazide;Chemical;PA31;Gene
NEDD4L;hydrochlorothiazide;Chemical;PA31534;Gene
NUCB2;hydrochlorothiazide;Chemical;PA31826;Gene
PDE3A;hydrochlorothiazide;Chemical;PA33126;Gene
PLCE1;hydrochlorothiazide;Chemical;PA33391;Gene
PRKAG2;hydrochlorothiazide;Chemical;PA33752;Gene
PRKCA;hydrochlorothiazide;Chemical;PA33759;Gene
WNK1;hydrochlorothiazide;Chemical;PA33782;Gene
SLIT1;hydrochlorothiazide;Chemical;PA35938;Gene
TCF7L2;hydrochlorothiazide;Chemical;PA36394;Gene
VASP;hydrochlorothiazide;Chemical;PA37276;Gene
ADRB1;hydrochlorothiazide;Chemical;PA38;Gene
UGGT2;hydrochlorothiazide;Chemical;PA38015;Gene
NELFCD;hydrochlorothiazide;Chemical;PA38055;Gene
ELF2;SLC9A3R2;Gene;PA27745;Gene
OVERALL SURVIVAL;GLI1;Gene;PA166123207;Disease
RECURRENCE FREE SURVIVAL;GLI1;Gene;PA166127658;Disease
LEUKEMIA, MYELOID, ACUTE;GLI1;Gene;PA444760;Disease
CYTARABINE;GLI1;Gene;PA449177;Chemical
SCHIZOPHRENIA;rs9346455;Variant;PA447216;Disease
ANTIPSYCHOTICS;rs9346455;Variant;PA452233;Chemical
SLCO1B1;caspofungin;Chemical;PA134865839;Gene
CYP2D6;agitation;Disease;PA128;Gene
CYP2D6*1;agitation;Disease;PA165816576;Haplotype
CYP2D6*2;agitation;Disease;PA165816577;Haplotype
CYP2D6*3;agitation;Disease;PA165816578;Haplotype
CYP2D6*4;agitation;Disease;PA165816579;Haplotype
CYP2D6*6;agitation;Disease;PA165816581;Haplotype
CYP2D6*10;agitation;Disease;PA165816582;Haplotype
CYP2D6*5;agitation;Disease;PA165948092;Haplotype
CYP2D6*81;agitation;Disease;PA166123321;Haplotype
DRUG TOXICITY;rs10958704;Variant;PA443937;Disease
SORAFENIB;rs10958704;Variant;PA7000;Chemical
MYALGIA;HTR3B;Gene;PA157379134;Disease
HEROIN DEPENDENCE;HTR3B;Gene;PA444460;Disease
TOBACCO USE DISORDER;HTR3B;Gene;PA445876;Disease
MENTAL DISORDERS;HTR3B;Gene;PA447208;Disease
ATORVASTATIN;HTR3B;Gene;PA448500;Chemical
NICOTINE;HTR3B;Gene;PA450626;Chemical
PAROXETINE;HTR3B;Gene;PA450801;Chemical
PRAVASTATIN;HTR3B;Gene;PA451089;Chemical
SIMVASTATIN;HTR3B;Gene;PA451363;Chemical
HEROIN;HTR3B;Gene;PA452619;Chemical
COLONIC NEOPLASMS;rs1105879;Variant;PA443756;Disease
EPILEPSY;rs1105879;Variant;PA444065;Disease
ASPIRIN;rs1105879;Variant;PA448497;Chemical
VALPROIC ACID;rs1105879;Variant;PA451846;Chemical
HIV INFECTIOUS DISEASE;rs212091;Variant;PA447230;Disease
LAMIVUDINE;rs212091;Variant;PA450163;Chemical
LOPINAVIR;rs212091;Variant;PA450264;Chemical
RITONAVIR;rs212091;Variant;PA451260;Chemical
ZIDOVUDINE;rs212091;Variant;PA451954;Chemical
DULOXETINE;ZNF385D;Gene;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;ZNF385D;Gene;PA447321;Disease
VENETOCLAX;IDH1;Gene;PA166153473;Chemical
IVOSIDENIB;IDH1;Gene;PA166182707;Chemical
RS121913500;IDH1;Gene;PA166182713;Variant
OLUTASIDENIB;IDH1;Gene;PA166293881;Chemical
RS121913499;IDH1;Gene;PA166293901;Variant
VORASIDENIB;IDH1;Gene;PA166400022;Chemical
CETUXIMAB;rs2236947;Variant;PA10040;Chemical
COLORECTAL NEOPLASMS;rs2236947;Variant;PA446108;Disease
NFKB1;CAMK1;Gene;PA248;Gene
ELK1;CAMK1;Gene;PA27749;Gene
FOS;CAMK1;Gene;PA28212;Gene
RELA;CAMK1;Gene;PA296;Gene
JUN;CAMK1;Gene;PA30006;Gene
MYC;CAMK1;Gene;PA31353;Gene
NFKB2;CAMK1;Gene;PA31600;Gene
STAT3;CAMK1;Gene;PA337;Gene
STAT5A;CAMK1;Gene;PA338;Gene
SP1;CAMK1;Gene;PA36042;Gene
STAT1;CAMK1;Gene;PA36183;Gene
STAT2;CAMK1;Gene;PA36184;Gene
STAT4;CAMK1;Gene;PA36185;Gene
STAT5B;CAMK1;Gene;PA36186;Gene
ALCOHOL ABUSE;rs1034936;Variant;PA443309;Disease
BIPOLAR DISORDER;rs1034936;Variant;PA447199;Disease
ETHANOL;rs1034936;Variant;PA448073;Chemical
FLUOROURACIL;TPMT;Gene;PA128406956;Chemical
TRANSPLANTATION;TPMT;Gene;PA134850491;Disease
OTOTOXICITY;TPMT;Gene;PA162263534;Disease
S-ADENOSYLMETHIONINE;TPMT;Gene;PA164754994;Chemical
KIDNEY TRANSPLANTATION;TPMT;Gene;PA165817016;Disease
MYELOSUPPRESSION;TPMT;Gene;PA165817398;Disease
TPMT*1;TPMT;Gene;PA165819268;Haplotype
TPMT*2;TPMT;Gene;PA165819269;Haplotype
TPMT*3A;TPMT;Gene;PA165819270;Haplotype
TPMT*3B;TPMT;Gene;PA165819271;Haplotype
TPMT*3C;TPMT;Gene;PA165819272;Haplotype
TPMT*4;TPMT;Gene;PA165819274;Haplotype
TPMT*5;TPMT;Gene;PA165819275;Haplotype
TPMT*6;TPMT;Gene;PA165819276;Haplotype
TPMT*7;TPMT;Gene;PA165819277;Haplotype
TPMT*8;TPMT;Gene;PA165819278;Haplotype
TPMT*9;TPMT;Gene;PA165819279;Haplotype
TPMT*10;TPMT;Gene;PA165819280;Haplotype
TPMT*11;TPMT;Gene;PA165819281;Haplotype
TPMT*12;TPMT;Gene;PA165819282;Haplotype
TPMT*13;TPMT;Gene;PA165819283;Haplotype
TPMT*14;TPMT;Gene;PA165819284;Haplotype
TPMT*15;TPMT;Gene;PA165819285;Haplotype
TPMT*16;TPMT;Gene;PA165819286;Haplotype
TPMT*17;TPMT;Gene;PA165819287;Haplotype
TPMT*18;TPMT;Gene;PA165819288;Haplotype
TRANSPLANT REJECTION;TPMT;Gene;PA166114454;Disease
HEART TRANSPLANTATION;TPMT;Gene;PA166114458;Disease
EVENT-FREE SURVIVAL;TPMT;Gene;PA166123366;Disease
DISCONTINUATION;TPMT;Gene;PA166123507;Disease
NUDT15*2;TPMT;Gene;PA166131620;Haplotype
NUDT15*3;TPMT;Gene;PA166131621;Haplotype
RS116855232;TPMT;Gene;PA166154759;Variant
DOSE REDUCTION;TPMT;Gene;PA166159953;Disease
THIOGUANOSINE MONOPHOSPHATE;TPMT;Gene;PA166160623;Chemical
THIOGUANOSINE DIPHOSPHATE;TPMT;Gene;PA166160632;Chemical
THIOGUANOSINE TRIPHOSPHATE;TPMT;Gene;PA166160633;Chemical
DEOXY-THIOGUANOSINE TRIPHOSPHATE;TPMT;Gene;PA166160634;Chemical
ARTHRITIS, RHEUMATOID;TPMT;Gene;PA443434;Disease
COLITIS, ULCERATIVE;TPMT;Gene;PA443750;Disease
CROHN DISEASE;TPMT;Gene;PA443815;Disease
DEATH;TPMT;Gene;PA443842;Disease
DIZZINESS;TPMT;Gene;PA443928;Disease
DRUG TOXICITY;TPMT;Gene;PA443937;Disease
FATIGUE;TPMT;Gene;PA444153;Disease
HEAD AND NECK NEOPLASMS;TPMT;Gene;PA444352;Disease
HEMATOLOGIC DISEASES;TPMT;Gene;PA444395;Disease
INFECTION;TPMT;Gene;PA444614;Disease
INFLAMMATION;TPMT;Gene;PA444620;Disease
LEUKEMIA;TPMT;Gene;PA444750;Disease
LEUKEMIA, MYELOID, ACUTE;TPMT;Gene;PA444760;Disease
LEUKOPENIA;TPMT;Gene;PA444773;Disease
LUPUS ERYTHEMATOSUS, SYSTEMIC;TPMT;Gene;PA444822;Disease
NEOPLASMS;TPMT;Gene;PA445062;Disease
NEUTROPENIA;TPMT;Gene;PA445113;Disease
OVARIAN NEOPLASMS;TPMT;Gene;PA445204;Disease
PANCYTOPENIA;TPMT;Gene;PA445221;Disease
RHEUMATIC DISEASES;TPMT;Gene;PA445555;Disease
SKIN NEOPLASMS;TPMT;Gene;PA445683;Disease
STOMATITIS;TPMT;Gene;PA445746;Disease
THROMBOCYTOPENIA;TPMT;Gene;PA445846;Disease
INFLAMMATORY BOWEL DISEASES;TPMT;Gene;PA446116;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;TPMT;Gene;PA446155;Disease
HEPATITIS, AUTOIMMUNE;TPMT;Gene;PA446861;Disease
LIVER TRANSPLANTATION;TPMT;Gene;PA447247;Disease
AZATHIOPRINE;TPMT;Gene;PA448515;Chemical
CISPLATIN;TPMT;Gene;PA449014;Chemical
CYCLOPHOSPHAMIDE;TPMT;Gene;PA449165;Chemical
CYCLOSPORINE;TPMT;Gene;PA449167;Chemical
MERCAPTOPURINE;TPMT;Gene;PA450379;Chemical
METHOTREXATE;TPMT;Gene;PA450428;Chemical
OLANZAPINE;TPMT;Gene;PA450688;Chemical
PREDNISONE;TPMT;Gene;PA451100;Chemical
THIOGUANINE;TPMT;Gene;PA451663;Chemical
PURINE ANALOGUES;TPMT;Gene;PA452634;Chemical
F13A1;Choroidal Neovascularization;Disease;PA162;Gene
RS5985;Choroidal Neovascularization;Disease;PA166156902;Variant
RS2010963;Choroidal Neovascularization;Disease;PA166157006;Variant
VEGFA;Choroidal Neovascularization;Disease;PA37302;Gene
CYP2D6;Head and Neck Neoplasms;Disease;PA128;Gene
DPYD;Head and Neck Neoplasms;Disease;PA145;Gene
CYP2D6*1;Head and Neck Neoplasms;Disease;PA165816576;Haplotype
CYP2D6*2;Head and Neck Neoplasms;Disease;PA165816577;Haplotype
CYP2D6*10;Head and Neck Neoplasms;Disease;PA165816582;Haplotype
TPMT*3B;Head and Neck Neoplasms;Disease;PA165819271;Haplotype
TPMT*3C;Head and Neck Neoplasms;Disease;PA165819272;Haplotype
CYP2D6*5;Head and Neck Neoplasms;Disease;PA165948092;Haplotype
RS1801274;Head and Neck Neoplasms;Disease;PA166153652;Variant
RS2227983;Head and Neck Neoplasms;Disease;PA166157331;Variant
DPYD DEFICIENCY;Head and Neck Neoplasms;Disease;PA166157931;Variant
FCGR2A;Head and Neck Neoplasms;Disease;PA28063;Gene
TPMT;Head and Neck Neoplasms;Disease;PA356;Gene
EGFR;Head and Neck Neoplasms;Disease;PA7360;Gene
CFTR;rs1800076;Variant;PA109;Gene
IVACAFTOR;rs1800076;Variant;PA165950341;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs1800076;Variant;PA166190041;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs1800076;Variant;PA166362502;Chemical
CYSTIC FIBROSIS;rs1800076;Variant;PA443829;Disease
FLUOROURACIL;PIK3R2;Gene;PA128406956;Chemical
AKT1;PIK3R2;Gene;PA24684;Gene
ERBB2;PIK3R2;Gene;PA27844;Gene
ERBB3;PIK3R2;Gene;PA27846;Gene
ERBB4;PIK3R2;Gene;PA27847;Gene
FLT1;PIK3R2;Gene;PA28180;Gene
FLT4;PIK3R2;Gene;PA28183;Gene
KDR;PIK3R2;Gene;PA30086;Gene
BREAST NEOPLASMS;PIK3R2;Gene;PA443560;Disease
NEUTROPENIA;PIK3R2;Gene;PA445113;Disease
CYCLOPHOSPHAMIDE;PIK3R2;Gene;PA449165;Chemical
EPIRUBICIN;PIK3R2;Gene;PA449476;Chemical
EGFR;PIK3R2;Gene;PA7360;Gene
TOBACCO USE DISORDER;DDC;Gene;PA445876;Disease
CARBIDOPA;DDC;Gene;PA448794;Chemical
NICOTINE;DDC;Gene;PA450626;Chemical
BIPOLAR DISORDER;FOXP1;Gene;PA447199;Disease
HYPERTENSION;rs3784921;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs3784921;Variant;PA449899;Chemical
RS17602729;regadenoson;Chemical;PA166153876;Variant
AMPD1;regadenoson;Chemical;PA24776;Gene
MECASERMIN;GHR;Gene;PA164774876;Chemical
FLUOROURACIL;CBR1;Gene;PA128406956;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;CBR1;Gene;PA130620651;Chemical
DOXORUBICINOL;CBR1;Gene;PA165291922;Chemical
BREAST NEOPLASMS;CBR1;Gene;PA443560;Disease
CARDIOMYOPATHIES;CBR1;Gene;PA445018;Disease
NEOPLASMS;CBR1;Gene;PA445062;Disease
CYCLOPHOSPHAMIDE;CBR1;Gene;PA449165;Chemical
DAUNORUBICIN;CBR1;Gene;PA449212;Chemical
DOXORUBICIN;CBR1;Gene;PA449412;Chemical
ALCOHOL ABUSE;rs1042173;Variant;PA443309;Disease
PAIN;rs1042173;Variant;PA445208;Disease
MORPHINE;rs1042173;Variant;PA450550;Chemical
ONDANSETRON;rs1042173;Variant;PA450705;Chemical
MAPK8;MAP2K4;Gene;PA283;Gene
MAP3K1;MAP2K4;Gene;PA30592;Gene
MAPK1;MAP2K4;Gene;PA30616;Gene
MAPK10;MAP2K4;Gene;PA30617;Gene
MAPK11;MAP2K4;Gene;PA30618;Gene
MAPK12;MAP2K4;Gene;PA30619;Gene
MAPK13;MAP2K4;Gene;PA30620;Gene
MAPK14;MAP2K4;Gene;PA30621;Gene
MAPK3;MAP2K4;Gene;PA30622;Gene
MAPK4;MAP2K4;Gene;PA30623;Gene
MAPK6;MAP2K4;Gene;PA30624;Gene
MAPK7;MAP2K4;Gene;PA30625;Gene
MAPK9;MAP2K4;Gene;PA30630;Gene
RAF1;MAP2K4;Gene;PA34183;Gene
ALCOHOL ABUSE;MAP2K4;Gene;PA443309;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;MAP2K4;Gene;PA447197;Disease
ETHANOL;MAP2K4;Gene;PA448073;Chemical
CYP3A5;hydroxyzine;Chemical;PA131;Gene
KCNH2;hydroxyzine;Chemical;PA212;Gene
OPIOID-RELATED DISORDERS;rs6973474;Variant;PA445043;Disease
BUPRENORPHINE;rs6973474;Variant;PA448685;Chemical
OPIOID-RELATED DISORDERS;GPR98;Gene;PA445043;Disease
SEIZURES;GPR98;Gene;PA445629;Disease
OPIOIDS;GPR98;Gene;PA452618;Chemical
COMT;hydrocodone;Chemical;PA117;Gene
CYP2D6;hydrocodone;Chemical;PA128;Gene
CYP3A5;hydrocodone;Chemical;PA131;Gene
WBP2NL;hydrocodone;Chemical;PA145147710;Gene
CYP2D6*1;hydrocodone;Chemical;PA165816576;Haplotype
CYP2D6*2;hydrocodone;Chemical;PA165816577;Haplotype
CYP2D6*3;hydrocodone;Chemical;PA165816578;Haplotype
CYP2D6*4;hydrocodone;Chemical;PA165816579;Haplotype
CYP2D6*6;hydrocodone;Chemical;PA165816581;Haplotype
CYP2D6*17;hydrocodone;Chemical;PA165816583;Haplotype
CYP2D6*41;hydrocodone;Chemical;PA165816584;Haplotype
CYP2D6*5;hydrocodone;Chemical;PA165948092;Haplotype
CYP2D6*2XN;hydrocodone;Chemical;PA165988480;Haplotype
RS1799971;hydrocodone;Chemical;PA166156991;Variant
RS62436463;hydrocodone;Chemical;PA166257861;Variant
RS739296;hydrocodone;Chemical;PA166257862;Variant
SEPTIN3;hydrocodone;Chemical;PA24355;Gene
OPRM1;hydrocodone;Chemical;PA31945;Gene
COMT;Temporomandibular joint dysfunction syndrome;Disease;PA117;Gene
RS4680;Temporomandibular joint dysfunction syndrome;Disease;PA166156024;Variant
CYP3A5;clindamycin;Chemical;PA131;Gene
HLA-B*15:27;clindamycin;Chemical;PA165954816;Haplotype
HLA-B*51:01;clindamycin;Chemical;PA165956201;Haplotype
HLA-B;clindamycin;Chemical;PA35056;Gene
NR1I2;clindamycin;Chemical;PA378;Gene
MAJOR DEPRESSIVE DISORDER;rs10879346;Variant;PA447321;Disease
MIRTAZAPINE;rs10879346;Variant;PA450522;Chemical
VENLAFAXINE;rs10879346;Variant;PA451866;Chemical
ANTIDEPRESSANTS;rs10879346;Variant;PA452229;Chemical
COMT;levodopa;Chemical;PA117;Gene
HOMER1;levodopa;Chemical;PA134972608;Gene
DBH;levodopa;Chemical;PA136;Gene
RS1799732;levodopa;Chemical;PA166154334;Variant
RS6280;levodopa;Chemical;PA166156277;Variant
RS3836790;levodopa;Chemical;PA166156819;Variant
RS4704559;levodopa;Chemical;PA166156833;Variant
RS622342;levodopa;Chemical;PA166156932;Variant
RS1611115;levodopa;Chemical;PA166157734;Variant
MTHFR;levodopa;Chemical;PA245;Gene
DRD2;levodopa;Chemical;PA27478;Gene
DRD3;levodopa;Chemical;PA27479;Gene
SLC6A3;levodopa;Chemical;PA311;Gene
SLC22A1;levodopa;Chemical;PA329;Gene
O-DESMETHYLTRAMADOL;SULT1A3;Gene;PA166131379;Chemical
TAPENTADOL;SULT1A3;Gene;PA166179720;Chemical
ACETAMINOPHEN;SULT1A3;Gene;PA448015;Chemical
MORPHINE;SULT1A3;Gene;PA450550;Chemical
TRAMADOL;SULT1A3;Gene;PA451735;Chemical
ASPIRIN;rs5050;Variant;PA448497;Chemical
DULOXETINE;rs61908409;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs61908409;Variant;PA447321;Disease
EVEROLIMUS;MTOR;Gene;PA164746311;Chemical
BREAST NEOPLASMS;MTOR;Gene;PA443560;Disease
KIDNEY NEOPLASMS;MTOR;Gene;PA444685;Disease
NEUROENDOCRINE TUMORS;MTOR;Gene;PA446713;Disease
ESCITALOPRAM;rs6313;Variant;PA10074;Chemical
WEIGHT GAIN;rs6313;Variant;PA128406954;Disease
ADVERSE EVENTS;rs6313;Variant;PA166151827;Disease
ALZHEIMER DISEASE;rs6313;Variant;PA443319;Disease
DRUG TOXICITY;rs6313;Variant;PA443937;Disease
ANXIETY DISORDERS;rs6313;Variant;PA447196;Disease
BIPOLAR DISORDER;rs6313;Variant;PA447199;Disease
SCHIZOPHRENIA;rs6313;Variant;PA447216;Disease
PHYSIOLOGICAL SEXUAL DISORDER;rs6313;Variant;PA447218;Disease
HIV INFECTIOUS DISEASE;rs6313;Variant;PA447230;Disease
DEPRESSION;rs6313;Variant;PA447278;Disease
MAJOR DEPRESSIVE DISORDER;rs6313;Variant;PA447321;Disease
CITALOPRAM;rs6313;Variant;PA449015;Chemical
EFAVIRENZ;rs6313;Variant;PA449441;Chemical
FLUOXETINE;rs6313;Variant;PA449673;Chemical
FLUVOXAMINE;rs6313;Variant;PA449690;Chemical
OLANZAPINE;rs6313;Variant;PA450688;Chemical
PAROXETINE;rs6313;Variant;PA450801;Chemical
RISPERIDONE;rs6313;Variant;PA451257;Chemical
SERTRALINE;rs6313;Variant;PA451333;Chemical
VENLAFAXINE;rs6313;Variant;PA451866;Chemical
ANTIDEPRESSANTS;rs6313;Variant;PA452229;Chemical
LAROTRECTINIB;NTRK3;Gene;PA166182733;Chemical
ENTRECTINIB;NTRK3;Gene;PA166190161;Chemical
REPOTRECTINIB;NTRK3;Gene;PA166328881;Chemical
BIPOLAR DISORDER;NTRK3;Gene;PA447199;Disease
FLUOROURACIL;rs17376848;Variant;PA128406956;Chemical
DPYD;rs17376848;Variant;PA145;Gene
NEOPLASMS;rs17376848;Variant;PA445062;Disease
CAPECITABINE;rs17376848;Variant;PA448771;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs2299939;Variant;PA443622;Disease
CARBOPLATIN;rs2299939;Variant;PA448803;Chemical
CISPLATIN;rs2299939;Variant;PA449014;Chemical
MGMT;Glioblastoma;Disease;PA239;Gene
TERT;Glioblastoma;Disease;PA36447;Gene
BIPOLAR DISORDER;ASIC2;Gene;PA447199;Disease
LITHIUM;ASIC2;Gene;PA450243;Chemical
CYP2B6;drug-induced liver injury;Disease;PA123;Gene
CYP2C9;drug-induced liver injury;Disease;PA126;Gene
CYP2E1;drug-induced liver injury;Disease;PA129;Gene
CYP3A5;drug-induced liver injury;Disease;PA131;Gene
SLCO1B1;drug-induced liver injury;Disease;PA134865839;Gene
DHFR;drug-induced liver injury;Disease;PA143;Gene
CYP2C9*1;drug-induced liver injury;Disease;PA165816542;Haplotype
CYP2C9*2;drug-induced liver injury;Disease;PA165816543;Haplotype
CYP2B6*1;drug-induced liver injury;Disease;PA165818750;Haplotype
CYP2B6*6;drug-induced liver injury;Disease;PA165818762;Haplotype
SLCO1B1*15;drug-induced liver injury;Disease;PA165819265;Haplotype
NAT2*4;drug-induced liver injury;Disease;PA165949098;Haplotype
NAT2*5A;drug-induced liver injury;Disease;PA165949099;Haplotype
NAT2*12A;drug-induced liver injury;Disease;PA165949138;Haplotype
HLA-DPB1*01:01;drug-induced liver injury;Disease;PA165951121;Haplotype
HLA-DPB1*10:01;drug-induced liver injury;Disease;PA165951154;Haplotype
HLA-DQA1*02:01;drug-induced liver injury;Disease;PA165951292;Haplotype
HLA-DRB1*04:04;drug-induced liver injury;Disease;PA165951511;Haplotype
HLA-DRB1*07:01;drug-induced liver injury;Disease;PA165951644;Haplotype
HLA-DRB1*15:01;drug-induced liver injury;Disease;PA165952269;Haplotype
HLA-DRB1*15:03;drug-induced liver injury;Disease;PA165952297;Haplotype
HLA-DRB1*16:01;drug-induced liver injury;Disease;PA165952366;Haplotype
HLA-A*01:01;drug-induced liver injury;Disease;PA165952609;Haplotype
HLA-A*30:02;drug-induced liver injury;Disease;PA165953969;Haplotype
HLA-A*31:01;drug-induced liver injury;Disease;PA165954030;Haplotype
HLA-A*33:01;drug-induced liver injury;Disease;PA165954144;Haplotype
HLA-B*08:01;drug-induced liver injury;Disease;PA165954547;Haplotype
HLA-B*18:01;drug-induced liver injury;Disease;PA165955030;Haplotype
HLA-B*39:01;drug-induced liver injury;Disease;PA165955543;Haplotype
HLA-B*52:01;drug-induced liver injury;Disease;PA165956366;Haplotype
HLA-B*57:03;drug-induced liver injury;Disease;PA165956579;Haplotype
HLA-C*06:02;drug-induced liver injury;Disease;PA165957286;Haplotype
HLA-C*12:03;drug-induced liver injury;Disease;PA165957729;Haplotype
HLA-DQB1*05:01;drug-induced liver injury;Disease;PA165958073;Haplotype
HLA-DQB1*05:02;drug-induced liver injury;Disease;PA165958077;Haplotype
HLA-DQB1*05:03;drug-induced liver injury;Disease;PA165958080;Haplotype
HLA-DQB1*06:02;drug-induced liver injury;Disease;PA165958103;Haplotype
HLA-DQB1*02:01;drug-induced liver injury;Disease;PA165958158;Haplotype
HLA-DQB1*03:03;drug-induced liver injury;Disease;PA165958180;Haplotype
NAT2*5;drug-induced liver injury;Disease;PA165981634;Haplotype
NAT2*6;drug-induced liver injury;Disease;PA165981635;Haplotype
NAT2*7;drug-induced liver injury;Disease;PA165981636;Haplotype
NAT2*14;drug-induced liver injury;Disease;PA165981640;Haplotype
SLCO1B1*1;drug-induced liver injury;Disease;PA165981641;Haplotype
HLA-B*57:01;drug-induced liver injury;Disease;PA165987830;Haplotype
HLA-B*58:01;drug-induced liver injury;Disease;PA165987831;Haplotype
HLA-C*03:02;drug-induced liver injury;Disease;PA166123425;Haplotype
HLA-DRB1*03:01;drug-induced liver injury;Disease;PA166123430;Haplotype
CYP3A5*1;drug-induced liver injury;Disease;PA166128213;Haplotype
CYP3A5*3;drug-induced liver injury;Disease;PA166128219;Haplotype
RS1695;drug-induced liver injury;Disease;PA166154249;Variant
RS11125883;drug-induced liver injury;Disease;PA166155800;Variant
RS2070401;drug-induced liver injury;Disease;PA166155995;Variant
RS70991108;drug-induced liver injury;Disease;PA166156893;Variant
RS4720833;drug-induced liver injury;Disease;PA166157396;Variant
RS2205986;drug-induced liver injury;Disease;PA166179805;Variant
HLA-B*35:02;drug-induced liver injury;Disease;PA166288241;Haplotype
NAT2;drug-induced liver injury;Disease;PA18;Gene
BACH1;drug-induced liver injury;Disease;PA25234;Gene
GSTP1;drug-induced liver injury;Disease;PA29028;Gene
IRF6;drug-induced liver injury;Disease;PA29920;Gene
MAFK;drug-induced liver injury;Disease;PA30540;Gene
HLA-A;drug-induced liver injury;Disease;PA35055;Gene
HLA-B;drug-induced liver injury;Disease;PA35056;Gene
HLA-C;drug-induced liver injury;Disease;PA35057;Gene
HLA-DPB1;drug-induced liver injury;Disease;PA35064;Gene
HLA-DQA1;drug-induced liver injury;Disease;PA35066;Gene
HLA-DQB1;drug-induced liver injury;Disease;PA35068;Gene
HLA-DRB1;drug-induced liver injury;Disease;PA35072;Gene
XPO1;drug-induced liver injury;Disease;PA37418;Gene
UGT1A9;drug-induced liver injury;Disease;PA419;Gene
HLA-B*35:03;Rubella vaccines;Chemical;PA165955249;Haplotype
HLA-C*15:02;Rubella vaccines;Chemical;PA165957859;Haplotype
HLA-B;Rubella vaccines;Chemical;PA35056;Gene
HLA-C;Rubella vaccines;Chemical;PA35057;Gene
COMT;fremanezumab;Chemical;PA117;Gene
RS4680;fremanezumab;Chemical;PA166156024;Variant
RS12615320;fremanezumab;Chemical;PA166349381;Variant
CYP2C9;SLCO1B1*15;Haplotype;PA126;Gene
ROSUVASTATIN;SLCO1B1*15;Haplotype;PA134308647;Chemical
SLCO1B1;SLCO1B1*15;Haplotype;PA134865839;Gene
PITAVASTATIN;SLCO1B1*15;Haplotype;PA142650384;Chemical
ATRASENTAN;SLCO1B1*15;Haplotype;PA143414738;Chemical
OLMESARTAN;SLCO1B1*15;Haplotype;PA164742950;Chemical
DRUG-INDUCED LIVER INJURY;SLCO1B1*15;Haplotype;PA166119041;Disease
SIMVASTATIN ACID;SLCO1B1*15;Haplotype;PA166129446;Chemical
LOVASTATIN ACID;SLCO1B1*15;Haplotype;PA166163161;Chemical
STATIN-RELATED MYOPATHY;SLCO1B1*15;Haplotype;PA166163391;Disease
ABCG2;SLCO1B1*15;Haplotype;PA390;Gene
BREAST NEOPLASMS;SLCO1B1*15;Haplotype;PA443560;Disease
HYPERCHOLESTEROLEMIA;SLCO1B1*15;Haplotype;PA444516;Disease
NAUSEA;SLCO1B1*15;Haplotype;PA445048;Disease
INFLAMMATORY BOWEL DISEASES;SLCO1B1*15;Haplotype;PA446116;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;SLCO1B1*15;Haplotype;PA446155;Disease
ATORVASTATIN;SLCO1B1*15;Haplotype;PA448500;Chemical
CERIVASTATIN;SLCO1B1*15;Haplotype;PA448897;Chemical
FLUVASTATIN;SLCO1B1*15;Haplotype;PA449688;Chemical
LOVASTATIN;SLCO1B1*15;Haplotype;PA450272;Chemical
METHOTREXATE;SLCO1B1*15;Haplotype;PA450428;Chemical
PACLITAXEL;SLCO1B1*15;Haplotype;PA450761;Chemical
PRAVASTATIN;SLCO1B1*15;Haplotype;PA451089;Chemical
REPAGLINIDE;SLCO1B1*15;Haplotype;PA451234;Chemical
RIFAMPIN;SLCO1B1*15;Haplotype;PA451250;Chemical
SIMVASTATIN;SLCO1B1*15;Haplotype;PA451363;Chemical
CYP2C8;gemcitabine;Chemical;PA125;Gene
ALG10;gemcitabine;Chemical;PA134732019;Gene
C6ORF15;gemcitabine;Chemical;PA134866404;Gene
PPP1R18;gemcitabine;Chemical;PA134918172;Gene
DOCK8;gemcitabine;Chemical;PA134918866;Gene
MUCL3;gemcitabine;Chemical;PA134926573;Gene
ATAT1;gemcitabine;Chemical;PA134948212;Gene
SLC29A3;gemcitabine;Chemical;PA134950750;Gene
HCP5;gemcitabine;Chemical;PA134951826;Gene
DCK;gemcitabine;Chemical;PA137;Gene
DCTD;gemcitabine;Chemical;PA138;Gene
SH2D5;gemcitabine;Chemical;PA142670927;Gene
PPCDC;gemcitabine;Chemical;PA142671157;Gene
KLC3;gemcitabine;Chemical;PA142671588;Gene
POLR1G;gemcitabine;Chemical;PA142672156;Gene
SLC29A1;gemcitabine;Chemical;PA154;Gene
ERCC1;gemcitabine;Chemical;PA155;Gene
CMPK1;gemcitabine;Chemical;PA162382539;Gene
FHL2;gemcitabine;Chemical;PA164;Gene
RS642990;gemcitabine;Chemical;PA166153582;Variant
RS1044457;gemcitabine;Chemical;PA166153608;Variant
RS1048977;gemcitabine;Chemical;PA166153610;Variant
RS1065634;gemcitabine;Chemical;PA166153621;Variant
RS2072671;gemcitabine;Chemical;PA166153667;Variant
RS4492666;gemcitabine;Chemical;PA166153766;Variant
RS7543016;gemcitabine;Chemical;PA166153793;Variant
RS10916852;gemcitabine;Chemical;PA166153814;Variant
RS11211524;gemcitabine;Chemical;PA166153822;Variant
RS12046844;gemcitabine;Chemical;PA166153842;Variant
RS12118636;gemcitabine;Chemical;PA166153850;Variant
RS35687416;gemcitabine;Chemical;PA166153880;Variant
RS60369023;gemcitabine;Chemical;PA166153893;Variant
RS201045130;gemcitabine;Chemical;PA166153937;Variant
RS370457585;gemcitabine;Chemical;PA166153938;Variant
RS374150125;gemcitabine;Chemical;PA166153939;Variant
RS1127687;gemcitabine;Chemical;PA166153965;Variant
RS2227310;gemcitabine;Chemical;PA166153999;Variant
RS4353229;gemcitabine;Chemical;PA166154054;Variant
RS7921977;gemcitabine;Chemical;PA166154092;Variant
RS11598702;gemcitabine;Chemical;PA166154142;Variant
RS12415607;gemcitabine;Chemical;PA166154152;Variant
RS9937;gemcitabine;Chemical;PA166154265;Variant
RS183484;gemcitabine;Chemical;PA166154269;Variant
RS232043;gemcitabine;Chemical;PA166154271;Variant
RS720106;gemcitabine;Chemical;PA166154298;Variant
RS1042858;gemcitabine;Chemical;PA166154309;Variant
RS1042927;gemcitabine;Chemical;PA166154311;Variant
RS2284449;gemcitabine;Chemical;PA166154365;Variant
RS11030918;gemcitabine;Chemical;PA166154447;Variant
RS12806698;gemcitabine;Chemical;PA166154468;Variant
RS1705772;gemcitabine;Chemical;PA166154517;Variant
RS6113;gemcitabine;Chemical;PA166154763;Variant
RS944050;gemcitabine;Chemical;PA166154769;Variant
RS1060896;gemcitabine;Chemical;PA166154857;Variant
RS2242046;gemcitabine;Chemical;PA166154881;Variant
RS11854484;gemcitabine;Chemical;PA166154934;Variant
RS11615;gemcitabine;Chemical;PA166155342;Variant
RS13181;gemcitabine;Chemical;PA166155343;Variant
RS3212986;gemcitabine;Chemical;PA166155407;Variant
RS1901440;gemcitabine;Chemical;PA166155653;Variant
RS17309872;gemcitabine;Chemical;PA166155966;Variant
RS1155463;gemcitabine;Chemical;PA166155992;Variant
RS11710163;gemcitabine;Chemical;PA166156444;Variant
RS11719165;gemcitabine;Chemical;PA166156446;Variant
RS2231142;gemcitabine;Chemical;PA166156544;Variant
RS4694362;gemcitabine;Chemical;PA166156595;Variant
RS12507552;gemcitabine;Chemical;PA166156661;Variant
RS66878317;gemcitabine;Chemical;PA166156693;Variant
RS274713;gemcitabine;Chemical;PA166156724;Variant
RS274717;gemcitabine;Chemical;PA166156725;Variant
RS451774;gemcitabine;Chemical;PA166156918;Variant
RS747199;gemcitabine;Chemical;PA166156945;Variant
RS760370;gemcitabine;Chemical;PA166156947;Variant
RS992160;gemcitabine;Chemical;PA166156966;Variant
RS1800629;gemcitabine;Chemical;PA166156997;Variant
RS9394992;gemcitabine;Chemical;PA166157157;Variant
RS73748206;gemcitabine;Chemical;PA166157218;Variant
RS3750117;gemcitabine;Chemical;PA166157378;Variant
RS7867504;gemcitabine;Chemical;PA166157795;Variant
RS11141915;gemcitabine;Chemical;PA166157828;Variant
RS780668;gemcitabine;Chemical;PA166179108;Variant
RS2228130;gemcitabine;Chemical;PA166179122;Variant
RS11280056;gemcitabine;Chemical;PA166180936;Variant
RS3825876;gemcitabine;Chemical;PA166182208;Variant
RS471760;gemcitabine;Chemical;PA166182211;Variant
RS12148896;gemcitabine;Chemical;PA166182212;Variant
RS147451859;gemcitabine;Chemical;PA166199721;Variant
RS17587029;gemcitabine;Chemical;PA166199722;Variant
RS5877;gemcitabine;Chemical;PA166201501;Variant
RS3094086;gemcitabine;Chemical;PA166201502;Variant
RS1049709;gemcitabine;Chemical;PA166201503;Variant
RS10885;gemcitabine;Chemical;PA166201504;Variant
RS3115672;gemcitabine;Chemical;PA166201505;Variant
RS9262132;gemcitabine;Chemical;PA166201521;Variant
RS9262143;gemcitabine;Chemical;PA166201522;Variant
RS886424;gemcitabine;Chemical;PA166201523;Variant
RS886423;gemcitabine;Chemical;PA166201524;Variant
RS2233980;gemcitabine;Chemical;PA166201525;Variant
RS3130985;gemcitabine;Chemical;PA166201526;Variant
RS3130907;gemcitabine;Chemical;PA166201527;Variant
RS11229;gemcitabine;Chemical;PA166201528;Variant
RS10491684;gemcitabine;Chemical;PA166201541;Variant
RS1058932;gemcitabine;Chemical;PA166201542;Variant
RS11572078;gemcitabine;Chemical;PA166201543;Variant
RS6118;gemcitabine;Chemical;PA166201545;Variant
RS6119;gemcitabine;Chemical;PA166201546;Variant
RS6504649;gemcitabine;Chemical;PA166201547;Variant
RS73450548;gemcitabine;Chemical;PA166201561;Variant
SLC29A2;gemcitabine;Chemical;PA191;Gene
ACSS2;gemcitabine;Chemical;PA24429;Gene
PRRC2A;gemcitabine;Chemical;PA25263;Gene
CASP7;gemcitabine;Chemical;PA26091;Gene
CDC5L;gemcitabine;Chemical;PA26270;Gene
CDSN;gemcitabine;Chemical;PA26348;Gene
DAPK1;gemcitabine;Chemical;PA27142;Gene
ERCC2;gemcitabine;Chemical;PA27848;Gene
ESR2;gemcitabine;Chemical;PA27886;Gene
ETS2;gemcitabine;Chemical;PA27903;Gene
FKBP5;gemcitabine;Chemical;PA28162;Gene
GPX5;gemcitabine;Chemical;PA28953;Gene
RRM1;gemcitabine;Chemical;PA298;Gene
MSH5;gemcitabine;Chemical;PA31136;Gene
NRAS;gemcitabine;Chemical;PA31768;Gene
NT5C;gemcitabine;Chemical;PA31798;Gene
NT5C1A;gemcitabine;Chemical;PA31799;Gene
NT5C2;gemcitabine;Chemical;PA31801;Gene
NT5C3A;gemcitabine;Chemical;PA31802;Gene
POLR2A;gemcitabine;Chemical;PA33507;Gene
TENT4A;gemcitabine;Chemical;PA33523;Gene
PSORS1C1;gemcitabine;Chemical;PA33919;Gene
RAF1;gemcitabine;Chemical;PA34183;Gene
PPP1R13L;gemcitabine;Chemical;PA34195;Gene
SERPINC1;gemcitabine;Chemical;PA35026;Gene
HLA-C;gemcitabine;Chemical;PA35057;Gene
SERPINA5;gemcitabine;Chemical;PA35505;Gene
TYMS;gemcitabine;Chemical;PA359;Gene
XYLT2;gemcitabine;Chemical;PA37974;Gene
SLC28A2;gemcitabine;Chemical;PA386;Gene
SLC28A1;gemcitabine;Chemical;PA387;Gene
ABCG2;gemcitabine;Chemical;PA390;Gene
SLC28A3;gemcitabine;Chemical;PA426;Gene
TNF;gemcitabine;Chemical;PA435;Gene
CDA;gemcitabine;Chemical;PA98;Gene
DIABETES MELLITUS;rs2241766;Variant;PA443886;Disease
PIOGLITAZONE;rs2241766;Variant;PA450970;Chemical
HBB;crizanlizumab-tmca;Chemical;PA29202;Gene
SELP;crizanlizumab-tmca;Chemical;PA35643;Gene
FLUCLOXACILLIN;ST6GAL1;Gene;PA164781042;Chemical
ENZYMES;A2M;Gene;PA164712734;Chemical
STROKE;A2M;Gene;PA447054;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;RRP7A;Gene;PA447197;Disease
METHYLPHENIDATE;RRP7A;Gene;PA450464;Chemical
ETHANOL;rs3778148;Variant;PA448073;Chemical
WARFARIN;rs61742245;Variant;PA451906;Chemical
ACENOCOUMAROL;rs61742245;Variant;PA452632;Chemical
FLUOROURACIL;PPP2R5D;Gene;PA128406956;Chemical
BREAST NEOPLASMS;PPP2R5D;Gene;PA443560;Disease
NEUTROPENIA;PPP2R5D;Gene;PA445113;Disease
CYCLOPHOSPHAMIDE;PPP2R5D;Gene;PA449165;Chemical
EPIRUBICIN;PPP2R5D;Gene;PA449476;Chemical
CYP2C9;nabumetone;Chemical;PA126;Gene
CYP2J2;nabumetone;Chemical;PA27112;Gene
MILNACIPRAN;rs1364043;Variant;PA164752812;Chemical
MAJOR DEPRESSIVE DISORDER;rs1364043;Variant;PA447321;Disease
FLUVOXAMINE;rs1364043;Variant;PA449690;Chemical
PAROXETINE;rs1364043;Variant;PA450801;Chemical
KIDNEY TRANSPLANTATION;KCNQ1;Gene;PA165817016;Disease
DIABETES MELLITUS, TYPE 2;KCNQ1;Gene;PA443890;Disease
CELECOXIB;KCNQ1;Gene;PA448871;Chemical
REPAGLINIDE;KCNQ1;Gene;PA451234;Chemical
TACROLIMUS;KCNQ1;Gene;PA451578;Chemical
ANEMIA;rs1799735;Variant;PA443340;Disease
OVARIAN NEOPLASMS;rs1799735;Variant;PA445204;Disease
PERIPHERAL NERVOUS SYSTEM DISEASES;rs1799735;Variant;PA445301;Disease
THROMBOCYTOPENIA;rs1799735;Variant;PA445846;Disease
CISPLATIN;rs1799735;Variant;PA449014;Chemical
CYCLOPHOSPHAMIDE;rs1799735;Variant;PA449165;Chemical
OLANZAPINE;rs1799735;Variant;PA450688;Chemical
ROSUVASTATIN;rs1621378;Variant;PA134308647;Chemical
ESTRONE SULFATE;rs1621378;Variant;PA166185957;Chemical
USTEKINUMAB;TIRAP;Gene;PA166048654;Chemical
PSORIASIS;TIRAP;Gene;PA445451;Disease
ENDOXIFEN;CYP2D6*8;Haplotype;PA166124478;Chemical
SPARTEINE;CYP2D6*8;Haplotype;PA452610;Chemical
DEBRISOQUINE;CYP2D6*8;Haplotype;PA452616;Chemical
PARKINSON DISEASE;HOMER1;Gene;PA445254;Disease
HALOPERIDOL;HOMER1;Gene;PA449841;Chemical
LEVODOPA;HOMER1;Gene;PA450213;Chemical
CYP2C19;desmethyl clomipramine;Chemical;PA124;Gene
CYP2D6;desmethyl clomipramine;Chemical;PA128;Gene
CYP2D6*4;desmethyl clomipramine;Chemical;PA165816579;Haplotype
CYP2D6*41;desmethyl clomipramine;Chemical;PA165816584;Haplotype
CYP2C19*1;desmethyl clomipramine;Chemical;PA165980634;Haplotype
CYP2C19*2;desmethyl clomipramine;Chemical;PA165980635;Haplotype
PLATINUM;HNF1B;Gene;PA150595617;Chemical
AKT1;HNF1B;Gene;PA24684;Gene
NEPHROTOXICITY;ARID5B;Gene;PA162263533;Disease
GLUCARPIDASE;ARID5B;Gene;PA165949771;Chemical
LEUKOPENIA;ARID5B;Gene;PA444773;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;ARID5B;Gene;PA446155;Disease
HALOPERIDOL;ARID5B;Gene;PA449841;Chemical
METHOTREXATE;ARID5B;Gene;PA450428;Chemical
ESSENTIAL HYPERTENSION;ILKAP;Gene;PA447288;Disease
HYDROCHLOROTHIAZIDE;ILKAP;Gene;PA449899;Chemical
ALOPECIA;rs1049305;Variant;PA443314;Disease
ANEMIA;rs1049305;Variant;PA443340;Disease
LEUKOPENIA;rs1049305;Variant;PA444773;Disease
MESOTHELIOMA;rs1049305;Variant;PA444937;Disease
THROMBOCYTOPENIA;rs1049305;Variant;PA445846;Disease
CISPLATIN;rs1049305;Variant;PA449014;Chemical
FLUVASTATIN;LIPC;Gene;PA449688;Chemical
PRAVASTATIN;LIPC;Gene;PA451089;Chemical
SIMVASTATIN;LIPC;Gene;PA451363;Chemical
MAJOR DEPRESSIVE DISORDER;rs8075924;Variant;PA447321;Disease
BUPROPION;rs8075924;Variant;PA448687;Chemical
ADEFOVIR DIPIVOXIL;rs11568626;Variant;PA10005;Chemical
TENOFOVIR;rs11568626;Variant;PA10204;Chemical
CIDOFOVIR;rs11568626;Variant;PA448997;Chemical
CORONARY ARTERY DISEASE;rs11039149;Variant;PA443796;Disease
HYPERTENSION;rs11039149;Variant;PA444552;Disease
ATENOLOL;rs11039149;Variant;PA448499;Chemical
VERAPAMIL;rs11039149;Variant;PA451868;Chemical
BRIVANIB;FGFRL1;Gene;PA164924492;Chemical
CRK;FGFRL1;Gene;PA26880;Gene
FGF2;FGFRL1;Gene;PA28115;Gene
PIK3C2A;FGFRL1;Gene;PA33304;Gene
PIK3C2B;FGFRL1;Gene;PA33305;Gene
SUBSTANCE-RELATED DISORDERS;rs34066662;Variant;PA446876;Disease
ALCOHOL ABUSE;PNPLA3;Gene;PA443309;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;PNPLA3;Gene;PA446155;Disease
ETHANOL;PNPLA3;Gene;PA448073;Chemical
ASPARAGINASE;PNPLA3;Gene;PA448492;Chemical
CYCLOPHOSPHAMIDE;PNPLA3;Gene;PA449165;Chemical
DAUNORUBICIN;PNPLA3;Gene;PA449212;Chemical
PREDNISOLONE;PNPLA3;Gene;PA451096;Chemical
VINCRISTINE;PNPLA3;Gene;PA451879;Chemical
ATAZANAVIR;UGT1A1*80;Haplotype;PA10251;Chemical
UGT1A1;UGT1A1*80;Haplotype;PA420;Gene
BRIVANIB;FGFR1OP;Gene;PA164924492;Chemical
CRK;FGFR1OP;Gene;PA26880;Gene
FGF2;FGFR1OP;Gene;PA28115;Gene
PIK3C2A;FGFR1OP;Gene;PA33304;Gene
PIK3C2B;FGFR1OP;Gene;PA33305;Gene
XENOBIOTICS;rs12720461;Variant;PA452604;Chemical
HLA-DRB1*08:03;propylthiouracil;Chemical;PA165951678;Haplotype
HLA-B*38:02;propylthiouracil;Chemical;PA165955505;Haplotype
HLA-B;propylthiouracil;Chemical;PA35056;Gene
HLA-DRB1;propylthiouracil;Chemical;PA35072;Gene
TOCILIZUMAB;rs12083537;Variant;PA165292659;Chemical
RHEUMATOID ARTHRITIS;rs12083537;Variant;PA443434;Disease
HEROIN DEPENDENCE;rs2758339;Variant;PA444460;Disease
HEROIN;rs2758339;Variant;PA452619;Chemical
RS12720441;Torsades de Pointes;Disease;PA166157459;Variant
KCNH2;Torsades de Pointes;Disease;PA212;Gene
TALAZOPARIB;MRE11;Gene;PA166182740;Chemical
ABCC2;antiepileptics;Chemical;PA116;Gene
CYP2C9;antiepileptics;Chemical;PA126;Gene
ACE;antiepileptics;Chemical;PA139;Gene
CYP2C9*1;antiepileptics;Chemical;PA165816542;Haplotype
CYP2C9*3;antiepileptics;Chemical;PA165816544;Haplotype
HLA-B*15:02;antiepileptics;Chemical;PA165954769;Haplotype
HLA-B*58:01;antiepileptics;Chemical;PA165987831;Haplotype
RS717620;antiepileptics;Chemical;PA166153953;Variant
RS2273697;antiepileptics;Chemical;PA166154007;Variant
RS3740066;antiepileptics;Chemical;PA166154028;Variant
RS1799752;antiepileptics;Chemical;PA166155187;Variant
RS1047891;antiepileptics;Chemical;PA166155617;Variant
RS2304016;antiepileptics;Chemical;PA166155682;Variant
RS17183814;antiepileptics;Chemical;PA166155842;Variant
RS1045642;antiepileptics;Chemical;PA166157284;Variant
RS1128503;antiepileptics;Chemical;PA166157288;Variant
RS2032582;antiepileptics;Chemical;PA166157316;Variant
RS3789243;antiepileptics;Chemical;PA166157380;Variant
RS16935279;antiepileptics;Chemical;PA166159072;Variant
ABCB1;antiepileptics;Chemical;PA267;Gene
CPS1;antiepileptics;Chemical;PA26840;Gene
SCN2A;antiepileptics;Chemical;PA35004;Gene
HLA-B;antiepileptics;Chemical;PA35056;Gene
PALONOSETRON;rs3212986;Variant;PA10352;Chemical
FLUOROURACIL;rs3212986;Variant;PA128406956;Chemical
PLATINUM COMPOUNDS;rs3212986;Variant;PA164713176;Chemical
BREAST NEOPLASMS;rs3212986;Variant;PA443560;Disease
NON-SMALL CELL LUNG CARCINOMA;rs3212986;Variant;PA443622;Disease
NEOPLASM OF ESOPHAGUS;rs3212986;Variant;PA444101;Disease
INFECTIOUS DISEASE;rs3212986;Variant;PA444614;Disease
LEUKOPENIA;rs3212986;Variant;PA444773;Disease
MESOTHELIOMA;rs3212986;Variant;PA444937;Disease
NAUSEA;rs3212986;Variant;PA445048;Disease
NEOPLASMS;rs3212986;Variant;PA445062;Disease
OVARIAN NEOPLASMS;rs3212986;Variant;PA445204;Disease
OSTEOSARCOMA;rs3212986;Variant;PA445601;Disease
STOMACH NEOPLASMS;rs3212986;Variant;PA445742;Disease
TESTICULAR NEOPLASMS;rs3212986;Variant;PA445828;Disease
VOMITING;rs3212986;Variant;PA446051;Disease
BLEOMYCIN;rs3212986;Variant;PA448645;Chemical
CISPLATIN;rs3212986;Variant;PA449014;Chemical
CYCLOPHOSPHAMIDE;rs3212986;Variant;PA449165;Chemical
DOCETAXEL;rs3212986;Variant;PA449383;Chemical
DOXORUBICIN;rs3212986;Variant;PA449412;Chemical
ETOPOSIDE;rs3212986;Variant;PA449552;Chemical
GEMCITABINE;rs3212986;Variant;PA449748;Chemical
GRANISETRON;rs3212986;Variant;PA449809;Chemical
PACLITAXEL;rs3212986;Variant;PA450761;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs886423;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs886423;Variant;PA445846;Disease
CARBOPLATIN;rs886423;Variant;PA448803;Chemical
GEMCITABINE;rs886423;Variant;PA449748;Chemical
VKORC1;Vascular Diseases;Disease;PA133787052;Gene
RS1433099;Vascular Diseases;Disease;PA166155367;Variant
RS2738466;Vascular Diseases;Disease;PA166155400;Variant
RS17655652;Vascular Diseases;Disease;PA166157478;Variant
LDLR;Vascular Diseases;Disease;PA227;Gene
NPC1L1;Vascular Diseases;Disease;PA31699;Gene
MEASLES VACCINES;HLA-DRB1*08:01;Haplotype;PA164712887;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-DRB1*08:01;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-DRB1*08:01;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-DRB1*08:01;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-DRB1*08:01;Haplotype;PA450616;Chemical
PAIN, POSTOPERATIVE;ASTN2;Gene;PA445210;Disease
FENTANYL;ASTN2;Gene;PA449599;Chemical
EFAVIRENZ;rs553968231;Variant;PA449441;Chemical
PROPOFOL;rs553968231;Variant;PA451141;Chemical
ALLOPURINOL;rs57449396;Variant;PA448320;Chemical
HIV INFECTIOUS DISEASE;TRAF3IP2;Gene;PA447230;Disease
NEVIRAPINE;TRAF3IP2;Gene;PA450616;Chemical
EPILEPSY;rs4148740;Variant;PA444065;Disease
MAJOR DEPRESSIVE DISORDER;rs4148740;Variant;PA447321;Disease
AMITRIPTYLINE;rs4148740;Variant;PA448385;Chemical
CARBAMAZEPINE;rs4148740;Variant;PA448785;Chemical
CITALOPRAM;rs4148740;Variant;PA449015;Chemical
PAROXETINE;rs4148740;Variant;PA450801;Chemical
VENLAFAXINE;rs4148740;Variant;PA451866;Chemical
METHADONE;rs8094439;Variant;PA450401;Chemical
IBUPROFEN;UGT2B4;Gene;PA449957;Chemical
CYP3A4;Transplant rejection;Disease;PA130;Gene
CYP3A5;Transplant rejection;Disease;PA131;Gene
CYP3A4*1;Transplant rejection;Disease;PA165819201;Haplotype
TPMT*1;Transplant rejection;Disease;PA165819268;Haplotype
TPMT*2;Transplant rejection;Disease;PA165819269;Haplotype
TPMT*3A;Transplant rejection;Disease;PA165819270;Haplotype
TPMT*3C;Transplant rejection;Disease;PA165819272;Haplotype
CYP3A4*22;Transplant rejection;Disease;PA166048680;Haplotype
CYP3A5*1;Transplant rejection;Disease;PA166128213;Haplotype
CYP3A5*3;Transplant rejection;Disease;PA166128219;Haplotype
CYP3A5*6;Transplant rejection;Disease;PA166128233;Haplotype
CYP3A5*7;Transplant rejection;Disease;PA166128234;Haplotype
RS4149117;Transplant rejection;Disease;PA166154583;Variant
RS7311358;Transplant rejection;Disease;PA166154602;Variant
RS1127354;Transplant rejection;Disease;PA166155915;Variant
RS776746;Transplant rejection;Disease;PA166157267;Variant
RS2740574;Transplant rejection;Disease;PA166157367;Variant
ITPA;Transplant rejection;Disease;PA29973;Gene
TPMT;Transplant rejection;Disease;PA356;Gene
SLCO1B3;Transplant rejection;Disease;PA35844;Gene
CORONARY ARTERY DISEASE;rs11887534;Variant;PA443796;Disease
HYPERCHOLESTEROLEMIA;rs11887534;Variant;PA444516;Disease
ATORVASTATIN;rs11887534;Variant;PA448500;Chemical
SLCO1B1;olmesartan;Chemical;PA134865839;Gene
SLCO1B1*37;olmesartan;Chemical;PA165819251;Haplotype
SLCO1B1*15;olmesartan;Chemical;PA165819265;Haplotype
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA;DSC2;Gene;PA446847;Disease
MYOTONIC DISORDERS;rs121908560;Variant;PA447130;Disease
MEXILETINE;rs121908560;Variant;PA450488;Chemical
WEIGHT GAIN;rs5443;Variant;PA128406954;Disease
HMG COA REDUCTASE INHIBITORS;rs5443;Variant;PA133950441;Chemical
BETA BLOCKING AGENTS;rs5443;Variant;PA164712535;Chemical
THIAZIDES, PLAIN;rs5443;Variant;PA164713347;Chemical
HYDRALAZINE / ISOSORBIDE DINITRATE;rs5443;Variant;PA166176017;Chemical
CLUSTER HEADACHE;rs5443;Variant;PA443742;Disease
DIABETES MELLITUS;rs5443;Variant;PA443886;Disease
HEART FAILURE;rs5443;Variant;PA444370;Disease
HYPERCHOLESTEROLEMIA;rs5443;Variant;PA444516;Disease
ERECTILE DYSFUNCTION;rs5443;Variant;PA444606;Disease
LIVER CIRRHOSIS;rs5443;Variant;PA444797;Disease
MYOCARDIAL INFARCTION;rs5443;Variant;PA445019;Disease
OPIOID-RELATED DISORDERS;rs5443;Variant;PA445043;Disease
OBESITY;rs5443;Variant;PA445131;Disease
SCHIZOPHRENIA;rs5443;Variant;PA447216;Disease
ESSENTIAL HYPERTENSION;rs5443;Variant;PA447288;Disease
MAJOR DEPRESSIVE DISORDER;rs5443;Variant;PA447321;Disease
ATENOLOL;rs5443;Variant;PA448499;Chemical
BUMETANIDE;rs5443;Variant;PA448682;Chemical
CLONIDINE;rs5443;Variant;PA449051;Chemical
FUROSEMIDE;rs5443;Variant;PA449719;Chemical
METHADONE;rs5443;Variant;PA450401;Chemical
NORTRIPTYLINE;rs5443;Variant;PA450657;Chemical
OLANZAPINE;rs5443;Variant;PA450688;Chemical
SIBUTRAMINE;rs5443;Variant;PA451344;Chemical
SILDENAFIL;rs5443;Variant;PA451346;Chemical
SUMATRIPTAN;rs5443;Variant;PA451566;Chemical
TELMISARTAN;rs5443;Variant;PA451605;Chemical
TORASEMIDE;rs5443;Variant;PA451733;Chemical
ANTIDEPRESSANTS;rs5443;Variant;PA452229;Chemical
ENZYMES;rs669;Variant;PA164712734;Chemical
STROKE;rs669;Variant;PA447054;Disease
OPIOID-RELATED DISORDERS;rs11265549;Variant;PA445043;Disease
PRURITUS;rs11265549;Variant;PA445437;Disease
METHADONE;rs11265549;Variant;PA450401;Chemical
OPIOID-RELATED DISORDERS;rs324029;Variant;PA445043;Disease
OPIOIDS;rs324029;Variant;PA452618;Chemical
CYP2D6;eletriptan;Chemical;PA128;Gene
METABOLIC SYNDROME;rs1417938;Variant;PA162370415;Disease
FENOFIBRATE;rs1417938;Variant;PA449594;Chemical
REMIMAZOLAM;rs143718310;Variant;PA166321761;Chemical
ODEVIXIBAT;rs72549402;Variant;PA166268805;Chemical
ATP8B1;rs72549402;Variant;PA265;Gene
ABCB11;rs72549402;Variant;PA374;Gene
MAJOR ADVERSE CARDIAC EVENTS (MACE);CYP2C19 poor metabolizer and intermediate metabolizer genotypes;Variant;PA166129560;Disease
CLOPIDOGREL;CYP2C19 poor metabolizer and intermediate metabolizer genotypes;Variant;PA449053;Chemical
CYP2C19;CYP2C19*7;Haplotype;PA124;Gene
CLOPIDOGREL;CYP2C19*7;Haplotype;PA449053;Chemical
MEPHENYTOIN;CYP2C19*7;Haplotype;PA450373;Chemical
CYP2B6;ethinyl estradiol;Chemical;PA123;Gene
CYP3A5;ethinyl estradiol;Chemical;PA131;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs1799964;Variant;PA164713366;Chemical
SPONDYLITIS, ANKYLOSING;rs1799964;Variant;PA445724;Disease
HIV INFECTIOUS DISEASE;rs1799964;Variant;PA447230;Disease
STAVUDINE;rs1799964;Variant;PA451494;Chemical
IMATINIB;rs1050152;Variant;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;rs1050152;Variant;PA151958383;Disease
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;rs1050152;Variant;PA446171;Disease
PEMETREXED;rs11280056;Variant;PA10810;Chemical
FLUOROURACIL;rs11280056;Variant;PA128406956;Chemical
HYDROXYCHLOROQUINE;rs11280056;Variant;PA164777036;Chemical
TOXIC LIVER DISEASE;rs11280056;Variant;PA164925725;Disease
MUCOSITIS;rs11280056;Variant;PA166122058;Disease
HEMATOPOIETIC STEM CELL TRANSPLANTATION;rs11280056;Variant;PA166123007;Disease
PROGRESSION-FREE SURVIVAL;rs11280056;Variant;PA166123026;Disease
OVERALL SURVIVAL;rs11280056;Variant;PA166123207;Disease
GASTROINTESTINAL TOXICITY;rs11280056;Variant;PA166124386;Disease
FOLFOX;rs11280056;Variant;PA166182862;Chemical
ARTHRITIS, RHEUMATOID;rs11280056;Variant;PA443434;Disease
BREAST NEOPLASMS;rs11280056;Variant;PA443560;Disease
DRUG TOXICITY;rs11280056;Variant;PA443937;Disease
MESOTHELIOMA;rs11280056;Variant;PA444937;Disease
MYELODYSPLASTIC SYNDROMES;rs11280056;Variant;PA445013;Disease
NEOPLASMS;rs11280056;Variant;PA445062;Disease
NEUTROPENIA;rs11280056;Variant;PA445113;Disease
PANCREATIC NEOPLASMS;rs11280056;Variant;PA445218;Disease
PSORIASIS;rs11280056;Variant;PA445451;Disease
STOMACH NEOPLASMS;rs11280056;Variant;PA445742;Disease
THROMBOCYTOPENIA;rs11280056;Variant;PA445846;Disease
COLORECTAL NEOPLASMS;rs11280056;Variant;PA446108;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;rs11280056;Variant;PA446155;Disease
NEUROTOXICITY SYNDROMES;rs11280056;Variant;PA446975;Disease
HYPERAMMONEMIA;rs11280056;Variant;PA447146;Disease
CAPECITABINE;rs11280056;Variant;PA448771;Chemical
CARBOPLATIN;rs11280056;Variant;PA448803;Chemical
FOLIC ACID;rs11280056;Variant;PA449692;Chemical
GEMCITABINE;rs11280056;Variant;PA449748;Chemical
METHOTREXATE;rs11280056;Variant;PA450428;Chemical
PACLITAXEL;rs11280056;Variant;PA450761;Chemical
SULFASALAZINE;rs11280056;Variant;PA451547;Chemical
AZACITIDINE;rs11280056;Variant;PA451996;Chemical
ANTINEOPLASTIC AGENTS;rs11280056;Variant;PA452621;Chemical
RADIOTHERAPY;CDK1;Gene;PA166122986;Chemical
PNEUMONITIS;CDK1;Gene;PA166124223;Disease
DPYD;Hyperbilirubinemia;Disease;PA145;Gene
UGT1A1*1;Hyperbilirubinemia;Disease;PA166115841;Haplotype
UGT1A1*28;Hyperbilirubinemia;Disease;PA166115842;Haplotype
UGT1A1*36;Hyperbilirubinemia;Disease;PA166115843;Haplotype
UGT1A1*37;Hyperbilirubinemia;Disease;PA166115844;Haplotype
UGT1A1*6;Hyperbilirubinemia;Disease;PA166115858;Haplotype
UGT1A1*27;Hyperbilirubinemia;Disease;PA166115865;Haplotype
RS1048977;Hyperbilirubinemia;Disease;PA166153610;Variant
RS3806596;Hyperbilirubinemia;Disease;PA166155712;Variant
RS7586110;Hyperbilirubinemia;Disease;PA166155768;Variant
RS17863778;Hyperbilirubinemia;Disease;PA166155853;Variant
RS17868323;Hyperbilirubinemia;Disease;PA166155857;Variant
G6PD DEFICIENCY;Hyperbilirubinemia;Disease;PA166157959;Variant
RS12119882;Hyperbilirubinemia;Disease;PA166163749;Variant
G6PD;Hyperbilirubinemia;Disease;PA28469;Gene
UGT1A3;Hyperbilirubinemia;Disease;PA37178;Gene
UGT1A7;Hyperbilirubinemia;Disease;PA37182;Gene
UGT1A1;Hyperbilirubinemia;Disease;PA420;Gene
CDA;Hyperbilirubinemia;Disease;PA98;Gene
PRASUGREL;rs12407843;Variant;PA154410481;Chemical
CFTR;rs397508783;Variant;PA109;Gene
IVACAFTOR;rs397508783;Variant;PA165950341;Chemical
LEUKEMIA, MYELOID, ACUTE;rs17343066;Variant;PA444760;Disease
CYTARABINE;rs17343066;Variant;PA449177;Chemical
PROSTATIC NEOPLASMS;rs12042763;Variant;PA445425;Disease
ASPIRIN;rs12042763;Variant;PA448497;Chemical
RS1544410;alendronate;Chemical;PA166154516;Variant
RS10161126;alendronate;Chemical;PA166154611;Variant
MVK;alendronate;Chemical;PA31331;Gene
VDR;alendronate;Chemical;PA37301;Gene
CYP3A5;cyclobenzaprine;Chemical;PA131;Gene
GSTM1 NULL;Deafness;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;Deafness;Disease;PA166048676;Haplotype
GSTT1 NULL;Deafness;Disease;PA166048678;Haplotype
GSTT1 NON-NULL;Deafness;Disease;PA166048679;Haplotype
GSTM1;Deafness;Disease;PA182;Gene
GSTT1;Deafness;Disease;PA183;Gene
MT-RNR1;Deafness;Disease;PA31274;Gene
IMATINIB;BCR;Gene;PA10804;Chemical
DASATINIB;BCR;Gene;PA162372878;Chemical
NILOTINIB;BCR;Gene;PA165958345;Chemical
PONATINIB;BCR;Gene;PA165980594;Chemical
BOSUTINIB;BCR;Gene;PA166114906;Chemical
OMACETAXINE;BCR;Gene;PA166114929;Chemical
BLINATUMOMAB;BCR;Gene;PA166129524;Chemical
RS121913459;BCR;Gene;PA166157848;Variant
INOTUZUMAB OZOGAMICIN;BCR;Gene;PA166177510;Chemical
ASCIMINIB;BCR;Gene;PA166268841;Chemical
PHILADELPHIA CHROMOSOME;BCR;Gene;PA445316;Disease
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;BCR;Gene;PA446171;Disease
BUSULFAN;BCR;Gene;PA448691;Chemical
VINCRISTINE;BCR;Gene;PA451879;Chemical
LEVOTHYROXINE;IRS4;Gene;PA450221;Chemical
ABCC2;tenofovir;Chemical;PA116;Gene
IFNL3;tenofovir;Chemical;PA134952671;Gene
AK4;tenofovir;Chemical;PA165750325;Gene
IFNL4;tenofovir;Chemical;PA166049147;Gene
RS717620;tenofovir;Chemical;PA166153953;Variant
RS2273697;tenofovir;Chemical;PA166154007;Variant
RS7917432;tenofovir;Chemical;PA166154090;Variant
RS8187707;tenofovir;Chemical;PA166154093;Variant
RS8187710;tenofovir;Chemical;PA166154094;Variant
RS17222723;tenofovir;Chemical;PA166154163;Variant
RS11568626;tenofovir;Chemical;PA166154458;Variant
RS899494;tenofovir;Chemical;PA166154688;Variant
RS1059751;tenofovir;Chemical;PA166154694;Variant
RS1751034;tenofovir;Chemical;PA166154702;Variant
RS3742106;tenofovir;Chemical;PA166154713;Variant
RS12979860;tenofovir;Chemical;PA166155468;Variant
RS2231142;tenofovir;Chemical;PA166156544;Variant
RS9349256;tenofovir;Chemical;PA166157146;Variant
RS757639;tenofovir;Chemical;PA166157265;Variant
RS113165732;tenofovir;Chemical;PA166157891;Variant
ABCC10;tenofovir;Chemical;PA24392;Gene
AK2;tenofovir;Chemical;PA24656;Gene
NME1;tenofovir;Chemical;PA249;Gene
NME2;tenofovir;Chemical;PA250;Gene
OCRL;tenofovir;Chemical;PA31896;Gene
SLC26A8;tenofovir;Chemical;PA37885;Gene
SLC22A6;tenofovir;Chemical;PA388;Gene
ABCG2;tenofovir;Chemical;PA390;Gene
ABCC4;tenofovir;Chemical;PA397;Gene
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA;DSG2;Gene;PA446847;Disease
IFNL3;peginterferon alfa-2a;Chemical;PA134952671;Gene
SLC29A1;peginterferon alfa-2a;Chemical;PA154;Gene
HLA-A*01:01;peginterferon alfa-2a;Chemical;PA165952609;Haplotype
HLA-B*38:01;peginterferon alfa-2a;Chemical;PA165955500;Haplotype
IFNL4;peginterferon alfa-2a;Chemical;PA166049147;Gene
IFNL3 RS12979860 REFERENCE (C);peginterferon alfa-2a;Chemical;PA166129427;Haplotype
IFNL3 RS12979860T;peginterferon alfa-2a;Chemical;PA166129428;Haplotype
RS1544410;peginterferon alfa-2a;Chemical;PA166154516;Variant
RS14158;peginterferon alfa-2a;Chemical;PA166155344;Variant
RS4803217;peginterferon alfa-2a;Chemical;PA166155416;Variant
RS4803219;peginterferon alfa-2a;Chemical;PA166155417;Variant
RS7248668;peginterferon alfa-2a;Chemical;PA166155429;Variant
RS8099917;peginterferon alfa-2a;Chemical;PA166155435;Variant
RS8103142;peginterferon alfa-2a;Chemical;PA166155437;Variant
RS8105790;peginterferon alfa-2a;Chemical;PA166155438;Variant
RS11881222;peginterferon alfa-2a;Chemical;PA166155462;Variant
RS12979860;peginterferon alfa-2a;Chemical;PA166155468;Variant
RS12980275;peginterferon alfa-2a;Chemical;PA166155469;Variant
RS28416813;peginterferon alfa-2a;Chemical;PA166155479;Variant
RS6051702;peginterferon alfa-2a;Chemical;PA166155952;Variant
RS56061981;peginterferon alfa-2a;Chemical;PA166156687;Variant
RS760370;peginterferon alfa-2a;Chemical;PA166156947;Variant
RS3828913;peginterferon alfa-2a;Chemical;PA166157089;Variant
RS10846744;peginterferon alfa-2a;Chemical;PA166160587;Variant
RS117648444;peginterferon alfa-2a;Chemical;PA166160628;Variant
RS4273729;peginterferon alfa-2a;Chemical;PA166160738;Variant
RS11506105;peginterferon alfa-2a;Chemical;PA166165309;Variant
RS11322783;peginterferon alfa-2a;Chemical;PA166190881;Variant
LDLR;peginterferon alfa-2a;Chemical;PA227;Gene
ITPA;peginterferon alfa-2a;Chemical;PA29973;Gene
MICB;peginterferon alfa-2a;Chemical;PA30812;Gene
HLA-A;peginterferon alfa-2a;Chemical;PA35055;Gene
HLA-B;peginterferon alfa-2a;Chemical;PA35056;Gene
CXCL10;peginterferon alfa-2a;Chemical;PA35568;Gene
VDR;peginterferon alfa-2a;Chemical;PA37301;Gene
EGFR;peginterferon alfa-2a;Chemical;PA7360;Gene
SCARB1;peginterferon alfa-2a;Chemical;PA97;Gene
CYP2D6;Low Back Pain;Disease;PA128;Gene
RS1045642;Low Back Pain;Disease;PA166157284;Variant
CYP2D6 POOR METABOLIZER;Low Back Pain;Disease;PA166157927;Variant
RS6517442;Low Back Pain;Disease;PA166182219;Variant
ABCB1;Low Back Pain;Disease;PA267;Gene
KCNJ6;Low Back Pain;Disease;PA30049;Gene
ASPIRIN-INDUCED ASTHMA;rs7862221;Variant;PA131285571;Disease
ASTHMA;rs7862221;Variant;PA443450;Disease
ASPIRIN;rs7862221;Variant;PA448497;Chemical
SULFAMETHOXAZOLE / TRIMETHOPRIM;rs1799930;Variant;PA10715;Chemical
DRUG INTERACTION WITH DRUG;rs1799930;Variant;PA165108622;Disease
ADVERSE EVENTS;rs1799930;Variant;PA166151827;Disease
DRUG TOXICITY;rs1799930;Variant;PA443937;Disease
HYPERSENSITIVITY;rs1799930;Variant;PA444546;Disease
ISONIAZID;rs1799930;Variant;PA450112;Chemical
PHENYTOIN;rs1799930;Variant;PA450947;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;rs3761554;Variant;PA164713257;Chemical
MAJOR DEPRESSIVE DISORDER;rs3761554;Variant;PA447321;Disease
VENLAFAXINE;rs3761554;Variant;PA451866;Chemical
ANTIDEPRESSANTS;rs3761554;Variant;PA452229;Chemical
CYP2C19;desipramine;Chemical;PA124;Gene
CYP2D6;desipramine;Chemical;PA128;Gene
CYP3A4;desipramine;Chemical;PA130;Gene
CYP2D6*1;desipramine;Chemical;PA165816576;Haplotype
CYP2D6*2;desipramine;Chemical;PA165816577;Haplotype
CYP2D6*3;desipramine;Chemical;PA165816578;Haplotype
CYP2D6*4;desipramine;Chemical;PA165816579;Haplotype
CYP2D6*6;desipramine;Chemical;PA165816581;Haplotype
CYP2D6*10;desipramine;Chemical;PA165816582;Haplotype
CYP2D6*41;desipramine;Chemical;PA165816584;Haplotype
CYP2D6*5;desipramine;Chemical;PA165948092;Haplotype
CYP2D6*9;desipramine;Chemical;PA165948317;Haplotype
CYP2D6*2XN;desipramine;Chemical;PA165988480;Haplotype
RS61888800;desipramine;Chemical;PA166154478;Variant
RS2228478;desipramine;Chemical;PA166155030;Variant
RS2228479;desipramine;Chemical;PA166155031;Variant
CYP2D6 POOR METABOLIZERS;desipramine;Chemical;PA166157895;Variant
ABCB1;desipramine;Chemical;PA267;Gene
CYP1A2;desipramine;Chemical;PA27093;Gene
MC1R;desipramine;Chemical;PA30673;Gene
SLC6A2;desipramine;Chemical;PA310;Gene
BDNF;desipramine;Chemical;PA31891;Gene
CYP2C19;temazepam;Chemical;PA124;Gene
CYP3A4;temazepam;Chemical;PA130;Gene
CYP2C19;Mycoses;Disease;PA124;Gene
CYP3A4;Mycoses;Disease;PA130;Gene
CYP2C19*17;Mycoses;Disease;PA165816533;Haplotype
CYP2C19*1;Mycoses;Disease;PA165980634;Haplotype
CYP2C19*2;Mycoses;Disease;PA165980635;Haplotype
CYP2C19*3;Mycoses;Disease;PA165980636;Haplotype
RS4646437;Mycoses;Disease;PA166157391;Variant
CYP2C19 POOR METABOLIZERS AND INTERMEDIATE METABOLIZERS;Mycoses;Disease;PA166157901;Variant
CYP2C19 POOR METABOLIZER;Mycoses;Disease;PA166157938;Variant
CYP2C19 ULTRARAPID METABOLIZER;Mycoses;Disease;PA166157942;Variant
CYP2C9;7-hydroxy r-warfarin;Chemical;PA126;Gene
WARFARIN;THBD;Gene;PA451906;Chemical
CYP2C9;Dyspepsia;Disease;PA126;Gene
CYP2C9*1;Dyspepsia;Disease;PA165816542;Haplotype
CYP2C9*2;Dyspepsia;Disease;PA165816543;Haplotype
ROSUVASTATIN;rs2808630;Variant;PA134308647;Chemical
CORONARY DISEASE;rs2808630;Variant;PA443797;Disease
DMD;golodirsen;Chemical;PA27378;Gene
EPILEPSY;HLA-B*37:01;Haplotype;PA444065;Disease
PHENYTOIN;HLA-B*37:01;Haplotype;PA450947;Chemical
NICOTINE;rs145157460;Variant;PA450626;Chemical
DRUGS USED IN NICOTINE DEPENDENCE;CHRNA5;Gene;PA164712720;Chemical
OPIUM ALKALOIDS AND DERIVATIVES;CHRNA5;Gene;PA164712950;Chemical
ECULIZUMAB;CHRNA5;Gene;PA164776637;Chemical
VARENICLINE;CHRNA5;Gene;PA164781343;Chemical
COTININE;CHRNA5;Gene;PA166114414;Chemical
EFGARTIGIMOD ALFA;CHRNA5;Gene;PA166268781;Chemical
RAVULIZUMAB;CHRNA5;Gene;PA166277861;Chemical
ROZANOLIXIZUMAB;CHRNA5;Gene;PA166313325;Chemical
ZILUCOPLAN;CHRNA5;Gene;PA166328901;Chemical
ALCOHOL ABUSE;CHRNA5;Gene;PA443309;Disease
PAIN;CHRNA5;Gene;PA445208;Disease
TOBACCO USE DISORDER;CHRNA5;Gene;PA445876;Disease
COCAINE DEPENDENCE;CHRNA5;Gene;PA446878;Disease
ETHANOL;CHRNA5;Gene;PA448073;Chemical
BUPROPION;CHRNA5;Gene;PA448687;Chemical
COCAINE;CHRNA5;Gene;PA449072;Chemical
NICOTINE;CHRNA5;Gene;PA450626;Chemical
ACUTE CORONARY SYNDROME;WDR24;Gene;PA165108401;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);WDR24;Gene;PA166129560;Disease
ASPIRIN;WDR24;Gene;PA448497;Chemical
CLOPIDOGREL;WDR24;Gene;PA449053;Chemical
KCNH2;terodiline;Chemical;PA212;Gene
CYP3A5;3,4-dehydrocilostazol;Chemical;PA131;Gene
CYP3A5*1;3,4-dehydrocilostazol;Chemical;PA166128213;Haplotype
CYP3A5*3;3,4-dehydrocilostazol;Chemical;PA166128219;Haplotype
LEUKEMIA, MYELOID, ACUTE;rs2291075;Variant;PA444760;Disease
CYTARABINE;rs2291075;Variant;PA449177;Chemical
DAUNORUBICIN;rs2291075;Variant;PA449212;Chemical
ETOPOSIDE;rs2291075;Variant;PA449552;Chemical
MITOXANTRONE;rs2291075;Variant;PA450526;Chemical
ESCITALOPRAM;rs1800532;Variant;PA10074;Chemical
BIPOLAR DISORDER;rs1800532;Variant;PA447199;Disease
MAJOR DEPRESSIVE DISORDER;rs1800532;Variant;PA447321;Disease
CITALOPRAM;rs1800532;Variant;PA449015;Chemical
FLUOXETINE;rs1800532;Variant;PA449673;Chemical
LITHIUM;rs1800532;Variant;PA450243;Chemical
PAROXETINE;rs1800532;Variant;PA450801;Chemical
ANTIDEPRESSANTS;rs1800532;Variant;PA452229;Chemical
SCHIZOPHRENIA;rs4586;Variant;PA447216;Disease
RISPERIDONE;rs4586;Variant;PA451257;Chemical
POLATUZUMAB VEDOTIN;BCL2;Gene;PA166313341;Chemical
HEPATITIS C VIRUS INFECTION;BCL2;Gene;PA444445;Disease
OVARIAN NEOPLASMS;BCL2;Gene;PA445204;Disease
CARBOPLATIN;BCL2;Gene;PA448803;Chemical
DOCETAXEL;BCL2;Gene;PA449383;Chemical
PACLITAXEL;BCL2;Gene;PA450761;Chemical
RIBAVIRIN;BCL2;Gene;PA451241;Chemical
VINCRISTINE;BCL2;Gene;PA451879;Chemical
INTERFERONS;BCL2;Gene;PA451999;Chemical
FLUOROURACIL;rs351855;Variant;PA128406956;Chemical
EVEROLIMUS;rs351855;Variant;PA164746311;Chemical
DISCONTINUATION;rs351855;Variant;PA166123507;Disease
BREAST NEOPLASMS;rs351855;Variant;PA443560;Disease
CYCLOPHOSPHAMIDE;rs351855;Variant;PA449165;Chemical
METHOTREXATE;rs351855;Variant;PA450428;Chemical
ASTHMA;GLCCI1;Gene;PA443450;Disease
BUDESONIDE;GLCCI1;Gene;PA448681;Chemical
FLUNISOLIDE;GLCCI1;Gene;PA449661;Chemical
FLUTICASONE PROPIONATE;GLCCI1;Gene;PA449686;Chemical
NEDOCROMIL;GLCCI1;Gene;PA450601;Chemical
TRIAMCINOLONE;GLCCI1;Gene;PA451749;Chemical
GLUCOCORTICOIDS;GLCCI1;Gene;PA452347;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*23;Haplotype;PA166127651;Chemical
NICOTINE;rs5031016;Variant;PA450626;Chemical
ALCOHOL ABUSE;DPP6;Gene;PA443309;Disease
ETHANOL;DPP6;Gene;PA448073;Chemical
HALOPERIDOL;DPP6;Gene;PA449841;Chemical
ANTITHYROID PREPARATIONS;rs1071816;Variant;PA164712499;Chemical
AGRANULOCYTOSIS;rs1071816;Variant;PA443297;Disease
PROPOFOL;rs58597806;Variant;PA451141;Chemical
CALCIUM CHANNEL BLOCKERS;ACE;Gene;PA10407;Chemical
ANTIEPILEPTICS;ACE;Gene;PA143485705;Chemical
DIURETICS;ACE;Gene;PA151249535;Chemical
ACE INHIBITORS, PLAIN;ACE;Gene;PA164712308;Chemical
BETA BLOCKING AGENTS;ACE;Gene;PA164712535;Chemical
THIAZIDES, PLAIN;ACE;Gene;PA164713347;Chemical
SALVIANOLIC ACID B;ACE;Gene;PA166128370;Chemical
COVID-19;ACE;Gene;PA166197121;Disease
ACE2;ACE;Gene;PA425;Gene
ALZHEIMER DISEASE;ACE;Gene;PA443319;Disease
ARTERIOSCLEROSIS;ACE;Gene;PA443425;Disease
ASTHMA;ACE;Gene;PA443450;Disease
CARDIOMYOPATHY, DILATED;ACE;Gene;PA443632;Disease
CARDIOVASCULAR DISEASES;ACE;Gene;PA443635;Disease
CORONARY ARTERY DISEASE;ACE;Gene;PA443796;Disease
CORONARY DISEASE;ACE;Gene;PA443797;Disease
COUGH;ACE;Gene;PA443803;Disease
DEATH;ACE;Gene;PA443842;Disease
DIABETES MELLITUS;ACE;Gene;PA443886;Disease
DIABETES MELLITUS, TYPE 1;ACE;Gene;PA443888;Disease
DIABETES MELLITUS, TYPE 2;ACE;Gene;PA443890;Disease
GLOMERULONEPHRITIS, IGA;ACE;Gene;PA444288;Disease
HEART FAILURE;ACE;Gene;PA444370;Disease
HYPERTENSION;ACE;Gene;PA444552;Disease
ERECTILE DYSFUNCTION;ACE;Gene;PA444606;Disease
KIDNEY DISORDER;ACE;Gene;PA444682;Disease
KIDNEY FAILURE, CHRONIC;ACE;Gene;PA444684;Disease
MIGRAINE WITHOUT AURA;ACE;Gene;PA444949;Disease
MULTIPLE SCLEROSIS;ACE;Gene;PA444987;Disease
CARDIOMYOPATHIES;ACE;Gene;PA445018;Disease
MYOCARDIAL INFARCTION;ACE;Gene;PA445019;Disease
HYPERTROPHY, LEFT VENTRICULAR;ACE;Gene;PA446479;Disease
MIGRAINE WITH AURA;ACE;Gene;PA447004;Disease
HEADACHE DISORDERS;ACE;Gene;PA447076;Disease
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;ACE;Gene;PA447178;Disease
DEPRESSIVE DISORDER;ACE;Gene;PA447207;Disease
ESSENTIAL HYPERTENSION;ACE;Gene;PA447288;Disease
MAJOR DEPRESSIVE DISORDER;ACE;Gene;PA447321;Disease
ACETYLCHOLINE;ACE;Gene;PA448031;Chemical
AMLODIPINE;ACE;Gene;PA448388;Chemical
ASPIRIN;ACE;Gene;PA448497;Chemical
ATENOLOL;ACE;Gene;PA448499;Chemical
ATORVASTATIN;ACE;Gene;PA448500;Chemical
BENAZEPRIL;ACE;Gene;PA448561;Chemical
BUMETANIDE;ACE;Gene;PA448682;Chemical
BUPROPION;ACE;Gene;PA448687;Chemical
CAPTOPRIL;ACE;Gene;PA448780;Chemical
CHLORTHALIDONE;ACE;Gene;PA448970;Chemical
DIGOXIN;ACE;Gene;PA449319;Chemical
ENALAPRIL;ACE;Gene;PA449456;Chemical
FLUOXETINE;ACE;Gene;PA449673;Chemical
FLUVASTATIN;ACE;Gene;PA449688;Chemical
FUROSEMIDE;ACE;Gene;PA449719;Chemical
HYDROCHLOROTHIAZIDE;ACE;Gene;PA449899;Chemical
INTERFERON BETA-1A;ACE;Gene;PA450037;Chemical
IRBESARTAN;ACE;Gene;PA450084;Chemical
LISINOPRIL;ACE;Gene;PA450242;Chemical
LOSARTAN;ACE;Gene;PA450268;Chemical
PERINDOPRIL;ACE;Gene;PA450877;Chemical
PRAVASTATIN;ACE;Gene;PA451089;Chemical
QUINAPRIL;ACE;Gene;PA451205;Chemical
RAMIPRIL;ACE;Gene;PA451223;Chemical
SERTRALINE;ACE;Gene;PA451333;Chemical
SILDENAFIL;ACE;Gene;PA451346;Chemical
NITROPRUSSIDE;ACE;Gene;PA451406;Chemical
SPIRONOLACTONE;ACE;Gene;PA451483;Chemical
TORASEMIDE;ACE;Gene;PA451733;Chemical
ANTIDEPRESSANTS;ACE;Gene;PA452229;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs7046653;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs7046653;Variant;PA443434;Disease
CELECOXIB;CA9;Gene;PA448871;Chemical
BISPHOSPHONATES;rs1886629;Variant;PA164712563;Chemical
OSTEONECROSIS;rs1886629;Variant;PA445187;Disease
SLC12A1;OXSR1;Gene;PA320;Gene
STK39;OXSR1;Gene;PA38243;Gene
MYCOPHENOLIC ACID;UGT1A8;Gene;PA164748728;Chemical
SN-38;UGT1A8;Gene;PA165110775;Chemical
KIDNEY TRANSPLANTATION;UGT1A8;Gene;PA165817016;Disease
FEBUXOSTAT;UGT1A8;Gene;PA165958521;Chemical
MENOPAUSE;UGT1A8;Gene;PA166048848;Disease
ABT-751;UGT1A8;Gene;PA166104276;Chemical
EPILEPSY;UGT1A8;Gene;PA444065;Disease
GOUT;UGT1A8;Gene;PA444318;Disease
NEOPLASMS;UGT1A8;Gene;PA445062;Disease
OSTEOSARCOMA;UGT1A8;Gene;PA445601;Disease
SEIZURES;UGT1A8;Gene;PA445629;Disease
SCHIZOPHRENIA;UGT1A8;Gene;PA447216;Disease
ALLOPURINOL;UGT1A8;Gene;PA448320;Chemical
CYCLOSPORINE;UGT1A8;Gene;PA449167;Chemical
METHOTREXATE;UGT1A8;Gene;PA450428;Chemical
MYCOPHENOLATE MOFETIL;UGT1A8;Gene;PA450566;Chemical
OXCARBAZEPINE;UGT1A8;Gene;PA450732;Chemical
RALOXIFENE;UGT1A8;Gene;PA451221;Chemical
RISPERIDONE;UGT1A8;Gene;PA451257;Chemical
SIROLIMUS;UGT1A8;Gene;PA451365;Chemical
TACROLIMUS;UGT1A8;Gene;PA451578;Chemical
VALPROIC ACID;UGT1A8;Gene;PA451846;Chemical
HIV INFECTIOUS DISEASE;TCF19;Gene;PA447230;Disease
NEVIRAPINE;TCF19;Gene;PA450616;Chemical
LIVER TRANSPLANTATION;rs10052999;Variant;PA447247;Disease
TACROLIMUS;rs10052999;Variant;PA451578;Chemical
URINARY BLADDER NEOPLASMS;TACC3;Gene;PA443512;Disease
CYP2D6;ondansetron;Chemical;PA128;Gene
CYP3A4;ondansetron;Chemical;PA130;Gene
CYP3A5;ondansetron;Chemical;PA131;Gene
CYP2D6*1;ondansetron;Chemical;PA165816576;Haplotype
CYP2D6*2;ondansetron;Chemical;PA165816577;Haplotype
CYP2D6*4;ondansetron;Chemical;PA165816579;Haplotype
CYP2D6*10;ondansetron;Chemical;PA165816582;Haplotype
CYP2D6*5;ondansetron;Chemical;PA165948092;Haplotype
CYP2D6*35XN;ondansetron;Chemical;PA165971588;Haplotype
CYP2D6*1XN;ondansetron;Chemical;PA165988479;Haplotype
CYP2D6*2XN;ondansetron;Chemical;PA165988480;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);ondansetron;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);ondansetron;Chemical;PA166116466;Haplotype
RS1042173;ondansetron;Chemical;PA166155172;Variant
RS776746;ondansetron;Chemical;PA166157267;Variant
RS1045642;ondansetron;Chemical;PA166157284;Variant
RS2032582;ondansetron;Chemical;PA166157316;Variant
ABCB1;ondansetron;Chemical;PA267;Gene
SLC6A4;ondansetron;Chemical;PA312;Gene
RS77709286;pralsetinib;Chemical;PA166235961;Variant
RS74799832;pralsetinib;Chemical;PA166235962;Variant
RET;pralsetinib;Chemical;PA34335;Gene
ANAKINRA;HLA-DRB1*15:01;Haplotype;PA10799;Chemical
CLAVULANATE;HLA-DRB1*15:01;Haplotype;PA164742987;Chemical
LUMIRACOXIB;HLA-DRB1*15:01;Haplotype;PA164769031;Chemical
FLUCLOXACILLIN;HLA-DRB1*15:01;Haplotype;PA164781042;Chemical
TOXIC LIVER DISEASE;HLA-DRB1*15:01;Haplotype;PA164925725;Disease
TOCILIZUMAB;HLA-DRB1*15:01;Haplotype;PA165292659;Chemical
CANAKINUMAB;HLA-DRB1*15:01;Haplotype;PA165958358;Chemical
DRUG-INDUCED LIVER INJURY;HLA-DRB1*15:01;Haplotype;PA166119041;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-DRB1*15:01;Haplotype;PA166120927;Disease
RILONACEPT;HLA-DRB1*15:01;Haplotype;PA166256441;Chemical
ARTHRITIS, JUVENILE RHEUMATOID;HLA-DRB1*15:01;Haplotype;PA443433;Disease
DRUG HYPERSENSITIVITY;HLA-DRB1*15:01;Haplotype;PA443936;Disease
HEPATITIS;HLA-DRB1*15:01;Haplotype;PA444435;Disease
INFECTION;HLA-DRB1*15:01;Haplotype;PA444614;Disease
JAUNDICE;HLA-DRB1*15:01;Haplotype;PA444648;Disease
MULTIPLE SCLEROSIS;HLA-DRB1*15:01;Haplotype;PA444987;Disease
STILL'S DISEASE, ADULT-ONSET;HLA-DRB1*15:01;Haplotype;PA446366;Disease
HIV INFECTIONS;HLA-DRB1*15:01;Haplotype;PA447230;Disease
AMOXICILLIN;HLA-DRB1*15:01;Haplotype;PA448406;Chemical
DAPSONE;HLA-DRB1*15:01;Haplotype;PA449211;Chemical
GLATIRAMER ACETATE;HLA-DRB1*15:01;Haplotype;PA449760;Chemical
NEVIRAPINE;HLA-DRB1*15:01;Haplotype;PA450616;Chemical
DICLOFENAC;CYP2C9*74;Haplotype;PA449293;Chemical
LOSARTAN;CYP2C9*74;Haplotype;PA450268;Chemical
TOLBUTAMIDE;CYP2C9*74;Haplotype;PA451718;Chemical
COQ8B;Mucocutaneous Lymph Node Syndrome;Disease;PA134988974;Gene
RS28493229;Mucocutaneous Lymph Node Syndrome;Disease;PA166155480;Variant
COVID-19;Mucocutaneous Lymph Node Syndrome;Disease;PA166197121;Disease
ITPKC;Mucocutaneous Lymph Node Syndrome;Disease;PA29977;Gene
NICOTINE;rs145014075;Variant;PA450626;Chemical
ADCY3;GNAS;Gene;PA164741137;Gene
ADCY1;GNAS;Gene;PA24560;Gene
ADCY2;GNAS;Gene;PA24561;Gene
ADCY4;GNAS;Gene;PA24562;Gene
ADCY5;GNAS;Gene;PA24563;Gene
ADCY6;GNAS;Gene;PA27;Gene
ADCY7;GNAS;Gene;PA28;Gene
PTGDR;GNAS;Gene;PA285;Gene
PTGER2;GNAS;Gene;PA287;Gene
ADCY8;GNAS;Gene;PA29;Gene
PTGIR;GNAS;Gene;PA291;Gene
HRH2;GNAS;Gene;PA29457;Gene
HTR4;GNAS;Gene;PA29557;Gene
HTR6;GNAS;Gene;PA29560;Gene
HTR7;GNAS;Gene;PA29561;Gene
ADCY9;GNAS;Gene;PA30;Gene
RGS1;GNAS;Gene;PA34361;Gene
ADRB2;GNAS;Gene;PA39;Gene
DOBUTAMINE;GNAS;Gene;PA449381;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;CERS6;Gene;PA164713366;Chemical
RHEUMATOID ARTHRITIS;CERS6;Gene;PA443434;Disease
IMATINIB;rs12659;Variant;PA10804;Chemical
FLUOROURACIL;rs12659;Variant;PA128406956;Chemical
GASTROINTESTINAL STROMAL TUMORS;rs12659;Variant;PA151958383;Disease
UTERINE CERVICAL NEOPLASM;rs12659;Variant;PA443685;Disease
CARBOPLATIN;rs12659;Variant;PA448803;Chemical
CISPLATIN;rs12659;Variant;PA449014;Chemical
HYPERTENSION;rs1104514;Variant;PA444552;Disease
ATENOLOL;rs1104514;Variant;PA448499;Chemical
DPYD;rs145529148;Variant;PA145;Gene
CAPECITABINE;rs145529148;Variant;PA448771;Chemical
DIARRHEA;rs11651488;Variant;PA443899;Disease
SORAFENIB;rs11651488;Variant;PA7000;Chemical
ACETALDEHYDE;ADH1A;Gene;PA166186245;Chemical
ALCOHOLISM;ADH1A;Gene;PA443309;Disease
ABACAVIR;ADH1A;Gene;PA448004;Chemical
BIPOLAR DISORDER;rs1801260;Variant;PA447199;Disease
LITHIUM;rs1801260;Variant;PA450243;Chemical
PEGINTERFERON ALFA-2A;HLA-B*38:01;Haplotype;PA164749390;Chemical
PEGINTERFERON ALFA-2B;HLA-B*38:01;Haplotype;PA164784024;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*38:01;Haplotype;PA166120927;Disease
SCHIZOAFFECTIVE DISORDER;HLA-B*38:01;Haplotype;PA166123368;Disease
AGRANULOCYTOSIS;HLA-B*38:01;Haplotype;PA443297;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*38:01;Haplotype;PA444059;Disease
HEPATITIS C;HLA-B*38:01;Haplotype;PA444445;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*38:01;Haplotype;PA445738;Disease
SCHIZOPHRENIA;HLA-B*38:01;Haplotype;PA447216;Disease
CLOZAPINE;HLA-B*38:01;Haplotype;PA449061;Chemical
LAMOTRIGINE;HLA-B*38:01;Haplotype;PA450164;Chemical
NEVIRAPINE;HLA-B*38:01;Haplotype;PA450616;Chemical
RIBAVIRIN;HLA-B*38:01;Haplotype;PA451241;Chemical
HAND-FOOT SYNDROME;rs143414470;Variant;PA166114377;Disease
BREAST NEOPLASMS;rs143414470;Variant;PA443560;Disease
NEOPLASMS;rs143414470;Variant;PA445062;Disease
COLORECTAL NEOPLASMS;rs143414470;Variant;PA446108;Disease
CAPECITABINE;rs143414470;Variant;PA448771;Chemical
CETP;Coronary Artery Disease;Disease;PA108;Gene
CYP2C19;Coronary Artery Disease;Disease;PA124;Gene
CYP2C9;Coronary Artery Disease;Disease;PA126;Gene
CYP3A4;Coronary Artery Disease;Disease;PA130;Gene
CYP3A5;Coronary Artery Disease;Disease;PA131;Gene
SLCO1B1;Coronary Artery Disease;Disease;PA134865839;Gene
P2RY12;Coronary Artery Disease;Disease;PA134971947;Gene
ACE;Coronary Artery Disease;Disease;PA139;Gene
MTTP;Coronary Artery Disease;Disease;PA164742099;Gene
CYP2C19*8;Coronary Artery Disease;Disease;PA165816524;Haplotype
CYP2C19*17;Coronary Artery Disease;Disease;PA165816533;Haplotype
CYP2C9*1;Coronary Artery Disease;Disease;PA165816542;Haplotype
CYP2C9*2;Coronary Artery Disease;Disease;PA165816543;Haplotype
CYP2C9*3;Coronary Artery Disease;Disease;PA165816544;Haplotype
CYP2C19*1;Coronary Artery Disease;Disease;PA165980634;Haplotype
CYP2C19*2;Coronary Artery Disease;Disease;PA165980635;Haplotype
CYP2C19*3;Coronary Artery Disease;Disease;PA165980636;Haplotype
CYP3A5*1;Coronary Artery Disease;Disease;PA166128213;Haplotype
CYP3A5*3;Coronary Artery Disease;Disease;PA166128219;Haplotype
RS699;Coronary Artery Disease;Disease;PA166153539;Variant
RS20417;Coronary Artery Disease;Disease;PA166153559;Variant
RS1801133;Coronary Artery Disease;Disease;PA166153644;Variant
RS1801253;Coronary Artery Disease;Disease;PA166153977;Variant
RS2279238;Coronary Artery Disease;Disease;PA166154362;Variant
RS11039149;Coronary Artery Disease;Disease;PA166154448;Variant
RS1051375;Coronary Artery Disease;Disease;PA166154509;Variant
RS2306283;Coronary Artery Disease;Disease;PA166154547;Variant
RS12817819;Coronary Artery Disease;Disease;PA166154643;Variant
RS12050217;Coronary Artery Disease;Disease;PA166154826;Variant
RS708272;Coronary Artery Disease;Disease;PA166154993;Variant
RS5918;Coronary Artery Disease;Disease;PA166155152;Variant
RS1799752;Coronary Artery Disease;Disease;PA166155187;Variant
RS1613662;Coronary Artery Disease;Disease;PA166155368;Variant
RS11887534;Coronary Artery Disease;Disease;PA166155810;Variant
RS13431554;Coronary Artery Disease;Disease;PA166155834;Variant
RS5182;Coronary Artery Disease;Disease;PA166156275;Variant
RS5186;Coronary Artery Disease;Disease;PA166156276;Variant
RS275651;Coronary Artery Disease;Disease;PA166156283;Variant
RS6809699;Coronary Artery Disease;Disease;PA166156418;Variant
RS1024323;Coronary Artery Disease;Disease;PA166156499;Variant
RS1800591;Coronary Artery Disease;Disease;PA166156523;Variant
RS1126643;Coronary Artery Disease;Disease;PA166156755;Variant
RS2301149;Coronary Artery Disease;Disease;PA166156798;Variant
RS10455872;Coronary Artery Disease;Disease;PA166157168;Variant
RS662;Coronary Artery Disease;Disease;PA166157238;Variant
RS342293;Coronary Artery Disease;Disease;PA166157255;Variant
RS1045642;Coronary Artery Disease;Disease;PA166157284;Variant
RS1799983;Coronary Artery Disease;Disease;PA166157303;Variant
RS2032582;Coronary Artery Disease;Disease;PA166157316;Variant
RS2242480;Coronary Artery Disease;Disease;PA166157345;Variant
RS4986790;Coronary Artery Disease;Disease;PA166157780;Variant
RS10306114;Coronary Artery Disease;Disease;PA166157803;Variant
RS35068180;Coronary Artery Disease;Disease;PA166181205;Variant
RS10787959;Coronary Artery Disease;Disease;PA166274201;Variant
RS3740563;Coronary Artery Disease;Disease;PA166274202;Variant
RS11198893;Coronary Artery Disease;Disease;PA166274203;Variant
RS4752292;Coronary Artery Disease;Disease;PA166274204;Variant
GRK5;Coronary Artery Disease;Disease;PA180;Gene
IRS1;Coronary Artery Disease;Disease;PA203;Gene
ITGA2;Coronary Artery Disease;Disease;PA204;Gene
ITGB3;Coronary Artery Disease;Disease;PA205;Gene
KCNMB1;Coronary Artery Disease;Disease;PA221;Gene
PTGS1;Coronary Artery Disease;Disease;PA24346;Gene
ABCG8;Coronary Artery Disease;Disease;PA24412;Gene
MTHFR;Coronary Artery Disease;Disease;PA245;Gene
ATP2B1;Coronary Artery Disease;Disease;PA25107;Gene
NOS3;Coronary Artery Disease;Disease;PA254;Gene
ABCB1;Coronary Artery Disease;Disease;PA267;Gene
CYP2J2;Coronary Artery Disease;Disease;PA27112;Gene
GP6;Coronary Artery Disease;Disease;PA28824;Gene
GRK4;Coronary Artery Disease;Disease;PA28941;Gene
PTGS2;Coronary Artery Disease;Disease;PA293;Gene
KCNIP1;Coronary Artery Disease;Disease;PA30041;Gene
LPA;Coronary Artery Disease;Disease;PA30432;Gene
MMP3;Coronary Artery Disease;Disease;PA30886;Gene
NR1H3;Coronary Artery Disease;Disease;PA31751;Gene
SLC22A3;Coronary Artery Disease;Disease;PA330;Gene
PON1;Coronary Artery Disease;Disease;PA33529;Gene
TLR4;Coronary Artery Disease;Disease;PA36552;Gene
ADRB1;Coronary Artery Disease;Disease;PA38;Gene
ADRB2;Coronary Artery Disease;Disease;PA39;Gene
AGT;Coronary Artery Disease;Disease;PA42;Gene
AGTR1;Coronary Artery Disease;Disease;PA43;Gene
ALOX5;Coronary Artery Disease;Disease;PA46;Gene
BDKRB1;Coronary Artery Disease;Disease;PA79;Gene
CACNA1C;Coronary Artery Disease;Disease;PA83;Gene
BIPOLAR DISORDER;rs62200793;Variant;PA447199;Disease
LITHIUM;rs62200793;Variant;PA450243;Chemical
BUPROPION;rs764288403;Variant;PA448687;Chemical
EFAVIRENZ;rs764288403;Variant;PA449441;Chemical
LEUKOTRIENE RECEPTOR ANTAGONISTS;LTC4S;Gene;PA164712863;Chemical
ASTHMA;LTC4S;Gene;PA443450;Disease
URTICARIA;LTC4S;Gene;PA445999;Disease
ASPIRIN;LTC4S;Gene;PA448497;Chemical
MONTELUKAST;LTC4S;Gene;PA450546;Chemical
PACLITAXEL;SPATA5;Gene;PA450761;Chemical
FENTANYL;rs79910351;Variant;PA449599;Chemical
REMIFENTANIL;rs79910351;Variant;PA451232;Chemical
COMT;Depressive Disorder;Disease;PA117;Gene
CYP2C19;Depressive Disorder;Disease;PA124;Gene
CYP2D6;Depressive Disorder;Disease;PA128;Gene
TPH2;Depressive Disorder;Disease;PA128747823;Gene
TSPAN5;Depressive Disorder;Disease;PA134864098;Gene
RABEP1;Depressive Disorder;Disease;PA134884097;Gene
RFK;Depressive Disorder;Disease;PA134916697;Gene
ACE;Depressive Disorder;Disease;PA139;Gene
ERICH3;Depressive Disorder;Disease;PA142672422;Gene
SH2B1;Depressive Disorder;Disease;PA145148084;Gene
CYP2C19*17;Depressive Disorder;Disease;PA165816533;Haplotype
CYP2D6*1;Depressive Disorder;Disease;PA165816576;Haplotype
CYP2D6*2;Depressive Disorder;Disease;PA165816577;Haplotype
CYP2D6*3;Depressive Disorder;Disease;PA165816578;Haplotype
CYP2D6*4;Depressive Disorder;Disease;PA165816579;Haplotype
CYP2D6*6;Depressive Disorder;Disease;PA165816581;Haplotype
CYP2D6*10;Depressive Disorder;Disease;PA165816582;Haplotype
CYP2D6*41;Depressive Disorder;Disease;PA165816584;Haplotype
CYP2D6*5;Depressive Disorder;Disease;PA165948092;Haplotype
CYP2C19*1;Depressive Disorder;Disease;PA165980634;Haplotype
CYP2C19*2;Depressive Disorder;Disease;PA165980635;Haplotype
CYP2C19*3;Depressive Disorder;Disease;PA165980636;Haplotype
CYP2C19*4;Depressive Disorder;Disease;PA165980637;Haplotype
CYP2D6*1XN;Depressive Disorder;Disease;PA165988479;Haplotype
CYP2D6*2XN;Depressive Disorder;Disease;PA165988480;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);Depressive Disorder;Disease;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);Depressive Disorder;Disease;PA166116466;Haplotype
CYP2D6*81;Depressive Disorder;Disease;PA166123321;Haplotype
RS696692;Depressive Disorder;Disease;PA166153586;Variant
RS11580409;Depressive Disorder;Disease;PA166153829;Variant
RS915120;Depressive Disorder;Disease;PA166153956;Variant
RS1800544;Depressive Disorder;Disease;PA166153974;Variant
RS6265;Depressive Disorder;Disease;PA166154259;Variant
RS1954787;Depressive Disorder;Disease;PA166154345;Variant
RS12800734;Depressive Disorder;Disease;PA166154467;Variant
RS4570625;Depressive Disorder;Disease;PA166154593;Variant
RS585719;Depressive Disorder;Disease;PA166154681;Variant
RS7997012;Depressive Disorder;Disease;PA166154726;Variant
RS9316233;Depressive Disorder;Disease;PA166154732;Variant
RS1799752;Depressive Disorder;Disease;PA166155187;Variant
RS4680;Depressive Disorder;Disease;PA166156024;Variant
RS1449683;Depressive Disorder;Disease;PA166156513;Variant
RS11947402;Depressive Disorder;Disease;PA166156657;Variant
RS6295;Depressive Disorder;Disease;PA166156708;Variant
RS4713916;Depressive Disorder;Disease;PA166157104;Variant
RS1045642;Depressive Disorder;Disease;PA166157284;Variant
RS2032582;Depressive Disorder;Disease;PA166157316;Variant
RS2032583;Depressive Disorder;Disease;PA166157317;Variant
RS2235015;Depressive Disorder;Disease;PA166157336;Variant
RS7787082;Depressive Disorder;Disease;PA166157428;Variant
RS11144870;Depressive Disorder;Disease;PA166157829;Variant
RS3888190;Depressive Disorder;Disease;PA166165398;Variant
RS1000940;Depressive Disorder;Disease;PA166165401;Variant
CYP2D6*14;Depressive Disorder;Disease;PA166181185;Haplotype
GRK5;Depressive Disorder;Disease;PA180;Gene
HTR1A;Depressive Disorder;Disease;PA192;Gene
HTR2A;Depressive Disorder;Disease;PA193;Gene
ABCB1;Depressive Disorder;Disease;PA267;Gene
FGF2;Depressive Disorder;Disease;PA28115;Gene
FKBP5;Depressive Disorder;Disease;PA28162;Gene
GRIK4;Depressive Disorder;Disease;PA28976;Gene
SLC6A4;Depressive Disorder;Disease;PA312;Gene
BDNF;Depressive Disorder;Disease;PA31891;Gene
ADRA2A;Depressive Disorder;Disease;PA35;Gene
ARIPIPRAZOLE;RELN;Gene;PA10026;Chemical
SCHIZOPHRENIA;RELN;Gene;PA447216;Disease
OLANZAPINE;RELN;Gene;PA450688;Chemical
PERPHENAZINE;RELN;Gene;PA450882;Chemical
QUETIAPINE;RELN;Gene;PA451201;Chemical
RISPERIDONE;RELN;Gene;PA451257;Chemical
CYP2C19;acenocoumarol;Chemical;PA124;Gene
CYP2C9;acenocoumarol;Chemical;PA126;Gene
CYP2C18;acenocoumarol;Chemical;PA127;Gene
VKORC1;acenocoumarol;Chemical;PA133787052;Gene
CYP2C9*1;acenocoumarol;Chemical;PA165816542;Haplotype
CYP2C9*2;acenocoumarol;Chemical;PA165816543;Haplotype
CYP2C9*3;acenocoumarol;Chemical;PA165816544;Haplotype
CYP2C9*5;acenocoumarol;Chemical;PA165816546;Haplotype
CYP2C9*8;acenocoumarol;Chemical;PA165816549;Haplotype
CYP2C9*9;acenocoumarol;Chemical;PA165816550;Haplotype
CYP2C9*11;acenocoumarol;Chemical;PA165816552;Haplotype
CYP2C19*2;acenocoumarol;Chemical;PA165980635;Haplotype
CYP2C19*3;acenocoumarol;Chemical;PA165980636;Haplotype
CYP2C9*57;acenocoumarol;Chemical;PA166048703;Haplotype
RS4086116;acenocoumarol;Chemical;PA166154045;Variant
RS7294;acenocoumarol;Chemical;PA166154977;Variant
RS7200749;acenocoumarol;Chemical;PA166155080;Variant
RS9923231;acenocoumarol;Chemical;PA166155091;Variant
RS9934438;acenocoumarol;Chemical;PA166155096;Variant
RS17878544;acenocoumarol;Chemical;PA166155122;Variant
RS55894764;acenocoumarol;Chemical;PA166155131;Variant
RS61742245;acenocoumarol;Chemical;PA166155134;Variant
RS104894542;acenocoumarol;Chemical;PA166155140;Variant
RS429358;acenocoumarol;Chemical;PA166155351;Variant
RS2108622;acenocoumarol;Chemical;PA166155381;Variant
RS11676382;acenocoumarol;Chemical;PA166155805;Variant
RS1043550;acenocoumarol;Chemical;PA166157283;Variant
RS1998591;acenocoumarol;Chemical;PA166247001;Variant
CALU;acenocoumarol;Chemical;PA26047;Gene
CYP4F2;acenocoumarol;Chemical;PA27121;Gene
GGCX;acenocoumarol;Chemical;PA28660;Gene
WARFARIN;acenocoumarol;Chemical;PA451906;Chemical
APOE;acenocoumarol;Chemical;PA55;Gene
LOVASTATIN;rs2291073;Variant;PA450272;Chemical
PANIC DISORDER;rs57098334;Variant;PA447212;Disease
DEPRESSION;rs57098334;Variant;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;rs57098334;Variant;PA447321;Disease
FLUOXETINE;rs57098334;Variant;PA449673;Chemical
PAROXETINE;rs57098334;Variant;PA450801;Chemical
SERTRALINE;rs57098334;Variant;PA451333;Chemical
ANTIDEPRESSANTS;rs57098334;Variant;PA452229;Chemical
TENOFOVIR;IFNL3;Gene;PA10204;Chemical
PEGINTERFERON ALFA-2A;IFNL3;Gene;PA164749390;Chemical
PEGINTERFERON ALFA-2B;IFNL3;Gene;PA164784024;Chemical
BOCEPREVIR;IFNL3;Gene;PA165948902;Chemical
TELAPREVIR;IFNL3;Gene;PA165958354;Chemical
SIMEPREVIR;IFNL3;Gene;PA166122590;Chemical
SOFOSBUVIR;IFNL3;Gene;PA166122593;Chemical
DELEOBUVIR;IFNL3;Gene;PA166128130;Chemical
FALDAPREVIR;IFNL3;Gene;PA166128132;Chemical
LEDIPASVIR;IFNL3;Gene;PA166128166;Chemical
DACLATASVIR;IFNL3;Gene;PA166128167;Chemical
RS12979860;IFNL3;Gene;PA166155468;Variant
DASABUVIR / OMBITASVIR / PARITAPREVIR / RITONAVIR;IFNL3;Gene;PA166160002;Chemical
OMBITASVIR / PARITAPREVIR / RITONAVIR;IFNL3;Gene;PA166163408;Chemical
DASABUVIR;IFNL3;Gene;PA166163411;Chemical
VELPATASVIR;IFNL3;Gene;PA166163415;Chemical
SOFOSBUVIR / VELPATASVIR;IFNL3;Gene;PA166163416;Chemical
LEDIPASVIR / SOFOSBUVIR;IFNL3;Gene;PA166163427;Chemical
ELBASVIR / GRAZOPREVIR;IFNL3;Gene;PA166163438;Chemical
VOXILAPREVIR;IFNL3;Gene;PA166171182;Chemical
SOFOSBUVIR / VELPATASVIR / VOXILAPREVIR;IFNL3;Gene;PA166177517;Chemical
HEPATITIS C VIRUS INFECTION;IFNL3;Gene;PA444445;Disease
MYELOPROLIFERATIVE DISORDER;IFNL3;Gene;PA445016;Disease
RECURRENCE;IFNL3;Gene;PA445506;Disease
HEPATITIS B, CHRONIC;IFNL3;Gene;PA446862;Disease
CHRONIC HEPATITIS C VIRUS INFECTION;IFNL3;Gene;PA446863;Disease
HIV INFECTIOUS DISEASE;IFNL3;Gene;PA447230;Disease
ATORVASTATIN;IFNL3;Gene;PA448500;Chemical
RIBAVIRIN;IFNL3;Gene;PA451241;Chemical
INTERFERONS;IFNL3;Gene;PA451999;Chemical
NTRK1;repotrectinib;Chemical;PA31817;Gene
NTRK2;repotrectinib;Chemical;PA31818;Gene
NTRK3;repotrectinib;Chemical;PA31819;Gene
ROS1;repotrectinib;Chemical;PA34633;Gene
RS1050828;Malaria, Falciparum;Disease;PA166157859;Variant
G6PD;Malaria, Falciparum;Disease;PA28469;Gene
ACUTE LYMPHOBLASTIC LEUKEMIA;NALCN;Gene;PA446155;Disease
METHOTREXATE;NALCN;Gene;PA450428;Chemical
RS137852517;Kallmann Syndrome;Disease;PA166339141;Variant
ANOS1;Kallmann Syndrome;Disease;PA30012;Gene
CFTR;rs397508453;Variant;PA109;Gene
IVACAFTOR;rs397508453;Variant;PA165950341;Chemical
CYSTIC FIBROSIS;rs397508453;Variant;PA443829;Disease
FLUOROURACIL;rs570122671;Variant;PA128406956;Chemical
DRUG TOXICITY;rs570122671;Variant;PA443937;Disease
SCHIZOPHRENIA;rs472660;Variant;PA447216;Disease
OLANZAPINE;rs472660;Variant;PA450688;Chemical
MELANOMA;SF3B1;Gene;PA444903;Disease
KIDNEY TRANSPLANTATION;HSD11B1;Gene;PA165817016;Disease
TACROLIMUS;HSD11B1;Gene;PA451578;Chemical
COL3A1;GP6;Gene;PA26716;Gene
COL4A1;GP6;Gene;PA26717;Gene
COL4A2;GP6;Gene;PA26718;Gene
PLCB1;GP6;Gene;PA33384;Gene
PLCG2;GP6;Gene;PA33393;Gene
COL1A1;GP6;Gene;PA35041;Gene
COL1A2;GP6;Gene;PA35042;Gene
CORONARY ARTERY DISEASE;GP6;Gene;PA443796;Disease
ASPIRIN;GP6;Gene;PA448497;Chemical
FLUOROURACIL;rs17626122;Variant;PA128406956;Chemical
OXALIPLATIN;rs17626122;Variant;PA131285527;Chemical
DRUG TOXICITY;rs17626122;Variant;PA443937;Disease
COLORECTAL NEOPLASMS;rs17626122;Variant;PA446108;Disease
FLUOROURACIL;rs149212925;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs149212925;Variant;PA443560;Disease
NEUTROPENIA;rs149212925;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs149212925;Variant;PA449165;Chemical
EPIRUBICIN;rs149212925;Variant;PA449476;Chemical
HEPATOCELLULAR CARCINOMA;SLC15A2;Gene;PA444447;Disease
SORAFENIB;SLC15A2;Gene;PA7000;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs2019604;Variant;PA130620651;Chemical
NEOPLASMS;rs2019604;Variant;PA445062;Disease
G6PD DEFICIENCY;Typhoid Fever;Disease;PA166157959;Variant
G6PD;Typhoid Fever;Disease;PA28469;Gene
PAIN, POSTOPERATIVE;rs696;Variant;PA445210;Disease
SUFENTANIL;rs696;Variant;PA451527;Chemical
RASBURICASE;G6PD A- 202A_376G;Haplotype;PA10176;Chemical
DIMERCAPROL;G6PD A- 202A_376G;Haplotype;PA165958406;Chemical
PEGLOTICASE;G6PD A- 202A_376G;Haplotype;PA165963961;Chemical
LEAD POISONING, NERVOUS SYSTEM, CHILDHOOD;G6PD A- 202A_376G;Haplotype;PA166048926;Disease
PAMAQUINE;G6PD A- 202A_376G;Haplotype;PA166115579;Chemical
TAFENOQUINE;G6PD A- 202A_376G;Haplotype;PA166115580;Chemical
SITAMAQUINE;G6PD A- 202A_376G;Haplotype;PA166115581;Chemical
ANEMIA, HEMOLYTIC;G6PD A- 202A_376G;Haplotype;PA443343;Disease
BURKITT LYMPHOMA;G6PD A- 202A_376G;Haplotype;PA443580;Disease
BURNS;G6PD A- 202A_376G;Haplotype;PA443582;Disease
DIABETES MELLITUS, TYPE 2;G6PD A- 202A_376G;Haplotype;PA443890;Disease
HEMOLYSIS;G6PD A- 202A_376G;Haplotype;PA444411;Disease
KIDNEY FAILURE, ACUTE;G6PD A- 202A_376G;Haplotype;PA444683;Disease
MALARIA;G6PD A- 202A_376G;Haplotype;PA444859;Disease
METHEMOGLOBINEMIA;G6PD A- 202A_376G;Haplotype;PA444942;Disease
PROTEIN DEFICIENCY;G6PD A- 202A_376G;Haplotype;PA445428;Disease
CHLORAMPHENICOL;G6PD A- 202A_376G;Haplotype;PA448927;Chemical
CHLOROQUINE;G6PD A- 202A_376G;Haplotype;PA448948;Chemical
DAPSONE;G6PD A- 202A_376G;Haplotype;PA449211;Chemical
DAUNORUBICIN;G6PD A- 202A_376G;Haplotype;PA449212;Chemical
GLYBURIDE;G6PD A- 202A_376G;Haplotype;PA449782;Chemical
MEFLOQUINE;G6PD A- 202A_376G;Haplotype;PA450348;Chemical
METHYLENE BLUE;G6PD A- 202A_376G;Haplotype;PA450457;Chemical
NITROFURANTOIN;G6PD A- 202A_376G;Haplotype;PA450640;Chemical
PRIMAQUINE;G6PD A- 202A_376G;Haplotype;PA451103;Chemical
SULFASALAZINE;G6PD A- 202A_376G;Haplotype;PA451547;Chemical
VITAMIN C;G6PD A- 202A_376G;Haplotype;PA451898;Chemical
LONAFARNIB;LMNA;Gene;PA166129466;Chemical
FLUOROURACIL;rs538703919;Variant;PA128406956;Chemical
DRUG TOXICITY;rs538703919;Variant;PA443937;Disease
BCHE;oxymetazoline and tetracaine;Chemical;PA25294;Gene
CYB5R3;oxymetazoline and tetracaine;Chemical;PA27331;Gene
G6PD;oxymetazoline and tetracaine;Chemical;PA28469;Gene
MAP2K7;MAPK6;Gene;PA284;Gene
MAP2K1;MAPK6;Gene;PA30584;Gene
MAP2K2;MAPK6;Gene;PA30587;Gene
MAP2K3;MAPK6;Gene;PA30588;Gene
MAP2K4;MAPK6;Gene;PA30589;Gene
MAP2K5;MAPK6;Gene;PA30590;Gene
MAP2K6;MAPK6;Gene;PA30591;Gene
SORAFENIB;MAPK6;Gene;PA7000;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;rs11045821;Variant;PA446155;Disease
METHOTREXATE;rs11045821;Variant;PA450428;Chemical
ACETALDEHYDE;rs1229984;Variant;PA166186245;Chemical
ALCOHOL ABUSE;rs1229984;Variant;PA443309;Disease
ETHANOL;rs1229984;Variant;PA448073;Chemical
OPIOID-RELATED DISORDERS;rs678849;Variant;PA445043;Disease
COCAINE DEPENDENCE;rs678849;Variant;PA446878;Disease
BUPRENORPHINE;rs678849;Variant;PA448685;Chemical
COCAINE;rs678849;Variant;PA449072;Chemical
DISULFIRAM;rs678849;Variant;PA449376;Chemical
METHADONE;rs678849;Variant;PA450401;Chemical
FGFR1OP;brivanib;Chemical;PA134941638;Gene
FGFR1OP2;brivanib;Chemical;PA134972108;Gene
FGFR1;brivanib;Chemical;PA28127;Gene
FGFR2;brivanib;Chemical;PA28128;Gene
FGFR3;brivanib;Chemical;PA28129;Gene
FGFR4;brivanib;Chemical;PA28130;Gene
FGFR3P1;brivanib;Chemical;PA28131;Gene
FGFRL1;brivanib;Chemical;PA28132;Gene
KDR;brivanib;Chemical;PA30086;Gene
CYP2C9;rimegepant;Chemical;PA126;Gene
CYP2C9*2;rimegepant;Chemical;PA165816543;Haplotype
CYP2C9*3;rimegepant;Chemical;PA165816544;Haplotype
BUFURALOL;rs777560972;Variant;PA166110256;Chemical
DEXTROMETHORPHAN;rs777560972;Variant;PA449273;Chemical
DPYD;rs142512579;Variant;PA145;Gene
CAPECITABINE;rs142512579;Variant;PA448771;Chemical
FLT3;gilteritinib;Chemical;PA28181;Gene
GEFITINIB;RELA;Gene;PA131301952;Chemical
CAMK1D;RELA;Gene;PA134992438;Gene
TOXIC LIVER DISEASE;RELA;Gene;PA164925725;Disease
AKT1;RELA;Gene;PA24684;Gene
AKT2;RELA;Gene;PA24685;Gene
AKT3;RELA;Gene;PA24686;Gene
CAMK1;RELA;Gene;PA26048;Gene
CAMK1G;RELA;Gene;PA26049;Gene
MAPK8;RELA;Gene;PA283;Gene
MAPK1;RELA;Gene;PA30616;Gene
MAPK3;RELA;Gene;PA30622;Gene
PPP3CA;RELA;Gene;PA33678;Gene
PPP3CB;RELA;Gene;PA33679;Gene
PPP3CC;RELA;Gene;PA33680;Gene
PPP3R1;RELA;Gene;PA33681;Gene
PPP3R2;RELA;Gene;PA33682;Gene
STAT3;RELA;Gene;PA337;Gene
PRKCA;RELA;Gene;PA33759;Gene
PRKCB;RELA;Gene;PA33761;Gene
PRKCG;RELA;Gene;PA33766;Gene
STAT5A;RELA;Gene;PA338;Gene
STAT1;RELA;Gene;PA36183;Gene
STAT2;RELA;Gene;PA36184;Gene
STAT4;RELA;Gene;PA36185;Gene
STAT5B;RELA;Gene;PA36186;Gene
NON-SMALL CELL LUNG CARCINOMA;RELA;Gene;PA443622;Disease
HYPERTENSION;RELA;Gene;PA444552;Disease
CAMK2A;RELA;Gene;PA90;Gene
CAMK2B;RELA;Gene;PA91;Gene
CAMK2D;RELA;Gene;PA92;Gene
CAMK2G;RELA;Gene;PA93;Gene
FLUOROURACIL;DPYD c.1679T>G (*13);Haplotype;PA128406956;Chemical
DPYD;DPYD c.1679T>G (*13);Haplotype;PA145;Gene
TEGAFUR / GIMERACIL / OTERACIL;DPYD c.1679T>G (*13);Haplotype;PA166115442;Chemical
CAPECITABINE;DPYD c.1679T>G (*13);Haplotype;PA448771;Chemical
TEGAFUR;DPYD c.1679T>G (*13);Haplotype;PA452620;Chemical
ENFORTUMAB VEDOTIN;NECTIN4;Gene;PA166190121;Chemical
OPIOID-RELATED DISORDERS;NECTIN4;Gene;PA445043;Disease
PRURITUS;NECTIN4;Gene;PA445437;Disease
METHADONE;NECTIN4;Gene;PA450401;Chemical
LUPUS ERYTHEMATOSUS, SYSTEMIC;TPMT*25;Haplotype;PA444822;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;TPMT*25;Haplotype;PA446155;Disease
MERCAPTOPURINE;TPMT*25;Haplotype;PA450379;Chemical
ECULIZUMAB;CHRNA6;Gene;PA164776637;Chemical
EFGARTIGIMOD ALFA;CHRNA6;Gene;PA166268781;Chemical
RAVULIZUMAB;CHRNA6;Gene;PA166277861;Chemical
ROZANOLIXIZUMAB;CHRNA6;Gene;PA166313325;Chemical
ZILUCOPLAN;CHRNA6;Gene;PA166328901;Chemical
TPMT;TPMT*14;Haplotype;PA356;Gene
AZATHIOPRINE;TPMT*14;Haplotype;PA448515;Chemical
MERCAPTOPURINE;TPMT*14;Haplotype;PA450379;Chemical
THIOGUANINE;TPMT*14;Haplotype;PA451663;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs1382368;Variant;PA443622;Disease
DOCETAXEL;rs1382368;Variant;PA449383;Chemical
OSTEOSARCOMA;rs462779;Variant;PA445601;Disease
CISPLATIN;rs462779;Variant;PA449014;Chemical
ACAMPROSATE;rs77583603;Variant;PA10344;Chemical
ALCOHOL ABUSE;rs77583603;Variant;PA443309;Disease
NITRENDIPINE;rs5186;Variant;PA146096020;Chemical
ACE INHIBITORS, PLAIN;rs5186;Variant;PA164712308;Chemical
THIAZIDES, PLAIN;rs5186;Variant;PA164713347;Chemical
ANGIOTENSIN II;rs5186;Variant;PA166109554;Chemical
CORONARY ARTERY DISEASE;rs5186;Variant;PA443796;Disease
DIABETES MELLITUS, TYPE 2;rs5186;Variant;PA443890;Disease
HEART FAILURE;rs5186;Variant;PA444370;Disease
HYPERTENSION;rs5186;Variant;PA444552;Disease
LIVER CIRRHOSIS;rs5186;Variant;PA444797;Disease
HYPERTROPHY, LEFT VENTRICULAR;rs5186;Variant;PA446479;Disease
ATORVASTATIN;rs5186;Variant;PA448500;Chemical
CANDESARTAN;rs5186;Variant;PA448765;Chemical
CAPTOPRIL;rs5186;Variant;PA448780;Chemical
IRBESARTAN;rs5186;Variant;PA450084;Chemical
LOSARTAN;rs5186;Variant;PA450268;Chemical
PERINDOPRIL;rs5186;Variant;PA450877;Chemical
AKT1;HNF1A;Gene;PA24684;Gene
OPIOIDS;HNF1A;Gene;PA452618;Chemical
HEROIN DEPENDENCE;rs2378676;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs2378676;Variant;PA445043;Disease
METHADONE;rs2378676;Variant;PA450401;Chemical
PAIN, POSTOPERATIVE;rs11959113;Variant;PA445210;Disease
FENTANYL;rs11959113;Variant;PA449599;Chemical
F13A1;Photodynamic therapy;Chemical;PA162;Gene
RS1061170;Photodynamic therapy;Chemical;PA166153617;Variant
RS5985;Photodynamic therapy;Chemical;PA166156902;Variant
CFH;Photodynamic therapy;Chemical;PA29261;Gene
RS1126742;amiloride;Chemical;PA166153623;Variant
CYP4A11;amiloride;Chemical;PA27118;Gene
SCNN1A;amiloride;Chemical;PA305;Gene
SCNN1B;amiloride;Chemical;PA306;Gene
SCNN1G;amiloride;Chemical;PA307;Gene
NON-SMALL CELL LUNG CARCINOMA;XYLT2;Gene;PA443622;Disease
THROMBOCYTOPENIA;XYLT2;Gene;PA445846;Disease
CARBOPLATIN;XYLT2;Gene;PA448803;Chemical
GEMCITABINE;XYLT2;Gene;PA449748;Chemical
OPIOID-RELATED DISORDERS;LKAAEAR1;Gene;PA445043;Disease
OPIOIDS;LKAAEAR1;Gene;PA452618;Chemical
COUMARIN;CYP2A6*6;Haplotype;PA134521193;Chemical
RS130058;liothyronine;Chemical;PA166156908;Variant
HTR1B;liothyronine;Chemical;PA29549;Gene
CYP2C9;CYP2C9*11;Haplotype;PA126;Gene
VKORC1;CYP2C9*11;Haplotype;PA133787052;Gene
HYDROXYPHENYTOIN;CYP2C9*11;Haplotype;PA165823907;Chemical
OVER-ANTICOAGULATION;CYP2C9*11;Haplotype;PA166123298;Disease
INTERNATIONAL NORMALIZED RATIO VARIABILITY (INR-VAR);CYP2C9*11;Haplotype;PA166160459;Disease
SIPONIMOD;CYP2C9*11;Haplotype;PA166182736;Chemical
CYP4F2;CYP2C9*11;Haplotype;PA27121;Gene
CARDIOVASCULAR DISEASES;CYP2C9*11;Haplotype;PA443635;Disease
EPILEPSY;CYP2C9*11;Haplotype;PA444065;Disease
HEMORRHAGE;CYP2C9*11;Haplotype;PA444417;Disease
TUBERCULOSIS;CYP2C9*11;Haplotype;PA445941;Disease
PHENYTOIN;CYP2C9*11;Haplotype;PA450947;Chemical
RIFAMPIN;CYP2C9*11;Haplotype;PA451250;Chemical
WARFARIN;CYP2C9*11;Haplotype;PA451906;Chemical
ACENOCOUMAROL;CYP2C9*11;Haplotype;PA452632;Chemical
NUDT15;NUDT15*3;Haplotype;PA134963132;Gene
MYELOSUPPRESSION;NUDT15*3;Haplotype;PA165817398;Disease
HEMATOPOIETIC STEM CELL TRANSPLANTATION;NUDT15*3;Haplotype;PA166123007;Disease
DISCONTINUATION;NUDT15*3;Haplotype;PA166123507;Disease
PRIMARY GRAFT FAILURE;NUDT15*3;Haplotype;PA166248341;Disease
TPMT;NUDT15*3;Haplotype;PA356;Gene
INFLAMMATION;NUDT15*3;Haplotype;PA444620;Disease
LEUKOPENIA;NUDT15*3;Haplotype;PA444773;Disease
NEUTROPENIA;NUDT15*3;Haplotype;PA445113;Disease
INFLAMMATORY BOWEL DISEASES;NUDT15*3;Haplotype;PA446116;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;NUDT15*3;Haplotype;PA446155;Disease
ACYCLOVIR;NUDT15*3;Haplotype;PA448045;Chemical
AZATHIOPRINE;NUDT15*3;Haplotype;PA448515;Chemical
MERCAPTOPURINE;NUDT15*3;Haplotype;PA450379;Chemical
ACUTE CORONARY SYNDROME;MYOM2;Gene;PA165108401;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);MYOM2;Gene;PA166129560;Disease
ASPIRIN;MYOM2;Gene;PA448497;Chemical
CLOPIDOGREL;MYOM2;Gene;PA449053;Chemical
SCHIZOPHRENIA;EPM2A;Gene;PA447216;Disease
CHLORPROMAZINE;EPM2A;Gene;PA448964;Chemical
CLOZAPINE;EPM2A;Gene;PA449061;Chemical
HALOPERIDOL;EPM2A;Gene;PA449841;Chemical
OLANZAPINE;EPM2A;Gene;PA450688;Chemical
QUETIAPINE;EPM2A;Gene;PA451201;Chemical
RISPERIDONE;EPM2A;Gene;PA451257;Chemical
TRIFLUOPERAZINE;EPM2A;Gene;PA451771;Chemical
HMG COA REDUCTASE INHIBITORS;rs1935349;Variant;PA133950441;Chemical
MYALGIA;rs1935349;Variant;PA157379134;Disease
ATORVASTATIN;rs1935349;Variant;PA448500;Chemical
PRAVASTATIN;rs1935349;Variant;PA451089;Chemical
SIMVASTATIN;rs1935349;Variant;PA451363;Chemical
CFTR;rs397508139;Variant;PA109;Gene
IVACAFTOR;rs397508139;Variant;PA165950341;Chemical
TEZACAFTOR;rs397508139;Variant;PA166175754;Chemical
ELEXACAFTOR;rs397508139;Variant;PA166185161;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs397508139;Variant;PA166362502;Chemical
CYSTIC FIBROSIS;rs397508139;Variant;PA443829;Disease
COCAINE DEPENDENCE;rs10111937;Variant;PA446878;Disease
COCAINE;rs10111937;Variant;PA449072;Chemical
PROSTATIC NEOPLASMS;rs4148947;Variant;PA445425;Disease
DOCETAXEL;rs4148947;Variant;PA449383;Chemical
THALIDOMIDE;rs4148947;Variant;PA451644;Chemical
BEVACIZUMAB;VEGFC;Gene;PA130232992;Chemical
AFLIBERCEPT;VEGFC;Gene;PA166118342;Chemical
FLT1;VEGFC;Gene;PA28180;Gene
KDR;VEGFC;Gene;PA30086;Gene
NRP1;VEGFC;Gene;PA31783;Gene
PLATINUM COMPOUNDS;CXXC4;Gene;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;CXXC4;Gene;PA443622;Disease
CYP2C19;proguanil;Chemical;PA124;Gene
CYP3A4;proguanil;Chemical;PA130;Gene
CYP2C19*1;proguanil;Chemical;PA165980634;Haplotype
CYP2C19*2;proguanil;Chemical;PA165980635;Haplotype
CYP2C19*3;proguanil;Chemical;PA165980636;Haplotype
RS12208357;proguanil;Chemical;PA166157178;Variant
RS34059508;proguanil;Chemical;PA166157196;Variant
RS34130495;proguanil;Chemical;PA166157197;Variant
RS55918055;proguanil;Chemical;PA166157206;Variant
RS72552763;proguanil;Chemical;PA166157216;Variant
SLC22A1;proguanil;Chemical;PA329;Gene
RS1801131;Lymphoma, T-Cell;Disease;PA166153643;Variant
RS1801133;Lymphoma, T-Cell;Disease;PA166153644;Variant
RS3215400;Lymphoma, T-Cell;Disease;PA166153738;Variant
RS1051266;Lymphoma, T-Cell;Disease;PA166155986;Variant
RS2231142;Lymphoma, T-Cell;Disease;PA166156544;Variant
RS1045642;Lymphoma, T-Cell;Disease;PA166157284;Variant
MTHFR;Lymphoma, T-Cell;Disease;PA245;Gene
ABCB1;Lymphoma, T-Cell;Disease;PA267;Gene
SLC19A1;Lymphoma, T-Cell;Disease;PA327;Gene
ABCG2;Lymphoma, T-Cell;Disease;PA390;Gene
CDA;Lymphoma, T-Cell;Disease;PA98;Gene
CREATINE;MOBP;Gene;PA164778930;Chemical
AMYOTROPHIC LATERAL SCLEROSIS;MOBP;Gene;PA443332;Disease
CYP3A4;trimethoprim;Chemical;PA130;Gene
FLT3;venetoclax;Chemical;PA28181;Gene
IDH1;venetoclax;Chemical;PA29630;Gene
IDH2;venetoclax;Chemical;PA29631;Gene
NPM1;venetoclax;Chemical;PA31712;Gene
TP53;venetoclax;Chemical;PA36679;Gene
NFKB1;CAMK2D;Gene;PA248;Gene
ELK1;CAMK2D;Gene;PA27749;Gene
FOS;CAMK2D;Gene;PA28212;Gene
RELA;CAMK2D;Gene;PA296;Gene
JUN;CAMK2D;Gene;PA30006;Gene
MYC;CAMK2D;Gene;PA31353;Gene
NFKB2;CAMK2D;Gene;PA31600;Gene
STAT3;CAMK2D;Gene;PA337;Gene
STAT5A;CAMK2D;Gene;PA338;Gene
SP1;CAMK2D;Gene;PA36042;Gene
STAT1;CAMK2D;Gene;PA36183;Gene
STAT2;CAMK2D;Gene;PA36184;Gene
STAT4;CAMK2D;Gene;PA36185;Gene
STAT5B;CAMK2D;Gene;PA36186;Gene
CARCINOMA, NON-SMALL-CELL LUNG;CAMK2D;Gene;PA443622;Disease
GNAI1;ADCY8;Gene;PA172;Gene
GNAI3;ADCY8;Gene;PA173;Gene
GNAS;ADCY8;Gene;PA175;Gene
GNAI2;ADCY8;Gene;PA24347;Gene
RS34059508;ranitidine;Chemical;PA166157196;Variant
RS55918055;ranitidine;Chemical;PA166157206;Variant
RS72552763;ranitidine;Chemical;PA166157216;Variant
ABCB1;ranitidine;Chemical;PA267;Gene
SLC22A1;ranitidine;Chemical;PA329;Gene
RS193922852;surgery;Disease;PA166183392;Variant
RYR1;surgery;Disease;PA34896;Gene
CETUXIMAB;rs4444903;Variant;PA10040;Chemical
RECTAL NEOPLASMS;rs4444903;Variant;PA445503;Disease
COLORECTAL NEOPLASMS;rs4444903;Variant;PA446108;Disease
CYP1A2;desmethyl olanzapine;Chemical;PA27093;Gene
NOS1AP;Shortened QT interval;Disease;PA142671259;Gene
RS10494366;Shortened QT interval;Disease;PA166153802;Variant
IMATINIB;SLC22A4;Gene;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;SLC22A4;Gene;PA151958383;Disease
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;SLC22A4;Gene;PA446171;Disease
DIABETES MELLITUS, TYPE 2;CPA6;Gene;PA443890;Disease
METFORMIN;CPA6;Gene;PA450395;Chemical
BREAST NEOPLASMS;rs6990851;Variant;PA443560;Disease
ANASTROZOLE;rs6990851;Variant;PA448432;Chemical
CORTICOSTEROIDS;rs1741981;Variant;PA10832;Chemical
ASTHMA;rs1741981;Variant;PA443450;Disease
CYP3A4;cisapride;Chemical;PA130;Gene
KCNH2;cisapride;Chemical;PA212;Gene
ACE INHIBITORS, PLAIN;rs8012552;Variant;PA164712308;Chemical
COUGH;rs8012552;Variant;PA443803;Disease
HYPERTENSION;rs8012552;Variant;PA444552;Disease
BISPHOSPHONATES;rs11189381;Variant;PA164712563;Chemical
OSTEONECROSIS;rs11189381;Variant;PA445187;Disease
DICLOFENAC;CYP2C9*47;Haplotype;PA449293;Chemical
PHENYTOIN;CYP2C9*47;Haplotype;PA450947;Chemical
NEPHROTOXICITY;INSRR;Gene;PA162263533;Disease
GLUCARPIDASE;INSRR;Gene;PA165949771;Chemical
DRUG HYPERSENSITIVITY;rs17211071;Variant;PA443936;Disease
DAPSONE;rs17211071;Variant;PA449211;Chemical
CORTICOSTEROIDS;TBX21;Gene;PA10832;Chemical
ASTHMA;TBX21;Gene;PA443450;Disease
PLATINUM COMPOUNDS;CASP7;Gene;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;CASP7;Gene;PA443622;Disease
DOCETAXEL;CASP7;Gene;PA449383;Chemical
GEMCITABINE;CASP7;Gene;PA449748;Chemical
PACLITAXEL;CASP7;Gene;PA450761;Chemical
VINORELBINE;CASP7;Gene;PA451881;Chemical
PTGS2;Coxibs;Chemical;PA293;Gene
DRUGS FOR TREATMENT OF TUBERCULOSIS;HLA-DQB1*05:03;Haplotype;PA164712708;Chemical
DRUG-INDUCED LIVER INJURY;HLA-DQB1*05:03;Haplotype;PA166119041;Disease
TUBERCULOSIS;HLA-DQB1*05:03;Haplotype;PA445941;Disease
KIDNEY TRANSPLANTATION;rs568408;Variant;PA165817016;Disease
MYCOPHENOLATE MOFETIL;rs568408;Variant;PA450566;Chemical
OPIOID-RELATED DISORDERS;rs933271;Variant;PA445043;Disease
METHADONE;rs933271;Variant;PA450401;Chemical
CYP2C9;7-hydroxy s-warfarin;Chemical;PA126;Gene
ARSENIC TRIOXIDE;PML;Gene;PA448486;Chemical
TRETINOIN;PML;Gene;PA451746;Chemical
TRIHEPTANOIN;CPT2;Gene;PA166350462;Chemical
CFTR;rs35516286;Variant;PA109;Gene
IVACAFTOR;rs35516286;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs35516286;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs35516286;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs35516286;Variant;PA443829;Disease
OXALIPLATIN;rs5275;Variant;PA131285527;Chemical
COLORECTAL NEOPLASMS;rs5275;Variant;PA446108;Disease
CAPECITABINE;rs5275;Variant;PA448771;Chemical
HIV INFECTIOUS DISEASE;rs4803419;Variant;PA447230;Disease
EFAVIRENZ;rs4803419;Variant;PA449441;Chemical
METHOTREXATE;rs4803419;Variant;PA450428;Chemical
DIABETES MELLITUS, TYPE 2;rs296766;Variant;PA443890;Disease
THIAZOLIDINEDIONES;rs296766;Variant;PA452631;Chemical
ALOPECIA;AQP1;Gene;PA443314;Disease
ANEMIA;AQP1;Gene;PA443340;Disease
LEUKOPENIA;AQP1;Gene;PA444773;Disease
MESOTHELIOMA;AQP1;Gene;PA444937;Disease
THROMBOCYTOPENIA;AQP1;Gene;PA445846;Disease
CISPLATIN;AQP1;Gene;PA449014;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*54:01;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*54:01;Haplotype;PA444059;Disease
EPILEPSY;HLA-B*54:01;Haplotype;PA444065;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*54:01;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-B*54:01;Haplotype;PA450616;Chemical
PHENYTOIN;HLA-B*54:01;Haplotype;PA450947;Chemical
O-DESMETHYLTRAMADOL;rs757573592;Variant;PA166131379;Chemical
TAPENTADOL;rs757573592;Variant;PA166179720;Chemical
ACETAMINOPHEN;rs757573592;Variant;PA448015;Chemical
MORPHINE;rs757573592;Variant;PA450550;Chemical
TRAMADOL;rs757573592;Variant;PA451735;Chemical
TUBERCULOSIS;NAT2*7G;Haplotype;PA445941;Disease
ISONIAZID;NAT2*7G;Haplotype;PA450112;Chemical
ASTHENIA;rs4678145;Variant;PA443448;Disease
NEOPLASMS;rs4678145;Variant;PA445062;Disease
CAPECITABINE;rs4678145;Variant;PA448771;Chemical
HTR2A;GNAQ;Gene;PA193;Gene
HTR2C;GNAQ;Gene;PA194;Gene
F2R;GNAQ;Gene;PA27946;Gene
F2RL3;GNAQ;Gene;PA27949;Gene
P2RY1;GNAQ;Gene;PA32868;Gene
PLCB1;GNAQ;Gene;PA33384;Gene
PLCB2;GNAQ;Gene;PA33385;Gene
PLCB3;GNAQ;Gene;PA33386;Gene
PLCB4;GNAQ;Gene;PA33387;Gene
PLCG2;GNAQ;Gene;PA33393;Gene
TBXA2R;GNAQ;Gene;PA348;Gene
MELANOMA;GNAQ;Gene;PA444903;Disease
VENETOCLAX;NPM1;Gene;PA166153473;Chemical
MIDOSTAURIN;NPM1;Gene;PA166169917;Chemical
ABCA5;NPM1;Gene;PA24380;Gene
ABCC4;NPM1;Gene;PA397;Gene
ALLOPURINOL;rs9366772;Variant;PA448320;Chemical
PRASUGREL;rs41273215;Variant;PA154410481;Chemical
CLOPIDOGREL;rs41273215;Variant;PA449053;Chemical
HEROIN DEPENDENCE;rs274618;Variant;PA444460;Disease
HEROIN;rs274618;Variant;PA452619;Chemical
MELANOMA;BAP1;Gene;PA444903;Disease
CYP3A4;CYP3A4*18;Haplotype;PA130;Gene
TICAGRELOR;CYP3A4*18;Haplotype;PA165374673;Chemical
KIDNEY TRANSPLANTATION;CYP3A4*18;Haplotype;PA165817016;Disease
CABOZANTINIB;CYP3A4*18;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*18;Haplotype;PA165958362;Chemical
LUNG TRANSPLANTATION;CYP3A4*18;Haplotype;PA166114457;Disease
REGORAFENIB;CYP3A4*18;Haplotype;PA166114943;Chemical
VANDETANIB;CYP3A4*18;Haplotype;PA166118341;Chemical
ALECTINIB;CYP3A4*18;Haplotype;PA166160050;Chemical
BREXPIPRAZOLE;CYP3A4*18;Haplotype;PA166160053;Chemical
LAPAROSCOPIC SLEEVE GASTRECTOMY;CYP3A4*18;Haplotype;PA166169562;Disease
BLONANSERIN;CYP3A4*18;Haplotype;PA166319041;Chemical
PAIN, POSTOPERATIVE;CYP3A4*18;Haplotype;PA445210;Disease
LIVER TRANSPLANTATION;CYP3A4*18;Haplotype;PA447247;Disease
AMIODARONE;CYP3A4*18;Haplotype;PA448383;Chemical
CYCLOSPORINE;CYP3A4*18;Haplotype;PA449167;Chemical
FENTANYL;CYP3A4*18;Haplotype;PA449599;Chemical
IBUPROFEN;CYP3A4*18;Haplotype;PA449957;Chemical
LIDOCAINE;CYP3A4*18;Haplotype;PA450226;Chemical
METHADONE;CYP3A4*18;Haplotype;PA450401;Chemical
OXYCODONE;CYP3A4*18;Haplotype;PA450741;Chemical
QUETIAPINE;CYP3A4*18;Haplotype;PA451201;Chemical
TACROLIMUS;CYP3A4*18;Haplotype;PA451578;Chemical
RS6923761;vildagliptin;Chemical;PA166157117;Variant
GLP1R;vildagliptin;Chemical;PA28725;Gene
ROSUVASTATIN;SLCO1B1*9;Haplotype;PA134308647;Chemical
ATRASENTAN;SLCO1B1*9;Haplotype;PA143414738;Chemical
CFTR;rs397508572;Variant;PA109;Gene
IVACAFTOR;rs397508572;Variant;PA165950341;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs397508572;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs397508572;Variant;PA443829;Disease
ALPHA-ADRENORECEPTOR ANTAGONISTS;ADRA1D;Gene;PA164712344;Chemical
DOPAMINE;ADRA1D;Gene;PA449396;Chemical
EPINEPHRINE;ADRA1D;Gene;PA449470;Chemical
ISOPROTERENOL;ADRA1D;Gene;PA450121;Chemical
METHOXAMINE;ADRA1D;Gene;PA450431;Chemical
NOREPINEPHRINE;ADRA1D;Gene;PA450649;Chemical
PHENYLEPHRINE;ADRA1D;Gene;PA450935;Chemical
DOXORUBICINOL;AKR1A1;Gene;PA165291922;Chemical
DAUNORUBICINOL;AKR1A1;Gene;PA166248083;Chemical
HYPERTENSION;rs45545233;Variant;PA444552;Disease
ATENOLOL;rs45545233;Variant;PA448499;Chemical
METOPROLOL;rs45545233;Variant;PA450480;Chemical
CANGRELOR;rs9859552;Variant;PA165945763;Chemical
HYPERTENSION;rs294610;Variant;PA444552;Disease
ATENOLOL;rs294610;Variant;PA448499;Chemical
METOPROLOL;rs294610;Variant;PA450480;Chemical
MAPK8;ATF2;Gene;PA283;Gene
MAPK14;ATF2;Gene;PA30621;Gene
PAIN, POSTOPERATIVE;ATF2;Gene;PA445210;Disease
FENTANYL;ATF2;Gene;PA449599;Chemical
ACE INHIBITORS, PLAIN;PTGER3;Gene;PA164712308;Chemical
ASTHMA;PTGER3;Gene;PA443450;Disease
COUGH;PTGER3;Gene;PA443803;Disease
HYPERTENSION;PTGER3;Gene;PA444552;Disease
ASPIRIN;PTGER3;Gene;PA448497;Chemical
CELECOXIB;CACNB1;Gene;PA448871;Chemical
UGT1A1*1;moxifloxacin;Chemical;PA166115841;Haplotype
UGT1A1*28;moxifloxacin;Chemical;PA166115842;Haplotype
UGT1A1*36;moxifloxacin;Chemical;PA166115843;Haplotype
UGT1A1*37;moxifloxacin;Chemical;PA166115844;Haplotype
KCNH2;moxifloxacin;Chemical;PA212;Gene
G6PD;moxifloxacin;Chemical;PA28469;Gene
UGT1A1;moxifloxacin;Chemical;PA420;Gene
CYP2C19;Severe Combined Immunodeficiency;Disease;PA124;Gene
CYP2C19*17;Severe Combined Immunodeficiency;Disease;PA165816533;Haplotype
FLUOROURACIL;FGFR4;Gene;PA128406956;Chemical
EVEROLIMUS;FGFR4;Gene;PA164746311;Chemical
BRIVANIB;FGFR4;Gene;PA164924492;Chemical
DISCONTINUATION;FGFR4;Gene;PA166123507;Disease
CRK;FGFR4;Gene;PA26880;Gene
FGF2;FGFR4;Gene;PA28115;Gene
PIK3C2A;FGFR4;Gene;PA33304;Gene
PIK3C2B;FGFR4;Gene;PA33305;Gene
BREAST NEOPLASMS;FGFR4;Gene;PA443560;Disease
CYCLOPHOSPHAMIDE;FGFR4;Gene;PA449165;Chemical
METHOTREXATE;FGFR4;Gene;PA450428;Chemical
HLA-DRB1*07:01;Fever;Disease;PA165951644;Haplotype
HLA-DRB1;Fever;Disease;PA35072;Gene
FLUOROURACIL;DPYD poor metabolizer;Variant;PA128406956;Chemical
GASTROINTESTINAL NEOPLASMS;DPYD poor metabolizer;Variant;PA444257;Disease
RECTAL NEOPLASMS;DPYD poor metabolizer;Variant;PA445503;Disease
COLORECTAL NEOPLASMS;DPYD poor metabolizer;Variant;PA446108;Disease
FREMANEZUMAB;rs12615320;Variant;PA166320903;Chemical
GALCANEZUMAB;rs12615320;Variant;PA166320904;Chemical
ERENUMAB;rs12615320;Variant;PA166320921;Chemical
MIGRAINE WITHOUT AURA;rs12615320;Variant;PA444949;Disease
MIGRAINE WITH AURA;rs12615320;Variant;PA447004;Disease
BOTULINUM TOXIN TYPE A;rs222749;Variant;PA164754825;Chemical
MIGRAINE DISORDER;rs222749;Variant;PA165108779;Disease
PLATINUM COMPOUNDS;rs1409314;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs1409314;Variant;PA443622;Disease
P2RY12;cangrelor;Chemical;PA134971947;Gene
RS6787801;cangrelor;Chemical;PA166156413;Variant
RS9859552;cangrelor;Chemical;PA166156432;Variant
CYP2D6;upadacitinib;Chemical;PA128;Gene
CYP2C9;CYP2C9*5;Haplotype;PA126;Gene
VKORC1;CYP2C9*5;Haplotype;PA133787052;Gene
OVER-ANTICOAGULATION;CYP2C9*5;Haplotype;PA166123298;Disease
SIPONIMOD;CYP2C9*5;Haplotype;PA166182736;Chemical
CYP4F2;CYP2C9*5;Haplotype;PA27121;Gene
CARDIOVASCULAR DISEASES;CYP2C9*5;Haplotype;PA443635;Disease
EPILEPSY;CYP2C9*5;Haplotype;PA444065;Disease
HEMORRHAGE;CYP2C9*5;Haplotype;PA444417;Disease
LOSARTAN;CYP2C9*5;Haplotype;PA450268;Chemical
PHENYTOIN;CYP2C9*5;Haplotype;PA450947;Chemical
WARFARIN;CYP2C9*5;Haplotype;PA451906;Chemical
ACENOCOUMAROL;CYP2C9*5;Haplotype;PA452632;Chemical
ARIPIPRAZOLE;CYP2D6*1xN;Haplotype;PA10026;Chemical
CYP2D6;CYP2D6*1xN;Haplotype;PA128;Gene
MIANSERIN;CYP2D6*1xN;Haplotype;PA134687937;Chemical
TROPISETRON;CYP2D6*1xN;Haplotype;PA161925594;Chemical
SUICIDE;CYP2D6*1xN;Haplotype;PA165374639;Disease
EVENT-FREE SURVIVAL;CYP2D6*1xN;Haplotype;PA166123366;Disease
DISCONTINUATION;CYP2D6*1xN;Haplotype;PA166123507;Disease
ENDOXIFEN;CYP2D6*1xN;Haplotype;PA166124478;Chemical
RECURRENCE FREE SURVIVAL;CYP2D6*1xN;Haplotype;PA166127658;Disease
CARDIOTOXICITY;CYP2D6*1xN;Haplotype;PA166128121;Disease
ALZHEIMER DISEASE;CYP2D6*1xN;Haplotype;PA443319;Disease
BREAST NEOPLASMS;CYP2D6*1xN;Haplotype;PA443560;Disease
DEMENTIA;CYP2D6*1xN;Haplotype;PA443853;Disease
DRUG TOXICITY;CYP2D6*1xN;Haplotype;PA443937;Disease
HEROIN DEPENDENCE;CYP2D6*1xN;Haplotype;PA444460;Disease
OPIOID-RELATED DISORDERS;CYP2D6*1xN;Haplotype;PA445043;Disease
NEOPLASMS;CYP2D6*1xN;Haplotype;PA445062;Disease
PAIN;CYP2D6*1xN;Haplotype;PA445208;Disease
RESPIRATORY INSUFFICIENCY;CYP2D6*1xN;Haplotype;PA445522;Disease
VOMITING;CYP2D6*1xN;Haplotype;PA446051;Disease
POSTOPERATIVE NAUSEA AND VOMITING;CYP2D6*1xN;Haplotype;PA446970;Disease
AGORAPHOBIA;CYP2D6*1xN;Haplotype;PA447194;Disease
DEPRESSIVE DISORDER;CYP2D6*1xN;Haplotype;PA447207;Disease
MENTAL DISORDERS;CYP2D6*1xN;Haplotype;PA447208;Disease
MOOD DISORDERS;CYP2D6*1xN;Haplotype;PA447209;Disease
PSYCHOTIC DISORDERS;CYP2D6*1xN;Haplotype;PA447215;Disease
SCHIZOPHRENIA;CYP2D6*1xN;Haplotype;PA447216;Disease
DEPRESSION;CYP2D6*1xN;Haplotype;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2D6*1xN;Haplotype;PA447321;Disease
AMITRIPTYLINE;CYP2D6*1xN;Haplotype;PA448385;Chemical
CITALOPRAM;CYP2D6*1xN;Haplotype;PA449015;Chemical
CLOMIPRAMINE;CYP2D6*1xN;Haplotype;PA449048;Chemical
CODEINE;CYP2D6*1xN;Haplotype;PA449088;Chemical
DOLASETRON;CYP2D6*1xN;Haplotype;PA449390;Chemical
DONEPEZIL;CYP2D6*1xN;Haplotype;PA449394;Chemical
DOXEPIN;CYP2D6*1xN;Haplotype;PA449409;Chemical
FLUOXETINE;CYP2D6*1xN;Haplotype;PA449673;Chemical
GALANTAMINE;CYP2D6*1xN;Haplotype;PA449726;Chemical
GRANISETRON;CYP2D6*1xN;Haplotype;PA449809;Chemical
IMIPRAMINE;CYP2D6*1xN;Haplotype;PA449969;Chemical
METHADONE;CYP2D6*1xN;Haplotype;PA450401;Chemical
MIRTAZAPINE;CYP2D6*1xN;Haplotype;PA450522;Chemical
NORTRIPTYLINE;CYP2D6*1xN;Haplotype;PA450657;Chemical
ONDANSETRON;CYP2D6*1xN;Haplotype;PA450705;Chemical
OXYCODONE;CYP2D6*1xN;Haplotype;PA450741;Chemical
PAROXETINE;CYP2D6*1xN;Haplotype;PA450801;Chemical
RISPERIDONE;CYP2D6*1xN;Haplotype;PA451257;Chemical
TAMOXIFEN;CYP2D6*1xN;Haplotype;PA451581;Chemical
TRAMADOL;CYP2D6*1xN;Haplotype;PA451735;Chemical
VENLAFAXINE;CYP2D6*1xN;Haplotype;PA451866;Chemical
ANTINEOPLASTIC AGENTS;CYP2D6*1xN;Haplotype;PA452621;Chemical
ROPEGINTERFERON ALFA-2B;JAK2;Gene;PA166268921;Chemical
RS77375493;JAK2;Gene;PA166268922;Variant
ABCB1;valinomycin;Chemical;PA267;Gene
PROGRESSION-FREE SURVIVAL;CYP2D6*35;Haplotype;PA166123026;Disease
OVERALL SURVIVAL;CYP2D6*35;Haplotype;PA166123207;Disease
EVENT-FREE SURVIVAL;CYP2D6*35;Haplotype;PA166123366;Disease
ENDOXIFEN;CYP2D6*35;Haplotype;PA166124478;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*35;Haplotype;PA166127651;Chemical
O-DESMETHYLTRAMADOL;CYP2D6*35;Haplotype;PA166131379;Chemical
N,O-DIDESMETHYLTRAMADOL;CYP2D6*35;Haplotype;PA166131494;Chemical
BREAST NEOPLASMS;CYP2D6*35;Haplotype;PA443560;Disease
DEATH;CYP2D6*35;Haplotype;PA443842;Disease
HYPERTENSION;CYP2D6*35;Haplotype;PA444552;Disease
RECURRENCE;CYP2D6*35;Haplotype;PA445506;Disease
DOXEPIN;CYP2D6*35;Haplotype;PA449409;Chemical
METOPROLOL;CYP2D6*35;Haplotype;PA450480;Chemical
PRIMAQUINE;CYP2D6*35;Haplotype;PA451103;Chemical
TAMOXIFEN;CYP2D6*35;Haplotype;PA451581;Chemical
ANTINEOPLASTIC AGENTS;CYP2D6*35;Haplotype;PA452621;Chemical
MIGALASTAT;rs869312136;Variant;PA166182881;Chemical
FABRY DISEASE;rs869312136;Variant;PA443367;Disease
O-DESMETHYLTRAMADOL;rs62435418;Variant;PA166131379;Chemical
TRAMADOL;rs62435418;Variant;PA451735;Chemical
CYP2B6;arteether;Chemical;PA123;Gene
CYP3A4;arteether;Chemical;PA130;Gene
CYP3A5;arteether;Chemical;PA131;Gene
CAMK1D;STAT1;Gene;PA134992438;Gene
AKT1;STAT1;Gene;PA24684;Gene
AKT2;STAT1;Gene;PA24685;Gene
AKT3;STAT1;Gene;PA24686;Gene
NFKB1;STAT1;Gene;PA248;Gene
CAMK1;STAT1;Gene;PA26048;Gene
CAMK1G;STAT1;Gene;PA26049;Gene
ELK1;STAT1;Gene;PA27749;Gene
FOS;STAT1;Gene;PA28212;Gene
MAPK8;STAT1;Gene;PA283;Gene
RELA;STAT1;Gene;PA296;Gene
JAK1;STAT1;Gene;PA29988;Gene
JUN;STAT1;Gene;PA30006;Gene
MAPK1;STAT1;Gene;PA30616;Gene
MAPK3;STAT1;Gene;PA30622;Gene
MYC;STAT1;Gene;PA31353;Gene
NFKB2;STAT1;Gene;PA31600;Gene
PIAS1;STAT1;Gene;PA33285;Gene
STAT3;STAT1;Gene;PA337;Gene
PRKCA;STAT1;Gene;PA33759;Gene
PRKCB;STAT1;Gene;PA33761;Gene
PRKCG;STAT1;Gene;PA33766;Gene
STAT5A;STAT1;Gene;PA338;Gene
SP1;STAT1;Gene;PA36042;Gene
STAT2;STAT1;Gene;PA36184;Gene
STAT4;STAT1;Gene;PA36185;Gene
STAT5B;STAT1;Gene;PA36186;Gene
CAMK2A;STAT1;Gene;PA90;Gene
CAMK2B;STAT1;Gene;PA91;Gene
CAMK2D;STAT1;Gene;PA92;Gene
CAMK2G;STAT1;Gene;PA93;Gene
SLCO1B1;letermovir;Chemical;PA134865839;Gene
UGT1A1*28;letermovir;Chemical;PA166115842;Haplotype
RS2306283;letermovir;Chemical;PA166154547;Variant
RS4149032;letermovir;Chemical;PA166154575;Variant
RS4149056;letermovir;Chemical;PA166154579;Variant
RS4148323;letermovir;Chemical;PA166155721;Variant
UGT1A1;letermovir;Chemical;PA420;Gene
ALK;lorlatinib;Chemical;PA24719;Gene
ROS1;lorlatinib;Chemical;PA34633;Gene
IMATINIB;rs2725252;Variant;PA10804;Chemical
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;rs2725252;Variant;PA446171;Disease
PACLITAXEL;rs10771973;Variant;PA450761;Chemical
HYPERTENSION;rs35123024;Variant;PA444552;Disease
ATENOLOL;rs35123024;Variant;PA448499;Chemical
HYDROCHLOROTHIAZIDE;rs35123024;Variant;PA449899;Chemical
ATP8B1;maralixibat;Chemical;PA265;Gene
ABCB4;maralixibat;Chemical;PA268;Gene
JAG1;maralixibat;Chemical;PA29986;Gene
MYO5B;maralixibat;Chemical;PA31408;Gene
TJP2;maralixibat;Chemical;PA36533;Gene
ABCB11;maralixibat;Chemical;PA374;Gene
HYPERCHOLESTEROLEMIA;rs1922242;Variant;PA444516;Disease
FLUVASTATIN;rs1922242;Variant;PA449688;Chemical
TIME TO THERAPEUTIC INR;CYP4F2*1;Haplotype;PA166129532;Disease
VITAMIN K1;CYP4F2*1;Haplotype;PA166197681;Chemical
ATRIAL FIBRILLATION;CYP4F2*1;Haplotype;PA443459;Disease
HEMORRHAGE;CYP4F2*1;Haplotype;PA444417;Disease
WARFARIN;CYP4F2*1;Haplotype;PA451906;Chemical
OPIOID-RELATED DISORDERS;rs735668;Variant;PA445043;Disease
OPIOIDS;rs735668;Variant;PA452618;Chemical
NAUSEA;MUC16;Gene;PA445048;Disease
VOMITING;MUC16;Gene;PA446051;Disease
OPIOIDS;MUC16;Gene;PA452618;Chemical
RS3731722;febuxostat;Chemical;PA166161450;Variant
RS75995567;febuxostat;Chemical;PA166161452;Variant
RS34650714;febuxostat;Chemical;PA166161456;Variant
AOX1;febuxostat;Chemical;PA24842;Gene
UGT1A10;febuxostat;Chemical;PA37174;Gene
UGT1A3;febuxostat;Chemical;PA37178;Gene
UGT1A4;febuxostat;Chemical;PA37179;Gene
UGT1A5;febuxostat;Chemical;PA37180;Gene
UGT1A6;febuxostat;Chemical;PA37181;Gene
UGT1A7;febuxostat;Chemical;PA37182;Gene
UGT1A8;febuxostat;Chemical;PA37183;Gene
XDH;febuxostat;Chemical;PA37404;Gene
UGT1A9;febuxostat;Chemical;PA419;Gene
UGT1A1;febuxostat;Chemical;PA420;Gene
LEUKEMIA, MYELOID, ACUTE;rs1044457;Variant;PA444760;Disease
NEOPLASMS;rs1044457;Variant;PA445062;Disease
CYTARABINE;rs1044457;Variant;PA449177;Chemical
GEMCITABINE;rs1044457;Variant;PA449748;Chemical
HLA-B*57:01;Sarcoma;Disease;PA165987830;Haplotype
RS3957357;Sarcoma;Disease;PA166157094;Variant
GSTA1;Sarcoma;Disease;PA29016;Gene
HLA-B;Sarcoma;Disease;PA35056;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs1816702;Variant;PA164713366;Chemical
CROHN DISEASE;rs1816702;Variant;PA443815;Disease
NON-SMALL CELL LUNG CARCINOMA;rs11229;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs11229;Variant;PA445846;Disease
CARBOPLATIN;rs11229;Variant;PA448803;Chemical
GEMCITABINE;rs11229;Variant;PA449748;Chemical
LEUKOTRIENE RECEPTOR ANTAGONISTS;PRORP;Gene;PA164712863;Chemical
ASTHMA;PRORP;Gene;PA443450;Disease
ZILEUTON;PRORP;Gene;PA451955;Chemical
ETHANOL;rs6350;Variant;PA448073;Chemical
ESSENTIAL HYPERTENSION;UGGT2;Gene;PA447288;Disease
HYDROCHLOROTHIAZIDE;UGGT2;Gene;PA449899;Chemical
PLATINUM COMPOUNDS;XPA;Gene;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;XPA;Gene;PA443622;Disease
CYP3A4;Liver Cirrhosis;Disease;PA130;Gene
CYP3A4*22;Liver Cirrhosis;Disease;PA166048680;Haplotype
RS5443;Liver Cirrhosis;Disease;PA166154486;Variant
RS5186;Liver Cirrhosis;Disease;PA166156276;Variant
RS4961;Liver Cirrhosis;Disease;PA166156480;Variant
RS11269124;Liver Cirrhosis;Disease;PA166156644;Variant
RS1042713;Liver Cirrhosis;Disease;PA166156748;Variant
GNB3;Liver Cirrhosis;Disease;PA176;Gene
ADD1;Liver Cirrhosis;Disease;PA31;Gene
ADRA2C;Liver Cirrhosis;Disease;PA37;Gene
ADRB2;Liver Cirrhosis;Disease;PA39;Gene
AGTR1;Liver Cirrhosis;Disease;PA43;Gene
BUFURALOL;CYP2D6*18;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*18;Haplotype;PA166127651;Chemical
DEXTROMETHORPHAN;CYP2D6*18;Haplotype;PA449273;Chemical
PRIMAQUINE;CYP2D6*18;Haplotype;PA451103;Chemical
TAMOXIFEN;CYP2D6*18;Haplotype;PA451581;Chemical
SPARTEINE;CYP2D6*18;Haplotype;PA452610;Chemical
DEBRISOQUINE;CYP2D6*18;Haplotype;PA452616;Chemical
DULOXETINE;rs12630569;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs12630569;Variant;PA447321;Disease
RS75193786;carbocisteine;Chemical;PA166189121;Variant
RS5030843;carbocisteine;Chemical;PA166189122;Variant
RS138809906;carbocisteine;Chemical;PA166189123;Variant
RS5030849;carbocisteine;Chemical;PA166189124;Variant
RS5030858;carbocisteine;Chemical;PA166189125;Variant
RS5030860;carbocisteine;Chemical;PA166189126;Variant
RS76394784;carbocisteine;Chemical;PA166189141;Variant
RS62516101;carbocisteine;Chemical;PA166189142;Variant
PAH;carbocisteine;Chemical;PA32911;Gene
TOBACCO USE DISORDER;rs6702335;Variant;PA445876;Disease
BUPROPION;rs6702335;Variant;PA448687;Chemical
NICOTINE;rs6702335;Variant;PA450626;Chemical
CYP3A7;cortisone acetate;Chemical;PA122;Gene
CYP3A7*1A;cortisone acetate;Chemical;PA165948045;Haplotype
CYP3A7*1C;cortisone acetate;Chemical;PA165948047;Haplotype
DIURETICS;PDE4D;Gene;PA151249535;Chemical
NEPHROSCLEROSIS;PDE4D;Gene;PA445086;Disease
SCHIZOPHRENIA;PDE4D;Gene;PA447216;Disease
QUETIAPINE;PDE4D;Gene;PA451201;Chemical
ARRB1;PDE4D;Gene;PA59;Gene
ARRB2;PDE4D;Gene;PA60;Gene
TEZACAFTOR;rs397508293;Variant;PA166175754;Chemical
ELEXACAFTOR;rs397508293;Variant;PA166185161;Chemical
DPYD;rs55971861;Variant;PA145;Gene
CAPECITABINE;rs55971861;Variant;PA448771;Chemical
ARIPIPRAZOLE;HLA-A;Gene;PA10026;Chemical
DULOXETINE;HLA-A;Gene;PA10066;Chemical
ESCITALOPRAM;HLA-A;Gene;PA10074;Chemical
LAPATINIB;HLA-A;Gene;PA152241907;Chemical
EGFR INHIBITORS;HLA-A;Gene;PA153561371;Chemical
MACULOPAPULAR EXANTHEMA;HLA-A;Gene;PA162316739;Disease
CLAVULANATE;HLA-A;Gene;PA164742987;Chemical
PEGINTERFERON ALFA-2A;HLA-A;Gene;PA164749390;Chemical
FLUCLOXACILLIN;HLA-A;Gene;PA164781042;Chemical
DIVALPROEX SODIUM;HLA-A;Gene;PA164783479;Chemical
PEGINTERFERON ALFA-2B;HLA-A;Gene;PA164784024;Chemical
TOXIC LIVER DISEASE;HLA-A;Gene;PA164925725;Disease
ERYTHEMA MULTIFORME NOS;HLA-A;Gene;PA165108357;Disease
HLA-A*31:01;HLA-A;Gene;PA165954030;Haplotype
HLA-B*15:02;HLA-A;Gene;PA165954769;Haplotype
DRUG-INDUCED LIVER INJURY;HLA-A;Gene;PA166119041;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-A;Gene;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-A;Gene;PA166120929;Disease
HLA-A*02:01;HLA-A;Gene;PA166123427;Haplotype
ADVERSE EVENTS;HLA-A;Gene;PA166151827;Disease
IPILIMUMAB;HLA-A;Gene;PA166182718;Chemical
TEBENTAFUSP;HLA-A;Gene;PA166277741;Chemical
BREAST NEOPLASMS;HLA-A;Gene;PA443560;Disease
DRUG HYPERSENSITIVITY;HLA-A;Gene;PA443936;Disease
DRUG TOXICITY;HLA-A;Gene;PA443937;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-A;Gene;PA444059;Disease
EPILEPSY;HLA-A;Gene;PA444065;Disease
EXANTHEMA;HLA-A;Gene;PA444109;Disease
HEPATITIS C;HLA-A;Gene;PA444445;Disease
HYPERSENSITIVITY;HLA-A;Gene;PA444546;Disease
KIDNEY FAILURE, CHRONIC;HLA-A;Gene;PA444684;Disease
NEOPLASMS;HLA-A;Gene;PA445062;Disease
NEURALGIA;HLA-A;Gene;PA445096;Disease
STEVENS-JOHNSON SYNDROME;HLA-A;Gene;PA445738;Disease
BIPOLAR DISORDER;HLA-A;Gene;PA447199;Disease
SCHIZOPHRENIA;HLA-A;Gene;PA447216;Disease
ACETAMINOPHEN;HLA-A;Gene;PA448015;Chemical
ALLOPURINOL;HLA-A;Gene;PA448320;Chemical
AMITRIPTYLINE;HLA-A;Gene;PA448385;Chemical
AMOXICILLIN;HLA-A;Gene;PA448406;Chemical
BUPROPION;HLA-A;Gene;PA448687;Chemical
BUSPIRONE;HLA-A;Gene;PA448689;Chemical
CARBAMAZEPINE;HLA-A;Gene;PA448785;Chemical
CITALOPRAM;HLA-A;Gene;PA449015;Chemical
DAPSONE;HLA-A;Gene;PA449211;Chemical
DIAZEPAM;HLA-A;Gene;PA449283;Chemical
FENOFIBRATE;HLA-A;Gene;PA449594;Chemical
FLUOXETINE;HLA-A;Gene;PA449673;Chemical
LAMOTRIGINE;HLA-A;Gene;PA450164;Chemical
LEVETIRACETAM;HLA-A;Gene;PA450206;Chemical
MIRTAZAPINE;HLA-A;Gene;PA450522;Chemical
MODAFINIL;HLA-A;Gene;PA450530;Chemical
NORTRIPTYLINE;HLA-A;Gene;PA450657;Chemical
OLANZAPINE;HLA-A;Gene;PA450688;Chemical
OXCARBAZEPINE;HLA-A;Gene;PA450732;Chemical
PAROXETINE;HLA-A;Gene;PA450801;Chemical
PHENYTOIN;HLA-A;Gene;PA450947;Chemical
QUETIAPINE;HLA-A;Gene;PA451201;Chemical
RIBAVIRIN;HLA-A;Gene;PA451241;Chemical
RISPERIDONE;HLA-A;Gene;PA451257;Chemical
SERTRALINE;HLA-A;Gene;PA451333;Chemical
TERBINAFINE;HLA-A;Gene;PA451614;Chemical
TETANUS ANTITOXIN;HLA-A;Gene;PA451632;Chemical
TICLOPIDINE;HLA-A;Gene;PA451686;Chemical
TRAZODONE;HLA-A;Gene;PA451744;Chemical
VALPROIC ACID;HLA-A;Gene;PA451846;Chemical
VANCOMYCIN;HLA-A;Gene;PA451850;Chemical
VENLAFAXINE;HLA-A;Gene;PA451866;Chemical
ZIPRASIDONE;HLA-A;Gene;PA451974;Chemical
ZONISAMIDE;HLA-A;Gene;PA451978;Chemical
ADVERSE EVENTS;rs1045280;Variant;PA166151827;Disease
OPIOID-RELATED DISORDERS;rs1045280;Variant;PA445043;Disease
SUBSTANCE-RELATED DISORDERS;rs1045280;Variant;PA446876;Disease
BUPRENORPHINE;rs1045280;Variant;PA448685;Chemical
FENTANYL;rs1045280;Variant;PA449599;Chemical
METHAMPHETAMINE;rs1045280;Variant;PA450403;Chemical
TRAMADOL;rs1045280;Variant;PA451735;Chemical
HLA-B*57:01;lamivudine / abacavir;Chemical;PA165987830;Haplotype
HLA-B;lamivudine / abacavir;Chemical;PA35056;Gene
ORGAN TRANSPLANTATION;rs1927907;Variant;PA133888799;Disease
TACROLIMUS;rs1927907;Variant;PA451578;Chemical
WEIGHT GAIN;rs2268639;Variant;PA128406954;Disease
SCHIZOPHRENIA;rs2268639;Variant;PA447216;Disease
CLOZAPINE;rs2268639;Variant;PA449061;Chemical
OLANZAPINE;rs2268639;Variant;PA450688;Chemical
ARAF;MAP2K2;Gene;PA24928;Gene
BRAF;MAP2K2;Gene;PA25408;Gene
MAPK8;MAP2K2;Gene;PA283;Gene
MAPK1;MAP2K2;Gene;PA30616;Gene
MAPK10;MAP2K2;Gene;PA30617;Gene
MAPK11;MAP2K2;Gene;PA30618;Gene
MAPK12;MAP2K2;Gene;PA30619;Gene
MAPK13;MAP2K2;Gene;PA30620;Gene
MAPK14;MAP2K2;Gene;PA30621;Gene
MAPK3;MAP2K2;Gene;PA30622;Gene
MAPK4;MAP2K2;Gene;PA30623;Gene
MAPK6;MAP2K2;Gene;PA30624;Gene
MAPK7;MAP2K2;Gene;PA30625;Gene
MAPK9;MAP2K2;Gene;PA30630;Gene
RAF1;MAP2K2;Gene;PA34183;Gene
FLUOROURACIL;rs117341846;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs117341846;Variant;PA443560;Disease
NEUTROPENIA;rs117341846;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs117341846;Variant;PA449165;Chemical
EPIRUBICIN;rs117341846;Variant;PA449476;Chemical
G6PD;furazolidone;Chemical;PA28469;Gene
ASTHMA;HSD3B1;Gene;PA443450;Disease
GLUCOCORTICOIDS;HSD3B1;Gene;PA452347;Chemical
ACE INHIBITORS, PLAIN;rs2253201;Variant;PA164712308;Chemical
ANGIOEDEMA;rs2253201;Variant;PA443371;Disease
CARBOCISTEINE;rs5030849;Variant;PA166184060;Chemical
L-PHENYLALANINE;rs5030849;Variant;PA450931;Chemical
DULOXETINE;rs963468;Variant;PA10066;Chemical
ANXIETY DISORDERS;rs963468;Variant;PA447196;Disease
ADRB2;CAVIN3;Gene;PA39;Gene
WARFARIN;rs2884737;Variant;PA451906;Chemical
CHOLIC ACID;HSD3B2;Gene;PA166160055;Chemical
FLUOROURACIL;rs367619008;Variant;PA128406956;Chemical
XELOX;rs367619008;Variant;PA166182864;Chemical
DRUG TOXICITY;rs367619008;Variant;PA443937;Disease
CAPECITABINE;rs367619008;Variant;PA448771;Chemical
MAPK8;JUNB;Gene;PA283;Gene
MAPK14;JUNB;Gene;PA30621;Gene
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;rs9263726;Variant;PA166120927;Disease
STEVENS-JOHNSON SYNDROME;rs9263726;Variant;PA445738;Disease
ALLOPURINOL;rs9263726;Variant;PA448320;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs1799724;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs1799724;Variant;PA443434;Disease
CROHN DISEASE;rs1799724;Variant;PA443815;Disease
PSORIASIS;rs1799724;Variant;PA445451;Disease
SPONDYLITIS, ANKYLOSING;rs1799724;Variant;PA445724;Disease
OVERDOSE;MCOLN1;Gene;PA446199;Disease
OPIOIDS;MCOLN1;Gene;PA452618;Chemical
LEUKOPENIA;MSH3;Gene;PA444773;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;MSH3;Gene;PA446155;Disease
METHOTREXATE;MSH3;Gene;PA450428;Chemical
PLATINUM COMPOUNDS;rs6983267;Variant;PA164713176;Chemical
LUNG NEOPLASMS;rs6983267;Variant;PA444818;Disease
WARFARIN;rs8050894;Variant;PA451906;Chemical
COMT;Dizziness;Disease;PA117;Gene
CYP2D6;Dizziness;Disease;PA128;Gene
CYP2D6*10;Dizziness;Disease;PA165816582;Haplotype
TPMT*1;Dizziness;Disease;PA165819268;Haplotype
TPMT*3A;Dizziness;Disease;PA165819270;Haplotype
TPMT*3C;Dizziness;Disease;PA165819272;Haplotype
CYP2D6*5;Dizziness;Disease;PA165948092;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);Dizziness;Disease;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);Dizziness;Disease;PA166116466;Haplotype
RS6311;Dizziness;Disease;PA166154673;Variant
RS4633;Dizziness;Disease;PA166156023;Variant
RS1799971;Dizziness;Disease;PA166156991;Variant
HTR2A;Dizziness;Disease;PA193;Gene
SLC6A4;Dizziness;Disease;PA312;Gene
OPRM1;Dizziness;Disease;PA31945;Gene
SLC22A1;Dizziness;Disease;PA329;Gene
TPMT;Dizziness;Disease;PA356;Gene
BUMETANIDE;NPPA-AS1;Gene;PA448682;Chemical
FUROSEMIDE;NPPA-AS1;Gene;PA449719;Chemical
TORASEMIDE;NPPA-AS1;Gene;PA451733;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs10836235;Variant;PA130620651;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;rs10836235;Variant;PA446155;Disease
ETHANOL;rs681243;Variant;PA448073;Chemical
CYP3A5;salmeterol;Chemical;PA131;Gene
RS1042713;salmeterol;Chemical;PA166156748;Variant
ADRB2;salmeterol;Chemical;PA39;Gene
NEOPLASMS;RHBDF2;Gene;PA445062;Disease
FENTANYL;RHBDF2;Gene;PA449599;Chemical
MORPHINE;RHBDF2;Gene;PA450550;Chemical
OXYCODONE;RHBDF2;Gene;PA450741;Chemical
OPIOIDS;RHBDF2;Gene;PA452618;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs734644;Variant;PA447197;Disease
METHYLPHENIDATE;rs734644;Variant;PA450464;Chemical
DAUNORUBICIN;rs1043657;Variant;PA449212;Chemical
DOXORUBICIN;rs1043657;Variant;PA449412;Chemical
SLC30A8;zinc acetate;Chemical;PA134915546;Gene
RS13266634;zinc acetate;Chemical;PA166157645;Variant
PAIN, POSTOPERATIVE;rs3845446;Variant;PA445210;Disease
FENTANYL;rs3845446;Variant;PA449599;Chemical
CYP2C19;dexlansoprazole;Chemical;PA124;Gene
CYP2C19*1;dexlansoprazole;Chemical;PA165980634;Haplotype
CYP2C19*2;dexlansoprazole;Chemical;PA165980635;Haplotype
CYP2C19*3;dexlansoprazole;Chemical;PA165980636;Haplotype
FLUOROURACIL;rs181501757;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs181501757;Variant;PA443560;Disease
NEUTROPENIA;rs181501757;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs181501757;Variant;PA449165;Chemical
EPIRUBICIN;rs181501757;Variant;PA449476;Chemical
GEFITINIB;rs12142086;Variant;PA131301952;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs12142086;Variant;PA443622;Disease
EXANTHEMA;rs12142086;Variant;PA444109;Disease
ARTHRITIS, RHEUMATOID;FCGR3B;Gene;PA443434;Disease
LEUKOTRIENE RECEPTOR ANTAGONISTS;MLLT3;Gene;PA164712863;Chemical
ASTHMA;MLLT3;Gene;PA443450;Disease
URINARY BLADDER NEOPLASMS;MLLT3;Gene;PA443512;Disease
CISPLATIN;MLLT3;Gene;PA449014;Chemical
MONTELUKAST;MLLT3;Gene;PA450546;Chemical
G6PD A- 202A_376G;tafenoquine;Chemical;PA165947827;Haplotype
RS62103056;tafenoquine;Chemical;PA166216422;Variant
G6PD;tafenoquine;Chemical;PA28469;Gene
HEROIN DEPENDENCE;rs3758987;Variant;PA444460;Disease
TOBACCO USE DISORDER;rs3758987;Variant;PA445876;Disease
NICOTINE;rs3758987;Variant;PA450626;Chemical
HEROIN;rs3758987;Variant;PA452619;Chemical
CYP2D6;endoxifen;Chemical;PA128;Gene
CYP3A4;endoxifen;Chemical;PA130;Gene
CYP2D6*1;endoxifen;Chemical;PA165816576;Haplotype
CYP2D6*2;endoxifen;Chemical;PA165816577;Haplotype
CYP2D6*3;endoxifen;Chemical;PA165816578;Haplotype
CYP2D6*4;endoxifen;Chemical;PA165816579;Haplotype
CYP2D6*6;endoxifen;Chemical;PA165816581;Haplotype
CYP2D6*10;endoxifen;Chemical;PA165816582;Haplotype
CYP2D6*17;endoxifen;Chemical;PA165816583;Haplotype
CYP2D6*41;endoxifen;Chemical;PA165816584;Haplotype
CYP3A4*1;endoxifen;Chemical;PA165819201;Haplotype
CYP2D6*5;endoxifen;Chemical;PA165948092;Haplotype
CYP2D6*9;endoxifen;Chemical;PA165948317;Haplotype
CYP2D6*29;endoxifen;Chemical;PA165948318;Haplotype
CYP2D6*8;endoxifen;Chemical;PA165971560;Haplotype
CYP2D6*1XN;endoxifen;Chemical;PA165988479;Haplotype
CYP2D6*2XN;endoxifen;Chemical;PA165988480;Haplotype
CYP2D6*35;endoxifen;Chemical;PA165988487;Haplotype
CYP3A4*22;endoxifen;Chemical;PA166048680;Haplotype
RS4386686;endoxifen;Chemical;PA166156826;Variant
CYP2D6 NORMAL METABOLIZER AND ULTRARAPID METABOLIZER;endoxifen;Chemical;PA166161134;Variant
ASTHMA;rs7604115;Variant;PA443450;Disease
MONTELUKAST;rs7604115;Variant;PA450546;Chemical
SN-38;rs6498588;Variant;PA165110775;Chemical
COLORECTAL NEOPLASMS;rs6498588;Variant;PA446108;Disease
ACUTE CORONARY SYNDROME;ITGB3;Gene;PA165108401;Disease
PLCB1;ITGB3;Gene;PA33384;Gene
PLCG2;ITGB3;Gene;PA33393;Gene
CORONARY ARTERY DISEASE;ITGB3;Gene;PA443796;Disease
MYOCARDIAL INFARCTION;ITGB3;Gene;PA445019;Disease
ABCIXIMAB;ITGB3;Gene;PA448006;Chemical
ASPIRIN;ITGB3;Gene;PA448497;Chemical
CLOPIDOGREL;ITGB3;Gene;PA449053;Chemical
EPTIFIBATIDE;ITGB3;Gene;PA449483;Chemical
TIROFIBAN;ITGB3;Gene;PA451698;Chemical
NEUTROPENIA;rs3825876;Variant;PA445113;Disease
PANCREATIC NEOPLASMS;rs3825876;Variant;PA445218;Disease
GEMCITABINE;rs3825876;Variant;PA449748;Chemical
BREAST NEOPLASMS;rs1437153;Variant;PA443560;Disease
ANASTROZOLE;rs1437153;Variant;PA448432;Chemical
G6PD B (REFERENCE);methylene blue;Chemical;PA165947826;Haplotype
G6PD A- 202A_376G;methylene blue;Chemical;PA165947827;Haplotype
G6PD DEFICIENCY;methylene blue;Chemical;PA166157959;Variant
BLVRB;methylene blue;Chemical;PA25374;Gene
G6PD;methylene blue;Chemical;PA28469;Gene
HIV INFECTIOUS DISEASE;rs3786547;Variant;PA447230;Disease
NEVIRAPINE;rs3786547;Variant;PA450616;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;GNMT;Gene;PA446155;Disease
MERCAPTOPURINE;GNMT;Gene;PA450379;Chemical
L-METHIONINE;GNMT;Gene;PA450423;Chemical
PENICILLIN V;rs115200108;Variant;PA164745442;Chemical
ADVERSE EVENTS;rs115200108;Variant;PA166151827;Disease
PENICILLIN G;rs115200108;Variant;PA450842;Chemical
RS1800559;desflurane;Chemical;PA166153638;Variant
RS772226819;desflurane;Chemical;PA166153940;Variant
RS1801086;desflurane;Chemical;PA166155375;Variant
RS28933396;desflurane;Chemical;PA166155481;Variant
RS28933397;desflurane;Chemical;PA166155482;Variant
RS63749869;desflurane;Chemical;PA166155516;Variant
RS111888148;desflurane;Chemical;PA166155524;Variant
RS112563513;desflurane;Chemical;PA166155526;Variant
RS118192116;desflurane;Chemical;PA166155528;Variant
RS118192122;desflurane;Chemical;PA166155529;Variant
RS118192124;desflurane;Chemical;PA166155531;Variant
RS118192161;desflurane;Chemical;PA166155532;Variant
RS118192162;desflurane;Chemical;PA166155533;Variant
RS118192163;desflurane;Chemical;PA166155534;Variant
RS118192167;desflurane;Chemical;PA166155535;Variant
RS118192170;desflurane;Chemical;PA166155536;Variant
RS118192172;desflurane;Chemical;PA166155537;Variant
RS118192175;desflurane;Chemical;PA166155538;Variant
RS118192176;desflurane;Chemical;PA166155539;Variant
RS118192177;desflurane;Chemical;PA166155540;Variant
RS118192178;desflurane;Chemical;PA166155541;Variant
RS121918592;desflurane;Chemical;PA166155543;Variant
RS121918593;desflurane;Chemical;PA166155544;Variant
RS121918594;desflurane;Chemical;PA166155545;Variant
RS121918595;desflurane;Chemical;PA166155546;Variant
RS193922747;desflurane;Chemical;PA166155564;Variant
RS193922753;desflurane;Chemical;PA166155565;Variant
RS193922770;desflurane;Chemical;PA166155567;Variant
RS193922772;desflurane;Chemical;PA166155568;Variant
RS193922802;desflurane;Chemical;PA166155569;Variant
RS193922803;desflurane;Chemical;PA166155570;Variant
RS193922807;desflurane;Chemical;PA166155571;Variant
RS193922809;desflurane;Chemical;PA166155572;Variant
RS193922816;desflurane;Chemical;PA166155573;Variant
RS193922818;desflurane;Chemical;PA166155574;Variant
RS193922876;desflurane;Chemical;PA166155575;Variant
RS193922878;desflurane;Chemical;PA166155576;Variant
RS193922843;desflurane;Chemical;PA166163663;Variant
RS193922832;desflurane;Chemical;PA166163667;Variant
RS118192168;desflurane;Chemical;PA166163669;Variant
RS193922764;desflurane;Chemical;PA166176176;Variant
RS121918596;desflurane;Chemical;PA166177994;Variant
RS193922748;desflurane;Chemical;PA166180322;Variant
RS193922762;desflurane;Chemical;PA166180323;Variant
RS193922768;desflurane;Chemical;PA166180324;Variant
RS144336148;desflurane;Chemical;PA166180325;Variant
RYR1;desflurane;Chemical;PA34896;Gene
CACNA1S;desflurane;Chemical;PA85;Gene
FLUOROURACIL;rs548783838;Variant;PA128406956;Chemical
DRUG TOXICITY;rs548783838;Variant;PA443937;Disease
2-OXO-CLOPIDOGREL;rs778068631;Variant;PA166131290;Chemical
CLOPIDOGREL;rs778068631;Variant;PA449053;Chemical
METHYLPHENIDATE;rs778068631;Variant;PA450464;Chemical
TRANDOLAPRIL;rs778068631;Variant;PA451737;Chemical
ALCOHOL ABUSE;rs846664;Variant;PA443309;Disease
ETHANOL;rs846664;Variant;PA448073;Chemical
G6PD;ofloxacin;Chemical;PA28469;Gene
CFTR;rs397508721;Variant;PA109;Gene
IVACAFTOR;rs397508721;Variant;PA165950341;Chemical
PRASUGREL;rs822441;Variant;PA154410481;Chemical
TOPOISOMERASE I INHIBITORS;SLFN11;Gene;PA150481186;Chemical
SARCOMA, EWING'S;SLFN11;Gene;PA445597;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;FXR2;Gene;PA447197;Disease
METHYLPHENIDATE;FXR2;Gene;PA450464;Chemical
PROSTATIC NEOPLASMS;rs4148945;Variant;PA445425;Disease
DOCETAXEL;rs4148945;Variant;PA449383;Chemical
THALIDOMIDE;rs4148945;Variant;PA451644;Chemical
FLUOROURACIL;rs17431184;Variant;PA128406956;Chemical
METASTATIC NEOPLASM;rs17431184;Variant;PA445058;Disease
CAPECITABINE;rs17431184;Variant;PA448771;Chemical
BEVACIZUMAB;rs6929249;Variant;PA130232992;Chemical
HYPERTENSION;rs6929249;Variant;PA444552;Disease
OPIOID-RELATED DISORDERS;rs2234918;Variant;PA445043;Disease
PHYSIOLOGICAL SEXUAL DISORDER;rs2234918;Variant;PA447218;Disease
BUPRENORPHINE;rs2234918;Variant;PA448685;Chemical
FENTANYL;rs2234918;Variant;PA449599;Chemical
TRAMADOL;rs2234918;Variant;PA451735;Chemical
LAPATINIB;HLA-A*26:01;Haplotype;PA152241907;Chemical
BREAST NEOPLASMS;HLA-A*26:01;Haplotype;PA443560;Disease
EXANTHEMA;HLA-A*26:01;Haplotype;PA444109;Disease
WARFARIN;rs4379440;Variant;PA451906;Chemical
LDLR;inclisiran;Chemical;PA227;Gene
PCSK9;inclisiran;Chemical;PA38617;Gene
APOB;inclisiran;Chemical;PA50;Gene
ARIPIPRAZOLE;CYP1A2;Gene;PA10026;Chemical
BROMAZEPAM;CYP1A2;Gene;PA10035;Chemical
DULOXETINE;CYP1A2;Gene;PA10066;Chemical
ESCITALOPRAM;CYP1A2;Gene;PA10074;Chemical
IMATINIB;CYP1A2;Gene;PA10804;Chemical
ERLOTINIB;CYP1A2;Gene;PA134687924;Chemical
GASTROINTESTINAL STROMAL TUMORS;CYP1A2;Gene;PA151958383;Disease
ALBENDAZOLE;CYP1A2;Gene;PA164746058;Chemical
DEFERASIROX;CYP1A2;Gene;PA164760843;Chemical
DIVALPROEX SODIUM;CYP1A2;Gene;PA164783479;Chemical
CYP1A2*3;CYP1A2;Gene;PA165819181;Haplotype
CYP1A2*4;CYP1A2;Gene;PA165819182;Haplotype
CYP1A2*6;CYP1A2;Gene;PA165819183;Haplotype
CYP1A2*7;CYP1A2;Gene;PA165819184;Haplotype
VEMURAFENIB;CYP1A2;Gene;PA165946873;Chemical
PREGNANCY;CYP1A2;Gene;PA166048714;Disease
INSOMNIA;CYP1A2;Gene;PA166123307;Disease
SCHIZOAFFECTIVE DISORDER;CYP1A2;Gene;PA166123368;Disease
RUCAPARIB;CYP1A2;Gene;PA166163418;Chemical
N-DESMETHYLCLOZAPINE;CYP1A2;Gene;PA166163659;Chemical
DESMETHYL OLANZAPINE;CYP1A2;Gene;PA166164916;Chemical
CYP1A2*30;CYP1A2;Gene;PA166363474;Haplotype
ABORTION, SPONTANEOUS;CYP1A2;Gene;PA443227;Disease
RHEUMATOID ARTHRITIS;CYP1A2;Gene;PA443434;Disease
PATENT DUCTUS ARTERIOSUS;CYP1A2;Gene;PA443940;Disease
MYOCARDIAL INFARCTION;CYP1A2;Gene;PA445019;Disease
OPIOID-RELATED DISORDERS;CYP1A2;Gene;PA445043;Disease
SEIZURES;CYP1A2;Gene;PA445629;Disease
TOBACCO USE DISORDER;CYP1A2;Gene;PA445876;Disease
BETA-THALASSEMIA AND RELATED DISEASES;CYP1A2;Gene;PA446432;Disease
SCHIZOPHRENIA;CYP1A2;Gene;PA447216;Disease
MAJOR DEPRESSIVE DISORDER;CYP1A2;Gene;PA447321;Disease
ACETAMINOPHEN;CYP1A2;Gene;PA448015;Chemical
AMITRIPTYLINE;CYP1A2;Gene;PA448385;Chemical
BUPROPION;CYP1A2;Gene;PA448687;Chemical
BUSPIRONE;CYP1A2;Gene;PA448689;Chemical
CAFFEINE;CYP1A2;Gene;PA448710;Chemical
CARBAMAZEPINE;CYP1A2;Gene;PA448785;Chemical
CITALOPRAM;CYP1A2;Gene;PA449015;Chemical
CLOMIPRAMINE;CYP1A2;Gene;PA449048;Chemical
CLOPIDOGREL;CYP1A2;Gene;PA449053;Chemical
CLOZAPINE;CYP1A2;Gene;PA449061;Chemical
DACARBAZINE;CYP1A2;Gene;PA449197;Chemical
DESIPRAMINE;CYP1A2;Gene;PA449233;Chemical
DIAZEPAM;CYP1A2;Gene;PA449283;Chemical
DOXEPIN;CYP1A2;Gene;PA449409;Chemical
FLUOXETINE;CYP1A2;Gene;PA449673;Chemical
FLUVOXAMINE;CYP1A2;Gene;PA449690;Chemical
IMIPRAMINE;CYP1A2;Gene;PA449969;Chemical
LAMOTRIGINE;CYP1A2;Gene;PA450164;Chemical
LANSOPRAZOLE;CYP1A2;Gene;PA450180;Chemical
LEFLUNOMIDE;CYP1A2;Gene;PA450192;Chemical
MIRTAZAPINE;CYP1A2;Gene;PA450522;Chemical
MODAFINIL;CYP1A2;Gene;PA450530;Chemical
NORTRIPTYLINE;CYP1A2;Gene;PA450657;Chemical
OLANZAPINE;CYP1A2;Gene;PA450688;Chemical
OMEPRAZOLE;CYP1A2;Gene;PA450704;Chemical
OXCARBAZEPINE;CYP1A2;Gene;PA450732;Chemical
PAROXETINE;CYP1A2;Gene;PA450801;Chemical
PHENYTOIN;CYP1A2;Gene;PA450947;Chemical
PRIMAQUINE;CYP1A2;Gene;PA451103;Chemical
PROPRANOLOL;CYP1A2;Gene;PA451145;Chemical
QUETIAPINE;CYP1A2;Gene;PA451201;Chemical
RISPERIDONE;CYP1A2;Gene;PA451257;Chemical
SERTRALINE;CYP1A2;Gene;PA451333;Chemical
TAMOXIFEN;CYP1A2;Gene;PA451581;Chemical
THEOPHYLLINE;CYP1A2;Gene;PA451647;Chemical
TRAZODONE;CYP1A2;Gene;PA451744;Chemical
VALPROIC ACID;CYP1A2;Gene;PA451846;Chemical
VENLAFAXINE;CYP1A2;Gene;PA451866;Chemical
WARFARIN;CYP1A2;Gene;PA451906;Chemical
ZIPRASIDONE;CYP1A2;Gene;PA451974;Chemical
ANTIPSYCHOTICS;CYP1A2;Gene;PA452233;Chemical
XENOBIOTICS;CYP1A2;Gene;PA452604;Chemical
OPIOIDS;CYP1A2;Gene;PA452618;Chemical
CYP2C19;Esophagitis;Disease;PA124;Gene
CYP2C19*1;Esophagitis;Disease;PA165980634;Haplotype
CYP2C19*2;Esophagitis;Disease;PA165980635;Haplotype
CYP2C19*3;Esophagitis;Disease;PA165980636;Haplotype
G6PD;acetaminophen / tramadol;Chemical;PA28469;Gene
DESFLURANE;rs118192170;Variant;PA164749136;Chemical
RYR1;rs118192170;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs118192170;Variant;PA444863;Disease
ENFLURANE;rs118192170;Variant;PA449461;Chemical
HALOTHANE;rs118192170;Variant;PA449845;Chemical
ISOFLURANE;rs118192170;Variant;PA450106;Chemical
METHOXYFLURANE;rs118192170;Variant;PA450434;Chemical
SEVOFLURANE;rs118192170;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs118192170;Variant;PA451522;Chemical
CACNA1S;rs118192170;Variant;PA85;Gene
FLUOROURACIL;XRCC1;Gene;PA128406956;Chemical
PLATINUM COMPOUNDS;XRCC1;Gene;PA164713176;Chemical
RADIOTHERAPY;XRCC1;Gene;PA166122986;Chemical
OVERALL SURVIVAL;XRCC1;Gene;PA166123207;Disease
BREAST NEOPLASMS;XRCC1;Gene;PA443560;Disease
NON-SMALL CELL LUNG CARCINOMA;XRCC1;Gene;PA443622;Disease
CARCINOMA, SQUAMOUS CELL;XRCC1;Gene;PA443626;Disease
UTERINE CERVICAL NEOPLASM;XRCC1;Gene;PA443685;Disease
COLONIC NEOPLASMS;XRCC1;Gene;PA443756;Disease
LUNG NEOPLASMS;XRCC1;Gene;PA444818;Disease
NEOPLASMS;XRCC1;Gene;PA445062;Disease
OVARIAN NEOPLASMS;XRCC1;Gene;PA445204;Disease
RECTAL NEOPLASMS;XRCC1;Gene;PA445503;Disease
COLORECTAL NEOPLASMS;XRCC1;Gene;PA446108;Disease
CISPLATIN;XRCC1;Gene;PA449014;Chemical
CYCLOPHOSPHAMIDE;XRCC1;Gene;PA449165;Chemical
DOXORUBICIN;XRCC1;Gene;PA449412;Chemical
CYP2C19;tranylcypromine;Chemical;PA124;Gene
CYP2C19*8;tranylcypromine;Chemical;PA165816524;Haplotype
CYP2C19*15;tranylcypromine;Chemical;PA165816531;Haplotype
CYP2C19*19;tranylcypromine;Chemical;PA165816535;Haplotype
CYP2C19*1;tranylcypromine;Chemical;PA165980634;Haplotype
ESCITALOPRAM;rs6311;Variant;PA10074;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;rs6311;Variant;PA164713257;Chemical
ADVERSE EVENTS;rs6311;Variant;PA166151827;Disease
DIMINISHED ABILITY TO CONCENTRATE;rs6311;Variant;PA166264221;Disease
DIARRHEA;rs6311;Variant;PA443899;Disease
DIZZINESS;rs6311;Variant;PA443928;Disease
NAUSEA;rs6311;Variant;PA445048;Disease
TREMOR;rs6311;Variant;PA445917;Disease
VOMITING;rs6311;Variant;PA446051;Disease
ANXIETY DISORDERS;rs6311;Variant;PA447196;Disease
AUTISM;rs6311;Variant;PA447198;Disease
BIPOLAR DISORDER;rs6311;Variant;PA447199;Disease
OBSESSIVE-COMPULSIVE DISORDER;rs6311;Variant;PA447211;Disease
PHYSIOLOGICAL SEXUAL DISORDER;rs6311;Variant;PA447218;Disease
TARDIVE DYSKINESIA;rs6311;Variant;PA447268;Disease
DEPRESSION;rs6311;Variant;PA447278;Disease
MAJOR DEPRESSIVE DISORDER;rs6311;Variant;PA447321;Disease
CITALOPRAM;rs6311;Variant;PA449015;Chemical
FLUOXETINE;rs6311;Variant;PA449673;Chemical
FLUVOXAMINE;rs6311;Variant;PA449690;Chemical
PAROXETINE;rs6311;Variant;PA450801;Chemical
RISPERIDONE;rs6311;Variant;PA451257;Chemical
SERTRALINE;rs6311;Variant;PA451333;Chemical
VENLAFAXINE;rs6311;Variant;PA451866;Chemical
ANTIDEPRESSANTS;rs6311;Variant;PA452229;Chemical
ANTIPSYCHOTICS;rs6311;Variant;PA452233;Chemical
DULOXETINE;rs4858478;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs4858478;Variant;PA447321;Disease
RS35320474;apnea of prematurity;Disease;PA166156166;Variant
ADORA2A;apnea of prematurity;Disease;PA24584;Gene
PDGFRA;olaratumab;Chemical;PA33147;Gene
ABCB1;fluoxetine glucuronide;Chemical;PA267;Gene
ESCITALOPRAM;rs1065852;Variant;PA10074;Chemical
ILOPERIDONE;rs1065852;Variant;PA161199368;Chemical
BUFURALOL;rs1065852;Variant;PA166110256;Chemical
OPIOID-RELATED DISORDERS;rs1065852;Variant;PA445043;Disease
SCHIZOPHRENIA;rs1065852;Variant;PA447216;Disease
MAJOR DEPRESSIVE DISORDER;rs1065852;Variant;PA447321;Disease
OPIOIDS;rs1065852;Variant;PA452618;Chemical
RS121908560;Myotonic Disorders;Disease;PA166185726;Variant
RS886043595;Myotonic Disorders;Disease;PA166185727;Variant
RS1567817380;Myotonic Disorders;Disease;PA166185728;Variant
RS121908547;Myotonic Disorders;Disease;PA166185729;Variant
SCN4A;Myotonic Disorders;Disease;PA35006;Gene
CYP2C9;losartan;Chemical;PA126;Gene
CYP3A4;losartan;Chemical;PA130;Gene
CYP3A5;losartan;Chemical;PA131;Gene
CAMK1D;losartan;Chemical;PA134992438;Gene
ACE;losartan;Chemical;PA139;Gene
CYP2C9*1;losartan;Chemical;PA165816542;Haplotype
CYP2C9*2;losartan;Chemical;PA165816543;Haplotype
CYP2C9*3;losartan;Chemical;PA165816544;Haplotype
CYP2C9*5;losartan;Chemical;PA165816546;Haplotype
CYP2C9*6;losartan;Chemical;PA165816547;Haplotype
CYP2C9*8;losartan;Chemical;PA165816549;Haplotype
CYP2C9*13;losartan;Chemical;PA165816554;Haplotype
CYP2C9*33;losartan;Chemical;PA165816561;Haplotype
CYP2C9*30;losartan;Chemical;PA165816574;Haplotype
CYP2C9*59;losartan;Chemical;PA166128210;Haplotype
RS1057910;losartan;Chemical;PA166153959;Variant
RS1934969;losartan;Chemical;PA166153986;Variant
RS10737062;losartan;Chemical;PA166154112;Variant
RS10752271;losartan;Chemical;PA166154113;Variant
RS1799752;losartan;Chemical;PA166155187;Variant
RS6749447;losartan;Chemical;PA166155757;Variant
RS5186;losartan;Chemical;PA166156276;Variant
RS12721226;losartan;Chemical;PA166156450;Variant
RS1045642;losartan;Chemical;PA166157284;Variant
RS3814995;losartan;Chemical;PA166159103;Variant
CYP2C9*62;losartan;Chemical;PA166219782;Haplotype
CYP2C9*72;losartan;Chemical;PA166257325;Haplotype
CYP2C9*73;losartan;Chemical;PA166257326;Haplotype
CYP2C9*74;losartan;Chemical;PA166257327;Haplotype
CYP2C9*75;losartan;Chemical;PA166257328;Haplotype
ABCB1;losartan;Chemical;PA267;Gene
NPHS1;losartan;Chemical;PA31709;Gene
UGT2B7;losartan;Chemical;PA361;Gene
STK39;losartan;Chemical;PA38243;Gene
UGT1A1;losartan;Chemical;PA420;Gene
AGTR1;losartan;Chemical;PA43;Gene
ABL1;bosutinib;Chemical;PA24413;Gene
BCR;bosutinib;Chemical;PA25321;Gene
CAMK2G;bosutinib;Chemical;PA93;Gene
CFTR;rs121909006;Variant;PA109;Gene
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs121909006;Variant;PA166362502;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;ABCC1;Gene;PA130620651;Chemical
LEUKOTRIENE RECEPTOR ANTAGONISTS;ABCC1;Gene;PA164712863;Chemical
SN-38;ABCC1;Gene;PA165110775;Chemical
NR1I2;ABCC1;Gene;PA378;Gene
CARDIAC RHYTHM DISEASE;ABCC1;Gene;PA443421;Disease
RHEUMATOID ARTHRITIS;ABCC1;Gene;PA443434;Disease
ASTHMA;ABCC1;Gene;PA443450;Disease
DRUG TOXICITY;ABCC1;Gene;PA443937;Disease
NON-HODGKIN LYMPHOMA;ABCC1;Gene;PA444845;Disease
NEOPLASMS;ABCC1;Gene;PA445062;Disease
NEUTROPENIA;ABCC1;Gene;PA445113;Disease
PSORIASIS;ABCC1;Gene;PA445451;Disease
COLORECTAL NEOPLASMS;ABCC1;Gene;PA446108;Disease
HIV INFECTIOUS DISEASE;ABCC1;Gene;PA447230;Disease
DOCETAXEL;ABCC1;Gene;PA449383;Chemical
DOXORUBICIN;ABCC1;Gene;PA449412;Chemical
IRINOTECAN;ABCC1;Gene;PA450085;Chemical
LAMIVUDINE;ABCC1;Gene;PA450163;Chemical
LOPINAVIR;ABCC1;Gene;PA450264;Chemical
METHOTREXATE;ABCC1;Gene;PA450428;Chemical
MONTELUKAST;ABCC1;Gene;PA450546;Chemical
PACLITAXEL;ABCC1;Gene;PA450761;Chemical
RITONAVIR;ABCC1;Gene;PA451260;Chemical
VINCRISTINE;ABCC1;Gene;PA451879;Chemical
ZIDOVUDINE;ABCC1;Gene;PA451954;Chemical
WEIGHT GAIN;PLIN1;Gene;PA128406954;Disease
DIABETES MELLITUS, TYPE 2;PLIN1;Gene;PA443890;Disease
ROSIGLITAZONE;PLIN1;Gene;PA451283;Chemical
ABCC2;Fanconi renotubular syndrome;Disease;PA116;Gene
RS8187710;Fanconi renotubular syndrome;Disease;PA166154094;Variant
WNK4;WNK1;Gene;PA134875400;Gene
KCNJ1;WNK1;Gene;PA213;Gene
SCNN1A;WNK1;Gene;PA305;Gene
SCNN1B;WNK1;Gene;PA306;Gene
SCNN1G;WNK1;Gene;PA307;Gene
WNK3;WNK1;Gene;PA33784;Gene
STK39;WNK1;Gene;PA38243;Gene
HYPERTENSION;WNK1;Gene;PA444552;Disease
HYDROCHLOROTHIAZIDE;WNK1;Gene;PA449899;Chemical
SCHIZOPHRENIA;rs6706232;Variant;PA447216;Disease
RISPERIDONE;rs6706232;Variant;PA451257;Chemical
NAUSEA;rs9393888;Variant;PA445048;Disease
VOMITING;rs9393888;Variant;PA446051;Disease
OPIOIDS;rs9393888;Variant;PA452618;Chemical
LUMEFANTRINE;ZSCAN25;Gene;PA165111722;Chemical
KIDNEY TRANSPLANTATION;ZSCAN25;Gene;PA165817016;Disease
DRUG TOXICITY;ZSCAN25;Gene;PA443937;Disease
MALARIA;ZSCAN25;Gene;PA444859;Disease
OPIOID-RELATED DISORDERS;ZSCAN25;Gene;PA445043;Disease
HIV INFECTIOUS DISEASE;ZSCAN25;Gene;PA447230;Disease
LIVER TRANSPLANTATION;ZSCAN25;Gene;PA447247;Disease
LOPINAVIR;ZSCAN25;Gene;PA450264;Chemical
TACROLIMUS;ZSCAN25;Gene;PA451578;Chemical
OPIOIDS;ZSCAN25;Gene;PA452618;Chemical
RHEUMATOID ARTHRITIS;CD84;Gene;PA443434;Disease
PSORIASIS;CD84;Gene;PA445451;Disease
ETANERCEPT;CD84;Gene;PA449515;Chemical
CYP2D6;Agoraphobia;Disease;PA128;Gene
CYP2D6*2;Agoraphobia;Disease;PA165816577;Haplotype
CYP2D6*1XN;Agoraphobia;Disease;PA165988479;Haplotype
DULOXETINE;rs10124893;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs10124893;Variant;PA447321;Disease
ACUTE CORONARY SYNDROME;rs75750968;Variant;PA165108401;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);rs75750968;Variant;PA166129560;Disease
ASPIRIN;rs75750968;Variant;PA448497;Chemical
CLOPIDOGREL;rs75750968;Variant;PA449053;Chemical
BIPOLAR DISORDER;GRAMD1B;Gene;PA447199;Disease
LITHIUM;GRAMD1B;Gene;PA450243;Chemical
LUPUS ERYTHEMATOSUS, SYSTEMIC;TPMT*37;Haplotype;PA444822;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;TPMT*37;Haplotype;PA446155;Disease
MERCAPTOPURINE;TPMT*37;Haplotype;PA450379;Chemical
CFTR;rs144055758;Variant;PA109;Gene
IVACAFTOR;rs144055758;Variant;PA165950341;Chemical
TICAGRELOR;CYP3A4*19;Haplotype;PA165374673;Chemical
CABOZANTINIB;CYP3A4*19;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*19;Haplotype;PA165958362;Chemical
VANDETANIB;CYP3A4*19;Haplotype;PA166118341;Chemical
IBRUTINIB;CYP3A4*19;Haplotype;PA166121346;Chemical
ALECTINIB;CYP3A4*19;Haplotype;PA166160050;Chemical
ACALABRUTINIB;CYP3A4*19;Haplotype;PA166198581;Chemical
AMIODARONE;CYP3A4*19;Haplotype;PA448383;Chemical
LIDOCAINE;CYP3A4*19;Haplotype;PA450226;Chemical
METHADONE;CYP3A4*19;Haplotype;PA450401;Chemical
OXYCODONE;CYP3A4*19;Haplotype;PA450741;Chemical
BREAST NEOPLASMS;rs1048943;Variant;PA443560;Disease
CAPECITABINE;rs1048943;Variant;PA448771;Chemical
DOCETAXEL;rs1048943;Variant;PA449383;Chemical
KCNJ11;Diabetes, Permanent Neonatal (PNDM);Disease;PA217;Gene
NAUSEA;rs10405238;Variant;PA445048;Disease
VOMITING;rs10405238;Variant;PA446051;Disease
OPIOIDS;rs10405238;Variant;PA452618;Chemical
ASTHMA;CEP68;Gene;PA443450;Disease
ASPIRIN;CEP68;Gene;PA448497;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs2242046;Variant;PA443622;Disease
GEMCITABINE;rs2242046;Variant;PA449748;Chemical
PLCH1;PRKCB;Gene;PA128394595;Gene
PLCZ1;PRKCB;Gene;PA134875646;Gene
PLCH2;PRKCB;Gene;PA134914471;Gene
NFKB1;PRKCB;Gene;PA248;Gene
ELK1;PRKCB;Gene;PA27749;Gene
FOS;PRKCB;Gene;PA28212;Gene
RELA;PRKCB;Gene;PA296;Gene
JUN;PRKCB;Gene;PA30006;Gene
MYC;PRKCB;Gene;PA31353;Gene
NFKB2;PRKCB;Gene;PA31600;Gene
PLCB1;PRKCB;Gene;PA33384;Gene
PLCB2;PRKCB;Gene;PA33385;Gene
PLCB3;PRKCB;Gene;PA33386;Gene
PLCB4;PRKCB;Gene;PA33387;Gene
PLCD1;PRKCB;Gene;PA33388;Gene
PLCD3;PRKCB;Gene;PA33389;Gene
PLCD4;PRKCB;Gene;PA33390;Gene
PLCE1;PRKCB;Gene;PA33391;Gene
PLCG1;PRKCB;Gene;PA33392;Gene
PLCG2;PRKCB;Gene;PA33393;Gene
PLCL1;PRKCB;Gene;PA33394;Gene
PLCL2;PRKCB;Gene;PA33395;Gene
STAT3;PRKCB;Gene;PA337;Gene
STAT5A;PRKCB;Gene;PA338;Gene
RAF1;PRKCB;Gene;PA34183;Gene
SP1;PRKCB;Gene;PA36042;Gene
STAT1;PRKCB;Gene;PA36183;Gene
STAT2;PRKCB;Gene;PA36184;Gene
STAT4;PRKCB;Gene;PA36185;Gene
STAT5B;PRKCB;Gene;PA36186;Gene
ADRB2;PRKCB;Gene;PA39;Gene
HYPERGLYCEMIA;PRKCB;Gene;PA444522;Disease
ATENOLOL;PRKCB;Gene;PA448499;Chemical
DEXMEDETOMIDINE;PRKCB;Gene;PA449256;Chemical
DIABETES MELLITUS;rs8192675;Variant;PA443886;Disease
METFORMIN;rs8192675;Variant;PA450395;Chemical
SEVOFLURANE;rs3813867;Variant;PA451341;Chemical
LEUKOPENIA;rs12046844;Variant;PA444773;Disease
NEOPLASMS;rs12046844;Variant;PA445062;Disease
GEMCITABINE;rs12046844;Variant;PA449748;Chemical
HEPATITIS VACCINES;rs1295686;Variant;PA164712789;Chemical
ABIRATERONE;DSE;Gene;PA166123407;Chemical
PROSTATIC NEOPLASMS;DSE;Gene;PA445425;Disease
PREDNISOLONE;DSE;Gene;PA451096;Chemical
PREGNENOLONE;rs762765702;Variant;PA166334121;Chemical
LEVOTHYROXINE;PAX8;Gene;PA450221;Chemical
TELMISARTAN;UGT1A3*3;Haplotype;PA451605;Chemical
GSTZ1;dichloroacetic acid;Chemical;PA29031;Gene
ESTRONE SULFATE;rs2306168;Variant;PA166185957;Chemical
FEXOFENADINE;rs2306168;Variant;PA449621;Chemical
TOBACCO USE DISORDER;EPB41;Gene;PA445876;Disease
BUPROPION;EPB41;Gene;PA448687;Chemical
NICOTINE;EPB41;Gene;PA450626;Chemical
NR1I2;st. john's wort;Chemical;PA378;Gene
TOXIC LIVER DISEASE;MAFK;Gene;PA164925725;Disease
DRUG-INDUCED LIVER INJURY;MAFK;Gene;PA166119041;Disease
MAPK8;MAFK;Gene;PA283;Gene
MAPK14;MAFK;Gene;PA30621;Gene
ISONIAZID;MAFK;Gene;PA450112;Chemical
PROSTATIC NEOPLASMS;rs1883322;Variant;PA445425;Disease
DOCETAXEL;rs1883322;Variant;PA449383;Chemical
THALIDOMIDE;rs1883322;Variant;PA451644;Chemical
CYP7A1;cholic acid;Chemical;PA132;Gene
HSD3B7;cholic acid;Chemical;PA134940289;Gene
CYP27A1;cholic acid;Chemical;PA135;Gene
AKR1D1;cholic acid;Chemical;PA24681;Gene
AMACR;cholic acid;Chemical;PA24757;Gene
DHCR7;cholic acid;Chemical;PA27321;Gene
HSD3B2;cholic acid;Chemical;PA29487;Gene
ADEFOVIR DIPIVOXIL;rs11568634;Variant;PA10005;Chemical
TPMT;TPMT*18;Haplotype;PA356;Gene
CROHN DISEASE;TPMT*18;Haplotype;PA443815;Disease
AZATHIOPRINE;TPMT*18;Haplotype;PA448515;Chemical
MERCAPTOPURINE;TPMT*18;Haplotype;PA450379;Chemical
THIOGUANINE;TPMT*18;Haplotype;PA451663;Chemical
HLA-DRB1*07:01;Influenza vaccines;Chemical;PA165951644;Haplotype
HLA-DRB1*13:01;Influenza vaccines;Chemical;PA165951968;Haplotype
HLA-DQB1*06:02;Influenza vaccines;Chemical;PA165958103;Haplotype
HLA-DQB1*03:03;Influenza vaccines;Chemical;PA165958180;Haplotype
HLA-DQB1;Influenza vaccines;Chemical;PA35068;Gene
HLA-DRB1;Influenza vaccines;Chemical;PA35072;Gene
ADVERSE EVENTS;rs34545984;Variant;PA166151827;Disease
CEPHALEXIN;rs34545984;Variant;PA448883;Chemical
OVARIAN NEOPLASMS;rs2070676;Variant;PA445204;Disease
CISPLATIN;rs2070676;Variant;PA449014;Chemical
CYCLOPHOSPHAMIDE;rs2070676;Variant;PA449165;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs6927172;Variant;PA164713366;Chemical
ULCERATIVE COLITIS;rs6927172;Variant;PA443750;Disease
INFLAMMATORY BOWEL DISEASES;rs6927172;Variant;PA446116;Disease
NAT2;amifampridine phosphate;Chemical;PA18;Gene
ASTHMA;rs10511905;Variant;PA443450;Disease
SALBUTAMOL;rs10511905;Variant;PA448068;Chemical
FLUOROURACIL;FOXO1;Gene;PA128406956;Chemical
BREAST NEOPLASMS;FOXO1;Gene;PA443560;Disease
NEUTROPENIA;FOXO1;Gene;PA445113;Disease
OVARIAN NEOPLASMS;FOXO1;Gene;PA445204;Disease
CYCLOPHOSPHAMIDE;FOXO1;Gene;PA449165;Chemical
EPIRUBICIN;FOXO1;Gene;PA449476;Chemical
PLATINUM COMPOUNDS;RRM1;Gene;PA164713176;Chemical
BREAST NEOPLASMS;RRM1;Gene;PA443560;Disease
NON-SMALL CELL LUNG CARCINOMA;RRM1;Gene;PA443622;Disease
LEUKEMIA, MYELOID, ACUTE;RRM1;Gene;PA444760;Disease
MESOTHELIOMA;RRM1;Gene;PA444937;Disease
NEOPLASMS;RRM1;Gene;PA445062;Disease
CISPLATIN;RRM1;Gene;PA449014;Chemical
CLADRIBINE;RRM1;Gene;PA449027;Chemical
CYTARABINE;RRM1;Gene;PA449177;Chemical
GEMCITABINE;RRM1;Gene;PA449748;Chemical
OVERALL SURVIVAL;rs1615111;Variant;PA166123207;Disease
ADENOCARCINOMA;rs1615111;Variant;PA443265;Disease
ADEFOVIR DIPIVOXIL;AK4;Gene;PA10005;Chemical
TENOFOVIR;AK4;Gene;PA10204;Chemical
CYP2C8;Weight gain;Disease;PA125;Gene
CYP2D6;Weight gain;Disease;PA128;Gene
GHRL;Weight gain;Disease;PA142671740;Gene
FTO;Weight gain;Disease;PA152208656;Gene
CYP2D6*1;Weight gain;Disease;PA165816576;Haplotype
CYP2D6*3;Weight gain;Disease;PA165816578;Haplotype
CYP2D6*4;Weight gain;Disease;PA165816579;Haplotype
CYP2D6*41;Weight gain;Disease;PA165816584;Haplotype
CYP2C8*3;Weight gain;Disease;PA165958685;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);Weight gain;Disease;PA166116466;Haplotype
RS5443;Weight gain;Disease;PA166154486;Variant
RS6313;Weight gain;Disease;PA166154675;Variant
RS489693;Weight gain;Disease;PA166155269;Variant
RS11872992;Weight gain;Disease;PA166155319;Variant
RS17782313;Weight gain;Disease;PA166155330;Variant
RS2268639;Weight gain;Disease;PA166157028;Variant
RS4994;Weight gain;Disease;PA166157543;Variant
RS6318;Weight gain;Disease;PA166157849;Variant
RS518147;Weight gain;Disease;PA166157854;Variant
RS2497538;Weight gain;Disease;PA166157870;Variant
RS894160;Weight gain;Disease;PA166183759;Variant
RS7720513;Weight gain;Disease;PA166200021;Variant
RS62097526;Weight gain;Disease;PA166200041;Variant
RS1525085;Weight gain;Disease;PA166200061;Variant
CYP2C8*1;Weight gain;Disease;PA166242948;Haplotype
GNB3;Weight gain;Disease;PA176;Gene
HTR2A;Weight gain;Disease;PA193;Gene
HTR2C;Weight gain;Disease;PA194;Gene
MTHFR;Weight gain;Disease;PA245;Gene
ADRB3;Weight gain;Disease;PA24598;Gene
NPY;Weight gain;Disease;PA255;Gene
CNR1;Weight gain;Disease;PA26681;Gene
DGKB;Weight gain;Disease;PA27311;Gene
GLP1R;Weight gain;Disease;PA28725;Gene
HRH1;Weight gain;Disease;PA29456;Gene
MC4R;Weight gain;Disease;PA30676;Gene
SLC6A4;Weight gain;Disease;PA312;Gene
BDNF;Weight gain;Disease;PA31891;Gene
PLIN1;Weight gain;Disease;PA33409;Gene
RHEUMATOID ARTHRITIS;rs6427528;Variant;PA443434;Disease
PSORIASIS;rs6427528;Variant;PA445451;Disease
ETANERCEPT;rs6427528;Variant;PA449515;Chemical
CONGENITAL ABNORMALITIES;rs2234922;Variant;PA443223;Disease
NON-SMALL CELL LUNG CARCINOMA;rs2234922;Variant;PA443622;Disease
EPILEPSY;rs2234922;Variant;PA444065;Disease
DISORDER OF FACIAL SKELETON;rs2234922;Variant;PA446836;Disease
CARBAMAZEPINE;rs2234922;Variant;PA448785;Chemical
DOCETAXEL;rs2234922;Variant;PA449383;Chemical
PHENYTOIN;rs2234922;Variant;PA450947;Chemical
BIPOLAR DISORDER;rs7959663;Variant;PA447199;Disease
LITHIUM;rs7959663;Variant;PA450243;Chemical
RS1800559;enflurane;Chemical;PA166153638;Variant
RS772226819;enflurane;Chemical;PA166153940;Variant
RS1801086;enflurane;Chemical;PA166155375;Variant
RS28933396;enflurane;Chemical;PA166155481;Variant
RS28933397;enflurane;Chemical;PA166155482;Variant
RS63749869;enflurane;Chemical;PA166155516;Variant
RS111888148;enflurane;Chemical;PA166155524;Variant
RS112563513;enflurane;Chemical;PA166155526;Variant
RS118192116;enflurane;Chemical;PA166155528;Variant
RS118192122;enflurane;Chemical;PA166155529;Variant
RS118192124;enflurane;Chemical;PA166155531;Variant
RS118192161;enflurane;Chemical;PA166155532;Variant
RS118192162;enflurane;Chemical;PA166155533;Variant
RS118192163;enflurane;Chemical;PA166155534;Variant
RS118192167;enflurane;Chemical;PA166155535;Variant
RS118192170;enflurane;Chemical;PA166155536;Variant
RS118192172;enflurane;Chemical;PA166155537;Variant
RS118192175;enflurane;Chemical;PA166155538;Variant
RS118192176;enflurane;Chemical;PA166155539;Variant
RS118192177;enflurane;Chemical;PA166155540;Variant
RS118192178;enflurane;Chemical;PA166155541;Variant
RS121918592;enflurane;Chemical;PA166155543;Variant
RS121918593;enflurane;Chemical;PA166155544;Variant
RS121918594;enflurane;Chemical;PA166155545;Variant
RS121918595;enflurane;Chemical;PA166155546;Variant
RS193922747;enflurane;Chemical;PA166155564;Variant
RS193922753;enflurane;Chemical;PA166155565;Variant
RS193922770;enflurane;Chemical;PA166155567;Variant
RS193922772;enflurane;Chemical;PA166155568;Variant
RS193922802;enflurane;Chemical;PA166155569;Variant
RS193922803;enflurane;Chemical;PA166155570;Variant
RS193922807;enflurane;Chemical;PA166155571;Variant
RS193922809;enflurane;Chemical;PA166155572;Variant
RS193922816;enflurane;Chemical;PA166155573;Variant
RS193922818;enflurane;Chemical;PA166155574;Variant
RS193922876;enflurane;Chemical;PA166155575;Variant
RS193922878;enflurane;Chemical;PA166155576;Variant
RS193922843;enflurane;Chemical;PA166163663;Variant
RS193922832;enflurane;Chemical;PA166163667;Variant
RS118192168;enflurane;Chemical;PA166163669;Variant
RS193922764;enflurane;Chemical;PA166176176;Variant
RS121918596;enflurane;Chemical;PA166177994;Variant
RS193922748;enflurane;Chemical;PA166180322;Variant
RS193922762;enflurane;Chemical;PA166180323;Variant
RS193922768;enflurane;Chemical;PA166180324;Variant
RS144336148;enflurane;Chemical;PA166180325;Variant
RYR1;enflurane;Chemical;PA34896;Gene
CACNA1S;enflurane;Chemical;PA85;Gene
ABCB1;reserpine;Chemical;PA267;Gene
NR1I2;reserpine;Chemical;PA378;Gene
PACLITAXEL;rs66501115;Variant;PA450761;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;rs6295;Variant;PA164713257;Chemical
MILNACIPRAN;rs6295;Variant;PA164752812;Chemical
LURASIDONE;rs6295;Variant;PA166129557;Chemical
DEPRESSIVE DISORDER;rs6295;Variant;PA447207;Disease
PANIC DISORDER;rs6295;Variant;PA447212;Disease
SCHIZOPHRENIA;rs6295;Variant;PA447216;Disease
MAJOR DEPRESSIVE DISORDER;rs6295;Variant;PA447321;Disease
CLOZAPINE;rs6295;Variant;PA449061;Chemical
FLUOXETINE;rs6295;Variant;PA449673;Chemical
FLUVOXAMINE;rs6295;Variant;PA449690;Chemical
PAROXETINE;rs6295;Variant;PA450801;Chemical
SERTRALINE;rs6295;Variant;PA451333;Chemical
ANTIDEPRESSANTS;rs6295;Variant;PA452229;Chemical
HYPERLIPIDEMIAS;rs12003906;Variant;PA444528;Disease
ATORVASTATIN;rs12003906;Variant;PA448500;Chemical
PRAVASTATIN;rs12003906;Variant;PA451089;Chemical
SIMVASTATIN;rs12003906;Variant;PA451363;Chemical
ASTHMA;CA10;Gene;PA443450;Disease
FLUTICASONE PROPIONATE;CA10;Gene;PA449686;Chemical
MONTELUKAST;CA10;Gene;PA450546;Chemical
FEBUXOSTAT;UGT1A5;Gene;PA165958521;Chemical
EPILEPSY;UGT1A5;Gene;PA444065;Disease
GOUT;UGT1A5;Gene;PA444318;Disease
OSTEOSARCOMA;UGT1A5;Gene;PA445601;Disease
SCHIZOPHRENIA;UGT1A5;Gene;PA447216;Disease
ALLOPURINOL;UGT1A5;Gene;PA448320;Chemical
METHOTREXATE;UGT1A5;Gene;PA450428;Chemical
RISPERIDONE;UGT1A5;Gene;PA451257;Chemical
VALPROIC ACID;UGT1A5;Gene;PA451846;Chemical
RS72549402;odevixibat;Chemical;PA166313821;Variant
RS11568372;odevixibat;Chemical;PA166313822;Variant
ATP8B1;odevixibat;Chemical;PA265;Gene
JAG1;odevixibat;Chemical;PA29986;Gene
NOTCH2;odevixibat;Chemical;PA31684;Gene
ABCB11;odevixibat;Chemical;PA374;Gene
BIPOLAR DISORDER;rs7588746;Variant;PA447199;Disease
LITHIUM;rs7588746;Variant;PA450243;Chemical
NAT2;drug-induced lupus erythematosus due to hydralazine;Disease;PA18;Gene
LAPATINIB;HLA-B*48:01;Haplotype;PA152241907;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*48:01;Haplotype;PA166120927;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-B*48:01;Haplotype;PA166120929;Disease
BREAST NEOPLASMS;HLA-B*48:01;Haplotype;PA443560;Disease
DRUG HYPERSENSITIVITY;HLA-B*48:01;Haplotype;PA443936;Disease
EXANTHEMA;HLA-B*48:01;Haplotype;PA444109;Disease
HEMATOLOGIC NEOPLASMS;HLA-B*48:01;Haplotype;PA446827;Disease
ALLOPURINOL;HLA-B*48:01;Haplotype;PA448320;Chemical
CARBAMAZEPINE;HLA-B*48:01;Haplotype;PA448785;Chemical
OXALIPLATIN;UGT1A6*2a;Haplotype;PA131285527;Chemical
TEGAFUR / GIMERACIL / OTERACIL;UGT1A6*2a;Haplotype;PA166115442;Chemical
EPILEPSY;UGT1A6*2a;Haplotype;PA444065;Disease
VOMITING;UGT1A6*2a;Haplotype;PA446051;Disease
COLORECTAL NEOPLASMS;UGT1A6*2a;Haplotype;PA446108;Disease
BETA-THALASSEMIA;UGT1A6*2a;Haplotype;PA446432;Disease
ACETAMINOPHEN;UGT1A6*2a;Haplotype;PA448015;Chemical
IRINOTECAN;UGT1A6*2a;Haplotype;PA450085;Chemical
VALPROIC ACID;UGT1A6*2a;Haplotype;PA451846;Chemical
COMT;erenumab;Chemical;PA117;Gene
RS4680;erenumab;Chemical;PA166156024;Variant
RS12615320;erenumab;Chemical;PA166349381;Variant
ENDOXIFEN;CYP2D6 normal metabolizer and ultrarapid metabolizer;Variant;PA166124478;Chemical
BREAST NEOPLASMS;CYP2D6 normal metabolizer and ultrarapid metabolizer;Variant;PA443560;Disease
DABIGATRAN;rs2244613;Variant;PA165110351;Chemical
ATRIAL FIBRILLATION;rs2244613;Variant;PA443459;Disease
DRUG TOXICITY;rs2244613;Variant;PA443937;Disease
CAPECITABINE;rs2244613;Variant;PA448771;Chemical
MEASLES VACCINES;HLA-B*44:02;Haplotype;PA164712887;Chemical
INTERFERON ALFA-2A, RECOMBINANT;HLA-B*44:02;Haplotype;PA164779048;Chemical
TRICHLOROETHYLENE;HLA-B*44:02;Haplotype;PA166115521;Chemical
DRUG HYPERSENSITIVITY;HLA-B*44:02;Haplotype;PA443936;Disease
HEPATITIS C;HLA-B*44:02;Haplotype;PA444445;Disease
RIBAVIRIN;HLA-B*44:02;Haplotype;PA451241;Chemical
KLKB1;ecallantide;Chemical;PA30160;Gene
SLCO1B1;ezetimibe;Chemical;PA134865839;Gene
RS4149056;ezetimibe;Chemical;PA166154579;Variant
DPYD;rs200687447;Variant;PA145;Gene
CAPECITABINE;rs200687447;Variant;PA448771;Chemical
GLATIRAMER ACETATE;rs75041078;Variant;PA449760;Chemical
IMMUNOGLOBULINS;ITPKC;Gene;PA164712817;Chemical
MUCOCUTANEOUS LYMPH NODE SYNDROME;ITPKC;Gene;PA444977;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*56:01;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*56:01;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*56:01;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-B*56:01;Haplotype;PA450616;Chemical
SCHIZOPHRENIA;rs711355;Variant;PA447216;Disease
RISPERIDONE;rs711355;Variant;PA451257;Chemical
NR1I2;isradipine;Chemical;PA378;Gene
CYP3A4;everolimus;Chemical;PA130;Gene
CYP3A5;everolimus;Chemical;PA131;Gene
ESR1;everolimus;Chemical;PA156;Gene
RPTOR;everolimus;Chemical;PA165432629;Gene
CYP3A4*1;everolimus;Chemical;PA165819201;Haplotype
CYP3A4*22;everolimus;Chemical;PA166048680;Haplotype
CYP3A5*1;everolimus;Chemical;PA166128213;Haplotype
CYP3A5*3;everolimus;Chemical;PA166128219;Haplotype
RS351855;everolimus;Chemical;PA166156731;Variant
RS1045642;everolimus;Chemical;PA166157284;Variant
RS2032582;everolimus;Chemical;PA166157316;Variant
RS10515074;everolimus;Chemical;PA166165378;Variant
RS9906827;everolimus;Chemical;PA166165381;Variant
RS2024627;everolimus;Chemical;PA166238104;Variant
ABCB1;everolimus;Chemical;PA267;Gene
ERBB2;everolimus;Chemical;PA27844;Gene
ESR2;everolimus;Chemical;PA27886;Gene
FGFR4;everolimus;Chemical;PA28130;Gene
MTOR;everolimus;Chemical;PA28360;Gene
PIK3R1;everolimus;Chemical;PA33312;Gene
RISPERIDONE;GRID2;Gene;PA451257;Chemical
CYP2D6;Gaucher Disease;Disease;PA128;Gene
RS12746200;propionic acid derivatives;Chemical;PA166153862;Variant
RS1805034;propionic acid derivatives;Chemical;PA166155281;Variant
RS2228246;propionic acid derivatives;Chemical;PA166155921;Variant
PLA2G4A;propionic acid derivatives;Chemical;PA271;Gene
PLCG1;propionic acid derivatives;Chemical;PA33392;Gene
TNFRSF11A;propionic acid derivatives;Chemical;PA36601;Gene
LATANOPROST;PTGFR;Gene;PA164774763;Chemical
OPEN-ANGLE GLAUCOMA;PTGFR;Gene;PA444282;Disease
PROSTATIC NEOPLASMS;SULT1C4;Gene;PA445425;Disease
DOCETAXEL;SULT1C4;Gene;PA449383;Chemical
THALIDOMIDE;SULT1C4;Gene;PA451644;Chemical
FLUOROURACIL;rs895819;Variant;PA128406956;Chemical
NEOPLASMS;rs895819;Variant;PA445062;Disease
CAPECITABINE;rs895819;Variant;PA448771;Chemical
SULT2A1;NR1H3;Gene;PA346;Gene
CORONARY ARTERY DISEASE;NR1H3;Gene;PA443796;Disease
HYPERTENSION;NR1H3;Gene;PA444552;Disease
ATENOLOL;NR1H3;Gene;PA448499;Chemical
VERAPAMIL;NR1H3;Gene;PA451868;Chemical
OVARIAN NEOPLASMS;LIG3;Gene;PA445204;Disease
CISPLATIN;LIG3;Gene;PA449014;Chemical
CYCLOPHOSPHAMIDE;LIG3;Gene;PA449165;Chemical
MIGALASTAT;rs398123212;Variant;PA166182881;Chemical
FABRY DISEASE;rs398123212;Variant;PA443367;Disease
THROMBOCYTOPENIA;rs28362731;Variant;PA445846;Disease
CISPLATIN;rs28362731;Variant;PA449014;Chemical
ALCOHOL ABUSE;rs9937709;Variant;PA443309;Disease
ETHANOL;rs9937709;Variant;PA448073;Chemical
FLUOROURACIL;EXO1;Gene;PA128406956;Chemical
METASTATIC NEOPLASM;EXO1;Gene;PA445058;Disease
CAPECITABINE;EXO1;Gene;PA448771;Chemical
RS9943291;chlorothiazide;Chemical;PA166177889;Variant
RS61824877;chlorothiazide;Chemical;PA166177898;Variant
HMGCS2;chlorothiazide;Chemical;PA29338;Gene
CETUXIMAB;EGF;Gene;PA10040;Chemical
PANITUMUMAB;EGF;Gene;PA162373091;Chemical
PROSTATIC NEOPLASMS;EGF;Gene;PA445425;Disease
RECTAL NEOPLASMS;EGF;Gene;PA445503;Disease
COLORECTAL NEOPLASMS;EGF;Gene;PA446108;Disease
DPYD;rs141462178;Variant;PA145;Gene
CAPECITABINE;rs141462178;Variant;PA448771;Chemical
DHFR;Multivitamins, Plain;Chemical;PA143;Gene
RS70991108;Multivitamins, Plain;Chemical;PA166156893;Variant
FLUOROURACIL;rs142244113;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs142244113;Variant;PA443560;Disease
NEUTROPENIA;rs142244113;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs142244113;Variant;PA449165;Chemical
EPIRUBICIN;rs142244113;Variant;PA449476;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs12191877;Variant;PA164713366;Chemical
PSORIASIS;rs12191877;Variant;PA445451;Disease
OLEZARSEN;LPL;Gene;PA166400181;Chemical
HYPERTRIGLYCERIDEMIA;LPL;Gene;PA446120;Disease
FENOFIBRATE;LPL;Gene;PA449594;Chemical
PRAVASTATIN;LPL;Gene;PA451089;Chemical
CYP2A6;tegafur;Chemical;PA121;Gene
DPYD;tegafur;Chemical;PA145;Gene
CYP2A6*1;tegafur;Chemical;PA165924690;Haplotype
CYP2A6*46;tegafur;Chemical;PA165924691;Haplotype
CYP2A6*4;tegafur;Chemical;PA165924721;Haplotype
CYP2A6*7;tegafur;Chemical;PA165924731;Haplotype
CYP2A6*10;tegafur;Chemical;PA165924735;Haplotype
CYP2A6*11;tegafur;Chemical;PA165924736;Haplotype
CYP2A6*19;tegafur;Chemical;PA165924748;Haplotype
CYP2A6*9;tegafur;Chemical;PA165980914;Haplotype
CYP2A6*18;tegafur;Chemical;PA165980916;Haplotype
RS1801266;tegafur;Chemical;PA166153649;Variant
RS1801268;tegafur;Chemical;PA166153651;Variant
RS3918290;tegafur;Chemical;PA166153760;Variant
RS55886062;tegafur;Chemical;PA166153888;Variant
RS56038477;tegafur;Chemical;PA166153889;Variant
RS67376798;tegafur;Chemical;PA166153895;Variant
RS72549303;tegafur;Chemical;PA166153897;Variant
RS72549309;tegafur;Chemical;PA166153902;Variant
RS78060119;tegafur;Chemical;PA166153913;Variant
RS115232898;tegafur;Chemical;PA166153919;Variant
RS45445694;tegafur;Chemical;PA166155331;Variant
RS183205964;tegafur;Chemical;PA166155336;Variant
RS8192720;tegafur;Chemical;PA166155445;Variant
RS8192725;tegafur;Chemical;PA166155446;Variant
RS28399433;tegafur;Chemical;PA166155471;Variant
RS1801019;tegafur;Chemical;PA166156330;Variant
RS712830;tegafur;Chemical;PA166157263;Variant
DPYD C.1905+1G>A (*2A);tegafur;Chemical;PA166171117;Haplotype
DPYD C.1679T>G (*13);tegafur;Chemical;PA166171118;Haplotype
DPYD C.2846A>T;tegafur;Chemical;PA166171119;Haplotype
DPYD C.1129-5923C>G, C.1236G>A (HAPB3);tegafur;Chemical;PA166171120;Haplotype
DPYD C.2194G>A (*6);tegafur;Chemical;PA166194413;Haplotype
TYMS;tegafur;Chemical;PA359;Gene
UMPS;tegafur;Chemical;PA363;Gene
EGFR;tegafur;Chemical;PA7360;Gene
DROTRECOGIN ALFA;rs7725278;Variant;PA131548935;Chemical
SEPSIS;rs7725278;Variant;PA446771;Disease
DIABETES MELLITUS, TYPE 2;rs290487;Variant;PA443890;Disease
LIVER TRANSPLANTATION;rs290487;Variant;PA447247;Disease
REPAGLINIDE;rs290487;Variant;PA451234;Chemical
TACROLIMUS;rs290487;Variant;PA451578;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;rs11545076;Variant;PA446155;Disease
METHOTREXATE;rs11545076;Variant;PA450428;Chemical
MUSCULAR DISEASES;SERPINE1;Gene;PA444997;Disease
OSTEONECROSIS;SERPINE1;Gene;PA445187;Disease
PEMPHIGUS;SERPINE1;Gene;PA445273;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;SERPINE1;Gene;PA446155;Disease
MAJOR DEPRESSIVE DISORDER;SERPINE1;Gene;PA447321;Disease
CITALOPRAM;SERPINE1;Gene;PA449015;Chemical
DEXAMETHASONE;SERPINE1;Gene;PA449247;Chemical
FLUOXETINE;SERPINE1;Gene;PA449673;Chemical
METHYLPREDNISOLONE;SERPINE1;Gene;PA450466;Chemical
ANTIDEPRESSANTS;SERPINE1;Gene;PA452229;Chemical
SLC31A1;Anemia;Disease;PA118;Gene
UGT1A1*1;Anemia;Disease;PA166115841;Haplotype
UGT1A1*28;Anemia;Disease;PA166115842;Haplotype
RS2501873;Anemia;Disease;PA166153711;Variant
RS2502815;Anemia;Disease;PA166153712;Variant
RS2236225;Anemia;Disease;PA166154789;Variant
RS4673;Anemia;Disease;PA166154969;Variant
RS45445694;Anemia;Disease;PA166155331;Variant
RS1799793;Anemia;Disease;PA166155371;Variant
RS1127354;Anemia;Disease;PA166155915;Variant
RS2273618;Anemia;Disease;PA166155926;Variant
RS3746574;Anemia;Disease;PA166155938;Variant
RS6130615;Anemia;Disease;PA166155962;Variant
RS7270101;Anemia;Disease;PA166155964;Variant
RS3732359;Anemia;Disease;PA166156374;Variant
RS3732360;Anemia;Disease;PA166156375;Variant
RS3814058;Anemia;Disease;PA166156385;Variant
RS3957357;Anemia;Disease;PA166157094;Variant
RS2234753;Anemia;Disease;PA166157746;Variant
RS6413517;Anemia;Disease;PA166157784;Variant
RS11185647;Anemia;Disease;PA166157831;Variant
RS10538494;Anemia;Disease;PA166159126;Variant
RS9725457;Anemia;Disease;PA166159127;Variant
RS1799735;Anemia;Disease;PA166159214;Variant
RS2027701;Anemia;Disease;PA166169891;Variant
RS1059698;Anemia;Disease;PA166169893;Variant
RS73594404;Anemia;Disease;PA166169897;Variant
RS10132552;Anemia;Disease;PA166169901;Variant
RS10817464;Anemia;Disease;PA166179458;Variant
RS1049305;Anemia;Disease;PA166186213;Variant
RS36120609;Anemia;Disease;PA166211543;Variant
AQP1;Anemia;Disease;PA24918;Gene
CYBA;Anemia;Disease;PA27075;Gene
ERCC2;Anemia;Disease;PA27848;Gene
G6PD;Anemia;Disease;PA28469;Gene
GSTA1;Anemia;Disease;PA29016;Gene
GSTM3;Anemia;Disease;PA29024;Gene
HNF4A;Anemia;Disease;PA29349;Gene
ITPA;Anemia;Disease;PA29973;Gene
MEG3;Anemia;Disease;PA30737;Gene
MTHFD1;Anemia;Disease;PA31236;Gene
RXRA;Anemia;Disease;PA34890;Gene
TYMS;Anemia;Disease;PA359;Gene
NR1I2;Anemia;Disease;PA378;Gene
NR1I3;Anemia;Disease;PA391;Gene
UGT1A1;Anemia;Disease;PA420;Gene
CYP2D6;Respiratory Insufficiency;Disease;PA128;Gene
CYP2D6*1;Respiratory Insufficiency;Disease;PA165816576;Haplotype
HLA-B*07:02;Respiratory Insufficiency;Disease;PA165954366;Haplotype
HLA-C*07:02;Respiratory Insufficiency;Disease;PA165957396;Haplotype
CYP2D6*1XN;Respiratory Insufficiency;Disease;PA165988479;Haplotype
RS324420;Respiratory Insufficiency;Disease;PA166153569;Variant
RS1799971;Respiratory Insufficiency;Disease;PA166156991;Variant
FAAH;Respiratory Insufficiency;Disease;PA27955;Gene
OPRM1;Respiratory Insufficiency;Disease;PA31945;Gene
HLA-B;Respiratory Insufficiency;Disease;PA35056;Gene
HLA-C;Respiratory Insufficiency;Disease;PA35057;Gene
CYP2C19;methylphenobarbital;Chemical;PA124;Gene
CYP2C19*16;methylphenobarbital;Chemical;PA165816532;Haplotype
CYP2C19*1;methylphenobarbital;Chemical;PA165980634;Haplotype
CYP2C19*2;methylphenobarbital;Chemical;PA165980635;Haplotype
PEMETREXED;TYMS;Gene;PA10810;Chemical
FLUOROURACIL;TYMS;Gene;PA128406956;Chemical
BEVACIZUMAB;TYMS;Gene;PA130232992;Chemical
OXALIPLATIN;TYMS;Gene;PA131285527;Chemical
RALTITREXED;TYMS;Gene;PA131625240;Chemical
PLATINUM;TYMS;Gene;PA150595617;Chemical
HYDROXYCHLOROQUINE;TYMS;Gene;PA164777036;Chemical
TOXIC LIVER DISEASE;TYMS;Gene;PA164925725;Disease
MYELOSUPPRESSION;TYMS;Gene;PA165817398;Disease
HAND-FOOT SYNDROME;TYMS;Gene;PA166114377;Disease
MUCOSITIS;TYMS;Gene;PA166122058;Disease
HEMATOPOIETIC STEM CELL TRANSPLANTATION;TYMS;Gene;PA166123007;Disease
PROGRESSION-FREE SURVIVAL;TYMS;Gene;PA166123026;Disease
OVERALL SURVIVAL;TYMS;Gene;PA166123207;Disease
DISCONTINUATION;TYMS;Gene;PA166123507;Disease
GASTROINTESTINAL TOXICITY;TYMS;Gene;PA166124386;Disease
ADVERSE EVENTS;TYMS;Gene;PA166151827;Disease
GASTROESOPHAGEAL CANCER;TYMS;Gene;PA166153403;Disease
RS45445694;TYMS;Gene;PA166155331;Variant
FOLFOX;TYMS;Gene;PA166182862;Chemical
FOLFIRI;TYMS;Gene;PA166182863;Chemical
XELOX;TYMS;Gene;PA166182864;Chemical
ADENOCARCINOMA;TYMS;Gene;PA443265;Disease
ANEMIA;TYMS;Gene;PA443340;Disease
ARTHRITIS, RHEUMATOID;TYMS;Gene;PA443434;Disease
ASTHENIA;TYMS;Gene;PA443448;Disease
BREAST NEOPLASMS;TYMS;Gene;PA443560;Disease
DIARRHEA;TYMS;Gene;PA443899;Disease
DRUG TOXICITY;TYMS;Gene;PA443937;Disease
ESOPHAGEAL NEOPLASMS;TYMS;Gene;PA444101;Disease
GASTROINTESTINAL NEOPLASMS;TYMS;Gene;PA444257;Disease
LYMPHOMA, NON-HODGKIN;TYMS;Gene;PA444845;Disease
MESOTHELIOMA;TYMS;Gene;PA444937;Disease
MYELODYSPLASTIC SYNDROMES;TYMS;Gene;PA445013;Disease
CARDIOMYOPATHIES;TYMS;Gene;PA445018;Disease
NAUSEA;TYMS;Gene;PA445048;Disease
NEOPLASMS;TYMS;Gene;PA445062;Disease
NEUTROPENIA;TYMS;Gene;PA445113;Disease
PANCREATIC NEOPLASMS;TYMS;Gene;PA445218;Disease
PSORIASIS;TYMS;Gene;PA445451;Disease
RECTAL NEOPLASMS;TYMS;Gene;PA445503;Disease
STOMACH NEOPLASMS;TYMS;Gene;PA445742;Disease
STOMATITIS;TYMS;Gene;PA445746;Disease
THROMBOCYTOPENIA;TYMS;Gene;PA445846;Disease
VOMITING;TYMS;Gene;PA446051;Disease
COLORECTAL NEOPLASMS;TYMS;Gene;PA446108;Disease
INFLAMMATORY BOWEL DISEASES;TYMS;Gene;PA446116;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;TYMS;Gene;PA446155;Disease
NEUROTOXICITY SYNDROMES;TYMS;Gene;PA446975;Disease
HYPERAMMONEMIA;TYMS;Gene;PA447146;Disease
ASPARAGINASE;TYMS;Gene;PA448492;Chemical
AZATHIOPRINE;TYMS;Gene;PA448515;Chemical
CAPECITABINE;TYMS;Gene;PA448771;Chemical
CARBOPLATIN;TYMS;Gene;PA448803;Chemical
CISPLATIN;TYMS;Gene;PA449014;Chemical
CYTARABINE;TYMS;Gene;PA449177;Chemical
DAUNORUBICIN;TYMS;Gene;PA449212;Chemical
DOCETAXEL;TYMS;Gene;PA449383;Chemical
EPIRUBICIN;TYMS;Gene;PA449476;Chemical
ETOPOSIDE;TYMS;Gene;PA449552;Chemical
FOLIC ACID;TYMS;Gene;PA449692;Chemical
GEMCITABINE;TYMS;Gene;PA449748;Chemical
IRINOTECAN;TYMS;Gene;PA450085;Chemical
LEUCOVORIN;TYMS;Gene;PA450198;Chemical
MERCAPTOPURINE;TYMS;Gene;PA450379;Chemical
METHOTREXATE;TYMS;Gene;PA450428;Chemical
PACLITAXEL;TYMS;Gene;PA450761;Chemical
PREDNISONE;TYMS;Gene;PA451100;Chemical
SULFASALAZINE;TYMS;Gene;PA451547;Chemical
TRASTUZUMAB;TYMS;Gene;PA451743;Chemical
VINCRISTINE;TYMS;Gene;PA451879;Chemical
AZACITIDINE;TYMS;Gene;PA451996;Chemical
TEGAFUR;TYMS;Gene;PA452620;Chemical
ANTINEOPLASTIC AGENTS;TYMS;Gene;PA452621;Chemical
TOBACCO USE DISORDER;rs2869950;Variant;PA445876;Disease
NICOTINE;rs2869950;Variant;PA450626;Chemical
G6PD;mepivacaine;Chemical;PA28469;Gene
ASTHMA;IL4;Gene;PA443450;Disease
ASPIRIN;IL4;Gene;PA448497;Chemical
LAMOTRIGINE;UGT1A4*3a;Haplotype;PA450164;Chemical
OLANZAPINE;UGT1A4*3a;Haplotype;PA450688;Chemical
TESTOSTERONE;UGT1A4*3a;Haplotype;PA451627;Chemical
RS2501873;Nasopharyngeal Neoplasms;Disease;PA166153711;Variant
RS2502815;Nasopharyngeal Neoplasms;Disease;PA166153712;Variant
RS75114882;Nasopharyngeal Neoplasms;Disease;PA166153907;Variant
RS3834935;Nasopharyngeal Neoplasms;Disease;PA166154568;Variant
RS2273618;Nasopharyngeal Neoplasms;Disease;PA166155926;Variant
RS3746574;Nasopharyngeal Neoplasms;Disease;PA166155938;Variant
RS6130615;Nasopharyngeal Neoplasms;Disease;PA166155962;Variant
RS3732359;Nasopharyngeal Neoplasms;Disease;PA166156374;Variant
RS3732360;Nasopharyngeal Neoplasms;Disease;PA166156375;Variant
RS3814058;Nasopharyngeal Neoplasms;Disease;PA166156385;Variant
RS1536475;Nasopharyngeal Neoplasms;Disease;PA166157728;Variant
RS2234753;Nasopharyngeal Neoplasms;Disease;PA166157746;Variant
RS6413517;Nasopharyngeal Neoplasms;Disease;PA166157784;Variant
RS11185647;Nasopharyngeal Neoplasms;Disease;PA166157831;Variant
RS62576288;Nasopharyngeal Neoplasms;Disease;PA166157845;Variant
RS11185648;Nasopharyngeal Neoplasms;Disease;PA166159089;Variant
RS10538494;Nasopharyngeal Neoplasms;Disease;PA166159126;Variant
RS9725457;Nasopharyngeal Neoplasms;Disease;PA166159127;Variant
RS1059698;Nasopharyngeal Neoplasms;Disease;PA166169893;Variant
RS1829346;Nasopharyngeal Neoplasms;Disease;PA166169895;Variant
RS36080650;Nasopharyngeal Neoplasms;Disease;PA166169899;Variant
HNF4A;Nasopharyngeal Neoplasms;Disease;PA29349;Gene
RXRA;Nasopharyngeal Neoplasms;Disease;PA34890;Gene
SLCO1B3;Nasopharyngeal Neoplasms;Disease;PA35844;Gene
NR1I2;Nasopharyngeal Neoplasms;Disease;PA378;Gene
NR1I3;Nasopharyngeal Neoplasms;Disease;PA391;Gene
ANTHRACYCLINES AND RELATED SUBSTANCES;FMO3;Gene;PA130620651;Chemical
ROSUVASTATIN;FMO3;Gene;PA134308647;Chemical
ITOPRIDE;FMO3;Gene;PA152432599;Chemical
OLANZAPINE 10-N-GLUCURONIDE;FMO3;Gene;PA166164918;Chemical
NEOPLASMS;FMO3;Gene;PA445062;Disease
TOBACCO USE DISORDER;FMO3;Gene;PA445876;Disease
DAUNORUBICIN;FMO3;Gene;PA449212;Chemical
NICOTINE;FMO3;Gene;PA450626;Chemical
OLANZAPINE;FMO3;Gene;PA450688;Chemical
SULINDAC;FMO3;Gene;PA451565;Chemical
TAMOXIFEN;FMO3;Gene;PA451581;Chemical
MAJOR DEPRESSIVE DISORDER;rs5441;Variant;PA447321;Disease
SERTRALINE;rs5441;Variant;PA451333;Chemical
DRUG HYPERSENSITIVITY;rs201929247;Variant;PA443936;Disease
DAPSONE;rs201929247;Variant;PA449211;Chemical
SCHIZOPHRENIA;rs10170310;Variant;PA447216;Disease
OLANZAPINE;rs10170310;Variant;PA450688;Chemical
RHEUMATOID ARTHRITIS;rs4846051;Variant;PA443434;Disease
DRUG TOXICITY;rs4846051;Variant;PA443937;Disease
METHOTREXATE;rs4846051;Variant;PA450428;Chemical
HYPERTENSION;rs10995311;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs10995311;Variant;PA449899;Chemical
ANTIHYPERTENSIVES;CLNK;Gene;PA164712445;Chemical
HYPERTENSION;CLNK;Gene;PA444552;Disease
PEGASPARGASE;rs79085477;Variant;PA164760860;Chemical
OSTEONECROSIS;rs79085477;Variant;PA445187;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs79085477;Variant;PA446155;Disease
CYCLOPHOSPHAMIDE;rs79085477;Variant;PA449165;Chemical
CYTARABINE;rs79085477;Variant;PA449177;Chemical
DAUNORUBICIN;rs79085477;Variant;PA449212;Chemical
DEXAMETHASONE;rs79085477;Variant;PA449247;Chemical
DOXORUBICIN;rs79085477;Variant;PA449412;Chemical
METHOTREXATE;rs79085477;Variant;PA450428;Chemical
PREDNISONE;rs79085477;Variant;PA451100;Chemical
THIOGUANINE;rs79085477;Variant;PA451663;Chemical
VINCRISTINE;rs79085477;Variant;PA451879;Chemical
ADVERSE EVENTS;rs113100019;Variant;PA166151827;Disease
MEPERIDINE;rs113100019;Variant;PA450369;Chemical
ESSENTIAL HYPERTENSION;rs12505746;Variant;PA447288;Disease
HYDROCHLOROTHIAZIDE;rs12505746;Variant;PA449899;Chemical
COLORECTAL NEOPLASMS;rs7518660;Variant;PA446108;Disease
CELECOXIB;rs7518660;Variant;PA448871;Chemical
FMO3;olanzapine 10-n-glucuronide;Chemical;PA166;Gene
ACUTE CORONARY SYNDROME;rs4736529;Variant;PA165108401;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);rs4736529;Variant;PA166129560;Disease
ASPIRIN;rs4736529;Variant;PA448497;Chemical
CLOPIDOGREL;rs4736529;Variant;PA449053;Chemical
MAJOR DEPRESSIVE DISORDER;rs13432159;Variant;PA447321;Disease
SERTRALINE;rs13432159;Variant;PA451333;Chemical
ANTITHYROID PREPARATIONS;rs199564443;Variant;PA164712499;Chemical
AGRANULOCYTOSIS;rs199564443;Variant;PA443297;Disease
ADALIMUMAB;TF;Gene;PA10004;Chemical
CROHN DISEASE;TF;Gene;PA443815;Disease
ESSENTIAL HYPERTENSION;rs11993031;Variant;PA447288;Disease
HYDROCHLOROTHIAZIDE;rs11993031;Variant;PA449899;Chemical
BREAST NEOPLASMS;RICTOR;Gene;PA443560;Disease
DESMOPRESSIN;F8;Gene;PA449237;Chemical
RHEUMATOID ARTHRITIS;PTPRM;Gene;PA443434;Disease
METHOTREXATE;PTPRM;Gene;PA450428;Chemical
CYP2D6;umeclidinium;Chemical;PA128;Gene
KIDNEY TRANSPLANTATION;rs4253728;Variant;PA165817016;Disease
PHENPROCOUMON;rs4253728;Variant;PA450921;Chemical
SIMVASTATIN;rs4253728;Variant;PA451363;Chemical
TACROLIMUS;rs4253728;Variant;PA451578;Chemical
MAJOR DEPRESSIVE DISORDER;rs363225;Variant;PA447321;Disease
BUPROPION;rs363225;Variant;PA448687;Chemical
ATAZANAVIR;rs8330;Variant;PA10251;Chemical
NEPHROLITHIASIS;rs8330;Variant;PA162355520;Disease
LIVER FAILURE, ACUTE;rs8330;Variant;PA446443;Disease
HIV INFECTIOUS DISEASE;rs8330;Variant;PA447230;Disease
ACETAMINOPHEN;rs8330;Variant;PA448015;Chemical
RITONAVIR;rs8330;Variant;PA451260;Chemical
AZATHIOPRINE;TPMT low activity;Variant;PA448515;Chemical
MERCAPTOPURINE;TPMT low activity;Variant;PA450379;Chemical
HMG COA REDUCTASE INHIBITORS;rs17238540;Variant;PA133950441;Chemical
ATORVASTATIN;rs17238540;Variant;PA448500;Chemical
FLUVASTATIN;rs17238540;Variant;PA449688;Chemical
LOVASTATIN;rs17238540;Variant;PA450272;Chemical
PRAVASTATIN;rs17238540;Variant;PA451089;Chemical
SIMVASTATIN;rs17238540;Variant;PA451363;Chemical
ASTHMA;ORMDL3;Gene;PA443450;Disease
NICOTINE;rs778019189;Variant;PA450626;Chemical
BUPROPION;rs148009906;Variant;PA448687;Chemical
EFAVIRENZ;rs148009906;Variant;PA449441;Chemical
COMT;alfentanil;Chemical;PA117;Gene
CYP3A5*3;alfentanil;Chemical;PA166128219;Haplotype
RS1799971;alfentanil;Chemical;PA166156991;Variant
OPRM1;alfentanil;Chemical;PA31945;Gene
DPYD;rs1801267;Variant;PA145;Gene
CAPECITABINE;rs1801267;Variant;PA448771;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;rs4958381;Variant;PA446155;Disease
ASPARAGINASE;rs4958381;Variant;PA448492;Chemical
DRUGS USED IN NICOTINE DEPENDENCE;rs4803381;Variant;PA164712720;Chemical
TOBACCO USE DISORDER;rs4803381;Variant;PA445876;Disease
BUPROPION;rs4803381;Variant;PA448687;Chemical
NICOTINE;rs4803381;Variant;PA450626;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;rs1799929;Variant;PA164712708;Chemical
DRUG INTERACTION WITH DRUG;rs1799929;Variant;PA165108622;Disease
DRUG TOXICITY;rs1799929;Variant;PA443937;Disease
TUBERCULOSIS;rs1799929;Variant;PA445941;Disease
ISONIAZID;rs1799929;Variant;PA450112;Chemical
PHENYTOIN;rs1799929;Variant;PA450947;Chemical
PPP3CA;NFATC1;Gene;PA33678;Gene
PPP3CB;NFATC1;Gene;PA33679;Gene
PPP3CC;NFATC1;Gene;PA33680;Gene
PPP3R1;NFATC1;Gene;PA33681;Gene
PPP3R2;NFATC1;Gene;PA33682;Gene
CYP2D6;levomepromazine;Chemical;PA128;Gene
CYP2D6*1;levomepromazine;Chemical;PA165816576;Haplotype
PEGASPARGASE;IGHMBP2;Gene;PA164760860;Chemical
ELEVATED LIVER ENZYMES;IGHMBP2;Gene;PA166279881;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;IGHMBP2;Gene;PA446155;Disease
CYCLOPHOSPHAMIDE;IGHMBP2;Gene;PA449165;Chemical
CYTARABINE;IGHMBP2;Gene;PA449177;Chemical
DAUNORUBICIN;IGHMBP2;Gene;PA449212;Chemical
DOXORUBICIN;IGHMBP2;Gene;PA449412;Chemical
MERCAPTOPURINE;IGHMBP2;Gene;PA450379;Chemical
METHOTREXATE;IGHMBP2;Gene;PA450428;Chemical
THIOGUANINE;IGHMBP2;Gene;PA451663;Chemical
VINCRISTINE;IGHMBP2;Gene;PA451879;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs2430561;Variant;PA164713366;Chemical
CROHN DISEASE;rs2430561;Variant;PA443815;Disease
INFLAMMATORY BOWEL DISEASES;rs2430561;Variant;PA446116;Disease
MAJOR DEPRESSIVE DISORDER;CACNA1A;Gene;PA447321;Disease
CELECOXIB;CACNA1A;Gene;PA448871;Chemical
ANTIDEPRESSANTS;CACNA1A;Gene;PA452229;Chemical
CYP3A4;desloratadine;Chemical;PA130;Gene
RS2298805;desloratadine;Chemical;PA166153699;Variant
RS901865;desloratadine;Chemical;PA166156299;Variant
FCER1A;desloratadine;Chemical;PA28056;Gene
HRH1;desloratadine;Chemical;PA29456;Gene
OSTEOSARCOMA;rs3087403;Variant;PA445601;Disease
CISPLATIN;rs3087403;Variant;PA449014;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs2284449;Variant;PA443622;Disease
CISPLATIN;rs2284449;Variant;PA449014;Chemical
GEMCITABINE;rs2284449;Variant;PA449748;Chemical
ABCB1;aldosterone;Chemical;PA267;Gene
IMMUNOGLOBULINS;rs28493229;Variant;PA164712817;Chemical
MUCOCUTANEOUS LYMPH NODE SYNDROME;rs28493229;Variant;PA444977;Disease
MACULAR DEGENERATION;rs833069;Variant;PA134850558;Disease
RANIBIZUMAB;rs833069;Variant;PA164746012;Chemical
NEUTROPENIA;rs12148896;Variant;PA445113;Disease
PANCREATIC NEOPLASMS;rs12148896;Variant;PA445218;Disease
GEMCITABINE;rs12148896;Variant;PA449748;Chemical
FMO3;itopride;Chemical;PA166;Gene
RS2266780;itopride;Chemical;PA166153687;Variant
RS2266782;itopride;Chemical;PA166153688;Variant
CYP3A4;Hepatitis C, Chronic;Disease;PA130;Gene
IFNL3;Hepatitis C, Chronic;Disease;PA134952671;Gene
CYP2R1;Hepatitis C, Chronic;Disease;PA134986407;Gene
FTO;Hepatitis C, Chronic;Disease;PA152208656;Gene
SLC29A1;Hepatitis C, Chronic;Disease;PA154;Gene
IFNL4;Hepatitis C, Chronic;Disease;PA166049147;Gene
SLC6A4 HTTLPR LONG FORM (L ALLELE);Hepatitis C, Chronic;Disease;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);Hepatitis C, Chronic;Disease;PA166116466;Haplotype
RS187238;Hepatitis C, Chronic;Disease;PA166154270;Variant
RS1946518;Hepatitis C, Chronic;Disease;PA166154344;Variant
RS2228570;Hepatitis C, Chronic;Disease;PA166154531;Variant
RS10877012;Hepatitis C, Chronic;Disease;PA166154623;Variant
RS9939609;Hepatitis C, Chronic;Disease;PA166155098;Variant
RS14158;Hepatitis C, Chronic;Disease;PA166155344;Variant
RS4803219;Hepatitis C, Chronic;Disease;PA166155417;Variant
RS7248668;Hepatitis C, Chronic;Disease;PA166155429;Variant
RS8099917;Hepatitis C, Chronic;Disease;PA166155435;Variant
RS8105790;Hepatitis C, Chronic;Disease;PA166155438;Variant
RS10853728;Hepatitis C, Chronic;Disease;PA166155456;Variant
RS12979860;Hepatitis C, Chronic;Disease;PA166155468;Variant
RS12980275;Hepatitis C, Chronic;Disease;PA166155469;Variant
RS28416813;Hepatitis C, Chronic;Disease;PA166155479;Variant
RS1127354;Hepatitis C, Chronic;Disease;PA166155915;Variant
RS7270101;Hepatitis C, Chronic;Disease;PA166155964;Variant
RS56061981;Hepatitis C, Chronic;Disease;PA166156687;Variant
RS760370;Hepatitis C, Chronic;Disease;PA166156947;Variant
RS3828913;Hepatitis C, Chronic;Disease;PA166157089;Variant
RS1800795;Hepatitis C, Chronic;Disease;PA166157304;Variant
RS9657182;Hepatitis C, Chronic;Disease;PA166157627;Variant
RS10846744;Hepatitis C, Chronic;Disease;PA166160587;Variant
RS117648444;Hepatitis C, Chronic;Disease;PA166160628;Variant
RS4273729;Hepatitis C, Chronic;Disease;PA166160738;Variant
RS10741657;Hepatitis C, Chronic;Disease;PA166163255;Variant
RS11506105;Hepatitis C, Chronic;Disease;PA166165309;Variant
RS11322783;Hepatitis C, Chronic;Disease;PA166190881;Variant
IL6;Hepatitis C, Chronic;Disease;PA198;Gene
LDLR;Hepatitis C, Chronic;Disease;PA227;Gene
CYP27B1;Hepatitis C, Chronic;Disease;PA27099;Gene
IL18;Hepatitis C, Chronic;Disease;PA29802;Gene
IDO1;Hepatitis C, Chronic;Disease;PA29869;Gene
ITPA;Hepatitis C, Chronic;Disease;PA29973;Gene
MICB;Hepatitis C, Chronic;Disease;PA30812;Gene
SLC6A4;Hepatitis C, Chronic;Disease;PA312;Gene
CXCL10;Hepatitis C, Chronic;Disease;PA35568;Gene
VDR;Hepatitis C, Chronic;Disease;PA37301;Gene
EGFR;Hepatitis C, Chronic;Disease;PA7360;Gene
SCARB1;Hepatitis C, Chronic;Disease;PA97;Gene
PLCB1;GNG2;Gene;PA33384;Gene
PLCB2;GNG2;Gene;PA33385;Gene
PLCB3;GNG2;Gene;PA33386;Gene
PLCB4;GNG2;Gene;PA33387;Gene
BIPOLAR DISORDER;GNG2;Gene;PA447199;Disease
F2;F2R;Gene;PA157;Gene
GNAQ;F2R;Gene;PA174;Gene
GNB3;F2R;Gene;PA176;Gene
GNA11;F2R;Gene;PA28764;Gene
GNA12;F2R;Gene;PA28765;Gene
GNA13;F2R;Gene;PA28766;Gene
GNA15;F2R;Gene;PA28768;Gene
MACULOPAPULAR EXANTHEMA;HLA-B*13:02;Haplotype;PA162316739;Disease
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*13:02;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*13:02;Haplotype;PA444059;Disease
EPILEPSY;HLA-B*13:02;Haplotype;PA444065;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*13:02;Haplotype;PA445738;Disease
LAMOTRIGINE;HLA-B*13:02;Haplotype;PA450164;Chemical
NEVIRAPINE;HLA-B*13:02;Haplotype;PA450616;Chemical
OXCARBAZEPINE;HLA-B*13:02;Haplotype;PA450732;Chemical
RHEUMATOID ARTHRITIS;rs1800471;Variant;PA443434;Disease
RITUXIMAB;rs1800471;Variant;PA451261;Chemical
ADH1B;Oropharyngeal Neoplasms;Disease;PA24571;Gene
CYP2D6;Poisoning;Disease;PA128;Gene
CYP2D6*3;Poisoning;Disease;PA165816578;Haplotype
CYP2D6*4;Poisoning;Disease;PA165816579;Haplotype
RS1799762;Pemphigus;Disease;PA166282801;Variant
SERPINE1;Pemphigus;Disease;PA261;Gene
ABCIXIMAB;FGA;Gene;PA448006;Chemical
EPTIFIBATIDE;FGA;Gene;PA449483;Chemical
TIROFIBAN;FGA;Gene;PA451698;Chemical
MTHFR;Neural Tube Defects;Disease;PA245;Gene
CFTR;rs77834169;Variant;PA109;Gene
IVACAFTOR;rs77834169;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs77834169;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs77834169;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs77834169;Variant;PA443829;Disease
RHEUMATOID ARTHRITIS;rs2233945;Variant;PA443434;Disease
ETANERCEPT;rs2233945;Variant;PA449515;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;rs943580;Variant;PA164712462;Chemical
ACUTE CORONARY SYNDROME;rs943580;Variant;PA165108401;Disease
PAIN, POSTOPERATIVE;rs7583431;Variant;PA445210;Disease
FENTANYL;rs7583431;Variant;PA449599;Chemical
HMG COA REDUCTASE INHIBITORS;CELSR2;Gene;PA133950441;Chemical
IFIH1;Arthritis, Psoriatic;Disease;PA134889215;Gene
RS1801133;Arthritis, Psoriatic;Disease;PA166153644;Variant
RS767455;Arthritis, Psoriatic;Disease;PA166154502;Variant
RS3794271;Arthritis, Psoriatic;Disease;PA166154566;Variant
RS610604;Arthritis, Psoriatic;Disease;PA166156931;Variant
RS1800629;Arthritis, Psoriatic;Disease;PA166156997;Variant
RS6920220;Arthritis, Psoriatic;Disease;PA166157114;Variant
MTHFR;Arthritis, Psoriatic;Disease;PA245;Gene
SH3BP2;Arthritis, Psoriatic;Disease;PA35733;Gene
TNFAIP3;Arthritis, Psoriatic;Disease;PA36593;Gene
TNFRSF1A;Arthritis, Psoriatic;Disease;PA36609;Gene
SLCO1C1;Arthritis, Psoriatic;Disease;PA37815;Gene
TNF;Arthritis, Psoriatic;Disease;PA435;Gene
TTR;patisiran;Chemical;PA37069;Gene
INTERFERON ALFA-2A, RECOMBINANT;IDO1;Gene;PA164779048;Chemical
PEGINTERFERON ALFA-2B;IDO1;Gene;PA164784024;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;IDO1;Gene;PA446863;Disease
TOBACCO USE DISORDER;rs2056527;Variant;PA445876;Disease
NICOTINE;rs2056527;Variant;PA450626;Chemical
FGFR1OP;FGF2;Gene;PA134941638;Gene
FGFR1OP2;FGF2;Gene;PA134972108;Gene
LENALIDOMIDE;FGF2;Gene;PA162363968;Chemical
FGFR1;FGF2;Gene;PA28127;Gene
FGFR2;FGF2;Gene;PA28128;Gene
FGFR3;FGF2;Gene;PA28129;Gene
FGFR4;FGF2;Gene;PA28130;Gene
FGFR3P1;FGF2;Gene;PA28131;Gene
FGFRL1;FGF2;Gene;PA28132;Gene
MULTIPLE MYELOMA;FGF2;Gene;PA444985;Disease
DEPRESSIVE DISORDER;FGF2;Gene;PA447207;Disease
FLUVOXAMINE;FGF2;Gene;PA449690;Chemical
THALIDOMIDE;FGF2;Gene;PA451644;Chemical
CFTR;rs368505753;Variant;PA109;Gene
IVACAFTOR;rs368505753;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs368505753;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs368505753;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs368505753;Variant;PA443829;Disease
CYP2D6;ranolazine;Chemical;PA128;Gene
CYP3A4;ranolazine;Chemical;PA130;Gene
ABCB1;ranolazine;Chemical;PA267;Gene
EFAVIRENZ;rs141666881;Variant;PA449441;Chemical
MERCAPTOPURINE;TPMT*26;Haplotype;PA450379;Chemical
O-DESMETHYLTRAMADOL;RFPL4B;Gene;PA166131379;Chemical
TRAMADOL;RFPL4B;Gene;PA451735;Chemical
COMT;entacapone;Chemical;PA117;Gene
RS4680;entacapone;Chemical;PA166156024;Variant
CYP2C19;chloramphenicol;Chemical;PA124;Gene
G6PD B (REFERENCE);chloramphenicol;Chemical;PA165947826;Haplotype
G6PD A- 202A_376G;chloramphenicol;Chemical;PA165947827;Haplotype
G6PD DEFICIENCY;chloramphenicol;Chemical;PA166157959;Variant
G6PD;chloramphenicol;Chemical;PA28469;Gene
FLUOROURACIL;rs117101815;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs117101815;Variant;PA443560;Disease
NEUTROPENIA;rs117101815;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs117101815;Variant;PA449165;Chemical
EPIRUBICIN;rs117101815;Variant;PA449476;Chemical
CYP3A4;CYP3A4*8;Haplotype;PA130;Gene
CABOZANTINIB;CYP3A4*8;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*8;Haplotype;PA165958362;Chemical
REGORAFENIB;CYP3A4*8;Haplotype;PA166114943;Chemical
VANDETANIB;CYP3A4*8;Haplotype;PA166118341;Chemical
TREATMENT MODIFICATION;CYP3A4*8;Haplotype;PA166124372;Disease
ALECTINIB;CYP3A4*8;Haplotype;PA166160050;Chemical
BREXPIPRAZOLE;CYP3A4*8;Haplotype;PA166160053;Chemical
BLONANSERIN;CYP3A4*8;Haplotype;PA166319041;Chemical
BREAST NEOPLASMS;CYP3A4*8;Haplotype;PA443560;Disease
OVARIAN NEOPLASMS;CYP3A4*8;Haplotype;PA445204;Disease
PERIPHERAL NERVOUS SYSTEM DISEASES;CYP3A4*8;Haplotype;PA445301;Disease
OXYCODONE;CYP3A4*8;Haplotype;PA450741;Chemical
PACLITAXEL;CYP3A4*8;Haplotype;PA450761;Chemical
QUETIAPINE;CYP3A4*8;Haplotype;PA451201;Chemical
ALCOHOL ABUSE;rs10432303;Variant;PA443309;Disease
ETHANOL;rs10432303;Variant;PA448073;Chemical
ESCITALOPRAM;CYP2C19*4;Haplotype;PA10074;Chemical
CYP2C19;CYP2C19*4;Haplotype;PA124;Gene
ACUTE CORONARY SYNDROME;CYP2C19*4;Haplotype;PA165108401;Disease
AMBRISENTAN;CYP2C19*4;Haplotype;PA165860521;Chemical
TREATMENT FAILURE;CYP2C19*4;Haplotype;PA166128095;Disease
CARDIOVASCULAR DISEASES;CYP2C19*4;Haplotype;PA443635;Disease
ISCHEMIC ATTACK, TRANSIENT;CYP2C19*4;Haplotype;PA443672;Disease
HYPERPROLACTINEMIA;CYP2C19*4;Haplotype;PA444545;Disease
MYOCARDIAL INFARCTION;CYP2C19*4;Haplotype;PA445019;Disease
STROKE;CYP2C19*4;Haplotype;PA447054;Disease
DEPRESSIVE DISORDER;CYP2C19*4;Haplotype;PA447207;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2C19*4;Haplotype;PA447321;Disease
CITALOPRAM;CYP2C19*4;Haplotype;PA449015;Chemical
CLOPIDOGREL;CYP2C19*4;Haplotype;PA449053;Chemical
QUETIAPINE;CYP2C19*4;Haplotype;PA451201;Chemical
SERTRALINE;CYP2C19*4;Haplotype;PA451333;Chemical
CYP3A4;methoxyflurane;Chemical;PA130;Gene
RS1800559;methoxyflurane;Chemical;PA166153638;Variant
RS772226819;methoxyflurane;Chemical;PA166153940;Variant
RS1801086;methoxyflurane;Chemical;PA166155375;Variant
RS28933396;methoxyflurane;Chemical;PA166155481;Variant
RS28933397;methoxyflurane;Chemical;PA166155482;Variant
RS63749869;methoxyflurane;Chemical;PA166155516;Variant
RS111888148;methoxyflurane;Chemical;PA166155524;Variant
RS112563513;methoxyflurane;Chemical;PA166155526;Variant
RS118192116;methoxyflurane;Chemical;PA166155528;Variant
RS118192122;methoxyflurane;Chemical;PA166155529;Variant
RS118192124;methoxyflurane;Chemical;PA166155531;Variant
RS118192161;methoxyflurane;Chemical;PA166155532;Variant
RS118192162;methoxyflurane;Chemical;PA166155533;Variant
RS118192163;methoxyflurane;Chemical;PA166155534;Variant
RS118192167;methoxyflurane;Chemical;PA166155535;Variant
RS118192170;methoxyflurane;Chemical;PA166155536;Variant
RS118192172;methoxyflurane;Chemical;PA166155537;Variant
RS118192175;methoxyflurane;Chemical;PA166155538;Variant
RS118192176;methoxyflurane;Chemical;PA166155539;Variant
RS118192177;methoxyflurane;Chemical;PA166155540;Variant
RS118192178;methoxyflurane;Chemical;PA166155541;Variant
RS121918592;methoxyflurane;Chemical;PA166155543;Variant
RS121918593;methoxyflurane;Chemical;PA166155544;Variant
RS121918594;methoxyflurane;Chemical;PA166155545;Variant
RS121918595;methoxyflurane;Chemical;PA166155546;Variant
RS193922747;methoxyflurane;Chemical;PA166155564;Variant
RS193922753;methoxyflurane;Chemical;PA166155565;Variant
RS193922770;methoxyflurane;Chemical;PA166155567;Variant
RS193922772;methoxyflurane;Chemical;PA166155568;Variant
RS193922802;methoxyflurane;Chemical;PA166155569;Variant
RS193922803;methoxyflurane;Chemical;PA166155570;Variant
RS193922807;methoxyflurane;Chemical;PA166155571;Variant
RS193922809;methoxyflurane;Chemical;PA166155572;Variant
RS193922816;methoxyflurane;Chemical;PA166155573;Variant
RS193922818;methoxyflurane;Chemical;PA166155574;Variant
RS193922876;methoxyflurane;Chemical;PA166155575;Variant
RS193922878;methoxyflurane;Chemical;PA166155576;Variant
RS193922843;methoxyflurane;Chemical;PA166163663;Variant
RS193922832;methoxyflurane;Chemical;PA166163667;Variant
RS118192168;methoxyflurane;Chemical;PA166163669;Variant
RS193922764;methoxyflurane;Chemical;PA166176176;Variant
RS121918596;methoxyflurane;Chemical;PA166177994;Variant
RS193922748;methoxyflurane;Chemical;PA166180322;Variant
RS193922762;methoxyflurane;Chemical;PA166180323;Variant
RS193922768;methoxyflurane;Chemical;PA166180324;Variant
RS144336148;methoxyflurane;Chemical;PA166180325;Variant
RYR1;methoxyflurane;Chemical;PA34896;Gene
CACNA1S;methoxyflurane;Chemical;PA85;Gene
CYP2D6;Opium derivatives and expectorants;Chemical;PA128;Gene
CYP3A4;CYP3A4*12;Haplotype;PA130;Gene
CABOZANTINIB;CYP3A4*12;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*12;Haplotype;PA165958362;Chemical
REGORAFENIB;CYP3A4*12;Haplotype;PA166114943;Chemical
VANDETANIB;CYP3A4*12;Haplotype;PA166118341;Chemical
ALECTINIB;CYP3A4*12;Haplotype;PA166160050;Chemical
BREXPIPRAZOLE;CYP3A4*12;Haplotype;PA166160053;Chemical
MACITENTAN;CYP3A4*12;Haplotype;PA166261201;Chemical
BLONANSERIN;CYP3A4*12;Haplotype;PA166319041;Chemical
OXYCODONE;CYP3A4*12;Haplotype;PA450741;Chemical
QUETIAPINE;CYP3A4*12;Haplotype;PA451201;Chemical
CYP2C9;zafirlukast;Chemical;PA126;Gene
CYP2C9*1;zafirlukast;Chemical;PA165816542;Haplotype
CYP2C9*3;zafirlukast;Chemical;PA165816544;Haplotype
CYP2C9*13;zafirlukast;Chemical;PA165816554;Haplotype
CYSLTR1;zafirlukast;Chemical;PA38453;Gene
CORONARY ARTERY DISEASE;rs35068180;Variant;PA443796;Disease
HYPERTENSION;rs35068180;Variant;PA444552;Disease
STROKE;rs35068180;Variant;PA447054;Disease
CHLORTHALIDONE;rs35068180;Variant;PA448970;Chemical
LISINOPRIL;rs35068180;Variant;PA450242;Chemical
PRAVASTATIN;rs35068180;Variant;PA451089;Chemical
ADRB2;orciprenaline;Chemical;PA39;Gene
ACE INHIBITORS, PLAIN;ABO;Gene;PA164712308;Chemical
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;ABO;Gene;PA452637;Chemical
TOBACCO USE DISORDER;rs11606194;Variant;PA445876;Disease
NICOTINE;rs11606194;Variant;PA450626;Chemical
HYPERTENSION;DOT1L;Gene;PA444552;Disease
CANDESARTAN;DOT1L;Gene;PA448765;Chemical
HYDROCHLOROTHIAZIDE;DOT1L;Gene;PA449899;Chemical
KIDNEY TRANSPLANTATION;rs1946518;Variant;PA165817016;Disease
LUNG TRANSPLANTATION;rs1946518;Variant;PA166114457;Disease
CHRONIC HEPATITIS C VIRUS INFECTION;rs1946518;Variant;PA446863;Disease
RIBAVIRIN;rs1946518;Variant;PA451241;Chemical
TACROLIMUS;rs1946518;Variant;PA451578;Chemical
INTERFERONS;rs1946518;Variant;PA451999;Chemical
RS1051740;Disorder of facial skeleton;Disease;PA166153612;Variant
RS2234922;Disorder of facial skeleton;Disease;PA166153680;Variant
EPHX1;Disorder of facial skeleton;Disease;PA27829;Gene
ESCITALOPRAM;ethanol;Chemical;PA10074;Chemical
CHRNA3;ethanol;Chemical;PA113;Gene
CYP2D6;ethanol;Chemical;PA128;Gene
ANKS1B;ethanol;Chemical;PA128394692;Gene
SRPRB;ethanol;Chemical;PA128394701;Gene
CYP2E1;ethanol;Chemical;PA129;Gene
ANKK1;ethanol;Chemical;PA134872551;Gene
MED19;ethanol;Chemical;PA134926032;Gene
SLC39A8;ethanol;Chemical;PA134931507;Gene
RABGAP1L;ethanol;Chemical;PA134940645;Gene
KLB;ethanol;Chemical;PA142671586;Gene
FTO;ethanol;Chemical;PA152208656;Gene
CADM2;ethanol;Chemical;PA162380882;Gene
THSD7B;ethanol;Chemical;PA162405776;Gene
TMX2;ethanol;Chemical;PA164726611;Gene
SLC6A4 HTTLPR LONG FORM (L ALLELE);ethanol;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);ethanol;Chemical;PA166116466;Haplotype
RS2031920;ethanol;Chemical;PA166153990;Variant
RS1001179;ethanol;Chemical;PA166154306;Variant
RS1799732;ethanol;Chemical;PA166154334;Variant
RS1800497;ethanol;Chemical;PA166154339;Variant
RS671;ethanol;Chemical;PA166154482;Variant
RS578776;ethanol;Chemical;PA166154840;Variant
RS615470;ethanol;Chemical;PA166154842;Variant
RS1051730;ethanol;Chemical;PA166154856;Variant
RS16969968;ethanol;Chemical;PA166154938;Variant
RS25531;ethanol;Chemical;PA166155159;Variant
RS2948694;ethanol;Chemical;PA166156371;Variant
RS1229984;ethanol;Chemical;PA166156507;Variant
RS2066702;ethanol;Chemical;PA166156533;Variant
RS28363170;ethanol;Chemical;PA166156890;Variant
RS1799971;ethanol;Chemical;PA166156991;Variant
RS2075572;ethanol;Chemical;PA166157015;Variant
RS846664;ethanol;Chemical;PA166157268;Variant
RS738409;ethanol;Chemical;PA166165078;Variant
RS6350;ethanol;Chemical;PA166170117;Variant
RS1799972;ethanol;Chemical;PA166177739;Variant
RS553202;ethanol;Chemical;PA166177789;Variant
RS495491;ethanol;Chemical;PA166177792;Variant
RS1260326;ethanol;Chemical;PA166177970;Variant
RS11940694;ethanol;Chemical;PA166177971;Variant
RS548646;ethanol;Chemical;PA166179967;Variant
RS4251417;ethanol;Chemical;PA166181168;Variant
RS1044394;ethanol;Chemical;PA166183681;Variant
RS511435;ethanol;Chemical;PA166183701;Variant
RS524731;ethanol;Chemical;PA166183702;Variant
RS3823010;ethanol;Chemical;PA166183703;Variant
RS1381376;ethanol;Chemical;PA166183704;Variant
RS3778156;ethanol;Chemical;PA166183705;Variant
RS3778148;ethanol;Chemical;PA166183856;Variant
RS1461773;ethanol;Chemical;PA166183858;Variant
RS648007;ethanol;Chemical;PA166183869;Variant
RS681243;ethanol;Chemical;PA166183871;Variant
RS6473797;ethanol;Chemical;PA166183884;Variant
RS10055255;ethanol;Chemical;PA166183982;Variant
RS2066713;ethanol;Chemical;PA166184026;Variant
RS3778150;ethanol;Chemical;PA166184666;Variant
RS10485057;ethanol;Chemical;PA166184699;Variant
RS6088638;ethanol;Chemical;PA166185175;Variant
RS4807493;ethanol;Chemical;PA166185410;Variant
RS10405681;ethanol;Chemical;PA166185412;Variant
RS2074957;ethanol;Chemical;PA166185417;Variant
RS10432303;ethanol;Chemical;PA166185418;Variant
RS8109485;ethanol;Chemical;PA166185420;Variant
RS1476592;ethanol;Chemical;PA166185422;Variant
RS10419980;ethanol;Chemical;PA166185423;Variant
RS4432372;ethanol;Chemical;PA166185425;Variant
RS10516440;ethanol;Chemical;PA166185686;Variant
RS2159140;ethanol;Chemical;PA166185779;Variant
RS17376019;ethanol;Chemical;PA166186238;Variant
RS61826952;ethanol;Chemical;PA166197261;Variant
RS7821592;ethanol;Chemical;PA166197841;Variant
RS1577857;ethanol;Chemical;PA166197842;Variant
RS77804065;ethanol;Chemical;PA166197843;Variant
RS2291317;ethanol;Chemical;PA166197844;Variant
RS7931459;ethanol;Chemical;PA166197845;Variant
RS61667602;ethanol;Chemical;PA166197846;Variant
RS1360983;ethanol;Chemical;PA166197861;Variant
RS2133896;ethanol;Chemical;PA166200161;Variant
RS1034936;ethanol;Chemical;PA166202881;Variant
RS6421482;ethanol;Chemical;PA166210001;Variant
RS61767420;ethanol;Chemical;PA166210002;Variant
RS494904;ethanol;Chemical;PA166210003;Variant
RS1402398;ethanol;Chemical;PA166210004;Variant
RS2673136;ethanol;Chemical;PA166210005;Variant
RS13129401;ethanol;Chemical;PA166210006;Variant
RS13125415;ethanol;Chemical;PA166210007;Variant
RS13135092;ethanol;Chemical;PA166210008;Variant
RS2533200;ethanol;Chemical;PA166210009;Variant
RS2582405;ethanol;Chemical;PA166210010;Variant
RS576859;ethanol;Chemical;PA166210013;Variant
RS1783835;ethanol;Chemical;PA166210014;Variant
RS12296477;ethanol;Chemical;PA166210015;Variant
RS61974485;ethanol;Chemical;PA166210016;Variant
RS72768626;ethanol;Chemical;PA166210017;Variant
RS492602;ethanol;Chemical;PA166210018;Variant
RS9679319;ethanol;Chemical;PA166210021;Variant
RS13382553;ethanol;Chemical;PA166210022;Variant
RS62250713;ethanol;Chemical;PA166210023;Variant
RS7900002;ethanol;Chemical;PA166210024;Variant
RS75967634;ethanol;Chemical;PA166210041;Variant
RS56722963;ethanol;Chemical;PA166210042;Variant
RS6589386;ethanol;Chemical;PA166210044;Variant
RS8008020;ethanol;Chemical;PA166210045;Variant
RS9937709;ethanol;Chemical;PA166210046;Variant
ACSS2;ethanol;Chemical;PA24429;Gene
ADH1B;ethanol;Chemical;PA24571;Gene
ADH1C;ethanol;Chemical;PA24572;Gene
ALDH1A1;ethanol;Chemical;PA24692;Gene
ALDH2;ethanol;Chemical;PA24696;Gene
CAT;ethanol;Chemical;PA26099;Gene
CHRNA4;ethanol;Chemical;PA26490;Gene
CHRNA5;ethanol;Chemical;PA26491;Gene
CRHBP;ethanol;Chemical;PA26873;Gene
DPP6;ethanol;Chemical;PA27468;Gene
DRD2;ethanol;Chemical;PA27478;Gene
DRD4;ethanol;Chemical;PA27480;Gene
FUT2;ethanol;Chemical;PA28429;Gene
GCKR;ethanol;Chemical;PA28611;Gene
GHSR;ethanol;Chemical;PA28677;Gene
MAP2K4;ethanol;Chemical;PA30589;Gene
SLC6A3;ethanol;Chemical;PA311;Gene
SLC6A4;ethanol;Chemical;PA312;Gene
OPRK1;ethanol;Chemical;PA31943;Gene
OPRM1;ethanol;Chemical;PA31945;Gene
PDE4B;ethanol;Chemical;PA33129;Gene
PIP5K1C;ethanol;Chemical;PA33329;Gene
ARID4A;ethanol;Chemical;PA34249;Gene
SLC4A8;ethanol;Chemical;PA35900;Gene
TNRC6A;ethanol;Chemical;PA36656;Gene
TAS2R16;ethanol;Chemical;PA37931;Gene
PNPLA3;ethanol;Chemical;PA38592;Gene
CACNA1C;ethanol;Chemical;PA83;Gene
PLATINUM COMPOUNDS;rs1799801;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs1799801;Variant;PA443622;Disease
CYP2C19;CYP2C19*5;Haplotype;PA124;Gene
ACUTE CORONARY SYNDROME;CYP2C19*5;Haplotype;PA165108401;Disease
CARDIOVASCULAR DISEASES;CYP2C19*5;Haplotype;PA443635;Disease
ISCHEMIC ATTACK, TRANSIENT;CYP2C19*5;Haplotype;PA443672;Disease
MYOCARDIAL INFARCTION;CYP2C19*5;Haplotype;PA445019;Disease
STROKE;CYP2C19*5;Haplotype;PA447054;Disease
CLOPIDOGREL;CYP2C19*5;Haplotype;PA449053;Chemical
MEPHENYTOIN;CYP2C19*5;Haplotype;PA450373;Chemical
TOLBUTAMIDE;CYP2C19*5;Haplotype;PA451718;Chemical
NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;rs2853826;Variant;PA164712943;Chemical
HIV INFECTIOUS DISEASE;rs2853826;Variant;PA447230;Disease
EFAVIRENZ;rs2853826;Variant;PA449441;Chemical
LOPINAVIR;rs2853826;Variant;PA450264;Chemical
RITONAVIR;rs2853826;Variant;PA451260;Chemical
CORTICOSTEROIDS;rs2241843;Variant;PA10832;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;rs2241843;Variant;PA446155;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs757978;Variant;PA447197;Disease
METHYLPHENIDATE;rs757978;Variant;PA450464;Chemical
DRUG TOXICITY;rs544027339;Variant;PA443937;Disease
PHENYTOIN;rs544027339;Variant;PA450947;Chemical
DRUG-INDUCED LIVER INJURY;HLA-B*35:02;Haplotype;PA166119041;Disease
MINOCYCLINE;HLA-B*35:02;Haplotype;PA450519;Chemical
CYP3A4;Neuroendocrine Tumors;Disease;PA130;Gene
CYP3A5;Neuroendocrine Tumors;Disease;PA131;Gene
CYP3A4*1;Neuroendocrine Tumors;Disease;PA165819201;Haplotype
CYP3A4*22;Neuroendocrine Tumors;Disease;PA166048680;Haplotype
CYP3A5*1;Neuroendocrine Tumors;Disease;PA166128213;Haplotype
CYP3A5*3;Neuroendocrine Tumors;Disease;PA166128219;Haplotype
RS2024627;Neuroendocrine Tumors;Disease;PA166238104;Variant
MTOR;Neuroendocrine Tumors;Disease;PA28360;Gene
DULOXETINE;rs6479008;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs6479008;Variant;PA447321;Disease
G6PD;erythromycin ethylsuccinate / sulfisoxazole acetyl;Chemical;PA28469;Gene
CETUXIMAB;rs113488022;Variant;PA10040;Chemical
CD274;rs113488022;Variant;PA134915280;Gene
VEMURAFENIB;rs113488022;Variant;PA165946873;Chemical
DABRAFENIB;rs113488022;Variant;PA166114911;Chemical
TRAMETINIB;rs113488022;Variant;PA166115364;Chemical
PEMBROLIZUMAB;rs113488022;Variant;PA166124615;Chemical
NIVOLUMAB;rs113488022;Variant;PA166129522;Chemical
ATEZOLIZUMAB;rs113488022;Variant;PA166129523;Chemical
COBIMETINIB;rs113488022;Variant;PA166160044;Chemical
BINIMETINIB;rs113488022;Variant;PA166179867;Chemical
ENCORAFENIB;rs113488022;Variant;PA166179872;Chemical
NIVOLUMAB / RELATLIMAB;rs113488022;Variant;PA166277902;Chemical
TOVORAFENIB;rs113488022;Variant;PA166345561;Chemical
ALK;rs113488022;Variant;PA24719;Gene
BRAF;rs113488022;Variant;PA25408;Gene
ERBB2;rs113488022;Variant;PA27844;Gene
KRAS;rs113488022;Variant;PA30196;Gene
LAG3;rs113488022;Variant;PA30265;Gene
NRAS;rs113488022;Variant;PA31768;Gene
EGFR;rs113488022;Variant;PA7360;Gene
ABCC2;efavirenz;Chemical;PA116;Gene
CYP2A6;efavirenz;Chemical;PA121;Gene
CYP2B6;efavirenz;Chemical;PA123;Gene
CYP2C19;efavirenz;Chemical;PA124;Gene
CYP3A4;efavirenz;Chemical;PA130;Gene
CYP3A5;efavirenz;Chemical;PA131;Gene
CYP2B6*1;efavirenz;Chemical;PA165818750;Haplotype
CYP2B6*2;efavirenz;Chemical;PA165818753;Haplotype
CYP2B6*4;efavirenz;Chemical;PA165818757;Haplotype
CYP2B6*5;efavirenz;Chemical;PA165818760;Haplotype
CYP2B6*6;efavirenz;Chemical;PA165818762;Haplotype
CYP2B6*11;efavirenz;Chemical;PA165818770;Haplotype
CYP2B6*26;efavirenz;Chemical;PA165818788;Haplotype
CYP2B6*27;efavirenz;Chemical;PA165818789;Haplotype
CYP2B6*9;efavirenz;Chemical;PA165818807;Haplotype
CYP2B6*18;efavirenz;Chemical;PA165818808;Haplotype
CYP2B6*28;efavirenz;Chemical;PA165818812;Haplotype
CYP2A6*2;efavirenz;Chemical;PA165924719;Haplotype
HLA-DRB1*01:01;efavirenz;Chemical;PA165951320;Haplotype
CYP2C19*1;efavirenz;Chemical;PA165980634;Haplotype
CYP2C19*2;efavirenz;Chemical;PA165980635;Haplotype
CYP2C19*3;efavirenz;Chemical;PA165980636;Haplotype
CYP2B6*38;efavirenz;Chemical;PA166117278;Haplotype
RS1800896;efavirenz;Chemical;PA166153642;Variant
RS2307424;efavirenz;Chemical;PA166153700;Variant
RS3003596;efavirenz;Chemical;PA166153729;Variant
RS717620;efavirenz;Chemical;PA166153953;Variant
RS6313;efavirenz;Chemical;PA166154675;Variant
RS2279343;efavirenz;Chemical;PA166155393;Variant
RS2279345;efavirenz;Chemical;PA166155395;Variant
RS3211371;efavirenz;Chemical;PA166155405;Variant
RS3745274;efavirenz;Chemical;PA166155409;Variant
RS4803419;efavirenz;Chemical;PA166155420;Variant
RS8192709;efavirenz;Chemical;PA166155442;Variant
RS8192719;efavirenz;Chemical;PA166155444;Variant
RS8192726;efavirenz;Chemical;PA166155447;Variant
RS12721655;efavirenz;Chemical;PA166155467;Variant
RS28399433;efavirenz;Chemical;PA166155471;Variant
RS28399454;efavirenz;Chemical;PA166155475;Variant
RS35303484;efavirenz;Chemical;PA166155496;Variant
RS36118214;efavirenz;Chemical;PA166155504;Variant
RS1884613;efavirenz;Chemical;PA166155918;Variant
RS2231142;efavirenz;Chemical;PA166156544;Variant
RS7439366;efavirenz;Chemical;PA166156619;Variant
RS28365062;efavirenz;Chemical;PA166156676;Variant
RS3842;efavirenz;Chemical;PA166157239;Variant
RS776746;efavirenz;Chemical;PA166157267;Variant
RS1045642;efavirenz;Chemical;PA166157284;Variant
RS1128503;efavirenz;Chemical;PA166157288;Variant
RS2032582;efavirenz;Chemical;PA166157316;Variant
RS2740574;efavirenz;Chemical;PA166157367;Variant
RS2853826;efavirenz;Chemical;PA166158911;Variant
RS70950385;efavirenz;Chemical;PA166170426;Variant
RS148009906;efavirenz;Chemical;PA166290041;Variant
RS535039125;efavirenz;Chemical;PA166290042;Variant
RS58871670;efavirenz;Chemical;PA166290043;Variant
RS200458614;efavirenz;Chemical;PA166290047;Variant
RS201500445;efavirenz;Chemical;PA166290048;Variant
RS200238771;efavirenz;Chemical;PA166290049;Variant
RS764288403;efavirenz;Chemical;PA166290050;Variant
RS374099483;efavirenz;Chemical;PA166290051;Variant
RS117872433;efavirenz;Chemical;PA166290052;Variant
CYP2B6*46;efavirenz;Chemical;PA166290060;Haplotype
CYP2B6*47;efavirenz;Chemical;PA166290061;Haplotype
RS1968919352;efavirenz;Chemical;PA166350621;Variant
RS141666881;efavirenz;Chemical;PA166350821;Variant
RS750671397;efavirenz;Chemical;PA166350823;Variant
RS1282926098;efavirenz;Chemical;PA166350825;Variant
RS1969255598;efavirenz;Chemical;PA166350826;Variant
RS1248477767;efavirenz;Chemical;PA166350828;Variant
RS373442191;efavirenz;Chemical;PA166350830;Variant
RS1969136524;efavirenz;Chemical;PA166350832;Variant
RS142421637;efavirenz;Chemical;PA166350842;Variant
RS752695347;efavirenz;Chemical;PA166350843;Variant
RS553968231;efavirenz;Chemical;PA166350862;Variant
RS772413158;efavirenz;Chemical;PA166350901;Variant
RS773494867;efavirenz;Chemical;PA166350903;Variant
RS1969376664;efavirenz;Chemical;PA166350922;Variant
NAT2;efavirenz;Chemical;PA18;Gene
HTR2A;efavirenz;Chemical;PA193;Gene
ABCB1;efavirenz;Chemical;PA267;Gene
HNF4A;efavirenz;Chemical;PA29349;Gene
IL10;efavirenz;Chemical;PA29778;Gene
HLA-DRB1;efavirenz;Chemical;PA35072;Gene
UGT2B7;efavirenz;Chemical;PA361;Gene
NR1I2;efavirenz;Chemical;PA378;Gene
ABCG2;efavirenz;Chemical;PA390;Gene
NR1I3;efavirenz;Chemical;PA391;Gene
UGT1A1;efavirenz;Chemical;PA420;Gene
RIFAMPIN;efavirenz;Chemical;PA451250;Chemical
ZIDOVUDINE;efavirenz;Chemical;PA451954;Chemical
IFNL3;Myeloproliferative Disorder;Disease;PA134952671;Gene
IFNL4;Myeloproliferative Disorder;Disease;PA166049147;Gene
RS12979860;Myeloproliferative Disorder;Disease;PA166155468;Variant
GLT1D1;Leukotriene receptor antagonists;Chemical;PA128394758;Gene
PRORP;Leukotriene receptor antagonists;Chemical;PA134879499;Gene
LTC4S;Leukotriene receptor antagonists;Chemical;PA235;Gene
LTA4H;Leukotriene receptor antagonists;Chemical;PA24345;Gene
ABCC1;Leukotriene receptor antagonists;Chemical;PA244;Gene
MLLT3;Leukotriene receptor antagonists;Chemical;PA30852;Gene
SLCO2B1;Leukotriene receptor antagonists;Chemical;PA35845;Gene
CYSLTR2;Leukotriene receptor antagonists;Chemical;PA38518;Gene
ALOX5;Leukotriene receptor antagonists;Chemical;PA46;Gene
ABCC2;ritonavir;Chemical;PA116;Gene
CYP2D6;ritonavir;Chemical;PA128;Gene
CYP3A4;ritonavir;Chemical;PA130;Gene
CYP3A5;ritonavir;Chemical;PA131;Gene
UGT1A1*1;ritonavir;Chemical;PA166115841;Haplotype
UGT1A1*28;ritonavir;Chemical;PA166115842;Haplotype
CYP3A5*1;ritonavir;Chemical;PA166128213;Haplotype
CYP3A5*3;ritonavir;Chemical;PA166128219;Haplotype
CYP3A5*6;ritonavir;Chemical;PA166128233;Haplotype
CYP3A5*7;ritonavir;Chemical;PA166128234;Haplotype
RS717620;ritonavir;Chemical;PA166153953;Variant
RS5128;ritonavir;Chemical;PA166154254;Variant
RS2854116;ritonavir;Chemical;PA166154390;Variant
RS2854117;ritonavir;Chemical;PA166154391;Variant
RS212091;ritonavir;Chemical;PA166154987;Variant
RS7412;ritonavir;Chemical;PA166155341;Variant
RS429358;ritonavir;Chemical;PA166155351;Variant
RS8330;ritonavir;Chemical;PA166155584;Variant
RS1042640;ritonavir;Chemical;PA166155616;Variant
RS3806596;ritonavir;Chemical;PA166155712;Variant
RS7586110;ritonavir;Chemical;PA166155768;Variant
RS10929303;ritonavir;Chemical;PA166155795;Variant
RS17863778;ritonavir;Chemical;PA166155853;Variant
RS17868323;ritonavir;Chemical;PA166155857;Variant
RS1045642;ritonavir;Chemical;PA166157284;Variant
RS2032582;ritonavir;Chemical;PA166157316;Variant
RS2853826;ritonavir;Chemical;PA166158911;Variant
ABCC1;ritonavir;Chemical;PA244;Gene
ABCB1;ritonavir;Chemical;PA267;Gene
UGT1A3;ritonavir;Chemical;PA37178;Gene
UGT1A7;ritonavir;Chemical;PA37182;Gene
NR1I2;ritonavir;Chemical;PA378;Gene
UGT1A1;ritonavir;Chemical;PA420;Gene
APOC3;ritonavir;Chemical;PA53;Gene
APOE;ritonavir;Chemical;PA55;Gene
RETINAL DISEASES;HCG22;Gene;PA445532;Disease
TRIAMCINOLONE;HCG22;Gene;PA451749;Chemical
CYP3A4;ruxolitinib;Chemical;PA130;Gene
MIDAZOLAM;CYP3A4*43;Haplotype;PA450496;Chemical
MIGALASTAT;rs398123226;Variant;PA166182881;Chemical
FABRY DISEASE;rs398123226;Variant;PA443367;Disease
DEPRESSION;rs10280101;Variant;PA447278;Disease
AMITRIPTYLINE;rs10280101;Variant;PA448385;Chemical
CITALOPRAM;rs10280101;Variant;PA449015;Chemical
PAROXETINE;rs10280101;Variant;PA450801;Chemical
VENLAFAXINE;rs10280101;Variant;PA451866;Chemical
ADALIMUMAB;ATG5;Gene;PA10004;Chemical
INFLAMMATORY BOWEL DISEASES;ATG5;Gene;PA446116;Disease
ASTHMA;FSIP1;Gene;PA443450;Disease
ASPIRIN;FSIP1;Gene;PA448497;Chemical
CYP2C19;abrocitinib;Chemical;PA124;Gene
CYP2C9;abrocitinib;Chemical;PA126;Gene
VENETOCLAX;IDH2;Gene;PA166153473;Chemical
ENASIDENIB;IDH2;Gene;PA166177484;Chemical
VORASIDENIB;IDH2;Gene;PA166400022;Chemical
PRDX2;TXN;Gene;PA33723;Gene
TXNRD1;TXN;Gene;PA37093;Gene
DICLOFENAC;CYP2C9*38;Haplotype;PA449293;Chemical
WARFARIN;rs17126068;Variant;PA451906;Chemical
RHEUMATOID ARTHRITIS;rs1703794;Variant;PA443434;Disease
METHOTREXATE;rs1703794;Variant;PA450428;Chemical
ASPIRIN-INDUCED ASTHMA;rs1042151;Variant;PA131285571;Disease
ASTHMA;rs1042151;Variant;PA443450;Disease
ASPIRIN;rs1042151;Variant;PA448497;Chemical
CYP1A2;CYP1A2*30;Haplotype;PA27093;Gene
CLOZAPINE;CYP1A2*30;Haplotype;PA449061;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs2108623;Variant;PA130620651;Chemical
NEOPLASMS;rs2108623;Variant;PA445062;Disease
ASTHMA;rs518350;Variant;PA443450;Disease
SALBUTAMOL;rs518350;Variant;PA448068;Chemical
RS6690497;daunorubicinol;Chemical;PA166248081;Variant
RS2229540;daunorubicinol;Chemical;PA166248082;Variant
AKR1A1;daunorubicinol;Chemical;PA24674;Gene
CATECHOLAMINES;COMT;Gene;PA133822447;Chemical
NEPHROTOXICITY;COMT;Gene;PA162263533;Disease
OTOTOXICITY;COMT;Gene;PA162263534;Disease
ANALGESICS;COMT;Gene;PA164712362;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;COMT;Gene;PA164712462;Chemical
DRUGS USED IN NICOTINE DEPENDENCE;COMT;Gene;PA164712720;Chemical
ERGOT ALKALOIDS;COMT;Gene;PA164712741;Chemical
METHYLDOPA;COMT;Gene;PA164712898;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;COMT;Gene;PA164713257;Chemical
BUTORPHANOL;COMT;Gene;PA164745398;Chemical
TRIHEXYPHENIDYL;COMT;Gene;PA164747026;Chemical
ENTACAPONE;COMT;Gene;PA164748726;Chemical
TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME;COMT;Gene;PA165108308;Disease
NEONATAL ABSTINENCE SYNDROME;COMT;Gene;PA165108809;Disease
METHAMPHETAMINE DEPENDENCE;COMT;Gene;PA166119022;Disease
SMOKING CESSATION;COMT;Gene;PA166123046;Disease
ETOPOSIDE CATECHOL;COMT;Gene;PA166131303;Chemical
ADVERSE EVENTS;COMT;Gene;PA166151827;Disease
RS4680;COMT;Gene;PA166156024;Variant
SOMNOLENCE;COMT;Gene;PA166185626;Disease
LEVOMETHADONE;COMT;Gene;PA166227621;Chemical
FREMANEZUMAB;COMT;Gene;PA166320903;Chemical
GALCANEZUMAB;COMT;Gene;PA166320904;Chemical
ERENUMAB;COMT;Gene;PA166320921;Chemical
BREAST NEOPLASMS;COMT;Gene;PA443560;Disease
CONSTIPATION;COMT;Gene;PA443782;Disease
DEATH;COMT;Gene;PA443842;Disease
DELIRIUM;COMT;Gene;PA443851;Disease
DIZZINESS;COMT;Gene;PA443928;Disease
DRUG TOXICITY;COMT;Gene;PA443937;Disease
ERYTHEMA;COMT;Gene;PA444083;Disease
EXANTHEMA;COMT;Gene;PA444109;Disease
HYPERALGESIA;COMT;Gene;PA444510;Disease
MIGRAINE WITHOUT AURA;COMT;Gene;PA444949;Disease
NARCOLEPSY;COMT;Gene;PA445042;Disease
OPIOID-RELATED DISORDERS;COMT;Gene;PA445043;Disease
NAUSEA;COMT;Gene;PA445048;Disease
NEOPLASMS;COMT;Gene;PA445062;Disease
PAIN;COMT;Gene;PA445208;Disease
PAIN, POSTOPERATIVE;COMT;Gene;PA445210;Disease
PARKINSON DISEASE;COMT;Gene;PA445254;Disease
PRURITUS;COMT;Gene;PA445437;Disease
TOBACCO USE DISORDER;COMT;Gene;PA445876;Disease
VOMITING;COMT;Gene;PA446051;Disease
URINARY RETENTION;COMT;Gene;PA446264;Disease
MIGRAINE WITH AURA;COMT;Gene;PA447004;Disease
ANXIETY DISORDERS;COMT;Gene;PA447196;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;COMT;Gene;PA447197;Disease
BIPOLAR DISORDER;COMT;Gene;PA447199;Disease
DEPRESSIVE DISORDER;COMT;Gene;PA447207;Disease
OBSESSIVE-COMPULSIVE DISORDER;COMT;Gene;PA447211;Disease
PANIC DISORDER;COMT;Gene;PA447212;Disease
SCHIZOPHRENIA;COMT;Gene;PA447216;Disease
PHYSIOLOGICAL SEXUAL DISORDER;COMT;Gene;PA447218;Disease
TARDIVE DYSKINESIA;COMT;Gene;PA447268;Disease
MAJOR DEPRESSIVE DISORDER;COMT;Gene;PA447321;Disease
ALFENTANIL;COMT;Gene;PA448084;Chemical
BENZTROPINE;COMT;Gene;PA448591;Chemical
BUPRENORPHINE;COMT;Gene;PA448685;Chemical
BUPROPION;COMT;Gene;PA448687;Chemical
CISPLATIN;COMT;Gene;PA449014;Chemical
CLOZAPINE;COMT;Gene;PA449061;Chemical
CODEINE;COMT;Gene;PA449088;Chemical
FENTANYL;COMT;Gene;PA449599;Chemical
FLUVOXAMINE;COMT;Gene;PA449690;Chemical
HALOPERIDOL;COMT;Gene;PA449841;Chemical
HYDROCODONE;COMT;Gene;PA449900;Chemical
HYDROMORPHONE;COMT;Gene;PA449918;Chemical
LEVODOPA;COMT;Gene;PA450213;Chemical
LITHIUM;COMT;Gene;PA450243;Chemical
METHADONE;COMT;Gene;PA450401;Chemical
METHYLPHENIDATE;COMT;Gene;PA450464;Chemical
MODAFINIL;COMT;Gene;PA450530;Chemical
MORPHINE;COMT;Gene;PA450550;Chemical
NALOXONE;COMT;Gene;PA450586;Chemical
NALTREXONE;COMT;Gene;PA450588;Chemical
NICOTINE;COMT;Gene;PA450626;Chemical
NOREPINEPHRINE;COMT;Gene;PA450649;Chemical
OLANZAPINE;COMT;Gene;PA450688;Chemical
OXYCODONE;COMT;Gene;PA450741;Chemical
PAROXETINE;COMT;Gene;PA450801;Chemical
PROPRANOLOL;COMT;Gene;PA451145;Chemical
QUETIAPINE;COMT;Gene;PA451201;Chemical
REMIFENTANIL;COMT;Gene;PA451232;Chemical
RISPERIDONE;COMT;Gene;PA451257;Chemical
SERTRALINE;COMT;Gene;PA451333;Chemical
SUFENTANIL;COMT;Gene;PA451527;Chemical
SUMATRIPTAN;COMT;Gene;PA451566;Chemical
TRAMADOL;COMT;Gene;PA451735;Chemical
VALPROIC ACID;COMT;Gene;PA451846;Chemical
VENLAFAXINE;COMT;Gene;PA451866;Chemical
ANTIPSYCHOTICS;COMT;Gene;PA452233;Chemical
OPIOIDS;COMT;Gene;PA452618;Chemical
HEROIN;COMT;Gene;PA452619;Chemical
SUCCINYLCHOLINE;BCHE deficiency;Variant;PA451522;Chemical
NEPHROTOXICITY;rs2248359;Variant;PA162263533;Disease
DEFERASIROX;rs2248359;Variant;PA164760843;Chemical
TENOFOVIR DISOPROXIL FUMARATE;rs2248359;Variant;PA166201941;Chemical
BETA-THALASSEMIA AND RELATED DISEASES;rs2248359;Variant;PA446432;Disease
HIV INFECTIOUS DISEASE;rs2248359;Variant;PA447230;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;rs3130501;Variant;PA166120929;Disease
EPIDERMAL NECROLYSIS, TOXIC;rs3130501;Variant;PA444059;Disease
STEVENS-JOHNSON SYNDROME;rs3130501;Variant;PA445738;Disease
ALLOPURINOL;rs3130501;Variant;PA448320;Chemical
NFKB1;PPP3R2;Gene;PA248;Gene
RELA;PPP3R2;Gene;PA296;Gene
NFATC1;PPP3R2;Gene;PA31582;Gene
NFATC2;PPP3R2;Gene;PA31583;Gene
NFATC4;PPP3R2;Gene;PA31584;Gene
NFKB2;PPP3R2;Gene;PA31600;Gene
REL;PPP3R2;Gene;PA34321;Gene
RELB;PPP3R2;Gene;PA34322;Gene
SLCO1B1;rs4149032;Variant;PA134865839;Gene
LETERMOVIR;rs4149032;Variant;PA166184379;Chemical
UGT1A1;rs4149032;Variant;PA420;Gene
TUBERCULOSIS;rs4149032;Variant;PA445941;Disease
RIFAMPIN;rs4149032;Variant;PA451250;Chemical
GNAQ;PLCG2;Gene;PA174;Gene
GNB3;PLCG2;Gene;PA176;Gene
GP1BB;PLCG2;Gene;PA179;Gene
ITGA2;PLCG2;Gene;PA204;Gene
ITGB3;PLCG2;Gene;PA205;Gene
CASR;PLCG2;Gene;PA26097;Gene
CD36;PLCG2;Gene;PA26212;Gene
PLA2G2A;PLCG2;Gene;PA270;Gene
PLA2G4A;PLCG2;Gene;PA271;Gene
ERBB2;PLCG2;Gene;PA27844;Gene
ERBB3;PLCG2;Gene;PA27846;Gene
ERBB4;PLCG2;Gene;PA27847;Gene
GNA11;PLCG2;Gene;PA28764;Gene
GNA12;PLCG2;Gene;PA28765;Gene
GNA13;PLCG2;Gene;PA28766;Gene
GNA15;PLCG2;Gene;PA28768;Gene
GP5;PLCG2;Gene;PA28823;Gene
GP6;PLCG2;Gene;PA28824;Gene
GP9;PLCG2;Gene;PA28825;Gene
ITGA2B;PLCG2;Gene;PA29938;Gene
KDR;PLCG2;Gene;PA30086;Gene
PLA2G4B;PLCG2;Gene;PA33364;Gene
PRKCA;PLCG2;Gene;PA33759;Gene
PRKCB;PLCG2;Gene;PA33761;Gene
PRKCD;PLCG2;Gene;PA33763;Gene
PRKCE;PLCG2;Gene;PA33765;Gene
PRKCG;PLCG2;Gene;PA33766;Gene
PRKCH;PLCG2;Gene;PA33767;Gene
PRKCI;PLCG2;Gene;PA33768;Gene
PRKD1;PLCG2;Gene;PA33771;Gene
PRKCQ;PLCG2;Gene;PA33773;Gene
PRKCZ;PLCG2;Gene;PA33775;Gene
EGFR;PLCG2;Gene;PA7360;Gene
OPIOID-RELATED DISORDERS;rs10799590;Variant;PA445043;Disease
OPIOIDS;rs10799590;Variant;PA452618;Chemical
ABL1;Philadelphia Chromosome;Disease;PA24413;Gene
BCR;Philadelphia Chromosome;Disease;PA25321;Gene
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;Philadelphia Chromosome;Disease;PA446171;Disease
RS7439366;buprenorphine / naloxone;Chemical;PA166156619;Variant
RS7662029;buprenorphine / naloxone;Chemical;PA166156621;Variant
UGT2B7;buprenorphine / naloxone;Chemical;PA361;Gene
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*55:02;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*55:02;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*55:02;Haplotype;PA445738;Disease
METHAZOLAMIDE;HLA-B*55:02;Haplotype;PA450413;Chemical
NEVIRAPINE;HLA-B*55:02;Haplotype;PA450616;Chemical
METHAMPHETAMINE DEPENDENCE;rs2133896;Variant;PA166119022;Disease
ALCOHOL ABUSE;rs2133896;Variant;PA443309;Disease
HEROIN DEPENDENCE;rs2133896;Variant;PA444460;Disease
ETHANOL;rs2133896;Variant;PA448073;Chemical
METHAMPHETAMINE;rs2133896;Variant;PA450403;Chemical
HEROIN;rs2133896;Variant;PA452619;Chemical
IL2RA;denileukin diftitox;Chemical;PA29828;Gene
ESR1;eribulin;Chemical;PA156;Gene
PGR;eribulin;Chemical;PA266;Gene
ERBB2;eribulin;Chemical;PA27844;Gene
ESR2;eribulin;Chemical;PA27886;Gene
DAUNORUBICIN;rs4987102;Variant;PA449212;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs6551665;Variant;PA447197;Disease
METHYLPHENIDATE;rs6551665;Variant;PA450464;Chemical
CISPLATIN;gemcitabine triphosphate;Chemical;PA449014;Chemical
DACARBAZINE;gemcitabine triphosphate;Chemical;PA449197;Chemical
GEFITINIB;ERBB3;Gene;PA131301952;Chemical
ERLOTINIB;ERBB3;Gene;PA134687924;Chemical
LAPATINIB;ERBB3;Gene;PA152241907;Chemical
JAK1;ERBB3;Gene;PA29988;Gene
PIK3CA;ERBB3;Gene;PA33308;Gene
PIK3CB;ERBB3;Gene;PA33309;Gene
PIK3CD;ERBB3;Gene;PA33310;Gene
PIK3CG;ERBB3;Gene;PA33311;Gene
PIK3R1;ERBB3;Gene;PA33312;Gene
PIK3R2;ERBB3;Gene;PA33313;Gene
PIK3R3;ERBB3;Gene;PA33314;Gene
PLCG1;ERBB3;Gene;PA33392;Gene
PLCG2;ERBB3;Gene;PA33393;Gene
BREAST NEOPLASMS;ERBB3;Gene;PA443560;Disease
CARBOPLATIN;ERBB3;Gene;PA448803;Chemical
DOCETAXEL;ERBB3;Gene;PA449383;Chemical
TRASTUZUMAB;ERBB3;Gene;PA451743;Chemical
ATORVASTATIN;rs3808607;Variant;PA448500;Chemical
RS1042713;phenylephrine;Chemical;PA166156748;Variant
ADRA1D;phenylephrine;Chemical;PA24597;Gene
ADRA1B;phenylephrine;Chemical;PA33;Gene
ADRA1A;phenylephrine;Chemical;PA34;Gene
ADRB2;phenylephrine;Chemical;PA39;Gene
FLUOROURACIL;rs118129530;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs118129530;Variant;PA443560;Disease
NEUTROPENIA;rs118129530;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs118129530;Variant;PA449165;Chemical
EPIRUBICIN;rs118129530;Variant;PA449476;Chemical
LIVER CIRRHOSIS;rs11269124;Variant;PA444797;Disease
CLONIDINE;rs11269124;Variant;PA449051;Chemical
MIGALASTAT;HNRNPH2;Gene;PA166182881;Chemical
FABRY DISEASE;HNRNPH2;Gene;PA443367;Disease
BISPHOSPHONATES;MEX3C;Gene;PA164712563;Chemical
OSTEONECROSIS;MEX3C;Gene;PA445187;Disease
NICOTINE;FMO1;Gene;PA450626;Chemical
OLANZAPINE;FMO1;Gene;PA450688;Chemical
TAMOXIFEN;FMO1;Gene;PA451581;Chemical
LEVOTHYROXINE;TSHB;Gene;PA450221;Chemical
RS1045642;agomelatine;Chemical;PA166157284;Variant
ABCB1;agomelatine;Chemical;PA267;Gene
CYP2B6;Adrenocortical Carcinoma;Disease;PA123;Gene
RS3745274;Adrenocortical Carcinoma;Disease;PA166155409;Variant
DIABETES MELLITUS, TYPE 2;rs10811661;Variant;PA443890;Disease
TROGLITAZONE;rs10811661;Variant;PA451799;Chemical
HYPERTENSION;NPHS1;Gene;PA444552;Disease
LOSARTAN;NPHS1;Gene;PA450268;Chemical
CES1;heroin;Chemical;PA107;Gene
COMT;heroin;Chemical;PA117;Gene
ANKS1B;heroin;Chemical;PA128394692;Gene
BDNF-AS;heroin;Chemical;PA134953249;Gene
DBH;heroin;Chemical;PA136;Gene
RS2236861;heroin;Chemical;PA166153682;Variant
RS4654327;heroin;Chemical;PA166153773;Variant
RS6265;heroin;Chemical;PA166154259;Variant
RS3758987;heroin;Chemical;PA166154401;Variant
RS12364283;heroin;Chemical;PA166154464;Variant
RS671;heroin;Chemical;PA166154482;Variant
RS71647871;heroin;Chemical;PA166155135;Variant
RS1534891;heroin;Chemical;PA166156078;Variant
RS510769;heroin;Chemical;PA166156924;Variant
RS1799971;heroin;Chemical;PA166156991;Variant
RS2075572;heroin;Chemical;PA166157015;Variant
RS3778151;heroin;Chemical;PA166157079;Variant
RS9479757;heroin;Chemical;PA166157164;Variant
RS274618;heroin;Chemical;PA166157251;Variant
RS274622;heroin;Chemical;PA166157252;Variant
RS724226;heroin;Chemical;PA166157264;Variant
RS1990040;heroin;Chemical;PA166157314;Variant
RS2189814;heroin;Chemical;PA166157328;Variant
RS13242038;heroin;Chemical;PA166157465;Variant
RS1051660;heroin;Chemical;PA166157551;Variant
RS2758339;heroin;Chemical;PA166177621;Variant
RS5746136;heroin;Chemical;PA166177622;Variant
RS495491;heroin;Chemical;PA166177792;Variant
RS62638690;heroin;Chemical;PA166177955;Variant
RS2236857;heroin;Chemical;PA166179883;Variant
RS562859;heroin;Chemical;PA166179966;Variant
RS511435;heroin;Chemical;PA166183701;Variant
RS524731;heroin;Chemical;PA166183702;Variant
RS3823010;heroin;Chemical;PA166183703;Variant
RS6473797;heroin;Chemical;PA166183884;Variant
RS694066;heroin;Chemical;PA166183887;Variant
RS3766951;heroin;Chemical;PA166183890;Variant
RS2236855;heroin;Chemical;PA166184206;Variant
RS2298897;heroin;Chemical;PA166184208;Variant
RS508448;heroin;Chemical;PA166184212;Variant
RS9478495;heroin;Chemical;PA166184665;Variant
RS3778150;heroin;Chemical;PA166184666;Variant
RS9384169;heroin;Chemical;PA166184667;Variant
RS16917234;heroin;Chemical;PA166185222;Variant
RS2133896;heroin;Chemical;PA166200161;Variant
RS1611114;heroin;Chemical;PA166233886;Variant
ALDH2;heroin;Chemical;PA24696;Gene
CSNK1E;heroin;Chemical;PA26953;Gene
DRD2;heroin;Chemical;PA27478;Gene
GAL;heroin;Chemical;PA28529;Gene
GRM3;heroin;Chemical;PA28992;Gene
HTR3B;heroin;Chemical;PA29556;Gene
BDNF;heroin;Chemical;PA31891;Gene
OPRD1;heroin;Chemical;PA31942;Gene
OPRK1;heroin;Chemical;PA31943;Gene
OPRM1;heroin;Chemical;PA31945;Gene
SOD2;heroin;Chemical;PA36017;Gene
IMATINIB;rs762551;Variant;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;rs762551;Variant;PA151958383;Disease
DEFERASIROX;rs762551;Variant;PA164760843;Chemical
INSOMNIA;rs762551;Variant;PA166123307;Disease
ABORTION, SPONTANEOUS;rs762551;Variant;PA443227;Disease
RHEUMATOID ARTHRITIS;rs762551;Variant;PA443434;Disease
MYOCARDIAL INFARCTION;rs762551;Variant;PA445019;Disease
SEIZURES;rs762551;Variant;PA445629;Disease
BETA-THALASSEMIA AND RELATED DISEASES;rs762551;Variant;PA446432;Disease
SCHIZOPHRENIA;rs762551;Variant;PA447216;Disease
MAJOR DEPRESSIVE DISORDER;rs762551;Variant;PA447321;Disease
CAFFEINE;rs762551;Variant;PA448710;Chemical
CARBAMAZEPINE;rs762551;Variant;PA448785;Chemical
CLOPIDOGREL;rs762551;Variant;PA449053;Chemical
CLOZAPINE;rs762551;Variant;PA449061;Chemical
LEFLUNOMIDE;rs762551;Variant;PA450192;Chemical
OLANZAPINE;rs762551;Variant;PA450688;Chemical
PAROXETINE;rs762551;Variant;PA450801;Chemical
ANTIPSYCHOTICS;rs762551;Variant;PA452233;Chemical
ACE INHIBITORS, PLAIN;rs6838116;Variant;PA164712308;Chemical
DIABETES MELLITUS;PLEKHH2;Gene;PA443886;Disease
HYPERTENSION;PLEKHH2;Gene;PA444552;Disease
ATENOLOL;PLEKHH2;Gene;PA448499;Chemical
VERAPAMIL;PLEKHH2;Gene;PA451868;Chemical
ACE;chlorthalidone;Chemical;PA139;Gene
RS5065;chlorthalidone;Chemical;PA166153549;Variant
RS11122576;chlorthalidone;Chemical;PA166153819;Variant
RS12143842;chlorthalidone;Chemical;PA166153854;Variant
RS4291;chlorthalidone;Chemical;PA166155143;Variant
RS200148;chlorthalidone;Chemical;PA166156912;Variant
RS35068180;chlorthalidone;Chemical;PA166181205;Variant
NPPA;chlorthalidone;Chemical;PA256;Gene
MMP3;chlorthalidone;Chemical;PA30886;Gene
AGT;chlorthalidone;Chemical;PA42;Gene
ARIPIPRAZOLE;HTR2A;Gene;PA10026;Chemical
DULOXETINE;HTR2A;Gene;PA10066;Chemical
ESCITALOPRAM;HTR2A;Gene;PA10074;Chemical
WEIGHT GAIN;HTR2A;Gene;PA128406954;Disease
ANALGESICS;HTR2A;Gene;PA164712362;Chemical
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;HTR2A;Gene;PA164712462;Chemical
ERGOT ALKALOIDS;HTR2A;Gene;PA164712741;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;HTR2A;Gene;PA164713257;Chemical
MILNACIPRAN;HTR2A;Gene;PA164752812;Chemical
DIVALPROEX SODIUM;HTR2A;Gene;PA164783479;Chemical
VILAZODONE;HTR2A;Gene;PA165958365;Chemical
DESVENLAFAXINE;HTR2A;Gene;PA165958374;Chemical
VORTIOXETINE;HTR2A;Gene;PA166122595;Chemical
ADVERSE EVENTS;HTR2A;Gene;PA166151827;Disease
LEVOMILNACIPRAN;HTR2A;Gene;PA166182150;Chemical
DIMINISHED ABILITY TO CONCENTRATE;HTR2A;Gene;PA166264221;Disease
GNAQ;HTR2A;Gene;PA174;Gene
ALZHEIMER DISEASE;HTR2A;Gene;PA443319;Disease
DIARRHEA;HTR2A;Gene;PA443899;Disease
DIZZINESS;HTR2A;Gene;PA443928;Disease
DRUG TOXICITY;HTR2A;Gene;PA443937;Disease
NAUSEA;HTR2A;Gene;PA445048;Disease
TREMOR;HTR2A;Gene;PA445917;Disease
VOMITING;HTR2A;Gene;PA446051;Disease
ANXIETY DISORDERS;HTR2A;Gene;PA447196;Disease
AUTISM;HTR2A;Gene;PA447198;Disease
BIPOLAR DISORDER;HTR2A;Gene;PA447199;Disease
DEPRESSIVE DISORDER;HTR2A;Gene;PA447207;Disease
OBSESSIVE-COMPULSIVE DISORDER;HTR2A;Gene;PA447211;Disease
PSYCHOTIC DISORDER;HTR2A;Gene;PA447215;Disease
SCHIZOPHRENIA;HTR2A;Gene;PA447216;Disease
PHYSIOLOGICAL SEXUAL DISORDER;HTR2A;Gene;PA447218;Disease
HIV INFECTIOUS DISEASE;HTR2A;Gene;PA447230;Disease
TARDIVE DYSKINESIA;HTR2A;Gene;PA447268;Disease
DEPRESSION;HTR2A;Gene;PA447278;Disease
MAJOR DEPRESSIVE DISORDER;HTR2A;Gene;PA447321;Disease
AMITRIPTYLINE;HTR2A;Gene;PA448385;Chemical
BUPROPION;HTR2A;Gene;PA448687;Chemical
BUSPIRONE;HTR2A;Gene;PA448689;Chemical
CARBAMAZEPINE;HTR2A;Gene;PA448785;Chemical
CITALOPRAM;HTR2A;Gene;PA449015;Chemical
CLOZAPINE;HTR2A;Gene;PA449061;Chemical
DIAZEPAM;HTR2A;Gene;PA449283;Chemical
EFAVIRENZ;HTR2A;Gene;PA449441;Chemical
FLUOXETINE;HTR2A;Gene;PA449673;Chemical
FLUVOXAMINE;HTR2A;Gene;PA449690;Chemical
LAMOTRIGINE;HTR2A;Gene;PA450164;Chemical
MIRTAZAPINE;HTR2A;Gene;PA450522;Chemical
MODAFINIL;HTR2A;Gene;PA450530;Chemical
NORTRIPTYLINE;HTR2A;Gene;PA450657;Chemical
OLANZAPINE;HTR2A;Gene;PA450688;Chemical
OXCARBAZEPINE;HTR2A;Gene;PA450732;Chemical
PAROXETINE;HTR2A;Gene;PA450801;Chemical
PHENYTOIN;HTR2A;Gene;PA450947;Chemical
QUETIAPINE;HTR2A;Gene;PA451201;Chemical
RISPERIDONE;HTR2A;Gene;PA451257;Chemical
SERTRALINE;HTR2A;Gene;PA451333;Chemical
SUMATRIPTAN;HTR2A;Gene;PA451566;Chemical
TRAZODONE;HTR2A;Gene;PA451744;Chemical
VALPROIC ACID;HTR2A;Gene;PA451846;Chemical
VENLAFAXINE;HTR2A;Gene;PA451866;Chemical
ZIPRASIDONE;HTR2A;Gene;PA451974;Chemical
ANTIDEPRESSANTS;HTR2A;Gene;PA452229;Chemical
ANTIPSYCHOTICS;HTR2A;Gene;PA452233;Chemical
OPIOIDS;HTR2A;Gene;PA452618;Chemical
CYP2B6;nevirapine;Chemical;PA123;Gene
CYP2C19;nevirapine;Chemical;PA124;Gene
CYP2C9;nevirapine;Chemical;PA126;Gene
CYP2D6;nevirapine;Chemical;PA128;Gene
CYP3A4;nevirapine;Chemical;PA130;Gene
CYP3A5;nevirapine;Chemical;PA131;Gene
CCHCR1;nevirapine;Chemical;PA134942738;Gene
HCP5;nevirapine;Chemical;PA134951826;Gene
POLR3G;nevirapine;Chemical;PA134986024;Gene
CYCSP5;nevirapine;Chemical;PA142672032;Gene
CYP2B6*1;nevirapine;Chemical;PA165818750;Haplotype
CYP2B6*6;nevirapine;Chemical;PA165818762;Haplotype
CYP2B6*18;nevirapine;Chemical;PA165818808;Haplotype
HLA-DRB1*01:01;nevirapine;Chemical;PA165951320;Haplotype
HLA-DRB1*01:02;nevirapine;Chemical;PA165951340;Haplotype
HLA-DRB1*01:03;nevirapine;Chemical;PA165951348;Haplotype
HLA-DRB1*04:04;nevirapine;Chemical;PA165951511;Haplotype
HLA-DRB1*08:01;nevirapine;Chemical;PA165951669;Haplotype
HLA-DRB1*10:01;nevirapine;Chemical;PA165951757;Haplotype
HLA-DRB1*15:01;nevirapine;Chemical;PA165952269;Haplotype
HLA-DRB1*15:03;nevirapine;Chemical;PA165952297;Haplotype
HLA-B*13:02;nevirapine;Chemical;PA165954649;Haplotype
HLA-B*14:02;nevirapine;Chemical;PA165954712;Haplotype
HLA-B*15:01;nevirapine;Chemical;PA165954745;Haplotype
HLA-B*15:12;nevirapine;Chemical;PA165954792;Haplotype
HLA-B*15:24;nevirapine;Chemical;PA165954811;Haplotype
HLA-B*15:25;nevirapine;Chemical;PA165954812;Haplotype
HLA-B*15:27;nevirapine;Chemical;PA165954816;Haplotype
HLA-B*15:32;nevirapine;Chemical;PA165954823;Haplotype
HLA-B*15:35;nevirapine;Chemical;PA165954826;Haplotype
HLA-B*35:01;nevirapine;Chemical;PA165955215;Haplotype
HLA-B*35:05;nevirapine;Chemical;PA165955262;Haplotype
HLA-B*35:10;nevirapine;Chemical;PA165955274;Haplotype
HLA-B*38:01;nevirapine;Chemical;PA165955500;Haplotype
HLA-B*38:02;nevirapine;Chemical;PA165955505;Haplotype
HLA-B*39:01;nevirapine;Chemical;PA165955543;Haplotype
HLA-B*39:05;nevirapine;Chemical;PA165955559;Haplotype
HLA-B*39:06;nevirapine;Chemical;PA165955561;Haplotype
HLA-B*39:09;nevirapine;Chemical;PA165955565;Haplotype
HLA-B*39:10;nevirapine;Chemical;PA165955566;Haplotype
HLA-B*40:01;nevirapine;Chemical;PA165955628;Haplotype
HLA-B*51:01;nevirapine;Chemical;PA165956201;Haplotype
HLA-B*51:02;nevirapine;Chemical;PA165956231;Haplotype
HLA-B*52:01;nevirapine;Chemical;PA165956366;Haplotype
HLA-B*54:01;nevirapine;Chemical;PA165956438;Haplotype
HLA-B*55:01;nevirapine;Chemical;PA165956463;Haplotype
HLA-B*55:02;nevirapine;Chemical;PA165956471;Haplotype
HLA-B*56:01;nevirapine;Chemical;PA165956528;Haplotype
HLA-B*56:06;nevirapine;Chemical;PA165956537;Haplotype
HLA-B*58:02;nevirapine;Chemical;PA165956639;Haplotype
HLA-B*67:01;nevirapine;Chemical;PA165956680;Haplotype
HLA-B*78:01;nevirapine;Chemical;PA165956686;Haplotype
HLA-C*02:10;nevirapine;Chemical;PA165956805;Haplotype
HLA-C*04:01;nevirapine;Chemical;PA165957046;Haplotype
HLA-C*04:03;nevirapine;Chemical;PA165957085;Haplotype
HLA-C*04:06;nevirapine;Chemical;PA165957089;Haplotype
HLA-C*04:07;nevirapine;Chemical;PA165957090;Haplotype
HLA-C*05:01;nevirapine;Chemical;PA165957192;Haplotype
HLA-C*05:09;nevirapine;Chemical;PA165957217;Haplotype
HLA-C*08:02;nevirapine;Chemical;PA165957658;Haplotype
HLA-C*18:01;nevirapine;Chemical;PA165958003;Haplotype
HLA-DQB1*05:01;nevirapine;Chemical;PA165958073;Haplotype
HLA-DQB1*06:02;nevirapine;Chemical;PA165958103;Haplotype
HLA-DQB1*06:03;nevirapine;Chemical;PA165958105;Haplotype
HLA-DQB1*06:09;nevirapine;Chemical;PA165958117;Haplotype
HLA-DQB1*02:01;nevirapine;Chemical;PA165958158;Haplotype
HLA-DQB1*03:02;nevirapine;Chemical;PA165958175;Haplotype
HLA-B*57:01;nevirapine;Chemical;PA165987830;Haplotype
HLA-B*58:01;nevirapine;Chemical;PA165987831;Haplotype
GSTM1 NULL;nevirapine;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;nevirapine;Chemical;PA166048676;Haplotype
HLA-C*03:02;nevirapine;Chemical;PA166123425;Haplotype
HLA-C*08:01;nevirapine;Chemical;PA166123426;Haplotype
RS12768009;nevirapine;Chemical;PA166154155;Variant
RS2054675;nevirapine;Chemical;PA166155378;Variant
RS3745274;nevirapine;Chemical;PA166155409;Variant
RS3786547;nevirapine;Chemical;PA166155411;Variant
RS12721646;nevirapine;Chemical;PA166155465;Variant
RS28399499;nevirapine;Chemical;PA166155478;Variant
RS58425034;nevirapine;Chemical;PA166155511;Variant
RS6545803;nevirapine;Chemical;PA166155746;Variant
RS28371706;nevirapine;Chemical;PA166156151;Variant
RS3842689;nevirapine;Chemical;PA166156387;Variant
RS2562519;nevirapine;Chemical;PA166156804;Variant
RS130072;nevirapine;Chemical;PA166156909;Variant
RS746647;nevirapine;Chemical;PA166156944;Variant
RS1265112;nevirapine;Chemical;PA166156982;Variant
RS2073724;nevirapine;Chemical;PA166157014;Variant
RS2125739;nevirapine;Chemical;PA166157018;Variant
RS3099844;nevirapine;Chemical;PA166157066;Variant
RS9461684;nevirapine;Chemical;PA166157160;Variant
RS76228616;nevirapine;Chemical;PA166157221;Variant
RS776746;nevirapine;Chemical;PA166157267;Variant
RS1045642;nevirapine;Chemical;PA166157284;Variant
NAT2;nevirapine;Chemical;PA18;Gene
GSTM1;nevirapine;Chemical;PA182;Gene
ABCC10;nevirapine;Chemical;PA24392;Gene
TRAF3IP2;nevirapine;Chemical;PA25938;Gene
ABCB1;nevirapine;Chemical;PA267;Gene
HLA-B;nevirapine;Chemical;PA35056;Gene
HLA-C;nevirapine;Chemical;PA35057;Gene
HLA-DQB1;nevirapine;Chemical;PA35068;Gene
HLA-DRB1;nevirapine;Chemical;PA35072;Gene
TCF19;nevirapine;Chemical;PA36384;Gene
NR1I2;nevirapine;Chemical;PA378;Gene
RS267606618;plazomicin;Chemical;PA166158908;Variant
RS267606619;plazomicin;Chemical;PA166158909;Variant
RS267606617;plazomicin;Chemical;PA166159181;Variant
MT-RNR1;plazomicin;Chemical;PA31274;Gene
FLUOROURACIL;rs374150125;Variant;PA128406956;Chemical
CLADRIBINE;rs374150125;Variant;PA449027;Chemical
GEMCITABINE;rs374150125;Variant;PA449748;Chemical
CDK4;somatropin recombinant;Chemical;PA102;Gene
RS2069502;somatropin recombinant;Chemical;PA166154525;Variant
RS2270777;somatropin recombinant;Chemical;PA166154538;Variant
RS1800012;somatropin recombinant;Chemical;PA166155190;Variant
COL1A1;somatropin recombinant;Chemical;PA35041;Gene
HYPERTENSION;rs4648287;Variant;PA444552;Disease
ATENOLOL;rs4648287;Variant;PA448499;Chemical
ABIRATERONE;SRD5A2;Gene;PA166123407;Chemical
PROSTATIC NEOPLASMS;SRD5A2;Gene;PA445425;Disease
VORICONAZOLE;CYP2C19 poor metabolizers and intermediate metabolizers;Variant;PA10233;Chemical
MYCOSES;CYP2C19 poor metabolizers and intermediate metabolizers;Variant;PA445009;Disease
ANTIEPILEPTICS;rs16935279;Variant;PA143485705;Chemical
PSYCHOTIC DISORDER;rs16935279;Variant;PA447215;Disease
SCHIZOPHRENIA;rs16935279;Variant;PA447216;Disease
ANTHRACYCLINES AND RELATED SUBSTANCES;ECT2L;Gene;PA130620651;Chemical
BREAST NEOPLASMS;ECT2L;Gene;PA443560;Disease
FLUOROURACIL;rs299293;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs299293;Variant;PA443560;Disease
NEUTROPENIA;rs299293;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs299293;Variant;PA449165;Chemical
EPIRUBICIN;rs299293;Variant;PA449476;Chemical
HEARING LOSS;ACYP2;Gene;PA145069467;Disease
OTOTOXICITY;ACYP2;Gene;PA162263534;Disease
BRAIN NEOPLASMS;ACYP2;Gene;PA443557;Disease
CISPLATIN;ACYP2;Gene;PA449014;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;CYP2E1*1A;Haplotype;PA164712708;Chemical
PYRIDOXAL PHOSPHATE;CYP2E1*1A;Haplotype;PA164749650;Chemical
TOXIC LIVER DISEASE;CYP2E1*1A;Haplotype;PA164925725;Disease
TUBERCULOSIS;CYP2E1*1A;Haplotype;PA445941;Disease
ISONIAZID;CYP2E1*1A;Haplotype;PA450112;Chemical
SCHIZOPHRENIA;rs11677416;Variant;PA447216;Disease
OLANZAPINE;rs11677416;Variant;PA450688;Chemical
CYP2D6;Patent Ductus Arteriosus;Disease;PA128;Gene
CYP2D6*10;Patent Ductus Arteriosus;Disease;PA165816582;Haplotype
RS2069514;Patent Ductus Arteriosus;Disease;PA166154874;Variant
CYP1A2;Patent Ductus Arteriosus;Disease;PA27093;Gene
SCHIZOPHRENIA;PPA2;Gene;PA447216;Disease
RISPERIDONE;PPA2;Gene;PA451257;Chemical
BIPOLAR DISORDER;rs2071427;Variant;PA447199;Disease
LITHIUM;rs2071427;Variant;PA450243;Chemical
THIAZIDES, PLAIN;rs13306673;Variant;PA164713347;Chemical
ESSENTIAL HYPERTENSION;rs13306673;Variant;PA447288;Disease
COTININE;rs2075572;Variant;PA166114414;Chemical
METHAMPHETAMINE DEPENDENCE;rs2075572;Variant;PA166119022;Disease
HEROIN DEPENDENCE;rs2075572;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs2075572;Variant;PA445043;Disease
ETHANOL;rs2075572;Variant;PA448073;Chemical
METHADONE;rs2075572;Variant;PA450401;Chemical
METHAMPHETAMINE;rs2075572;Variant;PA450403;Chemical
MORPHINE;rs2075572;Variant;PA450550;Chemical
NICOTINE;rs2075572;Variant;PA450626;Chemical
HEROIN;rs2075572;Variant;PA452619;Chemical
CYP2B6;Hepatic Veno-Occlusive Disease;Disease;PA123;Gene
RS3745274;Hepatic Veno-Occlusive Disease;Disease;PA166155409;Variant
TSBP1;Hypothyroidism;Disease;PA25923;Gene
DIABETES MELLITUS, TYPE 1;Hypothyroidism;Disease;PA443888;Disease
CORONARY ARTERY DISEASE;rs1126643;Variant;PA443796;Disease
CORONARY DISEASE;rs1126643;Variant;PA443797;Disease
MYOCARDIAL INFARCTION;rs1126643;Variant;PA445019;Disease
ASPIRIN;rs1126643;Variant;PA448497;Chemical
CLOPIDOGREL;rs1126643;Variant;PA449053;Chemical
CYP2C19;Mental Disorders;Disease;PA124;Gene
CYP2C9;Mental Disorders;Disease;PA126;Gene
CYP2D6;Mental Disorders;Disease;PA128;Gene
CYP2C19*17;Mental Disorders;Disease;PA165816533;Haplotype
CYP2C9*1;Mental Disorders;Disease;PA165816542;Haplotype
CYP2C9*2;Mental Disorders;Disease;PA165816543;Haplotype
CYP2C9*3;Mental Disorders;Disease;PA165816544;Haplotype
CYP2D6*1;Mental Disorders;Disease;PA165816576;Haplotype
CYP2D6*2;Mental Disorders;Disease;PA165816577;Haplotype
CYP2D6*3;Mental Disorders;Disease;PA165816578;Haplotype
CYP2D6*4;Mental Disorders;Disease;PA165816579;Haplotype
CYP2D6*6;Mental Disorders;Disease;PA165816581;Haplotype
CYP2D6*10;Mental Disorders;Disease;PA165816582;Haplotype
CYP2D6*17;Mental Disorders;Disease;PA165816583;Haplotype
CYP2D6*41;Mental Disorders;Disease;PA165816584;Haplotype
CYP2D6*5;Mental Disorders;Disease;PA165948092;Haplotype
CYP2D6*9;Mental Disorders;Disease;PA165948317;Haplotype
CYP2C19*1;Mental Disorders;Disease;PA165980634;Haplotype
CYP2C19*2;Mental Disorders;Disease;PA165980635;Haplotype
CYP2C19*3;Mental Disorders;Disease;PA165980636;Haplotype
CYP2D6*1XN;Mental Disorders;Disease;PA165988479;Haplotype
CYP2D6*2XN;Mental Disorders;Disease;PA165988480;Haplotype
RS1176744;Mental Disorders;Disease;PA166154324;Variant
RS2440390;Mental Disorders;Disease;PA166154369;Variant
RS1414334;Mental Disorders;Disease;PA166157862;Variant
RS3813929;Mental Disorders;Disease;PA166157875;Variant
HTR2C;Mental Disorders;Disease;PA194;Gene
DRD2;Mental Disorders;Disease;PA27478;Gene
HTR3B;Mental Disorders;Disease;PA29556;Gene
POLATUZUMAB VEDOTIN;BCL6;Gene;PA166313341;Chemical
NEPHROTOXICITY;rs4646316;Variant;PA162263533;Disease
OTOTOXICITY;rs4646316;Variant;PA162263534;Disease
DRUG TOXICITY;rs4646316;Variant;PA443937;Disease
NEOPLASMS;rs4646316;Variant;PA445062;Disease
CISPLATIN;rs4646316;Variant;PA449014;Chemical
HLA-A*31:01;Neuralgia;Disease;PA165954030;Haplotype
HLA-A;Neuralgia;Disease;PA35055;Gene
BETAINE;MMADHC;Gene;PA448603;Chemical
NICOTINE;rs61605570;Variant;PA450626;Chemical
NON-SELECTIVE MONOAMINE REUPTAKE INHIBITORS;SCN5A;Gene;PA10389;Chemical
BRUGADA SYNDROME;SCN5A;Gene;PA159018367;Disease
HEART BLOCK;SCN5A;Gene;PA444366;Disease
LONG QT SYNDROME;SCN5A;Gene;PA444807;Disease
SICK SINUS SYNDROME;SCN5A;Gene;PA445659;Disease
SUDDEN INFANT DEATH;SCN5A;Gene;PA445769;Disease
VENTRICULAR FIBRILLATION;SCN5A;Gene;PA446028;Disease
AMIODARONE;SCN5A;Gene;PA448383;Chemical
COCAINE;SCN5A;Gene;PA449072;Chemical
DISOPYRAMIDE;SCN5A;Gene;PA449373;Chemical
FLECAINIDE;SCN5A;Gene;PA449646;Chemical
LIDOCAINE;SCN5A;Gene;PA450226;Chemical
LITHIUM;SCN5A;Gene;PA450243;Chemical
MEXILETINE;SCN5A;Gene;PA450488;Chemical
PROCAINAMIDE;SCN5A;Gene;PA451108;Chemical
PROPAFENONE;SCN5A;Gene;PA451131;Chemical
QUINIDINE;SCN5A;Gene;PA451209;Chemical
IMATINIB;PDGFRB;Gene;PA10804;Chemical
SUNITINIB;PDGFRB;Gene;PA162372840;Chemical
HRAS;PDGFRB;Gene;PA29444;Gene
KRAS;PDGFRB;Gene;PA30196;Gene
NRAS;PDGFRB;Gene;PA31768;Gene
SORAFENIB;PDGFRB;Gene;PA7000;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs2228130;Variant;PA443622;Disease
GEMCITABINE;rs2228130;Variant;PA449748;Chemical
URTICARIA;HLA-DPB1*05:01;Haplotype;PA445999;Disease
ASPIRIN;HLA-DPB1*05:01;Haplotype;PA448497;Chemical
ADALIMUMAB;rs10919563;Variant;PA10004;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs10919563;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs10919563;Variant;PA443434;Disease
ETANERCEPT;rs10919563;Variant;PA449515;Chemical
INFLIXIMAB;rs10919563;Variant;PA452639;Chemical
CANGRELOR;rs6787801;Variant;PA165945763;Chemical
CLOPIDOGREL;rs6787801;Variant;PA449053;Chemical
ANEMIA;rs3732360;Variant;PA443340;Disease
NASOPHARYNGEAL NEOPLASMS;rs3732360;Variant;PA445046;Disease
DOCETAXEL;rs3732360;Variant;PA449383;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;TLR2;Gene;PA164713366;Chemical
ULCERATIVE COLITIS;TLR2;Gene;PA443750;Disease
CROHN DISEASE;TLR2;Gene;PA443815;Disease
PAIN, POSTOPERATIVE;TLR2;Gene;PA445210;Disease
PSORIASIS;TLR2;Gene;PA445451;Disease
INFLAMMATORY BOWEL DISEASES;TLR2;Gene;PA446116;Disease
MORPHINE;TLR2;Gene;PA450550;Chemical
BRENTUXIMAB VEDOTIN;TNFRSF8;Gene;PA165948903;Chemical
CYP3A5;Precursor T-Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA131;Gene
G6PD DEFICIENCY;Precursor T-Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA166157959;Variant
G6PD;Precursor T-Cell Lymphoblastic Leukemia-Lymphoma;Disease;PA28469;Gene
RS20417;rofecoxib;Chemical;PA166153559;Variant
PTGS2;rofecoxib;Chemical;PA293;Gene
COUMARIN;rs28399433;Variant;PA134521193;Chemical
TOBACCO USE DISORDER;rs28399433;Variant;PA445876;Disease
HIV INFECTIOUS DISEASE;rs28399433;Variant;PA447230;Disease
EFAVIRENZ;rs28399433;Variant;PA449441;Chemical
NICOTINE;rs28399433;Variant;PA450626;Chemical
TEGAFUR;rs28399433;Variant;PA452620;Chemical
PLATINUM COMPOUNDS;DYNC2H1;Gene;PA164713176;Chemical
ETOPOSIDE;DYNC2H1;Gene;PA449552;Chemical
BORTEZOMIB;rs4553808;Variant;PA10252;Chemical
KIDNEY TRANSPLANTATION;rs4553808;Variant;PA165817016;Disease
DEXAMETHASONE;rs4553808;Variant;PA449247;Chemical
MELPHALAN;rs4553808;Variant;PA450354;Chemical
PREDNISONE;rs4553808;Variant;PA451100;Chemical
TACROLIMUS;rs4553808;Variant;PA451578;Chemical
CYP2C19;ticagrelor;Chemical;PA124;Gene
CYP3A4;ticagrelor;Chemical;PA130;Gene
SLCO1B1;ticagrelor;Chemical;PA134865839;Gene
P2RY12;ticagrelor;Chemical;PA134971947;Gene
PEAR1;ticagrelor;Chemical;PA162399233;Gene
CYP3A4*1;ticagrelor;Chemical;PA165819201;Haplotype
CYP3A4*2;ticagrelor;Chemical;PA165819220;Haplotype
CYP3A4*3;ticagrelor;Chemical;PA165819221;Haplotype
CYP3A4*4;ticagrelor;Chemical;PA165819222;Haplotype
CYP3A4*5;ticagrelor;Chemical;PA165819223;Haplotype
CYP3A4*9;ticagrelor;Chemical;PA165819227;Haplotype
CYP3A4*11;ticagrelor;Chemical;PA165819229;Haplotype
CYP3A4*14;ticagrelor;Chemical;PA165819232;Haplotype
CYP3A4*15;ticagrelor;Chemical;PA165819233;Haplotype
CYP3A4*16;ticagrelor;Chemical;PA165819236;Haplotype
CYP3A4*17;ticagrelor;Chemical;PA165819239;Haplotype
CYP3A4*18;ticagrelor;Chemical;PA165819240;Haplotype
CYP3A4*19;ticagrelor;Chemical;PA165819243;Haplotype
CYP3A4*22;ticagrelor;Chemical;PA166048680;Haplotype
CYP3A4*24;ticagrelor;Chemical;PA166115837;Haplotype
RS12041331;ticagrelor;Chemical;PA166153839;Variant
RS12566888;ticagrelor;Chemical;PA166153859;Variant
RS4244285;ticagrelor;Chemical;PA166154053;Variant
RS4149056;ticagrelor;Chemical;PA166154579;Variant
RS113681054;ticagrelor;Chemical;PA166154664;Variant
RS61361928;ticagrelor;Chemical;PA166156689;Variant
RS56324128;ticagrelor;Chemical;PA166157496;Variant
RS62471956;ticagrelor;Chemical;PA166157501;Variant
RS4661012;ticagrelor;Chemical;PA166162370;Variant
CYP3A4*28;ticagrelor;Chemical;PA166245584;Haplotype
CYP3A4*29;ticagrelor;Chemical;PA166245585;Haplotype
CYP3A4*31;ticagrelor;Chemical;PA166245587;Haplotype
CYP3A4*33;ticagrelor;Chemical;PA166245589;Haplotype
SVEP1;ticagrelor;Chemical;PA25971;Gene
NUP153;ticagrelor;Chemical;PA31848;Gene
UGT2B7;ticagrelor;Chemical;PA361;Gene
CYP3A43;ticagrelor;Chemical;PA427;Gene
RS267606618;gentamicin;Chemical;PA166158908;Variant
RS267606619;gentamicin;Chemical;PA166158909;Variant
RS28358569;gentamicin;Chemical;PA166158910;Variant
RS267606617;gentamicin;Chemical;PA166159181;Variant
MT-RNR1;gentamicin;Chemical;PA31274;Gene
SCHIZOPHRENIA;rs1468412;Variant;PA447216;Disease
ANTIPSYCHOTICS;rs1468412;Variant;PA452233;Chemical
DPYD;rs137999090;Variant;PA145;Gene
CAPECITABINE;rs137999090;Variant;PA448771;Chemical
USTEKINUMAB;rs5744174;Variant;PA166048654;Chemical
PSORIASIS;rs5744174;Variant;PA445451;Disease
ANTHRACYCLINES AND RELATED SUBSTANCES;SLC10A2;Gene;PA130620651;Chemical
NEOPLASMS;SLC10A2;Gene;PA445062;Disease
PROSTATIC NEOPLASMS;SLC10A2;Gene;PA445425;Disease
DOCETAXEL;SLC10A2;Gene;PA449383;Chemical
THALIDOMIDE;SLC10A2;Gene;PA451644;Chemical
UGT2B15*1;sipoglitazar;Chemical;PA165984975;Haplotype
UGT2B15*2;sipoglitazar;Chemical;PA165984976;Haplotype
UGT2B15;sipoglitazar;Chemical;PA37188;Gene
BIPOLAR DISORDER;rs61123830;Variant;PA447199;Disease
LITHIUM;rs61123830;Variant;PA450243;Chemical
WARFARIN;rs10509680;Variant;PA451906;Chemical
DULOXETINE;rs17724464;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs17724464;Variant;PA447321;Disease
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;rs8176719;Variant;PA452637;Chemical
MAJOR DEPRESSIVE DISORDER;UST;Gene;PA447321;Disease
NORTRIPTYLINE;UST;Gene;PA450657;Chemical
COMT;Migraine without Aura;Disease;PA117;Gene
ACE;Migraine without Aura;Disease;PA139;Gene
RS6275;Migraine without Aura;Disease;PA166154260;Variant
RS1799752;Migraine without Aura;Disease;PA166155187;Variant
RS4680;Migraine without Aura;Disease;PA166156024;Variant
RS1800629;Migraine without Aura;Disease;PA166156997;Variant
RS1045642;Migraine without Aura;Disease;PA166157284;Variant
RS1799983;Migraine without Aura;Disease;PA166157303;Variant
RS12615320;Migraine without Aura;Disease;PA166349381;Variant
NOS3;Migraine without Aura;Disease;PA254;Gene
ABCB1;Migraine without Aura;Disease;PA267;Gene
DRD2;Migraine without Aura;Disease;PA27478;Gene
LTA;Migraine without Aura;Disease;PA30474;Gene
LST1;Migraine without Aura;Disease;PA37856;Gene
TNF;Migraine without Aura;Disease;PA435;Gene
MYELOSUPPRESSION;rs11969064;Variant;PA165817398;Disease
INFLAMMATORY BOWEL DISEASES;rs11969064;Variant;PA446116;Disease
AZATHIOPRINE;rs11969064;Variant;PA448515;Chemical
MERCAPTOPURINE;rs11969064;Variant;PA450379;Chemical
THIOGUANINE;rs11969064;Variant;PA451663;Chemical
TOBACCO USE DISORDER;GALR1;Gene;PA445876;Disease
BUPROPION;GALR1;Gene;PA448687;Chemical
NICOTINE;GALR1;Gene;PA450626;Chemical
PEMETREXED;rs1801131;Variant;PA10810;Chemical
FLUOROURACIL;rs1801131;Variant;PA128406956;Chemical
BEVACIZUMAB;rs1801131;Variant;PA130232992;Chemical
OXALIPLATIN;rs1801131;Variant;PA131285527;Chemical
SLCO1B1;rs1801131;Variant;PA134865839;Gene
F2;rs1801131;Variant;PA157;Gene
F5;rs1801131;Variant;PA159;Gene
VITAMIN B-COMPLEX, INCL. COMBINATIONS;rs1801131;Variant;PA164713398;Chemical
ETHINYL ESTRADIOL / NORELGESTROMIN;rs1801131;Variant;PA165290929;Chemical
SCHIZOAFFECTIVE DISORDER;rs1801131;Variant;PA166123368;Disease
L-METHYLFOLATE;rs1801131;Variant;PA166182939;Chemical
MTHFR;rs1801131;Variant;PA245;Gene
ABCB1;rs1801131;Variant;PA267;Gene
SLC19A1;rs1801131;Variant;PA327;Gene
PROC;rs1801131;Variant;PA33799;Gene
PROS1;rs1801131;Variant;PA33809;Gene
SERPINC1;rs1801131;Variant;PA35026;Gene
RHEUMATOID ARTHRITIS;rs1801131;Variant;PA443434;Disease
BURKITT LYMPHOMA;rs1801131;Variant;PA443580;Disease
NON-HODGKIN LYMPHOMA;rs1801131;Variant;PA444845;Disease
NEOPLASMS;rs1801131;Variant;PA445062;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs1801131;Variant;PA446155;Disease
LYMPHOMA, T-CELL;rs1801131;Variant;PA446309;Disease
SCHIZOPHRENIA;rs1801131;Variant;PA447216;Disease
MAJOR DEPRESSIVE DISORDER;rs1801131;Variant;PA447321;Disease
CAPECITABINE;rs1801131;Variant;PA448771;Chemical
CARBOPLATIN;rs1801131;Variant;PA448803;Chemical
CISPLATIN;rs1801131;Variant;PA449014;Chemical
CLOZAPINE;rs1801131;Variant;PA449061;Chemical
FOLIC ACID;rs1801131;Variant;PA449692;Chemical
LEUCOVORIN;rs1801131;Variant;PA450198;Chemical
METHOTREXATE;rs1801131;Variant;PA450428;Chemical
NITROUS OXIDE;rs1801131;Variant;PA450645;Chemical
OLANZAPINE;rs1801131;Variant;PA450688;Chemical
CYANOCOBALAMIN;rs1801131;Variant;PA451892;Chemical
OXALIPLATIN;UGT1A1*60;Haplotype;PA131285527;Chemical
LABETALOL;UGT1A1*60;Haplotype;PA164743150;Chemical
SN-38;UGT1A1*60;Haplotype;PA165110775;Chemical
BELINOSTAT;UGT1A1*60;Haplotype;PA165971474;Chemical
TEGAFUR / GIMERACIL / OTERACIL;UGT1A1*60;Haplotype;PA166115442;Chemical
NEOPLASMS;UGT1A1*60;Haplotype;PA445062;Disease
THROMBOCYTOPENIA;UGT1A1*60;Haplotype;PA445846;Disease
COLORECTAL NEOPLASMS;UGT1A1*60;Haplotype;PA446108;Disease
IRINOTECAN;UGT1A1*60;Haplotype;PA450085;Chemical
STROKE;ALDH1L1;Gene;PA447054;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;ALDH1L1;Gene;PA447197;Disease
L-METHIONINE;ALDH1L1;Gene;PA450423;Chemical
METHYLPHENIDATE;ALDH1L1;Gene;PA450464;Chemical
CD274;atezolizumab;Chemical;PA134915280;Gene
RS113488022;atezolizumab;Chemical;PA166157522;Variant
ALK;atezolizumab;Chemical;PA24719;Gene
BRAF;atezolizumab;Chemical;PA25408;Gene
EGFR;atezolizumab;Chemical;PA7360;Gene
ABCC2;Beta-thalassemia and related diseases;Disease;PA116;Gene
UGT1A6*1A;Beta-thalassemia and related diseases;Disease;PA166117614;Haplotype
UGT1A6*2A;Beta-thalassemia and related diseases;Disease;PA166117621;Haplotype
RS717620;Beta-thalassemia and related diseases;Disease;PA166153953;Variant
RS2273697;Beta-thalassemia and related diseases;Disease;PA166154007;Variant
RS8187710;Beta-thalassemia and related diseases;Disease;PA166154094;Variant
RS731236;Beta-thalassemia and related diseases;Disease;PA166154500;Variant
RS1544410;Beta-thalassemia and related diseases;Disease;PA166154516;Variant
RS10877012;Beta-thalassemia and related diseases;Disease;PA166154623;Variant
RS762551;Beta-thalassemia and related diseases;Disease;PA166154850;Variant
RS2470890;Beta-thalassemia and related diseases;Disease;PA166154893;Variant
RS2606345;Beta-thalassemia and related diseases;Disease;PA166154899;Variant
RS887829;Beta-thalassemia and related diseases;Disease;PA166155607;Variant
RS1983023;Beta-thalassemia and related diseases;Disease;PA166155655;Variant
RS3806596;Beta-thalassemia and related diseases;Disease;PA166155712;Variant
RS4124874;Beta-thalassemia and related diseases;Disease;PA166155720;Variant
RS6759892;Beta-thalassemia and related diseases;Disease;PA166155760;Variant
RS2585428;Beta-thalassemia and related diseases;Disease;PA166155928;Variant
RS13120400;Beta-thalassemia and related diseases;Disease;PA166156664;Variant
RS9376230;Beta-thalassemia and related diseases;Disease;PA166157152;Variant
RS9483947;Beta-thalassemia and related diseases;Disease;PA166157165;Variant
RS2248359;Beta-thalassemia and related diseases;Disease;PA166170863;Variant
RS927650;Beta-thalassemia and related diseases;Disease;PA166176111;Variant
RS7041;Beta-thalassemia and related diseases;Disease;PA166185751;Variant
CYP1A1;Beta-thalassemia and related diseases;Disease;PA27092;Gene
CYP1A2;Beta-thalassemia and related diseases;Disease;PA27093;Gene
CYP24A1;Beta-thalassemia and related diseases;Disease;PA27097;Gene
CYP27B1;Beta-thalassemia and related diseases;Disease;PA27099;Gene
GC;Beta-thalassemia and related diseases;Disease;PA28601;Gene
MAP3K5;Beta-thalassemia and related diseases;Disease;PA30601;Gene
UGT1A3;Beta-thalassemia and related diseases;Disease;PA37178;Gene
UGT1A6;Beta-thalassemia and related diseases;Disease;PA37181;Gene
VDR;Beta-thalassemia and related diseases;Disease;PA37301;Gene
ABCG2;Beta-thalassemia and related diseases;Disease;PA390;Gene
UGT1A1;Beta-thalassemia and related diseases;Disease;PA420;Gene
PLATINUM COMPOUNDS;rs619586;Variant;PA164713176;Chemical
LUNG NEOPLASMS;rs619586;Variant;PA444818;Disease
DPYD;rs141044036;Variant;PA145;Gene
CAPECITABINE;rs141044036;Variant;PA448771;Chemical
RS4240803;gabapentin;Chemical;PA166155063;Variant
SLC7A5;gabapentin;Chemical;PA35923;Gene
EFAVIRENZ;rs1282926098;Variant;PA449441;Chemical
PROPOFOL;rs1282926098;Variant;PA451141;Chemical
GH1;mecasermin;Chemical;PA171;Gene
GHR;mecasermin;Chemical;PA28674;Gene
IGF1;mecasermin;Chemical;PA29697;Gene
HLA-A*02:06;tetanus antitoxin;Chemical;PA165952829;Haplotype
HLA-A;tetanus antitoxin;Chemical;PA35055;Gene
BUFURALOL;CYP2D6*62;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*62;Haplotype;PA166127651;Chemical
DEXTROMETHORPHAN;CYP2D6*62;Haplotype;PA449273;Chemical
PROPAFENONE;CYP2D6*62;Haplotype;PA451131;Chemical
SPARTEINE;CYP2D6*62;Haplotype;PA452610;Chemical
PSYCHOTIC DISORDER;rs17143212;Variant;PA447215;Disease
HALOPERIDOL;rs17143212;Variant;PA449841;Chemical
LEUKOPENIA;rs238406;Variant;PA444773;Disease
TESTICULAR NEOPLASMS;rs238406;Variant;PA445828;Disease
BLEOMYCIN;rs238406;Variant;PA448645;Chemical
CISPLATIN;rs238406;Variant;PA449014;Chemical
ETOPOSIDE;rs238406;Variant;PA449552;Chemical
CYP3A5;Nephrotic Syndrome;Disease;PA131;Gene
CYP3A5*1;Nephrotic Syndrome;Disease;PA166128213;Haplotype
CYP3A5*3;Nephrotic Syndrome;Disease;PA166128219;Haplotype
RS1128503;Nephrotic Syndrome;Disease;PA166157288;Variant
RS2032582;Nephrotic Syndrome;Disease;PA166157316;Variant
ABCB1;Nephrotic Syndrome;Disease;PA267;Gene
AQP4;satralizumab;Chemical;PA24922;Gene
IL6R;satralizumab;Chemical;PA29835;Gene
OVARIAN NEOPLASMS;RAD52;Gene;PA445204;Disease
CISPLATIN;RAD52;Gene;PA449014;Chemical
CYCLOPHOSPHAMIDE;RAD52;Gene;PA449165;Chemical
PEMETREXED;ALK;Gene;PA10810;Chemical
CRIZOTINIB;ALK;Gene;PA165946122;Chemical
BRENTUXIMAB VEDOTIN;ALK;Gene;PA165948903;Chemical
PEMBROLIZUMAB;ALK;Gene;PA166124615;Chemical
CERITINIB;ALK;Gene;PA166124616;Chemical
NIVOLUMAB;ALK;Gene;PA166129522;Chemical
ATEZOLIZUMAB;ALK;Gene;PA166129523;Chemical
RS113488022;ALK;Gene;PA166157522;Variant
ALECTINIB;ALK;Gene;PA166160050;Chemical
BRIGATINIB;ALK;Gene;PA166163482;Chemical
DURVALUMAB;ALK;Gene;PA166169883;Chemical
IPILIMUMAB;ALK;Gene;PA166182718;Chemical
LORLATINIB;ALK;Gene;PA166182743;Chemical
RAMUCIRUMAB;ALK;Gene;PA166184558;Chemical
TEPOTINIB;ALK;Gene;PA166211181;Chemical
CEMIPLIMAB-RWLC;ALK;Gene;PA166251401;Chemical
TREMELIMUMAB;ALK;Gene;PA166293321;Chemical
ENSARTINIB;ALK;Gene;PA166400163;Chemical
EML4;ALK;Gene;PA27769;Gene
ROS1;ALK;Gene;PA34633;Gene
CARCINOMA, NON-SMALL-CELL LUNG;ALK;Gene;PA443622;Disease
NEUROBLASTOMA;ALK;Gene;PA445100;Disease
IFNAR1;anifrolumab;Chemical;PA29670;Gene
BELZUTIFAN;VHL;Gene;PA166268761;Chemical
VON HIPPEL-LINDAU DISEASE;VHL;Gene;PA444477;Disease
PEGINTERFERON ALFA-2A;rs56061981;Variant;PA164749390;Chemical
PEGINTERFERON ALFA-2B;rs56061981;Variant;PA164784024;Chemical
CHRONIC HEPATITIS C VIRUS INFECTION;rs56061981;Variant;PA446863;Disease
HYPERTENSION;SLC25A31;Gene;PA444552;Disease
ATENOLOL;SLC25A31;Gene;PA448499;Chemical
HYDROCHLOROTHIAZIDE;SLC25A31;Gene;PA449899;Chemical
METOPROLOL;SLC25A31;Gene;PA450480;Chemical
ATAZANAVIR;rs73208473;Variant;PA10251;Chemical
HIV INFECTIOUS DISEASE;rs73208473;Variant;PA447230;Disease
EFAVIRENZ;rs1968919352;Variant;PA449441;Chemical
HMG COA REDUCTASE INHIBITORS;CXCL5;Gene;PA133950441;Chemical
ACUTE CORONARY SYNDROME;CXCL5;Gene;PA165108401;Disease
BRIMONIDINE;ADRA2B;Gene;PA448665;Chemical
CLONIDINE;ADRA2B;Gene;PA449051;Chemical
DOPAMINE;ADRA2B;Gene;PA449396;Chemical
EPINEPHRINE;ADRA2B;Gene;PA449470;Chemical
ISOPROTERENOL;ADRA2B;Gene;PA450121;Chemical
NOREPINEPHRINE;ADRA2B;Gene;PA450649;Chemical
YOHIMBINE;ADRA2B;Gene;PA451946;Chemical
DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS;CDKAL1;Gene;PA164712689;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;CDKAL1;Gene;PA164713366;Chemical
DIABETES MELLITUS;CDKAL1;Gene;PA443886;Disease
PSORIASIS;CDKAL1;Gene;PA445451;Disease
HEROIN DEPENDENCE;BDNF-AS;Gene;PA444460;Disease
OPIOID-RELATED DISORDERS;BDNF-AS;Gene;PA445043;Disease
SCHIZOPHRENIA;BDNF-AS;Gene;PA447216;Disease
ANTIPSYCHOTICS;BDNF-AS;Gene;PA452233;Chemical
OPIOIDS;BDNF-AS;Gene;PA452618;Chemical
HEROIN;BDNF-AS;Gene;PA452619;Chemical
HLA-DRB1*08:03;methimazole;Chemical;PA165951678;Haplotype
HLA-B*38:02;methimazole;Chemical;PA165955505;Haplotype
HLA-B;methimazole;Chemical;PA35056;Gene
HLA-DRB1;methimazole;Chemical;PA35072;Gene
MYCN;dinutuximab;Chemical;PA31359;Gene
TOFERSEN;SOD1;Gene;PA166313342;Chemical
PLATINUM COMPOUNDS;H19;Gene;PA164713176;Chemical
HYPERTENSION;H19;Gene;PA444552;Disease
LUNG NEOPLASMS;H19;Gene;PA444818;Disease
BETA BLOCKING AGENTS;KL;Gene;PA164712535;Chemical
EPILEPSY;UGT1A4*2;Haplotype;PA444065;Disease
LAMOTRIGINE;UGT1A4*2;Haplotype;PA450164;Chemical
ALCOHOL ABUSE;ADH1C;Gene;PA443309;Disease
OVARIAN NEOPLASMS;ADH1C;Gene;PA445204;Disease
ABACAVIR;ADH1C;Gene;PA448004;Chemical
ETHANOL;ADH1C;Gene;PA448073;Chemical
CISPLATIN;ADH1C;Gene;PA449014;Chemical
CYCLOPHOSPHAMIDE;ADH1C;Gene;PA449165;Chemical
NALTREXONE;ADH1C;Gene;PA450588;Chemical
ASTHMA;rs2075797;Variant;PA443450;Disease
ASPIRIN;rs2075797;Variant;PA448497;Chemical
VORICONAZOLE;CYP2C19*29;Haplotype;PA10233;Chemical
FLUOXETINE;CYP2C19*29;Haplotype;PA449673;Chemical
MEPHENYTOIN;CYP2C19*29;Haplotype;PA450373;Chemical
METHADONE;CYP2C19*29;Haplotype;PA450401;Chemical
OMEPRAZOLE;CYP2C19*29;Haplotype;PA450704;Chemical
EFAVIRENZ;rs1969255598;Variant;PA449441;Chemical
INFLIXIMAB;rs361525;Variant;PA452639;Chemical
ACUTE CORONARY SYNDROME;ADCY9;Gene;PA165108401;Disease
DALCETRAPIB;ADCY9;Gene;PA166131581;Chemical
GNAI1;ADCY9;Gene;PA172;Gene
GNAI3;ADCY9;Gene;PA173;Gene
GNAS;ADCY9;Gene;PA175;Gene
GNAI2;ADCY9;Gene;PA24347;Gene
FLUOROURACIL;DPYD c.1905+1G>A (*2A);Haplotype;PA128406956;Chemical
DPYD;DPYD c.1905+1G>A (*2A);Haplotype;PA145;Gene
TEGAFUR / GIMERACIL / OTERACIL;DPYD c.1905+1G>A (*2A);Haplotype;PA166115442;Chemical
CAPECITABINE;DPYD c.1905+1G>A (*2A);Haplotype;PA448771;Chemical
TEGAFUR;DPYD c.1905+1G>A (*2A);Haplotype;PA452620;Chemical
PRASUGREL;rs77235035;Variant;PA154410481;Chemical
FLUOROURACIL;rs148994843;Variant;PA128406956;Chemical
DPYD;rs148994843;Variant;PA145;Gene
CAPECITABINE;rs148994843;Variant;PA448771;Chemical
NICOTINE;rs199515342;Variant;PA450626;Chemical
DRUG-INDUCED LIVER INJURY;HLA-C*12:03;Haplotype;PA166119041;Disease
INFLIXIMAB;HLA-C*12:03;Haplotype;PA452639;Chemical
DRUG TOXICITY;EPAS1;Gene;PA443937;Disease
SORAFENIB;EPAS1;Gene;PA7000;Chemical
DIABETES MELLITUS, TYPE 2;rs2162145;Variant;PA443890;Disease
METFORMIN;rs2162145;Variant;PA450395;Chemical
ATP1A1;ZEB1;Gene;PA62;Gene
OPIOID-RELATED DISORDERS;rs11030096;Variant;PA445043;Disease
OPIOIDS;rs11030096;Variant;PA452618;Chemical
PHOTODYNAMIC THERAPY;rs5985;Variant;PA165984462;Chemical
CHOROIDAL NEOVASCULARIZATION;rs5985;Variant;PA446974;Disease
ASPIRIN;rs5985;Variant;PA448497;Chemical
FLUOROURACIL;rs118088833;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs118088833;Variant;PA443560;Disease
NEUTROPENIA;rs118088833;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs118088833;Variant;PA449165;Chemical
EPIRUBICIN;rs118088833;Variant;PA449476;Chemical
DESFLURANE;rs118192168;Variant;PA164749136;Chemical
RYR1;rs118192168;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs118192168;Variant;PA444863;Disease
ENFLURANE;rs118192168;Variant;PA449461;Chemical
HALOTHANE;rs118192168;Variant;PA449845;Chemical
ISOFLURANE;rs118192168;Variant;PA450106;Chemical
METHOXYFLURANE;rs118192168;Variant;PA450434;Chemical
SEVOFLURANE;rs118192168;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs118192168;Variant;PA451522;Chemical
CACNA1S;rs118192168;Variant;PA85;Gene
USTEKINUMAB;rs8177374;Variant;PA166048654;Chemical
PSORIASIS;rs8177374;Variant;PA445451;Disease
HYPERTENSION;VASP;Gene;PA444552;Disease
HYDROCHLOROTHIAZIDE;VASP;Gene;PA449899;Chemical
CYP2C19;Ulcer;Disease;PA124;Gene
CYP2C19*1;Ulcer;Disease;PA165980634;Haplotype
CYP2C19*2;Ulcer;Disease;PA165980635;Haplotype
CYP2C19*3;Ulcer;Disease;PA165980636;Haplotype
NIFEDIPINE;rs72552791;Variant;PA450631;Chemical
VASCULITIS;rs3759467;Variant;PA446023;Disease
RITUXIMAB;rs3759467;Variant;PA451261;Chemical
FLUOROURACIL;rs144991623;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs144991623;Variant;PA443560;Disease
NEUTROPENIA;rs144991623;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs144991623;Variant;PA449165;Chemical
EPIRUBICIN;rs144991623;Variant;PA449476;Chemical
FATTY LIVER;TM6SF2;Gene;PA444154;Disease
SN-38;rs72551344;Variant;PA165110775;Chemical
CYP2D6;Binge eating disorder;Disease;PA128;Gene
CYP2D6*1;Binge eating disorder;Disease;PA165816576;Haplotype
CYP2D6*4;Binge eating disorder;Disease;PA165816579;Haplotype
CYP2D6*41;Binge eating disorder;Disease;PA165816584;Haplotype
ETONOGESTREL;CYP3A7*1A;Haplotype;PA164771231;Chemical
KIDNEY TRANSPLANTATION;CYP3A7*1A;Haplotype;PA165817016;Disease
ADRENAL HYPERPLASIA, CONGENITAL;CYP3A7*1A;Haplotype;PA443286;Disease
CORTISONE ACETATE;CYP3A7*1A;Haplotype;PA449130;Chemical
TACROLIMUS;CYP3A7*1A;Haplotype;PA451578;Chemical
NEPHROTOXICITY;rs9345389;Variant;PA162263533;Disease
GLUCARPIDASE;rs9345389;Variant;PA165949771;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;rs9345389;Variant;PA446155;Disease
RESIDUAL NEOPLASM;rs9345389;Variant;PA446714;Disease
METHOTREXATE;rs9345389;Variant;PA450428;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;rs6092;Variant;PA446155;Disease
DEXAMETHASONE;rs6092;Variant;PA449247;Chemical
CYP2A6;3-hydroxycotinine;Chemical;PA121;Gene
CYP2A6*1;3-hydroxycotinine;Chemical;PA165924690;Haplotype
CYP2A6*12;3-hydroxycotinine;Chemical;PA165980915;Haplotype
CYP2C19;treatment failure;Disease;PA124;Gene
CYP2C19*17;treatment failure;Disease;PA165816533;Haplotype
CYP2C19*1;treatment failure;Disease;PA165980634;Haplotype
CYP2C19*2;treatment failure;Disease;PA165980635;Haplotype
CYP2C19*3;treatment failure;Disease;PA165980636;Haplotype
CYP2C19*4;treatment failure;Disease;PA165980637;Haplotype
CYB5R3;articaine / epinephrine;Chemical;PA27331;Gene
G6PD;articaine / epinephrine;Chemical;PA28469;Gene
ARIPIPRAZOLE;CYP2D6*10;Haplotype;PA10026;Chemical
ESCITALOPRAM;CYP2D6*10;Haplotype;PA10074;Chemical
GEFITINIB;CYP2D6*10;Haplotype;PA131301952;Chemical
3,4-METHYLENEDIOXYMETHAMPHETAMINE;CYP2D6*10;Haplotype;PA131887008;Chemical
MIANSERIN;CYP2D6*10;Haplotype;PA134687937;Chemical
ATOMOXETINE;CYP2D6*10;Haplotype;PA134688071;Chemical
TROPISETRON;CYP2D6*10;Haplotype;PA161925594;Chemical
TOLTERODINE;CYP2D6*10;Haplotype;PA164746757;Chemical
BEPRIDIL;CYP2D6*10;Haplotype;PA164754755;Chemical
TOXIC LIVER DISEASE;CYP2D6*10;Haplotype;PA164925725;Disease
BERBERINE;CYP2D6*10;Haplotype;PA165860812;Chemical
HYDROXYAMITRIPTYLINE;CYP2D6*10;Haplotype;PA165946747;Chemical
BUFURALOL;CYP2D6*10;Haplotype;PA166110256;Chemical
DRY MOUTH;CYP2D6*10;Haplotype;PA166115462;Disease
VORTIOXETINE;CYP2D6*10;Haplotype;PA166122595;Chemical
PROGRESSION-FREE SURVIVAL;CYP2D6*10;Haplotype;PA166123026;Disease
OVERALL SURVIVAL;CYP2D6*10;Haplotype;PA166123207;Disease
AGITATION;CYP2D6*10;Haplotype;PA166123306;Disease
INSOMNIA;CYP2D6*10;Haplotype;PA166123307;Disease
EVENT-FREE SURVIVAL;CYP2D6*10;Haplotype;PA166123366;Disease
SCHIZOAFFECTIVE DISORDER;CYP2D6*10;Haplotype;PA166123368;Disease
ENDOXIFEN;CYP2D6*10;Haplotype;PA166124478;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*10;Haplotype;PA166127651;Chemical
4-HYDROXYTAMOXIFEN;CYP2D6*10;Haplotype;PA166127652;Chemical
RECURRENCE FREE SURVIVAL;CYP2D6*10;Haplotype;PA166127658;Disease
SEDATION;CYP2D6*10;Haplotype;PA166129521;Disease
O-DESMETHYLTRAMADOL;CYP2D6*10;Haplotype;PA166131379;Chemical
N-DESMETHYLTRAMADOL;CYP2D6*10;Haplotype;PA166131493;Chemical
N,O-DIDESMETHYLTRAMADOL;CYP2D6*10;Haplotype;PA166131494;Chemical
DAPOXETINE;CYP2D6*10;Haplotype;PA166151992;Chemical
COPTISINE;CYP2D6*10;Haplotype;PA166153416;Chemical
BREXPIPRAZOLE;CYP2D6*10;Haplotype;PA166160053;Chemical
EXTRAPYRAMIDAL SYMPTOMS;CYP2D6*10;Haplotype;PA166170367;Disease
MEPHEDRONE;CYP2D6*10;Haplotype;PA166184711;Chemical
ADENOCARCINOMA;CYP2D6*10;Haplotype;PA443265;Disease
ANGINA PECTORIS;CYP2D6*10;Haplotype;PA443362;Disease
ARRHYTHMIAS, CARDIAC;CYP2D6*10;Haplotype;PA443421;Disease
BREAST NEOPLASMS;CYP2D6*10;Haplotype;PA443560;Disease
CARCINOMA, NON-SMALL-CELL LUNG;CYP2D6*10;Haplotype;PA443622;Disease
CONSTIPATION;CYP2D6*10;Haplotype;PA443782;Disease
DEATH;CYP2D6*10;Haplotype;PA443842;Disease
DIZZINESS;CYP2D6*10;Haplotype;PA443928;Disease
DRUG TOXICITY;CYP2D6*10;Haplotype;PA443937;Disease
DUCTUS ARTERIOSUS, PATENT;CYP2D6*10;Haplotype;PA443940;Disease
DYSTONIA;CYP2D6*10;Haplotype;PA443970;Disease
EXANTHEMA;CYP2D6*10;Haplotype;PA444109;Disease
GASTROINTESTINAL NEOPLASMS;CYP2D6*10;Haplotype;PA444257;Disease
HEAD AND NECK NEOPLASMS;CYP2D6*10;Haplotype;PA444352;Disease
HEART DISEASES;CYP2D6*10;Haplotype;PA444368;Disease
HEART FAILURE;CYP2D6*10;Haplotype;PA444370;Disease
HYPERTENSION;CYP2D6*10;Haplotype;PA444552;Disease
MALARIA;CYP2D6*10;Haplotype;PA444859;Disease
PAIN;CYP2D6*10;Haplotype;PA445208;Disease
PAIN, POSTOPERATIVE;CYP2D6*10;Haplotype;PA445210;Disease
RECURRENCE;CYP2D6*10;Haplotype;PA445506;Disease
TACHYCARDIA;CYP2D6*10;Haplotype;PA445802;Disease
VOMITING;CYP2D6*10;Haplotype;PA446051;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CYP2D6*10;Haplotype;PA447197;Disease
AUTISTIC DISORDER;CYP2D6*10;Haplotype;PA447198;Disease
DEPRESSIVE DISORDER;CYP2D6*10;Haplotype;PA447207;Disease
MENTAL DISORDERS;CYP2D6*10;Haplotype;PA447208;Disease
OBSESSIVE-COMPULSIVE DISORDER;CYP2D6*10;Haplotype;PA447211;Disease
PSYCHOTIC DISORDERS;CYP2D6*10;Haplotype;PA447215;Disease
SCHIZOPHRENIA;CYP2D6*10;Haplotype;PA447216;Disease
TARDIVE DYSKINESIA;CYP2D6*10;Haplotype;PA447268;Disease
DEPRESSION;CYP2D6*10;Haplotype;PA447278;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2D6*10;Haplotype;PA447321;Disease
ACETAMINOPHEN;CYP2D6*10;Haplotype;PA448015;Chemical
AMITRIPTYLINE;CYP2D6*10;Haplotype;PA448385;Chemical
CARVEDILOL;CYP2D6*10;Haplotype;PA448817;Chemical
CITALOPRAM;CYP2D6*10;Haplotype;PA449015;Chemical
CLOMIPRAMINE;CYP2D6*10;Haplotype;PA449048;Chemical
CODEINE;CYP2D6*10;Haplotype;PA449088;Chemical
DESIPRAMINE;CYP2D6*10;Haplotype;PA449233;Chemical
DEXTROMETHORPHAN;CYP2D6*10;Haplotype;PA449273;Chemical
DOXEPIN;CYP2D6*10;Haplotype;PA449409;Chemical
FENTANYL;CYP2D6*10;Haplotype;PA449599;Chemical
FLECAINIDE;CYP2D6*10;Haplotype;PA449646;Chemical
FLUOXETINE;CYP2D6*10;Haplotype;PA449673;Chemical
FLUVOXAMINE;CYP2D6*10;Haplotype;PA449690;Chemical
HALOPERIDOL;CYP2D6*10;Haplotype;PA449841;Chemical
KETOPROFEN;CYP2D6*10;Haplotype;PA450149;Chemical
LOVASTATIN;CYP2D6*10;Haplotype;PA450272;Chemical
METHADONE;CYP2D6*10;Haplotype;PA450401;Chemical
METHYLPHENIDATE;CYP2D6*10;Haplotype;PA450464;Chemical
METOPROLOL;CYP2D6*10;Haplotype;PA450480;Chemical
NORTRIPTYLINE;CYP2D6*10;Haplotype;PA450657;Chemical
OLANZAPINE;CYP2D6*10;Haplotype;PA450688;Chemical
ONDANSETRON;CYP2D6*10;Haplotype;PA450705;Chemical
PAROXETINE;CYP2D6*10;Haplotype;PA450801;Chemical
PRIMAQUINE;CYP2D6*10;Haplotype;PA451103;Chemical
PROPAFENONE;CYP2D6*10;Haplotype;PA451131;Chemical
PROPRANOLOL;CYP2D6*10;Haplotype;PA451145;Chemical
RISPERIDONE;CYP2D6*10;Haplotype;PA451257;Chemical
TAMOXIFEN;CYP2D6*10;Haplotype;PA451581;Chemical
TOREMIFENE;CYP2D6*10;Haplotype;PA451731;Chemical
TRAMADOL;CYP2D6*10;Haplotype;PA451735;Chemical
VENLAFAXINE;CYP2D6*10;Haplotype;PA451866;Chemical
ANTIPSYCHOTICS;CYP2D6*10;Haplotype;PA452233;Chemical
SPARTEINE;CYP2D6*10;Haplotype;PA452610;Chemical
DEBRISOQUINE;CYP2D6*10;Haplotype;PA452616;Chemical
ANTINEOPLASTIC AGENTS;CYP2D6*10;Haplotype;PA452621;Chemical
GNAQ;TBXA2R;Gene;PA174;Gene
GNB3;TBXA2R;Gene;PA176;Gene
GNA11;TBXA2R;Gene;PA28764;Gene
GNA12;TBXA2R;Gene;PA28765;Gene
GNA13;TBXA2R;Gene;PA28766;Gene
GNA15;TBXA2R;Gene;PA28768;Gene
ASTHMA;TBXA2R;Gene;PA443450;Disease
DIABETES MELLITUS, TYPE 2;TBXA2R;Gene;PA443890;Disease
ASPIRIN;TBXA2R;Gene;PA448497;Chemical
HYPERTENSION;rs6722745;Variant;PA444552;Disease
CANDESARTAN;rs6722745;Variant;PA448765;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;GABRP;Gene;PA164713257;Chemical
MAJOR DEPRESSIVE DISORDER;GABRP;Gene;PA447321;Disease
VENLAFAXINE;GABRP;Gene;PA451866;Chemical
ANTIDEPRESSANTS;GABRP;Gene;PA452229;Chemical
ILOPERIDONE;rs993648;Variant;PA161199368;Chemical
ACQUIRED LONG QT SYNDROME (ALQTS);rs993648;Variant;PA447300;Disease
SULFAMETHOXAZOLE / TRIMETHOPRIM;HLA-C*08:01;Haplotype;PA10715;Chemical
MACULOPAPULAR EXANTHEMA;HLA-C*08:01;Haplotype;PA162316739;Disease
PEGINTERFERON ALFA-2B;HLA-C*08:01;Haplotype;PA164784024;Chemical
DRUG HYPERSENSITIVITY;HLA-C*08:01;Haplotype;PA443936;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-C*08:01;Haplotype;PA444059;Disease
EPILEPSY;HLA-C*08:01;Haplotype;PA444065;Disease
HEPATITIS C;HLA-C*08:01;Haplotype;PA444445;Disease
HYPERSENSITIVITY;HLA-C*08:01;Haplotype;PA444546;Disease
STEVENS-JOHNSON SYNDROME;HLA-C*08:01;Haplotype;PA445738;Disease
HEMATOLOGIC NEOPLASMS;HLA-C*08:01;Haplotype;PA446827;Disease
HIV INFECTIONS;HLA-C*08:01;Haplotype;PA447230;Disease
ALLOPURINOL;HLA-C*08:01;Haplotype;PA448320;Chemical
CARBAMAZEPINE;HLA-C*08:01;Haplotype;PA448785;Chemical
NEVIRAPINE;HLA-C*08:01;Haplotype;PA450616;Chemical
PHENYTOIN;HLA-C*08:01;Haplotype;PA450947;Chemical
RIBAVIRIN;HLA-C*08:01;Haplotype;PA451241;Chemical
ABCC2;docetaxel;Chemical;PA116;Gene
CYP2A6;docetaxel;Chemical;PA121;Gene
CYP3A4;docetaxel;Chemical;PA130;Gene
CYP3A5;docetaxel;Chemical;PA131;Gene
SLCO1B1;docetaxel;Chemical;PA134865839;Gene
VAC14;docetaxel;Chemical;PA142670633;Gene
PPCDC;docetaxel;Chemical;PA142671157;Gene
SNORD68;docetaxel;Chemical;PA145007789;Gene
ERCC1;docetaxel;Chemical;PA155;Gene
ESR1;docetaxel;Chemical;PA156;Gene
SULT1C4;docetaxel;Chemical;PA162405070;Gene
CYP2A6*1;docetaxel;Chemical;PA165924690;Haplotype
CYP2A6*4;docetaxel;Chemical;PA165924721;Haplotype
CYP3A4*22;docetaxel;Chemical;PA166048680;Haplotype
RS1563828;docetaxel;Chemical;PA166153633;Variant
RS2234922;docetaxel;Chemical;PA166153680;Variant
RS2501873;docetaxel;Chemical;PA166153711;Variant
RS2502815;docetaxel;Chemical;PA166153712;Variant
RS4646487;docetaxel;Chemical;PA166153768;Variant
RS75114882;docetaxel;Chemical;PA166153907;Variant
RS12418;docetaxel;Chemical;PA166153942;Variant
RS730720;docetaxel;Chemical;PA166153954;Variant
RS1871450;docetaxel;Chemical;PA166153978;Variant
RS1937840;docetaxel;Chemical;PA166153989;Variant
RS2227310;docetaxel;Chemical;PA166153999;Variant
RS4148943;docetaxel;Chemical;PA166154049;Variant
RS4148945;docetaxel;Chemical;PA166154050;Variant
RS4148947;docetaxel;Chemical;PA166154051;Variant
RS4148950;docetaxel;Chemical;PA166154052;Variant
RS4353229;docetaxel;Chemical;PA166154054;Variant
RS7921977;docetaxel;Chemical;PA166154092;Variant
RS12415607;docetaxel;Chemical;PA166154152;Variant
RS12762549;docetaxel;Chemical;PA166154154;Variant
RS3834935;docetaxel;Chemical;PA166154568;Variant
RS4149056;docetaxel;Chemical;PA166154579;Variant
RS7311358;docetaxel;Chemical;PA166154602;Variant
RS11045585;docetaxel;Chemical;PA166154626;Variant
RS2301159;docetaxel;Chemical;PA166154711;Variant
RS1048943;docetaxel;Chemical;PA166154855;Variant
RS12960;docetaxel;Chemical;PA166154981;Variant
RS875858;docetaxel;Chemical;PA166154996;Variant
RS2238472;docetaxel;Chemical;PA166155033;Variant
RS2292954;docetaxel;Chemical;PA166155038;Variant
RS879207;docetaxel;Chemical;PA166155169;Variant
RS1136201;docetaxel;Chemical;PA166155183;Variant
RS2849380;docetaxel;Chemical;PA166155289;Variant
RS45445694;docetaxel;Chemical;PA166155331;Variant
RS11615;docetaxel;Chemical;PA166155342;Variant
RS13181;docetaxel;Chemical;PA166155343;Variant
RS3212986;docetaxel;Chemical;PA166155407;Variant
RS1402467;docetaxel;Chemical;PA166155635;Variant
RS2273618;docetaxel;Chemical;PA166155926;Variant
RS3746574;docetaxel;Chemical;PA166155938;Variant
RS6130615;docetaxel;Chemical;PA166155962;Variant
RS17309872;docetaxel;Chemical;PA166155966;Variant
RS139887;docetaxel;Chemical;PA166156044;Variant
RS870995;docetaxel;Chemical;PA166156297;Variant
RS3732359;docetaxel;Chemical;PA166156374;Variant
RS3732360;docetaxel;Chemical;PA166156375;Variant
RS3814058;docetaxel;Chemical;PA166156385;Variant
RS11710163;docetaxel;Chemical;PA166156444;Variant
RS726501;docetaxel;Chemical;PA166156739;Variant
RS1382368;docetaxel;Chemical;PA166156761;Variant
RS16886403;docetaxel;Chemical;PA166156882;Variant
RS17661089;docetaxel;Chemical;PA166156888;Variant
RS544093;docetaxel;Chemical;PA166156925;Variant
RS699947;docetaxel;Chemical;PA166156938;Variant
RS1570360;docetaxel;Chemical;PA166156985;Variant
RS1883322;docetaxel;Chemical;PA166157003;Variant
RS2016520;docetaxel;Chemical;PA166157007;Variant
RS3734254;docetaxel;Chemical;PA166157077;Variant
RS6922548;docetaxel;Chemical;PA166157116;Variant
RS7769719;docetaxel;Chemical;PA166157128;Variant
RS13207351;docetaxel;Chemical;PA166157183;Variant
RS35864111;docetaxel;Chemical;PA166157202;Variant
RS144854329;docetaxel;Chemical;PA166157228;Variant
RS1045642;docetaxel;Chemical;PA166157284;Variant
RS2740574;docetaxel;Chemical;PA166157367;Variant
RS1799931;docetaxel;Chemical;PA166157565;Variant
RS1536475;docetaxel;Chemical;PA166157728;Variant
RS2234753;docetaxel;Chemical;PA166157746;Variant
RS2250242;docetaxel;Chemical;PA166157747;Variant
RS6413517;docetaxel;Chemical;PA166157784;Variant
RS11185647;docetaxel;Chemical;PA166157831;Variant
RS62576288;docetaxel;Chemical;PA166157845;Variant
RS518329;docetaxel;Chemical;PA166157855;Variant
RS2227291;docetaxel;Chemical;PA166157866;Variant
RS11185648;docetaxel;Chemical;PA166159089;Variant
RS10538494;docetaxel;Chemical;PA166159126;Variant
RS9725457;docetaxel;Chemical;PA166159127;Variant
RS2229046;docetaxel;Chemical;PA166179815;Variant
RS773123;docetaxel;Chemical;PA166179816;Variant
RS2284922;docetaxel;Chemical;PA166179817;Variant
RS2070096;docetaxel;Chemical;PA166179818;Variant
RS147451859;docetaxel;Chemical;PA166199721;Variant
RS17587029;docetaxel;Chemical;PA166199722;Variant
NAT2;docetaxel;Chemical;PA18;Gene
ABCC1;docetaxel;Chemical;PA244;Gene
ACSS2;docetaxel;Chemical;PA24429;Gene
AKR1C3;docetaxel;Chemical;PA24679;Gene
BARD1;docetaxel;Chemical;PA25256;Gene
BCL2;docetaxel;Chemical;PA25302;Gene
CASP7;docetaxel;Chemical;PA26091;Gene
CHST3;docetaxel;Chemical;PA26503;Gene
PGR;docetaxel;Chemical;PA266;Gene
ABCB1;docetaxel;Chemical;PA267;Gene
CYP1A1;docetaxel;Chemical;PA27092;Gene
CYP1B1;docetaxel;Chemical;PA27094;Gene
CYP4B1;docetaxel;Chemical;PA27119;Gene
EPHX1;docetaxel;Chemical;PA27829;Gene
ERBB2;docetaxel;Chemical;PA27844;Gene
ERBB3;docetaxel;Chemical;PA27846;Gene
ERCC2;docetaxel;Chemical;PA27848;Gene
ESR2;docetaxel;Chemical;PA27886;Gene
HNF4A;docetaxel;Chemical;PA29349;Gene
MAP3K1;docetaxel;Chemical;PA30592;Gene
MDM4;docetaxel;Chemical;PA30719;Gene
SLC10A2;docetaxel;Chemical;PA318;Gene
OPRM1;docetaxel;Chemical;PA31945;Gene
ORM2;docetaxel;Chemical;PA32818;Gene
PIK3CA;docetaxel;Chemical;PA33308;Gene
PPARD;docetaxel;Chemical;PA33557;Gene
PRDX4;docetaxel;Chemical;PA33725;Gene
RAF1;docetaxel;Chemical;PA34183;Gene
RNF8;docetaxel;Chemical;PA34445;Gene
RPL13;docetaxel;Chemical;PA34670;Gene
RXRA;docetaxel;Chemical;PA34890;Gene
SLCO1B3;docetaxel;Chemical;PA35844;Gene
TYMS;docetaxel;Chemical;PA359;Gene
SOX10;docetaxel;Chemical;PA36027;Gene
SPG7;docetaxel;Chemical;PA36067;Gene
VEGFA;docetaxel;Chemical;PA37302;Gene
XRCC4;docetaxel;Chemical;PA37423;Gene
NR1I2;docetaxel;Chemical;PA378;Gene
ABCG2;docetaxel;Chemical;PA390;Gene
NR1I3;docetaxel;Chemical;PA391;Gene
ABCC6;docetaxel;Chemical;PA58;Gene
ATP7A;docetaxel;Chemical;PA72;Gene
ADALIMUMAB;rs1800795;Variant;PA10004;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs1800795;Variant;PA164713366;Chemical
PEGINTERFERON ALFA-2B;rs1800795;Variant;PA164784024;Chemical
RHEUMATOID ARTHRITIS;rs1800795;Variant;PA443434;Disease
CARDIOVASCULAR DISEASE;rs1800795;Variant;PA443635;Disease
PSORIASIS;rs1800795;Variant;PA445451;Disease
CHRONIC HEPATITIS C VIRUS INFECTION;rs1800795;Variant;PA446863;Disease
ETANERCEPT;rs1800795;Variant;PA449515;Chemical
FENOFIBRATE;rs1800795;Variant;PA449594;Chemical
RIBAVIRIN;rs1800795;Variant;PA451241;Chemical
INFLIXIMAB;rs1800795;Variant;PA452639;Chemical
STK11;Peutz-Jeghers Syndrome;Disease;PA36198;Gene
CYP2B6;ketamine;Chemical;PA123;Gene
CYP2B6*1;ketamine;Chemical;PA165818750;Haplotype
CYP2B6*6;ketamine;Chemical;PA165818762;Haplotype
PROC;estradiol / progesterone;Chemical;PA33799;Gene
PROS1;estradiol / progesterone;Chemical;PA33809;Gene
SERPINC1;estradiol / progesterone;Chemical;PA35026;Gene
FLUOROURACIL;rs1799782;Variant;PA128406956;Chemical
PLATINUM COMPOUNDS;rs1799782;Variant;PA164713176;Chemical
RADIOTHERAPY;rs1799782;Variant;PA166122986;Chemical
OVERALL SURVIVAL;rs1799782;Variant;PA166123207;Disease
NON-SMALL CELL LUNG CARCINOMA;rs1799782;Variant;PA443622;Disease
CARCINOMA, SQUAMOUS CELL;rs1799782;Variant;PA443626;Disease
LUNG NEOPLASMS;rs1799782;Variant;PA444818;Disease
CISPLATIN;rs1799782;Variant;PA449014;Chemical
EPLONTERSEN;rs28933979;Variant;PA166328821;Chemical
TTR;rs28933979;Variant;PA37069;Gene
LIVER DISEASES, ALCOHOLIC;CYP2E1*1;Haplotype;PA444802;Disease
ACETAMINOPHEN;CYP2E1*1;Haplotype;PA448015;Chemical
HEROIN DEPENDENCE;rs2236857;Variant;PA444460;Disease
HEROIN;rs2236857;Variant;PA452619;Chemical
CORTICOSTEROIDS;CRHR1;Gene;PA10832;Chemical
ASTHMA;CRHR1;Gene;PA443450;Disease
ANXIETY DISORDERS;CRHR1;Gene;PA447196;Disease
MAJOR DEPRESSIVE DISORDER;CRHR1;Gene;PA447321;Disease
FLUOXETINE;CRHR1;Gene;PA449673;Chemical
ANTIDEPRESSANTS;CRHR1;Gene;PA452229;Chemical
WARFARIN;rs2288344;Variant;PA451906;Chemical
CYP2C19;oxazepam;Chemical;PA124;Gene
CYP3A4;oxazepam;Chemical;PA130;Gene
RS1902023;oxazepam;Chemical;PA166156530;Variant
RS1976391;oxazepam;Chemical;PA166179207;Variant
UGT2B7;oxazepam;Chemical;PA361;Gene
UGT2B15;oxazepam;Chemical;PA37188;Gene
UGT1A9;oxazepam;Chemical;PA419;Gene
ASTHMA;rs1522113;Variant;PA443450;Disease
SALBUTAMOL;rs1522113;Variant;PA448068;Chemical
VORICONAZOLE;CYP2C19*33;Haplotype;PA10233;Chemical
NEBIVOLOL;CYP2C19*33;Haplotype;PA151958426;Chemical
16ALPHA-HYDROXYPROGESTERONE;CYP2C19*33;Haplotype;PA166318321;Chemical
11A-HYDROXYPROGESTERONE;CYP2C19*33;Haplotype;PA166318342;Chemical
IBUPROFEN;CYP2C19*33;Haplotype;PA449957;Chemical
MEPHENYTOIN;CYP2C19*33;Haplotype;PA450373;Chemical
METHADONE;CYP2C19*33;Haplotype;PA450401;Chemical
OMEPRAZOLE;CYP2C19*33;Haplotype;PA450704;Chemical
RS6311;Tremor;Disease;PA166154673;Variant
HTR2A;Tremor;Disease;PA193;Gene
CYP3A5;heart transplantation;Disease;PA131;Gene
TPMT*1;heart transplantation;Disease;PA165819268;Haplotype
TPMT*2;heart transplantation;Disease;PA165819269;Haplotype
TPMT*3A;heart transplantation;Disease;PA165819270;Haplotype
TPMT*3C;heart transplantation;Disease;PA165819272;Haplotype
CYP3A5*1;heart transplantation;Disease;PA166128213;Haplotype
CYP3A5*3;heart transplantation;Disease;PA166128219;Haplotype
CYP3A5*6;heart transplantation;Disease;PA166128233;Haplotype
CYP3A5*7;heart transplantation;Disease;PA166128234;Haplotype
TPMT;heart transplantation;Disease;PA356;Gene
PSYCHOTIC DISORDER;ABCB5;Gene;PA447215;Disease
HALOPERIDOL;ABCB5;Gene;PA449841;Chemical
COMT;Bipolar Disorder;Disease;PA117;Gene
CYP2C19;Bipolar Disorder;Disease;PA124;Gene
CYP2C9;Bipolar Disorder;Disease;PA126;Gene
RPP30;Bipolar Disorder;Disease;PA134876345;Gene
RABEP1;Bipolar Disorder;Disease;PA134884097;Gene
NPAS3;Bipolar Disorder;Disease;PA134968746;Gene
GRAMD1B;Bipolar Disorder;Disease;PA142671708;Gene
SH2B1;Bipolar Disorder;Disease;PA145148084;Gene
DRD1;Bipolar Disorder;Disease;PA147;Gene
FAM177A1;Bipolar Disorder;Disease;PA162387378;Gene
FAM178B;Bipolar Disorder;Disease;PA162387456;Gene
ZNF804A;Bipolar Disorder;Disease;PA162410599;Gene
CYP2C19*17;Bipolar Disorder;Disease;PA165816533;Haplotype
CYP2C9*1;Bipolar Disorder;Disease;PA165816542;Haplotype
CYP2C9*2;Bipolar Disorder;Disease;PA165816543;Haplotype
CYP2C9*3;Bipolar Disorder;Disease;PA165816544;Haplotype
HLA-A*31:01;Bipolar Disorder;Disease;PA165954030;Haplotype
HLA-B*15:02;Bipolar Disorder;Disease;PA165954769;Haplotype
CYP2C19*1;Bipolar Disorder;Disease;PA165980634;Haplotype
CYP2C19*2;Bipolar Disorder;Disease;PA165980635;Haplotype
RS6275;Bipolar Disorder;Disease;PA166154260;Variant
RS6279;Bipolar Disorder;Disease;PA166154262;Variant
RS1800532;Bipolar Disorder;Disease;PA166154340;Variant
RS2499984;Bipolar Disorder;Disease;PA166154371;Variant
RS16909440;Bipolar Disorder;Disease;PA166154469;Variant
RS8192440;Bipolar Disorder;Disease;PA166154610;Variant
RS6311;Bipolar Disorder;Disease;PA166154673;Variant
RS6313;Bipolar Disorder;Disease;PA166154675;Variant
RS7997012;Bipolar Disorder;Disease;PA166154726;Variant
RS2071427;Bipolar Disorder;Disease;PA166155199;Variant
RS2314339;Bipolar Disorder;Disease;PA166155208;Variant
RS11869731;Bipolar Disorder;Disease;PA166155249;Variant
RS16973410;Bipolar Disorder;Disease;PA166155327;Variant
RS2826494;Bipolar Disorder;Disease;PA166155999;Variant
RS74795342;Bipolar Disorder;Disease;PA166156018;Variant
RS75222709;Bipolar Disorder;Disease;PA166156019;Variant
RS78015114;Bipolar Disorder;Disease;PA166156020;Variant
RS79663003;Bipolar Disorder;Disease;PA166156021;Variant
RS2284017;Bipolar Disorder;Disease;PA166156093;Variant
RS2284018;Bipolar Disorder;Disease;PA166156094;Variant
RS167771;Bipolar Disorder;Disease;PA166156280;Variant
RS334558;Bipolar Disorder;Disease;PA166156287;Variant
RS1523130;Bipolar Disorder;Disease;PA166156323;Variant
RS2276707;Bipolar Disorder;Disease;PA166156352;Variant
RS6438552;Bipolar Disorder;Disease;PA166156406;Variant
RS1801260;Bipolar Disorder;Disease;PA166156525;Variant
RS4532;Bipolar Disorder;Disease;PA166156706;Variant
RS1045642;Bipolar Disorder;Disease;PA166157284;Variant
RS1387923;Bipolar Disorder;Disease;PA166157727;Variant
RS2769605;Bipolar Disorder;Disease;PA166157756;Variant
RS3888190;Bipolar Disorder;Disease;PA166165398;Variant
RS1000940;Bipolar Disorder;Disease;PA166165401;Variant
RS324899;Bipolar Disorder;Disease;PA166171034;Variant
RS6942227;Bipolar Disorder;Disease;PA166171035;Variant
RS1611259;Bipolar Disorder;Disease;PA166171037;Variant
RS59724122;Bipolar Disorder;Disease;PA166171038;Variant
RS61123830;Bipolar Disorder;Disease;PA166171039;Variant
RS7959663;Bipolar Disorder;Disease;PA166171040;Variant
RS66486766;Bipolar Disorder;Disease;PA166171041;Variant
RS7405404;Bipolar Disorder;Disease;PA166171042;Variant
RS6728642;Bipolar Disorder;Disease;PA166171043;Variant
RS62200793;Bipolar Disorder;Disease;PA166171044;Variant
RS7588746;Bipolar Disorder;Disease;PA166171045;Variant
RS3919583;Bipolar Disorder;Disease;PA166171046;Variant
RS1611255;Bipolar Disorder;Disease;PA166171048;Variant
RS209474;Bipolar Disorder;Disease;PA166171049;Variant
RS1521470;Bipolar Disorder;Disease;PA166171050;Variant
RS79403677;Bipolar Disorder;Disease;PA166171051;Variant
RS7905446;Bipolar Disorder;Disease;PA166182096;Variant
RS1034936;Bipolar Disorder;Disease;PA166202881;Variant
HTR2A;Bipolar Disorder;Disease;PA193;Gene
ASIC2;Bipolar Disorder;Disease;PA24433;Gene
ADCY1;Bipolar Disorder;Disease;PA24560;Gene
CACNG2;Bipolar Disorder;Disease;PA26016;Gene
CLOCK;Bipolar Disorder;Disease;PA26609;Gene
ABCB1;Bipolar Disorder;Disease;PA267;Gene
CRY1;Bipolar Disorder;Disease;PA26904;Gene
DRD2;Bipolar Disorder;Disease;PA27478;Gene
DRD3;Bipolar Disorder;Disease;PA27479;Gene
DTNA;Bipolar Disorder;Disease;PA27510;Gene
EPHX2;Bipolar Disorder;Disease;PA27830;Gene
FOXP1;Bipolar Disorder;Disease;PA28241;Gene
GNG2;Bipolar Disorder;Disease;PA28784;Gene
GSK3B;Bipolar Disorder;Disease;PA29009;Gene
HTR7;Bipolar Disorder;Disease;PA29561;Gene
ITPR2;Bipolar Disorder;Disease;PA29979;Gene
LSAMP;Bipolar Disorder;Disease;PA30470;Gene
MYO1H;Bipolar Disorder;Disease;PA31404;Gene
NCOA2;Bipolar Disorder;Disease;PA31471;Gene
NR1D1;Bipolar Disorder;Disease;PA31748;Gene
NTRK2;Bipolar Disorder;Disease;PA31818;Gene
NTRK3;Bipolar Disorder;Disease;PA31819;Gene
OR52E2;Bipolar Disorder;Disease;PA32403;Gene
OR52J2P;Bipolar Disorder;Disease;PA32415;Gene
OR52J3;Bipolar Disorder;Disease;PA32416;Gene
HLA-A;Bipolar Disorder;Disease;PA35055;Gene
HLA-B;Bipolar Disorder;Disease;PA35056;Gene
TPH1;Bipolar Disorder;Disease;PA355;Gene
THRA;Bipolar Disorder;Disease;PA36507;Gene
NR1I2;Bipolar Disorder;Disease;PA378;Gene
CACNA1C;Bipolar Disorder;Disease;PA83;Gene
FLUOROURACIL;rs369103276;Variant;PA128406956;Chemical
DRUG TOXICITY;rs369103276;Variant;PA443937;Disease
HYPERTENSION;rs1378942;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs1378942;Variant;PA449899;Chemical
DICLOFENAC;CYP2C9*54;Haplotype;PA449293;Chemical
PHENYTOIN;CYP2C9*54;Haplotype;PA450947;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;SLC1A1;Gene;PA164713257;Chemical
OBSESSIVE-COMPULSIVE DISORDER;SLC1A1;Gene;PA447211;Disease
BREAST NEOPLASMS;rs6493497;Variant;PA443560;Disease
ANASTROZOLE;rs6493497;Variant;PA448432;Chemical
EXEMESTANE;rs6493497;Variant;PA449563;Chemical
LETROZOLE;rs6493497;Variant;PA450196;Chemical
OPIOID-RELATED DISORDERS;CNIH3;Gene;PA445043;Disease
OPIOIDS;CNIH3;Gene;PA452618;Chemical
COTININE;rs7748401;Variant;PA166114414;Chemical
NICOTINE;rs7748401;Variant;PA450626;Chemical
COLORECTAL NEOPLASMS;ALOX12;Gene;PA446108;Disease
CELECOXIB;ALOX12;Gene;PA448871;Chemical
FLUOROURACIL;MEGF11;Gene;PA128406956;Chemical
BUFURALOL;CYP2D6*55;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*55;Haplotype;PA166127651;Chemical
DEXTROMETHORPHAN;CYP2D6*55;Haplotype;PA449273;Chemical
PRIMAQUINE;CYP2D6*55;Haplotype;PA451103;Chemical
ETONOGESTREL;CYP3A7;Gene;PA164771231;Chemical
KIDNEY TRANSPLANTATION;CYP3A7;Gene;PA165817016;Disease
ADRENAL HYPERPLASIA, CONGENITAL;CYP3A7;Gene;PA443286;Disease
CORTISONE ACETATE;CYP3A7;Gene;PA449130;Chemical
TACROLIMUS;CYP3A7;Gene;PA451578;Chemical
RHEUMATOID ARTHRITIS;rs5760410;Variant;PA443434;Disease
METHOTREXATE;rs5760410;Variant;PA450428;Chemical
NILOTINIB;UGT1A1*27;Haplotype;PA165958345;Chemical
HYPERBILIRUBINEMIA;UGT1A1*27;Haplotype;PA444511;Disease
LEUKOPENIA;UGT1A1*27;Haplotype;PA444773;Disease
LUNG NEOPLASMS;UGT1A1*27;Haplotype;PA444818;Disease
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;UGT1A1*27;Haplotype;PA446171;Disease
IRINOTECAN;UGT1A1*27;Haplotype;PA450085;Chemical
P2RY12;GNAI3;Gene;PA134971947;Gene
ADCY3;GNAI3;Gene;PA164741137;Gene
HTR1A;GNAI3;Gene;PA192;Gene
ADCY1;GNAI3;Gene;PA24560;Gene
ADCY2;GNAI3;Gene;PA24561;Gene
ADCY4;GNAI3;Gene;PA24562;Gene
ADCY5;GNAI3;Gene;PA24563;Gene
ADCY6;GNAI3;Gene;PA27;Gene
ADCY7;GNAI3;Gene;PA28;Gene
ADCY8;GNAI3;Gene;PA29;Gene
HTR1B;GNAI3;Gene;PA29549;Gene
HTR1D;GNAI3;Gene;PA29550;Gene
HTR1E;GNAI3;Gene;PA29552;Gene
HTR1F;GNAI3;Gene;PA29553;Gene
ADCY9;GNAI3;Gene;PA30;Gene
RGS1;GNAI3;Gene;PA34361;Gene
ADRB2;GNAI3;Gene;PA39;Gene
CYP2C9;meloxicam;Chemical;PA126;Gene
CYP3A5;meloxicam;Chemical;PA131;Gene
CYP2C9*1;meloxicam;Chemical;PA165816542;Haplotype
CYP2C9*2;meloxicam;Chemical;PA165816543;Haplotype
CYP2C9*3;meloxicam;Chemical;PA165816544;Haplotype
CYP2C9*13;meloxicam;Chemical;PA165816554;Haplotype
CYB5R3;meloxicam;Chemical;PA27331;Gene
G6PD;meloxicam;Chemical;PA28469;Gene
PTGS2;meloxicam;Chemical;PA293;Gene
FLUOROURACIL;rs2293347;Variant;PA128406956;Chemical
GEFITINIB;rs2293347;Variant;PA131301952;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs2293347;Variant;PA443622;Disease
STOMACH NEOPLASMS;rs2293347;Variant;PA445742;Disease
HYPOTENSIVE DISORDER;rs1042718;Variant;PA444584;Disease
FENTANYL;rs1042718;Variant;PA449599;Chemical
PROPOFOL;rs1042718;Variant;PA451141;Chemical
REMIFENTANIL;rs1042718;Variant;PA451232;Chemical
SEVOFLURANE;rs1042718;Variant;PA451341;Chemical
ESR1;lapatinib;Chemical;PA156;Gene
HLA-DQA1*02:01;lapatinib;Chemical;PA165951292;Haplotype
HLA-DRB1*04:03;lapatinib;Chemical;PA165951504;Haplotype
HLA-DRB1*07:01;lapatinib;Chemical;PA165951644;Haplotype
HLA-A*26:01;lapatinib;Chemical;PA165953825;Haplotype
HLA-C*08:02;lapatinib;Chemical;PA165957658;Haplotype
HLA-B*48:01;lapatinib;Chemical;PA166123429;Haplotype
RS9344;lapatinib;Chemical;PA166154264;Variant
PGR;lapatinib;Chemical;PA266;Gene
ERBB2;lapatinib;Chemical;PA27844;Gene
ERBB3;lapatinib;Chemical;PA27846;Gene
ERBB4;lapatinib;Chemical;PA27847;Gene
ESR2;lapatinib;Chemical;PA27886;Gene
PIK3CA;lapatinib;Chemical;PA33308;Gene
HLA-A;lapatinib;Chemical;PA35055;Gene
HLA-B;lapatinib;Chemical;PA35056;Gene
HLA-C;lapatinib;Chemical;PA35057;Gene
HLA-DQA1;lapatinib;Chemical;PA35066;Gene
HLA-DRB1;lapatinib;Chemical;PA35072;Gene
ABCB11;lapatinib;Chemical;PA374;Gene
EGFR;lapatinib;Chemical;PA7360;Gene
CCND1;lapatinib;Chemical;PA75;Gene
WARFARIN;rs339097;Variant;PA451906;Chemical
OVARIAN NEOPLASMS;rs11226;Variant;PA445204;Disease
CISPLATIN;rs11226;Variant;PA449014;Chemical
CYCLOPHOSPHAMIDE;rs11226;Variant;PA449165;Chemical
BIPOLAR DISORDER;rs2314339;Variant;PA447199;Disease
LITHIUM;rs2314339;Variant;PA450243;Chemical
SELECTIVE BETA-2-ADRENORECEPTOR AGONISTS;rs2781659;Variant;PA134687887;Chemical
ASTHMA;rs2781659;Variant;PA443450;Disease
ARIPIPRAZOLE;RABEP1;Gene;PA10026;Chemical
AMISULPRIDE;RABEP1;Gene;PA162565877;Chemical
PALIPERIDONE;RABEP1;Gene;PA163518919;Chemical
SCHIZOAFFECTIVE DISORDER;RABEP1;Gene;PA166123368;Disease
BIPOLAR DISORDER;RABEP1;Gene;PA447199;Disease
DEPRESSIVE DISORDER;RABEP1;Gene;PA447207;Disease
PSYCHOTIC DISORDER;RABEP1;Gene;PA447215;Disease
CLOZAPINE;RABEP1;Gene;PA449061;Chemical
LITHIUM;RABEP1;Gene;PA450243;Chemical
MIRTAZAPINE;RABEP1;Gene;PA450522;Chemical
OLANZAPINE;RABEP1;Gene;PA450688;Chemical
QUETIAPINE;RABEP1;Gene;PA451201;Chemical
RISPERIDONE;RABEP1;Gene;PA451257;Chemical
VALPROIC ACID;RABEP1;Gene;PA451846;Chemical
ALCOHOL ABUSE;rs1783835;Variant;PA443309;Disease
ETHANOL;rs1783835;Variant;PA448073;Chemical
F5;relugolix / estradiol / norethindrone acetate;Chemical;PA159;Gene
RS6025;relugolix / estradiol / norethindrone acetate;Chemical;PA166153554;Variant
PROC;relugolix / estradiol / norethindrone acetate;Chemical;PA33799;Gene
PROS1;relugolix / estradiol / norethindrone acetate;Chemical;PA33809;Gene
SERPINC1;relugolix / estradiol / norethindrone acetate;Chemical;PA35026;Gene
HYPERTENSION;rs2514036;Variant;PA444552;Disease
BISOPROLOL;rs2514036;Variant;PA448641;Chemical
PDE4C;ARRB1;Gene;PA264;Gene
MAPK1;ARRB1;Gene;PA30616;Gene
PDE4A;ARRB1;Gene;PA33128;Gene
PDE4B;ARRB1;Gene;PA33129;Gene
PDE4D;ARRB1;Gene;PA33130;Gene
PRKACA;ARRB1;Gene;PA33748;Gene
PRKACB;ARRB1;Gene;PA33749;Gene
PRKACG;ARRB1;Gene;PA33750;Gene
SRC;ARRB1;Gene;PA36111;Gene
ADRB2;ARRB1;Gene;PA39;Gene
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;ZNF134;Gene;PA447197;Disease
METHYLPHENIDATE;ZNF134;Gene;PA450464;Chemical
DIABETES MELLITUS, TYPE 2;rs11212617;Variant;PA443890;Disease
METFORMIN;rs11212617;Variant;PA450395;Chemical
CYP2B6;Depression;Disease;PA123;Gene
CYP2C19;Depression;Disease;PA124;Gene
CYP2D6;Depression;Disease;PA128;Gene
TPH2;Depression;Disease;PA128747823;Gene
CYP3A5;Depression;Disease;PA131;Gene
SLC39A14;Depression;Disease;PA134863701;Gene
RPP30;Depression;Disease;PA134876345;Gene
METTL21A;Depression;Disease;PA145008433;Gene
CYP2C19*17;Depression;Disease;PA165816533;Haplotype
CYP2D6*1;Depression;Disease;PA165816576;Haplotype
CYP2D6*3;Depression;Disease;PA165816578;Haplotype
CYP2D6*4;Depression;Disease;PA165816579;Haplotype
CYP2D6*6;Depression;Disease;PA165816581;Haplotype
CYP2D6*10;Depression;Disease;PA165816582;Haplotype
CYP2D6*41;Depression;Disease;PA165816584;Haplotype
CYP2B6*1;Depression;Disease;PA165818750;Haplotype
CYP2B6*4;Depression;Disease;PA165818757;Haplotype
CYP2B6*5;Depression;Disease;PA165818760;Haplotype
CYP2B6*6;Depression;Disease;PA165818762;Haplotype
CYP2B6*7;Depression;Disease;PA165818765;Haplotype
CYP2D6*5;Depression;Disease;PA165948092;Haplotype
CYP2C19*1;Depression;Disease;PA165980634;Haplotype
CYP2C19*2;Depression;Disease;PA165980635;Haplotype
CYP2D6*1XN;Depression;Disease;PA165988479;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);Depression;Disease;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);Depression;Disease;PA166116466;Haplotype
SLC6A4 L ALLELE-RS25531T;Depression;Disease;PA166117146;Haplotype
CYP2D6*81;Depression;Disease;PA166123321;Haplotype
CYP3A5*1;Depression;Disease;PA166128213;Haplotype
CYP3A5*3;Depression;Disease;PA166128219;Haplotype
RS12082710;Depression;Disease;PA166153847;Variant
RS4244285;Depression;Disease;PA166154053;Variant
RS6275;Depression;Disease;PA166154260;Variant
RS6279;Depression;Disease;PA166154262;Variant
RS61888800;Depression;Disease;PA166154478;Variant
RS1487278;Depression;Disease;PA166154514;Variant
RS6311;Depression;Disease;PA166154673;Variant
RS6313;Depression;Disease;PA166154675;Variant
RS7997012;Depression;Disease;PA166154726;Variant
RS10514475;Depression;Disease;PA166155100;Variant
RS520210;Depression;Disease;PA166155271;Variant
RS1126757;Depression;Disease;PA166155364;Variant
RS7569963;Depression;Disease;PA166155763;Variant
RS6108160;Depression;Disease;PA166155959;Variant
RS1523130;Depression;Disease;PA166156323;Variant
RS2276707;Depression;Disease;PA166156352;Variant
RS130058;Depression;Disease;PA166156908;Variant
RS1360780;Depression;Disease;PA166156983;Variant
RS3800373;Depression;Disease;PA166157083;Variant
RS1045642;Depression;Disease;PA166157284;Variant
RS2032582;Depression;Disease;PA166157316;Variant
RS2032583;Depression;Disease;PA166157317;Variant
RS2235015;Depression;Disease;PA166157336;Variant
RS2235040;Depression;Disease;PA166157338;Variant
RS4148739;Depression;Disease;PA166157386;Variant
RS10248420;Depression;Disease;PA166157440;Variant
RS10280101;Depression;Disease;PA166157445;Variant
RS11983225;Depression;Disease;PA166157453;Variant
RS12720067;Depression;Disease;PA166157458;Variant
RS17060812;Depression;Disease;PA166157650;Variant
RS4825476;Depression;Disease;PA166157876;Variant
RS57098334;Depression;Disease;PA166158926;Variant
RS7905446;Depression;Disease;PA166182096;Variant
HTR2A;Depression;Disease;PA193;Gene
MTHFR;Depression;Disease;PA245;Gene
ABCB1;Depression;Disease;PA267;Gene
CREB1;Depression;Disease;PA26864;Gene
DRD2;Depression;Disease;PA27478;Gene
FKBP5;Depression;Disease;PA28162;Gene
GRIA3;Depression;Disease;PA28968;Gene
HTR1B;Depression;Disease;PA29549;Gene
HTR7;Depression;Disease;PA29561;Gene
IL11;Depression;Disease;PA29781;Gene
SLC6A4;Depression;Disease;PA312;Gene
NEDD4L;Depression;Disease;PA31534;Gene
BDNF;Depression;Disease;PA31891;Gene
PLCB1;Depression;Disease;PA33384;Gene
TGFBR3;Depression;Disease;PA36487;Gene
NR1I2;Depression;Disease;PA378;Gene
ADRB1;Depression;Disease;PA38;Gene
DULOXETINE;MIEF2;Gene;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;MIEF2;Gene;PA447321;Disease
CYP3A5;fluticasone propionate;Chemical;PA131;Gene
RS1786929;fluticasone propionate;Chemical;PA166153971;Variant
RS967676;fluticasone propionate;Chemical;PA166155171;Variant
RS37973;fluticasone propionate;Chemical;PA166157244;Variant
CA10;fluticasone propionate;Chemical;PA25985;Gene
GLCCI1;fluticasone propionate;Chemical;PA38657;Gene
HLA-B*58:01;Arthritis, Gouty;Disease;PA165987831;Haplotype
HLA-B;Arthritis, Gouty;Disease;PA35056;Gene
CYP2C19;platelet reactivity;Disease;PA124;Gene
CYP2C19*17;platelet reactivity;Disease;PA165816533;Haplotype
CYP2C19*1;platelet reactivity;Disease;PA165980634;Haplotype
CYP2C19*2;platelet reactivity;Disease;PA165980635;Haplotype
CYP2C19*3;platelet reactivity;Disease;PA165980636;Haplotype
RS1045642;platelet reactivity;Disease;PA166157284;Variant
ABCB1;platelet reactivity;Disease;PA267;Gene
MERCAPTOPURINE;rs17839843;Variant;PA450379;Chemical
HALOPERIDOL;fluorobenzoylpropionic acid;Chemical;PA449841;Chemical
FGFR2;infigratinib;Chemical;PA28128;Gene
HYPERTENSION;RRP1B;Gene;PA444552;Disease
ATENOLOL;RRP1B;Gene;PA448499;Chemical
PAIN, POSTOPERATIVE;rs10028494;Variant;PA445210;Disease
FENTANYL;rs10028494;Variant;PA449599;Chemical
ALCOHOL ABUSE;rs13125415;Variant;PA443309;Disease
ETHANOL;rs13125415;Variant;PA448073;Chemical
CORONARY ARTERY DISEASE;rs1613662;Variant;PA443796;Disease
ASPIRIN;rs1613662;Variant;PA448497;Chemical
BUTYRYLCHOLINESTERASE DEFICIENCY;rs28933389;Variant;PA166122649;Disease
APNEA;rs28933389;Variant;PA443407;Disease
SUCCINYLCHOLINE;rs28933389;Variant;PA451522;Chemical
CONGENITAL ABNORMALITIES;EPHX1;Gene;PA443223;Disease
NON-SMALL CELL LUNG CARCINOMA;EPHX1;Gene;PA443622;Disease
EPILEPSY;EPHX1;Gene;PA444065;Disease
OVARIAN NEOPLASMS;EPHX1;Gene;PA445204;Disease
DISORDER OF FACIAL SKELETON;EPHX1;Gene;PA446836;Disease
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;EPHX1;Gene;PA447178;Disease
ACETYLCYSTEINE;EPHX1;Gene;PA448033;Chemical
CARBAMAZEPINE;EPHX1;Gene;PA448785;Chemical
CISPLATIN;EPHX1;Gene;PA449014;Chemical
CYCLOPHOSPHAMIDE;EPHX1;Gene;PA449165;Chemical
DOCETAXEL;EPHX1;Gene;PA449383;Chemical
PHENPROCOUMON;EPHX1;Gene;PA450921;Chemical
PHENYTOIN;EPHX1;Gene;PA450947;Chemical
WARFARIN;EPHX1;Gene;PA451906;Chemical
CYP2A6;artemisinin;Chemical;PA121;Gene
CYP2B6;artemisinin;Chemical;PA123;Gene
CYP3A4;artemisinin;Chemical;PA130;Gene
NR1I2;artemisinin;Chemical;PA378;Gene
LIVER TRANSPLANTATION;rs237025;Variant;PA447247;Disease
TACROLIMUS;rs237025;Variant;PA451578;Chemical
COMT;Neonatal Abstinence Syndrome;Disease;PA117;Gene
CYP2B6;Neonatal Abstinence Syndrome;Disease;PA123;Gene
RS2279343;Neonatal Abstinence Syndrome;Disease;PA166155393;Variant
RS3745274;Neonatal Abstinence Syndrome;Disease;PA166155409;Variant
RS4680;Neonatal Abstinence Syndrome;Disease;PA166156024;Variant
RS740603;Neonatal Abstinence Syndrome;Disease;PA166156057;Variant
RS1799971;Neonatal Abstinence Syndrome;Disease;PA166156991;Variant
RS4732636;Neonatal Abstinence Syndrome;Disease;PA166218621;Variant
RS351776;Neonatal Abstinence Syndrome;Disease;PA166218661;Variant
CYP2A7P1;Neonatal Abstinence Syndrome;Disease;PA27103;Gene
OPRM1;Neonatal Abstinence Syndrome;Disease;PA31945;Gene
PNOC;Neonatal Abstinence Syndrome;Disease;PA33485;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;SLCO1C1;Gene;PA164713366;Chemical
RHEUMATOID ARTHRITIS;SLCO1C1;Gene;PA443434;Disease
ARTHRITIS, PSORIATIC;SLCO1C1;Gene;PA446198;Disease
VORICONAZOLE;CYP2C19*6;Haplotype;PA10233;Chemical
CYP2C19;CYP2C19*6;Haplotype;PA124;Gene
NEBIVOLOL;CYP2C19*6;Haplotype;PA151958426;Chemical
ACUTE CORONARY SYNDROME;CYP2C19*6;Haplotype;PA165108401;Disease
6BETA-HYDROXYTESTOSTERONE;CYP2C19*6;Haplotype;PA166318222;Chemical
CARDIOVASCULAR DISEASES;CYP2C19*6;Haplotype;PA443635;Disease
ISCHEMIC ATTACK, TRANSIENT;CYP2C19*6;Haplotype;PA443672;Disease
STROKE;CYP2C19*6;Haplotype;PA447054;Disease
CLOPIDOGREL;CYP2C19*6;Haplotype;PA449053;Chemical
MEPHENYTOIN;CYP2C19*6;Haplotype;PA450373;Chemical
ALCOHOL ABUSE;RABGAP1L;Gene;PA443309;Disease
ETHANOL;RABGAP1L;Gene;PA448073;Chemical
CYP2A6;3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one;Chemical;PA121;Gene
ADEFOVIR DIPIVOXIL;NME2;Gene;PA10005;Chemical
TENOFOVIR;NME2;Gene;PA10204;Chemical
LAMIVUDINE;NME2;Gene;PA450163;Chemical
ZIDOVUDINE;NME2;Gene;PA451954;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs6908425;Variant;PA164713366;Chemical
PSORIASIS;rs6908425;Variant;PA445451;Disease
KCNH2;mibefradil;Chemical;PA212;Gene
8-OXO-DGTP;NUDT1;Gene;PA166153171;Chemical
KCNH2;lidoflazine;Chemical;PA212;Gene
TAFENOQUINE;rs62103056;Variant;PA166115580;Chemical
MALARIA;rs62103056;Variant;PA444859;Disease
DRUGS FOR TREATMENT OF TUBERCULOSIS;XPO1;Gene;PA164712708;Chemical
TOXIC LIVER DISEASE;XPO1;Gene;PA164925725;Disease
DRUG-INDUCED LIVER INJURY;XPO1;Gene;PA166119041;Disease
DRUG TOXICITY;XPO1;Gene;PA443937;Disease
TUBERCULOSIS;XPO1;Gene;PA445941;Disease
ISONIAZID;XPO1;Gene;PA450112;Chemical
OLANZAPINE;rs1124493;Variant;PA450688;Chemical
ESCITALOPRAM;rs41271330;Variant;PA10074;Chemical
MAJOR DEPRESSIVE DISORDER;rs41271330;Variant;PA447321;Disease
PLCB1;PLA2G4B;Gene;PA33384;Gene
PLCG2;PLA2G4B;Gene;PA33393;Gene
RS7412;lecanemab;Chemical;PA166155341;Variant
RS429358;lecanemab;Chemical;PA166155351;Variant
APOE;lecanemab;Chemical;PA55;Gene
KIDNEY TRANSPLANTATION;rs2237895;Variant;PA165817016;Disease
DIABETES MELLITUS, TYPE 2;rs2237895;Variant;PA443890;Disease
REPAGLINIDE;rs2237895;Variant;PA451234;Chemical
TACROLIMUS;rs2237895;Variant;PA451578;Chemical
FTO;interferon alfa-2b, recombinant;Chemical;PA152208656;Gene
RS9939609;interferon alfa-2b, recombinant;Chemical;PA166155098;Variant
RS1127354;interferon alfa-2b, recombinant;Chemical;PA166155915;Variant
ITPA;interferon alfa-2b, recombinant;Chemical;PA29973;Gene
PLATINUM COMPOUNDS;rs716274;Variant;PA164713176;Chemical
ETOPOSIDE;rs716274;Variant;PA449552;Chemical
SLC12A3;WNK3;Gene;PA321;Gene
WNK1;WNK3;Gene;PA33782;Gene
STK39;WNK3;Gene;PA38243;Gene
IMATINIB;rs2235040;Variant;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;rs2235040;Variant;PA151958383;Disease
DEPRESSION;rs2235040;Variant;PA447278;Disease
AMITRIPTYLINE;rs2235040;Variant;PA448385;Chemical
CITALOPRAM;rs2235040;Variant;PA449015;Chemical
FLUVOXAMINE;rs2235040;Variant;PA449690;Chemical
PAROXETINE;rs2235040;Variant;PA450801;Chemical
SERTRALINE;rs2235040;Variant;PA451333;Chemical
VENLAFAXINE;rs2235040;Variant;PA451866;Chemical
ANTIDEPRESSANTS;rs2235040;Variant;PA452229;Chemical
RS6166;Ovarian hyperstimulation syndrome;Disease;PA166155582;Variant
FSHR;Ovarian hyperstimulation syndrome;Disease;PA28386;Gene
FLUOROURACIL;rs58695150;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs58695150;Variant;PA443560;Disease
NEUTROPENIA;rs58695150;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs58695150;Variant;PA449165;Chemical
EPIRUBICIN;rs58695150;Variant;PA449476;Chemical
SEDATION;KCNK2;Gene;PA166129521;Disease
SEVOFLURANE;KCNK2;Gene;PA451341;Chemical
BUFURALOL;rs138417770;Variant;PA166110256;Chemical
DEXTROMETHORPHAN;rs138417770;Variant;PA449273;Chemical
PLATINUM COMPOUNDS;rs2233914;Variant;PA164713176;Chemical
OVERALL SURVIVAL;rs2233914;Variant;PA166123207;Disease
DRUG TOXICITY;rs2233914;Variant;PA443937;Disease
ESR1;UGT2B10;Gene;PA156;Gene
COTININE;UGT2B10;Gene;PA166114414;Chemical
TOBACCO USE DISORDER;UGT2B10;Gene;PA445876;Disease
NICOTINE;UGT2B10;Gene;PA450626;Chemical
GEFITINIB;IKBKB;Gene;PA131301952;Chemical
NON-SMALL CELL LUNG CARCINOMA;IKBKB;Gene;PA443622;Disease
EXANTHEMA;IKBKB;Gene;PA444109;Disease
F12;Enzymes;Chemical;PA161;Gene
RS669;Enzymes;Chemical;PA166154481;Variant
RS1801020;Enzymes;Chemical;PA166156775;Variant
A2M;Enzymes;Chemical;PA24357;Gene
COTININE;rs7170068;Variant;PA166114414;Chemical
TOBACCO USE DISORDER;rs7170068;Variant;PA445876;Disease
IMATINIB;rs274558;Variant;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;rs274558;Variant;PA151958383;Disease
DIABETES MELLITUS, TYPE 2;rs17584499;Variant;PA443890;Disease
PIOGLITAZONE;rs17584499;Variant;PA450970;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs1051792;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs1051792;Variant;PA443434;Disease
SPONDYLARTHROPATHIES;rs1051792;Variant;PA447163;Disease
HYPERTENSION;GALNT2;Gene;PA444552;Disease
ATENOLOL;GALNT2;Gene;PA448499;Chemical
CYP3A4;Proteinuria;Disease;PA130;Gene
HLA-DRB1*08:02;Proteinuria;Disease;PA165951674;Haplotype
HLA-DQB1*04:02;Proteinuria;Disease;PA165958226;Haplotype
RS4646437;Proteinuria;Disease;PA166157391;Variant
HLA-DQB1;Proteinuria;Disease;PA35068;Gene
HLA-DRB1;Proteinuria;Disease;PA35072;Gene
ASTHMA;DUSP1;Gene;PA443450;Disease
SALBUTAMOL;DUSP1;Gene;PA448068;Chemical
NICOTINE;rs112561475;Variant;PA450626;Chemical
DIABETES MELLITUS, TYPE 2;rs254271;Variant;PA443890;Disease
METFORMIN;rs254271;Variant;PA450395;Chemical
ATAZANAVIR;rs2740574;Variant;PA10251;Chemical
LUMEFANTRINE;rs2740574;Variant;PA165111722;Chemical
KIDNEY TRANSPLANTATION;rs2740574;Variant;PA165817016;Disease
TRANSPLANT REJECTION;rs2740574;Variant;PA166114454;Disease
ALOPECIA;rs2740574;Variant;PA443314;Disease
BREAST NEOPLASMS;rs2740574;Variant;PA443560;Disease
EPILEPSY;rs2740574;Variant;PA444065;Disease
HYPERTENSION;rs2740574;Variant;PA444552;Disease
MALARIA;rs2740574;Variant;PA444859;Disease
OPIOID-RELATED DISORDERS;rs2740574;Variant;PA445043;Disease
NEOPLASMS;rs2740574;Variant;PA445062;Disease
PAIN;rs2740574;Variant;PA445208;Disease
TESTICULAR NEOPLASMS;rs2740574;Variant;PA445828;Disease
HIV INFECTIOUS DISEASE;rs2740574;Variant;PA447230;Disease
AMLODIPINE;rs2740574;Variant;PA448388;Chemical
ATORVASTATIN;rs2740574;Variant;PA448500;Chemical
BLEOMYCIN;rs2740574;Variant;PA448645;Chemical
BUPRENORPHINE;rs2740574;Variant;PA448685;Chemical
CARBAMAZEPINE;rs2740574;Variant;PA448785;Chemical
CISPLATIN;rs2740574;Variant;PA449014;Chemical
CYCLOPHOSPHAMIDE;rs2740574;Variant;PA449165;Chemical
CYCLOSPORINE;rs2740574;Variant;PA449167;Chemical
DOCETAXEL;rs2740574;Variant;PA449383;Chemical
EFAVIRENZ;rs2740574;Variant;PA449441;Chemical
ETOPOSIDE;rs2740574;Variant;PA449552;Chemical
FENTANYL;rs2740574;Variant;PA449599;Chemical
INDINAVIR;rs2740574;Variant;PA449977;Chemical
SIMVASTATIN;rs2740574;Variant;PA451363;Chemical
SIROLIMUS;rs2740574;Variant;PA451365;Chemical
TACROLIMUS;rs2740574;Variant;PA451578;Chemical
TAMOXIFEN;rs2740574;Variant;PA451581;Chemical
OPIOIDS;rs2740574;Variant;PA452618;Chemical
CFTR;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA109;Gene
RS74503330;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166157511;Variant
RS75527207;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166157516;Variant
RS113993960;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166157525;Variant
RS121908755;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166157529;Variant
RS121908757;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166157530;Variant
RS121909005;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166157531;Variant
RS267606723;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166157537;Variant
RS75961395;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166162699;Variant
RS74551128;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166162705;Variant
RS121908752;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166164946;Variant
RS121908753;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166164947;Variant
RS397508442;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166164949;Variant
RS75541969;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166164958;Variant
RS121909019;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166178049;Variant
RS397508139;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166178058;Variant
RS397508510;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166178060;Variant
RS36210737;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166178078;Variant
RS139304906;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166178080;Variant
RS397508573;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166394541;Variant
RS1800076;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166394661;Variant
RS1800097;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166394921;Variant
RS150157202;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166394982;Variant
RS397508616;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166395061;Variant
RS121909006;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166395342;Variant
RS397508533;vanzacaftor / tezacaftor / deutivacaftor;Chemical;PA166395502;Variant
CYP2B6;ticlopidine;Chemical;PA123;Gene
CYP2C19;ticlopidine;Chemical;PA124;Gene
P2RY12;ticlopidine;Chemical;PA134971947;Gene
CYP2C19*8;ticlopidine;Chemical;PA165816524;Haplotype
CYP2C19*16;ticlopidine;Chemical;PA165816532;Haplotype
CYP2C19*18;ticlopidine;Chemical;PA165816534;Haplotype
CYP2C19*19;ticlopidine;Chemical;PA165816535;Haplotype
HLA-DRB1*13:02;ticlopidine;Chemical;PA165951978;Haplotype
HLA-A*33:01;ticlopidine;Chemical;PA165954144;Haplotype
HLA-B*44:03;ticlopidine;Chemical;PA165955913;Haplotype
HLA-C*14:03;ticlopidine;Chemical;PA165957827;Haplotype
HLA-DQB1*06:04;ticlopidine;Chemical;PA165958107;Haplotype
CYP2C19*1;ticlopidine;Chemical;PA165980634;Haplotype
HLA-A*33:03;ticlopidine;Chemical;PA166123428;Haplotype
HLA-A;ticlopidine;Chemical;PA35055;Gene
HLA-B;ticlopidine;Chemical;PA35056;Gene
HLA-C;ticlopidine;Chemical;PA35057;Gene
HLA-DQB1;ticlopidine;Chemical;PA35068;Gene
HLA-DRB1;ticlopidine;Chemical;PA35072;Gene
CYP2B6;NR1I3;Gene;PA123;Gene
CYP3A4;NR1I3;Gene;PA130;Gene
SUNITINIB;NR1I3;Gene;PA162372840;Chemical
ANEMIA;NR1I3;Gene;PA443340;Disease
NASOPHARYNGEAL NEOPLASMS;NR1I3;Gene;PA445046;Disease
NEUTROPENIA;NR1I3;Gene;PA445113;Disease
HIV INFECTIOUS DISEASE;NR1I3;Gene;PA447230;Disease
CARBAMAZEPINE;NR1I3;Gene;PA448785;Chemical
DOCETAXEL;NR1I3;Gene;PA449383;Chemical
EFAVIRENZ;NR1I3;Gene;PA449441;Chemical
WARFARIN;NR1I3;Gene;PA451906;Chemical
ESCITALOPRAM;GLDC;Gene;PA10074;Chemical
MAJOR DEPRESSIVE DISORDER;GLDC;Gene;PA447321;Disease
CITALOPRAM;GLDC;Gene;PA449015;Chemical
IDH2;enasidenib;Chemical;PA29631;Gene
RS1800544;dexmedetomidine;Chemical;PA166153974;Variant
RS9922316;dexmedetomidine;Chemical;PA166155090;Variant
RS1800035;dexmedetomidine;Chemical;PA166209221;Variant
RS201376588;dexmedetomidine;Chemical;PA166209222;Variant
RS775887911;dexmedetomidine;Chemical;PA166209223;Variant
PRKCB;dexmedetomidine;Chemical;PA33761;Gene
ADRA2A;dexmedetomidine;Chemical;PA35;Gene
CYP2A6;coumarin;Chemical;PA121;Gene
CYP2A6*1;coumarin;Chemical;PA165924690;Haplotype
CYP2A6*4;coumarin;Chemical;PA165924721;Haplotype
CYP2A6*47;coumarin;Chemical;PA165924724;Haplotype
CYP2A6*5;coumarin;Chemical;PA165924729;Haplotype
CYP2A6*6;coumarin;Chemical;PA165924730;Haplotype
CYP2A6*7;coumarin;Chemical;PA165924731;Haplotype
CYP2A6*10;coumarin;Chemical;PA165924735;Haplotype
CYP2A6*17;coumarin;Chemical;PA165924744;Haplotype
CYP2A6*19;coumarin;Chemical;PA165924748;Haplotype
CYP2A6*20;coumarin;Chemical;PA165924749;Haplotype
CYP2A6*9;coumarin;Chemical;PA165980914;Haplotype
CYP2A6*12;coumarin;Chemical;PA165980915;Haplotype
CYP2A6*18;coumarin;Chemical;PA165980916;Haplotype
RS1801272;coumarin;Chemical;PA166155376;Variant
RS28399433;coumarin;Chemical;PA166155471;Variant
RS148044792;coumarin;Chemical;PA166155560;Variant
CYP2A13;coumarin;Chemical;PA27101;Gene
LORNOXICAM;valaciclovir;Chemical;PA165958395;Chemical
LOXOPROFEN;valaciclovir;Chemical;PA166049180;Chemical
DICLOFENAC;valaciclovir;Chemical;PA449293;Chemical
ETODOLAC;valaciclovir;Chemical;PA449550;Chemical
KETOROLAC;valaciclovir;Chemical;PA450150;Chemical
PIROXICAM;valaciclovir;Chemical;PA450985;Chemical
DESFLURANE;rs193922762;Variant;PA164749136;Chemical
RYR1;rs193922762;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs193922762;Variant;PA444863;Disease
ENFLURANE;rs193922762;Variant;PA449461;Chemical
HALOTHANE;rs193922762;Variant;PA449845;Chemical
ISOFLURANE;rs193922762;Variant;PA450106;Chemical
METHOXYFLURANE;rs193922762;Variant;PA450434;Chemical
SEVOFLURANE;rs193922762;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs193922762;Variant;PA451522;Chemical
CACNA1S;rs193922762;Variant;PA85;Gene
NICOTINE;rs777098658;Variant;PA450626;Chemical
HEROIN DEPENDENCE;rs4646440;Variant;PA444460;Disease
METHADONE;rs4646440;Variant;PA450401;Chemical
TOSITUMOMAB;MS4A1;Gene;PA164748364;Chemical
IBRITUMOMAB;MS4A1;Gene;PA164781375;Chemical
OFATUMUMAB;MS4A1;Gene;PA165291493;Chemical
OBINUTUZUMAB;MS4A1;Gene;PA166122586;Chemical
RITUXIMAB;MS4A1;Gene;PA451261;Chemical
FLUOROURACIL;rs370457585;Variant;PA128406956;Chemical
CLADRIBINE;rs370457585;Variant;PA449027;Chemical
GEMCITABINE;rs370457585;Variant;PA449748;Chemical
ASTHMA;rs12436663;Variant;PA443450;Disease
ZILEUTON;rs12436663;Variant;PA451955;Chemical
DESFLURANE;rs118192116;Variant;PA164749136;Chemical
RYR1;rs118192116;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs118192116;Variant;PA444863;Disease
ENFLURANE;rs118192116;Variant;PA449461;Chemical
HALOTHANE;rs118192116;Variant;PA449845;Chemical
ISOFLURANE;rs118192116;Variant;PA450106;Chemical
METHOXYFLURANE;rs118192116;Variant;PA450434;Chemical
SEVOFLURANE;rs118192116;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs118192116;Variant;PA451522;Chemical
CACNA1S;rs118192116;Variant;PA85;Gene
TUBERCULOSIS;rs319952;Variant;PA445941;Disease
RIFAMPIN;rs319952;Variant;PA451250;Chemical
WEIGHT GAIN;GLP1R;Gene;PA128406954;Disease
SITAGLIPTIN;GLP1R;Gene;PA164748978;Chemical
VILDAGLIPTIN;GLP1R;Gene;PA165958346;Chemical
LIRAGLUTIDE;GLP1R;Gene;PA165958364;Chemical
DIABETES MELLITUS, TYPE 2;GLP1R;Gene;PA443890;Disease
OBESITY;GLP1R;Gene;PA445131;Disease
POLYCYSTIC OVARY SYNDROME;GLP1R;Gene;PA445376;Disease
SCHIZOPHRENIA;GLP1R;Gene;PA447216;Disease
CLOZAPINE;GLP1R;Gene;PA449061;Chemical
OLANZAPINE;GLP1R;Gene;PA450688;Chemical
ATOMOXETINE;rs12708954;Variant;PA134688071;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs12708954;Variant;PA447197;Disease
CES1;mycophenolic acid;Chemical;PA107;Gene
ABCC2;mycophenolic acid;Chemical;PA116;Gene
CYP2C8;mycophenolic acid;Chemical;PA125;Gene
CYP3A4;mycophenolic acid;Chemical;PA130;Gene
CYP3A5;mycophenolic acid;Chemical;PA131;Gene
SLCO1B1;mycophenolic acid;Chemical;PA134865839;Gene
RS717620;mycophenolic acid;Chemical;PA166153953;Variant
RS3740066;mycophenolic acid;Chemical;PA166154028;Variant
RS2306283;mycophenolic acid;Chemical;PA166154547;Variant
RS4149117;mycophenolic acid;Chemical;PA166154583;Variant
RS7311358;mycophenolic acid;Chemical;PA166154602;Variant
RS3832043;mycophenolic acid;Chemical;PA166155718;Variant
RS11706052;mycophenolic acid;Chemical;PA166156443;Variant
HPRT1;mycophenolic acid;Chemical;PA29427;Gene
IMPDH1;mycophenolic acid;Chemical;PA29862;Gene
IMPDH2;mycophenolic acid;Chemical;PA29863;Gene
SLCO1B3;mycophenolic acid;Chemical;PA35844;Gene
UGT2B7;mycophenolic acid;Chemical;PA361;Gene
UGT1A10;mycophenolic acid;Chemical;PA37174;Gene
UGT1A7;mycophenolic acid;Chemical;PA37182;Gene
UGT1A8;mycophenolic acid;Chemical;PA37183;Gene
CES2;mycophenolic acid;Chemical;PA377;Gene
UGT1A9;mycophenolic acid;Chemical;PA419;Gene
LEUKOTRIENE RECEPTOR ANTAGONISTS;GLT1D1;Gene;PA164712863;Chemical
RS267606618;kanamycin;Chemical;PA166158908;Variant
RS267606619;kanamycin;Chemical;PA166158909;Variant
RS267606617;kanamycin;Chemical;PA166159181;Variant
RS28358571;kanamycin;Chemical;PA166229161;Variant
MT-RNR1;kanamycin;Chemical;PA31274;Gene
TOPOTECAN;DDO;Gene;PA451729;Chemical
ASTHMA;PPARG;Gene;PA443450;Disease
DIABETES MELLITUS, TYPE 2;PPARG;Gene;PA443890;Disease
SCHIZOPHRENIA;PPARG;Gene;PA447216;Disease
ASPIRIN;PPARG;Gene;PA448497;Chemical
CELECOXIB;PPARG;Gene;PA448871;Chemical
OLANZAPINE;PPARG;Gene;PA450688;Chemical
PIOGLITAZONE;PPARG;Gene;PA450970;Chemical
PAIN, POSTOPERATIVE;rs7858836;Variant;PA445210;Disease
FENTANYL;rs7858836;Variant;PA449599;Chemical
CLAVULANATE;rs9274407;Variant;PA164742987;Chemical
DRUG TOXICITY;rs9274407;Variant;PA443937;Disease
AMOXICILLIN;rs9274407;Variant;PA448406;Chemical
SELECTIVE BETA-2-ADRENORECEPTOR AGONISTS;rs1540339;Variant;PA134687887;Chemical
ASTHMA;rs1540339;Variant;PA443450;Disease
RS2368564;muraglitazar;Chemical;PA166153701;Variant
RS1801253;muraglitazar;Chemical;PA166153977;Variant
RS5370;muraglitazar;Chemical;PA166156901;Variant
EDN1;muraglitazar;Chemical;PA27614;Gene
REN;muraglitazar;Chemical;PA297;Gene
ADRB1;muraglitazar;Chemical;PA38;Gene
CD38;isatuximab;Chemical;PA26214;Gene
NEPHROTOXICITY;rs11854484;Variant;PA162263533;Disease
PEGINTERFERON ALFA-2B;rs11854484;Variant;PA164784024;Chemical
TENOFOVIR DISOPROXIL FUMARATE;rs11854484;Variant;PA166201941;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs11854484;Variant;PA443622;Disease
HEPATITIS C VIRUS INFECTION;rs11854484;Variant;PA444445;Disease
HIV INFECTIOUS DISEASE;rs11854484;Variant;PA447230;Disease
GEMCITABINE;rs11854484;Variant;PA449748;Chemical
PROTEASE INHIBITORS;rs11854484;Variant;PA451159;Chemical
RIBAVIRIN;rs11854484;Variant;PA451241;Chemical
TEMSIROLIMUS;rs3814055;Variant;PA164746890;Chemical
FLUCLOXACILLIN;rs3814055;Variant;PA164781042;Chemical
TOXIC LIVER DISEASE;rs3814055;Variant;PA164925725;Disease
MYELOSUPPRESSION;rs3814055;Variant;PA165817398;Disease
GASTROINTESTINAL TOXICITY;rs3814055;Variant;PA166124386;Disease
ADVERSE EVENTS;rs3814055;Variant;PA166151827;Disease
URINARY BLADDER NEOPLASMS;rs3814055;Variant;PA443512;Disease
EPILEPSY;rs3814055;Variant;PA444065;Disease
CARBAMAZEPINE;rs3814055;Variant;PA448785;Chemical
SIROLIMUS;rs3814055;Variant;PA451365;Chemical
TACROLIMUS;rs3814055;Variant;PA451578;Chemical
ESCITALOPRAM;rs4646425;Variant;PA10074;Chemical
MAJOR DEPRESSIVE DISORDER;rs4646425;Variant;PA447321;Disease
PAROXETINE;rs4646425;Variant;PA450801;Chemical
HEPATITIS VACCINES;rs1805015;Variant;PA164712789;Chemical
NEBIVOLOL;GRK4;Gene;PA151958426;Chemical
LABETALOL;GRK4;Gene;PA164743150;Chemical
HYPERTENSIVE NEPHROSCLEROSIS;GRK4;Gene;PA166152848;Disease
CORONARY ARTERY DISEASE;GRK4;Gene;PA443796;Disease
HYPERTENSION;GRK4;Gene;PA444552;Disease
KIDNEY DISORDER;GRK4;Gene;PA444682;Disease
NEPHROSCLEROSIS;GRK4;Gene;PA445086;Disease
ACEBUTOLOL;GRK4;Gene;PA448011;Chemical
ATENOLOL;GRK4;Gene;PA448499;Chemical
BETAXOLOL;GRK4;Gene;PA448611;Chemical
BISOPROLOL;GRK4;Gene;PA448641;Chemical
CARVEDILOL;GRK4;Gene;PA448817;Chemical
ESMOLOL;GRK4;Gene;PA449500;Chemical
METOPROLOL;GRK4;Gene;PA450480;Chemical
NADOLOL;GRK4;Gene;PA450573;Chemical
PINDOLOL;GRK4;Gene;PA450966;Chemical
PROPRANOLOL;GRK4;Gene;PA451145;Chemical
SOTALOL;GRK4;Gene;PA451457;Chemical
VERAPAMIL;GRK4;Gene;PA451868;Chemical
DPYD;rs190951787;Variant;PA145;Gene
CAPECITABINE;rs190951787;Variant;PA448771;Chemical
RS7439366;(R)-methadone;Chemical;PA166156619;Variant
UGT2B7;(R)-methadone;Chemical;PA361;Gene
MIGALASTAT;rs190347120;Variant;PA166182881;Chemical
FABRY DISEASE;rs190347120;Variant;PA443367;Disease
CETUXIMAB;VEGFA;Gene;PA10040;Chemical
FLUOROURACIL;VEGFA;Gene;PA128406956;Chemical
BEVACIZUMAB;VEGFA;Gene;PA130232992;Chemical
OXALIPLATIN;VEGFA;Gene;PA131285527;Chemical
MACULAR DEGENERATION;VEGFA;Gene;PA134850558;Disease
TAXANES;VEGFA;Gene;PA150481189;Chemical
SUNITINIB;VEGFA;Gene;PA162372840;Chemical
RANIBIZUMAB;VEGFA;Gene;PA164746012;Chemical
PEGAPTANIB;VEGFA;Gene;PA164771236;Chemical
HAND-FOOT SYNDROME;VEGFA;Gene;PA166114377;Disease
AFLIBERCEPT;VEGFA;Gene;PA166118342;Chemical
FLT1;VEGFA;Gene;PA28180;Gene
KDR;VEGFA;Gene;PA30086;Gene
NRP1;VEGFA;Gene;PA31783;Gene
BREAST NEOPLASMS;VEGFA;Gene;PA443560;Disease
RENAL CELL CARCINOMA;VEGFA;Gene;PA443624;Disease
HEPATOCELLULAR CARCINOMA;VEGFA;Gene;PA444447;Disease
HYPERTENSION;VEGFA;Gene;PA444552;Disease
ERECTILE DYSFUNCTION;VEGFA;Gene;PA444606;Disease
OVARIAN NEOPLASMS;VEGFA;Gene;PA445204;Disease
PROSTATIC NEOPLASMS;VEGFA;Gene;PA445425;Disease
STOMACH NEOPLASMS;VEGFA;Gene;PA445742;Disease
COLORECTAL NEOPLASMS;VEGFA;Gene;PA446108;Disease
CHOROIDAL NEOVASCULARIZATION;VEGFA;Gene;PA446974;Disease
CAPECITABINE;VEGFA;Gene;PA448771;Chemical
CARBOPLATIN;VEGFA;Gene;PA448803;Chemical
CELECOXIB;VEGFA;Gene;PA448871;Chemical
CISPLATIN;VEGFA;Gene;PA449014;Chemical
CYCLOPHOSPHAMIDE;VEGFA;Gene;PA449165;Chemical
DOCETAXEL;VEGFA;Gene;PA449383;Chemical
ENALAPRIL;VEGFA;Gene;PA449456;Chemical
IRINOTECAN;VEGFA;Gene;PA450085;Chemical
LEUCOVORIN;VEGFA;Gene;PA450198;Chemical
SILDENAFIL;VEGFA;Gene;PA451346;Chemical
SORAFENIB;VEGFA;Gene;PA7000;Chemical
DESLORATADINE;rs2298805;Variant;PA164776964;Chemical
MIZOLASTINE;rs2298805;Variant;PA166129535;Chemical
URTICARIA;rs2298805;Variant;PA445999;Disease
FGB;tirofiban;Chemical;PA163;Gene
ITGB3;tirofiban;Chemical;PA205;Gene
ITGA2B;tirofiban;Chemical;PA29938;Gene
FGA;tirofiban;Chemical;PA429;Gene
FGG;tirofiban;Chemical;PA430;Gene
CORTICOSTEROIDS;rs3842689;Variant;PA10832;Chemical
HIV INFECTIONS;rs3842689;Variant;PA447230;Disease
NEVIRAPINE;rs3842689;Variant;PA450616;Chemical
OMEPRAZOLE;rs148247410;Variant;PA450704;Chemical
AKT1;PDK1;Gene;PA24684;Gene
CELECOXIB;PDK1;Gene;PA448871;Chemical
CYP2B6;artemether;Chemical;PA123;Gene
CYP3A4;artemether;Chemical;PA130;Gene
CYP3A5;artemether;Chemical;PA131;Gene
CYP2B6*1;artemether;Chemical;PA165818750;Haplotype
CYP2B6*6;artemether;Chemical;PA165818762;Haplotype
ADALIMUMAB;CRP;Gene;PA10004;Chemical
ROSUVASTATIN;CRP;Gene;PA134308647;Chemical
METABOLIC SYNDROME;CRP;Gene;PA162370415;Disease
CORONARY DISEASE;CRP;Gene;PA443797;Disease
SCHIZOPHRENIA;CRP;Gene;PA447216;Disease
FENOFIBRATE;CRP;Gene;PA449594;Chemical
FLUOROURACIL;SELE;Gene;PA128406956;Chemical
OXALIPLATIN;SELE;Gene;PA131285527;Chemical
COLONIC NEOPLASMS;SELE;Gene;PA443756;Disease
CAPECITABINE;SELE;Gene;PA448771;Chemical
LEUCOVORIN;SELE;Gene;PA450198;Chemical
ACUTE LYMPHOBLASTIC LEUKEMIA;GRIA1;Gene;PA446155;Disease
ASPARAGINASE;GRIA1;Gene;PA448492;Chemical
HALOPERIDOL;GRIA1;Gene;PA449841;Chemical
HYPERTENSION;SLC14A2;Gene;PA444552;Disease
NIFEDIPINE;SLC14A2;Gene;PA450631;Chemical
CYP2C19;warfarin;Chemical;PA124;Gene
CYP2C9;warfarin;Chemical;PA126;Gene
CYP3A4;warfarin;Chemical;PA130;Gene
CYP3A5;warfarin;Chemical;PA131;Gene
VKORC1;warfarin;Chemical;PA133787052;Gene
DDHD1;warfarin;Chemical;PA134861440;Gene
SLCO1B1;warfarin;Chemical;PA134865839;Gene
VKORC1L1;warfarin;Chemical;PA134931578;Gene
VITAMIN K;warfarin;Chemical;PA164713404;Chemical
PRSS53;warfarin;Chemical;PA165450635;Gene
CYP2C9*1;warfarin;Chemical;PA165816542;Haplotype
CYP2C9*2;warfarin;Chemical;PA165816543;Haplotype
CYP2C9*3;warfarin;Chemical;PA165816544;Haplotype
CYP2C9*4;warfarin;Chemical;PA165816545;Haplotype
CYP2C9*5;warfarin;Chemical;PA165816546;Haplotype
CYP2C9*6;warfarin;Chemical;PA165816547;Haplotype
CYP2C9*8;warfarin;Chemical;PA165816549;Haplotype
CYP2C9*9;warfarin;Chemical;PA165816550;Haplotype
CYP2C9*10;warfarin;Chemical;PA165816551;Haplotype
CYP2C9*11;warfarin;Chemical;PA165816552;Haplotype
CYP2C9*12;warfarin;Chemical;PA165816553;Haplotype
CYP2C9*13;warfarin;Chemical;PA165816554;Haplotype
CYP2C9*14;warfarin;Chemical;PA165816555;Haplotype
CYP2C9*16;warfarin;Chemical;PA165816557;Haplotype
CYP2C9*24;warfarin;Chemical;PA165816569;Haplotype
CYP2C9*29;warfarin;Chemical;PA165816573;Haplotype
CYP4F2*1;warfarin;Chemical;PA165860685;Haplotype
CYP4F2*3;warfarin;Chemical;PA165860687;Haplotype
CYP2C19*1;warfarin;Chemical;PA165980634;Haplotype
CYP2C19*2;warfarin;Chemical;PA165980635;Haplotype
CYP2C19*3;warfarin;Chemical;PA165980636;Haplotype
CYP2C9*46;warfarin;Chemical;PA166048692;Haplotype
CYP2C9*57;warfarin;Chemical;PA166048703;Haplotype
UGT1A1*1;warfarin;Chemical;PA166115841;Haplotype
UGT1A1*28;warfarin;Chemical;PA166115842;Haplotype
CYP2C9*58;warfarin;Chemical;PA166122566;Haplotype
CYP2C9*59;warfarin;Chemical;PA166128210;Haplotype
CYP2C9*60;warfarin;Chemical;PA166128211;Haplotype
RS1131873;warfarin;Chemical;PA166153625;Variant
RS1877724;warfarin;Chemical;PA166153656;Variant
RS2501873;warfarin;Chemical;PA166153711;Variant
RS1057910;warfarin;Chemical;PA166153959;Variant
RS1799853;warfarin;Chemical;PA166153972;Variant
RS3814637;warfarin;Chemical;PA166154042;Variant
RS4917639;warfarin;Chemical;PA166154066;Variant
RS4918758;warfarin;Chemical;PA166154067;Variant
RS7089580;warfarin;Chemical;PA166154078;Variant
RS9332096;warfarin;Chemical;PA166154097;Variant
RS9332131;warfarin;Chemical;PA166154102;Variant
RS10509680;warfarin;Chemical;PA166154109;Variant
RS12777823;warfarin;Chemical;PA166154157;Variant
RS28371685;warfarin;Chemical;PA166154175;Variant
RS28371686;warfarin;Chemical;PA166154176;Variant
RS72558189;warfarin;Chemical;PA166154195;Variant
RS182132442;warfarin;Chemical;PA166154220;Variant
RS4149056;warfarin;Chemical;PA166154579;Variant
RS7294;warfarin;Chemical;PA166154977;Variant
RS10517;warfarin;Chemical;PA166154980;Variant
RS1800566;warfarin;Chemical;PA166155017;Variant
RS2359612;warfarin;Chemical;PA166155040;Variant
RS2884737;warfarin;Chemical;PA166155042;Variant
RS4889606;warfarin;Chemical;PA166155072;Variant
RS7196161;warfarin;Chemical;PA166155079;Variant
RS7200749;warfarin;Chemical;PA166155080;Variant
RS8050894;warfarin;Chemical;PA166155084;Variant
RS9923231;warfarin;Chemical;PA166155091;Variant
RS9934438;warfarin;Chemical;PA166155096;Variant
RS10871454;warfarin;Chemical;PA166155102;Variant
RS11150606;warfarin;Chemical;PA166155104;Variant
RS17708472;warfarin;Chemical;PA166155119;Variant
RS17880887;warfarin;Chemical;PA166155123;Variant
RS17886199;warfarin;Chemical;PA166155125;Variant
RS61162043;warfarin;Chemical;PA166155133;Variant
RS61742245;warfarin;Chemical;PA166155134;Variant
RS72547529;warfarin;Chemical;PA166155136;Variant
RS104894539;warfarin;Chemical;PA166155137;Variant
RS104894540;warfarin;Chemical;PA166155138;Variant
RS104894541;warfarin;Chemical;PA166155139;Variant
RS104894542;warfarin;Chemical;PA166155140;Variant
RS7412;warfarin;Chemical;PA166155341;Variant
RS429358;warfarin;Chemical;PA166155351;Variant
RS2108622;warfarin;Chemical;PA166155381;Variant
RS2189784;warfarin;Chemical;PA166155384;Variant
RS699664;warfarin;Chemical;PA166155598;Variant
RS887829;warfarin;Chemical;PA166155607;Variant
RS1367117;warfarin;Chemical;PA166155632;Variant
RS2592551;warfarin;Chemical;PA166155685;Variant
RS11676382;warfarin;Chemical;PA166155805;Variant
RS12714145;warfarin;Chemical;PA166155822;Variant
RS1042580;warfarin;Chemical;PA166155911;Variant
RS3212198;warfarin;Chemical;PA166155934;Variant
RS339097;warfarin;Chemical;PA166157254;Variant
RS1045642;warfarin;Chemical;PA166157284;Variant
RS2645400;warfarin;Chemical;PA166157578;Variant
RS4841588;warfarin;Chemical;PA166157607;Variant
RS7856096;warfarin;Chemical;PA166157792;Variant
RS41301394;warfarin;Chemical;PA166160014;Variant
RS17126068;warfarin;Chemical;PA166160025;Variant
RS2288344;warfarin;Chemical;PA166160028;Variant
RS4379440;warfarin;Chemical;PA166160033;Variant
RS2304429;warfarin;Chemical;PA166160865;Variant
RS3826041;warfarin;Chemical;PA166160867;Variant
RS72800847;warfarin;Chemical;PA166160869;Variant
RS1060467;warfarin;Chemical;PA166165118;Variant
RS4072879;warfarin;Chemical;PA166170886;Variant
RS4760658;warfarin;Chemical;PA166176700;Variant
RS11168292;warfarin;Chemical;PA166176701;Variant
RS11168293;warfarin;Chemical;PA166176702;Variant
RS679899;warfarin;Chemical;PA166197882;Variant
RS780801862;warfarin;Chemical;PA166209781;Variant
RS78132896;warfarin;Chemical;PA166223623;Variant
FPGS;warfarin;Chemical;PA167;Gene
ASPH;warfarin;Chemical;PA25056;Gene
CALU;warfarin;Chemical;PA26047;Gene
ABCB1;warfarin;Chemical;PA267;Gene
CYP1A1;warfarin;Chemical;PA27092;Gene
CYP1A2;warfarin;Chemical;PA27093;Gene
CYP4F11;warfarin;Chemical;PA27120;Gene
CYP4F2;warfarin;Chemical;PA27121;Gene
DNMT3A;warfarin;Chemical;PA27445;Gene
EPHA7;warfarin;Chemical;PA27822;Gene
EPHX1;warfarin;Chemical;PA27829;Gene
GATA4;warfarin;Chemical;PA28587;Gene
GGCX;warfarin;Chemical;PA28660;Gene
HNF4A;warfarin;Chemical;PA29349;Gene
NEDD4;warfarin;Chemical;PA31533;Gene
NQO1;warfarin;Chemical;PA31744;Gene
POR;warfarin;Chemical;PA33532;Gene
PROC;warfarin;Chemical;PA33799;Gene
PROS1;warfarin;Chemical;PA33809;Gene
STX4;warfarin;Chemical;PA36236;Gene
THBD;warfarin;Chemical;PA36496;Gene
VDR;warfarin;Chemical;PA37301;Gene
STX1B;warfarin;Chemical;PA38345;Gene
NR1I3;warfarin;Chemical;PA391;Gene
UGT1A1;warfarin;Chemical;PA420;Gene
QUINIDINE;warfarin;Chemical;PA451209;Chemical
ACENOCOUMAROL;warfarin;Chemical;PA452632;Chemical
APOB;warfarin;Chemical;PA50;Gene
APOE;warfarin;Chemical;PA55;Gene
ACETALDEHYDE;ALDH2;Gene;PA166186245;Chemical
ALCOHOL ABUSE;ALDH2;Gene;PA443309;Disease
HEROIN DEPENDENCE;ALDH2;Gene;PA444460;Disease
ETHANOL;ALDH2;Gene;PA448073;Chemical
NALTREXONE;ALDH2;Gene;PA450588;Chemical
NITROGLYCERIN;ALDH2;Gene;PA450644;Chemical
HEROIN;ALDH2;Gene;PA452619;Chemical
ABCC2;oxcarbazepine;Chemical;PA116;Gene
CYP2B6;oxcarbazepine;Chemical;PA123;Gene
CYP2C19;oxcarbazepine;Chemical;PA124;Gene
CYP2C9;oxcarbazepine;Chemical;PA126;Gene
CYP2D6;oxcarbazepine;Chemical;PA128;Gene
CYP3A4;oxcarbazepine;Chemical;PA130;Gene
CYP3A5;oxcarbazepine;Chemical;PA131;Gene
HLA-DRB1*04:03;oxcarbazepine;Chemical;PA165951504;Haplotype
HLA-A*31:01;oxcarbazepine;Chemical;PA165954030;Haplotype
HLA-B*13:02;oxcarbazepine;Chemical;PA165954649;Haplotype
HLA-B*15:01;oxcarbazepine;Chemical;PA165954745;Haplotype
HLA-B*15:02;oxcarbazepine;Chemical;PA165954769;Haplotype
HLA-B*15:18;oxcarbazepine;Chemical;PA165954803;Haplotype
HLA-B*15:19;oxcarbazepine;Chemical;PA165954807;Haplotype
HLA-B*15:27;oxcarbazepine;Chemical;PA165954816;Haplotype
HLA-B*27:09;oxcarbazepine;Chemical;PA165955138;Haplotype
HLA-B*38:02;oxcarbazepine;Chemical;PA165955505;Haplotype
HLA-B*40:01;oxcarbazepine;Chemical;PA165955628;Haplotype
HLA-B*40:02;oxcarbazepine;Chemical;PA165955651;Haplotype
HLA-B*48:04;oxcarbazepine;Chemical;PA165956139;Haplotype
RS2273697;oxcarbazepine;Chemical;PA166154007;Variant
RS2298771;oxcarbazepine;Chemical;PA166155680;Variant
RS2304016;oxcarbazepine;Chemical;PA166155682;Variant
RS2741049;oxcarbazepine;Chemical;PA166155690;Variant
RS7439366;oxcarbazepine;Chemical;PA166156619;Variant
RS1045642;oxcarbazepine;Chemical;PA166157284;Variant
HTR2A;oxcarbazepine;Chemical;PA193;Gene
HTR2C;oxcarbazepine;Chemical;PA194;Gene
ABCB1;oxcarbazepine;Chemical;PA267;Gene
CYP1A2;oxcarbazepine;Chemical;PA27093;Gene
DRD2;oxcarbazepine;Chemical;PA27478;Gene
SCN1A;oxcarbazepine;Chemical;PA301;Gene
SLC6A4;oxcarbazepine;Chemical;PA312;Gene
POLG;oxcarbazepine;Chemical;PA33500;Gene
SCN2A;oxcarbazepine;Chemical;PA35004;Gene
HLA-A;oxcarbazepine;Chemical;PA35055;Gene
HLA-B;oxcarbazepine;Chemical;PA35056;Gene
HLA-DRB1;oxcarbazepine;Chemical;PA35072;Gene
UGT2B7;oxcarbazepine;Chemical;PA361;Gene
UGT1A10;oxcarbazepine;Chemical;PA37174;Gene
UGT1A4;oxcarbazepine;Chemical;PA37179;Gene
UGT1A7;oxcarbazepine;Chemical;PA37182;Gene
UGT1A8;oxcarbazepine;Chemical;PA37183;Gene
UGT1A9;oxcarbazepine;Chemical;PA419;Gene
CYP2C9;rs9923231;Variant;PA126;Gene
VKORC1;rs9923231;Variant;PA133787052;Gene
FLUINDIONE;rs9923231;Variant;PA165980614;Chemical
OVER-ANTICOAGULATION;rs9923231;Variant;PA166123298;Disease
TIME IN THERAPEUTIC RANGE;rs9923231;Variant;PA166129531;Disease
TIME TO THERAPEUTIC INR;rs9923231;Variant;PA166129532;Disease
TIME ABOVE THERAPEUTIC RANGE;rs9923231;Variant;PA166129534;Disease
CYP4F2;rs9923231;Variant;PA27121;Gene
HEART DISEASES;rs9923231;Variant;PA444368;Disease
HEMORRHAGE;rs9923231;Variant;PA444417;Disease
PHENPROCOUMON;rs9923231;Variant;PA450921;Chemical
WARFARIN;rs9923231;Variant;PA451906;Chemical
ACENOCOUMAROL;rs9923231;Variant;PA452632;Chemical
NON-SMALL CELL LUNG CARCINOMA;SERPINA5;Gene;PA443622;Disease
THROMBOCYTOPENIA;SERPINA5;Gene;PA445846;Disease
CARBOPLATIN;SERPINA5;Gene;PA448803;Chemical
GEMCITABINE;SERPINA5;Gene;PA449748;Chemical
RENAL CELL CARCINOMA;rs2071559;Variant;PA443624;Disease
HEPATOCELLULAR CARCINOMA;rs2071559;Variant;PA444447;Disease
SORAFENIB;rs2071559;Variant;PA7000;Chemical
ALCOHOL ABUSE;rs576859;Variant;PA443309;Disease
ETHANOL;rs576859;Variant;PA448073;Chemical
DIABETES MELLITUS;rs7541245;Variant;PA443886;Disease
METFORMIN;rs7541245;Variant;PA450395;Chemical
AHR;methylcholanthrene;Chemical;PA24641;Gene
TAMSULOSIN;CYP2D6 extensive metabolizer genotype;Variant;PA451583;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;rs4261716;Variant;PA130620651;Chemical
NEOPLASMS;rs4261716;Variant;PA445062;Disease
EPILEPSY;rs71486745;Variant;PA444065;Disease
PHENYTOIN;rs71486745;Variant;PA450947;Chemical
MAJOR DEPRESSIVE DISORDER;PON2;Gene;PA447321;Disease
ANTIDEPRESSANTS;PON2;Gene;PA452229;Chemical
BREAST NEOPLASMS;rs934635;Variant;PA443560;Disease
EXEMESTANE;rs934635;Variant;PA449563;Chemical
DESFLURANE;rs118192175;Variant;PA164749136;Chemical
RYR1;rs118192175;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs118192175;Variant;PA444863;Disease
ENFLURANE;rs118192175;Variant;PA449461;Chemical
HALOTHANE;rs118192175;Variant;PA449845;Chemical
ISOFLURANE;rs118192175;Variant;PA450106;Chemical
METHOXYFLURANE;rs118192175;Variant;PA450434;Chemical
SEVOFLURANE;rs118192175;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs118192175;Variant;PA451522;Chemical
CACNA1S;rs118192175;Variant;PA85;Gene
CETUXIMAB;rs11942466;Variant;PA10040;Chemical
PANITUMUMAB;rs11942466;Variant;PA162373091;Chemical
RADIOTHERAPY;rs11942466;Variant;PA166122986;Chemical
RECTAL NEOPLASMS;rs11942466;Variant;PA445503;Disease
COLORECTAL NEOPLASMS;rs11942466;Variant;PA446108;Disease
CAPECITABINE;rs11942466;Variant;PA448771;Chemical
IRINOTECAN;rs11942466;Variant;PA450085;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs751655;Variant;PA447197;Disease
METHYLPHENIDATE;rs751655;Variant;PA450464;Chemical
ADVERSE EVENTS;rs739296;Variant;PA166151827;Disease
CODEINE;rs739296;Variant;PA449088;Chemical
HYDROCODONE;rs739296;Variant;PA449900;Chemical
OXYCODONE;rs739296;Variant;PA450741;Chemical
TRAMADOL;rs739296;Variant;PA451735;Chemical
ADALIMUMAB;HFE;Gene;PA10004;Chemical
CROHN DISEASE;HFE;Gene;PA443815;Disease
CFTR;rs397508513;Variant;PA109;Gene
IVACAFTOR;rs397508513;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs397508513;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs397508513;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs397508513;Variant;PA443829;Disease
ALCOHOL ABUSE;rs1402398;Variant;PA443309;Disease
ETHANOL;rs1402398;Variant;PA448073;Chemical
NASOPHARYNGEAL NEOPLASMS;rs3834935;Variant;PA445046;Disease
DOCETAXEL;rs3834935;Variant;PA449383;Chemical
EPILEPSY;UGT1A6*8;Haplotype;PA444065;Disease
VALPROIC ACID;UGT1A6*8;Haplotype;PA451846;Chemical
FLUOROURACIL;GSTP1;Gene;PA128406956;Chemical
OXALIPLATIN;GSTP1;Gene;PA131285527;Chemical
PLATINUM;GSTP1;Gene;PA150595617;Chemical
OTOTOXICITY;GSTP1;Gene;PA162263534;Disease
PLATINUM COMPOUNDS;GSTP1;Gene;PA164713176;Chemical
DRUG-INDUCED LIVER INJURY;GSTP1;Gene;PA166119041;Disease
CARDIOTOXICITY;GSTP1;Gene;PA166128121;Disease
DIMETHYL FUMARATE;GSTP1;Gene;PA166152838;Chemical
BREAST NEOPLASMS;GSTP1;Gene;PA443560;Disease
NON-SMALL CELL LUNG CARCINOMA;GSTP1;Gene;PA443622;Disease
DRUG TOXICITY;GSTP1;Gene;PA443937;Disease
GASTROINTESTINAL NEOPLASMS;GSTP1;Gene;PA444257;Disease
INFECTIOUS DISEASE;GSTP1;Gene;PA444614;Disease
LEUKOPENIA;GSTP1;Gene;PA444773;Disease
MEDULLOBLASTOMA;GSTP1;Gene;PA444898;Disease
NAUSEA;GSTP1;Gene;PA445048;Disease
NEOPLASMS;GSTP1;Gene;PA445062;Disease
NEUTROPENIA;GSTP1;Gene;PA445113;Disease
OVARIAN NEOPLASMS;GSTP1;Gene;PA445204;Disease
PSORIASIS;GSTP1;Gene;PA445451;Disease
RECTAL NEOPLASMS;GSTP1;Gene;PA445503;Disease
OSTEOSARCOMA;GSTP1;Gene;PA445601;Disease
TESTICULAR NEOPLASMS;GSTP1;Gene;PA445828;Disease
TUBERCULOSIS;GSTP1;Gene;PA445941;Disease
COLORECTAL NEOPLASMS;GSTP1;Gene;PA446108;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;GSTP1;Gene;PA446155;Disease
BLEOMYCIN;GSTP1;Gene;PA448645;Chemical
BUSULFAN;GSTP1;Gene;PA448691;Chemical
CAPECITABINE;GSTP1;Gene;PA448771;Chemical
CISPLATIN;GSTP1;Gene;PA449014;Chemical
CYCLOPHOSPHAMIDE;GSTP1;Gene;PA449165;Chemical
DAUNORUBICIN;GSTP1;Gene;PA449212;Chemical
DOXORUBICIN;GSTP1;Gene;PA449412;Chemical
EPIRUBICIN;GSTP1;Gene;PA449476;Chemical
ETOPOSIDE;GSTP1;Gene;PA449552;Chemical
ISONIAZID;GSTP1;Gene;PA450112;Chemical
LEUCOVORIN;GSTP1;Gene;PA450198;Chemical
MERCAPTOPURINE;GSTP1;Gene;PA450379;Chemical
METHOTREXATE;GSTP1;Gene;PA450428;Chemical
PYRIMETHAMINE;GSTP1;Gene;PA451193;Chemical
RIFAMPIN;GSTP1;Gene;PA451250;Chemical
SEVOFLURANE;GSTP1;Gene;PA451341;Chemical
THIOTEPA;GSTP1;Gene;PA451668;Chemical
RADIOTHERAPY;PRKCE;Gene;PA166122986;Chemical
PLCG1;PRKCE;Gene;PA33392;Gene
PLCG2;PRKCE;Gene;PA33393;Gene
RAF1;PRKCE;Gene;PA34183;Gene
ADRB2;PRKCE;Gene;PA39;Gene
HYPERTENSION;PRKCE;Gene;PA444552;Disease
ATP1A1;PRKCE;Gene;PA62;Gene
SORAFENIB;PRKCE;Gene;PA7000;Chemical
FLUOROURACIL;rs10937158;Variant;PA128406956;Chemical
COLORECTAL NEOPLASMS;rs10937158;Variant;PA446108;Disease
IRINOTECAN;rs10937158;Variant;PA450085;Chemical
LEUCOVORIN;rs10937158;Variant;PA450198;Chemical
CYP2C8;pamidronate;Chemical;PA125;Gene
RS1934951;pamidronate;Chemical;PA166153985;Variant
COMT;propranolol;Chemical;PA117;Gene
CYP2D6;propranolol;Chemical;PA128;Gene
CYP2D6*1;propranolol;Chemical;PA165816576;Haplotype
CYP2D6*10;propranolol;Chemical;PA165816582;Haplotype
RS4680;propranolol;Chemical;PA166156024;Variant
RS1042713;propranolol;Chemical;PA166156748;Variant
GRK5;propranolol;Chemical;PA180;Gene
ABCB1;propranolol;Chemical;PA267;Gene
CYP1A2;propranolol;Chemical;PA27093;Gene
GRK4;propranolol;Chemical;PA28941;Gene
ADRA2C;propranolol;Chemical;PA37;Gene
ADRB1;propranolol;Chemical;PA38;Gene
ADRB2;propranolol;Chemical;PA39;Gene
BREAST NEOPLASMS;SOD2;Gene;PA443560;Disease
EPILEPSY;SOD2;Gene;PA444065;Disease
HEROIN DEPENDENCE;SOD2;Gene;PA444460;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;SOD2;Gene;PA446155;Disease
ASPARAGINASE;SOD2;Gene;PA448492;Chemical
CYCLOPHOSPHAMIDE;SOD2;Gene;PA449165;Chemical
METHOTREXATE;SOD2;Gene;PA450428;Chemical
PACLITAXEL;SOD2;Gene;PA450761;Chemical
VALPROIC ACID;SOD2;Gene;PA451846;Chemical
HEROIN;SOD2;Gene;PA452619;Chemical
MIGALASTAT;rs372966991;Variant;PA166182881;Chemical
FABRY DISEASE;rs372966991;Variant;PA443367;Disease
ANTHRACYCLINES AND RELATED SUBSTANCES;rs9024;Variant;PA130620651;Chemical
BREAST NEOPLASMS;rs9024;Variant;PA443560;Disease
CARDIOMYOPATHIES;rs9024;Variant;PA445018;Disease
NEOPLASMS;rs9024;Variant;PA445062;Disease
DOXORUBICIN;rs9024;Variant;PA449412;Chemical
CYP2D6;betaxolol;Chemical;PA128;Gene
GRK5;betaxolol;Chemical;PA180;Gene
GRK4;betaxolol;Chemical;PA28941;Gene
ADRA2C;betaxolol;Chemical;PA37;Gene
ADRB1;betaxolol;Chemical;PA38;Gene
ACUTE LYMPHOBLASTIC LEUKEMIA;DROSHA;Gene;PA446155;Disease
CYCLOPHOSPHAMIDE;DROSHA;Gene;PA449165;Chemical
CYTARABINE;DROSHA;Gene;PA449177;Chemical
DAUNORUBICIN;DROSHA;Gene;PA449212;Chemical
MERCAPTOPURINE;DROSHA;Gene;PA450379;Chemical
METHOTREXATE;DROSHA;Gene;PA450428;Chemical
PREDNISONE;DROSHA;Gene;PA451100;Chemical
VINCRISTINE;DROSHA;Gene;PA451879;Chemical
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;HLA-B*15:32;Haplotype;PA166120927;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-B*15:32;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-B*15:32;Haplotype;PA445738;Disease
NEVIRAPINE;HLA-B*15:32;Haplotype;PA450616;Chemical
MAJOR DEPRESSIVE DISORDER;PARP11;Gene;PA447321;Disease
ANTIDEPRESSANTS;PARP11;Gene;PA452229;Chemical
SLCO1B1;conjugated estrogens;Chemical;PA134865839;Gene
ESR1;conjugated estrogens;Chemical;PA156;Gene
SLCO1B1*12;conjugated estrogens;Chemical;PA165819262;Haplotype
SLCO1B1*13;conjugated estrogens;Chemical;PA165819263;Haplotype
SLCO1B1*1;conjugated estrogens;Chemical;PA165981641;Haplotype
RS1544410;conjugated estrogens;Chemical;PA166154516;Variant
RS9340799;conjugated estrogens;Chemical;PA166157143;Variant
RS1042028;conjugated estrogens;Chemical;PA166186146;Variant
SULT1A1;conjugated estrogens;Chemical;PA343;Gene
VDR;conjugated estrogens;Chemical;PA37301;Gene
CYP2D6;Diabetic Neuropathies;Disease;PA128;Gene
CYP2D6*1;Diabetic Neuropathies;Disease;PA165816576;Haplotype
CYP2D6*5;Diabetic Neuropathies;Disease;PA165948092;Haplotype
PEGINTERFERON ALFA-2A;rs11322783;Variant;PA164749390;Chemical
PEGINTERFERON ALFA-2B;rs11322783;Variant;PA164784024;Chemical
BOCEPREVIR;rs11322783;Variant;PA165948902;Chemical
TELAPREVIR;rs11322783;Variant;PA165958354;Chemical
SIMEPREVIR;rs11322783;Variant;PA166122590;Chemical
SOFOSBUVIR;rs11322783;Variant;PA166122593;Chemical
RAPID VIROLOGICAL RESPONSE (RVR);rs11322783;Variant;PA166131628;Disease
SUSTAINED VIROLOGICAL RESPONSE (SVR);rs11322783;Variant;PA166131629;Disease
COMPLETE EARLY VIROLOGICAL RESPONSE;rs11322783;Variant;PA166170534;Disease
DIRECT ACTING ANTIVIRALS;rs11322783;Variant;PA166179660;Chemical
HEPATITIS B;rs11322783;Variant;PA444437;Disease
HEPATITIS C;rs11322783;Variant;PA444445;Disease
HEPATITIS C, CHRONIC;rs11322783;Variant;PA446863;Disease
RIBAVIRIN;rs11322783;Variant;PA451241;Chemical
SEVERE CUTANEOUS ADVERSE REACTIONS;HLA-DRB1*15:02;Haplotype;PA166120929;Disease
DRUG HYPERSENSITIVITY;HLA-DRB1*15:02;Haplotype;PA443936;Disease
EPIDERMAL NECROLYSIS, TOXIC;HLA-DRB1*15:02;Haplotype;PA444059;Disease
STEVENS-JOHNSON SYNDROME;HLA-DRB1*15:02;Haplotype;PA445738;Disease
ALLOPURINOL;HLA-DRB1*15:02;Haplotype;PA448320;Chemical
SITAGLIPTIN;rs6923761;Variant;PA164748978;Chemical
VILDAGLIPTIN;rs6923761;Variant;PA165958346;Chemical
LIRAGLUTIDE;rs6923761;Variant;PA165958364;Chemical
DIABETES MELLITUS, TYPE 2;rs6923761;Variant;PA443890;Disease
OBESITY;rs6923761;Variant;PA445131;Disease
POLYCYSTIC OVARY SYNDROME;rs6923761;Variant;PA445376;Disease
TICAGRELOR;CYP3A4*5;Haplotype;PA165374673;Chemical
CABOZANTINIB;CYP3A4*5;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*5;Haplotype;PA165958362;Chemical
VANDETANIB;CYP3A4*5;Haplotype;PA166118341;Chemical
IBRUTINIB;CYP3A4*5;Haplotype;PA166121346;Chemical
BREXPIPRAZOLE;CYP3A4*5;Haplotype;PA166160053;Chemical
MACITENTAN;CYP3A4*5;Haplotype;PA166261201;Chemical
BLONANSERIN;CYP3A4*5;Haplotype;PA166319041;Chemical
IBUPROFEN;CYP3A4*5;Haplotype;PA449957;Chemical
LIDOCAINE;CYP3A4*5;Haplotype;PA450226;Chemical
METHADONE;CYP3A4*5;Haplotype;PA450401;Chemical
OXYCODONE;CYP3A4*5;Haplotype;PA450741;Chemical
SILDENAFIL;CYP3A4*5;Haplotype;PA451346;Chemical
TESTOSTERONE;CYP3A4*5;Haplotype;PA451627;Chemical
SELECTIVE SEROTONIN REUPTAKE INHIBITORS;rs6108160;Variant;PA164713257;Chemical
DEPRESSION;rs6108160;Variant;PA447278;Disease
CYP2D6;dolasetron;Chemical;PA128;Gene
CYP3A4;dolasetron;Chemical;PA130;Gene
NOS1AP;dolasetron;Chemical;PA142671259;Gene
CYP2D6*1;dolasetron;Chemical;PA165816576;Haplotype
CYP2D6*1XN;dolasetron;Chemical;PA165988479;Haplotype
RS10494366;dolasetron;Chemical;PA166153802;Variant
HIV INFECTIOUS DISEASE;rs3003596;Variant;PA447230;Disease
EFAVIRENZ;rs3003596;Variant;PA449441;Chemical
CRIZOTINIB M10;crizotinib;Chemical;PA166163406;Chemical
ALK;crizotinib;Chemical;PA24719;Gene
MET;crizotinib;Chemical;PA30763;Gene
ROS1;crizotinib;Chemical;PA34633;Gene
NIROGACESTAT;APC;Gene;PA166328844;Chemical
ADENOMATOUS POLYPOSIS COLI;APC;Gene;PA445381;Disease
SELECTIVE BETA-2-ADRENORECEPTOR AGONISTS;rs2239179;Variant;PA134687887;Chemical
ASTHMA;rs2239179;Variant;PA443450;Disease
ROSUVASTATIN;SLCO1B1*1;Haplotype;PA134308647;Chemical
PITAVASTATIN;SLCO1B1*1;Haplotype;PA142650384;Chemical
ATRASENTAN;SLCO1B1*1;Haplotype;PA143414738;Chemical
CONJUGATED ESTROGENS;SLCO1B1*1;Haplotype;PA164754789;Chemical
DRUG-INDUCED LIVER INJURY;SLCO1B1*1;Haplotype;PA166119041;Disease
DISCONTINUATION;SLCO1B1*1;Haplotype;PA166123507;Disease
SIMVASTATIN ACID;SLCO1B1*1;Haplotype;PA166129446;Chemical
LOVASTATIN ACID;SLCO1B1*1;Haplotype;PA166163161;Chemical
STATIN-RELATED MYOPATHY;SLCO1B1*1;Haplotype;PA166163391;Disease
ESTRONE SULFATE;SLCO1B1*1;Haplotype;PA166185957;Chemical
BREAST NEOPLASMS;SLCO1B1*1;Haplotype;PA443560;Disease
DRUG TOXICITY;SLCO1B1*1;Haplotype;PA443937;Disease
HYPERCHOLESTEROLEMIA;SLCO1B1*1;Haplotype;PA444516;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;SLCO1B1*1;Haplotype;PA446155;Disease
ATORVASTATIN;SLCO1B1*1;Haplotype;PA448500;Chemical
CERIVASTATIN;SLCO1B1*1;Haplotype;PA448897;Chemical
ESTRONE;SLCO1B1*1;Haplotype;PA449512;Chemical
FLUVASTATIN;SLCO1B1*1;Haplotype;PA449688;Chemical
LOVASTATIN;SLCO1B1*1;Haplotype;PA450272;Chemical
METHOTREXATE;SLCO1B1*1;Haplotype;PA450428;Chemical
PRAVASTATIN;SLCO1B1*1;Haplotype;PA451089;Chemical
REPAGLINIDE;SLCO1B1*1;Haplotype;PA451234;Chemical
RIFAMPIN;SLCO1B1*1;Haplotype;PA451250;Chemical
SIMVASTATIN;SLCO1B1*1;Haplotype;PA451363;Chemical
MAJOR DEPRESSIVE DISORDER;rs760761;Variant;PA447321;Disease
CITALOPRAM;rs760761;Variant;PA449015;Chemical
GANAXOLONE;CDKL5;Gene;PA166278301;Chemical
PANCREATIC NEOPLASMS;SH2D5;Gene;PA445218;Disease
GEMCITABINE;SH2D5;Gene;PA449748;Chemical
SCHIZOPHRENIA;rs4795893;Variant;PA447216;Disease
RISPERIDONE;rs4795893;Variant;PA451257;Chemical
DIABETES MELLITUS, TYPE 2;TCIRG1;Gene;PA443890;Disease
MEN1;Multiple Endocrine Neoplasia Type 1;Disease;PA30746;Gene
IMATINIB;rs121913512;Variant;PA10804;Chemical
3,4-METHYLENEDIOXYMETHAMPHETAMINE;rs2242446;Variant;PA131887008;Chemical
MAJOR DEPRESSIVE DISORDER;rs2242446;Variant;PA447321;Disease
VENLAFAXINE;rs2242446;Variant;PA451866;Chemical
WARFARIN;rs41301394;Variant;PA451906;Chemical
CYP2D6;extrapyramidal symptoms;Disease;PA128;Gene
CYP2D6*1;extrapyramidal symptoms;Disease;PA165816576;Haplotype
CYP2D6*2;extrapyramidal symptoms;Disease;PA165816577;Haplotype
CYP2D6*4;extrapyramidal symptoms;Disease;PA165816579;Haplotype
CYP2D6*6;extrapyramidal symptoms;Disease;PA165816581;Haplotype
CYP2D6*10;extrapyramidal symptoms;Disease;PA165816582;Haplotype
CYP2D6*41;extrapyramidal symptoms;Disease;PA165816584;Haplotype
RALTEGRAVIR;UGT1A9*3a;Haplotype;PA164888966;Chemical
HIV INFECTIONS;UGT1A9*3a;Haplotype;PA447230;Disease
MORPHINE;rs4141964;Variant;PA450550;Chemical
THIOGUANINE;TPMT*27;Haplotype;PA451663;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;RIPOR2;Gene;PA164712708;Chemical
TUBERCULOSIS;RIPOR2;Gene;PA445941;Disease
RIFAMPIN;RIPOR2;Gene;PA451250;Chemical
CETUXIMAB;RASSF1;Gene;PA10040;Chemical
COLORECTAL NEOPLASMS;RASSF1;Gene;PA446108;Disease
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs6065221;Variant;PA164713366;Chemical
IMATINIB;PDGFRA;Gene;PA10804;Chemical
GASTROINTESTINAL STROMAL TUMORS;PDGFRA;Gene;PA151958383;Disease
OLARATUMAB;PDGFRA;Gene;PA166163434;Chemical
AVAPRITINIB;PDGFRA;Gene;PA166223903;Chemical
RS121908585;PDGFRA;Gene;PA166285041;Variant
MEPOLIZUMAB;PDGFRA;Gene;PA166313323;Chemical
KIT;PDGFRA;Gene;PA30128;Gene
CORONARY ARTERY DISEASE;rs275651;Variant;PA443796;Disease
PERINDOPRIL;rs275651;Variant;PA450877;Chemical
COMT;bupropion;Chemical;PA117;Gene
CYP2A6;bupropion;Chemical;PA121;Gene
CYP2B6;bupropion;Chemical;PA123;Gene
CYP2C19;bupropion;Chemical;PA124;Gene
CYP2C9;bupropion;Chemical;PA126;Gene
CYP2D6;bupropion;Chemical;PA128;Gene
CYP3A4;bupropion;Chemical;PA130;Gene
CYP3A5;bupropion;Chemical;PA131;Gene
ANKK1;bupropion;Chemical;PA134872551;Gene
DBH;bupropion;Chemical;PA136;Gene
ACE;bupropion;Chemical;PA139;Gene
DRD1;bupropion;Chemical;PA147;Gene
CYP2C19*17;bupropion;Chemical;PA165816533;Haplotype
CYP2B6*1;bupropion;Chemical;PA165818750;Haplotype
CYP2B6*4;bupropion;Chemical;PA165818757;Haplotype
CYP2B6*5;bupropion;Chemical;PA165818760;Haplotype
CYP2B6*6;bupropion;Chemical;PA165818762;Haplotype
CYP2B6*18;bupropion;Chemical;PA165818808;Haplotype
CYP2B6*22;bupropion;Chemical;PA165818809;Haplotype
CYP2C19*1;bupropion;Chemical;PA165980634;Haplotype
CYP2C19*2;bupropion;Chemical;PA165980635;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);bupropion;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);bupropion;Chemical;PA166116466;Haplotype
CYP2B6*30;bupropion;Chemical;PA166117272;Haplotype
RS6702335;bupropion;Chemical;PA166153786;Variant
RS1799732;bupropion;Chemical;PA166154334;Variant
RS1800497;bupropion;Chemical;PA166154339;Variant
RS16969968;bupropion;Chemical;PA166154938;Variant
RS2717162;bupropion;Chemical;PA166155286;Variant
RS2279343;bupropion;Chemical;PA166155393;Variant
RS3211371;bupropion;Chemical;PA166155405;Variant
RS4803381;bupropion;Chemical;PA166155418;Variant
RS12721655;bupropion;Chemical;PA166155467;Variant
RS165599;bupropion;Chemical;PA166156046;Variant
RS1969624;bupropion;Chemical;PA166156336;Variant
RS2245705;bupropion;Chemical;PA166156349;Variant
RS2251954;bupropion;Chemical;PA166156350;Variant
RS2742390;bupropion;Chemical;PA166156364;Variant
RS2742417;bupropion;Chemical;PA166156365;Variant
RS2742421;bupropion;Chemical;PA166156366;Variant
RS2742423;bupropion;Chemical;PA166156367;Variant
RS2742435;bupropion;Chemical;PA166156368;Variant
RS2168631;bupropion;Chemical;PA166156786;Variant
RS11746641;bupropion;Chemical;PA166156870;Variant
RS11749035;bupropion;Chemical;PA166156871;Variant
RS503464;bupropion;Chemical;PA166175850;Variant
RS8109525;bupropion;Chemical;PA166184141;Variant
RS2770296;bupropion;Chemical;PA166184248;Variant
RS8075924;bupropion;Chemical;PA166184249;Variant
RS2873804;bupropion;Chemical;PA166184250;Variant
RS363225;bupropion;Chemical;PA166184251;Variant
RS363226;bupropion;Chemical;PA166184252;Variant
RS17614642;bupropion;Chemical;PA166184253;Variant
RS2036527;bupropion;Chemical;PA166185387;Variant
RS148009906;bupropion;Chemical;PA166290041;Variant
RS535039125;bupropion;Chemical;PA166290042;Variant
RS58871670;bupropion;Chemical;PA166290043;Variant
RS200458614;bupropion;Chemical;PA166290047;Variant
RS201500445;bupropion;Chemical;PA166290048;Variant
RS200238771;bupropion;Chemical;PA166290049;Variant
RS764288403;bupropion;Chemical;PA166290050;Variant
RS374099483;bupropion;Chemical;PA166290051;Variant
RS117872433;bupropion;Chemical;PA166290052;Variant
CYP2B6*46;bupropion;Chemical;PA166290060;Haplotype
CYP2B6*47;bupropion;Chemical;PA166290061;Haplotype
HTR2A;bupropion;Chemical;PA193;Gene
HTR2C;bupropion;Chemical;PA194;Gene
CHRNA5;bupropion;Chemical;PA26491;Gene
CYP1A2;bupropion;Chemical;PA27093;Gene
DRD2;bupropion;Chemical;PA27478;Gene
EPB41;bupropion;Chemical;PA27810;Gene
FKBP5;bupropion;Chemical;PA28162;Gene
GALR1;bupropion;Chemical;PA28545;Gene
SLC6A4;bupropion;Chemical;PA312;Gene
SLC18A2;bupropion;Chemical;PA325;Gene
POLG;bupropion;Chemical;PA33500;Gene
SACM1L;bupropion;Chemical;PA34925;Gene
HLA-A;bupropion;Chemical;PA35055;Gene
HLA-B;bupropion;Chemical;PA35056;Gene
UGT1A4;bupropion;Chemical;PA37179;Gene
ROSUVASTATIN;rs2199936;Variant;PA134308647;Chemical
RISPERIDONE;GRM7;Gene;PA451257;Chemical
CD274;tremelimumab;Chemical;PA134915280;Gene
ALK;tremelimumab;Chemical;PA24719;Gene
EGFR;tremelimumab;Chemical;PA7360;Gene
TICAGRELOR;rs12566888;Variant;PA165374673;Chemical
TRANSPLANTATION;rs3957357;Variant;PA134850491;Disease
LYMPHOMA, LARGE B-CELL, DIFFUSE;rs3957357;Variant;PA160680212;Disease
ANEMIA;rs3957357;Variant;PA443340;Disease
OVARIAN NEOPLASMS;rs3957357;Variant;PA445204;Disease
SARCOMA;rs3957357;Variant;PA445594;Disease
BUSULFAN;rs3957357;Variant;PA448691;Chemical
CISPLATIN;rs3957357;Variant;PA449014;Chemical
CYCLOPHOSPHAMIDE;rs3957357;Variant;PA449165;Chemical
DOXORUBICIN;rs3957357;Variant;PA449412;Chemical
PREDNISONE;rs3957357;Variant;PA451100;Chemical
RITUXIMAB;rs3957357;Variant;PA451261;Chemical
VINCRISTINE;rs3957357;Variant;PA451879;Chemical
GNAI1;HTR1E;Gene;PA172;Gene
GNAI3;HTR1E;Gene;PA173;Gene
GNAI2;HTR1E;Gene;PA24347;Gene
ZIDOVUDINE;TK1;Gene;PA451954;Chemical
ABCB1;teniposide;Chemical;PA267;Gene
NUP50;teniposide;Chemical;PA31852;Gene
CYP2C9;venous thromboembolism;Disease;PA126;Gene
F5;venous thromboembolism;Disease;PA159;Gene
CYP2C9*1;venous thromboembolism;Disease;PA165816542;Haplotype
CYP2C9*2;venous thromboembolism;Disease;PA165816543;Haplotype
CYP2C9*3;venous thromboembolism;Disease;PA165816544;Haplotype
RS429358;venous thromboembolism;Disease;PA166155351;Variant
MTHFR;venous thromboembolism;Disease;PA245;Gene
APOE;venous thromboembolism;Disease;PA55;Gene
CYP3A4;regorafenib;Chemical;PA130;Gene
CYP3A4*1;regorafenib;Chemical;PA165819201;Haplotype
CYP3A4*2;regorafenib;Chemical;PA165819220;Haplotype
CYP3A4*3;regorafenib;Chemical;PA165819221;Haplotype
CYP3A4*4;regorafenib;Chemical;PA165819222;Haplotype
CYP3A4*7;regorafenib;Chemical;PA165819225;Haplotype
CYP3A4*8;regorafenib;Chemical;PA165819226;Haplotype
CYP3A4*9;regorafenib;Chemical;PA165819227;Haplotype
CYP3A4*10;regorafenib;Chemical;PA165819228;Haplotype
CYP3A4*11;regorafenib;Chemical;PA165819229;Haplotype
CYP3A4*12;regorafenib;Chemical;PA165819230;Haplotype
CYP3A4*13;regorafenib;Chemical;PA165819231;Haplotype
CYP3A4*14;regorafenib;Chemical;PA165819232;Haplotype
CYP3A4*15;regorafenib;Chemical;PA165819233;Haplotype
CYP3A4*17;regorafenib;Chemical;PA165819239;Haplotype
CYP3A4*18;regorafenib;Chemical;PA165819240;Haplotype
CYP3A4*20;regorafenib;Chemical;PA165819244;Haplotype
CYP3A4*23;regorafenib;Chemical;PA166115836;Haplotype
CYP3A4*28;regorafenib;Chemical;PA166245584;Haplotype
CYP3A4*31;regorafenib;Chemical;PA166245587;Haplotype
CYP3A4*32;regorafenib;Chemical;PA166245588;Haplotype
CYP3A4*33;regorafenib;Chemical;PA166245589;Haplotype
CYP3A4*34;regorafenib;Chemical;PA166245590;Haplotype
RS4864950;regorafenib;Chemical;PA166283282;Variant
KDR;regorafenib;Chemical;PA30086;Gene
KRAS;regorafenib;Chemical;PA30196;Gene
TOPIRAMATE;rs2396185;Variant;PA451728;Chemical
GEMTUZUMAB OZOGAMICIN;CD33;Gene;PA164749431;Chemical
LEUKEMIA, MYELOID, ACUTE;CD33;Gene;PA444760;Disease
TOBACCO USE DISORDER;rs1044397;Variant;PA445876;Disease
NICOTINE;rs1044397;Variant;PA450626;Chemical
PAIN;rs6517442;Variant;PA445208;Disease
LOW BACK PAIN;rs6517442;Variant;PA446444;Disease
MORPHINE;rs6517442;Variant;PA450550;Chemical
OPIOIDS;rs6517442;Variant;PA452618;Chemical
TOXIC LIVER DISEASE;HLA-B*58:02;Haplotype;PA164925725;Disease
HIV INFECTIONS;HLA-B*58:02;Haplotype;PA447230;Disease
NEVIRAPINE;HLA-B*58:02;Haplotype;PA450616;Chemical
PEGINTERFERON ALFA-2B;HLA-C*16:01;Haplotype;PA164784024;Chemical
HEPATITIS C;HLA-C*16:01;Haplotype;PA444445;Disease
RIBAVIRIN;HLA-C*16:01;Haplotype;PA451241;Chemical
ACUTE CORONARY SYNDROME;rs140410716;Variant;PA165108401;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);rs140410716;Variant;PA166129560;Disease
ASPIRIN;rs140410716;Variant;PA448497;Chemical
CLOPIDOGREL;rs140410716;Variant;PA449053;Chemical
MAJOR DEPRESSIVE DISORDER;rs2770296;Variant;PA447321;Disease
BUPROPION;rs2770296;Variant;PA448687;Chemical
SULFAMETHOXAZOLE / TRIMETHOPRIM;GSTM1 non-null;Haplotype;PA10715;Chemical
FLUOROURACIL;GSTM1 non-null;Haplotype;PA128406956;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;GSTM1 non-null;Haplotype;PA130620651;Chemical
OXALIPLATIN;GSTM1 non-null;Haplotype;PA131285527;Chemical
TAXANES;GSTM1 non-null;Haplotype;PA150481189;Chemical
OTOTOXICITY;GSTM1 non-null;Haplotype;PA162263534;Disease
DRUGS FOR TREATMENT OF TUBERCULOSIS;GSTM1 non-null;Haplotype;PA164712708;Chemical
PLATINUM COMPOUNDS;GSTM1 non-null;Haplotype;PA164713176;Chemical
ETHAMBUTOL;GSTM1 non-null;Haplotype;PA164784021;Chemical
RADIOTHERAPY;GSTM1 non-null;Haplotype;PA166122986;Chemical
HEMATOPOIETIC STEM CELL TRANSPLANTATION;GSTM1 non-null;Haplotype;PA166123007;Disease
ACQUIRED IMMUNODEFICIENCY SYNDROME;GSTM1 non-null;Haplotype;PA443250;Disease
ASTHMA;GSTM1 non-null;Haplotype;PA443450;Disease
BREAST NEOPLASMS;GSTM1 non-null;Haplotype;PA443560;Disease
UTERINE CERVICAL NEOPLASMS;GSTM1 non-null;Haplotype;PA443685;Disease
COLITIS, ULCERATIVE;GSTM1 non-null;Haplotype;PA443750;Disease
CROHN DISEASE;GSTM1 non-null;Haplotype;PA443815;Disease
DEAFNESS;GSTM1 non-null;Haplotype;PA443840;Disease
DEATH;GSTM1 non-null;Haplotype;PA443842;Disease
DRUG TOXICITY;GSTM1 non-null;Haplotype;PA443937;Disease
EPIDERMAL NECROLYSIS, TOXIC;GSTM1 non-null;Haplotype;PA444059;Disease
HODGKIN DISEASE;GSTM1 non-null;Haplotype;PA444485;Disease
CARDIOMYOPATHIES;GSTM1 non-null;Haplotype;PA445018;Disease
NEOPLASMS;GSTM1 non-null;Haplotype;PA445062;Disease
NEUTROPENIA;GSTM1 non-null;Haplotype;PA445113;Disease
OVARIAN NEOPLASMS;GSTM1 non-null;Haplotype;PA445204;Disease
RECURRENCE;GSTM1 non-null;Haplotype;PA445506;Disease
STEVENS-JOHNSON SYNDROME;GSTM1 non-null;Haplotype;PA445738;Disease
TESTICULAR NEOPLASMS;GSTM1 non-null;Haplotype;PA445828;Disease
TUBERCULOSIS;GSTM1 non-null;Haplotype;PA445941;Disease
COLORECTAL NEOPLASMS;GSTM1 non-null;Haplotype;PA446108;Disease
INFLAMMATORY BOWEL DISEASES;GSTM1 non-null;Haplotype;PA446116;Disease
HIV INFECTIONS;GSTM1 non-null;Haplotype;PA447230;Disease
AZATHIOPRINE;GSTM1 non-null;Haplotype;PA448515;Chemical
BLEOMYCIN;GSTM1 non-null;Haplotype;PA448645;Chemical
CAPECITABINE;GSTM1 non-null;Haplotype;PA448771;Chemical
CISPLATIN;GSTM1 non-null;Haplotype;PA449014;Chemical
CLOZAPINE;GSTM1 non-null;Haplotype;PA449061;Chemical
CYCLOPHOSPHAMIDE;GSTM1 non-null;Haplotype;PA449165;Chemical
DACARBAZINE;GSTM1 non-null;Haplotype;PA449197;Chemical
DOXORUBICIN;GSTM1 non-null;Haplotype;PA449412;Chemical
ISONIAZID;GSTM1 non-null;Haplotype;PA450112;Chemical
NEVIRAPINE;GSTM1 non-null;Haplotype;PA450616;Chemical
PACLITAXEL;GSTM1 non-null;Haplotype;PA450761;Chemical
PYRAZINAMIDE;GSTM1 non-null;Haplotype;PA451182;Chemical
RIFAMPIN;GSTM1 non-null;Haplotype;PA451250;Chemical
STREPTOMYCIN;GSTM1 non-null;Haplotype;PA451512;Chemical
VINBLASTINE;GSTM1 non-null;Haplotype;PA451877;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs4251961;Variant;PA164713366;Chemical
ULCERATIVE COLITIS;rs4251961;Variant;PA443750;Disease
HYPERTENSION;rs3814995;Variant;PA444552;Disease
LOSARTAN;rs3814995;Variant;PA450268;Chemical
NICOTINE;rs571335587;Variant;PA450626;Chemical
COMT;Methamphetamine dependence;Disease;PA117;Gene
ANKS1B;Methamphetamine dependence;Disease;PA128394692;Gene
RS6265;Methamphetamine dependence;Disease;PA166154259;Variant
RS4680;Methamphetamine dependence;Disease;PA166156024;Variant
RS2075572;Methamphetamine dependence;Disease;PA166157015;Variant
RS2133896;Methamphetamine dependence;Disease;PA166200161;Variant
BDNF;Methamphetamine dependence;Disease;PA31891;Gene
OPRM1;Methamphetamine dependence;Disease;PA31945;Gene
CYP2D6;iloperidone;Chemical;PA128;Gene
NUBPL;iloperidone;Chemical;PA134907818;Gene
CERKL;iloperidone;Chemical;PA134984780;Gene
RS4933824;iloperidone;Chemical;PA166154068;Variant
RS7142881;iloperidone;Chemical;PA166154809;Variant
RS4799915;iloperidone;Chemical;PA166155297;Variant
RS993648;iloperidone;Chemical;PA166155611;Variant
RS1065852;iloperidone;Chemical;PA166156062;Variant
CELF4;iloperidone;Chemical;PA25428;Gene
NRG3;iloperidone;Chemical;PA31778;Gene
RS267606618;ribostamycin;Chemical;PA166158908;Variant
RS267606619;ribostamycin;Chemical;PA166158909;Variant
RS267606617;ribostamycin;Chemical;PA166159181;Variant
MT-RNR1;ribostamycin;Chemical;PA31274;Gene
MULTIPLE MYELOMA;XRCC5;Gene;PA444985;Disease
THALIDOMIDE;XRCC5;Gene;PA451644;Chemical
SCHIZOPHRENIA;rs1150226;Variant;PA447216;Disease
CLOZAPINE;rs1150226;Variant;PA449061;Chemical
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs11553441;Variant;PA447197;Disease
METHYLPHENIDATE;rs11553441;Variant;PA450464;Chemical
DESMETHYLNAPROXEN;rs758145522;Variant;PA166163690;Chemical
TAPENTADOL;rs758145522;Variant;PA166179720;Chemical
ACETAMINOPHEN;rs758145522;Variant;PA448015;Chemical
HYPERTENSION;rs1275988;Variant;PA444552;Disease
CANDESARTAN;rs1275988;Variant;PA448765;Chemical
SEVOFLURANE;rs1275988;Variant;PA451341;Chemical
ADALIMUMAB;rs3761847;Variant;PA10004;Chemical
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs3761847;Variant;PA164713366;Chemical
RHEUMATOID ARTHRITIS;rs3761847;Variant;PA443434;Disease
ETANERCEPT;rs3761847;Variant;PA449515;Chemical
INFLIXIMAB;rs3761847;Variant;PA452639;Chemical
CALCIUM CHANNEL BLOCKERS;CACNA1C;Gene;PA10407;Chemical
ADVERSE EVENTS;CACNA1C;Gene;PA166151827;Disease
PRKACA;CACNA1C;Gene;PA33748;Gene
PRKACB;CACNA1C;Gene;PA33749;Gene
PRKACG;CACNA1C;Gene;PA33750;Gene
ALCOHOL ABUSE;CACNA1C;Gene;PA443309;Disease
CORONARY ARTERY DISEASE;CACNA1C;Gene;PA443796;Disease
HYPERTENSION;CACNA1C;Gene;PA444552;Disease
PREMATURE BIRTH;CACNA1C;Gene;PA444704;Disease
BIPOLAR DISORDER;CACNA1C;Gene;PA447199;Disease
MAJOR DEPRESSIVE DISORDER;CACNA1C;Gene;PA447321;Disease
ETHANOL;CACNA1C;Gene;PA448073;Chemical
ATENOLOL;CACNA1C;Gene;PA448499;Chemical
CELECOXIB;CACNA1C;Gene;PA448871;Chemical
CITALOPRAM;CACNA1C;Gene;PA449015;Chemical
HALOPERIDOL;CACNA1C;Gene;PA449841;Chemical
NIMODIPINE;CACNA1C;Gene;PA450633;Chemical
RITODRINE;CACNA1C;Gene;PA451258;Chemical
VALPROIC ACID;CACNA1C;Gene;PA451846;Chemical
VERAPAMIL;CACNA1C;Gene;PA451868;Chemical
ETONOGESTREL;CYP3A7*1C;Haplotype;PA164771231;Chemical
KIDNEY TRANSPLANTATION;CYP3A7*1C;Haplotype;PA165817016;Disease
ADRENAL HYPERPLASIA, CONGENITAL;CYP3A7*1C;Haplotype;PA443286;Disease
CORTISONE ACETATE;CYP3A7*1C;Haplotype;PA449130;Chemical
TACROLIMUS;CYP3A7*1C;Haplotype;PA451578;Chemical
SOCS3;STAT2;Gene;PA134885765;Gene
CAMK1D;STAT2;Gene;PA134992438;Gene
AKT1;STAT2;Gene;PA24684;Gene
AKT2;STAT2;Gene;PA24685;Gene
AKT3;STAT2;Gene;PA24686;Gene
NFKB1;STAT2;Gene;PA248;Gene
CAMK1;STAT2;Gene;PA26048;Gene
CAMK1G;STAT2;Gene;PA26049;Gene
ELK1;STAT2;Gene;PA27749;Gene
FOS;STAT2;Gene;PA28212;Gene
MAPK8;STAT2;Gene;PA283;Gene
RELA;STAT2;Gene;PA296;Gene
JAK1;STAT2;Gene;PA29988;Gene
JUN;STAT2;Gene;PA30006;Gene
MAPK1;STAT2;Gene;PA30616;Gene
MAPK3;STAT2;Gene;PA30622;Gene
MYC;STAT2;Gene;PA31353;Gene
NFKB2;STAT2;Gene;PA31600;Gene
STAT3;STAT2;Gene;PA337;Gene
PRKCA;STAT2;Gene;PA33759;Gene
PRKCB;STAT2;Gene;PA33761;Gene
PRKCG;STAT2;Gene;PA33766;Gene
STAT5A;STAT2;Gene;PA338;Gene
SP1;STAT2;Gene;PA36042;Gene
STAT1;STAT2;Gene;PA36183;Gene
STAT4;STAT2;Gene;PA36185;Gene
STAT5B;STAT2;Gene;PA36186;Gene
USP18;STAT2;Gene;PA37242;Gene
CAMK2A;STAT2;Gene;PA90;Gene
CAMK2B;STAT2;Gene;PA91;Gene
CAMK2D;STAT2;Gene;PA92;Gene
CAMK2G;STAT2;Gene;PA93;Gene
CLOPIDOGREL;CYP2C19*28;Haplotype;PA449053;Chemical
FLUOROURACIL;NOS3;Gene;PA128406956;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;NOS3;Gene;PA130620651;Chemical
OXALIPLATIN;NOS3;Gene;PA131285527;Chemical
HMG COA REDUCTASE INHIBITORS;NOS3;Gene;PA133950441;Chemical
DIURETICS;NOS3;Gene;PA151249535;Chemical
ACE INHIBITORS, PLAIN;NOS3;Gene;PA164712308;Chemical
ANGIOTENSIN II ANTAGONISTS;NOS3;Gene;PA164712372;Chemical
ANTIHYPERTENSIVES;NOS3;Gene;PA164712445;Chemical
ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;NOS3;Gene;PA164712446;Chemical
BETA BLOCKING AGENTS;NOS3;Gene;PA164712535;Chemical
PLATINUM COMPOUNDS;NOS3;Gene;PA164713176;Chemical
SALVIANOLIC ACID B;NOS3;Gene;PA166128370;Chemical
AKT1;NOS3;Gene;PA24684;Gene
AKT2;NOS3;Gene;PA24685;Gene
AKT3;NOS3;Gene;PA24686;Gene
BREAST NEOPLASMS;NOS3;Gene;PA443560;Disease
CORONARY ARTERY DISEASE;NOS3;Gene;PA443796;Disease
CORONARY DISEASE;NOS3;Gene;PA443797;Disease
HEART FAILURE;NOS3;Gene;PA444370;Disease
HEPATOCELLULAR CARCINOMA;NOS3;Gene;PA444447;Disease
HYPERTENSION;NOS3;Gene;PA444552;Disease
ERECTILE DYSFUNCTION;NOS3;Gene;PA444606;Disease
LEUKEMIA, MYELOID, ACUTE;NOS3;Gene;PA444760;Disease
MIGRAINE WITHOUT AURA;NOS3;Gene;PA444949;Disease
NEOPLASMS;NOS3;Gene;PA445062;Disease
OVARIAN NEOPLASMS;NOS3;Gene;PA445204;Disease
STOMACH NEOPLASMS;NOS3;Gene;PA445742;Disease
MIGRAINE WITH AURA;NOS3;Gene;PA447004;Disease
L-ARGININE;NOS3;Gene;PA448478;Chemical
ASPIRIN;NOS3;Gene;PA448497;Chemical
CLOPIDOGREL;NOS3;Gene;PA449053;Chemical
CYCLOPHOSPHAMIDE;NOS3;Gene;PA449165;Chemical
DAUNORUBICIN;NOS3;Gene;PA449212;Chemical
DIGOXIN;NOS3;Gene;PA449319;Chemical
DOXORUBICIN;NOS3;Gene;PA449412;Chemical
ENALAPRIL;NOS3;Gene;PA449456;Chemical
EPIRUBICIN;NOS3;Gene;PA449476;Chemical
IBUPROFEN;NOS3;Gene;PA449957;Chemical
METHOTREXATE;NOS3;Gene;PA450428;Chemical
NORTRIPTYLINE;NOS3;Gene;PA450657;Chemical
SILDENAFIL;NOS3;Gene;PA451346;Chemical
SPIRONOLACTONE;NOS3;Gene;PA451483;Chemical
SORAFENIB;NOS3;Gene;PA7000;Chemical
NRG1;zenocutuzumab;Chemical;PA31776;Gene
CHIA;aspirin-induced asthma;Disease;PA142672117;Gene
HLA-DPB1*03:01;aspirin-induced asthma;Disease;PA165951131;Haplotype
HLA-DPB1*04:01;aspirin-induced asthma;Disease;PA165951133;Haplotype
HLA-DQB1*03:02;aspirin-induced asthma;Disease;PA165958175;Haplotype
RS3818822;aspirin-induced asthma;Disease;PA166153756;Variant
RS11819745;aspirin-induced asthma;Disease;PA166154143;Variant
RS1047626;aspirin-induced asthma;Disease;PA166156500;Variant
RS1042136;aspirin-induced asthma;Disease;PA166156970;Variant
RS1042151;aspirin-induced asthma;Disease;PA166156971;Variant
RS3097671;aspirin-induced asthma;Disease;PA166157065;Variant
RS3129294;aspirin-induced asthma;Disease;PA166157067;Variant
RS3130100;aspirin-induced asthma;Disease;PA166157068;Variant
RS1074373;aspirin-induced asthma;Disease;PA166157287;Variant
RS7862221;aspirin-induced asthma;Disease;PA166157794;Variant
SLC30A9;aspirin-induced asthma;Disease;PA25909;Gene
HLA-DPB1;aspirin-induced asthma;Disease;PA35064;Gene
HLA-DPB2;aspirin-induced asthma;Disease;PA35065;Gene
HLA-DQB1;aspirin-induced asthma;Disease;PA35068;Gene
THRA;aspirin-induced asthma;Disease;PA36507;Gene
TSC1;aspirin-induced asthma;Disease;PA37034;Gene
ZBTB22;aspirin-induced asthma;Disease;PA37661;Gene
ALOX5;aspirin-induced asthma;Disease;PA46;Gene
EPILEPSY;rs7668258;Variant;PA444065;Disease
OPIOID-RELATED DISORDERS;rs7668258;Variant;PA445043;Disease
LAMOTRIGINE;rs7668258;Variant;PA450164;Chemical
METHADONE;rs7668258;Variant;PA450401;Chemical
VALPROIC ACID;rs7668258;Variant;PA451846;Chemical
HMG COA REDUCTASE INHIBITORS;UGT2B7;Gene;PA133950441;Chemical
ESR1;UGT2B7;Gene;PA156;Gene
APREPITANT;UGT2B7;Gene;PA164747039;Chemical
MYCOPHENOLIC ACID;UGT2B7;Gene;PA164748728;Chemical
ACUTE CORONARY SYNDROME;UGT2B7;Gene;PA165108401;Disease
TICAGRELOR;UGT2B7;Gene;PA165374673;Chemical
KIDNEY TRANSPLANTATION;UGT2B7;Gene;PA165817016;Disease
DICLOFENAC ACYL GLUCURONIDE;UGT2B7;Gene;PA166163692;Chemical
S-EDDP;UGT2B7;Gene;PA166177606;Chemical
(R)-METHADONE;UGT2B7;Gene;PA166178312;Chemical
BUPRENORPHINE / NALOXONE;UGT2B7;Gene;PA166182641;Chemical
ANEMIA, SICKLE CELL;UGT2B7;Gene;PA443355;Disease
EPILEPSY;UGT2B7;Gene;PA444065;Disease
OPIOID-RELATED DISORDERS;UGT2B7;Gene;PA445043;Disease
PAIN;UGT2B7;Gene;PA445208;Disease
PAIN, POSTOPERATIVE;UGT2B7;Gene;PA445210;Disease
HIV INFECTIOUS DISEASE;UGT2B7;Gene;PA447230;Disease
BUPRENORPHINE;UGT2B7;Gene;PA448685;Chemical
CARBAMAZEPINE;UGT2B7;Gene;PA448785;Chemical
CODEINE;UGT2B7;Gene;PA449088;Chemical
EFAVIRENZ;UGT2B7;Gene;PA449441;Chemical
FENTANYL;UGT2B7;Gene;PA449599;Chemical
FLURBIPROFEN;UGT2B7;Gene;PA449683;Chemical
IBUPROFEN;UGT2B7;Gene;PA449957;Chemical
LAMOTRIGINE;UGT2B7;Gene;PA450164;Chemical
LOSARTAN;UGT2B7;Gene;PA450268;Chemical
METHADONE;UGT2B7;Gene;PA450401;Chemical
MORPHINE;UGT2B7;Gene;PA450550;Chemical
MYCOPHENOLATE MOFETIL;UGT2B7;Gene;PA450566;Chemical
OXAZEPAM;UGT2B7;Gene;PA450731;Chemical
OXCARBAZEPINE;UGT2B7;Gene;PA450732;Chemical
OXYCODONE;UGT2B7;Gene;PA450741;Chemical
VALPROIC ACID;UGT2B7;Gene;PA451846;Chemical
ZIDOVUDINE;UGT2B7;Gene;PA451954;Chemical
CYP3A5;nimodipine;Chemical;PA131;Gene
CYP3A5*1;nimodipine;Chemical;PA166128213;Haplotype
CYP3A5*3;nimodipine;Chemical;PA166128219;Haplotype
RS2239050;nimodipine;Chemical;PA166154534;Variant
RS2239128;nimodipine;Chemical;PA166154535;Variant
CACNA1C;nimodipine;Chemical;PA83;Gene
PEMETREXED;rs1650697;Variant;PA10810;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs1650697;Variant;PA443622;Disease
MESOTHELIOMA;rs1650697;Variant;PA444937;Disease
CYP2D6;tetrabenazine;Chemical;PA128;Gene
CYP2D6 INTERMEDIATE METABOLIZER;tetrabenazine;Chemical;PA166157917;Variant
ABCB1;tetrabenazine;Chemical;PA267;Gene
CFTR;nppb;Chemical;PA109;Gene
RS75527207;nppb;Chemical;PA166157516;Variant
DAUNORUBICIN;rs35575889;Variant;PA449212;Chemical
DOXORUBICIN;rs35575889;Variant;PA449412;Chemical
SCHIZOPHRENIA;rs3787430;Variant;PA447216;Disease
RISPERIDONE;rs3787430;Variant;PA451257;Chemical
FLUOROURACIL;CBR3;Gene;PA128406956;Chemical
ANTHRACYCLINES AND RELATED SUBSTANCES;CBR3;Gene;PA130620651;Chemical
BREAST NEOPLASMS;CBR3;Gene;PA443560;Disease
HEART FAILURE;CBR3;Gene;PA444370;Disease
NEOPLASMS;CBR3;Gene;PA445062;Disease
NEUTROPENIA;CBR3;Gene;PA445113;Disease
CYCLOPHOSPHAMIDE;CBR3;Gene;PA449165;Chemical
DAUNORUBICIN;CBR3;Gene;PA449212;Chemical
DOXORUBICIN;CBR3;Gene;PA449412;Chemical
EPIRUBICIN;CBR3;Gene;PA449476;Chemical
ESTRADIOL;rs7158782;Variant;PA449503;Chemical
FLUOROURACIL;HLA-G;Gene;PA128406956;Chemical
HMG COA REDUCTASE INHIBITORS;HLA-G;Gene;PA133950441;Chemical
ARTHRITIS, RHEUMATOID;HLA-G;Gene;PA443434;Disease
ASTHMA;HLA-G;Gene;PA443450;Disease
COLORECTAL NEOPLASMS;HLA-G;Gene;PA446108;Disease
CAPECITABINE;HLA-G;Gene;PA448771;Chemical
METHOTREXATE;HLA-G;Gene;PA450428;Chemical
CYP2C9;4-hydroxycyclophosphamide;Chemical;PA126;Gene
CELECOXIB;KCNQ3;Gene;PA448871;Chemical
CYP2B6;3,4-methylenedioxymethamphetamine;Chemical;PA123;Gene
CYP2C19;3,4-methylenedioxymethamphetamine;Chemical;PA124;Gene
CYP2D6;3,4-methylenedioxymethamphetamine;Chemical;PA128;Gene
CYP2C19*17;3,4-methylenedioxymethamphetamine;Chemical;PA165816533;Haplotype
CYP2D6*1;3,4-methylenedioxymethamphetamine;Chemical;PA165816576;Haplotype
CYP2D6*2;3,4-methylenedioxymethamphetamine;Chemical;PA165816577;Haplotype
CYP2D6*3;3,4-methylenedioxymethamphetamine;Chemical;PA165816578;Haplotype
CYP2D6*4;3,4-methylenedioxymethamphetamine;Chemical;PA165816579;Haplotype
CYP2D6*6;3,4-methylenedioxymethamphetamine;Chemical;PA165816581;Haplotype
CYP2D6*10;3,4-methylenedioxymethamphetamine;Chemical;PA165816582;Haplotype
CYP2D6*41;3,4-methylenedioxymethamphetamine;Chemical;PA165816584;Haplotype
CYP2D6*5;3,4-methylenedioxymethamphetamine;Chemical;PA165948092;Haplotype
CYP2D6*9;3,4-methylenedioxymethamphetamine;Chemical;PA165948317;Haplotype
CYP2C19*1;3,4-methylenedioxymethamphetamine;Chemical;PA165980634;Haplotype
CYP2C19*2;3,4-methylenedioxymethamphetamine;Chemical;PA165980635;Haplotype
RS2242446;3,4-methylenedioxymethamphetamine;Chemical;PA166155036;Variant
RS3745274;3,4-methylenedioxymethamphetamine;Chemical;PA166155409;Variant
RS1861647;3,4-methylenedioxymethamphetamine;Chemical;PA166176140;Variant
RS36029;3,4-methylenedioxymethamphetamine;Chemical;PA166176143;Variant
SLC6A2;3,4-methylenedioxymethamphetamine;Chemical;PA310;Gene
NR1I2;oxiconazole;Chemical;PA378;Gene
CFTR;rs1800111;Variant;PA109;Gene
IVACAFTOR;rs1800111;Variant;PA165950341;Chemical
CYSTIC FIBROSIS;rs1800111;Variant;PA443829;Disease
HYPERCHOLESTEROLEMIA;rs6924995;Variant;PA444516;Disease
SIMVASTATIN;rs6924995;Variant;PA451363;Chemical
RS267606617;hygromycin b;Chemical;PA166159181;Variant
MT-RNR1;hygromycin b;Chemical;PA31274;Gene
COCAINE DEPENDENCE;rs2251214;Variant;PA446878;Disease
COCAINE;rs2251214;Variant;PA449072;Chemical
CFTR;rs74551128;Variant;PA109;Gene
IVACAFTOR;rs74551128;Variant;PA165950341;Chemical
IVACAFTOR / LUMACAFTOR;rs74551128;Variant;PA166152935;Chemical
IVACAFTOR / TEZACAFTOR;rs74551128;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs74551128;Variant;PA166190041;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs74551128;Variant;PA166362502;Chemical
CYSTIC FIBROSIS;rs74551128;Variant;PA443829;Disease
CYP2C9;Wegener Granulomatosis;Disease;PA126;Gene
CYP2C9 POOR METABOLIZER;Wegener Granulomatosis;Disease;PA166157932;Variant
DULOXETINE;rs7625956;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs7625956;Variant;PA447321;Disease
DRUGS FOR TREATMENT OF TUBERCULOSIS;rs3740065;Variant;PA164712708;Chemical
TOXIC LIVER DISEASE;rs3740065;Variant;PA164925725;Disease
MUCOSITIS;rs3740065;Variant;PA166122058;Disease
BREAST NEOPLASMS;rs3740065;Variant;PA443560;Disease
BURKITT LYMPHOMA;rs3740065;Variant;PA443580;Disease
NON-SMALL CELL LUNG CARCINOMA;rs3740065;Variant;PA443622;Disease
DRUG TOXICITY;rs3740065;Variant;PA443937;Disease
LYMPHOMA;rs3740065;Variant;PA444840;Disease
OSTEOSARCOMA;rs3740065;Variant;PA445601;Disease
TUBERCULOSIS;rs3740065;Variant;PA445941;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs3740065;Variant;PA446155;Disease
METHOTREXATE;rs3740065;Variant;PA450428;Chemical
TAMOXIFEN;rs3740065;Variant;PA451581;Chemical
NAT2;isoniazid / pyrazinamide / rifampin;Chemical;PA18;Gene
DPYD;rs60511679;Variant;PA145;Gene
CAPECITABINE;rs60511679;Variant;PA448771;Chemical
PANCREATIC NEOPLASMS;rs7543016;Variant;PA445218;Disease
GEMCITABINE;rs7543016;Variant;PA449748;Chemical
MYELOSUPPRESSION;TPMT*9;Haplotype;PA165817398;Disease
EVENT-FREE SURVIVAL;TPMT*9;Haplotype;PA166123366;Disease
DISCONTINUATION;TPMT*9;Haplotype;PA166123507;Disease
DOSE REDUCTION;TPMT*9;Haplotype;PA166159953;Disease
TPMT;TPMT*9;Haplotype;PA356;Gene
CROHN DISEASE;TPMT*9;Haplotype;PA443815;Disease
INFLAMMATION;TPMT*9;Haplotype;PA444620;Disease
NEOPLASMS;TPMT*9;Haplotype;PA445062;Disease
NEUTROPENIA;TPMT*9;Haplotype;PA445113;Disease
PANCYTOPENIA;TPMT*9;Haplotype;PA445221;Disease
THROMBOCYTOPENIA;TPMT*9;Haplotype;PA445846;Disease
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;TPMT*9;Haplotype;PA446155;Disease
AZATHIOPRINE;TPMT*9;Haplotype;PA448515;Chemical
MERCAPTOPURINE;TPMT*9;Haplotype;PA450379;Chemical
THIOGUANINE;TPMT*9;Haplotype;PA451663;Chemical
DPYD;rs199634007;Variant;PA145;Gene
CAPECITABINE;rs199634007;Variant;PA448771;Chemical
CORONARY ARTERY DISEASE;ABCG8;Gene;PA443796;Disease
HYPERCHOLESTEROLEMIA;ABCG8;Gene;PA444516;Disease
ATORVASTATIN;ABCG8;Gene;PA448500;Chemical
CALCIUM CHANNEL BLOCKERS;rs1137617;Variant;PA10407;Chemical
NITRENDIPINE;rs1137617;Variant;PA146096020;Chemical
ESSENTIAL HYPERTENSION;rs1137617;Variant;PA447288;Disease
ALCOHOL ABUSE;rs10419980;Variant;PA443309;Disease
ETHANOL;rs10419980;Variant;PA448073;Chemical
CYB5R4;rasburicase;Chemical;PA134904907;Gene
CYB5R1;rasburicase;Chemical;PA134979668;Gene
CYB5R2;rasburicase;Chemical;PA142672060;Gene
G6PD B (REFERENCE);rasburicase;Chemical;PA165947826;Haplotype
G6PD A- 202A_376G;rasburicase;Chemical;PA165947827;Haplotype
G6PD MEDITERRANEAN, DALLAS, PANAMA, SASSARI, CAGLIARI, BIRMINGHAM;rasburicase;Chemical;PA166121127;Haplotype
G6PD DEFICIENCY;rasburicase;Chemical;PA166157959;Variant
CYB5R3;rasburicase;Chemical;PA27331;Gene
G6PD;rasburicase;Chemical;PA28469;Gene
CYP2D6;Autistic Disorder;Disease;PA128;Gene
ANKK1;Autistic Disorder;Disease;PA134872551;Gene
MACROD2;Autistic Disorder;Disease;PA162394843;Gene
CYP2D6*1;Autistic Disorder;Disease;PA165816576;Haplotype
CYP2D6*4;Autistic Disorder;Disease;PA165816579;Haplotype
CYP2D6*10;Autistic Disorder;Disease;PA165816582;Haplotype
CYP2D6*41;Autistic Disorder;Disease;PA165816584;Haplotype
CYP2D6*5;Autistic Disorder;Disease;PA165948092;Haplotype
RS1800497;Autistic Disorder;Disease;PA166154339;Variant
RS6311;Autistic Disorder;Disease;PA166154673;Variant
RS6280;Autistic Disorder;Disease;PA166156277;Variant
RS1128503;Autistic Disorder;Disease;PA166157288;Variant
RS3813928;Autistic Disorder;Disease;PA166157874;Variant
HTR2A;Autistic Disorder;Disease;PA193;Gene
HTR2C;Autistic Disorder;Disease;PA194;Gene
ABCB1;Autistic Disorder;Disease;PA267;Gene
DRD2;Autistic Disorder;Disease;PA27478;Gene
DRD3;Autistic Disorder;Disease;PA27479;Gene
RS2231142;Opioid anesthetics;Chemical;PA166156544;Variant
RS1799971;Opioid anesthetics;Chemical;PA166156991;Variant
OPRM1;Opioid anesthetics;Chemical;PA31945;Gene
ABCG2;Opioid anesthetics;Chemical;PA390;Gene
NICOTINE;rs12459249;Variant;PA450626;Chemical
ILOPERIDONE;NUBPL;Gene;PA161199368;Chemical
ACQUIRED LONG QT SYNDROME (ALQTS);NUBPL;Gene;PA447300;Disease
SCHIZOPHRENIA;TJP1;Gene;PA447216;Disease
RISPERIDONE;TJP1;Gene;PA451257;Chemical
PYRAZOLONES;TNFRSF11A;Gene;PA164713217;Chemical
SCHIZOPHRENIA;TNFRSF11A;Gene;PA447216;Disease
ACETAMINOPHEN;TNFRSF11A;Gene;PA448015;Chemical
ASPIRIN;TNFRSF11A;Gene;PA448497;Chemical
DICLOFENAC;TNFRSF11A;Gene;PA449293;Chemical
PROPIONIC ACID DERIVATIVES;TNFRSF11A;Gene;PA451140;Chemical
RISPERIDONE;TNFRSF11A;Gene;PA451257;Chemical
CYP1A2;CYP1A2*4;Haplotype;PA27093;Gene
CLOZAPINE;CYP1A2*4;Haplotype;PA449061;Chemical
ARMS2;bevacizumab;Chemical;PA162376896;Gene
RS800292;bevacizumab;Chemical;PA166153588;Variant
RS1056515;bevacizumab;Chemical;PA166153615;Variant
RS1061170;bevacizumab;Chemical;PA166153617;Variant
RS1801131;bevacizumab;Chemical;PA166153643;Variant
RS10490924;bevacizumab;Chemical;PA166154107;Variant
RS11200638;bevacizumab;Chemical;PA166154135;Variant
RS1979277;bevacizumab;Chemical;PA166155196;Variant
RS45445694;bevacizumab;Chemical;PA166155331;Variant
RS885036;bevacizumab;Chemical;PA166155606;Variant
RS4073;bevacizumab;Chemical;PA166156478;Variant
RS5370;bevacizumab;Chemical;PA166156901;Variant
RS699947;bevacizumab;Chemical;PA166156938;Variant
RS2010963;bevacizumab;Chemical;PA166157006;Variant
RS3025000;bevacizumab;Chemical;PA166157058;Variant
RS3025039;bevacizumab;Chemical;PA166157061;Variant
RS3780126;bevacizumab;Chemical;PA166157594;Variant
RS2228014;bevacizumab;Chemical;PA166161516;Variant
RS6929249;bevacizumab;Chemical;PA166179287;Variant
RS3734704;bevacizumab;Chemical;PA166179288;Variant
RS834576;bevacizumab;Chemical;PA166179289;Variant
RS9381299;bevacizumab;Chemical;PA166179290;Variant
RS6770663;bevacizumab;Chemical;PA166348241;Variant
MTHFR;bevacizumab;Chemical;PA245;Gene
CXCR4;bevacizumab;Chemical;PA27058;Gene
EDN1;bevacizumab;Chemical;PA27614;Gene
CFH;bevacizumab;Chemical;PA29261;Gene
HSP90AB1;bevacizumab;Chemical;PA29524;Gene
CXCL8;bevacizumab;Chemical;PA29841;Gene
MGAT4A;bevacizumab;Chemical;PA30782;Gene
PRKCA;bevacizumab;Chemical;PA33759;Gene
HTRA1;bevacizumab;Chemical;PA33829;Gene
RGS5;bevacizumab;Chemical;PA34376;Gene
SHMT1;bevacizumab;Chemical;PA35753;Gene
TYMS;bevacizumab;Chemical;PA359;Gene
KCNAB1;bevacizumab;Chemical;PA370;Gene
VEGFA;bevacizumab;Chemical;PA37302;Gene
VEGFB;bevacizumab;Chemical;PA37303;Gene
VEGFC;bevacizumab;Chemical;PA37304;Gene
GGH;bevacizumab;Chemical;PA432;Gene
OPIOID-RELATED DISORDERS;rs11940316;Variant;PA445043;Disease
METHADONE;rs11940316;Variant;PA450401;Chemical
SCHIZOPHRENIA;TBC1D1;Gene;PA447216;Disease
CLOZAPINE;TBC1D1;Gene;PA449061;Chemical
OLANZAPINE;TBC1D1;Gene;PA450688;Chemical
CYP2E1;MIR570;Gene;PA129;Gene
BIPOLAR DISORDER;rs79663003;Variant;PA447199;Disease
LITHIUM;rs79663003;Variant;PA450243;Chemical
ALCOHOL ABUSE;GCKR;Gene;PA443309;Disease
ETHANOL;GCKR;Gene;PA448073;Chemical
NAUSEA;rs168107;Variant;PA445048;Disease
VOMITING;rs168107;Variant;PA446051;Disease
OPIOIDS;rs168107;Variant;PA452618;Chemical
FLUOROURACIL;rs528152707;Variant;PA128406956;Chemical
DRUG TOXICITY;rs528152707;Variant;PA443937;Disease
PEGINTERFERON ALFA-2A;SLC29A1;Gene;PA164749390;Chemical
PEGINTERFERON ALFA-2B;SLC29A1;Gene;PA164784024;Chemical
TIPIRACIL HYDROCHLORIDE;SLC29A1;Gene;PA166171170;Chemical
BREAST NEOPLASMS;SLC29A1;Gene;PA443560;Disease
LEUKEMIA, MYELOID, ACUTE;SLC29A1;Gene;PA444760;Disease
NEOPLASMS;SLC29A1;Gene;PA445062;Disease
PANCREATIC NEOPLASMS;SLC29A1;Gene;PA445218;Disease
COLORECTAL NEOPLASMS;SLC29A1;Gene;PA446108;Disease
CHRONIC HEPATITIS C VIRUS INFECTION;SLC29A1;Gene;PA446863;Disease
CYTARABINE;SLC29A1;Gene;PA449177;Chemical
GEMCITABINE;SLC29A1;Gene;PA449748;Chemical
PACLITAXEL;SLC29A1;Gene;PA450761;Chemical
RIBAVIRIN;SLC29A1;Gene;PA451241;Chemical
TRIFLURIDINE;SLC29A1;Gene;PA451775;Chemical
NPIPB8;tapentadol;Chemical;PA166123718;Gene
RS28374453;tapentadol;Chemical;PA166155127;Variant
RS776817009;tapentadol;Chemical;PA166179692;Variant
RS767263838;tapentadol;Chemical;PA166179693;Variant
RS762151655;tapentadol;Chemical;PA166179694;Variant
RS757573592;tapentadol;Chemical;PA166179695;Variant
RS750575779;tapentadol;Chemical;PA166179696;Variant
RS553050853;tapentadol;Chemical;PA166179697;Variant
RS751527244;tapentadol;Chemical;PA166179698;Variant
RS1293732453;tapentadol;Chemical;PA166179699;Variant
RS1328799050;tapentadol;Chemical;PA166179700;Variant
RS544820732;tapentadol;Chemical;PA166186134;Variant
RS1042008;tapentadol;Chemical;PA166186136;Variant
RS767487725;tapentadol;Chemical;PA166186137;Variant
RS552524124;tapentadol;Chemical;PA166186138;Variant
RS758145522;tapentadol;Chemical;PA166186139;Variant
RS72547527;tapentadol;Chemical;PA166186140;Variant
RS1042028;tapentadol;Chemical;PA166186146;Variant
SULT1A1;tapentadol;Chemical;PA343;Gene
SULT1A3;tapentadol;Chemical;PA344;Gene
FLUOROURACIL;rs714368;Variant;PA128406956;Chemical
DOXORUBICINOL;rs714368;Variant;PA165291922;Chemical
BREAST NEOPLASMS;rs714368;Variant;PA443560;Disease
CYCLOPHOSPHAMIDE;rs714368;Variant;PA449165;Chemical
DOXORUBICIN;rs714368;Variant;PA449412;Chemical
BUMETANIDE;rs5063;Variant;PA448682;Chemical
FUROSEMIDE;rs5063;Variant;PA449719;Chemical
TORASEMIDE;rs5063;Variant;PA451733;Chemical
FLUOROURACIL;rs4968187;Variant;PA128406956;Chemical
BREAST NEOPLASMS;rs4968187;Variant;PA443560;Disease
NEUTROPENIA;rs4968187;Variant;PA445113;Disease
CYCLOPHOSPHAMIDE;rs4968187;Variant;PA449165;Chemical
EPIRUBICIN;rs4968187;Variant;PA449476;Chemical
ALCOHOL ABUSE;rs3823010;Variant;PA443309;Disease
HEROIN DEPENDENCE;rs3823010;Variant;PA444460;Disease
OPIOID-RELATED DISORDERS;rs3823010;Variant;PA445043;Disease
COCAINE DEPENDENCE;rs3823010;Variant;PA446878;Disease
ETHANOL;rs3823010;Variant;PA448073;Chemical
COCAINE;rs3823010;Variant;PA449072;Chemical
OPIOIDS;rs3823010;Variant;PA452618;Chemical
HEROIN;rs3823010;Variant;PA452619;Chemical
SEVOFLURANE;DUX1;Gene;PA451341;Chemical
RS1799732;bromperidol;Chemical;PA166154334;Variant
ABCB1;bromperidol;Chemical;PA267;Gene
DRD2;bromperidol;Chemical;PA27478;Gene
NLRP1;glucocorticoids;Chemical;PA162397797;Gene
RS1059150;glucocorticoids;Chemical;PA166155914;Variant
RS1264457;glucocorticoids;Chemical;PA166156981;Variant
RS37973;glucocorticoids;Chemical;PA166157244;Variant
RS2302489;glucocorticoids;Chemical;PA166160715;Variant
RS7301582;glucocorticoids;Chemical;PA166160807;Variant
RS1047303;glucocorticoids;Chemical;PA166186981;Variant
NR3C1;glucocorticoids;Chemical;PA181;Gene
ATP5F1E;glucocorticoids;Chemical;PA25128;Gene
ABCB1;glucocorticoids;Chemical;PA267;Gene
CYP17A1;glucocorticoids;Chemical;PA27090;Gene
FKBP5;glucocorticoids;Chemical;PA28162;Gene
HSD3B1;glucocorticoids;Chemical;PA29486;Gene
KLRC1;glucocorticoids;Chemical;PA30163;Gene
KLRD1;glucocorticoids;Chemical;PA30167;Gene
HLA-E;glucocorticoids;Chemical;PA35081;Gene
GLCCI1;glucocorticoids;Chemical;PA38657;Gene
TNF;glucocorticoids;Chemical;PA435;Gene
ACUTE CORONARY SYNDROME;NECAB1;Gene;PA165108401;Disease
MAJOR ADVERSE CARDIAC EVENTS (MACE);NECAB1;Gene;PA166129560;Disease
ASPIRIN;NECAB1;Gene;PA448497;Chemical
CLOPIDOGREL;NECAB1;Gene;PA449053;Chemical
CYP2C9;Venous Thrombosis;Disease;PA126;Gene
F2;Venous Thrombosis;Disease;PA157;Gene
CYP2C9*1;Venous Thrombosis;Disease;PA165816542;Haplotype
CYP2C9*3;Venous Thrombosis;Disease;PA165816544;Haplotype
RS1799963;Venous Thrombosis;Disease;PA166154336;Variant
ALCOHOL ABUSE;rs4807493;Variant;PA443309;Disease
ETHANOL;rs4807493;Variant;PA448073;Chemical
GPAM;PRKAA1;Gene;PA134983031;Gene
CRTC2;PRKAA1;Gene;PA142672073;Gene
HMGCR;PRKAA1;Gene;PA189;Gene
ACACA;PRKAA1;Gene;PA24421;Gene
ACACB;PRKAA1;Gene;PA24422;Gene
MLYCD;PRKAA1;Gene;PA30861;Gene
SREBF1;PRKAA1;Gene;PA335;Gene
SLC2A4;PRKAA1;Gene;PA35879;Gene
STK11;PRKAA1;Gene;PA36198;Gene
MLXIPL;PRKAA1;Gene;PA37353;Gene
SIRT1;PRKAA1;Gene;PA37935;Gene
METFORMIN;PRKAA1;Gene;PA450395;Chemical
ATM;PRKAA1;Gene;PA61;Gene
RS2032582;Lymphopenia;Disease;PA166157316;Variant
ABCB1;Lymphopenia;Disease;PA267;Gene
PLCB1;GNG3;Gene;PA33384;Gene
PLCB2;GNG3;Gene;PA33385;Gene
PLCB3;GNG3;Gene;PA33386;Gene
PLCB4;GNG3;Gene;PA33387;Gene
CYP2C9;fluindione;Chemical;PA126;Gene
VKORC1;fluindione;Chemical;PA133787052;Gene
CYP2C9*2;fluindione;Chemical;PA165816543;Haplotype
CYP2C9*3;fluindione;Chemical;PA165816544;Haplotype
RS9923231;fluindione;Chemical;PA166155091;Variant
RS9934438;fluindione;Chemical;PA166155096;Variant
SCHIZOPHRENIA;rs2276302;Variant;PA447216;Disease
CLOZAPINE;rs2276302;Variant;PA449061;Chemical
CYP2D6;n-desmethyltramadol;Chemical;PA128;Gene
CYP2D6*1;n-desmethyltramadol;Chemical;PA165816576;Haplotype
CYP2D6*2;n-desmethyltramadol;Chemical;PA165816577;Haplotype
CYP2D6*10;n-desmethyltramadol;Chemical;PA165816582;Haplotype
CYP2D6*5;n-desmethyltramadol;Chemical;PA165948092;Haplotype
LEUKEMIA, MYELOID, ACUTE;rs2396243;Variant;PA444760;Disease
CYTARABINE;rs2396243;Variant;PA449177;Chemical
WARFARIN;VKORC1L1;Gene;PA451906;Chemical
DIABETES MELLITUS;rs17655652;Variant;PA443886;Disease
HYPERTENSION;rs17655652;Variant;PA444552;Disease
VASCULAR DISEASES;rs17655652;Variant;PA446021;Disease
PRAVASTATIN;rs17655652;Variant;PA451089;Chemical
SCHIZOPHRENIA;rs4731426;Variant;PA447216;Disease
OLANZAPINE;rs4731426;Variant;PA450688;Chemical
CFTR;rs397508440;Variant;PA109;Gene
IVACAFTOR;rs397508440;Variant;PA165950341;Chemical
CYP2B6;Antivirals for treatment of HIV infections, combinations;Chemical;PA123;Gene
NAT2*4;Antivirals for treatment of HIV infections, combinations;Chemical;PA165949098;Haplotype
NAT2*5A;Antivirals for treatment of HIV infections, combinations;Chemical;PA165949099;Haplotype
NAT2*12A;Antivirals for treatment of HIV infections, combinations;Chemical;PA165949138;Haplotype
NAT2*6;Antivirals for treatment of HIV infections, combinations;Chemical;PA165981635;Haplotype
NAT2*7;Antivirals for treatment of HIV infections, combinations;Chemical;PA165981636;Haplotype
UGT1A1*1;Antivirals for treatment of HIV infections, combinations;Chemical;PA166115841;Haplotype
UGT1A1*28;Antivirals for treatment of HIV infections, combinations;Chemical;PA166115842;Haplotype
RS7412;Antivirals for treatment of HIV infections, combinations;Chemical;PA166155341;Variant
RS429358;Antivirals for treatment of HIV infections, combinations;Chemical;PA166155351;Variant
RS3745274;Antivirals for treatment of HIV infections, combinations;Chemical;PA166155409;Variant
RS1045642;Antivirals for treatment of HIV infections, combinations;Chemical;PA166157284;Variant
NAT2;Antivirals for treatment of HIV infections, combinations;Chemical;PA18;Gene
ABCB1;Antivirals for treatment of HIV infections, combinations;Chemical;PA267;Gene
UGT1A1;Antivirals for treatment of HIV infections, combinations;Chemical;PA420;Gene
APOE;Antivirals for treatment of HIV infections, combinations;Chemical;PA55;Gene
BREAST NEOPLASMS;RNF8;Gene;PA443560;Disease
CARBOPLATIN;RNF8;Gene;PA448803;Chemical
DOCETAXEL;RNF8;Gene;PA449383;Chemical
TRASTUZUMAB;RNF8;Gene;PA451743;Chemical
ENZYMES;rs1801020;Variant;PA164712734;Chemical
STROKE;rs1801020;Variant;PA447054;Disease
MAVS;DDX58;Gene;PA164722208;Gene
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;rs12409352;Variant;PA447197;Disease
METHYLPHENIDATE;rs12409352;Variant;PA450464;Chemical
CYP2C19;Cardiovascular Diseases;Disease;PA124;Gene
CYP2C9;Cardiovascular Diseases;Disease;PA126;Gene
CYP3A5;Cardiovascular Diseases;Disease;PA131;Gene
SLCO1B1;Cardiovascular Diseases;Disease;PA134865839;Gene
P2RY12;Cardiovascular Diseases;Disease;PA134971947;Gene
ACE;Cardiovascular Diseases;Disease;PA139;Gene
EYS;Cardiovascular Diseases;Disease;PA164719488;Gene
MIR224;Cardiovascular Diseases;Disease;PA164722612;Gene
CYP2C19*6;Cardiovascular Diseases;Disease;PA165816522;Haplotype
CYP2C19*8;Cardiovascular Diseases;Disease;PA165816524;Haplotype
CYP2C19*17;Cardiovascular Diseases;Disease;PA165816533;Haplotype
CYP2C9*1;Cardiovascular Diseases;Disease;PA165816542;Haplotype
CYP2C9*2;Cardiovascular Diseases;Disease;PA165816543;Haplotype
CYP2C9*3;Cardiovascular Diseases;Disease;PA165816544;Haplotype
CYP2C9*4;Cardiovascular Diseases;Disease;PA165816545;Haplotype
CYP2C9*5;Cardiovascular Diseases;Disease;PA165816546;Haplotype
CYP2C9*6;Cardiovascular Diseases;Disease;PA165816547;Haplotype
CYP2C9*8;Cardiovascular Diseases;Disease;PA165816549;Haplotype
CYP2C9*11;Cardiovascular Diseases;Disease;PA165816552;Haplotype
CYP2C19*1;Cardiovascular Diseases;Disease;PA165980634;Haplotype
CYP2C19*2;Cardiovascular Diseases;Disease;PA165980635;Haplotype
CYP2C19*3;Cardiovascular Diseases;Disease;PA165980636;Haplotype
CYP2C19*4;Cardiovascular Diseases;Disease;PA165980637;Haplotype
CYP2C19*5;Cardiovascular Diseases;Disease;PA165980638;Haplotype
RS5065;Cardiovascular Diseases;Disease;PA166153549;Variant
RS2819742;Cardiovascular Diseases;Disease;PA166153719;Variant
RS4149056;Cardiovascular Diseases;Disease;PA166154579;Variant
RS3846662;Cardiovascular Diseases;Disease;PA166156820;Variant
RS1800795;Cardiovascular Diseases;Disease;PA166157304;Variant
RS9342288;Cardiovascular Diseases;Disease;PA166179568;Variant
HMGCR;Cardiovascular Diseases;Disease;PA189;Gene
IL6;Cardiovascular Diseases;Disease;PA198;Gene
KCNJ11;Cardiovascular Diseases;Disease;PA217;Gene
MTHFR;Cardiovascular Diseases;Disease;PA245;Gene
ADH1B;Cardiovascular Diseases;Disease;PA24571;Gene
ANGPTL3;Cardiovascular Diseases;Disease;PA24796;Gene
NPPA;Cardiovascular Diseases;Disease;PA256;Gene
COL4A1;Cardiovascular Diseases;Disease;PA26717;Gene
G6PD;Cardiovascular Diseases;Disease;PA28469;Gene
PTGIR;Cardiovascular Diseases;Disease;PA291;Gene
PTGS2;Cardiovascular Diseases;Disease;PA293;Gene
RYR2;Cardiovascular Diseases;Disease;PA300;Gene
PON1;Cardiovascular Diseases;Disease;PA33529;Gene
ADRB1;Cardiovascular Diseases;Disease;PA38;Gene
SCHIZOPHRENIA;Cardiovascular Diseases;Disease;PA447216;Disease
RS6431558;ABT-751;Chemical;PA166155742;Variant
RS6755571;ABT-751;Chemical;PA166155759;Variant
UGT1A4;ABT-751;Chemical;PA37179;Gene
UGT1A8;ABT-751;Chemical;PA37183;Gene
RS616147;creatine;Chemical;PA166202221;Variant
MOBP;creatine;Chemical;PA30899;Gene
RS36210421;dofetilide;Chemical;PA166157488;Variant
KCNH2;dofetilide;Chemical;PA212;Gene
GP1BB;COL3A1;Gene;PA179;Gene
ITGA2;COL3A1;Gene;PA204;Gene
CD36;COL3A1;Gene;PA26212;Gene
GP5;COL3A1;Gene;PA28823;Gene
GP6;COL3A1;Gene;PA28824;Gene
GP9;COL3A1;Gene;PA28825;Gene
EHLERS-DANLOS SYNDROME;COL3A1;Gene;PA443997;Disease
CYP2D6;metoprolol;Chemical;PA128;Gene
LRRC15;metoprolol;Chemical;PA134956867;Gene
SLC25A31;metoprolol;Chemical;PA142670904;Gene
CYP2D6*1;metoprolol;Chemical;PA165816576;Haplotype
CYP2D6*2;metoprolol;Chemical;PA165816577;Haplotype
CYP2D6*3;metoprolol;Chemical;PA165816578;Haplotype
CYP2D6*4;metoprolol;Chemical;PA165816579;Haplotype
CYP2D6*6;metoprolol;Chemical;PA165816581;Haplotype
CYP2D6*10;metoprolol;Chemical;PA165816582;Haplotype
CYP2D6*17;metoprolol;Chemical;PA165816583;Haplotype
CYP2D6*41;metoprolol;Chemical;PA165816584;Haplotype
CYP2D6*5;metoprolol;Chemical;PA165948092;Haplotype
CYP2D6*9;metoprolol;Chemical;PA165948317;Haplotype
CYP2D6*29;metoprolol;Chemical;PA165948318;Haplotype
CYP2D6*31;metoprolol;Chemical;PA165971582;Haplotype
CYP2D6*46;metoprolol;Chemical;PA165971600;Haplotype
CYP2D6*35;metoprolol;Chemical;PA165988487;Haplotype
CYP2D6*45;metoprolol;Chemical;PA165988489;Haplotype
RS1801252;metoprolol;Chemical;PA166153976;Variant
RS1801253;metoprolol;Chemical;PA166153977;Variant
RS3892097;metoprolol;Chemical;PA166156104;Variant
RS5030655;metoprolol;Chemical;PA166156111;Variant
RS11313667;metoprolol;Chemical;PA166156442;Variant
RS1024323;metoprolol;Chemical;PA166156499;Variant
RS1801058;metoprolol;Chemical;PA166156524;Variant
RS61767072;metoprolol;Chemical;PA166156691;Variant
RS201279313;metoprolol;Chemical;PA166156703;Variant
RS1042713;metoprolol;Chemical;PA166156748;Variant
RS1042714;metoprolol;Chemical;PA166156749;Variant
RS294610;metoprolol;Chemical;PA166196761;Variant
RS45545233;metoprolol;Chemical;PA166196763;Variant
RS1446468;metoprolol;Chemical;PA166199061;Variant
GRK5;metoprolol;Chemical;PA180;Gene
GRK4;metoprolol;Chemical;PA28941;Gene
SLC4A1;metoprolol;Chemical;PA35895;Gene
ADRA2C;metoprolol;Chemical;PA37;Gene
ADRB1;metoprolol;Chemical;PA38;Gene
ADRB2;metoprolol;Chemical;PA39;Gene
DPYD;rs138391898;Variant;PA145;Gene
CAPECITABINE;rs138391898;Variant;PA448771;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs6113;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs6113;Variant;PA445846;Disease
CARBOPLATIN;rs6113;Variant;PA448803;Chemical
GEMCITABINE;rs6113;Variant;PA449748;Chemical
DULOXETINE;rs4261893;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs4261893;Variant;PA447321;Disease
MULTIPLE SCLEROSIS;rs10819043;Variant;PA444987;Disease
INTERFERON BETA-1A;rs10819043;Variant;PA450037;Chemical
INTERFERON BETA-1B;rs10819043;Variant;PA450039;Chemical
ADVERSE EVENTS;rs185462714;Variant;PA166151827;Disease
MEPERIDINE;rs185462714;Variant;PA450369;Chemical
ETOPOSIDE;rs2784917;Variant;PA449552;Chemical
RS2231142;Gout;Disease;PA166156544;Variant
G6PD DEFICIENCY;Gout;Disease;PA166157959;Variant
RS3731722;Gout;Disease;PA166161450;Variant
RS75995567;Gout;Disease;PA166161452;Variant
RS34650714;Gout;Disease;PA166161456;Variant
ADH1B;Gout;Disease;PA24571;Gene
AOX1;Gout;Disease;PA24842;Gene
G6PD;Gout;Disease;PA28469;Gene
UGT1A10;Gout;Disease;PA37174;Gene
UGT1A3;Gout;Disease;PA37178;Gene
UGT1A4;Gout;Disease;PA37179;Gene
UGT1A5;Gout;Disease;PA37180;Gene
UGT1A6;Gout;Disease;PA37181;Gene
UGT1A7;Gout;Disease;PA37182;Gene
UGT1A8;Gout;Disease;PA37183;Gene
ABCG2;Gout;Disease;PA390;Gene
UGT1A9;Gout;Disease;PA419;Gene
UGT1A1;Gout;Disease;PA420;Gene
CYP2C19;rabeprazole;Chemical;PA124;Gene
CYP2C19*17;rabeprazole;Chemical;PA165816533;Haplotype
CYP2C19*1;rabeprazole;Chemical;PA165980634;Haplotype
CYP2C19*2;rabeprazole;Chemical;PA165980635;Haplotype
CYP2C19*3;rabeprazole;Chemical;PA165980636;Haplotype
RS16944;rabeprazole;Chemical;PA166155587;Variant
IL1B;rabeprazole;Chemical;PA29808;Gene
DESLORATADINE;rs901865;Variant;PA164776964;Chemical
SEDATION;rs901865;Variant;PA166129521;Disease
URTICARIA;rs901865;Variant;PA445999;Disease
DRUGS USED IN DIABETES;rs1801278;Variant;PA164712711;Chemical
DIABETES MELLITUS, TYPE 2;rs1801278;Variant;PA443890;Disease
HLA-B*55:01;penicillin v;Chemical;PA165956463;Haplotype
RS115200108;penicillin v;Chemical;PA166257881;Variant
HLA-B;penicillin v;Chemical;PA35056;Gene
NR1I2;penicillin v;Chemical;PA378;Gene
BILIRUBIN;rs11563250;Variant;PA166123346;Chemical
COLORECTAL NEOPLASMS;rs11563250;Variant;PA446108;Disease
IRINOTECAN;rs11563250;Variant;PA450085;Chemical
CACNA1B;PRKACB;Gene;PA26008;Gene
MAPK1;PRKACB;Gene;PA30616;Gene
ARRB1;PRKACB;Gene;PA59;Gene
ARRB2;PRKACB;Gene;PA60;Gene
CACNA1C;PRKACB;Gene;PA83;Gene
CACNA1D;PRKACB;Gene;PA84;Gene
CACNA1S;PRKACB;Gene;PA85;Gene
DULOXETINE;rs324023;Variant;PA10066;Chemical
ANXIETY DISORDERS;rs324023;Variant;PA447196;Disease
ESSENTIAL HYPERTENSION;rs9915451;Variant;PA447288;Disease
HYDROCHLOROTHIAZIDE;rs9915451;Variant;PA449899;Chemical
MACULOPAPULAR EXANTHEMA;HLA-B*48:04;Haplotype;PA162316739;Disease
EPILEPSY;HLA-B*48:04;Haplotype;PA444065;Disease
OXCARBAZEPINE;HLA-B*48:04;Haplotype;PA450732;Chemical
COUMARIN;CYP2A6*5;Haplotype;PA134521193;Chemical
SCHIZOPHRENIA;IL1A;Gene;PA447216;Disease
OLANZAPINE;IL1A;Gene;PA450688;Chemical
CYP2D6;noroxycodone;Chemical;PA128;Gene
SCHIZOPHRENIA;rs1360780;Variant;PA447216;Disease
DEPRESSION;rs1360780;Variant;PA447278;Disease
CITALOPRAM;rs1360780;Variant;PA449015;Chemical
CLOMIPRAMINE;rs1360780;Variant;PA449048;Chemical
CLOZAPINE;rs1360780;Variant;PA449061;Chemical
LITHIUM;rs1360780;Variant;PA450243;Chemical
NEFAZODONE;rs1360780;Variant;PA450603;Chemical
PAROXETINE;rs1360780;Variant;PA450801;Chemical
VENLAFAXINE;rs1360780;Variant;PA451866;Chemical
ANTIDEPRESSANTS;rs1360780;Variant;PA452229;Chemical
DICLOFENAC;CYP2C9*48;Haplotype;PA449293;Chemical
ESOMEPRAZOLE;dasatinib;Chemical;PA10075;Chemical
RS1061018;dasatinib;Chemical;PA166156501;Variant
RS2231137;dasatinib;Chemical;PA166156543;Variant
RS2231142;dasatinib;Chemical;PA166156544;Variant
RS41282401;dasatinib;Chemical;PA166156685;Variant
RS45605536;dasatinib;Chemical;PA166156686;Variant
RS58818712;dasatinib;Chemical;PA166156688;Variant
ABL1;dasatinib;Chemical;PA24413;Gene
BCR;dasatinib;Chemical;PA25321;Gene
ABCG2;dasatinib;Chemical;PA390;Gene
RS267606618;tobramycin;Chemical;PA166158908;Variant
RS267606619;tobramycin;Chemical;PA166158909;Variant
RS267606617;tobramycin;Chemical;PA166159181;Variant
MT-RNR1;tobramycin;Chemical;PA31274;Gene
DULOXETINE;rs7035619;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs7035619;Variant;PA447321;Disease
CYP2D6;bepridil;Chemical;PA128;Gene
CYP2D6*10;bepridil;Chemical;PA165816582;Haplotype
ABCB1;bepridil;Chemical;PA267;Gene
MACULOPAPULAR EXANTHEMA;rs4986893;Variant;PA162316739;Disease
ETHAMBUTOL;rs4986893;Variant;PA164784021;Chemical
TUBERCULOSIS;rs4986893;Variant;PA445941;Disease
ISONIAZID;rs4986893;Variant;PA450112;Chemical
PHENYTOIN;rs4986893;Variant;PA450947;Chemical
PYRAZINAMIDE;rs4986893;Variant;PA451182;Chemical
RIFAMPIN;rs4986893;Variant;PA451250;Chemical
ALDH5A1;sodium oxybate;Chemical;PA24702;Gene
HYPERTENSION;rs1048101;Variant;PA444552;Disease
NIFEDIPINE;rs1048101;Variant;PA450631;Chemical
COLORECTAL NEOPLASMS;rs1800469;Variant;PA446108;Disease
ASPIRIN;rs1800469;Variant;PA448497;Chemical
IRINOTECAN;rs1800469;Variant;PA450085;Chemical
RS5065;systolic blood pressure;Disease;PA166153549;Variant
NPPA;systolic blood pressure;Disease;PA256;Gene
CYP3A4;felodipine;Chemical;PA130;Gene
CYP3A5;felodipine;Chemical;PA131;Gene
CYP3A5*1;felodipine;Chemical;PA166128213;Haplotype
CYP3A5*3;felodipine;Chemical;PA166128219;Haplotype
ABCB1;felodipine;Chemical;PA267;Gene
ECALLANTIDE;KLKB1;Gene;PA166222861;Chemical
CYP2D6;tolterodine;Chemical;PA128;Gene
CYP3A4;tolterodine;Chemical;PA130;Gene
CYP2D6*1;tolterodine;Chemical;PA165816576;Haplotype
CYP2D6*3;tolterodine;Chemical;PA165816578;Haplotype
CYP2D6*4;tolterodine;Chemical;PA165816579;Haplotype
CYP2D6*10;tolterodine;Chemical;PA165816582;Haplotype
CYP2D6*5;tolterodine;Chemical;PA165948092;Haplotype
CYP2D6*87;tolterodine;Chemical;PA166123327;Haplotype
CYP2D6*88;tolterodine;Chemical;PA166123328;Haplotype
CYP2D6*89;tolterodine;Chemical;PA166123329;Haplotype
CYP2D6*90;tolterodine;Chemical;PA166123330;Haplotype
CYP2D6*91;tolterodine;Chemical;PA166123331;Haplotype
CYP2D6*92;tolterodine;Chemical;PA166123332;Haplotype
CYP2D6*93;tolterodine;Chemical;PA166123333;Haplotype
CYP2D6*95;tolterodine;Chemical;PA166123336;Haplotype
CYP2D6*96;tolterodine;Chemical;PA166123337;Haplotype
CYP2D6*97;tolterodine;Chemical;PA166123338;Haplotype
CYP2D6*98;tolterodine;Chemical;PA166123339;Haplotype
CYP2D6*94;tolterodine;Chemical;PA166128737;Haplotype
GALNT18;tocilizumab;Chemical;PA134950929;Gene
HLA-DRB1*15:01;tocilizumab;Chemical;PA165952269;Haplotype
RS396991;tocilizumab;Chemical;PA166153571;Variant
RS4329505;tocilizumab;Chemical;PA166153765;Variant
RS12083537;tocilizumab;Chemical;PA166153848;Variant
RS4910008;tocilizumab;Chemical;PA166159490;Variant
RS11052877;tocilizumab;Chemical;PA166159492;Variant
RS11265618;tocilizumab;Chemical;PA166161950;Variant
CD69;tocilizumab;Chemical;PA26233;Gene
FCGR3A;tocilizumab;Chemical;PA28065;Gene
IL6R;tocilizumab;Chemical;PA29835;Gene
HLA-DRB1;tocilizumab;Chemical;PA35072;Gene
OPIOID-RELATED DISORDERS;rs1997794;Variant;PA445043;Disease
OPIOIDS;rs1997794;Variant;PA452618;Chemical
TETRABENAZINE;CYP2D6 intermediate metabolizer;Variant;PA140222719;Chemical
TENOFOVIR;IFNL4;Gene;PA10204;Chemical
PEGINTERFERON ALFA-2A;IFNL4;Gene;PA164749390;Chemical
PEGINTERFERON ALFA-2B;IFNL4;Gene;PA164784024;Chemical
BOCEPREVIR;IFNL4;Gene;PA165948902;Chemical
TELAPREVIR;IFNL4;Gene;PA165958354;Chemical
SIMEPREVIR;IFNL4;Gene;PA166122590;Chemical
SOFOSBUVIR;IFNL4;Gene;PA166122593;Chemical
DELEOBUVIR;IFNL4;Gene;PA166128130;Chemical
FALDAPREVIR;IFNL4;Gene;PA166128132;Chemical
LEDIPASVIR;IFNL4;Gene;PA166128166;Chemical
DACLATASVIR;IFNL4;Gene;PA166128167;Chemical
RAPID VIROLOGICAL RESPONSE (RVR);IFNL4;Gene;PA166131628;Disease
SUSTAINED VIROLOGICAL RESPONSE (SVR);IFNL4;Gene;PA166131629;Disease
RS12979860;IFNL4;Gene;PA166155468;Variant
OMBITASVIR / PARITAPREVIR / RITONAVIR;IFNL4;Gene;PA166163408;Chemical
VELPATASVIR;IFNL4;Gene;PA166163415;Chemical
COMPLETE EARLY VIROLOGICAL RESPONSE;IFNL4;Gene;PA166170534;Disease
VOXILAPREVIR;IFNL4;Gene;PA166171182;Chemical
DIRECT ACTING ANTIVIRALS;IFNL4;Gene;PA166179660;Chemical
HEPATITIS B;IFNL4;Gene;PA444437;Disease
HEPATITIS C;IFNL4;Gene;PA444445;Disease
MYELOPROLIFERATIVE DISORDER;IFNL4;Gene;PA445016;Disease
RECURRENCE;IFNL4;Gene;PA445506;Disease
HEPATITIS B, CHRONIC;IFNL4;Gene;PA446862;Disease
HEPATITIS C, CHRONIC;IFNL4;Gene;PA446863;Disease
HIV INFECTIOUS DISEASE;IFNL4;Gene;PA447230;Disease
ATORVASTATIN;IFNL4;Gene;PA448500;Chemical
RIBAVIRIN;IFNL4;Gene;PA451241;Chemical
INTERFERONS;IFNL4;Gene;PA451999;Chemical
PAIN, POSTOPERATIVE;rs4587017;Variant;PA445210;Disease
FENTANYL;rs4587017;Variant;PA449599;Chemical
DULOXETINE;rs10771998;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs10771998;Variant;PA447321;Disease
SUBSTANCE-RELATED DISORDERS;rs9891146;Variant;PA446876;Disease
SOMATROPIN RECOMBINANT;rs2270777;Variant;PA451446;Chemical
IMATINIB;ULK3;Gene;PA10804;Chemical
CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;ULK3;Gene;PA446171;Disease
NON-SMALL CELL LUNG CARCINOMA;rs7779029;Variant;PA443622;Disease
IRINOTECAN;rs7779029;Variant;PA450085;Chemical
HYPERTENSION;rs4791040;Variant;PA444552;Disease
HYDROCHLOROTHIAZIDE;rs4791040;Variant;PA449899;Chemical
CYP2D6;clonidine;Chemical;PA128;Gene
RS5443;clonidine;Chemical;PA166154486;Variant
RS11269124;clonidine;Chemical;PA166156644;Variant
GNB3;clonidine;Chemical;PA176;Gene
ADRA2A;clonidine;Chemical;PA35;Gene
ADRA2B;clonidine;Chemical;PA36;Gene
ADRA2C;clonidine;Chemical;PA37;Gene
SULFAMETHOXAZOLE / TRIMETHOPRIM;NAT2*14;Haplotype;PA10715;Chemical
DRUGS FOR TREATMENT OF TUBERCULOSIS;NAT2*14;Haplotype;PA164712708;Chemical
TOXIC LIVER DISEASE;NAT2*14;Haplotype;PA164925725;Disease
DRUG-INDUCED LIVER INJURY;NAT2*14;Haplotype;PA166119041;Disease
SEVERE CUTANEOUS ADVERSE REACTIONS;NAT2*14;Haplotype;PA166120929;Disease
DIPYRONE;NAT2*14;Haplotype;PA166128206;Chemical
ADVERSE EVENTS;NAT2*14;Haplotype;PA166151827;Disease
SOLITHROMYCIN;NAT2*14;Haplotype;PA166165147;Chemical
HYPERSENSITIVITY;NAT2*14;Haplotype;PA444546;Disease
HYPERTENSION;NAT2*14;Haplotype;PA444552;Disease
TUBERCULOSIS;NAT2*14;Haplotype;PA445941;Disease
HYDRALAZINE;NAT2*14;Haplotype;PA449894;Chemical
ISONIAZID;NAT2*14;Haplotype;PA450112;Chemical
DICHLOROACETIC ACID;GSTZ1;Gene;PA165947835;Chemical
PPCDC;trastuzumab;Chemical;PA142671157;Gene
ESR1;trastuzumab;Chemical;PA156;Gene
RS396991;trastuzumab;Chemical;PA166153571;Variant
RS1801274;trastuzumab;Chemical;PA166153652;Variant
RS1136201;trastuzumab;Chemical;PA166155183;Variant
RS45445694;trastuzumab;Chemical;PA166155331;Variant
RS2229046;trastuzumab;Chemical;PA166179815;Variant
RS773123;trastuzumab;Chemical;PA166179816;Variant
RS2284922;trastuzumab;Chemical;PA166179817;Variant
RS2070096;trastuzumab;Chemical;PA166179818;Variant
RS147451859;trastuzumab;Chemical;PA166199721;Variant
RS17587029;trastuzumab;Chemical;PA166199722;Variant
BARD1;trastuzumab;Chemical;PA25256;Gene
PGR;trastuzumab;Chemical;PA266;Gene
ERBB2;trastuzumab;Chemical;PA27844;Gene
ERBB3;trastuzumab;Chemical;PA27846;Gene
ESR2;trastuzumab;Chemical;PA27886;Gene
FCGR2A;trastuzumab;Chemical;PA28063;Gene
FCGR3A;trastuzumab;Chemical;PA28065;Gene
PIK3CA;trastuzumab;Chemical;PA33308;Gene
RNF8;trastuzumab;Chemical;PA34445;Gene
TYMS;trastuzumab;Chemical;PA359;Gene
CYP2D6;eliglustat;Chemical;PA128;Gene
ABCC2;deferasirox;Chemical;PA116;Gene
UGT1A1*1;deferasirox;Chemical;PA166115841;Haplotype
UGT1A1*28;deferasirox;Chemical;PA166115842;Haplotype
RS717620;deferasirox;Chemical;PA166153953;Variant
RS2273697;deferasirox;Chemical;PA166154007;Variant
RS8187710;deferasirox;Chemical;PA166154094;Variant
RS731236;deferasirox;Chemical;PA166154500;Variant
RS1544410;deferasirox;Chemical;PA166154516;Variant
RS10877012;deferasirox;Chemical;PA166154623;Variant
RS762551;deferasirox;Chemical;PA166154850;Variant
RS2470890;deferasirox;Chemical;PA166154893;Variant
RS2606345;deferasirox;Chemical;PA166154899;Variant
RS887829;deferasirox;Chemical;PA166155607;Variant
RS1983023;deferasirox;Chemical;PA166155655;Variant
RS3806596;deferasirox;Chemical;PA166155712;Variant
RS4124874;deferasirox;Chemical;PA166155720;Variant
RS2585428;deferasirox;Chemical;PA166155928;Variant
RS13120400;deferasirox;Chemical;PA166156664;Variant
RS2248359;deferasirox;Chemical;PA166170863;Variant
RS927650;deferasirox;Chemical;PA166176111;Variant
RS7041;deferasirox;Chemical;PA166185751;Variant
CYP1A1;deferasirox;Chemical;PA27092;Gene
CYP1A2;deferasirox;Chemical;PA27093;Gene
CYP24A1;deferasirox;Chemical;PA27097;Gene
CYP27B1;deferasirox;Chemical;PA27099;Gene
GC;deferasirox;Chemical;PA28601;Gene
UGT1A3;deferasirox;Chemical;PA37178;Gene
VDR;deferasirox;Chemical;PA37301;Gene
ABCG2;deferasirox;Chemical;PA390;Gene
UGT1A1;deferasirox;Chemical;PA420;Gene
OTOTOXICITY;rs28358569;Variant;PA162263534;Disease
GENTAMICIN;rs28358569;Variant;PA449753;Chemical
STREPTOMYCIN;rs28358569;Variant;PA451512;Chemical
CYP2C19;Carotid Artery Diseases;Disease;PA124;Gene
CYP2C19*1;Carotid Artery Diseases;Disease;PA165980634;Haplotype
CYP2C19*2;Carotid Artery Diseases;Disease;PA165980635;Haplotype
CYP2D6;deutetrabenazine;Chemical;PA128;Gene
CYP2C8;CYP2C8*3;Haplotype;PA125;Gene
WEIGHT GAIN;CYP2C8*3;Haplotype;PA128406954;Disease
CALCINEURIN INHIBITORS;CYP2C8*3;Haplotype;PA164712580;Chemical
TOXIC LIVER DISEASE;CYP2C8*3;Haplotype;PA164925725;Disease
PAZOPANIB;CYP2C8*3;Haplotype;PA165291492;Chemical
KIDNEY TRANSPLANTATION;CYP2C8*3;Haplotype;PA165817016;Disease
DELAYED GRAFT FUNCTION;CYP2C8*3;Haplotype;PA166123755;Disease
ASTHMA;CYP2C8*3;Haplotype;PA443450;Disease
BREAST NEOPLASMS;CYP2C8*3;Haplotype;PA443560;Disease
DIABETES MELLITUS;CYP2C8*3;Haplotype;PA443886;Disease
DIABETES MELLITUS, TYPE 2;CYP2C8*3;Haplotype;PA443890;Disease
DRUG TOXICITY;CYP2C8*3;Haplotype;PA443937;Disease
EDEMA;CYP2C8*3;Haplotype;PA443994;Disease
KIDNEY DISEASES;CYP2C8*3;Haplotype;PA444682;Disease
NEOPLASMS;CYP2C8*3;Haplotype;PA445062;Disease
NEUTROPENIA;CYP2C8*3;Haplotype;PA445113;Disease
OVARIAN NEOPLASMS;CYP2C8*3;Haplotype;PA445204;Disease
PAIN, POSTOPERATIVE;CYP2C8*3;Haplotype;PA445210;Disease
PERIPHERAL NERVOUS SYSTEM DISEASES;CYP2C8*3;Haplotype;PA445301;Disease
LIVER TRANSPLANTATION;CYP2C8*3;Haplotype;PA447247;Disease
AMODIAQUINE;CYP2C8*3;Haplotype;PA448404;Chemical
CERIVASTATIN;CYP2C8*3;Haplotype;PA448897;Chemical
CYCLOSPORINE;CYP2C8*3;Haplotype;PA449167;Chemical
DICLOFENAC;CYP2C8*3;Haplotype;PA449293;Chemical
IBUPROFEN;CYP2C8*3;Haplotype;PA449957;Chemical
MONTELUKAST;CYP2C8*3;Haplotype;PA450546;Chemical
PACLITAXEL;CYP2C8*3;Haplotype;PA450761;Chemical
PIOGLITAZONE;CYP2C8*3;Haplotype;PA450970;Chemical
REPAGLINIDE;CYP2C8*3;Haplotype;PA451234;Chemical
ROSIGLITAZONE;CYP2C8*3;Haplotype;PA451283;Chemical
SIMVASTATIN;CYP2C8*3;Haplotype;PA451363;Chemical
TACROLIMUS;CYP2C8*3;Haplotype;PA451578;Chemical
LEVOTHYROXINE;NKX2-5;Gene;PA450221;Chemical
CYP2B6;citalopram;Chemical;PA123;Gene
CYP2C19;citalopram;Chemical;PA124;Gene
CYP2C9;citalopram;Chemical;PA126;Gene
CYP2D6;citalopram;Chemical;PA128;Gene
TPH2;citalopram;Chemical;PA128747823;Gene
CYP3A4;citalopram;Chemical;PA130;Gene
CYP3A5;citalopram;Chemical;PA131;Gene
TSPAN5;citalopram;Chemical;PA134864098;Gene
REEP5;citalopram;Chemical;PA134882361;Gene
COL26A1;citalopram;Chemical;PA134887081;Gene
PAPLN;citalopram;Chemical;PA134914395;Gene
RFK;citalopram;Chemical;PA134916697;Gene
ERICH3;citalopram;Chemical;PA142672422;Gene
METTL21A;citalopram;Chemical;PA145008433;Gene
CYP2C19*17;citalopram;Chemical;PA165816533;Haplotype
CYP2D6*1;citalopram;Chemical;PA165816576;Haplotype
CYP2D6*2;citalopram;Chemical;PA165816577;Haplotype
CYP2D6*3;citalopram;Chemical;PA165816578;Haplotype
CYP2D6*4;citalopram;Chemical;PA165816579;Haplotype
CYP2D6*10;citalopram;Chemical;PA165816582;Haplotype
CYP2D6*17;citalopram;Chemical;PA165816583;Haplotype
CYP2D6*41;citalopram;Chemical;PA165816584;Haplotype
CYP2D6*5;citalopram;Chemical;PA165948092;Haplotype
CYP2C19*1;citalopram;Chemical;PA165980634;Haplotype
CYP2C19*2;citalopram;Chemical;PA165980635;Haplotype
CYP2C19*3;citalopram;Chemical;PA165980636;Haplotype
CYP2C19*4;citalopram;Chemical;PA165980637;Haplotype
CYP2D6*1XN;citalopram;Chemical;PA165988479;Haplotype
CYP2D6*2XN;citalopram;Chemical;PA165988480;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);citalopram;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);citalopram;Chemical;PA166116466;Haplotype
SLC6A4 L ALLELE-RS25531T;citalopram;Chemical;PA166117146;Haplotype
SLC6A4 L ALLELE-RS25531C;citalopram;Chemical;PA166117147;Haplotype
CYP2D6*87;citalopram;Chemical;PA166123327;Haplotype
CYP2D6*88;citalopram;Chemical;PA166123328;Haplotype
CYP2D6*89;citalopram;Chemical;PA166123329;Haplotype
CYP2D6*90;citalopram;Chemical;PA166123330;Haplotype
CYP2D6*91;citalopram;Chemical;PA166123331;Haplotype
CYP2D6*93;citalopram;Chemical;PA166123333;Haplotype
CYP2D6*98;citalopram;Chemical;PA166123339;Haplotype
RS696692;citalopram;Chemical;PA166153586;Variant
RS915120;citalopram;Chemical;PA166153956;Variant
RS6265;citalopram;Chemical;PA166154259;Variant
RS1800532;citalopram;Chemical;PA166154340;Variant
RS7103411;citalopram;Chemical;PA166154418;Variant
RS7124442;citalopram;Chemical;PA166154421;Variant
RS1006737;citalopram;Chemical;PA166154507;Variant
RS4570625;citalopram;Chemical;PA166154593;Variant
RS10848635;citalopram;Chemical;PA166154620;Variant
RS6311;citalopram;Chemical;PA166154673;Variant
RS6313;citalopram;Chemical;PA166154675;Variant
RS585719;citalopram;Chemical;PA166154681;Variant
RS7997012;citalopram;Chemical;PA166154726;Variant
RS16965962;citalopram;Chemical;PA166154752;Variant
RS11628713;citalopram;Chemical;PA166154824;Variant
RS809736;citalopram;Chemical;PA166154851;Variant
RS25531;citalopram;Chemical;PA166155159;Variant
RS520210;citalopram;Chemical;PA166155271;Variant
RS4675690;citalopram;Chemical;PA166155734;Variant
RS7569963;citalopram;Chemical;PA166155763;Variant
RS6127921;citalopram;Chemical;PA166155961;Variant
RS334558;citalopram;Chemical;PA166156287;Variant
RS11947402;citalopram;Chemical;PA166156657;Variant
RS153549;citalopram;Chemical;PA166156716;Variant
RS153560;citalopram;Chemical;PA166156717;Variant
RS495794;citalopram;Chemical;PA166156736;Variant
RS12054895;citalopram;Chemical;PA166156874;Variant
RS6296;citalopram;Chemical;PA166156903;Variant
RS760761;citalopram;Chemical;PA166156948;Variant
RS1360780;citalopram;Chemical;PA166156983;Variant
RS9380524;citalopram;Chemical;PA166157154;Variant
RS1799889;citalopram;Chemical;PA166157302;Variant
RS2032583;citalopram;Chemical;PA166157317;Variant
RS2227631;citalopram;Chemical;PA166157329;Variant
RS2235015;citalopram;Chemical;PA166157336;Variant
RS2235040;citalopram;Chemical;PA166157338;Variant
RS2235067;citalopram;Chemical;PA166157341;Variant
RS2270007;citalopram;Chemical;PA166157349;Variant
RS4148739;citalopram;Chemical;PA166157386;Variant
RS4148740;citalopram;Chemical;PA166157387;Variant
RS6966038;citalopram;Chemical;PA166157424;Variant
RS7787082;citalopram;Chemical;PA166157428;Variant
RS10248420;citalopram;Chemical;PA166157440;Variant
RS10280101;citalopram;Chemical;PA166157445;Variant
RS11983225;citalopram;Chemical;PA166157453;Variant
RS12720067;citalopram;Chemical;PA166157458;Variant
RS17135437;citalopram;Chemical;PA166157468;Variant
RS28401781;citalopram;Chemical;PA166157485;Variant
RS352428;citalopram;Chemical;PA166157546;Variant
RS10975641;citalopram;Chemical;PA166157824;Variant
RS11144870;citalopram;Chemical;PA166157829;Variant
RS4825476;citalopram;Chemical;PA166157876;Variant
CYP2D6 POOR METABOLIZER;citalopram;Chemical;PA166157927;Variant
CYP2C19 POOR METABOLIZER;citalopram;Chemical;PA166157938;Variant
RS116692768;citalopram;Chemical;PA166176886;Variant
RS76191705;citalopram;Chemical;PA166176887;Variant
GRK5;citalopram;Chemical;PA180;Gene
HTR2A;citalopram;Chemical;PA193;Gene
HTR2C;citalopram;Chemical;PA194;Gene
SERPINE1;citalopram;Chemical;PA261;Gene
ABCB1;citalopram;Chemical;PA267;Gene
CREB1;citalopram;Chemical;PA26864;Gene
CRHR2;citalopram;Chemical;PA26875;Gene
CYP1A2;citalopram;Chemical;PA27093;Gene
DRD2;citalopram;Chemical;PA27478;Gene
DTNBP1;citalopram;Chemical;PA27512;Gene
FKBP5;citalopram;Chemical;PA28162;Gene
GLDC;citalopram;Chemical;PA28716;Gene
GRIA3;citalopram;Chemical;PA28968;Gene
GSK3B;citalopram;Chemical;PA29009;Gene
HTR1B;citalopram;Chemical;PA29549;Gene
IL11;citalopram;Chemical;PA29781;Gene
SLC6A4;citalopram;Chemical;PA312;Gene
NEDD4L;citalopram;Chemical;PA31534;Gene
BDNF;citalopram;Chemical;PA31891;Gene
POLG;citalopram;Chemical;PA33500;Gene
RORA;citalopram;Chemical;PA34630;Gene
HLA-A;citalopram;Chemical;PA35055;Gene
HLA-B;citalopram;Chemical;PA35056;Gene
TPH1;citalopram;Chemical;PA355;Gene
SRP19;citalopram;Chemical;PA36124;Gene
UGT1A4;citalopram;Chemical;PA37179;Gene
CACNA1C;citalopram;Chemical;PA83;Gene
PEGINTERFERON ALFA-2B;HLA-DPA1;Gene;PA164784024;Chemical
HEPATITIS B, CHRONIC;HLA-DPA1;Gene;PA446862;Disease
ANTHRACYCLINES AND RELATED SUBSTANCES;rs7319981;Variant;PA130620651;Chemical
NEOPLASMS;rs7319981;Variant;PA445062;Disease
COMT;morphine;Chemical;PA117;Gene
CYP2D6;morphine;Chemical;PA128;Gene
TAOK3;morphine;Chemical;PA134975064;Gene
RHBDF2;morphine;Chemical;PA134980674;Gene
SULT1A4;morphine;Chemical;PA142670856;Gene
CYP2D6*4;morphine;Chemical;PA165816579;Haplotype
RS324420;morphine;Chemical;PA166153569;Variant
RS2295632;morphine;Chemical;PA166153693;Variant
RS1042173;morphine;Chemical;PA166155172;Variant
RS4793665;morphine;Chemical;PA166155225;Variant
RS12948783;morphine;Chemical;PA166155254;Variant
RS1143634;morphine;Chemical;PA166155630;Variant
RS4680;morphine;Chemical;PA166156024;Variant
RS6269;morphine;Chemical;PA166156027;Variant
RS7438135;morphine;Chemical;PA166156617;Variant
RS7439366;morphine;Chemical;PA166156619;Variant
RS7668282;morphine;Chemical;PA166156626;Variant
RS1799971;morphine;Chemical;PA166156991;Variant
RS2075572;morphine;Chemical;PA166157015;Variant
RS72552763;morphine;Chemical;PA166157216;Variant
RS1045642;morphine;Chemical;PA166157284;Variant
RS1128503;morphine;Chemical;PA166157288;Variant
RS9282564;morphine;Chemical;PA166157435;Variant
RS1051660;morphine;Chemical;PA166157551;Variant
RS4141964;morphine;Chemical;PA166163281;Variant
RS3766246;morphine;Chemical;PA166163283;Variant
RS3804100;morphine;Chemical;PA166176322;Variant
RS767263838;morphine;Chemical;PA166179693;Variant
RS762151655;morphine;Chemical;PA166179694;Variant
RS757573592;morphine;Chemical;PA166179695;Variant
RS553050853;morphine;Chemical;PA166179697;Variant
RS751527244;morphine;Chemical;PA166179698;Variant
RS1293732453;morphine;Chemical;PA166179699;Variant
RS1328799050;morphine;Chemical;PA166179700;Variant
RS6517442;morphine;Chemical;PA166182219;Variant
RS795484;morphine;Chemical;PA166182407;Variant
RS1277441;morphine;Chemical;PA166182408;Variant
RS7824175;morphine;Chemical;PA166184290;Variant
ABCB1;morphine;Chemical;PA267;Gene
FAAH;morphine;Chemical;PA27955;Gene
IL1B;morphine;Chemical;PA29808;Gene
KCNJ6;morphine;Chemical;PA30049;Gene
SLC6A4;morphine;Chemical;PA312;Gene
OPRK1;morphine;Chemical;PA31943;Gene
OPRM1;morphine;Chemical;PA31945;Gene
SLC22A1;morphine;Chemical;PA329;Gene
SULT1A3;morphine;Chemical;PA344;Gene
UGT2B7;morphine;Chemical;PA361;Gene
TLR2;morphine;Chemical;PA36550;Gene
ABCC3;morphine;Chemical;PA376;Gene
ATRIAL FIBRILLATION;GGCX;Gene;PA443459;Disease
HEMORRHAGE;GGCX;Gene;PA444417;Disease
WARFARIN;GGCX;Gene;PA451906;Chemical
ACENOCOUMAROL;GGCX;Gene;PA452632;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs9597;Variant;PA443622;Disease
CISPLATIN;rs9597;Variant;PA449014;Chemical
IRINOTECAN;rs9597;Variant;PA450085;Chemical
CARBOCISTEINE;rs5030860;Variant;PA166184060;Chemical
L-PHENYLALANINE;rs5030860;Variant;PA450931;Chemical
CYP2B6;mirtazapine;Chemical;PA123;Gene
CYP2C19;mirtazapine;Chemical;PA124;Gene
CYP2C9;mirtazapine;Chemical;PA126;Gene
CYP2D6;mirtazapine;Chemical;PA128;Gene
TPH2;mirtazapine;Chemical;PA128747823;Gene
CYP3A4;mirtazapine;Chemical;PA130;Gene
CYP3A5;mirtazapine;Chemical;PA131;Gene
RABEP1;mirtazapine;Chemical;PA134884097;Gene
SH2B1;mirtazapine;Chemical;PA145148084;Gene
CYP2D6*1;mirtazapine;Chemical;PA165816576;Haplotype
CYP2D6*3;mirtazapine;Chemical;PA165816578;Haplotype
CYP2D6*4;mirtazapine;Chemical;PA165816579;Haplotype
CYP2D6*6;mirtazapine;Chemical;PA165816581;Haplotype
CYP2B6*1;mirtazapine;Chemical;PA165818750;Haplotype
CYP2B6*4;mirtazapine;Chemical;PA165818757;Haplotype
CYP2B6*5;mirtazapine;Chemical;PA165818760;Haplotype
CYP2B6*6;mirtazapine;Chemical;PA165818762;Haplotype
CYP2B6*7;mirtazapine;Chemical;PA165818765;Haplotype
CYP2D6*5;mirtazapine;Chemical;PA165948092;Haplotype
CYP2D6*1XN;mirtazapine;Chemical;PA165988479;Haplotype
CYP2D6*2XN;mirtazapine;Chemical;PA165988480;Haplotype
SLC6A4 HTTLPR LONG FORM (L ALLELE);mirtazapine;Chemical;PA166116465;Haplotype
SLC6A4 HTTLPR SHORT FORM (S ALLELE);mirtazapine;Chemical;PA166116466;Haplotype
RS948854;mirtazapine;Chemical;PA166154302;Variant
RS1487278;mirtazapine;Chemical;PA166154514;Variant
RS10879346;mirtazapine;Chemical;PA166154625;Variant
RS4713916;mirtazapine;Chemical;PA166157104;Variant
RS3888190;mirtazapine;Chemical;PA166165398;Variant
RS1000940;mirtazapine;Chemical;PA166165401;Variant
HTR2A;mirtazapine;Chemical;PA193;Gene
HTR2C;mirtazapine;Chemical;PA194;Gene
CYP1A2;mirtazapine;Chemical;PA27093;Gene
DRD2;mirtazapine;Chemical;PA27478;Gene
FKBP5;mirtazapine;Chemical;PA28162;Gene
GAL;mirtazapine;Chemical;PA28529;Gene
SLC6A4;mirtazapine;Chemical;PA312;Gene
POLG;mirtazapine;Chemical;PA33500;Gene
HLA-A;mirtazapine;Chemical;PA35055;Gene
HLA-B;mirtazapine;Chemical;PA35056;Gene
UGT1A4;mirtazapine;Chemical;PA37179;Gene
ASPIRIN-INDUCED ASTHMA;rs1074373;Variant;PA131285571;Disease
ASTHMA;rs1074373;Variant;PA443450;Disease
ASPIRIN;rs1074373;Variant;PA448497;Chemical
SEVERE CUTANEOUS ADVERSE REACTIONS;rs3094188;Variant;PA166120929;Disease
EPIDERMAL NECROLYSIS, TOXIC;rs3094188;Variant;PA444059;Disease
STEVENS-JOHNSON SYNDROME;rs3094188;Variant;PA445738;Disease
ALLOPURINOL;rs3094188;Variant;PA448320;Chemical
CAMK1D;JUN;Gene;PA134992438;Gene
AKT1;JUN;Gene;PA24684;Gene
AKT2;JUN;Gene;PA24685;Gene
AKT3;JUN;Gene;PA24686;Gene
CAMK1;JUN;Gene;PA26048;Gene
CAMK1G;JUN;Gene;PA26049;Gene
MAPK8;JUN;Gene;PA283;Gene
MAPK1;JUN;Gene;PA30616;Gene
MAPK14;JUN;Gene;PA30621;Gene
MAPK3;JUN;Gene;PA30622;Gene
STAT3;JUN;Gene;PA337;Gene
PRKCA;JUN;Gene;PA33759;Gene
PRKCB;JUN;Gene;PA33761;Gene
PRKCG;JUN;Gene;PA33766;Gene
STAT5A;JUN;Gene;PA338;Gene
STAT1;JUN;Gene;PA36183;Gene
STAT2;JUN;Gene;PA36184;Gene
STAT4;JUN;Gene;PA36185;Gene
STAT5B;JUN;Gene;PA36186;Gene
CAMK2A;JUN;Gene;PA90;Gene
CAMK2B;JUN;Gene;PA91;Gene
CAMK2D;JUN;Gene;PA92;Gene
CAMK2G;JUN;Gene;PA93;Gene
FLUOROURACIL;GNL3;Gene;PA128406956;Chemical
BREAST NEOPLASMS;GNL3;Gene;PA443560;Disease
NEUTROPENIA;GNL3;Gene;PA445113;Disease
CYCLOPHOSPHAMIDE;GNL3;Gene;PA449165;Chemical
EPIRUBICIN;GNL3;Gene;PA449476;Chemical
O-DESMETHYLTRAMADOL;rs762151655;Variant;PA166131379;Chemical
TAPENTADOL;rs762151655;Variant;PA166179720;Chemical
ACETAMINOPHEN;rs762151655;Variant;PA448015;Chemical
MORPHINE;rs762151655;Variant;PA450550;Chemical
TRAMADOL;rs762151655;Variant;PA451735;Chemical
C18ORF56;folic acid;Chemical;PA134956204;Gene
RS1801131;folic acid;Chemical;PA166153643;Variant
RS1801133;folic acid;Chemical;PA166153644;Variant
RS1805087;folic acid;Chemical;PA166153654;Variant
RS45445694;folic acid;Chemical;PA166155331;Variant
RS1801394;folic acid;Chemical;PA166156776;Variant
RS4986790;folic acid;Chemical;PA166157780;Variant
RS11280056;folic acid;Chemical;PA166180936;Variant
MTHFR;folic acid;Chemical;PA245;Gene
MTR;folic acid;Chemical;PA31272;Gene
MTRR;folic acid;Chemical;PA31277;Gene
TYMS;folic acid;Chemical;PA359;Gene
TLR4;folic acid;Chemical;PA36552;Gene
EPILEPSY;UGT1A6*4a;Haplotype;PA444065;Disease
VALPROIC ACID;UGT1A6*4a;Haplotype;PA451846;Chemical
RS6166;Infertility, Female;Disease;PA166155582;Variant
FSHR;Infertility, Female;Disease;PA28386;Gene
CYP2A6;zidovudine;Chemical;PA121;Gene
CYP2B6;zidovudine;Chemical;PA123;Gene
CYP2C9;zidovudine;Chemical;PA126;Gene
CYP2E1;zidovudine;Chemical;PA129;Gene
CYP3A4;zidovudine;Chemical;PA130;Gene
DTYMK;zidovudine;Chemical;PA150;Gene
CYP2B6*1;zidovudine;Chemical;PA165818750;Haplotype
CYP2B6*6;zidovudine;Chemical;PA165818762;Haplotype
UGT1A1*1;zidovudine;Chemical;PA166115841;Haplotype
UGT1A1*28;zidovudine;Chemical;PA166115842;Haplotype
UGT1A1*36;zidovudine;Chemical;PA166115843;Haplotype
UGT1A1*37;zidovudine;Chemical;PA166115844;Haplotype
RS11568695;zidovudine;Chemical;PA166154749;Variant
RS212091;zidovudine;Chemical;PA166154987;Variant
RS28365062;zidovudine;Chemical;PA166156676;Variant
ABCC1;zidovudine;Chemical;PA244;Gene
NME1;zidovudine;Chemical;PA249;Gene
NME2;zidovudine;Chemical;PA250;Gene
ABCB1;zidovudine;Chemical;PA267;Gene
POR;zidovudine;Chemical;PA33532;Gene
TK1;zidovudine;Chemical;PA352;Gene
SLC22A7;zidovudine;Chemical;PA35848;Gene
UGT2B7;zidovudine;Chemical;PA361;Gene
SLC22A11;zidovudine;Chemical;PA38295;Gene
SLC28A1;zidovudine;Chemical;PA387;Gene
SLC22A6;zidovudine;Chemical;PA388;Gene
SLC22A8;zidovudine;Chemical;PA389;Gene
ABCG2;zidovudine;Chemical;PA390;Gene
ABCC5;zidovudine;Chemical;PA395;Gene
ABCC4;zidovudine;Chemical;PA397;Gene
UGT1A1;zidovudine;Chemical;PA420;Gene
SLC28A3;zidovudine;Chemical;PA426;Gene
EFAVIRENZ;zidovudine;Chemical;PA449441;Chemical
CONGENITAL ABNORMALITIES;rs1051740;Variant;PA443223;Disease
EPILEPSY;rs1051740;Variant;PA444065;Disease
OVARIAN NEOPLASMS;rs1051740;Variant;PA445204;Disease
DISORDER OF FACIAL SKELETON;rs1051740;Variant;PA446836;Disease
CARBAMAZEPINE;rs1051740;Variant;PA448785;Chemical
CISPLATIN;rs1051740;Variant;PA449014;Chemical
CYCLOPHOSPHAMIDE;rs1051740;Variant;PA449165;Chemical
PHENPROCOUMON;rs1051740;Variant;PA450921;Chemical
PHENYTOIN;rs1051740;Variant;PA450947;Chemical
ABCC2;Carcinoma, Non-Small-Cell Lung;Disease;PA116;Gene
SLC31A1;Carcinoma, Non-Small-Cell Lung;Disease;PA118;Gene
CYP2A6;Carcinoma, Non-Small-Cell Lung;Disease;PA121;Gene
CYP2C8;Carcinoma, Non-Small-Cell Lung;Disease;PA125;Gene
CYP2D6;Carcinoma, Non-Small-Cell Lung;Disease;PA128;Gene
CYP3A4;Carcinoma, Non-Small-Cell Lung;Disease;PA130;Gene
CYP3A5;Carcinoma, Non-Small-Cell Lung;Disease;PA131;Gene
SLCO1B1;Carcinoma, Non-Small-Cell Lung;Disease;PA134865839;Gene
C6ORF15;Carcinoma, Non-Small-Cell Lung;Disease;PA134866404;Gene
PPP1R18;Carcinoma, Non-Small-Cell Lung;Disease;PA134918172;Gene
DOCK8;Carcinoma, Non-Small-Cell Lung;Disease;PA134918866;Gene
MUCL3;Carcinoma, Non-Small-Cell Lung;Disease;PA134926573;Gene
ATAT1;Carcinoma, Non-Small-Cell Lung;Disease;PA134948212;Gene
SLC29A3;Carcinoma, Non-Small-Cell Lung;Disease;PA134950750;Gene
HCP5;Carcinoma, Non-Small-Cell Lung;Disease;PA134951826;Gene
IKBKE;Carcinoma, Non-Small-Cell Lung;Disease;PA134962294;Gene
CXXC4;Carcinoma, Non-Small-Cell Lung;Disease;PA134992016;Gene
C8ORF34;Carcinoma, Non-Small-Cell Lung;Disease;PA142672353;Gene
DHFR;Carcinoma, Non-Small-Cell Lung;Disease;PA143;Gene
ERCC1;Carcinoma, Non-Small-Cell Lung;Disease;PA155;Gene
CMPK1;Carcinoma, Non-Small-Cell Lung;Disease;PA162382539;Gene
APLF;Carcinoma, Non-Small-Cell Lung;Disease;PA164715842;Gene
CYP2D6*1;Carcinoma, Non-Small-Cell Lung;Disease;PA165816576;Haplotype
CYP2D6*2;Carcinoma, Non-Small-Cell Lung;Disease;PA165816577;Haplotype
CYP2D6*10;Carcinoma, Non-Small-Cell Lung;Disease;PA165816582;Haplotype
CYP2A6*1;Carcinoma, Non-Small-Cell Lung;Disease;PA165924690;Haplotype
CYP2A6*4;Carcinoma, Non-Small-Cell Lung;Disease;PA165924721;Haplotype
CYP2A6*7;Carcinoma, Non-Small-Cell Lung;Disease;PA165924731;Haplotype
CYP2D6*5;Carcinoma, Non-Small-Cell Lung;Disease;PA165948092;Haplotype
CYP2A6*9;Carcinoma, Non-Small-Cell Lung;Disease;PA165980914;Haplotype
CYP3A5*1;Carcinoma, Non-Small-Cell Lung;Disease;PA166128213;Haplotype
CYP3A5*3;Carcinoma, Non-Small-Cell Lung;Disease;PA166128219;Haplotype
RS1065634;Carcinoma, Non-Small-Cell Lung;Disease;PA166153621;Variant
RS1801133;Carcinoma, Non-Small-Cell Lung;Disease;PA166153644;Variant
RS2072671;Carcinoma, Non-Small-Cell Lung;Disease;PA166153667;Variant
RS2234922;Carcinoma, Non-Small-Cell Lung;Disease;PA166153680;Variant
RS4492666;Carcinoma, Non-Small-Cell Lung;Disease;PA166153766;Variant
RS12118636;Carcinoma, Non-Small-Cell Lung;Disease;PA166153850;Variant
RS1127687;Carcinoma, Non-Small-Cell Lung;Disease;PA166153965;Variant
RS1409314;Carcinoma, Non-Small-Cell Lung;Disease;PA166153968;Variant
RS2227310;Carcinoma, Non-Small-Cell Lung;Disease;PA166153999;Variant
RS2299939;Carcinoma, Non-Small-Cell Lung;Disease;PA166154011;Variant
RS3740065;Carcinoma, Non-Small-Cell Lung;Disease;PA166154027;Variant
RS3740066;Carcinoma, Non-Small-Cell Lung;Disease;PA166154028;Variant
RS4353229;Carcinoma, Non-Small-Cell Lung;Disease;PA166154054;Variant
RS4752219;Carcinoma, Non-Small-Cell Lung;Disease;PA166154059;Variant
RS4752220;Carcinoma, Non-Small-Cell Lung;Disease;PA166154060;Variant
RS7091672;Carcinoma, Non-Small-Cell Lung;Disease;PA166154079;Variant
RS7921977;Carcinoma, Non-Small-Cell Lung;Disease;PA166154092;Variant
RS10510050;Carcinoma, Non-Small-Cell Lung;Disease;PA166154111;Variant
RS12415607;Carcinoma, Non-Small-Cell Lung;Disease;PA166154152;Variant
RS1695;Carcinoma, Non-Small-Cell Lung;Disease;PA166154249;Variant
RS232043;Carcinoma, Non-Small-Cell Lung;Disease;PA166154271;Variant
RS720106;Carcinoma, Non-Small-Cell Lung;Disease;PA166154298;Variant
RS2284449;Carcinoma, Non-Small-Cell Lung;Disease;PA166154365;Variant
RS12806698;Carcinoma, Non-Small-Cell Lung;Disease;PA166154468;Variant
RS61734430;Carcinoma, Non-Small-Cell Lung;Disease;PA166154476;Variant
RS4149015;Carcinoma, Non-Small-Cell Lung;Disease;PA166154574;Variant
RS4149056;Carcinoma, Non-Small-Cell Lung;Disease;PA166154579;Variant
RS7311358;Carcinoma, Non-Small-Cell Lung;Disease;PA166154602;Variant
RS10878232;Carcinoma, Non-Small-Cell Lung;Disease;PA166154624;Variant
RS12819505;Carcinoma, Non-Small-Cell Lung;Disease;PA166154645;Variant
RS6113;Carcinoma, Non-Small-Cell Lung;Disease;PA166154763;Variant
RS861539;Carcinoma, Non-Small-Cell Lung;Disease;PA166154768;Variant
RS2494752;Carcinoma, Non-Small-Cell Lung;Disease;PA166154795;Variant
RS2498804;Carcinoma, Non-Small-Cell Lung;Disease;PA166154797;Variant
RS2242046;Carcinoma, Non-Small-Cell Lung;Disease;PA166154881;Variant
RS11854484;Carcinoma, Non-Small-Cell Lung;Disease;PA166154934;Variant
RS9597;Carcinoma, Non-Small-Cell Lung;Disease;PA166154979;Variant
RS1799801;Carcinoma, Non-Small-Cell Lung;Disease;PA166155016;Variant
RS4541111;Carcinoma, Non-Small-Cell Lung;Disease;PA166155222;Variant
RS11868547;Carcinoma, Non-Small-Cell Lung;Disease;PA166155248;Variant
RS11615;Carcinoma, Non-Small-Cell Lung;Disease;PA166155342;Variant
RS13181;Carcinoma, Non-Small-Cell Lung;Disease;PA166155343;Variant
RS1052555;Carcinoma, Non-Small-Cell Lung;Disease;PA166155361;Variant
RS1799782;Carcinoma, Non-Small-Cell Lung;Disease;PA166155370;Variant
RS1799793;Carcinoma, Non-Small-Cell Lung;Disease;PA166155371;Variant
RS3212986;Carcinoma, Non-Small-Cell Lung;Disease;PA166155407;Variant
RS3213239;Carcinoma, Non-Small-Cell Lung;Disease;PA166155408;Variant
RS1143623;Carcinoma, Non-Small-Cell Lung;Disease;PA166155628;Variant
RS3738948;Carcinoma, Non-Small-Cell Lung;Disease;PA166155704;Variant
RS3832043;Carcinoma, Non-Small-Cell Lung;Disease;PA166155718;Variant
RS17309872;Carcinoma, Non-Small-Cell Lung;Disease;PA166155966;Variant
RS914232;Carcinoma, Non-Small-Cell Lung;Disease;PA166155984;Variant
RS1051266;Carcinoma, Non-Small-Cell Lung;Disease;PA166155986;Variant
RS1051298;Carcinoma, Non-Small-Cell Lung;Disease;PA166155988;Variant
RS3788189;Carcinoma, Non-Small-Cell Lung;Disease;PA166156005;Variant
RS9981861;Carcinoma, Non-Small-Cell Lung;Disease;PA166156013;Variant
RS2269577;Carcinoma, Non-Small-Cell Lung;Disease;PA166156092;Variant
RS870995;Carcinoma, Non-Small-Cell Lung;Disease;PA166156297;Variant
RS2699887;Carcinoma, Non-Small-Cell Lung;Disease;PA166156362;Variant
RS11710163;Carcinoma, Non-Small-Cell Lung;Disease;PA166156444;Variant
RS2231137;Carcinoma, Non-Small-Cell Lung;Disease;PA166156543;Variant
RS2231142;Carcinoma, Non-Small-Cell Lung;Disease;PA166156544;Variant
RS4413407;Carcinoma, Non-Small-Cell Lung;Disease;PA166156586;Variant
RS442767;Carcinoma, Non-Small-Cell Lung;Disease;PA166156733;Variant
RS1382368;Carcinoma, Non-Small-Cell Lung;Disease;PA166156761;Variant
RS1650697;Carcinoma, Non-Small-Cell Lung;Disease;PA166156770;Variant
RS16886403;Carcinoma, Non-Small-Cell Lung;Disease;PA166156882;Variant
RS316019;Carcinoma, Non-Small-Cell Lung;Disease;PA166156913;Variant
RS451774;Carcinoma, Non-Small-Cell Lung;Disease;PA166156918;Variant
RS1800629;Carcinoma, Non-Small-Cell Lung;Disease;PA166156997;Variant
RS1045642;Carcinoma, Non-Small-Cell Lung;Disease;PA166157284;Variant
RS1128503;Carcinoma, Non-Small-Cell Lung;Disease;PA166157288;Variant
RS2227983;Carcinoma, Non-Small-Cell Lung;Disease;PA166157331;Variant
RS2293347;Carcinoma, Non-Small-Cell Lung;Disease;PA166157355;Variant
RS7779029;Carcinoma, Non-Small-Cell Lung;Disease;PA166157427;Variant
RS12721627;Carcinoma, Non-Small-Cell Lung;Disease;PA166157460;Variant
RS121434568;Carcinoma, Non-Small-Cell Lung;Disease;PA166157527;Variant
RS121434569;Carcinoma, Non-Small-Cell Lung;Disease;PA166157528;Variant
RS1517114;Carcinoma, Non-Small-Cell Lung;Disease;PA166157561;Variant
RS3780126;Carcinoma, Non-Small-Cell Lung;Disease;PA166157594;Variant
RS11545078;Carcinoma, Non-Small-Cell Lung;Disease;PA166157634;Variant
RS430397;Carcinoma, Non-Small-Cell Lung;Disease;PA166157705;Variant
RS1800975;Carcinoma, Non-Small-Cell Lung;Disease;PA166157737;Variant
RS7851395;Carcinoma, Non-Small-Cell Lung;Disease;PA166157789;Variant
RS10981694;Carcinoma, Non-Small-Cell Lung;Disease;PA166157825;Variant
RS518329;Carcinoma, Non-Small-Cell Lung;Disease;PA166157855;Variant
RS11568315;Carcinoma, Non-Small-Cell Lung;Disease;PA166158794;Variant
RS50872;Carcinoma, Non-Small-Cell Lung;Disease;PA166159977;Variant
RS7170924;Carcinoma, Non-Small-Cell Lung;Disease;PA166159979;Variant
RS1690924;Carcinoma, Non-Small-Cell Lung;Disease;PA166159981;Variant
RS12621220;Carcinoma, Non-Small-Cell Lung;Disease;PA166159984;Variant
RS2228000;Carcinoma, Non-Small-Cell Lung;Disease;PA166171094;Variant
RS780668;Carcinoma, Non-Small-Cell Lung;Disease;PA166179108;Variant
RS2228130;Carcinoma, Non-Small-Cell Lung;Disease;PA166179122;Variant
CYP2D6*114;Carcinoma, Non-Small-Cell Lung;Disease;PA166181184;Haplotype
CYP2D6*14;Carcinoma, Non-Small-Cell Lung;Disease;PA166181185;Haplotype
RS5877;Carcinoma, Non-Small-Cell Lung;Disease;PA166201501;Variant
RS3094086;Carcinoma, Non-Small-Cell Lung;Disease;PA166201502;Variant
RS1049709;Carcinoma, Non-Small-Cell Lung;Disease;PA166201503;Variant
RS10885;Carcinoma, Non-Small-Cell Lung;Disease;PA166201504;Variant
RS3115672;Carcinoma, Non-Small-Cell Lung;Disease;PA166201505;Variant
RS9262132;Carcinoma, Non-Small-Cell Lung;Disease;PA166201521;Variant
RS9262143;Carcinoma, Non-Small-Cell Lung;Disease;PA166201522;Variant
RS886424;Carcinoma, Non-Small-Cell Lung;Disease;PA166201523;Variant
RS886423;Carcinoma, Non-Small-Cell Lung;Disease;PA166201524;Variant
RS2233980;Carcinoma, Non-Small-Cell Lung;Disease;PA166201525;Variant
RS3130985;Carcinoma, Non-Small-Cell Lung;Disease;PA166201526;Variant
RS3130907;Carcinoma, Non-Small-Cell Lung;Disease;PA166201527;Variant
RS11229;Carcinoma, Non-Small-Cell Lung;Disease;PA166201528;Variant
RS10491684;Carcinoma, Non-Small-Cell Lung;Disease;PA166201541;Variant
RS1058932;Carcinoma, Non-Small-Cell Lung;Disease;PA166201542;Variant
RS11572078;Carcinoma, Non-Small-Cell Lung;Disease;PA166201543;Variant
RS6118;Carcinoma, Non-Small-Cell Lung;Disease;PA166201545;Variant
RS6119;Carcinoma, Non-Small-Cell Lung;Disease;PA166201546;Variant
RS6504649;Carcinoma, Non-Small-Cell Lung;Disease;PA166201547;Variant
RS73450548;Carcinoma, Non-Small-Cell Lung;Disease;PA166201561;Variant
RS11227247;Carcinoma, Non-Small-Cell Lung;Disease;PA166203341;Variant
RS2272733;Carcinoma, Non-Small-Cell Lung;Disease;PA166203342;Variant
RS12142086;Carcinoma, Non-Small-Cell Lung;Disease;PA166203343;Variant
RS2151222;Carcinoma, Non-Small-Cell Lung;Disease;PA166203361;Variant
RS3748022;Carcinoma, Non-Small-Cell Lung;Disease;PA166203403;Variant
RS2233406;Carcinoma, Non-Small-Cell Lung;Disease;PA166203407;Variant
RS2233407;Carcinoma, Non-Small-Cell Lung;Disease;PA166203408;Variant
RS2233409;Carcinoma, Non-Small-Cell Lung;Disease;PA166203409;Variant
RS8904;Carcinoma, Non-Small-Cell Lung;Disease;PA166203410;Variant
RS2695121;Carcinoma, Non-Small-Cell Lung;Disease;PA166203413;Variant
RS9694958;Carcinoma, Non-Small-Cell Lung;Disease;PA166203441;Variant
ACSS2;Carcinoma, Non-Small-Cell Lung;Disease;PA24429;Gene
MTHFR;Carcinoma, Non-Small-Cell Lung;Disease;PA245;Gene
AKT1;Carcinoma, Non-Small-Cell Lung;Disease;PA24684;Gene
ALK;Carcinoma, Non-Small-Cell Lung;Disease;PA24719;Gene
AXIN2;Carcinoma, Non-Small-Cell Lung;Disease;PA25196;Gene
PRRC2A;Carcinoma, Non-Small-Cell Lung;Disease;PA25263;Gene
CASP7;Carcinoma, Non-Small-Cell Lung;Disease;PA26091;Gene
CDSN;Carcinoma, Non-Small-Cell Lung;Disease;PA26348;Gene
ABCB1;Carcinoma, Non-Small-Cell Lung;Disease;PA267;Gene
DSCAM;Carcinoma, Non-Small-Cell Lung;Disease;PA27491;Gene
EIF3A;Carcinoma, Non-Small-Cell Lung;Disease;PA27699;Gene
EPHX1;Carcinoma, Non-Small-Cell Lung;Disease;PA27829;Gene
ERCC2;Carcinoma, Non-Small-Cell Lung;Disease;PA27848;Gene
ERCC3;Carcinoma, Non-Small-Cell Lung;Disease;PA27849;Gene
ERCC4;Carcinoma, Non-Small-Cell Lung;Disease;PA27850;Gene
ETS2;Carcinoma, Non-Small-Cell Lung;Disease;PA27903;Gene
FOLR3;Carcinoma, Non-Small-Cell Lung;Disease;PA28211;Gene
GPX5;Carcinoma, Non-Small-Cell Lung;Disease;PA28953;Gene
GSTP1;Carcinoma, Non-Small-Cell Lung;Disease;PA29028;Gene
HSPA5;Carcinoma, Non-Small-Cell Lung;Disease;PA29504;Gene
RELA;Carcinoma, Non-Small-Cell Lung;Disease;PA296;Gene
IKBKB;Carcinoma, Non-Small-Cell Lung;Disease;PA29776;Gene
IL16;Carcinoma, Non-Small-Cell Lung;Disease;PA29793;Gene
RRM1;Carcinoma, Non-Small-Cell Lung;Disease;PA298;Gene
IL1B;Carcinoma, Non-Small-Cell Lung;Disease;PA29808;Gene
KRAS;Carcinoma, Non-Small-Cell Lung;Disease;PA30196;Gene
MAP3K1;Carcinoma, Non-Small-Cell Lung;Disease;PA30592;Gene
MDM2;Carcinoma, Non-Small-Cell Lung;Disease;PA30718;Gene
MSH5;Carcinoma, Non-Small-Cell Lung;Disease;PA31136;Gene
NFKBIA;Carcinoma, Non-Small-Cell Lung;Disease;PA31601;Gene
NR1H2;Carcinoma, Non-Small-Cell Lung;Disease;PA31750;Gene
NRAS;Carcinoma, Non-Small-Cell Lung;Disease;PA31768;Gene
SLC19A1;Carcinoma, Non-Small-Cell Lung;Disease;PA327;Gene
SLC22A2;Carcinoma, Non-Small-Cell Lung;Disease;PA331;Gene
PIK3CA;Carcinoma, Non-Small-Cell Lung;Disease;PA33308;Gene
POLR2A;Carcinoma, Non-Small-Cell Lung;Disease;PA33507;Gene
PRDX4;Carcinoma, Non-Small-Cell Lung;Disease;PA33725;Gene
PSORS1C1;Carcinoma, Non-Small-Cell Lung;Disease;PA33919;Gene
PTEN;Carcinoma, Non-Small-Cell Lung;Disease;PA33942;Gene
RAF1;Carcinoma, Non-Small-Cell Lung;Disease;PA34183;Gene
ROS1;Carcinoma, Non-Small-Cell Lung;Disease;PA34633;Gene
SERPINC1;Carcinoma, Non-Small-Cell Lung;Disease;PA35026;Gene
HLA-C;Carcinoma, Non-Small-Cell Lung;Disease;PA35057;Gene
SERPINA5;Carcinoma, Non-Small-Cell Lung;Disease;PA35505;Gene
SEMA3C;Carcinoma, Non-Small-Cell Lung;Disease;PA35647;Gene
SLCO1B3;Carcinoma, Non-Small-Cell Lung;Disease;PA35844;Gene
XPA;Carcinoma, Non-Small-Cell Lung;Disease;PA368;Gene
XRCC1;Carcinoma, Non-Small-Cell Lung;Disease;PA369;Gene
UBE2I;Carcinoma, Non-Small-Cell Lung;Disease;PA37134;Gene
XBP1;Carcinoma, Non-Small-Cell Lung;Disease;PA37400;Gene
XPC;Carcinoma, Non-Small-Cell Lung;Disease;PA37413;Gene
XRCC3;Carcinoma, Non-Small-Cell Lung;Disease;PA37422;Gene
XRCC4;Carcinoma, Non-Small-Cell Lung;Disease;PA37423;Gene
XYLT2;Carcinoma, Non-Small-Cell Lung;Disease;PA37974;Gene
WNT5B;Carcinoma, Non-Small-Cell Lung;Disease;PA38104;Gene
WIF1;Carcinoma, Non-Small-Cell Lung;Disease;PA38291;Gene
SLC28A2;Carcinoma, Non-Small-Cell Lung;Disease;PA386;Gene
SLC28A1;Carcinoma, Non-Small-Cell Lung;Disease;PA387;Gene
ABCG2;Carcinoma, Non-Small-Cell Lung;Disease;PA390;Gene
UGT1A9;Carcinoma, Non-Small-Cell Lung;Disease;PA419;Gene
GGH;Carcinoma, Non-Small-Cell Lung;Disease;PA432;Gene
TNF;Carcinoma, Non-Small-Cell Lung;Disease;PA435;Gene
EGFR;Carcinoma, Non-Small-Cell Lung;Disease;PA7360;Gene
CAMK2D;Carcinoma, Non-Small-Cell Lung;Disease;PA92;Gene
CDA;Carcinoma, Non-Small-Cell Lung;Disease;PA98;Gene
GEFITINIB;NFKBIA;Gene;PA131301952;Chemical
TOXIC LIVER DISEASE;NFKBIA;Gene;PA164925725;Disease
NON-SMALL CELL LUNG CARCINOMA;NFKBIA;Gene;PA443622;Disease
DIARRHEA;NFKBIA;Gene;PA443899;Disease
EXANTHEMA;NFKBIA;Gene;PA444109;Disease
PAIN, POSTOPERATIVE;NFKBIA;Gene;PA445210;Disease
SUFENTANIL;NFKBIA;Gene;PA451527;Chemical
ACE;captopril;Chemical;PA139;Gene
RS4291;captopril;Chemical;PA166155143;Variant
RS1799752;captopril;Chemical;PA166155187;Variant
RS5186;captopril;Chemical;PA166156276;Variant
RS2106809;captopril;Chemical;PA166157865;Variant
ACE2;captopril;Chemical;PA425;Gene
AGTR1;captopril;Chemical;PA43;Gene
DPYD;rs139834141;Variant;PA145;Gene
CAPECITABINE;rs139834141;Variant;PA448771;Chemical
ANTITHYROID PREPARATIONS;EHMT2;Gene;PA164712499;Chemical
AGRANULOCYTOSIS;EHMT2;Gene;PA443297;Disease
SCHIZOPHRENIA;rs951439;Variant;PA447216;Disease
OLANZAPINE;rs951439;Variant;PA450688;Chemical
PERPHENAZINE;rs951439;Variant;PA450882;Chemical
QUETIAPINE;rs951439;Variant;PA451201;Chemical
RISPERIDONE;rs951439;Variant;PA451257;Chemical
ZIPRASIDONE;rs951439;Variant;PA451974;Chemical
ANTIPSYCHOTICS;rs951439;Variant;PA452233;Chemical
DPYD;Mental Retardation;Disease;PA145;Gene
PLATINUM COMPOUNDS;rs12621220;Variant;PA164713176;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs12621220;Variant;PA443622;Disease
GEFITINIB;rs9694958;Variant;PA131301952;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs9694958;Variant;PA443622;Disease
EXANTHEMA;rs9694958;Variant;PA444109;Disease
SUBSTANCE-RELATED DISORDERS;rs2381356;Variant;PA446876;Disease
DDX58;MAVS;Gene;PA134994272;Gene
IRF3;MAVS;Gene;PA29917;Gene
IRF7;MAVS;Gene;PA29921;Gene
RS121913500;olutasidenib;Chemical;PA166182713;Variant
RS121913499;olutasidenib;Chemical;PA166293901;Variant
IDH1;olutasidenib;Chemical;PA29630;Gene
WARFARIN;rs17880887;Variant;PA451906;Chemical
AXITINIB;rs11549465;Variant;PA164924493;Chemical
SORAFENIB;rs11549465;Variant;PA7000;Chemical
RHEUMATOID ARTHRITIS;rs2298383;Variant;PA443434;Disease
HEMATOLOGIC NEOPLASMS;rs2298383;Variant;PA446827;Disease
CAFFEINE;rs2298383;Variant;PA448710;Chemical
METHOTREXATE;rs2298383;Variant;PA450428;Chemical
NAGS;glycerol phenylbutyrate;Chemical;PA134968729;Gene
ASS1;glycerol phenylbutyrate;Chemical;PA162376926;Gene
ARG1;glycerol phenylbutyrate;Chemical;PA24947;Gene
ASL;glycerol phenylbutyrate;Chemical;PA25046;Gene
CPS1;glycerol phenylbutyrate;Chemical;PA26840;Gene
OTC;glycerol phenylbutyrate;Chemical;PA32840;Gene
DULOXETINE;rs3128624;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs3128624;Variant;PA447321;Disease
HEROIN DEPENDENCE;rs2298897;Variant;PA444460;Disease
HEROIN;rs2298897;Variant;PA452619;Chemical
NALTREXONE;rs3829125;Variant;PA450588;Chemical
CFTR;rs78655421;Variant;PA109;Gene
IVACAFTOR;rs78655421;Variant;PA165950341;Chemical
IVACAFTOR / LUMACAFTOR;rs78655421;Variant;PA166152935;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs78655421;Variant;PA166190041;Chemical
CYSTIC FIBROSIS;rs78655421;Variant;PA443829;Disease
SCHIZOPHRENIA;rs1544938;Variant;PA447216;Disease
ANTIPSYCHOTICS;rs1544938;Variant;PA452233;Chemical
RADIOTHERAPY;rs10497203;Variant;PA166122986;Chemical
PROSTATIC NEOPLASMS;rs10497203;Variant;PA445425;Disease
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs6941263;Variant;PA164713366;Chemical
RS316019;l-tryptophan;Chemical;PA166156913;Variant
SLC22A2;l-tryptophan;Chemical;PA331;Gene
TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS;rs352139;Variant;PA164713366;Chemical
CROHN DISEASE;rs352139;Variant;PA443815;Disease
PSORIASIS;rs352139;Variant;PA445451;Disease
INFLAMMATORY BOWEL DISEASES;rs352139;Variant;PA446116;Disease
LAPATINIB;ESR1;Gene;PA152241907;Chemical
ALKYLATING AGENTS;ESR1;Gene;PA164712331;Chemical
EVEROLIMUS;ESR1;Gene;PA164746311;Chemical
FULVESTRANT;ESR1;Gene;PA164747170;Chemical
GOSERELIN;ESR1;Gene;PA164747674;Chemical
CONJUGATED ESTROGENS;ESR1;Gene;PA164754789;Chemical
OLAPARIB;ESR1;Gene;PA164920420;Chemical
IXABEPILONE;ESR1;Gene;PA165110439;Chemical
PERTUZUMAB;ESR1;Gene;PA165290933;Chemical
NERATINIB;ESR1;Gene;PA165291472;Chemical
MENOPAUSE;ESR1;Gene;PA166048848;Disease
PALBOCICLIB;ESR1;Gene;PA166153469;Chemical
RIBOCICLIB;ESR1;Gene;PA166153470;Chemical
ABEMACICLIB;ESR1;Gene;PA166153471;Chemical
ERIBULIN;ESR1;Gene;PA166182723;Chemical
ALPELISIB;ESR1;Gene;PA166184523;Chemical
TRASTUZUMAB DERUXTECAN;ESR1;Gene;PA166190621;Chemical
SACITUZUMAB GOVITECAN;ESR1;Gene;PA166225061;Chemical
ELACESTRANT;ESR1;Gene;PA166313327;Chemical
CAPIVASERTIB;ESR1;Gene;PA166328761;Chemical
INAVOLISIB;ESR1;Gene;PA166400101;Chemical
UGT2B7;ESR1;Gene;PA361;Gene
UGT2B10;ESR1;Gene;PA37186;Gene
UGT2B15;ESR1;Gene;PA37188;Gene
RHEUMATOID ARTHRITIS;ESR1;Gene;PA443434;Disease
BREAST NEOPLASMS;ESR1;Gene;PA443560;Disease
NEOPLASMS;ESR1;Gene;PA445062;Disease
PSYCHOTIC DISORDER;ESR1;Gene;PA447215;Disease
SCHIZOPHRENIA;ESR1;Gene;PA447216;Disease
ANASTROZOLE;ESR1;Gene;PA448432;Chemical
CISPLATIN;ESR1;Gene;PA449014;Chemical
DOCETAXEL;ESR1;Gene;PA449383;Chemical
DOXYCYCLINE;ESR1;Gene;PA449415;Chemical
EXEMESTANE;ESR1;Gene;PA449563;Chemical
LEFLUNOMIDE;ESR1;Gene;PA450192;Chemical
LETROZOLE;ESR1;Gene;PA450196;Chemical
MEDROXYPROGESTERONE;ESR1;Gene;PA450344;Chemical
METHAMPHETAMINE;ESR1;Gene;PA450403;Chemical
RALOXIFENE;ESR1;Gene;PA451221;Chemical
TAMOXIFEN;ESR1;Gene;PA451581;Chemical
TOREMIFENE;ESR1;Gene;PA451731;Chemical
TRASTUZUMAB;ESR1;Gene;PA451743;Chemical
CETUXIMAB;rs13104811;Variant;PA10040;Chemical
PANITUMUMAB;rs13104811;Variant;PA162373091;Chemical
COLORECTAL NEOPLASMS;rs13104811;Variant;PA446108;Disease
IRINOTECAN;rs13104811;Variant;PA450085;Chemical
BUFURALOL;CYP2D6*51;Haplotype;PA166110256;Chemical
N-DESMETHYLTAMOXIFEN;CYP2D6*51;Haplotype;PA166127651;Chemical
DEXTROMETHORPHAN;CYP2D6*51;Haplotype;PA449273;Chemical
PRIMAQUINE;CYP2D6*51;Haplotype;PA451103;Chemical
HALOPERIDOL;TOR1A;Gene;PA449841;Chemical
PLATELET AGGREGATION;rs5853517;Variant;PA166123766;Disease
CLOPIDOGREL;rs5853517;Variant;PA449053;Chemical
ASPIRIN;rs28360521;Variant;PA448497;Chemical
CFTR;ivacaftor;Chemical;PA109;Gene
RS74503330;ivacaftor;Chemical;PA166157511;Variant
RS75039782;ivacaftor;Chemical;PA166157514;Variant
RS75527207;ivacaftor;Chemical;PA166157516;Variant
RS77010898;ivacaftor;Chemical;PA166157518;Variant
RS78655421;ivacaftor;Chemical;PA166157519;Variant
RS80282562;ivacaftor;Chemical;PA166157521;Variant
RS113993960;ivacaftor;Chemical;PA166157525;Variant
RS121908755;ivacaftor;Chemical;PA166157529;Variant
RS121908757;ivacaftor;Chemical;PA166157530;Variant
RS121909005;ivacaftor;Chemical;PA166157531;Variant
RS121909013;ivacaftor;Chemical;PA166157532;Variant
RS121909041;ivacaftor;Chemical;PA166157533;Variant
RS193922525;ivacaftor;Chemical;PA166157534;Variant
RS267606723;ivacaftor;Chemical;PA166157537;Variant
RS77932196;ivacaftor;Chemical;PA166161186;Variant
RS121909011;ivacaftor;Chemical;PA166161188;Variant
RS80224560;ivacaftor;Chemical;PA166162698;Variant
RS74551128;ivacaftor;Chemical;PA166162705;Variant
RS7512462;ivacaftor;Chemical;PA166162981;Variant
RS397508256;ivacaftor;Chemical;PA166164939;Variant
RS368505753;ivacaftor;Chemical;PA166164940;Variant
RS115545701;ivacaftor;Chemical;PA166164941;Variant
RS397508537;ivacaftor;Chemical;PA166164942;Variant
RS113993958;ivacaftor;Chemical;PA166164943;Variant
RS77834169;ivacaftor;Chemical;PA166164944;Variant
RS397508759;ivacaftor;Chemical;PA166164945;Variant
RS121908752;ivacaftor;Chemical;PA166164946;Variant
RS121908753;ivacaftor;Chemical;PA166164947;Variant
RS397508288;ivacaftor;Chemical;PA166164948;Variant
RS397508442;ivacaftor;Chemical;PA166164949;Variant
RS141033578;ivacaftor;Chemical;PA166164950;Variant
RS150212784;ivacaftor;Chemical;PA166164951;Variant
RS397508513;ivacaftor;Chemical;PA166164952;Variant
RS121909020;ivacaftor;Chemical;PA166164953;Variant
RS200321110;ivacaftor;Chemical;PA166164954;Variant
RS78769542;ivacaftor;Chemical;PA166164955;Variant
RS202179988;ivacaftor;Chemical;PA166164956;Variant
RS186045772;ivacaftor;Chemical;PA166164957;Variant
RS75541969;ivacaftor;Chemical;PA166164958;Variant
RS11971167;ivacaftor;Chemical;PA166164959;Variant
RS34911792;ivacaftor;Chemical;PA166178021;Variant
RS1800100;ivacaftor;Chemical;PA166178025;Variant
RS1800111;ivacaftor;Chemical;PA166178032;Variant
RS121909019;ivacaftor;Chemical;PA166178049;Variant
RS77409459;ivacaftor;Chemical;PA166178052;Variant
RS397508139;ivacaftor;Chemical;PA166178058;Variant
RS397508510;ivacaftor;Chemical;PA166178060;Variant
RS397508328;ivacaftor;Chemical;PA166178063;Variant
RS397508435;ivacaftor;Chemical;PA166178067;Variant
RS121909047;ivacaftor;Chemical;PA166178088;Variant
RS397508453;ivacaftor;Chemical;PA166178138;Variant
RS397508602;ivacaftor;Chemical;PA166178193;Variant
RS76151804;ivacaftor;Chemical;PA166184909;Variant
RS397508761;ivacaftor;Chemical;PA166196981;Variant
RS397508387;ivacaftor;Chemical;PA166196982;Variant
RS186089140;ivacaftor;Chemical;PA166299361;Variant
RS35516286;ivacaftor;Chemical;PA166365261;Variant
RS397508783;ivacaftor;Chemical;PA166394302;Variant
RS397508556;ivacaftor;Chemical;PA166394341;Variant
RS2116683801;ivacaftor;Chemical;PA166394421;Variant
RS74571530;ivacaftor;Chemical;PA166394481;Variant
RS397508621;ivacaftor;Chemical;PA166394521;Variant
RS397508573;ivacaftor;Chemical;PA166394541;Variant
RS397508572;ivacaftor;Chemical;PA166394581;Variant
RS397508784;ivacaftor;Chemical;PA166394641;Variant
RS1800076;ivacaftor;Chemical;PA166394661;Variant
RS397508300;ivacaftor;Chemical;PA166394662;Variant
RS397508744;ivacaftor;Chemical;PA166394681;Variant
RS1800103;ivacaftor;Chemical;PA166394701;Variant
RS201958172;ivacaftor;Chemical;PA166394721;Variant
RS769016520;ivacaftor;Chemical;PA166394741;Variant
RS121909021;ivacaftor;Chemical;PA166394761;Variant
RS397508748;ivacaftor;Chemical;PA166394762;Variant
RS1800079;ivacaftor;Chemical;PA166394781;Variant
RS144476686;ivacaftor;Chemical;PA166394801;Variant
RS376008630;ivacaftor;Chemical;PA166394802;Variant
RS1800110;ivacaftor;Chemical;PA166394821;Variant
RS75763344;ivacaftor;Chemical;PA166394841;Variant
RS758818611;ivacaftor;Chemical;PA166394842;Variant
RS140883683;ivacaftor;Chemical;PA166394861;Variant
RS121909044;ivacaftor;Chemical;PA166394862;Variant
RS397508758;ivacaftor;Chemical;PA166394881;Variant
RS397508721;ivacaftor;Chemical;PA166394901;Variant
RS1800097;ivacaftor;Chemical;PA166394921;Variant
RS1800098;ivacaftor;Chemical;PA166394941;Variant
RS151048781;ivacaftor;Chemical;PA166394961;Variant
RS145449046;ivacaftor;Chemical;PA166394981;Variant
RS150157202;ivacaftor;Chemical;PA166394982;Variant
RS201759207;ivacaftor;Chemical;PA166394983;Variant
RS386134230;ivacaftor;Chemical;PA166395001;Variant
RS142773283;ivacaftor;Chemical;PA166395021;Variant
RS397508436;ivacaftor;Chemical;PA166395041;Variant
RS397508616;ivacaftor;Chemical;PA166395061;Variant
RS149279509;ivacaftor;Chemical;PA166395081;Variant
RS397508785;ivacaftor;Chemical;PA166395101;Variant
RS1800120;ivacaftor;Chemical;PA166395102;Variant
RS144055758;ivacaftor;Chemical;PA166395121;Variant
RS397508153;ivacaftor;Chemical;PA166395141;Variant
RS77902683;ivacaftor;Chemical;PA166395161;Variant
RS397508378;ivacaftor;Chemical;PA166395162;Variant
RS397508440;ivacaftor;Chemical;PA166395163;Variant
RS397508678;ivacaftor;Chemical;PA166395181;Variant
RS1800112;ivacaftor;Chemical;PA166395301;Variant
SLC26A9;ivacaftor;Chemical;PA37886;Gene
MUSCULAR DISEASES;rs4363657;Variant;PA444997;Disease
SIMVASTATIN;rs4363657;Variant;PA451363;Chemical
PRKAA1;MLXIPL;Gene;PA33744;Gene
PRKAA2;MLXIPL;Gene;PA33745;Gene
PRKAB1;MLXIPL;Gene;PA33746;Gene
PRKAB2;MLXIPL;Gene;PA33747;Gene
PRKAG1;MLXIPL;Gene;PA33751;Gene
PRKAG2;MLXIPL;Gene;PA33752;Gene
PRKAG3;MLXIPL;Gene;PA33753;Gene
PULMONARY FIBROSIS;TOLLIP;Gene;PA445468;Disease
ACETYLCYSTEINE;TOLLIP;Gene;PA448033;Chemical
HLA-A*11:01;levetiracetam;Chemical;PA165953358;Haplotype
RS2298771;levetiracetam;Chemical;PA166155680;Variant
ABCB1;levetiracetam;Chemical;PA267;Gene
SCN1A;levetiracetam;Chemical;PA301;Gene
HLA-A;levetiracetam;Chemical;PA35055;Gene
ACENOCOUMAROL;rs1998591;Variant;PA452632;Chemical
DEFERASIROX;rs2585428;Variant;PA164760843;Chemical
TELAPREVIR;rs2585428;Variant;PA165958354;Chemical
HEPATITIS C VIRUS INFECTION;rs2585428;Variant;PA444445;Disease
BETA-THALASSEMIA AND RELATED DISEASES;rs2585428;Variant;PA446432;Disease
DULOXETINE;rs13204353;Variant;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;rs13204353;Variant;PA447321;Disease
BREAST NEOPLASMS;rs773123;Variant;PA443560;Disease
CARBOPLATIN;rs773123;Variant;PA448803;Chemical
DOCETAXEL;rs773123;Variant;PA449383;Chemical
TRASTUZUMAB;rs773123;Variant;PA451743;Chemical
DPYD;rs112766203;Variant;PA145;Gene
CAPECITABINE;rs112766203;Variant;PA448771;Chemical
BETA-THALASSEMIA AND RELATED DISEASES;rs9483947;Variant;PA446432;Disease
HYDROXYUREA;rs9483947;Variant;PA449942;Chemical
CYP2C19;ibuprofen;Chemical;PA124;Gene
CYP2C8;ibuprofen;Chemical;PA125;Gene
CYP2C9;ibuprofen;Chemical;PA126;Gene
CYP3A4;ibuprofen;Chemical;PA130;Gene
NOS2;ibuprofen;Chemical;PA164724093;Gene
CYP2C9*1;ibuprofen;Chemical;PA165816542;Haplotype
CYP2C9*2;ibuprofen;Chemical;PA165816543;Haplotype
CYP2C9*3;ibuprofen;Chemical;PA165816544;Haplotype
CYP3A4*1;ibuprofen;Chemical;PA165819201;Haplotype
CYP3A4*4;ibuprofen;Chemical;PA165819222;Haplotype
CYP3A4*5;ibuprofen;Chemical;PA165819223;Haplotype
CYP3A4*18;ibuprofen;Chemical;PA165819240;Haplotype
CYP2C8*2;ibuprofen;Chemical;PA165958684;Haplotype
CYP2C8*3;ibuprofen;Chemical;PA165958685;Haplotype
CYP2C8*4;ibuprofen;Chemical;PA165958686;Haplotype
CYP2C19*1;ibuprofen;Chemical;PA165980634;Haplotype
CYP2C19*3;ibuprofen;Chemical;PA165980636;Haplotype
CYP3A4*23;ibuprofen;Chemical;PA166115836;Haplotype
CYP2C19*30;ibuprofen;Chemical;PA166123293;Haplotype
CYP2C19*31;ibuprofen;Chemical;PA166123294;Haplotype
CYP2C19*32;ibuprofen;Chemical;PA166123295;Haplotype
CYP2C19*33;ibuprofen;Chemical;PA166123296;Haplotype
CYP2C19*35;ibuprofen;Chemical;PA166128094;Haplotype
RS20417;ibuprofen;Chemical;PA166153559;Variant
RS1800629;ibuprofen;Chemical;PA166156997;Variant
RS6500265;ibuprofen;Chemical;PA166176206;Variant
RS9933632;ibuprofen;Chemical;PA166176208;Variant
CYP2C8*1;ibuprofen;Chemical;PA166242948;Haplotype
CYP3A4*28;ibuprofen;Chemical;PA166245584;Haplotype
CYP3A4*29;ibuprofen;Chemical;PA166245585;Haplotype
CYP3A4*31;ibuprofen;Chemical;PA166245587;Haplotype
CYP3A4*32;ibuprofen;Chemical;PA166245588;Haplotype
CYP3A4*33;ibuprofen;Chemical;PA166245589;Haplotype
CYP3A4*34;ibuprofen;Chemical;PA166245590;Haplotype
PTGS1;ibuprofen;Chemical;PA24346;Gene
AMACR;ibuprofen;Chemical;PA24757;Gene
NOS1;ibuprofen;Chemical;PA252;Gene
NOS3;ibuprofen;Chemical;PA254;Gene
FAAH;ibuprofen;Chemical;PA27955;Gene
PTGS2;ibuprofen;Chemical;PA293;Gene
LTA;ibuprofen;Chemical;PA30474;Gene
UGT2B4;ibuprofen;Chemical;PA360;Gene
UGT2B7;ibuprofen;Chemical;PA361;Gene
UGT1A3;ibuprofen;Chemical;PA37178;Gene
UGT2B17;ibuprofen;Chemical;PA37189;Gene
LST1;ibuprofen;Chemical;PA37856;Gene
UGT1A9;ibuprofen;Chemical;PA419;Gene
TNF;ibuprofen;Chemical;PA435;Gene
METHOTREXATE;ibuprofen;Chemical;PA450428;Chemical
PRAVASTATIN;ibuprofen;Chemical;PA451089;Chemical
CAMK1D;STAT5A;Gene;PA134992438;Gene
AKT1;STAT5A;Gene;PA24684;Gene
AKT2;STAT5A;Gene;PA24685;Gene
AKT3;STAT5A;Gene;PA24686;Gene
NFKB1;STAT5A;Gene;PA248;Gene
CAMK1;STAT5A;Gene;PA26048;Gene
CAMK1G;STAT5A;Gene;PA26049;Gene
ELK1;STAT5A;Gene;PA27749;Gene
FOS;STAT5A;Gene;PA28212;Gene
MAPK8;STAT5A;Gene;PA283;Gene
RELA;STAT5A;Gene;PA296;Gene
JAK1;STAT5A;Gene;PA29988;Gene
JUN;STAT5A;Gene;PA30006;Gene
MAPK1;STAT5A;Gene;PA30616;Gene
MAPK3;STAT5A;Gene;PA30622;Gene
MYC;STAT5A;Gene;PA31353;Gene
NFKB2;STAT5A;Gene;PA31600;Gene
STAT3;STAT5A;Gene;PA337;Gene
PRKCA;STAT5A;Gene;PA33759;Gene
PRKCB;STAT5A;Gene;PA33761;Gene
PRKCG;STAT5A;Gene;PA33766;Gene
SP1;STAT5A;Gene;PA36042;Gene
STAT1;STAT5A;Gene;PA36183;Gene
STAT2;STAT5A;Gene;PA36184;Gene
STAT4;STAT5A;Gene;PA36185;Gene
STAT5B;STAT5A;Gene;PA36186;Gene
CAMK2A;STAT5A;Gene;PA90;Gene
CAMK2B;STAT5A;Gene;PA91;Gene
CAMK2D;STAT5A;Gene;PA92;Gene
CAMK2G;STAT5A;Gene;PA93;Gene
SULFONAMIDES, UREA DERIVATIVES;rs12255372;Variant;PA10390;Chemical
DIABETES MELLITUS, TYPE 2;rs12255372;Variant;PA443890;Disease
ANTIINFLAMMATORY AGENTS, NON-STEROIDS;rs10306135;Variant;PA164712462;Chemical
ACUTE CORONARY SYNDROME;rs10306135;Variant;PA165108401;Disease
CYP2D6;Dystonia;Disease;PA128;Gene
CYP2D6*1;Dystonia;Disease;PA165816576;Haplotype
CYP2D6*3;Dystonia;Disease;PA165816578;Haplotype
CYP2D6*4;Dystonia;Disease;PA165816579;Haplotype
CYP2D6*6;Dystonia;Disease;PA165816581;Haplotype
CYP2D6*10;Dystonia;Disease;PA165816582;Haplotype
CYP2D6*41;Dystonia;Disease;PA165816584;Haplotype
CYP2D6*5;Dystonia;Disease;PA165948092;Haplotype
CYP2D6*7;Dystonia;Disease;PA165971559;Haplotype
CYP2D6*14;Dystonia;Disease;PA166181185;Haplotype
MIGALASTAT;rs104894828;Variant;PA166182881;Chemical
FABRY DISEASE;rs104894828;Variant;PA443367;Disease
CARBOCISTEINE;rs5030843;Variant;PA166184060;Chemical
L-PHENYLALANINE;rs5030843;Variant;PA450931;Chemical
CYP2A6;metronidazole;Chemical;PA121;Gene
CYP2A6*1;metronidazole;Chemical;PA165924690;Haplotype
CYP2A6*2;metronidazole;Chemical;PA165924719;Haplotype
CYP2A6*17;metronidazole;Chemical;PA165924744;Haplotype
CYP2A6*9;metronidazole;Chemical;PA165980914;Haplotype
DESFLURANE;rs193922878;Variant;PA164749136;Chemical
RYR1;rs193922878;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs193922878;Variant;PA444863;Disease
ENFLURANE;rs193922878;Variant;PA449461;Chemical
HALOTHANE;rs193922878;Variant;PA449845;Chemical
ISOFLURANE;rs193922878;Variant;PA450106;Chemical
METHOXYFLURANE;rs193922878;Variant;PA450434;Chemical
SEVOFLURANE;rs193922878;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs193922878;Variant;PA451522;Chemical
CACNA1S;rs193922878;Variant;PA85;Gene
CORONARY ARTERY DISEASE;rs13431554;Variant;PA443796;Disease
DIABETES MELLITUS, TYPE 2;rs13431554;Variant;PA443890;Disease
CLOPIDOGREL;rs13431554;Variant;PA449053;Chemical
CYP2D6;CYP2D6*2x2;Haplotype;PA128;Gene
CODEINE;CYP2D6*2x2;Haplotype;PA449088;Chemical
TOBACCO USE DISORDER;rs3743075;Variant;PA445876;Disease
NICOTINE;rs3743075;Variant;PA450626;Chemical
CYP2B6;Diarrhea;Disease;PA123;Gene
CYP3A5;Diarrhea;Disease;PA131;Gene
SLCO1B1;Diarrhea;Disease;PA134865839;Gene
IKBKE;Diarrhea;Disease;PA134962294;Gene
UGT1A1*1;Diarrhea;Disease;PA166115841;Haplotype
UGT1A1*28;Diarrhea;Disease;PA166115842;Haplotype
UGT1A1*37;Diarrhea;Disease;PA166115844;Haplotype
UGT1A1*6;Diarrhea;Disease;PA166115858;Haplotype
UGT1A7*1A;Diarrhea;Disease;PA166117636;Haplotype
UGT1A7*2;Diarrhea;Disease;PA166117638;Haplotype
UGT1A7*3;Diarrhea;Disease;PA166117639;Haplotype
CYP3A5*3;Diarrhea;Disease;PA166128219;Haplotype
RS2306283;Diarrhea;Disease;PA166154547;Variant
RS6311;Diarrhea;Disease;PA166154673;Variant
RS45445694;Diarrhea;Disease;PA166155331;Variant
RS3745274;Diarrhea;Disease;PA166155409;Variant
RS4149178;Diarrhea;Disease;PA166157095;Variant
RS2853741;Diarrhea;Disease;PA166163757;Variant
RS2151222;Diarrhea;Disease;PA166203361;Variant
RS2233406;Diarrhea;Disease;PA166203407;Variant
RS2233409;Diarrhea;Disease;PA166203409;Variant
RS2695121;Diarrhea;Disease;PA166203413;Variant
RS577001;Diarrhea;Disease;PA166203424;Variant
RS917881;Diarrhea;Disease;PA166283442;Variant
RS17682789;Diarrhea;Disease;PA166283521;Variant
RS11651488;Diarrhea;Disease;PA166283542;Variant
RS9927200;Diarrhea;Disease;PA166283544;Variant
HTR2A;Diarrhea;Disease;PA193;Gene
CDH13;Diarrhea;Disease;PA26287;Gene
CYP2A7P1;Diarrhea;Disease;PA27103;Gene
MAP2K6;Diarrhea;Disease;PA30591;Gene
TAB2;Diarrhea;Disease;PA30605;Gene
NFKBIA;Diarrhea;Disease;PA31601;Gene
NR1H2;Diarrhea;Disease;PA31750;Gene
SLC22A7;Diarrhea;Disease;PA35848;Gene
TYMS;Diarrhea;Disease;PA359;Gene
UGT1A7;Diarrhea;Disease;PA37182;Gene
WWOX;Diarrhea;Disease;PA37398;Gene
UGT1A1;Diarrhea;Disease;PA420;Gene
EGFR;Diarrhea;Disease;PA7360;Gene
HCG22;triamcinolone;Chemical;PA134876212;Gene
RS37973;triamcinolone;Chemical;PA166157244;Variant
RS2523864;triamcinolone;Chemical;PA166159310;Variant
RS3873352;triamcinolone;Chemical;PA166159319;Variant
GLCCI1;triamcinolone;Chemical;PA38657;Gene
LUTETIUM (177LU) OXODOTREOTIDE;SSTR5;Gene;PA166224981;Chemical
CYP2D6;Insomnia;Disease;PA128;Gene
CYP2D6*2;Insomnia;Disease;PA165816577;Haplotype
CYP2D6*10;Insomnia;Disease;PA165816582;Haplotype
RS762551;Insomnia;Disease;PA166154850;Variant
CYP1A2;Insomnia;Disease;PA27093;Gene
HEROIN DEPENDENCE;GAD1;Gene;PA444460;Disease
METHADONE;GAD1;Gene;PA450401;Chemical
VORICONAZOLE;CYP2C19 poor metabolizer;Variant;PA10233;Chemical
MYCOSES;CYP2C19 poor metabolizer;Variant;PA445009;Disease
DEPRESSIVE DISORDER, MAJOR;CYP2C19 poor metabolizer;Variant;PA447321;Disease
CITALOPRAM;CYP2C19 poor metabolizer;Variant;PA449015;Chemical
CYP2D6;ibrutinib;Chemical;PA128;Gene
CYP3A4;ibrutinib;Chemical;PA130;Gene
CYP3A4*1;ibrutinib;Chemical;PA165819201;Haplotype
CYP3A4*2;ibrutinib;Chemical;PA165819220;Haplotype
CYP3A4*3;ibrutinib;Chemical;PA165819221;Haplotype
CYP3A4*4;ibrutinib;Chemical;PA165819222;Haplotype
CYP3A4*5;ibrutinib;Chemical;PA165819223;Haplotype
CYP3A4*9;ibrutinib;Chemical;PA165819227;Haplotype
CYP3A4*14;ibrutinib;Chemical;PA165819232;Haplotype
CYP3A4*15;ibrutinib;Chemical;PA165819233;Haplotype
CYP3A4*16;ibrutinib;Chemical;PA165819236;Haplotype
CYP3A4*17;ibrutinib;Chemical;PA165819239;Haplotype
CYP3A4*19;ibrutinib;Chemical;PA165819243;Haplotype
CYP3A4*24;ibrutinib;Chemical;PA166115837;Haplotype
RS387907272;ibrutinib;Chemical;PA166224421;Variant
CYP3A4*28;ibrutinib;Chemical;PA166245584;Haplotype
CYP3A4*29;ibrutinib;Chemical;PA166245585;Haplotype
CYP3A4*31;ibrutinib;Chemical;PA166245587;Haplotype
CYP3A4*32;ibrutinib;Chemical;PA166245588;Haplotype
CYP3A4*34;ibrutinib;Chemical;PA166245590;Haplotype
BTK;ibrutinib;Chemical;PA25454;Gene
MYD88;ibrutinib;Chemical;PA31361;Gene
NICOTINE;rs61750900;Variant;PA450626;Chemical
OVARIAN NEOPLASMS;SOX10;Gene;PA445204;Disease
CARBOPLATIN;SOX10;Gene;PA448803;Chemical
DOCETAXEL;SOX10;Gene;PA449383;Chemical
PACLITAXEL;SOX10;Gene;PA450761;Chemical
RS1801253;dobutamine;Chemical;PA166153977;Variant
RS62205366;dobutamine;Chemical;PA166155967;Variant
GNAS;dobutamine;Chemical;PA175;Gene
ADRB1;dobutamine;Chemical;PA38;Gene
EPILEPSY;rs1934969;Variant;PA444065;Disease
LOSARTAN;rs1934969;Variant;PA450268;Chemical
PHENYTOIN;rs1934969;Variant;PA450947;Chemical
DULOXETINE;SKIC3;Gene;PA10066;Chemical
MAJOR DEPRESSIVE DISORDER;SKIC3;Gene;PA447321;Disease
DEXTROMETHORPHAN;CYP2D6*84;Haplotype;PA449273;Chemical
TICAGRELOR;CYP3A4*24;Haplotype;PA165374673;Chemical
CABOZANTINIB;CYP3A4*24;Haplotype;PA165906891;Chemical
SAXAGLIPTIN;CYP3A4*24;Haplotype;PA165958362;Chemical
VANDETANIB;CYP3A4*24;Haplotype;PA166118341;Chemical
IBRUTINIB;CYP3A4*24;Haplotype;PA166121346;Chemical
ALECTINIB;CYP3A4*24;Haplotype;PA166160050;Chemical
ACALABRUTINIB;CYP3A4*24;Haplotype;PA166198581;Chemical
MACITENTAN;CYP3A4*24;Haplotype;PA166261201;Chemical
BLONANSERIN;CYP3A4*24;Haplotype;PA166319041;Chemical
AMIODARONE;CYP3A4*24;Haplotype;PA448383;Chemical
LIDOCAINE;CYP3A4*24;Haplotype;PA450226;Chemical
METHADONE;CYP3A4*24;Haplotype;PA450401;Chemical
OXYCODONE;CYP3A4*24;Haplotype;PA450741;Chemical
SILDENAFIL;CYP3A4*24;Haplotype;PA451346;Chemical
TESTOSTERONE;CYP3A4*24;Haplotype;PA451627;Chemical
CYP2D6;terbinafine;Chemical;PA128;Gene
HLA-A*33:01;terbinafine;Chemical;PA165954144;Haplotype
HLA-A;terbinafine;Chemical;PA35055;Gene
NR1I2;terbinafine;Chemical;PA378;Gene
LONG QT SYNDROME;rs10919035;Variant;PA444807;Disease
AMIODARONE;rs10919035;Variant;PA448383;Chemical
HYPERTENSION;rs16872401;Variant;PA444552;Disease
ATENOLOL;rs16872401;Variant;PA448499;Chemical
MS4A1;afutuzumab;Chemical;PA31111;Gene
SHC3;RAF1;Gene;PA134913435;Gene
SHC2;RAF1;Gene;PA134971076;Gene
CSK;RAF1;Gene;PA26946;Gene
MAP2K7;RAF1;Gene;PA284;Gene
GRB2;RAF1;Gene;PA28962;Gene
HRAS;RAF1;Gene;PA29444;Gene
KRAS;RAF1;Gene;PA30196;Gene
MAP2K1;RAF1;Gene;PA30584;Gene
MAP2K2;RAF1;Gene;PA30587;Gene
MAP2K3;RAF1;Gene;PA30588;Gene
MAP2K4;RAF1;Gene;PA30589;Gene
MAP2K5;RAF1;Gene;PA30590;Gene
MAP2K6;RAF1;Gene;PA30591;Gene
MRAS;RAF1;Gene;PA30932;Gene
NRAS;RAF1;Gene;PA31768;Gene
PRKCA;RAF1;Gene;PA33759;Gene
PRKCB;RAF1;Gene;PA33761;Gene
PRKCD;RAF1;Gene;PA33763;Gene
PRKCE;RAF1;Gene;PA33765;Gene
PRKCG;RAF1;Gene;PA33766;Gene
PRKCH;RAF1;Gene;PA33767;Gene
PRKCI;RAF1;Gene;PA33768;Gene
PRKCQ;RAF1;Gene;PA33773;Gene
PRKCZ;RAF1;Gene;PA33775;Gene
RRAS;RAF1;Gene;PA34861;Gene
SHC1;RAF1;Gene;PA35746;Gene
SOS1;RAF1;Gene;PA36024;Gene
NON-SMALL CELL LUNG CARCINOMA;RAF1;Gene;PA443622;Disease
CARBOPLATIN;RAF1;Gene;PA448803;Chemical
CISPLATIN;RAF1;Gene;PA449014;Chemical
DOCETAXEL;RAF1;Gene;PA449383;Chemical
GEMCITABINE;RAF1;Gene;PA449748;Chemical
PACLITAXEL;RAF1;Gene;PA450761;Chemical
SORAFENIB;RAF1;Gene;PA7000;Chemical
RHEUMATOID ARTHRITIS;rs16853826;Variant;PA443434;Disease
METHOTREXATE;rs16853826;Variant;PA450428;Chemical
SEVERE CUTANEOUS ADVERSE REACTIONS;rs3815087;Variant;PA166120929;Disease
EPIDERMAL NECROLYSIS, TOXIC;rs3815087;Variant;PA444059;Disease
STEVENS-JOHNSON SYNDROME;rs3815087;Variant;PA445738;Disease
ALLOPURINOL;rs3815087;Variant;PA448320;Chemical
ALDH1A1;aldophosphamide;Chemical;PA24692;Gene
SULFAMETHOXAZOLE / TRIMETHOPRIM;rs1799931;Variant;PA10715;Chemical
DRUG INTERACTION WITH DRUG;rs1799931;Variant;PA165108622;Disease
ADVERSE EVENTS;rs1799931;Variant;PA166151827;Disease
DRUG TOXICITY;rs1799931;Variant;PA443937;Disease
HYPERSENSITIVITY;rs1799931;Variant;PA444546;Disease
PROSTATIC NEOPLASMS;rs1799931;Variant;PA445425;Disease
DOCETAXEL;rs1799931;Variant;PA449383;Chemical
ISONIAZID;rs1799931;Variant;PA450112;Chemical
PHENYTOIN;rs1799931;Variant;PA450947;Chemical
THALIDOMIDE;rs1799931;Variant;PA451644;Chemical
PLATINUM COMPOUNDS;rs36080650;Variant;PA164713176;Chemical
RADIOTHERAPY;rs36080650;Variant;PA166122986;Chemical
NASOPHARYNGEAL NEOPLASMS;rs36080650;Variant;PA445046;Disease
METHADONE;rs797397;Variant;PA450401;Chemical
CYP2D6;Postoperative Nausea and Vomiting;Disease;PA128;Gene
CYP2D6*1;Postoperative Nausea and Vomiting;Disease;PA165816576;Haplotype
CYP2D6*1XN;Postoperative Nausea and Vomiting;Disease;PA165988479;Haplotype
RS324420;Postoperative Nausea and Vomiting;Disease;PA166153569;Variant
RS1799971;Postoperative Nausea and Vomiting;Disease;PA166156991;Variant
RS1045642;Postoperative Nausea and Vomiting;Disease;PA166157284;Variant
RS2032582;Postoperative Nausea and Vomiting;Disease;PA166157316;Variant
ABCB1;Postoperative Nausea and Vomiting;Disease;PA267;Gene
FAAH;Postoperative Nausea and Vomiting;Disease;PA27955;Gene
OPRM1;Postoperative Nausea and Vomiting;Disease;PA31945;Gene
HEROIN DEPENDENCE;rs1386493;Variant;PA444460;Disease
METHADONE;rs1386493;Variant;PA450401;Chemical
VARENICLINE;rs2036527;Variant;PA164781343;Chemical
TOBACCO USE DISORDER;rs2036527;Variant;PA445876;Disease
BUPROPION;rs2036527;Variant;PA448687;Chemical
NICOTINE;rs2036527;Variant;PA450626;Chemical
NUDT15;rs116855232;Variant;PA134963132;Gene
MYELOSUPPRESSION;rs116855232;Variant;PA165817398;Disease
TPMT;rs116855232;Variant;PA356;Gene
PANCYTOPENIA;rs116855232;Variant;PA445221;Disease
THROMBOCYTOPENIA;rs116855232;Variant;PA445846;Disease
INFLAMMATORY BOWEL DISEASES;rs116855232;Variant;PA446116;Disease
AZATHIOPRINE;rs116855232;Variant;PA448515;Chemical
MERCAPTOPURINE;rs116855232;Variant;PA450379;Chemical
THIOGUANINE;rs116855232;Variant;PA451663;Chemical
OVARIAN NEOPLASMS;MAD1L1;Gene;PA445204;Disease
CARBOPLATIN;MAD1L1;Gene;PA448803;Chemical
PACLITAXEL;MAD1L1;Gene;PA450761;Chemical
HMG COA REDUCTASE INHIBITORS;SLC15A1;Gene;PA133950441;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs870995;Variant;PA443622;Disease
DOCETAXEL;rs870995;Variant;PA449383;Chemical
NON-SMALL CELL LUNG CARCINOMA;rs10885;Variant;PA443622;Disease
THROMBOCYTOPENIA;rs10885;Variant;PA445846;Disease
CARBOPLATIN;rs10885;Variant;PA448803;Chemical
GEMCITABINE;rs10885;Variant;PA449748;Chemical
DESFLURANE;rs193922807;Variant;PA164749136;Chemical
RYR1;rs193922807;Variant;PA34896;Gene
MALIGNANT HYPERTHERMIA;rs193922807;Variant;PA444863;Disease
ENFLURANE;rs193922807;Variant;PA449461;Chemical
HALOTHANE;rs193922807;Variant;PA449845;Chemical
ISOFLURANE;rs193922807;Variant;PA450106;Chemical
METHOXYFLURANE;rs193922807;Variant;PA450434;Chemical
SEVOFLURANE;rs193922807;Variant;PA451341;Chemical
SUCCINYLCHOLINE;rs193922807;Variant;PA451522;Chemical
CACNA1S;rs193922807;Variant;PA85;Gene
ILOPERIDONE;rs4933824;Variant;PA161199368;Chemical
ACQUIRED LONG QT SYNDROME (ALQTS);rs4933824;Variant;PA447300;Disease
GEFITINIB;rs2053071;Variant;PA131301952;Chemical
TOXIC LIVER DISEASE;rs2053071;Variant;PA164925725;Disease
BIPOLAR DISORDER;rs78015114;Variant;PA447199;Disease
LITHIUM;rs78015114;Variant;PA450243;Chemical
RASBURICASE;G6PD B (reference);Haplotype;PA10176;Chemical
SULFAMETHOXAZOLE / TRIMETHOPRIM;G6PD B (reference);Haplotype;PA10715;Chemical
PHENAZOPYRIDINE;G6PD B (reference);Haplotype;PA164746899;Chemical
SULFAMETOPYRAZINE;G6PD B (reference);Haplotype;PA164747038;Chemical
DIMERCAPROL;G6PD B (reference);Haplotype;PA165958406;Chemical
LEAD POISONING, NERVOUS SYSTEM, CHILDHOOD;G6PD B (reference);Haplotype;PA166048926;Disease
ANEMIA, HEMOLYTIC;G6PD B (reference);Haplotype;PA443343;Disease
HEMOLYSIS;G6PD B (reference);Haplotype;PA444411;Disease
MALARIA;G6PD B (reference);Haplotype;PA444859;Disease
METHEMOGLOBINEMIA;G6PD B (reference);Haplotype;PA444942;Disease
PROTEIN DEFICIENCY;G6PD B (reference);Haplotype;PA445428;Disease
ASPIRIN;G6PD B (reference);Haplotype;PA448497;Chemical
CHLORAMPHENICOL;G6PD B (reference);Haplotype;PA448927;Chemical
CHLOROQUINE;G6PD B (reference);Haplotype;PA448948;Chemical
CIPROFLOXACIN;G6PD B (reference);Haplotype;PA449009;Chemical
GLYBURIDE;G6PD B (reference);Haplotype;PA449782;Chemical
MEFLOQUINE;G6PD B (reference);Haplotype;PA450348;Chemical
METHYLENE BLUE;G6PD B (reference);Haplotype;PA450457;Chemical
NITROFURANTOIN;G6PD B (reference);Haplotype;PA450640;Chemical
PRIMAQUINE;G6PD B (reference);Haplotype;PA451103;Chemical
SULFADOXINE;G6PD B (reference);Haplotype;PA451540;Chemical
SULFAMETHOXAZOLE;G6PD B (reference);Haplotype;PA451544;Chemical
SULFASALAZINE;G6PD B (reference);Haplotype;PA451547;Chemical
SALICYLAMIDE;rs9933632;Variant;PA165958416;Chemical
LOXOPROFEN;rs9933632;Variant;PA166049180;Chemical
ACETAMINOPHEN;rs9933632;Variant;PA448015;Chemical
IBUPROFEN;rs9933632;Variant;PA449957;Chemical
PROPAFENONE;rs28371725;Variant;PA451131;Chemical
NEOPLASMS;rs9937;Variant;PA445062;Disease
GEMCITABINE;rs9937;Variant;PA449748;Chemical
CORONARY DISEASE;rs3785161;Variant;PA443797;Disease
CLOPIDOGREL;rs3785161;Variant;PA449053;Chemical
PRASUGREL;PEAR1;Gene;PA154410481;Chemical
TICAGRELOR;PEAR1;Gene;PA165374673;Chemical
MYOCARDIAL INFARCTION;PEAR1;Gene;PA445019;Disease
ASPIRIN;PEAR1;Gene;PA448497;Chemical
CLOPIDOGREL;PEAR1;Gene;PA449053;Chemical
ANTIHYPERTENSIVES;rs324498;Variant;PA164712445;Chemical
HYPERTENSION;rs324498;Variant;PA444552;Disease
SCHIZOPHRENIA;GABRG3;Gene;PA447216;Disease
ANTIPSYCHOTICS;GABRG3;Gene;PA452233;Chemical
ACENOCOUMAROL;rs17878544;Variant;PA452632;Chemical
GASTROINTESTINAL HEMORRHAGE;HGFAC;Gene;PA444418;Disease
CYP3A4;laparoscopic sleeve gastrectomy;Disease;PA130;Gene
CYP3A5;laparoscopic sleeve gastrectomy;Disease;PA131;Gene
CYP3A4*1;laparoscopic sleeve gastrectomy;Disease;PA165819201;Haplotype
CYP3A4*18;laparoscopic sleeve gastrectomy;Disease;PA165819240;Haplotype
CYP3A4*20;laparoscopic sleeve gastrectomy;Disease;PA165819244;Haplotype
CYP3A4*22;laparoscopic sleeve gastrectomy;Disease;PA166048680;Haplotype
CYP3A5*1;laparoscopic sleeve gastrectomy;Disease;PA166128213;Haplotype
CYP3A5*3;laparoscopic sleeve gastrectomy;Disease;PA166128219;Haplotype
CYP2C19;Major Adverse Cardiac Events (MACE);Disease;PA124;Gene
WDR24;Major Adverse Cardiac Events (MACE);Disease;PA134918496;Gene
KRTAP10-4;Major Adverse Cardiac Events (MACE);Disease;PA134942730;Gene
P2RY12;Major Adverse Cardiac Events (MACE);Disease;PA134971947;Gene
EFR3A;Major Adverse Cardiac Events (MACE);Disease;PA162384422;Gene
JMJD8;Major Adverse Cardiac Events (MACE);Disease;PA162392531;Gene
N6AMT1;Major Adverse Cardiac Events (MACE);Disease;PA162396656;Gene
NECAB1;Major Adverse Cardiac Events (MACE);Disease;PA162397411;Gene
CYP2C19*17;Major Adverse Cardiac Events (MACE);Disease;PA165816533;Haplotype
CYP2C19*1;Major Adverse Cardiac Events (MACE);Disease;PA165980634;Haplotype
CYP2C19*2;Major Adverse Cardiac Events (MACE);Disease;PA165980635;Haplotype
CYP2C19*3;Major Adverse Cardiac Events (MACE);Disease;PA165980636;Haplotype
RS1801252;Major Adverse Cardiac Events (MACE);Disease;PA166153976;Variant
RS2046934;Major Adverse Cardiac Events (MACE);Disease;PA166156339;Variant
CYP2C19 POOR METABOLIZER AND INTERMEDIATE METABOLIZER GENOTYPES;Major Adverse Cardiac Events (MACE);Disease;PA166157960;Variant
RS1330344;Major Adverse Cardiac Events (MACE);Disease;PA166159656;Variant
RS2254638;Major Adverse Cardiac Events (MACE);Disease;PA166164927;Variant
RS11640115;Major Adverse Cardiac Events (MACE);Disease;PA166268441;Variant
RS74569896;Major Adverse Cardiac Events (MACE);Disease;PA166268442;Variant
RS4736529;Major Adverse Cardiac Events (MACE);Disease;PA166268443;Variant
RS75750968;Major Adverse Cardiac Events (MACE);Disease;PA166268444;Variant
RS3749187;Major Adverse Cardiac Events (MACE);Disease;PA166268445;Variant
RS140410716;Major Adverse Cardiac Events (MACE);Disease;PA166268446;Variant
RS201441480;Major Adverse Cardiac Events (MACE);Disease;PA166268447;Variant
RS17064642;Major Adverse Cardiac Events (MACE);Disease;PA166268981;Variant
PTGS1;Major Adverse Cardiac Events (MACE);Disease;PA24346;Gene
TSPEAR;Major Adverse Cardiac Events (MACE);Disease;PA25824;Gene
AGAP3;Major Adverse Cardiac Events (MACE);Disease;PA26413;Gene
ECHS1;Major Adverse Cardiac Events (MACE);Disease;PA27597;Gene
MYOM2;Major Adverse Cardiac Events (MACE);Disease;PA31419;Gene
ADRB1;Major Adverse Cardiac Events (MACE);Disease;PA38;Gene
ZDHHC3;Major Adverse Cardiac Events (MACE);Disease;PA38544;Gene
GSTM1 NULL;streptomycin;Chemical;PA166048675;Haplotype
GSTM1 NON-NULL;streptomycin;Chemical;PA166048676;Haplotype
GSTT1 NULL;streptomycin;Chemical;PA166048678;Haplotype
GSTT1 NON-NULL;streptomycin;Chemical;PA166048679;Haplotype
RS267606618;streptomycin;Chemical;PA166158908;Variant
RS267606619;streptomycin;Chemical;PA166158909;Variant
RS28358569;streptomycin;Chemical;PA166158910;Variant
RS267606617;streptomycin;Chemical;PA166159181;Variant
RS28358571;streptomycin;Chemical;PA166229161;Variant
RS1556422499;streptomycin;Chemical;PA166241841;Variant
GSTM1;streptomycin;Chemical;PA182;Gene
GSTT1;streptomycin;Chemical;PA183;Gene
MT-RNR1;streptomycin;Chemical;PA31274;Gene
CFTR;rs77902683;Variant;PA109;Gene
IVACAFTOR;rs77902683;Variant;PA165950341;Chemical
COMT;fentanyl;Chemical;PA117;Gene
CYP2D6;fentanyl;Chemical;PA128;Gene
CYP3A4;fentanyl;Chemical;PA130;Gene
CYP3A5;fentanyl;Chemical;PA131;Gene
RHBDF2;fentanyl;Chemical;PA134980674;Gene
CYP2D6*1;fentanyl;Chemical;PA165816576;Haplotype
CYP2D6*10;fentanyl;Chemical;PA165816582;Haplotype
CYP3A4*1;fentanyl;Chemical;PA165819201;Haplotype
CYP3A4*3;fentanyl;Chemical;PA165819221;Haplotype
CYP3A4*18;fentanyl;Chemical;PA165819240;Haplotype
CYP3A4*20;fentanyl;Chemical;PA165819244;Haplotype
CYP2D6*9;fentanyl;Chemical;PA165948317;Haplotype
CYP2D6*29;fentanyl;Chemical;PA165948318;Haplotype
CYP3A4*22;fentanyl;Chemical;PA166048680;Haplotype
CYP3A5*1;fentanyl;Chemical;PA166128213;Haplotype
CYP3A5*3;fentanyl;Chemical;PA166128219;Haplotype
CYP3A5*6;fentanyl;Chemical;PA166128233;Haplotype
RS3845446;fentanyl;Chemical;PA166153757;Variant
RS1045280;fentanyl;Chemical;PA166155174;Variant
RS12948783;fentanyl;Chemical;PA166155254;Variant
RS2952768;fentanyl;Chemical;PA166155692;Variant
RS2835859;fentanyl;Chemical;PA166156003;Variant
RS4680;fentanyl;Chemical;PA166156024;Variant
RS7439366;fentanyl;Chemical;PA166156619;Variant
RS11959113;fentanyl;Chemical;PA166156872;Variant
RS1799971;fentanyl;Chemical;PA166156991;Variant
RS1045642;fentanyl;Chemical;PA166157284;Variant
RS1128503;fentanyl;Chemical;PA166157288;Variant
RS2032582;fentanyl;Chemical;PA166157316;Variant
RS2242480;fentanyl;Chemical;PA166157345;Variant
RS2740574;fentanyl;Chemical;PA166157367;Variant
RS1042718;fentanyl;Chemical;PA166160473;Variant
RS2234918;fentanyl;Chemical;PA166175997;Variant
RS6853;fentanyl;Chemical;PA166176305;Variant
RS540825;fentanyl;Chemical;PA166178596;Variant
RS4587017;fentanyl;Chemical;PA166180080;Variant
RS10028494;fentanyl;Chemical;PA166180083;Variant
RS7583431;fentanyl;Chemical;PA166180145;Variant
RS9397685;fentanyl;Chemical;PA166180172;Variant
RS13093031;fentanyl;Chemical;PA166180183;Variant
RS6961071;fentanyl;Chemical;PA166180184;Variant
RS1718125;fentanyl;Chemical;PA166184626;Variant
RS145837941;fentanyl;Chemical;PA166196166;Variant
RS79910351;fentanyl;Chemical;PA166231401;Variant
RS958804;fentanyl;Chemical;PA166254981;Variant
RS7858836;fentanyl;Chemical;PA166254982;Variant
ASTN2;fentanyl;Chemical;PA25076;Gene
ATF2;fentanyl;Chemical;PA25084;Gene
CACNA1E;fentanyl;Chemical;PA26009;Gene
CALCA;fentanyl;Chemical;PA26029;Gene
ABCB1;fentanyl;Chemical;PA267;Gene
KCNJ6;fentanyl;Chemical;PA30049;Gene
MYD88;fentanyl;Chemical;PA31361;Gene
OPRD1;fentanyl;Chemical;PA31942;Gene
OPRM1;fentanyl;Chemical;PA31945;Gene
P2RX7;fentanyl;Chemical;PA32866;Gene
UGT2B7;fentanyl;Chemical;PA361;Gene
ADRB2;fentanyl;Chemical;PA39;Gene
ARRB2;fentanyl;Chemical;PA60;Gene
ALZHEIMER DISEASE;IGHV1-67;Gene;PA443319;Disease
CYP2C19;Gastroesophageal Reflux;Disease;PA124;Gene
CYP2C19*8;Gastroesophageal Reflux;Disease;PA165816524;Haplotype
CYP2C19*9;Gastroesophageal Reflux;Disease;PA165816525;Haplotype
CYP2C19*10;Gastroesophageal Reflux;Disease;PA165816526;Haplotype
CYP2C19*17;Gastroesophageal Reflux;Disease;PA165816533;Haplotype
CYP2C19*24;Gastroesophageal Reflux;Disease;PA165816538;Haplotype
CYP2C19*26;Gastroesophageal Reflux;Disease;PA165816540;Haplotype
CYP2C19*1;Gastroesophageal Reflux;Disease;PA165980634;Haplotype
CYP2C19*2;Gastroesophageal Reflux;Disease;PA165980635;Haplotype
CYP2C19*3;Gastroesophageal Reflux;Disease;PA165980636;Haplotype
RS1045642;Gastroesophageal Reflux;Disease;PA166157284;Variant
ABCB1;Gastroesophageal Reflux;Disease;PA267;Gene
CORONARY ARTERY DISEASE;rs6809699;Variant;PA443796;Disease
CLOPIDOGREL;rs6809699;Variant;PA449053;Chemical
PEGINTERFERON ALFA-2B;HLA-C*02:02;Haplotype;PA164784024;Chemical
HEPATITIS C;HLA-C*02:02;Haplotype;PA444445;Disease
RIBAVIRIN;HLA-C*02:02;Haplotype;PA451241;Chemical
RS8832;pitrakinra;Chemical;PA166154978;Variant
RS1029489;pitrakinra;Chemical;PA166155004;Variant
RS1110470;pitrakinra;Chemical;PA166155008;Variant
RS1805010;pitrakinra;Chemical;PA166155022;Variant
RS2239347;pitrakinra;Chemical;PA166155035;Variant
RS3024530;pitrakinra;Chemical;PA166155046;Variant
IL4R;pitrakinra;Chemical;PA29832;Gene
MYCOPHENOLIC ACID;CES1;Gene;PA164748728;Chemical
ACUTE CORONARY SYNDROME;CES1;Gene;PA165108401;Disease
DABIGATRAN;CES1;Gene;PA165110351;Chemical
SN-38;CES1;Gene;PA165110775;Chemical
2-OXO-CLOPIDOGREL;CES1;Gene;PA166131290;Chemical
SACUBITRIL;CES1;Gene;PA166131580;Chemical
REMIMAZOLAM;CES1;Gene;PA166321761;Chemical
ATRIAL FIBRILLATION;CES1;Gene;PA443459;Disease
TRANSIENT ISCHEMIC ATTACK;CES1;Gene;PA443672;Disease
CEREBROVASCULAR DISORDERS;CES1;Gene;PA443678;Disease
DRUG TOXICITY;CES1;Gene;PA443937;Disease
STROKE;CES1;Gene;PA447054;Disease
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;CES1;Gene;PA447197;Disease
CAPECITABINE;CES1;Gene;PA448771;Chemical
CLOPIDOGREL;CES1;Gene;PA449053;Chemical
ENALAPRIL;CES1;Gene;PA449456;Chemical
IRINOTECAN;CES1;Gene;PA450085;Chemical
METHYLPHENIDATE;CES1;Gene;PA450464;Chemical
MYCOPHENOLATE MOFETIL;CES1;Gene;PA450566;Chemical
OSELTAMIVIR;CES1;Gene;PA450721;Chemical
TRANDOLAPRIL;CES1;Gene;PA451737;Chemical
HEROIN;CES1;Gene;PA452619;Chemical
ENZYMES;F12;Gene;PA164712734;Chemical
STROKE;F12;Gene;PA447054;Disease
ELF2;SLC9A3P1;Gene;PA27745;Gene
BSND;CLCNKA;Gene;PA134911659;Gene
ACUTE CORONARY SYNDROME;rs62471956;Variant;PA165108401;Disease
TICAGRELOR;rs62471956;Variant;PA165374673;Chemical
FLUOROURACIL;rs575853463;Variant;PA128406956;Chemical
DRUG TOXICITY;rs575853463;Variant;PA443937;Disease
LUTETIUM (177LU) OXODOTREOTIDE;SSTR1;Gene;PA166224981;Chemical
CYP2C19;hematopoietic stem cell transplantation;Disease;PA124;Gene
CYP2C9;hematopoietic stem cell transplantation;Disease;PA126;Gene
CYP3A5;hematopoietic stem cell transplantation;Disease;PA131;Gene
NUDT15;hematopoietic stem cell transplantation;Disease;PA134963132;Gene
CYP2C19*2;hematopoietic stem cell transplantation;Disease;PA165980635;Haplotype
GSTM1 NULL;hematopoietic stem cell transplantation;Disease;PA166048675;Haplotype
GSTM1 NON-NULL;hematopoietic stem cell transplantation;Disease;PA166048676;Haplotype
GSTT1 NULL;hematopoietic stem cell transplantation;Disease;PA166048678;Haplotype
GSTT1 NON-NULL;hematopoietic stem cell transplantation;Disease;PA166048679;Haplotype
CYP3A5*1;hematopoietic stem cell transplantation;Disease;PA166128213;Haplotype
CYP3A5*3;hematopoietic stem cell transplantation;Disease;PA166128219;Haplotype
CYP3A5*6;hematopoietic stem cell transplantation;Disease;PA166128233;Haplotype
CYP3A5*7;hematopoietic stem cell transplantation;Disease;PA166128234;Haplotype
NUDT15*1;hematopoietic stem cell transplantation;Disease;PA166131619;Haplotype
NUDT15*2;hematopoietic stem cell transplantation;Disease;PA166131620;Haplotype
NUDT15*3;hematopoietic stem cell transplantation;Disease;PA166131621;Haplotype
NUDT15*4;hematopoietic stem cell transplantation;Disease;PA166131622;Haplotype
NUDT15*5;hematopoietic stem cell transplantation;Disease;PA166131623;Haplotype
RS1799853;hematopoietic stem cell transplantation;Disease;PA166153972;Variant
RS12248560;hematopoietic stem cell transplantation;Disease;PA166154147;Variant
RS1128503;hematopoietic stem cell transplantation;Disease;PA166157288;Variant
RS2032582;hematopoietic stem cell transplantation;Disease;PA166157316;Variant
RS1021737;hematopoietic stem cell transplantation;Disease;PA166161880;Variant
RS11280056;hematopoietic stem cell transplantation;Disease;PA166180936;Variant
GSTM1;hematopoietic stem cell transplantation;Disease;PA182;Gene
GSTT1;hematopoietic stem cell transplantation;Disease;PA183;Gene
ABCB1;hematopoietic stem cell transplantation;Disease;PA267;Gene
CTH;hematopoietic stem cell transplantation;Disease;PA27004;Gene
TYMS;hematopoietic stem cell transplantation;Disease;PA359;Gene
MENTAL DISORDERS;rs1176744;Variant;PA447208;Disease
PAROXETINE;rs1176744;Variant;PA450801;Chemical
TENOFOVIR;rs717620;Variant;PA10204;Chemical
ATAZANAVIR;rs717620;Variant;PA10251;Chemical
FLUOROURACIL;rs717620;Variant;PA128406956;Chemical
OXALIPLATIN;rs717620;Variant;PA131285527;Chemical
PITAVASTATIN;rs717620;Variant;PA142650384;Chemical
ANTIEPILEPTICS;rs717620;Variant;PA143485705;Chemical
MYCOPHENOLIC ACID;rs717620;Variant;PA164748728;Chemical
DEFERASIROX;rs717620;Variant;PA164760843;Chemical
KIDNEY TRANSPLANTATION;rs717620;Variant;PA165817016;Disease
BREAST NEOPLASMS;rs717620;Variant;PA443560;Disease
COLONIC NEOPLASMS;rs717620;Variant;PA443756;Disease
EPILEPSY;rs717620;Variant;PA444065;Disease
EXANTHEMA;rs717620;Variant;PA444109;Disease
HYPERCHOLESTEROLEMIA;rs717620;Variant;PA444516;Disease
LEUKEMIA;rs717620;Variant;PA444750;Disease
LYMPHOID LEUKEMIA;rs717620;Variant;PA444756;Disease
LYMPHOMA;rs717620;Variant;PA444840;Disease
OSTEOSARCOMA;rs717620;Variant;PA445601;Disease
COLORECTAL NEOPLASMS;rs717620;Variant;PA446108;Disease
ACUTE LYMPHOBLASTIC LEUKEMIA;rs717620;Variant;PA446155;Disease
BETA-THALASSEMIA AND RELATED DISEASES;rs717620;Variant;PA446432;Disease
HIV INFECTIOUS DISEASE;rs717620;Variant;PA447230;Disease
ATORVASTATIN;rs717620;Variant;PA448500;Chemical
CISPLATIN;rs717620;Variant;PA449014;Chemical
DOXORUBICIN;rs717620;Variant;PA449412;Chemical
EFAVIRENZ;rs717620;Variant;PA449441;Chemical
ERYTHROMYCIN;rs717620;Variant;PA449493;Chemical
LEUCOVORIN;rs717620;Variant;PA450198;Chemical
LOPINAVIR;rs717620;Variant;PA450264;Chemical
METHOTREXATE;rs717620;Variant;PA450428;Chemical
RITONAVIR;rs717620;Variant;PA451260;Chemical
SIMVASTATIN;rs717620;Variant;PA451363;Chemical
TACROLIMUS;rs717620;Variant;PA451578;Chemical
TAMOXIFEN;rs717620;Variant;PA451581;Chemical
SORAFENIB;rs717620;Variant;PA7000;Chemical
CFTR;rs397508442;Variant;PA109;Gene
IVACAFTOR;rs397508442;Variant;PA165950341;Chemical
IVACAFTOR / TEZACAFTOR;rs397508442;Variant;PA166179845;Chemical
ELEXACAFTOR / TEZACAFTOR / IVACAFTOR;rs397508442;Variant;PA166190041;Chemical
VANZACAFTOR / TEZACAFTOR / DEUTIVACAFTOR;rs397508442;Variant;PA166362502;Chemical
CYSTIC FIBROSIS;rs397508442;Variant;PA443829;Disease
RHEUMATOID ARTHRITIS;rs6506569;Variant;PA443434;Disease
METHOTREXATE;rs6506569;Variant;PA450428;Chemical
